{"meta":{"query_hash":"606793aed8c0","filters":{"venue":"Clinical Cancer Research"},"cohort_total":2205,"direct_labels_cover":5,"predictions_cover":2205,"exported":2205,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/606793aed8c0","api":"https://metacan.xera.ac/api/v1/cohort?venue=Clinical+Cancer+Research"},"results":[{"id":"W1277142619","doi":"","title":"Targeting Y-box binding protein-1 (YB-1) in Her-2 over-expressing breast cancer cells induces apoptosis via the signal transducer and activator or transcription-3 (STAT3) pathway and suppresses tumor growth.","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"STAT3; Cancer research; Apoptosis; Carcinogenesis; STAT protein; Breast cancer; Biology; Cancer; Medicine; Chemistry; Molecular biology; Internal medicine","score_opus":0.08824881387887633,"score_gpt":0.38541249517700965,"score_spread":0.2971636812981333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1277142619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98813254,0.0060981167,0.0014253791,0.00034354485,0.00010296992,0.00006589817,0.00061556086,0.00017784041,0.0030381824],"genre_scores_gemma":[0.98241043,0.0049488638,0.0023318096,0.00015016885,0.00002202804,0.00007201209,0.0011483842,0.000023002689,0.008893342],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999027,0.000010898953,0.000007684551,0.000015468277,0.000030347112,0.00003292568],"domain_scores_gemma":[0.99997365,0.000004167518,0.0000086595755,0.0000026498135,0.0000030848237,0.000007708364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012798622,0.00025992014,0.00027895495,0.00016338399,0.00014098239,0.00023732394,0.00013486964,0.00020137632,0.0016972835],"category_scores_gemma":[0.00003702609,0.000155966,0.0002072409,0.00016953598,0.00017335462,0.00010936822,0.0001363653,0.0005979548,0.00049825583],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017979424,0.000055141183,0.00012331284,0.00004578476,0.0000066944644,0.000028534201,0.00000855729,0.000045482957,0.9969024,0.000056576977,0.0002580016,0.0022896347],"study_design_scores_gemma":[0.000092081405,0.0010503599,0.005124892,0.000008429096,0.000023282559,0.00025266942,0.000022705599,0.000856618,0.98597604,0.00004392294,0.006544846,0.0000042378047],"about_ca_topic_score_codex":0.00068933755,"about_ca_topic_score_gemma":0.0028453628,"teacher_disagreement_score":0.0016972835,"about_ca_system_score_codex":0.00035672466,"about_ca_system_score_gemma":0.00028582706,"threshold_uncertainty_score":0.0056779385},"labels":[],"label_agreement":null},{"id":"W1483638371","doi":"","title":"Detection of JAK2 V617F mutation in patients with myeloproliferative disorders using real-time PCR","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Biology; Essential thrombocythemia; Point mutation; ABL; Polycythemia vera; Mutation; Chronic myelogenous leukemia; Allele; Leukemia; Cancer research; Molecular biology; Genetics; Immunology; Gene; Tyrosine kinase","score_opus":0.07058238119344454,"score_gpt":0.4381847314717254,"score_spread":0.3676023502782808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1483638371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98598,0.0033499277,0.0069519207,0.00021479535,0.000063119674,0.00011473902,0.00068534684,0.0002494373,0.0023906904],"genre_scores_gemma":[0.9894226,0.0006766829,0.008333998,0.00017016113,0.00004849065,0.00012357901,0.00061827345,0.000020297903,0.0005858244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886924,0.000280368,0.0001514689,0.00023825586,0.00034593564,0.0001147843],"domain_scores_gemma":[0.99866724,0.00064945844,0.00031973075,0.000075513715,0.00020197229,0.000086006774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010848576,0.00051793875,0.00033932622,0.0021345487,0.00018099617,0.0008038338,0.0003280265,0.0006572846,0.0013255122],"category_scores_gemma":[0.002376769,0.00022917478,0.0001695502,0.0007542148,0.0003187523,0.00033149568,0.00022597995,0.00040610152,0.0005366727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015426785,0.0003751491,0.63140917,0.0003002624,0.00008464462,0.005677376,0.0011662118,0.0006407611,0.28969863,0.0005682741,0.0013552286,0.0671816],"study_design_scores_gemma":[0.00023601958,0.0025633397,0.67458475,0.0002443016,0.00020511223,0.04785819,0.0011869315,0.023302166,0.2283495,0.0015454162,0.019805059,0.00011923915],"about_ca_topic_score_codex":0.00015357118,"about_ca_topic_score_gemma":0.00015031078,"teacher_disagreement_score":0.0021345487,"about_ca_system_score_codex":0.00016529066,"about_ca_system_score_gemma":0.00011668678,"threshold_uncertainty_score":0.0057373643},"labels":[],"label_agreement":null},{"id":"W1486569912","doi":"","title":"17-allylamino-17-demethoxygeldanamycin disrupts SYT-SSX-β-catenin interaction in synovial sarcoma","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Pathogenesis; Catenin; Synovial sarcoma; Cancer research; Wnt signaling pathway; Transcription factor; Biology; Cell culture; Endogeny; Chromosomal translocation; Cell biology; Chemistry; Medicine; Signal transduction; Immunology; Sarcoma; Endocrinology; Pathology; Genetics; Gene","score_opus":0.1473770414746732,"score_gpt":0.5176270601803885,"score_spread":0.3702500187057153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1486569912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978434,0.0010326363,0.0004517692,0.000031061416,0.000012860026,0.000012175489,0.000090844434,0.000022367898,0.00050285005],"genre_scores_gemma":[0.99808455,0.00049179746,0.00044712974,0.0000161758,0.0000026345995,0.000011566563,0.000192468,0.0000058736805,0.0007477556],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999149,0.00001736155,0.000011088251,0.000011742226,0.000023844193,0.000021083564],"domain_scores_gemma":[0.9999398,0.00001285708,0.00001670289,0.0000064152287,0.0000053024073,0.000019029587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000111940055,0.0002207465,0.0002413936,0.00016543557,0.000096240066,0.00012727232,0.00011167151,0.00015993069,0.001007774],"category_scores_gemma":[0.00009473694,0.00009873607,0.00021161078,0.00011275264,0.000115249335,0.0001011363,0.00011370289,0.00026857143,0.00029216646],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079348676,0.000027355616,0.00016384342,0.00001853581,0.000006111983,0.000029272065,0.000009089501,0.000100633144,0.99888414,0.000022618728,0.000016623966,0.0006425077],"study_design_scores_gemma":[0.000022255403,0.0011496919,0.0046619214,0.000004175645,0.000014388804,0.0002648633,0.000024749163,0.0009429459,0.991364,0.000022874001,0.0015249668,0.0000031112984],"about_ca_topic_score_codex":0.0009587283,"about_ca_topic_score_gemma":0.001237796,"teacher_disagreement_score":0.001007774,"about_ca_system_score_codex":0.00019365379,"about_ca_system_score_gemma":0.00018663426,"threshold_uncertainty_score":0.0033712983},"labels":[],"label_agreement":null},{"id":"W1497876949","doi":"","title":"Hsp90 and histone deactylase inhibitor have synergistic activity against synovial sarcoma.","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Beetle Biology and Toxicology Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Synovial sarcoma; Cancer research; Histone deacetylase; Histone deacetylase inhibitor; Cancer; Sarcoma; Soft tissue sarcoma; Malignancy; Medicine; Biology; Pathology; Internal medicine; Histone","score_opus":0.10337064429237634,"score_gpt":0.4744434188321503,"score_spread":0.37107277453977394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1497876949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9668228,0.018118454,0.0018836393,0.0003972093,0.00021401022,0.00030769574,0.00078337133,0.0003131215,0.011159694],"genre_scores_gemma":[0.9860762,0.007665062,0.0019704169,0.00013839907,0.00005563795,0.000079316065,0.00092011626,0.000020935087,0.0030740541],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998356,0.000043880318,0.000013130805,0.000018143146,0.00003893695,0.000050230694],"domain_scores_gemma":[0.99985385,0.000027665445,0.000027272452,0.000018160563,0.000010266493,0.00006280784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026517088,0.00060360203,0.00064081396,0.0007185247,0.00014110452,0.00024735596,0.0003050155,0.0002881671,0.003013363],"category_scores_gemma":[0.00014465617,0.00025684427,0.0007352771,0.00055000524,0.00022883546,0.00025244075,0.00032427133,0.0007030449,0.00084175955],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006075115,0.0024377813,0.0015786762,0.00081443513,0.00042103027,0.00042900344,0.00012900546,0.0020713327,0.90861285,0.00048617582,0.0026542945,0.074290425],"study_design_scores_gemma":[0.0021754447,0.05854249,0.023818167,0.000056225894,0.0006373395,0.0026164209,0.00012651092,0.0028745902,0.88726294,0.00022183759,0.021622118,0.00004589829],"about_ca_topic_score_codex":0.0009647075,"about_ca_topic_score_gemma":0.0036445027,"teacher_disagreement_score":0.003013363,"about_ca_system_score_codex":0.00021894318,"about_ca_system_score_gemma":0.00043683007,"threshold_uncertainty_score":0.010080755},"labels":[],"label_agreement":null},{"id":"W1503342114","doi":"","title":"Shc proteins predict outcome in treatment-naïve breast cancer patients: Do they also predict chemotherapy benefit?","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Oncology; Chemotherapy; Breast cancer; Cancer; Proportional hazards model; Multivariate analysis; Population; Confidence interval","score_opus":0.09110228045427787,"score_gpt":0.4546474611291503,"score_spread":0.3635451806748724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1503342114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99848133,0.0005531884,0.00012470949,0.00014285841,0.00000854511,0.000005866195,0.00023652344,0.00000479121,0.0004422269],"genre_scores_gemma":[0.99937797,0.00009371539,0.00007499513,0.000027048576,0.000019980598,0.000004262781,0.00027447543,0.000001464134,0.0001260333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982244,0.000061527455,0.000017483842,0.000034821976,0.000033964916,0.000029764113],"domain_scores_gemma":[0.9987639,0.00047840338,0.00038957084,0.00007503702,0.000095365256,0.00019769356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005904047,0.00023235759,0.00030995734,0.00047629906,0.00015384937,0.0003597639,0.00022983189,0.0005540486,0.002369724],"category_scores_gemma":[0.0021654293,0.00012790448,0.00028937517,0.00045913694,0.0002699976,0.00029534826,0.00019098756,0.0004699727,0.00046761744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034823065,0.000021513139,0.9964478,0.000007769743,0.000038225342,0.000018562843,0.000011021305,0.00006879682,0.0002687288,0.0000067078577,0.00010162956,0.00266091],"study_design_scores_gemma":[0.000022047829,0.00012180131,0.99872416,0.0000051288425,0.000055306627,0.00014814534,0.000030339337,0.0004957446,0.00016229576,0.000055970468,0.00017630467,0.0000026714165],"about_ca_topic_score_codex":0.0009694203,"about_ca_topic_score_gemma":0.0018384184,"teacher_disagreement_score":0.002369724,"about_ca_system_score_codex":0.00017781668,"about_ca_system_score_gemma":0.00016188365,"threshold_uncertainty_score":0.007927537},"labels":[],"label_agreement":null},{"id":"W1511682218","doi":"10.1158/1078-0432.ccr-09-1363","title":"Preclinical Drug Development Must Consider the Impact on Metastasis","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institutes of Health","keywords":"Metastasis; Angiogenesis; Medicine; Drug development; Drug; Oncology; Cancer research; Internal medicine; Pharmacology; Cancer","score_opus":0.28783176779316944,"score_gpt":0.5706689580236055,"score_spread":0.2828371902304361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1511682218","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034273423,0.48112652,0.065333,0.27451608,0.014785075,0.0019803906,0.0019340613,0.001350607,0.124700926],"genre_scores_gemma":[0.25959006,0.53624433,0.052821424,0.09588709,0.016671015,0.0019825983,0.0019186208,0.0010300864,0.03385484],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940141,0.0024400374,0.0004291866,0.0004900553,0.0022123149,0.00041433165],"domain_scores_gemma":[0.9877628,0.0059767882,0.0008461639,0.0008985189,0.003716459,0.00079934264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012885369,0.0015057871,0.0030164374,0.0011220917,0.00082331867,0.0056767864,0.0018363729,0.0034327966,0.011527812],"category_scores_gemma":[0.012143206,0.0005838138,0.00072599755,0.0007228002,0.0029881117,0.007233503,0.0018919099,0.008652971,0.005092336],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020786293,0.0026692976,0.0036134874,0.005699935,0.00035645868,0.0013117428,0.00052729185,0.008105097,0.094261676,0.11678682,0.14793266,0.6166569],"study_design_scores_gemma":[0.00042370858,0.009514833,0.0031758558,0.0012874065,0.0002201987,0.0021956868,0.00038157313,0.002518851,0.027350882,0.041452,0.91135323,0.00012587651],"about_ca_topic_score_codex":0.0013782602,"about_ca_topic_score_gemma":0.0017299537,"teacher_disagreement_score":0.012885369,"about_ca_system_score_codex":0.0020538121,"about_ca_system_score_gemma":0.003054276,"threshold_uncertainty_score":0.068145216},"labels":[],"label_agreement":null},{"id":"W1517612673","doi":"10.1158/1078-0432.407.11.1","title":"Anti-Vascular Endothelial Growth Factor Receptor-2 Antibody Accelerates Renal Disease in the NZB/W F1 Murine Systemic Lupus Erythematosus Model","year":2005,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Lupus nephritis; Vascular endothelial growth factor; Angiogenesis; Systemic lupus erythematosus; Immunology; Cancer; Antibody; Vascular endothelial growth factor A; Internal medicine; Disease; Pharmacology; VEGF receptors","score_opus":0.11204262173738834,"score_gpt":0.43335119729407373,"score_spread":0.3213085755566854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1517612673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6181271,0.12463949,0.018099608,0.11167083,0.11030485,0.00046669377,0.0018368557,0.0025063131,0.0123482],"genre_scores_gemma":[0.7302006,0.0727382,0.013654175,0.0322862,0.08062797,0.00028424276,0.0011068129,0.00030405732,0.06879768],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99936634,0.0001307403,0.000077878525,0.000109043176,0.0002411029,0.00007486498],"domain_scores_gemma":[0.99860626,0.0003622868,0.00033493596,0.000079855956,0.00026413644,0.00035241494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013936436,0.0012694763,0.0011114463,0.0005814005,0.00034267548,0.0007760496,0.0010521294,0.0020944742,0.0028957606],"category_scores_gemma":[0.0008400565,0.00031924527,0.00051868375,0.00020857959,0.0006630395,0.0005361545,0.0002013362,0.0032761684,0.0011112907],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064844973,0.0016037298,0.0039813234,0.0022073598,0.00020283302,0.011434974,0.00014731921,0.0002624356,0.8576583,0.0015987256,0.07387078,0.040547635],"study_design_scores_gemma":[0.0016156522,0.008667594,0.032175053,0.0004072965,0.00072796666,0.032948133,0.00028998835,0.0065251705,0.5562878,0.0011945188,0.35904625,0.00011455765],"about_ca_topic_score_codex":0.00024387098,"about_ca_topic_score_gemma":0.00042197676,"teacher_disagreement_score":0.0028957606,"about_ca_system_score_codex":0.0005791608,"about_ca_system_score_gemma":0.00026519617,"threshold_uncertainty_score":0.0096873045},"labels":[],"label_agreement":null},{"id":"W1525177141","doi":"","title":"Characterization and functional implications of the interaction between the coxsackievirus and adenovirus receptor (CAR) and beta-catenin","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cell adhesion molecule; Biology; Cell adhesion; Immunoglobulin superfamily; Cancer cell; Cytoplasm; Cell biology; Neural cell adhesion molecule; Cancer; Cell; Cancer research; Genetics","score_opus":0.17589666114763355,"score_gpt":0.47508622111880017,"score_spread":0.2991895599711666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1525177141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571973,0.0016633408,0.0012300931,0.00011926298,0.000015779351,0.0000181925,0.00017114468,0.000007924435,0.0010545583],"genre_scores_gemma":[0.9906634,0.0014313144,0.002168827,0.000073721996,0.000010302814,0.000024874495,0.0019351688,0.000010784125,0.0036816013],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986076,0.000021433834,0.000010870761,0.000021180747,0.000047508114,0.000038140985],"domain_scores_gemma":[0.9998814,0.00003248158,0.000021092852,0.000009771005,0.000022307726,0.000032963966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002187579,0.00037454773,0.00016180726,0.00035001454,0.00020900661,0.00042281408,0.0002461378,0.0003848919,0.0013748936],"category_scores_gemma":[0.00023093547,0.00022063097,0.00045162346,0.00022551887,0.00020914995,0.00031359252,0.0001519452,0.0006014575,0.00054916186],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000553035,0.00004542803,0.0005299259,0.000022132572,0.0000065448157,0.000057616493,0.000011886707,0.000030678548,0.99852955,0.00011590679,0.000017333,0.00057764084],"study_design_scores_gemma":[0.000021380843,0.00051424844,0.047303986,0.000015977786,0.000054813256,0.0020085003,0.00016582523,0.0032843607,0.9399744,0.000116596755,0.0065257316,0.000014150917],"about_ca_topic_score_codex":0.0014667258,"about_ca_topic_score_gemma":0.0013115336,"teacher_disagreement_score":0.0014667258,"about_ca_system_score_codex":0.00054793374,"about_ca_system_score_gemma":0.0002598203,"threshold_uncertainty_score":0.0045995116},"labels":[],"label_agreement":null},{"id":"W1541275643","doi":"10.1158/1557-3265.pms14-a12","title":"Abstract A12: Identification of pathways associated with abiraterone resistance in metastatic castration resistant prostate cancer: Preliminary results from the SU2C/AACR West Coast Prostate Cancer Dream Team","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Enzalutamide; Prostate cancer; Medicine; Biopsy; Oncology; PTEN; Cancer; Metastasis; Liquid biopsy; Prostate biopsy; Abiraterone; Circulating tumor cell; Cancer research; Internal medicine; Pathology; Androgen receptor; Biology; PI3K/AKT/mTOR pathway; Genetics","score_opus":0.2170817800880807,"score_gpt":0.4558618881354091,"score_spread":0.2387801080473284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1541275643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97242343,0.0075620357,0.0025463619,0.001245831,0.000066735774,0.00059149635,0.012404475,0.00027898478,0.0028806715],"genre_scores_gemma":[0.928955,0.0052634724,0.0134760495,0.0013125531,0.0001315752,0.0005320503,0.042984772,0.00011227412,0.0072322586],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99953794,0.00011305515,0.000032945667,0.00010109844,0.0001419649,0.000073090785],"domain_scores_gemma":[0.999073,0.00013313253,0.000101103076,0.00007593018,0.00026099372,0.00035576613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013609515,0.0005212426,0.00057823805,0.0006084449,0.0005037248,0.00089539547,0.0003945237,0.00043690793,0.0035211642],"category_scores_gemma":[0.00064225815,0.00019885314,0.00065551954,0.0005041129,0.00031928212,0.00020410387,0.00060243194,0.00077312294,0.0009146381],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021514231,0.0042654937,0.18453285,0.001516444,0.0010199563,0.0012846963,0.0006447405,0.0025068622,0.5620482,0.0003385439,0.018774716,0.20155329],"study_design_scores_gemma":[0.0048591862,0.020683914,0.841736,0.00028504222,0.0014885545,0.0055764215,0.0007933364,0.0077645355,0.07914912,0.0008618216,0.03668208,0.00011997286],"about_ca_topic_score_codex":0.0051037148,"about_ca_topic_score_gemma":0.009902045,"teacher_disagreement_score":0.0051037148,"about_ca_system_score_codex":0.0005152971,"about_ca_system_score_gemma":0.0016266915,"threshold_uncertainty_score":0.011779487},"labels":[],"label_agreement":null},{"id":"W1595350374","doi":"","title":"Functional oxyhemoglobin and scattering indices for in-vivo characterization of breast cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Optical Imaging and Spectroscopy Techniques","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Medicine; Mammography; Cancer; Ductal carcinoma; Pathology; In vivo; Population; Angiogenesis; Cancer research; Internal medicine; Biology","score_opus":0.11298014684224644,"score_gpt":0.49799057718901163,"score_spread":0.3850104303467652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1595350374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6340475,0.20071615,0.15514737,0.0007182376,0.00022835459,0.00012982838,0.0010684306,0.00049455796,0.0074496954],"genre_scores_gemma":[0.8980105,0.037157726,0.060682938,0.00020764489,0.00021942951,0.00012331885,0.0006571328,0.00007373317,0.0028674488],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998048,0.00008765894,0.0000124710605,0.00002999963,0.000054278917,0.000010769998],"domain_scores_gemma":[0.9997002,0.00011631202,0.00006803878,0.000021254029,0.00007037935,0.000023803905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008769446,0.00030252774,0.00029525903,0.0013656,0.0001191994,0.00039346452,0.0002603162,0.00043247087,0.00072823156],"category_scores_gemma":[0.0007147266,0.00013524233,0.00016937134,0.0006059498,0.0002220591,0.00037534162,0.00017814488,0.00035544502,0.00029771737],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000794241,0.00013559913,0.033194683,0.0010682083,0.00014509256,0.00020190499,0.00015800362,0.002890836,0.8053684,0.0013679345,0.000988507,0.15368654],"study_design_scores_gemma":[0.00004554455,0.001463104,0.22746737,0.00028095857,0.00046212805,0.004905512,0.00039269737,0.062198706,0.6584726,0.004070931,0.040137943,0.000102608436],"about_ca_topic_score_codex":0.0004527013,"about_ca_topic_score_gemma":0.0005522602,"teacher_disagreement_score":0.0013656,"about_ca_system_score_codex":0.00026213532,"about_ca_system_score_gemma":0.0001622024,"threshold_uncertainty_score":0.004637778},"labels":[],"label_agreement":null},{"id":"W1623327531","doi":"","title":"Expression of β-catenin, CDX1 and CDX2 in esophageal adenocarcinoma: association with survival after esophageal resection","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Immunohistochemistry; Wnt signaling pathway; Catenin; CDX2; Adenocarcinoma; Biology; Messenger RNA; Beta-catenin; Cancer research; Barrett's esophagus; Pathogenesis; Pathology; Esophageal disease; Survival analysis; Esophagus; Medicine; Internal medicine; Gene expression; Signal transduction; Cancer; Gene; Homeobox; Cell biology","score_opus":0.03712039638996548,"score_gpt":0.3833804896636444,"score_spread":0.3462600932736789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1623327531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99950397,0.00028482772,0.000049303562,0.000007798286,0.0000010440789,0.0000011066716,0.000041848536,0.0000019680185,0.000108110165],"genre_scores_gemma":[0.99970275,0.000062301864,0.000036899928,0.0000036459473,0.0000019065496,0.0000019269053,0.000091069705,4.6123895e-7,0.00009897824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99994993,0.000008396457,0.000006543621,0.000013683258,0.000009821283,0.0000116897545],"domain_scores_gemma":[0.9996966,0.00008446643,0.00011349282,0.000012444122,0.000030956544,0.0000621056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013498311,0.00010411082,0.0001229478,0.0003938304,0.0001549905,0.00021567884,0.000081890736,0.00019426501,0.000989313],"category_scores_gemma":[0.00042363672,0.00007162656,0.00012983556,0.0002930547,0.00018244852,0.00012254025,0.00013297916,0.0001694707,0.00012022472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005318042,0.00002506732,0.9846645,0.000019493127,0.000024493407,0.00036776677,0.00004611113,0.00011657392,0.011498451,0.0000113918395,0.000051888954,0.002642449],"study_design_scores_gemma":[0.0000040166005,0.00015545184,0.9976616,0.0000018547572,0.000018554392,0.0009638354,0.000055742785,0.00015087443,0.0008301858,0.000011105642,0.0001449959,0.0000017599317],"about_ca_topic_score_codex":0.00053836213,"about_ca_topic_score_gemma":0.00074777246,"teacher_disagreement_score":0.000989313,"about_ca_system_score_codex":0.00012847225,"about_ca_system_score_gemma":0.00007712625,"threshold_uncertainty_score":0.0033096075},"labels":[],"label_agreement":null},{"id":"W1697331515","doi":"10.1158/1078-0432.ccr-15-0915","title":"Potential Proinvasive or Metastatic Effects of Preclinical Antiangiogenic Therapy Are Prevented by Concurrent Chemotherapy","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Bevacizumab; Chemotherapy; Metastasis; Paclitaxel; Oncology; Cancer; Adjuvant; Primary tumor; Combination therapy; Metastatic breast cancer; Breast cancer; Internal medicine; Cancer research; Pharmacology","score_opus":0.21296796785778155,"score_gpt":0.5138183914466772,"score_spread":0.30085042358889563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1697331515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98694056,0.0046064104,0.004622189,0.00018961285,0.000111004476,0.00021477161,0.00016610484,0.00009087829,0.003058488],"genre_scores_gemma":[0.994576,0.0014747339,0.0024449686,0.00006691832,0.000033992794,0.00010766417,0.00019998003,0.000020835674,0.0010749273],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996191,0.00009981481,0.000035808334,0.000057851517,0.0001265798,0.00006086539],"domain_scores_gemma":[0.99961346,0.00012313195,0.00009976561,0.000078601115,0.000030401354,0.000054715914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037906965,0.00040271453,0.00056035415,0.00022279182,0.00015671285,0.00040621997,0.0002463209,0.0002491565,0.0017852231],"category_scores_gemma":[0.00044727174,0.00014761448,0.00025197282,0.00018741177,0.0004225796,0.00036001214,0.00019221375,0.0010850034,0.00025792723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014413232,0.0010993363,0.0015917892,0.0002829418,0.00003410078,0.00011847225,0.00005203796,0.0006892914,0.9777753,0.00056532695,0.00026258334,0.016087413],"study_design_scores_gemma":[0.00017939157,0.007894991,0.0053369105,0.00003254239,0.00006644196,0.00046330402,0.000024791958,0.0017655691,0.97889495,0.000108450644,0.005226369,0.0000063317875],"about_ca_topic_score_codex":0.00037937445,"about_ca_topic_score_gemma":0.00088561204,"teacher_disagreement_score":0.0017852231,"about_ca_system_score_codex":0.0003229478,"about_ca_system_score_gemma":0.00048503766,"threshold_uncertainty_score":0.005972147},"labels":[],"label_agreement":null},{"id":"W1772419959","doi":"10.1158/1078-0432.ccr-15-0373","title":"Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":200,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Cancer Research UK","keywords":"Biology; Exome; Copy number analysis; Exome sequencing; Epigenomics; Gene expression profiling; Transcriptome; Carcinogenesis; Cancer research; Genetics; Gene; Genome; Copy-number variation; DNA methylation; Gene expression; Phenotype","score_opus":0.3227779994311764,"score_gpt":0.5517655373498642,"score_spread":0.2289875379186878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1772419959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99869967,0.00038786393,0.0002384336,0.000024971796,0.0000049334626,0.0000049775595,0.00032030634,0.000008262286,0.00031059995],"genre_scores_gemma":[0.9991204,0.00006982677,0.00014846299,0.000009255383,0.000006409415,0.0000044086273,0.00054508535,0.0000029825912,0.000093150185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982697,0.000026166124,0.000018183071,0.00006060758,0.00003955672,0.000028486256],"domain_scores_gemma":[0.99937755,0.00014267009,0.00023944477,0.000051450992,0.00005486978,0.0001339418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004030579,0.00024323263,0.00029528915,0.00049940863,0.00018313577,0.00046041975,0.00024160337,0.00028846614,0.001291505],"category_scores_gemma":[0.0010299394,0.00009909828,0.00026513246,0.00044458715,0.00023521385,0.00030083998,0.00031475557,0.0002450674,0.00024010817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052266475,0.000013661618,0.9894209,0.00001664917,0.000058057638,0.00014400682,0.00001547633,0.00015453492,0.005262871,0.00002055257,0.00007873408,0.0042918078],"study_design_scores_gemma":[0.000010353606,0.0000901602,0.9968555,0.0000039527476,0.000054284417,0.0008761963,0.00005622438,0.00067581993,0.0010348799,0.000059642232,0.00027975792,0.0000031627076],"about_ca_topic_score_codex":0.0004715424,"about_ca_topic_score_gemma":0.001136326,"teacher_disagreement_score":0.001291505,"about_ca_system_score_codex":0.00018229862,"about_ca_system_score_gemma":0.00014189423,"threshold_uncertainty_score":0.004320562},"labels":[],"label_agreement":null},{"id":"W1773612973","doi":"","title":"Molecular detection of lymph node micrometastases in colorectal cancer patients","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Lymph; Lymph node; Micrometastasis; Colorectal cancer; RNA; Medicine; Reverse transcriptase; Molecular biology; Housekeeping gene; Complementary DNA; Pathology; Cancer; Cancer research; Biology; Metastasis; Gene expression; Gene; Internal medicine; Genetics","score_opus":0.08325653762700597,"score_gpt":0.4583809284153194,"score_spread":0.37512439078831344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1773612973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997718,0.0013165894,0.00041802437,0.000020273152,0.0000060211237,0.0000102569875,0.00012335867,0.000010228258,0.00037725866],"genre_scores_gemma":[0.9989374,0.0002420442,0.00043483984,0.000007879281,0.0000063215566,0.000008936829,0.00015367742,0.0000014341971,0.00020738512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984074,0.000038349102,0.000014936153,0.000041941046,0.00004040607,0.000023627616],"domain_scores_gemma":[0.99972516,0.00008339714,0.00010091276,0.000014233999,0.00003956039,0.00003664919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037250007,0.00018132437,0.00017258374,0.0006527496,0.000105311214,0.0002559215,0.00013228609,0.00021694228,0.001295005],"category_scores_gemma":[0.00073289825,0.00010213356,0.00011886127,0.00029009473,0.00016871806,0.00019248427,0.00019702752,0.00014846004,0.00022480036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011083909,0.000045010136,0.9023694,0.00012040927,0.00004891898,0.0003144737,0.00007478036,0.00017330966,0.084191896,0.00002978077,0.00011887988,0.01140491],"study_design_scores_gemma":[0.000029190724,0.0007108353,0.9793035,0.000018922841,0.00008046615,0.0016005847,0.00015835561,0.00082400243,0.016443893,0.00004304833,0.0007826835,0.0000046391615],"about_ca_topic_score_codex":0.00034347974,"about_ca_topic_score_gemma":0.0007764413,"teacher_disagreement_score":0.001295005,"about_ca_system_score_codex":0.0001495244,"about_ca_system_score_gemma":0.00007027551,"threshold_uncertainty_score":0.004332185},"labels":[],"label_agreement":null},{"id":"W1823273489","doi":"10.1158/1078-0432.712.11.2","title":"Targeting Cyclooxygenase-2 Reduces Overt Toxicity toward Low-Dose Vinblastine and Extends Survival of Juvenile Mice with Friend Disease","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Vinblastine; Juvenile; Toxicity; Cyclooxygenase; Disease; Medicine; Pharmacology; Cancer research; Internal medicine; Oncology; Biology; Chemotherapy; Enzyme; Genetics; Biochemistry","score_opus":0.08365343658399149,"score_gpt":0.4381873482233783,"score_spread":0.3545339116393868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1823273489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99775237,0.0008034918,0.000728977,0.00003334579,0.000011867819,0.000024509005,0.0002084146,0.00004031164,0.00039672496],"genre_scores_gemma":[0.99611783,0.0008088557,0.0009419812,0.00002527162,0.0000109961675,0.00003830949,0.00042281277,0.000011916413,0.001622136],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990976,0.000017110056,0.000007899619,0.000017237677,0.000022145565,0.000025894838],"domain_scores_gemma":[0.9998553,0.000012895804,0.000065255685,0.000011121193,0.000009971226,0.000045470264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013859119,0.00043138675,0.00030242797,0.00019412022,0.00010439634,0.00018373884,0.00016795547,0.0002189576,0.0007521313],"category_scores_gemma":[0.00010752465,0.00009771569,0.00016233795,0.00010126948,0.00015995646,0.00017449193,0.00009575819,0.0004384203,0.0001560987],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000523052,0.00011478953,0.00038285297,0.000026549982,0.00000541704,0.000035826088,0.0000127721505,0.000056121626,0.9973527,0.000024284484,0.000031413092,0.0014341079],"study_design_scores_gemma":[0.00012933054,0.009652421,0.014899569,0.000011920166,0.000048669743,0.00045592178,0.00005754727,0.00073659554,0.97160923,0.00002756933,0.0023640045,0.000007158592],"about_ca_topic_score_codex":0.0005478264,"about_ca_topic_score_gemma":0.0015433466,"teacher_disagreement_score":0.0007521313,"about_ca_system_score_codex":0.0001770349,"about_ca_system_score_gemma":0.00014554358,"threshold_uncertainty_score":0.0025160909},"labels":[],"label_agreement":null},{"id":"W1840612622","doi":"10.1158/1078-0432.ccr-15-0632","title":"Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; Cancer Research UK; National Cancer Institute; National Center for Research Resources; Medical Research Council; Canadian Institutes of Health Research; Francis Crick Institute","keywords":"Ovarian cancer; Genome-wide association study; Cancer; Genome; Oncology; Biology; Medicine; Bioinformatics; Genetics; Internal medicine; Gene; Genotype; Single-nucleotide polymorphism","score_opus":0.15702767333752085,"score_gpt":0.43662526127310963,"score_spread":0.27959758793558875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1840612622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899872,0.00153766,0.0009781282,0.00075855874,0.000030397334,0.000019568597,0.005886145,0.00003948019,0.00076284294],"genre_scores_gemma":[0.9928919,0.00051345257,0.0009272389,0.0003706169,0.000049654693,0.00004821748,0.004834978,0.000028648888,0.0003351735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986895,0.00038963504,0.00010033633,0.00047005457,0.00020112011,0.00014943852],"domain_scores_gemma":[0.995826,0.0017863644,0.0011627699,0.00049863424,0.00026491104,0.00046122068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018918972,0.0004154241,0.0004929559,0.00070487167,0.00068562984,0.0010777654,0.00053537934,0.00056030025,0.0022005958],"category_scores_gemma":[0.005051208,0.00021826725,0.00080814824,0.002097507,0.00058246264,0.00020202405,0.0011810191,0.000864194,0.00021452048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012044928,0.000058644007,0.98329645,0.00009099165,0.0012571748,0.00037705587,0.00014219248,0.0005962961,0.0034450286,0.00018562136,0.001761943,0.0075840885],"study_design_scores_gemma":[0.00020271131,0.00008658696,0.99437803,0.000022995462,0.00090468617,0.0004386639,0.00011193917,0.00064880296,0.0005355906,0.0003468865,0.0023076944,0.000015496335],"about_ca_topic_score_codex":0.0076388186,"about_ca_topic_score_gemma":0.009073257,"teacher_disagreement_score":0.0076388186,"about_ca_system_score_codex":0.00028233323,"about_ca_system_score_gemma":0.0007282683,"threshold_uncertainty_score":0.015188694},"labels":[],"label_agreement":null},{"id":"W1845272216","doi":"10.1158/1078-0432.ccr-14-3122","title":"<i>CCR</i> 20th Anniversary Commentary: Triple-Negative Breast Cancer in 2015—Still in the Ballpark","year":2015,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Sunnybrook Health Science Centre; Jewish General Hospital; Women's College Hospital","funders":"","keywords":"Breast cancer; Triple-negative breast cancer; Medicine; Cancer; Metastatic breast cancer; Oncology; Triple negative; Internal medicine","score_opus":0.12707794617638332,"score_gpt":0.4753581876632572,"score_spread":0.34828024148687386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1845272216","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028237497,0.001823543,0.000067897825,0.9502772,0.044458397,0.000020943771,0.00013785502,0.00006477904,0.0028670742],"genre_scores_gemma":[0.00306056,0.0013762122,0.00014883523,0.91691774,0.0703295,0.000056380723,0.00007700931,0.000032573575,0.0080012055],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972343,0.00076465216,0.0003383278,0.00042026545,0.00087154633,0.00037099066],"domain_scores_gemma":[0.994375,0.0026183862,0.00043484892,0.00023607741,0.0012137989,0.0011218822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036670903,0.0012265886,0.0019368605,0.0008523822,0.0036502958,0.00323772,0.0026200025,0.045992363,0.008463743],"category_scores_gemma":[0.017770017,0.0008955648,0.0017596864,0.00074455346,0.0025444115,0.0032438722,0.0011561965,0.038260918,0.009598476],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004776964,0.000018221883,0.00015637897,0.000030312845,0.000007943072,0.0006939013,0.000025413608,0.000026620715,0.00007507576,0.000495943,0.99562496,0.002797471],"study_design_scores_gemma":[0.00020643293,0.00014312916,0.0020910795,0.00045518202,0.000069003225,0.002143589,0.00020903307,0.0006430529,0.00039039002,0.0043238536,0.98924047,0.00008476039],"about_ca_topic_score_codex":0.005642973,"about_ca_topic_score_gemma":0.008839877,"teacher_disagreement_score":0.045992363,"about_ca_system_score_codex":0.0059853774,"about_ca_system_score_gemma":0.0030479059,"threshold_uncertainty_score":0.04342717},"labels":[],"label_agreement":null},{"id":"W1861748936","doi":"10.1158/1078-0432.ccr-15-0468","title":"Preclinical Efficacy and Safety Assessment of an Antibody–Drug Conjugate Targeting the c-RET Proto-Oncogene for Breast Carcinoma","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Takeda Pharmaceuticals International","keywords":"Breast cancer; Medicine; Antibody-drug conjugate; Cancer; Cancer research; Tissue microarray; Antibody; Immunohistochemistry; Cytotoxic T cell; Pharmacology; Pathology; Internal medicine; Monoclonal antibody; Immunology; In vitro; Biology","score_opus":0.3735274212817079,"score_gpt":0.6302471702096378,"score_spread":0.2567197489279299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1861748936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954052,0.0009957169,0.0018662118,0.00007696208,0.000021926202,0.0003347478,0.00022751738,0.000049311704,0.001022333],"genre_scores_gemma":[0.99588674,0.00085873104,0.0017225972,0.00003569059,0.000019982172,0.00014423953,0.00035067444,0.000011951111,0.0009693019],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981564,0.000057799574,0.000011469627,0.000025918887,0.000056237743,0.00003293776],"domain_scores_gemma":[0.9997559,0.0000416986,0.0000817385,0.000025772115,0.000057907626,0.000036950732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005635784,0.00046912694,0.00037307898,0.00037178112,0.00019522576,0.0003074431,0.0003706805,0.00039994027,0.0011152453],"category_scores_gemma":[0.00040969616,0.00015346198,0.0002579695,0.00021862735,0.00025895497,0.00026876535,0.00013062287,0.0005080611,0.00029405527],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025885138,0.0024728822,0.0013611731,0.0001773525,0.000057459332,0.000096966,0.000063757754,0.0018999812,0.97315466,0.00013286839,0.00027221098,0.017722258],"study_design_scores_gemma":[0.00050199754,0.052628614,0.0036503149,0.000015749145,0.000117595955,0.00034236163,0.000031021624,0.0031912178,0.93695974,0.000047155583,0.002504646,0.000009592937],"about_ca_topic_score_codex":0.0006749359,"about_ca_topic_score_gemma":0.00087827083,"teacher_disagreement_score":0.0011152453,"about_ca_system_score_codex":0.0005832207,"about_ca_system_score_gemma":0.0006408173,"threshold_uncertainty_score":0.004231572},"labels":[],"label_agreement":null},{"id":"W1866474482","doi":"10.1158/1557-3265.pms14-b45","title":"Abstract B45: A search for ideal siRNA targets involved in pathway cross-talks for combinational silencing in human cancer cells","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Gene silencing; Survivin; RNA interference; Biology; PI3K/AKT/mTOR pathway; Cancer cell; Small interfering RNA; Cell biology; Protein kinase B; Signal transduction; Cell growth; MAPK/ERK pathway; Cancer research; Cancer; RNA; Genetics; Gene","score_opus":0.4204801651937695,"score_gpt":0.5800645947930788,"score_spread":0.1595844295993093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1866474482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93520683,0.015898246,0.03839298,0.0003934293,0.0002054201,0.0006988491,0.0012011665,0.0005313471,0.0074717426],"genre_scores_gemma":[0.9629232,0.0041187555,0.025514424,0.00022757777,0.000028970982,0.0004119129,0.0014462991,0.00008915202,0.0052396376],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996507,0.000049685186,0.000044687953,0.000107883054,0.00010119493,0.00004585235],"domain_scores_gemma":[0.99991727,0.000018018402,0.00001622251,0.000012352762,0.000018565743,0.000017505005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038060642,0.00048777828,0.0006557535,0.00043689128,0.00024682516,0.00042451336,0.00032007118,0.00045238849,0.0019612983],"category_scores_gemma":[0.00016361113,0.00020794872,0.00038883914,0.00037477957,0.00017945678,0.00020618839,0.00027854065,0.00045422825,0.0006770126],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007475315,0.00003665384,0.00008238946,0.00007322526,0.000013797119,0.00002513463,0.000009930463,0.00010314961,0.99660575,0.00010115856,0.00007726809,0.002796845],"study_design_scores_gemma":[0.00003167854,0.0006637261,0.0008571955,0.000007856235,0.00007461292,0.00020839696,0.00001186203,0.0011482594,0.9914744,0.000035546353,0.005479818,0.0000067509927],"about_ca_topic_score_codex":0.0005243244,"about_ca_topic_score_gemma":0.0008890803,"teacher_disagreement_score":0.0019612983,"about_ca_system_score_codex":0.00029379773,"about_ca_system_score_gemma":0.00031577543,"threshold_uncertainty_score":0.00656116},"labels":[],"label_agreement":null},{"id":"W1875927722","doi":"10.1158/1078-0432.ccr-15-1848","title":"Fc Gamma Receptor 3A and 2A Polymorphisms Do Not Predict Response to Rituximab in Follicular Lymphoma","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; American College of Radiology Imaging Network","keywords":"Rituximab; Medicine; Follicular lymphoma; Internal medicine; Genotyping; Oncology; Single-nucleotide polymorphism; Lymphoma; Genotype; SNP; Randomized controlled trial; Biology; Gene","score_opus":0.22202483359602618,"score_gpt":0.49515386741850004,"score_spread":0.2731290338224739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1875927722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995608,0.00020491585,0.0000757133,0.000020728794,0.0000019761237,0.0000056859762,0.000052445623,0.0000017463461,0.00007589736],"genre_scores_gemma":[0.99972516,0.000023541577,0.00006708636,0.000027918695,0.0000055949436,0.000007404889,0.000104487095,0.0000011827512,0.000037522877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993026,0.0003199061,0.00007216304,0.00015673105,0.00009892495,0.000049697024],"domain_scores_gemma":[0.99807054,0.000990164,0.0005499862,0.00018218879,0.00006733179,0.0001397764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014341084,0.00021299579,0.0004560839,0.00023331887,0.00018215181,0.00033695137,0.00035152168,0.0005571428,0.0015386144],"category_scores_gemma":[0.0035758466,0.00018175227,0.00034186573,0.00024915603,0.00035862208,0.00023036501,0.00017696673,0.00037263593,0.00025283507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011172912,0.00020786627,0.96791995,0.00005453773,0.00037180664,0.00016055095,0.00009922454,0.00060069334,0.007709625,0.000043831576,0.00023691916,0.011422124],"study_design_scores_gemma":[0.0010400288,0.001732768,0.99294454,0.000016851958,0.0003588455,0.00081560115,0.0000694562,0.0013937962,0.0010055436,0.00018456817,0.000429202,0.000008726072],"about_ca_topic_score_codex":0.0008501759,"about_ca_topic_score_gemma":0.0006729487,"teacher_disagreement_score":0.0015386144,"about_ca_system_score_codex":0.00024823437,"about_ca_system_score_gemma":0.00021699523,"threshold_uncertainty_score":0.0075843334},"labels":[],"label_agreement":null},{"id":"W1907272683","doi":"10.1158/1078-0432.ccr-15-0866","title":"siRNA Lipid Nanoparticle Potently Silences Clusterin and Delays Progression When Combined with Androgen Receptor Cotargeting in Enzalutamide-Resistant Prostate Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Clusterin; LNCaP; Enzalutamide; Prostate cancer; Cancer research; Androgen receptor; Gene silencing; Medicine; In vivo; Apoptosis; Chemistry; Cancer; Biology; Internal medicine","score_opus":0.16821349135734492,"score_gpt":0.4806860595481425,"score_spread":0.31247256819079755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1907272683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952922,0.000937886,0.0021656188,0.000069107344,0.000024863371,0.00006654341,0.00014558266,0.0001222226,0.0011760205],"genre_scores_gemma":[0.99538416,0.0005502889,0.0017056838,0.000025798445,0.0000050300514,0.000054527718,0.00019168842,0.000017534836,0.0020653915],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999089,0.00001133079,0.0000063333914,0.000022650702,0.000031333686,0.00001941214],"domain_scores_gemma":[0.9999647,0.000004185611,0.0000105693325,0.0000031292593,0.0000070838714,0.00001033954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011250916,0.00029503307,0.00028249936,0.00019595194,0.00012899801,0.0002250414,0.00018154408,0.00020662727,0.0005042667],"category_scores_gemma":[0.00006570279,0.00010047362,0.00020420937,0.00014745932,0.0002054895,0.00014524261,0.0001160576,0.0002928782,0.00013729387],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014979826,0.000065570384,0.00007511025,0.000040148334,0.000005972402,0.000026989557,0.00001653215,0.00018922391,0.9974503,0.000051518404,0.00007071315,0.0018581867],"study_design_scores_gemma":[0.00003183365,0.00083220034,0.0010025577,0.0000026058583,0.000020793008,0.00008960475,0.000010916385,0.00097025046,0.995666,0.0000094864545,0.0013597682,0.0000040021423],"about_ca_topic_score_codex":0.0017808481,"about_ca_topic_score_gemma":0.0032073685,"teacher_disagreement_score":0.0017808481,"about_ca_system_score_codex":0.00043282373,"about_ca_system_score_gemma":0.0004075339,"threshold_uncertainty_score":0.0035409927},"labels":[],"label_agreement":null},{"id":"W1907991309","doi":"10.1158/1078-0432.ccr-15-0215","title":"Effects of Adjuvant Sorafenib and Sunitinib on Cardiac Function in Renal Cell Carcinoma Patients without Overt Metastases: Results from ASSURE, ECOG 2805","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Sunitinib; Renal cell carcinoma; Medicine; Adjuvant; Sorafenib; Internal medicine; Renal function; Oncology; Urology; Hepatocellular carcinoma","score_opus":0.1551892286076148,"score_gpt":0.42482418811199524,"score_spread":0.26963495950438043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1907991309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99714845,0.0017667755,0.00009128661,0.00005668093,0.000016360435,0.000079216465,0.00039345902,0.000014406578,0.0004332997],"genre_scores_gemma":[0.99781775,0.00056089385,0.00016321323,0.00007799447,0.000048001806,0.000060389586,0.0010793622,0.0000034232448,0.00018893582],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99924636,0.00040210714,0.00006437139,0.00009138589,0.00011448735,0.00008132744],"domain_scores_gemma":[0.99825865,0.00048915093,0.00041968492,0.00014222876,0.00012870514,0.0005615512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002907061,0.0005485901,0.0014151611,0.00030458046,0.00024130549,0.00043424888,0.0003782726,0.00038797013,0.0010612872],"category_scores_gemma":[0.0017356013,0.00018844657,0.0014728885,0.00031198756,0.00038723092,0.00041824632,0.00035360575,0.0006967178,0.00020125482],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.70583224,0.009634709,0.21390061,0.0004640919,0.0026080972,0.00011203627,0.0001226057,0.0013316703,0.005630589,0.00006959875,0.0015129473,0.058780808],"study_design_scores_gemma":[0.07303906,0.29297218,0.624047,0.000058018977,0.0026064045,0.00043911766,0.00008196638,0.0017766119,0.0025558898,0.000104306455,0.0022856388,0.000033816294],"about_ca_topic_score_codex":0.0008951503,"about_ca_topic_score_gemma":0.0018354721,"teacher_disagreement_score":0.002907061,"about_ca_system_score_codex":0.00057003036,"about_ca_system_score_gemma":0.000887593,"threshold_uncertainty_score":0.015374243},"labels":[],"label_agreement":null},{"id":"W1913097128","doi":"10.1158/1078-0432.1336.11.3","title":"Dual Inhibition of <i>RET</i> and <i>FGFR4</i> Restrains Medullary Thyroid Cancer Cell Growth","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Immunovaccine (Canada); University of Toronto","funders":"","keywords":"Medullary thyroid cancer; Medicine; Cancer; Medullary cavity; Thyroid cancer; Cancer research; Internal medicine; Endocrinology; Oncology","score_opus":0.08149313244203124,"score_gpt":0.4432948344094236,"score_spread":0.36180170196739236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1913097128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956169,0.0014258076,0.00091255864,0.00006721387,0.000018796103,0.000018566514,0.00015428812,0.000063034735,0.0017228252],"genre_scores_gemma":[0.99664813,0.0007620097,0.0010419172,0.000024741663,0.000010796305,0.000025607267,0.00023161224,0.0000108303975,0.0012443193],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999845,0.000021019216,0.000014453999,0.000018459497,0.00004986584,0.000051234296],"domain_scores_gemma":[0.99992156,0.00001808676,0.000020497506,0.00000840253,0.00000870654,0.00002275268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015486922,0.00028577037,0.0003856292,0.00021324266,0.00013222618,0.00026320494,0.00021760665,0.0001690103,0.0007962165],"category_scores_gemma":[0.00012150318,0.00011755433,0.0002658138,0.00014578957,0.00020283277,0.00012972493,0.00016652317,0.0005277593,0.00024618473],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020523439,0.000056115347,0.0002487133,0.000042018917,0.000010293153,0.00003736723,0.000009825672,0.00021645962,0.99617934,0.00011641261,0.000080672355,0.0027975861],"study_design_scores_gemma":[0.000049082188,0.0009177254,0.0022226044,0.0000036254999,0.00003034274,0.00025631924,0.000015451851,0.001030749,0.99351233,0.000025082481,0.0019326386,0.0000040913355],"about_ca_topic_score_codex":0.0010516545,"about_ca_topic_score_gemma":0.0025720543,"teacher_disagreement_score":0.0010516545,"about_ca_system_score_codex":0.0003580883,"about_ca_system_score_gemma":0.00042054916,"threshold_uncertainty_score":0.002663672},"labels":[],"label_agreement":null},{"id":"W1923726874","doi":"10.1158/1078-0432.ccr-15-0744","title":"Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"National Cancer Institute","keywords":"Cyclin D1; Adenocarcinoma; Cancer research; Metastasis; Prostate; Medicine; Pathology; Carcinoma; Small-cell carcinoma; Cancer; Oncology; Biology; Cell cycle; Internal medicine","score_opus":0.35106830331324973,"score_gpt":0.49947318720320816,"score_spread":0.14840488388995843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1923726874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99831605,0.0008295808,0.00037094002,0.000022931656,0.0000024275078,0.0000100578445,0.000060892115,0.000008577101,0.00037862358],"genre_scores_gemma":[0.9994289,0.00017819155,0.00019397818,0.000009412876,0.0000028473219,0.0000043907603,0.00008130173,0.0000020853354,0.00009878321],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999882,0.000016659547,0.000017912675,0.000028779024,0.000039367333,0.000015362299],"domain_scores_gemma":[0.9997781,0.000052399428,0.00006301066,0.000024807578,0.000026902908,0.00005472305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020612983,0.00015743056,0.00026879457,0.0005892282,0.0002623356,0.00038793127,0.0001627665,0.00017853157,0.0006781804],"category_scores_gemma":[0.0005132593,0.00013987022,0.00014807406,0.00029737753,0.00037173682,0.00016690197,0.0001937007,0.00021115648,0.00015890843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011844834,0.000056040855,0.7793879,0.00015692349,0.00006835385,0.0014284961,0.00021439102,0.00026461302,0.20320395,0.000112095775,0.000117852614,0.013804916],"study_design_scores_gemma":[0.000037032372,0.00050389627,0.93377894,0.000014092654,0.000076343524,0.015497434,0.0002296952,0.0007105142,0.047644988,0.00013517722,0.0013637405,0.00000812986],"about_ca_topic_score_codex":0.0009503519,"about_ca_topic_score_gemma":0.002362416,"teacher_disagreement_score":0.0009503519,"about_ca_system_score_codex":0.0002877495,"about_ca_system_score_gemma":0.0002432127,"threshold_uncertainty_score":0.0022687316},"labels":[],"label_agreement":null},{"id":"W1933707168","doi":"10.1158/1078-0432.1302.11.3","title":"Potentiation of a Dendritic Cell Vaccine for Murine Renal Cell Carcinoma by CpG Oligonucleotides","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Immune system; Dendritic cell; CpG Oligodeoxynucleotide; Immunology; Cancer research; Immunotherapy; Antigen; CpG site; Biology; T cell; Tumor antigen","score_opus":0.0673276606742644,"score_gpt":0.4107871269102125,"score_spread":0.34345946623594814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1933707168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945914,0.0016755613,0.0024898502,0.000073806514,0.000058308517,0.000107777196,0.00013120269,0.000042767042,0.00082920754],"genre_scores_gemma":[0.9930735,0.0015506898,0.0038766377,0.000060423372,0.000028373772,0.0000774741,0.00025626246,0.000010990385,0.0010655961],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988425,0.00002123608,0.000010650802,0.00002499188,0.00003420738,0.000024663806],"domain_scores_gemma":[0.9999112,0.000018204626,0.000026018823,0.000009970557,0.0000134935335,0.000021153493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015833127,0.00039609498,0.0002802083,0.00012862818,0.000056483495,0.00015463016,0.00013640718,0.00023333333,0.0006186816],"category_scores_gemma":[0.0001359015,0.0000672554,0.0001968377,0.0000788472,0.00017438647,0.00012496661,0.0001251215,0.0004563255,0.000193071],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016729344,0.00013059442,0.00013898137,0.00008480543,0.0000065061436,0.000016974744,0.0000068637555,0.0002925563,0.99610114,0.000049778286,0.000020792457,0.0029837638],"study_design_scores_gemma":[0.000055263325,0.0019176262,0.0006700757,0.000010417454,0.00002867822,0.00006432545,0.0000050353424,0.0006894914,0.9951775,0.000019317946,0.0013597526,0.0000024676344],"about_ca_topic_score_codex":0.00030012894,"about_ca_topic_score_gemma":0.00043445965,"teacher_disagreement_score":0.0006186816,"about_ca_system_score_codex":0.00017859167,"about_ca_system_score_gemma":0.0003100791,"threshold_uncertainty_score":0.0020697713},"labels":[],"label_agreement":null},{"id":"W1945293306","doi":"10.1158/1078-0432.ccr-15-1181","title":"CD73 Expression Is an Independent Prognostic Factor in Prostate Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":198,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Prostate cancer; Prostate; Stromal cell; Cancer research; PCA3; Cancer; Stroma; Tissue microarray; Medicine; Biology; Pathology; Internal medicine; Immunohistochemistry","score_opus":0.30692829316027903,"score_gpt":0.5311385521616998,"score_spread":0.22421025900142078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1945293306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99491334,0.0031638078,0.0006102378,0.00009376931,0.0000199005,0.000013930972,0.0003111932,0.000031179046,0.0008425117],"genre_scores_gemma":[0.9991559,0.00030253775,0.00017849165,0.000011321706,0.000022597926,0.000004410832,0.00016857158,0.0000018934134,0.00015423921],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985945,0.000021948665,0.000007613803,0.000032237687,0.000049088492,0.000029550483],"domain_scores_gemma":[0.99961674,0.000051989955,0.00014443927,0.000020318554,0.000050715476,0.000115743765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020014204,0.00018315653,0.00021282221,0.00058460695,0.00030743488,0.00034192015,0.00014466637,0.00020034405,0.0017610289],"category_scores_gemma":[0.00042539058,0.00007783955,0.0001314603,0.0007931333,0.00019442344,0.0001539885,0.00016598307,0.0002978656,0.00022669899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015876443,0.00012788526,0.9082169,0.000096444615,0.00010334817,0.00047511465,0.000032061573,0.00022398248,0.06857222,0.00013543182,0.0007397166,0.019689295],"study_design_scores_gemma":[0.000016462067,0.00027035174,0.9845531,0.000009787648,0.00012589345,0.0020425408,0.000056070905,0.0010079591,0.010174561,0.000147407,0.0015868292,0.000009102184],"about_ca_topic_score_codex":0.0007410569,"about_ca_topic_score_gemma":0.0011705233,"teacher_disagreement_score":0.0017610289,"about_ca_system_score_codex":0.00026476567,"about_ca_system_score_gemma":0.00030465715,"threshold_uncertainty_score":0.005891204},"labels":[],"label_agreement":null},{"id":"W1953830900","doi":"10.1158/1078-0432.ccr-15-1186","title":"Defining a New Prognostic Index for Stage I Nonseminomatous Germ Cell Tumors Using CXCL12 Expression and Proportion of Embryonal Carcinoma","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"National Cancer Institute; National Cancer Research Institute","keywords":"Embryonal carcinoma; Medicine; Oncology; Germ cell tumors; Cancer; Carcinoma; Stage (stratigraphy); Adjuvant therapy; Immunohistochemistry; Internal medicine; Chemotherapy; Pathology; Biology; Cellular differentiation","score_opus":0.2965083251211305,"score_gpt":0.5206071515538885,"score_spread":0.22409882643275797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1953830900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99305046,0.0013401252,0.0033244085,0.0001964176,0.000025693522,0.000107543834,0.00089157996,0.00007153369,0.0009922902],"genre_scores_gemma":[0.99506456,0.00016121818,0.003403454,0.000033318785,0.000030728825,0.00005503611,0.0010366885,0.0000071118343,0.00020798639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996426,0.000111362366,0.000050308052,0.00006287781,0.00009764243,0.00003522688],"domain_scores_gemma":[0.9982222,0.00051279034,0.00063989655,0.00009177924,0.00024020435,0.00029319656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013073805,0.0006370358,0.0007238632,0.0013629126,0.0002493787,0.0007456597,0.00043409347,0.00043348002,0.0010410324],"category_scores_gemma":[0.0033755037,0.00015314682,0.00041378645,0.00082471315,0.0003304607,0.00058608095,0.00048282396,0.00057418604,0.00029131118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008878382,0.00003404449,0.9874325,0.00002970141,0.00005403757,0.000022811682,0.00002244804,0.0005603329,0.0013294269,0.0000393464,0.00033282646,0.009254668],"study_design_scores_gemma":[0.00014164725,0.0012282573,0.9742594,0.00003500373,0.0002292108,0.0007717413,0.00009639893,0.018774265,0.002686455,0.0002704712,0.0014825151,0.00002465614],"about_ca_topic_score_codex":0.0011559614,"about_ca_topic_score_gemma":0.0018517686,"teacher_disagreement_score":0.0013629126,"about_ca_system_score_codex":0.0005316652,"about_ca_system_score_gemma":0.0004979762,"threshold_uncertainty_score":0.0069141984},"labels":[],"label_agreement":null},{"id":"W1964066975","doi":"10.1158/1078-0432.ovca13-b14","title":"Abstract B14: Rapid RNA-based histotyping of ovarian carcinomas","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Serous fluid; Taxane; Serous carcinoma; Medicine; Oncology; Clear cell; Ovarian cancer; Internal medicine; Clear cell carcinoma; Ovarian carcinoma; Cancer; Pathology; Carcinoma; Breast cancer","score_opus":0.14243068921775606,"score_gpt":0.4747205185469886,"score_spread":0.33228982932923257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964066975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8916416,0.004933367,0.066415,0.00051907677,0.00020158554,0.0014830196,0.020900311,0.0011381789,0.012767759],"genre_scores_gemma":[0.82386166,0.0025598241,0.12203281,0.000689006,0.00015336987,0.0023852915,0.03826774,0.00052696944,0.009523231],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991026,0.0001626908,0.00009480336,0.00024925885,0.00030745534,0.00008330563],"domain_scores_gemma":[0.99932444,0.00020147284,0.00010222598,0.000074285075,0.00025616243,0.000041464053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011658875,0.00040557806,0.00030576493,0.002081114,0.00034393993,0.0006268898,0.00045523842,0.0004124795,0.004436317],"category_scores_gemma":[0.0011568635,0.00025484333,0.00024679105,0.0008335845,0.0002969067,0.00020588114,0.00049384433,0.00033655824,0.0027314436],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004635809,0.000055010783,0.04557597,0.00040720022,0.0000675994,0.00019022127,0.00011696516,0.00043257468,0.9018995,0.00022324054,0.0020152,0.048552882],"study_design_scores_gemma":[0.00008749816,0.0010242277,0.34544224,0.00018437776,0.0002521446,0.0029456138,0.00038661668,0.0060408954,0.5997625,0.00073005,0.043091103,0.0000528169],"about_ca_topic_score_codex":0.0006150327,"about_ca_topic_score_gemma":0.0013581857,"teacher_disagreement_score":0.004436317,"about_ca_system_score_codex":0.00030822607,"about_ca_system_score_gemma":0.0003995927,"threshold_uncertainty_score":0.0148409605},"labels":[],"label_agreement":null},{"id":"W1964627756","doi":"10.1158/1078-0432.ccr-07-1409","title":"A Multiparametric Panel for Ovarian Cancer Diagnosis, Prognosis, and Response to Chemotherapy","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Institutes of Health","keywords":"Ovarian cancer; Medicine; Confidence interval; Oncology; Chemotherapy; Internal medicine; Receiver operating characteristic; Hazard ratio; Cancer","score_opus":0.33078992845422023,"score_gpt":0.5583967393988145,"score_spread":0.22760681094459428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964627756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9650751,0.003503832,0.023639852,0.00054006645,0.00006023915,0.00024637426,0.0033986596,0.00045158985,0.003084294],"genre_scores_gemma":[0.9886728,0.00026569125,0.00874612,0.00013549361,0.00005131671,0.00013701379,0.0016119672,0.000010390851,0.00036925662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990195,0.00040297472,0.00008121009,0.00015719749,0.00028351755,0.000055485616],"domain_scores_gemma":[0.9973679,0.0010000045,0.0008680255,0.00020238663,0.000363118,0.00019856053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015996835,0.00040707842,0.0005091585,0.0012264644,0.00017199219,0.00045374548,0.0003136867,0.0004074682,0.0011696216],"category_scores_gemma":[0.0038215835,0.00012321092,0.0002830097,0.0005740528,0.00013310081,0.0003493022,0.00035963464,0.0004923935,0.000482945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013884475,0.0002693184,0.8851586,0.00013377034,0.0003037602,0.000106718566,0.000060890372,0.0021767316,0.018964408,0.000116833995,0.001531763,0.08978878],"study_design_scores_gemma":[0.000084144136,0.0012275308,0.9683926,0.000044630222,0.00020636924,0.0011122263,0.000042723786,0.014142888,0.01136389,0.00024245684,0.0031119604,0.000028587323],"about_ca_topic_score_codex":0.00036725838,"about_ca_topic_score_gemma":0.00045222486,"teacher_disagreement_score":0.0015996835,"about_ca_system_score_codex":0.00022598855,"about_ca_system_score_gemma":0.0002653173,"threshold_uncertainty_score":0.008460045},"labels":[],"label_agreement":null},{"id":"W1964963957","doi":"10.1158/1078-0432.ccr-08-1789","title":"Fascin Regulates Prostate Cancer Cell Invasion and Is Associated with Metastasis and Biochemical Failure in Prostate Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cellular Mechanics and Interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"DU145; Fascin; Prostate cancer; Cancer research; Prostate; Cancer; Metastasis; Medicine; Gene silencing; Internal medicine; Oncology; Biology; LNCaP; Immunohistochemistry","score_opus":0.05931760027762852,"score_gpt":0.41020200695574116,"score_spread":0.35088440667811266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964963957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99701464,0.002119465,0.00033275457,0.00003245716,0.0000026715325,0.000009144229,0.00011336053,0.000015909218,0.0003597135],"genre_scores_gemma":[0.9989421,0.0004418219,0.00010468821,0.000011769216,0.0000035105488,0.000007123211,0.00010892352,0.0000018956098,0.00037816737],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99995077,0.000010931957,0.0000030786516,0.000011570942,0.000012868665,0.000010743275],"domain_scores_gemma":[0.9998933,0.000012249619,0.000056882775,0.000003926525,0.000009631806,0.00002395134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000112702124,0.0001836306,0.00013909866,0.0002536555,0.00014143536,0.00014179495,0.00006475305,0.00012073595,0.00086790527],"category_scores_gemma":[0.000112965085,0.00005415477,0.00011558083,0.00017660565,0.00018182871,0.00006927625,0.00009273002,0.00015719477,0.00012172665],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014497289,0.000135467,0.15882057,0.0002237957,0.0000844202,0.00082860544,0.00010629602,0.00032635377,0.82485074,0.00015110677,0.00036310704,0.01265974],"study_design_scores_gemma":[0.00002940488,0.00059726596,0.91293466,0.000015458574,0.00006511755,0.0033776213,0.00008367768,0.00074383215,0.079847805,0.00009935521,0.002196675,0.000009203505],"about_ca_topic_score_codex":0.0004879697,"about_ca_topic_score_gemma":0.00062069733,"teacher_disagreement_score":0.00086790527,"about_ca_system_score_codex":0.0002133598,"about_ca_system_score_gemma":0.0001288371,"threshold_uncertainty_score":0.0029034019},"labels":[],"label_agreement":null},{"id":"W1965130823","doi":"10.1158/1078-0432.ccr-14-2668","title":"Treatment Planning and Fracture Prediction in Patients with Skeletal Metastasis with CT-Based Rigidity Analysis","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Foundation for the National Institutes of Health","keywords":"Metastasis; Rigidity (electromagnetism); Medicine; Radiology; Cancer; Internal medicine; Engineering; Structural engineering","score_opus":0.21530946700163828,"score_gpt":0.4998153551193157,"score_spread":0.2845058881176774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965130823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99828005,0.0002880264,0.00090973673,0.000058096022,0.000003690954,0.000021781898,0.00009878575,0.0000138774585,0.00032590952],"genre_scores_gemma":[0.9989447,0.000032886543,0.00086853723,0.000007142556,0.0000043546297,0.000006978583,0.00007743946,0.0000011927067,0.000056624856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992055,0.00035895503,0.000058986916,0.00010767409,0.00022329044,0.00004560721],"domain_scores_gemma":[0.99733293,0.0009509558,0.0012760503,0.000096350304,0.00020661924,0.00013709757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094686635,0.0003515936,0.00025724006,0.00065123936,0.00018948926,0.0002180241,0.0002576107,0.00029602568,0.0013192112],"category_scores_gemma":[0.0073489733,0.00020653212,0.00031909315,0.00035966892,0.00016379813,0.00023727871,0.00021476892,0.000266832,0.00022872901],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000227637,0.00004190838,0.99328315,0.000011481495,0.00001948562,0.00008126477,0.000017776714,0.0006744087,0.00039386915,0.0000090994645,0.000058849393,0.005181138],"study_design_scores_gemma":[0.00002566466,0.00066085707,0.98958325,0.0000124926855,0.000031537376,0.001070851,0.00005530534,0.0076891663,0.0006621807,0.000038529826,0.00015979432,0.000010309636],"about_ca_topic_score_codex":0.0022173969,"about_ca_topic_score_gemma":0.003156931,"teacher_disagreement_score":0.0022173969,"about_ca_system_score_codex":0.00029195676,"about_ca_system_score_gemma":0.00032947483,"threshold_uncertainty_score":0.005007565},"labels":[],"label_agreement":null},{"id":"W1965232242","doi":"10.1158/1078-0432.ovca13-a53","title":"Abstract A53: Biomarkers of chemotherapy resistance in serous epithelial ovarian cancer identified by integrative genomic and transcriptomic analysis","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Ottawa Hospital; Queen's University","funders":"","keywords":"Ovarian cancer; Chemotherapy; Gene expression profiling; Oncology; Microarray; Serous fluid; Microarray analysis techniques; Biology; Cancer research; Internal medicine; Cancer; Medicine; Gene expression; Bioinformatics; Gene; Genetics","score_opus":0.08205332957718654,"score_gpt":0.4533780097143822,"score_spread":0.37132468013719566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965232242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967489,0.00065841153,0.0012378403,0.000050705534,0.000004986553,0.000015846266,0.0009632494,0.000030084066,0.00029009767],"genre_scores_gemma":[0.99778724,0.00018093643,0.0010024353,0.000023940333,0.000005407506,0.000017529745,0.0007641359,0.0000034504947,0.0002149032],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998847,0.000023701348,0.000009364276,0.000035087734,0.000030026158,0.000016963922],"domain_scores_gemma":[0.9997794,0.000058720092,0.00009786061,0.000016538108,0.000027602458,0.000019816944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023976387,0.00017209027,0.00022243313,0.0009101219,0.00013221371,0.00031757387,0.0001086685,0.00017694953,0.0009852271],"category_scores_gemma":[0.0004650359,0.00007993221,0.00016813252,0.0006206169,0.00016570395,0.00011671327,0.00016747763,0.00016943482,0.00014525368],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091744534,0.00005918046,0.21516347,0.000115749666,0.00009948333,0.00034764266,0.000077422155,0.000754896,0.7660166,0.000120262164,0.00024009107,0.016087754],"study_design_scores_gemma":[0.000025332516,0.00034096054,0.9326458,0.000014869496,0.0001244044,0.0011152247,0.00015754951,0.003333897,0.06066924,0.0002699997,0.0012940076,0.000008702242],"about_ca_topic_score_codex":0.00041011875,"about_ca_topic_score_gemma":0.0004950263,"teacher_disagreement_score":0.0009852271,"about_ca_system_score_codex":0.00015961807,"about_ca_system_score_gemma":0.00010882799,"threshold_uncertainty_score":0.003295958},"labels":[],"label_agreement":null},{"id":"W1966248219","doi":"10.1158/1078-0432.ccr-08-0469","title":"Vorinostat and Sorafenib Synergistically Kill Tumor Cells via FLIP Suppression and CD95 Activation","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Vorinostat; Sorafenib; Histone deacetylase inhibitor; Cancer research; Histone deacetylase; Caspase 8; Chemistry; Programmed cell death; Apoptosis; Caspase 3; Biology; Histone; Biochemistry; Hepatocellular carcinoma","score_opus":0.1058552604124676,"score_gpt":0.4521050103355005,"score_spread":0.3462497499230329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966248219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922587,0.0031552082,0.0022436306,0.00014463764,0.000044561104,0.000077206016,0.00013845965,0.00008631454,0.001851359],"genre_scores_gemma":[0.99659014,0.00077467604,0.0010780739,0.00003365588,0.000013592266,0.000044765315,0.00016306172,0.000003915431,0.0012981681],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998684,0.000020589494,0.000011750038,0.000018293525,0.00003985474,0.000041059753],"domain_scores_gemma":[0.9999391,0.000008245351,0.000023225552,0.0000061431106,0.0000065025793,0.000016680147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011893599,0.00037463327,0.00034410722,0.00013719716,0.000107358064,0.0003222945,0.00017733614,0.00016237526,0.0012788214],"category_scores_gemma":[0.00010037412,0.00008439362,0.00024433996,0.00012267446,0.00020152518,0.00020953079,0.00020357153,0.00030093236,0.00027937815],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065538747,0.00012019064,0.0004146065,0.00011658379,0.000018615838,0.00014200572,0.000015327374,0.00025781413,0.99041677,0.00017655377,0.00012230198,0.007543816],"study_design_scores_gemma":[0.00016934327,0.0019334271,0.0028370686,0.0000064712544,0.000045586647,0.0006538201,0.00003007122,0.001277425,0.9890933,0.0000736093,0.0038745196,0.0000053437548],"about_ca_topic_score_codex":0.00017894314,"about_ca_topic_score_gemma":0.00050232233,"teacher_disagreement_score":0.0012788214,"about_ca_system_score_codex":0.00028938564,"about_ca_system_score_gemma":0.0002636417,"threshold_uncertainty_score":0.004278064},"labels":[],"label_agreement":null},{"id":"W1967264420","doi":"10.1158/1078-0432.ovca13-a17","title":"Abstract A17: FBxW7 duality in ovarian cancer: Novel insight into ovarian cancer pathogenesis","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ovarian cancer; Biology; Cancer research; Tissue microarray; Cell growth; Cell culture; Cancer; microRNA; Microarray analysis techniques; Transfection; Molecular biology; Immunohistochemistry; Immunology; Gene expression; Gene; Genetics","score_opus":0.16832284317935503,"score_gpt":0.46398677295393015,"score_spread":0.2956639297745751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967264420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8579811,0.11139101,0.0117047625,0.0049418407,0.00049904105,0.00008425359,0.000834543,0.0002821454,0.012281292],"genre_scores_gemma":[0.9606655,0.024824869,0.0030957824,0.00061017065,0.00031786042,0.000037859103,0.00067441,0.000024835948,0.009748657],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995625,0.0000069649477,0.0000036159597,0.00001093258,0.000009628353,0.0000126543],"domain_scores_gemma":[0.9999454,0.000006111047,0.000020364485,0.0000032945945,0.000008889621,0.0000159121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017419219,0.00042688407,0.00029085547,0.00042443024,0.00016133845,0.0005498352,0.0002481293,0.00058286305,0.0027778272],"category_scores_gemma":[0.000090592235,0.00011234996,0.00029962778,0.00028253195,0.00033659145,0.0003659415,0.0002660098,0.0006111792,0.00061667705],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011347499,0.00014848652,0.008485501,0.00084745785,0.000110468485,0.00351535,0.0001024622,0.00044595328,0.91162556,0.007502707,0.0031806943,0.062900506],"study_design_scores_gemma":[0.00027382822,0.002234126,0.08833671,0.00034713314,0.00041799233,0.021230258,0.00044143066,0.0067796186,0.7332607,0.013904705,0.13271491,0.00005845767],"about_ca_topic_score_codex":0.0002727492,"about_ca_topic_score_gemma":0.0002775135,"teacher_disagreement_score":0.0027778272,"about_ca_system_score_codex":0.00044026237,"about_ca_system_score_gemma":0.00025855112,"threshold_uncertainty_score":0.009292722},"labels":[],"label_agreement":null},{"id":"W1967639975","doi":"10.1158/1078-0432.ccr-14-2422","title":"First-in-Human Pharmacokinetic and Pharmacodynamic Study of the Dual m-TORC 1/2 Inhibitor AZD2014","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Institute for Health and Care Research; Cancer Research UK","keywords":"Mucositis; Medicine; Pharmacodynamics; Pharmacokinetics; Nausea; Cancer; Adverse effect; Cmax; Internal medicine; Pharmacology; Biopsy; Gastroenterology; In vivo; Oncology; Toxicity","score_opus":0.19641384518763919,"score_gpt":0.5264327362187183,"score_spread":0.3300188910310792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967639975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99352634,0.0014527384,0.0020695266,0.00023734037,0.000043724343,0.00033719602,0.0010436943,0.00018444697,0.0011050107],"genre_scores_gemma":[0.99454355,0.000424795,0.0012060336,0.0002167775,0.000055560726,0.00017716113,0.0016690918,0.00003058101,0.0016763022],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999589,0.00014666082,0.00001674824,0.000098770965,0.00007923485,0.00006956726],"domain_scores_gemma":[0.99970335,0.000044346245,0.000077264995,0.000038433343,0.000024694224,0.00011193347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008549185,0.0010390473,0.0014173149,0.00026541192,0.00036883834,0.0007503776,0.00044312005,0.0005469467,0.002060598],"category_scores_gemma":[0.000812023,0.00048737117,0.0005841956,0.00026302531,0.0005619796,0.00063479156,0.0002590441,0.0016724556,0.0006278627],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1422696,0.021448338,0.01941176,0.0005549922,0.0011041127,0.0011073432,0.0003430684,0.00788218,0.68247414,0.00035077936,0.0070487037,0.11600495],"study_design_scores_gemma":[0.032120787,0.42948544,0.092780605,0.000048955208,0.0014791606,0.007042354,0.00017011084,0.023879295,0.3889739,0.00051414577,0.023356523,0.00014880381],"about_ca_topic_score_codex":0.00095742074,"about_ca_topic_score_gemma":0.0011953117,"teacher_disagreement_score":0.002060598,"about_ca_system_score_codex":0.0014320769,"about_ca_system_score_gemma":0.0008233222,"threshold_uncertainty_score":0.0103904605},"labels":[],"label_agreement":null},{"id":"W1968120911","doi":"10.1158/1078-0432.ccr-14-1122-t","title":"A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein–Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity; Institute of Cancer Research","funders":"Hong Kong Cancer Fund; Cancer Research UK; Wellcome Trust","keywords":"ELISPOT; Vaccination; Modified vaccinia Ankara; Virology; Antigen; Immunogenicity; Immunology; Vaccinia; Virus; Epitope; Biology; CD8; Medicine; Recombinant DNA; Gene","score_opus":0.10733756620650188,"score_gpt":0.469174388612978,"score_spread":0.36183682240647613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968120911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936924,0.0042051086,0.0003611187,0.00023848124,0.00007991473,0.0006082838,0.00013344963,0.000040398056,0.00064088433],"genre_scores_gemma":[0.99407566,0.0027069193,0.0006517211,0.0003356267,0.000077740064,0.00075981056,0.00045488725,0.000011091092,0.00092656736],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996773,0.00018551243,0.00002126873,0.000043148382,0.000023134331,0.000049725848],"domain_scores_gemma":[0.9996131,0.000075906115,0.00008612306,0.000026523352,0.000032523196,0.00016582503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010252437,0.0007456459,0.0015498357,0.00018560162,0.00024337272,0.00048935774,0.000552855,0.0010631983,0.0014540794],"category_scores_gemma":[0.0009676514,0.0003818155,0.0005786546,0.00031851596,0.000586098,0.00058191526,0.00035282268,0.0016258731,0.00034229652],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6674239,0.021720491,0.011798584,0.002660285,0.0010658208,0.0010653776,0.0008566022,0.0034731717,0.07172017,0.00022512108,0.002900404,0.21509005],"study_design_scores_gemma":[0.35157967,0.6087499,0.027075268,0.00013086958,0.0005443214,0.0010524199,0.0001355316,0.0013185896,0.0049289837,0.00008694951,0.004363426,0.000034105913],"about_ca_topic_score_codex":0.0014435992,"about_ca_topic_score_gemma":0.0015685443,"teacher_disagreement_score":0.0015498357,"about_ca_system_score_codex":0.0008723372,"about_ca_system_score_gemma":0.0008348062,"threshold_uncertainty_score":0.006329298},"labels":[],"label_agreement":null},{"id":"W1968380007","doi":"10.1158/1078-0432.ccr-07-1347","title":"Rhabdoid Tumor Growth is Inhibited by Flavopiridol","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of General Medical Sciences; Albert Einstein College of Medicine, Yeshiva University; National Cancer Institute; Damon Runyon Cancer Research Foundation","keywords":"Cyclin D1; Cyclin-dependent kinase; Cancer research; Cyclin; In vivo; Cell cycle; Biology; Cell cycle checkpoint; Apoptosis; Cyclin A; In vitro; Cyclin B; Cell growth; Biochemistry","score_opus":0.17263395246410268,"score_gpt":0.48910284289031764,"score_spread":0.31646889042621495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968380007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98908114,0.005310763,0.0015634393,0.00011358312,0.000026113232,0.00007728562,0.00053903094,0.00013749838,0.0031512317],"genre_scores_gemma":[0.995008,0.0018344785,0.0012504503,0.00004717247,0.0000063726084,0.00004682635,0.0005891014,0.000011630972,0.0012059532],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991345,0.00001560797,0.0000070387546,0.000014666415,0.000026026051,0.000023212246],"domain_scores_gemma":[0.9999156,0.000018396126,0.000027645685,0.000009857578,0.0000119143815,0.00001656039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010869119,0.00047273975,0.00028959842,0.00021598917,0.0001528275,0.00015870656,0.00021290095,0.00020030049,0.0009070349],"category_scores_gemma":[0.000111824316,0.000102949845,0.00020473752,0.000119464305,0.00017426761,0.00014466829,0.00010934602,0.0004125605,0.00031638893],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019241308,0.000076813034,0.00027861804,0.000049487684,0.0000077948025,0.000052951964,0.0000097730235,0.00011359108,0.9965767,0.00003415544,0.00010958234,0.002497958],"study_design_scores_gemma":[0.000053953558,0.0009426535,0.007913409,0.000009706663,0.000016250518,0.00033258402,0.000022881393,0.00087377214,0.9871674,0.000027155462,0.0026365449,0.0000037559566],"about_ca_topic_score_codex":0.0019562263,"about_ca_topic_score_gemma":0.004080447,"teacher_disagreement_score":0.0019562263,"about_ca_system_score_codex":0.0005114887,"about_ca_system_score_gemma":0.00026579786,"threshold_uncertainty_score":0.00388968},"labels":[],"label_agreement":null},{"id":"W1969269674","doi":"10.1158/1078-0432.ccr-06-2971","title":"Hypoxia and Metastasis","year":2007,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Hypoxia (environmental); Metastasis; Medicine; Pathology; Internal medicine; Cancer; Chemistry; Oxygen","score_opus":0.4369067716985438,"score_gpt":0.5979723879879756,"score_spread":0.16106561628943178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969269674","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009508059,0.22482686,0.0006933494,0.14185432,0.6098544,0.00015846109,0.0007721108,0.0002142294,0.020675408],"genre_scores_gemma":[0.0053418954,0.11277491,0.00047759546,0.05283083,0.790661,0.00010325485,0.00097302714,0.00016726721,0.036670227],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976172,0.00025914615,0.00024269307,0.0003914717,0.001205878,0.00028353327],"domain_scores_gemma":[0.9961714,0.0009453302,0.0004930857,0.00021487093,0.00093117583,0.0012441416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00295189,0.0017931312,0.0024700828,0.0022646796,0.0021340929,0.008686355,0.0031165297,0.007911834,0.036633924],"category_scores_gemma":[0.004538716,0.0006996665,0.000969467,0.0015300091,0.0021745036,0.0042022117,0.0027764498,0.007582855,0.012167326],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007838154,0.00006114568,0.0004324433,0.000901585,0.000029687359,0.00016554553,0.00004916409,0.000099482924,0.0005073462,0.0035585614,0.90488386,0.08923277],"study_design_scores_gemma":[0.000020265334,0.00005050007,0.00061993534,0.00020670996,0.000014989592,0.00019744295,0.000043147204,0.00008996098,0.00016332856,0.001274889,0.9973085,0.000010425434],"about_ca_topic_score_codex":0.001055198,"about_ca_topic_score_gemma":0.002854252,"teacher_disagreement_score":0.036633924,"about_ca_system_score_codex":0.0025814874,"about_ca_system_score_gemma":0.0030026252,"threshold_uncertainty_score":0.12255275},"labels":[],"label_agreement":null},{"id":"W1969453628","doi":"10.1158/1078-0432.14aacriaslc-b19","title":"Abstract B19: Three-dimensional nuclear telomere organization and clinical significance in non-small cell lung cancer patients.","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Telomere; Cancer; Lung cancer; Oncology; Internal medicine; Interphase; Medicine; Biology; Pathology; Genetics; DNA","score_opus":0.0728585708960535,"score_gpt":0.4216324070994034,"score_spread":0.3487738362033499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969453628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99709964,0.0005431193,0.00014437293,0.00006702462,0.000012610787,0.00001439247,0.0010755624,0.000013369687,0.001029939],"genre_scores_gemma":[0.9986821,0.00007828524,0.00013310787,0.000016014637,0.000008780228,0.000011407431,0.00065177097,0.0000026234613,0.00041588358],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989355,0.000015157558,0.000013908985,0.000026916796,0.000031159685,0.000019318137],"domain_scores_gemma":[0.9995135,0.000063689076,0.0001751748,0.000020140595,0.00008368052,0.00014381783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021816406,0.00017397758,0.00020466119,0.0008222206,0.00038050432,0.000450233,0.0002242784,0.00038098104,0.0037339795],"category_scores_gemma":[0.0007889682,0.00010401735,0.00020216759,0.000785581,0.00023900863,0.00028402955,0.0002548878,0.00035070194,0.0006169892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046437577,0.0000262441,0.9931758,0.00001620823,0.00001783992,0.00028178067,0.000031027208,0.000040421364,0.0025741628,0.0000140664115,0.00027490433,0.0030831178],"study_design_scores_gemma":[0.0000072940634,0.000079670644,0.9980502,0.0000026418002,0.000011084887,0.0009523319,0.000054446748,0.00015305776,0.00036567554,0.00002482041,0.0002957937,0.000002958879],"about_ca_topic_score_codex":0.0024659212,"about_ca_topic_score_gemma":0.0027477175,"teacher_disagreement_score":0.0037339795,"about_ca_system_score_codex":0.00024279588,"about_ca_system_score_gemma":0.00017403264,"threshold_uncertainty_score":0.012491465},"labels":[],"label_agreement":null},{"id":"W1971460933","doi":"10.1158/1078-0432.mechres-a65","title":"Abstract A65: Combinational siRNA silencing of MCL-1 and P-gp enhances the apoptotic response in Human Breast Cancer Cells","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Gene silencing; Survivin; Small interfering RNA; Cancer research; Apoptosis; Cancer cell; Biology; Cell; Cancer; Chemistry; Cell culture; Transfection; Biochemistry","score_opus":0.11691506412690343,"score_gpt":0.4817236771012256,"score_spread":0.36480861297432216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971460933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99183345,0.0029907913,0.0021794522,0.00015176705,0.00006372626,0.00006528852,0.00038807353,0.0001466293,0.0021808536],"genre_scores_gemma":[0.99364305,0.00080666225,0.0016140718,0.00007464025,0.000013164903,0.000053434884,0.0004929667,0.000013827681,0.0032882409],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984753,0.000020430047,0.000017488666,0.000034261233,0.00004905908,0.000031152784],"domain_scores_gemma":[0.99995124,0.000009850074,0.000008437719,0.0000074491586,0.000011273345,0.000011667483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014192252,0.00025094525,0.00028143372,0.00021288026,0.00010286124,0.00024126083,0.0001202207,0.0002494805,0.0014341624],"category_scores_gemma":[0.00007677798,0.000098734185,0.00020850245,0.00016116578,0.00011180438,0.00011475903,0.00012174046,0.00036629123,0.00042955394],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001118233,0.000051040286,0.00010172785,0.000036359354,0.000006966344,0.000032829685,0.000016304592,0.000035562847,0.9980253,0.00003403978,0.00012948469,0.0014185454],"study_design_scores_gemma":[0.000023214776,0.00068868476,0.0017299437,0.0000037387297,0.000019561874,0.00020399694,0.000014041345,0.00055976404,0.9940995,0.000011578846,0.0026432117,0.0000027863455],"about_ca_topic_score_codex":0.00072724605,"about_ca_topic_score_gemma":0.00075156166,"teacher_disagreement_score":0.0014341624,"about_ca_system_score_codex":0.00019234869,"about_ca_system_score_gemma":0.00012984361,"threshold_uncertainty_score":0.0047978163},"labels":[],"label_agreement":null},{"id":"W1972275697","doi":"10.1158/1078-0432.ovca13-a18","title":"Abstract A18: Defining ovarian mucinous tumors: Cancer genes and heterogeneity","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"KRAS; CDKN2A; PTEN; Cancer research; Neuroblastoma RAS viral oncogene homolog; Ovarian cancer; Biology; Mucinous carcinoma; Genetic heterogeneity; Cancer; Mutation; Pathology; Gene; Adenocarcinoma; Medicine; Genetics; Phenotype; PI3K/AKT/mTOR pathway","score_opus":0.24405499687169965,"score_gpt":0.5141800381400699,"score_spread":0.2701250412683702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972275697","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98779374,0.0056168702,0.00184897,0.00025358296,0.000030053743,0.00006286881,0.0010409446,0.00005746537,0.0032956407],"genre_scores_gemma":[0.9932005,0.0012240577,0.0034842175,0.000077453784,0.000075840966,0.00003810622,0.0012609477,0.000024652078,0.00061410246],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972016,0.000044184042,0.000051098108,0.000059786365,0.00007241073,0.000052328578],"domain_scores_gemma":[0.9989962,0.0002878021,0.00034090134,0.000047034402,0.00017713362,0.00015093484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005266989,0.00032163764,0.00032772328,0.0030585013,0.00028431564,0.00087110914,0.00038976545,0.00041214484,0.002252293],"category_scores_gemma":[0.0012819318,0.00011560782,0.00020059463,0.0022259324,0.00055635953,0.00059608644,0.00069638033,0.00030024198,0.0005142826],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086796156,0.000047853937,0.81429017,0.00072065665,0.000100379126,0.007084579,0.00054087926,0.00037037634,0.120703146,0.0011671655,0.0017808584,0.052326005],"study_design_scores_gemma":[0.0000346962,0.00040333698,0.8915981,0.00015479595,0.00016138564,0.05425698,0.0010772642,0.0012195657,0.023423243,0.0019249858,0.02572356,0.000022072258],"about_ca_topic_score_codex":0.00050083833,"about_ca_topic_score_gemma":0.0005181795,"teacher_disagreement_score":0.0030585013,"about_ca_system_score_codex":0.00033757463,"about_ca_system_score_gemma":0.00025782172,"threshold_uncertainty_score":0.007534623},"labels":[],"label_agreement":null},{"id":"W1973137136","doi":"10.1158/1078-0432.ccr-07-1188","title":"New Approaches to Assessing and Treating Early-Stage Colon and Rectal Cancers: Cooperative Group Strategies for Assessing Optimal Approaches in Early-Stage Disease","year":2007,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Irinotecan; FOLFOX; Colorectal cancer; Bevacizumab; Internal medicine; Oncology; Clinical trial; Cetuximab; Oxaliplatin; Adjuvant therapy; Stage (stratigraphy); Randomized controlled trial; Cancer; Surgery; Chemotherapy","score_opus":0.704436166274384,"score_gpt":0.5804388981919771,"score_spread":0.12399726808240685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973137136","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029202225,0.2868536,0.29763293,0.30546507,0.008172263,0.023178102,0.0026201932,0.0007538858,0.04612168],"genre_scores_gemma":[0.17710814,0.06635655,0.6508007,0.053490337,0.006198631,0.0373141,0.003246028,0.00032076248,0.0051646815],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9185267,0.06625234,0.0036015995,0.0028860578,0.007569491,0.0011637382],"domain_scores_gemma":[0.92458326,0.02457038,0.008746025,0.00828095,0.026486568,0.0073328833],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.19609873,0.0022660606,0.0032716792,0.008251755,0.0029935476,0.0072727343,0.0047595208,0.0030910494,0.0020063587],"category_scores_gemma":[0.10001434,0.00077082805,0.0021813305,0.0064574666,0.0041706087,0.0059044044,0.007882168,0.006518391,0.00065255776],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019694176,0.0007866751,0.04915564,0.0025870944,0.0019250294,0.0000733181,0.0018649823,0.004763131,0.0012127637,0.045614187,0.08048929,0.8095586],"study_design_scores_gemma":[0.005111427,0.0049130293,0.09775606,0.015877644,0.0053107366,0.0003701708,0.005459367,0.023385586,0.0038060506,0.18963492,0.64770967,0.0006653712],"about_ca_topic_score_codex":0.024791593,"about_ca_topic_score_gemma":0.051303323,"teacher_disagreement_score":0.19609873,"about_ca_system_score_codex":0.012727668,"about_ca_system_score_gemma":0.041081253,"threshold_uncertainty_score":0.9913534},"labels":[],"label_agreement":null},{"id":"W1973250008","doi":"10.1158/1078-0432.ccr-07-1270","title":"Magnetic Resonance Imaging of the Breast Improves Detection of Invasive Cancer, Preinvasive Cancer, and Premalignant Lesions during Surveillance of Women at High Risk for Breast Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Mammography; Breast cancer; Magnetic resonance imaging; Radiology; Cancer; Ductal carcinoma; Ultrasound; Population; Prospective cohort study; Pathology; Internal medicine","score_opus":0.05557337028759279,"score_gpt":0.4089099272557698,"score_spread":0.353336556968177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973250008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99954504,0.00026121965,0.000037157733,0.000022314114,0.0000026860557,0.000007277924,0.000011761538,0.0000029377552,0.00010944746],"genre_scores_gemma":[0.9995821,0.00010797106,0.00017401575,0.00002761939,0.0000149723455,0.0000061077317,0.0000432273,7.558174e-7,0.00004327742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905556,0.0005322249,0.00006237094,0.000121558754,0.00014464179,0.00008362312],"domain_scores_gemma":[0.99659157,0.0018557293,0.00088524335,0.00016243335,0.00017996304,0.00032515137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018721287,0.00030207957,0.00034590007,0.0004920674,0.0001582039,0.00032015418,0.00024736446,0.00046234918,0.0006961958],"category_scores_gemma":[0.0064645465,0.00023441056,0.00020157994,0.00016157568,0.000284668,0.00033698222,0.00024020483,0.00030420785,0.000111945075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061958698,0.0012947163,0.9740968,0.00005499789,0.00013088179,0.0001404099,0.000118022035,0.000105657855,0.0049624136,0.00001173675,0.00007269581,0.012815852],"study_design_scores_gemma":[0.00016885216,0.0074108806,0.98916364,0.0000129628925,0.0000949212,0.0007140414,0.000079220736,0.00039929035,0.0018191524,0.00001462365,0.00011689635,0.0000055868413],"about_ca_topic_score_codex":0.00048865576,"about_ca_topic_score_gemma":0.0006412202,"teacher_disagreement_score":0.0018721287,"about_ca_system_score_codex":0.00016186574,"about_ca_system_score_gemma":0.00019790491,"threshold_uncertainty_score":0.009900868},"labels":[],"label_agreement":null},{"id":"W1974267960","doi":"10.1158/1078-0432.ccr-10-3077","title":"A Novel HSP90 Inhibitor Delays Castrate-Resistant Prostate Cancer without Altering Serum PSA Levels and Inhibits Osteoclastogenesis","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Canadian Institutes of Health Research; Association pour la Recherche sur le Cancer; Pfizer","keywords":"LNCaP; Prostate cancer; Cancer research; Protein kinase B; Geldanamycin; RANKL; Hsp90 inhibitor; Apoptosis; Metastasis; Medicine; Cancer; Endocrinology; Chemistry; Internal medicine; Hsp90; Receptor; Activator (genetics)","score_opus":0.255009640448238,"score_gpt":0.4650011787727075,"score_spread":0.20999153832446954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974267960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99034894,0.004130394,0.0019659302,0.0001511571,0.00006652553,0.00012760634,0.00043053797,0.0004775616,0.0023014015],"genre_scores_gemma":[0.99515367,0.0017968026,0.0011161795,0.00006922899,0.000016127668,0.000047049252,0.00059429987,0.000018901947,0.0011877313],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999379,0.000008534192,0.0000050425447,0.000009593036,0.00001658287,0.000022428321],"domain_scores_gemma":[0.9999672,0.0000022519544,0.00001211181,0.00000345479,0.0000033145209,0.00001153825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007840551,0.00049685437,0.00049334933,0.00031406136,0.00012995819,0.00021125196,0.00037313253,0.00020097273,0.0015166597],"category_scores_gemma":[0.000074665084,0.0001347659,0.00032210624,0.00033683557,0.00018043305,0.00017127095,0.0001649893,0.0007071937,0.000401607],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022544651,0.0011919213,0.00042822195,0.00032891583,0.00009512391,0.00021283056,0.0000309013,0.0010417317,0.9581196,0.0003372606,0.0008521637,0.035106864],"study_design_scores_gemma":[0.00345449,0.025400205,0.018628292,0.00004394187,0.0003402925,0.0034303342,0.00006835114,0.003573863,0.931107,0.00019255446,0.013710324,0.000050388924],"about_ca_topic_score_codex":0.00060965813,"about_ca_topic_score_gemma":0.0014092891,"teacher_disagreement_score":0.0015166597,"about_ca_system_score_codex":0.00020320248,"about_ca_system_score_gemma":0.00035092185,"threshold_uncertainty_score":0.005073786},"labels":[],"label_agreement":null},{"id":"W1974879801","doi":"10.1158/1078-0432.ccr-13-2574","title":"Toward a Drug Development Path That Targets Metastatic Progression in Osteosarcoma","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University; University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health","keywords":"Osteosarcoma; Metastasis; Medicine; Disease; Cancer; Drug development; Mechanism (biology); Clinical trial; Oncology; Bioinformatics; Drug; Internal medicine; Cancer research; Pharmacology; Biology","score_opus":0.3342715610672236,"score_gpt":0.5364661219312107,"score_spread":0.20219456086398707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974879801","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03836207,0.19226141,0.13162884,0.57604694,0.010538629,0.002416047,0.0005180774,0.0006729947,0.04755506],"genre_scores_gemma":[0.17083387,0.313559,0.3639564,0.118045494,0.0073468597,0.0016725977,0.0007893531,0.00024264264,0.02355379],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9977108,0.00083472783,0.00022356387,0.00024628875,0.0006751299,0.00030941566],"domain_scores_gemma":[0.9970151,0.0008203302,0.0004196885,0.00011688478,0.0009778135,0.0006501534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008045954,0.0006755846,0.00081729906,0.0019088436,0.001319661,0.0040852674,0.0010685679,0.0034182242,0.0042948485],"category_scores_gemma":[0.0044262423,0.00055276207,0.0008795019,0.0007178365,0.0024147904,0.0055145724,0.003112273,0.009383663,0.0016801257],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011674559,0.0026547885,0.002224251,0.0033995535,0.00011326669,0.001724225,0.0014399777,0.0051360964,0.08387782,0.16145149,0.09616524,0.64064574],"study_design_scores_gemma":[0.0012746798,0.0067514596,0.0023440665,0.00208042,0.00020324101,0.0018918826,0.0017790109,0.005639926,0.030290656,0.09670955,0.85087126,0.00016386618],"about_ca_topic_score_codex":0.0009652849,"about_ca_topic_score_gemma":0.004719563,"teacher_disagreement_score":0.008045954,"about_ca_system_score_codex":0.002425394,"about_ca_system_score_gemma":0.010679235,"threshold_uncertainty_score":0.042551577},"labels":[],"label_agreement":null},{"id":"W1975100932","doi":"10.1158/1078-0432.ccr-08-0736","title":"Irinophore C, a Novel Nanoformulation of Irinotecan, Alters Tumor Vascular Function and Enhances the Distribution of 5-Fluorouracil and Doxorubicin","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; TRIUMF; BC Cancer Agency","funders":"","keywords":"Doxorubicin; Irinotecan; Hypoxia (environmental); Chemistry; Pathology; Perfusion; Tumor hypoxia; Distribution (mathematics); Cancer research; Vascular endothelial growth factor; Medicine; Colorectal cancer; Internal medicine; Cancer; Chemotherapy","score_opus":0.10986905531051253,"score_gpt":0.4099216826880941,"score_spread":0.30005262737758154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975100932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962632,0.0009766889,0.002039293,0.000039573464,0.000014739259,0.000032218653,0.00005261606,0.000040437077,0.0005412599],"genre_scores_gemma":[0.993693,0.00083093316,0.004428538,0.0000690906,0.000009879707,0.000032033095,0.00013403746,0.000009202667,0.0007932741],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999001,0.000011709646,0.000006154529,0.000030849988,0.000031597385,0.00001956545],"domain_scores_gemma":[0.9999255,0.000014893522,0.000025849722,0.0000041494113,0.000011391263,0.000018105642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012315736,0.00029340107,0.00021592449,0.00013169493,0.000109789646,0.00017678864,0.00014972444,0.00034925775,0.00037963619],"category_scores_gemma":[0.00015638207,0.0000859363,0.00013643269,0.00007219091,0.00026946655,0.0002732234,0.000089874964,0.00025564447,0.000087769746],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041786367,0.000013762149,0.000037069214,0.000020820731,0.0000019064377,0.000012208482,0.0000037970383,0.000051039922,0.99907804,0.000016358113,0.000012020457,0.00071114406],"study_design_scores_gemma":[0.00002406518,0.0009103749,0.0024784333,0.000004080737,0.00001705883,0.00023583307,0.000007701323,0.0012015895,0.9942092,0.000009356975,0.0008967059,0.0000056459844],"about_ca_topic_score_codex":0.00091909076,"about_ca_topic_score_gemma":0.0011929588,"teacher_disagreement_score":0.00091909076,"about_ca_system_score_codex":0.0004355216,"about_ca_system_score_gemma":0.00023271635,"threshold_uncertainty_score":0.0031598806},"labels":[],"label_agreement":null},{"id":"W1975369490","doi":"10.1158/1078-0432.tcmusa10-a44","title":"Abstract A44: Inhibition of EGFR phosphorylation in a panel of human breast cancer cells correlates with synergistic interactions between gefitinib and 5'-DFUR, the bioactive metabolite of Xeloda®","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Gefitinib; Capecitabine; Pharmacology; Breast cancer; Chemistry; Cancer research; Thymidine phosphorylase; Growth inhibition; Cancer; Epidermal growth factor receptor; Cell growth; Medicine; Internal medicine; Colorectal cancer; Biochemistry","score_opus":0.17920524362037962,"score_gpt":0.5115915909656693,"score_spread":0.3323863473452897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975369490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894907,0.0034511902,0.0016046687,0.00010756973,0.00007504337,0.000083686915,0.0016605991,0.00014590957,0.003380638],"genre_scores_gemma":[0.9867622,0.0012766806,0.0019449213,0.000060248487,0.000033052576,0.00014794557,0.003930627,0.000020406611,0.005823765],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996238,0.000092800045,0.000034663055,0.00005538475,0.000110639594,0.00008272783],"domain_scores_gemma":[0.9998486,0.00004792889,0.000019852801,0.00001688474,0.00003077558,0.00003594833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002254462,0.0005589934,0.0005010167,0.00039785678,0.0001740997,0.00028602144,0.00015576878,0.00027878108,0.004361098],"category_scores_gemma":[0.00020253149,0.0001704622,0.00041101192,0.0004397071,0.00012603456,0.00015322817,0.0001700476,0.00046813104,0.0010103432],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041411046,0.00018832152,0.00066939567,0.000050675273,0.000018614906,0.00004379786,0.000016181937,0.000092709015,0.99548256,0.000022203403,0.00020068661,0.0028006649],"study_design_scores_gemma":[0.00003700578,0.0024275603,0.029817566,0.0000064102255,0.00004525541,0.00039137722,0.000036944177,0.0013713388,0.9634668,0.000019460324,0.0023706588,0.00000960719],"about_ca_topic_score_codex":0.0014316542,"about_ca_topic_score_gemma":0.001425761,"teacher_disagreement_score":0.004361098,"about_ca_system_score_codex":0.00021326482,"about_ca_system_score_gemma":0.00020191581,"threshold_uncertainty_score":0.01458931},"labels":[],"label_agreement":null},{"id":"W1976464671","doi":"10.1158/1078-0432.ccr-05-2354","title":"Serial Plasma Osteopontin Levels Have Prognostic Value in Metastatic Breast Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Alberta Cancer Foundation; University of Calgary; Western University","funders":"","keywords":"Osteopontin; Medicine; Internal medicine; Breast cancer; Oncology; Metastatic breast cancer; Multivariate analysis; Malignancy; Metastasis; Univariate analysis; Cancer; Proportional hazards model; Survival analysis; Prospective cohort study; Clinical significance","score_opus":0.2536032763087579,"score_gpt":0.5181946307969726,"score_spread":0.2645913544882147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976464671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993179,0.00042938354,0.0000899666,0.000027359089,0.0000050305066,0.0000065242975,0.000059294238,0.0000033086556,0.00006120707],"genre_scores_gemma":[0.9994783,0.000119768316,0.00016284126,0.0000149953385,0.000017732855,0.000009242308,0.00013416498,7.6174615e-7,0.00006216408],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997452,0.0000937458,0.00002077967,0.00005470132,0.000053447922,0.0000322404],"domain_scores_gemma":[0.9987791,0.00041798514,0.00046182936,0.000056668247,0.00007515353,0.00020925773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070609123,0.0003885068,0.00042538674,0.00027812825,0.00021331465,0.00026714563,0.00025905154,0.00036382844,0.00093555334],"category_scores_gemma":[0.0026173524,0.00022961397,0.00020386152,0.00028256536,0.00029060157,0.0002245022,0.00022483466,0.00044940604,0.00018681888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033473063,0.00014298111,0.9871802,0.000025546751,0.00006428109,0.00017065971,0.000026962143,0.00026747314,0.0030166036,0.000009589355,0.00012271648,0.005625716],"study_design_scores_gemma":[0.0002344406,0.0019130617,0.9934077,0.000010432841,0.00007924449,0.0012512374,0.000037086502,0.0014160215,0.001294346,0.00005349845,0.00029406784,0.0000088255065],"about_ca_topic_score_codex":0.00064959016,"about_ca_topic_score_gemma":0.00092649244,"teacher_disagreement_score":0.00093555334,"about_ca_system_score_codex":0.0002863311,"about_ca_system_score_gemma":0.00025459976,"threshold_uncertainty_score":0.003734231},"labels":[],"label_agreement":null},{"id":"W1976763248","doi":"10.1158/1078-0432.ccr-07-4781","title":"Oncostatin M Induces Bone Loss and Sensitizes Rat Osteosarcoma to the Antitumor Effect of Midostaurin <i>In vivo</i>","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Osteosarcoma; Oncostatin M; Medicine; Cancer research; Sarcoma; In vivo; Pathology; Bone cancer; Staurosporine; Internal medicine; Cytokine; Biology; Interleukin 6; Kinase; Protein kinase A","score_opus":0.1521995533053343,"score_gpt":0.4927389888784584,"score_spread":0.3405394355731241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976763248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997969,0.0004168799,0.0007337065,0.000033941196,0.000017886452,0.000023449225,0.00012972791,0.000048847174,0.0006265615],"genre_scores_gemma":[0.99689937,0.00060676323,0.0009163236,0.000029248356,0.000011218399,0.00003737702,0.00039130397,0.000010689757,0.00109788],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987316,0.000014816329,0.000012760566,0.000017168126,0.000036188485,0.000045882676],"domain_scores_gemma":[0.9999049,0.000012913931,0.000038751718,0.0000143117695,0.0000067315664,0.000022449407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009933604,0.00041014122,0.00032408562,0.00028801494,0.00010333746,0.00017732836,0.00012463874,0.00018102687,0.0011687775],"category_scores_gemma":[0.000077902005,0.00013665923,0.0002960683,0.00016835424,0.00023582013,0.00012208062,0.00014311569,0.00047510897,0.00024247362],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026253163,0.000082419596,0.0003982325,0.000025270869,0.0000052185655,0.00006193871,0.000008894204,0.00004314619,0.9979576,0.000045045123,0.000027353368,0.0010822786],"study_design_scores_gemma":[0.000055461678,0.0024340318,0.004585396,0.0000050092003,0.000024146348,0.00036649368,0.000031313357,0.0004090972,0.9912068,0.000023561188,0.0008562931,0.0000024593103],"about_ca_topic_score_codex":0.0005206728,"about_ca_topic_score_gemma":0.0010223064,"teacher_disagreement_score":0.0011687775,"about_ca_system_score_codex":0.0002460716,"about_ca_system_score_gemma":0.00022251415,"threshold_uncertainty_score":0.003910005},"labels":[],"label_agreement":null},{"id":"W1977732806","doi":"10.1158/1078-0432.ccr-06-1508","title":"Pathologic and Molecular Heterogeneity in Imatinib-Stable or Imatinib-Responsive Gastrointestinal Stromal Tumors","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Imatinib; PDGFRA; GiST; Cancer research; Imatinib mesylate; Tyrosine-kinase inhibitor; Stromal tumor; Stromal cell; Sarcoma; Tyrosine kinase; Pathology; Medicine; Proto-Oncogene Proteins c-kit; Biology; Cancer; Internal medicine; Receptor; Stem cell factor","score_opus":0.22951050713044943,"score_gpt":0.5427864574524165,"score_spread":0.3132759503219671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977732806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99961436,0.00015125208,0.000086230495,0.0000031182565,6.454874e-7,0.0000042480456,0.00002456751,0.000002810522,0.00011271563],"genre_scores_gemma":[0.99971825,0.000049916613,0.000080042606,0.000004033069,0.0000024668943,0.0000074044706,0.00009907734,0.0000014969451,0.00003725086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998135,0.000038382925,0.000029124598,0.000045339802,0.000044128155,0.000029618304],"domain_scores_gemma":[0.9996313,0.00010218055,0.00012325411,0.000029555407,0.000042403244,0.000071265735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002709825,0.00015726133,0.00022774952,0.0009376344,0.00018360488,0.00026617013,0.00012602769,0.00016425515,0.00079040544],"category_scores_gemma":[0.00062246807,0.00010822208,0.00011574129,0.00033296912,0.00029782866,0.00015993952,0.00025164918,0.00010822631,0.00018066324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011448049,0.00008156555,0.8348742,0.00006368278,0.00006879902,0.0033079966,0.00027323267,0.0002333495,0.15273051,0.00008297409,0.000073419396,0.0070654773],"study_design_scores_gemma":[0.000025362528,0.0004495193,0.9769315,0.0000043994937,0.000045453497,0.011193286,0.00021041691,0.0004274773,0.010274219,0.00008357324,0.00034936442,0.000005335815],"about_ca_topic_score_codex":0.00017279023,"about_ca_topic_score_gemma":0.00025232142,"teacher_disagreement_score":0.0009376344,"about_ca_system_score_codex":0.00014600994,"about_ca_system_score_gemma":0.00009048138,"threshold_uncertainty_score":0.0026441813},"labels":[],"label_agreement":null},{"id":"W1978066528","doi":"10.1158/1078-0432.ccr-14-2298","title":"Chemotherapy Rescues Hypoxic Tumor Cells and Induces Their Reoxygenation and Repopulation—An Effect That Is Inhibited by the Hypoxia-Activated Prodrug TH-302","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Chemotherapy; Hypoxia (environmental); Prodrug; Doxorubicin; Repopulation; Cancer research; Biology; Medicine; Pharmacology; Internal medicine; Chemistry; Stem cell; Oxygen; Cell biology; Haematopoiesis","score_opus":0.13531656723271088,"score_gpt":0.4325922844217213,"score_spread":0.29727571718901047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978066528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969199,0.0007640984,0.0011392664,0.00003903249,0.000010707107,0.000036943868,0.0000835509,0.000044958266,0.00096167607],"genre_scores_gemma":[0.9974468,0.00044776438,0.0009196606,0.000018704148,0.0000047103704,0.000020599322,0.0001412602,0.0000073846677,0.0009932439],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999652,0.000005954706,0.000002906429,0.0000070009046,0.000008337545,0.000010689827],"domain_scores_gemma":[0.99995494,0.0000063662446,0.000016097301,0.000004813011,0.0000040090526,0.000013713465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008466648,0.0002201483,0.0001983532,0.000112968955,0.00007190626,0.0001014598,0.00010358135,0.00011166203,0.000996033],"category_scores_gemma":[0.00006578317,0.000070928705,0.00009933196,0.000058169768,0.0001158736,0.000103552506,0.000088815184,0.00019722356,0.00016708637],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003692101,0.00006477688,0.00027817645,0.000032729855,0.0000036707804,0.000038824917,0.000006142519,0.000116979645,0.99636745,0.000059257523,0.000046003173,0.0026168134],"study_design_scores_gemma":[0.0000656886,0.0021521864,0.0040632077,0.0000048062357,0.000009756954,0.00028708024,0.000010673844,0.00078749866,0.9911385,0.000026217407,0.0014522804,0.0000020099635],"about_ca_topic_score_codex":0.00030283074,"about_ca_topic_score_gemma":0.0006405795,"teacher_disagreement_score":0.000996033,"about_ca_system_score_codex":0.00014210005,"about_ca_system_score_gemma":0.00014377346,"threshold_uncertainty_score":0.0033320189},"labels":[],"label_agreement":null},{"id":"W1979364783","doi":"10.1158/1078-0432.ccr-14-3026","title":"Systematic Screening Identifies Dual PI3K and mTOR Inhibition as a Conserved Therapeutic Vulnerability in Osteosarcoma","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Howard Hughes Medical Institute","keywords":"Osteosarcoma; PI3K/AKT/mTOR pathway; Druggability; Cancer research; Biology; Computational biology; Medicine; Bioinformatics; Signal transduction; Cell biology; Genetics; Gene","score_opus":0.27754495892627834,"score_gpt":0.5097353448381213,"score_spread":0.232190385911843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979364783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735274,0.00943601,0.010139492,0.0004411909,0.000069819056,0.00044508837,0.001344205,0.0003991857,0.0041975453],"genre_scores_gemma":[0.9823699,0.0064579844,0.0077470797,0.00019674966,0.000019417586,0.00015840534,0.0013332836,0.000038990125,0.001678146],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997106,0.000038739494,0.000029621866,0.00006158332,0.0001153425,0.00004400272],"domain_scores_gemma":[0.9998282,0.000034880377,0.00005733245,0.00002023011,0.000032625576,0.00002659416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038018904,0.00065356854,0.00076069526,0.00065490877,0.0002773114,0.0005281901,0.0003690617,0.00032621706,0.0014462452],"category_scores_gemma":[0.00027263898,0.00022528744,0.0005170763,0.00042530097,0.00044064384,0.00020932152,0.00040470058,0.0004995286,0.00033139013],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014879485,0.00011545421,0.0007855181,0.00016524621,0.000024803281,0.000097763965,0.000010273143,0.00032484726,0.9906669,0.00012441752,0.00010747393,0.0074283676],"study_design_scores_gemma":[0.00007800566,0.0023883826,0.006094329,0.00002600351,0.00019176885,0.0008456367,0.00004061518,0.0011275,0.98476,0.00010640423,0.0043267845,0.000014594996],"about_ca_topic_score_codex":0.00046045423,"about_ca_topic_score_gemma":0.0024220208,"teacher_disagreement_score":0.0014462452,"about_ca_system_score_codex":0.00044599915,"about_ca_system_score_gemma":0.0008635301,"threshold_uncertainty_score":0.0048381686},"labels":[],"label_agreement":null},{"id":"W1980136907","doi":"10.1158/1078-0432.ovca13-a81","title":"Abstract A81: Estrogen-responsiveness of the TFIID subunit TAF4B and its potential function in ovarian cancer, epigenetic regulation and meiotic DNA repair","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Biology; Estrogen; Epigenetics; Estrogen receptor; Endocrinology; Internal medicine; Cancer; Genetics; Medicine; Breast cancer; Gene","score_opus":0.14493503281830106,"score_gpt":0.45039400798789575,"score_spread":0.3054589751695947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980136907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748071,0.018135497,0.00252662,0.00038670463,0.00010558264,0.000024990313,0.0013410884,0.00005682041,0.002615569],"genre_scores_gemma":[0.9884729,0.0025391052,0.00096038147,0.00012149497,0.00004167414,0.000021371596,0.0016122245,0.000011371517,0.006219418],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999486,0.0000051354837,0.0000034582856,0.000017471479,0.000011323635,0.00001401243],"domain_scores_gemma":[0.99995077,0.000006736872,0.000016667685,0.000003873504,0.000008433378,0.000013507678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008099451,0.00020207143,0.00015389426,0.00027528097,0.00016813942,0.00021420183,0.00015246027,0.00023803687,0.0026800856],"category_scores_gemma":[0.00011126866,0.0000775367,0.00022564836,0.00021906347,0.00018430683,0.00010032178,0.00016106684,0.00017322093,0.00040826102],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000195285,0.000016849868,0.0021513947,0.000067646244,0.000008618761,0.00012409993,0.000011587186,0.000026003308,0.9938691,0.00010314633,0.000138766,0.003287468],"study_design_scores_gemma":[0.00009123258,0.0004927825,0.28162616,0.000047943224,0.00006449092,0.0020661277,0.00014866098,0.000994152,0.6905235,0.0004269907,0.023503635,0.000014401181],"about_ca_topic_score_codex":0.0013517006,"about_ca_topic_score_gemma":0.0007587766,"teacher_disagreement_score":0.0026800856,"about_ca_system_score_codex":0.00026378754,"about_ca_system_score_gemma":0.00010604877,"threshold_uncertainty_score":0.00896579},"labels":[],"label_agreement":null},{"id":"W1980243061","doi":"10.1158/1078-0432.ccr-10-3298","title":"Recombinant Human Erythropoietin in Combination with Chemotherapy Increases Breast Cancer Metastasis in Preclinical Mouse Models","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Janssen Canada; Canadian Institutes of Health Research","keywords":"Metastasis; Breast cancer; Erythropoietin; Recombinant DNA; Chemotherapy; Medicine; Cancer; Cancer research; Human breast; Oncology; Internal medicine; Biology; Gene; Biochemistry","score_opus":0.31986365134490014,"score_gpt":0.506537906879538,"score_spread":0.1866742555346379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980243061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863499,0.0050076954,0.0040012305,0.0004701758,0.00016138788,0.00016761804,0.0007848944,0.00040028582,0.0026567327],"genre_scores_gemma":[0.9852143,0.0033002524,0.004017753,0.00013743722,0.00004776973,0.00021696085,0.00090117974,0.000097277065,0.0060671065],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996544,0.00007183449,0.000026306741,0.00006483124,0.00012484398,0.00005773032],"domain_scores_gemma":[0.99965477,0.0000644165,0.00010967127,0.000039634866,0.000028353894,0.00010316604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035771143,0.00074890064,0.00066196773,0.0008011696,0.0001555954,0.00045260054,0.00036378458,0.00047788688,0.0020583556],"category_scores_gemma":[0.00025568175,0.00028245547,0.00040190914,0.00034975188,0.00037525807,0.0004231665,0.00021084929,0.0013688039,0.00048080133],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010189732,0.00076616294,0.00023845622,0.00008128275,0.00002442185,0.000047211477,0.000024584491,0.00022649064,0.99408674,0.00008311196,0.00023691914,0.0031656232],"study_design_scores_gemma":[0.00018672702,0.007061627,0.0028276504,0.000024009893,0.000079365185,0.00022209261,0.000027382737,0.0017626586,0.9847504,0.000057438432,0.0029919462,0.000008580396],"about_ca_topic_score_codex":0.00086788385,"about_ca_topic_score_gemma":0.0013429482,"teacher_disagreement_score":0.0020583556,"about_ca_system_score_codex":0.00050790515,"about_ca_system_score_gemma":0.000377529,"threshold_uncertainty_score":0.006885886},"labels":[],"label_agreement":null},{"id":"W1980754306","doi":"10.1158/1078-0432.ccr-11-0127","title":"Genetic Aberrations Leading to MAPK Pathway Activation Mediate Oncogene-Induced Senescence in Sporadic Pilocytic Astrocytomas","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; SickKids Foundation; Hospital for Sick Children; Montreal Children's Hospital","funders":"Canadian Institutes of Health Research; Hungarian Scientific Research Fund; Brain Tumour Charity","keywords":"Senescence; Cancer research; MAPK/ERK pathway; Biology; Pilocytic astrocytoma; Genetics; Medicine; Signal transduction; Astrocytoma; Glioma","score_opus":0.4508395135005584,"score_gpt":0.5157327345350291,"score_spread":0.0648932210344707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980754306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992655,0.0002472295,0.00021007143,0.0000060492634,0.0000016605137,0.000007742993,0.000045111516,0.000014419221,0.00020228456],"genre_scores_gemma":[0.999527,0.00012491786,0.00016567828,0.0000034791685,0.0000016243642,0.000009300275,0.00007217724,0.0000021792396,0.00009361439],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989057,0.00001920498,0.000015076894,0.000017032755,0.00003164748,0.000026488748],"domain_scores_gemma":[0.99980646,0.000031087904,0.00008044532,0.000028018647,0.000022594362,0.00003131781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013030552,0.00025875113,0.00015231408,0.00037254606,0.00020187213,0.00020776896,0.000097451404,0.00017339429,0.00078631344],"category_scores_gemma":[0.00036096442,0.000119845965,0.00016154318,0.00024059675,0.00019110157,0.00014481749,0.00019876669,0.00016075782,0.00028237252],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042243037,0.000060713042,0.057594813,0.00009008337,0.000019193103,0.0011986016,0.00009753729,0.000117071206,0.93609565,0.00008448011,0.00005438427,0.0041649793],"study_design_scores_gemma":[0.000039017086,0.0015611317,0.5475272,0.000021656673,0.00008747756,0.02253559,0.00031995703,0.0015545753,0.42290488,0.00023998103,0.0031970798,0.000011516239],"about_ca_topic_score_codex":0.000339725,"about_ca_topic_score_gemma":0.0005170075,"teacher_disagreement_score":0.00078631344,"about_ca_system_score_codex":0.00020799412,"about_ca_system_score_gemma":0.00015997888,"threshold_uncertainty_score":0.0026304722},"labels":[],"label_agreement":null},{"id":"W1981631249","doi":"10.1158/1078-0432.ccr-05-0429","title":"Intermittent Exposure of Primitive Quiescent Chronic Myeloid Leukemia Cells to Granulocyte-Colony Stimulating Factor <i>In vitro</i> Promotes their Elimination by Imatinib Mesylate","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Imatinib mesylate; Medicine; Myeloid leukemia; Granulocyte colony-stimulating factor; Imatinib; Mesylate; Pharmacology; CD34; Leukemia; Haematopoiesis; Immunology; Chemotherapy; Internal medicine; Stem cell; Chemistry; Biology","score_opus":0.073390416314338,"score_gpt":0.4188013356411297,"score_spread":0.3454109193267917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981631249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99742174,0.0012009724,0.0006488929,0.000021184607,0.000013410764,0.000016851469,0.00009699479,0.000021176607,0.00055867556],"genre_scores_gemma":[0.9979665,0.00047324665,0.0008065989,0.000030109097,0.000016500959,0.00003290338,0.00030625553,0.000005446459,0.00036245584],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990344,0.000018172794,0.000009086453,0.000018269497,0.000024918916,0.000026176062],"domain_scores_gemma":[0.99988747,0.00003017019,0.000031154264,0.000017179294,0.000009096418,0.000025022082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010324429,0.00021615955,0.000243276,0.000100008096,0.00010237344,0.00022425615,0.00017148405,0.00011713628,0.0009854743],"category_scores_gemma":[0.00014824954,0.000074253265,0.00019986858,0.00009995728,0.00015618924,0.0000959871,0.00015118472,0.00033660687,0.00024172665],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000670967,0.000093324954,0.0015684131,0.00005583817,0.0000072213625,0.000070601745,0.00003322996,0.000083886116,0.9929097,0.00005253661,0.00008154345,0.0043727015],"study_design_scores_gemma":[0.00009247333,0.003045699,0.04389285,0.00001779731,0.000047863483,0.00058323366,0.000051283365,0.0012042815,0.94745773,0.000038346916,0.0035616816,0.000006674959],"about_ca_topic_score_codex":0.00031139268,"about_ca_topic_score_gemma":0.00060830347,"teacher_disagreement_score":0.0009854743,"about_ca_system_score_codex":0.000193302,"about_ca_system_score_gemma":0.00011323783,"threshold_uncertainty_score":0.003296733},"labels":[],"label_agreement":null},{"id":"W1982792443","doi":"10.1158/1078-0432.ccr-03-0541","title":"Carbonic Anhydrase IX as a Marker for Poor Prognosis in Soft Tissue Sarcoma","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Enzyme function and inhibition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada); Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Sarcoma; Pathology; Soft tissue sarcoma; Soft tissue; Metastasis; Stroma; Immunohistochemistry; Medicine; Internal medicine; Cancer","score_opus":0.10740427588394963,"score_gpt":0.48592295641640376,"score_spread":0.37851868053245413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982792443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99898154,0.00039412198,0.00032685685,0.000015359401,0.0000017147427,0.0000047808544,0.000038832746,0.0000051554725,0.0002315723],"genre_scores_gemma":[0.99968827,0.000053507352,0.00015138579,0.0000028525023,0.0000027503706,0.0000026146192,0.00004629426,6.119689e-7,0.000051737654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999892,0.000027527276,0.000012855766,0.000019368339,0.000030671228,0.000017579692],"domain_scores_gemma":[0.9994661,0.00012568456,0.00023295659,0.00002625412,0.00005927278,0.00008982802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029536994,0.00018993678,0.0001570776,0.0006316837,0.00014741799,0.00025732003,0.000107324086,0.00016985978,0.00084746524],"category_scores_gemma":[0.00075526745,0.00006695515,0.00009758913,0.00035253388,0.00030565856,0.00019919548,0.0002799944,0.0001896035,0.00013856225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006207087,0.000016056825,0.9714947,0.0000341324,0.000031568816,0.00015332777,0.00004937631,0.00022400432,0.02163769,0.00003470087,0.0000603994,0.0056433687],"study_design_scores_gemma":[0.000011389094,0.00031168494,0.9903086,0.000010605643,0.00004234008,0.0013770682,0.00008723187,0.0011568497,0.0062993024,0.00009992164,0.00028999,0.000005008337],"about_ca_topic_score_codex":0.00044198186,"about_ca_topic_score_gemma":0.00062901503,"teacher_disagreement_score":0.00084746524,"about_ca_system_score_codex":0.000240533,"about_ca_system_score_gemma":0.00015750008,"threshold_uncertainty_score":0.0028350353},"labels":[],"label_agreement":null},{"id":"W1983400019","doi":"10.1158/1078-0432.ccr-12-1518","title":"Contrasted Outcomes to Gefitinib on Tumoral IGF1R Expression in Head and Neck Cancer Patients Receiving Postoperative Chemoradiation (GORTEC Trial 2004-02)","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institut National Du Cancer; Association pour la Recherche sur le Cancer; Institute of Cancer Research; AstraZeneca","keywords":"Gefitinib; Medicine; Internal medicine; Oncology; Population; Randomization; Placebo; Epidermal growth factor receptor; Cancer; Randomized controlled trial; Pathology","score_opus":0.24955806398645167,"score_gpt":0.5430750267725832,"score_spread":0.2935169627861316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983400019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982248,0.00080592174,0.000053201336,0.00013726047,0.000033196422,0.00019139981,0.00019877813,0.000009041687,0.00034643163],"genre_scores_gemma":[0.99754876,0.00035406766,0.00020107688,0.00024291377,0.00009872327,0.0003286457,0.0007388773,0.0000032049575,0.00048369932],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99914837,0.00053978607,0.00003677428,0.00010973642,0.000065197484,0.000100164005],"domain_scores_gemma":[0.9994998,0.00010710024,0.00016140222,0.00004743814,0.000024230027,0.00016002984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014959574,0.00077575794,0.0012988051,0.00017627036,0.00022271473,0.0006513409,0.0004472675,0.0007221399,0.001714378],"category_scores_gemma":[0.0010469935,0.00023143913,0.0011103097,0.00019094713,0.00054913154,0.00043148195,0.00031508133,0.0010090566,0.00025036238],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9213433,0.005919638,0.033675745,0.00038567456,0.0015268628,0.000092488386,0.000060950984,0.0011033119,0.0062887813,0.00011530439,0.0010128799,0.028475054],"study_design_scores_gemma":[0.5292679,0.2880703,0.17119588,0.000070254275,0.0026871555,0.00029334292,0.000070267204,0.0017391889,0.0034410846,0.00021083449,0.0029028575,0.000051069073],"about_ca_topic_score_codex":0.00074293505,"about_ca_topic_score_gemma":0.0022893888,"teacher_disagreement_score":0.001714378,"about_ca_system_score_codex":0.00088034413,"about_ca_system_score_gemma":0.0012216682,"threshold_uncertainty_score":0.007911444},"labels":[],"label_agreement":null},{"id":"W1984081057","doi":"10.1158/1078-0432.ccr-04-2472","title":"Reduction of Intracellular pH as a Strategy to Enhance the pH-Dependent Cytotoxic Effects of Melphalan for Human Breast Cancer Cells","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Intracellular; Extracellular; Melphalan; Pharmacology; Chemotherapy; Toxicity; Intracellular pH; Cancer cell; Cell culture; Cancer research; Cytotoxicity; Cancer; Chemistry; Biology; Medicine; Biochemistry; In vitro; Internal medicine","score_opus":0.06719563692912052,"score_gpt":0.5019993930199956,"score_spread":0.4348037560908751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984081057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954607,0.0010693689,0.002491109,0.00011038601,0.000020125804,0.00003769959,0.000085015694,0.00004081078,0.0006847738],"genre_scores_gemma":[0.99347854,0.00069351966,0.0047758278,0.000041655883,0.000007768059,0.000024994639,0.00009766106,0.000010747252,0.000869339],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999337,0.000017117616,0.000006682075,0.000013212743,0.000014140962,0.000015042988],"domain_scores_gemma":[0.9999536,0.000012534279,0.000011902898,0.0000067342958,0.0000052204327,0.000009894404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011934476,0.00020308976,0.0002029231,0.00009827308,0.00009626815,0.0002371715,0.00014971216,0.0001848221,0.00066653936],"category_scores_gemma":[0.00010636201,0.0001002491,0.00013700094,0.0000980735,0.00011380354,0.00014178616,0.0001313969,0.00030832514,0.00014667779],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075860204,0.000021786504,0.000065365646,0.0000146074035,0.000002222628,0.000014848747,0.0000064670844,0.000058410842,0.9987274,0.000021486712,0.000012997001,0.0009785123],"study_design_scores_gemma":[0.000010338991,0.00035285577,0.0007801951,0.0000014199345,0.0000059257845,0.000073047166,0.0000070825904,0.00031569152,0.9978521,0.0000074273844,0.0005921639,0.0000016425472],"about_ca_topic_score_codex":0.00054614997,"about_ca_topic_score_gemma":0.0014135048,"teacher_disagreement_score":0.00066653936,"about_ca_system_score_codex":0.00020509372,"about_ca_system_score_gemma":0.00018111459,"threshold_uncertainty_score":0.0022297502},"labels":[],"label_agreement":null},{"id":"W1984391626","doi":"10.1158/1078-0432.tcmusa10-a11","title":"Abstract A11: Regulation of CD133 by the tubulin deacetylase HDAC6 can alter cancer cell state","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Biology; HDAC6; Cell biology; Progenitor cell; Cancer research; Acetylation; Stem cell; Histone deacetylase; Molecular biology; Histone; Genetics","score_opus":0.06519240995401616,"score_gpt":0.4615438784333071,"score_spread":0.3963514684792909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984391626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869668,0.0014119569,0.005008021,0.00027148303,0.00011081936,0.000041175586,0.0020540215,0.00024109495,0.0038946378],"genre_scores_gemma":[0.9865137,0.0006121795,0.0027703163,0.0000856587,0.000013518308,0.000035417444,0.0021573785,0.00006310682,0.007748604],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988985,0.000011491982,0.000010513703,0.000027361542,0.000035420355,0.000025381425],"domain_scores_gemma":[0.99993205,0.000012588996,0.00001734558,0.000009806049,0.000009044764,0.000019079684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000815624,0.00024403822,0.00020919382,0.000121735015,0.00015494513,0.00030963484,0.00018376863,0.00022465015,0.0046293093],"category_scores_gemma":[0.000086217595,0.000095772426,0.00023759516,0.00017910787,0.00016848286,0.00014711411,0.00016399378,0.0005067608,0.0008377495],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007055988,0.000016024853,0.00013313068,0.00001901239,0.000003173116,0.00001979434,0.0000041799376,0.000023929142,0.99876654,0.000060320494,0.00006762207,0.00081565924],"study_design_scores_gemma":[0.0000054033126,0.00007409937,0.002161462,0.0000012491581,0.0000051954185,0.00004691635,0.0000059977833,0.0002739807,0.9956605,0.000020421567,0.0017430318,0.0000015614671],"about_ca_topic_score_codex":0.00071682513,"about_ca_topic_score_gemma":0.00089789915,"teacher_disagreement_score":0.0046293093,"about_ca_system_score_codex":0.00032622268,"about_ca_system_score_gemma":0.00014765335,"threshold_uncertainty_score":0.015486598},"labels":[],"label_agreement":null},{"id":"W1984727975","doi":"10.1158/1078-0432.ovca13-b70","title":"Abstract B70: Akt-activated endothelium constitute a niche for residual disease and resistance to bevacizumab in ovarian cancer","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Bevacizumab; Ovarian cancer; Angiogenesis; Cancer research; Medicine; Matrigel; Protein kinase B; Cancer; Cancer cell; Immunology; Vascular endothelial growth factor; Biology; Internal medicine; Chemotherapy; Signal transduction; Cell biology","score_opus":0.09998340124556057,"score_gpt":0.45204887550893214,"score_spread":0.35206547426337154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984727975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99344677,0.0029915937,0.0010114396,0.00019359947,0.000025631121,0.000016953743,0.00029254207,0.000030982796,0.00199055],"genre_scores_gemma":[0.9973182,0.00048764536,0.00042920036,0.00004795481,0.000007407802,0.000011307362,0.0002840203,0.0000032263495,0.0014111443],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999169,0.000012799519,0.000006399415,0.000015575666,0.000028090211,0.000020155316],"domain_scores_gemma":[0.9999291,0.000011889741,0.000020653993,0.0000069349067,0.000011079254,0.000020423862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011399286,0.00012744781,0.000109287845,0.00020903432,0.00010270902,0.00028237764,0.000094504874,0.00021482074,0.0022469843],"category_scores_gemma":[0.000109821885,0.00009113255,0.00015401434,0.00012312084,0.00012790179,0.00017567386,0.000099312936,0.0004156348,0.00029743026],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005769614,0.000085316744,0.0061892453,0.0001096629,0.000020345677,0.00036011764,0.000033786655,0.000099405785,0.98677385,0.00038463043,0.00027077505,0.0050959066],"study_design_scores_gemma":[0.0001985076,0.0017629307,0.24411675,0.00005536428,0.00013682758,0.011595808,0.00027871225,0.004574271,0.7156716,0.00090183015,0.020687144,0.000020260288],"about_ca_topic_score_codex":0.00048389198,"about_ca_topic_score_gemma":0.0004234605,"teacher_disagreement_score":0.0022469843,"about_ca_system_score_codex":0.00020326352,"about_ca_system_score_gemma":0.00017051537,"threshold_uncertainty_score":0.007516861},"labels":[],"label_agreement":null},{"id":"W1984747105","doi":"10.1158/1078-0432.ovca13-a45","title":"Abstract A45: Beclin1-independent autophagy promotes the survival of metastatic ovarian cancer cells","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Autophagy; Cell biology; Downregulation and upregulation; ATG5; BAG3; Biology; Autophagosome; Small interfering RNA; Cancer research; Chemistry; Cell culture; Transfection; Apoptosis; Biochemistry","score_opus":0.2438841706056255,"score_gpt":0.5240248442800706,"score_spread":0.28014067367444506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984747105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936399,0.0022721768,0.001076189,0.00016535513,0.000049747672,0.000026520074,0.0006629978,0.0001020604,0.0020050467],"genre_scores_gemma":[0.99509627,0.00068502565,0.0007654522,0.000071714356,0.000015044464,0.000030192221,0.00083125033,0.0000139622125,0.0024911684],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998982,0.000014020947,0.000011882663,0.000021488935,0.000028895438,0.000025487392],"domain_scores_gemma":[0.99994075,0.000009810906,0.000010817922,0.000007703555,0.000009354117,0.000021630718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012188683,0.00022960608,0.00031918686,0.00023199567,0.00023005025,0.00024034752,0.00009303799,0.00020081892,0.0017947434],"category_scores_gemma":[0.00007471644,0.000106930485,0.00026899143,0.00019094568,0.0001531128,0.00014136026,0.00020425611,0.00043394702,0.0005158018],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012834853,0.000036566355,0.00014325786,0.000041750973,0.0000049614205,0.000046537993,0.000010919733,0.00003994699,0.99842215,0.0000705772,0.00014474543,0.0009102148],"study_design_scores_gemma":[0.00003763568,0.0005904594,0.008111029,0.000010064884,0.000019709185,0.00029676166,0.000025772071,0.0012047152,0.9852669,0.000055001343,0.0043772263,0.0000046896894],"about_ca_topic_score_codex":0.00073985563,"about_ca_topic_score_gemma":0.0007964757,"teacher_disagreement_score":0.0017947434,"about_ca_system_score_codex":0.00025987878,"about_ca_system_score_gemma":0.00027720252,"threshold_uncertainty_score":0.0060040355},"labels":[],"label_agreement":null},{"id":"W1984754167","doi":"10.1158/1078-0432.ccr-06-2482","title":"Primary Tumor Levels of Human Tissue Kallikreins Affect Surgical Success and Survival in Ovarian Cancer Patients","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Ascites; Univariate analysis; Oncology; Internal medicine; Hazard ratio; Multivariate analysis; Plasminogen activator; Ovarian cancer; Kallikrein; Plasminogen activator inhibitor-1; Cancer; Gastroenterology; Gynecology; Confidence interval; Biology","score_opus":0.18198371862328605,"score_gpt":0.5220958549526304,"score_spread":0.3401121363293444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984754167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994025,0.00027987102,0.000033876524,0.00002919665,0.0000035374592,0.0000020744287,0.00007760243,0.0000019761762,0.00016926797],"genre_scores_gemma":[0.99978226,0.00005026309,0.000015357924,0.000007692299,0.000004979141,0.0000014375581,0.00008265845,4.05287e-7,0.00005494647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999206,0.00001732052,0.000006855794,0.000014525985,0.000014279901,0.000026352194],"domain_scores_gemma":[0.99943775,0.0001585631,0.00021492576,0.000020614942,0.00003185022,0.00013632659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016084644,0.0001432536,0.00015696949,0.00019326035,0.00018982362,0.00025215908,0.000098911536,0.00022588944,0.0014337758],"category_scores_gemma":[0.001279422,0.000087458204,0.00018641425,0.00022133872,0.00019482577,0.00021216292,0.00015297737,0.00022977777,0.00016563397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019487899,0.000015962962,0.9976635,0.0000051930074,0.000019730924,0.000079085454,0.000019609985,0.000057427846,0.00035641578,0.00000492872,0.00006971724,0.0015136444],"study_design_scores_gemma":[0.000008039143,0.00010527115,0.9989599,0.0000026724445,0.000018291796,0.00040173318,0.000043820735,0.00016510164,0.00015347656,0.000019998657,0.00011997947,0.0000016031388],"about_ca_topic_score_codex":0.00072734203,"about_ca_topic_score_gemma":0.00095741835,"teacher_disagreement_score":0.0014337758,"about_ca_system_score_codex":0.00015807374,"about_ca_system_score_gemma":0.00017582535,"threshold_uncertainty_score":0.004796505},"labels":[],"label_agreement":null},{"id":"W1985360090","doi":"10.1158/1078-0432.ccr-08-1726","title":"<i>In vivo</i> Knockdown of the Androgen Receptor Results in Growth Inhibition and Regression of Well-Established, Castration-Resistant Prostate Tumors","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Prostate cancer; In vivo; Androgen receptor; Gene knockdown; Prostate; Castration; Androgen; Internal medicine; Endocrinology; Medicine; Cancer research; Oncology; Biology; Cancer; Hormone; Cell culture","score_opus":0.10638888335839422,"score_gpt":0.432199639747603,"score_spread":0.32581075638920876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985360090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96383023,0.004827361,0.009311049,0.00071228464,0.0003323408,0.00025900704,0.007388191,0.0016826047,0.011657024],"genre_scores_gemma":[0.9673246,0.0024983769,0.007116429,0.00032868914,0.00006651272,0.00022357819,0.0070051737,0.00026454622,0.015172128],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997588,0.000025135187,0.000024405972,0.00005921984,0.00007452653,0.00005795127],"domain_scores_gemma":[0.9998216,0.000017543422,0.00007981662,0.000021919846,0.000017138173,0.00004197425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019308923,0.0007753489,0.00033197732,0.0003440229,0.00019452618,0.00032151223,0.00039565173,0.00027975958,0.003463509],"category_scores_gemma":[0.00010218198,0.0001803823,0.00041448718,0.00023334891,0.0003747942,0.000219727,0.00013632356,0.0010165399,0.0010469715],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020519055,0.00009457384,0.00017600239,0.00008507876,0.0000117846,0.000032346965,0.000006986521,0.00009223515,0.9971649,0.00012043794,0.00059270073,0.0014178557],"study_design_scores_gemma":[0.00003185362,0.0004934477,0.0022486497,0.000006165961,0.000021829606,0.00015092308,0.000009364098,0.0005408146,0.99385935,0.000023241351,0.0026103882,0.00000410361],"about_ca_topic_score_codex":0.0016971235,"about_ca_topic_score_gemma":0.002564114,"teacher_disagreement_score":0.003463509,"about_ca_system_score_codex":0.00055540603,"about_ca_system_score_gemma":0.00034599245,"threshold_uncertainty_score":0.0115866065},"labels":[],"label_agreement":null},{"id":"W1985878765","doi":"10.1158/1078-0432.ccr-07-1066","title":"Combining the Antigen Processing Components TAP and Tapasin Elicits Enhanced Tumor-Free Survival","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"University of Toronto; Yale University","keywords":"MHC class I; CD8; Antigen processing; Antigen; Biology; Immunology; CTL*; Antigen presentation; Priming (agriculture); Transporter associated with antigen processing; Major histocompatibility complex; MHC class II; Dendritic cell; T cell; Cancer research; Immune system","score_opus":0.21577369691725387,"score_gpt":0.45141489050465233,"score_spread":0.23564119358739846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985878765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99808574,0.0003925326,0.0008987444,0.000039959625,0.000025299267,0.000023947312,0.00012587153,0.000045218134,0.00036261915],"genre_scores_gemma":[0.9972807,0.0002596358,0.0009305087,0.000031281146,0.0000119295055,0.000028072373,0.0003270256,0.00001093096,0.0011198733],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998048,0.000022203127,0.000018751798,0.00004395821,0.00005923872,0.00005109795],"domain_scores_gemma":[0.9998312,0.000030521547,0.00004754229,0.0000234756,0.00001154007,0.00005562669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001377078,0.0006000727,0.00040390334,0.00018676581,0.000093250004,0.0002782991,0.00021929313,0.00030364082,0.0010375174],"category_scores_gemma":[0.000108869404,0.00012217576,0.0002289125,0.00014256827,0.00027965053,0.00024628214,0.00025820106,0.0007816517,0.00024456088],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020278557,0.00009189855,0.00010289588,0.000029140097,0.0000049973264,0.000026189686,0.000006653256,0.00009310543,0.9985347,0.0000249311,0.000024269988,0.00085847377],"study_design_scores_gemma":[0.00004961003,0.0023019707,0.0015894539,0.0000051625616,0.000026236783,0.00021409623,0.000014502004,0.0011017304,0.99380165,0.000023402516,0.00086802465,0.0000041331105],"about_ca_topic_score_codex":0.00030136073,"about_ca_topic_score_gemma":0.00037111714,"teacher_disagreement_score":0.0010375174,"about_ca_system_score_codex":0.0003334164,"about_ca_system_score_gemma":0.00023738707,"threshold_uncertainty_score":0.003470838},"labels":[],"label_agreement":null},{"id":"W1985964388","doi":"10.1158/1078-0432.ccr-14-0307","title":"Ectopic Expression of Cancer–Testis Antigens in Cutaneous T-cell Lymphoma Patients","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; SKiN Health; University of British Columbia; Quest University Canada; McGill University Health Centre","funders":"National Cancer Institute","keywords":"Antigen; Vorinostat; Ectopic expression; Cancer research; Romidepsin; Lymphoma; Cutaneous T-cell lymphoma; Biology; Cancer; Downregulation and upregulation; Immunology; Medicine; Mycosis fungoides; Cell culture; Histone deacetylase; Gene; Histone; Genetics","score_opus":0.11120879619057882,"score_gpt":0.49429017240956596,"score_spread":0.38308137621898714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985964388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99918145,0.0002966952,0.00016456927,0.0000100535635,0.0000019225092,0.000006473456,0.000056779863,0.000008264183,0.00027383034],"genre_scores_gemma":[0.9996371,0.00009191696,0.000117408854,0.0000060682496,0.0000033401307,0.000002952897,0.00008436029,0.0000017924783,0.000055014312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983287,0.000032613592,0.00001856483,0.00005224118,0.00003676145,0.000027002421],"domain_scores_gemma":[0.9997627,0.000053800395,0.000092932336,0.000019952353,0.000024116987,0.000046460475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012103347,0.00014540389,0.0002152304,0.0005013116,0.0001942289,0.00039593154,0.00010871224,0.00020059884,0.0011841931],"category_scores_gemma":[0.0004272963,0.000082527455,0.000139137,0.000539612,0.0001847821,0.00015460023,0.00013868505,0.00018907398,0.00020037421],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012030315,0.00012916986,0.68796456,0.0001463802,0.000068553265,0.008845469,0.0002919854,0.00023783058,0.2843755,0.000066346336,0.00017699899,0.016494235],"study_design_scores_gemma":[0.00006009899,0.00087426015,0.8824249,0.000019565156,0.0001336448,0.055778738,0.00041611778,0.0013829923,0.057211626,0.00009177279,0.0015949827,0.000011291954],"about_ca_topic_score_codex":0.00033773432,"about_ca_topic_score_gemma":0.00036883602,"teacher_disagreement_score":0.0011841931,"about_ca_system_score_codex":0.00021359857,"about_ca_system_score_gemma":0.00009386737,"threshold_uncertainty_score":0.0039615035},"labels":[],"label_agreement":null},{"id":"W1986849223","doi":"10.1158/1078-0432.tcmusa10-b44","title":"Abstract B44: Probing the effects of linker flexibility in second mitochondria-derived activator of caspases mimetic dimers and assessing their ability to induce apoptosis in a MDA-MB-231 cell line","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"XIAP; Caspase; Apoptosis; Inhibitor of apoptosis; Programmed cell death; Activator (genetics); Proteases; Intrinsic apoptosis; Amino acid; Cancer cell; Cell biology; Chemistry; Biochemistry; Biology; Molecular biology; Enzyme; Receptor; Cancer; Genetics","score_opus":0.08770937849672854,"score_gpt":0.4322579390847287,"score_spread":0.34454856058800015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986849223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99683726,0.0009655017,0.00096006284,0.00007513807,0.000028834413,0.000032094667,0.0003362311,0.00003355598,0.00073119614],"genre_scores_gemma":[0.99303,0.00069446146,0.0029717856,0.000061521765,0.0000088035,0.00006590584,0.000783022,0.000013392831,0.0023711165],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99978095,0.000052723644,0.000020796986,0.000035589244,0.00007332257,0.000036757086],"domain_scores_gemma":[0.9999001,0.00002019209,0.000022273282,0.000012066152,0.000021910366,0.000023370752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021451722,0.0003241842,0.00025394856,0.00014551125,0.00011777042,0.00019052338,0.00021285507,0.0003331047,0.0012505221],"category_scores_gemma":[0.00012741779,0.00011499761,0.00023267862,0.0002377436,0.000099135046,0.00015440548,0.00010094216,0.000605359,0.0002802505],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006677741,0.000060209157,0.000052255124,0.000018743365,0.0000047250887,0.000016619548,0.0000107327,0.00006841532,0.99920076,0.000018551216,0.000031921933,0.00045021524],"study_design_scores_gemma":[0.00001418412,0.00079579063,0.0009320293,0.0000018487507,0.000008086809,0.0000462935,0.000018473276,0.0006341777,0.99681014,0.000008893158,0.0007269455,0.0000032775342],"about_ca_topic_score_codex":0.00078513037,"about_ca_topic_score_gemma":0.00072396663,"teacher_disagreement_score":0.0012505221,"about_ca_system_score_codex":0.00021599309,"about_ca_system_score_gemma":0.00011663072,"threshold_uncertainty_score":0.004183471},"labels":[],"label_agreement":null},{"id":"W1987085807","doi":"10.1158/1078-0432.ccr-14-3141","title":"Clinically Relevant Molecular Subtypes in Leiomyosarcoma","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital","funders":"National Cancer Institute","keywords":"Leiomyosarcoma; Immunohistochemistry; Cancer; Tissue microarray; Biology; Pathology; Medicine; Oncology; Cancer research; Internal medicine","score_opus":0.3321692068341043,"score_gpt":0.5689218262367595,"score_spread":0.23675261940265518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987085807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941316,0.0016446081,0.0013299721,0.00009354171,0.000009530422,0.00006229718,0.001923101,0.000037932783,0.00076750776],"genre_scores_gemma":[0.99114555,0.00038537532,0.0022602489,0.000055992718,0.000013351171,0.00011863203,0.0057229497,0.000012919818,0.0002849941],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938273,0.000108805005,0.00010421728,0.00016881565,0.00017567916,0.00005961499],"domain_scores_gemma":[0.99900836,0.000288167,0.000415421,0.00010317389,0.00011668421,0.00006824816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010553217,0.00024801365,0.0003775195,0.0010979583,0.00031646373,0.00047782288,0.00036382428,0.00034639673,0.0013702244],"category_scores_gemma":[0.0021660237,0.00014109322,0.00044038016,0.0009308201,0.00030948457,0.00021516884,0.00043394265,0.00032102218,0.00035255085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007051934,0.00004542577,0.9497986,0.00023121994,0.00015665562,0.00041224482,0.00013140297,0.00096662046,0.030572314,0.00015687959,0.00068685715,0.016136559],"study_design_scores_gemma":[0.000045666828,0.00009694211,0.9867951,0.000039062288,0.00017026547,0.0025078712,0.00015898224,0.001696397,0.005705742,0.00053032,0.0022409924,0.000012845603],"about_ca_topic_score_codex":0.0012229531,"about_ca_topic_score_gemma":0.0024700311,"teacher_disagreement_score":0.0013702244,"about_ca_system_score_codex":0.0003874656,"about_ca_system_score_gemma":0.0004404845,"threshold_uncertainty_score":0.005581081},"labels":[],"label_agreement":null},{"id":"W1988632741","doi":"10.1158/1078-0432.ccr-13-2261","title":"“Quitting Smoking Will Benefit Your Health”: The Evolution of Clinician Messaging to Encourage Tobacco Cessation","year":2014,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Behavioral Health and Interventions","field":"Psychology","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Queen's University","funders":"National Institute on Drug Abuse; National Institute on Alcohol Abuse and Alcoholism","keywords":"Medicine; Smoking cessation; Harm; Psychological intervention; Disease; Lung cancer; Tobacco smoke; Cancer; Stroke (engine); Harm reduction; Psychiatry; Environmental health; Family medicine; Public health; Psychology; Pathology; Social psychology; Internal medicine","score_opus":0.5939706063707296,"score_gpt":0.6846968558702444,"score_spread":0.0907262494995148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988632741","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005606715,0.99566984,0.00030931763,0.0019219463,0.00043324966,0.00005300483,0.0000093217795,0.000008613364,0.0010339853],"genre_scores_gemma":[0.0060392977,0.9885783,0.0021677446,0.002432273,0.0003265581,0.000110686145,0.000018103841,0.000005801602,0.00032122925],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975732,0.0014258305,0.00024531272,0.00017536292,0.0004978975,0.00008238313],"domain_scores_gemma":[0.9959759,0.0031221055,0.00034919268,0.0000675647,0.0003700721,0.000115108814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055889627,0.0007870919,0.0015801627,0.0021672538,0.00038321887,0.0018778517,0.0011588002,0.0024775264,0.0023340096],"category_scores_gemma":[0.008313058,0.000424553,0.0016821065,0.0017248761,0.0008275983,0.0025150771,0.0010512302,0.003952581,0.00046291325],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015177656,0.00016828519,0.00019281154,0.100577444,0.0004961261,0.000039407834,0.00073650846,0.00016165842,0.0005047971,0.005256954,0.008038746,0.88367546],"study_design_scores_gemma":[0.0006255667,0.0010179479,0.0065099346,0.30229414,0.003113811,0.0010206784,0.0011055759,0.0007051078,0.0008459478,0.006867496,0.67580676,0.000087132365],"about_ca_topic_score_codex":0.002963939,"about_ca_topic_score_gemma":0.003990089,"teacher_disagreement_score":0.0055889627,"about_ca_system_score_codex":0.0017242653,"about_ca_system_score_gemma":0.0030771918,"threshold_uncertainty_score":0.029557645},"labels":[],"label_agreement":null},{"id":"W1988878042","doi":"10.1158/1078-0432.ccr-14-1814","title":"A Phase Ib Dose-Escalation Study of the Oral Pan-PI3K Inhibitor Buparlisib (BKM120) in Combination with the Oral MEK1/2 Inhibitor Trametinib (GSK1120212) in Patients with Selected Advanced Solid Tumors","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":326,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Trametinib; Internal medicine; Adverse effect; Stomatitis; MEK inhibitor; Rash; KRAS; Gastroenterology; Cancer; Oncology; Colorectal cancer; Kinase; MAPK/ERK pathway","score_opus":0.04835023933742931,"score_gpt":0.42858025652265425,"score_spread":0.3802300171852249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988878042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950158,0.00075910456,0.0005074607,0.000204425,0.000070808666,0.0019925206,0.00045831408,0.000075743876,0.000915854],"genre_scores_gemma":[0.9931271,0.0007492466,0.0014419839,0.0004314975,0.000103960854,0.0018534105,0.0011070747,0.000024447329,0.0011612563],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99935216,0.0003000277,0.000036238198,0.00012084366,0.00006515571,0.00012556733],"domain_scores_gemma":[0.9991315,0.00012605595,0.00019308025,0.00010483595,0.00004900749,0.0003956611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018780688,0.0020473104,0.0022108646,0.00065002305,0.00052019017,0.0010052046,0.0010221505,0.0011269002,0.0032419406],"category_scores_gemma":[0.00094158866,0.0009107001,0.001743841,0.00063177344,0.0013501111,0.0011611644,0.00042626148,0.0046417774,0.00087968964],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.63806236,0.21030031,0.006352157,0.0008078515,0.0013202253,0.00026359243,0.00044606053,0.003442099,0.056848288,0.00026592557,0.002570093,0.079321094],"study_design_scores_gemma":[0.4525857,0.53267175,0.008105381,0.000022280065,0.00034144393,0.0001918872,0.000050035047,0.0010882099,0.0036992042,0.00014163372,0.001079438,0.000023073979],"about_ca_topic_score_codex":0.0007563183,"about_ca_topic_score_gemma":0.0019270033,"teacher_disagreement_score":0.0032419406,"about_ca_system_score_codex":0.0012446097,"about_ca_system_score_gemma":0.0016479212,"threshold_uncertainty_score":0.010845304},"labels":[],"label_agreement":null},{"id":"W1988979114","doi":"10.1158/1078-0432.14aacriaslc-a16","title":"Abstract A16: Induction of activating transcription factor 3 is associated with cisplatin responsiveness in NSCLC: A potential predictive biomarker of response.","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Cisplatin; Cancer research; Transcriptome; Lung cancer; Biomarker; Medicine; Cell culture; In vivo; Ex vivo; Oncology; Predictive marker; Biology; Cancer; Internal medicine; Immunology; Chemotherapy; Gene expression; Gene; Genetics","score_opus":0.09948040028837343,"score_gpt":0.4366555907300218,"score_spread":0.33717519044164834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988979114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99293727,0.0014477762,0.0016932418,0.00013539728,0.00003491039,0.000054430566,0.0029197405,0.00006337004,0.0007138866],"genre_scores_gemma":[0.9905212,0.00068044115,0.0030680667,0.00012425042,0.00001937731,0.00007225689,0.0035422195,0.00001867221,0.0019535194],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99980754,0.000021504884,0.000021025384,0.00005775591,0.000068439294,0.000023802873],"domain_scores_gemma":[0.9996908,0.000043862412,0.00014790455,0.00001897871,0.000054702723,0.00004385455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003235176,0.00025358153,0.00033457635,0.00065635843,0.00021976994,0.00050074025,0.0001981942,0.00044001758,0.0028265964],"category_scores_gemma":[0.00036826666,0.00016216065,0.0002818776,0.00059378595,0.00020072646,0.00024243431,0.00022315429,0.0005391047,0.000656198],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050905754,0.000055902656,0.050013226,0.0001064057,0.000035032135,0.000095023825,0.000046673373,0.000118068616,0.94451576,0.000040189407,0.00020874731,0.0042560333],"study_design_scores_gemma":[0.000021057958,0.0010325441,0.6588209,0.000029811035,0.00008317417,0.0019474159,0.00024815855,0.0015935985,0.3321444,0.00024028646,0.00381385,0.00002473978],"about_ca_topic_score_codex":0.000521071,"about_ca_topic_score_gemma":0.00096725684,"teacher_disagreement_score":0.0028265964,"about_ca_system_score_codex":0.00031840062,"about_ca_system_score_gemma":0.00019649904,"threshold_uncertainty_score":0.009455919},"labels":[],"label_agreement":null},{"id":"W1989683475","doi":"10.1158/1078-0432.ccr-04-1399","title":"Metabolic Signatures Associated with a NAD Synthesis Inhibitor–Induced Tumor Apoptosis Identified by 1H-Decoupled-31P Magnetic Resonance Spectroscopy","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sirtuins and Resveratrol in Medicine","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Biology; In vivo; NAD+ kinase; Apoptosis; Phosphocholine; Cancer research; Mammary tumor; Bioenergetics; Programmed cell death; Biochemistry; Phospholipid; Mitochondrion; Cancer; Enzyme","score_opus":0.08103890061726868,"score_gpt":0.44479656908818904,"score_spread":0.3637576684709204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989683475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99492776,0.0008837464,0.0033721388,0.000044917233,0.000006698545,0.000019841076,0.00028305952,0.000043133212,0.00041878648],"genre_scores_gemma":[0.99236745,0.0010920108,0.004621514,0.000060536382,0.000008285385,0.00004774653,0.00071226305,0.000014834088,0.0010753431],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995494,0.000006649681,0.0000024255685,0.000010480249,0.00001615901,0.000009366149],"domain_scores_gemma":[0.9999192,0.000010399163,0.000038340077,0.0000066000566,0.000013090165,0.000012326707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007304418,0.00023788329,0.00016870568,0.0002532119,0.00011193334,0.00013833928,0.00014838007,0.00021892399,0.00045841865],"category_scores_gemma":[0.000120961595,0.00011977548,0.00010528791,0.00017569732,0.00015428539,0.000114451504,0.00010908097,0.00029412282,0.000120897355],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015469335,0.000007267253,0.00031622063,0.000014301522,0.000003880365,0.000051853694,0.000006518574,0.000050007988,0.99874216,0.000011491761,0.000010754489,0.00063088734],"study_design_scores_gemma":[0.000020292962,0.00043241252,0.023488568,0.000004390528,0.000029764673,0.00065463304,0.00003362701,0.0015219687,0.97291213,0.000054831824,0.0008411075,0.0000062735962],"about_ca_topic_score_codex":0.00035829094,"about_ca_topic_score_gemma":0.0004639927,"teacher_disagreement_score":0.00045841865,"about_ca_system_score_codex":0.00016912234,"about_ca_system_score_gemma":0.00010668869,"threshold_uncertainty_score":0.0015335679},"labels":[],"label_agreement":null},{"id":"W1989991921","doi":"10.1158/1078-0432.ccr-14-2565","title":"Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or <i>BRCA</i> -Mutant Ovarian Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health","keywords":"Medicine; Cyclophosphamide; Veliparib; Ovarian cancer; Fallopian tube cancer; Fallopian tube; PARP inhibitor; Oncology; Internal medicine; Cancer; Chemotherapy; Gastroenterology; Surgery; Biology","score_opus":0.2632031430878121,"score_gpt":0.5062227187434356,"score_spread":0.2430195756556235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989991921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887738,0.0018233724,0.00066267274,0.00076304236,0.000581374,0.0047056503,0.0009735337,0.00010555597,0.0016110659],"genre_scores_gemma":[0.9852411,0.0012698761,0.0017620719,0.0013159153,0.0005336216,0.0052511697,0.0013971482,0.000024714389,0.0032045322],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991339,0.0005169952,0.0000489927,0.00013327671,0.000053679614,0.00011315882],"domain_scores_gemma":[0.9982864,0.0004384255,0.00040888184,0.00015684232,0.000084864965,0.0006245325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019898773,0.001708043,0.0026222179,0.00041409244,0.000503361,0.0012807302,0.0009861548,0.0015765121,0.007167422],"category_scores_gemma":[0.0019444701,0.0008083905,0.0012528349,0.00044643364,0.0014712078,0.0007224883,0.0004607816,0.0034454162,0.00090547843],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.983148,0.0069422503,0.0004690508,0.0002004019,0.00041174013,0.000029870778,0.000024456944,0.00029763873,0.0021696538,0.00008409734,0.00049389125,0.0057290257],"study_design_scores_gemma":[0.9537946,0.04453543,0.00049973733,0.00001101595,0.00014842757,0.000021615833,0.0000068649424,0.0002666356,0.00033530477,0.000056787372,0.000317983,0.0000056583435],"about_ca_topic_score_codex":0.001324324,"about_ca_topic_score_gemma":0.0024294078,"teacher_disagreement_score":0.007167422,"about_ca_system_score_codex":0.0011781865,"about_ca_system_score_gemma":0.0022561946,"threshold_uncertainty_score":0.023977458},"labels":[],"label_agreement":null},{"id":"W1990275745","doi":"10.1158/1078-0432.ccr-09-0931","title":"Comparative Impact of Trastuzumab and Cyclophosphamide on HER-2–Positive Human Breast Cancer Xenografts","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; University Health Network; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Genentech; National Institutes of Health","keywords":"Trastuzumab; Medicine; Cyclophosphamide; Metastatic breast cancer; Breast cancer; Oncology; Internal medicine; Cancer; Chemotherapy","score_opus":0.31175981025520483,"score_gpt":0.6359241077453549,"score_spread":0.3241642974901501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990275745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973062,0.0013382945,0.00028249042,0.000031081458,0.000030154126,0.000026385083,0.00015437859,0.00001345625,0.0008174922],"genre_scores_gemma":[0.9972921,0.00076002965,0.0004493953,0.000027296754,0.000013937379,0.00003591583,0.00039839285,0.000010666691,0.0010123041],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997967,0.00006904977,0.000013095429,0.000028270217,0.00004763568,0.000045186145],"domain_scores_gemma":[0.99984384,0.000052230294,0.000024659095,0.00001826036,0.000017032446,0.000043899596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002329403,0.00031624778,0.00043504252,0.00013392758,0.0001001799,0.00026318285,0.00017898531,0.00020087906,0.0009277871],"category_scores_gemma":[0.0001843745,0.000091635535,0.00018434778,0.00013164082,0.00017938526,0.00022391453,0.000105961735,0.00042657144,0.00013820584],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003032658,0.0007272568,0.0007211982,0.00008458876,0.000032800606,0.00006924202,0.000029141573,0.00070513,0.9903238,0.00011846349,0.00015051375,0.0040051746],"study_design_scores_gemma":[0.000256243,0.01722355,0.008228058,0.000012125662,0.00005732716,0.0002290158,0.000043568678,0.0022055164,0.96997863,0.000036234454,0.0017226005,0.0000072153894],"about_ca_topic_score_codex":0.0013051777,"about_ca_topic_score_gemma":0.0019761717,"teacher_disagreement_score":0.0013051777,"about_ca_system_score_codex":0.00033809931,"about_ca_system_score_gemma":0.00027258205,"threshold_uncertainty_score":0.003103733},"labels":[],"label_agreement":null},{"id":"W1991216698","doi":"10.1158/1078-0432.ccr-07-0689","title":"BRCA1 Mutation and Young Age Predict Fast Breast Cancer Growth in the Dutch, United Kingdom, and Canadian Magnetic Resonance Imaging Screening Trials","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Coalition for Research in Women's Health","funders":"","keywords":"Medicine; Breast cancer; Magnetic resonance imaging; Mammography; Cancer; Oncology; Internal medicine; Mutation; Gynecology; Radiology; Genetics; Biology","score_opus":0.13282258588526952,"score_gpt":0.4620309556758927,"score_spread":0.3292083697906232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991216698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756934,0.01744724,0.00029249798,0.0006309761,0.000024897037,0.00019597517,0.0022252721,0.000007069097,0.0034825963],"genre_scores_gemma":[0.99376714,0.0024569663,0.00083299744,0.00024261081,0.000015754476,0.00012008961,0.0019638569,0.000010233757,0.00059025845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99346715,0.004319492,0.00049774547,0.0004531825,0.0008659687,0.00039644577],"domain_scores_gemma":[0.97546947,0.0121995425,0.007148613,0.0011480566,0.0027482274,0.0012860327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009574232,0.000372055,0.0007738973,0.00038996633,0.00085199863,0.00092062145,0.00068825606,0.00080977246,0.001381387],"category_scores_gemma":[0.028562304,0.0003104749,0.0007218351,0.0016225938,0.0006854933,0.00038632535,0.0004671461,0.00034692584,0.0001448157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022269117,0.00013573914,0.9499166,0.00056935934,0.0011449675,0.00020837493,0.0004920709,0.0008791158,0.001116195,0.0003728267,0.0022974238,0.020598266],"study_design_scores_gemma":[0.0018378253,0.0011557138,0.9864994,0.00028912566,0.0015458458,0.0003623572,0.0002220195,0.0009459917,0.0007781916,0.00015114374,0.0061633512,0.000049026854],"about_ca_topic_score_codex":0.53930944,"about_ca_topic_score_gemma":0.7190536,"teacher_disagreement_score":0.46069056,"about_ca_system_score_codex":0.0051295464,"about_ca_system_score_gemma":0.0071151564,"threshold_uncertainty_score":0.9268073},"labels":[],"label_agreement":null},{"id":"W1991981771","doi":"10.1158/1078-0432.12aacriaslc-b14","title":"Abstract B14: FISH-based differentiation of adenoma carcinoma (AC) from squamous cell carcinoma (SqCC): Optimizing probe selection using in silico modeling","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"In silico; Biology; Robustness (evolution); Computational biology; Computer science; Genetics; Gene","score_opus":0.12905630144277805,"score_gpt":0.3902430615559068,"score_spread":0.2611867601131288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991981771","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4513444,0.00016465785,0.5335951,0.0004778489,0.000063740044,0.00026021604,0.0010884891,0.004021555,0.008983989],"genre_scores_gemma":[0.851817,0.000103062564,0.14265497,0.00010230599,0.0000072786656,0.00028646598,0.00073541823,0.000286576,0.00400688],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998859,0.000037546528,0.0000053790986,0.000025379193,0.000029210883,0.00001658234],"domain_scores_gemma":[0.99920887,0.00062118855,0.000047385452,0.00002369032,0.000078708574,0.000020095227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057843677,0.0005904022,0.0003681424,0.00029401123,0.00023013317,0.0004877174,0.0006100354,0.00078802404,0.0048897145],"category_scores_gemma":[0.0013116753,0.00037450367,0.00049958646,0.00013481396,0.00023254156,0.0002052827,0.0003035317,0.0004322716,0.00065155415],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011947685,0.000033252243,0.0015452557,0.000058617545,0.000016976928,0.000057690275,0.000031285206,0.98489916,0.0072049154,0.0005117155,0.00030525052,0.0052162926],"study_design_scores_gemma":[0.0000105865065,0.000032081425,0.00026592237,0.000004147076,0.0000051148545,0.00001400832,0.00000512544,0.9951153,0.004073181,0.00020194742,0.0002693494,0.0000031792702],"about_ca_topic_score_codex":0.005834551,"about_ca_topic_score_gemma":0.003663491,"teacher_disagreement_score":0.005834551,"about_ca_system_score_codex":0.00069111824,"about_ca_system_score_gemma":0.00051831605,"threshold_uncertainty_score":0.01635778},"labels":[],"label_agreement":null},{"id":"W1993224446","doi":"10.1158/1078-0432.ovca13-a47","title":"Abstract A47: The LKB1-AMPK pathway mediates the metabolic stress response of dormant ovarian cancer spheroids","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"AMPK; Spheroid; Cancer research; Cell biology; Cytostasis; Ovarian cancer; Protein kinase A; Autophagy; Biology; Cell culture; Medicine; Cancer; Kinase; Internal medicine; Apoptosis","score_opus":0.09032175024011889,"score_gpt":0.43401724280893944,"score_spread":0.34369549256882054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993224446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886523,0.0024413713,0.0027335347,0.00036917467,0.00011176388,0.000042986165,0.0023246226,0.00019766677,0.0031266168],"genre_scores_gemma":[0.98860043,0.0008793937,0.0016574524,0.00013747625,0.000025339523,0.000056729295,0.0024739355,0.000041123476,0.00612805],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992645,0.000008389,0.00000811374,0.000020607624,0.000021265956,0.0000151831],"domain_scores_gemma":[0.99992836,0.000009625643,0.000017464112,0.00000853644,0.000011511292,0.000024337493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006340672,0.0002697542,0.00028020883,0.00017445299,0.00030545026,0.00031860798,0.00009952036,0.00023964826,0.0032177977],"category_scores_gemma":[0.000056841964,0.00012289223,0.0002379241,0.00014795213,0.00014340515,0.00020460755,0.00015008649,0.0005130167,0.0009601873],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113362184,0.000016096341,0.0001993304,0.00003438789,0.0000029595133,0.000045612887,0.000007788427,0.000026429196,0.99876213,0.000056216806,0.00016827392,0.00056737714],"study_design_scores_gemma":[0.000029039302,0.00018563337,0.012992891,0.0000072365788,0.000010581545,0.0002967038,0.000029703178,0.0009863598,0.9814563,0.00008120037,0.003920065,0.0000042994384],"about_ca_topic_score_codex":0.0006705786,"about_ca_topic_score_gemma":0.00065923785,"teacher_disagreement_score":0.0032177977,"about_ca_system_score_codex":0.00037456542,"about_ca_system_score_gemma":0.00021227321,"threshold_uncertainty_score":0.010764539},"labels":[],"label_agreement":null},{"id":"W1994269886","doi":"10.1158/1078-0432.ccr-09-1779","title":"Preclinical Evidence that Use of TRAIL in Ewing's Sarcoma and Osteosarcoma Therapy Inhibits Tumor Growth, Prevents Osteolysis, and Increases Animal Survival","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Ligue Contre le Cancer; Institut National Du Cancer; Association pour la Recherche sur le Cancer","keywords":"Osteosarcoma; Sarcoma; Medicine; Cancer research; Tumor necrosis factor alpha; In vivo; Pathology; Apoptosis; Immunology; Biology","score_opus":0.2590216982651042,"score_gpt":0.4641788879618897,"score_spread":0.20515718969678554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994269886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92722577,0.04686941,0.008184119,0.0011782895,0.0004987602,0.00045749458,0.001605229,0.0002805707,0.013700298],"genre_scores_gemma":[0.96483654,0.024273941,0.0026900084,0.0002761732,0.00010749247,0.00016257804,0.0019753159,0.000017815248,0.0056601143],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998313,0.00003280955,0.000026777276,0.000027973154,0.000058550235,0.000022519112],"domain_scores_gemma":[0.99968743,0.000083113875,0.000077514036,0.000037594316,0.000056977304,0.0000574019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051088765,0.00042106502,0.00032438763,0.00031487504,0.00012190868,0.000231472,0.000251187,0.0003176702,0.0027108453],"category_scores_gemma":[0.00038271653,0.00009724273,0.00029120094,0.00019600352,0.00038183024,0.00027611418,0.00015802176,0.00064841,0.00049328705],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028963757,0.0023940608,0.001864627,0.0014900338,0.00013115328,0.0002636869,0.000065647386,0.0010198107,0.9104978,0.0011417656,0.0015060975,0.07672899],"study_design_scores_gemma":[0.0015446092,0.044237804,0.009010012,0.0003077179,0.00043064827,0.0025855352,0.00006682238,0.0010556756,0.9049834,0.0007342895,0.03502439,0.000019033772],"about_ca_topic_score_codex":0.00043252244,"about_ca_topic_score_gemma":0.0008513631,"teacher_disagreement_score":0.0027108453,"about_ca_system_score_codex":0.0002371785,"about_ca_system_score_gemma":0.0005840899,"threshold_uncertainty_score":0.009068668},"labels":[],"label_agreement":null},{"id":"W1994354277","doi":"10.1158/1078-0432.ccr-05-1226","title":"The Use of Genetic Markers to Determine Risk for Prostate Cancer at Prostate Biopsy","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Prostate cancer; Genotype; Medicine; Odds ratio; Confidence interval; Prostate biopsy; Prostate-specific antigen; Prostate; Rectal examination; Internal medicine; Oncology; Cancer; Biopsy; Gynecology; Gastroenterology; Biology; Gene; Genetics","score_opus":0.2778636771371092,"score_gpt":0.5130617719701321,"score_spread":0.23519809483302295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994354277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99790215,0.0010177527,0.00043970376,0.000096723845,0.000008643129,0.000008602276,0.00015808546,0.000009863667,0.00035843893],"genre_scores_gemma":[0.99916744,0.00016544315,0.00041920255,0.000023783123,0.000010763194,0.000004995698,0.00011258113,0.000001321149,0.00009440917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99949443,0.00023548752,0.000030376987,0.000102951184,0.00009494588,0.000041823325],"domain_scores_gemma":[0.99829787,0.0006766797,0.00067905284,0.00008755536,0.000114443814,0.00014436016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008576314,0.00038075814,0.0002477213,0.00060799974,0.00017928489,0.00031523246,0.0002707679,0.00047133406,0.0009731227],"category_scores_gemma":[0.0035367412,0.00014931553,0.00029800535,0.0004599769,0.00023001584,0.00019037901,0.00017086758,0.00042518746,0.00021050399],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017433791,0.000023647322,0.995808,0.00000924902,0.00006835001,0.000054720116,0.000009704378,0.00010113053,0.0006011131,0.000007695024,0.000031812393,0.0031101622],"study_design_scores_gemma":[0.000016485956,0.00031505586,0.9972722,0.00000983452,0.00007595475,0.0007135455,0.000026303462,0.00070789276,0.0006077521,0.000047470563,0.00020240617,0.000005023537],"about_ca_topic_score_codex":0.0019457707,"about_ca_topic_score_gemma":0.0017186237,"teacher_disagreement_score":0.0019457707,"about_ca_system_score_codex":0.00017061799,"about_ca_system_score_gemma":0.00020247452,"threshold_uncertainty_score":0.004535675},"labels":[],"label_agreement":null},{"id":"W1995761153","doi":"10.1158/1078-0432.ccr-05-1668","title":"Time to Detectable Metastatic Disease in Patients with Rising Prostate-Specific Antigen Values following Surgery or Radiation Therapy","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Medicine; Doubling time; Nomogram; Prostate cancer; Prostate-specific antigen; Univariate analysis; Proportional hazards model; Radiation therapy; Urology; Metastasis; Biochemical recurrence; Stage (stratigraphy); Survival analysis; Progression-free survival; Prostate; Magnetic resonance imaging; Oncology; Internal medicine; Surgery; Cancer; Radiology; Prostatectomy; Multivariate analysis; Overall survival","score_opus":0.1597383171101356,"score_gpt":0.46066021138463337,"score_spread":0.3009218942744978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995761153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995765,0.00014156396,0.00009166139,0.000016357335,0.0000023428752,0.000005547202,0.00004145577,0.0000025509744,0.00012206627],"genre_scores_gemma":[0.9997515,0.000035128793,0.00006682033,0.0000076631995,0.0000046309,0.000006010745,0.000081063845,4.6816885e-7,0.000046664038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982244,0.00006029208,0.000013147197,0.000037186663,0.00003462676,0.000032304077],"domain_scores_gemma":[0.998823,0.00046483873,0.00044531008,0.00004802836,0.00004968051,0.00016914561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036787387,0.00013739945,0.00020543249,0.00021335656,0.00017985694,0.00022198056,0.0001420869,0.0002333747,0.0011664518],"category_scores_gemma":[0.0027656225,0.00009510098,0.00023614414,0.00019623447,0.0001519355,0.00018207837,0.00014333325,0.00035620405,0.00012027242],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010563603,0.000077827186,0.99265796,0.000013214865,0.000024258894,0.00016045355,0.000042017346,0.00014038585,0.0009934732,0.000016202775,0.00007880191,0.004739046],"study_design_scores_gemma":[0.000053910833,0.00160347,0.995587,0.0000062789763,0.00004293005,0.0011799907,0.000050350634,0.0006564228,0.00055017165,0.000038532486,0.00022552507,0.0000054486864],"about_ca_topic_score_codex":0.00071627746,"about_ca_topic_score_gemma":0.00088148017,"teacher_disagreement_score":0.0011664518,"about_ca_system_score_codex":0.00016979128,"about_ca_system_score_gemma":0.00029470105,"threshold_uncertainty_score":0.003902197},"labels":[],"label_agreement":null},{"id":"W1998478034","doi":"10.1158/1078-0432.ccr-07-4475","title":"Intravesical Chemotherapy of High-Grade Bladder Cancer with HTI-286, A Synthetic Analogue of the Marine Sponge Product Hemiasterlin","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Microbial Natural Products and Biosynthesis","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Université Laval; Hôtel-Dieu de Québec; Vancouver General Hospital","funders":"","keywords":"In vivo; Medicine; Bladder cancer; Bioluminescence imaging; Urinary bladder; In vitro; Cytotoxicity; Cancer; Urology; Chemotherapy; Cancer research; Pathology; Luciferase; Cell culture; Chemistry; Internal medicine; Biology; Biochemistry","score_opus":0.12123919443375632,"score_gpt":0.4175410524560927,"score_spread":0.2963018580223364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998478034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956677,0.0025853855,0.0008979041,0.00003884633,0.000020272842,0.00003790613,0.00008957201,0.000042314776,0.00062003994],"genre_scores_gemma":[0.9974955,0.0010431199,0.00084354635,0.000015777068,0.00000918216,0.000014685831,0.00011890074,0.000004168993,0.00045501615],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9999536,0.000010539391,0.000004078975,0.000008186416,0.000011444503,0.00001209304],"domain_scores_gemma":[0.9999293,0.000013196943,0.000024593726,0.000008942844,0.000005855974,0.000018151664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012154861,0.00018248524,0.00027385636,0.00014829096,0.00008265425,0.00014336317,0.00016842551,0.00015793108,0.0006053607],"category_scores_gemma":[0.00008267065,0.00007126016,0.00013885059,0.00013387676,0.00016723092,0.00010415074,0.00011848456,0.00032635767,0.00012122278],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012001849,0.00027377484,0.000903966,0.0002445896,0.000024670468,0.00017959322,0.000034941597,0.0006727713,0.9836844,0.00006250674,0.000110313646,0.01260836],"study_design_scores_gemma":[0.00014322979,0.00992033,0.0070352955,0.000015518197,0.00006230058,0.00077704026,0.000028622528,0.001579242,0.97826767,0.000016821117,0.0021462743,0.000007755057],"about_ca_topic_score_codex":0.00041494382,"about_ca_topic_score_gemma":0.0008002964,"teacher_disagreement_score":0.0006053607,"about_ca_system_score_codex":0.0002011422,"about_ca_system_score_gemma":0.00020342579,"threshold_uncertainty_score":0.002025187},"labels":[],"label_agreement":null},{"id":"W1998770217","doi":"10.1158/1078-0432.ccr-05-2282","title":"Synergistic Interactions between DMAG and Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitors in Bcr/abl+ Leukemia Cells Sensitive and Resistant to Imatinib Mesylate","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Imatinib mesylate; Cancer research; Imatinib; K562 cells; MAPK/ERK pathway; Kinase; Chemistry; Biology; Leukemia; Myeloid leukemia; Immunology; Cell biology","score_opus":0.0918782453012303,"score_gpt":0.44457176942121357,"score_spread":0.3526935241199833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998770217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970463,0.0015400401,0.00028595247,0.00005152775,0.000017029588,0.000031873522,0.00028526198,0.000023635597,0.00071840256],"genre_scores_gemma":[0.9974675,0.0007898834,0.00052883016,0.000035158275,0.00001373369,0.00004769948,0.0004959857,0.0000066715597,0.0006144702],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975735,0.000071086346,0.00002419666,0.000038728154,0.000061283594,0.000047371785],"domain_scores_gemma":[0.9999201,0.000018220386,0.000021320773,0.000013036682,0.000008284106,0.000019080457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001603269,0.0003533948,0.000627971,0.0002720441,0.00019654045,0.00032673407,0.00021985588,0.0003107737,0.0011870165],"category_scores_gemma":[0.00015021134,0.00019462878,0.00033553483,0.00029597516,0.00020651284,0.00022929063,0.00021048551,0.00037317094,0.00036593972],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080461125,0.00013895085,0.0009024549,0.00007425703,0.000028433626,0.00012861252,0.000042801283,0.00032806228,0.99512094,0.000059517788,0.00010521491,0.002266118],"study_design_scores_gemma":[0.00016352873,0.0040834025,0.026544861,0.000009932447,0.0000690415,0.0007439088,0.00010579335,0.001140212,0.9638072,0.0000444592,0.003273213,0.00001447455],"about_ca_topic_score_codex":0.00059450034,"about_ca_topic_score_gemma":0.0016137157,"teacher_disagreement_score":0.0011870165,"about_ca_system_score_codex":0.000328724,"about_ca_system_score_gemma":0.00019513346,"threshold_uncertainty_score":0.0039709806},"labels":[],"label_agreement":null},{"id":"W1999197387","doi":"10.1158/1078-0432.tcme10-a39","title":"Abstract A39: A newly defined role of clusterin in the formation of exosomes derived from prostate cancer cells","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Clusterin; Microvesicles; Exosome; LNCaP; Cell biology; Prostate cancer; Cancer cell; Cancer research; Heat shock protein; Biology; Chemistry; Cancer; Apoptosis; microRNA; Biochemistry","score_opus":0.14035107051236625,"score_gpt":0.49153556192562226,"score_spread":0.35118449141325603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999197387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9652775,0.013136412,0.010360256,0.0008991177,0.00030447304,0.00013321525,0.0027906997,0.00017827089,0.0069199703],"genre_scores_gemma":[0.9768554,0.0025986151,0.006578761,0.00014955371,0.00007312854,0.00010159605,0.0034050285,0.000048788177,0.010189161],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999033,0.000011862298,0.000008885476,0.000033921857,0.000020826606,0.000021063022],"domain_scores_gemma":[0.99991095,0.000010957428,0.000019071913,0.0000063506054,0.00001870888,0.000033888457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013433723,0.0004924252,0.00018179195,0.0003264781,0.0005329908,0.00042674757,0.00025998757,0.00043843113,0.0024230578],"category_scores_gemma":[0.00011049237,0.000120042576,0.0005339226,0.0002711802,0.00021956029,0.00044316778,0.00039988212,0.00046917773,0.0008942909],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027171962,0.000025027153,0.00046397367,0.00009807744,0.000012715685,0.00040098125,0.000037798807,0.0000523807,0.9957152,0.00055561506,0.00023407038,0.0021325403],"study_design_scores_gemma":[0.000049167058,0.00031221518,0.029904012,0.000039114628,0.000046403457,0.00338988,0.000117167714,0.0012000576,0.93395287,0.0006800592,0.030283011,0.000025947225],"about_ca_topic_score_codex":0.00055577914,"about_ca_topic_score_gemma":0.00045095367,"teacher_disagreement_score":0.0024230578,"about_ca_system_score_codex":0.0004532229,"about_ca_system_score_gemma":0.00032366844,"threshold_uncertainty_score":0.008105874},"labels":[],"label_agreement":null},{"id":"W2000425014","doi":"10.1158/1078-0432.ccr-14-1552","title":"A Phase I Study of Veliparib (ABT-888) in Combination with Low-Dose Fractionated Whole Abdominal Radiation Therapy in Patients with Advanced Solid Malignancies and Peritoneal Carcinomatosis","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Veliparib; Medicine; Internal medicine; Gastroenterology; PARP inhibitor; Neutropenia; Ascites; Oncology; Cancer; Ovarian cancer; Leukopenia; Chemotherapy","score_opus":0.07481250261711388,"score_gpt":0.4690696051276442,"score_spread":0.3942571025105303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000425014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99389654,0.0022077742,0.000703837,0.0002173927,0.000081652746,0.001671832,0.0003645922,0.00007087486,0.0007855315],"genre_scores_gemma":[0.99206346,0.00194803,0.0017425314,0.00033263295,0.0001449104,0.0018979562,0.0009330974,0.000021896169,0.00091554364],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995377,0.00021415295,0.000025683079,0.00009246706,0.00004484504,0.00008516336],"domain_scores_gemma":[0.9994276,0.00007981013,0.00013432819,0.00006376443,0.000027691707,0.00026685453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011970515,0.0016763933,0.002412213,0.00051442115,0.00042712403,0.00087817083,0.0012041683,0.000942255,0.0021896085],"category_scores_gemma":[0.0006802583,0.00068824587,0.0013865887,0.00065454503,0.0011822978,0.0007172569,0.0003910825,0.002880644,0.0006173992],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.560951,0.15554103,0.009422819,0.0018941367,0.0023027803,0.00055782765,0.00050242664,0.0065967706,0.11537261,0.00037697633,0.0029430743,0.14353861],"study_design_scores_gemma":[0.38760677,0.5938712,0.00880619,0.000037940204,0.00050901517,0.00041482472,0.000052503587,0.0015065272,0.005081342,0.00012003437,0.0019632822,0.000030307127],"about_ca_topic_score_codex":0.000633881,"about_ca_topic_score_gemma":0.0011968748,"teacher_disagreement_score":0.002412213,"about_ca_system_score_codex":0.00077551807,"about_ca_system_score_gemma":0.001592192,"threshold_uncertainty_score":0.007324934},"labels":[],"label_agreement":null},{"id":"W2001203107","doi":"10.1158/1078-0432.ccr-05-0953","title":"Establishment of a Serum Tumor Marker for Preclinical Trials of Mouse Prostate Cancer Models","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute","keywords":"Prostate cancer; Prostate; Cancer; Genetically modified mouse; Immunohistochemistry; PCA3; Intraepithelial neoplasia; Prostate-specific antigen; Biology; Tumor progression; Polyclonal antibodies; Medicine; Antibody; Cancer research; Pathology; Internal medicine; Transgene; Endocrinology; Immunology","score_opus":0.49579910674830113,"score_gpt":0.6044482097660626,"score_spread":0.10864910301776148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001203107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6387213,0.006979083,0.33266294,0.00075757835,0.0006940923,0.004685318,0.004778587,0.0029102624,0.007810811],"genre_scores_gemma":[0.70571274,0.006524603,0.2433967,0.0005251515,0.00020547351,0.010374199,0.014675905,0.0007176642,0.017867662],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99772805,0.00050340605,0.00032749263,0.00033912266,0.0007877769,0.00031421095],"domain_scores_gemma":[0.9983057,0.00022010414,0.0003776123,0.0003272681,0.0004873126,0.00028203827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002123335,0.0015248422,0.001017296,0.0025433651,0.00043875707,0.0009073971,0.0010577827,0.0010800626,0.0022722248],"category_scores_gemma":[0.0010642061,0.00059983134,0.00092072587,0.0010857519,0.00053864234,0.00077723194,0.0008147497,0.0030921588,0.0014875011],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026355777,0.00041749605,0.00048067592,0.00011147186,0.000023515146,0.000039311602,0.000042079813,0.00019292433,0.9939831,0.0003525999,0.00018940352,0.003903981],"study_design_scores_gemma":[0.00007912956,0.00256609,0.001947691,0.000027756118,0.000083370665,0.0002797332,0.000027169965,0.0017255167,0.9849733,0.00014144358,0.008132162,0.000016674307],"about_ca_topic_score_codex":0.0006348269,"about_ca_topic_score_gemma":0.001363406,"teacher_disagreement_score":0.0025433651,"about_ca_system_score_codex":0.0007287828,"about_ca_system_score_gemma":0.00082504645,"threshold_uncertainty_score":0.0112294555},"labels":[],"label_agreement":null},{"id":"W2002260284","doi":"10.1158/1078-0432.mechres-b24","title":"Abstract B24: De novo and acquired resistance to first-line standard therapy in colorectal cancer: from cell lines to metastatic tumors","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quebec - Clinical Research Organization in Cancer; Jewish General Hospital","funders":"","keywords":"Oxaliplatin; FOLFOX; Medicine; Folinic acid; Colorectal cancer; Regimen; Bevacizumab; Cancer; Oncology; Biopsy; Internal medicine; Cancer research; Clinical trial; Acquired resistance; Chemotherapy","score_opus":0.19251247305929647,"score_gpt":0.5070040595493386,"score_spread":0.3144915864900421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002260284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931805,0.0016695908,0.001194977,0.00016003234,0.000032646487,0.00010167368,0.0018704085,0.00007013286,0.001720003],"genre_scores_gemma":[0.9901664,0.0008533414,0.0017669518,0.000076410135,0.000018514016,0.0001310433,0.004141124,0.000025202842,0.002821021],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99963117,0.00008224779,0.000055360233,0.00006679127,0.0001128028,0.00005156054],"domain_scores_gemma":[0.9996031,0.000095175055,0.000048787144,0.000085857144,0.000095880554,0.000071267394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046391867,0.00035899648,0.0005371248,0.00063459796,0.00031392305,0.00054885267,0.00033820618,0.0004460457,0.0038610466],"category_scores_gemma":[0.0004819179,0.00019420241,0.0003770611,0.00050938904,0.00022765595,0.00024774374,0.00023771143,0.00088176713,0.00088256976],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018678559,0.00070876547,0.014041631,0.00017427086,0.00009042613,0.00036597395,0.00013696286,0.0006057544,0.9715587,0.00018530047,0.0009882428,0.009276112],"study_design_scores_gemma":[0.0003347851,0.013309354,0.13427813,0.00003245831,0.00018005956,0.0043455916,0.00022641936,0.0036543207,0.83423835,0.00016872899,0.009195426,0.0000363973],"about_ca_topic_score_codex":0.0023926878,"about_ca_topic_score_gemma":0.0018559519,"teacher_disagreement_score":0.0038610466,"about_ca_system_score_codex":0.00042474733,"about_ca_system_score_gemma":0.00032097168,"threshold_uncertainty_score":0.012916446},"labels":[],"label_agreement":null},{"id":"W2003512271","doi":"10.1158/1078-0432.ccr-05-0403","title":"Evaluation of Radiation-Induced Oral Mucositis by Optical Coherence Tomography","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Optical Coherence Tomography Applications","field":"Engineering","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Optical coherence tomography; Mucositis; Tongue; Medicine; Oral mucosa; Nuclear medicine; Pathology; Radiation therapy; Radiology","score_opus":0.2098655478044746,"score_gpt":0.49624647890632084,"score_spread":0.28638093110184626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003512271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924389,0.0022242954,0.004126249,0.000024239713,0.000009756301,0.000120338686,0.00019286854,0.00008137516,0.0007820561],"genre_scores_gemma":[0.9891621,0.0018991954,0.006935384,0.000059129296,0.000012248563,0.00016233728,0.0003873124,0.000018621764,0.0013636668],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99982774,0.000034901284,0.000013076666,0.000026945227,0.00006741233,0.00002977773],"domain_scores_gemma":[0.99979645,0.00002852116,0.0000996571,0.000012859123,0.000039915853,0.000022672075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041569702,0.00043281855,0.00027115102,0.0007199799,0.000112374924,0.00021458245,0.00013776375,0.00040575047,0.001054994],"category_scores_gemma":[0.00024049515,0.00013663227,0.00022467072,0.00019933264,0.00021848523,0.000260973,0.00013155198,0.00036537784,0.00019766034],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051056966,0.00012521699,0.0036559235,0.000114791,0.00001216924,0.00009979085,0.000017061006,0.00009177878,0.9908958,0.000021462998,0.000029485265,0.004425982],"study_design_scores_gemma":[0.0000564359,0.005166229,0.10604431,0.000039662995,0.00010730457,0.001027099,0.000098407094,0.0017638524,0.88463295,0.00003725869,0.001010583,0.000015949354],"about_ca_topic_score_codex":0.00033595492,"about_ca_topic_score_gemma":0.0005844989,"teacher_disagreement_score":0.001054994,"about_ca_system_score_codex":0.00020963831,"about_ca_system_score_gemma":0.00017898154,"threshold_uncertainty_score":0.0035293102},"labels":[],"label_agreement":null},{"id":"W2003852222","doi":"10.1158/1078-0432.ccr-05-2242","title":"Expression and Nuclear Localization of ErbB3 in Prostate Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal; University of British Columbia; Centre Hospitalier de l’Université de Montréal","funders":"Institut Du Cancer de Montréal","keywords":"DU145; LNCaP; Prostate cancer; Prostate; Cancer; Tissue microarray; Pathology; Biology; Cancer research; PCA3; Immunohistochemistry; Medicine; Internal medicine","score_opus":0.22629727301224037,"score_gpt":0.5769018912532754,"score_spread":0.35060461824103506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003852222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894533,0.007887273,0.0010251892,0.00006628395,0.000006945819,0.000008300556,0.00033137048,0.00004517277,0.0011760956],"genre_scores_gemma":[0.9969451,0.0015618567,0.00064949883,0.000032513446,0.0000048486836,0.000007873508,0.00041716886,0.0000051298825,0.00037604594],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99988484,0.000015797797,0.000007746057,0.000026195026,0.000042973097,0.00002236536],"domain_scores_gemma":[0.9998901,0.000019098197,0.000037967973,0.00001234761,0.00002197644,0.000018528659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017219745,0.00017328157,0.00013157117,0.00035172753,0.00022290462,0.00027639998,0.00014395632,0.00014390815,0.0011309825],"category_scores_gemma":[0.00014864035,0.00010979382,0.00016482733,0.0004542945,0.00022476456,0.000107000655,0.00017036943,0.00022219573,0.00027964063],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004536907,0.000035911475,0.053495128,0.00028544877,0.00005837486,0.0003353115,0.00009351452,0.00016416067,0.9355825,0.00015663021,0.00021748045,0.009121794],"study_design_scores_gemma":[0.000058471065,0.0006772928,0.71338785,0.000055127486,0.00019160629,0.010449723,0.00033131757,0.0013994788,0.26500756,0.0002901974,0.0081293555,0.00002198553],"about_ca_topic_score_codex":0.0018960589,"about_ca_topic_score_gemma":0.0027518624,"teacher_disagreement_score":0.0018960589,"about_ca_system_score_codex":0.00035208766,"about_ca_system_score_gemma":0.00031629213,"threshold_uncertainty_score":0.0037834644},"labels":[],"label_agreement":null},{"id":"W2005021386","doi":"10.1158/1078-0432.ccr-09-0227","title":"<i>SMAD4</i> Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":371,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institutes of Health; Rolfe Pancreatic Cancer Foundation; Lustgarten Foundation","keywords":"CDKN2A; Pancreatic cancer; Pancreas; Adenocarcinoma; Hazard ratio; Germline mutation; Gene; Internal medicine; Lymph node; Oncology; Biology; Cancer; Medicine; Cancer research; Mutation; Gastroenterology; Confidence interval; Genetics","score_opus":0.2538550752722822,"score_gpt":0.5412453488539867,"score_spread":0.2873902735817045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005021386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99919814,0.00045665604,0.00011324254,0.000036775797,0.0000022774464,0.000001920606,0.00005680578,0.0000059860636,0.00012819558],"genre_scores_gemma":[0.99933344,0.00024301,0.00018746148,0.000018144914,0.000009493379,0.0000031430409,0.0001446238,0.0000020029356,0.000058558486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987674,0.00003225092,0.00001508658,0.00002521835,0.000029172365,0.000021432214],"domain_scores_gemma":[0.9989524,0.000252425,0.00060695555,0.00003787587,0.0000602453,0.00009008821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030224264,0.00023353408,0.00022151691,0.0005433832,0.00017064695,0.0003401531,0.00015681509,0.00023110221,0.00095519394],"category_scores_gemma":[0.0012652304,0.00011344654,0.00016001152,0.00036479032,0.00035611627,0.00015746448,0.00019217745,0.00024886092,0.00016070448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084033597,0.000030306644,0.9804663,0.000037361126,0.00007770607,0.00031390958,0.000024516141,0.00018722708,0.013112564,0.00001901119,0.000095168434,0.004795548],"study_design_scores_gemma":[0.000033453125,0.00020497135,0.990234,0.000010891954,0.00011319701,0.0026723263,0.0000686282,0.00049294566,0.0057522026,0.000087705506,0.0003241351,0.000005583151],"about_ca_topic_score_codex":0.00045265874,"about_ca_topic_score_gemma":0.0005132706,"teacher_disagreement_score":0.00095519394,"about_ca_system_score_codex":0.00017388967,"about_ca_system_score_gemma":0.00014793858,"threshold_uncertainty_score":0.0031954646},"labels":[],"label_agreement":null},{"id":"W2005619963","doi":"10.1158/1078-0432.ccr-09-1676","title":"Pharmacologically Increased Tumor Hypoxia Can Be Measured by 18F-Fluoroazomycin Arabinoside Positron Emission Tomography and Enhances Tumor Response to Hypoxic Cytotoxin PR-104","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Terry Fox Foundation","keywords":"Positron emission tomography; Hypoxia (environmental); Tumor hypoxia; Cancer research; Medicine; Chemistry; Pharmacology; Internal medicine; Nuclear medicine; Oxygen","score_opus":0.05617671836184463,"score_gpt":0.4117741612188815,"score_spread":0.35559744285703687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005619963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99430025,0.0008456759,0.0032865142,0.00011543138,0.000015265356,0.000034757853,0.00016477215,0.00009305882,0.0011442339],"genre_scores_gemma":[0.9935237,0.00056436285,0.004264581,0.000040033556,0.000009119828,0.00004536587,0.0003363506,0.000019832038,0.001196544],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990046,0.000021200241,0.0000071276254,0.000020738944,0.00002789346,0.000022509397],"domain_scores_gemma":[0.99989986,0.000025513262,0.000035246532,0.000010228285,0.0000067366122,0.000022288978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013036317,0.0002753405,0.00019826811,0.00015801316,0.00009078742,0.00019870567,0.0001511379,0.00020372997,0.0014846984],"category_scores_gemma":[0.00011085457,0.00011240472,0.00014397952,0.0001473927,0.00022477379,0.00016981151,0.00011136408,0.00045581337,0.00021589342],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007676195,0.000026491944,0.00017053446,0.000009632014,0.000002701923,0.000013908327,0.0000031091765,0.000035775363,0.99915516,0.000021476511,0.000013705829,0.00047071482],"study_design_scores_gemma":[0.0000137298775,0.0003192248,0.0020593267,0.0000013177735,0.000008568404,0.00011655514,0.0000051359384,0.00042955042,0.99654514,0.000006192933,0.0004937985,0.0000014178611],"about_ca_topic_score_codex":0.00059853814,"about_ca_topic_score_gemma":0.0008304486,"teacher_disagreement_score":0.0014846984,"about_ca_system_score_codex":0.00030186135,"about_ca_system_score_gemma":0.00017260465,"threshold_uncertainty_score":0.0049667954},"labels":[],"label_agreement":null},{"id":"W2006003235","doi":"10.1158/1078-0432.ccr-14-3322","title":"The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL)","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; University of British Columbia; Jewish General Hospital; Université Laval; Quest University Canada; McGill University Health Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Mycosis fungoides; Cutaneous T-cell lymphoma; Lymphoma; Gene expression profiling; Medicine; Disease; Erythroderma; Oncology; Dermatology; Cancer research; Gene expression; Gene; Pathology; Biology; Genetics","score_opus":0.386392033437786,"score_gpt":0.5035192713262989,"score_spread":0.11712723788851293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006003235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96143985,0.0071713543,0.024990957,0.0018384799,0.000068830814,0.000106702355,0.0017887987,0.00030484927,0.0022901273],"genre_scores_gemma":[0.9873247,0.0019568994,0.009237702,0.00024901904,0.000049349823,0.000045098506,0.00074071024,0.000012554063,0.0003839186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998486,0.000043581356,0.000009821094,0.000037907426,0.000040238265,0.000019863273],"domain_scores_gemma":[0.99964607,0.00013407647,0.00012322783,0.000026828338,0.000044597233,0.000025184487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004550614,0.00019693005,0.00026981594,0.00046236752,0.00010815275,0.0005091368,0.00014636958,0.00022576738,0.0007057007],"category_scores_gemma":[0.0009940966,0.00006691634,0.00020143278,0.0003862272,0.0001470315,0.00026903453,0.00015079096,0.00034181573,0.00022330179],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010920452,0.0004112353,0.37149873,0.00040753116,0.00012702715,0.00019724255,0.00013237125,0.009668236,0.34031543,0.00048599864,0.0018802495,0.27378392],"study_design_scores_gemma":[0.00012711684,0.0025769938,0.6764009,0.00023462408,0.0005082577,0.0014869808,0.0005157319,0.117031954,0.18010497,0.0034656995,0.017493093,0.00005369459],"about_ca_topic_score_codex":0.0004590619,"about_ca_topic_score_gemma":0.0006776691,"teacher_disagreement_score":0.0007057007,"about_ca_system_score_codex":0.00033291677,"about_ca_system_score_gemma":0.00021045942,"threshold_uncertainty_score":0.0024155378},"labels":[],"label_agreement":null},{"id":"W2006064982","doi":"10.1158/1078-0432.ccr-08-0360","title":"Osteopontin Levels in an Asbestos-Exposed Population","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Workers Compensation Board of British Columbia","funders":"","keywords":"Osteopontin; Asbestosis; Asbestos; Mesothelioma; Medicine; Pathology; Gastroenterology; Population; Internal medicine; Pneumoconiosis; Lung","score_opus":0.3921080786062758,"score_gpt":0.5875942122883664,"score_spread":0.1954861336820906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006064982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995968,0.00020057826,0.00004122683,0.000012093036,0.0000026360358,0.000002541805,0.000038286544,0.0000021545252,0.00010376886],"genre_scores_gemma":[0.9997352,0.0000627796,0.000047712223,0.000012920855,0.00000788134,0.000003406168,0.00006908735,5.412198e-7,0.00006050563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997656,0.000050887913,0.000027535873,0.00006213465,0.000060451235,0.000033464257],"domain_scores_gemma":[0.9994491,0.00010263811,0.0002342501,0.000028713963,0.00006992925,0.000115378985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024217696,0.00028649933,0.00028555767,0.00053863187,0.00030217983,0.000374398,0.00011849666,0.0003785439,0.001250082],"category_scores_gemma":[0.001041963,0.00016591123,0.0001846611,0.00037640205,0.00022534135,0.00024268733,0.00018870208,0.00029942015,0.00026312188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013689311,0.000044193283,0.99696416,0.000011294383,0.000039484366,0.00011892812,0.000052267394,0.000017783274,0.001483676,0.0000050896797,0.000035654048,0.0010905545],"study_design_scores_gemma":[0.000008656983,0.00021539954,0.99867743,0.000002978782,0.000028226128,0.0006534328,0.00006717679,0.000049022976,0.00019325092,0.000008885669,0.00009402789,0.0000015461222],"about_ca_topic_score_codex":0.0009162727,"about_ca_topic_score_gemma":0.00084566796,"teacher_disagreement_score":0.001250082,"about_ca_system_score_codex":0.00012300514,"about_ca_system_score_gemma":0.0000993101,"threshold_uncertainty_score":0.004181981},"labels":[],"label_agreement":null},{"id":"W2007431287","doi":"10.1158/1078-0432.ccr-05-2719","title":"Bcl-2 Is a Prognostic Marker in Breast Cancer Independently of the Nottingham Prognostic Index","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":238,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Hazard ratio; Nottingham Prognostic Index; Breast cancer; Oncology; Medicine; Internal medicine; Tissue microarray; Immunohistochemistry; Estrogen receptor; Confidence interval; Cytokeratin; Univariate analysis; Multivariate analysis; Proportional hazards model; Progesterone receptor; Cancer; Pathology","score_opus":0.056888050917112104,"score_gpt":0.4291412701146157,"score_spread":0.37225321919750365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007431287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963678,0.0019572745,0.00059681543,0.00016271888,0.000038797836,0.0000132534415,0.0001193974,0.000019347528,0.00072450313],"genre_scores_gemma":[0.9991441,0.0002222559,0.00028138922,0.000020458336,0.000030736068,0.000008387097,0.00012517942,0.0000022624731,0.00016530397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99965143,0.00010735743,0.000026046018,0.00006987095,0.000101458325,0.000043847806],"domain_scores_gemma":[0.998365,0.0005338857,0.0005848977,0.00013696238,0.0001439187,0.0002353022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010183448,0.00029318157,0.000333757,0.00046193355,0.00022780338,0.00037687385,0.00025961056,0.00025536554,0.0012175448],"category_scores_gemma":[0.0031044243,0.00012037246,0.00021128719,0.00047817413,0.00035018378,0.00033710737,0.00025459004,0.0003934394,0.00023923274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016598454,0.000051825493,0.97464526,0.000055743032,0.00009617874,0.0002781252,0.00003718329,0.00028354282,0.0057321982,0.000051982457,0.00028246272,0.016825702],"study_design_scores_gemma":[0.000058474066,0.0006000463,0.987644,0.000024326731,0.00021898925,0.0020518235,0.000047501144,0.0028786913,0.005212913,0.00021059849,0.0010417168,0.000010918316],"about_ca_topic_score_codex":0.00091074134,"about_ca_topic_score_gemma":0.001544274,"teacher_disagreement_score":0.0012175448,"about_ca_system_score_codex":0.00040008366,"about_ca_system_score_gemma":0.00028910793,"threshold_uncertainty_score":0.0053855777},"labels":[],"label_agreement":null},{"id":"W2008392950","doi":"10.1158/1078-0432.ccr-04-0223","title":"Sp1-Mediated Transcriptional Control of Fibroblast Growth Factor Receptor 4 in Sarcomas of Skeletal Muscle Lineage","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Fibroblast growth factor receptor 4; Molecular biology; Biology; Cell culture; Transcription factor; Transfection; Fibroblast growth factor; Alveolar rhabdomyosarcoma; Gene; Cancer research; Receptor; Fibroblast growth factor receptor; Rhabdomyosarcoma; Genetics; Medicine; Pathology","score_opus":0.07681980686756272,"score_gpt":0.41707684945645424,"score_spread":0.3402570425888915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008392950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98847735,0.0029549354,0.0052754567,0.000114458424,0.000048913942,0.00003233711,0.00068509363,0.000104506,0.002307015],"genre_scores_gemma":[0.9900926,0.0008496347,0.0038229206,0.000057494228,0.000019275814,0.000032466152,0.0012931287,0.00003142838,0.0038011463],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997861,0.00004455969,0.000019122126,0.0000630847,0.000051733045,0.000035459023],"domain_scores_gemma":[0.999859,0.000035409805,0.00003318626,0.00001505297,0.00002813829,0.000029265891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019961032,0.00033091783,0.0002190925,0.00033760248,0.00021163076,0.00027653415,0.00015473105,0.00018876758,0.0015759313],"category_scores_gemma":[0.00019131562,0.0001908028,0.00037058667,0.00014036043,0.00031033048,0.00012944678,0.00029967233,0.00047891383,0.0007592638],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049987004,0.000008924478,0.00020120935,0.000020784353,0.0000017978296,0.00002565522,0.000017941053,0.000030403922,0.9987116,0.00009488417,0.000030841034,0.0008059638],"study_design_scores_gemma":[0.000026842608,0.00022175627,0.017229911,0.000017947114,0.00001682387,0.00041750004,0.00010658334,0.0025828283,0.97455376,0.00016518975,0.0046517435,0.000009066049],"about_ca_topic_score_codex":0.0009632651,"about_ca_topic_score_gemma":0.0014619206,"teacher_disagreement_score":0.0015759313,"about_ca_system_score_codex":0.00042128123,"about_ca_system_score_gemma":0.00021012417,"threshold_uncertainty_score":0.005271971},"labels":[],"label_agreement":null},{"id":"W2008401471","doi":"10.1158/1078-0432.ccr-13-2175","title":"Inactivation of the <i>CDKN2A</i> Tumor-Suppressor Gene by Deletion or Methylation Is Common at Diagnosis in Follicular Lymphoma and Associated with Poor Clinical Outcome","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"Health Research Board; King Fahad Medical City; University Health Network; Leukemia and Lymphoma Society of Canada","keywords":"CDKN2A; Follicular lymphoma; DNA methylation; Lymphoma; Methylation; CDKN2B; Biopsy; p14arf; Cancer research; CpG site; Oncology; Medicine; Mantle cell lymphoma; Pathology; Biology; Internal medicine; Cancer; Tumor suppressor gene; Carcinogenesis; Gene; Genetics; Gene expression","score_opus":0.15638008130249578,"score_gpt":0.47314775636562323,"score_spread":0.3167676750631274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008401471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988918,0.00034019785,0.0004310243,0.000021374786,0.0000015517872,0.0000053568406,0.000071454306,0.000012257638,0.0002250453],"genre_scores_gemma":[0.9996319,0.000063678825,0.00016171817,0.000008135668,0.0000047661747,0.000002924832,0.000083516294,0.0000016175857,0.000041648997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966097,0.00007688142,0.00003597029,0.000100339144,0.0000868247,0.000038931415],"domain_scores_gemma":[0.99860966,0.0003364634,0.0008089933,0.00007555064,0.00007165328,0.00009765341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005981449,0.0001753181,0.00024093811,0.0005774714,0.00013551394,0.00024346974,0.00018076385,0.00021037014,0.00080725894],"category_scores_gemma":[0.001411162,0.000095909156,0.000090025926,0.00033629284,0.00044543832,0.00015033298,0.00015070544,0.00019473421,0.00018091266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006600523,0.000029247869,0.94076884,0.000044028482,0.000053086253,0.00029063426,0.000041000487,0.00011690047,0.050755773,0.000027738399,0.00007297265,0.007139685],"study_design_scores_gemma":[0.000016585826,0.00030784975,0.983404,0.000006873726,0.00005296497,0.0029709183,0.000056766297,0.0004897891,0.012212361,0.00008307961,0.00039519474,0.0000037062584],"about_ca_topic_score_codex":0.00068630907,"about_ca_topic_score_gemma":0.0007156681,"teacher_disagreement_score":0.00080725894,"about_ca_system_score_codex":0.00022991079,"about_ca_system_score_gemma":0.00013620741,"threshold_uncertainty_score":0.0031633377},"labels":[],"label_agreement":null},{"id":"W2008413774","doi":"10.1158/1078-0432.mechres-ia11","title":"Abstract IA11: Using Molecular Profiling Strategies in Clinical Trials to Understand Resistance Mechanisms in the Era of Personalized Cancer Medicine","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Vemurafenib; Medicine; Acquired resistance; Druggability; Drug resistance; Clinical trial; Melanoma; Oncology; Precision medicine; Cancer; Cancer research; Ipilimumab; Internal medicine; Bioinformatics; Biology; Metastatic melanoma; Pathology; Immunotherapy; Gene; Genetics","score_opus":0.5070920791879917,"score_gpt":0.5937702580808246,"score_spread":0.08667817889283291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008413774","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4976553,0.106328785,0.12949048,0.112240806,0.008174869,0.02289899,0.018254243,0.0042971214,0.10065939],"genre_scores_gemma":[0.7932592,0.02487186,0.11646726,0.030990586,0.0024948437,0.0132798655,0.0062924186,0.00034040783,0.012003596],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9831844,0.01338299,0.0007208866,0.0008436212,0.001213821,0.000654321],"domain_scores_gemma":[0.9827811,0.0060837185,0.0046625873,0.0017159245,0.002760269,0.0019964464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03040442,0.001152672,0.0023412816,0.0010708332,0.00042726414,0.003961286,0.0010652026,0.0020899375,0.01053836],"category_scores_gemma":[0.019922825,0.0005399668,0.001552677,0.0014159051,0.0013509375,0.0026296822,0.001336877,0.0042122784,0.002579676],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050273877,0.0044962913,0.03342643,0.003200856,0.002335666,0.00015337433,0.00028873244,0.0064596324,0.035312578,0.0128993755,0.051064566,0.8000886],"study_design_scores_gemma":[0.059512805,0.2299921,0.1613565,0.004605367,0.0066834455,0.0013757413,0.0008154723,0.05153672,0.039611604,0.044834703,0.39898518,0.00069041713],"about_ca_topic_score_codex":0.0005979958,"about_ca_topic_score_gemma":0.0011044671,"teacher_disagreement_score":0.03040442,"about_ca_system_score_codex":0.0022284384,"about_ca_system_score_gemma":0.00336668,"threshold_uncertainty_score":0.16079587},"labels":[],"label_agreement":null},{"id":"W2008436378","doi":"10.1158/1078-0432.12aacriaslc-b9","title":"Abstract B9: Cost effectiveness of gene expression profiling for tumor site origin","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Medicaid; Referral; Chemotherapy; Internal medicine; Malignancy; Observational study; Oncology; Cancer; Quality-adjusted life year; Cost effectiveness; Surgery; Emergency medicine; Health care; Family medicine","score_opus":0.3974266369920159,"score_gpt":0.5976157337536503,"score_spread":0.20018909676163438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008436378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97446775,0.005424057,0.0067125433,0.002243523,0.00012601627,0.0005324638,0.004493373,0.00009706648,0.005903198],"genre_scores_gemma":[0.99784994,0.00032171165,0.0008681453,0.00009535006,0.00002321047,0.00010812247,0.00052633166,0.000005651333,0.0002015016],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9961624,0.002852322,0.00013779839,0.00028880822,0.00036164466,0.00019705493],"domain_scores_gemma":[0.9883216,0.00939685,0.0013051337,0.00022826792,0.00036654362,0.00038152578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004744826,0.00058189227,0.0008334276,0.000905516,0.00014690132,0.0011069197,0.0006589084,0.0007285158,0.007199703],"category_scores_gemma":[0.01806731,0.0001821275,0.0024488799,0.0009615106,0.00038636016,0.00092941464,0.0006438663,0.0009392214,0.00031445263],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.113364734,0.0039228867,0.20316815,0.0036336726,0.0076332893,0.00047135123,0.00014400497,0.27787176,0.004710437,0.0059837787,0.009725726,0.36937016],"study_design_scores_gemma":[0.01210201,0.037379503,0.39532003,0.0012443109,0.012915862,0.0011929664,0.00060957787,0.5132331,0.009271707,0.010733352,0.005771221,0.00022626898],"about_ca_topic_score_codex":0.003508608,"about_ca_topic_score_gemma":0.0011813579,"teacher_disagreement_score":0.007199703,"about_ca_system_score_codex":0.0023008664,"about_ca_system_score_gemma":0.0013218946,"threshold_uncertainty_score":0.025093377},"labels":[],"label_agreement":null},{"id":"W2008550171","doi":"10.1158/1078-0432.ccr-14-2199","title":"Detection, Characterization, and Inhibition of FGFR–TACC Fusions in IDH Wild-type Glioma","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":285,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Montreal Neurological Institute and Hospital; University of British Columbia","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"Fibroblast growth factor receptor; Biology; Glioma; IDH1; Cancer research; Fibroblast growth factor; Molecular biology; Mutant; Receptor; Gene; Genetics","score_opus":0.25454384176051664,"score_gpt":0.5072576175131832,"score_spread":0.25271377575266657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008550171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980216,0.00072560186,0.0007364214,0.000016073014,0.0000026939947,0.0000218564,0.00017898274,0.000017105865,0.0002797275],"genre_scores_gemma":[0.99723864,0.0002756719,0.0015588324,0.000014698343,0.0000021546862,0.000022627124,0.00059192535,0.0000053623717,0.00029001554],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998487,0.000015788792,0.000012314513,0.000029084766,0.000058612146,0.00003545631],"domain_scores_gemma":[0.99992645,0.000014691188,0.000019063626,0.000010053655,0.000011515388,0.000018213655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019572563,0.00021462626,0.00024455835,0.0004011671,0.00013619637,0.00018359523,0.00015190594,0.00025768438,0.0004689034],"category_scores_gemma":[0.0001930607,0.00010497413,0.00018752151,0.0002728665,0.00020767825,0.000108048735,0.00008942537,0.00020800365,0.00015355273],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015433448,0.000028226927,0.0044388985,0.000029826659,0.000009002951,0.00011886542,0.000017196127,0.00008559505,0.99277157,0.000029640953,0.000030455165,0.002286392],"study_design_scores_gemma":[0.000052823376,0.0011332161,0.09235223,0.0000051300444,0.000062588944,0.0034702434,0.000057104524,0.0014879049,0.899579,0.000040811265,0.0017523448,0.0000066035986],"about_ca_topic_score_codex":0.0021335192,"about_ca_topic_score_gemma":0.0023237516,"teacher_disagreement_score":0.0021335192,"about_ca_system_score_codex":0.00037301463,"about_ca_system_score_gemma":0.00020175992,"threshold_uncertainty_score":0.0042422414},"labels":[],"label_agreement":null},{"id":"W2008650353","doi":"10.1158/1078-0432.mechres-b32","title":"Abstract B32: Impact of Lipid-Substitution on Assembly and Delivery of siRNA by Cationic Polymers","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Transfection; Small interfering RNA; Polymer; Chemistry; In vitro; Biochemistry; Cationic polymerization; In vivo; Combinatorial chemistry; Biology; Gene; Organic chemistry; Biotechnology","score_opus":0.1328208918245548,"score_gpt":0.4889012117126326,"score_spread":0.3560803198880778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008650353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966354,0.00070544006,0.001040877,0.000029930237,0.000011759207,0.000040868174,0.00013350297,0.0000400368,0.0013620862],"genre_scores_gemma":[0.9946792,0.00040606147,0.0021915142,0.000031031235,0.0000052443975,0.00005487191,0.00034835146,0.00004839613,0.0022353837],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979633,0.00004531801,0.00002294125,0.000046914676,0.000042909505,0.00004562312],"domain_scores_gemma":[0.99975497,0.00006129484,0.000074477706,0.0000137491,0.000044561955,0.000050935872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024524436,0.0004519002,0.00017811311,0.0001967497,0.00011146332,0.00024164026,0.0001563278,0.00029153872,0.0015647567],"category_scores_gemma":[0.0004090643,0.0001773781,0.00013917322,0.00022649895,0.00012841653,0.00020405794,0.00015737383,0.00026937024,0.0005475096],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010441055,0.000017689235,0.000049330545,0.000030056504,0.0000036339995,0.000021808342,0.000009961913,0.00008759602,0.9990281,0.0000099161025,0.000014044852,0.00062340713],"study_design_scores_gemma":[0.000007303662,0.00031926547,0.000679875,0.0000041204426,0.0000055838286,0.000027815575,0.0000044716103,0.00024761906,0.99820733,0.0000036034169,0.0004893212,0.0000037965087],"about_ca_topic_score_codex":0.00045966572,"about_ca_topic_score_gemma":0.00037641212,"teacher_disagreement_score":0.0015647567,"about_ca_system_score_codex":0.00017079053,"about_ca_system_score_gemma":0.00017502598,"threshold_uncertainty_score":0.0052346587},"labels":[],"label_agreement":null},{"id":"W2009623159","doi":"10.1158/1078-0432.ccr-08-1916","title":"Genomic and Molecular Profiling Predicts Response to Temozolomide in Melanoma","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Temozolomide; Dacarbazine; Melanoma; Methyltransferase; Medicine; Cancer research; DNA methylation; Methylation; Oncology; Gene expression; Biology; Gene; Glioma; Genetics","score_opus":0.14309020578417922,"score_gpt":0.5072967140975089,"score_spread":0.3642065083133297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009623159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986797,0.0004223706,0.00037045157,0.00002560781,0.0000017784363,0.00000736797,0.00032315616,0.000012014793,0.0001574658],"genre_scores_gemma":[0.9982456,0.00021689203,0.0006925212,0.000027408454,0.0000042804295,0.000011751402,0.0006236595,0.0000028868856,0.00017500515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999143,0.000019282019,0.0000076323895,0.000027732473,0.000018718401,0.000012289439],"domain_scores_gemma":[0.9997416,0.000092847105,0.0000901771,0.000012048739,0.000030387859,0.000032862812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001464035,0.00016547865,0.00024087631,0.00037197932,0.00006941479,0.00025033733,0.0000908179,0.00023442287,0.0007254871],"category_scores_gemma":[0.00066985015,0.00009695052,0.00008479608,0.0002530333,0.00011340144,0.000114183116,0.00010497072,0.00020758738,0.00017488268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012541554,0.00014418524,0.7294268,0.00008126865,0.000086844724,0.0001184306,0.00005704853,0.0012677499,0.2510351,0.00003581761,0.00022520825,0.016267436],"study_design_scores_gemma":[0.000015888745,0.00042924003,0.964212,0.0000074448953,0.000056121633,0.000525379,0.00005561675,0.003115234,0.030999707,0.000062253894,0.0005163735,0.000004724228],"about_ca_topic_score_codex":0.00040879863,"about_ca_topic_score_gemma":0.00059858744,"teacher_disagreement_score":0.0007254871,"about_ca_system_score_codex":0.00011916555,"about_ca_system_score_gemma":0.00007280468,"threshold_uncertainty_score":0.002426982},"labels":[],"label_agreement":null},{"id":"W2010399667","doi":"10.1158/1078-0432.ccr-07-4879","title":"The Type 1 Insulin-Like Growth Factor Receptor Pathway","year":2008,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":447,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Cancer Research UK; Wellcome Trust","keywords":"Insulin-like growth factor 1 receptor; Insulin receptor; Insulin-like growth factor; Receptor tyrosine kinase; Medicine; Targeted therapy; Tyrosine kinase; Insulin-Like Growth Factor Receptor; Receptor; Signal transduction; Cancer; Pharmacology; Cancer research; Insulin; Biology; Insulin resistance; Growth factor; Internal medicine; Cell biology","score_opus":0.38927773568903495,"score_gpt":0.5307568062604718,"score_spread":0.14147907057143688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010399667","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019400474,0.9950955,0.00024323323,0.00027896775,0.0002912373,0.000007632597,0.000019802621,0.000013038801,0.0038565695],"genre_scores_gemma":[0.00093793275,0.9963689,0.00027369283,0.00020055196,0.00011466176,0.000009080475,0.000030000352,9.903841e-7,0.0020642139],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998863,0.0000151946,0.000012210263,0.000021732383,0.00005277609,0.00001178986],"domain_scores_gemma":[0.99992156,0.000027421447,0.000015536338,0.000003326358,0.00002341804,0.000008842702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027221403,0.0007428115,0.00091895193,0.0012039951,0.00022839101,0.00072323397,0.000604015,0.0006681745,0.0033323902],"category_scores_gemma":[0.0002595388,0.00015487956,0.00026568613,0.0014140987,0.00034096607,0.00074959424,0.00043967107,0.0011128951,0.0036664472],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063127954,0.000050990573,0.0001412163,0.005843459,0.00003757809,0.00021231531,0.000026348971,0.00018138638,0.0023485154,0.0024962032,0.018019335,0.9705795],"study_design_scores_gemma":[0.000018374523,0.000055370387,0.00073332584,0.0010978691,0.0000334061,0.0012779334,0.0000363818,0.00005528037,0.00088109734,0.0013975602,0.9944037,0.000009641164],"about_ca_topic_score_codex":0.0009083235,"about_ca_topic_score_gemma":0.001374851,"teacher_disagreement_score":0.0033323902,"about_ca_system_score_codex":0.0005520865,"about_ca_system_score_gemma":0.0008505402,"threshold_uncertainty_score":0.011147916},"labels":[],"label_agreement":null},{"id":"W2011143480","doi":"10.1158/1078-0432.ccr-09-1438","title":"Lymphocytic Reaction to Colorectal Cancer Is Associated with Longer Survival, Independent of Lymph Node Count, Microsatellite Instability, and CpG Island Methylator Phenotype","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":419,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Gary Bennett Family Fund; National Cancer Institute; Entertainment Industry Foundation","keywords":"Microsatellite instability; Colorectal cancer; KRAS; MLH1; Oncology; Medicine; CDKN2A; Hazard ratio; Internal medicine; Cancer; Lymph node; Cancer research; Pathology; Biology; DNA mismatch repair; Genetics; Microsatellite; Allele","score_opus":0.11687287108650775,"score_gpt":0.4473887609781676,"score_spread":0.33051588989165986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011143480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99954236,0.00015974452,0.00010187539,0.000017684475,0.000002615664,0.000002308945,0.00006464604,0.0000053467024,0.000103429964],"genre_scores_gemma":[0.9996247,0.000054099542,0.00006078215,0.000006769215,0.0000048844367,0.0000021110527,0.00010758548,0.0000011076067,0.00013787783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999026,0.0000232946,0.000007774117,0.000029938114,0.000018560195,0.000017789413],"domain_scores_gemma":[0.9991478,0.00013970831,0.00044260293,0.000056520304,0.000043006417,0.0001703929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002658199,0.00022839646,0.00017712203,0.00020756223,0.00015588733,0.00019504584,0.00010398721,0.00017026062,0.001728681],"category_scores_gemma":[0.00080293434,0.00010752639,0.00019467033,0.00023018014,0.00022923596,0.00014083098,0.0002149031,0.00028234185,0.00018505892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007580848,0.000030128,0.9900483,0.000019448555,0.000054059274,0.00010050303,0.000025407388,0.00007735898,0.006676184,0.0000069656226,0.000047126116,0.0021565524],"study_design_scores_gemma":[0.000009980075,0.00029102623,0.9981987,0.0000028644379,0.000037082922,0.00042714676,0.000037892256,0.00018948567,0.0006704861,0.000013578973,0.000119913544,0.0000019331326],"about_ca_topic_score_codex":0.00054914935,"about_ca_topic_score_gemma":0.0012129142,"teacher_disagreement_score":0.001728681,"about_ca_system_score_codex":0.00011770844,"about_ca_system_score_gemma":0.00015878648,"threshold_uncertainty_score":0.0057830215},"labels":[],"label_agreement":null},{"id":"W2011240752","doi":"10.1158/1078-0432.ccr-06-0383","title":"Sequential Positron Emission Tomography Using [18F]Fluorodeoxyglucose for Monitoring Response to Chemotherapy in Metastatic Breast Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Breast cancer; Chemotherapy; Progressive disease; Metastatic breast cancer; Standardized uptake value; Positron emission tomography; Fluorodeoxyglucose; Cancer; Nuclear medicine; Radiology; Internal medicine; Oncology","score_opus":0.23175786885143168,"score_gpt":0.581430282048542,"score_spread":0.3496724131971103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011240752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978174,0.0013140148,0.0005113506,0.000027379563,0.0000059411905,0.000043457418,0.000043340202,0.000011628803,0.00022547077],"genre_scores_gemma":[0.9982461,0.00033523003,0.0011209097,0.000026224,0.000011980944,0.00006218208,0.00010651353,0.0000012900889,0.0000896013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972135,0.00015638054,0.000016685264,0.000035242625,0.000049888786,0.000020415317],"domain_scores_gemma":[0.99963593,0.00013136542,0.00012367456,0.000024817964,0.000029431869,0.000054749093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006150936,0.00034685474,0.00032703072,0.00023737893,0.00012717818,0.00019166873,0.00016013393,0.0002576355,0.0005926786],"category_scores_gemma":[0.0011475141,0.00011436499,0.00013220374,0.0001665978,0.0002660212,0.00014053009,0.00011381428,0.00019687258,0.00012897527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05329658,0.0031040455,0.5979797,0.00037929742,0.00025081105,0.00075416046,0.00010776142,0.002235418,0.18211015,0.00008688703,0.00049939414,0.15919578],"study_design_scores_gemma":[0.0036164823,0.07898658,0.82725656,0.00005382598,0.00044029485,0.006873178,0.00009536775,0.0060247667,0.073712505,0.00013738367,0.00276493,0.000038128244],"about_ca_topic_score_codex":0.0003858767,"about_ca_topic_score_gemma":0.0007172026,"teacher_disagreement_score":0.0006150936,"about_ca_system_score_codex":0.00025490433,"about_ca_system_score_gemma":0.00025864778,"threshold_uncertainty_score":0.0032529235},"labels":[],"label_agreement":null},{"id":"W2011661083","doi":"10.1158/1078-0432.ovca13-ia8","title":"Abstract IA8: Discovering drivers in rare ovarian cancer subtypes","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Serous fluid; Serous carcinoma; Ovarian cancer; Clear cell carcinoma; Context (archaeology); Clear cell; Cancer; Cancer research; Biology; Ovarian carcinoma; ARID1A; Mutation; Carcinoma; Medicine; Oncology; Bioinformatics; Internal medicine; Gene; Genetics","score_opus":0.20641064351636376,"score_gpt":0.514709670638262,"score_spread":0.3082990271218983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011661083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95087,0.007895865,0.007927733,0.00230866,0.00032480116,0.00017058736,0.018750027,0.0009306442,0.010821803],"genre_scores_gemma":[0.95392996,0.0027844207,0.011031462,0.00083716895,0.00017399435,0.00012670654,0.02436555,0.00021996311,0.0065308274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960417,0.00005006528,0.00003303352,0.00012467589,0.00011586268,0.00007226058],"domain_scores_gemma":[0.9989785,0.00025478486,0.00029907207,0.00010042281,0.00016631444,0.00020095722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066843216,0.00032525283,0.0004932986,0.001290614,0.0004488332,0.0010119684,0.0005982416,0.0006710322,0.005622622],"category_scores_gemma":[0.0016480483,0.00027813303,0.00060981297,0.0011431425,0.00019275554,0.00038332414,0.00076290255,0.0009448419,0.0019333748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015399461,0.00018233998,0.6489355,0.0011297452,0.0006574395,0.0034307472,0.0003894927,0.0020156968,0.20887665,0.0020286525,0.02047303,0.11034082],"study_design_scores_gemma":[0.00015751022,0.000925287,0.7570258,0.00038244578,0.0012321494,0.016166015,0.0009370454,0.010796044,0.05992704,0.004607384,0.14774291,0.00010044706],"about_ca_topic_score_codex":0.0016602806,"about_ca_topic_score_gemma":0.0019594184,"teacher_disagreement_score":0.005622622,"about_ca_system_score_codex":0.00046155197,"about_ca_system_score_gemma":0.0005745285,"threshold_uncertainty_score":0.018809557},"labels":[],"label_agreement":null},{"id":"W2012668244","doi":"10.1158/1078-0432.ccr-06-0573","title":"HATH1 Expression in Mucinous Cancers of the Colorectum and Related Lesions","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Mucin 2; Mucin; Hyperplastic Polyp; Biology; Immunohistochemistry; Pathology; Cytoplasm; Carcinogenesis; Large intestine; Signet ring cell; Transcription factor; Cancer; Cancer research; Adenocarcinoma; Colorectal cancer; Gene expression; Immunology; Cell biology; Medicine; Gene","score_opus":0.07720023920719324,"score_gpt":0.4521628556623393,"score_spread":0.37496261645514606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012668244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99722856,0.0013381597,0.00073871727,0.000020451329,0.000006168012,0.000015398979,0.0001321292,0.00003481092,0.0004855806],"genre_scores_gemma":[0.998256,0.00038230617,0.0006563835,0.000011170209,0.000002891837,0.000009256385,0.00020525527,0.000004176774,0.00047255176],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99990165,0.000010845989,0.000007271562,0.000028299404,0.000025608131,0.000026332604],"domain_scores_gemma":[0.99985313,0.000014135103,0.00005370765,0.000015402298,0.000021079208,0.000042395586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017327578,0.00023390958,0.00014891854,0.000588847,0.00019534882,0.00024315472,0.00015882753,0.00022216265,0.00092530594],"category_scores_gemma":[0.00019548896,0.00013409677,0.00018256826,0.00028366502,0.00028143238,0.00017236797,0.00022119693,0.00020386794,0.0001873135],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005955583,0.000024293331,0.0221475,0.00011800661,0.000020091402,0.0007800806,0.00006162538,0.000048145408,0.97298074,0.00011124118,0.000060771654,0.0030519424],"study_design_scores_gemma":[0.000055550223,0.00072991994,0.4578019,0.000013217759,0.00010840573,0.010862425,0.00023516497,0.0011004788,0.523967,0.000095596035,0.005015633,0.000014613643],"about_ca_topic_score_codex":0.0014432493,"about_ca_topic_score_gemma":0.0016196852,"teacher_disagreement_score":0.0014432493,"about_ca_system_score_codex":0.00047787256,"about_ca_system_score_gemma":0.0002178076,"threshold_uncertainty_score":0.0034671426},"labels":[],"label_agreement":null},{"id":"W2012704875","doi":"10.1158/1078-0432.ccr-07-0926","title":"Immune Expression and Inhibition of Heat Shock Protein 90 in Uveal Melanoma","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Melanoma; Hsp90 inhibitor; Immunohistochemistry; Heat shock protein; Cancer research; Apoptosis; Cell culture; Cell cycle; Cell growth; Western blot; Cell; Biology; Pathology; Chemistry; Molecular biology; Hsp90; Medicine; Immunology","score_opus":0.11332003699064894,"score_gpt":0.4509431362315512,"score_spread":0.3376230992409023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012704875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99345726,0.004818629,0.0008501432,0.000034424756,0.000011232415,0.000018273699,0.00007749458,0.000024203247,0.00070829224],"genre_scores_gemma":[0.99643046,0.0020465134,0.0005486948,0.000027053913,0.000009927257,0.000019741787,0.00017704486,0.0000060321468,0.00073447987],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999136,0.000017484452,0.000006615282,0.000013268199,0.00002366867,0.000025376652],"domain_scores_gemma":[0.99994504,0.000007021893,0.000020059695,0.0000067157803,0.000009926879,0.000011346111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105882944,0.00021418244,0.00018259855,0.00018391605,0.000089773974,0.00015219867,0.00008487285,0.00013542402,0.0009241927],"category_scores_gemma":[0.00011169473,0.00007786256,0.0001602378,0.0001433547,0.000155256,0.00011742213,0.00010053907,0.00025740004,0.00022816074],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105841114,0.00002533855,0.0006673406,0.000053941247,0.000006672378,0.000063682026,0.000010062123,0.000021105692,0.9967482,0.00001624385,0.000025233408,0.0022563983],"study_design_scores_gemma":[0.000030545656,0.0017605661,0.048519142,0.000013118405,0.000049107657,0.001344591,0.000050904207,0.0004122032,0.9447281,0.00003257086,0.003055976,0.0000031746176],"about_ca_topic_score_codex":0.00026349496,"about_ca_topic_score_gemma":0.00030044845,"teacher_disagreement_score":0.0009241927,"about_ca_system_score_codex":0.00014481872,"about_ca_system_score_gemma":0.00008348505,"threshold_uncertainty_score":0.0030917525},"labels":[],"label_agreement":null},{"id":"W2013520562","doi":"10.1158/1078-0432.ccr-14-0521","title":"Design of Phase I Combination Trials: Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee","year":2014,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health","keywords":"Clinical trial; Medicine; Regimen; Drug development; Clinical study design; Clinical endpoint; Pharmacodynamics; Combination therapy; Phases of clinical research; Pharmacology; Intensive care medicine; Medical physics; Oncology; Drug; Pharmacokinetics; Internal medicine","score_opus":0.9658311449296211,"score_gpt":0.7722733089490966,"score_spread":0.19355783598052445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013520562","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008139624,0.60297084,0.13819699,0.15362552,0.019431774,0.04680429,0.004967182,0.0011848764,0.03200464],"genre_scores_gemma":[0.0067314226,0.45063207,0.40250114,0.059974108,0.0056174016,0.05795179,0.0050882217,0.00044279575,0.011061061],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.8847305,0.07558863,0.021595068,0.0021921704,0.014598706,0.00129499],"domain_scores_gemma":[0.7633509,0.12419167,0.02379677,0.009476103,0.074526645,0.004658002],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.18856578,0.002558201,0.0058306246,0.0065535177,0.0012173506,0.005657958,0.009003016,0.009508459,0.005297561],"category_scores_gemma":[0.186016,0.0023925514,0.006698928,0.008148495,0.003654094,0.0040080766,0.0027190724,0.013137495,0.0072765048],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078236236,0.00022822793,0.0003879181,0.03697242,0.00049348595,0.00017243501,0.00043044318,0.0017350607,0.0008652507,0.020614697,0.30836207,0.62895566],"study_design_scores_gemma":[0.0012656413,0.0002723592,0.0009896026,0.06546559,0.0010535892,0.00032178118,0.00013764424,0.0012198216,0.0008967294,0.02033364,0.907927,0.00011664227],"about_ca_topic_score_codex":0.005725434,"about_ca_topic_score_gemma":0.008151147,"teacher_disagreement_score":0.8114342,"about_ca_system_score_codex":0.006069164,"about_ca_system_score_gemma":0.047056895,"threshold_uncertainty_score":0.99724305},"labels":[],"label_agreement":null},{"id":"W2013537032","doi":"10.1158/1078-0432.ccr-05-0209","title":"Pseudolaric Acid B, a Novel Microtubule-Destabilizing Agent That Circumvents Multidrug Resistance Phenotype and Exhibits Antitumor Activity <i>In vivo</i>","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Biological Activity of Diterpenoids and Biflavonoids","field":"Biochemistry, Genetics and Molecular Biology","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"In vivo; Biology; Microtubule polymerization; Multiple drug resistance; Apoptosis; Cell cycle checkpoint; Cell culture; P-glycoprotein; Microtubule; Mechanism of action; Cell cycle; Tubulin; Cytotoxicity; Cell biology; Pharmacology; Drug resistance; Biochemistry; In vitro; Microbiology","score_opus":0.14493469520637312,"score_gpt":0.4273523832548519,"score_spread":0.2824176880484788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013537032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772275,0.013136569,0.0053959438,0.00023919626,0.00006155718,0.00007472845,0.00036164845,0.00014818531,0.0033547499],"genre_scores_gemma":[0.990306,0.0042291908,0.0032972803,0.00012891325,0.000033948876,0.00004178847,0.00052316225,0.000013018261,0.0014265348],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99996567,0.000007055507,0.0000030575254,0.000006881125,0.000009453926,0.000007915384],"domain_scores_gemma":[0.9999629,0.0000042342435,0.000012785675,0.0000041984567,0.0000072622843,0.0000086319105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006632026,0.00028011054,0.0001527577,0.00020513928,0.00012845841,0.00015697083,0.0001598383,0.00021081531,0.00066852075],"category_scores_gemma":[0.000051221537,0.00005207101,0.00012958448,0.000126392,0.00014842974,0.00019161466,0.000114556984,0.00026311664,0.00023799331],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002239676,0.000064247084,0.00026231326,0.00012014698,0.0000068448703,0.00012605605,0.0000073740225,0.00015531531,0.9899323,0.00017084359,0.00014387585,0.008786637],"study_design_scores_gemma":[0.000087398825,0.0018044217,0.003962182,0.000009822771,0.00003841192,0.0010257447,0.000011341707,0.00094357034,0.98212045,0.00007398474,0.009913545,0.000009037603],"about_ca_topic_score_codex":0.00020188,"about_ca_topic_score_gemma":0.0003369655,"teacher_disagreement_score":0.00066852075,"about_ca_system_score_codex":0.00015664771,"about_ca_system_score_gemma":0.00016350632,"threshold_uncertainty_score":0.0022364259},"labels":[],"label_agreement":null},{"id":"W2013612743","doi":"10.1158/1078-0432.ccr-08-1899","title":"Global Gene Expression Analysis of Reactive Stroma in Prostate Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Prostate cancer; Stroma; Cancer; Gene expression; Biology; Prostate; Cancer research; Pathology; Gene; Medicine; Genetics; Immunohistochemistry","score_opus":0.21587473288739326,"score_gpt":0.5894723836277024,"score_spread":0.37359765074030915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013612743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941499,0.001377461,0.0022174641,0.00003521592,0.000006791882,0.000026428957,0.0014610956,0.00006300954,0.00066261797],"genre_scores_gemma":[0.9921002,0.0006770478,0.003607256,0.000049523576,0.000010531656,0.00008168695,0.0026520859,0.000014579093,0.0008071864],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984086,0.000020916306,0.00000807184,0.0000466247,0.000058397767,0.000025050975],"domain_scores_gemma":[0.9998739,0.000025223113,0.000042833555,0.0000109258435,0.000026406233,0.000020689717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014142861,0.00018731528,0.00024921328,0.0008279399,0.00020203753,0.00023594676,0.0001267212,0.00015819604,0.0010642324],"category_scores_gemma":[0.00017579032,0.00009200311,0.00024253511,0.0007907599,0.00020623814,0.000121261284,0.00016143554,0.00020996956,0.0001542089],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047258523,0.000045273893,0.029281741,0.00015787529,0.00006007336,0.00006461375,0.000052447907,0.0003100682,0.9616998,0.00007534514,0.00013286092,0.007647351],"study_design_scores_gemma":[0.000033749533,0.0010211493,0.63589466,0.000018953686,0.0002231954,0.001211355,0.00019138929,0.002215433,0.35502937,0.00026420868,0.0038726097,0.000023876082],"about_ca_topic_score_codex":0.00046667675,"about_ca_topic_score_gemma":0.00084178086,"teacher_disagreement_score":0.0010642324,"about_ca_system_score_codex":0.00021648087,"about_ca_system_score_gemma":0.00019902196,"threshold_uncertainty_score":0.003560245},"labels":[],"label_agreement":null},{"id":"W2015965838","doi":"10.1158/1078-0432.ovca13-a84","title":"Abstract A84: Metronomic cyclophosphamide, when combined with vaccination, increases the immunogenicity of the vaccine and modulates the tumor microenvironment to provide better anti-tumor activity","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Sunnybrook Health Science Centre; Health Sciences Centre; Immunovaccine (Canada)","funders":"","keywords":"ELISPOT; Cytotoxic T cell; Immune system; Immunology; CD8; Tumor microenvironment; Immunogenicity; Tumor antigen; Antigen; CTL*; Granzyme B; Cancer vaccine; Medicine; Cancer research; Biology; Immunotherapy; In vitro","score_opus":0.03089693718776623,"score_gpt":0.33223389149760474,"score_spread":0.30133695430983853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015965838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941379,0.001489729,0.0014377706,0.00018216501,0.00011296631,0.00006750784,0.0003136816,0.00011586801,0.0021424822],"genre_scores_gemma":[0.9962528,0.00041120764,0.0011752205,0.000055744393,0.00003357362,0.00004593164,0.00023931357,0.000015545997,0.0017706031],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992204,0.000011707982,0.0000067241363,0.000017573215,0.000018927314,0.000023055054],"domain_scores_gemma":[0.9999528,0.0000064104192,0.000015327634,0.0000045618312,0.00000535512,0.000015477432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000784079,0.00033675288,0.00027985108,0.00023434844,0.000083225845,0.00021374892,0.00015398732,0.0002763515,0.0029455116],"category_scores_gemma":[0.00011519779,0.000102801525,0.00015231961,0.0001572231,0.00014750194,0.00014605603,0.00015093942,0.000447694,0.00042130615],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010831254,0.00022351928,0.00030453462,0.00007288005,0.00001302887,0.00004108258,0.000006846515,0.00023587051,0.9898992,0.000083741426,0.0002866144,0.007749497],"study_design_scores_gemma":[0.0003887977,0.008404444,0.005853027,0.00002001359,0.000049831186,0.0005878858,0.000011527063,0.0014915094,0.97778803,0.00007310404,0.0053250403,0.0000067522196],"about_ca_topic_score_codex":0.00031998602,"about_ca_topic_score_gemma":0.00045109706,"teacher_disagreement_score":0.0029455116,"about_ca_system_score_codex":0.00020910926,"about_ca_system_score_gemma":0.00025057254,"threshold_uncertainty_score":0.009853721},"labels":[],"label_agreement":null},{"id":"W2016493248","doi":"10.1158/1078-0432.ccr-06-0547","title":"DNA Repair Pathway Profiling and Microsatellite Instability in Colorectal Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health; Alvin J. Siteman Cancer Center","keywords":"DNA repair; Biology; MSH2; Microsatellite instability; XRCC1; DNA mismatch repair; MLH1; Cancer research; Gene; Colorectal cancer; Gene expression profiling; Genome instability; DNA damage; Gene expression; Molecular biology; DNA; Cancer; Genetics; Microsatellite","score_opus":0.08811990991537905,"score_gpt":0.45051447353895846,"score_spread":0.3623945636235794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016493248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958293,0.0030584096,0.0006103446,0.000033864322,0.0000034098152,0.000009573073,0.00022717778,0.000032619097,0.00019522244],"genre_scores_gemma":[0.99816436,0.0004167365,0.00089903554,0.00002189445,0.000005064838,0.000011482155,0.00029405716,0.000004318474,0.00018300679],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997938,0.000043466945,0.000019455516,0.00006709698,0.000051119518,0.000025066],"domain_scores_gemma":[0.99951124,0.000094478324,0.00025121667,0.000015890453,0.00007263052,0.00005448123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030255312,0.0002031994,0.0002147026,0.0009995983,0.00015271736,0.00028501425,0.00011729399,0.0002311747,0.00067117513],"category_scores_gemma":[0.00076570327,0.00011473419,0.00010977299,0.00053808535,0.00015520611,0.00014092971,0.00020395096,0.00019385849,0.0001329434],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018537196,0.00005886722,0.44558465,0.0004307736,0.00016289545,0.00029276236,0.00013706973,0.0005102123,0.525909,0.00006127086,0.00019738218,0.024801457],"study_design_scores_gemma":[0.00001905425,0.00055537035,0.9321301,0.000019851908,0.00011734008,0.0022092012,0.000094421914,0.0011389017,0.062707596,0.00013754117,0.000859141,0.000011361852],"about_ca_topic_score_codex":0.0005511895,"about_ca_topic_score_gemma":0.0010431852,"teacher_disagreement_score":0.0009995983,"about_ca_system_score_codex":0.00025506064,"about_ca_system_score_gemma":0.00013016655,"threshold_uncertainty_score":0.002245307},"labels":[],"label_agreement":null},{"id":"W2017858235","doi":"10.1158/1078-0432.ovca13-a27","title":"Abstract A27: The ovarian tumor tissue analysis (OTTA) consortium","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; University of Calgary","funders":"","keywords":"Serous fluid; Tissue microarray; Ovarian cancer; Serous carcinoma; Immunohistochemistry; Pathology; Biology; Clear cell; Cancer; Oncology; Molecular pathology; Cancer research; Internal medicine; Medicine; Gene; Genetics","score_opus":0.22185382597507952,"score_gpt":0.5372881851395189,"score_spread":0.3154343591644394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017858235","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12503365,0.006510716,0.04559749,0.020602673,0.003298857,0.012965034,0.65530765,0.009750236,0.12093368],"genre_scores_gemma":[0.16498101,0.0020053724,0.0524813,0.0052968017,0.0014678698,0.015945798,0.68505657,0.005479838,0.06728544],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9903154,0.0030616834,0.0008492847,0.0016188221,0.0030352913,0.0011194821],"domain_scores_gemma":[0.94909227,0.005346492,0.004145472,0.00795784,0.01823359,0.015224247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021923456,0.0009685751,0.0011417158,0.0051071323,0.0020912685,0.0049334792,0.0037683414,0.0010356136,0.039973345],"category_scores_gemma":[0.021887349,0.0007339109,0.0010466918,0.005162094,0.0010096186,0.001342505,0.0060463124,0.0020332674,0.019323243],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008058187,0.00085026637,0.1120035,0.0010375364,0.00061256235,0.0011448745,0.00051629945,0.0016835389,0.021277875,0.007189887,0.7195163,0.12610924],"study_design_scores_gemma":[0.003393469,0.0008433606,0.2074075,0.0006833433,0.0003286691,0.0011507135,0.0005788905,0.00529711,0.008589125,0.0051505347,0.76638746,0.00018982764],"about_ca_topic_score_codex":0.016773839,"about_ca_topic_score_gemma":0.0144247385,"teacher_disagreement_score":0.039973345,"about_ca_system_score_codex":0.0035169972,"about_ca_system_score_gemma":0.013846306,"threshold_uncertainty_score":0.13372415},"labels":[],"label_agreement":null},{"id":"W2018650005","doi":"10.1158/1078-0432.ccr-09-1192","title":"Tipifarnib Plus Tamoxifen in Tamoxifen-Resistant Metastatic Breast Cancer: A Negative Phase II and Screening of Potential Therapeutic Markers by Proteomic Analysis","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Tamoxifen; Medicine; Internal medicine; Oncology; Metastatic breast cancer; Breast cancer; Cancer; Metastasis","score_opus":0.1474246640642809,"score_gpt":0.5366681232496262,"score_spread":0.3892434591853453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018650005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997449,0.0011242621,0.00018986755,0.00010406265,0.000015434878,0.00054394646,0.00017483332,0.000014502714,0.00038411716],"genre_scores_gemma":[0.9936312,0.001442211,0.0012112572,0.00030820747,0.00007761022,0.0010710894,0.0012650553,0.000009342728,0.0009840813],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999729,0.00011314752,0.000015866988,0.000037086218,0.00005286691,0.00005203349],"domain_scores_gemma":[0.99977595,0.000037790902,0.000037612816,0.000023054457,0.000026125492,0.00009944335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009792486,0.000936558,0.0013580971,0.00036991728,0.00029692057,0.0005135958,0.00038515008,0.00068157533,0.0017709008],"category_scores_gemma":[0.00053855457,0.00032442968,0.00058301835,0.00028906303,0.00047267732,0.00038559444,0.00021469686,0.0010602317,0.00030882348],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27954844,0.07813829,0.02432561,0.0009030391,0.0013716032,0.0007059075,0.00036878622,0.0022821273,0.4565141,0.00017904892,0.0019132788,0.1537498],"study_design_scores_gemma":[0.17327908,0.6924964,0.076634996,0.000051423885,0.001111513,0.0014725619,0.00010981146,0.0028535987,0.048598036,0.00014310796,0.0032008232,0.000048589973],"about_ca_topic_score_codex":0.00042944707,"about_ca_topic_score_gemma":0.0010422072,"teacher_disagreement_score":0.0017709008,"about_ca_system_score_codex":0.00060445815,"about_ca_system_score_gemma":0.00066019606,"threshold_uncertainty_score":0.0059242845},"labels":[],"label_agreement":null},{"id":"W2019307617","doi":"10.1158/1078-0432.ccr-05-2050","title":"The Bisphosphonate Olpadronate Inhibits Skeletal Prostate Cancer Progression in a Green Fluorescent Protein Nude Mouse Model","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Environmental Health Sciences; National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Prostate cancer; Bisphosphonate; Green fluorescent protein; Osteoprotegerin; Bone resorption; Medicine; Bone metastasis; Etidronic acid; Cancer research; Cancer; Pathology; Metastasis; Internal medicine; Endocrinology; Chemistry; Osteoporosis; Biochemistry","score_opus":0.11088911916593962,"score_gpt":0.5037433444387305,"score_spread":0.39285422527279085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019307617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97710776,0.006288654,0.0090076635,0.0006099949,0.0002466928,0.00031817312,0.0017138072,0.0007644173,0.0039428747],"genre_scores_gemma":[0.9688849,0.005732227,0.010763994,0.00027780636,0.00005456545,0.0005313606,0.002463784,0.00009955324,0.01119195],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996445,0.000047950834,0.000023968822,0.000070582646,0.00013726181,0.00007571842],"domain_scores_gemma":[0.9998293,0.000014412835,0.000063690786,0.000016422564,0.00001943942,0.00005678093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028162592,0.0011355712,0.00056399725,0.0010065947,0.000261738,0.000320298,0.0006295713,0.0007844379,0.0018611028],"category_scores_gemma":[0.00010272165,0.00033001488,0.000739247,0.0005334637,0.00046121285,0.00030955247,0.0002192898,0.0014668894,0.0005706053],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043708202,0.00033015426,0.0001230018,0.00008333647,0.0000130633325,0.00004280211,0.000012337251,0.0001444198,0.99702674,0.00009824588,0.00012365455,0.0015651935],"study_design_scores_gemma":[0.00020145075,0.004397058,0.0024836687,0.00002198417,0.00006822843,0.00031371432,0.000027324642,0.001655068,0.98703974,0.000056083798,0.0037230735,0.000012582965],"about_ca_topic_score_codex":0.001874114,"about_ca_topic_score_gemma":0.003174991,"teacher_disagreement_score":0.001874114,"about_ca_system_score_codex":0.000453365,"about_ca_system_score_gemma":0.00069571426,"threshold_uncertainty_score":0.006226003},"labels":[],"label_agreement":null},{"id":"W2019458473","doi":"10.1158/1078-0432.ccr-10-1533","title":"Intrinsic Breast Tumor Subtypes, Race, and Long-Term Survival in the Carolina Breast Cancer Study","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":435,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Environmental Health Sciences; National Cancer Institute","keywords":"Breast cancer; Medicine; Estrogen receptor; Internal medicine; Oncology; Cancer; Basal (medicine); Population; Estrogen; Breast disease; Gynecology","score_opus":0.0692084032633277,"score_gpt":0.45154551464388737,"score_spread":0.3823371113805597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019458473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962715,0.00038515485,0.000060266342,0.00017105558,0.000010648156,0.000012525315,0.002245795,0.000004001022,0.0008390637],"genre_scores_gemma":[0.99658316,0.00020338222,0.00008150731,0.00008089577,0.000017031289,0.000028192684,0.0026895374,0.000002677315,0.00031364305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996799,0.000086124695,0.00001926186,0.000061825165,0.00007425617,0.00007862846],"domain_scores_gemma":[0.9983689,0.00020480702,0.0005338608,0.00013340781,0.00039545112,0.00036354447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005391445,0.00021947657,0.00021915205,0.00061888417,0.000733025,0.00037823437,0.00055779127,0.00035130093,0.0013086636],"category_scores_gemma":[0.0016827526,0.00013003219,0.00022887801,0.00095389795,0.00023339808,0.00020959793,0.00040742627,0.0005181417,0.00018674428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008987116,0.000022036753,0.9984968,0.000007990201,0.00003912153,0.00004215102,0.00005467168,0.00004044696,0.00007653534,0.000018674726,0.0005204247,0.0005912941],"study_design_scores_gemma":[0.000009011035,0.000021613383,0.9993691,0.00001312846,0.000027002434,0.000049731338,0.00009748732,0.00013125286,0.00002805293,0.000016552869,0.00023373663,0.0000033179763],"about_ca_topic_score_codex":0.10010594,"about_ca_topic_score_gemma":0.13831793,"teacher_disagreement_score":0.10010594,"about_ca_system_score_codex":0.00069601473,"about_ca_system_score_gemma":0.0009474755,"threshold_uncertainty_score":0.1990465},"labels":[],"label_agreement":null},{"id":"W2019624319","doi":"10.1158/1078-0432.ccr-14-0305","title":"miR-409-3p/-5p Promotes Tumorigenesis, Epithelial-to-Mesenchymal Transition, and Bone Metastasis of Human Prostate Cancer","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Prostate cancer; Bone metastasis; Metastasis; Epithelial–mesenchymal transition; Cancer research; Prostate; Cancer; Medicine; Carcinogenesis; Pathology; microRNA; Cancer cell; Cancer stem cell; Oncology; Mesenchymal stem cell; Biology; Internal medicine","score_opus":0.07423219067759994,"score_gpt":0.45062671169907,"score_spread":0.37639452102147003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019624319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898094,0.0031387133,0.0030137096,0.0001768166,0.000042333475,0.000077334415,0.0005502641,0.0002831555,0.002908239],"genre_scores_gemma":[0.99449426,0.000956376,0.0020851137,0.00008494239,0.000010159678,0.000049141618,0.0005413918,0.000026553205,0.0017519922],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997528,0.00003342536,0.000016335149,0.00004404866,0.000111902285,0.000041466563],"domain_scores_gemma":[0.9999063,0.00001293071,0.000031594056,0.000009372975,0.000011673258,0.0000281462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022354483,0.00033632762,0.00026194597,0.00039695227,0.00024043028,0.000327589,0.00014954821,0.00020582168,0.0013337033],"category_scores_gemma":[0.0001491802,0.00020826956,0.00036477068,0.0002149814,0.00024303883,0.00012597928,0.00023969302,0.0004776906,0.0005111181],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018947659,0.00008278022,0.0007876734,0.00005468642,0.000012383324,0.000075808886,0.000016796263,0.00013937659,0.99614054,0.00006785595,0.00011447554,0.0023181355],"study_design_scores_gemma":[0.000035764566,0.00092124677,0.015303204,0.000012310637,0.000051243667,0.00062619866,0.000034702378,0.0019589865,0.97671324,0.000083170184,0.0042522135,0.00000772096],"about_ca_topic_score_codex":0.0008746431,"about_ca_topic_score_gemma":0.0014993373,"teacher_disagreement_score":0.0013337033,"about_ca_system_score_codex":0.00039768175,"about_ca_system_score_gemma":0.0004957242,"threshold_uncertainty_score":0.0044617057},"labels":[],"label_agreement":null},{"id":"W2020369202","doi":"10.1158/1078-0432.ccr-13-2270","title":"Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung Cancer","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":360,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"Cancer Research UK","keywords":"Lung cancer; Monocarboxylate transporter; Medicine; Transporter; Cancer; Cancer research; Biology; Internal medicine; Biochemistry; Gene","score_opus":0.07982957861680824,"score_gpt":0.4191240128012518,"score_spread":0.33929443418444355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020369202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98626417,0.01175148,0.00037828294,0.00018782016,0.000028749502,0.000038781433,0.00044090202,0.00006375844,0.0008459157],"genre_scores_gemma":[0.9960718,0.002372009,0.00032981884,0.0000539357,0.0000098638175,0.000020768955,0.0007483736,0.00000428072,0.00038914988],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999874,0.000020055231,0.0000138106125,0.000027181344,0.00004112429,0.000023853361],"domain_scores_gemma":[0.9999186,0.000017232273,0.000018972049,0.000009152952,0.000014091853,0.000022038394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019661203,0.00023990794,0.00040143475,0.00029060603,0.00019042386,0.0003077821,0.00023137823,0.00026349872,0.0010581062],"category_scores_gemma":[0.0002156262,0.00011013493,0.00026248998,0.00037054816,0.00016577682,0.00018120027,0.00016525063,0.00032648933,0.0002656618],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038294457,0.00038061236,0.016727146,0.00039438956,0.00009737726,0.00028423805,0.000046414883,0.001085936,0.9274391,0.000074671916,0.0007813234,0.048859328],"study_design_scores_gemma":[0.00076277135,0.020272084,0.19564793,0.00005616476,0.0004176855,0.003299603,0.00016530993,0.005078125,0.75841933,0.00015812875,0.015699988,0.000022857903],"about_ca_topic_score_codex":0.0016334171,"about_ca_topic_score_gemma":0.0039476505,"teacher_disagreement_score":0.0016334171,"about_ca_system_score_codex":0.00063956896,"about_ca_system_score_gemma":0.00035488486,"threshold_uncertainty_score":0.00464046},"labels":[],"label_agreement":null},{"id":"W2020774281","doi":"10.1158/1078-0432.ccr-12-2557","title":"Sequence Dependence of MEK Inhibitor AZD6244 Combined with Gemcitabine for the Treatment of Biliary Cancer","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University Health Network","funders":"","keywords":"Gemcitabine; MEK inhibitor; Cancer; Medicine; Cancer research; Internal medicine; Chemotherapy; Oncology; MAPK/ERK pathway; Kinase; Biology","score_opus":0.3591914135442596,"score_gpt":0.5259425249704123,"score_spread":0.16675111142615268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020774281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953301,0.0029445083,0.0005535452,0.000059528935,0.0000324871,0.000054753666,0.00012103874,0.000041692863,0.00086237624],"genre_scores_gemma":[0.9964562,0.0013538128,0.0012104851,0.000029306677,0.000019951747,0.000040044342,0.0002307553,0.00000821443,0.0006511779],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998789,0.000027556176,0.00001386632,0.000022007905,0.000036067482,0.000021634165],"domain_scores_gemma":[0.9999136,0.000016092628,0.00002420028,0.000012158631,0.000011376145,0.000022690849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013464631,0.00024999148,0.00044840193,0.00028073136,0.000117429845,0.0001856786,0.00020525412,0.00015925366,0.0007937113],"category_scores_gemma":[0.000156042,0.00012804115,0.00026519515,0.00021006227,0.000144245,0.00019051938,0.00018451377,0.0004468726,0.00019774308],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034000373,0.0006213705,0.0016716691,0.00016674885,0.000044258944,0.000084665466,0.000033641612,0.00087971427,0.97390556,0.00006440474,0.00020913355,0.01891876],"study_design_scores_gemma":[0.00037901432,0.015712576,0.015796226,0.000015655945,0.00013845561,0.0005020734,0.000029263249,0.0032856292,0.96058553,0.00003650337,0.0035038474,0.000015302932],"about_ca_topic_score_codex":0.0005322724,"about_ca_topic_score_gemma":0.0017977786,"teacher_disagreement_score":0.0007937113,"about_ca_system_score_codex":0.0002549984,"about_ca_system_score_gemma":0.00029472326,"threshold_uncertainty_score":0.0026552677},"labels":[],"label_agreement":null},{"id":"W2021044447","doi":"10.1158/1078-0432.ccr-13-2659","title":"Molecular Testing for Lymph Node Metastases as a Determinant of Colon Cancer Recurrence: Results from a Retrospective Multicenter Study","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; DiagnoCure (Canada); BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Medicine; Lymph node; Hazard ratio; Internal medicine; Colorectal cancer; Lymph; Retrospective cohort study; Confidence interval; Proportional hazards model; Clinical endpoint; Cancer; Oncology; Gastroenterology; Pathology; Clinical trial","score_opus":0.24945192933218374,"score_gpt":0.5462985880595691,"score_spread":0.29684665872738536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021044447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99840134,0.0005296338,0.00031212877,0.000023873581,0.00000485478,0.000019948227,0.0005343876,0.000004713521,0.00016912243],"genre_scores_gemma":[0.99893993,0.000118967924,0.00021684078,0.000025462336,0.0000097271595,0.000019099529,0.00061895966,0.000004940644,0.000045952038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99690384,0.0013781163,0.0003434334,0.0007997309,0.00043859953,0.00013620443],"domain_scores_gemma":[0.9875645,0.0035252154,0.004699673,0.0026300552,0.001042343,0.0005381823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048802365,0.0003441866,0.00049361086,0.00064910535,0.0003717402,0.0006655976,0.00044625922,0.00042112946,0.0010401207],"category_scores_gemma":[0.010226705,0.0003094014,0.0007198773,0.0011328269,0.0004523937,0.0003833296,0.00052056316,0.0003722947,0.0002831959],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008679074,0.000029246601,0.9963994,0.000018545716,0.00022984364,0.00006412282,0.00006426025,0.000049732353,0.0005346717,0.000011409939,0.00007861687,0.0016522298],"study_design_scores_gemma":[0.00006649553,0.00052473124,0.9974788,0.000013829909,0.00028822589,0.0005724916,0.00011531582,0.0002530353,0.00025443686,0.000016975215,0.00040743977,0.00000824112],"about_ca_topic_score_codex":0.0017670358,"about_ca_topic_score_gemma":0.0017370823,"teacher_disagreement_score":0.0048802365,"about_ca_system_score_codex":0.00029525647,"about_ca_system_score_gemma":0.0003495805,"threshold_uncertainty_score":0.025809467},"labels":[],"label_agreement":null},{"id":"W2021333908","doi":"10.1158/1078-0432.ccr-14-1334","title":"A Phase I Monotherapy Study of RG7212, a First-in-Class Monoclonal Antibody Targeting TWEAK Signaling in Patients with Advanced Cancers","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Monoclonal antibody; Medicine; Antibody; Cancer; Monoclonal; Cancer research; Immunology; Oncology; Internal medicine","score_opus":0.06097244176865894,"score_gpt":0.458161321343711,"score_spread":0.39718887957505206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021333908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99305224,0.0016677004,0.0006498112,0.00036703475,0.00009212476,0.0018618387,0.000663309,0.00014142707,0.0015045776],"genre_scores_gemma":[0.99220616,0.0010693702,0.0014220823,0.00041482926,0.000103263264,0.0013057926,0.0010197844,0.000029695662,0.0024289454],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99978083,0.00007571583,0.000009147223,0.00004643022,0.000025504387,0.00006236255],"domain_scores_gemma":[0.9996604,0.000039540093,0.000058012083,0.000028154576,0.00002471295,0.00018925709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066188164,0.0013289631,0.0016836894,0.00034845772,0.00039968907,0.00053515175,0.0006853313,0.00096815947,0.002457964],"category_scores_gemma":[0.00041695352,0.00044825705,0.0007182813,0.00031663757,0.00062387955,0.00052809116,0.00018433917,0.0020979114,0.00078299025],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4396814,0.091182366,0.010610779,0.00113223,0.0012149233,0.0007825175,0.0006105026,0.005814453,0.24648945,0.0004032794,0.008181009,0.1938971],"study_design_scores_gemma":[0.33901584,0.62758535,0.015998984,0.00003451776,0.0003280396,0.0005867001,0.000059805723,0.0015268076,0.010595467,0.00018233011,0.0040492523,0.00003692164],"about_ca_topic_score_codex":0.00092985475,"about_ca_topic_score_gemma":0.0024452854,"teacher_disagreement_score":0.002457964,"about_ca_system_score_codex":0.0007459913,"about_ca_system_score_gemma":0.0011111351,"threshold_uncertainty_score":0.008222759},"labels":[],"label_agreement":null},{"id":"W2021424812","doi":"10.1158/1078-0432.ccr-08-2859","title":"Phase I Study of MG98, an Oligonucleotide Antisense Inhibitor of Human DNA Methyltransferase 1, Given as a 7-Day Infusion in Patients with Advanced Solid Tumors","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pyrogenesis (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Pharmacokinetics; Tolerability; Medicine; Pharmacology; Toxicity; Pharmacodynamics; Volume of distribution; Peripheral blood mononuclear cell; Methyltransferase; Internal medicine; Adverse effect; Biology; In vitro; Methylation","score_opus":0.062393287014908816,"score_gpt":0.4842561042323729,"score_spread":0.4218628172174641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021424812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979625,0.0006387013,0.00044981213,0.00008133022,0.000018156314,0.00035012548,0.00010509396,0.00003930375,0.00035503038],"genre_scores_gemma":[0.9960179,0.00062815327,0.0015828778,0.00017201503,0.00006765705,0.0005012738,0.00056145544,0.000014922728,0.0004536745],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997738,0.00009571766,0.000011367343,0.000046115172,0.00003106792,0.000041959876],"domain_scores_gemma":[0.99956626,0.00009300592,0.00012776649,0.00003923547,0.000020787564,0.00015300034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004579821,0.001261932,0.001245425,0.00025335437,0.00026075938,0.00046341147,0.0006319556,0.0008558155,0.00121711],"category_scores_gemma":[0.00055259693,0.00031133034,0.00061654893,0.00025546417,0.00079881784,0.00044920796,0.00023847599,0.002085733,0.00044122012],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29795673,0.057873994,0.025174493,0.0007474995,0.0008318781,0.0009911363,0.0007817939,0.007357182,0.3879124,0.00037287007,0.0026163864,0.21738365],"study_design_scores_gemma":[0.14658394,0.7887237,0.025499942,0.000035459878,0.00031670637,0.0010127663,0.0000804315,0.0027376183,0.031588275,0.00016717496,0.00322199,0.000032137228],"about_ca_topic_score_codex":0.0004372273,"about_ca_topic_score_gemma":0.0007488,"teacher_disagreement_score":0.001261932,"about_ca_system_score_codex":0.00054848916,"about_ca_system_score_gemma":0.0007063807,"threshold_uncertainty_score":0.0040715933},"labels":[],"label_agreement":null},{"id":"W2022033134","doi":"10.1158/1078-0432.tcmusa10-a1","title":"Abstract A1: Clinical and biological significance of GSK-3β inactivation in breast cancer: An immunohistochemical study","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Breast cancer; GSK-3; Protein kinase B; Immunohistochemistry; Medicine; Cancer; GSK3B; PI3K/AKT/mTOR pathway; Cancer research; Internal medicine; Oncology; Glycogen synthase; Biology; Phosphorylation; Signal transduction; Glycogen; Biochemistry","score_opus":0.18055240348889637,"score_gpt":0.5343270259261224,"score_spread":0.353774622437226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022033134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99831843,0.0006463497,0.00023104723,0.000032038246,0.000008080592,0.000010546056,0.00009790575,0.000007674109,0.0006479997],"genre_scores_gemma":[0.9992094,0.00023873351,0.00012882036,0.000012285156,0.000023755943,0.000008119496,0.00011940268,0.0000023841133,0.00025704395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998447,0.000030068511,0.000022450067,0.00003504109,0.000038925573,0.00002886855],"domain_scores_gemma":[0.9994809,0.00015260417,0.00014949392,0.00004464092,0.00007978448,0.00009253035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047010285,0.00018750077,0.00017980824,0.0009114315,0.00024229773,0.00026873357,0.00018523687,0.00027755872,0.0028168394],"category_scores_gemma":[0.0010119654,0.00017278001,0.00015480853,0.00058386556,0.00035918594,0.00027137264,0.00020578872,0.00018512688,0.00063939707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022838241,0.00014973599,0.93311286,0.00008088605,0.00005053332,0.0032651883,0.00009743006,0.00012669689,0.052283797,0.00006846436,0.000313999,0.008166584],"study_design_scores_gemma":[0.00003459357,0.0006283579,0.9823433,0.0000059919657,0.000045088666,0.009941303,0.00012099528,0.00035056652,0.0056595136,0.00007028032,0.0007937664,0.0000062797894],"about_ca_topic_score_codex":0.00042695587,"about_ca_topic_score_gemma":0.0003318011,"teacher_disagreement_score":0.0028168394,"about_ca_system_score_codex":0.0001507076,"about_ca_system_score_gemma":0.00013832543,"threshold_uncertainty_score":0.009423196},"labels":[],"label_agreement":null},{"id":"W2022709664","doi":"10.1158/1078-0432.tcme10-b28","title":"Abstract B28: Epigenetic contribution of Wnt antagonists SFRP1 and DKK1 as prognostic markers in colorectal cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland; University of Toronto","funders":"","keywords":"Colorectal cancer; DKK1; Methylation; Wnt signaling pathway; Microsatellite instability; Epigenetics; DNA methylation; Oncology; Population; Biology; Cancer; Internal medicine; Cancer research; Medicine; Genetics; Microsatellite; Gene; Allele; Gene expression","score_opus":0.05485635883217484,"score_gpt":0.470407721302421,"score_spread":0.41555136247024616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022709664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949833,0.0015887849,0.00043346637,0.00014335931,0.0000063860116,0.000013465297,0.0018182064,0.000023056444,0.0009899035],"genre_scores_gemma":[0.9987079,0.00015385427,0.0002391568,0.000011299364,0.0000060247644,0.0000045064485,0.0004972671,0.000002083684,0.00037780407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981564,0.000020046486,0.000016656473,0.000047572667,0.000058159203,0.000041909723],"domain_scores_gemma":[0.9994734,0.00007841485,0.00019005018,0.000028065037,0.00013210774,0.00009800818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034322654,0.00019674086,0.000250255,0.00067944906,0.00027384827,0.0003470416,0.00023646565,0.00016576938,0.0024257805],"category_scores_gemma":[0.0012170156,0.00007695999,0.00015010826,0.0008923711,0.00024000656,0.00011944814,0.00020985828,0.00018420353,0.00024106151],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079964026,0.00001513681,0.97116065,0.000061568506,0.00006426188,0.00012781499,0.00008345628,0.00017671435,0.013543734,0.000037786835,0.00040597137,0.013523161],"study_design_scores_gemma":[0.0000074732616,0.000040567513,0.99736017,0.000005193077,0.000049775037,0.0002481812,0.000032918182,0.0002490452,0.001343243,0.000022853768,0.0006386148,0.0000020239659],"about_ca_topic_score_codex":0.052940566,"about_ca_topic_score_gemma":0.05308206,"teacher_disagreement_score":0.052940566,"about_ca_system_score_codex":0.0010907504,"about_ca_system_score_gemma":0.00090623536,"threshold_uncertainty_score":0.10526484},"labels":[],"label_agreement":null},{"id":"W2024654743","doi":"10.1158/1078-0432.ovca13-a25","title":"Abstract A25: PPP2R1A mutations affect PP2A complex formation, and novel protein interactions in gynecological carcinoma cell lines","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Protein phosphatase 2; Cell culture; Somatic cell; Protein subunit; Genetics; Gene","score_opus":0.322294496576503,"score_gpt":0.5076780278910918,"score_spread":0.18538353131458885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024654743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991197,0.00078871584,0.0028934795,0.000101727775,0.00003637351,0.00003327796,0.0026294617,0.000096054326,0.0022239857],"genre_scores_gemma":[0.9905805,0.00038378467,0.0023497457,0.00007346983,0.000005464286,0.000053975695,0.0036969138,0.000033113392,0.0028230892],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99967706,0.000047101035,0.000049533395,0.000065829685,0.000113261376,0.00004728006],"domain_scores_gemma":[0.99985373,0.00003966113,0.000024111527,0.000034142915,0.000022543685,0.000025806168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017018043,0.0002441348,0.00023438175,0.00032752217,0.00021343467,0.0003038994,0.00024609087,0.00026976605,0.0017919724],"category_scores_gemma":[0.00017057083,0.0001229546,0.00025218455,0.000355998,0.00016176977,0.0001076339,0.00017941264,0.00033251423,0.00079534744],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004659334,0.000020578922,0.00057696935,0.000013408608,0.0000063397733,0.00014702024,0.000018209083,0.00005185692,0.99845576,0.00006291495,0.00011918093,0.00048119613],"study_design_scores_gemma":[0.000020084457,0.00017228967,0.022301422,0.000004352957,0.000028340106,0.0011042671,0.000069167814,0.0016713777,0.9699091,0.000042886535,0.004669489,0.0000071398936],"about_ca_topic_score_codex":0.0023938913,"about_ca_topic_score_gemma":0.0014937011,"teacher_disagreement_score":0.0023938913,"about_ca_system_score_codex":0.0002795007,"about_ca_system_score_gemma":0.00014134907,"threshold_uncertainty_score":0.0059947968},"labels":[],"label_agreement":null},{"id":"W2025795030","doi":"10.1158/1078-0432.ccr-14-2603","title":"Development and Clinical Validation of an <i>In Situ</i> Biopsy-Based Multimarker Assay for Risk Stratification in Prostate Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Computer Research Institute of Montréal; Centre Hospitalier de l’Université de Montréal; Queen's University","funders":"National Cancer Institute; National Comprehensive Cancer Network","keywords":"Medicine; Prostate cancer; Biomarker; Biopsy; Internal medicine; Risk assessment; Oncology; Cancer; Prostatectomy; Prostate; Predictive value; Predictive value of tests; Pathology","score_opus":0.32463453878355264,"score_gpt":0.5519130186668744,"score_spread":0.22727847988332173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025795030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9684268,0.0014958559,0.025090609,0.000343791,0.000100191195,0.00042337496,0.0010315692,0.0002844481,0.002803374],"genre_scores_gemma":[0.9727348,0.00018556444,0.024962066,0.00023504432,0.00005796102,0.00023648985,0.0010081547,0.00002001811,0.00055997085],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961743,0.0012219619,0.00027000866,0.00088286604,0.0013069678,0.00014382467],"domain_scores_gemma":[0.99559397,0.0013743124,0.0012801116,0.0004977955,0.00092802773,0.00032582617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005866604,0.0007272918,0.00041614682,0.0014149096,0.00041353467,0.0011486494,0.0006029613,0.00095133885,0.0011293654],"category_scores_gemma":[0.008717777,0.00026473083,0.0003203731,0.0004267083,0.00058549445,0.0003632481,0.00051891594,0.0007125207,0.0007219982],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022757144,0.0009027846,0.6619074,0.00026232045,0.00031861194,0.00014251878,0.00027620187,0.001742502,0.26546225,0.00043726395,0.00124598,0.0650265],"study_design_scores_gemma":[0.00023294151,0.0057302294,0.749763,0.00010543244,0.00034556302,0.003198015,0.00014404407,0.020268146,0.21370408,0.0006209292,0.0057922076,0.000095349424],"about_ca_topic_score_codex":0.00046137537,"about_ca_topic_score_gemma":0.0006694462,"teacher_disagreement_score":0.005866604,"about_ca_system_score_codex":0.00050869904,"about_ca_system_score_gemma":0.00047060993,"threshold_uncertainty_score":0.031025946},"labels":[],"label_agreement":null},{"id":"W2026022612","doi":"10.1158/1078-0432.ccr-07-1530","title":"Linking Antibody Fc Domain to Endostatin Significantly Improves Endostatin Half-life and Efficacy","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Public Health Agency of Canada","keywords":"Endostatin; Medicine; Chemistry; Cancer research; Immunology; Angiogenesis","score_opus":0.13695482618782623,"score_gpt":0.48156824361031697,"score_spread":0.34461341742249074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026022612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914022,0.0039764084,0.0034301332,0.00009384213,0.000046480876,0.00003504488,0.000069167196,0.00010852241,0.0008381257],"genre_scores_gemma":[0.99198455,0.0018714168,0.0041570123,0.00014200713,0.00003361975,0.00002986384,0.00029824435,0.000035926332,0.001447444],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986076,0.000019225738,0.00001620715,0.000031683674,0.000038997765,0.000033063025],"domain_scores_gemma":[0.9998616,0.000026657464,0.00004804832,0.000012995627,0.00002455454,0.000026189797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018024682,0.00037320243,0.00036374485,0.00019586415,0.000074266216,0.0002346402,0.0002715186,0.00045406498,0.0012677116],"category_scores_gemma":[0.0002856056,0.0000970793,0.00028718027,0.00013937827,0.00014529246,0.00024446135,0.00018743964,0.00047757063,0.0003132259],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016500695,0.00009000005,0.00019769021,0.000049652295,0.000013357554,0.000033109678,0.0000094086345,0.00010459882,0.9953591,0.00003379189,0.000054440352,0.003889723],"study_design_scores_gemma":[0.00005442537,0.0011753207,0.0032057317,0.000008691706,0.0000777372,0.0004140989,0.0000068772983,0.00056775316,0.99071336,0.000018967947,0.0037528216,0.0000042200277],"about_ca_topic_score_codex":0.00036258923,"about_ca_topic_score_gemma":0.000275192,"teacher_disagreement_score":0.0012677116,"about_ca_system_score_codex":0.00031291996,"about_ca_system_score_gemma":0.00015676547,"threshold_uncertainty_score":0.0042408705},"labels":[],"label_agreement":null},{"id":"W2026076019","doi":"10.1158/1078-0432.ccr-07-5237","title":"Loss of Heterozygosity at the <i>BRCA2</i> Locus Detected by Multiplex Ligation-Dependent Probe Amplification is Common in Prostate Cancers from Men with a Germline <i>BRCA2</i> Mutation","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Loss of heterozygosity; Germline mutation; Prostate cancer; Germline; Mutation; Cancer research; Biology; BRCA2 Protein; Cancer; Multiplex ligation-dependent probe amplification; Genetics; Gene; Exon; Allele","score_opus":0.06446206469220922,"score_gpt":0.39969916950797746,"score_spread":0.33523710481576824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026076019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99921334,0.00012776829,0.00046041916,0.000010053894,9.801612e-7,0.000005473699,0.000038061073,0.000011069498,0.00013281529],"genre_scores_gemma":[0.9989262,0.00006317397,0.0006630628,0.000014785423,0.00000400376,0.000010229966,0.000138971,0.00000198123,0.00017751759],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996884,0.000050558632,0.000018447738,0.00010703039,0.00009174669,0.000043857202],"domain_scores_gemma":[0.99961394,0.00010801611,0.00017431064,0.000025371493,0.000022037711,0.00005636749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034007462,0.00022691568,0.00017382683,0.00059747143,0.00019533711,0.00022943274,0.0001970886,0.00021411078,0.0012259895],"category_scores_gemma":[0.00068305305,0.00016964936,0.00009349227,0.00021093314,0.00028579056,0.00011069876,0.00014462802,0.00023375038,0.00020497799],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056678033,0.00014646385,0.5879182,0.000060510843,0.00007753358,0.0015212287,0.00029019595,0.00012606445,0.3984734,0.00006313723,0.00017360812,0.010582809],"study_design_scores_gemma":[0.000033903412,0.001086936,0.8729289,0.000010229771,0.000079244324,0.016340392,0.00018341161,0.0009475872,0.10727921,0.00005945107,0.0010399552,0.000010662832],"about_ca_topic_score_codex":0.0006057584,"about_ca_topic_score_gemma":0.0009399524,"teacher_disagreement_score":0.0012259895,"about_ca_system_score_codex":0.00017372626,"about_ca_system_score_gemma":0.000109090855,"threshold_uncertainty_score":0.0041012764},"labels":[],"label_agreement":null},{"id":"W2026504560","doi":"10.1158/1078-0432.ccr-14-2552","title":"<i>CCR</i> 20th Anniversary Commentary: The Development of Breast Cancer Molecular Subtyping","year":2015,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Subtyping; Breast cancer; Cancer; Medicine; Clinical trial; Oncology; Bioinformatics; Internal medicine; Biology","score_opus":0.15112496895435373,"score_gpt":0.4621677745794742,"score_spread":0.3110428056251205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026504560","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017326682,0.0018417747,0.00008211737,0.9511876,0.04485425,0.0000121580715,0.00009974958,0.00005220559,0.0016969497],"genre_scores_gemma":[0.0015882846,0.0011419248,0.00014287644,0.91653794,0.07695592,0.000035271707,0.000048239133,0.00002530742,0.0035242122],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99584806,0.0011293301,0.0004777137,0.00066089735,0.001434551,0.00044945898],"domain_scores_gemma":[0.98914284,0.0060157133,0.0006858361,0.00044198695,0.0022102986,0.0015033332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058267815,0.0013321217,0.0020842885,0.0009510068,0.0033906342,0.0034188821,0.0031407063,0.041906986,0.0059024617],"category_scores_gemma":[0.024697125,0.00093849824,0.0019165039,0.0008302899,0.0037990601,0.0038131007,0.0012926684,0.04776614,0.009777664],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003547722,0.000012826496,0.00014577781,0.000027661641,0.000007673966,0.000383154,0.000025592111,0.000024854093,0.00007794363,0.0006378861,0.9952739,0.0033471389],"study_design_scores_gemma":[0.00012784453,0.00010774267,0.0011943702,0.00031767724,0.00004748983,0.0014541579,0.00015582725,0.00043227556,0.0003755596,0.0045947195,0.9911221,0.00007007333],"about_ca_topic_score_codex":0.0051435526,"about_ca_topic_score_gemma":0.007560854,"teacher_disagreement_score":0.041906986,"about_ca_system_score_codex":0.005512721,"about_ca_system_score_gemma":0.003503379,"threshold_uncertainty_score":0.039997756},"labels":[],"label_agreement":null},{"id":"W2026813872","doi":"10.1158/1078-0432.ccr-13-2567","title":"Steroidogenic Germline Polymorphism Predictors of Prostate Cancer Progression in the Estradiol Pathway","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Prostate cancer; Single-nucleotide polymorphism; Oncology; Cancer; Internal medicine; SNP; Medicine; Disease; Prostate; Biology; Bioinformatics; Genotype; Genetics; Gene","score_opus":0.0762159687480923,"score_gpt":0.4414984084698597,"score_spread":0.36528243972176744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026813872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982514,0.0010087293,0.00022020763,0.000059170656,0.000005521019,0.0000030724468,0.00020085674,0.000007681684,0.00024348348],"genre_scores_gemma":[0.999561,0.00011033625,0.000096228636,0.0000099799245,0.0000060067464,9.930418e-7,0.00011709131,0.0000018625432,0.00009653084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983525,0.000047294398,0.0000121716475,0.00005107398,0.000032575223,0.000021627178],"domain_scores_gemma":[0.99941885,0.00015996242,0.00025024422,0.000038485927,0.000039291837,0.000093191775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034748492,0.000280669,0.00029264958,0.00041115138,0.00017526012,0.00032720505,0.00018562708,0.00022362756,0.0022090424],"category_scores_gemma":[0.00086648,0.00009995604,0.0003825812,0.00074138824,0.00020830492,0.000104174585,0.00022230421,0.0003421119,0.00021081972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044763886,0.000017421122,0.99011326,0.000025914429,0.00028216618,0.00012280555,0.000039523267,0.00024278938,0.003817787,0.000039848754,0.000078340825,0.0047724294],"study_design_scores_gemma":[0.000016945933,0.000120479366,0.9973596,0.000010479219,0.00021055424,0.00044433214,0.00003443424,0.00059213076,0.00068344857,0.0001216052,0.00040188982,0.0000041036196],"about_ca_topic_score_codex":0.0021343871,"about_ca_topic_score_gemma":0.0023050562,"teacher_disagreement_score":0.0022090424,"about_ca_system_score_codex":0.00012574585,"about_ca_system_score_gemma":0.00022279522,"threshold_uncertainty_score":0.0073899627},"labels":[],"label_agreement":null},{"id":"W2027287873","doi":"10.1158/1078-0432.ccr-14-2206","title":"NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell Carcinoma","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Lung cancer; Gene signature; Cancer research; Cisplatin; Oncology; Medicine; Gene expression profiling; Vinorelbine; ERCC1; Gene; Chemotherapy; Tissue microarray; Cancer; Gene expression; Biology; Internal medicine; Genetics; DNA repair","score_opus":0.11004222712469494,"score_gpt":0.4269269755545507,"score_spread":0.3168847484298558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027287873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983234,0.001064239,0.0001500135,0.00006013214,0.0000036002975,0.000012588103,0.0002373351,0.000008260403,0.0001404293],"genre_scores_gemma":[0.9993581,0.00014848159,0.0001284712,0.000019570163,0.0000039851975,0.000008458632,0.000253281,0.0000017522207,0.00007804331],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998173,0.000068606154,0.000016221167,0.000039932867,0.00003661658,0.000021407368],"domain_scores_gemma":[0.99960464,0.00014110468,0.00012695564,0.000032515043,0.000035631765,0.00005927342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007096762,0.0002014105,0.00040715915,0.00020312268,0.00014777954,0.00027063186,0.00013410891,0.00019316141,0.0010723292],"category_scores_gemma":[0.0009724938,0.00009197942,0.00036257744,0.00020162646,0.00014845791,0.00019186457,0.00017937209,0.0002227591,0.0001347961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026785064,0.0005510922,0.87785494,0.00032247783,0.00071755605,0.00020379107,0.000047809863,0.001675674,0.04909352,0.000072604795,0.00054722273,0.042128168],"study_design_scores_gemma":[0.0007100617,0.0042585484,0.9739957,0.00003807443,0.0008045037,0.00079126545,0.00007295,0.0047345576,0.013018246,0.00030824955,0.0012549007,0.000013010841],"about_ca_topic_score_codex":0.0005492752,"about_ca_topic_score_gemma":0.0014619867,"teacher_disagreement_score":0.0010723292,"about_ca_system_score_codex":0.00033515773,"about_ca_system_score_gemma":0.00040631817,"threshold_uncertainty_score":0.0037531853},"labels":[],"label_agreement":null},{"id":"W2030244887","doi":"10.1158/1078-0432.12aacriaslc-b34","title":"Abstract B34: Overcoming resistance to EGFR-Tyrosine Kinase Inhibitor therapy in non-small cell lung cancer","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Lung cancer; Cancer research; Targeted therapy; Medicine; Epidermal growth factor receptor; Receptor tyrosine kinase; Cancer; Small hairpin RNA; Tyrosine kinase; EGFR inhibitors; Bioinformatics; Biology; Gene; Oncology; Internal medicine; Receptor; Genetics","score_opus":0.1316648686409949,"score_gpt":0.519220940674001,"score_spread":0.3875560720330061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030244887","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97962165,0.0075007575,0.0050908974,0.0006498304,0.00018916943,0.00033041072,0.0012041635,0.0004302507,0.0049828766],"genre_scores_gemma":[0.97818094,0.0047254027,0.006280233,0.00033304404,0.000051229083,0.00018245672,0.0025124038,0.000057536312,0.007676774],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999192,0.000010597544,0.000006967905,0.000013947623,0.000028640727,0.000020719344],"domain_scores_gemma":[0.99996185,0.000005289035,0.000005988023,0.0000035126818,0.000010200492,0.000013129407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001590961,0.00035421326,0.00041763176,0.0004674526,0.00019922301,0.00030493786,0.00028844524,0.0003262006,0.0022118946],"category_scores_gemma":[0.000109750814,0.00011424106,0.00030979014,0.00026438324,0.00014837612,0.00016178782,0.00018409624,0.00054274756,0.00064288033],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045371408,0.000517536,0.0010242879,0.0001882622,0.000027566666,0.000158832,0.000022326893,0.00062063814,0.960098,0.00028424143,0.0015746835,0.035029817],"study_design_scores_gemma":[0.0003829244,0.008669836,0.01597787,0.000032946537,0.00016371999,0.0010332798,0.000040316616,0.0041938443,0.94677645,0.00026028193,0.022443142,0.000025284435],"about_ca_topic_score_codex":0.0010703075,"about_ca_topic_score_gemma":0.0014097455,"teacher_disagreement_score":0.0022118946,"about_ca_system_score_codex":0.00026737803,"about_ca_system_score_gemma":0.0004156025,"threshold_uncertainty_score":0.007399559},"labels":[],"label_agreement":null},{"id":"W2030882637","doi":"10.1158/1078-0432.ccr-06-0261","title":"Biological Markers for Non–Small Cell Lung Cancer Patient Selection for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy","year":2006,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Epidermal growth factor receptor; Cancer research; Tyrosine kinase; Lung cancer; Tyrosine-kinase inhibitor; Epidermal growth factor; Cancer; Receptor tyrosine kinase; Receptor; Medicine; Biology; Oncology; Internal medicine","score_opus":0.25774027928360477,"score_gpt":0.5452083421699896,"score_spread":0.2874680628863848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030882637","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031362165,0.99624157,0.00037728105,0.0006334721,0.00020325842,0.000010852443,0.000043281252,0.000015055345,0.0021616018],"genre_scores_gemma":[0.0037141663,0.99339116,0.00087264105,0.000523493,0.00024068887,0.000022350647,0.00008952169,0.000002824054,0.0011431968],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998374,0.000045033714,0.000022396871,0.000024525114,0.000061863335,0.000008735388],"domain_scores_gemma":[0.99965227,0.00017786426,0.00006456504,0.00000667263,0.00007923389,0.000019383759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004686813,0.0005720597,0.0013353525,0.0015059299,0.0001310964,0.00045449074,0.00064670667,0.00072775595,0.0023502435],"category_scores_gemma":[0.0008314533,0.00013682287,0.00033561687,0.0010490468,0.0002713618,0.00046951996,0.0002285762,0.0009766179,0.001957903],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092958486,0.000060564853,0.0005048326,0.004680561,0.00005232701,0.00031819538,0.000020689942,0.00018748302,0.0012303232,0.0011767927,0.032741133,0.9589341],"study_design_scores_gemma":[0.00008002027,0.00030359745,0.0070035323,0.0063708867,0.0002594722,0.006058908,0.000084493906,0.00021950481,0.0017733398,0.0018510241,0.97595495,0.00004043112],"about_ca_topic_score_codex":0.0006884427,"about_ca_topic_score_gemma":0.0019996215,"teacher_disagreement_score":0.0023502435,"about_ca_system_score_codex":0.00040059275,"about_ca_system_score_gemma":0.00049538934,"threshold_uncertainty_score":0.0078623295},"labels":[],"label_agreement":null},{"id":"W2031321898","doi":"10.1158/1078-0432.ccr-08-0566","title":"Cytosolic Phospholipase A2-α: A Potential Therapeutic Target for Prostate Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Heart, Lung, and Blood Institute","keywords":"Prostate cancer; Cancer research; Small interfering RNA; LNCaP; Prostate; Cyclin D1; Phospholipase A2; Biology; Cancer cell; Cancer; Internal medicine; Endocrinology; Cell culture; Medicine; Cell cycle; Transfection; Biochemistry","score_opus":0.19966497363755867,"score_gpt":0.514358958069352,"score_spread":0.3146939844317933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031321898","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20133604,0.76578206,0.012077103,0.007189381,0.0008161698,0.00021237161,0.00080286665,0.0005477399,0.011236241],"genre_scores_gemma":[0.700102,0.27637315,0.006616495,0.00139235,0.00073485094,0.00017188201,0.0013485264,0.00003691956,0.013223754],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999944,0.0000102398035,0.0000030168399,0.000010804955,0.000017608798,0.000014338806],"domain_scores_gemma":[0.9999558,0.000004837837,0.000015146232,0.0000032854982,0.000008994367,0.00001198049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017561977,0.00041763438,0.00034573753,0.00028074044,0.00014913625,0.00045082645,0.00021551971,0.00039018705,0.0023923137],"category_scores_gemma":[0.00009354552,0.000090347225,0.00028479286,0.0004089056,0.0002495521,0.00024280557,0.00018478598,0.0009839972,0.00071949017],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016913677,0.0005751837,0.0020339156,0.0030291053,0.00014805852,0.00075201795,0.00005801412,0.00080050825,0.7737509,0.0027280946,0.00856002,0.20587285],"study_design_scores_gemma":[0.001375606,0.009689872,0.022208633,0.0007894109,0.0006962031,0.010998771,0.00024001923,0.0039873477,0.5221793,0.0027530482,0.4250127,0.00006904371],"about_ca_topic_score_codex":0.0003876749,"about_ca_topic_score_gemma":0.0011325818,"teacher_disagreement_score":0.0023923137,"about_ca_system_score_codex":0.00048028532,"about_ca_system_score_gemma":0.00055481796,"threshold_uncertainty_score":0.008003116},"labels":[],"label_agreement":null},{"id":"W2032531505","doi":"10.1158/1078-0432.ccr-07-4049","title":"Radiation-Mediated Up-Regulation of Gene Expression from Replication-Defective Adenoviral Vectors: Implications for Sodium Iodide Symporter Gene Therapy","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Sodium-iodide symporter; Green fluorescent protein; Genetic enhancement; Cancer research; Multiplicity of infection; Transgene; Adenoviridae; In vivo; Viral vector; Molecular biology; Biology; Gene expression; Viral replication; Symporter; Chemistry; Virology; Virus; Gene","score_opus":0.15515661389208305,"score_gpt":0.46912257429037035,"score_spread":0.3139659603982873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032531505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9639724,0.009377123,0.024095848,0.00021261204,0.00006327372,0.00014986414,0.00035652978,0.0002505242,0.0015217655],"genre_scores_gemma":[0.9769672,0.004143684,0.015941318,0.0000626179,0.000017140703,0.000094675175,0.0005474673,0.000065262015,0.0021606213],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99967074,0.00007759173,0.00003961966,0.00006245716,0.00010937441,0.000040301995],"domain_scores_gemma":[0.9997409,0.00009296887,0.000081629216,0.000036063815,0.000029759472,0.000018634815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005975694,0.00046266092,0.0003913176,0.00020398965,0.00010061676,0.00043965154,0.00024968013,0.00029082166,0.0008228195],"category_scores_gemma":[0.00032538187,0.00017048042,0.00039821703,0.00014763787,0.00038577645,0.00037884605,0.00017295753,0.00054661656,0.0003009209],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035456604,0.000012997313,0.000090728645,0.00003172579,0.0000021160627,0.000009456766,0.0000067170326,0.000059186517,0.99887043,0.000057779802,0.000008988649,0.00081435195],"study_design_scores_gemma":[0.000007119805,0.00023315763,0.0014896594,0.000006280989,0.00000860892,0.00013247295,0.000008157894,0.0005408774,0.9965827,0.000026436994,0.00096053054,0.0000040768055],"about_ca_topic_score_codex":0.00035040334,"about_ca_topic_score_gemma":0.00045622044,"teacher_disagreement_score":0.0008228195,"about_ca_system_score_codex":0.00052888354,"about_ca_system_score_gemma":0.00026249347,"threshold_uncertainty_score":0.003837347},"labels":[],"label_agreement":null},{"id":"W2032550022","doi":"10.1158/1078-0432.ccr-07-1712","title":"Prognostic Significance of Macrophage Infiltration in Leiomyosarcomas","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"National Cancer Institute","keywords":"CD163; CD68; Tissue microarray; Pathology; Immunohistochemistry; Leiomyosarcoma; Immunostaining; Biology; Macrophage; Gene expression profiling; Medicine; Gene expression; Gene; In vitro","score_opus":0.35453724001654385,"score_gpt":0.537569916466439,"score_spread":0.18303267644989518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032550022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992163,0.0004590493,0.00013712284,0.000017903327,0.0000017446225,0.0000033721549,0.00008006065,0.0000036676659,0.000080742466],"genre_scores_gemma":[0.9995882,0.000090664915,0.00014545418,0.0000057478387,0.0000042403612,0.00000569852,0.00011903094,8.4132887e-7,0.000040042953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999892,0.0000308076,0.00001384845,0.000025533556,0.00002099592,0.000016865644],"domain_scores_gemma":[0.9993562,0.00019142317,0.00026204874,0.000025610132,0.00006208795,0.0001025725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034389502,0.00013196746,0.00017243931,0.00042250386,0.0001340161,0.00015157215,0.00009019554,0.00017719787,0.0007546774],"category_scores_gemma":[0.0007748743,0.000080179554,0.0001177035,0.0002579491,0.00025581513,0.000116552335,0.00018121806,0.0001501774,0.00010941047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005879568,0.000016598091,0.98021036,0.00003958485,0.000024013638,0.0001918342,0.00003172725,0.00011756668,0.016049167,0.000017480994,0.000055551303,0.00265825],"study_design_scores_gemma":[0.000015729313,0.00022468426,0.9934988,0.000010849878,0.000043871452,0.0014180244,0.00008487477,0.00051462115,0.0038900883,0.000060244427,0.00023345271,0.0000047531285],"about_ca_topic_score_codex":0.00014576288,"about_ca_topic_score_gemma":0.0003164191,"teacher_disagreement_score":0.0007546774,"about_ca_system_score_codex":0.00012758508,"about_ca_system_score_gemma":0.00012721615,"threshold_uncertainty_score":0.002524674},"labels":[],"label_agreement":null},{"id":"W2034735917","doi":"10.1158/1078-0432.ovca13-ia18","title":"Abstract IA18: Evolutionary dynamics of high-grade serous ovarian cancer genomes across anatomic space and time","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Ovarian cancer; Serous fluid; Fallopian tube; Copy-number variation; Somatic evolution in cancer; Carcinogenesis; Amplicon; Copy number analysis; Exome; Germline mutation; Deep sequencing; Exome sequencing; Genetics; Cancer; Mutation; Gene; Genome","score_opus":0.04732317796940549,"score_gpt":0.42187591453508333,"score_spread":0.37455273656567784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034735917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99819547,0.00015723746,0.0007687953,0.000017642633,0.0000014044479,0.000003826539,0.00056910666,0.000015437638,0.00027106912],"genre_scores_gemma":[0.99789053,0.00006583681,0.00081075204,0.000010079767,0.000002085683,0.000008337855,0.0010127141,0.000010050107,0.00018952927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998684,0.000019291048,0.000008052265,0.0000502424,0.000027457489,0.00002656547],"domain_scores_gemma":[0.9995739,0.0001263964,0.0001601063,0.00003525265,0.000057739933,0.00004647505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018658835,0.00010235313,0.00016585682,0.00075977336,0.00025689398,0.00050078984,0.00016495908,0.00022402855,0.0012192571],"category_scores_gemma":[0.00091443595,0.00010394873,0.00014389772,0.00089060556,0.00017946737,0.00018058176,0.00033593236,0.00021482649,0.00021050338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000595502,0.000035482877,0.72089815,0.00011176288,0.00012271298,0.0005481895,0.00067367975,0.0024438933,0.24657865,0.00066074886,0.00042987775,0.026901346],"study_design_scores_gemma":[0.0000066176453,0.00011675081,0.97604805,0.00001017359,0.000033404398,0.0016765364,0.000333851,0.0056844726,0.013459369,0.00037622516,0.0022450236,0.000009548531],"about_ca_topic_score_codex":0.0012516488,"about_ca_topic_score_gemma":0.0016804162,"teacher_disagreement_score":0.0012516488,"about_ca_system_score_codex":0.00025712213,"about_ca_system_score_gemma":0.000116283794,"threshold_uncertainty_score":0.004078746},"labels":[],"label_agreement":null},{"id":"W2037393257","doi":"10.1158/1078-0432.mechres-b45","title":"Abstract B45: Met-Dependent Positive and Negative Signaling Cascades in Gastric Cancer Cells","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Signal transduction; Phosphorylation; Autocrine signalling; Cell signaling; Cancer research; Receptor tyrosine kinase; Hepatocyte growth factor; Biology; Cell biology; Cancer; C-Met; Cancer cell; Receptor; Genetics","score_opus":0.22980232317326355,"score_gpt":0.5310729923425993,"score_spread":0.30127066916933576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037393257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880234,0.0034407247,0.0017447191,0.0002584981,0.000052945525,0.0000759142,0.0012366549,0.00011010607,0.0050569684],"genre_scores_gemma":[0.99222356,0.0011174927,0.0018334886,0.00013040964,0.00001181699,0.000080878715,0.0015660144,0.000008025647,0.0030282524],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998405,0.000024946281,0.000012780976,0.000018571893,0.00006674157,0.000036419824],"domain_scores_gemma":[0.99995327,0.0000096937765,0.000007673873,0.0000059683935,0.000007351394,0.000016078297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102727434,0.0003421587,0.00020563023,0.000339009,0.00015913982,0.00028116902,0.00018333597,0.00026263666,0.0020443003],"category_scores_gemma":[0.00007298131,0.00011747476,0.00027500186,0.00025054984,0.00012673558,0.00013166228,0.00015725022,0.00043418532,0.0005098522],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015655333,0.00005537025,0.00023544734,0.000044315464,0.000005313311,0.00007052281,0.000016422873,0.00006298299,0.9977022,0.00015355226,0.000113967435,0.0013833372],"study_design_scores_gemma":[0.00006358603,0.00088471867,0.016679373,0.000012249955,0.000023235578,0.0005546244,0.000060540006,0.0020031754,0.97496223,0.00013966153,0.0046083783,0.000008262815],"about_ca_topic_score_codex":0.0016426202,"about_ca_topic_score_gemma":0.0011521758,"teacher_disagreement_score":0.0020443003,"about_ca_system_score_codex":0.00026979588,"about_ca_system_score_gemma":0.00021249516,"threshold_uncertainty_score":0.006838858},"labels":[],"label_agreement":null},{"id":"W2037994659","doi":"10.1158/1078-0432.ovca13-b24","title":"Abstract B24: Using a unique genetically modified ovarian cancer cell line model to identify the targets for siRNA directed therapies","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Biology; Transcriptome; Ovarian cancer; Somatic cell; Missense mutation; Genetics; Gene; Cancer research; Cell culture; Synthetic lethality; Mutation; Cancer; DNA repair; Gene expression","score_opus":0.21377302288895195,"score_gpt":0.5268820149276521,"score_spread":0.31310899203870013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037994659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841474,0.0006991195,0.009132915,0.00020661265,0.00009480875,0.00010883527,0.003302015,0.00016368958,0.0021445637],"genre_scores_gemma":[0.97307485,0.00061066734,0.0137489615,0.00019052948,0.000014071403,0.00020755104,0.0055077304,0.00007047743,0.0065750703],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998647,0.000012157875,0.000015416203,0.000030866195,0.000058906047,0.000017986038],"domain_scores_gemma":[0.9998933,0.00001823043,0.000023657833,0.00002009308,0.000023359522,0.00002144588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001350153,0.00022099519,0.00023229758,0.0002456876,0.00019363181,0.00027103184,0.00016721067,0.0002759918,0.001032622],"category_scores_gemma":[0.000106957916,0.00007942935,0.00027788203,0.0002183586,0.0001603023,0.00013030788,0.00015904894,0.0005375422,0.00038404632],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002972426,0.000013702197,0.00017521692,0.000012688449,0.0000034433376,0.00003267468,0.00000885033,0.000062893196,0.9991248,0.00003857218,0.000059773844,0.0004376665],"study_design_scores_gemma":[0.000012122364,0.00028695137,0.0063885883,0.0000038093958,0.000023385663,0.00023340598,0.000048092978,0.0018372422,0.9860458,0.000046394358,0.005066145,0.000008161249],"about_ca_topic_score_codex":0.0016926973,"about_ca_topic_score_gemma":0.0024548934,"teacher_disagreement_score":0.0016926973,"about_ca_system_score_codex":0.00024289105,"about_ca_system_score_gemma":0.00019363883,"threshold_uncertainty_score":0.0034544468},"labels":[],"label_agreement":null},{"id":"W2040800786","doi":"10.1158/1078-0432.ccr-07-4066","title":"Higher Levels of the Anti-inflammatory Protein CC10 Are Associated with Improvement in Bronchial Dysplasia and Sputum Cytometric Assessment in Individuals at High Risk for Lung Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Sputum; Medicine; Lung cancer; Dysplasia; Lung; Cancer; Immunology; Pathology; Internal medicine; Tuberculosis","score_opus":0.10749661215189232,"score_gpt":0.4445755469010139,"score_spread":0.3370789347491216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040800786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987808,0.0005154206,0.00020178847,0.000067356705,0.000008580366,0.000008460158,0.000087926135,0.000010990877,0.00031874012],"genre_scores_gemma":[0.99950325,0.00007100507,0.00016407855,0.000019011195,0.000014633942,0.0000059454705,0.00007671141,0.0000017297009,0.00014360117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995709,0.00014182994,0.00003413469,0.00010568249,0.00009062445,0.000056808876],"domain_scores_gemma":[0.9975083,0.00069082883,0.0010783664,0.00017401378,0.00019033901,0.00035799656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006550664,0.00036500444,0.00037833554,0.0004144692,0.00025373753,0.00038518515,0.00025834216,0.0007415328,0.0021326025],"category_scores_gemma":[0.0029196288,0.0001972845,0.00039924163,0.00038868794,0.00028495636,0.0002282763,0.00023754897,0.00088990614,0.00022183353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006801744,0.000083763225,0.9955511,0.000017967019,0.00006937252,0.00005718833,0.000016823346,0.000053569158,0.0017334309,0.000009108056,0.000044723376,0.0016827647],"study_design_scores_gemma":[0.000011145173,0.00022690889,0.9988379,0.000003564617,0.00004619422,0.00023976254,0.000019336945,0.00024415032,0.00029371027,0.000014590877,0.000060517144,0.000002308665],"about_ca_topic_score_codex":0.0006915181,"about_ca_topic_score_gemma":0.0007321977,"teacher_disagreement_score":0.0021326025,"about_ca_system_score_codex":0.00016117714,"about_ca_system_score_gemma":0.00016494114,"threshold_uncertainty_score":0.0071342587},"labels":[],"label_agreement":null},{"id":"W2041226144","doi":"10.1158/1078-0432.ccr-10-1058","title":"DNA Ploidy Cytometry Testing for Cervical Cancer Screening in China – Letter","year":2010,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"False positive paradox; Medicine; Cancer; Table (database); False positive rate; Value (mathematics); Predictive value; Oncology; Statistics; Internal medicine; Mathematics; Computer science; Data mining","score_opus":0.39731410712005494,"score_gpt":0.5679452778277423,"score_spread":0.17063117070768735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041226144","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011081918,0.0037122115,0.0001689856,0.97066754,0.023829171,0.000014262423,0.0001293851,0.00004478219,0.00032542055],"genre_scores_gemma":[0.011095848,0.0027942536,0.00030272643,0.91468376,0.06946866,0.000056716915,0.00007452142,0.00003502716,0.0014885066],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9956391,0.0018080458,0.0007657208,0.00065582327,0.00072959054,0.00040179503],"domain_scores_gemma":[0.9874392,0.007356522,0.0008854834,0.00030515963,0.00281891,0.0011947735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005603751,0.00094504753,0.0018813969,0.0011049707,0.0015498601,0.0019363692,0.002529152,0.01903223,0.0023457399],"category_scores_gemma":[0.03432963,0.00070554443,0.0015560826,0.0009616036,0.0014733782,0.0030312052,0.0008289519,0.01673567,0.0017438857],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002484474,0.00004982714,0.0028762084,0.00031132108,0.00009603627,0.0026790516,0.00022783688,0.000092715025,0.00024104888,0.0006747353,0.9802397,0.0122629665],"study_design_scores_gemma":[0.00085031573,0.00074825494,0.0174234,0.0017315564,0.00052189216,0.020917226,0.001340183,0.0031340073,0.0014298296,0.007332225,0.94415134,0.00041977383],"about_ca_topic_score_codex":0.0097211925,"about_ca_topic_score_gemma":0.0064096064,"teacher_disagreement_score":0.01903223,"about_ca_system_score_codex":0.003887016,"about_ca_system_score_gemma":0.002884505,"threshold_uncertainty_score":0.029635787},"labels":[],"label_agreement":null},{"id":"W2041997366","doi":"10.1158/1078-0432.ccr-07-4427","title":"Evaluation of the Pharmacodynamic Effects of MGCD0103 from Preclinical Models to Human Using a Novel HDAC Enzyme Assay","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Pyrogenesis (Canada)","funders":"National Cancer Institute","keywords":"Ex vivo; In vivo; Histone deacetylase; Pharmacology; Pharmacodynamics; In vitro; Acetylation; Histone deacetylase inhibitor; Chemistry; Pharmacokinetics; Molecular biology; Cancer research; Biochemistry; Medicine; Histone; Biology","score_opus":0.4481591514104984,"score_gpt":0.5729885176329691,"score_spread":0.1248293662224707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041997366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94545233,0.010881896,0.03632832,0.00043926097,0.00021548754,0.00054168986,0.0018879916,0.0008327826,0.0034202437],"genre_scores_gemma":[0.9837414,0.0031470354,0.008632269,0.00017467512,0.000055015254,0.00022458611,0.0017120899,0.00007640581,0.0022364429],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996499,0.00008330303,0.000022739492,0.00007198593,0.00013312421,0.00003892445],"domain_scores_gemma":[0.99981195,0.000039051683,0.00005891811,0.000026441034,0.000033100347,0.00003062952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006049613,0.0008042633,0.0006940045,0.00027562026,0.00013910755,0.00043826696,0.00039412128,0.0003853466,0.0016457307],"category_scores_gemma":[0.00040495585,0.00020862155,0.00038248548,0.00030601805,0.00038027842,0.0002113277,0.00017009137,0.0011255881,0.00053020974],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011115271,0.00027512657,0.0011122905,0.00009638841,0.00003780028,0.000043949945,0.000021933485,0.00040377057,0.98532975,0.000044596396,0.00028946088,0.011233281],"study_design_scores_gemma":[0.00020760091,0.008478639,0.00659348,0.0000075950798,0.00012543892,0.0003296726,0.000020374782,0.0023581937,0.97788805,0.00004416897,0.0039339527,0.0000129259015],"about_ca_topic_score_codex":0.00089399406,"about_ca_topic_score_gemma":0.00213749,"teacher_disagreement_score":0.0016457307,"about_ca_system_score_codex":0.00064468326,"about_ca_system_score_gemma":0.00047542175,"threshold_uncertainty_score":0.005505562},"labels":[],"label_agreement":null},{"id":"W2043131346","doi":"10.1158/1078-0432.ccr-09-0552","title":"Tissue Targeting in Cancer: eIF4E's Tale","year":2009,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Cancer; Medicine; Biology; Cancer research; Internal medicine","score_opus":0.17645282955450728,"score_gpt":0.5362094550445523,"score_spread":0.35975662549004506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043131346","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052065677,0.0511567,0.0028934632,0.8736649,0.0567458,0.000059742506,0.00008900368,0.0001796676,0.010004244],"genre_scores_gemma":[0.074826114,0.0861557,0.005245225,0.6900791,0.09558182,0.00018048206,0.00012931666,0.00007824796,0.04772406],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995739,0.000099570425,0.000035334844,0.000049084487,0.00018703422,0.000055002172],"domain_scores_gemma":[0.9994618,0.0003399769,0.000029806517,0.000030443975,0.000058247064,0.00007969512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011878874,0.00060255826,0.0006903602,0.00024628895,0.0007178717,0.00096209295,0.00059864594,0.008171813,0.0022931525],"category_scores_gemma":[0.0019454911,0.00024575533,0.0007068703,0.00017367989,0.0010496251,0.0010845069,0.0005767093,0.008362981,0.0013483538],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036336796,0.00013399903,0.00064479955,0.00043800034,0.00006483447,0.0076410817,0.00013947388,0.00046755318,0.0102165425,0.016679723,0.84863555,0.114575095],"study_design_scores_gemma":[0.0003312645,0.00034700107,0.00097256084,0.00014700305,0.000046493802,0.011320553,0.00013287512,0.001023175,0.0046626707,0.02217671,0.95879227,0.00004744048],"about_ca_topic_score_codex":0.0003710008,"about_ca_topic_score_gemma":0.00092575664,"teacher_disagreement_score":0.008171813,"about_ca_system_score_codex":0.0011576043,"about_ca_system_score_gemma":0.0004934773,"threshold_uncertainty_score":0.008399129},"labels":[],"label_agreement":null},{"id":"W2044240004","doi":"10.1158/1078-0432.ccr-11-2863","title":"Prognostic and Predictive Role of JWA and XRCC1 Expressions in Gastric Cancer","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"XRCC1; Cohort; Cancer; Medicine; Internal medicine; Immunohistochemistry; Oncology; Chemotherapy; Adjuvant; Biology; Gene; Genotype; Genetics","score_opus":0.09206586708181473,"score_gpt":0.46933410214475746,"score_spread":0.3772682350629427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044240004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987306,0.00090071047,0.000108644446,0.00003359994,0.000005041123,0.0000038941776,0.000063639985,0.000005828863,0.0001480864],"genre_scores_gemma":[0.99952745,0.00016653743,0.00010163147,0.0000056601157,0.00001039282,0.0000029649207,0.00011352925,0.0000014097675,0.000070429494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983406,0.000045447792,0.000017246071,0.000037952166,0.000038298447,0.000026960639],"domain_scores_gemma":[0.9993461,0.00016285731,0.00024704722,0.00004882528,0.000062681844,0.00013246607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061785546,0.00031836177,0.000292639,0.00052810804,0.00018520157,0.00033177424,0.00024654178,0.0003196025,0.00069471716],"category_scores_gemma":[0.0014237372,0.00014264199,0.00022260178,0.00040532736,0.00037294134,0.00023895624,0.00027076376,0.00032322473,0.00014035907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005495206,0.00002793682,0.9914908,0.000017717546,0.000039846775,0.0001150813,0.000019904728,0.00011130525,0.0034388022,0.000008978765,0.000050963095,0.004129129],"study_design_scores_gemma":[0.00001402324,0.00018330902,0.9977163,0.000004237195,0.0000810774,0.00048012793,0.000042187497,0.00049064483,0.0007867263,0.000025903046,0.0001727007,0.000002785929],"about_ca_topic_score_codex":0.00071810023,"about_ca_topic_score_gemma":0.0009830142,"teacher_disagreement_score":0.00071810023,"about_ca_system_score_codex":0.00018510358,"about_ca_system_score_gemma":0.00019004947,"threshold_uncertainty_score":0.0032675862},"labels":[],"label_agreement":null},{"id":"W2045088884","doi":"10.1158/1078-0432.ccr-14-1961","title":"Improvements in Radiographic Progression-Free Survival Stratified by <i>ERG</i> Gene Status in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone Acetate","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Juravinski Cancer Centre","funders":"National Cancer Institute; National Institute for Health and Care Research; Cancer Research UK","keywords":"Abiraterone acetate; Prostate cancer; Medicine; Abiraterone; Oncology; Cancer; Internal medicine; Castration; Urology; Androgen deprivation therapy; Hormone","score_opus":0.15304353272124482,"score_gpt":0.47019087363733947,"score_spread":0.31714734091609464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045088884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989882,0.0006206635,0.00007159942,0.00003131917,0.0000054231505,0.000008352116,0.00008115443,0.000007611138,0.00018551809],"genre_scores_gemma":[0.99973303,0.000066743436,0.000032983036,0.000014058085,0.000007063964,0.00000307454,0.00008179917,7.5416807e-7,0.000060532282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966705,0.00011814212,0.000024760058,0.00007187357,0.00007347675,0.00004467765],"domain_scores_gemma":[0.99916446,0.00018466655,0.00038314998,0.000058156696,0.000042001182,0.00016755975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006918813,0.00022902469,0.00045330866,0.000254296,0.00013382392,0.00032108862,0.00018409202,0.0002348721,0.0008495981],"category_scores_gemma":[0.0011411868,0.000114365976,0.00063607754,0.00023279844,0.00025546123,0.0001977182,0.00018600785,0.00045656826,0.00009222692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059821375,0.000690272,0.8768155,0.00016220807,0.0009787829,0.00025080066,0.00014383192,0.0014799689,0.023951838,0.0000563951,0.0003835183,0.035265546],"study_design_scores_gemma":[0.00055590953,0.009018743,0.9871092,0.0000122508345,0.00041008345,0.0003344915,0.00004663938,0.0007396127,0.0014039378,0.000050963725,0.0003072184,0.000010995809],"about_ca_topic_score_codex":0.0011167588,"about_ca_topic_score_gemma":0.001851135,"teacher_disagreement_score":0.0011167588,"about_ca_system_score_codex":0.00026033036,"about_ca_system_score_gemma":0.00027273645,"threshold_uncertainty_score":0.00365901},"labels":[],"label_agreement":null},{"id":"W2047393760","doi":"10.1158/1078-0432.ccr-10-1962","title":"Evaluating Patient-Centered Outcomes in the Randomized Controlled Trial and Beyond: Informing the Future with Lessons from the Past","year":2010,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"American Society of Clinical Oncology","keywords":"Randomized controlled trial; Medicine; Population; Perspective (graphical); Alternative medicine; Clinical trial; Outcome (game theory); Intensive care medicine; Internal medicine; Pathology; Computer science; Artificial intelligence","score_opus":0.32007105933268865,"score_gpt":0.5863388468956071,"score_spread":0.26626778756291847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047393760","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022246744,0.97312015,0.0031871293,0.02057257,0.0018080871,0.00023662549,0.000041598334,0.000023819939,0.0007874282],"genre_scores_gemma":[0.012298968,0.9372964,0.026919425,0.01805199,0.0035053657,0.0015233753,0.00006441752,0.00003488958,0.00030511862],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.82007486,0.14402828,0.017888486,0.0031809395,0.014043786,0.00078356924],"domain_scores_gemma":[0.3913263,0.5688426,0.015958603,0.007916278,0.014241906,0.001714273],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.25274315,0.0019781976,0.014024697,0.005240793,0.0009209772,0.008647284,0.0047667404,0.010601809,0.0026559024],"category_scores_gemma":[0.35465384,0.0011697286,0.005809813,0.00783341,0.006411411,0.01483454,0.0024049182,0.013138559,0.0006079183],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001064491,0.0002863139,0.0014424893,0.15702417,0.005639582,0.0002772883,0.001089488,0.0016732628,0.00036149973,0.08293749,0.026105803,0.72209823],"study_design_scores_gemma":[0.004097238,0.0017058547,0.003499097,0.49248642,0.012545411,0.0007887983,0.0013979338,0.004739844,0.00088463473,0.21493736,0.26263577,0.00028160904],"about_ca_topic_score_codex":0.004001179,"about_ca_topic_score_gemma":0.005909044,"teacher_disagreement_score":0.7472569,"about_ca_system_score_codex":0.009191661,"about_ca_system_score_gemma":0.023865646,"threshold_uncertainty_score":0.92150074},"labels":[],"label_agreement":null},{"id":"W2047895823","doi":"10.1158/1078-0432.tcme10-a8","title":"Abstract A8: GPNMB is an independent prognostic indicator of recurrence and a therapeutic target in triple negative breast cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Armand Frappier Museum; Institut National de la Recherche Scientifique; McGill University","funders":"","keywords":"Breast cancer; Medicine; Triple-negative breast cancer; Cancer; Cancer research; Tissue microarray; CA15-3; CA 15-3; Antibody-drug conjugate; Oncology; Metastasis; Internal medicine; Biomarker; Clinical significance; Antibody; Immunology; Biology; Monoclonal antibody","score_opus":0.10659314455077115,"score_gpt":0.4912167240344509,"score_spread":0.38462357948367976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047895823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99618125,0.0016610231,0.00047484954,0.00019552476,0.000018004985,0.000022419792,0.00058450224,0.00003443031,0.00082790706],"genre_scores_gemma":[0.9971023,0.0002991037,0.00056611025,0.000044980905,0.000017164937,0.000019119509,0.0010872333,0.0000069475805,0.00085706456],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99989593,0.000015756232,0.00000854095,0.000022069316,0.000043799802,0.000013905743],"domain_scores_gemma":[0.99979025,0.000037138114,0.000070039634,0.000012548927,0.000038292823,0.00005177319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027692647,0.00015787312,0.0002704727,0.00031378423,0.00011920895,0.0003045015,0.00015385846,0.00026358364,0.0023028026],"category_scores_gemma":[0.00033346628,0.00007036477,0.00015082778,0.00024181769,0.00014105703,0.000113421986,0.000109296394,0.00034618762,0.0003717276],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006607735,0.00032409615,0.17033048,0.0002782589,0.00012549183,0.00042077954,0.00005623641,0.0003556373,0.7805875,0.000105782914,0.0020010031,0.03880692],"study_design_scores_gemma":[0.00022439317,0.0031666867,0.7849557,0.000037030048,0.00028804783,0.0035363245,0.00008697039,0.002691115,0.19973502,0.00014858213,0.005113035,0.000017124636],"about_ca_topic_score_codex":0.0007617569,"about_ca_topic_score_gemma":0.0009486764,"teacher_disagreement_score":0.0023028026,"about_ca_system_score_codex":0.0003092501,"about_ca_system_score_gemma":0.0002023946,"threshold_uncertainty_score":0.0077036023},"labels":[],"label_agreement":null},{"id":"W2048460059","doi":"10.1158/1078-0432.ccr-07-4530","title":"Pharmacology of the Novel Antiangiogenic Peptide ATN-161 (Ac-PHSCN-NH2): Observation of a U-Shaped Dose-Response Curve in Several Preclinical Models of Angiogenesis and Tumor Growth","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Angiogenesis; Matrigel; In vivo; Integrin; Cancer research; Medicine; Pharmacology; Chemistry; Biology; Internal medicine; Receptor","score_opus":0.3295201294263861,"score_gpt":0.496083023901811,"score_spread":0.16656289447542494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048460059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850847,0.0034492982,0.00895701,0.00011979968,0.0000614934,0.00019662037,0.0003697334,0.00018439254,0.0015768403],"genre_scores_gemma":[0.99027425,0.0015172361,0.005815933,0.00014279623,0.000044481912,0.0001682615,0.00065963616,0.000048953443,0.0013284096],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995654,0.00018520639,0.000020074447,0.000079135636,0.00009473662,0.0000554231],"domain_scores_gemma":[0.9989513,0.00033530899,0.00029755785,0.0001096104,0.00014310828,0.00016301933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005556354,0.00069743465,0.00067687966,0.00034292202,0.00012456888,0.00029999993,0.00039515982,0.0005595933,0.0008362947],"category_scores_gemma":[0.0006029785,0.00028724706,0.0004247439,0.00025087493,0.00038699954,0.0005032406,0.00013559588,0.0011434702,0.00037837322],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019704371,0.0006840647,0.00054903433,0.000115202936,0.000031967676,0.00006303919,0.000040334577,0.0009131176,0.9881225,0.000045643952,0.0001395971,0.007324959],"study_design_scores_gemma":[0.00018337322,0.029154558,0.010956365,0.000011232072,0.00007040333,0.00064586016,0.000030354891,0.0045491,0.9526199,0.000059351736,0.0016944064,0.000025041272],"about_ca_topic_score_codex":0.0006205243,"about_ca_topic_score_gemma":0.00070818205,"teacher_disagreement_score":0.0008362947,"about_ca_system_score_codex":0.00051365874,"about_ca_system_score_gemma":0.00035669238,"threshold_uncertainty_score":0.00372684},"labels":[],"label_agreement":null},{"id":"W2049601932","doi":"10.1158/1078-0432.ccr-13-0545","title":"Targeting CD73 Enhances the Antitumor Activity of Anti-PD-1 and Anti-CTLA-4 mAbs","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":451,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"CTLA-4; Medicine; Pharmacology; Immunology; Cancer research; Immune system; T cell","score_opus":0.09677112979043904,"score_gpt":0.45525412799294873,"score_spread":0.3584829982025097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049601932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99538654,0.0013693481,0.0014218582,0.000069702015,0.000023828337,0.000027532304,0.000057142675,0.00005615267,0.0015878765],"genre_scores_gemma":[0.99744296,0.00042568636,0.0010311558,0.000038118815,0.000016298449,0.000021078147,0.00007105203,0.0000056772524,0.00094794075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980646,0.000029739462,0.000009814369,0.000027746675,0.00005233095,0.00007399381],"domain_scores_gemma":[0.99993503,0.000010952228,0.000020426767,0.000005367075,0.000007600326,0.000020650963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013987528,0.0004371685,0.00024070965,0.00026920257,0.00010063422,0.00022823036,0.00013130408,0.00019529855,0.0012312914],"category_scores_gemma":[0.00008037284,0.000085512205,0.00020518544,0.00012109985,0.00015922314,0.00015250781,0.00013911365,0.00047006135,0.00026206885],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016433402,0.0001103657,0.0001470627,0.00003164887,0.000005418404,0.0000352283,0.0000039013157,0.00013589849,0.99662244,0.000087960325,0.00004038948,0.0026152313],"study_design_scores_gemma":[0.00005479711,0.0011488416,0.0019989896,0.000004853128,0.000031869364,0.00020969691,0.0000069008497,0.0011691465,0.99349,0.00002901155,0.0018534388,0.000002356447],"about_ca_topic_score_codex":0.00022596055,"about_ca_topic_score_gemma":0.00041003877,"teacher_disagreement_score":0.0012312914,"about_ca_system_score_codex":0.00031943314,"about_ca_system_score_gemma":0.00023183844,"threshold_uncertainty_score":0.0041190386},"labels":[],"label_agreement":null},{"id":"W2049810240","doi":"10.1158/1078-0432.ccr-04-0438","title":"Effects of the Steroidal Aromatase Inhibitor Exemestane and the Nonsteroidal Aromatase Inhibitor Letrozole on Bone and Lipid Metabolism in Ovariectomized Rats","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Endocrinology; Internal medicine; Ovariectomized rat; Bone remodeling; Osteocalcin; Medicine; Aromatase inhibitor; Letrozole; Osteoporosis; Bone resorption; Bone mineral; Bone density; Osteopenia; Pyridinoline; Estrogen; Aromatase; Chemistry; Breast cancer; Cancer; Alkaline phosphatase","score_opus":0.01997192011029481,"score_gpt":0.3525607030916615,"score_spread":0.3325887829813667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049810240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964941,0.0017434874,0.00040057552,0.00011396576,0.00004513397,0.000035116132,0.00054501835,0.00004845365,0.00057406805],"genre_scores_gemma":[0.9892502,0.002761143,0.0014729784,0.00014558058,0.00004345361,0.00014452786,0.0009360722,0.000023746958,0.0052223806],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999726,0.00003954684,0.000021129154,0.00005443798,0.00006105096,0.00009792698],"domain_scores_gemma":[0.9995592,0.000055556004,0.00013151304,0.000052194515,0.000042390966,0.00015900077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002476356,0.0007895078,0.00067204086,0.0010662478,0.0003357692,0.0002730393,0.0003565472,0.00059454935,0.0017083203],"category_scores_gemma":[0.0002128506,0.0005139406,0.0007360917,0.00036089664,0.000707319,0.00044704814,0.00023538055,0.0010564694,0.00035727993],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022475991,0.0014859425,0.0015945463,0.00012825326,0.00007146365,0.00022761754,0.00007722665,0.00021933837,0.96752787,0.000119752054,0.00013713923,0.005934806],"study_design_scores_gemma":[0.0013687357,0.033854477,0.025303235,0.00003289346,0.00029959282,0.0004025822,0.00035800048,0.0011311717,0.93424237,0.00023819243,0.0027190696,0.000049683473],"about_ca_topic_score_codex":0.001985541,"about_ca_topic_score_gemma":0.0035514457,"teacher_disagreement_score":0.001985541,"about_ca_system_score_codex":0.00042585513,"about_ca_system_score_gemma":0.00065655145,"threshold_uncertainty_score":0.005714953},"labels":[],"label_agreement":null},{"id":"W2050433141","doi":"10.1158/1078-0432.ccr-04-1751","title":"Preclinical Evaluation of the Pharmacodynamic Properties of 2,5-Diaziridinyl-3-Hydroxymethyl-6-Methyl-1,4-Benzoquinone","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bioactive Compounds and Antitumor Agents","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Christie (Canada)","funders":"Department of Health and Social Care; National Institute for Health and Care Research","keywords":"In vivo; Comet assay; DNA damage; Pharmacology; Cytotoxicity; Cisplatin; Mitomycin C; DNA; Topoisomerase; In vitro; Chemistry; Biochemistry; Biology; Chemotherapy","score_opus":0.7834550027564526,"score_gpt":0.6806333684334336,"score_spread":0.10282163432301905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050433141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99142414,0.003343343,0.0030529883,0.00018490381,0.000050034967,0.00020249945,0.00047190124,0.000091237445,0.001178985],"genre_scores_gemma":[0.99511874,0.0016373242,0.0010735982,0.000056056564,0.000029928613,0.00009990247,0.00054001826,0.000018020155,0.0014265043],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998553,0.000049143655,0.000006262255,0.000026912378,0.000033821707,0.000028465663],"domain_scores_gemma":[0.9997359,0.00006463895,0.000086129694,0.000026487782,0.00003868384,0.00004809821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004920398,0.0005224777,0.00042596803,0.00021140589,0.00013113067,0.0002991297,0.000357825,0.00034432692,0.0018072563],"category_scores_gemma":[0.00037390576,0.00014258214,0.00023679528,0.00013085213,0.00029545557,0.00034487672,0.00009466506,0.0007573471,0.00037319868],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042470945,0.003707743,0.0006631704,0.00020448498,0.000054482876,0.000066607114,0.0000557782,0.0011092498,0.97175914,0.00011595612,0.00036935046,0.017646866],"study_design_scores_gemma":[0.00071718596,0.13231818,0.008962392,0.000022635595,0.00024023818,0.00040694696,0.00005968123,0.0031048318,0.84796643,0.0001174891,0.006064539,0.00001937451],"about_ca_topic_score_codex":0.00040464773,"about_ca_topic_score_gemma":0.0005435515,"teacher_disagreement_score":0.0018072563,"about_ca_system_score_codex":0.00033753604,"about_ca_system_score_gemma":0.00034753527,"threshold_uncertainty_score":0.0060458183},"labels":[],"label_agreement":null},{"id":"W2050883767","doi":"10.1158/1078-0432.ccr-07-4992","title":"Shedding of Distinct Cryptic Collagen Epitope (HU177) in Sera of Melanoma Patients","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Epitope; Melanoma; Angiogenesis; In vivo; Medicine; Extracellular matrix; Pathology; Clinical significance; Immunology; Antibody; Biology; Internal medicine; Cancer research","score_opus":0.13522927311187388,"score_gpt":0.4640377832935589,"score_spread":0.328808510181685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050883767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994135,0.00024497177,0.00006589353,0.000022885493,0.000004422939,0.0000033654562,0.000062589905,0.000004465782,0.00017803983],"genre_scores_gemma":[0.99963415,0.000083186686,0.00008559247,0.000029258585,0.0000109379625,0.000004361648,0.000101890866,7.559902e-7,0.00004980533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997726,0.00006516497,0.000026143225,0.000053935833,0.000047622685,0.000034523247],"domain_scores_gemma":[0.9994752,0.0001596462,0.00019671758,0.000023225273,0.00005525376,0.00009000463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024464112,0.00034535327,0.00033352256,0.00043893448,0.0002886227,0.00030848713,0.00012192565,0.00034783542,0.0008316502],"category_scores_gemma":[0.0010708653,0.0001409027,0.00015720134,0.0003060344,0.00019445145,0.00021278893,0.00015802689,0.00029162073,0.0001926084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038013657,0.000043539127,0.98880464,0.000024983563,0.00003012656,0.0006533283,0.00009790289,0.000054087326,0.00633009,0.000013613791,0.00014492394,0.0034226603],"study_design_scores_gemma":[0.000030821226,0.0006689356,0.99003196,0.00001276135,0.00005148315,0.005778052,0.0001908287,0.00038237384,0.0024126,0.000035871657,0.00039882437,0.000005527923],"about_ca_topic_score_codex":0.0004379715,"about_ca_topic_score_gemma":0.00038899636,"teacher_disagreement_score":0.0008316502,"about_ca_system_score_codex":0.00017420898,"about_ca_system_score_gemma":0.00013044935,"threshold_uncertainty_score":0.002782166},"labels":[],"label_agreement":null},{"id":"W2051474057","doi":"10.1158/1078-0432.tcmusa10-a53","title":"Abstract A53: Lovastatin inhibits EGFR dimerization and AKT activation in squamous cell carcinoma cells: Potential regulation through targeting rho proteins","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"RHOA; Lovastatin; Gefitinib; Protein kinase B; PI3K/AKT/mTOR pathway; Cancer research; EGFR inhibitors; Epidermal growth factor receptor; Chemistry; Farnesyl pyrophosphate; Actin cytoskeleton; Geranylgeranyl pyrophosphate; Erlotinib; Farnesyltransferase inhibitor; Cell biology; Pharmacology; Signal transduction; Biology; Farnesyltransferase; Cell; Cytoskeleton; Biochemistry; Receptor; Prenylation; Cholesterol","score_opus":0.04603905007341682,"score_gpt":0.38712713739721655,"score_spread":0.34108808732379975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051474057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935136,0.0030209846,0.00062271964,0.00017444887,0.00007655591,0.00008138321,0.0006652774,0.00010816024,0.0017369015],"genre_scores_gemma":[0.9966208,0.0007090243,0.00040642597,0.000054601034,0.000015285916,0.00003707076,0.0005555293,0.000008920159,0.0015922852],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999826,0.000038518316,0.000024483448,0.00002239905,0.000035333753,0.000053369316],"domain_scores_gemma":[0.9999424,0.000008699517,0.00001248875,0.000008664097,0.000008653006,0.000018995006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014725445,0.00028448703,0.0005079979,0.00020018173,0.0001772016,0.00031645288,0.00020100475,0.00029597883,0.002490624],"category_scores_gemma":[0.00012063492,0.00008892629,0.0002960872,0.00016882797,0.00014783056,0.00012922578,0.00011321721,0.00042704973,0.0007055693],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029879147,0.0005912955,0.000764641,0.00010346247,0.00004018969,0.000085879816,0.000012696457,0.00013789597,0.9872357,0.00009350729,0.00041064378,0.0075361812],"study_design_scores_gemma":[0.0010813351,0.0071378397,0.015638553,0.000010955145,0.00009825172,0.00046423226,0.000037135924,0.0013470253,0.9681857,0.00006667416,0.0059224055,0.000009885442],"about_ca_topic_score_codex":0.0011827467,"about_ca_topic_score_gemma":0.0025523384,"teacher_disagreement_score":0.002490624,"about_ca_system_score_codex":0.00031881672,"about_ca_system_score_gemma":0.00036657086,"threshold_uncertainty_score":0.008331895},"labels":[],"label_agreement":null},{"id":"W2051976171","doi":"10.1158/1078-0432.ccr-10-2210","title":"Rapid Diagnosis of Medulloblastoma Molecular Subgroups","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"National Cancer Institute; Cancer Research UK; Children's Cancer and Leukaemia Group","keywords":"PTCH1; Medulloblastoma; Sonic hedgehog; Wnt signaling pathway; Biology; Pathology; Cancer research; DNA methylation; Oncology; Internal medicine; Genetics; Medicine; Gene; Gene expression","score_opus":0.31504301951135183,"score_gpt":0.49966772303043416,"score_spread":0.18462470351908233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051976171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903356,0.0009956703,0.006192321,0.000091894646,0.000016770598,0.00017922706,0.00092181674,0.0002059553,0.0010607021],"genre_scores_gemma":[0.985628,0.00035067525,0.011252875,0.000065849155,0.00002267532,0.00020499995,0.0020446312,0.00002343039,0.00040686238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99948335,0.000092316026,0.00005549587,0.00016754004,0.00013156352,0.00006974004],"domain_scores_gemma":[0.99923635,0.00018757883,0.00019812821,0.000107594155,0.00017162159,0.00009875053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009653947,0.0002870155,0.00044581827,0.0014230846,0.00028106154,0.00031958421,0.0002909093,0.000260978,0.0010238688],"category_scores_gemma":[0.00184148,0.00016593766,0.0001722495,0.00044311135,0.00023012045,0.0003828594,0.00057732494,0.0003650899,0.0004458689],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015269481,0.000046853384,0.6968045,0.00015059546,0.00004486516,0.00023716723,0.00022261491,0.00024348896,0.26116934,0.00018179734,0.0007344461,0.03863737],"study_design_scores_gemma":[0.0000586037,0.0006278718,0.9106286,0.000042309766,0.00008431885,0.0023621807,0.0004684264,0.0029502911,0.07793828,0.0004663064,0.0043490846,0.000023802693],"about_ca_topic_score_codex":0.0011681075,"about_ca_topic_score_gemma":0.0019305117,"teacher_disagreement_score":0.0014230846,"about_ca_system_score_codex":0.00038640582,"about_ca_system_score_gemma":0.00045016452,"threshold_uncertainty_score":0.0051056147},"labels":[],"label_agreement":null},{"id":"W2052404621","doi":"10.1158/1078-0432.tcmusa10-pr5","title":"Abstract PR5: Prediction of survival in diffuse large B-cell lymphoma based on the expression of two genes integrating tumor and microenvironment","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; International Prognostic Index; Univariate; Oncology; Medicine; Lymphoma; Stromal cell; Survival analysis; Internal medicine; Cancer research; Biology; Machine learning; Computer science; Multivariate statistics","score_opus":0.09799676627710484,"score_gpt":0.4264810766183701,"score_spread":0.32848431034126524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052404621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802756,0.00037358186,0.017946204,0.000131992,0.000013864784,0.000024019817,0.00068094453,0.0001352749,0.0004185207],"genre_scores_gemma":[0.99739933,0.00004015708,0.0018656781,0.000014146262,0.00000774792,0.0000126686855,0.00037674204,0.000006653498,0.00027688415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969745,0.0001228862,0.00001628649,0.000086296895,0.000045677378,0.000031472053],"domain_scores_gemma":[0.9995431,0.0002570744,0.00008434351,0.000026226311,0.00004114618,0.00004818116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091605005,0.00057348073,0.00043376835,0.0005585808,0.00009731416,0.0005393994,0.0003165365,0.00025897275,0.0009659629],"category_scores_gemma":[0.0011174813,0.00012612388,0.00072471384,0.0003239216,0.0001986231,0.0001836602,0.00035000738,0.00040847727,0.00024584742],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029549561,0.0003251024,0.75277346,0.00012382359,0.000585967,0.0002168503,0.00006740523,0.18019186,0.024799675,0.0003829782,0.0008450234,0.036732934],"study_design_scores_gemma":[0.00007944661,0.0008831169,0.18725784,0.00001551441,0.00022047594,0.00028372268,0.00006997251,0.8042146,0.005674302,0.0007232562,0.00055404153,0.000023808336],"about_ca_topic_score_codex":0.0043486375,"about_ca_topic_score_gemma":0.0026895865,"teacher_disagreement_score":0.0043486375,"about_ca_system_score_codex":0.0004842285,"about_ca_system_score_gemma":0.00046231042,"threshold_uncertainty_score":0.008646667},"labels":[],"label_agreement":null},{"id":"W2053290453","doi":"10.1158/1078-0432.ccr-07-0835","title":"Synergistic Interactions between Vorinostat and Sorafenib in Chronic Myelogenous Leukemia Cells Involve Mcl-1 and p21CIP1 Down-Regulation","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":65,"is_retracted":true,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institutes of Health; Leukemia and Lymphoma Society; U.S. Department of Defense","keywords":"Vorinostat; Imatinib mesylate; Sorafenib; Cancer research; Chronic myelogenous leukemia; Histone deacetylase inhibitor; Imatinib; Histone deacetylase; Pharmacology; Biology; Chemistry; Leukemia; Myeloid leukemia; Immunology; Histone; Biochemistry","score_opus":0.18198482242363437,"score_gpt":0.5002775618152996,"score_spread":0.31829273939166525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053290453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935684,0.0036126962,0.00083785283,0.00011869044,0.000044605626,0.000048527494,0.0002652893,0.000060739017,0.0014431269],"genre_scores_gemma":[0.9975063,0.00084618706,0.0005385411,0.000030727562,0.000018693638,0.000043536398,0.0002856929,0.000004479914,0.0007260064],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997856,0.000046573954,0.000019106403,0.00003587935,0.00006234578,0.00005052938],"domain_scores_gemma":[0.9999168,0.000019961863,0.00002491421,0.000009547692,0.000008816716,0.000019905665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016119298,0.000463559,0.0005368328,0.00024533743,0.00020257707,0.00033431206,0.00017723319,0.00022819554,0.0018961899],"category_scores_gemma":[0.0001421106,0.0001365092,0.00040133714,0.00018344702,0.00019192752,0.00023675372,0.00023663526,0.00036993175,0.00042899372],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006449402,0.00014443617,0.0005221861,0.00010788532,0.000022894788,0.000119553646,0.00001975187,0.0001336419,0.994165,0.000069926224,0.00012907748,0.003920712],"study_design_scores_gemma":[0.00016108854,0.0024348672,0.017985925,0.000008585077,0.000079998485,0.000818615,0.000058144098,0.001541756,0.9721106,0.00007174321,0.004719967,0.00000878399],"about_ca_topic_score_codex":0.00018580524,"about_ca_topic_score_gemma":0.00069850753,"teacher_disagreement_score":0.0018961899,"about_ca_system_score_codex":0.00028624758,"about_ca_system_score_gemma":0.0002230924,"threshold_uncertainty_score":0.0063434243},"labels":[],"label_agreement":null},{"id":"W2053442386","doi":"10.1158/1078-0432.ccr-07-1305","title":"High-Resolution DNA Copy Number Profiling of Malignant Peripheral Nerve Sheath Tumors Using Targeted Microarray-Based Comparative Genomic Hybridization","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Medical Research Council; University of Toronto","keywords":"CDKN2A; Comparative genomic hybridization; PDGFRA; Cancer research; Biology; Neurofibromatosis; Copy number analysis; Malignant peripheral nerve sheath tumor; Copy-number variation; Pathology; Tissue microarray; Microarray; Cancer; Gene; Medicine; Genetics; Gene expression","score_opus":0.24256511450375715,"score_gpt":0.45770958413560064,"score_spread":0.2151444696318435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053442386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839791,0.00061515695,0.013290863,0.0000748898,0.0000075649286,0.000033288863,0.0010826236,0.00012672502,0.00078982103],"genre_scores_gemma":[0.97249585,0.0004287273,0.023710279,0.00007677595,0.000008839398,0.00008723532,0.00220095,0.000019957197,0.00097148714],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997261,0.000040328836,0.000014042272,0.00010263699,0.000084400475,0.000032498967],"domain_scores_gemma":[0.9998363,0.00006835817,0.00004258098,0.000018497507,0.000022571194,0.0000116674555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001968803,0.00020717115,0.00017468503,0.0005039515,0.00014422451,0.00021554026,0.00018518126,0.00023375954,0.0006900501],"category_scores_gemma":[0.00037296503,0.00011446188,0.00014845181,0.000365124,0.0001826682,0.00010804256,0.00013179982,0.00020418465,0.00019519002],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007127869,0.000011680877,0.0029961423,0.000028555653,0.000008719687,0.000033412456,0.000020395606,0.00027504124,0.9938828,0.00003666038,0.000026559263,0.002608802],"study_design_scores_gemma":[0.000014576489,0.00034198057,0.09824109,0.000008025802,0.00007199955,0.00089927635,0.000057810572,0.0064498484,0.891608,0.00019737655,0.0020962178,0.000013863004],"about_ca_topic_score_codex":0.00039318838,"about_ca_topic_score_gemma":0.00078509934,"teacher_disagreement_score":0.0006900501,"about_ca_system_score_codex":0.00023163804,"about_ca_system_score_gemma":0.00010850189,"threshold_uncertainty_score":0.0023084283},"labels":[],"label_agreement":null},{"id":"W2053903430","doi":"10.1158/1078-0432.ccr-14-1370","title":"Molecular Pathways: GLI1-Induced Drug Glucuronidation in Resistant Cancer Cells","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Glucuronidation; Cancer; Drug; Drug resistance; Biology; Cancer research; Computational biology; Medicine; Pharmacology; Genetics; In vitro","score_opus":0.3357610343445079,"score_gpt":0.5071455677267337,"score_spread":0.1713845333822258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053903430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88601816,0.027165731,0.024900373,0.009093956,0.00037163965,0.0003481649,0.0030169806,0.0017194812,0.04736551],"genre_scores_gemma":[0.95633245,0.010784621,0.005224037,0.0009169865,0.0000592589,0.00011958772,0.0015268008,0.000067454326,0.02496878],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99984527,0.000023285113,0.000009941321,0.00003703031,0.000054676595,0.000029821393],"domain_scores_gemma":[0.9999124,0.0000059968584,0.000024800453,0.000013814673,0.00002064514,0.000022432068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015753717,0.0004369896,0.00027925114,0.00045395142,0.00029281285,0.00087923126,0.00021392651,0.00039105988,0.00386242],"category_scores_gemma":[0.00010243504,0.00016883844,0.00035507794,0.00034698192,0.00034545982,0.0004889901,0.0004677425,0.0009358288,0.0011871917],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033223844,0.00012729122,0.0018937443,0.00037217382,0.000043449396,0.0007870656,0.00012386117,0.00039833627,0.95041066,0.008060823,0.003024344,0.034426037],"study_design_scores_gemma":[0.00010160272,0.00061636016,0.017598584,0.000048566268,0.00006771558,0.0031760668,0.0001897179,0.0022054473,0.91133803,0.0031201418,0.061512202,0.000025587771],"about_ca_topic_score_codex":0.00089144986,"about_ca_topic_score_gemma":0.0013033324,"teacher_disagreement_score":0.00386242,"about_ca_system_score_codex":0.0010819843,"about_ca_system_score_gemma":0.0005321651,"threshold_uncertainty_score":0.012921035},"labels":[],"label_agreement":null},{"id":"W2054855574","doi":"10.1158/1078-0432.ccr-06-2987","title":"Cytochrome P450 17A1 and Catechol <i>O</i>-Methyltransferase Polymorphisms and Age at Lynch Syndrome Colon Cancer Onset in Newfoundland","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland; Lunenfeld-Tanenbaum Research Institute; Cancer Care Ontario; Mount Sinai Hospital","funders":"","keywords":"Lynch syndrome; Colorectal cancer; Catechol-O-methyl transferase; Methyltransferase; Genetics; Cancer; Cytochrome P450; Medicine; Oncology; Internal medicine; Biology; Allele; Gene; DNA mismatch repair; Metabolism","score_opus":0.15631922591016315,"score_gpt":0.5010666176078626,"score_spread":0.3447473916976995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054855574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992299,0.00015127828,0.000049258233,0.000045063898,0.000003205898,0.0000047496414,0.00030731014,0.0000020569114,0.00020732242],"genre_scores_gemma":[0.998787,0.00009684646,0.00007874342,0.000030968542,0.000003994297,0.0000098264145,0.0004570207,0.0000017622161,0.0005338216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997211,0.000060868464,0.00001787938,0.00008994927,0.000043244323,0.00006687248],"domain_scores_gemma":[0.9987588,0.0002193171,0.0004925934,0.00006903225,0.00012228588,0.00033798622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005159941,0.00020153652,0.00032112165,0.00043337757,0.0005581431,0.00033452694,0.00030227232,0.0002821204,0.002022981],"category_scores_gemma":[0.00092242187,0.0002589898,0.00027924954,0.00046594202,0.00033879446,0.00024905888,0.00028744267,0.00038035453,0.00018928177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020562147,0.000043347598,0.9979705,0.000004963084,0.000034947363,0.000116209594,0.00009978161,0.00003015856,0.00058997923,0.000009129336,0.00015546943,0.00073988055],"study_design_scores_gemma":[0.0000056534577,0.00004402156,0.99957985,0.0000027432045,0.000013572901,0.00008599314,0.00005593589,0.000051220366,0.000037362715,0.0000022797947,0.00012004179,0.0000014431207],"about_ca_topic_score_codex":0.38545558,"about_ca_topic_score_gemma":0.48542017,"teacher_disagreement_score":0.6145444,"about_ca_system_score_codex":0.0015897169,"about_ca_system_score_gemma":0.00087174773,"threshold_uncertainty_score":0.76642394},"labels":[],"label_agreement":null},{"id":"W2054913636","doi":"10.1158/1078-0432.ccr-14-0341","title":"Phase I Expansion and Pharmacodynamic Study of the Oral MEK Inhibitor RO4987655 (CH4987655) in Selected Patients with Advanced Cancer with <i>RAS–RAF</i> Mutations","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"KRAS; Medicine; MEK inhibitor; Colorectal cancer; Neuroblastoma RAS viral oncogene homolog; Melanoma; Cancer; Oncology; Internal medicine; Pharmacodynamics; Lung cancer; Adverse effect; Progressive disease; Cancer research; MAPK/ERK pathway; Pharmacokinetics; Kinase; Disease; Biology","score_opus":0.04652522395130103,"score_gpt":0.44238819226232884,"score_spread":0.3958629683110278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054913636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99724704,0.00033983777,0.00046955657,0.00007908818,0.000018643952,0.0012019994,0.00025790746,0.000035215664,0.0003507548],"genre_scores_gemma":[0.9950734,0.00030639305,0.0014737474,0.00028366927,0.000069399364,0.0012557874,0.00093918067,0.000018488916,0.0005799856],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993555,0.00032562992,0.000031282583,0.00010518557,0.00007215172,0.00011013613],"domain_scores_gemma":[0.99911505,0.00014148808,0.00021649028,0.00012581667,0.00006054658,0.00034055876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018184485,0.0014567025,0.0014987035,0.00036908188,0.00037260962,0.0006195475,0.00074108806,0.0006738626,0.0018169509],"category_scores_gemma":[0.0010459024,0.00053686375,0.0009771758,0.00030844685,0.0007919008,0.00064485596,0.00037389345,0.0022813058,0.0005123255],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4257371,0.1581893,0.053967126,0.00053083966,0.0014033964,0.00072829076,0.00087085355,0.006542593,0.19105731,0.00028930878,0.0033949025,0.15728907],"study_design_scores_gemma":[0.15139188,0.7847955,0.046973206,0.00001829746,0.00038843317,0.0005912097,0.00009152273,0.0015093052,0.012070596,0.000108913366,0.0020251088,0.000036056077],"about_ca_topic_score_codex":0.0006457212,"about_ca_topic_score_gemma":0.0014026319,"teacher_disagreement_score":0.0018184485,"about_ca_system_score_codex":0.0008378141,"about_ca_system_score_gemma":0.0012769579,"threshold_uncertainty_score":0.009616971},"labels":[],"label_agreement":null},{"id":"W2055340037","doi":"10.1158/1078-0432.ccr-14-1770","title":"Phase I Trial of Cyclophosphamide as an Immune Modulator for Optimizing Oncolytic Reovirus Delivery to Solid Tumors","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"National Cancer Institute; National Institute for Health and Care Research; Cancer Research UK","keywords":"Cyclophosphamide; Oncolytic virus; Medicine; Peripheral blood mononuclear cell; Neutralizing antibody; Titer; Antibody; Immunology; Immune system; Virology; Pharmacology; Chemotherapy; Internal medicine; Biology; In vitro","score_opus":0.1336147238726371,"score_gpt":0.5301574505187308,"score_spread":0.3965427266460937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055340037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949201,0.0013253965,0.0006260103,0.00016715853,0.000083379564,0.0015508714,0.00031439879,0.000066172375,0.0009465341],"genre_scores_gemma":[0.99306184,0.0011228303,0.0016279051,0.00022992384,0.00006446243,0.0017695752,0.0007473224,0.000018125193,0.001357935],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997732,0.00006991218,0.000012275769,0.00005110199,0.000020952302,0.00007257581],"domain_scores_gemma":[0.9997377,0.000038690956,0.00006644867,0.000032023327,0.0000190669,0.00010597668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006553474,0.0011358416,0.001238713,0.00035563234,0.00027547023,0.0007247992,0.0007590671,0.001070868,0.0019761692],"category_scores_gemma":[0.00030959613,0.0002675208,0.0007303481,0.00030283595,0.000654916,0.00043803954,0.00026530313,0.0022326133,0.000341602],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40297964,0.10474578,0.0044042165,0.0012846682,0.0010008194,0.00033234054,0.00037049502,0.008454257,0.32189822,0.00083068304,0.0029067553,0.15079214],"study_design_scores_gemma":[0.22371072,0.71388495,0.0048020976,0.000053364292,0.00040816618,0.00028216038,0.000044741308,0.0023414113,0.051550675,0.00019845288,0.0026984739,0.000024753921],"about_ca_topic_score_codex":0.00080650003,"about_ca_topic_score_gemma":0.0015476752,"teacher_disagreement_score":0.0019761692,"about_ca_system_score_codex":0.0008430981,"about_ca_system_score_gemma":0.0013219776,"threshold_uncertainty_score":0.00661093},"labels":[],"label_agreement":null},{"id":"W2055695109","doi":"10.1158/1078-0432.ccr-05-2130","title":"Irinotecan Inactivation Is Modulated by Epigenetic Silencing of<i>UGT1A1</i>in Colon Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Irinotecan; Epigenetics; Colorectal cancer; Gene silencing; Cancer; Medicine; Cancer research; Biology; Oncology; Internal medicine; Genetics","score_opus":0.10314148759952835,"score_gpt":0.48589279502434357,"score_spread":0.3827513074248152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055695109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978696,0.0009087806,0.00046542258,0.000036934904,0.000006393515,0.000009733599,0.00014595324,0.00004001843,0.0005171125],"genre_scores_gemma":[0.9985966,0.00039940333,0.00025565847,0.000015214808,0.00000242162,0.000007991959,0.00024597926,0.0000050885324,0.000471661],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999393,0.000009829162,0.0000047455947,0.000014402274,0.000015244452,0.000016424434],"domain_scores_gemma":[0.99995255,0.0000059809927,0.00001630187,0.0000062669505,0.0000061399196,0.000012689154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006715619,0.0002120151,0.00020552831,0.00017969341,0.00013097946,0.00017744067,0.0000877428,0.00012075587,0.00074064045],"category_scores_gemma":[0.00008438767,0.00008888178,0.00013755675,0.00016311624,0.0001779091,0.00007277323,0.00007542127,0.00022087006,0.00018226352],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015033245,0.000013611895,0.0010444638,0.000021524735,0.000005636421,0.000051306328,0.000011163414,0.00005807905,0.9973833,0.000028005705,0.000028912398,0.0012037256],"study_design_scores_gemma":[0.000014056439,0.00037626814,0.04055886,0.0000037123548,0.000029211717,0.00044163366,0.000024771665,0.00076452957,0.95612615,0.00002159449,0.0016360943,0.0000032195599],"about_ca_topic_score_codex":0.0015795955,"about_ca_topic_score_gemma":0.0016066073,"teacher_disagreement_score":0.0015795955,"about_ca_system_score_codex":0.0003650977,"about_ca_system_score_gemma":0.00017695862,"threshold_uncertainty_score":0.0031407475},"labels":[],"label_agreement":null},{"id":"W2057062854","doi":"10.1158/1078-0432.ovca13-b61","title":"Abstract B61: Proteomic profiling of ovarian cancer and mesothelial cells reveals novel mediators implicated in the metastatic progression of ovarian cancer to the peritoneum","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Ovarian cancer; Stromal cell; Proteome; Mesothelium; Mesothelial Cell; Cancer research; Biology; Cancer cell; Secretion; Cancer; Tumor microenvironment; Extracellular matrix; Cell culture; Proteomics; Transcriptome; Pathology; Medicine; Cell biology; Gene expression; Gene; Bioinformatics; Endocrinology; Biochemistry; Tumor cells; Genetics","score_opus":0.1030228359194799,"score_gpt":0.4835832791397178,"score_spread":0.3805604432202379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057062854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99527466,0.001793862,0.0009094296,0.000050068647,0.000016972535,0.00003244467,0.0012804703,0.000024941897,0.0006172234],"genre_scores_gemma":[0.9905399,0.0012340081,0.003214619,0.00008627842,0.000017829943,0.00004707983,0.0035255314,0.000010010118,0.0013247639],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999087,0.000009030934,0.000009530702,0.000019438312,0.00003305906,0.000020257494],"domain_scores_gemma":[0.99991584,0.000013756205,0.000020972968,0.0000069643875,0.000020389089,0.00002212404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001342732,0.00028493462,0.0002715665,0.00059196696,0.00021524905,0.00036265247,0.000080531885,0.00023298363,0.0008687687],"category_scores_gemma":[0.00020024092,0.000078970756,0.00031021895,0.0005266728,0.0001308837,0.00017943213,0.0002483371,0.00020836532,0.00032510402],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013770601,0.000011064793,0.0042926334,0.000060833798,0.000012741815,0.00014417173,0.00002374399,0.000022072289,0.9937691,0.000013914433,0.000039981245,0.0014720137],"study_design_scores_gemma":[0.000026224752,0.0005429992,0.41054785,0.000029632007,0.00011422593,0.002331655,0.00033801448,0.0019442118,0.5781628,0.000074530675,0.0058722063,0.00001564914],"about_ca_topic_score_codex":0.0006688735,"about_ca_topic_score_gemma":0.00063279364,"teacher_disagreement_score":0.0008687687,"about_ca_system_score_codex":0.00014645726,"about_ca_system_score_gemma":0.00019309125,"threshold_uncertainty_score":0.0029063225},"labels":[],"label_agreement":null},{"id":"W2057187391","doi":"10.1158/1078-0432.ccr-10-0505","title":"Tremelimumab in Combination with Exemestane in Patients with Advanced Breast Cancer and Treatment-Associated Modulation of Inducible Costimulator Expression on Patient T Cells","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":302,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Tremelimumab; Medicine; Exemestane; Internal medicine; Breast cancer; Oncology; Adverse effect; Cancer; FOXP3; Immune system; Pharmacology; Immunology; Immunotherapy; Ipilimumab; Aromatase","score_opus":0.054415058311515815,"score_gpt":0.40782249443378715,"score_spread":0.3534074361222713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057187391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948933,0.003785984,0.0001752996,0.00022342737,0.000022603163,0.000058016274,0.000058325106,0.00002190686,0.00076102134],"genre_scores_gemma":[0.998092,0.0010370933,0.00031698606,0.00013263893,0.000049690192,0.00005551478,0.00013249986,0.0000034313903,0.0001800191],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99977595,0.000116387964,0.000017277498,0.000027892836,0.00002788427,0.000034646022],"domain_scores_gemma":[0.99975497,0.00008079924,0.000070152484,0.000013436342,0.000010817615,0.00006978628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041839364,0.00027528647,0.0009121304,0.0001727912,0.00024300892,0.0002787739,0.0002682958,0.00031166917,0.0005640131],"category_scores_gemma":[0.0008169428,0.00017619054,0.00033040997,0.00026586806,0.00024080652,0.00019913357,0.00014937876,0.0005544334,0.00019456382],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13566138,0.0084908735,0.19008738,0.0018190749,0.001926931,0.0083947005,0.00096308923,0.0076848203,0.13451768,0.0004398177,0.006083099,0.5039312],"study_design_scores_gemma":[0.071160294,0.29198292,0.5178767,0.00027512573,0.0024035496,0.030028211,0.00035972174,0.011881797,0.04291301,0.00076282956,0.0302518,0.000104097526],"about_ca_topic_score_codex":0.00029917134,"about_ca_topic_score_gemma":0.00071198214,"teacher_disagreement_score":0.0009121304,"about_ca_system_score_codex":0.0003973625,"about_ca_system_score_gemma":0.00039170124,"threshold_uncertainty_score":0.0028831363},"labels":[],"label_agreement":null},{"id":"W2057985610","doi":"10.1158/1078-0432.ccr-10-2224","title":"The Ability to Form Primary Tumor Xenografts Is Predictive of Increased Risk of Disease Recurrence in Early-Stage Non–Small Cell Lung Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Histology; Primary tumor; Lung cancer; Pathology; Cancer; Epidermal growth factor receptor; Oncology; Stage (stratigraphy); Cancer research; Internal medicine; Metastasis; Biology","score_opus":0.06839996388077083,"score_gpt":0.4448765100299225,"score_spread":0.3764765461491517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057985610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99919766,0.00030593903,0.00018138324,0.000021496482,0.000004505091,0.000005459958,0.00006611804,0.000006313948,0.00021110589],"genre_scores_gemma":[0.9994418,0.00010546959,0.00011775469,0.0000087726985,0.000004222547,0.000004883333,0.00015693417,0.0000019927702,0.00015814434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985814,0.00003620907,0.000014573558,0.000030901807,0.000035599052,0.000024519262],"domain_scores_gemma":[0.99882704,0.00038886085,0.000349441,0.000073991585,0.00008271962,0.0002778223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004079626,0.0001496592,0.0002312587,0.0001654534,0.00014321454,0.0002841005,0.00013498272,0.0002715533,0.0017844458],"category_scores_gemma":[0.0009226645,0.00008811912,0.00016163486,0.00015873274,0.00017969581,0.00017305618,0.00014642751,0.0004679617,0.00020611408],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000757401,0.00014498417,0.96274245,0.000032649958,0.000056717403,0.00027619416,0.000032589858,0.00015202558,0.03168802,0.000021879609,0.00016664068,0.0039284267],"study_design_scores_gemma":[0.000011368419,0.0006123531,0.99388665,0.000003849297,0.00003830539,0.0015797365,0.00004383884,0.0003774066,0.003131209,0.00001568447,0.00029750794,0.0000021463522],"about_ca_topic_score_codex":0.00040754845,"about_ca_topic_score_gemma":0.0005940195,"teacher_disagreement_score":0.0017844458,"about_ca_system_score_codex":0.0001296354,"about_ca_system_score_gemma":0.00012546618,"threshold_uncertainty_score":0.005969584},"labels":[],"label_agreement":null},{"id":"W2058363411","doi":"10.1158/1078-0432.ccr-07-4381","title":"Decreased Expression of Gastrokine 1 and the Trefoil Factor Interacting Protein TFIZ1/GKN2 in Gastric Cancer: Influence of Tumor Histology and Relationship to Prognosis","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources; National Cancer Institute; National Institutes of Health","keywords":"Cancer; Biology; Immunohistochemistry; Tissue microarray; Adenocarcinoma; Pathology; Histology; Internal medicine; Cancer research; Medicine; Immunology; Genetics","score_opus":0.16990376046308517,"score_gpt":0.45906010153855686,"score_spread":0.2891563410754717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058363411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991647,0.00058463035,0.0001022039,0.000009370079,0.0000013510717,0.0000019920146,0.00006488852,0.000003257749,0.000067680005],"genre_scores_gemma":[0.9994135,0.00017090814,0.00011239996,0.000006658769,0.0000027704034,0.0000040636132,0.00013679655,0.0000010362118,0.00015195724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999293,0.000011891093,0.000004885259,0.00002060847,0.000017903683,0.000015381864],"domain_scores_gemma":[0.99980134,0.000033927427,0.00008703986,0.000014114731,0.00002319526,0.000040446117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016366356,0.00016074373,0.00017263212,0.0002784018,0.000103970735,0.0001663026,0.00011148829,0.00017557021,0.0006414968],"category_scores_gemma":[0.00034876415,0.00009159797,0.00009280494,0.00020116426,0.0002176185,0.00011115062,0.00011354404,0.0001490879,0.00013416239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026178393,0.000053116193,0.60261375,0.000118602205,0.000092105365,0.00037119206,0.00008857348,0.00020079555,0.38631088,0.000021105085,0.00014651845,0.007365531],"study_design_scores_gemma":[0.000015593145,0.00027954997,0.9796419,0.000004971706,0.000040366696,0.0012020646,0.000060721268,0.0004650933,0.01789735,0.0000155024,0.00037307452,0.0000036984654],"about_ca_topic_score_codex":0.0007993837,"about_ca_topic_score_gemma":0.0011359985,"teacher_disagreement_score":0.0007993837,"about_ca_system_score_codex":0.00021086233,"about_ca_system_score_gemma":0.00009272913,"threshold_uncertainty_score":0.0021460056},"labels":[],"label_agreement":null},{"id":"W2059939561","doi":"10.1158/1078-0432.ccr-08-0021","title":"Reply to Letter to the Editor: a Response to the Letter of M. Tisdale","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Colocalization; Proteolysis; Glycosylation; Monoclonal antibody; Peptide; Antibody; Oligosaccharide; Biochemistry; Glycoprotein; Biology; Chemistry; Cell biology; Immunology; Enzyme","score_opus":0.10577662078188033,"score_gpt":0.4502158833830138,"score_spread":0.3444392626011335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059939561","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033586446,0.0033920023,0.000209631,0.8145447,0.18029484,0.000023936924,0.00007350106,0.0000841384,0.0010413604],"genre_scores_gemma":[0.0030969693,0.0028684451,0.00033397833,0.84990084,0.13794488,0.000056240395,0.00005729935,0.00006235417,0.005679088],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975828,0.0006519321,0.0003311727,0.00047758027,0.0006772899,0.0002792477],"domain_scores_gemma":[0.9912579,0.0035917861,0.00048397775,0.00026458607,0.0028426833,0.0015591512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003761918,0.0015426523,0.0020177758,0.0009066987,0.0022688748,0.003752555,0.003761679,0.02747357,0.009448479],"category_scores_gemma":[0.023934623,0.0008561813,0.0014352793,0.00058728433,0.0026204924,0.0048818574,0.0017693251,0.036606606,0.009446524],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037756967,0.000020821886,0.00014436021,0.00007873093,0.000010695052,0.00058886356,0.000048444253,0.000023881772,0.00008577581,0.00033396075,0.9958183,0.0028083734],"study_design_scores_gemma":[0.00007776295,0.000080235,0.0007391559,0.00033745306,0.000033393248,0.0024610609,0.00037166596,0.0002663801,0.00034551122,0.0018845806,0.9933189,0.00008383885],"about_ca_topic_score_codex":0.0016866922,"about_ca_topic_score_gemma":0.0022656496,"teacher_disagreement_score":0.02747357,"about_ca_system_score_codex":0.002491745,"about_ca_system_score_gemma":0.0027785378,"threshold_uncertainty_score":0.031608284},"labels":[],"label_agreement":null},{"id":"W2060045463","doi":"10.1158/1078-0432.ovca13-a9","title":"Abstract A9: A whole-locus sequencing approach to identify polymorphisms associated with juvenile-onset granulosa cell tumor susceptibility in SWR mice","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Biology; Locus (genetics); Congenic; Carcinogenesis; Allele; Genetics; Epigenetics; Gene; Quantitative trait locus; Cancer research","score_opus":0.16583900280883065,"score_gpt":0.4523502060969039,"score_spread":0.2865112032880732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060045463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97749364,0.00017916466,0.015765289,0.000054804077,0.000021482881,0.00017005748,0.0049652318,0.000292426,0.0010579238],"genre_scores_gemma":[0.9505093,0.00027109837,0.03393381,0.0001969172,0.000026266369,0.00027930996,0.008189725,0.0004116319,0.006181909],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975926,0.00003348467,0.000024138762,0.00009217417,0.00005219202,0.000038668477],"domain_scores_gemma":[0.9995672,0.000087464265,0.00016735111,0.000042059328,0.00004096671,0.00009494582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002964417,0.00037198624,0.00027668235,0.001081876,0.00025088235,0.00023470778,0.00029867006,0.00039132356,0.0032000213],"category_scores_gemma":[0.00030060747,0.00021481748,0.0005883533,0.00038723976,0.00019956657,0.000063513646,0.00022157817,0.0004488298,0.0005947644],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021027685,0.000045423847,0.002175112,0.000019573308,0.00003118427,0.00015158215,0.00003548777,0.00007321839,0.9948125,0.00007256149,0.000074973155,0.002298132],"study_design_scores_gemma":[0.00028714642,0.002597205,0.29599798,0.000049048936,0.0005104314,0.0066915285,0.00025225713,0.0055848747,0.6739235,0.00038106058,0.01366584,0.000059114343],"about_ca_topic_score_codex":0.00075622025,"about_ca_topic_score_gemma":0.0016073388,"teacher_disagreement_score":0.0032000213,"about_ca_system_score_codex":0.00011753617,"about_ca_system_score_gemma":0.00017394705,"threshold_uncertainty_score":0.010705173},"labels":[],"label_agreement":null},{"id":"W2060277785","doi":"10.1158/1078-0432.ovca13-a20","title":"Abstract A20: Integrating high-throughput technologies for the identification and validation of ovarian cancer biomarkers","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Biological Research and Disease Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Ovarian cancer; Cancer; Medicine; Biomarker discovery; Malignancy; Identification (biology); Biomarker; Proteomics; Bioinformatics; Computational biology; Oncology; Biology; Internal medicine; Gene","score_opus":0.1586183839477584,"score_gpt":0.5001702391840552,"score_spread":0.34155185523629683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060277785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54470944,0.005112357,0.4289178,0.0011493086,0.000456986,0.0017897357,0.0073915753,0.006341347,0.004131516],"genre_scores_gemma":[0.47320995,0.002631589,0.50726545,0.00083912106,0.0002115802,0.001687171,0.00908667,0.00037064808,0.004697735],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972899,0.00055432547,0.00018044966,0.00050599815,0.0013270029,0.00014237165],"domain_scores_gemma":[0.9975204,0.0008968714,0.00033802586,0.0002038128,0.0008439134,0.00019692651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005094769,0.0012076555,0.0010737231,0.002745296,0.0009545129,0.0030248826,0.00090241444,0.001570947,0.00175055],"category_scores_gemma":[0.0037887893,0.0005186084,0.0012343604,0.0018193991,0.0005398775,0.0010018374,0.00096337154,0.00092162064,0.0014839295],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089723896,0.00052269065,0.01233899,0.0004113842,0.00022022381,0.00015919833,0.00007630761,0.0037420555,0.92690605,0.00082980364,0.0018325603,0.05206347],"study_design_scores_gemma":[0.00012449564,0.0016662813,0.026671423,0.000056127104,0.0002727296,0.0005793106,0.0000903657,0.08064611,0.87544364,0.0018321616,0.012479412,0.00013790783],"about_ca_topic_score_codex":0.0014046256,"about_ca_topic_score_gemma":0.0015744743,"teacher_disagreement_score":0.005094769,"about_ca_system_score_codex":0.00095118117,"about_ca_system_score_gemma":0.001552215,"threshold_uncertainty_score":0.026944041},"labels":[],"label_agreement":null},{"id":"W2063243732","doi":"10.1158/1078-0432.ccr-08-3076","title":"Targeting Rat Brainstem Glioma Using Human Neural Stem Cells and Human Mesenchymal Stem Cells","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Mesenchymal stem cell; Neural stem cell; Stem cell; Glioma; Cancer research; Brainstem; Pathology; Biology; Medicine; Immunology; Cell biology; Neuroscience","score_opus":0.3441829397796936,"score_gpt":0.5337337856382064,"score_spread":0.18955084585851278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063243732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826166,0.0045976765,0.008681357,0.0001526744,0.00009819793,0.00026555706,0.00040257061,0.00018410165,0.003001164],"genre_scores_gemma":[0.9864059,0.002113468,0.0077746,0.00007690404,0.000015816106,0.00015384995,0.00063759246,0.000014099813,0.0028076204],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984884,0.000017039129,0.000012917592,0.000035870395,0.000059416165,0.000026049573],"domain_scores_gemma":[0.9999509,0.0000060326247,0.000017280918,0.0000068118916,0.000009280894,0.000009714947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018712641,0.00045884642,0.0002214128,0.00027995274,0.000091938295,0.00022380674,0.00016229817,0.00031773106,0.0014058863],"category_scores_gemma":[0.00008406945,0.000082627856,0.00030417362,0.00017801701,0.00022025558,0.0001241085,0.00015625641,0.00039400277,0.00042003114],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033555832,0.00020270432,0.0004736935,0.00013319968,0.000017595048,0.0000963409,0.00003798766,0.0003088506,0.9887948,0.00019855499,0.00011582062,0.009284872],"study_design_scores_gemma":[0.000071941664,0.0025721395,0.0029189384,0.000022218854,0.000062712264,0.0004454663,0.00004947077,0.00094863394,0.9882854,0.000035948422,0.004580601,0.0000066143957],"about_ca_topic_score_codex":0.0019203165,"about_ca_topic_score_gemma":0.0030321705,"teacher_disagreement_score":0.0019203165,"about_ca_system_score_codex":0.00027796894,"about_ca_system_score_gemma":0.00037902774,"threshold_uncertainty_score":0.004703164},"labels":[],"label_agreement":null},{"id":"W2065037500","doi":"10.1158/1078-0432.ccr-07-1955","title":"Bcl-B Expression in Human Epithelial and Nonepithelial Malignancies","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nuclear Receptors and Signaling","field":"Neuroscience","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Cancer; Malignancy; Pathology; Lymphoma; Immunohistochemistry; Prostate cancer; Immunostaining; Carcinogenesis; Cancer research; Biology; Prostate; Germinal center; Breast cancer; Medicine; B cell; Internal medicine; Antibody; Immunology","score_opus":0.3592095641428239,"score_gpt":0.501245399538448,"score_spread":0.14203583539562414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065037500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950982,0.0038264804,0.0003261083,0.00002204459,0.000004412308,0.000008533253,0.00018419974,0.00001112789,0.0005188148],"genre_scores_gemma":[0.99758184,0.0013659279,0.0003407073,0.000016199383,0.000005015536,0.000012883879,0.00044269447,0.0000020986433,0.0002325735],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998803,0.000022334269,0.000013490158,0.00002551252,0.00003620031,0.000022066131],"domain_scores_gemma":[0.9998356,0.000040053896,0.00005066576,0.000013843826,0.000036128436,0.00002367328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017597698,0.000112775975,0.00009881708,0.0006747842,0.00016265574,0.00024339989,0.000115754425,0.00016769975,0.0008931529],"category_scores_gemma":[0.00038285082,0.000090867536,0.000071518174,0.0005292605,0.0001746294,0.00015893995,0.00018203756,0.00012433545,0.00016953048],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021442128,0.000104422186,0.36621624,0.0004690767,0.00009415054,0.0014855475,0.000394882,0.00021479849,0.60013545,0.00035099484,0.000423807,0.027966397],"study_design_scores_gemma":[0.00011723699,0.00088854827,0.87923604,0.00007111494,0.00016968447,0.014548668,0.000498645,0.0008315111,0.09356064,0.0002476188,0.009817232,0.0000131764755],"about_ca_topic_score_codex":0.00056316063,"about_ca_topic_score_gemma":0.0006813867,"teacher_disagreement_score":0.0008931529,"about_ca_system_score_codex":0.00018758392,"about_ca_system_score_gemma":0.00011752753,"threshold_uncertainty_score":0.0029878616},"labels":[],"label_agreement":null},{"id":"W2065915192","doi":"10.1158/1078-0432.ccr-14-0344","title":"Toll-like Receptor Agonist Imiquimod Facilitates Antigen-Specific CD8+ T-cell Accumulation in the Genital Tract Leading to Tumor Control through IFNγ","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Parks and Wilderness Society","funders":"National Institute of Dental and Craniofacial Research; National Cancer Institute","keywords":"Imiquimod; Agonist; Medicine; TLR7; CD8; Genital warts; Immunology; Toll-like receptor; Virology; Antigen; Cancer research; Receptor; Immune system; Internal medicine; Innate immune system","score_opus":0.3316480913202369,"score_gpt":0.5352566410897088,"score_spread":0.2036085497694719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065915192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967891,0.0009495135,0.00077197584,0.00006745113,0.00003700415,0.000046829937,0.00013498288,0.000041296586,0.0011619087],"genre_scores_gemma":[0.9969964,0.00046110572,0.0012165653,0.00004508727,0.00002327277,0.000038539005,0.0001285966,0.000006133251,0.001084243],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998877,0.000020144947,0.000007690322,0.000023373896,0.000023388324,0.00003763478],"domain_scores_gemma":[0.9999603,0.0000068094882,0.000012478675,0.000004504696,0.0000049163136,0.000010969072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009077444,0.00031132202,0.00023850644,0.00016204534,0.000078854646,0.00015928176,0.00010057551,0.00019461707,0.0011146314],"category_scores_gemma":[0.00005971337,0.00008459619,0.0001870572,0.00005768762,0.00015715818,0.0001325941,0.000087507506,0.0003826992,0.00027776335],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020630921,0.00006000569,0.00016500456,0.000045865054,0.0000025344152,0.000021387159,0.000008466449,0.00006212102,0.9979328,0.000016574526,0.000035057736,0.0014439322],"study_design_scores_gemma":[0.000060439266,0.002068471,0.002989415,0.000010173372,0.000018692863,0.00017871188,0.000025778638,0.0007876082,0.992543,0.000015493499,0.001300104,0.0000021845472],"about_ca_topic_score_codex":0.00026629196,"about_ca_topic_score_gemma":0.0004467581,"teacher_disagreement_score":0.0011146314,"about_ca_system_score_codex":0.00022688798,"about_ca_system_score_gemma":0.00016662941,"threshold_uncertainty_score":0.003728807},"labels":[],"label_agreement":null},{"id":"W2067155227","doi":"10.1158/1078-0432.ccr-07-4698","title":"Adjuvant Radioimmunotherapy Trial with Iodine-131–Labeled Anti–Carcinoembryonic Antigen Monoclonal Antibody F6 F(ab′)2 after Resection of Liver Metastases from Colorectal Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Carcinoembryonic antigen; Radioimmunotherapy; Medicine; Adjuvant; Colorectal cancer; Monoclonal antibody; Oncology; Surgical resection; Cancer; Antibody; Cancer research; Internal medicine; Pathology; Immunology","score_opus":0.2296091478252546,"score_gpt":0.5207940832102064,"score_spread":0.29118493538495177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067155227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99870646,0.0006429128,0.00016742226,0.000041096882,0.000024332478,0.00012532533,0.000025266763,0.000016047134,0.0002512088],"genre_scores_gemma":[0.9981869,0.00035925553,0.00031887525,0.0001077596,0.00008805657,0.00016336846,0.00027701506,0.0000035418836,0.00049527787],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997925,0.0000802998,0.00001173967,0.000033341177,0.000024105613,0.000058154754],"domain_scores_gemma":[0.99955446,0.00010368612,0.000077050194,0.000045342276,0.000023342498,0.00019604451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058196794,0.00073966634,0.0011388384,0.00022921366,0.00028541722,0.00028214,0.00032690074,0.00052711053,0.0008578218],"category_scores_gemma":[0.00057899114,0.00023206999,0.0004895808,0.0001523905,0.00046660425,0.0002505066,0.00019038045,0.0008625938,0.00018851271],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49943078,0.056167368,0.044889282,0.0008532721,0.001134864,0.002904864,0.00035565876,0.0056011947,0.19559611,0.00021669507,0.0015409037,0.19130899],"study_design_scores_gemma":[0.042027336,0.88644516,0.052005358,0.000033940796,0.00032040264,0.0011759268,0.000045103057,0.0015457553,0.014214489,0.000040124978,0.0021231691,0.00002327204],"about_ca_topic_score_codex":0.00065604324,"about_ca_topic_score_gemma":0.0012952449,"teacher_disagreement_score":0.0011388384,"about_ca_system_score_codex":0.0004626508,"about_ca_system_score_gemma":0.00055902393,"threshold_uncertainty_score":0.0033568144},"labels":[],"label_agreement":null},{"id":"W2067252902","doi":"10.1158/1078-0432.ccr-04-2488","title":"Effect of the St. John's Wort Constituent Hyperforin on Docetaxel Metabolism by Human Hepatocyte Cultures","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Natural Compound Pharmacology Studies","field":"Agricultural and Biological Sciences","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Cancer Institute, University of Pittsburgh","keywords":"Hyperforin; Docetaxel; Pharmacology; Hepatocyte; Metabolism; Metabolite; Chemistry; CYP3A4; Cytochrome P450; Hypericum perforatum; CYP3A; Pharmacokinetics; Hydroxylation; Biochemistry; Enzyme; Medicine; In vitro; Internal medicine; Chemotherapy","score_opus":0.1275411279311244,"score_gpt":0.5018379043689848,"score_spread":0.3742967764378604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067252902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99171066,0.004061143,0.0015368242,0.000107981985,0.00004679146,0.00005506272,0.00036696528,0.000047578702,0.0020668942],"genre_scores_gemma":[0.99478793,0.0011808829,0.0015893275,0.0000746363,0.000014308402,0.000025455041,0.00053961267,0.000010753507,0.0017770476],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998055,0.00006182031,0.000019716606,0.000037256243,0.000045563887,0.000030191404],"domain_scores_gemma":[0.9998441,0.0000413413,0.000035557598,0.000022817143,0.000037785154,0.000018391653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016358306,0.0002491888,0.0002510642,0.00013451862,0.0001598319,0.0002820217,0.00008678296,0.00014973656,0.0015732619],"category_scores_gemma":[0.00018564923,0.00010134502,0.00028039858,0.00020415604,0.00014253063,0.00014548615,0.00018078781,0.00025138134,0.00039949673],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016465866,0.000117728094,0.0015426463,0.00011170822,0.000034678505,0.0002668095,0.00009028334,0.00017793626,0.98807794,0.00004892221,0.00024422322,0.0076405797],"study_design_scores_gemma":[0.000051926694,0.0021800026,0.010070319,0.000009417341,0.000061373066,0.0005979158,0.000071136994,0.00047647866,0.98308945,0.000018038572,0.003364356,0.000009553007],"about_ca_topic_score_codex":0.0019467357,"about_ca_topic_score_gemma":0.0044698757,"teacher_disagreement_score":0.0019467357,"about_ca_system_score_codex":0.0003069721,"about_ca_system_score_gemma":0.00024863725,"threshold_uncertainty_score":0.00526309},"labels":[],"label_agreement":null},{"id":"W2067322982","doi":"10.1158/1078-0432.ccr-10-2577","title":"The Role of Erythropoietin and Erythropoiesis-Stimulating Agents in Tumor Progression","year":2011,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Janssen Canada; Canadian Institutes of Health Research","keywords":"Erythropoietin; Erythropoietin receptor; Erythropoiesis; Medicine; Cancer; Cancer research; Chemotherapy; Anemia; Apoptosis; Cancer cell; Pharmacology; Internal medicine; Biology","score_opus":0.3779031268016942,"score_gpt":0.5947016967869888,"score_spread":0.21679856998529462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067322982","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028894585,0.95453453,0.0029787994,0.00349387,0.0005664368,0.00005372908,0.00016355257,0.000062925385,0.0092515405],"genre_scores_gemma":[0.4174529,0.5654123,0.004184364,0.0021259387,0.0018936208,0.00015148698,0.0004372295,0.000034772394,0.0083073005],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996582,0.00011971543,0.000023029856,0.000049218947,0.00011169458,0.00003813028],"domain_scores_gemma":[0.9996526,0.00009662351,0.000106086474,0.000012918334,0.00006309662,0.00006879119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064081146,0.00027941758,0.00042006094,0.00064325385,0.00022620111,0.0008513311,0.0003340317,0.0005390003,0.001173099],"category_scores_gemma":[0.0008878975,0.00012000457,0.00022802569,0.00048869976,0.00040783937,0.0004718402,0.0005498205,0.0012700267,0.0003739842],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009811897,0.00040197402,0.009875517,0.0025052617,0.00015118663,0.0013677325,0.00027827348,0.0020766219,0.044946305,0.03201257,0.019375712,0.8860276],"study_design_scores_gemma":[0.00032021018,0.0020965189,0.047139883,0.001465069,0.00031347878,0.005774331,0.00030322818,0.0048499582,0.03381632,0.027909402,0.8759298,0.00008183645],"about_ca_topic_score_codex":0.0011217699,"about_ca_topic_score_gemma":0.0008464504,"teacher_disagreement_score":0.001173099,"about_ca_system_score_codex":0.0007537798,"about_ca_system_score_gemma":0.00071069575,"threshold_uncertainty_score":0.005469024},"labels":[],"label_agreement":null},{"id":"W2067841857","doi":"10.1158/1078-0432.ccr-10-3314","title":"IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":261,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Sunitinib; Medicine; Ovarian cancer; Cancer research; Cancer; Serous fluid; Angiogenesis; Internal medicine; Pathology","score_opus":0.34325376796023427,"score_gpt":0.49524241971514615,"score_spread":0.15198865175491189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067841857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985713,0.0010203721,0.00010827794,0.000042856682,0.0000030678,0.0000074088666,0.00009498655,0.00000985013,0.00014182112],"genre_scores_gemma":[0.9994704,0.0001327046,0.00013138891,0.00001911463,0.000004233095,0.0000053829335,0.00017895136,0.0000013380807,0.0000563386],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998585,0.00003310106,0.000016064587,0.000025386487,0.000042742755,0.0000240944],"domain_scores_gemma":[0.9996971,0.00008174086,0.00009853963,0.000019658914,0.00003193176,0.00007108667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032755808,0.00014789867,0.00035779018,0.0003250814,0.00015962856,0.00030044987,0.00011336953,0.00019509438,0.0004882863],"category_scores_gemma":[0.0005059509,0.000066492634,0.00022330841,0.00024083753,0.00018955578,0.00014471605,0.000099226316,0.0002557532,0.00007020364],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014857875,0.00066171907,0.54697365,0.0003420724,0.00036310774,0.0009406584,0.00023935153,0.002176225,0.35851723,0.0001216139,0.0005791341,0.07422735],"study_design_scores_gemma":[0.00034657813,0.005687972,0.9295253,0.000010748208,0.00017809246,0.0024175933,0.00010424225,0.003190753,0.056657795,0.00012602132,0.0017408855,0.000013941154],"about_ca_topic_score_codex":0.00061414903,"about_ca_topic_score_gemma":0.0011201975,"teacher_disagreement_score":0.00061414903,"about_ca_system_score_codex":0.0003797053,"about_ca_system_score_gemma":0.00025633397,"threshold_uncertainty_score":0.0027549863},"labels":[],"label_agreement":null},{"id":"W2069326446","doi":"10.1158/1078-0432.ccr-14-0158","title":"Tumor Stromal Phenotypes Define VEGF Sensitivity—Letter","year":2014,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Stromal cell; Stroma; Pathology; Angiogenesis; Phenotype; Parenchyma; Colorectal cancer; Cancer; Desmoplasia; Biology; Cancer research; Medicine; Immunohistochemistry; Internal medicine","score_opus":0.28807936222836933,"score_gpt":0.506240839727046,"score_spread":0.2181614774986767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069326446","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026084152,0.015827192,0.00046649954,0.90563166,0.07396732,0.000014403895,0.00013671524,0.00011705657,0.0012308151],"genre_scores_gemma":[0.027173907,0.015003573,0.00055962056,0.7313046,0.22225073,0.000047069363,0.00010447238,0.000059656824,0.0034963575],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981949,0.00043858704,0.0002764491,0.00041284488,0.00048596863,0.0001913169],"domain_scores_gemma":[0.9926542,0.0033870798,0.00037806455,0.00022070066,0.0024867654,0.00087318284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002097008,0.0006721734,0.001280393,0.00052676117,0.0008605275,0.0020269444,0.0016908837,0.010755701,0.0019133595],"category_scores_gemma":[0.011306588,0.00045886432,0.00084062864,0.0003912706,0.0019276317,0.0030671281,0.00087467354,0.019058885,0.0022344943],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031011103,0.00009965648,0.0024774557,0.00033074757,0.000059934297,0.0039139083,0.00021053581,0.00014073022,0.0017393464,0.0017862447,0.9513852,0.03754621],"study_design_scores_gemma":[0.0002107707,0.0003879377,0.0066120136,0.00043936804,0.00012909208,0.015817078,0.00080171,0.0011397926,0.0032254388,0.008996996,0.9620475,0.00019214788],"about_ca_topic_score_codex":0.0011621059,"about_ca_topic_score_gemma":0.0011590387,"teacher_disagreement_score":0.010755701,"about_ca_system_score_codex":0.0018052771,"about_ca_system_score_gemma":0.0009306002,"threshold_uncertainty_score":0.01309824},"labels":[],"label_agreement":null},{"id":"W2070462086","doi":"10.1158/1078-0432.ovca13-ia26","title":"Abstract IA26: Protective immune networks in ovarian cancer","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Ovarian cancer; Immune system; CD8; Antigen; Cancer; Immunology; Cytotoxic T cell; Biology; Cancer research; Medicine; Internal medicine; Genetics","score_opus":0.18369874708787964,"score_gpt":0.513201799612445,"score_spread":0.3295030525245654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070462086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8589219,0.08885128,0.0054901335,0.0058437404,0.0009878075,0.0001655457,0.0010913761,0.00038923672,0.038259093],"genre_scores_gemma":[0.9791935,0.008854715,0.0011016303,0.000616378,0.00024877847,0.00004682967,0.0005106974,0.00001908527,0.0094083585],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.999838,0.00004343799,0.000007475919,0.000029432005,0.000030486146,0.000051087907],"domain_scores_gemma":[0.9997819,0.000016353644,0.000063877436,0.000014853443,0.000032042462,0.00009097882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033729075,0.00040775226,0.0002011614,0.00036738758,0.00031379977,0.0006209426,0.0002194613,0.00039079136,0.004000808],"category_scores_gemma":[0.00027670423,0.00009027833,0.00021551253,0.00019028246,0.00039240374,0.00030551956,0.0006574813,0.0006637549,0.0010481552],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018089352,0.00024965886,0.024047589,0.0016064105,0.00009028964,0.0025587704,0.00049993215,0.0017428325,0.81955343,0.010257576,0.013523978,0.12406061],"study_design_scores_gemma":[0.0003459866,0.0060440833,0.3070659,0.00104284,0.00019236295,0.011411408,0.0023232773,0.006093948,0.16403173,0.016664123,0.48469546,0.00008894896],"about_ca_topic_score_codex":0.00018517648,"about_ca_topic_score_gemma":0.00016792472,"teacher_disagreement_score":0.004000808,"about_ca_system_score_codex":0.00044308518,"about_ca_system_score_gemma":0.00027558662,"threshold_uncertainty_score":0.013384044},"labels":[],"label_agreement":null},{"id":"W2070522618","doi":"10.1158/1078-0432.ccr-12-1397","title":"Serum Lactate Dehydrogenase Is Prognostic for Survival in Patients with Bone Metastases from Breast Cancer: A Retrospective Analysis in Bisphosphonate-Treated Patients","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Cancer Research UK; Novartis Pharmaceuticals Corporation","keywords":"Medicine; Lactate dehydrogenase; Internal medicine; Breast cancer; Proportional hazards model; Zoledronic acid; Cancer; Chemotherapy; Oncology; Relative risk; Gastroenterology; Retrospective cohort study; Urology; Surgery; Confidence interval; Biology","score_opus":0.08758147656428107,"score_gpt":0.4566996469113921,"score_spread":0.36911817034711103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070522618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99912494,0.00049423956,0.000096245654,0.00001665084,0.0000036121476,0.0000041584485,0.00017772266,0.0000025409518,0.000079867794],"genre_scores_gemma":[0.9995652,0.0000979713,0.000048191414,0.000009552986,0.0000058571136,0.0000046882387,0.00023737618,7.779194e-7,0.000030443985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99957925,0.00012960396,0.000058432513,0.000096893986,0.000087952554,0.000047936],"domain_scores_gemma":[0.99884284,0.0002895826,0.0005121373,0.000108482294,0.00008750547,0.00015937838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006662431,0.0002256759,0.0004256104,0.00047312607,0.00023328615,0.00044392355,0.00026356956,0.00030033247,0.00079902454],"category_scores_gemma":[0.0016101695,0.00023442665,0.0006169904,0.00063517614,0.00027977958,0.00023036743,0.00022975105,0.00038984147,0.0001647783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046873794,0.000015229525,0.99850875,0.000006652246,0.000096002914,0.000044795244,0.000009651917,0.000048088812,0.00021505181,0.0000042950373,0.000028348086,0.00055439747],"study_design_scores_gemma":[0.000034161418,0.00033823535,0.99803144,0.0000050369167,0.000116919604,0.00062042347,0.00004197557,0.00045289754,0.00016069686,0.000017663317,0.00017618055,0.000004239095],"about_ca_topic_score_codex":0.0014542269,"about_ca_topic_score_gemma":0.0012896212,"teacher_disagreement_score":0.0014542269,"about_ca_system_score_codex":0.00026327724,"about_ca_system_score_gemma":0.00028924938,"threshold_uncertainty_score":0.003523469},"labels":[],"label_agreement":null},{"id":"W2072638902","doi":"10.1158/1078-0432.ccr-10-3309","title":"Sequential FDG-PET/CT as a Biomarker of Response to Sunitinib in Metastatic Clear Cell Renal Cancer","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Sunitinib; Nuclear medicine; Positron emission tomography; Cancer; Clinical endpoint; Biomarker; Stage (stratigraphy); Internal medicine; Oncology; Clinical trial","score_opus":0.5055549876519253,"score_gpt":0.5522083451222032,"score_spread":0.04665335747027788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072638902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99908423,0.00066731207,0.000118488126,0.000015158771,0.0000027601118,0.000016268135,0.00003192582,0.00000394351,0.00005993575],"genre_scores_gemma":[0.9994455,0.00011082555,0.00026074486,0.000013349214,0.000009044753,0.000019168625,0.00008990192,9.966202e-7,0.00005051705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99953234,0.00020778862,0.000037495436,0.000070450864,0.00011276605,0.000039135222],"domain_scores_gemma":[0.99869365,0.00038218498,0.0005781596,0.00006210426,0.00011201638,0.00017191618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013748425,0.0003554698,0.0006647973,0.00027758308,0.00016889913,0.00037792118,0.00025027027,0.0004685281,0.0006743351],"category_scores_gemma":[0.0018185084,0.0001891986,0.00027834816,0.00022935512,0.0003110402,0.000299286,0.00018667911,0.00041480162,0.00012691239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03695272,0.0012624763,0.8612492,0.00024057565,0.00032153734,0.00027251046,0.00008977738,0.0018601161,0.06000902,0.000025128395,0.00019694435,0.037520036],"study_design_scores_gemma":[0.00092315115,0.019181842,0.95524836,0.000018197044,0.00029851805,0.0011805854,0.000068323476,0.0037729684,0.018764874,0.00005088461,0.00047519204,0.000017110297],"about_ca_topic_score_codex":0.00057695946,"about_ca_topic_score_gemma":0.0009236112,"teacher_disagreement_score":0.0013748425,"about_ca_system_score_codex":0.00037771027,"about_ca_system_score_gemma":0.00038837624,"threshold_uncertainty_score":0.007270932},"labels":[],"label_agreement":null},{"id":"W2072990829","doi":"10.1158/1078-0432.ccr-08-0121","title":"Expression of t-DARPP Mediates Trastuzumab Resistance in Breast Cancer Cells","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Genentech","keywords":"Trastuzumab; Gene knockdown; Cancer research; Apoptosis; Molecular biology; Cell culture; Small interfering RNA; Biology; Cancer cell; Cancer; Medicine; Internal medicine; Breast cancer; Transfection; Biochemistry","score_opus":0.2929450628927039,"score_gpt":0.5554410195244822,"score_spread":0.2624959566317783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072990829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942721,0.0027301859,0.0015717781,0.00007994732,0.000017122058,0.00003730974,0.00030949287,0.000042294894,0.000939753],"genre_scores_gemma":[0.9943356,0.001819794,0.0014446985,0.00004436679,0.000008430782,0.000039207327,0.00091055536,0.0000147236815,0.0013826385],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998425,0.000026449283,0.000016522472,0.000028044653,0.00005219587,0.000034149372],"domain_scores_gemma":[0.9998863,0.00002378342,0.000030181003,0.000017376871,0.000024725938,0.000017668335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012129064,0.00023936987,0.0002644241,0.00011784579,0.00013156577,0.00042511756,0.00016559103,0.00023010906,0.0009828139],"category_scores_gemma":[0.0001676852,0.000115662304,0.00025982872,0.00023778214,0.00015470966,0.00016418498,0.0001715192,0.0005020122,0.0006620412],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067869085,0.00003650124,0.00038423183,0.00003865457,0.0000069019343,0.00009578618,0.000023413317,0.00005623509,0.9982079,0.000048823054,0.000044299974,0.000989363],"study_design_scores_gemma":[0.000034450095,0.00042998127,0.00938013,0.000009682193,0.00003003103,0.0014822156,0.000059006983,0.0012238915,0.9829516,0.00003391777,0.004359438,0.0000057746465],"about_ca_topic_score_codex":0.00047580825,"about_ca_topic_score_gemma":0.00036932755,"teacher_disagreement_score":0.0009828139,"about_ca_system_score_codex":0.00021936862,"about_ca_system_score_gemma":0.00014219126,"threshold_uncertainty_score":0.0032878518},"labels":[],"label_agreement":null},{"id":"W2073042319","doi":"10.1158/1078-0432.ccr-08-2790","title":"Therapeutic Efficacy of Seliciclib in Combination with Ionizing Radiation for Human Nasopharyngeal Carcinoma","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Nasopharyngeal carcinoma; Cancer research; Apoptosis; Cell cycle; Cell cycle checkpoint; Cyclin-dependent kinase; Radiation therapy; Biology; Medicine; Immunology; Internal medicine; Biochemistry","score_opus":0.21045845608325892,"score_gpt":0.5280816959434151,"score_spread":0.3176232398601562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073042319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98772836,0.008376603,0.0007702929,0.00012717854,0.00007166309,0.00020267484,0.0002375489,0.0000861949,0.0023995799],"genre_scores_gemma":[0.9945623,0.00325207,0.00078683055,0.00004473456,0.000023803248,0.00008561756,0.000348016,0.000015345186,0.00088131346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982506,0.000043945478,0.00001646284,0.00003108306,0.00005338362,0.000030097299],"domain_scores_gemma":[0.9999317,0.000011929684,0.000013187639,0.000012677314,0.0000083030345,0.000022070337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032413937,0.0005626622,0.0009862164,0.0006081226,0.0002784379,0.00046494196,0.00042103074,0.00035446577,0.0017650955],"category_scores_gemma":[0.00019791756,0.00012701009,0.00050986704,0.00050443615,0.00028052158,0.00027471097,0.00032255947,0.0006738696,0.0003727896],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008378645,0.0042593936,0.0032476813,0.0005601302,0.000328387,0.00039068202,0.0001455167,0.0033319858,0.8743656,0.00021101095,0.00089514145,0.103885725],"study_design_scores_gemma":[0.0014976617,0.033660203,0.015337943,0.000060003036,0.0004361294,0.001544681,0.00015710012,0.003997095,0.93223566,0.000106420375,0.010932854,0.000034220015],"about_ca_topic_score_codex":0.00094655785,"about_ca_topic_score_gemma":0.0020404593,"teacher_disagreement_score":0.0017650955,"about_ca_system_score_codex":0.00056009006,"about_ca_system_score_gemma":0.00058060064,"threshold_uncertainty_score":0.0059048533},"labels":[],"label_agreement":null},{"id":"W2076669505","doi":"10.1158/1078-0432.ccr-13-3368","title":"Prognostic B-cell Signatures Using mRNA-Seq in Patients with Subtype-Specific Breast and Ovarian Cancer","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":281,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Biology; Ovarian cancer; Breast cancer; Cancer research; Population; Somatic hypermutation; Immune system; Metastasis; Cancer; B cell; Immunology; Antibody; Medicine; Genetics","score_opus":0.1014426997593371,"score_gpt":0.4251543637597016,"score_spread":0.3237116640003645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076669505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915733,0.0007755144,0.0007700559,0.00010219939,0.000013569485,0.00003080286,0.006012454,0.00003387443,0.0006881438],"genre_scores_gemma":[0.9890371,0.00027671878,0.0014235423,0.00020143956,0.000022413615,0.00007077124,0.008569305,0.000018615665,0.0003801275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979526,0.000023538267,0.000017015578,0.00007966251,0.00004193533,0.000042600393],"domain_scores_gemma":[0.9997192,0.000071538736,0.00008247348,0.00002591557,0.000060371407,0.000040414106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030361765,0.00018167205,0.0004544266,0.00056652166,0.00022845091,0.0004861722,0.00020675655,0.00030316756,0.0009190435],"category_scores_gemma":[0.0006552172,0.000115178904,0.00021296287,0.0006128066,0.00011588132,0.00013923494,0.00025237194,0.00027619264,0.0002819647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009805547,0.00007130504,0.932519,0.00015984348,0.00016494656,0.00020330997,0.00013237911,0.0009074142,0.04319134,0.00008348432,0.0016266435,0.019959792],"study_design_scores_gemma":[0.000043669475,0.00014611542,0.9828652,0.000029667572,0.00015278265,0.0007541434,0.00038966266,0.005017684,0.007196568,0.00027190647,0.0031168938,0.000015700154],"about_ca_topic_score_codex":0.0018894396,"about_ca_topic_score_gemma":0.0033717873,"teacher_disagreement_score":0.0018894396,"about_ca_system_score_codex":0.0002483662,"about_ca_system_score_gemma":0.000247894,"threshold_uncertainty_score":0.0037569404},"labels":[],"label_agreement":null},{"id":"W2076899053","doi":"10.1158/1078-0432.ccr-14-2655","title":"Thomas C. Hall, MD, FACP: In Memoriam","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Graduation (instrument); Gratitude; Medical school; Medicine; Gerontology; Family medicine; Medical education; Psychology","score_opus":0.24147763738237202,"score_gpt":0.5572348235703496,"score_spread":0.31575718618797755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076899053","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008039576,0.014844401,0.0007021718,0.40803894,0.5281227,0.00014245501,0.00077239866,0.000429435,0.046143554],"genre_scores_gemma":[0.016977103,0.030800248,0.0009328074,0.30530325,0.35651383,0.00043219022,0.0013085287,0.00034941768,0.2873826],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993013,0.000082028455,0.0000655612,0.0001441287,0.00030688226,0.000100169695],"domain_scores_gemma":[0.99622107,0.00055041915,0.00017737519,0.00010196258,0.0018624827,0.0010865993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010314157,0.0010147536,0.0009379873,0.0009137165,0.0011453436,0.0020019114,0.00168151,0.0028989923,0.05595314],"category_scores_gemma":[0.013504215,0.0003526833,0.0006122718,0.00040309824,0.000701749,0.0022573725,0.0010415735,0.0070409924,0.03925571],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000942087,0.00000547826,0.00010589761,0.000026099824,0.0000016996481,0.00021504569,0.000009880062,0.000013555643,0.000014473238,0.00014574357,0.99307775,0.0063750306],"study_design_scores_gemma":[0.000023744695,0.000022078311,0.0005626086,0.0002885659,0.000008642799,0.0025147474,0.00009726767,0.00008601477,0.000119844335,0.00071653724,0.9955449,0.000014833919],"about_ca_topic_score_codex":0.0039416966,"about_ca_topic_score_gemma":0.00601494,"teacher_disagreement_score":0.05595314,"about_ca_system_score_codex":0.0020344045,"about_ca_system_score_gemma":0.0025716752,"threshold_uncertainty_score":0.18718189},"labels":[],"label_agreement":null},{"id":"W2077665371","doi":"10.1158/1078-0432.ccr-07-4628","title":"Synergy of a Herpes Oncolytic Virus and Paclitaxel for Anaplastic Thyroid Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Oncolytic virus; Anaplastic thyroid cancer; Paclitaxel; Medicine; Cancer; Thyroid cancer; Virology; Oncology; Cancer research; Thyroid; Virus; Internal medicine","score_opus":0.1743229465674083,"score_gpt":0.5028413829996716,"score_spread":0.3285184364322633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077665371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99161434,0.004641439,0.0011286351,0.00013107945,0.000039477327,0.00007960446,0.000085076,0.000063047126,0.0022173855],"genre_scores_gemma":[0.9964887,0.0013628347,0.0013777828,0.00003080384,0.000023342987,0.000032661246,0.00008054325,0.000007743741,0.0005955729],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989116,0.000024828018,0.0000075902435,0.000015277832,0.000033770062,0.00002738826],"domain_scores_gemma":[0.9999238,0.000023672661,0.000018131152,0.000008820319,0.0000062977156,0.00001928623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013990702,0.0002839118,0.00040228287,0.00032204817,0.00017061035,0.00036802556,0.0002557393,0.00021320769,0.001016094],"category_scores_gemma":[0.00014680107,0.000093662704,0.00029053565,0.00026590002,0.00022909438,0.00022676644,0.00024098795,0.0003637225,0.00022223554],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002576008,0.00064641784,0.0033415472,0.00022748449,0.000104546154,0.0002708617,0.000058151472,0.0015290827,0.9483491,0.0004965551,0.000396827,0.04200341],"study_design_scores_gemma":[0.0004540381,0.00950836,0.009452044,0.00003148669,0.000272679,0.0017048348,0.00006288926,0.0047330605,0.96565175,0.00020030474,0.007914711,0.00001386262],"about_ca_topic_score_codex":0.00095224974,"about_ca_topic_score_gemma":0.0024452552,"teacher_disagreement_score":0.001016094,"about_ca_system_score_codex":0.00047565027,"about_ca_system_score_gemma":0.0005284766,"threshold_uncertainty_score":0.0034510493},"labels":[],"label_agreement":null},{"id":"W2078786745","doi":"10.1158/1078-0432.ccr-05-2762","title":"Influence of Formulation Vehicle on Metronomic Taxane Chemotherapy: Albumin-Bound versus Cremophor EL–Based Paclitaxel","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"Taxane; Paclitaxel; Pharmacology; Medicine; Chemotherapy; Cancer; Internal medicine; Breast cancer","score_opus":0.10160094611451055,"score_gpt":0.47012205534468504,"score_spread":0.3685211092301745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078786745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571985,0.0012910041,0.0013044905,0.00006813493,0.00006484587,0.00007249163,0.00013304965,0.000040734918,0.0013054083],"genre_scores_gemma":[0.9961308,0.00071827706,0.0020353007,0.00004898142,0.000021024298,0.00003884117,0.00016674717,0.000027506238,0.00081243954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99973804,0.00006720518,0.000029402358,0.000049700233,0.00007223319,0.000043339023],"domain_scores_gemma":[0.999734,0.00011607117,0.00005914105,0.000014192146,0.000036319736,0.000040236067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031787253,0.00026616556,0.00024050479,0.00015873274,0.000105431674,0.0005569739,0.00025358298,0.00022831981,0.0013769619],"category_scores_gemma":[0.00060254073,0.000110240115,0.00012307435,0.00018350493,0.000253041,0.00031673964,0.00015671988,0.0004037237,0.00026802375],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021641937,0.0005124676,0.00058453175,0.0001441383,0.000027262733,0.00008022849,0.00006206801,0.0006294515,0.9889021,0.00020446193,0.00020327169,0.006485928],"study_design_scores_gemma":[0.00009564343,0.0026156926,0.0013542271,0.000008919723,0.000048829996,0.00008563355,0.000029171824,0.0018350567,0.9919694,0.000017630593,0.001932524,0.0000073066076],"about_ca_topic_score_codex":0.0013174252,"about_ca_topic_score_gemma":0.0011850547,"teacher_disagreement_score":0.0013769619,"about_ca_system_score_codex":0.00034776644,"about_ca_system_score_gemma":0.00045261648,"threshold_uncertainty_score":0.004606366},"labels":[],"label_agreement":null},{"id":"W2080518844","doi":"10.1158/1078-0432.ccr-07-0701","title":"Human Breast Cancer Cells Selected for Resistance to Trastuzumab <i>In vivo</i> Overexpress Epidermal Growth Factor Receptor and ErbB Ligands and Remain Dependent on the ErbB Receptor Network","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":506,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Trastuzumab; Gefitinib; Lapatinib; Erlotinib; Cancer research; Epidermal growth factor receptor; ErbB; In vivo; Epidermal growth factor; Growth factor receptor; Biology; Cancer; Receptor; Medicine; Breast cancer; Internal medicine","score_opus":0.12656251714838357,"score_gpt":0.4760326595411657,"score_spread":0.3494701423927821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080518844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931774,0.0016954265,0.0014810914,0.000088272434,0.000024423374,0.00009057586,0.0009949676,0.000078311175,0.0023696104],"genre_scores_gemma":[0.9860838,0.001551487,0.0032001531,0.00010016809,0.000018557777,0.000104318984,0.0045377566,0.00003288213,0.004370875],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997923,0.000028266155,0.000024719724,0.000037837824,0.000068860005,0.000048029597],"domain_scores_gemma":[0.99987984,0.000027029144,0.000027434613,0.00002875981,0.000020065752,0.000016976477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022937218,0.00032608927,0.0003554881,0.00016801376,0.00016647713,0.0003453982,0.00021724471,0.0002286686,0.0025151],"category_scores_gemma":[0.0001608868,0.00017115375,0.00024434927,0.00033817443,0.0001601712,0.00014962709,0.00015300377,0.0005305874,0.0011294801],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029969143,0.00017817075,0.0036650477,0.00006351378,0.000025261867,0.0001976912,0.000045237535,0.00009048021,0.99119616,0.00014220776,0.0003031469,0.0037934221],"study_design_scores_gemma":[0.000115697316,0.0016339411,0.03108315,0.0000110038345,0.00008805179,0.0032266853,0.000075908574,0.00088349864,0.9548295,0.000048011192,0.007994322,0.00001023055],"about_ca_topic_score_codex":0.0016451041,"about_ca_topic_score_gemma":0.0013686391,"teacher_disagreement_score":0.0025151,"about_ca_system_score_codex":0.00032065637,"about_ca_system_score_gemma":0.0002297458,"threshold_uncertainty_score":0.008413851},"labels":[],"label_agreement":null},{"id":"W2080520842","doi":"10.1158/1078-0432.ccr-14-0508","title":"Polymorphisms of Asparaginase Pathway and Asparaginase-Related Complications in Children with Acute Lymphoblastic Leukemia","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Cancer Institute","keywords":"Asparaginase; Haplotype; Medicine; Genotype; Allele; Allergy; Immunology; Internal medicine; Pancreatitis; Gastroenterology; Leukemia; Oncology; Biology; Genetics; Lymphoblastic Leukemia; Gene","score_opus":0.05446510475932061,"score_gpt":0.4039746942426897,"score_spread":0.34950958948336913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080520842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994097,0.00022899827,0.0000842726,0.000027607939,0.0000027903377,0.0000044445164,0.00012528365,0.000003164902,0.00011376383],"genre_scores_gemma":[0.99949837,0.00013292808,0.00012354898,0.0000147185765,0.0000051877687,0.0000074934915,0.0001324298,0.000001722811,0.00008355979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997011,0.00010275635,0.00002506028,0.00006800134,0.000056969173,0.000046140278],"domain_scores_gemma":[0.9994368,0.00016494967,0.00025332897,0.000037661746,0.000029851311,0.00007737371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004797758,0.0003225152,0.00028284325,0.00036168503,0.00028905255,0.00031599193,0.00020642443,0.00034100216,0.0010599636],"category_scores_gemma":[0.0013814732,0.00017573117,0.00033061195,0.00070700835,0.0002441909,0.00020326333,0.00020501998,0.000559684,0.00015456603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050130713,0.00004728324,0.9957669,0.000013769948,0.000053427797,0.00026692,0.000070328235,0.0000767848,0.001361445,0.000027477996,0.00006215733,0.0017522268],"study_design_scores_gemma":[0.000030093868,0.00029232795,0.9971355,0.0000069525777,0.00006605052,0.0013863473,0.00008024427,0.00013393772,0.0005221211,0.0000383742,0.0003050719,0.0000030522756],"about_ca_topic_score_codex":0.0027825758,"about_ca_topic_score_gemma":0.002088177,"teacher_disagreement_score":0.0027825758,"about_ca_system_score_codex":0.00032644917,"about_ca_system_score_gemma":0.0003133917,"threshold_uncertainty_score":0.005532801},"labels":[],"label_agreement":null},{"id":"W2080887232","doi":"10.1158/1078-0432.ccr-06-2972","title":"Bcl-2 and Bax Expression Predict Prostate Cancer Outcome in Men Treated with Androgen Deprivation and Radiotherapy on Radiation Therapy Oncology Group Protocol 92-02","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute","keywords":"Radiation therapy; Prostate cancer; Androgen deprivation therapy; Medicine; Androgen; Internal medicine; Oncology; Cancer; Univariate analysis; Multivariate analysis; Hormone","score_opus":0.08647663225538417,"score_gpt":0.483430483112642,"score_spread":0.3969538508572578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080887232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938998,0.00051174086,0.00025215556,0.00013615347,0.000012664305,0.0008741776,0.002360782,0.00002272746,0.0019298306],"genre_scores_gemma":[0.993238,0.0001167453,0.0003733848,0.00006994681,0.000016544445,0.0009313932,0.0042976923,0.00000702328,0.0009492716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996208,0.00018925103,0.000028852013,0.000045384877,0.00007267735,0.000043009713],"domain_scores_gemma":[0.9992078,0.00011016575,0.00027189293,0.00007266569,0.00010295581,0.00023454378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010070005,0.00042034374,0.0003827729,0.00041005306,0.00036272578,0.00036908788,0.00065255683,0.00039444718,0.0025245873],"category_scores_gemma":[0.0012507573,0.00016982446,0.00028894673,0.0004513231,0.00024468615,0.00019557173,0.00039720986,0.0003560915,0.00049834035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01932249,0.0008895944,0.9655486,0.0001371137,0.00017096508,0.00008193964,0.00007931666,0.0006581037,0.0031436938,0.00004641809,0.0014635912,0.008458088],"study_design_scores_gemma":[0.0011504906,0.0047849272,0.9911005,0.000015353937,0.00010463294,0.00021922041,0.00004048284,0.00040952858,0.00081550877,0.000052546857,0.0013003321,0.0000064624833],"about_ca_topic_score_codex":0.0013610979,"about_ca_topic_score_gemma":0.002995687,"teacher_disagreement_score":0.0025245873,"about_ca_system_score_codex":0.00058109715,"about_ca_system_score_gemma":0.0007687221,"threshold_uncertainty_score":0.008445561},"labels":[],"label_agreement":null},{"id":"W2080924817","doi":"10.1158/1078-0432.ccr-07-0484","title":"Sorafenib Inhibits the Imatinib-Resistant <i>KIT</i> <i>T670I</i> Gatekeeper Mutation in Gastrointestinal Stromal Tumor","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Sorafenib; Nilotinib; Imatinib; Dasatinib; Cancer research; Imatinib mesylate; Tyrosine kinase; Proto-Oncogene Proteins c-kit; Tyrosine-kinase inhibitor; Sunitinib; PDGFRA; Medicine; Stromal cell; Pharmacology; Biology; GiST; Internal medicine; Cancer; Stem cell factor; Stem cell; Progenitor cell; Hepatocellular carcinoma","score_opus":0.1724011015825633,"score_gpt":0.5144914392089194,"score_spread":0.3420903376263561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080924817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99787414,0.00069990294,0.0004140601,0.000039564864,0.000008980814,0.00002363193,0.00012034051,0.00003208286,0.00078737276],"genre_scores_gemma":[0.99860567,0.00037530955,0.0003875612,0.000018997946,0.0000043127925,0.000011717305,0.00023317616,0.0000066289517,0.00035671736],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999348,0.00000997749,0.000006645756,0.0000074199734,0.000019185252,0.000021891448],"domain_scores_gemma":[0.9999591,0.0000060298394,0.000012336491,0.0000036040615,0.0000058135574,0.0000130972185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087262844,0.00026932862,0.0002623959,0.00012667748,0.000114896226,0.00016267078,0.00011365485,0.00011202111,0.00086604746],"category_scores_gemma":[0.00007813398,0.00006611964,0.00018503403,0.00010228395,0.00009528817,0.00006789659,0.00008136354,0.0002663816,0.0002463303],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026437335,0.00010871516,0.0011318127,0.000045493693,0.000010843678,0.0001254438,0.000008895233,0.00018642133,0.993436,0.0000418508,0.00011200603,0.0045282333],"study_design_scores_gemma":[0.00018529726,0.0030464467,0.017046649,0.000007751713,0.000054024644,0.0020951284,0.000021670747,0.0019315067,0.9726265,0.00003231187,0.0029470124,0.000005672665],"about_ca_topic_score_codex":0.0006892078,"about_ca_topic_score_gemma":0.001667556,"teacher_disagreement_score":0.00086604746,"about_ca_system_score_codex":0.00020839988,"about_ca_system_score_gemma":0.00017674884,"threshold_uncertainty_score":0.0028972626},"labels":[],"label_agreement":null},{"id":"W2080947811","doi":"10.1158/1078-0432.ccr-13-3045","title":"A Randomized Phase II Presurgical Trial of Transdermal 4-Hydroxytamoxifen Gel versus Oral Tamoxifen in Women with Ductal Carcinoma <i>In Situ</i> of the Breast","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"National Cancer Institute","keywords":"Transdermal; Tamoxifen; Medicine; Ductal carcinoma; Internal medicine; Breast cancer; Urology; Sex hormone-binding globulin; Selective estrogen receptor modulator; Gastroenterology; Endocrinology; Hormone; Cancer; Pharmacology","score_opus":0.07090408952545521,"score_gpt":0.42780496010190416,"score_spread":0.3569008705764489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080947811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868745,0.0022402282,0.00061714713,0.0006276776,0.0006934286,0.00677037,0.00085559674,0.0001073629,0.0012136637],"genre_scores_gemma":[0.9753812,0.0018466167,0.0024257374,0.0016246377,0.0008099533,0.01174784,0.0012350603,0.00003545587,0.0048935255],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99926,0.00038413936,0.000042428423,0.00013487865,0.000056149165,0.0001224209],"domain_scores_gemma":[0.9986117,0.00036093904,0.0003588873,0.00012967721,0.00009697186,0.00044177394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016090124,0.0020889223,0.0032997096,0.00046978364,0.0004322559,0.001070049,0.0009989357,0.0019561388,0.007341245],"category_scores_gemma":[0.0019642792,0.0009222689,0.0012932719,0.00036339863,0.0015725698,0.0008409795,0.00040156793,0.0026613441,0.0012594837],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98553896,0.0061094714,0.00021106169,0.00016390774,0.00021907482,0.00001491177,0.000020086964,0.00008915241,0.003604214,0.000026084483,0.00018873657,0.003814307],"study_design_scores_gemma":[0.9097684,0.08845651,0.00067929894,0.000008742945,0.00016238415,0.000013394188,0.000013943234,0.0001336667,0.00047930056,0.000051516545,0.00022585585,0.0000069943762],"about_ca_topic_score_codex":0.00076286326,"about_ca_topic_score_gemma":0.00182266,"teacher_disagreement_score":0.007341245,"about_ca_system_score_codex":0.00069447095,"about_ca_system_score_gemma":0.0015553174,"threshold_uncertainty_score":0.024558902},"labels":[],"label_agreement":null},{"id":"W2081370824","doi":"10.1158/1078-0432.ovca13-a13","title":"Abstract A13: Molecular profiling of low grade serous ovarian tumors","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia Hospital; University of British Columbia","funders":"","keywords":"Serous fluid; Serous carcinoma; Loss of heterozygosity; Pathology; Cystadenocarcinoma; Medicine; Ovarian tumor; Oncology; Clear cell; Ovary; Ovarian cancer; Cancer research; Biology; Internal medicine; Carcinoma; Cancer; Gene; Genetics","score_opus":0.1915692505941295,"score_gpt":0.5080251463816321,"score_spread":0.3164558957875026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081370824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99887675,0.00015578346,0.000460696,0.000011184501,0.0000016305705,0.000006523147,0.00029216334,0.000014675751,0.00018051869],"genre_scores_gemma":[0.99873835,0.0000653372,0.00061357144,0.000007821968,0.0000017926387,0.0000062687077,0.00038461608,0.0000034740672,0.00017882453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988186,0.000020964293,0.000015491352,0.000029010711,0.00003352386,0.000019215495],"domain_scores_gemma":[0.99961334,0.00011299976,0.00010485091,0.00003550196,0.00007211048,0.00006126454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028399733,0.00012011964,0.00018340819,0.000991196,0.0001628078,0.0004180245,0.00013946481,0.00013567555,0.000991657],"category_scores_gemma":[0.00075126305,0.00007104907,0.00012759263,0.0005253412,0.00014888872,0.00011212168,0.00017480616,0.00014776489,0.000187346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000626094,0.000037844347,0.6838,0.00007562113,0.000054516604,0.0004617192,0.00010878647,0.00032143088,0.30392236,0.000056140925,0.00013242298,0.010402994],"study_design_scores_gemma":[0.00000722871,0.00020169697,0.953741,0.0000050734034,0.000049759514,0.0016257799,0.00012899756,0.0011185277,0.04246916,0.000053945285,0.00059407164,0.0000047134345],"about_ca_topic_score_codex":0.0008608412,"about_ca_topic_score_gemma":0.0010231424,"teacher_disagreement_score":0.000991657,"about_ca_system_score_codex":0.00012285638,"about_ca_system_score_gemma":0.00012774128,"threshold_uncertainty_score":0.003317356},"labels":[],"label_agreement":null},{"id":"W2081436300","doi":"10.1158/1078-0432.ovca13-ia20","title":"Abstract IA20: Analyzing the cellular basis for heterogeneity in serous ovarian carcinoma","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"Serous fluid; Ovarian cancer; Cancer research; Population; Flow cytometry; Malignancy; Ovarian carcinoma; Medicine; Cancer stem cell; Cancer; Targeted therapy; Oncology; Biology; Pathology; Immunology; Internal medicine","score_opus":0.13728115749161565,"score_gpt":0.4445392617858377,"score_spread":0.30725810429422207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081436300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977082,0.00033825816,0.0011125096,0.000018386296,0.0000036412769,0.000022717324,0.00021435053,0.00002076068,0.0005611675],"genre_scores_gemma":[0.9981667,0.00014672043,0.00079383125,0.000016965114,0.000003333049,0.000018939043,0.00049377844,0.000008351067,0.0003514129],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999131,0.0000118096095,0.0000067244096,0.000020795887,0.000024087905,0.000023525938],"domain_scores_gemma":[0.99985945,0.000033101664,0.000024751507,0.000016042619,0.000026595195,0.00004004511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021550618,0.00011918133,0.0001453752,0.00059530063,0.00015433629,0.00035378296,0.00014627959,0.00017128664,0.0010588866],"category_scores_gemma":[0.00020551399,0.000063554005,0.000116254756,0.00036669933,0.00016311657,0.00014022463,0.00019595101,0.00021112307,0.00019779551],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021140986,0.00003935033,0.019100435,0.000027258451,0.000012062134,0.00012226775,0.000044963363,0.00016133726,0.9773086,0.00013100325,0.000070242335,0.0027710057],"study_design_scores_gemma":[0.00003463242,0.0009719996,0.41476217,0.000014365715,0.00007022666,0.0020360758,0.0004216836,0.009304959,0.565898,0.000336948,0.006134887,0.000014104527],"about_ca_topic_score_codex":0.00079280615,"about_ca_topic_score_gemma":0.00059470354,"teacher_disagreement_score":0.0010588866,"about_ca_system_score_codex":0.0002608377,"about_ca_system_score_gemma":0.00012965778,"threshold_uncertainty_score":0.003542304},"labels":[],"label_agreement":null},{"id":"W2082671989","doi":"10.1158/1078-0432.ccr-14-1324","title":"Molecular Characterization of Choroid Plexus Tumors Reveals Novel Clinically Relevant Subgroups","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Choroid plexus; Biology; DNA methylation; Gene; Copy-number variation; Cancer research; Somatic cell; Allele; Pathology; Methylation; Molecular biology; Genetics; Gene expression; Medicine; Genome; Endocrinology; Central nervous system","score_opus":0.13738952923192047,"score_gpt":0.4785498330281012,"score_spread":0.3411603037961808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082671989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982035,0.0006921887,0.00048177084,0.00003182888,0.0000016734417,0.000022503795,0.00029364746,0.00001386449,0.0002591027],"genre_scores_gemma":[0.9984565,0.00028032056,0.0006188404,0.000014096001,0.0000045309816,0.000025988127,0.0004929033,0.0000037061184,0.00010323044],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997482,0.000032178756,0.000025953297,0.000091601454,0.0000666458,0.00003545849],"domain_scores_gemma":[0.99951696,0.00010198274,0.00021182525,0.000052788506,0.000056164514,0.000060318453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039809788,0.00029042765,0.0003245986,0.0011443469,0.00028471442,0.0004839383,0.00021308799,0.0002805192,0.0005689098],"category_scores_gemma":[0.001084087,0.00014144926,0.00019663697,0.00066049123,0.00036809628,0.00026180665,0.0003253626,0.00026567242,0.00013298613],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087247824,0.000042597258,0.79396063,0.000117184536,0.00016149241,0.00067270664,0.00016987826,0.0004947241,0.19013983,0.000113110014,0.00014704066,0.0131082535],"study_design_scores_gemma":[0.000032525182,0.00022402772,0.97776914,0.000013126406,0.00011077534,0.0028058456,0.00022858029,0.0014665478,0.016292118,0.00020522584,0.00084312144,0.000008986586],"about_ca_topic_score_codex":0.002349148,"about_ca_topic_score_gemma":0.0026078434,"teacher_disagreement_score":0.002349148,"about_ca_system_score_codex":0.00048142756,"about_ca_system_score_gemma":0.00043900305,"threshold_uncertainty_score":0.004670918},"labels":[],"label_agreement":null},{"id":"W2082979527","doi":"10.1158/1078-0432.ccr-05-0415","title":"Identification of Mammaglobin as a Novel Serum Marker for Breast Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Alvin J. Siteman Cancer Center","keywords":"Mammaglobin; Breast cancer; Medicine; Immunostaining; Cancer; Biomarker; Oncology; Internal medicine; Pathology; Immunology; Immunohistochemistry; Biology","score_opus":0.22976940447946537,"score_gpt":0.5628755103185055,"score_spread":0.3331061058390401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082979527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95232606,0.024568785,0.019187564,0.0006571882,0.00008797433,0.00011902632,0.00027033497,0.00027393433,0.0025090398],"genre_scores_gemma":[0.9815073,0.0023968327,0.014836911,0.0001837462,0.000064921376,0.000045672317,0.0002865736,0.000007579282,0.00067060726],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997577,0.00009315246,0.000018586234,0.000038902446,0.000071220726,0.000020331032],"domain_scores_gemma":[0.99952006,0.00014186262,0.00014973279,0.000023935025,0.000113942755,0.000050422725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069975614,0.00032830777,0.00025478285,0.0006888519,0.00009319453,0.00031972074,0.00019414892,0.000388672,0.00062729296],"category_scores_gemma":[0.0009389839,0.00007678808,0.00015484293,0.00040389813,0.0003307308,0.00024806376,0.00016553972,0.00039230406,0.00038721305],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012394537,0.00036952083,0.15896262,0.0004928532,0.00009046258,0.00055383815,0.00007956061,0.00035287274,0.7800899,0.00037091968,0.00057664857,0.056821287],"study_design_scores_gemma":[0.00007900156,0.0040829172,0.36258566,0.00012367657,0.00023558039,0.010767497,0.00014106174,0.009869542,0.60082895,0.0005790882,0.01067832,0.000028674478],"about_ca_topic_score_codex":0.0002451221,"about_ca_topic_score_gemma":0.00028763813,"teacher_disagreement_score":0.00069975614,"about_ca_system_score_codex":0.00024482943,"about_ca_system_score_gemma":0.0002785672,"threshold_uncertainty_score":0.0037007332},"labels":[],"label_agreement":null},{"id":"W2086983721","doi":"10.1158/1078-0432.ccr-14-0831","title":"The Evolving Role of Molecular Markers in the Diagnosis and Management of Diffuse Glioma","year":2014,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"IDH1; Glioma; IDH2; Epigenomics; Biology; Pathology; Bioinformatics; Medicine; Mutation; Cancer research; Genetics; DNA methylation; Gene","score_opus":0.1970773954162701,"score_gpt":0.5315476576836274,"score_spread":0.3344702622673573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086983721","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000087244545,0.9990036,0.00014442434,0.00036684415,0.000084510895,0.0000019827576,0.000005599913,0.00000409126,0.00030161967],"genre_scores_gemma":[0.0007698152,0.9983746,0.00031409776,0.00021432643,0.000193722,0.0000031323982,0.000013579542,0.0000013041451,0.000115479386],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995901,0.000095096424,0.000077210054,0.0000707435,0.00013767096,0.000029237632],"domain_scores_gemma":[0.998917,0.00062041514,0.00012672272,0.00002591696,0.0002589101,0.000051092517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001453094,0.0007337147,0.0017091184,0.0032551186,0.00023918303,0.0011468787,0.0009795831,0.001271313,0.0012003788],"category_scores_gemma":[0.0018436165,0.00030996237,0.0006158389,0.0022995817,0.0009007697,0.0016900388,0.0007261321,0.0027922117,0.0008272388],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045447723,0.000036644244,0.000318616,0.006898909,0.00006728618,0.00021601733,0.000045173805,0.00038611982,0.00068678684,0.002476376,0.009856164,0.97896636],"study_design_scores_gemma":[0.000034509747,0.00020373231,0.0036166387,0.009634442,0.0003481836,0.004555765,0.00018756997,0.0004388104,0.001099771,0.005846335,0.97396755,0.000066709865],"about_ca_topic_score_codex":0.0019807355,"about_ca_topic_score_gemma":0.0026755088,"teacher_disagreement_score":0.0032551186,"about_ca_system_score_codex":0.0011318469,"about_ca_system_score_gemma":0.0012225495,"threshold_uncertainty_score":0.008212149},"labels":[],"label_agreement":null},{"id":"W2087146189","doi":"10.1158/1078-0432.ccr-1131-03","title":"<b> <i>In Vitro</i> </b> and <b> <i>in Vivo</i> </b> Characterization of Doxorubicin and Vincristine Coencapsulated within Liposomes through Use of Transition Metal Ion Complexation and pH Gradient Loading","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Stemcell Technologies; BC Cancer Agency","funders":"","keywords":"In vivo; Vincristine; In vitro; Liposome; Doxorubicin; Chemistry; Characterization (materials science); Biophysics; Materials science; Nanotechnology; Biochemistry; Medicine; Biology; Chemotherapy; Internal medicine; Cyclophosphamide","score_opus":0.11274904799988941,"score_gpt":0.3893579564175797,"score_spread":0.27660890841769026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087146189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99116033,0.0018318392,0.0051358426,0.00006133219,0.0000144192245,0.000052677333,0.00027330348,0.00006108993,0.0014091311],"genre_scores_gemma":[0.993048,0.0009103091,0.003975193,0.00003347826,0.0000075261923,0.00004162477,0.00042033134,0.000031508665,0.0015321365],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981195,0.000048913025,0.000019519392,0.000043127613,0.000042772,0.000033665972],"domain_scores_gemma":[0.99974686,0.000077118544,0.000070421105,0.000019792069,0.000057161826,0.000028540695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032914014,0.00034810227,0.00017350758,0.00022365892,0.00009942986,0.00027602285,0.00013186985,0.00027436885,0.0006747176],"category_scores_gemma":[0.00023722668,0.00014622674,0.00016178195,0.00012666864,0.00022628157,0.000159781,0.000096890624,0.00032035477,0.00030907002],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007950338,0.000009608737,0.00007884557,0.000021372429,0.0000018700291,0.000009098202,0.0000064482765,0.00006153883,0.99944097,0.000009639943,0.0000066112157,0.00027452124],"study_design_scores_gemma":[0.0000044345697,0.0001494198,0.00080593216,0.0000023305065,0.000005313846,0.000021548309,0.000004812725,0.0003362412,0.9984623,0.0000037590505,0.00020222628,0.0000016440001],"about_ca_topic_score_codex":0.00170149,"about_ca_topic_score_gemma":0.0012561926,"teacher_disagreement_score":0.00170149,"about_ca_system_score_codex":0.00029341367,"about_ca_system_score_gemma":0.00018658621,"threshold_uncertainty_score":0.0033831596},"labels":[],"label_agreement":null},{"id":"W2088060877","doi":"10.1158/1078-0432.tcme10-a27","title":"Abstract A27: Chronic exposure of malignant hematological cell lines to bortezomib induces de novo hot spot mutations in the PSMB5 gene","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Bortezomib; Cell culture; Medicine; Cancer research; Proteasome inhibitor; Multiple myeloma; Internal medicine; Biology; Genetics","score_opus":0.14305838479231506,"score_gpt":0.460805364926912,"score_spread":0.3177469801345969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088060877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99176335,0.00075084146,0.0014831104,0.0001398853,0.000053241718,0.00006928399,0.003121796,0.00010054683,0.0025180457],"genre_scores_gemma":[0.9852872,0.0004551205,0.0013263602,0.00009658124,0.000014595458,0.00009832238,0.0053289644,0.000040876283,0.0073520173],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979085,0.000027770411,0.000024208804,0.00004446829,0.000062057166,0.000050626546],"domain_scores_gemma":[0.99984074,0.000039120125,0.000023600252,0.000044557193,0.000016821026,0.0000351201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012505434,0.00031023347,0.00034371525,0.00019980226,0.00020412743,0.0002900234,0.00022359453,0.00026612345,0.0066426736],"category_scores_gemma":[0.00014472763,0.00017157989,0.00032960172,0.000216004,0.0002230762,0.00016659542,0.00024145645,0.00064734276,0.0018149664],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015033278,0.000102736405,0.0003765522,0.000019082036,0.00000576019,0.00017485654,0.000017630518,0.000047996757,0.9978517,0.00007952623,0.00033484393,0.00083896413],"study_design_scores_gemma":[0.000048281832,0.0015921782,0.017755797,0.0000072341054,0.000016665908,0.0011444021,0.00007557027,0.00068795803,0.973055,0.000058079324,0.005551003,0.000007772662],"about_ca_topic_score_codex":0.001674539,"about_ca_topic_score_gemma":0.0011494106,"teacher_disagreement_score":0.0066426736,"about_ca_system_score_codex":0.00033689817,"about_ca_system_score_gemma":0.00022810222,"threshold_uncertainty_score":0.022221923},"labels":[],"label_agreement":null},{"id":"W2088325873","doi":"10.1158/1078-0432.ccr-06-2882","title":"Amplification of <i>PVT1</i> Contributes to the Pathophysiology of Ovarian and Breast Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":351,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"PVT1; Cancer research; Ovarian cancer; Biology; Oncogene; Breast cancer; Small interfering RNA; Apoptosis; Cell culture; Gene duplication; Cancer; Long non-coding RNA; Molecular biology; RNA; Gene; Transfection; Cell cycle; Genetics","score_opus":0.06536243382452886,"score_gpt":0.43905936512894844,"score_spread":0.3736969313044196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088325873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940421,0.002855051,0.0015535409,0.0002212697,0.0000146261145,0.00003453469,0.000118124444,0.00005289759,0.0011078626],"genre_scores_gemma":[0.997593,0.0011411619,0.0005520207,0.00004625617,0.000018760793,0.000024666755,0.00012240015,0.000005534911,0.0004961188],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998907,0.000021433249,0.0000072328007,0.000028156446,0.00002618724,0.000026276073],"domain_scores_gemma":[0.9997893,0.000039974002,0.00011814992,0.000010562974,0.000014252544,0.000027763244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015767137,0.0002257762,0.0001832107,0.0002273085,0.00014689656,0.0002884565,0.00020565749,0.00020995954,0.0013964695],"category_scores_gemma":[0.00028667582,0.00009389173,0.00015348612,0.00019234318,0.00025657576,0.00014768617,0.00019886963,0.00044192327,0.00020026306],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010935627,0.00014499342,0.04428984,0.00018148651,0.000036598245,0.0008403688,0.00004961991,0.00037471135,0.93714136,0.00022333316,0.00021838196,0.015405691],"study_design_scores_gemma":[0.00015761062,0.0039886977,0.32461703,0.000039983825,0.00020113731,0.015078234,0.00017622135,0.0023491238,0.6423686,0.00061476947,0.010387046,0.000021576856],"about_ca_topic_score_codex":0.0001826163,"about_ca_topic_score_gemma":0.00014639302,"teacher_disagreement_score":0.0013964695,"about_ca_system_score_codex":0.00031050242,"about_ca_system_score_gemma":0.0001758153,"threshold_uncertainty_score":0.004671693},"labels":[],"label_agreement":null},{"id":"W2088337613","doi":"10.1158/1078-0432.ccr-14-0857","title":"Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Pharmacogenetics; Toxicity; Medicine; Colorectal cancer; Oncology; Internal medicine; Clinical trial; Cancer; Genotype; Pharmacology; Biology; Genetics; Gene","score_opus":0.08266971454554922,"score_gpt":0.42585393903017715,"score_spread":0.34318422448462793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088337613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99865687,0.0005311985,0.0001997621,0.00009796959,0.000016562368,0.00006519848,0.00016819217,0.0000079477795,0.0002562737],"genre_scores_gemma":[0.9983639,0.000121660916,0.00036314072,0.00014198515,0.000037930204,0.00014621786,0.00040724047,0.0000053941444,0.00041245672],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99868923,0.00094219437,0.00006968091,0.0001486448,0.0000766781,0.00007359013],"domain_scores_gemma":[0.9989022,0.0004001448,0.00037105678,0.00012468842,0.000032421467,0.00016947454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021991283,0.0005946344,0.001025484,0.00015924896,0.00019762809,0.0004975375,0.00040315202,0.0006785758,0.001639194],"category_scores_gemma":[0.0021591142,0.00022499613,0.0011646238,0.00036585654,0.00042884058,0.0002675017,0.00026291327,0.0009797356,0.00018228212],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74902606,0.0023788756,0.19619109,0.00038955332,0.0055305185,0.00018170518,0.00012990195,0.0020081874,0.011599641,0.0002312352,0.0008281758,0.031505037],"study_design_scores_gemma":[0.21140316,0.18076202,0.57668626,0.00012035918,0.010566227,0.0007982307,0.00009551698,0.0071501127,0.0066593904,0.0010502536,0.0046361373,0.00007236756],"about_ca_topic_score_codex":0.00032977774,"about_ca_topic_score_gemma":0.00078186294,"teacher_disagreement_score":0.0021991283,"about_ca_system_score_codex":0.0003839122,"about_ca_system_score_gemma":0.000629437,"threshold_uncertainty_score":0.011630237},"labels":[],"label_agreement":null},{"id":"W2089037180","doi":"10.1158/1078-0432.tcme10-b12","title":"Abstract B12: A novel gene signature associated with response to adoptively transferred T cells in a mouse model of breast cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"CD8; Adoptive cell transfer; Cancer research; Gene signature; Immunology; Breast cancer; Gene expression profiling; Cytotoxic T cell; Immunotherapy; Mammary tumor; Biology; Medicine; Cancer; T cell; Gene expression; Immune system; Internal medicine; Gene; In vitro","score_opus":0.09901090885076576,"score_gpt":0.44354881704082544,"score_spread":0.3445379081900597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089037180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99563783,0.0005352672,0.0018461504,0.00010034656,0.000016135777,0.00003950573,0.0012483468,0.00012270376,0.00045377781],"genre_scores_gemma":[0.99107015,0.0004947445,0.0028600267,0.00008328392,0.00001664789,0.00013817304,0.002020868,0.00004876675,0.0032672673],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99971193,0.000029655286,0.000024651938,0.00008063088,0.0000834573,0.00006966677],"domain_scores_gemma":[0.9997002,0.000030762887,0.0001293434,0.000019089108,0.000030241617,0.00009035793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001749509,0.00057408895,0.00029443286,0.0013018722,0.00018482334,0.00033271874,0.00015809365,0.00046239438,0.0014363677],"category_scores_gemma":[0.00013011716,0.0002331254,0.00027277233,0.0004618171,0.00031107696,0.00013014396,0.00014749996,0.0007678783,0.00041246478],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020268057,0.000029575847,0.00037778064,0.00001342844,0.000003101277,0.000026267728,0.00000760452,0.000029160112,0.9988908,0.000011144742,0.000025042045,0.00038335458],"study_design_scores_gemma":[0.00006637024,0.001667419,0.0388995,0.000011842335,0.00004948543,0.0008921945,0.000081777835,0.0011218119,0.9557371,0.00006505959,0.0013933177,0.0000141455475],"about_ca_topic_score_codex":0.0005698658,"about_ca_topic_score_gemma":0.0005941568,"teacher_disagreement_score":0.0014363677,"about_ca_system_score_codex":0.00031542635,"about_ca_system_score_gemma":0.00017065964,"threshold_uncertainty_score":0.0048052073},"labels":[],"label_agreement":null},{"id":"W2090950165","doi":"10.1158/1078-0432.ccr-04-0076","title":"BNIP3 Expression Is Linked with Hypoxia-Regulated Protein Expression and with Poor Prognosis in Non–Small Cell Lung Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Hypoxia (environmental); Biology; Phenotype; Cancer research; Hypoxia-inducible factors; Lung cancer; Gene expression; Hypoxia-Inducible Factor 1; In vivo; Transcription factor; Gene; Pathology; Medicine; Chemistry; Biochemistry; Genetics; Oxygen","score_opus":0.04907334760446654,"score_gpt":0.3875400082209513,"score_spread":0.3384666606164848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090950165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995035,0.00020658941,0.00009420318,0.000014207018,9.500642e-7,0.0000022606746,0.000032177937,0.000002604615,0.00014348155],"genre_scores_gemma":[0.99957913,0.00008778972,0.00007235248,0.0000080682585,0.0000024276555,0.0000034814245,0.000107563144,0.0000011884157,0.00013795517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999325,0.000014613389,0.0000050749327,0.000010806666,0.000016341077,0.000020640871],"domain_scores_gemma":[0.9997235,0.0000638309,0.000097962424,0.000013394595,0.000032542423,0.00006872184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001419217,0.00012707223,0.0001423933,0.00033067752,0.00018997736,0.00018214052,0.00007733142,0.00022565934,0.0007383874],"category_scores_gemma":[0.0003320204,0.00010559367,0.00007306863,0.000296451,0.00024217048,0.00011701124,0.00012241995,0.00026053222,0.00012985365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024006264,0.00010007577,0.71673685,0.00003831848,0.000052729178,0.0010021516,0.00012289906,0.0001976857,0.2729543,0.00005540477,0.00019937701,0.0061395783],"study_design_scores_gemma":[0.000016715547,0.00023465877,0.9877786,0.0000029319872,0.000017391963,0.0019430321,0.00004966696,0.000366221,0.009292547,0.0000541934,0.00023993666,0.0000039412757],"about_ca_topic_score_codex":0.0008831645,"about_ca_topic_score_gemma":0.0013976982,"teacher_disagreement_score":0.0008831645,"about_ca_system_score_codex":0.00019901132,"about_ca_system_score_gemma":0.000080530415,"threshold_uncertainty_score":0.0024701357},"labels":[],"label_agreement":null},{"id":"W2090985692","doi":"10.1158/1078-0432.ccr-07-5103","title":"RHAMM, p21 Combined Phenotype Identifies Microsatellite Instability-High Colorectal Cancers with a Highly Adverse Prognosis","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Microsatellite instability; Immunohistochemistry; Hazard ratio; Internal medicine; Colorectal cancer; Medicine; Tissue microarray; Epidermal growth factor receptor; Pathology; Oncology; Cancer research; Receptor; Gastroenterology; Cancer; Biology; Confidence interval; Microsatellite; Gene","score_opus":0.1424664337766563,"score_gpt":0.43913084560189386,"score_spread":0.29666441182523756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090985692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996197,0.00016749611,0.00009160147,0.000009913453,0.0000014689322,0.000001957061,0.000027743083,0.0000035360454,0.000076503275],"genre_scores_gemma":[0.9997458,0.00003654158,0.00009765399,0.000004911885,0.00000626489,0.0000015318302,0.00005896525,8.466212e-7,0.000047424437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998528,0.000040101557,0.000015705315,0.000029057437,0.00003515159,0.000027186989],"domain_scores_gemma":[0.99954045,0.000067407294,0.00023472123,0.000027189384,0.000033102213,0.00009717847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002483404,0.00028496425,0.00023958176,0.0005008653,0.00017637729,0.00027678392,0.00015623227,0.00020063651,0.00072554447],"category_scores_gemma":[0.00055946026,0.00010019119,0.00018253118,0.00027966703,0.00017878096,0.0001428644,0.00022320451,0.0001611899,0.000187477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005512154,0.000026525704,0.9779799,0.000017517545,0.000063180465,0.0004427896,0.000023532028,0.00008374347,0.017061362,0.000012650754,0.000072312105,0.0036652754],"study_design_scores_gemma":[0.000012369089,0.00023441101,0.9920763,0.0000032555547,0.00006715129,0.0032754752,0.00006741592,0.0005357387,0.0034284368,0.00003203095,0.0002635584,0.0000037863258],"about_ca_topic_score_codex":0.00038131227,"about_ca_topic_score_gemma":0.00086869835,"teacher_disagreement_score":0.00072554447,"about_ca_system_score_codex":0.00015586668,"about_ca_system_score_gemma":0.00016736316,"threshold_uncertainty_score":0.0024271607},"labels":[],"label_agreement":null},{"id":"W2092191811","doi":"10.1158/1078-0432.ccr-05-1980","title":"Genomic Alterations in Human Malignant Glioma Cells Associate with the Cell Resistance to the Combination Treatment with Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand and Chemotherapy","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; University of Pennsylvania","keywords":"Glioma; Biology; Cancer research; Comparative genomic hybridization; Fluorescence in situ hybridization; Chemotherapy; Apoptosis; Karyotype; Gene; Genetics; Chromosome","score_opus":0.034452235452986466,"score_gpt":0.3539885969643744,"score_spread":0.3195363615113879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092191811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979911,0.000699986,0.0005547972,0.00002114818,0.0000028790566,0.000017176435,0.00014855436,0.000036951275,0.0005275006],"genre_scores_gemma":[0.99856013,0.00033330597,0.00047470967,0.000012458505,0.000002092611,0.00001925271,0.0003093039,0.0000036787394,0.0002850955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998913,0.0000133994745,0.000009208841,0.000021177131,0.000046244175,0.000018746303],"domain_scores_gemma":[0.99990976,0.00001146959,0.000035201163,0.0000146841485,0.000015004888,0.000013882216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000065659326,0.00026087774,0.0001880994,0.0006078537,0.00013348224,0.00015174656,0.0001291089,0.00018244852,0.0011629355],"category_scores_gemma":[0.00014981454,0.00012506197,0.00014580862,0.00027618214,0.00018366931,0.00007523235,0.00013406454,0.00017300833,0.00027540643],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003175871,0.00004207785,0.0146265235,0.000048733298,0.000030825177,0.0007491326,0.000054338554,0.00009027981,0.9795177,0.000046882444,0.00006765877,0.0044081993],"study_design_scores_gemma":[0.00006670779,0.0013995874,0.40831208,0.000012855424,0.00017495829,0.011779262,0.00017929699,0.00081240456,0.5738383,0.00014962406,0.0032616027,0.00001333638],"about_ca_topic_score_codex":0.0007755281,"about_ca_topic_score_gemma":0.0011314086,"teacher_disagreement_score":0.0011629355,"about_ca_system_score_codex":0.0002020042,"about_ca_system_score_gemma":0.00013726299,"threshold_uncertainty_score":0.0038904548},"labels":[],"label_agreement":null},{"id":"W2092860006","doi":"10.1158/1078-0432.ccr-14-1549","title":"Correlation between Prostate-Specific Antigen Kinetics and Overall Survival in Abiraterone Acetate–Treated Castration-Resistant Prostate Cancer Patients","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Abiraterone acetate; Prostate cancer; Medicine; Prostate; Prostate-specific antigen; Urology; Castration; Oncology; Antigen; Internal medicine; Abiraterone; Cancer; Immunology; Hormone; Androgen receptor; Androgen deprivation therapy","score_opus":0.2623718972814189,"score_gpt":0.4778958899465421,"score_spread":0.21552399266512318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092860006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997681,0.00023582594,0.0018017284,0.00004421342,0.0000023885348,0.000017116457,0.0000997658,0.000011717401,0.00010622262],"genre_scores_gemma":[0.998988,0.00005559796,0.0007644742,0.000013124554,0.0000023769612,0.000011150833,0.00011071641,0.0000014747111,0.00005312014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999474,0.00033908247,0.000025380887,0.000069428155,0.00006506324,0.00002712679],"domain_scores_gemma":[0.99880695,0.0005879625,0.000399119,0.00008225909,0.000053641124,0.00007000393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021480639,0.00037071423,0.00041782428,0.00031028435,0.000118867625,0.00039167792,0.0002753371,0.00022200408,0.00046461896],"category_scores_gemma":[0.0026648485,0.00014818962,0.0005980691,0.00024744016,0.00018284263,0.00023091852,0.00025235655,0.0004573168,0.00007384505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064765923,0.0009332426,0.8738695,0.00012701488,0.0010159549,0.00013385311,0.0002016726,0.0812552,0.007500797,0.0004207112,0.00023650363,0.027828922],"study_design_scores_gemma":[0.0004924689,0.006121894,0.57604486,0.000030752868,0.00059720216,0.0003876715,0.000138998,0.40927055,0.004507607,0.0010899934,0.0012673807,0.00005066241],"about_ca_topic_score_codex":0.0032555058,"about_ca_topic_score_gemma":0.0031977135,"teacher_disagreement_score":0.0032555058,"about_ca_system_score_codex":0.0007164843,"about_ca_system_score_gemma":0.0008146313,"threshold_uncertainty_score":0.011360168},"labels":[],"label_agreement":null},{"id":"W2092865563","doi":"10.1158/1078-0432.ccr-11-1759","title":"Validation of Genetic Sequence Variants as Prognostic Factors in Early-Stage Head and Neck Squamous Cell Cancer Survival","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"ERCC1; Oncology; XRCC1; Internal medicine; Biology; Cancer; Head and neck cancer; Proportional hazards model; ERCC2; Medicine; XRCC3; DNA repair; Cancer research; Genotype; Single-nucleotide polymorphism; Genetics; Nucleotide excision repair; Gene","score_opus":0.4444109265001216,"score_gpt":0.5233155150313068,"score_spread":0.0789045885311852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092865563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937598,0.0026908233,0.0008570155,0.00008531554,0.000021840371,0.000023035976,0.0022784043,0.000020465695,0.0002633471],"genre_scores_gemma":[0.99746716,0.00031193637,0.0004832766,0.00003951111,0.000025538766,0.000019613773,0.0015532027,0.000008085792,0.00009156711],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838805,0.0004959357,0.00023932749,0.0005313704,0.00026853426,0.00007683708],"domain_scores_gemma":[0.992904,0.0038113254,0.001905134,0.0006539493,0.0004587565,0.0002668016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003276363,0.00045787034,0.00059230224,0.0013511627,0.0003434396,0.00065973564,0.000863812,0.0005665929,0.0024597126],"category_scores_gemma":[0.0069619194,0.00014911946,0.0010271315,0.0014044417,0.00051795406,0.00025416512,0.00037346614,0.00037223668,0.00036888703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024829428,0.00007257349,0.97645855,0.00026891677,0.0016675738,0.00049906655,0.0001037915,0.0007180588,0.00643068,0.0000671833,0.00025941824,0.010971223],"study_design_scores_gemma":[0.00030410563,0.00075825036,0.98829365,0.00009776415,0.0018780467,0.001418518,0.00011487299,0.0015903997,0.003838707,0.00028042065,0.0014036888,0.000021593385],"about_ca_topic_score_codex":0.0014603852,"about_ca_topic_score_gemma":0.0018213799,"teacher_disagreement_score":0.003276363,"about_ca_system_score_codex":0.00028115965,"about_ca_system_score_gemma":0.0006979859,"threshold_uncertainty_score":0.017327249},"labels":[],"label_agreement":null},{"id":"W2093783077","doi":"10.1158/1078-0432.ccr-06-2309","title":"Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1075,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"Medicine; Bevacizumab; Irinotecan; Glioma; Surgery; Internal medicine; Chemotherapy; Gastroenterology; Cancer; Colorectal cancer","score_opus":0.2874148997796409,"score_gpt":0.5805459813262088,"score_spread":0.2931310815465679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093783077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99317145,0.002582929,0.0004863111,0.00033898448,0.000115508235,0.0020199583,0.00030865124,0.00007415645,0.0009020666],"genre_scores_gemma":[0.9888305,0.0016139287,0.001996127,0.00068611396,0.0002494371,0.003303884,0.0015719847,0.000021395317,0.0017265435],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99931645,0.00037764295,0.00004488842,0.000085381864,0.00007318925,0.00010247866],"domain_scores_gemma":[0.9991166,0.00010941056,0.00024158254,0.00006226326,0.00005033661,0.00041975288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002007415,0.0017749995,0.0024085485,0.00042773315,0.00028394075,0.0007276651,0.00095996086,0.0010378913,0.002217171],"category_scores_gemma":[0.0010496986,0.0004899937,0.0010091143,0.00039164006,0.0009320225,0.00046625079,0.00038076667,0.0028160587,0.00056854123],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7987017,0.04416473,0.008723975,0.00094243826,0.0020169548,0.0006359356,0.00029337828,0.0022968824,0.043227986,0.00028701354,0.0033218872,0.09538712],"study_design_scores_gemma":[0.5835414,0.39944708,0.008043157,0.000044151297,0.00045778725,0.000644887,0.000040681643,0.0012527956,0.004115153,0.00012289973,0.002269195,0.000020843981],"about_ca_topic_score_codex":0.0010994022,"about_ca_topic_score_gemma":0.0021017632,"teacher_disagreement_score":0.0024085485,"about_ca_system_score_codex":0.0011700117,"about_ca_system_score_gemma":0.0019616035,"threshold_uncertainty_score":0.0106163025},"labels":[],"label_agreement":null},{"id":"W2093916414","doi":"10.1158/1078-0432.ccr-05-1664","title":"The Distribution of the Anticancer Drug Doxorubicin in Relation to Blood Vessels in Solid Tumors","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":496,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Doxorubicin; Distribution (mathematics); Hypoxia (environmental); Pathology; Cancer research; Medicine; Biology; Chemistry; Chemotherapy; Internal medicine; Oxygen","score_opus":0.09744040762682671,"score_gpt":0.4903308333198168,"score_spread":0.3928904256929901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093916414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864139,0.0037191734,0.008769849,0.000054107637,0.0000056177546,0.000012974618,0.00008459787,0.000056551755,0.00088305894],"genre_scores_gemma":[0.9953244,0.001006893,0.002890212,0.000014349401,0.0000051724046,0.000010302715,0.00006908454,0.000009017952,0.0006704955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999405,0.000011707372,0.0000023484138,0.000020437208,0.000014513008,0.000010447229],"domain_scores_gemma":[0.999818,0.000061104234,0.00007224792,0.000008009705,0.000021260244,0.000019414114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114092785,0.00010227644,0.000098702185,0.00017977088,0.00010930651,0.00021920365,0.00010275037,0.00017265501,0.00066006207],"category_scores_gemma":[0.00016972296,0.0000954647,0.000049153416,0.00011999406,0.00027188438,0.00031869032,0.00009272003,0.00024206661,0.00021841691],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028648507,0.000017263343,0.005025228,0.00006630249,0.0000058735113,0.00005762949,0.000031088748,0.00030585768,0.9880834,0.00017600348,0.00003605681,0.005908778],"study_design_scores_gemma":[0.000018602674,0.0006839839,0.05431442,0.000007920128,0.00003005638,0.00074325624,0.00005887308,0.00288236,0.93897337,0.00015001859,0.002129597,0.0000075243997],"about_ca_topic_score_codex":0.00061808655,"about_ca_topic_score_gemma":0.0004841706,"teacher_disagreement_score":0.00066006207,"about_ca_system_score_codex":0.0003114684,"about_ca_system_score_gemma":0.00013498582,"threshold_uncertainty_score":0.0022598505},"labels":[],"label_agreement":null},{"id":"W2094557342","doi":"10.1158/1078-0432.ccr-14-0959","title":"Molecular Pathways: Leveraging the BCL-2 Interactome to Kill Cancer Cells—Mitochondrial Outer Membrane Permeabilization and Beyond","year":2015,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Autophagy; Bcl-2 family; Endoplasmic reticulum; Apoptosis; Interactome; Cancer; Mitochondrion; Programmed cell death; Biology; Cancer research; Unfolded protein response; Cancer cell; Cell biology; Genetics; Gene","score_opus":0.22788029592145786,"score_gpt":0.4959826187632003,"score_spread":0.26810232284174246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094557342","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024375721,0.9967276,0.0003857452,0.0005054763,0.0003513734,0.000009119349,0.000023631626,0.000018164828,0.0017350771],"genre_scores_gemma":[0.0011251721,0.9968721,0.0003705254,0.00032110963,0.00014430613,0.0000110609735,0.000040393323,0.0000022008358,0.0011131117],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989045,0.000017628134,0.00001406667,0.00001734504,0.00004528966,0.000015206825],"domain_scores_gemma":[0.9998869,0.00003643878,0.000017047352,0.0000056238177,0.000038676622,0.000015427633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003238765,0.00077860407,0.00090836815,0.0015744817,0.0002779981,0.0008050654,0.0008304497,0.0007960245,0.0024012523],"category_scores_gemma":[0.00027604416,0.00021112307,0.00039462943,0.0011763216,0.0004727064,0.0013918377,0.00057064,0.0022719912,0.0020378558],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082638835,0.00011222248,0.00014799106,0.011945309,0.000090065434,0.0003057341,0.000077896984,0.0005341412,0.01058257,0.009737681,0.0362537,0.9301301],"study_design_scores_gemma":[0.000015154244,0.00007401294,0.000366165,0.0008945072,0.000038880346,0.00090514123,0.0000279117,0.00008713981,0.001750759,0.0022470457,0.9935787,0.000014549169],"about_ca_topic_score_codex":0.00055816356,"about_ca_topic_score_gemma":0.0013043222,"teacher_disagreement_score":0.0024012523,"about_ca_system_score_codex":0.00071873836,"about_ca_system_score_gemma":0.0006029328,"threshold_uncertainty_score":0.008033037},"labels":[],"label_agreement":null},{"id":"W2095911832","doi":"10.1158/1078-0432.ccr-09-1611","title":"Glycoprotein Nonmetastatic B Is an Independent Prognostic Indicator of Recurrence and a Novel Therapeutic Target in Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":194,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Institute for Research in Immunology and Cancer; Institut National de la Recherche Scientifique","funders":"Canadian Institutes of Health Research; Celldex Therapeutics","keywords":"Breast cancer; Medicine; Cancer; Triple-negative breast cancer; Oncology; CA15-3; Tissue microarray; Internal medicine; Metastasis; Antibody-drug conjugate; Cancer research; Targeted therapy; Population; Clinical significance; Antibody; Immunology; Monoclonal antibody","score_opus":0.10772947021456651,"score_gpt":0.47237341969999735,"score_spread":0.36464394948543083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095911832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858948,0.012156041,0.0007627716,0.00031438578,0.000012024017,0.000021584074,0.00020327601,0.000028143395,0.00060699135],"genre_scores_gemma":[0.99580234,0.0022479314,0.00093988527,0.000060005634,0.00002474333,0.000016876626,0.0004610083,0.000005220004,0.00044211512],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998971,0.00003163145,0.000007890604,0.000017053542,0.000033966837,0.000012340786],"domain_scores_gemma":[0.9997584,0.00004913299,0.00011960793,0.000014224933,0.000023495371,0.000035134864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033364724,0.00019358381,0.0002706858,0.00032218147,0.0000972405,0.00026397168,0.00015074956,0.00023992876,0.0007928904],"category_scores_gemma":[0.00044138564,0.00007873908,0.00013489215,0.00048713546,0.00018019407,0.00016201167,0.00014110828,0.00034102608,0.00018328756],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049142893,0.00035422773,0.34434208,0.0006880683,0.00018469138,0.0005045435,0.00009069219,0.0006153386,0.5269391,0.00032187396,0.0011063607,0.119938776],"study_design_scores_gemma":[0.00014904008,0.0030654287,0.90537596,0.0000593035,0.00025321447,0.0045305714,0.000114412236,0.0029042677,0.07648186,0.00033881707,0.0067084255,0.000018627265],"about_ca_topic_score_codex":0.00071520277,"about_ca_topic_score_gemma":0.0007522363,"teacher_disagreement_score":0.0007928904,"about_ca_system_score_codex":0.00027633805,"about_ca_system_score_gemma":0.00022279267,"threshold_uncertainty_score":0.0026524663},"labels":[],"label_agreement":null},{"id":"W2096139566","doi":"10.1158/1078-0432.ccr-08-2383","title":"DNMT3B Expression Might Contribute to CpG Island Methylator Phenotype in Colorectal Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Japan Society for the Promotion of Science; National Cancer Institute; National Institutes of Health; Gary Bennett Family Fund; Entertainment Industry Foundation","keywords":"DNA methylation; MLH1; Microsatellite instability; Biology; CpG site; Cancer research; Methylation; DNMT3B; Colorectal cancer; CDKN2A; Methyltransferase; Genetics; Molecular biology; Oncology; Cancer; Medicine; DNA mismatch repair; Microsatellite; Gene expression; Gene; Allele","score_opus":0.08936718973930444,"score_gpt":0.4964698144373147,"score_spread":0.4071026246980103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096139566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99855024,0.00087250996,0.0002731685,0.00004505894,0.0000014853186,0.0000045841966,0.00010647274,0.000010397937,0.0001361902],"genre_scores_gemma":[0.99943763,0.00018675707,0.00019173017,0.000008461767,0.0000032147427,0.0000038003325,0.000086839085,0.0000021561016,0.000079327256],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984396,0.000043731205,0.000015695006,0.00004507405,0.000027406848,0.000024039264],"domain_scores_gemma":[0.9992398,0.00019147006,0.0003883351,0.000046995963,0.000042995536,0.000090382666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037133077,0.0002972704,0.0002052369,0.0004921749,0.0001665238,0.00020477422,0.00014914421,0.00031531844,0.0014475818],"category_scores_gemma":[0.001130878,0.00017789518,0.00019341629,0.0003788238,0.0002741163,0.00015639608,0.00022588536,0.00032020392,0.00018231706],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010012239,0.000030384057,0.9563036,0.00007772638,0.00009179943,0.00019527499,0.00004748931,0.0001377668,0.03660683,0.000046821504,0.00005558897,0.0054053487],"study_design_scores_gemma":[0.000017532817,0.00015219876,0.9911199,0.000008782387,0.000090889735,0.0010897348,0.000028046743,0.0005915146,0.0065859496,0.000059029142,0.0002530756,0.0000033791955],"about_ca_topic_score_codex":0.0014077111,"about_ca_topic_score_gemma":0.0013832512,"teacher_disagreement_score":0.0014475818,"about_ca_system_score_codex":0.00027452613,"about_ca_system_score_gemma":0.00018231792,"threshold_uncertainty_score":0.004842639},"labels":[],"label_agreement":null},{"id":"W2096382704","doi":"10.1158/1078-0432.ccr-05-2106","title":"Human Kallikrein 8 Protein Is a Favorable Prognostic Marker in Ovarian Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Ovarian cancer; Medicine; Internal medicine; Debulking; Kallikrein; Cancer; Oncology; Biomarker; Ovarian carcinoma; Ovarian tumor; Gastroenterology; Population; Ovary; Pathology; Biology; Enzyme","score_opus":0.17788709505015693,"score_gpt":0.5011132889933266,"score_spread":0.3232261939431697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096382704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99838567,0.000861729,0.00024317576,0.00005292453,0.000009249327,0.000005457811,0.00009593837,0.000009046758,0.00033677233],"genre_scores_gemma":[0.9994099,0.00016858728,0.00015975487,0.00000797634,0.000015246162,0.0000030481249,0.00012251658,7.835238e-7,0.00011223085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998623,0.000038874176,0.000011981428,0.000021949021,0.000037516216,0.000027240452],"domain_scores_gemma":[0.99951994,0.00013677655,0.00017743772,0.000021501959,0.00004638642,0.00009806146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037977844,0.00014179523,0.00022758216,0.00040313607,0.00020918404,0.00023438531,0.000101990794,0.00020627964,0.0007936928],"category_scores_gemma":[0.00125579,0.0000882514,0.00009587221,0.00040153388,0.00019640462,0.00019851251,0.00028755696,0.00023325079,0.00018279818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005656428,0.000021064907,0.98857623,0.000015905418,0.000019305153,0.00012344797,0.000030566185,0.000098117474,0.0040795063,0.000015992297,0.00011446136,0.0063399025],"study_design_scores_gemma":[0.000009682951,0.00019593266,0.9971425,0.00000335753,0.000024090374,0.000670738,0.00004759003,0.00044134134,0.00093906705,0.000058033027,0.00046480054,0.0000029029497],"about_ca_topic_score_codex":0.0006508916,"about_ca_topic_score_gemma":0.0007923786,"teacher_disagreement_score":0.0007936928,"about_ca_system_score_codex":0.00014700992,"about_ca_system_score_gemma":0.00021029897,"threshold_uncertainty_score":0.0026551485},"labels":[],"label_agreement":null},{"id":"W2096465543","doi":"10.1158/1078-0432.ccr-14-1213","title":"Intratumoral Heterogeneity: From Diversity Comes Resistance","year":2015,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":156,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"Epigenetics; Cancer; Biology; Cancer research; Disease; Cancer cell; Chemotherapy; Immunology; Medicine; Genetics; Pathology; Gene","score_opus":0.44339554056848224,"score_gpt":0.5623207732485241,"score_spread":0.1189252326800419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096465543","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001326158,0.99753356,0.00020707549,0.0008639912,0.00023211888,0.000003978191,0.000015054642,0.000009023938,0.0010026693],"genre_scores_gemma":[0.0013571444,0.9969722,0.0001396913,0.0005443859,0.00026464977,0.000006741319,0.000026175878,0.0000024734877,0.00068651076],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972874,0.000055793436,0.000031482374,0.000053236337,0.00009728878,0.00003344949],"domain_scores_gemma":[0.9995597,0.00023650515,0.000051263953,0.00001793753,0.000090807094,0.00004375235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007855371,0.00068351766,0.0015805117,0.0020025403,0.00026108974,0.0019017535,0.0011290901,0.0015648588,0.002551097],"category_scores_gemma":[0.0008937241,0.00032245464,0.0004733101,0.0013229172,0.0012122581,0.0024149893,0.0010396596,0.0023129939,0.0016354292],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006266327,0.00003527637,0.00033731517,0.0109076,0.000091074406,0.0004835604,0.000104142244,0.00035910765,0.0020912464,0.011992435,0.041245222,0.9322904],"study_design_scores_gemma":[0.000008093162,0.00004353367,0.00053634495,0.0021838364,0.000057466692,0.0023965132,0.000085351196,0.00006653664,0.0005450676,0.005384452,0.9886741,0.000018714743],"about_ca_topic_score_codex":0.0006800341,"about_ca_topic_score_gemma":0.0012518555,"teacher_disagreement_score":0.002551097,"about_ca_system_score_codex":0.0010210517,"about_ca_system_score_gemma":0.0009212598,"threshold_uncertainty_score":0.008534312},"labels":[],"label_agreement":null},{"id":"W2096574915","doi":"10.1158/1078-0432.ccr-05-2038","title":"A Phase 1 Clinical Study of Intravenous Administration of PV701, an Oncolytic Virus, Using Two-Step Desensitization","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Ottawa Regional Cancer Foundation; University of Ottawa","funders":"","keywords":"Tolerability; Medicine; Desensitization (medicine); Adverse effect; Oncolytic virus; Regimen; Internal medicine; Dosing; Cohort; Cancer; Gastroenterology; Surgery","score_opus":0.2512174761703061,"score_gpt":0.5851435929750995,"score_spread":0.33392611680479345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096574915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948913,0.0007332674,0.001144576,0.00012064145,0.000044101776,0.0019990117,0.00028191495,0.00007541367,0.0007096581],"genre_scores_gemma":[0.9870566,0.001073196,0.0040147845,0.00044224353,0.00008355082,0.0036342335,0.0014358854,0.000031819556,0.002227835],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995584,0.00016471678,0.00002002039,0.000111557805,0.000050217677,0.000095173615],"domain_scores_gemma":[0.9995121,0.00009813899,0.00014017746,0.00006180807,0.00003085775,0.00015695328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011416232,0.001561805,0.0011804557,0.00030016902,0.00029123618,0.00059049565,0.0008617501,0.0012591687,0.0020813101],"category_scores_gemma":[0.0006398918,0.0004447249,0.0006034571,0.00024537346,0.0010306682,0.00058656547,0.00029641937,0.0025949022,0.0005435955],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17668317,0.16239166,0.0077122096,0.0011842445,0.0005251624,0.0004231368,0.00053054595,0.00524034,0.4876787,0.00050205627,0.0026297427,0.15449911],"study_design_scores_gemma":[0.06462202,0.8957733,0.008035679,0.00002570053,0.0001279908,0.00037410762,0.000030155072,0.0008634812,0.028000798,0.000115479845,0.0020072174,0.000024176315],"about_ca_topic_score_codex":0.0004099651,"about_ca_topic_score_gemma":0.0007334016,"teacher_disagreement_score":0.0020813101,"about_ca_system_score_codex":0.0005912267,"about_ca_system_score_gemma":0.0011723628,"threshold_uncertainty_score":0.006962657},"labels":[],"label_agreement":null},{"id":"W2096651314","doi":"10.1158/1078-0432.ccr-12-3166","title":"A Multicenter, First-in-Pediatrics, Phase 1, Pharmacokinetic and Pharmacodynamic Study of Ridaforolimus in Patients with Refractory Solid Tumors","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"National Cancer Institute; Merck Sharp and Dohme","keywords":"Medicine; Pharmacokinetics; Pharmacodynamics; Adverse effect; Tolerability; Pharmacology; Toxicity; Refractory (planetary science); Internal medicine; Oncology","score_opus":0.05185369558170813,"score_gpt":0.4665576708053146,"score_spread":0.41470397522360647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096651314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951703,0.0015669824,0.0006879331,0.00023021038,0.000034317065,0.0008681154,0.0006993244,0.00007314985,0.0006696297],"genre_scores_gemma":[0.99188495,0.0012928771,0.0026046978,0.00065068534,0.00011870513,0.000787639,0.0018475633,0.000039817744,0.0007730123],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993339,0.0003849049,0.000033350778,0.000099109355,0.00007118049,0.00007750184],"domain_scores_gemma":[0.9992124,0.00013191864,0.00018696176,0.00005584509,0.000060579623,0.0003521637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017465042,0.0010638366,0.0017997562,0.0002994019,0.0004351201,0.0007344343,0.00053905946,0.00061351014,0.0013205243],"category_scores_gemma":[0.0010959394,0.00047460516,0.00074339,0.00039555144,0.0006571136,0.00055786973,0.00021660085,0.0017277662,0.00046829635],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40393302,0.08350499,0.111496456,0.0014420856,0.0028607838,0.0017865036,0.0012688176,0.0050077937,0.16537334,0.00059829105,0.011620315,0.21110767],"study_design_scores_gemma":[0.22011255,0.6380153,0.10649302,0.00006155624,0.0011838041,0.0036415188,0.00019906787,0.0029820837,0.014476762,0.00017841163,0.012597124,0.000058864553],"about_ca_topic_score_codex":0.0008026375,"about_ca_topic_score_gemma":0.0016056233,"teacher_disagreement_score":0.0017997562,"about_ca_system_score_codex":0.0008492444,"about_ca_system_score_gemma":0.0019146859,"threshold_uncertainty_score":0.009236515},"labels":[],"label_agreement":null},{"id":"W2096674277","doi":"10.1158/1078-0432.ccr-07-1632","title":"Stress, Immunity, and Cervical Cancer: Biobehavioral Outcomes of a Randomized Clinical Trail","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Medicine; Psychosocial; Psychological intervention; Population; Randomized controlled trial; Cervical cancer; Cellular immunity; Quality of life (healthcare); Survivorship curve; Internal medicine; Cancer; Oncology; Psychoneuroimmunology; Immune system; Clinical trial; ELISPOT; Immunology; T cell; Psychiatry","score_opus":0.33210520181570763,"score_gpt":0.55984974275025,"score_spread":0.22774454093454238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096674277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96031207,0.002078752,0.00077678997,0.0005650451,0.00046382856,0.03254503,0.0013995394,0.00011802275,0.0017408574],"genre_scores_gemma":[0.9267941,0.0019810474,0.0035415045,0.001104299,0.000923182,0.061383624,0.001250641,0.000026317322,0.0029952747],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99440247,0.0038509795,0.0003566577,0.00055657927,0.0003436007,0.0004896202],"domain_scores_gemma":[0.9925176,0.0023432649,0.0017626262,0.0009871646,0.00069240166,0.0016969432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007968344,0.0021135118,0.0040428364,0.0011157038,0.0012769969,0.001562638,0.0015227034,0.0037755715,0.0076985057],"category_scores_gemma":[0.008201272,0.0009452776,0.0023595248,0.0014130521,0.0035061466,0.0013280179,0.0010596784,0.002953673,0.0010870731],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9723541,0.020835236,0.0010852617,0.00021659362,0.00034140403,0.000017966235,0.000046188106,0.00009450487,0.00047084803,0.00003201789,0.00020853514,0.0042974115],"study_design_scores_gemma":[0.8604934,0.1358633,0.0025941045,0.000033191867,0.00030795,0.000009949758,0.000025231471,0.00014293785,0.00021012766,0.0000732693,0.00023681323,0.000009819024],"about_ca_topic_score_codex":0.0021584434,"about_ca_topic_score_gemma":0.002699512,"teacher_disagreement_score":0.007968344,"about_ca_system_score_codex":0.0015268887,"about_ca_system_score_gemma":0.004965356,"threshold_uncertainty_score":0.0421412},"labels":[],"label_agreement":null},{"id":"W2096688512","doi":"10.1158/1078-0432.ccr-06-1317","title":"Fluorescence Visualization Detection of Field Alterations in Tumor Margins of Oral Cancer Patients","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Oral Health Pathology and Treatment","field":"Dentistry","cited_by":311,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Simon Fraser University; Vancouver General Hospital; University of British Columbia","funders":"National Institute of Dental and Craniofacial Research","keywords":"Pathology; Dysplasia; Biopsy; Subclinical infection; Loss of heterozygosity; Cancer; Histology; Carcinoma; Medicine; Epithelial dysplasia; Field cancerization; Biology; Basal cell; Internal medicine; Genetics; Allele","score_opus":0.16247608680602926,"score_gpt":0.5561283828978899,"score_spread":0.39365229609186064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096688512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998806,0.00023584634,0.00066237064,0.000009393364,0.0000012744315,0.000004997378,0.000022179656,0.000017278328,0.00024060375],"genre_scores_gemma":[0.9989318,0.000053331554,0.0007821522,0.000006922364,0.0000014992779,0.0000058473433,0.00003083525,0.0000031990114,0.00018438586],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998597,0.00002348581,0.000007150087,0.000043533077,0.0000444694,0.000021707116],"domain_scores_gemma":[0.99971265,0.00007872678,0.00011408204,0.000018841489,0.000041361815,0.000034404107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033895439,0.0001835408,0.00018130742,0.00041648437,0.00017764482,0.0001960568,0.00017340272,0.00026703282,0.0018420008],"category_scores_gemma":[0.00059136894,0.00014288374,0.00009760253,0.00012577546,0.00026087425,0.00017726496,0.00024426566,0.0001778448,0.00024814467],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016993748,0.00008721338,0.28997052,0.000114615345,0.000034746183,0.00081130525,0.00043918582,0.00023906954,0.6831867,0.00006339514,0.0001759009,0.023177924],"study_design_scores_gemma":[0.000038067068,0.0014285502,0.81254387,0.000020117852,0.00007613077,0.005347386,0.00034602368,0.0014499718,0.17775427,0.00007725086,0.000901977,0.000016396241],"about_ca_topic_score_codex":0.0007073919,"about_ca_topic_score_gemma":0.00074766984,"teacher_disagreement_score":0.0018420008,"about_ca_system_score_codex":0.0002995795,"about_ca_system_score_gemma":0.00012568866,"threshold_uncertainty_score":0.006162107},"labels":[],"label_agreement":null},{"id":"W2096806100","doi":"10.1158/1078-0432.ccr-08-0706","title":"High-Throughput Screening Identifies Cardiac Glycosides as Potent Inhibitors of Human Tissue Kallikrein Expression: Implications for Cancer Therapies","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Proteases; Cancer; Biology; Kallikrein; Cancer research; Oncogene; Angiogenesis; Computational biology; Cell cycle; Genetics; Biochemistry; Enzyme","score_opus":0.28760387254845543,"score_gpt":0.5326923560664861,"score_spread":0.2450884835180307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096806100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977475,0.011415688,0.006171783,0.00033126742,0.000043807024,0.00048755333,0.001327238,0.00019127845,0.0025564476],"genre_scores_gemma":[0.9772767,0.009598661,0.0077636717,0.00025155966,0.000034641133,0.00021900238,0.002147203,0.000026776583,0.002681708],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984705,0.00003081265,0.000009825387,0.000023844623,0.00006071559,0.000027874608],"domain_scores_gemma":[0.9998909,0.000025038997,0.000026649019,0.000008800762,0.000024641166,0.000023908287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028860284,0.00068599655,0.00064067316,0.00037649536,0.0001678746,0.00041867714,0.00035973272,0.0003673657,0.0013498043],"category_scores_gemma":[0.00020391673,0.00013928434,0.00038343173,0.00041024742,0.00017268349,0.00021974166,0.00022904176,0.0005192752,0.00041547455],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005461403,0.0004741247,0.001087051,0.00022335829,0.000050383627,0.0001668665,0.000026455347,0.0016308526,0.977262,0.00010728864,0.00036275934,0.01806276],"study_design_scores_gemma":[0.00035032738,0.008876356,0.00933202,0.0000424732,0.0002538176,0.0007323731,0.000052392857,0.004293026,0.9696694,0.00014001306,0.0062263766,0.00003133277],"about_ca_topic_score_codex":0.00046343045,"about_ca_topic_score_gemma":0.0013611335,"teacher_disagreement_score":0.0013498043,"about_ca_system_score_codex":0.00044738984,"about_ca_system_score_gemma":0.00030812062,"threshold_uncertainty_score":0.0045155287},"labels":[],"label_agreement":null},{"id":"W2096822640","doi":"10.1158/1078-0432.ccr-07-4946","title":"Translocations Involving the Immunoglobulin Heavy Chain Gene Locus Predict Better Survival in Gastric Diffuse Large B-Cell Lymphoma","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AGE-WELL; Wellcome Trust","keywords":"BCL6; Chromosomal translocation; Fluorescence in situ hybridization; Lymphoma; Biology; MALT lymphoma; Germinal center; Immunoglobulin heavy chain; Immunophenotyping; Pathology; Mucosa-associated lymphoid tissue; Diffuse large B-cell lymphoma; Gene rearrangement; BCL10; Cancer research; B cell; Immunology; Antibody; Medicine; Genetics; Antigen; Gene; Chromosome","score_opus":0.14671510116045278,"score_gpt":0.42349920412208497,"score_spread":0.2767841029616322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096822640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996841,0.00016031403,0.00004169123,0.000010893048,0.0000019179408,0.0000017891792,0.00003421074,0.0000027173314,0.000062397026],"genre_scores_gemma":[0.9997751,0.000053875618,0.000035068068,0.000005185495,0.0000044726667,0.0000018946192,0.00008716783,7.828172e-7,0.0000363206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998585,0.000032251926,0.000016130232,0.00004124038,0.000026779866,0.000025037467],"domain_scores_gemma":[0.99939394,0.0001795421,0.00018365264,0.000046413006,0.000049839637,0.00014663835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036689703,0.00025840793,0.00023572866,0.000445718,0.00020463018,0.00033421296,0.00018063342,0.0003521545,0.0017172603],"category_scores_gemma":[0.0012637627,0.00016772038,0.00017511897,0.0003562679,0.00033651476,0.0003029942,0.00023820125,0.0002607345,0.0002467927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024419234,0.000021930598,0.9958584,0.00000931551,0.000021802267,0.0001789419,0.00002915744,0.00004560588,0.0015060023,0.000004001869,0.00006134198,0.0020192524],"study_design_scores_gemma":[0.000020716741,0.00012622382,0.9974412,0.0000033020517,0.00003392263,0.0015709858,0.00009553278,0.00027896027,0.00023853523,0.000022099193,0.00016594926,0.000002568165],"about_ca_topic_score_codex":0.0006554983,"about_ca_topic_score_gemma":0.0007863685,"teacher_disagreement_score":0.0017172603,"about_ca_system_score_codex":0.00017351666,"about_ca_system_score_gemma":0.0001594033,"threshold_uncertainty_score":0.005744815},"labels":[],"label_agreement":null},{"id":"W2096844711","doi":"10.1158/1078-0432.ccr-06-0957","title":"CHIR-258 Is Efficacious in A Newly Developed Fibroblast Growth Factor Receptor 3–Expressing Orthotopic Multiple Myeloma Model in Mice","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Fibroblast growth factor receptor 3; Receptor tyrosine kinase; In vivo; Cancer research; Medicine; Fibroblast growth factor; Fibroblast growth factor receptor; Multiple myeloma; Receptor; Tyrosine-kinase inhibitor; Pathology; Biology; Internal medicine; Cancer","score_opus":0.18414792516677891,"score_gpt":0.4696726158016773,"score_spread":0.2855246906348984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096844711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99169296,0.0013483838,0.0025918216,0.00037554844,0.00009350984,0.0002719443,0.00059130817,0.00034023737,0.0026941726],"genre_scores_gemma":[0.9840169,0.002205851,0.0070919744,0.00022744822,0.00007114626,0.00034529838,0.0014901505,0.00005206791,0.0044992124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998184,0.000030636842,0.000013953083,0.000034849905,0.00006573654,0.000036424157],"domain_scores_gemma":[0.99982053,0.000022492171,0.00007527926,0.000019677718,0.0000123171485,0.000049730934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033389893,0.0007936122,0.0006532372,0.00071573904,0.0002713289,0.0003468207,0.00044687602,0.0005419786,0.0015143292],"category_scores_gemma":[0.00012805629,0.00025749797,0.00037965772,0.00022607324,0.0004964418,0.00036904108,0.00013336138,0.0012663275,0.0004431948],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009329474,0.0010384665,0.0001617722,0.00007644654,0.000013660866,0.000120331184,0.000018860104,0.00020263204,0.9934111,0.0001125257,0.00023058122,0.003680716],"study_design_scores_gemma":[0.0010427653,0.019292818,0.0033902924,0.000021425945,0.00007470984,0.0007237056,0.0000243828,0.0013859208,0.9702663,0.000050101204,0.003713098,0.000014569148],"about_ca_topic_score_codex":0.000706063,"about_ca_topic_score_gemma":0.0016734041,"teacher_disagreement_score":0.0015143292,"about_ca_system_score_codex":0.0005810529,"about_ca_system_score_gemma":0.00041833287,"threshold_uncertainty_score":0.005065918},"labels":[],"label_agreement":null},{"id":"W2096850750","doi":"10.1158/1078-0432.ccr-04-0634","title":"Phase II Study of Feasibility of Dose-Dense FEC Followed by Alternating Weekly Taxanes in High-Risk, Four or More Node-Positive Breast Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"Pfizer","keywords":"Medicine; Epirubicin; Regimen; Breast cancer; Surgery; Docetaxel; Internal medicine; Chemotherapy; Cyclophosphamide; Gastroenterology; Cancer","score_opus":0.13489051055253148,"score_gpt":0.5051278133788082,"score_spread":0.3702373028262767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096850750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99876714,0.00019821373,0.00017878265,0.000042223153,0.000017246739,0.00050398125,0.00007111875,0.00001329906,0.0002080448],"genre_scores_gemma":[0.9957476,0.00029927472,0.0017264473,0.00012975086,0.0000635437,0.001090537,0.0004349503,0.000008645987,0.000499225],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999584,0.0002037825,0.000028671213,0.00007226519,0.000041397452,0.0000698709],"domain_scores_gemma":[0.9991623,0.00019550725,0.00017813519,0.00012024252,0.00004315273,0.00030063972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013881035,0.0008994335,0.0012826707,0.0003517493,0.00034178738,0.00047079523,0.00085891783,0.0008335114,0.0018888508],"category_scores_gemma":[0.0009289153,0.00043297498,0.0006262879,0.00028819236,0.00081108575,0.00055768096,0.00029823868,0.0021892628,0.0003094023],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43406975,0.26408827,0.017963734,0.0006262115,0.00081723055,0.00052889134,0.00035078608,0.0069738235,0.19265494,0.00027039545,0.001056659,0.0805994],"study_design_scores_gemma":[0.12384061,0.84768134,0.009441275,0.000015014778,0.0001825487,0.0003523683,0.000040909563,0.0011388271,0.016308997,0.00007214231,0.00091075664,0.000015187046],"about_ca_topic_score_codex":0.0007085358,"about_ca_topic_score_gemma":0.0014231441,"teacher_disagreement_score":0.0018888508,"about_ca_system_score_codex":0.0006343228,"about_ca_system_score_gemma":0.0013990726,"threshold_uncertainty_score":0.007341087},"labels":[],"label_agreement":null},{"id":"W2096932937","doi":"10.1158/1078-0432.ccr-05-0371","title":"PEX-Producing Human Neural Stem Cells Inhibit Tumor Growth in a Mouse Glioma Model","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neurogenesis and neuroplasticity mechanisms","field":"Neuroscience","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"","keywords":"Glioma; Angiogenesis; Neural stem cell; Stem cell; Cancer research; Pathology; Cell culture; Transfection; Brain tumor; Biology; In vivo; U87; Medicine; Cell biology","score_opus":0.3616759159353036,"score_gpt":0.47574334626769726,"score_spread":0.11406743033239364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096932937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922971,0.0012238633,0.004193795,0.00013607166,0.000050263952,0.000130379,0.0004326908,0.00023790848,0.0012979413],"genre_scores_gemma":[0.98794866,0.0015595106,0.0043044705,0.00006449016,0.000016320011,0.00018838333,0.000988406,0.00003440131,0.0048953895],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983895,0.000023192948,0.000013472399,0.000029623976,0.000060854458,0.000033865308],"domain_scores_gemma":[0.99991345,0.000013251999,0.000027349613,0.000013939486,0.000009504797,0.00002247644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024476595,0.0006414023,0.00042244908,0.0005099601,0.00011744295,0.00021940148,0.00031152242,0.00038756643,0.0011001879],"category_scores_gemma":[0.000078506804,0.00017541008,0.00031668952,0.00021180174,0.00025215378,0.00018293732,0.00013570867,0.00094613136,0.00034233212],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026345294,0.00029816965,0.00012622081,0.000033647797,0.0000077886225,0.000042426065,0.00002099822,0.00012145313,0.9967452,0.000077187935,0.00009374123,0.0021696244],"study_design_scores_gemma":[0.00007174978,0.0026677032,0.0014335013,0.00000468015,0.000020776708,0.00014227853,0.000014072335,0.0012192763,0.993056,0.000030650688,0.0013361421,0.0000031175807],"about_ca_topic_score_codex":0.0015056509,"about_ca_topic_score_gemma":0.0021543046,"teacher_disagreement_score":0.0015056509,"about_ca_system_score_codex":0.00029424147,"about_ca_system_score_gemma":0.00027662117,"threshold_uncertainty_score":0.0036804676},"labels":[],"label_agreement":null},{"id":"W2097079447","doi":"10.1158/1078-0432.ccr-12-3696","title":"USP8 Is a Novel Target for Overcoming Gefitinib Resistance in Lung Cancer","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; University of Seoul; Seoul National University; University of Minnesota","keywords":"Gefitinib; Cancer research; Gene knockdown; Erlotinib; Lung cancer; ERBB3; Gene silencing; T790M; Downregulation and upregulation; Epidermal growth factor receptor; Tyrosine kinase; Biology; Cancer; Cell culture; Signal transduction; Medicine; Oncology; Gene; Cell biology; Biochemistry; Genetics","score_opus":0.1609707046166292,"score_gpt":0.4892345612672475,"score_spread":0.3282638566506183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097079447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89153033,0.08143317,0.016721075,0.001153526,0.00036403476,0.00034328015,0.0011320469,0.00058556814,0.006737036],"genre_scores_gemma":[0.9634211,0.021061232,0.007530582,0.00034031965,0.00012092628,0.00015172429,0.0017542847,0.000038291768,0.0055815107],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987674,0.000015097922,0.000011782992,0.000024879853,0.00005104162,0.000020457355],"domain_scores_gemma":[0.99992776,0.000009170187,0.00002480287,0.0000069271373,0.000016851296,0.000014544718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024125694,0.0003965427,0.0005281437,0.00027701308,0.00018059398,0.0004277093,0.00028240998,0.00048512506,0.0012919547],"category_scores_gemma":[0.000111511894,0.00011811074,0.00035721814,0.00017009738,0.00019392061,0.0002793875,0.0002034836,0.0005736806,0.00046173125],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028403217,0.00011061494,0.00064219645,0.00035360226,0.000037687852,0.00023790714,0.000026114276,0.00028822367,0.9680026,0.0004175884,0.0007724351,0.028826987],"study_design_scores_gemma":[0.00019446554,0.00263873,0.0049415524,0.00005070847,0.00014581195,0.002513206,0.000042806412,0.002440729,0.9328994,0.00025136373,0.053857796,0.000023470884],"about_ca_topic_score_codex":0.00022563309,"about_ca_topic_score_gemma":0.00057323434,"teacher_disagreement_score":0.0012919547,"about_ca_system_score_codex":0.0004267012,"about_ca_system_score_gemma":0.00021895426,"threshold_uncertainty_score":0.004322052},"labels":[],"label_agreement":null},{"id":"W2097112996","doi":"10.1158/1078-0432.ccr-11-0563","title":"Phase II Efficacy and Pharmacogenomic Study of Selumetinib (AZD6244; ARRY-142886) in Iodine-131 Refractory Papillary Thyroid Carcinoma with or without Follicular Elements","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; U.S. Food and Drug Administration","keywords":"Follicular phase; Thyroid carcinoma; Medicine; Iodine; Refractory (planetary science); Selumetinib; Internal medicine; Oncology; Thyroid; Cancer; Biology; Chemistry","score_opus":0.21567589773801968,"score_gpt":0.5295338984641391,"score_spread":0.31385800072611947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097112996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977143,0.00066595606,0.00025773022,0.00012430805,0.0000224367,0.0005400571,0.00027368029,0.00002268356,0.00037877678],"genre_scores_gemma":[0.9960039,0.00053259166,0.00074769807,0.00027230073,0.00005596663,0.00077780633,0.0010523639,0.000011647023,0.000545733],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999592,0.00022428443,0.000019690602,0.000059209964,0.0000467586,0.000058107722],"domain_scores_gemma":[0.9994778,0.00010349808,0.00012650665,0.000046794074,0.000032564443,0.00021290957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016332935,0.0010826301,0.0015491173,0.0003231705,0.00029770544,0.00072351145,0.0007072418,0.00091303297,0.001610092],"category_scores_gemma":[0.0007512541,0.00045358957,0.00087194704,0.00033705818,0.0008579743,0.0006145519,0.00023587568,0.0020338346,0.00045516228],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58010036,0.09514737,0.021339552,0.0008711638,0.0023305372,0.000673972,0.00040755037,0.005400684,0.20168807,0.0003724733,0.0025314107,0.089136854],"study_design_scores_gemma":[0.42269132,0.5379045,0.020532308,0.000024551666,0.0006321514,0.000618529,0.00007338173,0.0024421816,0.012880898,0.00016156698,0.002002556,0.00003608224],"about_ca_topic_score_codex":0.00068613974,"about_ca_topic_score_gemma":0.0014854429,"teacher_disagreement_score":0.0016332935,"about_ca_system_score_codex":0.0008835441,"about_ca_system_score_gemma":0.0011429443,"threshold_uncertainty_score":0.008637726},"labels":[],"label_agreement":null},{"id":"W2097150676","doi":"10.1158/1078-0432.ccr-09-3013","title":"<i>Fibroblast Growth Factor Receptor 3</i> Mutation Analysis on Voided Urine for Surveillance of Patients with Low-Grade Non-Muscle–Invasive Bladder Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"KWF Kankerbestrijding","keywords":"Concomitant; Urine; Bladder cancer; Medicine; Cystoscopy; Fibroblast growth factor receptor 3; Urology; Internal medicine; Gastroenterology; Proportional hazards model; Prospective cohort study; Cancer; Urinary system; Pathology; Fibroblast growth factor; Receptor","score_opus":0.059444911751871866,"score_gpt":0.426285465540906,"score_spread":0.36684055378903413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097150676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988557,0.00053872314,0.00025786026,0.000033417673,0.000007536209,0.00001100771,0.00011132819,0.000013317273,0.00017108893],"genre_scores_gemma":[0.999345,0.00009610632,0.00034660398,0.000024952284,0.0000114737,0.000004896771,0.00012846167,0.0000021914568,0.000040282874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993839,0.00021271422,0.00006932762,0.00011341318,0.00015947779,0.00006109425],"domain_scores_gemma":[0.9974825,0.0008244504,0.001023125,0.000121676094,0.00027337152,0.00027498824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013841625,0.00029112014,0.00040321393,0.0006944524,0.0002471664,0.00051193114,0.0004009211,0.00035739903,0.00043761716],"category_scores_gemma":[0.0037181247,0.00018430648,0.00039290363,0.0003377105,0.0002718634,0.0002847337,0.00018138421,0.00031498045,0.00013489473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050444034,0.000044189423,0.9924907,0.000020386684,0.0000323754,0.00012808821,0.00003596376,0.00007314803,0.0028820746,0.0000060330203,0.00009094378,0.003691506],"study_design_scores_gemma":[0.000028573646,0.0009443231,0.99013877,0.000020561873,0.000086314816,0.0014673863,0.00005725462,0.001591891,0.005296099,0.000017206454,0.00034030093,0.000011370799],"about_ca_topic_score_codex":0.0016025412,"about_ca_topic_score_gemma":0.0026600535,"teacher_disagreement_score":0.0016025412,"about_ca_system_score_codex":0.00037281215,"about_ca_system_score_gemma":0.00032558572,"threshold_uncertainty_score":0.007320285},"labels":[],"label_agreement":null},{"id":"W2097392662","doi":"10.1158/1078-0432.ccr-08-1970","title":"Quantitative Ultrasound Characterization of Responses to Radiotherapy in Cancer Mouse Models","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Metropolitan University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"F. Hoffmann-La Roche","keywords":"Radiation therapy; Ultrasound; Medicine; Nuclear medicine; Head and neck cancer; Cancer; In vivo; Radiology; Pathology; Internal medicine; Biology","score_opus":0.22808522426751734,"score_gpt":0.5001903900467286,"score_spread":0.2721051657792113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097392662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96560115,0.0022713458,0.030746687,0.000053587843,0.000020577072,0.00008090443,0.00040796923,0.00025811707,0.00055968296],"genre_scores_gemma":[0.9774563,0.0014178952,0.017846966,0.00005759225,0.000016405682,0.00020170187,0.0007208192,0.00006357553,0.0022187587],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99967074,0.00007507063,0.000022045291,0.000060485003,0.00014099725,0.000030686646],"domain_scores_gemma":[0.9995272,0.00011523658,0.00018361739,0.000050806248,0.000080865,0.000042291165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055410346,0.0005596768,0.00027819164,0.00071590143,0.000089349254,0.0002066852,0.00025262617,0.0003911117,0.0009495156],"category_scores_gemma":[0.00042668267,0.00019103508,0.00023397336,0.00025557453,0.0003162608,0.0002217502,0.00017000528,0.0005040779,0.0002308344],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007037031,0.000014537768,0.00028579758,0.000020103296,0.0000034855752,0.0000062188205,0.000010428439,0.000080794845,0.998723,0.000012621855,0.000008314816,0.0007644081],"study_design_scores_gemma":[0.0000063532525,0.0007835096,0.007742943,0.000004560575,0.000021444333,0.00013133316,0.000020723086,0.0010518609,0.9897093,0.000021624812,0.00049817626,0.000008141571],"about_ca_topic_score_codex":0.00031498403,"about_ca_topic_score_gemma":0.00041520098,"teacher_disagreement_score":0.0009495156,"about_ca_system_score_codex":0.00019391635,"about_ca_system_score_gemma":0.000088458495,"threshold_uncertainty_score":0.0031763911},"labels":[],"label_agreement":null},{"id":"W2097478662","doi":"10.1158/1078-0432.ccr-08-3012","title":"<i>MSH6</i> Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":388,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Royal College of Physicians and Surgeons of Canada; Wellcome Trust","keywords":"Temozolomide; MSH6; Cancer research; Biology; Medicine; Glioma; DNA mismatch repair; DNA repair; Genetics; Gene","score_opus":0.16339379708801627,"score_gpt":0.4951790380765004,"score_spread":0.3317852409884841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097478662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998254,0.00035783616,0.000679454,0.000027445172,0.000005189232,0.000017575449,0.00014270662,0.00003434706,0.00048140204],"genre_scores_gemma":[0.99878937,0.00024548676,0.00040566514,0.000023016008,0.000003477891,0.000010955486,0.00021834834,0.000005319324,0.00029839075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999205,0.000009768032,0.00000824629,0.000014219575,0.000025602487,0.00002169881],"domain_scores_gemma":[0.9999362,0.0000053444137,0.000030288913,0.0000059152417,0.000009213569,0.000013002201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011824675,0.00017350625,0.00015878951,0.00017570368,0.000115980045,0.00020212887,0.00011320987,0.00013934598,0.00057653507],"category_scores_gemma":[0.00010194898,0.00008965001,0.000111591355,0.00009999752,0.00013690534,0.00010098712,0.00010687564,0.00026531806,0.00022239811],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015044396,0.00003503086,0.0037059789,0.000020888618,0.0000064256637,0.00012622343,0.000020212106,0.00006438315,0.993828,0.000056485507,0.00006835046,0.0019175587],"study_design_scores_gemma":[0.000015181904,0.00071567827,0.064679444,0.000006212757,0.000025798408,0.0013687471,0.00005287314,0.0008956385,0.9307073,0.00006111788,0.0014680319,0.000003932701],"about_ca_topic_score_codex":0.0011349963,"about_ca_topic_score_gemma":0.0013621347,"teacher_disagreement_score":0.0011349963,"about_ca_system_score_codex":0.0003495707,"about_ca_system_score_gemma":0.0001520265,"threshold_uncertainty_score":0.0025362968},"labels":[],"label_agreement":null},{"id":"W2097556456","doi":"10.1158/1078-0432.ccr-07-0013","title":"A Polymorphism in HDM2 (SNP309) Associates with Early Onset in Superficial Tumors, TP53 Mutations, and Poor Outcome in Invasive Bladder Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Genotype; Genotyping; Bladder cancer; Biology; Single-nucleotide polymorphism; Cancer research; Molecular biology; Cancer; Internal medicine; Gene; Pathology; Medicine; Genetics","score_opus":0.14525737766863403,"score_gpt":0.48464544222902695,"score_spread":0.33938806456039294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097556456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996555,0.00007967393,0.00011285202,0.000013147534,0.0000025623212,0.0000027699118,0.0000502272,0.0000033488839,0.00007999889],"genre_scores_gemma":[0.9997241,0.000024717778,0.00009923915,0.0000075182857,0.0000042135607,0.0000026084465,0.000050438983,0.000001252891,0.00008597053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987876,0.000027017517,0.00001533049,0.00003279412,0.000025165667,0.000020824229],"domain_scores_gemma":[0.9995333,0.000108127155,0.0001863849,0.00002116402,0.000029444034,0.000121610974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018789056,0.00020810124,0.00024520297,0.000501014,0.0003435146,0.00017898309,0.0001483638,0.00035072854,0.0013502525],"category_scores_gemma":[0.00056717027,0.00012591707,0.00020008271,0.00039540042,0.0001899779,0.00009629799,0.0001840987,0.0002582412,0.00017829138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013788663,0.00009800251,0.9449633,0.000026095087,0.00010231723,0.0012417213,0.000079408,0.00010445074,0.048425447,0.000028210996,0.00012034309,0.0034318853],"study_design_scores_gemma":[0.000010671143,0.00015837146,0.9945364,0.000005463104,0.000053890988,0.0023228836,0.000039617986,0.00031873907,0.0023803175,0.000038249364,0.00013130494,0.0000041095354],"about_ca_topic_score_codex":0.0010753834,"about_ca_topic_score_gemma":0.0014108602,"teacher_disagreement_score":0.0013502525,"about_ca_system_score_codex":0.00012404898,"about_ca_system_score_gemma":0.00012973916,"threshold_uncertainty_score":0.0045170784},"labels":[],"label_agreement":null},{"id":"W2097755642","doi":"10.1158/1078-0432.ccr-03-0087","title":"Epithelial-Cadherin and β-Catenin Expression Changes in Pancreatic Intraepithelial Neoplasia","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Pancreatic Intraepithelial Neoplasia; Catenin; Cadherin; Pathology; Wnt signaling pathway; Carcinogenesis; Adenocarcinoma; Adherens junction; Cancer research; GSK-3; Biology; Medicine; Pancreatic cancer; Kinase; Cell; Pancreatic ductal adenocarcinoma; Cancer; Internal medicine; Signal transduction; Cell biology","score_opus":0.09106746560202092,"score_gpt":0.43162321251512603,"score_spread":0.3405557469131051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097755642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99858665,0.00095073023,0.00015729519,0.000006310725,0.0000014364854,0.000006863488,0.000042597778,0.0000049861655,0.0002432041],"genre_scores_gemma":[0.99822193,0.00076356245,0.00026613308,0.000009315757,0.000001996732,0.0000148648305,0.00019388698,0.000001245201,0.0005270817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987745,0.000016480843,0.000012330321,0.0000324962,0.000040326635,0.000020930962],"domain_scores_gemma":[0.9998965,0.000012115736,0.00004152203,0.00000951073,0.000020164576,0.000020171423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001751395,0.00019936381,0.00016456758,0.00050639524,0.00017594258,0.000285632,0.00011812188,0.00019565344,0.00087109505],"category_scores_gemma":[0.00020836669,0.00013920374,0.00011716242,0.00044036462,0.00023905012,0.00023948424,0.00018104691,0.00017849565,0.00015414217],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081109256,0.00009446829,0.12602091,0.00015838865,0.000034355922,0.00073926285,0.00016168258,0.00009548992,0.8633456,0.0000463489,0.00006343027,0.008428935],"study_design_scores_gemma":[0.00001611439,0.00048079374,0.9086023,0.000011284159,0.000044638015,0.0025023965,0.00022109215,0.00023275701,0.08636795,0.000035948095,0.001480673,0.0000041349476],"about_ca_topic_score_codex":0.0010046609,"about_ca_topic_score_gemma":0.0015714944,"teacher_disagreement_score":0.0010046609,"about_ca_system_score_codex":0.0003999311,"about_ca_system_score_gemma":0.00017873204,"threshold_uncertainty_score":0.002914071},"labels":[],"label_agreement":null},{"id":"W2098342989","doi":"10.1158/1078-0432.ccr-07-0525","title":"Gene Expression Profiling from Formalin-Fixed Paraffin-Embedded Tumors of Pediatric Glioblastoma","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital; Biotechnology Research Institute; McGill University Health Centre; National Institute for Nanotechnology; Montreal Children's Hospital","funders":"Fonds de Recherche du Québec - Santé; Hungarian Scientific Research Fund","keywords":"Housekeeping gene; Gene expression profiling; RNA; Biology; Microarray analysis techniques; Microarray; Gene expression; Computational biology; Gene; Genetics","score_opus":0.08852408516250958,"score_gpt":0.4784650267202843,"score_spread":0.3899409415577747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098342989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98875844,0.0026159128,0.005149562,0.00007194769,0.000023480765,0.00008190358,0.0021698242,0.00007658631,0.001052349],"genre_scores_gemma":[0.9641761,0.0051423158,0.018183962,0.00014242015,0.000039639726,0.0003317761,0.010218415,0.000072352,0.0016929216],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998777,0.000015364474,0.0000145062,0.000027287724,0.000039985815,0.000025218591],"domain_scores_gemma":[0.99984634,0.000038861617,0.000036085577,0.000018720842,0.000043365093,0.000016499263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021707015,0.00022596269,0.00022069304,0.00081298844,0.00020088039,0.0002546415,0.00020038702,0.0001841452,0.000792802],"category_scores_gemma":[0.00027508708,0.00010799538,0.0001309917,0.0006663142,0.0002597247,0.00017299662,0.00017275166,0.00025564496,0.00034749683],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022594004,0.000023295912,0.0072409767,0.00016033607,0.000019533454,0.00030957328,0.0000843247,0.0001063161,0.986502,0.000045986715,0.00010364383,0.005178156],"study_design_scores_gemma":[0.000030220823,0.00082671474,0.30947974,0.00006633852,0.000197179,0.0042454205,0.00077698845,0.0011103135,0.6731809,0.00020248929,0.009867289,0.00001636082],"about_ca_topic_score_codex":0.0004517268,"about_ca_topic_score_gemma":0.000997149,"teacher_disagreement_score":0.00081298844,"about_ca_system_score_codex":0.00014838814,"about_ca_system_score_gemma":0.00023838732,"threshold_uncertainty_score":0.0026521683},"labels":[],"label_agreement":null},{"id":"W2098653766","doi":"10.1158/1078-0432.ccr-07-1400","title":"Enhanced <i>In vitro</i> and <i>In vivo</i> Cytotoxicity of Combined Reovirus and Radiotherapy","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Cytotoxicity; In vivo; In vitro; Radiation therapy; Cell culture; Cancer research; Combination therapy; Apoptosis; Biology; Pharmacology; Medicine; Biochemistry; Internal medicine","score_opus":0.1609870948368256,"score_gpt":0.48924520010780387,"score_spread":0.32825810527097826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098653766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9706873,0.009462884,0.013546258,0.00016365082,0.00012659037,0.00023777402,0.0005305848,0.00029660255,0.004948359],"genre_scores_gemma":[0.98761404,0.0022613434,0.0076591256,0.00004795157,0.000046379642,0.00012443801,0.00040866513,0.0000650316,0.0017730218],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994783,0.0001534754,0.000050285293,0.00011486995,0.00013769667,0.00006535967],"domain_scores_gemma":[0.9996971,0.00010403127,0.000066327775,0.00006163101,0.000036191293,0.000034631597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005416002,0.0009747759,0.00078871823,0.00046794588,0.00016310147,0.00051929173,0.00035262952,0.00043064516,0.0025850835],"category_scores_gemma":[0.00035744824,0.0003107263,0.0006411383,0.00022955092,0.00039423254,0.00039016546,0.00024622676,0.00074675557,0.0006610649],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008201501,0.00016310236,0.00075522845,0.0001760465,0.00004315958,0.000040540654,0.000019692208,0.00068908464,0.9930962,0.00007552007,0.00010994164,0.004011275],"study_design_scores_gemma":[0.00004133029,0.0020749401,0.002702018,0.000013781316,0.000083943276,0.00029490548,0.000012759875,0.0008379315,0.9928722,0.000020909887,0.0010394047,0.000006081341],"about_ca_topic_score_codex":0.00066668773,"about_ca_topic_score_gemma":0.00080450514,"teacher_disagreement_score":0.0025850835,"about_ca_system_score_codex":0.00047454433,"about_ca_system_score_gemma":0.00036123034,"threshold_uncertainty_score":0.008647978},"labels":[],"label_agreement":null},{"id":"W2098739456","doi":"10.1158/1078-0432.ccr-08-1291","title":"Genome-Wide Loss of Heterozygosity and Uniparental Disomy in BRCA1/2-Associated Ovarian Carcinomas","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Loss of heterozygosity; Uniparental disomy; Serous fluid; Biology; Ovarian cancer; Genome instability; Genetics; Gene duplication; Cancer research; Allele; Cancer; Chromosome; Gene; DNA damage; DNA; Karyotype","score_opus":0.21731051445294747,"score_gpt":0.46542768542570057,"score_spread":0.2481171709727531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098739456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99967647,0.00012969929,0.0001255774,0.000002567877,3.9248104e-7,0.0000017659837,0.000013959034,0.0000021352598,0.00004737197],"genre_scores_gemma":[0.9997633,0.00004206774,0.00013132404,0.0000032992134,0.0000016176565,0.0000020150692,0.00003553686,8.663945e-7,0.000019934827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962425,0.000095253614,0.000045665936,0.000087062705,0.000106490035,0.000041249674],"domain_scores_gemma":[0.99929845,0.00023822916,0.00028405472,0.00005459158,0.000048442504,0.00007623481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005824382,0.00013247658,0.0001867277,0.0010565902,0.00017832979,0.00021641795,0.00018355323,0.00019753916,0.0005388488],"category_scores_gemma":[0.0013226036,0.000100183155,0.00010482469,0.0003962177,0.00029012104,0.0001305148,0.00024799426,0.00012460322,0.00007235901],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000539304,0.00005194093,0.92944384,0.00004231847,0.00007456618,0.0009057036,0.00014855654,0.00023366924,0.061890256,0.000049090657,0.00004156523,0.006579156],"study_design_scores_gemma":[0.000009725118,0.00019267078,0.9871954,0.000003093837,0.00003132443,0.0043067154,0.00006740984,0.00031995526,0.007698923,0.000052677577,0.00011894068,0.0000030568976],"about_ca_topic_score_codex":0.00040029976,"about_ca_topic_score_gemma":0.0007084801,"teacher_disagreement_score":0.0010565902,"about_ca_system_score_codex":0.00017356616,"about_ca_system_score_gemma":0.00013509282,"threshold_uncertainty_score":0.0030803084},"labels":[],"label_agreement":null},{"id":"W2098749503","doi":"10.1158/1078-0432.ccr-15-0156","title":"An Antibody–Drug Conjugate Directed against Lymphocyte Antigen 6 Complex, Locus E (LY6E) Provides Robust Tumor Killing in a Wide Range of Solid Tumor Malignancies","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"In vivo; Cancer research; Antigen; Monoclonal antibody; Antibody; Biology; Immunohistochemistry; Cytotoxic T cell; In vitro; Immunology","score_opus":0.32669273389124903,"score_gpt":0.5304941585481654,"score_spread":0.20380142465691636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098749503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.968493,0.003981056,0.025039202,0.00013152121,0.000022348338,0.00010897389,0.0003228768,0.00016263593,0.0017382802],"genre_scores_gemma":[0.9841539,0.0014124111,0.012321295,0.0000565975,0.000006674118,0.000036434532,0.00048579354,0.000017002178,0.0015098656],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984515,0.000024932271,0.00000995426,0.00003428534,0.00006859446,0.000016956554],"domain_scores_gemma":[0.9999143,0.00001851773,0.00003117029,0.00000870182,0.00001331577,0.00001398557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027976732,0.00033804966,0.00028593338,0.00028727116,0.000104656,0.00033982345,0.00017190495,0.00034214972,0.0008379598],"category_scores_gemma":[0.00019319826,0.00010740834,0.00023127414,0.00019094275,0.00020370085,0.00020118862,0.0002098639,0.00034811324,0.00044169798],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008466045,0.000041699583,0.0003783169,0.00004949785,0.0000062473687,0.000026405072,0.0000042876977,0.00048261404,0.99615616,0.00006738143,0.000025979713,0.0026766276],"study_design_scores_gemma":[0.000014837895,0.00028708339,0.00078927114,0.0000026584619,0.000011426996,0.00017887756,0.0000031765778,0.0017570601,0.9955924,0.000016791777,0.0013446489,0.0000017218802],"about_ca_topic_score_codex":0.00015027566,"about_ca_topic_score_gemma":0.00020876066,"teacher_disagreement_score":0.0008379598,"about_ca_system_score_codex":0.00029206258,"about_ca_system_score_gemma":0.0001472525,"threshold_uncertainty_score":0.0028032064},"labels":[],"label_agreement":null},{"id":"W2098844349","doi":"10.1158/1078-0432.ccr-05-2352","title":"ErbB Receptor Signaling and Therapeutic Resistance to Aromatase Inhibitors","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Aromatase; Coactivator; Estrogen receptor; Letrozole; Chromatin immunoprecipitation; Cancer research; Androstenedione; Biology; Aromatase inhibitor; Endocrinology; Promoter; Internal medicine; Molecular biology; Transcription factor; Cancer; Gene expression; Gene; Breast cancer; Medicine; Androgen; Biochemistry; Hormone","score_opus":0.055577664717632314,"score_gpt":0.4305431315087353,"score_spread":0.374965466791103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098844349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99396354,0.0037486842,0.00037028466,0.000153615,0.000011277832,0.000013412734,0.00010834036,0.000027874834,0.0016030973],"genre_scores_gemma":[0.99748933,0.0013276924,0.00014634118,0.000029430099,0.00000563458,0.000006959848,0.00016472483,0.0000040258465,0.0008259131],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99983037,0.000046833575,0.000010949274,0.000014945288,0.000047843532,0.000049033584],"domain_scores_gemma":[0.99991024,0.000032137228,0.000022574715,0.000009675664,0.000009865238,0.000015556474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024731728,0.00018199261,0.00029160266,0.00013474122,0.00009245366,0.0003377889,0.00014254313,0.00022492427,0.0014574087],"category_scores_gemma":[0.00027742801,0.00009660149,0.00014704876,0.00013378818,0.00016095661,0.00015689601,0.00008762967,0.00041299453,0.00024072548],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005783783,0.00014300572,0.0020218475,0.000045476663,0.000022935485,0.00026801607,0.000034964003,0.00029380698,0.9891143,0.00029952807,0.0001787573,0.006998909],"study_design_scores_gemma":[0.000119453005,0.0039867405,0.025464712,0.000014166447,0.00008651319,0.0029038351,0.00011929214,0.0017707029,0.95508116,0.00020555867,0.010235321,0.000012561913],"about_ca_topic_score_codex":0.00029445026,"about_ca_topic_score_gemma":0.00063813897,"teacher_disagreement_score":0.0014574087,"about_ca_system_score_codex":0.00024767005,"about_ca_system_score_gemma":0.00010798848,"threshold_uncertainty_score":0.0048755407},"labels":[],"label_agreement":null},{"id":"W2099146388","doi":"10.1158/1078-0432.ccr-05-0130","title":"Objective Responses in Patients with Malignant Melanoma or Renal Cell Cancer in Early Clinical Studies Do Not Predict Regulatory Approval","year":2005,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Melanoma; Renal cell carcinoma; Cancer; Oncology; Internal medicine; Clinical trial; Phases of clinical research; Kidney cancer; Carcinoma; Colorectal cancer; Cancer research","score_opus":0.8410193157045681,"score_gpt":0.7118782048524943,"score_spread":0.1291411108520738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099146388","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022348557,0.9934232,0.0021782625,0.000655286,0.00010624688,0.000044653585,0.000058959657,0.000018508636,0.0012799947],"genre_scores_gemma":[0.07162688,0.9215776,0.0047133486,0.0006618679,0.00043674096,0.00023185185,0.00015304478,0.000014947403,0.00058376195],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99027187,0.0066469973,0.0011370761,0.00044324575,0.0014255894,0.00007522346],"domain_scores_gemma":[0.959981,0.02980885,0.008285621,0.000511865,0.0012608768,0.00015181753],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.011401891,0.0005111227,0.0019024722,0.0019689614,0.00010740895,0.00081396627,0.0007805389,0.0004757207,0.0017405389],"category_scores_gemma":[0.03566802,0.00024270073,0.0009444922,0.0026002019,0.00090841216,0.0009763932,0.00039474753,0.0007832746,0.000588503],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045892605,0.00003728999,0.009580556,0.04183571,0.00067883893,0.000089118206,0.00013352938,0.0010881199,0.0007267351,0.0035355825,0.00544457,0.936391],"study_design_scores_gemma":[0.0018217436,0.004579046,0.16407996,0.1409996,0.012109543,0.014237185,0.0013465208,0.0060655675,0.009473763,0.043228794,0.60180044,0.00025795912],"about_ca_topic_score_codex":0.0003104879,"about_ca_topic_score_gemma":0.0006433459,"teacher_disagreement_score":0.9885981,"about_ca_system_score_codex":0.00058063684,"about_ca_system_score_gemma":0.0014332782,"threshold_uncertainty_score":0.060299695},"labels":[],"label_agreement":null},{"id":"W2099233066","doi":"10.1158/1078-0432.ccr-04-0681","title":"Correlation of Molecular Genetics with Molecular and Morphological Imaging in Gliomas with an Oligodendroglial Component","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Douglas College","funders":"","keywords":"Oligodendroglioma; Histopathology; Positron emission tomography; Nuclear medicine; Medicine; Pathology; Magnetic resonance imaging; Population; Single-photon emission computed tomography; Glioma; Radiology; Cancer research; Astrocytoma","score_opus":0.08857859999147794,"score_gpt":0.4497766269489197,"score_spread":0.36119802695744174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099233066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997775,0.000071006536,0.00005357652,0.000007898611,8.676719e-7,0.0000024158146,0.000017188811,0.0000018640217,0.00006764631],"genre_scores_gemma":[0.9997776,0.000029177596,0.00010675714,0.000004384562,0.0000027566591,0.0000025588588,0.000039419498,0.0000010624776,0.000036345784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997687,0.0000634012,0.000035384695,0.000051588533,0.000049011625,0.00003197095],"domain_scores_gemma":[0.9983543,0.00042937777,0.0007572812,0.00009760777,0.0001714884,0.00018995872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004956916,0.00028230093,0.00019152278,0.0010496225,0.00021272237,0.00034775864,0.00021007509,0.00032136362,0.0013273844],"category_scores_gemma":[0.002409762,0.00018161611,0.00010580867,0.00047297683,0.00043352816,0.00024898455,0.00027044848,0.00018061652,0.00026978378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034621445,0.000032543358,0.99313617,0.000010207674,0.000017582597,0.0005101891,0.00004415234,0.000058248752,0.004070681,0.000014224842,0.000018316498,0.0017414793],"study_design_scores_gemma":[0.000016904418,0.0003724772,0.9940995,0.000004784412,0.00003531391,0.003646867,0.00013713377,0.00023385888,0.0012949713,0.00004550459,0.000108330176,0.0000044308076],"about_ca_topic_score_codex":0.00081780145,"about_ca_topic_score_gemma":0.00094688084,"teacher_disagreement_score":0.0013273844,"about_ca_system_score_codex":0.00018243461,"about_ca_system_score_gemma":0.00021649018,"threshold_uncertainty_score":0.0044406056},"labels":[],"label_agreement":null},{"id":"W2099243020","doi":"10.1158/1078-0432.ccr-10-2981","title":"<i>In vivo</i> Evaluation of Mucoadhesive Nanoparticulate Docetaxel for Intravesical Treatment of Non–Muscle-Invasive Bladder Cancer","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Centre for Drug Research and Development","funders":"Canadian Institutes of Health Research","keywords":"In vivo; Chemistry; Bladder cancer; Docetaxel; In vitro; Pharmacology; Cancer research; Cancer; Medicine; Biochemistry; Internal medicine; Biology","score_opus":0.4088717360453616,"score_gpt":0.5471438405819348,"score_spread":0.13827210453657318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099243020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98963237,0.0031742216,0.0049173576,0.000116249415,0.000047781148,0.00013320716,0.00024370072,0.00011575535,0.0016193001],"genre_scores_gemma":[0.9903424,0.0023989766,0.0046041314,0.00007848055,0.000019904419,0.00009557293,0.00038822825,0.00003406419,0.0020382174],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983454,0.000054220982,0.00001243745,0.000029132934,0.00004110785,0.000028601511],"domain_scores_gemma":[0.9998771,0.000019626466,0.00004916085,0.000010939692,0.000023593213,0.000019572186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003369061,0.00041409166,0.00033627005,0.00015374452,0.000113385424,0.0003425804,0.00022801285,0.0003525598,0.0006220322],"category_scores_gemma":[0.00017577893,0.00014926372,0.0002719912,0.000119847005,0.00023931536,0.00022754418,0.0000851791,0.00043667914,0.00023281109],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004618751,0.00017257399,0.00017321423,0.00008416008,0.000008960507,0.00002911364,0.00001430479,0.00025494056,0.9959293,0.000029174898,0.00007428029,0.0027682537],"study_design_scores_gemma":[0.000029935933,0.0024730037,0.00084036705,0.000004726084,0.000027814247,0.00012112404,0.000008593237,0.00074953295,0.99495405,0.0000056261897,0.0007818436,0.0000033359513],"about_ca_topic_score_codex":0.001203506,"about_ca_topic_score_gemma":0.00133994,"teacher_disagreement_score":0.001203506,"about_ca_system_score_codex":0.00041299258,"about_ca_system_score_gemma":0.00040361503,"threshold_uncertainty_score":0.0029964447},"labels":[],"label_agreement":null},{"id":"W2099335989","doi":"10.1158/1078-0432.ccr-04-0220","title":"Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":2657,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University; University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; University of North Carolina at Chapel Hill; Michael Smith Health Research BC","keywords":"Cytokeratin; Tissue microarray; Immunohistochemistry; Basal (medicine); Breast cancer; Pathology; Breast carcinoma; Estrogen receptor; Biology; Estrogen; Oncology; Internal medicine; Medicine; Cancer; Endocrinology","score_opus":0.11674354598862836,"score_gpt":0.44685973792177414,"score_spread":0.3301161919331458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099335989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99754435,0.00072436215,0.0005311685,0.000040523573,0.0000051932734,0.000018710865,0.0002473838,0.0000076039223,0.00088074576],"genre_scores_gemma":[0.99843436,0.00023334325,0.00048354827,0.000026556756,0.000006434137,0.000016320733,0.0005132844,0.0000021989981,0.00028404035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980193,0.000034082525,0.00002634467,0.0000431294,0.00006978956,0.000024724086],"domain_scores_gemma":[0.9996717,0.000068273424,0.00008739202,0.000023404042,0.00008757273,0.000061655024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044364223,0.00017225558,0.0001837313,0.0004963552,0.000162255,0.00032571735,0.0001821315,0.00020239443,0.0009878258],"category_scores_gemma":[0.00068241404,0.00006808766,0.00012190634,0.0002658848,0.00020661841,0.0001504001,0.00012676229,0.00018065977,0.00027474633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003025662,0.00005894364,0.92985535,0.00005607196,0.000047923397,0.0002704584,0.000042524352,0.00009023904,0.06256558,0.00002606574,0.00017481386,0.006509395],"study_design_scores_gemma":[0.00001191097,0.00013263927,0.98484313,0.00001017731,0.000044855995,0.0030396983,0.00017847595,0.00030580655,0.010690992,0.000035000445,0.0007036083,0.0000037785953],"about_ca_topic_score_codex":0.00076827867,"about_ca_topic_score_gemma":0.0011499089,"teacher_disagreement_score":0.0009878258,"about_ca_system_score_codex":0.00020722885,"about_ca_system_score_gemma":0.00016651284,"threshold_uncertainty_score":0.0033046007},"labels":[],"label_agreement":null},{"id":"W2099370186","doi":"10.1158/1078-0432.ccr-11-0642","title":"β1-Integrin: A Potential Therapeutic Target in the Battle against Cancer Recurrence","year":2011,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institutes of Health","keywords":"Metastasis; Cancer; Breast cancer; Cancer research; Medicine; Melanoma; Dormancy; Cancer cell; Integrin; Primary tumor; Immunology; Oncology; Internal medicine; Biology; Receptor","score_opus":0.537161964723045,"score_gpt":0.6091279636354181,"score_spread":0.0719659989123731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099370186","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017148032,0.9976011,0.00015911664,0.0004819064,0.00024951453,0.0000049665255,0.000010089248,0.000009692099,0.0013120385],"genre_scores_gemma":[0.001036103,0.9974214,0.00021990015,0.00028055627,0.00016288098,0.000008959445,0.000020114103,0.0000014793472,0.0008486569],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998791,0.000024112436,0.00001317988,0.00002168298,0.0000449677,0.000016889666],"domain_scores_gemma":[0.99984276,0.000067998655,0.000020016254,0.0000055704813,0.000042219635,0.000021392465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053518795,0.0008346281,0.0011653445,0.0015878419,0.0003197049,0.00090319716,0.0008585995,0.0012944427,0.00261676],"category_scores_gemma":[0.00038333106,0.00026700483,0.00037396047,0.0015297782,0.00067000557,0.0014582395,0.00043640222,0.0023790107,0.0022975153],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011404168,0.00013672543,0.00016520554,0.0059279543,0.0000626441,0.00028145805,0.00005955737,0.0005111035,0.004430954,0.0066612707,0.041213624,0.94043547],"study_design_scores_gemma":[0.000040133054,0.00015549822,0.00059978274,0.0012915011,0.000054283966,0.0012693065,0.000051740997,0.00013846227,0.000764319,0.0026952822,0.9929249,0.000014849286],"about_ca_topic_score_codex":0.0006912625,"about_ca_topic_score_gemma":0.0016753649,"teacher_disagreement_score":0.00261676,"about_ca_system_score_codex":0.0007203944,"about_ca_system_score_gemma":0.0006236272,"threshold_uncertainty_score":0.008753955},"labels":[],"label_agreement":null},{"id":"W2099678391","doi":"10.1158/1078-0432.ccr-06-1250","title":"Pharmacokinetics, Metabolism, and Oral Bioavailability of the DNA Methyltransferase Inhibitor 5-Fluoro-2′-Deoxycytidine in Mice","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; University of Pittsburgh","keywords":"Bioavailability; Pharmacokinetics; Pharmacology; Chemistry; In vivo; Catabolism; Cytidine; Metabolism; Metabolite; Oral administration; Deoxycytidine; Methyltransferase; Biochemistry; Enzyme; DNA; Biology; Medicine; Chemotherapy; Internal medicine; Methylation","score_opus":0.08026696402152493,"score_gpt":0.44568044347323726,"score_spread":0.3654134794517123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099678391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98132104,0.005329074,0.008565231,0.0002900072,0.00007657892,0.00014529256,0.0019213466,0.00051686604,0.0018344995],"genre_scores_gemma":[0.98057693,0.0031385385,0.0070468974,0.00025907217,0.00005021352,0.00028865202,0.0023154274,0.00013422978,0.006190002],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99971384,0.000045120825,0.000013614353,0.00009061839,0.000075668155,0.00006119204],"domain_scores_gemma":[0.9997651,0.000030126277,0.00009519575,0.000029398612,0.000025303727,0.000054908654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034175446,0.0008379335,0.00059956586,0.00061156,0.00024680846,0.000492651,0.00033694057,0.00066518894,0.0006809663],"category_scores_gemma":[0.00019552548,0.0004337669,0.0005425422,0.00028843203,0.0004162996,0.00047185374,0.00010401625,0.0012321356,0.00051463104],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028167628,0.00033012684,0.0011204467,0.000038231283,0.000023626839,0.000034774377,0.00002958198,0.00038570332,0.9899435,0.00006673367,0.0002060535,0.0050044884],"study_design_scores_gemma":[0.00023998803,0.0077950098,0.007953075,0.00000988307,0.00009948238,0.00023859508,0.000024938783,0.0032047282,0.9777078,0.00007213359,0.0026345493,0.000019765035],"about_ca_topic_score_codex":0.0019490931,"about_ca_topic_score_gemma":0.0017477501,"teacher_disagreement_score":0.0019490931,"about_ca_system_score_codex":0.0008141238,"about_ca_system_score_gemma":0.0004964042,"threshold_uncertainty_score":0.0059069395},"labels":[],"label_agreement":null},{"id":"W2099772080","doi":"10.1158/1078-0432.ccr-14-0706","title":"Identification of Differentially Expressed Long Noncoding RNAs in Bladder Cancer","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Biology; Long non-coding RNA; Epigenetics; Gene knockdown; Transcriptome; Phenotype; Cancer; Bladder cancer; Cancer research; Downregulation and upregulation; Disease; Gene expression profiling; Regulation of gene expression; Gene expression; Microarray; Computational biology; Gene; Genetics; Medicine; Pathology","score_opus":0.0977685692194695,"score_gpt":0.4781465611297945,"score_spread":0.38037799191032495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099772080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99158317,0.004849653,0.0020052823,0.00006769597,0.000018014205,0.000032736192,0.00089544686,0.00006402702,0.00048403267],"genre_scores_gemma":[0.9921612,0.0014116138,0.0044517317,0.000087832384,0.000014849842,0.00006683822,0.0012797671,0.000015032283,0.0005110557],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99981326,0.000022844897,0.00002351982,0.000061492276,0.00004884508,0.000030087673],"domain_scores_gemma":[0.9996954,0.0000827576,0.000112518435,0.000028145469,0.000043894837,0.00003729644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028307416,0.000213764,0.00029732139,0.00074643147,0.00023228496,0.00029816758,0.00017251215,0.00026313268,0.0007322789],"category_scores_gemma":[0.00042221198,0.00012383991,0.00024561337,0.00074774894,0.00024247292,0.00016933017,0.00024687627,0.00024610868,0.00022432566],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054089865,0.000047250218,0.051069517,0.00048604916,0.000053200692,0.00035264276,0.000097087264,0.00022574993,0.9313155,0.00008165157,0.0001353173,0.015595161],"study_design_scores_gemma":[0.000037980866,0.0008443232,0.5527265,0.000070286325,0.00023879681,0.003430837,0.00023829553,0.0020898296,0.4350605,0.00028842728,0.0049464963,0.000027737327],"about_ca_topic_score_codex":0.00031603893,"about_ca_topic_score_gemma":0.0005579112,"teacher_disagreement_score":0.00074643147,"about_ca_system_score_codex":0.00032355185,"about_ca_system_score_gemma":0.00036753857,"threshold_uncertainty_score":0.0024496913},"labels":[],"label_agreement":null},{"id":"W2099814169","doi":"10.1158/1078-0432.ccr-08-0408","title":"Insulin-Like Growth Factor Binding Protein-2 Is a Novel Therapeutic Target Associated with Breast Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Jewish General Hospital; Vancouver General Hospital; McGill University; University of British Columbia","funders":"","keywords":"Breast cancer; In vivo; Cancer research; Cancer; Insulin-like growth factor-binding protein; Biology; Tissue microarray; Growth factor; Internal medicine; Endocrinology; Insulin-like growth factor; Medicine; Receptor","score_opus":0.2161812379310138,"score_gpt":0.4342498657276004,"score_spread":0.2180686277965866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099814169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8696935,0.10858876,0.0079016145,0.0019664774,0.0004872895,0.00017174253,0.0008435835,0.00031842655,0.010028517],"genre_scores_gemma":[0.96048874,0.028160814,0.0040863045,0.0005033354,0.00017938265,0.0000909322,0.0011167005,0.000019056608,0.005354731],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990857,0.000011706127,0.000005489524,0.000019174433,0.000038679933,0.000016364844],"domain_scores_gemma":[0.99995637,0.0000065863683,0.00001515377,0.0000039269107,0.000008228768,0.000009779867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015136389,0.00041490106,0.00024609765,0.00020876582,0.00013581043,0.0003813828,0.00020127285,0.0003201737,0.0013557406],"category_scores_gemma":[0.00011128627,0.000100405414,0.00024249767,0.00029410602,0.00018673805,0.00015174973,0.00016328479,0.000566614,0.00034494643],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045390186,0.00016355669,0.003958823,0.00043066795,0.000040206014,0.00032389566,0.000028901257,0.00018089784,0.95341027,0.00023004798,0.00097433856,0.039804444],"study_design_scores_gemma":[0.00016475958,0.0029159915,0.05050859,0.00007600245,0.00027694218,0.0053435895,0.00008402601,0.0015737399,0.8782387,0.00027681704,0.060521733,0.000019165805],"about_ca_topic_score_codex":0.0006678661,"about_ca_topic_score_gemma":0.0011336154,"teacher_disagreement_score":0.0013557406,"about_ca_system_score_codex":0.00054487603,"about_ca_system_score_gemma":0.00029630665,"threshold_uncertainty_score":0.004535377},"labels":[],"label_agreement":null},{"id":"W2099842815","doi":"10.1158/1078-0432.ccr-13-2147","title":"Surveillance of the Tumor Mutanome by T Cells during Progression from Primary to Recurrent Ovarian Cancer","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of Victoria; Simon Fraser University; University of British Columbia","funders":"","keywords":"Ovarian cancer; ELISPOT; CD8; Epitope; Biology; Ovarian tumor; Cancer; Cancer research; Nonsynonymous substitution; Primary tumor; T cell; Immune system; Mutation; Cytotoxic T cell; Immunology; Medicine; Antibody; Metastasis; Genetics; Gene; Genome","score_opus":0.08844247405143725,"score_gpt":0.46397425790737373,"score_spread":0.3755317838559365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099842815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992562,0.00040529852,0.00007562342,0.000016149505,0.0000030138938,0.000008801092,0.000026076248,0.000008994247,0.00019990905],"genre_scores_gemma":[0.9996805,0.000069866575,0.00006407247,0.000020088559,0.000009029373,0.000007838477,0.000058257137,0.0000015643036,0.000088615096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99986637,0.000026413993,0.0000095933565,0.00003264095,0.00002528723,0.00003973235],"domain_scores_gemma":[0.999724,0.00006849535,0.0000930813,0.000021025851,0.000033572596,0.00005977149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021939435,0.00017160704,0.00032125917,0.00024441452,0.00017932747,0.00031073458,0.00012100924,0.0002833223,0.00080178137],"category_scores_gemma":[0.0007912152,0.00007951711,0.00016251295,0.00018719405,0.00016900175,0.00016401302,0.00014778716,0.00027271255,0.00017439046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003878377,0.00021358544,0.70782626,0.00022595075,0.000071852795,0.0025872705,0.0008088768,0.0008180722,0.22902527,0.00008038678,0.0005131437,0.05395102],"study_design_scores_gemma":[0.0001385224,0.0037731188,0.94652927,0.000020714977,0.00014176937,0.011087723,0.00041282372,0.0013794323,0.034156535,0.00013219716,0.002215395,0.000012494428],"about_ca_topic_score_codex":0.00060745265,"about_ca_topic_score_gemma":0.0005414816,"teacher_disagreement_score":0.00080178137,"about_ca_system_score_codex":0.0002742483,"about_ca_system_score_gemma":0.00015369966,"threshold_uncertainty_score":0.002682209},"labels":[],"label_agreement":null},{"id":"W2099886521","doi":"10.1158/1078-0432.ccr-05-2508","title":"Human Neural Stem Cells Target Experimental Intracranial Medulloblastoma and Deliver a Therapeutic Gene Leading to Tumor Regression","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":203,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"","keywords":"Medulloblastoma; Neural stem cell; Brain tumor; In vivo; Cancer research; Glioma; In vitro; Suicide gene; Stem cell; Biology; Genetic enhancement; Medicine; Pharmacology; Pathology; Gene; Cell biology; Biochemistry; Genetics","score_opus":0.1957928397752684,"score_gpt":0.5101373092039596,"score_spread":0.3143444694286912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099886521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930964,0.00090496975,0.003514359,0.00006205061,0.000035981353,0.00015900294,0.00032142276,0.00011914314,0.0017865916],"genre_scores_gemma":[0.9920292,0.00081555627,0.0046783173,0.000025478796,0.000009730906,0.00009193959,0.00044348364,0.000017911107,0.0018884039],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990976,0.000008474763,0.000007755771,0.000020694168,0.000032820164,0.000020518171],"domain_scores_gemma":[0.9999597,0.000009027813,0.000011620343,0.000006239777,0.0000047270273,0.000008731235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012636163,0.00035399297,0.00019656726,0.00026698064,0.000104176775,0.0001378522,0.00015984058,0.00023394704,0.0012136312],"category_scores_gemma":[0.00006015362,0.00006948717,0.0002386236,0.00014768813,0.00022554812,0.000110072455,0.000090569854,0.00042195324,0.0002545143],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001749815,0.00016081818,0.00024484433,0.00007089249,0.000008338058,0.00006988238,0.00003496411,0.00019617006,0.99587446,0.00018393058,0.000096114316,0.0028845211],"study_design_scores_gemma":[0.000036555757,0.0010455222,0.0012009434,0.0000049431387,0.000018913257,0.00012882485,0.000016192076,0.0007737352,0.99537414,0.000019548925,0.001379377,0.000001472399],"about_ca_topic_score_codex":0.0025250185,"about_ca_topic_score_gemma":0.0030956033,"teacher_disagreement_score":0.0025250185,"about_ca_system_score_codex":0.00034409508,"about_ca_system_score_gemma":0.0003514185,"threshold_uncertainty_score":0.005020678},"labels":[],"label_agreement":null},{"id":"W2100100178","doi":"10.1158/1078-0432.ccr-05-2152","title":"Phase 1 and Pharmacokinetic Study of Intravenous Irinotecan in Refractory Solid Tumor Patients with Hepatic Dysfunction","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"National Center for Research Resources","keywords":"Medicine; Irinotecan; Bilirubin; Gastroenterology; Internal medicine; Pharmacokinetics; Neutropenia; Liver function; Nausea; Vomiting; Adverse effect; Jaundice; Liver function tests; Alanine transaminase; Toxicity; Cancer; Colorectal cancer","score_opus":0.06193093059145054,"score_gpt":0.4521873401978237,"score_spread":0.39025640960637314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100100178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99842405,0.0004537035,0.0002924063,0.0000772192,0.000011983594,0.00025417912,0.00010591498,0.000022902443,0.00035752307],"genre_scores_gemma":[0.9960759,0.00050068664,0.001263276,0.0002131568,0.000042740296,0.0005203649,0.0007497958,0.000013656763,0.00062037783],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996927,0.00014869926,0.00001287056,0.0000414736,0.000039730257,0.00006462384],"domain_scores_gemma":[0.99952567,0.00010344274,0.00011373104,0.00003938845,0.000029100667,0.00018878907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000578897,0.00096372684,0.0014672106,0.0002279605,0.00036669458,0.00044025193,0.00042385163,0.00047096153,0.0013364829],"category_scores_gemma":[0.0008614381,0.00033632072,0.0004474967,0.0002913956,0.0006282919,0.00042834645,0.00018174516,0.0015447926,0.0003876372],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37945572,0.0993136,0.051400755,0.0006544421,0.00089714077,0.0013136542,0.00075632107,0.014190031,0.22001486,0.00039499972,0.004565593,0.22704288],"study_design_scores_gemma":[0.19805576,0.6946637,0.06250625,0.000046689525,0.00048772714,0.0014774888,0.00013153766,0.0071421387,0.029607296,0.00029408367,0.0055277953,0.000059584152],"about_ca_topic_score_codex":0.0006221146,"about_ca_topic_score_gemma":0.0012326668,"teacher_disagreement_score":0.0014672106,"about_ca_system_score_codex":0.00065732934,"about_ca_system_score_gemma":0.0016007486,"threshold_uncertainty_score":0.0047693253},"labels":[],"label_agreement":null},{"id":"W2100157279","doi":"10.1158/1078-0432.ccr-13-2076","title":"Telomere Content and Risk of Second Malignant Neoplasm in Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Cancer; Thyroid cancer; Medicine; Breast cancer; Telomere; Oncology; Internal medicine; Sarcoma; Pathology; Biology; Genetics","score_opus":0.1332779358747268,"score_gpt":0.42846442833934845,"score_spread":0.29518649246462164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100157279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983845,0.00046452408,0.00008614272,0.000038520997,0.0000036362467,0.000005577411,0.0008575272,0.000003581955,0.00015587636],"genre_scores_gemma":[0.99885964,0.00026851406,0.000062155596,0.000009821322,0.0000056410076,0.0000081546805,0.0006838498,0.0000014218591,0.00010084501],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999798,0.000055790813,0.00002194916,0.000048825983,0.000048881797,0.00002663826],"domain_scores_gemma":[0.99861455,0.00023002469,0.00070439663,0.000135187,0.00015618655,0.00015966276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005274952,0.00019470227,0.0002575488,0.00051997503,0.00019288533,0.0002789805,0.0001678639,0.00020291767,0.00085515314],"category_scores_gemma":[0.0017924391,0.00014052003,0.00043034228,0.0006952497,0.00013019957,0.00012857838,0.00023961444,0.00025773328,0.00007618032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000630602,0.0000066274697,0.99905676,0.000008830961,0.00005635015,0.00003115128,0.000042155396,0.000015997455,0.000112374844,0.0000071640766,0.000058794158,0.0005406733],"study_design_scores_gemma":[0.0000064654514,0.000049482664,0.9993173,0.0000064974697,0.000055153174,0.00019066308,0.00006352131,0.0000571432,0.00007998159,0.0000057380557,0.00016639417,0.0000016875356],"about_ca_topic_score_codex":0.01034586,"about_ca_topic_score_gemma":0.007967639,"teacher_disagreement_score":0.01034586,"about_ca_system_score_codex":0.00021739265,"about_ca_system_score_gemma":0.00028668728,"threshold_uncertainty_score":0.020571232},"labels":[],"label_agreement":null},{"id":"W2100204192","doi":"10.1158/1078-0432.ccr-07-1392","title":"Treatment of Human Colon Cancer Xenografts with TRA-8 Anti-death Receptor 5 Antibody Alone or in Combination with CPT-11","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"Daiichi Sankyo Europe; National Cancer Institute; National Institutes of Health","keywords":"Cytotoxicity; Apoptosis; In vivo; Cancer research; Flow cytometry; Monoclonal antibody; Cell culture; Biodistribution; Programmed cell death; Tumor necrosis factor alpha; Cancer; Colorectal cancer; Cancer cell; In vitro; Antibody; Molecular biology; Medicine; Pathology; Biology; Immunology; Internal medicine; Biochemistry","score_opus":0.16091068210962134,"score_gpt":0.48472095671322557,"score_spread":0.32381027460360423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100204192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99488395,0.0025090321,0.0006710689,0.00009590441,0.00007696287,0.00007094224,0.00026842018,0.000056208304,0.0013674049],"genre_scores_gemma":[0.99243486,0.0018995181,0.0024905375,0.000060663995,0.00002206238,0.000064152155,0.00073469663,0.000010070643,0.0022835382],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998889,0.000023532906,0.000010044931,0.000023153221,0.000027759153,0.0000266178],"domain_scores_gemma":[0.9999168,0.000015954221,0.000017840228,0.000011981874,0.000012260905,0.000025120105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015853536,0.00033975253,0.00042192588,0.00020856109,0.00013300985,0.00019968228,0.00018975812,0.00023344235,0.0010884207],"category_scores_gemma":[0.00010414926,0.00011861705,0.00022175866,0.00016372863,0.00012211961,0.00015618373,0.00008810493,0.0005156747,0.0003038522],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001183977,0.00047324633,0.000845382,0.00015274037,0.000038366215,0.00008482089,0.000026954156,0.00040333552,0.9902506,0.000044040604,0.00028198957,0.006214429],"study_design_scores_gemma":[0.00034116398,0.012985378,0.011038008,0.000018024766,0.00010448487,0.00068856246,0.00004941337,0.0023812111,0.966932,0.000015912306,0.005433732,0.000012192723],"about_ca_topic_score_codex":0.0015307415,"about_ca_topic_score_gemma":0.0041865953,"teacher_disagreement_score":0.0015307415,"about_ca_system_score_codex":0.00042955886,"about_ca_system_score_gemma":0.00043555812,"threshold_uncertainty_score":0.003641069},"labels":[],"label_agreement":null},{"id":"W2100232885","doi":"10.1158/1078-0432.ccr-03-0287","title":"Antisense RNA Down-Regulation of bcl-2 Expression in DU145 Prostate Cancer Cells Does Not Diminish the Cytostatic Effects of G3139 (Oblimersen)","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of General Medical Sciences","keywords":"DU145; Biology; RNA; Antisense therapy; Messenger RNA; Cancer cell; Small interfering RNA; Protein biosynthesis; Antisense RNA; RNA interference; Sense (electronics); Cancer research; Molecular biology; Cell biology; Cancer; Chemistry; Biochemistry; Gene; Genetics; LNCaP","score_opus":0.042924687359141005,"score_gpt":0.4116320285965079,"score_spread":0.36870734123736687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100232885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948035,0.0013995053,0.0022017634,0.00006484146,0.000049049384,0.00004841132,0.00018072787,0.00007491501,0.00117727],"genre_scores_gemma":[0.99292105,0.0009889088,0.0033287925,0.00005514654,0.0000197733,0.0000605586,0.00045569983,0.000017423803,0.0021527398],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997608,0.0000300836,0.000029528806,0.000052887863,0.00008987653,0.00003686169],"domain_scores_gemma":[0.9998975,0.000028712195,0.000027311906,0.000012178581,0.000014097927,0.000020201012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016279833,0.0003401406,0.00027246072,0.00018605609,0.00018153593,0.00037742034,0.00018960764,0.00020857103,0.00086489005],"category_scores_gemma":[0.000118472475,0.000115374576,0.0002179422,0.00017419102,0.00029147175,0.00014484512,0.000108176166,0.0005424385,0.00023713961],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027681825,0.000023684499,0.00005928592,0.000016716907,0.0000015799312,0.000008045767,0.000007719002,0.000013674947,0.9994474,0.000032576565,0.000010699372,0.00035103457],"study_design_scores_gemma":[0.000012771323,0.00039774625,0.0009265573,0.0000015300476,0.0000119004935,0.000052663556,0.000009634179,0.00025701354,0.9974783,0.000005866038,0.0008440823,0.0000019488775],"about_ca_topic_score_codex":0.001207594,"about_ca_topic_score_gemma":0.0021235116,"teacher_disagreement_score":0.001207594,"about_ca_system_score_codex":0.00027177084,"about_ca_system_score_gemma":0.00031915095,"threshold_uncertainty_score":0.0028933287},"labels":[],"label_agreement":null},{"id":"W2100378516","doi":"10.1158/1078-0432.ccr-10-0662","title":"Inhaled Granulocyte-Macrophage Colony Stimulating Factor for First Pulmonary Recurrence of Osteosarcoma: Effects on Disease-Free Survival and Immunomodulation. A Report From the Children's Oncology Group","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre","funders":"National Cancer Institute","keywords":"Granulocyte macrophage colony-stimulating factor; Medicine; Osteosarcoma; Internal medicine; Granulocyte; Oncology; Immunology; Respiratory disease; Granulocyte colony-stimulating factor; Chemotherapy; Pathology; Cytokine; Lung","score_opus":0.10764705623666995,"score_gpt":0.4748981249410533,"score_spread":0.3672510687043834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100378516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8828715,0.11040404,0.0024261905,0.0012900167,0.00025427967,0.00024780628,0.00025418462,0.00011555008,0.0021364193],"genre_scores_gemma":[0.9478955,0.04557241,0.0030156372,0.0010461595,0.0004653515,0.00019030426,0.00059136946,0.000034056833,0.0011891403],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99988055,0.000027670934,0.000019145686,0.000021167578,0.00003189407,0.000019435487],"domain_scores_gemma":[0.99969363,0.00012990898,0.00006351336,0.000024250792,0.00003145432,0.000057250978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040652,0.00040448285,0.00044889757,0.00020082753,0.00015454851,0.00020399355,0.00021745195,0.000318288,0.00057598396],"category_scores_gemma":[0.00051916676,0.000091965296,0.00045626194,0.00015716598,0.0003705987,0.0001308958,0.000113580325,0.0005432581,0.00015649812],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01756615,0.002985569,0.044575773,0.0027575698,0.00093673926,0.0065247156,0.0005519306,0.0011032203,0.22489546,0.00035760007,0.006727894,0.6910174],"study_design_scores_gemma":[0.012857485,0.1466421,0.2951248,0.00056191254,0.003703968,0.059139892,0.0003121519,0.0023708513,0.40540594,0.000322626,0.073457636,0.00010066037],"about_ca_topic_score_codex":0.0010152821,"about_ca_topic_score_gemma":0.0014944872,"teacher_disagreement_score":0.0010152821,"about_ca_system_score_codex":0.0003306271,"about_ca_system_score_gemma":0.0005492514,"threshold_uncertainty_score":0.0023988485},"labels":[],"label_agreement":null},{"id":"W2100491190","doi":"10.1158/1078-0432.ccr-09-0628","title":"Adjuvant Trastuzumab Induces Ventricular Remodeling Despite Aerobic Exercise Training","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Ejection fraction; Medicine; Trastuzumab; Cardiology; Internal medicine; Aerobic exercise; VO2 max; Diastole; Breast cancer; Heart rate; Blood pressure; Cancer; Heart failure","score_opus":0.3383140390610262,"score_gpt":0.5224949249815398,"score_spread":0.18418088592051363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100491190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996147,0.00016629709,0.000044234694,0.000021105478,0.0000054674647,0.000007727999,0.000006112942,0.0000016749717,0.00013246732],"genre_scores_gemma":[0.9994615,0.00015035877,0.00008416291,0.00006420944,0.000021926397,0.000023298007,0.000032815904,8.494452e-7,0.00016086634],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999915,0.000029684883,0.00000426707,0.000009704209,0.000010556809,0.00003071391],"domain_scores_gemma":[0.9998878,0.000033151002,0.000030094252,0.000009889169,0.000005410834,0.00003370126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022593662,0.00017313194,0.00022100785,0.000044241435,0.000084026884,0.00012282265,0.000110855515,0.00016229911,0.0005646179],"category_scores_gemma":[0.00042400922,0.000059382077,0.00009940673,0.00003694155,0.00015206216,0.000079871024,0.00011546274,0.00021425638,0.000068978945],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06313908,0.014428639,0.21941775,0.00030549607,0.0003109787,0.0012732809,0.00035176956,0.0009642122,0.49033195,0.00017877463,0.000752449,0.20854563],"study_design_scores_gemma":[0.002235653,0.08931578,0.8759355,0.00006767296,0.00018215922,0.0011037452,0.00029124008,0.0014591642,0.027714655,0.00017177152,0.0015131882,0.00000957986],"about_ca_topic_score_codex":0.00018755763,"about_ca_topic_score_gemma":0.00033203495,"teacher_disagreement_score":0.0005646179,"about_ca_system_score_codex":0.00008043518,"about_ca_system_score_gemma":0.00010036541,"threshold_uncertainty_score":0.0018888116},"labels":[],"label_agreement":null},{"id":"W2101076259","doi":"10.1158/1078-0432.ccr-04-2587","title":"A Predictive Model of Rectal Tumor Response to Preoperative Radiotherapy Using Classification and Regression Tree Methods","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Brachytherapy; Radiation therapy; Overfitting; Colorectal cancer; VEGF receptors; Cart; Oncology; Internal medicine; Pathology; Cancer; Machine learning","score_opus":0.47001025376073763,"score_gpt":0.634020811843012,"score_spread":0.16401055808227433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101076259","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4882199,0.0014593974,0.50447917,0.001247574,0.0001312556,0.00019531949,0.0015059599,0.0014892477,0.0012721602],"genre_scores_gemma":[0.9300768,0.00034158467,0.066500776,0.00011778773,0.00007259577,0.00020474404,0.0018435698,0.000045689143,0.0007964138],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9992785,0.00038913012,0.00003614441,0.00010824577,0.00010513555,0.00008284529],"domain_scores_gemma":[0.99710315,0.0022188623,0.00020039795,0.000068419715,0.00032897855,0.000080125435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026217727,0.00095025497,0.0008404568,0.0013919339,0.0002804427,0.0007604883,0.00057532225,0.00064251834,0.0011190376],"category_scores_gemma":[0.0046003307,0.00027908798,0.0010127819,0.0007245554,0.00023286816,0.00040035718,0.0002654833,0.00083089375,0.00041624566],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044726895,0.00024279449,0.028069215,0.00010008799,0.00027118018,0.00016719644,0.000074143674,0.8636062,0.0019726001,0.000619002,0.0020939708,0.10233623],"study_design_scores_gemma":[0.000009103848,0.000050977233,0.0012437055,0.000008035082,0.000021365835,0.000018588238,0.0000046666673,0.9979937,0.00017473473,0.00035490695,0.000115548995,0.0000047508956],"about_ca_topic_score_codex":0.00685577,"about_ca_topic_score_gemma":0.003504924,"teacher_disagreement_score":0.00685577,"about_ca_system_score_codex":0.0006584266,"about_ca_system_score_gemma":0.0010125036,"threshold_uncertainty_score":0.013865411},"labels":[],"label_agreement":null},{"id":"W2101657563","doi":"10.1158/1078-0432.ccr-05-1029","title":"The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":600,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Missense mutation; Breast cancer; Exon; Mutation; Germline mutation; Biology; Gene; Cancer research; Genetics; Cancer; Internal medicine; Oncology; Medicine","score_opus":0.10311501091779605,"score_gpt":0.49384996581352814,"score_spread":0.39073495489573207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101657563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988381,0.00036897068,0.0000677506,0.00003496514,0.00000511573,0.000005850934,0.0005117783,0.000004396421,0.00016311111],"genre_scores_gemma":[0.99840707,0.00014513038,0.000106683816,0.000021479473,0.000020906242,0.000015064664,0.0011527458,0.0000033723234,0.0001275042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999343,0.0001248227,0.00008847271,0.00017871537,0.00013191375,0.00013309857],"domain_scores_gemma":[0.998018,0.0007130522,0.0006186447,0.00014229865,0.00017408878,0.0003338584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055590336,0.00040716305,0.000529001,0.0018053985,0.0005883516,0.00061378686,0.0004836667,0.0007443123,0.0013069118],"category_scores_gemma":[0.0032484299,0.00039001319,0.00031434922,0.001300779,0.0004254689,0.00048486708,0.00051638053,0.0004298886,0.00036291257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008155874,0.000016407354,0.99786085,0.00000703253,0.000023368888,0.00041681444,0.000037672966,0.000051829975,0.00020212606,0.000005337545,0.00007297845,0.0012240201],"study_design_scores_gemma":[0.000017562097,0.00016404565,0.9950728,0.0000074263808,0.000051045856,0.003400838,0.00014074266,0.0003545311,0.00021010752,0.00003315601,0.000540191,0.0000075535727],"about_ca_topic_score_codex":0.002556755,"about_ca_topic_score_gemma":0.0026217713,"teacher_disagreement_score":0.002556755,"about_ca_system_score_codex":0.00042503673,"about_ca_system_score_gemma":0.0003168218,"threshold_uncertainty_score":0.0050837398},"labels":[],"label_agreement":null},{"id":"W2101886132","doi":"10.1158/1078-0432.ccr-06-1590","title":"Unexpected Immunohistochemical Localization of Deoxycytidine Kinase","year":2006,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Immunohistochemistry; Deoxycytidine; Deoxycytidine kinase; Cancer research; Kinase; Medicine; Pathology; Biology; Cancer; Cell biology; Internal medicine; Gemcitabine","score_opus":0.22737901066006602,"score_gpt":0.5476180348224294,"score_spread":0.3202390241623634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101886132","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0101857195,0.011147607,0.000995964,0.86957866,0.102074176,0.0000340549,0.00013092044,0.00014232709,0.0057105524],"genre_scores_gemma":[0.10138135,0.008001262,0.0012479108,0.61966044,0.25932464,0.000048063575,0.00013010748,0.000093869705,0.010112373],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99832124,0.0006586849,0.00019890485,0.0002442077,0.0003550786,0.00022181844],"domain_scores_gemma":[0.9950913,0.002703347,0.0003922594,0.0002106612,0.0010706811,0.0005316537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018394146,0.0007818993,0.0011925147,0.0006079473,0.0012147577,0.0017776366,0.001785257,0.012089179,0.002468387],"category_scores_gemma":[0.010982948,0.0005641892,0.0005230628,0.0005482717,0.0016162782,0.001968611,0.0005269932,0.011777265,0.0025178492],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036040455,0.00008724369,0.0035656493,0.00027962797,0.00007541418,0.09753545,0.00024116108,0.00013689161,0.0028267093,0.0021030414,0.87318456,0.019603781],"study_design_scores_gemma":[0.00028771037,0.0004878254,0.0070918435,0.0004592005,0.00021206037,0.21200359,0.0007700395,0.002209271,0.0049347617,0.0058916537,0.7655077,0.00014432357],"about_ca_topic_score_codex":0.0005897602,"about_ca_topic_score_gemma":0.0010097158,"teacher_disagreement_score":0.012089179,"about_ca_system_score_codex":0.0016148023,"about_ca_system_score_gemma":0.0005571818,"threshold_uncertainty_score":0.011716306},"labels":[],"label_agreement":null},{"id":"W2102094932","doi":"10.1158/1078-0432.ccr-04-2379","title":"Increased Cyclooxygenase-2 Expression in Duodenal Compared with Colonic Tissues in Familial Adenomatous Polyposis and Relationship to the −765G → <i>C COX-2</i> Polymorphism","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Familial adenomatous polyposis; Gastroenterology; Internal medicine; Medicine; Colorectal cancer; Duodenum; Cyclooxygenase; Adenomatous polyposis coli; Intestinal polyp; Adenocarcinoma; COX-2 inhibitor; Duodenal cancer; Immunohistochemistry; Pathology; Cancer; Biology; Enzyme","score_opus":0.09705796834636993,"score_gpt":0.4373965849768265,"score_spread":0.34033861663045656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102094932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99972457,0.00015203601,0.000032736072,0.0000072229836,0.0000013607586,0.000001052756,0.000025307792,0.000001295484,0.00005447654],"genre_scores_gemma":[0.999778,0.00005625692,0.0000638569,0.000007169987,0.0000036201868,0.000001648031,0.000041830004,7.957836e-7,0.0000468615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982387,0.000037622187,0.000016999473,0.00006013511,0.000033671804,0.000027594078],"domain_scores_gemma":[0.9994324,0.00015871912,0.00025512488,0.000021850088,0.00003719116,0.000094741175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017113466,0.00022954872,0.000223089,0.0007492604,0.0002952703,0.0002779692,0.000107462125,0.00032819665,0.0009976608],"category_scores_gemma":[0.0008020351,0.00021493752,0.00015666235,0.0004421582,0.00030895954,0.00011089834,0.00016466771,0.00025629118,0.00011833451],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013423332,0.000042837593,0.9524008,0.00003327698,0.0000667997,0.0016397777,0.00016947203,0.000041089475,0.04217466,0.000019224963,0.000054835284,0.002014802],"study_design_scores_gemma":[0.000015284397,0.00016863701,0.99292445,0.000003243797,0.00003171676,0.005072075,0.00009995692,0.00008093461,0.0014777333,0.00002014253,0.00010303454,0.0000028648774],"about_ca_topic_score_codex":0.0010265196,"about_ca_topic_score_gemma":0.0011620518,"teacher_disagreement_score":0.0010265196,"about_ca_system_score_codex":0.00020456366,"about_ca_system_score_gemma":0.00007422318,"threshold_uncertainty_score":0.0033375025},"labels":[],"label_agreement":null},{"id":"W2102161352","doi":"10.1158/1078-0432.ccr-04-2064","title":"Placental Cadherin and the Basal Epithelial Phenotype of <i>BRCA1</i>-Related Breast Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":160,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada); McGill University; Jewish General Hospital; McGill University Health Centre; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Breast cancer; Oncology; Internal medicine; Cancer; Medicine; Univariate analysis; Lymph node; Cytokeratin; Basal (medicine); Pathology; Progesterone receptor; Estrogen receptor; Biology; Cancer research; Immunohistochemistry; Multivariate analysis","score_opus":0.05690589327891108,"score_gpt":0.441891027783803,"score_spread":0.3849851345048919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102161352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990771,0.00045965315,0.00010600507,0.0000415916,0.000001926605,0.000002428529,0.0000398319,0.00000554808,0.0002658948],"genre_scores_gemma":[0.99970055,0.00010510354,0.00005199228,0.000005207811,0.000004260597,0.0000011028262,0.000054407683,7.49609e-7,0.00007656997],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998672,0.00005013962,0.0000071546156,0.000021502763,0.00002683783,0.00002711933],"domain_scores_gemma":[0.99901414,0.00025177823,0.000502155,0.00005854301,0.000079032725,0.000094288975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004649375,0.00020199477,0.00012378902,0.00035886368,0.00012522606,0.00031966894,0.00016413287,0.000162407,0.0013964389],"category_scores_gemma":[0.0019963384,0.00012403433,0.00013447039,0.00022219826,0.0003533471,0.00016100818,0.00015592898,0.00031581454,0.00019740079],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003292068,0.000027573218,0.9945563,0.000020271624,0.00003280611,0.00017195125,0.000024780882,0.00009451103,0.0016957916,0.000028162403,0.00007355067,0.0029451456],"study_design_scores_gemma":[0.000008426868,0.00014135765,0.997543,0.0000065944837,0.000032925378,0.0012008658,0.00003582018,0.0003406409,0.00048665362,0.000041343512,0.00016076319,0.000001725173],"about_ca_topic_score_codex":0.0026534256,"about_ca_topic_score_gemma":0.0018589381,"teacher_disagreement_score":0.0026534256,"about_ca_system_score_codex":0.00027106027,"about_ca_system_score_gemma":0.00014559676,"threshold_uncertainty_score":0.0052759647},"labels":[],"label_agreement":null},{"id":"W2102275596","doi":"10.1158/1078-0432.ccr-07-4418","title":"<i>In vivo</i>Optical Coherence Tomography Imaging of Preinvasive Bronchial Lesions","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Optical Coherence Tomography Applications","field":"Engineering","cited_by":199,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia; University of Toronto; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Autofluorescence; Carcinoma in situ; Dysplasia; Medicine; Pathology; Optical coherence tomography; Histopathology; Metaplasia; Hyperplasia; Squamous metaplasia; Bronchoscopy; Endomicroscopy; In vivo; Carcinoma; Radiology; Epithelium; Biology","score_opus":0.12514116094198532,"score_gpt":0.42949127071195925,"score_spread":0.3043501097699739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102275596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936846,0.00084996514,0.0042673773,0.00008994775,0.00000726734,0.000042042593,0.00006983619,0.000041584102,0.0009474653],"genre_scores_gemma":[0.991523,0.0005507415,0.0070861145,0.00008068877,0.000019740075,0.000045835546,0.00014941864,0.000008026882,0.0005363409],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989545,0.000045482626,0.000006350422,0.00001640022,0.000020481104,0.000015885136],"domain_scores_gemma":[0.99983525,0.00004409992,0.000053408763,0.000014926047,0.00003060115,0.000021629014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002902209,0.00019014026,0.00010293551,0.00025424486,0.00011104733,0.00021443378,0.00011741261,0.0003358313,0.0010152995],"category_scores_gemma":[0.0004383294,0.000112540816,0.00007833757,0.00008514929,0.00016034387,0.00022142884,0.00007651406,0.00022899044,0.00020281575],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008742714,0.00022294898,0.02628833,0.00015351245,0.00001645211,0.00028099952,0.00006239585,0.0002594455,0.95846397,0.0000841081,0.0001998334,0.013093752],"study_design_scores_gemma":[0.00014800309,0.0033068107,0.31256527,0.000054609856,0.0001036142,0.0067647537,0.00022332228,0.0060904217,0.6671482,0.0002164623,0.003353726,0.000024780216],"about_ca_topic_score_codex":0.0004206857,"about_ca_topic_score_gemma":0.0007273133,"teacher_disagreement_score":0.0010152995,"about_ca_system_score_codex":0.00020943272,"about_ca_system_score_gemma":0.00013507904,"threshold_uncertainty_score":0.003396511},"labels":[],"label_agreement":null},{"id":"W2102533320","doi":"10.1158/1078-0432.ccr-07-4457","title":"Up-Regulation of Peroxiredoxin 1 in Lung Cancer and Its Implication as a Prognostic and Therapeutic Target","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Redox biology and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Lung cancer; Immunohistochemistry; Biology; Biomarker; Peroxiredoxin; Survival analysis; Cancer research; Phenotype; Cancer; Gene; Oncology; Internal medicine; Medicine; Immunology; Genetics; Enzyme","score_opus":0.11592304915459783,"score_gpt":0.49125056369645953,"score_spread":0.3753275145418617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102533320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98967826,0.008285304,0.0010070379,0.00021942398,0.000016923792,0.00001600417,0.00013373893,0.000035893227,0.0006074609],"genre_scores_gemma":[0.99661034,0.0017337848,0.0007535449,0.000051190447,0.000020462814,0.00001209279,0.00021603222,0.000002914515,0.000599585],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99989736,0.000025003794,0.0000074581326,0.00002461042,0.000029541687,0.000015960391],"domain_scores_gemma":[0.9998642,0.000036119,0.00005080506,0.0000094410025,0.000018201445,0.000021213225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033622776,0.0001857985,0.00019618022,0.00023854423,0.00016450294,0.00023993585,0.00014538657,0.0002099978,0.001065897],"category_scores_gemma":[0.00026348364,0.00008150549,0.0001472209,0.00019548877,0.00019888005,0.00019431206,0.00014761787,0.0002836415,0.00017847931],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014701342,0.00014121331,0.08535314,0.00038469682,0.00006893374,0.0007834358,0.000093599534,0.00045294396,0.8872829,0.00024136838,0.00031036977,0.023417125],"study_design_scores_gemma":[0.00011229615,0.0030874833,0.64412016,0.000057890884,0.00020250835,0.0060086474,0.00032583508,0.0035766365,0.33395374,0.000717658,0.007819539,0.000017540642],"about_ca_topic_score_codex":0.00017754339,"about_ca_topic_score_gemma":0.0002430168,"teacher_disagreement_score":0.001065897,"about_ca_system_score_codex":0.00017769785,"about_ca_system_score_gemma":0.00017433027,"threshold_uncertainty_score":0.0035658479},"labels":[],"label_agreement":null},{"id":"W2102550616","doi":"10.1158/1078-0432.ccr-08-3357","title":"Sequence Variant Discovery in DNA Repair Genes from Radiosensitive and Radiotolerant Prostate Brachytherapy Patients","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency; Canada's Michael Smith Genome Sciences Centre","keywords":"Biology; Prostate cancer; DNA repair; Genetics; Missense mutation; DNA damage; Cancer research; Population; Radiosensitivity; Amplicon; Gene; Mutation; Cancer; Radiation therapy; Internal medicine; DNA; Medicine; Polymerase chain reaction","score_opus":0.1335603701311492,"score_gpt":0.4723985845695263,"score_spread":0.33883821443837714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102550616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99923706,0.00023945495,0.00024036395,0.0000146506245,0.0000036748775,0.000004981013,0.00015916357,0.0000049764826,0.0000956151],"genre_scores_gemma":[0.9995505,0.000041945626,0.0001282633,0.000017174947,0.000006172247,0.0000052511423,0.0001969543,0.0000038392213,0.000049869224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996166,0.000074556876,0.000046566347,0.00015050794,0.00007152096,0.000040197097],"domain_scores_gemma":[0.999374,0.00021344183,0.00024152636,0.000044635122,0.00004132624,0.00008510866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026348716,0.00033553227,0.00034760818,0.0008887584,0.0003224202,0.00034075958,0.00026820347,0.00043583885,0.0017616022],"category_scores_gemma":[0.0011007887,0.00012818811,0.0004077612,0.00096079306,0.00031255474,0.00009291475,0.00023833438,0.0003194901,0.00018829353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015880652,0.000056775774,0.9419984,0.00007928299,0.00034098976,0.002656025,0.0003878074,0.0003175252,0.04412796,0.00011274006,0.00017467252,0.008159829],"study_design_scores_gemma":[0.00005469329,0.00032802738,0.9869847,0.0000146115435,0.0002078892,0.0066618286,0.00014291926,0.0004897763,0.0042094416,0.00012273548,0.0007692609,0.000014093576],"about_ca_topic_score_codex":0.0010318368,"about_ca_topic_score_gemma":0.0010018107,"teacher_disagreement_score":0.0017616022,"about_ca_system_score_codex":0.0001776606,"about_ca_system_score_gemma":0.00016766602,"threshold_uncertainty_score":0.005893171},"labels":[],"label_agreement":null},{"id":"W2102596641","doi":"10.1158/1078-0432.ccr-07-1658","title":"Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1188,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; BC Cancer Agency","funders":"Michael Smith Health Research BC; National Cancer Institute; Sanofi","keywords":"Breast cancer; Triple-negative breast cancer; Oncology; Progesterone receptor; Internal medicine; Medicine; Cytokeratin; Anthracycline; Tissue microarray; Basal (medicine); Biomarker; Estrogen receptor; Cancer; Proportional hazards model; Pathology; Surrogate endpoint; Immunohistochemistry; Biology","score_opus":0.1088655616907161,"score_gpt":0.41913822685961005,"score_spread":0.31027266516889396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102596641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99905056,0.000266355,0.00032929145,0.000019701118,0.0000034439615,0.0000050465387,0.00010860341,0.0000053400468,0.00021166826],"genre_scores_gemma":[0.99919564,0.0000632936,0.00031598125,0.000009113056,0.0000036536255,0.000004117998,0.00034353865,9.5004157e-7,0.00006371092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996581,0.00009440412,0.000035978588,0.000077338686,0.00009735179,0.00003679002],"domain_scores_gemma":[0.9990195,0.00027230225,0.00034447896,0.00008551864,0.000097788936,0.00018034763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097566785,0.00022826933,0.00029903732,0.0003760728,0.00022323302,0.0004724487,0.00016567457,0.00021016145,0.0014794553],"category_scores_gemma":[0.0016139054,0.00009013329,0.00028117278,0.0002715401,0.0002379191,0.00027351687,0.0003425306,0.00027511828,0.00021014581],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012578998,0.00006124852,0.982199,0.00003815107,0.000095466625,0.00005942918,0.000037333677,0.0003063045,0.007844559,0.000039096678,0.00008664328,0.007974877],"study_design_scores_gemma":[0.000029834646,0.0006392427,0.99011165,0.000018991002,0.000118010015,0.000624298,0.00010881737,0.0021295575,0.0055118566,0.0001434314,0.00055177737,0.000012552275],"about_ca_topic_score_codex":0.000510645,"about_ca_topic_score_gemma":0.0009870416,"teacher_disagreement_score":0.0014794553,"about_ca_system_score_codex":0.00033020374,"about_ca_system_score_gemma":0.00024327924,"threshold_uncertainty_score":0.0051599145},"labels":[],"label_agreement":null},{"id":"W2102819165","doi":"10.1158/1078-0432.58.11.1","title":"Vaccination of Dendritic Cells Loaded with Interleukin-12-Secreting Cancer Cells Augments <i>In vivo</i> Antitumor Immunity: Characteristics of Syngeneic and Allogeneic Antigen-Presenting Cell Cancer Hybrid Cells","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"Japan Society for the Promotion of Science","keywords":"Cancer immunotherapy; Immunotherapy; Cancer; Cancer cell; Immunology; Immune system; Dendritic cell; Cancer research; Cancer vaccine; Interleukin 12; Medicine; Antigen; Antigen-presenting cell; T cell; Cytotoxic T cell; Biology; In vitro; Internal medicine","score_opus":0.056096816531421366,"score_gpt":0.3836351251316134,"score_spread":0.32753830860019206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102819165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958264,0.00086331007,0.002160391,0.00006611849,0.0000386541,0.00006219165,0.00011857021,0.00005791555,0.00080639584],"genre_scores_gemma":[0.9965809,0.00056517,0.001813296,0.000058771406,0.00002289062,0.000037962687,0.0002688503,0.000015015614,0.00063712255],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998641,0.000024721381,0.000014170661,0.000024937453,0.000029164095,0.00004282803],"domain_scores_gemma":[0.99991596,0.000017357945,0.000017803364,0.000010341737,0.00001376198,0.000024864912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016472866,0.00042808152,0.00038124665,0.0001937766,0.00008322005,0.00027051012,0.0001195638,0.00028374212,0.00050988694],"category_scores_gemma":[0.000113313334,0.000094380324,0.00022671846,0.00013928155,0.00016953438,0.00016480013,0.000095634445,0.0005216937,0.00021027007],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013702826,0.00009778586,0.00015915379,0.000027653248,0.0000038449766,0.000018276078,0.0000060902516,0.000062509636,0.9985404,0.000027562468,0.000017043303,0.0009027966],"study_design_scores_gemma":[0.000037652506,0.0009743015,0.0013266728,0.000003068377,0.000030308356,0.00015844182,0.000008260919,0.0007431584,0.9957509,0.000017967297,0.00094665895,0.000002647981],"about_ca_topic_score_codex":0.00015423802,"about_ca_topic_score_gemma":0.00019005073,"teacher_disagreement_score":0.00050988694,"about_ca_system_score_codex":0.00018131314,"about_ca_system_score_gemma":0.00018509229,"threshold_uncertainty_score":0.0017057657},"labels":[],"label_agreement":null},{"id":"W2102881335","doi":"10.1158/1078-0432.ccr-07-0867","title":"Prostate-Restricted Replicative Adenovirus Expressing Human Endostatin-Angiostatin Fusion Gene Exhibiting Dramatic Antitumor Efficacy","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Cancer research; Biology; Internal medicine; Medicine","score_opus":0.18087703472038388,"score_gpt":0.4915214089841079,"score_spread":0.31064437426372404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102881335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891515,0.0014170479,0.0077752364,0.00006563028,0.000038349004,0.00005582041,0.00021705046,0.0001391528,0.001140298],"genre_scores_gemma":[0.98976225,0.0008593373,0.006740656,0.0000240766,0.000011143768,0.00003511768,0.00053517695,0.00001781875,0.002014536],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998753,0.000014887464,0.000011897132,0.000034100012,0.000038963088,0.000024821446],"domain_scores_gemma":[0.9999002,0.000019278825,0.000026886855,0.000018772698,0.000011930697,0.000022803435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002198848,0.00040614427,0.00017637275,0.00014530327,0.00007845906,0.00020402856,0.0001459583,0.00017657905,0.0007809191],"category_scores_gemma":[0.00008480401,0.0001053087,0.0002453372,0.00010077875,0.00020429643,0.00016331126,0.00011711249,0.0004830944,0.00023190654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043383538,0.000025772624,0.00013412506,0.000025142177,0.0000041123876,0.000024856112,0.00000714387,0.00004361672,0.9985464,0.000076934404,0.000018891868,0.0010496414],"study_design_scores_gemma":[0.000019478928,0.00056433637,0.001526711,0.0000031354484,0.000023368537,0.00037797293,0.000007379145,0.00055864616,0.99483573,0.00001386415,0.0020667082,0.0000027258766],"about_ca_topic_score_codex":0.00043281278,"about_ca_topic_score_gemma":0.0005273771,"teacher_disagreement_score":0.0007809191,"about_ca_system_score_codex":0.0002582252,"about_ca_system_score_gemma":0.00026042594,"threshold_uncertainty_score":0.002612412},"labels":[],"label_agreement":null},{"id":"W2102925061","doi":"10.1158/1078-0432.ccr-10-3405","title":"The Role of <i>KRAS</i> rs61764370 in Invasive Epithelial Ovarian Cancer: Implications for Clinical Testing","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"National Cancer Institute; Cancer Research UK; Peter MacCallum Cancer Centre; Wellcome Trust; Friedrich-Schiller-Universität Jena; Moffitt Cancer Center; University of South Florida; Deutsches Krebsforschungszentrum; Helsingin ja Uudenmaan Sairaanhoitopiiri; University College London; Helsingin Yliopisto","keywords":"KRAS; Ovarian cancer; Epithelial ovarian cancer; Medicine; Cancer; Oncology; Internal medicine; Pathology; Gynecology; Cancer research; Biology; Colorectal cancer","score_opus":0.5335970556706076,"score_gpt":0.5682043515900453,"score_spread":0.034607295919437786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102925061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9570938,0.03189334,0.0018006681,0.0051497053,0.00012711865,0.00004641383,0.000452082,0.000039772305,0.0033971092],"genre_scores_gemma":[0.99736243,0.0011792958,0.0006311169,0.00047587344,0.00011076471,0.000010731913,0.00010905308,0.0000042909865,0.00011635352],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966529,0.0017424362,0.00035728523,0.0006607899,0.00046367067,0.0001229579],"domain_scores_gemma":[0.9748471,0.017159622,0.0058253473,0.0008164508,0.0006938286,0.00065774214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006848907,0.00049067236,0.00058698887,0.00067449256,0.00028343982,0.0011423456,0.0007802667,0.0009680847,0.0019298447],"category_scores_gemma":[0.014892471,0.0001467066,0.0006590428,0.0012339331,0.0010128104,0.0004786619,0.00033235198,0.00058054936,0.00018083607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025638458,0.000059647737,0.9463741,0.00073884154,0.0017521208,0.0007754998,0.00020298989,0.00048737647,0.0043680044,0.00056823285,0.00063010206,0.04147934],"study_design_scores_gemma":[0.0003818098,0.000914621,0.9807027,0.00048885035,0.0029880058,0.0026775524,0.00021356442,0.002237085,0.0021886355,0.0034508896,0.0037233087,0.000032960786],"about_ca_topic_score_codex":0.001167629,"about_ca_topic_score_gemma":0.0015434207,"teacher_disagreement_score":0.006848907,"about_ca_system_score_codex":0.00025250527,"about_ca_system_score_gemma":0.00049179356,"threshold_uncertainty_score":0.03622091},"labels":[],"label_agreement":null},{"id":"W2102984838","doi":"10.1158/1078-0432.ccr-07-4077","title":"Dietary Intake of Lactose as a Strong Predictor for Secretor Status of Nipple Aspirate Fluid in Healthy Premenopausal Nonlactating Women","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; NIH Clinical Center; National Center for Research Resources; National Institute of Environmental Health Sciences; University of Minnesota","keywords":"Menarche; Medicine; Odds ratio; Lactose; Confidence interval; Logistic regression; Physiology; Obstetrics; Breast cancer; Endocrinology; Breast feeding; Hormone; Anthropometry; Internal medicine; Pregnancy; Childbirth; Gynecology; Cancer; Food science; Biology; Pediatrics","score_opus":0.32998196154980924,"score_gpt":0.517350976716185,"score_spread":0.18736901516637577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102984838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99917406,0.00047217758,0.000026514257,0.00003876563,0.000004540473,0.0000042895376,0.00009691208,0.0000024984836,0.00018018899],"genre_scores_gemma":[0.999684,0.000110248315,0.000046844,0.000014259812,0.0000060241114,0.0000032502169,0.00007944372,8.072549e-7,0.00005507731],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978,0.00007061652,0.000029206452,0.00003761243,0.00005158164,0.000031002997],"domain_scores_gemma":[0.9984713,0.0005117176,0.0006022987,0.000077850935,0.00009219214,0.00024457165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051412947,0.00029069526,0.00029646434,0.00057467824,0.0003692906,0.00044074826,0.0002837919,0.0005018043,0.0012029123],"category_scores_gemma":[0.0027029715,0.00022059942,0.00034475655,0.0005869964,0.0003200678,0.000261422,0.00027243473,0.00050521473,0.0001873594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013738983,0.000021460395,0.9991026,0.0000054282477,0.000022371896,0.00004118543,0.000021235714,0.000006802479,0.00020704903,0.0000024446015,0.000014955104,0.00041710155],"study_design_scores_gemma":[0.0000045304264,0.00012736597,0.9993678,0.0000031676982,0.000025010984,0.00019808681,0.00007875555,0.00009783049,0.00004375371,0.000006621546,0.00004581236,0.0000013467044],"about_ca_topic_score_codex":0.0026193785,"about_ca_topic_score_gemma":0.0028430165,"teacher_disagreement_score":0.0026193785,"about_ca_system_score_codex":0.00015800082,"about_ca_system_score_gemma":0.00026448083,"threshold_uncertainty_score":0.005208254},"labels":[],"label_agreement":null},{"id":"W2103114638","doi":"10.1158/1078-0432.ccr-14-2993","title":"PTEN Loss Is Associated with Worse Outcome in <i>HER2</i> -Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"National Cancer Institute","keywords":"PTEN; Trastuzumab; Breast cancer; Medicine; Immunohistochemistry; Population; Cancer; Oncology; Internal medicine; Cancer research; Pathology; Biology; PI3K/AKT/mTOR pathway; Apoptosis","score_opus":0.332316024989978,"score_gpt":0.5229535913488315,"score_spread":0.19063756635885348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103114638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99941087,0.00018366275,0.00005197895,0.00003433961,0.000003070684,0.000007251723,0.000047250254,0.0000030293545,0.00025847522],"genre_scores_gemma":[0.9996811,0.000052757914,0.00003879536,0.00003172996,0.000011051722,0.0000061753553,0.000113307746,0.0000013115166,0.00006379679],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997011,0.00007460456,0.000032770942,0.00007786331,0.000060446877,0.00005316926],"domain_scores_gemma":[0.9987043,0.00026432317,0.0006711287,0.00006452116,0.000050897146,0.00024471697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072790857,0.00023868254,0.00046450453,0.00043133515,0.00020413715,0.0004229806,0.00023101608,0.00038421387,0.0012179364],"category_scores_gemma":[0.0014027875,0.00013283682,0.00028845403,0.0003868424,0.00039502367,0.00023028791,0.00024072455,0.00049881847,0.00014757283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006343775,0.00025926993,0.9751383,0.00003748165,0.00013489298,0.0004322676,0.000035272962,0.00014620725,0.011499774,0.0000318062,0.00014761108,0.0057933126],"study_design_scores_gemma":[0.00020834387,0.0017787411,0.9940182,0.00000705912,0.00014360347,0.0015364909,0.000038058246,0.0003261803,0.0015469248,0.00006614506,0.00032391984,0.0000062426766],"about_ca_topic_score_codex":0.0003632078,"about_ca_topic_score_gemma":0.00044519358,"teacher_disagreement_score":0.0012179364,"about_ca_system_score_codex":0.00019726681,"about_ca_system_score_gemma":0.00023244247,"threshold_uncertainty_score":0.0040743947},"labels":[],"label_agreement":null},{"id":"W2103156714","doi":"10.1158/1078-0432.ccr-10-1233","title":"REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada); St. Thomas Hospital","funders":"National Cancer Institute; National Center for Research Resources; Cancer Research UK","keywords":"Docetaxel; Medicine; Neutropenia; Oncolytic virus; Cancer; Chemotherapy; Phases of clinical research; Internal medicine; Oncology; Progressive disease; Toxicity; Pharmacology; Gastroenterology","score_opus":0.07597896873666508,"score_gpt":0.5028271086333926,"score_spread":0.42684813989672754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103156714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99071395,0.0035806892,0.00074351236,0.00035778782,0.00012568424,0.0020057124,0.00049287215,0.00012000276,0.0018596986],"genre_scores_gemma":[0.98795766,0.0030694136,0.0024022977,0.0005290024,0.00013881504,0.0018134159,0.0013360851,0.000038237646,0.0027150468],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99960965,0.00015947623,0.000018471632,0.00008295482,0.00004061855,0.00008889481],"domain_scores_gemma":[0.9994733,0.00008229074,0.00008465519,0.000037181973,0.000026283118,0.000296264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011142907,0.0015658888,0.0018927257,0.00039741516,0.00033765525,0.0009612541,0.0009559268,0.0011150079,0.0023958064],"category_scores_gemma":[0.00054185843,0.00058148976,0.0009495427,0.00048008875,0.0009744147,0.0006375375,0.00034181375,0.0033301455,0.00072654884],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40788686,0.20288417,0.015403104,0.0016850141,0.0017927322,0.0008195575,0.0006931609,0.006597795,0.11976074,0.0006578491,0.006290523,0.23552854],"study_design_scores_gemma":[0.29558632,0.67396027,0.012644924,0.00006113871,0.0005353905,0.000671123,0.000078564386,0.0018743653,0.009340827,0.000119243006,0.0050886427,0.00003934783],"about_ca_topic_score_codex":0.0020101308,"about_ca_topic_score_gemma":0.004738168,"teacher_disagreement_score":0.0023958064,"about_ca_system_score_codex":0.0012814532,"about_ca_system_score_gemma":0.0019103058,"threshold_uncertainty_score":0.009297669},"labels":[],"label_agreement":null},{"id":"W2103323117","doi":"10.1158/1078-0432.ccr-08-3275","title":"Effective Treatment of Advanced Human Melanoma Metastasis in Immunodeficient Mice Using Combination Metronomic Chemotherapy Regimens","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Chemotherapy; Melanoma; Oncology; Metastasis; Cancer; Internal medicine; Cancer research","score_opus":0.11522847609623008,"score_gpt":0.4832665285959733,"score_spread":0.3680380524997432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103323117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877994,0.002991951,0.004794923,0.00020623897,0.00011151465,0.00037512052,0.0010924081,0.0002602939,0.0023681638],"genre_scores_gemma":[0.98665166,0.0017644356,0.0070237797,0.00009701532,0.000038936334,0.0003266311,0.0012112381,0.00005307217,0.0028331678],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997217,0.000053797678,0.00002789095,0.000057373272,0.00007772003,0.0000614955],"domain_scores_gemma":[0.999833,0.000022919938,0.000054198044,0.000026160968,0.000009640376,0.000053997253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034973622,0.00078616693,0.0005419984,0.0005544525,0.0001795384,0.0003414552,0.00047727546,0.00045662376,0.0015834437],"category_scores_gemma":[0.00010552623,0.00022245177,0.0003515978,0.00021488793,0.0003188365,0.00035533003,0.00016553624,0.0010485401,0.00031130185],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000809508,0.00067349244,0.00020428967,0.00008789138,0.000018345136,0.000049677954,0.000012718726,0.0003307765,0.9941626,0.00017781898,0.00014322753,0.0033295143],"study_design_scores_gemma":[0.00052920857,0.009313161,0.002233246,0.00002265673,0.0000631941,0.0004077852,0.000013202012,0.0020578897,0.9815655,0.00007336903,0.0037106294,0.000010119159],"about_ca_topic_score_codex":0.00047107646,"about_ca_topic_score_gemma":0.0008211515,"teacher_disagreement_score":0.0015834437,"about_ca_system_score_codex":0.00040383905,"about_ca_system_score_gemma":0.00035699652,"threshold_uncertainty_score":0.005297184},"labels":[],"label_agreement":null},{"id":"W2103346522","doi":"10.1158/1078-0432.ccr-10-3024","title":"Pentraxin-3 Is a Novel Biomarker of Lung Carcinoma","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Biomarkers in Disease Mechanisms","field":"Immunology and Microbiology","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Lung cancer; Medicine; Biomarker; Cancer; Receiver operating characteristic; Internal medicine; Stage (stratigraphy); Oncology; Carcinoma; Lung; Area under the curve; Gastroenterology; Pathology; Biology","score_opus":0.4052341066776421,"score_gpt":0.49071715523306314,"score_spread":0.08548304855542105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103346522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948315,0.0018152151,0.0026689556,0.000092960014,0.000013246389,0.000035719815,0.00016065114,0.00003388102,0.00034779994],"genre_scores_gemma":[0.99633884,0.00023437562,0.0028662265,0.00006590774,0.0000139657495,0.000022525792,0.00024210672,0.000004159055,0.00021191123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925524,0.00022405176,0.00006328723,0.0001801696,0.00023465916,0.000042646632],"domain_scores_gemma":[0.99898106,0.00031138182,0.00042981515,0.00007075368,0.00012736466,0.00007960515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010063823,0.00034753262,0.0004410868,0.00043371748,0.00016207795,0.000601483,0.0002798946,0.0005431113,0.0006759543],"category_scores_gemma":[0.0015605058,0.00016291122,0.00025526548,0.0003231175,0.0003753103,0.00027927323,0.00028008036,0.00043810593,0.00027209314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021993257,0.00019070334,0.6097165,0.00029284199,0.00033608166,0.00040676104,0.00010997578,0.00090869353,0.36553413,0.000116108735,0.00020376958,0.019985024],"study_design_scores_gemma":[0.000079461985,0.0017378527,0.82331336,0.00003933106,0.00025862106,0.004494988,0.00011229803,0.005753024,0.16213727,0.00026159376,0.0017878445,0.00002444824],"about_ca_topic_score_codex":0.0004756958,"about_ca_topic_score_gemma":0.00048602282,"teacher_disagreement_score":0.0010063823,"about_ca_system_score_codex":0.0003727802,"about_ca_system_score_gemma":0.00025706206,"threshold_uncertainty_score":0.005322337},"labels":[],"label_agreement":null},{"id":"W2103727417","doi":"10.1158/1078-0432.ccr-03-0569","title":"Changes in Gene Expression Induced by Phosphorothioate Oligodeoxynucleotides (Including G3139) in PC3 Prostate Carcinoma Cells Are Recapitulated at Least in Part by Treatment with Interferon-β and -γ","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Prostate; Gene expression; Carcinoma; Gene; Interferon; Biology; Cancer research; Medicine; Cancer; Internal medicine; Immunology; Genetics","score_opus":0.11748575378069331,"score_gpt":0.3874279057922098,"score_spread":0.2699421520115165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103727417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947883,0.0010231322,0.0017910729,0.000059136077,0.000020744943,0.00004840656,0.001315076,0.00011982121,0.0008342423],"genre_scores_gemma":[0.9909586,0.00092760747,0.003744822,0.0000702485,0.000009038966,0.00012819235,0.0023112702,0.000025768679,0.0018244488],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99978405,0.000021617265,0.000015321804,0.00006725303,0.00006132551,0.00005037331],"domain_scores_gemma":[0.9998982,0.00001663321,0.000034479377,0.0000121094945,0.000014156638,0.000024469085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000101742895,0.0003772824,0.0003328879,0.00035057293,0.00023407312,0.00025471483,0.00014098536,0.00024573915,0.001195613],"category_scores_gemma":[0.00008429823,0.0001733847,0.00033599674,0.0005381054,0.00029984725,0.00011364586,0.00011543751,0.00050025433,0.00034221887],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008894931,0.000010676753,0.00017469775,0.000012103886,0.000003257086,0.000012113019,0.000007550783,0.000025260271,0.99934345,0.000008346923,0.00000983339,0.0003038032],"study_design_scores_gemma":[0.000009297932,0.00035030724,0.01669428,0.0000025130316,0.000017288156,0.000081796556,0.000032151813,0.00028412364,0.9818856,0.000014649477,0.00062460813,0.0000034396246],"about_ca_topic_score_codex":0.0021966647,"about_ca_topic_score_gemma":0.0034427112,"teacher_disagreement_score":0.0021966647,"about_ca_system_score_codex":0.0003918789,"about_ca_system_score_gemma":0.0004044564,"threshold_uncertainty_score":0.0043677688},"labels":[],"label_agreement":null},{"id":"W2103808961","doi":"10.1158/1078-0432.ccr-06-2379","title":"Characterization and Magnetic Resonance Imaging of a Rat Model of Human B-Cell Central Nervous System Lymphoma","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health","keywords":"Magnetic resonance imaging; Central nervous system; Lymphoma; Pathology; Characterization (materials science); Primary central nervous system lymphoma; Nuclear magnetic resonance; Medicine; Neuroscience; Biology; Radiology; Materials science; Nanotechnology; Physics","score_opus":0.10302826105775215,"score_gpt":0.4329346755516833,"score_spread":0.32990641449393115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103808961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99146664,0.0022785068,0.0046720407,0.00008442213,0.000030178846,0.00011326769,0.00028804422,0.00012132789,0.00094570447],"genre_scores_gemma":[0.98924387,0.0017517564,0.0050535263,0.00005863462,0.000018462946,0.00011577834,0.0010963685,0.000027338898,0.0026342538],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998267,0.000030047158,0.000009913057,0.00003758328,0.0000569941,0.000038862894],"domain_scores_gemma":[0.9998318,0.000021396247,0.00004712266,0.000029491614,0.000029157785,0.000041014773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025582075,0.00058373174,0.00037088568,0.0006581694,0.00016012174,0.00022831437,0.00031040507,0.00034333256,0.0015770985],"category_scores_gemma":[0.00014335716,0.00016398425,0.0002175913,0.00024126109,0.00029399834,0.00029302706,0.00016021077,0.0005567075,0.00065745565],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042311088,0.0003983521,0.00078586413,0.000051510466,0.000012553481,0.00014393852,0.000017102766,0.000097518954,0.9954731,0.00004155903,0.00006653869,0.0024888734],"study_design_scores_gemma":[0.00017003069,0.010082532,0.017204523,0.000021566342,0.0001305187,0.0032256711,0.00009762356,0.0020119352,0.96288234,0.0000582469,0.00409901,0.000016113334],"about_ca_topic_score_codex":0.0017684073,"about_ca_topic_score_gemma":0.00219169,"teacher_disagreement_score":0.0017684073,"about_ca_system_score_codex":0.0003729988,"about_ca_system_score_gemma":0.00027581427,"threshold_uncertainty_score":0.0052759647},"labels":[],"label_agreement":null},{"id":"W2103812354","doi":"10.1158/1078-0432.ccr-11-2080","title":"Copy Number Aberrations in Benign Serous Ovarian Tumors: A Case for Reclassification?","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Serous fluid; Serous carcinoma; Serous Cystadenoma; Pathology; Biology; Carcinogenesis; Cystadenocarcinoma; Ovary; Ovarian cancer; Cancer research; Medicine; Cancer; Genetics","score_opus":0.5835839815901704,"score_gpt":0.5824806149641291,"score_spread":0.00110336662604138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103812354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98332316,0.0049159564,0.004531096,0.0031196014,0.00028016913,0.00007705085,0.00017079095,0.00017100478,0.0034112225],"genre_scores_gemma":[0.9934104,0.00066940085,0.0045865965,0.0005573153,0.0002198112,0.000019014902,0.00022382702,0.00003719906,0.00027657382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809116,0.00036064492,0.00029981404,0.00043874307,0.0006232604,0.00018638918],"domain_scores_gemma":[0.99160707,0.0029309916,0.0016050739,0.0016503251,0.0016459634,0.0005606812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040101465,0.00037506028,0.00049775315,0.0015779772,0.0007082765,0.0009785994,0.0013820102,0.000859183,0.0010489997],"category_scores_gemma":[0.0140500665,0.00014031077,0.00034021604,0.00097555586,0.0013144097,0.0008622388,0.00058037456,0.0010049925,0.00048705257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034969053,0.000034766625,0.9049664,0.000111300855,0.00005510864,0.007908436,0.0007689976,0.00018556946,0.008261119,0.00056606147,0.0018297416,0.07496283],"study_design_scores_gemma":[0.00006525418,0.0004972035,0.8164806,0.0004767375,0.0002755175,0.13831483,0.002919252,0.008093412,0.0068785897,0.0065694256,0.019363612,0.00006562081],"about_ca_topic_score_codex":0.0017056138,"about_ca_topic_score_gemma":0.0026608203,"teacher_disagreement_score":0.0040101465,"about_ca_system_score_codex":0.00040896586,"about_ca_system_score_gemma":0.00043767117,"threshold_uncertainty_score":0.021207929},"labels":[],"label_agreement":null},{"id":"W2103830942","doi":"10.1158/1078-0432.ccr-04-2534","title":"Genetic Polymorphisms of Selected DNA Repair Genes, Estrogen and Progesterone Receptor Status, and Breast Cancer Risk","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Breast cancer; ERCC1; Odds ratio; Genotype; Oncology; Internal medicine; DNA repair; Biology; Cancer; Estrogen receptor; Medicine; Genetics; Gene; Nucleotide excision repair","score_opus":0.03953477060863891,"score_gpt":0.3877575085352418,"score_spread":0.3482227379266029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103830942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985108,0.00093807565,0.00014490343,0.000036414633,0.000004277396,0.000008422358,0.00021848864,0.0000052672203,0.00013333696],"genre_scores_gemma":[0.99900514,0.00033062862,0.00027097433,0.000020647389,0.00000812456,0.000008348459,0.00021791784,0.0000016518848,0.00013661904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999734,0.00006781202,0.000032375734,0.0000833908,0.000054769032,0.000027510647],"domain_scores_gemma":[0.9991047,0.00017915493,0.0004869613,0.000057912694,0.00007720246,0.00009398186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051142875,0.00039858127,0.00032488123,0.0004491795,0.00013955875,0.00027597576,0.00027569936,0.00030959025,0.0012477505],"category_scores_gemma":[0.0015015226,0.00016716731,0.00022364315,0.0006483757,0.00022546986,0.00012754276,0.00011676526,0.00025362312,0.00016682767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003730257,0.00004210337,0.9959214,0.000028975772,0.00018084454,0.00011010057,0.000018408868,0.000070773625,0.0016838674,0.000012752386,0.000034326004,0.0015235196],"study_design_scores_gemma":[0.00003833131,0.00021938521,0.9972984,0.00001121092,0.00020195608,0.00097053015,0.00003669856,0.0002204561,0.0007105255,0.00003583316,0.00025328624,0.00000329285],"about_ca_topic_score_codex":0.0021863522,"about_ca_topic_score_gemma":0.0015060151,"teacher_disagreement_score":0.0021863522,"about_ca_system_score_codex":0.00018158442,"about_ca_system_score_gemma":0.00023620314,"threshold_uncertainty_score":0.0043472648},"labels":[],"label_agreement":null},{"id":"W2103937028","doi":"10.1158/1078-0432.ccr-05-0157","title":"Low Levels of Her2/neu Expressed by Ewing's Family Tumor Cell Lines Can Redirect Cytokine-Induced Killer Cells","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"HER2/neu; Trastuzumab; Cancer research; Cell sorting; In vivo; Neuroblastoma; Cell culture; Cytokine-induced killer cell; Cytotoxicity; Biology; Antibody; In vitro; Cell growth; Cytokine; Immunology; Cancer; Medicine; Internal medicine; Antigen; Flow cytometry; Breast cancer; CD3","score_opus":0.198309089651138,"score_gpt":0.48059172732610295,"score_spread":0.282282637674965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103937028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994997,0.0011585291,0.0022770916,0.000066965236,0.000017886496,0.00004626278,0.00020726323,0.00008913839,0.0011399131],"genre_scores_gemma":[0.9960147,0.0004971465,0.001728324,0.00003464126,0.000006297029,0.000045869718,0.0003937066,0.000011254009,0.0012680421],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998305,0.000020357116,0.000017578832,0.000031587686,0.00006078202,0.00003920593],"domain_scores_gemma":[0.9999069,0.000025485231,0.000025324263,0.000017330562,0.000010958449,0.000014021872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017898905,0.0003967281,0.0003047033,0.00014510418,0.000080567595,0.00033332073,0.00017094758,0.0002745913,0.0013878254],"category_scores_gemma":[0.00013881762,0.00007701792,0.00017146181,0.000107685235,0.00017508423,0.00022222557,0.00013654616,0.0005741688,0.00036228827],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007455826,0.000062976724,0.0002703533,0.000036595775,0.0000039633805,0.000031949978,0.000008873898,0.00009534173,0.99786747,0.00006128879,0.000043169657,0.0014434885],"study_design_scores_gemma":[0.000017082944,0.00033376567,0.0011950432,0.0000025076808,0.000007459022,0.00016043709,0.000008929826,0.00034629108,0.9971054,0.000009154293,0.00081273704,0.0000010708206],"about_ca_topic_score_codex":0.00024811746,"about_ca_topic_score_gemma":0.00035954872,"teacher_disagreement_score":0.0013878254,"about_ca_system_score_codex":0.00030100698,"about_ca_system_score_gemma":0.00015567122,"threshold_uncertainty_score":0.0046427846},"labels":[],"label_agreement":null},{"id":"W2103977830","doi":"10.1158/1078-0432.ccr-07-0828","title":"Nuclear Factor-Y and Epstein Barr Virus in Nasopharyngeal Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research","keywords":"BZLF1; Chromatin immunoprecipitation; Lytic cycle; Biology; Transactivation; Transcription factor; Cancer research; Molecular biology; Nasopharyngeal carcinoma; Virus latency; Promoter; Gene expression; Viral replication; Virology; Virus; Genetics; Gene; Herpesviridae; Medicine; Internal medicine; Radiation therapy","score_opus":0.220601259047563,"score_gpt":0.49657411486172154,"score_spread":0.27597285581415854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103977830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.57184166,0.41545856,0.0026601702,0.0011794283,0.00039689185,0.00008165855,0.0003867866,0.00013847524,0.007856406],"genre_scores_gemma":[0.90205014,0.08975212,0.0012486224,0.00020989477,0.00011366999,0.00006284376,0.00055908377,0.0000084615185,0.0059952047],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999262,0.000020681646,0.0000071587233,0.00001571661,0.000018453567,0.000011775745],"domain_scores_gemma":[0.9999474,0.0000111992995,0.000018974857,0.0000045837774,0.0000068203317,0.0000109974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018830269,0.00027490247,0.00021592945,0.00022437742,0.00017881353,0.00027706724,0.0002057738,0.0003504379,0.0023737294],"category_scores_gemma":[0.00013737874,0.00006389101,0.00020387047,0.00028847082,0.00031621524,0.00020563023,0.0002547617,0.00040067924,0.00042340215],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052869627,0.0007390365,0.0543488,0.0031809264,0.00023725623,0.004996479,0.00037496362,0.0009821814,0.7677568,0.004257861,0.0031496685,0.15468906],"study_design_scores_gemma":[0.00046346136,0.0039613945,0.37454534,0.00081135926,0.000614798,0.032556035,0.0013665697,0.003918291,0.3530906,0.00679743,0.22180411,0.00007063165],"about_ca_topic_score_codex":0.0010348778,"about_ca_topic_score_gemma":0.000983262,"teacher_disagreement_score":0.0023737294,"about_ca_system_score_codex":0.00040085692,"about_ca_system_score_gemma":0.00035283327,"threshold_uncertainty_score":0.007940888},"labels":[],"label_agreement":null},{"id":"W2104165403","doi":"10.1158/1078-0432.ccr-06-0235","title":"Expression of Late Cell Cycle Genes and an Increased Proliferative Capacity Characterize Very Early Relapse of Childhood Acute Lymphoblastic Leukemia","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"Deutsche Kinderkrebsstiftung","keywords":"Immunophenotyping; Cell cycle; Oncology; Minimal residual disease; Gene expression profiling; Disease; Gene; Medicine; Mitosis; Internal medicine; Cancer research; Biology; Leukemia; Immunology; Gene expression; Cancer; Flow cytometry; Genetics","score_opus":0.052740009395507666,"score_gpt":0.3818445829184736,"score_spread":0.32910457352296596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104165403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988009,0.0006487616,0.00014405709,0.000011134284,0.0000018851638,0.000007000026,0.0002493379,0.000007735194,0.00012918157],"genre_scores_gemma":[0.99827564,0.0003445954,0.00040243933,0.000031954976,0.000009509449,0.000019804695,0.000737651,0.0000034448565,0.00017494983],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998547,0.000020562211,0.000013162852,0.000034841236,0.000034986308,0.000041721018],"domain_scores_gemma":[0.99973613,0.000059175705,0.00012775311,0.000014570028,0.000021920105,0.000040389747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010831788,0.00019805253,0.00032230682,0.0008395847,0.00015839633,0.0003667722,0.00012455106,0.0002942597,0.0006489188],"category_scores_gemma":[0.00034944876,0.000095093455,0.0001516135,0.000677786,0.00031993724,0.0001311763,0.00018725672,0.00021609607,0.00016501478],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021089464,0.00014721231,0.40747717,0.00025986487,0.00007658148,0.0007624227,0.00028639112,0.00022326571,0.5697201,0.00013645226,0.00026604134,0.018535508],"study_design_scores_gemma":[0.000018391518,0.00048190673,0.97022635,0.000011728048,0.000043359094,0.0028718903,0.00016064355,0.0002014326,0.025036134,0.00008759112,0.00085225055,0.000008253098],"about_ca_topic_score_codex":0.0002269661,"about_ca_topic_score_gemma":0.00044255375,"teacher_disagreement_score":0.0008395847,"about_ca_system_score_codex":0.00020944489,"about_ca_system_score_gemma":0.000109651744,"threshold_uncertainty_score":0.0021708608},"labels":[],"label_agreement":null},{"id":"W2104192439","doi":"10.1158/1078-0432.ccr-06-0089","title":"Strategies to Enhance Epidermal Growth Factor Inhibition: Targeting the Mevalonate Pathway","year":2006,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Ottawa Regional Cancer Foundation; University of Ottawa","funders":"","keywords":"Lovastatin; Gefitinib; Mevalonate pathway; Epidermal growth factor receptor; Pharmacology; Erlotinib; HMG-CoA reductase; Tyrosine-kinase inhibitor; Cancer research; EGFR inhibitors; CYP3A4; Signal transduction; Reductase; Biology; Chemistry; Cancer; Medicine; Endocrinology; Biochemistry; Internal medicine; Receptor; Cholesterol; Enzyme; Cytochrome P450","score_opus":0.16510943824146354,"score_gpt":0.5140349773078748,"score_spread":0.3489255390664113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104192439","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71141744,0.16969763,0.08895265,0.004527353,0.0010576792,0.0014398935,0.0009724455,0.0010771686,0.020857766],"genre_scores_gemma":[0.8933614,0.06444458,0.031357966,0.0010688178,0.00017424533,0.00035939403,0.00059644633,0.0000826667,0.00855449],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977976,0.0000434682,0.00001274534,0.00004051628,0.000063991385,0.000059510392],"domain_scores_gemma":[0.9999101,0.000017457181,0.000023907585,0.000008847275,0.000020198533,0.000019489833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035202914,0.00075809186,0.000579604,0.0007229159,0.00018263877,0.0007453592,0.00049914356,0.0005840203,0.001563645],"category_scores_gemma":[0.00017369412,0.00022901269,0.00063354557,0.00034710678,0.00023492608,0.00059705705,0.00043637058,0.0012132047,0.0005539049],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000414081,0.00055504777,0.00025875436,0.0007906248,0.00011155674,0.00026594655,0.00007350254,0.001220442,0.9318286,0.0012360584,0.0011794787,0.062065966],"study_design_scores_gemma":[0.00044659883,0.0054749153,0.0034620257,0.00011314666,0.00032536912,0.0015265743,0.0001023956,0.003536311,0.88146806,0.0010548824,0.10243871,0.00005108224],"about_ca_topic_score_codex":0.00075003656,"about_ca_topic_score_gemma":0.001903764,"teacher_disagreement_score":0.001563645,"about_ca_system_score_codex":0.000494234,"about_ca_system_score_gemma":0.0002770329,"threshold_uncertainty_score":0.0052309036},"labels":[],"label_agreement":null},{"id":"W2104296738","doi":"10.1158/1078-0432.ccr-04-1114","title":"Low Levels of Estrogen Receptor β Protein Predict Resistance to Tamoxifen Therapy in Breast Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":197,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Tamoxifen; Breast cancer; Oncology; Medicine; Estrogen receptor; Internal medicine; Proportional hazards model; Population; Adjuvant therapy; Progesterone receptor; Univariate analysis; Cancer; Estrogen; Hormonal therapy; Antiestrogen; Multivariate analysis","score_opus":0.06753129881208497,"score_gpt":0.43911928178271187,"score_spread":0.3715879829706269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104296738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990982,0.00044986216,0.00012054019,0.00003492871,0.000004953302,0.000003869204,0.00008137099,0.0000036717186,0.00020258292],"genre_scores_gemma":[0.9995726,0.00010549235,0.00007628766,0.000013114687,0.0000080414275,0.000003302676,0.00014707314,9.091155e-7,0.00007330246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998698,0.000038287108,0.000024162488,0.000021985259,0.000030177167,0.000015555726],"domain_scores_gemma":[0.9990959,0.00030279407,0.00037659297,0.000039604394,0.00007699413,0.00010813231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045509893,0.00024130939,0.00020956834,0.00057351164,0.00014288252,0.0002797041,0.0001779639,0.00030008517,0.0012441938],"category_scores_gemma":[0.0017051647,0.00011322067,0.00019253272,0.0003700395,0.00018845736,0.00016741137,0.00015669344,0.00029295834,0.0002916808],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029060154,0.000020864489,0.9964018,0.000009824494,0.000028212295,0.000041162482,0.000014497523,0.00007547128,0.0012958769,0.0000050913613,0.000046547088,0.0017700634],"study_design_scores_gemma":[0.000012876673,0.0001876099,0.99782,0.000005689829,0.00005180098,0.0005220188,0.000050876337,0.0005582335,0.0005486604,0.000033140645,0.00020676588,0.0000024008534],"about_ca_topic_score_codex":0.0005767005,"about_ca_topic_score_gemma":0.00053929584,"teacher_disagreement_score":0.0012441938,"about_ca_system_score_codex":0.00012432218,"about_ca_system_score_gemma":0.00014177941,"threshold_uncertainty_score":0.0041621923},"labels":[],"label_agreement":null},{"id":"W2104514175","doi":"10.1158/1078-0432.ccr-06-0571","title":"Prognostic Significance of the Epstein-Barr Virus, p53, Bcl-2, and Survivin in Nasopharyngeal Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Survivin; Nasopharyngeal carcinoma; Immunohistochemistry; Epstein–Barr virus; In situ hybridization; Medicine; Oncology; Cancer; Cancer research; Biopsy; Internal medicine; Pathology; Radiation therapy; Virus; Biology; Immunology; Gene expression; Gene","score_opus":0.16903640305834577,"score_gpt":0.48823226402700565,"score_spread":0.3191958609686599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104514175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988721,0.0008504458,0.00007211035,0.000017919087,0.0000042912034,0.0000035825155,0.00003913926,0.0000028231132,0.00013764072],"genre_scores_gemma":[0.9996804,0.0001416535,0.000048811304,0.000005249186,0.000006805602,0.0000033621839,0.00006315435,6.956134e-7,0.00004977407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982077,0.000041704883,0.000024681394,0.000040440344,0.000041066454,0.000031368654],"domain_scores_gemma":[0.9994373,0.00012095727,0.00017867361,0.000034883564,0.00008235914,0.00014587922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047242327,0.00022102722,0.00030921708,0.00040378186,0.0003133896,0.00038322015,0.00022465872,0.0002898498,0.00097650057],"category_scores_gemma":[0.0014964895,0.00012979087,0.00019540622,0.00037988907,0.00032904098,0.00030969208,0.00026707584,0.00026582726,0.00017833506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042372657,0.000016351863,0.9937588,0.00001373851,0.00003040166,0.0001651549,0.000027456026,0.00006132139,0.00212516,0.000007672637,0.000050497383,0.0033197377],"study_design_scores_gemma":[0.00003117642,0.00023751096,0.99637234,0.0000124205435,0.00008246173,0.0015239972,0.00012182418,0.00035375418,0.0009213442,0.000029385088,0.00030966935,0.000004068244],"about_ca_topic_score_codex":0.0009930161,"about_ca_topic_score_gemma":0.002108348,"teacher_disagreement_score":0.0009930161,"about_ca_system_score_codex":0.00029184046,"about_ca_system_score_gemma":0.00026792948,"threshold_uncertainty_score":0.0032667518},"labels":[],"label_agreement":null},{"id":"W2104564014","doi":"10.1158/1078-0432.ccr-05-2423","title":"A Phase I Biological and Pharmacologic Study of the Heparanase Inhibitor PI-88 in Patients with Advanced Solid Tumors","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Pharmacokinetics; Medicine; Toxicity; Partial thromboplastin time; Pharmacology; Heparanase; Pharmacodynamics; Internal medicine; Gastroenterology; Coagulation; Cancer; Metastasis","score_opus":0.07814163126720325,"score_gpt":0.4798012006300278,"score_spread":0.40165956936282454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104564014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966486,0.0010641268,0.00041701717,0.00019652225,0.000034433135,0.00073890854,0.00023369555,0.00003361054,0.0006330553],"genre_scores_gemma":[0.99497473,0.0009278115,0.0011258562,0.00028860944,0.000093665345,0.0010185847,0.00070982985,0.000010932999,0.0008500199],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996767,0.0001517192,0.000013875871,0.000039561713,0.0000446725,0.00007356643],"domain_scores_gemma":[0.99963,0.000060221348,0.00007295391,0.000034005014,0.000024702254,0.00017823165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000746883,0.0012384433,0.00127114,0.0003045767,0.0003529349,0.0005477888,0.00046534455,0.00069764437,0.0015983727],"category_scores_gemma":[0.00057418767,0.0004015446,0.000655997,0.00032476574,0.0007766792,0.00048146953,0.00026695593,0.0023022592,0.00049331924],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32086653,0.10673455,0.045302052,0.0012005689,0.0014807977,0.0017243797,0.00088985753,0.007491879,0.23897368,0.00059967017,0.0061944746,0.26854154],"study_design_scores_gemma":[0.16810383,0.7701344,0.039692257,0.00003293369,0.0003112391,0.0013044878,0.00009964623,0.0020539686,0.0133962585,0.0001484991,0.0046921694,0.000030267312],"about_ca_topic_score_codex":0.00054187165,"about_ca_topic_score_gemma":0.0008369469,"teacher_disagreement_score":0.0015983727,"about_ca_system_score_codex":0.0006580358,"about_ca_system_score_gemma":0.0011231765,"threshold_uncertainty_score":0.0053470135},"labels":[],"label_agreement":null},{"id":"W2104707958","doi":"10.1158/1078-0432.ccr-1123-03","title":"PC Cell-Derived Growth Factor Expression in Prostatic Intraepithelial Neoplasia and Prostatic Adenocarcinoma","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Prostate cancer; Intraepithelial neoplasia; Prostate; Medicine; High-grade prostatic intraepithelial neoplasia; Adenocarcinoma; Perineural invasion; Cancer; Cancer research; Oncology; Pathology; Internal medicine","score_opus":0.15024029292201196,"score_gpt":0.46486680585303125,"score_spread":0.3146265129310193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104707958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996269,0.0023395054,0.00038457417,0.000015714539,0.000004379943,0.000012217726,0.00005495657,0.000012223646,0.00090740464],"genre_scores_gemma":[0.9985245,0.0006279763,0.00033273577,0.0000090280455,0.0000041623316,0.000011171211,0.00015527902,0.0000015630521,0.00033366363],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99990046,0.00001778371,0.000007769631,0.000016923017,0.000035680605,0.000021393698],"domain_scores_gemma":[0.99985385,0.000037637023,0.000041286465,0.000011924047,0.00002470661,0.000030688698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011941863,0.0001585553,0.00011109786,0.00042590997,0.0001583776,0.00018264224,0.00009050856,0.00016320492,0.0006978365],"category_scores_gemma":[0.00027412333,0.00007675426,0.000096745134,0.00031739016,0.00026659452,0.00011231622,0.00013377659,0.0001703764,0.00011697265],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016819203,0.0001319101,0.26985738,0.0004441394,0.000052490628,0.0034380432,0.00019337084,0.0003420274,0.70149267,0.0003507212,0.00019972041,0.021815557],"study_design_scores_gemma":[0.00003823126,0.0009757143,0.8002731,0.00002958752,0.00007386718,0.013602117,0.00016491344,0.00094337435,0.17861006,0.00022520412,0.005053715,0.000009994147],"about_ca_topic_score_codex":0.0011838435,"about_ca_topic_score_gemma":0.0010855136,"teacher_disagreement_score":0.0011838435,"about_ca_system_score_codex":0.0002842189,"about_ca_system_score_gemma":0.0002491646,"threshold_uncertainty_score":0.0023539662},"labels":[],"label_agreement":null},{"id":"W2104721463","doi":"10.1158/1078-0432.ccr-07-0382","title":"Phase I Targeted Combination Trial of Sorafenib and Erlotinib in Patients with Advanced Solid Tumors","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Sorafenib; Medicine; Erlotinib; Pharmacokinetics; Adverse effect; Rash; Pharmacology; Internal medicine; Oncology; Hepatocellular carcinoma; Epidermal growth factor receptor; Cancer","score_opus":0.11430761267286169,"score_gpt":0.5290445278227675,"score_spread":0.41473691514990574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104721463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99500895,0.0012436584,0.00040682298,0.00023825422,0.00008727715,0.0015846462,0.00035388212,0.000045846653,0.0010306784],"genre_scores_gemma":[0.9941964,0.0006963581,0.0009896456,0.000288,0.00014142417,0.0014284349,0.0010653003,0.000008597026,0.0011858025],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995536,0.00017817352,0.0000299852,0.00007749516,0.000065799024,0.00009485212],"domain_scores_gemma":[0.99947065,0.00007259025,0.000107223335,0.000031221658,0.000032133426,0.000286128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011182731,0.001626398,0.0022729144,0.0003654665,0.00039340602,0.00067904516,0.00058676116,0.000708422,0.002707281],"category_scores_gemma":[0.00068263133,0.00047306498,0.00089662784,0.00035856428,0.0007204078,0.00059179467,0.0003383513,0.0022114085,0.00062498706],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78035337,0.066676535,0.011151255,0.00081602606,0.0013951516,0.00054311956,0.00032406277,0.0037644766,0.04574423,0.0002366421,0.0030551073,0.08594],"study_design_scores_gemma":[0.47548187,0.5045904,0.011989529,0.000028368537,0.00035177352,0.00033448866,0.000040696283,0.0017724901,0.003499436,0.000090725574,0.0018003273,0.000019935238],"about_ca_topic_score_codex":0.00056780665,"about_ca_topic_score_gemma":0.0015125602,"teacher_disagreement_score":0.002707281,"about_ca_system_score_codex":0.0008046236,"about_ca_system_score_gemma":0.0015850164,"threshold_uncertainty_score":0.009056747},"labels":[],"label_agreement":null},{"id":"W2105260398","doi":"10.1158/1078-0432.ccr-09-2166","title":"Comprehensive MicroRNA Profiling for Head and Neck Squamous Cell Carcinomas","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":396,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"microRNA; Head and neck squamous-cell carcinoma; Cancer research; Downregulation and upregulation; Cell cycle; Clonogenic assay; Gene knockdown; Biology; Cell growth; Flow cytometry; Cell; Cell culture; Cancer; Head and neck cancer; Molecular biology; Gene","score_opus":0.11343328049493545,"score_gpt":0.4556207139829654,"score_spread":0.34218743348802994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105260398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979412,0.011914441,0.0036033795,0.00009683623,0.000030950363,0.00010021732,0.0032357632,0.00015074029,0.0014556554],"genre_scores_gemma":[0.98146707,0.0032254015,0.0085949255,0.00012541426,0.000026402977,0.00012437432,0.0050831717,0.00003197583,0.0013211332],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997439,0.00002501732,0.000033167922,0.000075551594,0.00009158253,0.00003088717],"domain_scores_gemma":[0.99986196,0.00002791277,0.000030512096,0.0000142515555,0.00004758635,0.000017742115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002945561,0.0002927456,0.0004903479,0.000944377,0.00027476257,0.00042333174,0.00017221914,0.000254329,0.0011458899],"category_scores_gemma":[0.00037922888,0.00012534516,0.0003553026,0.0006060745,0.0001279828,0.00014958915,0.00028381112,0.0002172329,0.000467037],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010926332,0.000060503055,0.12293754,0.0006336727,0.00016555694,0.00054371747,0.00015596466,0.00035295697,0.8101086,0.00009377485,0.00091290957,0.06294222],"study_design_scores_gemma":[0.000041165553,0.00091711327,0.6423819,0.00009361336,0.00065172394,0.0072410344,0.00032184803,0.0024127807,0.32733998,0.00019030583,0.018372359,0.0000361649],"about_ca_topic_score_codex":0.00060319836,"about_ca_topic_score_gemma":0.0015148447,"teacher_disagreement_score":0.0011458899,"about_ca_system_score_codex":0.0002637176,"about_ca_system_score_gemma":0.0004121884,"threshold_uncertainty_score":0.0038334131},"labels":[],"label_agreement":null},{"id":"W2105298716","doi":"10.1158/1078-0432.ccr-04-0499","title":"A Clinicobiological Model Predicting Survival in Medulloblastoma","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Hospital for Sick Children","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; National Cancer Institute; Cancer Care Ontario; Eli Lilly and Company","keywords":"Medulloblastoma; Biology; Genetics","score_opus":0.4143517323627871,"score_gpt":0.5749078252633686,"score_spread":0.16055609290058148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105298716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895522,0.00048177564,0.007975405,0.0006138485,0.000027639926,0.000026015674,0.0006315644,0.00009624474,0.00059535],"genre_scores_gemma":[0.99807835,0.00007270472,0.0011489316,0.000023971286,0.000021013375,0.000017737324,0.0004289781,0.000006207485,0.00020197431],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997805,0.000093654664,0.00001099288,0.000050215138,0.000027424432,0.000037234146],"domain_scores_gemma":[0.9992607,0.00043354454,0.00011055659,0.000029228388,0.00007509081,0.00009093339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009155305,0.0005575462,0.00031663728,0.0007771798,0.0002554795,0.0005292643,0.00039973596,0.00030073704,0.0014901594],"category_scores_gemma":[0.0026477983,0.0001238437,0.00038092025,0.00034704327,0.0002490083,0.00016706708,0.00033224616,0.0004419553,0.0003251056],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054375146,0.00008922167,0.9626395,0.000024653777,0.00018739775,0.00014443308,0.000046169615,0.018632611,0.00068662135,0.00016882492,0.00095682323,0.015879963],"study_design_scores_gemma":[0.000115566705,0.0004649443,0.49410847,0.000037292495,0.0003361562,0.00096570095,0.00019421027,0.49855503,0.0007059814,0.0023832773,0.0021057886,0.000027590171],"about_ca_topic_score_codex":0.0074304547,"about_ca_topic_score_gemma":0.006582066,"teacher_disagreement_score":0.0074304547,"about_ca_system_score_codex":0.000609972,"about_ca_system_score_gemma":0.0008300794,"threshold_uncertainty_score":0.014774442},"labels":[],"label_agreement":null},{"id":"W2105398998","doi":"10.1158/1078-0432.ccr-08-2635","title":"Imaging Biomarkers Predict Response to Anti-HER2 (ErbB2) Therapy in Preclinical Models of Breast Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Biomedical Imaging and Bioengineering; National Cancer Institute","keywords":"Trastuzumab; Medicine; Apoptosis; Breast cancer; Positron emission tomography; Cancer; Cancer research; Immunohistochemistry; Annexin; Annexin A5; Pathology; Oncology; Internal medicine; Nuclear medicine; Biology","score_opus":0.3413549984427097,"score_gpt":0.6007117179825404,"score_spread":0.2593567195398307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105398998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986289,0.0067621316,0.004981029,0.00015999218,0.00003135931,0.00011957062,0.0005905325,0.00019420114,0.0008722228],"genre_scores_gemma":[0.9903066,0.0023718015,0.0044362843,0.00010947485,0.000033031643,0.00016536878,0.0008500032,0.000021914271,0.001705452],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997018,0.000055715263,0.000017106533,0.00005218947,0.00013178619,0.000041332423],"domain_scores_gemma":[0.99967885,0.000057755635,0.00015035404,0.00001933472,0.00005819785,0.000035523557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062318513,0.00074771687,0.0005619442,0.00059825694,0.00007644943,0.00048678502,0.0002401638,0.0005600642,0.0007934357],"category_scores_gemma":[0.00061900716,0.00021314203,0.00016061595,0.00030826105,0.00017690632,0.00035354708,0.00015455749,0.00063721155,0.00035973697],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020956162,0.00084971014,0.0277309,0.00023267894,0.00008488382,0.00008414947,0.000036300706,0.0016035299,0.93972003,0.00006325102,0.00039229207,0.027106617],"study_design_scores_gemma":[0.00020002454,0.007326072,0.14100283,0.000043780197,0.00030713764,0.0008265615,0.00010984822,0.014719926,0.83152205,0.00016305922,0.0037464728,0.000032315376],"about_ca_topic_score_codex":0.0004139468,"about_ca_topic_score_gemma":0.00072179735,"teacher_disagreement_score":0.0007934357,"about_ca_system_score_codex":0.00042300622,"about_ca_system_score_gemma":0.00023858744,"threshold_uncertainty_score":0.0032957196},"labels":[],"label_agreement":null},{"id":"W2105400786","doi":"10.1158/1078-0432.ccr-09-1357","title":"The Cross-Validated Adaptive Signature Design","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":190,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Classifier (UML); Adaptive design; Computer science; Signature (topology); Clinical trial; Cross-validation; Data mining; Medicine; Artificial intelligence; Machine learning; Mathematics; Pathology","score_opus":0.9293997658481492,"score_gpt":0.77552257358576,"score_spread":0.15387719226238916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105400786","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026946321,0.00013836316,0.97143483,0.00017081482,0.000063906125,0.000469242,0.00006799173,0.000190016,0.0005184615],"genre_scores_gemma":[0.60704094,0.00016277387,0.38736916,0.00048337525,0.00010490875,0.0023451634,0.000439724,0.000067836125,0.0019860796],"study_design_codex":"simulation_or_modeling","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9699589,0.024686262,0.00085012446,0.002208736,0.0018466036,0.00044941314],"domain_scores_gemma":[0.94659495,0.03682836,0.0033978403,0.006461304,0.005970668,0.00074695406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.042219777,0.0016742016,0.0018055427,0.0010235421,0.0005306671,0.0010955512,0.0026180272,0.0019476338,0.0037230013],"category_scores_gemma":[0.054232385,0.00077004987,0.0018281057,0.00071277644,0.0025258306,0.0013614058,0.002028939,0.0022082292,0.00064026786],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046366183,0.0006760247,0.009860823,0.00040875463,0.00081702444,0.00022971311,0.0001848818,0.6919904,0.007815803,0.06671737,0.0017340953,0.21492846],"study_design_scores_gemma":[0.0006462603,0.0020366537,0.0013156993,0.000040113802,0.0001519329,0.000109997854,0.000011996979,0.96904725,0.0037747598,0.021517865,0.0013027915,0.00004462046],"about_ca_topic_score_codex":0.0005321141,"about_ca_topic_score_gemma":0.00035210393,"teacher_disagreement_score":0.042219777,"about_ca_system_score_codex":0.000971571,"about_ca_system_score_gemma":0.0020205162,"threshold_uncertainty_score":0.22328216},"labels":[],"label_agreement":null},{"id":"W2105448858","doi":"10.1158/1078-0432.ccr-08-1898","title":"Expression of Hepatocyte Growth Factor and Its Receptor Met in Wilms' Tumors and Nephrogenic Rests Reflects Their Roles in Kidney Development","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Cancer Research UK","keywords":"Hepatocyte growth factor; Biology; Carcinogenesis; Stromal cell; Cancer research; Wilms' tumor; Epithelial–mesenchymal transition; Mesenchymal stem cell; Kidney development; Stroma; Pathology; Cell biology; Cancer; Receptor; Immunohistochemistry; Embryonic stem cell; Immunology; Medicine; Gene; Genetics; Metastasis","score_opus":0.08173116888536038,"score_gpt":0.4257291680823693,"score_spread":0.34399799919700896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105448858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988337,0.00042672694,0.00042539602,0.0000053485146,0.0000012511856,0.000003957639,0.00007057143,0.000011181568,0.00022180556],"genre_scores_gemma":[0.9992481,0.00012853267,0.00032269163,0.0000040095747,0.0000029667165,0.0000049768273,0.00014450212,0.0000028762931,0.00014131892],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998246,0.000016663214,0.000021058795,0.000041383253,0.0000723443,0.00002397682],"domain_scores_gemma":[0.99971586,0.000051385967,0.00013078938,0.000021352145,0.000030802737,0.000049862825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022498218,0.00014447185,0.00016594667,0.0007644916,0.00012978073,0.00018268944,0.00012121977,0.00014810557,0.0006487982],"category_scores_gemma":[0.0003733535,0.000094272196,0.00010422327,0.00028439617,0.00026354016,0.00013868902,0.00020869795,0.00013312556,0.00013545128],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000612179,0.000022298245,0.30516967,0.0001090291,0.000037670827,0.0011003675,0.00015704053,0.000100286874,0.68559766,0.000113725124,0.00007199363,0.00690812],"study_design_scores_gemma":[0.000007940764,0.00021986617,0.85244924,0.0000076273864,0.000055352022,0.009000215,0.00015645912,0.00046223364,0.13657568,0.00008359651,0.0009767419,0.000004923141],"about_ca_topic_score_codex":0.00039283454,"about_ca_topic_score_gemma":0.0007047058,"teacher_disagreement_score":0.0007644916,"about_ca_system_score_codex":0.00017034961,"about_ca_system_score_gemma":0.0001360034,"threshold_uncertainty_score":0.0021704435},"labels":[],"label_agreement":null},{"id":"W2105454171","doi":"10.1158/1078-0432.ccr-06-1716","title":"Tubedown Expression Correlates with the Differentiation Status and Aggressiveness of Neuroblastic Tumors","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"National Cancer Institute","keywords":"Neuroblastoma; Retinoic acid; Immunohistochemistry; Ganglioneuroma; Biology; Histopathology; Cellular differentiation; Western blot; Pathology; Blot; Cancer research; Internal medicine; Medicine; Cell culture; Immunology; Gene; Genetics","score_opus":0.08959263899150108,"score_gpt":0.46947758189421995,"score_spread":0.3798849429027189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105454171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99895394,0.0002295849,0.0005679886,0.000007893423,9.385527e-7,0.0000037356644,0.000082258804,0.000009431976,0.00014415503],"genre_scores_gemma":[0.99824774,0.00027178225,0.00076868746,0.00000888049,0.000002589546,0.000008466552,0.0003702767,0.0000046678374,0.00031686263],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99992204,0.0000095719015,0.000011089885,0.000020359368,0.000026045445,0.000010825388],"domain_scores_gemma":[0.9996704,0.00005723174,0.00014841727,0.00002013738,0.000039972336,0.000064018925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011149595,0.00018339,0.00012841298,0.00042445023,0.00009764759,0.00025139045,0.00007620218,0.00016314222,0.0005211773],"category_scores_gemma":[0.00029226535,0.00008538469,0.00008539429,0.00016643379,0.0002282704,0.00012438075,0.00015698222,0.00026684703,0.00016163856],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002445762,0.000018047274,0.10897139,0.000024385245,0.000014245725,0.00012014587,0.000047564477,0.000078852834,0.88820475,0.000034947578,0.000026657981,0.002214362],"study_design_scores_gemma":[0.0000055409378,0.00020885143,0.76818687,0.000006740785,0.00003851683,0.0017746735,0.00008040905,0.0006020319,0.22833815,0.000049753486,0.0007027881,0.0000057260363],"about_ca_topic_score_codex":0.00039481456,"about_ca_topic_score_gemma":0.00056025456,"teacher_disagreement_score":0.0005211773,"about_ca_system_score_codex":0.00013456648,"about_ca_system_score_gemma":0.000088707944,"threshold_uncertainty_score":0.0017435551},"labels":[],"label_agreement":null},{"id":"W2105537697","doi":"10.1158/1078-0432.ccr-11-2711","title":"Tumor Hypoxia Predicts Biochemical Failure following Radiotherapy for Clinically Localized Prostate Cancer","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":293,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Prostate cancer; Radiation therapy; Hypoxia (environmental); Medicine; Tumor hypoxia; Internal medicine; Prostate; Oncology; Cancer; Hormonal therapy; Urology; Oxygen","score_opus":0.08039201231230002,"score_gpt":0.4619518288379821,"score_spread":0.38155981652568205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105537697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99920183,0.00052051456,0.000081750644,0.000025560501,0.000002751288,0.000004740919,0.00004449442,0.0000034488617,0.00011489997],"genre_scores_gemma":[0.9998004,0.000054191056,0.00003260688,0.000006188096,0.0000042157794,0.00000232124,0.00006816075,5.4520535e-7,0.000031425054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998217,0.000080750244,0.000011754062,0.000026634141,0.00003277168,0.000026368267],"domain_scores_gemma":[0.9990415,0.00026569446,0.00043553015,0.00003167943,0.000048768943,0.00017686193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036890004,0.00021466473,0.0002472932,0.00023779598,0.0001887656,0.00020207278,0.00023033097,0.00026057,0.0011208139],"category_scores_gemma":[0.0012393586,0.00009596596,0.00023395105,0.00021514091,0.00025884857,0.00011677539,0.00022157395,0.00031979696,0.00017208814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004425244,0.00004283428,0.9956327,0.000020467694,0.00003521799,0.000063780295,0.000026639895,0.00013936507,0.0008449256,0.000005146414,0.000055634093,0.0026908075],"study_design_scores_gemma":[0.000009211294,0.000555336,0.9984707,0.0000033032381,0.000021184429,0.00039416115,0.000030533196,0.00024016427,0.00018764095,0.000010485053,0.000074838565,0.000002285454],"about_ca_topic_score_codex":0.0014161984,"about_ca_topic_score_gemma":0.0022714639,"teacher_disagreement_score":0.0014161984,"about_ca_system_score_codex":0.00023073693,"about_ca_system_score_gemma":0.00025421384,"threshold_uncertainty_score":0.0037494898},"labels":[],"label_agreement":null},{"id":"W2105763895","doi":"10.1158/1078-0432.ccr-10-3097","title":"Molecular Target Characterization and Antimyeloma Activity of the Novel, Insulin-like Growth Factor 1 Receptor Inhibitor, GTx-134","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Cancer research; Receptor; Multiple myeloma; Growth factor; Growth inhibition; Insulin-like growth factor; In vivo; Bone marrow; Cell culture; Apoptosis; Biology; Fibroblast growth factor receptor 3; Pharmacology; Internal medicine; Fibroblast growth factor; Immunology; Medicine; Biochemistry","score_opus":0.1895705407986632,"score_gpt":0.4392424509220034,"score_spread":0.24967191012334022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105763895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953831,0.0015394035,0.0016339798,0.000058307924,0.000009053428,0.00008726751,0.00046114984,0.000047642214,0.0007800904],"genre_scores_gemma":[0.99228024,0.0012261561,0.0034709994,0.00004222196,0.000006169388,0.000059804916,0.0013037903,0.000013546411,0.0015971257],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993443,0.000008523378,0.0000044343533,0.0000145623035,0.000024516503,0.000013530096],"domain_scores_gemma":[0.99996686,0.000004150656,0.000010393581,0.0000036493948,0.0000065573504,0.000008352831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012617331,0.00035205344,0.00019773461,0.0001861922,0.00007169257,0.00019111068,0.00019841072,0.00022552643,0.00089275505],"category_scores_gemma":[0.000088892964,0.00008574034,0.00019335322,0.00015442698,0.00016306726,0.00016090689,0.00008308953,0.00044567106,0.00024031545],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018256408,0.000094713265,0.00030448058,0.0000495733,0.00000715525,0.000024214372,0.000007205553,0.0003155932,0.99559206,0.00006460707,0.00004955236,0.0033083225],"study_design_scores_gemma":[0.000091707094,0.0024419231,0.00458025,0.0000050088925,0.00003242834,0.00036281478,0.0000075896255,0.0014880969,0.98783374,0.000021474314,0.0031306657,0.0000043594237],"about_ca_topic_score_codex":0.0011086509,"about_ca_topic_score_gemma":0.0013167203,"teacher_disagreement_score":0.0011086509,"about_ca_system_score_codex":0.0004985449,"about_ca_system_score_gemma":0.00029939445,"threshold_uncertainty_score":0.003617227},"labels":[],"label_agreement":null},{"id":"W2105870502","doi":"10.1158/1078-0432.ccr-12-3572","title":"Potentially Prognostic miRNAs in HPV-Associated Oropharyngeal Carcinoma","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"microRNA; Metastasis; Oncology; Downregulation and upregulation; Internal medicine; Medicine; Human papillomavirus; Biomarker; Real-time polymerase chain reaction; Cancer research; Biology; Cancer; Gene; Genetics","score_opus":0.08864923568849564,"score_gpt":0.43346468408869726,"score_spread":0.3448154484002016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105870502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99056995,0.006890296,0.0011160326,0.000056371675,0.00001546891,0.000023033972,0.00038253,0.00002769964,0.00091854704],"genre_scores_gemma":[0.9963691,0.0015681506,0.0012084608,0.000019428817,0.0000111579675,0.000024215551,0.0002876539,0.000008086539,0.0005037326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999833,0.000024172428,0.000019110881,0.00004655653,0.00004918166,0.000027936065],"domain_scores_gemma":[0.9998267,0.000035494468,0.00007785291,0.00001259569,0.000029115818,0.000018238607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030587893,0.00029802806,0.00037095655,0.00046919784,0.0002530478,0.0005519983,0.00016171795,0.00025016244,0.0010970149],"category_scores_gemma":[0.00065262587,0.0001915005,0.00017905682,0.0005444779,0.00023240614,0.00024553097,0.0003762053,0.00023056894,0.00039558747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003584078,0.00010442652,0.53994685,0.0007038605,0.00018968062,0.0014728531,0.0003948435,0.0009314104,0.38596985,0.00042475853,0.00050932344,0.065768056],"study_design_scores_gemma":[0.00006351421,0.00076412,0.8296009,0.00012932013,0.00052641035,0.007321068,0.0004770914,0.0037943837,0.14507589,0.0010819748,0.011131838,0.00003357751],"about_ca_topic_score_codex":0.00034404141,"about_ca_topic_score_gemma":0.00047798894,"teacher_disagreement_score":0.0010970149,"about_ca_system_score_codex":0.00027678313,"about_ca_system_score_gemma":0.00027427025,"threshold_uncertainty_score":0.0036699176},"labels":[],"label_agreement":null},{"id":"W2106062955","doi":"10.1158/1078-0432.ccr-04-0651","title":"Characterization of Mutator Phenotype in Familial Colorectal Cancer Patients Not Fulfilling Amsterdam Criteria","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Microsatellite instability; DNA mismatch repair; Colorectal cancer; Medicine; Epigenetics; Phenotype; Familial adenomatous polyposis; Cancer; Lynch syndrome; Proband; Adenomatous polyposis coli; DNA methylation; Cancer research; Oncology; Genetics; Internal medicine; Biology; Mutation; Gene; Microsatellite; Allele; Gene expression","score_opus":0.13921050433544424,"score_gpt":0.48021050464886533,"score_spread":0.3410000003134211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106062955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99972576,0.00009279544,0.000031777377,0.000006991236,0.0000014589391,0.0000034766197,0.00003766502,0.000001606165,0.00009838115],"genre_scores_gemma":[0.99969435,0.000036621503,0.00008450443,0.0000065494887,0.0000039725605,0.0000047280946,0.00010708309,9.506336e-7,0.000061285165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997596,0.000056841385,0.000030170791,0.00007251484,0.000038382943,0.000042524596],"domain_scores_gemma":[0.9993224,0.00017757919,0.00024535018,0.00003943787,0.000055009892,0.0001600883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024835818,0.00032027415,0.00038626624,0.00074817985,0.0004256092,0.00021354461,0.00017703205,0.00037964995,0.001636148],"category_scores_gemma":[0.0016546769,0.00013290031,0.00014888674,0.00040784656,0.00022346493,0.00016288622,0.00021919739,0.00018105762,0.00016240546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000334965,0.0000312741,0.99298614,0.000014525136,0.000012942081,0.0018452309,0.000083691506,0.000028869825,0.0033643274,0.000019206342,0.000060976938,0.0012179448],"study_design_scores_gemma":[0.000021069734,0.00036430312,0.9851959,0.000007717502,0.000022679758,0.013115946,0.00015835355,0.00015526614,0.00059473806,0.000029024868,0.00033017818,0.0000048981005],"about_ca_topic_score_codex":0.0011345932,"about_ca_topic_score_gemma":0.0014526437,"teacher_disagreement_score":0.001636148,"about_ca_system_score_codex":0.00016917137,"about_ca_system_score_gemma":0.00017589764,"threshold_uncertainty_score":0.005473435},"labels":[],"label_agreement":null},{"id":"W2106314624","doi":"10.1158/1078-0432.ccr-04-0165","title":"Patterns of Chromosomal Alterations in Breast Ductal Carcinoma <b> <i>In situ</i> </b>","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Cancer Institute","keywords":"Ductal carcinoma; Breast cancer; Cancer; Biology; Mammary gland; Chromosome instability; Pathology; In situ; Comparative genomic hybridization; Histology; Carcinoma in situ; Oncology; Internal medicine; Medicine; Chromosome; Gene; Genetics","score_opus":0.06031662902823734,"score_gpt":0.39507401928895247,"score_spread":0.33475739026071516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106314624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99919766,0.0002510945,0.00025058043,0.000007705461,7.130577e-7,0.000003990144,0.00008804794,0.0000079133715,0.00019226158],"genre_scores_gemma":[0.9994742,0.00008986952,0.00017584393,0.000004787365,0.000001141556,0.0000057220536,0.00012788844,0.0000019431652,0.00011858491],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997874,0.000042023443,0.000023147735,0.00006103801,0.000058659884,0.000027748316],"domain_scores_gemma":[0.9995821,0.00010983747,0.0001918865,0.000029377312,0.000046981,0.00003992568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018790847,0.00017426678,0.00013883933,0.0012327818,0.00012624565,0.00021101217,0.00013802332,0.0001799451,0.0009985656],"category_scores_gemma":[0.00072741654,0.0001335529,0.00009288143,0.00053850096,0.00028814015,0.00014255047,0.00019176782,0.00013042013,0.000158941],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013232934,0.000062268446,0.5994321,0.00015640556,0.0002557614,0.0009540815,0.00035746474,0.00034664467,0.37935135,0.00014490016,0.000093870054,0.01752188],"study_design_scores_gemma":[0.000015491789,0.00025904397,0.98179686,0.0000060449684,0.000053696116,0.0029781095,0.00016047862,0.00030339247,0.013984373,0.0000885453,0.00034730422,0.0000066040516],"about_ca_topic_score_codex":0.00084888237,"about_ca_topic_score_gemma":0.0013164337,"teacher_disagreement_score":0.0012327818,"about_ca_system_score_codex":0.00019891116,"about_ca_system_score_gemma":0.00007730812,"threshold_uncertainty_score":0.0033404827},"labels":[],"label_agreement":null},{"id":"W2106381426","doi":"10.1158/1078-0432.ccr-05-2290","title":"Phase II Study of Pomegranate Juice for Men with Rising Prostate-Specific Antigen following Surgery or Radiation for Prostate Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pomegranate: compositions and health benefits","field":"Nursing","cited_by":461,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"LNCaP; Medicine; Prostate cancer; Prostate-specific antigen; Gallic acid; Nitric oxide; Lipid peroxidation; Apoptosis; Internal medicine; Prostate; Gastroenterology; Cancer; Urology; Antioxidant; Endocrinology; Oxidative stress; Biology; Biochemistry","score_opus":0.24204669345587299,"score_gpt":0.5389426306171787,"score_spread":0.29689593716130575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106381426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99091536,0.0018191623,0.00047662825,0.0003731312,0.00012910405,0.004279694,0.0008106935,0.00011079809,0.0010853317],"genre_scores_gemma":[0.98403937,0.0020527367,0.0023290915,0.0008609721,0.0002470644,0.0046262573,0.0017716786,0.000030427238,0.0040423344],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997279,0.00013516695,0.000009538463,0.00004806802,0.000024876459,0.000054417116],"domain_scores_gemma":[0.9993968,0.000103847495,0.00011365848,0.00004724013,0.000040765346,0.00029771554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011738972,0.0017161376,0.002007862,0.0004734728,0.00039948645,0.0007765901,0.00104499,0.0015004514,0.0066310037],"category_scores_gemma":[0.0006651005,0.00055024197,0.0011126954,0.00038921225,0.00094273366,0.00056320115,0.00029908007,0.0021381767,0.00092625414],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8164095,0.09527501,0.0025450788,0.00084079406,0.00068465417,0.0001469087,0.0001891986,0.0010646239,0.041607954,0.00012859315,0.0017956622,0.03931191],"study_design_scores_gemma":[0.49124953,0.49830535,0.0047703227,0.000021856715,0.00019993626,0.00008433666,0.00003662378,0.00042977536,0.0034909383,0.00006510173,0.0013341134,0.000012152199],"about_ca_topic_score_codex":0.0007074785,"about_ca_topic_score_gemma":0.001831715,"teacher_disagreement_score":0.0066310037,"about_ca_system_score_codex":0.00051549263,"about_ca_system_score_gemma":0.001469112,"threshold_uncertainty_score":0.022182941},"labels":[],"label_agreement":null},{"id":"W2106728539","doi":"10.1158/1078-0432.ccr-11-3216","title":"The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the Literature","year":2012,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":434,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Value (mathematics); Cancer; Medicine; Pathology; Oncology; Internal medicine; Statistics","score_opus":0.3397851811151872,"score_gpt":0.5872416934896351,"score_spread":0.24745651237444788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106728539","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016510642,0.99959034,0.000028714956,0.000120694385,0.00004090496,0.0000031215436,0.000022089394,0.000001856823,0.000027306718],"genre_scores_gemma":[0.0032263696,0.99613756,0.00016660156,0.00023432805,0.00013884854,0.000015458632,0.000055616038,0.0000019821382,0.000023271179],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.998028,0.0004436326,0.000815425,0.00031425682,0.00032331105,0.0000754561],"domain_scores_gemma":[0.9823325,0.013590722,0.0018238998,0.00024149763,0.0017827064,0.0002286781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005000341,0.0011141124,0.004181356,0.012100653,0.00040780066,0.0016125015,0.0014484547,0.0013533804,0.0014206804],"category_scores_gemma":[0.013560549,0.00072462513,0.0030172463,0.011654165,0.0010483329,0.001881242,0.0009934419,0.00097110687,0.00024805337],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005615465,0.000040974155,0.004550869,0.41857743,0.003754373,0.0002544875,0.0002878142,0.00039135508,0.00062812323,0.00070937333,0.010573362,0.55967027],"study_design_scores_gemma":[0.0002369599,0.0009678245,0.03615648,0.65144855,0.052901257,0.0043601934,0.0010131127,0.0005389491,0.0008728112,0.0026985013,0.24859215,0.0002131648],"about_ca_topic_score_codex":0.0032136373,"about_ca_topic_score_gemma":0.0053851604,"teacher_disagreement_score":0.012100653,"about_ca_system_score_codex":0.0015960322,"about_ca_system_score_gemma":0.003867052,"threshold_uncertainty_score":0.026444614},"labels":[],"label_agreement":null},{"id":"W2106733257","doi":"10.1158/1078-0432.ccr-05-2433","title":"Antisense Suppression of Pygopus2 Results in Growth Arrest of Epithelial Ovarian Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Ovarian cancer; Wnt signaling pathway; Cancer research; Biology; Cancer; Cell growth; Cell culture; Pathology; Signal transduction; Medicine; Cell biology","score_opus":0.08580160190825953,"score_gpt":0.44292132029260506,"score_spread":0.35711971838434553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106733257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964222,0.00061054813,0.0013681758,0.0000553976,0.000022924633,0.00001788617,0.00042785154,0.00007374103,0.0010013718],"genre_scores_gemma":[0.9956642,0.00038473785,0.001071275,0.000037016005,0.0000054404686,0.00002883593,0.0006911805,0.000019808007,0.0020975159],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999269,0.000006062887,0.00000766948,0.000022181583,0.000024489656,0.000012778705],"domain_scores_gemma":[0.99993324,0.000013541671,0.000018317322,0.000008559812,0.0000059857102,0.000020359616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006983986,0.00021866115,0.00014195053,0.0001205758,0.00011611083,0.00018852492,0.000106134554,0.00012787875,0.0013406518],"category_scores_gemma":[0.00006886321,0.000092803704,0.00014200076,0.00009966994,0.00020496371,0.000092920774,0.0001359978,0.00029456764,0.0002665427],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045060577,0.000007818951,0.000153416,0.000013361369,0.0000020508837,0.000027099319,0.0000060981583,0.0000336697,0.99923813,0.000032506316,0.000028181681,0.0004126165],"study_design_scores_gemma":[0.000017953533,0.00021121181,0.0048365355,0.0000031966724,0.000010592837,0.00033325248,0.00002790937,0.0007345938,0.99085945,0.000018711964,0.0029444762,0.0000021696724],"about_ca_topic_score_codex":0.0007629105,"about_ca_topic_score_gemma":0.0011436358,"teacher_disagreement_score":0.0013406518,"about_ca_system_score_codex":0.0001974057,"about_ca_system_score_gemma":0.00017586107,"threshold_uncertainty_score":0.0044849515},"labels":[],"label_agreement":null},{"id":"W2106960759","doi":"10.1158/1078-0432.ccr-14-0289","title":"Validation of Biomarkers That Complement CA19.9 in Detecting Early Pancreatic Cancer","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Mount Sinai Hospital","funders":"National Cancer Institute; University of Pittsburgh; Abbott Laboratories","keywords":"Biomarker; Pancreatic cancer; Medicine; Stage (stratigraphy); Cancer; CA19-9; Internal medicine; Biomarker discovery; Oncology; Population; Immunoassay; Pathology; Gastroenterology; Immunology; Biology; Proteomics; Antibody","score_opus":0.38768451371904855,"score_gpt":0.5759903231922189,"score_spread":0.18830580947317033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106960759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99460655,0.0015094676,0.002810094,0.00006458031,0.00003416678,0.00010969621,0.00038006125,0.00005276957,0.0004326756],"genre_scores_gemma":[0.99343127,0.00019977006,0.0050861873,0.00007230667,0.000024785473,0.000051344545,0.00090672215,0.0000068980075,0.00022080372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981236,0.00067086,0.00014900161,0.00040500244,0.0005635034,0.000088040906],"domain_scores_gemma":[0.9973398,0.00079065794,0.0006638381,0.00027187707,0.0007398841,0.00019392377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042951563,0.0006297055,0.00048581482,0.0012131477,0.00031528898,0.0006967325,0.00043633295,0.00068928365,0.00049271795],"category_scores_gemma":[0.0063743466,0.00028320888,0.00040557515,0.0005810925,0.0004265926,0.00036877152,0.00040919907,0.0004950671,0.00033928483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037527576,0.00069248147,0.8016649,0.00020021685,0.00040395302,0.00017082815,0.00017394294,0.0016509771,0.15485749,0.00010056011,0.00046899723,0.035862803],"study_design_scores_gemma":[0.00036871422,0.0062128617,0.83714825,0.00009074478,0.0005471366,0.0022276873,0.000120095836,0.017157158,0.13171044,0.0002326911,0.004139278,0.000045085617],"about_ca_topic_score_codex":0.0008492266,"about_ca_topic_score_gemma":0.0008915174,"teacher_disagreement_score":0.0042951563,"about_ca_system_score_codex":0.00036591795,"about_ca_system_score_gemma":0.0004749403,"threshold_uncertainty_score":0.02271521},"labels":[],"label_agreement":null},{"id":"W2107089530","doi":"10.1158/1078-0432.ccr-09-1525","title":"Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":664,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Overweight; Sarcopenia; Hazard ratio; Pancreatic cancer; Internal medicine; Body mass index; Confidence interval; Underweight; Weight loss; Cancer; Gastroenterology; Sarcopenic obesity; Obesity; Cachexia","score_opus":0.43357358609268365,"score_gpt":0.6035947952703241,"score_spread":0.17002120917764046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107089530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995691,0.00022079081,0.000036626592,0.00003274253,0.000003924967,0.0000034488037,0.000029380573,0.0000017221083,0.00010220978],"genre_scores_gemma":[0.9996113,0.00013234337,0.000080308295,0.000023247518,0.000015785736,0.000005357709,0.00009239532,5.29034e-7,0.00003882315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99986386,0.00004459113,0.000017397277,0.000024363231,0.000030299921,0.000019494806],"domain_scores_gemma":[0.999273,0.0001554768,0.0003502815,0.000030319034,0.000043694065,0.00014714058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003478233,0.00024036357,0.00033013604,0.00031979207,0.00034456942,0.00036648192,0.0001376373,0.00034576195,0.0008252556],"category_scores_gemma":[0.0015810453,0.00013765648,0.00018864538,0.0004007958,0.00032804496,0.000251302,0.00029754144,0.00046416878,0.00017020169],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040879857,0.000043433974,0.99685514,0.000009716881,0.000015515348,0.000108680935,0.000021999516,0.00003595104,0.00049945165,0.0000037199673,0.000045774734,0.0019517435],"study_design_scores_gemma":[0.000015156845,0.00042449278,0.99823254,0.0000075855914,0.000024937131,0.0007908583,0.00006768822,0.0002371902,0.00010148703,0.000015838934,0.00007937583,0.000002798349],"about_ca_topic_score_codex":0.0005585265,"about_ca_topic_score_gemma":0.0007708553,"teacher_disagreement_score":0.0008252556,"about_ca_system_score_codex":0.00012749813,"about_ca_system_score_gemma":0.00016853331,"threshold_uncertainty_score":0.002760768},"labels":[],"label_agreement":null},{"id":"W2107151233","doi":"10.1158/1078-0432.ccr-06-1692","title":"Down-Regulation of CD9 Expression during Prostate Carcinoma Progression Is Associated with <i>CD9</i> mRNA Modifications","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McGill University Health Centre; Hôpital du Sacré-Cœur de Montréal; McGill University; McMaster University Medical Centre","funders":"","keywords":"Prostate cancer; Prostate; Carcinogenesis; Tetraspanin; Adenocarcinoma; Lymph node; Immunohistochemistry; Cancer research; Cancer; Intraepithelial neoplasia; Biology; Malignancy; Pathology; PCA3; Tumor progression; Medicine; Cell","score_opus":0.15378807464769353,"score_gpt":0.49925383344740915,"score_spread":0.34546575879971564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107151233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973416,0.00093712105,0.00075096445,0.000024404333,0.0000074761097,0.000010986224,0.00017136117,0.0000381373,0.00071782793],"genre_scores_gemma":[0.9977527,0.00049554283,0.00059203594,0.000016520738,0.0000067539613,0.000014074558,0.00037424144,0.0000059228837,0.0007422535],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999136,0.000007031107,0.0000059603867,0.00002662201,0.000026459615,0.00002039398],"domain_scores_gemma":[0.9998543,0.000022001888,0.000057089135,0.00001073329,0.000028588005,0.000027217695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006493002,0.00015135638,0.00015696918,0.0002047178,0.00016337962,0.0002547481,0.00011267161,0.00013935992,0.0011832989],"category_scores_gemma":[0.00015281,0.00008394528,0.00011691054,0.0002046054,0.00019025743,0.00010698791,0.0001186416,0.000249693,0.0003572544],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020427203,0.000016754737,0.0072755255,0.000040961182,0.000006770378,0.00009036982,0.000017473587,0.00003514361,0.99000484,0.000027154338,0.000043710406,0.0022371109],"study_design_scores_gemma":[0.000017445442,0.00039523924,0.27991763,0.0000104972405,0.000048965325,0.001540539,0.00008836684,0.0008610643,0.71418697,0.000048695554,0.0028771355,0.0000074545483],"about_ca_topic_score_codex":0.00057112076,"about_ca_topic_score_gemma":0.00057104405,"teacher_disagreement_score":0.0011832989,"about_ca_system_score_codex":0.00024097279,"about_ca_system_score_gemma":0.00012838384,"threshold_uncertainty_score":0.0039585233},"labels":[],"label_agreement":null},{"id":"W2107296734","doi":"10.1158/1078-0432.ccr-08-3007","title":"Concurrent and Sequential Administration of Chemotherapy and the Mammalian Target of Rapamycin Inhibitor Temsirolimus in Human Cancer Cells and Xenografts","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Temsirolimus; LNCaP; Cell cycle; Cancer research; Chemotherapy; Medicine; Cancer cell; Pharmacology; Cancer; Biology; PI3K/AKT/mTOR pathway; Oncology; Internal medicine; Apoptosis; Discovery and development of mTOR inhibitors","score_opus":0.08325751658416727,"score_gpt":0.47348989003807546,"score_spread":0.39023237345390815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107296734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950565,0.0021778129,0.0011775732,0.000055374985,0.000064889995,0.00017475794,0.00038516897,0.00004691992,0.0008610357],"genre_scores_gemma":[0.9930687,0.0011467916,0.003634838,0.000037482783,0.000026422706,0.00023569737,0.0007620713,0.000021822267,0.0010662938],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999521,0.000121570636,0.000053501968,0.00009695581,0.00010846747,0.0000985939],"domain_scores_gemma":[0.99961,0.00011328975,0.00007051872,0.00008203595,0.000042334053,0.000081898295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005534616,0.00038404448,0.0008775197,0.00031407902,0.00019905137,0.00042186296,0.00047338975,0.00041024524,0.0011989841],"category_scores_gemma":[0.00036805365,0.00028650614,0.00043676677,0.0004147077,0.00025990553,0.00034770477,0.00020071364,0.0009937547,0.00026447553],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068047913,0.0033267757,0.0018233999,0.00025462953,0.00009714361,0.00014873473,0.00011130499,0.0020039561,0.9730089,0.0002833525,0.00053593615,0.0116011],"study_design_scores_gemma":[0.0007987342,0.029730761,0.007922539,0.000018074854,0.0001447892,0.0006027848,0.00006738616,0.0050196056,0.95236415,0.00004689298,0.0032695176,0.000014930319],"about_ca_topic_score_codex":0.0019044564,"about_ca_topic_score_gemma":0.0029017807,"teacher_disagreement_score":0.0019044564,"about_ca_system_score_codex":0.0004996158,"about_ca_system_score_gemma":0.000700035,"threshold_uncertainty_score":0.0040109754},"labels":[],"label_agreement":null},{"id":"W2107365189","doi":"10.1158/1078-0432.ccr-04-0097","title":"A Phase I and Pharmacodynamic Study of Fludarabine, Carboplatin, and Topotecan in Patients With Relapsed, Refractory, or High-Risk Acute Leukemia","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Carboplatin; Medicine; Topotecan; Fludarabine; Internal medicine; Leukemia; Regimen; Gastroenterology; Acute leukemia; Platelet transfusion; Oncology; Surgery; Chemotherapy; Cyclophosphamide; Platelet; Cisplatin","score_opus":0.06352704510688084,"score_gpt":0.4685404394304402,"score_spread":0.4050133943235594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107365189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998059,0.0008600654,0.00024379014,0.00010555796,0.000021025295,0.00024302966,0.00010238983,0.000022973529,0.0003420657],"genre_scores_gemma":[0.9973138,0.00040671634,0.00078613666,0.00021746509,0.0000760124,0.00036365085,0.00050610607,0.0000065157105,0.0003236681],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996191,0.00017548443,0.000022346414,0.000060437134,0.000045370343,0.00007708605],"domain_scores_gemma":[0.9994837,0.00011559963,0.0001083528,0.00003724262,0.000024482886,0.00023074473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076898513,0.0009992912,0.0015038886,0.0002124143,0.00026118956,0.00054647203,0.00053232134,0.00064932526,0.0010064183],"category_scores_gemma":[0.0010051955,0.00033015147,0.00061075005,0.0002578697,0.00069054216,0.00045642728,0.0002086872,0.001483235,0.00026726793],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5423509,0.05316212,0.09066079,0.0006531691,0.0018795803,0.0010152174,0.00054704334,0.007663523,0.09260718,0.00034341693,0.0029933252,0.20612371],"study_design_scores_gemma":[0.27190503,0.61138475,0.089631766,0.000038963426,0.00083167537,0.001962915,0.00010754516,0.0042699096,0.014619167,0.00020920293,0.004988311,0.000050826082],"about_ca_topic_score_codex":0.00063759217,"about_ca_topic_score_gemma":0.0013120377,"teacher_disagreement_score":0.0015038886,"about_ca_system_score_codex":0.0006842248,"about_ca_system_score_gemma":0.0008960582,"threshold_uncertainty_score":0.004964471},"labels":[],"label_agreement":null},{"id":"W2107505408","doi":"10.1158/1078-0432.ccr-10-0054","title":"Two-Stage Phase I Dose-Escalation Study of Intratumoral Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"National Cancer Institute","keywords":"Medicine; Radiation therapy; Gastroenterology; Neutropenia; Asymptomatic; Toxicity; Internal medicine; Cancer; Mesothelioma; Oncology; Pathology","score_opus":0.09101283434535412,"score_gpt":0.5106174238592381,"score_spread":0.419604589513884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107505408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957064,0.0010321464,0.0005814486,0.000096531265,0.000044157823,0.001644664,0.0001892992,0.000043926895,0.0006614946],"genre_scores_gemma":[0.991861,0.00083949044,0.0023953477,0.00025584904,0.000057791916,0.0027283977,0.0006655417,0.000019659783,0.0011769077],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99947387,0.00026606562,0.000023164985,0.00007819778,0.00005912623,0.00009972705],"domain_scores_gemma":[0.9995023,0.00009066474,0.000119577286,0.00007256105,0.000029871182,0.00018488357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001324584,0.0012252377,0.0022904593,0.00033111192,0.00026827506,0.00064221316,0.0008578733,0.00082584476,0.0022666836],"category_scores_gemma":[0.0006781973,0.00047831872,0.00094296184,0.00041191975,0.00074848544,0.00045563412,0.00033795336,0.002116348,0.00045382185],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5640238,0.12168244,0.010635505,0.0013464866,0.0014946937,0.00027391326,0.000645058,0.007509727,0.14844859,0.00041484815,0.001955563,0.14156939],"study_design_scores_gemma":[0.24253988,0.72539216,0.014215706,0.000038288665,0.00039907408,0.0003298661,0.000073162395,0.0019155676,0.012169656,0.00015251989,0.0027455192,0.000028529801],"about_ca_topic_score_codex":0.00053800433,"about_ca_topic_score_gemma":0.0013415726,"teacher_disagreement_score":0.0022904593,"about_ca_system_score_codex":0.00076024054,"about_ca_system_score_gemma":0.0011564113,"threshold_uncertainty_score":0.0075827837},"labels":[],"label_agreement":null},{"id":"W2107529812","doi":"10.1158/1078-0432.ccr-13-1100","title":"Importance of 5α-Reductase Gene Polymorphisms on Circulating and Intraprostatic Androgens in Prostate Cancer","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Canadian Institutes of Health Research","keywords":"Dihydrotestosterone; Androsterone; Prostate cancer; Endocrinology; Internal medicine; Testosterone (patch); Androgen; Biology; Linkage disequilibrium; Prostate; Cancer; Allele; Hormone; Medicine; Genetics; Gene; Steroid; Haplotype","score_opus":0.18140556058099866,"score_gpt":0.5032266453304121,"score_spread":0.3218210847494134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107529812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770385,0.0016340298,0.0002083329,0.000039563587,0.0000067820815,0.000003491789,0.00011978017,0.000008507593,0.00027568085],"genre_scores_gemma":[0.9995839,0.00012538915,0.00010387803,0.000017030456,0.0000072352586,0.0000019235295,0.00007408819,0.0000018236776,0.00008461654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973685,0.00008536143,0.000019694431,0.000075578886,0.000055138717,0.000027335762],"domain_scores_gemma":[0.9995497,0.0001234486,0.0001617192,0.000046913527,0.000031414867,0.000086760905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031154265,0.00024141364,0.00029826426,0.00027744417,0.00016494209,0.0002895275,0.0001708889,0.00028209997,0.0010948224],"category_scores_gemma":[0.0006141195,0.00011327455,0.00029064593,0.00035993356,0.00020389303,0.000087464454,0.00015919658,0.00024973918,0.00014208948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00325593,0.00011151023,0.90846217,0.000099067984,0.0006094663,0.00032788952,0.000095746305,0.00024487713,0.074335076,0.00009476421,0.00009392056,0.012269631],"study_design_scores_gemma":[0.000021675642,0.00026319022,0.9954645,0.000005845275,0.00015549311,0.0005535127,0.000023599903,0.00020504626,0.0030501743,0.000042017724,0.0002112652,0.000003730185],"about_ca_topic_score_codex":0.0011620955,"about_ca_topic_score_gemma":0.0014888345,"teacher_disagreement_score":0.0011620955,"about_ca_system_score_codex":0.00017147914,"about_ca_system_score_gemma":0.00018377195,"threshold_uncertainty_score":0.0036625266},"labels":[],"label_agreement":null},{"id":"W2107566256","doi":"10.1158/1078-0432.ccr-05-1258","title":"Effect of the Selective Estrogen Receptor Modulator Arzoxifene on Repopulation of Hormone-Responsive Breast Cancer Xenografts between Courses of Chemotherapy","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Chemotherapy; Breast cancer; Medicine; Paclitaxel; Clonogenic assay; Internal medicine; Estrogen receptor; Cancer research; Cancer; Estrogen; Adjuvant; Oncology; Endocrinology; Biology; Cell","score_opus":0.035433248075361926,"score_gpt":0.44801880723813103,"score_spread":0.4125855591627691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107566256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99746656,0.0013423831,0.0003374002,0.000028211645,0.000021619215,0.000023764767,0.000111472335,0.0000324767,0.0006360798],"genre_scores_gemma":[0.996543,0.0010924604,0.00056669884,0.000027906319,0.000013598845,0.000042932486,0.00031318862,0.000014036889,0.001386292],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998956,0.000023746925,0.000006204292,0.00001802083,0.000019914758,0.000036573027],"domain_scores_gemma":[0.99981874,0.000058006168,0.000042021675,0.000020957454,0.000016280406,0.000043934684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014602038,0.00025000886,0.00040768384,0.00015039422,0.000114015675,0.00016539141,0.00021416774,0.00018060915,0.0010646711],"category_scores_gemma":[0.00016575579,0.000114619696,0.00018077472,0.00012185347,0.00011000425,0.00016550295,0.00010270618,0.00043065293,0.00018721208],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028896248,0.00049315725,0.00075029547,0.000052102063,0.00002399058,0.000046612546,0.00002751877,0.0003085116,0.98402774,0.000053373857,0.00013500887,0.011191973],"study_design_scores_gemma":[0.0002155916,0.014872126,0.0110925045,0.000008410804,0.000040900177,0.00018692772,0.000026700156,0.00097653654,0.9699885,0.000017301469,0.0025679544,0.0000065262475],"about_ca_topic_score_codex":0.00054940063,"about_ca_topic_score_gemma":0.0013616924,"teacher_disagreement_score":0.0010646711,"about_ca_system_score_codex":0.00019729165,"about_ca_system_score_gemma":0.00016689465,"threshold_uncertainty_score":0.003561616},"labels":[],"label_agreement":null},{"id":"W2107838011","doi":"10.1158/1078-0432.ccr-14-2810","title":"Translational Impact of Nanoparticle–Drug Conjugate CRLX101 with or without Bevacizumab in Advanced Ovarian Cancer","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"Translational Impacts; Canadian Institutes of Health Research","keywords":"Bevacizumab; Medicine; Ovarian cancer; Camptothecin; Cancer; Combination therapy; Oncology; Cancer research; Internal medicine; Pharmacology; Chemotherapy; Biology","score_opus":0.08414878315593641,"score_gpt":0.4837361792371491,"score_spread":0.39958739608121274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107838011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953701,0.0013883555,0.00094872713,0.00025828814,0.00013679107,0.00022135623,0.00015397606,0.00006255213,0.0014598083],"genre_scores_gemma":[0.99648535,0.0005751014,0.0009012419,0.00011550262,0.00002746197,0.00009138072,0.00030575146,0.000015624215,0.0014826729],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998449,0.00003846416,0.000007716389,0.00003046357,0.000040512812,0.000037844253],"domain_scores_gemma":[0.9998971,0.000014433951,0.00002316432,0.000009456885,0.000015086758,0.000040677536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003340957,0.00028435414,0.00037770343,0.00018536602,0.00016923026,0.00042970118,0.00021146353,0.00038415857,0.0016899913],"category_scores_gemma":[0.00023095813,0.00013379035,0.00023457086,0.0001500606,0.00036009846,0.00032378695,0.00017496024,0.00081024715,0.00028395967],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005877113,0.0034249593,0.00044336892,0.0002957414,0.00005033694,0.00009903904,0.00007835635,0.0006616379,0.96609116,0.00029138912,0.00070762367,0.02197938],"study_design_scores_gemma":[0.004284104,0.08586314,0.007667841,0.000039194063,0.00022827153,0.00047474893,0.00012796157,0.0049866247,0.8860564,0.00012533444,0.010125876,0.00002048922],"about_ca_topic_score_codex":0.0017473715,"about_ca_topic_score_gemma":0.002242007,"teacher_disagreement_score":0.0017473715,"about_ca_system_score_codex":0.00065316656,"about_ca_system_score_gemma":0.0007426112,"threshold_uncertainty_score":0.0056536198},"labels":[],"label_agreement":null},{"id":"W2108067150","doi":"10.1158/1078-0432.ccr-09-1877","title":"Smoking and Colorectal Cancer in Lynch Syndrome: Results from the Colon Cancer Family Registry and The University of Texas M.D. Anderson Cancer Center","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Lynch syndrome; Medicine; Colorectal cancer; Microsatellite instability; Hazard ratio; Internal medicine; Cohort; Oncology; Cancer; Proportional hazards model; Confidence interval; Cancer registry; DNA mismatch repair; Allele; Genetics; Gene; Biology; Microsatellite","score_opus":0.10328428493311516,"score_gpt":0.425660060234612,"score_spread":0.32237577530149686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108067150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99667835,0.00048760563,0.00006515426,0.0000837493,0.000006465953,0.000012854055,0.0024123017,0.000005309261,0.00024814167],"genre_scores_gemma":[0.9968599,0.00028110386,0.000104478764,0.000038010996,0.00001592363,0.00001727228,0.002484392,0.000002650685,0.0001963168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994773,0.00015063169,0.000056298548,0.00012623363,0.0001320993,0.000057366302],"domain_scores_gemma":[0.9978254,0.0003194527,0.0010858992,0.0001608139,0.00023686247,0.00037170155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008551115,0.00019447184,0.00028380138,0.0008824534,0.00026403385,0.00029331775,0.00036318996,0.00035272614,0.0011452427],"category_scores_gemma":[0.0021950724,0.00023936004,0.0004017069,0.0011518279,0.00011014175,0.00021355336,0.00035203397,0.0003225438,0.00018141567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046954814,0.0000088446195,0.9993337,0.000005175964,0.000046661575,0.000023235787,0.000013461146,0.00002585471,0.000054123986,0.000004493877,0.00013418806,0.00030337033],"study_design_scores_gemma":[0.000008555145,0.000022066166,0.99957293,0.0000053559456,0.000034746383,0.000068076064,0.000028084833,0.00010782528,0.000023042083,0.0000030490203,0.00012447122,0.0000016555686],"about_ca_topic_score_codex":0.026609482,"about_ca_topic_score_gemma":0.040618375,"teacher_disagreement_score":0.026609482,"about_ca_system_score_codex":0.00045885541,"about_ca_system_score_gemma":0.0005503212,"threshold_uncertainty_score":0.052909195},"labels":[],"label_agreement":null},{"id":"W2108097215","doi":"10.1158/1078-0432.ccr-15-0831","title":"New Strategies in Sarcoma: Linking Genomic and Immunotherapy Approaches to Molecular Subtype","year":2015,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Immunotherapy; Sarcoma; Cancer immunotherapy; Medicine; Cancer; Computational biology; Biology; Genetics; Pathology","score_opus":0.6559328705354502,"score_gpt":0.5692865870122779,"score_spread":0.08664628352317238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108097215","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010518758,0.9979127,0.0002926769,0.00065049855,0.00016719046,0.000004398333,0.000009557989,0.000007367867,0.0008503614],"genre_scores_gemma":[0.0008612608,0.99776614,0.00038472403,0.00037173321,0.00022065711,0.000006131673,0.000019308296,0.0000016215259,0.00036837562],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997441,0.00006242667,0.0000393101,0.000045436856,0.00008792186,0.000020702346],"domain_scores_gemma":[0.99947804,0.00032314443,0.00004779362,0.00001728166,0.00010272196,0.000031072002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009440873,0.0006238858,0.0010458445,0.0026441643,0.00029772957,0.0009955748,0.00064025074,0.0011358428,0.0029477137],"category_scores_gemma":[0.0011088622,0.00026679283,0.0005662698,0.0016280542,0.0007346933,0.0019069159,0.0008039549,0.0022200001,0.0014863259],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044854245,0.00007561322,0.00027162375,0.011493572,0.00007841729,0.00027171161,0.00008648141,0.00041655035,0.0020306134,0.007822223,0.017886717,0.9595216],"study_design_scores_gemma":[0.000016122596,0.000115993826,0.00077755767,0.0041372688,0.00011369401,0.0023118947,0.00011516417,0.00016183035,0.000978313,0.0055418657,0.9857056,0.000024744486],"about_ca_topic_score_codex":0.0008233901,"about_ca_topic_score_gemma":0.001760815,"teacher_disagreement_score":0.0029477137,"about_ca_system_score_codex":0.00064151175,"about_ca_system_score_gemma":0.00097319,"threshold_uncertainty_score":0.009861112},"labels":[],"label_agreement":null},{"id":"W2108685474","doi":"10.1158/1078-0432.ccr-1127-3","title":"Molecular Pathology Shows p16 Methylation in Nonadenomatous Pituitaries from Patients with Cushing’s Disease","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of California, Los Angeles; Trent University","keywords":"Corticotropic cell; Methylation; CpG site; Adenoma; Hyperplasia; DNA methylation; Cushing's disease; Biology; Pathology; Endocrinology; Internal medicine; Immunohistochemistry; Pituitary gland; Medicine; Disease; Gene; Gene expression; Hormone; Genetics","score_opus":0.08051291271177252,"score_gpt":0.4388766333275909,"score_spread":0.3583637206158184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108685474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99952567,0.00019738055,0.00008604492,0.000012948045,0.000003928804,0.0000026898438,0.000018570014,0.0000036124452,0.00014923126],"genre_scores_gemma":[0.9996393,0.00007211606,0.00012210164,0.000009012191,0.000005264571,0.0000027526419,0.00005401898,0.0000014565428,0.00009404794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987376,0.00001545777,0.000012874524,0.000033236956,0.000045353347,0.000019386982],"domain_scores_gemma":[0.9996568,0.00010723993,0.000101038546,0.000021435673,0.00004233741,0.00007114104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017353636,0.00024826796,0.00016017348,0.00050844747,0.00027495387,0.00022746308,0.00014618254,0.0002388945,0.0015790142],"category_scores_gemma":[0.0008387564,0.00018385434,0.0001049331,0.00021049615,0.00036381077,0.00015864364,0.00014355853,0.00024250783,0.00018905397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011178716,0.00006012585,0.6706195,0.00010969229,0.000052113704,0.009505905,0.0006855194,0.00009427479,0.3109499,0.0000539086,0.0001600452,0.006591199],"study_design_scores_gemma":[0.00003750426,0.00043726843,0.96214306,0.000006760839,0.000034852786,0.023098757,0.00022230954,0.00024537242,0.0131825525,0.000043547458,0.0005427014,0.0000053190724],"about_ca_topic_score_codex":0.0011408167,"about_ca_topic_score_gemma":0.0012916907,"teacher_disagreement_score":0.0015790142,"about_ca_system_score_codex":0.00016920138,"about_ca_system_score_gemma":0.000120355246,"threshold_uncertainty_score":0.0052823424},"labels":[],"label_agreement":null},{"id":"W2108729187","doi":"10.1158/1078-0432.ccr-03-0774","title":"Mcl-1 Is a Novel Therapeutic Target for Human Sarcoma","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Oesterreichische Nationalbank; Kamillo Eisner Stiftung; Universität Wien; Austrian Science Fund","keywords":"Apoptosis; Terminal deoxynucleotidyl transferase; Saline; TUNEL assay; Sarcoma; Immunohistochemistry; Cyclophosphamide; Cancer research; Medicine; Oligonucleotide; Biology; Pathology; Chemotherapy; Internal medicine; Biochemistry","score_opus":0.2572669998544351,"score_gpt":0.5329620560572201,"score_spread":0.27569505620278506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108729187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9290934,0.048958328,0.012022374,0.0018391688,0.00025462778,0.00020614387,0.00048696232,0.0004259384,0.006713038],"genre_scores_gemma":[0.98495746,0.007514002,0.0037365088,0.0003246612,0.00006806574,0.00006356252,0.00039657604,0.000012220203,0.002926971],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999472,0.000007650502,0.0000027167355,0.00001350745,0.000015504558,0.000013363266],"domain_scores_gemma":[0.9999695,0.000004692672,0.000009359838,0.0000026461132,0.000004566047,0.00000924737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012890456,0.00028909885,0.00020484708,0.00021212087,0.000117414966,0.0002173916,0.00017496958,0.00028916693,0.0018379733],"category_scores_gemma":[0.00006523027,0.00006961598,0.0001585978,0.000118630625,0.0002121328,0.00017270078,0.0002198018,0.00052955694,0.00045960725],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034138619,0.00013679136,0.0006911795,0.00028028956,0.000013771909,0.00014621537,0.000034872533,0.000296108,0.96874547,0.0006407639,0.00064537977,0.028027752],"study_design_scores_gemma":[0.0003479195,0.0050769136,0.0060137035,0.00008648483,0.0001272108,0.0026715351,0.000057331185,0.0024109967,0.9297629,0.0005415395,0.052887343,0.000016135435],"about_ca_topic_score_codex":0.00022696197,"about_ca_topic_score_gemma":0.00066873006,"teacher_disagreement_score":0.0018379733,"about_ca_system_score_codex":0.00033936845,"about_ca_system_score_gemma":0.0002607263,"threshold_uncertainty_score":0.0061486363},"labels":[],"label_agreement":null},{"id":"W2109098197","doi":"10.1158/1078-0432.ccr-09-1602","title":"Expression Signature Developed from a Complex Series of Mouse Models Accurately Predicts Human Breast Cancer Survival","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Institutes of Health; University of Michigan","keywords":"Breast cancer; Gene expression profiling; Cancer; Gene signature; Metastasis; Lung cancer; Microarray analysis techniques; Survival analysis; DNA microarray; Biology; Computational biology; Oncology; Bioinformatics; Gene expression; Gene; Medicine; Internal medicine; Genetics","score_opus":0.4161668514677751,"score_gpt":0.5156638214219026,"score_spread":0.09949696995412749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109098197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799597,0.00049497175,0.016708717,0.00009238506,0.000021456062,0.00004484759,0.0019164238,0.00020019179,0.00056129013],"genre_scores_gemma":[0.9834653,0.0005655927,0.009893677,0.00007204378,0.000008547912,0.000111370435,0.0046921833,0.000053947548,0.0011373031],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996747,0.000059703765,0.000027994281,0.00009016745,0.00010399274,0.000043403154],"domain_scores_gemma":[0.9995701,0.00009263864,0.00017176603,0.00006319606,0.000046687615,0.00005562754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006379386,0.0005262671,0.00032615798,0.0011268068,0.00012412743,0.00040227675,0.00021961347,0.00027312705,0.0008511093],"category_scores_gemma":[0.0004399119,0.00013160781,0.00047298742,0.000424462,0.0002263422,0.00017543651,0.00021849002,0.0005731936,0.00032338008],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053179945,0.00014509031,0.01951455,0.000059503556,0.00006018332,0.000064242675,0.000025919133,0.002139617,0.97045195,0.00021496766,0.00019374683,0.006598395],"study_design_scores_gemma":[0.00006917453,0.0024521307,0.120675,0.00003889587,0.0003021857,0.0009956198,0.000096722804,0.03822138,0.83165705,0.00057398115,0.004878058,0.000039698327],"about_ca_topic_score_codex":0.00053746486,"about_ca_topic_score_gemma":0.0008518582,"teacher_disagreement_score":0.0011268068,"about_ca_system_score_codex":0.00040329658,"about_ca_system_score_gemma":0.00027335394,"threshold_uncertainty_score":0.003373742},"labels":[],"label_agreement":null},{"id":"W2109140694","doi":"10.1158/1078-0432.621.11.2","title":"Classic and Molecular Cytogenetic Analyses Reveal Chromosomal Gains and Losses Correlated with Survival in Head and Neck Cancer Patients","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Head and neck cancer; Head and neck; Cancer; Biology; Cytogenetics; Oncology; Genetics; Pathology; Medicine; Chromosome; Surgery; Gene","score_opus":0.2669193044050199,"score_gpt":0.5405949756844544,"score_spread":0.2736756712794345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109140694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99965096,0.00015126598,0.000048916485,0.000015509162,0.0000015056147,0.0000015412928,0.000046955836,0.0000019218412,0.00008131313],"genre_scores_gemma":[0.9997601,0.000043625027,0.00003594669,0.0000061817773,0.0000033824438,0.000001990584,0.000080580336,3.4179232e-7,0.00006791494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999112,0.000018035897,0.000008902366,0.000019901037,0.000021398866,0.00002051053],"domain_scores_gemma":[0.99968946,0.00008733034,0.000108227505,0.0000128841375,0.000041818883,0.0000602694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016019763,0.00014195906,0.00009139424,0.0004002078,0.00015993389,0.0001559947,0.000097972916,0.0002049723,0.0013819212],"category_scores_gemma":[0.00080773217,0.00006940274,0.000088924506,0.00027516967,0.0002060518,0.00012903455,0.00013163767,0.00017677549,0.00014383845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031049512,0.000013943029,0.992195,0.000009529998,0.000022206883,0.00010550422,0.00003144094,0.00008592727,0.0046706665,0.000010199333,0.000069302376,0.002475784],"study_design_scores_gemma":[0.000007107648,0.0001181795,0.9982816,0.0000017761683,0.000018975123,0.00054788525,0.00007204821,0.00015976881,0.0006505234,0.000018748102,0.00012174675,0.0000016656049],"about_ca_topic_score_codex":0.0011895383,"about_ca_topic_score_gemma":0.0017212952,"teacher_disagreement_score":0.0013819212,"about_ca_system_score_codex":0.00015336061,"about_ca_system_score_gemma":0.00012485417,"threshold_uncertainty_score":0.0046230555},"labels":[],"label_agreement":null},{"id":"W2109142777","doi":"10.1158/1078-0432.ccr-05-1798","title":"Evaluation of Adverse Events Experienced by Older Patients Participating in Studies of Molecularly Targeted Agents Alone or in Combination","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Tolerability; Adverse effect; Medicine; Internal medicine; Toxicity; Clinical trial; Oncology; Database","score_opus":0.34036259393371626,"score_gpt":0.621832050974023,"score_spread":0.2814694570403068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109142777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920421,0.005962223,0.00038855383,0.000047776284,0.00001067611,0.000149292,0.0007148515,0.00000750727,0.000677004],"genre_scores_gemma":[0.9969002,0.001211397,0.0005704148,0.00009889921,0.00003925345,0.00016316285,0.0008950342,0.0000026478438,0.000119035765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996416,0.001812548,0.0007458935,0.00037246267,0.0005434873,0.000109470144],"domain_scores_gemma":[0.97612417,0.0065724985,0.014833865,0.0005409579,0.0010533215,0.00087520597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009588622,0.0002214432,0.0010184335,0.0011214783,0.000254968,0.0006444689,0.00024699632,0.0002707862,0.0010575771],"category_scores_gemma":[0.0080552865,0.00012161551,0.0010152971,0.0014816766,0.00019820819,0.0004467898,0.0004206456,0.00035330033,0.000092578484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044007483,0.000074999014,0.98030293,0.00021326574,0.0008687063,0.00009590727,0.000096927,0.00015864064,0.0010320871,0.000018359784,0.00013139009,0.01260615],"study_design_scores_gemma":[0.00042083638,0.005260106,0.98956674,0.00006947924,0.0009928627,0.00097648933,0.00011907877,0.00028867886,0.00089885556,0.000054736993,0.0013383026,0.0000137977195],"about_ca_topic_score_codex":0.0002466859,"about_ca_topic_score_gemma":0.0005132953,"teacher_disagreement_score":0.009588622,"about_ca_system_score_codex":0.00038519473,"about_ca_system_score_gemma":0.00028304584,"threshold_uncertainty_score":0.050710022},"labels":[],"label_agreement":null},{"id":"W2109227311","doi":"10.1158/1078-0432.ccr-11-0237","title":"Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Cancer Institute","keywords":"Medicine; Sunitinib; Pharmacokinetics; Neutropenia; Mucositis; Internal medicine; Population; Pharmacodynamics; Gastroenterology; Cancer; Toxicity; Oncology; Pharmacology","score_opus":0.20572552419620968,"score_gpt":0.5238092103061034,"score_spread":0.3180836861098937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109227311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963018,0.0014819736,0.00041851704,0.00017434584,0.000021302048,0.00041667395,0.0005543807,0.000026981214,0.0006040956],"genre_scores_gemma":[0.9928946,0.0018240261,0.0018158357,0.0003010562,0.000061928404,0.00068963197,0.0018386206,0.000024467443,0.0005499073],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99963725,0.00016949528,0.00002156988,0.000057668254,0.000062515726,0.00005148793],"domain_scores_gemma":[0.99919933,0.00011588735,0.00021400207,0.000058183858,0.000080254074,0.00033224566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083010754,0.0007646548,0.0014777819,0.00019076712,0.0003431508,0.0004189634,0.0003802824,0.00049877283,0.0012978944],"category_scores_gemma":[0.00068300066,0.00021229626,0.00077448564,0.00036178352,0.000480487,0.0002997612,0.0001696196,0.0013916317,0.00030128143],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24395722,0.028510354,0.36283922,0.0015463548,0.004055468,0.0035991631,0.0014213945,0.012145026,0.13471463,0.0008981435,0.015517548,0.1907953],"study_design_scores_gemma":[0.12322547,0.3824493,0.41644982,0.00011725446,0.0019092951,0.008377083,0.00034584428,0.004501187,0.0336244,0.00030529383,0.02861095,0.00008419499],"about_ca_topic_score_codex":0.0021760468,"about_ca_topic_score_gemma":0.0033291278,"teacher_disagreement_score":0.0021760468,"about_ca_system_score_codex":0.0013643028,"about_ca_system_score_gemma":0.0024926008,"threshold_uncertainty_score":0.009898782},"labels":[],"label_agreement":null},{"id":"W2109743880","doi":"10.1158/1078-0432.14aacriaslc-ia10","title":"Abstract IA10: Molecular testing to personalized EGFR and ALK inhibitor therapies in lung cancer.","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Anaplastic lymphoma kinase; Lung cancer; Cancer research; Adenocarcinoma; Crizotinib; Targeted therapy; Tyrosine-kinase inhibitor; Epidermal growth factor receptor; Cancer; Medicine; Fusion gene; Tyrosine kinase; Fluorescence in situ hybridization; Biology; Pathology; Internal medicine; Gene; Genetics; Chromosome","score_opus":0.1627069123620948,"score_gpt":0.5623998535843598,"score_spread":0.39969294122226506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109743880","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13737972,0.24251133,0.043878675,0.091857925,0.013646995,0.0033691074,0.020371709,0.011778014,0.4352065],"genre_scores_gemma":[0.6634339,0.08324489,0.062489394,0.033334605,0.006484678,0.0017491733,0.02071539,0.00072020275,0.12782766],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99923074,0.00024512233,0.000043882468,0.00011261168,0.00025551554,0.00011223568],"domain_scores_gemma":[0.9988023,0.00022430439,0.00018090679,0.00007546605,0.00033391308,0.0003831751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027199385,0.0011256991,0.0006146011,0.0016238063,0.00025097348,0.0019047499,0.0011097715,0.0012505673,0.015117923],"category_scores_gemma":[0.0022414918,0.00033241409,0.0005215155,0.0007905889,0.00062278466,0.000825497,0.00092809694,0.0021102591,0.006425937],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002252311,0.00067846855,0.02308228,0.001006113,0.00012001395,0.0012983776,0.00005984784,0.001597821,0.033300877,0.009689042,0.16552992,0.7613849],"study_design_scores_gemma":[0.0012300104,0.0073039215,0.05877458,0.0011800596,0.00040227734,0.009860205,0.00019532834,0.014025401,0.04981267,0.014614796,0.8424677,0.00013306842],"about_ca_topic_score_codex":0.0013756185,"about_ca_topic_score_gemma":0.002004572,"teacher_disagreement_score":0.015117923,"about_ca_system_score_codex":0.0017764887,"about_ca_system_score_gemma":0.001727665,"threshold_uncertainty_score":0.05057448},"labels":[],"label_agreement":null},{"id":"W2109841006","doi":"10.1158/1078-0432.ccr-07-4926","title":"Epidermal Growth Factor Receptor Controls Flat Dysplastic Aberrant Crypt Foci Development and Colon Cancer Progression in the Rat Azoxymethane Model","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; University of Chicago","keywords":"Azoxymethane; Aberrant crypt foci; Epidermal growth factor receptor; Gefitinib; Cancer research; Colorectal cancer; Cyclin D1; EGFR inhibitors; Cancer; Protein kinase B; Carcinogenesis; Growth factor receptor; Biology; Pathology; Medicine; Internal medicine; Signal transduction; Cell cycle; Cell biology","score_opus":0.3039764773076946,"score_gpt":0.5049068096902137,"score_spread":0.20093033238251912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109841006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99738234,0.0009674075,0.0008414482,0.0000591865,0.000021219985,0.00003705892,0.00013838857,0.000076404,0.00047657237],"genre_scores_gemma":[0.9951297,0.0007637767,0.0011478288,0.000035927544,0.000009877427,0.00006805968,0.00029366204,0.0000152067605,0.0025360922],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972576,0.000040966017,0.000022335034,0.00005735933,0.000069014124,0.000084666324],"domain_scores_gemma":[0.9996487,0.000020008876,0.000117957345,0.000043205535,0.000033572473,0.0001364796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021512843,0.0007441477,0.00046462077,0.0009291499,0.00025385877,0.00024418134,0.0003405738,0.00042425605,0.0018443571],"category_scores_gemma":[0.00014717487,0.00034150123,0.0003930117,0.00025875136,0.00049275154,0.00039125324,0.00018966134,0.00090846623,0.00054741115],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015080497,0.0003374981,0.00094998,0.00003669299,0.000012598358,0.00013499736,0.000015096317,0.00008687745,0.9949462,0.00007706493,0.00005500302,0.0018399596],"study_design_scores_gemma":[0.00017602347,0.008048442,0.020174464,0.000013263494,0.00006553204,0.00097061676,0.00009263399,0.0015442371,0.96724194,0.000091351736,0.001564477,0.000016975111],"about_ca_topic_score_codex":0.0011647885,"about_ca_topic_score_gemma":0.001749373,"teacher_disagreement_score":0.0018443571,"about_ca_system_score_codex":0.0005084804,"about_ca_system_score_gemma":0.00034518295,"threshold_uncertainty_score":0.006169975},"labels":[],"label_agreement":null},{"id":"W2109881048","doi":"10.1158/1078-0432.ccr-07-0245","title":"Adeno-Associated Virus–Mediated Antiangiogenic Gene Therapy with Thrombospondin-1 Type 1 Repeats and Endostatin","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Endostatin; Adeno-associated virus; Angiogenesis; Angiogenesis inhibitor; Genetic enhancement; Thrombospondin 1; Angiostatin; Cancer research; Medicine; Vascular endothelial growth factor; Neovascularization; Pancreatic cancer; Cancer; Pathology; Immunology; Biology; Vector (molecular biology); Recombinant DNA; Internal medicine; Gene; VEGF receptors","score_opus":0.14684926569595355,"score_gpt":0.4769950841792521,"score_spread":0.3301458184832986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109881048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747993,0.0039988323,0.017397424,0.00023326214,0.00011201394,0.00021709353,0.0003025288,0.00022144185,0.002718157],"genre_scores_gemma":[0.9784064,0.0023697605,0.014916076,0.000070924165,0.000029151164,0.00013045734,0.0005107143,0.000022917939,0.0035436035],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998233,0.000025444757,0.0000140723,0.000041562926,0.000059284463,0.00003641218],"domain_scores_gemma":[0.9999335,0.0000091495795,0.000031299514,0.0000067353167,0.000005916292,0.000013339603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021723185,0.00045459904,0.00022507337,0.00027145958,0.00010869917,0.00022943076,0.00025061148,0.0003614093,0.00078549865],"category_scores_gemma":[0.00009060917,0.00013947133,0.0004007805,0.00015544161,0.00038703662,0.00023572956,0.00017295622,0.00060285925,0.00027445544],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009294064,0.00006836093,0.00013024095,0.000064974294,0.000010357797,0.000065601096,0.000015417787,0.0003476829,0.9959407,0.0005365251,0.00006578271,0.0026614866],"study_design_scores_gemma":[0.00010142839,0.0010445903,0.001294686,0.000011796072,0.00004382229,0.0006000646,0.000010169935,0.0025652759,0.98752815,0.00009737042,0.006693984,0.000008606297],"about_ca_topic_score_codex":0.0005616926,"about_ca_topic_score_gemma":0.00060402683,"teacher_disagreement_score":0.00078549865,"about_ca_system_score_codex":0.0004550684,"about_ca_system_score_gemma":0.000413772,"threshold_uncertainty_score":0.0033017397},"labels":[],"label_agreement":null},{"id":"W2109890006","doi":"10.1158/1078-0432.ccr-06-1234","title":"A Mass Balance and Disposition Study of the DNA Methyltransferase Inhibitor Zebularine (NSC 309132) and Three of Its Metabolites in Mice","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Biomedical Imaging and Bioengineering; National Cancer Institute; University of Pittsburgh","keywords":"Uridine; Uracil; Metabolite; Urine; Chemistry; Cytidine; In vivo; Chromatography; Endocrinology; Internal medicine; Biochemistry; DNA; Biology; Medicine; RNA; Enzyme","score_opus":0.05843800623851291,"score_gpt":0.41694205755718,"score_spread":0.3585040513186671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109890006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99361104,0.001421976,0.0032480482,0.00007497078,0.000012189047,0.00004608428,0.000771439,0.00012329972,0.0006909199],"genre_scores_gemma":[0.9901327,0.0014598162,0.003376511,0.00013293355,0.000014293406,0.000097056494,0.0014968695,0.00006860514,0.0032211829],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998956,0.000012388973,0.00000398114,0.0000359683,0.00003074657,0.000021384556],"domain_scores_gemma":[0.99986446,0.00000990555,0.000058487996,0.000014816682,0.000018057668,0.00003423699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015459626,0.0006422373,0.00046868066,0.00042896692,0.00020010083,0.00028056302,0.00031810993,0.00054801756,0.00078229816],"category_scores_gemma":[0.0001506619,0.00027440785,0.00032122518,0.00020356066,0.0002781447,0.0004839937,0.000094645555,0.0006729362,0.00040883975],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023775394,0.00011836789,0.0015785305,0.000033833083,0.000024033014,0.000046320965,0.00002357845,0.00021815082,0.9893028,0.000054472675,0.00009097244,0.006131336],"study_design_scores_gemma":[0.0001889464,0.0068126367,0.013003087,0.0000077348495,0.00014501772,0.00030661456,0.00003887838,0.0016675432,0.97519684,0.00008316112,0.002533491,0.00001611268],"about_ca_topic_score_codex":0.0018825111,"about_ca_topic_score_gemma":0.0023534747,"teacher_disagreement_score":0.0018825111,"about_ca_system_score_codex":0.0006661199,"about_ca_system_score_gemma":0.0004216129,"threshold_uncertainty_score":0.004833102},"labels":[],"label_agreement":null},{"id":"W2109957199","doi":"10.1158/1078-0432.ccr-13-0526","title":"Hypoxic Activation of the PERK/eIF2α Arm of the Unfolded Protein Response Promotes Metastasis through Induction of LAMP3","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Metastasis; Cancer research; Hypoxia (environmental); Tumor hypoxia; Cervix; Cancer cell; Medicine; Mediator; Cancer; Biology; Signal transduction; Pathology; Internal medicine; Cell biology; Radiation therapy; Chemistry","score_opus":0.12678368595981854,"score_gpt":0.4416587083226234,"score_spread":0.31487502236280485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109957199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99706143,0.00049904105,0.0012893657,0.000083640494,0.000008145878,0.000017922037,0.00030452135,0.000043337735,0.00069242413],"genre_scores_gemma":[0.9970746,0.0003512742,0.00076081965,0.000037790145,0.0000036279832,0.000030044172,0.00039630444,0.00000816931,0.0013372955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999354,0.000007690286,0.000004963129,0.000014148918,0.000019930274,0.000017868653],"domain_scores_gemma":[0.9999324,0.00000811173,0.000023894485,0.000008817435,0.000008606035,0.00001829112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008285849,0.0001544906,0.00014019829,0.00013584811,0.00013903673,0.00017505586,0.000074469186,0.00013388506,0.0012832003],"category_scores_gemma":[0.00007936764,0.00008560032,0.00020979226,0.00009967526,0.0001422782,0.0000937543,0.00014452173,0.00024190004,0.0002328826],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000748004,0.000009943888,0.0007159904,0.00001460758,0.0000027689891,0.000034889472,0.0000062610434,0.000029546,0.99860233,0.000022875402,0.000028192826,0.00045790352],"study_design_scores_gemma":[0.00001351101,0.00031676082,0.034919348,0.0000057410452,0.000018165141,0.00041838078,0.000036256853,0.00086110394,0.96132934,0.00003754884,0.0020398595,0.000003917768],"about_ca_topic_score_codex":0.00059756055,"about_ca_topic_score_gemma":0.00081120356,"teacher_disagreement_score":0.0012832003,"about_ca_system_score_codex":0.00032963758,"about_ca_system_score_gemma":0.00019512861,"threshold_uncertainty_score":0.0042927265},"labels":[],"label_agreement":null},{"id":"W2110155621","doi":"10.1158/1078-0432.ccr-05-0158","title":"Evaluating the Expression and Prognostic Value of TRAIL-R1 and TRAIL-R2 in Breast Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Environmental Health Sciences; National Cancer Institute","keywords":"Breast cancer; Tissue microarray; Cytokeratin; Medicine; Cancer; Oncology; Stage (stratigraphy); Lymph node; Internal medicine; Immunohistochemistry; Receptor; Pathology; Receptor expression; Cancer research; Biology","score_opus":0.1752315273467045,"score_gpt":0.5236478960077964,"score_spread":0.3484163686610919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110155621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980254,0.0014195205,0.00028622724,0.000020281062,0.0000028898155,0.000005643165,0.00006526423,0.000007958039,0.00016694024],"genre_scores_gemma":[0.99878246,0.00028940022,0.00054989423,0.000012046447,0.0000067504297,0.0000071889344,0.00017891687,0.0000011125423,0.00017215296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997664,0.00006867205,0.000024419216,0.000040047762,0.00006764614,0.000032768115],"domain_scores_gemma":[0.99958986,0.00014261945,0.00012497434,0.000026560147,0.00006426217,0.000051723287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007054173,0.00023097004,0.00022877219,0.00057134154,0.00015826816,0.00031313035,0.0001555623,0.00026012617,0.0006509158],"category_scores_gemma":[0.0009893846,0.000110120964,0.0001449095,0.00039350145,0.00021284107,0.00020658689,0.00015322729,0.00016427253,0.00018055663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024219616,0.00015083552,0.8880731,0.00015354434,0.00013224679,0.00025342163,0.00008326379,0.00065775425,0.08045339,0.000052722462,0.000221242,0.027346494],"study_design_scores_gemma":[0.00006676467,0.0015986941,0.95398515,0.000018970979,0.00016048487,0.0020582478,0.00009811824,0.0023276152,0.038466163,0.00009020139,0.0011148711,0.000014764867],"about_ca_topic_score_codex":0.0005636976,"about_ca_topic_score_gemma":0.0008560854,"teacher_disagreement_score":0.0007054173,"about_ca_system_score_codex":0.00032626092,"about_ca_system_score_gemma":0.00021956115,"threshold_uncertainty_score":0.0037306547},"labels":[],"label_agreement":null},{"id":"W2110410873","doi":"10.1158/1078-0432.ccr-08-0524","title":"A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":239,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Oncolytic virus; Carcinoembryonic antigen; Antibody; Medicine; Cancer; Antigen; Oncolytic adenovirus; Toxicity; Internal medicine; Virology; Immunology","score_opus":0.15553678229178985,"score_gpt":0.5162728224528756,"score_spread":0.3607360401610858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110410873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955283,0.0017269438,0.00095882546,0.000107503554,0.000041820764,0.0006983568,0.0001719308,0.00005315755,0.00071320584],"genre_scores_gemma":[0.9941643,0.0011200358,0.002463309,0.00022313998,0.00006297885,0.00077603804,0.0005998513,0.000018983346,0.00057147915],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99979156,0.00009202291,0.000008605119,0.00004161269,0.000025476314,0.000040694733],"domain_scores_gemma":[0.9996604,0.00009274558,0.00007075212,0.000042804975,0.000019291008,0.00011396679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053546374,0.00065957627,0.0011415298,0.00013198206,0.0002349899,0.00048588912,0.00037986191,0.0005437715,0.0012262809],"category_scores_gemma":[0.00048296596,0.00023739252,0.0005245709,0.00020637503,0.00049465697,0.0003419914,0.00015553962,0.0015862974,0.00031419704],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24923094,0.0504164,0.022234768,0.0011641466,0.0008039378,0.00086449756,0.0006027711,0.009452241,0.34006578,0.00045417703,0.003020828,0.32168958],"study_design_scores_gemma":[0.122102216,0.80619454,0.026119506,0.00005731776,0.0003962529,0.0017108192,0.000100411664,0.0040640095,0.032179404,0.00024542713,0.0067925835,0.00003752679],"about_ca_topic_score_codex":0.00045447424,"about_ca_topic_score_gemma":0.0007492708,"teacher_disagreement_score":0.0012262809,"about_ca_system_score_codex":0.00047325846,"about_ca_system_score_gemma":0.0007505045,"threshold_uncertainty_score":0.0041022897},"labels":[],"label_agreement":null},{"id":"W2110496394","doi":"10.1158/1078-0432.ccr-08-1593","title":"Utility of Incorporating Genetic Variants for the Early Detection of Prostate Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Prostate cancer; Rectal examination; Nomogram; Medicine; Single-nucleotide polymorphism; Prostate biopsy; Oncology; Odds ratio; Prostate; Genotype; Confidence interval; Internal medicine; Cancer; Prostate-specific antigen; SNP; Genotyping; Biology; Genetics; Gene","score_opus":0.24755085391538156,"score_gpt":0.5216926095025093,"score_spread":0.2741417555871277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110496394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98652923,0.0035022437,0.007567895,0.00060240907,0.00003841378,0.0000577064,0.00054380007,0.00010093712,0.0010574161],"genre_scores_gemma":[0.99407226,0.00040809362,0.0050541433,0.00008963775,0.000040461284,0.000016951612,0.00020590876,0.000006368735,0.000106152474],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773574,0.0014242966,0.00013614868,0.0003402828,0.00028957764,0.00007388043],"domain_scores_gemma":[0.9919087,0.005960795,0.0014530604,0.00025162904,0.00023985298,0.0001859332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003490541,0.00080769096,0.00040677973,0.0010914645,0.00021887683,0.0008178147,0.0003911425,0.00070062367,0.0014327754],"category_scores_gemma":[0.012369515,0.00023114054,0.00052158505,0.0006729102,0.0005469931,0.00041698493,0.00039720343,0.0006493256,0.00027698983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008356293,0.000081445476,0.9633991,0.00007773256,0.00026995674,0.00010754986,0.000023479795,0.002252035,0.0036844385,0.00005518018,0.00016998459,0.029043494],"study_design_scores_gemma":[0.00016345008,0.0015536764,0.96555114,0.00009181984,0.00092216016,0.0020554091,0.000058698886,0.02032048,0.0070200423,0.0009984669,0.0012120948,0.00005251407],"about_ca_topic_score_codex":0.00087165425,"about_ca_topic_score_gemma":0.0013411569,"teacher_disagreement_score":0.003490541,"about_ca_system_score_codex":0.00020326042,"about_ca_system_score_gemma":0.00036609644,"threshold_uncertainty_score":0.018459976},"labels":[],"label_agreement":null},{"id":"W2110531477","doi":"10.1158/1557-3265.pms14-b06","title":"Abstract B06: Chemotherapeutic agents attenuate subsequent CXCL12-induced migration of colon cancer cells by selecting for CXCR4-negative cells and increasing peptidase CD26","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Waterloo","funders":"","keywords":"Cancer research; Propidium iodide; Colorectal cancer; Population; Cancer cell; Oxaliplatin; Irinotecan; Medicine; Cancer; Biology; Immunology; Internal medicine; Apoptosis; Programmed cell death; Biochemistry","score_opus":0.3588524277753227,"score_gpt":0.5301632315803533,"score_spread":0.17131080380503055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110531477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941711,0.0013401764,0.00096773956,0.00017119902,0.000077120574,0.000068360496,0.0008954299,0.00014236874,0.0021664354],"genre_scores_gemma":[0.98727745,0.0009427123,0.003417022,0.00010920974,0.000027774284,0.00010968549,0.00164403,0.000029268032,0.0064428314],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989367,0.000020780557,0.000012647946,0.000015657515,0.000024598925,0.000032665943],"domain_scores_gemma":[0.99990857,0.000013566763,0.000016708233,0.00000962782,0.000012674398,0.00003889967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008157189,0.00034865094,0.00029027872,0.000204892,0.00011772854,0.0001748385,0.0001617303,0.0002498166,0.005348114],"category_scores_gemma":[0.00008619679,0.000102381826,0.00018376179,0.00016745208,0.00013368107,0.0001161425,0.00010757019,0.0005991357,0.0010604135],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086690584,0.0003015739,0.00011181904,0.00005816268,0.0000049764913,0.000024421905,0.000009500612,0.00007174507,0.996002,0.00004379452,0.00025199025,0.0022530712],"study_design_scores_gemma":[0.00015027763,0.003719086,0.0041829185,0.000008043348,0.000011034604,0.00012612536,0.000016973712,0.00085945165,0.9882951,0.000019124614,0.0026067323,0.0000051234006],"about_ca_topic_score_codex":0.0008867279,"about_ca_topic_score_gemma":0.0009980558,"teacher_disagreement_score":0.005348114,"about_ca_system_score_codex":0.00015884585,"about_ca_system_score_gemma":0.00023724588,"threshold_uncertainty_score":0.017891228},"labels":[],"label_agreement":null},{"id":"W2110949408","doi":"10.1158/1078-0432.ccr-13-3389","title":"Dual mTORC1/2 Blockade Inhibits Glioblastoma Brain Tumor Initiating Cells <i>In Vitro</i> and <i>In Vivo</i> and Synergizes with Temozolomide to Increase Orthotopic Xenograft Survival","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"American Association for Cancer Research","keywords":"Temozolomide; In vivo; Glioblastoma; Blockade; In vitro; mTORC1; Medicine; Cancer research; Pharmacology; Chemistry; Internal medicine; Biology; PI3K/AKT/mTOR pathway; Apoptosis; Receptor","score_opus":0.03427321049620357,"score_gpt":0.37481956940058114,"score_spread":0.34054635890437757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110949408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99540377,0.0013811601,0.0005578931,0.00010659422,0.00004615594,0.00006230621,0.0004397333,0.0001466374,0.0018557716],"genre_scores_gemma":[0.9953602,0.0011251001,0.0010599449,0.00007116176,0.000026766053,0.00008802612,0.000940324,0.000017192924,0.0013111202],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998573,0.00001661715,0.000015268139,0.000020003265,0.00003835994,0.00005245043],"domain_scores_gemma":[0.99993706,0.0000066746516,0.000015263708,0.000007220565,0.0000065149184,0.000027230644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016831682,0.00073356554,0.00066634687,0.00038095633,0.00017154406,0.00037829604,0.0002569741,0.00019390654,0.00089651934],"category_scores_gemma":[0.00007907845,0.00014465408,0.00034401045,0.0002135782,0.00020211209,0.00018563842,0.00012018586,0.0007836198,0.00028589112],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012618181,0.0007771245,0.00056626444,0.00009430759,0.000048332517,0.00004554997,0.0000151262275,0.00041142883,0.9891594,0.00012036591,0.00057938026,0.006920849],"study_design_scores_gemma":[0.0003647746,0.0073259636,0.008666479,0.0000121205185,0.00011447555,0.000356034,0.000023555087,0.0022787414,0.97809005,0.000039974548,0.0027187075,0.000009197424],"about_ca_topic_score_codex":0.0012253989,"about_ca_topic_score_gemma":0.003610393,"teacher_disagreement_score":0.0012253989,"about_ca_system_score_codex":0.0005213815,"about_ca_system_score_gemma":0.00047726618,"threshold_uncertainty_score":0.0037828684},"labels":[],"label_agreement":null},{"id":"W2111144249","doi":"10.1158/1078-0432.ccr-06-1119","title":"The Combination of the Rexinoid, LG100268, and a Selective Estrogen Receptor Modulator, Either Arzoxifene or Acolbifene, Synergizes in the Prevention and Treatment of Mammary Tumors in an Estrogen Receptor–Negative Model of Breast Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Cancer Institute","keywords":"Selective estrogen receptor modulator; Estrogen receptor; Estrogen; Pharmacology; In vivo; Mammary tumor; Cancer; Antiestrogen; Medicine; Internal medicine; Cancer research; Breast cancer; Biology; Biotechnology","score_opus":0.04765602354531068,"score_gpt":0.402088793871903,"score_spread":0.3544327703265923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111144249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99723357,0.0011948515,0.00042860257,0.00009687749,0.000032954304,0.00005398862,0.00013849822,0.000037942908,0.0007828475],"genre_scores_gemma":[0.9933395,0.0019082767,0.0015037488,0.000067457484,0.00002777854,0.0000829095,0.00037451714,0.000011638531,0.0026841604],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998117,0.000032654734,0.000016074993,0.000025817835,0.000062419516,0.000051277562],"domain_scores_gemma":[0.99988353,0.000012892306,0.000042307976,0.000011028226,0.000010134305,0.000040066054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022181153,0.0006624976,0.0006468192,0.00044143762,0.0001357387,0.00021083461,0.00036098954,0.00040208927,0.0010224851],"category_scores_gemma":[0.00009548846,0.00018277623,0.00044626262,0.0001704601,0.00026164146,0.0002084444,0.00013772724,0.0007217605,0.00025811148],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029104517,0.0009668333,0.0005566711,0.00010518724,0.000040631803,0.00007704321,0.000014561769,0.00013651996,0.9890386,0.000047503934,0.00010176272,0.0060042473],"study_design_scores_gemma":[0.00070493575,0.024442816,0.0064573674,0.000023099803,0.00013810062,0.0005342694,0.00004298307,0.0005055848,0.9640951,0.000031086372,0.0030114867,0.000013069699],"about_ca_topic_score_codex":0.0004687821,"about_ca_topic_score_gemma":0.0020263041,"teacher_disagreement_score":0.0010224851,"about_ca_system_score_codex":0.00025171204,"about_ca_system_score_gemma":0.00031173188,"threshold_uncertainty_score":0.0034205914},"labels":[],"label_agreement":null},{"id":"W2111159494","doi":"10.1158/1078-0432.ccr-06-0324","title":"Identification of α-Enolase as an Autoantigen in Lung Cancer: Its Overexpression Is Associated with Clinical Outcomes","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Lung cancer; Immunohistochemistry; Pleural effusion; Antigen; Pathology; Medicine; Cancer; Antibody; Stage (stratigraphy); Effusion; Cancer research; Biology; Immunology; Internal medicine","score_opus":0.11075730612434151,"score_gpt":0.5258183928856719,"score_spread":0.41506108676133036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111159494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991148,0.0005529115,0.00013127892,0.000017252083,0.000002808397,0.0000039757097,0.000035557594,0.0000039265224,0.00013745112],"genre_scores_gemma":[0.9996704,0.00011312461,0.00006873785,0.0000047304347,0.000004908227,0.000002802102,0.00005117701,6.3562715e-7,0.00008354485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998419,0.000036151618,0.00001961975,0.000038225404,0.000036810718,0.000027185915],"domain_scores_gemma":[0.99943036,0.00010802594,0.00024207291,0.000029416164,0.000065937835,0.00012414125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003213333,0.00018477031,0.0002213898,0.0004057985,0.00015478417,0.00031700305,0.00013231814,0.00024042133,0.0008575733],"category_scores_gemma":[0.0006321661,0.00008470678,0.0000987485,0.00035095363,0.00025592835,0.000212545,0.00021957933,0.00026471645,0.00017450373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006936163,0.00004876241,0.9573157,0.00005191781,0.00004155378,0.00034568776,0.000045261717,0.000060163027,0.03768441,0.00001178966,0.00003657908,0.0036644202],"study_design_scores_gemma":[0.0000083851555,0.00026971695,0.9910787,0.0000057141237,0.000047603917,0.0015120691,0.00007335495,0.00022502085,0.006520407,0.00002525143,0.00023149828,0.0000023293132],"about_ca_topic_score_codex":0.00023738935,"about_ca_topic_score_gemma":0.000261216,"teacher_disagreement_score":0.0008575733,"about_ca_system_score_codex":0.00013929789,"about_ca_system_score_gemma":0.00012136088,"threshold_uncertainty_score":0.0028688312},"labels":[],"label_agreement":null},{"id":"W2111331823","doi":"10.1158/1078-0432.ccr-07-4969","title":"Improved Prediction of Disease Relapse after Radical Prostatectomy through a Panel of Preoperative Blood-Based Biomarkers","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Urology; Endoglin; Biochemical recurrence; Plasminogen activator; Stage (stratigraphy); Internal medicine; Plasminogen activator inhibitor-1; Adjuvant therapy; Oncology; Cancer","score_opus":0.1822599578442139,"score_gpt":0.4472976957362071,"score_spread":0.2650377378919932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111331823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984865,0.0004428494,0.0007707659,0.000064751235,0.000007993747,0.0000063013717,0.000080380814,0.000016756978,0.00012362922],"genre_scores_gemma":[0.99935716,0.00005980257,0.00041226522,0.000013181018,0.000011804496,0.0000035953476,0.00008995212,0.0000012791237,0.00005088129],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961436,0.00019456744,0.00002126451,0.000060411607,0.00007500578,0.000034478533],"domain_scores_gemma":[0.99853766,0.0007525652,0.00035656925,0.00007841513,0.000114892384,0.0001599516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085031736,0.00043494324,0.00048484973,0.00048119514,0.00010862571,0.0004253681,0.00021937344,0.0003038392,0.0006596787],"category_scores_gemma":[0.0032594225,0.00017072458,0.00034060693,0.0002953066,0.00018765994,0.00024465373,0.00027228516,0.00058161526,0.00012204616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006208119,0.000055973655,0.9880839,0.000012302641,0.00008720606,0.00002243395,0.00001644416,0.0008934969,0.0011830275,0.000010657593,0.00007406971,0.008939585],"study_design_scores_gemma":[0.00005332405,0.0007513689,0.97804755,0.0000131550105,0.00015862941,0.00031000812,0.000049353148,0.018807964,0.001465333,0.00010818453,0.00022095483,0.0000141970695],"about_ca_topic_score_codex":0.000837143,"about_ca_topic_score_gemma":0.0011578166,"teacher_disagreement_score":0.00085031736,"about_ca_system_score_codex":0.00015232513,"about_ca_system_score_gemma":0.00023990909,"threshold_uncertainty_score":0.0044969916},"labels":[],"label_agreement":null},{"id":"W2111382211","doi":"10.1158/1078-0432.ccr-05-2703","title":"Association of DNA Repair and Steroid Metabolism Gene Polymorphisms with Clinical Late Toxicity in Patients Treated with Conformal Radiotherapy for Prostate Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Prostate cancer; Internal medicine; Oncology; XRCC3; Medicine; Single-nucleotide polymorphism; Biology; Cancer research; Cancer; Urology; Genotype; Genetics; Gene","score_opus":0.06221923651045298,"score_gpt":0.4224770252036543,"score_spread":0.36025778869320135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111382211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997068,0.00011148204,0.00006767127,0.000009389918,0.0000011598148,0.0000021004237,0.00005057341,0.0000015216136,0.00004919886],"genre_scores_gemma":[0.99975234,0.000026965174,0.000058716767,0.000012578501,0.0000034222494,0.000002611313,0.0000975634,0.0000010457775,0.00004479939],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999718,0.00008936671,0.000025213985,0.00007182166,0.000059085534,0.000036378082],"domain_scores_gemma":[0.9990734,0.00024271749,0.00043222218,0.000066371475,0.00006190573,0.00012336764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029546965,0.00017262602,0.0003314467,0.00022894984,0.00023042344,0.00027009673,0.00015827797,0.00020797212,0.0007979673],"category_scores_gemma":[0.0013925929,0.00013441937,0.000254264,0.00034561596,0.00020432,0.00010027395,0.00014006426,0.0002931187,0.000090799105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021024008,0.00002246915,0.9972572,0.0000045390725,0.000048592043,0.000088875764,0.000022972745,0.00005337647,0.0013798181,0.0000037108355,0.000019385527,0.0008888985],"study_design_scores_gemma":[0.000011647041,0.00019130971,0.9987791,9.582727e-7,0.000023840606,0.0005505893,0.000018961584,0.0000994297,0.000251982,0.0000069632006,0.00006371467,0.0000016143943],"about_ca_topic_score_codex":0.0010423403,"about_ca_topic_score_gemma":0.0014358864,"teacher_disagreement_score":0.0010423403,"about_ca_system_score_codex":0.00015239457,"about_ca_system_score_gemma":0.0001623008,"threshold_uncertainty_score":0.0026694536},"labels":[],"label_agreement":null},{"id":"W2111419022","doi":"10.1158/1078-0432.ccr-08-1770","title":"Polymorphisms in the <i>FAS</i> and <i>FASL</i> Genes and Survival of Early Stage Non–small Cell Lung Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Fas ligand; Stage (stratigraphy); Biology; Cancer; Gene; Lung cancer; Oncology; Cancer research; Internal medicine; Medicine; Apoptosis; Genetics; Programmed cell death","score_opus":0.09465072844011445,"score_gpt":0.4296336444515013,"score_spread":0.33498291601138686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111419022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995689,0.00020754036,0.000076900076,0.000013816896,0.0000036413037,0.000003447083,0.00005886324,0.0000012876534,0.00006570471],"genre_scores_gemma":[0.9995566,0.0000793255,0.00008673238,0.000016668266,0.000009782121,0.00000563163,0.00012656006,9.768701e-7,0.00011768401],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984086,0.00005614147,0.000016950176,0.000039960247,0.000023444863,0.00002264333],"domain_scores_gemma":[0.9993325,0.000182025,0.00029820044,0.00003358337,0.000046497382,0.00010721904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028095758,0.00026523232,0.00025381325,0.00020781334,0.00016542105,0.00022726947,0.00014124438,0.00026184434,0.0011068048],"category_scores_gemma":[0.00071398926,0.000120096156,0.00028428718,0.00023514299,0.00020083998,0.00013220022,0.00012737552,0.00026504198,0.00014640839],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027478028,0.00014405017,0.9851252,0.000040900715,0.00019674531,0.0002069363,0.000057032168,0.00013474812,0.0067354757,0.000033997505,0.000089834226,0.00448722],"study_design_scores_gemma":[0.00011161591,0.0009041286,0.99609935,0.00000878015,0.00019095314,0.00078108447,0.000056254114,0.00041817708,0.0010114686,0.00008677102,0.0003246968,0.000006753156],"about_ca_topic_score_codex":0.00064673316,"about_ca_topic_score_gemma":0.0008020106,"teacher_disagreement_score":0.0011068048,"about_ca_system_score_codex":0.00014341978,"about_ca_system_score_gemma":0.00017427294,"threshold_uncertainty_score":0.003702581},"labels":[],"label_agreement":null},{"id":"W2111422801","doi":"10.1158/1078-0432.ccr-13-3191","title":"Overexpression of Smad7 Blocks Primary Tumor Growth and Lung Metastasis Development in Osteosarcoma","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Université de Nantes; Ligue Contre le Cancer","keywords":"Osteosarcoma; Cancer research; SMAD; Metastasis; Medicine; Bone metastasis; Transforming growth factor; Primary tumor; Tumor progression; Cell cycle; Cell growth; Pathology; Cancer; Internal medicine; Biology","score_opus":0.070120306180943,"score_gpt":0.43119096240794674,"score_spread":0.36107065622700374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111422801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99495596,0.0017123873,0.0014222328,0.000102894526,0.000060887975,0.0000540318,0.00023379555,0.00009497376,0.001362873],"genre_scores_gemma":[0.9924159,0.0018211927,0.0021474862,0.000061685576,0.000024359559,0.00008798405,0.00078786345,0.000025728603,0.002627657],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998623,0.000021787479,0.000015648724,0.00001594167,0.00004200772,0.000042353546],"domain_scores_gemma":[0.999879,0.000023004164,0.000028698963,0.000011584841,0.000014588128,0.0000431275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015035163,0.00033569575,0.000378408,0.0003134673,0.00013920016,0.00015443213,0.00023732329,0.00020425221,0.0017044045],"category_scores_gemma":[0.00009252368,0.00013707699,0.00040517456,0.00012109823,0.00019393743,0.00009361449,0.00013518405,0.00049428135,0.0003663354],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059481076,0.0003211978,0.000273618,0.000085816064,0.000011082565,0.000047830843,0.00001001936,0.00008674884,0.9965659,0.00006480584,0.00007893775,0.0018592969],"study_design_scores_gemma":[0.00008983844,0.0021627622,0.0019395353,0.000010001669,0.000033060558,0.0001621068,0.000023900127,0.0010395763,0.9929276,0.000021848986,0.0015863841,0.000003364753],"about_ca_topic_score_codex":0.00056148006,"about_ca_topic_score_gemma":0.0012430352,"teacher_disagreement_score":0.0017044045,"about_ca_system_score_codex":0.00019556725,"about_ca_system_score_gemma":0.00042066944,"threshold_uncertainty_score":0.0057017803},"labels":[],"label_agreement":null},{"id":"W2111488265","doi":"10.1158/1078-0432.ccr-14-2497","title":"Germline Mutation in <i>BRCA1</i> or <i>BRCA2</i> and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":160,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute","funders":"National Cancer Institute; Cancer Research UK; Francis Crick Institute","keywords":"Germline; Ovarian cancer; Germline mutation; Cancer; Epithelial ovarian cancer; Gynecology; Medicine; Oncology; Mutation; Internal medicine; Cancer research; Biology; Genetics; Gene","score_opus":0.08217853277080826,"score_gpt":0.4480162240044228,"score_spread":0.36583769123361454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111488265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994072,0.00023179936,0.00007297481,0.000030563264,0.0000044546427,0.000005216227,0.00013942138,0.0000031961933,0.00010521328],"genre_scores_gemma":[0.9993942,0.000070081966,0.00009474207,0.000024565752,0.000009229807,0.000007890803,0.00029155964,0.0000010944512,0.000106746025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995534,0.00017690532,0.000037294725,0.000119184,0.000059411068,0.00005371767],"domain_scores_gemma":[0.9951965,0.001943972,0.0020887922,0.0003295573,0.000112730086,0.000328362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021784327,0.00030975675,0.00018777324,0.0003657242,0.00014385505,0.0003080049,0.00035291185,0.00043300798,0.0014903516],"category_scores_gemma":[0.0050562765,0.0001918033,0.00053615216,0.00020559297,0.0003166889,0.00028880243,0.0002705341,0.00046417807,0.00011776952],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023030916,0.00013804059,0.99477106,0.000025654621,0.00021929889,0.00004236991,0.00002497444,0.00014861107,0.00052764284,0.000014793509,0.000071758564,0.0017127091],"study_design_scores_gemma":[0.00007076904,0.0011526113,0.99748033,0.000009505635,0.00016886639,0.00021535218,0.00003409313,0.00036381982,0.00036039017,0.000039983708,0.00009966652,0.0000045692077],"about_ca_topic_score_codex":0.0013476362,"about_ca_topic_score_gemma":0.0011240639,"teacher_disagreement_score":0.0021784327,"about_ca_system_score_codex":0.0002133238,"about_ca_system_score_gemma":0.00023147334,"threshold_uncertainty_score":0.011520803},"labels":[],"label_agreement":null},{"id":"W2111568097","doi":"10.1158/1078-0432.ccr-12-0286","title":"A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant Tamoxifen","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":310,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Sunnybrook Health Science Centre; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Subtyping; Oncology; Breast cancer; Immunohistochemistry; Tamoxifen; Medicine; Internal medicine; Estrogen receptor; Progesterone receptor; Confidence interval; Population; Tissue microarray; Bioinformatics; Cancer; Biology","score_opus":0.18582417323574202,"score_gpt":0.4539281997971556,"score_spread":0.2681040265614136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111568097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759054,0.0001857755,0.0011162023,0.00006943572,0.0000068720456,0.00001943941,0.00055683847,0.000014253284,0.00044074387],"genre_scores_gemma":[0.9973665,0.000048198213,0.0012768285,0.00002807417,0.000019719633,0.000023658866,0.0010996001,0.0000033030674,0.0001340729],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99969864,0.00009966057,0.000026540882,0.000067539004,0.00006117529,0.000046482488],"domain_scores_gemma":[0.99931693,0.0002933961,0.00015100591,0.00006145642,0.00008085817,0.000096264244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007493133,0.00030738473,0.00047736787,0.0004895591,0.00016358898,0.0003562161,0.0003153954,0.00030767708,0.0012952695],"category_scores_gemma":[0.0018674406,0.00009042427,0.0003618254,0.00028136183,0.00013818423,0.00019602201,0.00025736837,0.00028714768,0.00040151202],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022622824,0.00010938801,0.9608574,0.000028552036,0.00015636015,0.00006687488,0.000029018349,0.0013772966,0.0074641085,0.00006878269,0.0007039459,0.026875995],"study_design_scores_gemma":[0.00016665772,0.0010076361,0.9509203,0.000035466863,0.0003402295,0.0006263289,0.00012023381,0.040450793,0.0045571397,0.0006239573,0.0011296134,0.000021559696],"about_ca_topic_score_codex":0.00067513343,"about_ca_topic_score_gemma":0.001232436,"teacher_disagreement_score":0.0012952695,"about_ca_system_score_codex":0.00021139278,"about_ca_system_score_gemma":0.00026859602,"threshold_uncertainty_score":0.004333079},"labels":[],"label_agreement":null},{"id":"W2111923037","doi":"10.1158/1078-0432.ccr-06-0330","title":"Nuclear Localization of Nuclear Factor-κB p65 in Primary Prostate Tumors Is Highly Predictive of Pelvic Lymph Node Metastases","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Prostatectomy; Prostate cancer; Odds ratio; Lymph node; Medicine; Logistic regression; Univariate analysis; Receiver operating characteristic; Oncology; Univariate; Prostate; Urology; Internal medicine; Multivariate analysis; Pathology; Multivariate statistics; Cancer; Mathematics; Statistics","score_opus":0.057873054949210224,"score_gpt":0.3872536656666992,"score_spread":0.329380610717489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111923037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99899906,0.0006029787,0.00019987267,0.00002849507,0.0000068813606,0.0000027984286,0.000031031534,0.000011395479,0.000117460426],"genre_scores_gemma":[0.99977905,0.000082899125,0.00005641273,0.0000033863748,0.000007048448,0.0000010815302,0.000029894929,8.41512e-7,0.00003950664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998248,0.00004807736,0.000014598109,0.000045645487,0.000040960233,0.000025886393],"domain_scores_gemma":[0.99847275,0.00040595926,0.0006524139,0.000092662434,0.0000882067,0.00028806552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005510408,0.00033657762,0.00019635107,0.00036427702,0.00021350675,0.00033647416,0.00021370388,0.00025360982,0.0013164298],"category_scores_gemma":[0.002325854,0.00019788793,0.00021351101,0.00022718108,0.00056374975,0.00014791856,0.00024253721,0.00051240367,0.0003001281],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037622688,0.00004242229,0.99393517,0.000027963979,0.00003836414,0.000119085336,0.000028186314,0.00012194983,0.0028927461,0.000008118819,0.00006201454,0.002347796],"study_design_scores_gemma":[0.000011177819,0.00024639023,0.9970145,0.000007118252,0.000040193987,0.0011574379,0.000053941458,0.00048961915,0.00082294096,0.000040464445,0.00011280717,0.000003442277],"about_ca_topic_score_codex":0.0009003575,"about_ca_topic_score_gemma":0.0012997412,"teacher_disagreement_score":0.0013164298,"about_ca_system_score_codex":0.00021800787,"about_ca_system_score_gemma":0.0002363978,"threshold_uncertainty_score":0.004403889},"labels":[],"label_agreement":null},{"id":"W2112162466","doi":"10.1158/1078-0432.ccr-04-2047","title":"Antisense Inhibition of Methylenetetrahydrofolate Reductase Reduces Cancer Cell Survival <i>In vitro</i> and Tumor Growth <i>In vivo</i>","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"","keywords":"In vivo; Cisplatin; Methylenetetrahydrofolate reductase; Cytotoxic T cell; Growth inhibition; Cancer research; Cell growth; Biology; Pharmacology; Colorectal cancer; Cancer; Medicine; In vitro; Internal medicine; Chemotherapy; Biochemistry","score_opus":0.11079809504736059,"score_gpt":0.4649986918685726,"score_spread":0.354200596821212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112162466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99250185,0.0042286706,0.0014995356,0.00011217617,0.000059024584,0.000029397052,0.00032296183,0.00007566095,0.0011705757],"genre_scores_gemma":[0.9919471,0.003085103,0.0022765333,0.00008321021,0.000027835536,0.00004855085,0.0008224745,0.000015210837,0.0016940911],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989986,0.000012799276,0.000011932968,0.00002619265,0.000027326976,0.000021878786],"domain_scores_gemma":[0.999907,0.00002596995,0.000027087399,0.0000066858233,0.000014582361,0.000018673014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012651704,0.00041884978,0.00025695353,0.00015148445,0.000107535314,0.00017489886,0.0001418853,0.0002067595,0.0009719214],"category_scores_gemma":[0.00011185888,0.000099124656,0.00022209913,0.000097122625,0.000144962,0.0001239966,0.000064333224,0.00043264634,0.00017466636],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015269735,0.00005359348,0.0001979808,0.000045497214,0.000006728321,0.000009537389,0.0000058156065,0.000065303764,0.99827206,0.000026676022,0.000052082138,0.0011119745],"study_design_scores_gemma":[0.000026264988,0.0014553206,0.0023628091,0.0000046782034,0.000028297438,0.00009155944,0.000008919728,0.0005355986,0.99436635,0.000009103508,0.0011086806,0.00000238798],"about_ca_topic_score_codex":0.0015044234,"about_ca_topic_score_gemma":0.0021040435,"teacher_disagreement_score":0.0015044234,"about_ca_system_score_codex":0.00033816087,"about_ca_system_score_gemma":0.00022006499,"threshold_uncertainty_score":0.0032513738},"labels":[],"label_agreement":null},{"id":"W2112377066","doi":"10.1158/1078-0432.ccr-12-2812","title":"Molecular Markers in Key Steroidogenic Pathways, Circulating Steroid Levels, and Prostate Cancer Progression","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"CYP17A1; Prostate cancer; Single-nucleotide polymorphism; Oncology; Internal medicine; Dihydrotestosterone; SNP; Proportional hazards model; Cancer; Androgen deprivation therapy; Medicine; Biology; Androgen; Endocrinology; Hormone; Genetics; Gene; Genotype","score_opus":0.11095048884618637,"score_gpt":0.4624147126594092,"score_spread":0.35146422381322284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112377066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982444,0.0010020565,0.00026206818,0.00004011601,0.000004671812,0.0000048558645,0.00023311249,0.000007905815,0.00020083252],"genre_scores_gemma":[0.9992556,0.0001529789,0.00019418588,0.000015276306,0.000010166416,0.0000037866143,0.0002023665,0.0000017905627,0.00016391718],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997464,0.00007063832,0.000021128677,0.00008041756,0.000057584304,0.000023929031],"domain_scores_gemma":[0.9989128,0.00026100883,0.0005344273,0.00009509174,0.0000786779,0.00011798556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056991575,0.0003417134,0.00028616135,0.00050248683,0.00021290926,0.00036386936,0.0002158784,0.00022096909,0.00168249],"category_scores_gemma":[0.00127754,0.000109679975,0.00029706015,0.00072995224,0.00030020994,0.000120627315,0.00021300695,0.0003579277,0.0001784982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057777995,0.00003651577,0.98508954,0.000045485234,0.00019881311,0.000134468,0.000059585775,0.00016805714,0.008010675,0.000038591665,0.00005680679,0.0055836397],"study_design_scores_gemma":[0.000014396343,0.00018229368,0.99708265,0.000007325929,0.00013107552,0.00044975127,0.00003685411,0.00027363747,0.0014931532,0.00007091773,0.0002544804,0.0000035153173],"about_ca_topic_score_codex":0.0013897384,"about_ca_topic_score_gemma":0.0014574142,"teacher_disagreement_score":0.00168249,"about_ca_system_score_codex":0.00014273831,"about_ca_system_score_gemma":0.00026065746,"threshold_uncertainty_score":0.0056284666},"labels":[],"label_agreement":null},{"id":"W2112505356","doi":"10.1158/1078-0432.ccr-07-4393","title":"Profound Inhibition of Antigen-Specific T-Cell Effector Functions by Dasatinib","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Dasatinib; T cell; Cytotoxic T cell; Cytokine; Degranulation; Cancer research; CD8; Biology; LYN; Tyrosine kinase; CD28; Immunology; Cell biology; Signal transduction; Antigen; Immune system; Receptor; In vitro; Biochemistry","score_opus":0.23667664232533722,"score_gpt":0.48237610064549724,"score_spread":0.24569945832016002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112505356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98952544,0.004244408,0.0035771169,0.000098656645,0.000036924128,0.00008871417,0.00033909926,0.00011695628,0.0019728197],"genre_scores_gemma":[0.99771047,0.0008483955,0.0007809735,0.000028885746,0.000008308621,0.0000251743,0.00017468563,0.0000053615636,0.00041766517],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997758,0.000045324,0.000034925906,0.000035329955,0.000052414252,0.000056220808],"domain_scores_gemma":[0.99994206,0.000015808224,0.000014607815,0.000010253132,0.000007065697,0.00001021164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015168522,0.00033869146,0.00034854427,0.000092203,0.000085523374,0.0002662798,0.00016126646,0.00018339089,0.0011621596],"category_scores_gemma":[0.00015746134,0.000060358012,0.0001972074,0.00012762146,0.00017016291,0.00016402491,0.00016189662,0.00041422548,0.00032482675],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020794733,0.000048260637,0.00023212454,0.00009811043,0.000010957025,0.00007339125,0.000008080698,0.00028444236,0.9936877,0.00007884447,0.000062733336,0.0052075656],"study_design_scores_gemma":[0.00005720337,0.0009300999,0.0018040898,0.000004673545,0.000019618426,0.000673847,0.0000098812225,0.00065311545,0.99366623,0.000045987046,0.0021326044,0.0000025752286],"about_ca_topic_score_codex":0.00010000067,"about_ca_topic_score_gemma":0.00015956024,"teacher_disagreement_score":0.0011621596,"about_ca_system_score_codex":0.00017627994,"about_ca_system_score_gemma":0.00018444254,"threshold_uncertainty_score":0.0038878322},"labels":[],"label_agreement":null},{"id":"W2112598101","doi":"10.1158/1078-0432.ccr-13-3063","title":"Noninvasive Diagnosis of Actionable Mutations by Deep Sequencing of Circulating Free DNA in Lung Cancer from Never-Smokers: A Proof-of-Concept Study from BioCAST/IFCT-1002","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":211,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"World Health Organization","keywords":"Lung cancer; Liquid biopsy; Mutation; Cancer; DNA sequencing; Medicine; Somatic cell; Germline mutation; Cell-free fetal DNA; Deep sequencing; Oncology; Genome; DNA; Internal medicine; Pathology; Biology; Genetics; Gene","score_opus":0.08841003771622559,"score_gpt":0.42858706443737776,"score_spread":0.3401770267211522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112598101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894862,0.000860019,0.008055347,0.0001321785,0.00002867959,0.00022589548,0.0005695402,0.00014998783,0.0004921402],"genre_scores_gemma":[0.976146,0.00046560296,0.01895037,0.00052885036,0.000036161546,0.00032615394,0.0028347548,0.00007163271,0.00064053264],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988902,0.00031095534,0.000035432422,0.00023009587,0.0004633614,0.000069899754],"domain_scores_gemma":[0.9991761,0.0002583174,0.00011387541,0.00009531348,0.00019184111,0.00016448663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023131038,0.0006777789,0.0006324385,0.00033563428,0.0002147925,0.0004881216,0.00066473964,0.00068284705,0.0005661144],"category_scores_gemma":[0.0013275918,0.00034058045,0.00039054913,0.00014117153,0.00054224103,0.000287803,0.0004041082,0.00063427683,0.00022160732],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039853537,0.0022188097,0.04988642,0.00015426875,0.00020152854,0.00036051913,0.00009596493,0.001177212,0.9195046,0.00008546873,0.00080189394,0.021527957],"study_design_scores_gemma":[0.0026254996,0.03935542,0.23341171,0.000059085658,0.0006284794,0.0080429865,0.00017419005,0.05115716,0.65834355,0.0003446313,0.0057398006,0.000117536016],"about_ca_topic_score_codex":0.0010929274,"about_ca_topic_score_gemma":0.0014080079,"teacher_disagreement_score":0.0023131038,"about_ca_system_score_codex":0.0003353268,"about_ca_system_score_gemma":0.00060836755,"threshold_uncertainty_score":0.012233019},"labels":[],"label_agreement":null},{"id":"W2112663560","doi":"10.1158/1078-0432.ccr-05-2079","title":"Real-time Dose Adjustment of Cyclophosphamide in a Preparative Regimen for Hematopoietic Cell Transplant: A Bayesian Pharmacokinetic Approach","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Biomedical Imaging and Bioengineering; National Cancer Institute","keywords":"NONMEM; Pharmacokinetics; Cyclophosphamide; Medicine; Regimen; Mean squared error; Population; Bayesian probability; Statistics; Oncology; Chemotherapy; Pharmacology; Surgery; Mathematics","score_opus":0.07709430576573807,"score_gpt":0.44158611466975106,"score_spread":0.364491808904013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112663560","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02887342,0.00016286715,0.96850276,0.0001998558,0.0000114461645,0.00006758568,0.00009082219,0.0013703604,0.00072096346],"genre_scores_gemma":[0.48475888,0.00029609734,0.51281327,0.00018302965,0.000037925183,0.00029707243,0.00026003463,0.00028917563,0.0010645173],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99931765,0.00034505004,0.000042383188,0.000100700054,0.00016353108,0.00003062121],"domain_scores_gemma":[0.99766773,0.0015723484,0.0003126526,0.00008038002,0.00030110776,0.00006572663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025800734,0.0005663913,0.00055328757,0.00070940534,0.00032843955,0.00072558527,0.0009406184,0.0007538103,0.001230677],"category_scores_gemma":[0.008537224,0.00073587225,0.00055444083,0.00027815215,0.00033638775,0.0005805588,0.0005625994,0.0008948893,0.00030078838],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026817125,0.00017169214,0.0063165054,0.00013275072,0.00014268202,0.000087828346,0.00012420688,0.8477934,0.008978215,0.003777386,0.0010541875,0.13115291],"study_design_scores_gemma":[0.000020712385,0.000025718933,0.0006869039,0.000010101267,0.00001815319,0.000022689304,0.000004121671,0.9959437,0.0014058021,0.0013706213,0.00048102273,0.000010438557],"about_ca_topic_score_codex":0.007569482,"about_ca_topic_score_gemma":0.011372726,"teacher_disagreement_score":0.007569482,"about_ca_system_score_codex":0.0010332188,"about_ca_system_score_gemma":0.0019399743,"threshold_uncertainty_score":0.015050888},"labels":[],"label_agreement":null},{"id":"W2112732161","doi":"10.1158/1078-0432.ccr-07-4960","title":"Genomic Differences Between Pure Ductal Carcinoma <i>In Situ</i> of the Breast and that Associated with Invasive Disease: a Calibrated aCGH Study","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research; University of Manitoba; University Health Network","funders":"University Health Network","keywords":"Ductal carcinoma; Breast cancer; Comparative genomic hybridization; Biology; Metastasis; Pathology; Cancer; Lymph node; Lymph; Oncology; Medicine; Genome; Gene; Genetics","score_opus":0.10998153372340977,"score_gpt":0.3547301772067752,"score_spread":0.24474864348336542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112732161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99913114,0.00009536557,0.0004935898,0.0000044094277,0.0000011315213,0.00000532152,0.000028448574,0.000004257877,0.00023636452],"genre_scores_gemma":[0.9995814,0.000024583034,0.00028200814,0.000006493357,0.000003330641,0.000004454166,0.000052542677,0.0000023879368,0.000042814896],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99961996,0.00009614248,0.000029653604,0.00012608546,0.00008907929,0.000038971753],"domain_scores_gemma":[0.999032,0.00048897555,0.0002098836,0.00010678857,0.00006028275,0.00010208513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006086949,0.00023230798,0.00022993117,0.0011947039,0.00015067152,0.00035496033,0.00017372941,0.00021546402,0.0012389395],"category_scores_gemma":[0.0017716121,0.00015901134,0.00014057446,0.0005828439,0.0005632548,0.0002080336,0.00033308056,0.00022754028,0.00014396387],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016828844,0.0001487965,0.88193506,0.00007687848,0.0001969176,0.001068301,0.0005034364,0.0004909313,0.10035772,0.00024140842,0.00005496495,0.01324275],"study_design_scores_gemma":[0.000023858776,0.0006975197,0.9836536,0.000004880402,0.000083554456,0.004301891,0.00033236414,0.0009551282,0.0093609765,0.00019490124,0.00038100086,0.000010318607],"about_ca_topic_score_codex":0.0003045468,"about_ca_topic_score_gemma":0.00020442053,"teacher_disagreement_score":0.0012389395,"about_ca_system_score_codex":0.00017839798,"about_ca_system_score_gemma":0.00010334485,"threshold_uncertainty_score":0.0041446686},"labels":[],"label_agreement":null},{"id":"W2112967018","doi":"10.1158/1078-0432.ccr-11-1344","title":"Skin Tumors Induced by Sorafenib; Paradoxic RAS–RAF Pathway Activation and Oncogenic Mutations of <i>HRAS</i> , <i>TP53</i> , and <i>TGFBR1</i>","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"HRAS; Sorafenib; Neuroblastoma RAS viral oncogene homolog; Cancer research; Keratinocyte; MAPK/ERK pathway; In vivo; Kinase; Malignant transformation; Medicine; Pathology; Biology; Cancer; KRAS; In vitro; Internal medicine; Hepatocellular carcinoma","score_opus":0.15463426291045915,"score_gpt":0.41440380203132415,"score_spread":0.259769539120865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112967018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992105,0.00023083879,0.00015815148,0.0000057941725,0.000002444702,0.000010157962,0.0000306181,0.000014045593,0.0003373229],"genre_scores_gemma":[0.9997229,0.000051016155,0.00009017266,0.000006663651,0.0000023534196,0.000002992923,0.00004737291,0.0000012926962,0.00007520791],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998529,0.000037788766,0.0000105666695,0.00003067839,0.00003445704,0.000033580356],"domain_scores_gemma":[0.99974257,0.000042622774,0.00010199623,0.000027781336,0.000018422998,0.000066565895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013626328,0.00020761095,0.00020625346,0.0003007898,0.00022100743,0.00021943828,0.00009202083,0.00015481842,0.0011357074],"category_scores_gemma":[0.00023333913,0.00014137334,0.0002895791,0.00016040352,0.00016135752,0.000115864525,0.00015327538,0.0002701905,0.00022961354],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026875802,0.00026060457,0.12952626,0.00016044822,0.00007884838,0.0076694265,0.00010631096,0.00021808765,0.85003775,0.000072296374,0.00012146257,0.009060966],"study_design_scores_gemma":[0.00016224345,0.004696692,0.5948448,0.000012123478,0.0001370409,0.048834536,0.00022511376,0.0010952869,0.3482426,0.00009299166,0.0016393517,0.000017234222],"about_ca_topic_score_codex":0.00020826302,"about_ca_topic_score_gemma":0.00026457716,"teacher_disagreement_score":0.0011357074,"about_ca_system_score_codex":0.00015399158,"about_ca_system_score_gemma":0.000111611254,"threshold_uncertainty_score":0.0037993193},"labels":[],"label_agreement":null},{"id":"W2113038794","doi":"10.1158/1078-0432.963.11.3","title":"Plasma Protein Profiling by Mass Spectrometry for Cancer Diagnosis: Opportunities and Limitations","year":2005,"lang":"en","type":"editorial","venue":"Clinical Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Profiling (computer programming); Mass spectrometry; Computational biology; Medicine; Chemistry; Computer science; Biology; Chromatography","score_opus":0.2656850612986036,"score_gpt":0.5102683841393999,"score_spread":0.2445833228407963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113038794","genre_codex":"review","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02168588,0.7516284,0.10133856,0.10669676,0.005002273,0.0006097657,0.0017507182,0.0009410055,0.01034667],"genre_scores_gemma":[0.2247514,0.48635972,0.23244868,0.035263684,0.013276678,0.0015843621,0.0013963437,0.00035227608,0.0045668217],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9812874,0.009547363,0.0011036666,0.002240388,0.0054139937,0.00040713372],"domain_scores_gemma":[0.96452665,0.022902545,0.0020735308,0.002212592,0.0070303427,0.0012542147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.045792714,0.0025225985,0.0029283492,0.003188481,0.0011010199,0.0056643835,0.0060490044,0.005206688,0.0039161327],"category_scores_gemma":[0.03048381,0.0009688192,0.0016392524,0.0027051663,0.0035669652,0.0066465572,0.0030159787,0.0036614414,0.0035811786],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021441067,0.0007223412,0.05128345,0.017727735,0.0023424542,0.0010411588,0.001251857,0.004022542,0.04370671,0.027745396,0.069466665,0.77854556],"study_design_scores_gemma":[0.0004508723,0.0036004863,0.057038147,0.015689425,0.0015815224,0.01669048,0.0043072454,0.073309764,0.04462555,0.18033136,0.601437,0.00093820674],"about_ca_topic_score_codex":0.0024733641,"about_ca_topic_score_gemma":0.0032347145,"teacher_disagreement_score":0.045792714,"about_ca_system_score_codex":0.0018253165,"about_ca_system_score_gemma":0.0034702488,"threshold_uncertainty_score":0.2421779},"labels":[],"label_agreement":null},{"id":"W2113128219","doi":"10.1158/1078-0432.ccr-04-0940","title":"Efficacy and Safety Evaluation of Human Reovirus Type 3 in Immunocompetent Animals","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Provincial Laboratory of Public Health; University of Toronto; Oncolytics Biotech (Canada); University of Calgary","funders":"","keywords":"Glioma; Antibody; Pathology; Virology; Biology; Reoviridae; Medicine; Immunology; Virus; Cancer research","score_opus":0.5094955707187374,"score_gpt":0.6364664885630844,"score_spread":0.126970917844347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113128219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99437165,0.0015307667,0.0019248041,0.000078024845,0.000047690723,0.00033797248,0.00032467968,0.000060888444,0.0013234877],"genre_scores_gemma":[0.9911237,0.0018868503,0.0029300656,0.00012854145,0.00005505165,0.000515972,0.0008873886,0.000023452241,0.0024490163],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994524,0.00020949607,0.000036778103,0.000116592775,0.00010988503,0.00007483959],"domain_scores_gemma":[0.9993399,0.00012511418,0.00020984777,0.00015366955,0.00008819865,0.00008341247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090604194,0.00081174483,0.00046430354,0.00057426543,0.00035343674,0.00040579945,0.00038777487,0.0006681338,0.0013369127],"category_scores_gemma":[0.0005011272,0.00014554594,0.00045310816,0.00017246348,0.00050696783,0.0005126902,0.00013728433,0.00082035054,0.00035783745],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069030533,0.00643466,0.0035094193,0.0002722627,0.00007820426,0.00033302698,0.00019754712,0.00048698235,0.96284324,0.00029809983,0.0003410689,0.018302416],"study_design_scores_gemma":[0.000682974,0.1433201,0.011779207,0.000082228114,0.00020130919,0.0013142416,0.00015671489,0.0010515637,0.8339974,0.00016491821,0.0072166435,0.000032579665],"about_ca_topic_score_codex":0.00066338084,"about_ca_topic_score_gemma":0.00083656766,"teacher_disagreement_score":0.0013369127,"about_ca_system_score_codex":0.00047155205,"about_ca_system_score_gemma":0.00033106867,"threshold_uncertainty_score":0.0047916174},"labels":[],"label_agreement":null},{"id":"W2113151539","doi":"10.1158/1078-0432.ccr-07-1037","title":"Molecular Alterations in Prostate Carcinomas that Associate with <i>In vivo</i> Exposure to Chemotherapy: Identification of a Cytoprotective Mechanism Involving Growth Differentiation Factor 15","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"GDF15 and Related Biomarkers","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; U.S. Department of Veterans Affairs","keywords":"Docetaxel; Prostate cancer; Chemotherapy; Mitoxantrone; Medicine; Cancer research; Prostate; Prostatectomy; Cancer; Oncology; Biology; Pathology; Internal medicine","score_opus":0.07075281388575705,"score_gpt":0.40936318319274495,"score_spread":0.3386103693069879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113151539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99911445,0.00036177444,0.00020415409,0.000019678868,0.0000024312662,0.00001729367,0.00011412082,0.000007632665,0.00015855851],"genre_scores_gemma":[0.99883026,0.00020590461,0.0003334836,0.000027408245,0.000004586847,0.000027737779,0.00034726743,0.0000020051564,0.00022133949],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999236,0.0000142526915,0.000004980196,0.000020356954,0.000015928683,0.000020770696],"domain_scores_gemma":[0.9998851,0.000018270504,0.00005080772,0.000008652964,0.000009625538,0.00002751609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007000209,0.00020156169,0.0002596254,0.00020264796,0.000113399816,0.00020401475,0.00009692528,0.00019409394,0.000902964],"category_scores_gemma":[0.00015350383,0.00010621808,0.0001354567,0.00019058751,0.00023115907,0.00006969914,0.00007603748,0.00025246918,0.00016729328],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001834679,0.00022449563,0.04933953,0.000096731055,0.000040028863,0.00021438424,0.00003883395,0.00020114948,0.94296575,0.000038315033,0.00011562758,0.004890481],"study_design_scores_gemma":[0.00019723788,0.005236401,0.6518822,0.000009784121,0.0001492886,0.0031821562,0.000120909346,0.000895492,0.33661386,0.000056645025,0.0016432015,0.000012918822],"about_ca_topic_score_codex":0.00033295073,"about_ca_topic_score_gemma":0.0005387782,"teacher_disagreement_score":0.000902964,"about_ca_system_score_codex":0.00022508562,"about_ca_system_score_gemma":0.00019544107,"threshold_uncertainty_score":0.0030206442},"labels":[],"label_agreement":null},{"id":"W2113171275","doi":"10.1158/1078-0432.ccr-07-2003","title":"Fibroblast Growth Factor 2 and Estrogen Control the Balance of Histone 3 Modifications Targeting MAGE-A3 in Pituitary Neoplasia","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Biology; DNA methylation; Chromatin immunoprecipitation; Histone; Cancer research; Histone methylation; Methylation; Molecular biology; Endocrinology; Internal medicine; Gene expression; Promoter; Medicine; Genetics; Gene","score_opus":0.09073692824392346,"score_gpt":0.44820552559561105,"score_spread":0.35746859735168757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113171275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99339277,0.00378093,0.001107792,0.00009468023,0.000022089953,0.000014123364,0.00022180905,0.000047797414,0.0013178971],"genre_scores_gemma":[0.9965167,0.00088836165,0.00055348617,0.000038714403,0.000006255456,0.000010796734,0.00017277838,0.000009235306,0.001803525],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999347,0.00000926677,0.000004314152,0.000015760721,0.000017909877,0.000018107328],"domain_scores_gemma":[0.9999263,0.000010215453,0.000024733154,0.000005134625,0.000009311953,0.000024308913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010658537,0.00021849254,0.00014556038,0.0001829614,0.00013546563,0.00019363404,0.00013938796,0.00018785546,0.0011099735],"category_scores_gemma":[0.00012891243,0.00010877673,0.00019323932,0.00010192575,0.00020825805,0.0001289197,0.00017075991,0.00019133167,0.00021967378],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022111715,0.0000063256066,0.000802058,0.000015896127,0.000004980466,0.00007820104,0.00001242458,0.000023345236,0.99770504,0.00004854775,0.000028974317,0.0010530363],"study_design_scores_gemma":[0.000049069055,0.00045325124,0.08203678,0.0000079558995,0.00003778169,0.001181169,0.00013132088,0.00079117354,0.90915453,0.00019984187,0.0059472965,0.000009776343],"about_ca_topic_score_codex":0.0012713427,"about_ca_topic_score_gemma":0.0019498022,"teacher_disagreement_score":0.0012713427,"about_ca_system_score_codex":0.00036290527,"about_ca_system_score_gemma":0.00024811082,"threshold_uncertainty_score":0.0037132502},"labels":[],"label_agreement":null},{"id":"W2113325722","doi":"10.1158/1078-0432.ccr-11-1331","title":"Indoleamine 2,3-Dioxygenase Expression in Human Cancers: Clinical and Immunologic Perspectives","year":2011,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":388,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame; Montreal General Hospital","funders":"","keywords":"Indoleamine 2,3-dioxygenase; Immune system; Medicine; Immunology; Immunotherapy; Cancer; Cancer immunotherapy; Clinical trial; Cancer research; Tryptophan Metabolism; Biology; Internal medicine; Tryptophan","score_opus":0.5876062187741322,"score_gpt":0.5994187160481229,"score_spread":0.011812497273990696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113325722","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010468141,0.99924684,0.000058094694,0.00013059545,0.000057047862,0.0000015460643,0.000009743557,0.0000033144397,0.00038814862],"genre_scores_gemma":[0.0006177936,0.99886835,0.0001015906,0.00007307304,0.00007405663,0.0000035798723,0.000017245146,6.627051e-7,0.0002436911],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999846,0.00002965635,0.000026729294,0.000032535114,0.000051752875,0.00001332379],"domain_scores_gemma":[0.99975485,0.00010630363,0.000037534875,0.000008998564,0.000073154915,0.000019096819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047868903,0.0007756903,0.001354879,0.002345809,0.00021459862,0.0008242701,0.000708421,0.0009419695,0.0018346905],"category_scores_gemma":[0.00047300773,0.00022983934,0.00042131517,0.0027874243,0.00044736362,0.0009959722,0.00039556745,0.0010393645,0.0015070954],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010774252,0.00007532932,0.00046342376,0.014760177,0.0000898214,0.00036937077,0.000050305345,0.00030280196,0.003328291,0.0019208043,0.019020915,0.95951104],"study_design_scores_gemma":[0.000038422357,0.0002511792,0.0056859213,0.006436345,0.00029455303,0.0071532135,0.00013493621,0.00020687684,0.0017324063,0.0030300934,0.9749933,0.000042836265],"about_ca_topic_score_codex":0.001497995,"about_ca_topic_score_gemma":0.0022489245,"teacher_disagreement_score":0.002345809,"about_ca_system_score_codex":0.0006673345,"about_ca_system_score_gemma":0.0009990124,"threshold_uncertainty_score":0.006137669},"labels":[],"label_agreement":null},{"id":"W2113341349","doi":"10.1158/1078-0432.ccr-04-1951","title":"Targeting the Mevalonate Pathway Inhibits the Function of the Epidermal Growth Factor Receptor","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Regional Cancer Foundation","funders":"AstraZeneca","keywords":"Gefitinib; Epidermal growth factor receptor; Lovastatin; EGFR inhibitors; Protein kinase B; Cancer research; Epidermal growth factor; Biology; Erlotinib; Pharmacology; Signal transduction; Receptor; Endocrinology; Biochemistry; Cholesterol","score_opus":0.09143395515179983,"score_gpt":0.40995660071998064,"score_spread":0.3185226455681808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113341349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98919195,0.007245386,0.0018213455,0.000104659775,0.000053641583,0.000055608885,0.0001671049,0.00009527309,0.0012649536],"genre_scores_gemma":[0.99268734,0.0036304235,0.0016890727,0.000031729942,0.000014797732,0.00004333194,0.0002979435,0.000013287315,0.0015921439],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998481,0.000029537921,0.000013745791,0.000029303359,0.000039307404,0.000039923663],"domain_scores_gemma":[0.99994147,0.000016241758,0.000014972315,0.000006654952,0.0000071528066,0.00001343813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014457769,0.00045343395,0.0003896113,0.0002499214,0.00015230116,0.00028831052,0.00024233357,0.00020696622,0.0009131369],"category_scores_gemma":[0.000099247605,0.000105290725,0.00028611772,0.00015966495,0.00019411724,0.00017774175,0.00014023398,0.00038812548,0.00029411077],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032667405,0.00007220815,0.0001914086,0.000078488556,0.000011533039,0.000023619028,0.000008292933,0.00007192815,0.996278,0.000039069273,0.000046826644,0.0028518303],"study_design_scores_gemma":[0.000041201747,0.0014222949,0.0017186773,0.000006673734,0.00002604337,0.00019192659,0.000015747593,0.00035160215,0.99374807,0.000022337279,0.002452593,0.000002855302],"about_ca_topic_score_codex":0.00067061506,"about_ca_topic_score_gemma":0.0016354129,"teacher_disagreement_score":0.0009131369,"about_ca_system_score_codex":0.00038701837,"about_ca_system_score_gemma":0.00031608474,"threshold_uncertainty_score":0.0030547976},"labels":[],"label_agreement":null},{"id":"W2113586691","doi":"10.1158/1078-0432.ccr-07-5063","title":"Cell Proliferation, Cell Cycle Abnormalities, and Cancer Outcome in Patients with Barrett's Esophagus: A Long-term Prospective Study","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institute on Aging","keywords":"CDKN2A; Cell cycle; Esophagus; Barrett's esophagus; Flow cytometry; Biology; Adenocarcinoma; Aneuploidy; Cancer; Pathology; Cell growth; Cancer research; Loss of heterozygosity; Gastroenterology; Internal medicine; Medicine; Molecular biology; Genetics; Gene; Allele","score_opus":0.10157212689956134,"score_gpt":0.4577409821482149,"score_spread":0.35616885524865355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113586691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990902,0.0004147023,0.00007075021,0.000024851961,0.000005279372,0.000007876473,0.00020723432,0.000002700624,0.00017645274],"genre_scores_gemma":[0.99909997,0.00013203458,0.000064531705,0.000027890434,0.000014004986,0.000012450188,0.0004910115,0.000001859005,0.00015630717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960786,0.00009115743,0.000039817955,0.000113413495,0.00007277559,0.00007503728],"domain_scores_gemma":[0.99821067,0.00029530766,0.0005816996,0.00017759016,0.00026432914,0.0004705579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008853539,0.0003826525,0.0005277392,0.0006018007,0.0007308979,0.000706211,0.000360785,0.0008119952,0.0010244279],"category_scores_gemma":[0.001818413,0.00031720774,0.0004789136,0.0008037098,0.0003959172,0.0007071815,0.0004809998,0.0009989842,0.0003401103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003320335,0.00006190222,0.9986527,0.000005076429,0.000055832654,0.000055111606,0.000022501943,0.000018557103,0.0002453518,0.0000039953147,0.000025244615,0.0005216805],"study_design_scores_gemma":[0.000015607833,0.00046681787,0.9987411,0.000004396036,0.000058387413,0.0003118422,0.000059289123,0.000090095964,0.0000919627,0.000009320388,0.0001472666,0.000003921869],"about_ca_topic_score_codex":0.00182136,"about_ca_topic_score_gemma":0.0019426682,"teacher_disagreement_score":0.00182136,"about_ca_system_score_codex":0.00030829778,"about_ca_system_score_gemma":0.0003003007,"threshold_uncertainty_score":0.004682243},"labels":[],"label_agreement":null},{"id":"W2113618415","doi":"10.1158/1078-0432.ccr-07-0471","title":"Genome-Wide Allelotypes of Familial Pancreatic Adenocarcinomas and Familial and Sporadic Intraductal Papillary Mucinous Neoplasms","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Human Genome Research Institute","keywords":"Pathology; Medicine; Adenocarcinoma; Cancer; Biology; Cancer research; Internal medicine","score_opus":0.1203055730905282,"score_gpt":0.45483293816342213,"score_spread":0.33452736507289393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113618415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99956185,0.00010019887,0.0001635888,0.000007664764,6.584062e-7,0.000001419013,0.000055943525,0.0000035220557,0.00010514971],"genre_scores_gemma":[0.9996704,0.000024131534,0.00012061959,0.000004904985,0.0000015616256,0.0000023778407,0.000121888224,0.0000017676848,0.000052451025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997346,0.000052668533,0.000025246816,0.00008936751,0.00006504744,0.00003299306],"domain_scores_gemma":[0.99910307,0.00030887764,0.00038842935,0.00006467892,0.00005993528,0.000075109616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000304674,0.00017535624,0.00016837253,0.00078139623,0.00024061442,0.00020614947,0.00011346698,0.00025807015,0.0010605373],"category_scores_gemma":[0.0011613718,0.00011085415,0.00014062713,0.00035311814,0.00021897972,0.00010917932,0.00020094457,0.0001941813,0.00009613266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006142221,0.000031643776,0.9234357,0.000023630986,0.000117422984,0.0010095823,0.00021497687,0.00022438639,0.06902092,0.00007961347,0.00010262503,0.0051252805],"study_design_scores_gemma":[0.0000074601276,0.000058944133,0.9934344,0.0000026806279,0.000030221789,0.0032004048,0.00005297336,0.00029909587,0.0026597346,0.00003342339,0.00021795431,0.000002766538],"about_ca_topic_score_codex":0.00068899273,"about_ca_topic_score_gemma":0.0011593782,"teacher_disagreement_score":0.0010605373,"about_ca_system_score_codex":0.00012059443,"about_ca_system_score_gemma":0.00006699762,"threshold_uncertainty_score":0.0035479069},"labels":[],"label_agreement":null},{"id":"W2113679067","doi":"10.1158/1078-0432.ccr-12-2155","title":"Proliferation in the Normal FTE Is a Hallmark of the Follicular Phase, Not BRCA Mutation Status","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Congressionally Directed Medical Research Programs","keywords":"Fallopian tube; Serous fluid; Ovarian cancer; Germline mutation; Biology; Serous Cystadenoma; Population; Pathology; BRCA mutation; Cancer; Cancer research; Medicine; Internal medicine; Gynecology; Mutation; Genetics","score_opus":0.28016628688970757,"score_gpt":0.5606441821127327,"score_spread":0.28047789522302513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113679067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99405944,0.0017915562,0.0006341871,0.000034165736,0.000011358485,0.00001852964,0.00015644968,0.000050271796,0.0032441327],"genre_scores_gemma":[0.99765706,0.00046305242,0.00070190313,0.000023145116,0.000016749365,0.000016880282,0.00018383838,0.00000778594,0.00092949736],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998745,0.000012378897,0.0000110113315,0.000032200318,0.00004876931,0.000021210773],"domain_scores_gemma":[0.9997719,0.000038727758,0.00008253976,0.000024890509,0.0000421231,0.00003978911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000185251,0.00016847097,0.0001366247,0.00085073424,0.00028508328,0.00026942906,0.00013509205,0.00018074662,0.0024108076],"category_scores_gemma":[0.00045477954,0.00009527299,0.00010002298,0.0003508556,0.0003953405,0.00026199015,0.00020091468,0.00016709464,0.0003786796],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010589627,0.00010918345,0.1769482,0.00019096071,0.000031427775,0.0017900007,0.0003737109,0.00009353573,0.7863553,0.00030135995,0.00042562734,0.032321695],"study_design_scores_gemma":[0.00004304663,0.0009820985,0.87153536,0.000046166355,0.000036873043,0.021061737,0.0004578728,0.0003908327,0.09676019,0.00026475143,0.008408953,0.000012088342],"about_ca_topic_score_codex":0.0010608056,"about_ca_topic_score_gemma":0.0014556804,"teacher_disagreement_score":0.0024108076,"about_ca_system_score_codex":0.00031589947,"about_ca_system_score_gemma":0.00015769919,"threshold_uncertainty_score":0.008064926},"labels":[],"label_agreement":null},{"id":"W2114080249","doi":"10.1158/1078-0432.ccr-08-2024","title":"Role of Eotaxin-1 Signaling in Ovarian Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"CCL11; Ovarian cancer; Cancer research; Ovarian carcinoma; Chemokine; Cancer; Receptor; Ovarian tumor; Medicine; Biology; Internal medicine; Eotaxin","score_opus":0.18701482953628157,"score_gpt":0.5346850819076691,"score_spread":0.3476702523713875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114080249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97518456,0.020431835,0.0011790941,0.00060380093,0.000059450074,0.000055227592,0.0002996252,0.00004641617,0.0021400794],"genre_scores_gemma":[0.9932535,0.0046878653,0.0005388457,0.00013254338,0.000029229763,0.00003361823,0.00025297786,0.0000022384095,0.0010692333],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999467,0.000014096927,0.0000038227713,0.000007768597,0.0000085450165,0.000018969651],"domain_scores_gemma":[0.9999479,0.0000074875657,0.00002380978,0.0000020948123,0.0000059486947,0.000012671269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010914183,0.00018344422,0.0001385246,0.00020162108,0.00015727167,0.0001821591,0.000082316736,0.00017951496,0.0010632464],"category_scores_gemma":[0.00011362408,0.000047309386,0.00009982821,0.0001322895,0.00013607526,0.00016836917,0.0001797042,0.0002190309,0.00014140055],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017272371,0.00020987183,0.038795758,0.0011538505,0.00004194043,0.0014706508,0.00017553885,0.0005546181,0.90413123,0.001437245,0.0014418297,0.04886034],"study_design_scores_gemma":[0.0004521708,0.002680865,0.33048683,0.0003789185,0.00023325911,0.007590413,0.0007581142,0.009472553,0.57793313,0.0022663318,0.067712344,0.00003509499],"about_ca_topic_score_codex":0.00024626055,"about_ca_topic_score_gemma":0.00039626003,"teacher_disagreement_score":0.0010632464,"about_ca_system_score_codex":0.0003296118,"about_ca_system_score_gemma":0.00028988047,"threshold_uncertainty_score":0.0035569668},"labels":[],"label_agreement":null},{"id":"W2114549720","doi":"10.1158/1078-0432.ccr-08-1325","title":"CBL Exon 8/9 Mutants Activate the FLT3 Pathway and Cluster in Core Binding Factor/11q Deletion Acute Myeloid Leukemia/Myelodysplastic Syndrome Subtypes","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Core binding factor; Midostaurin; Myeloid leukemia; Cancer research; Biology; Autophosphorylation; Haematopoiesis; Exon; Leukemia; Fms-Like Tyrosine Kinase 3; Mutant; Tyrosine kinase; Protein kinase B; Molecular biology; Mutation; Transcription factor; Kinase; Signal transduction; Genetics; Gene; Protein kinase A; Stem cell","score_opus":0.14834580115023244,"score_gpt":0.45602768931853915,"score_spread":0.3076818881683067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114549720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995365,0.00009518606,0.00013542129,0.000009490981,6.48803e-7,0.000004174258,0.0000658914,0.0000090802605,0.00014359225],"genre_scores_gemma":[0.9991991,0.00005128946,0.00028559504,0.0000079044,0.0000015444018,0.0000045152306,0.00021532572,0.0000030513,0.00023176636],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99991727,0.000009878054,0.000008059004,0.000019394429,0.000026363192,0.000018949746],"domain_scores_gemma":[0.9999113,0.000016523136,0.000042483818,0.0000058486576,0.0000061577216,0.00001763173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000756999,0.00026900118,0.0001128005,0.0002567855,0.00012958658,0.00010768432,0.0001220961,0.0001626365,0.0010959394],"category_scores_gemma":[0.00015203665,0.00008198036,0.00011884711,0.0001208818,0.00014878002,0.00007352407,0.00011280297,0.0001698397,0.00022010233],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044506096,0.00004864843,0.07613876,0.000036180903,0.00002372134,0.0020650243,0.00006742647,0.0002602318,0.91641515,0.0001212249,0.00014775038,0.004230753],"study_design_scores_gemma":[0.0000996509,0.0003656575,0.6513589,0.000019212675,0.000103127124,0.036818262,0.0001255692,0.0023023877,0.3056515,0.00022996108,0.002915162,0.000010656823],"about_ca_topic_score_codex":0.0009459038,"about_ca_topic_score_gemma":0.0019186155,"teacher_disagreement_score":0.0010959394,"about_ca_system_score_codex":0.00027724056,"about_ca_system_score_gemma":0.00013773065,"threshold_uncertainty_score":0.0036663413},"labels":[],"label_agreement":null},{"id":"W2114553251","doi":"10.1158/1078-0432.ccr-07-0547","title":"Relationship of<i>EGFR</i>Mutations, Expression, Amplification, and Polymorphisms to Epidermal Growth Factor Receptor Inhibitors in the NCI60 Cell Lines","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Erlotinib; Epidermal growth factor receptor; Biology; EGFR inhibitors; Cancer research; Tyrosine kinase; Molecular biology; Gene; Lung cancer; Cancer; Genetics; Receptor; Medicine; Internal medicine","score_opus":0.1712660412785758,"score_gpt":0.5120324427055788,"score_spread":0.340766401427003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114553251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99822015,0.00028494545,0.00031607616,0.000017621056,0.0000036473239,0.000014319438,0.0005724327,0.000017320937,0.00055335346],"genre_scores_gemma":[0.99840134,0.00014521941,0.00032282367,0.000026006925,0.0000030157328,0.00003048758,0.0008289676,0.0000076167285,0.00023455101],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995239,0.00005016439,0.000062657426,0.00010442701,0.00020286841,0.000055984787],"domain_scores_gemma":[0.99943274,0.00011737242,0.0001872941,0.00008913075,0.000116570256,0.000056934547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028613434,0.00019282171,0.00029321626,0.0005555787,0.0001986066,0.00035879647,0.000182851,0.00027158565,0.0008616508],"category_scores_gemma":[0.0006406329,0.00013277453,0.00022107108,0.00047111753,0.00021551951,0.000098954755,0.00016351303,0.0003008142,0.00024055112],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084691553,0.00017011676,0.23873508,0.000049751874,0.00010594064,0.00035843323,0.00016530887,0.0003769475,0.7529704,0.00009449301,0.0003165045,0.005810164],"study_design_scores_gemma":[0.00002607518,0.00065476954,0.8229712,0.000005970083,0.0001103613,0.00152889,0.00013550601,0.0010104531,0.17150526,0.00006210275,0.0019762386,0.00001319134],"about_ca_topic_score_codex":0.004019316,"about_ca_topic_score_gemma":0.0032771854,"teacher_disagreement_score":0.004019316,"about_ca_system_score_codex":0.00030985184,"about_ca_system_score_gemma":0.00015656321,"threshold_uncertainty_score":0.00799185},"labels":[],"label_agreement":null},{"id":"W2114584615","doi":"10.1158/1078-0432.ccr-08-3114","title":"γH2AX Expression in Tumors Exposed to Cisplatin and Fractionated Irradiation","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Cisplatin; Clonogenic assay; Cervix; Cancer research; Biomarker; Biopsy; Medicine; Cancer; Radiation therapy; In vivo; Pathology; Chemotherapy; Chemistry; Biology; Internal medicine","score_opus":0.2669365559779408,"score_gpt":0.5548692426604351,"score_spread":0.28793268668249433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114584615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985764,0.0005382049,0.00052514207,0.00001370922,0.0000035687647,0.000019115532,0.00010441412,0.000012039747,0.00020733211],"genre_scores_gemma":[0.9988889,0.00018302721,0.00038580343,0.000011185694,0.0000024330923,0.00002653722,0.00018852869,0.0000037559828,0.0003099276],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991024,0.0000148993895,0.0000059432477,0.000031551426,0.000020837599,0.000016436663],"domain_scores_gemma":[0.999902,0.000022987326,0.00002515543,0.0000157517,0.000012614107,0.000021446209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016815322,0.00019717055,0.00025215643,0.00022903497,0.00012894734,0.00018356461,0.00015713107,0.0003229361,0.0011216801],"category_scores_gemma":[0.0003216781,0.00013487233,0.00012432016,0.0001625655,0.00025918346,0.00018240209,0.000100805184,0.00029718253,0.00020225611],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011331002,0.000076406766,0.012933329,0.00004569981,0.00002316062,0.00008533861,0.000049776332,0.00021973158,0.9824457,0.000018683131,0.000041039773,0.002927887],"study_design_scores_gemma":[0.000091967864,0.004770179,0.31497884,0.000012069416,0.00008685464,0.0015168084,0.00018155415,0.001676614,0.67568845,0.000053006657,0.0009337424,0.000009917819],"about_ca_topic_score_codex":0.00093359617,"about_ca_topic_score_gemma":0.00073703163,"teacher_disagreement_score":0.0011216801,"about_ca_system_score_codex":0.00030032932,"about_ca_system_score_gemma":0.00017699187,"threshold_uncertainty_score":0.0037523508},"labels":[],"label_agreement":null},{"id":"W2114622090","doi":"10.1158/1078-0432.ccr-04-1284","title":"Antitumor Efficacy of <i>bcl-2</i> and <i>c-myc</i> Antisense Oligonucleotides in Combination with Cisplatin in Human Melanoma Xenografts: Relevance of the Administration Sequence","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"DNA and Nucleic Acid Chemistry","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada)","funders":"Associazione Italiana per la Ricerca sul Cancro; Consiglio Nazionale delle Ricerche; Ministero della Salute","keywords":"Melanoma; Oligonucleotide; Cancer research; Cisplatin; Messenger RNA; Apoptosis; Molecular biology; Biology; N-Myc; Medicine; Chemotherapy; Cell culture; Gene; Internal medicine; Biochemistry; Neuroblastoma","score_opus":0.061269247467943856,"score_gpt":0.4245529808550566,"score_spread":0.36328373338711273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114622090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759287,0.0010504527,0.000366655,0.000043727054,0.00003175776,0.00005011888,0.0000697659,0.000033694945,0.00076089427],"genre_scores_gemma":[0.9972957,0.0006824588,0.0010280908,0.000030254423,0.000021210128,0.000051616586,0.00014859093,0.0000118980415,0.00073032547],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979454,0.00006415841,0.000023307748,0.000037609676,0.00004867249,0.00003167152],"domain_scores_gemma":[0.9998443,0.0000398115,0.000033062042,0.000014907063,0.00001374612,0.000054177835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002816082,0.0004091423,0.00051802816,0.00024509124,0.0001297065,0.00028099722,0.00023649338,0.00034781816,0.0006805018],"category_scores_gemma":[0.00019644077,0.00016860774,0.00021133413,0.00014032186,0.00026362963,0.00020659517,0.0001222022,0.00054588716,0.00015612252],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015734854,0.00047427474,0.00047833746,0.00007167009,0.000023184408,0.000028880004,0.000028054315,0.0004452655,0.99305576,0.00005982056,0.0000752548,0.003685965],"study_design_scores_gemma":[0.0003940543,0.015137683,0.003215498,0.000011693037,0.00007683492,0.00017038819,0.000022077676,0.0015711236,0.9780141,0.00002097377,0.0013563314,0.000009156298],"about_ca_topic_score_codex":0.00055308326,"about_ca_topic_score_gemma":0.0009888012,"teacher_disagreement_score":0.0006805018,"about_ca_system_score_codex":0.00026153246,"about_ca_system_score_gemma":0.00027589788,"threshold_uncertainty_score":0.0022765398},"labels":[],"label_agreement":null},{"id":"W2114645683","doi":"10.1158/1078-0432.ccr-12-3114","title":"Blocked Autophagy Using Lysosomotropic Agents Sensitizes Resistant Prostate Tumor Cells to the Novel Akt Inhibitor AZD5363","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Astex Pharmaceuticals; AstraZeneca","keywords":"Autophagy; Protein kinase B; Prostate; Cancer research; PI3K/AKT/mTOR pathway; Medicine; Chemistry; Biology; Cell biology; Signal transduction; Cancer; Internal medicine; Apoptosis; Biochemistry","score_opus":0.27633364181972353,"score_gpt":0.5225578416554204,"score_spread":0.24622419983569688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114645683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948821,0.0024659084,0.0011228676,0.00007808843,0.000042907595,0.000051862076,0.0003083113,0.00013595143,0.0009120521],"genre_scores_gemma":[0.99652654,0.0013967648,0.0010115405,0.000031699983,0.000010952402,0.000029511137,0.00036287017,0.000012735747,0.00061732327],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986887,0.000017248645,0.000020255608,0.000027244294,0.00004163512,0.000024708654],"domain_scores_gemma":[0.9999367,0.000009021031,0.000022744756,0.0000115380735,0.000006935846,0.000013085477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012425166,0.00039497926,0.00054919906,0.0003336927,0.0001664687,0.0003179932,0.00020995935,0.00024826347,0.0007647692],"category_scores_gemma":[0.000076955876,0.00015088618,0.0003398591,0.0002915657,0.00023583545,0.00020309904,0.0001519494,0.0005317253,0.0002549065],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003206412,0.00009544315,0.00034339438,0.0000512489,0.000018316365,0.000055156033,0.000016405662,0.00021211652,0.9964503,0.000072690724,0.00006275764,0.002301661],"study_design_scores_gemma":[0.00006637055,0.0012223093,0.0030057437,0.000005244805,0.00004260848,0.00025078986,0.00001362319,0.00077955326,0.9932133,0.000022914312,0.0013719595,0.000005483184],"about_ca_topic_score_codex":0.0005908089,"about_ca_topic_score_gemma":0.0010689242,"teacher_disagreement_score":0.0007647692,"about_ca_system_score_codex":0.00030763278,"about_ca_system_score_gemma":0.00024360258,"threshold_uncertainty_score":0.0025583506},"labels":[],"label_agreement":null},{"id":"W2114721535","doi":"10.1158/1078-0432.672.11.2","title":"A Phase I and Pharmacokinetic Study of Ecteinascidin-743 (Yondelis) in Children with Refractory Solid Tumors. A Children's Oncology Group Study","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Synthesis and Biological Activity","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children","funders":"PharmaMar","keywords":"Pharmacokinetics; Medicine; Neutropenia; Refractory (planetary science); Transaminase; Toxicity; Gastroenterology; Internal medicine; Chemistry","score_opus":0.10661188160395,"score_gpt":0.5099653221440231,"score_spread":0.4033534405400731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114721535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965172,0.0015405013,0.0003392715,0.0001269753,0.000015994316,0.00037699242,0.00045421498,0.000025856669,0.000602908],"genre_scores_gemma":[0.98988134,0.0028546772,0.002715529,0.00036444527,0.000055990135,0.0008217943,0.0022752287,0.000028760134,0.0010022958],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997404,0.00013356128,0.000013258857,0.000034260407,0.00003703038,0.000041448693],"domain_scores_gemma":[0.99937624,0.000117185504,0.00017013373,0.00004089253,0.000033226595,0.00026232578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006507464,0.0007745111,0.001089472,0.00017208995,0.00025566347,0.00032439225,0.00044052437,0.00049312814,0.0012249011],"category_scores_gemma":[0.0004327604,0.0002103595,0.00051899586,0.00034676745,0.00062980177,0.00028154562,0.000178908,0.0014137028,0.00028842242],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3249441,0.051247876,0.10173603,0.0019995237,0.002565829,0.0032765102,0.0012699944,0.01541294,0.23423383,0.0012069244,0.011648253,0.2504582],"study_design_scores_gemma":[0.16929275,0.6248368,0.13720217,0.000113071466,0.0010609735,0.004813886,0.00024132448,0.0027390323,0.036977682,0.00029168592,0.022375591,0.0000550342],"about_ca_topic_score_codex":0.0028440834,"about_ca_topic_score_gemma":0.0046756384,"teacher_disagreement_score":0.0028440834,"about_ca_system_score_codex":0.0011992309,"about_ca_system_score_gemma":0.0016308235,"threshold_uncertainty_score":0.008701086},"labels":[],"label_agreement":null},{"id":"W2114722760","doi":"10.1158/1078-0432.ccr-07-4187","title":"MDM2 Promoter Polymorphism and Pancreatic Cancer Risk and Prognosis","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Pancreatic cancer; Medicine; Biology; Mdm2; Genetics; Oncology; Cancer research; Cancer; Internal medicine; Bioinformatics; Gene","score_opus":0.2048309299605218,"score_gpt":0.47649832289413374,"score_spread":0.271667392933612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114722760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991621,0.00046010807,0.0001220912,0.00005060759,0.0000036571107,0.0000019594418,0.0000627963,0.0000063970174,0.00013035332],"genre_scores_gemma":[0.9996594,0.00009914041,0.00007147336,0.0000071595573,0.00000879886,0.0000017613182,0.00006341647,0.0000014979737,0.00008734829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998388,0.0000617687,0.000011367291,0.000040952837,0.00002594558,0.00002115953],"domain_scores_gemma":[0.9990398,0.00026005507,0.00043972125,0.000056407636,0.00005807784,0.0001459222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004565182,0.00023520354,0.00019237236,0.0003427877,0.00014442489,0.00022132965,0.00014467948,0.00025953187,0.0013260033],"category_scores_gemma":[0.0014178745,0.00011919076,0.00020921677,0.00031183177,0.00017631709,0.00011785648,0.00015175146,0.00024606904,0.00016465657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043376978,0.000017374827,0.9965282,0.000008023338,0.000049764265,0.00013213314,0.000016193295,0.00007526112,0.0012489931,0.0000110410365,0.00003969801,0.0014395772],"study_design_scores_gemma":[0.000021245545,0.00014482946,0.99756145,0.000008329036,0.0000708551,0.00086223654,0.00002072011,0.0006183207,0.00047617225,0.00005557869,0.00015748234,0.0000028059515],"about_ca_topic_score_codex":0.0010808742,"about_ca_topic_score_gemma":0.0008531347,"teacher_disagreement_score":0.0013260033,"about_ca_system_score_codex":0.00012857225,"about_ca_system_score_gemma":0.00013477965,"threshold_uncertainty_score":0.004435897},"labels":[],"label_agreement":null},{"id":"W2114735994","doi":"10.1158/1078-0432.ccr-12-0274","title":"Molecular Pathways: PI3K Pathway Targets in Triple-Negative Breast Cancers","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"CancerCare Manitoba Foundation","keywords":"PI3K/AKT/mTOR pathway; Breast cancer; Triple-negative breast cancer; Cancer research; Medicine; Targeted therapy; Cancer; Estrogen receptor; Bioinformatics; Phosphoinositide 3-kinase; Estrogen; Oncology; Biology; Computational biology; Internal medicine; Signal transduction; Genetics","score_opus":0.1061242414244697,"score_gpt":0.4365045039051222,"score_spread":0.3303802624806525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114735994","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18022281,0.7302252,0.007722341,0.032965068,0.0011717534,0.0001976806,0.0015265713,0.0005658286,0.045402747],"genre_scores_gemma":[0.5557446,0.421169,0.006642687,0.0034434195,0.0006893005,0.00017801826,0.0008636643,0.000031106876,0.011238107],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991775,0.000015537877,0.000008183312,0.000011489169,0.000031960713,0.00001505641],"domain_scores_gemma":[0.9999567,0.0000060682796,0.000010648355,0.0000023407797,0.000009869009,0.000014331059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003095433,0.0004743245,0.00035562995,0.0008187149,0.00033496032,0.00084525073,0.00028409075,0.0004593022,0.002384406],"category_scores_gemma":[0.00016292614,0.00014527446,0.00020599189,0.0009951812,0.0003475704,0.0006789542,0.0003736576,0.0010025741,0.00071310764],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037985286,0.00087722065,0.009783596,0.0040939082,0.00020958499,0.0026656848,0.0001899525,0.0034125338,0.407599,0.027098618,0.033705484,0.5065659],"study_design_scores_gemma":[0.0011699104,0.0033662762,0.10873914,0.0016997398,0.0007751404,0.022680452,0.0007279354,0.008098352,0.29294214,0.060977396,0.49867913,0.00014437134],"about_ca_topic_score_codex":0.0010707225,"about_ca_topic_score_gemma":0.0021479568,"teacher_disagreement_score":0.002384406,"about_ca_system_score_codex":0.0013341068,"about_ca_system_score_gemma":0.0010847822,"threshold_uncertainty_score":0.0096796155},"labels":[],"label_agreement":null},{"id":"W2114871138","doi":"10.1158/1078-0432.ccr-03-0215","title":"The Expression of ERβcx in Human Breast Cancer and the Relationship to Endocrine Therapy and Survival","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact","funders":"","keywords":"Endocrine system; Estrogen receptor; Aromatase; Breast cancer; Internal medicine; Medicine; Estrogen receptor alpha; Oncology; Estrogen receptor beta; Immunohistochemistry; Estrogen; Cancer; Endocrinology; Cancer research; Hormone","score_opus":0.11496202055350736,"score_gpt":0.4873093557583002,"score_spread":0.37234733520479285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114871138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973929,0.0017727155,0.00021245309,0.00003682257,0.0000035620612,0.000004919729,0.00012539884,0.0000065642166,0.00044454404],"genre_scores_gemma":[0.9989016,0.0004398915,0.00009521899,0.0000132844725,0.000005355141,0.000005819174,0.00024931002,0.0000012680526,0.0002883333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998834,0.000028790675,0.000012066248,0.000020922824,0.000031551303,0.000023208737],"domain_scores_gemma":[0.9995708,0.00014761231,0.00016153597,0.000026216185,0.000055881796,0.00003795491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029621652,0.00012801099,0.00011508646,0.00038103282,0.00011503962,0.00020802328,0.00007788017,0.00014618562,0.0012709403],"category_scores_gemma":[0.0008162825,0.000061373146,0.00008931041,0.00039411325,0.0002342421,0.00012156427,0.00012978741,0.00016064076,0.00020333778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014988923,0.00005181755,0.9315711,0.00008883247,0.00009765237,0.00031456357,0.00012287076,0.0003509682,0.052572776,0.00008598106,0.000197044,0.013047565],"study_design_scores_gemma":[0.000011501298,0.00029124826,0.9899156,0.000008801951,0.000050174895,0.0014801587,0.0000795735,0.00029560179,0.0068666423,0.000064593296,0.0009326595,0.0000035407961],"about_ca_topic_score_codex":0.00070415734,"about_ca_topic_score_gemma":0.00045134808,"teacher_disagreement_score":0.0012709403,"about_ca_system_score_codex":0.00015998665,"about_ca_system_score_gemma":0.000097466276,"threshold_uncertainty_score":0.004251778},"labels":[],"label_agreement":null},{"id":"W2114919368","doi":"10.1158/1078-0432.ccr-08-0816","title":"The Desmoplastic Reaction Surrounding Hepatic Colorectal Adenocarcinoma Metastases Aids Tumor Growth and Survival via αv Integrin Ligation","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"Wellcome Trust","keywords":"Colorectal cancer; Integrin; Metastasis; Adenocarcinoma; Cancer research; Pathology; Medicine; Internal medicine; Cancer; Receptor","score_opus":0.16585828433615218,"score_gpt":0.4558229190407099,"score_spread":0.2899646347045577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114919368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99620605,0.0014401805,0.0010205838,0.00005898768,0.000007377304,0.000013134632,0.000039396324,0.000022370159,0.001191892],"genre_scores_gemma":[0.99808335,0.0005368099,0.00040022176,0.000015680704,0.0000048423185,0.0000053344856,0.000052533178,0.0000018124196,0.0008993176],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993384,0.000013098499,0.0000042801594,0.000010999516,0.000018580538,0.00001911412],"domain_scores_gemma":[0.99994516,0.000010811133,0.000021994047,0.0000035158573,0.00000559307,0.00001289658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000068678535,0.00024621972,0.00010514043,0.00009147115,0.00008141686,0.00015657947,0.0000629976,0.00012047753,0.00123099],"category_scores_gemma":[0.00009238236,0.00006530676,0.00009978729,0.000055971803,0.00013640002,0.000083069805,0.000075833785,0.00021823977,0.00018618406],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071520604,0.000009224018,0.00078979525,0.000024062598,0.000002366528,0.00008292896,0.000005958683,0.000027633932,0.9979685,0.000043604075,0.000016909207,0.0009574563],"study_design_scores_gemma":[0.000019371955,0.0008450439,0.025708666,0.000007868739,0.00002252417,0.0018059808,0.00005381837,0.0010294992,0.9677023,0.000038566275,0.0027630702,0.000003248549],"about_ca_topic_score_codex":0.0004738518,"about_ca_topic_score_gemma":0.00068783085,"teacher_disagreement_score":0.00123099,"about_ca_system_score_codex":0.0002194684,"about_ca_system_score_gemma":0.000092635535,"threshold_uncertainty_score":0.0041180253},"labels":[],"label_agreement":null},{"id":"W2115105515","doi":"10.1158/1078-0432.ccr-12-3946","title":"EZH2 Protein Expression Associates with the Early Pathogenesis, Tumor Progression, and Prognosis of Non–Small Cell Lung Carcinoma","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":156,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute","keywords":"Adenocarcinoma; Immunohistochemistry; Carcinogenesis; EZH2; Lung cancer; Pathogenesis; Cancer research; Medicine; Pathology; Cancer; Oncology; Biology; Internal medicine; Gene expression; Gene","score_opus":0.04840865712471666,"score_gpt":0.39190574834231395,"score_spread":0.3434970912175973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115105515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992711,0.00041155194,0.00011187664,0.000016156217,0.0000018442103,0.0000031665338,0.00004964671,0.0000034107059,0.00013133114],"genre_scores_gemma":[0.9996177,0.00011634512,0.00006253168,0.000003936494,0.0000075490457,0.0000025991258,0.00008290044,8.568163e-7,0.00010566819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99986136,0.00003281789,0.000013602215,0.0000315855,0.000039148257,0.00002153646],"domain_scores_gemma":[0.999553,0.000088526256,0.00020420065,0.000029775623,0.00004697076,0.000077485805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030884793,0.00021365337,0.00018529836,0.00053792767,0.00017094579,0.00021630057,0.00014564632,0.00019119015,0.0009076495],"category_scores_gemma":[0.0007818256,0.0001150224,0.00014465836,0.00040127747,0.0002541106,0.00017721967,0.00016475929,0.00018945927,0.00015000638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066215533,0.000034717643,0.9786724,0.000021328628,0.00006696726,0.00022697115,0.000029012048,0.00007507189,0.017365992,0.00001951622,0.00006962523,0.0027561786],"study_design_scores_gemma":[0.0000059125737,0.000059633046,0.99764913,0.0000012421898,0.0000223323,0.0004936851,0.000019105217,0.00017515362,0.0014536334,0.000017525163,0.00010119419,0.0000014314188],"about_ca_topic_score_codex":0.0007763544,"about_ca_topic_score_gemma":0.0011643786,"teacher_disagreement_score":0.0009076495,"about_ca_system_score_codex":0.00020469028,"about_ca_system_score_gemma":0.0001565341,"threshold_uncertainty_score":0.0030364394},"labels":[],"label_agreement":null},{"id":"W2115610792","doi":"10.1158/1078-0432.ccr-14-2650","title":"Spinal Myxopapillary Ependymomas Demonstrate a Warburg Phenotype","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Hamilton General Hospital; University of Toronto","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; Canadian Institutes of Health Research","keywords":"Ependymoma; Warburg effect; PKM2; Cancer research; Phenotype; Gene expression profiling; Downregulation and upregulation; Gene isoform; Biology; Medicine; Western blot; Glycolysis; Pyruvate kinase; Pathology; Gene expression; Gene; Internal medicine; Genetics; Metabolism","score_opus":0.5145980164788173,"score_gpt":0.5822764792221038,"score_spread":0.06767846274328648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115610792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99835986,0.0002510872,0.0008416971,0.000015020257,0.000002471131,0.00001475814,0.000120707555,0.000019228246,0.0003750862],"genre_scores_gemma":[0.99855834,0.00016213022,0.0007408075,0.000013704319,0.0000043100636,0.000012039701,0.00020810409,0.0000045486895,0.00029601343],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999162,0.000005589367,0.000008513117,0.000026057713,0.000026306403,0.000017323318],"domain_scores_gemma":[0.9998079,0.000038717037,0.00008168578,0.000019831687,0.000023209395,0.00002875105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000086443,0.00039744796,0.00021021556,0.00038735627,0.00016873768,0.0002449777,0.00013501839,0.00020942712,0.0010556293],"category_scores_gemma":[0.00035544301,0.000109515066,0.00014490783,0.00027172422,0.00030746037,0.00020132026,0.00023579181,0.00026165493,0.00031807504],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031434713,0.000057178964,0.08877371,0.00008895487,0.000039458468,0.0068679606,0.00010475319,0.000162244,0.8968926,0.00015741221,0.000073104275,0.0064682765],"study_design_scores_gemma":[0.00002825758,0.0005975484,0.7286181,0.000016067184,0.00006701553,0.043056745,0.00017456445,0.0007720791,0.22483498,0.00037726693,0.0014464541,0.000010860253],"about_ca_topic_score_codex":0.00025119827,"about_ca_topic_score_gemma":0.00039143028,"teacher_disagreement_score":0.0010556293,"about_ca_system_score_codex":0.00014742221,"about_ca_system_score_gemma":0.000076995515,"threshold_uncertainty_score":0.003531456},"labels":[],"label_agreement":null},{"id":"W2115824225","doi":"10.1158/1078-0432.ccr-05-1954","title":"Transcriptional Regulation of the Human Reduced Folate Carrier in Childhood Acute Lymphoblastic Leukemia Cells","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institutes of Health; Children's Hospital of Michigan","keywords":"Promoter; Chromatin immunoprecipitation; Molecular biology; Biology; Genetics; Gene; Gene expression","score_opus":0.0873774477662076,"score_gpt":0.4447184123881267,"score_spread":0.3573409646219191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115824225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99351007,0.0029289208,0.0014081611,0.00007625034,0.000011541903,0.0000163772,0.0010054943,0.000052295705,0.0009909407],"genre_scores_gemma":[0.9949857,0.0008113237,0.0012509305,0.000033286102,0.000006371044,0.000016886795,0.0015682897,0.000012908854,0.0013142542],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998481,0.000028071649,0.000009081809,0.000042275868,0.000045846715,0.000026513453],"domain_scores_gemma":[0.9998963,0.000026730078,0.00002166572,0.000015762656,0.000022305954,0.000017202234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001180649,0.00018556675,0.0001701832,0.00021119355,0.00014215602,0.00028127735,0.00007177158,0.00011490466,0.00105686],"category_scores_gemma":[0.0001622055,0.000075696655,0.000116584684,0.00020948325,0.0001904974,0.00008272822,0.00013837621,0.00017469085,0.00036691962],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030759,0.000013926496,0.002438856,0.00004332177,0.0000060761613,0.00004565177,0.00007114617,0.000101337566,0.9944457,0.00012784115,0.000101452824,0.0022971074],"study_design_scores_gemma":[0.000048362268,0.000345376,0.079248205,0.000015236712,0.00003660916,0.00063846936,0.00018821443,0.00198233,0.90581954,0.000093776755,0.011574353,0.00000955858],"about_ca_topic_score_codex":0.0028319291,"about_ca_topic_score_gemma":0.0027147466,"teacher_disagreement_score":0.0028319291,"about_ca_system_score_codex":0.0005242002,"about_ca_system_score_gemma":0.00018527132,"threshold_uncertainty_score":0.0056309104},"labels":[],"label_agreement":null},{"id":"W2115961074","doi":"10.1158/1078-0432.ccr-14-1760","title":"The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Lapatinib; Medicine; Trastuzumab; Breast cancer; Oncology; Clinical trial; Internal medicine; Neoadjuvant therapy; Cancer; Clinical endpoint; Surrogate endpoint; Regimen; Hazard ratio; Confidence interval","score_opus":0.8736747486636635,"score_gpt":0.7238382028301892,"score_spread":0.14983654583347428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115961074","genre_codex":"methods","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008684222,0.16003866,0.4209949,0.3549692,0.019102799,0.0018996202,0.0042061997,0.0011600491,0.028944433],"genre_scores_gemma":[0.25302863,0.12624061,0.35432586,0.21685539,0.021377958,0.01029963,0.002504065,0.0010561128,0.014311791],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9385394,0.055078644,0.0011772189,0.0019847634,0.0029041264,0.00031585654],"domain_scores_gemma":[0.90496486,0.0723065,0.006016843,0.011391819,0.0037071595,0.0016127594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07299884,0.0010272034,0.0033849508,0.0011046218,0.0008030549,0.005087847,0.0021650956,0.0023223283,0.00970612],"category_scores_gemma":[0.098234154,0.0007428448,0.0027153832,0.0018759561,0.003969358,0.008069767,0.002483662,0.009893812,0.0033160693],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030112043,0.00040042607,0.0062595285,0.009714589,0.003250589,0.00017041137,0.0005043215,0.008115766,0.0019705386,0.47249228,0.15638626,0.33772418],"study_design_scores_gemma":[0.0008364529,0.0022041108,0.0022987577,0.0036525407,0.0015645965,0.00024362591,0.00022615836,0.01591651,0.00092629023,0.6631396,0.30881017,0.00018120313],"about_ca_topic_score_codex":0.0018016641,"about_ca_topic_score_gemma":0.0028157802,"teacher_disagreement_score":0.07299884,"about_ca_system_score_codex":0.0023167657,"about_ca_system_score_gemma":0.007523085,"threshold_uncertainty_score":0.38605934},"labels":[],"label_agreement":null},{"id":"W2115962698","doi":"10.1158/1078-0432.ccr-07-0416","title":"Enhanced Antitumor Effect of Combined Triptolide and Ionizing Radiation","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Natural Compounds in Disease Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Public Health Agency of Canada","keywords":"Triptolide; In vivo; Apoptosis; TUNEL assay; Chemistry; Pancreatic cancer; Cancer research; Propidium iodide; Programmed cell death; Molecular biology; Cancer; Medicine; Biology; Internal medicine; Biochemistry","score_opus":0.12753337280438087,"score_gpt":0.5602392752244691,"score_spread":0.4327059024200883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115962698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847023,0.007919464,0.004174194,0.00017718502,0.000096621814,0.000092662776,0.00020501201,0.00012625534,0.00250627],"genre_scores_gemma":[0.9912579,0.002636477,0.003972974,0.00009869017,0.00007887349,0.0000738707,0.00031317075,0.000020574358,0.0015475189],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987507,0.000026412812,0.0000113431,0.000025992611,0.000035860052,0.000025262045],"domain_scores_gemma":[0.9999057,0.000019981942,0.000022874261,0.000013126442,0.000010104785,0.000028108789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016404947,0.00053322583,0.00060594926,0.0004375329,0.00011054791,0.00028436066,0.00027654495,0.0003396233,0.001276702],"category_scores_gemma":[0.00013614548,0.00013768286,0.00034068665,0.00025073026,0.00018226317,0.0002530456,0.00028644004,0.00051717163,0.00032687737],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011383971,0.00025003782,0.0007772932,0.00022648228,0.00007932145,0.0002211875,0.000023077451,0.00045045672,0.98184055,0.00011420296,0.00016601717,0.014712943],"study_design_scores_gemma":[0.000298488,0.009598534,0.0047022663,0.000031765594,0.000311249,0.0018057751,0.0000344276,0.0017713355,0.9728036,0.00010609819,0.00852154,0.000014965419],"about_ca_topic_score_codex":0.00014434531,"about_ca_topic_score_gemma":0.00024038146,"teacher_disagreement_score":0.001276702,"about_ca_system_score_codex":0.0001715632,"about_ca_system_score_gemma":0.00018033519,"threshold_uncertainty_score":0.004270971},"labels":[],"label_agreement":null},{"id":"W2115999357","doi":"10.1158/1078-0432.ccr-11-2599","title":"Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":421,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Breast cancer; Oncology; Estrogen receptor; Medicine; Internal medicine; Young adult; Gene expression profiling; Proportional hazards model; Cancer; Adjuvant; Gene expression; Biology; Cancer research; Gene; Genetics","score_opus":0.21047814094491935,"score_gpt":0.5165689887103124,"score_spread":0.3060908477653931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115999357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981894,0.00083694846,0.00042631116,0.00003063232,0.0000029620248,0.000006859894,0.0003554262,0.00000537765,0.00014596661],"genre_scores_gemma":[0.9982785,0.00048224535,0.0006006387,0.000028700855,0.000010374261,0.000011018485,0.00044737232,0.000001994599,0.00013915295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988246,0.0000339529,0.0000104614965,0.00002708056,0.000022739965,0.000023264934],"domain_scores_gemma":[0.9996449,0.00011489721,0.00015093104,0.000017966417,0.00002922131,0.000042058145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003260352,0.00014317124,0.0003074932,0.00045079188,0.00010684151,0.00023123359,0.00009241972,0.00017258307,0.00046570576],"category_scores_gemma":[0.0008638268,0.0000670476,0.00018490071,0.00044857958,0.0001584669,0.00017713623,0.00016229291,0.000121166726,0.00019681029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002968498,0.000025777415,0.9762666,0.00004255209,0.000030384605,0.00015198678,0.00005687792,0.00010583365,0.014234679,0.00002828251,0.00009420592,0.008665994],"study_design_scores_gemma":[0.0000048272946,0.00015578336,0.99593794,0.000009813105,0.00003948983,0.0006206585,0.00009565872,0.00049927586,0.0021765754,0.00007627211,0.00038013162,0.0000035145615],"about_ca_topic_score_codex":0.00066733133,"about_ca_topic_score_gemma":0.0010375051,"teacher_disagreement_score":0.00066733133,"about_ca_system_score_codex":0.00014870144,"about_ca_system_score_gemma":0.00014449982,"threshold_uncertainty_score":0.0017242432},"labels":[],"label_agreement":null},{"id":"W2116138223","doi":"10.1158/1078-0432.ccr-12-1983","title":"<i>p53 Arg72Pro</i> Polymorphism, HPV Status and Initiation, Progression, and Development of Cervical Cancer: A Systematic Review and Meta-Analysis","year":2012,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Cervical cancer; Medicine; Meta-analysis; Oncology; Internal medicine; Odds ratio; Allele; Cervical intraepithelial neoplasia; Cancer; Cancer research; Biology; Gene; Genetics","score_opus":0.5859377676565747,"score_gpt":0.6116006165596907,"score_spread":0.025662848903115987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116138223","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0058547156,0.9918465,0.00031245462,0.00020455738,0.00010163215,0.00025492613,0.0010846171,0.000018485993,0.00032223744],"genre_scores_gemma":[0.18227006,0.8118019,0.0015046755,0.00097616756,0.00021073208,0.0012376345,0.0014584566,0.000022777565,0.00051760825],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99496067,0.0020835348,0.0014904161,0.00060976046,0.0006350702,0.00022060629],"domain_scores_gemma":[0.9876323,0.009159108,0.0018971798,0.00027749856,0.0008644924,0.00016934649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006725515,0.0017244049,0.013475355,0.0044844,0.0006281871,0.0025780273,0.0015720639,0.0016695975,0.0034520405],"category_scores_gemma":[0.017483532,0.001009659,0.01986247,0.0076866257,0.0006205175,0.0012401922,0.0010863588,0.0012049944,0.00029831348],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013322033,0.000017611506,0.008310028,0.57122713,0.408014,0.00020706485,0.00008951729,0.00046056687,0.00031565788,0.00014274052,0.0012631333,0.008620268],"study_design_scores_gemma":[0.0004788247,0.00016667855,0.008405875,0.048618346,0.93900156,0.00016858672,0.000057898986,0.00021249804,0.00013265791,0.00018494362,0.002548773,0.000023381841],"about_ca_topic_score_codex":0.010689979,"about_ca_topic_score_gemma":0.02245182,"teacher_disagreement_score":0.013475355,"about_ca_system_score_codex":0.0023718094,"about_ca_system_score_gemma":0.0033367614,"threshold_uncertainty_score":0.035568357},"labels":[],"label_agreement":null},{"id":"W2116145684","doi":"10.1158/1078-0432.ccr-07-4959","title":"Gene Expression Profiles of Luteal Phase Fallopian Tube Epithelium from <i>BRCA</i> Mutation Carriers Resemble High-Grade Serous Carcinoma","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"University Health Network","keywords":"Luteal phase; Biology; Serous carcinoma; Cancer research; Follicular phase; Pathology; Ovarian cancer; Internal medicine; Endocrinology; Genetics; Medicine; Cancer","score_opus":0.1903665756927608,"score_gpt":0.47073682850195914,"score_spread":0.28037025280919836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116145684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995727,0.00006802309,0.00012817787,0.0000052391083,6.938742e-7,0.0000029670775,0.000093623676,0.0000049306504,0.00012374483],"genre_scores_gemma":[0.99872667,0.000080075464,0.0004655241,0.0000124163125,0.0000021034132,0.000012196963,0.00038502336,0.000003847781,0.00031201143],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999374,0.0000077801515,0.000004518938,0.000019637517,0.000015778827,0.000014843885],"domain_scores_gemma":[0.99991786,0.000018306839,0.000026052365,0.000008129936,0.00001186022,0.000017751552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000691864,0.000119155986,0.00015552405,0.0004158187,0.00015761274,0.000182813,0.000074110365,0.00017400195,0.00079400255],"category_scores_gemma":[0.00020722667,0.000073077,0.00011447443,0.00022104221,0.00015022322,0.00008526109,0.0000943886,0.000113161725,0.00013841435],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006076738,0.000025385265,0.07835228,0.000032916516,0.000014406433,0.00027788797,0.00016393764,0.000051695588,0.9176333,0.000024777595,0.000041523635,0.0027741573],"study_design_scores_gemma":[0.000009516136,0.00025715842,0.92008626,0.0000041840563,0.000024687757,0.0013764632,0.00025288944,0.0003413462,0.07707381,0.00003150237,0.0005375331,0.0000045101724],"about_ca_topic_score_codex":0.0005720488,"about_ca_topic_score_gemma":0.00078415987,"teacher_disagreement_score":0.00079400255,"about_ca_system_score_codex":0.00012150237,"about_ca_system_score_gemma":0.00007559249,"threshold_uncertainty_score":0.0026561618},"labels":[],"label_agreement":null},{"id":"W2116456322","doi":"10.1158/1078-0432.ccr-08-1708","title":"Preferential Killing of Breast Tumor Initiating Cells by <i>N,N</i> -Diethyl-2-[4-(Phenylmethyl)Phenoxy]Ethanamine/Tesmilifene","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Immunovaccine (Canada); University Health Network","funders":"","keywords":"CD44; CD24; Flow cytometry; Breast cancer; Doxorubicin; Medicine; Cancer research; In vitro; Cytotoxic T cell; Transplantation; Apoptosis; Mammary gland; Internal medicine; Cancer; Immunology; Oncology; Chemotherapy; Chemistry; Biochemistry","score_opus":0.183836946052417,"score_gpt":0.45905721270477623,"score_spread":0.2752202666523592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116456322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994241,0.001953973,0.0012313926,0.00009454813,0.000031442683,0.000057865713,0.00017528159,0.000054158,0.0021603832],"genre_scores_gemma":[0.9959021,0.00087700156,0.0015998367,0.000057709993,0.000020154248,0.00005003661,0.0002867433,0.000013870305,0.0011925133],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998727,0.000027431957,0.000009141453,0.000031018528,0.000022093167,0.00003760831],"domain_scores_gemma":[0.99991524,0.000022781,0.000021388852,0.0000100570915,0.000007965174,0.000022621096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016497592,0.00030343156,0.00030289544,0.00015590266,0.00011638053,0.0003043178,0.00021738603,0.0002337292,0.0014150154],"category_scores_gemma":[0.00013968974,0.00009823158,0.00019196705,0.00010182278,0.00018359821,0.00016119468,0.00011807425,0.00044074722,0.0004582913],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005146872,0.00014021665,0.00033042222,0.000053136253,0.0000067777933,0.00003796159,0.000007757021,0.00008303609,0.99503267,0.000043453998,0.000075302356,0.003674635],"study_design_scores_gemma":[0.0000831335,0.0018440947,0.0021946596,0.000005555655,0.000019850044,0.00038198943,0.000010657499,0.00062112696,0.99371666,0.000013229186,0.0011062927,0.000002734802],"about_ca_topic_score_codex":0.00031165345,"about_ca_topic_score_gemma":0.00065978314,"teacher_disagreement_score":0.0014150154,"about_ca_system_score_codex":0.00022697108,"about_ca_system_score_gemma":0.00023102245,"threshold_uncertainty_score":0.0047336817},"labels":[],"label_agreement":null},{"id":"W2116561474","doi":"10.1158/1078-0432.ccr-14-2391","title":"Hotspot Mutation Panel Testing Reveals Clonal Evolution in a Study of 265 Paired Primary and Metastatic Tumors","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Canadian Institutes of Health Research; European Hematology Association","keywords":"Primary tumor; Somatic evolution in cancer; Metastasis; Mutation; Mutation frequency; Biology; Cancer research; Somatic cell; Germline mutation; Gene; Cancer; Genetics","score_opus":0.37024928076093,"score_gpt":0.4846348879119194,"score_spread":0.11438560715098939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116561474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992428,0.0001343665,0.0002764768,0.0000042909983,0.0000027570218,0.000011289126,0.00010043213,0.000007781608,0.0002198515],"genre_scores_gemma":[0.9991598,0.00004088391,0.00039555403,0.000012125934,0.0000035160456,0.000007648992,0.00028740757,0.0000032869964,0.00008972464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99957114,0.000058268215,0.00003510387,0.0001389536,0.00013773928,0.000058745045],"domain_scores_gemma":[0.99933654,0.00022890138,0.00010174743,0.00008048753,0.00010967025,0.0001426139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056447857,0.00025907427,0.00032367802,0.0007735688,0.00043981927,0.00030877374,0.00023505019,0.0002734762,0.0013592454],"category_scores_gemma":[0.0013717978,0.00023091499,0.00017945164,0.00034545996,0.0003678991,0.00013300109,0.00036363132,0.00017688963,0.00033785927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016705382,0.0001642848,0.88911235,0.000099315126,0.00008160088,0.006237067,0.00036710224,0.00038839414,0.088033296,0.00005956041,0.00025189167,0.013534503],"study_design_scores_gemma":[0.00007628306,0.0015440171,0.93500626,0.000015803496,0.00015046539,0.027697338,0.00026232973,0.0016332741,0.03236212,0.00006669594,0.0011695364,0.000015817159],"about_ca_topic_score_codex":0.0013592779,"about_ca_topic_score_gemma":0.0023909314,"teacher_disagreement_score":0.0013592779,"about_ca_system_score_codex":0.0003156869,"about_ca_system_score_gemma":0.00028392018,"threshold_uncertainty_score":0.0045471787},"labels":[],"label_agreement":null},{"id":"W2116636243","doi":"10.1158/1078-0432.ccr-0734-04","title":"The Effects of Standard Anthracycline-Based Chemotherapy on Soluble ICAM-1 and Vascular Endothelial Growth Factor Levels in Breast Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institute on Aging","keywords":"Chemotherapy; Von Willebrand factor; Breast cancer; Internal medicine; Vascular endothelial growth factor; Medicine; Anthracycline; Endocrinology; Cancer; Gastroenterology; Oncology; VEGF receptors; Platelet","score_opus":0.08710551742658029,"score_gpt":0.47499468835298125,"score_spread":0.38788917092640096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116636243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993759,0.00049412,0.000019503772,0.000012084404,0.0000034682841,0.000005388583,0.000012517902,0.0000022776928,0.00007480232],"genre_scores_gemma":[0.99912506,0.0003855044,0.00016710872,0.000029522951,0.000012897585,0.000023576682,0.000092264636,0.0000012201077,0.0001627671],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99985826,0.000049831135,0.0000093744475,0.000016149559,0.000038621518,0.000027750706],"domain_scores_gemma":[0.99974614,0.000083148334,0.00007940132,0.000024694997,0.000021419524,0.00004522628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024126294,0.00013964807,0.00023866388,0.00013621728,0.00009655223,0.00013317686,0.00012848867,0.00013977915,0.0007589549],"category_scores_gemma":[0.0005490768,0.000098686374,0.00011256313,0.000118204254,0.00021827662,0.00010782786,0.00010518556,0.00021922938,0.00008491454],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054378204,0.0048343465,0.24816114,0.0004597506,0.00036851375,0.0005595879,0.00026926005,0.0016471267,0.5791576,0.00007916869,0.0009754493,0.109109856],"study_design_scores_gemma":[0.0013634386,0.05030707,0.8634185,0.000030621217,0.00019700182,0.0011831471,0.00013291562,0.0014803373,0.07901692,0.0000974948,0.0027572254,0.000015409683],"about_ca_topic_score_codex":0.00036605247,"about_ca_topic_score_gemma":0.00091658917,"teacher_disagreement_score":0.0007589549,"about_ca_system_score_codex":0.00035988513,"about_ca_system_score_gemma":0.00017988523,"threshold_uncertainty_score":0.0026111007},"labels":[],"label_agreement":null},{"id":"W2116725504","doi":"10.1158/1078-0432.ccr-08-1002","title":"Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":188,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Hsp90 inhibitor; Melanoma; Kinase; Medicine; Protein kinase B; MAPK/ERK pathway; Cancer research; Heat shock protein; V600E; Cancer; Hsp90; Internal medicine; Biology; Mutation; Phosphorylation; Biochemistry","score_opus":0.1834560186482281,"score_gpt":0.5047167894168516,"score_spread":0.32126077076862347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116725504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99433386,0.0014093482,0.0003851239,0.00040838888,0.00013371445,0.0018021661,0.00034912434,0.00005179367,0.0011265122],"genre_scores_gemma":[0.9920202,0.0009939523,0.0011188391,0.0006288712,0.00020657301,0.002051702,0.0009059058,0.000015450098,0.0020585302],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99974495,0.000117546,0.000009694328,0.000035930483,0.000026274773,0.00006570745],"domain_scores_gemma":[0.9996265,0.000059341237,0.000057076286,0.000023840954,0.000023561535,0.00020956334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008564884,0.0014643178,0.001517637,0.00029419377,0.00033616766,0.00050727814,0.0004760251,0.0009354897,0.0030121086],"category_scores_gemma":[0.0005871055,0.0003781253,0.0006576311,0.00022646652,0.0006039684,0.00037269402,0.00020908234,0.0018623511,0.00067025947],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6080354,0.06855278,0.018629307,0.0011774977,0.0013396986,0.0007223404,0.00041712448,0.006194169,0.138563,0.00043154065,0.0055817105,0.15035541],"study_design_scores_gemma":[0.46756145,0.5038893,0.015662564,0.000048102815,0.00024102567,0.00044577214,0.000059434522,0.0015560378,0.0071031046,0.00017027196,0.003240605,0.000022313041],"about_ca_topic_score_codex":0.00051460083,"about_ca_topic_score_gemma":0.0013209367,"teacher_disagreement_score":0.0030121086,"about_ca_system_score_codex":0.0006352839,"about_ca_system_score_gemma":0.0011007609,"threshold_uncertainty_score":0.010076523},"labels":[],"label_agreement":null},{"id":"W2116773250","doi":"10.1158/1078-0432.ccr-07-4713","title":"Comparison of Nomograms With Other Methods for Predicting Outcomes in Prostate Cancer: A Critical Analysis of the Literature","year":2008,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":301,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nomogram; Prostate cancer; Medicine; Oncology; Cancer; Prostate; Internal medicine","score_opus":0.45754472748798086,"score_gpt":0.6962229096126618,"score_spread":0.2386781821246809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116773250","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0048126574,0.98447025,0.003880628,0.0041821213,0.00089491945,0.0006650787,0.00025456844,0.000039068196,0.00080078194],"genre_scores_gemma":[0.15641873,0.78818774,0.046449453,0.0026419288,0.0028835915,0.0024032413,0.0006823469,0.00007438863,0.00025862464],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.8686258,0.08543586,0.019564932,0.0022752457,0.023644445,0.00045372767],"domain_scores_gemma":[0.32344562,0.61060774,0.022887396,0.005169837,0.036750697,0.0011387022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.18457024,0.0024852336,0.006010808,0.06679206,0.0016190237,0.006612138,0.0036844695,0.0030386744,0.0024796852],"category_scores_gemma":[0.44952878,0.0011921489,0.005816266,0.024190865,0.003159369,0.009255089,0.0023675999,0.0026955288,0.00042258907],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00336352,0.0001712266,0.030595489,0.20933156,0.017969893,0.00071886217,0.0015919433,0.0036062133,0.00051470514,0.008053869,0.013938382,0.7101442],"study_design_scores_gemma":[0.0016124286,0.006075054,0.101002894,0.61949867,0.07354111,0.006242707,0.0085715465,0.020904938,0.0021830923,0.03134956,0.12789948,0.0011184827],"about_ca_topic_score_codex":0.0021332968,"about_ca_topic_score_gemma":0.0033746343,"teacher_disagreement_score":0.18457024,"about_ca_system_score_codex":0.008101823,"about_ca_system_score_gemma":0.006726515,"threshold_uncertainty_score":0.97611237},"labels":[],"label_agreement":null},{"id":"W2116831767","doi":"10.1158/1078-0432.ccr-09-1961","title":"Approaches to Phase 1 Clinical Trial Design Focused on Safety, Efficiency, and Selected Patient Populations: A Report from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":199,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institutes of Health","keywords":"Clinical trial; Medicine; Clinical study design; Population; Drug development; Investigational Drugs; Phases of clinical research; Patient safety; Intensive care medicine; Medical physics; Drug; Oncology; Pharmacology; Internal medicine; Health care","score_opus":0.9461285919310349,"score_gpt":0.6823623987532028,"score_spread":0.2637661931778321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116831767","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010968742,0.24126008,0.39612472,0.24201728,0.0134754805,0.046001285,0.0016992827,0.0015717308,0.046881385],"genre_scores_gemma":[0.04701016,0.21621612,0.5451788,0.12446826,0.011108072,0.03791676,0.0025081437,0.0009825451,0.014611209],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.76181513,0.1560448,0.022686342,0.0056685624,0.0500359,0.0037492877],"domain_scores_gemma":[0.7171371,0.14817587,0.028625917,0.011416059,0.086470656,0.008174328],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.3633127,0.002543186,0.0026164488,0.0033478262,0.0021937275,0.010347974,0.0054563372,0.007287952,0.0015894088],"category_scores_gemma":[0.20710726,0.0021765986,0.003501884,0.0045042858,0.0047125504,0.0042779283,0.0034952126,0.020131173,0.0014390361],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001250675,0.0010295535,0.0047509465,0.0048247115,0.0005314246,0.0002919871,0.0015680151,0.006596709,0.004795644,0.03333565,0.18883766,0.752187],"study_design_scores_gemma":[0.0026958596,0.0032323608,0.011099634,0.011618856,0.0009183137,0.0008975929,0.00049405993,0.006304085,0.0077499496,0.022039859,0.9325008,0.00044873825],"about_ca_topic_score_codex":0.0071551865,"about_ca_topic_score_gemma":0.0147794485,"teacher_disagreement_score":0.3633127,"about_ca_system_score_codex":0.009679984,"about_ca_system_score_gemma":0.041657623,"threshold_uncertainty_score":0.7851488},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch"],"domain":"methods","study_design":"theoretical_or_conceptual","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W2116871245","doi":"10.1158/1078-0432.ccr-06-1805","title":"Multiplex Analysis of Serum Cytokines in Melanoma Patients Treated with Interferon-α2b","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":208,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Melanoma; Medicine; Proinflammatory cytokine; Immunology; Vascular endothelial growth factor; Tumor necrosis factor alpha; Interferon; Macrophage inflammatory protein; Chemokine; Hepatocyte growth factor; Internal medicine; Cancer research; Inflammation; Receptor","score_opus":0.09514980259824807,"score_gpt":0.4932633248787742,"score_spread":0.39811352228052616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116871245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99895597,0.00042144314,0.00028706327,0.000021175812,0.0000073034826,0.000011503893,0.000098886485,0.000007356792,0.00018938597],"genre_scores_gemma":[0.99928445,0.00010482411,0.00035033663,0.00002021182,0.000009007978,0.000012613062,0.0001283367,9.938906e-7,0.000089246634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997259,0.00009390478,0.000030397063,0.00006672819,0.000058650905,0.000024469815],"domain_scores_gemma":[0.9997365,0.000066313,0.00011675434,0.00001265823,0.000030756022,0.000036985126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036220398,0.00030738916,0.00033697064,0.0006664177,0.0002331923,0.00037859296,0.00010926993,0.00026632549,0.0004916764],"category_scores_gemma":[0.0007500166,0.00013305589,0.00014090148,0.00034760687,0.00014919684,0.00014423195,0.00013855314,0.00025034376,0.00017232345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001272965,0.00009157283,0.9747917,0.000031279164,0.000044713343,0.0003866141,0.00011989191,0.00024448647,0.015965935,0.000016420703,0.000105384715,0.0069289324],"study_design_scores_gemma":[0.000071874725,0.0011181934,0.9779635,0.000027450358,0.00009913898,0.002981812,0.00023512398,0.0046306076,0.012057541,0.00009574266,0.0007078005,0.000011194726],"about_ca_topic_score_codex":0.0004130467,"about_ca_topic_score_gemma":0.00046981522,"teacher_disagreement_score":0.0006664177,"about_ca_system_score_codex":0.00023221542,"about_ca_system_score_gemma":0.00011320436,"threshold_uncertainty_score":0.0019155145},"labels":[],"label_agreement":null},{"id":"W2116985652","doi":"10.1158/1078-0432.ccr-10-3113","title":"Occult Tumor Burden Predicts Disease Recurrence in Lymph Node–Negative Colorectal Cancer","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Medicine; Colorectal cancer; Occult; Internal medicine; Lymph node; Oncology; Histopathology; Cancer; Proportional hazards model; Gastroenterology; Primary tumor; Metastasis; Pathology","score_opus":0.28136083719521043,"score_gpt":0.5074077404730899,"score_spread":0.22604690327787946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116985652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996138,0.00016713004,0.000055867364,0.00001856501,0.0000016507661,0.0000025713448,0.00004832294,0.0000020832244,0.0000901268],"genre_scores_gemma":[0.99979407,0.000033104552,0.00005767329,0.0000037799966,0.000003865889,0.0000016386182,0.00007351405,6.8788773e-7,0.00003173666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998709,0.000044480075,0.000010321891,0.000028722387,0.00002387591,0.000021666967],"domain_scores_gemma":[0.9992685,0.00018707213,0.0003420058,0.000046782618,0.00004147874,0.00011418446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036903794,0.00022543504,0.00018518441,0.00032265234,0.00020273066,0.00026499524,0.00022933171,0.00022678697,0.001201037],"category_scores_gemma":[0.0016370908,0.00014696227,0.00016561692,0.00024194339,0.00022063202,0.00015601612,0.0002524369,0.00027214683,0.00019133805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013933949,0.0000112182015,0.9984212,0.000005088808,0.00001311273,0.000018873832,0.000008791398,0.0000539531,0.00028154333,0.0000041194194,0.000036192218,0.0010066256],"study_design_scores_gemma":[0.0000127409285,0.000106483036,0.99855715,0.0000035707624,0.000026715723,0.00023270033,0.000027803093,0.00077427836,0.00014256274,0.000025051426,0.00008880299,0.000002109418],"about_ca_topic_score_codex":0.0015031928,"about_ca_topic_score_gemma":0.0031467762,"teacher_disagreement_score":0.0015031928,"about_ca_system_score_codex":0.00021136539,"about_ca_system_score_gemma":0.00014078559,"threshold_uncertainty_score":0.00401783},"labels":[],"label_agreement":null},{"id":"W2117327517","doi":"10.1158/1078-0432.ccr-07-1720","title":"Predicting Outcome in Follicular Lymphoma by Using Interactive Gene Pairs","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Follicular lymphoma; Lymphoma; International Prognostic Index; Oncology; Medicine; Gene expression profiling; Follicular phase; Internal medicine; Gene; Bioinformatics; Gene expression; Biology; Diffuse large B-cell lymphoma; Genetics","score_opus":0.3324872493807791,"score_gpt":0.5375851220581682,"score_spread":0.2050978726773891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117327517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98062,0.0003267383,0.017406378,0.00010234165,0.000009746663,0.00003964364,0.00058724516,0.0002106871,0.0006973582],"genre_scores_gemma":[0.9911684,0.000059900376,0.007597025,0.000027300024,0.0000112076905,0.000039235998,0.0009650528,0.000010512797,0.00012136613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99942786,0.00017844,0.000024703124,0.00015412709,0.00014152228,0.00007340447],"domain_scores_gemma":[0.9987286,0.00086756714,0.00018266182,0.00004974788,0.00009136154,0.000080166705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008241267,0.00077983487,0.0006286831,0.0014119322,0.00040460392,0.00052424415,0.0004989852,0.0003359751,0.0008494853],"category_scores_gemma":[0.002684941,0.00017132387,0.00050280837,0.0012043156,0.00050700305,0.0003271592,0.000465684,0.00040583833,0.0002504352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030867786,0.00058869604,0.67311853,0.00038202715,0.0005871491,0.0006839803,0.00018530406,0.12714958,0.079623915,0.0010740499,0.0012970769,0.112222835],"study_design_scores_gemma":[0.00015618645,0.0012581446,0.29078433,0.000034922938,0.00056938326,0.0008852988,0.00017230884,0.65788674,0.039267465,0.0074836314,0.0014090738,0.000092484835],"about_ca_topic_score_codex":0.0021208215,"about_ca_topic_score_gemma":0.0024116246,"teacher_disagreement_score":0.0021208215,"about_ca_system_score_codex":0.0005810277,"about_ca_system_score_gemma":0.0004762568,"threshold_uncertainty_score":0.004358411},"labels":[],"label_agreement":null},{"id":"W2117384590","doi":"10.1158/1078-0432.ccr-04-2346","title":"The Farnesyltransferase Inhibitor L744832 Potentiates UCN-01–Induced Apoptosis in Human Multiple Myeloma Cells","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Farnesyltransferase; Protein kinase B; Apoptosis; Cancer research; Signal transduction; Farnesyltransferase inhibitor; STAT3; Biology; Chemistry; Cell biology; Biochemistry","score_opus":0.18401171325008112,"score_gpt":0.49324428906053913,"score_spread":0.30923257581045804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117384590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951971,0.0023159387,0.0011726201,0.00008299661,0.00002364377,0.00003884327,0.00028792638,0.00006361793,0.00081744004],"genre_scores_gemma":[0.9962769,0.0010198103,0.0009226161,0.000036318477,0.0000068985555,0.000037590715,0.00064540695,0.000007465038,0.0010469191],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984694,0.0000255015,0.000013732934,0.000027656706,0.000053095635,0.00003318039],"domain_scores_gemma":[0.9999492,0.000006587056,0.000014576747,0.000009569068,0.000008790312,0.000011212656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000110295514,0.00037457145,0.00041639485,0.0001942876,0.00016160219,0.00020898349,0.00020044054,0.00021944373,0.0012262955],"category_scores_gemma":[0.000091616836,0.00010834877,0.0002720848,0.00021592637,0.0001426054,0.0001348353,0.00018645621,0.00047966905,0.00036753804],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004059331,0.00008630919,0.00039470056,0.000052508974,0.000013977504,0.00007263689,0.000019061887,0.000143177,0.99559915,0.000035584082,0.000102100086,0.0030749456],"study_design_scores_gemma":[0.00005385581,0.00093915366,0.004598624,0.000005602214,0.000019141737,0.00030516283,0.000024607632,0.00056794775,0.9910052,0.000014900962,0.0024623994,0.0000034898378],"about_ca_topic_score_codex":0.0010565253,"about_ca_topic_score_gemma":0.0019251956,"teacher_disagreement_score":0.0012262955,"about_ca_system_score_codex":0.00039410123,"about_ca_system_score_gemma":0.00028205826,"threshold_uncertainty_score":0.004102409},"labels":[],"label_agreement":null},{"id":"W2117535432","doi":"10.1158/1078-0432.ccr-13-0954","title":"The Mechanism of DAB2IP in Chemoresistance of Prostate Cancer Cells","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Clusterin; Gene knockdown; Cancer research; Prostate cancer; Prostate; Biology; Wnt signaling pathway; Cancer; Cell culture; Apoptosis; Molecular biology; Medicine; Cell biology; Signal transduction; Internal medicine","score_opus":0.18366842598862074,"score_gpt":0.5351700505050089,"score_spread":0.3515016245163881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117535432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9564017,0.021446051,0.012676534,0.0009717929,0.0001454248,0.00019063917,0.0013500903,0.0004178145,0.0063998788],"genre_scores_gemma":[0.9915052,0.0034752612,0.0011942971,0.00011084047,0.00001381784,0.00008479651,0.0005628849,0.000016770946,0.0030361067],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998435,0.000019809615,0.0000113794595,0.000038807288,0.0000447714,0.000041701376],"domain_scores_gemma":[0.99993527,0.0000040851755,0.000019809147,0.000007704335,0.000012736374,0.000020401485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015110604,0.0005788399,0.00030742254,0.00033443258,0.00036175246,0.00051849644,0.00039421694,0.00035727007,0.001390315],"category_scores_gemma":[0.000079796264,0.00020404393,0.00041581492,0.0002913206,0.0003747231,0.00037708032,0.00030351954,0.0005683313,0.0004394735],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003004608,0.000059610076,0.0016130587,0.00030143693,0.000022423194,0.00027505963,0.0000331508,0.00017660855,0.9928295,0.0006860489,0.00032525163,0.0033774646],"study_design_scores_gemma":[0.000074700496,0.00041825353,0.024928873,0.00002885418,0.0000783677,0.0019848265,0.00012261383,0.00210051,0.9602216,0.00027909534,0.009740595,0.00002158314],"about_ca_topic_score_codex":0.00087468605,"about_ca_topic_score_gemma":0.0007848555,"teacher_disagreement_score":0.001390315,"about_ca_system_score_codex":0.0006039246,"about_ca_system_score_gemma":0.00035934793,"threshold_uncertainty_score":0.0046510696},"labels":[],"label_agreement":null},{"id":"W2117677224","doi":"10.1158/1078-0432.ccr-09-1510","title":"Functional Imaging Using Diffuse Optical Spectroscopy of Neoadjuvant Chemotherapy Response in Women with Locally Advanced Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Optical Imaging and Spectroscopy Techniques","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Medicine; Chemotherapy; Cancer; Oncology; Functional imaging; Diffuse optical imaging; Radiology; Internal medicine; Tomography","score_opus":0.05943641004008538,"score_gpt":0.48496892865497554,"score_spread":0.42553251861489017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117677224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994343,0.00021697393,0.00009001398,0.000034405122,0.0000016639665,0.0000070562382,0.000015992835,0.0000034961176,0.00019611817],"genre_scores_gemma":[0.9996369,0.00006642126,0.00013783781,0.000018251376,0.000003762719,0.000010000901,0.00003600556,8.439592e-7,0.00008981509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999188,0.000037263417,0.000005665794,0.0000136469425,0.000014063971,0.000010471339],"domain_scores_gemma":[0.99979347,0.00005613811,0.00008916496,0.000011147379,0.000021183381,0.000028921522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029749578,0.00017132763,0.00016957447,0.00015959433,0.000091405396,0.00011566924,0.00011021478,0.00019873258,0.0006283784],"category_scores_gemma":[0.00087159657,0.00007489899,0.00009000223,0.00009124159,0.00016828714,0.00012063791,0.00008903312,0.00016646362,0.00011724602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005807442,0.0004770245,0.89780366,0.00009775444,0.00007869178,0.00039878392,0.00018331248,0.0007533529,0.054428358,0.000026492744,0.0002663292,0.039678805],"study_design_scores_gemma":[0.000087846354,0.0031566292,0.98624694,0.000009207742,0.000057741734,0.0014005153,0.00013895369,0.0012491386,0.007226041,0.000037780588,0.00038156094,0.00000773161],"about_ca_topic_score_codex":0.00043961257,"about_ca_topic_score_gemma":0.00085600663,"teacher_disagreement_score":0.0006283784,"about_ca_system_score_codex":0.0001935124,"about_ca_system_score_gemma":0.00011127025,"threshold_uncertainty_score":0.0021021366},"labels":[],"label_agreement":null},{"id":"W2117679726","doi":"10.1158/1078-0432.ccr-06-0158","title":"<i>CHEK2</i>-Positive Breast Cancers in Young Polish Women","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health","funders":"","keywords":"CHEK2; Breast cancer; Odds ratio; Internal medicine; Population; Medicine; Oncology; Cancer; Mutation; Biology; Germline mutation; Genetics; Gene","score_opus":0.05196128539755703,"score_gpt":0.45219154977863046,"score_spread":0.40023026438107345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117679726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99961805,0.0001516225,0.000036092235,0.0000113909,0.0000015547502,0.000006209962,0.000058320984,0.0000014338282,0.00011535161],"genre_scores_gemma":[0.9995579,0.00017139528,0.000066066095,0.000016417416,0.0000037040058,0.000006784053,0.00008597314,8.511961e-7,0.00009091569],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998405,0.000026296286,0.000015257925,0.00005195163,0.000024644318,0.00004130332],"domain_scores_gemma":[0.9997521,0.0000337364,0.00012874792,0.000013017423,0.000019572726,0.000052929634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024605848,0.00022818227,0.0002254286,0.0005643115,0.0002379275,0.00027894354,0.00017766024,0.0002529906,0.0009932691],"category_scores_gemma":[0.00073930307,0.0002722353,0.00018687893,0.0003835407,0.0003003007,0.00023519144,0.0003331663,0.00018577902,0.0001728212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020954349,0.000021391255,0.99581355,0.000021832559,0.0000169896,0.00041562523,0.00011622823,0.00001616225,0.0014727045,0.000017120155,0.000057874167,0.0018209006],"study_design_scores_gemma":[0.000014924894,0.000108035696,0.99817467,0.0000062278427,0.000015652524,0.0011320409,0.00016030371,0.00003628204,0.00014560798,0.000015802589,0.00018886646,0.0000015879597],"about_ca_topic_score_codex":0.005127104,"about_ca_topic_score_gemma":0.005201316,"teacher_disagreement_score":0.005127104,"about_ca_system_score_codex":0.00020389303,"about_ca_system_score_gemma":0.00022500084,"threshold_uncertainty_score":0.01019454},"labels":[],"label_agreement":null},{"id":"W2117701024","doi":"10.1158/1078-0432.ccr-07-1310","title":"A Phase I Study of OGX-011, a 2′-Methoxyethyl Phosphorothioate Antisense to Clusterin, in Combination with Docetaxel in Patients with Advanced Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Princess Margaret Cancer Centre; Juravinski Cancer Centre; University Health Network; BC Cancer Agency","funders":"","keywords":"Clusterin; Docetaxel; Medicine; Internal medicine; Pharmacology; Cancer; Chills; Peripheral blood mononuclear cell; Pharmacokinetics; Oncology; Apoptosis; Biology; In vitro","score_opus":0.17631573474176207,"score_gpt":0.5407528954729974,"score_spread":0.36443716073123533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117701024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99650985,0.0007743758,0.00031836194,0.00012588248,0.000040001913,0.0011100988,0.00029535717,0.000039948543,0.0007862255],"genre_scores_gemma":[0.99318063,0.0011951554,0.0012767614,0.00025188658,0.00006893292,0.0012867004,0.0009545827,0.000021243377,0.0017641982],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997396,0.000094436844,0.000012805758,0.00006410768,0.000026274329,0.00006293562],"domain_scores_gemma":[0.9995906,0.000057749818,0.00007483273,0.00003353705,0.000021433152,0.00022192557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007154932,0.0013581022,0.001599347,0.00037806944,0.00039186337,0.0007533194,0.0007112005,0.0008045745,0.0021938162],"category_scores_gemma":[0.00042818562,0.0005318827,0.00074239966,0.00040169733,0.00094770215,0.00050729094,0.00028037798,0.00208053,0.00048047924],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.546662,0.11281929,0.014206079,0.00097191514,0.0011012075,0.0005453728,0.0007303716,0.0060708676,0.17959204,0.0004370316,0.0036760606,0.13318782],"study_design_scores_gemma":[0.2509422,0.7179656,0.014998853,0.000026862203,0.0004096571,0.00040985775,0.00009305015,0.0012800071,0.010742719,0.00010006193,0.0030001155,0.000031012114],"about_ca_topic_score_codex":0.0016339943,"about_ca_topic_score_gemma":0.0036909396,"teacher_disagreement_score":0.0021938162,"about_ca_system_score_codex":0.001140412,"about_ca_system_score_gemma":0.001712873,"threshold_uncertainty_score":0.008274317},"labels":[],"label_agreement":null},{"id":"W2117783793","doi":"10.1158/1078-0432.ccr-07-1036","title":"A Contemporary Prognostic Nomogram for Men with Hormone-Refractory Metastatic Prostate Cancer: A TAX327 Study Analysis","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":362,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Celgene; Sanofi; Bristol-Myers Squibb","keywords":"Medicine; Nomogram; Internal medicine; Hazard ratio; Prostate cancer; Proportional hazards model; Oncology; Docetaxel; Prostate-specific antigen; Multivariate analysis; Urology; Performance status; Mitoxantrone; Cancer; Gastroenterology; Chemotherapy; Confidence interval","score_opus":0.28410465965835746,"score_gpt":0.5593244166085639,"score_spread":0.27521975695020645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117783793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99416167,0.00090034335,0.0029156425,0.00030883407,0.000030395773,0.00007717472,0.00067579834,0.00002476616,0.00090543256],"genre_scores_gemma":[0.9967237,0.00024251087,0.0015384653,0.000066277156,0.000041112256,0.00007050781,0.0011476437,0.00000801082,0.00016174593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996131,0.00023615333,0.000015795129,0.00006107703,0.000051153434,0.000022745246],"domain_scores_gemma":[0.9985947,0.0006541649,0.00022445868,0.00016842486,0.0001725632,0.00018557574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026952636,0.00060374243,0.0005862042,0.00039714287,0.00022805657,0.0007559972,0.00047150796,0.00036964266,0.0012354725],"category_scores_gemma":[0.0038780498,0.00015090834,0.0008362664,0.00035268348,0.00022389553,0.00043714602,0.00035884866,0.0005340386,0.00031405507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008428792,0.00023125211,0.922377,0.00010896857,0.0011294656,0.00017176465,0.000081263264,0.0105955405,0.0006653659,0.00057114346,0.002602346,0.0530372],"study_design_scores_gemma":[0.0050725397,0.0075530177,0.73087853,0.0001648699,0.0031442272,0.0012447846,0.0003578164,0.23726973,0.0012988294,0.003118859,0.009807231,0.00008952578],"about_ca_topic_score_codex":0.001305769,"about_ca_topic_score_gemma":0.0012930792,"teacher_disagreement_score":0.0026952636,"about_ca_system_score_codex":0.0005439887,"about_ca_system_score_gemma":0.0005878962,"threshold_uncertainty_score":0.014254093},"labels":[],"label_agreement":null},{"id":"W2117857186","doi":"10.1158/1078-0432.ccr-14-1108","title":"Generation 2.5 Antisense Oligonucleotides Targeting the Androgen Receptor and Its Splice Variants Suppress Enzalutamide-Resistant Prostate Cancer Cell Growth","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Prostate Cancer Canada; Prostate Cancer Foundation","keywords":"Enzalutamide; Prostate cancer; Androgen receptor; splice; Cancer research; Cancer; Oligonucleotide; Biology; Medicine; Cell growth; Prostate; Internal medicine; Genetics; Gene","score_opus":0.2523537678405155,"score_gpt":0.4732531516307663,"score_spread":0.22089938379025081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117857186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892146,0.0010397106,0.006898392,0.000119007,0.000092999726,0.00013350275,0.00046033377,0.00022974276,0.0018116366],"genre_scores_gemma":[0.9822365,0.0010404798,0.010167643,0.0001466673,0.000028020067,0.0001968744,0.0014014959,0.0000671372,0.0047153253],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998129,0.000024291487,0.000019113122,0.000051519426,0.00005141061,0.000040909697],"domain_scores_gemma":[0.9998826,0.00002375939,0.000046247344,0.000009867007,0.000016716056,0.00002088469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022627834,0.00048169517,0.00026604682,0.000195126,0.00013857613,0.0002890776,0.0002461129,0.0002821742,0.0011333606],"category_scores_gemma":[0.0001177373,0.00016751516,0.00028423572,0.000101064186,0.0002364005,0.00010385838,0.00012992375,0.0005931301,0.00033350094],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058754587,0.00004174418,0.00008300721,0.000023355075,0.0000047658414,0.000013513749,0.000010708437,0.0000830004,0.9987225,0.00007763672,0.00004765471,0.0008334831],"study_design_scores_gemma":[0.000052784722,0.0006959711,0.0009249768,0.0000045662396,0.000032293065,0.00014658773,0.000014839156,0.0007213561,0.9946502,0.000019623398,0.0027322855,0.0000046387318],"about_ca_topic_score_codex":0.00083335734,"about_ca_topic_score_gemma":0.0017920877,"teacher_disagreement_score":0.0011333606,"about_ca_system_score_codex":0.00035594337,"about_ca_system_score_gemma":0.00031983232,"threshold_uncertainty_score":0.0037914515},"labels":[],"label_agreement":null},{"id":"W2117878645","doi":"10.1158/1078-0432.ccr-09-0265","title":"Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 Antibody","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1648,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; York University; Chemotherapy Foundation; Breast Cancer Research Foundation; U.S. Department of Defense","keywords":"Abscopal effect; Radiation therapy; Medicine; CD8; Cancer research; Antibody; Immunotherapy; Growth inhibition; Nasopharyngeal carcinoma; Carcinoma; Dose fractionation; Regimen; Immune system; Oncology; Internal medicine; Immunology; Cell growth; Biology","score_opus":0.12192583124804135,"score_gpt":0.4906271966923983,"score_spread":0.36870136544435694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117878645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972107,0.00075873727,0.0008932771,0.000031598676,0.000031630512,0.000043316,0.000066843706,0.000060410202,0.0009034845],"genre_scores_gemma":[0.9974602,0.00047203727,0.0008881383,0.000042602755,0.000026878319,0.00003910686,0.0001501818,0.00001117319,0.00090972026],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998299,0.00003892689,0.000009191624,0.00003072228,0.000039546198,0.000051713017],"domain_scores_gemma":[0.99985313,0.000030064433,0.00003482281,0.000028094366,0.000010096413,0.000043738197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001823767,0.00046340373,0.0005489899,0.0002844466,0.0000867779,0.00014575412,0.00023992716,0.00020121374,0.001528751],"category_scores_gemma":[0.0001256078,0.00014307475,0.00034780242,0.0001169519,0.00022928318,0.00013107629,0.00016199514,0.00064017356,0.00035598374],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005942277,0.0004331321,0.0003228904,0.00006768854,0.000023188215,0.000032552543,0.000010974436,0.00019711541,0.99392176,0.000044009288,0.0000562838,0.004296228],"study_design_scores_gemma":[0.00019578423,0.0148226945,0.009791841,0.000018810124,0.00011967981,0.00039680544,0.000023868606,0.0012205123,0.9718431,0.00004897366,0.0015104036,0.000007421751],"about_ca_topic_score_codex":0.00023736988,"about_ca_topic_score_gemma":0.00060713576,"teacher_disagreement_score":0.001528751,"about_ca_system_score_codex":0.00015015391,"about_ca_system_score_gemma":0.00023488552,"threshold_uncertainty_score":0.005114138},"labels":[],"label_agreement":null},{"id":"W2118010724","doi":"10.1158/1078-0432.ccr-10-0527","title":"“Contextual” Synthetic Lethality and/or Loss of Heterozygosity: Tumor Hypoxia and Modification of DNA Repair","year":2010,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Synthetic lethality; Loss of heterozygosity; DNA repair; Cancer research; Carcinogenesis; Genome instability; Biology; Hypoxia (environmental); Phenotype; DNA damage; DNA mismatch repair; Context (archaeology); Tumor hypoxia; DNA; Genetics; Cancer; Medicine; Chemistry; Internal medicine; Gene; Radiation therapy","score_opus":0.2810343166911639,"score_gpt":0.5143855926620859,"score_spread":0.23335127597092203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118010724","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001513266,0.9975568,0.00026342843,0.0003735424,0.00023317774,0.0000037744633,0.000010999216,0.000010288176,0.0013966124],"genre_scores_gemma":[0.0008803425,0.99748284,0.00024739027,0.00026235142,0.00016922069,0.000006636557,0.000020182926,0.0000021211547,0.00092893624],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998733,0.000025510637,0.000016684111,0.000024788278,0.00004669305,0.0000130089475],"domain_scores_gemma":[0.99973506,0.00011658094,0.0000382921,0.000012670228,0.00006689651,0.00003052691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005321167,0.00088442053,0.0012687898,0.001883591,0.00028051247,0.0008818381,0.00096431514,0.0013014135,0.0021039296],"category_scores_gemma":[0.00063055736,0.00025082447,0.00029173642,0.0017224196,0.0009763904,0.0016636036,0.0006103276,0.0014830353,0.0023850389],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007798093,0.00006746808,0.00021703553,0.0070013576,0.000059307113,0.0003647276,0.000052145188,0.00037382738,0.002434319,0.006715335,0.03277955,0.949857],"study_design_scores_gemma":[0.000016757735,0.00006289556,0.0007736581,0.0012244821,0.000041352254,0.003017228,0.000058776484,0.00009020825,0.0007827569,0.0034023481,0.99051064,0.000018902745],"about_ca_topic_score_codex":0.00108669,"about_ca_topic_score_gemma":0.0019750954,"teacher_disagreement_score":0.0021039296,"about_ca_system_score_codex":0.0009153478,"about_ca_system_score_gemma":0.00079603103,"threshold_uncertainty_score":0.007038355},"labels":[],"label_agreement":null},{"id":"W2118236177","doi":"10.1158/1078-0432.ccr-04-0657","title":"Species Differences in Troxacitabine Pharmacokinetics and Pharmacodynamics","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Pharmacokinetics; Pharmacodynamics; Pharmacology; Toxicity; Bolus (digestion); In vitro; Nucleoside; Dose–response relationship; Intracellular; Biology; Medicine; Internal medicine; Biochemistry","score_opus":0.30468296612125617,"score_gpt":0.5476224035942685,"score_spread":0.24293943747301233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118236177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96677977,0.011465446,0.010701065,0.00037026708,0.00014973432,0.0002844164,0.0014615328,0.00027639023,0.008511427],"genre_scores_gemma":[0.98714966,0.0028046442,0.0036527598,0.00046977054,0.000042654578,0.0002213761,0.0016928151,0.00010213173,0.0038642401],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99969494,0.0000857364,0.000024316572,0.00010524257,0.000061194274,0.000028619672],"domain_scores_gemma":[0.99962926,0.000116887764,0.00007986583,0.00007021802,0.00005887196,0.0000449457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004707349,0.00026747672,0.00025501882,0.00022593535,0.00015329862,0.00051872677,0.00020836212,0.00030475215,0.003672394],"category_scores_gemma":[0.0005606784,0.00018328127,0.00037819723,0.00013517478,0.00027145958,0.0003335111,0.00022367598,0.0004543224,0.0007619493],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001236753,0.00007189778,0.0015918281,0.0001122166,0.000050237177,0.00014189607,0.00007362862,0.00009165065,0.9884957,0.0002899786,0.00022177333,0.007622525],"study_design_scores_gemma":[0.00021126829,0.008338874,0.074958384,0.00007118581,0.00032335252,0.0052259094,0.00019689083,0.0013643568,0.8805227,0.00060511456,0.028137838,0.000044024215],"about_ca_topic_score_codex":0.00045840512,"about_ca_topic_score_gemma":0.00039499864,"teacher_disagreement_score":0.003672394,"about_ca_system_score_codex":0.00031798196,"about_ca_system_score_gemma":0.00022576803,"threshold_uncertainty_score":0.012285352},"labels":[],"label_agreement":null},{"id":"W2118325904","doi":"10.1158/1078-0432.ccr-13-0691","title":"Adrenomedullin Blockade Suppresses Growth of Human Hormone–Independent Prostate Tumor Xenograft in Mice","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neuropeptides and Animal Physiology","field":"Neuroscience","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Association pour la Recherche sur les Tumeurs de la Prostate; Institut National Du Cancer","keywords":"Adrenomedullin; DU145; Prostate cancer; Angiogenesis; Autocrine signalling; Cancer research; LNCaP; Lymphangiogenesis; Medicine; Internal medicine; Endocrinology; Paracrine signalling; Prostate; Androgen receptor; Cancer; Androgen; Metastasis; Receptor; Hormone","score_opus":0.19311970115876617,"score_gpt":0.46596091872972145,"score_spread":0.27284121757095525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118325904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98848444,0.0042337026,0.002348014,0.00020336416,0.00015020368,0.00010202843,0.0008990759,0.00040301532,0.003176164],"genre_scores_gemma":[0.98612857,0.0022247247,0.0019937397,0.0001617754,0.000054940247,0.00012729116,0.001598912,0.00008652221,0.0076236296],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997454,0.00003708669,0.000015614427,0.000054304117,0.00007863174,0.000068872156],"domain_scores_gemma":[0.9997687,0.000028599245,0.0000607687,0.00003438986,0.000017577291,0.00009009882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027438192,0.0008888007,0.0005260171,0.0006210908,0.00019136122,0.00031177409,0.00042152486,0.00040088635,0.0016759584],"category_scores_gemma":[0.0001309792,0.00024235806,0.00042535472,0.00023626666,0.00028332366,0.00029058332,0.00016376065,0.001255014,0.0006789086],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006028543,0.000497958,0.0002466829,0.000044020857,0.000011526482,0.00004405361,0.000018104549,0.00013219759,0.9957676,0.00008168906,0.0001226595,0.0024305931],"study_design_scores_gemma":[0.00015015852,0.0059337895,0.0072154393,0.00001971931,0.000032873493,0.0004248272,0.000037161735,0.0020238776,0.98024476,0.000055457494,0.0038510133,0.000010943591],"about_ca_topic_score_codex":0.0012386002,"about_ca_topic_score_gemma":0.002153044,"teacher_disagreement_score":0.0016759584,"about_ca_system_score_codex":0.00046333525,"about_ca_system_score_gemma":0.00042943112,"threshold_uncertainty_score":0.0056066513},"labels":[],"label_agreement":null},{"id":"W2118385994","doi":"10.1158/1078-0432.ccr-14-2352","title":"ERG/AKR1C3/AR Constitutes a Feed-Forward Loop for AR Signaling in Prostate Cancer Cells","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Aldose Reductase and Taurine","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Center for Research Resources; National Cancer Institute; National Institutes of Health","keywords":"Prostate cancer; Prostate; Cancer; Cancer research; Erg; Internal medicine; Biology; Oncology; Medicine; Neuroscience; Retina","score_opus":0.22095041484596406,"score_gpt":0.5114372484737918,"score_spread":0.29048683362782773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118385994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9365053,0.02059281,0.026212482,0.0010236066,0.00034027055,0.00016821873,0.0045289197,0.0020012823,0.008626984],"genre_scores_gemma":[0.9843687,0.0031237747,0.0047169207,0.00024204946,0.0000326257,0.000054875058,0.0029643583,0.00006738106,0.0044293036],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996227,0.00004172622,0.000022705892,0.00009519181,0.000148708,0.000068831454],"domain_scores_gemma":[0.9998548,0.000018775749,0.00003971912,0.000022866117,0.000037679943,0.00002620696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002502853,0.0007522932,0.00054828555,0.00038108914,0.00035944014,0.000868955,0.0004245255,0.00037948496,0.0029405414],"category_scores_gemma":[0.00017410751,0.00021316236,0.00071065716,0.00039637563,0.0002856391,0.00030806745,0.0003250467,0.00078763405,0.0017590409],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034979824,0.000043767483,0.00087961165,0.00013391992,0.000025196692,0.00010957936,0.00001809425,0.00034906666,0.9932706,0.00018624814,0.00026184265,0.0043723136],"study_design_scores_gemma":[0.000058271427,0.0004023932,0.028542163,0.000028999093,0.00013743194,0.0007443061,0.00010851221,0.0064146984,0.9521097,0.0003599545,0.011053157,0.00004056952],"about_ca_topic_score_codex":0.0015175482,"about_ca_topic_score_gemma":0.0018675899,"teacher_disagreement_score":0.0029405414,"about_ca_system_score_codex":0.0007320142,"about_ca_system_score_gemma":0.00046832318,"threshold_uncertainty_score":0.009837091},"labels":[],"label_agreement":null},{"id":"W2118421998","doi":"10.1158/1078-0432.ccr-05-2568","title":"Xenografts of Human Hepatocellular Carcinoma: A Useful Model for Testing Drugs","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Hepatocellular carcinoma; Doxorubicin; Cancer research; Cell growth; Cisplatin; Biology; Internal medicine; Medicine; Endocrinology; Chemotherapy","score_opus":0.5342079340183039,"score_gpt":0.48644512565081327,"score_spread":0.04776280836749064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118421998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9252137,0.022128018,0.035277132,0.0011232808,0.0006413279,0.00097162084,0.0055035385,0.0006719101,0.008469469],"genre_scores_gemma":[0.9377064,0.014608109,0.02612653,0.0002554364,0.0001492315,0.0005893387,0.008328945,0.00010542733,0.01213047],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996823,0.000095396696,0.00002789158,0.000049115755,0.00008723808,0.000058129543],"domain_scores_gemma":[0.9997112,0.00006874852,0.000043148033,0.000059605245,0.00005246823,0.00006485309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050053786,0.00057851616,0.00055326807,0.00044616754,0.00026227257,0.0003344469,0.00037029939,0.000426163,0.0022939427],"category_scores_gemma":[0.00019730613,0.00019502298,0.00040102855,0.00042460082,0.00024950356,0.00046306706,0.00027110317,0.0011823784,0.0010765704],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036361397,0.00032088495,0.0012426605,0.00021293775,0.000025084517,0.00037619204,0.000035790832,0.00022027049,0.9924452,0.0004186546,0.0006013375,0.0037374005],"study_design_scores_gemma":[0.00014060787,0.005191192,0.00775264,0.000045985926,0.00013007053,0.0037305928,0.00013238208,0.0026531823,0.957344,0.0002523593,0.0226055,0.00002150972],"about_ca_topic_score_codex":0.0011144149,"about_ca_topic_score_gemma":0.0023856256,"teacher_disagreement_score":0.0022939427,"about_ca_system_score_codex":0.00048977893,"about_ca_system_score_gemma":0.00039903962,"threshold_uncertainty_score":0.007673979},"labels":[],"label_agreement":null},{"id":"W2118563466","doi":"10.1158/1078-0432.ccr-04-2352","title":"Induction of Apoptosis Using Inhibitors of Lysophosphatidic Acid Acyltransferase-β and Anti-CD20 Monoclonal Antibodies for Treatment of Human Non-Hodgkin's Lymphomas","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Rituximab; Lysophosphatidic acid; Apoptosis; Lymphoma; Cancer research; In vivo; Pharmacology; CD20; Monoclonal antibody; Chemistry; Medicine; Immunology; Antibody; Biology; Biochemistry; Receptor","score_opus":0.1477683575060193,"score_gpt":0.47111415806059675,"score_spread":0.32334580055457746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118563466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98383635,0.011591953,0.0020092186,0.00010619033,0.000059783182,0.00019405769,0.00016015158,0.00008494522,0.0019573178],"genre_scores_gemma":[0.9905094,0.0052300687,0.00235044,0.00009061381,0.00003079882,0.00018414941,0.00038362687,0.000010026337,0.00121088],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998468,0.000030001205,0.000016788692,0.000023222789,0.0000459132,0.000037183312],"domain_scores_gemma":[0.99994504,0.000009584911,0.000017127903,0.0000063173693,0.000007971871,0.000013921911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022868605,0.0003673104,0.0004350496,0.00033837534,0.0001260569,0.00021850046,0.00025353004,0.00022799612,0.0006857462],"category_scores_gemma":[0.00010999031,0.00013246697,0.00025457257,0.00021392018,0.00015762117,0.0001704146,0.00017176043,0.0005042098,0.0001803737],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015127258,0.0008349622,0.0009934423,0.00017910615,0.00005717336,0.000143356,0.00004854749,0.00040263624,0.9721467,0.00012546626,0.00024061408,0.023315256],"study_design_scores_gemma":[0.0006542567,0.010744944,0.007921114,0.00002433353,0.00014181373,0.000895784,0.000031471252,0.0012656208,0.9700721,0.00004616768,0.008193238,0.000009249197],"about_ca_topic_score_codex":0.00031752817,"about_ca_topic_score_gemma":0.00089767936,"teacher_disagreement_score":0.0006857462,"about_ca_system_score_codex":0.0002659464,"about_ca_system_score_gemma":0.00023990085,"threshold_uncertainty_score":0.0022940636},"labels":[],"label_agreement":null},{"id":"W2118731629","doi":"10.1158/1078-0432.ccr-05-2286","title":"Expression of Carcinoembryonic Antigen Cell Adhesion Molecule 6 Oncoprotein in Atypical Ductal Hyperplastic Tissues Is Associated with the Development of Invasive Breast Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Center for Research Resources; National Cancer Institute","keywords":"Carcinoembryonic antigen; Breast cancer; Cancer; Immunohistochemistry; Medicine; Internal medicine; Colorectal cancer; Predictive marker; Oncology; Predictive value; Antigen; Pathology; Immunology","score_opus":0.11901408041275666,"score_gpt":0.46132421227370185,"score_spread":0.34231013186094517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118731629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99942374,0.00024985912,0.00007873991,0.000011948131,0.000002173697,0.0000022142094,0.000034452634,0.0000026880614,0.00019419078],"genre_scores_gemma":[0.9997086,0.00008353824,0.00008055437,0.00000471733,0.000005389271,0.0000014168166,0.000056757017,6.751868e-7,0.00005840191],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974066,0.000058428686,0.000032121054,0.00004886893,0.000080044396,0.000039735918],"domain_scores_gemma":[0.9982027,0.00044311848,0.0008822461,0.0000934753,0.00018575181,0.00019267242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033256496,0.00015368045,0.0001537819,0.00083671673,0.00018418227,0.00031919996,0.0001967782,0.00027884514,0.0010320181],"category_scores_gemma":[0.0017639273,0.00019259754,0.00013789083,0.0005183035,0.0003077912,0.00019269747,0.00022832178,0.0003526058,0.00014655756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012212597,0.000016380965,0.9960412,0.000009375746,0.0000164557,0.00020011446,0.000014771714,0.00002073817,0.0024437474,0.000007027938,0.000022614013,0.0010856466],"study_design_scores_gemma":[0.0000035019414,0.00008180134,0.99653554,0.0000024382573,0.00002146257,0.0021839077,0.000042034622,0.00013231719,0.00086585945,0.000019041132,0.00011038555,0.0000016252848],"about_ca_topic_score_codex":0.0004707196,"about_ca_topic_score_gemma":0.0005774585,"teacher_disagreement_score":0.0010320181,"about_ca_system_score_codex":0.00013363035,"about_ca_system_score_gemma":0.00010236562,"threshold_uncertainty_score":0.0034524798},"labels":[],"label_agreement":null},{"id":"W2118837528","doi":"10.1158/1078-0432.ccr-10-0395","title":"HDAC5 and HDAC9 in Medulloblastoma: Novel Markers for Risk Stratification and Role in Tumor Cell Growth","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":193,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Bundesministerium für Bildung und Forschung","keywords":"Medulloblastoma; Histone deacetylase 5; Gene knockdown; Cancer research; Biology; Histone deacetylase; Immunology; Oncology; Medicine; Cell culture; Histone; Genetics","score_opus":0.04207828477692169,"score_gpt":0.43113763143858047,"score_spread":0.38905934666165876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118837528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9394894,0.047901504,0.007654134,0.00032951948,0.000068952075,0.000078901576,0.0019120505,0.00018331944,0.0023821737],"genre_scores_gemma":[0.9875557,0.006160417,0.003944261,0.000042414285,0.00004690255,0.00002226587,0.0010861276,0.000010048848,0.0011319453],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998518,0.000019723426,0.000014499132,0.000042832326,0.00004560834,0.000025373973],"domain_scores_gemma":[0.9998678,0.0000141869,0.00006457908,0.0000075262465,0.000021534093,0.000024305056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023571157,0.0005039061,0.00036262794,0.0007817362,0.00018750077,0.00044650794,0.00023206536,0.00021639523,0.0008565615],"category_scores_gemma":[0.00021829014,0.00014563034,0.0003347375,0.0005238261,0.00024047749,0.00022455162,0.0001916468,0.00035330807,0.00031847134],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017482617,0.00008904431,0.20887403,0.0006406644,0.00025685626,0.0005684859,0.00011819316,0.0006636757,0.71243286,0.0003916419,0.0009136571,0.073302574],"study_design_scores_gemma":[0.000043197513,0.0004945075,0.7655903,0.00006946595,0.0003626309,0.0026244556,0.00016435777,0.0035045224,0.21553239,0.00036097606,0.011227211,0.000026019214],"about_ca_topic_score_codex":0.002709071,"about_ca_topic_score_gemma":0.0041877306,"teacher_disagreement_score":0.002709071,"about_ca_system_score_codex":0.00075590255,"about_ca_system_score_gemma":0.0002949588,"threshold_uncertainty_score":0.0054845214},"labels":[],"label_agreement":null},{"id":"W2118922417","doi":"10.1158/1078-0432.ccr-11-2094","title":"Prognostic and Predictive Significance of Plasma HGF and IL-8 in a Phase III Trial of Chemoradiation with or without Tirapazamine in Locoregionally Advanced Head and Neck Cancer","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Hepatocyte growth factor; Tirapazamine; Medicine; Head and neck cancer; Cisplatin; Oncology; Tumor hypoxia; Internal medicine; Radiation therapy; Cancer research; Cancer; Chemotherapy; Biology; In vitro; Cytotoxicity","score_opus":0.09141139621870341,"score_gpt":0.4533343857705327,"score_spread":0.3619229895518293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118922417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99905294,0.00043790368,0.00006704515,0.00006699192,0.000017871163,0.00015631592,0.00007274837,0.0000060940747,0.00012212561],"genre_scores_gemma":[0.9987129,0.000199917,0.00019055141,0.000095829884,0.00003527651,0.0002927686,0.00027439243,0.0000030275507,0.00019533157],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99927443,0.00041235928,0.00004308848,0.000104306004,0.000073926385,0.000091825794],"domain_scores_gemma":[0.999087,0.00029715896,0.00021785278,0.00008824397,0.00004747257,0.0002622861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001801647,0.00072162435,0.0014177366,0.00022143181,0.00025881082,0.0006505583,0.0006140987,0.0007711249,0.000970711],"category_scores_gemma":[0.0014759339,0.00036082714,0.0010262609,0.0002593901,0.0006827504,0.00038332667,0.00024354662,0.0014198336,0.00023978013],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89883673,0.009802446,0.031042678,0.0002327146,0.001545084,0.000096388605,0.00017173051,0.0014247283,0.022192914,0.00005976315,0.0005268713,0.034067873],"study_design_scores_gemma":[0.4153411,0.4441848,0.12725557,0.000038760292,0.002221661,0.00028088686,0.00009694616,0.0033468811,0.005749145,0.00018577592,0.0012566523,0.000041746716],"about_ca_topic_score_codex":0.00062353414,"about_ca_topic_score_gemma":0.0018504418,"teacher_disagreement_score":0.001801647,"about_ca_system_score_codex":0.0007985142,"about_ca_system_score_gemma":0.0010296283,"threshold_uncertainty_score":0.0095281005},"labels":[],"label_agreement":null},{"id":"W2118995187","doi":"10.1158/1078-0432.ccr-07-0618","title":"The Cancer/Testis Antigen Melanoma-Associated Antigen-A3/A6 Is a Novel Target of Fibroblast Growth Factor Receptor 2-IIIb through Histone H3 Modifications in Thyroid Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Immunovaccine (Canada); University Health Network","funders":"","keywords":"Cancer research; Chromatin immunoprecipitation; Biology; DNA methylation; Thyroid cancer; Molecular biology; Carcinogenesis; Epigenetics; FGF10; Fibroblast growth factor receptor 2; Cancer; Fibroblast growth factor; Gene expression; Promoter; Receptor; Gene; Genetics","score_opus":0.13887603713944804,"score_gpt":0.4830170187010986,"score_spread":0.3441409815616505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118995187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913967,0.0031231055,0.0030967363,0.00011069831,0.000026032569,0.000038248614,0.00051908125,0.00010460045,0.0015848236],"genre_scores_gemma":[0.9948736,0.00084362534,0.0016198063,0.00004887549,0.000008698331,0.000016986873,0.0006626878,0.000008390206,0.0019173295],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994147,0.0000054479397,0.000002700256,0.00001701466,0.000022181608,0.000011175504],"domain_scores_gemma":[0.99995565,0.000004536621,0.000013279986,0.0000032171915,0.0000069527464,0.000016428836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007031755,0.00018255608,0.00012267224,0.00013272591,0.00020821656,0.00015688359,0.00012048167,0.00016102123,0.0010656127],"category_scores_gemma":[0.000063207255,0.00008290069,0.0002534967,0.00013451606,0.00013492057,0.00006827524,0.000094431816,0.00026008103,0.00029653864],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052494852,0.000007743678,0.00050861185,0.000021567754,0.0000031517222,0.000048771813,0.0000065948902,0.000029155632,0.9983069,0.000041153457,0.000031166364,0.0009427467],"study_design_scores_gemma":[0.000027586444,0.00042447232,0.058718827,0.000007760829,0.000038168793,0.0011955284,0.000040208877,0.0014262841,0.93206704,0.00013679345,0.005909452,0.00000778755],"about_ca_topic_score_codex":0.001402328,"about_ca_topic_score_gemma":0.0020254452,"teacher_disagreement_score":0.001402328,"about_ca_system_score_codex":0.0003429987,"about_ca_system_score_gemma":0.0002224853,"threshold_uncertainty_score":0.0035648346},"labels":[],"label_agreement":null},{"id":"W2119081353","doi":"10.1158/1078-0432.ccr-11-1122","title":"RAF265 Inhibits the Growth of Advanced Human Melanoma Tumors","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of General Medical Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute; U.S. Public Health Service; U.S. Food and Drug Administration; Vanderbilt University Medical Center; Vanderbilt University; U.S. Department of Veterans Affairs","keywords":"Cancer research; Melanoma; MAPK/ERK pathway; Cell growth; V600E; Kinase; Cancer; Medicine; Apoptosis; Signal transduction; Mutation; Biology; Internal medicine; Gene; Cell biology","score_opus":0.15127478355897447,"score_gpt":0.4782351862684745,"score_spread":0.3269604027095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119081353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973531,0.0013716009,0.00035106504,0.00004900169,0.000013573761,0.00004050445,0.00014554682,0.00004858374,0.000627032],"genre_scores_gemma":[0.99715084,0.00084277656,0.00052301545,0.000024670455,0.000013167266,0.000023573759,0.00041160092,0.0000089715995,0.0010013576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999261,0.000012867317,0.0000033336582,0.000010108653,0.00002397946,0.000023644647],"domain_scores_gemma":[0.9999391,0.000011554276,0.000013130149,0.0000059191184,0.000008042074,0.000022335582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013958056,0.00051569263,0.0003082593,0.00018338407,0.00012130997,0.00016849139,0.00013884343,0.00014449927,0.0011807532],"category_scores_gemma":[0.000072253584,0.00007863111,0.0001987487,0.00007627634,0.00014397553,0.00009529579,0.0001080373,0.0005043898,0.0003400022],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010298664,0.0007610641,0.0008344194,0.00008972129,0.000018200019,0.000113941314,0.000019191855,0.00042883266,0.98672545,0.000042770476,0.00023942611,0.009697142],"study_design_scores_gemma":[0.00069627,0.032280378,0.020790214,0.000025820236,0.00008881901,0.0019489431,0.000053219006,0.0029173254,0.9353109,0.00006600317,0.005810856,0.000011090847],"about_ca_topic_score_codex":0.00042066845,"about_ca_topic_score_gemma":0.00080897426,"teacher_disagreement_score":0.0011807532,"about_ca_system_score_codex":0.00019310783,"about_ca_system_score_gemma":0.00020312809,"threshold_uncertainty_score":0.0039500594},"labels":[],"label_agreement":null},{"id":"W2119283670","doi":"10.1158/1078-0432.ccr-05-0726","title":"High Frequency of Hereditary Colorectal Cancer in Newfoundland Likely Involves Novel Susceptibility Genes","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"MSH6; MLH1; MSH2; Colorectal cancer; Microsatellite instability; Population; Genetics; Cancer; Lynch syndrome; DNA mismatch repair; Medicine; Biology; Oncology; Microsatellite; Gene; Allele","score_opus":0.17536262644779682,"score_gpt":0.4798452594927786,"score_spread":0.3044826330449818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119283670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983632,0.00031334415,0.000109533554,0.00012149967,0.0000047947615,0.0000046674027,0.0002503499,0.0000075164694,0.0008251638],"genre_scores_gemma":[0.99897075,0.00015996603,0.00012607379,0.00004844671,0.000006987496,0.0000036333752,0.0002700054,0.0000021956687,0.00041192095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975044,0.000033701963,0.000015635487,0.00007158874,0.000043835673,0.00008485207],"domain_scores_gemma":[0.99925345,0.000088425906,0.00035462333,0.000047694553,0.00012749223,0.00012832171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020561337,0.00020523749,0.00021385249,0.0008066503,0.00074203464,0.00035228123,0.00035185696,0.00022206122,0.003908486],"category_scores_gemma":[0.00076745404,0.00012022173,0.00016874379,0.00082082127,0.0005359238,0.0001899089,0.0003578692,0.00024410477,0.00017245888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040302602,0.0000133734875,0.9952301,0.000010017759,0.00002340678,0.00058745284,0.00008712463,0.000033969278,0.0013684822,0.000035086236,0.00028064748,0.0022900505],"study_design_scores_gemma":[0.0000022223312,0.000017465529,0.99820757,0.0000059616455,0.000011053296,0.0011597803,0.00014764667,0.00004503609,0.00011178273,0.000009296914,0.0002803456,0.0000017571858],"about_ca_topic_score_codex":0.23602192,"about_ca_topic_score_gemma":0.38931555,"teacher_disagreement_score":0.76397806,"about_ca_system_score_codex":0.00189335,"about_ca_system_score_gemma":0.0010758005,"threshold_uncertainty_score":0.46929628},"labels":[],"label_agreement":null},{"id":"W2119325428","doi":"10.1158/1078-0432.ccr-05-0252","title":"Activation of the Steroid and Xenobiotic Receptor (Human Pregnane X Receptor) by Nontaxane Microtubule-Stabilizing Agents","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Pregnane X receptor; Pharmacology; Paclitaxel; Nuclear receptor; Transcription factor; Biology; In vivo; Chemistry; Cell biology; Biochemistry; Cancer; Gene","score_opus":0.4170434883543968,"score_gpt":0.5987963018884374,"score_spread":0.18175281353404055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119325428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99286216,0.0033429312,0.0016171797,0.00008655289,0.000020382455,0.000051266463,0.00015328551,0.00003970677,0.001826555],"genre_scores_gemma":[0.99335724,0.002109501,0.0016963748,0.000039999064,0.000014545815,0.00004387085,0.000316487,0.0000063534326,0.0024156426],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998264,0.000055799628,0.000018270199,0.000025028881,0.000046466845,0.000028073073],"domain_scores_gemma":[0.9999063,0.000027517932,0.000032531556,0.000012068067,0.000010254476,0.000011281292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014092219,0.00026774104,0.0001908188,0.00015557179,0.000112570226,0.00018390342,0.00012373214,0.00013220437,0.0019605742],"category_scores_gemma":[0.00013279845,0.00007428789,0.00030959232,0.0001168226,0.00017035886,0.00013669598,0.000097762655,0.00021955234,0.00038656924],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014875962,0.000028712819,0.0002976519,0.00004961376,0.000006239513,0.000057425008,0.000009482472,0.00003799755,0.99754566,0.000060208215,0.00002267953,0.0017356212],"study_design_scores_gemma":[0.000021100166,0.00054086605,0.0032488084,0.000004146433,0.000012648194,0.00025374867,0.000015890177,0.00022381157,0.99393976,0.000016326667,0.0017203316,0.000002553601],"about_ca_topic_score_codex":0.00038991688,"about_ca_topic_score_gemma":0.00072411913,"teacher_disagreement_score":0.0019605742,"about_ca_system_score_codex":0.00027471333,"about_ca_system_score_gemma":0.00019603437,"threshold_uncertainty_score":0.006558776},"labels":[],"label_agreement":null},{"id":"W2119413329","doi":"10.1158/1078-0432.ccr-06-2377","title":"A Randomized, Double-Blind, Phase II Study of Two Doses of Pemetrexed as First-Line Chemotherapy for Advanced Breast Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Pemetrexed; Medicine; Neutropenia; Internal medicine; Breast cancer; Metastatic breast cancer; Oncology; Leukopenia; Population; Gastroenterology; Chemotherapy; Cancer; Phases of clinical research; Surgery","score_opus":0.3282812492929229,"score_gpt":0.6418834965688445,"score_spread":0.31360224727592156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119413329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931652,0.0007068156,0.00071815867,0.00018288453,0.00017571117,0.0039440985,0.0003312492,0.00007009815,0.0007057541],"genre_scores_gemma":[0.984738,0.0009284434,0.003176665,0.00079749385,0.00029526206,0.007409121,0.0007254526,0.000022712886,0.0019067643],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993206,0.0003620809,0.00004195882,0.00013343224,0.000073290204,0.000068724155],"domain_scores_gemma":[0.9988932,0.00033687573,0.00025392315,0.00012334259,0.000050928433,0.00034172973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016306728,0.0013327282,0.0023717224,0.00045233913,0.00031077254,0.0006404772,0.0008147609,0.0014022238,0.0039888155],"category_scores_gemma":[0.0017329191,0.00060207,0.0006896911,0.00033841326,0.0012246753,0.0006992409,0.00028507347,0.0023678038,0.0005786598],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91720384,0.04692642,0.0009628429,0.00029493083,0.0003629206,0.00003864841,0.00005801365,0.0004991096,0.01454323,0.00012302064,0.00047654856,0.018510547],"study_design_scores_gemma":[0.8113202,0.18479945,0.0014693196,0.000008598139,0.000107533706,0.000037939448,0.000009437465,0.00041848855,0.0014195106,0.00007163986,0.0003282592,0.000009514587],"about_ca_topic_score_codex":0.00036351974,"about_ca_topic_score_gemma":0.00059299986,"teacher_disagreement_score":0.0039888155,"about_ca_system_score_codex":0.00062963855,"about_ca_system_score_gemma":0.0011112409,"threshold_uncertainty_score":0.013343871},"labels":[],"label_agreement":null},{"id":"W2119452594","doi":"10.1158/1078-0432.ccr-12-3661","title":"Infection and Cancer: Revaluation of the Hygiene Hypothesis","year":2013,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital","funders":"","keywords":"Carcinogenesis; Cancer; Immune system; Immunology; Hygiene hypothesis; Inflammation; Biology; Immunity; Medicine; Bioinformatics; Genetics","score_opus":0.5861999431800313,"score_gpt":0.5690808140674459,"score_spread":0.017119129112585396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119452594","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000095230804,0.99795246,0.00012352459,0.00090023834,0.0002744674,0.0000014928197,0.0000047173003,0.0000032319163,0.00064461556],"genre_scores_gemma":[0.0008533457,0.99782455,0.00009691271,0.00042009272,0.0004168098,0.000002884438,0.000007556071,0.000001090804,0.00037685197],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99969923,0.00008251455,0.000030988966,0.00004951267,0.00010604894,0.00003170909],"domain_scores_gemma":[0.99937207,0.00039595115,0.000050707993,0.000018688352,0.00011862109,0.000043901153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010898712,0.0006858014,0.0012231406,0.0019126012,0.00035426728,0.0012778626,0.0009095433,0.0017639893,0.0022161945],"category_scores_gemma":[0.0010009601,0.00025984162,0.00054064766,0.0017083229,0.0016930584,0.0024047066,0.0012797951,0.0029514215,0.0010448323],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010478222,0.00006705205,0.00039634976,0.015196298,0.00011566776,0.0004719233,0.00024866452,0.00047696938,0.0017586974,0.030586446,0.04171228,0.9088649],"study_design_scores_gemma":[0.00001254621,0.00006616033,0.00095482904,0.003568579,0.000053620286,0.0014299051,0.00015644947,0.000091599446,0.00035873818,0.010182634,0.98310685,0.000018086641],"about_ca_topic_score_codex":0.0012097647,"about_ca_topic_score_gemma":0.0015259766,"teacher_disagreement_score":0.0022161945,"about_ca_system_score_codex":0.001153503,"about_ca_system_score_gemma":0.0018202169,"threshold_uncertainty_score":0.008369267},"labels":[],"label_agreement":null},{"id":"W2119661337","doi":"10.1158/1078-0432.ccr-07-1254","title":"Acquirement of Rituximab Resistance in Lymphoma Cell Lines Is Associated with Both Global<i>CD20</i>Gene and Protein Down-Regulation Regulated at the Pretranscriptional and Posttranscriptional Levels","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":231,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"CD20; Rituximab; Lymphoma; Medicine; Cancer research; Transfection; Immunology; Chemistry; Gene; Biochemistry","score_opus":0.14338762689709106,"score_gpt":0.40205136518796136,"score_spread":0.2586637382908703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119661337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954721,0.001517252,0.001670337,0.000050017294,0.000009277256,0.000025488513,0.00026158048,0.00011987739,0.0008741025],"genre_scores_gemma":[0.9959908,0.0006246534,0.0014696433,0.00005266361,0.000010828313,0.00004633359,0.0008652763,0.000021821601,0.0009178537],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997297,0.00005514369,0.000037803715,0.000046119552,0.000087988694,0.00004333556],"domain_scores_gemma":[0.9997662,0.000054824253,0.000063332875,0.000048783564,0.000041253606,0.000025698113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001893984,0.000246558,0.00035133862,0.00035679375,0.00010772138,0.00036397311,0.00014697824,0.00021778121,0.0011799729],"category_scores_gemma":[0.00025804283,0.00012196577,0.00023046935,0.00025546513,0.00015916668,0.00014618045,0.0001434128,0.00041757105,0.00047875888],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050905674,0.000034135475,0.00094748545,0.000014196167,0.0000064768265,0.000060712955,0.000015461419,0.000022067132,0.9974789,0.000026652438,0.000026607817,0.0013164171],"study_design_scores_gemma":[0.000019652118,0.0008808333,0.033099797,0.0000045670868,0.000040301267,0.0012435449,0.000052451596,0.00062546186,0.96140605,0.00003649628,0.0025839356,0.000006927055],"about_ca_topic_score_codex":0.00030329853,"about_ca_topic_score_gemma":0.0003639058,"teacher_disagreement_score":0.0011799729,"about_ca_system_score_codex":0.00019887702,"about_ca_system_score_gemma":0.00008694671,"threshold_uncertainty_score":0.003947377},"labels":[],"label_agreement":null},{"id":"W2119729273","doi":"10.1158/1078-0432.ccr-14-3370","title":"A Phase I/II Trial of BNC105P with Everolimus in Metastatic Renal Cell Carcinoma","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Everolimus; Renal cell carcinoma; Medicine; Carcinoma; Oncology; Phases of clinical research; Internal medicine; Cancer research; Clinical trial","score_opus":0.442022090306782,"score_gpt":0.5456514551660511,"score_spread":0.10362936485926905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119729273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922401,0.0032050642,0.000310724,0.00041812003,0.00010371636,0.0020448554,0.00039791694,0.00004592796,0.0012336425],"genre_scores_gemma":[0.9903619,0.0019804535,0.0015768063,0.00081508607,0.00017931184,0.0019770341,0.001216171,0.000015303538,0.0018780299],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99949694,0.00024857654,0.00002740834,0.000091937465,0.000059543163,0.00007560154],"domain_scores_gemma":[0.9994012,0.00007254126,0.00011447409,0.000034019966,0.00003754103,0.00034019077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018069055,0.0013478377,0.0016893503,0.00043542238,0.0003676337,0.0008118469,0.0007072826,0.0010426546,0.002671809],"category_scores_gemma":[0.00067189324,0.00044300238,0.0009563791,0.00038383828,0.00081854523,0.00067334,0.00035613563,0.002517374,0.0005189993],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.787281,0.061373405,0.005420666,0.0010680548,0.0014008962,0.00028793237,0.00017624158,0.0020377208,0.04071982,0.00029464863,0.0030943071,0.096845426],"study_design_scores_gemma":[0.6395045,0.34627077,0.007067707,0.000046712685,0.00031209798,0.0002736021,0.00003626179,0.0008519576,0.0034587076,0.00013302219,0.0020258368,0.00001882741],"about_ca_topic_score_codex":0.0010932023,"about_ca_topic_score_gemma":0.0027914098,"teacher_disagreement_score":0.002671809,"about_ca_system_score_codex":0.001043895,"about_ca_system_score_gemma":0.0020595598,"threshold_uncertainty_score":0.009555936},"labels":[],"label_agreement":null},{"id":"W2119938419","doi":"10.1158/1078-0432.ccr-06-2476","title":"Promoter Hypermethylation Identifies Progression Risk in Bladder Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Medical Research Council","keywords":"Tumor progression; Bladder cancer; DNA methylation; Cancer; Oncology; Epigenetics; Medicine; Methylation; Proportional hazards model; Internal medicine; Cancer research; Biology; Gene; Gene expression; Genetics","score_opus":0.14459420340458817,"score_gpt":0.551341042201575,"score_spread":0.4067468387969868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119938419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982535,0.00076280127,0.00057745696,0.00003112137,0.0000025818229,0.000010200912,0.00016968882,0.000016128499,0.0001764375],"genre_scores_gemma":[0.99882954,0.00020755462,0.0005833417,0.000011662723,0.0000054048282,0.000008944978,0.00022567905,0.0000023958726,0.0001254496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998325,0.00005169338,0.000014330618,0.000046307032,0.00004059616,0.0000144983],"domain_scores_gemma":[0.9994042,0.00020898969,0.00023980218,0.000036746245,0.0000586449,0.000051645176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005300481,0.00015636566,0.00025178454,0.0005944879,0.00013817711,0.00023714436,0.00014376688,0.0002452682,0.0009570185],"category_scores_gemma":[0.0015201537,0.00011352164,0.0001869258,0.00037519727,0.00013694947,0.00011519253,0.00019534549,0.0002782643,0.00012547981],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005790779,0.00005724057,0.96688277,0.000060077997,0.00008828739,0.00006739713,0.00009584766,0.00055347953,0.013287779,0.000022029726,0.00008131414,0.018224763],"study_design_scores_gemma":[0.0000146388775,0.0003628662,0.99190444,0.000021420625,0.00010836924,0.0004682634,0.00005626188,0.0020499576,0.004551866,0.00010616197,0.00034974946,0.0000060062366],"about_ca_topic_score_codex":0.0011818458,"about_ca_topic_score_gemma":0.0015883475,"teacher_disagreement_score":0.0011818458,"about_ca_system_score_codex":0.00017416877,"about_ca_system_score_gemma":0.00028062268,"threshold_uncertainty_score":0.0032015443},"labels":[],"label_agreement":null},{"id":"W2120010339","doi":"10.1158/1078-0432.ccr-12-3654","title":"Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Cancer Institute","keywords":"Pharmacokinetics; Medicine; Nausea; Dosing; Toxicity; Internal medicine; Bilirubin; Response Evaluation Criteria in Solid Tumors; Pharmacology; Gastroenterology; Pharmacodynamics; Phases of clinical research","score_opus":0.08924151496282696,"score_gpt":0.4542747164838444,"score_spread":0.3650332015210174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120010339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931545,0.0026363132,0.0007596906,0.00025830252,0.000049363247,0.0012748645,0.00060483743,0.00010350065,0.0011587649],"genre_scores_gemma":[0.9893981,0.0025193763,0.0027652155,0.0004953051,0.00010839747,0.0015039141,0.0019255296,0.000025894009,0.0012583068],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997645,0.00010750381,0.000016980268,0.00003022828,0.000032900698,0.000047909507],"domain_scores_gemma":[0.99962366,0.000050705192,0.00008146824,0.00003540026,0.000029897466,0.00017880631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007999033,0.0009808798,0.0012979351,0.00020438449,0.00029023748,0.0005186786,0.00043769498,0.00043400243,0.0020131443],"category_scores_gemma":[0.00047225758,0.00031752695,0.00048331067,0.00027775887,0.0004320341,0.00043954953,0.00023252936,0.0018212247,0.000756377],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33786353,0.08451777,0.035947036,0.0014350532,0.0011319135,0.0008473382,0.0005700772,0.0043891734,0.24515165,0.00035156525,0.007829339,0.27996555],"study_design_scores_gemma":[0.16203187,0.7546105,0.041136224,0.000054700522,0.00054548547,0.0020037715,0.00013894904,0.0021732114,0.028936138,0.00015314903,0.008185743,0.000030287309],"about_ca_topic_score_codex":0.00057897536,"about_ca_topic_score_gemma":0.0011427157,"teacher_disagreement_score":0.0020131443,"about_ca_system_score_codex":0.00048291738,"about_ca_system_score_gemma":0.0010762521,"threshold_uncertainty_score":0.006734669},"labels":[],"label_agreement":null},{"id":"W2120067300","doi":"10.1158/1078-0432.ccr-07-1510","title":"Cyclophosphamide Facilitates Antitumor Efficacy against Subcutaneous Tumors following Intravenous Delivery of Reovirus","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"National Cancer Institute","keywords":"Oncolytic virus; Cyclophosphamide; Viral replication; Virus; Medicine; Toxicity; Virology; Chemotherapy; Immunology; Internal medicine","score_opus":0.10438848279109997,"score_gpt":0.4301367782182994,"score_spread":0.3257482954271994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120067300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957207,0.0013168352,0.001618902,0.000037943595,0.000025998961,0.000045289275,0.00011896116,0.00009451733,0.0010209853],"genre_scores_gemma":[0.9967818,0.00062357646,0.0014120386,0.00002148168,0.000014340841,0.000031885378,0.0001392684,0.00001929874,0.00095629593],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988306,0.000021422868,0.000006981848,0.00003055613,0.000021176857,0.00003665477],"domain_scores_gemma":[0.9998801,0.00003153032,0.000045309578,0.000017287044,0.000008272154,0.000017625649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013198043,0.00043602337,0.00029939134,0.00018247949,0.00007229218,0.000297689,0.0001965678,0.00019526038,0.0009815047],"category_scores_gemma":[0.00011699529,0.00009936076,0.0001673421,0.000098774304,0.00020745421,0.0002076232,0.00010307764,0.0006027535,0.00020626195],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002693292,0.00010378419,0.00013919442,0.000039375995,0.0000044725716,0.000021524125,0.000008689444,0.00012590409,0.99686533,0.00004604381,0.000030523057,0.0023458526],"study_design_scores_gemma":[0.000041277006,0.001680169,0.0014450153,0.0000073463507,0.000015920092,0.000107925625,0.0000070858737,0.00047240919,0.9956392,0.000012317261,0.0005691274,0.0000021705212],"about_ca_topic_score_codex":0.0004737064,"about_ca_topic_score_gemma":0.0009195804,"teacher_disagreement_score":0.0009815047,"about_ca_system_score_codex":0.00021319631,"about_ca_system_score_gemma":0.00024004707,"threshold_uncertainty_score":0.0032835007},"labels":[],"label_agreement":null},{"id":"W2120160125","doi":"10.1158/1078-0432.ccr-06-2039","title":"A Phase I Study of Immunization Using Particle-Mediated Epidermal Delivery of Genes for gp100 and GM-CSF into Uninvolved Skin of Melanoma Patients","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"NIH Clinical Center; National Center for Research Resources; National Cancer Institute","keywords":"Medicine; Melanoma; Immunology; Cancer research","score_opus":0.17062146564313396,"score_gpt":0.49079584088996897,"score_spread":0.320174375246835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120160125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956727,0.00034551727,0.0007394219,0.000087592605,0.000057191275,0.0023857057,0.00019774005,0.000029902525,0.00048414152],"genre_scores_gemma":[0.99067557,0.0005179528,0.0024249963,0.00038288083,0.000120133336,0.0037751885,0.0006917038,0.000018933893,0.0013926034],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99934894,0.00027030215,0.000026608246,0.0001499781,0.0000645705,0.00013958728],"domain_scores_gemma":[0.9994229,0.00010506193,0.000109411754,0.00011906654,0.000052469557,0.00019123722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013695067,0.001419176,0.0013801424,0.00034862055,0.0003951463,0.0005604503,0.00072951725,0.0012565671,0.0022737936],"category_scores_gemma":[0.00067272905,0.000386779,0.0007456697,0.0002284069,0.0008878468,0.0006301638,0.0003009777,0.0020047028,0.0005377705],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2197876,0.28491762,0.00928426,0.00091862073,0.0005622275,0.00056951324,0.00059004495,0.0031984558,0.39118293,0.0004481133,0.0016626182,0.086878],"study_design_scores_gemma":[0.045682583,0.92531705,0.004398918,0.000013123646,0.000112295704,0.00023434317,0.00004654454,0.0005653194,0.022406133,0.000059278587,0.0011558522,0.000008585932],"about_ca_topic_score_codex":0.0002871893,"about_ca_topic_score_gemma":0.00029286143,"teacher_disagreement_score":0.0022737936,"about_ca_system_score_codex":0.0005494179,"about_ca_system_score_gemma":0.00075258897,"threshold_uncertainty_score":0.0076066256},"labels":[],"label_agreement":null},{"id":"W2120217529","doi":"10.1158/1078-0432.ccr-09-0312","title":"Subsets of Very Low Risk Wilms Tumor Show Distinctive Gene Expression, Histologic, and Clinical Features","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Wilms' tumor; Loss of heterozygosity; Histology; Immunohistochemistry; Stage (stratigraphy); Pathology; Nephrectomy; Tissue microarray; Gene expression; Biology; Oncology; Medicine; Gene; Allele; Internal medicine; Kidney; Genetics","score_opus":0.05383079192339157,"score_gpt":0.4405551571181337,"score_spread":0.3867243651947421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120217529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994407,0.000108202235,0.00026219065,0.00000801177,8.105766e-7,0.000006302133,0.0000719927,0.000007884115,0.000093894305],"genre_scores_gemma":[0.99859744,0.00004254002,0.00054102327,0.0000128965285,0.00000650294,0.00002296399,0.0006315143,0.0000073519354,0.0001377377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978346,0.000026557489,0.000028242814,0.000066691384,0.000054059707,0.00004096002],"domain_scores_gemma":[0.9995529,0.0000795235,0.00020765523,0.000047104528,0.000034539662,0.00007814925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019458386,0.00021330285,0.00027650935,0.0005207545,0.00022540517,0.00033169167,0.00016780243,0.00020021058,0.00075601885],"category_scores_gemma":[0.000543357,0.000101063604,0.00016997627,0.00024647618,0.00031823764,0.0001423698,0.0003345939,0.00018714444,0.00019964174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012734261,0.00008784922,0.71186054,0.00008636444,0.00005935158,0.0011803365,0.0003235951,0.00021280437,0.274886,0.0001360184,0.00018808398,0.0097057205],"study_design_scores_gemma":[0.000033649892,0.0005311695,0.96652037,0.000008728688,0.00005206959,0.007472049,0.0002737548,0.0004099084,0.023836968,0.0001569965,0.00069363974,0.000010814333],"about_ca_topic_score_codex":0.00029813946,"about_ca_topic_score_gemma":0.00044209816,"teacher_disagreement_score":0.00075601885,"about_ca_system_score_codex":0.00019795078,"about_ca_system_score_gemma":0.00012005746,"threshold_uncertainty_score":0.0025291443},"labels":[],"label_agreement":null},{"id":"W2120223472","doi":"10.1158/1078-0432.ccr-08-2131","title":"Administration of Glucocorticoids to Ovarian Cancer Patients Is Associated with Expression of the Anti-apoptotic Genes <i>SGK1</i> and <i>MKP1/DUSP1</i> in Ovarian Tissues","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Dexamethasone; Glucocorticoid; Ovarian cancer; Biology; Glucocorticoid receptor; Apoptosis; Endocrinology; In situ hybridization; Internal medicine; Chemotherapy; Cancer; Pathology; Gene expression; Cancer research; Medicine; Gene","score_opus":0.051961531699529905,"score_gpt":0.4158934390545863,"score_spread":0.3639319073550564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120223472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988092,0.0007245993,0.00013005102,0.00003953888,0.000012686181,0.000037499012,0.000039712228,0.000006983135,0.0001996381],"genre_scores_gemma":[0.9991848,0.00025667142,0.00025172206,0.000040470622,0.000025519828,0.0000426046,0.00008610438,0.0000012604727,0.00011092479],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997874,0.000075459764,0.000018226274,0.000034683908,0.000046881567,0.000037394104],"domain_scores_gemma":[0.99952865,0.000110757224,0.00017929781,0.000030536154,0.00001618262,0.0001345826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020748963,0.00019816757,0.00053034065,0.00009818213,0.00014873745,0.00024375287,0.000093719886,0.00017360786,0.0011279495],"category_scores_gemma":[0.00055837585,0.00009193487,0.0001579222,0.000130744,0.00039442087,0.000116100535,0.00012133935,0.0005122032,0.00013696855],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1766157,0.0061601195,0.10103642,0.0004999395,0.00031045146,0.0006277539,0.00022348975,0.0009027621,0.59138596,0.00020497,0.0009299729,0.12110242],"study_design_scores_gemma":[0.017526364,0.3810957,0.41440085,0.00006908389,0.0004919681,0.004539659,0.00040251896,0.0021364526,0.17081006,0.0002606152,0.008221059,0.000045581957],"about_ca_topic_score_codex":0.00013306667,"about_ca_topic_score_gemma":0.00034514774,"teacher_disagreement_score":0.0011279495,"about_ca_system_score_codex":0.00021253608,"about_ca_system_score_gemma":0.00032876505,"threshold_uncertainty_score":0.0037733912},"labels":[],"label_agreement":null},{"id":"W2120225336","doi":"10.1158/1078-0432.ccr-05-9010","title":"Localized Non–Small Cell Lung Cancer: Adjuvant Radiotherapy in the Era of Effective Systemic Therapy","year":2005,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Context (archaeology); Systemic therapy; Lung cancer; Randomized controlled trial; Cancer; Clinical trial; Oncology; Stage (stratigraphy); Intensive care medicine; Medical physics; Surgery; Internal medicine; Breast cancer","score_opus":0.16999701728562894,"score_gpt":0.5588199164230927,"score_spread":0.38882289913746376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120225336","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005277889,0.99955136,0.00002197985,0.00018512925,0.0000477594,0.0000016087513,0.0000018425542,0.0000010725407,0.00013635767],"genre_scores_gemma":[0.0005643813,0.9990428,0.000058134094,0.00016997367,0.00006872411,0.000003066601,0.0000039302927,3.291462e-7,0.00008854193],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996407,0.00014179127,0.0000560431,0.00004069837,0.00010106564,0.000019713112],"domain_scores_gemma":[0.99925774,0.000455767,0.00014415047,0.00001772823,0.00009655137,0.000027997503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014621107,0.0006520573,0.0027768181,0.001708583,0.00020428942,0.00081598735,0.00068995997,0.0011189721,0.0023928531],"category_scores_gemma":[0.0015667202,0.00024973726,0.00095188065,0.0029335916,0.00062604353,0.0014183592,0.00042753344,0.0014363518,0.00067933515],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022536697,0.00004991359,0.00024170875,0.047720883,0.00028902362,0.00012742478,0.000042387215,0.00031874978,0.00059550325,0.0018565366,0.015619814,0.93291265],"study_design_scores_gemma":[0.0005189532,0.00055438135,0.0073100147,0.06396335,0.0024131967,0.0033779962,0.00021754247,0.0003389856,0.0007334263,0.0066159246,0.9139098,0.00004637466],"about_ca_topic_score_codex":0.0014973006,"about_ca_topic_score_gemma":0.00439114,"teacher_disagreement_score":0.0027768181,"about_ca_system_score_codex":0.0009194139,"about_ca_system_score_gemma":0.0015042925,"threshold_uncertainty_score":0.008004904},"labels":[],"label_agreement":null},{"id":"W2120286226","doi":"10.1158/1078-0432.ccr-11-2901","title":"Correlation of ERG Expression and DNA Methylation Biomarkers with Adverse Clinicopathologic Features of Prostate Cancer","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Erg; Methylation; DNA methylation; TMPRSS2; Prostate cancer; Immunohistochemistry; Cancer; Biology; Cancer research; Internal medicine; Oncology; Gene expression; Medicine; Gene; Immunology; Genetics","score_opus":0.15345956948294687,"score_gpt":0.5082174998636494,"score_spread":0.3547579303807025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120286226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99912375,0.00044110397,0.00019340977,0.000019354342,0.0000014802762,0.0000032393682,0.00008170107,0.000005841722,0.00013014732],"genre_scores_gemma":[0.9997255,0.000057798774,0.00007756269,0.0000039733363,0.0000025194981,0.0000020114067,0.00006603005,7.667053e-7,0.00006376313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998522,0.000041237756,0.000014131235,0.00003607794,0.000034176282,0.00002210441],"domain_scores_gemma":[0.9993405,0.00016906162,0.00027804574,0.00003602569,0.0000494975,0.00012689037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000343292,0.00021347661,0.00017102176,0.00041339174,0.00011078545,0.00021762843,0.00013739656,0.00016619862,0.001091698],"category_scores_gemma":[0.00086180924,0.00009438508,0.00014508812,0.0003388397,0.0002679042,0.00013828243,0.00015965261,0.00025867368,0.000122111],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027251896,0.0000161681,0.99361974,0.000011977654,0.0000434185,0.00007842043,0.000015058775,0.00008838345,0.004168398,0.000010439547,0.000019878758,0.0016555573],"study_design_scores_gemma":[0.0000043964965,0.00010617001,0.997789,0.0000018284954,0.00002860698,0.0006209689,0.000021280608,0.00024630572,0.0010396658,0.000025713809,0.00011412201,0.0000019840086],"about_ca_topic_score_codex":0.0005364635,"about_ca_topic_score_gemma":0.00090359704,"teacher_disagreement_score":0.001091698,"about_ca_system_score_codex":0.00018007332,"about_ca_system_score_gemma":0.00020662314,"threshold_uncertainty_score":0.0036520362},"labels":[],"label_agreement":null},{"id":"W2120365528","doi":"10.1158/1078-0432.ccr-05-0926","title":"Response of Some Head and Neck Cancers to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors May Be Linked to Mutation of<i>ERBB2</i>rather than<i>EGFR</i>","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Epidermal growth factor receptor; Cancer research; Tyrosine kinase; Mutation; Head and neck; Epidermal growth factor; Biology; Receptor tyrosine kinase; Medicine; Cancer; Receptor; Internal medicine; Genetics; Gene","score_opus":0.16865743541689038,"score_gpt":0.4874833173590821,"score_spread":0.31882588194219175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120365528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990978,0.00020582763,0.00007539952,0.000017663497,0.0000015913652,0.0000109481825,0.000053075033,0.0000056194017,0.0005319777],"genre_scores_gemma":[0.99945813,0.00009282697,0.00009671718,0.000029758035,0.000003951078,0.0000101402675,0.00013748487,0.0000021013595,0.00016882792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997558,0.000080258185,0.000029630579,0.0000453033,0.000054206885,0.000034751745],"domain_scores_gemma":[0.9994394,0.00025875194,0.00014729144,0.00005372784,0.000050976694,0.00004981995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004921542,0.00015347911,0.00015233035,0.00031355576,0.00022789463,0.00018263458,0.00014916284,0.0002066517,0.0019683964],"category_scores_gemma":[0.0010718692,0.000072055765,0.00015105504,0.000235661,0.0003235972,0.00009719712,0.00012544035,0.00016393,0.0002450417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091015996,0.00017964748,0.90600073,0.00015119887,0.00011051939,0.0016090932,0.00029363713,0.00019411618,0.069585204,0.00007258885,0.00029949,0.02059353],"study_design_scores_gemma":[0.000028973867,0.00097513344,0.97748417,0.000008299268,0.00007524737,0.0050468235,0.00014894818,0.00015605766,0.015082012,0.000048554914,0.00094138825,0.0000043773916],"about_ca_topic_score_codex":0.0011978089,"about_ca_topic_score_gemma":0.0021426587,"teacher_disagreement_score":0.0019683964,"about_ca_system_score_codex":0.0002859241,"about_ca_system_score_gemma":0.00020615202,"threshold_uncertainty_score":0.0065848827},"labels":[],"label_agreement":null},{"id":"W2120620347","doi":"10.1158/1078-0432.ccr-06-1772","title":"Standard Treatments Induce Antigen-Specific Immune Responses in Prostate Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Prostate cancer; Antigen; Immune system; Prostate-specific antigen; Medicine; Immunology; Immunotherapy; Autoantibody; Cancer; Hormonal therapy; Carcinoembryonic antigen; Cancer research; Radiation therapy; Internal medicine; Antibody","score_opus":0.2743677418458901,"score_gpt":0.5638471543117376,"score_spread":0.2894794124658475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120620347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99751955,0.0013587159,0.00054337026,0.000023474413,0.000010452163,0.000028092727,0.00004305217,0.00002562516,0.00044757847],"genre_scores_gemma":[0.99881184,0.0003364187,0.00032916604,0.000041522544,0.000022053884,0.000022240234,0.00017603168,0.000003662875,0.00025707795],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979633,0.00004576789,0.0000125496135,0.0000414177,0.000065836095,0.000038214475],"domain_scores_gemma":[0.99976534,0.0000683929,0.00007636039,0.000030372616,0.000019353403,0.000040196486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022408988,0.0002487582,0.00021221492,0.00023791504,0.00017021663,0.00015942381,0.00012536609,0.00017042922,0.0016418353],"category_scores_gemma":[0.0003092212,0.00011098583,0.0002007146,0.00018507057,0.00019793569,0.00012097024,0.00018232419,0.0003351884,0.0002839245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017813158,0.0011897963,0.07311183,0.00031277034,0.000098208475,0.000499859,0.0001281078,0.00033277503,0.88368136,0.00009662543,0.000489009,0.038278308],"study_design_scores_gemma":[0.00022611512,0.020116352,0.67539746,0.000036941194,0.000155483,0.005640358,0.00017104304,0.0016354002,0.29122144,0.00015119881,0.0052317237,0.000016540214],"about_ca_topic_score_codex":0.00018202454,"about_ca_topic_score_gemma":0.0003290504,"teacher_disagreement_score":0.0016418353,"about_ca_system_score_codex":0.0002361689,"about_ca_system_score_gemma":0.00016837045,"threshold_uncertainty_score":0.0054925084},"labels":[],"label_agreement":null},{"id":"W2120638451","doi":"10.1158/1078-0432.ccr-09-0192","title":"Vascular Endothelial Growth Factor Polymorphisms and Esophageal Cancer Prognosis","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; McMaster University","funders":"National Cancer Institute","keywords":"Single-nucleotide polymorphism; Haplotype; Vascular endothelial growth factor; Internal medicine; Genotype; Hazard ratio; SNP; Angiogenesis; Biology; Gastroenterology; Confidence interval; Endocrinology; Medicine; VEGF receptors; Genetics; Gene","score_opus":0.10918280160559377,"score_gpt":0.4507385567829537,"score_spread":0.3415557551773599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120638451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982406,0.0011559896,0.00012170112,0.00007300407,0.000009734878,0.0000032260336,0.00018977882,0.0000051809343,0.00020085476],"genre_scores_gemma":[0.9994351,0.00019768233,0.00010004,0.000017315182,0.000009181574,0.0000025635136,0.00013424673,0.0000011747393,0.00010265057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982846,0.000058475736,0.000017146856,0.000041591844,0.000029802524,0.000024435853],"domain_scores_gemma":[0.9993124,0.00024407,0.00025825115,0.000043560813,0.000052968855,0.00008871164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048237818,0.00024510807,0.00022766463,0.00017678525,0.00015885964,0.00025827935,0.00012277452,0.0003103086,0.0013714476],"category_scores_gemma":[0.0013006373,0.00008677699,0.00020463039,0.00041885677,0.00019025161,0.00010860375,0.00011611449,0.0003850286,0.0002670952],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00144069,0.00004904445,0.9902805,0.000033645516,0.00014298792,0.00010700909,0.000022684684,0.00022377647,0.002029188,0.000016678277,0.00015313135,0.0055007236],"study_design_scores_gemma":[0.00005668315,0.00029244862,0.9968491,0.000016465718,0.00016673713,0.0006493478,0.000022653237,0.0006105421,0.0008884953,0.00007596366,0.00036545133,0.0000060406005],"about_ca_topic_score_codex":0.00111179,"about_ca_topic_score_gemma":0.0010953071,"teacher_disagreement_score":0.0013714476,"about_ca_system_score_codex":0.00015962688,"about_ca_system_score_gemma":0.0001859745,"threshold_uncertainty_score":0.0045879483},"labels":[],"label_agreement":null},{"id":"W2120680169","doi":"10.1158/1078-0432.ccr-05-2081","title":"Novel Blood Biomarkers of Human Urinary Bladder Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Bladder cancer; Cancer; Medicine; Biology; Cancer research; Pathology; Oncology; Internal medicine","score_opus":0.22950828589444366,"score_gpt":0.5299358628931056,"score_spread":0.3004275769986619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120680169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95900834,0.027399985,0.0078340825,0.0005712397,0.00014357752,0.00007413793,0.0019119586,0.0002513736,0.0028053403],"genre_scores_gemma":[0.9901399,0.0019529463,0.005392283,0.0002583891,0.00010900681,0.00006456943,0.0010860779,0.000010670179,0.0009860843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997186,0.000073247895,0.000023102984,0.000075904216,0.00008306378,0.00002599672],"domain_scores_gemma":[0.9995365,0.000118542885,0.00013957659,0.00001875807,0.00013238774,0.000054243395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039811136,0.0003047231,0.00036780548,0.001058457,0.0001984196,0.00052620564,0.00027128158,0.0004917432,0.0010517676],"category_scores_gemma":[0.0011267832,0.000107026375,0.00014092958,0.0007967823,0.0001815375,0.00018562001,0.0002567713,0.00035992084,0.00028752573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011432865,0.00023084682,0.8102004,0.00064165535,0.00022537565,0.0004285403,0.00015148953,0.0006955256,0.10029454,0.00026449034,0.0021562104,0.08356767],"study_design_scores_gemma":[0.00007119161,0.0007375668,0.90319824,0.00017881549,0.00045168062,0.0027091086,0.00016617647,0.0053825905,0.07534914,0.00060175057,0.011109611,0.000044275006],"about_ca_topic_score_codex":0.0008596772,"about_ca_topic_score_gemma":0.0010177012,"teacher_disagreement_score":0.001058457,"about_ca_system_score_codex":0.00032098638,"about_ca_system_score_gemma":0.00026442687,"threshold_uncertainty_score":0.0035184622},"labels":[],"label_agreement":null},{"id":"W2120706978","doi":"10.1158/1078-0432.ccr-08-2999","title":"A Phase I, Pharmacokinetic and Pharmacodynamic Study on Vorinostat in Combination with 5-Fluorouracil, Leucovorin, and Oxaliplatin in Patients with Refractory Colorectal Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Kimberly-Clark","keywords":"Vorinostat; Pharmacokinetics; Medicine; Oxaliplatin; FOLFOX; Pharmacology; Cmax; Fluorouracil; Leukopenia; Internal medicine; Gastroenterology; Colorectal cancer; Oncology; Chemotherapy; Cancer; Chemistry; Histone deacetylase","score_opus":0.05236298826956668,"score_gpt":0.4732157032925411,"score_spread":0.4208527150229744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120706978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99656624,0.0014341897,0.0003841172,0.00024014458,0.00006125242,0.0006037349,0.00019899763,0.000040393712,0.00047089823],"genre_scores_gemma":[0.99517375,0.000991734,0.0011097152,0.0004132112,0.00015421165,0.000672444,0.0006988648,0.000016557698,0.0007695395],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99937063,0.00033140383,0.000031765725,0.00009007729,0.00008043327,0.000095650954],"domain_scores_gemma":[0.99912447,0.00019644048,0.00022026175,0.00006244697,0.000046998157,0.00034938473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013011241,0.0013095022,0.0020692556,0.0004505105,0.0005225891,0.0007776113,0.00070864183,0.0008923273,0.0016755508],"category_scores_gemma":[0.0011224989,0.00067759445,0.0010289012,0.00048633537,0.001183769,0.00079024886,0.00022847137,0.0025083108,0.00043881795],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.561492,0.10161388,0.01564147,0.0012774671,0.0018804036,0.00087057386,0.000619505,0.004777244,0.18041348,0.0003172759,0.0031096423,0.12798698],"study_design_scores_gemma":[0.24493901,0.72577304,0.016416576,0.000028553437,0.00045927163,0.0005142205,0.00006467432,0.0015530952,0.007958914,0.00008896478,0.002166046,0.00003769273],"about_ca_topic_score_codex":0.0006629188,"about_ca_topic_score_gemma":0.001773779,"teacher_disagreement_score":0.0020692556,"about_ca_system_score_codex":0.0008684112,"about_ca_system_score_gemma":0.0016007532,"threshold_uncertainty_score":0.006881058},"labels":[],"label_agreement":null},{"id":"W2120775216","doi":"10.1158/1078-0432.ccr-05-0577","title":"Immunomodulatory Drug CC-5013 or CC-4047 and Rituximab Enhance Antitumor Activity in a Severe Combined Immunodeficient Mouse Lymphoma Model","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Medicine; Rituximab; Lymphoma; Pharmacology; In vivo; Immunology; Thalidomide; Cytokine; Biology","score_opus":0.1365087731726329,"score_gpt":0.48959190980645084,"score_spread":0.35308313663381796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120775216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99592483,0.0011346899,0.0010156251,0.00008572202,0.00002281733,0.00004380399,0.00020466896,0.0000922979,0.0014755868],"genre_scores_gemma":[0.99505556,0.0008363131,0.0012355977,0.000045469056,0.000016498674,0.00006512427,0.00033786273,0.000010164509,0.0023973747],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972314,0.000051217303,0.000025605954,0.0000417324,0.00008433345,0.0000738971],"domain_scores_gemma":[0.99985814,0.000018935132,0.0000453203,0.00001251636,0.000011268727,0.0000537767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024065067,0.0005346658,0.0004657411,0.000564403,0.00010343122,0.0002953435,0.0003456751,0.00038799862,0.0011004086],"category_scores_gemma":[0.00008533999,0.00021263499,0.00029174142,0.00021161282,0.00023089562,0.00029867204,0.00014240618,0.00082890614,0.00026909506],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054601795,0.00032447372,0.00019436856,0.000033318986,0.000010888878,0.00005685696,0.000017643693,0.00016379342,0.9965329,0.00009273694,0.00007932468,0.0019477162],"study_design_scores_gemma":[0.00015159948,0.00628756,0.003442681,0.000011125819,0.000059892613,0.0003354304,0.000028512097,0.0025599927,0.98512506,0.00004244168,0.0019484323,0.0000071729223],"about_ca_topic_score_codex":0.0008026834,"about_ca_topic_score_gemma":0.0012696051,"teacher_disagreement_score":0.0011004086,"about_ca_system_score_codex":0.00030626266,"about_ca_system_score_gemma":0.00021481216,"threshold_uncertainty_score":0.003681302},"labels":[],"label_agreement":null},{"id":"W2120998010","doi":"10.1158/1078-0432.ccr-09-1713","title":"Mechanisms of Ascorbate-Induced Cytotoxicity in Pancreatic Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Vitamin C and Antioxidants Research","field":"Nursing","cited_by":318,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Connaught Fund; University of Toronto; U.S. Department of Veterans Affairs","keywords":"Pancreatic cancer; Clonogenic assay; In vivo; Cancer research; Cancer; Viability assay; Apoptosis; Cell culture; Pharmacology; Medicine; Chemistry; Internal medicine; Biology; Biochemistry","score_opus":0.2205539197400399,"score_gpt":0.5355244103895571,"score_spread":0.3149704906495172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120998010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8914782,0.07650123,0.024543095,0.0012595922,0.00017052337,0.00045665508,0.00043744393,0.0004079686,0.004745279],"genre_scores_gemma":[0.98143905,0.014051989,0.002761749,0.0002402262,0.000050159222,0.00015840064,0.0002142384,0.000013111021,0.0010709342],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99964523,0.00012799147,0.000037343674,0.000064103086,0.000084384636,0.000041053685],"domain_scores_gemma":[0.99961025,0.00011027047,0.00015487093,0.000043095235,0.00005254464,0.00002890263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005794314,0.0006413449,0.0005579029,0.0005598163,0.00026065297,0.0007467804,0.00046184615,0.0007949633,0.0013333433],"category_scores_gemma":[0.00047265206,0.0001901613,0.00050246913,0.00033454894,0.0005558655,0.000560368,0.000464646,0.00059369457,0.00027016448],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00171878,0.000404863,0.004381159,0.0013178833,0.00011292312,0.0005572149,0.00012439181,0.0014437379,0.9568192,0.001926224,0.00038418104,0.030809479],"study_design_scores_gemma":[0.00012408842,0.0044740415,0.012220161,0.000087751025,0.00011624512,0.0024034726,0.00011744938,0.0017712844,0.9691078,0.0013830573,0.008178184,0.000016416678],"about_ca_topic_score_codex":0.00012821452,"about_ca_topic_score_gemma":0.00014277194,"teacher_disagreement_score":0.0013333433,"about_ca_system_score_codex":0.000695474,"about_ca_system_score_gemma":0.0002935281,"threshold_uncertainty_score":0.00504601},"labels":[],"label_agreement":null},{"id":"W2121042425","doi":"10.1158/1078-0432.ccr-12-3199","title":"Leukemia Cell-Rhabdovirus Vaccine: Personalized Immunotherapy for Acute Lymphoblastic Leukemia","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research; Terry Fox Foundation","keywords":"Immune system; Leukemia; Immunology; Immunotherapy; Biology; Virology; Adoptive cell transfer; Splenocyte; Vaccination; T cell","score_opus":0.06954736455926046,"score_gpt":0.4524370846223443,"score_spread":0.3828897200630838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121042425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98479545,0.008561841,0.0039441884,0.00030447438,0.00006619729,0.00011893101,0.00023455081,0.00011862641,0.0018557329],"genre_scores_gemma":[0.9911158,0.004079283,0.00288261,0.00008569778,0.000030609714,0.000046812696,0.00038008022,0.000007960804,0.0013711776],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999236,0.000012138964,0.000004267289,0.00001558329,0.000023138087,0.00002129106],"domain_scores_gemma":[0.9999682,0.000003678566,0.000012318145,0.0000036180659,0.0000037546658,0.0000085592455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012922048,0.00028340658,0.0002434498,0.00016522591,0.00006707011,0.00030905294,0.00017032264,0.00021080888,0.00097363786],"category_scores_gemma":[0.0000690464,0.000062284016,0.000118254524,0.00013311984,0.00012811711,0.00016201213,0.00020048239,0.00048552084,0.00024248079],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006715144,0.0004107047,0.0020178112,0.00020133151,0.0000371245,0.00007609727,0.00003080874,0.001472112,0.95594406,0.00063523557,0.00040508164,0.038098007],"study_design_scores_gemma":[0.0005334585,0.010553704,0.01524661,0.00008014513,0.00028352684,0.0015838158,0.00007221043,0.0051152343,0.9268971,0.0005845606,0.039031923,0.000017664477],"about_ca_topic_score_codex":0.00024132343,"about_ca_topic_score_gemma":0.0005493187,"teacher_disagreement_score":0.00097363786,"about_ca_system_score_codex":0.0003024545,"about_ca_system_score_gemma":0.00022490861,"threshold_uncertainty_score":0.0032571554},"labels":[],"label_agreement":null},{"id":"W2121229095","doi":"10.1158/1078-0432.ccr-04-0506","title":"Characterization of a Gemcitabine-Resistant Murine Leukemic Cell Line","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Ligue Contre le Cancer; Association pour la Recherche sur le Cancer","keywords":"Gemcitabine; Deoxycytidine kinase; Ribonucleotide reductase; In vivo; L1210 cells; Nucleoside analogue; Deoxycytidine; Biology; Nucleoside; Prodrug; Antimetabolite; Cell culture; Cancer research; Molecular biology; In vitro; Pharmacology; Cytotoxicity; Chemotherapy; Biochemistry; Gene; Protein subunit","score_opus":0.17151313713702143,"score_gpt":0.49568231001022267,"score_spread":0.32416917287320124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121229095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9681391,0.0024753883,0.016967978,0.00029943231,0.00006860119,0.00036582997,0.005433689,0.00024188028,0.0060080793],"genre_scores_gemma":[0.9423519,0.002482277,0.021508949,0.00028037725,0.00003404,0.00048240236,0.021244418,0.00011334457,0.011502292],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997627,0.00003418503,0.00004121154,0.000052877673,0.00007511851,0.000033893062],"domain_scores_gemma":[0.9998654,0.000026678928,0.000019080413,0.000030598923,0.000027389931,0.000030796593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014611705,0.00032790616,0.0003589193,0.0003536368,0.00023212067,0.00037252635,0.00022283834,0.00030428794,0.0016545762],"category_scores_gemma":[0.00013798673,0.0001622349,0.0002600116,0.0003885753,0.0001337012,0.00014449307,0.00021247509,0.0007086445,0.0016025236],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008406707,0.00006899563,0.00041718603,0.000019012417,0.0000042994725,0.000064854474,0.000021999396,0.000070280745,0.9980368,0.00008695687,0.00007968159,0.0010458257],"study_design_scores_gemma":[0.000057951143,0.001161502,0.013107368,0.000013213677,0.000048177615,0.00180387,0.000052663767,0.002169182,0.9664833,0.00006759724,0.015023328,0.000011879733],"about_ca_topic_score_codex":0.0007105915,"about_ca_topic_score_gemma":0.0007862396,"teacher_disagreement_score":0.0016545762,"about_ca_system_score_codex":0.00030444548,"about_ca_system_score_gemma":0.00020795943,"threshold_uncertainty_score":0.005535066},"labels":[],"label_agreement":null},{"id":"W2121302081","doi":"10.1158/1078-0432.ccr-07-1934","title":"Interactions between Bortezomib and Romidepsin and Belinostat in Chronic Lymphocytic Leukemia Cells","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Romidepsin; Bortezomib; Cancer research; Histone deacetylase; Vorinostat; Apoptosis; Chronic lymphocytic leukemia; Transfection; Proteasome inhibitor; Chemistry; Biology; Molecular biology; Cell culture; Leukemia; Histone; Immunology; Biochemistry; Multiple myeloma","score_opus":0.16226796167219082,"score_gpt":0.4939002752768028,"score_spread":0.331632313604612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121302081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880288,0.008387594,0.0008119946,0.00017748018,0.000049545877,0.00003185509,0.00033732894,0.00004621929,0.0021291715],"genre_scores_gemma":[0.99536586,0.0018567472,0.0006050051,0.00010627997,0.000019287065,0.000035368812,0.00059547083,0.000005220752,0.0014107585],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999635,0.000088999535,0.000023122453,0.000058084348,0.00012459583,0.00007017785],"domain_scores_gemma":[0.99991703,0.000016814081,0.000023850544,0.00000745316,0.00001481243,0.000020039573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014656161,0.00029341393,0.00048719466,0.00016438065,0.00026222406,0.00046264942,0.00016502845,0.0002628927,0.0015293509],"category_scores_gemma":[0.0001279307,0.00015967256,0.00033861544,0.00020960851,0.00015773498,0.00022895986,0.00021074538,0.00031467396,0.00067220035],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057511893,0.00008751008,0.0017398878,0.00013579015,0.000049070823,0.000140857,0.00004026667,0.00016039453,0.9930559,0.000057809084,0.00020071892,0.0037566903],"study_design_scores_gemma":[0.00017385269,0.001975432,0.048044324,0.000024207331,0.0001087179,0.0014393474,0.00020921876,0.0017511903,0.93251663,0.00008120392,0.013659084,0.000016800197],"about_ca_topic_score_codex":0.0011901582,"about_ca_topic_score_gemma":0.0020302797,"teacher_disagreement_score":0.0015293509,"about_ca_system_score_codex":0.0006257166,"about_ca_system_score_gemma":0.00029070023,"threshold_uncertainty_score":0.0051162243},"labels":[],"label_agreement":null},{"id":"W2121394959","doi":"10.1158/1078-0432.ccr-05-0398","title":"Hsp90 Inhibitor 17-Allylamino-17-Demethoxygeldanamycin Prevents Synovial Sarcoma Proliferation via Apoptosis in <i>In vitro</i> Models","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Hokkaido University","keywords":"Synovial sarcoma; Cancer research; Tyrosine kinase; Platelet-derived growth factor receptor; Receptor tyrosine kinase; Imatinib mesylate; Tyrosine-kinase inhibitor; Growth factor receptor; Sarcoma; Imatinib; Biology; Medicine; Growth factor; Internal medicine; Receptor; Pathology; Cancer","score_opus":0.17569501786950167,"score_gpt":0.47618722829911164,"score_spread":0.30049221042960994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121394959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801657,0.003988409,0.0070679383,0.00030891394,0.00017458048,0.00013022311,0.0017842243,0.0003965149,0.0059834523],"genre_scores_gemma":[0.98588794,0.0027307377,0.0051366347,0.00010261058,0.00002447774,0.000121317506,0.0020704262,0.000030358662,0.0038954443],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977964,0.000053629803,0.000028939385,0.000034307952,0.00005738513,0.000046118515],"domain_scores_gemma":[0.99990296,0.00001617476,0.000028048757,0.00001851662,0.000013144218,0.000021217851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002029529,0.00040963403,0.00038414958,0.00025835892,0.00012529641,0.00021896826,0.00025187532,0.00021495207,0.0013392359],"category_scores_gemma":[0.00007012061,0.0001485066,0.00043080567,0.00019340854,0.00016640205,0.0001705087,0.00011591646,0.0007708755,0.0005136467],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032402776,0.00014788767,0.00015335603,0.00007266188,0.000015525367,0.00006483801,0.000023354172,0.00029104945,0.9964729,0.0001076654,0.00035380502,0.00197284],"study_design_scores_gemma":[0.000027746362,0.00092683855,0.0009932996,0.000004531517,0.000015295023,0.00014136556,0.000016078973,0.0009026509,0.9948474,0.000024417359,0.0020966965,0.000003632443],"about_ca_topic_score_codex":0.0012471689,"about_ca_topic_score_gemma":0.0016512485,"teacher_disagreement_score":0.0013392359,"about_ca_system_score_codex":0.00028921076,"about_ca_system_score_gemma":0.00026603133,"threshold_uncertainty_score":0.004480183},"labels":[],"label_agreement":null},{"id":"W2121855882","doi":"10.1158/1078-0432.ccr-11-1104","title":"Achieving the Goals of Effective, Safe, and Individualized Cancer Care","year":2011,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Research Society; American Association for Cancer Research","keywords":"Intensive care medicine; Medicine; Cancer; Internal medicine","score_opus":0.26429913025576557,"score_gpt":0.4561631805785194,"score_spread":0.19186405032275383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121855882","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010525812,0.0329147,0.015630206,0.9104978,0.014791779,0.00018947502,0.00023175588,0.0002389086,0.024452819],"genre_scores_gemma":[0.06790437,0.094214715,0.081372656,0.68513167,0.044581596,0.0016121842,0.0013992854,0.0007783867,0.023005277],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.95377547,0.018017646,0.00270698,0.003195893,0.018036177,0.0042678155],"domain_scores_gemma":[0.9290271,0.02360656,0.0058945836,0.00492856,0.014104067,0.022439219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.056199457,0.0015125717,0.002046689,0.0020245777,0.0077117216,0.01866481,0.004018369,0.019127583,0.011082743],"category_scores_gemma":[0.058414068,0.0009737168,0.0013348974,0.0021929063,0.012986812,0.01375176,0.0161521,0.030054506,0.006135155],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044121713,0.00011478469,0.0012258556,0.00082414603,0.00006564299,0.00006450909,0.0012874594,0.00052402297,0.0005496681,0.10249642,0.7958795,0.096923865],"study_design_scores_gemma":[0.000040590345,0.00009258425,0.0016512468,0.001453734,0.000029457759,0.00016617725,0.0018323081,0.0003452368,0.0007439612,0.055173747,0.9384005,0.000070415976],"about_ca_topic_score_codex":0.0067556994,"about_ca_topic_score_gemma":0.013336827,"teacher_disagreement_score":0.056199457,"about_ca_system_score_codex":0.013977657,"about_ca_system_score_gemma":0.0681286,"threshold_uncertainty_score":0.2972147},"labels":[],"label_agreement":null},{"id":"W2121968091","doi":"10.1158/1078-0432.ccr-14-3253","title":"The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Follicular lymphoma; Lymphoma; Cancer; Medicine; CD163; International agency; Oncology; Pathology; Internal medicine; Immunology; Biology; Macrophage","score_opus":0.14753129388764258,"score_gpt":0.5131827052500217,"score_spread":0.36565141136237916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121968091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997801,0.000948271,0.00008572034,0.00016002334,0.000010524187,0.000018192926,0.0006288344,0.0000026081507,0.0003449977],"genre_scores_gemma":[0.9987073,0.00021797672,0.00005761697,0.000073095056,0.00002631894,0.000016379809,0.00077853195,0.00000285066,0.00011998597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988741,0.00044120871,0.000086596665,0.00025706852,0.00022121122,0.0001197537],"domain_scores_gemma":[0.99617696,0.00072253635,0.0011409046,0.00046036352,0.00089826307,0.0006010299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020233893,0.00025278542,0.00043222855,0.00064987346,0.0005792839,0.0007717181,0.0004295144,0.00044389305,0.0012780719],"category_scores_gemma":[0.005431727,0.00020748269,0.00032573257,0.00090125046,0.00035766605,0.00026584827,0.00052706606,0.00047424654,0.00021160352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088069524,0.000034763543,0.99515355,0.000023633178,0.00015000737,0.000046855985,0.000099109115,0.000030819123,0.00039444977,0.000017245444,0.00047896226,0.0026900936],"study_design_scores_gemma":[0.0001329623,0.00012669482,0.9973997,0.000019861163,0.0001869418,0.00029424636,0.00017037647,0.00023620685,0.000113561786,0.00003469111,0.00127916,0.000005610599],"about_ca_topic_score_codex":0.020349784,"about_ca_topic_score_gemma":0.021833297,"teacher_disagreement_score":0.020349784,"about_ca_system_score_codex":0.0008146775,"about_ca_system_score_gemma":0.00086780114,"threshold_uncertainty_score":0.040462673},"labels":[],"label_agreement":null},{"id":"W2122036933","doi":"10.1158/1078-0432.ccr-07-0408","title":"Prognostic Significance of Nuclear ING3 Expression in Human Cutaneous Melanoma","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genomics and Chromatin Dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; SKiN Health","funders":"National Cancer Institute; Canadian Institutes of Health Research; University of British Columbia; Canadian Dermatology Foundation","keywords":"Melanoma; Medicine; Immunohistochemistry; Pathology; Tissue microarray; Cancer research; Apoptosis; Pathogenesis; Biology; Genetics","score_opus":0.07216867771073518,"score_gpt":0.44174279788655435,"score_spread":0.36957412017581914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122036933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99881077,0.00053108187,0.00019078629,0.000014963902,0.000002731754,0.0000033141248,0.00010429878,0.000011297349,0.00033076678],"genre_scores_gemma":[0.99963105,0.000077922334,0.0001137695,0.0000038297662,0.0000026759644,0.000003192108,0.00010041847,0.0000015525876,0.000065708366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999925,0.000015644095,0.000007981829,0.00001823379,0.00001687262,0.000016236721],"domain_scores_gemma":[0.99950397,0.00010566856,0.00021581768,0.00003644105,0.00005696098,0.000081157625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017585974,0.00016772134,0.00015812049,0.0003054782,0.00016591202,0.00024302144,0.0001412025,0.00025445415,0.0011242672],"category_scores_gemma":[0.000712148,0.00008412686,0.00012647928,0.0002922241,0.000260571,0.00013013527,0.00015756181,0.00018985367,0.00018808326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006222675,0.000013142025,0.9793808,0.00003166976,0.00002481529,0.00041737396,0.00003062608,0.0001607823,0.015787475,0.000022715807,0.000096850046,0.0034114455],"study_design_scores_gemma":[0.000008189168,0.00007964863,0.9922867,0.0000077609,0.000037375412,0.0028826885,0.000063257175,0.00045364272,0.0038341559,0.00004442891,0.00029876258,0.0000034207494],"about_ca_topic_score_codex":0.000556652,"about_ca_topic_score_gemma":0.0009177235,"teacher_disagreement_score":0.0011242672,"about_ca_system_score_codex":0.00017564054,"about_ca_system_score_gemma":0.00010954097,"threshold_uncertainty_score":0.003761053},"labels":[],"label_agreement":null},{"id":"W2122045485","doi":"10.1158/1078-0432.ccr-04-1944","title":"<i>In vitro</i>Canine Distemper Virus Infection of Canine Lymphoid Cells: A Prelude to Oncolytic Therapy for Lymphoma","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"","keywords":"Canine distemper; Measles virus; Biology; Virology; Canine Lymphoma; Oncolytic virus; Morbillivirus; Lymphoma; Virus; Mononegavirales; Paramyxoviridae; Propidium iodide; Programmed cell death; Apoptosis; Immunology; Viral disease; Measles","score_opus":0.09536830390652214,"score_gpt":0.4804342277136332,"score_spread":0.3850659238071111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122045485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98684365,0.002922085,0.0064504556,0.00019560235,0.00005534539,0.00010121146,0.0004298565,0.000112561414,0.0028892704],"genre_scores_gemma":[0.99224055,0.0012719634,0.003959272,0.0000669261,0.00001813483,0.000068439025,0.0009019106,0.0000182118,0.0014547134],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998155,0.00005611826,0.000019822422,0.00002983117,0.000044270597,0.000034580582],"domain_scores_gemma":[0.9998915,0.000037258345,0.000027026214,0.000018529216,0.000015719632,0.000009930637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023753922,0.00021822582,0.00020782663,0.00013432378,0.000148116,0.000458385,0.00017379502,0.0002780021,0.0008658771],"category_scores_gemma":[0.0001973816,0.000090543006,0.00017860973,0.00009054887,0.0002059811,0.00022136529,0.0001221634,0.0006570118,0.00036162572],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016792548,0.00007026469,0.00064523006,0.00007026582,0.000005998487,0.000054954497,0.000028334807,0.00013695945,0.996774,0.00021420314,0.00010787361,0.0017240562],"study_design_scores_gemma":[0.000015222551,0.00091514975,0.001836179,0.000009221241,0.00001748098,0.00039114704,0.000028613857,0.0006159513,0.9931618,0.000038522736,0.0029681465,0.0000023970588],"about_ca_topic_score_codex":0.0005331646,"about_ca_topic_score_gemma":0.0008382825,"teacher_disagreement_score":0.0008658771,"about_ca_system_score_codex":0.00049067306,"about_ca_system_score_gemma":0.00018005478,"threshold_uncertainty_score":0.0035601258},"labels":[],"label_agreement":null},{"id":"W2122227569","doi":"10.1158/1078-0432.ccr-1115-03","title":"Predictive Models for Breast Cancer Susceptibility from Multiple Single Nucleotide Polymorphisms","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":200,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Cancer Foundation","funders":"","keywords":"Single-nucleotide polymorphism; Breast cancer; SNP; Biology; Genetics; Cancer; Genotype; Computational biology; Oncology; Bioinformatics; Medicine; Gene","score_opus":0.1299888912551065,"score_gpt":0.4278457033816551,"score_spread":0.29785681212654863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122227569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5088708,0.0034360043,0.47662866,0.0025982505,0.0002872498,0.00029290357,0.0027855216,0.0013508804,0.0037497287],"genre_scores_gemma":[0.9701164,0.0008160527,0.023702247,0.00024479083,0.0002056935,0.0003067321,0.0017730349,0.00005038294,0.002784716],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9987594,0.0005436748,0.000070947695,0.00027355526,0.00021215537,0.00014020663],"domain_scores_gemma":[0.9894276,0.009119315,0.00059174595,0.0002485808,0.0004773454,0.00013539084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005549899,0.0012953257,0.0015041878,0.0019392004,0.0004605802,0.001381899,0.0015481875,0.0011324466,0.0026676597],"category_scores_gemma":[0.0113899,0.00061877974,0.0015124537,0.0010591465,0.00069635536,0.0009071105,0.0008284801,0.0020830352,0.0006586758],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044596483,0.00015207726,0.027461229,0.00011420669,0.00037278642,0.00037392942,0.000122063466,0.9114632,0.0006988233,0.0060919533,0.0018318472,0.050871883],"study_design_scores_gemma":[0.000020646054,0.000034559707,0.0020419408,0.000020040306,0.000046713285,0.000054343716,0.000010571886,0.9883095,0.00009630197,0.009139269,0.0002124283,0.000013682265],"about_ca_topic_score_codex":0.0075192233,"about_ca_topic_score_gemma":0.004760994,"teacher_disagreement_score":0.0075192233,"about_ca_system_score_codex":0.00080274924,"about_ca_system_score_gemma":0.00074267486,"threshold_uncertainty_score":0.029350996},"labels":[],"label_agreement":null},{"id":"W2122267374","doi":"10.1158/1078-0432.ccr-06-1592","title":"Activated Pregnenolone X-Receptor Is a Target for Ketoconazole and Its Analogs","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"Damon Runyon Cancer Research Foundation","keywords":"Pregnane X receptor; Ketoconazole; Pharmacology; Paclitaxel; CYP3A4; Pregnenolone; Transcription factor; Chemistry; In vivo; Biology; Drug metabolism; Nuclear receptor; Cytochrome P450; Drug; Gene; Biochemistry; Cancer; Metabolism; Steroid; Genetics; Antifungal; Hormone","score_opus":0.5732678557880453,"score_gpt":0.6682249783394519,"score_spread":0.09495712255140665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122267374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9617259,0.02758297,0.0043938817,0.0008719608,0.0000892503,0.000050281156,0.00032114773,0.00014240737,0.004822218],"genre_scores_gemma":[0.9915455,0.0048493836,0.00088396703,0.0001353143,0.000028107046,0.000019319496,0.00030620839,0.000010190878,0.002221934],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983776,0.00002876661,0.000013337766,0.000024846659,0.00006625725,0.000029041154],"domain_scores_gemma":[0.9998671,0.000025462985,0.000054581455,0.000016714901,0.000017383467,0.000018723107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015883798,0.0002373312,0.00023168178,0.000111561996,0.0001428053,0.00035060034,0.00019867574,0.0001959895,0.0019116156],"category_scores_gemma":[0.00019075896,0.000078158126,0.00022698406,0.00018465475,0.00025787854,0.00012756928,0.000119245684,0.0003948518,0.00045171328],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045053771,0.000041177434,0.0022481924,0.00013448551,0.000015508893,0.00036045283,0.00002064935,0.00021167692,0.982819,0.00038285606,0.00028307733,0.013032528],"study_design_scores_gemma":[0.00010527278,0.0013279001,0.020876778,0.000027947206,0.000092462644,0.004338922,0.00007427924,0.0013949324,0.95055187,0.00031136104,0.020885564,0.000012640356],"about_ca_topic_score_codex":0.0006465033,"about_ca_topic_score_gemma":0.0009419515,"teacher_disagreement_score":0.0019116156,"about_ca_system_score_codex":0.00038933245,"about_ca_system_score_gemma":0.00031520185,"threshold_uncertainty_score":0.0063949823},"labels":[],"label_agreement":null},{"id":"W2122298066","doi":"10.1158/1078-0432.ccr-08-2917","title":"A Vasculature-Targeting Regimen of Preoperative Docetaxel with or without Bevacizumab for Locally Advanced Breast Cancer: Impact on Angiogenic Biomarkers","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Center for Research Resources; U.S. Public Health Service","keywords":"Docetaxel; Bevacizumab; Medicine; Oncology; Regimen; Breast cancer; Internal medicine; Chemotherapy; Cancer","score_opus":0.06158739226960218,"score_gpt":0.46876339262746486,"score_spread":0.40717600035786267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122298066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983498,0.00063023786,0.00014384997,0.00008837198,0.00004633415,0.00030181292,0.000066954206,0.000017253973,0.00035549808],"genre_scores_gemma":[0.997454,0.0004943293,0.0006227438,0.00016945752,0.00009299801,0.00044822562,0.00020249079,0.0000051029438,0.0005107282],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99965024,0.0001380915,0.000027329717,0.00006279469,0.000041837702,0.00007976307],"domain_scores_gemma":[0.9994498,0.00011237596,0.00016023258,0.00004491831,0.000019112886,0.00021360605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000497286,0.0007078096,0.0011792509,0.00035545064,0.00019082773,0.0005601918,0.0004896526,0.0006489408,0.0021377516],"category_scores_gemma":[0.0009009921,0.00035218167,0.00046429693,0.00033012943,0.00070564967,0.00047043702,0.00026369473,0.0014749315,0.0003021565],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79914576,0.04496382,0.004882208,0.00050818175,0.0005867227,0.000120188575,0.000098026976,0.0021798124,0.040185686,0.0002100128,0.00088509126,0.10623453],"study_design_scores_gemma":[0.36515132,0.61377364,0.010884611,0.00004193603,0.0004069346,0.00018957065,0.000035265817,0.0012183037,0.00686296,0.000106902204,0.0013008916,0.000027580718],"about_ca_topic_score_codex":0.0007446748,"about_ca_topic_score_gemma":0.002484703,"teacher_disagreement_score":0.0021377516,"about_ca_system_score_codex":0.0006535916,"about_ca_system_score_gemma":0.0009277398,"threshold_uncertainty_score":0.0071514845},"labels":[],"label_agreement":null},{"id":"W2122327814","doi":"10.1158/1078-0432.ccr-12-1818","title":"Comprehensive Biomarker Analysis and Final Efficacy Results of Sorafenib in the BATTLE Trial","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute","keywords":"Sorafenib; Battle; Biomarker; Medicine; Oncology; Internal medicine; Clinical trial; Hepatocellular carcinoma; History; Biology; Archaeology","score_opus":0.4025781398296305,"score_gpt":0.5987744791664563,"score_spread":0.19619633933682584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122327814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99593747,0.0018916266,0.00035922963,0.00017825792,0.00002583845,0.0000871199,0.0006883954,0.000035853434,0.0007961304],"genre_scores_gemma":[0.9977088,0.00019268291,0.00024325297,0.00009963897,0.000035336318,0.00008225058,0.0013610808,0.0000072071407,0.00026978087],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9980605,0.0011841622,0.00011054771,0.00025461218,0.00023871272,0.00015150686],"domain_scores_gemma":[0.99738187,0.0005742229,0.0010194606,0.00024536348,0.00016597753,0.00061311945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041003227,0.0006178157,0.0015369882,0.00032171002,0.00018516801,0.001026882,0.00037707185,0.00034007628,0.0013211274],"category_scores_gemma":[0.0036853568,0.00019259259,0.0010360092,0.0003537391,0.00037988994,0.00071301655,0.00047684895,0.00078343274,0.00027141947],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74793804,0.0022040762,0.12658717,0.0005826607,0.00782923,0.00015872852,0.00017793084,0.0065892586,0.012596568,0.0007646692,0.003514918,0.091056705],"study_design_scores_gemma":[0.14055903,0.15846474,0.6547506,0.00014637942,0.008539243,0.00092376454,0.0001728542,0.014126088,0.008822519,0.0025203214,0.010792462,0.00018198251],"about_ca_topic_score_codex":0.00021638017,"about_ca_topic_score_gemma":0.00041866954,"teacher_disagreement_score":0.0041003227,"about_ca_system_score_codex":0.00057904545,"about_ca_system_score_gemma":0.00055566104,"threshold_uncertainty_score":0.021684825},"labels":[],"label_agreement":null},{"id":"W2122438358","doi":"10.1158/1078-0432.ccr-11-3149","title":"Molecular Pathways: Multimodal Cancer-Killing Mechanisms Employed by Oncolytic Vesiculoviruses","year":2012,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Oncolytic virus; Cancer; Medicine; Disease; Immune system; Cancer cell; Cancer research; Cancer therapy; Clinical trial; Immunotherapy; Immunology; Pathology; Internal medicine","score_opus":0.31984987580334523,"score_gpt":0.5399484884806124,"score_spread":0.22009861267726716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122438358","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003651525,0.99567974,0.0006331164,0.00026474588,0.00027178615,0.000013522611,0.00002039697,0.000020931611,0.002730497],"genre_scores_gemma":[0.0015844187,0.9963905,0.0004908097,0.00017192126,0.0000901448,0.000015979385,0.000026491276,0.0000022384215,0.001227404],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998863,0.000018532828,0.000010782037,0.000021809537,0.000047323836,0.000015264926],"domain_scores_gemma":[0.9999417,0.000017837405,0.000009926326,0.0000033025033,0.000019091825,0.000008193363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032988374,0.00089799234,0.0008723555,0.0015661205,0.00034618133,0.00095675315,0.0008010841,0.0008930192,0.001592493],"category_scores_gemma":[0.00022470734,0.00025032394,0.0003841348,0.001214999,0.00056249625,0.0013706863,0.0005069847,0.0017289708,0.0015279345],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009322839,0.0001179448,0.00014638822,0.0123824915,0.000062036015,0.00037795215,0.00014320336,0.0007183847,0.018824836,0.015686858,0.02462714,0.9268197],"study_design_scores_gemma":[0.000014539345,0.00009097436,0.00031052093,0.001013,0.000031517528,0.0012199068,0.00005297982,0.00010451571,0.003433286,0.0023233509,0.99138826,0.00001732875],"about_ca_topic_score_codex":0.0007159028,"about_ca_topic_score_gemma":0.001087589,"teacher_disagreement_score":0.001592493,"about_ca_system_score_codex":0.0007221726,"about_ca_system_score_gemma":0.00061319943,"threshold_uncertainty_score":0.0053274035},"labels":[],"label_agreement":null},{"id":"W2122626752","doi":"10.1158/1557-3265.pms14-a04","title":"Abstract A04: Changes in matrix metalloproteinase expression in SN-38 resistant colorectal cancer cells","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Matrix metalloproteinase; TIMP1; MMP1; Metastasis; Cancer research; Colorectal cancer; Cancer; Extracellular matrix; Cell culture; Biology; Cancer cell; Proteolytic enzymes; Pathology; Medicine; Cell biology; Internal medicine; Biochemistry; Enzyme; Gene expression","score_opus":0.1531170009676041,"score_gpt":0.4788733247898995,"score_spread":0.3257563238222954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122626752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99529856,0.0007608236,0.0008233136,0.000070364986,0.00002801468,0.000041541243,0.0011666424,0.00006026867,0.0017504051],"genre_scores_gemma":[0.98920935,0.00047817721,0.0016781805,0.00004340133,0.000010598601,0.000079863275,0.0027263314,0.000016653947,0.005757312],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998055,0.000032435284,0.000029253026,0.000035108988,0.00006548434,0.00003238614],"domain_scores_gemma":[0.99984825,0.000031225114,0.000023128756,0.000027296655,0.000034301145,0.000035755344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001021248,0.00023477561,0.00026809456,0.0003600329,0.0001729384,0.00020100398,0.00015045244,0.0002650089,0.0024994798],"category_scores_gemma":[0.00013773236,0.00010391147,0.00027658528,0.00031497923,0.0001446527,0.000115709954,0.00009762385,0.0003364952,0.0009098146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001631986,0.000056469944,0.00026610345,0.00002087717,0.0000044418744,0.000120214194,0.00002215152,0.0000316489,0.9985108,0.000039983886,0.000059948725,0.00070428674],"study_design_scores_gemma":[0.00003204392,0.0019751142,0.024401214,0.000004975018,0.000021197362,0.0009361406,0.00012833385,0.0014235218,0.9672194,0.000044097767,0.0038038387,0.000010097174],"about_ca_topic_score_codex":0.0028727672,"about_ca_topic_score_gemma":0.0014023754,"teacher_disagreement_score":0.0028727672,"about_ca_system_score_codex":0.00024020688,"about_ca_system_score_gemma":0.00016882943,"threshold_uncertainty_score":0.008361638},"labels":[],"label_agreement":null},{"id":"W2122664628","doi":"10.1158/1078-0432.ccr-04-0684","title":"Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":444,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"Ligue Contre le Cancer","keywords":"Breast cancer; Infiltration (HVAC); Stage (stratigraphy); Medicine; Cancer; Pathology; Oncology; Biology; Internal medicine","score_opus":0.11111734512194295,"score_gpt":0.4492887814914478,"score_spread":0.33817143636950486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122664628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99918216,0.00049022085,0.000048522816,0.000023865881,0.0000033804822,0.0000036649215,0.00006872918,0.000003767462,0.00017577563],"genre_scores_gemma":[0.99954706,0.00011943311,0.00004759573,0.000008445181,0.0000080338405,0.0000036111378,0.00012462432,7.8454656e-7,0.00014045696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99990773,0.000022194234,0.000008010363,0.000019112857,0.000017377128,0.000025514559],"domain_scores_gemma":[0.99964,0.00007397853,0.00012067701,0.000018949859,0.000041171603,0.000105251434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030013724,0.00019862347,0.00025287364,0.0003106354,0.00017403548,0.00025934263,0.000106450396,0.00028891422,0.0011549543],"category_scores_gemma":[0.0005485634,0.000086074906,0.00013019485,0.00021866073,0.0002061019,0.000111273745,0.00015837626,0.00021943056,0.0003423654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012750516,0.00006527146,0.98745805,0.000030404111,0.000026326094,0.00023253233,0.000030982465,0.000092971386,0.005638446,0.000011742191,0.00014147784,0.004996737],"study_design_scores_gemma":[0.00003155898,0.0004445666,0.9956625,0.000009827518,0.000040398285,0.0014089546,0.000044851233,0.00032002004,0.0014760769,0.000027349945,0.00053001865,0.000003961413],"about_ca_topic_score_codex":0.0004461386,"about_ca_topic_score_gemma":0.0006821316,"teacher_disagreement_score":0.0011549543,"about_ca_system_score_codex":0.00020389068,"about_ca_system_score_gemma":0.00016245533,"threshold_uncertainty_score":0.003863752},"labels":[],"label_agreement":null},{"id":"W2123098020","doi":"10.1158/1078-0432.ccr-07-0944","title":"Treatment of Hormone-Refractory Prostate Cancer with Docetaxel or Mitoxantrone: Relationships between Prostate-Specific Antigen, Pain, and Quality of Life Response and Survival in the TAX-327 Study","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Mitoxantrone; Docetaxel; Prostate cancer; Quality of life (healthcare); Internal medicine; Oncology; Prostate-specific antigen; Cancer; Chemotherapy","score_opus":0.4838946235681214,"score_gpt":0.5233336333598677,"score_spread":0.039439009791746305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123098020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998793,0.00066155486,0.00005790633,0.000064024796,0.00001305103,0.000070905975,0.00019135396,0.0000031654477,0.00014504643],"genre_scores_gemma":[0.99849486,0.0003718784,0.00010913183,0.00009189436,0.000041723484,0.00007559853,0.0005847114,0.0000016434079,0.00022858604],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99878246,0.000923908,0.000058412,0.00007238857,0.00009355751,0.00006921524],"domain_scores_gemma":[0.9977696,0.0008396574,0.000726028,0.00018907324,0.00006249058,0.00041327198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035727662,0.00040281034,0.0007704525,0.00022603857,0.00017299711,0.00063717697,0.00038058884,0.0005351247,0.0012300642],"category_scores_gemma":[0.0023393878,0.00024412898,0.001146752,0.0003170058,0.00053470785,0.00032782767,0.00025496073,0.0008421122,0.00014602928],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.62962824,0.011646229,0.31774628,0.0005117452,0.004965172,0.00014108844,0.00013914358,0.002180254,0.0038542154,0.00016969508,0.0012328172,0.027785152],"study_design_scores_gemma":[0.17830925,0.16143994,0.64518714,0.00014073619,0.0042752125,0.00045892564,0.0001580967,0.004986475,0.0020979634,0.00036670643,0.0025150878,0.000064457075],"about_ca_topic_score_codex":0.0009061257,"about_ca_topic_score_gemma":0.0013519229,"teacher_disagreement_score":0.0035727662,"about_ca_system_score_codex":0.00048081574,"about_ca_system_score_gemma":0.0006144699,"threshold_uncertainty_score":0.018894792},"labels":[],"label_agreement":null},{"id":"W2123137241","doi":"10.1158/1078-0432.ccr-07-1964","title":"The Use of Magnetic Resonance Imaging to Noninvasively Detect Genetic Signatures in Oligodendroglioma","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Calgary Laboratory Services","keywords":"Oligodendroglioma; Magnetic resonance imaging; Medicine; Oligodendroglial Tumor; Glioma; Radiology; Pathology; Nuclear medicine; Astrocytoma; Cancer research","score_opus":0.23530621321954348,"score_gpt":0.4647090391620519,"score_spread":0.22940282594250844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123137241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99375474,0.00085669244,0.0042674667,0.000111687565,0.0000076340175,0.000018771687,0.000051444895,0.000041458577,0.0008901351],"genre_scores_gemma":[0.99303013,0.0003006055,0.006356007,0.00003917288,0.000017979004,0.000016824797,0.0000430882,0.0000063387542,0.000189824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998909,0.000046515557,0.000006596617,0.000018879675,0.000027324022,0.000009865687],"domain_scores_gemma":[0.99954695,0.00019828413,0.000109167566,0.000025719248,0.00007786171,0.00004212254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004778304,0.00024923965,0.00011474666,0.0012878518,0.00007948049,0.00038878742,0.000205418,0.00028438045,0.00040597492],"category_scores_gemma":[0.00213432,0.00016884423,0.0000705036,0.0002169487,0.00037929145,0.0003094716,0.00014108111,0.00024769388,0.0001320722],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001973826,0.00021108898,0.49021122,0.00017587778,0.00009410245,0.0010740024,0.00014324354,0.001483507,0.39483318,0.0004984777,0.00055814633,0.108743295],"study_design_scores_gemma":[0.00022906566,0.0024147003,0.7348822,0.0000551228,0.00023692258,0.014735499,0.0003431675,0.035068795,0.2074619,0.0016899997,0.0028108768,0.00007173151],"about_ca_topic_score_codex":0.000525382,"about_ca_topic_score_gemma":0.0008224839,"teacher_disagreement_score":0.0012878518,"about_ca_system_score_codex":0.00014656482,"about_ca_system_score_gemma":0.000107552856,"threshold_uncertainty_score":0.0025270581},"labels":[],"label_agreement":null},{"id":"W2123158115","doi":"10.1158/1078-0432.ccr-06-1863","title":"Phase I Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Advanced Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":212,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Medicine; Dosing; Nausea; Pharmacokinetics; Pharmacodynamics; Toxicity; Adverse effect; Tolerability; Pharmacology; Internal medicine; Anesthesia","score_opus":0.13591248393524,"score_gpt":0.5333629320324956,"score_spread":0.3974504480972556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123158115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99246925,0.0029419533,0.00046556588,0.00030730615,0.00009902161,0.0014474891,0.00039301833,0.000080648235,0.0017957895],"genre_scores_gemma":[0.99139273,0.0016598244,0.0017390721,0.0004606652,0.00013266932,0.001806819,0.0010987177,0.00002043635,0.0016889239],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997832,0.00008894102,0.000011326059,0.00003980831,0.000024176436,0.000052582665],"domain_scores_gemma":[0.9995789,0.000087397915,0.00009407472,0.00002974211,0.000022777464,0.00018723236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068279076,0.0011395307,0.0015650241,0.00025247326,0.00028153652,0.0005746739,0.0006177933,0.0009365973,0.0024908325],"category_scores_gemma":[0.0005896754,0.0002837716,0.0005210196,0.00031537376,0.0007749245,0.0004157503,0.00024639466,0.0022577206,0.00050906575],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5418643,0.053048637,0.012295858,0.001694782,0.0010503364,0.0006864162,0.0005448492,0.009526061,0.13742423,0.00067821314,0.0072075413,0.23397888],"study_design_scores_gemma":[0.43021694,0.5354658,0.013801488,0.00006895083,0.00033349553,0.0005364437,0.00006687852,0.0025050347,0.011119041,0.0002705457,0.0055895946,0.000025819649],"about_ca_topic_score_codex":0.0007740917,"about_ca_topic_score_gemma":0.0017804488,"teacher_disagreement_score":0.0024908325,"about_ca_system_score_codex":0.0008603394,"about_ca_system_score_gemma":0.0014678466,"threshold_uncertainty_score":0.00833261},"labels":[],"label_agreement":null},{"id":"W2123437999","doi":"10.1158/1078-0432.ccr-10-0822","title":"Phase I Dose Finding Studies of Obatoclax (GX15-070), a Small Molecule Pan-BCL-2 Family Antagonist, in Patients with Advanced Solid Tumors or Lymphoma","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Tolerability; Medicine; Regimen; Lymphoma; Pharmacokinetics; Maximum tolerated dose; Antagonist; Nausea; Pharmacology; Toxicity; Internal medicine; Adverse effect; Oncology; Receptor","score_opus":0.12773900908343086,"score_gpt":0.48252961052984666,"score_spread":0.35479060144641583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123437999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99578696,0.0010612454,0.00048511036,0.00019395635,0.000030202631,0.0013907311,0.00024361847,0.00006125055,0.00074695155],"genre_scores_gemma":[0.992722,0.0010445286,0.0020017182,0.00040483798,0.00006966814,0.0015952925,0.0011402573,0.000013300698,0.0010083574],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99960214,0.00021096609,0.000023410896,0.00004855946,0.00004175744,0.000073239506],"domain_scores_gemma":[0.99936527,0.00014872244,0.00013586582,0.000051720643,0.000032690492,0.00026587033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014633224,0.0013444512,0.0013254004,0.00040833477,0.0002911121,0.00052461406,0.000851237,0.0009351403,0.0024200238],"category_scores_gemma":[0.00075184176,0.0003926872,0.0007712315,0.00029711568,0.00099807,0.0006173871,0.0003358792,0.0023443946,0.00045653022],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4167791,0.103324376,0.021269612,0.0013691911,0.0012652815,0.0008925524,0.00087531965,0.007050201,0.27164426,0.00076272397,0.004584766,0.17018253],"study_design_scores_gemma":[0.22729735,0.73910165,0.013764926,0.000034059987,0.00025562342,0.00043071463,0.0000665907,0.0010855715,0.015368462,0.00014662009,0.0024251926,0.000023289444],"about_ca_topic_score_codex":0.00060269696,"about_ca_topic_score_gemma":0.0016413946,"teacher_disagreement_score":0.0024200238,"about_ca_system_score_codex":0.00094207947,"about_ca_system_score_gemma":0.0013369756,"threshold_uncertainty_score":0.0080958605},"labels":[],"label_agreement":null},{"id":"W2123467424","doi":"10.1158/1078-0432.ccr-12-0078","title":"A Phase I Trial and Pharmacokinetic Study of Aflibercept (VEGF Trap) in Children with Refractory Solid Tumors: A Children's Oncology Group Phase I Consortium Report","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Aflibercept; Refractory (planetary science); Pharmacokinetics; Medicine; VEGF receptors; Solid tumor; Phase (matter); Oncology; Internal medicine; Clinical trial; Cancer; Bevacizumab; Chemotherapy; Chemistry; Materials science","score_opus":0.124022776189928,"score_gpt":0.5307793011535353,"score_spread":0.4067565249636073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123467424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99462587,0.0015901496,0.0008403411,0.00039490627,0.000037547892,0.0010676645,0.00076925446,0.000060156064,0.0006140795],"genre_scores_gemma":[0.98710525,0.001933468,0.0046771886,0.0006609198,0.0001236335,0.0016785932,0.002618753,0.000047686826,0.0011545155],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999637,0.00016152186,0.000025707759,0.000057990095,0.000053174015,0.00006457711],"domain_scores_gemma":[0.998946,0.00019413442,0.00027582826,0.00007125492,0.0000771172,0.00043560646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012949876,0.0009722105,0.0011811857,0.00019908781,0.00032523795,0.0004938794,0.0006410439,0.0007246662,0.001332633],"category_scores_gemma":[0.0008125795,0.0003233033,0.000684747,0.00038246394,0.00073380076,0.00046510107,0.00022747609,0.0026461617,0.00034721405],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4363582,0.06911627,0.06361708,0.0016909078,0.0023142442,0.0023209332,0.0014064262,0.00932233,0.19313878,0.00093993364,0.018867236,0.20090759],"study_design_scores_gemma":[0.35041606,0.5612769,0.049720563,0.00008220837,0.0006034226,0.003250708,0.00016072286,0.0027148086,0.022843491,0.00023813065,0.008644168,0.000048839178],"about_ca_topic_score_codex":0.0022474802,"about_ca_topic_score_gemma":0.0035473038,"teacher_disagreement_score":0.0022474802,"about_ca_system_score_codex":0.0012242198,"about_ca_system_score_gemma":0.0027312436,"threshold_uncertainty_score":0.008882403},"labels":[],"label_agreement":null},{"id":"W2123476312","doi":"10.1158/1078-0432.ccr-08-1006","title":"A Phase 1 Dose-Escalation Study of Irinotecan in Combination with 17-Allylamino-17-Demethoxygeldanamycin in Patients with Solid Tumors","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Memorial Sloan-Kettering Cancer Center","keywords":"Irinotecan; Medicine; Pharmacodynamics; Response Evaluation Criteria in Solid Tumors; Pharmacokinetics; Internal medicine; Hsp90 inhibitor; Pharmacology; Oncology; Cancer; Gastroenterology; Progressive disease; Chemotherapy; Heat shock protein; Hsp90; Chemistry; Colorectal cancer","score_opus":0.12178086575357222,"score_gpt":0.482684104983306,"score_spread":0.3609032392297338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123476312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973424,0.0006558366,0.00026961078,0.00013218069,0.000028963535,0.00089030986,0.00019426229,0.000042433312,0.00044400105],"genre_scores_gemma":[0.99461704,0.00065842655,0.001564708,0.0002745937,0.00006718826,0.0012057484,0.0008052514,0.000018023544,0.0007890779],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992894,0.00032812366,0.000029785177,0.00014624039,0.00008275554,0.00012364856],"domain_scores_gemma":[0.99937695,0.000092131195,0.00016655048,0.00006815924,0.000035772217,0.00026052294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012505495,0.0019055224,0.0024658123,0.0005942341,0.0004266001,0.0007581197,0.0009147723,0.0009635,0.0019781985],"category_scores_gemma":[0.0009253192,0.000687322,0.0010025998,0.0005798145,0.0010392101,0.00076614966,0.00034732808,0.0031507562,0.00056415884],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.531866,0.1350381,0.01996079,0.0009249313,0.0018597054,0.00061760546,0.00074207917,0.007955648,0.14822909,0.00029399063,0.0027374285,0.14977466],"study_design_scores_gemma":[0.24843462,0.7140725,0.020440258,0.000026400126,0.00042011373,0.0004797012,0.00005971501,0.0021402487,0.011536823,0.0001490732,0.0022082021,0.00003226093],"about_ca_topic_score_codex":0.0006219551,"about_ca_topic_score_gemma":0.0014786194,"teacher_disagreement_score":0.0024658123,"about_ca_system_score_codex":0.0012317947,"about_ca_system_score_gemma":0.0015638027,"threshold_uncertainty_score":0.008937299},"labels":[],"label_agreement":null},{"id":"W2123477611","doi":"10.1158/1078-0432.ccr-07-0780","title":"Irinophore C: A Liposome Formulation of Irinotecan with Substantially Improved Therapeutic Efficacy against a Panel of Human Xenograft Tumors","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Irinotecan; Pharmacokinetics; Pharmacology; Chemistry; Camptothecin; Medicine; Internal medicine; Cancer; Biochemistry; Colorectal cancer","score_opus":0.2222694447999352,"score_gpt":0.4494059536909869,"score_spread":0.2271365088910517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123477611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906323,0.0019559832,0.0046441243,0.00020190053,0.000050637616,0.00026303253,0.00043849816,0.000116303636,0.0016972262],"genre_scores_gemma":[0.98756903,0.0014176684,0.007985104,0.00014518606,0.00002683148,0.00011134329,0.0007683764,0.000028078523,0.0019484012],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998055,0.000031235875,0.0000158881,0.00005938832,0.00005664269,0.000031374577],"domain_scores_gemma":[0.9998779,0.000016042333,0.000038860624,0.000013507454,0.000022865164,0.00003077789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035495593,0.000544847,0.0003770688,0.0002564662,0.00011060052,0.0003235176,0.00022473969,0.000434371,0.0010189741],"category_scores_gemma":[0.00017755135,0.00012096321,0.00020478613,0.00016455738,0.00027959238,0.00046885447,0.00018727778,0.0006222486,0.00029733102],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005345461,0.00019270535,0.00013521753,0.00008483464,0.000013490267,0.000047059617,0.000011721687,0.00025875363,0.99436533,0.00009728622,0.00013145739,0.004127478],"study_design_scores_gemma":[0.00023520464,0.0032181994,0.002345224,0.0000078690155,0.000042054242,0.00045347493,0.000008199167,0.0011987728,0.98904675,0.000015531503,0.0034147822,0.000013877927],"about_ca_topic_score_codex":0.0010133147,"about_ca_topic_score_gemma":0.0013533058,"teacher_disagreement_score":0.0010189741,"about_ca_system_score_codex":0.0007415401,"about_ca_system_score_gemma":0.0005430096,"threshold_uncertainty_score":0.005380273},"labels":[],"label_agreement":null},{"id":"W2123540640","doi":"10.1158/1078-0432.ccr-14-2424","title":"Higher Risk of Infections with PI3K–AKT–mTOR Pathway Inhibitors in Patients with Advanced Solid Tumors on Phase I Clinical Trials","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Institute for Health and Care Research; Cancer Research UK","keywords":"PI3K/AKT/mTOR pathway; Protein kinase B; Medicine; Clinical trial; Pharmacology; Internal medicine; Incidence (geometry); Oncology; Biology; Signal transduction; Biochemistry","score_opus":0.24552592430868617,"score_gpt":0.554175465829488,"score_spread":0.3086495415208018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123540640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912698,0.005879761,0.0007121772,0.00013672204,0.000037729595,0.00015439332,0.00026857964,0.0000101241385,0.0015306171],"genre_scores_gemma":[0.9985274,0.000498342,0.0002556217,0.00014078927,0.00005661465,0.000057217465,0.00034852422,0.000004901194,0.00011057643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9902828,0.0054281256,0.001122125,0.0011150575,0.0016542245,0.00039772992],"domain_scores_gemma":[0.9725037,0.010884733,0.012679085,0.0013746894,0.0011107255,0.0014470189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010105391,0.00035963583,0.0012104391,0.00062991976,0.0005143032,0.0012341335,0.00041528294,0.00079876906,0.0017180411],"category_scores_gemma":[0.01288372,0.0002671161,0.00097603415,0.00084879133,0.0006410177,0.0007198019,0.00053833163,0.0013101633,0.00016592578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009339506,0.00037194046,0.975315,0.00017989735,0.0006103757,0.00027532128,0.000085161155,0.00029121435,0.0014777934,0.00018013256,0.0004529272,0.0114206625],"study_design_scores_gemma":[0.001533197,0.008856786,0.97741926,0.0001475549,0.00089867256,0.0037696755,0.00023549522,0.0017039534,0.0015546095,0.00042070294,0.0034282575,0.00003172271],"about_ca_topic_score_codex":0.0002032703,"about_ca_topic_score_gemma":0.00023003358,"teacher_disagreement_score":0.010105391,"about_ca_system_score_codex":0.00040425136,"about_ca_system_score_gemma":0.00046490828,"threshold_uncertainty_score":0.053443015},"labels":[],"label_agreement":null},{"id":"W2123607020","doi":"10.1158/1078-0432.ccr-05-0564","title":"Serum Markers in Patients with Resectable Pancreatic Adenocarcinoma: Macrophage Inhibitory Cytokine 1 versus CA19-9","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"GDF15 and Related Biomarkers","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Pancreatic cancer; Medicine; Pancreatitis; CA19-9; Gastroenterology; Pancreas; Internal medicine; Adenocarcinoma; Osteopontin; Cancer; Receiver operating characteristic; Pancreatic disease; Pathology; Pancreatitis, chronic; Differential diagnosis","score_opus":0.06347453845517328,"score_gpt":0.40498768165852683,"score_spread":0.3415131432033536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123607020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991053,0.0005313534,0.00012672352,0.000034215496,0.000005675326,0.00000771605,0.000049185062,0.000005405687,0.00013432292],"genre_scores_gemma":[0.9996158,0.00007071577,0.00014314326,0.000023841834,0.000013929277,0.0000070820884,0.00009081834,8.474433e-7,0.000033833505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99959654,0.00014351681,0.00004985678,0.000084380365,0.0000748958,0.00005082664],"domain_scores_gemma":[0.9985328,0.00061784056,0.00047874195,0.000053670756,0.00009940384,0.00021756794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071608194,0.00041954571,0.0005096683,0.00078885915,0.00024057267,0.00046188448,0.0001885607,0.00048748267,0.0008310276],"category_scores_gemma":[0.0035272078,0.00017723607,0.00020761111,0.00047176558,0.0003281601,0.00033299896,0.00027840098,0.0003676924,0.000226375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076458487,0.00003274428,0.9967229,0.000010021187,0.000026353007,0.00007939862,0.000019314502,0.000061931845,0.0007575381,0.0000064697456,0.000037139496,0.0014816162],"study_design_scores_gemma":[0.000101874226,0.0010296019,0.9943104,0.000012448277,0.00009043753,0.0013455461,0.00011384069,0.0011330721,0.0016019455,0.000037291255,0.00021679096,0.0000068432987],"about_ca_topic_score_codex":0.0004712458,"about_ca_topic_score_gemma":0.0006183868,"teacher_disagreement_score":0.0008310276,"about_ca_system_score_codex":0.0002430868,"about_ca_system_score_gemma":0.00018743695,"threshold_uncertainty_score":0.0037870407},"labels":[],"label_agreement":null},{"id":"W2123824015","doi":"10.1158/1078-0432.ccr-05-0607","title":"Intraperitoneal Pretarget Radioimmunotherapy with CC49 Fusion Protein","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Radioimmunotherapy; DOTA; Biodistribution; Pretargeting; Biotin; Avidin; Medicine; Streptavidin; Fusion protein; Antibody; Chemistry; Chelation; Immunology; Biochemistry; Monoclonal antibody; In vitro; Recombinant DNA","score_opus":0.2334103874893006,"score_gpt":0.5694372802231085,"score_spread":0.33602689273380787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123824015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98359054,0.0033286351,0.010117762,0.00019831814,0.0001276662,0.00027178164,0.00024111426,0.0003871725,0.0017369889],"genre_scores_gemma":[0.9887573,0.0017818527,0.0063261082,0.00008821689,0.00005706247,0.00017906282,0.00045629955,0.000039072085,0.002315077],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998716,0.000017575816,0.0000048980946,0.000029708177,0.000034160068,0.00004200959],"domain_scores_gemma":[0.9999248,0.000012837357,0.000023168233,0.000013141323,0.000008576401,0.000017485065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014841063,0.0006427903,0.0005224354,0.0002781296,0.00013455057,0.00026241664,0.0003163247,0.00038504545,0.0012659053],"category_scores_gemma":[0.000091593865,0.00010428769,0.0002796292,0.00015884389,0.0002788704,0.0002523751,0.00015340389,0.00085178355,0.00046843346],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003893543,0.0003850179,0.00014387573,0.00008143661,0.000010388328,0.000069270805,0.000009548251,0.00020838845,0.993881,0.00009773735,0.00011658626,0.004607338],"study_design_scores_gemma":[0.00009528792,0.0052831904,0.0012002315,0.0000059133154,0.00004046046,0.00038250847,0.000009789201,0.00080292067,0.99015486,0.000025239206,0.0019946403,0.0000049484224],"about_ca_topic_score_codex":0.00057454355,"about_ca_topic_score_gemma":0.0006994778,"teacher_disagreement_score":0.0012659053,"about_ca_system_score_codex":0.0003916574,"about_ca_system_score_gemma":0.0003920053,"threshold_uncertainty_score":0.00423491},"labels":[],"label_agreement":null},{"id":"W2124191068","doi":"10.1158/1078-0432.ccr-07-4282","title":"GLI2 Knockdown Using an Antisense Oligonucleotide Induces Apoptosis and Chemosensitizes Cells to Paclitaxel in Androgen-Independent Prostate Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Prostate cancer; Gene knockdown; Cancer research; Prostate; Androgen deprivation therapy; Biology; Medicine; GLI2; Cancer; Apoptosis; Internal medicine; Hedgehog signaling pathway; Signal transduction; Cell biology","score_opus":0.22950828153090683,"score_gpt":0.47463158165338915,"score_spread":0.24512330012248232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124191068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947014,0.0009522204,0.002052323,0.00009159579,0.000045668603,0.00006193321,0.0003743397,0.00016842708,0.0015520722],"genre_scores_gemma":[0.9914459,0.0010115659,0.0023718902,0.00008634119,0.000012772107,0.00010438372,0.0007877978,0.000027019965,0.004152412],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999255,0.0000065440977,0.0000056921695,0.000020307974,0.000024401847,0.000017535642],"domain_scores_gemma":[0.99997044,0.0000028414247,0.000008457836,0.0000030914048,0.000004867105,0.00001030197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007395195,0.00032722286,0.00027084714,0.00021139943,0.00013681948,0.00015320304,0.00013644608,0.00014643268,0.0010044469],"category_scores_gemma":[0.00004120709,0.00014241229,0.00022679153,0.00014764407,0.00014971814,0.000094359886,0.00010407221,0.0004236125,0.00019354543],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000633305,0.000027393628,0.00007844631,0.000021636855,0.0000046831824,0.000012725074,0.0000059049626,0.0000460889,0.9990233,0.000026393911,0.000048418133,0.000641659],"study_design_scores_gemma":[0.00002909987,0.0008823106,0.0036762364,0.000003392049,0.00002488683,0.00011879809,0.00001615858,0.0008347624,0.99242026,0.000018024668,0.001972596,0.0000034871173],"about_ca_topic_score_codex":0.0013422173,"about_ca_topic_score_gemma":0.0029860483,"teacher_disagreement_score":0.0013422173,"about_ca_system_score_codex":0.0002719116,"about_ca_system_score_gemma":0.0002897042,"threshold_uncertainty_score":0.0033602715},"labels":[],"label_agreement":null},{"id":"W2124214040","doi":"10.1158/1078-0432.ccr-06-0099","title":"<i>Epidermal Growth Factor Receptor</i>Mutation Testing in the Care of Lung Cancer Patients","year":2006,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Erlotinib; Gefitinib; Epidermal growth factor receptor; Medicine; Lung cancer; Oncology; Mutation; Clinical trial; Internal medicine; Cancer; Tyrosine kinase; Targeted therapy; T790M; Companion diagnostic; Cancer research; Biology; Genetics; Gene; Receptor","score_opus":0.3017331670672577,"score_gpt":0.6000678028015249,"score_spread":0.2983346357342672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124214040","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9256892,0.008225578,0.0026742246,0.041164096,0.0005470096,0.00034944352,0.00030311735,0.00022789772,0.020819282],"genre_scores_gemma":[0.9908116,0.0016275345,0.0031017386,0.0036286593,0.00037795593,0.0000676318,0.00009433385,0.000013419382,0.0002772034],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99891686,0.00063719816,0.00011787841,0.0000799686,0.00016034841,0.00008764342],"domain_scores_gemma":[0.9971733,0.00093812705,0.0006692045,0.000082875056,0.00039611902,0.0007403778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001713421,0.00013418579,0.00016472174,0.00045938976,0.00055442547,0.0009942363,0.00049689796,0.00077490974,0.0010297323],"category_scores_gemma":[0.0075029247,0.00013739473,0.00014413612,0.00043033162,0.0005492967,0.0004438626,0.00055471994,0.00074883254,0.0002624109],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034201873,0.00024755337,0.8814323,0.00022426459,0.000029743467,0.005882048,0.0009633715,0.0011930377,0.0030406986,0.00042969186,0.020798566,0.08541686],"study_design_scores_gemma":[0.0000900884,0.0011654419,0.95294356,0.0005796404,0.000055187487,0.014192689,0.0028287403,0.0040977495,0.0020388481,0.0013716504,0.020588908,0.000047488826],"about_ca_topic_score_codex":0.0048819804,"about_ca_topic_score_gemma":0.008848772,"teacher_disagreement_score":0.0048819804,"about_ca_system_score_codex":0.0011545165,"about_ca_system_score_gemma":0.0018327911,"threshold_uncertainty_score":0.009707153},"labels":[],"label_agreement":null},{"id":"W2124813591","doi":"10.1158/1078-0432.ccr-08-1030","title":"Predicting Relapse in Favorable Histology Wilms Tumor Using Gene Expression Analysis: A Report from the Renal Tumor Committee of the Children's Oncology Group","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; inVentiv Health Clinical","funders":"National Cancer Institute","keywords":"Wilms' tumor; Renal tumor; Medicine; Oncology; Histology; Internal medicine; Pathology; Kidney; Nephrectomy","score_opus":0.062452356122579676,"score_gpt":0.41973231450080195,"score_spread":0.3572799583782223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124813591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901238,0.0034351107,0.003166767,0.0010052387,0.000054660526,0.00008590029,0.0011167808,0.000090232636,0.00092158845],"genre_scores_gemma":[0.99338657,0.0011880863,0.0032664398,0.0001475682,0.000036404737,0.00005872511,0.0015297957,0.000021096932,0.00036528407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994273,0.0001617133,0.000059404934,0.00009363587,0.00020801203,0.000049909417],"domain_scores_gemma":[0.99841046,0.00061688473,0.0001760148,0.000076312856,0.00056700135,0.00015323365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020107324,0.00025389556,0.0002534957,0.0007031256,0.00019121057,0.0003125538,0.00021054212,0.00023046891,0.00024903845],"category_scores_gemma":[0.0029685278,0.00008223192,0.00021772496,0.00040935611,0.00024108311,0.00014528568,0.00017219335,0.00031117364,0.00011712109],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003007306,0.00004133818,0.9487742,0.000066040266,0.000075917924,0.00023780561,0.00009038944,0.0007289636,0.0070240963,0.00003537697,0.002233106,0.04039201],"study_design_scores_gemma":[0.00003012844,0.00029008734,0.9734379,0.000036907484,0.0001572424,0.0009963891,0.00016312029,0.0042911805,0.016062437,0.00006750398,0.0044488558,0.000018213485],"about_ca_topic_score_codex":0.0043363622,"about_ca_topic_score_gemma":0.004694222,"teacher_disagreement_score":0.0043363622,"about_ca_system_score_codex":0.0005345497,"about_ca_system_score_gemma":0.0008454867,"threshold_uncertainty_score":0.010633886},"labels":[],"label_agreement":null},{"id":"W2124885699","doi":"10.1158/1078-0432.ccr-13-0029","title":"Relationship of Mammographic Density and Gene Expression: Analysis of Normal Breast Tissue Surrounding Breast Cancer","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute; National Institutes of Health; National Institute of Environmental Health Sciences; Avon Foundation for Women","keywords":"Breast cancer; Breast tissue; MAMMOGRAPHIC DENSITY; Medicine; Gene expression; Breast density; Cancer; Mammary gland; Oncology; Mammography; Gene; Internal medicine; Pathology; Cancer research; Biology; Genetics","score_opus":0.11616570707329706,"score_gpt":0.4571665939511582,"score_spread":0.3410008868778612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124885699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992459,0.00026847422,0.00022193433,0.0000047815906,8.071451e-7,0.000005969281,0.00010253458,0.000003081632,0.00014655011],"genre_scores_gemma":[0.9995161,0.000072116534,0.0001738006,0.0000033719512,0.0000018471658,0.000005553271,0.00018156655,9.056488e-7,0.000044664594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997887,0.000051166768,0.000027528713,0.000049912513,0.00005873161,0.000023911682],"domain_scores_gemma":[0.9995473,0.00015145872,0.00014149841,0.000047313166,0.00006843767,0.000043922963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029263648,0.00012978307,0.00027308566,0.00073546,0.00012663363,0.00027072942,0.0001601799,0.00013762811,0.00058263843],"category_scores_gemma":[0.0013553126,0.000121725374,0.00013220626,0.0006761534,0.00024308819,0.00011703155,0.00022770415,0.00012851685,0.00011619867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032687886,0.00002022323,0.9900817,0.00002436836,0.00004652143,0.00006894595,0.000036710342,0.00008504121,0.005925187,0.000009561918,0.000017932703,0.0033568807],"study_design_scores_gemma":[0.000004124593,0.000051248604,0.9980367,0.0000017852175,0.000020053727,0.00041750856,0.000046309815,0.0002401178,0.0010783776,0.000011169001,0.00009155083,0.0000011819773],"about_ca_topic_score_codex":0.0015399891,"about_ca_topic_score_gemma":0.0015544661,"teacher_disagreement_score":0.0015399891,"about_ca_system_score_codex":0.00017164633,"about_ca_system_score_gemma":0.00010748231,"threshold_uncertainty_score":0.0030620694},"labels":[],"label_agreement":null},{"id":"W2124890939","doi":"10.1158/1078-0432.ccr-11-1431","title":"Integrative Genomics Identified <i>RFC3</i> As an Amplified Candidate Oncogene in Esophageal Adenocarcinoma","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"Canadian Institutes of Health Research; National Institutes of Health; Wellcome Trust; University of Michigan","keywords":"Biology; Carcinogenesis; Cancer; Gene duplication; Oncogene; Copy-number variation; Gene knockdown; Candidate gene; Malignancy; Cancer research; CDKN2A; Barrett's esophagus; Comparative genomic hybridization; Genomics; Adenocarcinoma; Gene; Genome; Genetics; Cell cycle","score_opus":0.20908925067347603,"score_gpt":0.5412453445037941,"score_spread":0.3321560938303181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124890939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939121,0.00051384076,0.003938809,0.00008688545,0.0000063217713,0.000045043522,0.00067633786,0.00008751689,0.00073312304],"genre_scores_gemma":[0.99318236,0.00023836314,0.0046232347,0.00009039853,0.0000049766204,0.000021745132,0.0013258976,0.000025812276,0.00048718447],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998976,0.0000065774134,0.000005418033,0.000035735633,0.00003177296,0.000022933315],"domain_scores_gemma":[0.99986684,0.000034952584,0.000040653966,0.000012729541,0.000024341125,0.000020512556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021248906,0.000282809,0.00028904568,0.00057942147,0.00024276669,0.00024253997,0.00020777906,0.0003126334,0.0009520217],"category_scores_gemma":[0.0002198366,0.0001098707,0.00047813245,0.00042246698,0.0002349393,0.00010137344,0.00020802565,0.00034435795,0.00021183646],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023157528,0.000029496827,0.008899816,0.000054569813,0.000020789861,0.00025614278,0.000038158192,0.00039355256,0.98529196,0.000078990925,0.00007354566,0.0046313247],"study_design_scores_gemma":[0.00006395884,0.000672965,0.37264064,0.000029504417,0.00026135863,0.0055276356,0.0001850629,0.011674324,0.603773,0.00030899068,0.0048340056,0.000028621214],"about_ca_topic_score_codex":0.0024905435,"about_ca_topic_score_gemma":0.0035213062,"teacher_disagreement_score":0.0024905435,"about_ca_system_score_codex":0.0004796261,"about_ca_system_score_gemma":0.00034475804,"threshold_uncertainty_score":0.004952073},"labels":[],"label_agreement":null},{"id":"W2124992375","doi":"10.1158/1078-0432.ccr-08-1644","title":"Color Fluorescence Ratio for Detection of Bronchial Dysplasia and Carcinoma <i>In situ</i>","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Carcinoma in situ; Medicine; Autofluorescence; Dysplasia; Confidence interval; Receiver operating characteristic; Biopsy; Lung cancer; Bronchoscopy; Pathology; Area under the curve; Cancer; Nuclear medicine; Carcinoma; Radiology; Internal medicine; Fluorescence","score_opus":0.11451053429559621,"score_gpt":0.4942561034365501,"score_spread":0.37974556914095386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124992375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951546,0.0014045428,0.0017468319,0.00005768065,0.000016738515,0.0000457368,0.00018636062,0.00009620012,0.001291301],"genre_scores_gemma":[0.9959193,0.00019092408,0.0034660427,0.000023283483,0.000010987917,0.000024087502,0.00016277612,0.000008711011,0.00019390075],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998684,0.00050967274,0.00013187581,0.00024140932,0.00035983196,0.00007317782],"domain_scores_gemma":[0.99653494,0.0013923366,0.0011549735,0.00015875376,0.0004695082,0.00028951885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024012786,0.0004106976,0.00030392897,0.0019393639,0.00027018276,0.0005292923,0.00048536883,0.000571651,0.0019139872],"category_scores_gemma":[0.0048172176,0.00025112333,0.00025871734,0.00060218223,0.00043408334,0.0003272082,0.00033860237,0.0003934987,0.0006606766],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083433976,0.000067246845,0.9821101,0.000053174826,0.000069057765,0.000097635544,0.000057755416,0.00015001217,0.0061210506,0.000032983797,0.00030763182,0.010098954],"study_design_scores_gemma":[0.000037395803,0.00056164095,0.990957,0.000016296248,0.00008561291,0.0017170012,0.00007446355,0.0017914235,0.004263347,0.000057358142,0.00042332365,0.00001509818],"about_ca_topic_score_codex":0.0013380743,"about_ca_topic_score_gemma":0.0020808952,"teacher_disagreement_score":0.0024012786,"about_ca_system_score_codex":0.00040811647,"about_ca_system_score_gemma":0.00026568663,"threshold_uncertainty_score":0.012699306},"labels":[],"label_agreement":null},{"id":"W2125078645","doi":"10.1158/1078-0432.ccr-04-0686","title":"A Randomized Phase IIb Trial of Pulmicort Turbuhaler (Budesonide) in People with Dysplasia of the Bronchial Epithelium","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; AstraZeneca","keywords":"Medicine; Budesonide; Placebo; Biopsy; Bronchoscopy; Gastroenterology; Inhalation; Lung; Dysplasia; Pathology; Internal medicine; Radiology; Anesthesia","score_opus":0.08740307409998185,"score_gpt":0.4709134309035914,"score_spread":0.38351035680360956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125078645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98143494,0.0058619464,0.0006073569,0.0009707554,0.0005615682,0.0074990634,0.000803454,0.00012089043,0.002139971],"genre_scores_gemma":[0.9739127,0.003481733,0.0018981637,0.0026574086,0.00066945574,0.011917358,0.0014051397,0.000020901576,0.004037223],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99931085,0.000406,0.00004482742,0.00008843359,0.000043680593,0.00010615513],"domain_scores_gemma":[0.99939895,0.00013223957,0.00016854652,0.000056838064,0.000049990504,0.00019335032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001753994,0.0013992179,0.0024788454,0.00032341862,0.0004944965,0.0008221638,0.0006712372,0.0023819709,0.006220591],"category_scores_gemma":[0.0013678708,0.0007119129,0.0015463723,0.00028910354,0.00091073656,0.00053377065,0.00031051252,0.0018742103,0.0010809844],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9720363,0.006059606,0.0014678602,0.00046206158,0.00052727584,0.00006065434,0.00005165607,0.00015338135,0.0041981647,0.000054630123,0.0006447769,0.01428366],"study_design_scores_gemma":[0.9168034,0.07873443,0.0029585091,0.000030162462,0.00027851606,0.000037183843,0.000019713943,0.00012984924,0.00032442395,0.000063528365,0.00061405473,0.000006258375],"about_ca_topic_score_codex":0.00080323464,"about_ca_topic_score_gemma":0.0015523229,"teacher_disagreement_score":0.006220591,"about_ca_system_score_codex":0.00058147,"about_ca_system_score_gemma":0.0011228679,"threshold_uncertainty_score":0.020809889},"labels":[],"label_agreement":null},{"id":"W2125181296","doi":"10.1158/1078-0432.ccr-10-1434","title":"Urine Metabolite Analysis Offers Potential Early Diagnosis of Ovarian and Breast Cancers","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":243,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Metabolistics (Canada); University of Alberta","funders":"","keywords":"Urine; Metabolite; Medicine; Breast cancer; Internal medicine; Oncology; Cancer","score_opus":0.0471323739682425,"score_gpt":0.4264624558984703,"score_spread":0.3793300819302278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125181296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94861937,0.026221782,0.01657451,0.000907352,0.00012668046,0.00008789079,0.0025738112,0.00048009242,0.0044084755],"genre_scores_gemma":[0.9839643,0.0040497137,0.010450014,0.00021301939,0.00007106245,0.00002385066,0.000461273,0.000022251643,0.0007444516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998467,0.000054218952,0.000010319308,0.00003315318,0.000035599867,0.000019956045],"domain_scores_gemma":[0.99960214,0.00014715325,0.00011363533,0.00001916651,0.00006221676,0.000055700304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032491842,0.00042702162,0.00040936915,0.0014062626,0.0001915845,0.0004889892,0.00016210886,0.00038996467,0.0014640096],"category_scores_gemma":[0.0010985035,0.00013810111,0.00017573619,0.00063751714,0.00025597276,0.00026595528,0.00027590315,0.00034686236,0.0002945415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043270225,0.0002971516,0.41484627,0.0006715133,0.00016744799,0.00073513156,0.00008688466,0.00057949213,0.39378262,0.0005159736,0.0010607345,0.1829298],"study_design_scores_gemma":[0.00010699294,0.0018441003,0.6036283,0.00012376187,0.0003906526,0.0043183696,0.0002165439,0.004219067,0.37182444,0.0017881057,0.011463081,0.00007666133],"about_ca_topic_score_codex":0.00054158556,"about_ca_topic_score_gemma":0.0011828239,"teacher_disagreement_score":0.0014640096,"about_ca_system_score_codex":0.00018937675,"about_ca_system_score_gemma":0.00030107013,"threshold_uncertainty_score":0.0048975945},"labels":[],"label_agreement":null},{"id":"W2125513860","doi":"10.1158/1078-0432.ccr-12-2965","title":"Quantitative Ultrasound Evaluation of Tumor Cell Death Response in Locally Advanced Breast Cancer Patients Receiving Chemotherapy","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Chemotherapy; Breast cancer; Ultrasound; Cancer; Clinical trial; Internal medicine; Oncology; Urology; Surgery; Radiology","score_opus":0.10248189379294537,"score_gpt":0.44659841211131834,"score_spread":0.344116518318373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125513860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99874973,0.00030946205,0.000704053,0.000015054378,0.0000020525495,0.000013315936,0.000034336404,0.00001598583,0.00015598944],"genre_scores_gemma":[0.99921656,0.00006855048,0.000534431,0.000010383702,0.0000038933686,0.000014550544,0.000051466064,0.0000014650427,0.00009860561],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997801,0.00010209797,0.00001640989,0.000027036605,0.00005612955,0.000018185618],"domain_scores_gemma":[0.99940467,0.00020827292,0.00022752013,0.000025267118,0.00009200572,0.000042297434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003716695,0.0001842847,0.00022505557,0.00041363895,0.00007263187,0.0001448679,0.00010139286,0.00021523346,0.00062333187],"category_scores_gemma":[0.0013266021,0.00007572691,0.00008452853,0.00017245953,0.00014095887,0.000119610326,0.00009336247,0.00017839731,0.00013132964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049400195,0.00039000047,0.58604693,0.00017869337,0.0000701639,0.00026719834,0.00037947157,0.0009073664,0.3590487,0.000039359882,0.00017610795,0.047555998],"study_design_scores_gemma":[0.000075142525,0.006677052,0.89876914,0.000014671021,0.000098320554,0.0014971121,0.0003139704,0.0034746015,0.08828558,0.000058310925,0.0007187152,0.000017399088],"about_ca_topic_score_codex":0.00017529019,"about_ca_topic_score_gemma":0.0001995407,"teacher_disagreement_score":0.00062333187,"about_ca_system_score_codex":0.00011548927,"about_ca_system_score_gemma":0.000059456477,"threshold_uncertainty_score":0.0020852685},"labels":[],"label_agreement":null},{"id":"W2125702108","doi":"10.1158/1078-0432.ccr-04-1036","title":"Antitumor Efficacy of Oblimersen Bcl-2 Antisense Oligonucleotide Alone and in Combination with Vinorelbine in Xenograft Models of Human Non–Small Cell Lung Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stemcell Technologies; University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Vinorelbine; Lung cancer; Cancer research; Cancer; Pharmacology; Apoptosis; Paclitaxel; Medicine; Biology; Chemotherapy; Pathology; Internal medicine; Biochemistry; Cisplatin","score_opus":0.1256711117554593,"score_gpt":0.4880451359847064,"score_spread":0.3623740242292471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125702108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975949,0.00094607007,0.00053365674,0.00006328134,0.00005164724,0.00004311841,0.00016963201,0.000053396427,0.0005442663],"genre_scores_gemma":[0.99613047,0.0009203448,0.0010456189,0.000024176803,0.000015390915,0.000057645382,0.00030828954,0.00001465455,0.0014832555],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983287,0.000048973565,0.000014263907,0.000029841618,0.00003263699,0.00004133958],"domain_scores_gemma":[0.9998605,0.000026128475,0.00002976604,0.000020028963,0.000011050184,0.000052428295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000303499,0.0005492757,0.0008408705,0.00035356262,0.0001346431,0.00023215475,0.00028703382,0.00032841013,0.0008151621],"category_scores_gemma":[0.00013393702,0.0001995658,0.00030923597,0.00022048627,0.00020721817,0.00032681943,0.00012401043,0.0007368374,0.0001421331],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015008313,0.0008754259,0.0002326022,0.00006377659,0.000026222457,0.00003514797,0.00003193999,0.00034651312,0.99320215,0.00007392206,0.0000976555,0.0035138654],"study_design_scores_gemma":[0.00068707246,0.026143325,0.005166677,0.000013140686,0.00010534492,0.00023714187,0.00006636132,0.0030519436,0.9621891,0.00006016884,0.0022640731,0.000015635593],"about_ca_topic_score_codex":0.0009337189,"about_ca_topic_score_gemma":0.0020196943,"teacher_disagreement_score":0.0009337189,"about_ca_system_score_codex":0.00034282316,"about_ca_system_score_gemma":0.00030414318,"threshold_uncertainty_score":0.002726972},"labels":[],"label_agreement":null},{"id":"W2125702644","doi":"10.1158/1078-0432.ccr-14-1749","title":"Integrating RAS Status into Prognostic Signatures for Adenocarcinomas of the Lung","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Canadian Institutes of Health Research; Ontario Institute for Cancer Research; Memorial Sloan-Kettering Cancer Center","keywords":"Lung cancer; Adenocarcinoma; Oncology; Medicine; Internal medicine; Mutation; Cancer research; Cancer; Gene; Biology; Genetics","score_opus":0.256740816745565,"score_gpt":0.5908408432994869,"score_spread":0.33410002655392196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125702644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96611595,0.0002553078,0.03268672,0.00015044252,0.000010317251,0.000059730944,0.00033225722,0.00012405432,0.00026515272],"genre_scores_gemma":[0.993008,0.000051087052,0.0063939993,0.000014141854,0.0000054698985,0.000026840182,0.00031394156,0.00000637911,0.00018011598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994029,0.00021021476,0.000040366576,0.0001734961,0.00011098709,0.00006201332],"domain_scores_gemma":[0.997931,0.0012722004,0.00038605588,0.00016270457,0.00013899735,0.00010910995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026813543,0.0006151133,0.00063151214,0.00052021747,0.00020171012,0.00065113325,0.0004458608,0.00046652596,0.00055755954],"category_scores_gemma":[0.0049021062,0.00028200878,0.0008335694,0.00036113703,0.0005631141,0.00050637085,0.00061053265,0.00060300034,0.00020015884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019373744,0.00042739848,0.497207,0.000111214686,0.0004010804,0.00023975225,0.00014298236,0.4235702,0.022818053,0.0008926313,0.0002870225,0.051965334],"study_design_scores_gemma":[0.000041513675,0.00058001856,0.04813205,0.000011738349,0.00013415446,0.00018461091,0.000021702823,0.94421065,0.0047065523,0.0017276963,0.00022316245,0.000026211927],"about_ca_topic_score_codex":0.0032458138,"about_ca_topic_score_gemma":0.003684002,"teacher_disagreement_score":0.0032458138,"about_ca_system_score_codex":0.0007647189,"about_ca_system_score_gemma":0.00086842023,"threshold_uncertainty_score":0.014180541},"labels":[],"label_agreement":null},{"id":"W2125787669","doi":"10.1158/1078-0432.ccr-07-1224","title":"NOXA and PUMA Expression Add to Clinical Markers in Predicting Biochemical Recurrence of Prostate Cancer Patients in a Survival Tree Model","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal; McGill University Health Centre; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Puma; Prostate cancer; Cancer; Biochemical recurrence; Oncology; breakpoint cluster region; Immunohistochemistry; Tissue microarray; Medicine; Internal medicine; Cancer research; Biology; Apoptosis; Prostatectomy; Receptor","score_opus":0.17325344452730862,"score_gpt":0.5258623476190568,"score_spread":0.3526089030917482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125787669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9494991,0.00079826335,0.046636153,0.0007804382,0.000042587584,0.00008890111,0.00076855783,0.00028779003,0.0010982953],"genre_scores_gemma":[0.99070436,0.00017325065,0.0071151913,0.00008751617,0.000027837592,0.00006953186,0.0009548567,0.00001957495,0.00084788044],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99939346,0.00033629726,0.000022247053,0.00010639135,0.00005568119,0.00008593596],"domain_scores_gemma":[0.9980118,0.0014072153,0.0001905746,0.000060113485,0.00019056753,0.00013962695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032727614,0.0010757134,0.0008653685,0.0012709426,0.00046505476,0.0009403366,0.00093094783,0.0006208713,0.0012045313],"category_scores_gemma":[0.0032232164,0.00031536203,0.0012196028,0.00041462947,0.00028570744,0.00037852206,0.0006111006,0.00086954713,0.00039557213],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020100623,0.0004099653,0.25012133,0.000088333334,0.0007881049,0.00026589425,0.00020303931,0.6867563,0.0012500971,0.0011868216,0.0023491047,0.05457097],"study_design_scores_gemma":[0.000029094283,0.00018061599,0.0069894004,0.000013383542,0.00012214715,0.000056889196,0.000021810654,0.9917075,0.00008080335,0.0006047031,0.00018273944,0.000010901412],"about_ca_topic_score_codex":0.010652129,"about_ca_topic_score_gemma":0.006819158,"teacher_disagreement_score":0.010652129,"about_ca_system_score_codex":0.0007517676,"about_ca_system_score_gemma":0.0011093054,"threshold_uncertainty_score":0.021180272},"labels":[],"label_agreement":null},{"id":"W2125877270","doi":"10.1158/1078-0432.ccr-11-3007","title":"A Phase I Single-Agent Study of Twice-Weekly Consecutive-Day Dosing of the Proteasome Inhibitor Carfilzomib in Patients with Relapsed or Refractory Multiple Myeloma or Lymphoma","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Onyx Pharmaceuticals","keywords":"Carfilzomib; Medicine; Adverse effect; Tolerability; Dosing; Multiple myeloma; Pharmacokinetics; Proteasome inhibitor; Pharmacology; Refractory (planetary science); Internal medicine; Oncology; Gastroenterology","score_opus":0.2172473456305167,"score_gpt":0.4730811051271257,"score_spread":0.255833759496609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125877270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930326,0.0014828212,0.00059157866,0.00024414001,0.00010626042,0.0030383545,0.00047484363,0.00011879511,0.0009105819],"genre_scores_gemma":[0.99008584,0.0013573407,0.0018625756,0.0005004552,0.00018643714,0.0032889007,0.0011044388,0.00002982633,0.0015841869],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994597,0.0002027782,0.000020847365,0.0001239491,0.00006307889,0.0001297288],"domain_scores_gemma":[0.9993316,0.00008647536,0.00012891772,0.0000867951,0.00004017372,0.0003260914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012245761,0.0022499615,0.0028924718,0.00060242816,0.00049502135,0.0008955069,0.0011991994,0.001572168,0.0023693622],"category_scores_gemma":[0.00083494786,0.00072316884,0.0011728683,0.0005070285,0.0013446952,0.00082001963,0.0003137615,0.0039650844,0.0007243686],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6215266,0.16172692,0.0050212652,0.0010451366,0.0013754199,0.00039727424,0.00043794728,0.004322605,0.10479912,0.00028137385,0.003035588,0.0960308],"study_design_scores_gemma":[0.39327368,0.5920065,0.006391386,0.000016303964,0.00023484124,0.00016914592,0.000027670254,0.0008549566,0.005449124,0.00008015845,0.0014699318,0.00002619857],"about_ca_topic_score_codex":0.001114427,"about_ca_topic_score_gemma":0.0023407561,"teacher_disagreement_score":0.0028924718,"about_ca_system_score_codex":0.0011900993,"about_ca_system_score_gemma":0.0017933806,"threshold_uncertainty_score":0.008634806},"labels":[],"label_agreement":null},{"id":"W2125955619","doi":"10.1158/1078-0432.ccr-13-0606","title":"<i>PIK3CA, BRAF</i>, and PTEN Status and Benefit from Cetuximab in the Treatment of Advanced Colorectal Cancer—Results from NCIC CTG/AGITG CO.17","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"PTEN; Cetuximab; Colorectal cancer; Medicine; Oncology; Internal medicine; Biomarker; Immunohistochemistry; Cancer; Tissue microarray; Cancer research; Biology","score_opus":0.13139375769860068,"score_gpt":0.4804904139291039,"score_spread":0.34909665623050323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125955619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936528,0.004335095,0.000087669134,0.00037935076,0.00003519025,0.00009595625,0.0006657794,0.000011268567,0.0007368463],"genre_scores_gemma":[0.9962632,0.0010545872,0.00019609886,0.0002814918,0.00010186231,0.000057630034,0.0014919224,0.000008508687,0.00054460735],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9991991,0.00042195214,0.000043051714,0.00009750049,0.00015305051,0.000085421605],"domain_scores_gemma":[0.9984263,0.0005255787,0.00029177076,0.000122017926,0.0000959323,0.00053841714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023499897,0.0005865308,0.0011541443,0.00040578554,0.00019302368,0.00047040876,0.0004626889,0.0004815168,0.0015160872],"category_scores_gemma":[0.0014100147,0.00021587283,0.0010354838,0.00040573522,0.00044552048,0.00017864208,0.0002813181,0.00083940866,0.00021763655],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5318089,0.003223703,0.36062232,0.00059537304,0.004519213,0.00035808317,0.00008198713,0.002117335,0.01679877,0.00009379497,0.005371804,0.074408665],"study_design_scores_gemma":[0.053267945,0.04442246,0.8826119,0.00012619916,0.0072161984,0.00065185584,0.00006477537,0.0027523034,0.0038909786,0.00012179844,0.004828198,0.00004543075],"about_ca_topic_score_codex":0.0053744665,"about_ca_topic_score_gemma":0.012880705,"teacher_disagreement_score":0.0053744665,"about_ca_system_score_codex":0.0010689867,"about_ca_system_score_gemma":0.0013698654,"threshold_uncertainty_score":0.012428045},"labels":[],"label_agreement":null},{"id":"W2126005827","doi":"10.1158/1078-0432.ccr-07-5268","title":"Expression of Aurora A (but Not Aurora B) Is Predictive of Survival in Breast Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; National Institutes of Health; Breast Cancer Alliance; Susan G. Komen for the Cure","keywords":"Breast cancer; Oncology; Cancer research; Cancer; Medicine; Internal medicine; Biology","score_opus":0.11859906226793113,"score_gpt":0.4550499644780676,"score_spread":0.3364509022101365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126005827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983771,0.0010805127,0.00020490814,0.000049668422,0.0000046383498,0.0000029662851,0.00008547685,0.000008143258,0.00018666763],"genre_scores_gemma":[0.99938416,0.00024738433,0.00013448232,0.000013101828,0.000008652721,0.0000035556784,0.000122028585,0.0000015042142,0.000085051026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984896,0.000038757276,0.000021942764,0.000038243976,0.000028345288,0.00002370925],"domain_scores_gemma":[0.9989955,0.00032722202,0.00037768407,0.00004328697,0.00011061203,0.00014573745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003640224,0.00017491737,0.00021164185,0.00047981722,0.00017928694,0.00028451253,0.00016151207,0.00027343057,0.0008731119],"category_scores_gemma":[0.0014731691,0.000114128365,0.00015054356,0.0004623501,0.00023701641,0.00018528473,0.00017787976,0.00028704558,0.00020466042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004057178,0.000025962914,0.9870351,0.000027882657,0.000039907056,0.000053812983,0.000022280254,0.00015425126,0.00649415,0.000010319833,0.00010571408,0.0056249877],"study_design_scores_gemma":[0.000006754493,0.00009111395,0.99750024,0.000005332808,0.000038919425,0.00033918346,0.000034087927,0.0005254153,0.001176554,0.00004857349,0.00023156391,0.0000022658187],"about_ca_topic_score_codex":0.0009976375,"about_ca_topic_score_gemma":0.0011152666,"teacher_disagreement_score":0.0009976375,"about_ca_system_score_codex":0.00019267744,"about_ca_system_score_gemma":0.00015706186,"threshold_uncertainty_score":0.002920866},"labels":[],"label_agreement":null},{"id":"W2126142987","doi":"10.1158/1078-0432.ccr-04-1884","title":"P16 Loss and Mitotic Activity Predict Poor Survival in Patients with Peritoneal Malignant Mesothelioma","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Peritoneal mesothelioma; Medicine; Mesothelioma; Hazard ratio; Internal medicine; Histology; Gastroenterology; Oncology; Survival rate; Pathology; Confidence interval","score_opus":0.07645368928944643,"score_gpt":0.43531887056543644,"score_spread":0.35886518127599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126142987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995964,0.00020777897,0.000046767367,0.000027850272,0.0000021288245,0.0000022421762,0.000026387654,0.0000017143129,0.00008867366],"genre_scores_gemma":[0.99980515,0.000046380457,0.000042245112,0.000008504673,0.0000060301413,0.0000025284344,0.000049499504,2.9440048e-7,0.000039319362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998714,0.00003682048,0.0000151650875,0.000024625557,0.000028106457,0.000023868635],"domain_scores_gemma":[0.9989717,0.00022743328,0.0005312842,0.00004628393,0.00005733728,0.00016602695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030899607,0.00017622147,0.00017154783,0.00035047167,0.000248592,0.00024346137,0.00015756466,0.0003020545,0.00096983643],"category_scores_gemma":[0.0017887214,0.00014829492,0.00013534335,0.0002540079,0.00030438948,0.00021216494,0.0002183886,0.00033547866,0.00013413385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003067415,0.000021326645,0.9970956,0.000006620948,0.000012519449,0.00011897521,0.000019735215,0.00005526075,0.00075148983,0.0000044543835,0.000047092355,0.0015602574],"study_design_scores_gemma":[0.000029480261,0.00024589774,0.99787927,0.0000040047125,0.000018944047,0.0010574096,0.000060862392,0.0002272448,0.00033892927,0.000024529707,0.0001113326,0.0000021333203],"about_ca_topic_score_codex":0.00046253102,"about_ca_topic_score_gemma":0.00084935006,"teacher_disagreement_score":0.00096983643,"about_ca_system_score_codex":0.00018626537,"about_ca_system_score_gemma":0.00017627994,"threshold_uncertainty_score":0.0032444},"labels":[],"label_agreement":null},{"id":"W2126372889","doi":"10.1158/1078-0432.ccr-06-2610","title":"Correlation between Development of Rash and Efficacy in Patients Treated with the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib in Two Large Phase III Studies","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":383,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rash; Erlotinib; Internal medicine; Medicine; Gefitinib; Gemcitabine; Epidermal growth factor receptor; Erlotinib Hydrochloride; Hazard ratio; Gastroenterology; Oncology; Cancer; Confidence interval","score_opus":0.1488288453879716,"score_gpt":0.5328739408514896,"score_spread":0.38404509546351806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126372889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98314613,0.013652533,0.0009120731,0.0001706858,0.00003527851,0.00045806792,0.00075687456,0.000028072107,0.0008402667],"genre_scores_gemma":[0.9971968,0.00092489715,0.00045225688,0.00016968547,0.000041177416,0.00020533003,0.00091536663,0.00000751475,0.00008698964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9874406,0.008628652,0.00144323,0.0010600222,0.0011806916,0.0002468395],"domain_scores_gemma":[0.94456977,0.030209107,0.01749834,0.0033970778,0.0025859743,0.0017396181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023362702,0.0006081443,0.002005009,0.0005904169,0.00043094615,0.0014892146,0.00064099196,0.000904542,0.00096038677],"category_scores_gemma":[0.020049471,0.00043165166,0.0023595719,0.0009602752,0.0007085132,0.00084409973,0.0007719844,0.0013431796,0.00011599056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15292135,0.0016541978,0.7671614,0.0021505118,0.022468552,0.00039305762,0.00027241034,0.0010490087,0.010322694,0.00013053861,0.00083698425,0.040639233],"study_design_scores_gemma":[0.01635816,0.027879437,0.9407432,0.0001425366,0.0086061675,0.00092255493,0.00010483993,0.0008528923,0.002442112,0.00015436065,0.0017290071,0.00006470295],"about_ca_topic_score_codex":0.00027051088,"about_ca_topic_score_gemma":0.00078005146,"teacher_disagreement_score":0.023362702,"about_ca_system_score_codex":0.00062924024,"about_ca_system_score_gemma":0.0006595342,"threshold_uncertainty_score":0.12355524},"labels":[],"label_agreement":null},{"id":"W2126466275","doi":"10.1158/1078-0432.573.11.2","title":"Age- and Disease-Related Methylation of Multiple Genes in Nonneoplastic Duodenum and in Duodenal Juice","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Pancreatic cancer; Methylation; Duodenum; Pancreatitis; DNA methylation; CpG site; Pancreatic disease; Pancreas; Gastroenterology; Internal medicine; Cancer; Medicine; Biology; Cancer research; Pathology; Gene; Gene expression; Genetics","score_opus":0.09255907806145015,"score_gpt":0.44987726667681255,"score_spread":0.3573181886153624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126466275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99923956,0.0004560426,0.00012681563,0.000008157012,0.0000017365228,0.0000024552596,0.00006066649,0.0000019252689,0.00010255026],"genre_scores_gemma":[0.99948126,0.00014282785,0.00013834216,0.000008888394,0.0000026650412,0.0000036729512,0.00009599649,0.0000014471348,0.00012496694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999859,0.000033984918,0.000013277538,0.00004529579,0.000027982253,0.000020462492],"domain_scores_gemma":[0.9997502,0.00005968755,0.00010339526,0.00001811048,0.00003159262,0.00003697731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016462596,0.00013460997,0.00018481963,0.0004893554,0.00015434514,0.00019287449,0.00009999428,0.00021239325,0.0009578386],"category_scores_gemma":[0.00071963517,0.00011853113,0.000108856206,0.00029525592,0.00016709848,0.00017399433,0.00015147246,0.00018367509,0.0001285671],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014270309,0.00005562086,0.81707424,0.00006845685,0.000092122114,0.0005691251,0.00031914553,0.00009174756,0.17309833,0.000041261406,0.0000655953,0.007097333],"study_design_scores_gemma":[0.000014315095,0.00033611665,0.9839707,0.0000055574005,0.00004121916,0.0016311904,0.00012616262,0.00019263994,0.013226453,0.000039655617,0.00041222127,0.0000037491245],"about_ca_topic_score_codex":0.0005834152,"about_ca_topic_score_gemma":0.0005806922,"teacher_disagreement_score":0.0009578386,"about_ca_system_score_codex":0.00017071319,"about_ca_system_score_gemma":0.00007605336,"threshold_uncertainty_score":0.0032043457},"labels":[],"label_agreement":null},{"id":"W2126640098","doi":"10.1158/1078-0432.ccr-08-2480","title":"Circulating Levels of Soluble KIT Serve as a Biomarker for Clinical Outcome in Gastrointestinal Stromal Tumor Patients Receiving Sunitinib following Imatinib Failure","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Sunitinib; Medicine; Hazard ratio; Placebo; Internal medicine; Biomarker; Gastroenterology; Tyrosine-kinase inhibitor; Imatinib; GiST; Adverse effect; Confidence interval; Oncology; Stromal cell; Cancer; Pathology","score_opus":0.40999426022985846,"score_gpt":0.5692956083639206,"score_spread":0.1593013481340621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126640098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996904,0.00015510253,0.000048285878,0.000007795012,0.0000021668975,0.000007887483,0.000028006072,0.000001888499,0.000058459693],"genre_scores_gemma":[0.999746,0.00003807461,0.00005973109,0.0000113139795,0.0000068209742,0.000010492458,0.00007717822,6.1707254e-7,0.000049726328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997012,0.00011955022,0.00002671658,0.0000547885,0.00005892642,0.00003881172],"domain_scores_gemma":[0.99926025,0.00020149429,0.00033726217,0.000029991155,0.0000477357,0.00012320424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068585994,0.00031863322,0.00071719504,0.00022184812,0.00018451517,0.00033871602,0.0001852941,0.0003339607,0.0006853042],"category_scores_gemma":[0.000996414,0.00013836725,0.00031566405,0.00022470285,0.00022308134,0.00028529888,0.00015366156,0.00040479275,0.00012867234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045875106,0.0011315527,0.8936412,0.0001081117,0.00039520842,0.00042002412,0.00014533084,0.0011709796,0.029524509,0.000024099205,0.00019568976,0.027368173],"study_design_scores_gemma":[0.00075009477,0.017713416,0.97396594,0.000009986438,0.00022671896,0.00063902326,0.00005974625,0.0020037906,0.004339707,0.00003662508,0.00024298424,0.000011910316],"about_ca_topic_score_codex":0.0003152935,"about_ca_topic_score_gemma":0.0005255803,"teacher_disagreement_score":0.00071719504,"about_ca_system_score_codex":0.00028626615,"about_ca_system_score_gemma":0.00020821874,"threshold_uncertainty_score":0.003627181},"labels":[],"label_agreement":null},{"id":"W2126702649","doi":"10.1158/1078-0432.ccr-14-2180","title":"RAS Synthetic Lethal Screens Revisited: Still Seeking the Elusive Prize?","year":2015,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Cancer Research UK; Francis Crick Institute","keywords":"Synthetic lethality; Biology; Olaparib; RNA interference; Cancer; Mutant; Gene silencing; Small interfering RNA; Gene; Genetic screen; Mutation; Cancer research; Computational biology; Genetics; RNA; Poly ADP ribose polymerase","score_opus":0.2867914726154852,"score_gpt":0.6023166328049955,"score_spread":0.31552516018951027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126702649","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09055071,0.45041218,0.1599847,0.24644457,0.005981069,0.00058016105,0.0012427568,0.0041616145,0.040642295],"genre_scores_gemma":[0.2792274,0.49931252,0.11300549,0.05985804,0.002663618,0.0008111039,0.0017709364,0.0017050935,0.041645817],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996439,0.0013668466,0.00026099736,0.00034863915,0.0013040737,0.00028060545],"domain_scores_gemma":[0.99639744,0.0015833535,0.0002673066,0.0003241967,0.0010825257,0.00034523068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008525007,0.0011644075,0.001684759,0.0017148253,0.0008339484,0.0032738382,0.0018037998,0.0022085423,0.0022898058],"category_scores_gemma":[0.0043978677,0.00045643334,0.000772186,0.0008865974,0.0024408242,0.0029731917,0.0021918402,0.0068679624,0.0011233189],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008404415,0.0004407512,0.0029125407,0.0028420328,0.0005453041,0.00253344,0.0021976298,0.0017782443,0.30911493,0.12751223,0.09574445,0.453538],"study_design_scores_gemma":[0.00029285115,0.0032830723,0.0038615179,0.0014287208,0.00041231926,0.006345878,0.0024637536,0.0032965462,0.104520574,0.09024736,0.7835681,0.00027938854],"about_ca_topic_score_codex":0.0008600627,"about_ca_topic_score_gemma":0.0028597075,"teacher_disagreement_score":0.008525007,"about_ca_system_score_codex":0.0016506849,"about_ca_system_score_gemma":0.0014217204,"threshold_uncertainty_score":0.045085132},"labels":[],"label_agreement":null},{"id":"W2126709547","doi":"10.1158/1078-0432.ccr-11-3090","title":"Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":551,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"National Cancer Institute; U.S. Food and Drug Administration","keywords":"Medicine; Internal medicine; Oncology; Biomarker; Toxicity; Phases of clinical research; Clinical endpoint; Lung cancer; Clinical trial; Biology","score_opus":0.1977189728280281,"score_gpt":0.5160958239841599,"score_spread":0.3183768511561318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126709547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977564,0.00051999366,0.0001855661,0.00007752073,0.000025971742,0.0008172336,0.00024165917,0.000027349526,0.00034834212],"genre_scores_gemma":[0.99557436,0.00043927672,0.0007176253,0.00023470692,0.00007711263,0.0010358153,0.0011056155,0.000011975652,0.0008036463],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99961394,0.0001877591,0.000019245259,0.00006392319,0.000048528786,0.00006655396],"domain_scores_gemma":[0.99914455,0.000120294295,0.0001437757,0.00007062315,0.000064970125,0.0004558849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014909882,0.0013802549,0.0018130919,0.00037466345,0.00046150954,0.000706244,0.00070633256,0.0009638315,0.0018784623],"category_scores_gemma":[0.0009113763,0.00047348972,0.00084261823,0.00041644028,0.0010191328,0.00056107965,0.00032398335,0.0018996774,0.00061055506],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6903481,0.093028136,0.051362082,0.00048188423,0.00097140763,0.0005808228,0.00047984123,0.003808775,0.08455473,0.00017049588,0.0018105514,0.07240317],"study_design_scores_gemma":[0.15165688,0.8013475,0.03829591,0.000017597424,0.00031226408,0.00033635693,0.0000929448,0.0014429605,0.00515469,0.000100945006,0.0012127792,0.00002916477],"about_ca_topic_score_codex":0.0011595379,"about_ca_topic_score_gemma":0.0023770889,"teacher_disagreement_score":0.0018784623,"about_ca_system_score_codex":0.00088972726,"about_ca_system_score_gemma":0.002013883,"threshold_uncertainty_score":0.007885218},"labels":[],"label_agreement":null},{"id":"W2126993300","doi":"10.1158/1078-0432.520.11.2","title":"Expression and Signaling Activity of Wnt-5a/Discoidin Domain Receptor-1 and Syk Plays Distinct but Decisive Roles in Breast Cancer Patient Survival","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Kungliga Fysiografiska Sällskapet i Lund; Svenska Sällskapet för Medicinsk Forskning; Swedish Foundation for International Cooperation in Research and Higher Education; Swedish Cancer Foundation","keywords":"Syk; Wnt signaling pathway; DDR1; Cancer research; Breast cancer; Cancer; Biology; Dishevelled; Signal transduction; Metastasis; Medicine; Frizzled; Internal medicine; Cell biology; Receptor tyrosine kinase; Tyrosine kinase","score_opus":0.06817285325885358,"score_gpt":0.41406976822184216,"score_spread":0.3458969149629886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126993300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976732,0.0015758798,0.00016926056,0.000036193258,0.0000033486433,0.0000041459048,0.000175331,0.0000080682485,0.0003545961],"genre_scores_gemma":[0.9989446,0.00041590704,0.00013512187,0.000010184482,0.0000055876594,0.0000039313227,0.00028115656,0.0000014140256,0.00020207674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998006,0.000034835597,0.000022419274,0.00004657532,0.000055022363,0.000040482824],"domain_scores_gemma":[0.9996401,0.00006858784,0.00017019942,0.000021260495,0.00004118449,0.000058655158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023522037,0.00020345801,0.00022700442,0.000508509,0.00012661552,0.00029737866,0.00009913411,0.00018162752,0.0011671125],"category_scores_gemma":[0.00063659454,0.00010058616,0.00017269303,0.00037381417,0.00023380121,0.00013271111,0.00017290114,0.00020975624,0.0002670323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012642418,0.00008155232,0.8503969,0.000103027225,0.00011416066,0.00046091288,0.00011818936,0.0002802168,0.12726022,0.00011918132,0.00024307263,0.019558322],"study_design_scores_gemma":[0.000010666879,0.00015469555,0.9773542,0.0000119916185,0.00008816775,0.001850646,0.00007775458,0.0005949613,0.018973975,0.00006206423,0.00081653864,0.0000044588037],"about_ca_topic_score_codex":0.00039621734,"about_ca_topic_score_gemma":0.0006009999,"teacher_disagreement_score":0.0011671125,"about_ca_system_score_codex":0.000276145,"about_ca_system_score_gemma":0.0002183378,"threshold_uncertainty_score":0.0039044023},"labels":[],"label_agreement":null},{"id":"W2127003779","doi":"10.1158/1078-0432.ccr-11-0034","title":"<i>BRAF-KIAA1549</i> Fusion Predicts Better Clinical Outcome in Pediatric Low-Grade Astrocytoma","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":241,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; McMaster Children's Hospital; McGill University Health Centre; Hospital for Sick Children; Montreal Children's Hospital","funders":"","keywords":"Fusion gene; Medicine; Oncology; Internal medicine; Multivariate analysis; Cancer research; Pathology; Biology; Gene","score_opus":0.393667423146274,"score_gpt":0.5348865283983283,"score_spread":0.14121910525205428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127003779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99969506,0.00010475333,0.00005893145,0.000007874502,0.0000010350379,0.0000016788296,0.000045194054,0.0000043081527,0.00008111827],"genre_scores_gemma":[0.9996867,0.000054859436,0.00008555462,0.0000043487807,0.0000023011357,0.0000022164909,0.00013472821,0.0000014635085,0.000027917009],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999912,0.0000142063745,0.000011102505,0.00002177668,0.000023023931,0.000017864215],"domain_scores_gemma":[0.99946374,0.000083017425,0.00027812726,0.000016861026,0.000048673926,0.00010962826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020711368,0.00019475575,0.00019903942,0.0004177789,0.00017226134,0.00026932478,0.00013323808,0.00021711693,0.0007989739],"category_scores_gemma":[0.0008117484,0.00011079117,0.00014968545,0.00026948968,0.00023167206,0.00021965976,0.00013821111,0.00020554985,0.00018382419],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017995815,0.000014116909,0.993255,0.000012682635,0.000013713381,0.00036881008,0.000018912648,0.00014336177,0.0040150783,0.000008172173,0.000060860097,0.0019093321],"study_design_scores_gemma":[0.0000051217485,0.00013280517,0.99491453,0.0000044803837,0.000020613028,0.0030784318,0.000047538615,0.00042751594,0.0012167721,0.000015209055,0.00013503853,0.0000019112751],"about_ca_topic_score_codex":0.0014676899,"about_ca_topic_score_gemma":0.0022525545,"teacher_disagreement_score":0.0014676899,"about_ca_system_score_codex":0.0002765439,"about_ca_system_score_gemma":0.00021215806,"threshold_uncertainty_score":0.002918303},"labels":[],"label_agreement":null},{"id":"W2127159621","doi":"10.1158/1078-0432.ccr-08-0351","title":"Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and Bevacizumab","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Genotype; Bevacizumab; Ovarian cancer; Exact test; Gastroenterology; Internal medicine; Cyclophosphamide; Allele; Progression-free survival; Medicine; Biology; Oncology; Cancer; Chemotherapy; Gene; Genetics","score_opus":0.23775193141506812,"score_gpt":0.5075417239301775,"score_spread":0.2697897925151094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127159621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994448,0.00033705,0.00005101077,0.000023209534,0.000004420126,0.000005427539,0.000036680307,0.0000021264848,0.00009530529],"genre_scores_gemma":[0.9996867,0.000054865246,0.000048583952,0.000021840022,0.000010875037,0.000008855731,0.000105433886,8.4771034e-7,0.000062114705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978715,0.00007816607,0.000021813865,0.00003638615,0.000041070245,0.00003540706],"domain_scores_gemma":[0.9993988,0.00013525384,0.0002981554,0.000019180603,0.00003240793,0.00011608594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033567735,0.00014979696,0.00038110168,0.00018113498,0.00015236478,0.00023871119,0.00013876244,0.00028036305,0.00071847095],"category_scores_gemma":[0.0008882568,0.0000751615,0.00024974346,0.00026305518,0.00014978868,0.00009533515,0.00011226,0.00029034403,0.00008226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009821255,0.0003711412,0.9705035,0.00004122244,0.00024879735,0.00022519259,0.000036874815,0.00029676646,0.0073608328,0.00002438411,0.00014366466,0.010926282],"study_design_scores_gemma":[0.0004908279,0.0035184263,0.992769,0.00000975454,0.00020836781,0.0008205174,0.000032925152,0.0007202713,0.0010206109,0.00004277332,0.00036066512,0.0000058251517],"about_ca_topic_score_codex":0.00064210355,"about_ca_topic_score_gemma":0.00083084824,"teacher_disagreement_score":0.00071847095,"about_ca_system_score_codex":0.00026390955,"about_ca_system_score_gemma":0.00023261298,"threshold_uncertainty_score":0.0024035573},"labels":[],"label_agreement":null},{"id":"W2127206464","doi":"10.1158/1078-0432.ccr-06-3067","title":"Body Composition as an Independent Determinant of 5-Fluorouracil–Based Chemotherapy Toxicity","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":613,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Toxicity; Body surface area; Lean body mass; Fluorouracil; Population; Medicine; Chemotherapy; Internal medicine; Body weight","score_opus":0.3008704198020518,"score_gpt":0.6177990339498245,"score_spread":0.3169286141477727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127206464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99856347,0.00063074316,0.0002229302,0.00006221436,0.000007994225,0.0000060336447,0.00007304433,0.000005648507,0.00042801638],"genre_scores_gemma":[0.99967265,0.00006648967,0.000090611815,0.000015730571,0.000008314187,0.0000023305718,0.00005029143,0.0000013571293,0.00009227568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975115,0.000121597004,0.000021352205,0.000031487136,0.000045833916,0.000028529117],"domain_scores_gemma":[0.99848086,0.00046610818,0.00066009356,0.000072815455,0.000092583155,0.00022755664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044961902,0.0002042859,0.00024149744,0.0003382331,0.000169167,0.00028211018,0.000120275516,0.00022968317,0.0016619791],"category_scores_gemma":[0.0024470668,0.00008560831,0.00018593496,0.00033588527,0.00022303178,0.000139178,0.00016144694,0.00031635998,0.00016499306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038575055,0.000031268522,0.9958825,0.0000060479138,0.00003863899,0.00003983299,0.000009851058,0.000056816658,0.00083390967,0.000010425182,0.000026999533,0.002677974],"study_design_scores_gemma":[0.000005769873,0.00021664343,0.9988601,0.0000037181687,0.000028410956,0.00025752644,0.00001223548,0.00025533114,0.00025082493,0.000017478262,0.00009048455,0.0000013736969],"about_ca_topic_score_codex":0.0007911507,"about_ca_topic_score_gemma":0.00080406904,"teacher_disagreement_score":0.0016619791,"about_ca_system_score_codex":0.00014321384,"about_ca_system_score_gemma":0.00020666982,"threshold_uncertainty_score":0.0055599213},"labels":[],"label_agreement":null},{"id":"W2127376103","doi":"10.1158/1078-0432.ccr-05-0754","title":"Herceptin Sensitizes ErbB2–Overexpressing Cells to Apoptosis by Reducing Antiapoptotic Mcl-1 Expression","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Research Manitoba","keywords":"Apoptosis; Trastuzumab; Etoposide; Cancer research; Cell culture; Medicine; Chemistry; Breast cancer; Biology; Cancer; Chemotherapy; Internal medicine","score_opus":0.19438652816364593,"score_gpt":0.5409689330364883,"score_spread":0.34658240487284236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127376103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937854,0.0028327387,0.001771421,0.00013599505,0.000037460646,0.000033053104,0.000173668,0.00007302388,0.0011572099],"genre_scores_gemma":[0.9946636,0.0014918108,0.0018036149,0.0000847838,0.000016042875,0.000024427589,0.00033237538,0.000008917682,0.0015743903],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999081,0.000015254126,0.000007681911,0.00001913369,0.000028727234,0.000021202952],"domain_scores_gemma":[0.99995136,0.000009619054,0.000015008432,0.000007262997,0.0000063363545,0.000010439693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001499509,0.0003053693,0.00018104656,0.00015605584,0.00009598069,0.0002027672,0.0001239441,0.0001866419,0.0013753381],"category_scores_gemma":[0.00009351314,0.00010605737,0.00017587298,0.00010275938,0.0001469816,0.00015070099,0.00010852301,0.0003943577,0.00023366458],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059551905,0.000035327143,0.00014978631,0.000036610676,0.000006071786,0.000017031782,0.0000057047146,0.000065042834,0.99864227,0.000038602186,0.00003308117,0.00091093],"study_design_scores_gemma":[0.000040801428,0.00041395138,0.0020330776,0.0000062783574,0.000013754332,0.00027750025,0.000007630132,0.00049822143,0.9940374,0.00002237564,0.0026462483,0.000002850604],"about_ca_topic_score_codex":0.00029426898,"about_ca_topic_score_gemma":0.00049384264,"teacher_disagreement_score":0.0013753381,"about_ca_system_score_codex":0.00031754817,"about_ca_system_score_gemma":0.00014065168,"threshold_uncertainty_score":0.0046010017},"labels":[],"label_agreement":null},{"id":"W2127518288","doi":"10.1158/1078-0432.ccr-07-4886","title":"Improving the Quality of Abstract Reporting for Phase I Cancer Trials","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Confidence interval; Odds ratio; Presentation (obstetrics); Quality Score; Rating scale; Family medicine; Quality (philosophy); Scale (ratio); Medical physics; Internal medicine; Statistics; Surgery; Mathematics","score_opus":0.983076230406273,"score_gpt":0.8466821809333631,"score_spread":0.1363940494729099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127518288","genre_codex":"empirical","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3873123,0.16019166,0.3008514,0.073144816,0.008363917,0.038436532,0.008082787,0.00432891,0.019287704],"genre_scores_gemma":[0.6531442,0.03565988,0.28139132,0.006675339,0.004941702,0.011901713,0.0044404287,0.0005998685,0.0012455622],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.31059065,0.39784116,0.21249235,0.0071312315,0.06949131,0.0024533428],"domain_scores_gemma":[0.057924327,0.4517548,0.30500507,0.04159738,0.13844109,0.005277369],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.5951421,0.0019524186,0.0029783484,0.01887196,0.0021778045,0.011867851,0.0042452402,0.0026899867,0.0026798309],"category_scores_gemma":[0.832404,0.0017846929,0.004170403,0.013003045,0.003624066,0.010793677,0.008511166,0.0040351544,0.0013776664],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044007483,0.00059099495,0.2696102,0.034323994,0.0021395686,0.0003084071,0.0075739026,0.0020481586,0.0045695147,0.0018345137,0.026794525,0.64580554],"study_design_scores_gemma":[0.0030418248,0.00940961,0.7260035,0.055062857,0.006051142,0.0045940066,0.008769287,0.017683102,0.018711472,0.017026862,0.13220176,0.0014446048],"about_ca_topic_score_codex":0.0017053247,"about_ca_topic_score_gemma":0.001683405,"teacher_disagreement_score":0.40485787,"about_ca_system_score_codex":0.0059170346,"about_ca_system_score_gemma":0.018710516,"threshold_uncertainty_score":0.49926186},"labels":[],"label_agreement":null},{"id":"W2127680641","doi":"10.1158/1078-0432.ccr-05-2255","title":"Phase II Clinical Trial Results Involving Treatment with Low-Dose Daily Oral Cyclophosphamide, Weekly Vinblastine, and Rofecoxib in Patients with Advanced Solid Tumors","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sudbury Regional Hospital","funders":"","keywords":"Medicine; Internal medicine; Mucositis; Neutropenia; Cyclophosphamide; Chemotherapy; Gastroenterology; Vinblastine; Regimen; Surgery; Clinical endpoint; Performance status; Phases of clinical research; Clinical trial","score_opus":0.07054438524096894,"score_gpt":0.4518263761429414,"score_spread":0.38128199090197246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127680641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98192453,0.0046823327,0.0014098387,0.0008934109,0.00020108561,0.0058193714,0.0013259747,0.0001448201,0.003598551],"genre_scores_gemma":[0.97772527,0.003241768,0.003970267,0.0011812673,0.00034552437,0.0064389613,0.0045281937,0.000023229253,0.0025455242],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99945754,0.00029320378,0.00004056708,0.00006949273,0.000044858803,0.00009429232],"domain_scores_gemma":[0.99864215,0.00035517293,0.00031504486,0.00007664349,0.000078409124,0.00053255295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020480363,0.001639002,0.0017987535,0.00032065727,0.00038088864,0.00081745244,0.0008294042,0.0016229245,0.0038663503],"category_scores_gemma":[0.001274937,0.00032902282,0.0009415159,0.00035087767,0.0010245021,0.0005318282,0.00029610895,0.0025958044,0.00083712384],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6857301,0.11441752,0.012157347,0.0019335678,0.0019297048,0.00047945709,0.00029386667,0.0055862013,0.043145593,0.0006603408,0.009953183,0.12371318],"study_design_scores_gemma":[0.6569959,0.32204482,0.010826122,0.00006637722,0.0003312092,0.0003887205,0.00003192769,0.00154621,0.004736346,0.0001466222,0.0028642518,0.000021486981],"about_ca_topic_score_codex":0.00045902122,"about_ca_topic_score_gemma":0.0007845505,"teacher_disagreement_score":0.0038663503,"about_ca_system_score_codex":0.0006238608,"about_ca_system_score_gemma":0.0015380277,"threshold_uncertainty_score":0.012934208},"labels":[],"label_agreement":null},{"id":"W2127783189","doi":"10.1158/1078-0432.ccr-08-2076","title":"A Phase I Trial to Determine the Safety, Tolerability, and Maximum Tolerated Dose of Deforolimus in Patients with Advanced Malignancies","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of General Medical Sciences","keywords":"Mucositis; Tolerability; Pharmacokinetics; Medicine; Toxicity; Dosing; Pharmacodynamics; Pharmacology; Internal medicine; Phases of clinical research; Gastroenterology; Adverse effect; Oncology","score_opus":0.08724902439158091,"score_gpt":0.45578113637616813,"score_spread":0.36853211198458724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127783189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99622846,0.0011401305,0.00043396055,0.00021588727,0.000046618105,0.0010231225,0.00021222346,0.0000336661,0.00066590135],"genre_scores_gemma":[0.9939885,0.00070854364,0.00185823,0.00041287503,0.00013737459,0.0013859883,0.00076592364,0.000011681429,0.00073098985],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99973685,0.00014052773,0.000014632951,0.000037843376,0.000024126579,0.000046082783],"domain_scores_gemma":[0.9994388,0.00012482157,0.00014663082,0.000033797012,0.000023505203,0.00023235405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000868268,0.00078440015,0.0010535347,0.00021943098,0.00028525267,0.00032569314,0.0004081795,0.0006662396,0.0022606398],"category_scores_gemma":[0.000617051,0.00024851473,0.0004869588,0.00022793375,0.00052768935,0.00040201645,0.00020730335,0.0013921341,0.00032863187],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6388945,0.045640558,0.014902991,0.001001009,0.0006119518,0.00046179423,0.00037925597,0.0033794818,0.13238427,0.00043600236,0.003673308,0.15823483],"study_design_scores_gemma":[0.40299702,0.566375,0.017149815,0.000037638067,0.00020400787,0.0005338073,0.000039513932,0.001666871,0.008496892,0.0001512247,0.0023228636,0.000025268038],"about_ca_topic_score_codex":0.00032870396,"about_ca_topic_score_gemma":0.00063242647,"teacher_disagreement_score":0.0022606398,"about_ca_system_score_codex":0.0004589556,"about_ca_system_score_gemma":0.0008743973,"threshold_uncertainty_score":0.007562518},"labels":[],"label_agreement":null},{"id":"W2127839329","doi":"10.1158/1078-0432.ccr-09-0796","title":"Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"Cancer Research UK","keywords":"Cytotoxicity; Cisplatin; In vivo; Melanoma; Propidium iodide; Cancer research; Oncolytic virus; Apoptosis; Combination therapy; Biology; Combination chemotherapy; In vitro; Chemotherapy; Immunology; Pharmacology; Programmed cell death","score_opus":0.06577905292304735,"score_gpt":0.46888945951222805,"score_spread":0.4031104065891807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127839329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905284,0.0047390554,0.0026917555,0.000057060868,0.000058863137,0.00018167436,0.0001580101,0.00005796282,0.0015271271],"genre_scores_gemma":[0.9935334,0.0015821612,0.0038642755,0.000023066204,0.000021302056,0.00009295876,0.00013546992,0.0000155068,0.0007318494],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995584,0.00012698126,0.000033430497,0.00008170473,0.00014288287,0.000056597648],"domain_scores_gemma":[0.99981004,0.00005064355,0.000043680622,0.00003420269,0.000020306074,0.00004126285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033308787,0.00060691446,0.0007092931,0.0005477259,0.00014623413,0.0003329577,0.00034198162,0.0003387073,0.00075170596],"category_scores_gemma":[0.00023428409,0.00023100925,0.0003459131,0.00029496048,0.0002842964,0.0003012912,0.00030185792,0.0005634038,0.0001909688],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010436903,0.00048776835,0.0009791106,0.00013956311,0.000057198748,0.00007089942,0.000040732713,0.0013807891,0.98542225,0.00011846827,0.000110853165,0.010148592],"study_design_scores_gemma":[0.00009740101,0.008468863,0.003757612,0.000014454233,0.00010270502,0.00030684547,0.000025736339,0.0019374754,0.98306894,0.000038173315,0.0021724715,0.000009445271],"about_ca_topic_score_codex":0.00045392028,"about_ca_topic_score_gemma":0.0011542982,"teacher_disagreement_score":0.00075170596,"about_ca_system_score_codex":0.0003478767,"about_ca_system_score_gemma":0.00027052456,"threshold_uncertainty_score":0.002524078},"labels":[],"label_agreement":null},{"id":"W2127851311","doi":"10.1158/1078-0432.ccr-07-5134","title":"Regulation of Hematopoietic Stem Cells by the Steel Factor/KIT Signaling Pathway","year":2008,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Haematopoiesis; Stem cell; Biology; Effector; Cell biology; Signal transduction; Hematopoietic stem cell; Myeloid; Stem cell factor; Cancer research; Immunology","score_opus":0.3565737676871354,"score_gpt":0.5070292293159093,"score_spread":0.15045546162877393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127851311","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003928904,0.996781,0.00039946777,0.00021876862,0.00018144169,0.0000059331746,0.000021856727,0.000019914636,0.0019787098],"genre_scores_gemma":[0.0009917737,0.99754167,0.0003669528,0.000119511744,0.0001028572,0.000006349058,0.00003101399,0.0000014834137,0.00083846744],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989927,0.000013842873,0.000014907825,0.000019626788,0.000043244643,0.000009030385],"domain_scores_gemma":[0.9998791,0.00003808157,0.000023992883,0.0000046218806,0.000036885784,0.00001732621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000278935,0.0007063322,0.0008715533,0.0013681672,0.00019220386,0.0005396833,0.00066932145,0.00060907326,0.0018046983],"category_scores_gemma":[0.00027355758,0.00014942078,0.00022434235,0.0012178707,0.00032910687,0.0007827705,0.00033155255,0.00071339717,0.0022945353],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045685556,0.00003108403,0.00018247003,0.0058451947,0.000036966256,0.0002240893,0.000032093965,0.0003478656,0.006785464,0.0024185632,0.01232171,0.9717288],"study_design_scores_gemma":[0.000016531201,0.000106987776,0.0014552389,0.0014874748,0.000060367784,0.001794184,0.000064031155,0.00013491492,0.003078807,0.0019537872,0.9898274,0.00002026301],"about_ca_topic_score_codex":0.00075713964,"about_ca_topic_score_gemma":0.0011103172,"teacher_disagreement_score":0.0018046983,"about_ca_system_score_codex":0.00043284477,"about_ca_system_score_gemma":0.000664962,"threshold_uncertainty_score":0.0060373545},"labels":[],"label_agreement":null},{"id":"W2128021317","doi":"10.1158/1078-0432.ccr-06-0357","title":"Gene Expression Profiling in Cervical Cancer: An Exploration of Intratumor Heterogeneity","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research; University of Toronto","keywords":"Genetic heterogeneity; Gene expression; Gene expression profiling; Cervical cancer; Gene; Molecular biology; Biology; Gene ontology; Cancer research; Cancer; Pathology; Medicine; Phenotype; Genetics","score_opus":0.35996146327319045,"score_gpt":0.5445051033131305,"score_spread":0.18454364003994006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128021317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99605006,0.0014219398,0.0017553798,0.00003647861,0.0000030518652,0.000020409034,0.0002575903,0.00001268252,0.00044241044],"genre_scores_gemma":[0.99794513,0.0003506136,0.0009942359,0.0000331025,0.0000072506164,0.00004583204,0.00042590656,0.000008666306,0.00018918172],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996462,0.00006069245,0.000021271617,0.00012133416,0.00009859158,0.00005185902],"domain_scores_gemma":[0.999795,0.00008883612,0.000050216295,0.000022263486,0.00002538122,0.000018298239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003019546,0.0001532992,0.00035065497,0.00057598227,0.00024226311,0.00032975478,0.00014578734,0.0002920534,0.0005549415],"category_scores_gemma":[0.00045777188,0.00010408045,0.00022058681,0.0007331179,0.00030390752,0.00018434584,0.00024971346,0.00023446286,0.00012666224],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007825164,0.0000727524,0.2292368,0.00030658854,0.00020204589,0.00040628915,0.00029664696,0.0007971777,0.7491444,0.00015724683,0.00016631257,0.018431373],"study_design_scores_gemma":[0.000025063047,0.0004560204,0.89323366,0.000022558948,0.0002341601,0.002601216,0.00035229727,0.002801943,0.09728142,0.00032426743,0.0026494158,0.000018008526],"about_ca_topic_score_codex":0.00054733764,"about_ca_topic_score_gemma":0.0010606358,"teacher_disagreement_score":0.00057598227,"about_ca_system_score_codex":0.0002489117,"about_ca_system_score_gemma":0.00022781706,"threshold_uncertainty_score":0.0018565059},"labels":[],"label_agreement":null},{"id":"W2128168096","doi":"10.1158/1078-0432.ccr-05-1167","title":"Effects of HIV Protease Inhibitor Ritonavir on Akt-Regulated Cell Proliferation in Breast Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences; National Cancer Institute","keywords":"Ritonavir; Protein kinase B; Cell growth; Cancer research; Chemistry; Growth inhibition; Cyclin D1; Biology; Apoptosis; Biochemistry; Cell cycle; Virology; Virus; Viral load","score_opus":0.03742455038747397,"score_gpt":0.4229952260042277,"score_spread":0.38557067561675373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128168096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978284,0.015492279,0.0005770681,0.00019846602,0.00007408668,0.000064885455,0.0003832986,0.00008865333,0.004837257],"genre_scores_gemma":[0.98733866,0.008554136,0.0012490492,0.00012458937,0.000023118962,0.000055027027,0.00058697397,0.000015663449,0.0020528263],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998111,0.00006495076,0.000017276247,0.000019325464,0.000044577297,0.000042759606],"domain_scores_gemma":[0.9999242,0.000026115737,0.000014143161,0.000012155804,0.0000130337385,0.000010343441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002661719,0.00027721122,0.000355828,0.00022664582,0.00017166745,0.0003839098,0.00028209054,0.0002432579,0.0016096629],"category_scores_gemma":[0.00018326641,0.00013986448,0.00024986587,0.00024248102,0.00016286633,0.00023016654,0.00011272232,0.00054396514,0.00040728803],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034829387,0.0010206307,0.0024904285,0.00041908413,0.0000710097,0.00017738067,0.000076426644,0.00069045165,0.94364077,0.0004394346,0.0005352766,0.046956163],"study_design_scores_gemma":[0.00030887817,0.006397465,0.018160226,0.000040844396,0.00012051064,0.00066147227,0.00008767996,0.0022885012,0.9629302,0.00012009336,0.008870483,0.000013593593],"about_ca_topic_score_codex":0.0007280393,"about_ca_topic_score_gemma":0.0018246998,"teacher_disagreement_score":0.0016096629,"about_ca_system_score_codex":0.00039351106,"about_ca_system_score_gemma":0.00030680036,"threshold_uncertainty_score":0.005384803},"labels":[],"label_agreement":null},{"id":"W2128192445","doi":"10.1158/1078-0432.ccr-07-4619","title":"Safety and Immunogenicity Study of NY-ESO-1b Peptide and Montanide ISA-51 Vaccination of Patients with Epithelial Ovarian Cancer in High-Risk First Remission","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"Eli Lilly and Company; National Cancer Institute; Ludwig Institute for Cancer Research; Damon Runyon Cancer Research Foundation; Cancer Research Institute","keywords":"ELISPOT; Medicine; Internal medicine; Adverse effect; Vaccination; Immunology; Immunogenicity; Gastroenterology; Cancer; Ovarian cancer; Oncology; Antigen; Immune system; T cell","score_opus":0.04623632557742297,"score_gpt":0.3742542925332915,"score_spread":0.32801796695586855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128192445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99937004,0.00029359976,0.00009030827,0.000032356387,0.0000076188853,0.00003705894,0.00001912903,0.0000069195507,0.00014293239],"genre_scores_gemma":[0.9995437,0.0000845008,0.000069576774,0.000056178444,0.000014952192,0.00003180142,0.000068084984,0.0000014549056,0.00012974243],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998223,0.000075437856,0.000011067354,0.00002847727,0.000031975196,0.000030761683],"domain_scores_gemma":[0.9995554,0.000103423925,0.00014425242,0.000045565957,0.000029356392,0.000121990255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053035433,0.00024367504,0.00064814405,0.000076358214,0.00016792344,0.00018628863,0.00016344554,0.0003958113,0.0005620252],"category_scores_gemma":[0.00065491814,0.00009206278,0.0002816643,0.00007328314,0.00021117943,0.00020988811,0.00011433119,0.0006280479,0.00016336997],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23399755,0.032955613,0.16837518,0.00074409763,0.0012067737,0.00083731505,0.0007959812,0.0038168821,0.2967442,0.00017960864,0.0013460697,0.25900075],"study_design_scores_gemma":[0.01928031,0.69938403,0.23749347,0.0000383596,0.00036152275,0.0013060437,0.00011136417,0.0028600355,0.036032338,0.00007154273,0.0030449394,0.000015981439],"about_ca_topic_score_codex":0.00022439925,"about_ca_topic_score_gemma":0.0002494824,"teacher_disagreement_score":0.00064814405,"about_ca_system_score_codex":0.00025401614,"about_ca_system_score_gemma":0.00024936945,"threshold_uncertainty_score":0.0028047562},"labels":[],"label_agreement":null},{"id":"W2128407187","doi":"10.1158/1078-0432.ccr-13-3206","title":"U.S. Food and Drug Administration Inspections of Clinical Investigators: Overview of Results from 1977 to 2009","year":2014,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Food and drug administration; Medicine; Drug; Administration (probate law); Drug administration; Clinical pharmacology; Pharmacology; Political science; Law","score_opus":0.8812733416136131,"score_gpt":0.7414920111272241,"score_spread":0.13978133048638908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128407187","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17437117,0.5693503,0.010453114,0.025287144,0.002269908,0.0020945524,0.09696779,0.0025719565,0.1166342],"genre_scores_gemma":[0.46208328,0.37485322,0.023068285,0.021510148,0.001673545,0.0013077139,0.09019121,0.0008245946,0.024488078],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.96899945,0.005988817,0.0062917937,0.002729432,0.014121086,0.0018694336],"domain_scores_gemma":[0.82804364,0.03326495,0.04754324,0.003962945,0.08302501,0.0041602748],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.029563788,0.00086300645,0.0007827672,0.021233791,0.0011286583,0.0029880607,0.0017015493,0.001142676,0.0041997423],"category_scores_gemma":[0.06060648,0.0010126473,0.001433034,0.023710636,0.00084902433,0.0019221114,0.0017564252,0.0018837149,0.002441953],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053390017,0.00028359672,0.2917345,0.0048790514,0.0003950515,0.00035790543,0.0009665189,0.00086329726,0.00079527794,0.0013032652,0.24047408,0.45741355],"study_design_scores_gemma":[0.000061436855,0.00040649538,0.7511526,0.006203326,0.00039996774,0.0011323906,0.0012274951,0.0006789796,0.0015275549,0.00020842791,0.23691702,0.000084349056],"about_ca_topic_score_codex":0.087321386,"about_ca_topic_score_gemma":0.114188164,"teacher_disagreement_score":0.9988573,"about_ca_system_score_codex":0.008161921,"about_ca_system_score_gemma":0.014207672,"threshold_uncertainty_score":0.17362624},"labels":[],"label_agreement":null},{"id":"W2128452890","doi":"10.1158/1078-0432.ccr-05-2148","title":"Gefitinib Inhibits the Growth and Invasion of Urothelial Carcinoma Cell Lines in which Akt and MAPK Activation Is Dependent on Constitutive Epidermal Growth Factor Receptor Activation","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Gefitinib; Protein kinase B; MAPK/ERK pathway; Epidermal growth factor receptor; Cancer research; Epidermal growth factor; Cell growth; EGFR inhibitors; PI3K/AKT/mTOR pathway; Tyrosine kinase; Kinase; Biology; Cell culture; Chemistry; Medicine; Phosphorylation; Internal medicine; Signal transduction; Cancer; Cell biology; Biochemistry","score_opus":0.08137028910011788,"score_gpt":0.3888915653661901,"score_spread":0.3075212762660722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128452890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99438184,0.0036669804,0.00060675084,0.000055018863,0.000029511217,0.0000265477,0.00023480503,0.00006413008,0.00093438814],"genre_scores_gemma":[0.99502605,0.001728522,0.0011682153,0.00003210462,0.000009050137,0.000038404858,0.0009069448,0.000010384329,0.0010803634],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997979,0.00003776802,0.000024789908,0.00002191552,0.00007251194,0.00004520426],"domain_scores_gemma":[0.9998956,0.000021679014,0.0000234364,0.000017538594,0.000017833792,0.000023791354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016062039,0.0004414839,0.0004618924,0.0003015142,0.000188487,0.00024149768,0.000146602,0.000203286,0.0009305014],"category_scores_gemma":[0.00014099678,0.00012089045,0.0003958919,0.00019680784,0.00014932123,0.00013408423,0.0001122979,0.00038583972,0.00031822943],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020396622,0.00011599543,0.00069044164,0.000080439546,0.000018032213,0.00005317008,0.000015918578,0.000086589884,0.99558914,0.000023494611,0.000109316214,0.0030133966],"study_design_scores_gemma":[0.00003480258,0.0012834488,0.01594857,0.000008969671,0.000044654513,0.00066828285,0.000029448644,0.0010354541,0.97855127,0.000011764374,0.0023769937,0.0000063708057],"about_ca_topic_score_codex":0.0009832071,"about_ca_topic_score_gemma":0.00182961,"teacher_disagreement_score":0.0009832071,"about_ca_system_score_codex":0.00028378892,"about_ca_system_score_gemma":0.00027952893,"threshold_uncertainty_score":0.003112793},"labels":[],"label_agreement":null},{"id":"W2128715593","doi":"10.1158/1078-0432.ccr-09-0051","title":"MicroRNA Regulation of Oncolytic Herpes Simplex Virus-1 for Selective Killing of Prostate Cancer Cells","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Oncolytic virus; LNCaP; Prostate cancer; Herpes simplex virus; microRNA; Biology; Amplicon; Cancer research; Viral replication; Virus; Virology; Untranslated region; Cancer; Cancer cell; Gene; Messenger RNA; Genetics","score_opus":0.1112225201738669,"score_gpt":0.49753326473474946,"score_spread":0.38631074456088255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128715593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97831225,0.005119208,0.0128603205,0.000115681905,0.000090997935,0.0001425264,0.0003978098,0.00022054593,0.0027406856],"genre_scores_gemma":[0.98712826,0.0015590648,0.009258153,0.000046837114,0.000011826771,0.00010749646,0.00035109016,0.000034671022,0.0015025738],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997905,0.000035057605,0.000019223671,0.00004340562,0.00008263879,0.000029299603],"domain_scores_gemma":[0.999936,0.0000134321635,0.00002121823,0.000007709191,0.000012321039,0.000009420311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021238271,0.00026158706,0.00022963586,0.00013685289,0.000116484116,0.00032534555,0.00029362243,0.00016527239,0.0006058265],"category_scores_gemma":[0.00014171872,0.00011272684,0.0002759105,0.00012407135,0.00019276528,0.00013327441,0.00021534185,0.00039651644,0.00022442087],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057966856,0.000017981885,0.00007279574,0.000045137356,0.000003882119,0.000012532578,0.000013671002,0.00013493325,0.9976548,0.00017454382,0.000043889286,0.0017678632],"study_design_scores_gemma":[0.000008903343,0.0001611192,0.00044799148,0.000002596039,0.000007856484,0.000065068874,0.000004954885,0.0011425652,0.9963731,0.00002513159,0.0017581653,0.0000024775713],"about_ca_topic_score_codex":0.00034134547,"about_ca_topic_score_gemma":0.00041712247,"teacher_disagreement_score":0.0006058265,"about_ca_system_score_codex":0.00039153756,"about_ca_system_score_gemma":0.00030045447,"threshold_uncertainty_score":0.0028408766},"labels":[],"label_agreement":null},{"id":"W2128766159","doi":"10.1158/1078-0432.ccr-08-2554","title":"Survivin as a Prognostic Marker for Urothelial Carcinoma of the Bladder: A Multicenter External Validation Study","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université Laval","funders":"","keywords":"Survivin; Medicine; Bladder cancer; Cystectomy; Oncology; Hazard ratio; Internal medicine; Concordance; Cancer; Proportional hazards model; Lymphadenectomy; Urology; Confidence interval","score_opus":0.18005516118753936,"score_gpt":0.513638916897088,"score_spread":0.33358375570954857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128766159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981047,0.00023142289,0.0009193194,0.000029600298,0.000011152126,0.000092891365,0.0003609127,0.000018070898,0.0002319034],"genre_scores_gemma":[0.99786025,0.000065818735,0.000594633,0.000027728076,0.000021772383,0.0000873229,0.001249421,0.000009156559,0.000083928535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99690396,0.0015992575,0.0002019898,0.00070432253,0.000455264,0.00013512207],"domain_scores_gemma":[0.9912043,0.0025478513,0.0018463808,0.0019152343,0.0019393135,0.0005469767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007815064,0.00086258067,0.0005522723,0.0005607538,0.0005418688,0.00090541504,0.00086278206,0.000563435,0.0005941899],"category_scores_gemma":[0.0146353515,0.00024601907,0.0005206515,0.00071885105,0.0008080859,0.00033995326,0.00085263455,0.00054639234,0.00040298357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011773659,0.00025806713,0.98783445,0.00004949769,0.00019380498,0.00010498346,0.00027612125,0.00032678826,0.0018224386,0.000029063469,0.0003423506,0.007585066],"study_design_scores_gemma":[0.00028424387,0.001854027,0.99147934,0.000030533112,0.00026694578,0.00075869815,0.00017046706,0.0016182119,0.0017456858,0.00004692447,0.0017297937,0.00001530153],"about_ca_topic_score_codex":0.00149532,"about_ca_topic_score_gemma":0.0012951283,"teacher_disagreement_score":0.007815064,"about_ca_system_score_codex":0.0004921153,"about_ca_system_score_gemma":0.000590968,"threshold_uncertainty_score":0.041330516},"labels":[],"label_agreement":null},{"id":"W2128830817","doi":"10.1158/1078-0432.ccr-05-2043","title":"Lost in (the Business of) Translation: Invest in the Youth","year":2006,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Health and Medical Research Impacts","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Enthusiasm; Publication; Teamwork; Public relations; Dream; Psychology; Medical education; Sociology; Medicine; Political science; Law; Social psychology","score_opus":0.7993934033838257,"score_gpt":0.6432055590149117,"score_spread":0.15618784436891398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128830817","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022019936,0.009704053,0.0002787483,0.57024676,0.41720757,0.00001412833,0.000037225924,0.00009193108,0.0021994563],"genre_scores_gemma":[0.0043252343,0.014176157,0.00044268204,0.41982946,0.5466032,0.000036121608,0.00004382038,0.00018026956,0.014363177],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9901472,0.0031596245,0.0011952551,0.0011974376,0.0030953959,0.0012052035],"domain_scores_gemma":[0.949679,0.020673703,0.0031445865,0.0016527254,0.014298462,0.010551514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0113444915,0.0013046284,0.0012223916,0.0012335207,0.0029745686,0.0102284765,0.0029317443,0.014194709,0.016610857],"category_scores_gemma":[0.06681607,0.0006442524,0.0008799797,0.00094705675,0.004096634,0.008011998,0.002807606,0.016282678,0.0083961],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002234138,0.000010069166,0.000093305156,0.00014885612,0.000008643792,0.00029490414,0.00012678166,0.0000075859843,0.00005063015,0.0009664445,0.9879985,0.010272038],"study_design_scores_gemma":[0.000019106408,0.000026893013,0.00028502382,0.00051842583,0.000020396299,0.0006744311,0.00042793,0.00006996163,0.00014254244,0.0014306785,0.9963631,0.000021381782],"about_ca_topic_score_codex":0.0015391009,"about_ca_topic_score_gemma":0.0037523573,"teacher_disagreement_score":0.016610857,"about_ca_system_score_codex":0.0030942366,"about_ca_system_score_gemma":0.007496061,"threshold_uncertainty_score":0.059996128},"labels":[],"label_agreement":null},{"id":"W2128851111","doi":"10.1158/1078-0432.ccr-07-1189","title":"Plasma Stromal Cell–Derived Factor-1: Host Derived Marker Predictive of Distant Metastasis in Breast Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Breast cancer; Medicine; Stromal cell-derived factor 1; Metastasis; Oncology; Internal medicine; Hazard ratio; Stromal cell; CA15-3; Cancer; CA 15-3; CXCR4; Confidence interval; Receptor","score_opus":0.17050428201655832,"score_gpt":0.45566968099172406,"score_spread":0.28516539897516574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128851111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994363,0.00031148424,0.00011005914,0.000020446705,0.0000025691922,0.0000025049235,0.00005306037,0.0000023727043,0.000061146355],"genre_scores_gemma":[0.99958736,0.0000792521,0.00015799401,0.000010823983,0.000009598421,0.0000038106036,0.00008936185,7.809509e-7,0.0000610184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99990547,0.000031450098,0.000007237061,0.000023982007,0.000016969581,0.000014921616],"domain_scores_gemma":[0.99952364,0.00017254116,0.00016349256,0.000020084906,0.000033185483,0.000087036264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026749633,0.00021778766,0.00026181364,0.00038381593,0.00016194819,0.00024558807,0.00014395233,0.00032774423,0.00094889704],"category_scores_gemma":[0.0009556522,0.000119191674,0.00013842042,0.00034592746,0.00018833896,0.000115783354,0.0001488196,0.0003166862,0.0001517713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009081295,0.00005593655,0.98643315,0.000024529167,0.000038456143,0.000121962104,0.000024034482,0.000132589,0.008530437,0.000013641671,0.00006563338,0.003651543],"study_design_scores_gemma":[0.00004413526,0.0005494472,0.9945515,0.000006384031,0.00007527118,0.0013690975,0.000042671993,0.0007415313,0.0023059805,0.00005996805,0.00024888918,0.000005210127],"about_ca_topic_score_codex":0.00045420526,"about_ca_topic_score_gemma":0.0005525866,"teacher_disagreement_score":0.00094889704,"about_ca_system_score_codex":0.0001425918,"about_ca_system_score_gemma":0.00016713592,"threshold_uncertainty_score":0.0031744242},"labels":[],"label_agreement":null},{"id":"W2128942433","doi":"10.1158/1078-0432.ccr-07-1984","title":"Molecular Characterization of Pediatric Gastrointestinal Stromal Tumors","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":248,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"PDGFRA; GiST; Sunitinib; Cancer research; Imatinib; Tyrosine kinase; Exon; Dasatinib; Tyrosine-kinase inhibitor; Biology; Medicine; Stromal tumor; Imatinib mesylate; Stromal cell; Cancer; Internal medicine; Gene; Receptor; Genetics","score_opus":0.2226870164576549,"score_gpt":0.48617680277974806,"score_spread":0.2634897863220932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128942433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99643815,0.0013506892,0.0011420856,0.000024616525,0.0000033146468,0.000017107139,0.0004628357,0.00002395619,0.00053728046],"genre_scores_gemma":[0.9922273,0.0013580859,0.003808837,0.00003113003,0.000011808361,0.000040200473,0.0021748904,0.000014028019,0.00033374596],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99989736,0.00000923367,0.000013232515,0.000026543195,0.000036309597,0.000017284494],"domain_scores_gemma":[0.99977833,0.00003826984,0.00008163033,0.000011682745,0.000045761917,0.000044291246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012408364,0.00024011779,0.00018024356,0.0008141117,0.000105445455,0.00019723109,0.00012481965,0.00015766415,0.0008363584],"category_scores_gemma":[0.00030566438,0.0000764937,0.0001497664,0.0004484216,0.00014461714,0.00015503248,0.00013108029,0.00018614817,0.00030105517],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046366375,0.000042183117,0.24479091,0.0002337392,0.00003836248,0.0031186917,0.000123041,0.00052356743,0.7275396,0.00015700622,0.0002541041,0.022715075],"study_design_scores_gemma":[0.000024343906,0.0006519861,0.7345822,0.000023656165,0.00007341191,0.038513638,0.0002578949,0.0015204159,0.21736835,0.00010336076,0.006871897,0.000008863915],"about_ca_topic_score_codex":0.000320374,"about_ca_topic_score_gemma":0.00042221678,"teacher_disagreement_score":0.0008363584,"about_ca_system_score_codex":0.00019027849,"about_ca_system_score_gemma":0.00018976192,"threshold_uncertainty_score":0.0027979612},"labels":[],"label_agreement":null},{"id":"W2128973831","doi":"10.1158/1078-0432.ccr-07-0213","title":"L-BLP25: A Peptide Vaccine Strategy in Non–Small Cell Lung Cancer","year":2007,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; MUC1; Peptide vaccine; Oncology; Lung cancer; Internal medicine; Phases of clinical research; Clinical trial; Immunotherapy; Immunology; Cancer; Immune system; Antigen; Epitope","score_opus":0.26149908534422905,"score_gpt":0.5451270522815505,"score_spread":0.2836279669373214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128973831","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027162005,0.9981193,0.00019977397,0.00026997703,0.00027149444,0.000008302439,0.000011644364,0.000011173047,0.0008366299],"genre_scores_gemma":[0.001159835,0.9972193,0.0002896862,0.00029051234,0.00015890322,0.000014613736,0.000030414189,0.000002092849,0.0008346059],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998828,0.000024734294,0.000012637236,0.000020959118,0.000045660236,0.000013218044],"domain_scores_gemma":[0.999887,0.00004393047,0.00001843376,0.0000037543898,0.000029170216,0.00001767531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059955305,0.00088392774,0.0012347625,0.0014093663,0.0002324017,0.0007335981,0.0010699308,0.0012734169,0.0018127096],"category_scores_gemma":[0.00038570937,0.00026696993,0.0003498646,0.0014711777,0.0005420697,0.0014029732,0.00045626154,0.0015334768,0.001965173],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016584758,0.000146612,0.00012551527,0.0070350813,0.00006695297,0.00032080454,0.000042868374,0.0006815982,0.0033765796,0.0025285059,0.03533246,0.9501773],"study_design_scores_gemma":[0.00007715901,0.00024858443,0.00081886986,0.0015802609,0.00006476468,0.0019221047,0.000050337487,0.00018830878,0.0010575347,0.0020178256,0.99195355,0.00002063564],"about_ca_topic_score_codex":0.00082733383,"about_ca_topic_score_gemma":0.001233577,"teacher_disagreement_score":0.0018127096,"about_ca_system_score_codex":0.0006430608,"about_ca_system_score_gemma":0.0005647614,"threshold_uncertainty_score":0.0060640574},"labels":[],"label_agreement":null},{"id":"W2129051737","doi":"10.1158/1078-0432.ccr-08-2080","title":"Human Equilibrative Nucleoside Transporter 1 and Human Concentrative Nucleoside Transporter 3 Predict Survival after Adjuvant Gemcitabine Therapy in Resected Pancreatic Adenocarcinoma","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":218,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Gemcitabine; Medicine; Oncology; Adenocarcinoma; Nucleoside transporter; Internal medicine; Adjuvant therapy; Deoxycytidine; Nucleoside analogue; Chemoradiotherapy; Radiation therapy; Gastroenterology; Chemotherapy; Nucleoside; Cancer; Transporter; Biology","score_opus":0.0951877190489821,"score_gpt":0.43583357500775016,"score_spread":0.34064585595876806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129051737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99964714,0.00018516535,0.000047905116,0.000010567679,0.0000012882824,0.0000015668343,0.000030688258,0.0000014757418,0.00007412822],"genre_scores_gemma":[0.999726,0.00006157329,0.000048444002,0.000006384143,0.0000022403462,0.0000022233146,0.00009047952,6.61465e-7,0.000062027575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999368,0.000015715967,0.000008461255,0.000014723375,0.00001060131,0.0000136414355],"domain_scores_gemma":[0.9996325,0.00009351211,0.00013773299,0.000017224584,0.000027750924,0.000091242124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001894562,0.00016684437,0.00018697733,0.00021837401,0.00018384084,0.00023153427,0.00009063759,0.0002705942,0.0007130787],"category_scores_gemma":[0.0005832963,0.00009069319,0.0001895668,0.00021666984,0.00018080143,0.00016348902,0.00016459567,0.00022475129,0.00011450587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069648697,0.00001868539,0.994449,0.0000067417554,0.000018539906,0.000075657495,0.000021392709,0.00009434774,0.0031730738,0.000003631854,0.000027316246,0.0014151757],"study_design_scores_gemma":[0.000011082332,0.00016968035,0.99801624,0.0000021219655,0.000032218548,0.00044406022,0.000053642943,0.000380505,0.00075458345,0.000013855228,0.00012013174,0.0000019369825],"about_ca_topic_score_codex":0.0010606934,"about_ca_topic_score_gemma":0.0015639814,"teacher_disagreement_score":0.0010606934,"about_ca_system_score_codex":0.00018181518,"about_ca_system_score_gemma":0.00014726864,"threshold_uncertainty_score":0.002385497},"labels":[],"label_agreement":null},{"id":"W2129204208","doi":"10.1158/1078-0432.ccr-08-2138","title":"Overexpression of Phosphorylated Mammalian Target of Rapamycin Predicts Lymph Node Metastasis and Prognosis of Chinese Patients with Gastric Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"Changhai Hospital of Shanghai","keywords":"PI3K/AKT/mTOR pathway; Cancer; Cancer research; Angiogenesis; Lymph node; Malignancy; Immunohistochemistry; Medicine; Tissue microarray; Metastasis; RPTOR; Pathology; Biology; Internal medicine; Signal transduction","score_opus":0.04266997979009579,"score_gpt":0.4012280669517324,"score_spread":0.3585580871616366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129204208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99924743,0.00029664766,0.00007210649,0.000036005335,0.0000030878352,0.0000048730194,0.00013899394,0.0000029041573,0.00019803559],"genre_scores_gemma":[0.9995097,0.00010900942,0.00007361035,0.000011250564,0.0000067378896,0.0000053197446,0.00015253235,8.4747614e-7,0.00013092575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998814,0.000019776804,0.000010449939,0.000038015867,0.000025883832,0.000024427267],"domain_scores_gemma":[0.999772,0.00004823095,0.000069140115,0.0000210894,0.000031777272,0.000057741632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026723352,0.00028459038,0.00030592558,0.0006765272,0.0004441593,0.00021513252,0.00019732381,0.00026711888,0.0009235149],"category_scores_gemma":[0.00061979436,0.00018112185,0.00020770142,0.00067633577,0.00032640406,0.000186413,0.00018701136,0.00022547072,0.00011821732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000308802,0.000027090648,0.9897043,0.000028000835,0.00005101308,0.00026816316,0.000068458954,0.00012433599,0.0061936406,0.000024206694,0.00015966853,0.0030424113],"study_design_scores_gemma":[0.000013078142,0.00008336954,0.9976526,0.0000027126582,0.000054105647,0.00068519433,0.000059784146,0.0003812768,0.0007527717,0.000033926353,0.0002771632,0.00000409259],"about_ca_topic_score_codex":0.0042215153,"about_ca_topic_score_gemma":0.0053745024,"teacher_disagreement_score":0.0042215153,"about_ca_system_score_codex":0.00035562826,"about_ca_system_score_gemma":0.00041767218,"threshold_uncertainty_score":0.008393884},"labels":[],"label_agreement":null},{"id":"W2129219564","doi":"10.1158/1078-0432.ccr-05-1266","title":"Combination Bcl-2 Antisense and Radiation Therapy for Nasopharyngeal Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Radiation therapy; Nasopharyngeal carcinoma; Combination therapy; Cancer; Medicine; Cancer research; Apoptosis; In vitro; In vivo; Chemotherapy; Pharmacology; Internal medicine; Biology","score_opus":0.12311765098564023,"score_gpt":0.4946832448766778,"score_spread":0.3715655938910376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129219564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98829424,0.00602007,0.003305473,0.000103725535,0.000106484775,0.000143227,0.00011802775,0.00013563226,0.0017730386],"genre_scores_gemma":[0.9920271,0.0030005414,0.0029121707,0.000045749206,0.000038774047,0.00008869908,0.00015833658,0.000020361584,0.0017082054],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99985063,0.0000219013,0.000011073453,0.00003726752,0.000054358334,0.000024794148],"domain_scores_gemma":[0.9999391,0.000010087694,0.000017636172,0.000010282361,0.000006243518,0.000016729377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018926355,0.00057809777,0.0006085044,0.000313271,0.00016462753,0.0002988911,0.00028553346,0.00029439974,0.0015019387],"category_scores_gemma":[0.00009516993,0.00014267898,0.00040541607,0.00021071684,0.00026418772,0.00029268223,0.00025374867,0.00062888407,0.00026388638],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068901264,0.00036930537,0.0005027445,0.00016841938,0.000050165138,0.00007021789,0.000028061893,0.00041317032,0.986126,0.00012660753,0.00012919086,0.01132712],"study_design_scores_gemma":[0.00022110695,0.011108322,0.003688386,0.00002116303,0.00017194769,0.0007079765,0.000035161574,0.0011886366,0.9776584,0.000061677245,0.0051231612,0.000014187578],"about_ca_topic_score_codex":0.00052937225,"about_ca_topic_score_gemma":0.0013133317,"teacher_disagreement_score":0.0015019387,"about_ca_system_score_codex":0.00025370027,"about_ca_system_score_gemma":0.00035741535,"threshold_uncertainty_score":0.0050244927},"labels":[],"label_agreement":null},{"id":"W2129272684","doi":"10.1158/1078-0432.ccr-11-0267","title":"BCL2 Predicts Survival in Germinal Center B-cell–like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Diffuse large B-cell lymphoma; Rituximab; Vincristine; Internal medicine; Oncology; CHOP; Lymphoma; Medicine; Germinal center; Survival analysis; Cohort; Cyclophosphamide; B cell; Immunology; Chemotherapy; Antibody","score_opus":0.18120615402389872,"score_gpt":0.4198209906312234,"score_spread":0.2386148366073247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129272684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993819,0.00035577128,0.00004613773,0.000029518967,0.0000048494044,0.0000024313742,0.000040668827,0.0000021636417,0.00013641235],"genre_scores_gemma":[0.9996637,0.000068631016,0.000027371012,0.000019970174,0.000012271054,0.0000026360012,0.00014311027,9.1066755e-7,0.000061416154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998242,0.000059595215,0.000016297445,0.000040990533,0.000030693493,0.000028093662],"domain_scores_gemma":[0.9993468,0.00018261478,0.00021242921,0.000034656525,0.000048401624,0.00017519738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047622772,0.0001609827,0.00032090684,0.00029029726,0.000183443,0.0003427047,0.00016772293,0.00033132854,0.000724525],"category_scores_gemma":[0.001254463,0.00009131471,0.0002378495,0.00026380262,0.00019696762,0.00027502334,0.00020074847,0.0003666266,0.00016809662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016101808,0.00007481394,0.99197876,0.000010322438,0.00006578392,0.000104764826,0.00003736488,0.00013293675,0.0014338245,0.000009584489,0.00011624057,0.0044254246],"study_design_scores_gemma":[0.00005296258,0.0004380328,0.9975145,0.000006684038,0.00006960479,0.00055268884,0.00006594802,0.00062202534,0.0003176849,0.000028502043,0.00032807136,0.0000033255008],"about_ca_topic_score_codex":0.0005447203,"about_ca_topic_score_gemma":0.0007395755,"teacher_disagreement_score":0.000724525,"about_ca_system_score_codex":0.00021770483,"about_ca_system_score_gemma":0.00015054099,"threshold_uncertainty_score":0.0025185347},"labels":[],"label_agreement":null},{"id":"W2129421122","doi":"10.1158/1078-0432.ccr-06-0417","title":"Preoperative Serum Caveolin-1 as a Prognostic Marker for Recurrence in a Radical Prostatectomy Cohort","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Caveolin-1 and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"U.S. Public Health Service","keywords":"Medicine; Prostate cancer; Prostatectomy; Biochemical recurrence; Urology; Cancer; Biopsy; Prostate; Hyperplasia; Internal medicine; Prostate-specific antigen; Gastroenterology","score_opus":0.06217896681813289,"score_gpt":0.45919158165975277,"score_spread":0.39701261484161987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129421122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99967873,0.00012223695,0.000059595808,0.000016030635,0.0000031549278,0.000002713174,0.00004582793,0.0000030805686,0.00006866806],"genre_scores_gemma":[0.9997974,0.000030208786,0.000035508798,0.0000075910807,0.0000067345923,0.000002814363,0.00008356065,8.157966e-7,0.000035269382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998029,0.000043758948,0.0000143701,0.00005844893,0.000043734122,0.00003675274],"domain_scores_gemma":[0.9993104,0.00016829917,0.00020535804,0.000068582485,0.000038084054,0.00020923308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043003046,0.00021118145,0.00035305638,0.0004185879,0.0003119983,0.00036982435,0.00028271842,0.0002905049,0.001032802],"category_scores_gemma":[0.0012394777,0.00020016647,0.00030578708,0.00028515368,0.00030732324,0.00026963797,0.00031194504,0.00046533658,0.00013282568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037207687,0.000023744908,0.99747735,0.0000043040923,0.00004365429,0.00011240538,0.000026988899,0.000058726633,0.0008236285,0.0000071446243,0.000057744528,0.0009920979],"study_design_scores_gemma":[0.000015636799,0.00018909658,0.9983583,0.0000022720128,0.000041500247,0.00066471036,0.000051479856,0.00039577196,0.00018426294,0.000014812433,0.000077359975,0.0000047180847],"about_ca_topic_score_codex":0.0015178069,"about_ca_topic_score_gemma":0.0017829125,"teacher_disagreement_score":0.0015178069,"about_ca_system_score_codex":0.00018825944,"about_ca_system_score_gemma":0.00026277266,"threshold_uncertainty_score":0.0034550428},"labels":[],"label_agreement":null},{"id":"W2129471398","doi":"10.1158/1078-0432.ccr-06-3085","title":"Imaging and Modulating Antisense Microdistribution in Solid Human Xenograft Tumor Models","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"University of Pennsylvania","keywords":"Biodistribution; Tumor microenvironment; Distribution (mathematics); Apoptosis; Necrosis; Cancer research; Tumor hypoxia; Hypoxia (environmental); Pathology; Chemistry; Medicine; Radiation therapy; Tumor cells; In vitro; Internal medicine; Biochemistry; Oxygen","score_opus":0.1504211699665401,"score_gpt":0.5180432461237009,"score_spread":0.3676220761571608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129471398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9513342,0.0018980748,0.04389671,0.000094151575,0.00003997128,0.00015439701,0.0006784948,0.00040066373,0.0015034938],"genre_scores_gemma":[0.970719,0.0017746565,0.023763366,0.000025878466,0.000010888452,0.00016108772,0.0007747527,0.000058043923,0.002712331],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998646,0.000021687854,0.0000070085102,0.000044082753,0.00004386226,0.000018776112],"domain_scores_gemma":[0.999923,0.000016431699,0.000024222329,0.000009949976,0.00001538828,0.000011014964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027624876,0.00047335433,0.00026297467,0.00028210884,0.000110236004,0.00023072089,0.00021498428,0.00023983225,0.0007288189],"category_scores_gemma":[0.00010202766,0.00016877358,0.00018594028,0.00021314203,0.000216107,0.00016690644,0.000141367,0.00043324684,0.0002704784],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007393043,0.000035292796,0.00015679607,0.000025846384,0.0000036411839,0.000018139994,0.000017024053,0.00042955895,0.997934,0.00006336566,0.00004190172,0.0012006325],"study_design_scores_gemma":[0.000014525716,0.0003910543,0.0012616967,0.0000026425332,0.000013414274,0.00010034948,0.000016263688,0.004339449,0.9928156,0.000023371182,0.0010182129,0.0000033819988],"about_ca_topic_score_codex":0.0020428668,"about_ca_topic_score_gemma":0.002542193,"teacher_disagreement_score":0.0020428668,"about_ca_system_score_codex":0.00037982443,"about_ca_system_score_gemma":0.00025110153,"threshold_uncertainty_score":0.004061997},"labels":[],"label_agreement":null},{"id":"W2129522972","doi":"10.1158/1078-0432.ccr-07-0318","title":"Tolerability, Pharmacodynamics, and Pharmacokinetics Studies of Depsipeptide (Romidepsin) in Patients with Acute Myelogenous Leukemia or Advanced Myelodysplastic Syndromes","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Leukemia and Lymphoma Society","keywords":"Medicine; Neutropenia; Tolerability; Depsipeptide; Pharmacology; Pharmacodynamics; Internal medicine; Leukemia; Myeloid leukemia; Oncology; Pharmacokinetics; Chemotherapy; Adverse effect; Biology","score_opus":0.12817282416867606,"score_gpt":0.4773455310330927,"score_spread":0.3491727068644166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129522972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972222,0.001715695,0.00043415985,0.00007622995,0.000007660896,0.00004832973,0.00009786794,0.000020893043,0.00037714007],"genre_scores_gemma":[0.9985153,0.0005536688,0.00037562184,0.00011099295,0.000026614262,0.000038301005,0.00020040272,0.000004992756,0.00017398526],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99975735,0.00014119127,0.000015966927,0.00003192001,0.000034185952,0.000019373821],"domain_scores_gemma":[0.9996294,0.000110324116,0.00013760681,0.000018184714,0.000024807201,0.000079684316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004846058,0.00045089202,0.00061238674,0.00010170798,0.00012081531,0.00021040124,0.00015857542,0.0002221796,0.00057959574],"category_scores_gemma":[0.00074744655,0.00012255895,0.00032200766,0.0001418991,0.00022602259,0.00016321737,0.000086903274,0.0005493315,0.00017180188],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15228848,0.0066610146,0.16725813,0.00093741115,0.0014472093,0.0026849457,0.00067370036,0.007596958,0.3943139,0.00026507577,0.0023992346,0.26347387],"study_design_scores_gemma":[0.014914698,0.52740055,0.38345906,0.000066678695,0.0010215518,0.0072287773,0.00019599547,0.0057523455,0.052246936,0.00020830167,0.007463822,0.000041225667],"about_ca_topic_score_codex":0.00022848707,"about_ca_topic_score_gemma":0.00039250214,"teacher_disagreement_score":0.00061238674,"about_ca_system_score_codex":0.00024571994,"about_ca_system_score_gemma":0.0001614842,"threshold_uncertainty_score":0.002562821},"labels":[],"label_agreement":null},{"id":"W2129567747","doi":"10.1158/1078-0432.ccr-09-2824","title":"Cancer Stem Cells and Self-renewal","year":2010,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":474,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Cancer; Cancer stem cell; Context (archaeology); Stem cell; Cancer cell; Biology; Cancer research; Confusion; Neuroscience; Cell biology; Psychology; Genetics","score_opus":0.4688566519017544,"score_gpt":0.611672748125227,"score_spread":0.14281609622347258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129567747","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015903056,0.98864615,0.0010604555,0.0026474497,0.0005592665,0.000011471955,0.00003675422,0.000018941637,0.005429317],"genre_scores_gemma":[0.031982116,0.96097285,0.0006771461,0.0017193787,0.0011887049,0.00003685111,0.00012410816,0.000008137391,0.0032906786],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995839,0.00009907007,0.00003636113,0.00006774787,0.00016343975,0.00004949497],"domain_scores_gemma":[0.9996339,0.00015542707,0.00005468928,0.000015257479,0.00009707558,0.000043571752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073120993,0.00029408385,0.00065057,0.0009234358,0.00032164776,0.0011650432,0.00056231103,0.0011503235,0.0019455994],"category_scores_gemma":[0.0006792516,0.00010653325,0.00022930918,0.0010787268,0.0013639773,0.0010243884,0.00078139134,0.0014223874,0.00095345225],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001387246,0.00006535991,0.0008731347,0.007934829,0.000048351285,0.00067200046,0.0006490814,0.0008511676,0.014743939,0.17168306,0.037534725,0.7648057],"study_design_scores_gemma":[0.000013016705,0.00011790715,0.0013549614,0.001147952,0.000023564116,0.0012588936,0.00019063169,0.00026480982,0.0044926833,0.038643386,0.9524731,0.000019110743],"about_ca_topic_score_codex":0.0008318495,"about_ca_topic_score_gemma":0.00065241876,"teacher_disagreement_score":0.0019455994,"about_ca_system_score_codex":0.00092937605,"about_ca_system_score_gemma":0.0011675311,"threshold_uncertainty_score":0.0067430735},"labels":[],"label_agreement":null},{"id":"W2129726505","doi":"10.1158/1078-0432.ccr-05-1109","title":"Strategies for Delaying or Treating<i>In vivo</i>Acquired Resistance to Trastuzumab in Human Breast Cancer Xenografts","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Health Sciences Centre; Mount Sinai Hospital; Sunnybrook Health Science Centre","funders":"Oncosuisse; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Trastuzumab; In vivo; Breast cancer; Medicine; Acquired resistance; Human breast; Oncology; Cancer; Internal medicine; Cancer research; Biology; Biotechnology","score_opus":0.276028954774144,"score_gpt":0.5780301207621373,"score_spread":0.3020011659879933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129726505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9684079,0.009591966,0.014616143,0.0006798677,0.0001645764,0.00056172354,0.000627894,0.00036035536,0.0049894904],"genre_scores_gemma":[0.9804869,0.004872733,0.010679967,0.00021381269,0.00004093042,0.00024165618,0.0008933604,0.0000405325,0.002530215],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999075,0.000018745644,0.000008554516,0.000019689418,0.000019413892,0.000026026988],"domain_scores_gemma":[0.99993443,0.000009714862,0.000020287656,0.000010196653,0.000009437705,0.000015991396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018840111,0.00038923448,0.00030062956,0.00016064229,0.00011871743,0.000379211,0.00039760084,0.00028470735,0.0008810309],"category_scores_gemma":[0.00011339462,0.000117506024,0.00024777162,0.00011460942,0.0001277888,0.00017416196,0.00015121486,0.000678906,0.0003327197],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002279413,0.00042262065,0.00035312606,0.00013850928,0.000016928248,0.00005378186,0.000021591846,0.0005486442,0.986167,0.00022382475,0.0003728199,0.011453129],"study_design_scores_gemma":[0.00026328216,0.004735666,0.0029466692,0.000030671017,0.000084482526,0.00056886324,0.000031406504,0.0023024895,0.97605056,0.00007306948,0.012901381,0.000011456365],"about_ca_topic_score_codex":0.00044530927,"about_ca_topic_score_gemma":0.00090710097,"teacher_disagreement_score":0.0008810309,"about_ca_system_score_codex":0.0002798025,"about_ca_system_score_gemma":0.00024074614,"threshold_uncertainty_score":0.0029472709},"labels":[],"label_agreement":null},{"id":"W2129802843","doi":"10.1158/1078-0432.ccr-06-0527","title":"Cancer-Testis Antigens: Expression and Correlation with Survival in Human Urothelial Carcinoma","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Antigen; Urothelium; Immunohistochemistry; Cancer; Medicine; Bladder cancer; Cancer research; Cancer vaccine; Immunogenicity; Immunotherapy; Carcinoma; Pathology; Oncology; Urinary bladder; Immunology; Internal medicine","score_opus":0.10172343922386193,"score_gpt":0.43310771858183345,"score_spread":0.33138427935797155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129802843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985734,0.0009308183,0.00014056296,0.000027855274,0.0000025764189,0.0000033790154,0.00009860091,0.0000056687136,0.0002170918],"genre_scores_gemma":[0.9993672,0.0002127281,0.00008102812,0.000009184023,0.00000336496,0.0000030751125,0.0001576044,8.637243e-7,0.00016496194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999224,0.000019697223,0.0000072065213,0.000014462633,0.000015937916,0.000020260266],"domain_scores_gemma":[0.99954045,0.00013210501,0.0001625045,0.000023265275,0.00006135385,0.00008028851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017586377,0.00011438364,0.000103278166,0.00037002168,0.00010606343,0.00018657341,0.000058389232,0.0002042082,0.0010471796],"category_scores_gemma":[0.000712353,0.00005972026,0.00006285125,0.0003454104,0.00018336152,0.00010920597,0.00012239626,0.00018771579,0.00015090978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076843286,0.00007236546,0.9373947,0.000072254916,0.00005202768,0.00020414135,0.00009480644,0.0003799378,0.0490938,0.000046827525,0.00022988858,0.01159093],"study_design_scores_gemma":[0.000012344521,0.00034500088,0.9887997,0.0000065615486,0.00003374207,0.0011659447,0.00006574405,0.000466383,0.008357286,0.00004716972,0.0006963818,0.0000036555396],"about_ca_topic_score_codex":0.0006246307,"about_ca_topic_score_gemma":0.0005464616,"teacher_disagreement_score":0.0010471796,"about_ca_system_score_codex":0.0001480066,"about_ca_system_score_gemma":0.000104372455,"threshold_uncertainty_score":0.0035032034},"labels":[],"label_agreement":null},{"id":"W2129890171","doi":"10.1158/1078-0432.ccr-03-0561","title":"Synergistic Induction of Oxidative Injury and Apoptosis in Human Multiple Myeloma Cells by the Proteasome Inhibitor Bortezomib and Histone Deacetylase Inhibitors","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":381,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Bortezomib; Sodium butyrate; Apoptosis; Histone deacetylase inhibitor; Histone deacetylase; Proteasome inhibitor; Chemistry; Pharmacology; Cancer research; Biology; Multiple myeloma; Biochemistry; Histone; Immunology","score_opus":0.05259905812903075,"score_gpt":0.42632650504431585,"score_spread":0.3737274469152851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129890171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924205,0.005333503,0.0010347196,0.00008110186,0.00004168075,0.000045099063,0.00017960781,0.000033916596,0.00082992093],"genre_scores_gemma":[0.995769,0.0020305393,0.0009694097,0.00006522668,0.000023987799,0.00004705734,0.00032875934,0.000004555326,0.00076147733],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997508,0.00004795488,0.000023352917,0.000043072694,0.00007778235,0.00005698787],"domain_scores_gemma":[0.99993753,0.000008364575,0.000019821004,0.000009211551,0.000009807468,0.00001534788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021303863,0.0003919607,0.0005060203,0.0001795492,0.00019070585,0.0002690984,0.00016382438,0.0002807407,0.0011082692],"category_scores_gemma":[0.00009669708,0.00017304892,0.00043216735,0.00022018378,0.00014957233,0.00015756603,0.00023753765,0.00043936353,0.0002068238],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071655336,0.00008794105,0.00077016314,0.00007962356,0.00003609424,0.00012795885,0.000022145294,0.00009404003,0.99562895,0.00003608185,0.000047426794,0.0023530386],"study_design_scores_gemma":[0.00012818718,0.0020552615,0.016428307,0.00001074277,0.0000734521,0.0005043104,0.00005323139,0.0005367568,0.9779816,0.000035778277,0.0021870856,0.0000052128644],"about_ca_topic_score_codex":0.0005230999,"about_ca_topic_score_gemma":0.0011156555,"teacher_disagreement_score":0.0011082692,"about_ca_system_score_codex":0.000329879,"about_ca_system_score_gemma":0.00023819853,"threshold_uncertainty_score":0.0037074685},"labels":[],"label_agreement":null},{"id":"W2130227695","doi":"10.1158/1078-0432.ccr-11-2893","title":"L1 Cell Adhesion Molecule Promotes Tumorigenicity and Metastatic Potential in Non–Small Cell Lung Cancer","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neurogenesis and neuroplasticity mechanisms","field":"Neuroscience","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Cell adhesion molecule; Cancer; Cell adhesion; Cancer research; Cell; Lung cancer; Medicine; Pathology; Lung; Biology; Immunology; Internal medicine; Biochemistry","score_opus":0.18954530492282795,"score_gpt":0.455530337104357,"score_spread":0.265985032181529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130227695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99524236,0.0032369413,0.0005919307,0.00012481943,0.0000101201795,0.000018376764,0.00027939954,0.00006415278,0.00043200562],"genre_scores_gemma":[0.9972801,0.0010417923,0.0003027186,0.000046250792,0.000008768446,0.000020134996,0.00057139184,0.000006673755,0.00072201353],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998846,0.00001917105,0.000009130183,0.000022255525,0.00004123493,0.000023582143],"domain_scores_gemma":[0.9997831,0.00005063011,0.00008942326,0.000013372736,0.000026016107,0.000037484784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021245968,0.000291752,0.00027228775,0.00039813525,0.00018973586,0.00033621877,0.00015364867,0.00017805997,0.0014864072],"category_scores_gemma":[0.00029501395,0.00010507467,0.0002558532,0.00023295941,0.00018551138,0.00015660052,0.0001888457,0.00047578785,0.00026123118],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010297075,0.00027736227,0.04807885,0.00030448314,0.00007269109,0.00020664441,0.00005399394,0.0005920465,0.9284017,0.00011615692,0.00054824946,0.020318104],"study_design_scores_gemma":[0.00012071934,0.002772527,0.5313408,0.000047961075,0.00029043737,0.0011445027,0.0001541877,0.008343985,0.450177,0.00020097462,0.0053829295,0.000024020354],"about_ca_topic_score_codex":0.0010652792,"about_ca_topic_score_gemma":0.0014267524,"teacher_disagreement_score":0.0014864072,"about_ca_system_score_codex":0.00037347898,"about_ca_system_score_gemma":0.0003444379,"threshold_uncertainty_score":0.004972577},"labels":[],"label_agreement":null},{"id":"W2130368065","doi":"10.1158/1078-0432.ccr-12-1175","title":"Optimizing Cancer Treatments to Induce an Acute Immune Response: Radiation Abscopal Effects, PAMPs, and DAMPs","year":2012,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Abscopal effect; Immune system; Cancer; Medicine; Immunology; Bystander effect; Cancer research; Immunotherapy; Internal medicine","score_opus":0.2939837311303082,"score_gpt":0.6082649828642805,"score_spread":0.31428125173397237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130368065","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027387176,0.9988914,0.00016175749,0.000095997406,0.000050120794,0.000007707177,0.000008186592,0.000004799307,0.0005061828],"genre_scores_gemma":[0.0018660349,0.9971493,0.00033213905,0.00011189586,0.000058203637,0.000014587187,0.00002235494,0.0000014267436,0.00044406793],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998375,0.0000398336,0.000023194287,0.00002666328,0.0000563067,0.000016419284],"domain_scores_gemma":[0.9998103,0.00009564049,0.000039272345,0.000005941917,0.00003760342,0.000011138162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045300668,0.00081773766,0.0013351967,0.0019722306,0.00020153864,0.00062851736,0.0005679636,0.0010075124,0.0019747308],"category_scores_gemma":[0.00046153174,0.00026351528,0.0005861416,0.001473444,0.00035324943,0.0008322662,0.00040646226,0.0011228187,0.0008757706],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010927399,0.00017561585,0.00020585256,0.03027254,0.00014570123,0.00018792755,0.000063240885,0.000559387,0.0071535944,0.0022098166,0.007830603,0.9510864],"study_design_scores_gemma":[0.00008415097,0.00060211204,0.002574326,0.008230191,0.00037108726,0.0037885823,0.00014253643,0.00032937172,0.00746699,0.0029257487,0.97343916,0.000045803085],"about_ca_topic_score_codex":0.0006861319,"about_ca_topic_score_gemma":0.0012834962,"teacher_disagreement_score":0.0019747308,"about_ca_system_score_codex":0.0004138671,"about_ca_system_score_gemma":0.00052279956,"threshold_uncertainty_score":0.0066061616},"labels":[],"label_agreement":null},{"id":"W2130493310","doi":"10.1158/1078-0432.ccr-07-1655","title":"Vascular Endothelial Growth Factor Genotypes, Haplotypes, Gender, and the Risk of Non–Small Cell Lung Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Massachusetts General Hospital","keywords":"Haplotype; Odds ratio; Genotype; Adenocarcinoma; Lung cancer; Internal medicine; Oncology; Vascular endothelial growth factor; Confidence interval; Angiogenesis; Risk factor; Metastasis; Biology; Adenocarcinoma of the lung; Medicine; Cancer; Gastroenterology; Genetics; VEGF receptors; Gene","score_opus":0.09929758452073889,"score_gpt":0.40676638897279505,"score_spread":0.30746880445205615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130493310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99936813,0.00026440705,0.00009934555,0.000025969299,0.000007952196,0.0000033143301,0.00011342728,0.0000029325472,0.000114445735],"genre_scores_gemma":[0.99957854,0.00006330698,0.00010040553,0.000015207868,0.000010603385,0.0000041709236,0.00011546812,0.0000020266002,0.00011016932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996972,0.00011130951,0.000022869732,0.00008848408,0.00004559546,0.000034555622],"domain_scores_gemma":[0.9988343,0.00036553957,0.00040657766,0.000093529095,0.00006712125,0.00023280045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005977648,0.00030069347,0.0002657046,0.0003047388,0.00025577002,0.00030182998,0.00022370307,0.00040766696,0.001577031],"category_scores_gemma":[0.0024200974,0.00017387392,0.00026793024,0.00033776282,0.00023711608,0.00016761439,0.00013551756,0.0003295804,0.00018236591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037754647,0.00003863925,0.9975231,0.0000062325566,0.000078248995,0.00008024806,0.000021156535,0.000042657644,0.00074428366,0.000011644248,0.000050249044,0.001025832],"study_design_scores_gemma":[0.000029787587,0.00024664853,0.99835,0.000005084628,0.000072117495,0.0005679961,0.000028624294,0.00033978108,0.000182873,0.00005439199,0.00011926597,0.000003365288],"about_ca_topic_score_codex":0.0015624386,"about_ca_topic_score_gemma":0.0017056486,"teacher_disagreement_score":0.001577031,"about_ca_system_score_codex":0.00011191616,"about_ca_system_score_gemma":0.00016896518,"threshold_uncertainty_score":0.0052756667},"labels":[],"label_agreement":null},{"id":"W2130626169","doi":"10.1158/1078-0432.ccr-08-2034","title":"Alternate Endpoints for Screening Phase II Studies","year":2009,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Surrogate endpoint; Clinical trial; Clinical endpoint; Medicine; Oncology; Phases of clinical research; Clinical study design; Endpoint Determination; Internal medicine; Progression-free survival; Intensive care medicine; Overall survival","score_opus":0.8305681950274587,"score_gpt":0.737661612883971,"score_spread":0.09290658214348768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130626169","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008060194,0.9515372,0.028781252,0.0026497673,0.0022858481,0.0032376023,0.00065756997,0.00017281338,0.0098720435],"genre_scores_gemma":[0.015669588,0.85864925,0.10169335,0.006191434,0.002229673,0.009317517,0.0014695674,0.00014768902,0.0046319254],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9421726,0.039576195,0.008012755,0.0014958387,0.008412666,0.00033006672],"domain_scores_gemma":[0.8620111,0.112306096,0.012423147,0.00366536,0.008470559,0.0011237619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06396719,0.0020747238,0.006836609,0.0062063634,0.000426916,0.0038899619,0.0029977374,0.0034709247,0.0076006055],"category_scores_gemma":[0.07271254,0.00055620016,0.003466471,0.0061284825,0.0022303401,0.0037333695,0.0016242516,0.005256637,0.0027558003],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011917563,0.00026849023,0.0010746802,0.07738984,0.00087197335,0.00019361399,0.0002389806,0.0008867901,0.0012352306,0.027861636,0.029056158,0.8597308],"study_design_scores_gemma":[0.0014372517,0.002188482,0.004870848,0.07424111,0.0023119245,0.0017390233,0.00032680997,0.001710094,0.0024715206,0.041386653,0.867102,0.00021423474],"about_ca_topic_score_codex":0.0004178675,"about_ca_topic_score_gemma":0.00080876146,"teacher_disagreement_score":0.06396719,"about_ca_system_score_codex":0.001874412,"about_ca_system_score_gemma":0.004155494,"threshold_uncertainty_score":0.33829486},"labels":[],"label_agreement":null},{"id":"W2130742597","doi":"10.1158/1078-0432.ccr-06-1248","title":"Chromosomal Instability in Microsatellite-Unstable and Stable Colon Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Microsatellite instability; Comparative genomic hybridization; Genome instability; Chromosome instability; Biology; Cancer; Colorectal cancer; Fluorescence in situ hybridization; Chromosome; Microsatellite; Cancer research; Genetics; Gene; DNA","score_opus":0.16768312542311398,"score_gpt":0.5015137866955154,"score_spread":0.3338306612724014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130742597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99823344,0.0012019726,0.00024959748,0.000013275789,0.0000012813949,0.000003805054,0.000074019015,0.000007384933,0.00021525308],"genre_scores_gemma":[0.9992236,0.00027596045,0.00023179702,0.000009039303,0.000004470617,0.0000050712188,0.00014922074,0.0000017468161,0.00009894694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999816,0.000032613636,0.000017552225,0.000045349774,0.00006198325,0.000026585467],"domain_scores_gemma":[0.9996662,0.00007613541,0.00015927566,0.000014421676,0.000034893084,0.000049039798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019189733,0.0001501542,0.00015996973,0.000993751,0.00016907864,0.00024019885,0.00010638118,0.00018725333,0.0010498846],"category_scores_gemma":[0.0006149289,0.00007623635,0.00009385198,0.000571206,0.00018653322,0.00012185393,0.00020539919,0.00012349816,0.00015053124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016478455,0.00004186442,0.5692943,0.00022123332,0.0001222602,0.0010519852,0.00021847452,0.00025620582,0.40493843,0.00015625662,0.00013623928,0.021915043],"study_design_scores_gemma":[0.00001551338,0.0003712511,0.97457135,0.000013626217,0.000050508712,0.004328479,0.00011476302,0.00037806068,0.019083466,0.00013704013,0.0009299033,0.00000607748],"about_ca_topic_score_codex":0.00044203788,"about_ca_topic_score_gemma":0.00064933795,"teacher_disagreement_score":0.0010498846,"about_ca_system_score_codex":0.00021517991,"about_ca_system_score_gemma":0.00012145557,"threshold_uncertainty_score":0.0035122037},"labels":[],"label_agreement":null},{"id":"W2130754064","doi":"10.1158/1078-0432.ccr-04-2326","title":"Dietary Flaxseed Alters Tumor Biological Markers in Postmenopausal Breast Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Phytoestrogen effects and research","field":"Medicine","cited_by":258,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Placebo; Medicine; Lignan; Internal medicine; Endocrinology; Breast cancer; Cancer; Excretion; Estrogen receptor; Apoptosis; Gastroenterology; Pathology; Biology; Biochemistry","score_opus":0.22389807704100073,"score_gpt":0.5382547488973091,"score_spread":0.31435667185630833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130754064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99853635,0.001071932,0.00005976673,0.00004648551,0.000016637476,0.000060521437,0.000047071564,0.000008158099,0.00015295322],"genre_scores_gemma":[0.9984988,0.0006009257,0.00020376054,0.00009720051,0.000025680272,0.00007410353,0.00009517115,0.000002109041,0.00040229768],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9998895,0.00004437498,0.000010644471,0.000019662642,0.000014685461,0.00002123773],"domain_scores_gemma":[0.99984956,0.000040300976,0.000045459597,0.0000111789,0.000011239126,0.00004228609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031311603,0.00031769348,0.0005895469,0.00015178461,0.00016124171,0.00017405207,0.00016052638,0.00042649807,0.0016659319],"category_scores_gemma":[0.00043847653,0.00016266629,0.0002815631,0.00012841482,0.0002100657,0.00015634763,0.000118922384,0.0003915342,0.00012777367],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.67875016,0.01633139,0.013805698,0.00071287405,0.0008255504,0.00011869659,0.000107906504,0.00029885644,0.21489707,0.000043589396,0.00032367828,0.073784605],"study_design_scores_gemma":[0.110575885,0.6773639,0.16345993,0.00008718707,0.0017245897,0.00036943238,0.00016420906,0.0008101963,0.041903745,0.00015048853,0.00335986,0.000030667983],"about_ca_topic_score_codex":0.00051216513,"about_ca_topic_score_gemma":0.0011370844,"teacher_disagreement_score":0.0016659319,"about_ca_system_score_codex":0.0001824687,"about_ca_system_score_gemma":0.00021212915,"threshold_uncertainty_score":0.0055730343},"labels":[],"label_agreement":null},{"id":"W2130808338","doi":"10.1158/1078-0432.ccr-09-1467","title":"MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":378,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan","funders":"National Institutes of Health; Howard Hughes Medical Institute","keywords":"Adenocarcinoma; Tissue microarray; Medicine; Esophagus; microRNA; Cancer; Carcinogenesis; Oncology; Carcinoma; Stage (stratigraphy); Pathology; Internal medicine; Esophageal cancer; Biology; Gene","score_opus":0.06184540703168849,"score_gpt":0.3949153091517561,"score_spread":0.3330699021200676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130808338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99832267,0.0011584824,0.0001281005,0.00003275145,0.0000050712483,0.0000054701854,0.0002118639,0.000006498782,0.00012896786],"genre_scores_gemma":[0.99917895,0.00026103432,0.0001924816,0.000014466978,0.000009181925,0.000008628714,0.00027178347,0.0000025142285,0.000060904942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970967,0.00007056382,0.00004354058,0.00009367536,0.000056303794,0.000026372325],"domain_scores_gemma":[0.99901366,0.00015337304,0.0004627447,0.000087920314,0.00013809661,0.00014412118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054589676,0.0002493723,0.00037237207,0.0005257201,0.00023003094,0.00034691312,0.00019082463,0.00027079837,0.00076650386],"category_scores_gemma":[0.0014182607,0.00013529818,0.00029652083,0.00072804384,0.00021367555,0.00016323326,0.00034015471,0.00022147065,0.00016651253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045584422,0.000024596991,0.9924697,0.000029299037,0.00009828049,0.000044984976,0.00003227717,0.000057318248,0.004546852,0.000009367518,0.00005580677,0.0021755958],"study_design_scores_gemma":[0.0000062036706,0.00010982844,0.9983701,0.0000053005406,0.000079522026,0.00028062504,0.000046015477,0.00018341656,0.0007096892,0.000014321153,0.00019258514,0.000002469003],"about_ca_topic_score_codex":0.0010643004,"about_ca_topic_score_gemma":0.0011832302,"teacher_disagreement_score":0.0010643004,"about_ca_system_score_codex":0.00023983362,"about_ca_system_score_gemma":0.00022034401,"threshold_uncertainty_score":0.0028870702},"labels":[],"label_agreement":null},{"id":"W2131040288","doi":"10.1158/1078-0432.ccr-05-2249","title":"Population Pharmacokinetics of Troxacitabine, a Novel Dioxolane Nucleoside Analogue","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pharmacokinetics; NONMEM; Population; Body surface area; Renal function; Urology; Medicine; Creatinine; Population pharmacokinetics; Pharmacology; Internal medicine","score_opus":0.20776488926564352,"score_gpt":0.5311713751562727,"score_spread":0.32340648589062915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131040288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73112607,0.0014382933,0.26490882,0.00025358106,0.000019840003,0.00011926934,0.0005514233,0.0003162479,0.0012663573],"genre_scores_gemma":[0.9812618,0.0007045611,0.01585033,0.00008786641,0.000015720232,0.00021369982,0.0006265211,0.000027352688,0.0012121754],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99969125,0.00012719957,0.0000088995075,0.00009842091,0.000047610225,0.00002658598],"domain_scores_gemma":[0.99942124,0.0003533134,0.00011304928,0.00003010845,0.00006588443,0.000016405154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009352089,0.0004665064,0.00066922355,0.00012737175,0.00007839048,0.00053549337,0.00045275068,0.00049667916,0.00056322047],"category_scores_gemma":[0.0020550427,0.00021356861,0.0005034807,0.00013693368,0.0002271696,0.00038582555,0.00017361101,0.0006797101,0.00020230857],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016022419,0.00033878,0.03426045,0.00019394311,0.0005167774,0.00029580944,0.00019016073,0.8787039,0.035809238,0.0019616836,0.0009341205,0.045192923],"study_design_scores_gemma":[0.00011008796,0.00096000143,0.010504743,0.000009338825,0.00015688325,0.00018980414,0.000014541557,0.9812367,0.0044338335,0.0010725709,0.0012914235,0.000020140089],"about_ca_topic_score_codex":0.0026055463,"about_ca_topic_score_gemma":0.0014435098,"teacher_disagreement_score":0.0026055463,"about_ca_system_score_codex":0.0006307515,"about_ca_system_score_gemma":0.00061834767,"threshold_uncertainty_score":0.005180776},"labels":[],"label_agreement":null},{"id":"W2131053533","doi":"10.1158/1078-0432.ccr-04-2528","title":"Human Kallikrein 6: A New Potential Serum Biomarker for Uterine Serous Papillary Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Serous fluid; Carcinoma; Serous carcinoma; Endometrial cancer; Clear cell carcinoma; Ovarian cancer; Cancer; Ovarian carcinoma; Pathology; Internal medicine; Biomarker; Biology","score_opus":0.31802781249648887,"score_gpt":0.5754897536771071,"score_spread":0.2574619411806182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131053533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99049485,0.006775393,0.0017706151,0.00016922539,0.000027718652,0.000021672171,0.00021923674,0.0000640725,0.00045721978],"genre_scores_gemma":[0.99627113,0.0009225224,0.0022945306,0.000051064704,0.000031766354,0.000009858701,0.00018180863,0.000002304503,0.00023503744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99990475,0.000027669941,0.000009945554,0.000019031097,0.000028618853,0.000010060198],"domain_scores_gemma":[0.9998042,0.000043628326,0.0000706511,0.000009390305,0.000037624606,0.000034434666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030520544,0.00024841973,0.00025752228,0.00045591412,0.000112700836,0.00032995606,0.00019272209,0.0003615837,0.00060111185],"category_scores_gemma":[0.0006774072,0.000090379624,0.00011861276,0.0002747657,0.00026318937,0.00018518478,0.00017891533,0.00023701844,0.00017928849],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025371874,0.00010763401,0.6693291,0.00043675123,0.00012960997,0.0009265947,0.00012853953,0.0004002196,0.27304476,0.00012075978,0.0008094997,0.052029394],"study_design_scores_gemma":[0.00007825668,0.0017875658,0.88538206,0.000058073067,0.00023993978,0.00965176,0.0002149711,0.0062832157,0.09112513,0.0002918119,0.0048617725,0.000025378278],"about_ca_topic_score_codex":0.00046844306,"about_ca_topic_score_gemma":0.00045945958,"teacher_disagreement_score":0.00060111185,"about_ca_system_score_codex":0.00019114059,"about_ca_system_score_gemma":0.00018817975,"threshold_uncertainty_score":0.0020109415},"labels":[],"label_agreement":null},{"id":"W2131505683","doi":"10.1158/1078-0432.ccr-12-2745","title":"Changing the Way We Do Business: Recommendations to Accelerate Biomarker Development in Pancreatic Cancer","year":2013,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; U.S. Food and Drug Administration","keywords":"Medicine; Pancreatic cancer; Food and drug administration; Pancreatic ductal adenocarcinoma; Cancer; Biomarker; Internal medicine; Adenocarcinoma; Disease; Oncology; Drug development; Drug; Pharmacology","score_opus":0.6160954965165775,"score_gpt":0.6202262790805119,"score_spread":0.004130782563934399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131505683","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012540926,0.89673865,0.0011574186,0.09433275,0.004034469,0.00007888612,0.0000789105,0.00007908898,0.0033744455],"genre_scores_gemma":[0.0010677298,0.9635485,0.004599224,0.027318608,0.0013419634,0.000115153045,0.00009947539,0.000014249619,0.0018949369],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99588877,0.0018887239,0.00053767493,0.0002578044,0.0011867634,0.00024031113],"domain_scores_gemma":[0.98708296,0.0062139817,0.0015688199,0.0002935063,0.003766687,0.0010740684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011700236,0.0013567732,0.001957902,0.0033686468,0.0008027194,0.0039043576,0.0027718788,0.0067545325,0.0060147406],"category_scores_gemma":[0.016892916,0.00055768096,0.0017518264,0.0037512288,0.0021185433,0.0087396195,0.0019636098,0.009879893,0.005162512],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005202915,0.00011241202,0.00034095254,0.014061551,0.00011219877,0.00021250061,0.00018737238,0.00025673298,0.0003381952,0.01118673,0.3096989,0.66344047],"study_design_scores_gemma":[0.00004656545,0.000050331873,0.00048329704,0.01913642,0.00009744441,0.00029824444,0.00022222292,0.00007422645,0.00010222172,0.007912167,0.9715465,0.000030353523],"about_ca_topic_score_codex":0.0042597577,"about_ca_topic_score_gemma":0.009614237,"teacher_disagreement_score":0.011700236,"about_ca_system_score_codex":0.0028551708,"about_ca_system_score_gemma":0.011763327,"threshold_uncertainty_score":0.06187755},"labels":[],"label_agreement":null},{"id":"W2131525679","doi":"10.1158/1078-0432.ccr-12-1315","title":"Vascular Endothelial Growth Factor Pathway Polymorphisms as Prognostic and Pharmacogenetic Factors in Cancer: A Systematic Review and Meta-analysis","year":2012,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network; Memorial University of Newfoundland","funders":"","keywords":"Angiogenesis; Medicine; Cancer; Vascular endothelial growth factor; Pharmacogenetics; Internal medicine; Metastasis; Endostatin; Oncology; Cancer research; Meta-analysis; Pharmacology; Biology; VEGF receptors; Genotype; Genetics; Gene","score_opus":0.3506542912261175,"score_gpt":0.5183297164893457,"score_spread":0.16767542526322815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131525679","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009316821,0.98803025,0.00056524493,0.00023982413,0.00009273039,0.0002398612,0.001252157,0.000019435362,0.0002437026],"genre_scores_gemma":[0.29446787,0.6984189,0.0026436858,0.0008160131,0.00022358246,0.0014400623,0.0016241047,0.000024785131,0.0003410718],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99154156,0.004144437,0.0022177324,0.0010127698,0.00078759284,0.00029599303],"domain_scores_gemma":[0.9776994,0.016926486,0.0031710328,0.0006044269,0.0013682474,0.00023056369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010990892,0.0017353211,0.012791488,0.0050152456,0.00057294127,0.002014832,0.0017310295,0.0016526923,0.0028033946],"category_scores_gemma":[0.028218318,0.0010511881,0.023601223,0.009677991,0.00057033065,0.0010558506,0.001008421,0.0010676795,0.00024485277],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019745838,0.000027221166,0.017605655,0.33437732,0.6289268,0.00025422074,0.000093726965,0.0009864246,0.00028900098,0.0001634995,0.0012920002,0.014009537],"study_design_scores_gemma":[0.00061730744,0.00016841889,0.009535963,0.018843243,0.9683603,0.0001624004,0.000041535484,0.0002869917,0.00011825286,0.00018301967,0.0016587644,0.0000238036],"about_ca_topic_score_codex":0.009821505,"about_ca_topic_score_gemma":0.019505542,"teacher_disagreement_score":0.012791488,"about_ca_system_score_codex":0.0023512635,"about_ca_system_score_gemma":0.003451045,"threshold_uncertainty_score":0.058126092},"labels":[],"label_agreement":null},{"id":"W2131555383","doi":"10.1158/1078-0432.ccr-04-0224","title":"The Absence of Human Equilibrative Nucleoside Transporter 1 Is Associated with Reduced Survival in Patients With Gemcitabine-Treated Pancreas Adenocarcinoma","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":425,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Gemcitabine; Pancreatic cancer; Adenocarcinoma; Nucleoside analogue; Immunohistochemistry; Medicine; Nucleoside transporter; Internal medicine; Oncology; Chemotherapy; Nucleoside; Cancer; Pathology; Cancer research; Gastroenterology; Biology; Transporter","score_opus":0.06715783176234653,"score_gpt":0.39105214755343554,"score_spread":0.323894315791089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131555383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99931216,0.00037986328,0.00007440668,0.000026512915,0.000003140559,0.0000019295226,0.00004993618,0.0000038459525,0.00014817149],"genre_scores_gemma":[0.9996867,0.00009474197,0.00004342107,0.000010120411,0.000004474353,0.000001947644,0.0000986348,0.0000012210685,0.000058683803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998785,0.000026538795,0.000014293879,0.000039002218,0.00002053793,0.000021135522],"domain_scores_gemma":[0.9991968,0.0001623413,0.00039222543,0.00003915023,0.000047477883,0.00016197417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020469632,0.00023389306,0.00036547484,0.00041336793,0.00036442603,0.00039675328,0.00019505755,0.00042184303,0.0011341339],"category_scores_gemma":[0.00085459556,0.00015995782,0.0002706378,0.0005295968,0.00027763337,0.00027524735,0.00023480716,0.00046512234,0.0001507648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094298704,0.000024310133,0.9914163,0.00001548524,0.000040779156,0.000591992,0.000039865674,0.0000819778,0.0048517073,0.000011776968,0.00004864571,0.0019341939],"study_design_scores_gemma":[0.000012736087,0.00022161234,0.9959556,0.0000042091106,0.000051085834,0.0025653578,0.00006647159,0.0003069008,0.0006031579,0.000030941595,0.00017774868,0.000004138767],"about_ca_topic_score_codex":0.0006409224,"about_ca_topic_score_gemma":0.0008127735,"teacher_disagreement_score":0.0011341339,"about_ca_system_score_codex":0.00025384425,"about_ca_system_score_gemma":0.00015601568,"threshold_uncertainty_score":0.0037940145},"labels":[],"label_agreement":null},{"id":"W2131593373","doi":"10.1158/1078-0432.ccr-08-0196","title":"Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1511,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Serous fluid; Serous ovarian cancer; Ovarian cancer; Cancer; Medicine; Oncology; Ovary; Internal medicine; Biology; Cancer research; Pathology","score_opus":0.4324944750005766,"score_gpt":0.571834478133757,"score_spread":0.1393400031331804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131593373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985671,0.00028112618,0.0006099962,0.000024015757,0.0000027227447,0.000014112602,0.00036122903,0.000008144902,0.00013150348],"genre_scores_gemma":[0.9983083,0.000083093546,0.0007369797,0.000011953819,0.000007129264,0.000016589382,0.0007570867,0.0000031490467,0.0000756747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966013,0.000070987975,0.00004642829,0.00010173903,0.00007238174,0.000048295053],"domain_scores_gemma":[0.999087,0.00016699018,0.0004923522,0.0000969985,0.00007785988,0.000078736884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005023159,0.00024188342,0.00043094967,0.0006640358,0.000223744,0.0005373371,0.0002163511,0.00026245092,0.0005722983],"category_scores_gemma":[0.0013524005,0.00008212418,0.000294662,0.0007699687,0.00028860066,0.0001820537,0.0002971103,0.00026638084,0.00015279703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062901585,0.000040604064,0.9766623,0.000053301515,0.000087690554,0.00010110925,0.00005591073,0.0003629669,0.014156381,0.000047888334,0.0001013713,0.0077014365],"study_design_scores_gemma":[0.000017449396,0.00011660515,0.9951717,0.000007522921,0.00006741757,0.0006277082,0.000109984554,0.0014260953,0.0019431266,0.00017292605,0.00033421977,0.0000052401433],"about_ca_topic_score_codex":0.00065812486,"about_ca_topic_score_gemma":0.00094615936,"teacher_disagreement_score":0.0006640358,"about_ca_system_score_codex":0.00021120642,"about_ca_system_score_gemma":0.00035178152,"threshold_uncertainty_score":0.0026565194},"labels":[],"label_agreement":null},{"id":"W2132257982","doi":"10.1158/1078-0432.ccr-08-0804","title":"Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal Doxorubicin","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chorioallantoic membrane; Doxorubicin; Medicine; Neuroblastoma; Angiogenesis; In vivo; Apoptosis; Neovascularization; Ovarian cancer; Immunohistochemistry; Pathology; Cancer research; Cancer; Debulking; Chemotherapy; Internal medicine; Biology; Cell culture","score_opus":0.21763588018107674,"score_gpt":0.49284517797519733,"score_spread":0.2752092977941206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132257982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973908,0.000780257,0.001168339,0.000038353326,0.000010464268,0.000033317403,0.000057417077,0.000024105522,0.0004969451],"genre_scores_gemma":[0.9977723,0.00037968127,0.0010926331,0.000018823614,0.000006262483,0.000024956555,0.00015183348,0.0000052700652,0.000548181],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998882,0.000034591936,0.000006274118,0.000027004533,0.000027049433,0.00001680377],"domain_scores_gemma":[0.9999094,0.000026869775,0.000028084027,0.000008315283,0.000012146262,0.000015071658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002850417,0.00025006323,0.00014412114,0.000114447896,0.00005276829,0.0001802592,0.0001301704,0.0002615055,0.00076629606],"category_scores_gemma":[0.00021249898,0.00007544227,0.0000938118,0.00007308076,0.00021306137,0.00020241932,0.00008865002,0.00023037006,0.00012776807],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004138413,0.00013631495,0.00023031213,0.000046576602,0.000005422609,0.000020965688,0.000010447608,0.000251075,0.9966979,0.000039700753,0.000033920503,0.0021134508],"study_design_scores_gemma":[0.00010140629,0.004610289,0.0024814615,0.00000416986,0.000024280896,0.00017240072,0.000008840154,0.0014611053,0.9902711,0.000015341675,0.0008463429,0.000003255264],"about_ca_topic_score_codex":0.00026267322,"about_ca_topic_score_gemma":0.00035062656,"teacher_disagreement_score":0.00076629606,"about_ca_system_score_codex":0.00025986513,"about_ca_system_score_gemma":0.0001458196,"threshold_uncertainty_score":0.0025635362},"labels":[],"label_agreement":null},{"id":"W2132268633","doi":"10.1158/1078-0432.ccr-06-0812","title":"The Combi-Targeting Concept: <i>In vitro</i> and <i>In vivo</i> Fragmentation of a Stable Combi-Nitrosourea Engineered to Interact with the Epidermal Growth Factor Receptor while Remaining DNA Reactive","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cyclization and Aryne Chemistry","field":"Chemistry","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Health Canada; Royal Victoria Hospital; Royal Victoria Regional Health Centre","funders":"Cancer Research Society","keywords":"In vivo; DU145; Comet assay; Molecular biology; Epidermal growth factor receptor; In vitro; Biology; Chemistry; DNA damage; Cancer cell; Biochemistry; Receptor; DNA; Cancer; LNCaP","score_opus":0.05636942584909254,"score_gpt":0.39265585542737724,"score_spread":0.3362864295782847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132268633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922546,0.00083838403,0.0052696327,0.00004500732,0.000015423682,0.000055839653,0.000090852795,0.00005070202,0.0013795118],"genre_scores_gemma":[0.9930462,0.00037520903,0.004644381,0.000030544143,0.000005329211,0.00003707841,0.00012014024,0.000008414744,0.0017325556],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999442,0.000006663423,0.0000028930915,0.00001946802,0.000017233471,0.000009485938],"domain_scores_gemma":[0.9999329,0.000008554823,0.00003227956,0.000007603747,0.00000871001,0.0000099871995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010576005,0.00026938925,0.000118061864,0.00008793336,0.000056167817,0.0001460279,0.00017231012,0.00026197542,0.00078093994],"category_scores_gemma":[0.00012130037,0.00007125262,0.00010686759,0.000049005514,0.00016521315,0.00018607632,0.00010548096,0.00022907343,0.0001986229],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046278637,0.000017211343,0.000056185396,0.00002367194,0.0000023874954,0.000021129448,0.000005702337,0.000037322254,0.99853265,0.000056304158,0.00001544375,0.0011855949],"study_design_scores_gemma":[0.0000111969675,0.00045035072,0.0006306842,0.0000016272804,0.000006435012,0.0002532766,0.0000038323396,0.00046506885,0.9972796,0.000014213799,0.00088215095,0.000001724757],"about_ca_topic_score_codex":0.00020254731,"about_ca_topic_score_gemma":0.0002224944,"teacher_disagreement_score":0.00078093994,"about_ca_system_score_codex":0.00018266891,"about_ca_system_score_gemma":0.00008540244,"threshold_uncertainty_score":0.0026125312},"labels":[],"label_agreement":null},{"id":"W2132365366","doi":"10.1158/1078-0432.ccr-09-2944","title":"Phase I Open-Label Study of Continuous Treatment with BIBF 1120, a Triple Angiokinase Inhibitor, and Pemetrexed in Pretreated Non–Small Cell Lung Cancer Patients","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Pemetrexed; Medicine; Tolerability; Lung cancer; Regimen; Internal medicine; Response Evaluation Criteria in Solid Tumors; Adverse effect; Pharmacokinetics; Oncology; Pharmacology; Gastroenterology; Phases of clinical research; Chemotherapy; Cisplatin","score_opus":0.09942401494546313,"score_gpt":0.4720793940494459,"score_spread":0.3726553791039827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132365366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99609864,0.00067188824,0.0004401985,0.0001383315,0.000080303216,0.0015276335,0.0003633008,0.00006538569,0.00061423064],"genre_scores_gemma":[0.99302304,0.0006398769,0.0012839485,0.0003365651,0.00013657009,0.0021276297,0.001111891,0.000019415973,0.0013209184],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994609,0.00022519777,0.000026649323,0.00011466339,0.000058923095,0.00011358623],"domain_scores_gemma":[0.9988865,0.00016476423,0.00019260742,0.00012542063,0.000057055797,0.0005736231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001433326,0.0014921856,0.0025124957,0.00044263704,0.0005179696,0.0011668096,0.001210619,0.0012963796,0.0031256925],"category_scores_gemma":[0.0011520984,0.0008660796,0.0009764973,0.00048500922,0.0015657322,0.0010254951,0.0004093643,0.0039862874,0.00073437404],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6486462,0.18895465,0.0073993863,0.00064040895,0.0008973243,0.0003301566,0.0005784399,0.002521075,0.06967174,0.00024836668,0.0023434001,0.07776886],"study_design_scores_gemma":[0.36441138,0.61975116,0.00956281,0.000016524242,0.00019711994,0.0002116365,0.00006125973,0.0011571702,0.0033387467,0.00008850236,0.0011769251,0.000026743337],"about_ca_topic_score_codex":0.0011957126,"about_ca_topic_score_gemma":0.0023535038,"teacher_disagreement_score":0.0031256925,"about_ca_system_score_codex":0.001067411,"about_ca_system_score_gemma":0.0018210937,"threshold_uncertainty_score":0.010456502},"labels":[],"label_agreement":null},{"id":"W2132557004","doi":"10.1158/1078-0432.ccr-06-1539","title":"First Study of the Safety, Tolerability, and Pharmacokinetics of CP-724,714 in Patients with Advanced Malignant Solid HER2-Expressing Tumors","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Tolerability; Rash; Pharmacokinetics; Adverse effect; Gastroenterology; Internal medicine; Nausea; Dosing; Pharmacodynamics; Cmax; Toxicity; Pharmacology","score_opus":0.14627582029163708,"score_gpt":0.5347873946819192,"score_spread":0.38851157439028206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132557004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975926,0.0008650619,0.00033751913,0.00012246419,0.000020012123,0.0003314009,0.00015166013,0.000026577649,0.0005527678],"genre_scores_gemma":[0.9967411,0.0005375294,0.0008499935,0.00029340916,0.00014280228,0.0002905262,0.00063237303,0.000011013924,0.00050123606],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99945146,0.00029989245,0.00003350937,0.00007161677,0.000072595016,0.00007102124],"domain_scores_gemma":[0.99896336,0.00031779637,0.00023948756,0.00012240461,0.00006390487,0.00029305238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012218754,0.0011640382,0.001487161,0.00014287203,0.0003845662,0.00045419837,0.0005206907,0.00068369816,0.0017535641],"category_scores_gemma":[0.0014582375,0.0003457049,0.0006007548,0.00017616586,0.00086424133,0.0005734373,0.00018614552,0.0016329071,0.0004667751],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40408012,0.060617685,0.08368391,0.0015685556,0.0015581222,0.0024470976,0.0008237358,0.0046302015,0.21529636,0.00040826952,0.003314022,0.22157194],"study_design_scores_gemma":[0.10263824,0.8366916,0.03937814,0.00003153032,0.00039640034,0.0015249756,0.00007500268,0.0011976305,0.0152289895,0.00009580884,0.0027089848,0.00003266092],"about_ca_topic_score_codex":0.0005423224,"about_ca_topic_score_gemma":0.0007744716,"teacher_disagreement_score":0.0017535641,"about_ca_system_score_codex":0.0006206547,"about_ca_system_score_gemma":0.001030033,"threshold_uncertainty_score":0.006461978},"labels":[],"label_agreement":null},{"id":"W2133155058","doi":"10.1158/1078-0432.ccr-10-1161","title":"Primary CNS Lymphoma in Children and Adolescents: A Descriptive Analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG)","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Chemotherapy; Methotrexate; Internal medicine; Univariate analysis; Hazard ratio; Odds ratio; Primary central nervous system lymphoma; Oncology; Retrospective cohort study; Radiation therapy; Lymphoma; Multivariate analysis; Pediatrics; Confidence interval","score_opus":0.10238581394737113,"score_gpt":0.40287852568233323,"score_spread":0.3004927117349621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133155058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99823713,0.00025869292,0.00009335736,0.000025796258,0.000003448987,0.000029447807,0.0010907922,0.0000036809952,0.00025769178],"genre_scores_gemma":[0.9972887,0.0002673302,0.00013713764,0.000037569764,0.000008733278,0.00005343102,0.0021485945,0.0000035095684,0.00005506594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994816,0.00010368826,0.00008506645,0.000097346856,0.00013890114,0.00009333782],"domain_scores_gemma":[0.99870276,0.00029243273,0.0005558858,0.00007040058,0.00020583712,0.00017265367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075929315,0.00023325525,0.00042283325,0.0018129323,0.00028576766,0.0004334683,0.0002683884,0.00026063336,0.0008878392],"category_scores_gemma":[0.00181287,0.00014098441,0.0002897023,0.0016604143,0.00026714665,0.00037426682,0.0004424449,0.00023919466,0.00015704944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003230633,0.000010832127,0.99861896,0.0000113805345,0.000011003968,0.00012502164,0.00009370864,0.000015726899,0.00005886751,0.0000073340125,0.00013126395,0.0008835703],"study_design_scores_gemma":[0.0000074602704,0.00008556412,0.99719906,0.000015829204,0.000020999487,0.0013321097,0.00071619626,0.00008050156,0.000056796787,0.000009186008,0.00047348245,0.0000028065053],"about_ca_topic_score_codex":0.0068397955,"about_ca_topic_score_gemma":0.008171503,"teacher_disagreement_score":0.0068397955,"about_ca_system_score_codex":0.0005169003,"about_ca_system_score_gemma":0.00064364204,"threshold_uncertainty_score":0.013599932},"labels":[],"label_agreement":null},{"id":"W2133164395","doi":"10.1158/1078-0432.ccr-05-2049","title":"An Evaluation of Tumor Oxygenation and Gene Expression in Patients with Early Stage Non–Small Cell Lung Cancers","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":294,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Osteopontin; Medicine; Lung cancer; Lung; Tumor hypoxia; Tumor progression; Pathology; Hypoxia (environmental); Immunohistochemistry; Cancer; Internal medicine; Chemistry","score_opus":0.058019308844871754,"score_gpt":0.4131657608518553,"score_spread":0.3551464520069835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133164395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999574,0.000119388504,0.00006580093,0.000015430898,0.0000018030115,0.0000051614775,0.00007370641,0.0000014621828,0.00014321935],"genre_scores_gemma":[0.99965274,0.000038523798,0.00009189823,0.000011080779,0.0000059642953,0.00000905608,0.00012422667,6.1078805e-7,0.000065862994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998634,0.00003476407,0.000013298709,0.00003428371,0.000028448118,0.000025657338],"domain_scores_gemma":[0.9994592,0.00014144859,0.00020381148,0.000016530226,0.00006622926,0.000112716836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002767528,0.00020730136,0.0002713173,0.00041478738,0.00020953499,0.00031332,0.00016306291,0.00036213978,0.0006580681],"category_scores_gemma":[0.0007932883,0.00009511649,0.00013415227,0.00045057517,0.00020390275,0.00025391008,0.00017433891,0.0003356095,0.00015018256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038879173,0.000041309515,0.99589807,0.000009471794,0.000014205049,0.000100817255,0.00002942656,0.000050891103,0.0019562445,0.000006003175,0.00003416348,0.001470576],"study_design_scores_gemma":[0.000012199653,0.00042159468,0.9981013,0.0000020778793,0.000015062033,0.00039975802,0.000076491306,0.00027793093,0.00055640447,0.0000148168265,0.000119796576,0.0000025785207],"about_ca_topic_score_codex":0.00044720908,"about_ca_topic_score_gemma":0.0006435577,"teacher_disagreement_score":0.0006580681,"about_ca_system_score_codex":0.00023658448,"about_ca_system_score_gemma":0.00016161945,"threshold_uncertainty_score":0.002201438},"labels":[],"label_agreement":null},{"id":"W2133312268","doi":"10.1158/1078-0432.ccr-06-1651","title":"Flaxseed and Its Lignans Inhibit Estradiol-Induced Growth, Angiogenesis, and Secretion of Vascular Endothelial Growth Factor in Human Breast Cancer Xenografts <i>In vivo</i>","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Phytoestrogen effects and research","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Enterolactone; Phytoestrogens; Angiogenesis; Endocrinology; Internal medicine; Vascular endothelial growth factor; In vivo; Biology; Kinase insert domain receptor; Estrogen receptor; Breast cancer; Medicine; Cancer research; Vascular endothelial growth factor A; Cancer; Estrogen; VEGF receptors","score_opus":0.09553616797418367,"score_gpt":0.4469377798305834,"score_spread":0.35140161185639973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133312268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99493694,0.0028351531,0.00071739295,0.000091856324,0.000030506575,0.000031804517,0.0002687418,0.000075748416,0.0010119821],"genre_scores_gemma":[0.99321085,0.0022314147,0.0013788379,0.000083249346,0.00001632853,0.000050248287,0.0008507522,0.000015839849,0.0021625045],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999479,0.000010601711,0.0000049685145,0.000008655736,0.000012393238,0.000015401996],"domain_scores_gemma":[0.9999472,0.000012427432,0.00001544199,0.000004375264,0.000006009055,0.000014556894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001007212,0.00040704195,0.00026001682,0.00020986269,0.00009050537,0.00013103729,0.00013130909,0.00019316841,0.0008836136],"category_scores_gemma":[0.0000905734,0.00009697511,0.000281858,0.00015324615,0.00012403278,0.00013773261,0.0000943016,0.00034425568,0.00019540994],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010698022,0.00027141278,0.00021799874,0.00007087346,0.000016484992,0.000029458248,0.000014606537,0.00006558462,0.99550074,0.000024026067,0.000085124666,0.002633825],"study_design_scores_gemma":[0.000115957475,0.004257475,0.0046449993,0.000009373733,0.00005082434,0.00015359717,0.000022443095,0.0006133925,0.9880155,0.000016575163,0.0020942471,0.0000055231494],"about_ca_topic_score_codex":0.0010924413,"about_ca_topic_score_gemma":0.0016495452,"teacher_disagreement_score":0.0010924413,"about_ca_system_score_codex":0.000172172,"about_ca_system_score_gemma":0.00016507221,"threshold_uncertainty_score":0.0029559731},"labels":[],"label_agreement":null},{"id":"W2133535272","doi":"10.1158/1078-0432.ccr-12-2117","title":"Sequential Binary Gene Ratio Tests Define a Novel Molecular Diagnostic Strategy for Malignant Pleural Mesothelioma","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; U.S. Public Health Service; Vancouver Foundation","keywords":"Mesothelioma; Pleural disease; Computational biology; Medicine; Pathology; Oncology; Biology; Respiratory disease; Internal medicine; Lung","score_opus":0.2551047890606198,"score_gpt":0.5033452066928817,"score_spread":0.24824041763226196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133535272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8261759,0.0016111728,0.1662711,0.0006019907,0.0000767147,0.00029247458,0.00097583624,0.0012510619,0.0027436668],"genre_scores_gemma":[0.87813824,0.0003112443,0.11969567,0.0002786398,0.000044340806,0.00018316251,0.0007715439,0.000054064312,0.00052305486],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991328,0.00021786836,0.000049923838,0.00023005014,0.00030681735,0.00006260866],"domain_scores_gemma":[0.9992242,0.00032838807,0.00019946997,0.00006686997,0.00012272462,0.00005838135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010573197,0.00065170537,0.0004912791,0.0015427971,0.00018149301,0.0006293377,0.0005094434,0.00040780124,0.000998802],"category_scores_gemma":[0.002258637,0.00021074718,0.00040632611,0.0005911686,0.00053654175,0.00053710386,0.00045234303,0.0004324447,0.00036158023],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010961561,0.00024625027,0.057457827,0.00033893692,0.000097390475,0.00031378126,0.00007459173,0.0052550826,0.8027873,0.0017266119,0.00060348754,0.13000253],"study_design_scores_gemma":[0.00019774042,0.0031066064,0.16241626,0.000064416156,0.0003820386,0.0032638481,0.0002545168,0.16025531,0.6530957,0.00940825,0.0074619013,0.00009343402],"about_ca_topic_score_codex":0.00024969538,"about_ca_topic_score_gemma":0.00045799563,"teacher_disagreement_score":0.0015427971,"about_ca_system_score_codex":0.00037392235,"about_ca_system_score_gemma":0.00042794136,"threshold_uncertainty_score":0.00559175},"labels":[],"label_agreement":null},{"id":"W2133999831","doi":"10.1158/1078-0432.ccr-03-0785","title":"Rationale for Biomarkers and Surrogate End Points in Mechanism-Driven Oncology Drug Development","year":2004,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Drug development; Mechanism (biology); Surrogate endpoint; Medicine; Drug; Oncology; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.5913131394625564,"score_gpt":0.6546057634251068,"score_spread":0.06329262396255042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133999831","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005855785,0.92514294,0.04182143,0.022899246,0.002179031,0.0003059262,0.00018825957,0.00008311278,0.006794468],"genre_scores_gemma":[0.01822981,0.90076905,0.05411916,0.017287923,0.0025029606,0.0015573795,0.0002460937,0.000042870433,0.005244827],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99563223,0.0022376194,0.00056303956,0.00046960008,0.0009889978,0.000108435146],"domain_scores_gemma":[0.9931833,0.0052814335,0.0004531321,0.00025974552,0.0007029427,0.00011950794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017333217,0.0024949103,0.004506362,0.0033478322,0.0006111128,0.0037426974,0.0038360057,0.0058619,0.0027720872],"category_scores_gemma":[0.010324308,0.0010926453,0.0018591707,0.002032301,0.0069510792,0.006317447,0.0022502067,0.010949596,0.0024220704],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003311377,0.00021922713,0.00056383834,0.009826492,0.00017870398,0.0007418021,0.00015309485,0.0041947826,0.0020013114,0.5269316,0.02137023,0.43348774],"study_design_scores_gemma":[0.0003402945,0.00051717804,0.0006754591,0.012129557,0.00025357827,0.0026026673,0.0001322179,0.002621646,0.0030610154,0.34864616,0.62889004,0.00013010151],"about_ca_topic_score_codex":0.0008476643,"about_ca_topic_score_gemma":0.00090057665,"teacher_disagreement_score":0.017333217,"about_ca_system_score_codex":0.0040286495,"about_ca_system_score_gemma":0.0045612855,"threshold_uncertainty_score":0.09166795},"labels":[],"label_agreement":null},{"id":"W2134076692","doi":"10.1158/1078-0432.ccr-0779-3","title":"Allelic Loss of a Common Microsatellite Marker<b><i>MYCL1</i></b>","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Loss of heterozygosity; Microsatellite; Colorectal cancer; Biology; Locus (genetics); Allele; Chromosome; Metastasis; Internal medicine; Cancer; Pathology; Oncology; Genetics; Medicine; Gene","score_opus":0.21348424118071532,"score_gpt":0.5328374061692768,"score_spread":0.3193531649885615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134076692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99908185,0.00019628547,0.00042573773,0.000019455887,0.0000017102943,0.000004927393,0.00006307959,0.000007677145,0.00019940066],"genre_scores_gemma":[0.9995714,0.000036516536,0.0001952226,0.000011663117,0.0000040642976,0.0000040183418,0.00009862192,0.0000012622646,0.000077156576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970007,0.00007519234,0.000031209263,0.00007006077,0.000084109015,0.000039297724],"domain_scores_gemma":[0.99864215,0.00032520018,0.00074012426,0.000057627167,0.00009908931,0.00013587202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004134747,0.0001514362,0.00016524624,0.00052922114,0.00017518793,0.00021839402,0.00019758476,0.00015735537,0.0012860224],"category_scores_gemma":[0.001394731,0.000077763805,0.000096713855,0.0003036136,0.00033636467,0.00013109329,0.00018558056,0.00025136888,0.00019699842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006794816,0.000053320833,0.93907493,0.00004925928,0.00007569664,0.00051111437,0.000059048427,0.00016653698,0.04984178,0.00004262027,0.00012052037,0.009325661],"study_design_scores_gemma":[0.000044013508,0.0011162227,0.9683034,0.000013721821,0.00009621679,0.008547324,0.00012622768,0.0006583827,0.020145483,0.000075548865,0.0008631389,0.000010256588],"about_ca_topic_score_codex":0.0004625068,"about_ca_topic_score_gemma":0.00048369553,"teacher_disagreement_score":0.0012860224,"about_ca_system_score_codex":0.00014515012,"about_ca_system_score_gemma":0.00010959216,"threshold_uncertainty_score":0.0043022037},"labels":[],"label_agreement":null},{"id":"W2134095592","doi":"10.1158/1078-0432.ccr-06-0909","title":"Setting the Bar in Phase II Trials: The Use of Historical Data for Determining “Go/No Go” Decision for Definitive Phase III Testing","year":2007,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institutes of Health","keywords":"Null hypothesis; Clinical trial; Medicine; Null (SQL); Sample size determination; Protocol (science); Phase (matter); Statistics; Oncology; Research design; Internal medicine; Data mining; Computer science; Pathology; Alternative medicine; Mathematics","score_opus":0.991818251432903,"score_gpt":0.8241548003108323,"score_spread":0.1676634511220707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134095592","genre_codex":"methods","genre_gemma":"review","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05669127,0.3242654,0.4067573,0.11666243,0.023342159,0.041728932,0.0069225295,0.0008699694,0.022760035],"genre_scores_gemma":[0.49670815,0.038833715,0.32324204,0.067736395,0.009011243,0.059731282,0.0028484645,0.00045124558,0.0014375186],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.1428849,0.6971204,0.10660601,0.015287874,0.036882028,0.0012188765],"domain_scores_gemma":[0.043281123,0.8477887,0.06220457,0.024785573,0.020245742,0.0016941999],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.74154896,0.0026372932,0.013046798,0.020226356,0.0035805134,0.015457674,0.009417468,0.014377665,0.005804708],"category_scores_gemma":[0.9045036,0.0033400152,0.009226432,0.014614318,0.013449048,0.036705688,0.009284117,0.012834347,0.0020713017],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024276966,0.0004534295,0.04620581,0.16511005,0.02035041,0.0015810999,0.008905421,0.00436318,0.0023308506,0.082199804,0.047954347,0.59626865],"study_design_scores_gemma":[0.019477714,0.011228063,0.04063925,0.28926525,0.025623495,0.0029646878,0.005506321,0.018588273,0.009354145,0.36812124,0.20702185,0.0022097775],"about_ca_topic_score_codex":0.0010591106,"about_ca_topic_score_gemma":0.0013742482,"teacher_disagreement_score":0.25845104,"about_ca_system_score_codex":0.0056076082,"about_ca_system_score_gemma":0.013578011,"threshold_uncertainty_score":0.31871623},"labels":[],"label_agreement":null},{"id":"W2134311215","doi":"10.1158/1078-0432.ccr-14-3147","title":"Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor–Initiating Cells","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; McMaster University Medical Centre","funders":"Canadian Institutes of Health Research","keywords":"Wnt signaling pathway; Cancer stem cell; In vivo; Cancer research; Stem cell; Biology; In silico; Cancer; Population; Tumor initiation; Glioblastoma; Glioma; Signal transduction; Medicine; Cell biology; Genetics; Carcinogenesis; Gene","score_opus":0.34221407580638186,"score_gpt":0.5561032548937777,"score_spread":0.2138891790873958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134311215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99422777,0.0014736779,0.0018162731,0.00011212364,0.000021187232,0.00013871933,0.00056446204,0.00009204385,0.0015536577],"genre_scores_gemma":[0.9947008,0.001081857,0.001984851,0.000055210254,0.000004859302,0.00006581947,0.00083659607,0.000013709905,0.00125637],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999305,0.000006863542,0.000005291639,0.000014929689,0.000024825395,0.000017661772],"domain_scores_gemma":[0.999966,0.0000074156214,0.000010569598,0.0000045497786,0.0000050952576,0.0000063093976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008125576,0.0003092631,0.00027515343,0.00022572455,0.00012524074,0.00023390866,0.00019803894,0.00018910048,0.0007392851],"category_scores_gemma":[0.00010682133,0.000111087254,0.00022913107,0.00017782244,0.00013061041,0.00008559215,0.00016886822,0.00031903808,0.00019506944],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010155541,0.00006658991,0.00033618923,0.000055343033,0.000007706217,0.00004364679,0.000010578147,0.0006078037,0.99409926,0.000073104515,0.0000665849,0.00453165],"study_design_scores_gemma":[0.00004526706,0.0008288339,0.0019856344,0.000006000449,0.00002259778,0.0001622064,0.000011668472,0.0014389397,0.9936419,0.00004100004,0.0018127013,0.0000032522266],"about_ca_topic_score_codex":0.0010956487,"about_ca_topic_score_gemma":0.002499212,"teacher_disagreement_score":0.0010956487,"about_ca_system_score_codex":0.00043434018,"about_ca_system_score_gemma":0.00035393678,"threshold_uncertainty_score":0.0031513572},"labels":[],"label_agreement":null},{"id":"W2134318552","doi":"10.1158/1078-0432.ccr-07-4575","title":"Phase II, Open-Label Study Evaluating the Activity of Imatinib in Treating Life-Threatening Malignancies Known to Be Associated with Imatinib-Sensitive Tyrosine Kinases","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":216,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Imatinib; Medicine; Systemic mastocytosis; Tyrosine kinase; Dermatofibrosarcoma protuberans; Imatinib mesylate; Tyrosine-kinase inhibitor; PDGFRA; Malignancy; Cancer research; Internal medicine; GiST; Oncology; Pathology; Cancer; Disease; Receptor; Stromal cell","score_opus":0.5138175632808544,"score_gpt":0.5818905854513831,"score_spread":0.06807302217052869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134318552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99403703,0.0018178861,0.0006953185,0.00016304574,0.000075341515,0.0019393761,0.0005438726,0.000046271904,0.0006818971],"genre_scores_gemma":[0.9874998,0.0016873388,0.002344428,0.000706031,0.00035271433,0.004274463,0.0019177706,0.000020945106,0.0011964939],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992149,0.00043714425,0.000048014957,0.00011153595,0.00007948638,0.00010900772],"domain_scores_gemma":[0.9980368,0.0005835389,0.00053004647,0.00013938299,0.00009085545,0.0006193904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017467552,0.0016560884,0.0027226019,0.0003525201,0.00035663764,0.00089532294,0.0009318313,0.0013973454,0.004150865],"category_scores_gemma":[0.0013704723,0.0005725695,0.00088240625,0.00036665928,0.0013449565,0.0010523399,0.00032980574,0.0027307202,0.0007276714],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8272311,0.08128744,0.007246001,0.0008189142,0.0009545526,0.0003198449,0.00016682882,0.0015783734,0.04040821,0.00019010468,0.001481245,0.038317423],"study_design_scores_gemma":[0.47988543,0.5067692,0.0071788966,0.000029258083,0.00022407366,0.00027501982,0.000034971214,0.000909859,0.0033924584,0.00010657114,0.001173354,0.00002091988],"about_ca_topic_score_codex":0.0002471136,"about_ca_topic_score_gemma":0.00067259633,"teacher_disagreement_score":0.004150865,"about_ca_system_score_codex":0.0006069616,"about_ca_system_score_gemma":0.0012881603,"threshold_uncertainty_score":0.0138860345},"labels":[],"label_agreement":null},{"id":"W2134612158","doi":"10.1158/1078-0432.ccr-08-3120","title":"<i>p53 Arg72Pro</i> and <i>MDM2 T309G</i> Polymorphisms, Histology, and Esophageal Cancer Prognosis","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Hazard ratio; Medicine; Internal medicine; Confidence interval; Oncology; Prospective cohort study; Adenocarcinoma; Proportional hazards model; Cohort; Gastroenterology; Histology; Cancer; Carcinoma; Cohort study","score_opus":0.1494843578025383,"score_gpt":0.49128887674041244,"score_spread":0.3418045189378741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134612158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99962616,0.00014268461,0.00006537446,0.000023057972,0.0000026006503,0.000002594727,0.0000638119,0.0000020635403,0.00007164391],"genre_scores_gemma":[0.99962187,0.000055658766,0.00008324954,0.000014782266,0.0000096870435,0.0000036780532,0.000104095685,0.0000010217169,0.00010595127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998766,0.000043195483,0.000011589608,0.000032574484,0.000018146087,0.000017939572],"domain_scores_gemma":[0.99939394,0.00017949964,0.0002659378,0.000035101595,0.000042342424,0.00008319962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042868633,0.00026332392,0.00022938025,0.00023629503,0.00014921292,0.00023600299,0.00012858807,0.0002436711,0.0013088662],"category_scores_gemma":[0.0008199398,0.00009331208,0.00020162264,0.00019406764,0.00018591934,0.0000974071,0.00009533688,0.00019678552,0.00020986129],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016687339,0.00006122053,0.98937,0.000017797289,0.00010488516,0.00019557583,0.00002382665,0.000115699055,0.006117381,0.000009893787,0.000059203066,0.0022557843],"study_design_scores_gemma":[0.00006222504,0.00063267513,0.99597836,0.000005690219,0.00011211783,0.0009551037,0.000030555344,0.00037525143,0.0016345455,0.000030902997,0.00017966735,0.0000030440272],"about_ca_topic_score_codex":0.0008783696,"about_ca_topic_score_gemma":0.001274906,"teacher_disagreement_score":0.0013088662,"about_ca_system_score_codex":0.0001595143,"about_ca_system_score_gemma":0.00013719207,"threshold_uncertainty_score":0.004378557},"labels":[],"label_agreement":null},{"id":"W2134724478","doi":"10.1158/1078-0432.ccr-10-0948","title":"A Viral Vaccine Encoding Prostate-Specific Antigen Induces Antigen Spreading to a Common Set of Self-Proteins in Prostate Cancer Patients","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia; BC Cancer Agency","funders":"National Institutes of Health","keywords":"Antigen; Autoantibody; Medicine; Immunology; Prostate-specific antigen; Prostate cancer; Cancer; Cancer vaccine; Vaccination; Western blot; Immunotherapy; Immune system; Antibody; Oncology; Internal medicine; Biology","score_opus":0.08730486969594273,"score_gpt":0.436091545109557,"score_spread":0.3487866754136143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134724478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990214,0.00050590717,0.00019856336,0.00002455879,0.000010231439,0.000072506984,0.000014834843,0.000008886762,0.0001430119],"genre_scores_gemma":[0.9992716,0.00018242437,0.00022508256,0.000045322875,0.000017551722,0.00005354088,0.00007662505,0.0000016028133,0.00012625109],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998466,0.000059505965,0.000009035938,0.000028840646,0.000026151967,0.000029877283],"domain_scores_gemma":[0.9998429,0.000055453187,0.00003627529,0.000014160945,0.0000119572915,0.000039341703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039394214,0.00023854898,0.0004653417,0.000104886974,0.00010160832,0.00019097698,0.00013698057,0.00027236826,0.000962406],"category_scores_gemma":[0.000396617,0.00007984848,0.00021894526,0.000100301404,0.00021725403,0.00015709421,0.00013996469,0.00042392072,0.00011590862],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044878248,0.014585021,0.08254313,0.000958903,0.0005950309,0.00043253182,0.00023243882,0.00324793,0.6844824,0.00026650477,0.0009376383,0.16684033],"study_design_scores_gemma":[0.017988324,0.5073906,0.2522931,0.00009824884,0.0007260766,0.003164866,0.0002050523,0.0068605333,0.20670004,0.00025580064,0.0042895675,0.000027745387],"about_ca_topic_score_codex":0.00018227742,"about_ca_topic_score_gemma":0.00020392315,"teacher_disagreement_score":0.000962406,"about_ca_system_score_codex":0.00017489953,"about_ca_system_score_gemma":0.00028750682,"threshold_uncertainty_score":0.003219545},"labels":[],"label_agreement":null},{"id":"W2134912068","doi":"10.1158/1078-0432.ccr-06-2659","title":"The Biology of Metastasis to a Sanctuary Site","year":2007,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute; National Institutes of Health; Canada Research Chairs; California Breast Cancer Research Program; U.S. Department of Defense","keywords":"Metastasis; Brain metastasis; Angiogenesis; Biology; Disease; Cancer research; Blood–brain barrier; Medicine; Cancer; Central nervous system; Neuroscience; Pathology; Internal medicine","score_opus":0.7405054295768351,"score_gpt":0.7173850200839833,"score_spread":0.023120409492851768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134912068","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001733023,0.9982838,0.00016741462,0.00030048366,0.00015544634,0.0000033337485,0.000009007733,0.000005180318,0.0009018926],"genre_scores_gemma":[0.00095830334,0.9979972,0.00009929104,0.00014884456,0.00009796016,0.000004372924,0.000014838684,6.9471906e-7,0.00067842146],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998801,0.000021728725,0.000012571065,0.000022713662,0.000047930447,0.000015020778],"domain_scores_gemma":[0.99988055,0.00004010118,0.0000216136,0.0000051504267,0.00003248812,0.000020034218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032860716,0.0007498083,0.0013122032,0.001313707,0.0003147043,0.0011175909,0.0007910965,0.0011767206,0.002135211],"category_scores_gemma":[0.00031271626,0.0002605705,0.00031878697,0.0012805894,0.0007740544,0.0015057249,0.0005990709,0.0017381551,0.0020432635],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008704473,0.000059162623,0.0002588359,0.008731369,0.000056044068,0.0005615742,0.000074313124,0.0007403714,0.006913886,0.010019862,0.034937818,0.9375598],"study_design_scores_gemma":[0.000016128652,0.00006567834,0.00085831777,0.0011881021,0.000033930635,0.002722768,0.000060565013,0.00011371785,0.00133203,0.0038984804,0.9896926,0.000017591954],"about_ca_topic_score_codex":0.0009858158,"about_ca_topic_score_gemma":0.0016104539,"teacher_disagreement_score":0.002135211,"about_ca_system_score_codex":0.0008567713,"about_ca_system_score_gemma":0.0008261321,"threshold_uncertainty_score":0.0071430206},"labels":[],"label_agreement":null},{"id":"W2134970255","doi":"10.1158/1078-0432.ccr-12-0199","title":"Prolonged Postovulatory Proinflammatory Signaling in the Fallopian Tube Epithelium May Be Mediated through a BRCA1/DAB2 Axis","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Proinflammatory cytokine; Biology; Luteal phase; Transfection; Inflammation; Gene expression; Small interfering RNA; Luciferase; Molecular biology; Tumor necrosis factor alpha; Signal transduction; Cancer research; Cell biology; Follicular phase; Immunology; Gene; Endocrinology; Genetics","score_opus":0.280077492417682,"score_gpt":0.5072895510402354,"score_spread":0.22721205862255345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134970255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99258524,0.0048384103,0.0008653127,0.000118452735,0.000018216353,0.000023340303,0.00070394657,0.000042138985,0.00080498785],"genre_scores_gemma":[0.9959955,0.001365443,0.00070524006,0.000074255484,0.000011066625,0.000030218238,0.0007753528,0.0000055427317,0.0010373383],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999025,0.000015827662,0.00000728211,0.000027003116,0.000020393443,0.000026980513],"domain_scores_gemma":[0.99990904,0.000011612709,0.000041369152,0.000005546782,0.000010923851,0.000021490501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013480149,0.00028448703,0.00021285651,0.00041352693,0.0001939232,0.0003667442,0.00009754503,0.00013494605,0.0014086572],"category_scores_gemma":[0.00016525158,0.0000993709,0.00020599877,0.00020800642,0.00014454819,0.00018179005,0.00016226289,0.00018682033,0.00021845358],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094528,0.00005118012,0.027867896,0.00018535566,0.000041445142,0.00044026773,0.000061058796,0.00006409656,0.9646125,0.00008041027,0.00014297818,0.0055076187],"study_design_scores_gemma":[0.00008341803,0.0009060743,0.6227676,0.000067555404,0.00015036785,0.0034359412,0.0005420343,0.0009983109,0.3640382,0.0001718752,0.0068240124,0.000014573699],"about_ca_topic_score_codex":0.00055885746,"about_ca_topic_score_gemma":0.000982015,"teacher_disagreement_score":0.0014086572,"about_ca_system_score_codex":0.00022258714,"about_ca_system_score_gemma":0.0002016749,"threshold_uncertainty_score":0.0047124624},"labels":[],"label_agreement":null},{"id":"W2135286184","doi":"10.1158/1078-0432.ccr-06-0054","title":"Roles of KLF6 and KLF6-SV1 in Ovarian Cancer Progression and Intraperitoneal Dissemination","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"U.S. Department of Defense","keywords":"Ovarian cancer; Medicine; Cancer; Cancer research; Internal medicine; Oncology","score_opus":0.06108880549184777,"score_gpt":0.5244778804454527,"score_spread":0.463389074953605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135286184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948708,0.002678225,0.001497291,0.000047279318,0.0000066520215,0.000023910185,0.00020001603,0.000037639613,0.00063831464],"genre_scores_gemma":[0.99718165,0.00087490835,0.00078273594,0.000018096074,0.0000062006666,0.000021036923,0.00025082866,0.000007462545,0.00085706654],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998666,0.000027733742,0.00001365714,0.000024673958,0.00003217864,0.000035083616],"domain_scores_gemma":[0.9997625,0.000037127877,0.00010919319,0.000016202466,0.000021930302,0.000053156153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022965534,0.00030337198,0.00021300632,0.00031067623,0.000118653596,0.00024338132,0.00012011895,0.00022879512,0.0012734532],"category_scores_gemma":[0.00020424949,0.00009004524,0.00020982626,0.00011801504,0.0001954433,0.00023682688,0.00020455664,0.00038323607,0.00025824955],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005862022,0.00007121633,0.008694259,0.00009516021,0.0000069964303,0.00015346243,0.000030293477,0.00010989619,0.9831202,0.0001550938,0.00003860619,0.0069385758],"study_design_scores_gemma":[0.000057050536,0.0014359722,0.08175415,0.000023280147,0.00005135227,0.0019484517,0.00009450533,0.0018411953,0.9093624,0.00012494743,0.0032971909,0.000009487743],"about_ca_topic_score_codex":0.00025812967,"about_ca_topic_score_gemma":0.00023570706,"teacher_disagreement_score":0.0012734532,"about_ca_system_score_codex":0.00019363273,"about_ca_system_score_gemma":0.00019825377,"threshold_uncertainty_score":0.004260123},"labels":[],"label_agreement":null},{"id":"W2135430006","doi":"10.1158/1078-0432.ccr-04-1106","title":"Results of a Multicenter Randomized Phase II Trial of Thalidomide and Prednisone Maintenance Therapy for Multiple Myeloma after Autologous Stem Cell Transplant","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Hamilton Regional Laboratory Medicine Program; Ontario Institute for Cancer Research; McGill University; Université de Montréal; Western University; Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre; Nova Scotia Cancer Centre; University Health Network","funders":"","keywords":"Thalidomide; Medicine; Prednisone; Maintenance therapy; Multiple myeloma; Tolerability; Discontinuation; Surgery; Clinical endpoint; Melphalan; Internal medicine; Randomized controlled trial; Gastroenterology; Adverse effect; Chemotherapy","score_opus":0.13535450184085993,"score_gpt":0.47176959708396127,"score_spread":0.3364150952431013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135430006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985776,0.005448735,0.0010281394,0.0011964595,0.0004982439,0.0037459603,0.0007326513,0.000099902274,0.0014738382],"genre_scores_gemma":[0.9854748,0.0018519099,0.0024213018,0.0018348399,0.0006671891,0.00416444,0.0018622457,0.000038929822,0.0016842907],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99705565,0.0021979562,0.00017753936,0.00022124418,0.0001525068,0.00019514101],"domain_scores_gemma":[0.99721515,0.00082068145,0.00077038334,0.00021851792,0.00017542775,0.0007997925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006315391,0.0015558685,0.002318221,0.00037008338,0.00056858105,0.0010980451,0.0007758559,0.0015447374,0.0027095631],"category_scores_gemma":[0.003785853,0.00062299066,0.0020260543,0.00031080365,0.00088121014,0.00084778626,0.00040230592,0.00250697,0.0004858947],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9422276,0.014686434,0.0024638989,0.00034166133,0.0018033474,0.00009642241,0.00007909049,0.00073611387,0.007586843,0.00010806812,0.0014210672,0.02844946],"study_design_scores_gemma":[0.8689542,0.12502214,0.0032189086,0.000022205319,0.0007979185,0.00005107104,0.000013910332,0.00041438953,0.0007026958,0.000081911174,0.00070736033,0.000013276623],"about_ca_topic_score_codex":0.00042892442,"about_ca_topic_score_gemma":0.0010404568,"teacher_disagreement_score":0.006315391,"about_ca_system_score_codex":0.0005290141,"about_ca_system_score_gemma":0.001452912,"threshold_uncertainty_score":0.033399403},"labels":[],"label_agreement":null},{"id":"W2135432827","doi":"10.1158/1078-0432.ccr-07-4899","title":"Oxidation of Ovarian Epithelial Cancer Cells by Hypochlorous Acid Enhances Immunogenicity and Stimulates T Cells that Recognize Autologous Primary Tumor","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Cancer Research UK","keywords":"Ovarian cancer; Antigen; Cancer research; Tumor antigen; Epitope; CD40; Hypochlorous acid; Ovarian tumor; Antigen-presenting cell; Medicine; Cytotoxic T cell; Immunology; Immunotherapy; Immune system; T cell; Biology; Cancer; Internal medicine; In vitro; Biochemistry","score_opus":0.10749293945849012,"score_gpt":0.3800637311833616,"score_spread":0.27257079172487153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135432827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987563,0.00033067618,0.00024231347,0.000016864766,0.000006857169,0.000012876187,0.000027518228,0.000009236688,0.0005973035],"genre_scores_gemma":[0.9989429,0.00016897357,0.00022096351,0.00003873988,0.0000086884265,0.000009713803,0.00009053418,0.0000037647496,0.00051570684],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990535,0.000018332748,0.000004660021,0.000013423761,0.000017638622,0.0000406141],"domain_scores_gemma":[0.9999472,0.000013486815,0.0000097916845,0.0000083854375,0.0000087374065,0.0000124488315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000074385505,0.00021775278,0.00015212351,0.00009881868,0.000087494576,0.00015386022,0.000060375336,0.00019717749,0.0014148483],"category_scores_gemma":[0.000083459905,0.00007177144,0.00019915997,0.00006333136,0.00009641744,0.000084537794,0.000153359,0.00023505333,0.00028107362],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001336944,0.000021784439,0.00040529796,0.000017788336,0.0000028937561,0.000034504577,0.000015482243,0.000026008662,0.9986185,0.000008438174,0.000016943572,0.0006987464],"study_design_scores_gemma":[0.00008021136,0.0024853346,0.025582677,0.0000110729525,0.000037298192,0.00081756816,0.00011104747,0.00070857233,0.96719444,0.000041695537,0.0029257184,0.000004460896],"about_ca_topic_score_codex":0.00034202953,"about_ca_topic_score_gemma":0.00058995787,"teacher_disagreement_score":0.0014148483,"about_ca_system_score_codex":0.00013014794,"about_ca_system_score_gemma":0.00008659604,"threshold_uncertainty_score":0.0047330856},"labels":[],"label_agreement":null},{"id":"W2135456387","doi":"10.1158/1078-0432.ccr-04-2109","title":"Up-Regulation of EphB4 in Mesothelioma and Its Biological Significance","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Axon Guidance and Neuronal Signaling","field":"Neuroscience","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Mesothelioma; Gene knockdown; Cancer research; Apoptosis; Small interfering RNA; Protein kinase B; Cell growth; Biology; Tumor progression; Cell culture; Medicine; Pathology; Cancer; Internal medicine; Transfection","score_opus":0.5606383961043458,"score_gpt":0.5543797437522127,"score_spread":0.006258652352133187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135456387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99338394,0.0043034423,0.0010342918,0.00012475233,0.000014887212,0.000014164204,0.00013187987,0.000022480071,0.0009700866],"genre_scores_gemma":[0.99543625,0.0020127443,0.001102049,0.00003094883,0.0000089961495,0.000021096936,0.00023557825,0.0000045056163,0.0011478156],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999132,0.000018067714,0.000007402596,0.000013243163,0.000029130724,0.000019049108],"domain_scores_gemma":[0.9999331,0.000013675317,0.000022153687,0.000006967205,0.000009709986,0.0000144377755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015360897,0.00017443836,0.0001552033,0.00021670724,0.00017472118,0.00020583953,0.00011683218,0.00020437494,0.00085059815],"category_scores_gemma":[0.00013224724,0.00009373856,0.00013119471,0.00011308331,0.0002894088,0.00015220795,0.00019659873,0.0002966102,0.0002180742],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017402935,0.000016334432,0.0009933123,0.000060992363,0.0000048931843,0.00020810975,0.0000074980794,0.000058578753,0.99682045,0.00007760453,0.00003282284,0.00154538],"study_design_scores_gemma":[0.000029641738,0.0004686667,0.02126906,0.000010949041,0.000033466033,0.0017036159,0.00004696071,0.0005676695,0.9721824,0.00012381103,0.0035601377,0.0000036009442],"about_ca_topic_score_codex":0.00036463232,"about_ca_topic_score_gemma":0.00045417843,"teacher_disagreement_score":0.00085059815,"about_ca_system_score_codex":0.0003925049,"about_ca_system_score_gemma":0.00021520862,"threshold_uncertainty_score":0.00284791},"labels":[],"label_agreement":null},{"id":"W2135457855","doi":"10.1158/1078-0432.ccr-06-0625","title":"Prognostic Value of Prostate Secretory Protein of 94 Amino Acids and its Binding Protein after Radical Prostatectomy","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prostatectomy; Prostate cancer; Biochemical recurrence; Medicine; Urology; Prostate-specific antigen; Proportional hazards model; Univariate analysis; Prostate; Internal medicine; Multivariate analysis; Surgical margin; Oncology; Cancer","score_opus":0.08217133761936016,"score_gpt":0.43020693889273276,"score_spread":0.34803560127337263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135457855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991985,0.00061431417,0.000045200173,0.000022508402,0.000005033442,0.0000042902725,0.000042191303,0.0000028591205,0.00006511885],"genre_scores_gemma":[0.9996755,0.000081643346,0.000039039878,0.000011472504,0.000012110864,0.000002757579,0.00010825067,6.9387215e-7,0.00006850738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997652,0.00007306099,0.000016326661,0.000040167743,0.000059267004,0.000046022862],"domain_scores_gemma":[0.9982804,0.0004946172,0.0005964139,0.00006980733,0.00011200634,0.0004467028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048088064,0.00024623427,0.00034860324,0.0003603806,0.00024517937,0.00028331068,0.00028524912,0.00037348396,0.0009907485],"category_scores_gemma":[0.0022833755,0.00012879718,0.0002942151,0.00025995163,0.00034163732,0.00022184219,0.00021759109,0.00040193176,0.000118549666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012189733,0.000046166184,0.9933675,0.00001689761,0.00006421164,0.0001538974,0.000024351431,0.000121000456,0.0010790778,0.000007797754,0.00010349046,0.0037966361],"study_design_scores_gemma":[0.000023592165,0.0004592681,0.99789894,0.000005825831,0.00003341095,0.0008687789,0.000035279576,0.00026727756,0.00028246615,0.000010800993,0.00010897261,0.0000052668256],"about_ca_topic_score_codex":0.0016201502,"about_ca_topic_score_gemma":0.0027606678,"teacher_disagreement_score":0.0016201502,"about_ca_system_score_codex":0.00028242558,"about_ca_system_score_gemma":0.00033177927,"threshold_uncertainty_score":0.0033143759},"labels":[],"label_agreement":null},{"id":"W2135493854","doi":"10.1158/1078-0432.ccr-09-1135","title":"Loss of SNF5 Expression Correlates with Poor Patient Survival in Melanoma","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Melanoma; Tissue microarray; Cancer research; Gene knockdown; Immunohistochemistry; Cancer; Medicine; Chromatin remodeling; Pathology; Biology; Apoptosis; Oncology; Gene expression; Internal medicine; Gene","score_opus":0.0783046504938187,"score_gpt":0.4430197915257031,"score_spread":0.3647151410318844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135493854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987729,0.0006619499,0.00018307159,0.000032550724,0.000004802423,0.0000028401796,0.00009937666,0.0000067186124,0.00023584797],"genre_scores_gemma":[0.9996049,0.00009220988,0.00007937565,0.000008532718,0.0000032958417,0.000001837818,0.00009863181,6.7473053e-7,0.00011050611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999918,0.000016093636,0.0000094563065,0.000021668546,0.00002069063,0.000014049441],"domain_scores_gemma":[0.9997166,0.00004910971,0.00013344681,0.000015396745,0.00003269266,0.000052745298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002019083,0.00016196331,0.00017176355,0.00027810122,0.00017538031,0.00019570903,0.00012290735,0.00022420229,0.0014343235],"category_scores_gemma":[0.0004905344,0.00006325887,0.0001537904,0.00022846834,0.00015701799,0.000114328024,0.00012118996,0.00021252269,0.00014914478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037237673,0.000027383177,0.9850085,0.000029445122,0.00005398569,0.00018059494,0.00003137156,0.000102142156,0.008847136,0.000020290614,0.00011199361,0.00521481],"study_design_scores_gemma":[0.0000053283156,0.00012428686,0.99622846,0.0000061030505,0.000050644656,0.0009888471,0.000040521867,0.00043004955,0.0017184619,0.00003366135,0.00037171468,0.000002036197],"about_ca_topic_score_codex":0.00048763282,"about_ca_topic_score_gemma":0.0009789892,"teacher_disagreement_score":0.0014343235,"about_ca_system_score_codex":0.00014390225,"about_ca_system_score_gemma":0.00010256905,"threshold_uncertainty_score":0.004798293},"labels":[],"label_agreement":null},{"id":"W2135676046","doi":"10.1158/1078-0432.ccr-12-3066","title":"Inhibition of BET Bromodomain Targets Genetically Diverse Glioblastoma","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":295,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Wellcome Trust","keywords":"Bromodomain; Glioblastoma; Biology; Cancer research; Computational biology; Medicine; Genetics; Epigenetics; Gene","score_opus":0.0788149943909722,"score_gpt":0.42841887486752256,"score_spread":0.34960388047655033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135676046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971602,0.0012176207,0.00069883117,0.00003738601,0.000010689719,0.00002708359,0.00017043858,0.000031054806,0.0006466149],"genre_scores_gemma":[0.99731344,0.0010687677,0.0006611828,0.000027620297,0.0000043281048,0.000023002804,0.00040712036,0.000007684061,0.00048688837],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999316,0.000006737629,0.0000060042066,0.000012961372,0.00002305123,0.000019756118],"domain_scores_gemma":[0.9999591,0.0000064607684,0.0000143348125,0.0000046132577,0.0000048158595,0.00001077501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011551559,0.00031779832,0.00030206374,0.0002418456,0.000128176,0.00019530022,0.00013870979,0.00014201348,0.00053785637],"category_scores_gemma":[0.00007184957,0.00007745999,0.00016916588,0.0001555273,0.00014240958,0.00012454786,0.00012052235,0.0003225884,0.00012690804],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009926221,0.000048346374,0.00035839324,0.00003794522,0.000008740527,0.00003774761,0.000009280954,0.00015264285,0.9969217,0.00006239813,0.00005077259,0.0022127377],"study_design_scores_gemma":[0.000055960096,0.00084970647,0.007349022,0.0000076464285,0.000051705298,0.0005178245,0.000025821244,0.0011659628,0.9868418,0.000050728733,0.0030795187,0.0000042192405],"about_ca_topic_score_codex":0.00047191244,"about_ca_topic_score_gemma":0.0013845534,"teacher_disagreement_score":0.00053785637,"about_ca_system_score_codex":0.00029386804,"about_ca_system_score_gemma":0.00016885244,"threshold_uncertainty_score":0.0021321774},"labels":[],"label_agreement":null},{"id":"W2136226205","doi":"10.1158/1078-0432.ccr-05-0343","title":"Determination of Doxorubicin Levels in Whole Tumor and Tumor Nuclei in Murine Breast Cancer Tumors","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":440,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Alberta","keywords":"Doxorubicin; Bioavailability; Pharmacokinetics; Pharmacology; Liposome; In vivo; Medicine; Drug; Chemistry; Chemotherapy; Internal medicine; Biology; Biochemistry","score_opus":0.11191515615459292,"score_gpt":0.44853446946362974,"score_spread":0.3366193133090368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136226205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96739846,0.0053778472,0.024310002,0.0000645936,0.000023461753,0.00009127629,0.00083550456,0.00028588102,0.0016130564],"genre_scores_gemma":[0.97006625,0.0024192864,0.022346018,0.000052922456,0.000014661906,0.00017407302,0.0012720942,0.00009376969,0.0035608937],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998247,0.00002059201,0.0000114577915,0.00007218346,0.000052526706,0.000018577339],"domain_scores_gemma":[0.9997441,0.00007466871,0.000063884225,0.000024003877,0.00005329197,0.00004001312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024315123,0.00039582356,0.00022789593,0.00054463773,0.0001080373,0.0002396071,0.0001722262,0.00025421893,0.0008715031],"category_scores_gemma":[0.00019157374,0.00015762643,0.00014265912,0.0001664165,0.00031486154,0.00031514774,0.00016432595,0.00037672315,0.00038940762],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050511255,0.000006903112,0.0003448947,0.000024876326,0.0000031734742,0.0000071869645,0.000011352451,0.000033968718,0.9986992,0.000016743437,0.000007141352,0.00079407595],"study_design_scores_gemma":[0.000009214749,0.0002181926,0.005463504,0.000006840699,0.00001565241,0.00008074851,0.000012947501,0.0005098124,0.99296814,0.000027111253,0.00068403274,0.0000037068264],"about_ca_topic_score_codex":0.000807272,"about_ca_topic_score_gemma":0.001088837,"teacher_disagreement_score":0.0008715031,"about_ca_system_score_codex":0.00044160892,"about_ca_system_score_gemma":0.0001700252,"threshold_uncertainty_score":0.0032041073},"labels":[],"label_agreement":null},{"id":"W2136700890","doi":"10.1158/1078-0432.ccr-15-0263","title":"Boosting Cancer Immunotherapy with Anti-CD137 Antibody Therapy","year":2015,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":139,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Cancer Institute","keywords":"CD137; Immunotherapy; Antibody; Medicine; Immune system; Cancer immunotherapy; Immunology; Cancer; Cancer research; Monoclonal antibody; Internal medicine","score_opus":0.4112265724873624,"score_gpt":0.5903691924447901,"score_spread":0.17914261995742775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136700890","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005453172,0.9969194,0.00037613345,0.0003151421,0.00023975478,0.000011539407,0.000019653506,0.000013779327,0.0015592878],"genre_scores_gemma":[0.003625273,0.9938148,0.00040040154,0.000403248,0.00022049982,0.000017579701,0.000054138396,0.0000026476557,0.0014614566],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998658,0.00002346059,0.000014016883,0.0000200348,0.00005777277,0.000018854511],"domain_scores_gemma":[0.9999174,0.000030334824,0.000013386643,0.000002962693,0.000023972163,0.00001202044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036253754,0.0004879257,0.0008360581,0.0012280389,0.00013983248,0.0006546926,0.0004901014,0.0008281029,0.0022791906],"category_scores_gemma":[0.00031844157,0.00017134332,0.00042643727,0.0006795372,0.00023820216,0.00064983976,0.00048356276,0.0013533875,0.0015279352],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009970332,0.00014020252,0.00024314046,0.010937978,0.00008642908,0.00025847388,0.000044684544,0.0003931702,0.009497294,0.004090671,0.024663428,0.9495449],"study_design_scores_gemma":[0.00003918594,0.00017701888,0.0006945503,0.0015179486,0.00008515195,0.0019043388,0.000029118852,0.00016559784,0.0033715847,0.0017456914,0.99025506,0.000014632442],"about_ca_topic_score_codex":0.000341746,"about_ca_topic_score_gemma":0.00073363964,"teacher_disagreement_score":0.0022791906,"about_ca_system_score_codex":0.0004602721,"about_ca_system_score_gemma":0.0005220377,"threshold_uncertainty_score":0.0076246858},"labels":[],"label_agreement":null},{"id":"W2136709806","doi":"10.1158/1078-0432.ccr-07-5110","title":"Predictive Value of Plasma Hepatocyte Growth Factor/Scatter Factor Levels in Patients with Clinically Localized Prostate Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Liver physiology and pathology","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Université de Montréal","funders":"","keywords":"Medicine; Hepatocyte growth factor; Prostate cancer; Internal medicine; Prostatectomy; Lymph node; Oncology; Metastasis; Urology; Cancer","score_opus":0.18182476130054928,"score_gpt":0.4641010617020106,"score_spread":0.28227630040146134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136709806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998901,0.00052541075,0.00027232655,0.000055816985,0.000010613988,0.000005922252,0.000076252116,0.00001158117,0.0001410675],"genre_scores_gemma":[0.9997081,0.000045904602,0.00011613061,0.0000076160422,0.000009930767,0.0000036516947,0.000082496634,0.000001191871,0.000024895284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960953,0.0001505831,0.00003320888,0.00007919499,0.000098654185,0.000028808383],"domain_scores_gemma":[0.9968941,0.0017939958,0.00061122474,0.00015107974,0.00021426572,0.00033533724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075456634,0.00051969534,0.00044801657,0.0005539981,0.0002663712,0.0004228522,0.0003620181,0.0005666807,0.0010421344],"category_scores_gemma":[0.0054163216,0.00023329974,0.00030575765,0.0003640651,0.00046717285,0.00027745686,0.00032545443,0.00076590956,0.00019590488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031014206,0.000025807673,0.9968747,0.0000093688195,0.000038222468,0.00006098108,0.000015622258,0.00047333678,0.0003425562,0.000007640936,0.000062984676,0.0017786494],"study_design_scores_gemma":[0.000042486445,0.00034600782,0.99085605,0.000010338384,0.000086629945,0.0006354805,0.00008412428,0.007229883,0.0004563737,0.00008056607,0.00016274981,0.000009293058],"about_ca_topic_score_codex":0.0012425097,"about_ca_topic_score_gemma":0.0015737376,"teacher_disagreement_score":0.0012425097,"about_ca_system_score_codex":0.0002383187,"about_ca_system_score_gemma":0.00035958816,"threshold_uncertainty_score":0.0039905906},"labels":[],"label_agreement":null},{"id":"W2136802909","doi":"10.1158/1078-0432.ccr-06-2630","title":"Molecular Pathways Mediating Liver Metastasis in Patients with Uveal Melanoma","year":2008,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Melanoma; Metastasis; Medicine; Uvea; Disease; Ocular Melanoma; Cancer; Pathology; Cancer research; Oncology; Internal medicine","score_opus":0.31595493502663785,"score_gpt":0.534959405665413,"score_spread":0.21900447063877515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136802909","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010378481,0.99691075,0.00017843502,0.00022823318,0.00007292865,0.000008606548,0.000026555635,0.000011966595,0.0015247808],"genre_scores_gemma":[0.005076209,0.99332124,0.00034180516,0.00014418429,0.000083701474,0.000013482837,0.000054874814,0.000001092078,0.00096335396],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999373,0.000014177904,0.000008942284,0.000010590069,0.000019401681,0.00000957877],"domain_scores_gemma":[0.99994683,0.00001563492,0.000016384194,0.0000013454879,0.000014082928,0.0000058455644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016161158,0.00051804393,0.00086628017,0.00092813326,0.00017770378,0.00051029853,0.00039463013,0.0004980103,0.0022172555],"category_scores_gemma":[0.00020168089,0.000121811645,0.00031641126,0.00081754907,0.00018113601,0.0004245957,0.00026391758,0.00055036554,0.0012168671],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022958074,0.000107193555,0.0015285172,0.012839291,0.0001614857,0.0023628587,0.00013721043,0.00044305122,0.014679945,0.0026146907,0.017475275,0.94742095],"study_design_scores_gemma":[0.00013396649,0.0005006497,0.015702913,0.0044339243,0.00046421928,0.020656656,0.00030910104,0.00030294133,0.00715894,0.003695691,0.9465916,0.000049396163],"about_ca_topic_score_codex":0.00066598755,"about_ca_topic_score_gemma":0.0012163527,"teacher_disagreement_score":0.0022172555,"about_ca_system_score_codex":0.0003772306,"about_ca_system_score_gemma":0.00052779703,"threshold_uncertainty_score":0.0074175},"labels":[],"label_agreement":null},{"id":"W2137025653","doi":"10.1158/1078-0432.ccr-08-1888","title":"A Simple and Accurate Model for Prediction of Cancer-Specific Mortality in Patients Treated with Surgery for Primary Penile Squamous Cell Carcinoma","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genital Health and Disease","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nomogram; Penectomy; Surveillance, Epidemiology, and End Results; Proportional hazards model; Receiver operating characteristic; Penile cancer; Stage (stratigraphy); Prognostic variable; Oncology; Surgery; Internal medicine; Epidemiology; Cancer; Cancer registry","score_opus":0.25719215037944554,"score_gpt":0.4846290437228462,"score_spread":0.22743689334340067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137025653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9337981,0.0006744975,0.058625054,0.0015975017,0.00014535927,0.00023508901,0.0027978614,0.00058279664,0.0015437766],"genre_scores_gemma":[0.98996043,0.000106952466,0.0076491013,0.000079058496,0.000057754387,0.00011170917,0.0013400038,0.000012304337,0.00068271894],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99927,0.00032115198,0.00005280214,0.00016476856,0.00011700421,0.00007436389],"domain_scores_gemma":[0.9961979,0.0027190996,0.00040669428,0.00010355528,0.00040819647,0.00016455752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031872035,0.00077183475,0.0011208043,0.001488936,0.0003826279,0.0011337353,0.0009799149,0.0007271698,0.0019903327],"category_scores_gemma":[0.007897878,0.00032974192,0.000769205,0.0005687019,0.0002729253,0.0004057149,0.00041217823,0.0007910116,0.00045435058],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008924984,0.00053589576,0.4332909,0.000110403504,0.0005554095,0.00044976437,0.00010608737,0.50838315,0.0005090528,0.00085270306,0.0049837367,0.049330376],"study_design_scores_gemma":[0.00006160054,0.00018158561,0.023549939,0.000022988212,0.000058796413,0.00008948767,0.000017522249,0.97489244,0.00011196185,0.00068748166,0.00031288678,0.000013378364],"about_ca_topic_score_codex":0.012557887,"about_ca_topic_score_gemma":0.007360114,"teacher_disagreement_score":0.012557887,"about_ca_system_score_codex":0.0009434147,"about_ca_system_score_gemma":0.0015317576,"threshold_uncertainty_score":0.024969578},"labels":[],"label_agreement":null},{"id":"W2137130674","doi":"10.1158/1078-0432.ccr-04-2159","title":"Inhibition of Heme Oxygenase-1 Increases Responsiveness of Pancreatic Cancer Cells to Anticancer Treatment","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":264,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Pancreatic cancer; Heme oxygenase; Cancer cell; Cancer research; Cancer; Gemcitabine; Transfection; Pancreas; Chemotherapy; Gene knockdown; Cell growth; Cell culture; Biology; Internal medicine; Medicine; Endocrinology; Heme; Enzyme; Biochemistry","score_opus":0.10618582911356644,"score_gpt":0.4645964321959659,"score_spread":0.35841060308239947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137130674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906826,0.0047374773,0.0014238363,0.00019708688,0.000093564355,0.000058338603,0.00043214276,0.00020208319,0.0021728105],"genre_scores_gemma":[0.9930906,0.0022603066,0.0012737756,0.00009729224,0.00002068607,0.000080463644,0.00094622053,0.000020515305,0.0022100352],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998293,0.00003454714,0.00001679714,0.000033797194,0.000041724015,0.00004385494],"domain_scores_gemma":[0.99986744,0.00004772195,0.000024591547,0.000018412089,0.000015391006,0.000026538755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013234564,0.0002448404,0.0005060119,0.00022564922,0.000115330135,0.00027660295,0.00017401257,0.0002347127,0.0014679716],"category_scores_gemma":[0.0001810614,0.00012857729,0.00024104494,0.00025323097,0.0001304578,0.00012512674,0.00018660259,0.00073171814,0.00036332675],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038335056,0.00020958293,0.00025252192,0.00007917814,0.000012734604,0.00005383233,0.000033330074,0.0001451632,0.9947337,0.000045575238,0.00025131612,0.003799714],"study_design_scores_gemma":[0.000044978002,0.0014679679,0.008858511,0.000011597855,0.0000279493,0.00023808752,0.00003608973,0.0018039282,0.9830446,0.000039178205,0.004419186,0.000007983581],"about_ca_topic_score_codex":0.00040141598,"about_ca_topic_score_gemma":0.00043309754,"teacher_disagreement_score":0.0014679716,"about_ca_system_score_codex":0.00020473557,"about_ca_system_score_gemma":0.00018670778,"threshold_uncertainty_score":0.0049108863},"labels":[],"label_agreement":null},{"id":"W2137134338","doi":"10.1158/1078-0432.ccr-031213","title":"Proceedings of the Third International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Endocrine system; Breast cancer; Medicine; Cancer; Political science; Library science; Internal medicine; Computer science; Hormone","score_opus":0.06777746877021625,"score_gpt":0.448472388051013,"score_spread":0.3806949192807968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137134338","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062231654,0.44581127,0.0074276496,0.0755206,0.3399164,0.0004390354,0.00088760094,0.00038331526,0.12339093],"genre_scores_gemma":[0.021385936,0.3843962,0.006186422,0.014196545,0.14702553,0.00046282532,0.0020414034,0.0003021414,0.424003],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988606,0.00019134155,0.00007966511,0.000107296444,0.0005708276,0.00019032857],"domain_scores_gemma":[0.99731356,0.00026456296,0.00015580376,0.000054718977,0.0012236964,0.0009876566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002685891,0.0011309346,0.0010221462,0.0013248981,0.00084072794,0.0035459541,0.0012462793,0.0019887583,0.03237451],"category_scores_gemma":[0.0024518194,0.0002668178,0.0008035211,0.001178108,0.00058446993,0.0014720093,0.0011955474,0.0035007976,0.012422726],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054928503,0.00025171015,0.0005892581,0.0008318054,0.00006666915,0.00028347803,0.0000845469,0.00019633105,0.0032579077,0.0018935512,0.7955441,0.19645137],"study_design_scores_gemma":[0.000027051,0.00008679887,0.0008163684,0.00017969098,0.000041526786,0.00023868703,0.000060398874,0.000066036126,0.0007668515,0.00047842803,0.99722725,0.000010854936],"about_ca_topic_score_codex":0.0015649637,"about_ca_topic_score_gemma":0.0051324307,"teacher_disagreement_score":0.03237451,"about_ca_system_score_codex":0.0015786979,"about_ca_system_score_gemma":0.0021681273,"threshold_uncertainty_score":0.10830349},"labels":[],"label_agreement":null},{"id":"W2137434859","doi":"10.1158/1078-0432.ccr-05-0725","title":"Radioimmunotherapy of CD22-Expressing Daudi Tumors in Nude Mice with a 90Y-Labeled Anti-CD22 Monoclonal Antibody","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Radioimmunotherapy; CD22; Monoclonal antibody; In vivo; Antibody; Cancer research; Bone marrow; Lymphoma; Medicine; Pathology; Immunology; Biology","score_opus":0.20793409613900835,"score_gpt":0.5765092146798357,"score_spread":0.36857511854082736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137434859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99319893,0.0017070303,0.0030711503,0.00008220921,0.00004211713,0.000082130224,0.0001208366,0.0001287509,0.0015667862],"genre_scores_gemma":[0.99122286,0.0015573174,0.0034321272,0.000050047667,0.000024972613,0.000101423255,0.00027589215,0.00004472565,0.0032905524],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998772,0.00002441254,0.000006282491,0.000023516277,0.000023946706,0.00004451855],"domain_scores_gemma":[0.999933,0.0000093784565,0.00002432155,0.000008878413,0.000007033645,0.000017350478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001734677,0.00051523914,0.00046886926,0.0003633832,0.00016554793,0.00032552396,0.0002938543,0.000354349,0.00072130153],"category_scores_gemma":[0.00009288365,0.000217572,0.00025806742,0.00015119612,0.00019124978,0.0002058513,0.00016714372,0.00057955616,0.00028864498],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017992155,0.00011672101,0.0000675876,0.000020419822,0.0000068286517,0.000030767187,0.000010342125,0.00010138615,0.99790335,0.0000673884,0.000025978687,0.0014695291],"study_design_scores_gemma":[0.00008056633,0.003812186,0.0012304379,0.0000051367565,0.000039075792,0.00029538508,0.000015173838,0.0011027482,0.99106044,0.00003218339,0.0023207772,0.0000058759015],"about_ca_topic_score_codex":0.0008612313,"about_ca_topic_score_gemma":0.0009988319,"teacher_disagreement_score":0.0008612313,"about_ca_system_score_codex":0.00030621098,"about_ca_system_score_gemma":0.0002735526,"threshold_uncertainty_score":0.0024130344},"labels":[],"label_agreement":null},{"id":"W2137551916","doi":"10.1158/1078-0432.ccr-05-2215","title":"Phase 1 Trial of Gefitinib Plus Sirolimus in Adults with Recurrent Malignant Glioma","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources; National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"Gefitinib; Medicine; Sirolimus; Rash; Mucositis; Pharmacology; Dosing; Internal medicine; Glioma; Chemotherapy; Tyrosine-kinase inhibitor; Anaplastic astrocytoma; Epidermal growth factor receptor; Oncology; Gastroenterology; Cancer; Cancer research; Astrocytoma","score_opus":0.1872098037025844,"score_gpt":0.5209507669304803,"score_spread":0.33374096322789587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137551916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957926,0.0016524933,0.0002560414,0.00033824265,0.00006345471,0.0009647815,0.0003319954,0.00006994631,0.0005302737],"genre_scores_gemma":[0.99504244,0.00096975284,0.00081931276,0.00045210996,0.00013986732,0.0009437367,0.00084466586,0.000014619053,0.00077355484],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995516,0.00020272491,0.0000357726,0.00008603304,0.00005182806,0.00007203469],"domain_scores_gemma":[0.9994382,0.00006515392,0.00016337604,0.00003195118,0.00004148531,0.00025988353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011823052,0.0017174435,0.0021440396,0.0003725393,0.00036924978,0.00062474323,0.0007250897,0.001000108,0.0021421819],"category_scores_gemma":[0.0009448018,0.00047843772,0.0009850637,0.00030288097,0.0005573924,0.0005561546,0.0003037569,0.0022020745,0.00066836085],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7730575,0.032646645,0.015253149,0.0009478759,0.0024041657,0.00046855444,0.00044503313,0.0027680858,0.03426973,0.00018794299,0.0045232363,0.13302802],"study_design_scores_gemma":[0.511542,0.4483667,0.029743612,0.000036360583,0.0008403604,0.0006788508,0.00006747371,0.0019557916,0.0035201244,0.00012885795,0.0030806973,0.000039220267],"about_ca_topic_score_codex":0.0012655014,"about_ca_topic_score_gemma":0.003928322,"teacher_disagreement_score":0.0021440396,"about_ca_system_score_codex":0.0011760213,"about_ca_system_score_gemma":0.0016660533,"threshold_uncertainty_score":0.008532643},"labels":[],"label_agreement":null},{"id":"W2137737798","doi":"10.1158/1078-0432.ccr-06-1503","title":"Class III β-Tubulin Expression and Benefit from Adjuvant Cisplatin/Vinorelbine Chemotherapy in Operable Non–Small Cell Lung Cancer: Analysis of NCIC JBR.10","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":139,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; University of Alberta","funders":"National Cancer Institute; Alberta Cancer Foundation; GlaxoSmithKline","keywords":"Vinorelbine; Medicine; Chemotherapy; Oncology; Internal medicine; Lung cancer; Cisplatin; Adjuvant; Cancer; Stage (stratigraphy); Immunohistochemistry; Biology","score_opus":0.038747437186724604,"score_gpt":0.41320546629958144,"score_spread":0.37445802911285686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137737798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991665,0.00037370366,0.00003927476,0.000025179968,0.000003552213,0.000025927264,0.00021624575,0.000003134548,0.00014650532],"genre_scores_gemma":[0.99830437,0.00012931589,0.00011813521,0.000053658634,0.000012902387,0.000042435735,0.0011579603,0.0000037006732,0.00017760038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995524,0.00020887941,0.00003050777,0.00006779311,0.00008724704,0.000053209387],"domain_scores_gemma":[0.999228,0.00022090245,0.00020130129,0.000063922154,0.000045289577,0.00024060672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014468177,0.00034477116,0.00073231,0.00026495758,0.00018946687,0.00040585845,0.00038811364,0.00038081876,0.0010364772],"category_scores_gemma":[0.00089698884,0.00016389249,0.00071290345,0.00028786666,0.0002774672,0.00017014718,0.00021829076,0.00049157074,0.00014436472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15997185,0.0039868406,0.7595752,0.0005650801,0.002039763,0.00032286803,0.00014034956,0.0013137291,0.037437856,0.00009733391,0.0013503865,0.03319874],"study_design_scores_gemma":[0.0050157253,0.011172183,0.97900736,0.000020182042,0.0007001244,0.0003550143,0.000044327317,0.0014906987,0.001420102,0.000041586143,0.0007214655,0.00001125103],"about_ca_topic_score_codex":0.001884452,"about_ca_topic_score_gemma":0.004535242,"teacher_disagreement_score":0.001884452,"about_ca_system_score_codex":0.0005118008,"about_ca_system_score_gemma":0.00050719205,"threshold_uncertainty_score":0.0076515675},"labels":[],"label_agreement":null},{"id":"W2137937825","doi":"10.1158/1078-0432.ccr-10-0457","title":"The Effectiveness of Off-Protocol Adjuvant Chemotherapy for Patients with Urothelial Carcinoma of the Urinary Bladder","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université Laval","funders":"","keywords":"Medicine; Cystectomy; Hazard ratio; Chemotherapy; Proportional hazards model; Bladder cancer; Internal medicine; Oncology; Adjuvant; Confidence interval; Urology; Cancer; Surgery","score_opus":0.06501876921638866,"score_gpt":0.4640252263772062,"score_spread":0.39900645716081756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137937825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980028,0.0012934268,0.00023425446,0.00010258336,0.0000131260995,0.00004635375,0.000065391214,0.00000871301,0.000233278],"genre_scores_gemma":[0.9990421,0.00031661466,0.00029436682,0.00006168345,0.000019885541,0.000029788855,0.00019401002,0.000002052614,0.000039408984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755436,0.0017694543,0.00014855918,0.00020749772,0.00021872758,0.00010148106],"domain_scores_gemma":[0.99378127,0.002861665,0.0021817852,0.00060714246,0.00018552433,0.0003825453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003496354,0.00027581266,0.0005394421,0.00028927476,0.0002220227,0.0005532981,0.0005348269,0.0003496752,0.00061834673],"category_scores_gemma":[0.013109544,0.0001493779,0.00055817154,0.000373581,0.00044745702,0.00045454223,0.00064364326,0.00045103024,0.00006393996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033596188,0.0021838658,0.80957556,0.00053401035,0.0012643308,0.00012665224,0.00012648966,0.002243766,0.0030912706,0.00012087327,0.00062803295,0.14650898],"study_design_scores_gemma":[0.0022653318,0.02831934,0.95835614,0.00018411307,0.0009985659,0.0007387469,0.00020837631,0.004617917,0.0023571318,0.00033136024,0.0016004452,0.000022476821],"about_ca_topic_score_codex":0.00056203105,"about_ca_topic_score_gemma":0.0009341572,"teacher_disagreement_score":0.003496354,"about_ca_system_score_codex":0.0005090495,"about_ca_system_score_gemma":0.0009053137,"threshold_uncertainty_score":0.018490672},"labels":[],"label_agreement":null},{"id":"W2138047541","doi":"10.1158/1078-0432.ccr-04-1169","title":"Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Represses Cyclin D1 in Aerodigestive Tract Cancers","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institutes of Health; National Cancer Institute; Samuel Waxman Cancer Research Foundation","keywords":"Erlotinib; Cyclin D1; Epidermal growth factor receptor; Cancer research; Cell cycle; Epidermal growth factor; Tyrosine kinase; Biology; Erlotinib Hydrochloride; Lung cancer; Cell growth; Cancer; Medicine; Internal medicine; Receptor","score_opus":0.16625342764581966,"score_gpt":0.5242624049371198,"score_spread":0.3580089772913002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138047541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940872,0.003958038,0.00074310845,0.000074427124,0.00001527168,0.000029037825,0.00029775506,0.000024854118,0.00077028916],"genre_scores_gemma":[0.9967339,0.0013208481,0.00056291,0.000028367545,0.0000047749863,0.000021951408,0.0004087711,0.000005924154,0.00091251754],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998957,0.000019820458,0.000009793926,0.000023294417,0.000034004097,0.000017473603],"domain_scores_gemma":[0.999949,0.000010637666,0.00001461034,0.0000079105885,0.000010562304,0.000007185172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013218421,0.00017053535,0.00028256213,0.00012849137,0.00012041872,0.0002485261,0.00010760055,0.00011415515,0.0010154345],"category_scores_gemma":[0.00012383342,0.000079044745,0.00016046914,0.00013629394,0.00014024589,0.00009345608,0.000082422535,0.00031588983,0.00020835777],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047293442,0.00007904974,0.0013888483,0.0000888742,0.000011800509,0.000048545095,0.000014357035,0.0001542685,0.9935725,0.000033699245,0.0000767053,0.0040583913],"study_design_scores_gemma":[0.0000792105,0.0012249469,0.029164543,0.0000075336675,0.000031372445,0.00048394996,0.0000516261,0.0007751212,0.96376073,0.000025014584,0.0043919366,0.000004142658],"about_ca_topic_score_codex":0.00079579133,"about_ca_topic_score_gemma":0.001552983,"teacher_disagreement_score":0.0010154345,"about_ca_system_score_codex":0.00036449067,"about_ca_system_score_gemma":0.0002627629,"threshold_uncertainty_score":0.0033969283},"labels":[],"label_agreement":null},{"id":"W2138090961","doi":"10.1158/1078-0432.ccr-12-3283","title":"Urinary TMPRSS2:ERG and PCA3 in an Active Surveillance Cohort: Results from a Baseline Analysis in the Canary Prostate Active Surveillance Study","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"TMPRSS2; Prostate; Medicine; Prostate cancer; Erg; Urinary system; Cohort; Baseline (sea); Cohort study; Oncology; Internal medicine; Urology; Cancer; Biology; Ophthalmology; Coronavirus disease 2019 (COVID-19)","score_opus":0.14102702987533422,"score_gpt":0.48799266167321287,"score_spread":0.34696563179787865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138090961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988232,0.00016960134,0.000074855416,0.000023824226,0.000005729255,0.000010792453,0.00066144497,0.0000054672632,0.00022500863],"genre_scores_gemma":[0.998563,0.00005035038,0.000060707458,0.000019583595,0.000010732828,0.000011638214,0.0010950105,0.000004578248,0.00018438825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987067,0.000336711,0.00006864461,0.00041508174,0.00029549692,0.00017734626],"domain_scores_gemma":[0.997601,0.000388463,0.00062455505,0.00046793566,0.0003352804,0.0005827692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018118306,0.000607176,0.0006995588,0.0008186423,0.0007726512,0.0011967021,0.0007907784,0.000805697,0.0015420244],"category_scores_gemma":[0.002568623,0.0004336879,0.0008344631,0.0014360134,0.00039697537,0.00048290656,0.00075114775,0.0010023481,0.00030339716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009575593,0.00008878788,0.99746597,0.000007880088,0.00017464964,0.000052110747,0.000081883576,0.00004071259,0.00034599978,0.000012948797,0.00014780047,0.00062357425],"study_design_scores_gemma":[0.000024731453,0.00023262484,0.9991217,0.0000021720168,0.00007518448,0.000085747575,0.0000644986,0.0001645643,0.00007286121,0.000009042634,0.0001426605,0.0000040797972],"about_ca_topic_score_codex":0.016103495,"about_ca_topic_score_gemma":0.015275633,"teacher_disagreement_score":0.016103495,"about_ca_system_score_codex":0.00067588856,"about_ca_system_score_gemma":0.0006866153,"threshold_uncertainty_score":0.032019556},"labels":[],"label_agreement":null},{"id":"W2138120234","doi":"10.1158/1078-0432.ccr-0974-3","title":"Osteoblast-Derived Factors Induce Androgen-Independent Proliferation and Expression of Prostate-Specific Antigen in Human Prostate Cancer Cells","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"LNCaP; Prostate cancer; Androgen; Cancer research; Endocrinology; Internal medicine; DU145; Prostate-specific antigen; Androgen receptor; Medicine; Biology; Cancer; Hormone","score_opus":0.18724392962339972,"score_gpt":0.48806405064692054,"score_spread":0.30082012102352085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138120234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95845026,0.020159656,0.0066569196,0.00036229784,0.0003063544,0.00043809705,0.0025592754,0.0002815626,0.0107855005],"genre_scores_gemma":[0.9720231,0.007919964,0.0057051675,0.00029713847,0.00010265238,0.00021995389,0.003721608,0.000037745696,0.009972598],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996526,0.000038375798,0.000023299172,0.00003460853,0.00018380373,0.000067288696],"domain_scores_gemma":[0.9998406,0.000046662277,0.000021466542,0.000020513973,0.0000329847,0.000037679336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022669144,0.00047531165,0.00044305265,0.0003908812,0.00016128,0.00030581828,0.00014714806,0.00020719999,0.0024027766],"category_scores_gemma":[0.00019430726,0.00018349793,0.00044270649,0.00040165422,0.00019564596,0.00007199525,0.00028199345,0.00068983505,0.00080173824],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022947999,0.00015836119,0.00030968647,0.00017937695,0.000013821832,0.000118745134,0.000038659513,0.0000861284,0.99425006,0.00010905243,0.0002687551,0.004237774],"study_design_scores_gemma":[0.00021606713,0.0022517934,0.014512108,0.000038433165,0.00006150741,0.0005388417,0.00007993981,0.0014881266,0.9641554,0.00013695112,0.01650587,0.000014942465],"about_ca_topic_score_codex":0.0013551016,"about_ca_topic_score_gemma":0.003653462,"teacher_disagreement_score":0.0024027766,"about_ca_system_score_codex":0.0002813511,"about_ca_system_score_gemma":0.00039483546,"threshold_uncertainty_score":0.008038104},"labels":[],"label_agreement":null},{"id":"W2138228574","doi":"10.1158/1078-0432.ccr-10-0627","title":"System-Level Analysis of Neuroblastoma Tumor–Initiating Cells Implicates AURKB as a Novel Drug Target for Neuroblastoma","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University Health Network; University of Toronto; BC Cancer Agency; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research; Canada's Michael Smith Genome Sciences Centre","keywords":"Neuroblastoma; Tics; Cancer research; Transcriptome; Neural crest; Aurora kinase; Biology; Cancer; Medicine; Gene; Bioinformatics; Oncology; Internal medicine; Computational biology; Cell culture; Gene expression; Genetics; Neuroscience; Cell cycle","score_opus":0.1805011976891704,"score_gpt":0.5070562974969719,"score_spread":0.3265550998078015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138228574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882754,0.0015397258,0.0060170623,0.000058973448,0.000013106129,0.00004516863,0.0027160146,0.000113029266,0.0012215406],"genre_scores_gemma":[0.98463005,0.0010516389,0.0068913396,0.000061003455,0.0000061251526,0.000050304363,0.0061440705,0.000029179195,0.0011362922],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999001,0.0000069834055,0.000008424624,0.000034472538,0.00003531403,0.000014679177],"domain_scores_gemma":[0.99993694,0.000012093634,0.000013229063,0.000009065793,0.000016710046,0.0000119456745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009821228,0.00018153871,0.00028057562,0.00019502518,0.00021564882,0.00033144606,0.00010428023,0.00014366451,0.0006829561],"category_scores_gemma":[0.000106662956,0.00008375241,0.00028510284,0.00019674256,0.00017228778,0.00015497956,0.00016945243,0.00039416677,0.00024996692],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028021068,0.0000048449797,0.0014511043,0.000029867266,0.0000054579446,0.000020289093,0.00001137055,0.000078955265,0.99758494,0.00001391375,0.000014656646,0.00075650855],"study_design_scores_gemma":[0.00000784351,0.0003584164,0.17391099,0.0000104606215,0.00008453269,0.00062110915,0.000109951,0.0032030724,0.8183999,0.000086258086,0.003196452,0.0000110893225],"about_ca_topic_score_codex":0.0015570831,"about_ca_topic_score_gemma":0.0023587672,"teacher_disagreement_score":0.0015570831,"about_ca_system_score_codex":0.00039494951,"about_ca_system_score_gemma":0.00036016834,"threshold_uncertainty_score":0.0030961037},"labels":[],"label_agreement":null},{"id":"W2138255741","doi":"10.1158/1078-0432.ccr-08-3041","title":"Bendamustine in B-Cell Malignancies: The New 46-Year-Old Kid on the Block","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Bendamustine; Medicine; Block (permutation group theory); Oncology; Internal medicine; Lymphoma; Rituximab","score_opus":0.20114278304669014,"score_gpt":0.4986546305078373,"score_spread":0.29751184746114717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138255741","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028642453,0.68119156,0.0011992824,0.27612922,0.016581278,0.000038980117,0.00028148593,0.00012900535,0.02158489],"genre_scores_gemma":[0.020129485,0.72030336,0.0033667337,0.17143218,0.030673124,0.000070649796,0.0005655005,0.00012951135,0.053329483],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.999424,0.000105544386,0.00006305981,0.00008681306,0.00018902782,0.00013155382],"domain_scores_gemma":[0.99871635,0.00021281757,0.00009536925,0.000047114547,0.00025886056,0.0006695839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025075518,0.0005738427,0.0007674762,0.00076012744,0.00083232805,0.0016892529,0.0005762046,0.0025788932,0.0060001593],"category_scores_gemma":[0.0022207503,0.00032707752,0.0004428996,0.0005812623,0.0010161941,0.0035202678,0.001364959,0.0062429863,0.0038640187],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041862173,0.00014275864,0.0012814288,0.00030671858,0.000028443967,0.0005295706,0.00013086159,0.00017677227,0.0014774533,0.0114071295,0.62851834,0.35558188],"study_design_scores_gemma":[0.000057243637,0.00017875225,0.00068614155,0.00040915568,0.000014665729,0.00080298673,0.0000503212,0.00007200305,0.0001295825,0.0026944673,0.9948949,0.000009792129],"about_ca_topic_score_codex":0.0027480414,"about_ca_topic_score_gemma":0.009327128,"teacher_disagreement_score":0.0060001593,"about_ca_system_score_codex":0.0014969056,"about_ca_system_score_gemma":0.0023729345,"threshold_uncertainty_score":0.02007252},"labels":[],"label_agreement":null},{"id":"W2138501761","doi":"10.1158/1078-0432.ccr-03-0463","title":"Phase II Study of Celecoxib and Trastuzumab in Metastatic Breast Cancer Patients Who Have Progressed after Prior Trastuzumab-Based Treatments","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Trastuzumab; Medicine; Metastatic breast cancer; Celecoxib; Breast cancer; Internal medicine; Oncology; Regimen; Rash; Cancer","score_opus":0.1846703249882754,"score_gpt":0.5588671635938909,"score_spread":0.3741968386056155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138501761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918001,0.00173686,0.0005738836,0.00044465755,0.00015601715,0.0035036718,0.00047237225,0.000054043077,0.0012583596],"genre_scores_gemma":[0.9847178,0.0017832905,0.0016608761,0.0011091753,0.00033592063,0.0055577657,0.001889414,0.000024544868,0.0029212025],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99933773,0.0003265094,0.000031498912,0.000086216496,0.00006876873,0.00014935624],"domain_scores_gemma":[0.9990947,0.000119630255,0.000121666744,0.0000770354,0.000066769935,0.00052003976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018503317,0.0015722092,0.0027367065,0.00047388414,0.00059626286,0.0010083517,0.0009174992,0.0016116981,0.0029969793],"category_scores_gemma":[0.0011394786,0.00072695327,0.00114626,0.0004388378,0.00101457,0.0007055488,0.0004032512,0.0037518512,0.0008065846],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6458616,0.19557829,0.01322802,0.00061231246,0.0012399121,0.0005832939,0.00036078217,0.002534293,0.05418788,0.000310719,0.0033772856,0.08212563],"study_design_scores_gemma":[0.5009121,0.48237613,0.00961347,0.00002364902,0.0002286933,0.00028411538,0.00004333502,0.001015133,0.0032290134,0.00009636601,0.002161869,0.000016160038],"about_ca_topic_score_codex":0.00084486295,"about_ca_topic_score_gemma":0.001762394,"teacher_disagreement_score":0.0029969793,"about_ca_system_score_codex":0.0007959536,"about_ca_system_score_gemma":0.0018923716,"threshold_uncertainty_score":0.0100259185},"labels":[],"label_agreement":null},{"id":"W2138666899","doi":"10.1158/1078-0432.ccr-11-2956","title":"Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC.CTG MA.5 Randomized Trial","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of British Columbia; McMaster University; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Epirubicin; Medicine; Internal medicine; Anthracycline; Cyclophosphamide; Oncology; Breast cancer; Fluorouracil; Chemotherapy; Proportional hazards model; Cancer; Confidence interval","score_opus":0.149470228483138,"score_gpt":0.5124521046489711,"score_spread":0.36298187616583305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138666899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98014706,0.013452456,0.00036713484,0.0014031155,0.0003597572,0.0009234612,0.0007040538,0.00006152742,0.0025813521],"genre_scores_gemma":[0.9946537,0.0011650661,0.00045774662,0.0010042484,0.00026229632,0.00085408374,0.00064376026,0.0000063686202,0.00095268205],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99791855,0.0015787276,0.000078638805,0.00016610516,0.000094572955,0.00016338966],"domain_scores_gemma":[0.9982357,0.0007515112,0.00047386892,0.00012244922,0.00007611751,0.00034033594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030061346,0.00078667654,0.001749916,0.00030135756,0.00025952543,0.00076041627,0.0006372857,0.0011754591,0.0023700737],"category_scores_gemma":[0.0043213586,0.00023731489,0.0014909918,0.0003086875,0.00064132805,0.0004795657,0.00027424569,0.0016745508,0.0002569028],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96756995,0.00085362693,0.005423854,0.0005540753,0.001622657,0.00005061826,0.000035378915,0.00084462384,0.0010035519,0.00031491893,0.0015209072,0.020205868],"study_design_scores_gemma":[0.88863474,0.076240696,0.024458984,0.0003493998,0.0035956441,0.00014453595,0.000042873315,0.0025790757,0.00078434666,0.0006645085,0.002469928,0.000035400135],"about_ca_topic_score_codex":0.0018744835,"about_ca_topic_score_gemma":0.005864112,"teacher_disagreement_score":0.0030061346,"about_ca_system_score_codex":0.0011084862,"about_ca_system_score_gemma":0.0016331115,"threshold_uncertainty_score":0.015898108},"labels":[],"label_agreement":null},{"id":"W2138717155","doi":"10.1158/1078-0432.ccr-09-2014","title":"Serum Prognostic Markers in Head and Neck Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Internal medicine; Medicine; Oncology; Hazard ratio; Quartile; Confidence interval; Head and neck cancer; Proportional hazards model; Cancer; Head and neck squamous-cell carcinoma; Incidence (geometry); Gastroenterology","score_opus":0.24941591033495822,"score_gpt":0.5694165880369855,"score_spread":0.3200006777020272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138717155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8484716,0.14616705,0.0023877318,0.0011568967,0.00021434139,0.00007618418,0.00068333634,0.000063811254,0.0007790613],"genre_scores_gemma":[0.9924064,0.0057440638,0.0010626899,0.00017485824,0.00015946552,0.00004481793,0.00034302645,0.0000025545344,0.00006206826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998635,0.0007176777,0.00013674058,0.00012979197,0.0003292082,0.00005161202],"domain_scores_gemma":[0.9924474,0.004646255,0.0021808865,0.0001981918,0.00039525135,0.00013201905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035612383,0.000491285,0.000785035,0.0007571042,0.0002175156,0.0006033059,0.0004586892,0.0005320449,0.00052861235],"category_scores_gemma":[0.013663717,0.00016000115,0.0005330546,0.0012861211,0.0004420602,0.00035797546,0.00026702418,0.000499928,0.00011433086],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008204134,0.00024273705,0.86696136,0.0014176866,0.0010741022,0.00016819549,0.000038065125,0.0017412899,0.00066550716,0.00014246441,0.00072224176,0.11862232],"study_design_scores_gemma":[0.002645729,0.009023002,0.95390576,0.0011723592,0.004543611,0.0022599043,0.00013580092,0.013931627,0.0049495148,0.0016794215,0.005694298,0.000059057482],"about_ca_topic_score_codex":0.00077405846,"about_ca_topic_score_gemma":0.00096299394,"teacher_disagreement_score":0.0035612383,"about_ca_system_score_codex":0.0004587994,"about_ca_system_score_gemma":0.00082824443,"threshold_uncertainty_score":0.018833876},"labels":[],"label_agreement":null},{"id":"W2138777076","doi":"10.1158/1078-0432.ccr-06-0719","title":"The Thalidomide Analogue, CC-4047, Induces Apoptosis Signaling and Growth Arrest in Childhood Acute Lymphoblastic Leukemia Cells <i>In vitro</i> and <i>In vivo</i>","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Thalidomide; Apoptosis; In vivo; In vitro; Leukemia; Immunology; Cell culture; Biology; Cancer research; Medicine; Multiple myeloma; Biochemistry","score_opus":0.04908071187165018,"score_gpt":0.38682727263138134,"score_spread":0.33774656075973114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138777076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99736565,0.001253053,0.00029578336,0.000035066823,0.000006563574,0.000015965928,0.00021305271,0.000028132734,0.00078678096],"genre_scores_gemma":[0.9970721,0.0011053196,0.0005430872,0.00003543106,0.000004792563,0.000032422802,0.00062620925,0.0000074995073,0.00057312066],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998927,0.00002167178,0.000011803953,0.000015690235,0.000025230758,0.000032832755],"domain_scores_gemma":[0.99993074,0.000014510126,0.00002426057,0.000008879104,0.0000065034674,0.000015006047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001079578,0.0003586708,0.00023640275,0.00019268332,0.000113190436,0.00027952017,0.00015876,0.00017648091,0.0007407255],"category_scores_gemma":[0.00008116321,0.00011224683,0.00017976778,0.0002136344,0.00020190926,0.00015544961,0.00009094876,0.00045480664,0.00020699008],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003551805,0.00009132861,0.0005223921,0.000052494997,0.000009313511,0.00006298378,0.000020599591,0.00013311752,0.9969406,0.00007677369,0.000071822535,0.0016634921],"study_design_scores_gemma":[0.00004924822,0.0011545961,0.0045811418,0.0000050841704,0.000023552522,0.0002948889,0.000023186467,0.0004283559,0.9920676,0.0000144768655,0.0013555279,0.000002444929],"about_ca_topic_score_codex":0.0010072691,"about_ca_topic_score_gemma":0.0013744098,"teacher_disagreement_score":0.0010072691,"about_ca_system_score_codex":0.00038485095,"about_ca_system_score_gemma":0.0002655038,"threshold_uncertainty_score":0.0027922988},"labels":[],"label_agreement":null},{"id":"W2138902181","doi":"10.1158/1078-0432.ccr-09-1945","title":"Efficacy of Combining GMX1777 with Radiation Therapy for Human Head and Neck Carcinoma","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sirtuins and Resveratrol in Medicine","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Chinese University of Hong Kong; University of Hong Kong; Ontario Institute for Cancer Research","keywords":"Nicotinamide phosphoribosyltransferase; Radiation therapy; In vivo; NAD+ kinase; Cancer research; Nicotinamide; Cytotoxicity; Head and neck cancer; Radiosensitizer; Medicine; Pharmacology; In vitro; Chemistry; Internal medicine; Biology; Biochemistry; Enzyme","score_opus":0.22564228384680132,"score_gpt":0.5545886528281585,"score_spread":0.3289463689813572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138902181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99248236,0.0050447583,0.00042926145,0.00006979848,0.00005216474,0.0001503535,0.00015893615,0.00004702393,0.0015652805],"genre_scores_gemma":[0.9948573,0.0026630117,0.000971619,0.00004361443,0.000030290108,0.00007008845,0.00034178278,0.000012576909,0.0010096901],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998504,0.000041302235,0.000010291063,0.000021516185,0.000041382744,0.00003520891],"domain_scores_gemma":[0.99992955,0.00001682836,0.000011699386,0.000010940266,0.0000074821673,0.000023430894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027991273,0.0006957335,0.0008307929,0.00041410152,0.00023106145,0.0003801376,0.00044820856,0.00043564945,0.001390254],"category_scores_gemma":[0.00019013247,0.00017959475,0.0005067618,0.00033531626,0.0004222808,0.0002382787,0.00034837137,0.00048495835,0.00034614914],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037879338,0.0012122496,0.0012283999,0.00042081103,0.00015154327,0.00029377177,0.00010471139,0.0015531459,0.9586673,0.00017886328,0.00032323584,0.032078095],"study_design_scores_gemma":[0.00044231155,0.020355841,0.0070122844,0.000030994932,0.0002940858,0.00068880094,0.00008309813,0.0012404212,0.96499103,0.000041466705,0.004800667,0.0000190231],"about_ca_topic_score_codex":0.0019335265,"about_ca_topic_score_gemma":0.0029454988,"teacher_disagreement_score":0.0019335265,"about_ca_system_score_codex":0.0004782608,"about_ca_system_score_gemma":0.00074562634,"threshold_uncertainty_score":0.004650831},"labels":[],"label_agreement":null},{"id":"W2139069376","doi":"10.1158/1078-0432.ccr-14-0513","title":"Preoperative<i>GNAS</i>and<i>KRAS</i>Testing in the Diagnosis of Pancreatic Mucinous Cysts","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Pancreas Foundation","keywords":"GNAS complex locus; KRAS; Medicine; Cyst; Adenocarcinoma; Intraductal papillary mucinous neoplasm; Cystadenocarcinoma; Pathology; Internal medicine; Gastroenterology; Pancreas; Cancer; Biology; Colorectal cancer; Gene","score_opus":0.33101797268851635,"score_gpt":0.5445068994625288,"score_spread":0.2134889267740125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139069376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931878,0.0031416882,0.0011743399,0.00025938873,0.00005513937,0.000048911377,0.00007125405,0.000036143254,0.0020254592],"genre_scores_gemma":[0.9977736,0.0006997377,0.0012891113,0.00005224721,0.00004017897,0.000015743675,0.00008070142,0.0000027466479,0.000045911078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989009,0.00040282196,0.0002266427,0.000102058584,0.00025248423,0.000115171395],"domain_scores_gemma":[0.9976434,0.0011112328,0.0004621823,0.0001352205,0.00032322807,0.00032474363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002549156,0.00047549655,0.0003948678,0.0014187185,0.00034507154,0.0006535181,0.00050669076,0.0006175464,0.0006241641],"category_scores_gemma":[0.008699706,0.0002876661,0.00021146072,0.0005879275,0.00087617495,0.00079977675,0.00050539296,0.0006806539,0.00030257102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012388452,0.00009016959,0.9764008,0.00007466053,0.000025404073,0.0016965689,0.00006920456,0.00021261605,0.0044166613,0.000025785335,0.00027705642,0.015472176],"study_design_scores_gemma":[0.00011224479,0.0019916235,0.93835044,0.00030868186,0.00020231228,0.034602728,0.00079689175,0.004592154,0.016378352,0.00028237936,0.002352368,0.000029790392],"about_ca_topic_score_codex":0.00089441746,"about_ca_topic_score_gemma":0.0012784159,"teacher_disagreement_score":0.002549156,"about_ca_system_score_codex":0.00033461337,"about_ca_system_score_gemma":0.0006269723,"threshold_uncertainty_score":0.013481379},"labels":[],"label_agreement":null},{"id":"W2139093684","doi":"10.1158/1078-0432.ccr-08-1159","title":"Phase II Trial of OGX-011 in Combination with Docetaxel in Metastatic Breast Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Juravinski Cancer Centre; Ottawa Regional Cancer Foundation; BC Cancer Agency; Ottawa Hospital; University of British Columbia","funders":"","keywords":"Docetaxel; Metastatic breast cancer; Clusterin; Medicine; Breast cancer; Internal medicine; Regimen; Chemotherapy; Cancer; Oncology; Apoptosis; Biology","score_opus":0.2940175623616857,"score_gpt":0.5994853272054937,"score_spread":0.30546776484380805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139093684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937236,0.0016696181,0.00027602876,0.00035250717,0.00010344624,0.0021007503,0.00035298822,0.00006268303,0.0013584137],"genre_scores_gemma":[0.9881924,0.0020346034,0.001353904,0.0004996868,0.00014425468,0.0030630976,0.0015578384,0.000021790958,0.0031324325],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996996,0.00013659957,0.000015640895,0.000046645862,0.000034689863,0.000066914035],"domain_scores_gemma":[0.9995307,0.00006569976,0.000097447126,0.000026163782,0.00002202598,0.00025793095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008835151,0.0014101577,0.0018517739,0.00036677168,0.00034630526,0.0007740411,0.00092929025,0.001090013,0.0034414171],"category_scores_gemma":[0.0005998545,0.0004606955,0.00074083416,0.00040940839,0.0009085256,0.00038036305,0.00031802471,0.0021329476,0.0007154291],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7430277,0.07633883,0.006082912,0.001269157,0.00084190624,0.00046025193,0.0003117244,0.0036094459,0.045570295,0.00039618896,0.00455119,0.11754039],"study_design_scores_gemma":[0.5883034,0.39734912,0.005694398,0.00004918684,0.00023360895,0.0003418461,0.00004745651,0.0011049296,0.0041714143,0.00010281956,0.0025820911,0.000019695508],"about_ca_topic_score_codex":0.0010670029,"about_ca_topic_score_gemma":0.0030838505,"teacher_disagreement_score":0.0034414171,"about_ca_system_score_codex":0.0010058547,"about_ca_system_score_gemma":0.0019180257,"threshold_uncertainty_score":0.011512697},"labels":[],"label_agreement":null},{"id":"W2139094645","doi":"10.1158/1078-0432.1237.11.3","title":"Impact of Gene Polymorphisms on Clinical Outcome for Stage IV Melanoma Patients Treated with Biochemotherapy: An Exploratory Study","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"ERCC1; Dacarbazine; Oncology; Internal medicine; Medicine; Melanoma; Single-nucleotide polymorphism; Chemotherapy; Genotype; Biology; Cancer research; Nucleotide excision repair; DNA repair; Gene; Genetics","score_opus":0.22751542823112494,"score_gpt":0.5138049049169285,"score_spread":0.2862894766858036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139094645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99975234,0.000053410193,0.00003905181,0.0000056014064,0.0000012291498,0.000009959508,0.00004959058,7.183515e-7,0.00008806264],"genre_scores_gemma":[0.9996592,0.000022869343,0.000060835857,0.000010903555,0.000005811692,0.000018095434,0.00013953264,7.475398e-7,0.00008197383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998373,0.00006192295,0.0000115046905,0.000037508267,0.000022777986,0.00002895196],"domain_scores_gemma":[0.99951816,0.0001338825,0.00016084724,0.000031835258,0.00002478855,0.0001304892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025461018,0.00027173717,0.0003310043,0.00021031259,0.000250758,0.00023302228,0.00014451306,0.0003187128,0.0015404813],"category_scores_gemma":[0.0005649568,0.00011577165,0.00047537734,0.00020145641,0.00021439228,0.00011970126,0.00016381843,0.00033177895,0.0002093706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008430346,0.0005546989,0.9827738,0.000023227845,0.00014871795,0.00019814969,0.00007653513,0.00015720051,0.003982198,0.000018494955,0.00006928987,0.0035675347],"study_design_scores_gemma":[0.00034279437,0.0069659813,0.9904142,0.000005914153,0.00013572411,0.00051057705,0.000091660186,0.0003471447,0.00081757136,0.000037052752,0.0003244774,0.000006937595],"about_ca_topic_score_codex":0.00040065058,"about_ca_topic_score_gemma":0.0004895698,"teacher_disagreement_score":0.0015404813,"about_ca_system_score_codex":0.00020445389,"about_ca_system_score_gemma":0.00023149807,"threshold_uncertainty_score":0.0051534176},"labels":[],"label_agreement":null},{"id":"W2139161666","doi":"10.1158/1078-0432.12aacriaslc-b15","title":"Abstract B15: Genomic and epigenomic events in arsenic-related lung squamous cell carcinomas from smokers and never smokers","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Arsenic contamination and mitigation","field":"Environmental Science","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lung cancer; Carcinogenesis; Arsenic; Epigenomics; DNA methylation; Population; Cancer research; Epigenetics; Biology; Methylation; Oncology; Medicine; Cancer; Physiology; Genetics; Environmental health; Chemistry; Gene","score_opus":0.07254531636113877,"score_gpt":0.39422747808628955,"score_spread":0.3216821617251508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139161666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983193,0.00019102333,0.00014295067,0.00001115796,0.000001791796,0.0000091662605,0.00089409336,0.0000074698123,0.00042294074],"genre_scores_gemma":[0.9975434,0.00010137887,0.00015208266,0.0000185646,0.0000025598429,0.000019007966,0.0013454234,0.0000047910385,0.0008127041],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99990773,0.000009070995,0.000011488955,0.000032375152,0.000020634396,0.000018703522],"domain_scores_gemma":[0.9998777,0.000024533401,0.00002874538,0.000014416887,0.000031832016,0.000022777058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010741992,0.00012344259,0.00015078377,0.0007355108,0.0002666118,0.00026317532,0.0001427002,0.00019125304,0.0028739145],"category_scores_gemma":[0.00024813213,0.00011151466,0.00018623447,0.00053733605,0.00015194331,0.000083855506,0.00027404208,0.000117206226,0.00032142826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007057194,0.000031643925,0.84225595,0.00007293316,0.00009177429,0.0005173011,0.0003334231,0.000089534275,0.14952122,0.000026975054,0.00017429907,0.006179224],"study_design_scores_gemma":[0.000005801789,0.000069797476,0.9920706,0.0000037698562,0.000034189172,0.0007192726,0.0001878836,0.00009823123,0.0061975406,0.000016104603,0.00059436384,0.0000023405025],"about_ca_topic_score_codex":0.0039416496,"about_ca_topic_score_gemma":0.0042838836,"teacher_disagreement_score":0.0039416496,"about_ca_system_score_codex":0.00017122753,"about_ca_system_score_gemma":0.00013859449,"threshold_uncertainty_score":0.009614229},"labels":[],"label_agreement":null},{"id":"W2139638366","doi":"10.1158/1078-0432.ccr-10-0093","title":"Dynamic Single-Cell Network Profiles in Acute Myelogenous Leukemia Are Associated with Patient Response to Standard Induction Therapy","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Induction chemotherapy; Oncology; Leukemia; Medicine; Chemotherapy; Univariate analysis; Internal medicine; Flow cytometry; Immunology; Multivariate analysis","score_opus":0.09079508066410974,"score_gpt":0.43003394922789573,"score_spread":0.339238868563786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139638366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99883,0.00019582172,0.0006907596,0.000019516257,0.0000015173085,0.0000053518775,0.00013732798,0.0000138714195,0.000105759165],"genre_scores_gemma":[0.9992912,0.000068695066,0.0003504265,0.000007983079,0.0000031232591,0.000009032143,0.00023320298,0.0000012480967,0.00003508624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998616,0.00003416944,0.0000112216,0.000041580613,0.000030798587,0.00002062225],"domain_scores_gemma":[0.9992459,0.00030391407,0.0002901963,0.00003202812,0.000055922425,0.00007220183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031884987,0.00016114149,0.00023604104,0.0004088797,0.00008427612,0.00026561294,0.00012016339,0.00019332852,0.00042990153],"category_scores_gemma":[0.0016669894,0.0000725248,0.00008242969,0.00026688902,0.00012999872,0.00024051142,0.00020987529,0.00018162199,0.00010726577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010498468,0.0000917307,0.9314248,0.000041536718,0.00008175139,0.000119282675,0.00008279049,0.0038276226,0.035091434,0.000086553606,0.00023437638,0.02786825],"study_design_scores_gemma":[0.000017813729,0.00045890448,0.96538,0.00000592071,0.000045645083,0.00055637094,0.000058361635,0.022043841,0.010700732,0.00027189968,0.00045237143,0.000008126735],"about_ca_topic_score_codex":0.00026111063,"about_ca_topic_score_gemma":0.0003158552,"teacher_disagreement_score":0.00042990153,"about_ca_system_score_codex":0.00019610298,"about_ca_system_score_gemma":0.00008563828,"threshold_uncertainty_score":0.001686275},"labels":[],"label_agreement":null},{"id":"W2139734459","doi":"10.1158/1078-0432.ccr-04-0524","title":"Overexpression of G1-S Cyclins and Cyclin-Dependent Kinases during Multistage Human Pancreatic Duct Cell Carcinogenesis","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Pancreatic Intraepithelial Neoplasia; Cancer research; Cyclin-dependent kinase; Pancreatic cancer; Cyclin D; Biology; Carcinogenesis; Cyclin; Cyclin D1; Pancreatic duct; Cell cycle; Cyclin E; Pancreas; Cyclin B; Pathology; Cancer; Medicine; Endocrinology; Pancreatic ductal adenocarcinoma","score_opus":0.140467234971327,"score_gpt":0.47738595163333236,"score_spread":0.33691871666200535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139734459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980263,0.00093183824,0.0005411758,0.000015505471,0.0000028945265,0.000013653615,0.0001277469,0.000020282783,0.00032061676],"genre_scores_gemma":[0.9970084,0.0006998461,0.001016974,0.000015818106,0.000003933512,0.00003032155,0.0004184599,0.0000051458046,0.0008012424],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998888,0.000018053941,0.000009400767,0.000029051167,0.000029315424,0.000025336947],"domain_scores_gemma":[0.9998692,0.00003913673,0.000031370895,0.000019240611,0.000017992776,0.000023083294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001873621,0.00019586789,0.00018964995,0.00035568402,0.0001636066,0.00025937552,0.000097150696,0.00019222366,0.00080115814],"category_scores_gemma":[0.00019959015,0.0001687837,0.00015535389,0.00023692874,0.00017546896,0.00020844996,0.00018117901,0.00020773745,0.00022838818],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030224238,0.000023500339,0.0038878461,0.000040805873,0.0000075489756,0.00004905899,0.000024678102,0.00008278883,0.99441683,0.000031661937,0.00002119797,0.0011117137],"study_design_scores_gemma":[0.000023218894,0.00053585076,0.101068094,0.000006735659,0.00003407808,0.00057199266,0.000047477162,0.00087698887,0.8949469,0.00004979604,0.001833453,0.000005361677],"about_ca_topic_score_codex":0.0007063336,"about_ca_topic_score_gemma":0.00070243643,"teacher_disagreement_score":0.00080115814,"about_ca_system_score_codex":0.0003342082,"about_ca_system_score_gemma":0.0002165197,"threshold_uncertainty_score":0.0026801229},"labels":[],"label_agreement":null},{"id":"W2139763823","doi":"10.1158/1078-0432.ccr-08-2644","title":"Local Recurrence after Breast-Conserving Therapy in Relation to Gene Expression Patterns in a Large Series of Patients","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cytodiagnostics (Canada)","funders":"Radboud Universiteit","keywords":"Breast cancer; Gene expression; Grading (engineering); Oncology; Gene signature; DNA microarray; Multivariate analysis; Gene expression profiling; Significance analysis of microarrays; Gene; Microarray; Internal medicine; Medicine; Cancer; Biology; Genetics","score_opus":0.0632151097720133,"score_gpt":0.4312425097902956,"score_spread":0.36802740001828227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139763823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995772,0.00015917144,0.00009900481,0.000013567882,0.000003046217,0.0000038317953,0.00006095671,0.0000037740697,0.0000794682],"genre_scores_gemma":[0.99950075,0.00006535783,0.00008640235,0.000014180016,0.000008144886,0.000010655219,0.00023861167,0.0000023224038,0.00007364156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997305,0.000059913586,0.000021400365,0.000092771814,0.00006510582,0.000030269228],"domain_scores_gemma":[0.99943703,0.00018554728,0.00018571403,0.00007713465,0.000048887738,0.00006562522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030286828,0.00014457025,0.0003148408,0.0004732255,0.00024973988,0.0003321331,0.0001439102,0.00023483357,0.0007572587],"category_scores_gemma":[0.0012681717,0.00012875801,0.00018604526,0.0004456972,0.0002761034,0.00017178975,0.00019675419,0.000307069,0.00019753785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003396677,0.00005233426,0.9908784,0.000015633477,0.000055648998,0.00026478412,0.00007692873,0.00011810895,0.0032938947,0.0000123091595,0.0001338711,0.0047585834],"study_design_scores_gemma":[0.00001574283,0.0002156302,0.9964335,0.0000036284696,0.000041755287,0.0015305682,0.00008720403,0.0005016159,0.00084684265,0.000020884921,0.00029710974,0.000005554225],"about_ca_topic_score_codex":0.00054060435,"about_ca_topic_score_gemma":0.00052983896,"teacher_disagreement_score":0.0007572587,"about_ca_system_score_codex":0.00018059416,"about_ca_system_score_gemma":0.00013055277,"threshold_uncertainty_score":0.002533257},"labels":[],"label_agreement":null},{"id":"W2139830524","doi":"10.1158/1078-0432.ccr-10-2372","title":"Measurements of Tumor Cell Autophagy Predict Invasiveness, Resistance to Chemotherapy, and Survival in Melanoma","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":233,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Center for Research Resources; National Cancer Institute; Abramson Cancer Center","keywords":"Autophagy; ATG5; Melanoma; Cancer research; Programmed cell death; Temozolomide; Small hairpin RNA; Medicine; Dacarbazine; Cell culture; Biology; Apoptosis; Pathology; Glioma; Gene knockdown","score_opus":0.2931685604140283,"score_gpt":0.46976088378464576,"score_spread":0.17659232337061748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139830524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987031,0.00046172045,0.0004435552,0.000012536728,0.0000026626385,0.000012931838,0.00014007535,0.000015997834,0.0002073681],"genre_scores_gemma":[0.99917126,0.00012683068,0.00036742783,0.000008014699,0.0000022958336,0.000010081044,0.00019675285,0.0000017985386,0.00011553903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99990165,0.000021002492,0.0000122722195,0.000023939621,0.000031766787,0.000009263531],"domain_scores_gemma":[0.9995245,0.00010769233,0.0002048408,0.000025585756,0.000061680235,0.00007577318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002698198,0.00021039322,0.00027015674,0.000457249,0.00011909181,0.0002855917,0.00008343443,0.0002704557,0.0006390291],"category_scores_gemma":[0.0005373527,0.00011761128,0.00016314643,0.00026465638,0.00013089705,0.00016595062,0.00013406365,0.0002758361,0.00018680036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014617472,0.00018429694,0.8803724,0.000070476606,0.00008707423,0.00016521453,0.00007950194,0.0008156078,0.106177494,0.000027897797,0.00019062613,0.010367604],"study_design_scores_gemma":[0.000017591641,0.00065019465,0.9750788,0.00000861216,0.00005851395,0.0009130968,0.00007917707,0.0027629533,0.020021386,0.000060432438,0.0003413712,0.000007860336],"about_ca_topic_score_codex":0.000497173,"about_ca_topic_score_gemma":0.00078405713,"teacher_disagreement_score":0.0006390291,"about_ca_system_score_codex":0.00020672087,"about_ca_system_score_gemma":0.00010169216,"threshold_uncertainty_score":0.0021377206},"labels":[],"label_agreement":null},{"id":"W2139995572","doi":"10.1158/1078-0432.ccr-09-2514","title":"Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":206,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Docetaxel; Prostate cancer; Internal medicine; Oncology; Prednisone; Mitoxantrone; Chemotherapy; Cancer","score_opus":0.2418637237828623,"score_gpt":0.5093903416955697,"score_spread":0.26752661791270743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139995572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99870956,0.00028383103,0.0006120031,0.000055657412,0.000005844732,0.000015671701,0.00014315569,0.000017383558,0.00015685777],"genre_scores_gemma":[0.99932384,0.00004511127,0.00029865178,0.000012135525,0.0000070176116,0.0000072413063,0.00023963292,0.0000014228251,0.00006497131],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997373,0.00013143476,0.00001655534,0.000044489578,0.000045697852,0.00002454786],"domain_scores_gemma":[0.99835134,0.0008235993,0.00051778613,0.00007361478,0.000110999805,0.00012263497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011550131,0.00034544646,0.00030794236,0.00040217632,0.00013639391,0.00031695623,0.0002695375,0.00030423453,0.0009149841],"category_scores_gemma":[0.004348274,0.00012635379,0.0003982683,0.0002123402,0.00019141143,0.0001756335,0.00024205299,0.00041461698,0.00016319807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036972854,0.000059105158,0.99162054,0.0000129524415,0.00006231733,0.000017236543,0.000018841269,0.0010637144,0.00016708153,0.000011001131,0.00010771659,0.0064898725],"study_design_scores_gemma":[0.0000688613,0.00068784744,0.988079,0.000014680332,0.00007600025,0.00014183208,0.000024901386,0.010258181,0.00036238073,0.000055970708,0.00022465579,0.000005776495],"about_ca_topic_score_codex":0.0014379073,"about_ca_topic_score_gemma":0.0014727882,"teacher_disagreement_score":0.0014379073,"about_ca_system_score_codex":0.00020843447,"about_ca_system_score_gemma":0.00038610352,"threshold_uncertainty_score":0.006108403},"labels":[],"label_agreement":null},{"id":"W2140155875","doi":"10.1158/1078-0432.ccr-06-0486","title":"Acceleration of Telomere Loss by Chemotherapy Is Greater in Older Patients with Locally Advanced Head and Neck Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Calgary","funders":"Canadian Institutes of Health Research; Fondation pour la Recherche Médicale","keywords":"Telomere; Head and neck cancer; Head and neck; Medicine; Cancer; Chemotherapy; Oncology; Head (geology); Internal medicine; Gerontology; Surgery; Biology; Genetics","score_opus":0.06570106926521715,"score_gpt":0.4436917247389739,"score_spread":0.37799065547375676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140155875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99925333,0.0004929308,0.00005051596,0.000017078159,0.0000030332594,0.000004523402,0.000042179698,0.000002376665,0.00013412788],"genre_scores_gemma":[0.99942064,0.0002092149,0.000093134906,0.00002904787,0.000011889351,0.000004670956,0.00008586686,8.941189e-7,0.0001446767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989116,0.000026849917,0.000011819569,0.000022150982,0.000030219255,0.00001772398],"domain_scores_gemma":[0.99929273,0.00015418726,0.0003673863,0.000035354533,0.000053813685,0.00009647687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025976976,0.00013694321,0.0002711404,0.0003040142,0.00019614468,0.00020062429,0.00007954221,0.00022297117,0.0012582445],"category_scores_gemma":[0.0010692801,0.00009043135,0.00016225237,0.00029260942,0.000114826245,0.0001708547,0.00013509205,0.00024326649,0.00018298531],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008236785,0.00007035764,0.9813441,0.000039741833,0.000033717843,0.00019379164,0.00011216151,0.000047671692,0.010723145,0.0000070360556,0.00006979852,0.00653476],"study_design_scores_gemma":[0.000010053305,0.00053748226,0.9978902,0.0000046181667,0.00002596368,0.0005684879,0.000051225397,0.000052672138,0.0006055924,0.000007967394,0.00024350356,0.0000021952771],"about_ca_topic_score_codex":0.0006027268,"about_ca_topic_score_gemma":0.0009628168,"teacher_disagreement_score":0.0012582445,"about_ca_system_score_codex":0.00013600625,"about_ca_system_score_gemma":0.00011529297,"threshold_uncertainty_score":0.00420928},"labels":[],"label_agreement":null},{"id":"W2140210955","doi":"10.1158/1078-0432.ccr-10-0513","title":"Epigenetic Modifications in Double-Strand Break DNA Damage Signaling and Repair","year":2010,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":185,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research","keywords":"DNA damage; Chromatin; DNA repair; Biology; Cell biology; Cell cycle checkpoint; Histone; G2-M DNA damage checkpoint; Epigenetics; Cell cycle; DNA; Cancer research; Cell; Genetics; Gene","score_opus":0.288933985244428,"score_gpt":0.5364368782454557,"score_spread":0.24750289300102774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140210955","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023519876,0.99787664,0.0002064275,0.00015868015,0.00012992701,0.0000050456874,0.00001227317,0.000010013621,0.0013658117],"genre_scores_gemma":[0.0011272131,0.9968919,0.0003145449,0.00010276482,0.00011526754,0.000006110313,0.000026493059,0.0000015369304,0.0014142181],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999045,0.000015418524,0.000011052526,0.000017098728,0.000040986983,0.000010815147],"domain_scores_gemma":[0.99987745,0.000037918286,0.000022845232,0.000004044331,0.000039434,0.000018184024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003397493,0.00068049465,0.00095932226,0.0011365311,0.00024189796,0.0006551763,0.00061669934,0.00076454476,0.0032279014],"category_scores_gemma":[0.0002640623,0.00020430169,0.00022423071,0.0016088646,0.00034815472,0.0008844661,0.00043625495,0.0008392084,0.0029591222],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005899601,0.000058832513,0.00018633067,0.008383745,0.000045342993,0.00024306502,0.00005209648,0.00027068172,0.006290289,0.0027832352,0.01415768,0.96746963],"study_design_scores_gemma":[0.000013512314,0.00007944362,0.0011560429,0.0010830174,0.0000483107,0.0015844835,0.00005555693,0.00008220529,0.0015445403,0.0016629096,0.9926772,0.000012763223],"about_ca_topic_score_codex":0.00072846335,"about_ca_topic_score_gemma":0.0015288265,"teacher_disagreement_score":0.0032279014,"about_ca_system_score_codex":0.00057829206,"about_ca_system_score_gemma":0.00071254413,"threshold_uncertainty_score":0.010798395},"labels":[],"label_agreement":null},{"id":"W2140250503","doi":"10.1158/1078-0432.ccr-03-0376","title":"Improved Outcome When B-Cell Lymphoma Is Treated with Combinations of Immunoliposomal Anticancer Drugs Targeted to Both the CD19 and CD20 Epitopes","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Lymphoma; Epitope; CD20; Liposome; CD19; Antigen; Doxorubicin; Cancer research; Vincristine; Pharmacology; Immunology; Chemotherapy; Internal medicine; Chemistry; Cyclophosphamide","score_opus":0.05950840233909255,"score_gpt":0.39944722818674544,"score_spread":0.3399388258476529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140250503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953218,0.0022480406,0.00056167226,0.00012799674,0.000036034344,0.00006124284,0.000097650045,0.00007840522,0.0014671392],"genre_scores_gemma":[0.9971949,0.0008715834,0.00058125675,0.00009018049,0.000038369384,0.00004546823,0.00039821348,0.000011371298,0.00076854054],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987173,0.000029536788,0.000008963743,0.000020284815,0.00002950458,0.00003993169],"domain_scores_gemma":[0.9998758,0.000022752918,0.000033235534,0.000012165688,0.000008527707,0.000047415906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028035528,0.00044583017,0.0008177625,0.00027282696,0.0001845414,0.00037479366,0.00025159304,0.0004478532,0.0012904155],"category_scores_gemma":[0.00017727494,0.000100014775,0.0002052604,0.00020768499,0.00029394563,0.0002805109,0.00023315275,0.00069943914,0.00043300263],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007018756,0.0018376518,0.005959278,0.00024286102,0.0001446809,0.0012183,0.00007055886,0.00035207218,0.95703524,0.00012423187,0.00045095372,0.025545437],"study_design_scores_gemma":[0.002545815,0.06534594,0.07780148,0.00008262817,0.00066699716,0.011145515,0.00017268158,0.0021838732,0.83000803,0.00020753038,0.009805285,0.000034200526],"about_ca_topic_score_codex":0.00028762798,"about_ca_topic_score_gemma":0.00046118075,"teacher_disagreement_score":0.0012904155,"about_ca_system_score_codex":0.00025081512,"about_ca_system_score_gemma":0.00017645484,"threshold_uncertainty_score":0.0043168664},"labels":[],"label_agreement":null},{"id":"W2140287543","doi":"10.1158/1078-0432.ccr-05-1170","title":"Mcl-1, Vascular Endothelial Growth Factor-R2, and 14-3-3σ Expression Might Predict Primary Response against Radiotherapy and Chemotherapy in Patients with Locally Advanced Squamous Cell Carcinomas of the Head and Neck","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Radiation therapy; Medicine; Chemotherapy; Concomitant; Head and neck cancer; Cisplatin; Epidermoid carcinoma; Vascular endothelial growth factor; Immunohistochemistry; Pathology; Oncology; Cancer; Internal medicine; Primary tumor; Head and neck squamous-cell carcinoma; Metastasis; VEGF receptors","score_opus":0.020264201783638747,"score_gpt":0.34533881014885026,"score_spread":0.3250746083652115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140287543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997135,0.00015517701,0.000051376734,0.000008948872,0.0000012282806,0.0000034331554,0.000019761852,0.000001528681,0.000045061337],"genre_scores_gemma":[0.9997793,0.00003222877,0.00006702329,0.00000769075,0.000003911979,0.0000050909553,0.000058837464,3.9495237e-7,0.000045473786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989295,0.000029281684,0.00001119303,0.000023111928,0.000019949051,0.000023495508],"domain_scores_gemma":[0.999696,0.00010566588,0.000090433066,0.000015388428,0.00002646953,0.00006604625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025464076,0.00021527718,0.00025800345,0.0002567216,0.00018611607,0.00018467043,0.00013752934,0.00027762595,0.0009040409],"category_scores_gemma":[0.0006963046,0.00012011861,0.00018024974,0.00013555671,0.00021729153,0.00013551665,0.00014075056,0.00020735433,0.00018992937],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008581744,0.00006219731,0.98680705,0.000023170065,0.000039385388,0.0001533549,0.00004796304,0.00021283055,0.007537976,0.0000061600067,0.000061479725,0.004190179],"study_design_scores_gemma":[0.000043518463,0.00088264677,0.9951279,0.0000041875865,0.0000524035,0.000972129,0.000088517605,0.0006621515,0.0019663293,0.000016422277,0.00018049052,0.000003421921],"about_ca_topic_score_codex":0.0005287666,"about_ca_topic_score_gemma":0.0008445736,"teacher_disagreement_score":0.0009040409,"about_ca_system_score_codex":0.00020204119,"about_ca_system_score_gemma":0.00016060016,"threshold_uncertainty_score":0.0030243397},"labels":[],"label_agreement":null},{"id":"W2140293999","doi":"10.1158/1078-0432.ccr-14-0861","title":"PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Cancer Institute","keywords":"Brain metastasis; Melanoma; Gene knockdown; Metastasis; Cancer research; Immunofluorescence; Cell culture; Pathology; Biology; Tissue microarray; Medicine; Gene expression profiling; Viability assay; Gene expression; Cancer; Immunology; Immunohistochemistry; Internal medicine; Gene; Antibody","score_opus":0.19360210735127073,"score_gpt":0.5340645592303275,"score_spread":0.34046245187905677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140293999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98668694,0.010621219,0.001132526,0.000117746145,0.000017702116,0.000030955292,0.00066157186,0.000039312043,0.0006920629],"genre_scores_gemma":[0.9969375,0.0012586397,0.00078140845,0.000039749477,0.000013373863,0.000016199887,0.0005452999,0.0000025463585,0.00040527515],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99991035,0.00001580709,0.000010308084,0.000024136198,0.000020398662,0.000019045438],"domain_scores_gemma":[0.9998305,0.000026200574,0.00008122076,0.000008270647,0.000019664389,0.000034190998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016835246,0.00028270064,0.00029065285,0.0007169351,0.00018361589,0.00042373952,0.00017657685,0.00033971804,0.001763488],"category_scores_gemma":[0.00021461521,0.00008923515,0.00026434823,0.0004098227,0.0002119486,0.0003000969,0.00021697683,0.0002864403,0.0002844214],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022632012,0.00017348859,0.2410377,0.0007498242,0.00021053648,0.0009232006,0.00007717298,0.0004661069,0.73040146,0.00020326438,0.00049303006,0.023001008],"study_design_scores_gemma":[0.00003895665,0.0013285229,0.8286796,0.00007440543,0.00026617164,0.0042516505,0.00028931038,0.002293776,0.15863594,0.00023718926,0.0038832054,0.000021212543],"about_ca_topic_score_codex":0.00043361064,"about_ca_topic_score_gemma":0.00053765165,"teacher_disagreement_score":0.001763488,"about_ca_system_score_codex":0.00022824931,"about_ca_system_score_gemma":0.00013837976,"threshold_uncertainty_score":0.005899489},"labels":[],"label_agreement":null},{"id":"W2140334270","doi":"10.1158/1078-0432.ccr-10-1224","title":"Absence of MMP2 Expression Correlates with Poor Clinical Outcomes in Rectal Cancer, and Is Distinct from MMP1-Related Outcomes in Colon Cancer","year":2011,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"MMP1; MMP2; Colorectal cancer; Oncology; Metastasis; Medicine; Stage (stratigraphy); Internal medicine; Cancer; Disease; Clinical significance; Biology; Gene expression; Gene; Genetics","score_opus":0.17669090695550047,"score_gpt":0.5056073819229776,"score_spread":0.3289164749674771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140334270","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98155653,0.016190523,0.00080747943,0.00013099023,0.000021582544,0.000016999826,0.00085957453,0.000019591178,0.00039680462],"genre_scores_gemma":[0.99746156,0.0016095433,0.0003596466,0.000025219193,0.000022815431,0.000009662266,0.0004133712,0.0000050092667,0.000093162314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923015,0.00023708535,0.000111479385,0.00020569554,0.00016952307,0.000046084464],"domain_scores_gemma":[0.997366,0.00097309146,0.0011062803,0.00024104751,0.00018745678,0.00012605023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015130528,0.0002944803,0.00075578614,0.0015070373,0.00023970354,0.0008255623,0.00028182685,0.00026090036,0.0006823159],"category_scores_gemma":[0.0027151483,0.00019061568,0.0010967489,0.0021381003,0.00033113718,0.00027212713,0.0002953052,0.00033771273,0.000111217734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070457684,0.000016727501,0.98446506,0.00038434908,0.0014035207,0.00013182645,0.000047066605,0.00014305805,0.0069353967,0.00002426837,0.00008492374,0.0056592133],"study_design_scores_gemma":[0.000012391225,0.000102084196,0.9961052,0.00003399325,0.0012154484,0.0004110005,0.00006238122,0.00037666466,0.0012688403,0.00005640362,0.00035073698,0.000004843388],"about_ca_topic_score_codex":0.0008416032,"about_ca_topic_score_gemma":0.0018593674,"teacher_disagreement_score":0.0015130528,"about_ca_system_score_codex":0.00029019406,"about_ca_system_score_gemma":0.0002646314,"threshold_uncertainty_score":0.008001864},"labels":[],"label_agreement":null},{"id":"W2140338938","doi":"10.1158/1078-0432.ccr-05-0262","title":"Phase I Trial of a Monoclonal Antibody Specific for αvβ3 Integrin (MEDI-522) in Patients with Advanced Malignancies, Including an Assessment of Effect on Tumor Perfusion","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources; National Cancer Institute","keywords":"Medicine; Adverse effect; Response Evaluation Criteria in Solid Tumors; Asymptomatic; Cancer; Metastasis; Pathology; Internal medicine; Oncology; Phases of clinical research; Chemotherapy","score_opus":0.1781517426797625,"score_gpt":0.588530311715438,"score_spread":0.4103785690356755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140338938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914204,0.0026645886,0.0007942689,0.000278552,0.000063905136,0.0015774713,0.00061425177,0.000116578565,0.002469978],"genre_scores_gemma":[0.9910998,0.0018722205,0.0016345902,0.00046626394,0.00009579591,0.0013513918,0.0013866707,0.000023125485,0.0020701047],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998486,0.000055578977,0.000007345789,0.000030557203,0.00001683117,0.00004109275],"domain_scores_gemma":[0.99975806,0.000036669764,0.000063693915,0.00002139675,0.000015250266,0.00010493192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005272778,0.0011632157,0.0012680654,0.0003462325,0.00029267973,0.00058019045,0.0005213331,0.0008221528,0.002489274],"category_scores_gemma":[0.00039320995,0.00038354617,0.00066655903,0.00032653383,0.00056580664,0.00041864061,0.00023459637,0.0020506654,0.00044646725],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36194873,0.07167452,0.013507131,0.0009978014,0.0012601488,0.0006004909,0.0005151793,0.0093514435,0.31647682,0.00097482966,0.0077209203,0.21497194],"study_design_scores_gemma":[0.21295105,0.7304566,0.022085302,0.00005181846,0.0005117233,0.00060593156,0.000079734804,0.0031341503,0.023232883,0.0003438047,0.006510845,0.000036184156],"about_ca_topic_score_codex":0.0007211129,"about_ca_topic_score_gemma":0.0016720059,"teacher_disagreement_score":0.002489274,"about_ca_system_score_codex":0.00062394404,"about_ca_system_score_gemma":0.0006832956,"threshold_uncertainty_score":0.0083274245},"labels":[],"label_agreement":null},{"id":"W2140418236","doi":"10.1158/1078-0432.ccr-09-1065","title":"Loss of Heterozygosity at 2q37 in Sporadic Wilms' Tumor: Putative Role for <i>miR-562</i>","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; Cancer Research UK","keywords":"Loss of heterozygosity; Wilms' tumor; Carcinogenesis; Biology; Tumor suppressor gene; Cancer research; Genetics; Tumor progression; Candidate gene; Gene; Allele","score_opus":0.0731258647060366,"score_gpt":0.46784506700075845,"score_spread":0.39471920229472185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140418236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989612,0.00035920762,0.00044645698,0.000020123594,0.0000020885182,0.0000047748335,0.000062179104,0.0000111500785,0.00013280877],"genre_scores_gemma":[0.9994374,0.00007605464,0.00031425167,0.000010352001,0.0000045265706,0.0000031496513,0.0000884173,0.0000028851932,0.00006293515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982685,0.00002014449,0.000018012202,0.000058775207,0.00004900195,0.000027227876],"domain_scores_gemma":[0.99972135,0.000053777963,0.00014732372,0.000017807013,0.000018742992,0.000041075375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027333622,0.00029428018,0.00026434442,0.0007673801,0.00020076532,0.0002029796,0.00023602304,0.00024559346,0.0011271911],"category_scores_gemma":[0.0005703872,0.00012256023,0.00019770989,0.0003186411,0.0004037459,0.00010580221,0.00019575626,0.00014654387,0.00020262708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090646907,0.00006570086,0.6003015,0.00014983116,0.00011923581,0.0114253005,0.0002884955,0.0005640173,0.3758369,0.00021114615,0.00027473725,0.00985685],"study_design_scores_gemma":[0.000071081355,0.0005539262,0.8305287,0.000032833428,0.00030262748,0.04594935,0.00021434764,0.0025039031,0.1176997,0.0002895881,0.0018306059,0.000023289671],"about_ca_topic_score_codex":0.0007391865,"about_ca_topic_score_gemma":0.00084893533,"teacher_disagreement_score":0.0011271911,"about_ca_system_score_codex":0.00020359112,"about_ca_system_score_gemma":0.00016630007,"threshold_uncertainty_score":0.0037708282},"labels":[],"label_agreement":null},{"id":"W2140427893","doi":"10.1158/1078-0432.ccr-04-0429","title":"Hierarchical Clustering Analysis of Tissue Microarray Immunostaining Data Identifies Prognostically Significant Groups of Breast Carcinoma","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":203,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Breast cancer; Oncology; Tissue microarray; Clinical significance; Hierarchical clustering; Survival analysis; Internal medicine; Lymph node; Pathology; Medicine; Cancer; Biology; Cluster analysis","score_opus":0.15052236807356562,"score_gpt":0.46971136932017393,"score_spread":0.3191890012466083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140427893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9591456,0.0008315104,0.037954483,0.00013075751,0.0000202242,0.0001522605,0.00068942324,0.0002511592,0.00082459784],"genre_scores_gemma":[0.96376216,0.00030834146,0.0331575,0.000036717007,0.000016496107,0.00019196293,0.0020863744,0.000026699277,0.00041358074],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991548,0.00028290282,0.00006565251,0.000179668,0.00020375017,0.000113153095],"domain_scores_gemma":[0.998808,0.0004257276,0.00025947677,0.0001578162,0.0002784996,0.00007051149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071667554,0.00033641278,0.0005737656,0.0014763507,0.00038510605,0.00069986726,0.0002806797,0.00024188182,0.00037256983],"category_scores_gemma":[0.0029797035,0.00013527264,0.0005153096,0.0010024976,0.0002544733,0.0002094401,0.00028962165,0.00030631403,0.00032682723],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013890916,0.00045038553,0.3643474,0.0005589117,0.00081312336,0.0006063514,0.0016661201,0.024020214,0.42422217,0.0010607247,0.0034623968,0.17740315],"study_design_scores_gemma":[0.00006683372,0.0005885494,0.849282,0.00007022882,0.00029278977,0.00092216587,0.0007999712,0.0840965,0.05494191,0.0033848626,0.005444332,0.000109886794],"about_ca_topic_score_codex":0.0021523118,"about_ca_topic_score_gemma":0.002579666,"teacher_disagreement_score":0.0021523118,"about_ca_system_score_codex":0.0004942074,"about_ca_system_score_gemma":0.00045445623,"threshold_uncertainty_score":0.0042796135},"labels":[],"label_agreement":null},{"id":"W2140484012","doi":"10.1158/1078-0432.ccr-1405-2","title":"Correlation of Osteopontin Protein Expression and Pathological Stage across a Wide Variety of Tumor Histologies","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":346,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"National Cancer Institute","keywords":"Pathology; Prostate; Medicine; Osteopontin; Metastasis; Immunohistochemistry; Carcinoma; Adenocarcinoma; Cancer; Internal medicine","score_opus":0.20227700794819006,"score_gpt":0.5120730653074815,"score_spread":0.3097960573592915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140484012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981133,0.0008058256,0.0004927219,0.000011714834,0.0000033808228,0.000009939368,0.00016264475,0.000007449477,0.00039306862],"genre_scores_gemma":[0.9988372,0.0002961407,0.00028542,0.000010183163,0.000004464202,0.000013662036,0.0003276416,0.0000035428022,0.00022182114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997937,0.000036379035,0.000024939192,0.00006865899,0.000044571803,0.000031791875],"domain_scores_gemma":[0.9993362,0.00020810161,0.00019724359,0.00005964548,0.00010447513,0.00009431074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041562231,0.00015778493,0.00021765292,0.0006914582,0.00015016222,0.00025403357,0.0001339706,0.00019566239,0.0010108906],"category_scores_gemma":[0.0007845983,0.00010730515,0.00013130133,0.00042715677,0.0002637146,0.00023247371,0.00020576145,0.00020180648,0.00017556135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006333906,0.000032100445,0.95579964,0.000044043805,0.00006131788,0.00021068145,0.00004990274,0.000103098886,0.038094785,0.000026348684,0.00007645775,0.004868261],"study_design_scores_gemma":[0.000007826122,0.00018559389,0.99333316,0.000005141932,0.000042909527,0.001133993,0.00007010598,0.00021693282,0.0045545287,0.000034696575,0.00041210218,0.000003078119],"about_ca_topic_score_codex":0.00051877944,"about_ca_topic_score_gemma":0.0009376813,"teacher_disagreement_score":0.0010108906,"about_ca_system_score_codex":0.00013082106,"about_ca_system_score_gemma":0.00009322929,"threshold_uncertainty_score":0.0033817887},"labels":[],"label_agreement":null},{"id":"W2140641884","doi":"10.1158/1078-0432.ccr-09-1476","title":"Vascular Endothelial Growth Factor Concentration as a Predictive Marker: Ready for Primetime?","year":2010,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Clinical Laboratory Practices and Quality Control","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Vascular endothelial growth factor; Medicine; Growth factor; Internal medicine; VEGF receptors; Receptor","score_opus":0.28725245569168745,"score_gpt":0.5549046254222392,"score_spread":0.2676521697305517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140641884","genre_codex":"editorial","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027080553,0.014076769,0.0006459239,0.23792726,0.7464282,0.000018138599,0.000091128226,0.00007645329,0.00046537997],"genre_scores_gemma":[0.001562237,0.0057270913,0.00040975076,0.09337367,0.8978745,0.000020797284,0.000032184405,0.000045202065,0.00095458433],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99063444,0.0032488324,0.0017365152,0.0014981173,0.0024414333,0.0004406198],"domain_scores_gemma":[0.9372133,0.034274608,0.003026104,0.0011553987,0.021073846,0.0032568127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014501473,0.0026920484,0.0038877197,0.002251226,0.0014640584,0.00733924,0.005998715,0.013318736,0.0029627963],"category_scores_gemma":[0.06494273,0.0011480488,0.0014169599,0.0014316821,0.0033589355,0.0054381303,0.0012847356,0.024250086,0.0035570408],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028581996,0.000045867644,0.0005263337,0.0005513989,0.000082463936,0.00022158546,0.000061612736,0.00007378251,0.00013621365,0.00087018585,0.9721319,0.025012737],"study_design_scores_gemma":[0.0003553457,0.00027995787,0.0028678456,0.0018378085,0.00043017993,0.0014011797,0.0003179862,0.0017818079,0.0009412047,0.0049693547,0.9846473,0.00017008666],"about_ca_topic_score_codex":0.0013052609,"about_ca_topic_score_gemma":0.0021478166,"teacher_disagreement_score":0.014501473,"about_ca_system_score_codex":0.0023858787,"about_ca_system_score_gemma":0.002504198,"threshold_uncertainty_score":0.076691985},"labels":[],"label_agreement":null},{"id":"W2140728431","doi":"10.1158/1078-0432.ccr-07-1489","title":"Prognostic Significance of Defective Mismatch Repair and BRAF V600E in Patients with Colon Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":253,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Colorectal cancer; Internal medicine; Oncology; DNA mismatch repair; Cancer; Cohort; V600E; Prospective cohort study; Mutation; Biology; Gene","score_opus":0.14970964905147943,"score_gpt":0.4622277157691086,"score_spread":0.31251806671762916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140728431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995858,0.00021123866,0.000026440222,0.000019608964,0.0000025164736,0.0000038253143,0.0000549732,0.0000019985182,0.00009370798],"genre_scores_gemma":[0.9997446,0.000040026152,0.000050404913,0.000011698082,0.000007378542,0.000004622449,0.00010197378,6.462602e-7,0.00003866817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979824,0.00007004654,0.000018334142,0.000043811313,0.00003743683,0.000032168893],"domain_scores_gemma":[0.99888974,0.00027858905,0.0004678423,0.00005766053,0.000047839338,0.00025825642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043489842,0.00024472838,0.0003253251,0.00040123635,0.00028474643,0.00024298715,0.00019340542,0.00047318378,0.0013141375],"category_scores_gemma":[0.0014635538,0.00015256526,0.00018599241,0.0003975527,0.00035326008,0.00022529882,0.00019984628,0.00033371084,0.00017487917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017996887,0.00004803066,0.9944331,0.000013739471,0.000034840763,0.0001599403,0.000015399837,0.00010273547,0.0018536623,0.000010347682,0.00006249384,0.0014660698],"study_design_scores_gemma":[0.000095053176,0.00076792814,0.99684936,0.0000050094736,0.00004139273,0.0013051236,0.00004018676,0.00025511865,0.00042347852,0.000025144753,0.00018783342,0.000004351164],"about_ca_topic_score_codex":0.0005915133,"about_ca_topic_score_gemma":0.0010067832,"teacher_disagreement_score":0.0013141375,"about_ca_system_score_codex":0.00019532799,"about_ca_system_score_gemma":0.00023376466,"threshold_uncertainty_score":0.0043962},"labels":[],"label_agreement":null},{"id":"W2140778393","doi":"10.1158/1078-0432.ccr-05-1624","title":"The Putative Tumor Suppressor Cdx2 Is Overexpressed by Human Colorectal Adenocarcinomas","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Digestive system and related health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"CDX2; Immunohistochemistry; Carcinogenesis; Colorectal cancer; Biology; Cancer research; Transcription factor; Reverse transcription polymerase chain reaction; Intestinal mucosa; Endogeny; Epithelium; Tumor suppressor gene; Pathology; Messenger RNA; Cancer; Medicine; Homeobox; Internal medicine; Gene; Immunology; Endocrinology","score_opus":0.09412990076868448,"score_gpt":0.4991898561619032,"score_spread":0.4050599553932187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140778393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979292,0.0010374351,0.0006328253,0.000022589455,0.0000059095883,0.000008116203,0.00011385669,0.000025834479,0.00022414551],"genre_scores_gemma":[0.9983134,0.00033639904,0.0005826137,0.000010178532,0.000004529084,0.0000075731805,0.00029266768,0.0000044687945,0.00044814637],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998653,0.000017305429,0.000010145665,0.0000361646,0.000046101493,0.000024930041],"domain_scores_gemma":[0.9998871,0.000018579934,0.000033401364,0.000013949131,0.0000170138,0.000029898958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012729879,0.0002704802,0.00019397553,0.00033477452,0.00015704164,0.00029561447,0.000078536235,0.00019192001,0.00069084263],"category_scores_gemma":[0.00020083692,0.000115333874,0.0001271315,0.00023246973,0.00020259617,0.00012989463,0.00021132264,0.00017227232,0.00020891077],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012142992,0.0000069989137,0.002548714,0.000023550188,0.0000048231127,0.000110690125,0.00001401822,0.000019674178,0.9965491,0.000020579937,0.000015078274,0.00056526274],"study_design_scores_gemma":[0.000034602268,0.0005634177,0.12410701,0.000008807063,0.000050340863,0.004181574,0.0001754169,0.001133152,0.8659141,0.000050731192,0.0037729412,0.0000078544535],"about_ca_topic_score_codex":0.00069224735,"about_ca_topic_score_gemma":0.0006556116,"teacher_disagreement_score":0.00069224735,"about_ca_system_score_codex":0.00027473873,"about_ca_system_score_gemma":0.00014348408,"threshold_uncertainty_score":0.0023111105},"labels":[],"label_agreement":null},{"id":"W2140793516","doi":"10.1158/1078-0432.ccr-04-2517","title":"Anti-CD19-Targeted Liposomal Doxorubicin Improves the Therapeutic Efficacy in Murine B-Cell Lymphoma and Ameliorates the Toxicity of Liposomes with Varying Drug Release Rates","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Liposome; Pharmacology; Doxorubicin; Pharmacokinetics; Toxicity; Drug; Chemistry; Therapeutic index; Biodistribution; In vivo; Drug carrier; Phosphatidylcholine; Medicine; Biology; In vitro; Biochemistry; Chemotherapy; Internal medicine; Phospholipid; Membrane","score_opus":0.05686369356701386,"score_gpt":0.3860456470176086,"score_spread":0.3291819534505947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140793516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99561936,0.0012462576,0.0022241436,0.00007613959,0.000016204422,0.000029232762,0.00010909218,0.00011579249,0.00056364556],"genre_scores_gemma":[0.99536043,0.0007983027,0.0022092334,0.000041263364,0.000007755729,0.00002329402,0.00023029851,0.000032141543,0.0012972539],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998925,0.000021085623,0.000012232228,0.000021389058,0.000024931382,0.000027800608],"domain_scores_gemma":[0.9999087,0.000014514415,0.00003208099,0.000007749522,0.000011347624,0.000025602967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020094706,0.0003702117,0.0002613809,0.00026380012,0.00006882368,0.00021406323,0.0001921936,0.0002685896,0.00046529312],"category_scores_gemma":[0.00014197855,0.00013486076,0.00014018212,0.00011333549,0.00012883071,0.00031376988,0.00012208318,0.0004313446,0.00018033416],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020534405,0.000077606725,0.00010168633,0.000024122994,0.000005535245,0.000026703961,0.0000099480885,0.00017428088,0.99647117,0.000058990998,0.00003380497,0.002810823],"study_design_scores_gemma":[0.000058404534,0.0011731245,0.0011205744,0.0000047957915,0.000023048071,0.00010392291,0.000005636851,0.0012968888,0.99509925,0.000022048169,0.0010872898,0.000005078435],"about_ca_topic_score_codex":0.00054219656,"about_ca_topic_score_gemma":0.00060320925,"teacher_disagreement_score":0.00054219656,"about_ca_system_score_codex":0.0002921255,"about_ca_system_score_gemma":0.00014298542,"threshold_uncertainty_score":0.0021194816},"labels":[],"label_agreement":null},{"id":"W2141170383","doi":"10.1158/1078-0432.ccr-07-0517","title":"Low-Dose Paclitaxel Prior to Intratumoral Dendritic Cell Vaccine Modulates Intratumoral Cytokine Network and Lung Cancer Growth","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Paclitaxel; Dendritic cell; Cancer research; Lewis lung carcinoma; Tumor microenvironment; Medicine; CD8; Cytokine; Lung cancer; In vivo; Lymph node; Immunology; Cancer; Immune system; Pathology; Biology; Internal medicine; Metastasis","score_opus":0.047189118033625084,"score_gpt":0.4168403109560373,"score_spread":0.3696511929224122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141170383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99618006,0.0010058776,0.0019523506,0.00008328333,0.000035550795,0.000045543457,0.00010643418,0.000049467,0.00054138096],"genre_scores_gemma":[0.996798,0.000511376,0.0015040186,0.00005239697,0.000019666408,0.000049623548,0.00017879723,0.000013511641,0.00087255397],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999125,0.000015502688,0.000006526138,0.000021490001,0.000017848557,0.00002610119],"domain_scores_gemma":[0.99993193,0.000016741991,0.00002475845,0.000007054906,0.0000075959115,0.000011787756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006410431,0.00026349543,0.00026826203,0.00012681658,0.00010496162,0.0002925893,0.00014000418,0.00022476907,0.0006564385],"category_scores_gemma":[0.000110826244,0.00007067814,0.00014785453,0.00012615936,0.00022797525,0.00020547853,0.00009336158,0.0005146698,0.00024460102],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037283404,0.00011883586,0.0002528267,0.000031575302,0.0000028958484,0.000021228861,0.0000077639315,0.00010777287,0.99734676,0.000030919582,0.000022449962,0.001684148],"study_design_scores_gemma":[0.000033440094,0.0010225839,0.001411703,0.0000031223904,0.000017223896,0.00006330565,0.000009844458,0.0006914809,0.9960147,0.000019929012,0.00071037066,0.0000022952736],"about_ca_topic_score_codex":0.0003200385,"about_ca_topic_score_gemma":0.00052940025,"teacher_disagreement_score":0.0006564385,"about_ca_system_score_codex":0.00035950026,"about_ca_system_score_gemma":0.00028667145,"threshold_uncertainty_score":0.0026084185},"labels":[],"label_agreement":null},{"id":"W2141272738","doi":"10.1158/1078-0432.ccr-07-5234","title":"Extended Efficacy and Safety of Denosumab in Breast Cancer Patients with Bone Metastases Not Receiving Prior Bisphosphonate Therapy","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":161,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Denosumab; Medicine; Breast cancer; Internal medicine; Urology; Bisphosphonate; Adverse effect; Bone resorption; Creatinine; Zoledronic acid; Oncology; Gastroenterology; Cancer; Osteoporosis","score_opus":0.14421644474625697,"score_gpt":0.4772672333406095,"score_spread":0.33305078859435255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141272738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961182,0.003152417,0.00010116212,0.00006759789,0.000013862694,0.000068115914,0.00006249935,0.000006860928,0.00040931],"genre_scores_gemma":[0.9986792,0.0007511618,0.00014508981,0.000087234686,0.000033964705,0.0000476253,0.00013944051,9.987124e-7,0.00011524262],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995184,0.0002402013,0.000039366983,0.000047254256,0.00009391395,0.0000609701],"domain_scores_gemma":[0.9992773,0.00023045871,0.00026873348,0.00003907497,0.000037362053,0.00014705241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092029606,0.00023230864,0.0010320364,0.00016208862,0.00016265326,0.00031538098,0.00019486218,0.00027273723,0.0008888829],"category_scores_gemma":[0.0014324343,0.00012495111,0.0005052056,0.00022166711,0.00021526014,0.00018767123,0.00017259213,0.0005125109,0.00016648395],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46034798,0.01236509,0.14719313,0.0010232544,0.0021639303,0.00044458592,0.00028931536,0.002111658,0.049831893,0.00013189559,0.0012024995,0.32289475],"study_design_scores_gemma":[0.13010977,0.41352192,0.43061587,0.0002043403,0.0022526234,0.0017613246,0.00017339259,0.0026355584,0.012691189,0.00027542305,0.005726585,0.000031980326],"about_ca_topic_score_codex":0.00048659477,"about_ca_topic_score_gemma":0.0010900825,"teacher_disagreement_score":0.0010320364,"about_ca_system_score_codex":0.00027762225,"about_ca_system_score_gemma":0.00048708788,"threshold_uncertainty_score":0.004867077},"labels":[],"label_agreement":null},{"id":"W2141275127","doi":"10.1158/1078-0432.ccr-12-0482","title":"A Phase II Pharmacodynamic Study of Preoperative Figitumumab in Patients with Localized Prostate Cancer","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; BC Cancer Agency","funders":"","keywords":"Prostate cancer; Medicine; Prostatectomy; Prostate; Urology; Immunohistochemistry; Prostate-specific antigen; Cancer; Biopsy; Internal medicine; Prostate biopsy","score_opus":0.13249645557582498,"score_gpt":0.5120284825193231,"score_spread":0.3795320269434981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141275127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966102,0.0013253343,0.00037273264,0.00016660051,0.00006199049,0.0006141904,0.00025305062,0.00005293723,0.0005429342],"genre_scores_gemma":[0.99692947,0.0006607414,0.00059373333,0.00025312466,0.00006827628,0.00047551648,0.0004086595,0.0000098008295,0.00060064846],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99976176,0.00011302753,0.000010515143,0.000042877833,0.000023087418,0.000048744238],"domain_scores_gemma":[0.99960595,0.00006319567,0.000087403954,0.00003734933,0.000021015112,0.00018522413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007924719,0.0012031319,0.0014491894,0.00023881321,0.00023381859,0.00071707653,0.00048289206,0.000650156,0.0019803378],"category_scores_gemma":[0.00070401037,0.00045315485,0.0009916632,0.00027706724,0.0006384772,0.00052083965,0.00020481387,0.0021837282,0.00053364324],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.69849473,0.07214144,0.020752707,0.0008506736,0.0015384147,0.0004383313,0.0002774354,0.004306585,0.062587894,0.00022908718,0.003170783,0.135212],"study_design_scores_gemma":[0.36942837,0.5915546,0.02877797,0.000027748612,0.0005329903,0.0005070562,0.00006300873,0.0024154314,0.0040725474,0.00012163426,0.002459423,0.000039317958],"about_ca_topic_score_codex":0.0007880842,"about_ca_topic_score_gemma":0.0020417522,"teacher_disagreement_score":0.0019803378,"about_ca_system_score_codex":0.0007200039,"about_ca_system_score_gemma":0.0010814216,"threshold_uncertainty_score":0.0066248775},"labels":[],"label_agreement":null},{"id":"W2141284512","doi":"10.1158/1078-0432.ccr-10-1551","title":"Array-Based Comparative Genomic Hybridization Identifies <i>CDK4</i> and <i>FOXM1</i> Alterations as Independent Predictors of Survival in Malignant Peripheral Nerve Sheath Tumor","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University Health Network","funders":"","keywords":"Comparative genomic hybridization; Biology; FOXM1; Candidate gene; Malignant peripheral nerve sheath tumor; Tissue microarray; Cancer research; Fluorescence in situ hybridization; Microarray; Microarray analysis techniques; Copy-number variation; Cancer; Gene expression profiling; Gene; In situ hybridization; Immunohistochemistry; Pathology; Gene expression; Genetics; Cell cycle; Genome; Medicine; Chromosome; Immunology","score_opus":0.22293613027951611,"score_gpt":0.4414306515887627,"score_spread":0.2184945213092466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141284512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99933916,0.00012614505,0.0003658391,0.000013468399,0.0000010563309,0.0000023903926,0.000056350655,0.000008060139,0.000087441476],"genre_scores_gemma":[0.99926907,0.000041846604,0.00049070764,0.000008263284,0.0000039400175,0.0000056183817,0.00013021109,0.0000012218371,0.00004920016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988866,0.000029872612,0.000007344542,0.000031710682,0.000024039766,0.000018224087],"domain_scores_gemma":[0.99973875,0.00012315395,0.0000752238,0.00001624469,0.000018412247,0.000028230294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002824754,0.00020094284,0.00016667217,0.0004705545,0.00009560107,0.00014638536,0.00012690187,0.00014410738,0.0005678304],"category_scores_gemma":[0.0006423989,0.00008486233,0.000118022916,0.00022954369,0.0002250648,0.00009533534,0.00009303923,0.00017383546,0.00008275497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015830141,0.000078510864,0.8553787,0.00004460881,0.000099283,0.00026197056,0.000059389276,0.00096302066,0.12939739,0.000050625396,0.00016289113,0.011920701],"study_design_scores_gemma":[0.000040149363,0.00038953975,0.9699627,0.0000046350774,0.0000826234,0.0010260212,0.000047418445,0.003573827,0.024471555,0.00009538143,0.00029957807,0.000006596713],"about_ca_topic_score_codex":0.00067110895,"about_ca_topic_score_gemma":0.0007101819,"teacher_disagreement_score":0.00067110895,"about_ca_system_score_codex":0.00018002302,"about_ca_system_score_gemma":0.0000995195,"threshold_uncertainty_score":0.0018995404},"labels":[],"label_agreement":null},{"id":"W2141325836","doi":"10.1158/1078-0432.ccr-06-0252","title":"Establishment in Severe Combined Immunodeficiency Mice of Subrenal Capsule Xenografts and Transplantable Tumor Lines from a Variety of Primary Human Lung Cancers: Potential Models for Studying Tumor Progression–Related Changes","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University Health Network; University of Toronto; BC Cancer Agency","funders":"BC Cancer Agency; Immunodeficiency Canada","keywords":"Pathology; Biology; Adenocarcinoma; Cancer; Carcinoma; Fluorescence in situ hybridization; Transplantation; Lung cancer; Carcinosarcoma; Cancer research; Adenosquamous carcinoma; Tumor progression; Medicine; Internal medicine; Chromosome","score_opus":0.06316110491169903,"score_gpt":0.40742697637299174,"score_spread":0.3442658714612927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141325836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9698527,0.0016765692,0.022779591,0.00015011446,0.00008325594,0.00066107797,0.0020976753,0.00031045076,0.002388603],"genre_scores_gemma":[0.9549569,0.0019605057,0.029818807,0.0001168532,0.000038233127,0.0009704133,0.0061918744,0.0001169357,0.005829378],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99951386,0.000077368684,0.00006666304,0.00012193459,0.00014169975,0.00007855334],"domain_scores_gemma":[0.9993987,0.00011827576,0.00018247959,0.00013618365,0.000037478516,0.00012681952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095822784,0.0009996607,0.0004442643,0.0008541921,0.0002902336,0.000516244,0.000649291,0.0005195185,0.002464249],"category_scores_gemma":[0.00024320363,0.000380362,0.0006941371,0.0003393524,0.0004846555,0.00058907125,0.000397853,0.0013810345,0.00071532954],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030208426,0.00027802592,0.000579329,0.00005616902,0.000016202182,0.00014139134,0.00003292114,0.00012862994,0.99690586,0.00035032327,0.000073242845,0.0011359142],"study_design_scores_gemma":[0.00021276624,0.0031396027,0.008084627,0.000029601948,0.000092461945,0.0019186708,0.000072054776,0.0025789393,0.9777868,0.00013240987,0.0059344852,0.00001760982],"about_ca_topic_score_codex":0.0006440958,"about_ca_topic_score_gemma":0.0013475361,"teacher_disagreement_score":0.002464249,"about_ca_system_score_codex":0.00037331966,"about_ca_system_score_gemma":0.00043563347,"threshold_uncertainty_score":0.00824368},"labels":[],"label_agreement":null},{"id":"W2141410122","doi":"10.1158/1078-0432.ccr-07-0674","title":"Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia Xenografts","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":466,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Chimeric antigen receptor; Immunology; Adoptive cell transfer; Cancer research; T cell; Homing (biology); Medicine; Ex vivo; Systemic administration; CD28; Immunotherapy; Leukemia; In vivo; Biology; Immune system","score_opus":0.1267420617162681,"score_gpt":0.4841363589671988,"score_spread":0.35739429725093075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141410122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933211,0.0009434708,0.0041535837,0.00007915941,0.000019313013,0.000080266866,0.00014111584,0.00020193466,0.0010600749],"genre_scores_gemma":[0.99465466,0.00062596385,0.0025466685,0.00003272002,0.000020809637,0.00004856656,0.00027487395,0.000035363366,0.0017602791],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998746,0.000015081225,0.000008949701,0.000025850873,0.000039994,0.00003544489],"domain_scores_gemma":[0.9999207,0.0000125923825,0.000028597186,0.000012114966,0.0000073008787,0.000018731453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001151104,0.00043785915,0.00031862652,0.00017176321,0.00008756335,0.00023363074,0.00015450842,0.0001957822,0.0008215331],"category_scores_gemma":[0.00010757818,0.0000828088,0.00016769639,0.000098124576,0.00016677089,0.00013602298,0.000117466916,0.000588138,0.00031625837],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012131326,0.00011408352,0.0003105089,0.000033994267,0.000006670906,0.000038437393,0.000012061975,0.00031584842,0.99465215,0.00008313387,0.00007679385,0.0042350544],"study_design_scores_gemma":[0.00010962312,0.0013032261,0.0019123127,0.0000066204266,0.000037358266,0.0003946045,0.000011744083,0.0015929192,0.9917,0.000033960892,0.0028952614,0.0000023164428],"about_ca_topic_score_codex":0.00037435035,"about_ca_topic_score_gemma":0.0006079035,"teacher_disagreement_score":0.0008215331,"about_ca_system_score_codex":0.00021176357,"about_ca_system_score_gemma":0.0002447907,"threshold_uncertainty_score":0.0027483106},"labels":[],"label_agreement":null},{"id":"W2141453591","doi":"10.1158/1078-0432.ccr-11-0859","title":"Randomized Phase II Trial of Custirsen (OGX-011) in Combination with Docetaxel or Mitoxantrone as Second-line Therapy in Patients with Metastatic Castrate-Resistant Prostate Cancer Progressing after First-line Docetaxel: CUOG Trial P-06c","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Queen Elizabeth II Health Sciences Centre; Juravinski Cancer Centre","funders":"","keywords":"Docetaxel; Mitoxantrone; Medicine; Prostate cancer; Internal medicine; Prednisone; Oncology; Cancer; Chemotherapy; Urology; Surgery; Gastroenterology","score_opus":0.21425801524656538,"score_gpt":0.5016571026383948,"score_spread":0.2873990873918294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141453591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99074554,0.0018785854,0.0003334499,0.0005413443,0.0002688057,0.0030508712,0.001088629,0.00012803126,0.0019647528],"genre_scores_gemma":[0.9848909,0.0017308992,0.0011528335,0.0010238767,0.0002785667,0.0034302576,0.0023789902,0.000032197666,0.0050814413],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99967325,0.000175382,0.000010875709,0.000053829248,0.000022026034,0.00006462381],"domain_scores_gemma":[0.9993204,0.00010958097,0.00014642034,0.000045721765,0.000030150575,0.00034776123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001231112,0.0015920375,0.001876039,0.00035138064,0.00045457325,0.0010421844,0.0008652956,0.0014424683,0.0076774945],"category_scores_gemma":[0.00082447624,0.0006412831,0.0009538116,0.00036581975,0.0010949653,0.0006179708,0.00036185543,0.0029305066,0.0009812621],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9551161,0.013444974,0.001371074,0.0003575499,0.00056423654,0.00007419407,0.00007531775,0.0007238194,0.004635953,0.00016941971,0.002139755,0.021327525],"study_design_scores_gemma":[0.9201462,0.07618403,0.0016675546,0.000015428992,0.00015656093,0.00005441992,0.000018402972,0.00038085706,0.00044832128,0.000072692696,0.00084571494,0.000009883308],"about_ca_topic_score_codex":0.0018173392,"about_ca_topic_score_gemma":0.0048555625,"teacher_disagreement_score":0.0076774945,"about_ca_system_score_codex":0.0010670379,"about_ca_system_score_gemma":0.0017734913,"threshold_uncertainty_score":0.02568376},"labels":[],"label_agreement":null},{"id":"W2141668657","doi":"10.1158/1078-0432.ccr-13-0128","title":"Use of the Proton Pump Inhibitor Pantoprazole to Modify the Distribution and Activity of Doxorubicin: A Potential Strategy to Improve the Therapy of Solid Tumors","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Pantoprazole; Doxorubicin; Pharmacology; Distribution (mathematics); Proton-pump inhibitor; Chemistry; Cancer research; Medicine; Chemotherapy; Internal medicine; Biochemistry; Omeprazole","score_opus":0.13406983096115255,"score_gpt":0.46313515347315026,"score_spread":0.3290653225119977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141668657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9263053,0.052291483,0.014377534,0.0021345161,0.00014572102,0.00016924548,0.00028445266,0.00034905173,0.003942562],"genre_scores_gemma":[0.98265266,0.01161329,0.0039010209,0.00017856997,0.000033843913,0.00003346931,0.00016278762,0.000012814792,0.0014116109],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999946,0.000010384655,0.000003569385,0.0000128214915,0.000011092605,0.000016134783],"domain_scores_gemma":[0.9999467,0.0000094529,0.000021680453,0.0000039307583,0.000007751991,0.000010503998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009205988,0.00028905668,0.00026464704,0.00022112124,0.000106587206,0.00023806388,0.00026922236,0.00043005194,0.0008266849],"category_scores_gemma":[0.00008923439,0.000091660004,0.00015141036,0.000177418,0.00020737787,0.00023556844,0.00015784947,0.00044345937,0.00020292251],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023325438,0.00012959923,0.00044753903,0.0002510799,0.000015003346,0.00013259011,0.000012995883,0.0002694442,0.97511077,0.00017030185,0.000295629,0.022931797],"study_design_scores_gemma":[0.00027198202,0.0050765737,0.011827838,0.000044770957,0.00012778213,0.0015069689,0.00006240469,0.0033101994,0.95558494,0.00021594425,0.021946907,0.000023540159],"about_ca_topic_score_codex":0.00091866177,"about_ca_topic_score_gemma":0.002161607,"teacher_disagreement_score":0.00091866177,"about_ca_system_score_codex":0.00039670395,"about_ca_system_score_gemma":0.00023278002,"threshold_uncertainty_score":0.0028782487},"labels":[],"label_agreement":null},{"id":"W2141762477","doi":"10.1158/1078-0432.ccr-031210","title":"Prevention Strategies with Aromatase Inhibitors","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Exemestane; Anastrozole; Medicine; Aromatase; Breast cancer; Tamoxifen; Letrozole; Aromatase inhibitor; Internal medicine; Oncology; Cancer; Clinical trial; Pharmacology","score_opus":0.08574232485257798,"score_gpt":0.49146827692662176,"score_spread":0.40572595207404377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141762477","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.047547895,0.70346624,0.033882275,0.05276014,0.0058403937,0.0008115201,0.00097172015,0.0007062184,0.15401357],"genre_scores_gemma":[0.37585708,0.4803978,0.033217456,0.041583475,0.0075821797,0.0010392391,0.0014009573,0.00013486354,0.058786925],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995154,0.00013807761,0.00003893443,0.00009049523,0.00014823045,0.000068780835],"domain_scores_gemma":[0.9994542,0.00021660198,0.000098271346,0.00005123205,0.00010217074,0.00007741382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009696849,0.00052180287,0.0004890884,0.00071685587,0.00035941132,0.00091571274,0.00056701025,0.0007865926,0.0122600915],"category_scores_gemma":[0.0018954743,0.00016007807,0.00093449274,0.00046815912,0.00033288184,0.00086557964,0.00090569333,0.0018332265,0.0024574704],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080941763,0.0009815432,0.0017937483,0.0024841523,0.00037980298,0.00032013227,0.0001941978,0.00053943833,0.003096322,0.0148181105,0.030734468,0.9438488],"study_design_scores_gemma":[0.001604777,0.0027058863,0.007229269,0.0035799204,0.0008233655,0.0025441071,0.00026919154,0.0007900526,0.0047515403,0.029484013,0.9461579,0.000060078157],"about_ca_topic_score_codex":0.00094947673,"about_ca_topic_score_gemma":0.0015723103,"teacher_disagreement_score":0.0122600915,"about_ca_system_score_codex":0.00053047185,"about_ca_system_score_gemma":0.0007450808,"threshold_uncertainty_score":0.041014075},"labels":[],"label_agreement":null},{"id":"W2141933631","doi":"10.1158/1078-0432.ccr-08-1622","title":"Successes and Challenges in Translational Research: The Development of Targeted Therapy for Gastrointestinal Stromal Tumours","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"GiST; Imatinib; Imatinib mesylate; Medicine; Tyrosine-kinase inhibitor; Targeted therapy; Gastrointestinal tract; Stromal cell; Clinical trial; Oncology; Mesenchymal stem cell; Tyrosine kinase; Stomach; Stromal tumor; Internal medicine; Cancer research; Pathology; Cancer; Receptor","score_opus":0.5878703424315738,"score_gpt":0.5614306214041053,"score_spread":0.0264397210274685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141933631","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015374846,0.4275723,0.031137517,0.50391036,0.008226993,0.00038216982,0.00019493811,0.00031387634,0.0128869675],"genre_scores_gemma":[0.18792756,0.59894073,0.08880905,0.08465821,0.03325527,0.0010673926,0.0005060268,0.0002460849,0.004589615],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97907925,0.012918163,0.0018647902,0.0012821296,0.003360296,0.0014953774],"domain_scores_gemma":[0.919769,0.053092714,0.0031244296,0.0054854588,0.011763776,0.0067645805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10534564,0.0013321191,0.0024925712,0.0024180342,0.0020543223,0.010873416,0.0029869257,0.008475015,0.004680809],"category_scores_gemma":[0.052245982,0.0006716746,0.0016459243,0.0020494957,0.013129579,0.016510095,0.0056851925,0.014320442,0.0019374386],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011427073,0.0014932792,0.0055154976,0.008113498,0.00033446087,0.0015623426,0.0029499421,0.0031446263,0.011826485,0.24104613,0.062534444,0.66033655],"study_design_scores_gemma":[0.0011219948,0.0054201647,0.006391191,0.005963563,0.00032921677,0.003234905,0.0071583334,0.0066424133,0.0097633,0.34991977,0.60374063,0.00031440772],"about_ca_topic_score_codex":0.0009174065,"about_ca_topic_score_gemma":0.0010329767,"teacher_disagreement_score":0.10534564,"about_ca_system_score_codex":0.0028211463,"about_ca_system_score_gemma":0.013680216,"threshold_uncertainty_score":0.5571276},"labels":[],"label_agreement":null},{"id":"W2142019712","doi":"10.1158/1078-0432.ccr-07-1061","title":"Bendamustine (Treanda) Displays a Distinct Pattern of Cytotoxicity and Unique Mechanistic Features Compared with Other Alkylating Agents","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":366,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Cancer Institute; University of California, San Diego; National Institutes of Health","keywords":"Bendamustine; DNA damage; DNA repair; Biology; Nitrogen mustard; Mitotic catastrophe; Mechanism of action; Chlorambucil; Cancer research; DNA; Pharmacology; Chemotherapy; In vitro; Genetics; Leukemia; Chronic lymphocytic leukemia; Cyclophosphamide","score_opus":0.2350859728693352,"score_gpt":0.48595794570328527,"score_spread":0.2508719728339501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142019712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877564,0.0063057975,0.0028766694,0.00018256926,0.00001818664,0.0000456734,0.00044256804,0.0000673177,0.0023048772],"genre_scores_gemma":[0.9923968,0.0023041784,0.002081199,0.00008249239,0.000012189521,0.00002812466,0.0013030154,0.000015297763,0.0017767375],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998684,0.00002249638,0.00001322064,0.000030577718,0.00004403922,0.000021251099],"domain_scores_gemma":[0.9998838,0.000024456042,0.000040973002,0.000014511852,0.000016817226,0.000019411633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015307892,0.0002712984,0.00028443252,0.00027300234,0.00009764824,0.0002314621,0.00013506706,0.00026849873,0.0014450316],"category_scores_gemma":[0.00021243295,0.00008699166,0.0002555119,0.00019382281,0.00016176591,0.00018965267,0.00012230013,0.00037564518,0.00027695895],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024409147,0.000028881597,0.00091353996,0.000054630582,0.000014817488,0.00005970121,0.0000071192176,0.0001955708,0.99306893,0.00008354848,0.000028383303,0.0053007784],"study_design_scores_gemma":[0.00006300905,0.0021243615,0.023078213,0.000009562608,0.00004072929,0.003010142,0.000017833283,0.0003370953,0.9667035,0.00010596432,0.0045025754,0.000007045029],"about_ca_topic_score_codex":0.00020428571,"about_ca_topic_score_gemma":0.0005141804,"teacher_disagreement_score":0.0014450316,"about_ca_system_score_codex":0.00023228717,"about_ca_system_score_gemma":0.00012632861,"threshold_uncertainty_score":0.0048341155},"labels":[],"label_agreement":null},{"id":"W2142088661","doi":"10.1158/1078-0432.ccr-06-0372","title":"Nomograms Provide Improved Accuracy for Predicting Survival after Radical Cystectomy","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":262,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nomogram; Cystectomy; Bladder cancer; Lymphovascular invasion; Urology; Lymphadenectomy; Proportional hazards model; Radiation therapy; Stage (stratigraphy); AJCC staging system; Carcinoma in situ; Lymph node; Surgery; Cancer; Oncology; Internal medicine; Metastasis","score_opus":0.14711538628860785,"score_gpt":0.4994884676199847,"score_spread":0.3523730813313769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142088661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83073825,0.011420199,0.13701187,0.0019234926,0.0004965039,0.00014165495,0.006459462,0.0027354842,0.009073095],"genre_scores_gemma":[0.98377556,0.0008811851,0.012634421,0.000097355456,0.00015798898,0.0000305827,0.0018244951,0.00006852046,0.0005299173],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99731344,0.0016370948,0.00018005732,0.0003022262,0.00043725004,0.00012990012],"domain_scores_gemma":[0.98001194,0.014245109,0.0025644838,0.0016508909,0.0012515876,0.00027608871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065780673,0.0012303536,0.00084299286,0.002389943,0.0003087022,0.0019025465,0.0004783073,0.0008261572,0.0018691169],"category_scores_gemma":[0.042677466,0.00032295304,0.0010140941,0.0009760667,0.0004415637,0.0014316487,0.0007419424,0.00077125576,0.0010071554],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008200477,0.00009766519,0.71981406,0.00023802558,0.0007080729,0.00013367238,0.00025178664,0.026947698,0.0011050438,0.00089944183,0.005599323,0.24338509],"study_design_scores_gemma":[0.00012874565,0.0004975232,0.70201445,0.000500502,0.000708139,0.0011532804,0.00040468737,0.26740825,0.0024026628,0.005744252,0.01887614,0.0001613616],"about_ca_topic_score_codex":0.0017796101,"about_ca_topic_score_gemma":0.0024043988,"teacher_disagreement_score":0.0065780673,"about_ca_system_score_codex":0.000348052,"about_ca_system_score_gemma":0.00042747534,"threshold_uncertainty_score":0.03478861},"labels":[],"label_agreement":null},{"id":"W2142306777","doi":"10.1158/1078-0432.ccr-12-2789","title":"Mammographic Breast Density Response to Aromatase Inhibition","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Institute of General Medical Sciences; National Cancer Institute; Avon Foundation for Women","keywords":"Aromatase inhibitor; Aromatase; Medicine; Internal medicine; Breast cancer; Letrozole; Tamoxifen; Body mass index; Estrogen; Cancer; Endocrinology; Oncology","score_opus":0.11402935958682121,"score_gpt":0.4777098744885168,"score_spread":0.3636805149016956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142306777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99890566,0.00025444193,0.00013209063,0.000022587268,0.0000046667865,0.000034495843,0.00016426141,0.000009616147,0.00047216757],"genre_scores_gemma":[0.99920696,0.00007306506,0.00013300902,0.000026882975,0.0000077578625,0.00002965221,0.0002794416,0.0000012018127,0.00024199295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996567,0.000114438284,0.000023616012,0.000070068825,0.000092563394,0.00004260611],"domain_scores_gemma":[0.99946946,0.0001224803,0.00024559113,0.00005474446,0.000043908316,0.00006384268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041706781,0.00020248842,0.00028901728,0.0002556647,0.00012739569,0.00020515648,0.00026873534,0.00018662376,0.001432343],"category_scores_gemma":[0.001355354,0.00012486131,0.00022503217,0.00020412743,0.00023509009,0.00007595305,0.00016365683,0.00021976723,0.00017617761],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013650378,0.002037258,0.8993713,0.00012051661,0.00026473548,0.0004231306,0.00009104431,0.00029292703,0.06092363,0.00006625225,0.0003621964,0.02239672],"study_design_scores_gemma":[0.00018139713,0.0049398867,0.98274004,0.000006908239,0.00010124512,0.0008820097,0.000027459599,0.00021345755,0.010387636,0.000027001619,0.00048916513,0.000003830652],"about_ca_topic_score_codex":0.0009198845,"about_ca_topic_score_gemma":0.000674769,"teacher_disagreement_score":0.001432343,"about_ca_system_score_codex":0.00028923008,"about_ca_system_score_gemma":0.00015474093,"threshold_uncertainty_score":0.0047916174},"labels":[],"label_agreement":null},{"id":"W2142308379","doi":"10.1158/1078-0432.ccr-07-4496","title":"Inverse Association between Raf Kinase Inhibitory Protein and Signal Transducers and Activators of Transcription 3 Expression in Gastric Adenocarcinoma Patients: Implications for Clinical Outcome","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources","keywords":"STAT3; Tissue microarray; Cancer research; Immunohistochemistry; STAT protein; Adenocarcinoma; Medicine; Cancer; Metastasis; Transcription factor; Pathology; Signal transduction; Biology; Internal medicine; Gene","score_opus":0.23121385549468268,"score_gpt":0.45240654009255904,"score_spread":0.22119268459787636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142308379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990996,0.0003530524,0.00007202718,0.000056305456,0.0000040791074,0.0000029465928,0.000121822115,0.000004461332,0.00028573498],"genre_scores_gemma":[0.9996661,0.00007085489,0.000050054347,0.000012465953,0.000007176682,0.0000032716787,0.00012121132,0.0000010168472,0.00006794069],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998826,0.000026202513,0.000011868751,0.00003002031,0.00002638255,0.000022943732],"domain_scores_gemma":[0.9994554,0.000120835626,0.00021644036,0.000025312345,0.000053510754,0.00012845037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026164768,0.0001882526,0.00022362288,0.00036897513,0.00021103512,0.00027382374,0.00017171525,0.0003393979,0.0014035217],"category_scores_gemma":[0.00093166396,0.000104908286,0.00024665345,0.000449783,0.00027759315,0.00020779471,0.00018412521,0.0004781254,0.00021172703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005554859,0.000020568577,0.9959496,0.000013236059,0.00003101092,0.000123707,0.00002145478,0.000079756464,0.0016147412,0.000019011435,0.00008032866,0.0014909601],"study_design_scores_gemma":[0.000014668062,0.00009141924,0.9981754,0.0000039995375,0.000039317834,0.0006435414,0.000053620293,0.00045913932,0.0003199688,0.00006406508,0.0001311311,0.000003668138],"about_ca_topic_score_codex":0.00058105896,"about_ca_topic_score_gemma":0.0009030298,"teacher_disagreement_score":0.0014035217,"about_ca_system_score_codex":0.00020491153,"about_ca_system_score_gemma":0.00019066314,"threshold_uncertainty_score":0.0046952367},"labels":[],"label_agreement":null},{"id":"W2142315632","doi":"10.1158/1078-0432.ccr-03-0634","title":"Phase I Study of Concomitant Chemoradiotherapy with Paclitaxel, Fluorouracil, Gemcitabine, and Twice-Daily Radiation in Patients with Poor-Prognosis Cancer of the Head and Neck","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Dental and Craniofacial Research; National Cancer Institute","keywords":"Mucositis; Medicine; Gemcitabine; Concomitant; Antimetabolite; Fluorouracil; Chemoradiotherapy; Regimen; Neutropenia; Internal medicine; Radiation therapy; Head and neck cancer; Chemotherapy; Surgery; Gastroenterology; Phases of clinical research; Oncology","score_opus":0.1034947615815202,"score_gpt":0.4728574492912854,"score_spread":0.3693626877097652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142315632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971879,0.0009456642,0.00025544077,0.00012426189,0.00003632587,0.00084698695,0.0001557378,0.000027027834,0.0004206176],"genre_scores_gemma":[0.99374866,0.00092694483,0.0015562061,0.0003217753,0.00012512038,0.0017321896,0.000857959,0.000012121931,0.000719092],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995784,0.00021882741,0.000024640867,0.00006225254,0.00003590713,0.000079913654],"domain_scores_gemma":[0.9990938,0.00015353359,0.00017309969,0.00006781669,0.00003782279,0.00047394706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011382711,0.0010339268,0.0015532381,0.00020953958,0.00035159726,0.00053577777,0.00069138565,0.00067588565,0.0022943846],"category_scores_gemma":[0.00083595887,0.00040116406,0.0007842978,0.00028843508,0.0009335308,0.0004918081,0.00029224055,0.0017074919,0.00046080988],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.75592196,0.07756065,0.02502564,0.0007036206,0.0014064824,0.00026374374,0.00044888805,0.0023252575,0.046102438,0.00016090275,0.0020197432,0.088060685],"study_design_scores_gemma":[0.36089498,0.6101169,0.019425184,0.000033324304,0.00056706124,0.00033131527,0.00006764477,0.00085386937,0.0055944156,0.000072795716,0.002025853,0.000016653437],"about_ca_topic_score_codex":0.00085802824,"about_ca_topic_score_gemma":0.0021571827,"teacher_disagreement_score":0.0022943846,"about_ca_system_score_codex":0.0007459063,"about_ca_system_score_gemma":0.00167188,"threshold_uncertainty_score":0.0076755285},"labels":[],"label_agreement":null},{"id":"W2142727073","doi":"10.1158/1078-0432.ccr-14-1651","title":"Bromodomain Inhibition in Diffuse Large B-cell Lymphoma—Giving MYC a Brake","year":2014,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Bromodomain; Epigenetics; Cancer research; Enhancer; Cancer; Lymphoma; Biology; Histone; Diffuse large B-cell lymphoma; Pathogenesis; Mef2; Gene; Genetics; Transcription factor; Immunology","score_opus":0.09706866988461825,"score_gpt":0.4317421091213841,"score_spread":0.33467343923676585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142727073","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19438946,0.049421456,0.0042784372,0.66582066,0.024900286,0.00043696922,0.00079145055,0.0009261841,0.05903509],"genre_scores_gemma":[0.5857021,0.025874056,0.003196608,0.311223,0.037682034,0.0003608311,0.00042413227,0.00013456476,0.03540266],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997073,0.00008686368,0.00003187367,0.00003213046,0.000079652986,0.00006231325],"domain_scores_gemma":[0.99954754,0.0002843223,0.000026361513,0.00003456795,0.00003471119,0.00007254628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007858853,0.00056538644,0.00074682815,0.00034218104,0.00047584932,0.0006804367,0.00046554775,0.005910668,0.0013597984],"category_scores_gemma":[0.0015056088,0.00021555691,0.000680895,0.00027790404,0.0006733602,0.00040923222,0.00019353158,0.0039395588,0.001457274],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047616,0.0011897716,0.008073849,0.00082574633,0.00020889219,0.21623653,0.00019207051,0.002912333,0.048129175,0.015318525,0.462563,0.23958845],"study_design_scores_gemma":[0.006227128,0.007173942,0.027154276,0.0004514859,0.00032939998,0.22317544,0.0002516706,0.011364094,0.05167946,0.032163106,0.63985676,0.00017319962],"about_ca_topic_score_codex":0.0006261939,"about_ca_topic_score_gemma":0.0011414418,"teacher_disagreement_score":0.005910668,"about_ca_system_score_codex":0.0013670197,"about_ca_system_score_gemma":0.00033933527,"threshold_uncertainty_score":0.009918451},"labels":[],"label_agreement":null},{"id":"W2142840053","doi":"10.1158/1078-0432.ccr-12-0694","title":"Metformin and Pancreatic Cancer: A Clue Requiring Investigation","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Metformin; Medicine; Cancer; Pancreatic cancer; Oncology; Internal medicine; Diabetes mellitus; Endocrinology","score_opus":0.2437892454370035,"score_gpt":0.5144246904101659,"score_spread":0.2706354449731624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142840053","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012644537,0.7535078,0.0007152048,0.2313896,0.009915394,0.000036403348,0.00017284814,0.000063036015,0.0029352058],"genre_scores_gemma":[0.011665175,0.8429396,0.0025420738,0.08201364,0.056610703,0.000098074815,0.00024026465,0.000031637766,0.003858848],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981218,0.000732824,0.00035258237,0.00023550032,0.0003478037,0.00020956883],"domain_scores_gemma":[0.9783232,0.011488842,0.0015068298,0.0011364104,0.0051163,0.002428351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008231619,0.0013092171,0.00497266,0.0027745455,0.0018776702,0.006378742,0.003924128,0.01524641,0.019704266],"category_scores_gemma":[0.011301898,0.0006742586,0.0025597105,0.003100183,0.0041205585,0.01796202,0.0037200365,0.013312546,0.0043465937],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020399957,0.00096070516,0.008728853,0.010158886,0.0009915737,0.004205203,0.0004357986,0.0008633282,0.0020884275,0.042484812,0.27980727,0.64723516],"study_design_scores_gemma":[0.00034359764,0.0008293115,0.009048565,0.010230801,0.000789856,0.0031614976,0.004302949,0.0007390462,0.0002681019,0.10094198,0.86911154,0.00023269543],"about_ca_topic_score_codex":0.004275463,"about_ca_topic_score_gemma":0.009799165,"teacher_disagreement_score":0.019704266,"about_ca_system_score_codex":0.0016607123,"about_ca_system_score_gemma":0.008351161,"threshold_uncertainty_score":0.06591731},"labels":[],"label_agreement":null},{"id":"W2142934889","doi":"10.1158/1078-0432.ccr-11-3314","title":"Tumoral Lymphocytic Infiltration and Expression of the Chemokine CXCL10 in Breast Cancers from the Ontario Familial Breast Cancer Registry","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Lunenfeld-Tanenbaum Research Institute; St. Michael's Hospital; Mount Sinai Hospital","funders":"National Institutes of Health; National Cancer Institute; Cancer Care Ontario","keywords":"CXCL10; CXCR3; Lymphocytic infiltration; Pathology; Cancer research; Medicine; CD8; Tumor microenvironment; Breast cancer; Chemokine; Chemokine receptor; Cancer; Biology; Immunology; Internal medicine; Immune system","score_opus":0.11481022475663079,"score_gpt":0.43370869248844135,"score_spread":0.3188984677318106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142934889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99494994,0.00028637247,0.000098392666,0.000075760465,0.0000027949409,0.000016950115,0.003262316,0.000010464395,0.0012969286],"genre_scores_gemma":[0.9972487,0.00022033163,0.0000992391,0.00002005636,0.0000033417962,0.000015864072,0.0018614831,0.000002709559,0.00052829535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996489,0.000027922584,0.000024115072,0.000063294174,0.00014704777,0.000088672314],"domain_scores_gemma":[0.9993086,0.000057243116,0.00025199345,0.00005302632,0.00022645945,0.00010276843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023372678,0.00012798171,0.000150862,0.0009905037,0.0006908074,0.0002775238,0.00032918816,0.00016936699,0.0017231347],"category_scores_gemma":[0.00076062314,0.00018318483,0.00012135556,0.0014226929,0.00025872866,0.00013028401,0.0003051042,0.00014499809,0.0002251193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003669049,0.000004261332,0.9976927,0.000013898251,0.00000707079,0.00010307772,0.000106549756,0.000021576077,0.0006818495,0.000011256295,0.00036058517,0.00096049183],"study_design_scores_gemma":[0.0000023386383,0.0000063049065,0.9990294,0.0000043873815,0.000006590883,0.00019724209,0.00011203469,0.000044539807,0.00012370093,0.00000424492,0.00046759658,0.0000016251093],"about_ca_topic_score_codex":0.61518025,"about_ca_topic_score_gemma":0.8012505,"teacher_disagreement_score":0.61518025,"about_ca_system_score_codex":0.0031757548,"about_ca_system_score_gemma":0.002687464,"threshold_uncertainty_score":0.77417207},"labels":[],"label_agreement":null},{"id":"W2143134002","doi":"10.1158/1078-0432.ccr-08-2589","title":"Induction of Wilms' Tumor Protein (WT1)–Specific Antitumor Immunity Using a Truncated WT1-Expressing Adenovirus Vaccine","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Michigan State University Foundation; Osteopathic Heritage Foundation","keywords":"Wilms' tumor; Immunity; Virology; Cancer research; Biology; Adenoviridae; Immunology; Medicine; Immune system; Genetic enhancement; Gene; Genetics","score_opus":0.1624954002347909,"score_gpt":0.4704725585254231,"score_spread":0.3079771582906322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143134002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99343795,0.00078030163,0.004757584,0.00008439772,0.000039386796,0.00007200657,0.00024121355,0.00008911754,0.0004980129],"genre_scores_gemma":[0.99394363,0.00068089965,0.0037892442,0.0000410562,0.000013065719,0.00004731158,0.0006075695,0.000012655483,0.0008646177],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998647,0.000018597017,0.000017585335,0.00003447132,0.000032087653,0.00003254023],"domain_scores_gemma":[0.9998826,0.000022495326,0.000045457065,0.000015360534,0.000010453399,0.000023697274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021398322,0.0005655268,0.00027748835,0.00021296997,0.00008569047,0.00024882436,0.00019056443,0.00033405557,0.0006397768],"category_scores_gemma":[0.00012277733,0.00012357638,0.0003051359,0.0001372177,0.00026375082,0.00022077345,0.0001736938,0.0006913277,0.00022268119],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010154549,0.00007885258,0.00020523438,0.000052464515,0.0000070189576,0.000031926604,0.0000097203165,0.00027940527,0.99784124,0.000095579206,0.00003748769,0.0012595315],"study_design_scores_gemma":[0.000074488846,0.0014894836,0.0017144554,0.000010988017,0.00004099124,0.00037081534,0.000015995156,0.0023812698,0.99153286,0.000042178453,0.0023209557,0.0000054692996],"about_ca_topic_score_codex":0.00019404101,"about_ca_topic_score_gemma":0.00021128822,"teacher_disagreement_score":0.0006397768,"about_ca_system_score_codex":0.000362865,"about_ca_system_score_gemma":0.00022860212,"threshold_uncertainty_score":0.0026327372},"labels":[],"label_agreement":null},{"id":"W2143358417","doi":"10.1158/1078-0432.ccr-03-0041","title":"Improved Therapeutic Responses in a Xenograft Model of Human B Lymphoma (Namalwa) for Liposomal Vincristine<b><i>versus</i></b>Liposomal Doxorubicin Targeted via Anti-CD19 IgG2a or Fab′ Fragments","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Animal Health Research Institute","keywords":"Doxorubicin; Liposome; Vincristine; Pharmacology; In vivo; Medicine; Cytotoxicity; Pharmacokinetics; Monoclonal antibody; CD19; Chemistry; Cancer research; In vitro; Antibody; Chemotherapy; Immunology; Cyclophosphamide; Internal medicine; Biology; Biochemistry","score_opus":0.17424059401354755,"score_gpt":0.4634790582557968,"score_spread":0.2892384642422493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143358417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970413,0.0006601217,0.001067898,0.000050632258,0.000020135394,0.000039400864,0.00017347248,0.00007998731,0.0008671527],"genre_scores_gemma":[0.9957476,0.0003921643,0.0014805158,0.000031225492,0.0000057927286,0.00006740899,0.00031627348,0.000024387602,0.0019346037],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999267,0.000013166587,0.0000053925655,0.000020343528,0.000019373518,0.000014952688],"domain_scores_gemma":[0.99991095,0.000017423601,0.0000286394,0.000011321048,0.000010846597,0.000020811061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014169872,0.00041836893,0.00027730587,0.00017036991,0.000096031414,0.0002181187,0.00017828167,0.00027305208,0.0012597985],"category_scores_gemma":[0.000091031885,0.00011575763,0.00015587948,0.00010753398,0.00016764874,0.00024779476,0.00009082093,0.00051673234,0.00027710528],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049999764,0.00016547354,0.00017647656,0.000028192793,0.000006653236,0.000023042876,0.000016532944,0.00008236466,0.9976902,0.000035735382,0.000039907314,0.0012354554],"study_design_scores_gemma":[0.00008333227,0.0027673473,0.002115052,0.000003902181,0.000029308112,0.00015506757,0.000018824177,0.0011034275,0.9927128,0.000010472598,0.0009970462,0.0000033990987],"about_ca_topic_score_codex":0.0011159452,"about_ca_topic_score_gemma":0.0009329688,"teacher_disagreement_score":0.0012597985,"about_ca_system_score_codex":0.00027700144,"about_ca_system_score_gemma":0.00015433703,"threshold_uncertainty_score":0.0042144656},"labels":[],"label_agreement":null},{"id":"W2143894266","doi":"10.1158/1078-0432.ccr-05-2172","title":"Physiologic Levels of 2-Methoxyestradiol Interfere with Nongenomic Signaling of 17β-Estradiol in Human Breast Cancer Cells","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Environmental Health Sciences; National Cancer Institute","keywords":"2-Methoxyestradiol; Human breast; Breast cancer; Cancer research; Cancer; Signal transduction; Estrogen; Internal medicine; Endocrinology; Biology; Medicine; Chemistry; Cell biology","score_opus":0.08229787583734517,"score_gpt":0.4416115170264622,"score_spread":0.359313641189117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143894266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98571014,0.009402792,0.001791395,0.00018142017,0.00007304665,0.00006077244,0.0005960927,0.00005795027,0.0021263466],"genre_scores_gemma":[0.98515356,0.0065502,0.0026491173,0.00019759,0.00003390517,0.00014342048,0.0014924573,0.00001643028,0.003763261],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99976987,0.00007465817,0.000026857953,0.000033485852,0.000054261287,0.00004097732],"domain_scores_gemma":[0.99993217,0.000023179146,0.000011415177,0.000012787172,0.000013408153,0.0000070698734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002015248,0.00028604927,0.00033434774,0.00015778943,0.00014038786,0.00026310585,0.00016576558,0.00020547284,0.0012906515],"category_scores_gemma":[0.00013433967,0.00012841077,0.00023142988,0.00019006053,0.00014466445,0.00013808347,0.0001471642,0.00032770642,0.0005167735],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003328656,0.0001225944,0.00043445913,0.000060938815,0.000009618227,0.00007876156,0.000030147863,0.00006636493,0.99649733,0.00004668911,0.00006935315,0.0022509487],"study_design_scores_gemma":[0.000039509756,0.0010122464,0.0050438084,0.000007418844,0.000021262145,0.00029023946,0.00004625846,0.00022852901,0.98854095,0.000022058544,0.0047437376,0.000004064993],"about_ca_topic_score_codex":0.00056355365,"about_ca_topic_score_gemma":0.0010534684,"teacher_disagreement_score":0.0012906515,"about_ca_system_score_codex":0.00016687269,"about_ca_system_score_gemma":0.00021189911,"threshold_uncertainty_score":0.0043176413},"labels":[],"label_agreement":null},{"id":"W2143908316","doi":"10.1158/1078-0432.ccr-06-0030","title":"Aberrant Expression of Collagen Triple Helix Repeat Containing 1 in Human Solid Cancers","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Vancouver Coastal Health Research Institute; University of British Columbia; Quest University Canada; Vancouver Coastal Health","funders":"","keywords":"Melanoma; Cancer; Carcinogenesis; Medicine; Cancer research; Immunohistochemistry; Metastasis; Pathology; Breast cancer; Pancreatic cancer; Biology; Internal medicine","score_opus":0.11845292001450686,"score_gpt":0.4776809257349224,"score_spread":0.3592280057204155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143908316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975547,0.001461907,0.0004075903,0.00001408675,0.000002857364,0.000009107762,0.00019102344,0.000012718843,0.00034603436],"genre_scores_gemma":[0.9979645,0.0006601163,0.0006432662,0.0000103763505,0.0000031038517,0.000008466959,0.000480759,0.0000024019569,0.00022713984],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998394,0.000020710737,0.000015713058,0.000045291235,0.000049752416,0.000029114854],"domain_scores_gemma":[0.99981326,0.000036349433,0.000073438736,0.000016136395,0.000031837248,0.000029091418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012984064,0.0001698716,0.00014144857,0.00053730607,0.00018453102,0.00017114231,0.00009641533,0.00017461459,0.00078036863],"category_scores_gemma":[0.00023295986,0.000097135686,0.00011803844,0.0004224086,0.00024209892,0.00006365505,0.00013083866,0.00013669833,0.00025254572],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008497307,0.00003203547,0.13354878,0.00025323505,0.0000381751,0.0012656128,0.00014127544,0.00017986636,0.85626304,0.00008984322,0.00016033967,0.007177984],"study_design_scores_gemma":[0.00002543811,0.00071152864,0.7356384,0.000025653644,0.000103423336,0.013667637,0.00026571847,0.0008191433,0.24493726,0.00011704499,0.0036785789,0.000010210194],"about_ca_topic_score_codex":0.0009489345,"about_ca_topic_score_gemma":0.0014406512,"teacher_disagreement_score":0.0009489345,"about_ca_system_score_codex":0.00024208322,"about_ca_system_score_gemma":0.00020294361,"threshold_uncertainty_score":0.0026106238},"labels":[],"label_agreement":null},{"id":"W2143918464","doi":"10.1158/1078-0432.ccr-09-1180","title":"c-Jun-NH2-kinase-1 Inhibition Leads to Antitumor Activity in Ovarian Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Center for Research Resources; National Cancer Institute","keywords":"Ovarian cancer; Cancer research; Debulking; Ovarian carcinoma; In vivo; Cancer; Medicine; Kinase; Apoptosis; Docetaxel; Cell growth; Internal medicine; Biology","score_opus":0.15785474597755314,"score_gpt":0.4952506165954008,"score_spread":0.3373958706178477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143918464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99624985,0.0021346693,0.00062039925,0.00006575257,0.000021619011,0.00003413356,0.00015450802,0.00004364787,0.0006754238],"genre_scores_gemma":[0.9965971,0.0012272171,0.0007969218,0.000024178027,0.00000715884,0.00003517299,0.0003380752,0.000006655169,0.0009675926],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993634,0.000008495493,0.0000064604055,0.000010634985,0.000019531706,0.00001859354],"domain_scores_gemma":[0.99995625,0.000008422888,0.000014620595,0.000004731548,0.000005131063,0.000010762204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013382928,0.00032673593,0.00032496676,0.00014512106,0.000112374175,0.00018733207,0.00015419228,0.00014751502,0.0009317922],"category_scores_gemma":[0.000081972226,0.00008782434,0.00015633556,0.00013833558,0.00015638892,0.00010996787,0.00010211906,0.00046987412,0.00016635923],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003055604,0.00013566417,0.00025360784,0.00009821348,0.0000069751964,0.00002752552,0.000009128039,0.00012807571,0.995445,0.00004056158,0.00005196511,0.0034976993],"study_design_scores_gemma":[0.00007353784,0.0015528986,0.00417347,0.000004755117,0.00002410768,0.00023527666,0.000014386377,0.00059092866,0.9919373,0.000018692486,0.0013721035,0.0000025902727],"about_ca_topic_score_codex":0.00024278523,"about_ca_topic_score_gemma":0.00064813596,"teacher_disagreement_score":0.0009317922,"about_ca_system_score_codex":0.00023469815,"about_ca_system_score_gemma":0.00022934702,"threshold_uncertainty_score":0.0031172037},"labels":[],"label_agreement":null},{"id":"W2143985899","doi":"10.1158/1078-0432.ccr-09-2228","title":"Performing Phase I Clinical Trials of Anticancer Agents: Perspectives from within the European Union and Japan","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Clinical trial; European union; General partnership; Medicine; Drug development; Political science; Drug; Business; Pharmacology; International trade; Pathology; Law","score_opus":0.2813594209494206,"score_gpt":0.57100025106528,"score_spread":0.28964083011585934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143985899","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05307611,0.405456,0.007141851,0.48018438,0.0037501235,0.00012710283,0.00023547585,0.00010545136,0.04992344],"genre_scores_gemma":[0.53222984,0.30848506,0.018265044,0.12395967,0.009865237,0.00045544756,0.0005380169,0.00018609827,0.006015541],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9791286,0.011856531,0.0026260535,0.0011418691,0.0023400506,0.0029069067],"domain_scores_gemma":[0.9455171,0.012493942,0.006511812,0.0023436062,0.020615153,0.012518338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06775861,0.0007730003,0.0014597261,0.0013825499,0.0021754578,0.010323645,0.0017001664,0.006385479,0.0041830563],"category_scores_gemma":[0.023190055,0.00048906606,0.0015018386,0.00195642,0.0043308437,0.007870825,0.0050452272,0.005315492,0.0009002571],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063258717,0.0013422364,0.04073866,0.003370818,0.0006789333,0.0014000122,0.006913545,0.0018448052,0.011936925,0.065168336,0.053584617,0.8066952],"study_design_scores_gemma":[0.002603644,0.008153352,0.09754921,0.010410028,0.0019915178,0.0039653378,0.023007436,0.0023476323,0.0078278035,0.060246985,0.78145355,0.00044345748],"about_ca_topic_score_codex":0.010147506,"about_ca_topic_score_gemma":0.02444882,"teacher_disagreement_score":0.06775861,"about_ca_system_score_codex":0.0062376405,"about_ca_system_score_gemma":0.02811676,"threshold_uncertainty_score":0.3583461},"labels":[],"label_agreement":null},{"id":"W2144239232","doi":"10.1158/1078-0432.ccr-05-1696","title":"Purification and Characterization of Human Kallikrein 11, a Candidate Prostate and Ovarian Cancer Biomarker, from Seminal Plasma","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Kallikrein; Aprotinin; Chemistry; Affinity chromatography; Plasmin; Trypsin; Biochemistry; Molecular biology; Enzyme; Proteases; Biology","score_opus":0.11183794272183109,"score_gpt":0.44982758942405837,"score_spread":0.3379896467022273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144239232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96390104,0.013761391,0.019317511,0.00025543838,0.00007458044,0.00016570238,0.0017172996,0.000099527824,0.0007076029],"genre_scores_gemma":[0.94877654,0.0066205896,0.029445864,0.00021233967,0.00007557044,0.00007278726,0.010036828,0.000033888853,0.0047255],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999008,0.000018169714,0.0000124282315,0.00002831674,0.000023806935,0.000016391972],"domain_scores_gemma":[0.99986196,0.00003399951,0.000024404579,0.000010764987,0.00004021939,0.000028615608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021705731,0.00048464438,0.00025379052,0.00024689414,0.000121021694,0.0003207108,0.0002060357,0.00025352667,0.0007418823],"category_scores_gemma":[0.00045055733,0.00010844728,0.0002984836,0.00028267663,0.0001650804,0.00019107333,0.00018095941,0.00034180918,0.00049752305],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033104137,0.000048927803,0.0034627721,0.000288713,0.00004894871,0.00017446284,0.000058130358,0.00018400153,0.9802005,0.000077007055,0.00026213887,0.014863346],"study_design_scores_gemma":[0.000081312166,0.0013345708,0.062268384,0.000045077926,0.00018330307,0.0030479126,0.00011409649,0.003312481,0.91062367,0.00016540542,0.01879661,0.000027106003],"about_ca_topic_score_codex":0.0009085321,"about_ca_topic_score_gemma":0.00059019885,"teacher_disagreement_score":0.0009085321,"about_ca_system_score_codex":0.00018478968,"about_ca_system_score_gemma":0.0002840878,"threshold_uncertainty_score":0.0024818182},"labels":[],"label_agreement":null},{"id":"W2144247813","doi":"10.1158/1078-0432.ccr-08-2132","title":"Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":485,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Breast cancer; Oncology; Medicine; Basal (medicine); Immunohistochemistry; Internal medicine; Progesterone receptor; Estrogen receptor; Cancer; Metastasis; Pathology; Cancer research","score_opus":0.12067959121337787,"score_gpt":0.4911984173744459,"score_spread":0.370518826161068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144247813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985461,0.0005924359,0.0003261556,0.0000138848245,0.0000029128082,0.000021476279,0.000088141955,0.000004556288,0.0004044485],"genre_scores_gemma":[0.9986753,0.00023323491,0.00067644956,0.000013416008,0.0000039291917,0.000013571808,0.000256133,0.0000018521004,0.00012621161],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998388,0.000025771302,0.000016507354,0.000029880526,0.00006261797,0.000026443588],"domain_scores_gemma":[0.99980074,0.000043619813,0.00004861582,0.000022105425,0.000031343985,0.000053557585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054547965,0.00018645267,0.00024746446,0.00045058588,0.00018407956,0.0005715774,0.00018508892,0.00019439361,0.00054643844],"category_scores_gemma":[0.0005971279,0.00008815291,0.00013396946,0.00035710525,0.00021087662,0.00018138817,0.00034747334,0.00019957207,0.00016593211],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015764238,0.00015088964,0.86988777,0.0001225314,0.000038103313,0.00048252803,0.00014039909,0.00015965721,0.109728105,0.00007979309,0.00011288013,0.017520824],"study_design_scores_gemma":[0.00003661793,0.0005106525,0.9743954,0.00003547632,0.000061720755,0.006319244,0.0003894523,0.0009797532,0.016213806,0.00015095643,0.00089758687,0.000009377242],"about_ca_topic_score_codex":0.0010338303,"about_ca_topic_score_gemma":0.0016985484,"teacher_disagreement_score":0.0010338303,"about_ca_system_score_codex":0.00017980688,"about_ca_system_score_gemma":0.0002113003,"threshold_uncertainty_score":0.0028848648},"labels":[],"label_agreement":null},{"id":"W2144445863","doi":"10.1158/1078-0432.ccr-10-3266","title":"Internalization of Oncolytic Reovirus by Human Dendritic Cell Carriers Protects the Virus from Neutralization","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"Oncolytics Biotech; U.S. Public Health Service; Cancer Research UK; National Cancer Institute; Richard M. Schulze Family Foundation","keywords":"Oncolytic virus; Virology; Virus; Immune system; Neutralizing antibody; Internalization; Biology; Cell culture; Cell; Immunology","score_opus":0.17670751161946088,"score_gpt":0.47270838750832395,"score_spread":0.29600087588886304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144445863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891278,0.0018608001,0.007167134,0.00007172672,0.000033669454,0.000062459454,0.000094647585,0.00010498897,0.0014767314],"genre_scores_gemma":[0.9948891,0.00061189546,0.0026227848,0.000034606925,0.000009636528,0.000018753868,0.00018678304,0.000021177437,0.001605311],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998553,0.000021562757,0.000009438001,0.00003429586,0.000037913574,0.00004148703],"domain_scores_gemma":[0.9999112,0.000020644682,0.000019662526,0.000021997412,0.000015787398,0.000010786512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016240204,0.00036729634,0.00024618543,0.0001476694,0.00011103187,0.0003772984,0.00017424767,0.0003585932,0.0007692988],"category_scores_gemma":[0.00020216299,0.00009946997,0.0002608469,0.00007265958,0.00022362266,0.00024404869,0.00016099114,0.0003829676,0.00039103828],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094443094,0.000023307075,0.00011023945,0.000025744412,0.0000030409767,0.000037856487,0.000014176281,0.000120463126,0.99780065,0.00010345989,0.000028818464,0.0016377493],"study_design_scores_gemma":[0.000017487719,0.00031684188,0.0004527382,0.0000076016486,0.00000926342,0.00016858877,0.000009152643,0.0011852514,0.99621755,0.000030165795,0.0015828147,0.0000026384632],"about_ca_topic_score_codex":0.0007084554,"about_ca_topic_score_gemma":0.00046871885,"teacher_disagreement_score":0.0007692988,"about_ca_system_score_codex":0.00040836007,"about_ca_system_score_gemma":0.00035423218,"threshold_uncertainty_score":0.002962947},"labels":[],"label_agreement":null},{"id":"W2144466430","doi":"10.1158/1078-0432.ccr-07-0330","title":"Preoperative Plasma HER2 and Epidermal Growth Factor Receptor for Staging and Prognostication in Patients with Clinically Localized Prostate Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Interquartile range; Prostate cancer; Prostatectomy; Epidermal growth factor receptor; Urology; Internal medicine; Metastasis; Prostate; Oncology; Lymphadenectomy; Cancer; Adenocarcinoma; Pathology","score_opus":0.10789014035487311,"score_gpt":0.47625994879743194,"score_spread":0.36836980844255884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144466430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99938107,0.00033300088,0.00008474883,0.00003736476,0.000005873093,0.000004179376,0.000058666814,0.0000027857643,0.000092280796],"genre_scores_gemma":[0.9997148,0.000045360237,0.000063487576,0.000017148406,0.000009279119,0.000004016577,0.000091566864,4.6825525e-7,0.00005386872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998337,0.000064226064,0.00001119463,0.00003313947,0.000032471853,0.000025255387],"domain_scores_gemma":[0.9994554,0.00019351603,0.00013779281,0.00002924189,0.000034151126,0.0001498088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029803402,0.00027168123,0.00028615398,0.00030948076,0.00021107013,0.00032981046,0.00019260708,0.00033565928,0.0012393206],"category_scores_gemma":[0.0011245384,0.00014787696,0.00019535498,0.0003237925,0.00028979924,0.00021480928,0.00017568174,0.00036980957,0.00018983158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005681331,0.000048859783,0.9959074,0.000012792648,0.000034150253,0.000084261024,0.000024125608,0.00010427845,0.0011273883,0.000009179264,0.00010255549,0.0019769229],"study_design_scores_gemma":[0.00005456282,0.00037588848,0.99757165,0.0000068752647,0.0000402615,0.0006206589,0.00006962444,0.00067764346,0.00037809578,0.000036031306,0.0001631031,0.000005570702],"about_ca_topic_score_codex":0.0009546999,"about_ca_topic_score_gemma":0.0020053936,"teacher_disagreement_score":0.0012393206,"about_ca_system_score_codex":0.00023822441,"about_ca_system_score_gemma":0.000397501,"threshold_uncertainty_score":0.00414598},"labels":[],"label_agreement":null},{"id":"W2144547786","doi":"10.1158/1078-0432.ccr-11-2436","title":"Phase I Study of the Combination of Sorafenib and Temsirolimus in Patients with Metastatic Melanoma","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Temsirolimus; Sorafenib; Medicine; Internal medicine; Oncology; Response Evaluation Criteria in Solid Tumors; Neuroblastoma RAS viral oncogene homolog; Cancer; Gastroenterology; Phases of clinical research; Toxicity; Surgery; Hepatocellular carcinoma; KRAS; Biology","score_opus":0.1270920474656933,"score_gpt":0.4640427284017923,"score_spread":0.336950680936099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144547786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904979,0.0034303628,0.00075796235,0.0006409021,0.00017420253,0.0021490874,0.000525458,0.00013267616,0.0016915234],"genre_scores_gemma":[0.9905075,0.0018963679,0.0018418181,0.000568461,0.0003119876,0.0017452191,0.001226844,0.000025882975,0.0018759259],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995833,0.00018669471,0.000023982078,0.00006126468,0.000058477846,0.00008628112],"domain_scores_gemma":[0.9994112,0.00006211843,0.00010166501,0.000030296058,0.000034395274,0.00036033892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001393367,0.0016757287,0.0022686536,0.00041891448,0.0004272582,0.0006827973,0.0008624401,0.00088064733,0.0031117585],"category_scores_gemma":[0.0007115402,0.00068482565,0.0009562219,0.0003586908,0.0007462476,0.0005737744,0.00032478495,0.0027531297,0.00095273263],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5766771,0.11325663,0.012919645,0.0017156561,0.001947725,0.0010419685,0.00042673916,0.0055954386,0.12005364,0.00044139542,0.0097816875,0.15614243],"study_design_scores_gemma":[0.5165944,0.4595424,0.012191145,0.000048035385,0.00037719068,0.00071854325,0.000040282353,0.0016492973,0.005019741,0.00014804649,0.0036380035,0.000033015527],"about_ca_topic_score_codex":0.0005789191,"about_ca_topic_score_gemma":0.001537505,"teacher_disagreement_score":0.0031117585,"about_ca_system_score_codex":0.0007429141,"about_ca_system_score_gemma":0.0017155331,"threshold_uncertainty_score":0.010409832},"labels":[],"label_agreement":null},{"id":"W2144614118","doi":"10.1158/1078-0432.ccr-04-0764","title":"Nuclear Factor-κB Nuclear Localization Is Predictive of Biochemical Recurrence in Patients with Positive Margin Prostate Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Prostate Cancer Research Initiative","keywords":"Biochemical recurrence; Univariate analysis; Prostate cancer; Medicine; Prostatectomy; Confidence interval; Lymph node; Surgical margin; Proportional hazards model; Oncology; Immunohistochemistry; Internal medicine; Prostate-specific antigen; Prostate; Risk factor; Multivariate analysis; Pathology; Urology; Cancer","score_opus":0.04758190669353778,"score_gpt":0.39691658490330317,"score_spread":0.3493346782097654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144614118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99913764,0.00061848375,0.00011492436,0.00002527044,0.0000053163444,0.0000017967981,0.00002426057,0.000003923063,0.00006822648],"genre_scores_gemma":[0.9998203,0.000059622325,0.00003791127,0.000005682454,0.000008460955,0.0000015247252,0.000029359691,6.153847e-7,0.000036605725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998023,0.00006976256,0.000018346356,0.000036363595,0.000047544363,0.000025696369],"domain_scores_gemma":[0.99845135,0.000400608,0.00077646045,0.00006809171,0.00007880755,0.00022464487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005053282,0.00023441369,0.00025273263,0.0002832564,0.0001957527,0.00032189625,0.00023577923,0.0002978045,0.0011968588],"category_scores_gemma":[0.0024354535,0.00015950669,0.0002496504,0.00025122176,0.00035876656,0.00022510192,0.00022080331,0.0003891571,0.0002210774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043246098,0.00003084774,0.9965765,0.00001722689,0.000041856336,0.00009935472,0.000034870664,0.00006762673,0.0009364629,0.000005961198,0.000054184464,0.0017026485],"study_design_scores_gemma":[0.00002184664,0.00033624,0.9970499,0.00000855273,0.000056164925,0.0015635642,0.00008409494,0.0004009603,0.0002993422,0.000025794638,0.00014826188,0.000005195137],"about_ca_topic_score_codex":0.0005875973,"about_ca_topic_score_gemma":0.0007758851,"teacher_disagreement_score":0.0011968588,"about_ca_system_score_codex":0.00013888886,"about_ca_system_score_gemma":0.00018527433,"threshold_uncertainty_score":0.0040038824},"labels":[],"label_agreement":null},{"id":"W2144712720","doi":"10.1158/1078-0432.ccr-11-1403","title":"Dicer-Mediated Upregulation of BCRP Confers Tamoxifen Resistance in Human Breast Cancer Cells","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Cancer Institute; National Institutes of Health","keywords":"Downregulation and upregulation; Abcg2; Dicer; Tamoxifen; Cancer research; Toremifene; Human breast; Breast cancer; Cancer; Medicine; Biology; Internal medicine; Cell culture; ATP-binding cassette transporter; Small interfering RNA; Transfection; Transporter; Genetics; Gene","score_opus":0.23712640514454647,"score_gpt":0.4819766399503201,"score_spread":0.24485023480577361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144712720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98919326,0.0024362826,0.004292515,0.00021510525,0.000049962433,0.00010079425,0.0010882323,0.00014539323,0.002478491],"genre_scores_gemma":[0.9884892,0.001132615,0.0044866684,0.00010375194,0.000015203344,0.000083042636,0.0018922926,0.000022026912,0.0037751282],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99968517,0.000048010257,0.000034643672,0.000067462584,0.00011693076,0.00004782842],"domain_scores_gemma":[0.9998429,0.000029497794,0.000036167727,0.00004396307,0.000025760055,0.000021800355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028811954,0.00026033953,0.00030878725,0.00024128224,0.00020531814,0.00028352172,0.00016722677,0.0003589713,0.001925554],"category_scores_gemma":[0.00023514904,0.00014775644,0.00022083808,0.00023628061,0.00016446703,0.00016233455,0.00020232322,0.00041541574,0.0007150413],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042017724,0.000013794389,0.00015197009,0.000028002682,0.0000043147443,0.00006161392,0.0000128628135,0.000043952008,0.9987204,0.00004985562,0.000086228094,0.00078498584],"study_design_scores_gemma":[0.000017666398,0.00027168548,0.004210509,0.000004757128,0.000015034815,0.0010015867,0.000020584286,0.00082398567,0.98889333,0.000024162744,0.0047116773,0.0000049361024],"about_ca_topic_score_codex":0.00039970013,"about_ca_topic_score_gemma":0.00051403366,"teacher_disagreement_score":0.001925554,"about_ca_system_score_codex":0.00032458158,"about_ca_system_score_gemma":0.0001510572,"threshold_uncertainty_score":0.006441653},"labels":[],"label_agreement":null},{"id":"W2144823506","doi":"10.1158/1078-0432.ccr-06-0328","title":"Isolation of Human Prostatic Epithelial Plasma Membranes for Proteomics Using Mirror Image Tissue Banking of Radical Prostatectomy Specimens","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; Caprion (Canada); McGill University Health Centre","funders":"","keywords":"Histology; Prostate cancer; Prostatectomy; Prostate; Pathology; Glutamate carboxypeptidase II; Antigen; Cancer; Medicine; Epithelium; Biology; Internal medicine; Immunology","score_opus":0.2061568061306547,"score_gpt":0.5199524363641375,"score_spread":0.3137956302334828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144823506","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9567464,0.004331609,0.03568238,0.00022494743,0.00006686832,0.00037591037,0.0005718272,0.00017501073,0.0018250203],"genre_scores_gemma":[0.9273038,0.0040580654,0.062845595,0.00020265862,0.0000783593,0.0003929318,0.0031767013,0.000060337516,0.0018815724],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997682,0.00003417824,0.00002382156,0.000055433495,0.0000853204,0.000032990924],"domain_scores_gemma":[0.9997975,0.00002539603,0.000035975852,0.000054081607,0.00006311532,0.000023913237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035582038,0.00035896534,0.00027284728,0.00039237546,0.00033336584,0.00036896073,0.00038209063,0.0002707537,0.0012570693],"category_scores_gemma":[0.00049957004,0.000198671,0.00030734667,0.00030536434,0.00021977918,0.00038932078,0.0005112031,0.0003683808,0.0010303794],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014457307,0.000027760067,0.0034617488,0.00010411489,0.000015084512,0.0001878298,0.0000502413,0.00005338385,0.9896616,0.000046486348,0.000086359236,0.006160955],"study_design_scores_gemma":[0.00003274964,0.0007311657,0.09986246,0.000041325184,0.00012289966,0.005206811,0.00024274796,0.0013806205,0.88433826,0.00013248622,0.007891346,0.000017118793],"about_ca_topic_score_codex":0.0003974875,"about_ca_topic_score_gemma":0.00054123177,"teacher_disagreement_score":0.0012570693,"about_ca_system_score_codex":0.00015958093,"about_ca_system_score_gemma":0.00032010503,"threshold_uncertainty_score":0.0042052865},"labels":[],"label_agreement":null},{"id":"W2145145182","doi":"10.1158/1078-0432.ccr-06-1104","title":"Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer—A Plan to Move Forward","year":2006,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":271,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Drug development; Clinical trial; Cancer prevention; Medicine; Biomarker; Intraepithelial neoplasia; Cancer; Drug; Personalized medicine; Precision medicine; Mechanism (biology); Disease; Bioinformatics; Pharmacology; Biology; Internal medicine; Pathology","score_opus":0.20237258777256706,"score_gpt":0.5620448995892942,"score_spread":0.3596723118167271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145145182","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009112241,0.99472106,0.00052988366,0.0032993997,0.00050144654,0.000005611296,0.0000059706076,0.000016050995,0.00082943344],"genre_scores_gemma":[0.000770631,0.9952068,0.0014418724,0.0015045468,0.00060966087,0.000011764164,0.000012847274,0.000004402323,0.00043754652],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986821,0.00047347942,0.00014891531,0.00015352054,0.000470483,0.0000714509],"domain_scores_gemma":[0.9960686,0.0025463933,0.0002737842,0.00016937134,0.00071183423,0.0002299778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049655,0.0013002452,0.002331759,0.003817677,0.0006409037,0.0025978524,0.0015253229,0.0029757412,0.002744068],"category_scores_gemma":[0.0036473658,0.00048616523,0.0008619333,0.0033060452,0.0026259692,0.006894276,0.0012539995,0.005896332,0.0024899286],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010082061,0.00018490541,0.0004319296,0.008858117,0.00010684648,0.00025475174,0.00013679564,0.0007722066,0.0017944437,0.02292909,0.038623054,0.92580706],"study_design_scores_gemma":[0.00005389609,0.00029569076,0.000873806,0.004202657,0.00007937208,0.0013125214,0.0002837857,0.00026000346,0.0007123796,0.015690649,0.9761846,0.000050521685],"about_ca_topic_score_codex":0.0014325011,"about_ca_topic_score_gemma":0.0023323193,"teacher_disagreement_score":0.0049655,"about_ca_system_score_codex":0.00173937,"about_ca_system_score_gemma":0.0028306125,"threshold_uncertainty_score":0.026260376},"labels":[],"label_agreement":null},{"id":"W2145263179","doi":"10.1158/1078-0432.ccr-05-2452","title":"Germ Line Mutations of Mismatch Repair Genes in Hereditary Nonpolyposis Colorectal Cancer Patients with Small Bowel Cancer: International Society for Gastrointestinal Hereditary Tumours Collaborative Study","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"MSH6; MLH1; PMS2; MSH2; DNA mismatch repair; Medicine; Colorectal cancer; Population; Cancer; Germline mutation; Lynch syndrome; Mutation; Internal medicine; Cancer research; Genetics; Biology; Gene","score_opus":0.07774063884718146,"score_gpt":0.42821451213250267,"score_spread":0.3504738732853212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145263179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99964917,0.000087403394,0.000031360698,0.000013264589,0.000002177061,0.000007827408,0.00009256225,0.0000010841787,0.000115083145],"genre_scores_gemma":[0.99963987,0.00004573726,0.00004196634,0.000017067734,0.000007261635,0.000007902504,0.0001914481,9.367784e-7,0.000047757705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940634,0.00018000328,0.000060522314,0.00017013706,0.00010502994,0.000077971934],"domain_scores_gemma":[0.9984658,0.00030304038,0.00061171193,0.000100438105,0.00017403538,0.00034510475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000633468,0.0003257074,0.00039705355,0.00091673376,0.000551646,0.0005057012,0.00035145017,0.0005386539,0.001261151],"category_scores_gemma":[0.0022076028,0.00027632856,0.00033097022,0.0010724922,0.00028910022,0.00040276942,0.00041656438,0.00033647867,0.00018119163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009496822,0.000033300064,0.99913305,0.000005549523,0.000028021841,0.00010784735,0.000044903387,0.000011880604,0.00016502319,0.0000043180635,0.000034740468,0.0003363429],"study_design_scores_gemma":[0.000018012952,0.0001227917,0.9986744,0.000002763385,0.000027108372,0.0008104635,0.00011472394,0.00007731948,0.000052239855,0.000006640361,0.00009159273,0.0000020093762],"about_ca_topic_score_codex":0.004052413,"about_ca_topic_score_gemma":0.0042735473,"teacher_disagreement_score":0.004052413,"about_ca_system_score_codex":0.00029713777,"about_ca_system_score_gemma":0.00037700863,"threshold_uncertainty_score":0.008057654},"labels":[],"label_agreement":null},{"id":"W2145300105","doi":"10.1158/1078-0432.ccr-12-0087","title":"Profiling Three-Dimensional Nuclear Telomeric Architecture of Myelodysplastic Syndromes and Acute Myeloid Leukemia Defines Patient Subgroups","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"Canadian Institutes of Health Research; McGill University","keywords":"Myelodysplastic syndromes; Myeloid leukemia; Telomere; Cytopenia; Internal medicine; International Prognostic Scoring System; Medicine; Oncology; Leukemia; Bone marrow failure; Bone marrow; Pathology; Biology; Stem cell; Genetics; Gene; Haematopoiesis","score_opus":0.09979247352306594,"score_gpt":0.40678059266492017,"score_spread":0.3069881191418542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145300105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991691,0.00014175966,0.0004123174,0.000010674534,7.526982e-7,0.0000079622905,0.000091546295,0.0000065199056,0.00015952137],"genre_scores_gemma":[0.9989272,0.00005247525,0.0005367995,0.000010826423,0.0000018447257,0.000013122654,0.0003670413,0.000002440094,0.000088368455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998454,0.000037522346,0.000019908231,0.000039609164,0.000036247922,0.0000213004],"domain_scores_gemma":[0.9997718,0.000055712146,0.00008061402,0.000024352907,0.000030882227,0.00003678414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029958892,0.00017743459,0.00020940854,0.0005193019,0.00019131762,0.00033602957,0.00012976155,0.000270131,0.0006965396],"category_scores_gemma":[0.00073221826,0.00008104605,0.00015296994,0.00030315891,0.00019827131,0.00017598066,0.0003077422,0.00015973393,0.00018710643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014192379,0.000052855237,0.78825027,0.000057897807,0.00006413429,0.00053313293,0.00042349147,0.00074541784,0.19095658,0.00017881925,0.00018085535,0.017137239],"study_design_scores_gemma":[0.000032453976,0.000452011,0.96576416,0.000013398609,0.000068929134,0.004578991,0.00046037236,0.0034625106,0.022887709,0.0002829484,0.001982953,0.0000135360715],"about_ca_topic_score_codex":0.00034258154,"about_ca_topic_score_gemma":0.00052589027,"teacher_disagreement_score":0.0006965396,"about_ca_system_score_codex":0.0001712685,"about_ca_system_score_gemma":0.00010272097,"threshold_uncertainty_score":0.002330184},"labels":[],"label_agreement":null},{"id":"W2145335139","doi":"10.1158/1078-0432.ccr-14-0114","title":"Phase I Dose-Escalation Study of MEDI-573, a Bispecific, Antiligand Monoclonal Antibody against IGFI and IGFII, in Patients with Advanced Solid Tumors","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Heart and Stroke Foundation of Canada","keywords":"Medicine; Tolerability; Adverse effect; Nausea; Pharmacokinetics; Internal medicine; Pharmacodynamics; Refractory (planetary science); Gastroenterology; Anorexia; Response Evaluation Criteria in Solid Tumors; Anemia; Pharmacology; Phases of clinical research; Toxicity","score_opus":0.09062321050583509,"score_gpt":0.48918843589913574,"score_spread":0.39856522539330064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145335139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972218,0.0009853189,0.00040032194,0.0000947956,0.000026989423,0.0005868777,0.00017841904,0.000040902327,0.0004646066],"genre_scores_gemma":[0.9957765,0.0007788347,0.0013778529,0.00027358098,0.000059169197,0.00057813735,0.0006358174,0.000012077003,0.00050809875],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99976057,0.00009640373,0.000014584897,0.000040148785,0.000039056304,0.00004920033],"domain_scores_gemma":[0.9996257,0.00006304631,0.000113746,0.00003102394,0.000024862342,0.0001415261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009546757,0.0011637022,0.0012433466,0.00035395636,0.00026004756,0.00047050565,0.0005741527,0.00053249823,0.00146434],"category_scores_gemma":[0.00046490185,0.0003998101,0.0007556151,0.00034553357,0.00064723904,0.00046076858,0.0002615534,0.0021459053,0.00039001484],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43066645,0.089560084,0.020826034,0.0013383188,0.0014481273,0.0003836844,0.00048107695,0.009117547,0.26844662,0.00035484397,0.0033071516,0.17406999],"study_design_scores_gemma":[0.29198366,0.6413266,0.029339213,0.00005033157,0.0005999291,0.00049211073,0.00007028415,0.0037240575,0.02914798,0.00018502648,0.0030418993,0.000038903534],"about_ca_topic_score_codex":0.0005495782,"about_ca_topic_score_gemma":0.0012722028,"teacher_disagreement_score":0.00146434,"about_ca_system_score_codex":0.0007501488,"about_ca_system_score_gemma":0.0010037185,"threshold_uncertainty_score":0.005442798},"labels":[],"label_agreement":null},{"id":"W2145788892","doi":"10.1158/1078-0432.ccr-03-0545","title":"Demethylation of Urokinase Promoter as a Prognostic Marker in Patients with Breast Carcinoma","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; McGill University Health Centre","funders":"","keywords":"Breast cancer; Methylation; Cancer research; Epigenetics; Biology; DNA methylation; Promoter; Estrogen receptor; Cancer; Bisulfite sequencing; Gene expression; Gene; Genetics","score_opus":0.050655132997275705,"score_gpt":0.41371867242001165,"score_spread":0.36306353942273595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145788892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980552,0.0010374443,0.0002587911,0.000048746497,0.0000074095233,0.0000072950593,0.0001808075,0.000013128715,0.00039114058],"genre_scores_gemma":[0.9994517,0.00012682151,0.00013694483,0.000011747279,0.0000089348405,0.0000043494047,0.00015169894,0.0000013521636,0.000106429616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998709,0.000030407069,0.000013957914,0.000029958412,0.000032544616,0.000022291459],"domain_scores_gemma":[0.9995757,0.00010624992,0.0001585251,0.000025879126,0.000057699577,0.000076012366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023816038,0.00018832549,0.00029266576,0.000556179,0.00020175398,0.00024591587,0.00013447553,0.00025843133,0.00084211706],"category_scores_gemma":[0.00085089763,0.00009059136,0.00014197001,0.0005815917,0.00013911538,0.00019013212,0.00017700216,0.00029959693,0.00018016882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045851804,0.0000205673,0.99107754,0.000015905644,0.000020520965,0.00017521113,0.00003647368,0.000069777365,0.003950466,0.000010721074,0.00005665031,0.004107652],"study_design_scores_gemma":[0.000011498055,0.00021996176,0.9942416,0.000006735562,0.00007132313,0.0014359035,0.000056774457,0.0005609271,0.0028780745,0.000044632747,0.00046780938,0.0000047417907],"about_ca_topic_score_codex":0.0004944314,"about_ca_topic_score_gemma":0.00057176646,"teacher_disagreement_score":0.00084211706,"about_ca_system_score_codex":0.00016165813,"about_ca_system_score_gemma":0.00014374714,"threshold_uncertainty_score":0.0028172135},"labels":[],"label_agreement":null},{"id":"W2146218303","doi":"10.1158/1078-0432.ccr-08-2533","title":"Phosphorylation of the src Epithelial Substrate Trask Is Tightly Regulated in Normal Epithelia but Widespread in Many Human Epithelial Cancers","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; University of California, San Francisco","keywords":"Proto-oncogene tyrosine-protein kinase Src; Phosphorylation; Biology; Carcinogenesis; Kinase; Oncogene; Cancer research; Cell biology; Cancer; Cell; Cell cycle; Biochemistry","score_opus":0.07442720431742295,"score_gpt":0.4112289446642709,"score_spread":0.33680174034684796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146218303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99445856,0.0031651857,0.0010512186,0.00004662484,0.000005668493,0.0000096001595,0.0003900843,0.00004239883,0.00083070656],"genre_scores_gemma":[0.9962548,0.001195501,0.00083250395,0.000019664749,0.000006178607,0.0000066886614,0.0005564335,0.0000063422103,0.0011218116],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998548,0.000011871184,0.00001360018,0.000037790134,0.000049854443,0.000032066135],"domain_scores_gemma":[0.99982494,0.000018266113,0.000072067916,0.000017657887,0.000029473335,0.000037660422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010396737,0.00023462545,0.0001542642,0.00043793683,0.00019023765,0.00033066713,0.000110005305,0.00017079753,0.0012342628],"category_scores_gemma":[0.00014754159,0.00013317673,0.0001929179,0.00029137338,0.00017574255,0.00018404183,0.00016802242,0.0002338806,0.0003925766],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093335875,0.0000071075665,0.005556609,0.000052381554,0.000007746414,0.00012905925,0.000029470975,0.000041441213,0.9920888,0.000044032524,0.000036452097,0.001913712],"study_design_scores_gemma":[0.000007730627,0.00030247742,0.2412605,0.000017701353,0.000058060872,0.0046511074,0.00023419564,0.00045890902,0.7485087,0.00010323026,0.004385481,0.000011918403],"about_ca_topic_score_codex":0.000500281,"about_ca_topic_score_gemma":0.00084700104,"teacher_disagreement_score":0.0012342628,"about_ca_system_score_codex":0.00018976607,"about_ca_system_score_gemma":0.00020664559,"threshold_uncertainty_score":0.0041289926},"labels":[],"label_agreement":null},{"id":"W2146441141","doi":"10.1158/1078-0432.ccr-07-5165","title":"Polymorphisms in<i>Cyclooxygenase-2</i>and<i>Epidermal Growth Factor Receptor</i>Are Associated with Progression-Free Survival Independent of K-ras in Metastatic Colorectal Cancer Patients Treated with Single-Agent Cetuximab","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"National Cancer Institute; National Institutes of Health; European Commission; Dhont Family Foundation; University of Southern California","keywords":"Cetuximab; Colorectal cancer; Internal medicine; Epidermal growth factor receptor; Medicine; Irinotecan; Genotype; Oxaliplatin; Oncology; Cancer; Cancer research; Gastroenterology; Biology; Gene; Genetics","score_opus":0.12934169160089506,"score_gpt":0.40500517731353497,"score_spread":0.2756634857126399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146441141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99962306,0.00015457529,0.000067094166,0.000026345107,0.0000036677661,0.0000041707435,0.000043632448,0.0000036554886,0.00007381927],"genre_scores_gemma":[0.9997216,0.000036804504,0.00007132732,0.000018414828,0.0000105831605,0.0000036547124,0.00007142527,0.0000014621867,0.00006469643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997811,0.000082167375,0.000015320647,0.00005088064,0.0000385355,0.00003202313],"domain_scores_gemma":[0.999171,0.00025550855,0.00035237256,0.00004551587,0.000034174504,0.00014142532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044022736,0.00027886988,0.00026233535,0.00026203287,0.00017149614,0.0002804392,0.00017563885,0.00034905036,0.0010173871],"category_scores_gemma":[0.0009121165,0.00019404027,0.00027059342,0.00020790132,0.00029935452,0.000097102624,0.000097948905,0.0004413133,0.00012631441],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012130577,0.00033746887,0.9516956,0.00006053759,0.000539986,0.00041568902,0.00006632092,0.0005271214,0.028303929,0.000047738657,0.00032253278,0.0055524055],"study_design_scores_gemma":[0.0002982453,0.0010295789,0.99228185,0.0000082547795,0.00024396455,0.0014002045,0.000032027896,0.0013335155,0.003037927,0.00004615797,0.00028159792,0.0000066363436],"about_ca_topic_score_codex":0.0010287175,"about_ca_topic_score_gemma":0.0013078693,"teacher_disagreement_score":0.0010287175,"about_ca_system_score_codex":0.00017520982,"about_ca_system_score_gemma":0.00018195686,"threshold_uncertainty_score":0.0034034848},"labels":[],"label_agreement":null},{"id":"W2146471206","doi":"10.1158/1078-0432.14aacriaslc-pr08","title":"Abstract PR08: Pro-surfactant protein B as a biomarker for lung cancer prediction.","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control","funders":"","keywords":"Lung cancer; Medicine; National Lung Screening Trial; Logistic regression; Biomarker; Internal medicine; Lung cancer screening; Cancer; Oncology; Lung","score_opus":0.1640341854560385,"score_gpt":0.5196460299657452,"score_spread":0.3556118445097066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146471206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95478857,0.014859791,0.0067892238,0.0019568268,0.00023933478,0.0005521311,0.015266755,0.00092554366,0.004621714],"genre_scores_gemma":[0.9854753,0.0011370275,0.005635972,0.00027116996,0.000090906215,0.0001691274,0.0053819437,0.000025216337,0.0018134142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877805,0.0003693479,0.00008071266,0.00022082191,0.00046884536,0.00008217195],"domain_scores_gemma":[0.99732155,0.000631939,0.00072221336,0.00012889125,0.00083082105,0.0003645572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022065255,0.000948119,0.0008207033,0.0011914535,0.00025956356,0.00073208706,0.0010791555,0.0007073919,0.0019320457],"category_scores_gemma":[0.0065260567,0.00022812204,0.000568142,0.001139573,0.00030320138,0.0003219828,0.00046879996,0.0010887126,0.0010563975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009840981,0.00035728127,0.88936734,0.0005081452,0.0010002968,0.00016035976,0.00006328591,0.0021649455,0.007348218,0.00015742678,0.006580916,0.0824508],"study_design_scores_gemma":[0.0006929016,0.0029803787,0.95792264,0.0001000837,0.0007613128,0.0010493834,0.00006331747,0.027041236,0.004560762,0.0003783616,0.004401892,0.000047678168],"about_ca_topic_score_codex":0.029445956,"about_ca_topic_score_gemma":0.02235797,"teacher_disagreement_score":0.029445956,"about_ca_system_score_codex":0.0012630329,"about_ca_system_score_gemma":0.0016587798,"threshold_uncertainty_score":0.058549106},"labels":[],"label_agreement":null},{"id":"W2146684793","doi":"10.1158/1078-0432.ccr-05-1855","title":"Anti-CD3 × Anti-Epidermal Growth Factor Receptor (EGFR) Bispecific Antibody Redirects T-Cell Cytolytic Activity to EGFR-Positive Cancers <i>In vitro</i> and in an Animal Model","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Cetuximab; Epidermal growth factor receptor; Cancer research; Pancreatic cancer; EGFR inhibitors; Monoclonal antibody; Cytotoxic T cell; Medicine; In vivo; CD3; Antibody; Cancer; Epidermal growth factor; Immunology; Receptor; Biology; Antigen; In vitro; Internal medicine; CD8","score_opus":0.1702311512438923,"score_gpt":0.505965953970119,"score_spread":0.3357348027262267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146684793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958823,0.00066025,0.0016999337,0.00004129842,0.000018400648,0.000037828053,0.000096555035,0.00009449977,0.001469022],"genre_scores_gemma":[0.99647105,0.00041592782,0.0014973672,0.000040874493,0.000013543739,0.00003353665,0.00024483705,0.000015946498,0.0012669716],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998543,0.000023156572,0.000011337392,0.000033117598,0.000034987228,0.00004305851],"domain_scores_gemma":[0.9999217,0.000017611732,0.000019650302,0.000011110015,0.000009651132,0.000020212525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014222489,0.00046290134,0.00025255317,0.00019295322,0.00010538966,0.00022718782,0.00015601062,0.00022189213,0.0009115044],"category_scores_gemma":[0.00008079317,0.00009503734,0.00023540275,0.000116747775,0.00017394737,0.00012645722,0.00009539689,0.00064857287,0.0003239577],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018409046,0.000146919,0.0001371655,0.000026787826,0.0000061235223,0.000022230945,0.0000068837717,0.00012102089,0.9979662,0.000033995813,0.000045754918,0.0013030953],"study_design_scores_gemma":[0.000041870167,0.0013310366,0.0016223689,0.0000038811395,0.000017660463,0.00019641798,0.0000048591482,0.0008581955,0.9952728,0.000009190087,0.0006399205,0.0000016940783],"about_ca_topic_score_codex":0.0006135087,"about_ca_topic_score_gemma":0.0009964478,"teacher_disagreement_score":0.0009115044,"about_ca_system_score_codex":0.00030041495,"about_ca_system_score_gemma":0.00022753356,"threshold_uncertainty_score":0.003049314},"labels":[],"label_agreement":null},{"id":"W2146913502","doi":"10.1158/1078-0432.ccr-08-1572","title":"Advancing Treatment for Metastatic Bone Cancer: Consensus Recommendations from the Second Cambridge Conference","year":2008,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Hôpital Notre-Dame","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Medicine; Clinical trial; Multidisciplinary approach; Cancer; Translational research; Bioinformatics; Pathology; Biology; Internal medicine","score_opus":0.6217175520794711,"score_gpt":0.6371576173543072,"score_spread":0.015440065274836101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146913502","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015527668,0.8709935,0.0018201451,0.1013322,0.019905007,0.00059769885,0.00031982307,0.00006097115,0.004815383],"genre_scores_gemma":[0.0011544591,0.9374439,0.007827663,0.04260131,0.0032157905,0.0008431653,0.00068008393,0.000026649706,0.006207022],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99439335,0.0018653107,0.0011055369,0.00041627357,0.0018557992,0.00036383208],"domain_scores_gemma":[0.99167246,0.0020733264,0.0009982598,0.0001638364,0.0042460086,0.0008462068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016572896,0.001977649,0.003606035,0.0052398383,0.000901439,0.0029603885,0.0050819027,0.008652092,0.007500486],"category_scores_gemma":[0.0144122625,0.0007692127,0.0037461463,0.0043024244,0.0009902961,0.003674654,0.0036079853,0.008312936,0.0048054545],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016380002,0.00013782,0.00019835698,0.022824556,0.00016966324,0.00023152969,0.00014314264,0.0005097686,0.00048060706,0.0044946983,0.48829457,0.4823515],"study_design_scores_gemma":[0.000106682615,0.000076048746,0.0005138637,0.032604497,0.00022660308,0.0003054179,0.00012451688,0.00009314434,0.0001523455,0.0028419115,0.9629209,0.000033954093],"about_ca_topic_score_codex":0.006095915,"about_ca_topic_score_gemma":0.0106827,"teacher_disagreement_score":0.016572896,"about_ca_system_score_codex":0.006494518,"about_ca_system_score_gemma":0.017584486,"threshold_uncertainty_score":0.0876469},"labels":[],"label_agreement":null},{"id":"W2146915953","doi":"10.1158/1078-0432.ccr-11-3085","title":"Reovirus as a Viable Therapeutic Option for the Treatment of Multiple Myeloma","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary; University of Alberta; Alberta Health Services","funders":"","keywords":"Multiple myeloma; Oncolytic virus; Bone marrow; Population; Ex vivo; Cancer research; Haematopoiesis; In vivo; Medicine; Stem cell; Immunology; Biology; Immune system; Cell biology","score_opus":0.26589091370456647,"score_gpt":0.5385767344523856,"score_spread":0.27268582074781916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146915953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8427404,0.12516676,0.018928852,0.0019415031,0.00054003956,0.00028417434,0.00062165764,0.00034556843,0.009431046],"genre_scores_gemma":[0.9632418,0.027046774,0.005143527,0.00019048409,0.00010128301,0.000086003776,0.0004675525,0.000023808298,0.003698793],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990034,0.000019224042,0.0000047098056,0.000016522703,0.000035942237,0.000023150153],"domain_scores_gemma":[0.99995244,0.000011782682,0.000014496567,0.000006378864,0.0000049407154,0.000010025395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022232774,0.00033300975,0.00023746496,0.00027043093,0.00013584319,0.00046940587,0.0002934159,0.00044751226,0.001536806],"category_scores_gemma":[0.000084985186,0.00008206061,0.00030069146,0.00015735657,0.00029563054,0.00023788464,0.0002124449,0.0007505682,0.0003142168],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006562759,0.00028038071,0.000654211,0.00032011874,0.00003217312,0.000237417,0.000038817183,0.00054097915,0.9623799,0.0014475351,0.00057248765,0.0328399],"study_design_scores_gemma":[0.00032584713,0.007535008,0.0042162226,0.00016473272,0.00019855745,0.0024266443,0.000082479186,0.0023417806,0.92710346,0.00077394553,0.054810833,0.000020497124],"about_ca_topic_score_codex":0.00033573847,"about_ca_topic_score_gemma":0.00059335626,"teacher_disagreement_score":0.001536806,"about_ca_system_score_codex":0.00032576986,"about_ca_system_score_gemma":0.0002596014,"threshold_uncertainty_score":0.005141139},"labels":[],"label_agreement":null},{"id":"W2146934372","doi":"10.1158/1078-0432.ovca13-a28","title":"Abstract A28: Analyses of FOXM1 isoforms in ovarian cancer","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"FOXM1; Ovarian cancer; Cancer research; Medicine; Carcinogenesis; Breast cancer; Cancer; Serous fluid; Oncology; Internal medicine; Cell cycle","score_opus":0.32849230393534345,"score_gpt":0.5638476740987607,"score_spread":0.23535537016341723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146934372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918744,0.00307879,0.0018674233,0.00007253455,0.000025182713,0.00004581953,0.0018836024,0.00003780409,0.0011143861],"genre_scores_gemma":[0.98148704,0.0022709465,0.0055203587,0.00011671928,0.000030348725,0.00013571515,0.0054518,0.000024601793,0.0049625505],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994206,0.0000043981454,0.0000049630444,0.000019410787,0.00001637899,0.000012795057],"domain_scores_gemma":[0.9999324,0.000012197651,0.000017438137,0.000006023333,0.000017353064,0.000014604192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015915406,0.00014020203,0.00014362574,0.0004886867,0.00019777137,0.00015052837,0.000090447815,0.00015083657,0.0020209998],"category_scores_gemma":[0.00015093181,0.000068831556,0.00019488596,0.00041766578,0.00011183018,0.000094197705,0.00012350605,0.00016518023,0.00037742953],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045348666,0.000027407505,0.017998202,0.00017938756,0.000022193071,0.00017762189,0.00006005024,0.000063508975,0.97177327,0.0000738025,0.00022642611,0.008944662],"study_design_scores_gemma":[0.00004011449,0.0007171489,0.40032834,0.000033406624,0.00012905152,0.0023052846,0.00022915902,0.0010838668,0.5720897,0.00020659936,0.022823926,0.000013465702],"about_ca_topic_score_codex":0.0009424261,"about_ca_topic_score_gemma":0.001006018,"teacher_disagreement_score":0.0020209998,"about_ca_system_score_codex":0.00018243113,"about_ca_system_score_gemma":0.00017159854,"threshold_uncertainty_score":0.0067608953},"labels":[],"label_agreement":null},{"id":"W2146948875","doi":"10.1158/1078-0432.ccr-08-2704","title":"The Importance of Protein Kinase A in Prostate Cancer: Relationship to Patient Outcome in Radiation Therapy Oncology Group Trial 92-02","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute","keywords":"Medicine; Prostate cancer; Proportional hazards model; Radiation therapy; Oncology; Internal medicine; Immunohistochemistry; Multivariate analysis; Cohort; Metastasis; Prostate; Cancer; Pathology","score_opus":0.3069216573441769,"score_gpt":0.576214524932824,"score_spread":0.26929286758864707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146948875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949768,0.0028001473,0.00012479197,0.00027017857,0.000038410286,0.00016689679,0.00078831054,0.000022677223,0.0008117619],"genre_scores_gemma":[0.99667776,0.0005822832,0.00020714344,0.00023397601,0.0001035937,0.00031274295,0.0014091759,0.000008236608,0.0004650183],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9991003,0.00063179404,0.000043493375,0.00010019875,0.000060931347,0.00006326572],"domain_scores_gemma":[0.998725,0.00037361018,0.0004723481,0.00010278543,0.000043745924,0.00028258166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018830955,0.00051008404,0.00092331745,0.0002069315,0.00021749568,0.00089467445,0.0005746169,0.000837143,0.0018653771],"category_scores_gemma":[0.0022674883,0.00017250938,0.00068401976,0.0004784534,0.00046613923,0.00041549891,0.00033788165,0.0009825237,0.00033585262],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71935624,0.0037972678,0.21306005,0.0011054125,0.0027319086,0.00020281132,0.00012641007,0.00246058,0.0068282215,0.00021665674,0.0028990924,0.047215283],"study_design_scores_gemma":[0.20368956,0.15230681,0.62511766,0.0002018237,0.003683213,0.00077239174,0.000117856966,0.0039502336,0.0028422985,0.0005613372,0.0066885077,0.00006823783],"about_ca_topic_score_codex":0.0007500337,"about_ca_topic_score_gemma":0.0014474487,"teacher_disagreement_score":0.0018830955,"about_ca_system_score_codex":0.00039257697,"about_ca_system_score_gemma":0.0006364672,"threshold_uncertainty_score":0.009958863},"labels":[],"label_agreement":null},{"id":"W2147132202","doi":"10.1158/1078-0432.ccr-05-0247","title":"Characterization of a Recurrent Germ Line Mutation of the <i>E-Cadherin</i> Gene: Implications for Genetic Testing and Clinical Management","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Vancouver General Hospital; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Missense mutation; Nonsense mutation; CDH1; Mutation; Family history; Breast cancer; Germline mutation; Cancer; Genetics; Medicine; Asymptomatic; Biology; Oncology; Internal medicine; Gene; Cadherin","score_opus":0.18286813188873155,"score_gpt":0.48107150095455475,"score_spread":0.29820336906582323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147132202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99935657,0.00017822218,0.0002165385,0.000024397548,0.0000013128013,0.0000037644845,0.000026011283,0.0000052154755,0.00018804544],"genre_scores_gemma":[0.9993135,0.0000814491,0.00047802497,0.000015296784,0.0000043280825,0.0000024445158,0.0000544041,0.000001896043,0.000048740927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988973,0.00001843158,0.000015250325,0.000030268417,0.000026218273,0.000020053021],"domain_scores_gemma":[0.99958104,0.00015872986,0.000119201395,0.000020860678,0.000052283685,0.00006795376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022445124,0.0002700012,0.00016526484,0.00043409824,0.00017470917,0.00018879816,0.00022357341,0.00035744192,0.0008822045],"category_scores_gemma":[0.001285478,0.0000684694,0.00009522794,0.00019857915,0.00030834659,0.00012542048,0.00014223994,0.00021679816,0.000112784575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002194886,0.000091009555,0.89855486,0.000068219124,0.000029929904,0.01574925,0.00028894382,0.00031362372,0.06469671,0.00009592543,0.00024470338,0.01964751],"study_design_scores_gemma":[0.000048127833,0.00068505586,0.829588,0.000035200803,0.00010633423,0.13811983,0.00047061156,0.0018573941,0.027375326,0.00011451304,0.0015855763,0.000014044427],"about_ca_topic_score_codex":0.0016877635,"about_ca_topic_score_gemma":0.0013620205,"teacher_disagreement_score":0.0016877635,"about_ca_system_score_codex":0.0002026217,"about_ca_system_score_gemma":0.00018133456,"threshold_uncertainty_score":0.0033558607},"labels":[],"label_agreement":null},{"id":"W2147140054","doi":"10.1158/1078-0432.ccr-04-1610","title":"Endocrine Effects of Tamoxifen Plus Exemestane in Postmenopausal Women with Breast Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Exemestane; Tamoxifen; Medicine; Breast cancer; Internal medicine; Endocrinology; Estrone; Cancer; Aromatase; Aromatase inhibitor; Estrogen; Oncology","score_opus":0.026152678972106595,"score_gpt":0.421814416130802,"score_spread":0.3956617371586954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147140054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942093,0.005091727,0.00004708882,0.00006365894,0.00001695744,0.000021311504,0.000048484802,0.000004045739,0.0004975402],"genre_scores_gemma":[0.9974778,0.0017561057,0.00021332738,0.00007867118,0.00005147587,0.00002465495,0.00008390085,0.0000013256893,0.00031263035],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998722,0.00004487378,0.0000122751,0.000015748903,0.000041660995,0.000013156531],"domain_scores_gemma":[0.99982387,0.000069549504,0.000045228076,0.000009283061,0.00001695176,0.00003524597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024570426,0.00012486202,0.00029748757,0.00017428007,0.000118019656,0.00011872828,0.00006734165,0.0001650102,0.0011660663],"category_scores_gemma":[0.00078010577,0.00007132325,0.00014191156,0.00014879023,0.000093248134,0.000072097486,0.00012770547,0.00020074847,0.00017744997],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07011977,0.0021218709,0.36673996,0.0010656528,0.0008440968,0.00300117,0.00062333385,0.0006145309,0.32288614,0.00007100494,0.00090815104,0.23100425],"study_design_scores_gemma":[0.0028410235,0.09431858,0.84312534,0.00011904642,0.0011113443,0.0077014943,0.00050978217,0.00065324095,0.03790608,0.0001070747,0.011584263,0.000022707647],"about_ca_topic_score_codex":0.00030749055,"about_ca_topic_score_gemma":0.00087801187,"teacher_disagreement_score":0.0011660663,"about_ca_system_score_codex":0.00010086038,"about_ca_system_score_gemma":0.00017794338,"threshold_uncertainty_score":0.0039008856},"labels":[],"label_agreement":null},{"id":"W2147195978","doi":"10.1158/1078-0432.ccr-09-1563","title":"Biomarkers in GIST: Partly Ready for Prime-Time Use","year":2009,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Pfizer","keywords":"GiST; Medicine; Cancer; Stromal cell; Oncology; Biomarker; Tyrosine kinase; Internal medicine; Cancer research; Biology","score_opus":0.510996129011477,"score_gpt":0.583929544555299,"score_spread":0.07293341554382204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147195978","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007757551,0.008969375,0.00037725977,0.96815467,0.020006593,0.000013843336,0.000032564978,0.000038400205,0.0016315343],"genre_scores_gemma":[0.011756605,0.017808324,0.0016072438,0.7811936,0.18172507,0.00007831164,0.00007490322,0.00003401607,0.005721941],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99742955,0.0009589879,0.000427395,0.00025778252,0.0007869511,0.00013939466],"domain_scores_gemma":[0.98841804,0.0073133092,0.0005373366,0.00036507694,0.0023949582,0.0009712632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003527935,0.0008976934,0.001651975,0.0007834369,0.0013147935,0.0023341242,0.0012026506,0.02725422,0.0025662016],"category_scores_gemma":[0.021972332,0.0004941994,0.0009966714,0.0006021796,0.0021628756,0.004949378,0.0009630559,0.020631555,0.0028479456],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020668248,0.00007781299,0.001934921,0.00022157664,0.000028094006,0.0062581534,0.00009326853,0.00020227455,0.00089329673,0.0036340924,0.9174036,0.06904615],"study_design_scores_gemma":[0.00048081396,0.0004446828,0.0036010172,0.00094267953,0.00009141618,0.02591387,0.00041545974,0.0016495765,0.0013379396,0.026020857,0.9389911,0.000110445144],"about_ca_topic_score_codex":0.00088566565,"about_ca_topic_score_gemma":0.0015608646,"teacher_disagreement_score":0.02725422,"about_ca_system_score_codex":0.002044784,"about_ca_system_score_gemma":0.0012496113,"threshold_uncertainty_score":0.018657744},"labels":[],"label_agreement":null},{"id":"W2147263959","doi":"10.1158/1078-0432.ccr-05-0844","title":"Effects of Exercise Training on Antitumor Efficacy of Doxorubicin in MDA-MB-231 Breast Cancer Xenografts","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Doxorubicin; Medicine; Breast cancer; Chemotherapy; Cancer; Adjuvant; Internal medicine; Physical exercise; Oncology","score_opus":0.1489587679016724,"score_gpt":0.500114077743414,"score_spread":0.3511553098417416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147263959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99910116,0.00044346065,0.00008191776,0.000026178841,0.000013893987,0.000013181186,0.00006603509,0.0000074861714,0.00024666276],"genre_scores_gemma":[0.9983032,0.00060125644,0.00021419853,0.000028963885,0.0000128942775,0.00004504079,0.00017046316,0.0000033268198,0.0006206886],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998816,0.000026685877,0.000008987954,0.000019463496,0.000018536279,0.000044652857],"domain_scores_gemma":[0.99986756,0.000036084002,0.00003177243,0.00001273329,0.00000828138,0.000043597487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016640253,0.0002614235,0.000323774,0.00011916872,0.000098779674,0.00013883192,0.000120611105,0.00014335143,0.0010799618],"category_scores_gemma":[0.00016666295,0.00007493271,0.00019013228,0.00008625057,0.00020549145,0.00016835424,0.00012301312,0.0005014139,0.000103777],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015173239,0.0036147581,0.001983656,0.00016003872,0.000043523763,0.0000466908,0.000052720738,0.00034401068,0.96273535,0.00005183042,0.00018389434,0.0156103205],"study_design_scores_gemma":[0.0009811965,0.1279207,0.09499421,0.000050563645,0.000195093,0.00021363645,0.00013269,0.002620252,0.7710228,0.00007543163,0.0017700059,0.000023372044],"about_ca_topic_score_codex":0.0004899727,"about_ca_topic_score_gemma":0.0012435254,"teacher_disagreement_score":0.0010799618,"about_ca_system_score_codex":0.00014099167,"about_ca_system_score_gemma":0.00018801923,"threshold_uncertainty_score":0.003612876},"labels":[],"label_agreement":null},{"id":"W2147383407","doi":"10.1158/1078-0432.ccr-06-2974","title":"Akt/cAMP-Responsive Element Binding Protein/Cyclin D1 Network: A Novel Target for Prostate Cancer Inhibition in Transgenic Adenocarcinoma of Mouse Prostate Model Mediated by Nexrutine, a <i>Phellodendron Amurense</i> Bark Extract","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Synthesis and Biological Activity","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; U.S. Public Health Service; National Institutes of Health; Thomas Jefferson University","keywords":"Tramp; CREB; Prostate cancer; Protein kinase B; Cyclin D1; Cancer research; Prostate; PI3K/AKT/mTOR pathway; LNCaP; Cancer; Phosphorylation; Genetically modified mouse; Medicine; Transgene; Signal transduction; Endocrinology; Internal medicine; Biology; Cell cycle; Cell biology; Transcription factor; Biochemistry","score_opus":0.0986099828606956,"score_gpt":0.41832673369566714,"score_spread":0.31971675083497153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147383407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98956966,0.0028627752,0.004648789,0.00026236454,0.000053761338,0.000074385964,0.00049250195,0.00024911345,0.0017866122],"genre_scores_gemma":[0.9912397,0.0020078374,0.0033962876,0.00007837267,0.000010495873,0.0001144674,0.00056730607,0.000017709717,0.002567768],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999505,0.0000054147504,0.0000028792838,0.000014104673,0.000013656345,0.000013438508],"domain_scores_gemma":[0.99997365,0.0000016773879,0.000011043702,0.0000021561887,0.0000024882631,0.000008959264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000079408754,0.00035890305,0.00029846167,0.0002796793,0.0001497497,0.00016179723,0.00020448117,0.0001922638,0.001286806],"category_scores_gemma":[0.00003579126,0.00012429302,0.00025656674,0.00014419976,0.00019829876,0.00020776202,0.00012241925,0.00056695053,0.00018019906],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024975944,0.00007074222,0.00013236645,0.000071651506,0.0000067283695,0.000039474515,0.000008515984,0.0000632276,0.9977568,0.00007745086,0.000054533095,0.00146876],"study_design_scores_gemma":[0.00011463252,0.0011105646,0.005120662,0.000014503552,0.00005392291,0.00034304315,0.00003636948,0.0014843085,0.9880078,0.000102499806,0.0036054219,0.0000062621293],"about_ca_topic_score_codex":0.00040372857,"about_ca_topic_score_gemma":0.00088997954,"teacher_disagreement_score":0.001286806,"about_ca_system_score_codex":0.00027139203,"about_ca_system_score_gemma":0.0002074305,"threshold_uncertainty_score":0.0043047667},"labels":[],"label_agreement":null},{"id":"W2147445587","doi":"10.1158/1078-0432.ccr-06-1599","title":"The Tyrosine Kinase Inhibitor Imatinib Mesylate Enhances the Efficacy of Photodynamic Therapy by Inhibiting ABCG2","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Cheng Kung University Hospital","keywords":"Photosensitizer; Imatinib mesylate; Photodynamic therapy; Abcg2; In vivo; Pharmacology; Chemistry; Tyrosine-kinase inhibitor; Cancer research; Tyrosine kinase; Imatinib; Medicine; Cancer; Biochemistry; Biology; Internal medicine; Receptor; ATP-binding cassette transporter; Transporter","score_opus":0.09949047583321888,"score_gpt":0.5060864885694308,"score_spread":0.40659601273621193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147445587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99585766,0.0019457747,0.000857907,0.00008612282,0.000011376015,0.000019505576,0.000116793184,0.000053471507,0.0010514294],"genre_scores_gemma":[0.9981945,0.0005235237,0.0005976881,0.000020755613,0.00000482619,0.000010270943,0.00010939218,0.000005471675,0.0005335558],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999928,0.000016994321,0.000006310854,0.000012655862,0.0000203376,0.000015670304],"domain_scores_gemma":[0.9999646,0.000011442512,0.000010419936,0.0000037878194,0.0000035224095,0.0000062214945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000125707,0.00018093475,0.00020607165,0.00010817018,0.00006493844,0.00016394735,0.0000952422,0.00013225696,0.0014872397],"category_scores_gemma":[0.000095515235,0.00005418634,0.000100326746,0.00008572612,0.000098975135,0.0001577914,0.0000966649,0.00025063107,0.0001830024],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016627093,0.000029600305,0.00019019257,0.0000309732,0.000004355856,0.000012049015,0.0000037260168,0.00008678476,0.9967314,0.00003844849,0.000051695188,0.0026544936],"study_design_scores_gemma":[0.00003132278,0.000637051,0.0041884207,0.0000027508597,0.00001396802,0.00017840095,0.0000045120746,0.0007347,0.9925695,0.00001756573,0.001620121,0.0000016932272],"about_ca_topic_score_codex":0.00025137703,"about_ca_topic_score_gemma":0.00039911948,"teacher_disagreement_score":0.0014872397,"about_ca_system_score_codex":0.0001802544,"about_ca_system_score_gemma":0.00011060728,"threshold_uncertainty_score":0.0049752593},"labels":[],"label_agreement":null},{"id":"W2147619880","doi":"10.1158/1078-0432.ccr-10-1382","title":"Tumor Growth Inhibition by Olaparib in <i>BRCA2</i> Germline-Mutated Patient-Derived Ovarian Cancer Tissue Xenografts","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Olaparib; PARP inhibitor; Ovarian cancer; Synthetic lethality; Cancer research; Carboplatin; BRCA mutation; Medicine; Cancer; Serous fluid; Serous carcinoma; In vivo; DNA repair; Biology; Internal medicine; Poly ADP ribose polymerase; Chemotherapy; Cisplatin; DNA; Genetics","score_opus":0.10164309985967723,"score_gpt":0.49531777570483054,"score_spread":0.3936746758451533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147619880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962191,0.0009262692,0.0011540581,0.000058470487,0.000017328934,0.00004720557,0.0005062306,0.00007262072,0.0009987246],"genre_scores_gemma":[0.99580187,0.00062762573,0.0017620128,0.0000307098,0.0000068036343,0.00005250209,0.0010084858,0.00002004425,0.00068989047],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990857,0.000025419688,0.0000112896905,0.000016968177,0.000021651114,0.000016037013],"domain_scores_gemma":[0.99988425,0.000040212384,0.00002150639,0.000020964986,0.000009437015,0.000023701226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016659558,0.00030945125,0.00028076666,0.00017022295,0.00010829651,0.00021976451,0.00018751793,0.00018058985,0.000905324],"category_scores_gemma":[0.0001373168,0.00009113864,0.00018568446,0.00016139784,0.00011393786,0.00015693148,0.00010915422,0.00050081493,0.00026203314],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057774177,0.0003164051,0.0010321154,0.000064784836,0.000011946527,0.00017223904,0.000028240896,0.00040921033,0.9936893,0.00010164992,0.00018993713,0.0034063612],"study_design_scores_gemma":[0.00015935965,0.0034697205,0.00905593,0.000009256448,0.00003391213,0.0019154537,0.00003276098,0.0030531953,0.9787829,0.000047659178,0.0034340294,0.000005774639],"about_ca_topic_score_codex":0.0003894934,"about_ca_topic_score_gemma":0.00047442425,"teacher_disagreement_score":0.000905324,"about_ca_system_score_codex":0.00021118086,"about_ca_system_score_gemma":0.0001905768,"threshold_uncertainty_score":0.0030286312},"labels":[],"label_agreement":null},{"id":"W2147621051","doi":"10.1158/1078-0432.ccr-11-2181","title":"Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced Malignancies","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":187,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada); Institute of Cancer Research","funders":"National Cancer Institute; Cancer Research UK","keywords":"Oncolytic virus; Carboplatin; Paclitaxel; Medicine; Chemotherapy; Oncology; Internal medicine; Cancer; Cisplatin","score_opus":0.06457057541320321,"score_gpt":0.4478147690360461,"score_spread":0.3832441936228429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147621051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98947746,0.0027125385,0.0007390752,0.0005653354,0.00015021696,0.0032101881,0.0006256755,0.00012827777,0.0023911854],"genre_scores_gemma":[0.9876709,0.0017756672,0.0024760296,0.000803398,0.00017432435,0.0030637197,0.0017694582,0.000034715365,0.00223174],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996573,0.00015210234,0.000018236073,0.00006876318,0.000031259013,0.000072445895],"domain_scores_gemma":[0.999403,0.00009418868,0.000113758084,0.000061329505,0.000025523577,0.00030219526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011108557,0.0016566213,0.0023673186,0.00042683646,0.00045225592,0.0010786657,0.00096988224,0.0012719557,0.002936479],"category_scores_gemma":[0.00069554924,0.00051373313,0.0010488109,0.00062032323,0.0011312901,0.00063928554,0.00034693148,0.0036380794,0.0006808391],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.69672155,0.07979519,0.010660615,0.00095745,0.0014321025,0.00045156182,0.00041584158,0.004749687,0.058385197,0.00059600873,0.005112881,0.140722],"study_design_scores_gemma":[0.6261614,0.3532859,0.008348415,0.00004647798,0.00036003243,0.00038209563,0.000059506197,0.0018853846,0.0060750116,0.00023784324,0.0031357894,0.000022158829],"about_ca_topic_score_codex":0.0010396611,"about_ca_topic_score_gemma":0.0020589542,"teacher_disagreement_score":0.002936479,"about_ca_system_score_codex":0.0010809241,"about_ca_system_score_gemma":0.0017156736,"threshold_uncertainty_score":0.009823501},"labels":[],"label_agreement":null},{"id":"W2147660153","doi":"10.1158/1078-0432.ccr-07-5194","title":"Characterization of <i>TMPRSS2-ERG</i> Fusion High-Grade Prostatic Intraepithelial Neoplasia and Potential Clinical Implications","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; National Institute on Aging","keywords":"TMPRSS2; Prostate cancer; Intraepithelial neoplasia; High-grade prostatic intraepithelial neoplasia; Erg; Prostate; Fusion gene; Medicine; Cancer; PCA3; Oncology; Internal medicine; Disease; Biology; Gene; Ophthalmology","score_opus":0.16540031438320849,"score_gpt":0.48039530901470073,"score_spread":0.3149949946314923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147660153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989083,0.00037068268,0.00027115148,0.000018906861,0.000002455129,0.000015140543,0.00007561959,0.000007965215,0.00032974078],"genre_scores_gemma":[0.99934775,0.00008303344,0.00031623556,0.000013997388,0.0000044013286,0.0000058637806,0.00016370248,0.0000013017861,0.000063583844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999721,0.000044372875,0.00003041846,0.000060392416,0.000092544185,0.000051185747],"domain_scores_gemma":[0.9995105,0.000085080115,0.00017580925,0.00003757799,0.00008210261,0.00010881591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048172436,0.00019376313,0.00015922831,0.0007925082,0.00024781012,0.00046933047,0.00025342806,0.00044692654,0.0006975124],"category_scores_gemma":[0.0007391259,0.00011356224,0.0001358923,0.00046519487,0.000419312,0.00025246458,0.00022676233,0.00023351784,0.00017731129],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049379416,0.00015885246,0.7404,0.0001454951,0.00004033777,0.0032084107,0.0001897167,0.00026260596,0.2480724,0.00016836058,0.00013956438,0.0067205327],"study_design_scores_gemma":[0.000013444578,0.0007172815,0.93136644,0.0000110775545,0.000041232674,0.022263011,0.00042916535,0.0008867197,0.04292229,0.00011656788,0.0012234554,0.000009382633],"about_ca_topic_score_codex":0.00078123464,"about_ca_topic_score_gemma":0.0010787603,"teacher_disagreement_score":0.0007925082,"about_ca_system_score_codex":0.00030883114,"about_ca_system_score_gemma":0.00026738874,"threshold_uncertainty_score":0.0025476217},"labels":[],"label_agreement":null},{"id":"W2147711165","doi":"10.1158/1078-0432.ccr-07-2028","title":"Prognostic Significance of Cyclooxygenase-2 Overexpression in Glottic Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Chicoutimi; Hôpital Fleurimont; Centre Hospitalier Universitaire de Sherbrooke; Hôtel-Dieu de Québec; Centre Hospitalier de l’Université de Montréal; Université Laval; Hôpital Notre-Dame; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Proportional hazards model; Hazard ratio; Cancer; Internal medicine; Oncology; Cyclooxygenase; Head and neck cancer; Confidence interval; Gastroenterology","score_opus":0.2442396820770942,"score_gpt":0.5209343141086445,"score_spread":0.2766946320315503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147711165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954294,0.0041056992,0.00013427026,0.00006231994,0.000008602911,0.000013201481,0.00007577377,0.0000031118957,0.00016765515],"genre_scores_gemma":[0.9994326,0.0003578124,0.00007009924,0.000014029181,0.000014152962,0.000007053912,0.00006297315,5.0181006e-7,0.000040747025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966824,0.00015487488,0.000022335666,0.0000516273,0.00006565105,0.00003728102],"domain_scores_gemma":[0.99837166,0.00063832186,0.00066177675,0.00007974253,0.00008117817,0.000167384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012837914,0.00018059829,0.00037006894,0.00019472475,0.00013624741,0.00023169546,0.00015390145,0.00028046328,0.001129082],"category_scores_gemma":[0.002138315,0.00010060371,0.00030352618,0.000227796,0.00036274357,0.0001868848,0.0001743454,0.00036571533,0.00008924707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010641511,0.00012075299,0.96741986,0.00017774745,0.00017164538,0.00019063936,0.000030222696,0.00033002757,0.007575759,0.000030526506,0.00010615232,0.013205215],"study_design_scores_gemma":[0.00025470357,0.0020379752,0.9943176,0.000022944952,0.00021126645,0.0006682799,0.000032170305,0.00040209666,0.0016603841,0.000054362852,0.00033243155,0.000005767213],"about_ca_topic_score_codex":0.00040381515,"about_ca_topic_score_gemma":0.00060645735,"teacher_disagreement_score":0.0012837914,"about_ca_system_score_codex":0.0002938322,"about_ca_system_score_gemma":0.0003663087,"threshold_uncertainty_score":0.006789446},"labels":[],"label_agreement":null},{"id":"W2147909933","doi":"10.1158/1078-0432.ccr-07-0268","title":"Potential Applications for Circulating Tumor Cells Expressing the Insulin-Like Growth Factor-I Receptor","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Circulating tumor cell; Prostate cancer; Medicine; Docetaxel; Antibody; Internal medicine; Prostate; Cancer; Chemotherapy; Prostate-specific antigen; Biomarker; Oncology; Antigen; Cancer research; Immunology; Biology; Metastasis","score_opus":0.15877099046722987,"score_gpt":0.4711906642311944,"score_spread":0.3124196737639645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147909933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88996464,0.01990185,0.0807646,0.0009977748,0.00020323017,0.00061278464,0.000588269,0.0008684655,0.006098356],"genre_scores_gemma":[0.9430438,0.0025568441,0.050766356,0.00035684882,0.00006661351,0.00026624755,0.00051207596,0.000028704291,0.0024023955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997496,0.0000712029,0.000009645054,0.000058754635,0.00008442548,0.00002642169],"domain_scores_gemma":[0.999723,0.000121307035,0.000038069014,0.00002173294,0.00005449958,0.00004144698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050964934,0.00040372397,0.00028552065,0.0003299743,0.00013462757,0.000543536,0.0003398761,0.00045961884,0.0022316247],"category_scores_gemma":[0.00068755035,0.00014992528,0.00022047851,0.0002281057,0.00023281264,0.00017816068,0.00017563015,0.00042865792,0.0004382494],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001039423,0.00017527405,0.00854293,0.00026654146,0.000018080276,0.00015877926,0.000045111396,0.00048848416,0.91440773,0.0003227436,0.0004642819,0.07407076],"study_design_scores_gemma":[0.00051725336,0.0053265966,0.039866466,0.000060618167,0.00019016459,0.002569549,0.00006609864,0.014069566,0.92130184,0.00042623925,0.015579315,0.000026273025],"about_ca_topic_score_codex":0.000868283,"about_ca_topic_score_gemma":0.001292626,"teacher_disagreement_score":0.0022316247,"about_ca_system_score_codex":0.0005453416,"about_ca_system_score_gemma":0.000391359,"threshold_uncertainty_score":0.0074655414},"labels":[],"label_agreement":null},{"id":"W2148021011","doi":"10.1158/1078-0432.ccr-12-1384","title":"Publication and Reporting Conduct for Pharmacodynamic Analyses of Tumor Tissue in Early-Phase Oncology Trials","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Clinical trial; Cancer; Pharmacodynamics; Internal medicine; Oncology; Family medicine; Pharmacokinetics","score_opus":0.9837610538107621,"score_gpt":0.8569733973284804,"score_spread":0.12678765648228163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148021011","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28173283,0.046274517,0.36779654,0.0639528,0.012559663,0.15587765,0.027197417,0.0027072052,0.041901376],"genre_scores_gemma":[0.6716216,0.0065166103,0.19804633,0.009120547,0.003422197,0.10289847,0.0053792377,0.00041347436,0.0025814294],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.07082386,0.596319,0.2565835,0.009991254,0.06394566,0.0023366776],"domain_scores_gemma":[0.011876683,0.60274136,0.26322562,0.07027343,0.0498905,0.0019924399],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.7790341,0.00212142,0.0032813936,0.019721763,0.004214377,0.011291369,0.004831129,0.004434142,0.0063498365],"category_scores_gemma":[0.9083164,0.0019118523,0.0054465802,0.026834052,0.0064113652,0.010505451,0.006770431,0.004926667,0.0020396449],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009962116,0.0009828304,0.5092354,0.048836462,0.005833102,0.0007929732,0.017080761,0.0023564089,0.0028667606,0.013327935,0.036684163,0.35204113],"study_design_scores_gemma":[0.007023692,0.009275696,0.59857285,0.05824569,0.009814631,0.0036720654,0.013974116,0.027211642,0.025930965,0.045212686,0.19978955,0.0012764467],"about_ca_topic_score_codex":0.0016362414,"about_ca_topic_score_gemma":0.0019232534,"teacher_disagreement_score":0.22096592,"about_ca_system_score_codex":0.010110998,"about_ca_system_score_gemma":0.038501542,"threshold_uncertainty_score":0.27249038},"labels":[],"label_agreement":null},{"id":"W2148168351","doi":"10.1158/1078-0432.ccr-09-2878","title":"Patient-Derived First Generation Xenografts of Non–Small Cell Lung Cancers: Promising Tools for Predicting Drug Responses for Personalized Chemotherapy","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":195,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency; Genome Canada","keywords":"Vinorelbine; Medicine; Gemcitabine; Cisplatin; Docetaxel; Chemotherapy; Oncology; Lung cancer; Regimen; Internal medicine; Cancer; Chemotherapy regimen; Metastasis","score_opus":0.12519461811814736,"score_gpt":0.4642212352664629,"score_spread":0.33902661714831556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148168351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904385,0.0016264633,0.0065165926,0.000073083014,0.000015967249,0.00010417597,0.0005260158,0.00010100365,0.0005982212],"genre_scores_gemma":[0.98637915,0.0009903902,0.01059062,0.000032447697,0.000009687958,0.0000635803,0.0013097947,0.000014981395,0.00060947426],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998747,0.00003218356,0.000008592647,0.00002226477,0.000044511307,0.000017818496],"domain_scores_gemma":[0.9997124,0.00008837056,0.00007628189,0.000040386592,0.00002784219,0.000054710687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044651685,0.0002594616,0.0003296165,0.00016631164,0.000079406556,0.00032918848,0.00016887306,0.00020328563,0.0009996417],"category_scores_gemma":[0.00040283607,0.00015536367,0.00017074819,0.00016057551,0.00016313506,0.00024476057,0.00014251622,0.00066793576,0.0003220577],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009428956,0.00029566628,0.020376852,0.00008152065,0.000029879548,0.00012693524,0.000058234244,0.0009758778,0.9667322,0.00014645548,0.00027598368,0.009957529],"study_design_scores_gemma":[0.00021039079,0.0066835,0.10677043,0.0000293432,0.00015743934,0.0028231023,0.0001141741,0.0148609,0.86147815,0.00015721352,0.0066843606,0.00003095638],"about_ca_topic_score_codex":0.00035835363,"about_ca_topic_score_gemma":0.00059762463,"teacher_disagreement_score":0.0009996417,"about_ca_system_score_codex":0.00019357073,"about_ca_system_score_gemma":0.00016641189,"threshold_uncertainty_score":0.0033441186},"labels":[],"label_agreement":null},{"id":"W2148172443","doi":"10.1158/1078-0432.ccr-06-0133","title":"Expression of Stress Response Protein Grp78 Is Associated with the Development of Castration-Resistant Prostate Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"National Cancer Institute","keywords":"LNCaP; Prostate cancer; Castration; Androgen; Medicine; Prostate; Cancer research; Immunohistochemistry; Cancer; Internal medicine; Oncology; Hormone","score_opus":0.09347425136553072,"score_gpt":0.45420048140919006,"score_spread":0.36072623004365933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148172443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99850297,0.00080552883,0.000233688,0.000022785365,0.000004131127,0.000007861889,0.000119175995,0.000023359316,0.0002805647],"genre_scores_gemma":[0.99929905,0.00018765108,0.0001304284,0.000009031051,0.0000047500926,0.0000045494116,0.00018800235,0.000002968441,0.00017352834],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99992025,0.00000949938,0.0000049769606,0.000019023915,0.000029639552,0.000016528737],"domain_scores_gemma":[0.9996649,0.000018757652,0.00016961883,0.000020379654,0.00003403076,0.00009231854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009839404,0.0001955186,0.00020799374,0.00041200753,0.00018120304,0.0002048158,0.00016155027,0.0001592971,0.0011872042],"category_scores_gemma":[0.00015658872,0.00009557782,0.00020004227,0.0002952027,0.00023233057,0.00007415356,0.0001343398,0.00035838078,0.00017955244],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014751331,0.00013388788,0.16567087,0.00012146693,0.00009785922,0.0007822603,0.000092838054,0.0001130663,0.8258622,0.00006572138,0.00029420172,0.005290406],"study_design_scores_gemma":[0.000013973173,0.0004797611,0.9650129,0.0000038608823,0.000044811994,0.0030036601,0.00004363043,0.00025013415,0.030525628,0.000039912757,0.000575821,0.000006022914],"about_ca_topic_score_codex":0.00064884673,"about_ca_topic_score_gemma":0.0005474044,"teacher_disagreement_score":0.0011872042,"about_ca_system_score_codex":0.00019818686,"about_ca_system_score_gemma":0.00014349133,"threshold_uncertainty_score":0.0039715767},"labels":[],"label_agreement":null},{"id":"W2148543405","doi":"10.1158/1078-0432.ccr-09-1634","title":"Anti–Transforming Growth Factor β Receptor II Antibody Has Therapeutic Efficacy against Primary Tumor Growth and Metastasis through Multieffects on Cancer, Stroma, and Immune Cells","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Metastasis; Cancer research; Transforming growth factor; Antibody; Immune system; Tumor microenvironment; Cancer cell; Cancer; Primary tumor; Medicine; Cytokine; Immunology; Biology; Internal medicine","score_opus":0.08819860391322959,"score_gpt":0.4358811532673409,"score_spread":0.3476825493541113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148543405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98577994,0.008141083,0.0029210015,0.00015097835,0.000087883585,0.00009865453,0.00013140388,0.00014780422,0.0025411583],"genre_scores_gemma":[0.9905985,0.004065654,0.0023841225,0.000079519494,0.000077121316,0.00008072038,0.0003588351,0.000016976579,0.0023384911],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985564,0.000026799898,0.000009619583,0.000023371585,0.000042377706,0.000042072865],"domain_scores_gemma":[0.9998833,0.000019682931,0.000034733977,0.000013500417,0.000018602788,0.00003025059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020794118,0.0005628585,0.00046413625,0.00025520002,0.0000922344,0.00021599719,0.00021324692,0.00019380637,0.0013398846],"category_scores_gemma":[0.00010198739,0.000126243,0.00028773278,0.00013879579,0.0001912808,0.00013524105,0.00008067262,0.00073315494,0.000346948],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027686954,0.00026865,0.00022183049,0.000076470744,0.000015887617,0.000040118717,0.00000679388,0.00007256058,0.99383754,0.000055518427,0.000064199645,0.0050635724],"study_design_scores_gemma":[0.00013283745,0.004951931,0.0029665069,0.000008519862,0.00007837746,0.0003549775,0.000007508756,0.0005514906,0.98849165,0.000017097453,0.00243668,0.0000024432495],"about_ca_topic_score_codex":0.0003730644,"about_ca_topic_score_gemma":0.00071069243,"teacher_disagreement_score":0.0013398846,"about_ca_system_score_codex":0.00027355365,"about_ca_system_score_gemma":0.0003132268,"threshold_uncertainty_score":0.004482329},"labels":[],"label_agreement":null},{"id":"W2148833625","doi":"10.1158/1078-0432.ccr-06-0654","title":"Multistate Analysis of Skeletal Events in Patients with Bone Metastases","year":2006,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Waterloo","funders":"","keywords":"Medicine; Intensive care medicine; Disease; Clinical trial; Cancer; Pathology; Internal medicine","score_opus":0.30327506354956807,"score_gpt":0.6032553946682392,"score_spread":0.2999803311186711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148833625","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020602685,0.9878225,0.008129449,0.00073528773,0.0001002329,0.0000156747,0.00011435184,0.000024324538,0.0009979735],"genre_scores_gemma":[0.02794782,0.96565896,0.0052709654,0.0001575115,0.0001570618,0.000031713666,0.00017938082,0.0000052118403,0.000591378],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9995177,0.00022012685,0.000048365786,0.000085717926,0.000114170245,0.000013922943],"domain_scores_gemma":[0.998825,0.0008455347,0.00018108299,0.00003510581,0.00009510587,0.000018046157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013605095,0.0005786455,0.0015020166,0.0015245401,0.00011996327,0.0007358708,0.00086472684,0.0007396586,0.0009269379],"category_scores_gemma":[0.0026978473,0.00024526913,0.0011177165,0.0021000148,0.00040331983,0.00059590413,0.00036636787,0.0008720472,0.00036313888],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015844416,0.00008673896,0.0068851328,0.0059151,0.00080309255,0.0001383863,0.00008134846,0.014702683,0.00057839736,0.0069303145,0.0057257055,0.9579947],"study_design_scores_gemma":[0.0002770671,0.0014929689,0.12724584,0.015680548,0.0048531285,0.010301089,0.00069120247,0.09973712,0.0048014666,0.15832919,0.57612664,0.00046380254],"about_ca_topic_score_codex":0.0033118986,"about_ca_topic_score_gemma":0.0043755155,"teacher_disagreement_score":0.0033118986,"about_ca_system_score_codex":0.0006171907,"about_ca_system_score_gemma":0.00091031316,"threshold_uncertainty_score":0.007195115},"labels":[],"label_agreement":null},{"id":"W2149055857","doi":"10.1158/1078-0432.ccr-14-0624","title":"On-Target Effect of FK866, a Nicotinamide Phosphoribosyl Transferase Inhibitor, by Apoptosis-Mediated Death in Chronic Lymphocytic Leukemia Cells","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Biochemical and Molecular Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba; Research Manitoba","funders":"","keywords":"Nicotinamide phosphoribosyltransferase; Biology; CD38; Chronic lymphocytic leukemia; Fludarabine; NAD+ kinase; Apoptosis; Cancer research; Programmed cell death; Viability assay; Cell biology; Leukemia; Biochemistry; Immunology; Stem cell; CD34; Enzyme; Chemotherapy","score_opus":0.026536041997663917,"score_gpt":0.39104190058066257,"score_spread":0.36450585858299867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149055857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959621,0.001992393,0.0007953548,0.00003865929,0.000017465369,0.000023790148,0.00022919393,0.000040388746,0.0009007734],"genre_scores_gemma":[0.99737036,0.0007197761,0.0005198118,0.000029260194,0.0000060416614,0.000022633674,0.0003496029,0.000004447286,0.0009780648],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991226,0.000014460458,0.00000910904,0.000018538365,0.000022974806,0.00002266091],"domain_scores_gemma":[0.9999597,0.000006276751,0.000010836352,0.000007828234,0.0000068103673,0.000008596444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007117228,0.00028950485,0.00036251853,0.00010704188,0.00013253558,0.00019257404,0.0001310293,0.00013962622,0.0010833519],"category_scores_gemma":[0.000061874176,0.00005270638,0.00019306657,0.00010749728,0.00012387488,0.00009676044,0.00010322361,0.00030890974,0.00027041676],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067938596,0.00014488363,0.0008360121,0.00008376061,0.000010999404,0.00006758965,0.000021143855,0.00014979669,0.99196905,0.000035974317,0.00008610504,0.0059152953],"study_design_scores_gemma":[0.0000582403,0.0026266337,0.01023672,0.000008693091,0.000028508006,0.00052503427,0.00002790515,0.00078380835,0.98317426,0.00002231735,0.0025039888,0.0000038809817],"about_ca_topic_score_codex":0.0006672404,"about_ca_topic_score_gemma":0.0011917095,"teacher_disagreement_score":0.0010833519,"about_ca_system_score_codex":0.0002798575,"about_ca_system_score_gemma":0.00015102552,"threshold_uncertainty_score":0.0036241412},"labels":[],"label_agreement":null},{"id":"W2149134506","doi":"10.1158/1078-0432.ccr-03-0783","title":"Biomarkers, Surrogate End Points, and the Acceleration of Drug Development for Cancer Prevention and Treatment","year":2004,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Drug development; Clinical trial; Surrogate endpoint; Cancer; Cancer drugs; Clinical endpoint; Intensive care medicine; Drug; Clinical Oncology; Oncology; Internal medicine; Pharmacology","score_opus":0.8866212378948998,"score_gpt":0.7355782408196071,"score_spread":0.15104299707529267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149134506","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014554609,0.5398954,0.25638866,0.13793261,0.008056417,0.0025413954,0.0029774227,0.0009447937,0.036708627],"genre_scores_gemma":[0.27352646,0.34055096,0.31629863,0.040854637,0.016802339,0.0041208453,0.0021731383,0.00034749677,0.0053254613],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.91642016,0.06621933,0.0040176217,0.002505918,0.01026746,0.000569441],"domain_scores_gemma":[0.78784174,0.16011955,0.024932312,0.007534713,0.016094796,0.0034768162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.12197667,0.0018956736,0.0034229723,0.0036101404,0.0006615036,0.0064319596,0.0019163678,0.0039482224,0.0070625814],"category_scores_gemma":[0.14653888,0.00061363535,0.0012413356,0.0037492479,0.0038713322,0.007200415,0.0039058416,0.00695981,0.0018295158],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003827655,0.0006493204,0.016500708,0.005541322,0.00062210107,0.00019552573,0.00026654615,0.010197049,0.0014726964,0.1974265,0.03737476,0.7259258],"study_design_scores_gemma":[0.002460584,0.0126944855,0.027848143,0.013873824,0.0012656315,0.001384429,0.00037703593,0.033100035,0.009542486,0.38033193,0.51665634,0.00046501946],"about_ca_topic_score_codex":0.0010758471,"about_ca_topic_score_gemma":0.00074050523,"teacher_disagreement_score":0.12197667,"about_ca_system_score_codex":0.0042560133,"about_ca_system_score_gemma":0.007674204,"threshold_uncertainty_score":0.645082},"labels":[],"label_agreement":null},{"id":"W2149167468","doi":"10.1158/1078-0432.ccr-06-2224","title":"Validation and Characterization of Human Kallikrein 11 as a Serum Marker for Diagnosis of Ovarian Carcinoma","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Ovarian cancer; Tumor marker; Kallikrein; Biomarker; Ovarian carcinoma; Internal medicine; Cancer; Medicine; Oncology; Ovarian tumor; Pathology; Biology","score_opus":0.18694433161032287,"score_gpt":0.5010333615223433,"score_spread":0.3140890299120205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149167468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927182,0.00058271014,0.0057603065,0.000040091418,0.000021737187,0.00012380454,0.00028470546,0.000026741534,0.00044168142],"genre_scores_gemma":[0.9942696,0.000103956154,0.0047806036,0.000031268773,0.000011623472,0.00006033425,0.0005146537,0.000005863709,0.00022216495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971733,0.0009954615,0.00026018484,0.0005002228,0.0009626716,0.000108134496],"domain_scores_gemma":[0.996194,0.0013274417,0.0005908981,0.0005692342,0.0010679138,0.00025037458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004843844,0.0003982281,0.00032904226,0.00089674024,0.0002891884,0.00069696293,0.00035162512,0.00036342393,0.0004627648],"category_scores_gemma":[0.006784859,0.00017648327,0.00024694405,0.00046720557,0.0007187075,0.00022979267,0.00037732846,0.0003747949,0.0002039356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035765085,0.0006345646,0.5704858,0.00021804788,0.00024538892,0.00018440615,0.000371254,0.0015154827,0.39526057,0.0002385252,0.00033166184,0.026937751],"study_design_scores_gemma":[0.00013119577,0.0034715582,0.642413,0.000030114166,0.00027493245,0.0017443361,0.00020424133,0.011575443,0.3365354,0.00014697673,0.0034334848,0.000039324517],"about_ca_topic_score_codex":0.0014225345,"about_ca_topic_score_gemma":0.0009938248,"teacher_disagreement_score":0.004843844,"about_ca_system_score_codex":0.00035406032,"about_ca_system_score_gemma":0.0006017439,"threshold_uncertainty_score":0.025617003},"labels":[],"label_agreement":null},{"id":"W2149286249","doi":"10.1158/1078-0432.ccr-06-1165","title":"A Phase I Pharmacokinetic and Pharmacodynamic Study of Intravenous Calcitriol in Combination with Oral Gefitinib in Patients with Advanced Solid Tumors","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Calcitriol; Gefitinib; Medicine; Pharmacology; Pharmacokinetics; Pharmacodynamics; Epidermal growth factor receptor; Tyrosine-kinase inhibitor; Vandetanib; Protein kinase B; Internal medicine; Dosing; Endocrinology; Tyrosine kinase; Cancer; Chemistry; Receptor; Signal transduction; Vitamin D and neurology","score_opus":0.060167436873666776,"score_gpt":0.480103932089061,"score_spread":0.4199364952153942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149286249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996278,0.0010520066,0.00063183066,0.00017694537,0.000041430398,0.0009786343,0.00018816882,0.000059250735,0.00059370673],"genre_scores_gemma":[0.99582124,0.00051291747,0.0014406337,0.00017858301,0.00009357139,0.0009206094,0.00042687252,0.000017990275,0.00058752013],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992804,0.00031673518,0.000033577326,0.00013207605,0.00011437437,0.00012292012],"domain_scores_gemma":[0.9991073,0.00016173336,0.0002268277,0.00007492464,0.00005120377,0.00037803012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013041147,0.0015189121,0.0027243076,0.00047078333,0.0005629368,0.0010513759,0.0007624657,0.0010838881,0.0013477254],"category_scores_gemma":[0.0011695353,0.00068137335,0.0011613811,0.00047647548,0.0012997251,0.0007433196,0.0002991642,0.002994211,0.0004554307],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5034551,0.11785102,0.025414228,0.0007854079,0.0017984982,0.001117008,0.0007628324,0.008474469,0.18821318,0.00040473946,0.0029958966,0.14872761],"study_design_scores_gemma":[0.21597688,0.7403912,0.022393543,0.000025294916,0.00050246,0.0009784815,0.00009713711,0.0032655734,0.013578834,0.0001769691,0.0025596751,0.00005401166],"about_ca_topic_score_codex":0.00088633253,"about_ca_topic_score_gemma":0.0014523462,"teacher_disagreement_score":0.0027243076,"about_ca_system_score_codex":0.0012467526,"about_ca_system_score_gemma":0.001793862,"threshold_uncertainty_score":0.009045839},"labels":[],"label_agreement":null},{"id":"W2149823386","doi":"10.1158/1078-0432.ccr-06-1213","title":"Advances in Treating Metastatic Bone Cancer: Summary Statement for the First Cambridge Conference","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Cancer Institute","keywords":"Statement (logic); Medicine; Bone cancer; Cancer; Multiple myeloma; Natural history; Library science; Internal medicine; Computer science; Philosophy","score_opus":0.29910109682118047,"score_gpt":0.5782517255290097,"score_spread":0.27915062870782925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149823386","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009430026,0.49821278,0.0006396284,0.22542524,0.25031567,0.00049121253,0.00042746574,0.00008249394,0.023462506],"genre_scores_gemma":[0.010011145,0.5593597,0.0025664875,0.11911702,0.18637112,0.0008904194,0.0015085918,0.000101221274,0.12007434],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99820554,0.00030538382,0.00021440523,0.00014478069,0.00080731395,0.000322649],"domain_scores_gemma":[0.9950559,0.00042532646,0.00030123082,0.00007691645,0.0023720406,0.0017685738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006218769,0.0018436566,0.0013415753,0.0019151743,0.001191011,0.0045432234,0.0017525125,0.007845745,0.01743367],"category_scores_gemma":[0.0054476443,0.0005049644,0.0015822441,0.0013753761,0.00053906353,0.002098163,0.0020756854,0.0071152947,0.0067722844],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022074381,0.00009181896,0.00018405162,0.0012326199,0.000029714003,0.0001492716,0.00004094147,0.00016611877,0.0005567188,0.0013008524,0.9367077,0.059319347],"study_design_scores_gemma":[0.000067048524,0.000121569414,0.00095492945,0.0011825549,0.00004319913,0.000110988934,0.00006185547,0.000050614686,0.00020375945,0.00044132164,0.9967429,0.000019140323],"about_ca_topic_score_codex":0.008216421,"about_ca_topic_score_gemma":0.013392428,"teacher_disagreement_score":0.01743367,"about_ca_system_score_codex":0.0039464864,"about_ca_system_score_gemma":0.0077449647,"threshold_uncertainty_score":0.058321476},"labels":[],"label_agreement":null},{"id":"W2150092010","doi":"10.1158/1078-0432.ccr-08-1355","title":"Uncovering Growth-Suppressive MicroRNAs in Lung Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Dartmouth College","keywords":"microRNA; Lung cancer; Biology; Cancer research; Transfection; Cell growth; Molecular biology; Cancer; Cell culture; In situ hybridization; Pathology; Gene expression; Medicine; Gene; Genetics","score_opus":0.0656494295987841,"score_gpt":0.47502960030663327,"score_spread":0.40938017070784916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150092010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808092,0.0074899592,0.00979599,0.000120845376,0.000019006253,0.000055506312,0.00060721545,0.00014413068,0.0009579996],"genre_scores_gemma":[0.98779154,0.001921798,0.008489368,0.00008146252,0.00001617213,0.000032169264,0.0009787023,0.000017483106,0.000671293],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998097,0.000019865758,0.000017399352,0.00006648002,0.000064313885,0.000022283803],"domain_scores_gemma":[0.9998203,0.0000381097,0.00006697282,0.000019028437,0.000036199825,0.000019400408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026672037,0.0003230679,0.00031430848,0.00035372292,0.00015647947,0.00041864603,0.00019003208,0.00027466723,0.00036794908],"category_scores_gemma":[0.00029806074,0.00018271072,0.0002452647,0.00025608455,0.00022214402,0.00017612957,0.00018710928,0.0003051644,0.00021175509],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008472902,0.00001268646,0.0028035878,0.00007305471,0.000007712772,0.000053145643,0.000012703458,0.00010280851,0.9936418,0.000068180576,0.000028116043,0.0031115923],"study_design_scores_gemma":[0.000015961548,0.00028084964,0.03426592,0.000013982665,0.0000626992,0.0012663878,0.000040697952,0.002580893,0.95766217,0.00014878857,0.003653184,0.00000844442],"about_ca_topic_score_codex":0.00029423923,"about_ca_topic_score_gemma":0.00047378454,"teacher_disagreement_score":0.00041864603,"about_ca_system_score_codex":0.00027310074,"about_ca_system_score_gemma":0.0003096239,"threshold_uncertainty_score":0.0019814372},"labels":[],"label_agreement":null},{"id":"W2150095362","doi":"10.1158/1078-0432.ccr-07-4430","title":"Monoclonal Antibody CC188 Binds a Carbohydrate Epitope Expressed on the Surface of Both Colorectal Cancer Stem Cells and their Differentiated Progeny","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institute of Biomedical Imaging and Bioengineering; China Scholarship Council","keywords":"Epitope; Monoclonal antibody; Cancer stem cell; Cancer research; Biology; Molecular biology; Colorectal cancer; CD44; Cancer cell; Antibody; Stem cell; Cancer; Pathology; Immunology; Cell; Medicine; Cell biology; Biochemistry","score_opus":0.2128003088883914,"score_gpt":0.44997734660162725,"score_spread":0.23717703771323584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150095362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837923,0.0035992176,0.0084484555,0.00017701555,0.00004085819,0.00009119473,0.00025250396,0.000091411894,0.0035071431],"genre_scores_gemma":[0.9880944,0.0018830558,0.0066217603,0.000088355795,0.000030320558,0.00007250649,0.00062633865,0.000018497381,0.0025648202],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982506,0.00003239558,0.000011979667,0.00004053102,0.000044690976,0.000045360914],"domain_scores_gemma":[0.9999006,0.000022186583,0.000025420695,0.000011964473,0.0000204064,0.00001944062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012692716,0.000455335,0.00022627792,0.00030417362,0.00012224929,0.0001619925,0.00019324393,0.00025996575,0.0024385843],"category_scores_gemma":[0.00015568353,0.000110485635,0.00029148118,0.0001691404,0.00015973805,0.00016098132,0.00015042619,0.00037674006,0.0006368091],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009129049,0.000023873032,0.0010737738,0.00006104791,0.000007818948,0.00008838538,0.000011530655,0.0000676268,0.99472225,0.00009127804,0.00011752399,0.003643485],"study_design_scores_gemma":[0.000048537837,0.00060704217,0.012705265,0.000024523622,0.0000768231,0.0015964264,0.00004434746,0.0010749864,0.97132045,0.000034794448,0.0124599915,0.000006976073],"about_ca_topic_score_codex":0.0008128684,"about_ca_topic_score_gemma":0.001111861,"teacher_disagreement_score":0.0024385843,"about_ca_system_score_codex":0.00039291373,"about_ca_system_score_gemma":0.00020893928,"threshold_uncertainty_score":0.008157849},"labels":[],"label_agreement":null},{"id":"W2150115389","doi":"10.1158/1078-0432.ccr-10-1893","title":"Phase I Study of Decitabine in Combination with Vorinostat in Patients with Advanced Solid Tumors and Non-Hodgkin's Lymphomas","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Decitabine; Medicine; Vorinostat; Neutropenia; Tolerability; Febrile neutropenia; Leukopenia; Internal medicine; Maximum tolerated dose; Adverse effect; Pharmacokinetics; Gastroenterology; Pharmacology; Oncology; Toxicity","score_opus":0.0606253614671827,"score_gpt":0.4430309267504193,"score_spread":0.38240556528323655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150115389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484384,0.0028580856,0.00040845535,0.00012918965,0.00003524715,0.00075514975,0.00020956455,0.00003932535,0.0007211505],"genre_scores_gemma":[0.9939756,0.0019340339,0.0014209872,0.00020243342,0.00008780531,0.0008052917,0.00070531113,0.000013215229,0.00085541315],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997334,0.000113245726,0.000018100542,0.000042443906,0.00003865461,0.00005423649],"domain_scores_gemma":[0.99953794,0.00007643474,0.000109908164,0.000032221364,0.000025855603,0.0002177554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006445088,0.00080795423,0.001960869,0.0002938501,0.00027955748,0.0005314256,0.0005621202,0.0005063957,0.0021099306],"category_scores_gemma":[0.00046978003,0.00035132255,0.000610122,0.00040208045,0.0005288737,0.0003613323,0.00026906966,0.0016662658,0.00040093486],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45337534,0.08098493,0.024171846,0.0016810165,0.0020772675,0.00091541413,0.00046007612,0.0053100185,0.1871082,0.00030917578,0.0027862494,0.24082044],"study_design_scores_gemma":[0.20826164,0.7372478,0.02277401,0.000059939124,0.00073605514,0.001258089,0.00007356688,0.0015021332,0.022561457,0.0001449731,0.005351809,0.000028437258],"about_ca_topic_score_codex":0.00047135,"about_ca_topic_score_gemma":0.0011835159,"teacher_disagreement_score":0.0021099306,"about_ca_system_score_codex":0.0006282368,"about_ca_system_score_gemma":0.0011834579,"threshold_uncertainty_score":0.0070584416},"labels":[],"label_agreement":null},{"id":"W2150323133","doi":"10.1158/1078-0432.ccr-06-0608","title":"Preclinical Characterization of AEG35156/GEM 640, a Second-Generation Antisense Oligonucleotide Targeting X-Linked Inhibitor of Apoptosis","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aegera Therapeutics (Canada)","funders":"","keywords":"XIAP; Cancer research; Inhibitor of apoptosis; Apoptosis; Docetaxel; Cancer; In vivo; Cancer cell; Medicine; Pharmacology; Biology; Programmed cell death; Internal medicine; Caspase; Biochemistry","score_opus":0.09553153310765983,"score_gpt":0.41868614835354495,"score_spread":0.3231546152458851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150323133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860617,0.0022841033,0.005972367,0.00018025932,0.00006211887,0.001158054,0.0013156869,0.0001174453,0.0028483276],"genre_scores_gemma":[0.98908687,0.0020093536,0.0041846875,0.00009488171,0.000020112535,0.00040119447,0.0018835322,0.000023248947,0.002296074],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998952,0.000025724332,0.000007939366,0.000022918917,0.00002385496,0.000024273293],"domain_scores_gemma":[0.99984705,0.000018239985,0.000044471806,0.00001624498,0.000023709294,0.000050223414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041923946,0.0007476991,0.0003772763,0.00030557433,0.00013391237,0.00025224107,0.00032415852,0.00038997267,0.0017682634],"category_scores_gemma":[0.0002476743,0.00016234105,0.00030137738,0.00016248165,0.00023865567,0.0002728262,0.00012028183,0.0007696027,0.00043583638],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013088819,0.0015453773,0.00066138845,0.00013261267,0.00003845303,0.000069137546,0.000042265994,0.0014855415,0.983374,0.0001504026,0.0003911339,0.010800887],"study_design_scores_gemma":[0.0015225293,0.0835968,0.006184524,0.000029766392,0.00021698502,0.000732337,0.000046423494,0.0030617788,0.8952547,0.00010754032,0.0092286635,0.000018038843],"about_ca_topic_score_codex":0.000894239,"about_ca_topic_score_gemma":0.0013678129,"teacher_disagreement_score":0.0017682634,"about_ca_system_score_codex":0.00053412287,"about_ca_system_score_gemma":0.00059400784,"threshold_uncertainty_score":0.0059154034},"labels":[],"label_agreement":null},{"id":"W2150413368","doi":"10.1158/1078-0432.ccr-03-0112","title":"Phospho-Serine-118 Estrogen Receptor-α Detection in Human Breast Tumors <b> <i>in Vivo</i> </b>","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Estrogen receptor; Breast cancer; Immunohistochemistry; In vivo; Progesterone receptor; Cancer; Biopsy; Kinase; Biology; Medicine; Pathology; Cancer research; Internal medicine","score_opus":0.041865629735090094,"score_gpt":0.4244489185982646,"score_spread":0.3825832888631745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150413368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99461174,0.0015329854,0.0022598708,0.000052464457,0.000019188219,0.000026205485,0.0002628341,0.000049750997,0.0011849975],"genre_scores_gemma":[0.99106544,0.0013101901,0.004416443,0.00006088169,0.000020571424,0.00006202176,0.0011866901,0.00002086678,0.0018568888],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998629,0.000031034444,0.000011654843,0.000035756348,0.00003189125,0.000026676775],"domain_scores_gemma":[0.99987614,0.000024580202,0.00003657448,0.000015495532,0.000018796609,0.000028393053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023699946,0.0002864376,0.00017991698,0.0002894386,0.00013095773,0.00025714614,0.00014096183,0.00022731564,0.0012992269],"category_scores_gemma":[0.00018016555,0.00019478379,0.00013530359,0.00021476751,0.0001598418,0.00019322864,0.00011350475,0.00041009393,0.00056548667],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043494903,0.000046360285,0.0010369367,0.000033370252,0.000008837221,0.00003403248,0.00000834753,0.000026086691,0.9971445,0.000019414882,0.000035741392,0.0011714956],"study_design_scores_gemma":[0.00007056865,0.0015042541,0.036565576,0.00000855544,0.000053176704,0.001798184,0.000053182684,0.0014838718,0.95692253,0.000049298647,0.0014846178,0.000006097131],"about_ca_topic_score_codex":0.00034832602,"about_ca_topic_score_gemma":0.0003100185,"teacher_disagreement_score":0.0012992269,"about_ca_system_score_codex":0.00014300246,"about_ca_system_score_gemma":0.000097111144,"threshold_uncertainty_score":0.0043463707},"labels":[],"label_agreement":null},{"id":"W2150563430","doi":"10.1158/1078-0432.ccr-07-0073","title":"p66 Shc Tumor Levels Show a Strong Prognostic Correlation with Disease Outcome in Stage IIA Colon Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Medicine; Lymphovascular invasion; Internal medicine; Colorectal cancer; Oncology; Cancer; Stage (stratigraphy); Hazard ratio; Proportional hazards model; Multivariate analysis; Disease; Prognostic variable; Survival analysis; Adjuvant therapy; Confidence interval; Metastasis; Biology","score_opus":0.3388416997744702,"score_gpt":0.5628151602963438,"score_spread":0.2239734605218736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150563430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994419,0.00029690555,0.00008172794,0.000011293303,0.0000016318479,0.0000027674614,0.000061198385,0.0000030143015,0.00009953601],"genre_scores_gemma":[0.999655,0.000081196835,0.00006479839,0.000003956611,0.00000419931,0.0000019780032,0.0001357477,9.589147e-7,0.000052171745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988043,0.00002700829,0.000013627015,0.000028722057,0.000028301041,0.000021982516],"domain_scores_gemma":[0.99934715,0.000116646566,0.00030811218,0.000049939164,0.00006215143,0.00011601232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034697697,0.00020237744,0.00013653145,0.0003880659,0.00016669839,0.00023025258,0.00008358478,0.00020435799,0.0009571352],"category_scores_gemma":[0.00087155786,0.00013555284,0.00013031806,0.00033947086,0.0002775246,0.000113813316,0.00020191717,0.0002315623,0.00017379635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091353257,0.000021954973,0.98735374,0.000018878976,0.00004725466,0.00007455601,0.00003564983,0.0000941586,0.0077334144,0.000008731044,0.000087767396,0.003610315],"study_design_scores_gemma":[0.000010031711,0.0001694297,0.99846256,0.0000024659796,0.000024411873,0.00025508864,0.000021077049,0.00013592212,0.0008079582,0.000011936241,0.00009719661,0.0000019857305],"about_ca_topic_score_codex":0.00084356545,"about_ca_topic_score_gemma":0.0012117393,"teacher_disagreement_score":0.0009571352,"about_ca_system_score_codex":0.00013341403,"about_ca_system_score_gemma":0.00012735912,"threshold_uncertainty_score":0.003201902},"labels":[],"label_agreement":null},{"id":"W2150584794","doi":"10.1158/1078-0432.ccr-06-2788","title":"Molecular Characterization of Waldenstrom's Macroglobulinemia Reveals Frequent Occurrence of Two B-Cell Clones Having Distinct IgH VDJ Sequences","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"clone (Java method); Biology; Bone marrow; Somatic cell; Macroglobulinemia; Germline; Waldenstrom macroglobulinemia; B cell; Germline mutation; Antibody; Immunology; Genetics; Mutation; Gene; Lymphoma; Multiple myeloma","score_opus":0.13103462314872952,"score_gpt":0.5109195788758971,"score_spread":0.37988495572716763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150584794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997004,0.000092564085,0.00010273394,0.0000030841454,5.714249e-7,0.0000024777125,0.00001566109,0.0000031243594,0.00007936991],"genre_scores_gemma":[0.9995709,0.000038868704,0.00026060804,0.000004101641,0.0000023189239,0.0000044577105,0.00006660291,0.0000011908439,0.000051017156],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999912,0.000010359544,0.000011009981,0.000021960623,0.000024401052,0.000020209263],"domain_scores_gemma":[0.9998889,0.000024376113,0.00003415669,0.000012869366,0.00001233005,0.000027413127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013546665,0.00021898287,0.00014808423,0.00066999154,0.00013125989,0.00018780673,0.00014227263,0.00021572656,0.0007337914],"category_scores_gemma":[0.00036902016,0.00010502821,0.000091308524,0.00022257611,0.00015512311,0.00010981037,0.000148431,0.00011985089,0.00014001566],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004681156,0.00007117063,0.31758845,0.00007866459,0.00004821817,0.0032769993,0.00018791617,0.00016891622,0.6647475,0.0001361218,0.00008808655,0.013139918],"study_design_scores_gemma":[0.000067403824,0.00076087523,0.8309955,0.000014581535,0.000101895326,0.03766719,0.00022501459,0.0014986767,0.12694141,0.00017784016,0.0015395578,0.000010125575],"about_ca_topic_score_codex":0.00022276124,"about_ca_topic_score_gemma":0.0004026731,"teacher_disagreement_score":0.0007337914,"about_ca_system_score_codex":0.00012224288,"about_ca_system_score_gemma":0.00007862496,"threshold_uncertainty_score":0.0024547577},"labels":[],"label_agreement":null},{"id":"W2150765090","doi":"10.1158/1078-0432.ccr-05-0545","title":"Glioblastoma Patients Exhibit Circulating Tumor-Specific CD8+ T Cells","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Dendritic cell; CD8; Cancer research; Peripheral blood mononuclear cell; Brain tumor; Antigen; Cytotoxic T cell; Immune system; Antigen-presenting cell; Medicine; Immunology; Pathology; Biology; T cell; In vitro","score_opus":0.10522315470737163,"score_gpt":0.42428494081525114,"score_spread":0.3190617861078795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150765090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963174,0.0008874571,0.00042608744,0.00009327295,0.000017888793,0.000030924308,0.00018556655,0.000079857164,0.001961449],"genre_scores_gemma":[0.99832076,0.00024101057,0.00040439834,0.00008844276,0.0000299641,0.00001404665,0.00039692974,0.0000056515682,0.0004987972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99992466,0.000009260334,0.0000074301092,0.000021863561,0.000012489398,0.000024332809],"domain_scores_gemma":[0.99986935,0.000026452944,0.000047159945,0.000010570007,0.000020631911,0.000025747424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006957689,0.00031280096,0.00026525455,0.00016610435,0.00016941818,0.00020657075,0.00007483659,0.00023158084,0.0025482178],"category_scores_gemma":[0.00027312417,0.000075538665,0.00009401671,0.000176305,0.00009866991,0.00011485471,0.00010360287,0.00023097907,0.00074735854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023047712,0.00038186304,0.52104604,0.00026086633,0.00008086249,0.012367391,0.00035651505,0.00030703962,0.3588335,0.00025185986,0.003612365,0.10019702],"study_design_scores_gemma":[0.00029994603,0.0031103194,0.8192687,0.00009567702,0.00020538094,0.09169989,0.0004022924,0.0011364263,0.06685716,0.000567958,0.016325258,0.00003097753],"about_ca_topic_score_codex":0.00057578797,"about_ca_topic_score_gemma":0.00092316914,"teacher_disagreement_score":0.0025482178,"about_ca_system_score_codex":0.0001855917,"about_ca_system_score_gemma":0.00011380594,"threshold_uncertainty_score":0.008524656},"labels":[],"label_agreement":null},{"id":"W2150851460","doi":"10.1158/1078-0432.ccr-05-0661","title":"Isolated Loss of PMS2 Expression in Colorectal Cancers: Frequency, Patient Age, and Familial Aggregation","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; BC Cancer Agency","funders":"National Cancer Institute","keywords":"PMS2; MSH6; MSH2; MLH1; Microsatellite instability; Lynch syndrome; Colorectal cancer; DNA mismatch repair; Biology; Medicine; Cancer research; Cancer; Pathology; Internal medicine; Genetics; Microsatellite","score_opus":0.11642444566557208,"score_gpt":0.46610188504871475,"score_spread":0.34967743938314266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150851460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99931645,0.00031827245,0.000100998855,0.000013835095,0.0000027344456,0.0000031861891,0.00007682972,0.0000065665477,0.00016104715],"genre_scores_gemma":[0.99969745,0.000082712155,0.00006850594,0.0000052548353,0.000006063305,0.0000024690908,0.000086872766,0.000001203807,0.000049397502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952126,0.00010796891,0.00006542265,0.00014040688,0.00010019824,0.00006477075],"domain_scores_gemma":[0.9979684,0.0005350447,0.0009643502,0.00014750533,0.0001365852,0.00024818908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051810197,0.000227758,0.00032348768,0.001239662,0.00043384774,0.00032057965,0.00024888178,0.0003878823,0.001693118],"category_scores_gemma":[0.0027418504,0.00026365227,0.0001874307,0.0009529791,0.00039209283,0.00034395323,0.00030101184,0.00024699984,0.00029643349],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010363568,0.000010778538,0.99777126,0.000006377369,0.000014598598,0.00031414095,0.000033694258,0.000013734622,0.0006831767,0.0000066582456,0.00003780966,0.0010041808],"study_design_scores_gemma":[0.0000039811007,0.00008956866,0.9961433,0.0000025707984,0.000017441214,0.0031729646,0.000056987083,0.000100378165,0.0002884077,0.000013573324,0.0001078399,0.0000030402311],"about_ca_topic_score_codex":0.0009450264,"about_ca_topic_score_gemma":0.0012784153,"teacher_disagreement_score":0.001693118,"about_ca_system_score_codex":0.00020891277,"about_ca_system_score_gemma":0.0001651936,"threshold_uncertainty_score":0.00566411},"labels":[],"label_agreement":null},{"id":"W2151119213","doi":"10.1158/1078-0432.ccr-07-1223","title":"Pretargeted Radioimmunotherapy for B-Cell Lymphomas","year":2007,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Radioimmunotherapy; Medicine; Lymphoma; Monoclonal antibody; Pretargeting; Cancer research; Oncology; Refractory (planetary science); Internal medicine; Immunology; Antibody; Biology","score_opus":0.7771471648139743,"score_gpt":0.7280431915978613,"score_spread":0.04910397321611293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151119213","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00079624413,0.99677014,0.0006792281,0.00013007708,0.00014287223,0.000015753843,0.00000965975,0.000022210188,0.0014337378],"genre_scores_gemma":[0.0030547539,0.9943123,0.00073714164,0.00019564207,0.000120039,0.000023493565,0.0000392671,0.000003486732,0.0015139162],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998838,0.000020642168,0.000008898319,0.000020589261,0.000051554092,0.000014455054],"domain_scores_gemma":[0.99990296,0.000036825928,0.000013637748,0.0000051926168,0.000027662636,0.00001373766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036881567,0.0008502541,0.0010475008,0.0015136041,0.00022327944,0.00042652735,0.0008466641,0.0007811591,0.002167497],"category_scores_gemma":[0.00025645128,0.0002251734,0.00033336837,0.001357808,0.00037500702,0.00072504964,0.00030402112,0.0012136839,0.0016879315],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011914702,0.0002229752,0.00015187863,0.005980095,0.00006412591,0.00039934897,0.000041764353,0.0005726012,0.015960816,0.0019001457,0.015126994,0.95946014],"study_design_scores_gemma":[0.00010168369,0.0004500358,0.0017151075,0.0009786523,0.0001291721,0.005142931,0.00004511141,0.0003298755,0.009879444,0.0017929404,0.9794087,0.000026437285],"about_ca_topic_score_codex":0.0007380824,"about_ca_topic_score_gemma":0.0011737121,"teacher_disagreement_score":0.002167497,"about_ca_system_score_codex":0.0005119814,"about_ca_system_score_gemma":0.000553325,"threshold_uncertainty_score":0.0072509646},"labels":[],"label_agreement":null},{"id":"W2151325774","doi":"10.1158/1078-0432.ccr-09-0245","title":"Longitudinal Cytokine Expression during IMRT for Prostate Cancer and Acute Treatment Toxicity","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Prostate cancer; Cytokine; Toxicity; Biomarker; Oncology; Internal medicine; Tumor necrosis factor alpha; Cancer; Prostate; Radiation therapy; Urine; Acute toxicity; Interleukin 6; Urology; Gastroenterology; Biology","score_opus":0.17236568781552064,"score_gpt":0.5230518343101851,"score_spread":0.35068614649466445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151325774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99884963,0.00037706233,0.0004720411,0.000015054419,0.0000038246853,0.00001805507,0.00012393783,0.000009384203,0.00013093054],"genre_scores_gemma":[0.9991536,0.000083735555,0.00033331357,0.000022241438,0.000009159967,0.000033594173,0.0002201319,0.0000023773325,0.000141713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973506,0.00008064444,0.000017580556,0.00006790256,0.00006297448,0.000035823992],"domain_scores_gemma":[0.9993368,0.00010722993,0.00033173725,0.000042836316,0.0000811213,0.00010027696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036225872,0.0002459977,0.00031581573,0.00025746482,0.00020398539,0.00030491315,0.00015876468,0.00022532072,0.00070469605],"category_scores_gemma":[0.0010207162,0.00009585722,0.00014760479,0.0003187903,0.0001774219,0.00015546815,0.00016708237,0.00033434806,0.00022789484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035986144,0.0002671039,0.86647177,0.000086588094,0.00008822325,0.00024367959,0.00026054843,0.000433583,0.11127242,0.000026938922,0.00016169445,0.017088903],"study_design_scores_gemma":[0.000023021217,0.0028657187,0.9742172,0.00000796146,0.00006202406,0.00066864135,0.000107301516,0.0007192711,0.020786474,0.000026042931,0.00050697906,0.000009422101],"about_ca_topic_score_codex":0.00027997865,"about_ca_topic_score_gemma":0.00032746504,"teacher_disagreement_score":0.00070469605,"about_ca_system_score_codex":0.00022540968,"about_ca_system_score_gemma":0.00016676485,"threshold_uncertainty_score":0.002357483},"labels":[],"label_agreement":null},{"id":"W2151390901","doi":"10.1158/1078-0432.ccr-11-2465","title":"<i>Here, There Be Dragons</i> : Charting Autophagy-Related Alterations in Human Tumors","year":2012,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Autophagy; Biology; Cancer; Carcinogenesis; Cell biology; Cancer research; Cancer cell; Function (biology); Lysosome; Genetics; Biochemistry; Apoptosis","score_opus":0.46429398715904197,"score_gpt":0.6077967453604527,"score_spread":0.14350275820141073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151390901","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013770784,0.9902857,0.00028319727,0.0031138153,0.0035845095,0.000007331573,0.00004913736,0.000026176567,0.0025123672],"genre_scores_gemma":[0.0009819905,0.9890259,0.0005578823,0.0031215881,0.0027392474,0.000009919648,0.00007482907,0.000008729964,0.003480026],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985015,0.000024611814,0.000021264355,0.000023054803,0.000068940084,0.000012003045],"domain_scores_gemma":[0.99967635,0.00011466143,0.00004226441,0.000014609533,0.000121968136,0.000030220226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039793854,0.0005787936,0.00074679893,0.0025159172,0.00029789595,0.00093146163,0.0005972249,0.0008691032,0.0028023634],"category_scores_gemma":[0.0008170935,0.0001420388,0.00038763537,0.002492939,0.000493737,0.0021101215,0.000600991,0.0019558494,0.0028297794],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007473749,0.000027066886,0.00028495362,0.005753099,0.000051724142,0.00026379386,0.000086983884,0.00017369879,0.0019567213,0.00494148,0.3274243,0.6589614],"study_design_scores_gemma":[0.0000038132873,0.00003328012,0.00065120234,0.0014114084,0.000021852773,0.0015143703,0.00005408479,0.000039608392,0.00035249523,0.0018346596,0.9940719,0.000011402572],"about_ca_topic_score_codex":0.0010475877,"about_ca_topic_score_gemma":0.002124108,"teacher_disagreement_score":0.0028023634,"about_ca_system_score_codex":0.000515544,"about_ca_system_score_gemma":0.0006099842,"threshold_uncertainty_score":0.009374857},"labels":[],"label_agreement":null},{"id":"W2151472455","doi":"10.1158/1078-0432.ccr-08-0480","title":"Plasma Insulin-like Growth Factors, Insulin-like Binding Protein-3, and Outcome in Metastatic Colorectal Cancer: Results from Intergroup Trial N9741","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Cancer Institute","keywords":"Colorectal cancer; Internal medicine; Medicine; Chemotherapy; Insulin-like growth factor-binding protein; Oncology; Endocrinology; Cancer; Insulin-like growth factor; Growth factor; Receptor","score_opus":0.24570754211453077,"score_gpt":0.44977571487353885,"score_spread":0.20406817275900807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151472455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937723,0.0036430862,0.00013120132,0.000493421,0.00012663196,0.00033659846,0.000915199,0.00002010267,0.0005613932],"genre_scores_gemma":[0.99203426,0.0019534011,0.00040017115,0.0005762504,0.0003079035,0.00096465496,0.0026614235,0.000012528214,0.0010893062],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987431,0.0008958075,0.00004926519,0.00011476816,0.00009216887,0.00010494532],"domain_scores_gemma":[0.99841595,0.00045723293,0.00039697404,0.00016480789,0.000082190905,0.0004827975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036747027,0.0010841266,0.0019410951,0.0003288049,0.00040561825,0.0006175649,0.00071267347,0.001032409,0.0018997497],"category_scores_gemma":[0.0020597763,0.00027396707,0.0017513692,0.0004811892,0.00067810644,0.00042966777,0.00039542923,0.0018338409,0.00028056547],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94013,0.004686069,0.029287303,0.0005220267,0.0033515287,0.00007361941,0.000053778225,0.0007016007,0.0019805226,0.00007709233,0.0017580402,0.017378367],"study_design_scores_gemma":[0.7769872,0.11059939,0.10370306,0.00015780715,0.004263889,0.00015835637,0.00005237615,0.0014474199,0.0009022844,0.00022889161,0.0014623721,0.00003701275],"about_ca_topic_score_codex":0.0016342665,"about_ca_topic_score_gemma":0.0032485381,"teacher_disagreement_score":0.0036747027,"about_ca_system_score_codex":0.0008690635,"about_ca_system_score_gemma":0.0016390216,"threshold_uncertainty_score":0.019433916},"labels":[],"label_agreement":null},{"id":"W2151637779","doi":"10.1158/1078-0432.ccr-09-0095","title":"Tumor and Host-Mediated Pathways of Resistance and Disease Progression in Response to Antiangiogenic Therapy","year":2009,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":286,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Disease; Cancer; Drug resistance; Host factors; Drug; Cancer research; Vascular endothelial growth factor; Tumor progression; Tumor microenvironment; Oncology; Immunology; VEGF receptors; Biology; Internal medicine; Pharmacology","score_opus":0.18026741778241065,"score_gpt":0.5179156002485141,"score_spread":0.3376481824661035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151637779","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036365876,0.9968581,0.00040774466,0.00025374632,0.00013423737,0.0000062169597,0.000012645931,0.000010917319,0.0019527427],"genre_scores_gemma":[0.0014037405,0.9970734,0.00030239043,0.00009356637,0.00007283662,0.0000076051037,0.000015604093,0.0000011915287,0.0010296277],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984205,0.00002962726,0.000018646819,0.000026765052,0.00006703287,0.000015915295],"domain_scores_gemma":[0.99987376,0.00004633412,0.000025068624,0.000004336444,0.00003627233,0.000014255856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000412625,0.0005760891,0.001235798,0.0014074302,0.00020766696,0.0008501634,0.000687824,0.0009666263,0.001877747],"category_scores_gemma":[0.00032943522,0.00024624882,0.00025754413,0.0014252817,0.00044111835,0.0009321088,0.00040640222,0.0011403598,0.0017860314],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011256978,0.00009259261,0.0003013572,0.00868884,0.000054783497,0.0005374565,0.000082392224,0.0007694018,0.010045692,0.0080379825,0.018364433,0.9529125],"study_design_scores_gemma":[0.0000230911,0.00012934412,0.001690074,0.001622468,0.000058756483,0.0041654776,0.00009119199,0.00022327292,0.0032236576,0.0034055903,0.985344,0.000023088765],"about_ca_topic_score_codex":0.0006997815,"about_ca_topic_score_gemma":0.0013320607,"teacher_disagreement_score":0.001877747,"about_ca_system_score_codex":0.00078884524,"about_ca_system_score_gemma":0.00072454644,"threshold_uncertainty_score":0.0062817335},"labels":[],"label_agreement":null},{"id":"W2151656051","doi":"10.1158/1078-0432.ccr-06-1563","title":"<i>In vivo</i> 19F Magnetic Resonance Spectroscopy and Chemical Shift Imaging of Tri-Fluoro-Nitroimidazole as a Potential Hypoxia Reporter in Solid Tumors","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced MRI Techniques and Applications","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Penticton Regional Hospital","funders":"National Cancer Institute","keywords":"In vivo; Tumor hypoxia; Chemistry; Hypoxia (environmental); Ex vivo; In vitro; Magnetic resonance imaging; Nuclear magnetic resonance; Nitroimidazole; Oxygen; Pathology; Biochemistry; Medicine; Biology; Internal medicine","score_opus":0.05478165907637512,"score_gpt":0.4959365768890489,"score_spread":0.4411549178126738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151656051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850722,0.0025285585,0.010276573,0.00021009317,0.000020698031,0.000023925108,0.0002300617,0.00012984623,0.0015080565],"genre_scores_gemma":[0.9866822,0.0015027209,0.009510816,0.00007726224,0.000027386315,0.000029338387,0.00040957564,0.000021897835,0.001738853],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993396,0.000017493665,0.000002892684,0.000015056598,0.000015348365,0.000015234792],"domain_scores_gemma":[0.9999136,0.000016358716,0.00003544962,0.0000047340855,0.000018064895,0.000011825337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016183581,0.0002601202,0.00012471246,0.00015077458,0.000100202175,0.00014921947,0.00020101911,0.00036680786,0.00058938825],"category_scores_gemma":[0.00014291113,0.000088671666,0.00011360946,0.00009927458,0.00018887721,0.0001954692,0.00006383608,0.00017718184,0.00022557653],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010884952,0.000008788986,0.00016528022,0.000018655908,0.0000014198332,0.000026125826,0.0000044797544,0.000057928308,0.99883,0.000019126097,0.000029574556,0.0007298172],"study_design_scores_gemma":[0.00000750046,0.0002530861,0.0023262901,0.000001979419,0.000007661329,0.00026933942,0.000010166023,0.000789404,0.9958074,0.000009785821,0.0005151081,0.0000023108516],"about_ca_topic_score_codex":0.0012169523,"about_ca_topic_score_gemma":0.001283201,"teacher_disagreement_score":0.0012169523,"about_ca_system_score_codex":0.00026551317,"about_ca_system_score_gemma":0.00016629991,"threshold_uncertainty_score":0.0024197102},"labels":[],"label_agreement":null},{"id":"W2151698969","doi":"10.1158/1078-0432.ccr-04-2140","title":"Timing Is Everything: Preclinical Evidence Supporting Simultaneous Rather Than Sequential Chemohormonal Therapy for Prostate Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Paclitaxel; LNCaP; Prostate cancer; Medicine; Internal medicine; Oncology; Chemotherapy; Androgen; Cancer; Castration; Endocrinology; Cancer research; Hormone","score_opus":0.46391349536295806,"score_gpt":0.6067462781873147,"score_spread":0.14283278282435669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151698969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9707635,0.022358816,0.0034374348,0.00042728844,0.00032041222,0.0001492103,0.00018556812,0.00009381319,0.002264061],"genre_scores_gemma":[0.98240465,0.013494453,0.0023602745,0.00018656065,0.00024834136,0.0001001643,0.00018511023,0.000020385896,0.0009999203],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979514,0.00004105436,0.000018701077,0.00005151232,0.000059187492,0.000034340403],"domain_scores_gemma":[0.9994325,0.00017046861,0.00022498854,0.000063512154,0.00002828904,0.00008029025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045163985,0.00046443832,0.0004728035,0.0002189221,0.0001498314,0.0005003199,0.00040965492,0.00029919957,0.002472207],"category_scores_gemma":[0.00040885556,0.00016238965,0.0004386109,0.00024625703,0.00050241215,0.0004966659,0.0001821843,0.00090774376,0.00030338007],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017242214,0.0033584826,0.003816702,0.0020595226,0.00023309779,0.00010812373,0.000076853044,0.0014808283,0.8655181,0.0010387031,0.00045266675,0.10461476],"study_design_scores_gemma":[0.0027653081,0.2176917,0.05206038,0.00058424054,0.0017570923,0.0015818438,0.00035400412,0.0034293642,0.69455665,0.0015297843,0.02360449,0.00008513325],"about_ca_topic_score_codex":0.00022098613,"about_ca_topic_score_gemma":0.0007718902,"teacher_disagreement_score":0.002472207,"about_ca_system_score_codex":0.00026390603,"about_ca_system_score_gemma":0.00056342175,"threshold_uncertainty_score":0.008270323},"labels":[],"label_agreement":null},{"id":"W2151860429","doi":"10.1158/1078-0432.ccr-11-2189","title":"<i>PTEN</i> Deletion in Prostate Cancer Cells Does Not Associate with Loss of RAD51 Function: Implications for Radiotherapy and Chemotherapy","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Alberta Cancer Foundation; University of Calgary; University Health Network","funders":"Biotechnology and Biological Sciences Research Council","keywords":"PTEN; Cancer research; Prostate cancer; DU145; RAD51; Cancer; Clonogenic assay; Prostate; Biology; Medicine; DNA repair; Oncology; Internal medicine; Cell; PI3K/AKT/mTOR pathway; Apoptosis; Genetics","score_opus":0.11075015458791759,"score_gpt":0.4437701251567133,"score_spread":0.33301997056879573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151860429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98978233,0.0036721213,0.0021748415,0.00033593958,0.000033604803,0.00003594935,0.0010986917,0.0001680928,0.0026984278],"genre_scores_gemma":[0.99521494,0.0012641856,0.0006766001,0.00006837644,0.000009021149,0.000025900446,0.0014206048,0.000022589176,0.0012977676],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998472,0.000017981882,0.000015573007,0.000031532287,0.000055765413,0.00003187813],"domain_scores_gemma":[0.9998388,0.000019377987,0.00006052437,0.000019266467,0.000013127104,0.00004884139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014403748,0.00031700518,0.00035402318,0.00030417915,0.00018642048,0.00044424844,0.00028379678,0.00024745645,0.0020178363],"category_scores_gemma":[0.00013639171,0.00016607299,0.00024791362,0.00027322653,0.0003056396,0.00022710249,0.0002096299,0.00045446813,0.00064315915],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024979873,0.00004958599,0.0022977965,0.000050427658,0.000012610149,0.00019353605,0.000009361322,0.00010330272,0.99426794,0.00017832266,0.00014713226,0.0024401613],"study_design_scores_gemma":[0.000040979194,0.0008942893,0.099567994,0.000020058016,0.00006810253,0.0047840183,0.00006388196,0.0016106346,0.88612884,0.00021230358,0.006593768,0.0000151165195],"about_ca_topic_score_codex":0.00069279916,"about_ca_topic_score_gemma":0.0007049848,"teacher_disagreement_score":0.0020178363,"about_ca_system_score_codex":0.0003208738,"about_ca_system_score_gemma":0.00026169908,"threshold_uncertainty_score":0.0067502856},"labels":[],"label_agreement":null},{"id":"W2152114243","doi":"10.1158/1078-0432.ccr-06-1807","title":"Chemosensitization of Cancer <i>In vitro</i> and <i>In vivo</i> by Nitric Oxide Signaling","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Medical Research and Materiel Command; Canadian Institutes of Health Research; Canadian Prostate Cancer Research Initiative; Queen's University; Heart and Stroke Foundation of Canada","keywords":"Pharmacology; In vivo; Doxorubicin; Nitric oxide; Hypoxia (environmental); Clonogenic assay; Chemistry; Cancer research; Biology; Medicine; Internal medicine; Chemotherapy","score_opus":0.07419504929233707,"score_gpt":0.46986411549976376,"score_spread":0.3956690662074267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152114243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989185,0.004869096,0.0025983956,0.00028259557,0.00007610862,0.0000624934,0.00028990337,0.000107519576,0.0025289329],"genre_scores_gemma":[0.99367344,0.0023738742,0.0016978473,0.00011720744,0.000020652229,0.00006121142,0.0004333767,0.000016204169,0.0016062536],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998797,0.000030114332,0.000009919654,0.000027223135,0.000024565197,0.000028525059],"domain_scores_gemma":[0.99993145,0.00001574871,0.000021904367,0.000010528819,0.0000072475955,0.000013093584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015710996,0.00033950678,0.0002735813,0.000111919784,0.00010798725,0.00021834967,0.00017504467,0.00020882813,0.0011073854],"category_scores_gemma":[0.000102358696,0.0001075746,0.00025509298,0.00008147736,0.00020979266,0.00016827126,0.00011633126,0.0004598879,0.00024460987],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014969373,0.00006474835,0.000154943,0.00005954088,0.0000054950133,0.000018273493,0.000007399449,0.00009362432,0.99773103,0.00005679794,0.00008472252,0.0015737031],"study_design_scores_gemma":[0.000018986038,0.0010383093,0.0029352608,0.000007170304,0.000017029543,0.00015353391,0.000009439598,0.0006182486,0.9937914,0.0000186901,0.0013892443,0.0000026444568],"about_ca_topic_score_codex":0.0007312371,"about_ca_topic_score_gemma":0.001071665,"teacher_disagreement_score":0.0011073854,"about_ca_system_score_codex":0.0004418188,"about_ca_system_score_gemma":0.00022914288,"threshold_uncertainty_score":0.0037046075},"labels":[],"label_agreement":null},{"id":"W2152209571","doi":"10.1158/1078-0432.ccr-07-0823","title":"Nutritional Modulation of Antitumor Efficacy and Diarrhea Toxicity Related to Irinotecan Chemotherapy in Rats Bearing the Ward Colon Tumor","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Crohn's and Colitis Foundation of Canada; Natural Sciences and Engineering Research Council of Canada; Crohn's and Colitis Foundation","keywords":"Diarrhea; Irinotecan; Gastroenterology; Medicine; Glutamine; Internal medicine; Chemotherapy; Toxicity; Bolus (digestion); Loperamide; Colorectal cancer; Cancer; Biology; Biochemistry","score_opus":0.09254496655887531,"score_gpt":0.46593629279175547,"score_spread":0.3733913262328802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152209571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99934703,0.00019324462,0.00019154175,0.000022078795,0.000008289701,0.00001112415,0.00006979706,0.000013355398,0.00014349222],"genre_scores_gemma":[0.99606776,0.0006066035,0.0014403013,0.00005140036,0.000009999751,0.00006288809,0.00033265323,0.000014060815,0.0014142664],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998816,0.000017828681,0.000009039211,0.00002606049,0.000025481382,0.000039864128],"domain_scores_gemma":[0.9997224,0.000022401131,0.0001034266,0.00002683525,0.00003067951,0.00009426516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001529336,0.00057025754,0.0004525022,0.0004708668,0.00019307708,0.00020811374,0.0002528522,0.00033149376,0.0011234799],"category_scores_gemma":[0.00015116729,0.00022986259,0.0002477428,0.0002458969,0.0004784546,0.00032568132,0.00016042416,0.00072824326,0.0001841728],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004396077,0.00073095626,0.0013637437,0.000049551345,0.000014051026,0.000080426085,0.000026350523,0.00013257201,0.9907573,0.000052343737,0.00003681725,0.0023599225],"study_design_scores_gemma":[0.00036457618,0.020788006,0.024653737,0.000013287311,0.00010477038,0.00037481036,0.00012008811,0.0010788146,0.9511519,0.000067324014,0.0012634533,0.000019240462],"about_ca_topic_score_codex":0.0011246722,"about_ca_topic_score_gemma":0.0019957838,"teacher_disagreement_score":0.0011246722,"about_ca_system_score_codex":0.0004531905,"about_ca_system_score_gemma":0.0004343555,"threshold_uncertainty_score":0.0037584305},"labels":[],"label_agreement":null},{"id":"W2152452482","doi":"10.1158/1078-0432.795.11.2","title":"The Effects of Cetuximab Alone and in Combination With Radiation and/or Chemotherapy in Lung Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":241,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Cetuximab; Epidermal growth factor receptor; Lung cancer; Cancer research; Medicine; Cancer; Cell cycle; EGFR inhibitors; In vivo; Oncology; Internal medicine; Biology; Colorectal cancer","score_opus":0.049015660487748455,"score_gpt":0.5172781675729077,"score_spread":0.4682625070851592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152452482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887533,0.009289163,0.0002720136,0.00013172976,0.00008513901,0.00010797461,0.00010155094,0.00003681939,0.001222323],"genre_scores_gemma":[0.99575704,0.0024185232,0.00056091184,0.00006627726,0.000028663413,0.000043120977,0.00017645759,0.000007068232,0.0009419665],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996644,0.00010529357,0.000030573523,0.000060085797,0.00008450424,0.000055133987],"domain_scores_gemma":[0.99982315,0.000046058507,0.000034820372,0.000022002818,0.000020950254,0.000053017262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046870948,0.00048263255,0.0007923276,0.0005030449,0.00027560082,0.00046576856,0.00041011642,0.0004712871,0.001254224],"category_scores_gemma":[0.0003612033,0.0002468499,0.00044300454,0.00034427718,0.00035256564,0.00039912213,0.00023780028,0.00088105357,0.00022427582],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0152290575,0.0043623447,0.005195959,0.00080098794,0.00034143394,0.00031379558,0.00013931992,0.0021099127,0.90508896,0.00016031481,0.00077903754,0.06547883],"study_design_scores_gemma":[0.003385706,0.089017965,0.06409988,0.00010141172,0.0009468903,0.0021998775,0.00019794478,0.0064687445,0.8214359,0.00012906139,0.011964708,0.00005189572],"about_ca_topic_score_codex":0.0017946092,"about_ca_topic_score_gemma":0.005250863,"teacher_disagreement_score":0.0017946092,"about_ca_system_score_codex":0.000727436,"about_ca_system_score_gemma":0.00064352644,"threshold_uncertainty_score":0.005277872},"labels":[],"label_agreement":null},{"id":"W2152680582","doi":"10.1158/1078-0432.ccr-05-1387","title":"A Dynamic De-Escalating Dosing Strategy to Determine the Optimal Biological Dose for Antiangiogenic Drugs","year":2005,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; U.S. Food and Drug Administration","keywords":"Dosing; Medicine; Pharmacology; Intensive care medicine","score_opus":0.19948879983941725,"score_gpt":0.49760285566370926,"score_spread":0.298114055824292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152680582","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17823324,0.06279966,0.35264724,0.3308585,0.0185573,0.0030886754,0.0009265148,0.0024004148,0.05048848],"genre_scores_gemma":[0.6895148,0.018058775,0.1735117,0.0932457,0.0090676285,0.0019352244,0.0003244031,0.00025667538,0.01408514],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991761,0.00023894488,0.000085440246,0.00013462741,0.00029062637,0.00007433513],"domain_scores_gemma":[0.999116,0.00048316523,0.000103022765,0.00012493749,0.00009816149,0.00007473296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001185548,0.00049322617,0.0012852375,0.0005372943,0.00044944673,0.0013198289,0.0011085158,0.0025486555,0.0020277528],"category_scores_gemma":[0.0031245395,0.00028427472,0.0005247984,0.0005002016,0.00074209017,0.0009837417,0.0004636945,0.005411646,0.0014080368],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028198557,0.001735769,0.0025026712,0.0006456407,0.00013362583,0.002837984,0.00026357855,0.011916514,0.19458304,0.018973963,0.09065991,0.6729275],"study_design_scores_gemma":[0.0057267407,0.007742039,0.008077478,0.00031127437,0.00029500053,0.019993747,0.00018516697,0.09316969,0.14673229,0.05473708,0.66270864,0.0003208617],"about_ca_topic_score_codex":0.00021083141,"about_ca_topic_score_gemma":0.00083563954,"teacher_disagreement_score":0.0025486555,"about_ca_system_score_codex":0.001200297,"about_ca_system_score_gemma":0.0005533345,"threshold_uncertainty_score":0.008708835},"labels":[],"label_agreement":null},{"id":"W2152723932","doi":"10.1158/1078-0432.ccr-10-2273","title":"Biomarkers for Cetuximab-Based Neoadjuvant Radiochemotherapy in Locally Advanced Rectal Cancer","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Response Biomedical (Canada)","funders":"","keywords":"KRAS; Cetuximab; Medicine; Colorectal cancer; Oncology; Internal medicine; Cancer; Cancer research; Epidermal growth factor receptor; Neoadjuvant therapy","score_opus":0.3959506586468158,"score_gpt":0.560738633194411,"score_spread":0.1647879745475952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152723932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99447256,0.0036472057,0.00062783575,0.000151473,0.000025177407,0.00006909167,0.00027131298,0.00003640893,0.0006988584],"genre_scores_gemma":[0.9974317,0.0003685274,0.0009923166,0.000070726586,0.000017397131,0.00007007969,0.0005788245,0.0000030172635,0.00046746738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985206,0.000048996924,0.00001601103,0.000023177332,0.000039314382,0.000020478281],"domain_scores_gemma":[0.9995204,0.00011149327,0.00020598363,0.00001703077,0.00006674839,0.000078364625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004149402,0.00030250553,0.00035547573,0.0007034293,0.00019327433,0.00042098275,0.00020699721,0.00034994335,0.001600937],"category_scores_gemma":[0.0011978374,0.00013614715,0.00016610276,0.00045092855,0.00020614456,0.00017956684,0.00019910945,0.00034690634,0.00031257258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036823165,0.0003500835,0.9088157,0.00029719758,0.00015456007,0.00020455643,0.00007557835,0.00096426555,0.0436138,0.000081398444,0.0010530959,0.04070746],"study_design_scores_gemma":[0.00017684464,0.0021878495,0.9745681,0.000060456005,0.0001903651,0.001369622,0.00013772832,0.0039306884,0.014027062,0.00016837467,0.0031690595,0.000013795237],"about_ca_topic_score_codex":0.0004603638,"about_ca_topic_score_gemma":0.00088498445,"teacher_disagreement_score":0.001600937,"about_ca_system_score_codex":0.00032932754,"about_ca_system_score_gemma":0.00026362183,"threshold_uncertainty_score":0.0053557158},"labels":[],"label_agreement":null},{"id":"W2152770850","doi":"10.1158/1078-0432.ccr-07-1216","title":"TACE/ADAM-17: A Component of the Epidermal Growth Factor Receptor Axis and a Promising Therapeutic Target in Colorectal Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Amphiregulin; Epidermal growth factor receptor; Ectodomain; Cancer research; Epidermal growth factor; TGF alpha; Tyrosine kinase; Receptor tyrosine kinase; Growth factor receptor; EGFR inhibitors; Transforming growth factor; Biology; Chemistry; Kinase; Signal transduction; Cell biology; Receptor; Biochemistry","score_opus":0.30923134052828233,"score_gpt":0.5201451766951082,"score_spread":0.21091383616682585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152770850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9392438,0.050958548,0.005060231,0.0008905658,0.00009886436,0.00009452561,0.0002796207,0.0001967749,0.0031771187],"genre_scores_gemma":[0.9806157,0.012345282,0.0037893432,0.00016937473,0.00006675187,0.00004390639,0.0004246298,0.000015036417,0.0025300067],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991715,0.000015661795,0.0000053934136,0.000011560582,0.000026380341,0.000023940445],"domain_scores_gemma":[0.999933,0.000007792607,0.0000207449,0.0000046279342,0.000013167574,0.000020662861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016463554,0.00032951534,0.00036887085,0.00024068073,0.00013741398,0.00039386854,0.00017912529,0.0002553962,0.0009379355],"category_scores_gemma":[0.00008954637,0.0000973979,0.00015494469,0.00020056078,0.00024487634,0.0002619824,0.0001690522,0.00056967355,0.00029121232],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041415307,0.00009630376,0.0015124629,0.00024890713,0.000021218735,0.00035473326,0.000022260638,0.00019936533,0.97544503,0.00021944537,0.00026726536,0.021198813],"study_design_scores_gemma":[0.00014390932,0.0021150615,0.014611988,0.000029716406,0.000110992165,0.004743411,0.00007846302,0.0017433276,0.95681983,0.00018062412,0.019413238,0.000009383698],"about_ca_topic_score_codex":0.00025371043,"about_ca_topic_score_gemma":0.00059672934,"teacher_disagreement_score":0.0009379355,"about_ca_system_score_codex":0.00032983968,"about_ca_system_score_gemma":0.00025985276,"threshold_uncertainty_score":0.0031377077},"labels":[],"label_agreement":null},{"id":"W2152963742","doi":"10.1158/1078-0432.ccr-08-2242","title":"Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":1111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Sarcopenia; Capecitabine; Breast cancer; Internal medicine; Oncology; Metastatic breast cancer; Toxicity; Anthracycline; Cancer; Taxane; Chemotherapy; Surgery; Colorectal cancer","score_opus":0.13656555023818767,"score_gpt":0.5512843355968937,"score_spread":0.41471878535870604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152963742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997092,0.00013207478,0.000028539484,0.0000120962195,0.0000013048601,0.000003749808,0.000027482167,5.585474e-7,0.00008500845],"genre_scores_gemma":[0.9998381,0.000034731613,0.000023823792,0.000008566037,0.000003473845,0.000003406655,0.00005673715,2.5774307e-7,0.000030907377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999816,0.000059612117,0.000022025168,0.000036045272,0.000036955,0.000029364466],"domain_scores_gemma":[0.999198,0.00015302145,0.00043390054,0.000025358251,0.000050009206,0.00013961145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003266995,0.00017384258,0.0002596425,0.00023445346,0.00023864841,0.0003211682,0.0000904574,0.0002296932,0.00076598214],"category_scores_gemma":[0.0014349184,0.00011782625,0.00020363928,0.00032536386,0.00014629535,0.00015062887,0.00015928799,0.0003260103,0.000079938916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081000745,0.000052150757,0.996132,0.000007798826,0.000032491826,0.00009893587,0.00003092613,0.00010502533,0.00066335266,0.0000073942792,0.000036217465,0.002023745],"study_design_scores_gemma":[0.000025472304,0.0005959952,0.99849653,0.0000043135883,0.000024770936,0.00032984352,0.000029189106,0.00032137195,0.00008706988,0.000011105476,0.0000722263,0.0000020311106],"about_ca_topic_score_codex":0.0009800657,"about_ca_topic_score_gemma":0.0017769987,"teacher_disagreement_score":0.0009800657,"about_ca_system_score_codex":0.0002474548,"about_ca_system_score_gemma":0.00020516843,"threshold_uncertainty_score":0.0025624633},"labels":[],"label_agreement":null},{"id":"W2153129739","doi":"10.1158/1078-0432.ccr-13-0246","title":"Perioperative Influenza Vaccination Reduces Postoperative Metastatic Disease by Reversing Surgery-Induced Dysfunction in Natural Killer Cells","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Perioperative; Medicine; Vaccination; Disease; Reversing; Immunology; Natural history; Immunotherapy; Surgery; Internal medicine; Immune system","score_opus":0.14382753712063343,"score_gpt":0.46438189049404177,"score_spread":0.3205543533734083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153129739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99462366,0.0031510666,0.0012351928,0.000100214245,0.00007710493,0.000056569934,0.00006841862,0.000062458974,0.00062531006],"genre_scores_gemma":[0.9959228,0.0016720634,0.001280117,0.000084793806,0.000039652634,0.000059451675,0.00017308742,0.000009720179,0.00075831544],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994016,0.000010960653,0.000007206004,0.000009417295,0.000013884426,0.000018499075],"domain_scores_gemma":[0.9999273,0.0000103552375,0.000028521601,0.000006886415,0.000008535958,0.000018360552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010980818,0.00036719991,0.0003258124,0.00009198275,0.00006390801,0.0001392145,0.0001350292,0.00014857404,0.0011823412],"category_scores_gemma":[0.00017304793,0.00006134166,0.0002000312,0.000045954494,0.00014815711,0.00015666265,0.00012388184,0.0005286698,0.00020623537],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029016056,0.0011047968,0.001207409,0.0002562152,0.000027080549,0.000037506692,0.000021450096,0.0002230354,0.95907325,0.00006962761,0.00019957787,0.034878463],"study_design_scores_gemma":[0.00084449316,0.06399436,0.044726122,0.000114373775,0.00028640867,0.0008057242,0.00012434198,0.0028646945,0.880255,0.00019941057,0.0057679107,0.000017282406],"about_ca_topic_score_codex":0.00012503396,"about_ca_topic_score_gemma":0.00024065157,"teacher_disagreement_score":0.0011823412,"about_ca_system_score_codex":0.00008444515,"about_ca_system_score_gemma":0.00020548892,"threshold_uncertainty_score":0.003955364},"labels":[],"label_agreement":null},{"id":"W2153518552","doi":"10.1158/1078-0432.ccr-06-0190","title":"Expression of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptors 1 and 2 in Melanoma","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; U.S. Public Health Service","keywords":"Melanoma; Tissue microarray; Receptor; Medicine; Receptor expression; Tumor necrosis factor alpha; Cancer research; Pathology; Necrosis; Apoptosis; Oncology; Immunohistochemistry; Internal medicine; Biology","score_opus":0.060662448574517,"score_gpt":0.40026709417671386,"score_spread":0.33960464560219683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153518552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99856997,0.00080118136,0.00023326681,0.00001572025,0.000002496616,0.000006300805,0.0000848677,0.000010502959,0.00027556618],"genre_scores_gemma":[0.9987546,0.00030590256,0.00046851815,0.00001025905,0.000004420951,0.000011735874,0.00016360922,0.0000027283174,0.00027825002],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998468,0.000028001987,0.00001599663,0.000045931552,0.000044924236,0.000018290932],"domain_scores_gemma":[0.9997149,0.000054907934,0.00013332587,0.000021858392,0.000045838155,0.000029087363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031999123,0.00015541256,0.00014254422,0.0006193621,0.00017129105,0.00026561468,0.00010595577,0.00020183844,0.00091335573],"category_scores_gemma":[0.00060012616,0.00013122923,0.00012366573,0.00026456884,0.00016922783,0.00020794633,0.00014376208,0.00017870155,0.00018829138],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010587184,0.0000830179,0.49824503,0.00016588566,0.000068479414,0.0003995554,0.00019052134,0.00033601237,0.48416165,0.00009371155,0.00017099745,0.015026415],"study_design_scores_gemma":[0.000029977538,0.0005615584,0.9374709,0.00001956761,0.00006852491,0.0033971078,0.0001629721,0.00088692707,0.055835396,0.00013575102,0.0014224964,0.000008794431],"about_ca_topic_score_codex":0.0003896191,"about_ca_topic_score_gemma":0.00047261448,"teacher_disagreement_score":0.00091335573,"about_ca_system_score_codex":0.0002260922,"about_ca_system_score_gemma":0.00013519218,"threshold_uncertainty_score":0.0030554533},"labels":[],"label_agreement":null},{"id":"W2153554960","doi":"10.1158/1078-0432.ccr-08-2678","title":"Association of <i>MDM2</i> SNP309, Age of Onset, and Gender in Cutaneous Melanoma","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Melanoma Research Alliance","keywords":"Medicine; Genotype; Melanoma; Incidence (geometry); Internal medicine; Age of onset; Epidemiology; Demography; Gynecology; Gastroenterology; Pediatrics; Genetics; Biology; Disease","score_opus":0.1579351492409101,"score_gpt":0.4779649724588059,"score_spread":0.32002982321789586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153554960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990055,0.00049920403,0.00009143752,0.000039128772,0.000007029091,0.000003106417,0.000089330446,0.000003106494,0.00026214795],"genre_scores_gemma":[0.9997328,0.0000759604,0.000050333703,0.000013538247,0.000008893938,0.0000020276282,0.00003592813,0.0000012400141,0.000079214355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997954,0.00006581664,0.00002066589,0.000046311143,0.000027161197,0.000044696764],"domain_scores_gemma":[0.9985222,0.0005006141,0.0006077521,0.00006024291,0.00007532375,0.00023384346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003600269,0.00018352488,0.00021054753,0.0003786805,0.00019051919,0.0002463047,0.00015079585,0.00035254617,0.0017983065],"category_scores_gemma":[0.0014326907,0.000107339336,0.00024252053,0.00030096565,0.00017578814,0.00017368683,0.00013069164,0.00026524547,0.000253104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004237964,0.000022588016,0.9958929,0.0000069503194,0.00002289317,0.00023057008,0.000021825554,0.00002802689,0.0020046227,0.000008646357,0.0000388072,0.0012982902],"study_design_scores_gemma":[0.0000068154945,0.00015977878,0.9975938,0.0000052304918,0.000029141585,0.0014251597,0.000044565648,0.000134267,0.00042842794,0.0000340322,0.00013588883,0.0000027389813],"about_ca_topic_score_codex":0.00068008626,"about_ca_topic_score_gemma":0.0011165699,"teacher_disagreement_score":0.0017983065,"about_ca_system_score_codex":0.000121049976,"about_ca_system_score_gemma":0.00013894011,"threshold_uncertainty_score":0.006015897},"labels":[],"label_agreement":null},{"id":"W2153666475","doi":"10.1158/1078-0432.ccr-06-0536","title":"Benzethonium Chloride: A Novel Anticancer Agent Identified by Using a Cell-Based Small-Molecule Screen","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Synthesis of Tetrazole Derivatives","field":"Chemistry","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Ontario Genomics","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Small molecule; Chemistry; Cell; Chloride; Computational biology; Combinatorial chemistry; Cancer research; Biology; Biochemistry; Organic chemistry","score_opus":0.2570836665959272,"score_gpt":0.47444212376281886,"score_spread":0.21735845716689167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153666475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93823963,0.03483931,0.015555889,0.0005454502,0.00014238169,0.0007995314,0.002201562,0.0004491989,0.007226941],"genre_scores_gemma":[0.95995927,0.017583411,0.011968295,0.0002893034,0.00004966623,0.0002113793,0.0030741447,0.000028799459,0.006835704],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982375,0.000023976503,0.00001565054,0.000036364272,0.00007894748,0.000021448415],"domain_scores_gemma":[0.9999138,0.000015441798,0.000019454583,0.000007765498,0.000030036914,0.000013471133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017388652,0.0007768758,0.0005964729,0.00057851756,0.00017412078,0.00040957428,0.0003875733,0.0004792904,0.0013595808],"category_scores_gemma":[0.00014401384,0.0001433089,0.0003541199,0.00038605643,0.00018736155,0.00022920776,0.00026672316,0.00029132282,0.00064670015],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001296849,0.00007503889,0.0007524877,0.00018505634,0.000032255826,0.00017415232,0.000011216374,0.00035637442,0.9875473,0.000068048044,0.00011724325,0.010551093],"study_design_scores_gemma":[0.000072485615,0.0015641036,0.0033231722,0.000020475967,0.00014092031,0.0007232821,0.000017810129,0.0011162767,0.9857406,0.00003478651,0.007234094,0.000012090583],"about_ca_topic_score_codex":0.00095574424,"about_ca_topic_score_gemma":0.0031210496,"teacher_disagreement_score":0.0013595808,"about_ca_system_score_codex":0.0005106905,"about_ca_system_score_gemma":0.00042412462,"threshold_uncertainty_score":0.0045482516},"labels":[],"label_agreement":null},{"id":"W2153666842","doi":"10.1158/1078-0432.ccr-12-3064","title":"New Strategies in Hodgkin Lymphoma: Better Risk Profiling and Novel Treatments","year":2013,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Lymphoma; Disease; Hodgkin lymphoma; Risk stratification; Intensive care medicine; Cancer; Oncology; Internal medicine","score_opus":0.4180967346009461,"score_gpt":0.5835940175821612,"score_spread":0.16549728298121513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153666842","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051422383,0.99904186,0.0000837016,0.00039490563,0.00008730532,0.0000029342666,0.00000619406,0.0000034670456,0.0003280965],"genre_scores_gemma":[0.00047067946,0.99876,0.00019019566,0.0002222336,0.0001408371,0.0000047644935,0.000015125494,9.0972713e-7,0.0001952564],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996482,0.00010309771,0.00005556858,0.000046476158,0.000115623174,0.000031141793],"domain_scores_gemma":[0.9994042,0.00034090612,0.000073023606,0.000020097374,0.00012838328,0.000033337063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012178447,0.0008230637,0.002022981,0.0029764273,0.00029507666,0.001199152,0.0010690353,0.0014339718,0.0033343455],"category_scores_gemma":[0.0013634027,0.00032721413,0.0007983282,0.0021674877,0.00074318494,0.0021222592,0.0008137208,0.0029841622,0.0014346684],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000687992,0.000098762095,0.00018496343,0.015977763,0.0001268578,0.00023830112,0.00009169085,0.00045703925,0.0007676508,0.0066956105,0.023085179,0.9522075],"study_design_scores_gemma":[0.000042287043,0.00012150738,0.0009599516,0.009151388,0.00016607187,0.0016964778,0.00013169755,0.00015597916,0.0002982548,0.0059313774,0.9813168,0.00002819214],"about_ca_topic_score_codex":0.0012588295,"about_ca_topic_score_gemma":0.002400969,"teacher_disagreement_score":0.0033343455,"about_ca_system_score_codex":0.0009378828,"about_ca_system_score_gemma":0.0010967207,"threshold_uncertainty_score":0.011154473},"labels":[],"label_agreement":null},{"id":"W2153732710","doi":"10.1158/1078-0432.ccr-03-0470","title":"<b> <i>Skp2</i> </b> Gene Copy Number Aberrations Are Common in Non-Small Cell Lung Carcinoma, and Its Overexpression in Tumors with <b> <i>ras</i> </b> Mutation Is a Poor Prognostic Marker","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Biology; Cancer research; SKP2; Mutation; Cell cycle; Adenocarcinoma; Gene; Lung cancer; Copy-number variation; Gene mutation; Gene dosage; Gene expression; Cancer; Molecular biology; Pathology; Genetics; Medicine; Ubiquitin","score_opus":0.05996688744326527,"score_gpt":0.44183755208976144,"score_spread":0.38187066464649616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153732710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986632,0.0005819497,0.00030583516,0.000010596211,0.0000012328725,0.000007298731,0.00020465982,0.000014114579,0.00021114152],"genre_scores_gemma":[0.99833184,0.00036042568,0.0004168466,0.0000069715416,0.000004010998,0.000011507126,0.00056999025,0.0000040214386,0.00029428772],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998653,0.000016187143,0.000014334479,0.000034975266,0.00004936247,0.000019859684],"domain_scores_gemma":[0.9997365,0.000049797516,0.00012017515,0.000020766394,0.0000330053,0.000039779276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015891645,0.00027885553,0.00021616656,0.00064262486,0.00013925407,0.00026410611,0.00014297765,0.00020272778,0.0017434749],"category_scores_gemma":[0.00034232673,0.00010887345,0.00012436912,0.0004334604,0.00027965318,0.00016750461,0.00016635256,0.00016686172,0.00041057836],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008395679,0.000060860042,0.25024098,0.0001469224,0.000074349715,0.000624676,0.000040323863,0.00015430895,0.73958373,0.000034993438,0.00008287502,0.0081164185],"study_design_scores_gemma":[0.000018803199,0.0005755928,0.82213336,0.000008089238,0.00008707132,0.0057519055,0.00007177944,0.0005552594,0.16969493,0.00007067826,0.0010260512,0.000006503011],"about_ca_topic_score_codex":0.00065256737,"about_ca_topic_score_gemma":0.000871734,"teacher_disagreement_score":0.0017434749,"about_ca_system_score_codex":0.00020514769,"about_ca_system_score_gemma":0.00014309125,"threshold_uncertainty_score":0.0058324933},"labels":[],"label_agreement":null},{"id":"W2153921055","doi":"10.1158/1078-0432.ccr-08-0529","title":"Phase II Trial of Short-Course CHOP-R Followed by 90Y-ibritumomab Tiuxetan and Extended Rituximab in Previously Untreated Follicular Lymphoma","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Rituximab; Medicine; Chemoimmunotherapy; Radioimmunotherapy; Follicular lymphoma; Ibritumomab tiuxetan; CHOP; Nuclear medicine; Vincristine; Lymphoma; Internal medicine; Gastroenterology; Cyclophosphamide; Chemotherapy; Immunology; Antibody","score_opus":0.1457220537021659,"score_gpt":0.4981432744785355,"score_spread":0.3524212207763696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153921055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974662,0.0006989626,0.00024014837,0.00014030057,0.000059802802,0.00087637536,0.000119422955,0.000033914814,0.00036482172],"genre_scores_gemma":[0.994922,0.00052739994,0.0008954168,0.00035884968,0.00016127227,0.0015047512,0.00071683165,0.00001205615,0.0009013577],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99935156,0.00039106136,0.000034602264,0.0000861871,0.00004357561,0.00009308345],"domain_scores_gemma":[0.99876416,0.00025886405,0.00026181233,0.000116423966,0.000055026478,0.0005436919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022198448,0.0012745404,0.0016939774,0.0002980073,0.00040240353,0.00060915196,0.00085055147,0.0010387369,0.0025933713],"category_scores_gemma":[0.0013487135,0.00052884093,0.0008029791,0.0002756339,0.001058015,0.0007133714,0.00037643831,0.0023417617,0.0006026214],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8831716,0.052524906,0.0052500553,0.0002996602,0.00060649286,0.00020482561,0.00021546347,0.0014860282,0.016278675,0.000120389865,0.0009654985,0.038876347],"study_design_scores_gemma":[0.5898954,0.39874104,0.006890701,0.000023291852,0.00017254293,0.00018954146,0.000034355366,0.001037658,0.0020742514,0.00006103981,0.000866052,0.000014103959],"about_ca_topic_score_codex":0.00075649767,"about_ca_topic_score_gemma":0.0011893088,"teacher_disagreement_score":0.0025933713,"about_ca_system_score_codex":0.0008148724,"about_ca_system_score_gemma":0.0012922056,"threshold_uncertainty_score":0.01173979},"labels":[],"label_agreement":null},{"id":"W2154297950","doi":"10.1158/1078-0432.ccr-08-3291","title":"Abnormalities in Glucose Uptake and Metabolism in Imatinib-Resistant Human BCR-ABL–Positive Cells","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Novartis Pharma","keywords":"Imatinib; Oxidative phosphorylation; Glycolysis; K562 cells; Citric acid cycle; Glucose uptake; Biology; Imatinib mesylate; Biochemistry; Chemistry; Metabolism; Internal medicine; Endocrinology; Cancer research; Cell; Myeloid leukemia; Medicine; Insulin","score_opus":0.1295846495074042,"score_gpt":0.4863216507226815,"score_spread":0.3567370012152773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154297950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99562967,0.0014240681,0.0010192061,0.000044979795,0.000013530806,0.000018599272,0.001074323,0.00003676708,0.00073884084],"genre_scores_gemma":[0.99545926,0.00070647954,0.0013684953,0.000040488303,0.000004941082,0.000044950917,0.0016480086,0.0000109682405,0.00071625935],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998331,0.000032577416,0.000024379078,0.000034019286,0.00005314115,0.000022624741],"domain_scores_gemma":[0.99994075,0.0000132495925,0.000016197891,0.000009396676,0.000010095901,0.000010291384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011746065,0.00029270595,0.00029437954,0.00034808088,0.00015611017,0.00022246387,0.00013999525,0.00027510858,0.00087938795],"category_scores_gemma":[0.00012546295,0.00014486376,0.00021352648,0.00041941614,0.00014402442,0.00016069699,0.0001502999,0.00022847007,0.00029201581],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021635134,0.000017246459,0.0008410569,0.00001591721,0.0000077398045,0.00008652515,0.000025401401,0.000077907804,0.9978941,0.00003426749,0.000020675056,0.00076272915],"study_design_scores_gemma":[0.000025405407,0.00066150393,0.06854758,0.0000061334213,0.000032529108,0.0010252459,0.00010535532,0.0016203563,0.92619294,0.00008572241,0.0016775168,0.000019636738],"about_ca_topic_score_codex":0.0009925342,"about_ca_topic_score_gemma":0.0006745443,"teacher_disagreement_score":0.0009925342,"about_ca_system_score_codex":0.00019117046,"about_ca_system_score_gemma":0.000101697595,"threshold_uncertainty_score":0.0029417872},"labels":[],"label_agreement":null},{"id":"W2154442758","doi":"10.1158/1078-0432.ccr-05-1331","title":"Measurement of Serum Levels of Macrophage Inhibitory Cytokine 1 Combined with Prostate-Specific Antigen Improves Prostate Cancer Diagnosis","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"GDF15 and Related Biomarkers","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Prostate cancer; Medicine; Prostate-specific antigen; Prostate; Macrophage migration inhibitory factor; Antigen; Cancer; Population; Immunoassay; Internal medicine; Pathology; Oncology; Cytokine; Immunology; Urology; Antibody","score_opus":0.12499139623553443,"score_gpt":0.4176536910026246,"score_spread":0.29266229476709016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154442758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922706,0.0043447814,0.0020683696,0.0002080133,0.000029485569,0.00004353992,0.00019328675,0.0001014063,0.00074055104],"genre_scores_gemma":[0.99684024,0.00045802543,0.002286184,0.000068827525,0.000034141773,0.000016714406,0.00015254277,0.000003160485,0.00014022375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958926,0.0001721836,0.000028226881,0.00007868119,0.00009387369,0.000037785394],"domain_scores_gemma":[0.99912196,0.0004231145,0.00025187767,0.0000426647,0.000079853315,0.000080596816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007072577,0.00047187755,0.0006291338,0.0005822467,0.0001229751,0.00038640306,0.00024371964,0.00040761722,0.001403846],"category_scores_gemma":[0.0027033698,0.00016911299,0.00017156548,0.0003539177,0.0002805649,0.00028175671,0.00028850825,0.0004463294,0.00032676177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022591578,0.0005081489,0.9025492,0.00015527141,0.00014464498,0.000060580925,0.000040785722,0.0005072062,0.032863017,0.000040903047,0.0005925265,0.060278572],"study_design_scores_gemma":[0.00008752136,0.0029306842,0.9683216,0.000031900625,0.00017603669,0.0012275163,0.000055143624,0.0045275567,0.021447113,0.0001440665,0.0010364323,0.000014321805],"about_ca_topic_score_codex":0.00027619608,"about_ca_topic_score_gemma":0.00034535985,"teacher_disagreement_score":0.001403846,"about_ca_system_score_codex":0.00017615897,"about_ca_system_score_gemma":0.00015921601,"threshold_uncertainty_score":0.0046963096},"labels":[],"label_agreement":null},{"id":"W2154488022","doi":"10.1158/1078-0432.ccr-10-1869","title":"Gefitinib or Placebo in Combination with Tamoxifen in Patients with Hormone Receptor–Positive Metastatic Breast Cancer: A Randomized Phase II Study","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"National Cancer Institute","keywords":"Gefitinib; Tamoxifen; Medicine; Internal medicine; Breast cancer; Placebo; Oncology; Metastatic breast cancer; Cancer; Epidermal growth factor receptor; Pathology","score_opus":0.13883671522188215,"score_gpt":0.4788527990782955,"score_spread":0.34001608385641335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154488022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793555,0.009312292,0.0007606397,0.0008850692,0.00085032504,0.00601187,0.0010286138,0.00013732006,0.0016584132],"genre_scores_gemma":[0.9806958,0.0052358513,0.0012558699,0.001193766,0.0009462307,0.0073988675,0.0010378644,0.000025399091,0.0022103381],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989215,0.0006670812,0.00006388464,0.0001592276,0.00006561428,0.00012275556],"domain_scores_gemma":[0.99890876,0.00033967698,0.0002802751,0.000096093776,0.000073483214,0.0003016903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025337467,0.0021984589,0.004529623,0.00068022753,0.00047514567,0.0011256905,0.0009334534,0.0021654312,0.006928897],"category_scores_gemma":[0.0022953528,0.00086936663,0.0024848909,0.0005607241,0.0012253829,0.0013231264,0.00043843768,0.002458655,0.0011435475],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97820264,0.0072928537,0.0004529713,0.0005485288,0.0008253509,0.000028154582,0.000028244218,0.00022440124,0.0013473926,0.000043228014,0.0003740315,0.010632222],"study_design_scores_gemma":[0.94104797,0.057235785,0.0007906979,0.000019808736,0.00028819358,0.000019327203,0.000009055454,0.00016073986,0.00010603414,0.000050181698,0.00026496718,0.000007229807],"about_ca_topic_score_codex":0.0006491121,"about_ca_topic_score_gemma":0.0017162494,"teacher_disagreement_score":0.006928897,"about_ca_system_score_codex":0.00088599144,"about_ca_system_score_gemma":0.0011926964,"threshold_uncertainty_score":0.023179471},"labels":[],"label_agreement":null},{"id":"W2154638518","doi":"10.1158/1078-0432.ccr-04-1261","title":"Gain of OGP, an Estrogen-Regulated Oviduct-Specific Glycoprotein, Is Associated with the Development of Endometrial Hyperplasia and Endometrial Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Vancouver Hospital and Health Sciences Centre; University of British Columbia","funders":"","keywords":"Oviduct; Endometrium; Atypical hyperplasia; Endometrial cancer; Immunohistochemistry; PTEN; Endometrial hyperplasia; Tissue microarray; Hyperplasia; Biology; Internal medicine; Endometrial Polyp; Endocrinology; Cancer; Medicine; Apoptosis","score_opus":0.15676110840128546,"score_gpt":0.4450517754876193,"score_spread":0.2882906670863339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154638518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99892455,0.0005632864,0.000275545,0.000012614304,0.0000016724733,0.0000045454735,0.00004342286,0.000005137975,0.00016903735],"genre_scores_gemma":[0.9991873,0.00024325986,0.00028302186,0.000009440613,0.0000032439798,0.0000051673546,0.00012209952,0.0000018957749,0.00014457783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979,0.000044358676,0.000021351369,0.000049291153,0.00006436668,0.00003065725],"domain_scores_gemma":[0.9993937,0.00010655994,0.0002985892,0.00005227748,0.00005343311,0.00009544431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049896206,0.00017759706,0.00020568905,0.0006624171,0.00016942335,0.0002873117,0.00016215927,0.0001978436,0.0008770382],"category_scores_gemma":[0.000852133,0.00015614933,0.00015447086,0.00038562587,0.0003489747,0.00020347392,0.0003031407,0.00024140558,0.00015550846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019968897,0.000087627246,0.73595446,0.0001278628,0.00012181558,0.00093166437,0.0001062313,0.00011346991,0.24821217,0.00009581716,0.00009647238,0.012155435],"study_design_scores_gemma":[0.00001594971,0.00026821566,0.98152506,0.000006137263,0.000044249147,0.002858489,0.0000833448,0.00038172206,0.014075124,0.000073023555,0.0006647441,0.0000038891203],"about_ca_topic_score_codex":0.00037957865,"about_ca_topic_score_gemma":0.00039140918,"teacher_disagreement_score":0.0008770382,"about_ca_system_score_codex":0.00022901312,"about_ca_system_score_gemma":0.00017775598,"threshold_uncertainty_score":0.0029340386},"labels":[],"label_agreement":null},{"id":"W2154670277","doi":"10.1158/1078-0432.ccr-05-0421","title":"Molecular Study of Malignant Gliomas Treated with Epidermal Growth Factor Receptor Inhibitors: Tissue Analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":250,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; Memorial Sloan-Kettering Cancer Center","keywords":"Gefitinib; Erlotinib; Epidermal growth factor receptor; Erlotinib Hydrochloride; Glioma; Lung cancer; Cancer research; EGFR inhibitors; Medicine; Oncology; Biology; Internal medicine; Cancer","score_opus":0.12680459887152382,"score_gpt":0.4648447428145399,"score_spread":0.33804014394301607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154670277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99830663,0.0005930223,0.00010004556,0.000045507597,0.0000040948516,0.00006805872,0.0004012077,0.0000043192176,0.00047715663],"genre_scores_gemma":[0.99663216,0.0003100193,0.00027590655,0.00007080915,0.000016007863,0.00013289065,0.0022426925,0.0000046687924,0.00031482693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933916,0.0003163903,0.00004926193,0.00008762647,0.00013010489,0.000077412056],"domain_scores_gemma":[0.9992536,0.00017189611,0.0002556964,0.00007605617,0.0001079188,0.00013478662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010057014,0.00036546227,0.0006528974,0.00051170256,0.00028205718,0.0003656491,0.0004117939,0.00030092403,0.0010669088],"category_scores_gemma":[0.0009207947,0.00019297493,0.0003256891,0.0006493466,0.00034291486,0.00016008264,0.00019143515,0.000317212,0.00025889598],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049971692,0.00235813,0.7848202,0.00056198775,0.0015125761,0.0020216517,0.00038988388,0.0010995467,0.11680049,0.00019670796,0.0021003305,0.038166825],"study_design_scores_gemma":[0.002743072,0.009872145,0.96465355,0.000015562273,0.0005144472,0.0034377675,0.00016122706,0.000408876,0.014284314,0.00005310947,0.003841551,0.000014490356],"about_ca_topic_score_codex":0.0033442816,"about_ca_topic_score_gemma":0.0071019707,"teacher_disagreement_score":0.0033442816,"about_ca_system_score_codex":0.0007014685,"about_ca_system_score_gemma":0.00089609704,"threshold_uncertainty_score":0.0066496134},"labels":[],"label_agreement":null},{"id":"W2154736427","doi":"10.1158/1078-0432.ccr-06-0474","title":"High-Dose Celecoxib and Metronomic “Low-dose” Cyclophosphamide Is an Effective and Safe Therapy in Patients with Relapsed and Refractory Aggressive Histology Non–Hodgkin's Lymphoma","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Cyclophosphamide; Chemotherapy; Phases of clinical research; Lymphoma; Oncology; Surgery","score_opus":0.03089044926751248,"score_gpt":0.3818962638238433,"score_spread":0.3510058145563308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154736427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99736905,0.0019255799,0.00016991269,0.00010224512,0.000010669793,0.000052466097,0.00004104013,0.000020738786,0.00030832688],"genre_scores_gemma":[0.9987791,0.00045953054,0.00031528014,0.000101089725,0.000035169207,0.00003174653,0.00015972105,0.0000019730874,0.00011645347],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997881,0.00011370732,0.000019425906,0.00002158468,0.000031124473,0.000026032669],"domain_scores_gemma":[0.99965966,0.00007777059,0.000104441395,0.000024037263,0.00001491129,0.00011920008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046650265,0.0003329939,0.0008557473,0.00015842867,0.00015821957,0.0002965562,0.00028712495,0.00027152197,0.0006003186],"category_scores_gemma":[0.0006316719,0.0001309862,0.00024032622,0.0002415108,0.00041629185,0.00024965015,0.00016150622,0.00052008877,0.00013459842],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13666826,0.012404369,0.25025502,0.0010893251,0.0012103999,0.0019266608,0.00047130528,0.0028407734,0.17000932,0.00022746471,0.0036310302,0.41926622],"study_design_scores_gemma":[0.041892663,0.23840113,0.6794607,0.00011197284,0.0007426876,0.0043391604,0.00025728974,0.0036941068,0.023768403,0.00021113937,0.0070764255,0.0000444423],"about_ca_topic_score_codex":0.0002498316,"about_ca_topic_score_gemma":0.0009666111,"teacher_disagreement_score":0.0008557473,"about_ca_system_score_codex":0.0002663679,"about_ca_system_score_gemma":0.00032911944,"threshold_uncertainty_score":0.0024670959},"labels":[],"label_agreement":null},{"id":"W2154796235","doi":"10.1158/1078-0432.ccr-07-0342","title":"Fas Ligand Delivery by a Prostate-Restricted Replicative Adenovirus Enhances Safety and Antitumor Efficacy","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Fas ligand; Prostate cancer; Bystander effect; Cancer research; Apoptosis; Prostate; Oncolytic virus; Systemic administration; In vivo; Biology; Antigen; Gene delivery; Genetic enhancement; Immune system; Cancer; Immunology; Medicine; Internal medicine; Programmed cell death; Gene","score_opus":0.0613555043708848,"score_gpt":0.4433051042977801,"score_spread":0.38194959992689526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154796235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98947936,0.003988746,0.004966821,0.00010209061,0.000031695945,0.000057135847,0.00009442937,0.00018282703,0.00109682],"genre_scores_gemma":[0.9945681,0.00085947505,0.0034924226,0.000023115985,0.000013752637,0.000014331334,0.000115178846,0.000014438502,0.00089914986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977285,0.000041769912,0.000023913102,0.000043404852,0.00007679981,0.000041250536],"domain_scores_gemma":[0.9997905,0.000039873496,0.000072703486,0.0000313439,0.000035334317,0.000030286143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029235595,0.00041346782,0.0003166222,0.00032988374,0.00008577019,0.00036956178,0.00020445584,0.00026000617,0.0008239446],"category_scores_gemma":[0.00018122222,0.000092035225,0.0002569077,0.00020259617,0.00024057129,0.0003039,0.0001401995,0.00048014658,0.00022231587],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018477727,0.000073516356,0.00034627703,0.000075164775,0.000009736599,0.00003697068,0.000015993724,0.00018716443,0.99204564,0.00015215664,0.000029220731,0.0068434817],"study_design_scores_gemma":[0.000042261585,0.0014967809,0.0014693654,0.0000070205606,0.000038849706,0.00034353705,0.0000112081725,0.0010221988,0.99340653,0.000039542265,0.0021180182,0.0000046582377],"about_ca_topic_score_codex":0.00030644517,"about_ca_topic_score_gemma":0.0003149258,"teacher_disagreement_score":0.0008239446,"about_ca_system_score_codex":0.0003974784,"about_ca_system_score_gemma":0.00032249247,"threshold_uncertainty_score":0.0028839111},"labels":[],"label_agreement":null},{"id":"W2154812064","doi":"10.1158/1078-0432.ccr-06-1653","title":"A Phase Ib and Pharmacokinetic Trial of Patupilone Combined with Carboplatin in Patients with Advanced Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Carboplatin; Tolerability; Nausea; Pharmacokinetics; Vomiting; Adverse effect; Phases of clinical research; Area under the curve; Neutropenia; Internal medicine; Urology; Chemotherapy; Oncology; Gastroenterology; Pharmacology; Surgery; Cisplatin","score_opus":0.14233468841941216,"score_gpt":0.5699323937793035,"score_spread":0.42759770535989133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154812064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946642,0.001476156,0.0003067716,0.00032810064,0.000072658484,0.0012819127,0.0004118667,0.00008876227,0.0013695362],"genre_scores_gemma":[0.9947359,0.0009787242,0.0008035788,0.00035470678,0.000101719146,0.0008590329,0.0010712014,0.000019047338,0.0010760304],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99968123,0.00012747446,0.000020072293,0.000065755165,0.000030965304,0.00007448997],"domain_scores_gemma":[0.99943095,0.000059133275,0.00011342782,0.000039888593,0.00002643348,0.00033015784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008469264,0.0014662482,0.0017396061,0.0004835164,0.00039168686,0.0010090495,0.0008749077,0.0010625847,0.0034276294],"category_scores_gemma":[0.000623306,0.00047527882,0.000902356,0.0006439224,0.00089684146,0.00085764856,0.0003565389,0.0034710122,0.0007025265],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73550886,0.07042591,0.008622792,0.00086084247,0.0012645024,0.0004745356,0.00033833706,0.0035906788,0.057266362,0.00028300003,0.0036114713,0.11775262],"study_design_scores_gemma":[0.48931506,0.48701823,0.011682305,0.000040521092,0.00040514197,0.00048233816,0.000059399008,0.0016568308,0.0068161795,0.00012981164,0.0023660418,0.000028080456],"about_ca_topic_score_codex":0.0009420028,"about_ca_topic_score_gemma":0.0017823431,"teacher_disagreement_score":0.0034276294,"about_ca_system_score_codex":0.0011223,"about_ca_system_score_gemma":0.0014648031,"threshold_uncertainty_score":0.011466563},"labels":[],"label_agreement":null},{"id":"W2155041167","doi":"10.1158/1078-0432.ccr-12-2459","title":"Topotecan and Doxorubicin Combination to Treat Recurrent Ovarian Cancer: The Influence of Drug Exposure Time and Delivery Systems to Achieve Optimum Therapeutic Activity","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Centre for Drug Research and Development","funders":"University of British Columbia; Canadian Institutes of Health Research; British Columbia Innovation Council","keywords":"Topotecan; Pharmacology; Medicine; Doxorubicin; Ovarian cancer; Pharmacokinetics; Combination therapy; Drug; Paclitaxel; Chemotherapy; Cancer; Internal medicine","score_opus":0.06097591290692741,"score_gpt":0.40184297557309395,"score_spread":0.34086706266616656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155041167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99232364,0.0035596879,0.002697127,0.00009728342,0.00002011921,0.00010206285,0.00013337034,0.00005212582,0.0010145124],"genre_scores_gemma":[0.99512523,0.0016421193,0.0025153996,0.000021656562,0.000009961234,0.000035246598,0.000112989896,0.000010901167,0.0005265173],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988294,0.0000201335,0.000010821104,0.00002550597,0.000035946243,0.00002453395],"domain_scores_gemma":[0.9999397,0.000014801949,0.00002187897,0.000004813488,0.000006469108,0.000012300304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019141378,0.00035334122,0.00033443258,0.0001839071,0.00009802301,0.00046111352,0.00018224215,0.00025276205,0.0008035646],"category_scores_gemma":[0.00018626661,0.00011112519,0.0001533552,0.00016267899,0.0001577586,0.0003777636,0.00015731367,0.00040131537,0.00016063968],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007941138,0.00018778889,0.0003028331,0.00009546821,0.000016010476,0.00005123992,0.00001754288,0.0006795305,0.9874702,0.000093538954,0.00008284192,0.010208913],"study_design_scores_gemma":[0.00014412125,0.0028197842,0.0025845582,0.0000082889865,0.000067078494,0.00027756346,0.000013548477,0.001961659,0.9897794,0.000019410296,0.002313065,0.0000115522125],"about_ca_topic_score_codex":0.00081941887,"about_ca_topic_score_gemma":0.0019871925,"teacher_disagreement_score":0.00081941887,"about_ca_system_score_codex":0.0005010174,"about_ca_system_score_gemma":0.0003404055,"threshold_uncertainty_score":0.003635168},"labels":[],"label_agreement":null},{"id":"W2155054198","doi":"10.1158/1078-0432.ccr-04-1439","title":"An 19F Magnetic Resonance–Based <i>In Vivo</i> Assay of Solid Tumor Methotrexate Resistance: Proof of Principle","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lanthanide and Transition Metal Complexes","field":"Materials Science","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"In vivo; Methotrexate; Magnetic resonance imaging; Sarcoma; Pharmacokinetics; Chemotherapy; Antifolate; Medicine; Bolus (digestion); Pharmacology; Chemistry; Pathology; Nuclear magnetic resonance; Cancer research; Antimetabolite; Internal medicine; Biology","score_opus":0.14480404926727497,"score_gpt":0.48723478994590874,"score_spread":0.34243074067863377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155054198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.716682,0.0054236143,0.26667136,0.00096228835,0.00012605201,0.0008027929,0.0014322925,0.0015195084,0.0063800937],"genre_scores_gemma":[0.90145075,0.0025520367,0.090838864,0.00024779054,0.0000840629,0.00036283064,0.0007022872,0.00010877728,0.0036526131],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997098,0.000083644605,0.000011632051,0.00007109448,0.00010247403,0.000021238004],"domain_scores_gemma":[0.9996959,0.00008882417,0.000117620286,0.000030085032,0.000040741626,0.000026844367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005506019,0.00060564495,0.00029043652,0.00021517456,0.00012241691,0.00037491016,0.00033535797,0.000544309,0.001016798],"category_scores_gemma":[0.0004973317,0.00022907188,0.00022357234,0.00011384902,0.0004399354,0.00029611768,0.0001582822,0.00059700554,0.00052161067],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091318165,0.00003663222,0.00023347394,0.00003313917,0.0000039341603,0.000019806903,0.0000090549165,0.00012613485,0.99655473,0.000070907845,0.000093280934,0.0027275546],"study_design_scores_gemma":[0.000022353528,0.0006222382,0.0013975013,0.0000049874748,0.000016499804,0.00023800075,0.000007753966,0.0011834058,0.9949804,0.000039392424,0.0014815655,0.0000058772875],"about_ca_topic_score_codex":0.0004381527,"about_ca_topic_score_gemma":0.00046001264,"teacher_disagreement_score":0.001016798,"about_ca_system_score_codex":0.00026183584,"about_ca_system_score_gemma":0.00027283112,"threshold_uncertainty_score":0.0034015179},"labels":[],"label_agreement":null},{"id":"W2155244882","doi":"10.1158/1078-0432.ccr-11-2890","title":"Failure of Iniparib to Inhibit Poly(ADP-Ribose) Polymerase <i>In Vitro</i>","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":211,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Veliparib; Olaparib; PARP inhibitor; Poly ADP ribose polymerase; Cancer research; Pharmacology; Medicine; Biology; Polymerase; Biochemistry; Enzyme","score_opus":0.2767273602044271,"score_gpt":0.5716575263099984,"score_spread":0.2949301661055713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155244882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863101,0.002169439,0.007085288,0.00008188737,0.00006481982,0.000072956354,0.0006901328,0.00013402804,0.003391427],"genre_scores_gemma":[0.9925674,0.0010317656,0.0027652641,0.00011984343,0.000021745125,0.00006024566,0.0016146326,0.000036455636,0.0017826997],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995733,0.00011343056,0.000059314538,0.0000994488,0.00008158107,0.00007285911],"domain_scores_gemma":[0.99945194,0.00016991732,0.00013313071,0.00012997136,0.000054583877,0.000060546783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033120724,0.0005407373,0.00041783546,0.00019353878,0.00021076748,0.0005454804,0.00045642073,0.0003647491,0.0016638776],"category_scores_gemma":[0.00038058794,0.00012900245,0.00030162287,0.00018777845,0.00022580591,0.00021921787,0.00016854664,0.0008215522,0.00064407557],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004880516,0.00047949422,0.00062560325,0.00009384348,0.000025211883,0.00009112023,0.00002011925,0.00044239435,0.99042904,0.0001734549,0.00019660396,0.0069349646],"study_design_scores_gemma":[0.000021931985,0.0014686909,0.001559818,0.0000039302795,0.000021458874,0.00040883667,0.000007179951,0.00066117186,0.99409455,0.000031901778,0.0017174862,0.0000030272413],"about_ca_topic_score_codex":0.00061510125,"about_ca_topic_score_gemma":0.00041482237,"teacher_disagreement_score":0.0016638776,"about_ca_system_score_codex":0.00047139786,"about_ca_system_score_gemma":0.00040748922,"threshold_uncertainty_score":0.0055661798},"labels":[],"label_agreement":null},{"id":"W2155311753","doi":"10.1158/1078-0432.ccr-13-1049","title":"<i>TMPRSS2-ERG</i> Status Is Not Prognostic Following Prostate Cancer Radiotherapy: Implications for Fusion Status and DSB Repair","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"TMPRSS2; Erg; Prostate cancer; Medicine; Oncology; Prostate; Internal medicine; Cohort; Context (archaeology); Tissue microarray; Proportional hazards model; Cancer; Biology; Ophthalmology","score_opus":0.16376934668636645,"score_gpt":0.5108692551667048,"score_spread":0.34709990848033834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155311753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995875,0.00008148456,0.00009094032,0.000017863356,0.0000014594247,0.0000024788364,0.00008093878,0.000002122924,0.00013533937],"genre_scores_gemma":[0.99983346,0.000010206306,0.000021778187,0.000005526774,0.0000023681073,0.0000012752586,0.00009103846,8.4730044e-7,0.000033317334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981934,0.0000406727,0.000015767442,0.00005222473,0.000032081796,0.00004002476],"domain_scores_gemma":[0.999193,0.00020409247,0.0003449706,0.00007649118,0.000042381904,0.00013901462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000408613,0.00016081655,0.00026606026,0.00022515471,0.00021545212,0.00030211787,0.00028699002,0.00025841754,0.0017880575],"category_scores_gemma":[0.0010547026,0.00008200162,0.00026928034,0.0003164043,0.0003594704,0.00016863893,0.00020240137,0.00032147393,0.00018265356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014101597,0.00002481345,0.99121207,0.0000119163815,0.000050432045,0.00012828458,0.000044529133,0.00017191931,0.0042799264,0.00002309881,0.0000705051,0.002572255],"study_design_scores_gemma":[0.000025547082,0.00046664182,0.9969644,0.000003135243,0.000056548022,0.0009678735,0.000052527004,0.00043541245,0.0007746337,0.0000706256,0.0001790882,0.0000035222424],"about_ca_topic_score_codex":0.0011109747,"about_ca_topic_score_gemma":0.0013263312,"teacher_disagreement_score":0.0017880575,"about_ca_system_score_codex":0.00018312335,"about_ca_system_score_gemma":0.00022232455,"threshold_uncertainty_score":0.005981624},"labels":[],"label_agreement":null},{"id":"W2155457708","doi":"10.1158/1078-0432.ccr-04-1130","title":"Dietary Flaxseed Enhances the Inhibitory Effect of Tamoxifen on the Growth of Estrogen-Dependent Human Breast Cancer (MCF-7) in Nude Mice","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Phytoestrogen effects and research","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health","keywords":"Ovariectomized rat; Tamoxifen; Estrogen; MCF-7; Breast cancer; Endocrinology; Internal medicine; Medicine; Implant; Estrogen receptor; Antiestrogen; Cancer; Human breast; Surgery","score_opus":0.11442193029961356,"score_gpt":0.5019148404907169,"score_spread":0.3874929101911033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155457708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962541,0.0020451436,0.000361768,0.00012262337,0.000036276935,0.000025848363,0.00022515852,0.000059298716,0.0008698274],"genre_scores_gemma":[0.9917434,0.0024493723,0.0012293088,0.00013072396,0.00003132935,0.0000610962,0.0005523297,0.000027147316,0.0037752679],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988484,0.000024965977,0.000009279078,0.000021317926,0.000026769365,0.000032767246],"domain_scores_gemma":[0.99988246,0.000019610368,0.000033387576,0.000009437142,0.000011846495,0.00004329699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014181038,0.00052095554,0.0004335672,0.00039643855,0.00013929854,0.00018877424,0.0001991311,0.00036464655,0.001234204],"category_scores_gemma":[0.00012765518,0.00016701852,0.00034282528,0.0001267693,0.00020510152,0.00024222268,0.00015051012,0.0004800187,0.00025840622],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016424344,0.0002872222,0.00019262933,0.00005396046,0.000013929012,0.00003448121,0.000013790795,0.000036817702,0.9954462,0.000015621787,0.000044861976,0.002217984],"study_design_scores_gemma":[0.00020682371,0.010324587,0.0072836913,0.000018626546,0.00010025779,0.00021235974,0.000049530016,0.00050445367,0.9782799,0.000030498439,0.0029786178,0.000010636594],"about_ca_topic_score_codex":0.0010972092,"about_ca_topic_score_gemma":0.002036674,"teacher_disagreement_score":0.001234204,"about_ca_system_score_codex":0.00020163474,"about_ca_system_score_gemma":0.00018855117,"threshold_uncertainty_score":0.0041288137},"labels":[],"label_agreement":null},{"id":"W2155724119","doi":"10.1158/1078-0432.ccr-05-1652","title":"Application of Oligonucleotide Microarrays to Assess the Biological Effects of Neoadjuvant Imatinib Mesylate Treatment for Localized Prostate Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Imatinib mesylate; Prostate cancer; Tissue microarray; Cancer research; Medicine; Cancer; Immunohistochemistry; Pathology; Laser capture microdissection; Gene expression; Oncology; Biology; Internal medicine; Imatinib; Gene","score_opus":0.27743457004309985,"score_gpt":0.5688233716791935,"score_spread":0.29138880163609365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155724119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840285,0.002168245,0.01086132,0.00015984272,0.00003646722,0.00010010928,0.0012979949,0.0001255229,0.0012219686],"genre_scores_gemma":[0.97627705,0.0010989663,0.01882103,0.00017343607,0.000024607147,0.00028807585,0.0022548456,0.00001243156,0.0010497007],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997557,0.0000668785,0.000015653266,0.00006187923,0.0000731261,0.000026808004],"domain_scores_gemma":[0.99986625,0.000052494233,0.000031857893,0.000013823472,0.000024445912,0.0000111271065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023548875,0.00019949654,0.0002116241,0.00028004326,0.00013971106,0.00019324874,0.00009116175,0.00021917504,0.00069894636],"category_scores_gemma":[0.00034235578,0.0001327616,0.00014959229,0.00023286395,0.00012993341,0.00011732364,0.00008685299,0.0002829336,0.00024063209],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015486793,0.000032347463,0.0034348844,0.000041125517,0.000018549596,0.000018737957,0.00001677364,0.00032573708,0.9911691,0.000023469469,0.000079932106,0.004684483],"study_design_scores_gemma":[0.00004239194,0.001649949,0.13679546,0.000016247322,0.00014622464,0.00053123076,0.00009039078,0.0086783925,0.84818226,0.00019626881,0.0036491842,0.00002205915],"about_ca_topic_score_codex":0.00027531272,"about_ca_topic_score_gemma":0.0007298973,"teacher_disagreement_score":0.00069894636,"about_ca_system_score_codex":0.0002583816,"about_ca_system_score_gemma":0.00017197529,"threshold_uncertainty_score":0.0023382306},"labels":[],"label_agreement":null},{"id":"W2155998628","doi":"10.1158/1078-0432.ccr-07-4117","title":"A Multiparametric Serum Kallikrein Panel for Diagnosis of Non–Small Cell Lung Carcinoma","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"National Cancer Institute; Medical University of South Carolina","keywords":"Kallikrein; Lung cancer; Proteases; Cancer; Receiver operating characteristic; Medicine; Pathology; Internal medicine; Oncology; Biology","score_opus":0.37173242829733394,"score_gpt":0.4890334696600283,"score_spread":0.11730104136269437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155998628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99403524,0.0012833485,0.0026628866,0.00016076246,0.00003532591,0.00008517527,0.00040921738,0.000108992375,0.0012190893],"genre_scores_gemma":[0.9972154,0.00012583088,0.0020140228,0.00005480885,0.000019362229,0.000044882818,0.00034574777,0.0000034665638,0.00017653091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992126,0.00024064686,0.0000970776,0.00013153728,0.0002568659,0.00006127047],"domain_scores_gemma":[0.9988085,0.00036748624,0.00026021412,0.0000659552,0.0002896226,0.00020829066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010707802,0.00046376875,0.00051605655,0.00094448455,0.00023689281,0.00039083892,0.00026812754,0.00040290615,0.00093918026],"category_scores_gemma":[0.0023474477,0.0001287132,0.0002480465,0.00035112165,0.00018953696,0.00028493462,0.00033061855,0.00039508223,0.00040828047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011268309,0.00013218053,0.95266306,0.00005981316,0.00007126458,0.0001626948,0.00004484774,0.00037571942,0.02465641,0.000032199183,0.00047733734,0.02019764],"study_design_scores_gemma":[0.00007185518,0.0011881936,0.97688305,0.000032843815,0.00012442285,0.0019642008,0.000058767982,0.0063743396,0.011800252,0.00009288957,0.0013906123,0.000018518744],"about_ca_topic_score_codex":0.00033276223,"about_ca_topic_score_gemma":0.00067119754,"teacher_disagreement_score":0.0010707802,"about_ca_system_score_codex":0.00025881405,"about_ca_system_score_gemma":0.00033081215,"threshold_uncertainty_score":0.005662918},"labels":[],"label_agreement":null},{"id":"W2156013764","doi":"10.1158/1078-0432.ccr-04-2282","title":"High Relapse Rate in Patients with MALT Lymphoma Warrants Lifelong Follow-up","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"MALT lymphoma; Gastroenterology; Medicine; Lymphoma; Trisomy; Internal medicine; Mucosa-associated lymphoid tissue; Chemotherapy; Pathology; Biology","score_opus":0.1009771849710758,"score_gpt":0.4403394357388169,"score_spread":0.33936225076774107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156013764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99801147,0.000992077,0.00016872234,0.00015530406,0.000009211853,0.0000066849,0.000053040032,0.00001764493,0.000585768],"genre_scores_gemma":[0.99955004,0.00012282719,0.00006963564,0.000052431158,0.000023982744,0.0000043264326,0.00009950464,0.00000262755,0.0000747154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995802,0.00010378595,0.000047335034,0.000070033006,0.00010952221,0.00008912886],"domain_scores_gemma":[0.9976265,0.00066949904,0.0009398298,0.00018795457,0.0002373158,0.00033892825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005810742,0.00015384496,0.00042096808,0.00036959758,0.0003132071,0.0004746244,0.00024583476,0.0005526625,0.0010955611],"category_scores_gemma":[0.0035311698,0.00007432977,0.0002423881,0.00041027338,0.00020029879,0.0004715597,0.00023977006,0.00052797137,0.00034213244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002466359,0.000020759768,0.9906398,0.000007883615,0.00001442316,0.0012026496,0.00006600222,0.00005125807,0.000668823,0.000017373544,0.00017883934,0.0068856254],"study_design_scores_gemma":[0.000018464842,0.00026949856,0.98329824,0.000017964867,0.000067532186,0.013823048,0.00020420921,0.0006330204,0.00058925146,0.00007398627,0.0009954607,0.000009360526],"about_ca_topic_score_codex":0.0004659007,"about_ca_topic_score_gemma":0.00056109065,"teacher_disagreement_score":0.0010955611,"about_ca_system_score_codex":0.0002516751,"about_ca_system_score_gemma":0.00016066221,"threshold_uncertainty_score":0.00366503},"labels":[],"label_agreement":null},{"id":"W2156060932","doi":"10.1158/1078-0432.ccr-08-2502","title":"Immunodeficient Mouse Strains Display Marked Variability in Growth of Human Melanoma Lung Metastases","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institutes of Health; National Institute of Allergy and Infectious Diseases; Alvin J. Siteman Cancer Center","keywords":"Melanoma; Lung; Pathology; Medicine; Human lung; Biology; Cancer research; Internal medicine","score_opus":0.09612453328570297,"score_gpt":0.45407500888261904,"score_spread":0.35795047559691606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156060932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99024117,0.0020000194,0.0042990996,0.00006301977,0.00002152082,0.00010559825,0.0011862629,0.00023844664,0.0018449579],"genre_scores_gemma":[0.9897994,0.0010489662,0.0041994415,0.000073653755,0.000010052544,0.00022935256,0.0023115308,0.00006226127,0.0022653446],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993253,0.00012985157,0.00013748847,0.00014892912,0.00016772342,0.000090706795],"domain_scores_gemma":[0.9994661,0.00013177961,0.00019013546,0.00009985551,0.00003499987,0.00007710263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005383857,0.00077232806,0.00031940846,0.0011568503,0.00022386074,0.00045229043,0.00028035662,0.00045121965,0.0019908093],"category_scores_gemma":[0.00033281744,0.00024748783,0.00034534457,0.00027935632,0.0002890925,0.0002454027,0.0003698538,0.0005998779,0.00062029343],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021837835,0.00010073766,0.001752674,0.00002417787,0.000011759037,0.00012536671,0.000022935044,0.000053820346,0.9963074,0.00008574251,0.0000587014,0.0012384193],"study_design_scores_gemma":[0.000063625506,0.0013000476,0.03124405,0.00002837747,0.000075710355,0.0036654877,0.000058933765,0.00078410906,0.95963883,0.00010429304,0.0030160854,0.000020450134],"about_ca_topic_score_codex":0.0003942284,"about_ca_topic_score_gemma":0.0008877225,"teacher_disagreement_score":0.0019908093,"about_ca_system_score_codex":0.00025818875,"about_ca_system_score_gemma":0.0001548924,"threshold_uncertainty_score":0.0066598654},"labels":[],"label_agreement":null},{"id":"W2156223179","doi":"10.1158/1078-0432.ccr-03-0218","title":"High Expression of Methionine Aminopeptidase 2 in Human Colorectal Adenocarcinomas","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Saskatchewan Cancer Agency","funders":"","keywords":"Immunohistochemistry; Biology; Western blot; Adenocarcinoma; Cancer research; Internal medicine; Immunology; Medicine; Cancer; Biochemistry; Gene; Genetics","score_opus":0.19351963609193693,"score_gpt":0.5280612397376486,"score_spread":0.3345416036457117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156223179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985656,0.00078564417,0.0002674066,0.00001012814,0.0000029801365,0.000007978902,0.000062409476,0.000011821826,0.00028604618],"genre_scores_gemma":[0.9990445,0.00026688224,0.00034405137,0.0000069489483,0.0000038599082,0.000006101048,0.00013984396,0.0000022995125,0.00018554907],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985445,0.000018865881,0.000017245833,0.000033041575,0.000044687687,0.00003170179],"domain_scores_gemma":[0.9997757,0.00004140334,0.00006988283,0.00002400555,0.00003534586,0.000053692176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016051735,0.00026669266,0.00016180356,0.0007869288,0.00024326926,0.0002662963,0.0001032058,0.00027250228,0.00060827564],"category_scores_gemma":[0.00034382485,0.00015389602,0.00013426642,0.00040202678,0.00025258595,0.00011187625,0.00019971408,0.0001554262,0.00019112689],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096830254,0.000057211113,0.1487479,0.00017173118,0.000052162897,0.0063759433,0.0001830295,0.00007570046,0.83880013,0.000068097965,0.00008956594,0.004410098],"study_design_scores_gemma":[0.000046672496,0.0008225448,0.7795368,0.000016188806,0.000119387616,0.035582177,0.00033374596,0.00060668786,0.18085153,0.000069225855,0.0020007808,0.00001431019],"about_ca_topic_score_codex":0.000808664,"about_ca_topic_score_gemma":0.0008583083,"teacher_disagreement_score":0.000808664,"about_ca_system_score_codex":0.00022618817,"about_ca_system_score_gemma":0.00015085597,"threshold_uncertainty_score":0.002034843},"labels":[],"label_agreement":null},{"id":"W2156375860","doi":"10.1158/1078-0432.ccr-13-1877","title":"Tumor-Infiltrating Lymphocytes Expressing the Tissue Resident Memory Marker CD103 Are Associated with Increased Survival in High-Grade Serous Ovarian Cancer","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":418,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia; BC Cancer Agency","funders":"","keywords":"CD8; Tumor-infiltrating lymphocytes; Serous fluid; Cancer research; Ovarian cancer; Immunotherapy; Intraepithelial lymphocyte; Biology; Antigen; Pathology; Cancer; Immunology; Medicine; Immune system; Internal medicine","score_opus":0.11773343481620593,"score_gpt":0.43122414660490305,"score_spread":0.31349071178869714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156375860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989993,0.0005241512,0.00011475962,0.000011843551,0.0000025668885,0.000005169527,0.00013585958,0.000011726195,0.00019462973],"genre_scores_gemma":[0.9995036,0.00012159797,0.000080441896,0.0000071928084,0.00000419025,0.000004967344,0.000200485,0.0000016715463,0.00007574335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999925,0.000010485354,0.000009548453,0.000017786182,0.00001761078,0.000019572079],"domain_scores_gemma":[0.999408,0.000090764144,0.0002933221,0.000036234695,0.000060724768,0.00011093306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014087113,0.00011863651,0.00019481016,0.00043276657,0.00017078841,0.00031678344,0.0000986795,0.0001811431,0.0011629537],"category_scores_gemma":[0.0005231273,0.000081430604,0.00014313193,0.0005727657,0.0001630856,0.00015410836,0.00017562279,0.00024332147,0.00011950191],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007647141,0.00003476255,0.9704095,0.000057511083,0.000045761448,0.0002873767,0.00007323923,0.00009695232,0.020660326,0.000013190097,0.00016420579,0.007392514],"study_design_scores_gemma":[0.000008155934,0.00008215612,0.9976927,0.0000035525593,0.00002963117,0.0007476945,0.000072832474,0.00014848502,0.0009185693,0.000020319674,0.0002741286,0.0000018814674],"about_ca_topic_score_codex":0.0007058807,"about_ca_topic_score_gemma":0.0010378867,"teacher_disagreement_score":0.0011629537,"about_ca_system_score_codex":0.0001433528,"about_ca_system_score_gemma":0.00010108945,"threshold_uncertainty_score":0.0038904548},"labels":[],"label_agreement":null},{"id":"W2156520838","doi":"10.1158/1078-0432.ccr-09-1993","title":"An Overview of the Optimal Planning, Design, and Conduct of Phase I Studies of New Therapeutics","year":2010,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Clinical trial; Clinical study design; Medicine; Drug development; Research design; Clinical endpoint; Medical physics; Drug; Pharmacology; Pathology","score_opus":0.9926679819552562,"score_gpt":0.8542575059713408,"score_spread":0.13841047598391543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156520838","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041739247,0.8694053,0.08375742,0.024896272,0.0038949565,0.002152688,0.0006714197,0.00056250347,0.014241971],"genre_scores_gemma":[0.0032032477,0.86786306,0.10968943,0.008499913,0.0041922424,0.0027942301,0.000660003,0.0001870917,0.0029107828],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9622712,0.022638839,0.005757853,0.0017389567,0.0067309355,0.0008621581],"domain_scores_gemma":[0.93044096,0.048146743,0.006479604,0.0021187218,0.010799037,0.002015027],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.054064807,0.0031972225,0.0034855767,0.006840832,0.0011453273,0.0066154585,0.0039633955,0.0048214323,0.006693073],"category_scores_gemma":[0.06040624,0.0023474044,0.0034427487,0.005909223,0.0029020759,0.00695583,0.0026302638,0.008985403,0.0074825776],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003489061,0.00022835191,0.0005079557,0.020144435,0.00022073371,0.00021685548,0.00024710374,0.004939884,0.00089137163,0.02256741,0.0765885,0.8730985],"study_design_scores_gemma":[0.00016593942,0.00080310437,0.0014957298,0.027441896,0.00034478641,0.00071709795,0.00015022319,0.0015271181,0.0007626013,0.03207749,0.93441325,0.0001007112],"about_ca_topic_score_codex":0.0042543528,"about_ca_topic_score_gemma":0.007261176,"teacher_disagreement_score":0.9459352,"about_ca_system_score_codex":0.0060273255,"about_ca_system_score_gemma":0.017336678,"threshold_uncertainty_score":0.28592545},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":["metaresearch"],"domain":"methods","study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W2156564774","doi":"10.1158/1078-0432.ccr-07-4669","title":"Efficacy of Superoxide Dismutase Mimetic M40403 in Attenuating Radiation-Induced Oral Mucositis in Hamsters","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Oral health in cancer treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Mucositis; Cheek pouch; Medicine; Placebo; Superoxide dismutase; Chemotherapy; Gastroenterology; Radiation therapy; Pharmacology; Toxicity; Hamster; Internal medicine; Pathology; Oxidative stress","score_opus":0.4876983976109072,"score_gpt":0.6040630978796575,"score_spread":0.11636470026875029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156564774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962578,0.0018231162,0.0005599897,0.00008119052,0.00006055905,0.00005555966,0.000264941,0.00010949223,0.000787436],"genre_scores_gemma":[0.9938041,0.001853324,0.0012090694,0.00008753176,0.000030313584,0.00010400741,0.0004903725,0.000018785227,0.0024024185],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998983,0.00001669013,0.000012274179,0.000021378497,0.000024454672,0.000026879265],"domain_scores_gemma":[0.9998692,0.000015998285,0.000044187254,0.00001730068,0.000015772983,0.000037533657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021065115,0.00054118823,0.00056009035,0.0004898872,0.00021197023,0.0002069676,0.00029371792,0.00050148036,0.0014425796],"category_scores_gemma":[0.00010641974,0.00016841716,0.0004891071,0.0002194385,0.0002945946,0.00022477719,0.00016038408,0.00072751846,0.00026010783],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077709503,0.00034694033,0.0002906582,0.000092126094,0.000010241897,0.000032412943,0.000022222895,0.00008762218,0.99625105,0.000046633882,0.000071647504,0.0019713626],"study_design_scores_gemma":[0.00025428119,0.018249866,0.007979448,0.000029951603,0.00007946151,0.00020001995,0.00006223227,0.0007733923,0.9704396,0.00006483499,0.0018534528,0.000013395544],"about_ca_topic_score_codex":0.00055909296,"about_ca_topic_score_gemma":0.00058873446,"teacher_disagreement_score":0.0014425796,"about_ca_system_score_codex":0.0002584205,"about_ca_system_score_gemma":0.00029850408,"threshold_uncertainty_score":0.00482589},"labels":[],"label_agreement":null},{"id":"W2156636883","doi":"10.1158/1078-0432.ccr-13-1856","title":"Novel <i>MSH6</i> Mutations in Treatment-Naïve Glioblastoma and Anaplastic Oligodendroglioma Contribute to Temozolomide Resistance Independently of <i>MGMT</i> Promoter Methylation","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"Stem Cell Network; American Association for Cancer Research","keywords":"Temozolomide; MSH6; Glioma; Cancer research; Oligodendroglioma; Biology; Methyltransferase; Medicine; Methylation; DNA repair; DNA mismatch repair; Genetics; Astrocytoma; Gene","score_opus":0.09377303030076796,"score_gpt":0.45042246244682055,"score_spread":0.3566494321460526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156636883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995664,0.00016766026,0.00006418127,0.0000061236856,0.000001123476,0.000005335757,0.000041743526,0.0000052998107,0.00014213937],"genre_scores_gemma":[0.99961144,0.00007147239,0.00011470013,0.000008918074,0.0000018012505,0.0000034384339,0.00011632532,0.0000017945172,0.00007003773],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99987626,0.00001586067,0.000016914959,0.00003224875,0.00003670692,0.000022011289],"domain_scores_gemma":[0.99983966,0.00002502912,0.00006281588,0.000013097716,0.000020875052,0.000038548787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014737919,0.00017694056,0.00022987157,0.0003282314,0.00018686788,0.00022142546,0.00014706544,0.000224337,0.0007758182],"category_scores_gemma":[0.0002994527,0.000121291,0.0001380424,0.00020403926,0.00020995554,0.00008810442,0.00009934239,0.00021318858,0.00015109725],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014368561,0.00014497255,0.18533416,0.00007476638,0.000068549845,0.0016014619,0.00019728603,0.00020270416,0.80159104,0.00007408055,0.00014032928,0.009133714],"study_design_scores_gemma":[0.00006626111,0.0015451056,0.8454214,0.00000790913,0.00011752946,0.010921612,0.0001682357,0.000687068,0.14004052,0.00006971111,0.00094573176,0.00000899352],"about_ca_topic_score_codex":0.0017083284,"about_ca_topic_score_gemma":0.0027465576,"teacher_disagreement_score":0.0017083284,"about_ca_system_score_codex":0.00033329433,"about_ca_system_score_gemma":0.00018493984,"threshold_uncertainty_score":0.0033967495},"labels":[],"label_agreement":null},{"id":"W2156896944","doi":"10.1158/1078-0432.ccr-05-2185","title":"Managing Patients on Endocrine Therapy: Focus on Quality-of-Life Issues","year":2006,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; McMaster University","funders":"","keywords":"Tamoxifen; Medicine; Aromatase; Breast cancer; Quality of life (healthcare); Sexual function; Vasomotor; Randomized controlled trial; Oncology; Placebo; Internal medicine; Gynecology; Adjuvant therapy; Clinical trial; Adjuvant; Cancer; Alternative medicine; Pathology","score_opus":0.6761268946566242,"score_gpt":0.6797870358801116,"score_spread":0.0036601412234873454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156896944","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020799812,0.99860495,0.000066033215,0.0006045297,0.00009692637,0.0000067312,0.0000069859966,0.0000018694452,0.0004039716],"genre_scores_gemma":[0.0028852816,0.9959507,0.0002514427,0.0005269922,0.00017752331,0.000019844721,0.000015388094,0.0000010325447,0.00017190569],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99890316,0.00053754426,0.0001469476,0.00006784062,0.00029074706,0.000053685595],"domain_scores_gemma":[0.9981012,0.0012253785,0.00028702314,0.000024898825,0.000302396,0.000059127746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018827888,0.0007128348,0.0024790824,0.0012330249,0.00029844575,0.0009284928,0.00070693396,0.0011571556,0.002280658],"category_scores_gemma":[0.003937131,0.00017615913,0.0008314779,0.0023294075,0.00035406873,0.0009039126,0.00057678187,0.0011904071,0.00050793035],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012246676,0.00005757665,0.00080924015,0.054683212,0.00056284684,0.00018107389,0.00018088595,0.00034307793,0.00052157685,0.0013106996,0.020577485,0.92064995],"study_design_scores_gemma":[0.00040341058,0.00086702243,0.021404926,0.16448835,0.0032682493,0.0058299606,0.0017011551,0.00043143565,0.0009206198,0.0055567175,0.795038,0.00009013995],"about_ca_topic_score_codex":0.0014490789,"about_ca_topic_score_gemma":0.0033392296,"teacher_disagreement_score":0.0024790824,"about_ca_system_score_codex":0.0008209735,"about_ca_system_score_gemma":0.0017257498,"threshold_uncertainty_score":0.009957254},"labels":[],"label_agreement":null},{"id":"W2156902079","doi":"10.1158/1078-0432.ccr-11-0078","title":"Metronomic Oral Topotecan with Pazopanib Is an Active Antiangiogenic Regimen in Mouse Models of Aggressive Pediatric Solid Tumor","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Hospital for Sick Children; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Pazopanib; Topotecan; Medicine; Pharmacology; Angiogenesis; In vivo; Neuroblastoma; Cancer research; Pharmacokinetics; Rhabdomyosarcoma; Cancer; Chemotherapy; Oncology; Sarcoma; Internal medicine; Cell culture; Biology; Sunitinib; Pathology","score_opus":0.3053773045261252,"score_gpt":0.4944461548165539,"score_spread":0.1890688502904287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156902079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99427587,0.0014101721,0.002016525,0.00013748615,0.000065274195,0.000244552,0.0006740784,0.00016501849,0.0010110907],"genre_scores_gemma":[0.99120075,0.0015590681,0.0038431152,0.000053207656,0.00003069457,0.00035740316,0.0009973763,0.000027184937,0.0019311941],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995641,0.00008672162,0.000029723296,0.0000700439,0.00014414379,0.000105265135],"domain_scores_gemma":[0.9998023,0.000019907373,0.00005907756,0.000028942057,0.000014039323,0.00007575775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003843848,0.0009351564,0.00081921794,0.0007003696,0.000241847,0.0004262855,0.000462574,0.0004592109,0.0008837878],"category_scores_gemma":[0.00011977924,0.00029947382,0.00044960208,0.00044861078,0.00041608492,0.0005148572,0.00016088404,0.0017481053,0.00024480655],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024183635,0.002105912,0.0009960186,0.00013064101,0.000052112402,0.00013785025,0.00005241325,0.0009127095,0.98358214,0.00024155456,0.00037054738,0.008999867],"study_design_scores_gemma":[0.0005215789,0.02245087,0.00662609,0.000014264945,0.00009164147,0.00042316277,0.00003777699,0.0025331005,0.9636387,0.000050745082,0.0035975643,0.000014581645],"about_ca_topic_score_codex":0.0013806302,"about_ca_topic_score_gemma":0.0034396336,"teacher_disagreement_score":0.0013806302,"about_ca_system_score_codex":0.00073565735,"about_ca_system_score_gemma":0.0006597234,"threshold_uncertainty_score":0.005337596},"labels":[],"label_agreement":null},{"id":"W2156924387","doi":"10.1158/1078-0432.ccr-1032-3","title":"Cyclooxygenase-2 and Microsomal Prostaglandin E Synthase-1 Are Overexpressed in Squamous Cell Carcinoma of the Penis","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Immunohistochemistry; Carcinogenesis; Prostaglandin E2; Prostaglandin; Cyclooxygenase; Cancer research; Prostaglandin E2 receptor; Biology; Pathology; Prostaglandin E; Receptor; Medicine; Cancer; Internal medicine; Enzyme; Endocrinology; Biochemistry","score_opus":0.07663006170547743,"score_gpt":0.4129403872223207,"score_spread":0.33631032551684326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156924387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955824,0.002494232,0.00077085826,0.000045135617,0.000016540804,0.000021264512,0.00023714417,0.000046390538,0.0007861461],"genre_scores_gemma":[0.9952213,0.0014272556,0.0012199864,0.000027390855,0.000013793546,0.000026445028,0.00039277648,0.0000060678663,0.0016650034],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99983644,0.000018710465,0.000013342724,0.000031853844,0.000068901616,0.000030725645],"domain_scores_gemma":[0.9998023,0.000027886626,0.00007281467,0.000017803515,0.00003340184,0.00004581939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018000379,0.00034856805,0.0002226971,0.00059865735,0.00017012836,0.00035182227,0.00012361197,0.00025661982,0.0015810498],"category_scores_gemma":[0.0002027585,0.00018018066,0.00014910582,0.0003828977,0.00021613069,0.00022902974,0.00017544505,0.00027936857,0.00037978098],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028168614,0.00004964451,0.011948302,0.00012949885,0.000020860187,0.0006995846,0.000030832914,0.00004680428,0.9840224,0.000054725173,0.0000549303,0.002660742],"study_design_scores_gemma":[0.00004980167,0.00087279006,0.35795093,0.000031236203,0.000110827954,0.009052229,0.00023449025,0.00088717765,0.6264977,0.00012324998,0.0041751573,0.000014348298],"about_ca_topic_score_codex":0.00043297705,"about_ca_topic_score_gemma":0.00062476407,"teacher_disagreement_score":0.0015810498,"about_ca_system_score_codex":0.0002973044,"about_ca_system_score_gemma":0.0002522471,"threshold_uncertainty_score":0.0052891374},"labels":[],"label_agreement":null},{"id":"W2157216556","doi":"10.1158/1078-0432.ccr-04-1353","title":"Stratification of Intermediate-Risk Endometrial Cancer Patients into Groups at High Risk or Low Risk for Recurrence Based on Tumor Gene Expression Profiles","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institutes of Health; National Cancer Institute; W. M. Keck Foundation","keywords":"Risk stratification; Endometrial cancer; Cancer; Oncology; Medicine; Internal medicine; Gene; Gene expression; Risk factor; Risk assessment; Biology; Genetics","score_opus":0.13065683072731443,"score_gpt":0.4747480442083266,"score_spread":0.3440912134810122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157216556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99937135,0.00018781218,0.00028747533,0.00001710081,0.0000015564906,0.000006174254,0.00003148463,0.0000031521865,0.00009396956],"genre_scores_gemma":[0.9994924,0.000033887485,0.0003080074,0.000013911708,0.0000026970233,0.000005774142,0.00009777692,7.7474596e-7,0.00004468071],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998456,0.000049981667,0.000014527388,0.000033175158,0.000030497458,0.000026105046],"domain_scores_gemma":[0.9997043,0.00009707575,0.00008966401,0.00002212299,0.00002992407,0.000056918958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003573368,0.0001907815,0.00028464792,0.0004589022,0.00014968717,0.0002742088,0.00011569594,0.00021614511,0.0005253955],"category_scores_gemma":[0.0010578043,0.00006562997,0.00023878565,0.00018432405,0.00019132694,0.00011651878,0.00018221783,0.00018779241,0.000114727634],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009641128,0.000060958617,0.97755116,0.000029762003,0.00005971576,0.00010131513,0.00008503663,0.0002208947,0.01304877,0.00003992967,0.00007089251,0.0077675083],"study_design_scores_gemma":[0.000042767853,0.0005650283,0.993214,0.000013415536,0.0000956011,0.0006188512,0.00014318054,0.001573842,0.0033391556,0.00015777763,0.00022794007,0.000008495938],"about_ca_topic_score_codex":0.00036183902,"about_ca_topic_score_gemma":0.0006175705,"teacher_disagreement_score":0.0005253955,"about_ca_system_score_codex":0.00015246986,"about_ca_system_score_gemma":0.0001486225,"threshold_uncertainty_score":0.0018897653},"labels":[],"label_agreement":null},{"id":"W2157282974","doi":"10.1158/1078-0432.ccr-07-0901","title":"Use of Preoperative Plasma Endoglin for Prediction of Lymph Node Metastasis in Patients with Clinically Localized Prostate Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Center for Research Resources","keywords":"Medicine; Nomogram; Endoglin; Prostatectomy; Prostate cancer; Lymph node; Confidence interval; Metastasis; Odds ratio; Stage (stratigraphy); Lymphadenectomy; Urology; Biochemical recurrence; Radiology; Cancer; Oncology; Internal medicine","score_opus":0.2588083980748202,"score_gpt":0.4676495572714807,"score_spread":0.20884115919666052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157282974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99915266,0.00039343836,0.00024614722,0.000057701014,0.000005931839,0.0000039896104,0.000038542657,0.0000074707596,0.000094052186],"genre_scores_gemma":[0.9996675,0.000058301233,0.00017883856,0.000012479103,0.0000069452694,0.0000027745452,0.00004449258,6.802039e-7,0.000028053253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995678,0.00022967976,0.000027136763,0.00006404484,0.0000839647,0.00002727154],"domain_scores_gemma":[0.9977724,0.0013303731,0.0004610929,0.000106106905,0.00012143043,0.00020845594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007991426,0.00042066665,0.0003886946,0.00035597183,0.00016169605,0.0003222088,0.0002415488,0.0003450589,0.00064292963],"category_scores_gemma":[0.0046784636,0.00015042577,0.00021066381,0.0002428732,0.00033588143,0.00027603604,0.00019239179,0.00044176306,0.00015395971],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037586762,0.000033974753,0.99570763,0.000009573374,0.000031655873,0.000041216863,0.000014304362,0.00019224528,0.0006170913,0.000004094916,0.000043765045,0.002928458],"study_design_scores_gemma":[0.000060372262,0.00092630816,0.9932389,0.0000116666215,0.0000764736,0.0005330977,0.00006586354,0.0039534634,0.0009475187,0.000036847116,0.00013993664,0.000009579812],"about_ca_topic_score_codex":0.00093495275,"about_ca_topic_score_gemma":0.0016146924,"teacher_disagreement_score":0.00093495275,"about_ca_system_score_codex":0.00020977725,"about_ca_system_score_gemma":0.00029282767,"threshold_uncertainty_score":0.004226327},"labels":[],"label_agreement":null},{"id":"W2157709503","doi":"10.1158/1078-0432.ccr-06-1593","title":"Genetic Deletions in Sputum as Diagnostic Markers for Early Detection of Stage I Non–Small Cell Lung Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"FHIT; Sputum; Lung cancer; Biology; Cancer; Stage (stratigraphy); Pathology; Loss of heterozygosity; Lung; Cancer research; Medicine; Internal medicine; Gene; Carcinogenesis; Tumor suppressor gene; Genetics; Tuberculosis","score_opus":0.09187760573161653,"score_gpt":0.5262772465952479,"score_spread":0.43439964086363136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157709503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99671483,0.0017163175,0.0011048898,0.00003096211,0.000008634285,0.000016966002,0.000062177416,0.000026975315,0.00031831328],"genre_scores_gemma":[0.9986059,0.00020100147,0.0009997587,0.000012509008,0.000008178416,0.000007984675,0.00007780643,0.000002128547,0.000084585845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99965787,0.00013889807,0.000024862715,0.000050630144,0.00009462583,0.000033020086],"domain_scores_gemma":[0.99921405,0.00031862184,0.00022101674,0.000044859215,0.00011157842,0.000089846566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000584094,0.0003382123,0.00026407794,0.00093250006,0.00014184079,0.0003120661,0.00020565453,0.00035717574,0.00059001945],"category_scores_gemma":[0.001561802,0.00016076564,0.00012372708,0.00028113206,0.0003058903,0.00019289767,0.00023718778,0.0002404862,0.00015321546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012576828,0.000053428073,0.8230855,0.00008285754,0.000049080518,0.00049379776,0.000082487066,0.00026459375,0.1615318,0.000027924167,0.00009787364,0.012973052],"study_design_scores_gemma":[0.000037914735,0.0008524883,0.9138538,0.000030247871,0.00013265309,0.0033348668,0.0001585628,0.0032462268,0.07748913,0.00008342622,0.0007685082,0.00001209537],"about_ca_topic_score_codex":0.0003685329,"about_ca_topic_score_gemma":0.00063342357,"teacher_disagreement_score":0.00093250006,"about_ca_system_score_codex":0.00015460052,"about_ca_system_score_gemma":0.00012690766,"threshold_uncertainty_score":0.0030890107},"labels":[],"label_agreement":null},{"id":"W2157717805","doi":"10.1158/1078-0432.ccr-08-0999","title":"A Phase I Study of the Pan Bcl-2 Family Inhibitor Obatoclax Mesylate in Patients with Advanced Hematologic Malignancies","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":186,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Refractory (planetary science); Myeloid leukemia; Leukemia; Adverse effect; Internal medicine; Acute leukemia; Chemotherapy; Gastroenterology; Pharmacology; Oncology","score_opus":0.09721187264383828,"score_gpt":0.42839780003217226,"score_spread":0.33118592738833397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157717805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99621564,0.0014053326,0.00033997165,0.0001587059,0.000029099163,0.00095208426,0.00019909692,0.000030060688,0.0006699973],"genre_scores_gemma":[0.994165,0.0014778541,0.0014003828,0.00026512882,0.00007885053,0.0010722909,0.00065975485,0.000010288633,0.00087045506],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99980885,0.00008610558,0.000011302902,0.000028790506,0.000023674815,0.000041237192],"domain_scores_gemma":[0.99967694,0.0000525478,0.000058514623,0.000030764426,0.000019746738,0.00016143946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005909641,0.00087548734,0.0012782764,0.0002588925,0.0003729853,0.00040020898,0.00043713063,0.000516432,0.0023027621],"category_scores_gemma":[0.0004830882,0.00032174465,0.00043856615,0.00029044648,0.00063490134,0.00041812015,0.00023603835,0.0014407351,0.0004047955],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49946088,0.0505223,0.023795405,0.0010981885,0.0009863221,0.00089650066,0.000490767,0.004766031,0.20641932,0.0004963044,0.0030920454,0.2079759],"study_design_scores_gemma":[0.4183288,0.5349247,0.024116483,0.00004261473,0.00037085332,0.0008611783,0.00006779191,0.0015862802,0.015319542,0.00017675346,0.004178156,0.000026870264],"about_ca_topic_score_codex":0.00056444417,"about_ca_topic_score_gemma":0.0011651114,"teacher_disagreement_score":0.0023027621,"about_ca_system_score_codex":0.00040863693,"about_ca_system_score_gemma":0.00093734404,"threshold_uncertainty_score":0.0077035427},"labels":[],"label_agreement":null},{"id":"W2157774521","doi":"10.1158/1078-0432.ccr-05-0319","title":"ZD6474, a Novel Tyrosine Kinase Inhibitor of Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor, Inhibits Tumor Growth of Multiple Nervous System Tumors","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources; National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"Vascular endothelial growth factor; Epidermal growth factor receptor; Angiogenesis; Cancer research; Epidermal growth factor; Receptor tyrosine kinase; Glioma; Growth factor receptor; Biology; Growth factor receptor inhibitor; Tyrosine kinase; Medicine; Internal medicine; Receptor; Endocrinology","score_opus":0.06965143392391154,"score_gpt":0.367977038097077,"score_spread":0.29832560417316545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157774521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902384,0.0057114335,0.0020496387,0.0001039621,0.000065316,0.00009007489,0.00031334403,0.00017005183,0.0012576735],"genre_scores_gemma":[0.9873418,0.0062175617,0.002505068,0.000064559805,0.000034184115,0.0000661338,0.0010612428,0.000015494265,0.0026940752],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999572,0.0000049610508,0.000004093752,0.0000054051384,0.00001292868,0.000015557145],"domain_scores_gemma":[0.99995804,0.0000054089646,0.000014820442,0.00000297126,0.0000059356694,0.000012791186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000090828464,0.00044622607,0.00032834502,0.00038871774,0.00012735244,0.00015009622,0.00032183915,0.00017673722,0.00085233443],"category_scores_gemma":[0.00007443979,0.0000821548,0.00026904582,0.00021921349,0.00017789112,0.00014237876,0.00008493941,0.00038605017,0.00024099255],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014615224,0.00095940055,0.0012187265,0.00028504676,0.00005331185,0.00017735556,0.000012580679,0.0012728984,0.96219045,0.00016879976,0.0005439461,0.031655982],"study_design_scores_gemma":[0.0012166182,0.011386218,0.012649717,0.000019257828,0.00014307485,0.0009418221,0.000022511334,0.002853677,0.9630827,0.000073069634,0.0075973007,0.000014016743],"about_ca_topic_score_codex":0.000982929,"about_ca_topic_score_gemma":0.0023079398,"teacher_disagreement_score":0.000982929,"about_ca_system_score_codex":0.00032644946,"about_ca_system_score_gemma":0.00037352135,"threshold_uncertainty_score":0.002851367},"labels":[],"label_agreement":null},{"id":"W2158378642","doi":"10.1158/1078-0432.ccr-08-1720","title":"Relationship Between Angiotensin-Converting Enzyme Gene Polymorphism and Body Composition, Functional Performance, and Blood Biomarkers in Advanced Cancer Patients","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renin-Angiotensin System Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Lean body mass; Body mass index; Internal medicine; Angiotensin-converting enzyme; Medicine; Endocrinology; Hemoglobin; Cancer; Gastroenterology; Allele; Biology; Blood pressure; Gene; Genetics; Body weight","score_opus":0.14525124809194692,"score_gpt":0.43407056546787076,"score_spread":0.2888193173759238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158378642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996044,0.0001523838,0.00003570659,0.000015817604,0.00000306678,0.000003230623,0.00008685987,0.0000011791781,0.000097185344],"genre_scores_gemma":[0.9996817,0.00005279373,0.000049875485,0.000014796183,0.0000068826093,0.0000044456456,0.00012819955,4.7644423e-7,0.000060912756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981624,0.00005201243,0.000017690198,0.000043716318,0.000040501913,0.00002993778],"domain_scores_gemma":[0.9991732,0.00023890409,0.00026276193,0.000051642695,0.000068997164,0.00020452838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036015856,0.00019442698,0.00032988153,0.00039800376,0.00022368836,0.0003269955,0.00014338834,0.00031314619,0.0010294468],"category_scores_gemma":[0.0013055998,0.00013900053,0.00019458629,0.00048725877,0.00018528386,0.00018972339,0.0001965588,0.0005409894,0.00013668269],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029146278,0.000042253156,0.99872404,0.0000036153567,0.000031686526,0.000026839174,0.000013645449,0.000023691271,0.00023685432,0.0000040219293,0.000020490595,0.0005813268],"study_design_scores_gemma":[0.000015481583,0.00022350774,0.99932086,0.000001632799,0.000022075732,0.00013464333,0.000024583755,0.00014549712,0.000053999353,0.000008920814,0.0000474453,0.0000013424443],"about_ca_topic_score_codex":0.001553003,"about_ca_topic_score_gemma":0.0014545961,"teacher_disagreement_score":0.001553003,"about_ca_system_score_codex":0.0001405313,"about_ca_system_score_gemma":0.00017047813,"threshold_uncertainty_score":0.0034438968},"labels":[],"label_agreement":null},{"id":"W2158470474","doi":"10.1158/1078-0432.ccr-08-0515","title":"Safety, Pharmacokinetics, and Efficacy of CPX-1 Liposome Injection in Patients with Advanced Solid Tumors","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":211,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; BC Cancer Agency; Jewish General Hospital","funders":"","keywords":"Medicine; Irinotecan; Pharmacokinetics; Neutropenia; Floxuridine; Gastroenterology; Internal medicine; Diarrhea; Hypokalemia; Response Evaluation Criteria in Solid Tumors; Colorectal cancer; Phases of clinical research; Pharmacology; Cancer; Urology; Chemotherapy; Fluorouracil","score_opus":0.047884919946826886,"score_gpt":0.44910929243566855,"score_spread":0.4012243724888417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158470474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978961,0.0011521811,0.00050770695,0.00006532694,0.000006221801,0.00007419411,0.00004083267,0.000026028043,0.00023152748],"genre_scores_gemma":[0.9988544,0.0003600293,0.00048159694,0.000035087563,0.000013195812,0.000046388217,0.000090559144,0.0000035721832,0.000115192175],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998342,0.00006082092,0.000009765121,0.000034010438,0.00003748648,0.000023631628],"domain_scores_gemma":[0.99978656,0.000054748463,0.00008660314,0.000014384728,0.0000134453285,0.000044247106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048966176,0.0003334135,0.0005945476,0.00011671305,0.00015231481,0.00031489876,0.00016311268,0.0002523979,0.00069249317],"category_scores_gemma":[0.00047747887,0.00013241835,0.00022452122,0.0001369359,0.000424755,0.00032541627,0.00014441166,0.00070940773,0.00024164507],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.109938316,0.010901942,0.05487619,0.00082371803,0.00037150405,0.0012303141,0.0006410585,0.0077617923,0.524058,0.0003777732,0.0019130706,0.2871064],"study_design_scores_gemma":[0.03947995,0.51499015,0.19268152,0.000095093346,0.0004583845,0.0046260147,0.00020557211,0.019256018,0.21925409,0.00037058638,0.008519839,0.00006278067],"about_ca_topic_score_codex":0.00030479455,"about_ca_topic_score_gemma":0.00028919065,"teacher_disagreement_score":0.00069249317,"about_ca_system_score_codex":0.00044206757,"about_ca_system_score_gemma":0.00043738945,"threshold_uncertainty_score":0.0032075047},"labels":[],"label_agreement":null},{"id":"W2158479847","doi":"10.1158/1078-0432.ccr-10-1113","title":"Expression of Receptors for Luteinizing Hormone-Releasing Hormone (LH-RH) in Prostate Cancers following Therapy with LH-RH Agonists","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hypothalamic control of reproductive hormones","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; Receptor; Internal medicine; Endocrinology; Luteinizing hormone; Medicine; Hormone receptor; Hormone; Prostate; Cancer; Lymph node; Breast cancer","score_opus":0.1268379528435064,"score_gpt":0.47003412216019075,"score_spread":0.34319616931668434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158479847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989114,0.00056036486,0.00012975102,0.000013368457,0.0000029148798,0.000011041276,0.00006345616,0.000006210652,0.0003015671],"genre_scores_gemma":[0.999374,0.00017037347,0.0000825379,0.000012367428,0.0000036954145,0.000013628947,0.00015289185,0.0000018434856,0.00018872712],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999068,0.000014140824,0.000007100952,0.00002043835,0.00002687639,0.000024701743],"domain_scores_gemma":[0.9998265,0.0000449181,0.000048458718,0.000015468186,0.00002074724,0.000043956312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000108809305,0.00012460594,0.00022210844,0.0002796724,0.00020994234,0.00028841087,0.00011459598,0.00016388514,0.00092880154],"category_scores_gemma":[0.00033215462,0.0001213927,0.00016580733,0.000205466,0.00023360022,0.00014052085,0.00011662004,0.00026377142,0.00016318905],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031826694,0.00018017934,0.15080073,0.00014458197,0.00009403589,0.0012225838,0.00037656134,0.00026476895,0.833856,0.00008129293,0.00016401183,0.009632518],"study_design_scores_gemma":[0.00008484198,0.0035079473,0.8653318,0.000011445292,0.00018159981,0.005100267,0.00031798985,0.00067853363,0.12318837,0.000041914598,0.0015394423,0.00001593319],"about_ca_topic_score_codex":0.0010365088,"about_ca_topic_score_gemma":0.0009931703,"teacher_disagreement_score":0.0010365088,"about_ca_system_score_codex":0.0002715564,"about_ca_system_score_gemma":0.00028783592,"threshold_uncertainty_score":0.0031071305},"labels":[],"label_agreement":null},{"id":"W2158629784","doi":"10.1158/1078-0432.ccr-04-0191","title":"Phospho-Serine-118 Estrogen Receptor-α Expression Is Associated with Better Disease Outcome in Women Treated with Tamoxifen","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Estrogen receptor; Tamoxifen; Estrogen; Progesterone receptor; Estrogen receptor alpha; Internal medicine; Breast cancer; Estrogen receptor beta; Endocrinology; Estrogen-related receptor alpha; Receptor; Medicine; Receptor expression; Cancer research; Biology; Cancer","score_opus":0.07671504173985719,"score_gpt":0.4255130496329013,"score_spread":0.34879800789304416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158629784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994106,0.00034867966,0.000032417618,0.000021981727,0.000003715683,0.0000020457676,0.000030015213,0.0000014779389,0.0001489927],"genre_scores_gemma":[0.9996207,0.00015299246,0.000029345685,0.000016420701,0.00000850235,0.000002544141,0.00007012473,5.853817e-7,0.000098811404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99993753,0.0000130862245,0.0000059470385,0.000013645167,0.000013185931,0.000016563265],"domain_scores_gemma":[0.9997317,0.00004965406,0.0001356463,0.00001050236,0.00001948972,0.00005299305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012853634,0.00012691904,0.00023356636,0.0002182662,0.0001313592,0.00020480216,0.00008589107,0.00021907077,0.00099091],"category_scores_gemma":[0.0005110258,0.000080294776,0.00018665864,0.00023427249,0.00015357981,0.00010387947,0.00010309003,0.00017661476,0.00014145316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014062541,0.00005449842,0.9822712,0.000021047414,0.00006374708,0.00029266803,0.000051819883,0.0000517129,0.01049155,0.000010930694,0.00007125995,0.005213209],"study_design_scores_gemma":[0.000021967822,0.00034770166,0.997797,0.000004077668,0.000046624093,0.00083826744,0.000043808264,0.00010831818,0.0005986938,0.000013695529,0.00017831844,0.0000015393355],"about_ca_topic_score_codex":0.00048338488,"about_ca_topic_score_gemma":0.00069646427,"teacher_disagreement_score":0.00099091,"about_ca_system_score_codex":0.00012138901,"about_ca_system_score_gemma":0.00009448901,"threshold_uncertainty_score":0.0033148527},"labels":[],"label_agreement":null},{"id":"W2158732520","doi":"10.1158/1078-0432.ccr-05-1849","title":"Prostate-Specific Antigen Modulates Genes Involved in Bone Remodeling and Induces Osteoblast Differentiation of Human Osteosarcoma Cell Line SaOS-2","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bone Metabolism and Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Osteoblast; Osteoprotegerin; Prostate cancer; Osteocalcin; Cancer research; RANKL; LNCaP; Osteosarcoma; Osteopontin; Biology; Internal medicine; Endocrinology; Alkaline phosphatase; Activator (genetics); Cancer; Receptor; Medicine; In vitro","score_opus":0.09392863630694223,"score_gpt":0.4000807126062378,"score_spread":0.30615207629929553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158732520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947543,0.0020726437,0.0012380795,0.000073590716,0.000035192323,0.000026816988,0.00045442596,0.000047038266,0.0012978408],"genre_scores_gemma":[0.9924567,0.001737713,0.0014645325,0.000085818385,0.000018561615,0.00004298642,0.0012628185,0.000018847879,0.0029120152],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989045,0.000013523116,0.000007696441,0.0000205148,0.000043609878,0.000024079758],"domain_scores_gemma":[0.9999292,0.000016356833,0.00001719024,0.000006291104,0.0000134133315,0.000017523937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008873358,0.00032259084,0.00023225747,0.00026319918,0.0001165838,0.0002200035,0.00007724011,0.00012958264,0.0011873596],"category_scores_gemma":[0.00009335285,0.00014026529,0.00024035462,0.0002855713,0.0001700262,0.00009564073,0.00011653155,0.00033081754,0.0003832779],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005147526,0.00003052287,0.00040283814,0.000024524412,0.0000032746996,0.000037282916,0.000012562607,0.000020154483,0.9988386,0.000023533088,0.000028496552,0.0005267772],"study_design_scores_gemma":[0.00005134129,0.00089163176,0.044338286,0.000010675435,0.00004988822,0.000534927,0.00013096548,0.0010495866,0.94864815,0.00008625898,0.0041995374,0.000008821326],"about_ca_topic_score_codex":0.0005867075,"about_ca_topic_score_gemma":0.00095278746,"teacher_disagreement_score":0.0011873596,"about_ca_system_score_codex":0.00014303614,"about_ca_system_score_gemma":0.00021873684,"threshold_uncertainty_score":0.003972113},"labels":[],"label_agreement":null},{"id":"W2158858339","doi":"10.1158/1078-0432.ccr-1044-3","title":"Synergistic Cytotoxicity of Pyrazoloacridine with Doxorubicin, Etoposide, and Topotecan in Drug-Resistant Tumor Cells","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Stemcell Technologies; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Topotecan; Cytotoxicity; Doxorubicin; Etoposide; Topoisomerase; Pharmacology; Clonogenic assay; Cancer research; Medicine; Chemistry; Chemotherapy; In vitro; Biochemistry; Internal medicine","score_opus":0.0633163827293256,"score_gpt":0.41743363077443707,"score_spread":0.35411724804511147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158858339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99242777,0.0035436784,0.0016793293,0.0000769388,0.000046252982,0.00006825637,0.00032039374,0.000067245215,0.0017700541],"genre_scores_gemma":[0.99395955,0.0017130444,0.0027052124,0.00003243262,0.000016669475,0.00006563332,0.0004706795,0.000010708686,0.0010261581],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995889,0.00012256586,0.00006008384,0.0000586356,0.000116698706,0.00005322148],"domain_scores_gemma":[0.99986553,0.000037967402,0.000022904951,0.000025203428,0.00002052153,0.000027931565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002750097,0.00057875714,0.0007867403,0.0005331549,0.00017749956,0.00037120582,0.0002921191,0.0002626522,0.00067128066],"category_scores_gemma":[0.00017659909,0.00023126134,0.00034543476,0.0004334354,0.00017346175,0.00024140283,0.00035051763,0.00038920314,0.00028343388],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051175937,0.00013173428,0.0005338507,0.000109762455,0.000035612706,0.00012794576,0.000041693005,0.00042578322,0.99362636,0.00009284165,0.00010245104,0.004260247],"study_design_scores_gemma":[0.000066758184,0.0016006266,0.0033345895,0.000007736146,0.000053692125,0.0003985772,0.000028418373,0.001511372,0.99143547,0.000027533473,0.0015269077,0.000008269106],"about_ca_topic_score_codex":0.001017629,"about_ca_topic_score_gemma":0.0023137948,"teacher_disagreement_score":0.001017629,"about_ca_system_score_codex":0.0002953353,"about_ca_system_score_gemma":0.0004075558,"threshold_uncertainty_score":0.002245605},"labels":[],"label_agreement":null},{"id":"W2158890671","doi":"10.1158/1078-0432.ccr-07-1416","title":"A Phase 1 Study of Mapatumumab (Fully Human Monoclonal Antibody to TRAIL-R1) in Patients with Advanced Solid Malignancies","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":189,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Juravinski Cancer Centre","funders":"","keywords":"Tolerability; Medicine; Adverse effect; Toxicity; Internal medicine; Nausea; Pharmacokinetics; Cancer; Tumor necrosis factor alpha; Gastroenterology; Monoclonal antibody; Pharmacology; Oncology; Antibody; Immunology","score_opus":0.10579520366800418,"score_gpt":0.49704933906458154,"score_spread":0.3912541353965774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158890671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947654,0.0015538717,0.0004076095,0.00027853315,0.00006669855,0.0014565436,0.00045511257,0.00005796286,0.00095831684],"genre_scores_gemma":[0.99173975,0.0015208297,0.0013136803,0.0006101216,0.00015575018,0.0015712279,0.001668789,0.000021362543,0.0013986037],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996439,0.0001653406,0.000016347114,0.0000663462,0.000036640162,0.00007147389],"domain_scores_gemma":[0.99942076,0.000092796945,0.00011971529,0.000039593247,0.000035562985,0.00029165752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011077251,0.0014570631,0.0016863927,0.00034943677,0.00041688635,0.00071025226,0.0007163802,0.0009885908,0.0024730582],"category_scores_gemma":[0.00087912614,0.00057493686,0.00088242476,0.0003410324,0.00086132117,0.0007142509,0.00031581573,0.0021009122,0.00069241965],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6197147,0.086689465,0.019439569,0.0015463902,0.001289615,0.0014838566,0.00075943064,0.0056427405,0.09041057,0.00039383452,0.0074843084,0.16514552],"study_design_scores_gemma":[0.4662754,0.50060153,0.021796491,0.000033357264,0.00030177148,0.0009016508,0.000055847828,0.0014363381,0.0050556785,0.00016192377,0.003349215,0.000030882125],"about_ca_topic_score_codex":0.00054577633,"about_ca_topic_score_gemma":0.0013631611,"teacher_disagreement_score":0.0024730582,"about_ca_system_score_codex":0.00080612587,"about_ca_system_score_gemma":0.0014296623,"threshold_uncertainty_score":0.008273184},"labels":[],"label_agreement":null},{"id":"W2158927044","doi":"10.1158/1078-0432.ccr-11-3284","title":"A Phase I Trial and Pharmacokinetic Study of Sorafenib in Children with Refractory Solid Tumors or Leukemias: A Children's Oncology Group Phase I Consortium Report","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Sorafenib; Rash; Pharmacokinetics; Tolerability; Response Evaluation Criteria in Solid Tumors; Internal medicine; Pharmacodynamics; Refractory (planetary science); Adverse effect; Gastroenterology; Oncology; Pharmacology; Toxicity; Phases of clinical research; Hepatocellular carcinoma","score_opus":0.21090893836538757,"score_gpt":0.5746474152749125,"score_spread":0.3637384769095249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158927044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99399227,0.0019281695,0.00055816903,0.0004244549,0.000040254858,0.0012129975,0.0010777593,0.000043050717,0.0007227923],"genre_scores_gemma":[0.98582274,0.0026184365,0.0038752214,0.000765186,0.00014364811,0.002172715,0.003428528,0.00004458834,0.0011289519],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99952173,0.00024369708,0.000033822744,0.000074352974,0.000056733697,0.00006973075],"domain_scores_gemma":[0.9989017,0.00019288938,0.00028511853,0.000072409784,0.00007362854,0.00047426103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012804924,0.0009228398,0.0015518559,0.00018933647,0.00030779734,0.00044562438,0.00057546207,0.0006307317,0.0019580193],"category_scores_gemma":[0.0008390469,0.0002992689,0.0008047095,0.00044224778,0.000808528,0.00043049883,0.0002852796,0.00242197,0.00038850456],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6126875,0.044801585,0.07339099,0.0021263992,0.002984951,0.0020538378,0.0009855093,0.0070520127,0.08726124,0.0006805752,0.014969555,0.15100583],"study_design_scores_gemma":[0.58075505,0.3263956,0.06674876,0.00009948673,0.0007213344,0.002272073,0.00015201964,0.0019442571,0.010368461,0.00019786015,0.010298315,0.000046797955],"about_ca_topic_score_codex":0.0018017584,"about_ca_topic_score_gemma":0.003965657,"teacher_disagreement_score":0.0019580193,"about_ca_system_score_codex":0.0010192469,"about_ca_system_score_gemma":0.00277461,"threshold_uncertainty_score":0.0073952675},"labels":[],"label_agreement":null},{"id":"W2159112711","doi":"10.1158/1078-0432.ccr-10-2075","title":"Neural Tumor-Initiating Cells Have Distinct Telomere Maintenance and Can be Safely Targeted for Telomerase Inhibition","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Telomerase; Telomere; Stem cell; Telomerase reverse transcriptase; Biology; Cancer research; Neural stem cell; Immunology; Cell biology; Genetics; DNA","score_opus":0.3038499232206262,"score_gpt":0.4603910254492899,"score_spread":0.1565411022286637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159112711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98502755,0.0033699293,0.0071719424,0.00007407449,0.00003076696,0.000091746726,0.00058356795,0.00020190698,0.0034484928],"genre_scores_gemma":[0.98998135,0.0015340054,0.00445721,0.00004429484,0.000008932146,0.000100736404,0.0014497931,0.000023920697,0.0023996853],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993324,0.000004806815,0.00000895867,0.0000115395305,0.000028687711,0.000012679328],"domain_scores_gemma":[0.9998888,0.000016649432,0.00003541623,0.00002100026,0.000018336868,0.00001977184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012696262,0.00025417263,0.0002933927,0.0002139369,0.0000838911,0.00026924623,0.00018309997,0.00017037363,0.0010015859],"category_scores_gemma":[0.0001773693,0.00006589599,0.00018439665,0.00016132815,0.00013009657,0.00016392766,0.00011501067,0.00042832212,0.000388909],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025689363,0.00013424503,0.0015256614,0.00010903712,0.000015425321,0.0001153154,0.000027759568,0.00020554743,0.9821278,0.00032328174,0.00012201952,0.01503701],"study_design_scores_gemma":[0.00003202112,0.000923269,0.008494934,0.000014082555,0.00006175895,0.00073381176,0.0000246985,0.0009802205,0.98436177,0.00012868036,0.004240831,0.000003913793],"about_ca_topic_score_codex":0.00035357324,"about_ca_topic_score_gemma":0.0007122199,"teacher_disagreement_score":0.0010015859,"about_ca_system_score_codex":0.00018429189,"about_ca_system_score_gemma":0.00026751828,"threshold_uncertainty_score":0.003350675},"labels":[],"label_agreement":null},{"id":"W2159122128","doi":"10.1158/1078-0432.ccr-04-1258","title":"Variance in the Expression of 5-Fluorouracil Pathway Genes in Colorectal Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Colorectal cancer; Gene; Gene expression; Biology; Fluorouracil; Thymidylate synthase; DPYD; Cancer; Cancer research; Genetics; Oncology; Internal medicine; Medicine; Genotype; Pharmacogenetics","score_opus":0.21335776997608874,"score_gpt":0.5192893717533912,"score_spread":0.30593160177730244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159122128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999358,0.00015530908,0.00028845956,0.000009725423,0.0000017493552,0.0000030728768,0.000069617,0.0000032585344,0.000110768415],"genre_scores_gemma":[0.999645,0.000028626866,0.00013035712,0.000007631382,0.0000020086338,0.000004240069,0.00011464941,0.0000012809877,0.0000660832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995441,0.00011415781,0.0000341326,0.00013712975,0.00010010597,0.00007039057],"domain_scores_gemma":[0.99951494,0.00023517973,0.00011365565,0.00004064981,0.000059987728,0.000035616646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024428475,0.00008528093,0.0002235587,0.0005066992,0.00015576446,0.00027934168,0.00006903073,0.00018710608,0.00047989705],"category_scores_gemma":[0.0010417555,0.00008408981,0.00013570493,0.00040108355,0.00018376179,0.00007292718,0.00013420665,0.00013200044,0.000098627286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008238886,0.000038392598,0.7760321,0.000049716746,0.00015318014,0.0002798452,0.0004830996,0.00035949273,0.20810409,0.00008549436,0.00008991969,0.013500811],"study_design_scores_gemma":[0.0000046683713,0.0001487007,0.99439657,0.0000018842182,0.000020722362,0.00036132408,0.000096843825,0.0002722115,0.0044953963,0.00003517782,0.00016178882,0.000004734205],"about_ca_topic_score_codex":0.0009445097,"about_ca_topic_score_gemma":0.0014660521,"teacher_disagreement_score":0.0009445097,"about_ca_system_score_codex":0.00016196132,"about_ca_system_score_gemma":0.00009579955,"threshold_uncertainty_score":0.0018780231},"labels":[],"label_agreement":null},{"id":"W2159360580","doi":"10.1158/1078-0432.ccr-04-2245","title":"Acquired Resistance to Imatinib in Gastrointestinal Stromal Tumor Occurs Through Secondary Gene Mutation","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":831,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Imatinib; GiST; PDGFRA; Medicine; Tyrosine-kinase inhibitor; Imatinib mesylate; Mutation; Cancer research; Drug resistance; Exon; Stromal tumor; Tyrosine kinase; Gene mutation; Internal medicine; Stromal cell; Biology; Cancer; Gene; Genetics; Receptor","score_opus":0.1862819145099767,"score_gpt":0.5172058367657747,"score_spread":0.33092392225579803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159360580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985623,0.0005162697,0.00030763567,0.000031180673,0.000001738944,0.000005619529,0.000020893305,0.000004755988,0.00054957066],"genre_scores_gemma":[0.9994005,0.00021810013,0.00016158223,0.000017383989,0.0000060791435,0.0000033767674,0.000048339407,0.0000015993216,0.00014314232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984753,0.000049147446,0.000019458214,0.000024175315,0.00003057842,0.000029111703],"domain_scores_gemma":[0.99976915,0.000057507797,0.00008013505,0.00002612347,0.000022494749,0.000044561613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016996995,0.00013070235,0.00022128702,0.00030404926,0.00012180061,0.0002417225,0.00008569481,0.0001647797,0.0016808873],"category_scores_gemma":[0.00078720856,0.000079058766,0.00013345425,0.00019104073,0.00025276447,0.00016451014,0.00017301393,0.00019440471,0.0003235358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013427079,0.0002563516,0.7022481,0.00017520097,0.00014239758,0.020637013,0.0005146168,0.0008036579,0.20862481,0.0008109017,0.00081309985,0.06363116],"study_design_scores_gemma":[0.00015726498,0.002969854,0.7466103,0.000035524314,0.00015618526,0.1675235,0.00024044554,0.0027272294,0.072611384,0.0007766217,0.0061724856,0.000019030143],"about_ca_topic_score_codex":0.00017833966,"about_ca_topic_score_gemma":0.00033244007,"teacher_disagreement_score":0.0016808873,"about_ca_system_score_codex":0.00015506145,"about_ca_system_score_gemma":0.00009421261,"threshold_uncertainty_score":0.005623102},"labels":[],"label_agreement":null},{"id":"W2159470156","doi":"10.1158/1078-0432.ccr-11-2147","title":"<i>NKX3.1</i> Haploinsufficiency Is Prognostic for Prostate Cancer Relapse following Surgery or Image-Guided Radiotherapy","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University; University Health Network","funders":"Memorial Sloan-Kettering Cancer Center","keywords":"Haploinsufficiency; Medicine; Prostate cancer; Prostatectomy; Oncology; Radiation therapy; Internal medicine; Proportional hazards model; Image-guided radiation therapy; Prostate; Comparative genomic hybridization; Cancer; Gene; Biology; Genetics; Phenotype","score_opus":0.4063422715897345,"score_gpt":0.541383628515185,"score_spread":0.13504135692545044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159470156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996742,0.000111017114,0.000054742522,0.000016787488,0.0000013901392,0.0000023255354,0.00004149819,0.0000034135692,0.00009448832],"genre_scores_gemma":[0.99985087,0.000017524168,0.000036824214,0.0000052993278,0.0000027539443,0.0000011207807,0.000054284003,0.0000010536857,0.000030307534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988985,0.000025303265,0.000013842888,0.000028874258,0.000020648182,0.000021495644],"domain_scores_gemma":[0.99903405,0.000281351,0.00044387704,0.000046446632,0.00004194687,0.00015238693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022652162,0.00014567284,0.00017537395,0.00040021466,0.00016748466,0.00025250384,0.00025416972,0.00026885912,0.0015472649],"category_scores_gemma":[0.0012187643,0.00007518967,0.00012735378,0.00025125744,0.00030102534,0.00009576503,0.00018310711,0.0002450118,0.00012234865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000585099,0.00001817818,0.9890837,0.0000101684755,0.000031240357,0.00018492545,0.000035053064,0.00010058865,0.006574795,0.000014244397,0.000079643374,0.003282465],"study_design_scores_gemma":[0.000008818416,0.00012851554,0.9967283,0.0000024800008,0.000025701027,0.0016536975,0.00003579734,0.00034750797,0.0009334685,0.000023366285,0.00010984962,0.0000024197022],"about_ca_topic_score_codex":0.0011197579,"about_ca_topic_score_gemma":0.0010011166,"teacher_disagreement_score":0.0015472649,"about_ca_system_score_codex":0.00014576095,"about_ca_system_score_gemma":0.00010094437,"threshold_uncertainty_score":0.0051761866},"labels":[],"label_agreement":null},{"id":"W2159484131","doi":"10.1158/1078-0432.ccr-05-2208","title":"Ectopic Expression of the Proto-oncogene Mer in Pediatric T-Cell Acute Lymphoblastic Leukemia","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Center, University of Colorado; National Cancer Institute; National Institutes of Health; Bear Necessities Pediatric Cancer Foundation; West Virginia University; Louisiana State University; Children's Hospital of Michigan; McGill University; University of Oklahoma; University of Miami; National Childhood Cancer Foundation","keywords":"Lymphoblast; Molecular biology; Jurkat cells; Flow cytometry; Biology; CD3; Ectopic expression; Thymocyte; Phorbol; Western blot; T cell; Oncogene; Reverse transcription polymerase chain reaction; Cell culture; Immunology; Cell; CD8; Gene expression; Antigen; Kinase; Cell cycle; Immune system; Protein kinase C; Gene; Cell biology; Biochemistry","score_opus":0.06729700719109331,"score_gpt":0.4082430459181411,"score_spread":0.34094603872704776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159484131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976597,0.0006417699,0.0010655131,0.0000259462,0.0000065880263,0.000017335995,0.00018233797,0.000036933052,0.0003639439],"genre_scores_gemma":[0.9969651,0.0005821068,0.0017359061,0.000015673297,0.000005630835,0.000016483675,0.00039969556,0.000011540277,0.00026788216],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998473,0.000027339773,0.000016490767,0.000029348588,0.00004923539,0.000030285726],"domain_scores_gemma":[0.9998926,0.00002935725,0.000038390463,0.000013503813,0.0000093297995,0.000016822765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001277922,0.00020339362,0.000195166,0.00019673599,0.00014221173,0.00032000954,0.00010619176,0.00014848991,0.0007185414],"category_scores_gemma":[0.00019319457,0.00013025917,0.000109986635,0.0003101075,0.00017317089,0.00013640523,0.00014627485,0.00038824428,0.00026753024],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030061835,0.000032296928,0.0042869067,0.000057483656,0.000010389086,0.00026958666,0.00003670725,0.00023248246,0.99152714,0.00007940556,0.00007485037,0.0030922033],"study_design_scores_gemma":[0.00007075722,0.0007542389,0.03942123,0.000013142755,0.00008594544,0.005890933,0.00014761508,0.0025846052,0.94549197,0.00007620337,0.0054569324,0.000006382815],"about_ca_topic_score_codex":0.0003061339,"about_ca_topic_score_gemma":0.00055946957,"teacher_disagreement_score":0.0007185414,"about_ca_system_score_codex":0.00031729153,"about_ca_system_score_gemma":0.00019434025,"threshold_uncertainty_score":0.002403736},"labels":[],"label_agreement":null},{"id":"W2159489772","doi":"10.1158/1078-0432.ccr-06-1817","title":"An Optimized Clinical Regimen for the Oncolytic Virus PV701","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Tolerability; Medicine; Dosing; Regimen; Oncolytic virus; Bolus (digestion); Pharmacokinetics; Clinical trial; Toxicity; Adverse effect; Pharmacology; Internal medicine; Anesthesia; Urology; Cancer","score_opus":0.2683399938072698,"score_gpt":0.5974442074075578,"score_spread":0.32910421360028796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159489772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9668256,0.004882135,0.016845703,0.00040027467,0.00026390443,0.0022371532,0.000891325,0.0005772113,0.007076742],"genre_scores_gemma":[0.97043544,0.001600703,0.021155376,0.0003447726,0.00012406518,0.0018606466,0.0016903818,0.00009661358,0.0026919364],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977344,0.00006200923,0.000016882763,0.000045427834,0.000054476193,0.000047749832],"domain_scores_gemma":[0.9998715,0.000020477783,0.0000386333,0.000020902131,0.000017421864,0.000031088446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028946207,0.00046397548,0.0006382871,0.0004088857,0.00015984791,0.00045189218,0.00045716576,0.0004082001,0.0033805494],"category_scores_gemma":[0.0004961073,0.00014295515,0.0002680432,0.0004754664,0.0002737449,0.00037894357,0.000318349,0.0014663655,0.001159566],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032275215,0.01148658,0.004536994,0.0007360104,0.00019196491,0.00027168222,0.00024794153,0.01684969,0.49316758,0.001542916,0.0083734635,0.4303199],"study_design_scores_gemma":[0.037997786,0.32694054,0.052984733,0.00026978896,0.0008176549,0.005559809,0.00016305935,0.028118271,0.4063414,0.0026621337,0.13790356,0.00024119938],"about_ca_topic_score_codex":0.0002639118,"about_ca_topic_score_gemma":0.00038073616,"teacher_disagreement_score":0.0033805494,"about_ca_system_score_codex":0.00043489886,"about_ca_system_score_gemma":0.0005357576,"threshold_uncertainty_score":0.011309028},"labels":[],"label_agreement":null},{"id":"W2159582600","doi":"10.1158/1078-0432.ccr-12-3139","title":"Altered DNA Methylation Landscapes of Polycomb-Repressed Loci Are Associated with Prostate Cancer Progression and ERG Oncogene Expression in Prostate Cancer","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Prostate cancer; Erg; DNA methylation; CpG site; Biology; Cancer; Cancer research; Methylation; Prostate; PCA3; Differentially methylated regions; Oncology; Medicine; Gene expression; Genetics; Gene","score_opus":0.07008673684970736,"score_gpt":0.4448200420246015,"score_spread":0.37473330517489417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159582600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964199,0.0007806334,0.00079471816,0.000030367386,0.0000015318607,0.000006150052,0.0016385,0.000037878664,0.0002902883],"genre_scores_gemma":[0.99701345,0.00018264019,0.0004104168,0.000016713597,0.0000025983838,0.000005971711,0.0022009488,0.0000056826875,0.00016167542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998122,0.000023227078,0.000016080641,0.00007619462,0.000039427177,0.00003292537],"domain_scores_gemma":[0.9996488,0.00008305053,0.0001474792,0.000040463052,0.000036602625,0.00004357473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022249101,0.0001680229,0.00031761295,0.0007059685,0.00015379026,0.00040428236,0.00017519762,0.00015978771,0.0010012544],"category_scores_gemma":[0.00063925085,0.00010848462,0.00020403558,0.0007943268,0.00017633173,0.00012830221,0.000310657,0.00022625588,0.00017224933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000603371,0.000033974204,0.8317426,0.00018782147,0.0002891191,0.00010809353,0.00017424271,0.0012659255,0.15111081,0.0001403582,0.00033712614,0.014006599],"study_design_scores_gemma":[0.000004645657,0.000042107145,0.9916877,0.0000045308225,0.000049592294,0.00031004054,0.000054007483,0.0011459336,0.0060847457,0.00015483596,0.00045558542,0.0000062245845],"about_ca_topic_score_codex":0.0023953905,"about_ca_topic_score_gemma":0.0057436745,"teacher_disagreement_score":0.0023953905,"about_ca_system_score_codex":0.00023541981,"about_ca_system_score_gemma":0.00018161575,"threshold_uncertainty_score":0.004762888},"labels":[],"label_agreement":null},{"id":"W2159677222","doi":"10.1158/1078-0432.ccr-09-0641","title":"DNA Variants in Region for Noncoding Interfering Transcript of <i>Dihydrofolate Reductase</i> Gene and Outcome in Childhood Acute Lymphoblastic Leukemia","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Haplotype; Biology; Dihydrofolate reductase; Genetics; Promoter; Allele; Gene; Single-nucleotide polymorphism; Genotype; Gene expression","score_opus":0.12660202531230605,"score_gpt":0.45598286909941205,"score_spread":0.32938084378710597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159677222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999468,0.00016057803,0.000143978,0.000015197792,0.0000032654202,0.000003881208,0.00011775913,0.0000033452939,0.00008399405],"genre_scores_gemma":[0.99950325,0.000054851884,0.0001864017,0.000014803167,0.0000055480227,0.0000071300415,0.00015188917,0.0000023451069,0.00007374943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998254,0.00004813418,0.000015142655,0.000057280704,0.000030841853,0.000023215292],"domain_scores_gemma":[0.99951863,0.00017251413,0.00020104689,0.000027196053,0.00002308242,0.000057591616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020087676,0.00019466755,0.00017044142,0.00023918097,0.00014845535,0.00014033994,0.00013617118,0.00019047741,0.0010422171],"category_scores_gemma":[0.000573604,0.00007771769,0.00014117287,0.00026005178,0.00018963224,0.00005854055,0.00009117784,0.00026188826,0.00014598404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020980386,0.00012307602,0.9163687,0.000052670468,0.00014888079,0.0007116432,0.00011392509,0.00021731945,0.072932296,0.00010401179,0.00016595284,0.0069635236],"study_design_scores_gemma":[0.000059560658,0.00048270044,0.9896318,0.00001192502,0.000090354886,0.0020832375,0.000036758734,0.000398308,0.006684551,0.000096329706,0.00041854914,0.000005862654],"about_ca_topic_score_codex":0.00071232446,"about_ca_topic_score_gemma":0.00097183447,"teacher_disagreement_score":0.0010422171,"about_ca_system_score_codex":0.00015303586,"about_ca_system_score_gemma":0.000095652686,"threshold_uncertainty_score":0.0034865737},"labels":[],"label_agreement":null},{"id":"W2159724629","doi":"10.1158/1078-0432.ccr-06-2950","title":"Cross-Linking of Signal Transducer and Activator of Transcription 3—A Molecular Marker for the Photodynamic Reaction in Cells and Tumors","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; BC Cancer Agency","keywords":"Photosensitizer; Photodynamic therapy; STAT protein; STAT3; Cancer research; Singlet oxygen; Reactive oxygen species; Chemistry; Biology; Biophysics; Pathology; Medicine; Cell biology; Photochemistry; Apoptosis; Biochemistry; Oxygen","score_opus":0.09854650017475727,"score_gpt":0.49607002460480465,"score_spread":0.39752352443004735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159724629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97819227,0.0041928706,0.01570052,0.000091587906,0.000030820185,0.000086883636,0.00038276025,0.00009858444,0.0012237953],"genre_scores_gemma":[0.9908087,0.00092829415,0.0069562565,0.000060481827,0.000011812548,0.000056333236,0.000431468,0.000008679396,0.0007377976],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997483,0.000047509708,0.000024689021,0.000055314948,0.00010074624,0.000023554183],"domain_scores_gemma":[0.9996935,0.00007617504,0.0001420436,0.000025943167,0.000036562153,0.000025795634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004067057,0.00037838044,0.0001655113,0.00047817332,0.00014094046,0.00024237421,0.0001688721,0.00042306745,0.0014726523],"category_scores_gemma":[0.0002929815,0.00011951855,0.00027062,0.0003119519,0.0003242265,0.0002507054,0.00017150104,0.00060306874,0.00030889],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006584782,0.000026733693,0.0014824288,0.000033830638,0.0000069915545,0.000012588604,0.00000998465,0.00009050553,0.99682176,0.00007846095,0.00001604261,0.0013548223],"study_design_scores_gemma":[0.000008067909,0.0004411879,0.014135237,0.000011143562,0.000023352706,0.00027584226,0.00001722847,0.0013013517,0.98286533,0.0000993321,0.00081678986,0.000005182228],"about_ca_topic_score_codex":0.00029302397,"about_ca_topic_score_gemma":0.00031589373,"teacher_disagreement_score":0.0014726523,"about_ca_system_score_codex":0.00046003461,"about_ca_system_score_gemma":0.00018092507,"threshold_uncertainty_score":0.0049265027},"labels":[],"label_agreement":null},{"id":"W2159753688","doi":"10.1158/1078-0432.ccr-07-0648","title":"An Antibody Targeting the Type I Insulin-like Growth Factor Receptor Enhances the Castration-Induced Response in Androgen-Dependent Prostate Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"DOD Prostate Cancer Research Program; National Cancer Institute; National Institutes of Health; U.S. Department of Veterans Affairs; U.S. Department of Defense","keywords":"Castration; Prostate cancer; Medicine; Androgen receptor; Androgen; Prostate; Internal medicine; Orchiectomy; Cancer; Endocrinology; Urology; Hormone","score_opus":0.16681916483910428,"score_gpt":0.5321808771038311,"score_spread":0.3653617122647268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159753688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951382,0.002798986,0.00061242294,0.00007749138,0.000056208304,0.00004631212,0.00019369178,0.00010959011,0.00096702186],"genre_scores_gemma":[0.99377054,0.0017801306,0.0013357201,0.00006923167,0.000034047316,0.000050034003,0.0004876046,0.000018734,0.002454092],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998797,0.000014778437,0.000008692072,0.000019807254,0.00003849097,0.00003847643],"domain_scores_gemma":[0.9998847,0.000017038601,0.000027948168,0.000008334211,0.000013343864,0.000048680035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001568169,0.0005284318,0.00035594997,0.0003627505,0.00013329438,0.00024726728,0.00024848158,0.00025416876,0.0012426061],"category_scores_gemma":[0.0000905766,0.00014645181,0.00031332477,0.00021387756,0.0002261763,0.00017076706,0.00009243832,0.0007091262,0.00034075958],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005580517,0.00030258036,0.00014406275,0.00007089181,0.000009517042,0.000021816408,0.000007239865,0.0000601277,0.99641305,0.000018813611,0.00006495782,0.0023289495],"study_design_scores_gemma":[0.00021526842,0.009428133,0.009683823,0.000009745498,0.00006390817,0.00023824883,0.000020631374,0.0007251929,0.97782737,0.000016881608,0.0017613878,0.000009433155],"about_ca_topic_score_codex":0.0012854908,"about_ca_topic_score_gemma":0.003018631,"teacher_disagreement_score":0.0012854908,"about_ca_system_score_codex":0.0003289187,"about_ca_system_score_gemma":0.00039667045,"threshold_uncertainty_score":0.004156947},"labels":[],"label_agreement":null},{"id":"W2159849977","doi":"10.1158/1078-0432.ccr-12-0060","title":"The Effects of Chemotherapy on Cognitive Function in a Mouse Model: A Prospective Study","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trent University; University of Toronto; SickKids Foundation; Princess Margaret Cancer Centre; Hospital for Sick Children; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Cognition; Frontal lobe; Prospective cohort study; Medicine; Associative learning; Psychology; Oncology; Audiology; Internal medicine; Neuroscience; Psychiatry","score_opus":0.13954201744766864,"score_gpt":0.519909629011882,"score_spread":0.38036761156421334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159849977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99631363,0.001773625,0.0007472451,0.000094251096,0.00002576625,0.00022742529,0.00043506332,0.0000404918,0.00034242577],"genre_scores_gemma":[0.99000263,0.0029891594,0.0021115942,0.00024252184,0.000057039175,0.00058647734,0.0016461643,0.000024376248,0.0023401065],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9995789,0.00009332678,0.000038753085,0.00010289892,0.00009169457,0.00009436684],"domain_scores_gemma":[0.9989178,0.000095553114,0.0003652556,0.00020550772,0.00013712619,0.00027870317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012733587,0.0013476844,0.0008967897,0.0010596754,0.00049481285,0.0006162018,0.00066643965,0.000869145,0.00092263886],"category_scores_gemma":[0.0003450385,0.00037422637,0.0009706906,0.00050045847,0.0007453749,0.00067988434,0.00038705824,0.0018127417,0.00044391252],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022776684,0.037745886,0.058350984,0.00038254025,0.00041158206,0.0008018759,0.00020767908,0.00061045284,0.8573107,0.0002817433,0.0007365648,0.020383282],"study_design_scores_gemma":[0.002953825,0.36136186,0.17953226,0.00009204125,0.0013260469,0.0031859518,0.00027414886,0.0032198045,0.44045627,0.0003107776,0.00714538,0.00014160575],"about_ca_topic_score_codex":0.000989322,"about_ca_topic_score_gemma":0.0015238421,"teacher_disagreement_score":0.0013476844,"about_ca_system_score_codex":0.00053824205,"about_ca_system_score_gemma":0.00061898056,"threshold_uncertainty_score":0.006734252},"labels":[],"label_agreement":null},{"id":"W2159863629","doi":"10.1158/1078-0432.ccr-06-0839","title":"A Tracer Dose of Technetium-99m–Labeled Liposomes Can Estimate the Effect of Hyperthermia on Intratumoral Doxil Extravasation","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Extravasation; Liposome; Doxorubicin; Technetium; Hyperthermia; Biodistribution; Technetium-99m; Medicine; Pharmacokinetics; Nuclear medicine; Pharmacology; Chemistry; Chemotherapy; Scintigraphy; Pathology; In vitro; Surgery; Internal medicine","score_opus":0.06502978572385026,"score_gpt":0.44517376991814234,"score_spread":0.3801439841942921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159863629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844844,0.0020736118,0.012717315,0.0000449265,0.000012595701,0.00006264617,0.000057440007,0.00006217306,0.0004850184],"genre_scores_gemma":[0.9919808,0.0005971128,0.0066429162,0.000031534444,0.00000821291,0.000059349106,0.00012573914,0.000014596259,0.0005398042],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982435,0.000053198186,0.000010292757,0.00004393417,0.000046421614,0.000021963724],"domain_scores_gemma":[0.99975604,0.000093900104,0.00007092724,0.000025601083,0.000021474922,0.00003208683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003663815,0.00039798787,0.00027416047,0.00030618266,0.000082448874,0.0002153443,0.00014905535,0.00042128706,0.0008528442],"category_scores_gemma":[0.0004897045,0.00014192252,0.00017636351,0.00012226596,0.00034453627,0.00029442666,0.00014716729,0.00043375077,0.00022714339],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028534737,0.000048239242,0.0011970048,0.00002042245,0.0000061638207,0.000012222873,0.000007016162,0.00007824173,0.99615186,0.000014351281,0.000010174952,0.0021688996],"study_design_scores_gemma":[0.000025441466,0.0013887854,0.010977772,0.000004699506,0.00003475036,0.000121977035,0.000010640918,0.0018688008,0.985246,0.000017092423,0.0002984793,0.0000055309324],"about_ca_topic_score_codex":0.00046269948,"about_ca_topic_score_gemma":0.00048799923,"teacher_disagreement_score":0.0008528442,"about_ca_system_score_codex":0.00033252532,"about_ca_system_score_gemma":0.00021326402,"threshold_uncertainty_score":0.0028530955},"labels":[],"label_agreement":null},{"id":"W2159875179","doi":"10.1158/1078-0432.ccr-08-0405","title":"Tris (Dibenzylideneacetone) Dipalladium, a<i>N</i>-Myristoyltransferase-1 Inhibitor, Is Effective against Melanoma Growth<i>In vitro</i>and<i>In vivo</i>","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Protein Kinase Regulation and GTPase Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Canadian Institutes of Health Research; National Institutes of Health; Emory University","keywords":"Tris; In vivo; Protein kinase B; Melanoma; Cancer research; PI3K/AKT/mTOR pathway; Phosphorylation; Signal transduction; Kinase; In vitro; Mechanism of action; Chemistry; Protein kinase A; Biology; Molecular biology; Biochemistry","score_opus":0.05516778673941028,"score_gpt":0.3757980825299887,"score_spread":0.32063029579057845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159875179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9705687,0.019299097,0.0031677994,0.00019707382,0.00008079198,0.00008628078,0.0005982317,0.00032531266,0.0056767548],"genre_scores_gemma":[0.98756033,0.0065989117,0.001953345,0.00009646227,0.000016814342,0.000027467735,0.000751614,0.000023524644,0.0029715698],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999944,0.0000052358937,0.000005062075,0.000012552174,0.000018854837,0.000014422106],"domain_scores_gemma":[0.999951,0.000005222092,0.000018627466,0.0000026982584,0.000006390301,0.000016032218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006308826,0.0003417481,0.00017175355,0.00019827568,0.000081748425,0.00013145192,0.0001794542,0.0001233213,0.0010867723],"category_scores_gemma":[0.000052264528,0.00009188307,0.00017796253,0.00013563805,0.0001238705,0.000095461604,0.00008872867,0.0003225272,0.00026470938],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025785668,0.000052672713,0.00018141947,0.00011330356,0.000009633972,0.000024554749,0.0000025157638,0.0000652574,0.9952988,0.00003444735,0.000090145775,0.003869531],"study_design_scores_gemma":[0.000041172396,0.0010569228,0.002296735,0.000006919435,0.000028870434,0.00019364282,0.00000626709,0.00029034543,0.9932173,0.000015641324,0.0028430664,0.0000030964993],"about_ca_topic_score_codex":0.0008035283,"about_ca_topic_score_gemma":0.0018897842,"teacher_disagreement_score":0.0010867723,"about_ca_system_score_codex":0.0002629556,"about_ca_system_score_gemma":0.00020190349,"threshold_uncertainty_score":0.0036355853},"labels":[],"label_agreement":null},{"id":"W2160257239","doi":"10.1158/1078-0432.ccr-08-0608","title":"Familial Non-VHL Clear Cell (Conventional) Renal Cell Carcinoma: Clinical Features, Segregation Analysis, and Mutation Analysis of <i>FLCN</i>","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Cancer Research UK; National Institutes of Health; Institut National Du Cancer; Ligue Contre le Cancer; National Institute for Health and Care Research","keywords":"Folliculin; Penetrance; Germline mutation; Germline; Medicine; Birt–Hogg–Dubé syndrome; Renal cell carcinoma; Mutation; Cancer; Clear cell renal cell carcinoma; Oncology; Genetics; Internal medicine; Cancer research; Biology; Phenotype; Surgery","score_opus":0.14348036675283019,"score_gpt":0.4542025237708297,"score_spread":0.31072215701799955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160257239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995908,0.00010256655,0.0000981223,0.000008066637,0.0000011612684,0.0000062541058,0.000040004164,0.0000027034723,0.00015031672],"genre_scores_gemma":[0.999655,0.000032157255,0.00014331882,0.000010627258,0.0000025313332,0.0000037034897,0.000084685846,0.0000013697517,0.000066624394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976104,0.000035414843,0.000025596866,0.00008534478,0.00005255984,0.000040067105],"domain_scores_gemma":[0.99968135,0.00009329933,0.00008355358,0.000026109996,0.000037676353,0.000078084566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020834543,0.0003481154,0.00017835667,0.0004998735,0.00042264746,0.00016340376,0.00014876171,0.0002958908,0.0010009573],"category_scores_gemma":[0.00077797996,0.00014052514,0.00015664831,0.00034562434,0.00046437344,0.0001093333,0.00025732446,0.00018229724,0.00015767288],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054517534,0.00019775321,0.93531644,0.00005413701,0.000059129,0.017448273,0.0004408073,0.00014155633,0.04091105,0.00006687337,0.00017548188,0.00464344],"study_design_scores_gemma":[0.000050164526,0.0006568032,0.9331391,0.0000050875965,0.000042198277,0.05912686,0.00015994733,0.00023925515,0.005929574,0.000037454654,0.00060421973,0.000009288411],"about_ca_topic_score_codex":0.0027680553,"about_ca_topic_score_gemma":0.0026131694,"teacher_disagreement_score":0.0027680553,"about_ca_system_score_codex":0.00029225115,"about_ca_system_score_gemma":0.0002617602,"threshold_uncertainty_score":0.0055038333},"labels":[],"label_agreement":null},{"id":"W2160270310","doi":"10.1158/1078-0432.ccr-06-0860","title":"Distribution of GPR30, a Seven Membrane–Spanning Estrogen Receptor, in Primary Breast Cancer and its Association with Clinicopathologic Determinants of Tumor Progression","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":360,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources","keywords":"GPER; Estrogen receptor; Breast cancer; Metastasis; Estrogen; Internal medicine; Cancer research; Medicine; Cancer; Endocrinology; Biology; Oncology","score_opus":0.03277814508457424,"score_gpt":0.41069458192318486,"score_spread":0.37791643683861065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160270310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995579,0.00017452575,0.00007068336,0.000007693895,0.0000010321352,0.0000038283906,0.000042706157,0.000003055649,0.00013842761],"genre_scores_gemma":[0.99961406,0.00007054577,0.00006373632,0.0000054205793,0.000002904791,0.000006288006,0.000112724076,0.0000011988756,0.00012316067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998011,0.00003885704,0.000017731918,0.00005023624,0.00005114993,0.00004095543],"domain_scores_gemma":[0.999516,0.000087373584,0.00016835838,0.000055268774,0.0000841529,0.00008881513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003623363,0.00012823139,0.00020437455,0.0005087924,0.00020423625,0.00020664718,0.00014824021,0.00021180235,0.0010390339],"category_scores_gemma":[0.0006606612,0.0001338372,0.0001171651,0.00029135754,0.0002994824,0.0001642213,0.0001871341,0.00020937042,0.000326921],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012406416,0.00006960242,0.9286012,0.000028620181,0.000034547596,0.00060097786,0.00007710026,0.00005904101,0.06524833,0.000024214232,0.00009662868,0.0039191446],"study_design_scores_gemma":[0.000008221547,0.00017122396,0.9940532,0.0000019961715,0.000015337246,0.001975916,0.00005663133,0.00011972057,0.0033680953,0.000014138201,0.00021355815,0.0000019934475],"about_ca_topic_score_codex":0.00055796356,"about_ca_topic_score_gemma":0.0007987432,"teacher_disagreement_score":0.0010390339,"about_ca_system_score_codex":0.00028567258,"about_ca_system_score_gemma":0.00011438975,"threshold_uncertainty_score":0.0034759045},"labels":[],"label_agreement":null},{"id":"W2160298696","doi":"10.1158/1078-0432.ccr-07-4543","title":"Prognostic Effect of Basal-Like Breast Cancers Is Time Dependent: Evidence from Tissue Microarray Studies on a Lymph Node–Negative Cohort","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Tissue microarray; Breast cancer; Concordance; Oncology; Internal medicine; Medicine; Lymph node; Proportional hazards model; Progesterone receptor; Estrogen receptor; Basal (medicine); Cohort; Immunohistochemistry; Pathology; Univariate analysis; Cancer; Multivariate analysis","score_opus":0.10249135375368104,"score_gpt":0.45954335227857773,"score_spread":0.35705199852489666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160298696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982309,0.0007755845,0.00041237558,0.000048323236,0.000007196197,0.000006474777,0.00024441324,0.000008143712,0.00026667025],"genre_scores_gemma":[0.99902534,0.00028257663,0.00018457675,0.000020999641,0.000012081791,0.0000075467674,0.00033321138,0.0000042420133,0.00012950643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925345,0.00026238433,0.000058484482,0.00017655244,0.00019221164,0.000056850873],"domain_scores_gemma":[0.99642795,0.0013167425,0.0010760137,0.00071284967,0.00022348347,0.0002429671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015266787,0.00019157592,0.0003218091,0.00050164026,0.000202962,0.0004377849,0.00024193256,0.00024719117,0.0009993545],"category_scores_gemma":[0.0041740225,0.00015133646,0.00031126474,0.0004330158,0.00030751489,0.00031654644,0.0003011789,0.00026713035,0.0002753865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020352704,0.000051627365,0.98054457,0.000031345073,0.00017817804,0.00016355932,0.00009561161,0.00013748444,0.010141973,0.000032079737,0.00009140829,0.006496851],"study_design_scores_gemma":[0.00001335837,0.00027048195,0.9974687,0.0000048822244,0.00006938693,0.00041297264,0.000046961497,0.00024035631,0.0011278846,0.000029362878,0.00031086034,0.0000048111187],"about_ca_topic_score_codex":0.00071609794,"about_ca_topic_score_gemma":0.00083348283,"teacher_disagreement_score":0.0015266787,"about_ca_system_score_codex":0.00017216642,"about_ca_system_score_gemma":0.00018820827,"threshold_uncertainty_score":0.008073986},"labels":[],"label_agreement":null},{"id":"W2160363714","doi":"10.1158/1078-0432.ccr-08-1627","title":"Dose-Dependent Increases in Circulating TGF-α and Other EGFR Ligands Act As Pharmacodynamic Markers for Optimal Biological Dosing of Cetuximab and Are Tumor Independent","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Cetuximab; Amphiregulin; Epidermal growth factor receptor; Epiregulin; In vivo; Cancer research; Epidermal growth factor; EGFR inhibitors; Monoclonal antibody; Transforming growth factor; Medicine; Pharmacology; Antibody; Cancer; Receptor; Internal medicine; Biology; Immunology","score_opus":0.18541814581743665,"score_gpt":0.5158474330850727,"score_spread":0.3304292872676361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160363714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99618536,0.0010729174,0.0021072957,0.0000374439,0.000009526034,0.000037005408,0.00007532017,0.000031822623,0.0004433198],"genre_scores_gemma":[0.9978011,0.00019217787,0.0014363265,0.000036861253,0.000008147748,0.00003898452,0.00018841482,0.000007914191,0.00029015946],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997336,0.00007273694,0.00002274977,0.000052087256,0.00009113395,0.000027627371],"domain_scores_gemma":[0.9997249,0.00007614852,0.00010088541,0.000024356574,0.000040036935,0.000033513577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038245192,0.00022410844,0.00034939643,0.00020398246,0.00014949091,0.0003403701,0.00010757613,0.00023021502,0.00093360327],"category_scores_gemma":[0.00063904,0.0001009747,0.00015224148,0.00013983688,0.00019646119,0.000172563,0.0001337674,0.0005104698,0.00023865228],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018042324,0.00016969362,0.03676559,0.00007060221,0.000032563716,0.00023194944,0.00012022836,0.00038922927,0.9427839,0.00005063983,0.00008452864,0.017496832],"study_design_scores_gemma":[0.00014047135,0.007402069,0.21919298,0.000018858396,0.00010670079,0.0025260919,0.00014270902,0.0026939148,0.76447433,0.00008574713,0.0032025846,0.000013562393],"about_ca_topic_score_codex":0.00026778365,"about_ca_topic_score_gemma":0.00046087295,"teacher_disagreement_score":0.00093360327,"about_ca_system_score_codex":0.00035515017,"about_ca_system_score_gemma":0.00023316318,"threshold_uncertainty_score":0.0031232834},"labels":[],"label_agreement":null},{"id":"W2160378267","doi":"10.1158/1078-0432.ccr-11-3281","title":"Molecular Pathways: Tumor Cells Co-opt the Brain-Specific Metabolism Gene <i>CPT1C</i> to Promote Survival","year":2012,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Gene; Biology; Metabolism; Cancer research; Brain cancer; Cancer; Genetics; Cell biology; Endocrinology","score_opus":0.25257633878264385,"score_gpt":0.4803918267372346,"score_spread":0.22781548795459072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160378267","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046362192,0.9928082,0.00056782534,0.0005505355,0.00040138673,0.000014132161,0.000055291242,0.000029407529,0.0051096613],"genre_scores_gemma":[0.0020440305,0.9928213,0.00055814907,0.00035980134,0.0001272172,0.000017810302,0.00007085892,0.000004024831,0.0039968854],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999366,0.000008705914,0.000006604705,0.0000142100025,0.000025137715,0.000008846344],"domain_scores_gemma":[0.99993813,0.000017344295,0.000010140456,0.000002951491,0.000021664724,0.000009698827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002483655,0.00070341956,0.0007401722,0.0010670171,0.00021775505,0.00072549924,0.0006176609,0.00073817035,0.0037635255],"category_scores_gemma":[0.00019777306,0.0001794609,0.0002608235,0.00097131514,0.0004125892,0.00082655094,0.00043162392,0.0014822904,0.003403415],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001117931,0.00007726745,0.00013736603,0.006391146,0.000046340683,0.00026756153,0.000036835296,0.00040297228,0.014955597,0.008470742,0.03291699,0.9361854],"study_design_scores_gemma":[0.000015402024,0.00005259593,0.00036712608,0.0006410307,0.000026932941,0.0008704028,0.000019275752,0.00006172135,0.0026715908,0.0011857023,0.9940773,0.000010805202],"about_ca_topic_score_codex":0.00081170467,"about_ca_topic_score_gemma":0.0016969063,"teacher_disagreement_score":0.0037635255,"about_ca_system_score_codex":0.0007367507,"about_ca_system_score_gemma":0.0005626716,"threshold_uncertainty_score":0.0125902295},"labels":[],"label_agreement":null},{"id":"W2160463964","doi":"10.1158/1078-0432.ccr-14-2666","title":"Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":479,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Prostate cancer; Androgen receptor; Medicine; Cancer research; Prostate; Androgen; Cancer; Castration; Oncology; Internal medicine; Hormone","score_opus":0.2777102049017103,"score_gpt":0.5002984513579463,"score_spread":0.22258824645623598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160463964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983552,0.00093600346,0.00041576018,0.000020638778,0.0000043915807,0.000008429934,0.000082693005,0.000012462698,0.00016440325],"genre_scores_gemma":[0.99921525,0.00012543486,0.00044512528,0.00001662128,0.0000068813665,0.0000056697827,0.000100827245,0.000001687159,0.00008249749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997019,0.000060297745,0.000029770688,0.00007820758,0.000101632926,0.000028092823],"domain_scores_gemma":[0.9991003,0.0002910678,0.0003660975,0.000049639362,0.00009687139,0.00009600365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030423858,0.00020740891,0.00024710962,0.00086807285,0.00017038843,0.00033252625,0.0002258522,0.00031516215,0.0012634408],"category_scores_gemma":[0.0014788067,0.000113935144,0.000084763495,0.00054758,0.0003083551,0.00019463841,0.00015836237,0.0002707493,0.00013109729],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012781497,0.00009503498,0.8668679,0.00012901408,0.00008263707,0.00074941275,0.00018745694,0.00027747915,0.10294609,0.00006251184,0.00013035882,0.027193997],"study_design_scores_gemma":[0.00007101552,0.0012464486,0.96549994,0.000022601756,0.00009324324,0.008967698,0.00016566856,0.0010023651,0.021900278,0.000111248686,0.00090954837,0.000010003801],"about_ca_topic_score_codex":0.00071000186,"about_ca_topic_score_gemma":0.0010247485,"teacher_disagreement_score":0.0012634408,"about_ca_system_score_codex":0.00023449394,"about_ca_system_score_gemma":0.0001908239,"threshold_uncertainty_score":0.004226625},"labels":[],"label_agreement":null},{"id":"W2160506158","doi":"10.1158/1078-0432.ccr-07-0437","title":"A Phase I and Pharmacokinetic Trial of Erlotinib in Combination with Weekly Docetaxel in Patients with Taxane-Naive Malignancies","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources; Sanofi","keywords":"Docetaxel; Medicine; Erlotinib; Neutropenia; Taxane; Internal medicine; Pharmacokinetics; Gastroenterology; Oncology; Mucositis; Pharmacology; Chemotherapy; Cancer; Epidermal growth factor receptor; Breast cancer","score_opus":0.18398884871801144,"score_gpt":0.5254690886657982,"score_spread":0.34148023994778676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160506158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966869,0.0014391124,0.0002453326,0.00018595377,0.00006061536,0.0005583928,0.00016320137,0.000042893294,0.00061768555],"genre_scores_gemma":[0.995786,0.00093981833,0.0008559947,0.00028944894,0.00011904989,0.0005622578,0.0005889107,0.000012518769,0.0008460717],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99958175,0.00018266191,0.00003328415,0.00008117648,0.00004445297,0.00007671633],"domain_scores_gemma":[0.9995552,0.00006659475,0.000116595096,0.00003488781,0.00001845471,0.00020816011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094674545,0.0012708289,0.0018496661,0.00033258589,0.00035172518,0.0008031375,0.0007161471,0.00087131007,0.0016943985],"category_scores_gemma":[0.0007516336,0.0005106576,0.0008101352,0.00042687877,0.00068511843,0.0006734292,0.00026201564,0.0027649952,0.00043611732],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6795384,0.06896081,0.0139137255,0.0008561511,0.001574645,0.0005038247,0.00031859087,0.004095886,0.06226662,0.00020273127,0.0027739906,0.16499466],"study_design_scores_gemma":[0.52829593,0.44107214,0.019537022,0.00004092512,0.0005153634,0.00067267526,0.000049405575,0.0016743732,0.005216388,0.00011424431,0.00277534,0.00003619508],"about_ca_topic_score_codex":0.0005893144,"about_ca_topic_score_gemma":0.0023608676,"teacher_disagreement_score":0.0018496661,"about_ca_system_score_codex":0.00096148485,"about_ca_system_score_gemma":0.0012583003,"threshold_uncertainty_score":0.006976068},"labels":[],"label_agreement":null},{"id":"W2160614740","doi":"10.1158/1078-0432.ccr-08-1007","title":"Histone Deacetylase Inhibitor Romidepsin Has Differential Activity in Core Binding Factor Acute Myeloid Leukemia","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Romidepsin; Medicine; Myeloid leukemia; Histone deacetylase inhibitor; Leukemia; Myeloid; Bone marrow; Internal medicine; Oncology; Cohort; Hematology; Cancer research; Immunology; Histone deacetylase; Biology; Histone; Genetics","score_opus":0.32182533066670976,"score_gpt":0.5046025705707391,"score_spread":0.18277723990402933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160614740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977216,0.0011983361,0.00035681354,0.000032208085,0.000005408862,0.000034340366,0.00008026226,0.000019301284,0.00055177027],"genre_scores_gemma":[0.9979837,0.00058659614,0.00058437214,0.000042624342,0.000012601907,0.000027870115,0.0003517062,0.0000049665587,0.00040550609],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984956,0.00004314413,0.0000107539145,0.000028714761,0.000037491667,0.000030290503],"domain_scores_gemma":[0.99986637,0.000029277693,0.00003298328,0.000015181159,0.000012023622,0.00004415849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002511918,0.0002466048,0.0005099144,0.0001550591,0.00009840709,0.00023690028,0.00014158526,0.00018104537,0.001065867],"category_scores_gemma":[0.00023782613,0.000085732565,0.00023847031,0.00017328635,0.00019389676,0.00013493512,0.00015742831,0.00047341414,0.0002913406],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017123504,0.0011076599,0.013053876,0.00015119788,0.00011227846,0.00036077158,0.00006233683,0.0008823189,0.90864164,0.00013103765,0.00038897598,0.05798434],"study_design_scores_gemma":[0.0036023306,0.110681675,0.20479816,0.0000311148,0.00036967025,0.0052107438,0.000091596725,0.0042406805,0.66217846,0.00024188409,0.008528505,0.00002517726],"about_ca_topic_score_codex":0.00037971002,"about_ca_topic_score_gemma":0.00065162306,"teacher_disagreement_score":0.001065867,"about_ca_system_score_codex":0.00031268317,"about_ca_system_score_gemma":0.00019445311,"threshold_uncertainty_score":0.0035657287},"labels":[],"label_agreement":null},{"id":"W2160767552","doi":"10.1158/1078-0432.ccr-10-2694","title":"STAT3 Expression, Molecular Features, Inflammation Patterns, and Prognosis in a Database of 724 Colorectal Cancers","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Gary Bennett Family Fund; National Cancer Institute; Entertainment Industry Foundation","keywords":"Colorectal cancer; Microsatellite instability; KRAS; Cancer research; Immunohistochemistry; STAT3; Medicine; DNA methylation; Oncology; Angiogenesis; Biology; Cancer; Internal medicine; Gene expression; Signal transduction; Gene; Microsatellite; Genetics","score_opus":0.20603125582226103,"score_gpt":0.4858001389337855,"score_spread":0.2797688831115245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160767552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902085,0.00061465264,0.00015060173,0.000024673656,0.0000038814164,0.00002101805,0.0087531125,0.0000138308105,0.00020971887],"genre_scores_gemma":[0.98534495,0.00026763073,0.000310434,0.00001731016,0.000008959161,0.000047900976,0.013767625,0.0000064291467,0.00022876526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99946755,0.00006845317,0.00009709293,0.00017723105,0.00010731374,0.00008233791],"domain_scores_gemma":[0.99865615,0.00030561117,0.00048153193,0.00022095254,0.00015711572,0.00017857552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005136729,0.000292106,0.00055406836,0.0023775965,0.00042020355,0.00042507824,0.00045302007,0.00033415144,0.001942988],"category_scores_gemma":[0.0018314046,0.00028876608,0.0005038809,0.0025455519,0.00025531295,0.00022545781,0.0005120487,0.00018473718,0.00049890974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005758376,0.000026732638,0.9930782,0.000074172545,0.00013036234,0.00037897832,0.00004128048,0.00016601705,0.001088632,0.000014435831,0.0005199552,0.0039053638],"study_design_scores_gemma":[0.000042406227,0.00011892191,0.9953551,0.000017152368,0.00014270887,0.0016971246,0.00012028826,0.0005208162,0.0004655073,0.000031734246,0.0014801433,0.000008172147],"about_ca_topic_score_codex":0.008031034,"about_ca_topic_score_gemma":0.010627614,"teacher_disagreement_score":0.008031034,"about_ca_system_score_codex":0.000589211,"about_ca_system_score_gemma":0.0007167701,"threshold_uncertainty_score":0.015968561},"labels":[],"label_agreement":null},{"id":"W2160890790","doi":"10.1158/1078-0432.ccr-09-2879","title":"Transcriptional Profiles Predict Disease Outcome in Patients with Cutaneous T-Cell Lymphoma","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute","keywords":"Stage (stratigraphy); Disease; Lymphoma; Oncology; Medicine; Cutaneous T-cell lymphoma; Microarray; Internal medicine; Microarray analysis techniques; Survival analysis; Gene; Gene expression profiling; Gene expression; Biology; Mycosis fungoides; Genetics","score_opus":0.0916328320573467,"score_gpt":0.4531037524457182,"score_spread":0.36147092038837153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160890790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99912006,0.00017635421,0.00024428824,0.000035551813,0.0000035130633,0.0000049621385,0.00020751207,0.0000071493373,0.00020070375],"genre_scores_gemma":[0.9992986,0.00005454626,0.00017790413,0.000018900331,0.000005777252,0.0000082428905,0.00032150774,0.0000022393288,0.00011231482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998945,0.000021340182,0.000010371245,0.00003219421,0.00001988782,0.000021711889],"domain_scores_gemma":[0.99966764,0.000092786424,0.00012222254,0.000015351858,0.000041767114,0.000060265556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015557343,0.00015050439,0.00018685522,0.0004195211,0.00014803722,0.00028545372,0.00008766001,0.00025175096,0.0009465128],"category_scores_gemma":[0.0006435335,0.00006723635,0.00012216621,0.00038014702,0.0001509672,0.00013940658,0.00013235903,0.00029239635,0.00027407787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000554833,0.000053129726,0.97799325,0.00001713671,0.000027740578,0.00007848179,0.00004518984,0.00018510755,0.01712375,0.000012062507,0.00012967996,0.0037796185],"study_design_scores_gemma":[0.00000881848,0.00015476272,0.9964162,0.0000034614739,0.000024752942,0.0003549649,0.000101260164,0.0008652523,0.0018443661,0.000043341668,0.0001797026,0.0000030914412],"about_ca_topic_score_codex":0.0003767903,"about_ca_topic_score_gemma":0.00047034668,"teacher_disagreement_score":0.0009465128,"about_ca_system_score_codex":0.00013703438,"about_ca_system_score_gemma":0.00008077785,"threshold_uncertainty_score":0.0031664371},"labels":[],"label_agreement":null},{"id":"W2161090963","doi":"10.1158/1078-0432.ccr-05-2070","title":"Variant diphtheria toxin-interleukin-3 fusion proteins with increased receptor affinity have enhanced cytotoxicity against acute myeloid leukemia progenitors.","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Myeloid leukemia; Diphtheria toxin; Progenitor cell; Biology; Molecular biology; Cytotoxicity; Leukemia; Fusion protein; Interleukin 3; Cancer research; Receptor; Immunology; Stem cell; Toxin; Interleukin 21; CD8; Cell biology; Immune system; Genetics; Gene; In vitro; Recombinant DNA","score_opus":0.043342469770564516,"score_gpt":0.35804099655516125,"score_spread":0.31469852678459675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161090963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971444,0.0006305058,0.0016238991,0.00003595993,0.000006760234,0.000016230357,0.00013637224,0.000035125242,0.00037066618],"genre_scores_gemma":[0.99684554,0.00023467111,0.0021484704,0.000028153483,0.0000033254962,0.000009546858,0.00038170902,0.000009306675,0.00033926906],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998741,0.00002372414,0.000013559363,0.000021381527,0.00004150784,0.000025657098],"domain_scores_gemma":[0.9998919,0.00002903295,0.00003716836,0.000013605277,0.000009278294,0.000018965593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013243426,0.00025168253,0.00023226436,0.00009105229,0.000068556044,0.0002707676,0.00013994373,0.00020544739,0.000607987],"category_scores_gemma":[0.00018021521,0.00008657391,0.00020216565,0.00015392274,0.00016370897,0.00013715072,0.00014441731,0.0004159055,0.00026194772],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098979515,0.0000101541455,0.00059702987,0.0000105445915,0.0000045100314,0.000026113727,0.000007960068,0.0001207657,0.9976926,0.000035982615,0.000016568009,0.0013788495],"study_design_scores_gemma":[0.000032127064,0.000772276,0.0076676244,0.0000035582707,0.000039173112,0.001556197,0.000019247425,0.0012228998,0.98629344,0.000034267316,0.0023533355,0.0000059382182],"about_ca_topic_score_codex":0.000407992,"about_ca_topic_score_gemma":0.00051189156,"teacher_disagreement_score":0.000607987,"about_ca_system_score_codex":0.0003608765,"about_ca_system_score_gemma":0.00010212032,"threshold_uncertainty_score":0.0026183724},"labels":[],"label_agreement":null},{"id":"W2161109798","doi":"10.1158/1078-0432.ccr-10-1282","title":"A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":824,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; BC Cancer Agency","keywords":"Breast cancer; Oncology; Immunohistochemistry; Internal medicine; Medicine; Estrogen receptor; Hazard ratio; Progesterone receptor; Tamoxifen; Proportional hazards model; Subtyping; Hormone receptor; Cancer; Confidence interval","score_opus":0.07446867362571363,"score_gpt":0.4895050496537869,"score_spread":0.41503637602807325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161109798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99782455,0.00032301803,0.0014007279,0.000036545378,0.000004702673,0.000013082418,0.000099619465,0.000011216481,0.00028657194],"genre_scores_gemma":[0.999338,0.00004568914,0.00033654203,0.000013248489,0.0000068493555,0.000008566587,0.00020019748,0.0000030271813,0.000048055183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983308,0.0008788367,0.00009702153,0.00029067363,0.00029251567,0.0001101538],"domain_scores_gemma":[0.9953577,0.0026680203,0.0008938487,0.0005259624,0.0003522595,0.00020219186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046636746,0.00045743017,0.0005246591,0.00047990913,0.00017985985,0.00054298656,0.00045730872,0.00039905842,0.00066775817],"category_scores_gemma":[0.009663817,0.00018955271,0.00054234883,0.00033156932,0.00034534093,0.00037891453,0.00045593418,0.00036909262,0.00021140427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002377594,0.00005849575,0.97614485,0.000045613877,0.00030356183,0.000054257674,0.00007778659,0.0025799125,0.0033394273,0.00006773315,0.000121878635,0.01482896],"study_design_scores_gemma":[0.000060423004,0.0015392872,0.9676884,0.000013624322,0.00024286484,0.0003993222,0.00009131,0.02711969,0.00217516,0.0002813351,0.00037300697,0.000015606274],"about_ca_topic_score_codex":0.00072446256,"about_ca_topic_score_gemma":0.0011249058,"teacher_disagreement_score":0.0046636746,"about_ca_system_score_codex":0.0004255646,"about_ca_system_score_gemma":0.0003184182,"threshold_uncertainty_score":0.024664164},"labels":[],"label_agreement":null},{"id":"W2161134408","doi":"10.1158/1078-0432.ccr-06-1526","title":"The Bcl-2 Family Protein Inhibitor, ABT-737, Has Substantial Antimyeloma Activity and Shows Synergistic Effect with Dexamethasone and Melphalan","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Multiple myeloma; Dexamethasone; Melphalan; Apoptosis; Cancer research; Medicine; Cell culture; Bone marrow; Pharmacology; Progenitor cell; Internal medicine; Stem cell; Chemistry; Biology; Biochemistry","score_opus":0.15956877610764686,"score_gpt":0.47939545742552253,"score_spread":0.31982668131787567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161134408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98507684,0.010271105,0.0024167292,0.00012767037,0.00003462023,0.00005049632,0.00025018014,0.00012793619,0.0016444192],"genre_scores_gemma":[0.99423933,0.0025606526,0.0018529318,0.000045952744,0.000015197445,0.000027137161,0.0005033634,0.000013574812,0.00074188836],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999759,0.000038645496,0.000016796086,0.000032281332,0.00010945575,0.000043855704],"domain_scores_gemma":[0.99987805,0.000021783955,0.000028979519,0.000012452768,0.00002551032,0.000033201013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002011355,0.0004528066,0.00046953475,0.00032321824,0.0002048168,0.00034492766,0.00028360015,0.0002173398,0.0010651539],"category_scores_gemma":[0.0001496592,0.000108735665,0.0002607121,0.0003127285,0.00021180032,0.0001874727,0.00012420972,0.0006346282,0.0003862968],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051012746,0.00027058527,0.0012326221,0.000110226036,0.000060411785,0.00013833487,0.000010390167,0.0003007448,0.98517334,0.00004501994,0.00015252912,0.011995646],"study_design_scores_gemma":[0.0000490128,0.001323595,0.0047278022,0.0000049978844,0.000055575234,0.0005382246,0.000011735216,0.0008543213,0.9904619,0.000011206047,0.0019582831,0.0000033632027],"about_ca_topic_score_codex":0.0014478809,"about_ca_topic_score_gemma":0.0035006846,"teacher_disagreement_score":0.0014478809,"about_ca_system_score_codex":0.00062484597,"about_ca_system_score_gemma":0.00045371085,"threshold_uncertainty_score":0.0045336485},"labels":[],"label_agreement":null},{"id":"W2161384666","doi":"10.1158/1078-0432.ccr-08-2581","title":"Bcl-2 Blocks Cisplatin-Induced Apoptosis and Predicts Poor Outcome Following Chemoradiation Treatment in Advanced Oropharyngeal Squamous Cell Carcinoma","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Dental and Craniofacial Research; National Institutes of Health; Flight Attendant Medical Research Institute","keywords":"Oncology; Head and neck squamous-cell carcinoma; Cisplatin; Medicine; Internal medicine; Hazard ratio; Immunohistochemistry; Confidence interval; Head and neck cancer; Radiation therapy; Cancer research; Pathology; Chemotherapy","score_opus":0.08203433884347096,"score_gpt":0.4239287561051464,"score_spread":0.34189441726167547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161384666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996222,0.00018187612,0.00007236906,0.000010738363,0.0000014681501,0.00000404684,0.00002169422,0.0000024625747,0.00008314072],"genre_scores_gemma":[0.99979943,0.000050293875,0.000039169245,0.0000061555993,0.000002691327,0.0000025550178,0.000052239327,5.852341e-7,0.000046787125],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998603,0.000046186236,0.00001174163,0.000020532189,0.00003869397,0.00002247621],"domain_scores_gemma":[0.99954647,0.00012340183,0.00017104487,0.000029030643,0.000051933777,0.00007818408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003603952,0.00018708021,0.0002634613,0.00027933874,0.00017755051,0.00031665422,0.0001554671,0.0001920421,0.00061365374],"category_scores_gemma":[0.0010326422,0.00008053818,0.00015681211,0.00023564708,0.00021088446,0.00015779004,0.0001968223,0.00028520182,0.00012315877],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016486563,0.00017180858,0.9688709,0.000036409725,0.00008623636,0.00026615208,0.00006433348,0.00042257775,0.021553172,0.000020932086,0.00009201953,0.0067667593],"study_design_scores_gemma":[0.00003278762,0.0007750345,0.99220556,0.0000060350153,0.000074300275,0.0008181305,0.00007510344,0.0010992065,0.004560501,0.000054387816,0.0002940424,0.000004850941],"about_ca_topic_score_codex":0.00073975616,"about_ca_topic_score_gemma":0.0011564443,"teacher_disagreement_score":0.00073975616,"about_ca_system_score_codex":0.00026158258,"about_ca_system_score_gemma":0.00020297225,"threshold_uncertainty_score":0.0020529032},"labels":[],"label_agreement":null},{"id":"W2161520972","doi":"10.1158/1078-0432.ccr-08-2342","title":"Efficacy of Systemically Administered Oncolytic Vaccinia Virotherapy for Malignant Gliomas Is Enhanced by Combination Therapy with Rapamycin or Cyclophosphamide","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":160,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Children's Hospital of Eastern Ontario; Toronto General Hospital; University of Calgary","funders":"","keywords":"Oncolytic virus; Vaccinia; Virotherapy; Glioma; Cancer research; Virology; Virus; Biology; Genetic enhancement; Medicine; Immunology","score_opus":0.10254567586752597,"score_gpt":0.4781078364417772,"score_spread":0.3755621605742512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161520972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99342984,0.0036398133,0.0012260862,0.0000774052,0.00004337399,0.00003843507,0.00011368826,0.00009534814,0.0013360544],"genre_scores_gemma":[0.9962352,0.0013789076,0.001426706,0.000021278596,0.000025550076,0.0000330905,0.00015119804,0.000017954073,0.00071017863],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998511,0.000030505946,0.000011530046,0.00003215697,0.000035964986,0.00003862935],"domain_scores_gemma":[0.9999261,0.000015655603,0.000017929135,0.0000127921185,0.000006607282,0.000021009535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018238748,0.00047612382,0.0006044143,0.0002954181,0.000109624874,0.00028550488,0.00018707254,0.00020565631,0.00067189],"category_scores_gemma":[0.00009657783,0.00009886628,0.00027403398,0.00014594007,0.00027384565,0.00020986747,0.00013824986,0.00046552115,0.00020820007],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006429884,0.00019417921,0.0003206812,0.000089930356,0.000021344184,0.000047590333,0.000021424024,0.00022051828,0.9919086,0.000067808,0.00013534773,0.00632945],"study_design_scores_gemma":[0.00008316232,0.0031482845,0.0033664783,0.000010774681,0.00006471865,0.00032558554,0.000016299831,0.0009600837,0.9898505,0.000018532784,0.002149407,0.000006217718],"about_ca_topic_score_codex":0.00034843513,"about_ca_topic_score_gemma":0.0006353898,"teacher_disagreement_score":0.00067189,"about_ca_system_score_codex":0.00022646999,"about_ca_system_score_gemma":0.00022637178,"threshold_uncertainty_score":0.0022476912},"labels":[],"label_agreement":null},{"id":"W2161551303","doi":"10.1158/1078-0432.ccr-10-1891","title":"Pancreatic Tumor Suppression by Benzyl Isothiocyanate Is Associated with Inhibition of PI3K/AKT/FOXO Pathway","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":209,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto; National Cancer Institute; University of Pittsburgh","keywords":"Benzyl isothiocyanate; FOXO1; PI3K/AKT/mTOR pathway; Protein kinase B; Chemistry; Apoptosis; Cancer research; Western blot; Molecular biology; Isothiocyanate; Biology; Biochemistry","score_opus":0.13351204368015232,"score_gpt":0.4011759671457218,"score_spread":0.26766392346556944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161551303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99393696,0.0020974395,0.0020534073,0.00015887214,0.000026020736,0.000038605453,0.00036395132,0.0001287342,0.0011960109],"genre_scores_gemma":[0.99442756,0.0017839544,0.0015513654,0.00007277079,0.000012939453,0.000040731276,0.00050419377,0.000020658186,0.0015859542],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999409,0.000006563136,0.0000056310396,0.0000123430455,0.000019686451,0.000014916751],"domain_scores_gemma":[0.9999269,0.000009249605,0.00003134752,0.000008730764,0.000009002586,0.000014725673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000904951,0.0003389793,0.0001980078,0.000209282,0.00010661638,0.000120684395,0.00013004831,0.00018314712,0.0013659206],"category_scores_gemma":[0.00007019152,0.000085165855,0.0002794442,0.00018189113,0.00019819062,0.00013062211,0.000116362884,0.0004959173,0.00020481835],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033087854,0.00004440891,0.0003331914,0.00004894512,0.0000058517517,0.000034530458,0.000005240826,0.000039257757,0.9973519,0.00002574965,0.000036556674,0.0017435335],"study_design_scores_gemma":[0.00005060835,0.0012966564,0.00988026,0.0000132764435,0.000029926518,0.00024870707,0.000017013119,0.00050741324,0.9861406,0.000032758544,0.0017791041,0.000003630755],"about_ca_topic_score_codex":0.0004746194,"about_ca_topic_score_gemma":0.0009924978,"teacher_disagreement_score":0.0013659206,"about_ca_system_score_codex":0.00023354945,"about_ca_system_score_gemma":0.00022115246,"threshold_uncertainty_score":0.004569471},"labels":[],"label_agreement":null},{"id":"W2161609794","doi":"10.1158/1078-0432.ccr-07-4921","title":"Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":605,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Institutes of Health; European Commission","keywords":"Biology; Cancer research; Carcinogenesis; Epigenetics; Clear cell; Cancer; DNA methylation; Clear cell renal cell carcinoma; CpG site; Germline mutation; Mutation; Gene; Pathology; Renal cell carcinoma; Medicine; Genetics; Gene expression; Carcinoma","score_opus":0.2289285019524419,"score_gpt":0.47762697916421604,"score_spread":0.24869847721177413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161609794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946978,0.0009162418,0.0037684392,0.000032678876,0.0000031366767,0.000022282124,0.00024629993,0.000047256082,0.0002658975],"genre_scores_gemma":[0.9924556,0.00024747642,0.00667763,0.000023555847,0.000005453671,0.00001237625,0.000360489,0.0000072697544,0.00021016132],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997373,0.00004675661,0.00001666006,0.00006643674,0.00010937052,0.000023364231],"domain_scores_gemma":[0.9996321,0.00012145725,0.0000986518,0.000035268393,0.00007734102,0.00003513123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005677647,0.00018517577,0.00021415693,0.0011679372,0.00012752549,0.0002719453,0.0001617033,0.00023410324,0.00077260745],"category_scores_gemma":[0.0012114577,0.00013046802,0.00010092242,0.00022497146,0.00018220617,0.0002083379,0.00019004132,0.00015693177,0.00014969616],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034590365,0.00007129043,0.34633872,0.00015301866,0.000059250833,0.00031442905,0.0001417213,0.0005250126,0.6251718,0.000115235096,0.000126136,0.026637526],"study_design_scores_gemma":[0.000024604002,0.00028221155,0.8302127,0.000014766492,0.00008114673,0.0033147405,0.000084283376,0.003464391,0.16078895,0.000109815606,0.0016105967,0.000011656885],"about_ca_topic_score_codex":0.0011149102,"about_ca_topic_score_gemma":0.0025109954,"teacher_disagreement_score":0.0011679372,"about_ca_system_score_codex":0.00018940346,"about_ca_system_score_gemma":0.00031893956,"threshold_uncertainty_score":0.0030026436},"labels":[],"label_agreement":null},{"id":"W2161991320","doi":"10.1158/1078-0432.ccr-07-0122","title":"FOXA1 Expression in Breast Cancer—Correlation with Luminal Subtype A and Survival","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":289,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"National Cancer Institute; School of Medicine, Indiana University","keywords":"FOXA1; Breast cancer; Estrogen receptor; Medicine; Oncology; Immunohistochemistry; Internal medicine; Cancer; Cancer research","score_opus":0.0913976187551956,"score_gpt":0.457122373456357,"score_spread":0.3657247547011614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161991320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989189,0.000608927,0.00006277964,0.000039334518,0.0000034469415,0.000001792255,0.000102787744,0.0000039951183,0.00025810837],"genre_scores_gemma":[0.9993284,0.00016416785,0.00005873907,0.000014198434,0.00000776061,0.0000026111868,0.00018216266,0.0000012713897,0.00024072705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999268,0.000012920694,0.000007171574,0.000016231485,0.000021292528,0.000015495061],"domain_scores_gemma":[0.9996325,0.00008691783,0.00013688186,0.000017515064,0.000040576964,0.00008556165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028001468,0.00010040236,0.00014366985,0.00034690023,0.00016656875,0.00020666707,0.000105441744,0.00021795405,0.0012281612],"category_scores_gemma":[0.0006649569,0.000076875855,0.00015673556,0.0002897227,0.00016993996,0.00014222747,0.00012138577,0.00017922095,0.00022853784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028923817,0.000018444673,0.9941531,0.000012190057,0.00003227794,0.000053769618,0.000022711494,0.000072800394,0.0019038458,0.0000115881985,0.00010295759,0.0033271129],"study_design_scores_gemma":[0.000007467081,0.000119878234,0.99825984,0.0000056241847,0.000035547535,0.0004812848,0.00004518696,0.00028709148,0.00038931018,0.000040970834,0.00032557055,0.0000021523947],"about_ca_topic_score_codex":0.0016055959,"about_ca_topic_score_gemma":0.0019597637,"teacher_disagreement_score":0.0016055959,"about_ca_system_score_codex":0.00020668205,"about_ca_system_score_gemma":0.00016391343,"threshold_uncertainty_score":0.004108608},"labels":[],"label_agreement":null},{"id":"W2162110703","doi":"10.1158/1078-0432.ccr-03-1061","title":"Estrogen Receptor Status in <b> <i>BRCA1</i> </b>- and <b> <i>BRCA2</i> </b>-Related Breast Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":293,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; BC Cancer Agency; Coalition for Research in Women's Health; Sunnybrook Health Science Centre; Hôtel-Dieu de Montréal; Health Sciences Centre; McGill University; University of Toronto; Jewish General Hospital","funders":"","keywords":"Breast cancer; Medicine; Estrogen receptor; Internal medicine; Cancer; Oncology","score_opus":0.06710784466175702,"score_gpt":0.45300722840408725,"score_spread":0.38589938374233024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162110703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99980277,0.00007760368,0.0000121797275,0.0000057008524,6.2527926e-7,0.0000024665312,0.00004139534,5.222451e-7,0.000056740606],"genre_scores_gemma":[0.9996581,0.000048691563,0.000039604656,0.000011020988,0.0000020493092,0.000005207356,0.00015194168,5.652679e-7,0.00008281016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983704,0.00006448196,0.000010326986,0.00003853942,0.000020388356,0.000029124478],"domain_scores_gemma":[0.99960786,0.00011686876,0.00014966042,0.00003310101,0.00002422056,0.00006832143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004233275,0.00013856898,0.00014709504,0.0003465287,0.00019302039,0.00019044639,0.00013793884,0.00021730748,0.0011018934],"category_scores_gemma":[0.00096178456,0.00017768431,0.00011729164,0.00023252028,0.0002478028,0.00015705662,0.00014011971,0.00019719875,0.00014527944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012885932,0.00016037673,0.99162173,0.000011876641,0.00003120838,0.000116731644,0.00006859256,0.00004915413,0.004154252,0.000019452063,0.00008956487,0.00238845],"study_design_scores_gemma":[0.000035186193,0.00028510074,0.998628,0.0000028864715,0.000014243581,0.000337979,0.000049459664,0.00008389632,0.0004390511,0.000014866185,0.000107969274,0.0000014877056],"about_ca_topic_score_codex":0.003150918,"about_ca_topic_score_gemma":0.0033116592,"teacher_disagreement_score":0.003150918,"about_ca_system_score_codex":0.0002870144,"about_ca_system_score_gemma":0.00018382068,"threshold_uncertainty_score":0.0062651634},"labels":[],"label_agreement":null},{"id":"W2162340188","doi":"10.1158/1078-0432.ccr-09-0145","title":"Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Genes to Predict Response and Resistance to Imatinib Therapy in Chronic Myeloid Leukemia","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":186,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Myeloid leukemia; Imatinib; Pharmacogenetics; Medicine; Clinical significance; Oncology; Gene; Bioinformatics; Immunology; Internal medicine; Biology; Genetics; Genotype","score_opus":0.1807922541795707,"score_gpt":0.5079772695143526,"score_spread":0.32718501533478195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162340188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99810517,0.0003844551,0.0007596753,0.00023746387,0.000009521781,0.000017506623,0.00012986024,0.000006997646,0.00034930685],"genre_scores_gemma":[0.999148,0.000035592122,0.00060302485,0.00004343129,0.000016658863,0.000012409025,0.000071428214,0.0000011050774,0.00006821412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987967,0.00070841936,0.00008839476,0.00020225793,0.00014473786,0.00005949072],"domain_scores_gemma":[0.9973711,0.0017229704,0.00053620664,0.00009727553,0.00011231101,0.0001600322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017053401,0.00047929288,0.0005025218,0.00066980894,0.00023991229,0.00034284245,0.00026523636,0.0005396674,0.0014045602],"category_scores_gemma":[0.005827162,0.00013222391,0.00028525048,0.00053673435,0.0003589121,0.00022242527,0.00025038648,0.0004803066,0.00021420715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011992396,0.00010941059,0.9800136,0.000023577542,0.0001591259,0.00019065556,0.000028806982,0.001179791,0.0022016796,0.00006558806,0.00015192851,0.014676605],"study_design_scores_gemma":[0.0002995953,0.0012376859,0.9766759,0.00002147605,0.00033061727,0.0016511437,0.00006970793,0.015591243,0.0025093635,0.0007878687,0.0008060411,0.000019302222],"about_ca_topic_score_codex":0.00050985976,"about_ca_topic_score_gemma":0.00078799325,"teacher_disagreement_score":0.0017053401,"about_ca_system_score_codex":0.00024027603,"about_ca_system_score_gemma":0.00031159847,"threshold_uncertainty_score":0.009018779},"labels":[],"label_agreement":null},{"id":"W2162630386","doi":"10.1158/1078-0432.ccr-05-0464","title":"Dendritic Cell Vaccination in Glioblastoma Patients Induces Systemic and Intracranial T-cell Responses Modulated by the Local Central Nervous System Tumor Microenvironment","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":541,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"Jonsson Cancer Center Foundation; National Center for Research Resources; National Cancer Institute; National Institutes of Health","keywords":"Medicine; Immune system; Dendritic cell; Cytotoxic T cell; Adverse effect; Vaccination; Immunotherapy; Tumor microenvironment; CTL*; T cell; Immunology; Pathology; CD8; Cancer research; Internal medicine; Biology; In vitro","score_opus":0.02518037491735347,"score_gpt":0.33009177011250956,"score_spread":0.3049113951951561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162630386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99866784,0.00059134857,0.0002083114,0.00007553242,0.000009985185,0.00005048328,0.000025473224,0.000017135888,0.0003538353],"genre_scores_gemma":[0.9989826,0.00028970622,0.00032763556,0.000093446055,0.000024896774,0.00003788926,0.00011936544,0.000002633168,0.000121731784],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99991524,0.000026483844,0.0000065622417,0.000012936401,0.000009985652,0.000028784454],"domain_scores_gemma":[0.9999168,0.000012150973,0.000027024731,0.0000055923133,0.000007989699,0.00003038904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016538698,0.00029020788,0.0006044841,0.000105793224,0.0001992477,0.00016307473,0.00009045127,0.00020877917,0.00050056766],"category_scores_gemma":[0.0002864974,0.00009286479,0.00013647549,0.00012473053,0.00019531997,0.00010220848,0.00013064117,0.0002498516,0.00020610269],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02730762,0.0052829143,0.36732215,0.00064607454,0.00028355108,0.0056217248,0.0004546055,0.0018763803,0.2831268,0.0002483697,0.0054823663,0.3023475],"study_design_scores_gemma":[0.009900796,0.15177105,0.7056589,0.00016744481,0.0007561666,0.025228214,0.0004973614,0.005723702,0.08607381,0.0006448727,0.013524186,0.00005356765],"about_ca_topic_score_codex":0.00043506408,"about_ca_topic_score_gemma":0.00066068355,"teacher_disagreement_score":0.0006044841,"about_ca_system_score_codex":0.00030920765,"about_ca_system_score_gemma":0.0003623264,"threshold_uncertainty_score":0.0022435188},"labels":[],"label_agreement":null},{"id":"W2162692860","doi":"10.1158/1078-0432.ccr-13-1485","title":"Nab-Paclitaxel Is an Active Drug in Preclinical Model of Pediatric Solid Tumors","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Paclitaxel; Rhabdomyosarcoma; In vivo; Neuroblastoma; Medicine; Cancer research; Chemotherapy; Pharmacology; Cell culture; Internal medicine; Sarcoma; Pathology; Biology","score_opus":0.24984792316112422,"score_gpt":0.5535701934128054,"score_spread":0.3037222702516812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162692860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97920746,0.009877814,0.0070780786,0.00019213167,0.00008768036,0.00023136834,0.0006794155,0.00012284845,0.0025232432],"genre_scores_gemma":[0.9779158,0.009221946,0.007330018,0.00009265998,0.000035202982,0.00021639388,0.0019719806,0.000036838053,0.0031791115],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989724,0.000021822676,0.0000063703046,0.00001816317,0.00004183192,0.000014604486],"domain_scores_gemma":[0.99992526,0.000009719276,0.000027381646,0.00000587433,0.000019163055,0.000012573709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014298828,0.000336733,0.000314605,0.00022970876,0.00011383469,0.0001461962,0.00020782105,0.00020921657,0.000835417],"category_scores_gemma":[0.00009534724,0.0000958862,0.00018013085,0.00025376584,0.0001259734,0.00017851693,0.000082434875,0.00044234624,0.00027326273],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065674377,0.000266783,0.0012074598,0.00018927238,0.000024977366,0.0001286406,0.000019475743,0.00055026956,0.9851365,0.00014914617,0.0002974213,0.0113732675],"study_design_scores_gemma":[0.000093087096,0.0040578414,0.005229348,0.0000150115375,0.00006411861,0.0010253424,0.000026952077,0.0013260926,0.978224,0.000037008285,0.009895462,0.0000057617563],"about_ca_topic_score_codex":0.001000431,"about_ca_topic_score_gemma":0.001561069,"teacher_disagreement_score":0.001000431,"about_ca_system_score_codex":0.00034733274,"about_ca_system_score_gemma":0.0003490938,"threshold_uncertainty_score":0.0027947426},"labels":[],"label_agreement":null},{"id":"W2162713325","doi":"10.1158/1078-0432.ccr-10-1264","title":"Fyn Is Downstream of the HGF/MET Signaling Axis and Affects Cellular Shape and Tropism in PC3 Cells","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Liver physiology and pathology","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; University of Chicago","keywords":"FYN; Cancer research; Gene knockdown; Cell growth; DU145; Cell biology; Cancer; Biology; Chemistry; Cancer cell; Proto-oncogene tyrosine-protein kinase Src; Kinase; Cell culture; Biochemistry; Genetics","score_opus":0.2745063226434822,"score_gpt":0.4635810763183067,"score_spread":0.18907475367482451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162713325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99472505,0.00069548766,0.0020737906,0.00010234019,0.000027101887,0.000025759438,0.0008387594,0.00008009145,0.0014314731],"genre_scores_gemma":[0.99386734,0.00048054248,0.0016416123,0.000045949357,0.000003826625,0.00003951276,0.0009316559,0.000029412156,0.0029601455],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998418,0.0000093770295,0.00000943369,0.00002690198,0.000074818076,0.000037626778],"domain_scores_gemma":[0.999925,0.000009761986,0.000020708798,0.0000077167715,0.000010261292,0.000026449423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000098099306,0.0003698949,0.00024369525,0.00020274847,0.0003497042,0.0002671986,0.00017485116,0.00026804113,0.0012464373],"category_scores_gemma":[0.0000880767,0.00014399656,0.0002885729,0.00022530419,0.00023461628,0.00017210258,0.00019159437,0.0006300209,0.00034549768],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011384919,0.000023705035,0.00022617035,0.000013470883,0.0000022661034,0.000039452352,0.000010272864,0.00006119253,0.99873644,0.000030902334,0.000056590543,0.0006858103],"study_design_scores_gemma":[0.000012198485,0.00017599112,0.008793612,0.0000025374495,0.000007880111,0.00022896747,0.000024595649,0.0009021845,0.9888576,0.000019051593,0.0009721971,0.0000032275393],"about_ca_topic_score_codex":0.008310031,"about_ca_topic_score_gemma":0.008780208,"teacher_disagreement_score":0.008310031,"about_ca_system_score_codex":0.00064728135,"about_ca_system_score_gemma":0.00050922035,"threshold_uncertainty_score":0.016523302},"labels":[],"label_agreement":null},{"id":"W2162804910","doi":"10.1158/1078-0432.ccr-04-1347","title":"Pulsatile Administration of the Epidermal Growth Factor Receptor Inhibitor Gefitinib Is Significantly More Effective than Continuous Dosing for Sensitizing Tumors to Paclitaxel","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; National Institutes of Health; Memorial Sloan-Kettering Cancer Center","keywords":"Gefitinib; Paclitaxel; Pharmacology; Tyrosine-kinase inhibitor; Epidermal growth factor receptor; Medicine; Dosing; Chemotherapy; Internal medicine; Cancer","score_opus":0.17029377243080993,"score_gpt":0.516426543690462,"score_spread":0.34613277125965214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162804910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936213,0.0028653208,0.0021365609,0.0000936086,0.00009921033,0.00006000568,0.00007800709,0.00009806768,0.00094794313],"genre_scores_gemma":[0.9962924,0.0010185816,0.0017059292,0.000054767625,0.00007096797,0.000062016545,0.00011369553,0.000023218709,0.0006582916],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99976665,0.000047771275,0.00001834206,0.000045630164,0.000073127594,0.00004840515],"domain_scores_gemma":[0.9995024,0.00016642768,0.00015382243,0.00006751918,0.000018165349,0.00009171852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036365716,0.00024684166,0.00051323685,0.00036686927,0.0001300668,0.00042753667,0.00023040059,0.00025296022,0.0016384888],"category_scores_gemma":[0.0005602065,0.00011408735,0.00028879553,0.00025357574,0.00031465627,0.00040166767,0.00013991904,0.00073680305,0.00016558154],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005721559,0.0020739145,0.0019215378,0.00015473037,0.00007000593,0.000056396802,0.00004892821,0.0010716763,0.9126971,0.00028114545,0.00047374642,0.07542923],"study_design_scores_gemma":[0.0009933533,0.07308034,0.03953933,0.000049827024,0.00030807094,0.00074069673,0.000056016048,0.0051287194,0.8729885,0.00019707196,0.006886124,0.00003188288],"about_ca_topic_score_codex":0.000211612,"about_ca_topic_score_gemma":0.00037018344,"teacher_disagreement_score":0.0016384888,"about_ca_system_score_codex":0.0003062244,"about_ca_system_score_gemma":0.00028278204,"threshold_uncertainty_score":0.0054813623},"labels":[],"label_agreement":null},{"id":"W2162812530","doi":"10.1158/1078-0432.ccr-11-0244","title":"Early G1 Cyclin-Dependent Kinases as Prognostic Markers and Potential Therapeutic Targets in Esophageal Adenocarcinoma","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute; Medical Center, University of Pittsburgh; National Institutes of Health; University of Rochester","keywords":"Cyclin-dependent kinase 6; Amplicon; Biology; Cancer research; Tissue microarray; Gene knockdown; Gene duplication; Cyclin; Cell cycle; Cancer; Gene; Genetics; Polymerase chain reaction","score_opus":0.15895241496436774,"score_gpt":0.4577620976479351,"score_spread":0.29880968268356733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162812530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9665418,0.03035055,0.0009956165,0.00033721465,0.000023093387,0.00004376007,0.0005170846,0.00004090133,0.0011498744],"genre_scores_gemma":[0.9923915,0.005349413,0.0011124229,0.000064266984,0.00002766124,0.000029850973,0.00049710507,0.0000074095706,0.0005204008],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999274,0.000017183454,0.0000064245287,0.00001473661,0.000019050342,0.000015116178],"domain_scores_gemma":[0.99988425,0.000036850037,0.00003578406,0.0000070512065,0.000016692298,0.000019419902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026233008,0.00029806074,0.00049700687,0.00042978371,0.00012857238,0.00034817745,0.00018923359,0.00025420196,0.0008452389],"category_scores_gemma":[0.00034689115,0.00010639487,0.00018758,0.00043964363,0.00014776236,0.00017632837,0.00016841637,0.0003284405,0.00022470714],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009861096,0.0004968403,0.35493845,0.0010589446,0.00023833405,0.0009389634,0.00011051128,0.005299548,0.38497943,0.000413435,0.0012950703,0.24036936],"study_design_scores_gemma":[0.0006523543,0.0043605636,0.68116736,0.00013981976,0.0007359139,0.0036049627,0.00015365367,0.01050477,0.2798196,0.0010817688,0.017751245,0.000027977238],"about_ca_topic_score_codex":0.00033827164,"about_ca_topic_score_gemma":0.0005919111,"teacher_disagreement_score":0.0008452389,"about_ca_system_score_codex":0.00043530512,"about_ca_system_score_gemma":0.00024927768,"threshold_uncertainty_score":0.0031583905},"labels":[],"label_agreement":null},{"id":"W2162885883","doi":"10.1158/1078-0432.ccr-05-1771","title":"Erythropoietin Biology in Cancer","year":2006,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":224,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Erythropoietin receptor; Erythropoietin; Paracrine signalling; Cancer research; Erythropoiesis; Angiogenesis; Autocrine signalling; Haematopoiesis; Cancer; Hematopoietic growth factor; Medicine; Cytokine; Cancer cell; Ovarian cancer; Biology; Immunology; Internal medicine; Anemia; Receptor; Stem cell; Cell biology","score_opus":0.5925182864790159,"score_gpt":0.6841651057528677,"score_spread":0.09164681927385177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162885883","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001033989,0.9989096,0.00005672399,0.00015269451,0.00011428637,0.0000034240243,0.000010669736,0.000003769093,0.0006453655],"genre_scores_gemma":[0.00090498413,0.99826115,0.000087280365,0.00015524265,0.00009659084,0.00000476864,0.000022068354,8.8916806e-7,0.0004670908],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998636,0.000026386126,0.000020645157,0.000021342168,0.000056159668,0.000011872285],"domain_scores_gemma":[0.9998281,0.000083259496,0.00002368977,0.0000056174626,0.000044623564,0.0000146908915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036095548,0.0004562748,0.00081349764,0.0014317497,0.00021155895,0.00075368246,0.00043883736,0.0006231424,0.0027266964],"category_scores_gemma":[0.0005396064,0.00015411983,0.0003485629,0.0016279706,0.00029928715,0.0006832608,0.0005028395,0.0012478372,0.0010553634],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006930876,0.000048749083,0.00018137423,0.021892568,0.00010760743,0.00014728798,0.00006358455,0.00030007315,0.0016819404,0.0035108712,0.028241668,0.94375503],"study_design_scores_gemma":[0.000015545389,0.00006709011,0.0007326034,0.0037896268,0.00010329152,0.0011788531,0.0000334494,0.000061811144,0.00038060138,0.0018501135,0.99177754,0.000009533833],"about_ca_topic_score_codex":0.0010034379,"about_ca_topic_score_gemma":0.0011975733,"teacher_disagreement_score":0.0027266964,"about_ca_system_score_codex":0.0005089954,"about_ca_system_score_gemma":0.00087177305,"threshold_uncertainty_score":0.009121716},"labels":[],"label_agreement":null},{"id":"W2162891536","doi":"10.1158/1078-0432.ccr-09-0557","title":"Down-regulation of ZIP4 by RNA Interference Inhibits Pancreatic Cancer Growth and Increases the Survival of Nude Mice with Pancreatic Cancer Xenografts","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Trace Elements in Health","field":"Nursing","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Public Health Agency of Canada","keywords":"Pancreatic cancer; Gene silencing; Cancer research; Cancer; Small hairpin RNA; Metastasis; Nude mouse; In vivo; Tumor progression; Medicine; Biology; Pathology; Internal medicine; Cell culture; Gene knockdown; Biochemistry","score_opus":0.12165660850417004,"score_gpt":0.47294074354651955,"score_spread":0.3512841350423495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162891536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923104,0.001415784,0.0034375528,0.00012234758,0.000049008086,0.000052382013,0.0008634584,0.0003243758,0.0014247425],"genre_scores_gemma":[0.9900143,0.0011348983,0.0036623906,0.000058555455,0.00001722672,0.00010628373,0.0014834614,0.000064166554,0.0034587167],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998524,0.000018682254,0.000015045036,0.00003263393,0.000045710174,0.00003548367],"domain_scores_gemma":[0.9998671,0.00002202564,0.00005182741,0.00001350352,0.000010389868,0.000035163426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015985552,0.0006019639,0.00038046928,0.00038753875,0.00014471797,0.00024968537,0.0002856895,0.00027731486,0.0015412978],"category_scores_gemma":[0.00010173688,0.00016880494,0.00032058332,0.00021105906,0.00026005326,0.00022071303,0.0001674904,0.00077795814,0.00044096806],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016990944,0.000046661466,0.00015595471,0.000024899216,0.000007233264,0.00001910878,0.000006224389,0.00006586474,0.99854916,0.00003397538,0.000056615016,0.00086439546],"study_design_scores_gemma":[0.00003399966,0.0007170675,0.0029075833,0.0000042838233,0.000025799995,0.00015125585,0.000017851597,0.0019558074,0.9926985,0.000022467364,0.0014615953,0.0000038117757],"about_ca_topic_score_codex":0.00058016664,"about_ca_topic_score_gemma":0.00068467425,"teacher_disagreement_score":0.0015412978,"about_ca_system_score_codex":0.0003486348,"about_ca_system_score_gemma":0.0001947992,"threshold_uncertainty_score":0.0051561},"labels":[],"label_agreement":null},{"id":"W2162916961","doi":"10.1158/1078-0432.756.11.2","title":"Intracellular Localization and Trafficking of Fluorescein-Labeled Cisplatin in Human Ovarian Carcinoma Cells","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cellular transport and secretion","field":"Biochemistry, Genetics and Molecular Biology","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Golgi apparatus; Vesicle; Brefeldin A; Endosome; Cell biology; Secretory pathway; Biology; Vesicular transport protein; Wortmannin; Cytoplasm; Organelle; Secretory Vesicle; Intracellular; Endoplasmic reticulum; Biochemistry; Signal transduction; PI3K/AKT/mTOR pathway; Membrane","score_opus":0.0681913804312433,"score_gpt":0.4035619845125073,"score_spread":0.335370604081264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162916961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862846,0.003077689,0.007167828,0.00013886149,0.000026983991,0.00006073813,0.00052924507,0.00008009967,0.0026339106],"genre_scores_gemma":[0.98576236,0.0017706278,0.0089088045,0.00005538776,0.000007506427,0.000084108375,0.0005970594,0.000016582657,0.002797503],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989474,0.000013822995,0.000008224481,0.000032082837,0.00003234427,0.000018873123],"domain_scores_gemma":[0.99994814,0.000014121154,0.000008799277,0.000008606351,0.000014624352,0.0000056805843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012703177,0.00019587237,0.00029610388,0.00022745784,0.00018971344,0.00026730078,0.00015922147,0.00035158303,0.0007521796],"category_scores_gemma":[0.00012364403,0.000113877686,0.00016946002,0.00033305548,0.00017317866,0.00023286906,0.00011978039,0.00024140283,0.00038825686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011744744,0.000023469582,0.00070357096,0.000060799688,0.0000052837163,0.00010824007,0.000037105936,0.00014020244,0.9956151,0.00016904014,0.000046739915,0.0029729696],"study_design_scores_gemma":[0.0000330557,0.00035663796,0.009278749,0.000008176585,0.00002127461,0.0007938802,0.0000604244,0.0019436762,0.9834731,0.000050343293,0.0039727734,0.00000789742],"about_ca_topic_score_codex":0.0022826532,"about_ca_topic_score_gemma":0.0015468826,"teacher_disagreement_score":0.0022826532,"about_ca_system_score_codex":0.0005743924,"about_ca_system_score_gemma":0.00032523362,"threshold_uncertainty_score":0.0045387745},"labels":[],"label_agreement":null},{"id":"W2163045779","doi":"10.1158/1078-0432.ccr-10-2159","title":"A Phase I Study of the Combination of Intravenous Reovirus Type 3 Dearing and Gemcitabine in Patients with Advanced Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Cancer Research UK","keywords":"Gemcitabine; Medicine; Asymptomatic; Oncolytic virus; Toxicity; Concomitant; Chemotherapy; Neutralizing antibody; Cancer; Antibody; Pharmacology; Gastroenterology; Internal medicine; Immunology","score_opus":0.06696256626864659,"score_gpt":0.476728483187022,"score_spread":0.4097659169183754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163045779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936422,0.0021523463,0.00081158505,0.00014024791,0.00008702098,0.0018059078,0.00020893091,0.000055750967,0.0010959847],"genre_scores_gemma":[0.9923138,0.0016638432,0.002357073,0.0002869392,0.0001246838,0.0015553395,0.00063060224,0.000023699884,0.0010439627],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99955386,0.00022870369,0.000023654471,0.000080253,0.000040212057,0.00007327572],"domain_scores_gemma":[0.99950945,0.000109208246,0.00008965988,0.000075818454,0.000026612217,0.00018932366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009403774,0.0010586749,0.0021058144,0.00030359506,0.0002926588,0.0007173971,0.00061412825,0.0007359865,0.0018282953],"category_scores_gemma":[0.00064124615,0.00044027733,0.00093721953,0.00038958824,0.0006419723,0.0004779495,0.00029920015,0.0023338075,0.00042255665],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46060416,0.11945368,0.016736912,0.0016419336,0.0018974361,0.0006437316,0.0005197217,0.0063894503,0.1352801,0.00040400325,0.0023198363,0.2541091],"study_design_scores_gemma":[0.16346757,0.8073247,0.012357303,0.000042305517,0.0004890886,0.00055649504,0.00005801303,0.0013088833,0.010861326,0.000090742156,0.003418416,0.000025264093],"about_ca_topic_score_codex":0.00057456706,"about_ca_topic_score_gemma":0.0012249751,"teacher_disagreement_score":0.0021058144,"about_ca_system_score_codex":0.0006041802,"about_ca_system_score_gemma":0.0012028534,"threshold_uncertainty_score":0.0061162114},"labels":[],"label_agreement":null},{"id":"W2163214318","doi":"10.1158/1078-0432.ccr-03-0123","title":"Pharmacokinetics of O6-benzylguanine in Pediatric Patients with Central Nervous System Tumors","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Pharmacokinetics; Metabolite; Active metabolite; Pharmacology; Chemistry; Nitrosourea; High-performance liquid chromatography; Half-life; Medicine; Internal medicine; Chemotherapy; Chromatography","score_opus":0.04969822153573047,"score_gpt":0.4072209915819189,"score_spread":0.35752277004618843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163214318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962327,0.002557056,0.00052903325,0.00004880313,0.0000037975976,0.000020673731,0.0001375004,0.000025803847,0.0004446386],"genre_scores_gemma":[0.99684083,0.0013249792,0.0009839853,0.00009393431,0.000017376597,0.00003413248,0.0004951867,0.000011851551,0.00019775315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998857,0.0000422785,0.000005896003,0.000020178593,0.000028811204,0.000017214656],"domain_scores_gemma":[0.99962807,0.00012065497,0.00013518606,0.00001720474,0.00003649907,0.000062476654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018681906,0.00026398778,0.000505792,0.000098381184,0.0001432697,0.00025075176,0.00011597396,0.00018997573,0.0005102706],"category_scores_gemma":[0.0008845414,0.00011177815,0.00013174769,0.00019784454,0.00022103838,0.0001907617,0.00008811702,0.00040965492,0.00016312854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01993584,0.00075532397,0.71893024,0.00038751593,0.00033690935,0.0024564732,0.00068622414,0.003424872,0.1205261,0.00021522054,0.0020592823,0.13028605],"study_design_scores_gemma":[0.0012556176,0.04061717,0.8711718,0.000048658007,0.0005338589,0.016138861,0.00033702937,0.0030061612,0.051744465,0.00015488203,0.014961958,0.000029672192],"about_ca_topic_score_codex":0.0011325236,"about_ca_topic_score_gemma":0.0011372393,"teacher_disagreement_score":0.0011325236,"about_ca_system_score_codex":0.00038045607,"about_ca_system_score_gemma":0.00035520556,"threshold_uncertainty_score":0.0027604103},"labels":[],"label_agreement":null},{"id":"W2163299200","doi":"10.1158/1078-0432.ccr-06-1892","title":"Phase I Pharmacokinetic and Pharmacodynamic Study of 17-<i>N</i>-Allylamino-17-Demethoxygeldanamycin in Pediatric Patients with Recurrent or Refractory Solid Tumors: A Pediatric Oncology Experimental Therapeutics Investigators Consortium Study","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"National Center for Research Resources; National Cancer Institute","keywords":"Medicine; Pharmacokinetics; Toxicity; Pharmacodynamics; Internal medicine; Hsp90 inhibitor; Adverse effect; Pediatric cancer; Pharmacology; Gastroenterology; Oncology; Heat shock protein; Cancer; Hsp90; Biology","score_opus":0.14863615986751028,"score_gpt":0.5409377296812757,"score_spread":0.39230156981376546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163299200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959245,0.0012098553,0.00086954207,0.00018079353,0.000020713804,0.0006142178,0.00048387542,0.00006164063,0.0006349135],"genre_scores_gemma":[0.9909242,0.0017743497,0.0030561232,0.00038863823,0.0000607009,0.0012814322,0.0016253493,0.00004757172,0.0008416217],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99963975,0.00019212847,0.000015208814,0.000053419353,0.000048872527,0.000050545666],"domain_scores_gemma":[0.99937516,0.00009129531,0.00018599677,0.00005545135,0.000050116,0.00024202929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008549466,0.0011593937,0.0013312529,0.00021496501,0.00026126727,0.0005391306,0.00053592713,0.00059238914,0.0011500841],"category_scores_gemma":[0.0005697143,0.00034192996,0.0006235903,0.000386968,0.0006751755,0.00038018016,0.00019693455,0.002446273,0.0003455629],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30010158,0.074119836,0.052062746,0.0010678613,0.0026198758,0.0014409277,0.0013388351,0.017197879,0.32168272,0.0010783753,0.009525563,0.21776374],"study_design_scores_gemma":[0.1592773,0.71594983,0.054554023,0.00007825107,0.0010252998,0.0023274072,0.0001865798,0.0053487015,0.048093252,0.00034496863,0.012761559,0.000052835396],"about_ca_topic_score_codex":0.0012850985,"about_ca_topic_score_gemma":0.0022442534,"teacher_disagreement_score":0.0013312529,"about_ca_system_score_codex":0.001169937,"about_ca_system_score_gemma":0.002001477,"threshold_uncertainty_score":0.008488536},"labels":[],"label_agreement":null},{"id":"W2163299518","doi":"10.1158/1078-0432.ccr-07-0393","title":"<i>KIF14</i> Messenger RNA Expression Is Independently Prognostic for Outcome in Lung Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Immunovaccine (Canada); University Health Network","funders":"National Cancer Institute","keywords":"Hazard ratio; Lung cancer; Biology; Proportional hazards model; Oncology; Internal medicine; Confidence interval; Carcinoma; Medicine; Pathology","score_opus":0.12241240031886057,"score_gpt":0.5210315122914074,"score_spread":0.39861911197254685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163299518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99882287,0.0005794102,0.00021435828,0.00004189663,0.000005386402,0.000007790551,0.00015730225,0.000016254826,0.00015482731],"genre_scores_gemma":[0.99916697,0.00015765971,0.00020766653,0.0000169294,0.000011067548,0.000010790485,0.00026904434,0.0000037169848,0.00015618996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989355,0.000019001161,0.000008515173,0.000027389475,0.000026691947,0.000024875691],"domain_scores_gemma":[0.99957496,0.00011842519,0.00017015408,0.000027006427,0.000046562098,0.00006280212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003170919,0.00022632084,0.00020299527,0.00033335088,0.00012125295,0.00028187092,0.00016377814,0.00025129723,0.001001491],"category_scores_gemma":[0.0006661437,0.00009471499,0.00015074093,0.0001992046,0.00022694512,0.00011879907,0.000110936104,0.0002454392,0.00022537379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032680612,0.00013040667,0.853001,0.000088380315,0.00014805196,0.0001894455,0.000035296423,0.00031348842,0.13084802,0.00003971978,0.00043101623,0.011507164],"study_design_scores_gemma":[0.000046164358,0.000492371,0.9771673,0.000010918071,0.000114537936,0.0005928528,0.00003786011,0.0010999984,0.01987837,0.00006284864,0.00049061794,0.0000061537157],"about_ca_topic_score_codex":0.0007186685,"about_ca_topic_score_gemma":0.0007790649,"teacher_disagreement_score":0.001001491,"about_ca_system_score_codex":0.00024479395,"about_ca_system_score_gemma":0.0001793892,"threshold_uncertainty_score":0.0033502579},"labels":[],"label_agreement":null},{"id":"W2163375473","doi":"10.1158/1078-0432.ccr-14-1437","title":"miR-137 and miR-197 Induce Apoptosis and Suppress Tumorigenicity by Targeting MCL-1 in Multiple Myeloma","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital","funders":"","keywords":"Multiple myeloma; Cancer research; Clonogenic assay; Apoptosis; microRNA; Transfection; Viability assay; In vivo; Plasma cell leukemia; Biology; Cell culture; Immunology; Gene; Genetics","score_opus":0.2832308845321098,"score_gpt":0.5013554029379498,"score_spread":0.21812451840583996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163375473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859707,0.004010534,0.0073869345,0.00016549656,0.00004378782,0.00006334183,0.00031306298,0.00019939864,0.0018466922],"genre_scores_gemma":[0.9935023,0.0011738641,0.0031973866,0.00006886831,0.000010464248,0.0000382241,0.00042917204,0.000018238088,0.0015614867],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987173,0.000012177408,0.000009954696,0.000021449445,0.00006233516,0.000022274857],"domain_scores_gemma":[0.99993813,0.000010752569,0.000023185781,0.000006134616,0.000008824543,0.000012920717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014965892,0.00028758685,0.00023788193,0.00023449596,0.00012470342,0.00027593868,0.0001583305,0.00019644301,0.0009132004],"category_scores_gemma":[0.00012004612,0.00011488023,0.00024333979,0.00013833307,0.00023618873,0.00014349516,0.00019361981,0.0004364715,0.00032621613],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105140956,0.000022842694,0.00030243033,0.000043027056,0.0000058746746,0.00005175448,0.000008777682,0.000083434,0.9976882,0.00013600868,0.000037864393,0.0015146898],"study_design_scores_gemma":[0.000019794063,0.00026382392,0.0020854105,0.000004246983,0.000021932983,0.00034353766,0.000018917459,0.0007812429,0.99384695,0.00005667117,0.0025546842,0.0000027812341],"about_ca_topic_score_codex":0.00032189625,"about_ca_topic_score_gemma":0.00046793203,"teacher_disagreement_score":0.0009132004,"about_ca_system_score_codex":0.00042707354,"about_ca_system_score_gemma":0.00030020767,"threshold_uncertainty_score":0.003098607},"labels":[],"label_agreement":null},{"id":"W2163409320","doi":"10.1158/1078-0432.ccr-04-0221","title":"Liposomal Irinotecan","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Irinotecan; Liposome; Pharmacology; Drug; Pharmacokinetics; In vivo; Medicine; Chemistry; SN-38; Saline; Internal medicine; Colorectal cancer; Biology; Cancer; Biochemistry","score_opus":0.2169374239171557,"score_gpt":0.5007776273332275,"score_spread":0.2838402034160718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163409320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761915,0.0055758148,0.013718014,0.00037462031,0.0001381904,0.00042746076,0.0004242224,0.00027168688,0.0028785206],"genre_scores_gemma":[0.9840847,0.0020071964,0.009309314,0.00018177737,0.000035208886,0.00018021472,0.0006271481,0.000033792152,0.003540651],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987996,0.000021949492,0.000011925199,0.000033937016,0.00003109028,0.000021140471],"domain_scores_gemma":[0.99994457,0.000007798511,0.000016142008,0.0000054955153,0.000013486149,0.000012526493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015114999,0.0003787312,0.00027386786,0.00013082754,0.000102008686,0.00028170057,0.00016998939,0.0003180499,0.0012343305],"category_scores_gemma":[0.0001241472,0.00007733186,0.00011364369,0.000088469715,0.00023675285,0.00032163764,0.00017108994,0.0004349036,0.00063682726],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022642882,0.00009492272,0.0000798716,0.000105401065,0.0000078840285,0.000060301,0.000011207741,0.00025728781,0.99509203,0.0001818359,0.00007320516,0.0038096346],"study_design_scores_gemma":[0.00013245642,0.001162624,0.00031157213,0.000009579613,0.000025905294,0.00020252162,0.00000620946,0.00072791794,0.99272776,0.00004184079,0.0046455427,0.0000061078886],"about_ca_topic_score_codex":0.00027867476,"about_ca_topic_score_gemma":0.00031528086,"teacher_disagreement_score":0.0012343305,"about_ca_system_score_codex":0.0004135737,"about_ca_system_score_gemma":0.00034786394,"threshold_uncertainty_score":0.004129231},"labels":[],"label_agreement":null},{"id":"W2163435127","doi":"10.1158/1078-0432.ccr-08-3329","title":"Expression of DBC1 and SIRT1 Is Associated with Poor Prognosis of Gastric Carcinoma","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sirtuins and Resveratrol in Medicine","field":"Medicine","cited_by":188,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Immunohistochemistry; Medicine; Cancer; Internal medicine; Stage (stratigraphy); Univariate analysis; Lymph node; Metastasis; Tissue microarray; Carcinoma; Oncology; Multivariate analysis; Cancer research; Biology","score_opus":0.18603828043135331,"score_gpt":0.4983316477260869,"score_spread":0.31229336729473356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163435127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988551,0.00075051165,0.000087914996,0.000026841237,0.000003499864,0.0000035360945,0.000120672565,0.0000042900665,0.00014759402],"genre_scores_gemma":[0.99925596,0.00022688137,0.00013701494,0.000012299703,0.000007722279,0.000004911848,0.00023313072,0.0000013507479,0.00012079504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989367,0.000022204253,0.00001108124,0.000022827786,0.000029289662,0.000020835663],"domain_scores_gemma":[0.9996056,0.00005608968,0.00018119132,0.00002876473,0.000052507883,0.00007573576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003126191,0.0002587188,0.00028894123,0.0005294934,0.00019559466,0.00025803124,0.00017288464,0.00022120876,0.00081618526],"category_scores_gemma":[0.00062594924,0.00013401649,0.0001840406,0.00048747734,0.00027064193,0.00013498067,0.00022413775,0.00025751122,0.00017196905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006592067,0.000023786091,0.98019594,0.000035243494,0.000057832927,0.00012538687,0.000039318606,0.00008492405,0.015142283,0.00001433676,0.00013059589,0.0034911546],"study_design_scores_gemma":[0.000012434024,0.00007832127,0.99626154,0.000004372473,0.00005770242,0.00063326495,0.00005099724,0.00039931826,0.0021746396,0.000021889195,0.00030228947,0.0000033043423],"about_ca_topic_score_codex":0.0008652981,"about_ca_topic_score_gemma":0.0011766533,"teacher_disagreement_score":0.0008652981,"about_ca_system_score_codex":0.00028217043,"about_ca_system_score_gemma":0.00015929269,"threshold_uncertainty_score":0.0027304292},"labels":[],"label_agreement":null},{"id":"W2163700401","doi":"10.1158/1078-0432.ccr-04-1235","title":"Intermittent Hypoxia Induces Proteasome-Dependent Down-Regulation of Estrogen Receptor α in Human Breast Carcinoma","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Hypoxia (environmental); Bortezomib; Proteasome inhibitor; Estrogen receptor; Estrogen receptor alpha; Endocrinology; Internal medicine; Biology; Cancer research; HIF1A; Estrogen; Proteasome; Breast cancer; Medicine; Chemistry; Cancer; Cell biology; Angiogenesis","score_opus":0.08653163114555301,"score_gpt":0.42565729878708136,"score_spread":0.33912566764152835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163700401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298215,0.005111877,0.0005365704,0.00005909264,0.000032499884,0.000022995724,0.00034644993,0.00002426869,0.0008840575],"genre_scores_gemma":[0.99575704,0.0017963958,0.0004015921,0.000039684848,0.000019800542,0.000031878764,0.0006915516,0.0000046860596,0.0012573623],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999236,0.000009112323,0.0000075177354,0.000016528178,0.000021022592,0.00002225807],"domain_scores_gemma":[0.9999367,0.0000085277625,0.000021950005,0.000010137926,0.000009364719,0.000013324085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000097446115,0.00013496651,0.00021063667,0.00015399804,0.0001458431,0.000174728,0.00009397789,0.000117511845,0.0014400766],"category_scores_gemma":[0.00010751419,0.00010488417,0.00019673262,0.00015310098,0.0001147495,0.000079967656,0.0001538215,0.00017900918,0.00044308178],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042606203,0.00006163366,0.0029204728,0.00008628493,0.0000202875,0.0001789298,0.000031353466,0.000056963454,0.9927047,0.000031691725,0.0001534595,0.0033283161],"study_design_scores_gemma":[0.0001077855,0.0016847551,0.30745026,0.000022999799,0.00007379678,0.00209877,0.00017487805,0.0008242812,0.67896676,0.00008080056,0.008505907,0.000008958827],"about_ca_topic_score_codex":0.0008043994,"about_ca_topic_score_gemma":0.0012597217,"teacher_disagreement_score":0.0014400766,"about_ca_system_score_codex":0.00025387667,"about_ca_system_score_gemma":0.00014191183,"threshold_uncertainty_score":0.0048175454},"labels":[],"label_agreement":null},{"id":"W2163833439","doi":"10.1158/1078-0432.ccr-11-0998","title":"The Insulin Receptor/Insulin-Like Growth Factor Receptor Family as a Therapeutic Target in Oncology","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Insulin receptor; Metformin; Growth factor receptor; Insulin-Like Growth Factor Receptor; Clinical trial; Receptor tyrosine kinase; Insulin; Tyrosine kinase; Receptor; Insulin-like growth factor; Insulin-like growth factor 1 receptor; Oncology; Antibody; Cancer; Internal medicine; Pharmacology; Immunology; Growth factor; Insulin resistance","score_opus":0.21130708825562863,"score_gpt":0.4926170336702079,"score_spread":0.2813099454145793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163833439","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013822071,0.91197544,0.0039326963,0.04540186,0.0016867578,0.000034458164,0.000024270717,0.000049988943,0.023072442],"genre_scores_gemma":[0.18411635,0.78176636,0.01143058,0.01074899,0.0049202368,0.00006298578,0.000049755246,0.000027633027,0.006877001],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996369,0.0002057461,0.000023511388,0.000026298805,0.00007737496,0.000030263418],"domain_scores_gemma":[0.9994753,0.0002600062,0.000054119628,0.000026944,0.00009183418,0.000091762915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022376166,0.00035006145,0.00053439557,0.00073296734,0.0003140979,0.0011698724,0.0004718895,0.0012164349,0.0023831339],"category_scores_gemma":[0.0010778311,0.00013385479,0.00016551746,0.0008942948,0.0013397748,0.0013816562,0.00045893434,0.0014910082,0.0006676902],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000947885,0.00041915188,0.004162211,0.0018982224,0.000029465391,0.0011863376,0.00022032818,0.001584384,0.014611886,0.056748953,0.02504577,0.89314544],"study_design_scores_gemma":[0.0005123095,0.003274537,0.009935993,0.0021354812,0.00015204698,0.005831612,0.0008639255,0.0027722209,0.0092112385,0.084856294,0.88038015,0.00007411669],"about_ca_topic_score_codex":0.00040513364,"about_ca_topic_score_gemma":0.0011162987,"teacher_disagreement_score":0.0023831339,"about_ca_system_score_codex":0.0009582895,"about_ca_system_score_gemma":0.0013055812,"threshold_uncertainty_score":0.011833787},"labels":[],"label_agreement":null},{"id":"W2164077501","doi":"10.1158/1078-0432.ccr-05-0859","title":"The Relationship between Global Methylation Level, Loss of Heterozygosity, and Microsatellite Instability in Sporadic Colorectal Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Microsatellite instability; Loss of heterozygosity; Methylation; Colorectal cancer; DNA methylation; Biology; Cancer; Cancer research; Chromosome instability; Internal medicine; Oncology; Microsatellite; Medicine; Genetics; Gene; Chromosome; Gene expression; Allele","score_opus":0.36375649461039583,"score_gpt":0.5378855263739727,"score_spread":0.17412903176357686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164077501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99894947,0.00070015085,0.00016976729,0.000011960572,7.6161984e-7,0.000002732365,0.00003995155,0.000003828776,0.000121462304],"genre_scores_gemma":[0.9996238,0.00013847883,0.00012786513,0.000005577819,0.0000028115967,0.000003134093,0.00004918394,0.0000011161117,0.000047919122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979395,0.000047652364,0.000020528163,0.000052509764,0.000054429016,0.000030990184],"domain_scores_gemma":[0.99920684,0.00021890968,0.00034649542,0.000032789278,0.00009626024,0.00009872341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031584405,0.00016813028,0.00023628626,0.0006410815,0.00011043391,0.00021073833,0.0001230956,0.00020135846,0.00066631543],"category_scores_gemma":[0.0013019436,0.00013394571,0.00009439508,0.00028676796,0.00029380835,0.00016458546,0.00020070311,0.00015870114,0.000095798096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048600705,0.000019010295,0.96621567,0.0000426698,0.00007743343,0.00015345367,0.00006215552,0.00011597406,0.027078003,0.000015245207,0.00003201882,0.005702292],"study_design_scores_gemma":[0.000007500147,0.0002290164,0.99531305,0.000003572213,0.000040896943,0.001198299,0.000048216185,0.0002696983,0.0027265188,0.000027994362,0.00013239242,0.0000028765662],"about_ca_topic_score_codex":0.0006806902,"about_ca_topic_score_gemma":0.00086117507,"teacher_disagreement_score":0.0006806902,"about_ca_system_score_codex":0.00016004633,"about_ca_system_score_gemma":0.00009893644,"threshold_uncertainty_score":0.002229035},"labels":[],"label_agreement":null},{"id":"W2164243186","doi":"10.1158/1078-0432.ccr-05-2019","title":"Enhanced Killing of Primary Ovarian Cancer by Retargeting Autologous Cytokine-Induced Killer Cells with Bispecific Antibodies: A Preclinical Study","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of California, Irvine; U.S. Public Health Service; University of Alberta","keywords":"Cytokine-induced killer cell; Ovarian cancer; NKG2D; Antibody; Cancer research; Cytotoxic T cell; Immunotherapy; Medicine; CD8; Antigen; Cancer; Cancer cell; Immunology; CD3; Immune system; Biology; Internal medicine; In vitro","score_opus":0.10249766169932147,"score_gpt":0.4192407169054804,"score_spread":0.316743055206159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164243186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920793,0.0025382587,0.0030203413,0.00014596852,0.000073443654,0.0004257173,0.00031917868,0.00014718255,0.001250516],"genre_scores_gemma":[0.9918662,0.0027887442,0.002100979,0.0001029908,0.00004904322,0.00035924136,0.00066857575,0.0000318381,0.0020323985],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975234,0.00004732079,0.000010468279,0.000040416297,0.00004962275,0.000099910394],"domain_scores_gemma":[0.9998622,0.000028229364,0.000026406327,0.000017125501,0.000020132296,0.000045776145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047048833,0.0008093736,0.00084432616,0.00038471233,0.00014498261,0.00043037493,0.00047514838,0.00045938208,0.0013132422],"category_scores_gemma":[0.00023945159,0.00019205271,0.00045334708,0.00020499848,0.00032755776,0.0003341269,0.00020549125,0.0010864255,0.00032069825],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001437243,0.003626035,0.0003466326,0.0002984563,0.000039391627,0.00013631616,0.00010226604,0.00079310656,0.9807444,0.00013901177,0.00037688672,0.011960247],"study_design_scores_gemma":[0.0012767245,0.056662895,0.0035655126,0.000024460765,0.00014302394,0.0006489285,0.000063840314,0.0026172202,0.9303038,0.0000757256,0.004606224,0.000011626872],"about_ca_topic_score_codex":0.0007171346,"about_ca_topic_score_gemma":0.0008181799,"teacher_disagreement_score":0.0013132422,"about_ca_system_score_codex":0.00047046077,"about_ca_system_score_gemma":0.0004318017,"threshold_uncertainty_score":0.00439322},"labels":[],"label_agreement":null},{"id":"W2164358237","doi":"10.1158/1078-0432.ccr-13-1222","title":"Phase III Trials of Targeted Anticancer Therapies: Redesigning the Concept","year":2013,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Clinical trial; Medicine; Drug development; Intensive care medicine; Phases of clinical research; Cancer; Clinical endpoint; Drug; Clinical study design; Anticancer drug; Drug trial; Standard of care; Randomized controlled trial; Oncology; Pharmacology; Internal medicine","score_opus":0.9689936851649781,"score_gpt":0.8078461069799944,"score_spread":0.1611475781849837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164358237","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015531012,0.774248,0.18826717,0.025712729,0.003604428,0.0018437185,0.0001964245,0.00026361848,0.004310839],"genre_scores_gemma":[0.025232429,0.64186,0.30552903,0.018054558,0.0036765474,0.0038165222,0.00019687889,0.00017021492,0.0014638215],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9457446,0.044605795,0.0035706575,0.0015356328,0.0042725066,0.00027084004],"domain_scores_gemma":[0.83173895,0.14969985,0.0070464322,0.005055127,0.005718,0.00074154127],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.106546596,0.0016529189,0.004257426,0.0043031517,0.00027602602,0.0037772737,0.0030584228,0.0031648462,0.00260977],"category_scores_gemma":[0.09574557,0.00096920837,0.0028064982,0.00319551,0.0059291665,0.0067843907,0.0021155595,0.008708206,0.0011915086],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004646062,0.000109081826,0.00033837365,0.018531747,0.000502954,0.000054604327,0.00030666642,0.004375576,0.00058915676,0.16334313,0.00973,0.80165416],"study_design_scores_gemma":[0.0018954116,0.0020233549,0.0015127573,0.03218312,0.0017975321,0.0009422854,0.00032564314,0.008470087,0.0014420536,0.41819102,0.53102356,0.00019317975],"about_ca_topic_score_codex":0.0010033108,"about_ca_topic_score_gemma":0.0009958242,"teacher_disagreement_score":0.8934534,"about_ca_system_score_codex":0.0022887103,"about_ca_system_score_gemma":0.008672751,"threshold_uncertainty_score":0.56347895},"labels":[],"label_agreement":null},{"id":"W2164536651","doi":"10.1158/1078-0432.ccr-13-0283","title":"Genome-Wide Study of Hypomethylated and Induced Genes in Patients with Liver Cancer Unravels Novel Anticancer Targets","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Metastasis; Cancer; Biology; Cancer research; Wnt signaling pathway; Cancer cell; Epigenetics; Cell growth; DNA methylation; Liver cancer; Gene; Genetics; Gene expression","score_opus":0.10140815794137993,"score_gpt":0.4089392078616567,"score_spread":0.3075310499202768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164536651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952082,0.0020279689,0.001150553,0.00015120416,0.000007145714,0.000015521078,0.00070111937,0.00003987061,0.00069841195],"genre_scores_gemma":[0.99859816,0.0002649924,0.0003701177,0.000048350423,0.000010011721,0.000007535056,0.00046179237,0.000006174398,0.00023300236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998901,0.00002001657,0.000009724108,0.000040668554,0.000023175935,0.000016290689],"domain_scores_gemma":[0.9998173,0.000042542055,0.00007335776,0.000013225726,0.000024451176,0.000029168572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019091326,0.0001779812,0.0003032861,0.00042872984,0.0000981987,0.00020364161,0.00013937762,0.00019791549,0.0011447557],"category_scores_gemma":[0.0003077595,0.000086100685,0.00017190495,0.0004170463,0.00012793095,0.0001269585,0.00013179581,0.00021396058,0.00015773905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011404288,0.000058069207,0.8349647,0.00012870874,0.00018192797,0.00034335555,0.00006265033,0.00036345745,0.14328565,0.00012209082,0.00034907743,0.018999917],"study_design_scores_gemma":[0.000020323789,0.0002604943,0.98090726,0.000009345997,0.00014740923,0.00091140176,0.00007651072,0.00084596174,0.014890858,0.00010018719,0.0018256088,0.0000047708377],"about_ca_topic_score_codex":0.00048955885,"about_ca_topic_score_gemma":0.0009052662,"teacher_disagreement_score":0.0011447557,"about_ca_system_score_codex":0.00014649204,"about_ca_system_score_gemma":0.00014775095,"threshold_uncertainty_score":0.0038295984},"labels":[],"label_agreement":null},{"id":"W2164563042","doi":"10.1158/1078-0432.ccr-05-0621","title":"Metronomic Low-Dose Chemotherapy Boosts CD95-Dependent Antiangiogenic Effect of the Thrombospondin Peptide ABT-510: A Complementation Antiangiogenic Strategy","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Heart, Lung, and Blood Institute","keywords":"Angiogenesis; Docetaxel; Cisplatin; Cancer research; Endothelial stem cell; In vivo; Medicine; Fas receptor; Progenitor cell; Pharmacology; Apoptosis; Chemotherapy; Biology; Programmed cell death; Internal medicine; Stem cell; In vitro; Cell biology; Biochemistry","score_opus":0.08055689484300803,"score_gpt":0.4719427441858524,"score_spread":0.39138584934284437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164563042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968791,0.0005284532,0.0014927146,0.00006576167,0.000019156088,0.00006305731,0.00008775973,0.000044114564,0.0008199383],"genre_scores_gemma":[0.99720156,0.00031734272,0.0016197788,0.000028597638,0.000005567026,0.00002765043,0.00014222226,0.0000045192533,0.0006527176],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999194,0.000012682563,0.000007788295,0.000016920238,0.000020460999,0.000022732784],"domain_scores_gemma":[0.9999635,0.0000050381223,0.000009063077,0.000005969035,0.0000038165554,0.000012595084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001017523,0.0002871151,0.00022128111,0.00017118899,0.00008632924,0.0002001552,0.00021543753,0.00019680316,0.0008232512],"category_scores_gemma":[0.00007008471,0.000100372104,0.00017260613,0.00011790537,0.00015892161,0.00016362345,0.00013224069,0.00048641718,0.00013737376],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021867744,0.00017939006,0.00013255124,0.00003637249,0.000007373553,0.000040431238,0.000009875791,0.0002540574,0.99525625,0.00016098862,0.00006723343,0.0036368864],"study_design_scores_gemma":[0.00015585098,0.0037234863,0.0016460588,0.000005473512,0.000029268931,0.00031190342,0.000008481948,0.0015133915,0.99038297,0.00004242839,0.002174372,0.000006304601],"about_ca_topic_score_codex":0.00028949298,"about_ca_topic_score_gemma":0.0005150941,"teacher_disagreement_score":0.0008232512,"about_ca_system_score_codex":0.00023035688,"about_ca_system_score_gemma":0.0002168908,"threshold_uncertainty_score":0.0027540922},"labels":[],"label_agreement":null},{"id":"W2164603058","doi":"10.1158/1078-0432.ccr-08-0276","title":"Combination Chemotherapy and ALVAC-CEA/B7.1 Vaccine in Patients with Metastatic Colorectal Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada); Concordia University; McGill University; Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Colorectal cancer; Chemotherapy; Cancer; Oncology; Internal medicine","score_opus":0.07841285888194537,"score_gpt":0.4210567814780933,"score_spread":0.3426439225961479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164603058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99603516,0.003036785,0.00013799634,0.00013203199,0.000030464094,0.0001173052,0.000037493424,0.000008771483,0.0004639305],"genre_scores_gemma":[0.99835265,0.00078020844,0.00029983913,0.00011662142,0.000061376275,0.00012767843,0.00008663106,0.0000012695525,0.00017374654],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999796,0.00008775167,0.000014584816,0.00003600744,0.000031131967,0.00003463558],"domain_scores_gemma":[0.99970967,0.00008531582,0.00005885918,0.000016257438,0.000013420135,0.000116439194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035776684,0.00027727732,0.001073966,0.00014571952,0.00023204919,0.00015391437,0.00018172228,0.00028874737,0.0012251041],"category_scores_gemma":[0.0006140513,0.00016257775,0.0003328076,0.00016952128,0.00026443417,0.00018521497,0.00016010112,0.00043986033,0.0001621435],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38671294,0.015912907,0.1653591,0.0015265266,0.0015717968,0.0012067284,0.0002611673,0.0050848257,0.08645726,0.00021632065,0.002593716,0.33309668],"study_design_scores_gemma":[0.069495365,0.63234663,0.27295163,0.00016989511,0.0015754459,0.0022415135,0.0001363384,0.0034892182,0.010494937,0.00025525715,0.006805248,0.00003852058],"about_ca_topic_score_codex":0.0003792314,"about_ca_topic_score_gemma":0.0014322073,"teacher_disagreement_score":0.0012251041,"about_ca_system_score_codex":0.0003138677,"about_ca_system_score_gemma":0.00047479,"threshold_uncertainty_score":0.0040984154},"labels":[],"label_agreement":null},{"id":"W2164672043","doi":"10.1158/1078-0432.ccr-11-0544","title":"TGFβ1 Inhibition Increases the Radiosensitivity of Breast Cancer Cells<i>In Vitro</i>and Promotes Tumor Control by Radiation<i>In Vivo</i>","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":240,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institute of Arthritis and Musculoskeletal and Skin Diseases; York University; U.S. Department of Defense","keywords":"Clonogenic assay; In vivo; Cancer research; Radiosensitivity; Growth inhibition; Cancer cell; Transforming growth factor; Radiation sensitivity; Cancer; Biology; In vitro; Chemistry; Medicine; Radiation therapy; Internal medicine; Endocrinology; Biochemistry; Irradiation","score_opus":0.04347169386366349,"score_gpt":0.3680141626137282,"score_spread":0.3245424687500647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164672043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99206173,0.0032301543,0.0017998338,0.00013989762,0.000051826537,0.000049526006,0.0005076323,0.00011398789,0.0020454724],"genre_scores_gemma":[0.99070776,0.0025862125,0.0017959202,0.00007920635,0.000021715541,0.00007701237,0.0010855547,0.00002952877,0.0036171195],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989295,0.000015615155,0.000008970895,0.000024327583,0.000027582304,0.000030600113],"domain_scores_gemma":[0.999925,0.000011870273,0.000031037907,0.000009939138,0.000008074098,0.0000140621405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012646204,0.0004272598,0.00027498402,0.00017140328,0.000116341806,0.00022719432,0.00014716729,0.00019181975,0.0021270914],"category_scores_gemma":[0.00006566809,0.00014993631,0.0003147799,0.00012475111,0.00016777428,0.00013727948,0.00009125369,0.00065976015,0.00047848266],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017229859,0.0000581928,0.00015379016,0.00003491726,0.000004663958,0.000016927399,0.0000068492873,0.00003745825,0.9986811,0.000028342924,0.000054407697,0.0007510608],"study_design_scores_gemma":[0.0000107134065,0.00062315696,0.0020707003,0.000004148728,0.0000115066605,0.00010484065,0.00001079068,0.00017233832,0.9960871,0.0000091410375,0.00089420227,0.0000014598402],"about_ca_topic_score_codex":0.0005405765,"about_ca_topic_score_gemma":0.0007922918,"teacher_disagreement_score":0.0021270914,"about_ca_system_score_codex":0.00025343194,"about_ca_system_score_gemma":0.00019382928,"threshold_uncertainty_score":0.0071157813},"labels":[],"label_agreement":null},{"id":"W2164815481","doi":"10.1158/1078-0432.ccr-04-1676","title":"Phase I Trial and Pharmacokinetic Study of Raltitrexed in Children with Recurrent or Refractory Leukemia: A Pediatric Oncology Group Study","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Raltitrexed; Medicine; Pharmacokinetics; Refractory (planetary science); Dosing; Toxicity; Internal medicine; Pharmacology; Gastroenterology; Leukemia; Thymidylate synthase; Chemotherapy; Oncology; Fluorouracil","score_opus":0.18595001990932006,"score_gpt":0.5569707131992239,"score_spread":0.37102069328990384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164815481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945926,0.002645961,0.00059404183,0.00023693098,0.000024503257,0.0006738853,0.00048479775,0.000051746414,0.000695545],"genre_scores_gemma":[0.989794,0.0027962863,0.0028454305,0.0004481091,0.00010637374,0.0012942221,0.0017569656,0.000033505807,0.00092504686],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99963844,0.00019367148,0.00001785771,0.000052843832,0.00004734185,0.000049796618],"domain_scores_gemma":[0.99937207,0.00009944964,0.00019312068,0.000056335957,0.000036625202,0.00024253827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075995224,0.0010061293,0.0015287414,0.00020756936,0.00018567631,0.0004054259,0.0006499878,0.00069491216,0.0013901322],"category_scores_gemma":[0.00063437724,0.00024420695,0.0007018533,0.00035128166,0.00063766935,0.0003146839,0.00018644963,0.0018772635,0.0003636818],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37347254,0.044395074,0.088904,0.002188398,0.003583015,0.0035451269,0.0013853648,0.013342133,0.17433958,0.00096190657,0.010374238,0.28350866],"study_design_scores_gemma":[0.28502855,0.601036,0.06508393,0.00010316885,0.0011814907,0.004001119,0.00013788558,0.0031231062,0.026401065,0.00023777585,0.013622463,0.00004349592],"about_ca_topic_score_codex":0.0012318856,"about_ca_topic_score_gemma":0.002023163,"teacher_disagreement_score":0.0015287414,"about_ca_system_score_codex":0.00094476796,"about_ca_system_score_gemma":0.0014460317,"threshold_uncertainty_score":0.0068547726},"labels":[],"label_agreement":null},{"id":"W2164846084","doi":"10.1158/1078-0432.ccr-10-3083","title":"Induction of HLA-DP4–Restricted Anti-Survivin Th1 and Th2 Responses Using an Artificial Antigen-Presenting Cell","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Survivin; Biology; CD8; Cancer research; Antigen; Immunology; Cancer immunotherapy; T cell; Immunotherapy; Cytotoxic T cell; Antigen-presenting cell; Cancer; Immune system; In vitro; Genetics","score_opus":0.4470129665054379,"score_gpt":0.49040526565864057,"score_spread":0.04339229915320264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164846084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99287087,0.0006975249,0.0053731087,0.000041968684,0.000030226429,0.00010775279,0.0001368952,0.000043457203,0.0006983233],"genre_scores_gemma":[0.9936748,0.00038194712,0.0046355845,0.000049469527,0.000019808174,0.00008582594,0.00031504012,0.000009296671,0.0008282119],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998053,0.000042014333,0.000025293644,0.000051513773,0.000039504663,0.000036531488],"domain_scores_gemma":[0.9998714,0.00003432897,0.000032282438,0.000021689904,0.00001669455,0.000023594157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023155544,0.00036882164,0.00026581078,0.00017252879,0.00011968128,0.00026150054,0.00015171139,0.00031752454,0.0010559009],"category_scores_gemma":[0.00019557509,0.00009580541,0.00022263001,0.00012792533,0.00017768463,0.00015698161,0.00021239671,0.00055998575,0.0003129182],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011502226,0.000065067085,0.0003655522,0.000047374342,0.0000053178496,0.000038781476,0.000011638104,0.00011057902,0.9975389,0.000046029418,0.000021837664,0.001633797],"study_design_scores_gemma":[0.00004724866,0.0015390702,0.0019659821,0.00000696102,0.000031783446,0.00045974646,0.00001535917,0.0014740255,0.9924722,0.000036957772,0.0019464367,0.0000043419564],"about_ca_topic_score_codex":0.00009961881,"about_ca_topic_score_gemma":0.00008390373,"teacher_disagreement_score":0.0010559009,"about_ca_system_score_codex":0.00019129574,"about_ca_system_score_gemma":0.00017062515,"threshold_uncertainty_score":0.00353235},"labels":[],"label_agreement":null},{"id":"W2164885520","doi":"10.1158/1078-0432.ccr-04-0209","title":"Imaging Correlates of Molecular Signatures in Oligodendrogliomas","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Western University","funders":"National Cancer Institute","keywords":"Oligodendroglioma; Magnetic resonance imaging; Pathology; Calcification; Oligodendroglial Tumor; Medicine; Biology; Glioma; Radiology; Astrocytoma; Cancer research","score_opus":0.09893873783720904,"score_gpt":0.49364948085259075,"score_spread":0.3947107430153817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164885520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99641967,0.0010577807,0.00038583402,0.00007055598,0.000004459399,0.000012687276,0.00009031351,0.000014031123,0.0019445643],"genre_scores_gemma":[0.9989047,0.00034587685,0.00041642046,0.00001727608,0.000016235566,0.00000793225,0.000110697365,0.000004292907,0.00017658542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998884,0.000024614235,0.000013016914,0.000020415418,0.00002738061,0.000026159621],"domain_scores_gemma":[0.9990711,0.00016116585,0.00041519242,0.0000431975,0.00017979965,0.00012948619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040508015,0.00020869139,0.00020356434,0.001899474,0.00015404474,0.00050863676,0.00026920642,0.00034195508,0.0011418631],"category_scores_gemma":[0.0022466637,0.00017181909,0.00009438482,0.0005147765,0.0003147451,0.00044335113,0.00026044407,0.00028476788,0.0002815156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022569536,0.00014768745,0.82010573,0.00013753059,0.00010080143,0.003666473,0.00029044173,0.0006295027,0.14330609,0.00060684694,0.00036029145,0.028391652],"study_design_scores_gemma":[0.000031506563,0.00042549096,0.97198594,0.000020892,0.000099657795,0.008839458,0.0003480385,0.00085730455,0.016034402,0.000529299,0.0008123731,0.000015566358],"about_ca_topic_score_codex":0.00096654013,"about_ca_topic_score_gemma":0.0007359627,"teacher_disagreement_score":0.001899474,"about_ca_system_score_codex":0.00018850695,"about_ca_system_score_gemma":0.00013588853,"threshold_uncertainty_score":0.0038199425},"labels":[],"label_agreement":null},{"id":"W2165316988","doi":"10.1158/1078-0432.ccr-07-0946","title":"Is There a Human Homologue to the Murine Proteolysis-Inducing Factor?","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Proteolysis; Antibody; Monoclonal antibody; Biology; Cancer; Molecular biology; Skeletal muscle; Cancer research; Immunology; Biochemistry; Endocrinology","score_opus":0.2962211129013626,"score_gpt":0.572158495960484,"score_spread":0.27593738305912136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165316988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96272033,0.027524194,0.0048921956,0.0012283218,0.00012930919,0.000025747258,0.0004740351,0.00007550693,0.0029303527],"genre_scores_gemma":[0.9927026,0.002801061,0.0022195512,0.0002902362,0.00012066811,0.00002171273,0.00085246365,0.0000069931684,0.0009847085],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998733,0.000020295742,0.000009846094,0.000047083377,0.00002397792,0.000025504798],"domain_scores_gemma":[0.9996573,0.00008144643,0.000116133124,0.00005367563,0.000034892408,0.000056515484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024234765,0.0002579154,0.00027619608,0.00017678492,0.00010007116,0.0003670797,0.00024411781,0.0004560326,0.0016071192],"category_scores_gemma":[0.0006151622,0.0000630526,0.00025184962,0.00018786924,0.00036314063,0.00024708276,0.00013387816,0.00023024161,0.0005790535],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034345826,0.0002801232,0.09041309,0.001204158,0.00017331618,0.005804576,0.0002719642,0.0009691797,0.7742684,0.0051262714,0.0022583068,0.115795985],"study_design_scores_gemma":[0.0003567844,0.0068744356,0.36258087,0.00054016575,0.00039616277,0.09183854,0.00059447763,0.0069813025,0.35146818,0.0067788684,0.17150281,0.000087416855],"about_ca_topic_score_codex":0.00020302954,"about_ca_topic_score_gemma":0.000079513695,"teacher_disagreement_score":0.0016071192,"about_ca_system_score_codex":0.0002733034,"about_ca_system_score_gemma":0.00021241028,"threshold_uncertainty_score":0.005376339},"labels":[],"label_agreement":null},{"id":"W2165424687","doi":"10.1158/1078-0432.ccr-05-2187","title":"Phosphatidylinositol 3′-Kinase/AKT Signaling Is Activated in Medulloblastoma Cell Proliferation and Is Associated with Reduced Expression of <i>PTEN</i>","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"PTEN; Medulloblastoma; PI3K/AKT/mTOR pathway; Protein kinase B; Cancer research; Biology; Signal transduction; Cell biology","score_opus":0.04973267562810274,"score_gpt":0.39339771069056245,"score_spread":0.3436650350624597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165424687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972108,0.0014333556,0.00055687316,0.000023331115,0.0000053225585,0.00001064029,0.00021025076,0.00004078774,0.00050865207],"genre_scores_gemma":[0.99807775,0.00081167516,0.00038127584,0.000009545613,0.0000039079628,0.000011960077,0.00035967646,0.0000042707848,0.0003398263],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987125,0.000012324918,0.000012532171,0.000027624928,0.00005131579,0.000024940438],"domain_scores_gemma":[0.9998926,0.000013223191,0.000053101958,0.000007234291,0.000009285709,0.000024542614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011782343,0.00023804097,0.00021065537,0.00039149445,0.00014285663,0.00020269066,0.0001307228,0.00013705046,0.0006724698],"category_scores_gemma":[0.00013748503,0.00012240537,0.0001433264,0.00029869625,0.00021428785,0.00010177559,0.00010269149,0.00027790482,0.00019366357],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021575343,0.00002748826,0.007566861,0.000060094077,0.000015824535,0.00025023922,0.00001883123,0.000060917253,0.989698,0.000040750077,0.000045081328,0.0020000674],"study_design_scores_gemma":[0.00003811794,0.0006352224,0.28213134,0.0000144021915,0.00008606066,0.004516605,0.00007746446,0.001011656,0.7070468,0.00008236546,0.0043529463,0.0000070179026],"about_ca_topic_score_codex":0.0019076049,"about_ca_topic_score_gemma":0.0018565377,"teacher_disagreement_score":0.0019076049,"about_ca_system_score_codex":0.00027173045,"about_ca_system_score_gemma":0.00022357151,"threshold_uncertainty_score":0.0037929416},"labels":[],"label_agreement":null},{"id":"W2165477627","doi":"10.1158/1078-0432.ccr-03-0426","title":"Hypoxia and Hypoxia-Inducible Factor-1 Target Genes in Central Nervous System Radiation Injury","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":188,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute; Sunnybrook Health Science Centre","funders":"","keywords":"Vascular endothelial growth factor; Hypoxia (environmental); In situ hybridization; Biology; Vascular endothelial growth factor A; Central nervous system; Pathology; Spinal cord; Endocrinology; Cancer research; Internal medicine; Medicine; Gene expression; Chemistry; Neuroscience; VEGF receptors","score_opus":0.0797703368587973,"score_gpt":0.4194308042309488,"score_spread":0.3396604673721515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165477627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9566933,0.037517488,0.0025928684,0.0003307831,0.000037382764,0.000044683064,0.00020523263,0.00010092866,0.0024773683],"genre_scores_gemma":[0.97967464,0.014328924,0.0014944536,0.0001582429,0.000043247383,0.0000627985,0.00033144455,0.000010017859,0.0038962383],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991846,0.00001837447,0.000004012842,0.000017218932,0.000024631672,0.00001722519],"domain_scores_gemma":[0.9999002,0.00001053903,0.000050769206,0.0000047345598,0.000015096981,0.000018525418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015418376,0.00026726484,0.00019754954,0.00017926455,0.00011781231,0.00014207579,0.00015573758,0.00030497188,0.0012759586],"category_scores_gemma":[0.00009663504,0.000078581186,0.0001117999,0.00012747529,0.0002728626,0.00016734497,0.000090527894,0.00031769773,0.00022674786],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000545744,0.000072991694,0.0020730542,0.00032944127,0.000014030598,0.00021726759,0.000029096927,0.00018075612,0.98624784,0.0001364998,0.00021230381,0.009940957],"study_design_scores_gemma":[0.00005816898,0.003117538,0.1935071,0.0001030172,0.00012309547,0.003938073,0.00011552065,0.0014985605,0.7893694,0.0003125017,0.007840387,0.00001667124],"about_ca_topic_score_codex":0.0005675907,"about_ca_topic_score_gemma":0.0008355376,"teacher_disagreement_score":0.0012759586,"about_ca_system_score_codex":0.0003112588,"about_ca_system_score_gemma":0.00014734913,"threshold_uncertainty_score":0.004268527},"labels":[],"label_agreement":null},{"id":"W2165582512","doi":"10.1158/1078-0432.ccr-11-2102","title":"Significance of Dysregulated Metadherin and MicroRNA-375 in Head and Neck Cancer","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; Ontario Institute for Cancer Research; Cancer Research Institute","keywords":"Gene knockdown; Clonogenic assay; Cancer research; microRNA; Metastasis; Biology; Viability assay; In vivo; Cancer; Downregulation and upregulation; Blot; Cell growth; Medicine; Oncology; Cell; Cell culture; Internal medicine; Gene","score_opus":0.35484614614979065,"score_gpt":0.5237625743841676,"score_spread":0.16891642823437697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165582512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912286,0.0054752314,0.0010383171,0.00012798587,0.000030370418,0.000028628705,0.0005564858,0.000057192494,0.0014571621],"genre_scores_gemma":[0.9979978,0.00059266476,0.0006009216,0.00003290645,0.000005314566,0.000012755961,0.00017477894,0.0000058711425,0.00057686126],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998522,0.000014509179,0.000012884171,0.000035606445,0.00006440236,0.00002039238],"domain_scores_gemma":[0.9999231,0.000010338913,0.000030788557,0.000007590486,0.000013317233,0.00001482032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013509874,0.00021498918,0.00022921759,0.00021632819,0.00019079061,0.00037173627,0.00017823154,0.00017739499,0.0009203215],"category_scores_gemma":[0.00026898502,0.000108413464,0.0001759899,0.00021030377,0.00027367836,0.000121236415,0.00016837045,0.00024366808,0.00022628524],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010771909,0.00005322553,0.044825476,0.00024889025,0.0000686364,0.00087903586,0.00011274542,0.00041909827,0.9343735,0.00028604228,0.00038072272,0.01727544],"study_design_scores_gemma":[0.000044505585,0.00074349664,0.54240966,0.000041128955,0.0002559703,0.004577871,0.00035033905,0.0035424014,0.44000456,0.0004273736,0.0075740055,0.000028803968],"about_ca_topic_score_codex":0.0028610155,"about_ca_topic_score_gemma":0.0040896637,"teacher_disagreement_score":0.0028610155,"about_ca_system_score_codex":0.0008011418,"about_ca_system_score_gemma":0.00050852477,"threshold_uncertainty_score":0.005812764},"labels":[],"label_agreement":null},{"id":"W2166056954","doi":"10.1158/1078-0432.ccr-07-1187","title":"<i>N</i>-Acetylcysteine Protects Melanocytes against Oxidative Stress/Damage and Delays Onset of Ultraviolet-Induced Melanoma in Mice","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Redox biology and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Cancer Institute","keywords":"Oxidative stress; Acetylcysteine; Glutathione; In vivo; Melanocyte; Melanoma; DNA damage; Pathogenesis; Cancer research; Pharmacology; Antioxidant; Chemistry; Medicine; Biology; Immunology; Internal medicine; Biochemistry","score_opus":0.0815463929412166,"score_gpt":0.44753918461439385,"score_spread":0.3659927916731772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166056954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298745,0.0022368673,0.0018149937,0.00022335183,0.000085390166,0.0000726582,0.00049347366,0.0002551118,0.0018306695],"genre_scores_gemma":[0.9913385,0.0013617377,0.0031115941,0.00013606447,0.000026471447,0.00008064867,0.0005970131,0.000048717517,0.0032992214],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998456,0.000028469269,0.000023143013,0.000035059667,0.000032864664,0.000034835706],"domain_scores_gemma":[0.99974984,0.00002203375,0.00010396108,0.000027459497,0.000034306275,0.00006240315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002108553,0.00043666642,0.00035718153,0.00036808278,0.00016006052,0.00022924974,0.0003486963,0.00038924636,0.0013657465],"category_scores_gemma":[0.0001493819,0.00018550041,0.00029832427,0.0001464162,0.00028621865,0.00023354679,0.00010894594,0.00063743873,0.0003376963],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088182825,0.00015222422,0.00027609602,0.0000492737,0.000010991901,0.00002921487,0.000009205386,0.000046422356,0.9967784,0.000049236452,0.00006326043,0.0016538681],"study_design_scores_gemma":[0.0000666364,0.0023326864,0.0029915404,0.000012087215,0.000028306995,0.00015706317,0.00001595348,0.00035518833,0.9929261,0.00002423834,0.0010861985,0.0000040658124],"about_ca_topic_score_codex":0.001002948,"about_ca_topic_score_gemma":0.001641576,"teacher_disagreement_score":0.0013657465,"about_ca_system_score_codex":0.00031281527,"about_ca_system_score_gemma":0.0003783954,"threshold_uncertainty_score":0.004568875},"labels":[],"label_agreement":null},{"id":"W2166065611","doi":"10.1158/1078-0432.ccr-07-1724","title":"CD8+ T Cells Induce Complete Regression of Advanced Ovarian Cancers by an Interleukin (IL)-2/IL-15–Dependent Mechanism","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Ovarian cancer; Biology; IL-2 receptor; CD8; Ovarian tumor; Cancer research; Adoptive cell transfer; Cytotoxic T cell; Immune system; Cytokine; T cell; Immunology; Cancer; In vitro","score_opus":0.12861261439292754,"score_gpt":0.459709908561663,"score_spread":0.33109729416873546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166065611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947889,0.0009764594,0.0022420113,0.00008375778,0.000052089184,0.00010404597,0.00016741567,0.00021637694,0.0013689921],"genre_scores_gemma":[0.9951138,0.0004991523,0.0020983103,0.00007967919,0.000040192346,0.000083190775,0.00028592456,0.000019626668,0.00178007],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998559,0.000018111186,0.0000155032,0.000027063264,0.000032094562,0.000051331397],"domain_scores_gemma":[0.9998698,0.000017648948,0.000038891634,0.000016766995,0.000012228964,0.00004461066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000116453135,0.0005347915,0.0002744251,0.00026689717,0.00007940557,0.00020495588,0.00014652878,0.00020940676,0.00092885556],"category_scores_gemma":[0.00013162212,0.000098279364,0.00027457584,0.00010566549,0.00020625918,0.0001372253,0.0001668396,0.0006947238,0.00028011002],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023012878,0.00019161074,0.0003559737,0.000046558962,0.000005681398,0.000053771906,0.000021031692,0.0001802538,0.99397165,0.00004211703,0.00007462443,0.004826592],"study_design_scores_gemma":[0.0003209482,0.00415819,0.0050414437,0.000018105087,0.000039590166,0.00039064104,0.00003658919,0.0020704435,0.9841188,0.00006992616,0.0037301956,0.0000051750935],"about_ca_topic_score_codex":0.00020726047,"about_ca_topic_score_gemma":0.00035822074,"teacher_disagreement_score":0.00092885556,"about_ca_system_score_codex":0.00014172358,"about_ca_system_score_gemma":0.00017576937,"threshold_uncertainty_score":0.0031073093},"labels":[],"label_agreement":null},{"id":"W2166233649","doi":"10.1158/1078-0432.ccr-04-2507","title":"Flavopiridol Sensitivity of Cancer Cells Isolated from Ascites and Pleural Fluids","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thunder Bay Regional Health Sciences Centre","funders":"","keywords":"Cancer; Cancer research; Cancer cell; Cell culture; Ascites; Chemotherapy; Kinase; Biology; Medicine; Pathology; Immunology; Internal medicine; Cell biology","score_opus":0.1755694433709364,"score_gpt":0.505313710966786,"score_spread":0.3297442675958496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166233649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992898,0.0044178376,0.0012516434,0.000047661066,0.000029172132,0.00007878091,0.0005020519,0.000033600496,0.0007413586],"genre_scores_gemma":[0.9948073,0.0015385094,0.0015483564,0.00004814841,0.000022873035,0.0000730089,0.0012816938,0.000008564049,0.0006715333],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997975,0.000039097777,0.00002528865,0.000041190462,0.00006558794,0.00003141786],"domain_scores_gemma":[0.9997346,0.000069157446,0.00003782518,0.000042375283,0.00006744238,0.00004864363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002532568,0.00035952064,0.0004910022,0.00030066166,0.00021406669,0.000350766,0.00021999849,0.00024892713,0.0012284624],"category_scores_gemma":[0.00034507798,0.00013045744,0.00029977522,0.00023869233,0.00021417713,0.00020685,0.00020904766,0.0005246591,0.00041456046],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051172863,0.000103685205,0.004158234,0.0001090929,0.000027969452,0.00013747577,0.000053774096,0.00010146625,0.99062514,0.000019176725,0.00007587421,0.004076302],"study_design_scores_gemma":[0.00012968329,0.0037137207,0.05271551,0.000014996248,0.000080355945,0.0014439325,0.000107731066,0.0009520008,0.93842936,0.000024258441,0.002379284,0.000009166638],"about_ca_topic_score_codex":0.0010349073,"about_ca_topic_score_gemma":0.0010675453,"teacher_disagreement_score":0.0012284624,"about_ca_system_score_codex":0.00026880737,"about_ca_system_score_gemma":0.00024858108,"threshold_uncertainty_score":0.0041095614},"labels":[],"label_agreement":null},{"id":"W2166246129","doi":"10.1158/1078-0432.ccr-04-0452","title":"Phase I Study of Docetaxel in Combination with the P-Glycoprotein Inhibitor, Zosuquidar, in Resistant Malignancies","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources","keywords":"Docetaxel; Pharmacokinetics; Medicine; Neutropenia; Pharmacology; Dosing; Toxicity; Chemotherapy; Internal medicine; Urology; Oncology","score_opus":0.1295801785086009,"score_gpt":0.47364825405095895,"score_spread":0.3440680755423581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166246129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99554694,0.0020216578,0.00044600718,0.000193927,0.000048026075,0.0008743404,0.00026860338,0.00004209617,0.000558355],"genre_scores_gemma":[0.994484,0.0017523693,0.0011549066,0.00017795619,0.00006302783,0.00067870057,0.0007187742,0.000018456234,0.000951784],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996748,0.00013406383,0.000018982026,0.00006059731,0.00004731464,0.00006434336],"domain_scores_gemma":[0.9995746,0.000065108834,0.000109578534,0.000042279822,0.00002485851,0.00018348134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007313093,0.00109408,0.0018293087,0.00036948588,0.0003587922,0.000689286,0.0007602561,0.00070092385,0.0016315054],"category_scores_gemma":[0.0006886101,0.00054284633,0.00089669105,0.00044094745,0.0009096833,0.0004480992,0.0002003064,0.001945092,0.0003799731],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42132497,0.08304417,0.015828224,0.0017731632,0.0020408158,0.0008251835,0.00083059026,0.008704599,0.29719058,0.00058651937,0.0041599036,0.16369128],"study_design_scores_gemma":[0.35661423,0.59644246,0.0187668,0.00005854608,0.0006238978,0.00097637123,0.00008615735,0.002212573,0.020168858,0.00015074106,0.0038552647,0.000044100027],"about_ca_topic_score_codex":0.0014220779,"about_ca_topic_score_gemma":0.003670775,"teacher_disagreement_score":0.0018293087,"about_ca_system_score_codex":0.0009801871,"about_ca_system_score_gemma":0.0015995556,"threshold_uncertainty_score":0.007111788},"labels":[],"label_agreement":null},{"id":"W2166395740","doi":"10.1158/1078-0432.ccr-03-0795","title":"Antiangiogenic Properties of 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Sunnybrook Health Science Centre","funders":"National Cancer Institute; U.S. Public Health Service; National Institutes of Health","keywords":"Matrigel; Angiogenesis; Vascular endothelial growth factor; Human umbilical vein endothelial cell; Umbilical vein; Extracellular matrix; Cell biology; CD31; Biology; Fibroblast growth factor; Endothelial stem cell; Cancer research; Molecular biology; Chemistry; In vitro; Biochemistry","score_opus":0.2096314781247637,"score_gpt":0.4844562148011677,"score_spread":0.27482473667640395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166395740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99406743,0.0046587014,0.00053348305,0.000035350444,0.000014463116,0.00001124949,0.00011426443,0.000017007036,0.0005481022],"genre_scores_gemma":[0.9961998,0.0020544014,0.00084820663,0.000022563452,0.000009699015,0.000010872851,0.00017629379,0.0000045329366,0.00067358935],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995375,0.000009583203,0.0000038799662,0.000007874618,0.0000137386205,0.000011106675],"domain_scores_gemma":[0.9999441,0.000010850101,0.000018299275,0.000005456856,0.000009918457,0.000011381093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008777143,0.00022645769,0.00015608323,0.000114648225,0.000050337854,0.00008149368,0.0000876417,0.0001325275,0.000684201],"category_scores_gemma":[0.00006623279,0.000044814427,0.00015223611,0.000056134675,0.000109188055,0.00008802448,0.000057318735,0.0001628932,0.00018602966],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102642305,0.00002675859,0.00028157094,0.000053930773,0.0000064085157,0.000037476577,0.000007765116,0.00013264509,0.99636555,0.000026329493,0.000021417161,0.002937497],"study_design_scores_gemma":[0.00002299456,0.0017218199,0.0053302194,0.000005943556,0.00002642945,0.00043509167,0.000013604754,0.0002765086,0.988777,0.000019386383,0.0033669744,0.000004003137],"about_ca_topic_score_codex":0.00024547923,"about_ca_topic_score_gemma":0.00035957908,"teacher_disagreement_score":0.000684201,"about_ca_system_score_codex":0.00013015364,"about_ca_system_score_gemma":0.00012242695,"threshold_uncertainty_score":0.002288878},"labels":[],"label_agreement":null},{"id":"W2166455683","doi":"10.1158/1078-0432.ccr-13-2491","title":"Molecular Pathways: Epigenetic Modulation of Wnt–Glycogen Synthase Kinase-3 Signaling to Target Human Cancer Stem Cells","year":2014,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Wnt signaling pathway; Biology; Cancer stem cell; Epigenetics; Cancer research; LRP6; Cancer; Stem cell; GSK-3; Signal transduction; LRP5; Cell biology; Genetics; Gene","score_opus":0.2676060883690465,"score_gpt":0.5161031545792915,"score_spread":0.24849706621024498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166455683","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003007659,0.9969438,0.00040854613,0.00028360763,0.00025205084,0.000009374598,0.000028896433,0.000015072339,0.0017578843],"genre_scores_gemma":[0.001490991,0.9965988,0.00033453674,0.00018776633,0.00013022985,0.000010598376,0.00004453283,0.0000022029114,0.0012004479],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999107,0.0000144988235,0.0000113049055,0.000018737017,0.000035037552,0.0000097301245],"domain_scores_gemma":[0.999907,0.0000326444,0.000016252416,0.00000418067,0.00002800864,0.000011939404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003293018,0.00067009724,0.0007649441,0.0014538573,0.00020258845,0.00057226454,0.0006178242,0.00060743757,0.0024432195],"category_scores_gemma":[0.0002866313,0.00019461577,0.00030898018,0.001105783,0.00033271336,0.0007562166,0.00048293947,0.0011469913,0.0016827304],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064144755,0.000059514376,0.0001845755,0.009591326,0.00009619144,0.00028168783,0.000047321922,0.00048564048,0.008258365,0.005216996,0.021704791,0.9540095],"study_design_scores_gemma":[0.000016103912,0.00007945181,0.000796573,0.0009645054,0.0000698926,0.0011177991,0.000034438694,0.000117677766,0.0024297708,0.001633593,0.9927246,0.000015742618],"about_ca_topic_score_codex":0.0006834314,"about_ca_topic_score_gemma":0.0016523029,"teacher_disagreement_score":0.0024432195,"about_ca_system_score_codex":0.00056280935,"about_ca_system_score_gemma":0.0006205524,"threshold_uncertainty_score":0.008173406},"labels":[],"label_agreement":null},{"id":"W2166594813","doi":"10.1158/1078-0432.ccr-13-1869","title":"Phase II Randomized Study of Figitumumab plus Docetaxel and Docetaxel Alone with Crossover for Metastatic Castration-Resistant Prostate Cancer","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Marsden Fund; Pfizer; Prostate Cancer Foundation","keywords":"Medicine; Docetaxel; Prostate cancer; Clinical endpoint; Internal medicine; Adverse effect; Prednisone; Urology; Phases of clinical research; Oncology; Chemotherapy; Cancer; Randomized controlled trial; Surgery; Gastroenterology","score_opus":0.21302490922324202,"score_gpt":0.5482458703631305,"score_spread":0.33522096113988853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166594813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829338,0.0023624527,0.0009863664,0.0006736291,0.00073294505,0.008742426,0.0012842001,0.00016017353,0.0021238828],"genre_scores_gemma":[0.9795909,0.0017443061,0.0017836891,0.0014536217,0.00056402286,0.008522455,0.0015491426,0.00004033327,0.004751642],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988556,0.000643738,0.00005346416,0.0001864976,0.0000813763,0.00017943152],"domain_scores_gemma":[0.9978084,0.00052298786,0.00037634268,0.00019058483,0.00011825649,0.000983403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028717073,0.002378994,0.0031780214,0.000690523,0.0005986916,0.0013677288,0.0011617402,0.0020596383,0.008846075],"category_scores_gemma":[0.0023662478,0.00103661,0.002051209,0.0006541135,0.0015302736,0.0012674339,0.00056244584,0.004202641,0.0014595545],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9713117,0.018367011,0.00040851976,0.00016915999,0.00042368556,0.00003457193,0.000043865275,0.00033474073,0.0014926688,0.00008301969,0.00058513874,0.0067459913],"study_design_scores_gemma":[0.92714685,0.07128514,0.0006783645,0.000008770119,0.000098850236,0.00001732593,0.000010056056,0.00020179048,0.00016147672,0.00007450159,0.0003090371,0.000007832344],"about_ca_topic_score_codex":0.0018185152,"about_ca_topic_score_gemma":0.0029679579,"teacher_disagreement_score":0.008846075,"about_ca_system_score_codex":0.0013163171,"about_ca_system_score_gemma":0.0022992294,"threshold_uncertainty_score":0.02959305},"labels":[],"label_agreement":null},{"id":"W2166760601","doi":"10.1158/1078-0432.ccr-05-0771","title":"Basic Fibroblast Growth Factor (FGF-2) Overexpression Is a Risk Factor for Esophageal Cancer Recurrence and Reduced Survival, which Is Ameliorated by Coexpression of the FGF-2 Antisense Gene","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Dalhousie University","funders":"Nova Scotia Health Research Foundation; Dalhousie University; Cancer Research Society","keywords":"Fibroblast growth factor; Cancer research; Basic fibroblast growth factor; Cancer; Esophageal cancer; Gene; Risk factor; Biology; Fibroblast growth factor receptor 3; Growth factor; Medicine; Internal medicine; Genetics","score_opus":0.09332772790006028,"score_gpt":0.44446837922420285,"score_spread":0.35114065132414257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166760601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99785393,0.0012874423,0.0006284733,0.000033777098,0.000005459531,0.00000479973,0.000033859338,0.000013066281,0.00013921665],"genre_scores_gemma":[0.99863404,0.000562356,0.00043480107,0.000014689952,0.000009061867,0.000008148012,0.00007979027,0.0000031469576,0.00025392917],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998988,0.000023701072,0.000008447002,0.000021919113,0.000030079833,0.0000171124],"domain_scores_gemma":[0.9998036,0.000050124912,0.00009052849,0.000015481144,0.000014643603,0.00002557985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023561002,0.0002400917,0.0002538711,0.00014995818,0.00008480369,0.00012367459,0.00007597747,0.00014354881,0.0005952314],"category_scores_gemma":[0.00030095904,0.00010013712,0.000201994,0.00011278479,0.00018162405,0.00007293664,0.00013087134,0.00021725257,0.00010197309],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015999568,0.000065881846,0.09609182,0.00013399059,0.0000997236,0.0004149871,0.000032083393,0.00017283091,0.89126086,0.000049617574,0.00008249317,0.009995706],"study_design_scores_gemma":[0.00008445316,0.0034604387,0.7236433,0.000018363622,0.00033613242,0.0075444267,0.00008614448,0.0015129999,0.2609245,0.00008433196,0.0022916556,0.000013208064],"about_ca_topic_score_codex":0.00030770025,"about_ca_topic_score_gemma":0.00043719122,"teacher_disagreement_score":0.0005952314,"about_ca_system_score_codex":0.00013818331,"about_ca_system_score_gemma":0.00013399195,"threshold_uncertainty_score":0.001991272},"labels":[],"label_agreement":null},{"id":"W2166913340","doi":"10.1158/1078-0432.ccr-13-1215","title":"<i>Bim</i> Polymorphisms: Influence on Function and Response to Treatment in Children with Acute Lymphoblastic Leukemia","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Jewish General Hospital","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"MCL1; Genotype; Cohort; Apoptosis; Cancer; Leukemia; Gene isoform; Medicine; Oncology; Internal medicine; Cancer research; Immunology; Biology; Gene; Downregulation and upregulation; Genetics","score_opus":0.04711484774247606,"score_gpt":0.40126830346331366,"score_spread":0.3541534557208376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166913340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993735,0.00023547813,0.00005992441,0.00004211459,0.0000024818441,0.0000024470908,0.00016409137,0.0000047598514,0.0001151815],"genre_scores_gemma":[0.99947006,0.00009752069,0.00012407017,0.00002492351,0.0000061318733,0.0000062705135,0.00018460365,0.0000036818421,0.00008280311],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975675,0.00007781799,0.00001952913,0.00006073918,0.00004722642,0.000037936563],"domain_scores_gemma":[0.999554,0.00010121216,0.00022809034,0.000017172157,0.000022908056,0.00007667296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002718701,0.00026547874,0.000276464,0.00031203966,0.00018212246,0.00025886958,0.00020500591,0.00029765524,0.0010493506],"category_scores_gemma":[0.00084653025,0.000105158375,0.00024488778,0.0005603173,0.00023935571,0.00013378845,0.000156475,0.0003703799,0.00018209469],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010267494,0.00007571518,0.9881058,0.000027039181,0.000069262955,0.0004022467,0.000077148026,0.00014193633,0.005527161,0.00003208025,0.00013788187,0.0043769088],"study_design_scores_gemma":[0.000027056001,0.00033796305,0.9962185,0.0000077368295,0.000060669558,0.0015199623,0.00007754871,0.00021236205,0.00114655,0.000047159916,0.0003412225,0.0000033080146],"about_ca_topic_score_codex":0.0015324514,"about_ca_topic_score_gemma":0.0013018164,"teacher_disagreement_score":0.0015324514,"about_ca_system_score_codex":0.00032343832,"about_ca_system_score_gemma":0.00023889837,"threshold_uncertainty_score":0.0035104156},"labels":[],"label_agreement":null},{"id":"W2167244585","doi":"10.1158/1078-0432.ccr-1167-3","title":"Serum Diagnosis of Pancreatic Adenocarcinoma Using Surface-Enhanced Laser Desorption and Ionization Mass Spectrometry","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":284,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Pancreatic cancer; CA19-9; Medicine; Pancreatic disease; Internal medicine; Adenocarcinoma; Gastroenterology; Pancreas; Cancer; Pathology","score_opus":0.1290911887960914,"score_gpt":0.4591416555298894,"score_spread":0.330050466733798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167244585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837684,0.003203857,0.0115872575,0.0001390972,0.000030926043,0.00007956312,0.0004036678,0.00016348195,0.00062371726],"genre_scores_gemma":[0.98419535,0.0005838433,0.014378505,0.00011474355,0.000019885487,0.000037667567,0.0004762669,0.0000057976904,0.0001879691],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992488,0.00018008855,0.00009231823,0.00015609151,0.00028764212,0.000035036537],"domain_scores_gemma":[0.9993104,0.00020371155,0.00020480943,0.00004254864,0.00018376551,0.000054806373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009595535,0.00041786453,0.00043987838,0.0012562901,0.00022594804,0.0005296493,0.0002601842,0.0003444149,0.00035855148],"category_scores_gemma":[0.0018081185,0.00015639339,0.00028696543,0.0005644006,0.0002646647,0.0001963874,0.0002609133,0.00028156603,0.00017652535],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014857933,0.00022783791,0.7150135,0.0002630431,0.00019075553,0.00036074696,0.00009651544,0.00075788464,0.23499912,0.00008998072,0.00037176005,0.046143055],"study_design_scores_gemma":[0.000105430576,0.0014107235,0.7948186,0.00006295463,0.00022601905,0.005060762,0.00014208627,0.0142820515,0.18154219,0.00030456783,0.002008541,0.000036074453],"about_ca_topic_score_codex":0.00067896233,"about_ca_topic_score_gemma":0.00090368994,"teacher_disagreement_score":0.0012562901,"about_ca_system_score_codex":0.0003023559,"about_ca_system_score_gemma":0.00032075052,"threshold_uncertainty_score":0.00507468},"labels":[],"label_agreement":null},{"id":"W2167290534","doi":"10.1158/1078-0432.ccr-06-1432","title":"Phase I Trial of Sorafenib in Combination with IFN α-2a in Patients with Unresectable and/or Metastatic Renal Cell Carcinoma or Malignant Melanoma","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Sorafenib; Medicine; Renal cell carcinoma; Melanoma; Internal medicine; Response Evaluation Criteria in Solid Tumors; Oncology; Pharmacokinetics; Adverse effect; Cohort; Progressive disease; Gastroenterology; Combination therapy; Chemotherapy; Hepatocellular carcinoma; Cancer research","score_opus":0.17133590328777443,"score_gpt":0.46470068394029906,"score_spread":0.29336478065252464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167290534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945651,0.0013421801,0.00035736265,0.0005036988,0.00016613155,0.0015535431,0.00040849633,0.00006603607,0.0010374517],"genre_scores_gemma":[0.9930958,0.00095167535,0.0008825117,0.00060958124,0.00023466312,0.0016711521,0.0011018539,0.000015611307,0.0014371425],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996113,0.00020105288,0.000019947276,0.00005662321,0.000030248997,0.00008082184],"domain_scores_gemma":[0.99925536,0.00010974545,0.00013790141,0.000053044787,0.00003704561,0.00040685924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011902052,0.0016707233,0.0021525156,0.00033245562,0.00044083208,0.00090964336,0.0008519551,0.0009835487,0.0027474575],"category_scores_gemma":[0.0008820317,0.00063378044,0.0010550638,0.00031745978,0.0009909585,0.0005916779,0.00032166953,0.0029184935,0.00070820673],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82788455,0.05788301,0.008335155,0.00066553184,0.0011733262,0.0004440367,0.00028059114,0.0028703702,0.032131393,0.00022662248,0.0032966316,0.0648088],"study_design_scores_gemma":[0.71444577,0.27247941,0.007435658,0.000028457087,0.00024856327,0.0002125695,0.000038415143,0.0012415713,0.0022184732,0.00011406252,0.0015184584,0.000018646779],"about_ca_topic_score_codex":0.0008903378,"about_ca_topic_score_gemma":0.0021811582,"teacher_disagreement_score":0.0027474575,"about_ca_system_score_codex":0.000916037,"about_ca_system_score_gemma":0.0017703235,"threshold_uncertainty_score":0.009191096},"labels":[],"label_agreement":null},{"id":"W2167436791","doi":"10.1158/1078-0432.ccr-13-1787","title":"Reprogramming Metabolism with Metformin Improves Tumor Oxygenation and Radiotherapy Response","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":316,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"Turun Yliopistollinen Keskussairaala; University of Pennsylvania","keywords":"Metformin; Medicine; Tumor hypoxia; Radiation therapy; Hypoxia (environmental); Oxygenation; Internal medicine; Oncology; Cancer research; Pathology; Oxygen; Chemistry; Insulin","score_opus":0.06269851163208219,"score_gpt":0.4345203638725105,"score_spread":0.3718218522404283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167436791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997738,0.0011869307,0.00042831746,0.00006468221,0.00002279387,0.000022917417,0.00007204208,0.000023858925,0.00044049238],"genre_scores_gemma":[0.9980179,0.00065753906,0.00060166937,0.000039324532,0.0000111763775,0.000022237928,0.00013770253,0.000005953945,0.00050646317],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994326,0.000012750051,0.000006412437,0.000009822755,0.000014833063,0.0000129528735],"domain_scores_gemma":[0.9999211,0.0000116874,0.000039996623,0.0000068437575,0.0000053498766,0.000014965472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001283891,0.0001594451,0.0002440601,0.00015779576,0.0000843797,0.00016259712,0.00015569454,0.00014813607,0.00088225445],"category_scores_gemma":[0.00020762737,0.000051106195,0.00018831938,0.00014589248,0.00008075136,0.00013105717,0.000121863806,0.00026770326,0.00012978804],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060541965,0.0019813299,0.025105435,0.00033260928,0.00016238613,0.00012016925,0.0000482582,0.002014929,0.8341811,0.00018430829,0.0005806712,0.12923467],"study_design_scores_gemma":[0.0012169742,0.044248417,0.28024945,0.00007430411,0.0005283042,0.00084400224,0.00014007294,0.0075312927,0.6525451,0.00028331153,0.012298513,0.00004033966],"about_ca_topic_score_codex":0.00022193635,"about_ca_topic_score_gemma":0.00066125643,"teacher_disagreement_score":0.00088225445,"about_ca_system_score_codex":0.00018547405,"about_ca_system_score_gemma":0.00015993252,"threshold_uncertainty_score":0.0029515028},"labels":[],"label_agreement":null},{"id":"W2167521129","doi":"10.1158/1078-0432.ccr-07-1561","title":"Fractionated versus Standard Continuous Light Delivery in Interstitial Photodynamic Therapy of Dunning Prostate Carcinomas","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Photodynamic therapy; Medicine; Prostate cancer; Prostate; Perfusion; Nuclear medicine; Magnetic resonance imaging; Cancer; Urology; Pathology; Internal medicine; Chemistry; Radiology","score_opus":0.12976499426975882,"score_gpt":0.5086043330160913,"score_spread":0.37883933874633247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167521129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975551,0.001072245,0.0010306325,0.000017109842,0.000017152957,0.000023730956,0.00004414574,0.000030278576,0.00020969687],"genre_scores_gemma":[0.99678826,0.00060041505,0.0018727246,0.0000236186,0.000015991878,0.000033106946,0.00009629209,0.000011923251,0.0005575112],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99981385,0.000027436858,0.0000116313095,0.00005176982,0.00005561947,0.00003967044],"domain_scores_gemma":[0.99980944,0.000035273573,0.000056003297,0.000023348586,0.000015941998,0.00005999928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026872125,0.00033587695,0.000364021,0.0003190974,0.00012259389,0.0002546262,0.00030217695,0.0002139357,0.0008966001],"category_scores_gemma":[0.00016337745,0.00009993413,0.00029065035,0.00020068014,0.00029144646,0.00027811155,0.00015439252,0.00049518986,0.00008935198],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052141496,0.0011170331,0.0009748461,0.0001904453,0.000051554005,0.000032609827,0.000033729655,0.0005569575,0.97622174,0.00012782625,0.00009973801,0.015379291],"study_design_scores_gemma":[0.0005805058,0.04533228,0.016111076,0.000023810382,0.00025333444,0.00037135684,0.00005741677,0.0028415234,0.93242157,0.00007612844,0.0019035342,0.000027522346],"about_ca_topic_score_codex":0.001387436,"about_ca_topic_score_gemma":0.0025041408,"teacher_disagreement_score":0.001387436,"about_ca_system_score_codex":0.00046372585,"about_ca_system_score_gemma":0.00037356102,"threshold_uncertainty_score":0.003364563},"labels":[],"label_agreement":null},{"id":"W2167570951","doi":"10.1158/1078-0432.ccr-0571-03","title":"Nuclear Factor-κB Is Constitutively Activated in Prostate Cancer <b> <i>In vitro</i> </b> and Is Overexpressed in Prostatic Intraepithelial Neoplasia and Adenocarcinoma of the Prostate","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Prostate cancer; Intraepithelial neoplasia; Prostate; Immunohistochemistry; Carcinogenesis; Cancer research; Cancer; Biology; Parthenolide; Pathology; Molecular biology; Medicine; Internal medicine; Apoptosis","score_opus":0.05589962748068334,"score_gpt":0.3906717512679411,"score_spread":0.3347721237872578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167570951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98173577,0.01329432,0.0017772977,0.0001160025,0.000045228906,0.000025350171,0.0006057716,0.0001246698,0.0022756255],"genre_scores_gemma":[0.9941526,0.0027905158,0.00072462414,0.000042737942,0.000027446535,0.000025768442,0.0010110791,0.000014689334,0.0012105297],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975926,0.00003361059,0.000020819298,0.00004792804,0.000090050555,0.000048265305],"domain_scores_gemma":[0.99976724,0.000026465736,0.00008719266,0.000024578041,0.000028004219,0.00006647574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018611623,0.000312181,0.00020594928,0.00063419226,0.00028828002,0.00048385156,0.00019308517,0.00021464693,0.0017430293],"category_scores_gemma":[0.00026260962,0.00024821944,0.00019296151,0.00058744586,0.00029837972,0.00014734687,0.00022337952,0.00039231507,0.0008783838],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012993907,0.000020852978,0.0017095846,0.00008296874,0.000010961816,0.00018692392,0.000023755983,0.000028090175,0.9963831,0.000045336215,0.000080997626,0.0012975673],"study_design_scores_gemma":[0.00007598391,0.00081020984,0.21329303,0.00006497165,0.00010563587,0.014790909,0.00039809055,0.0009370492,0.7498611,0.00028566248,0.019339608,0.000037656577],"about_ca_topic_score_codex":0.0013006236,"about_ca_topic_score_gemma":0.0010149615,"teacher_disagreement_score":0.0017430293,"about_ca_system_score_codex":0.00038015153,"about_ca_system_score_gemma":0.00027245603,"threshold_uncertainty_score":0.005831003},"labels":[],"label_agreement":null},{"id":"W2167689405","doi":"10.1158/1078-0432.ccr-07-1380","title":"Node-Negative Colorectal Cancer at High Risk of Distant Metastasis Identified by Combined Analysis of Lymph Node Status, Vascular Invasion, and Raf-1 Kinase Inhibitor Protein Expression","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Colorectal cancer; Medicine; Univariate analysis; Oncology; Internal medicine; Stage (stratigraphy); Metastasis; Cancer; Immunohistochemistry; Multivariate analysis; Lymph node; Tissue microarray; Pathology; Cancer research; Biology","score_opus":0.056547800871899354,"score_gpt":0.3718547099314861,"score_spread":0.31530690905958675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167689405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997063,0.00008568629,0.000059841495,0.000013413948,0.0000016672092,0.0000024703938,0.000040513227,0.00000134859,0.00008869398],"genre_scores_gemma":[0.99967515,0.000039861785,0.00010028546,0.000008608533,0.000004611548,0.0000033678334,0.00010119846,5.3194964e-7,0.00006639916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99991596,0.000019765157,0.0000051945613,0.000022312115,0.000019728886,0.000016890743],"domain_scores_gemma":[0.9997805,0.00004857878,0.00007391009,0.000009726826,0.00001784833,0.00006950034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014380788,0.00025511245,0.0002609367,0.0003015412,0.0002054756,0.00020534945,0.000117895135,0.00020105766,0.00117489],"category_scores_gemma":[0.0004575165,0.000114184324,0.00013892553,0.00025841015,0.0001712455,0.00012639609,0.00014431257,0.00018793982,0.00015837459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044137906,0.000041883988,0.98541,0.000014589178,0.00004325814,0.0004597085,0.000024825998,0.00012302889,0.011481221,0.00001537161,0.000089029025,0.0018557339],"study_design_scores_gemma":[0.000018504348,0.00019013965,0.9967325,0.0000031280695,0.00004718613,0.0015462858,0.00005238833,0.0004686311,0.0007390691,0.0000281577,0.00017092383,0.0000030025255],"about_ca_topic_score_codex":0.00085895625,"about_ca_topic_score_gemma":0.0023286685,"teacher_disagreement_score":0.00117489,"about_ca_system_score_codex":0.00013854692,"about_ca_system_score_gemma":0.00024013543,"threshold_uncertainty_score":0.0039304495},"labels":[],"label_agreement":null},{"id":"W2168193627","doi":"10.1158/1078-0432.ccr-07-4723","title":"Analysis of the MammaPrint Breast Cancer Assay in a Predominantly Postmenopausal Cohort","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":145,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Cohort; Distant metastasis; Cancer; Metastasis","score_opus":0.09167216163521853,"score_gpt":0.4584146057830925,"score_spread":0.366742444147874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168193627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99942136,0.00016705134,0.00015315713,0.000013661398,0.0000013740155,0.0000045316806,0.000052309348,0.0000029232792,0.00018359462],"genre_scores_gemma":[0.99960595,0.000051459465,0.00012132129,0.000013785714,0.0000037951736,0.000004940761,0.00011242161,8.747124e-7,0.00008539862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997204,0.00009205586,0.000019820029,0.000067054185,0.000066885514,0.000033795513],"domain_scores_gemma":[0.9993623,0.00019958298,0.00023768927,0.000055060584,0.0000720954,0.000073366835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060573267,0.00018618013,0.00017979006,0.00041946615,0.00016615266,0.00022026147,0.00013040172,0.0002331494,0.0005463395],"category_scores_gemma":[0.002193069,0.00010912654,0.0001144563,0.00027200676,0.00018787784,0.00011766838,0.00016054489,0.00018701494,0.0001686817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002673471,0.000021970689,0.98878646,0.000009319849,0.000023782413,0.00021768603,0.000041527805,0.000047111454,0.0076433504,0.0000126469795,0.00005136158,0.002877436],"study_design_scores_gemma":[0.000008356645,0.00030630588,0.99504167,0.000002506644,0.000026817264,0.0016377745,0.0000366334,0.00025409734,0.002368388,0.000016803851,0.0002981877,0.000002428997],"about_ca_topic_score_codex":0.0014503456,"about_ca_topic_score_gemma":0.0014663704,"teacher_disagreement_score":0.0014503456,"about_ca_system_score_codex":0.00016599066,"about_ca_system_score_gemma":0.00013095535,"threshold_uncertainty_score":0.0032034516},"labels":[],"label_agreement":null},{"id":"W2168295595","doi":"10.1158/1078-0432.ccr-08-1688","title":"Improved Systemic Delivery of Oncolytic Reovirus to Established Tumors Using Preconditioning with Cyclophosphamide-Mediated Treg Modulation and Interleukin-2","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"National Institutes of Health; National Cancer Institute; Richard M. Schulze Family Foundation; Mayo Foundation for Medical Education and Research","keywords":"Oncolytic virus; Medicine; Toxicity; Cyclophosphamide; Systemic administration; Pharmacology; Cancer research; Immunology; Chemotherapy; Internal medicine; In vivo; Immune system; Biology","score_opus":0.07224054727839395,"score_gpt":0.43033735699186704,"score_spread":0.3580968097134731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168295595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99447376,0.0008675458,0.0036383532,0.000048290618,0.00003792211,0.000075617034,0.00010726276,0.000093446826,0.0006578676],"genre_scores_gemma":[0.99553066,0.00049003685,0.0029335832,0.000037057347,0.00001683918,0.00005914861,0.00014300026,0.000019260295,0.00077048497],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998628,0.000016876511,0.000010527314,0.000038657843,0.000026769794,0.000044390094],"domain_scores_gemma":[0.9999105,0.000015165825,0.000032734166,0.000013825849,0.000007116829,0.000020570184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016130845,0.00065697305,0.00036143273,0.00015693132,0.00008398506,0.00031623515,0.00023411149,0.00025763057,0.0008362214],"category_scores_gemma":[0.000100477926,0.00011068673,0.0002846493,0.00007634409,0.0002608929,0.00028562086,0.00018441705,0.0006880042,0.0001704471],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015159605,0.000063682324,0.00004959754,0.000028145412,0.0000034206378,0.000013499449,0.0000062578974,0.000096171374,0.99847,0.000039397088,0.000013652482,0.001064479],"study_design_scores_gemma":[0.000053583888,0.0013316299,0.000881054,0.000005124763,0.000019326917,0.0000794689,0.0000058316527,0.00067401427,0.99635774,0.000013694097,0.00057567353,0.0000027835815],"about_ca_topic_score_codex":0.00033966347,"about_ca_topic_score_gemma":0.00053126784,"teacher_disagreement_score":0.0008362214,"about_ca_system_score_codex":0.00022354806,"about_ca_system_score_gemma":0.00022485695,"threshold_uncertainty_score":0.0027974248},"labels":[],"label_agreement":null},{"id":"W2168315857","doi":"10.1158/1078-0432.ccr-040019","title":"Molecularly Targeted Approaches to the Chemoprevention of Lung Cancer","year":2004,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Gefitinib; Erlotinib; Lung cancer; Medicine; Retinoid; Epidermal growth factor receptor; Cancer prevention; Cancer; Cancer research; Bexarotene; Isotretinoin; Fenretinide; Oncology; Internal medicine; Retinoic acid; Biology; Dermatology; Biochemistry","score_opus":0.39691480833262327,"score_gpt":0.5340960007000445,"score_spread":0.1371811923674212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168315857","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000842217,0.9978702,0.00018782145,0.00029176683,0.00019678564,0.00000868572,0.0000100569005,0.000010360725,0.0013401156],"genre_scores_gemma":[0.0005152254,0.9979405,0.0002693131,0.0002350017,0.00013036192,0.000010864782,0.000018849298,0.0000017209035,0.0008782268],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973375,0.00006127612,0.000028016502,0.000062817795,0.000092274895,0.000021907344],"domain_scores_gemma":[0.999602,0.00020508247,0.00004252941,0.000022330734,0.000089760586,0.00003833954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009423938,0.0013863788,0.0018264367,0.0028211623,0.0003971332,0.0010280164,0.0012225424,0.001694083,0.00487816],"category_scores_gemma":[0.000892173,0.0002916071,0.00054424204,0.002864898,0.000914037,0.0014279201,0.00066843757,0.0023832563,0.0041371044],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011898025,0.00013062652,0.00012834037,0.0068428,0.000080609316,0.00017280447,0.000032585667,0.00029183834,0.001948534,0.003211992,0.022553211,0.96448773],"study_design_scores_gemma":[0.00006995591,0.00017121139,0.00094965944,0.0023473292,0.000088190085,0.0014971262,0.000057818655,0.000067933295,0.0007483671,0.0025051925,0.991479,0.000018170109],"about_ca_topic_score_codex":0.0013486654,"about_ca_topic_score_gemma":0.0024787027,"teacher_disagreement_score":0.00487816,"about_ca_system_score_codex":0.00091004214,"about_ca_system_score_gemma":0.00091223605,"threshold_uncertainty_score":0.016319096},"labels":[],"label_agreement":null},{"id":"W2168339179","doi":"10.1158/1078-0432.ccr-03-0740","title":"Intravenous RNA Interference Gene Therapy Targeting the Human Epidermal Growth Factor Receptor Prolongs Survival in Intracranial Brain Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":326,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"RNA interference; Cancer research; Epidermal growth factor receptor; Genetic enhancement; Glioma; Gene silencing; Transferrin receptor; Cancer; Biology; Small hairpin RNA; Brain tumor; Medicine; Molecular biology; Receptor; Gene; RNA; Pathology; Internal medicine","score_opus":0.12506824874547218,"score_gpt":0.4455297765496041,"score_spread":0.3204615278041319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168339179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99334043,0.0021814257,0.0028444969,0.000103103266,0.00005731702,0.00008271412,0.00014356276,0.00021830459,0.0010285049],"genre_scores_gemma":[0.9932301,0.0015384312,0.0025425944,0.00006095442,0.00003805782,0.00013370506,0.0004143434,0.00003589872,0.0020058767],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999311,0.0000070926917,0.0000038531084,0.00001654781,0.000015744621,0.00002568221],"domain_scores_gemma":[0.99993265,0.000010468908,0.00002461584,0.000008287474,0.000006801771,0.000017152175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010191593,0.0005450332,0.00047851662,0.00034668398,0.00012534647,0.00020858158,0.00032180114,0.00026095906,0.00080161483],"category_scores_gemma":[0.00009445352,0.00008718317,0.00023801396,0.0001998564,0.0002713416,0.0002355514,0.00010629245,0.00065163575,0.0002165649],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010249653,0.00078261027,0.00032757188,0.00011077445,0.000018777862,0.00009890111,0.000029535331,0.000199169,0.9812867,0.0001342136,0.00031981437,0.015666893],"study_design_scores_gemma":[0.00029141217,0.012311341,0.0038580464,0.000015769887,0.000088088156,0.00042626885,0.000024695335,0.0018146099,0.97872156,0.000060617556,0.0023776013,0.000009937496],"about_ca_topic_score_codex":0.00059317646,"about_ca_topic_score_gemma":0.0011342684,"teacher_disagreement_score":0.00080161483,"about_ca_system_score_codex":0.0002988381,"about_ca_system_score_gemma":0.0003637702,"threshold_uncertainty_score":0.0026816726},"labels":[],"label_agreement":null},{"id":"W2168430622","doi":"10.1158/1078-0432.ccr-03-0165","title":"Serum Macrophage Inhibitory Cytokine 1 as a Marker of Pancreatic and Other Periampullary Cancers","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"GDF15 and Related Biomarkers","field":"Medicine","cited_by":277,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Pancreatic cancer; Medicine; Pancreatic disease; Adenocarcinoma; Pathology; CA19-9; Tissue microarray; Immunohistochemistry; Pancreas; Cancer; Pancreatitis; Internal medicine; Cancer research","score_opus":0.1025234701828855,"score_gpt":0.47666278675125373,"score_spread":0.37413931656836824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168430622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969194,0.0021131504,0.00038944403,0.00006232448,0.000008352126,0.000010695152,0.00006538791,0.00001141977,0.00041983635],"genre_scores_gemma":[0.99859613,0.00042794977,0.0006075378,0.00003602516,0.000017698627,0.000012796931,0.00013662901,0.0000012486365,0.00016388681],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984777,0.00004046543,0.000020212476,0.000034103825,0.000034739434,0.000022749415],"domain_scores_gemma":[0.999691,0.000091424285,0.000090558264,0.000017653803,0.000053595544,0.00005575431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028616108,0.00027395037,0.00022089029,0.0004983815,0.00018612636,0.00026338015,0.00014148175,0.00018119578,0.0009921981],"category_scores_gemma":[0.0007694659,0.00008177884,0.00012820205,0.00033757463,0.00021783501,0.00016439099,0.00022593059,0.00028769244,0.00021233676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076875876,0.00006615329,0.9414896,0.00012790719,0.00003960578,0.00043167733,0.00007423075,0.00012255445,0.043548763,0.000035519763,0.00019788032,0.013097441],"study_design_scores_gemma":[0.00005963522,0.00084181316,0.9535338,0.000041865253,0.00012359922,0.00789098,0.00021798872,0.00095525844,0.034081087,0.00010789651,0.002137504,0.00000854925],"about_ca_topic_score_codex":0.00024443454,"about_ca_topic_score_gemma":0.0003926408,"teacher_disagreement_score":0.0009921981,"about_ca_system_score_codex":0.00023403762,"about_ca_system_score_gemma":0.00017481332,"threshold_uncertainty_score":0.0033192635},"labels":[],"label_agreement":null},{"id":"W2168482167","doi":"10.1158/1078-0432.ccr-03-0244","title":"Treatment of HER-2/<b> <i>neu</i> </b> Overexpressing Breast Cancer Xenograft Models with Trastuzumab (Herceptin) and Gefitinib (ZD1839): Drug Combination Effects on Tumor Growth, HER-2/<b> <i>neu</i> </b> and Epidermal Growth Factor Receptor Expression, and Viable Hypoxic Cell Fraction","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stemcell Technologies; University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Gefitinib; Trastuzumab; Medicine; Cancer research; Epidermal growth factor receptor; In vivo; Estrogen receptor; Breast cancer; Growth inhibition; Cell growth; Cancer; Internal medicine; Pharmacology; Biology","score_opus":0.08032479363375436,"score_gpt":0.4131441111757406,"score_spread":0.33281931754198624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168482167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969627,0.001306019,0.0005249599,0.00007190014,0.000045071174,0.000060221257,0.0003399157,0.00005756236,0.000631633],"genre_scores_gemma":[0.9922388,0.0014893028,0.0033005804,0.00005381194,0.00003017497,0.00011318047,0.0009224778,0.000026372994,0.0018252585],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998276,0.000026657728,0.000017501381,0.00003703778,0.000048674654,0.00004248079],"domain_scores_gemma":[0.99988735,0.000015617361,0.000028962715,0.000013359447,0.000012584579,0.00004207031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020037747,0.000547687,0.0008262143,0.00027423888,0.00019139079,0.0002564337,0.00035533274,0.00035486204,0.0010825122],"category_scores_gemma":[0.000093665396,0.00018721743,0.00036559,0.0001787767,0.00014178846,0.00027026187,0.00013461152,0.0006880974,0.00024615045],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010472552,0.00064006593,0.00045047599,0.000059647504,0.000025614761,0.00003383368,0.000011121565,0.00020062765,0.99493575,0.000021134365,0.000121632285,0.002452868],"study_design_scores_gemma":[0.00019503114,0.0063216737,0.0051417714,0.0000048709476,0.000058005877,0.0003081049,0.00001920365,0.000936792,0.9855876,0.000012558979,0.0014051291,0.000009204438],"about_ca_topic_score_codex":0.0008523039,"about_ca_topic_score_gemma":0.0021827123,"teacher_disagreement_score":0.0010825122,"about_ca_system_score_codex":0.00041084856,"about_ca_system_score_gemma":0.00029793943,"threshold_uncertainty_score":0.0036213398},"labels":[],"label_agreement":null},{"id":"W2168565140","doi":"10.1158/1078-0432.ccr-06-1485","title":"Variants of the hK2 Protein Gene (<i>KLK2</i>) Are Associated with Serum hK2 Levels and Predict the Presence of Prostate Cancer at Biopsy","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre; University Health Network","funders":"","keywords":"Prostate cancer; Prostate; Medicine; Oncology; Cancer; Biopsy; Gene; Internal medicine; Biology; Cancer research; Genetics","score_opus":0.11285458192423571,"score_gpt":0.4095499342154282,"score_spread":0.2966953522911925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168565140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99934,0.0001321473,0.0002708556,0.000018045548,0.0000033092435,0.000004662008,0.000095292395,0.000006203388,0.00012949436],"genre_scores_gemma":[0.99946254,0.000038907023,0.0002510253,0.000013699628,0.000007727693,0.0000030595738,0.00011315816,0.0000025514935,0.000107176464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99965537,0.00012283662,0.000030480316,0.00010119713,0.0000559383,0.000034178553],"domain_scores_gemma":[0.9988218,0.00027311745,0.00060742564,0.000075024625,0.00006324035,0.00015947582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047570193,0.0004846809,0.00025108957,0.00035126007,0.00017842095,0.0002790252,0.00028415956,0.00031183028,0.0018867088],"category_scores_gemma":[0.0011561144,0.00019332668,0.00031163832,0.00037489997,0.00033306342,0.00011885504,0.00018959824,0.00038271054,0.00021219408],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011793893,0.000073020514,0.9870345,0.000025678048,0.00026300238,0.0001625866,0.000033951834,0.00012464699,0.009464723,0.000021086882,0.00008423877,0.001533193],"study_design_scores_gemma":[0.00004065032,0.00022615225,0.99681634,0.0000053569784,0.00012346612,0.00076099834,0.0000256283,0.00047081365,0.0013738167,0.000038695034,0.00011429709,0.0000038260614],"about_ca_topic_score_codex":0.002000224,"about_ca_topic_score_gemma":0.0014396693,"teacher_disagreement_score":0.002000224,"about_ca_system_score_codex":0.0001317458,"about_ca_system_score_gemma":0.0001425695,"threshold_uncertainty_score":0.006311655},"labels":[],"label_agreement":null},{"id":"W2168572010","doi":"10.1158/1078-0432.ccr-12-0234","title":"CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27− Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":547,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Antigen; CD20; Biology; CD8; Immunology; Tumor-infiltrating lymphocytes; Ovarian cancer; CD5; Cancer research; Cancer","score_opus":0.14974751668996145,"score_gpt":0.4592862070979238,"score_spread":0.30953869040796234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168572010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99866295,0.0007180963,0.00014428163,0.000012988295,0.0000032183102,0.0000064280784,0.00003599371,0.000015046397,0.00040111272],"genre_scores_gemma":[0.99930954,0.00019310343,0.00009022464,0.000011143716,0.000012428418,0.0000074301997,0.00010215761,0.0000022338309,0.0002717389],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99996614,0.0000063777225,0.00000320233,0.0000074205464,0.0000058861565,0.000010969408],"domain_scores_gemma":[0.99987745,0.000017327207,0.00004008259,0.000009449045,0.000015018003,0.000040701336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113938724,0.00017897932,0.00011925044,0.00038977232,0.00012709222,0.00014705451,0.000078949,0.00014617557,0.0018935051],"category_scores_gemma":[0.00021259383,0.000052496052,0.00007297296,0.00019685834,0.000092177506,0.000112278525,0.0001242199,0.0001167196,0.0002565425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032192476,0.00026955662,0.6449115,0.00020757211,0.000064164036,0.0012089749,0.00012845229,0.00033320655,0.3047116,0.00011010204,0.00055681326,0.04427873],"study_design_scores_gemma":[0.00011195451,0.0011195979,0.96019685,0.000018351942,0.00010127229,0.0055351285,0.00016119482,0.0011522865,0.027964205,0.00019563685,0.0034370571,0.000006452898],"about_ca_topic_score_codex":0.00022471527,"about_ca_topic_score_gemma":0.00024211901,"teacher_disagreement_score":0.0018935051,"about_ca_system_score_codex":0.000101628575,"about_ca_system_score_gemma":0.00008685664,"threshold_uncertainty_score":0.0063343644},"labels":[],"label_agreement":null},{"id":"W2168740323","doi":"10.1158/1078-0432.ccr-06-0551","title":"Celecoxib and Mucosal Protection: Translation from an Animal Model to a Phase I Clinical Trial of Celecoxib, Irinotecan, and 5-Fluorouracil","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Irinotecan; Medicine; Celecoxib; Pharmacokinetics; FOLFIRI; Diarrhea; Pharmacology; Regimen; Gastroenterology; Chemotherapy; Toxicity; Colorectal cancer; Fluorouracil; Internal medicine; Cancer","score_opus":0.4642957321047138,"score_gpt":0.6033448793573953,"score_spread":0.13904914725268153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168740323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889586,0.0021509535,0.0011913693,0.0012090278,0.00023386476,0.0037321015,0.0005626901,0.00007021866,0.0018911132],"genre_scores_gemma":[0.9811188,0.004647108,0.0045259744,0.0010118732,0.00025463087,0.004292862,0.0017142373,0.000026580583,0.0024079785],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994885,0.00024420032,0.000036284368,0.00004807961,0.00007676552,0.000106184336],"domain_scores_gemma":[0.99948174,0.000052780197,0.00011306248,0.000092307,0.000055069846,0.0002050312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023504258,0.0010259823,0.0010877433,0.00041717698,0.00044413644,0.00084849226,0.0008232739,0.0010944746,0.0025009804],"category_scores_gemma":[0.0008301831,0.0005134169,0.0008174825,0.0005030756,0.0009204934,0.0005891574,0.0004378692,0.002758088,0.00047137425],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21316442,0.11517569,0.006919417,0.0016264819,0.00067386456,0.00097281765,0.0004536733,0.0030780574,0.46515423,0.0014884173,0.0060183937,0.18527457],"study_design_scores_gemma":[0.12783158,0.7973618,0.017938863,0.00012381194,0.0004970951,0.00067903416,0.00013805767,0.001277865,0.044600204,0.00022599939,0.009290684,0.000034929824],"about_ca_topic_score_codex":0.00092562736,"about_ca_topic_score_gemma":0.002110683,"teacher_disagreement_score":0.0025009804,"about_ca_system_score_codex":0.0011155099,"about_ca_system_score_gemma":0.0019986967,"threshold_uncertainty_score":0.01243037},"labels":[],"label_agreement":null},{"id":"W2168762256","doi":"10.1158/1078-0432.ccr-08-1081","title":"Expanding the Use of Retinoids in Acute Myeloid Leukemia: Spotlight on Bexarotene","year":2008,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Myeloid leukemia; Bexarotene; Medicine; Myeloid; Acute promyelocytic leukemia; Differentiation therapy; Oncology; Leukemia; Internal medicine; Retinoid; Cancer research; Chemotherapy; Minimal residual disease; Immunology; Tretinoin; Retinoic acid; Biology; Nuclear receptor; Cell culture","score_opus":0.1915147763695664,"score_gpt":0.44100509248774644,"score_spread":0.24949031611818004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168762256","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014426048,0.8534014,0.0012319986,0.09384326,0.045919225,0.000052734,0.00015304152,0.00010756946,0.0038481532],"genre_scores_gemma":[0.0064780274,0.81820977,0.0018803895,0.036698367,0.13279423,0.00005920201,0.00019775056,0.00007388553,0.0036083185],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986512,0.00028184836,0.00020834587,0.00014392908,0.0005876525,0.0001270738],"domain_scores_gemma":[0.9948019,0.0026289828,0.0003774907,0.0001248606,0.0013675955,0.0006992949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004315397,0.00079924194,0.0015877866,0.0012605373,0.00066084915,0.0030245604,0.0014829441,0.0039136023,0.0040505985],"category_scores_gemma":[0.0039953697,0.00039624603,0.0007759531,0.0008578369,0.0016272113,0.004326249,0.001118826,0.008280994,0.0020452023],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010119973,0.0002812828,0.0005611628,0.002453493,0.00007982005,0.0003072169,0.00013113246,0.00029533688,0.0031862424,0.0060213744,0.32946092,0.6562101],"study_design_scores_gemma":[0.00017106469,0.0005013815,0.0005955879,0.00070755306,0.00006956009,0.00033144304,0.00006470032,0.00014965475,0.0005241186,0.0018020221,0.9950636,0.000019391407],"about_ca_topic_score_codex":0.00050731876,"about_ca_topic_score_gemma":0.0020122929,"teacher_disagreement_score":0.004315397,"about_ca_system_score_codex":0.0008823343,"about_ca_system_score_gemma":0.0010771321,"threshold_uncertainty_score":0.02282226},"labels":[],"label_agreement":null},{"id":"W2168805837","doi":"10.1158/1078-0432.ccr-05-2510","title":"Use of an Orthotopic Xenograft Model for Assessing the Effect of Epidermal Growth Factor Receptor Amplification on Glioblastoma Radiation Response","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":279,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"Radioresistance; Epidermal growth factor receptor; Medicine; PTEN; EGFR inhibitors; Cancer research; Radiation therapy; Erlotinib; Radiosensitivity; Oncology; Radiosensitizer; Cancer; Pathology; Internal medicine; PI3K/AKT/mTOR pathway; Biology; Signal transduction","score_opus":0.22769211722499452,"score_gpt":0.5237699565291969,"score_spread":0.2960778393042024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168805837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941187,0.00088499254,0.003446135,0.00004831736,0.00004611781,0.00015172425,0.00055089354,0.00011195993,0.0006410847],"genre_scores_gemma":[0.9864094,0.0012178409,0.009362223,0.000036672707,0.00001877467,0.00033742495,0.0010148955,0.000051061135,0.0015517138],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997004,0.00005710877,0.000038241575,0.00006385621,0.00009072968,0.000049702634],"domain_scores_gemma":[0.9997054,0.000050734536,0.0000961199,0.00006017795,0.000035021138,0.00005245946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000518938,0.00092307024,0.00071837165,0.0005293604,0.00021529607,0.0003369777,0.00036139227,0.0004144777,0.0013737064],"category_scores_gemma":[0.00016274449,0.00024437674,0.00051070825,0.00027299323,0.00028969537,0.00029561308,0.00020600799,0.001154336,0.00029544826],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040702973,0.00029316387,0.0009799874,0.00004920842,0.000018875904,0.000028767086,0.00002161497,0.00015521632,0.9968238,0.000035285957,0.000040578037,0.0011465385],"study_design_scores_gemma":[0.00005938436,0.006958157,0.0114914095,0.000009382682,0.000076113276,0.00024414316,0.000026858452,0.0012311435,0.9792518,0.000023262703,0.0006176857,0.000010558623],"about_ca_topic_score_codex":0.0011861636,"about_ca_topic_score_gemma":0.0018896548,"teacher_disagreement_score":0.0013737064,"about_ca_system_score_codex":0.00042649137,"about_ca_system_score_gemma":0.00035761867,"threshold_uncertainty_score":0.004595518},"labels":[],"label_agreement":null},{"id":"W2168841302","doi":"10.1158/1078-0432.ccr-06-0462","title":"Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":584,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Gefitinib; Erlotinib; Epidermal growth factor receptor; Lung cancer; Medicine; Exon; Erlotinib Hydrochloride; Internal medicine; Oncology; Mutation; Point mutation; Cancer research; Cancer; Biology; Genetics; Gene","score_opus":0.09555870628366898,"score_gpt":0.44217766275407155,"score_spread":0.3466189564704026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168841302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996884,0.00016396472,0.000025362471,0.000016675107,0.000002232486,0.0000018260055,0.000020704747,0.0000012116501,0.00007958034],"genre_scores_gemma":[0.99982256,0.000043472213,0.000022895843,0.00000981949,0.000005517572,0.0000019428662,0.000055664044,4.7676318e-7,0.000037736983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997032,0.000072457035,0.000036017944,0.000058954753,0.000072840514,0.000056581288],"domain_scores_gemma":[0.9988875,0.00026985188,0.00058082194,0.00004118846,0.000059510487,0.0001611462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003367163,0.00017384374,0.00038436076,0.00024377798,0.0002832256,0.00025736936,0.00016089415,0.00031993876,0.00085253577],"category_scores_gemma":[0.0010669901,0.00013109954,0.00038294808,0.0002742054,0.00023436407,0.00020934807,0.00015815532,0.0004127519,0.00010780997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014034287,0.00010137059,0.9877252,0.000022619979,0.000102695005,0.0006850413,0.00006348009,0.0001393467,0.0049822126,0.000010451141,0.00007616405,0.004687903],"study_design_scores_gemma":[0.000030892552,0.000581072,0.9954111,0.0000050705253,0.00005889201,0.002745404,0.000052453317,0.00023223482,0.0006661296,0.000014223353,0.00019844613,0.0000041639487],"about_ca_topic_score_codex":0.00041483244,"about_ca_topic_score_gemma":0.00091706525,"teacher_disagreement_score":0.00085253577,"about_ca_system_score_codex":0.00019007247,"about_ca_system_score_gemma":0.00020668816,"threshold_uncertainty_score":0.002851963},"labels":[],"label_agreement":null},{"id":"W2168871518","doi":"10.1158/1078-0432.ccr-10-1638","title":"The<i>IFNG</i>(IFN-γ) Genotype Predicts Cytogenetic and Molecular Response to Imatinib Therapy in Chronic Myeloid Leukemia","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Imatinib; Myeloid leukemia; Genotype; Cancer research; Immunology; Medicine; Angiogenesis; Biology; Myeloid; Oncology; Genetics; Gene","score_opus":0.09263302505358723,"score_gpt":0.4697962569955494,"score_spread":0.37716323194196216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168871518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995981,0.00006537367,0.00006901604,0.000018491179,0.0000019254067,0.0000032458054,0.00013850672,0.0000012337923,0.000104199586],"genre_scores_gemma":[0.99963295,0.000023211976,0.000082843384,0.000017578912,0.000004284511,0.0000035097955,0.00016676959,0.0000011106569,0.00006770074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983764,0.000043942804,0.000020454525,0.0000545441,0.000024385141,0.000018869918],"domain_scores_gemma":[0.9995233,0.000083972816,0.0002834664,0.000034569086,0.000020665506,0.00005405749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036589004,0.0002752975,0.00018493175,0.000247434,0.00019463284,0.00023911828,0.00017207058,0.0002735234,0.0012924155],"category_scores_gemma":[0.0006750266,0.000089646164,0.0002321747,0.0003727878,0.00023332778,0.00010205373,0.00015196926,0.00029106133,0.00018333826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011063671,0.000028723643,0.98947996,0.0000113917695,0.00009561846,0.000095384115,0.000031091207,0.00017657562,0.00614549,0.00002870647,0.00006672985,0.002733982],"study_design_scores_gemma":[0.000046276593,0.00018907149,0.9971915,0.0000067144133,0.000100179044,0.0004679546,0.000043092594,0.00047595525,0.0011313561,0.0000722353,0.00027186985,0.0000037813481],"about_ca_topic_score_codex":0.0012956976,"about_ca_topic_score_gemma":0.0014187868,"teacher_disagreement_score":0.0012956976,"about_ca_system_score_codex":0.00019084355,"about_ca_system_score_gemma":0.00019138712,"threshold_uncertainty_score":0.004323542},"labels":[],"label_agreement":null},{"id":"W2168960014","doi":"10.1158/1078-0432.ccr-04-2208","title":"A Haplotype Analysis of <i>HER-2</i> Gene Polymorphisms: Association with Breast Cancer Risk, HER-2 Protein Expression in the Tumor, and Disease Recurrence in Korea","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"College of Medicine, Seoul National University; Seoul National University","keywords":"Haplotype; Single-nucleotide polymorphism; Linkage disequilibrium; Breast cancer; Genetics; Biology; Tag SNP; Allele; SNP; Minor allele frequency; Case-control study; Cancer; Genotype; Oncology; Internal medicine; Medicine; Gene","score_opus":0.10833714557625322,"score_gpt":0.4753167939647972,"score_spread":0.36697964838854397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168960014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99969137,0.000039334274,0.00017501226,0.000006729192,8.5506315e-7,0.0000037405869,0.000039470753,0.0000013686158,0.000042156036],"genre_scores_gemma":[0.9996865,0.000017456641,0.00017586317,0.0000061187066,0.0000012846291,0.0000038360536,0.00007051886,9.825753e-7,0.000037568618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999826,0.00005607247,0.000017027709,0.00006433874,0.00001663664,0.000019877909],"domain_scores_gemma":[0.9995896,0.000086422,0.00019512157,0.000042151423,0.00003123276,0.000055497694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003057221,0.00017606175,0.00012046536,0.000267579,0.00016845507,0.00014296238,0.00013468188,0.00013507776,0.0008517401],"category_scores_gemma":[0.0005864545,0.00011635389,0.00023113747,0.00023152346,0.00013693799,0.00008597589,0.00014836252,0.00016534411,0.00010633574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045232085,0.000052281954,0.9825088,0.000018800332,0.00016612413,0.00019780856,0.000076403,0.00015948054,0.011619469,0.000023252273,0.000070097354,0.004655263],"study_design_scores_gemma":[0.00006145651,0.0004877027,0.9949269,0.0000071691647,0.0001629696,0.0010378245,0.00008508793,0.0009089966,0.0019861565,0.0000584415,0.00027106472,0.0000062929116],"about_ca_topic_score_codex":0.0009992465,"about_ca_topic_score_gemma":0.0015079611,"teacher_disagreement_score":0.0009992465,"about_ca_system_score_codex":0.00009150962,"about_ca_system_score_gemma":0.00012208236,"threshold_uncertainty_score":0.0028494},"labels":[],"label_agreement":null},{"id":"W2169039067","doi":"10.1158/1078-0432.ccr-13-2293","title":"Erlotinib, Gefitinib, and Vandetanib Inhibit Human Nucleoside Transporters and Protect Cancer Cells from Gemcitabine Cytotoxicity","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Erlotinib; Vandetanib; Gemcitabine; Gefitinib; Cytotoxicity; Pharmacology; Cabozantinib; Medicine; Nucleoside; Cancer research; Cancer; Chemistry; Internal medicine; In vitro; Epidermal growth factor receptor; Hepatocellular carcinoma; Sorafenib; Biochemistry","score_opus":0.10489414162740847,"score_gpt":0.4375857204330001,"score_spread":0.33269157880559164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169039067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826151,0.010928247,0.0022940168,0.00015419096,0.000038387312,0.0000670406,0.00054217974,0.00018228253,0.003178409],"genre_scores_gemma":[0.99217516,0.0027858827,0.0020180973,0.0000536476,0.000009877607,0.0000538167,0.00094009604,0.000020009626,0.0019432597],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999801,0.000036202095,0.000025022233,0.00003742844,0.000056709025,0.000043693057],"domain_scores_gemma":[0.9999368,0.00000912032,0.000022308133,0.000007921349,0.000011151243,0.000012583822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017495872,0.0003879827,0.00048756658,0.00025257198,0.0001512127,0.0004374989,0.00021025384,0.00030329044,0.00088856404],"category_scores_gemma":[0.0001623559,0.00014809666,0.00027918487,0.0002606321,0.00015689885,0.00018430366,0.0001390594,0.00028772233,0.00033792612],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063968834,0.00014382155,0.0012430456,0.0001424501,0.000042066546,0.00006818918,0.000022382874,0.0006200421,0.982285,0.00013617348,0.00029449537,0.014362541],"study_design_scores_gemma":[0.00015416101,0.0013826814,0.010324171,0.000012006466,0.000048699003,0.00070282904,0.000025376054,0.0017065078,0.97656643,0.000035514156,0.009029962,0.00001177661],"about_ca_topic_score_codex":0.0015497975,"about_ca_topic_score_gemma":0.0031591062,"teacher_disagreement_score":0.0015497975,"about_ca_system_score_codex":0.00053013244,"about_ca_system_score_gemma":0.00034257304,"threshold_uncertainty_score":0.0038464665},"labels":[],"label_agreement":null},{"id":"W2169180994","doi":"10.1158/1078-0432.ccr-09-2502","title":"Functional Proteomic Analysis of Advanced Serous Ovarian Cancer Using Reverse Phase Protein Array: TGF-β Pathway Signaling Indicates Response to Primary Chemotherapy","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital; University of British Columbia","funders":"National Cancer Institute; Cancer Research UK","keywords":"Debulking; Ovarian cancer; Cancer research; Biology; Transforming growth factor beta; Signal transduction; Cancer; Oncology; Serous fluid; Medicine; Internal medicine; Transforming growth factor","score_opus":0.0938306591590965,"score_gpt":0.47774811023549074,"score_spread":0.38391745107639424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169180994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99902976,0.00041067557,0.00021933496,0.000020167972,0.0000029948899,0.000008204461,0.00016861703,0.000007719618,0.00013258551],"genre_scores_gemma":[0.99879944,0.00017254165,0.00047484107,0.000026301344,0.0000057970715,0.000012903456,0.0003563671,0.0000015619117,0.00015012237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999095,0.000020546559,0.0000085568345,0.00002078372,0.000025213287,0.00001528559],"domain_scores_gemma":[0.9998398,0.00004350681,0.000050008548,0.000011365135,0.00003093317,0.000024327215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016681686,0.00017122769,0.00028376645,0.00043593426,0.00012934339,0.0002513394,0.00010323798,0.00020083539,0.0006936818],"category_scores_gemma":[0.00049453985,0.00009240271,0.00016812258,0.00037903534,0.0001449027,0.00008977089,0.00009253516,0.00017408757,0.00015503263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00285683,0.00018193819,0.57038605,0.00014523134,0.00017166899,0.00039160837,0.0001364001,0.0005192443,0.40965015,0.00003241115,0.00035245996,0.015175974],"study_design_scores_gemma":[0.000060042166,0.00065452495,0.9550801,0.0000058685387,0.00009534754,0.0012895467,0.00008222694,0.0017358615,0.040331382,0.00003272977,0.0006267328,0.0000056235713],"about_ca_topic_score_codex":0.00057974574,"about_ca_topic_score_gemma":0.0007551087,"teacher_disagreement_score":0.0006936818,"about_ca_system_score_codex":0.00014304774,"about_ca_system_score_gemma":0.00011976634,"threshold_uncertainty_score":0.0023205876},"labels":[],"label_agreement":null},{"id":"W2169216883","doi":"10.1158/1078-0432.ccr-06-2385","title":"Dose-Escalating and Pharmacologic Study of Oxaliplatin in Adult Cancer Patients with Impaired Hepatic Function: A National Cancer Institute Organ Dysfunction Working Group Study","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"National Center for Research Resources; National Cancer Institute","keywords":"Oxaliplatin; Medicine; Bilirubin; Gastroenterology; Internal medicine; Liver function tests; Liver function; Liver transplantation; Population; Cancer; Colorectal cancer; Transplantation","score_opus":0.21210268984697117,"score_gpt":0.5243792897065563,"score_spread":0.31227659985958517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169216883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99881554,0.00026174667,0.00022657102,0.00007635365,0.000012948696,0.00024896278,0.00013980018,0.000010318039,0.00020775746],"genre_scores_gemma":[0.99720865,0.00040587026,0.0007776065,0.00035513876,0.0000586289,0.0003643312,0.0006125499,0.000005997521,0.00021121698],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99885404,0.0006315046,0.00010228101,0.00013004793,0.00014112801,0.00014100062],"domain_scores_gemma":[0.9983198,0.00023153987,0.00042409208,0.0003156868,0.00010218868,0.00060652953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002651,0.0010698962,0.0017529407,0.00028232517,0.00035472977,0.0005999357,0.00068888965,0.00064709043,0.00088002416],"category_scores_gemma":[0.0015632064,0.00041803345,0.0011143873,0.00061633653,0.0007812469,0.00049731607,0.0003686578,0.0016735068,0.00026657266],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39206257,0.11215237,0.3373158,0.00040861292,0.0032894039,0.00064637343,0.0006759805,0.0031389957,0.0547291,0.00025091268,0.0023055102,0.09302437],"study_design_scores_gemma":[0.13020614,0.47607455,0.37680337,0.000033750297,0.0010979959,0.0013255263,0.00018186113,0.0023920615,0.008338976,0.00016395343,0.0033245545,0.000057276004],"about_ca_topic_score_codex":0.00089617516,"about_ca_topic_score_gemma":0.0009987555,"teacher_disagreement_score":0.002651,"about_ca_system_score_codex":0.0009059069,"about_ca_system_score_gemma":0.0014421352,"threshold_uncertainty_score":0.014020026},"labels":[],"label_agreement":null},{"id":"W2169394417","doi":"10.1158/1078-0432.ccr-07-0146","title":"<i>BRCA</i> Mutations in Women with Ductal Carcinoma <i>In situ</i>","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Ductal carcinoma; In situ; Carcinoma in situ; Carcinoma; Oncology; Medicine; Internal medicine; Cancer; Biology; Cancer research; Breast cancer; Chemistry","score_opus":0.07733633286611866,"score_gpt":0.45336700251550016,"score_spread":0.3760306696493815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169394417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996773,0.0001449159,0.000021276133,0.000018582894,0.00000200339,0.000003314685,0.000026084927,0.0000017616958,0.000104760555],"genre_scores_gemma":[0.9997559,0.000073303534,0.000059508173,0.00001508142,0.000009046708,0.0000035684716,0.000049244227,6.9260886e-7,0.00003361991],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994242,0.0002263943,0.000044375192,0.00015568551,0.00008914461,0.0000603147],"domain_scores_gemma":[0.998206,0.000536423,0.0008317323,0.00013898288,0.00010749152,0.00017937724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010541225,0.00028035796,0.00024549957,0.00066615996,0.00033812926,0.00039728865,0.00038703365,0.0005100454,0.00078468653],"category_scores_gemma":[0.0035795388,0.0002672934,0.00018579779,0.0003487625,0.0004790994,0.00027058853,0.00028567394,0.0003472228,0.00013543062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039066974,0.000061393315,0.9975713,0.000009623443,0.000028427141,0.0000760514,0.000048958176,0.000014127074,0.0005789643,0.000006726471,0.000035228357,0.0011784649],"study_design_scores_gemma":[0.00005956923,0.0006578381,0.9972138,0.000008693418,0.00008000238,0.0011735047,0.00011832112,0.00016487749,0.0003565362,0.000031224772,0.00013275028,0.0000029921555],"about_ca_topic_score_codex":0.0027159515,"about_ca_topic_score_gemma":0.0024518732,"teacher_disagreement_score":0.0027159515,"about_ca_system_score_codex":0.00022100974,"about_ca_system_score_gemma":0.00025011186,"threshold_uncertainty_score":0.0055748224},"labels":[],"label_agreement":null},{"id":"W2169497913","doi":"10.1158/1078-0432.ccr-06-1567","title":"Amplification and Overexpression of <i>CACNA1E</i> Correlates with Relapse in Favorable Histology Wilms' Tumors","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Cancer Research UK","keywords":"Wilms' tumor; Loss of heterozygosity; Biology; Cancer research; Gene; Molecular biology; Genetics; Allele","score_opus":0.041125378315695627,"score_gpt":0.39483945158594624,"score_spread":0.3537140732702506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169497913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99967396,0.00011767437,0.00006938426,0.000010621036,0.0000010351878,0.0000016350731,0.00003371347,0.000007492614,0.00008449417],"genre_scores_gemma":[0.9996847,0.000048593352,0.000089246794,0.0000049132054,0.0000028476052,0.0000026435514,0.00007960821,0.0000021957253,0.000085217085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998723,0.000018686367,0.000014175253,0.00003301123,0.000038739257,0.000023086777],"domain_scores_gemma":[0.9993704,0.00013790217,0.00030310094,0.000025297548,0.00004353771,0.00011981753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002619482,0.00014569369,0.00021816466,0.0004940211,0.00013440823,0.00022980844,0.00014851114,0.00019254998,0.0010267455],"category_scores_gemma":[0.00090193347,0.00011397558,0.00009836806,0.00022791572,0.0003252922,0.00012282617,0.00012649773,0.00020861182,0.00016801138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008517138,0.000040368108,0.8874936,0.00004387298,0.000035406738,0.00065797614,0.0000998542,0.00014559741,0.10490568,0.000026451187,0.00013134666,0.0055681434],"study_design_scores_gemma":[0.000006595351,0.00011851763,0.9909842,0.0000022463037,0.000017030321,0.0018314011,0.000056203036,0.00017503697,0.006637122,0.000015188407,0.00015385415,0.0000026153782],"about_ca_topic_score_codex":0.0005173548,"about_ca_topic_score_gemma":0.0006536894,"teacher_disagreement_score":0.0010267455,"about_ca_system_score_codex":0.00019812695,"about_ca_system_score_gemma":0.00011423017,"threshold_uncertainty_score":0.0034348369},"labels":[],"label_agreement":null},{"id":"W2169508419","doi":"10.1158/1078-0432.ccr-10-2334","title":"Ribavirin Treatment Effects on Breast Cancers Overexpressing eIF4E, a Biomarker with Prognostic Specificity for Luminal B-Type Breast Cancer","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Jewish General Hospital","funders":"National Cancer Institute; National Institute on Aging; Canadian Institutes of Health Research; U.S. Public Health Service","keywords":"Breast cancer; EIF4E; Cancer research; Cancer; Medicine; Oncology; Metastasis; Biomarker; Gene knockdown; Internal medicine; Biology; Messenger RNA; Cell culture; Translation (biology); Gene","score_opus":0.22084065200133157,"score_gpt":0.4714431623378206,"score_spread":0.250602510336489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169508419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99726933,0.0018638211,0.00017681916,0.000038070477,0.000020064257,0.000020098998,0.00017754795,0.000017166076,0.00041704654],"genre_scores_gemma":[0.99746823,0.0008919235,0.0005196028,0.00003497004,0.000013437916,0.000023226343,0.0004494093,0.000006270667,0.00059303304],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989474,0.00003054658,0.000009092494,0.000021445725,0.000017213599,0.00002703625],"domain_scores_gemma":[0.9998996,0.00003433066,0.000017946779,0.000015145079,0.000013105461,0.000019816263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016076473,0.0002854613,0.00054693397,0.00022236441,0.00014918475,0.00021321583,0.000092004506,0.00022639723,0.0009853353],"category_scores_gemma":[0.0001731747,0.00009827317,0.00022218574,0.00017772565,0.00017056853,0.000105019586,0.00008933374,0.00036257764,0.00019565174],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026976317,0.0004110838,0.0025088834,0.00007695009,0.000028946524,0.000041240888,0.000020808578,0.00025619325,0.98411393,0.000013329789,0.00007360949,0.009757237],"study_design_scores_gemma":[0.00024389976,0.021009687,0.072699025,0.000017188246,0.00014633531,0.00053454674,0.00005932408,0.0011780912,0.9011394,0.000036243513,0.0029208704,0.0000154538],"about_ca_topic_score_codex":0.00028115188,"about_ca_topic_score_gemma":0.0005419132,"teacher_disagreement_score":0.0009853353,"about_ca_system_score_codex":0.00013858682,"about_ca_system_score_gemma":0.00011119303,"threshold_uncertainty_score":0.003296256},"labels":[],"label_agreement":null},{"id":"W2169733452","doi":"10.1158/1078-0432.787.11.2","title":"Biodistribution of Yttrium-90–Labeled Anti-CD45 Antibody in a Nonhuman Primate Model","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Biodistribution; Radioimmunotherapy; Spleen; Lymph; Antibody; Pathology; Bone marrow; Medicine; Transplantation; Haematopoiesis; Lymph node; Nuclear medicine; Biology; Immunology; Internal medicine; In vivo; Stem cell; Monoclonal antibody","score_opus":0.39008598252390236,"score_gpt":0.6559256920686046,"score_spread":0.26583970954470226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169733452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98585296,0.0035107275,0.0073798276,0.00015488637,0.000028534389,0.00015836081,0.00026676527,0.00014324853,0.00250463],"genre_scores_gemma":[0.97883224,0.0025600952,0.012395311,0.00018789337,0.000024824252,0.00041408846,0.0007635196,0.00005551734,0.0047665266],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997867,0.00004733993,0.000009106913,0.00007185188,0.000052548858,0.00003257721],"domain_scores_gemma":[0.9998554,0.00001883365,0.000038623988,0.00002698717,0.00002723512,0.000032940858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044263725,0.0006674121,0.0003820746,0.0005141917,0.00040898498,0.000382103,0.00032315694,0.0004834687,0.002085877],"category_scores_gemma":[0.00017051845,0.00023079019,0.0002536531,0.00023128913,0.000468123,0.00028987162,0.00017382087,0.0006892942,0.0006362488],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001039429,0.00045182672,0.0016551827,0.00012499256,0.000027999618,0.00023542014,0.00012370895,0.00026281705,0.9889631,0.0002358127,0.00019185118,0.006687891],"study_design_scores_gemma":[0.00025715542,0.014849513,0.02136668,0.00009237003,0.00024615708,0.0034708022,0.0002293815,0.0045351298,0.9373863,0.000549372,0.016986087,0.000031109386],"about_ca_topic_score_codex":0.0017847874,"about_ca_topic_score_gemma":0.0023317426,"teacher_disagreement_score":0.002085877,"about_ca_system_score_codex":0.00059503975,"about_ca_system_score_gemma":0.00036471468,"threshold_uncertainty_score":0.0069779158},"labels":[],"label_agreement":null},{"id":"W2169820481","doi":"10.1158/1078-0432.ccr-07-4707","title":"Preoperative Plasma Endoglin Levels Predict Biochemical Progression After Radical Prostatectomy","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Center for Research Resources","keywords":"Prostatectomy; Endoglin; Medicine; Urology; Prostate cancer; Biochemical recurrence; Prostate-specific antigen; Prostate; Internal medicine; Cancer","score_opus":0.15548224058078014,"score_gpt":0.48034102634461123,"score_spread":0.3248587857638311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169820481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995165,0.0002466383,0.000076112825,0.000014634191,0.0000023434384,0.0000024751573,0.00003595442,0.0000031118257,0.000102064034],"genre_scores_gemma":[0.99984014,0.00003261483,0.00003901496,0.000004432392,0.0000029645926,0.0000013183156,0.000046367266,3.4627004e-7,0.000032800577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998671,0.00003637324,0.0000106836305,0.000024622304,0.000038208214,0.000022934451],"domain_scores_gemma":[0.9991817,0.00020710472,0.0003370058,0.00003643625,0.000047651625,0.00019013027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002679816,0.00018544399,0.00019068168,0.00021821127,0.00013227815,0.0002641235,0.00013245422,0.0002159727,0.001170457],"category_scores_gemma":[0.0012653947,0.00010028543,0.00016607932,0.00022089324,0.00018832406,0.00015495002,0.00017118132,0.00045979547,0.00009806723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032730238,0.000037332735,0.9959235,0.00001108267,0.000033332763,0.000044822278,0.000022769565,0.00012622423,0.0009245279,0.000008044687,0.000051411444,0.002489628],"study_design_scores_gemma":[0.00001020672,0.00016334864,0.99897623,0.0000031694178,0.00001629829,0.0002269349,0.000027628776,0.00030764408,0.00019572061,0.000012175533,0.00005822293,0.0000024461112],"about_ca_topic_score_codex":0.0007037793,"about_ca_topic_score_gemma":0.0011777714,"teacher_disagreement_score":0.001170457,"about_ca_system_score_codex":0.0001384801,"about_ca_system_score_gemma":0.00021630096,"threshold_uncertainty_score":0.0039155483},"labels":[],"label_agreement":null},{"id":"W2169923369","doi":"10.1158/1078-0432.ccr-13-2060","title":"Autophagy Inhibition Augments the Anticancer Effects of Epirubicin Treatment in Anthracycline-Sensitive and -Resistant Triple-Negative Breast Cancer","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia; BC Cancer Agency","funders":"Pfizer; Canadian Institutes of Health Research; Pfizer Canada; Avon Foundation for Women","keywords":"Autophagy; Epirubicin; Anthracycline; Cancer research; Triple-negative breast cancer; Breast cancer; Medicine; Biology; Chemotherapy; Pharmacology; Cancer; Internal medicine; Apoptosis","score_opus":0.0743658566658117,"score_gpt":0.488136597543408,"score_spread":0.4137707408775963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169923369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974921,0.0012900769,0.0002601933,0.000040468116,0.000021027747,0.000034713754,0.00011627746,0.00004168623,0.0007035233],"genre_scores_gemma":[0.9972851,0.00083916285,0.0005594528,0.000030621824,0.000009991045,0.000036188914,0.00033417047,0.000008556649,0.0008966676],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998987,0.000024302723,0.000013365676,0.000018489312,0.000020841015,0.000024285046],"domain_scores_gemma":[0.9999349,0.000013235876,0.000014613005,0.000009791508,0.00000725419,0.000020131225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014158216,0.00029273133,0.00068817934,0.0003204736,0.0001454681,0.0002577431,0.00018606531,0.00023666481,0.0008610381],"category_scores_gemma":[0.00012506614,0.00010831943,0.00019907395,0.0002028699,0.00017798206,0.0001776257,0.0001222121,0.00045114072,0.00018496948],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014194989,0.00069583114,0.00041637066,0.00010859684,0.000023056293,0.00009015761,0.000047165362,0.00025391,0.988846,0.0000776268,0.00019486435,0.007826915],"study_design_scores_gemma":[0.00033252922,0.008435296,0.018742988,0.000024974204,0.00009130132,0.00061171636,0.000048300677,0.0018469574,0.96571666,0.000039512004,0.0040947986,0.000015069582],"about_ca_topic_score_codex":0.0005682774,"about_ca_topic_score_gemma":0.0014685525,"teacher_disagreement_score":0.0008610381,"about_ca_system_score_codex":0.00018806891,"about_ca_system_score_gemma":0.00022738913,"threshold_uncertainty_score":0.0028805137},"labels":[],"label_agreement":null},{"id":"W2169961538","doi":"10.1158/1078-0432.ccr-11-0211","title":"Targeting the Hedgehog Pathway in Cancer: Can the Spines Be Smoothened?","year":2011,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Smoothened; Hedgehog signaling pathway; Hedgehog; Cancer research; Cancer; Patched; Vismodegib; Biology; Medicine; Signal transduction; Genetics","score_opus":0.28949148368323396,"score_gpt":0.4760581475419214,"score_spread":0.18656666385868742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169961538","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002482546,0.016602144,0.00037741548,0.9612901,0.015445271,0.000027883985,0.00004957786,0.00006121599,0.003663855],"genre_scores_gemma":[0.04708629,0.050796025,0.0014305933,0.7924843,0.08762143,0.00015001692,0.000114182054,0.000045428184,0.02027172],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99952245,0.00012540202,0.00005923826,0.000048221304,0.00017056234,0.000074269046],"domain_scores_gemma":[0.999097,0.00046473552,0.00007172299,0.000053729615,0.0001485408,0.00016429741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010102739,0.00053637836,0.0010454108,0.00025967072,0.0011660263,0.0011660418,0.00074949145,0.014013487,0.0026097156],"category_scores_gemma":[0.0040750424,0.00028331284,0.0007272332,0.00025115852,0.0015256789,0.0017191693,0.0005570674,0.011336382,0.0028405748],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005088051,0.00012825934,0.0013654678,0.0002882232,0.00003641716,0.01037379,0.00010802404,0.0002593891,0.0031974309,0.0077827023,0.8819501,0.09400141],"study_design_scores_gemma":[0.00068117335,0.000633313,0.0019111405,0.00030166958,0.00006571043,0.0195614,0.00028595267,0.0011634975,0.0026503273,0.028228344,0.94444895,0.000068413974],"about_ca_topic_score_codex":0.00086192467,"about_ca_topic_score_gemma":0.0016307546,"teacher_disagreement_score":0.014013487,"about_ca_system_score_codex":0.001613006,"about_ca_system_score_gemma":0.0009259595,"threshold_uncertainty_score":0.011703253},"labels":[],"label_agreement":null},{"id":"W2169983495","doi":"10.1158/1078-0432.ccr-06-1005","title":"Summary Statement: Novel Agents in the Treatment of Lung Cancer: Advances in Epidermal Growth Factor Receptor-Targeted Agents","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Epidermal growth factor receptor; Statement (logic); Lung cancer; Medicine; Cancer; Epidermal growth factor; Cancer research; Receptor; Oncology; Internal medicine; Political science","score_opus":0.1906762735697729,"score_gpt":0.5538509507929525,"score_spread":0.36317467722317964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169983495","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024297729,0.11047545,0.0019942117,0.44332814,0.40614516,0.00058307085,0.0018758557,0.00026444357,0.03290391],"genre_scores_gemma":[0.011201361,0.07669614,0.0037120613,0.3002785,0.41157925,0.0004805526,0.0018651076,0.00016171292,0.19402532],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99874914,0.00019268067,0.00024180066,0.00015858976,0.00044367445,0.0002140879],"domain_scores_gemma":[0.9956204,0.0011445687,0.0005741605,0.00011352104,0.0014370462,0.0011102344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035618441,0.0015663585,0.002189618,0.0009467856,0.0012387884,0.0026438534,0.002412795,0.015116623,0.012071634],"category_scores_gemma":[0.0031989554,0.0004906939,0.0013117265,0.0009632986,0.00068357406,0.0019322122,0.0008175225,0.008027563,0.007529981],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003058894,0.00010367164,0.00021038893,0.00068566174,0.00002997629,0.0003328948,0.000029441553,0.00012340322,0.0015083143,0.0013132261,0.9407186,0.05463853],"study_design_scores_gemma":[0.00014149096,0.0002771194,0.0012123007,0.0002845544,0.00004951203,0.0002512959,0.000030810166,0.00019372546,0.0007814469,0.00061500806,0.9961384,0.00002444713],"about_ca_topic_score_codex":0.0016912677,"about_ca_topic_score_gemma":0.006287068,"teacher_disagreement_score":0.015116623,"about_ca_system_score_codex":0.0015954131,"about_ca_system_score_gemma":0.0030842347,"threshold_uncertainty_score":0.040383637},"labels":[],"label_agreement":null},{"id":"W2170104632","doi":"10.1158/1078-0432.ccr-07-4134","title":"Efficacy of Systemically Administered Mutant Vesicular Stomatitis Virus (VSVΔ51) Combined with Radiation for Nasopharyngeal Carcinoma","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virology and Viral Diseases","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Ottawa; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Nasopharyngeal carcinoma; Vesicular stomatitis virus; Virology; Mutant; Nasopharyngeal cancer; Medicine; Vesicular Stomatitis; Virus; Biology; Internal medicine; Radiation therapy; Genetics; Gene","score_opus":0.17976898122576723,"score_gpt":0.4703670472311288,"score_spread":0.2905980660053616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170104632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956664,0.002535739,0.0009045,0.000036706948,0.000046817495,0.00005686644,0.000076801,0.000060048154,0.0006160779],"genre_scores_gemma":[0.9977139,0.00097397034,0.0006195268,0.000012361541,0.000012887183,0.000034945173,0.000094914045,0.000010322447,0.00052711094],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983656,0.000044805733,0.000014443045,0.00003908976,0.000036713096,0.000028381775],"domain_scores_gemma":[0.9999013,0.000026416528,0.000023780849,0.00002253762,0.000007784203,0.000018103065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025277844,0.00049479987,0.0006891888,0.00029131977,0.00017351187,0.00029129896,0.00033600008,0.00033077117,0.0011692797],"category_scores_gemma":[0.00016461012,0.00012349039,0.00044515837,0.00018955956,0.00040301832,0.00028513273,0.00016092623,0.00052085426,0.00020996596],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002393341,0.0009779882,0.0008274234,0.00025566758,0.00008100214,0.00007692575,0.00005655297,0.0008300015,0.97621834,0.00014393515,0.0001663667,0.017972378],"study_design_scores_gemma":[0.0002230396,0.016612973,0.004543692,0.000017405124,0.00015966638,0.00032794516,0.00004310439,0.001675592,0.97485095,0.000035693552,0.0014996221,0.000010302432],"about_ca_topic_score_codex":0.0006627979,"about_ca_topic_score_gemma":0.00090054836,"teacher_disagreement_score":0.0011692797,"about_ca_system_score_codex":0.00031534611,"about_ca_system_score_gemma":0.000383785,"threshold_uncertainty_score":0.003911674},"labels":[],"label_agreement":null},{"id":"W2170270019","doi":"10.1158/1078-0432.ccr-07-1330","title":"Oncolytic Efficacy of Recombinant Vesicular Stomatitis Virus and Myxoma Virus in Experimental Models of Rhabdoid Tumors","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials; University of Calgary","funders":"National Cancer Institute","keywords":"Oncolytic virus; Vesicular stomatitis virus; Myxoma virus; Virus; Vesicular Stomatitis; Virology; In vivo; Biology; Cell culture; Cytopathic effect; Pathology; Medicine","score_opus":0.1560289831561946,"score_gpt":0.4741199758990431,"score_spread":0.31809099274284847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170270019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967733,0.0014990066,0.0009214039,0.000041171978,0.000026151096,0.000075734664,0.00017876313,0.000031309446,0.0004531111],"genre_scores_gemma":[0.99451435,0.0012690895,0.0026863778,0.000017579934,0.0000140459315,0.00013657277,0.00044653995,0.000011563855,0.0009039723],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99968195,0.000082579085,0.000038483646,0.000060846352,0.00006869932,0.000067561516],"domain_scores_gemma":[0.99978834,0.0000559227,0.000070762995,0.000028377404,0.000018709654,0.000037849404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000473911,0.0005498546,0.00039524928,0.00037168877,0.00016319202,0.00032592547,0.00032394534,0.00046450231,0.0005751832],"category_scores_gemma":[0.00021230661,0.00015479406,0.00036905007,0.00018795561,0.00042327243,0.0003642543,0.0001656809,0.00076325814,0.00014262728],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071540324,0.00041996525,0.00032933365,0.00008797365,0.000021013477,0.000042787968,0.000036287816,0.00023663192,0.9962507,0.00015202716,0.000042540705,0.0016653145],"study_design_scores_gemma":[0.00010489385,0.0064711175,0.0017132019,0.0000094736715,0.000040884934,0.0002122182,0.000029435145,0.0007554177,0.98983043,0.000024571664,0.0008032798,0.000005133558],"about_ca_topic_score_codex":0.00092878524,"about_ca_topic_score_gemma":0.0010101296,"teacher_disagreement_score":0.00092878524,"about_ca_system_score_codex":0.0005532926,"about_ca_system_score_gemma":0.00044894108,"threshold_uncertainty_score":0.0040144324},"labels":[],"label_agreement":null},{"id":"W2170428165","doi":"10.1158/1078-0432.ccr-07-4932","title":"A Functional Epidermal Growth Factor (EGF) Polymorphism, EGF Serum Levels, and Esophageal Adenocarcinoma Risk and Outcome","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; National Institutes of Health; Flight Attendant Medical Research Institute","keywords":"Epidermal growth factor; Esophageal adenocarcinoma; Internal medicine; Adenocarcinoma; Epidermal growth factor receptor; Risk factor; Oncology; Medicine; Biology; Endocrinology; Cancer; Receptor","score_opus":0.33652662964346813,"score_gpt":0.4791541241929214,"score_spread":0.14262749454945328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170428165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996835,0.00013345257,0.00006418727,0.00001739875,0.0000024271171,0.0000019853735,0.00004867251,0.0000018564047,0.00004657306],"genre_scores_gemma":[0.9997582,0.00003662545,0.0000738587,0.000008996217,0.000005141434,0.0000030929896,0.00006351122,5.681069e-7,0.000049930415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980134,0.00007550653,0.00001843691,0.000041897896,0.000034138586,0.0000286842],"domain_scores_gemma":[0.99895525,0.00039291053,0.00031985468,0.00007002206,0.000047688733,0.00021426138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054557767,0.0002947564,0.00027847904,0.0003004029,0.00018104915,0.00024387354,0.00014257086,0.00041502787,0.0010331549],"category_scores_gemma":[0.0016383366,0.00010462057,0.0002577908,0.00029276512,0.00031427524,0.00016685933,0.00019445385,0.00035975515,0.00012792826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019784812,0.00011525537,0.9940943,0.000015403755,0.00008247077,0.000083362014,0.00001148731,0.00013300267,0.0017118338,0.000015720336,0.000035869085,0.001722837],"study_design_scores_gemma":[0.000079375866,0.0013206622,0.995421,0.0000076059573,0.00013598408,0.0008909218,0.00003243174,0.000971209,0.00095125585,0.000084221,0.000100288744,0.0000051434213],"about_ca_topic_score_codex":0.0006399964,"about_ca_topic_score_gemma":0.00044206614,"teacher_disagreement_score":0.0010331549,"about_ca_system_score_codex":0.0001535337,"about_ca_system_score_gemma":0.00019883492,"threshold_uncertainty_score":0.003456235},"labels":[],"label_agreement":null},{"id":"W2170476788","doi":"10.1158/1078-0432.ccr-10-0939","title":"Poly(ADP-Ribose) Polymerase Inhibition: “Targeted” Therapy for Triple-Negative Breast Cancer","year":2010,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Breast cancer; Triple-negative breast cancer; PARP inhibitor; Cancer research; Poly ADP ribose polymerase; Cancer; Synthetic lethality; Medicine; DNA repair; Targeted therapy; Polymerase; Biology; Internal medicine; DNA; Genetics","score_opus":0.4045928384629675,"score_gpt":0.609833792293307,"score_spread":0.20524095383033952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170476788","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022705011,0.9967629,0.00023999298,0.00022824395,0.00023363385,0.000008974474,0.00001339056,0.000013125177,0.0022726718],"genre_scores_gemma":[0.00079876697,0.99726367,0.00029148298,0.00023368037,0.00013253263,0.0000080751415,0.000025803121,0.0000016832955,0.0012442177],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998895,0.000017165525,0.000012168106,0.000020070158,0.000052077743,0.000008959219],"domain_scores_gemma":[0.9999207,0.000027031178,0.000013979659,0.0000035987887,0.0000241787,0.0000104575765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002748181,0.00067144964,0.0010767238,0.001856953,0.00028323615,0.0005996078,0.0006997815,0.0008625802,0.002646839],"category_scores_gemma":[0.00026861165,0.00019493187,0.0003026423,0.0023991251,0.00037623596,0.0011917566,0.00045019775,0.0013793515,0.0032994275],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007546375,0.000109465574,0.00010248144,0.007623688,0.00004897149,0.00023219855,0.000051327115,0.0003527454,0.0034942103,0.0031474403,0.031327166,0.95343477],"study_design_scores_gemma":[0.00002494214,0.000111265166,0.00086619897,0.0016407482,0.000047120546,0.002005533,0.000049121973,0.00011183719,0.0008082155,0.0016678432,0.9926548,0.000012400405],"about_ca_topic_score_codex":0.0007460606,"about_ca_topic_score_gemma":0.0018660707,"teacher_disagreement_score":0.002646839,"about_ca_system_score_codex":0.000530664,"about_ca_system_score_gemma":0.0005964359,"threshold_uncertainty_score":0.008854568},"labels":[],"label_agreement":null},{"id":"W2170565025","doi":"10.1158/1078-0432.ccr-06-0269","title":"Markers of Bone Metabolism and Survival in Men with Hormone-Refractory Metastatic Prostate Cancer","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame; Hamilton Regional Laboratory Medicine Program; McMaster University; University of Waterloo","funders":"Massachusetts General Hospital","keywords":"Medicine; Internal medicine; N-terminal telopeptide; Prostate cancer; Oncology; Hazard ratio; Prostate-specific antigen; Endocrinology; Bone metastasis; Urology; Cancer; Confidence interval; Alkaline phosphatase; Osteocalcin; Biology","score_opus":0.12062218524287126,"score_gpt":0.4906579282345033,"score_spread":0.37003574299163206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170565025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99792635,0.0017371996,0.000073437484,0.000036899157,0.000006127952,0.000009725078,0.00013143926,0.000004064522,0.000074683],"genre_scores_gemma":[0.9994253,0.00022091826,0.000099928206,0.000024602201,0.000015558984,0.000010506473,0.00013818358,5.6526784e-7,0.0000643578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981874,0.00008229712,0.000010850542,0.000030018964,0.000035745634,0.000022382894],"domain_scores_gemma":[0.9992849,0.00023293834,0.0003066116,0.000031804768,0.000035718505,0.000108027634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006892078,0.000394033,0.0005157728,0.0003145117,0.00023247905,0.00029173834,0.00019663529,0.00034246693,0.00091323344],"category_scores_gemma":[0.0016392034,0.00017356053,0.0004286066,0.00038059553,0.0002049811,0.00018791422,0.00017043929,0.00033456332,0.000085506166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008217168,0.00025133527,0.98106074,0.000073876436,0.0003729909,0.00006570481,0.000036880752,0.00033576065,0.001071476,0.00001698207,0.000119974946,0.0083772065],"study_design_scores_gemma":[0.00034476866,0.0027165692,0.99516934,0.000011291233,0.00022967027,0.0002375459,0.000030477231,0.00068615185,0.00031105042,0.000045188153,0.00021114013,0.000006765562],"about_ca_topic_score_codex":0.0013958047,"about_ca_topic_score_gemma":0.002253724,"teacher_disagreement_score":0.0013958047,"about_ca_system_score_codex":0.00021736074,"about_ca_system_score_gemma":0.00026925496,"threshold_uncertainty_score":0.0036449432},"labels":[],"label_agreement":null},{"id":"W2170602872","doi":"10.1158/1078-0432.ccr-06-3045","title":"Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Medicine; Triple-negative breast cancer; Hazard ratio; Internal medicine; Oncology; Confidence interval; Cancer; Cohort; Proportional hazards model; Gynecology","score_opus":0.13123511639770377,"score_gpt":0.5259002702839296,"score_spread":0.3946651538862258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170602872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99957055,0.00022547695,0.000015269668,0.000014367501,0.0000012071051,0.0000034120144,0.00008501636,6.554585e-7,0.000083987674],"genre_scores_gemma":[0.9996216,0.00008814766,0.000024663444,0.000007676883,0.0000040220593,0.0000036425376,0.00020298657,3.375832e-7,0.000046843626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998679,0.000027034857,0.0000111997115,0.000031764685,0.000029624916,0.00003240846],"domain_scores_gemma":[0.9994248,0.000096423304,0.0003159627,0.000025914338,0.00003618002,0.00010067811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031803866,0.0001563451,0.0002064585,0.00040789865,0.0002342812,0.00027864182,0.00018026022,0.00025026762,0.00081707595],"category_scores_gemma":[0.0011502737,0.000107703716,0.00013839376,0.00032767115,0.00028305905,0.00014379306,0.0002051469,0.00017597346,0.00009975684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022711871,0.00001731892,0.9980773,0.000008684664,0.00001977117,0.00013982187,0.00003251196,0.000027330416,0.0003296714,0.000006493035,0.000039825904,0.0010741898],"study_design_scores_gemma":[0.000011885626,0.000103100116,0.99858344,0.0000039788547,0.000013569242,0.0009753004,0.00006926562,0.000064834574,0.00008003161,0.00001175761,0.00008091502,0.0000019699487],"about_ca_topic_score_codex":0.00611237,"about_ca_topic_score_gemma":0.0068576634,"teacher_disagreement_score":0.00611237,"about_ca_system_score_codex":0.00040214753,"about_ca_system_score_gemma":0.0003024862,"threshold_uncertainty_score":0.012153566},"labels":[],"label_agreement":null},{"id":"W2170814332","doi":"10.1158/1078-0432.ccr-05-1810","title":"Neosquamous Epithelium Does Not Typically Arise from Barrett's Epithelium","year":2006,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Epithelium; Microdissection; Biology; Barrett's esophagus; Progenitor cell; Pathology; Intestinal epithelium; Esophagus; CDX2; Dysplasia; Respiratory epithelium; CDKN2A; Stem cell; Adenocarcinoma; Medicine; Cancer; Anatomy; Gene; Genetics","score_opus":0.11364728829849473,"score_gpt":0.47803695330642143,"score_spread":0.3643896650079267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170814332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924304,0.0020298003,0.0015438197,0.000066769375,0.000012860373,0.00003354703,0.00010408011,0.000051183557,0.00372746],"genre_scores_gemma":[0.9984144,0.00028714963,0.0005678914,0.00005209418,0.0000065806976,0.000007936625,0.00016692984,0.000006962384,0.0004901278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985266,0.000016863727,0.000023481549,0.000043062377,0.00003726802,0.000026656819],"domain_scores_gemma":[0.9993812,0.00018358094,0.00015993475,0.00009452137,0.00007717596,0.000103623475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016871499,0.00022937,0.0002951062,0.00026592205,0.00030144176,0.00030130413,0.00017480782,0.00036417006,0.0027775273],"category_scores_gemma":[0.00088994385,0.00015301807,0.00013885561,0.00020183306,0.00042633427,0.00033778246,0.0003836965,0.00025355324,0.00077834586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012343581,0.0001333464,0.60976255,0.0007170126,0.00013887337,0.034477644,0.00083892606,0.00016356213,0.3093045,0.0011853228,0.00055022445,0.04149369],"study_design_scores_gemma":[0.0000674147,0.0010605057,0.66915417,0.00010762004,0.0001277079,0.2631867,0.0005567779,0.00046836643,0.053522576,0.0006274444,0.011102838,0.000017868824],"about_ca_topic_score_codex":0.0002778725,"about_ca_topic_score_gemma":0.0006677672,"teacher_disagreement_score":0.0027775273,"about_ca_system_score_codex":0.00014576441,"about_ca_system_score_gemma":0.000108239925,"threshold_uncertainty_score":0.0092917085},"labels":[],"label_agreement":null},{"id":"W2171046634","doi":"10.1158/1078-0432.ccr-08-0761","title":"Phase I Study of Cediranib in Combination with Oxaliplatin and Infusional 5-Fluorouracil in Patients with Advanced Colorectal Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"Sanofi; AstraZeneca","keywords":"Medicine; Oxaliplatin; Pharmacokinetics; Tolerability; FOLFOX; Internal medicine; Colorectal cancer; Fluorouracil; Regimen; Dosing; Pharmacology; Oncology; Phases of clinical research; Gastroenterology; Toxicity; Chemotherapy; Cancer; Adverse effect","score_opus":0.08583454801042077,"score_gpt":0.48511259051821104,"score_spread":0.39927804250779025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171046634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930581,0.002775259,0.0006788993,0.00038493576,0.00013297025,0.0013607302,0.000351841,0.00007117521,0.001186081],"genre_scores_gemma":[0.9929028,0.0016284673,0.001729457,0.0004415525,0.00016887748,0.0010028923,0.0011062815,0.000018896983,0.0010007883],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99937516,0.00032279667,0.000036039826,0.00009029271,0.000079524754,0.00009605654],"domain_scores_gemma":[0.9991641,0.00013273113,0.00016881737,0.00006324236,0.000055231194,0.000415883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013691612,0.0014598991,0.0025599294,0.0005161697,0.00049643114,0.0009343547,0.0010117828,0.0010089917,0.0016835941],"category_scores_gemma":[0.0010913039,0.0007076589,0.0009970507,0.0005366492,0.0009728604,0.00057804794,0.0003155157,0.0031762726,0.0005643952],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5703619,0.14381899,0.018821875,0.001389585,0.0029082128,0.0008741978,0.00068093964,0.0057980577,0.10198641,0.00034976436,0.0046895165,0.14832056],"study_design_scores_gemma":[0.3943685,0.5779862,0.0157575,0.00004362851,0.0005520149,0.0005383984,0.000057459067,0.0020653126,0.0056416006,0.000078746176,0.0028773942,0.000033254662],"about_ca_topic_score_codex":0.0010899189,"about_ca_topic_score_gemma":0.0025708352,"teacher_disagreement_score":0.0025599294,"about_ca_system_score_codex":0.0010854076,"about_ca_system_score_gemma":0.0017181842,"threshold_uncertainty_score":0.0078751445},"labels":[],"label_agreement":null},{"id":"W2171079592","doi":"10.1158/1078-0432.ccr-08-0810","title":"Retinoblastoma Tumor Suppressor Gene Expression Determines the Response to Sequential Flavopiridol and Doxorubicin Treatment in Small-Cell Lung Carcinoma","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Doxorubicin; Cancer research; Gene knockdown; Retinoblastoma protein; In vivo; Apoptosis; Cell cycle; Cell growth; Cell culture; Small interfering RNA; Biology; Cell cycle checkpoint; Retinoblastoma; Transfection; Chemotherapy; Gene; Biochemistry","score_opus":0.15630511695266835,"score_gpt":0.5023661816812044,"score_spread":0.34606106472853604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171079592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985417,0.00054582866,0.00028087973,0.000028571938,0.000008333342,0.00002145334,0.00014140797,0.000019262585,0.0004124711],"genre_scores_gemma":[0.9983725,0.00023491003,0.0004721897,0.00001547372,0.0000029953324,0.000026819927,0.00020824243,0.000004752917,0.0006621905],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998741,0.000019300249,0.000014911119,0.000028192466,0.000037643207,0.000025845018],"domain_scores_gemma":[0.9998734,0.000032344415,0.000026634147,0.000012770261,0.000016406693,0.000038480925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014345451,0.00014594535,0.0002727141,0.00023161132,0.00014296932,0.00022115286,0.00013276047,0.00023977121,0.0010342057],"category_scores_gemma":[0.00017438729,0.00014780069,0.00019419797,0.00017383497,0.0002103196,0.00018348481,0.0000936653,0.00033489388,0.00028673979],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029951934,0.00005254149,0.00065707404,0.0000136523095,0.0000030293986,0.000026879494,0.000012503786,0.00006188397,0.99817944,0.000017768192,0.000022108254,0.00065371295],"study_design_scores_gemma":[0.00003325267,0.0009229893,0.016529273,0.0000028128031,0.00001564454,0.00017016674,0.000044420038,0.0010831748,0.9806033,0.000013235882,0.00057801895,0.0000037395237],"about_ca_topic_score_codex":0.0013712138,"about_ca_topic_score_gemma":0.0020605824,"teacher_disagreement_score":0.0013712138,"about_ca_system_score_codex":0.000560057,"about_ca_system_score_gemma":0.0002644246,"threshold_uncertainty_score":0.0040635467},"labels":[],"label_agreement":null},{"id":"W2171351296","doi":"10.1158/1078-0432.ccr-04-2145","title":"A Phase II, Pharmacokinetic, and Biological Correlative Study of Oblimersen Sodium and Docetaxel in Patients with Hormone-Refractory Prostate Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Docetaxel; Medicine; Pharmacokinetics; Prostate cancer; Refractory (planetary science); Oncology; Pharmacology; Internal medicine; Pharmacodynamics; Cancer; Peripheral blood mononuclear cell; Gastroenterology; Urology; Chemistry; Biology; In vitro","score_opus":0.167860845813344,"score_gpt":0.5188297234039012,"score_spread":0.35096887759055717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171351296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987789,0.00048746102,0.00013919454,0.000053330816,0.000015754189,0.00024863452,0.000061877334,0.000010425006,0.0002044584],"genre_scores_gemma":[0.99723744,0.00044656772,0.00075949787,0.00017238341,0.00006962754,0.0004393895,0.0003484119,0.000006648086,0.0005198028],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995121,0.00026246806,0.000020880336,0.00007176387,0.00006311813,0.00006971671],"domain_scores_gemma":[0.9991167,0.00019178198,0.00021060318,0.000070878654,0.000041096835,0.00036898226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001006425,0.0008112824,0.001671148,0.00023381635,0.0003045169,0.0005215433,0.0004742497,0.0005382213,0.0011260288],"category_scores_gemma":[0.0010490288,0.00041363813,0.00061348215,0.0003077196,0.0008676035,0.00046566097,0.00023681943,0.0016020882,0.00029717857],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5463953,0.08524323,0.074854605,0.000590878,0.0013042057,0.00072559604,0.0010463845,0.0048481897,0.12716879,0.0002556135,0.0016728498,0.1558943],"study_design_scores_gemma":[0.14654723,0.78201884,0.057426635,0.000017526245,0.00039876296,0.00084214483,0.00013145486,0.0015620863,0.008187767,0.00009334329,0.002742178,0.000032041993],"about_ca_topic_score_codex":0.0006818999,"about_ca_topic_score_gemma":0.0012248532,"teacher_disagreement_score":0.001671148,"about_ca_system_score_codex":0.00071322866,"about_ca_system_score_gemma":0.001590907,"threshold_uncertainty_score":0.005322516},"labels":[],"label_agreement":null},{"id":"W2171459779","doi":"10.1158/1078-0432.ccr-09-2917","title":"Targeting the Cytoprotective Chaperone, Clusterin, for Treatment of Advanced Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Clusterin; Medicine; Cancer research; Prostate cancer; Docetaxel; Gene knockdown; Cancer; Prostate; Oncology; Internal medicine; Apoptosis; Biology","score_opus":0.24486042154164997,"score_gpt":0.5755378547747337,"score_spread":0.33067743323308374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171459779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4944357,0.45815694,0.0153434295,0.0092389295,0.00077124423,0.0003501297,0.00038801922,0.0005701629,0.020745398],"genre_scores_gemma":[0.84807247,0.12688181,0.0099908,0.00084034697,0.0003194939,0.00012701168,0.0004639308,0.00004331934,0.01326086],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999666,0.000006308745,0.0000012206627,0.000005650756,0.00001193743,0.000008262147],"domain_scores_gemma":[0.9999732,0.0000032688845,0.000005688588,0.0000017758013,0.000004445916,0.000011600758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012180201,0.00023664182,0.00020502547,0.00025748493,0.00017581263,0.00019450429,0.0001444275,0.00018098202,0.0015488672],"category_scores_gemma":[0.000059508664,0.000050387953,0.00016054919,0.00022094927,0.0002570834,0.000120510864,0.00020453832,0.0004854556,0.00035294262],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002476327,0.0006579964,0.001242779,0.001145923,0.00009084551,0.0002953399,0.00011021237,0.0018681961,0.5567254,0.0041787424,0.02146828,0.40973988],"study_design_scores_gemma":[0.00174891,0.009671374,0.015166888,0.00019535943,0.0002361498,0.003456212,0.00013662949,0.004877467,0.4724462,0.003722132,0.48826945,0.000073247174],"about_ca_topic_score_codex":0.0009332093,"about_ca_topic_score_gemma":0.0024736077,"teacher_disagreement_score":0.0015488672,"about_ca_system_score_codex":0.0004937344,"about_ca_system_score_gemma":0.00036740754,"threshold_uncertainty_score":0.005181432},"labels":[],"label_agreement":null},{"id":"W2172101615","doi":"10.1158/1078-0432.ccr-07-4150","title":"Mitogen-Activated Protein Kinase Activation in Lung Adenocarcinoma: A Comparative Study between Ever Smokers and Never Smokers","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Kinase; Adenocarcinoma; Medicine; MAPK/ERK pathway; Lung cancer; p38 mitogen-activated protein kinases; Protein kinase A; Internal medicine; Cisplatin; Lung; Cancer; Biology; Chemotherapy; Biochemistry","score_opus":0.35111240558703977,"score_gpt":0.5603538008838003,"score_spread":0.2092413952967605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172101615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993724,0.00037740867,0.00005030491,0.0000059623103,0.0000027672158,0.000002422935,0.000033687487,0.0000012164382,0.00015385127],"genre_scores_gemma":[0.99956614,0.00016276736,0.00004239486,0.0000102352315,0.0000096928325,0.0000037004243,0.00008315453,0.0000014091851,0.00012044413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997477,0.000053102973,0.000021886142,0.00006715317,0.00006227841,0.00004780934],"domain_scores_gemma":[0.9994791,0.00015944903,0.00011794937,0.000030287656,0.00006377477,0.00014946958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038941004,0.00014054576,0.00026171107,0.00060552923,0.00024393096,0.00034450143,0.00012801819,0.00030648903,0.0011912691],"category_scores_gemma":[0.0007823872,0.00015921994,0.00020936383,0.00027124563,0.00021461192,0.00031590578,0.00023352673,0.00018825333,0.00022315687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000678878,0.000046617457,0.99278224,0.000015578304,0.00005783561,0.00012340334,0.00010230993,0.000011051466,0.0032503551,0.000013095846,0.000018931862,0.0028997492],"study_design_scores_gemma":[0.000008037976,0.00040803186,0.99803036,0.0000027098938,0.00003233653,0.0008401207,0.00012688378,0.00005437753,0.00030253836,0.000011308359,0.0001813876,0.0000018749776],"about_ca_topic_score_codex":0.0006046745,"about_ca_topic_score_gemma":0.00094424875,"teacher_disagreement_score":0.0011912691,"about_ca_system_score_codex":0.00011479777,"about_ca_system_score_gemma":0.00009302451,"threshold_uncertainty_score":0.0039851665},"labels":[],"label_agreement":null},{"id":"W2172126351","doi":"10.1158/1078-0432.ccr-07-0688","title":"Inflammatory Breast Cancer as a Model Disease to Study Tumor Angiogenesis: Results of a Phase IB Trial of Combination SU5416 and Doxorubicin","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources; National Cancer Institute; National Institutes of Health","keywords":"Medicine; Doxorubicin; Breast cancer; Internal medicine; Cancer; Angiogenesis; Mastectomy; Oncology; Urology; Chemotherapy; Surgery","score_opus":0.1167378232532578,"score_gpt":0.5094048077838809,"score_spread":0.3926669845306231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172126351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975981,0.0011883476,0.00022813062,0.000119490585,0.000028339253,0.0003449183,0.00008735101,0.000011059849,0.00039421217],"genre_scores_gemma":[0.995027,0.0014821806,0.0013595457,0.00016761295,0.0000791183,0.0006303407,0.00052283006,0.000009455589,0.00072196627],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99938977,0.00035125445,0.00003370382,0.000052102223,0.0000733825,0.00009971485],"domain_scores_gemma":[0.9994605,0.00011301374,0.00011341939,0.00007486068,0.000035234036,0.00020297553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019132147,0.0009183038,0.0012693348,0.00028618373,0.00033791145,0.0005150096,0.0004442118,0.00051556906,0.0010032959],"category_scores_gemma":[0.0005577546,0.0003195961,0.00053387217,0.00028470383,0.00074414915,0.00037343803,0.00020750823,0.0018213954,0.00022806569],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23218986,0.12900077,0.018921541,0.0009132845,0.0009948899,0.00052371743,0.00041933008,0.0038580445,0.51885134,0.00044185686,0.00174881,0.09213657],"study_design_scores_gemma":[0.077925906,0.8267853,0.021018539,0.000049047896,0.00075823383,0.00090580364,0.00008939909,0.001994816,0.066853255,0.00010071359,0.0034931432,0.000025772168],"about_ca_topic_score_codex":0.00056236616,"about_ca_topic_score_gemma":0.0013455988,"teacher_disagreement_score":0.0019132147,"about_ca_system_score_codex":0.00057852885,"about_ca_system_score_gemma":0.00078876555,"threshold_uncertainty_score":0.0101181865},"labels":[],"label_agreement":null},{"id":"W2176023620","doi":"10.1158/1078-0432.ccr-15-0190","title":"Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; U.S. Army; China Scholarship Council","keywords":"Prostate cancer; Cancer; Castration; Cancer stem cell; Medicine; Prostate; Cancer research; Stem cell; Oncology; Biology; Internal medicine; Hormone; Genetics","score_opus":0.40711258571478265,"score_gpt":0.5514625435392363,"score_spread":0.14434995782445365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2176023620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94935447,0.03834542,0.007590092,0.0004005358,0.00012834709,0.00027063242,0.000267643,0.0004604196,0.0031824263],"genre_scores_gemma":[0.9822505,0.0116009945,0.0034773306,0.00009158785,0.000051535168,0.00007557925,0.00030819708,0.000024841764,0.0021194443],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998946,0.000014462824,0.000005985679,0.000014192274,0.000053433996,0.000017384313],"domain_scores_gemma":[0.9999609,0.0000042240067,0.000012820606,0.0000049171226,0.000004819976,0.000012301374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017831771,0.00041035848,0.00038783238,0.00056049944,0.0001507086,0.00021734685,0.00025931842,0.00019668273,0.0008819868],"category_scores_gemma":[0.000059522514,0.000117767384,0.00029791726,0.00029090015,0.00023739049,0.0001146877,0.00014378922,0.0005118635,0.0002033752],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031807087,0.0002772341,0.0010480921,0.0005356807,0.00004561753,0.00021610745,0.00004319858,0.0005289226,0.9605346,0.00039303975,0.00042227798,0.035637278],"study_design_scores_gemma":[0.00025701383,0.0066492185,0.010558821,0.000048530666,0.00023763886,0.0018633652,0.000034403944,0.0032515475,0.9566711,0.00019473844,0.020217264,0.000016288293],"about_ca_topic_score_codex":0.00071965606,"about_ca_topic_score_gemma":0.0023106446,"teacher_disagreement_score":0.0008819868,"about_ca_system_score_codex":0.00026876995,"about_ca_system_score_gemma":0.0003513815,"threshold_uncertainty_score":0.0029506087},"labels":[],"label_agreement":null},{"id":"W2179851135","doi":"10.1158/1078-0432.ccr-15-1253","title":"The Opposing Function of STAT3 as an Oncoprotein and Tumor Suppressor Is Dictated by the Expression Status of STAT3β in Esophageal Squamous Cell Carcinoma","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Medical Association; Alberta Cancer Foundation; University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Cancer research; STAT3; CD44; Biology; Medicine; Cell; Phosphorylation; Cell biology","score_opus":0.17645243510206632,"score_gpt":0.47771892773123925,"score_spread":0.30126649262917293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2179851135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99861884,0.0008685251,0.00023563353,0.000017989927,0.0000023992445,0.0000030042688,0.00005871248,0.000005123218,0.00018981111],"genre_scores_gemma":[0.9994917,0.00020210202,0.00008352354,0.000011620445,0.0000014400296,0.0000033962604,0.00009035011,0.0000012920856,0.00011459696],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999168,0.000012910317,0.000008723469,0.000015859016,0.000027898974,0.000017807351],"domain_scores_gemma":[0.99994683,0.0000073565084,0.00001869432,0.0000046808914,0.0000070205397,0.000015382133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015335242,0.00014280979,0.00015027623,0.00025997293,0.00014498786,0.0001904974,0.000071999166,0.00012616116,0.00056702376],"category_scores_gemma":[0.000088098284,0.00009289685,0.00019782172,0.00024052979,0.00026223456,0.00012882371,0.00010332012,0.00019158049,0.00013129432],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093079946,0.000035635465,0.044399966,0.0000720917,0.000026123831,0.0002006822,0.00005766439,0.00020069061,0.94952196,0.00011202258,0.000060503324,0.00438185],"study_design_scores_gemma":[0.000058517904,0.0010031046,0.5454636,0.000017831591,0.00012639591,0.0025690251,0.00027774528,0.0025663804,0.44567996,0.00025787874,0.0019693503,0.000010206545],"about_ca_topic_score_codex":0.00036613044,"about_ca_topic_score_gemma":0.00055429206,"teacher_disagreement_score":0.00056702376,"about_ca_system_score_codex":0.0002555572,"about_ca_system_score_gemma":0.00015384408,"threshold_uncertainty_score":0.0018968582},"labels":[],"label_agreement":null},{"id":"W2181264562","doi":"10.1158/1078-0432.ccr-15-0256","title":"Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Research Canada","funders":"National Institute of General Medical Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Prostate cancer; Medicine; Oncology; Metastasis; Internal medicine; Prostatectomy; Cancer","score_opus":0.16251123600554596,"score_gpt":0.4444655447820131,"score_spread":0.28195430877646716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2181264562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99929845,0.00019104371,0.0002079059,0.000017548275,0.000002708833,0.0000020907682,0.00009156478,0.0000041892217,0.00018440092],"genre_scores_gemma":[0.9996131,0.000065902226,0.000118111406,0.0000108060885,0.0000053371054,0.0000015373503,0.00007592552,0.0000030042586,0.00010633236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975806,0.00006914033,0.00001650687,0.00008293866,0.000044074946,0.000029149156],"domain_scores_gemma":[0.99943835,0.00013926812,0.0002830638,0.00004064274,0.000028825187,0.00006986305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027856373,0.0002134585,0.00023954659,0.00029055367,0.00019328945,0.0002288455,0.00018815321,0.0002258634,0.0016843877],"category_scores_gemma":[0.0009579828,0.000116744544,0.00022666917,0.00044367966,0.00025809227,0.00010522569,0.00018773369,0.0002401036,0.000121628495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000611801,0.000032225133,0.97966385,0.000015230644,0.00020055896,0.00028477487,0.00008774909,0.00016178517,0.014495292,0.00009934053,0.00009150692,0.0042559276],"study_design_scores_gemma":[0.0000129627015,0.00012055294,0.9969252,0.0000043196956,0.00006816681,0.0010558793,0.000047062218,0.00039354278,0.0010391903,0.00010418064,0.00022474387,0.000004240126],"about_ca_topic_score_codex":0.0013702465,"about_ca_topic_score_gemma":0.0017211288,"teacher_disagreement_score":0.0016843877,"about_ca_system_score_codex":0.00010467296,"about_ca_system_score_gemma":0.00012955964,"threshold_uncertainty_score":0.0056348443},"labels":[],"label_agreement":null},{"id":"W2182708897","doi":"10.1158/1078-0432.ccr-15-0481","title":"Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":353,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University; Princess Margaret Cancer Centre","funders":"National Cancer Institute; F. Hoffmann-La Roche","keywords":"Medicine; Leukemia; Chronic lymphocytic leukemia; Internal medicine; Refractory (planetary science); Oncology; Clinical trial; Adverse effect; Chronic myelogenous leukemia; Pharmacodynamics; Acute promyelocytic leukemia; Acute lymphocytic leukemia; Pharmacokinetics; Immunology; Pharmacology; Cancer research; Biology; Retinoic acid; Lymphoblastic Leukemia; Cell culture","score_opus":0.402294990732033,"score_gpt":0.5563611615816644,"score_spread":0.15406617084963137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2182708897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991033,0.0033047064,0.0007190406,0.00041940785,0.00008458115,0.0011891186,0.0014551203,0.00010179275,0.0016932089],"genre_scores_gemma":[0.99126863,0.0015867314,0.0010288047,0.00048660414,0.00012191089,0.0006831385,0.00350803,0.0000251251,0.0012909375],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995554,0.0002310859,0.00003430222,0.000054185166,0.00004935117,0.00007560553],"domain_scores_gemma":[0.99930084,0.00014588503,0.00013678672,0.0000718173,0.00005443995,0.00029022113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011728967,0.0010387037,0.0015106753,0.0002751311,0.00028653617,0.00050339673,0.0004642668,0.000674705,0.0021827207],"category_scores_gemma":[0.00083985395,0.00027599314,0.000784958,0.00023710117,0.00048310545,0.00039932746,0.00021808855,0.00167811,0.0005259845],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6357843,0.037846852,0.013963384,0.0009630044,0.0016674171,0.00046314028,0.0002222133,0.0043172985,0.1257879,0.00026144055,0.0077259424,0.1709972],"study_design_scores_gemma":[0.31479573,0.62300515,0.035330456,0.00006780027,0.0010769721,0.0008407464,0.000047174402,0.0014619502,0.01787504,0.00023721604,0.0052248137,0.000036985824],"about_ca_topic_score_codex":0.00054161344,"about_ca_topic_score_gemma":0.0008131454,"teacher_disagreement_score":0.0021827207,"about_ca_system_score_codex":0.00049402064,"about_ca_system_score_gemma":0.00087856385,"threshold_uncertainty_score":0.0073019266},"labels":[],"label_agreement":null},{"id":"W2184282455","doi":"10.1158/1078-0432.ccr-15-1235","title":"Multimodal Image-Guided Surgical and Photodynamic Interventions in Head and Neck Cancer: From Primary Tumor to Metastatic Drainage","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Princess Margaret Cancer Foundation","keywords":"Medicine; Positron emission tomography; Head and neck cancer; Primary tumor; Photodynamic therapy; Metastasis; Cancer; Radiology; Lymphatic system; Fluorescence-lifetime imaging microscopy; Multimodal therapy; Head and neck squamous-cell carcinoma; Lymph; Pathology; Radiation therapy; Internal medicine","score_opus":0.268035425114945,"score_gpt":0.561841403148284,"score_spread":0.293805978033339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2184282455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92684305,0.037811384,0.03075051,0.0005211789,0.000076295284,0.00019049656,0.00008158349,0.00019585181,0.0035296811],"genre_scores_gemma":[0.9861266,0.00475519,0.00799504,0.00012436902,0.000024816845,0.00007023923,0.000035773217,0.000008808447,0.00085922313],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992955,0.000015072707,0.0000036331878,0.00001801596,0.000020316385,0.000013498041],"domain_scores_gemma":[0.99996865,0.000007769524,0.000010171265,0.0000032377202,0.0000055261617,0.0000046890177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016534569,0.00024837544,0.00016785445,0.00024418064,0.00013981128,0.00023737915,0.00019885939,0.00028245896,0.00051089254],"category_scores_gemma":[0.00016877294,0.00011883737,0.00016695673,0.00012237397,0.00036084055,0.00022872248,0.00023876947,0.00025970762,0.00011268095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046423697,0.000102864855,0.004250545,0.0005293749,0.00002250542,0.0008720354,0.00008799471,0.00079660036,0.89668506,0.00036443674,0.00057299645,0.09525131],"study_design_scores_gemma":[0.00011540102,0.0022704531,0.029580574,0.00010744808,0.0002298109,0.01057269,0.00018868771,0.014409441,0.9252294,0.00054490607,0.016713507,0.000037651986],"about_ca_topic_score_codex":0.0010215908,"about_ca_topic_score_gemma":0.0015283005,"teacher_disagreement_score":0.0010215908,"about_ca_system_score_codex":0.00041955512,"about_ca_system_score_gemma":0.0003677389,"threshold_uncertainty_score":0.0030441284},"labels":[],"label_agreement":null},{"id":"W2184558141","doi":"10.1158/1078-0432.ccr-15-2023","title":"Toward Personalized Lymphoma Immunotherapy: Identification of Common Driver Mutations Recognized by Patient CD8+ T Cells","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; University of Victoria; Simon Fraser University; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Canada's Michael Smith Genome Sciences Centre","keywords":"Follicular lymphoma; Lymphoma; CD8; Biology; Immunogenicity; Immunology; Immunotherapy; Cancer research; Antigen; Immune system","score_opus":0.26599864206247,"score_gpt":0.5073295551678475,"score_spread":0.24133091310537752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2184558141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931288,0.0012794958,0.004098791,0.00020046295,0.000007772874,0.00006280744,0.000048503898,0.000075296804,0.0010980662],"genre_scores_gemma":[0.9963607,0.00033537237,0.0027173313,0.00022706091,0.000029543675,0.000029074272,0.00007776303,0.0000066820076,0.00021637868],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979705,0.00006468688,0.000016384567,0.000054501015,0.00003801618,0.00002940757],"domain_scores_gemma":[0.9998529,0.000060631755,0.000032040825,0.000018074948,0.000017107908,0.000019139403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039476543,0.00028716604,0.0003009074,0.00030123434,0.00015541256,0.00044202965,0.00015994212,0.00044656178,0.0011736233],"category_scores_gemma":[0.0005056047,0.000119786666,0.00013304435,0.00013748252,0.00019517979,0.00024328135,0.00021958543,0.00042766263,0.00042026705],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013637224,0.00039611754,0.23174894,0.00029776167,0.00006050463,0.0020511667,0.00047643392,0.002150613,0.63803273,0.0004146868,0.0011222031,0.121885225],"study_design_scores_gemma":[0.0004791535,0.005358701,0.39068672,0.000266203,0.00043733066,0.051818177,0.0009201708,0.026043687,0.50111604,0.0028815363,0.019946946,0.000045313518],"about_ca_topic_score_codex":0.000150627,"about_ca_topic_score_gemma":0.00019578554,"teacher_disagreement_score":0.0011736233,"about_ca_system_score_codex":0.00021535353,"about_ca_system_score_gemma":0.00014517212,"threshold_uncertainty_score":0.003926158},"labels":[],"label_agreement":null},{"id":"W2185706465","doi":"10.1158/1078-0432.ccr-15-1250","title":"The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Prostate cancer; Prostatectomy; Medicine; Oncology; Cancer; Biomarker; Prostate; Internal medicine; Biology; Bioinformatics; Computational biology; Genetics","score_opus":0.21574197886550836,"score_gpt":0.508185454731571,"score_spread":0.29244347586606256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2185706465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99558264,0.0016397686,0.0018412904,0.00011675714,0.0000059791764,0.000009473274,0.0005031024,0.000044714987,0.00025640964],"genre_scores_gemma":[0.9982553,0.00028987628,0.00073355006,0.000037702343,0.000011385182,0.0000068725008,0.0005560502,0.000008632379,0.0001005159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995104,0.00009597741,0.000035170866,0.00011860346,0.00016479766,0.000075105985],"domain_scores_gemma":[0.9986702,0.00031182988,0.0006643279,0.0001014273,0.00013639386,0.00011585172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006130017,0.0002681889,0.00059636065,0.0007777065,0.00028453203,0.00074502546,0.00028178384,0.0003011453,0.0008189112],"category_scores_gemma":[0.0016069172,0.00014469132,0.00022782444,0.0012081427,0.0004165153,0.00036571638,0.00042098016,0.0003737552,0.00018603286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010474874,0.00005237052,0.9018698,0.00017836985,0.00017537201,0.000427763,0.00015432767,0.0019433884,0.064812034,0.0004505786,0.00044778097,0.028440785],"study_design_scores_gemma":[0.00002605296,0.00038986883,0.97130954,0.00002768659,0.00021544138,0.002110288,0.00028446075,0.0052979398,0.01623687,0.0015623379,0.002510464,0.000028974982],"about_ca_topic_score_codex":0.00058690854,"about_ca_topic_score_gemma":0.00086236,"teacher_disagreement_score":0.0008189112,"about_ca_system_score_codex":0.00032098914,"about_ca_system_score_gemma":0.0003944852,"threshold_uncertainty_score":0.0032418966},"labels":[],"label_agreement":null},{"id":"W2185778972","doi":"10.1158/1078-0432.ccr-15-0916","title":"A Supplemented High-Fat Low-Carbohydrate Diet for the Treatment of Glioblastoma","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Diet and metabolism studies","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"Clonogenic assay; In vivo; Population; Cancer research; Cancer; Biology; Neurosphere; Stem cell; Pharmacology; Medicine; In vitro; Internal medicine; Biochemistry; Cell biology; Biotechnology; Adult stem cell","score_opus":0.3180853962030638,"score_gpt":0.5431670512723747,"score_spread":0.22508165506931094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2185778972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98903954,0.0062931473,0.0020034476,0.00035222378,0.0001548936,0.00017088512,0.0003691413,0.00011014008,0.0015065775],"genre_scores_gemma":[0.98370206,0.0073067877,0.0054774284,0.00043789163,0.000058619764,0.00020559004,0.000983875,0.000026135325,0.0018015094],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99996006,0.000004671245,0.0000053075037,0.000005663062,0.000015017727,0.000009168794],"domain_scores_gemma":[0.99997115,0.0000011891414,0.000009003721,0.0000022254426,0.0000049610726,0.00001138379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005927244,0.00030287926,0.00023995164,0.00039490487,0.00016336405,0.00018586653,0.0002711929,0.00020618604,0.0008558252],"category_scores_gemma":[0.00005197253,0.00004782432,0.00020904468,0.00024548837,0.00016765387,0.00014466292,0.00017760435,0.0004494407,0.00014940697],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005992776,0.0036267154,0.0016560784,0.0009366753,0.00014128533,0.0003710531,0.000028241597,0.0005195458,0.8827459,0.00040164526,0.0012593201,0.1023208],"study_design_scores_gemma":[0.0026657663,0.04920275,0.04816944,0.00045581753,0.0010089745,0.0034207187,0.00014055245,0.0040265694,0.8415326,0.00090749946,0.04837093,0.00009830745],"about_ca_topic_score_codex":0.0007646883,"about_ca_topic_score_gemma":0.0023678704,"teacher_disagreement_score":0.0008558252,"about_ca_system_score_codex":0.00025706037,"about_ca_system_score_gemma":0.00042361452,"threshold_uncertainty_score":0.0028630495},"labels":[],"label_agreement":null},{"id":"W2186638557","doi":"10.1158/1078-0432.ccr-15-0822","title":"New Strategies in Stereotactic Radiotherapy for Oligometastases","year":2015,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; SABR volatility model; Radiation therapy; Radiosurgery; Abscopal effect; Systemic therapy; Clinical trial; Oncology; Randomized controlled trial; Population; Surgery; Cancer; Internal medicine; Immunotherapy","score_opus":0.6590124990815568,"score_gpt":0.672304298957894,"score_spread":0.013291799876337218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2186638557","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000057440757,0.99920005,0.00008213434,0.000120185956,0.000075809505,0.000004440657,0.0000064392984,0.000004133546,0.00044941998],"genre_scores_gemma":[0.00042550094,0.99893767,0.00018366228,0.000136278,0.00007042708,0.0000056179542,0.00001446612,0.0000010771381,0.00022540105],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997943,0.000042302065,0.00003945619,0.00003262665,0.000076524375,0.00001476692],"domain_scores_gemma":[0.999803,0.00011325728,0.000032241038,0.000005822992,0.00003547255,0.00001013142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060357735,0.0007571035,0.001277803,0.0029424655,0.0002726889,0.0008031122,0.0008479386,0.00092844904,0.003186363],"category_scores_gemma":[0.0006106741,0.00027479322,0.00075581856,0.0018992859,0.0005080669,0.0014506385,0.00059592427,0.0019942087,0.001124946],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051382827,0.0000743075,0.00012142364,0.03483403,0.0001492111,0.00022405779,0.00009661202,0.0004365962,0.0011289916,0.004296229,0.014805497,0.9437817],"study_design_scores_gemma":[0.000032423995,0.00010724116,0.0008201723,0.007816454,0.00019749287,0.0019244893,0.000083566185,0.00010435667,0.0003764763,0.0028302665,0.9856878,0.000019328914],"about_ca_topic_score_codex":0.0012339766,"about_ca_topic_score_gemma":0.003105819,"teacher_disagreement_score":0.003186363,"about_ca_system_score_codex":0.00059137406,"about_ca_system_score_gemma":0.0008473852,"threshold_uncertainty_score":0.010659456},"labels":[],"label_agreement":null},{"id":"W2189438879","doi":"10.1158/1078-0432.ccr-15-1506","title":"Exposure and Tumor Fn14 Expression as Determinants of Pharmacodynamics of the Anti-TWEAK Monoclonal Antibody RG7212 in Patients with Fn14-Positive Solid Tumors","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Pharmacodynamics; Monoclonal antibody; Cancer research; Solid tumor; Antibody; Medicine; Monoclonal; Cancer; Immunology; Pharmacokinetics; Pharmacology; Internal medicine","score_opus":0.06514888782452963,"score_gpt":0.45943845400067446,"score_spread":0.39428956617614486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2189438879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99955004,0.0001583533,0.00009389347,0.000013528662,0.0000013088022,0.000009613708,0.000045199133,0.000002502195,0.00012564934],"genre_scores_gemma":[0.9997454,0.000031196305,0.000067439956,0.000013726984,0.00000311166,0.0000089068,0.000060095652,7.7550544e-7,0.00006935813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971575,0.00007424,0.00002709356,0.00007077804,0.00006214506,0.000050067094],"domain_scores_gemma":[0.99931204,0.00023304978,0.0002614361,0.0000346615,0.000038711092,0.00012007969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044573628,0.00020485428,0.00042024936,0.00017016064,0.00021337323,0.0003244504,0.00015382838,0.00029311227,0.0008560981],"category_scores_gemma":[0.0009402986,0.00014642207,0.00029162352,0.00019445775,0.00023853853,0.00028150593,0.00016285267,0.00042614123,0.00014901641],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014442175,0.00041226207,0.9402912,0.00005752907,0.00014637031,0.00066759397,0.00016477994,0.0008743809,0.02541652,0.00005617123,0.00014522625,0.01732564],"study_design_scores_gemma":[0.00013957465,0.006743876,0.9859023,0.00000606483,0.00009035669,0.0012492709,0.00007870093,0.0011845812,0.0040798057,0.00004454357,0.00047114625,0.000009712981],"about_ca_topic_score_codex":0.0003809424,"about_ca_topic_score_gemma":0.0005269249,"teacher_disagreement_score":0.0008560981,"about_ca_system_score_codex":0.0003435377,"about_ca_system_score_gemma":0.00023995072,"threshold_uncertainty_score":0.0028639436},"labels":[],"label_agreement":null},{"id":"W2191511762","doi":"10.1158/1078-0432.ccr-15-1349","title":"Gemtuzumab Ozogamicin Reduces Relapse Risk in <i>FLT3</i> /ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; Alex's Lemonade Stand Foundation for Childhood Cancer","keywords":"Gemtuzumab ozogamicin; Medicine; Oncology; Myeloid leukemia; Internal medicine; Leukemia; Calicheamicin; Biology; CD33","score_opus":0.1479212835732433,"score_gpt":0.48909489567443043,"score_spread":0.34117361210118713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2191511762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986032,0.012142223,0.00025155587,0.00061659975,0.000028640536,0.0000593872,0.00023364814,0.000019394796,0.0006165097],"genre_scores_gemma":[0.9933984,0.004687637,0.00057798624,0.00042104008,0.00005918561,0.000037910737,0.00046137496,0.000008935095,0.00034746274],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99983215,0.000072961855,0.0000146411585,0.000025253517,0.00003386795,0.000021086284],"domain_scores_gemma":[0.99971527,0.00012156643,0.00008146739,0.000022408447,0.000025501133,0.00003372039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082729285,0.0002135053,0.00026980796,0.00014002167,0.00007536174,0.00024890102,0.00014034047,0.00016648188,0.0003881344],"category_scores_gemma":[0.00088197365,0.00005757945,0.0004346991,0.0001526015,0.00018046316,0.000118975695,0.00010251371,0.0005099448,0.00005130704],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050749328,0.0025977124,0.15257415,0.001135928,0.0026041332,0.00036532996,0.0002760342,0.0030282703,0.07107612,0.00046217503,0.009648425,0.70548236],"study_design_scores_gemma":[0.014724306,0.06494026,0.83628213,0.00033030595,0.004428902,0.0019026375,0.00015596129,0.0036813503,0.040848188,0.00032682333,0.032336555,0.000042652042],"about_ca_topic_score_codex":0.0013586702,"about_ca_topic_score_gemma":0.0025728093,"teacher_disagreement_score":0.0013586702,"about_ca_system_score_codex":0.00052511465,"about_ca_system_score_gemma":0.00032757962,"threshold_uncertainty_score":0.0043752193},"labels":[],"label_agreement":null},{"id":"W2192572578","doi":"10.1158/1078-0432.ccr-15-1681","title":"A Phase I Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Combination Therapy with Refametinib plus Sorafenib in Patients with Advanced Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Cancer Institute; Bayer HealthCare","keywords":"Sorafenib; Pharmacokinetics; Medicine; Tolerability; Pharmacodynamics; Dosing; Pharmacology; Internal medicine; Hepatocellular carcinoma; Adverse effect; Cancer; Oncology; Gastroenterology","score_opus":0.11807690024990147,"score_gpt":0.47949471591080817,"score_spread":0.3614178156609067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2192572578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99733424,0.0006619161,0.00044164495,0.00011813549,0.000035614088,0.0006496374,0.00022302789,0.000034795325,0.0005008322],"genre_scores_gemma":[0.99507624,0.0006422357,0.0016954837,0.00021068854,0.000102625396,0.00072086614,0.00085754495,0.00001677811,0.0006775124],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99934834,0.000299126,0.000039384766,0.000124707,0.00009631382,0.00009215228],"domain_scores_gemma":[0.9991999,0.00013047142,0.00020461364,0.000106784624,0.000049401933,0.00030881775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013187319,0.0015351307,0.0020287654,0.00037437887,0.00034212836,0.00067641377,0.00080979057,0.00065791915,0.0018297902],"category_scores_gemma":[0.00088905945,0.00070258474,0.0011339745,0.00042449514,0.0007450155,0.00071143307,0.00030187517,0.0024074719,0.0005214419],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5130092,0.13258411,0.018751293,0.0008086016,0.0017547872,0.00058708206,0.00044125106,0.005850504,0.1561683,0.0002552259,0.002383158,0.16740653],"study_design_scores_gemma":[0.23054376,0.7365344,0.018129667,0.000020077394,0.00040190155,0.00065499503,0.00004177371,0.0021344402,0.009396119,0.00009428811,0.0020072132,0.00004135391],"about_ca_topic_score_codex":0.00045997163,"about_ca_topic_score_gemma":0.001079156,"teacher_disagreement_score":0.0020287654,"about_ca_system_score_codex":0.00076611247,"about_ca_system_score_gemma":0.0013671364,"threshold_uncertainty_score":0.0069742203},"labels":[],"label_agreement":null},{"id":"W2192931230","doi":"10.1158/1078-0432.ccr-15-1221","title":"A Phase I First-in-Human Study of Nesvacumab (REGN910), a Fully Human Anti–Angiopoietin-2 (Ang2) Monoclonal Antibody, in Patients with Advanced Solid Tumors","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pharmacokinetics; Tolerability; Response Evaluation Criteria in Solid Tumors; Peripheral edema; Pharmacodynamics; Adverse effect; Internal medicine; Angiopoietin receptor; Gastroenterology; Refractory (planetary science); Antibody; Pharmacology; Toxicity; Oncology; Angiogenesis; Phases of clinical research; Immunology","score_opus":0.11567495151876894,"score_gpt":0.5107361207049393,"score_spread":0.3950611691861704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2192931230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993922,0.001175735,0.00075060147,0.00016550938,0.00006415118,0.0021225067,0.00068150944,0.000057296074,0.0010608138],"genre_scores_gemma":[0.99092394,0.0012525686,0.0016694305,0.0004335617,0.000109822584,0.0016830553,0.00173427,0.000030384455,0.0021629422],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995915,0.00020574049,0.00001730277,0.00006805695,0.000039689392,0.00007769872],"domain_scores_gemma":[0.9994579,0.000094461386,0.000109815024,0.000055098528,0.000040537936,0.00024222622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012471938,0.0017885913,0.0014440846,0.0003045395,0.00039058801,0.00069901336,0.0005751331,0.0008507574,0.0025626887],"category_scores_gemma":[0.0006438982,0.0006149509,0.00089536095,0.0002279633,0.00090626214,0.0006851569,0.00024494197,0.002477252,0.00059967814],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5267737,0.16488265,0.010070244,0.0014540345,0.0017853105,0.00071969803,0.00072829373,0.0060494617,0.15856516,0.00048244523,0.0052703717,0.12321871],"study_design_scores_gemma":[0.35061038,0.6193421,0.012419611,0.000031415744,0.00032100762,0.0005703826,0.0000608657,0.0015376043,0.011648722,0.00017262567,0.0032521572,0.00003320218],"about_ca_topic_score_codex":0.0006172907,"about_ca_topic_score_gemma":0.0015916403,"teacher_disagreement_score":0.0025626887,"about_ca_system_score_codex":0.00094209163,"about_ca_system_score_gemma":0.0011771091,"threshold_uncertainty_score":0.008573115},"labels":[],"label_agreement":null},{"id":"W2193707124","doi":"10.1158/1078-0432.ccr-15-2123","title":"Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":227,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Quebec - Clinical Research Organization in Cancer; Dalhousie University; University of British Columbia; McGill University; McGill Genome Centre; Hôpital du Sacré-Cœur de Montréal; Concordia University; BC Cancer Agency; Simon Fraser University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Cancer research; Exome sequencing; Biology; Mutation; Lymphoma; Diffuse large B-cell lymphoma; Cancer; Gene; Somatic evolution in cancer; Exome; Oncology; Medicine; Genetics; Immunology","score_opus":0.1875933151340006,"score_gpt":0.48015110530225413,"score_spread":0.29255779016825356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2193707124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999438,0.00019835576,0.00006431904,0.000012553361,3.198757e-7,0.0000025174334,0.000086476975,0.0000043905866,0.00019302736],"genre_scores_gemma":[0.9996486,0.000084231346,0.00006047357,0.000012355427,0.0000010130371,0.0000027118813,0.0001393038,0.000002347784,0.000049023314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998561,0.000030180898,0.000012684373,0.000037228223,0.000038072776,0.000025854215],"domain_scores_gemma":[0.99986506,0.00002781523,0.00006580766,0.0000074294467,0.0000096980075,0.000024229219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013004348,0.00013871692,0.00019669472,0.0007424226,0.00015717512,0.0003392434,0.0001526795,0.00025495002,0.00093165995],"category_scores_gemma":[0.0003932594,0.00009953421,0.00010757613,0.0004303706,0.00024966706,0.00014079499,0.00027571278,0.00011144249,0.00014491059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016110333,0.000110669855,0.5277109,0.00014342423,0.0001703499,0.003491778,0.0004918247,0.0014149554,0.44256213,0.0004705822,0.00023751699,0.021584803],"study_design_scores_gemma":[0.00003733504,0.00029698052,0.9739007,0.000014172486,0.00007557424,0.010665118,0.00044217528,0.0015297551,0.01154466,0.00043030333,0.0010528774,0.000010362051],"about_ca_topic_score_codex":0.00035165073,"about_ca_topic_score_gemma":0.0004763708,"teacher_disagreement_score":0.00093165995,"about_ca_system_score_codex":0.00023272788,"about_ca_system_score_gemma":0.000077551784,"threshold_uncertainty_score":0.0031166673},"labels":[],"label_agreement":null},{"id":"W2203142821","doi":"10.1158/1078-0432.ccr-15-0124","title":"Failures in Phase III: Causes and Consequences","year":2015,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Clinical trial; Randomized controlled trial; Drug development; Phases of clinical research; Population; Intensive care medicine; Cancer; Oncology; Pharmacology; Internal medicine; Drug","score_opus":0.9760698571292453,"score_gpt":0.8318534788750754,"score_spread":0.14421637825416989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2203142821","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046281475,0.9089777,0.041656133,0.027441863,0.0031118323,0.0030042524,0.0008832806,0.00025402213,0.010042708],"genre_scores_gemma":[0.1609282,0.6830961,0.064562075,0.067378215,0.005468837,0.011842325,0.0011131738,0.0006373257,0.004973811],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.80839866,0.12677954,0.029987508,0.0079028485,0.025431411,0.0015000934],"domain_scores_gemma":[0.47473648,0.44905818,0.041943725,0.017201776,0.014942869,0.0021169302],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.23763482,0.0017429546,0.0053265383,0.002397139,0.0011513978,0.0035237903,0.0038714868,0.004051347,0.008011115],"category_scores_gemma":[0.29658034,0.0014491417,0.0064078784,0.004536293,0.006787505,0.004941353,0.0036601315,0.006987607,0.0023148595],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022040708,0.00023745772,0.005566278,0.07212984,0.0047308467,0.0005922385,0.001098868,0.0026447321,0.00051496574,0.09066025,0.044351455,0.77526903],"study_design_scores_gemma":[0.004128172,0.0028664228,0.010899377,0.11023723,0.0076142694,0.0055801882,0.0010008725,0.004889579,0.0032401236,0.31339642,0.5358744,0.00027289882],"about_ca_topic_score_codex":0.0016454974,"about_ca_topic_score_gemma":0.002025257,"teacher_disagreement_score":0.76236516,"about_ca_system_score_codex":0.004591453,"about_ca_system_score_gemma":0.009437007,"threshold_uncertainty_score":0.940132},"labels":[],"label_agreement":null},{"id":"W2206903933","doi":"10.1158/1078-0432.ccr-15-1853","title":"Combined Antitumor Therapy with Metronomic Topotecan and Hypoxia-Activated Prodrug, Evofosfamide, in Neuroblastoma and Rhabdomyosarcoma Preclinical Models","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Topotecan; Neuroblastoma; Rhabdomyosarcoma; Cancer research; Medicine; In vivo; Pharmacology; Chemotherapy; Cell culture; Internal medicine; Sarcoma; Biology; Pathology","score_opus":0.1878130194153975,"score_gpt":0.4377215972499732,"score_spread":0.24990857783457573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2206903933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956567,0.0020684255,0.0008740875,0.00004790744,0.00003981747,0.0001582734,0.00020441103,0.00003608065,0.00091432873],"genre_scores_gemma":[0.99433583,0.0015415744,0.001977483,0.00002516989,0.000017134067,0.00015419089,0.00049978716,0.00000852122,0.0014403188],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985206,0.000027564321,0.000010536311,0.00003087287,0.00004328894,0.000035710164],"domain_scores_gemma":[0.9999373,0.000006761549,0.000016299584,0.000008193468,0.000008146579,0.000023273136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023219283,0.000566395,0.00076929224,0.00035249523,0.0001397116,0.00019313415,0.0004080581,0.00031185587,0.00076203427],"category_scores_gemma":[0.000081321414,0.00015366053,0.00033869888,0.00019302388,0.00019095678,0.00026468997,0.00017019601,0.0006030664,0.00014181605],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034040355,0.0022006114,0.0010135032,0.00024082247,0.000121660225,0.00013829561,0.000041997842,0.001192533,0.9743853,0.00014979985,0.0002686226,0.016842715],"study_design_scores_gemma":[0.00081869564,0.04385604,0.008384986,0.000020949781,0.00026530444,0.0005861112,0.00004189495,0.0023281712,0.93976253,0.000049376464,0.0038703326,0.000015632635],"about_ca_topic_score_codex":0.0011779089,"about_ca_topic_score_gemma":0.003947133,"teacher_disagreement_score":0.0011779089,"about_ca_system_score_codex":0.00050000974,"about_ca_system_score_gemma":0.0005216671,"threshold_uncertainty_score":0.0036278367},"labels":[],"label_agreement":null},{"id":"W2207200267","doi":"10.1158/1078-0432.ccr-15-0039","title":"Advancing Clinical Trials to Streamline Drug Development","year":2015,"lang":"en","type":"editorial","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University College of the North","funders":"National Cancer Institute; National Institutes of Health","keywords":"Clinical trial; Drug development; Medicine; Intensive care medicine; Clinical study design; Clinical research; Medical physics; Drug; Pharmacology; Internal medicine","score_opus":0.2816678969915981,"score_gpt":0.6088188489688697,"score_spread":0.3271509519772716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2207200267","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000373309,0.02818787,0.00151661,0.09954303,0.8676766,0.000047685968,0.0000352576,0.00016311066,0.002792571],"genre_scores_gemma":[0.0006695458,0.026619414,0.0014776036,0.07375869,0.8872551,0.000051452334,0.000039342944,0.00009287716,0.0100359535],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97664195,0.008407896,0.003018397,0.0018902305,0.009321874,0.0007196489],"domain_scores_gemma":[0.8845649,0.076084524,0.0047737327,0.0038750963,0.022867136,0.007834729],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.041907273,0.0036875934,0.0029722208,0.0033233326,0.0022929714,0.013030133,0.0049913223,0.020986997,0.010577883],"category_scores_gemma":[0.09927173,0.0012738275,0.0031270564,0.0017443573,0.0075022643,0.013476337,0.004302028,0.04828367,0.009983608],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035965528,0.000019300704,0.00003127619,0.0004187417,0.00002623534,0.0000807865,0.000057809608,0.00009704786,0.00007874089,0.004388363,0.9661884,0.028577205],"study_design_scores_gemma":[0.000039119175,0.000025471676,0.000073111645,0.0004177783,0.000019861347,0.000098462435,0.000030269228,0.00013786888,0.00006314957,0.004515792,0.994565,0.000014151903],"about_ca_topic_score_codex":0.0009917865,"about_ca_topic_score_gemma":0.0024806869,"teacher_disagreement_score":0.95809275,"about_ca_system_score_codex":0.005470323,"about_ca_system_score_gemma":0.006894028,"threshold_uncertainty_score":0.22162944},"labels":[],"label_agreement":null},{"id":"W2208384071","doi":"10.1158/1078-0432.ccr-15-2361","title":"Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; University of Chicago; Connaught Fund; Universitätsspital Zürich; Universität Zürich; Berlin Institute of Health; University of Toronto","keywords":"T-cell receptor; Biology; Cancer research; Cancer; Antigen; Targeted therapy; Adoptive cell transfer; Cancer cell; Avidity; T cell; Molecular biology; Immunology; Immune system; Genetics","score_opus":0.22862007228663447,"score_gpt":0.49842278518530214,"score_spread":0.26980271289866764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2208384071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993403,0.0011551881,0.0046170237,0.00006853176,0.000022096248,0.00005524924,0.000049330556,0.00010710824,0.0005225141],"genre_scores_gemma":[0.99609405,0.0006711353,0.0023087931,0.000028116785,0.000016861408,0.00003079863,0.00008185163,0.000013837381,0.0007545166],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998975,0.000010582469,0.000008472396,0.000027898433,0.00002598568,0.000029548424],"domain_scores_gemma":[0.9999137,0.000018627179,0.000034765555,0.000009848859,0.000006758398,0.000016174856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012676169,0.00043703063,0.0002838644,0.0002227179,0.00009808397,0.00020478282,0.00019752902,0.00037460364,0.0007195779],"category_scores_gemma":[0.000108814704,0.00008072917,0.00028002614,0.0001317953,0.00027924046,0.00017281709,0.00013315552,0.0004995396,0.0002447685],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009190277,0.000072485214,0.00021167423,0.00005312902,0.000006586333,0.00007859557,0.000010407986,0.00020108379,0.9965932,0.000085912834,0.000028654315,0.0025663087],"study_design_scores_gemma":[0.00007252668,0.001405416,0.0009644482,0.000007724383,0.000042747222,0.00074480666,0.000008988308,0.0012110309,0.9943504,0.00004880736,0.0011401041,0.0000030593253],"about_ca_topic_score_codex":0.00015745757,"about_ca_topic_score_gemma":0.00015728996,"teacher_disagreement_score":0.0007195779,"about_ca_system_score_codex":0.00017244967,"about_ca_system_score_gemma":0.00017796458,"threshold_uncertainty_score":0.0024072528},"labels":[],"label_agreement":null},{"id":"W2214455720","doi":"10.1158/1078-0432.ccr-14-3215","title":"Next-Generation Sequencing to Guide Clinical Trials","year":2015,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Clinical trial; Medicine; Computational biology; Intensive care medicine; Biology; Pathology","score_opus":0.87215389658377,"score_gpt":0.6872007949276112,"score_spread":0.18495310165615875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2214455720","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046349433,0.92878956,0.027282111,0.02196396,0.0050730687,0.0007410762,0.0006015884,0.00031971972,0.014765466],"genre_scores_gemma":[0.007113441,0.8932536,0.06588946,0.021069396,0.004278934,0.0019006695,0.0009937085,0.00012481828,0.005376081],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926616,0.0044587497,0.00072876754,0.00050438003,0.001471918,0.00017450517],"domain_scores_gemma":[0.9682796,0.02562829,0.0014631463,0.00090846344,0.0030516712,0.0006687917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024956908,0.0013687706,0.0028427287,0.0028337354,0.00033415432,0.0033234183,0.0024650628,0.0036304162,0.010423733],"category_scores_gemma":[0.038555052,0.00058950763,0.0015945709,0.001910184,0.0016199759,0.0030549136,0.0017099346,0.006368164,0.0054081874],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021566213,0.00010595818,0.00037681978,0.009851652,0.00036712384,0.0001524253,0.00009766055,0.0013711764,0.0007292852,0.02050886,0.06710678,0.89911664],"study_design_scores_gemma":[0.00030718802,0.00022425436,0.0008128095,0.015666649,0.00036627392,0.0005517733,0.000089701694,0.0009658669,0.0008227908,0.054833826,0.92529386,0.000064972905],"about_ca_topic_score_codex":0.001317161,"about_ca_topic_score_gemma":0.0018081066,"teacher_disagreement_score":0.024956908,"about_ca_system_score_codex":0.001734337,"about_ca_system_score_gemma":0.0066203736,"threshold_uncertainty_score":0.13198632},"labels":[],"label_agreement":null},{"id":"W2216971459","doi":"10.1158/1078-0432.ccr-15-2239","title":"Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Adipose tissue; Breast cancer; Inflammation; Medicine; Stage (stratigraphy); Cancer; White adipose tissue; Pathology; Oncology; Mammary gland; Systemic inflammation; Internal medicine; Biology","score_opus":0.2086173912445005,"score_gpt":0.5151647425670107,"score_spread":0.3065473513225102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2216971459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99903286,0.00062487466,0.00007844489,0.000014737109,0.0000029953503,0.000004980431,0.00008980483,0.0000017422806,0.00014958874],"genre_scores_gemma":[0.99952376,0.00014369906,0.0000868252,0.000009232544,0.000008973914,0.000005612706,0.0001509254,6.522154e-7,0.0000704072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998235,0.000052402305,0.00001902006,0.000041683925,0.000037764417,0.000025616244],"domain_scores_gemma":[0.99914706,0.00012282123,0.0004988006,0.000057688863,0.00006942008,0.00010411106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004218879,0.00019776062,0.0002200566,0.00048291072,0.00018400673,0.0002975596,0.00014992528,0.00019890034,0.0009596307],"category_scores_gemma":[0.0010910055,0.00013467006,0.00013646559,0.0005572538,0.00019701458,0.00015877499,0.00023800578,0.00024163701,0.00011563759],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003860478,0.000023485349,0.9967269,0.000014707159,0.000030710988,0.00005097836,0.000013084386,0.00003475739,0.0011456325,0.0000070952256,0.00002939804,0.001537299],"study_design_scores_gemma":[0.000010358513,0.00013967427,0.9991491,0.0000040266505,0.000023952625,0.00028121733,0.000030405552,0.00008021224,0.00019808124,0.000015231793,0.000066333094,0.000001422149],"about_ca_topic_score_codex":0.00057602563,"about_ca_topic_score_gemma":0.0012147716,"teacher_disagreement_score":0.0009596307,"about_ca_system_score_codex":0.00010762344,"about_ca_system_score_gemma":0.00014396127,"threshold_uncertainty_score":0.0032103062},"labels":[],"label_agreement":null},{"id":"W2220868592","doi":"10.1158/1078-0432.ccr-14-3246","title":"The Urgent Need for Clinical Research Reform to Permit Faster, Less Expensive Access to New Therapies for Lethal Diseases","year":2015,"lang":"en","type":"editorial","venue":"Clinical Cancer Research","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Wood Council; Jewish General Hospital; Ottawa Hospital","funders":"","keywords":"Intensive care medicine; Medicine","score_opus":0.7134583301985442,"score_gpt":0.6907358896432467,"score_spread":0.022722440555297485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2220868592","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00061477814,0.011797505,0.009651335,0.9587753,0.008144717,0.00021165019,0.00011142454,0.00041445065,0.010278796],"genre_scores_gemma":[0.026557967,0.02318834,0.048319686,0.86226493,0.022943681,0.0010504655,0.00052415015,0.0003893059,0.014761526],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.878358,0.059454497,0.008861101,0.010947913,0.03404104,0.008337542],"domain_scores_gemma":[0.57099026,0.16387755,0.028946683,0.05928679,0.10799713,0.06890161],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.17916743,0.0014850328,0.0027885947,0.0027141438,0.0041882857,0.025556944,0.0064645587,0.025637282,0.030119719],"category_scores_gemma":[0.22039317,0.0011698044,0.002817922,0.003190147,0.021977497,0.029634656,0.010891217,0.043156736,0.019130787],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022525681,0.00058710953,0.001439232,0.002444826,0.00013839296,0.0002995215,0.0009996763,0.00084626046,0.0022627974,0.33972782,0.47248408,0.1785449],"study_design_scores_gemma":[0.0003262486,0.00044783697,0.0019786817,0.0018591939,0.00007199434,0.00041377288,0.0011487204,0.000524401,0.0007245946,0.16172981,0.83066124,0.00011350087],"about_ca_topic_score_codex":0.0023507948,"about_ca_topic_score_gemma":0.0027409235,"teacher_disagreement_score":0.82083255,"about_ca_system_score_codex":0.011190729,"about_ca_system_score_gemma":0.11318811,"threshold_uncertainty_score":0.94753927},"labels":[],"label_agreement":null},{"id":"W2223730291","doi":"10.1158/1078-0432.ccr-15-1071","title":"A Validated Prognostic Multigene Expression Assay for Overall Survival in Resected Colorectal Cancer Liver Metastases","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute; National Institutes of Health","keywords":"Colorectal cancer; Cancer; Medicine; Oncology; Colonic disease; Survival analysis; Internal medicine; Overall survival; Biology; Cancer research; Pathology","score_opus":0.4281226969249695,"score_gpt":0.4948229130398226,"score_spread":0.0667002161148531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2223730291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952195,0.00070054585,0.0026715707,0.000062562234,0.000016570213,0.00004755432,0.0008005263,0.000028027553,0.00045314184],"genre_scores_gemma":[0.9939374,0.00012012965,0.0037485426,0.00005752879,0.000017974113,0.000070297836,0.0017447909,0.0000062332338,0.00029708227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993586,0.0002157768,0.00005192882,0.00013419216,0.0001810652,0.00005844073],"domain_scores_gemma":[0.99912244,0.00026250113,0.0003137634,0.000083704595,0.00015776683,0.000059847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008687584,0.00032406554,0.00023864704,0.00059346436,0.00015409969,0.00031186003,0.00021526177,0.00031846922,0.00063878857],"category_scores_gemma":[0.0018232395,0.000093231596,0.00018281685,0.00041812295,0.0003031043,0.0001310223,0.00021565867,0.00031396854,0.00029163325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019239741,0.00027703628,0.65419525,0.00013593907,0.00020466569,0.00015116006,0.00010357708,0.0018226543,0.31756538,0.00010283476,0.00045064662,0.023066886],"study_design_scores_gemma":[0.0001026482,0.0022952608,0.88550764,0.00002540978,0.00016879613,0.0012326144,0.000075979486,0.0055152248,0.10296638,0.0000908323,0.0019940448,0.0000250271],"about_ca_topic_score_codex":0.0005609914,"about_ca_topic_score_gemma":0.0008781914,"teacher_disagreement_score":0.0008687584,"about_ca_system_score_codex":0.00032118536,"about_ca_system_score_gemma":0.0002251824,"threshold_uncertainty_score":0.004594445},"labels":[],"label_agreement":null},{"id":"W2233214336","doi":"10.1158/1078-0432.ccr-15-1624","title":"The <i>MCT4</i> Gene: A Novel, Potential Target for Therapy of Advanced Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Prostate cancer; DU145; Lactic acid; Cancer research; Glycolysis; Secretion; Cancer; Biology; Internal medicine; Metabolism; Medicine; Endocrinology; Genetics; LNCaP","score_opus":0.0851120495211847,"score_gpt":0.46553372426026896,"score_spread":0.3804216747390843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2233214336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9412409,0.023244625,0.02256689,0.0025249866,0.00034894378,0.00024583994,0.0012804505,0.00055934844,0.007988039],"genre_scores_gemma":[0.9694276,0.010092258,0.010919522,0.000573909,0.00009548075,0.000110433684,0.0010632252,0.00005600266,0.0076616346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999527,0.000006889651,0.0000021645449,0.00000950141,0.000015188161,0.000013611919],"domain_scores_gemma":[0.999962,0.000004280525,0.000014543219,0.0000023268772,0.000006184836,0.000010654729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010742257,0.00028120118,0.00019480869,0.00015744676,0.000100300254,0.00021536998,0.00023058387,0.0002576942,0.0014885602],"category_scores_gemma":[0.000066664434,0.000074812684,0.00019680877,0.00012802564,0.00026946375,0.00015768221,0.00010125093,0.0004201969,0.00037544183],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026090868,0.000039370512,0.0004648256,0.00013275593,0.000007971723,0.000057687306,0.00000854043,0.00023617377,0.99114543,0.00040153024,0.0003683489,0.00687655],"study_design_scores_gemma":[0.00016011238,0.001793271,0.00382505,0.00003221631,0.00008502807,0.0006545409,0.000025222373,0.0017558488,0.96358633,0.00019919487,0.027871443,0.000011691521],"about_ca_topic_score_codex":0.00080377335,"about_ca_topic_score_gemma":0.0012077125,"teacher_disagreement_score":0.0014885602,"about_ca_system_score_codex":0.0004168494,"about_ca_system_score_gemma":0.00037550446,"threshold_uncertainty_score":0.0049797297},"labels":[],"label_agreement":null},{"id":"W2233600556","doi":"10.1158/1078-0432.ccr-15-2360","title":"Not all NOTCH Is Created Equal: The Oncogenic Role of NOTCH2 in Bladder Cancer and Its Implications for Targeted Therapy","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cerebrovascular and genetic disorders","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Prevention of Organ Failure; University of British Columbia","funders":"Canadian Cancer Society Research Institute; Vancouver Coastal Health Research Institute; National Health Research Institutes; Canadian Urological Association; Urology Care Foundation","keywords":"Cancer research; Notch signaling pathway; Bladder cancer; Epithelial–mesenchymal transition; Oncogene; Cancer; Metastasis; Biology; Gene silencing; Tumor progression; Carcinogenesis; Cell cycle; Medicine; Internal medicine; Signal transduction; Cell biology","score_opus":0.3062541810693193,"score_gpt":0.5504529491950023,"score_spread":0.24419876812568303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2233600556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6915801,0.23274949,0.024949547,0.024143716,0.0013892888,0.0000752983,0.00065991306,0.00025808628,0.024194567],"genre_scores_gemma":[0.9462424,0.038131345,0.0030880235,0.0025721777,0.00022213516,0.000026913072,0.00017822646,0.000029976924,0.009508865],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984586,0.000029500976,0.000011706554,0.000031384105,0.000052017,0.000029544784],"domain_scores_gemma":[0.9998388,0.00002887788,0.000040590796,0.000020400275,0.000033125107,0.000038140948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004925247,0.00021295618,0.00031569082,0.00020524317,0.00027096207,0.00096225884,0.0002894193,0.00050040527,0.0025176373],"category_scores_gemma":[0.00033328927,0.000103372855,0.0002461812,0.00031790315,0.0004517559,0.0007473347,0.00048353575,0.00089546887,0.00038965716],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021711667,0.00013762922,0.012726405,0.0018462645,0.00015358072,0.0014025943,0.00028003412,0.0019111517,0.6875575,0.01637623,0.00545512,0.26998225],"study_design_scores_gemma":[0.00021613181,0.0021196154,0.042868618,0.0009663165,0.0004524734,0.014350241,0.0010921032,0.009804252,0.64298505,0.020354684,0.26468945,0.000101055346],"about_ca_topic_score_codex":0.0005289947,"about_ca_topic_score_gemma":0.0006654261,"teacher_disagreement_score":0.0025176373,"about_ca_system_score_codex":0.00078655884,"about_ca_system_score_gemma":0.0007495068,"threshold_uncertainty_score":0.008422375},"labels":[],"label_agreement":null},{"id":"W2234923158","doi":"10.1158/1078-0432.ccr-15-2762","title":"Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":606,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia; BC Cancer Agency","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Battle Creek Community Foundation; U.S. Department of Defense","keywords":"Ovarian cancer; Biology; CD8; Antigen; CD20; Cancer research; Tumor-infiltrating lymphocytes; Cytotoxic T cell; Immunology; Cancer","score_opus":0.06570438379216074,"score_gpt":0.3745017896595933,"score_spread":0.30879740586743254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2234923158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99880123,0.0005822433,0.00023231104,0.0000118710195,0.0000017043618,0.000006557644,0.00012926986,0.000021791377,0.00021298268],"genre_scores_gemma":[0.9994867,0.00009848452,0.00018578474,0.0000052189407,0.000002935019,0.000004631669,0.00013488006,0.000001943664,0.000079339625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999192,0.000013180271,0.000008466046,0.000022520533,0.000021409425,0.0000151921295],"domain_scores_gemma":[0.9997328,0.00003930242,0.00012084162,0.000029139916,0.000029796887,0.000048169353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022902034,0.0001478083,0.00019276804,0.000621585,0.00021434751,0.0002643283,0.00009665274,0.00017139298,0.0010949152],"category_scores_gemma":[0.0002988777,0.00009296384,0.00010533492,0.0005132388,0.0002338313,0.00015837581,0.00022858099,0.00019250922,0.00013028178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014027819,0.00004729522,0.81282717,0.00014034819,0.000059386537,0.00050841604,0.00013479104,0.00020565554,0.16962,0.00007271141,0.00021084254,0.014770564],"study_design_scores_gemma":[0.000019126648,0.00016711628,0.98752964,0.000005140705,0.000043136493,0.0014272801,0.00010142739,0.00045567434,0.0095933555,0.00007932578,0.0005755302,0.0000031613479],"about_ca_topic_score_codex":0.0004853168,"about_ca_topic_score_gemma":0.00059010746,"teacher_disagreement_score":0.0010949152,"about_ca_system_score_codex":0.0001829021,"about_ca_system_score_gemma":0.00015194331,"threshold_uncertainty_score":0.0036628246},"labels":[],"label_agreement":null},{"id":"W2238237545","doi":"10.1158/1078-0432.ccr-15-2233","title":"Endometrial Carcinomas with <i>POLE</i> Exonuclease Domain Mutations Have a Favorable Prognosis","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of British Columbia; Vancouver General Hospital; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Internal medicine; Oncology; Endometrial cancer; Medicine; Carcinoma; Stage (stratigraphy); Lymphovascular invasion; Cancer; Biology; Metastasis","score_opus":0.23122253905590462,"score_gpt":0.4839051951767981,"score_spread":0.25268265612089347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2238237545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71702576,0.27762178,0.0022949514,0.0006125899,0.000120158926,0.00005133302,0.0010623417,0.00003966909,0.001171324],"genre_scores_gemma":[0.98648536,0.01231668,0.0005582315,0.00017892383,0.000085374966,0.000010329785,0.00026886712,0.000004257425,0.00009193904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920624,0.00038780243,0.0001270403,0.00011753197,0.00012325775,0.000038032613],"domain_scores_gemma":[0.9971419,0.0014698048,0.0009881792,0.00021543745,0.00013285001,0.00005172738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022808327,0.0003699134,0.0009309638,0.00044000646,0.00013956938,0.00047075952,0.00024485722,0.0004123012,0.0007597404],"category_scores_gemma":[0.0042986204,0.00019031712,0.0019891919,0.0005590232,0.00022481747,0.00029005657,0.00021250831,0.00030790447,0.00008760903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018323861,0.00013688135,0.78285146,0.009152537,0.06805589,0.0006078423,0.00010763086,0.0034830244,0.021529619,0.00030117042,0.00079818437,0.09465189],"study_design_scores_gemma":[0.00091654796,0.0026850703,0.89996386,0.0011451099,0.07475043,0.0024662015,0.00014990964,0.002393494,0.007867869,0.0008053843,0.006815034,0.000041257797],"about_ca_topic_score_codex":0.0008380062,"about_ca_topic_score_gemma":0.0013738981,"teacher_disagreement_score":0.0022808327,"about_ca_system_score_codex":0.00019314096,"about_ca_system_score_gemma":0.00023717128,"threshold_uncertainty_score":0.012062311},"labels":[],"label_agreement":null},{"id":"W2243499413","doi":"10.1158/1557-3265.pms14-a57","title":"Abstract A57: Effects of pre-exposure to siRNA on silencing response: Do cells become resistant to siRNA silencing?","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Gene silencing; Small interfering RNA; RNA interference; Internalization; Cancer research; Biology; Cell biology; Cell; Chemistry; Cell culture; Transfection; RNA; Genetics; Gene","score_opus":0.1041272549679348,"score_gpt":0.4626611717672729,"score_spread":0.3585339167993381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2243499413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98413634,0.0037179696,0.0027674476,0.0005432514,0.000298005,0.00015401519,0.0009660065,0.00016906294,0.007247899],"genre_scores_gemma":[0.9804216,0.0013814191,0.0027391007,0.0005837674,0.00004929097,0.00016850061,0.0018072788,0.000073019204,0.012776008],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99953485,0.00007901226,0.000076770404,0.00010688767,0.00014322234,0.00005930739],"domain_scores_gemma":[0.999426,0.00029870993,0.00007846842,0.000058341375,0.000093238494,0.00004512113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004365437,0.00028000187,0.0005101986,0.00018409659,0.0002321273,0.00040805282,0.0002905254,0.0006745864,0.0072111636],"category_scores_gemma":[0.00051613944,0.0001735329,0.00049777306,0.00020860664,0.00032141112,0.00023794884,0.00019586865,0.0008510878,0.00148356],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035174424,0.00010191382,0.00042705206,0.000118432676,0.00001363701,0.00018484364,0.00005830936,0.000045420344,0.99467224,0.000055613033,0.00035722394,0.0036136932],"study_design_scores_gemma":[0.000020895879,0.0014629344,0.00959982,0.000011188256,0.000026484508,0.00026411627,0.0000641288,0.00028851535,0.98578775,0.000038192105,0.0024269426,0.000009023026],"about_ca_topic_score_codex":0.0012665736,"about_ca_topic_score_gemma":0.00089883135,"teacher_disagreement_score":0.0072111636,"about_ca_system_score_codex":0.00028143535,"about_ca_system_score_gemma":0.00021236774,"threshold_uncertainty_score":0.024123788},"labels":[],"label_agreement":null},{"id":"W2252455678","doi":"10.1158/1078-0432.ccr-15-0035","title":"Impact of the 2010 Consensus Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Concordance; Medicine; Clinical trial; Drug development; Task force; Steering committee; Clinical study design; Randomized controlled trial; Medical physics; Research design; Oncology; Investigational Drugs; Drug; Internal medicine; Pharmacology","score_opus":0.9426179993832116,"score_gpt":0.7345665705338479,"score_spread":0.20805142884936367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2252455678","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01748609,0.05138822,0.016060261,0.8150267,0.052966733,0.004994171,0.0040589417,0.00055462884,0.03746429],"genre_scores_gemma":[0.18101642,0.023230491,0.12518364,0.6144014,0.021329997,0.008395107,0.0071122246,0.001294581,0.018036187],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.3136422,0.35686928,0.111292176,0.017872801,0.18991366,0.010409938],"domain_scores_gemma":[0.11974994,0.49472848,0.0681018,0.041117996,0.2575902,0.018711595],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.66724634,0.0018830093,0.0035371433,0.0046653594,0.004367967,0.01675991,0.0081344135,0.018284852,0.0060043586],"category_scores_gemma":[0.7971363,0.0026959765,0.0070592146,0.004617181,0.00347933,0.007809295,0.007611198,0.021386415,0.0030769987],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00272219,0.00075195736,0.020555519,0.010388071,0.0027267835,0.00046210078,0.0023792977,0.0034883593,0.0014922203,0.023311958,0.5054066,0.42631486],"study_design_scores_gemma":[0.0021951178,0.0030057142,0.05369044,0.038713664,0.003153397,0.0005607308,0.0023651547,0.005536516,0.0038509276,0.01588426,0.87028575,0.00075823086],"about_ca_topic_score_codex":0.02917234,"about_ca_topic_score_gemma":0.036479626,"teacher_disagreement_score":0.33275366,"about_ca_system_score_codex":0.025615439,"about_ca_system_score_gemma":0.07674598,"threshold_uncertainty_score":0.41034454},"labels":[],"label_agreement":null},{"id":"W2259127335","doi":"10.1158/1078-0432.ccr-15-2218","title":"Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"National Cancer Institute; Universitat de Girona; Astellas Pharma US","keywords":"Medicine; Erlotinib; Internal medicine; Pharmacodynamics; Adverse effect; Nausea; Epidermal growth factor receptor; Oncology; Insulin-like growth factor 1 receptor; Cohort; Vomiting; Cancer; Pharmacology; Pharmacokinetics; Gastroenterology; Receptor","score_opus":0.11269773919679285,"score_gpt":0.5568681410234685,"score_spread":0.44417040182667566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2259127335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974758,0.0005410013,0.00021608584,0.00012333541,0.00003190916,0.0007581331,0.00023557672,0.000042438176,0.0005757507],"genre_scores_gemma":[0.9962863,0.00034743652,0.00083949283,0.00022726186,0.00004864015,0.000684631,0.00075450994,0.000010267529,0.0008014554],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99948287,0.00021758044,0.000031195013,0.000089007466,0.00006693598,0.000112349786],"domain_scores_gemma":[0.99940586,0.00006946648,0.00013923025,0.00005593501,0.000032689826,0.00029677764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015327506,0.0012305253,0.0016468616,0.00036909562,0.00035288476,0.00063821446,0.00071745313,0.0006876555,0.0019661654],"category_scores_gemma":[0.0007197912,0.00049609126,0.0009025215,0.0004205309,0.0007552383,0.000725296,0.00033931472,0.0031246229,0.00055709603],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5757958,0.13396315,0.0216319,0.0006158344,0.0013247015,0.00033233874,0.00063621544,0.005091746,0.10360069,0.00032282152,0.0041706646,0.1525141],"study_design_scores_gemma":[0.33775008,0.61030954,0.033904433,0.000029137607,0.00041193038,0.00048633173,0.000085703425,0.0028182461,0.010919843,0.00015993317,0.003094857,0.000029977162],"about_ca_topic_score_codex":0.000793863,"about_ca_topic_score_gemma":0.002404868,"teacher_disagreement_score":0.0019661654,"about_ca_system_score_codex":0.00102668,"about_ca_system_score_gemma":0.001524366,"threshold_uncertainty_score":0.008106053},"labels":[],"label_agreement":null},{"id":"W2260128833","doi":"10.1158/1557-3265.hemmal14-b12","title":"Abstract B12: EIF4E deregulation drives simultaneous expression of B-cell lymphoma oncogenes.","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"","keywords":"EIF4E; Biology; Nuclear export signal; Cancer research; Oncogene; Eukaryotic translation; Translation (biology); EIF4A1; Messenger RNA; Molecular biology; Cell cycle; Cell biology; Gene; Cytoplasm; Cell nucleus; Genetics","score_opus":0.26007171454945693,"score_gpt":0.5127443101287255,"score_spread":0.2526725955792685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2260128833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914063,0.00064259936,0.003719034,0.00013400988,0.00010339929,0.00010810142,0.0017203133,0.00024177998,0.001924398],"genre_scores_gemma":[0.98926044,0.00028087117,0.0032366172,0.00007178725,0.000014518244,0.00009307573,0.0020177532,0.00009411524,0.0049308273],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995453,0.000057000125,0.00006104959,0.000103384125,0.00013235306,0.00010096072],"domain_scores_gemma":[0.99977094,0.0000503947,0.000054992823,0.000035371653,0.000020007203,0.00006836582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002436056,0.00037616782,0.00028457356,0.00033868838,0.00019102653,0.0005135067,0.0002813283,0.00037126243,0.0025258954],"category_scores_gemma":[0.00014595134,0.0002095196,0.00026947376,0.00041410053,0.00025528957,0.00016141553,0.0003048059,0.00071621325,0.0008431716],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013643154,0.00004400892,0.00012441013,0.000017603175,0.0000045068223,0.000022162953,0.000011018516,0.000042281412,0.99868697,0.00009977966,0.00006871478,0.00074203644],"study_design_scores_gemma":[0.00002608743,0.00024830693,0.0022330526,0.000004133859,0.00001376146,0.00014385766,0.000030192416,0.0013496648,0.9925712,0.000029300467,0.0033463654,0.0000042035094],"about_ca_topic_score_codex":0.0007314692,"about_ca_topic_score_gemma":0.0011144701,"teacher_disagreement_score":0.0025258954,"about_ca_system_score_codex":0.0004907112,"about_ca_system_score_gemma":0.00022442751,"threshold_uncertainty_score":0.008449972},"labels":[],"label_agreement":null},{"id":"W2261762138","doi":"10.1158/1078-0432.ccr-15-1784","title":"STAT3/5-Dependent IL9 Overexpression Contributes to Neoplastic Cell Survival in Mycosis Fungoides","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Novo Nordisk Fonden; Harvard University","keywords":"Mycosis fungoides; Medicine; Dermatology; Mycosis; Lymphoma; Cancer research; Pathology; Biology; Immunology","score_opus":0.18895620218587397,"score_gpt":0.5266381113907551,"score_spread":0.33768190920488117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2261762138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574214,0.0020954707,0.00092633057,0.00008584642,0.000026970793,0.000016103935,0.00028006366,0.000051901563,0.00077521545],"genre_scores_gemma":[0.99812084,0.00045570888,0.00038565698,0.000032661963,0.0000061244536,0.00001660108,0.00024557664,0.000004292108,0.0007326179],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998956,0.000014663412,0.000009848445,0.000019550274,0.000027182812,0.000033115048],"domain_scores_gemma":[0.99993765,0.00000839099,0.000021247828,0.000007990475,0.0000056104004,0.000019123529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010798776,0.00021351386,0.00017901756,0.00015341898,0.00018247306,0.00023402266,0.000112509384,0.0002739799,0.0016560843],"category_scores_gemma":[0.000069219655,0.00009150578,0.00026811092,0.00009400739,0.00017580758,0.00014155949,0.00014045881,0.00046243428,0.00048030526],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021555265,0.000031016512,0.00071833655,0.000051212257,0.000002840951,0.000094366296,0.00001383279,0.000036535614,0.99749905,0.000055883473,0.000055057702,0.0012262726],"study_design_scores_gemma":[0.0000647997,0.00084742904,0.043286797,0.000028542241,0.00004312377,0.0014771316,0.00012489277,0.0019257748,0.947391,0.00012737248,0.0046757273,0.0000073823235],"about_ca_topic_score_codex":0.0002654471,"about_ca_topic_score_gemma":0.0003642932,"teacher_disagreement_score":0.0016560843,"about_ca_system_score_codex":0.0002096091,"about_ca_system_score_gemma":0.00013621975,"threshold_uncertainty_score":0.0055401325},"labels":[],"label_agreement":null},{"id":"W2263864814","doi":"10.1158/1078-0432.ccr-15-2631","title":"Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":228,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada); University Hospital Foundation","funders":"National Cancer Institute","keywords":"TSC1; PI3K/AKT/mTOR pathway; TSC2; Medicine; Cancer; Cancer research; Oncology; Internal medicine; Renal cell carcinoma; Sirolimus; Biology; Genetics; Apoptosis","score_opus":0.1292294006372624,"score_gpt":0.4265416049270228,"score_spread":0.2973122042897604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2263864814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997547,0.000087323555,0.000029005252,0.000014288538,0.0000012165252,0.0000035949156,0.00004038014,0.0000018921342,0.000067525856],"genre_scores_gemma":[0.9998118,0.000020434247,0.00003805744,0.00001050173,0.0000060866937,0.0000036775593,0.000065909546,8.515926e-7,0.000042610605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995777,0.00012301838,0.000045241697,0.00010596861,0.00008847881,0.0000594789],"domain_scores_gemma":[0.99874973,0.00043127942,0.00047176305,0.000084175525,0.00009584877,0.00016722716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060319144,0.00023354321,0.000441993,0.0005330058,0.00038034603,0.000264055,0.0002487238,0.00045256602,0.001123974],"category_scores_gemma":[0.0018965463,0.00017722863,0.00029259935,0.00042242312,0.00029509663,0.00022344747,0.00017854977,0.00035570862,0.00018665953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059777056,0.0000663525,0.9940224,0.000011181588,0.000050582028,0.00030045336,0.00005473009,0.00008800579,0.0026962243,0.000012004607,0.000067353976,0.0020329577],"study_design_scores_gemma":[0.00003784211,0.00045396094,0.9963037,0.0000030902168,0.000052914034,0.0018735232,0.00006705292,0.00041173724,0.0006062703,0.00002008553,0.00016600316,0.000003675681],"about_ca_topic_score_codex":0.0008752546,"about_ca_topic_score_gemma":0.0009724077,"teacher_disagreement_score":0.001123974,"about_ca_system_score_codex":0.0002274982,"about_ca_system_score_gemma":0.0002130047,"threshold_uncertainty_score":0.0037600398},"labels":[],"label_agreement":null},{"id":"W2268068174","doi":"","title":"Bivalent binding properties of epidermal growth factor receptor targeted monoclonal antibodies: Factors contributing to differences in observed clinical profiles.","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Nimotuzumab; Cetuximab; Monoclonal antibody; Epidermal growth factor receptor; Antibody; Chemistry; Panitumumab; Cancer research; Cell culture; Molecular biology; Antibody-dependent cell-mediated cytotoxicity; A431 cells; Cell growth; Monoclonal; Cell; Receptor; Immunology; Cell cycle; Medicine; Biology; Biochemistry; Molecular medicine","score_opus":0.6654379160890438,"score_gpt":0.5353623484376453,"score_spread":0.1300755676513985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2268068174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9563971,0.02620897,0.0093601765,0.00050462084,0.00006676517,0.0002082665,0.00049164775,0.00014908344,0.006613242],"genre_scores_gemma":[0.99448544,0.0017232847,0.0018965364,0.0002505826,0.00003245792,0.000084080646,0.0005282117,0.000028638988,0.0009706678],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986338,0.0003810841,0.00011175626,0.00023649549,0.000501471,0.00013535564],"domain_scores_gemma":[0.9980647,0.0008914909,0.000478917,0.00014037189,0.00024335738,0.0001812391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017140189,0.00029785818,0.000493942,0.0005927975,0.00021883092,0.0007739603,0.00041342722,0.0005190137,0.0022579343],"category_scores_gemma":[0.0026023807,0.00020381312,0.00020289775,0.0004738024,0.0002954505,0.00041535244,0.00031299575,0.00062935625,0.00069500785],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014470046,0.0003647936,0.024863677,0.00040862933,0.00015627172,0.00037580958,0.00013980707,0.000851305,0.8721248,0.00066290726,0.0008793325,0.09772572],"study_design_scores_gemma":[0.00028706467,0.008117986,0.25714812,0.000096795535,0.0004777864,0.011537785,0.00021970627,0.008269947,0.684993,0.0014752717,0.02730174,0.00007478894],"about_ca_topic_score_codex":0.00032982524,"about_ca_topic_score_gemma":0.0003800472,"teacher_disagreement_score":0.0022579343,"about_ca_system_score_codex":0.00042057823,"about_ca_system_score_gemma":0.00016944841,"threshold_uncertainty_score":0.009064734},"labels":[],"label_agreement":null},{"id":"W2282026400","doi":"10.1158/1078-0432.ccr-15-2305","title":"Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"Institut National Du Cancer","keywords":"Diffuse large B-cell lymphoma; DNA sequencing; Computational biology; Lymphoma; Divergence (linguistics); Cancer research; Biology; Medicine; Genetics; DNA; Pathology","score_opus":0.437137671494779,"score_gpt":0.4702727758321284,"score_spread":0.0331351043373494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2282026400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98673207,0.0065058107,0.0043558,0.0007805572,0.000026971453,0.00005440797,0.00041154333,0.00006304733,0.001069879],"genre_scores_gemma":[0.9918105,0.0012246866,0.0052638017,0.00058116805,0.00003574152,0.000046215133,0.00060234184,0.000021160788,0.00041441896],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9995079,0.00019555792,0.000029646153,0.00012669229,0.00009145271,0.000048624162],"domain_scores_gemma":[0.99947435,0.0002038787,0.00007541621,0.0000683071,0.000078758465,0.00009933706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021592674,0.00028136987,0.00036012696,0.00034887256,0.0001790476,0.00074337557,0.00022501434,0.00054199534,0.000674018],"category_scores_gemma":[0.0014423652,0.000108324595,0.00028961833,0.0003111366,0.00037101563,0.0003894527,0.00043682053,0.00046975142,0.00016106284],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010168197,0.0008217125,0.20422453,0.0006575142,0.0008754061,0.0018460008,0.00049959257,0.0040515293,0.4893322,0.002763796,0.002257828,0.28250173],"study_design_scores_gemma":[0.0022516304,0.0121704,0.654187,0.00033599575,0.0017068195,0.01890422,0.0009777292,0.036948197,0.20954335,0.006492718,0.056348905,0.00013305889],"about_ca_topic_score_codex":0.00044522053,"about_ca_topic_score_gemma":0.00075779425,"teacher_disagreement_score":0.0021592674,"about_ca_system_score_codex":0.00051330484,"about_ca_system_score_gemma":0.00039589152,"threshold_uncertainty_score":0.0114194155},"labels":[],"label_agreement":null},{"id":"W2286693725","doi":"10.1158/1078-0432.ccr-15-2499","title":"Relationship between Tumor Biomarkers and Efficacy in EMILIA, a Phase III Study of Trastuzumab Emtansine in HER2-Positive Metastatic Breast Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":226,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Lapatinib; Trastuzumab emtansine; Trastuzumab; Capecitabine; Medicine; Cancer; Breast cancer; Metastatic breast cancer; Biomarker; Cancer research; Oncology; PTEN; Antibody-drug conjugate; Internal medicine; Antibody; Immunology; Biology; Monoclonal antibody; Apoptosis; Colorectal cancer","score_opus":0.3463970865185873,"score_gpt":0.593692150892299,"score_spread":0.24729506437371168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2286693725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969909,0.0010705293,0.00015809287,0.00013587512,0.000013540148,0.0003667425,0.00033923492,0.00002677832,0.0008982356],"genre_scores_gemma":[0.9948656,0.00065624184,0.00097076845,0.00045440745,0.00005138647,0.0003523191,0.0017041743,0.000011530161,0.0009335656],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99944156,0.00031402378,0.000029736266,0.00006369069,0.000076690514,0.000074159565],"domain_scores_gemma":[0.9990395,0.0001571501,0.00035120166,0.0000874863,0.000074516516,0.0002900506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024445332,0.00069760915,0.0008823028,0.00047490478,0.00022590475,0.0005501644,0.000582456,0.000502095,0.00090193824],"category_scores_gemma":[0.0010759865,0.0002644019,0.0006423867,0.00036889352,0.00037056158,0.00035515017,0.00025913873,0.0014084284,0.0002973798],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41345698,0.059012767,0.17253545,0.0010284029,0.0029906936,0.00040054493,0.00046781087,0.0053069126,0.14748344,0.0002642678,0.0045600347,0.19249266],"study_design_scores_gemma":[0.08557031,0.44578835,0.42443955,0.00008354282,0.0017396209,0.00089358503,0.000114046285,0.003500733,0.031831414,0.00011098817,0.0058656163,0.00006222857],"about_ca_topic_score_codex":0.00040360025,"about_ca_topic_score_gemma":0.001543944,"teacher_disagreement_score":0.0024445332,"about_ca_system_score_codex":0.00084157835,"about_ca_system_score_gemma":0.0007602626,"threshold_uncertainty_score":0.012928069},"labels":[],"label_agreement":null},{"id":"W2291969671","doi":"10.1158/1078-0432.ccr-15-1698","title":"Targeting MDM2 for Treatment of Adenoid Cystic Carcinoma","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Dental and Craniofacial Research; National Cancer Institute","keywords":"Adenoid cystic carcinoma; Medicine; Carcinoma; Oncology; Pathology; Dermatology","score_opus":0.3352563750347625,"score_gpt":0.5488742793984507,"score_spread":0.21361790436368816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2291969671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8989402,0.08961373,0.0030365903,0.0011673307,0.00019156274,0.00022330905,0.00043763255,0.00018301493,0.006206624],"genre_scores_gemma":[0.9766881,0.019014489,0.0020088248,0.00015761133,0.000047563844,0.00007419656,0.00032111153,0.000009966653,0.0016781567],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995065,0.0000075532744,0.000003820257,0.000007357406,0.000018694214,0.000011921266],"domain_scores_gemma":[0.999972,0.0000066545967,0.00000738629,0.0000024147341,0.0000028457055,0.000008731067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013474571,0.00027344935,0.00033275207,0.00022700006,0.00017063312,0.00027390258,0.000179147,0.00025208504,0.0016528205],"category_scores_gemma":[0.00006738669,0.000072708106,0.00024198262,0.00019405913,0.00025526888,0.00015105346,0.00019209008,0.0006390644,0.00037206602],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010805934,0.0003589402,0.0018673766,0.00073740515,0.0000647722,0.00068062474,0.00004686816,0.000727867,0.94073653,0.00059806084,0.0009804077,0.05212047],"study_design_scores_gemma":[0.00079529337,0.0069746613,0.016039068,0.00013309147,0.0001967073,0.0060165953,0.00010471145,0.0027831213,0.90465146,0.000339882,0.061937954,0.00002731202],"about_ca_topic_score_codex":0.0004229096,"about_ca_topic_score_gemma":0.0013101172,"teacher_disagreement_score":0.0016528205,"about_ca_system_score_codex":0.0003631055,"about_ca_system_score_gemma":0.0002760176,"threshold_uncertainty_score":0.0055291653},"labels":[],"label_agreement":null},{"id":"W2303705342","doi":"10.1158/1078-0432.ccr-15-1798","title":"Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":200,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; Amgen (Canada); Ontario Institute for Cancer Research; Hospital for Sick Children; Lunenfeld-Tanenbaum Research Institute; Alberta Cancer Foundation; University of Calgary","funders":"","keywords":"Disulfiram; Temozolomide; Glioblastoma; Medicine; Pharmacology; Oncology; Cancer research","score_opus":0.13350458886721747,"score_gpt":0.4733294582649805,"score_spread":0.339824869397763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2303705342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995754,0.0025798853,0.00041979612,0.000090872694,0.000023413566,0.000044245848,0.00007799053,0.000055264496,0.0009544465],"genre_scores_gemma":[0.99701595,0.0015234278,0.00073203794,0.00002268572,0.000011884239,0.000011374029,0.00014548124,0.000005450911,0.00053175696],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994946,0.000012886949,0.00000383323,0.0000073157394,0.000014460292,0.000012124179],"domain_scores_gemma":[0.9999726,0.0000034932768,0.000007889372,0.0000018009392,0.0000047569492,0.000009512687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011026713,0.0002487492,0.00025305984,0.00026269676,0.00009229246,0.0001606573,0.00016372598,0.00013014991,0.0007100574],"category_scores_gemma":[0.00009227539,0.00006782016,0.00016907605,0.00012768013,0.00011349231,0.0000820243,0.00011783108,0.00019907946,0.00009576813],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011539591,0.00043284034,0.00089426787,0.00020279834,0.000045498113,0.000104438644,0.00003437596,0.00041959886,0.97043693,0.00009021111,0.00036892595,0.0258163],"study_design_scores_gemma":[0.00037448798,0.010205198,0.013696077,0.000029487826,0.00021632586,0.0004617743,0.000036733876,0.0022589208,0.9648332,0.000041533454,0.00783467,0.000011684466],"about_ca_topic_score_codex":0.0015208937,"about_ca_topic_score_gemma":0.0044814465,"teacher_disagreement_score":0.0015208937,"about_ca_system_score_codex":0.000250846,"about_ca_system_score_gemma":0.00027682958,"threshold_uncertainty_score":0.0030240417},"labels":[],"label_agreement":null},{"id":"W2308342896","doi":"10.1158/1078-0432.ccr-15-0965","title":"Integrated Analysis of PTEN and p4EBP1 Protein Expression as Predictors for pCR in HER2-Positive Breast Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada)","funders":"","keywords":"PTEN; Tensin; Trastuzumab; Breast cancer; Cancer research; Medicine; Cancer; Phosphatase; Internal medicine; Protein kinase B; Oncology; Biology; PI3K/AKT/mTOR pathway; Phosphorylation; Signal transduction","score_opus":0.08363033479904568,"score_gpt":0.47490335020492563,"score_spread":0.39127301540587994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2308342896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994369,0.00017452243,0.00017083343,0.000009096169,0.0000012027407,0.000004329724,0.00004930863,0.0000041418857,0.00014966994],"genre_scores_gemma":[0.9995561,0.000041573378,0.000207243,0.0000056041804,0.000003581859,0.000007275333,0.000121345205,0.0000010840096,0.000056085944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972075,0.000109552966,0.000024759407,0.0000462027,0.00006494879,0.00003375674],"domain_scores_gemma":[0.9991792,0.00034144605,0.0002809647,0.000033299948,0.00008031285,0.000084752246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010977346,0.00016883554,0.00019963851,0.00065235223,0.000111704736,0.00026295762,0.00018693061,0.00017538649,0.000800254],"category_scores_gemma":[0.0016999067,0.00012611943,0.00018226595,0.00045013253,0.0002251605,0.00021887201,0.00023702996,0.00024060823,0.00013808162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017308339,0.000057216854,0.9871547,0.000017828299,0.000051657065,0.000086463035,0.000023811941,0.00049497024,0.0038639929,0.000015845873,0.00006302179,0.006439672],"study_design_scores_gemma":[0.00005246909,0.0008007069,0.99072343,0.0000042529177,0.00009962849,0.0009459977,0.00006489872,0.0029578998,0.0039916877,0.00007350265,0.0002799538,0.000005502855],"about_ca_topic_score_codex":0.0003802619,"about_ca_topic_score_gemma":0.0006037413,"teacher_disagreement_score":0.0010977346,"about_ca_system_score_codex":0.00021616551,"about_ca_system_score_gemma":0.00017747807,"threshold_uncertainty_score":0.0058054924},"labels":[],"label_agreement":null},{"id":"W2312246075","doi":"10.1158/1557-3265.hemmal14-b08","title":"Abstract B08: eIF4E3 forms a novel cap-binding complex for mRNA translation initiation.","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"EIF4G; EIF4E; eIF4A; Eukaryotic translation; Biology; Internal ribosome entry site; Messenger RNA; Translation (biology); RNA-binding protein; Initiation factor; Cell biology; Eukaryotic initiation factor; Translational regulation; Untranslated region; Molecular biology; Genetics; Gene","score_opus":0.6274882464662679,"score_gpt":0.5714631894365825,"score_spread":0.05602505702968541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312246075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96699774,0.004548256,0.019720875,0.00047281996,0.00023948807,0.000110499896,0.0043548997,0.00047122283,0.0030840614],"genre_scores_gemma":[0.9716878,0.00072659843,0.012783104,0.0002377269,0.000042124844,0.00007881267,0.009675805,0.000115644136,0.0046523702],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986315,0.00001851228,0.000009949798,0.000036301637,0.000041960746,0.000030120786],"domain_scores_gemma":[0.99991024,0.000013462286,0.00002893886,0.000009314584,0.00001216584,0.000025866517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021116917,0.00054410717,0.0002650526,0.00023662421,0.00047266652,0.00036905587,0.00034866112,0.00051314244,0.0027423382],"category_scores_gemma":[0.00021032241,0.00017640486,0.00041001296,0.00029791158,0.00022508968,0.00020727864,0.00030398983,0.0004697008,0.0014719638],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020947731,0.00002070243,0.00051937613,0.0000658353,0.000009460553,0.00008632316,0.0000087700155,0.00006576834,0.99711716,0.00013453899,0.00023573604,0.0015269113],"study_design_scores_gemma":[0.00005579436,0.00013985572,0.025725346,0.000019611605,0.000020325235,0.0008100241,0.00002551399,0.0024128773,0.95799875,0.00030212468,0.012475619,0.000014074141],"about_ca_topic_score_codex":0.00085976074,"about_ca_topic_score_gemma":0.00097057136,"teacher_disagreement_score":0.0027423382,"about_ca_system_score_codex":0.00069541734,"about_ca_system_score_gemma":0.000300596,"threshold_uncertainty_score":0.009174049},"labels":[],"label_agreement":null},{"id":"W2315061030","doi":"10.1158/1078-0432.tcme10-b13","title":"Abstract B13: TIA1+ and FOXP3+ tumor infiltrating lymphocytes are positive prognostic factors in estrogen receptor negative breast cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Breast cancer; Medicine; Tissue microarray; FOXP3; Oncology; Estrogen receptor; Cancer; Internal medicine; Tumor-infiltrating lymphocytes; Pathology; Immune system; Immunology; Immunotherapy","score_opus":0.10158320996902187,"score_gpt":0.4645544918253545,"score_spread":0.36297128185633265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315061030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99927384,0.0002071262,0.00008085098,0.00002658314,0.0000035503729,0.0000030878343,0.00011651949,0.0000046329183,0.00028376016],"genre_scores_gemma":[0.99958307,0.000037050195,0.00006180279,0.000009353973,0.000008281803,0.0000025038964,0.00014628391,0.0000011702087,0.00015048853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99991786,0.000018624736,0.000009370894,0.000019518482,0.00001574192,0.000018829925],"domain_scores_gemma":[0.9993831,0.00019095479,0.00022250589,0.000029627558,0.000062182946,0.00011159612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037163138,0.00015683543,0.00013567542,0.0004804536,0.00016963882,0.0002673617,0.00017975648,0.00022670957,0.0026488362],"category_scores_gemma":[0.00095025776,0.00007591823,0.00013049066,0.00036151748,0.00023612274,0.00013182685,0.00013472543,0.00021908164,0.00031052405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003893643,0.000016267328,0.9950171,0.000010517901,0.000012541879,0.00013015606,0.000016002148,0.000044850036,0.0024270976,0.0000067131973,0.00010404443,0.0018253428],"study_design_scores_gemma":[0.000011093479,0.00010645359,0.99772996,0.0000032912476,0.00003404259,0.00094647385,0.00004592549,0.00020508822,0.0006752314,0.000029996245,0.00021083218,0.0000015167248],"about_ca_topic_score_codex":0.0008489091,"about_ca_topic_score_gemma":0.0010331189,"teacher_disagreement_score":0.0026488362,"about_ca_system_score_codex":0.00012593088,"about_ca_system_score_gemma":0.00014322667,"threshold_uncertainty_score":0.008861244},"labels":[],"label_agreement":null},{"id":"W2329400486","doi":"10.1158/1078-0432.ccr-16-0316","title":"A Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the European EPIC Cohort","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Cancer Institute; Instituto de Salud Carlos III; World Cancer Research Fund; Medical Research Council; National Institutes of Health; Institut Gustave-Roussy; Deutsche Krebshilfe; Associazione Italiana per la Ricerca sul Cancro; NordForsk; Hellenic Health Foundation; Stavros Niarchos Foundation; Institut National de la Santé et de la Recherche Médicale; World Health Organization; European Commission; Bundesministerium für Bildung und Forschung; Ligue Contre le Cancer; National Institute for Health and Care Research; Cancer Research UK; Cancerfonden; Fujirebio US; Deutsches Krebsforschungszentrum","keywords":"European Prospective Investigation into Cancer and Nutrition; EPIC; Prospective cohort study; Ovarian cancer; Cohort; Medicine; Cancer; Oncology; Cohort study; Gynecology; Internal medicine","score_opus":0.2989766636547487,"score_gpt":0.5522878446054476,"score_spread":0.2533111809506989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329400486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997938,0.00037970595,0.00048811227,0.000037255766,0.000008530699,0.000034494846,0.0007710796,0.000006925475,0.00033588038],"genre_scores_gemma":[0.9979061,0.00012086137,0.00042502955,0.000040201132,0.00001141665,0.000045032793,0.0012561267,0.0000036415822,0.00019165137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847394,0.0006948856,0.000109335495,0.00038622762,0.00021651918,0.00011902123],"domain_scores_gemma":[0.9975858,0.0005324179,0.0006892872,0.0005604881,0.00032284987,0.00030914092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003949297,0.00048705234,0.00044860863,0.0008040897,0.0003899946,0.0006607591,0.00045662723,0.00065608264,0.00076749496],"category_scores_gemma":[0.0051474217,0.0002906074,0.0006385898,0.0010045541,0.00026602222,0.00043519036,0.00069791765,0.00039236515,0.00021119435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008287813,0.000049946644,0.99667645,0.00001032228,0.00016176558,0.000048669917,0.000038573915,0.000092379974,0.00045668692,0.000030053978,0.00009305154,0.0015133147],"study_design_scores_gemma":[0.000035648784,0.00022360444,0.99884015,0.0000049020473,0.00008283517,0.00011449223,0.000035467496,0.00025797012,0.00013206055,0.000022115653,0.0002468002,0.0000039951383],"about_ca_topic_score_codex":0.0033503757,"about_ca_topic_score_gemma":0.0022906316,"teacher_disagreement_score":0.003949297,"about_ca_system_score_codex":0.0002597252,"about_ca_system_score_gemma":0.0003064455,"threshold_uncertainty_score":0.020886123},"labels":[],"label_agreement":null},{"id":"W2338520375","doi":"10.1158/1557-3265.ovcasymp14-poster-tech-1130","title":"Abstract POSTER-TECH-1130: Identification of putative genes involved in early steps of epithelial ovarian cancer pathogenesis","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Ovarian cancer; Transcription factor; Disease; Biology; Pathogenesis; Gene; Cancer; Chromatin immunoprecipitation; Biomarker; Cancer research; Bioinformatics; Medicine; Promoter; Gene expression; Immunology; Genetics; Internal medicine","score_opus":0.30147284438947997,"score_gpt":0.511912477007406,"score_spread":0.2104396326179261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338520375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8296209,0.023139179,0.022187168,0.0042371894,0.0036168247,0.00084757886,0.056283865,0.0013934136,0.05867389],"genre_scores_gemma":[0.73336893,0.009177773,0.029520847,0.0017597452,0.0010800625,0.00048296843,0.11204163,0.00024122905,0.11232689],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998281,0.000021117876,0.000013465944,0.00004878203,0.00004733214,0.000041201863],"domain_scores_gemma":[0.99983394,0.00002747742,0.000015916183,0.0000110688015,0.000044115972,0.00006737469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026708018,0.0005520428,0.00037092582,0.00059222797,0.00042426802,0.0005839045,0.00032560065,0.00073531986,0.030032545],"category_scores_gemma":[0.00023385427,0.00012482132,0.00065348943,0.0005494928,0.00017392483,0.00023733865,0.0002797057,0.0005814717,0.009042347],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013343556,0.00019539775,0.007125723,0.0010346872,0.000045144836,0.0005715908,0.000053815922,0.00018553193,0.95730543,0.00042751792,0.0094000455,0.022320744],"study_design_scores_gemma":[0.00017278925,0.0016840973,0.1825784,0.00014936518,0.00025418584,0.0031569614,0.00029275144,0.0013869457,0.69586056,0.00095289847,0.11347021,0.000040823186],"about_ca_topic_score_codex":0.00055560196,"about_ca_topic_score_gemma":0.00047854352,"teacher_disagreement_score":0.030032545,"about_ca_system_score_codex":0.000361729,"about_ca_system_score_gemma":0.0004373926,"threshold_uncertainty_score":0.100468874},"labels":[],"label_agreement":null},{"id":"W2338707509","doi":"10.1158/1557-3265.pmsclingen15-pr03","title":"Abstract PR03: Molecular profiling of advanced solid tumors at Princess Margaret Cancer Centre and patient outcomes with genotype-matched clinical trials","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Markham Stouffville Hospital; Grand River Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Amplicon; Oncology; Clinical trial; Genotype; Molecular diagnostics; Genotyping; Molecular pathology; Response Evaluation Criteria in Solid Tumors; Bioinformatics; Gene; Genetics; Biology; Polymerase chain reaction; Phases of clinical research","score_opus":0.11951752050236168,"score_gpt":0.4952102138303327,"score_spread":0.375692693327971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338707509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811256,0.0029056882,0.0020848387,0.00093525316,0.000049472364,0.0012557158,0.0078065153,0.000099490266,0.0037374913],"genre_scores_gemma":[0.99214184,0.00021349888,0.0021029464,0.00047911156,0.00006177897,0.0007255124,0.0037293788,0.000040760497,0.00050518336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9888799,0.007302481,0.0013058088,0.0012102941,0.000996123,0.00030544985],"domain_scores_gemma":[0.9649898,0.010614634,0.016892921,0.002910116,0.0024195754,0.0021730424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011213065,0.00027865008,0.0006306436,0.00060335186,0.00042677118,0.0013623338,0.0009607761,0.00073849683,0.0059489817],"category_scores_gemma":[0.028843937,0.00020991433,0.0010124929,0.0017848264,0.0004973692,0.0010495131,0.00094471447,0.0006626826,0.0009517885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2125458,0.001020785,0.661517,0.0017569171,0.0039027734,0.00042074625,0.00043296354,0.0021153193,0.006612293,0.00088365126,0.0137933055,0.09499842],"study_design_scores_gemma":[0.010105157,0.02347809,0.9493842,0.00017909233,0.0017243486,0.0015880249,0.00016163281,0.0023187245,0.0026980876,0.0006041317,0.0077022496,0.000056171735],"about_ca_topic_score_codex":0.0011224289,"about_ca_topic_score_gemma":0.00143864,"teacher_disagreement_score":0.011213065,"about_ca_system_score_codex":0.0010017777,"about_ca_system_score_gemma":0.0013059175,"threshold_uncertainty_score":0.05930108},"labels":[],"label_agreement":null},{"id":"W2339497078","doi":"10.1158/1078-0432.ccr-15-2507","title":"Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunologic and Clinical Outcomes","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development","funders":"Cancer Research UK","keywords":"Carcinoembryonic antigen; Medicine; Immunology; Vaccination; DNA vaccination; Adverse effect; Antigen; DNA; Virology; Cancer; Immunization; Biology; Internal medicine; Genetics","score_opus":0.09134343134888132,"score_gpt":0.43407437618502764,"score_spread":0.3427309448361463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339497078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985713,0.00077413314,0.00017046276,0.00003293164,0.0000072554008,0.000035147576,0.00003165332,0.0000034011543,0.0003736259],"genre_scores_gemma":[0.99958354,0.00008562799,0.000056091918,0.000030165651,0.000011907847,0.000013509556,0.000053120944,7.767187e-7,0.0001651746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966335,0.0001534924,0.000022586644,0.000032045264,0.000058331134,0.00007014859],"domain_scores_gemma":[0.99865013,0.00040031003,0.0005517597,0.000055819946,0.00011161397,0.00023031254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007293594,0.0002697218,0.00037235735,0.00011419358,0.00007905477,0.00019987524,0.00009527563,0.00029755902,0.0013157342],"category_scores_gemma":[0.0010912659,0.0000692223,0.00021111622,0.000078643854,0.00018476571,0.00018886461,0.00016004372,0.00040321774,0.00015130342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05892492,0.007751767,0.57983226,0.0010103617,0.00095608877,0.0009386959,0.00019064546,0.0017794792,0.21710798,0.00015161156,0.0006623454,0.13069397],"study_design_scores_gemma":[0.0013263451,0.12381919,0.83095187,0.000069386115,0.0005626569,0.0015666286,0.00008762841,0.0021217556,0.037686948,0.00011242219,0.0016757799,0.000019401881],"about_ca_topic_score_codex":0.00007471452,"about_ca_topic_score_gemma":0.00012133923,"teacher_disagreement_score":0.0013157342,"about_ca_system_score_codex":0.00017596674,"about_ca_system_score_gemma":0.00013741346,"threshold_uncertainty_score":0.004401624},"labels":[],"label_agreement":null},{"id":"W2339885882","doi":"10.1158/1557-3265.ovcasymp14-poster-biol-1327","title":"Abstract POSTER-BIOL-1327: Small cell carcinoma of the ovary, hypercalcemic type displays frequent inactivating germline and somatic mutations in SMARCA4","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University Health Network; University of British Columbia; BC Cancer Agency","funders":"","keywords":"SMARCA4; Biology; Germline; Exome sequencing; Germline mutation; Cancer research; Ovarian cancer; Small-cell carcinoma; Somatic cell; Mutation; Cancer; Carcinoma; Genetics; Chromatin remodeling; Epigenetics; Gene","score_opus":0.19202934675100566,"score_gpt":0.441347908459064,"score_spread":0.24931856170805836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339885882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9703782,0.0020562082,0.0011812226,0.0013465164,0.00027141417,0.00022246962,0.0031773914,0.00020478001,0.021161847],"genre_scores_gemma":[0.9764872,0.0008988553,0.0012291819,0.00049137505,0.00021421554,0.00005652842,0.0036232711,0.00006636443,0.016933091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998956,0.000008860352,0.000012630697,0.000028347013,0.00002227337,0.000032330176],"domain_scores_gemma":[0.99986386,0.000024041256,0.000016510428,0.000012030784,0.000029768584,0.00005366205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025012498,0.00034949672,0.000339009,0.0004935441,0.00038539764,0.00031906058,0.00029513097,0.00053758704,0.018049533],"category_scores_gemma":[0.00025438186,0.00012572535,0.00022973222,0.0003927744,0.00026566788,0.00015628636,0.0002846254,0.00035262128,0.0033728934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005086542,0.0009573006,0.38602203,0.0012318369,0.00037108097,0.12721327,0.00075681735,0.00059389515,0.32720983,0.0012113762,0.049831133,0.09951485],"study_design_scores_gemma":[0.0006425025,0.00203607,0.59623575,0.000111249436,0.00030207672,0.24307816,0.0006102832,0.0014859685,0.0985315,0.00081914995,0.056100342,0.000046952315],"about_ca_topic_score_codex":0.0011866122,"about_ca_topic_score_gemma":0.001323865,"teacher_disagreement_score":0.018049533,"about_ca_system_score_codex":0.0004611153,"about_ca_system_score_gemma":0.00027735424,"threshold_uncertainty_score":0.06038171},"labels":[],"label_agreement":null},{"id":"W2340925103","doi":"10.1158/1557-3265.ovcasymp14-poster-ther-1415","title":"Abstract POSTER-THER-1415: Translational study of DPX-survivac peptide vaccine and metronomic cyclophosphamide using a novel HLA-A2/ survivin expressing ovarian tumor model to mimic phase I clinical data","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Dalhousie University; Immunovaccine (Canada)","funders":"","keywords":"Survivin; Ovarian cancer; Cancer research; Peptide vaccine; ELISPOT; Immune system; Immunology; Cytotoxic T cell; In vivo; Medicine; Cancer; Biology; T cell; Antigen; Internal medicine; In vitro; Epitope","score_opus":0.4938239212117624,"score_gpt":0.54292182611424,"score_spread":0.04909790490247762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340925103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99436617,0.0007644465,0.0014493972,0.000172396,0.00017454512,0.0004642868,0.00058239687,0.00006488197,0.001961643],"genre_scores_gemma":[0.99120754,0.0006151451,0.0017526268,0.000150501,0.000061219405,0.0005272847,0.0011682886,0.00002431524,0.0044931127],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998642,0.000022171605,0.000008956225,0.00003159574,0.0000241521,0.000048885595],"domain_scores_gemma":[0.9999119,0.000008051372,0.000013399995,0.000009480105,0.000009720499,0.000047479112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026450455,0.00042789325,0.00048864994,0.00020309498,0.00017630264,0.00030513242,0.00025986365,0.00042702854,0.0027494545],"category_scores_gemma":[0.00009411986,0.00011550722,0.00038746372,0.00013430792,0.00023932288,0.0002924365,0.00014989985,0.0010699909,0.00048581482],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011817129,0.009566875,0.00056304457,0.00023643997,0.00005880626,0.00015852257,0.00006659162,0.0008679956,0.9567565,0.00041257145,0.001053505,0.018442],"study_design_scores_gemma":[0.00407661,0.18060446,0.0059877215,0.000028617327,0.00017817579,0.0005151839,0.00008170656,0.0032515228,0.79475844,0.00019123532,0.01030756,0.000018705625],"about_ca_topic_score_codex":0.0005142843,"about_ca_topic_score_gemma":0.0004428084,"teacher_disagreement_score":0.0027494545,"about_ca_system_score_codex":0.0003100463,"about_ca_system_score_gemma":0.0005022996,"threshold_uncertainty_score":0.009197831},"labels":[],"label_agreement":null},{"id":"W2343487664","doi":"","title":"The Kisspeptin and GPR54 ligand-receptor pair are associated with favorable prognosis and clear cell subtype in human ovarian carcinoma","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Kisspeptin; Biology; Ovarian carcinoma; Immunohistochemistry; Ovary; Tissue microarray; Cancer research; Internal medicine; Receptor; Ovarian cancer; Endocrinology; Oncology; Cancer; Medicine; Immunology; Genetics","score_opus":0.1264533606682524,"score_gpt":0.4374532210557041,"score_spread":0.3109998603874517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343487664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99925786,0.00023075486,0.00009805697,0.000018410869,0.00000368032,0.000004201214,0.00014009437,0.00000332591,0.00024359883],"genre_scores_gemma":[0.99945027,0.000078426565,0.00004647697,0.0000069781076,0.00000410753,0.000005050908,0.00021409073,0.0000012650231,0.000193425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998596,0.000019783898,0.00001992806,0.000032372816,0.000035386907,0.000032899054],"domain_scores_gemma":[0.999521,0.00006728318,0.0001937934,0.000035309502,0.0000668906,0.00011576138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020580106,0.00011455392,0.0002658194,0.0007141859,0.00038344966,0.00034597036,0.00011360003,0.00024006539,0.0017305393],"category_scores_gemma":[0.0007441793,0.00014386397,0.00021046946,0.0005522238,0.00016865275,0.00015114955,0.0003021631,0.00023201911,0.00022621556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042675406,0.000024224806,0.9869561,0.000015974649,0.000039540122,0.00033366404,0.00007247969,0.00004021572,0.00969046,0.000032548807,0.00009927245,0.0022687358],"study_design_scores_gemma":[0.000005116458,0.00004299035,0.9983688,0.0000019360969,0.000022764127,0.00066151295,0.00010512171,0.00011028813,0.00041763496,0.000040508825,0.00022060455,0.0000027527167],"about_ca_topic_score_codex":0.0016500407,"about_ca_topic_score_gemma":0.0022527336,"teacher_disagreement_score":0.0017305393,"about_ca_system_score_codex":0.00014846584,"about_ca_system_score_gemma":0.00021382964,"threshold_uncertainty_score":0.0057892203},"labels":[],"label_agreement":null},{"id":"W2345499901","doi":"10.1158/1078-0432.ccr-15-2901","title":"Targeting Androgen Receptor Activation Function-1 with EPI to Overcome Resistance Mechanisms in Castration-Resistant Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Medical Research and Materiel Command; Canadian Institutes of Health Research","keywords":"Enzalutamide; Androgen receptor; Prostate cancer; Transactivation; LNCaP; Cancer research; In vivo; Biology; Mediator; Coactivator; Chemistry; Cancer; Transcription factor; Cell biology; Gene; Biochemistry; Genetics","score_opus":0.12729191842097548,"score_gpt":0.4604209835904444,"score_spread":0.33312906516946894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345499901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98693323,0.0073395083,0.0036752545,0.0001071228,0.00004282483,0.00007865695,0.00019675147,0.00012668157,0.0014999836],"genre_scores_gemma":[0.99287474,0.003083255,0.0020650944,0.000057045847,0.000016559117,0.000037816062,0.0003887854,0.000017685483,0.0014590233],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991965,0.000013937724,0.0000066181556,0.000013138147,0.000027713479,0.00001894804],"domain_scores_gemma":[0.99996114,0.000007650937,0.0000116769825,0.000005373679,0.000004587085,0.000009579547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016852753,0.0003817755,0.00033438473,0.0002211301,0.00008591426,0.00021418938,0.0002431378,0.00014856922,0.0006780137],"category_scores_gemma":[0.00007099191,0.000084094056,0.00023852805,0.00016332432,0.00015595737,0.00014801505,0.00010984672,0.000621697,0.00021085993],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014094113,0.00018783506,0.00026189224,0.00009864664,0.000018890041,0.000056012384,0.00001865587,0.00032619975,0.9910919,0.00016987715,0.00010373366,0.007525346],"study_design_scores_gemma":[0.000092764385,0.0033161552,0.0048777685,0.0000121371295,0.000092854134,0.0006419155,0.000020287755,0.002080931,0.9828917,0.000044754473,0.005919615,0.000009094158],"about_ca_topic_score_codex":0.00029431385,"about_ca_topic_score_gemma":0.0007069619,"teacher_disagreement_score":0.0006780137,"about_ca_system_score_codex":0.0001841052,"about_ca_system_score_gemma":0.00016082452,"threshold_uncertainty_score":0.0022681355},"labels":[],"label_agreement":null},{"id":"W2346128427","doi":"10.1158/1078-0432.ccr-15-2488","title":"Phase I Study of Inotuzumab Ozogamicin Combined with R-CVP for Relapsed/Refractory CD22+ B-cell Non-Hodgkin Lymphoma","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre","funders":"Pfizer","keywords":"Calicheamicin; Medicine; Rituximab; Gastroenterology; Internal medicine; Neutropenia; Tolerability; Leukopenia; Lymphoma; Febrile neutropenia; Adverse effect; Chemotherapy","score_opus":0.16024338282444303,"score_gpt":0.5031085037615861,"score_spread":0.34286512093714305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346128427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99521035,0.0013610929,0.00043231566,0.00017771698,0.000070483526,0.0015023929,0.00034227662,0.00007117481,0.00083229324],"genre_scores_gemma":[0.9936147,0.0013608469,0.0011194054,0.00033425452,0.00011115301,0.0014075694,0.0008227465,0.000022898617,0.0012064256],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999629,0.00016353256,0.00002004565,0.00006970446,0.000040329498,0.000077403725],"domain_scores_gemma":[0.9994592,0.0000583992,0.00010613911,0.000061726874,0.00003432005,0.00028017556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010508487,0.0013941035,0.0022529862,0.00037666247,0.0003625849,0.0008649345,0.0011155731,0.0009547267,0.001737906],"category_scores_gemma":[0.0005938884,0.0006060809,0.000848027,0.00038437283,0.0009946798,0.00070455973,0.00031207118,0.0027934376,0.0007436976],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47025722,0.1781081,0.008448874,0.0014883005,0.0020677368,0.0006860512,0.00062758796,0.0051858784,0.18776184,0.00038317594,0.0036722447,0.14131293],"study_design_scores_gemma":[0.28529584,0.6899293,0.0093796905,0.000040293366,0.00052005606,0.0003501695,0.00006506006,0.001146833,0.010569662,0.00010940856,0.0025675937,0.000026071531],"about_ca_topic_score_codex":0.0010855859,"about_ca_topic_score_gemma":0.0024323217,"teacher_disagreement_score":0.0022529862,"about_ca_system_score_codex":0.0009380387,"about_ca_system_score_gemma":0.0016978952,"threshold_uncertainty_score":0.006806016},"labels":[],"label_agreement":null},{"id":"W2347062064","doi":"10.1158/1078-0432.ccr-15-3086","title":"Changes in Bone Turnover Marker Levels and Clinical Outcomes in Patients with Advanced Cancer and Bone Metastases Treated with Bone Antiresorptive Agents","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bone health and treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Zoledronic acid; Denosumab; Bone remodeling; Internal medicine; N-terminal telopeptide; Cancer; Bone disease; Urology; Gastroenterology; Oncology; Osteoporosis; Endocrinology; Alkaline phosphatase; Osteocalcin","score_opus":0.18668600302445276,"score_gpt":0.5044671221239153,"score_spread":0.31778111909946255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2347062064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99788624,0.0015301319,0.00015364065,0.000043389307,0.000008050263,0.00005508349,0.00013808819,0.000004154953,0.00018120962],"genre_scores_gemma":[0.9990963,0.00019533985,0.00019113389,0.000050577575,0.000023134007,0.000058073645,0.00029137183,8.33981e-7,0.00009335318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986761,0.00065421476,0.00010001532,0.00016719635,0.00028002067,0.00012243877],"domain_scores_gemma":[0.99770397,0.000560112,0.0011070289,0.0001487479,0.00012889002,0.00035122255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025866122,0.00039996617,0.0011879253,0.00032161587,0.00023913855,0.00046147563,0.00035544301,0.00053747353,0.0008249686],"category_scores_gemma":[0.0022136897,0.00023080823,0.0010415855,0.00049326447,0.00041461247,0.00035893076,0.00035582413,0.000812206,0.00010132415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13685322,0.0024911228,0.822211,0.00021153317,0.0023800742,0.00008513904,0.00006455096,0.0009620795,0.0081725065,0.000046982295,0.0002292095,0.026292406],"study_design_scores_gemma":[0.005274244,0.034793377,0.9559833,0.000020044037,0.00080729456,0.00025350376,0.00003455487,0.0007429518,0.001483017,0.000068782516,0.0005267453,0.000012180823],"about_ca_topic_score_codex":0.00056374277,"about_ca_topic_score_gemma":0.00090731366,"teacher_disagreement_score":0.0025866122,"about_ca_system_score_codex":0.0003606815,"about_ca_system_score_gemma":0.0005387656,"threshold_uncertainty_score":0.013679504},"labels":[],"label_agreement":null},{"id":"W2368782122","doi":"10.1158/1078-0432.ccr-15-0414","title":"Fc-γ Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Queen's University; Princess Margaret Cancer Centre","funders":"","keywords":"Cetuximab; KRAS; Internal medicine; Colorectal cancer; Medicine; Oncology; Hazard ratio; Progression-free survival; Cancer; Chemotherapy; Confidence interval","score_opus":0.2803279015445654,"score_gpt":0.525412478317876,"score_spread":0.24508457677331058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2368782122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99551314,0.0029170234,0.00005704926,0.00035414737,0.00005883859,0.00009980225,0.00031094134,0.000010117489,0.0006789049],"genre_scores_gemma":[0.9973072,0.0006540377,0.0001614831,0.00024572748,0.000090042995,0.00016169576,0.000725383,0.000004774644,0.0006496691],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993056,0.00041282544,0.00003232096,0.00009863623,0.00007178422,0.00007880813],"domain_scores_gemma":[0.9989772,0.00027959884,0.00036794867,0.000060476887,0.00005528852,0.00025949944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016632352,0.00064847583,0.001038458,0.00023815127,0.0002790233,0.00056773354,0.00045936214,0.00073848414,0.0016300684],"category_scores_gemma":[0.0019452542,0.00018373097,0.00069678493,0.00035896036,0.0004900505,0.00023981305,0.00026344095,0.0011542899,0.00016278436],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8862924,0.0023194542,0.074408665,0.0006344089,0.0037928796,0.00014572464,0.00009262257,0.0015702895,0.004168962,0.00019170092,0.0032990556,0.023083754],"study_design_scores_gemma":[0.486834,0.114069775,0.3666082,0.0003773288,0.013792552,0.0007086554,0.00014674454,0.0070034456,0.0035506324,0.00049969973,0.00633253,0.00007637834],"about_ca_topic_score_codex":0.004175882,"about_ca_topic_score_gemma":0.009580614,"teacher_disagreement_score":0.004175882,"about_ca_system_score_codex":0.0010825414,"about_ca_system_score_gemma":0.0015624409,"threshold_uncertainty_score":0.008796155},"labels":[],"label_agreement":null},{"id":"W2388122605","doi":"10.1158/1078-0432.ccr-16-0381","title":"Testosterone in Androgen Receptor Signaling and DNA Repair: Enemy or <i>Frenemy</i>?","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Androgen receptor; Testosterone (patch); Androgen; Receptor; Signal transduction; Endocrinology; DNA repair; Internal medicine; Biology; DNA; Medicine; Cell biology; Genetics; Hormone; Cancer; Prostate cancer","score_opus":0.2828770154323315,"score_gpt":0.5202913688394077,"score_spread":0.23741435340707623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2388122605","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15496838,0.6906629,0.004008526,0.06565858,0.009568952,0.00005602436,0.0007731365,0.0003534819,0.07395006],"genre_scores_gemma":[0.67104477,0.25150862,0.0015099347,0.0062514427,0.0065028435,0.000026245025,0.0004377507,0.00007244908,0.06264591],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998597,0.000033039545,0.000009729377,0.00001728366,0.00004260842,0.00003765764],"domain_scores_gemma":[0.9999167,0.00001765725,0.000018134462,0.00000677209,0.000011358509,0.000029495553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039256815,0.00038650588,0.00043685402,0.0004017592,0.0004585836,0.0017952098,0.00031735262,0.0005839184,0.0058496115],"category_scores_gemma":[0.0001935541,0.00018030906,0.00035150343,0.00038632736,0.0011269968,0.00091466773,0.00035151886,0.0011181085,0.0013205651],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059102313,0.00058918895,0.010127663,0.0026521273,0.00023052497,0.0044899825,0.0012479128,0.0014296535,0.17185473,0.16985247,0.09360935,0.53800625],"study_design_scores_gemma":[0.00065467984,0.0026006657,0.06694012,0.0009697054,0.0003529867,0.008709191,0.0026990147,0.0033179505,0.09496569,0.05042397,0.7681988,0.00016717603],"about_ca_topic_score_codex":0.0022765582,"about_ca_topic_score_gemma":0.006181658,"teacher_disagreement_score":0.0058496115,"about_ca_system_score_codex":0.00069582503,"about_ca_system_score_gemma":0.0007394665,"threshold_uncertainty_score":0.01956886},"labels":[],"label_agreement":null},{"id":"W2394766804","doi":"10.1158/1557-3265.ovca15-a33","title":"Abstract A33: Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcemic type.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"SMARCA4; Trichostatin A; Cancer research; Biology; Chromatin remodeling; Histone deacetylase; Chromatin; Histone; Genetics; Gene","score_opus":0.17639603994395195,"score_gpt":0.4095317544062311,"score_spread":0.23313571446227913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2394766804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945721,0.0013913424,0.0015680998,0.00008575569,0.000027367896,0.000036017398,0.00034306236,0.00012231997,0.0018539011],"genre_scores_gemma":[0.997809,0.00020769265,0.00075913954,0.00003707555,0.00000752333,0.000016289603,0.0004317837,0.000010153034,0.00072141574],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997396,0.000036499314,0.000027524446,0.000063085135,0.00007619962,0.000057114274],"domain_scores_gemma":[0.99987626,0.000021929953,0.000030415149,0.000015677098,0.000021091337,0.000034571636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002817806,0.00031920482,0.00027414426,0.00074689114,0.00021332502,0.00021663183,0.00020686362,0.00034368917,0.002682275],"category_scores_gemma":[0.00024210098,0.0001893556,0.00021459862,0.00030417886,0.0003351603,0.0001524639,0.00020501178,0.00028504114,0.0004414412],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003199085,0.000035988334,0.024739863,0.000051415936,0.000029881136,0.0016509118,0.000020055431,0.00004811011,0.9695627,0.00008091501,0.00036376665,0.0030964324],"study_design_scores_gemma":[0.00009593515,0.00089729915,0.34878406,0.000015997077,0.00011457564,0.04844942,0.00010778361,0.0028370037,0.5903871,0.00022051085,0.008073625,0.000016668184],"about_ca_topic_score_codex":0.0008615682,"about_ca_topic_score_gemma":0.00090108305,"teacher_disagreement_score":0.002682275,"about_ca_system_score_codex":0.00028013857,"about_ca_system_score_gemma":0.00012858574,"threshold_uncertainty_score":0.008973062},"labels":[],"label_agreement":null},{"id":"W2394806078","doi":"10.1158/1557-3265.ovca15-a11","title":"Abstract A11: NGS-based tumor genomic profiling to identify ovarian cancer patients who benefit from the PARP inhibitor rucaparib.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Loss of heterozygosity; PARP inhibitor; Ovarian cancer; Olaparib; Biology; Cancer research; Synthetic lethality; Single-nucleotide polymorphism; Cancer; Genetics; Genotype; DNA repair; Gene; Allele; Poly ADP ribose polymerase","score_opus":0.20544118528878735,"score_gpt":0.5203825821443089,"score_spread":0.3149413968555215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2394806078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96572024,0.0009356974,0.003212899,0.0005793464,0.000048689573,0.00066891464,0.023681274,0.0003588684,0.004794029],"genre_scores_gemma":[0.9654717,0.00021260852,0.0075756228,0.00046509373,0.000036151567,0.0005819543,0.02278628,0.0000476146,0.0028230445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998388,0.000037045258,0.000014687127,0.000052069394,0.00003764199,0.000019741274],"domain_scores_gemma":[0.99956554,0.000095566385,0.00008258081,0.00003957867,0.00008130331,0.00013543633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005030526,0.00023166787,0.0002809,0.0005111256,0.0001959783,0.00045361207,0.00023990429,0.00035534072,0.0038872636],"category_scores_gemma":[0.0009650978,0.00015422376,0.00015127788,0.00038715027,0.00011573666,0.00017692994,0.0002479427,0.0003115869,0.0007462462],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012801414,0.00087084476,0.769413,0.00027742787,0.00017387835,0.0008374912,0.00014747186,0.0014147296,0.07848498,0.00031261978,0.0190226,0.116243646],"study_design_scores_gemma":[0.0009369526,0.0034293586,0.952518,0.000042511972,0.00016975024,0.0018845514,0.00013347581,0.005802378,0.020135114,0.00042790623,0.014496515,0.000023536255],"about_ca_topic_score_codex":0.0011794537,"about_ca_topic_score_gemma":0.0024659634,"teacher_disagreement_score":0.0038872636,"about_ca_system_score_codex":0.00034072937,"about_ca_system_score_gemma":0.00041399413,"threshold_uncertainty_score":0.013004184},"labels":[],"label_agreement":null},{"id":"W2394908773","doi":"10.1158/1557-3265.ovca15-b82","title":"Abstract B82: Application of modulated electro-hyperthermia for the cellular target therapy in ovarian cancer cells.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Microbial Inactivation Methods","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Cancer research; Cancer cell; Cancer; Apoptosis; Hyperthermia; Medicine; Viability assay; Autophagy; PARP inhibitor; Chemistry; Internal medicine; Poly ADP ribose polymerase; Enzyme","score_opus":0.1456638070780321,"score_gpt":0.5015157636757647,"score_spread":0.3558519565977326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2394908773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758455,0.010075189,0.006369121,0.0002444312,0.00011958656,0.000116913754,0.00050467526,0.0001589234,0.0065656765],"genre_scores_gemma":[0.9900087,0.0025071902,0.002506526,0.000087572735,0.000021809432,0.00010032472,0.0005810197,0.00001868873,0.0041680974],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995315,0.0000064925266,0.0000038079936,0.000011416243,0.000016654252,0.000008466955],"domain_scores_gemma":[0.99998593,0.0000031320458,0.0000032857354,0.0000019094484,0.0000030406895,0.0000025393776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007611598,0.0001989821,0.00018334718,0.00015250812,0.000080170226,0.000115271105,0.00012477003,0.00026205837,0.0017126545],"category_scores_gemma":[0.0000520582,0.00008667949,0.00014847163,0.00015874319,0.00008398067,0.000107771324,0.000117830736,0.00022826933,0.00028516565],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000957758,0.000029945528,0.000064219385,0.00009717324,0.0000041355875,0.000044901415,0.000013334939,0.00010853855,0.995421,0.000058008307,0.00017731999,0.003885629],"study_design_scores_gemma":[0.000041848423,0.0004979479,0.0023169033,0.000008306554,0.00001559282,0.00024723358,0.000011249973,0.00064494397,0.9906775,0.000028734858,0.005506564,0.000003225367],"about_ca_topic_score_codex":0.00030750435,"about_ca_topic_score_gemma":0.00040047686,"teacher_disagreement_score":0.0017126545,"about_ca_system_score_codex":0.000102962214,"about_ca_system_score_gemma":0.00010278976,"threshold_uncertainty_score":0.0057293773},"labels":[],"label_agreement":null},{"id":"W2395110963","doi":"10.1158/1557-3265.pmsclingen15-02","title":"Abstract 02: Pan-cancer analysis of hotspot mutations in genes encoding the members of mitogen activated protein kinase (MAPK) and phosphoinosidtide-3 kinase (PI3K) pathways among smokers and non-smokers","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"KRAS; PTEN; Neuroblastoma RAS viral oncogene homolog; Medicine; Lung cancer; Cancer research; Oncology; CDKN2A; STK11; Internal medicine; Amplicon; PI3K/AKT/mTOR pathway; Cancer; Gene; Biology; Genetics; Colorectal cancer; Signal transduction","score_opus":0.11947682819167309,"score_gpt":0.46531219065385726,"score_spread":0.34583536246218416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395110963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951132,0.0002572452,0.0001845123,0.000030074709,0.0000063367434,0.000026453909,0.0035159457,0.000024945248,0.00084141415],"genre_scores_gemma":[0.9926016,0.00006712269,0.0002817459,0.000044029617,0.000009355316,0.000036999794,0.005885294,0.000013536679,0.0010604179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999828,0.000024983086,0.000015535328,0.00006585351,0.000043012762,0.00002265351],"domain_scores_gemma":[0.99968565,0.0000597022,0.000087396416,0.000027163318,0.00005317001,0.00008698764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004036356,0.0001561252,0.0002623316,0.00047837,0.00023225727,0.00049119414,0.00023677923,0.00030573402,0.0051012943],"category_scores_gemma":[0.00056364556,0.00011789266,0.00024661582,0.00048809504,0.00012532723,0.00021001243,0.0002549279,0.0002481811,0.0005235471],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048232265,0.00012683819,0.95971423,0.00008865853,0.00018439667,0.00016445875,0.00005944401,0.00009344456,0.023435932,0.000039544397,0.0012594732,0.010010221],"study_design_scores_gemma":[0.00006184334,0.0004033002,0.9953934,0.00000444574,0.000101410245,0.0005673122,0.000037277725,0.00016876042,0.0025504564,0.000030460931,0.0006783931,0.0000029142254],"about_ca_topic_score_codex":0.0011182916,"about_ca_topic_score_gemma":0.0018020468,"teacher_disagreement_score":0.0051012943,"about_ca_system_score_codex":0.00020588486,"about_ca_system_score_gemma":0.00016726393,"threshold_uncertainty_score":0.017065525},"labels":[],"label_agreement":null},{"id":"W2396152701","doi":"10.1158/1557-3265.ovca15-ia06","title":"Abstract IA06: Regulation of BRCA1- and BRCA2-dependent DNA repair.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Olaparib; PALB2; Synthetic lethality; DNA repair; Cancer research; PARP inhibitor; Homologous recombination; Ovarian cancer; Cancer; DNA damage; Poly ADP ribose polymerase; BRCA2 Protein; Medicine; Biology; Polymerase; Mutation; DNA; Genetics; Gene; Germline mutation","score_opus":0.291583553690724,"score_gpt":0.5529012675953581,"score_spread":0.2613177139046341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396152701","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30690598,0.3471449,0.05209019,0.013739216,0.014913018,0.00089760014,0.024412803,0.00787074,0.23202555],"genre_scores_gemma":[0.61172426,0.103040636,0.026674403,0.003988507,0.001814254,0.00058539957,0.029832086,0.0005262728,0.22181417],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.999775,0.000034848625,0.000016413826,0.000069780624,0.00006636198,0.0000375511],"domain_scores_gemma":[0.999828,0.000016994063,0.000047314803,0.00001363103,0.000044034,0.00005003773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032914203,0.0010308429,0.00039788993,0.0008538415,0.0005244996,0.0015862227,0.0007882918,0.00070207205,0.006864133],"category_scores_gemma":[0.00019140083,0.0002704374,0.0005726631,0.00052144786,0.00042277682,0.00046152336,0.0005895731,0.0013459572,0.004271543],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006717514,0.00021974002,0.0007018028,0.00077254354,0.000026740956,0.00048344216,0.000066624,0.0005482199,0.8849223,0.006742902,0.03515549,0.06968848],"study_design_scores_gemma":[0.000113646405,0.000802776,0.0132185565,0.00022425981,0.000055835724,0.0020323223,0.0001256716,0.0025336673,0.6899858,0.0023177855,0.28855053,0.000039119495],"about_ca_topic_score_codex":0.00120638,"about_ca_topic_score_gemma":0.0008934997,"teacher_disagreement_score":0.006864133,"about_ca_system_score_codex":0.0010733078,"about_ca_system_score_gemma":0.000504377,"threshold_uncertainty_score":0.022962809},"labels":[],"label_agreement":null},{"id":"W2397394221","doi":"10.1158/1557-3265.ovca15-b51","title":"Abstract B51: Stress management: LKB1 controls growth and survival of dormant epithelial ovarian cancer spheroid cells.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Spheroid; Ovarian cancer; Biology; Cancer cell; Cancer research; Anoikis; Cell biology; Metastasis; Cancer; Cell culture; Genetics","score_opus":0.05861054569952125,"score_gpt":0.4069470954499852,"score_spread":0.34833654975046396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397394221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98827773,0.003630073,0.0019579218,0.0004305399,0.00015391025,0.000063961525,0.002025679,0.00019751428,0.0032627627],"genre_scores_gemma":[0.9937133,0.0008393431,0.00095561676,0.00011751368,0.000017144077,0.00007136889,0.0012881919,0.000033961915,0.0029633727],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99990416,0.0000138464,0.000011129842,0.000027332517,0.000018925388,0.000024669098],"domain_scores_gemma":[0.99991894,0.000011505783,0.000021561313,0.000008290538,0.0000087700755,0.00003089909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010388145,0.00028266964,0.00031204202,0.00021496296,0.00033304375,0.00035293755,0.00015746448,0.00029428158,0.002549287],"category_scores_gemma":[0.00009038213,0.00014359357,0.00019669792,0.00023486336,0.00023708127,0.00023612523,0.00017589696,0.0004690002,0.00063733914],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003393026,0.00005341798,0.00027591645,0.00008049392,0.0000042408274,0.000052848034,0.00002487621,0.00006693876,0.99720603,0.00012508157,0.00036240663,0.0014084606],"study_design_scores_gemma":[0.000072595714,0.0006312433,0.007853069,0.000012087557,0.000020401769,0.00021075414,0.000070881644,0.0014417871,0.9827608,0.00008540889,0.006832486,0.000008492792],"about_ca_topic_score_codex":0.0010848008,"about_ca_topic_score_gemma":0.0013935282,"teacher_disagreement_score":0.002549287,"about_ca_system_score_codex":0.00058771914,"about_ca_system_score_gemma":0.00035302894,"threshold_uncertainty_score":0.008528233},"labels":[],"label_agreement":null},{"id":"W2398137018","doi":"10.1158/1557-3265.ovca15-b72","title":"Abstract B72: Long-term survival and outcome update on patients (pts) with recurrent ovarian cancer who received Ipilimumab post GVAX vaccine.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ipilimumab; Medicine; Internal medicine; Ovarian cancer; Oncology; Cancer; Nivolumab; Cancer immunotherapy; Immunotherapy; Immunology","score_opus":0.15463686632635967,"score_gpt":0.48019858411441674,"score_spread":0.3255617177880571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398137018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98337525,0.007718997,0.0003282287,0.00056282274,0.000039446513,0.000058238376,0.00339852,0.000037016656,0.004481503],"genre_scores_gemma":[0.9909859,0.00225157,0.00022915912,0.0002816255,0.00013470143,0.000048248166,0.0051274416,0.000005311114,0.0009360474],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987197,0.000030389794,0.00001832095,0.000020750915,0.000028462175,0.000030055167],"domain_scores_gemma":[0.9995932,0.00008174437,0.00014641575,0.000017207192,0.000053507418,0.00010796155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031244804,0.00023218396,0.00046740912,0.0005429713,0.00027518044,0.0005822401,0.00017491753,0.00039618203,0.0016345247],"category_scores_gemma":[0.00048326992,0.00008450564,0.0004144828,0.0006890669,0.00013349102,0.0003605928,0.00024142562,0.0004742411,0.00044365745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00551159,0.00033398526,0.9121921,0.0002484428,0.00028961877,0.001178988,0.0002067555,0.00042763955,0.0029757891,0.00006546429,0.003508616,0.07306099],"study_design_scores_gemma":[0.00032161843,0.0042583817,0.98183846,0.000085984604,0.0004828569,0.003457045,0.00017701123,0.00046129464,0.00094823306,0.000085227635,0.007866634,0.000017226794],"about_ca_topic_score_codex":0.0012484393,"about_ca_topic_score_gemma":0.0026919295,"teacher_disagreement_score":0.0016345247,"about_ca_system_score_codex":0.00027618476,"about_ca_system_score_gemma":0.0001780138,"threshold_uncertainty_score":0.0054680705},"labels":[],"label_agreement":null},{"id":"W2398467218","doi":"10.1158/1557-3265.ovca15-b27","title":"Abstract B27: Investigation of small GTPase genes in epithelial ovarian cancer.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Biology; Single-nucleotide polymorphism; Small GTPase; Ovarian cancer; Gene; GTPase; Cancer; Cancer research; Rab; Ras superfamily; Odds ratio; Carcinogenesis; Genetics; Bioinformatics; Internal medicine; Oncology; Signal transduction; Genotype; Medicine; GTP'","score_opus":0.32991778770584873,"score_gpt":0.5111181086346965,"score_spread":0.1812003209288478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398467218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899974,0.003018718,0.0014809786,0.00023880477,0.000036607373,0.00004137925,0.0043438375,0.000054210235,0.0007881565],"genre_scores_gemma":[0.9943719,0.00047409695,0.0018163578,0.00010332761,0.000032203312,0.000068991976,0.002254952,0.000020585643,0.0008574808],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991041,0.00028638716,0.000066726,0.0002888203,0.00017518723,0.00007881635],"domain_scores_gemma":[0.9982697,0.0008819432,0.00041218245,0.00009250921,0.00012822461,0.00021541184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010646457,0.0004109723,0.00043551868,0.0014639163,0.00041053497,0.00050877954,0.00042746615,0.0005761978,0.0021702358],"category_scores_gemma":[0.0024963669,0.00019039917,0.0005796018,0.002183034,0.0003831124,0.00015301253,0.0004158026,0.00056948734,0.0003862626],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018142243,0.00012149091,0.9585059,0.0003741677,0.00074424053,0.00060597976,0.00012376384,0.0006573834,0.020231878,0.00025729736,0.0012671264,0.015296602],"study_design_scores_gemma":[0.00009481105,0.00045885943,0.98881125,0.000031664033,0.0005289964,0.0011054275,0.000087226326,0.0012176197,0.0037800479,0.00033781235,0.0035355464,0.00001070602],"about_ca_topic_score_codex":0.0029056654,"about_ca_topic_score_gemma":0.0018405872,"teacher_disagreement_score":0.0029056654,"about_ca_system_score_codex":0.00030921886,"about_ca_system_score_gemma":0.0006185109,"threshold_uncertainty_score":0.0072601438},"labels":[],"label_agreement":null},{"id":"W2398536625","doi":"10.1158/1557-3265.ovca15-a27","title":"Abstract A27: Transcriptome analyses of human ampulla and fimbriae highlight similarities and differences.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Transcriptome; Fallopian tube; Biology; Ampulla; Serous fluid; Andrology; Oviduct; Genetics; Gene; Gene expression; Medicine; Endocrinology; Anatomy","score_opus":0.4691759364194461,"score_gpt":0.5744284520348472,"score_spread":0.10525251561540105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398536625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98505175,0.0029555452,0.0038731822,0.00010973043,0.000024169603,0.00005988136,0.00539178,0.00011150691,0.0024223765],"genre_scores_gemma":[0.9714944,0.001382993,0.008682132,0.00013116017,0.00002473534,0.00015010635,0.013147512,0.00004936085,0.0049376343],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988055,0.00000857989,0.0000068275544,0.00004500938,0.000031751635,0.000027334869],"domain_scores_gemma":[0.99991775,0.0000204384,0.000015759071,0.000013273355,0.000017609931,0.00001512164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001207789,0.00015283565,0.00026548962,0.0005132459,0.0004086167,0.00041569624,0.0001368825,0.0002767887,0.0019640257],"category_scores_gemma":[0.0002841693,0.00010292982,0.0003298155,0.0006197297,0.00019301228,0.0001885598,0.00033703778,0.00027729027,0.00067652884],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024749068,0.000013266544,0.0071934313,0.0001409885,0.000015822861,0.00021987705,0.00013011167,0.00008177066,0.9828693,0.00006925525,0.00020210409,0.008816586],"study_design_scores_gemma":[0.000019543155,0.00037611532,0.7603483,0.000049474434,0.00007504614,0.0033016554,0.0004949613,0.001654362,0.21391502,0.00023758897,0.019508423,0.000019525512],"about_ca_topic_score_codex":0.0011097154,"about_ca_topic_score_gemma":0.0011492398,"teacher_disagreement_score":0.0019640257,"about_ca_system_score_codex":0.00018377564,"about_ca_system_score_gemma":0.00018911113,"threshold_uncertainty_score":0.006570339},"labels":[],"label_agreement":null},{"id":"W2398537820","doi":"10.1158/1557-3265.ovca15-b20","title":"Abstract B20: Uptake and safety of bilateral salpingectomy for ovarian cancer prevention in the United States.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Salpingectomy; Tubal ligation; Hysterectomy; Fallopian tube; Perioperative; Ovarian cancer; Odds ratio; Obstetrics; Gynecology; Blood transfusion; Surgery; Cancer; Population; Family planning; Internal medicine; Pregnancy","score_opus":0.24702994200356687,"score_gpt":0.5268873059424586,"score_spread":0.2798573639388917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398537820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99246806,0.0008716697,0.00008804803,0.00075925165,0.000022615815,0.000023276267,0.0039667003,0.000009801996,0.001790575],"genre_scores_gemma":[0.9977563,0.00030992323,0.00007211139,0.0001623599,0.000021642765,0.000015003561,0.0014339605,0.0000019740203,0.00022686472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99950886,0.00014490905,0.00006788564,0.00006736018,0.00015360558,0.000057403682],"domain_scores_gemma":[0.996498,0.00052322686,0.002059736,0.00008708883,0.00043375997,0.00039820131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075071806,0.00011383762,0.00013731116,0.000492532,0.00018264122,0.0002861829,0.00031071712,0.0002890677,0.0015440659],"category_scores_gemma":[0.0043296968,0.00012996042,0.00041856163,0.000797137,0.00013024079,0.0002937462,0.00036821244,0.0003903606,0.00017654707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000690928,0.000048022863,0.99542624,0.000025185214,0.000044813016,0.00001597726,0.000028787335,0.000046088273,0.00005467166,0.0000136722165,0.000526381,0.003700974],"study_design_scores_gemma":[0.000005900446,0.000053541193,0.9993612,0.000013305766,0.000019448025,0.00003076407,0.000084604144,0.00017599316,0.00002647649,0.000009016431,0.00021846898,0.000001260378],"about_ca_topic_score_codex":0.044314925,"about_ca_topic_score_gemma":0.04833266,"teacher_disagreement_score":0.044314925,"about_ca_system_score_codex":0.000600786,"about_ca_system_score_gemma":0.0009274133,"threshold_uncertainty_score":0.08811396},"labels":[],"label_agreement":null},{"id":"W2398570616","doi":"10.1158/1078-0432.ccr-16-0506","title":"A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development","funders":"Cancer Research UK","keywords":"Glioblastoma; Temozolomide; Immunogenicity; Medicine; Adjuvant; Cancer; Oncology; Clinical trial; Chemoradiotherapy; Internal medicine; Antigen; Cancer research; Immunology","score_opus":0.10926358659076571,"score_gpt":0.46764253870010813,"score_spread":0.35837895210934245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398570616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99554944,0.0012939051,0.0002816004,0.000296896,0.00013203181,0.0013209693,0.00042118365,0.000039621897,0.00066427287],"genre_scores_gemma":[0.9931103,0.0008757386,0.00075545243,0.0008380046,0.00014103261,0.0014476847,0.001164703,0.000014724203,0.0016524598],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99953675,0.00021442148,0.000024802632,0.00008116717,0.000038850994,0.000104028375],"domain_scores_gemma":[0.9993469,0.000059769856,0.00011931483,0.00006166281,0.000045140412,0.00036715684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012638007,0.0010985276,0.0016480852,0.00021326443,0.00032581954,0.00068553776,0.00053052546,0.0008109864,0.0024491546],"category_scores_gemma":[0.00076023326,0.00044134838,0.00079489785,0.00021716436,0.00063861295,0.00064235576,0.00035073303,0.002206197,0.0006877607],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7422111,0.0497866,0.017002426,0.0008009276,0.0014461491,0.00058907806,0.00042231506,0.0017948938,0.06240368,0.00026458706,0.0049529877,0.11832525],"study_design_scores_gemma":[0.3407639,0.63094264,0.019598901,0.000033411074,0.00035617346,0.00030584077,0.000065503926,0.0006901733,0.003858125,0.00011099977,0.0032492669,0.000025034911],"about_ca_topic_score_codex":0.0009918611,"about_ca_topic_score_gemma":0.0024873505,"teacher_disagreement_score":0.0024491546,"about_ca_system_score_codex":0.00084003,"about_ca_system_score_gemma":0.0014763696,"threshold_uncertainty_score":0.0081932545},"labels":[],"label_agreement":null},{"id":"W2400235072","doi":"10.1158/1557-3265.ovca15-a01","title":"Abstract A01: A comparison of the mechanisms and cytotoxic activity of dianhydrogalactitol (VAL-083) to cisplatin in ovarian tumor models harboring wild-type and mutant p53.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Carboplatin; Cisplatin; Ovarian cancer; DNA damage; Cancer research; Medicine; Serous carcinoma; Ovarian carcinoma; Oncology; Mutant; Cancer; Internal medicine; Pharmacology; Biology; Chemotherapy; DNA; Genetics; Gene","score_opus":0.19226069816223063,"score_gpt":0.4747115077011167,"score_spread":0.28245080953888607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400235072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99383485,0.0016705242,0.0011237134,0.00008436689,0.00007345668,0.000121745565,0.0014041987,0.00007640996,0.0016107977],"genre_scores_gemma":[0.98976153,0.0013440262,0.0021013701,0.00007822954,0.000017958455,0.00012594851,0.0032801675,0.000030470499,0.0032602933],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998634,0.000035564353,0.000012572942,0.000027588618,0.000031757783,0.000029204375],"domain_scores_gemma":[0.99985313,0.000031248026,0.00002890505,0.000015781216,0.000028053191,0.00004286605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018108386,0.00041214816,0.00033397533,0.00034762657,0.00012208341,0.0002121605,0.00030775805,0.00034391126,0.0015444681],"category_scores_gemma":[0.0001238835,0.00011574769,0.0004088308,0.00038060846,0.00017051944,0.00021021857,0.00012718643,0.00066719425,0.00032778704],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018863194,0.00081796973,0.00032740465,0.00014613956,0.000030236162,0.000074634656,0.000028352066,0.00061204005,0.98993194,0.000097530574,0.0003493667,0.005698052],"study_design_scores_gemma":[0.00016440374,0.0145559935,0.004933261,0.000012681749,0.00005129373,0.00019671,0.00004320383,0.0027133038,0.9744272,0.00005713341,0.002828421,0.000016468566],"about_ca_topic_score_codex":0.0012551347,"about_ca_topic_score_gemma":0.0009995007,"teacher_disagreement_score":0.0015444681,"about_ca_system_score_codex":0.00025614805,"about_ca_system_score_gemma":0.00021931218,"threshold_uncertainty_score":0.005166769},"labels":[],"label_agreement":null},{"id":"W2400789541","doi":"10.1158/1557-3265.ovca15-b21","title":"Abstract B21: <i>BRCA</i> mutation status is not associated with better long-term survival from epithelial ovarian cancer.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; Women's College Hospital","funders":"","keywords":"Ovarian cancer; Medicine; Cancer; BRCA mutation; Oncology; Cancer registry; Population; Mutation; Internal medicine; Disease; Cohort; Medical record; Gynecology; Genetics; Biology; Gene","score_opus":0.18987173276025182,"score_gpt":0.4788354603427074,"score_spread":0.2889637275824556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400789541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970521,0.00036937726,0.000032183834,0.00015457257,0.000008053389,0.0000056277236,0.0014521284,0.0000043199693,0.0009215952],"genre_scores_gemma":[0.9985506,0.00007056891,0.000019235587,0.000030466092,0.000007832343,0.0000028741454,0.0008026379,0.0000015686078,0.00051424094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998841,0.000012979756,0.000009997766,0.000025429785,0.00003242868,0.000035005425],"domain_scores_gemma":[0.9989447,0.00010921338,0.00050016766,0.000041250496,0.00020922656,0.00019551259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023864362,0.00014779477,0.00015213627,0.00030851242,0.00032300293,0.0003729078,0.0002854322,0.00024114587,0.003787265],"category_scores_gemma":[0.0013276075,0.00006638056,0.00020680664,0.000485621,0.0002918872,0.00018360802,0.00014972029,0.00020707991,0.00023263092],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002223921,0.000010422916,0.99731666,0.000014680539,0.00002628896,0.00010448926,0.000030517724,0.000029877892,0.00048636808,0.000009116632,0.00040032275,0.0013488197],"study_design_scores_gemma":[0.0000061813093,0.000025189274,0.99944323,0.000005427639,0.00001825428,0.00015030972,0.000028687658,0.0000359569,0.00005525368,0.000007891566,0.00022280087,7.8348415e-7],"about_ca_topic_score_codex":0.22326246,"about_ca_topic_score_gemma":0.20576058,"teacher_disagreement_score":0.22326246,"about_ca_system_score_codex":0.0012622597,"about_ca_system_score_gemma":0.001388091,"threshold_uncertainty_score":0.44392586},"labels":[],"label_agreement":null},{"id":"W2401633919","doi":"10.1158/1557-3265.ovca15-a82","title":"Abstract A82: Ovarian cancer cells hijack immune functions of omental milky spots for metastatic colonization.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Intraperitoneal and Appendiceal Malignancies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Biology; Ovarian cancer; Pathology; Immune system; Stromal cell; Peritoneal cavity; Homing (biology); Immunology; Cancer research; Cancer; Medicine; Anatomy","score_opus":0.20531678017353266,"score_gpt":0.4956104931747954,"score_spread":0.2902937130012627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401633919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901642,0.00093195867,0.0033935737,0.00018697059,0.000037471014,0.00008298028,0.0012606449,0.00011677491,0.0038254475],"genre_scores_gemma":[0.9833965,0.00074332196,0.0036753074,0.00010004116,0.000027447612,0.00012732818,0.0021911475,0.000036288322,0.009702613],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998597,0.00001697994,0.000009813562,0.000027285228,0.00004520481,0.000041022962],"domain_scores_gemma":[0.99989295,0.000025964831,0.000025684316,0.000015743779,0.000014357956,0.000025343214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015606091,0.00034723422,0.0001982186,0.00021255776,0.0001866211,0.00029379156,0.00016682416,0.00029451904,0.004446243],"category_scores_gemma":[0.00012985748,0.00011538206,0.00019350594,0.00018709627,0.0002560797,0.00023052518,0.00021579854,0.0004793148,0.0010950571],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019325376,0.00004275173,0.0004544247,0.00005636591,0.0000028666414,0.00010478895,0.00001906655,0.000037928563,0.9971751,0.00016811503,0.00016049744,0.001584893],"study_design_scores_gemma":[0.00007087345,0.00070738775,0.0108412355,0.00001036139,0.000014035548,0.0008193596,0.000051053008,0.0007199615,0.98036516,0.00010693585,0.0062891115,0.0000045530523],"about_ca_topic_score_codex":0.00045177186,"about_ca_topic_score_gemma":0.00041851093,"teacher_disagreement_score":0.004446243,"about_ca_system_score_codex":0.00024951546,"about_ca_system_score_gemma":0.00021761245,"threshold_uncertainty_score":0.01487416},"labels":[],"label_agreement":null},{"id":"W2401783873","doi":"10.1158/1078-0432.ccr-16-0143","title":"Repurposing Sunitinib with Oncolytic Reovirus as a Novel Immunotherapeutic Strategy for Renal Cell Carcinoma","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Oncolytic virus; Sunitinib; Immune system; Cancer research; Medicine; Immunotherapy; Renal cell carcinoma; Chemokine; Immunology; Oncology","score_opus":0.25016306034826696,"score_gpt":0.5153506754140655,"score_spread":0.2651876150657986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401783873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833754,0.008184359,0.0058756513,0.00014523769,0.000095512354,0.00012423798,0.00013911552,0.00012114641,0.0019392376],"genre_scores_gemma":[0.9935382,0.0022287231,0.0028865088,0.00003691978,0.000022552065,0.00004102114,0.00010539296,0.000010476188,0.0011302168],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999163,0.000012638092,0.00000603141,0.000015403655,0.000027495884,0.000022026916],"domain_scores_gemma":[0.9999726,0.0000032051246,0.0000091359,0.0000042109805,0.0000039907904,0.0000068310096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013117056,0.0002533196,0.0003793039,0.00024951497,0.0001107675,0.0002484882,0.00020653234,0.00021506051,0.0007597784],"category_scores_gemma":[0.000050921964,0.00008379347,0.00034559323,0.00012240477,0.00012793326,0.00020002338,0.00013345093,0.00032529066,0.00016690754],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037996835,0.0002010621,0.00035525142,0.00013865222,0.00002633061,0.000093819566,0.000020284158,0.0006642039,0.980251,0.0001727053,0.00013700579,0.017559702],"study_design_scores_gemma":[0.000106332285,0.0033862516,0.002929035,0.000012472359,0.000079289086,0.0006633503,0.000025690804,0.0025720885,0.98404074,0.000066964894,0.006106671,0.000011183883],"about_ca_topic_score_codex":0.00034039983,"about_ca_topic_score_gemma":0.0009782647,"teacher_disagreement_score":0.0007597784,"about_ca_system_score_codex":0.00023386498,"about_ca_system_score_gemma":0.00019939766,"threshold_uncertainty_score":0.0025417209},"labels":[],"label_agreement":null},{"id":"W2402661058","doi":"10.1158/1078-0432.ccr-15-1790","title":"The Spectrum and Clinical Impact of Epigenetic Modifier Mutations in Myeloma","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Cancer Institute; Wellcome Trust","keywords":"Multiple myeloma; Epigenetics; Medicine; Genetics; Biology; Cancer research; Oncology; Computational biology; Internal medicine; Gene","score_opus":0.26439112371027307,"score_gpt":0.5900468396188847,"score_spread":0.32565571590861164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402661058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972029,0.0013059762,0.00030792053,0.00011754648,0.0000033808556,0.000009117018,0.00025395997,0.000019182275,0.00078010256],"genre_scores_gemma":[0.9993105,0.00017991754,0.00021825651,0.000028086082,0.000006686998,0.00000439668,0.00016868243,0.0000035997596,0.00007987806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995314,0.00013135307,0.00004615572,0.000118170145,0.0001258847,0.00004719587],"domain_scores_gemma":[0.9989236,0.0005022002,0.00032167658,0.00007534101,0.0000695851,0.000107664855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010681389,0.00020443984,0.00033864818,0.0007444999,0.00029922838,0.0005017426,0.00023916502,0.00048266244,0.0015787745],"category_scores_gemma":[0.0021234318,0.00013790898,0.00017436019,0.000529899,0.0003936966,0.00025848654,0.00039938572,0.000309139,0.00022060405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012872897,0.00006562585,0.9524769,0.000047309833,0.00008881836,0.0013040554,0.00007200266,0.00045414647,0.021942204,0.00012756918,0.00023710685,0.021896949],"study_design_scores_gemma":[0.00002743007,0.0003168585,0.9903474,0.0000132250325,0.000058944664,0.0047430024,0.000048553655,0.00054385245,0.0031904292,0.00020272253,0.0005017981,0.0000057880006],"about_ca_topic_score_codex":0.00043677696,"about_ca_topic_score_gemma":0.0006364696,"teacher_disagreement_score":0.0015787745,"about_ca_system_score_codex":0.00031184306,"about_ca_system_score_gemma":0.00019470301,"threshold_uncertainty_score":0.0056489706},"labels":[],"label_agreement":null},{"id":"W2403126261","doi":"10.1158/1557-3265.ovca15-a65","title":"Abstract A65: Nodal contributes to cisplatin resistance in ovarian cancer cells.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Tissue Engineering and Regenerative Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cisplatin; Clonogenic assay; Ovarian cancer; Stem cell; Cancer stem cell; Biology; NODAL; Cancer research; Metastasis; Stem cell marker; Cell growth; Cell culture; Molecular biology; Cancer; Cell biology; Chemotherapy; Anatomy","score_opus":0.172899734597248,"score_gpt":0.516692959167029,"score_spread":0.34379322456978095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403126261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817949,0.0067992047,0.0024624679,0.00040804897,0.00010678238,0.00007727139,0.0019483959,0.00020198291,0.0062010013],"genre_scores_gemma":[0.9883527,0.0017558407,0.0005522707,0.00011375998,0.000022466798,0.00005382355,0.001776689,0.000034594952,0.007337741],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990046,0.000011690881,0.000009094368,0.000024935147,0.000031483905,0.00002240809],"domain_scores_gemma":[0.999926,0.000011403725,0.000016135828,0.000009018112,0.000008169624,0.000029241626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010292874,0.00034447582,0.00021224974,0.00028153867,0.00021623973,0.0003593243,0.00020437298,0.00040068076,0.0054179532],"category_scores_gemma":[0.00014142336,0.00014077914,0.00027357662,0.0002498716,0.0002364068,0.00018801636,0.0002494327,0.00044429567,0.0013859438],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023547883,0.000039978007,0.0006909949,0.00014291887,0.000007966207,0.00025495037,0.00002469088,0.00006669292,0.9952459,0.00029885446,0.00036765615,0.0026238929],"study_design_scores_gemma":[0.00026915298,0.0011305425,0.053901657,0.00007357994,0.00013122286,0.004485958,0.00022026006,0.0031216114,0.8976556,0.0006800248,0.038310494,0.000019861365],"about_ca_topic_score_codex":0.00065560103,"about_ca_topic_score_gemma":0.00046383328,"teacher_disagreement_score":0.0054179532,"about_ca_system_score_codex":0.0002656418,"about_ca_system_score_gemma":0.00020573751,"threshold_uncertainty_score":0.018124819},"labels":[],"label_agreement":null},{"id":"W2403652567","doi":"10.1158/1557-3265.ovca15-ia15","title":"Abstract IA15: Rarer, yet both interesting and relevant: Other ovarian cancers.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Foundation","funders":"","keywords":"Ovarian cancer; Serous fluid; Medicine; Cancer; Germ cell tumors; Serous carcinoma; Oncology; Ovarian carcinoma; Gynecology; Pathology; Internal medicine; Cancer research; Chemotherapy","score_opus":0.3079086064732586,"score_gpt":0.5336703794071166,"score_spread":0.22576177293385802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403652567","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05381485,0.49878398,0.0068776207,0.098455735,0.040839978,0.000669879,0.010959161,0.0018509999,0.2877478],"genre_scores_gemma":[0.36540207,0.25746953,0.009498592,0.035764758,0.036089983,0.00023975113,0.0130098425,0.0005985276,0.28192693],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994579,0.00007229633,0.0000545892,0.00008600135,0.00022299905,0.00010624966],"domain_scores_gemma":[0.9989095,0.00016396545,0.00033861186,0.0000870314,0.0001982866,0.00030261232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008159221,0.0006060075,0.0008392872,0.0018427559,0.00071310863,0.0025342323,0.0005687252,0.0012625001,0.02174976],"category_scores_gemma":[0.0018288072,0.00026314473,0.00054302276,0.0017360788,0.00077365024,0.0009194026,0.0010528578,0.0014522666,0.0061331517],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049171963,0.00009272906,0.020764515,0.001665783,0.00009799607,0.016883673,0.00028905575,0.0003455108,0.01090029,0.01487916,0.543701,0.38988853],"study_design_scores_gemma":[0.00004422971,0.0001497301,0.026740026,0.00084518763,0.00008117365,0.0624963,0.00032731646,0.00020987164,0.0031308874,0.0065809446,0.89935935,0.00003494733],"about_ca_topic_score_codex":0.0022596354,"about_ca_topic_score_gemma":0.005323576,"teacher_disagreement_score":0.02174976,"about_ca_system_score_codex":0.0011694802,"about_ca_system_score_gemma":0.0014362144,"threshold_uncertainty_score":0.072760224},"labels":[],"label_agreement":null},{"id":"W2403913515","doi":"10.1158/1557-3265.ovca15-b13","title":"Abstract B13: Discovery of novel subtype-specific ovarian cancer biomarkers via integrated tissue proteomics.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital","funders":"","keywords":"Serous fluid; Biomarker discovery; Clear cell; Ovarian cancer; Serous ovarian cancer; Proteomics; Biomarker; Serous Cystadenoma; Endometriosis; Proteome; Cancer; Clear cell carcinoma; Computational biology; Medicine; Bioinformatics; Cancer research; Biology; Carcinoma; Pathology; Internal medicine; Gene","score_opus":0.11385020745931351,"score_gpt":0.43932762014833027,"score_spread":0.32547741268901675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403913515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82266873,0.014429708,0.09784467,0.0009543727,0.00023460512,0.0010292408,0.052977055,0.0037863564,0.0060752816],"genre_scores_gemma":[0.55427074,0.006564336,0.31897706,0.0007754121,0.00014930395,0.0006726953,0.1109004,0.00052809017,0.007161832],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99961865,0.000036235353,0.000035276666,0.00012567714,0.0001386367,0.00004555172],"domain_scores_gemma":[0.99971277,0.0000538833,0.00006765155,0.00002331749,0.00008960759,0.000052661057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081621564,0.00088165444,0.0010143322,0.001470983,0.00040633598,0.0011415009,0.00061298884,0.00071898603,0.002943732],"category_scores_gemma":[0.00078638684,0.0003229266,0.0007671246,0.0019985351,0.00015750338,0.00047831345,0.00054955616,0.0005961668,0.0027266094],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009690149,0.00020732109,0.0122679565,0.0009909165,0.00017342674,0.0004001972,0.000052556436,0.0008503942,0.9332726,0.00027409848,0.0030076136,0.047533866],"study_design_scores_gemma":[0.00032457433,0.001777645,0.12805423,0.00020179493,0.000869397,0.005087502,0.00022816827,0.03953307,0.78223103,0.0013336998,0.040231656,0.00012726404],"about_ca_topic_score_codex":0.0010532687,"about_ca_topic_score_gemma":0.0016126551,"teacher_disagreement_score":0.002943732,"about_ca_system_score_codex":0.0003785567,"about_ca_system_score_gemma":0.0009865754,"threshold_uncertainty_score":0.00984776},"labels":[],"label_agreement":null},{"id":"W2405826784","doi":"10.1158/1557-3265.pmsclingen15-pr02","title":"Abstract PR02: Integrated genomic analysis of a recurrent ghost cell odontogenic carcinoma","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Oral and Maxillofacial Pathology","field":"Dentistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; PTEN; Loss of heterozygosity; Copy-number variation; Comparative genomic hybridization; Cancer; Genome; Genetics; CDKN2A; Gene; Cancer research; Bioinformatics; Allele","score_opus":0.24833284982520185,"score_gpt":0.5041195481080826,"score_spread":0.2557866982828807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405826784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9708745,0.0009727562,0.0059337746,0.00043589357,0.000059170223,0.0001814524,0.018542074,0.00040486464,0.0025955446],"genre_scores_gemma":[0.9620519,0.0006212898,0.014007111,0.00034176104,0.000030289799,0.00007995261,0.020703504,0.00015878184,0.0020053426],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99965274,0.000016751083,0.000023723187,0.000107818065,0.00014568416,0.000053194486],"domain_scores_gemma":[0.99962103,0.00008427869,0.00006501308,0.000047704867,0.000097116914,0.0000847434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003240334,0.0002957512,0.00042534355,0.0014331663,0.00055103505,0.00072752574,0.00034999754,0.0007250434,0.0019977354],"category_scores_gemma":[0.0009374892,0.00017894484,0.0005468855,0.0011831541,0.0002298444,0.00012949703,0.0007050182,0.00057918124,0.0007216068],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015159982,0.0002193245,0.14324196,0.00059100264,0.00029012607,0.039601173,0.000843359,0.002028307,0.72862303,0.0007724597,0.005501403,0.0767718],"study_design_scores_gemma":[0.00012854891,0.001020231,0.6806003,0.00015942093,0.0006948613,0.0809246,0.0013120382,0.011109344,0.16922888,0.0012445594,0.05348413,0.00009319635],"about_ca_topic_score_codex":0.0041827285,"about_ca_topic_score_gemma":0.005839479,"teacher_disagreement_score":0.0041827285,"about_ca_system_score_codex":0.00050612935,"about_ca_system_score_gemma":0.00067940925,"threshold_uncertainty_score":0.008316755},"labels":[],"label_agreement":null},{"id":"W2406092735","doi":"10.1158/1557-3265.ovca15-b54","title":"Abstract B54: Single and collective cell dissemination modes in ovarian cancer.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Occupational Cancer Research Centre","funders":"","keywords":"Ovarian cancer; Cancer research; Ascites; Spheroid; Cancer cell; Cancer; Biology; In vivo; Peritoneal cavity; Pathology; In vitro; Medicine; Internal medicine; Anatomy","score_opus":0.253045088764766,"score_gpt":0.5389415179272586,"score_spread":0.28589642916249264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406092735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837113,0.005597709,0.0057181967,0.00019123498,0.000028318831,0.00007464947,0.0007362184,0.0001427861,0.0037996708],"genre_scores_gemma":[0.9914151,0.0013401,0.004154527,0.000049889615,0.000010132133,0.00006642157,0.000716781,0.000023249155,0.0022237655],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988747,0.000010319198,0.000009045112,0.00003560125,0.000033088705,0.000024363111],"domain_scores_gemma":[0.9998932,0.000021241798,0.000032366806,0.000011770841,0.000017006894,0.000024349592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013098009,0.00028830834,0.00028017224,0.0005682289,0.00031218366,0.00046196155,0.00024593182,0.00042964672,0.0021641017],"category_scores_gemma":[0.00013748213,0.0001650176,0.00029392072,0.00041862603,0.00023754715,0.00044386555,0.00043510433,0.000427425,0.0005990198],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101079735,0.000033879434,0.0027639354,0.00017721107,0.000009823474,0.00022946863,0.00009646282,0.0002702234,0.9902473,0.00029439104,0.00030190824,0.0054742526],"study_design_scores_gemma":[0.0000668092,0.0009453312,0.060258366,0.000083877065,0.00009396724,0.0036134925,0.00045149704,0.007888671,0.9082154,0.00064576126,0.017698605,0.00003825879],"about_ca_topic_score_codex":0.0017689848,"about_ca_topic_score_gemma":0.0012868317,"teacher_disagreement_score":0.0021641017,"about_ca_system_score_codex":0.0003678039,"about_ca_system_score_gemma":0.00018276925,"threshold_uncertainty_score":0.0072396398},"labels":[],"label_agreement":null},{"id":"W2407048108","doi":"10.1158/1557-3265.ovca15-a35","title":"Abstract A35: Elucidating mechanisms involved in long-term response to platinum-based chemotherapy in high-grade serous ovarian cancer.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Debulking; Ovarian cancer; Chemotherapy; Cancer; Medicine; Pathology; Oncology; Internal medicine","score_opus":0.16630467607272914,"score_gpt":0.49017947605795675,"score_spread":0.3238747999852276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407048108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99604493,0.0027045433,0.00044840804,0.00008229623,0.000005818663,0.000017015112,0.00039738233,0.00001541674,0.0002841001],"genre_scores_gemma":[0.9982405,0.000516993,0.00037202556,0.000036035795,0.000008956086,0.000013830746,0.0004937135,0.0000027129938,0.0003153025],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999174,0.000017620829,0.000007922985,0.000019586081,0.000023170647,0.0000144067935],"domain_scores_gemma":[0.9997483,0.000052653086,0.00010903451,0.000020905576,0.000030540534,0.000038619517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045268142,0.00013575696,0.00018093405,0.00044559926,0.00012653682,0.0004177988,0.0002247982,0.00023981006,0.0009872848],"category_scores_gemma":[0.00036949365,0.00008243111,0.00023850666,0.0003460637,0.0001957346,0.00027868222,0.0001834717,0.00023200385,0.00021554335],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002699514,0.00021774707,0.3767237,0.00055074174,0.00016991571,0.0009597328,0.00031430324,0.0009792448,0.56441694,0.0003355083,0.0007153924,0.05191729],"study_design_scores_gemma":[0.00003394124,0.0010603635,0.9607918,0.000025469348,0.00010473509,0.0014312846,0.00016002302,0.001768408,0.032803323,0.00026559088,0.0015467186,0.000008449989],"about_ca_topic_score_codex":0.00056889653,"about_ca_topic_score_gemma":0.0005696277,"teacher_disagreement_score":0.0009872848,"about_ca_system_score_codex":0.00023743325,"about_ca_system_score_gemma":0.00015744468,"threshold_uncertainty_score":0.0033028126},"labels":[],"label_agreement":null},{"id":"W2407055211","doi":"10.1158/1557-3265.pmsclingen15-ia15","title":"Abstract IA15: “Next-gen” genomics-based clinical trials","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Druggability; Clinical trial; Genomics; Precision medicine; Profiling (computer programming); Computational biology; Bioinformatics; Medicine; Biology; Genome; Pathology; Genetics; Computer science; Gene","score_opus":0.5029259291989813,"score_gpt":0.5949847621123466,"score_spread":0.09205883291336536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407055211","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19787125,0.10432625,0.09650434,0.21428539,0.03420198,0.06223733,0.0615725,0.0057661007,0.22323482],"genre_scores_gemma":[0.52093923,0.028556744,0.13803181,0.16992417,0.007599274,0.06249783,0.033415593,0.000821842,0.038213633],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9817821,0.014567184,0.00065832335,0.0010341231,0.0012662278,0.00069207774],"domain_scores_gemma":[0.98747987,0.0040480406,0.0021662218,0.001440279,0.001423455,0.0034421931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027792158,0.001214653,0.0017903355,0.0007970147,0.00069336523,0.0042050183,0.0014103727,0.0040958035,0.018369848],"category_scores_gemma":[0.017946996,0.00040960984,0.0026666145,0.00074256695,0.0013701688,0.0016341778,0.0024600693,0.0047008567,0.0054676435],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12730953,0.0059823575,0.008157994,0.0066892514,0.00507921,0.0005726674,0.00034240703,0.006321522,0.013840301,0.042316075,0.26641014,0.51697856],"study_design_scores_gemma":[0.19892982,0.08964527,0.017891327,0.0062549976,0.0029404408,0.0011781908,0.00019711921,0.010292076,0.008764624,0.061917678,0.6017706,0.00021789268],"about_ca_topic_score_codex":0.0007025958,"about_ca_topic_score_gemma":0.00090961956,"teacher_disagreement_score":0.027792158,"about_ca_system_score_codex":0.0026098746,"about_ca_system_score_gemma":0.0060643647,"threshold_uncertainty_score":0.1469807},"labels":[],"label_agreement":null},{"id":"W2407450722","doi":"10.1158/1557-3265.ovca15-b08","title":"Abstract B08: Genomics analyses of less common epithelial ovarian cancer subtypes.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Calgary; University of British Columbia","funders":"","keywords":"KRAS; Serous fluid; Neuroblastoma RAS viral oncogene homolog; CDKN2A; Serous carcinoma; Exome sequencing; Ovarian carcinoma; Mucinous carcinoma; Massive parallel sequencing; Ovarian cancer; Cancer; Exome; Carcinoma; Oncology; Biology; Internal medicine; Medicine; Adenocarcinoma; Mutation; Genetics; Colorectal cancer; DNA sequencing; Gene","score_opus":0.4500648755636732,"score_gpt":0.5782385353566344,"score_spread":0.1281736597929612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407450722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860561,0.0006760718,0.00049532147,0.00022596867,0.000013699113,0.000045006207,0.01046264,0.000053765605,0.0019714264],"genre_scores_gemma":[0.9718236,0.00035023713,0.0027655696,0.00026466476,0.000019159801,0.000062068226,0.022612462,0.0000728451,0.0020294187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998142,0.00002264227,0.000014815159,0.00006642411,0.00004697121,0.00003505489],"domain_scores_gemma":[0.9995921,0.0000805499,0.00011205174,0.00003765826,0.000092257775,0.000085395564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027728948,0.00019440732,0.00027682536,0.0010247251,0.00049592386,0.0005020617,0.00017323894,0.0002671105,0.0018982288],"category_scores_gemma":[0.00071327615,0.00009652517,0.00027565073,0.0012020074,0.00013857678,0.00012138889,0.00042237315,0.00030994316,0.00047409645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016085248,0.00012674852,0.65070945,0.00030070936,0.00018358906,0.0025751705,0.0009238443,0.00040698083,0.29260916,0.00035451353,0.006473873,0.043727387],"study_design_scores_gemma":[0.000026131145,0.0001718017,0.97457844,0.00001881585,0.00006526649,0.0033503224,0.00037138394,0.00046119242,0.009832177,0.000120409895,0.010995299,0.000008735209],"about_ca_topic_score_codex":0.009080458,"about_ca_topic_score_gemma":0.014841016,"teacher_disagreement_score":0.009080458,"about_ca_system_score_codex":0.00044259257,"about_ca_system_score_gemma":0.00038828386,"threshold_uncertainty_score":0.01805526},"labels":[],"label_agreement":null},{"id":"W2407900667","doi":"10.1158/1557-3265.ovca15-b10","title":"Abstract B10: FOXL2 402C&amp;gt;G mutation can be identified in the circulating tumor DNA of patients with adult-type granulosa cell tumor.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Mutation; Internal medicine; Medicine; Mutation frequency; Mutation testing; Ovary; Pathology; Biology; Gastroenterology; Oncology; Molecular biology; Genetics","score_opus":0.08070958269579487,"score_gpt":0.40860588868994785,"score_spread":0.327896305994153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407900667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99917334,0.00027044033,0.00012462144,0.000012914875,0.000002443511,0.0000047975723,0.00016633862,0.000007749814,0.00023721116],"genre_scores_gemma":[0.99934655,0.00005967694,0.00021922235,0.000018547733,0.000002392853,0.000003883239,0.00021724745,0.0000021148878,0.00013027198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980193,0.000025412372,0.000019653797,0.00005942142,0.000058480207,0.000035051788],"domain_scores_gemma":[0.9996088,0.00010961458,0.00014915218,0.000016057911,0.00005623469,0.00006011816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024576398,0.00014245359,0.00017693063,0.000602144,0.00015912844,0.00034504294,0.00015258607,0.00028170325,0.0012948305],"category_scores_gemma":[0.000976803,0.00010791128,0.0000815428,0.00050168997,0.00023579855,0.00012065333,0.000121218276,0.00014703459,0.00024614998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004816016,0.000022288366,0.9697761,0.000028875846,0.000014753967,0.0012721154,0.000116247764,0.000059389968,0.022766171,0.000014098702,0.00015747143,0.0052908016],"study_design_scores_gemma":[0.000014072444,0.00024342045,0.9851909,0.0000132966625,0.000021741436,0.0067165596,0.0001629184,0.00040196275,0.006550942,0.000023854534,0.00065660564,0.0000037298294],"about_ca_topic_score_codex":0.0056824656,"about_ca_topic_score_gemma":0.00669068,"teacher_disagreement_score":0.0056824656,"about_ca_system_score_codex":0.0003217815,"about_ca_system_score_gemma":0.00020947684,"threshold_uncertainty_score":0.011298776},"labels":[],"label_agreement":null},{"id":"W2408324580","doi":"10.1158/1557-3265.ovca15-pr07","title":"Abstract PR07: Synchronous ovarian and endometrial carcinomas: The case for pseudo-metastasis.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Metastasis; Massive parallel sequencing; Ovary; Ovarian cancer; Biology; Cancer; Endometrial cancer; Carcinoma; Ovarian carcinoma; Primary tumor; Endometrium; Cancer research; Oncology; Pathology; Medicine; Internal medicine; Gene; DNA sequencing; Genetics","score_opus":0.264980268446836,"score_gpt":0.5113102394665525,"score_spread":0.24632997101971654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408324580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786026,0.001918489,0.004556137,0.0010932836,0.0001696237,0.00014108709,0.00049936934,0.00025861888,0.012760753],"genre_scores_gemma":[0.99558014,0.00032312056,0.0020498699,0.00025103198,0.00017665775,0.000021867152,0.00024378562,0.00004840007,0.001305174],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994067,0.0000711913,0.00006004264,0.00016948546,0.00013345927,0.00015919877],"domain_scores_gemma":[0.9982823,0.00044584542,0.00035855224,0.00035480986,0.00013114263,0.00042731923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004748425,0.0007555658,0.0004140567,0.0013450083,0.0008784412,0.0008937944,0.000721831,0.0018118989,0.006364276],"category_scores_gemma":[0.0028679494,0.00050308113,0.000578227,0.0007369502,0.0008151818,0.0007691621,0.0010494125,0.0013346698,0.0017691356],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023155342,0.000039677794,0.10513859,0.00011516956,0.000036104244,0.87118727,0.00027131225,0.00010054708,0.0076999324,0.00094542705,0.0012858971,0.012948492],"study_design_scores_gemma":[0.0000066991906,0.000053563097,0.022277344,0.000012650183,0.00001750403,0.9744186,0.0001549075,0.0002789561,0.0009830621,0.00031559446,0.0014749658,0.0000061015444],"about_ca_topic_score_codex":0.0006299095,"about_ca_topic_score_gemma":0.0012037072,"teacher_disagreement_score":0.006364276,"about_ca_system_score_codex":0.00024649358,"about_ca_system_score_gemma":0.000404047,"threshold_uncertainty_score":0.02129066},"labels":[],"label_agreement":null},{"id":"W2408535955","doi":"10.1158/1557-3265.ovca15-a53","title":"Abstract A53: Combining oncolytic virotherapy with immunotherapy for ovarian cancer treatment.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Oncolytic virus; Immunotherapy; Medicine; Tumor microenvironment; Ovarian cancer; Antigen; Virotherapy; Cancer immunotherapy; CD8; Immune system; Tumor antigen; Cancer; Cancer research; Immunology; Adoptive cell transfer; Cytotoxic T cell; T cell; Combination therapy; Biology; Internal medicine","score_opus":0.1681519695379367,"score_gpt":0.5131536857754148,"score_spread":0.34500171623747805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408535955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97663546,0.010390861,0.0063101766,0.0005502595,0.00025364503,0.00028721555,0.00030752522,0.00023342221,0.0050314725],"genre_scores_gemma":[0.9925844,0.0021661525,0.0028294206,0.00009436593,0.00004322242,0.00006991605,0.00020279677,0.000016161252,0.0019934888],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989915,0.000023096536,0.000007799182,0.000019947389,0.000025013689,0.00002507591],"domain_scores_gemma":[0.99996614,0.0000054849315,0.000009720396,0.0000044756976,0.0000030900474,0.000011063384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017965966,0.00033021002,0.0002801199,0.0003807518,0.00011406201,0.0003846819,0.00021705174,0.00034971922,0.0015617046],"category_scores_gemma":[0.00011347953,0.00014783931,0.0002841558,0.000190835,0.00023180994,0.00025545905,0.00024873306,0.0005310392,0.00038205527],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011573767,0.0005810732,0.00062866247,0.0002176358,0.00005153243,0.00018159284,0.000036863104,0.0014120323,0.9448132,0.0007212884,0.0006119694,0.049586795],"study_design_scores_gemma":[0.0010682143,0.018890357,0.009814816,0.00007534014,0.00023564787,0.001563283,0.000047093046,0.008912217,0.9358912,0.00050010654,0.022973154,0.000028573893],"about_ca_topic_score_codex":0.0007908854,"about_ca_topic_score_gemma":0.0010073214,"teacher_disagreement_score":0.0015617046,"about_ca_system_score_codex":0.0002959715,"about_ca_system_score_gemma":0.00032762426,"threshold_uncertainty_score":0.0052244067},"labels":[],"label_agreement":null},{"id":"W2408568328","doi":"10.1158/1557-3265.ovca15-pr16","title":"Abstract PR16: Computational modeling of serous ovarian carcinoma dynamics: Implications for screening and therapy.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Debulking; Medicine; Chemotherapy; Ovarian cancer; Serous fluid; Ovarian carcinoma; Oncology; Internal medicine; Serous carcinoma; Stage (stratigraphy); Cancer; Adjuvant; Surgery; Biology","score_opus":0.3802367171197038,"score_gpt":0.5335727253135414,"score_spread":0.15333600819383758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408568328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7630775,0.001938336,0.21368562,0.0041529187,0.00035248214,0.00019621692,0.0027052113,0.0006590527,0.0132326],"genre_scores_gemma":[0.9735763,0.0004899991,0.021912765,0.00023394533,0.000049703878,0.00017554495,0.0007555482,0.00006608701,0.0027400574],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9999056,0.000034891124,0.0000057661427,0.000020743875,0.00001634946,0.000016729677],"domain_scores_gemma":[0.999153,0.00057991024,0.00009566863,0.000032549546,0.00007823974,0.00006067732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004355415,0.0005319247,0.00065239985,0.00035009917,0.0003772074,0.00080485473,0.0010243235,0.0013484181,0.0021881745],"category_scores_gemma":[0.0022581234,0.00041848802,0.0009871714,0.0003287541,0.00046213286,0.0005487396,0.00053286913,0.0007554812,0.00020750605],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000119630595,0.000010352316,0.0011034813,0.00001133569,0.0000070355504,0.0000236068,0.000006449735,0.9971106,0.00013379853,0.0006317577,0.000154328,0.0007951917],"study_design_scores_gemma":[0.000002639786,0.000004363796,0.000087952394,0.0000014824261,0.0000013882744,0.0000032774465,0.0000029801477,0.99950683,0.000025232808,0.00029208514,0.000070320246,0.0000014166416],"about_ca_topic_score_codex":0.025547177,"about_ca_topic_score_gemma":0.011586965,"teacher_disagreement_score":0.025547177,"about_ca_system_score_codex":0.0007649197,"about_ca_system_score_gemma":0.0011287772,"threshold_uncertainty_score":0.050796926},"labels":[],"label_agreement":null},{"id":"W2411964580","doi":"10.1158/1078-0432.ccr-15-2644","title":"Rendering the 3 + 3 Design to Rest: More Efficient Approaches to Oncology Dose-Finding Trials in the Era of Targeted Therapy","year":2016,"lang":"en","type":"editorial","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University College of the North","funders":"Bristol-Myers Squibb; American Association for Cancer Research","keywords":"Medicine; Clinical trial; Maximum tolerated dose; Dosing; Adaptive design; Pharmacodynamics; Oncology; Medical physics; Pharmacokinetics; Pharmacology; Internal medicine","score_opus":0.9658752865274041,"score_gpt":0.7506138417031166,"score_spread":0.21526144482428744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411964580","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031188462,0.060602237,0.07682645,0.2845971,0.5722294,0.00018535012,0.00014415782,0.0007979983,0.004305488],"genre_scores_gemma":[0.004010794,0.038570255,0.03620316,0.082337245,0.826825,0.0003177593,0.000058919893,0.00037114887,0.011305722],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9813494,0.010926485,0.0019205769,0.001115269,0.0044673346,0.00022090468],"domain_scores_gemma":[0.89094037,0.09439042,0.0020772319,0.0022350128,0.00881346,0.0015434365],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.04987425,0.0029839748,0.0027335277,0.0029981819,0.00096972,0.007188143,0.0040137307,0.008999413,0.0056563937],"category_scores_gemma":[0.10417648,0.0013078188,0.0039034218,0.0013474462,0.0065987427,0.008556821,0.0020419776,0.029255118,0.0031357985],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025547677,0.00006071243,0.00011700707,0.0012833261,0.0002172554,0.00013864806,0.00013568981,0.0026019558,0.00032864147,0.047737747,0.8350119,0.112111636],"study_design_scores_gemma":[0.00054059085,0.0001810921,0.00037253098,0.0009279823,0.000205556,0.000279884,0.00006298095,0.008105075,0.00024696402,0.09997903,0.8890028,0.000095604635],"about_ca_topic_score_codex":0.00096149865,"about_ca_topic_score_gemma":0.0024118356,"teacher_disagreement_score":0.95012575,"about_ca_system_score_codex":0.004330801,"about_ca_system_score_gemma":0.0032478385,"threshold_uncertainty_score":0.26376337},"labels":[],"label_agreement":null},{"id":"W2420141433","doi":"10.1158/1078-0432.ccr-16-0610","title":"Somatic and Germline <i>TP53</i> Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Germline; Somatic cell; Cancer; Germline mutation; Medicine; Oncology; Biology; Cancer research; Internal medicine; Genetics; Mutation; Gene","score_opus":0.12969336034865328,"score_gpt":0.4616537037362212,"score_spread":0.33196034338756797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2420141433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994425,0.0001048898,0.00010426447,0.000007820015,0.0000010648193,0.000004358101,0.00017958712,0.000004723974,0.00015086206],"genre_scores_gemma":[0.9991372,0.00015379541,0.00017597033,0.000011905119,0.0000032407374,0.000007951466,0.00043935666,0.0000044553176,0.000066235836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998826,0.000013157872,0.0000115356015,0.000038605227,0.000030186708,0.000023977685],"domain_scores_gemma":[0.99969554,0.00006348847,0.00013392796,0.000023706652,0.000041008443,0.000042335334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015837504,0.00020801673,0.00016625662,0.0006613526,0.00030678516,0.00027604128,0.00011920043,0.00016265822,0.0010420182],"category_scores_gemma":[0.0005394017,0.00009870613,0.00013881881,0.0005460578,0.0002578028,0.00011660537,0.0002874731,0.00018400217,0.00013714276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001982263,0.000018871382,0.9721168,0.000035673438,0.00003053876,0.0015163076,0.00032067933,0.00010878564,0.018239755,0.000035855126,0.00016544622,0.007213016],"study_design_scores_gemma":[0.000008498377,0.00019687662,0.98091733,0.000012128124,0.000047674366,0.009282869,0.00038662116,0.00020630604,0.007970106,0.000043050124,0.0009245519,0.000003970771],"about_ca_topic_score_codex":0.001505395,"about_ca_topic_score_gemma":0.0016221644,"teacher_disagreement_score":0.001505395,"about_ca_system_score_codex":0.00019784321,"about_ca_system_score_gemma":0.00021266338,"threshold_uncertainty_score":0.0034858584},"labels":[],"label_agreement":null},{"id":"W2422917950","doi":"10.1158/1078-0432.ccr-15-1314","title":"Molecular Pathways: Emergence of Protein Kinase CK2 (CSNK2) as a Potential Target to Inhibit Survival and DNA Damage Response and Repair Pathways in Cancer Cells","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Biology; DNA damage; Kinase; Phosphorylation; Cancer research; Cancer cell; DNA repair; Protein kinase A; Cancer; Caspase; Cell biology; Apoptosis; Programmed cell death; Biochemistry; DNA; Genetics","score_opus":0.07282055038973116,"score_gpt":0.4010784169604375,"score_spread":0.3282578665707063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2422917950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66601765,0.24480365,0.038999252,0.008187125,0.0014412627,0.00053066615,0.0016475,0.00063784665,0.0377351],"genre_scores_gemma":[0.90936947,0.06109106,0.008964759,0.0012180718,0.00029432448,0.00026008373,0.0009089684,0.000033615972,0.017859507],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988043,0.0000185492,0.00000757619,0.000024826733,0.000041714015,0.000026832427],"domain_scores_gemma":[0.99994445,0.0000036715778,0.0000141012115,0.000004797522,0.000017238965,0.000015769896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023620202,0.00053379027,0.00023751479,0.00030429024,0.00021867262,0.00068477506,0.00024018166,0.00039826526,0.0015507458],"category_scores_gemma":[0.000103463375,0.00013527187,0.00027258723,0.0002827761,0.00024634908,0.00065807276,0.00030124668,0.00087782834,0.00044068083],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006970599,0.0001829193,0.00079398166,0.0007172855,0.00004784832,0.00021997046,0.000043945456,0.0004966419,0.9595551,0.005095747,0.0018365345,0.030313002],"study_design_scores_gemma":[0.00019273457,0.0009856408,0.0060423957,0.00006941032,0.00008528777,0.0015038546,0.00006445968,0.0021967883,0.90498966,0.0018144717,0.082034715,0.000020511645],"about_ca_topic_score_codex":0.00033450528,"about_ca_topic_score_gemma":0.000639529,"teacher_disagreement_score":0.0015507458,"about_ca_system_score_codex":0.00076078624,"about_ca_system_score_gemma":0.0004287613,"threshold_uncertainty_score":0.005519867},"labels":[],"label_agreement":null},{"id":"W2465555849","doi":"10.1158/1078-0432.ccr-16-0549","title":"Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"National Cancer Institute; KWF Kankerbestrijding","keywords":"Epigenome; Prostate cancer; DNA methylation; Medicine; Cancer; Oncology; Cancer research; Prostate; Pathology; Biology; Internal medicine; Gene; Genetics","score_opus":0.09249531019013431,"score_gpt":0.4609511249069322,"score_spread":0.3684558147167979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2465555849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991109,0.00027932625,0.00024266526,0.000027111997,0.0000016801014,0.0000045011225,0.00022694557,0.0000084540325,0.00009835196],"genre_scores_gemma":[0.9994136,0.000051854473,0.00013994366,0.000015881598,0.00000362597,0.0000030720018,0.00031599504,0.0000011716227,0.000054902797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980825,0.00004703297,0.000012352358,0.00007336353,0.000039918228,0.000019067265],"domain_scores_gemma":[0.99964976,0.00009119177,0.00013184884,0.00003618792,0.000034643897,0.000056419096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039802352,0.00020200766,0.00031059067,0.00029960464,0.00012507295,0.00023433572,0.00020674591,0.00021508084,0.0006222949],"category_scores_gemma":[0.0013425951,0.000112252405,0.0002085253,0.00026215232,0.00013625495,0.00012207305,0.00022728617,0.00026213983,0.000107607426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005642401,0.00004649439,0.98121613,0.000025488174,0.00013257518,0.00005738138,0.000051769108,0.000293818,0.008849563,0.000020557616,0.00018824034,0.008553707],"study_design_scores_gemma":[0.000025088222,0.00017012599,0.99671245,0.0000043458476,0.00006510053,0.00029544256,0.000045940436,0.0011356068,0.0012964244,0.0000498996,0.00019632878,0.0000032956073],"about_ca_topic_score_codex":0.0017238074,"about_ca_topic_score_gemma":0.003993336,"teacher_disagreement_score":0.0017238074,"about_ca_system_score_codex":0.0001719184,"about_ca_system_score_gemma":0.0002051062,"threshold_uncertainty_score":0.003427565},"labels":[],"label_agreement":null},{"id":"W2465921301","doi":"10.1158/1557-3265.ovcasymp14-poster-tech-1119","title":"Abstract POSTER-TECH-1119: Phylogenetic portraits of high grade serous ovarian cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Genome instability; Genetics; Microsatellite instability; CDKN2A; Germline mutation; Indel; Germline; ATRX; Somatic evolution in cancer; Mutation; Cancer; Gene; Genotype; DNA; DNA damage; Microsatellite","score_opus":0.16666152563998096,"score_gpt":0.4634385112940502,"score_spread":0.2967769856540693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2465921301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98356676,0.0008339715,0.0038001686,0.00023661391,0.000017801962,0.000021772266,0.0047625173,0.00014301177,0.006617425],"genre_scores_gemma":[0.98991627,0.00026734415,0.0033717158,0.000039783572,0.0000142175295,0.000011799927,0.004302391,0.000030347366,0.002046119],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999424,0.000008252467,0.0000034685895,0.000015690879,0.0000181738,0.000012054377],"domain_scores_gemma":[0.99983,0.000047750433,0.000034487282,0.000018782608,0.000034154025,0.00003482081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001356392,0.00008631063,0.00010086778,0.00083091867,0.00026671274,0.0003343449,0.00012230048,0.00022824842,0.0040636174],"category_scores_gemma":[0.0003448655,0.00007721029,0.00013822046,0.00079147535,0.000102258105,0.00015748912,0.0002006767,0.00021170967,0.00064196624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014489081,0.00011027095,0.4949853,0.00034778684,0.00009565643,0.002698169,0.0010945785,0.01540144,0.3433545,0.0027244096,0.005895532,0.13184337],"study_design_scores_gemma":[0.000011704951,0.0002371259,0.91994977,0.000033400895,0.00004811793,0.004529638,0.00049834437,0.024324581,0.027737644,0.0017098712,0.020899333,0.000020408504],"about_ca_topic_score_codex":0.0010681292,"about_ca_topic_score_gemma":0.0014449725,"teacher_disagreement_score":0.0040636174,"about_ca_system_score_codex":0.00019534325,"about_ca_system_score_gemma":0.00009579033,"threshold_uncertainty_score":0.013594091},"labels":[],"label_agreement":null},{"id":"W2469919626","doi":"10.1158/1078-0432.ccr-16-0067","title":"Physical Activity and Cancer Outcomes: A Precision Medicine Approach","year":2016,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":300,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Cancer Foundation; University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Prostate cancer; Oncology; Cancer; Colorectal cancer; Internal medicine; Breast cancer; Confidence interval; Observational study; Relative risk; Cancer prevention; Gynecology","score_opus":0.5472715530470443,"score_gpt":0.6483473026894041,"score_spread":0.10107574964235977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2469919626","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017949691,0.67522043,0.21083012,0.07963307,0.003465324,0.0009380833,0.0040951604,0.0005245881,0.007343595],"genre_scores_gemma":[0.56119245,0.21237728,0.17923844,0.031898234,0.010612731,0.001702354,0.0020367554,0.00010394116,0.0008378433],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.929139,0.05497386,0.004846673,0.0042037307,0.0064099575,0.0004267172],"domain_scores_gemma":[0.7498761,0.20642474,0.017934589,0.014381877,0.0105125485,0.00087019656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09867473,0.0017474339,0.007443464,0.009502762,0.0008999801,0.008302086,0.0033162253,0.003174256,0.002236062],"category_scores_gemma":[0.15018843,0.0009613823,0.0043398654,0.0067485273,0.0034044757,0.0037430709,0.0032259892,0.005325424,0.00035057007],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002018534,0.0006007715,0.12754317,0.052606165,0.064964086,0.0005094166,0.0015903808,0.024445605,0.0016797264,0.078879535,0.030245258,0.61491734],"study_design_scores_gemma":[0.0017155845,0.0029283203,0.12935942,0.07295848,0.04011185,0.0012431522,0.0018371681,0.05071784,0.002985693,0.60495365,0.09045159,0.00073722395],"about_ca_topic_score_codex":0.0045270156,"about_ca_topic_score_gemma":0.003221521,"teacher_disagreement_score":0.09867473,"about_ca_system_score_codex":0.003336536,"about_ca_system_score_gemma":0.0048141503,"threshold_uncertainty_score":0.5218481},"labels":[],"label_agreement":null},{"id":"W2507865108","doi":"10.1158/1078-0432.ccr-16-0594","title":"Survival of Del17p CLL Depends on Genomic Complexity and Somatic Mutation","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute; Broad Institute; National Human Genome Research Institute; Leukemia and Lymphoma Society; American Cancer Society","keywords":"Somatic cell; Chronic lymphocytic leukemia; Mutation; Somatic evolution in cancer; Biology; Germline mutation; Genetics; Survival analysis; Cancer research; Cancer; Oncology; Leukemia; Internal medicine; Medicine; Gene","score_opus":0.45392629328106837,"score_gpt":0.5684538915852584,"score_spread":0.11452759830419001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507865108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992342,0.00030708383,0.0001235348,0.00002323425,0.0000015534981,0.000003131342,0.00009415284,0.0000061404494,0.00020704808],"genre_scores_gemma":[0.99955195,0.00011778362,0.00006540751,0.0000085286865,0.0000042305583,0.0000049992127,0.0001792871,0.0000021905253,0.000065548455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984,0.00002945116,0.000013246755,0.000038094066,0.000038868446,0.000040286493],"domain_scores_gemma":[0.9991491,0.0003087125,0.0003218213,0.00004007765,0.000043043237,0.0001373438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031445417,0.00023793773,0.00019758043,0.00046985463,0.00017704554,0.0003258994,0.0001129206,0.00022496289,0.0015650815],"category_scores_gemma":[0.0010482975,0.0000969974,0.00015210437,0.00026728524,0.00030210117,0.00027143318,0.0003218048,0.00025321406,0.0002419014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007656335,0.000034352797,0.9516727,0.000028578721,0.000042489883,0.0005030894,0.000067467845,0.0004042915,0.037284147,0.00007480256,0.00012328928,0.008999117],"study_design_scores_gemma":[0.0000119720635,0.0002727663,0.9916549,0.00001369202,0.00003879733,0.0030730814,0.000066512825,0.0007739202,0.003525113,0.0002004168,0.0003618491,0.0000069108037],"about_ca_topic_score_codex":0.0002728327,"about_ca_topic_score_gemma":0.0003979281,"teacher_disagreement_score":0.0015650815,"about_ca_system_score_codex":0.0002389462,"about_ca_system_score_gemma":0.00017481833,"threshold_uncertainty_score":0.005235672},"labels":[],"label_agreement":null},{"id":"W2507950939","doi":"10.1158/1078-0432.ccr-16-1192","title":"MAPK Pathway Inhibitors Sensitize BRAF-Mutant Melanoma to an Antibody-Drug Conjugate Targeting GPNMB","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"National Cancer Institute; Deutsches Krebsforschungszentrum; McGill University","keywords":"Microphthalmia-associated transcription factor; Melanoma; MEK inhibitor; MAPK/ERK pathway; Cancer research; Gene knockdown; Medicine; Antibody-drug conjugate; Trametinib; Dabrafenib; Antibody; Monoclonal antibody; Cell culture; Immunology; Biology; Vemurafenib; Signal transduction; Tyrosinase; Metastatic melanoma; Cell biology","score_opus":0.08395417958845613,"score_gpt":0.44757959507761497,"score_spread":0.36362541548915883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507950939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99653995,0.0010451224,0.0004522427,0.000050096452,0.000018992214,0.000058274014,0.0008837247,0.00007083379,0.00088080467],"genre_scores_gemma":[0.9951199,0.0007104618,0.0008746758,0.000045871056,0.000005714369,0.00005263513,0.0018527274,0.000015171036,0.0013229689],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998795,0.000012951072,0.000008001846,0.00003198837,0.000044133973,0.000023478975],"domain_scores_gemma":[0.9999467,0.00000798022,0.000016802076,0.000007748975,0.000007970859,0.000012774948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013405713,0.00024670918,0.00031226073,0.00019743392,0.00012651728,0.0002532266,0.00013333926,0.00018266316,0.0022826304],"category_scores_gemma":[0.0001535564,0.0001262354,0.00028604595,0.00013214904,0.00009248091,0.00012224288,0.00012979175,0.00035865285,0.00038397242],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005070199,0.00013117946,0.0029765104,0.00012318986,0.00003930654,0.000047644266,0.000016050455,0.00032703124,0.98826456,0.00003722807,0.000346771,0.007183382],"study_design_scores_gemma":[0.00012994076,0.0033703076,0.05768664,0.000020619347,0.00010563325,0.0010536074,0.000047255537,0.0023301765,0.9261615,0.00005798899,0.009026828,0.0000094378665],"about_ca_topic_score_codex":0.0009165398,"about_ca_topic_score_gemma":0.0021574383,"teacher_disagreement_score":0.0022826304,"about_ca_system_score_codex":0.00037679463,"about_ca_system_score_gemma":0.00019484694,"threshold_uncertainty_score":0.00763613},"labels":[],"label_agreement":null},{"id":"W2508835981","doi":"10.1158/1078-0432.ccr-16-1406","title":"Biospecimen Complexity—the Next Challenge for Cancer Research Biobanks?","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biobank; Translational research; Standardization; Medicine; Quality (philosophy); Data science; Medical research; Computer science; Bioinformatics; Pathology; Biology","score_opus":0.9717589302380174,"score_gpt":0.7845106315198176,"score_spread":0.1872482987181998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508835981","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010736377,0.07255955,0.025748443,0.87170714,0.0067710667,0.00066943263,0.0029869408,0.000375986,0.008445003],"genre_scores_gemma":[0.23578003,0.11319027,0.25495747,0.3382357,0.034405153,0.0056847995,0.010012807,0.0012547047,0.0064790365],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.79678595,0.13204159,0.02978091,0.009415923,0.027468136,0.0045074937],"domain_scores_gemma":[0.21075511,0.5578634,0.069221,0.067863256,0.070699856,0.023597414],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.3029679,0.00086529314,0.004298151,0.008672152,0.004342926,0.025473017,0.0069236914,0.0059876107,0.017334616],"category_scores_gemma":[0.4944288,0.001569032,0.0037076173,0.016342787,0.011486223,0.04970108,0.014180949,0.012528486,0.00437951],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017971814,0.00023100784,0.023245037,0.02502429,0.0014593756,0.00054813316,0.0071612936,0.002224305,0.0020902865,0.18494448,0.20577434,0.5455003],"study_design_scores_gemma":[0.00036319398,0.00043137878,0.018428886,0.034859456,0.00077166286,0.0011436087,0.009977082,0.0019418518,0.0014986855,0.30000678,0.630235,0.00034236972],"about_ca_topic_score_codex":0.0068148407,"about_ca_topic_score_gemma":0.0077766096,"teacher_disagreement_score":0.3029679,"about_ca_system_score_codex":0.015074143,"about_ca_system_score_gemma":0.06574701,"threshold_uncertainty_score":0.85956466},"labels":[],"label_agreement":null},{"id":"W2509844702","doi":"10.1158/1078-0432.ccr-16-1278","title":"High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical Trial","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes","funders":"Forskerakademiet; Canadian Cancer Society","keywords":"Medicine; Internal medicine; Breast cancer; Oncology; Cyclophosphamide; Chemotherapy; Hazard ratio; Proportional hazards model; Tissue microarray; Cancer; Clinical endpoint; Randomized controlled trial; Confidence interval","score_opus":0.07161111733640327,"score_gpt":0.4182395047963901,"score_spread":0.3466283874599868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2509844702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979223,0.013508314,0.00018988884,0.0012994325,0.00033762332,0.00037878356,0.001096205,0.000029251023,0.0039376724],"genre_scores_gemma":[0.99178725,0.00311063,0.00028585223,0.0014059525,0.00031928747,0.00028339846,0.0014483319,0.000012235255,0.0013470473],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999057,0.00059371145,0.000054464414,0.00011092096,0.00008746782,0.0000965409],"domain_scores_gemma":[0.99887305,0.00039125173,0.00023820634,0.00013314006,0.000070636954,0.00029375197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016556296,0.000664611,0.0015752458,0.00019541907,0.00027653782,0.0011343391,0.0005131483,0.001088599,0.0032409288],"category_scores_gemma":[0.0022390469,0.00021570001,0.0014731804,0.00031704237,0.0006649804,0.000467451,0.000269881,0.0014388751,0.00056336116],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9544266,0.0027432877,0.004509739,0.0008055339,0.0031641396,0.00006708981,0.000048314356,0.00044852696,0.0022738222,0.0002699512,0.00241108,0.028831907],"study_design_scores_gemma":[0.89423674,0.065992534,0.024612878,0.00032662324,0.007212061,0.00018855043,0.000106335705,0.0007941685,0.0010630798,0.00086974975,0.0045517078,0.000045569326],"about_ca_topic_score_codex":0.0012360582,"about_ca_topic_score_gemma":0.002705668,"teacher_disagreement_score":0.0032409288,"about_ca_system_score_codex":0.000749108,"about_ca_system_score_gemma":0.0011100612,"threshold_uncertainty_score":0.010842025},"labels":[],"label_agreement":null},{"id":"W2510150379","doi":"10.1158/1078-0432.ccr-15-2899","title":"IgMκ and IgMλ Measurements for the Assessment of Patients with Waldenström's Macroglobulinaemia","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Nephelometry; Immunoglobulin M; Serum protein electrophoresis; Waldenstrom macroglobulinemia; Medicine; Immunology; Antibody; Immunoglobulin G; Monoclonal; Monoclonal antibody; Lymphoma","score_opus":0.29176124911133,"score_gpt":0.5591102016073598,"score_spread":0.2673489524960298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2510150379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946179,0.0013698288,0.002586195,0.00015580018,0.000030598287,0.00003917386,0.00010850374,0.00009755754,0.0009945707],"genre_scores_gemma":[0.9978466,0.00012698461,0.0017528156,0.000047567533,0.000023811534,0.000018138058,0.000068014124,0.0000051415577,0.00011103091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984232,0.0006804399,0.00015699222,0.00020685102,0.00046513794,0.00006740557],"domain_scores_gemma":[0.9979931,0.0008491989,0.00050010893,0.00016614769,0.0003334787,0.00015788621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003422385,0.00063162774,0.00034418906,0.00084520754,0.00025561938,0.00054277,0.00040068783,0.0004474617,0.00084441586],"category_scores_gemma":[0.0065816483,0.00016039617,0.00017633643,0.00036524114,0.00035763197,0.00033250725,0.00037448312,0.0005360623,0.0003667855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012455964,0.00014061957,0.95136905,0.000098111836,0.000057327383,0.0002265457,0.00013700455,0.00033941632,0.019940045,0.00006259684,0.00042344743,0.025960216],"study_design_scores_gemma":[0.00011840354,0.0016428847,0.9616507,0.00006838466,0.000105645864,0.0035651706,0.00019986916,0.004693666,0.026219869,0.00019769948,0.0015189947,0.000018739682],"about_ca_topic_score_codex":0.00042292353,"about_ca_topic_score_gemma":0.00050293753,"teacher_disagreement_score":0.003422385,"about_ca_system_score_codex":0.0002959475,"about_ca_system_score_gemma":0.0002697465,"threshold_uncertainty_score":0.018099487},"labels":[],"label_agreement":null},{"id":"W2511827811","doi":"10.1158/1557-3265.ovcasymp14-poster-biol-1349","title":"Abstract POSTER-BIOL-1349: The oncogenic role of DICER1 RNase IIIb domain mutations in ovarian sertoli-leydig cell tumors","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; microRNA; Cancer research; Germline mutation; Somatic cell; Germline; Genetics; Gene; Mutation","score_opus":0.19655783500639704,"score_gpt":0.49370869882028373,"score_spread":0.29715086381388667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511827811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94711286,0.0036079732,0.0038101852,0.0024760668,0.00078563753,0.00017563092,0.003940051,0.00049131224,0.037600283],"genre_scores_gemma":[0.9650675,0.0010770339,0.0020549174,0.00044483025,0.0002680326,0.000044327415,0.002565375,0.0001076212,0.028370278],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992526,0.000012371182,0.000008284418,0.000022365668,0.000016794043,0.000015028492],"domain_scores_gemma":[0.999928,0.000011369714,0.000008511009,0.0000052104856,0.00001101254,0.000035981473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019155236,0.00024530958,0.00017091108,0.0003240028,0.0002317969,0.00020855315,0.00015160539,0.00044597025,0.012171071],"category_scores_gemma":[0.00012840184,0.00008079449,0.00018191004,0.00012902668,0.00012370276,0.00010679068,0.00024451403,0.00035260982,0.002364625],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028317221,0.000364071,0.043562997,0.0006322691,0.00011873556,0.039631996,0.00022603764,0.0007161033,0.77678376,0.0022047039,0.033915907,0.099011764],"study_design_scores_gemma":[0.00042054954,0.0021321552,0.20487118,0.00009510472,0.00019834157,0.11839886,0.0002048186,0.0028854595,0.48050427,0.0015861547,0.18864368,0.0000594037],"about_ca_topic_score_codex":0.00025692437,"about_ca_topic_score_gemma":0.00025257148,"teacher_disagreement_score":0.012171071,"about_ca_system_score_codex":0.00024303093,"about_ca_system_score_gemma":0.00011564729,"threshold_uncertainty_score":0.04071623},"labels":[],"label_agreement":null},{"id":"W2515679040","doi":"10.1158/1078-0432.ccr-16-1433","title":"Neoadjuvant Chemotherapy of Ovarian Cancer Results in Three Patterns of Tumor-Infiltrating Lymphocyte Response with Distinct Implications for Immunotherapy","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; Université de Montréal; University Health Network; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; U.S. Department of Defense","keywords":"Immunotherapy; Chemotherapy; Cancer; Ovarian cancer; Medicine; Lymphocyte; Tumor-infiltrating lymphocytes; Oncology; Immunology; Pathology; Cancer research; Internal medicine","score_opus":0.1628242435155388,"score_gpt":0.48815544820918283,"score_spread":0.325331204693644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2515679040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99916637,0.0001980724,0.00018186288,0.000008828965,0.000001158201,0.000013614153,0.00007169794,0.000010060145,0.00034831231],"genre_scores_gemma":[0.99923277,0.00008593197,0.00025625818,0.000010164905,0.0000019024266,0.000019541001,0.00021106336,0.0000028072157,0.00017961932],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99989617,0.000021868946,0.000015755999,0.000021677206,0.000023608023,0.000020981275],"domain_scores_gemma":[0.99980646,0.000032623742,0.00007598049,0.00002957415,0.000019547264,0.00003588571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012700174,0.00015340872,0.00020254016,0.0002895871,0.000117784344,0.00023119565,0.00008025183,0.00013024278,0.00072649546],"category_scores_gemma":[0.00028476326,0.00010614842,0.00015089309,0.00019126291,0.00017152492,0.00010065179,0.00018978925,0.00018511203,0.00020216085],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026827513,0.00015741351,0.21833304,0.00011393251,0.000047130245,0.00038328,0.00016858845,0.00025226318,0.75938076,0.00007833111,0.00013701362,0.01826552],"study_design_scores_gemma":[0.00007349336,0.0013474001,0.91025233,0.000010811733,0.000067240406,0.0025774175,0.00015106398,0.0006775618,0.083688274,0.00009261212,0.0010532112,0.000008493869],"about_ca_topic_score_codex":0.0001808992,"about_ca_topic_score_gemma":0.00033950646,"teacher_disagreement_score":0.00072649546,"about_ca_system_score_codex":0.0001733728,"about_ca_system_score_gemma":0.00010914018,"threshold_uncertainty_score":0.0024303794},"labels":[],"label_agreement":null},{"id":"W2520704033","doi":"10.1158/1078-0432.ccr-16-0933","title":"Molecular Pathways: Targeting CD96 and TIGIT for Cancer Immunotherapy","year":2016,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":214,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Cancer Council Queensland; National Health and Medical Research Council; Medical Research Council; Bristol-Myers Squibb; Cancer Research Institute","keywords":"TIGIT; Immune system; Cancer research; Immunotherapy; Cancer immunotherapy; Immunology; Downregulation and upregulation; Biology","score_opus":0.28179630753995233,"score_gpt":0.5304092569494819,"score_spread":0.2486129494095296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520704033","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003102497,0.9964232,0.00038983626,0.00041768936,0.00036859023,0.000015159644,0.000023519697,0.000017787952,0.002033949],"genre_scores_gemma":[0.0018897968,0.9947777,0.00051705027,0.00037813617,0.00022457501,0.00002418107,0.00005970905,0.0000029171483,0.002125979],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998754,0.000022013686,0.000013395889,0.000018111607,0.00005391058,0.0000171962],"domain_scores_gemma":[0.999913,0.000022385666,0.00001617384,0.0000038197522,0.000030137286,0.000014457022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044400795,0.0009555316,0.0010088586,0.0019215799,0.00021711424,0.0007926754,0.0007775494,0.00089121936,0.003015286],"category_scores_gemma":[0.00023196028,0.00024793512,0.00044391127,0.0012999102,0.00038218917,0.0010433457,0.0005356644,0.0022207745,0.0027858168],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012789281,0.00019823543,0.00015242625,0.010167364,0.00008234103,0.0003470208,0.000055877237,0.0006763265,0.014598032,0.006365754,0.03998553,0.92724323],"study_design_scores_gemma":[0.000043923734,0.00017832205,0.00057293824,0.0015546452,0.000058507845,0.0015483466,0.00003461662,0.00017335435,0.0024910455,0.0018673446,0.99145997,0.000016881704],"about_ca_topic_score_codex":0.00048406888,"about_ca_topic_score_gemma":0.0011558078,"teacher_disagreement_score":0.003015286,"about_ca_system_score_codex":0.0007347427,"about_ca_system_score_gemma":0.0006204708,"threshold_uncertainty_score":0.010087132},"labels":[],"label_agreement":null},{"id":"W2522167924","doi":"10.1158/1078-0432.ccr-16-0718","title":"<i>BIRC6</i> Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Enzalutamide; Prostate cancer; Cancer research; Downregulation and upregulation; Apoptosis; Androgen receptor; Biology; Medicine; Cancer; Gene; Internal medicine; Genetics","score_opus":0.1496112798920293,"score_gpt":0.5339874969569492,"score_spread":0.38437621706492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522167924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96870005,0.014422599,0.0072739953,0.00060069724,0.00014326903,0.00017207376,0.0011239168,0.00060031755,0.0069631385],"genre_scores_gemma":[0.9874444,0.0037711237,0.0047574094,0.00019207534,0.000033341006,0.000054988275,0.0010101655,0.000031733973,0.0027048078],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999211,0.000010877929,0.000004990101,0.000014319783,0.000024401877,0.000024261884],"domain_scores_gemma":[0.9999528,0.000004324801,0.000013230042,0.000004177183,0.0000103941475,0.000015057082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001790727,0.0003746113,0.00028521157,0.00023601044,0.00015585228,0.00037875955,0.00020633117,0.00020100245,0.0012440605],"category_scores_gemma":[0.0000614702,0.00007586634,0.00017853515,0.00019203057,0.00022165845,0.00012535472,0.00010120007,0.0005318254,0.00033887426],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004423601,0.000076460776,0.000509899,0.0001215537,0.000014574533,0.00008591479,0.000009472604,0.00027743605,0.9902852,0.00017957877,0.00050818233,0.00748945],"study_design_scores_gemma":[0.00010089604,0.0018366635,0.006746196,0.000018725399,0.00007646097,0.0012830931,0.000023828106,0.0019022478,0.9765743,0.00008763284,0.011338732,0.000011248464],"about_ca_topic_score_codex":0.0008626703,"about_ca_topic_score_gemma":0.0015018693,"teacher_disagreement_score":0.0012440605,"about_ca_system_score_codex":0.00046739978,"about_ca_system_score_gemma":0.00025921458,"threshold_uncertainty_score":0.0041618347},"labels":[],"label_agreement":null},{"id":"W2522467111","doi":"10.1158/1078-0432.ccr-16-1333","title":"Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ovarian cancer; Cancer research; Apoptosis; Biology; Nuclear export signal; Cancer; Transcriptome; Tissue microarray; Cancer cell; Internal medicine; Oncology; Medicine; Gene expression; Cell nucleus; Gene; Biochemistry; Genetics","score_opus":0.08905943793458003,"score_gpt":0.4270692073350998,"score_spread":0.33800976940051974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522467111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99551314,0.0027323295,0.0008722923,0.00012362967,0.000013949371,0.000032177333,0.00010251128,0.000045268906,0.00056469266],"genre_scores_gemma":[0.9976041,0.0010915365,0.00047593357,0.000028070684,0.000005570112,0.000022543341,0.00019787361,0.0000069643406,0.00056736876],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999298,0.000013437077,0.000007249485,0.00001722895,0.000019056019,0.000013153072],"domain_scores_gemma":[0.99994123,0.000010558234,0.000019032408,0.000009719023,0.0000072634084,0.000012108689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016775125,0.00020544404,0.00036598774,0.00016731817,0.00012382952,0.0003022504,0.00016878483,0.00014206007,0.00091892044],"category_scores_gemma":[0.00013127553,0.00009220846,0.00017838506,0.00014362384,0.00017605435,0.00014742825,0.00017330685,0.00044874466,0.00014807958],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009087596,0.00021695314,0.004319579,0.00013361227,0.000048085185,0.00013976109,0.000037966536,0.0005402387,0.9746669,0.00012841662,0.00027640598,0.018583374],"study_design_scores_gemma":[0.00030478806,0.0048507196,0.03244268,0.000020022018,0.00014652495,0.0012989695,0.00008172423,0.0033105593,0.9482937,0.000121488745,0.009118584,0.000010286812],"about_ca_topic_score_codex":0.00019076097,"about_ca_topic_score_gemma":0.00044672654,"teacher_disagreement_score":0.00091892044,"about_ca_system_score_codex":0.00027710845,"about_ca_system_score_gemma":0.00017343413,"threshold_uncertainty_score":0.0030741096},"labels":[],"label_agreement":null},{"id":"W2523893120","doi":"","title":"Development and optimization of a protocol for automated, low-throughput RNA purification from whole blood using the PAXgene blood RNA system","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"RNA; RNA extraction; DNA; Whole blood; Nucleic acid; Biology; Molecular biology; Chromatography; Chemistry; Biochemistry; Gene; Immunology","score_opus":0.14349242283400548,"score_gpt":0.5013129238549419,"score_spread":0.3578205010209364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523893120","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031292446,0.002749247,0.92537504,0.0004262834,0.0009142542,0.017623331,0.0071174633,0.0068568815,0.007645141],"genre_scores_gemma":[0.026744008,0.0023233262,0.90523773,0.00063589605,0.00022451558,0.028014518,0.02433686,0.0013218847,0.01116126],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9918969,0.0017706855,0.0011094211,0.0018866032,0.002849569,0.00048675443],"domain_scores_gemma":[0.99759054,0.00067605125,0.00023235983,0.00056721235,0.0008060774,0.00012777127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049878443,0.0023158675,0.0017048847,0.0029612374,0.0014936109,0.0013739079,0.0019495765,0.0014150814,0.010906283],"category_scores_gemma":[0.0043694396,0.0017475802,0.0018058126,0.0018505201,0.0014069224,0.00092114566,0.0012238008,0.0029224467,0.016412552],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027562288,0.00026686428,0.000643543,0.000888105,0.000062820385,0.0002779325,0.00023733637,0.00092519366,0.9527346,0.0017429134,0.006341591,0.035603505],"study_design_scores_gemma":[0.00016290133,0.001472004,0.00487167,0.00030446792,0.00015171191,0.0009968234,0.00008738677,0.0052217315,0.8474649,0.0010328321,0.13801107,0.0002224797],"about_ca_topic_score_codex":0.0007519818,"about_ca_topic_score_gemma":0.0016360064,"teacher_disagreement_score":0.010906283,"about_ca_system_score_codex":0.00070502824,"about_ca_system_score_gemma":0.002735015,"threshold_uncertainty_score":0.036485136},"labels":[],"label_agreement":null},{"id":"W2525038995","doi":"10.1158/1078-0432.ccr-16-0987","title":"A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute","keywords":"Medicine; Prostate cancer; Discontinuation; Dutasteride; Abiraterone acetate; Urology; Prednisone; Internal medicine; Clinical endpoint; Oncology; Enzalutamide; Cancer; Androgen receptor; Androgen deprivation therapy; Clinical trial","score_opus":0.26474424529358437,"score_gpt":0.5426248698811699,"score_spread":0.2778806245875855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525038995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99560624,0.0014379764,0.00025746447,0.00016858961,0.0000997522,0.0013302894,0.00033305926,0.000046827925,0.0007198678],"genre_scores_gemma":[0.9938869,0.0010845384,0.00073462905,0.00032156662,0.00016271963,0.0013670615,0.0007360825,0.0000113979495,0.0016952095],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996947,0.00015091007,0.000017744207,0.00004680945,0.00003723006,0.000052663017],"domain_scores_gemma":[0.999358,0.00009757553,0.00011862665,0.000047535246,0.000034373574,0.00034385917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009247578,0.0013310658,0.0015469549,0.00034580828,0.00036888546,0.0006944276,0.0006077645,0.00076588284,0.0035682907],"category_scores_gemma":[0.00072535785,0.0004850009,0.0008370429,0.00034080815,0.0006796055,0.00041248894,0.00027399138,0.0021126673,0.0006092942],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85394704,0.04195542,0.004218031,0.0007817414,0.0011261735,0.00022259705,0.0001888355,0.0012715504,0.03772047,0.00014799157,0.0015059501,0.056914102],"study_design_scores_gemma":[0.6214087,0.367815,0.006700779,0.000026332127,0.00025195265,0.0002007133,0.000036114703,0.0005551741,0.0020138738,0.00007933003,0.0008959431,0.000016122625],"about_ca_topic_score_codex":0.0009127846,"about_ca_topic_score_gemma":0.0022320005,"teacher_disagreement_score":0.0035682907,"about_ca_system_score_codex":0.00053353165,"about_ca_system_score_gemma":0.001323018,"threshold_uncertainty_score":0.011937141},"labels":[],"label_agreement":null},{"id":"W2525564587","doi":"10.1158/1078-0432.ccr-16-0844","title":"Patient-Derived Xenograft Establishment from Human Malignant Pleural Mesothelioma","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Pemetrexed; Mesothelioma; Cisplatin; Cancer; Pathology; Oncology; Chemotherapy; Pleural disease; Cancer research; Internal medicine; Respiratory disease; Lung","score_opus":0.1827863891041366,"score_gpt":0.49079579224057573,"score_spread":0.3080094031364391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525564587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962566,0.0005376215,0.0019447661,0.000017056522,0.00001327006,0.00006658026,0.00057952374,0.000030923453,0.00055365736],"genre_scores_gemma":[0.99524236,0.00034555208,0.0019099065,0.000016157925,0.0000048985294,0.00004818748,0.0020617736,0.000008572568,0.00036264386],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997075,0.000069249545,0.00004237955,0.000054072712,0.00009770502,0.00002901506],"domain_scores_gemma":[0.9995153,0.00015951015,0.000063478474,0.00014181688,0.00006368282,0.000056266013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005935101,0.0002677714,0.00026115048,0.0003314211,0.00019803026,0.0003049902,0.00019129354,0.00029103135,0.0017284984],"category_scores_gemma":[0.0006319194,0.00016393156,0.00032243866,0.00032206354,0.00018142122,0.0002695182,0.00036356944,0.0004596784,0.0004867472],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014268382,0.00045622847,0.06337366,0.00023361201,0.000101057536,0.0006987901,0.00020287333,0.0011494708,0.9210965,0.00027490963,0.00046559118,0.010520611],"study_design_scores_gemma":[0.00017798028,0.010642451,0.2588423,0.00004465942,0.00021188337,0.013484995,0.0003708363,0.00796642,0.6983469,0.00021722392,0.009668601,0.000025779835],"about_ca_topic_score_codex":0.00042514998,"about_ca_topic_score_gemma":0.00042458496,"teacher_disagreement_score":0.0017284984,"about_ca_system_score_codex":0.00019926918,"about_ca_system_score_gemma":0.00019651589,"threshold_uncertainty_score":0.0057824254},"labels":[],"label_agreement":null},{"id":"W2525688488","doi":"10.1158/1078-0432.ccr-16-1224","title":"The Added Value of Circulating Tumor Cell Enumeration to Standard Markers in Assessing Prognosis in a Metastatic Castration-Resistant Prostate Cancer Population","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; Université de Montréal","funders":"National Cancer Institute","keywords":"Prostate cancer; Context (archaeology); Oncology; Medicine; Proportional hazards model; Internal medicine; Population; Biomarker; Enumeration; Circulating tumor cell; Cancer; Metastasis; Biology; Mathematics","score_opus":0.17360426255789002,"score_gpt":0.5257510472557954,"score_spread":0.35214678469790534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525688488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913658,0.0016515796,0.0055679292,0.00029436595,0.000035768247,0.00004088884,0.000386631,0.00006738524,0.0005896031],"genre_scores_gemma":[0.9979613,0.00011171412,0.001509985,0.00006737953,0.000024972236,0.000009662341,0.0002288097,0.000006490918,0.00007975683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99425286,0.0039617745,0.00025350662,0.0005282433,0.00087186217,0.00013175464],"domain_scores_gemma":[0.955107,0.035188194,0.003913524,0.0030683961,0.001998413,0.0007245328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012303127,0.00075051165,0.0009347332,0.0008694452,0.00015744151,0.0010048988,0.0005145104,0.0008170611,0.00065303245],"category_scores_gemma":[0.043852545,0.00021794408,0.0008943677,0.0006586711,0.00042969277,0.0008925407,0.00065391615,0.0012161429,0.00018911365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014708854,0.00037377528,0.88536346,0.00015873786,0.0015120838,0.00016984901,0.00011493446,0.016783852,0.0038657398,0.00017022993,0.0004623092,0.076316305],"study_design_scores_gemma":[0.0007373496,0.0147102475,0.80203795,0.00009299046,0.0022419852,0.0011735678,0.000115032424,0.16388765,0.011708972,0.0018601515,0.001317887,0.00011616084],"about_ca_topic_score_codex":0.00069371745,"about_ca_topic_score_gemma":0.0008105136,"teacher_disagreement_score":0.012303127,"about_ca_system_score_codex":0.00038083186,"about_ca_system_score_gemma":0.00037269277,"threshold_uncertainty_score":0.06506592},"labels":[],"label_agreement":null},{"id":"W2526793520","doi":"10.1158/1078-0432.ccr-16-0453","title":"The MAPK Pathway Regulates Intrinsic Resistance to BET Inhibitors in Colorectal Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Minority Health and Health Disparities; National Institute of Diabetes and Digestive and Kidney Diseases; Structural Genomics Consortium; Ontario Ministry of Economic Development and Innovation; National Institute of General Medical Sciences; Ontario Genomics Institute; Vanderbilt University; Wellcome Trust; National Cancer Institute; National Institutes of Health","keywords":"BET inhibitor; Bromodomain; Colorectal cancer; Cancer research; MAPK/ERK pathway; Cancer; Medicine; Epigenetics; Cell growth; Pharmacology; Signal transduction; Biology; Internal medicine; Biochemistry","score_opus":0.0648854301857114,"score_gpt":0.42844302759857616,"score_spread":0.36355759741286475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526793520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99518293,0.0024453388,0.0005909743,0.000111331305,0.000010728535,0.000027190363,0.000195504,0.000048525068,0.0013875775],"genre_scores_gemma":[0.99820054,0.00069028843,0.00033721456,0.000023176726,0.0000038215803,0.00001245801,0.00017468593,0.000005017407,0.0005527392],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999176,0.000016872995,0.000006056347,0.000011484457,0.000019189134,0.000028681217],"domain_scores_gemma":[0.99995005,0.000008407065,0.000015471205,0.000004093332,0.0000073160504,0.000014726168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001341868,0.00026955828,0.00021721612,0.00019008771,0.0001282797,0.0003033555,0.00010674497,0.00017219894,0.0012291892],"category_scores_gemma":[0.00012220524,0.00011668956,0.00015225339,0.0001269774,0.00013020603,0.00014368766,0.00012149462,0.0004065667,0.000300378],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005388974,0.00014965383,0.0027205648,0.00006878718,0.000013468202,0.00013135256,0.000015253033,0.0003463806,0.9895857,0.00017649514,0.0001910868,0.0060624233],"study_design_scores_gemma":[0.00018126071,0.0021034824,0.065603584,0.000020854277,0.000064388296,0.0028184827,0.00006611346,0.007555563,0.9154548,0.00027312318,0.005844578,0.000013829076],"about_ca_topic_score_codex":0.00028514172,"about_ca_topic_score_gemma":0.0006119681,"teacher_disagreement_score":0.0012291892,"about_ca_system_score_codex":0.00045398864,"about_ca_system_score_gemma":0.00023183403,"threshold_uncertainty_score":0.004112065},"labels":[],"label_agreement":null},{"id":"W2528447231","doi":"10.1158/1078-0432.ccr-16-1730","title":"Plerixafor Improves Primary Tumor Response and Reduces Metastases in Cervical Cancer Treated with Radio-Chemotherapy","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Public Health Ontario; Princess Margaret Cancer Centre","funders":"Terry Fox Research Institute","keywords":"Plerixafor; Medicine; Cervical cancer; Chemotherapy; CXCR4; Cancer; Primary tumor; Toxicity; Lymph node; Oncology; Cisplatin; Metastasis; Internal medicine; Cancer research; Receptor","score_opus":0.10958758333207723,"score_gpt":0.465174888907309,"score_spread":0.35558730557523177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528447231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99691284,0.0014843922,0.0004010784,0.00006319937,0.000018082486,0.000067608795,0.00013581292,0.000092816896,0.00082419335],"genre_scores_gemma":[0.9976482,0.0006211056,0.00043309742,0.000032578046,0.000012813614,0.000043583845,0.00030094053,0.000009590375,0.0008980814],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993193,0.000011430163,0.0000051745797,0.000012715421,0.000019532421,0.000019190542],"domain_scores_gemma":[0.9999379,0.000009910226,0.000015572667,0.000007897325,0.0000065673235,0.000022167362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000090623245,0.0002830035,0.00049579015,0.00023274386,0.000124845,0.00019510795,0.00019129337,0.00017047927,0.0017814772],"category_scores_gemma":[0.0001408346,0.00007051274,0.00021634738,0.00014869309,0.00014363123,0.00011219333,0.00010741428,0.0005565913,0.00023096564],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058669616,0.0016494732,0.0040244334,0.00025838718,0.00009069265,0.0001267561,0.00005059634,0.00086223654,0.92549366,0.00004720962,0.00065587676,0.060873676],"study_design_scores_gemma":[0.0010726115,0.03584805,0.09360478,0.000038006714,0.0003485689,0.0011860635,0.00007802384,0.0035285212,0.8567757,0.000053984902,0.007451388,0.000014271097],"about_ca_topic_score_codex":0.0008031333,"about_ca_topic_score_gemma":0.001163034,"teacher_disagreement_score":0.0017814772,"about_ca_system_score_codex":0.000208958,"about_ca_system_score_gemma":0.00021967421,"threshold_uncertainty_score":0.0059595704},"labels":[],"label_agreement":null},{"id":"W2529309126","doi":"10.1158/1078-0432.ccr-16-0985","title":"Significance of <i>TP53</i> Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Anaplasia; Wilms' tumor; Wilms tumour; Immunohistochemistry; Mutation; Clinical significance; Medicine; Cancer; Oncology; Biology; Pathology; Cancer research; Internal medicine; Genetics; Gene","score_opus":0.046183534993365055,"score_gpt":0.4099504478028438,"score_spread":0.3637669128094787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529309126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980835,0.0010969721,0.00011734293,0.00003117375,0.0000051212533,0.000005997833,0.00013998845,0.00000754956,0.00051229703],"genre_scores_gemma":[0.9993273,0.00033958704,0.00010439214,0.000014427912,0.000009070512,0.0000024516987,0.00014366998,0.0000022336856,0.000056967314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982184,0.000023887902,0.000021533842,0.000051860865,0.000053491694,0.000027329537],"domain_scores_gemma":[0.9995283,0.00015187344,0.00014103336,0.000029524417,0.00006452023,0.000084731175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029064342,0.00021905427,0.00013127166,0.00070528523,0.0001997419,0.00021223698,0.0001600625,0.00016303151,0.0004248735],"category_scores_gemma":[0.0007823272,0.00009319693,0.00010894448,0.00039168296,0.0003732204,0.00010202085,0.00014224307,0.0001612434,0.00008644654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117782394,0.000012237629,0.98217654,0.000056819452,0.00003260027,0.003907211,0.00011976471,0.00008679207,0.005528268,0.00004215442,0.0002481045,0.0076717096],"study_design_scores_gemma":[0.000018366394,0.00022370454,0.9558347,0.000014405546,0.00007002117,0.037341714,0.00017182279,0.00016847339,0.0041678227,0.000034990106,0.0019466497,0.0000074200293],"about_ca_topic_score_codex":0.0025928493,"about_ca_topic_score_gemma":0.0027406397,"teacher_disagreement_score":0.0025928493,"about_ca_system_score_codex":0.00025304442,"about_ca_system_score_gemma":0.00024478414,"threshold_uncertainty_score":0.0051555634},"labels":[],"label_agreement":null},{"id":"W2531125083","doi":"10.1158/1078-0432.ccr-15-3069","title":"Randomized, Placebo-Controlled, Phase II Study of Veliparib in Combination with Carboplatin and Paclitaxel for Advanced/Metastatic Non–Small Cell Lung Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Saint-Laurent; Hôpital Notre-Dame","funders":"AbbVie","keywords":"Veliparib; Carboplatin; Medicine; Placebo; PARP inhibitor; Internal medicine; Lung cancer; Paclitaxel; Clinical endpoint; Oncology; Urology; Cancer; Surgery; Chemotherapy; Randomized controlled trial; Pathology; Cisplatin; Biology; Poly ADP ribose polymerase","score_opus":0.13960711677473045,"score_gpt":0.5230751276709501,"score_spread":0.3834680108962196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531125083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9651446,0.0050075813,0.0017660159,0.0011307866,0.0015716125,0.020151012,0.0021129793,0.00028649732,0.0028288946],"genre_scores_gemma":[0.96412545,0.0031186207,0.0033647509,0.001806799,0.0011352596,0.020448413,0.0017245678,0.000053120806,0.0042230044],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987656,0.0007133312,0.00007494403,0.00021271301,0.00008979733,0.00014377669],"domain_scores_gemma":[0.99842095,0.00039362104,0.00035537456,0.00014827291,0.00013232428,0.0005494636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030476106,0.0021901003,0.0047729905,0.0007017784,0.00070412277,0.0016158657,0.0016428675,0.0021057513,0.0074807936],"category_scores_gemma":[0.0026327607,0.001205574,0.001679394,0.0007771201,0.0018846089,0.0012766917,0.0005452806,0.004428519,0.0014663767],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9819043,0.009999632,0.00021035792,0.00033879973,0.0005409607,0.000024130435,0.000025039782,0.0001752812,0.001958787,0.000054358392,0.0004381347,0.0043302057],"study_design_scores_gemma":[0.9635938,0.03529358,0.00033747806,0.00000975317,0.0001426758,0.0000107721835,0.000007265686,0.00016067989,0.00015704293,0.000048422688,0.00023295994,0.000005621184],"about_ca_topic_score_codex":0.00090269995,"about_ca_topic_score_gemma":0.0018344371,"teacher_disagreement_score":0.0074807936,"about_ca_system_score_codex":0.0010541008,"about_ca_system_score_gemma":0.001953125,"threshold_uncertainty_score":0.025025785},"labels":[],"label_agreement":null},{"id":"W2532841680","doi":"10.1158/1078-0432.ccr-16-0184","title":"New Strategies in Multiple Myeloma: Immunotherapy as a Novel Approach to Treat Patients with Multiple Myeloma","year":2016,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; SAIT Polytechnic","funders":"","keywords":"Multiple myeloma; Medicine; Immunotherapy; Cancer; Oncology; Immunology; Internal medicine","score_opus":0.262883191333897,"score_gpt":0.5140105323390389,"score_spread":0.25112734100514195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2532841680","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000053171145,0.99846065,0.00009793334,0.0004865221,0.00022835944,0.0000043272767,0.00000632817,0.0000055971736,0.000657078],"genre_scores_gemma":[0.00038400595,0.9980907,0.00021372733,0.000515036,0.00026047288,0.00000775798,0.00001840649,0.0000014609155,0.0005084883],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972945,0.00005414666,0.000031890613,0.000036029778,0.00012438223,0.00002403587],"domain_scores_gemma":[0.99975914,0.00009346939,0.000032710865,0.000008282378,0.00007587892,0.000030490286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007648012,0.00084989454,0.0013789784,0.0024302665,0.00034027264,0.00107641,0.0008684728,0.0014858079,0.0032015564],"category_scores_gemma":[0.00060413417,0.00025137773,0.0006232,0.0020265614,0.00059874036,0.001920928,0.0007855544,0.003448858,0.0026535932],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007422422,0.00012479689,0.00015300034,0.011652669,0.00009848062,0.00024475722,0.00007355255,0.000246981,0.001900103,0.004848368,0.041428797,0.9391542],"study_design_scores_gemma":[0.000045417026,0.00013208535,0.0006056467,0.0035769828,0.00008955831,0.0015045599,0.000049293936,0.0000911618,0.000341198,0.0023428088,0.991204,0.000017262477],"about_ca_topic_score_codex":0.00070545764,"about_ca_topic_score_gemma":0.0017671888,"teacher_disagreement_score":0.0032015564,"about_ca_system_score_codex":0.0007750397,"about_ca_system_score_gemma":0.0009566124,"threshold_uncertainty_score":0.010710239},"labels":[],"label_agreement":null},{"id":"W2533101571","doi":"10.1158/1078-0432.ccr-16-1790","title":"A Phase II, Randomized, Open-Label Study of Neoadjuvant Degarelix versus LHRH Agonist in Prostate Cancer Patients Prior to Radical Prostatectomy","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"","keywords":"Bicalutamide; Prostate cancer; Urology; Medicine; Testosterone (patch); Agonist; Antiandrogen; Goserelin; Luteinizing hormone; Androgen deprivation therapy; Dihydrotestosterone; Prostatectomy; Internal medicine; Leuprorelin; Hormone; Endocrinology; Androgen; Gonadotropin-releasing hormone; Cancer; Androgen receptor; Receptor","score_opus":0.2569833737468409,"score_gpt":0.5723141692703112,"score_spread":0.3153307955234703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533101571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994193,0.00088226463,0.0004931673,0.0002807762,0.0004111613,0.0026831138,0.00030705586,0.000045627767,0.00070388283],"genre_scores_gemma":[0.98883367,0.00094402174,0.0018448322,0.0008473543,0.0005985902,0.004733096,0.0005479619,0.000019462374,0.0016311186],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99899644,0.00058952335,0.000053756343,0.000146956,0.00007773293,0.00013564662],"domain_scores_gemma":[0.9979978,0.00061007886,0.0003813804,0.00020790259,0.000095720185,0.00070695404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021156801,0.001703925,0.0031562978,0.00044031907,0.00056606473,0.0011362468,0.0009515895,0.0014019588,0.005394503],"category_scores_gemma":[0.001972884,0.0010043418,0.0013187118,0.0004436623,0.0018304967,0.001184966,0.0003864445,0.0031937093,0.00087882],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96349883,0.024624491,0.00048430453,0.00013783302,0.00022689569,0.000022185124,0.000034658406,0.00029334327,0.0042832126,0.000051389045,0.00022756943,0.006115324],"study_design_scores_gemma":[0.7698281,0.22778623,0.0010696425,0.000009567857,0.00012419162,0.000021273303,0.00001893112,0.00036302538,0.00047702156,0.000067277564,0.00022163529,0.0000131217475],"about_ca_topic_score_codex":0.00077718124,"about_ca_topic_score_gemma":0.0019327289,"teacher_disagreement_score":0.005394503,"about_ca_system_score_codex":0.00089014106,"about_ca_system_score_gemma":0.0021513198,"threshold_uncertainty_score":0.01804638},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W2533262657","doi":"10.1158/1078-0432.ccr-16-1241","title":"An Open-Label, Dose–Escalation Phase I Study of Anti-TYRP1 Monoclonal Antibody IMC-20D7S for Patients with Relapsed or Refractory Melanoma","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University College of the North","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Adverse effect; Melanoma; Internal medicine; Cancer; Oncology; Monoclonal antibody; Refractory (planetary science); Maximum tolerated dose; Gastroenterology; Antibody; Pharmacology; Immunology; Cancer research","score_opus":0.1974395985532057,"score_gpt":0.5574835291935856,"score_spread":0.3600439306403799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533262657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933136,0.001211384,0.00060009677,0.000307472,0.00011821509,0.002419524,0.00059339165,0.000111776695,0.0013245038],"genre_scores_gemma":[0.9897558,0.0009235061,0.0021435905,0.000798618,0.0002116012,0.002527215,0.0016397106,0.000035025,0.0019649954],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995223,0.0002045029,0.000024309567,0.000076158074,0.00006524604,0.000107366504],"domain_scores_gemma":[0.9993457,0.000103527345,0.00013333702,0.000059770526,0.000050000428,0.0003075771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017888723,0.001857431,0.0020583626,0.0005378154,0.00047173974,0.00088119163,0.0010375165,0.0011941412,0.002582692],"category_scores_gemma":[0.0008303263,0.0005753335,0.0010492922,0.0003885653,0.0010046432,0.0008991332,0.00032756868,0.0037832987,0.00084795797],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.51525766,0.17830212,0.010729219,0.0012975476,0.0014552877,0.0006036994,0.00070452923,0.004514309,0.10868908,0.0004913816,0.0072796065,0.1706756],"study_design_scores_gemma":[0.39457554,0.5837873,0.010256167,0.000031392803,0.00024846414,0.0003116917,0.000055227076,0.0022530905,0.005388599,0.00017644808,0.0028867803,0.000029259134],"about_ca_topic_score_codex":0.0006320113,"about_ca_topic_score_gemma":0.0020206296,"teacher_disagreement_score":0.002582692,"about_ca_system_score_codex":0.0010988347,"about_ca_system_score_gemma":0.0016207024,"threshold_uncertainty_score":0.009460568},"labels":[],"label_agreement":null},{"id":"W2533419167","doi":"10.1158/1078-0432.ccr-16-0460","title":"Role of the Microenvironment in Liver Metastasis: From Pre- to Prometastatic Niches","year":2016,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":318,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Canadian Institutes of Health Research; Canadian HIV Trials Network, Canadian Institutes of Health Research","keywords":"Niche; Metastasis; Tumor microenvironment; Biology; Cancer research; Medicine; Cancer; Tumor cells; Ecology; Genetics","score_opus":0.21651350391828286,"score_gpt":0.49994288196650516,"score_spread":0.2834293780482223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533419167","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000073729854,0.9990741,0.00007361224,0.00018811891,0.00015533989,0.0000018653394,0.0000043033833,0.0000036629983,0.0004251879],"genre_scores_gemma":[0.0005110639,0.9987476,0.00009722602,0.00011748687,0.00018181455,0.0000035250278,0.000009089549,7.504008e-7,0.00033138425],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998394,0.00002821026,0.000024761897,0.000023510433,0.00006328336,0.000020691274],"domain_scores_gemma":[0.99975735,0.000098912686,0.000034597833,0.000007153502,0.00006603354,0.000035974612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005402703,0.00069793366,0.0012229227,0.0018276394,0.00026046543,0.0012099255,0.0007011991,0.0010370892,0.001809651],"category_scores_gemma":[0.0004968634,0.0001887924,0.00033364215,0.0015776842,0.00061617413,0.0014425912,0.0007419278,0.0016628023,0.0016925273],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007963163,0.00005852018,0.00029145792,0.0102343075,0.0000469651,0.0002942289,0.000087825574,0.00023644799,0.0028089352,0.0039819973,0.022458445,0.9594213],"study_design_scores_gemma":[0.000017044178,0.00015916227,0.0014507163,0.00425676,0.00006689996,0.0024485898,0.000120169374,0.000094027084,0.00073517463,0.0025248588,0.9881067,0.00001993841],"about_ca_topic_score_codex":0.00054141216,"about_ca_topic_score_gemma":0.0008839175,"teacher_disagreement_score":0.0018276394,"about_ca_system_score_codex":0.0006294016,"about_ca_system_score_gemma":0.00095465616,"threshold_uncertainty_score":0.0060539246},"labels":[],"label_agreement":null},{"id":"W2540213618","doi":"10.1158/1557-3265.hemmal14-a19","title":"Abstract A19: MALT1 inhibition as an anchor for combinatorial therapy of ABC-DLBCL.","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bioactive Compounds and Antitumor Agents","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Université de Montréal","funders":"","keywords":"Cancer research; breakpoint cluster region; Diffuse large B-cell lymphoma; Chemistry; Cell growth; Biology; Lymphoma; Molecular biology; Cell biology; Receptor; Biochemistry; Immunology","score_opus":0.7850792158000355,"score_gpt":0.6958353942198646,"score_spread":0.08924382158017086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540213618","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96504796,0.012541197,0.0051521217,0.00043381532,0.00021813366,0.00048136403,0.003998555,0.0004971799,0.011629719],"genre_scores_gemma":[0.9810167,0.0052111335,0.002854842,0.00017864197,0.000022968741,0.00016111047,0.0025187333,0.00004934762,0.007986584],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999579,0.0000057993966,0.000002818148,0.000007873524,0.000012926556,0.000012654779],"domain_scores_gemma":[0.99997306,0.000002479003,0.000005183209,0.0000023060377,0.0000045859456,0.000012506535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006047358,0.0003847776,0.00027184913,0.0004308412,0.00011759188,0.00025871216,0.00023652901,0.00021814449,0.0037570589],"category_scores_gemma":[0.000056804245,0.000085210864,0.0002126644,0.00032593077,0.000104246734,0.00014473742,0.0001920443,0.0005860743,0.00071379263],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013153538,0.0007842073,0.00037085076,0.00031353848,0.00004858724,0.00032427302,0.00003457243,0.0008722239,0.9475717,0.00090271566,0.0016321138,0.045829937],"study_design_scores_gemma":[0.00070711155,0.00769067,0.0051642815,0.000039047336,0.00014402045,0.0011478605,0.000035283192,0.0021036263,0.9434146,0.00026652473,0.03926335,0.000023563935],"about_ca_topic_score_codex":0.00071229937,"about_ca_topic_score_gemma":0.0015433127,"teacher_disagreement_score":0.0037570589,"about_ca_system_score_codex":0.0003220359,"about_ca_system_score_gemma":0.0001493779,"threshold_uncertainty_score":0.012568593},"labels":[],"label_agreement":null},{"id":"W2550395684","doi":"10.1158/1078-0432.ccr-16-1640","title":"BRM Promoter Polymorphisms and Survival of Advanced Non–Small Cell Lung Cancer Patients in the Princess Margaret Cohort and CCTG BR.24 Trial","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Occupational Cancer Research Centre; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Biology; Epigenetics; Promoter; Chromatin immunoprecipitation; Lung cancer; Cancer research; Hazard ratio; Gene; Genetics; Oncology; Internal medicine; Gene expression; Medicine; Confidence interval","score_opus":0.06154146814150814,"score_gpt":0.42101119650562585,"score_spread":0.3594697283641177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550395684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947025,0.002070887,0.000088444416,0.0003560383,0.000033735218,0.000035356534,0.0020281556,0.000012901967,0.00067203556],"genre_scores_gemma":[0.99602604,0.00028059617,0.00010598515,0.00017520269,0.000057034846,0.00008823324,0.002632001,0.00000898156,0.0006258121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993926,0.00027498382,0.00003499653,0.00013430402,0.00009923076,0.00006384021],"domain_scores_gemma":[0.99897575,0.00026393146,0.00039020233,0.000117435615,0.0000715504,0.00018104176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012742461,0.0002360928,0.00071083294,0.00017605066,0.00018256564,0.000500245,0.00036957816,0.00047025742,0.0028152808],"category_scores_gemma":[0.0017933403,0.00016787829,0.00076576974,0.00047431074,0.00016856562,0.00022464908,0.00021591832,0.0004944453,0.00031564626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16582026,0.00055821904,0.7577635,0.0013664055,0.007378481,0.00042232053,0.00021215407,0.0021850846,0.012002749,0.00049007,0.014987263,0.036813464],"study_design_scores_gemma":[0.0092680305,0.0058077555,0.97320527,0.00014874914,0.003629366,0.00025568603,0.00006514178,0.002576005,0.0012037185,0.00023895121,0.0035652674,0.00003623094],"about_ca_topic_score_codex":0.0025118517,"about_ca_topic_score_gemma":0.004824927,"teacher_disagreement_score":0.0028152808,"about_ca_system_score_codex":0.00036120316,"about_ca_system_score_gemma":0.00037996442,"threshold_uncertainty_score":0.009418011},"labels":[],"label_agreement":null},{"id":"W2550646651","doi":"10.1158/1078-0432.ccr-16-1700","title":"TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":276,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Lawson Health Research Institute; Western University; Trillium Therapeutics (Canada)","funders":"","keywords":"CD47; Phagocytosis; Cancer research; Macrophage; Immune system; Innate immune system; In vivo; Flow cytometry; Immunology; Antibody; Biology; Cancer cell; Cancer; In vitro; Biochemistry","score_opus":0.10955072930007535,"score_gpt":0.4224291831128441,"score_spread":0.31287845381276874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550646651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98785365,0.005637067,0.0034598564,0.00018874428,0.000048178765,0.00006846917,0.00033408325,0.0001429739,0.0022670717],"genre_scores_gemma":[0.9937791,0.0019102576,0.0016886083,0.00006378651,0.000015403395,0.000041953346,0.0005568978,0.00001193747,0.0019319966],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999368,0.000009454537,0.0000061776304,0.000011295222,0.000019140627,0.000016983357],"domain_scores_gemma":[0.9999633,0.0000036742251,0.0000108281465,0.000003490207,0.000005092407,0.000013537766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013491401,0.00039212158,0.0002510422,0.00016521504,0.00007827313,0.0001849365,0.00018548607,0.000249798,0.0005429568],"category_scores_gemma":[0.000060573715,0.00007966518,0.0001897346,0.0001397373,0.00014566228,0.00013228925,0.00010049555,0.00050326844,0.00025054888],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031948386,0.00009503537,0.00010889803,0.000049096543,0.000009234598,0.0000538815,0.000007442844,0.00021852768,0.99577904,0.00009391286,0.0001345482,0.003130896],"study_design_scores_gemma":[0.0001422617,0.0011375191,0.0013214324,0.0000053705903,0.000028607046,0.00034883883,0.0000065193894,0.0012905474,0.99279284,0.000023998722,0.0028977706,0.0000043388923],"about_ca_topic_score_codex":0.00050795096,"about_ca_topic_score_gemma":0.0005019449,"teacher_disagreement_score":0.0005429568,"about_ca_system_score_codex":0.0002816643,"about_ca_system_score_gemma":0.00022995661,"threshold_uncertainty_score":0.0020436049},"labels":[],"label_agreement":null},{"id":"W2553214654","doi":"10.1158/1078-0432.ccr-16-1357","title":"Neoadjuvant Enzalutamide Prior to Prostatectomy","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Princess Margaret Cancer Centre","funders":"National Cancer Institute; U.S. Department of Veterans Affairs","keywords":"Enzalutamide; Prostatectomy; Medicine; Prostate cancer; Urology; Oncology; Internal medicine; Cancer","score_opus":0.306227843421037,"score_gpt":0.5871699679220427,"score_spread":0.2809421245010057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553214654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961332,0.0016991163,0.0004987441,0.000087043336,0.000042790063,0.00009867046,0.00008620418,0.00003065537,0.0013235778],"genre_scores_gemma":[0.9989329,0.00023178595,0.0003048789,0.000040655555,0.000019227158,0.000037370843,0.00010444064,0.000002261943,0.00032652164],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99984944,0.00005988289,0.000011159289,0.00003004578,0.000021585058,0.000027853655],"domain_scores_gemma":[0.99982125,0.000053835472,0.000038264658,0.000017316686,0.000008881501,0.00006045893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001579838,0.00025628583,0.0004391556,0.00009387955,0.00017914647,0.00017130117,0.00010838102,0.00013995933,0.0016188903],"category_scores_gemma":[0.00040149078,0.00010097326,0.00012698151,0.00008600779,0.00023005113,0.00012106278,0.00011172615,0.00039616882,0.00020860683],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18725413,0.010553338,0.06226891,0.0007661738,0.00036999586,0.0013536752,0.0002741315,0.006684538,0.5224887,0.0003038419,0.002452274,0.20523027],"study_design_scores_gemma":[0.011476303,0.42804646,0.28737074,0.00019756022,0.00047149608,0.008434793,0.00031203512,0.007299468,0.23439145,0.00033390298,0.021587312,0.00007853001],"about_ca_topic_score_codex":0.0006354077,"about_ca_topic_score_gemma":0.0021427353,"teacher_disagreement_score":0.0016188903,"about_ca_system_score_codex":0.00022813072,"about_ca_system_score_gemma":0.0004133788,"threshold_uncertainty_score":0.0054157376},"labels":[],"label_agreement":null},{"id":"W2553293645","doi":"10.1158/1078-0432.ccr-16-1617","title":"E6 and E7 Antibody Levels Are Potential Biomarkers of Recurrence in Patients with Advanced-Stage Human Papillomavirus–Positive Oropharyngeal Squamous Cell Carcinoma","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Dental and Craniofacial Research; National Institute on Deafness and Other Communication Disorders; National Cancer Institute; National Institutes of Health","keywords":"Medicine; Antibody; Stage (stratigraphy); Biomarker; Internal medicine; Oncology; Disease; Gastroenterology; Cancer; Papillomaviridae; Human papillomavirus; Immunology; Cervical cancer; Biology","score_opus":0.10375449504864877,"score_gpt":0.46487705244048677,"score_spread":0.361122557391838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553293645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99968874,0.0001604226,0.00004055685,0.000007401619,0.0000012874664,0.0000033174997,0.000018201461,0.0000017681423,0.000078243844],"genre_scores_gemma":[0.999795,0.00003738922,0.000053705757,0.000007764131,0.000003235263,0.0000028247787,0.000047121237,4.360991e-7,0.000052609816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973077,0.00009245308,0.000033811433,0.00003939563,0.00006252659,0.000040902123],"domain_scores_gemma":[0.9990846,0.00025133227,0.00033797833,0.000055340784,0.00015434093,0.00011636196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000639675,0.00021207595,0.00035624567,0.00036783933,0.00018452591,0.00034231285,0.00018944427,0.00033594386,0.0007266433],"category_scores_gemma":[0.0016144596,0.00013151622,0.0002419127,0.00025653932,0.00016634367,0.0003146173,0.00021464609,0.00032465553,0.0001576616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007227023,0.00009009645,0.9938116,0.000009572008,0.00003108588,0.000051076593,0.00003219413,0.000045296427,0.0022661234,0.000004113341,0.000033996064,0.0029020736],"study_design_scores_gemma":[0.000022458691,0.0012917651,0.9960337,0.000004154773,0.000055697918,0.00044438386,0.00008953097,0.0004474551,0.0014657922,0.000010828015,0.0001310108,0.0000032069488],"about_ca_topic_score_codex":0.0007181407,"about_ca_topic_score_gemma":0.0008445237,"teacher_disagreement_score":0.0007266433,"about_ca_system_score_codex":0.000180558,"about_ca_system_score_gemma":0.00015439591,"threshold_uncertainty_score":0.0033829808},"labels":[],"label_agreement":null},{"id":"W2556245106","doi":"10.1158/1078-0432.ccr-16-1708","title":"Rapid and Continued T-Cell Differentiation into Long-term Effector and Memory Stem Cells in Vaccinated Melanoma Patients","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Center of Competence in Research Chemical Biology; Swiss Cancer Research Foundation; Ludwig Institute for Cancer Research; Centre Hospitalier Universitaire Vaudois; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Cancer Research Institute; National Science Foundation","keywords":"Effector; Stem cell; Melanoma; Immunology; Biology; Cancer research; Medicine; Cell biology","score_opus":0.049189110276810596,"score_gpt":0.372197245648685,"score_spread":0.3230081353718744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556245106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999428,0.00011006599,0.00020909734,0.000009279544,0.0000016153012,0.000010939191,0.00003480807,0.000007729121,0.00018844739],"genre_scores_gemma":[0.99953306,0.00003973513,0.00016250856,0.000018246872,0.0000033124309,0.000009936398,0.00008852127,0.0000020442026,0.00014260468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999231,0.000016879685,0.000009325192,0.000023013692,0.0000118860535,0.000015718151],"domain_scores_gemma":[0.99983156,0.000031422947,0.000046846184,0.000014317928,0.000021827549,0.000054024167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001956512,0.00017160704,0.00027217122,0.00021175468,0.00022352269,0.00024255663,0.00009634401,0.0002695149,0.0010576436],"category_scores_gemma":[0.00036281758,0.000113440154,0.00013737715,0.00012166005,0.0001497447,0.00019119745,0.0001306347,0.00034582146,0.00030622672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052689374,0.0008566378,0.58724123,0.00010515432,0.00006783249,0.0019236183,0.00057467615,0.00065767503,0.3631924,0.00009557333,0.0003165139,0.03969974],"study_design_scores_gemma":[0.00033461998,0.017716795,0.86586696,0.00004492242,0.00017664085,0.01265571,0.00045242422,0.0029017306,0.09747189,0.00016712157,0.0021875377,0.000023683131],"about_ca_topic_score_codex":0.0001974358,"about_ca_topic_score_gemma":0.0002474779,"teacher_disagreement_score":0.0010576436,"about_ca_system_score_codex":0.00015649306,"about_ca_system_score_gemma":0.00013546574,"threshold_uncertainty_score":0.0035381913},"labels":[],"label_agreement":null},{"id":"W2558481997","doi":"10.1158/1078-0432.ccr-16-0133","title":"Molecular Pathways: Deciphering Mechanisms of Resistance to Macrophage-Targeted Therapies","year":2016,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"National Cancer Institute","keywords":"Reprogramming; Effector; Cancer; Phenotype; Medicine; Macrophage; Cancer research; Bioinformatics; Immunology; Biology; Cell; In vitro; Internal medicine; Gene; Genetics","score_opus":0.20808815734506164,"score_gpt":0.4914011704334131,"score_spread":0.28331301308835144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558481997","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013264762,0.99845076,0.00016225969,0.0003560355,0.00017629896,0.0000046729824,0.000012293027,0.0000072646685,0.0006978482],"genre_scores_gemma":[0.00085132546,0.9980446,0.00016451534,0.00021186488,0.0001616674,0.0000075020916,0.000021147478,0.0000010994298,0.0005362562],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998447,0.000032595508,0.000019250418,0.000026422615,0.000056368946,0.00002065745],"domain_scores_gemma":[0.999785,0.00007492407,0.000031386622,0.000008739097,0.00007638062,0.000023617376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060985546,0.00078518427,0.0012896053,0.0021342856,0.00024106403,0.0012748708,0.0009039418,0.0011049632,0.0022603783],"category_scores_gemma":[0.0004504609,0.0002340644,0.00040032342,0.0012204453,0.00062352675,0.0012802143,0.00063381426,0.0020702453,0.0019062336],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010083414,0.000084827174,0.0002365729,0.010976417,0.000088079716,0.00026596044,0.00007192697,0.00047563974,0.008469259,0.00984857,0.0308387,0.9385432],"study_design_scores_gemma":[0.00002716992,0.00014129344,0.0009938831,0.003874803,0.00009773092,0.0013795642,0.0000828753,0.00019551767,0.002156188,0.004651469,0.98637414,0.000025476038],"about_ca_topic_score_codex":0.000532449,"about_ca_topic_score_gemma":0.0009623166,"teacher_disagreement_score":0.0022603783,"about_ca_system_score_codex":0.00083056296,"about_ca_system_score_gemma":0.00090368954,"threshold_uncertainty_score":0.0075617433},"labels":[],"label_agreement":null},{"id":"W2560151975","doi":"10.1158/1078-0432.ccr-16-1922","title":"Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P–Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Ligue Contre le Cancer","keywords":"Diffuse large B-cell lymphoma; Mutant; Cancer research; Lymphoma; Mutation; Biology; Gene; Genetics; Computational biology; Immunology","score_opus":0.17577848966985388,"score_gpt":0.49663357487402604,"score_spread":0.32085508520417216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560151975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996045,0.00015602903,0.000058942245,0.0000048877446,7.4402755e-7,0.0000046137466,0.00009008223,0.0000024650642,0.00007770988],"genre_scores_gemma":[0.999597,0.00006553247,0.0000759054,0.0000036680728,0.0000020741736,0.0000039916663,0.00020208978,0.0000016787353,0.00004816892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999694,0.00003228213,0.000031666794,0.00012288614,0.000064737906,0.000054407275],"domain_scores_gemma":[0.99972254,0.0000506652,0.00008478281,0.000043219112,0.000026457234,0.00007241816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023633313,0.00025311005,0.00031141168,0.001230942,0.00038215402,0.00037369266,0.0003363943,0.00030317105,0.0011108653],"category_scores_gemma":[0.0005694678,0.00026779412,0.00032064904,0.0005866225,0.0004524575,0.00015592985,0.0005558263,0.00018313629,0.0002667748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005637049,0.000056764322,0.96842134,0.000040933322,0.00006792103,0.0035318232,0.00024471432,0.00016523621,0.021229751,0.000034744433,0.00008879269,0.0055543296],"study_design_scores_gemma":[0.000015905101,0.00015115718,0.983518,0.0000066066823,0.00006293733,0.012677696,0.00028936792,0.0003750024,0.0023286913,0.000042694508,0.000524348,0.000007654164],"about_ca_topic_score_codex":0.0010982779,"about_ca_topic_score_gemma":0.0012623756,"teacher_disagreement_score":0.001230942,"about_ca_system_score_codex":0.0002866031,"about_ca_system_score_gemma":0.00015555015,"threshold_uncertainty_score":0.0037161708},"labels":[],"label_agreement":null},{"id":"W2560331278","doi":"10.1158/1078-0432.ccr-16-1968","title":"Exploring the Benefit/Risk Associated with Antiangiogenic Agents for the Treatment of Non–Small Cell Lung Cancer Patients","year":2016,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Nintedanib; Vandetanib; Ramucirumab; Sunitinib; Bevacizumab; Erlotinib; Lung cancer; Oncology; Aflibercept; Sorafenib; Internal medicine; Vascular endothelial growth factor; Population; Cancer; Cancer research; Epidermal growth factor receptor; Hepatocellular carcinoma; Idiopathic pulmonary fibrosis; Lung; Chemotherapy; VEGF receptors","score_opus":0.42812998280999054,"score_gpt":0.5598813256620567,"score_spread":0.1317513428520662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560331278","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8754529,0.09577296,0.0031255055,0.010078326,0.00073198596,0.00027987675,0.0022747214,0.00004002793,0.012243701],"genre_scores_gemma":[0.987721,0.0070270854,0.001073019,0.0016251361,0.0008734901,0.00008331717,0.0006199563,0.00001058322,0.0009664266],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.9984718,0.00071274914,0.00013603023,0.00018491731,0.00037724135,0.00011729435],"domain_scores_gemma":[0.99672335,0.001623571,0.00088346604,0.00009386208,0.00030947162,0.00036624007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022747642,0.00024232526,0.00071461516,0.00043021288,0.0002325584,0.000986541,0.00029419348,0.00058480765,0.0054391613],"category_scores_gemma":[0.0075596487,0.0001314583,0.001845315,0.0005497317,0.00020238844,0.0008949516,0.00041564944,0.0013950604,0.00063968386],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022988733,0.001184359,0.64187616,0.0022330936,0.008092528,0.00040120428,0.00017381285,0.001965711,0.0029313457,0.0025880537,0.00730732,0.3082576],"study_design_scores_gemma":[0.0038643745,0.020296099,0.8678292,0.001406272,0.0194823,0.0017084201,0.0007692272,0.009494075,0.0035365168,0.014108761,0.05734717,0.00015757846],"about_ca_topic_score_codex":0.0003741568,"about_ca_topic_score_gemma":0.0010769526,"teacher_disagreement_score":0.0054391613,"about_ca_system_score_codex":0.00060549256,"about_ca_system_score_gemma":0.0004659167,"threshold_uncertainty_score":0.018195808},"labels":[],"label_agreement":null},{"id":"W2561130337","doi":"10.1158/1078-0432.ccr-16-1952","title":"A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Male Breast Health Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Medical Research Council; Cancerfonden; University of Leeds; Breast Cancer Research Trust; Breast Cancer Campaign","keywords":"Breast cancer; Transcriptome; Oncology; Medicine; Cancer; Biology; Internal medicine; Cancer research; Genetics; Gene; Gene expression","score_opus":0.24958663724412217,"score_gpt":0.5293314118989004,"score_spread":0.27974477465477826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561130337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99810326,0.00049997214,0.00044998716,0.00003500772,0.000016146203,0.000014507135,0.00054917746,0.000006338665,0.00032559707],"genre_scores_gemma":[0.9986313,0.000108239845,0.00027308438,0.000034402376,0.000017659158,0.000017362661,0.0006894702,0.0000033638162,0.00022515768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974996,0.000040475985,0.000015065288,0.000099083314,0.000048886443,0.000046612902],"domain_scores_gemma":[0.99975973,0.000056203502,0.00007656801,0.000030845888,0.000038503746,0.0000381749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039049366,0.00020092752,0.00032294102,0.0006712186,0.00038135154,0.00029501083,0.00013243804,0.00021846005,0.0027203332],"category_scores_gemma":[0.00070128497,0.00011866344,0.0003479326,0.00032225365,0.00020832676,0.00011196131,0.00021859568,0.00013376038,0.0003005427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004125116,0.00019573762,0.9032947,0.00009493704,0.00017534517,0.0013401483,0.00015023147,0.00012539148,0.075040296,0.0001421338,0.0007231385,0.014592769],"study_design_scores_gemma":[0.000035597717,0.00058848487,0.98848164,0.000012577707,0.00017304304,0.0026729258,0.00023711848,0.00046104428,0.0056288657,0.00014003634,0.001561111,0.000007611338],"about_ca_topic_score_codex":0.0006066019,"about_ca_topic_score_gemma":0.00096902135,"teacher_disagreement_score":0.0027203332,"about_ca_system_score_codex":0.0002180216,"about_ca_system_score_gemma":0.00019280333,"threshold_uncertainty_score":0.009100378},"labels":[],"label_agreement":null},{"id":"W2562462106","doi":"10.1158/1557-3265.ovcasymp14-poster-ther-1410","title":"Abstract POSTER-THER-1410: Combining small molecule drugs and standard chemotherapy for treatment of granulosa cell tumour cells","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brain Tumour Foundation of Canada; University of Alberta","funders":"","keywords":"XIAP; Carboplatin; Apoptosis; Viability assay; Programmed cell death; Cancer cell; Inhibitor of apoptosis; Cell culture; In vitro; Chemistry; Cancer research; Chemotherapy; Cell; Cancer; Pharmacology; Caspase; Biology; Cisplatin; Medicine; Biochemistry; Internal medicine","score_opus":0.13943149301767244,"score_gpt":0.4645891736443152,"score_spread":0.32515768062664274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562462106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90369934,0.03842539,0.0057103154,0.0016993572,0.0012760771,0.0009169964,0.0031358118,0.0006541304,0.044482674],"genre_scores_gemma":[0.9279915,0.018597899,0.010359711,0.0007069727,0.00038256525,0.00047018917,0.0042958795,0.000087090375,0.037108142],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994135,0.000008372699,0.0000050961285,0.000010257839,0.000019548112,0.00001535123],"domain_scores_gemma":[0.9999676,0.000004024676,0.000005557316,0.000003178614,0.000005787872,0.000013752338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010839972,0.00036593436,0.00038177875,0.00033279837,0.00016224416,0.00025141393,0.00022078102,0.00032559532,0.0083931945],"category_scores_gemma":[0.00005789942,0.00009228269,0.0003667341,0.00025599473,0.00012414176,0.00015883449,0.00020508529,0.0005615205,0.0019515872],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038016085,0.0017284562,0.0008787972,0.0011664894,0.00009004008,0.000541754,0.000048749742,0.000667365,0.8790116,0.00058895996,0.006365625,0.10511061],"study_design_scores_gemma":[0.00064687105,0.01061334,0.009141346,0.000069436435,0.00016522109,0.001993273,0.00003566998,0.0012590906,0.9196967,0.00023663962,0.056122575,0.00001990482],"about_ca_topic_score_codex":0.00032030288,"about_ca_topic_score_gemma":0.0005053328,"teacher_disagreement_score":0.0083931945,"about_ca_system_score_codex":0.00020079786,"about_ca_system_score_gemma":0.00026926317,"threshold_uncertainty_score":0.02807802},"labels":[],"label_agreement":null},{"id":"W2563017322","doi":"10.1158/1557-3265.ovcasymp14-as18","title":"Abstract AS18: The somatic mutational landscape of endometriosis associated ovarian cancers and precursor lesions","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Université de Montréal; BC Cancer Agency; University of British Columbia","funders":"","keywords":"ARID1A; Biology; Endometriosis; Somatic cell; Cancer research; Mutation; Somatic evolution in cancer; Ovarian cancer; Genetics; Gene; Cancer; Pathology; Medicine","score_opus":0.34112812295943756,"score_gpt":0.5212013930610312,"score_spread":0.18007327010159363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563017322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960024,0.0012385321,0.0007996195,0.00005983817,0.0000067455217,0.000011619036,0.00092200795,0.000032964224,0.000926217],"genre_scores_gemma":[0.99773693,0.00032310706,0.0006806962,0.000022934028,0.00000785946,0.000008680677,0.0008695562,0.000008394965,0.0003417993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998641,0.000016242358,0.000013012278,0.000044702352,0.00004135159,0.000020642767],"domain_scores_gemma":[0.9997079,0.00005825485,0.00011904474,0.000014611318,0.000052889955,0.000047259655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023414141,0.00023282599,0.00022149431,0.0007124718,0.00016639888,0.00049739884,0.00016162083,0.00021236815,0.0023660024],"category_scores_gemma":[0.00058032066,0.00009686854,0.00016293344,0.0006032288,0.0001863089,0.00020501627,0.00026890452,0.00016835808,0.0003212956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014601169,0.00007127898,0.73964137,0.0004105696,0.00013796485,0.0027955018,0.00019785727,0.0010825536,0.20633191,0.0006448707,0.0011005733,0.04612548],"study_design_scores_gemma":[0.0000365901,0.00045033832,0.92882967,0.00005236803,0.00015519671,0.014891279,0.00027637347,0.0037294112,0.043613713,0.0013958303,0.006549098,0.000020183166],"about_ca_topic_score_codex":0.0004477147,"about_ca_topic_score_gemma":0.00043008535,"teacher_disagreement_score":0.0023660024,"about_ca_system_score_codex":0.00023226898,"about_ca_system_score_gemma":0.00017185496,"threshold_uncertainty_score":0.00791508},"labels":[],"label_agreement":null},{"id":"W2563952521","doi":"10.1158/1078-0432.ccr-16-2809","title":"Variants in <i>WFS1</i> and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hearing, Cochlea, Tinnitus, Genetics","field":"Neuroscience","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institute of Mental Health","keywords":"Ototoxicity; Hearing loss; Genetics; Mendelian inheritance; Biology; Gene; Cisplatin; Medicine; Audiology; Chemotherapy","score_opus":0.325807192970612,"score_gpt":0.4829229424264863,"score_spread":0.1571157494558743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563952521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99842155,0.00015196692,0.00045716052,0.000047306137,0.0000064086653,0.000008562666,0.00064370263,0.000022350165,0.00024100457],"genre_scores_gemma":[0.99901485,0.0000391729,0.00036804783,0.000042742628,0.000008170528,0.0000072893135,0.00036865516,0.000006629809,0.00014431802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961615,0.00006794066,0.0000507849,0.00016125884,0.00006202112,0.000041909472],"domain_scores_gemma":[0.9991658,0.00023725214,0.00039279286,0.00009561977,0.000035906007,0.000072697985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041476663,0.00047766647,0.0003050283,0.000610047,0.0003615656,0.00044201786,0.000360903,0.00043941045,0.004121247],"category_scores_gemma":[0.001490668,0.00014190207,0.00061092497,0.0007951292,0.00032741166,0.00013679052,0.00031701635,0.0003199394,0.00025635914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002421938,0.00015068582,0.9275787,0.00013219076,0.0010278218,0.0014306937,0.00017097215,0.000807014,0.05502422,0.00029941057,0.00077376986,0.0101825],"study_design_scores_gemma":[0.00013499739,0.0002712143,0.9900349,0.000025504927,0.00039282002,0.0017408051,0.000067999776,0.0014879426,0.0049356148,0.00034299347,0.0005487124,0.00001659957],"about_ca_topic_score_codex":0.0032943902,"about_ca_topic_score_gemma":0.0029353509,"teacher_disagreement_score":0.004121247,"about_ca_system_score_codex":0.00017527163,"about_ca_system_score_gemma":0.00023646362,"threshold_uncertainty_score":0.013786912},"labels":[],"label_agreement":null},{"id":"W2564624504","doi":"10.1158/1557-3265.ovcasymp14-poster-biol-1312","title":"Abstract POSTER-BIOL-1312: The role of BRCA and CEBPD in serous ovarian cancer carcinogenesis","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Ovarian cancer; Cancer research; Carcinogenesis; Fallopian tube; Tissue microarray; Ovarian carcinoma; Serous fluid; Serous carcinoma; Biology; Medicine; Cancer; Pathology; Immunohistochemistry; Internal medicine; Gynecology","score_opus":0.2830037735646006,"score_gpt":0.5131848304737923,"score_spread":0.23018105690919166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564624504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8163283,0.06679032,0.0047911536,0.006879409,0.002364861,0.0007218671,0.009800525,0.00045656718,0.091867186],"genre_scores_gemma":[0.81975985,0.019695967,0.0032421334,0.0011034029,0.0013598771,0.0003053312,0.008278719,0.00009991733,0.14615478],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998803,0.000023968807,0.00000825526,0.000035395435,0.000027650509,0.000024466526],"domain_scores_gemma":[0.9998783,0.000015671883,0.000013268604,0.000008272928,0.000027170317,0.00005733407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046371442,0.00038683042,0.0002645416,0.0004781603,0.00034960738,0.0006600026,0.00039438496,0.0005962168,0.029005872],"category_scores_gemma":[0.00020827235,0.000116135314,0.00025390307,0.00032707222,0.0002328584,0.00022591531,0.00040530012,0.0005125993,0.006224244],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015432167,0.0013666942,0.030883456,0.0041019386,0.00019324967,0.0022998098,0.00022474035,0.0007657173,0.6968563,0.0028888516,0.045138393,0.19984867],"study_design_scores_gemma":[0.0010817127,0.005660374,0.27306205,0.00046977127,0.00034225674,0.007941378,0.00031447766,0.0015799131,0.38272774,0.0018972349,0.32485846,0.00006464504],"about_ca_topic_score_codex":0.0005883718,"about_ca_topic_score_gemma":0.0004593013,"teacher_disagreement_score":0.029005872,"about_ca_system_score_codex":0.0005000884,"about_ca_system_score_gemma":0.00050028914,"threshold_uncertainty_score":0.097034335},"labels":[],"label_agreement":null},{"id":"W2565248748","doi":"10.1158/1557-3265.ovcasymp14-as01","title":"Abstract AS01: Molecular genetic approaches to understanding ovarian cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; McGill University and Génome Québec Innovation Centre; Jewish General Hospital","funders":"","keywords":"Sanger sequencing; COLD-PCR; Ovarian cancer; Biology; Cancer research; Exome sequencing; Mutation; Carboplatin; Metastasis; Cancer; Chemotherapy; Genetics; Gene; Point mutation","score_opus":0.7612715649881563,"score_gpt":0.5303225873727327,"score_spread":0.23094897761542355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565248748","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19433197,0.10220073,0.33814692,0.112459615,0.0064995536,0.0003886948,0.006140463,0.0027921153,0.23703995],"genre_scores_gemma":[0.6291965,0.07124858,0.1695565,0.01257494,0.0045381724,0.0003615599,0.004582708,0.0004740213,0.10746694],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989116,0.00004511506,0.000007917671,0.0000186851,0.0000237188,0.000013473153],"domain_scores_gemma":[0.9997228,0.000090152615,0.00003886193,0.000022834816,0.00006883638,0.000056501296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006187983,0.00032957722,0.00026134774,0.0008931937,0.00026416883,0.00093338225,0.0005766189,0.00081607566,0.008183206],"category_scores_gemma":[0.0006719012,0.00010524073,0.00021663512,0.00063044345,0.00064420386,0.0013592746,0.0005318305,0.001179965,0.0017598262],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038957997,0.00020864546,0.012301006,0.001248606,0.00007463752,0.0027607367,0.00056286214,0.0055722618,0.10225103,0.39812607,0.140628,0.33587658],"study_design_scores_gemma":[0.000077666846,0.0003028489,0.015834976,0.00037858458,0.00006455852,0.004808699,0.0006648696,0.013863959,0.019797545,0.24892426,0.6952332,0.000048898826],"about_ca_topic_score_codex":0.0006177224,"about_ca_topic_score_gemma":0.00058492663,"teacher_disagreement_score":0.008183206,"about_ca_system_score_codex":0.0005800823,"about_ca_system_score_gemma":0.00032830873,"threshold_uncertainty_score":0.027375579},"labels":[],"label_agreement":null},{"id":"W2566145140","doi":"10.1158/1557-3265.ovcasymp14-poster-tech-1101","title":"Abstract POSTER-TECH-1101: Characterization of genomic landscapes of BRCA1 and BRCA2 implicated ovarian cancer specimens from a founder french canadian population","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; McGill University Health Centre; McGill University","funders":"","keywords":"Biology; Ovarian cancer; Genetics; BRCA2 Protein; Founder effect; Germline mutation; Missense mutation; Population; Cancer; Mutation; Genotype; Gene; Medicine; Haplotype","score_opus":0.12755855170975594,"score_gpt":0.43322890527687047,"score_spread":0.30567035356711453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566145140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886594,0.00060291233,0.000483834,0.00022283009,0.00001562023,0.0000749052,0.0060966187,0.000040432533,0.0038033186],"genre_scores_gemma":[0.98799163,0.0003705397,0.001162226,0.00019272412,0.000018026254,0.00003930933,0.006097724,0.000030230474,0.0040975683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955696,0.000026053123,0.000016193313,0.00010631716,0.0001569494,0.000137502],"domain_scores_gemma":[0.9996525,0.000027323813,0.000025095846,0.000027237696,0.00018882653,0.00007896558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044215485,0.0003404949,0.00028035208,0.0019316174,0.0019857925,0.00074214104,0.0004877281,0.00035410083,0.00453989],"category_scores_gemma":[0.00071137334,0.00018603215,0.0003200614,0.0016906052,0.00047271993,0.00007579887,0.00045973956,0.00024367828,0.00065994536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006406032,0.00007872782,0.91223,0.00012245472,0.00011579813,0.00245671,0.002300888,0.00031737468,0.05025619,0.00027079278,0.0058051366,0.025405457],"study_design_scores_gemma":[0.000011055745,0.000052989442,0.9880285,0.000010531112,0.00003222575,0.0014481937,0.00089018093,0.00014886507,0.002090646,0.00002538534,0.007252365,0.000009020125],"about_ca_topic_score_codex":0.7814882,"about_ca_topic_score_gemma":0.83056897,"teacher_disagreement_score":0.21851182,"about_ca_system_score_codex":0.0032787542,"about_ca_system_score_gemma":0.0030051987,"threshold_uncertainty_score":0.4395973},"labels":[],"label_agreement":null},{"id":"W2567870461","doi":"10.1158/1557-3265.pmccavuln16-b18","title":"Abstract B18: Development of human STING agonists for prostate cancer immunotherapy","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cancer; Prostate cancer; Sting; Immunotherapy; Cancer research; Cancer immunotherapy; Cytotoxic T cell; Medicine; Cancer cell; Immune system; In vivo; Pharmacology; In silico; Innate immune system; In vitro; Immunology; Biology; Internal medicine; Biochemistry","score_opus":0.3306226409225515,"score_gpt":0.574342886797812,"score_spread":0.24372024587526048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567870461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9152278,0.03897189,0.01716676,0.0017718115,0.0005436367,0.0012401566,0.0051004547,0.00054125336,0.019436276],"genre_scores_gemma":[0.9437552,0.019877655,0.01655582,0.00086967705,0.00017586809,0.0003534371,0.0036958153,0.000060182512,0.014656263],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992824,0.00001643547,0.000005140328,0.000010596065,0.000022545384,0.000017052445],"domain_scores_gemma":[0.99993765,0.0000060976686,0.000012716307,0.0000049038963,0.000010385886,0.000028196971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017329198,0.00047308684,0.0002803379,0.0004267207,0.00011139978,0.0002254503,0.00028738758,0.00027651963,0.005233658],"category_scores_gemma":[0.000098295015,0.00013237467,0.00032735203,0.00022239368,0.00011046761,0.00018457712,0.00017940835,0.00063023955,0.0010843152],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007471667,0.00065575616,0.0006306814,0.00049435446,0.000060830796,0.0001968493,0.00004582458,0.0015463395,0.9286815,0.00060809223,0.0023439417,0.063988715],"study_design_scores_gemma":[0.000827502,0.01699091,0.004243146,0.0001263027,0.00018045017,0.00091373076,0.00004047705,0.0023389454,0.91316295,0.00028052143,0.060862165,0.00003287602],"about_ca_topic_score_codex":0.00048988935,"about_ca_topic_score_gemma":0.00087510614,"teacher_disagreement_score":0.005233658,"about_ca_system_score_codex":0.00019746348,"about_ca_system_score_gemma":0.00036383644,"threshold_uncertainty_score":0.017508268},"labels":[],"label_agreement":null},{"id":"W2570267880","doi":"10.1158/1557-3265.pmccavuln16-a25","title":"Abstract A25: COTI-2, a novel small molecule that is effective against multiple human cancer cell lines in vitro and in vivo","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute","funders":"","keywords":"In vivo; Cancer; Flow cytometry; In silico; Cancer cell; In vitro; Cell growth; Cell culture; Apoptosis; PI3K/AKT/mTOR pathway; Cancer research; Viability assay; Pharmacology; Drug discovery; Chemistry; Biology; Biochemistry; Molecular biology; Genetics","score_opus":0.2372363984106822,"score_gpt":0.5182743531454814,"score_spread":0.2810379547347992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570267880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9245048,0.016476348,0.0128041655,0.0011361688,0.0008317051,0.00067478395,0.008630449,0.001315923,0.0336256],"genre_scores_gemma":[0.95881784,0.0055322754,0.007335711,0.0002986849,0.000081443824,0.00018840066,0.005261353,0.00006035934,0.02242378],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999378,0.00000415656,0.0000045789448,0.000015981004,0.000027398262,0.000010181878],"domain_scores_gemma":[0.99996185,0.0000043757113,0.000007707685,0.0000033289039,0.000008318455,0.000014307686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009394671,0.00069998094,0.00030566496,0.0003098563,0.00018290542,0.00024813923,0.00033011776,0.0002791183,0.0066667865],"category_scores_gemma":[0.00006753317,0.000121001045,0.0002851939,0.00022703556,0.00014596595,0.00019378401,0.0001362972,0.00048301613,0.0010761253],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051798514,0.00024979553,0.00039752116,0.00029204812,0.000029249977,0.00026268157,0.000014181942,0.000856453,0.978571,0.00044172132,0.0025035732,0.015863707],"study_design_scores_gemma":[0.00037311055,0.00273445,0.0037121794,0.000016397462,0.000057437483,0.00054369384,0.000010476375,0.0028170242,0.9743834,0.00008388261,0.0152530335,0.000015028039],"about_ca_topic_score_codex":0.0019152847,"about_ca_topic_score_gemma":0.0030466705,"teacher_disagreement_score":0.0066667865,"about_ca_system_score_codex":0.00044893226,"about_ca_system_score_gemma":0.00044077367,"threshold_uncertainty_score":0.022302628},"labels":[],"label_agreement":null},{"id":"W2570635734","doi":"10.1158/1557-3265.pmccavuln16-b03","title":"Abstract B03: Development of retroviral replicating vectors expressing codon-optimized nitroreductase for prodrug activator gene therapy in human glioma models","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytosine deaminase; Prodrug; Genetic enhancement; Biology; Cytotoxicity; Glioma; Viral vector; Activator (genetics); Vector (molecular biology); Cancer research; Nitroreductase; Gene; Molecular biology; In vitro; Pharmacology; Biochemistry; Recombinant DNA","score_opus":0.2909986533785346,"score_gpt":0.5285114433284737,"score_spread":0.23751278994993907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570635734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8743675,0.0034721403,0.099694744,0.0005661264,0.000381344,0.0022925297,0.0066487826,0.0015251571,0.011051711],"genre_scores_gemma":[0.8703122,0.002084914,0.09886443,0.00021932118,0.000040155162,0.0011646168,0.01075,0.00035248074,0.016211899],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99948466,0.00009569235,0.00006768438,0.0001040808,0.00017313029,0.000074798765],"domain_scores_gemma":[0.99980646,0.000036260102,0.00004140453,0.000042304393,0.00003794692,0.00003567987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081591157,0.00068988703,0.00038895593,0.0006066808,0.00028117356,0.00059634726,0.000739587,0.0008477031,0.0021179595],"category_scores_gemma":[0.00027387438,0.00028846585,0.0004604305,0.00038099306,0.0003404597,0.0003509006,0.00020475958,0.0011175793,0.0015462877],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002127916,0.0001601761,0.000104441,0.000059254024,0.000012010434,0.000051279058,0.000035354064,0.00024912806,0.99411523,0.0005090371,0.00037803687,0.0041131955],"study_design_scores_gemma":[0.0000742403,0.00084215665,0.00058371574,0.000011275411,0.000023625997,0.00024817907,0.000013793491,0.0015632093,0.9892616,0.000058036723,0.0073108934,0.000009259082],"about_ca_topic_score_codex":0.0023794635,"about_ca_topic_score_gemma":0.0016671156,"teacher_disagreement_score":0.0023794635,"about_ca_system_score_codex":0.0006144084,"about_ca_system_score_gemma":0.00059645926,"threshold_uncertainty_score":0.0070852637},"labels":[],"label_agreement":null},{"id":"W2571057012","doi":"10.1158/1078-0432.ccr-16-1496","title":"Phase I Study of ONT-380, a HER2 Inhibitor, in Patients with HER2+-Advanced Solid Tumors, with an Expansion Cohort in HER2+ Metastatic Breast Cancer (MBC)","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Queen's University","funders":"","keywords":"Medicine; Internal medicine; Rash; Gastroenterology; Nausea; Cohort; Anemia; Metastatic breast cancer; Pharmacokinetics; Diarrhea; Vomiting; Neutropenia; Breast cancer; Cancer; Toxicity","score_opus":0.18753899173105087,"score_gpt":0.5709110171428204,"score_spread":0.38337202541176957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571057012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986771,0.00021284574,0.00014084623,0.000040759303,0.000008708501,0.00036085473,0.0001679537,0.00001894813,0.00037200018],"genre_scores_gemma":[0.99606824,0.00029902553,0.00089255976,0.00012306767,0.000033808064,0.00060673745,0.0010602584,0.000010314162,0.00090597896],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997979,0.00007510295,0.000010481662,0.000036605183,0.000031082924,0.00004886944],"domain_scores_gemma":[0.9996158,0.00005174219,0.000057065663,0.000039707396,0.00002468297,0.00021092893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080092764,0.0009221596,0.0010140897,0.00021379092,0.00024756027,0.0003624487,0.0005067965,0.0003692811,0.0018218281],"category_scores_gemma":[0.00041430743,0.00030467284,0.0004817179,0.00024135842,0.0005249552,0.0005028925,0.00027436833,0.0014355049,0.00032215935],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44628525,0.14139627,0.033147328,0.0006607147,0.0008914559,0.0008682413,0.0008376227,0.0067544812,0.17859432,0.00047600004,0.0047474857,0.18534087],"study_design_scores_gemma":[0.14810745,0.79665506,0.037469845,0.000023592907,0.00031083415,0.0007454402,0.00009567702,0.002458066,0.0110803535,0.00014996901,0.0028787407,0.000025021998],"about_ca_topic_score_codex":0.0010769546,"about_ca_topic_score_gemma":0.0028288323,"teacher_disagreement_score":0.0018218281,"about_ca_system_score_codex":0.0007356457,"about_ca_system_score_gemma":0.0009837662,"threshold_uncertainty_score":0.006094575},"labels":[],"label_agreement":null},{"id":"W2573357968","doi":"10.1158/1078-0432.ccr-16-2265","title":"Differentiation between Radiation Necrosis and Tumor Progression Using Chemical Exchange Saturation Transfer","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lanthanide and Transition Metal Complexes","field":"Materials Science","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Terry Fox Research Institute","keywords":"Necrosis; Magnetization transfer; Medicine; Radiosurgery; Nuclear medicine; Tumor progression; Magnetic resonance imaging; Radiation therapy; Pathology; Nuclear magnetic resonance; Radiology; Internal medicine; Cancer","score_opus":0.35350923040369303,"score_gpt":0.5312767104444008,"score_spread":0.1777674800407078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573357968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983512,0.00018321343,0.0010443395,0.000010728157,0.0000019218355,0.000018344484,0.000017741022,0.000012066214,0.00036045501],"genre_scores_gemma":[0.9988354,0.000048484933,0.0009364902,0.0000048210013,0.0000023091766,0.000009382647,0.000040501018,0.0000025352854,0.00012019378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998541,0.00005887195,0.0000144272335,0.00002644061,0.000033120432,0.000012977967],"domain_scores_gemma":[0.99941623,0.00018803569,0.00022325404,0.000032294774,0.00008226211,0.000057945115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007705431,0.00026143895,0.00019055445,0.00055823085,0.000115782685,0.00026378126,0.00010274928,0.00023286218,0.0012962433],"category_scores_gemma":[0.0012394647,0.00011073549,0.0001514209,0.00018849832,0.00033924842,0.00028932717,0.00014993631,0.00023194149,0.00025576467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050228485,0.0003610795,0.53438026,0.00020046147,0.00012278622,0.00077992136,0.0003201777,0.0013929807,0.4140779,0.00017876472,0.00012436126,0.043038473],"study_design_scores_gemma":[0.00032962984,0.014262139,0.71207905,0.000035544115,0.00023159623,0.009331286,0.0002716683,0.01554884,0.2460658,0.00042913924,0.0013644692,0.000050910563],"about_ca_topic_score_codex":0.00029775713,"about_ca_topic_score_gemma":0.00038997398,"teacher_disagreement_score":0.0012962433,"about_ca_system_score_codex":0.00016753546,"about_ca_system_score_gemma":0.00015664233,"threshold_uncertainty_score":0.0043364167},"labels":[],"label_agreement":null},{"id":"W2576009444","doi":"10.1158/1078-0432.ccr-16-2353","title":"Disease Characteristics and Prognostic Implications of Cell-Surface FLT3 Receptor (CD135) Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Medicine; Myeloid leukemia; Oncology; Myeloid; Flow cytometry; Internal medicine; Leukemia; Cancer; Cancer research; Receptor expression; Cell; Receptor; Immunology; Biology","score_opus":0.09331618270559418,"score_gpt":0.4623432076157812,"score_spread":0.369027024910187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576009444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975993,0.0016198099,0.00012948005,0.000053929874,0.000003898234,0.0000072650523,0.00031645875,0.0000034529949,0.0002664103],"genre_scores_gemma":[0.9985637,0.00076441484,0.00015432373,0.000022234773,0.000015704089,0.0000061485543,0.00042772575,0.0000015892892,0.000044134697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997955,0.000041677034,0.000023075298,0.000052518757,0.000062065854,0.000025076082],"domain_scores_gemma":[0.9994236,0.00022555585,0.0001632844,0.000030769188,0.00009196781,0.00006470065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004157509,0.00019677839,0.00021684052,0.0004939474,0.00016119298,0.00030963836,0.000146742,0.00018551119,0.00031186742],"category_scores_gemma":[0.00093590596,0.00010534245,0.000139024,0.0006372122,0.000281558,0.00015891402,0.00014998678,0.00023339361,0.00008018169],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018022653,0.000015128062,0.9876938,0.000032504086,0.000041601797,0.00030106682,0.000072897026,0.00014489952,0.0017786481,0.000027375883,0.00030428966,0.009407618],"study_design_scores_gemma":[0.000019927984,0.00014058023,0.9948224,0.000009473337,0.00007344277,0.0022452394,0.00008600293,0.00019534316,0.0011594408,0.000022133054,0.0012206027,0.0000054644765],"about_ca_topic_score_codex":0.0030991915,"about_ca_topic_score_gemma":0.002130187,"teacher_disagreement_score":0.0030991915,"about_ca_system_score_codex":0.00036164123,"about_ca_system_score_gemma":0.00029056697,"threshold_uncertainty_score":0.0061623454},"labels":[],"label_agreement":null},{"id":"W2584563327","doi":"10.1158/1078-0432.ccr-16-2266","title":"Body Composition as a Predictor of Toxicity in Patients Receiving Anthracycline and Taxane–Based Chemotherapy for Early-Stage Breast Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"National Institute on Aging; American Federation for Aging Research","keywords":"Taxane; Anthracycline; Medicine; Chemotherapy; Oncology; Toxicity; Stage (stratigraphy); Breast cancer; Internal medicine; Cancer; Mammary gland; Paclitaxel; Biology","score_opus":0.19338898375264835,"score_gpt":0.5625247914972552,"score_spread":0.36913580774460686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584563327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993895,0.00032618773,0.00011038584,0.000018252586,0.0000026634905,0.0000055858154,0.00005189255,0.000002234468,0.00009333892],"genre_scores_gemma":[0.9996972,0.00006203715,0.0000992609,0.000011258137,0.000005471536,0.000004181906,0.0000876684,6.612574e-7,0.000032181135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968445,0.00014814672,0.000031510743,0.000039528983,0.00007036113,0.000026099171],"domain_scores_gemma":[0.9985165,0.00042644763,0.00073582213,0.00006228892,0.00010901249,0.00014990849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084321183,0.0002375433,0.00033416992,0.00047217766,0.00017642119,0.00029197265,0.00018504639,0.00024437628,0.00063151063],"category_scores_gemma":[0.0022456804,0.000115218674,0.00030341742,0.00050335884,0.00017330139,0.00018078092,0.00026334953,0.0003909089,0.000092848146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036820673,0.000027573305,0.9974784,0.0000066372118,0.000041117033,0.000015851754,0.0000062772947,0.00007774097,0.00026229824,0.0000026682571,0.000017155959,0.0016960728],"study_design_scores_gemma":[0.000013057467,0.00031057477,0.9987331,0.0000033402562,0.00003866041,0.00012160346,0.000016061127,0.0005632806,0.00014385581,0.000010758032,0.000044010532,0.0000016482534],"about_ca_topic_score_codex":0.0007351674,"about_ca_topic_score_gemma":0.0009951243,"teacher_disagreement_score":0.00084321183,"about_ca_system_score_codex":0.00021689553,"about_ca_system_score_gemma":0.00022973616,"threshold_uncertainty_score":0.004459381},"labels":[],"label_agreement":null},{"id":"W2586956252","doi":"10.1158/1078-0432.ccr-16-2814","title":"An Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous Carcinoma","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Head and neck squamous-cell carcinoma; Medicine; Oncology; Biomarker; microRNA; Head and neck cancer; Internal medicine; Gene signature; Cancer research; Cancer; Bioinformatics; Biology; Gene; Gene expression","score_opus":0.1128784340432035,"score_gpt":0.4708680782620183,"score_spread":0.35798964421881485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586956252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843411,0.0034081885,0.009572256,0.0000762038,0.000027983757,0.00011730948,0.0010605374,0.00017405106,0.001222471],"genre_scores_gemma":[0.9834135,0.0010521703,0.0120688705,0.000091636066,0.000017720433,0.00010984462,0.0020685147,0.00002745013,0.0011503304],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99982625,0.00001982668,0.000011662065,0.00005609318,0.000064303356,0.000021846821],"domain_scores_gemma":[0.99988914,0.000016603026,0.000038188948,0.00001187646,0.000028713544,0.00001546957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002791199,0.00032630883,0.00053981395,0.00067612017,0.00017303754,0.0005397443,0.00018711785,0.00023165262,0.0010400104],"category_scores_gemma":[0.0002603033,0.0001875435,0.00045290412,0.00033981263,0.00012784607,0.00022119863,0.00039698958,0.00031963905,0.00043773834],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079651654,0.00008942645,0.016343825,0.00018935533,0.00008985775,0.00008293769,0.000039849423,0.00042424508,0.95803726,0.000085011125,0.00017009175,0.02365161],"study_design_scores_gemma":[0.000081673075,0.0024052109,0.20268174,0.00005466167,0.00070957345,0.0012479415,0.00020478637,0.018315652,0.76807207,0.00042956308,0.0057578646,0.000039267154],"about_ca_topic_score_codex":0.00032117617,"about_ca_topic_score_gemma":0.0007048696,"teacher_disagreement_score":0.0010400104,"about_ca_system_score_codex":0.0003116594,"about_ca_system_score_gemma":0.00035306494,"threshold_uncertainty_score":0.0034791827},"labels":[],"label_agreement":null},{"id":"W2587481375","doi":"10.1158/1078-0432.ccr-16-1859","title":"CT Perfusion as an Early Biomarker of Treatment Efficacy in Advanced Ovarian Cancer: An ACRIN and GOG Study","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Mediprobe Research (Canada)","funders":"National Institute of General Medical Sciences; National Cancer Institute; American College of Radiology Imaging Network","keywords":"Ovarian cancer; Medicine; Biomarker; Oncology; Cancer; Internal medicine; Biology","score_opus":0.21568864824237696,"score_gpt":0.5951311830547018,"score_spread":0.3794425348123248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587481375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987112,0.0006386488,0.00007639957,0.0000755285,0.00000710399,0.00008805881,0.0001529873,0.0000034501181,0.0002465162],"genre_scores_gemma":[0.99914336,0.00014066519,0.00013787598,0.00009735587,0.000026109832,0.00006974146,0.00021924925,0.000002029293,0.00016361017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992719,0.00047431036,0.000026321968,0.0001103157,0.00006704546,0.000050059713],"domain_scores_gemma":[0.998862,0.0002565584,0.00042324068,0.00014841087,0.000060282033,0.00024962178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002047247,0.0007283086,0.0005555842,0.00029016804,0.00023327238,0.00070562685,0.000345002,0.0005990561,0.0010947296],"category_scores_gemma":[0.0017765419,0.00028858666,0.0005969884,0.00041904606,0.0005338676,0.00050655456,0.000445714,0.0007685397,0.00017889828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34941497,0.0054538003,0.58976704,0.00041906015,0.0022976513,0.000247562,0.00032908836,0.0008743944,0.012013531,0.00027188874,0.001077991,0.037832998],"study_design_scores_gemma":[0.048219897,0.06318136,0.8800012,0.00006959575,0.0023609179,0.0003750743,0.00017077722,0.0015840442,0.001530792,0.00024185482,0.002215837,0.00004861848],"about_ca_topic_score_codex":0.0007771624,"about_ca_topic_score_gemma":0.00093884877,"teacher_disagreement_score":0.002047247,"about_ca_system_score_codex":0.0005298932,"about_ca_system_score_gemma":0.00045761836,"threshold_uncertainty_score":0.010826945},"labels":[],"label_agreement":null},{"id":"W2589712516","doi":"10.1158/1078-0432.ccr-16-2615","title":"Long-Term Responders on Olaparib Maintenance in High-Grade Serous Ovarian Cancer: Clinical and Molecular Characterization","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Olaparib; Medicine; Oncology; Ovarian cancer; Internal medicine; BRCA mutation; Serous ovarian cancer; PARP inhibitor; Cancer research; Cancer; Biology; Genetics","score_opus":0.2561304436178418,"score_gpt":0.5529180762777554,"score_spread":0.29678763265991354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589712516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995763,0.00021759227,0.000036963018,0.000008586995,0.0000012022477,0.0000074445543,0.000065057735,0.0000010820401,0.000085832],"genre_scores_gemma":[0.9995776,0.0000485843,0.000048788414,0.000021623438,0.000007629943,0.000010755389,0.00020139515,7.59213e-7,0.00008284828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997607,0.00007986049,0.000031716543,0.000049341015,0.00004136743,0.000037041587],"domain_scores_gemma":[0.9986339,0.0003782018,0.00055552425,0.00010801492,0.000090795096,0.0002335413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066006614,0.000119830314,0.00026669825,0.00030418902,0.00018034085,0.00029987068,0.00016445699,0.00026165665,0.0012120706],"category_scores_gemma":[0.0010166386,0.00007818638,0.00022733168,0.00029706868,0.00022400336,0.00024062474,0.00019089178,0.0002895965,0.00013662796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011029642,0.00031455402,0.959701,0.00006012611,0.00010679396,0.00026804197,0.00008205445,0.00013089587,0.012618339,0.00003032901,0.00013535937,0.015522938],"study_design_scores_gemma":[0.00023855516,0.0035358951,0.9931846,0.000006879295,0.00006298884,0.0010569843,0.00007748617,0.00025637134,0.0011761177,0.000031394007,0.00036776208,0.000004976229],"about_ca_topic_score_codex":0.00022352993,"about_ca_topic_score_gemma":0.0003757877,"teacher_disagreement_score":0.0012120706,"about_ca_system_score_codex":0.00020339963,"about_ca_system_score_gemma":0.00015986481,"threshold_uncertainty_score":0.004054725},"labels":[],"label_agreement":null},{"id":"W2591962416","doi":"10.1158/1557-3265.pdx16-a10","title":"Abstract A10: Plerixafor inhibits myeloid cell recruitment and improves the radioresponse in patient-derived cervix cancer xenograft models","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Cervical cancer; Cervix; Cancer; Radiation therapy; Plerixafor; Oncology; Pathology; Cancer research; CXCR4; Internal medicine","score_opus":0.19943615139642307,"score_gpt":0.4146981631303971,"score_spread":0.21526201173397402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591962416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935773,0.0010290012,0.0014186127,0.00017680867,0.000059835023,0.00011043026,0.0013400327,0.0001633249,0.0021246097],"genre_scores_gemma":[0.9911548,0.00064375426,0.0019896305,0.00006771765,0.000011791109,0.00013446025,0.0024387564,0.00003063925,0.0035282853],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977976,0.000041071035,0.0000227087,0.00003858885,0.000059724676,0.000058170986],"domain_scores_gemma":[0.9998282,0.000036007437,0.00003552229,0.000031880685,0.000017430419,0.000050974744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033640748,0.00044779963,0.00045626654,0.0002851325,0.00013783155,0.00036844227,0.00039080833,0.00035502444,0.0031593975],"category_scores_gemma":[0.0001426511,0.000135965,0.00034488476,0.00022569226,0.00021353584,0.00026018918,0.00016729344,0.0011651248,0.00053576595],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017680397,0.0011427293,0.0005292959,0.00013987719,0.000028215532,0.00006402938,0.000052283838,0.00066480855,0.988865,0.00015668802,0.00096571335,0.005623413],"study_design_scores_gemma":[0.00024541933,0.008772939,0.005500383,0.000012162335,0.000054990353,0.0003337276,0.00005544575,0.002913575,0.9774955,0.000031217012,0.0045763105,0.000008411742],"about_ca_topic_score_codex":0.0015141302,"about_ca_topic_score_gemma":0.0017426461,"teacher_disagreement_score":0.0031593975,"about_ca_system_score_codex":0.00036154976,"about_ca_system_score_gemma":0.00042978616,"threshold_uncertainty_score":0.010569274},"labels":[],"label_agreement":null},{"id":"W2592672980","doi":"10.1158/1557-3265.pdx16-b32","title":"Abstract B32: Fidelity of genomic and proteomic features of patient-derived xenografts of lung cancers","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University Health Network","funders":"","keywords":"Transcriptome; Cancer research; Biology; Lung cancer; Cancer; Gene; Proteome; Exome sequencing; Exome; Pathology; Medicine; Gene expression; Mutation; Bioinformatics; Genetics","score_opus":0.05526853431076217,"score_gpt":0.4230242684744786,"score_spread":0.36775573416371643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592672980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778326,0.000755481,0.010903771,0.0001481938,0.000040894192,0.0001303664,0.0064486065,0.00027856408,0.0034614443],"genre_scores_gemma":[0.9765146,0.00042306268,0.0052453936,0.00011393181,0.0000065707695,0.00015206003,0.014654563,0.0001232677,0.0027665994],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996216,0.00006455155,0.000043864984,0.0000988031,0.00012405467,0.00004703522],"domain_scores_gemma":[0.99956757,0.00011793832,0.000049914226,0.00010641729,0.00009072203,0.00006741773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000577355,0.00025993973,0.00030305603,0.00032565405,0.00018296785,0.000549064,0.00025667268,0.00033313074,0.0032167274],"category_scores_gemma":[0.00071510294,0.00017660532,0.00021616738,0.0002822794,0.00014466402,0.00024348739,0.00028787958,0.0005790261,0.0014740174],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026498735,0.00006795082,0.003689183,0.000026379283,0.00001987051,0.00010893921,0.00003070882,0.0002518578,0.99243283,0.00008700695,0.00034732302,0.0026729451],"study_design_scores_gemma":[0.000047235346,0.001196215,0.099453375,0.0000220644,0.0000609907,0.0031485576,0.0001813865,0.0044023506,0.8799246,0.00017460377,0.0113692675,0.000019472433],"about_ca_topic_score_codex":0.0009500336,"about_ca_topic_score_gemma":0.00055823085,"teacher_disagreement_score":0.0032167274,"about_ca_system_score_codex":0.00024110288,"about_ca_system_score_gemma":0.0002010197,"threshold_uncertainty_score":0.010760963},"labels":[],"label_agreement":null},{"id":"W2593067736","doi":"10.1158/1078-0432.ccr-16-2796","title":"A Phase I–II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline <i>BRCA1/2</i> -Mutated Ovarian Carcinoma or Other Solid Tumors","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":236,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"PARP inhibitor; Ovarian cancer; Germline; Medicine; Cancer research; Germline mutation; Ovarian carcinoma; Internal medicine; Oncology; Cancer; Mutation; Poly ADP ribose polymerase; Biology; Genetics; DNA; Polymerase","score_opus":0.24196756652240917,"score_gpt":0.5440788431986607,"score_spread":0.3021112766762516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593067736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930841,0.001589839,0.0005235683,0.000314882,0.0000910933,0.0023907283,0.00055362104,0.000051690007,0.0014006597],"genre_scores_gemma":[0.99123454,0.0013573101,0.0015228591,0.00077613787,0.00019641475,0.0019943565,0.0015273948,0.000021693879,0.001369279],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995079,0.00023654071,0.000027108963,0.00009908248,0.0000494862,0.000079892015],"domain_scores_gemma":[0.9992292,0.00013454357,0.00011478658,0.00007118675,0.00004955211,0.00040075497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014641206,0.0013268983,0.0022432692,0.00035588245,0.000504827,0.0008440273,0.0006220864,0.0009321487,0.0029649425],"category_scores_gemma":[0.0010290801,0.00076841266,0.001049567,0.00043104106,0.00081517716,0.00071811187,0.000316621,0.0029550705,0.0007189531],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.65949917,0.13804457,0.018267421,0.00097470614,0.0016370267,0.00057329785,0.00043436416,0.0027068255,0.050721474,0.00030007347,0.004889319,0.1219518],"study_design_scores_gemma":[0.50842774,0.4673535,0.017234726,0.000026018784,0.00039356702,0.00034225275,0.000054352167,0.0010495265,0.0024057443,0.00013704864,0.002548712,0.00002675028],"about_ca_topic_score_codex":0.000878704,"about_ca_topic_score_gemma":0.0018759889,"teacher_disagreement_score":0.0029649425,"about_ca_system_score_codex":0.0008150145,"about_ca_system_score_gemma":0.0017655804,"threshold_uncertainty_score":0.009918749},"labels":[],"label_agreement":null},{"id":"W2593592874","doi":"10.1158/1557-3265.pdx16-b08","title":"Abstract B08: Patient-derived xenografts of oral squamous cell carcinoma: A model system for the identification of prognostic molecular signatures and for preclinical assessment of targeted therapies","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Clinical significance; Oncology; Internal medicine; Lymph node; Basal cell; Cancer; Disease; Biomarker; Histology; Personalized medicine; Pathology; Bioinformatics; Biology","score_opus":0.10694029556156544,"score_gpt":0.46894997873096766,"score_spread":0.36200968316940224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593592874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98963416,0.00058631663,0.0040163593,0.00013968737,0.000055736553,0.00028433028,0.0035057124,0.000084017025,0.0016937634],"genre_scores_gemma":[0.9832335,0.00060000276,0.0071691936,0.000076445496,0.000017660323,0.00041054533,0.00551872,0.000043862925,0.0029300854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99962854,0.00010204997,0.000046674144,0.00006247501,0.0000942983,0.00006590828],"domain_scores_gemma":[0.999648,0.000094493145,0.00005885027,0.000082083985,0.000047245016,0.0000693759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095336686,0.00046042088,0.0004682379,0.0003906599,0.00030700167,0.0005422519,0.00035993167,0.00048429478,0.0032241908],"category_scores_gemma":[0.00033692486,0.00022633423,0.00041196824,0.00033980777,0.00024720482,0.00034194803,0.00034274947,0.0014570762,0.0009668257],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015479733,0.0014322108,0.0044058,0.00012278026,0.000043306343,0.00020425757,0.00013470609,0.0010839677,0.9837938,0.0008133123,0.0011653011,0.0052527017],"study_design_scores_gemma":[0.0005001144,0.014393944,0.03217523,0.000059302587,0.0001325347,0.0023316098,0.00026207906,0.014579839,0.9224204,0.0004373893,0.012664647,0.000042976204],"about_ca_topic_score_codex":0.0014616582,"about_ca_topic_score_gemma":0.0011883032,"teacher_disagreement_score":0.0032241908,"about_ca_system_score_codex":0.00039791313,"about_ca_system_score_gemma":0.00036906663,"threshold_uncertainty_score":0.010785997},"labels":[],"label_agreement":null},{"id":"W2593824144","doi":"10.1158/1557-3265.pdx16-b09","title":"Abstract B09: Efficient generation of patient-matched malignant and normal primary cell cultures from clear cell renal cell carcinoma patients: clinically relevant models for research and personalized medicine","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Clear cell renal cell carcinoma; Cell culture; Cancer research; Renal cell carcinoma; Biology; Cancer; Cell; Medicine; Oncology; Pathology; Internal medicine; Genetics","score_opus":0.19953860731325393,"score_gpt":0.4357282740736187,"score_spread":0.23618966676036476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593824144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9428376,0.003564778,0.031680316,0.0006717722,0.00029547594,0.00094016036,0.012007811,0.00047964414,0.007522384],"genre_scores_gemma":[0.95462185,0.0014018688,0.023192935,0.00030118,0.0000494756,0.0006365814,0.012697767,0.000118923606,0.006979291],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99949133,0.00011147652,0.000055434,0.00012004833,0.00015766185,0.00006408521],"domain_scores_gemma":[0.9996761,0.000060251583,0.000030754545,0.000096123316,0.000072246,0.00006455679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006837529,0.0003037207,0.00042899512,0.00035478116,0.00036336586,0.00051010353,0.00044552557,0.000417708,0.003275396],"category_scores_gemma":[0.00037790043,0.00020530305,0.00031873133,0.00030434853,0.00020136,0.00022185067,0.00032416318,0.0009359462,0.0019236936],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005472941,0.00030144196,0.0013997906,0.00009918946,0.000019062694,0.00023359185,0.00008908652,0.00034216567,0.9895489,0.00040045206,0.0018787372,0.0051401337],"study_design_scores_gemma":[0.00017165072,0.0020756426,0.015402053,0.000027127122,0.000055671375,0.0020498137,0.00013402791,0.00560814,0.9534026,0.00016082017,0.020891024,0.000021441767],"about_ca_topic_score_codex":0.002179348,"about_ca_topic_score_gemma":0.0026691735,"teacher_disagreement_score":0.003275396,"about_ca_system_score_codex":0.0003486963,"about_ca_system_score_gemma":0.00046700894,"threshold_uncertainty_score":0.010957301},"labels":[],"label_agreement":null},{"id":"W2593859985","doi":"10.1158/1557-3265.pdx16-b31","title":"Abstract B31: Establishment and molecular characterization of patient-derived tumor xenografts from resected tumors or ascites fluids of patients with pancreatic/ampullary/bile duct carcinomas","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University Health Network","funders":"","keywords":"Medicine; Pancreas; Pancreatic cancer; Bile duct; Adenocarcinoma; Cancer; Context (archaeology); Ampulla of Vater; Population; Cancer research; Oncology; Internal medicine; Pathology; Carcinoma; Biology","score_opus":0.031859893377286376,"score_gpt":0.33634338311578704,"score_spread":0.30448348973850065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593859985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908749,0.000558129,0.0032394256,0.0001421816,0.000054198605,0.00022028343,0.0032156538,0.00006704005,0.0016282122],"genre_scores_gemma":[0.9768903,0.0006450187,0.0046270834,0.00015322145,0.000017804816,0.00027696363,0.014387676,0.000040925992,0.0029609606],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99965,0.00006593584,0.00003988664,0.00009418897,0.00008840694,0.000061515435],"domain_scores_gemma":[0.99972206,0.000057924055,0.000027438891,0.000058922138,0.000059744354,0.0000739076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046002603,0.00023654345,0.00026812803,0.000407536,0.0003382339,0.00043513023,0.00024686637,0.00037277857,0.002466062],"category_scores_gemma":[0.00046210308,0.00018116641,0.00028491236,0.00040094214,0.00020946247,0.0002695907,0.00027197847,0.00083311443,0.0014040339],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010219956,0.0005206951,0.011881406,0.000066298206,0.000031088282,0.0006117689,0.00016263143,0.00031299275,0.9801083,0.000276629,0.00093044224,0.004075736],"study_design_scores_gemma":[0.00043438823,0.009010734,0.23773283,0.000049413702,0.00011679476,0.014238747,0.0008702961,0.008729848,0.6989443,0.00038251525,0.029443393,0.00004676999],"about_ca_topic_score_codex":0.0009870863,"about_ca_topic_score_gemma":0.0007518489,"teacher_disagreement_score":0.002466062,"about_ca_system_score_codex":0.00022356,"about_ca_system_score_gemma":0.0003248797,"threshold_uncertainty_score":0.00824976},"labels":[],"label_agreement":null},{"id":"W2593868250","doi":"10.1158/1557-3265.pdx16-a09","title":"Abstract A09: PDXovo: Ultra-fast in vivo drug sensitivity matrices for renal cell carcinoma patients prior to administration of targeted therapy","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Context (archaeology); In vivo; Cancer; Sunitinib; Renal cell carcinoma; Cancer research; Oncology; Internal medicine; Pathology; Biology","score_opus":0.1315724551539969,"score_gpt":0.4790096325894567,"score_spread":0.3474371774354598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593868250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9165895,0.005584059,0.055651933,0.00087292946,0.00037941078,0.0007051315,0.0021370086,0.0012925599,0.01678756],"genre_scores_gemma":[0.9523358,0.0015505585,0.03028644,0.00029585644,0.00004165627,0.0004030407,0.0012370262,0.00014897852,0.013700665],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998716,0.000022875705,0.0000068980858,0.000025675932,0.000054721593,0.000018223674],"domain_scores_gemma":[0.99986494,0.000028883509,0.000040994157,0.000014234578,0.000018978306,0.00003199218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027052817,0.00022407086,0.00024321474,0.00021967673,0.00020120837,0.0003935439,0.00023572684,0.000382901,0.0037252535],"category_scores_gemma":[0.000296094,0.00019356536,0.00016644855,0.00009457176,0.00012828129,0.00023585884,0.0002585558,0.0005237934,0.0005998025],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066914485,0.00010269384,0.00058777136,0.000076911056,0.000009512144,0.00011644696,0.000027507953,0.0003404124,0.9830032,0.00037506103,0.0015698047,0.01312161],"study_design_scores_gemma":[0.0001149481,0.0016452126,0.0058936942,0.000022465549,0.000025919115,0.0012395998,0.000032623087,0.0035999098,0.96177673,0.00014503236,0.025483036,0.000020812615],"about_ca_topic_score_codex":0.0007154663,"about_ca_topic_score_gemma":0.0011817778,"teacher_disagreement_score":0.0037252535,"about_ca_system_score_codex":0.00028328423,"about_ca_system_score_gemma":0.0002902704,"threshold_uncertainty_score":0.012462258},"labels":[],"label_agreement":null},{"id":"W2597783812","doi":"10.1158/1078-0432.ccr-15-2440","title":"Molecular Pathways: Evaluating the Potential for B7-H4 as an Immunoregulatory Target","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Blockade; Medicine; Cancer research; Fusion protein; Cytokine; Chimeric antigen receptor; T cell; Cancer; Antibody; Immunology; Immunotherapy; Antigen; Receptor; Biology; Immune system; Internal medicine; Gene","score_opus":0.6778716969775834,"score_gpt":0.676147262922812,"score_spread":0.0017244340547714065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597783812","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023927848,0.9970847,0.0001672416,0.00026866858,0.00024363137,0.000011099634,0.000025594185,0.000007284505,0.0019525662],"genre_scores_gemma":[0.0011786523,0.99670607,0.00026339057,0.00030739987,0.000112945774,0.00001532275,0.00005142319,0.0000020928433,0.0013626629],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989533,0.000017945502,0.0000118648495,0.000018625806,0.00004326568,0.000012848626],"domain_scores_gemma":[0.999874,0.000045533383,0.000015451526,0.000003911402,0.00004648271,0.0000145815175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046140086,0.000687822,0.0010234875,0.0020010418,0.00021801182,0.0009270135,0.00065525935,0.0008637473,0.003302278],"category_scores_gemma":[0.0003001284,0.00024110333,0.00046103023,0.0013503953,0.00031471148,0.0009912244,0.00044093045,0.0016722821,0.0024065706],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013229388,0.00011667035,0.00014479719,0.014876757,0.00010926051,0.00022337744,0.00005515992,0.00047714176,0.0057956283,0.0058783605,0.028577838,0.94361264],"study_design_scores_gemma":[0.000035200428,0.00015674913,0.00045604314,0.0026735668,0.00009879767,0.0007162779,0.00004588944,0.00013021508,0.0013458522,0.0015676171,0.9927579,0.000015941745],"about_ca_topic_score_codex":0.0009158834,"about_ca_topic_score_gemma":0.0014310784,"teacher_disagreement_score":0.003302278,"about_ca_system_score_codex":0.00069012836,"about_ca_system_score_gemma":0.00084501144,"threshold_uncertainty_score":0.0110471845},"labels":[],"label_agreement":null},{"id":"W2604205643","doi":"10.1158/1078-0432.ccr-16-3230","title":"Vulvar Squamous Cell Carcinoma (VSCC) as Two Diseases: HPV Status Identifies Distinct Mutational Profiles Including Oncogenic Fibroblast Growth Factor Receptor 3","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Hospital; Ontario Institute for Cancer Research","funders":"","keywords":"HRAS; CDKN2A; PTEN; Oncology; Cancer research; Vulvar Carcinoma; Vulva; Fibroblast growth factor receptor 3; Papillomaviridae; Internal medicine; Medicine; Cancer; Biology; Carcinoma; Pathology; KRAS; Cervical cancer; Genetics; PI3K/AKT/mTOR pathway; Receptor; Fibroblast growth factor","score_opus":0.2127881975698915,"score_gpt":0.5204065018682588,"score_spread":0.30761830429836723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604205643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986615,0.0006199014,0.000097361,0.000013057951,0.0000034309035,0.000009817801,0.00018562216,0.000003092521,0.00040618493],"genre_scores_gemma":[0.9996594,0.00010840927,0.00005522248,0.000005983826,0.0000022257504,0.0000023077032,0.00012418733,6.065963e-7,0.000041647523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970835,0.000048572725,0.000039855433,0.00007430164,0.00007483271,0.00005409298],"domain_scores_gemma":[0.99962854,0.00007785009,0.00014302255,0.000031220574,0.000051374125,0.00006797696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003578294,0.00021211742,0.00024606433,0.00084933307,0.00037432212,0.0005504655,0.00019659723,0.0002463862,0.0015758766],"category_scores_gemma":[0.00068091153,0.0001395401,0.00022104029,0.0008881861,0.0003659715,0.000293951,0.0003395605,0.0001751714,0.0001545401],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013178257,0.000009247304,0.9955871,0.000017162896,0.000021698705,0.00039015358,0.000037122903,0.000032448726,0.0014179809,0.000027271226,0.000043446544,0.0022845212],"study_design_scores_gemma":[0.0000065093795,0.00010688859,0.9929195,0.00001672108,0.0000428596,0.0053562676,0.00023341806,0.0001430753,0.0007822938,0.000055958233,0.00033251927,0.000004067926],"about_ca_topic_score_codex":0.0020351957,"about_ca_topic_score_gemma":0.0044721467,"teacher_disagreement_score":0.0020351957,"about_ca_system_score_codex":0.00035764408,"about_ca_system_score_gemma":0.00044766266,"threshold_uncertainty_score":0.005271852},"labels":[],"label_agreement":null},{"id":"W2605009867","doi":"10.1158/1078-0432.ccr-16-2818","title":"A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institutes of Health; American Association for Cancer Research","keywords":"Lenalidomide; Medicine; Internal medicine; Diffuse large B-cell lymphoma; Neutropenia; Clinical endpoint; Oncology; Rituximab; Thalidomide; Phases of clinical research; Febrile neutropenia; Gastroenterology; Surgery; Lymphoma; Multiple myeloma; Randomized controlled trial; Clinical trial; Chemotherapy","score_opus":0.2495991745781395,"score_gpt":0.5288692121540582,"score_spread":0.27927003757591873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605009867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98780906,0.0018288702,0.0006528492,0.00076906534,0.00039409913,0.0060376464,0.0010535592,0.00009797703,0.0013567815],"genre_scores_gemma":[0.9844322,0.0009955524,0.0022459417,0.0018034846,0.0005503754,0.0068865684,0.0013401828,0.0000354846,0.0017101686],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987803,0.00075371854,0.0000619601,0.00018772832,0.00007428068,0.00014202514],"domain_scores_gemma":[0.9981552,0.00046361051,0.00042930027,0.00017039206,0.00011879548,0.0006627542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036927527,0.002161064,0.0030810386,0.00050737243,0.0006827628,0.0013897815,0.0012003244,0.0020556708,0.005738318],"category_scores_gemma":[0.0024672635,0.00093904376,0.0019359115,0.00047735078,0.0018451394,0.0015461795,0.00044337628,0.004251711,0.0010356022],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96877366,0.017978258,0.0010027528,0.00021977267,0.00049004256,0.00003672553,0.000052785595,0.0002981569,0.0030459051,0.00008722425,0.0006495765,0.0073652235],"study_design_scores_gemma":[0.93498635,0.06312171,0.000853643,0.000008542655,0.00012334203,0.000021141905,0.000012118541,0.0002868943,0.00023182743,0.000093510294,0.00025299483,0.000007886926],"about_ca_topic_score_codex":0.00085787947,"about_ca_topic_score_gemma":0.00209883,"teacher_disagreement_score":0.005738318,"about_ca_system_score_codex":0.0013910991,"about_ca_system_score_gemma":0.0019863888,"threshold_uncertainty_score":0.019529343},"labels":[],"label_agreement":null},{"id":"W2605062205","doi":"10.1158/1078-0432.ccr-16-2354","title":"Use of Expansion Cohorts in Phase I Trials and Probability of Success in Phase II for 381 Anticancer Drugs","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health","keywords":"Medicine; Cohort; Confidence interval; Internal medicine; Clinical trial; Cohort study; Logistic regression; Phases of clinical research; Oncology","score_opus":0.935117757440753,"score_gpt":0.7769513201782015,"score_spread":0.15816643726255153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605062205","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.366834,0.59546095,0.014754715,0.0027482593,0.00064159016,0.0044122874,0.008718684,0.00019572694,0.006233774],"genre_scores_gemma":[0.9437457,0.038815767,0.009080509,0.0009927198,0.0005216828,0.0034194868,0.0029714743,0.00006142404,0.0003911802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.88098925,0.06094189,0.033841986,0.009732744,0.013604532,0.0008895239],"domain_scores_gemma":[0.32085687,0.5505176,0.113465354,0.008014453,0.005696879,0.0014488376],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.10487716,0.000977145,0.003059003,0.0064594764,0.0006550674,0.002832527,0.0016234491,0.0017627514,0.0035564103],"category_scores_gemma":[0.28566024,0.00091688614,0.008486082,0.007837592,0.001614926,0.0053828545,0.0020183655,0.002146325,0.00033491402],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027497161,0.00027837724,0.6743969,0.094895154,0.06199804,0.0006686136,0.00059873186,0.0022343071,0.0015729147,0.0018046288,0.0034831935,0.13057216],"study_design_scores_gemma":[0.012743992,0.009835461,0.6917938,0.060219217,0.1646297,0.00728405,0.00094707566,0.008967643,0.0034787678,0.008142438,0.0315827,0.00037518257],"about_ca_topic_score_codex":0.00036412844,"about_ca_topic_score_gemma":0.0007256655,"teacher_disagreement_score":0.8951228,"about_ca_system_score_codex":0.0010213923,"about_ca_system_score_gemma":0.0020788615,"threshold_uncertainty_score":0.55465007},"labels":[],"label_agreement":null},{"id":"W2606582837","doi":"","title":"Impact of sustained versus intermittent chemotherapy on rate of tumor repopulation in a xenograft model of human ovarian cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"In vivo; Medicine; Chemotherapy; Paclitaxel; Clonogenic assay; Ovarian cancer; Apoptosis; In vitro; Radiation therapy; Pharmacology; Andrology; Cancer; Internal medicine; Biology","score_opus":0.21183272815032642,"score_gpt":0.5754557536500886,"score_spread":0.3636230254997622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606582837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99787796,0.0006960386,0.00062699005,0.000030324965,0.000021364784,0.000023150065,0.00024505536,0.000032554733,0.0004465359],"genre_scores_gemma":[0.9966414,0.0005557856,0.0010575264,0.000019806886,0.000010046193,0.000050595925,0.00030836443,0.000015218159,0.001341068],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998548,0.000024446239,0.000015506615,0.000027729977,0.000042552172,0.000034897406],"domain_scores_gemma":[0.9998006,0.000051868865,0.0000591367,0.000028071654,0.00001753138,0.000042873122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002113694,0.00022943561,0.00034313396,0.00019374964,0.000091122034,0.00025693563,0.00017811074,0.00021187951,0.0014638723],"category_scores_gemma":[0.00012981663,0.000120045544,0.00022867495,0.00018284454,0.00015994074,0.00026078522,0.00012291849,0.00059733994,0.00019358123],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013515633,0.00036617427,0.00039235607,0.0000450625,0.0000087325825,0.000021482389,0.000022153767,0.00015765228,0.99480045,0.00002602462,0.00006353831,0.002744825],"study_design_scores_gemma":[0.000094613344,0.012229763,0.008557624,0.000006419108,0.00004069634,0.000116233976,0.000041219944,0.0018725209,0.975994,0.000018577653,0.0010232215,0.000005153355],"about_ca_topic_score_codex":0.0007690683,"about_ca_topic_score_gemma":0.0010391095,"teacher_disagreement_score":0.0014638723,"about_ca_system_score_codex":0.00023727099,"about_ca_system_score_gemma":0.0002102839,"threshold_uncertainty_score":0.0048971176},"labels":[],"label_agreement":null},{"id":"W2606664616","doi":"10.1158/1078-0432.ccr-16-2895","title":"The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Memorial Sloan-Kettering Cancer Center; International Myeloma Foundation; Multiple Myeloma Research Foundation; Foundation for the National Institutes of Health","keywords":"Medicine; Multiple myeloma; Minimal residual disease; Oncology; Disease; Bone marrow; Drug development; Internal medicine; Intensive care medicine; Immunology; Drug; Pharmacology","score_opus":0.16667201864935197,"score_gpt":0.5103978063235773,"score_spread":0.34372578767422535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606664616","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011859716,0.93044096,0.011871603,0.03421331,0.0010139978,0.00011556654,0.00023155237,0.00036041412,0.009892903],"genre_scores_gemma":[0.3547037,0.5548116,0.056572005,0.02117682,0.0070445947,0.00032175885,0.0007793849,0.00015165612,0.004438473],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954952,0.0021094447,0.00036308347,0.000547196,0.0012953,0.0001897244],"domain_scores_gemma":[0.968326,0.016778834,0.0037617194,0.0011505648,0.008054466,0.0019284261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019961365,0.000798749,0.0021494657,0.0027993799,0.00038241933,0.0044609685,0.0021925108,0.002811769,0.004513566],"category_scores_gemma":[0.017865507,0.0005046151,0.00094611564,0.0017227969,0.0025509256,0.0033167643,0.0013075828,0.0035860075,0.0015084508],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069635076,0.00028367667,0.014105025,0.0017002422,0.00017416947,0.00019605327,0.00009430092,0.0016660499,0.0038615214,0.0059597776,0.017570661,0.9536923],"study_design_scores_gemma":[0.0009296012,0.0067557315,0.068062894,0.013166525,0.0012250192,0.0062630284,0.001115019,0.041361976,0.019632064,0.06993809,0.7709897,0.0005603439],"about_ca_topic_score_codex":0.001856458,"about_ca_topic_score_gemma":0.0021927247,"teacher_disagreement_score":0.019961365,"about_ca_system_score_codex":0.0021323734,"about_ca_system_score_gemma":0.0027909027,"threshold_uncertainty_score":0.1055671},"labels":[],"label_agreement":null},{"id":"W2607628501","doi":"10.1158/1078-0432.ccr-17-0257","title":"Analytic, Preanalytic, and Clinical Validation of p53 IHC for Detection of <i>TP53</i> Missense Mutation in Prostate Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"Congressionally Directed Medical Research Programs; National Cancer Institute; National Institutes of Health","keywords":"Missense mutation; Prostate cancer; DU145; Biochemical recurrence; Cancer research; Immunohistochemistry; Prostate; Medicine; Prostatectomy; Pathology; Cancer; Immunostaining; Mutation; Biology; Oncology; Internal medicine; LNCaP; Genetics; Gene","score_opus":0.29749477977787564,"score_gpt":0.5982011123550526,"score_spread":0.30070633257717694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607628501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96721005,0.0015660949,0.028419018,0.00013270238,0.00005068404,0.0004378166,0.0002887588,0.00028323234,0.0016116445],"genre_scores_gemma":[0.9877636,0.00021555198,0.011027572,0.0001030743,0.000024040679,0.00012148978,0.000508773,0.000031122017,0.00020472359],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99728453,0.0008022913,0.0002203551,0.0005748471,0.000985591,0.00013231162],"domain_scores_gemma":[0.99699855,0.0008968785,0.0005794395,0.0005349169,0.0008059649,0.00018431054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004585979,0.00054139335,0.0002773262,0.0006084733,0.0003186229,0.0006458425,0.0005297609,0.00039934268,0.0006653719],"category_scores_gemma":[0.005695032,0.00024723145,0.0002288228,0.00026924853,0.00087483606,0.00025393526,0.00045553426,0.00046104824,0.00037301762],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019196039,0.00054043805,0.34536952,0.00020292022,0.00017966423,0.0004623546,0.00032515355,0.0016776144,0.6113527,0.00021716487,0.00072553504,0.037027314],"study_design_scores_gemma":[0.00013947685,0.0048196623,0.52495974,0.00005708794,0.00030199834,0.004429569,0.00022409591,0.010219478,0.45107472,0.00020163006,0.0035228734,0.000049612863],"about_ca_topic_score_codex":0.0008958358,"about_ca_topic_score_gemma":0.0014137654,"teacher_disagreement_score":0.004585979,"about_ca_system_score_codex":0.00036943762,"about_ca_system_score_gemma":0.0006423854,"threshold_uncertainty_score":0.02425325},"labels":[],"label_agreement":null},{"id":"W2619129176","doi":"10.1158/1078-0432.ccr-16-2540","title":"Detecting the Presence and Progression of Premalignant Lung Lesions via Airway Gene Expression","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"National Cancer Institute; BC Cancer Agency; Roswell Park Cancer Institute","keywords":"Lung cancer; Biomarker; Cancer; Transcriptome; Biology; Pathology; Medicine; Cancer research; Oncology; Internal medicine; Gene; Gene expression; Genetics","score_opus":0.13029225750471282,"score_gpt":0.4961929541292279,"score_spread":0.3659006966245151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619129176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97289485,0.0026845208,0.012094438,0.00025000027,0.000025942607,0.000077607656,0.010219626,0.00034205712,0.0014108384],"genre_scores_gemma":[0.9817593,0.00073809386,0.009835524,0.000107500695,0.000017286424,0.000072429735,0.006860912,0.000023755762,0.0005851747],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999777,0.000029468942,0.000012544909,0.00010060396,0.00004888469,0.00003149792],"domain_scores_gemma":[0.9996929,0.00011574496,0.000087495784,0.000019385878,0.000053573418,0.000030851064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035513446,0.00031276487,0.00049609196,0.00095451344,0.00026393268,0.00052671577,0.00023228872,0.00029650616,0.001283218],"category_scores_gemma":[0.0007483859,0.00014209165,0.0005450875,0.0009025696,0.0001844174,0.00019192293,0.0003795571,0.00037240222,0.00034813315],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012057581,0.00021811979,0.780731,0.0007032786,0.00046353816,0.00020829002,0.0001366639,0.010467419,0.14569591,0.00039288306,0.00183688,0.057940315],"study_design_scores_gemma":[0.00004878286,0.0006315003,0.8694215,0.00010197528,0.00044114175,0.0005502059,0.00031146622,0.086372934,0.03581984,0.0020010856,0.0042583635,0.000041150335],"about_ca_topic_score_codex":0.002736679,"about_ca_topic_score_gemma":0.0045824824,"teacher_disagreement_score":0.002736679,"about_ca_system_score_codex":0.000316186,"about_ca_system_score_gemma":0.0004937718,"threshold_uncertainty_score":0.0054415464},"labels":[],"label_agreement":null},{"id":"W2619606660","doi":"","title":"Real-time quantitative PCR for rapid detection of translocations, amplifications, polymorphisms, and viral/bacterial load in blood or formalin-fixed paraffin embedded tissues","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"","keywords":"Biology; Genotyping; Real-time polymerase chain reaction; TaqMan; Amplicon; Molecular biology; Chronic myelogenous leukemia; Leukemia; Concordance; Polymerase chain reaction; Genotype; Virology; Gene; Immunology; Genetics","score_opus":0.16673668296149532,"score_gpt":0.49122057125903,"score_spread":0.3244838882975347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619606660","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027034001,0.0055381046,0.9457813,0.0004079321,0.0008272455,0.002239061,0.005927342,0.0053028353,0.0069422335],"genre_scores_gemma":[0.075464025,0.0041127563,0.8883466,0.0007480624,0.0003247162,0.0077887615,0.0069034225,0.0007498448,0.015561792],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9922206,0.0025089378,0.00058373844,0.0023423806,0.0019305309,0.0004139096],"domain_scores_gemma":[0.9970812,0.0014166791,0.00039695937,0.00046973332,0.0005344816,0.000100779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005367599,0.002555273,0.0015049572,0.004068845,0.00069575076,0.0016544099,0.0016668427,0.0014407996,0.011063695],"category_scores_gemma":[0.003557575,0.0015298038,0.0015484728,0.0019197902,0.0014118764,0.0014904006,0.00093972404,0.0025113237,0.005033961],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024813105,0.00021450495,0.0014846221,0.00063527905,0.000073877636,0.00013205114,0.00016235706,0.0005365819,0.96278656,0.0012092757,0.0022897283,0.030226966],"study_design_scores_gemma":[0.00017157287,0.0018498909,0.008504764,0.00034897143,0.00026153607,0.0011830018,0.00015670113,0.021816429,0.8820554,0.002072242,0.08135249,0.0002270614],"about_ca_topic_score_codex":0.0005215145,"about_ca_topic_score_gemma":0.001571282,"teacher_disagreement_score":0.011063695,"about_ca_system_score_codex":0.0008617616,"about_ca_system_score_gemma":0.001087933,"threshold_uncertainty_score":0.037011743},"labels":[],"label_agreement":null},{"id":"W2619858742","doi":"10.1158/1078-0432.ccr-17-0515","title":"Pediatric Cancer Predisposition Imaging: Focus on Whole-Body MRI","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Radiation Therapy and Dosimetry","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Magnetic resonance imaging; Modalities; Pediatric cancer; Medical physics; Cancer; Childhood cancer; Radiology; Internal medicine","score_opus":0.46189219952699734,"score_gpt":0.644978539981934,"score_spread":0.18308634045493666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619858742","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000078750396,0.99865544,0.00009208522,0.00040423058,0.00011832911,0.0000024744807,0.00000999927,0.0000046166642,0.0006340345],"genre_scores_gemma":[0.0005696129,0.9986457,0.00018024354,0.00025891536,0.00016721613,0.0000029433081,0.000016773609,0.0000017214054,0.00015691314],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995751,0.00009250244,0.000092646704,0.00007366334,0.00013111526,0.00003495088],"domain_scores_gemma":[0.99817216,0.0011322447,0.00020814723,0.000039541446,0.000378006,0.00006987075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012280138,0.0007663928,0.0014097294,0.003969179,0.0003025439,0.0011182571,0.0009905295,0.0013348496,0.0026317616],"category_scores_gemma":[0.0023420025,0.00036459023,0.0009068478,0.0036199703,0.00079481263,0.002409447,0.0008182049,0.0021200287,0.0010689852],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048604063,0.000036278136,0.00070083124,0.03199369,0.00013238136,0.0005695246,0.00014140374,0.0003349436,0.00081994577,0.004357258,0.028454814,0.9324105],"study_design_scores_gemma":[0.000012251109,0.00006237269,0.002373856,0.019684905,0.00023286587,0.00804814,0.00015164986,0.000106659936,0.00040499127,0.0021531212,0.9667422,0.000027001413],"about_ca_topic_score_codex":0.0023053554,"about_ca_topic_score_gemma":0.0037474865,"teacher_disagreement_score":0.003969179,"about_ca_system_score_codex":0.0008618195,"about_ca_system_score_gemma":0.00203189,"threshold_uncertainty_score":0.008804083},"labels":[],"label_agreement":null},{"id":"W2620621399","doi":"","title":"Caulobacter in cancer immunotherapy","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of British Columbia","funders":"","keywords":"In vivo; Biology; Immunotherapy; Cell culture; Molecular biology; Cancer immunotherapy; Cancer research; Microbiology; Immunology; Immune system","score_opus":0.20529653708355172,"score_gpt":0.595213787108048,"score_spread":0.38991725002449623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620621399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8289315,0.14143662,0.010324692,0.002655839,0.00060284155,0.00021111174,0.000520219,0.00036516727,0.01495201],"genre_scores_gemma":[0.96551514,0.02031622,0.0075651887,0.0005713701,0.00010809357,0.00004554024,0.00036407897,0.000019932244,0.005494394],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992347,0.00001228859,0.0000038672115,0.000016570584,0.000025593505,0.000018266657],"domain_scores_gemma":[0.99994564,0.000005614888,0.00001467538,0.000005499338,0.000008492454,0.000020076644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013773328,0.0005227587,0.00017778497,0.000260733,0.00015545228,0.0003685255,0.0002563765,0.0005429157,0.0010461984],"category_scores_gemma":[0.000079501646,0.00007614676,0.00023717713,0.00021564141,0.00022664064,0.00021919173,0.00021444481,0.00057456543,0.00040000223],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015331445,0.00010247422,0.00039530985,0.0002584692,0.000009974873,0.00013490784,0.000013280076,0.0003205612,0.97801197,0.00088616123,0.0003586014,0.019354945],"study_design_scores_gemma":[0.00016148089,0.002337024,0.0061329883,0.00017809136,0.00007956403,0.0024349738,0.00005662034,0.0021755828,0.90278155,0.0011493444,0.08249311,0.000019785797],"about_ca_topic_score_codex":0.0010294577,"about_ca_topic_score_gemma":0.0009567299,"teacher_disagreement_score":0.0010461984,"about_ca_system_score_codex":0.00041057955,"about_ca_system_score_gemma":0.0004169879,"threshold_uncertainty_score":0.0034999251},"labels":[],"label_agreement":null},{"id":"W2620853632","doi":"10.1158/1078-0432.ccr-17-0574","title":"Clinical Management and Tumor Surveillance Recommendations of Inherited Mismatch Repair Deficiency in Childhood","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":221,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"PMS2; MSH6; MSH2; Proofreading; DNA mismatch repair; MLH1; Medicine; Lynch syndrome; Cancer; DNA repair; Germline mutation; Genetics; Mutation; Biology; Cancer research; Gene; Polymerase","score_opus":0.51746341951559,"score_gpt":0.62373909157499,"score_spread":0.10627567205939992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620853632","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007921476,0.98886687,0.0012201241,0.0039792047,0.0005621423,0.00006098892,0.00012879405,0.00004794541,0.0043418217],"genre_scores_gemma":[0.008901649,0.98376286,0.0036078473,0.0015932913,0.00052914844,0.00010333742,0.00044242328,0.000008763207,0.0010507061],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99945396,0.00018069228,0.00011937029,0.000050274197,0.00015740193,0.000038241156],"domain_scores_gemma":[0.9990081,0.00033210256,0.00019086656,0.000018802712,0.00035566295,0.000094530245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014180331,0.0006236617,0.0011942538,0.002541105,0.0002769069,0.00055903115,0.0011017607,0.0010010197,0.0017930075],"category_scores_gemma":[0.0030464155,0.00018076299,0.00058220624,0.0013295595,0.0002615282,0.0006204368,0.00046112208,0.001298225,0.0009982388],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053169693,0.000045747885,0.0014700616,0.0084785875,0.00008932272,0.0006916423,0.000074882024,0.0005189354,0.00030971592,0.0017143773,0.05837447,0.9281791],"study_design_scores_gemma":[0.00014079809,0.00022370304,0.017812574,0.05172849,0.0007416429,0.015568119,0.00055138377,0.0009169017,0.001051941,0.0037984229,0.9073841,0.00008203552],"about_ca_topic_score_codex":0.0027066462,"about_ca_topic_score_gemma":0.004191759,"teacher_disagreement_score":0.0027066462,"about_ca_system_score_codex":0.0010394517,"about_ca_system_score_gemma":0.002308223,"threshold_uncertainty_score":0.007541716},"labels":[],"label_agreement":null},{"id":"W2620901258","doi":"10.1158/1078-0432.ccr-17-0408","title":"Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":521,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"National Institute for Health and Care Research","keywords":"Li–Fraumeni syndrome; Medicine; Psychosocial; Cancer; Germline; Germline mutation; Pediatric cancer; Oncology; Internal medicine; Mutation; Gene; Genetics; Psychiatry; Biology","score_opus":0.7166226886873909,"score_gpt":0.659810640990961,"score_spread":0.05681204769642989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620901258","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031859012,0.9740778,0.0008333623,0.013452813,0.002407992,0.0001534071,0.00046023293,0.00007676777,0.0082189925],"genre_scores_gemma":[0.0012432074,0.9859971,0.002147834,0.0059335567,0.00051276735,0.00013686456,0.00081588706,0.000007741271,0.003205117],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999534,0.00012658547,0.00010167479,0.000039277857,0.00016604752,0.000032377095],"domain_scores_gemma":[0.998911,0.00040744405,0.00014759031,0.000023233977,0.0004393527,0.000071367496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014470546,0.00054668565,0.0010181731,0.0024384337,0.00032507334,0.0006222267,0.0018856273,0.0020544278,0.0053368662],"category_scores_gemma":[0.0030958166,0.00026587516,0.0008972889,0.0015756874,0.00025779003,0.0009870079,0.00067052274,0.002285436,0.0024414407],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004023678,0.00004426903,0.00023126666,0.012412806,0.00006347635,0.00017291677,0.00007544922,0.00015937269,0.00034260825,0.0022837196,0.20853677,0.775637],"study_design_scores_gemma":[0.000025124367,0.000028282697,0.00088698353,0.012576852,0.0001368969,0.0006179239,0.00006192267,0.000044539593,0.00013368881,0.0010288635,0.9844445,0.000014403761],"about_ca_topic_score_codex":0.0035260497,"about_ca_topic_score_gemma":0.007929509,"teacher_disagreement_score":0.0053368662,"about_ca_system_score_codex":0.00097158726,"about_ca_system_score_gemma":0.002400938,"threshold_uncertainty_score":0.017853618},"labels":[],"label_agreement":null},{"id":"W2621081192","doi":"10.1158/1078-0432.ccr-17-0702","title":"Pediatric Cancer Predisposition and Surveillance: An Overview, and a Tribute to Alfred G. Knudson Jr","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Human Genome Research Institute; National Institutes of Health; General Motors Foundation","keywords":"Cancer; Medicine; Genetic predisposition; Pediatric cancer; Genetic testing; Family medicine; Internal medicine; Disease","score_opus":0.6250210048115101,"score_gpt":0.6573310754797627,"score_spread":0.03231007066825253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621081192","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024090573,0.39078653,0.00057751086,0.5726914,0.033398498,0.00002593556,0.000037453065,0.000025298885,0.0022165219],"genre_scores_gemma":[0.0033516134,0.7342153,0.002469301,0.16653363,0.08921185,0.00009563121,0.0000864223,0.000048927657,0.003987253],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99181056,0.0035386593,0.0012974037,0.0006870777,0.0022172362,0.00044910706],"domain_scores_gemma":[0.9541731,0.025180848,0.0019879427,0.0010181718,0.013085304,0.004554675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018488854,0.0011213879,0.0013379705,0.00567232,0.0012985553,0.004300072,0.0018189723,0.0068077412,0.0026153566],"category_scores_gemma":[0.037201006,0.00081414514,0.0011143693,0.0038025302,0.0035509935,0.008483538,0.002638853,0.020819103,0.0011631703],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050346265,0.00008600127,0.0020728435,0.0012584012,0.000043845004,0.0004181221,0.000583127,0.00024200734,0.00012162606,0.006226116,0.7502547,0.2386429],"study_design_scores_gemma":[0.000015728898,0.00008533377,0.003556325,0.005582264,0.00003837636,0.0015333318,0.0006043484,0.00013880513,0.000055943776,0.004251741,0.984092,0.000045704503],"about_ca_topic_score_codex":0.0104159145,"about_ca_topic_score_gemma":0.016575282,"teacher_disagreement_score":0.018488854,"about_ca_system_score_codex":0.004431505,"about_ca_system_score_gemma":0.009563007,"threshold_uncertainty_score":0.09777957},"labels":[],"label_agreement":null},{"id":"W2621474688","doi":"10.1158/1557-3265.ovcasymp16-ntoc-093","title":"Abstract NTOC-093: SYNTHETIC LETHAL APPROACHES TO TARGET ARID1A DEFICIENT OVARIAN CANCERS","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"ARID1A; Synthetic lethality; Cancer research; Ovarian cancer; Clear cell carcinoma; Clear cell; Serous fluid; Biology; Cancer; Endometrial cancer; Ovarian carcinoma; Medicine; DNA repair; Carcinoma; Mutation; Internal medicine; Gene; Genetics","score_opus":0.4763574319646575,"score_gpt":0.5026225866717711,"score_spread":0.026265154707113547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621474688","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9697724,0.005450549,0.0073282993,0.0004782841,0.00022924459,0.00068888284,0.006098582,0.0005466514,0.009407085],"genre_scores_gemma":[0.9699776,0.0045431135,0.007603435,0.00026460123,0.000027367454,0.00038887796,0.006111067,0.00006497121,0.011018971],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999021,0.000016685544,0.00000833814,0.000016379807,0.000032275675,0.00002409676],"domain_scores_gemma":[0.99993753,0.00001014694,0.000011960967,0.000006285915,0.000011375258,0.00002282831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016759521,0.0005026183,0.00041253082,0.0004503422,0.0001839906,0.0002988193,0.0004076384,0.0003028059,0.0030587397],"category_scores_gemma":[0.00010438988,0.00014606648,0.00033968323,0.00029970004,0.00018689015,0.0001538636,0.00020987389,0.00083291717,0.0005688095],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007847588,0.00055091205,0.0002725317,0.00019586229,0.000028648521,0.00015545162,0.000020653815,0.0012973843,0.98345727,0.000443356,0.00090340525,0.0118897585],"study_design_scores_gemma":[0.00072328065,0.009951822,0.004281056,0.00003351763,0.00010609867,0.0008925445,0.000056738936,0.003088574,0.9594675,0.0002081676,0.021158153,0.00003244256],"about_ca_topic_score_codex":0.0010831315,"about_ca_topic_score_gemma":0.002750239,"teacher_disagreement_score":0.0030587397,"about_ca_system_score_codex":0.00040547558,"about_ca_system_score_gemma":0.00044881715,"threshold_uncertainty_score":0.010232449},"labels":[],"label_agreement":null},{"id":"W2621682721","doi":"10.1158/1557-3265.ovcasymp16-ap12","title":"Abstract AP12: CYSTEINE METABOLISM IN CLEAR CELL OVARIAN CANCER","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University Health Network; University of British Columbia; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"Proteomics; ARID1A; Ovarian cancer; Biology; Tissue microarray; Clear cell; Serous fluid; Cancer research; Computational biology; Gene expression profiling; Bioinformatics; Cancer; Gene; Gene expression; Genetics; Biochemistry; Carcinoma","score_opus":0.1896733283505102,"score_gpt":0.5253544161814757,"score_spread":0.3356810878309655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621682721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98857796,0.00523998,0.0015667124,0.00021125087,0.000026703452,0.000035808218,0.0026664378,0.00008078407,0.0015942234],"genre_scores_gemma":[0.99130076,0.0014027456,0.0024048095,0.0000824958,0.000018661472,0.000018334225,0.0031068886,0.000016625077,0.0016487323],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998957,0.000014362694,0.000011437523,0.000024676725,0.000039812487,0.000013959286],"domain_scores_gemma":[0.9998202,0.000019260855,0.00004391271,0.000012031818,0.00006360918,0.00004111016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017522236,0.0002522086,0.00023715227,0.00067563483,0.00025814248,0.00039704161,0.0002056267,0.0003057524,0.0012300161],"category_scores_gemma":[0.00020647484,0.000088212284,0.00020688452,0.0007072995,0.00012280917,0.00016707601,0.00024672048,0.00024658337,0.00036944958],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005397083,0.000025582496,0.01861186,0.00020438718,0.00002872855,0.00032732746,0.000026201833,0.0001030546,0.9723575,0.00007198495,0.00037719647,0.0073264614],"study_design_scores_gemma":[0.000040643532,0.0005422353,0.3801421,0.000026618609,0.000090236485,0.0037274614,0.00017897233,0.0016285728,0.6031329,0.00025518078,0.010216825,0.00001826059],"about_ca_topic_score_codex":0.0022252176,"about_ca_topic_score_gemma":0.0020467122,"teacher_disagreement_score":0.0022252176,"about_ca_system_score_codex":0.0003750072,"about_ca_system_score_gemma":0.00027860518,"threshold_uncertainty_score":0.0044245124},"labels":[],"label_agreement":null},{"id":"W2621869975","doi":"10.1158/1557-3265.ovcasymp16-tmem-035","title":"Abstract TMEM-035: GLYCOMARKERS FOR PREDICTING PLATINUM–DRUG RESPONSE IN OVARIAN CANCER","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Cancer; Drug resistance; Cancer research; Cell culture; Drug; Chemotherapy; Flow cytometry; Cell; Medicine; Cancer cell; Oncology; Biology; Internal medicine; Pharmacology; Immunology; Genetics","score_opus":0.17852880795052598,"score_gpt":0.5318410715277939,"score_spread":0.35331226357726797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621869975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99209434,0.0016645464,0.0047152387,0.00013305066,0.000034977224,0.000063826476,0.00050596776,0.00014499316,0.00064298837],"genre_scores_gemma":[0.9910416,0.0002879015,0.00774435,0.000057198115,0.000014131749,0.000024903553,0.00042145394,0.0000055765136,0.0004028889],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998355,0.00005514195,0.000013434669,0.000040081402,0.00004034579,0.00001537369],"domain_scores_gemma":[0.99986863,0.000029703388,0.00003588938,0.000008950193,0.00002799277,0.000028860211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045248488,0.00032166095,0.00034363611,0.0005599956,0.000105009065,0.00035233883,0.00021223658,0.00046789146,0.00078000914],"category_scores_gemma":[0.00055934215,0.00010350493,0.00020598895,0.0002979349,0.00010965383,0.0001611332,0.00018234644,0.00042861316,0.00022054558],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030720173,0.00044052984,0.12124301,0.00021057481,0.00015778892,0.00019368004,0.00003420495,0.004559182,0.8061692,0.00016527732,0.0014532835,0.062301237],"study_design_scores_gemma":[0.00016784729,0.0028755914,0.17890793,0.000029782444,0.00019609195,0.0017079752,0.000074713564,0.18358043,0.6284774,0.00032250385,0.0036060587,0.000053765023],"about_ca_topic_score_codex":0.0007347065,"about_ca_topic_score_gemma":0.00054727186,"teacher_disagreement_score":0.00078000914,"about_ca_system_score_codex":0.0003371061,"about_ca_system_score_gemma":0.00012465003,"threshold_uncertainty_score":0.0026094317},"labels":[],"label_agreement":null},{"id":"W2622097897","doi":"10.1158/1557-3265.ovcasymp16-ap28","title":"Abstract AP28: <i>BRCA1</i> and <i>RAD51C</i> Promoter Hypermethylation Confer Sensitivity to PARP Inhibitors in Patients with Platinum Sensitive Ovarian Carcinoma","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Cancer research; Ovarian cancer; Loss of heterozygosity; Methylation; DNA methylation; Biology; Germline mutation; PARP inhibitor; Germline; Cancer; Oncology; Medicine; Mutation; Genetics; Gene; Poly ADP ribose polymerase; Polymerase; Gene expression; Allele","score_opus":0.07066324461844924,"score_gpt":0.40642818289501065,"score_spread":0.3357649382765614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622097897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994068,0.00008799644,0.00003886714,0.000023418042,0.0000028934483,0.0000055299924,0.0001670862,0.0000041211747,0.00026331586],"genre_scores_gemma":[0.99967873,0.000016696764,0.000036091365,0.000017101343,0.0000037159107,0.0000042377374,0.00013250677,0.0000018359653,0.00010907747],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997758,0.0000438761,0.00002287369,0.000083185536,0.000041436168,0.000032736436],"domain_scores_gemma":[0.9992872,0.000237729,0.00018242965,0.00004373062,0.0000833188,0.0001657474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024292254,0.00015791618,0.00028395996,0.00039487515,0.00021222261,0.00038407635,0.00015177738,0.00025667658,0.0018766131],"category_scores_gemma":[0.0013324191,0.00013117344,0.00022877633,0.00032678235,0.00015128813,0.00020178706,0.00020334958,0.00037341722,0.00025637087],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014141431,0.00009349657,0.98555446,0.000014216614,0.000047023248,0.00047515452,0.00010428475,0.00011704661,0.0077318917,0.000018020482,0.00024814287,0.0041821133],"study_design_scores_gemma":[0.000035810088,0.0005369554,0.99579084,0.0000026002713,0.00003672565,0.0013550653,0.00010854098,0.00039148759,0.001384287,0.000038262635,0.0003144196,0.0000049767077],"about_ca_topic_score_codex":0.0011028653,"about_ca_topic_score_gemma":0.0008917438,"teacher_disagreement_score":0.0018766131,"about_ca_system_score_codex":0.00023862884,"about_ca_system_score_gemma":0.0001641961,"threshold_uncertainty_score":0.006277919},"labels":[],"label_agreement":null},{"id":"W2622153623","doi":"10.1158/1557-3265.ovcasymp16-mip-059","title":"Abstract MIP-059: MITOCHONDRIAL DYNAMICS AND DYSFUNCTION IN OVARIAN CANCER","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mitochondrial fission; mitochondrial fusion; Biology; Cancer research; Ovarian cancer; Mitochondrion; DNM1L; Cancer; Programmed cell death; Apoptosis; Cell biology; Mitochondrial DNA; Gene; Genetics","score_opus":0.12732443554963552,"score_gpt":0.4762068126604482,"score_spread":0.34888237711081266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622153623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97172415,0.013109233,0.0016170837,0.001139186,0.000085051135,0.00007955053,0.007125147,0.00023011597,0.0048904754],"genre_scores_gemma":[0.98947537,0.0024555873,0.0009030482,0.00015592229,0.000040617895,0.00004210675,0.0051254784,0.000018957273,0.0017828498],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990976,0.000013652025,0.000009542819,0.000018103736,0.000026013498,0.000022913655],"domain_scores_gemma":[0.99986005,0.000010860535,0.00006239444,0.000009387293,0.000022444847,0.000034946643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017581547,0.0002279896,0.00020917327,0.00054533145,0.0001986981,0.0004888992,0.00022929456,0.0002832572,0.0023885826],"category_scores_gemma":[0.00021504145,0.000092848495,0.00023016786,0.00087813573,0.00011562525,0.00015285402,0.00032350185,0.00046177857,0.00062081066],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005416269,0.00043732446,0.13611892,0.001182843,0.00021667055,0.0021649636,0.00014383781,0.0011148455,0.7269603,0.0010181634,0.0076759527,0.11754988],"study_design_scores_gemma":[0.00019343842,0.0016649986,0.6517304,0.00015820615,0.00033116443,0.012682841,0.00034580883,0.0043878397,0.2740043,0.0011707876,0.05329437,0.00003577275],"about_ca_topic_score_codex":0.0007468894,"about_ca_topic_score_gemma":0.00042601087,"teacher_disagreement_score":0.0023885826,"about_ca_system_score_codex":0.00051593385,"about_ca_system_score_gemma":0.00032202178,"threshold_uncertainty_score":0.007990658},"labels":[],"label_agreement":null},{"id":"W2622400237","doi":"10.1158/1557-3265.ovcasymp16-ntoc-083","title":"Abstract NTOC-083: TARGETED APPROACH WITH MOMELOTINIB TREATMENT ATTENUATES PACLITAXEL–INDUCED ENRICHMENT OF CANCER STEM CELLS (CSC)–LIKE AND SUPPRESSES OVARIAN CANCER TUMORIGENESIS AND RECURRENCE","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"","keywords":"Paclitaxel; Ovarian cancer; Medicine; In vivo; Cancer; Immunohistochemistry; Chemotherapy; Internal medicine; Oncology; Cancer research; Biology","score_opus":0.24230385602564472,"score_gpt":0.48325985584467324,"score_spread":0.24095599981902852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622400237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952401,0.00081397855,0.0007240417,0.00016853212,0.00007290738,0.00012945748,0.0007138594,0.00014671666,0.0019903078],"genre_scores_gemma":[0.9938731,0.00060112576,0.0007476891,0.000088116096,0.000021066822,0.00014287497,0.000860392,0.0000134475285,0.0036520776],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999238,0.0000073064457,0.0000061438845,0.000015139149,0.000016795862,0.0000307133],"domain_scores_gemma":[0.9999615,0.0000025826466,0.000009965364,0.0000041398057,0.0000038198323,0.000018004239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007792385,0.00033070336,0.0004869191,0.00022504076,0.00017634063,0.000280184,0.00026096407,0.0003030364,0.0024671801],"category_scores_gemma":[0.000050515013,0.00009171797,0.00023310632,0.0001796297,0.00023335622,0.00017940938,0.000089500274,0.000861164,0.00037255368],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051985546,0.002131084,0.00050563185,0.00016063363,0.00003061837,0.00010021403,0.000033459688,0.00037567163,0.9750304,0.00027106292,0.0010124237,0.015150328],"study_design_scores_gemma":[0.0010288452,0.012250042,0.005338389,0.00001533345,0.000070063965,0.00025753432,0.000050456998,0.0016095213,0.97447646,0.00007108239,0.0048207697,0.000011437889],"about_ca_topic_score_codex":0.0010341775,"about_ca_topic_score_gemma":0.0019507767,"teacher_disagreement_score":0.0024671801,"about_ca_system_score_codex":0.0003465067,"about_ca_system_score_gemma":0.0005525761,"threshold_uncertainty_score":0.008253574},"labels":[],"label_agreement":null},{"id":"W2622451667","doi":"10.1158/1557-3265.ovcasymp16-ntoc-084","title":"Abstract NTOC-084: THE PROMISE OF COMBINATIONAL TREATMENT OF HISTONE DEACETYLASE 6 INHIBITOR ACY-1215 AND PROTEASOME INHIBITOR BORTEZOMIB IN SCCOHT","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Bortezomib; Proteasome inhibitor; Proteasome; Cancer research; Biology; Histone deacetylase inhibitor; Cancer; Pharmacology; Histone deacetylase; Cell biology; Multiple myeloma; Immunology; Biochemistry; Histone","score_opus":0.24554270286648328,"score_gpt":0.5711893694116348,"score_spread":0.3256466665451515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622451667","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95179206,0.03900739,0.0023741235,0.00081319315,0.00044970505,0.000290667,0.0009076767,0.00024335379,0.004121902],"genre_scores_gemma":[0.9844595,0.008728541,0.0027083815,0.00022084756,0.00009068668,0.00012362686,0.0010573826,0.000020154486,0.0025908444],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998723,0.000027321534,0.00001615105,0.00002309409,0.000036046407,0.000025022919],"domain_scores_gemma":[0.9999068,0.00001069889,0.000019719844,0.000009478492,0.000018118602,0.000035192363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021202904,0.0004209655,0.0007603728,0.00035163734,0.00020800781,0.0004061156,0.00039048938,0.0003067919,0.0020225672],"category_scores_gemma":[0.0001387615,0.00013374968,0.0005097324,0.0003230328,0.00017805098,0.00032007816,0.00019383353,0.00095768535,0.00033573993],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008508009,0.0037527445,0.0021428023,0.001704183,0.00027433442,0.00055644795,0.00007502833,0.0013548748,0.88053787,0.00034101366,0.0037258898,0.09702684],"study_design_scores_gemma":[0.0028677594,0.048020978,0.017462842,0.0001498938,0.00076584,0.0021697881,0.0001803119,0.0047716177,0.88815254,0.00024134036,0.035148006,0.00006909896],"about_ca_topic_score_codex":0.0006247843,"about_ca_topic_score_gemma":0.0026414054,"teacher_disagreement_score":0.0020225672,"about_ca_system_score_codex":0.0002988008,"about_ca_system_score_gemma":0.0004723654,"threshold_uncertainty_score":0.0067661405},"labels":[],"label_agreement":null},{"id":"W2622532295","doi":"10.1158/1078-0432.ccr-16-0115","title":"Precision Medicine in Pediatric Oncology: Translating Genomic Discoveries into Optimized Therapies","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Precision medicine; Epigenetics; Medicine; Personalized medicine; Cancer; Disease; Genomics; Bioinformatics; Targeted therapy; Oncology; Computational biology; Internal medicine; Biology; Pathology; Genome; Gene; Genetics","score_opus":0.55646142280636,"score_gpt":0.6598406016677948,"score_spread":0.10337917886143477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622532295","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000090788184,0.9965544,0.00038832994,0.0012337281,0.0002916,0.0000066561975,0.00002400095,0.0000124732305,0.0013980198],"genre_scores_gemma":[0.0009358746,0.99734,0.00060249306,0.0004483762,0.00022394439,0.000009005639,0.000027424987,0.000002237518,0.0004106027],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996629,0.000095186195,0.00003772239,0.00004409358,0.00012687953,0.00003317343],"domain_scores_gemma":[0.9992131,0.0004579582,0.00006436789,0.000029484498,0.00018409404,0.000050976432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014553402,0.0006729612,0.0011858925,0.002117075,0.00023648459,0.0013371559,0.0008704786,0.0011603915,0.0038824328],"category_scores_gemma":[0.0015313354,0.00023197841,0.00060077535,0.0014612902,0.0006774502,0.001328908,0.0008506832,0.0026752888,0.0019553348],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041794374,0.00005223395,0.00019655857,0.007964735,0.00011208192,0.00025034594,0.00006939211,0.00066079764,0.0011357629,0.01718101,0.036725897,0.93560934],"study_design_scores_gemma":[0.000018142253,0.00007444952,0.00044924527,0.005119665,0.00007871052,0.0008239353,0.00006813387,0.00020069037,0.00048786437,0.008098184,0.9845622,0.000018622784],"about_ca_topic_score_codex":0.0012667797,"about_ca_topic_score_gemma":0.0024826487,"teacher_disagreement_score":0.0038824328,"about_ca_system_score_codex":0.0013310341,"about_ca_system_score_gemma":0.0016946137,"threshold_uncertainty_score":0.012988031},"labels":[],"label_agreement":null},{"id":"W2622925394","doi":"10.1158/1557-3265.ovcasymp16-ntoc-108","title":"Abstract NTOC-108: ACTIVITY OF DIANHYDROGALACTITOL (VAL–083) IN OVARIAN TUMOR MODELS, SENSITIVE OR RESISTANT TO CISPLATIN","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Cisplatin; Carboplatin; Ovarian cancer; Cytotoxicity; Cancer research; MTT assay; DNA damage; Pharmacology; Chemistry; Biology; Medicine; Cell culture; Cancer; In vitro; Internal medicine; DNA; Chemotherapy; Biochemistry; Genetics","score_opus":0.3315009651501813,"score_gpt":0.5394924676631716,"score_spread":0.2079915025129903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622925394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99791414,0.0005290692,0.00024554005,0.000032293072,0.000016574104,0.000030180076,0.00034521817,0.000025248739,0.00086177135],"genre_scores_gemma":[0.9967776,0.00040709492,0.0006452502,0.000026035417,0.0000056751587,0.000024425215,0.0008442007,0.000008593073,0.0012610677],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999946,0.000013271806,0.000006092128,0.000009455147,0.000010729975,0.000014514416],"domain_scores_gemma":[0.9999286,0.000010468766,0.000014933022,0.000008486035,0.00001040817,0.000027120761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000075265285,0.00030802016,0.00017130167,0.00017673435,0.000097836615,0.00011944894,0.00016130075,0.00018892188,0.0010440482],"category_scores_gemma":[0.00007676341,0.00007355282,0.00015854866,0.00019576223,0.00011906751,0.00010140689,0.000098599085,0.0003337379,0.00017251381],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013103604,0.00030686863,0.00034546322,0.00006207184,0.000011201359,0.000055505003,0.000018063969,0.00027744696,0.99525404,0.00003727279,0.00012745403,0.002194311],"study_design_scores_gemma":[0.00006768422,0.004214746,0.0033051646,0.0000065484683,0.000020838892,0.0001238954,0.00002257844,0.00065038935,0.99025166,0.000014129779,0.0013178344,0.000004450184],"about_ca_topic_score_codex":0.0017505351,"about_ca_topic_score_gemma":0.002133641,"teacher_disagreement_score":0.0017505351,"about_ca_system_score_codex":0.00016116301,"about_ca_system_score_gemma":0.00022429702,"threshold_uncertainty_score":0.0034926534},"labels":[],"label_agreement":null},{"id":"W2623044754","doi":"10.1158/1557-3265.ovcasymp16-ap09","title":"Abstract AP09: GENOMIC ALTERATIONS IN ENDOMETRIOSIS","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"B.C. Women's Hospital & Health Centre; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Endometriosis; KRAS; Clear cell; Stromal cell; Cancer research; Stroma; Ovarian cancer; Somatic cell; Endometrial cancer; Pathology; Cancer; Biology; Medicine; Oncology; Carcinoma; Internal medicine; Gene; Immunohistochemistry; Genetics; Colorectal cancer","score_opus":0.44060986255906176,"score_gpt":0.6133139086823258,"score_spread":0.17270404612326407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623044754","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9452701,0.012497709,0.0052955076,0.001205629,0.00025257492,0.000178657,0.007852925,0.00029648925,0.027150415],"genre_scores_gemma":[0.98933357,0.0017491357,0.0018290228,0.00029946136,0.00011519606,0.00003929371,0.0032923368,0.00002735854,0.0033146895],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996439,0.00006189976,0.000045618996,0.00007490971,0.0001244225,0.000049165043],"domain_scores_gemma":[0.9992611,0.0002540426,0.00017996253,0.00006111937,0.00014030286,0.00010348561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033775024,0.00037662138,0.00017291862,0.0015193932,0.00031954917,0.00058861636,0.0003158859,0.00060875266,0.010688049],"category_scores_gemma":[0.0013750814,0.000099580546,0.00017964355,0.0010332607,0.00035755357,0.0002025815,0.00050620607,0.00035570117,0.0015226034],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002264127,0.00027162227,0.4845307,0.0018817785,0.00024392357,0.030668886,0.00039725652,0.00095168734,0.28182855,0.0018136692,0.012936463,0.18221134],"study_design_scores_gemma":[0.00006537027,0.00085276586,0.7281233,0.00024355196,0.0002033102,0.14775996,0.00034887038,0.000995431,0.06626944,0.0016832335,0.053423353,0.000031397885],"about_ca_topic_score_codex":0.0003357484,"about_ca_topic_score_gemma":0.00028169117,"teacher_disagreement_score":0.010688049,"about_ca_system_score_codex":0.0001754151,"about_ca_system_score_gemma":0.00018885633,"threshold_uncertainty_score":0.03575504},"labels":[],"label_agreement":null},{"id":"W2623437396","doi":"10.1158/1557-3265.ovcasymp16-tmem-036","title":"Abstract TMEM-036: INTERFERON INDUCED STAT1 ASSOCIATES WITH DIFFERENTIAL CHEMOTHERAPY RESPONSE IN HIGH-GRADE SEROUS OVARIAN CANCER","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"","keywords":"STAT1; Ovarian cancer; Tumor microenvironment; Cancer research; Biology; Immune system; Gene signature; Gene knockdown; Chemotherapy; Small hairpin RNA; Cancer; Immunology; Interferon; Gene expression; Cell culture; Gene","score_opus":0.22922710584305234,"score_gpt":0.5245707499841041,"score_spread":0.2953436441410518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623437396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99927205,0.0001652216,0.00013676465,0.000018179671,0.000003874475,0.000006873533,0.00021259833,0.000009733772,0.00017466546],"genre_scores_gemma":[0.9990108,0.000051379706,0.0001774925,0.00002326781,0.0000034774148,0.0000115776065,0.00042531604,0.0000024879257,0.00029420212],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99993014,0.0000140876355,0.00000836421,0.000017016446,0.000016477765,0.000014004717],"domain_scores_gemma":[0.9998416,0.000028878207,0.00007228043,0.0000117780155,0.000014749685,0.000030735064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013004211,0.00012651233,0.00013977608,0.0002924772,0.00010388076,0.00022068,0.000069333946,0.00017733885,0.0017055927],"category_scores_gemma":[0.00021079702,0.00006789769,0.00012239403,0.00027351768,0.00016377032,0.00007177952,0.00009240271,0.0002544874,0.00018845052],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036624111,0.00018885756,0.23638983,0.00013601319,0.000046896454,0.00029611783,0.000088389905,0.00036104495,0.7500998,0.000067453904,0.00039371435,0.008269581],"study_design_scores_gemma":[0.000070100774,0.0012791032,0.9039762,0.000009773933,0.000054846696,0.0012726017,0.00012421151,0.0019496381,0.09001554,0.00009871068,0.0011426238,0.0000065798117],"about_ca_topic_score_codex":0.00016663005,"about_ca_topic_score_gemma":0.00027451015,"teacher_disagreement_score":0.0017055927,"about_ca_system_score_codex":0.00013362091,"about_ca_system_score_gemma":0.00007779362,"threshold_uncertainty_score":0.005705774},"labels":[],"label_agreement":null},{"id":"W2623453429","doi":"10.1158/1557-3265.ovcasymp16-ap27","title":"Abstract AP27: FEASIBILITY OF MONITORING RESPONSE TO THE PARP INHIBITOR RUCAPARIB WITH TARGETED DEEP SEQUENCING OF CIRCULATING TUMOR DNA (CTDNA) IN WOMEN WITH HIGH GRADE OVARIAN CARCINOMA ON THE ARIEL2 TRIAL","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; PARP inhibitor; Ovarian cancer; Internal medicine; Oncology; Cancer; Interquartile range; Cancer research; Biology; Gene; Genetics; Poly ADP ribose polymerase","score_opus":0.3201574844223511,"score_gpt":0.4925623626280325,"score_spread":0.1724048782056814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623453429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910812,0.0022967455,0.000725894,0.00059117284,0.000048422356,0.00027099982,0.0022575997,0.0001185299,0.0026094315],"genre_scores_gemma":[0.9959883,0.00022814576,0.00069875584,0.00026725014,0.000058642883,0.00025861376,0.0016609096,0.000018454226,0.0008208937],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9983368,0.0011010274,0.000065090004,0.00024620295,0.00016140965,0.000089474444],"domain_scores_gemma":[0.99805695,0.0007740167,0.00037958645,0.00019786869,0.00017277335,0.00041885368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038936944,0.0004962261,0.0008652449,0.0001837278,0.00013655255,0.0009938774,0.00064702507,0.0005686379,0.0030170584],"category_scores_gemma":[0.0037738157,0.0001981094,0.0005474641,0.00026763487,0.00025210428,0.0006248251,0.00043745947,0.0013346709,0.0005450104],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6483629,0.0029661092,0.111261964,0.0006430267,0.0024506834,0.00018748334,0.00016755935,0.0051777344,0.016472602,0.0002372645,0.007294572,0.20477813],"study_design_scores_gemma":[0.22540699,0.24249111,0.44179568,0.00023170354,0.004849948,0.0009778867,0.00038170663,0.039332915,0.025204932,0.0018155186,0.017322645,0.00018894569],"about_ca_topic_score_codex":0.00050193776,"about_ca_topic_score_gemma":0.00076321623,"teacher_disagreement_score":0.0038936944,"about_ca_system_score_codex":0.00051244296,"about_ca_system_score_gemma":0.0005090745,"threshold_uncertainty_score":0.020592034},"labels":[],"label_agreement":null},{"id":"W2623526312","doi":"10.1158/1557-3265.ovcasymp16-ntoc-110","title":"Abstract NTOC-110: UNEXPECTED ROLES FOR KDM4A: PROTEIN SYNTHESIS AND MTOR INHIBITOR SENSITIVITY","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Structural Genomics Consortium","funders":"","keywords":"PI3K/AKT/mTOR pathway; Biology; Protein biosynthesis; Translation (biology); Translational regulation; Cancer research; Cell biology; Biochemistry; Messenger RNA; Signal transduction; Gene","score_opus":0.12485655307155465,"score_gpt":0.46529569942321425,"score_spread":0.3404391463516596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623526312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802833,0.0061713113,0.0020546736,0.0011816518,0.00021917476,0.000057499135,0.0021407197,0.00032721506,0.0075643747],"genre_scores_gemma":[0.98459226,0.0016536656,0.0017947238,0.00025450604,0.000068847396,0.000042067993,0.0019894969,0.00008305278,0.009521426],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998274,0.0000147954315,0.000018009947,0.00004576835,0.00006683725,0.000027139746],"domain_scores_gemma":[0.99986947,0.00001854896,0.000032737724,0.000014338695,0.000019926261,0.000044971166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014776082,0.00025846387,0.000359665,0.00027253423,0.00031959702,0.0004779755,0.00041515075,0.00035699923,0.0041192085],"category_scores_gemma":[0.00020402351,0.00015643964,0.00021365682,0.00028151076,0.00033618032,0.00017272368,0.00025303886,0.0006358202,0.00086438213],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051888044,0.000046117926,0.0012518716,0.00009173806,0.000016939306,0.0002129756,0.0000136802955,0.00012862809,0.99080384,0.00025881917,0.0007034485,0.005953139],"study_design_scores_gemma":[0.00006685182,0.00043113023,0.024584044,0.000011915847,0.000041003113,0.0013212258,0.000029790797,0.00087820814,0.9602824,0.00027142465,0.012068594,0.0000133832355],"about_ca_topic_score_codex":0.0017862839,"about_ca_topic_score_gemma":0.0023210868,"teacher_disagreement_score":0.0041192085,"about_ca_system_score_codex":0.0006736096,"about_ca_system_score_gemma":0.00030598597,"threshold_uncertainty_score":0.013780177},"labels":[],"label_agreement":null},{"id":"W2623577366","doi":"10.1158/1557-3265.ovcasymp16-ap32","title":"Abstract AP32: THE METHYLTRANSFERASE EZH2 IS A VULNERABLE TARGET IN SMALL CELL CARCINOMA OF THE OVARY, HYPERCALCEMIC TYPE (SCCOHT)","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; SMARCA4; EZH2; Cancer research; Chromatin; Chromatin remodeling; Histone methyltransferase; Cell cycle checkpoint; Cell biology; Cell cycle; Genetics; Cell; Gene","score_opus":0.17924978000521433,"score_gpt":0.461124827851324,"score_spread":0.2818750478461097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623577366","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99414575,0.0030646892,0.0014982125,0.00015340728,0.00002770924,0.00002583379,0.00042432066,0.00003407014,0.00062595715],"genre_scores_gemma":[0.995531,0.0009776946,0.0009978667,0.00008515835,0.000014538618,0.00002627903,0.000710958,0.000007869542,0.0016484897],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999281,0.0000048671636,0.00000591375,0.000022378768,0.000025909492,0.000012815589],"domain_scores_gemma":[0.999949,0.000006044183,0.000016460688,0.000004481365,0.00000944864,0.000014643428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009262962,0.00025537162,0.00021875226,0.00023655743,0.0001836439,0.00019486924,0.0001656869,0.00027641578,0.0014899153],"category_scores_gemma":[0.00013635596,0.00009234185,0.0002179501,0.00026544253,0.00018104796,0.00018439013,0.00017640572,0.00031729334,0.00024586992],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002491244,0.000015334654,0.00406296,0.00009675196,0.000017534669,0.0003315223,0.0000141145565,0.000055804936,0.99190444,0.00005864174,0.00012044398,0.0030733196],"study_design_scores_gemma":[0.000067156565,0.00062793365,0.085322656,0.000012235695,0.000106278545,0.005174545,0.00011005805,0.0014096019,0.8990486,0.00022023547,0.007889634,0.000010990088],"about_ca_topic_score_codex":0.00041111303,"about_ca_topic_score_gemma":0.0005593619,"teacher_disagreement_score":0.0014899153,"about_ca_system_score_codex":0.00024359328,"about_ca_system_score_gemma":0.00016652237,"threshold_uncertainty_score":0.0049842596},"labels":[],"label_agreement":null},{"id":"W2623871371","doi":"10.1158/1557-3265.ovcasymp16-ntoc-086","title":"Abstract NTOC-086: PAC–1 COMBINATION WITH TRAIL ENHANCES APOPTOSIS IN CELL–LINE AND PRIMARY CULTURED ADULT GRANULOSA CELL TUMOUR CELLS","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Apoptosis; In vivo; Programmed cell death; In vitro; Cell culture; Cancer research; Cell; Chemistry; Cancer cell; Cell biology; Caspase; Pharmacology; Cancer; Biology; Medicine; Internal medicine; Biochemistry","score_opus":0.06219226028149043,"score_gpt":0.4304599824405146,"score_spread":0.36826772215902415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623871371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815953,0.006138584,0.0031978271,0.00030014073,0.00020569396,0.00025806227,0.002228408,0.00020457846,0.005871499],"genre_scores_gemma":[0.97868365,0.0028699986,0.0067000673,0.0001410404,0.0000652816,0.00023354306,0.0040896093,0.000026017347,0.00719067],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99974173,0.000058908918,0.000048631595,0.000037905287,0.000071050395,0.00004174512],"domain_scores_gemma":[0.9998555,0.00003990546,0.000022641047,0.000024026156,0.000025886964,0.00003201849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024262509,0.00038025793,0.0005305288,0.00029085134,0.00018750291,0.0003088273,0.00027880102,0.0002946842,0.0022281087],"category_scores_gemma":[0.000115954936,0.000102612205,0.00037680814,0.00039701132,0.00020458433,0.00021348982,0.00014948235,0.00080448785,0.0008627537],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010995017,0.00044507635,0.0003157822,0.00024911246,0.00001909956,0.0002245876,0.00008200314,0.0003005208,0.99185795,0.00012830111,0.0006141163,0.004663889],"study_design_scores_gemma":[0.000081273036,0.002433385,0.002415549,0.000017239114,0.000027884505,0.0003836971,0.000031827432,0.00074897154,0.9892972,0.000021887132,0.004535011,0.000006205258],"about_ca_topic_score_codex":0.0013185944,"about_ca_topic_score_gemma":0.0015913357,"teacher_disagreement_score":0.0022281087,"about_ca_system_score_codex":0.0003173003,"about_ca_system_score_gemma":0.0003679035,"threshold_uncertainty_score":0.0074537992},"labels":[],"label_agreement":null},{"id":"W2624138802","doi":"10.1158/1557-3265.ovcasymp16-mip-049","title":"Abstract MIP-049: ATR–DEPENDENT REGULATION OF THE OVARIAN CANCER PROTEIN PALB2 AT DNA DOUBLE–STRAND BREAKS","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"PALB2; RAD51; Homologous recombination; DNA repair; BRCA2 Protein; DNA damage; Biology; Cancer research; Ovarian cancer; Genetics; Cell biology; DNA; Cancer; Mutation; Germline mutation; Gene","score_opus":0.1409290364741854,"score_gpt":0.46880232414752576,"score_spread":0.32787328767334034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624138802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9638214,0.008638469,0.0092657395,0.0013430446,0.00050290953,0.0001242801,0.0056791883,0.0006888609,0.00993618],"genre_scores_gemma":[0.971632,0.002347492,0.004055861,0.00039830705,0.000063481704,0.00012623038,0.008249244,0.00015798584,0.012969467],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986017,0.00001564384,0.000009089648,0.000043158416,0.000030518153,0.000041392304],"domain_scores_gemma":[0.9999249,0.0000059010554,0.000022061624,0.000008975358,0.000009664499,0.00002855242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009397968,0.0003594617,0.00019968342,0.00025435953,0.00031839847,0.00047186564,0.00032372554,0.00029676943,0.005168133],"category_scores_gemma":[0.00009094425,0.00015510996,0.00042188365,0.00020156341,0.00018893088,0.00026058665,0.00043414996,0.0010952449,0.002082284],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035946484,0.00008374766,0.0003772703,0.00011617425,0.000010297008,0.0001009709,0.000012627629,0.00011498974,0.99505675,0.0003260015,0.0007083979,0.00273338],"study_design_scores_gemma":[0.0000928717,0.0002492009,0.01730331,0.000033425873,0.00003956797,0.00069750665,0.00008846368,0.003672832,0.9497488,0.00021405447,0.027844658,0.000015442627],"about_ca_topic_score_codex":0.00035630885,"about_ca_topic_score_gemma":0.00036490947,"teacher_disagreement_score":0.005168133,"about_ca_system_score_codex":0.00041822338,"about_ca_system_score_gemma":0.00022762034,"threshold_uncertainty_score":0.017289162},"labels":[],"label_agreement":null},{"id":"W2624569919","doi":"10.1158/1557-3265.ovcasymp16-dpoc-014","title":"Abstract DPOC-014: BEYOND CODING MUTATIONS: USING RETROTRANSPOSONS TO PREDICT OVARIAN CANCER DEVELOPMENT","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Ovarian cancer; Sanger sequencing; Endometriosis; Biology; Cancer research; Frameshift mutation; Cancer; Epigenetics; Retrotransposon; Massive parallel sequencing; Genetics; Mutation; Medicine; DNA sequencing; Gene; Genome; Pathology","score_opus":0.2348676825987793,"score_gpt":0.5157947380122851,"score_spread":0.2809270554135058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624569919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99828786,0.00035172282,0.00042186637,0.000030203933,0.0000064364212,0.00002314657,0.0002609147,0.0000148357585,0.00060312427],"genre_scores_gemma":[0.9986808,0.00007656894,0.0006549298,0.00001885972,0.0000047939775,0.000010278102,0.00030579828,0.0000034909706,0.000244543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997726,0.000052370066,0.000023039807,0.000056937937,0.00006123469,0.000033793698],"domain_scores_gemma":[0.9993376,0.00021117553,0.00019586146,0.000033864824,0.00010057835,0.00012098523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003753597,0.0002474463,0.00017185824,0.0011992817,0.00016646062,0.00042460565,0.00024920757,0.00044049267,0.0015795015],"category_scores_gemma":[0.0012000244,0.000112620684,0.00014609545,0.00048750176,0.0002647909,0.00016100926,0.00027125547,0.00030194107,0.00026714132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003595792,0.000025503248,0.980667,0.00002556476,0.000021834023,0.00029889244,0.000029377976,0.00010089588,0.013583591,0.000020499941,0.00008779614,0.0047795074],"study_design_scores_gemma":[0.000027813696,0.00034541992,0.9811968,0.000015278238,0.000065824315,0.0037711721,0.00017573785,0.0023133603,0.010924593,0.00009542881,0.0010626855,0.000005966843],"about_ca_topic_score_codex":0.0011069071,"about_ca_topic_score_gemma":0.0009846522,"teacher_disagreement_score":0.0015795015,"about_ca_system_score_codex":0.00017765042,"about_ca_system_score_gemma":0.00011545954,"threshold_uncertainty_score":0.0052839518},"labels":[],"label_agreement":null},{"id":"W2625162530","doi":"10.1158/1078-0432.ccr-17-0629","title":"<i>PTEN, DICER1, FH</i>, and Their Associated Tumor Susceptibility Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Amgen (Canada); University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; PTEN; Cowden syndrome; Thyroid cancer; Cancer; Thyroid; Pathology; Oncology; Cancer syndrome; Endometrial cancer; Internal medicine; Germline mutation; Mutation; PI3K/AKT/mTOR pathway; Biology","score_opus":0.5654025693032506,"score_gpt":0.6253678440929122,"score_spread":0.05996527478966163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625162530","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012726978,0.9962845,0.00014457056,0.0011777066,0.00036929254,0.000006843278,0.00004837061,0.000014217854,0.0018271815],"genre_scores_gemma":[0.000871918,0.9968521,0.00037905414,0.00055674376,0.00029768137,0.000010542725,0.00012093964,0.0000028087413,0.00090812496],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997336,0.000053419837,0.00006252712,0.000028029594,0.000099551384,0.000022828139],"domain_scores_gemma":[0.9991743,0.00029791333,0.00013860813,0.000017596754,0.00030436015,0.00006720714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006837046,0.0006082455,0.0012754573,0.0037119265,0.00029694856,0.0007763174,0.0008762493,0.0009406319,0.003229912],"category_scores_gemma":[0.0014797921,0.00025788174,0.00058700057,0.0028313352,0.00033198684,0.00095778104,0.00049902394,0.0015915586,0.00206357],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048837002,0.000032314125,0.00075337256,0.010520527,0.000092359594,0.0010813832,0.000061279694,0.00024830017,0.00055376877,0.0016590335,0.11749095,0.8674579],"study_design_scores_gemma":[0.00002400356,0.000044331275,0.0033463868,0.014685921,0.00026110507,0.010418503,0.00014443953,0.00010185623,0.00023963982,0.0011264983,0.96958256,0.00002479028],"about_ca_topic_score_codex":0.0029848334,"about_ca_topic_score_gemma":0.0057968437,"teacher_disagreement_score":0.0037119265,"about_ca_system_score_codex":0.0009435604,"about_ca_system_score_gemma":0.0015014168,"threshold_uncertainty_score":0.01080513},"labels":[],"label_agreement":null},{"id":"W2625265855","doi":"10.1158/1078-0432.ccr-17-0631","title":"Recommendations for Cancer Surveillance in Individuals with RASopathies and Other Rare Genetic Conditions with Increased Cancer Risk","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Costello syndrome; Medicine; PTPN11; Noonan syndrome; Cancer; KRAS; Family history; Genetic testing; Pediatrics; Oncology; Internal medicine; Colorectal cancer","score_opus":0.285208259087977,"score_gpt":0.5512515786068394,"score_spread":0.2660433195188624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625265855","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005024515,0.8718726,0.0030677167,0.09156725,0.011592257,0.0002160586,0.00061058335,0.0002957503,0.020275302],"genre_scores_gemma":[0.0033493293,0.92584515,0.009206757,0.04281715,0.004815003,0.00037200592,0.0017795187,0.000039882765,0.011775149],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9988018,0.00041123727,0.00020298302,0.000104961,0.00040390636,0.00007510072],"domain_scores_gemma":[0.9954124,0.0015003103,0.0004134716,0.00010930234,0.0022281148,0.00033646464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032364875,0.0007287355,0.001248714,0.00251577,0.00048799248,0.0011311797,0.0023055442,0.003790532,0.006249877],"category_scores_gemma":[0.0068610418,0.00033068666,0.0014093267,0.0014097092,0.00047359194,0.0018837021,0.0010677649,0.005189255,0.0045492053],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053104573,0.00006792729,0.00049859757,0.0041638655,0.000068867084,0.0004062796,0.0000630929,0.00024635854,0.00041542787,0.0027705429,0.39360029,0.5976457],"study_design_scores_gemma":[0.000036241523,0.000035420868,0.00092379405,0.009267334,0.00010144867,0.0010028298,0.00007372866,0.00008987528,0.00014700582,0.0020355454,0.9862656,0.000021255448],"about_ca_topic_score_codex":0.002772902,"about_ca_topic_score_gemma":0.00486942,"teacher_disagreement_score":0.006249877,"about_ca_system_score_codex":0.0013254004,"about_ca_system_score_gemma":0.0032687634,"threshold_uncertainty_score":0.020907938},"labels":[],"label_agreement":null},{"id":"W2625448727","doi":"10.1158/1078-0432.ccr-17-0438","title":"<i>In Situ</i> Vaccination after Accelerated Hypofractionated Radiation and Surgery in a Mesothelioma Mouse Model","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Toronto General Hospital","funders":"","keywords":"Medicine; Radiation therapy; Immune system; Immunotherapy; Mesothelioma; Immune checkpoint; Blockade; Surgery; Oncology; Internal medicine; Immunology; Pathology","score_opus":0.2499333826277477,"score_gpt":0.5176092521322413,"score_spread":0.2676758695044936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625448727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99138194,0.0012796721,0.0046761995,0.00022931193,0.00014400382,0.00013005086,0.00057805586,0.00029920752,0.0012817369],"genre_scores_gemma":[0.9903246,0.0007903868,0.004398634,0.00014005104,0.00005853204,0.00022991128,0.0006641154,0.000054013133,0.0033397898],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99970585,0.000041078813,0.00002803828,0.00007571996,0.00007383849,0.00007548852],"domain_scores_gemma":[0.99978155,0.000018577919,0.00009366387,0.00004147234,0.000014296526,0.000050441446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030103765,0.0008149325,0.00052938005,0.00045977926,0.00016199637,0.00030406492,0.00042329464,0.0007326622,0.0014996721],"category_scores_gemma":[0.00009556553,0.0002673375,0.0007114334,0.00020774874,0.0004046074,0.00033829617,0.00021842858,0.0013542759,0.0004303203],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006793643,0.00030302285,0.0001826708,0.00006773481,0.000015358246,0.000044567543,0.000013166391,0.0002452405,0.9969981,0.00006946904,0.00010427146,0.0012771629],"study_design_scores_gemma":[0.00015927419,0.006320306,0.004197497,0.000020279298,0.00006840994,0.00033188594,0.000030808966,0.0020810934,0.9846976,0.000083662126,0.0019994506,0.000009740744],"about_ca_topic_score_codex":0.00046138326,"about_ca_topic_score_gemma":0.000541701,"teacher_disagreement_score":0.0014996721,"about_ca_system_score_codex":0.00032436472,"about_ca_system_score_gemma":0.00027977105,"threshold_uncertainty_score":0.005016923},"labels":[],"label_agreement":null},{"id":"W2625567931","doi":"10.1158/1078-0432.ccr-17-0547","title":"Von Hippel–Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":279,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"SDHD; SDHB; SDHA; Pheochromocytoma; Medicine; Paraganglioma; Cancer; Von Hippel–Lindau disease; Disease; Oncology; Stromal tumor; Internal medicine; Germline mutation; Pathology; Bioinformatics; Stromal cell; Genetics; Biology; Mutation; Gene","score_opus":0.4547394839743073,"score_gpt":0.6025139689033184,"score_spread":0.14777448492901113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625567931","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27849066,0.30709702,0.05321023,0.22624013,0.0061196424,0.0011845437,0.004972296,0.0019812833,0.12070416],"genre_scores_gemma":[0.7462827,0.13037539,0.07245488,0.020201033,0.005587554,0.0007900418,0.0055067562,0.00031560333,0.018485995],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99931073,0.00017655062,0.00013095727,0.00006441041,0.00020095121,0.00011640661],"domain_scores_gemma":[0.99849606,0.0002935095,0.00019227614,0.00003685767,0.0005210602,0.0004602091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010666853,0.0006094905,0.00077142444,0.0016446046,0.0007486505,0.0008724482,0.00077685685,0.0016602742,0.0018910464],"category_scores_gemma":[0.0037631178,0.00022478642,0.0007071701,0.0006733089,0.00047443714,0.0011505362,0.0007257087,0.0025808134,0.0006895632],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035885823,0.0003793781,0.4141089,0.0012711902,0.00014925707,0.037318967,0.001035278,0.003998887,0.0036771134,0.0069318805,0.18148716,0.34928313],"study_design_scores_gemma":[0.00017051265,0.00059912883,0.4573793,0.009678693,0.00053609814,0.1682099,0.0051500504,0.007962471,0.0046520596,0.012055144,0.33330125,0.0003054706],"about_ca_topic_score_codex":0.008977683,"about_ca_topic_score_gemma":0.010873509,"teacher_disagreement_score":0.008977683,"about_ca_system_score_codex":0.0010478521,"about_ca_system_score_gemma":0.0024576904,"threshold_uncertainty_score":0.017850876},"labels":[],"label_agreement":null},{"id":"W2625687193","doi":"10.1158/1078-0432.ccr-16-3224","title":"Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Common Fund; National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences; National Cancer Institute; NIH Office of the Director; National Human Genome Research Institute; National Institute of Mental Health; National Heart, Lung, and Blood Institute; National Institutes of Health; Université de Genève; University of Pennsylvania; RIKEN; Broad Institute; Harvard University; National Institute on Drug Abuse; University of Miami","keywords":"Medicine; Internal medicine; Cancer; Imputation (statistics); Peripheral neuropathy; Cisplatin; Genome-wide association study; Oncology; Diabetes mellitus; Body mass index; Single-nucleotide polymorphism; Genotype; Chemotherapy; Endocrinology; Genetics; Gene; Biology","score_opus":0.28480858156993494,"score_gpt":0.5834587144445557,"score_spread":0.2986501328746207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625687193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99861264,0.00021798642,0.00012494244,0.000020126281,0.0000026327025,0.000007855264,0.00087784167,0.0000042162037,0.00013168667],"genre_scores_gemma":[0.99877685,0.00007506189,0.000094967516,0.000025369352,0.0000038439175,0.000009917278,0.0009174223,0.0000023464167,0.00009418966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995946,0.00012494846,0.000038835165,0.00014373336,0.0000623372,0.000035535475],"domain_scores_gemma":[0.9990338,0.00016041123,0.00041502964,0.00014260836,0.00013538804,0.00011268595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060099876,0.00018310398,0.0002569822,0.0003645181,0.0002629135,0.00039377657,0.00030014126,0.00021924463,0.0013177904],"category_scores_gemma":[0.0015463539,0.00013192192,0.00028164554,0.0010479875,0.00018387221,0.0001663513,0.00035215667,0.00031835565,0.00013813087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048254427,0.00002267905,0.99607396,0.000023936816,0.00018275874,0.000038576603,0.000026031013,0.00008209514,0.00079288305,0.000012837982,0.00017779472,0.002084001],"study_design_scores_gemma":[0.000018379737,0.000105866675,0.99922967,0.0000041186095,0.0000809996,0.00010892163,0.000034080564,0.00016012856,0.000093082665,0.000017554232,0.00014540755,0.0000017094269],"about_ca_topic_score_codex":0.0043977047,"about_ca_topic_score_gemma":0.00620554,"teacher_disagreement_score":0.0043977047,"about_ca_system_score_codex":0.00020792948,"about_ca_system_score_gemma":0.0002680299,"threshold_uncertainty_score":0.00874418},"labels":[],"label_agreement":null},{"id":"W2625944954","doi":"10.1158/1078-0432.ccr-17-0589","title":"Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute for Health and Care Research","keywords":"Medicine; Neurofibromatosis; Rhabdomyosarcoma; Population; Pediatrics; Malignancy; Neurocognitive; Cancer; Pediatric cancer; Pilocytic astrocytoma; Pathology; Intensive care medicine; Sarcoma; Internal medicine; Glioma; Astrocytoma; Psychiatry","score_opus":0.38658817522756533,"score_gpt":0.5440567199945632,"score_spread":0.15746854476699784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625944954","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9503065,0.029522028,0.00077033637,0.005201194,0.00013943721,0.00005234354,0.0006725442,0.000076999844,0.01325863],"genre_scores_gemma":[0.9915746,0.006555648,0.0008555976,0.00030191446,0.00009940437,0.00001897989,0.0002679468,0.0000070138854,0.00031896762],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.99958414,0.00014981466,0.00004702162,0.00004234507,0.00010524496,0.00007147773],"domain_scores_gemma":[0.99847394,0.0004150521,0.00064969016,0.00002642661,0.00020137089,0.00023348651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056875695,0.00014774672,0.00019801344,0.0007027883,0.00030624337,0.00042595688,0.00022676754,0.00037152143,0.0013025388],"category_scores_gemma":[0.0039060088,0.00009378873,0.00017814046,0.00062726246,0.00020182611,0.00050383934,0.00031370975,0.00054858485,0.00016506277],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076654585,0.00003886511,0.94191146,0.000090806134,0.000019528257,0.0024734647,0.00020685294,0.00028185302,0.00028981105,0.00024041081,0.0030890254,0.051281158],"study_design_scores_gemma":[0.000010470548,0.00024260864,0.96423954,0.0003120175,0.000052543106,0.022121139,0.0007668629,0.0011705748,0.00071481767,0.00040540824,0.009950891,0.000013150504],"about_ca_topic_score_codex":0.005458081,"about_ca_topic_score_gemma":0.0061163222,"teacher_disagreement_score":0.005458081,"about_ca_system_score_codex":0.0006973784,"about_ca_system_score_gemma":0.00071284024,"threshold_uncertainty_score":0.010852635},"labels":[],"label_agreement":null},{"id":"W2626568439","doi":"10.1158/1078-0432.ccr-15-1636","title":"Molecular Pathways: Targeting the Microenvironment of Liver Metastases","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"National Cancer Institute","keywords":"Colorectal cancer; Paracrine signalling; Medicine; Cancer; Autocrine signalling; Cancer research; Metastasis; Gastrointestinal tract; Tumor microenvironment; Liver cancer; Internal medicine; Receptor","score_opus":0.6281386272263334,"score_gpt":0.6151416007931797,"score_spread":0.012997026433153702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626568439","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018938714,0.99758637,0.00016501854,0.00030528434,0.00021197554,0.000008536285,0.000024164989,0.000010251479,0.0014990574],"genre_scores_gemma":[0.0011746329,0.9972671,0.00018716989,0.0001841439,0.00010258675,0.000010367487,0.000039448518,0.0000014908857,0.001033093],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998827,0.000022058734,0.000014342139,0.000019328485,0.00004748819,0.000014213086],"domain_scores_gemma":[0.9998926,0.00003230425,0.000018450166,0.0000041407843,0.000039771607,0.000012683433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003275718,0.000712665,0.0010333405,0.0017861046,0.00024285793,0.00097251794,0.00067423517,0.000764732,0.0034171783],"category_scores_gemma":[0.0003210418,0.00018766389,0.00040802683,0.0012170294,0.00036808578,0.0009176181,0.00052781566,0.0016336753,0.0022807568],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009673656,0.000116160845,0.0001643001,0.016206644,0.00010532116,0.0002774049,0.000061506275,0.00047849177,0.007246772,0.006392958,0.032027215,0.9368264],"study_design_scores_gemma":[0.0000268028,0.00012989627,0.0006858206,0.0032185852,0.00009408295,0.0012659582,0.0000549401,0.000118410266,0.0015441313,0.0017786357,0.99106616,0.00001653261],"about_ca_topic_score_codex":0.0007113131,"about_ca_topic_score_gemma":0.0014695794,"teacher_disagreement_score":0.0034171783,"about_ca_system_score_codex":0.0005585148,"about_ca_system_score_gemma":0.00084842386,"threshold_uncertainty_score":0.011431575},"labels":[],"label_agreement":null},{"id":"W2626586502","doi":"10.1158/1078-0432.ccr-17-0590","title":"Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 2 and Related Disorders","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); Hospital for Sick Children; University of Toronto","funders":"National Institute for Health and Care Research","keywords":"Neurofibromatosis; Medicine; Cancer; Central nervous system; Nervous system; Pathology; Internal medicine; Psychiatry","score_opus":0.21737772456651003,"score_gpt":0.5003276220571397,"score_spread":0.2829498974906296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626586502","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9131561,0.06622164,0.0005205053,0.005158709,0.00021295225,0.000038512655,0.0009596262,0.000053259795,0.013678679],"genre_scores_gemma":[0.98608714,0.012060149,0.00046239936,0.00034562068,0.00016595155,0.000017845403,0.0004197229,0.000006492744,0.0004346753],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.9996768,0.000097690005,0.00003955802,0.000037845723,0.00008250373,0.00006559892],"domain_scores_gemma":[0.9988889,0.00025340266,0.00049698463,0.00001738711,0.00015071683,0.00019252815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044986058,0.00016702487,0.00023020933,0.0008108044,0.00030526886,0.00056055794,0.00020847798,0.00040002473,0.0013654402],"category_scores_gemma":[0.0025642726,0.00009075903,0.00023151992,0.0010112225,0.00020379078,0.00044497062,0.0003421321,0.00052652776,0.00013705713],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009001502,0.000035405705,0.9660004,0.00009372345,0.0000315019,0.0025174557,0.00016304635,0.00019394814,0.0001789541,0.00030231918,0.0027153203,0.02767804],"study_design_scores_gemma":[0.000010450087,0.00011420264,0.9716603,0.00022279202,0.000056270776,0.018789584,0.00058252644,0.00045495105,0.00021788753,0.00030147555,0.007581054,0.0000085365655],"about_ca_topic_score_codex":0.0067775627,"about_ca_topic_score_gemma":0.0065219183,"teacher_disagreement_score":0.0067775627,"about_ca_system_score_codex":0.00063945557,"about_ca_system_score_gemma":0.0006497431,"threshold_uncertainty_score":0.013476193},"labels":[],"label_agreement":null},{"id":"W2725653968","doi":"10.1158/1078-0432.ccr-17-0174","title":"FDG PET and FES PET Predict PFS on Endocrine Therapy—Letter","year":2017,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Standardized uptake value; Fluorodeoxyglucose; Nuclear medicine; Positron emission tomography; Hormonal therapy; Cancer; Metastatic breast cancer; Predictive value; Breast cancer; Progression-free survival; Oncology; Internal medicine; Overall survival; Radiology","score_opus":0.3725870187245502,"score_gpt":0.5908566526554052,"score_spread":0.21826963393085502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2725653968","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039166696,0.009695241,0.00041375592,0.93391174,0.050851867,0.000026398217,0.00019057281,0.00009677454,0.00089706527],"genre_scores_gemma":[0.03620111,0.0065880073,0.00081655796,0.75021535,0.20349967,0.00008017454,0.00015818205,0.00006899399,0.0023720567],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997324,0.0009061121,0.00055613846,0.00045637324,0.00051511364,0.00024212548],"domain_scores_gemma":[0.98385054,0.009467609,0.0008388196,0.00041421686,0.004142076,0.0012866168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039294064,0.0008552778,0.0022095395,0.00074170734,0.0011057546,0.0019777599,0.0024861335,0.015109107,0.001989487],"category_scores_gemma":[0.024155883,0.00051193254,0.0010649206,0.00063630583,0.0016999333,0.0037507121,0.00064574403,0.017724682,0.0022273383],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007568845,0.00016655476,0.0075576724,0.0005685327,0.00014182525,0.009707548,0.00033464158,0.00021643203,0.0009560679,0.0012443751,0.9453396,0.033009943],"study_design_scores_gemma":[0.0007934882,0.0010180674,0.018625818,0.0012689964,0.0004916547,0.0521742,0.0015396259,0.004456676,0.0038344169,0.009902356,0.9054591,0.00043545524],"about_ca_topic_score_codex":0.0018953984,"about_ca_topic_score_gemma":0.0017054237,"teacher_disagreement_score":0.015109107,"about_ca_system_score_codex":0.0020876543,"about_ca_system_score_gemma":0.0013448988,"threshold_uncertainty_score":0.020780921},"labels":[],"label_agreement":null},{"id":"W2725857922","doi":"10.1158/1078-0432.ccr-17-0652","title":"Retinoblastoma and Neuroblastoma Predisposition and Surveillance","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":230,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; American Association for Cancer Research","keywords":"Retinoblastoma; Neuroblastoma; Medicine; Genetic predisposition; Pathology; Biology; Cancer research; Genetics; Gene; Disease; Cell culture","score_opus":0.5637842129581868,"score_gpt":0.6469697183172912,"score_spread":0.0831855053591044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2725857922","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000057570454,0.9983504,0.00003471994,0.00039674775,0.00011548848,0.0000026294495,0.000014287312,0.0000035359565,0.0010247367],"genre_scores_gemma":[0.00070693466,0.9984554,0.000080405596,0.00023359733,0.000116236675,0.0000052274463,0.000029381781,8.2311266e-7,0.00037192155],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974614,0.00005605842,0.000039184677,0.000036732537,0.000099278164,0.000022579168],"domain_scores_gemma":[0.9995459,0.00018949277,0.00007063217,0.000009961507,0.00014714497,0.000036796908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073595846,0.00046559126,0.0008449306,0.0025258486,0.00026686612,0.00075611647,0.00069290015,0.0008550651,0.003818961],"category_scores_gemma":[0.0012337957,0.00018056868,0.0004688766,0.0019920527,0.00030526074,0.00074407464,0.0005341985,0.0012854671,0.0015822343],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043464104,0.000035551315,0.00046971327,0.014809446,0.00008123362,0.00026075428,0.00005877256,0.00020845962,0.0004028288,0.003414813,0.05741184,0.9228032],"study_design_scores_gemma":[0.000015408496,0.000048622212,0.0016471744,0.013829546,0.00015662532,0.00232409,0.000071111455,0.00005582619,0.00023299344,0.0017310483,0.9798728,0.0000148100125],"about_ca_topic_score_codex":0.0031251842,"about_ca_topic_score_gemma":0.00483503,"teacher_disagreement_score":0.003818961,"about_ca_system_score_codex":0.0009074817,"about_ca_system_score_gemma":0.0016313035,"threshold_uncertainty_score":0.012775719},"labels":[],"label_agreement":null},{"id":"W2726357279","doi":"10.1158/1078-0432.ccr-17-0595","title":"Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":187,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute for Health and Care Research","keywords":"Cancer; Medicine; Pathology; Internal medicine","score_opus":0.3089927966369647,"score_gpt":0.5738066049425926,"score_spread":0.2648138083056279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2726357279","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861243,0.0055022226,0.00057183544,0.0006781029,0.000040934698,0.000034866887,0.00023416325,0.000049073125,0.0067646494],"genre_scores_gemma":[0.99788207,0.00083994184,0.000454248,0.00014203512,0.000024099829,0.000007890263,0.00020639141,0.000004866078,0.00043833358],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997906,0.000041291652,0.000025497511,0.000046237223,0.000042885615,0.000053522326],"domain_scores_gemma":[0.99967587,0.00006439413,0.00009284446,0.000010996668,0.000034700948,0.000121200945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016199621,0.00035452135,0.00022869543,0.0006550961,0.00036985736,0.00028689593,0.00018208165,0.0005777265,0.0015222069],"category_scores_gemma":[0.0010462293,0.00010788874,0.0002976433,0.00040509755,0.00026478613,0.0002559271,0.00038551213,0.00033926137,0.0001614919],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004681778,0.00007953586,0.74469054,0.00021882702,0.00008506683,0.20140399,0.00035994756,0.0005877263,0.011302675,0.0009026567,0.0020149949,0.037885863],"study_design_scores_gemma":[0.000037426682,0.00030824612,0.41961935,0.00013928024,0.00012093309,0.5692951,0.00031804913,0.0010387703,0.0028515598,0.00088365393,0.005358009,0.00002953807],"about_ca_topic_score_codex":0.0035000343,"about_ca_topic_score_gemma":0.0033862074,"teacher_disagreement_score":0.0035000343,"about_ca_system_score_codex":0.0004230838,"about_ca_system_score_gemma":0.0003451117,"threshold_uncertainty_score":0.006959319},"labels":[],"label_agreement":null},{"id":"W2726739357","doi":"10.1158/1078-0432.ccr-17-0900","title":"Neratinib Efficacy and Circulating Tumor DNA Detection of <i>HER2</i> Mutations in <i>HER2</i> Nonamplified Metastatic Breast Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Puma Biotechnology","keywords":"Neratinib; Metastatic breast cancer; Breast cancer; Circulating tumor DNA; Cancer; Medicine; Oncology; Trastuzumab; Cancer research; Internal medicine; Biology","score_opus":0.3070330761576317,"score_gpt":0.5647289912994085,"score_spread":0.25769591514177675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2726739357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99898857,0.00043012918,0.00011619442,0.000039419727,0.000007790734,0.00006572791,0.000048443602,0.000008800773,0.00029496787],"genre_scores_gemma":[0.99935013,0.00011784769,0.00017301868,0.00004350508,0.000016229398,0.000047147638,0.0000827751,0.0000027280337,0.0001666504],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996749,0.0001366491,0.000038694354,0.00006273836,0.000049017308,0.00003805314],"domain_scores_gemma":[0.9995128,0.0001515652,0.0001594015,0.00003382228,0.000036794005,0.00010553272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092140905,0.00034437762,0.00095835386,0.00013137083,0.000120545796,0.00033386616,0.00025987258,0.00027880925,0.0010931382],"category_scores_gemma":[0.0009864151,0.00013327404,0.00028012603,0.000109988105,0.0003125616,0.0002810093,0.00012118637,0.0007843041,0.0001827459],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3456404,0.018419039,0.058163624,0.0010116566,0.0010628853,0.0004367557,0.00027961066,0.0044632745,0.37135267,0.00033848255,0.0017099407,0.19712165],"study_design_scores_gemma":[0.09888995,0.6104384,0.13115832,0.00006839356,0.0011688335,0.0028360107,0.00012584649,0.006212597,0.14553323,0.00036566093,0.0031407885,0.00006199177],"about_ca_topic_score_codex":0.00021471859,"about_ca_topic_score_gemma":0.00039985887,"teacher_disagreement_score":0.0010931382,"about_ca_system_score_codex":0.00045094657,"about_ca_system_score_gemma":0.0003373332,"threshold_uncertainty_score":0.0048729777},"labels":[],"label_agreement":null},{"id":"W2727107256","doi":"10.1158/1078-0432.ccr-17-0548","title":"Multiple Endocrine Neoplasia and Hyperparathyroid-Jaw Tumor Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"MEN1; Penetrance; Multiple endocrine neoplasia; Medicine; Germline mutation; Cancer; Germline; Genetic testing; Cowden syndrome; Pheochromocytoma; Hyperparathyroidism; Genetic counseling; Pathology; Internal medicine; Mutation; Genetics; Biology; Gene","score_opus":0.40401425315292894,"score_gpt":0.6033101247625904,"score_spread":0.19929587160966145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2727107256","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41302052,0.19584922,0.010546254,0.16010599,0.0046360455,0.0005474323,0.004733174,0.0014724052,0.20908892],"genre_scores_gemma":[0.8158226,0.12478228,0.021222405,0.010810201,0.0026087912,0.00027775537,0.0046839095,0.0002144189,0.01957756],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996654,0.000072440394,0.00006280505,0.0000226337,0.000105824605,0.00007087301],"domain_scores_gemma":[0.99912304,0.00020541846,0.00014737547,0.000016146214,0.00022193986,0.0002861368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045873533,0.00039905234,0.00036009657,0.0011345132,0.00062768767,0.0005835979,0.00037604143,0.0008540575,0.002755242],"category_scores_gemma":[0.0022183456,0.00017202955,0.00026340855,0.0008063306,0.0003110304,0.00060566573,0.00048497133,0.0014914391,0.0008692324],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014348046,0.0002691098,0.5006488,0.00048235938,0.000052062205,0.05279395,0.0010952727,0.0016663496,0.0017118935,0.0028751292,0.24419458,0.19406705],"study_design_scores_gemma":[0.00006745328,0.00023995423,0.39500433,0.0039035487,0.00014809045,0.3175381,0.004843997,0.001753431,0.002132895,0.0029382834,0.27134496,0.0000849754],"about_ca_topic_score_codex":0.0058163633,"about_ca_topic_score_gemma":0.012892176,"teacher_disagreement_score":0.0058163633,"about_ca_system_score_codex":0.0009352628,"about_ca_system_score_gemma":0.0016186805,"threshold_uncertainty_score":0.01156503},"labels":[],"label_agreement":null},{"id":"W2729499120","doi":"10.1158/1078-0432.ccr-17-0387","title":"DNA-Methyltransferase 1 Induces Dedifferentiation of Pancreatic Cancer Cells through Silencing of Krüppel-Like Factor 4 Expression","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; National Cancer Institute; Public Health Agency of Canada; American Institute for Cancer Research","keywords":"KLF4; Pancreatic cancer; Cancer research; Epigenetics; DNA methylation; Biology; Carcinogenesis; Cancer; DNA methyltransferase; Gene silencing; Cellular differentiation; Cancer cell; Transcription factor; SOX2; Gene expression; Genetics","score_opus":0.22113515894677874,"score_gpt":0.5153545929712718,"score_spread":0.29421943402449313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2729499120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99080056,0.0018561799,0.0044717174,0.000118439966,0.00004828674,0.000053958447,0.00063270505,0.0002526066,0.0017654549],"genre_scores_gemma":[0.9931766,0.0007653246,0.0025976705,0.000062042185,0.00000753052,0.000049395003,0.0006510314,0.000021642163,0.002668797],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998584,0.000017474618,0.000022763763,0.000039808114,0.000031799296,0.000029691413],"domain_scores_gemma":[0.9999038,0.000014188737,0.000034609897,0.00001559501,0.000008721193,0.00002313121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015234212,0.00032113606,0.00028091526,0.00023527733,0.00012136932,0.0002168972,0.00023508201,0.00018371116,0.00159572],"category_scores_gemma":[0.000105915366,0.00017325283,0.00031970793,0.00015050826,0.00020105708,0.00014834371,0.0002074461,0.0006371848,0.00037079025],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085117026,0.00002310855,0.00016434157,0.000037367314,0.0000055224336,0.000020306843,0.00000695447,0.00003484246,0.99869764,0.000046466957,0.000032427964,0.00084589905],"study_design_scores_gemma":[0.000016666858,0.00024273308,0.0022174718,0.000003602581,0.000013958976,0.00010951109,0.000013015738,0.00059177034,0.9953458,0.000026649444,0.0014161541,0.0000027158435],"about_ca_topic_score_codex":0.0003355951,"about_ca_topic_score_gemma":0.0004841231,"teacher_disagreement_score":0.00159572,"about_ca_system_score_codex":0.00032721725,"about_ca_system_score_gemma":0.00024884526,"threshold_uncertainty_score":0.005338192},"labels":[],"label_agreement":null},{"id":"W2731009462","doi":"10.1158/1078-0432.ccr-17-0790","title":"Cancer Screening Recommendations and Clinical Management of Inherited Gastrointestinal Cancer Syndromes in Childhood","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University; McGill Genome Centre; Hospital for Sick Children","funders":"National Institutes of Health; National Institute for Health and Care Research","keywords":"Medicine; Cancer; Gastrointestinal cancer; Childhood cancer; Intensive care medicine; Internal medicine; Colorectal cancer","score_opus":0.6863700664617289,"score_gpt":0.6628334277154109,"score_spread":0.02353663874631806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2731009462","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0368588,0.3675274,0.013057445,0.39359555,0.00991867,0.00045567047,0.0019071226,0.0013039456,0.17537548],"genre_scores_gemma":[0.3155687,0.5069231,0.05196782,0.08324649,0.012050006,0.00067582703,0.0058382214,0.0003608325,0.023369003],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986619,0.00050494634,0.00023740741,0.000088801884,0.00037439584,0.00013259066],"domain_scores_gemma":[0.9967014,0.0008836542,0.0005172231,0.000055599456,0.0012521283,0.0005900331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020012627,0.00034486124,0.00036054966,0.0015694032,0.00059339247,0.00073169294,0.00066054973,0.0011637986,0.004380435],"category_scores_gemma":[0.010068178,0.00016186251,0.00037205734,0.0008641013,0.00037383303,0.00078659743,0.00092617614,0.002370228,0.0017190686],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059193015,0.00008503123,0.03269544,0.00080564665,0.00003652125,0.0031846324,0.0005382207,0.0006866219,0.0005823086,0.0027223427,0.53824466,0.4203594],"study_design_scores_gemma":[0.00007296429,0.00016030263,0.06284039,0.009913407,0.00010733888,0.021047464,0.0017807599,0.0011002586,0.00096173683,0.004347065,0.8975928,0.000075566786],"about_ca_topic_score_codex":0.0049643433,"about_ca_topic_score_gemma":0.008781117,"teacher_disagreement_score":0.0049643433,"about_ca_system_score_codex":0.0011849378,"about_ca_system_score_gemma":0.0022335397,"threshold_uncertainty_score":0.01465404},"labels":[],"label_agreement":null},{"id":"W2731855054","doi":"10.1158/1078-0432.ccr-17-0834","title":"Genetic Counselor Recommendations for Cancer Predisposition Evaluation and Surveillance in the Pediatric Oncology Patient","year":2017,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Genetic counseling; Genetic predisposition; Medicine; Cancer; Genetic testing; Family medicine; Population; Pediatric cancer; Pediatric oncology; Internal medicine; Genetics; Disease; Environmental health","score_opus":0.6558376855245642,"score_gpt":0.6763505522947697,"score_spread":0.020512866770205473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2731855054","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004961749,0.97372705,0.00081778574,0.014855806,0.0012267212,0.000080987586,0.00015977702,0.000059762875,0.008575828],"genre_scores_gemma":[0.0045798486,0.98728704,0.0023735117,0.0032674172,0.0005524699,0.00009412208,0.00025674296,0.0000051527813,0.0015836592],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99898356,0.0004892158,0.000115678056,0.00005661988,0.0002989612,0.000056028483],"domain_scores_gemma":[0.9975967,0.0012925657,0.00032385194,0.000038172166,0.00060628675,0.00014248486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018899767,0.00053557655,0.0007672624,0.0018326209,0.00045282644,0.0007781138,0.0012733927,0.0016194908,0.0073878015],"category_scores_gemma":[0.008695488,0.00017970541,0.0007371697,0.0012567724,0.00024266257,0.0009654983,0.00060205825,0.0022453428,0.0018523424],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033811673,0.00007973896,0.000982994,0.0077592283,0.00009517509,0.000373027,0.0001151902,0.00016854052,0.00010799964,0.0015575947,0.17961055,0.8091161],"study_design_scores_gemma":[0.000089393805,0.000074462805,0.008402675,0.086969845,0.0004998889,0.0043579447,0.00056908745,0.00023880442,0.0002137396,0.0026036815,0.8959397,0.000040748666],"about_ca_topic_score_codex":0.004534248,"about_ca_topic_score_gemma":0.009350756,"teacher_disagreement_score":0.0073878015,"about_ca_system_score_codex":0.0010632986,"about_ca_system_score_gemma":0.0028550825,"threshold_uncertainty_score":0.02471459},"labels":[],"label_agreement":null},{"id":"W2739459975","doi":"","title":"Different response of breast cancer cell lines to PMA treatment","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Breast cancer; Cell culture; Cancer; Cancer research; Integrin; Cell; Cancer cell; Cell adhesion; Medicine; Biology; Immunology; Oncology; Internal medicine; Genetics","score_opus":0.25816404293991924,"score_gpt":0.5800651535950977,"score_spread":0.32190111065517846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739459975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9660213,0.009901201,0.0031774682,0.0007355401,0.00066939346,0.00022785165,0.0068200203,0.00022639005,0.012220855],"genre_scores_gemma":[0.94099385,0.008782099,0.0054452773,0.0007360251,0.00013847562,0.0007061485,0.01565762,0.000071614195,0.027468968],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996045,0.00006386513,0.00005715227,0.00007687936,0.0001041045,0.00009346661],"domain_scores_gemma":[0.99980813,0.000042203763,0.000017662054,0.00003203218,0.000071102295,0.000028825569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015598726,0.00030701573,0.00057356607,0.0003046551,0.00026090286,0.00039389875,0.00020801098,0.00035750994,0.003344326],"category_scores_gemma":[0.00021879919,0.00016213344,0.0004070099,0.0005030955,0.00011846491,0.00021376563,0.00017562698,0.00088167883,0.0016761658],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010832204,0.00032203554,0.0008648945,0.00024345847,0.000022801498,0.00019800795,0.00014955977,0.00010277103,0.99135464,0.00012261,0.001129734,0.004406215],"study_design_scores_gemma":[0.00006225178,0.0016217858,0.022804588,0.000037049707,0.00005436619,0.0005034185,0.00046070496,0.00077513984,0.9596045,0.00008247367,0.013970066,0.000023668234],"about_ca_topic_score_codex":0.0017051429,"about_ca_topic_score_gemma":0.0017896728,"teacher_disagreement_score":0.003344326,"about_ca_system_score_codex":0.0002925804,"about_ca_system_score_gemma":0.00022367235,"threshold_uncertainty_score":0.011187911},"labels":[],"label_agreement":null},{"id":"W2739763269","doi":"10.1158/1078-0432.ccr-16-2882","title":"Pediatric Phase I Trial and Pharmacokinetic Study of Trebananib in Relapsed Solid Tumors, Including Primary Tumors of the Central Nervous System ADVL1115: A Children's Oncology Group Phase I Consortium Report","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Medicine; Pharmacokinetics; Neutropenia; Anemia; Internal medicine; Toxicity; Gastroenterology; Surgery","score_opus":0.18848043433589654,"score_gpt":0.5543462899047323,"score_spread":0.3658658555688358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739763269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944364,0.0012234831,0.00097460474,0.00022770512,0.000033826633,0.001071127,0.0011198958,0.00007484468,0.000838245],"genre_scores_gemma":[0.9875525,0.0016972432,0.0034768756,0.00040534846,0.000092693954,0.0016282258,0.0037418364,0.000049019785,0.0013562758],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995832,0.00018812054,0.000023804048,0.000070971815,0.00006534939,0.00006862457],"domain_scores_gemma":[0.99900645,0.00016654845,0.00022142309,0.000105842126,0.00009829592,0.00040157148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013489126,0.0010961692,0.0012764424,0.00024804534,0.0002830577,0.0004808501,0.0005181269,0.00058191497,0.0014659984],"category_scores_gemma":[0.00064974895,0.00037192204,0.0006640235,0.0003731448,0.000529846,0.00036903072,0.0001966833,0.0024388987,0.00040881112],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37907013,0.083266914,0.055249162,0.0012117495,0.002143264,0.0018410556,0.0008202892,0.009879934,0.24247533,0.0007919693,0.017356839,0.20589337],"study_design_scores_gemma":[0.2744405,0.5993386,0.07448741,0.000069955786,0.0008026776,0.0030526936,0.00011770613,0.004944156,0.03247348,0.0002821678,0.009942444,0.000048257916],"about_ca_topic_score_codex":0.00156285,"about_ca_topic_score_gemma":0.0032089895,"teacher_disagreement_score":0.00156285,"about_ca_system_score_codex":0.0010883259,"about_ca_system_score_gemma":0.002189197,"threshold_uncertainty_score":0.007896364},"labels":[],"label_agreement":null},{"id":"W2741219503","doi":"10.1158/1078-0432.ccr-17-1140","title":"Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; BC Cancer Agency; University of British Columbia","funders":"","keywords":"ARID1A; Bladder cancer; Somatic hypermutation; Cancer research; Metastasis; Targeted therapy; Cancer; Exome; Medicine; Biology; Exome sequencing; Oncology; Gene; Mutation; Internal medicine; Immunology; Genetics","score_opus":0.2092261080348713,"score_gpt":0.5197973101985911,"score_spread":0.3105712021637198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741219503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99644476,0.0004647445,0.0022002563,0.000037536003,0.000005953649,0.000009393384,0.00039120874,0.00004006741,0.00040612946],"genre_scores_gemma":[0.9983278,0.00008218443,0.001060753,0.000027570057,0.000004730786,0.000007848059,0.00029017005,0.0000061564183,0.00019279125],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99982077,0.000022259155,0.000015971535,0.00006982056,0.00004538274,0.000025842799],"domain_scores_gemma":[0.99974734,0.000088287554,0.000057133453,0.000022172902,0.000044052118,0.000040969833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019450579,0.00020567984,0.00020962312,0.0006282883,0.00017325992,0.00032433966,0.00014690244,0.00029339633,0.0018762738],"category_scores_gemma":[0.0008095495,0.00012323125,0.00009425108,0.00037417925,0.00019769519,0.00013269782,0.00024774397,0.00023636152,0.00022809548],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074913213,0.000050782757,0.18374747,0.00014701289,0.000050658826,0.0006885721,0.00023178189,0.0005385797,0.7900632,0.000201443,0.00022264032,0.023308745],"study_design_scores_gemma":[0.00006606595,0.0011636986,0.6091926,0.000046442965,0.00015455866,0.013546848,0.0002927514,0.0055143056,0.36576173,0.0005570916,0.003681905,0.000021938185],"about_ca_topic_score_codex":0.0005747917,"about_ca_topic_score_gemma":0.00085396395,"teacher_disagreement_score":0.0018762738,"about_ca_system_score_codex":0.00022736765,"about_ca_system_score_gemma":0.000161823,"threshold_uncertainty_score":0.0062767267},"labels":[],"label_agreement":null},{"id":"W2743213992","doi":"10.1158/1078-0432.ccr-17-0700","title":"<i>In Vivo</i> Validation of PAPSS1 (3′-phosphoadenosine 5′-phosphosulfate synthase 1) as a Cisplatin-sensitizing Therapeutic Target","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of British Columbia; Centre for Drug Research and Development; BC Cancer Agency","funders":"","keywords":"Cisplatin; In vivo; Lung cancer; Cancer research; Adenocarcinoma; Chemotherapy; Medicine; Carboplatin; Cancer; Pharmacology; Oncology; Biology; Internal medicine","score_opus":0.13762338989949802,"score_gpt":0.4927778633327871,"score_spread":0.3551544734332891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743213992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848037,0.0018587674,0.008498942,0.0003172945,0.00009664945,0.00026636242,0.0013096434,0.00026603317,0.0025826027],"genre_scores_gemma":[0.9911754,0.00108919,0.003799034,0.00010430449,0.000023844623,0.00018436639,0.0015310895,0.000048044647,0.0020447408],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977463,0.00006215791,0.000019622583,0.000043474774,0.00006681174,0.000033189004],"domain_scores_gemma":[0.9997805,0.000032510656,0.000064011016,0.000036016158,0.0000518035,0.00003511407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005664609,0.00055169617,0.00040817852,0.00022979334,0.00017380164,0.0003583924,0.0003126486,0.00033683702,0.0014746604],"category_scores_gemma":[0.00023928453,0.000151559,0.0003893989,0.000167769,0.00031786104,0.00023537043,0.00014924935,0.0008862321,0.0005719267],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025005825,0.00018090397,0.00043150148,0.00007068705,0.000012775861,0.000017339977,0.000010480721,0.00024628433,0.996854,0.000049277296,0.00015516524,0.0017215722],"study_design_scores_gemma":[0.000030129426,0.0024534562,0.0015814281,0.0000036201318,0.000026477559,0.00009709587,0.000011542252,0.00089563883,0.993884,0.000020900157,0.0009930023,0.0000027565945],"about_ca_topic_score_codex":0.00064681517,"about_ca_topic_score_gemma":0.0005966645,"teacher_disagreement_score":0.0014746604,"about_ca_system_score_codex":0.00049539923,"about_ca_system_score_gemma":0.00032522183,"threshold_uncertainty_score":0.0049331784},"labels":[],"label_agreement":null},{"id":"W2749663845","doi":"10.1158/1078-0432.ccr-17-1034","title":"Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation Therapy","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Docetaxel; Prostate cancer; Androgen deprivation therapy; Medicine; Oncology; Internal medicine; Neoadjuvant therapy; Cancer; Transcriptome; Genomics; Biology; Gene; Genetics; Genome; Breast cancer; Gene expression","score_opus":0.17695288912995027,"score_gpt":0.5022077878579497,"score_spread":0.32525489872799945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749663845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985135,0.00055226794,0.00016011117,0.000082244565,0.0000041643184,0.000012193337,0.00023796508,0.0000072680705,0.0004303301],"genre_scores_gemma":[0.99918467,0.00013197036,0.00016723906,0.00007347485,0.000003846511,0.00001470826,0.00026222348,0.000001944406,0.00015979048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998735,0.00003419449,0.0000066748707,0.000029055378,0.000032464908,0.000024107747],"domain_scores_gemma":[0.9998722,0.000032377306,0.000043068845,0.0000062346157,0.00001705606,0.000029137644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017455083,0.000118245625,0.00025861376,0.00019977825,0.0001387504,0.00037606276,0.0000931549,0.0001505647,0.0006716868],"category_scores_gemma":[0.0003470408,0.000063061496,0.00011744508,0.0002630672,0.00015127975,0.00010636302,0.000110072884,0.00019816737,0.00008835017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0115874475,0.00063108193,0.6925454,0.00019143228,0.00022684655,0.0008400943,0.00026224222,0.0017656358,0.22967087,0.00019262392,0.0011763275,0.060909968],"study_design_scores_gemma":[0.00006443826,0.0013404823,0.9816139,0.000013250469,0.00008099298,0.0006921915,0.00018365122,0.0014820249,0.013352251,0.00012452906,0.0010453269,0.0000070602014],"about_ca_topic_score_codex":0.0011077917,"about_ca_topic_score_gemma":0.0021400496,"teacher_disagreement_score":0.0011077917,"about_ca_system_score_codex":0.00044310142,"about_ca_system_score_gemma":0.00034542737,"threshold_uncertainty_score":0.0032149553},"labels":[],"label_agreement":null},{"id":"W2749893104","doi":"10.1158/1078-0432.ccr-17-1098","title":"Synergy of WEE1 and mTOR Inhibition in Mutant <i>KRAS</i> -Driven Lung Cancers","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; AstraZeneca","keywords":"KRAS; PI3K/AKT/mTOR pathway; Wee1; Cancer research; Mutant; Medicine; Discovery and development of mTOR inhibitors; Lung; Lung cancer; Biology; Cancer; Oncology; Internal medicine; Signal transduction; Genetics; Cell cycle; Colorectal cancer","score_opus":0.11755136203765608,"score_gpt":0.4947710386391381,"score_spread":0.37721967660148203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749893104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925609,0.0035340101,0.0013562208,0.000117558986,0.000036747904,0.000085764485,0.00022270152,0.00008981922,0.0019962008],"genre_scores_gemma":[0.99678814,0.00092404784,0.0012387411,0.000038740982,0.000013390286,0.000036554626,0.00014699026,0.000011523493,0.0008018954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984753,0.000033126435,0.000015038421,0.000024924391,0.00004383767,0.000035537447],"domain_scores_gemma":[0.99992275,0.00001487327,0.000017470944,0.0000074450613,0.00000840375,0.000028939388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022314473,0.00047655404,0.0006612852,0.00039461398,0.00014263735,0.00042038484,0.00029181293,0.000219156,0.0010805787],"category_scores_gemma":[0.00010357176,0.00016127477,0.00038154444,0.000188211,0.00016017837,0.00023266175,0.0003138255,0.0005639572,0.00026656553],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015662728,0.00055827503,0.0011431541,0.00021207459,0.00009484798,0.0001536422,0.000026916066,0.0011450221,0.975221,0.0002377475,0.0002963523,0.019344606],"study_design_scores_gemma":[0.00029714714,0.007201468,0.007474326,0.000016690832,0.00016853253,0.0008336233,0.000036152418,0.0044454457,0.97517586,0.00010110413,0.0042360188,0.000013620347],"about_ca_topic_score_codex":0.0002986245,"about_ca_topic_score_gemma":0.0011733008,"teacher_disagreement_score":0.0010805787,"about_ca_system_score_codex":0.0002814509,"about_ca_system_score_gemma":0.000322741,"threshold_uncertainty_score":0.0036149025},"labels":[],"label_agreement":null},{"id":"W2751623946","doi":"10.1158/1078-0432.ccr-17-0895","title":"Low-Dose Cyclophosphamide Induces Antitumor T-Cell Responses, which Associate with Survival in Metastatic Colorectal Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Academy of Medical Sciences; Cancer Research UK; Wellcome Trust","keywords":"Cyclophosphamide; Colorectal cancer; Medicine; Cytotoxic T cell; Immunology; T cell; Cancer research; Cancer; Granzyme B; Internal medicine; Immune system; Chemotherapy; Biology; In vitro","score_opus":0.13246427819783974,"score_gpt":0.4599727787529263,"score_spread":0.32750850055508657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751623946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967884,0.0022386652,0.00036853022,0.000061447245,0.000014368752,0.00003094849,0.00006035485,0.000024312883,0.0004130646],"genre_scores_gemma":[0.99926263,0.00030161935,0.000113791575,0.00002963057,0.000009524954,0.000011989131,0.00009589653,0.0000016600166,0.0001733315],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998852,0.000041125815,0.00000794571,0.000021379685,0.000024622892,0.000019655301],"domain_scores_gemma":[0.99957913,0.000118626434,0.00014349954,0.000032827655,0.00003278773,0.00009319588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003106813,0.00023782522,0.00030199808,0.00010221141,0.00008903362,0.00015382413,0.00009963791,0.0001478014,0.0012415834],"category_scores_gemma":[0.0004791442,0.00008413648,0.00021378214,0.000089459056,0.00013152162,0.000085648,0.00013231297,0.00053342636,0.00009370863],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07405597,0.0036710775,0.19570726,0.0010836405,0.0007432051,0.00052771013,0.00008471886,0.002136098,0.5864624,0.00020100964,0.0020137131,0.13331318],"study_design_scores_gemma":[0.002282668,0.05208326,0.8827382,0.00007026802,0.00081069703,0.001661047,0.000064245854,0.004066276,0.052368604,0.00017856064,0.0036595503,0.000016620676],"about_ca_topic_score_codex":0.00037856103,"about_ca_topic_score_gemma":0.00095273176,"teacher_disagreement_score":0.0012415834,"about_ca_system_score_codex":0.00025845747,"about_ca_system_score_gemma":0.00023430465,"threshold_uncertainty_score":0.0041535497},"labels":[],"label_agreement":null},{"id":"W2751649617","doi":"10.1158/1078-0432.ccr-16-3066","title":"Immuno-oncology Clinical Trial Design: Limitations, Challenges, and Opportunities","year":2017,"lang":"en","type":"editorial","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University College of the North","funders":"National Cancer Institute","keywords":"Dosing; Clinical trial; Medicine; Clinical study design; Intensive care medicine; Cancer; Immunotherapy; Oncology; Precision medicine; Internal medicine; Pathology","score_opus":0.8329008721661434,"score_gpt":0.6316473128910778,"score_spread":0.2012535592750656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751649617","genre_codex":"methods","genre_gemma":"editorial","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028181804,0.22485925,0.3310956,0.23910572,0.042588264,0.097800896,0.004374853,0.0012185564,0.03077499],"genre_scores_gemma":[0.22947809,0.03956096,0.41817006,0.09644761,0.018889593,0.19121265,0.0017098472,0.00076885475,0.0037623402],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.38945276,0.553642,0.03245731,0.005047009,0.01814948,0.00125156],"domain_scores_gemma":[0.38055494,0.5009662,0.035877373,0.03946481,0.036722124,0.006414559],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.5562447,0.0020195032,0.006822252,0.00217681,0.0016846026,0.0077381916,0.0053330245,0.0038185588,0.0063780625],"category_scores_gemma":[0.53246856,0.0012554527,0.0039990623,0.0045152446,0.006183093,0.007944166,0.0034497166,0.0067611607,0.002071358],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021267416,0.0014032694,0.022193627,0.042128514,0.010120632,0.00038230052,0.0016745628,0.00860563,0.0012274642,0.0811222,0.08129086,0.7285835],"study_design_scores_gemma":[0.037062425,0.020660978,0.023998404,0.06844686,0.012319583,0.0014882892,0.001532242,0.033653546,0.0032618667,0.2802598,0.5166709,0.0006451487],"about_ca_topic_score_codex":0.0015378189,"about_ca_topic_score_gemma":0.003802093,"teacher_disagreement_score":0.44375533,"about_ca_system_score_codex":0.0047455328,"about_ca_system_score_gemma":0.017634002,"threshold_uncertainty_score":0.5472294},"labels":[],"label_agreement":null},{"id":"W2752475919","doi":"10.1158/1078-0432.ccr-16-3064","title":"From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials Wisely","year":2017,"lang":"en","type":"editorial","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Immunotherapy; Medicine; Clinical trial; Cancer immunotherapy; Cancer; Intensive care medicine; Immune system; Oncology; Immunology; Internal medicine","score_opus":0.4070754855804582,"score_gpt":0.6245596429953687,"score_spread":0.2174841574149105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752475919","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015963738,0.039611246,0.0009265703,0.13197319,0.82494587,0.000079627134,0.00007556249,0.00015154576,0.0020768435],"genre_scores_gemma":[0.0010898612,0.021600584,0.00096523156,0.09828234,0.87213105,0.0000914423,0.000053302625,0.00007333384,0.005712888],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99115026,0.0029809033,0.0013011058,0.00085008866,0.0033612088,0.00035634506],"domain_scores_gemma":[0.9471939,0.033515804,0.002159538,0.0011053697,0.011105772,0.0049196198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027816957,0.002279146,0.0031570767,0.002045975,0.001929559,0.007106754,0.004083896,0.016285282,0.0053272485],"category_scores_gemma":[0.05595528,0.00097411947,0.0025419318,0.0010308861,0.0029818336,0.008299687,0.0014726557,0.028413724,0.0042864145],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019648782,0.000027243765,0.000054027347,0.00053288304,0.000052310545,0.00014455008,0.000030324347,0.000055296598,0.00014342408,0.0011426589,0.9650782,0.0325426],"study_design_scores_gemma":[0.00037555755,0.00014701393,0.00025572287,0.0011989467,0.00010893114,0.00029128365,0.00004761841,0.00030042857,0.00024798777,0.0041090394,0.9928848,0.00003263151],"about_ca_topic_score_codex":0.0007215617,"about_ca_topic_score_gemma":0.0017186701,"teacher_disagreement_score":0.027816957,"about_ca_system_score_codex":0.0030076227,"about_ca_system_score_gemma":0.0031766652,"threshold_uncertainty_score":0.14711183},"labels":[],"label_agreement":null},{"id":"W2753016068","doi":"10.1158/1078-0432.ccr-17-1259","title":"Chemogenomic Landscape of <i>RUNX1</i> -mutated AML Reveals Importance of <i>RUNX1</i> Allele Dosage in Genetics and Glucocorticoid Sensitivity","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; Institute for Research in Immunology and Cancer","funders":"","keywords":"RUNX1; Biology; Myeloid leukemia; Leukemia; Myeloid; Allele; Pharmacogenomics; Glucocorticoid receptor; Cancer research; Gene; Genetics; Transcription factor","score_opus":0.1365045459684899,"score_gpt":0.48259546705936207,"score_spread":0.34609092109087214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753016068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99751437,0.00033465048,0.00079437013,0.00005033868,0.000002505386,0.0000136704475,0.000711841,0.000042461477,0.00053580164],"genre_scores_gemma":[0.99794585,0.00021216417,0.00066640164,0.000034172535,0.0000029161672,0.000012935151,0.0007085932,0.000016856739,0.0004001244],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99990916,0.000009231076,0.0000061755627,0.0000243206,0.000034036348,0.000016969352],"domain_scores_gemma":[0.999915,0.000017538032,0.000030712123,0.000010148918,0.000009550825,0.000017004735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008237319,0.00015590443,0.00018627301,0.00028961638,0.000098105105,0.00022165486,0.00012011734,0.00021262364,0.0014378971],"category_scores_gemma":[0.00015978861,0.00008138286,0.00014075781,0.0002032926,0.00019096788,0.000074422824,0.00012118383,0.00022515515,0.0002572391],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013181305,0.000011261076,0.00498697,0.0000130255585,0.00000587463,0.000055889966,0.000013521954,0.000112611466,0.99274904,0.000029196031,0.000030188843,0.001860578],"study_design_scores_gemma":[0.000013586612,0.00047802232,0.20354803,0.000006200131,0.00005932832,0.0015418526,0.0001142468,0.0021510236,0.7897814,0.00013647601,0.0021608248,0.000008980382],"about_ca_topic_score_codex":0.00074193,"about_ca_topic_score_gemma":0.0010550236,"teacher_disagreement_score":0.0014378971,"about_ca_system_score_codex":0.00020606497,"about_ca_system_score_gemma":0.000117383606,"threshold_uncertainty_score":0.0048102736},"labels":[],"label_agreement":null},{"id":"W2753127471","doi":"10.1158/1078-0432.ccr-16-3079","title":"Challenges and Opportunities in Adapting Clinical Trial Design for Immunotherapies","year":2017,"lang":"en","type":"editorial","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Clinical trial; Medicine; Immunotherapy; Cancer; Cancer immunotherapy; Pillar; Clinical study design; Biomarker; Oncology; Intensive care medicine; Internal medicine; Biology","score_opus":0.7863942232871721,"score_gpt":0.6191165422598202,"score_spread":0.16727768102735197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753127471","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002799185,0.07358148,0.024192894,0.39072582,0.50626576,0.00057310023,0.00014054206,0.00042624972,0.00381419],"genre_scores_gemma":[0.0043828823,0.043839652,0.023851905,0.21943201,0.7024919,0.000992298,0.00008672671,0.0003260169,0.0045966874],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.8389977,0.11069709,0.016619932,0.0054237163,0.026830798,0.0014307841],"domain_scores_gemma":[0.31097296,0.5967405,0.0098752985,0.013597319,0.05928596,0.009528039],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.27997747,0.0023917549,0.004471563,0.0032637662,0.0016175375,0.011240527,0.006999296,0.017967893,0.0073523005],"category_scores_gemma":[0.43138,0.0014528123,0.0045002615,0.0023367072,0.009298062,0.011308688,0.0034358273,0.04787794,0.0037879616],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044133695,0.00008092739,0.0001905066,0.003394755,0.00038986254,0.00022249253,0.0002814238,0.0012745522,0.00020228694,0.02734035,0.76456887,0.2016126],"study_design_scores_gemma":[0.00062164356,0.00029478307,0.00038796628,0.005092589,0.00031437815,0.00030158262,0.00014412524,0.002409728,0.00022445041,0.05013986,0.93996495,0.00010414071],"about_ca_topic_score_codex":0.000873972,"about_ca_topic_score_gemma":0.0020834098,"teacher_disagreement_score":0.27997747,"about_ca_system_score_codex":0.0064056567,"about_ca_system_score_gemma":0.0114859035,"threshold_uncertainty_score":0.88791597},"labels":[],"label_agreement":null},{"id":"W2753890414","doi":"10.1158/1078-0432.ccr-16-3065","title":"Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Clinical trial; Medicine; Surrogate endpoint; Oncology; Clinical endpoint; Milestone; Clinical study design; Drug development; Cancer; Internal medicine; Phases of clinical research; Biomarker; Pharmacology; Drug","score_opus":0.511372098794355,"score_gpt":0.6422053277657701,"score_spread":0.13083322897141514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753890414","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2947968,0.13586277,0.42279488,0.024121555,0.005307313,0.03178465,0.018174311,0.0014268407,0.065730825],"genre_scores_gemma":[0.81790143,0.008193358,0.13420744,0.0049177003,0.0016897755,0.025243375,0.005316179,0.00029111555,0.0022395987],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.7200614,0.24694319,0.018539658,0.0035590862,0.009936955,0.0009597266],"domain_scores_gemma":[0.75252956,0.17271422,0.043963846,0.018739542,0.00903304,0.0030198363],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.214657,0.0019493289,0.003077082,0.0030087293,0.0005908596,0.005545587,0.0013353105,0.0018421613,0.0026498316],"category_scores_gemma":[0.23683947,0.00035284975,0.0030732786,0.0038473306,0.002226979,0.004463472,0.0032363152,0.0041587492,0.00090826594],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03908412,0.0016987943,0.12346603,0.018901495,0.009671037,0.00020918385,0.0014148211,0.024137931,0.0057547567,0.05772683,0.019655576,0.6982795],"study_design_scores_gemma":[0.014473105,0.08165504,0.24007551,0.011247864,0.01387122,0.0022030557,0.0015921402,0.09352826,0.028614221,0.30120248,0.21067446,0.00086273765],"about_ca_topic_score_codex":0.00018022259,"about_ca_topic_score_gemma":0.00030347612,"teacher_disagreement_score":0.214657,"about_ca_system_score_codex":0.0015078742,"about_ca_system_score_gemma":0.0027935305,"threshold_uncertainty_score":0.9684677},"labels":[],"label_agreement":null},{"id":"W2754100498","doi":"10.1158/1078-0432.ccr-17-0901","title":"Targeting Prostate Cancer Subtype 1 by Forkhead Box M1 Pathway Inhibition","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"FOXM1; Prostate cancer; Enzalutamide; Cancer research; In vivo; Cancer; Cancer cell; Medicine; Biology; Androgen receptor; Internal medicine; Cell cycle","score_opus":0.13766782737854977,"score_gpt":0.4794562398448544,"score_spread":0.34178841246630465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754100498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.972368,0.013677119,0.0029809454,0.00052857975,0.00008103406,0.00023783071,0.0012901323,0.00048468076,0.008351563],"genre_scores_gemma":[0.9871546,0.0044543385,0.0022104464,0.000117697076,0.000017741306,0.000072375246,0.0011792185,0.000020203226,0.0047732326],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999943,0.0000049195864,0.0000025234758,0.00001144947,0.00001573319,0.000022387107],"domain_scores_gemma":[0.99997747,0.0000024486794,0.000006305566,0.0000026943594,0.000002617649,0.000008496216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011467316,0.00045910894,0.00030944802,0.00027141455,0.00015308637,0.0002771642,0.0002881116,0.00016766792,0.0016422262],"category_scores_gemma":[0.000050267867,0.000084959334,0.0002336216,0.00020105591,0.00021312314,0.00011804644,0.00015336016,0.0006912789,0.000399852],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001562306,0.0007970758,0.002600322,0.0005775868,0.000070496186,0.00021357957,0.00005078822,0.0014846104,0.92059845,0.000991503,0.002605955,0.06844734],"study_design_scores_gemma":[0.0005318071,0.004914616,0.022039255,0.00004016969,0.00012827519,0.0015953771,0.0000635759,0.0043820436,0.9304139,0.0003132122,0.035557598,0.000020088206],"about_ca_topic_score_codex":0.0026427761,"about_ca_topic_score_gemma":0.007797566,"teacher_disagreement_score":0.0026427761,"about_ca_system_score_codex":0.0008336449,"about_ca_system_score_gemma":0.0007563492,"threshold_uncertainty_score":0.00604856},"labels":[],"label_agreement":null},{"id":"W2755035474","doi":"10.1158/1078-0432.ccr-17-0811","title":"Antagonism of EG-VEGF Receptors as Targeted Therapy for Choriocarcinoma Progression <i>In Vitro</i> and <i>In Vivo</i>","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Choriocarcinoma; Trophoblast; Vascular endothelial growth factor; Receptor; Cancer research; Biology; Internal medicine; Endocrinology; Medicine; Placenta; Fetus; Pregnancy; VEGF receptors","score_opus":0.16042562393736792,"score_gpt":0.5321193465435675,"score_spread":0.3716937226061996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755035474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98694104,0.008125601,0.0015360134,0.00020007034,0.0000873461,0.00013997058,0.00025744186,0.00011212467,0.0026003085],"genre_scores_gemma":[0.99397063,0.002729449,0.0014444852,0.00012178799,0.00002160558,0.00013034494,0.00029014476,0.000014708581,0.0012769944],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998903,0.000029606515,0.00000856049,0.00001867028,0.000019006773,0.000033866145],"domain_scores_gemma":[0.9999455,0.000011388406,0.000015670294,0.000007063215,0.0000056670046,0.000014709945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020612607,0.00038892348,0.0003387063,0.00018416964,0.00010432956,0.00027236983,0.00021095204,0.00029064843,0.0010244821],"category_scores_gemma":[0.00011794788,0.00009450929,0.00027581427,0.00010702719,0.00022578784,0.00019439397,0.0001294432,0.0006860753,0.00021990725],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002541905,0.0004938278,0.00036565107,0.00023178202,0.00003565302,0.0001128149,0.000038309754,0.0002927921,0.98505026,0.00018367739,0.0004362159,0.010216998],"study_design_scores_gemma":[0.0006996474,0.013762502,0.005877581,0.000026395477,0.0001244129,0.0005481764,0.00006427171,0.0015459083,0.97044724,0.0000798782,0.006811805,0.000012218905],"about_ca_topic_score_codex":0.00061853713,"about_ca_topic_score_gemma":0.0010258358,"teacher_disagreement_score":0.0010244821,"about_ca_system_score_codex":0.00031242424,"about_ca_system_score_gemma":0.0002857772,"threshold_uncertainty_score":0.003427267},"labels":[],"label_agreement":null},{"id":"W2755675304","doi":"10.1158/1078-0432.ccr-17-0413","title":"TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer Subgroup","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"National Institute of General Medical Sciences; National Cancer Institute; Memorial Sloan-Kettering Cancer Center","keywords":"Prostate cancer; Medicine; Oncology; Metastasis; Internal medicine; Prostate; Cancer; EZH2; Cancer research; Biology; Gene expression; Gene","score_opus":0.22242729292081326,"score_gpt":0.5604947531443503,"score_spread":0.338067460223537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755675304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99517727,0.0014271822,0.0011298702,0.000117910015,0.000009954917,0.000025767462,0.0011438148,0.000061309904,0.0009069927],"genre_scores_gemma":[0.9980274,0.00026599012,0.00047944929,0.000041501007,0.000013298098,0.000008727062,0.0008528165,0.00000574274,0.00030500337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997707,0.00002544815,0.000014476292,0.00008827371,0.00006825246,0.000032813317],"domain_scores_gemma":[0.99975973,0.00004825953,0.00006028031,0.000026346623,0.000035519013,0.00006978448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002981568,0.00026548025,0.000470179,0.0004939815,0.00020579518,0.0005070255,0.00020633335,0.00022987441,0.0024272893],"category_scores_gemma":[0.000501961,0.0001319623,0.00029642784,0.00041645873,0.00016073912,0.00018812002,0.00031739712,0.00037495125,0.000263557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020510373,0.00010311891,0.72518086,0.00020108573,0.0005698643,0.0002909028,0.00007337205,0.0005924519,0.24142426,0.00009873195,0.0011903233,0.028223962],"study_design_scores_gemma":[0.000025791249,0.00031166564,0.971208,0.0000071689,0.0002681913,0.0010027519,0.000066516724,0.001221656,0.024184067,0.00010841654,0.0015889596,0.000006818169],"about_ca_topic_score_codex":0.0015588491,"about_ca_topic_score_gemma":0.004428605,"teacher_disagreement_score":0.0024272893,"about_ca_system_score_codex":0.00031432946,"about_ca_system_score_gemma":0.0003299696,"threshold_uncertainty_score":0.00812006},"labels":[],"label_agreement":null},{"id":"W2760759644","doi":"10.1158/1078-0432.ccr-17-0618","title":"Mutational Analysis of Gene Fusions Predicts Novel MHC Class I–Restricted T-Cell Epitopes and Immune Signatures in a Subset of Prostate Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Simon Fraser University; University of Victoria; BC Cancer Agency","funders":"National Institute of General Medical Sciences; National Institutes of Health","keywords":"Epitope; Prostate cancer; Biology; Major histocompatibility complex; Human leukocyte antigen; Fusion gene; MHC class I; CD8; Immune system; In silico; Gene; Cancer research; Cancer; Prostate; Antigen; Genetics; Immunology","score_opus":0.0985425850999792,"score_gpt":0.44648004340706077,"score_spread":0.34793745830708156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760759644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988305,0.000062353145,0.0008127976,0.0000075152916,7.747159e-7,0.0000039913944,0.00019157461,0.00001872663,0.00007163333],"genre_scores_gemma":[0.9987386,0.000022658392,0.0007481329,0.000005802493,0.0000012279866,0.0000036580336,0.00043376329,0.000004227148,0.00004199253],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998852,0.000014284053,0.000009408429,0.000041961313,0.00003216187,0.000016938777],"domain_scores_gemma":[0.9998191,0.00005912657,0.00006921007,0.000012680976,0.0000184142,0.00002152902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019663153,0.00021248056,0.00024216056,0.00052108394,0.00017400809,0.0002595633,0.00013811282,0.00020061262,0.00065646914],"category_scores_gemma":[0.00041507,0.00010268611,0.00040614718,0.00041839026,0.00014557065,0.00010522408,0.0001585145,0.00018368156,0.00013057691],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011735397,0.0001484568,0.4087257,0.00017024374,0.00022238046,0.00060439715,0.0000935851,0.02426766,0.54861397,0.0003022895,0.0002967391,0.015381089],"study_design_scores_gemma":[0.00005893415,0.0006329327,0.70468396,0.000016260568,0.00029455166,0.0029167095,0.00019273942,0.17895976,0.110368714,0.00067152805,0.0011708793,0.00003306994],"about_ca_topic_score_codex":0.0008330696,"about_ca_topic_score_gemma":0.0009369462,"teacher_disagreement_score":0.0008330696,"about_ca_system_score_codex":0.00025936414,"about_ca_system_score_gemma":0.00019588413,"threshold_uncertainty_score":0.0021960735},"labels":[],"label_agreement":null},{"id":"W2762066258","doi":"10.1158/1078-0432.ccr-16-2433","title":"Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Lesions","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Doxorubicin; Clinical endpoint; Radiofrequency ablation; Confidence interval; Internal medicine; Gemcitabine; Urology; Target lesion; Surrogate endpoint; Population; Progression-free survival; Gastroenterology; Oncology; Chemotherapy; Surgery; Ablation; Randomized controlled trial","score_opus":0.2560754220210897,"score_gpt":0.4613457821156232,"score_spread":0.20527036009453353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762066258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955546,0.0016202792,0.00051842205,0.00018873395,0.00012084353,0.0011656145,0.00030290926,0.00005090413,0.00047763786],"genre_scores_gemma":[0.99434584,0.001106137,0.00072148716,0.00039497024,0.00019432597,0.0016539121,0.0005212136,0.000015646781,0.0010463808],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99951863,0.00026840542,0.000024683704,0.00006946497,0.000041796346,0.00007702429],"domain_scores_gemma":[0.99933475,0.00019173494,0.00015370117,0.00008128283,0.000055309836,0.00018322331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016171049,0.0010174928,0.0021554108,0.00028378054,0.0002665175,0.00076985324,0.000542332,0.0009124494,0.002514087],"category_scores_gemma":[0.0010412451,0.00048391038,0.0016069057,0.0002978,0.00074127666,0.00061077945,0.0002788765,0.0020847297,0.0004804151],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90692663,0.027222656,0.0030234356,0.0006378478,0.0015820677,0.000069100424,0.00012974902,0.001427653,0.023228036,0.00010870835,0.0009290132,0.034715164],"study_design_scores_gemma":[0.526044,0.46342644,0.006175146,0.000021465617,0.00052192656,0.000047597492,0.000035749716,0.0006949053,0.0023050266,0.00006325278,0.0006470151,0.000017505097],"about_ca_topic_score_codex":0.00081311434,"about_ca_topic_score_gemma":0.0011805558,"teacher_disagreement_score":0.002514087,"about_ca_system_score_codex":0.00066773145,"about_ca_system_score_gemma":0.0010958904,"threshold_uncertainty_score":0.008552194},"labels":[],"label_agreement":null},{"id":"W2764050294","doi":"10.1158/1078-0432.ccr-17-1401","title":"Common <i>TDP1</i> Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer Consortium","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute","funders":"National Center for Advancing Translational Sciences; U.S. Department of Defense; National Heart, Lung, and Blood Institute; National Institute of Environmental Health Sciences; American Cancer Society; Canadian Cancer Society Research Institute; National Cancer Institute; National Institutes of Health","keywords":"Genotype; Lung cancer; Internal medicine; Single-nucleotide polymorphism; Minor allele frequency; Allele; Hazard ratio; Oncology; Biology; Medicine; Confidence interval; Gastroenterology; Immunology; Genetics; Gene","score_opus":0.09920181072574709,"score_gpt":0.45440136907321255,"score_spread":0.35519955834746547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2764050294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99917054,0.00022014652,0.00008531903,0.000028371827,0.0000050024737,0.000009780666,0.00033765752,0.0000022006907,0.00014105349],"genre_scores_gemma":[0.9992797,0.0000508241,0.00007002411,0.000029123154,0.000012452154,0.000014086382,0.00048158795,0.000002644411,0.000059475686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927455,0.00023382489,0.00008286551,0.00026262473,0.00008364248,0.000062460276],"domain_scores_gemma":[0.9982468,0.00029104666,0.0007947036,0.00021210514,0.00017963743,0.00027575012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011199099,0.0004901315,0.0005028064,0.0005431281,0.0006471657,0.0006815331,0.000413002,0.0005337206,0.0012073335],"category_scores_gemma":[0.001654258,0.0002481771,0.00078187627,0.0010527731,0.00029921526,0.00023803959,0.00041492085,0.0005037666,0.00017186183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008086337,0.000043406202,0.9965559,0.000016497115,0.00043977733,0.00008145574,0.000053672346,0.000045157823,0.0010766529,0.000011812331,0.00013059338,0.0007364533],"study_design_scores_gemma":[0.00008225071,0.00024154689,0.9982492,0.00000839395,0.0003733524,0.00031397387,0.00009244973,0.0001867851,0.00020801922,0.000023324825,0.00021475,0.000005893863],"about_ca_topic_score_codex":0.0025455798,"about_ca_topic_score_gemma":0.0024530466,"teacher_disagreement_score":0.0025455798,"about_ca_system_score_codex":0.00020104558,"about_ca_system_score_gemma":0.00020641972,"threshold_uncertainty_score":0.0059227347},"labels":[],"label_agreement":null},{"id":"W2765304775","doi":"10.1158/1078-0432.ccr-17-1621","title":"Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; BC Cancer Agency","funders":"Medical Research and Materiel Command; National Health and Medical Research Council; Canadian Institutes of Health Research; Cancer Institute NSW; Cancer Australia; National Breast Cancer Foundation","keywords":"Homologous recombination; Serous fluid; Ovarian cancer; Retinoblastoma; Biology; DNA repair; Homologous chromosome; Serous ovarian cancer; Cancer; Cancer research; Genetics; DNA; Gene; Biochemistry","score_opus":0.17617826697787467,"score_gpt":0.4742512406429381,"score_spread":0.29807297366506347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765304775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999772,0.000076135846,0.000052035284,0.000005218489,4.84206e-7,0.0000015425913,0.000034889923,0.0000020764505,0.00005565449],"genre_scores_gemma":[0.9998617,0.000018043142,0.000028329785,0.0000030736956,9.117153e-7,0.0000011365595,0.00006256305,5.6490285e-7,0.000023637218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987626,0.000030086843,0.000016234504,0.000025998837,0.000022885633,0.00002850288],"domain_scores_gemma":[0.9990559,0.00023097041,0.0004502176,0.00006700477,0.00004769313,0.0001483177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002288418,0.00008787812,0.00015458462,0.00044250145,0.00022954808,0.00022023144,0.00012752281,0.00019348584,0.0008985132],"category_scores_gemma":[0.0009915597,0.0000819444,0.000115929506,0.0003832028,0.00028687404,0.000117156495,0.00023525131,0.0001901613,0.000074628144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019299312,0.0000110345445,0.9947349,0.000008668748,0.0000146138245,0.00028483174,0.00004192571,0.000054727705,0.0032972298,0.000012760963,0.000025068695,0.0013213797],"study_design_scores_gemma":[0.0000040006544,0.000104590385,0.9964832,0.0000017867275,0.000011059379,0.0021793956,0.00009498284,0.00016617803,0.0007987857,0.000032992248,0.000121354045,0.0000016262103],"about_ca_topic_score_codex":0.00043835407,"about_ca_topic_score_gemma":0.00070542004,"teacher_disagreement_score":0.0008985132,"about_ca_system_score_codex":0.00013517542,"about_ca_system_score_gemma":0.00013631149,"threshold_uncertainty_score":0.0030058026},"labels":[],"label_agreement":null},{"id":"W2765485679","doi":"10.1158/1078-0432.ccr-17-2260","title":"A Phase I Open-Label Study to Identify a Dosing Regimen of the Pan-AKT Inhibitor AZD5363 for Evaluation in Solid Tumors and in <i>PIK3CA</i> -Mutated Breast and Gynecologic Cancers","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital","funders":"National Institute for Health and Care Research; Cancer Research UK; Astex Pharmaceuticals; Imperial Experimental Cancer Medicine Centre; AstraZeneca","keywords":"Medicine; Tolerability; Adverse effect; Common Terminology Criteria for Adverse Events; Pharmacodynamics; Pharmacokinetics; Dosing; Rash; Internal medicine; Nausea; Breast cancer; Oncology; Regimen; Phases of clinical research; Pharmacology; Toxicity; Cancer","score_opus":0.2654129356727883,"score_gpt":0.5986973071580772,"score_spread":0.33328437148528894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765485679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921347,0.0008855588,0.0009527221,0.00027885748,0.00009369506,0.0032239088,0.0010496537,0.00009620399,0.0012847835],"genre_scores_gemma":[0.9869245,0.00093721284,0.0035101485,0.0007476004,0.00012438542,0.003260496,0.0020681033,0.000033668963,0.002393832],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99967635,0.00011637305,0.000017453765,0.000078908975,0.000043815417,0.00006716553],"domain_scores_gemma":[0.9994566,0.00006555845,0.00013271935,0.000051708106,0.00004379776,0.00024959655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012197567,0.0010928869,0.0012878132,0.00040548333,0.00043427225,0.0008550081,0.0007680085,0.0010271716,0.0035993853],"category_scores_gemma":[0.0006821156,0.00046190803,0.0008086036,0.0003637546,0.0008433416,0.0008972039,0.00026081406,0.0028813523,0.000764849],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.55162704,0.15931839,0.008910593,0.000819513,0.00083951623,0.00026810143,0.0003201293,0.0034854207,0.1462597,0.00054504536,0.0056704273,0.121936165],"study_design_scores_gemma":[0.39588326,0.5815202,0.008607139,0.00003599508,0.0002533591,0.00024019032,0.00005079418,0.0018472678,0.008500257,0.00023392389,0.0027980113,0.00002964833],"about_ca_topic_score_codex":0.00081972504,"about_ca_topic_score_gemma":0.0025705488,"teacher_disagreement_score":0.0035993853,"about_ca_system_score_codex":0.0009356907,"about_ca_system_score_gemma":0.0018848098,"threshold_uncertainty_score":0.012041092},"labels":[],"label_agreement":null},{"id":"W2766484571","doi":"10.1158/1078-0432.ccr-17-2026","title":"The Future of Surveillance in the Context of Cancer Predisposition: Through the Murky Looking Glass","year":2017,"lang":"en","type":"editorial","venue":"Clinical Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Cancer; Context (archaeology); Medicine; Genetic predisposition; Disease; Etiology; Pathology; Internal medicine; Biology","score_opus":0.12615118626318184,"score_gpt":0.5348646910486844,"score_spread":0.40871350478550256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766484571","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010654991,0.053829577,0.00027646116,0.24893779,0.6956743,0.000011162709,0.000029100915,0.000051976138,0.0010829922],"genre_scores_gemma":[0.0012373073,0.024793696,0.00015972735,0.05480162,0.9168961,0.000012214452,0.000011160314,0.000019450517,0.002068759],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.994487,0.0021002376,0.00072428567,0.0006209508,0.001715686,0.00035193202],"domain_scores_gemma":[0.9490416,0.033945795,0.0014830774,0.00079777685,0.010905482,0.0038262592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012024158,0.0024425152,0.0029161286,0.0030117263,0.0026449289,0.0082170535,0.0031789925,0.013483681,0.0039589726],"category_scores_gemma":[0.039532796,0.0008815818,0.0018521625,0.001263099,0.0048161107,0.008507075,0.0019649486,0.037919372,0.0020480715],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044259497,0.000015781558,0.00008617256,0.0004057487,0.000025861753,0.00018127852,0.00011962574,0.000046978945,0.00004161687,0.0022789575,0.9820572,0.014696576],"study_design_scores_gemma":[0.00008110088,0.00007437362,0.00038025941,0.0019792367,0.00009821895,0.00062678003,0.0004401142,0.0002717699,0.00008337682,0.0056268065,0.9902879,0.000050128798],"about_ca_topic_score_codex":0.0021306116,"about_ca_topic_score_gemma":0.0039534145,"teacher_disagreement_score":0.013483681,"about_ca_system_score_codex":0.004103147,"about_ca_system_score_gemma":0.004217672,"threshold_uncertainty_score":0.063590646},"labels":[],"label_agreement":null},{"id":"W2767090199","doi":"10.1158/1078-0432.ccr-17-2228","title":"Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute Myeloid Leukemia and Its Underlying Mechanisms","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; National Institutes of Health; Canadian Cancer Society; Leukemia and Lymphoma Society","keywords":"Myeloid leukemia; Immunotherapy; Leukemia; Medicine; Immunology; Myeloid; Cancer research; Biology; Immune system","score_opus":0.42368212276545314,"score_gpt":0.5829602507286331,"score_spread":0.15927812796317997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767090199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977236,0.012455497,0.006912162,0.0002797197,0.00008664396,0.00011227242,0.00011692612,0.00005894562,0.0027418183],"genre_scores_gemma":[0.99484575,0.0025367024,0.0012783307,0.00009313598,0.000029160923,0.000041839827,0.00010766934,0.0000034420948,0.0010638735],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992,0.000022943235,0.000006127126,0.000019234873,0.000018050803,0.000013727732],"domain_scores_gemma":[0.99997544,0.000003904289,0.0000074333293,0.0000043108985,0.0000025279464,0.0000063987636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013787046,0.00028830173,0.00017440958,0.0001082548,0.000063552005,0.00026314624,0.00015010654,0.00019344561,0.00076473673],"category_scores_gemma":[0.00006230493,0.00005088842,0.000116158786,0.000071417104,0.00019248777,0.0001564019,0.00016299388,0.0003312218,0.00014962467],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008453648,0.0003189789,0.0020843614,0.00026982903,0.00002231982,0.00037503088,0.0000429474,0.000785901,0.95762527,0.0016183613,0.0003138764,0.03569775],"study_design_scores_gemma":[0.0005898294,0.010790437,0.012390125,0.00008471575,0.00018942766,0.008612816,0.00011184261,0.006363585,0.9216873,0.001606166,0.03755636,0.000017395569],"about_ca_topic_score_codex":0.000049287468,"about_ca_topic_score_gemma":0.000080190104,"teacher_disagreement_score":0.00076473673,"about_ca_system_score_codex":0.00012370088,"about_ca_system_score_gemma":0.00011252033,"threshold_uncertainty_score":0.002558291},"labels":[],"label_agreement":null},{"id":"W2769972801","doi":"10.1158/1078-0432.ccr-17-1590","title":"A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid Tumors","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Cancer Institute; Ovarian Cancer Research Fund","keywords":"Veliparib; Topotecan; Medicine; PARP inhibitor; Internal medicine; Neutropenia; Olaparib; Oncology; Febrile neutropenia; Gastroenterology; Clinical endpoint; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Surgery; Pharmacology; Clinical trial; Chemotherapy; Poly ADP ribose polymerase; Biology","score_opus":0.2537814787584608,"score_gpt":0.5781930088015869,"score_spread":0.32441153004312606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769972801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949704,0.0011007787,0.00037882203,0.0003208157,0.000111631656,0.0016274414,0.00038407746,0.00004782048,0.0010581786],"genre_scores_gemma":[0.99250937,0.0008141517,0.0013572929,0.00050461147,0.00024198207,0.0021606658,0.0011072321,0.0000149597445,0.0012898184],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993168,0.00036898965,0.000040466395,0.000094940406,0.000060371054,0.000118332515],"domain_scores_gemma":[0.99873835,0.00026541966,0.00024029006,0.00009731325,0.000059023696,0.00059958076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001959729,0.0018197135,0.0024617256,0.00043931958,0.00049083424,0.0010110553,0.0010422866,0.0011917759,0.0027654502],"category_scores_gemma":[0.0013052933,0.00085166586,0.0011282187,0.0005080742,0.0011763856,0.000769356,0.00039215075,0.004043372,0.0006466121],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8107709,0.08028834,0.0064736553,0.0006956036,0.0010798669,0.000431962,0.00026125467,0.0033968394,0.033662185,0.00028873008,0.002908157,0.05974248],"study_design_scores_gemma":[0.6254877,0.36430743,0.004792739,0.000022744533,0.00024188815,0.00021809831,0.00003272943,0.0013514899,0.0024829048,0.00010679732,0.00093809265,0.000017348171],"about_ca_topic_score_codex":0.00073281996,"about_ca_topic_score_gemma":0.0014191165,"teacher_disagreement_score":0.0027654502,"about_ca_system_score_codex":0.001107417,"about_ca_system_score_gemma":0.002153616,"threshold_uncertainty_score":0.010364175},"labels":[],"label_agreement":null},{"id":"W2770347143","doi":"10.1158/1078-0432.ccr-17-2484","title":"Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":318,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Royal College of Physicians and Surgeons of Canada; Conquer Cancer Foundation","keywords":"KRAS; Splenic flexure; Colorectal cancer; Medicine; Mutation; GNAS complex locus; Internal medicine; Cancer; Rectum; Oncology; Cancer research; Gastroenterology; Biology; Genetics; Gene; Colonoscopy","score_opus":0.1301473757666578,"score_gpt":0.4891342404451145,"score_spread":0.3589868646784567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770347143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993542,0.00014989566,0.00018970338,0.000026231235,0.0000025211914,0.0000033664312,0.00009306932,0.000003025851,0.00017800397],"genre_scores_gemma":[0.9995105,0.000034686906,0.00022007784,0.000016691836,0.0000048139927,0.0000024431797,0.00017488634,0.0000020538505,0.000033810884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904066,0.000281093,0.00012700193,0.00028092682,0.00017892422,0.00009143],"domain_scores_gemma":[0.9971765,0.0008881148,0.0009864912,0.00039501046,0.00026958907,0.00028424468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011340027,0.00021801723,0.00046636836,0.0006691499,0.00020499225,0.0004961728,0.00028398784,0.00027713669,0.0013094816],"category_scores_gemma":[0.0032816913,0.00013250108,0.0003264912,0.0005200625,0.0002802211,0.00039106753,0.0006092306,0.00028590366,0.00032395616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005861699,0.000017529597,0.99094546,0.00001873959,0.000051236977,0.00007035826,0.00005599877,0.00009351004,0.0022057274,0.000029626977,0.000070689835,0.005854936],"study_design_scores_gemma":[0.00002137769,0.00023534114,0.99689937,0.000014090254,0.000032510652,0.0008228039,0.00022350243,0.00086024223,0.0005304445,0.00022378568,0.00013098319,0.000005542083],"about_ca_topic_score_codex":0.0007524811,"about_ca_topic_score_gemma":0.0016777487,"teacher_disagreement_score":0.0013094816,"about_ca_system_score_codex":0.00016670585,"about_ca_system_score_gemma":0.00017639984,"threshold_uncertainty_score":0.0059973},"labels":[],"label_agreement":null},{"id":"W2771217224","doi":"10.1158/1078-0432.ccr-17-1941","title":"Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":195,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Canada's Michael Smith Genome Sciences Centre","funders":"National Cancer Institute; Infrastructure Canada; Canadian Institutes of Health Research","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Mutation; Cancer; Genetics; Biology; Gene","score_opus":0.12065816621638803,"score_gpt":0.49762456415821293,"score_spread":0.3769663979418249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771217224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99939525,0.00012050431,0.00015684622,0.0000126583745,0.0000011877722,0.0000032225719,0.00018608851,0.0000033150964,0.00012096718],"genre_scores_gemma":[0.99967813,0.000022637354,0.00008135816,0.0000038026285,0.0000015090021,0.0000014743696,0.00018625287,7.127111e-7,0.000024071658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999703,0.00009149699,0.000039838575,0.00007241426,0.00006673214,0.000026471733],"domain_scores_gemma":[0.997416,0.0006540542,0.0014220774,0.0001570889,0.00015346533,0.00019725098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009634147,0.00014789923,0.00020253612,0.00036284025,0.00012554984,0.00033442714,0.00017213819,0.0002104825,0.0005507736],"category_scores_gemma":[0.0027829225,0.000076308206,0.00019552979,0.0003566094,0.00018135842,0.00015671554,0.0002847831,0.00027670767,0.000085806016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029969553,0.000025353349,0.99711263,0.0000081140415,0.000039693914,0.000013928811,0.000010607846,0.00022142928,0.00069406,0.0000074002596,0.000026975453,0.0015401192],"study_design_scores_gemma":[0.00000875621,0.00018981419,0.99771845,0.00000229262,0.000026121379,0.00015610013,0.000016972364,0.0010282559,0.0007021183,0.0000413237,0.00010742241,0.0000022732847],"about_ca_topic_score_codex":0.000965789,"about_ca_topic_score_gemma":0.00096122664,"teacher_disagreement_score":0.000965789,"about_ca_system_score_codex":0.0002557342,"about_ca_system_score_gemma":0.00016480799,"threshold_uncertainty_score":0.0050951242},"labels":[],"label_agreement":null},{"id":"W2772855375","doi":"10.1158/1078-0432.ccr-17-0866","title":"CD271 Confers an Invasive and Metastatic Phenotype of Head and Neck Squamous Cell Carcinoma through the Upregulation of Slug","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Dental and Craniofacial Research; Ministère de l'Éducation, du Loisir et du Sport Québec","keywords":"Slug; Downregulation and upregulation; Head and neck squamous-cell carcinoma; Head and neck; Phenotype; Basal cell; Carcinoma; Pathology; Medicine; Cancer research; Head and neck cancer; Cancer; Biology; Internal medicine; Gene; Surgery","score_opus":0.3318697800946926,"score_gpt":0.5207519200272349,"score_spread":0.18888213993254233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772855375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99816847,0.00028713062,0.00044000108,0.000032924512,0.000006125932,0.000012952542,0.00022980181,0.00003076224,0.0007918788],"genre_scores_gemma":[0.9969668,0.00025070144,0.0004021624,0.00001511753,0.0000020911439,0.000018118351,0.00040200882,0.0000059103786,0.0019371015],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992764,0.000008034563,0.000005506765,0.000011166039,0.000026534684,0.000021110794],"domain_scores_gemma":[0.9999597,0.000004167376,0.000008753863,0.000005059558,0.0000050917088,0.000017225326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000064839245,0.00024113,0.000118349635,0.0001917424,0.0001599537,0.00018553171,0.00008912996,0.00009720722,0.001552229],"category_scores_gemma":[0.00004091221,0.000094192765,0.00017655852,0.000110628265,0.00017984939,0.000096371856,0.00013775508,0.0003427977,0.0003248834],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049180053,0.00002193425,0.0002314072,0.000017586684,0.0000020948926,0.000029769873,0.000008781053,0.000035283618,0.9992142,0.000047535297,0.000035182846,0.00030691957],"study_design_scores_gemma":[0.000008929913,0.00017307546,0.00793666,0.00000279644,0.000010187529,0.00015006472,0.000037478847,0.0007426324,0.9895555,0.000013527326,0.0013669812,0.0000022460986],"about_ca_topic_score_codex":0.0014071212,"about_ca_topic_score_gemma":0.0024962302,"teacher_disagreement_score":0.001552229,"about_ca_system_score_codex":0.00038683577,"about_ca_system_score_gemma":0.00029433152,"threshold_uncertainty_score":0.005192697},"labels":[],"label_agreement":null},{"id":"W2773306487","doi":"10.1158/1557-3265.aacrahns17-08","title":"Abstract 08: Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Princess Margaret Cancer Centre; McGill University","funders":"","keywords":"Cancer research; Methylation; Carcinogenesis; Histone H3; DNA methylation; Histone; Biology; Cancer; Chromatin; Gene; Genetics; Gene expression","score_opus":0.18787474886431765,"score_gpt":0.4845795257798759,"score_spread":0.29670477691555824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2773306487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944206,0.00028212066,0.0004446038,0.000099810204,0.000012378328,0.000019388159,0.002742966,0.00006505666,0.0019131887],"genre_scores_gemma":[0.9955473,0.00016075675,0.00028858142,0.000051768333,0.000011097644,0.000014473214,0.0023406942,0.000017693223,0.0015674564],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99985147,0.000008777231,0.000015120018,0.000046416328,0.000046294575,0.000031922376],"domain_scores_gemma":[0.9998336,0.00001809319,0.000042902757,0.000025732683,0.000030774707,0.00004889044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012871934,0.0001587317,0.00025591734,0.0008062138,0.00024981753,0.00039110126,0.00020656975,0.00025400086,0.0063894223],"category_scores_gemma":[0.00025256618,0.00010469054,0.00018514435,0.0005757819,0.00022420165,0.00012186068,0.00028097583,0.0002478439,0.0010124116],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001273748,0.000091944945,0.47614846,0.00011998035,0.00012739799,0.0016657028,0.00017386567,0.00021091616,0.49475393,0.00028020772,0.0030183648,0.022135563],"study_design_scores_gemma":[0.00001192879,0.00011982533,0.95234823,0.000008814245,0.000041697916,0.005080592,0.00014117487,0.00031447437,0.038448725,0.00016140922,0.0033151808,0.000007942559],"about_ca_topic_score_codex":0.0019949346,"about_ca_topic_score_gemma":0.002917676,"teacher_disagreement_score":0.0063894223,"about_ca_system_score_codex":0.00031040565,"about_ca_system_score_gemma":0.00024778344,"threshold_uncertainty_score":0.021374702},"labels":[],"label_agreement":null},{"id":"W2780727948","doi":"10.1158/1078-0432.ccr-17-2994","title":"Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":636,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Ontario Institute for Cancer Research; University of Toronto; University Health Network; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"Canadian Cancer Society Research Institute; National Cancer Institute; Canadian Friends of Tel Aviv University; Ontario Institute for Cancer Research; Division of Cancer Prevention, National Cancer Institute","keywords":"Pancreatic cancer; Transcriptome; Medicine; Clinical endpoint; Oncology; FOLFIRINOX; Biopsy; Cancer; Precision medicine; Internal medicine; Biology; Pathology; Gene; Clinical trial; Gene expression; Genetics","score_opus":0.4546718383273811,"score_gpt":0.6054100502091737,"score_spread":0.1507382118817926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2780727948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97199225,0.015848167,0.0011592307,0.0049063973,0.00027512774,0.00016048105,0.001202757,0.000068263726,0.004387283],"genre_scores_gemma":[0.9899143,0.0034347558,0.0012182116,0.0018848355,0.0004157567,0.00013533671,0.0014618239,0.000017433073,0.0015175159],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994106,0.00040997713,0.000013112976,0.00006185197,0.00006079904,0.000043663713],"domain_scores_gemma":[0.9993086,0.00022054177,0.00014211709,0.00006333952,0.00006840776,0.0001970757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016028747,0.0005074687,0.00051942666,0.00015002053,0.00012446559,0.00078806013,0.0001902598,0.00033023235,0.002665466],"category_scores_gemma":[0.0014131214,0.000068099085,0.0005169247,0.00029421845,0.00040356923,0.000307281,0.00035333014,0.00058750936,0.00023436142],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.51134616,0.003251251,0.08301807,0.0014519738,0.00599768,0.0004363353,0.00027863155,0.005519439,0.01896494,0.0032615385,0.01902146,0.3474525],"study_design_scores_gemma":[0.33269542,0.1566128,0.36203086,0.0012998043,0.009830845,0.0016246835,0.0007728941,0.00968835,0.024432613,0.0089676315,0.091823585,0.000220473],"about_ca_topic_score_codex":0.00062451256,"about_ca_topic_score_gemma":0.0011028317,"teacher_disagreement_score":0.002665466,"about_ca_system_score_codex":0.0007390298,"about_ca_system_score_gemma":0.0008075793,"threshold_uncertainty_score":0.008916855},"labels":[],"label_agreement":null},{"id":"W2786732655","doi":"10.1158/1078-0432.ccr-18-2521","title":"Circulating Tumor DNA in HER2-Amplified Breast Cancer: A Translational Research Substudy of the NeoALTTO Phase III Trial","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Genentech; Fonds De La Recherche Scientifique - FNRS; National Breast Cancer Foundation; Breast Cancer Research Foundation; Pfizer; GlaxoSmithKline","keywords":"Digital polymerase chain reaction; Medicine; Circulating tumor DNA; Internal medicine; Breast cancer; Oncology; Nat; Neoadjuvant therapy; Cancer; Odds ratio; Gastroenterology; Polymerase chain reaction; Biology; Genetics; Gene","score_opus":0.19049809849347235,"score_gpt":0.5213238206696866,"score_spread":0.3308257221762143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2786732655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911987,0.0030394797,0.0004464664,0.0005746175,0.00009284917,0.0006767072,0.0015570582,0.000036497033,0.0023775725],"genre_scores_gemma":[0.9882218,0.0014429662,0.001224929,0.0011420344,0.000254369,0.0018766185,0.00421182,0.000021022981,0.0016044911],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9991897,0.00055987027,0.000037230104,0.00009009276,0.00007743511,0.000045676043],"domain_scores_gemma":[0.99842864,0.00047475056,0.000497568,0.00022527372,0.00011896545,0.0002547248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030260477,0.0006143856,0.0009977996,0.0001726909,0.00023582847,0.0007511668,0.00046189193,0.00059545384,0.0016183539],"category_scores_gemma":[0.0020547817,0.00019047633,0.0006905402,0.00025517668,0.0005121981,0.00069159194,0.0003782688,0.0011007929,0.00043053678],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81244034,0.009678202,0.0648408,0.001743875,0.004105854,0.00017475209,0.00027682816,0.0017089641,0.02023291,0.000504598,0.0065425006,0.07775037],"study_design_scores_gemma":[0.5381988,0.20804569,0.21585399,0.00038835715,0.0058621895,0.000953478,0.000250888,0.0044921464,0.008239334,0.0015069676,0.016103469,0.00010471572],"about_ca_topic_score_codex":0.00025145995,"about_ca_topic_score_gemma":0.0010012725,"teacher_disagreement_score":0.0030260477,"about_ca_system_score_codex":0.0004406905,"about_ca_system_score_gemma":0.0005721162,"threshold_uncertainty_score":0.01600349},"labels":[],"label_agreement":null},{"id":"W2789460069","doi":"10.1158/1078-0432.ccr-17-3771","title":"Molecular Lymph Node Status for Prognostic Stratification of Prostate Cancer Patients Undergoing Radical Prostatectomy with Extended Pelvic Lymph Node Dissection","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Prostatectomy; Histopathology; Medicine; Prostate cancer; Lymph node; Dissection (medical); Biochemical recurrence; Urology; Lymph; Cancer; Internal medicine; Pathology; Surgery","score_opus":0.08283417945246835,"score_gpt":0.45806292069891635,"score_spread":0.375228741246448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789460069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981887,0.0011039245,0.00025104653,0.00005213672,0.000014420492,0.0000073859114,0.00016286752,0.000005710047,0.00021394592],"genre_scores_gemma":[0.99952865,0.00011011109,0.00013636966,0.000011689856,0.000009704771,0.000003306981,0.00014117539,7.4872787e-7,0.00005832622],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998766,0.000041390776,0.000012353392,0.000028271557,0.000024673524,0.000016672444],"domain_scores_gemma":[0.9995641,0.00013187803,0.00012757737,0.000021893813,0.00003680488,0.00011765437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004477582,0.00026996055,0.00025118823,0.0003701808,0.00013823721,0.00032067837,0.00023296296,0.0002354243,0.0012306559],"category_scores_gemma":[0.0011490164,0.00010368303,0.00024291649,0.0002595539,0.00015236028,0.00020015807,0.00022295333,0.00027580085,0.00016829965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005142238,0.000021298012,0.9935448,0.00002266952,0.000040810857,0.000051649225,0.000013510073,0.00016425709,0.0009916831,0.000009770675,0.00011573529,0.004509624],"study_design_scores_gemma":[0.000030561925,0.00024184464,0.99689615,0.000017441484,0.000098972116,0.00038040828,0.00003999491,0.0016030922,0.00036154312,0.000050237482,0.00027307202,0.000006640768],"about_ca_topic_score_codex":0.0008337442,"about_ca_topic_score_gemma":0.001982514,"teacher_disagreement_score":0.0012306559,"about_ca_system_score_codex":0.00019598819,"about_ca_system_score_gemma":0.00025888067,"threshold_uncertainty_score":0.0041169524},"labels":[],"label_agreement":null},{"id":"W2789664849","doi":"10.1158/1078-0432.ccr-17-3473","title":"Association of p27 and Cyclin D1 Expression and Benefit from Adjuvant Trastuzumab Treatment in HER2-Positive Early Breast Cancer: A TransHERA Study","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Institute for Health and Care Research","keywords":"Trastuzumab; Medicine; Tissue microarray; Hazard ratio; Internal medicine; Breast cancer; Cyclin D1; Oncology; Clinical endpoint; Proportional hazards model; Cancer; Clinical trial; Cell cycle; Confidence interval","score_opus":0.14554333420835522,"score_gpt":0.5289420088485274,"score_spread":0.3833986746401722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789664849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991953,0.00048816073,0.0000626795,0.000034436347,0.000004914202,0.000011856532,0.00007327409,0.0000019050076,0.00012756349],"genre_scores_gemma":[0.9991375,0.00018703673,0.00007194128,0.000045657238,0.000035754914,0.00001875067,0.0002226121,0.000002359498,0.0002783065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943846,0.00031984187,0.000028430359,0.00009952883,0.000065682485,0.00004804214],"domain_scores_gemma":[0.9985039,0.00052263547,0.00033217913,0.00025294317,0.00008707003,0.0003013162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019923286,0.0005723332,0.0009197622,0.00023369602,0.00016300804,0.00049456436,0.0003095696,0.000460447,0.0012477195],"category_scores_gemma":[0.0013729321,0.00027999628,0.0009188504,0.00023935025,0.0003246252,0.00024306848,0.00029685916,0.0007076754,0.00023022735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45697477,0.0046385727,0.45738572,0.00040825258,0.006387616,0.0006541872,0.00030658743,0.0008589167,0.040537566,0.0001512265,0.00068656966,0.031010112],"study_design_scores_gemma":[0.029752694,0.04808794,0.9050562,0.000040907045,0.0056432537,0.0014545568,0.00014084595,0.0023495313,0.00531758,0.00019918743,0.0019080997,0.00004930536],"about_ca_topic_score_codex":0.0004893554,"about_ca_topic_score_gemma":0.00074146915,"teacher_disagreement_score":0.0019923286,"about_ca_system_score_codex":0.00032539273,"about_ca_system_score_gemma":0.0002990416,"threshold_uncertainty_score":0.0105365515},"labels":[],"label_agreement":null},{"id":"W2790461643","doi":"10.1158/1078-0432.ccr-17-1199","title":"The Magnitude of Androgen Receptor Positivity in Breast Cancer Is Critical for Reliable Prediction of Disease Outcome","year":2018,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Centre for Advancing Health Outcomes; University of British Columbia","funders":"Cancer Institute NSW; National Breast Cancer Foundation; National Health and Medical Research Council; Susan G. Komen for the Cure","keywords":"Breast cancer; Androgen receptor; Oncology; Disease; Medicine; Outcome (game theory); Internal medicine; Magnitude (astronomy); Cancer; Androgen; Prostate cancer; Hormone; Mathematics; Physics; Astrophysics","score_opus":0.2428120515914355,"score_gpt":0.5623552974058443,"score_spread":0.31954324581440885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790461643","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97529626,0.015554199,0.004243948,0.0010417324,0.00013548032,0.0000637681,0.0005963867,0.000051850515,0.003016441],"genre_scores_gemma":[0.9962463,0.0016387043,0.0013872981,0.00010215437,0.00017861274,0.000025566836,0.00027552684,0.000007658859,0.00013820273],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99736696,0.0013000618,0.00035553306,0.00028608588,0.0005857731,0.000105591556],"domain_scores_gemma":[0.98423475,0.009303291,0.0038673538,0.00080069195,0.001424824,0.00036909766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008345697,0.00040321815,0.00064232846,0.00091501896,0.00023610047,0.001031168,0.0003876335,0.00049742206,0.0014776757],"category_scores_gemma":[0.016557254,0.0001765129,0.00048339408,0.0007251201,0.0006683,0.0005666059,0.000441181,0.0005666996,0.00055036263],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007393972,0.00008928006,0.95441604,0.0002425678,0.0002194042,0.00014504277,0.00007573979,0.00067131215,0.00364537,0.00010007564,0.0004529689,0.039202753],"study_design_scores_gemma":[0.000026300177,0.0005476798,0.9910669,0.00013137003,0.00028965273,0.00088974007,0.00011362646,0.0015228417,0.0033729319,0.00049533823,0.001525554,0.000017993634],"about_ca_topic_score_codex":0.00048530914,"about_ca_topic_score_gemma":0.00093129737,"teacher_disagreement_score":0.008345697,"about_ca_system_score_codex":0.00025121696,"about_ca_system_score_gemma":0.00055734674,"threshold_uncertainty_score":0.044136763},"labels":[],"label_agreement":null},{"id":"W2790799851","doi":"10.1158/1078-0432.ccr-17-2810","title":"Further Investigation of the Role of <i>ACYP2</i> and <i>WFS1</i> Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer Patients","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; Occupational Cancer Research Centre; Vancouver General Hospital; BC Children's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Ototoxicity; Pharmacogenomics; Testicular cancer; Cisplatin; Medicine; Oncology; Hearing loss; Internal medicine; Cancer; Pharmacology; Chemotherapy; Audiology","score_opus":0.1073215202032255,"score_gpt":0.43381164654845283,"score_spread":0.32649012634522734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790799851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982462,0.00042546153,0.0003115272,0.000108488035,0.0000069001326,0.000014735394,0.00048683182,0.0000060679254,0.0003937389],"genre_scores_gemma":[0.99900407,0.000117562326,0.00022792963,0.00006278242,0.000013647088,0.000009464022,0.0003952701,0.0000036699655,0.00016558576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999691,0.00009184025,0.00003246982,0.00007709292,0.00005723434,0.000050405764],"domain_scores_gemma":[0.9989298,0.0003095787,0.0004134155,0.0000936188,0.00010836662,0.00014514073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000507033,0.0003221839,0.0004143323,0.00037650668,0.00033084812,0.0004246455,0.00033177802,0.00027242434,0.003348289],"category_scores_gemma":[0.0016250389,0.000091847076,0.00066896115,0.0009446856,0.00021822874,0.00025358057,0.00023135288,0.00035822467,0.00025202063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074042927,0.00006302742,0.9841719,0.000058021353,0.0003477764,0.0004674568,0.000093995084,0.0002289595,0.006736538,0.00007980607,0.00033376916,0.006678335],"study_design_scores_gemma":[0.000052587788,0.0002904726,0.99556184,0.00001498176,0.0001834215,0.0008657248,0.0001083171,0.00061605696,0.0012691644,0.00012343131,0.00090662134,0.000007374136],"about_ca_topic_score_codex":0.004810006,"about_ca_topic_score_gemma":0.005675395,"teacher_disagreement_score":0.004810006,"about_ca_system_score_codex":0.00033228673,"about_ca_system_score_gemma":0.00044628474,"threshold_uncertainty_score":0.011201143},"labels":[],"label_agreement":null},{"id":"W2790809604","doi":"10.1158/1078-0432.ccr-18-0380","title":"Biomarker Discovery from We to Me: Is Learning from Each Patient a New Approach?","year":2018,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Cancer; Ovarian cancer; Biomarker discovery; Identification (biology); Mechanism (biology); Medicine; Biomarker; Computational biology; Immunotherapy; Internal medicine; Biology; Proteomics","score_opus":0.3369151465285287,"score_gpt":0.49592690996692385,"score_spread":0.15901176343839513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790809604","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005444689,0.011629751,0.0016300842,0.9764147,0.008401016,0.000018686913,0.000053858177,0.000067138586,0.0012403305],"genre_scores_gemma":[0.022138981,0.038004786,0.004939115,0.80607826,0.12415417,0.000108027096,0.00017075222,0.00009713083,0.0043087923],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9946802,0.0025453428,0.0005853954,0.00065052824,0.0012158395,0.00032261366],"domain_scores_gemma":[0.9737152,0.016931226,0.0009869114,0.0014958502,0.004641188,0.0022296626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009342808,0.0008997113,0.003165162,0.0012575998,0.0020650998,0.0043883533,0.0018164841,0.011652527,0.0056989403],"category_scores_gemma":[0.057249792,0.00071866333,0.0013277706,0.0007679343,0.004284235,0.009335754,0.0018251428,0.034404837,0.00690562],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022619849,0.0001128981,0.002694561,0.00037512308,0.000111217225,0.0024725536,0.00022706561,0.00034949614,0.0006197251,0.006577458,0.78478605,0.20144762],"study_design_scores_gemma":[0.00040999704,0.00046842778,0.002951877,0.0026645388,0.00026756345,0.01664995,0.0010341993,0.0038101198,0.0013910767,0.15757506,0.8125855,0.0001918294],"about_ca_topic_score_codex":0.0011418771,"about_ca_topic_score_gemma":0.0016711282,"teacher_disagreement_score":0.011652527,"about_ca_system_score_codex":0.0032450224,"about_ca_system_score_gemma":0.0021668277,"threshold_uncertainty_score":0.049410045},"labels":[],"label_agreement":null},{"id":"W2791308824","doi":"10.1158/1078-0432.ccr-17-3452","title":"Safety and Antitumor Activity of Pembrolizumab in Patients with Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":387,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Breast cancer; Internal medicine; Oncology; Adverse effect; Cancer; Response Evaluation Criteria in Solid Tumors; Estrogen receptor; Nausea; Gastroenterology; Phases of clinical research; Toxicity; Immunotherapy","score_opus":0.06109298004932549,"score_gpt":0.4370445413124408,"score_spread":0.3759515612631153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791308824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960961,0.0031151474,0.0001498792,0.000086183216,0.000013665846,0.00006697779,0.00010227084,0.000008133437,0.00036169493],"genre_scores_gemma":[0.9987317,0.0005521959,0.0001658149,0.00013264395,0.00002882415,0.000047674104,0.0001674696,0.0000019342792,0.00017180831],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999619,0.00019068683,0.000034977325,0.000060018523,0.00005748852,0.000037846024],"domain_scores_gemma":[0.99949646,0.00015187336,0.00019418972,0.000031776875,0.000041048865,0.00008455034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013560177,0.00032764487,0.0008186615,0.00019419388,0.00018501605,0.00042773114,0.00019935603,0.0003945352,0.00079528947],"category_scores_gemma":[0.0010977685,0.00017897761,0.00049185945,0.00019798777,0.00023863929,0.000400208,0.00013558993,0.0007945142,0.00019024003],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3380796,0.017109795,0.19967552,0.0017861924,0.0031990907,0.000816722,0.00045583883,0.0034945414,0.114614554,0.00022079873,0.0031180994,0.31742924],"study_design_scores_gemma":[0.11582845,0.43298438,0.4036038,0.0002274797,0.0028981916,0.003437915,0.00024828926,0.0063574747,0.023694526,0.00035724582,0.0103082815,0.000054031803],"about_ca_topic_score_codex":0.00021339582,"about_ca_topic_score_gemma":0.0004650876,"teacher_disagreement_score":0.0013560177,"about_ca_system_score_codex":0.0004166706,"about_ca_system_score_gemma":0.00038176202,"threshold_uncertainty_score":0.0071713924},"labels":[],"label_agreement":null},{"id":"W2791469985","doi":"10.1158/1078-0432.ccr-17-1715","title":"Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health; Structural Genomics Consortium; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Institute of Cancer Research; Canadian Institutes of Health Research; Government of Canada","keywords":"Prodrug; Colorectal cancer; Hypoxia (environmental); Tumor hypoxia; Medicine; Cancer research; In vivo; Cancer cell; Cancer; Radiation therapy; Chemoradiotherapy; Combination therapy; Pharmacology; Oncology; Internal medicine; Chemistry; Biology","score_opus":0.16995247305556574,"score_gpt":0.4820761485974125,"score_spread":0.3121236755418467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791469985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99736893,0.0007964053,0.0007345091,0.000049355254,0.00003623056,0.00006706639,0.00013795317,0.00006766572,0.00074184337],"genre_scores_gemma":[0.9973199,0.0003999259,0.0009806837,0.00001997009,0.000015032396,0.000048997863,0.00021034315,0.000009203959,0.0009960659],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990666,0.000015555677,0.0000068178815,0.00001916175,0.000020004994,0.00003175828],"domain_scores_gemma":[0.99989176,0.00001611816,0.000034185625,0.00001198274,0.000008249231,0.0000377473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015873335,0.00044198628,0.00048190623,0.00024248056,0.000100293946,0.00019039371,0.00021134663,0.0002953249,0.0009776303],"category_scores_gemma":[0.000093672264,0.00011651934,0.00017881148,0.00015093942,0.00018327673,0.00019684332,0.00009060356,0.0006960074,0.00015300333],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022795438,0.0010086694,0.00026055696,0.00007167874,0.000017258782,0.000037730206,0.000020218744,0.00033117938,0.99013317,0.00006826815,0.00013911289,0.005632625],"study_design_scores_gemma":[0.00034119742,0.019857245,0.004834944,0.000008084495,0.000054738775,0.0001961825,0.000017831413,0.0017343925,0.9715029,0.000021113745,0.0014252403,0.0000060099896],"about_ca_topic_score_codex":0.00079116353,"about_ca_topic_score_gemma":0.0015213615,"teacher_disagreement_score":0.0009776303,"about_ca_system_score_codex":0.00029605022,"about_ca_system_score_gemma":0.00027019228,"threshold_uncertainty_score":0.0032705069},"labels":[],"label_agreement":null},{"id":"W2792399344","doi":"10.1158/1078-0432.ccr-17-2776","title":"Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University and Génome Québec Innovation Centre","funders":"European Molecular Biology Organization","keywords":"Tamoxifen; Breast cancer; Pharmacology; Medicine; Cancer research; Drug resistance; Cancer; Internal medicine; Biology","score_opus":0.07550429526998252,"score_gpt":0.4344719173807309,"score_spread":0.35896762211074834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792399344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.959487,0.023160042,0.009987934,0.0010713817,0.00016065285,0.00011306358,0.0013769144,0.00031576326,0.0043270686],"genre_scores_gemma":[0.9839971,0.00798391,0.0044797035,0.00019606514,0.00003196298,0.000056886514,0.0010866569,0.000018892955,0.0021488522],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999417,0.000009810812,0.0000048022457,0.000013662907,0.000016019003,0.000014032647],"domain_scores_gemma":[0.99995923,0.0000062436616,0.00001433886,0.000005724093,0.000006279233,0.0000082022625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015944024,0.00026532033,0.00028294494,0.00021517088,0.00013137046,0.00036507176,0.00021948683,0.00021694684,0.0013566396],"category_scores_gemma":[0.00011857431,0.000116290015,0.0002884362,0.00015602773,0.0001966801,0.00017776462,0.00018943506,0.0004719808,0.00033803904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023468406,0.00004398927,0.0015626859,0.00015139284,0.000025926309,0.000067104615,0.00001173484,0.00024086978,0.987983,0.00026727814,0.00032005057,0.009091262],"study_design_scores_gemma":[0.00015847264,0.0010780189,0.025490135,0.000053285476,0.00019379031,0.00069204933,0.00009609202,0.0060625323,0.9409884,0.0004514586,0.02471736,0.00001827213],"about_ca_topic_score_codex":0.00033991225,"about_ca_topic_score_gemma":0.0006676316,"teacher_disagreement_score":0.0013566396,"about_ca_system_score_codex":0.0003544203,"about_ca_system_score_gemma":0.0002744552,"threshold_uncertainty_score":0.0045383573},"labels":[],"label_agreement":null},{"id":"W2792841925","doi":"10.1158/1078-0432.ccr-17-3089","title":"<i>DICER1</i> and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies","year":2018,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":373,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; National Institutes of Health","keywords":"Identification (biology); Environmental health; Medicine; Risk assessment; Computer security; Computer science; Biology","score_opus":0.3394422382492218,"score_gpt":0.5825319509312992,"score_spread":0.24308971268207735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792841925","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0736391,0.32444185,0.043781072,0.42485237,0.008716044,0.0022003052,0.004216868,0.0015153185,0.116637],"genre_scores_gemma":[0.37710395,0.3171434,0.16378865,0.09263255,0.010990458,0.003350911,0.009117786,0.0002949433,0.025577338],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981337,0.00074863876,0.00035358904,0.00015674999,0.00042308535,0.00018416703],"domain_scores_gemma":[0.99363285,0.001836951,0.00062246365,0.00017670055,0.0029559876,0.0007750395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042804927,0.00059210387,0.0007792948,0.0024507383,0.001128389,0.001208609,0.000976121,0.0024279763,0.0060218573],"category_scores_gemma":[0.01786533,0.00022777407,0.00088677224,0.0007853684,0.0004720377,0.0015800678,0.0011329838,0.0026829932,0.0016264112],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023178975,0.00030407083,0.072845034,0.002496394,0.00012227002,0.004492019,0.0010021748,0.0007100847,0.0012001579,0.00526868,0.32469168,0.5866357],"study_design_scores_gemma":[0.00032073693,0.0007143438,0.18665805,0.04922877,0.0008740129,0.03663112,0.008071915,0.005009465,0.0033482201,0.031361442,0.67743075,0.00035129374],"about_ca_topic_score_codex":0.00764497,"about_ca_topic_score_gemma":0.012994773,"teacher_disagreement_score":0.00764497,"about_ca_system_score_codex":0.0010862827,"about_ca_system_score_gemma":0.0031446335,"threshold_uncertainty_score":0.022637665},"labels":[],"label_agreement":null},{"id":"W2793003004","doi":"10.1158/1078-0432.ccr-17-2243","title":"A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University; Hospital for Sick Children","funders":"National Institute of Mental Health","keywords":"Medulloblastoma; DNA methylation; Biology; Cancer research; Microarray; Methylation; Computational biology; DNA microarray; Oncology; Bioinformatics; Medicine; DNA; Gene; Genetics; Gene expression","score_opus":0.31684663531270923,"score_gpt":0.5993657968865472,"score_spread":0.282519161573838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793003004","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12949598,0.00034974117,0.8633107,0.0002058718,0.00008061748,0.00031856276,0.0010939819,0.0038167774,0.001327797],"genre_scores_gemma":[0.4159998,0.00014435861,0.5793151,0.00010158339,0.000069426635,0.00039832867,0.0020280073,0.00014260427,0.0018008089],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990928,0.0001814628,0.000075274555,0.00026479698,0.00031273096,0.000072921255],"domain_scores_gemma":[0.9987607,0.000491259,0.00015504005,0.00010669382,0.00043292134,0.000053453783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012269515,0.0007812559,0.00064454967,0.0018207254,0.00036238375,0.00067458,0.00053092407,0.00048792057,0.0015429528],"category_scores_gemma":[0.0037807436,0.00022686721,0.0005513565,0.0007113649,0.00025862904,0.00043153975,0.0005952232,0.00069761317,0.0012452928],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008067659,0.00025070456,0.036252502,0.00023663677,0.00020161014,0.00016450106,0.0001383718,0.01911293,0.19291542,0.0014598949,0.005375055,0.7430856],"study_design_scores_gemma":[0.00008001895,0.0002478769,0.027167631,0.000036857175,0.00010508266,0.0005077002,0.000075967924,0.87368375,0.0884362,0.0022001236,0.0073836218,0.000075221695],"about_ca_topic_score_codex":0.0025214744,"about_ca_topic_score_gemma":0.0026974434,"teacher_disagreement_score":0.0025214744,"about_ca_system_score_codex":0.0004811367,"about_ca_system_score_gemma":0.00090825855,"threshold_uncertainty_score":0.0064888},"labels":[],"label_agreement":null},{"id":"W2793031031","doi":"10.1158/1078-0432.ccr-18-1740","title":"USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Human Genome Research Institute; National Cancer Institute; National Institutes of Health; Associazione Italiana per la Ricerca sul Cancro; York University; European Hematology Association; Northwestern University","keywords":"Demethylase; Deubiquitinating enzyme; Biology; Cancer research; Leukemia; Chromatin; Druggability; Cell growth; Transcription factor; Epigenetics; Gene; Ubiquitin; Genetics","score_opus":0.12625554376420625,"score_gpt":0.46814042109286663,"score_spread":0.34188487732866035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793031031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99566346,0.00092070585,0.0021218352,0.000057627974,0.0000113070355,0.000015470796,0.00024984538,0.00006810119,0.0008915863],"genre_scores_gemma":[0.99687815,0.0002747349,0.0014046947,0.000029862476,0.000003997693,0.000011315099,0.00047473036,0.000017665112,0.0009047975],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988854,0.000019103523,0.000012654795,0.000021963793,0.000035291774,0.000022426892],"domain_scores_gemma":[0.9998914,0.000019251042,0.000027835546,0.000016270771,0.000013521104,0.000031679512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001435458,0.00021874392,0.000186178,0.00019841696,0.00017724806,0.00029972263,0.00019934539,0.00020590294,0.0009870515],"category_scores_gemma":[0.000106821535,0.00012670188,0.00028497458,0.00013721353,0.00018246542,0.000120589604,0.00022067725,0.00029308128,0.0003831418],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007580475,0.000022844524,0.00042859782,0.000022514325,0.0000052199985,0.00005679155,0.0000057754664,0.00006445927,0.9982412,0.00014306957,0.000036343816,0.00089735084],"study_design_scores_gemma":[0.000014464208,0.00014029483,0.0035878795,0.0000029442654,0.000012093703,0.0002780536,0.000018983852,0.0023377892,0.99212885,0.00008770806,0.0013887091,0.0000023786563],"about_ca_topic_score_codex":0.00033951568,"about_ca_topic_score_gemma":0.0005171394,"teacher_disagreement_score":0.0009870515,"about_ca_system_score_codex":0.00038574077,"about_ca_system_score_gemma":0.00017692943,"threshold_uncertainty_score":0.0033020377},"labels":[],"label_agreement":null},{"id":"W2793442391","doi":"10.1158/1078-0432.ccr-17-2644","title":"Molecular Alterations and Buparlisib Efficacy in Patients with Squamous Cell Carcinoma of the Head and Neck: Biomarker Analysis from BERIL-1","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Biomarker; Oncology; Internal medicine; Paclitaxel; Head and neck squamous-cell carcinoma; Head and neck cancer; Carcinoma; Chemotherapy; Cancer; Biology","score_opus":0.09891533955088294,"score_gpt":0.45176606395237323,"score_spread":0.3528507244014903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793442391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99772376,0.0015092939,0.00007852806,0.00006439521,0.000008731399,0.00007615723,0.00018920649,0.000009952902,0.00034007384],"genre_scores_gemma":[0.9986902,0.000284696,0.00015557754,0.000112469315,0.00002000972,0.000068920155,0.0004546395,0.0000028208526,0.00021054901],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99968517,0.00013919522,0.00002606146,0.000058145513,0.000048637005,0.000042775755],"domain_scores_gemma":[0.9995666,0.00011578278,0.00016362329,0.000027714581,0.000032127133,0.000094102994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010358853,0.00039267444,0.0009293393,0.00026762337,0.00016396408,0.0005004458,0.00029105827,0.00035677294,0.0018765205],"category_scores_gemma":[0.0006125426,0.00020689065,0.0004668087,0.00022400015,0.00023293721,0.00032664064,0.00019021987,0.0006161891,0.00021970877],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5698068,0.0074180784,0.18721078,0.0011353297,0.0030133259,0.00026471232,0.00016000906,0.0023748698,0.108733326,0.00013229754,0.0014159898,0.11833445],"study_design_scores_gemma":[0.11818645,0.27768108,0.55783266,0.00010662306,0.0046215914,0.0012658151,0.00014792802,0.0044706007,0.031160781,0.00028182738,0.004163435,0.000081215876],"about_ca_topic_score_codex":0.00017741276,"about_ca_topic_score_gemma":0.00051979686,"teacher_disagreement_score":0.0018765205,"about_ca_system_score_codex":0.00047764598,"about_ca_system_score_gemma":0.00031823185,"threshold_uncertainty_score":0.006277621},"labels":[],"label_agreement":null},{"id":"W2793448070","doi":"10.1158/1078-0432.ccr-17-2651","title":"Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"Deutsche Krebshilfe; Else Kröner-Fresenius-Stiftung; Deutsche Forschungsgemeinschaft; Deutsches Krebsforschungszentrum","keywords":"Oncolytic virus; Medicine; Immunotherapy; In vivo; Cancer research; Antigen; Immunology; Cancer; Virotherapy; Immune system; Internal medicine; Biology","score_opus":0.13834220553939205,"score_gpt":0.5154351187130839,"score_spread":0.37709291317369187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793448070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969606,0.0005157519,0.0015772113,0.000046720266,0.000016759475,0.000034256005,0.00012167751,0.00006733611,0.0006595834],"genre_scores_gemma":[0.99725807,0.00040282775,0.0012364811,0.000015972613,0.0000062215545,0.000017673396,0.00021473248,0.000007284257,0.00084078225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998981,0.00001265179,0.000010337313,0.00001934979,0.000032811273,0.00002676063],"domain_scores_gemma":[0.99993896,0.000013794002,0.000017302611,0.000009630832,0.0000058039127,0.000014470087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000097378484,0.00037553362,0.00029369607,0.00016776069,0.00008813559,0.00031235843,0.00013416135,0.00030018244,0.000871572],"category_scores_gemma":[0.00009035868,0.00009319791,0.00017029585,0.00012508857,0.00019252264,0.00023532286,0.00022044865,0.00077550404,0.00020088902],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095832256,0.000094761854,0.00013185019,0.000030326062,0.000004122934,0.00001994996,0.000010931833,0.00013479567,0.9975401,0.000085619016,0.000033957265,0.0018177436],"study_design_scores_gemma":[0.000033082462,0.0016677751,0.0015059523,0.0000051437,0.00001912854,0.00015266151,0.000017140057,0.0012684456,0.994251,0.000036163692,0.0010408333,0.0000027172634],"about_ca_topic_score_codex":0.00016813862,"about_ca_topic_score_gemma":0.00021435016,"teacher_disagreement_score":0.000871572,"about_ca_system_score_codex":0.00020524472,"about_ca_system_score_gemma":0.00017483,"threshold_uncertainty_score":0.0029156804},"labels":[],"label_agreement":null},{"id":"W2795460644","doi":"10.1158/1078-0432.ccr-18-0101","title":"Cell-Free DNA Modification Dynamics in Abiraterone Acetate-Treated Prostate Cancer Patients","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre; Public Health Ontario; BC Cancer Agency; Centre for Addiction and Mental Health","funders":"Lietuvos Mokslo Taryba","keywords":"Prostate cancer; Abiraterone acetate; Internal medicine; Oncology; Medicine; Cancer; DNA methylation; Abiraterone; Cancer research; Biology; Genetics; Gene; Androgen deprivation therapy; Androgen receptor; Gene expression","score_opus":0.17158423012631732,"score_gpt":0.507320787629032,"score_spread":0.3357365575027147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795460644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99846905,0.000627815,0.00029111144,0.000020924053,0.000003911255,0.000006607767,0.0002686275,0.000014224102,0.00029772465],"genre_scores_gemma":[0.9992926,0.00008085789,0.00017463691,0.00002003409,0.0000030798722,0.000005625248,0.00021843481,0.0000024633857,0.00020217878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997155,0.000068940404,0.000019499348,0.000083415034,0.000081692495,0.000030890387],"domain_scores_gemma":[0.99962914,0.00009704937,0.00013323805,0.000039459377,0.00004580722,0.00005536012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019083281,0.00016975598,0.00025431733,0.0003594591,0.00020423236,0.000389939,0.00018402745,0.00022690487,0.0011602908],"category_scores_gemma":[0.0008935308,0.000118240096,0.000119492564,0.00053529587,0.00016065959,0.00013260143,0.00015148922,0.0002639123,0.00020965649],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003397416,0.00015331233,0.89068323,0.00007999411,0.00014952866,0.0003305017,0.00054338004,0.00078544766,0.07030648,0.000073284595,0.0003714632,0.033125892],"study_design_scores_gemma":[0.000041778927,0.000693285,0.97618127,0.000008385881,0.00007847217,0.0012029983,0.00015015398,0.0017098765,0.018614255,0.00011775036,0.0011851533,0.000016693657],"about_ca_topic_score_codex":0.0021144424,"about_ca_topic_score_gemma":0.002223478,"teacher_disagreement_score":0.0021144424,"about_ca_system_score_codex":0.00032458376,"about_ca_system_score_gemma":0.00021214936,"threshold_uncertainty_score":0.0042042136},"labels":[],"label_agreement":null},{"id":"W2800246113","doi":"10.1158/1557-3265.sarcomas17-a13","title":"Abstract A13: Genome-wide transcriptional analysis of HDAC inhibition-induced apoptosis in synovial sarcoma","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Synovial sarcoma; Cancer research; CDKN2A; Transcriptome; Apoptosis; Biology; Cell cycle; Sarcoma; Programmed cell death; Cell cycle checkpoint; Cancer; Medicine; Pathology; Gene expression; Genetics; Gene","score_opus":0.25348705596299875,"score_gpt":0.5041732476739577,"score_spread":0.2506861917109589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800246113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55041313,0.0038768705,0.008819514,0.0008342272,0.0002875258,0.0001853208,0.42934498,0.002004517,0.0042338916],"genre_scores_gemma":[0.5019881,0.002204715,0.012802209,0.00079778204,0.00017178644,0.000542083,0.47257057,0.00037129584,0.008551508],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996568,0.000034735713,0.000027726493,0.0001465093,0.0000894622,0.000044697263],"domain_scores_gemma":[0.9995048,0.00014600488,0.00011025715,0.000046328027,0.00011586398,0.00007684772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054095074,0.00042405006,0.00071138184,0.0008357606,0.000497009,0.0006467652,0.00034121634,0.00038535887,0.008832431],"category_scores_gemma":[0.000594627,0.00021510707,0.00079382135,0.0018802269,0.00014486528,0.000171627,0.00045458772,0.00049215066,0.0020998449],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005174724,0.000331199,0.19660188,0.0026899534,0.0013142357,0.0008811631,0.00036086,0.0034188027,0.6500262,0.00064846297,0.06944285,0.069109716],"study_design_scores_gemma":[0.00032265883,0.0010522343,0.8750013,0.00015512569,0.00071606494,0.0012515282,0.00034042276,0.004258149,0.06823778,0.00072652334,0.047856983,0.000081265585],"about_ca_topic_score_codex":0.0026815303,"about_ca_topic_score_gemma":0.0052942154,"teacher_disagreement_score":0.008832431,"about_ca_system_score_codex":0.0003090886,"about_ca_system_score_gemma":0.00061573886,"threshold_uncertainty_score":0.029547393},"labels":[],"label_agreement":null},{"id":"W2801249627","doi":"10.1158/1078-0432.ccr-17-3775","title":"ΔNp63γ/SRC/Slug Signaling Axis Promotes Epithelial-to-Mesenchymal Transition in Squamous Cancers","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Medical Research Council; Public Health Agency; Friends of the Cancer Centre; Queen's University Belfast; U.S. Department of Veterans Affairs","keywords":"Slug; Epithelial–mesenchymal transition; Head and neck squamous-cell carcinoma; Cancer research; Proto-oncogene tyrosine-protein kinase Src; Effector; Biology; Cancer; Signal transduction; Head and neck cancer; Cell biology; Metastasis; Genetics","score_opus":0.16786761900950808,"score_gpt":0.4941545636897182,"score_spread":0.32628694468021013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801249627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952649,0.0017897706,0.0005598901,0.00009152436,0.000012567143,0.000028125762,0.0007335319,0.00009618877,0.0014235566],"genre_scores_gemma":[0.99718815,0.000831003,0.00038896862,0.00003297962,0.000003689196,0.000014773471,0.00071517244,0.0000069335038,0.0008183228],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999083,0.00000869339,0.000007776564,0.000016467886,0.000036320525,0.00002245792],"domain_scores_gemma":[0.99994624,0.0000047723092,0.0000146063585,0.0000064705573,0.000011090312,0.00001677426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012530321,0.00023093172,0.00022305986,0.00040601884,0.00019505867,0.00040345828,0.00011740925,0.00015519102,0.0017400441],"category_scores_gemma":[0.000097257565,0.00012631621,0.0002393514,0.00023967406,0.00021160513,0.00012622435,0.00017682083,0.00040583021,0.00041999746],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004216073,0.00009735055,0.01005817,0.00012879743,0.000030756855,0.00024028248,0.00003289442,0.00027140309,0.97828853,0.0001296778,0.0004085495,0.009891945],"study_design_scores_gemma":[0.00006053339,0.00055195205,0.20748596,0.000023545652,0.00007733911,0.001341587,0.00017668353,0.0023396,0.7821914,0.00021929879,0.0055224136,0.000009707572],"about_ca_topic_score_codex":0.0013143546,"about_ca_topic_score_gemma":0.0023323481,"teacher_disagreement_score":0.0017400441,"about_ca_system_score_codex":0.00037673573,"about_ca_system_score_gemma":0.00040835948,"threshold_uncertainty_score":0.0058209896},"labels":[],"label_agreement":null},{"id":"W2801510798","doi":"10.1158/1078-0432.ccr-17-2386","title":"Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":309,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Merck","keywords":"Medicine; Pembrolizumab; Internal medicine; Logistic regression; Univariate analysis; Proportional hazards model; Oncology; Post-hoc analysis; Gastroenterology; Stage (stratigraphy); Multivariate analysis; Cancer; Immunotherapy","score_opus":0.12898013682164816,"score_gpt":0.4481364110601866,"score_spread":0.31915627423853843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801510798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99845314,0.0009487225,0.00008010485,0.000088553825,0.000013146946,0.000006237255,0.00016178108,0.0000038251874,0.00024453737],"genre_scores_gemma":[0.9995827,0.0001142524,0.000039655293,0.000024839326,0.00001963806,0.0000061586334,0.00013105337,8.761831e-7,0.000080731246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978846,0.000083290906,0.000021087333,0.000041779014,0.00004132678,0.000024075924],"domain_scores_gemma":[0.99901974,0.0002754307,0.00043432196,0.00005852023,0.00007068628,0.00014124946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005777276,0.00014508619,0.0003048187,0.00016802081,0.00010431445,0.0002486015,0.00017877208,0.00020358007,0.0013029396],"category_scores_gemma":[0.0015466742,0.000093154995,0.00028096323,0.00024010339,0.00014343989,0.00021608041,0.00015372867,0.00041389395,0.00014166116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007907773,0.00023815087,0.97226197,0.00007852589,0.00030358924,0.00011050389,0.000031668438,0.00026748842,0.004022623,0.000019833486,0.000502151,0.014255714],"study_design_scores_gemma":[0.00011947584,0.0009286783,0.9975454,0.00000932758,0.000105848616,0.00019498791,0.000022757979,0.0004930781,0.0002924601,0.000025747768,0.00025907313,0.0000031682605],"about_ca_topic_score_codex":0.00048883836,"about_ca_topic_score_gemma":0.00085987546,"teacher_disagreement_score":0.0013029396,"about_ca_system_score_codex":0.00019950075,"about_ca_system_score_gemma":0.00022653391,"threshold_uncertainty_score":0.004358709},"labels":[],"label_agreement":null},{"id":"W2803586475","doi":"10.1158/1078-0432.ccr-18-1089","title":"Ad5NULL-A20: A Tropism-Modified, αvβ6 Integrin-Selective Oncolytic Adenovirus for Epithelial Ovarian Cancer Therapies","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Tenovus; Cancer Research UK; Cancer Research Wales","keywords":"Oncolytic virus; Tropism; Virotherapy; Oncolytic adenovirus; Cancer research; Ex vivo; Biology; Genetic enhancement; In vivo; Adenoviridae; Transgene; Gene delivery; Integrin; Immunology; Immune system; Cell; Virus; Gene","score_opus":0.1777316418186462,"score_gpt":0.5172641653514678,"score_spread":0.3395325235328216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803586475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98611856,0.0013074871,0.0097479755,0.00008744259,0.000050659175,0.00012476908,0.00038710108,0.00012839322,0.0020475402],"genre_scores_gemma":[0.98956245,0.0006670369,0.006813974,0.000037159654,0.000007755006,0.000044373748,0.00048384897,0.000018360659,0.0023651195],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999056,0.000013606475,0.00001291835,0.000016657874,0.0000329356,0.000018427458],"domain_scores_gemma":[0.9999505,0.000004645057,0.000014077084,0.0000072818766,0.000007986122,0.00001548788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018871897,0.0004165437,0.00013342687,0.0001803701,0.00010621039,0.00023789848,0.0001957303,0.00023068611,0.0008029557],"category_scores_gemma":[0.00007972005,0.000116961266,0.00017985712,0.0001286451,0.0001727342,0.00018587522,0.00015020417,0.00031793953,0.000302937],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007748943,0.000028060314,0.00018853751,0.000025312575,0.0000032836303,0.000028996197,0.0000092235305,0.00010554836,0.9981243,0.0001759652,0.00004146548,0.0011917789],"study_design_scores_gemma":[0.000033395012,0.0005043596,0.0013084481,0.0000059157674,0.000016775502,0.00042945961,0.000013703313,0.0013892077,0.99073845,0.00005639326,0.00549955,0.000004252447],"about_ca_topic_score_codex":0.0005082396,"about_ca_topic_score_gemma":0.0005464439,"teacher_disagreement_score":0.0008029557,"about_ca_system_score_codex":0.00040799624,"about_ca_system_score_gemma":0.0002998458,"threshold_uncertainty_score":0.002960205},"labels":[],"label_agreement":null},{"id":"W2803839803","doi":"10.1158/1078-0432.ccr-17-3262","title":"Tumor Elastography and Its Association with Collagen and the Tumor Microenvironment","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ultrasound Imaging and Elastography","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Microsemi (Canada)","funders":"University of California, San Francisco; Zoetis","keywords":"Extracellular matrix; Tumor microenvironment; Stromal cell; Ex vivo; Stroma; Pathology; Elastography; Hyaluronic acid; Collagenase; Myofibroblast; In vivo; Chemistry; Biomedical engineering; Ultrasound; Medicine; Cancer; Fibrosis; Immunohistochemistry; Anatomy; Biology; In vitro; Internal medicine; Radiology; Biochemistry","score_opus":0.052591849489150876,"score_gpt":0.4077563775703006,"score_spread":0.35516452808114973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803839803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923361,0.0019742826,0.00502037,0.00004029839,0.0000050622034,0.000014062818,0.000073558855,0.000032804193,0.0005035224],"genre_scores_gemma":[0.9976228,0.00039319444,0.001548578,0.000016239832,0.000006000498,0.000010842974,0.00005942726,0.0000050859417,0.00033783994],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99986875,0.00004358315,0.000008791633,0.000023977947,0.000039956252,0.0000149691705],"domain_scores_gemma":[0.999265,0.00029304333,0.0002756405,0.000030123932,0.0000770705,0.00005915346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002819709,0.0001867099,0.00011538613,0.0003396617,0.00005422531,0.00021043232,0.00006168483,0.00014933519,0.00069895],"category_scores_gemma":[0.0006094191,0.00008780751,0.000059160287,0.00019575139,0.00017726801,0.00014755173,0.000084531435,0.00019922091,0.00013023271],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026696053,0.000027532118,0.013222767,0.00004377071,0.0000103307,0.000094263036,0.000023634222,0.00014927307,0.98276776,0.000027536478,0.000018704752,0.0033473708],"study_design_scores_gemma":[0.000010695172,0.0006445415,0.24669978,0.000011720432,0.000035806184,0.0018939261,0.00008058006,0.0052323975,0.7446059,0.00008427308,0.0006900102,0.000010366788],"about_ca_topic_score_codex":0.00034077352,"about_ca_topic_score_gemma":0.00035950745,"teacher_disagreement_score":0.00069895,"about_ca_system_score_codex":0.00013560482,"about_ca_system_score_gemma":0.00009784295,"threshold_uncertainty_score":0.0023382306},"labels":[],"label_agreement":null},{"id":"W2804058066","doi":"10.1158/1078-0432.ccr-17-2745","title":"Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aptose Biosciences (Canada)","funders":"National Cancer Institute","keywords":"Prostatectomy; Prostate cancer; Androgen deprivation therapy; Medicine; Oncology; Propensity score matching; Biochemical recurrence; Internal medicine; Metastasis; Proportional hazards model; Cancer; Urology","score_opus":0.1901585316872817,"score_gpt":0.4922202416215116,"score_spread":0.3020617099342299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804058066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980153,0.00011187391,0.0011822806,0.0000278541,0.0000042783972,0.00003374141,0.00044342608,0.000015345044,0.0001658457],"genre_scores_gemma":[0.99737203,0.000033196822,0.0012174846,0.000024723604,0.0000046692876,0.000028148266,0.0012256645,0.0000037847788,0.000090194786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994861,0.00017829779,0.00003555575,0.0001240329,0.00012473145,0.000051347557],"domain_scores_gemma":[0.99878615,0.00032139223,0.00037542035,0.00017751842,0.00021779818,0.00012183047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013057516,0.00029065923,0.0004496372,0.0005795258,0.00017188628,0.0005505004,0.00035876178,0.00029574105,0.0005432322],"category_scores_gemma":[0.0021849659,0.00014216156,0.00033472443,0.00041952974,0.00028765597,0.00016554887,0.00035604349,0.0003749793,0.00018185488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016060998,0.00034151107,0.93974704,0.00004713889,0.0002195521,0.000052112795,0.00005292982,0.0025611415,0.032969665,0.00005118884,0.00038001663,0.021971624],"study_design_scores_gemma":[0.00010296616,0.0012762009,0.9664627,0.000011688605,0.00015747476,0.0002911928,0.00009033878,0.016378384,0.0145734,0.00012729499,0.0005091377,0.000019361258],"about_ca_topic_score_codex":0.001146623,"about_ca_topic_score_gemma":0.0011541486,"teacher_disagreement_score":0.0013057516,"about_ca_system_score_codex":0.00032704975,"about_ca_system_score_gemma":0.00050875894,"threshold_uncertainty_score":0.0069056153},"labels":[],"label_agreement":null},{"id":"W2804378061","doi":"10.1158/1078-0432.ccr-18-0613","title":"Phase II Study of Taselisib (GDC-0032) in Combination with Fulvestrant in Patients with HER2-Negative, Hormone Receptor–Positive Advanced Breast Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Genentech","keywords":"Fulvestrant; Breast cancer; Cancer; Medicine; Internal medicine; Oncology; Hormone receptor; Phases of clinical research; Hormone; Metastatic breast cancer; Toxicity; Estrogen receptor","score_opus":0.06313931023451126,"score_gpt":0.4699763740301713,"score_spread":0.40683706379566004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804378061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960283,0.0012096723,0.00041006305,0.00020810228,0.00006205186,0.0009720027,0.00031751848,0.00006832491,0.00072390854],"genre_scores_gemma":[0.9945468,0.0009741827,0.0010771046,0.0003270782,0.000089700654,0.0010115664,0.00081906054,0.000017648188,0.0011369117],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998012,0.00009149081,0.000011120825,0.000035581685,0.000021199452,0.000039447583],"domain_scores_gemma":[0.99963176,0.000046593086,0.00007387937,0.000027276017,0.000021092013,0.00019937918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009370115,0.001205731,0.0015420662,0.00033112045,0.0002504218,0.0005556568,0.0006067551,0.00063262717,0.0026780218],"category_scores_gemma":[0.00052711024,0.00050288404,0.00082836126,0.00032020453,0.00057196274,0.00047103563,0.00024841525,0.0020817807,0.0007645145],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6466423,0.08181971,0.00981632,0.0010565954,0.0020630197,0.00038478195,0.00032239495,0.0040019173,0.11372878,0.00026905167,0.0037272477,0.13616781],"study_design_scores_gemma":[0.59362084,0.38713184,0.009905925,0.00002595883,0.0003987242,0.00030411078,0.000036131463,0.0015863624,0.0051891725,0.000094604104,0.0016852192,0.000021146709],"about_ca_topic_score_codex":0.00075183745,"about_ca_topic_score_gemma":0.0019166707,"teacher_disagreement_score":0.0026780218,"about_ca_system_score_codex":0.00061981793,"about_ca_system_score_gemma":0.0012241558,"threshold_uncertainty_score":0.0089588165},"labels":[],"label_agreement":null},{"id":"W2807016784","doi":"10.1158/1078-0432.ccr-18-0481","title":"Phase I Trials of Anti-ENPP3 Antibody–Drug Conjugates in Advanced Refractory Renal Cell Carcinomas","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency; London Health Sciences Centre; Alberta Cancer Foundation","funders":"National Cancer Institute","keywords":"Medicine; Pharmacokinetics; Toxicity; Refractory (planetary science); Renal cell carcinoma; Pharmacology; Internal medicine; Gastroenterology; Urology","score_opus":0.2753566075983032,"score_gpt":0.5755549612296069,"score_spread":0.3001983536313037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807016784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967811,0.0014170925,0.00041208937,0.00008258892,0.000036966358,0.0006302989,0.0001323392,0.00003610597,0.00047142355],"genre_scores_gemma":[0.99656314,0.0006219194,0.0008177732,0.00013704205,0.000059224807,0.0005487378,0.00040310965,0.0000141232185,0.0008348736],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995726,0.0002068803,0.000029956473,0.00006670116,0.00004987551,0.000073992946],"domain_scores_gemma":[0.99946946,0.00010803974,0.00012629824,0.0000577902,0.000058323996,0.00018001995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014003816,0.0009820177,0.0018190336,0.0002732646,0.0003631837,0.0005986945,0.0007346293,0.0008474673,0.00159346],"category_scores_gemma":[0.0007310824,0.00039984667,0.0006158451,0.00032402753,0.00056750607,0.00051162357,0.00021099126,0.0019774635,0.000370675],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36728862,0.075380266,0.008724768,0.0012471036,0.0014741964,0.0006374179,0.0006852911,0.0074472222,0.40681365,0.0004540769,0.0026983449,0.12714912],"study_design_scores_gemma":[0.20890798,0.715788,0.012392299,0.000035247216,0.00043957942,0.00060056394,0.000078335805,0.0027481457,0.054766484,0.00016984671,0.0040408787,0.000032651362],"about_ca_topic_score_codex":0.0009990466,"about_ca_topic_score_gemma":0.0020589936,"teacher_disagreement_score":0.0018190336,"about_ca_system_score_codex":0.0010581173,"about_ca_system_score_gemma":0.0012208843,"threshold_uncertainty_score":0.0076771975},"labels":[],"label_agreement":null},{"id":"W2807849948","doi":"10.1158/1078-0432.ccr-18-0415","title":"Pembrolizumab Exposure–Response Assessments Challenged by Association of Cancer Cachexia and Catabolic Clearance","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":212,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Lung cancer; Confidence interval; Oncology; Melanoma; Proportional hazards model; Cachexia; Cancer; Immunotherapy; Cancer research","score_opus":0.1687627955113297,"score_gpt":0.5617169475500441,"score_spread":0.3929541520387144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807849948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99867237,0.0005161661,0.0004239694,0.000022899818,0.0000020519522,0.000024656054,0.00012777318,0.0000070485867,0.00020304171],"genre_scores_gemma":[0.99960667,0.000039779043,0.00013305587,0.000017194676,0.0000030265835,0.0000121345265,0.00011112221,0.0000015010721,0.00007550421],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998855,0.00069654343,0.00008202607,0.0001609338,0.00015882256,0.000046631754],"domain_scores_gemma":[0.9968984,0.0012000932,0.0013173615,0.0002678443,0.00017865536,0.0001377191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003048252,0.00024253741,0.00040384155,0.00030436655,0.0001287353,0.00039666952,0.00017822678,0.00029321513,0.0010708449],"category_scores_gemma":[0.0035837914,0.0001690551,0.0005600824,0.0003036709,0.00018688374,0.00030634645,0.00025439254,0.00050112314,0.00014002647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023145583,0.00046851012,0.9279007,0.00021038236,0.001152774,0.00011247273,0.0001687086,0.0018252991,0.026761452,0.00005725785,0.0001811098,0.018015858],"study_design_scores_gemma":[0.00016078026,0.004282917,0.9879424,0.0000104658175,0.00027220167,0.00043080203,0.00004986472,0.0026329516,0.0036891259,0.000059646114,0.00045948554,0.000009395395],"about_ca_topic_score_codex":0.0004367853,"about_ca_topic_score_gemma":0.0004886029,"teacher_disagreement_score":0.003048252,"about_ca_system_score_codex":0.00029632304,"about_ca_system_score_gemma":0.00023443425,"threshold_uncertainty_score":0.01612091},"labels":[],"label_agreement":null},{"id":"W2807902048","doi":"10.1158/1078-0432.ccr-18-1475","title":"Unexpected Benefits of Aging for Favorable Responses to PD-1 Blockade in Melanoma?","year":2018,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North","funders":"","keywords":"Blockade; Immunosenescence; Melanoma; Immune checkpoint; Cancer; Medicine; Immune system; CD8; PD-L1; Immunotherapy; Cancer research; Oncology; Immunology; Internal medicine; Receptor","score_opus":0.30777271043350346,"score_gpt":0.5352811957631706,"score_spread":0.2275084853296671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807902048","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03846071,0.01629361,0.00055625266,0.92045164,0.011185476,0.00004031222,0.00023278326,0.00014459123,0.0126346825],"genre_scores_gemma":[0.37545392,0.014060142,0.0010215691,0.46353465,0.1349743,0.00015149772,0.00017208082,0.00007134943,0.010560449],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995271,0.00017441419,0.00004563999,0.000078072364,0.00008833168,0.00008654854],"domain_scores_gemma":[0.99797744,0.0012746326,0.00014782492,0.0001364155,0.00022746317,0.00023616162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012620342,0.00033882403,0.0007978327,0.00020905325,0.00056037685,0.00081507774,0.00038448538,0.0071897055,0.0038153855],"category_scores_gemma":[0.0052079572,0.00013565201,0.0004401871,0.00018936265,0.0009557556,0.0009789622,0.0002661412,0.006198545,0.0020512422],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036077823,0.0005157904,0.019895585,0.00052650296,0.000109389046,0.056280285,0.00026748597,0.0005930464,0.010918586,0.01775298,0.6720588,0.21747367],"study_design_scores_gemma":[0.0031069454,0.0025982289,0.05539112,0.00082906615,0.000255807,0.07759577,0.0007926984,0.0031900187,0.005688681,0.0627317,0.78768986,0.00013012085],"about_ca_topic_score_codex":0.00030742754,"about_ca_topic_score_gemma":0.00065809384,"teacher_disagreement_score":0.0071897055,"about_ca_system_score_codex":0.0009543925,"about_ca_system_score_gemma":0.0004758863,"threshold_uncertainty_score":0.012763739},"labels":[],"label_agreement":null},{"id":"W2808608845","doi":"10.1158/1078-0432.ccr-17-3384","title":"Dual MAPK Inhibition Is an Effective Therapeutic Strategy for a Subset of Class II BRAF Mutant Melanomas","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Nickel Institute; Montreal General Hospital; McGill University; McGill University Health Centre","funders":"Melanoma Research Alliance; Canadian Institutes of Health Research; V Foundation for Cancer Research; U.S. Department of Defense","keywords":"Mutant; Melanoma; Cancer research; Class (philosophy); MAPK/ERK pathway; Medicine; Biology; Genetics; Computer science; Gene; Kinase","score_opus":0.21338425190616878,"score_gpt":0.49637302213594536,"score_spread":0.2829887702297766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808608845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99393785,0.0015131347,0.0016214743,0.00015656471,0.000021586618,0.00006912977,0.00018396635,0.00007756002,0.002418695],"genre_scores_gemma":[0.996806,0.0004878618,0.0010468281,0.000059135888,0.000011199947,0.00003527463,0.00028030248,0.0000075603466,0.0012659298],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995446,0.0000052802015,0.0000032459382,0.000010201439,0.000011295593,0.00001556424],"domain_scores_gemma":[0.9999683,0.0000030554959,0.000007719211,0.0000036451356,0.0000036132385,0.000013662463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006817856,0.00035875954,0.00023668242,0.00012397827,0.00014741292,0.00027757327,0.00013845725,0.00016930288,0.0012557588],"category_scores_gemma":[0.000055257588,0.00007068718,0.00020519698,0.000069312526,0.000104877385,0.00011929413,0.00010619125,0.00046618414,0.00033689995],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046704127,0.0002247877,0.0030679365,0.00005454996,0.000013962172,0.00028143573,0.000013715434,0.000118000185,0.97987515,0.000091780305,0.00037841836,0.015413291],"study_design_scores_gemma":[0.00034632138,0.007690763,0.049829632,0.000024566143,0.00011313106,0.010634245,0.00008937702,0.0022521438,0.91131496,0.00018166503,0.01750968,0.000013459878],"about_ca_topic_score_codex":0.00021306078,"about_ca_topic_score_gemma":0.0005785195,"teacher_disagreement_score":0.0012557588,"about_ca_system_score_codex":0.00023141706,"about_ca_system_score_gemma":0.00013455788,"threshold_uncertainty_score":0.0042008758},"labels":[],"label_agreement":null},{"id":"W2808639537","doi":"10.1158/1557-3265.hemmal17-45","title":"Abstract 45: BTM-3528 potently induces G1/G0 cell cycle arrest and is efficacious in preclinical models of diffuse large B-cell lymphoma","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Paraza Pharma (Canada)","funders":"","keywords":"Cell growth; Cell cycle; Cancer research; Cell cycle checkpoint; Cell culture; Biology; Cell; Biochemistry","score_opus":0.18941580753380277,"score_gpt":0.48094813316957546,"score_spread":0.2915323256357727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808639537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98201984,0.0034150905,0.0023238787,0.0003736498,0.00013659448,0.00041082763,0.0027492126,0.00083700044,0.007733923],"genre_scores_gemma":[0.9847339,0.0019572296,0.0016184351,0.00014370664,0.000024633162,0.00022182598,0.0029835221,0.000054583965,0.008262187],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998555,0.000020199548,0.000008963512,0.00002172069,0.00004471655,0.000048863076],"domain_scores_gemma":[0.9999012,0.000009016668,0.000017799232,0.000009610714,0.000012955837,0.000049456503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018981875,0.0007057185,0.0004550992,0.0007379323,0.00020036563,0.00032185513,0.0003643816,0.00045665572,0.0039048716],"category_scores_gemma":[0.00010482958,0.00021349634,0.0003269528,0.0003285088,0.00028068744,0.0002583306,0.00018312581,0.0013259597,0.00088914466],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011590536,0.001468276,0.00016111597,0.00014794001,0.000028820052,0.00006155835,0.000028718729,0.0004852872,0.9885882,0.00021994533,0.0009096155,0.0067414786],"study_design_scores_gemma":[0.00084105285,0.020642381,0.0053640543,0.000031732317,0.000072444775,0.0003043188,0.000043121756,0.0013850348,0.9624304,0.00014436357,0.008725472,0.000015594744],"about_ca_topic_score_codex":0.001221154,"about_ca_topic_score_gemma":0.002028024,"teacher_disagreement_score":0.0039048716,"about_ca_system_score_codex":0.0004288363,"about_ca_system_score_gemma":0.00042536968,"threshold_uncertainty_score":0.013063133},"labels":[],"label_agreement":null},{"id":"W2809695328","doi":"10.1158/1078-0432.ccr-18-1552","title":"Two Weeks' Notice from Allogeneic Sources","year":2018,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"T-cell receptor; Human leukocyte antigen; Medicine; Notice; Cancer; Immunology; T cell; Antigen; Biology; Internal medicine; Immune system; Political science","score_opus":0.34897601776317844,"score_gpt":0.565567767512028,"score_spread":0.21659174974884954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809695328","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007832678,0.007474154,0.002822211,0.8467809,0.10061497,0.00014814598,0.00033683737,0.0005800825,0.033409998],"genre_scores_gemma":[0.066750646,0.0043768375,0.0015106593,0.7045979,0.08169313,0.00018191956,0.0003632537,0.00014929954,0.14037637],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991054,0.00026784552,0.00007075101,0.0001403099,0.0002686014,0.00014713524],"domain_scores_gemma":[0.99868625,0.000649678,0.00008223307,0.00013070142,0.00020671342,0.0002444373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091178186,0.00053307635,0.00036989243,0.00026116343,0.0010780329,0.0011481675,0.00057040405,0.0070532784,0.0138814105],"category_scores_gemma":[0.007483651,0.00018107229,0.00070605864,0.00013538981,0.0006310338,0.0010696785,0.0008361154,0.012948818,0.010937766],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032204305,0.00020443612,0.0013527339,0.0000864027,0.000037451944,0.028440021,0.00020889932,0.00015450791,0.0021197181,0.004362144,0.9112084,0.051503245],"study_design_scores_gemma":[0.00008078188,0.00030043494,0.0013001348,0.00008046157,0.000018670848,0.018648243,0.00017807497,0.00032420666,0.0008070357,0.0046227034,0.97361404,0.000025226553],"about_ca_topic_score_codex":0.0007606804,"about_ca_topic_score_gemma":0.0010769095,"teacher_disagreement_score":0.0138814105,"about_ca_system_score_codex":0.0010223677,"about_ca_system_score_gemma":0.00040106944,"threshold_uncertainty_score":0.04643798},"labels":[],"label_agreement":null},{"id":"W2810239069","doi":"10.1158/1078-0432.ccr-18-0784","title":"Consensus on Molecular Subtypes of High-Grade Serous Ovarian Carcinoma","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":161,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre","funders":"National Cancer Institute; American Association for Cancer Research","keywords":"Ovarian carcinoma; Serous fluid; Serous carcinoma; Medicine; Carcinoma; Oncology; Ovarian cancer; Pathology; Internal medicine; Cancer","score_opus":0.21726211750262264,"score_gpt":0.5089269287165084,"score_spread":0.2916648112138857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810239069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83648753,0.013924621,0.1308351,0.0014221824,0.00031326918,0.00068355986,0.01039801,0.00091542513,0.005020265],"genre_scores_gemma":[0.96011674,0.0007817198,0.029687582,0.00041211734,0.000090671354,0.00016763857,0.008243892,0.00011428904,0.0003854056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99091434,0.0027881719,0.0009780335,0.002381719,0.0026286829,0.00030904097],"domain_scores_gemma":[0.9724448,0.012728702,0.0041320776,0.0040398506,0.006146587,0.0005080269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015429369,0.00064823515,0.0018340609,0.0022847836,0.0007943878,0.0023021717,0.0018114867,0.0011306955,0.0010341652],"category_scores_gemma":[0.042441502,0.00038921688,0.0028031894,0.0016593799,0.00048413232,0.00090910704,0.0012169657,0.00146111,0.00040680415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027852103,0.00018987316,0.7539594,0.0025069416,0.01042771,0.00025103326,0.00045158286,0.030314201,0.009626164,0.0018997777,0.012736243,0.17485201],"study_design_scores_gemma":[0.0010048341,0.000988766,0.68682754,0.0017424576,0.014122278,0.0018013911,0.0010141004,0.22630696,0.027513325,0.019516004,0.018936222,0.00022606879],"about_ca_topic_score_codex":0.0039423686,"about_ca_topic_score_gemma":0.005503553,"teacher_disagreement_score":0.015429369,"about_ca_system_score_codex":0.0009677523,"about_ca_system_score_gemma":0.0020395915,"threshold_uncertainty_score":0.081599236},"labels":[],"label_agreement":null},{"id":"W2810785104","doi":"10.1158/1557-3265.tcm17-a09","title":"Abstract A09: Development of epigenetic-based strategies for blocking breast cancer growth, invasion, and metastasis in vitro and in vivo","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Metastasis; In vivo; Cancer research; Biology; Breast cancer; Cancer; Mammary tumor; Cell growth; Epigenetics; Gene; Genetics","score_opus":0.1484753244992321,"score_gpt":0.47218790880765593,"score_spread":0.32371258430842387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810785104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9374502,0.009544179,0.03876852,0.0006459664,0.00029192027,0.00055744813,0.0018779924,0.0008496949,0.0100141205],"genre_scores_gemma":[0.95835054,0.0056528444,0.023970822,0.0002755403,0.00005148244,0.00029274749,0.0017446184,0.00007255744,0.009588802],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989426,0.00001735376,0.00001064576,0.00002447333,0.000033769134,0.000019554202],"domain_scores_gemma":[0.9999187,0.000010019541,0.000026817723,0.000009369722,0.00001515028,0.000019923327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021054492,0.0003685654,0.00022463879,0.0002810862,0.00010434111,0.00021283966,0.00035409338,0.00033513887,0.002453783],"category_scores_gemma":[0.000103061335,0.0001264419,0.00029304298,0.00016071582,0.00013662183,0.00015816497,0.0001916607,0.000586499,0.00064580276],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070546834,0.000060068378,0.000058111316,0.000048752692,0.000006900617,0.000013590485,0.000004019217,0.00007453107,0.99548596,0.00011237789,0.000103391896,0.003961722],"study_design_scores_gemma":[0.000042747466,0.0014847443,0.0014421575,0.0000094147435,0.00003125685,0.00013401144,0.000008948835,0.0007038284,0.9900997,0.00005085972,0.005987045,0.0000052380155],"about_ca_topic_score_codex":0.00038940037,"about_ca_topic_score_gemma":0.0007014621,"teacher_disagreement_score":0.002453783,"about_ca_system_score_codex":0.00015539907,"about_ca_system_score_gemma":0.0002422116,"threshold_uncertainty_score":0.008208692},"labels":[],"label_agreement":null},{"id":"W2811276423","doi":"10.1158/1078-0432.ccr-17-3284","title":"Parallel Accumulation of Tumor Hyaluronan, Collagen, and Other Drivers of Tumor Progression","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Public Health Agency of Canada; National Foundation for Cancer Research; American Association for Cancer Research","keywords":"Tumor microenvironment; In vivo; Pancreatic cancer; Tumor hypoxia; Pathology; Cancer research; Malignancy; Pancreatic tumor; Hypoxia (environmental); Cancer; Tumor progression; Medicine; Chemistry; Biology; Radiation therapy; Internal medicine","score_opus":0.23243685116403362,"score_gpt":0.5415738840743519,"score_spread":0.3091370329103183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811276423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957497,0.00080462336,0.0025849266,0.000025303703,0.000004770699,0.000026162586,0.00026707834,0.00003776052,0.0004997152],"genre_scores_gemma":[0.9969958,0.00029591066,0.0017066527,0.000018360015,0.000004415262,0.000025236042,0.00023358196,0.000007046921,0.0007129591],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989843,0.000014440689,0.000008589025,0.000031107727,0.000029273857,0.000018145116],"domain_scores_gemma":[0.9998211,0.000023946435,0.0000730097,0.000014034997,0.000026099453,0.000041752333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015859371,0.00019082808,0.00014090822,0.00028078945,0.00008583237,0.00032055855,0.00008014424,0.000121845915,0.00053661666],"category_scores_gemma":[0.00010919253,0.00011469426,0.00012044205,0.00018708697,0.00013601143,0.00017800141,0.00017126427,0.00038009248,0.000097808064],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013866776,0.000012299402,0.0027869327,0.000017575458,0.0000053870135,0.000029108453,0.000008823978,0.000053067313,0.9958192,0.00003478683,0.000011364516,0.0010827141],"study_design_scores_gemma":[0.000011227134,0.00033473707,0.047676053,0.0000044328544,0.000025474623,0.00059276243,0.000035827397,0.001581803,0.94863355,0.000062136525,0.0010379358,0.0000041938574],"about_ca_topic_score_codex":0.00033200328,"about_ca_topic_score_gemma":0.0003908091,"teacher_disagreement_score":0.00053661666,"about_ca_system_score_codex":0.00026896785,"about_ca_system_score_gemma":0.00021575371,"threshold_uncertainty_score":0.0019515157},"labels":[],"label_agreement":null},{"id":"W2884100356","doi":"10.1158/1078-0432.ccr-18-1481","title":"Prognostic Significance of Tumor-Infiltrating B Cells and Plasma Cells in Human Cancer","year":2018,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":523,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Victoria","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute; Networks of Centres of Excellence of Canada; Michael Smith Health Research BC","keywords":"Cancer; Tumor cells; Cancer research; Medicine; Pathology; Human plasma; Cancer cell; Biology; Internal medicine; Chemistry","score_opus":0.3274036531060941,"score_gpt":0.5512920413785712,"score_spread":0.22388838827247715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884100356","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015373197,0.9829806,0.00016821777,0.00014297986,0.000067984074,0.000025735477,0.00076701737,0.000005189572,0.0004690725],"genre_scores_gemma":[0.4010349,0.5952277,0.0011130645,0.0004661263,0.00040567215,0.00011475544,0.0014078803,0.000008779147,0.00022112815],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99755824,0.0006763453,0.0010013139,0.00025745606,0.00044247526,0.00006410545],"domain_scores_gemma":[0.978622,0.014897339,0.004529253,0.00030716052,0.0014578496,0.00018648962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042621894,0.0003412996,0.0014159854,0.0069665364,0.00020503017,0.0010735512,0.0004459583,0.0005579854,0.002397504],"category_scores_gemma":[0.013597625,0.00019315128,0.0014282812,0.009416151,0.00038090427,0.00076605444,0.00043430104,0.00035127986,0.00024108494],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034148563,0.00004468667,0.26947135,0.35961175,0.0188902,0.0012661869,0.0004727784,0.00043488518,0.004766367,0.00050760095,0.00361175,0.33750758],"study_design_scores_gemma":[0.00076586736,0.001644284,0.6283437,0.17679808,0.0813831,0.012953474,0.001279474,0.00045265857,0.006387427,0.0021741537,0.08770082,0.00011697185],"about_ca_topic_score_codex":0.0007933711,"about_ca_topic_score_gemma":0.0011842569,"teacher_disagreement_score":0.0069665364,"about_ca_system_score_codex":0.00039956605,"about_ca_system_score_gemma":0.00070482434,"threshold_uncertainty_score":0.022540927},"labels":[],"label_agreement":null},{"id":"W2884214860","doi":"10.1158/1078-0432.ccr-18-0551","title":"Brain Development and Heart Function after Systemic Single-Agent Chemotherapy in a Mouse Model of Childhood Leukemia Treatment","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ted Rogers Centre for Heart Research; Ontario Institute for Cancer Research; University of Toronto; University of Waterloo; Hospital for Sick Children","funders":"Canadian Cancer Society Research Institute","keywords":"Vincristine; Medicine; Chemotherapy; Cardiotoxicity; Methotrexate; Doxorubicin; Chemotherapy regimen; In vivo; Childhood leukemia; Oncology; Internal medicine; Acute lymphocytic leukemia; Leukemia; Cyclophosphamide; Biology; Lymphoblastic Leukemia","score_opus":0.13574354777783376,"score_gpt":0.43165048476670753,"score_spread":0.29590693698887377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884214860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924259,0.0017804212,0.0030330962,0.00014320412,0.000032558313,0.00008371556,0.0008210016,0.00018155065,0.0014985974],"genre_scores_gemma":[0.98518074,0.0020398293,0.004887441,0.00011664349,0.000012756279,0.00024877916,0.0008788275,0.000056688008,0.006578185],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999795,0.00003303016,0.000017766579,0.000049695955,0.00006221986,0.00004234068],"domain_scores_gemma":[0.9997696,0.000021988173,0.000097189724,0.000024347511,0.000025632018,0.00006134469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028444527,0.00056965917,0.00036702788,0.00075701764,0.00018874057,0.0003461521,0.00035208414,0.00044383638,0.0013508005],"category_scores_gemma":[0.00009789923,0.00022487837,0.00030142625,0.00025384812,0.00043685755,0.00035144045,0.00019665385,0.0010185412,0.000292632],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005042245,0.00020845063,0.00068146986,0.000048826016,0.000010855769,0.00008706877,0.000037118494,0.00018705112,0.995204,0.000099284516,0.000099231045,0.00283251],"study_design_scores_gemma":[0.000100217316,0.0038867886,0.009681084,0.000023395934,0.000071521274,0.00039870883,0.00008254476,0.0015822098,0.98165613,0.00008683364,0.0024179176,0.000012640481],"about_ca_topic_score_codex":0.0010235811,"about_ca_topic_score_gemma":0.001849263,"teacher_disagreement_score":0.0013508005,"about_ca_system_score_codex":0.00055754656,"about_ca_system_score_gemma":0.0003421013,"threshold_uncertainty_score":0.0045188665},"labels":[],"label_agreement":null},{"id":"W2884876277","doi":"10.1158/1078-0432.ccr-18-0981","title":"Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":310,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Genentech; F. Hoffmann-La Roche","keywords":"PTEN; Prostate cancer; Medicine; Abiraterone; Blockade; Oncology; Cancer; Randomized controlled trial; Prostate; Internal medicine; Metastatic breast cancer; PI3K/AKT/mTOR pathway; Breast cancer; Androgen receptor; Biology; Receptor; Apoptosis","score_opus":0.18489000572405279,"score_gpt":0.5496204690412394,"score_spread":0.3647304633171866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884876277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97432476,0.0055089677,0.0016887699,0.0026780465,0.0011211653,0.0077257305,0.0028649217,0.00023078288,0.003856808],"genre_scores_gemma":[0.9766168,0.0031610709,0.0026445107,0.0030610054,0.0007875558,0.0066384757,0.0027114106,0.000059450755,0.0043197405],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992549,0.00042113545,0.000044672983,0.00012536785,0.000056508576,0.00009745638],"domain_scores_gemma":[0.99869365,0.00030442185,0.00027127686,0.00010922312,0.00009626872,0.0005251074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021543968,0.0017007184,0.002513135,0.0003481476,0.00044612758,0.0012193815,0.000999647,0.0018232516,0.0050751376],"category_scores_gemma":[0.0021472985,0.00085865223,0.0018063423,0.00059925765,0.0012109956,0.0011595368,0.00041096724,0.0046312697,0.0009804943],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9543137,0.014571041,0.0013658461,0.0003785612,0.0013627483,0.00008519387,0.00007848786,0.0004823092,0.0070900773,0.0001707608,0.0020103904,0.018090839],"study_design_scores_gemma":[0.90638506,0.09006647,0.001337447,0.000014812549,0.00040908938,0.000048967566,0.000017259159,0.00026986568,0.00042305558,0.00013152842,0.00088482804,0.00001168846],"about_ca_topic_score_codex":0.0009693649,"about_ca_topic_score_gemma":0.0028057804,"teacher_disagreement_score":0.0050751376,"about_ca_system_score_codex":0.0010118436,"about_ca_system_score_gemma":0.0018854089,"threshold_uncertainty_score":0.016977966},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2884963065","doi":"10.1158/1078-0432.ccr-18-1187","title":"Serum Sex Steroids as Prognostic Biomarkers in Patients Receiving Androgen Deprivation Therapy for Recurrent Prostate Cancer: A <i>Post Hoc</i> Analysis of the PR.7 Trial","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Queen's University; University of Toronto; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Prostate cancer; Medicine; Androgen deprivation therapy; Internal medicine; Oncology; Androstenediol; Testosterone (patch); Hormonal therapy; Cancer; Proportional hazards model; Biochemical recurrence; Androgen; Cohort; Dehydroepiandrosterone; Endocrinology; Prostatectomy; Hormone","score_opus":0.1535565012202698,"score_gpt":0.5071333865013424,"score_spread":0.3535768852810727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884963065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99680835,0.0009993606,0.00020176098,0.00015913446,0.00005840478,0.0003867943,0.00069731683,0.000013075178,0.000675729],"genre_scores_gemma":[0.9970192,0.00022079008,0.0003509246,0.00018122526,0.00013660608,0.00023717406,0.0012445641,0.000010014706,0.00059963507],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9974253,0.0015437797,0.00009541654,0.0003412191,0.00025656985,0.00033777935],"domain_scores_gemma":[0.99669147,0.0012027489,0.00075116096,0.00044832056,0.00036105202,0.00054527965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047456454,0.001145641,0.0015197324,0.00025002938,0.00044920068,0.0009836574,0.00090036896,0.0006423707,0.0015920367],"category_scores_gemma":[0.004228376,0.00037627094,0.0029146813,0.00037467037,0.00066260144,0.00045527637,0.00043082764,0.0013464624,0.00020326527],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.75476086,0.0021775505,0.21127278,0.0003072839,0.008545336,0.00013036333,0.00015843692,0.0006850539,0.0032508853,0.00013363527,0.0019229153,0.016654773],"study_design_scores_gemma":[0.14673504,0.11842173,0.7077761,0.000079331585,0.014927513,0.00030376064,0.00023359983,0.005071175,0.002341475,0.00025057181,0.0037522311,0.00010739419],"about_ca_topic_score_codex":0.013865956,"about_ca_topic_score_gemma":0.020566976,"teacher_disagreement_score":0.013865956,"about_ca_system_score_codex":0.0013179064,"about_ca_system_score_gemma":0.0030322068,"threshold_uncertainty_score":0.027570486},"labels":[],"label_agreement":null},{"id":"W2885095998","doi":"10.1158/1557-3265.ovca17-b46","title":"Abstract B46: DICER1 and FOXL2 mutations correlate with clinicopathologic features of ovarian Sertoli-Leydig cell tumors","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biology; Mutation; Pathology; Sexual differentiation; Cancer research; Internal medicine; Medicine; Genetics; Gene","score_opus":0.15577223194139478,"score_gpt":0.49851166330251695,"score_spread":0.34273943136112217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885095998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992581,0.00014789977,0.00010117631,0.0000152069215,0.0000028644006,0.0000032253424,0.00014401875,0.0000044346893,0.0003229972],"genre_scores_gemma":[0.9996239,0.000028772749,0.00007304119,0.0000062060617,0.0000045831775,0.000002852759,0.00013305043,0.0000018459666,0.00012582325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979323,0.00003429651,0.00003619036,0.000051518065,0.000045414785,0.000039312818],"domain_scores_gemma":[0.9987846,0.0003412728,0.00038628554,0.000069473295,0.00010659619,0.00031188846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003493553,0.00017781566,0.00021013439,0.0008460637,0.00027618505,0.00032081845,0.0001210315,0.00029535222,0.002997223],"category_scores_gemma":[0.0013624596,0.00014972471,0.00017716967,0.00045812398,0.0002641323,0.00030148975,0.00017301065,0.00020649847,0.00047877207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001894481,0.0000128765,0.992191,0.0000073696697,0.000011817426,0.0011157555,0.00003743277,0.00004874621,0.005247318,0.000014130866,0.00008088377,0.0010432448],"study_design_scores_gemma":[0.0000076212777,0.00010044064,0.98797125,0.0000030454905,0.000013659501,0.0100714,0.000068043446,0.00022514022,0.0012841832,0.000027031863,0.0002250874,0.000003166018],"about_ca_topic_score_codex":0.00059983396,"about_ca_topic_score_gemma":0.0006613476,"teacher_disagreement_score":0.002997223,"about_ca_system_score_codex":0.00014341719,"about_ca_system_score_gemma":0.00010012824,"threshold_uncertainty_score":0.010026693},"labels":[],"label_agreement":null},{"id":"W2885129203","doi":"10.1158/1557-3265.sarcomas17-b32","title":"Abstract B32: Lymphocytes and immune checkpoint biomarker expression in sarcomas","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Tumor-infiltrating lymphocytes; Sarcoma; Immune checkpoint; Cancer research; Tumor microenvironment; CD8; Immune system; Pathology; FOXP3; Liposarcoma; Immunotherapy; Medicine; Biology; Immunology","score_opus":0.2638934910241973,"score_gpt":0.5311568172637428,"score_spread":0.26726332623954546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885129203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99435544,0.0028406593,0.00077008567,0.000045015764,0.0000059135805,0.000014729439,0.0010840537,0.000024556546,0.000859483],"genre_scores_gemma":[0.9971066,0.0005390615,0.000638356,0.00003177781,0.000011795133,0.000022658936,0.0011073551,0.000005916577,0.0005364818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998042,0.000035351517,0.000028980696,0.000053863878,0.00004882964,0.000028759145],"domain_scores_gemma":[0.99964345,0.000074728225,0.00015343314,0.000020037072,0.00006134426,0.00004686601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004425263,0.0001798897,0.00031084396,0.00142138,0.00016225888,0.0004441915,0.00012216014,0.00021588539,0.0027950516],"category_scores_gemma":[0.0006026062,0.00011351503,0.00015917092,0.00095364527,0.00017517775,0.0002296606,0.00024876697,0.000259616,0.00070294034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011505471,0.00008652811,0.74078804,0.00036834626,0.00015681882,0.00025078474,0.0001112205,0.00060771866,0.2212413,0.00009257968,0.0005709832,0.03457523],"study_design_scores_gemma":[0.000026237545,0.00040650455,0.9660696,0.000055814842,0.00010718509,0.0022078315,0.00022520793,0.0009168915,0.025697513,0.0002866024,0.0039905603,0.0000100512],"about_ca_topic_score_codex":0.00046017033,"about_ca_topic_score_gemma":0.0005524539,"teacher_disagreement_score":0.0027950516,"about_ca_system_score_codex":0.00016007226,"about_ca_system_score_gemma":0.00014535399,"threshold_uncertainty_score":0.009350359},"labels":[],"label_agreement":null},{"id":"W2885351104","doi":"10.1158/1078-0432.ccr-18-0269","title":"Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"National Cancer Institute","keywords":"PI3K/AKT/mTOR pathway; Renal cell carcinoma; Chromosomal translocation; Cancer research; TFE3; Medicine; Targeted therapy; Pathology; Biology; Internal medicine; Cancer; Signal transduction; Cell biology; Genetics; Gene","score_opus":0.24536082572216666,"score_gpt":0.4940059777601674,"score_spread":0.24864515203800075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885351104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866528,0.0039696023,0.0056812414,0.00029899503,0.0000631807,0.000107631335,0.0009584128,0.0004080087,0.0018601755],"genre_scores_gemma":[0.99467623,0.00082624925,0.0029603573,0.00006419178,0.000008509062,0.00005637553,0.0006130892,0.00002395638,0.0007709643],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999876,0.000014954953,0.000008933307,0.000029595056,0.000039189545,0.000031280288],"domain_scores_gemma":[0.9999503,0.000007766314,0.000015816498,0.0000062615836,0.0000066006332,0.000013224332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002083663,0.0003162047,0.00039917487,0.00023412869,0.00017655513,0.00030155934,0.00019902822,0.00032252353,0.0017011466],"category_scores_gemma":[0.00012639958,0.00009397225,0.00035340406,0.00022289572,0.00023435672,0.00016352502,0.00017354464,0.000659586,0.00039754304],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050263875,0.00015560452,0.0009835742,0.00015033945,0.000028190918,0.00015240215,0.000021172518,0.0005714032,0.98915815,0.00021356909,0.00041598265,0.0076468578],"study_design_scores_gemma":[0.00023233856,0.0022947006,0.009767701,0.000018859228,0.00010351232,0.0016787525,0.00006943281,0.004624371,0.9708193,0.00022058295,0.010154556,0.000015846372],"about_ca_topic_score_codex":0.00047361202,"about_ca_topic_score_gemma":0.00091744546,"teacher_disagreement_score":0.0017011466,"about_ca_system_score_codex":0.00041694078,"about_ca_system_score_gemma":0.00038023543,"threshold_uncertainty_score":0.0056908727},"labels":[],"label_agreement":null},{"id":"W2885352041","doi":"10.1158/1557-3265.ovca17-a17","title":"Abstract A17: NUAK1 acts as a growth suppressor in epithelial ovarian cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Western University","funders":"","keywords":"AMPK; Cancer research; Cell biology; Cell growth; Biology; Viability assay; Kinase; Ovarian cancer; Protein kinase A; Chemistry; Cell; Cancer; Biochemistry","score_opus":0.11707324732153512,"score_gpt":0.48821201102926753,"score_spread":0.3711387637077324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885352041","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896616,0.0035903184,0.0018664887,0.00026616533,0.00014654898,0.000030137033,0.0028121683,0.00031150656,0.0013151502],"genre_scores_gemma":[0.9905771,0.0012223824,0.0016695171,0.0001254145,0.000015969134,0.000037289745,0.002976551,0.0000708298,0.0033050012],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998859,0.000012064794,0.000017699429,0.00003287135,0.00003250912,0.000018959401],"domain_scores_gemma":[0.99985707,0.000017629429,0.000054578773,0.000013302735,0.000012975803,0.000044440116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012002323,0.00037157367,0.0003130044,0.0004319907,0.0002510027,0.00032243866,0.00019328596,0.0002934657,0.002475345],"category_scores_gemma":[0.00013129995,0.00014468665,0.00029427963,0.00027352394,0.0001904117,0.00014187556,0.00023468296,0.0004666058,0.00092791487],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013566582,0.000019562101,0.00043732763,0.000052450592,0.000009922737,0.00012778446,0.0000064022943,0.000059025067,0.99785906,0.00004530104,0.00013568833,0.0011118727],"study_design_scores_gemma":[0.000036603407,0.00029484252,0.01527895,0.000012373502,0.000032321193,0.0011001411,0.00004907288,0.0012994875,0.974404,0.00007412816,0.0074104206,0.000007730729],"about_ca_topic_score_codex":0.00052429165,"about_ca_topic_score_gemma":0.0006364602,"teacher_disagreement_score":0.002475345,"about_ca_system_score_codex":0.00030724087,"about_ca_system_score_gemma":0.00023332442,"threshold_uncertainty_score":0.008280873},"labels":[],"label_agreement":null},{"id":"W2885529712","doi":"10.1158/1557-3265.ovca17-pr13","title":"Abstract PR13: TERT is frequently mutated in adult-type granulosa cell tumors of the ovary compared to other malignant sex cord-stromal tumors","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Telomerase; Biology; Telomerase reverse transcriptase; Carcinogenesis; Telomere; Somatic cell; Cancer research; Mutation; Granulosa cell; Molecular biology; Ovary; Cancer; Gene; Genetics","score_opus":0.1600306288318013,"score_gpt":0.46779032296318385,"score_spread":0.30775969413138254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885529712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99903935,0.00027484493,0.00021436956,0.000012354281,0.000004399068,0.00000548356,0.00012701485,0.000014750464,0.00030750013],"genre_scores_gemma":[0.99945825,0.00006421266,0.00022294045,0.00000812076,0.0000044581006,0.0000028581353,0.00012429159,0.0000056938898,0.00010927599],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996847,0.000036362093,0.00005201809,0.00008138251,0.00009111072,0.000054452863],"domain_scores_gemma":[0.99919575,0.00014975775,0.000393439,0.00006112085,0.000077033634,0.0001229151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022318622,0.00020407233,0.00025886882,0.0009988168,0.00019531662,0.00031178867,0.00018536992,0.00029279193,0.0018572854],"category_scores_gemma":[0.0009895383,0.00011498446,0.00019812337,0.0006496264,0.0002933541,0.00012341482,0.00023335601,0.00015624912,0.0002770186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012689373,0.000039278548,0.72090775,0.00012043951,0.000109955065,0.019445658,0.00023035801,0.000089689485,0.24791633,0.00010165553,0.00022524464,0.009544815],"study_design_scores_gemma":[0.000023009872,0.00015318228,0.8960756,0.000013146864,0.000081268576,0.07209998,0.0001845058,0.00048029397,0.029533658,0.000092367656,0.0012563186,0.0000068071045],"about_ca_topic_score_codex":0.0006827286,"about_ca_topic_score_gemma":0.0006166042,"teacher_disagreement_score":0.0018572854,"about_ca_system_score_codex":0.00015481857,"about_ca_system_score_gemma":0.000094415074,"threshold_uncertainty_score":0.006213248},"labels":[],"label_agreement":null},{"id":"W2885788384","doi":"10.1158/1078-0432.ccr-18-0554","title":"Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; Institute of Cancer Research; Government of Canada; Ontario Institute for Cancer Research; Garron Family Cancer Centre","keywords":"Phenotype; FOXP3; Melanoma; Ovarian cancer; Biology; Cancer research; Transcription factor; Immunology; Cancer; Immune tolerance; Immune system; Gene; Genetics","score_opus":0.10270236954902545,"score_gpt":0.40393007527106684,"score_spread":0.3012277057220414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885788384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99486685,0.0024458962,0.00089964084,0.000049991366,0.000018566032,0.000026963588,0.00013068423,0.000052549174,0.0015087638],"genre_scores_gemma":[0.997879,0.0007316174,0.0004499871,0.00006307947,0.000025444562,0.000025498197,0.00019271193,0.000010420243,0.00062219054],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988794,0.000016875938,0.000007894025,0.000028718987,0.000025462155,0.000033026205],"domain_scores_gemma":[0.9998965,0.000017820345,0.00004367153,0.000009272075,0.000014195063,0.000018535598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011553807,0.00018037904,0.00017348524,0.0004649517,0.00016555913,0.0002721375,0.00009133204,0.00020466415,0.0014269209],"category_scores_gemma":[0.00021757428,0.0000860827,0.00014632409,0.0002452079,0.00017128795,0.00012758655,0.00015042133,0.00025752178,0.00027705295],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045236383,0.00006645429,0.025499733,0.0001840082,0.000021172884,0.0008912238,0.00019673895,0.00011110441,0.9551458,0.00037183546,0.0002609621,0.016798584],"study_design_scores_gemma":[0.000352051,0.0024871703,0.6449163,0.00016621848,0.00029675764,0.025256747,0.001386836,0.0032998065,0.27688548,0.0024661398,0.042435434,0.00005101619],"about_ca_topic_score_codex":0.00019497126,"about_ca_topic_score_gemma":0.00025758686,"teacher_disagreement_score":0.0014269209,"about_ca_system_score_codex":0.00010113514,"about_ca_system_score_gemma":0.00012021463,"threshold_uncertainty_score":0.004773557},"labels":[],"label_agreement":null},{"id":"W2885806694","doi":"10.1158/1557-3265.ovca17-ia23","title":"Abstract IA23: How does the immune system contend with intratumoral heterogeneity in ovarian cancer?","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Immune system; Biology; Ovarian cancer; Antibody; Antigen; Immunology; Cancer research; Cancer; Genetics","score_opus":0.1845318137194227,"score_gpt":0.4851670211719057,"score_spread":0.30063520745248296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885806694","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9643302,0.024833001,0.0057427874,0.0019090704,0.00012993728,0.000033841163,0.0005113509,0.00009562791,0.0024142647],"genre_scores_gemma":[0.99645305,0.0016823484,0.00076053245,0.0002743301,0.000067468914,0.000022659162,0.00020196933,0.000022423512,0.00051520526],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996716,0.000082629915,0.000015960472,0.00008428857,0.00006806493,0.00007751961],"domain_scores_gemma":[0.9995091,0.00009647448,0.00014703533,0.000042519943,0.00008683817,0.000117990814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008054026,0.00020917588,0.00041842696,0.0006655269,0.00031615677,0.0015094265,0.00038992043,0.00044257843,0.0011841366],"category_scores_gemma":[0.00084384275,0.00015301604,0.00021871785,0.0004991481,0.000494091,0.00087029615,0.0005315821,0.0008464984,0.00033859105],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012097146,0.00013755391,0.1858883,0.0008864991,0.0002604829,0.0010434802,0.00056751526,0.00347048,0.71225524,0.0023732623,0.0043533035,0.08755422],"study_design_scores_gemma":[0.000058883415,0.0008503158,0.7780994,0.00037711975,0.00038429568,0.00398832,0.0036247491,0.02639727,0.1316634,0.0077805775,0.04666929,0.000106366344],"about_ca_topic_score_codex":0.00063612027,"about_ca_topic_score_gemma":0.0006669562,"teacher_disagreement_score":0.0015094265,"about_ca_system_score_codex":0.00069410633,"about_ca_system_score_gemma":0.0002634786,"threshold_uncertainty_score":0.0050361753},"labels":[],"label_agreement":null},{"id":"W2885953918","doi":"10.1158/1557-3265.sarcomas17-b06","title":"Abstract B06: Targeting PI3K/mTOR in mouse rhabdomyosarcoma models driven by FGFR4 activation","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"PI3K/AKT/mTOR pathway; Cancer research; Protein kinase B; Rhabdomyosarcoma; Biology; Oncogene; Cell culture; Cell; Cell cycle; Sarcoma; Signal transduction; Medicine; Cell biology; Pathology","score_opus":0.1384394694771033,"score_gpt":0.4746343058332434,"score_spread":0.3361948363561401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885953918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863602,0.0014877643,0.0030693978,0.00025865526,0.00009524692,0.00028506128,0.003981948,0.00034764866,0.004113961],"genre_scores_gemma":[0.9756883,0.0017901183,0.0073446096,0.00013542394,0.000017533275,0.0003228477,0.0047686,0.00006202182,0.009870466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997335,0.000036300877,0.000031392792,0.00004997878,0.00008325218,0.000065562046],"domain_scores_gemma":[0.99989307,0.0000111076215,0.000028240658,0.00001367005,0.000015996684,0.000037909114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002759045,0.0006875474,0.00040489293,0.000762218,0.00019560792,0.00032384656,0.00035828358,0.0005240391,0.0018401745],"category_scores_gemma":[0.00009262591,0.00025054626,0.0005198068,0.00033547226,0.00023843325,0.00020426273,0.00014702366,0.0010319902,0.0006380195],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004508967,0.0002795818,0.00015013466,0.000060917337,0.000013452998,0.000047260488,0.000012548006,0.00029858784,0.99628484,0.0001290277,0.00024874086,0.002023968],"study_design_scores_gemma":[0.000076634795,0.0028525982,0.0017524682,0.000009333393,0.00002428061,0.0001469382,0.000020299209,0.0008785649,0.99178773,0.000030098294,0.0024141108,0.000006983406],"about_ca_topic_score_codex":0.0016527646,"about_ca_topic_score_gemma":0.0034327165,"teacher_disagreement_score":0.0018401745,"about_ca_system_score_codex":0.0005093584,"about_ca_system_score_gemma":0.0004082283,"threshold_uncertainty_score":0.0061559677},"labels":[],"label_agreement":null},{"id":"W2886002467","doi":"10.1158/1557-3265.ovca17-b22","title":"Abstract B22: Capturing L1 retrotransposon-mediated DNA transductions in endometriosis associated ovarian cancers as a way to track tumor development","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Ovarian cancer; Cancer research; Biology; Frameshift mutation; Cancer; Retrotransposon; DNA damage; Endometriosis; Gene; DNA; Genome; Mutation; Genetics; Medicine; Pathology; Transposable element","score_opus":0.12378981065637598,"score_gpt":0.46363467851319345,"score_spread":0.33984486785681745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886002467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891495,0.0007254654,0.008883021,0.000029994937,0.000011323917,0.000049853326,0.00034590223,0.000102167796,0.0007027654],"genre_scores_gemma":[0.9869306,0.0003327858,0.011159144,0.000036412275,0.0000035642317,0.000035186393,0.00067351636,0.000028577599,0.00080022943],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998264,0.00003983783,0.000011780578,0.00004928284,0.00004636937,0.000026368138],"domain_scores_gemma":[0.99979776,0.000063368534,0.000057514928,0.00002431302,0.00003555178,0.000021531352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025901076,0.00022360602,0.00014548226,0.0004965244,0.0001059387,0.00024249351,0.00016457449,0.0002604123,0.00087363657],"category_scores_gemma":[0.00032138292,0.0001554056,0.00015506722,0.00029651745,0.00018845429,0.00012720087,0.00015268766,0.00023506499,0.00036153887],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004998407,0.000011332057,0.003149134,0.00002466945,0.0000036631134,0.00003192979,0.00002143824,0.00007634558,0.99490285,0.000018570598,0.00001489234,0.0016951155],"study_design_scores_gemma":[0.000008646218,0.00035583554,0.037784647,0.0000067440283,0.00002523059,0.0007493661,0.00007345165,0.0035241647,0.95613015,0.000045744466,0.0012888412,0.000007170523],"about_ca_topic_score_codex":0.00077577453,"about_ca_topic_score_gemma":0.00093957764,"teacher_disagreement_score":0.00087363657,"about_ca_system_score_codex":0.00014263164,"about_ca_system_score_gemma":0.0000871112,"threshold_uncertainty_score":0.0029225945},"labels":[],"label_agreement":null},{"id":"W2886023759","doi":"10.1158/1557-3265.ovca17-b12","title":"Abstract B12: Differences in neoplastic transformation potential between OSE and FTE","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Ovarian cancer; Cancer research; Cell culture; Immortalised cell line; Serous fluid; Biology; In vivo; Transfection; Fallopian tube; Cancer; BRCA mutation; Neoplastic transformation; Mutation; Pathology; Medicine; Carcinogenesis; Genetics; Gene","score_opus":0.2956874030233323,"score_gpt":0.5332519298147181,"score_spread":0.23756452679138584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886023759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953584,0.0004886101,0.0009840659,0.000032570235,0.000012130375,0.000029468505,0.0010357015,0.000047596575,0.002011514],"genre_scores_gemma":[0.99164575,0.00034168616,0.00091268594,0.00003274787,0.000006584383,0.00003632597,0.0031373715,0.000031763462,0.0038550068],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99978524,0.000019114597,0.00003204575,0.000053901447,0.000057116828,0.000052549083],"domain_scores_gemma":[0.9997284,0.00005762024,0.00004430766,0.0000363063,0.000044030367,0.00008932103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021951154,0.0002762161,0.00021156599,0.0008094786,0.00023073914,0.00047160458,0.00016216544,0.00028955177,0.005481427],"category_scores_gemma":[0.000256941,0.00014461891,0.00029449182,0.00032360735,0.00023009874,0.0002507984,0.00030354992,0.00047540886,0.0012820789],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054012245,0.00009884044,0.007719676,0.00004188905,0.000013776929,0.00023369184,0.00006809128,0.000034066765,0.9878967,0.00019754942,0.000113886774,0.0030417356],"study_design_scores_gemma":[0.00006886147,0.0015295743,0.17314559,0.000023188377,0.000083515864,0.0060517215,0.000399583,0.00093927584,0.80819863,0.00028801503,0.009250096,0.000021880654],"about_ca_topic_score_codex":0.0010626105,"about_ca_topic_score_gemma":0.00064988557,"teacher_disagreement_score":0.005481427,"about_ca_system_score_codex":0.00020462803,"about_ca_system_score_gemma":0.00013637857,"threshold_uncertainty_score":0.01833719},"labels":[],"label_agreement":null},{"id":"W2886034558","doi":"10.1158/1557-3265.ovca17-a12","title":"Abstract A12: The metabolic stress mediator LKB1 is required for ovarian cancer metastasis","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cancer research; Metastasis; Ovarian cancer; Biology; Cytotoxic T cell; Cancer; Cancer cell; Cell culture; Cell growth; Paclitaxel; In vitro; Biochemistry; Genetics","score_opus":0.18856077519838738,"score_gpt":0.5073003857449753,"score_spread":0.3187396105465879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886034558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97709334,0.0038488545,0.00560079,0.00076554774,0.00018110822,0.000054380052,0.006767907,0.0004985378,0.0051894216],"genre_scores_gemma":[0.9860058,0.0009231707,0.0018822339,0.00015672969,0.000018599785,0.000038735277,0.0044723945,0.00009255636,0.0064099208],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999083,0.000008232879,0.000011321063,0.000029432955,0.000024304813,0.000018333152],"domain_scores_gemma":[0.9998604,0.0000139376425,0.00004891022,0.0000112275175,0.000017444134,0.00004808228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006909567,0.00037954352,0.0002462345,0.00023062082,0.00040623292,0.00042194198,0.00019540808,0.00040304518,0.004920997],"category_scores_gemma":[0.00010924211,0.00017754831,0.00027694734,0.00019782227,0.0002291905,0.00021550513,0.00033330865,0.0006111495,0.0020924152],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001993057,0.000010823168,0.00047595997,0.00006456664,0.0000043112723,0.000121889374,0.000011231134,0.000041370044,0.99762934,0.00015674013,0.0002592947,0.0010252371],"study_design_scores_gemma":[0.00007497396,0.00021683163,0.028515976,0.00003463256,0.000041815423,0.0014731808,0.00011402395,0.0013132985,0.9475303,0.0002807977,0.020384857,0.000019237432],"about_ca_topic_score_codex":0.0012009814,"about_ca_topic_score_gemma":0.001145246,"teacher_disagreement_score":0.004920997,"about_ca_system_score_codex":0.00045627376,"about_ca_system_score_gemma":0.00029500324,"threshold_uncertainty_score":0.016462326},"labels":[],"label_agreement":null},{"id":"W2886216115","doi":"10.1158/1557-3265.sarcomas17-b10","title":"Abstract B10: Modulation of mRNA translation regulation in highly metastatic ssteosarcoma cells increases their sensitivity to redox stress","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Metastasis; Osteosarcoma; Cell culture; Cancer research; Tumor microenvironment; Oxidative stress; Nitrotyrosine; Cell; Medicine; Biology; Chemistry; Cancer; Internal medicine; Biochemistry; Nitric oxide","score_opus":0.1538964346618831,"score_gpt":0.45963426921157086,"score_spread":0.3057378345496877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886216115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953135,0.0009980398,0.0013656941,0.00011890152,0.000053274674,0.000028686352,0.0008905639,0.000058833302,0.0011724605],"genre_scores_gemma":[0.9926369,0.0007242708,0.0014823154,0.000075668075,0.0000150495625,0.000055737233,0.0017830312,0.000023534596,0.0032035022],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998838,0.000017519815,0.000015470077,0.000026223495,0.000030686362,0.000026313579],"domain_scores_gemma":[0.999905,0.00002041669,0.000020367177,0.000011357619,0.000015685342,0.00002711849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015920417,0.00021224041,0.00024586148,0.00014092783,0.00013958641,0.00023444879,0.000099152065,0.0001971914,0.0029872751],"category_scores_gemma":[0.000110156994,0.00009190831,0.00023436855,0.00016295984,0.00015342452,0.000098406716,0.00012148986,0.00041388642,0.00062789023],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010257677,0.000026691743,0.00015598323,0.000014736294,0.0000018349891,0.000015010985,0.0000062654335,0.00001724983,0.99916625,0.00001751157,0.00004444369,0.0004316309],"study_design_scores_gemma":[0.000024496867,0.000957239,0.012791426,0.0000066894627,0.000012519964,0.00015747233,0.000044959157,0.00072233385,0.9828333,0.000034228968,0.0024112505,0.0000040498294],"about_ca_topic_score_codex":0.0010956351,"about_ca_topic_score_gemma":0.0012434775,"teacher_disagreement_score":0.0029872751,"about_ca_system_score_codex":0.00019815133,"about_ca_system_score_gemma":0.0001974151,"threshold_uncertainty_score":0.009993374},"labels":[],"label_agreement":null},{"id":"W2886228434","doi":"10.1158/1078-0432.ccr-18-0717","title":"Targeting the CDK4/6-Rb Pathway Enhances Response to PI3K Inhibition in <i>PIK3CA</i> -Mutant Lung Squamous Cell Carcinoma","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"PI3K/AKT/mTOR pathway; In vivo; Cancer research; Medicine; Mutant; Lung cancer; Biology; Oncology; Signal transduction; Cell biology; Genetics; Gene","score_opus":0.09080625717076041,"score_gpt":0.46307274969746887,"score_spread":0.37226649252670846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886228434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99799347,0.00034681722,0.00036952473,0.00006676189,0.00001582827,0.00003623749,0.0001992089,0.000068725494,0.0009034128],"genre_scores_gemma":[0.9983902,0.00021087695,0.00040899022,0.000031451138,0.0000046107402,0.00002608055,0.00023957327,0.000008756676,0.00067947805],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989855,0.000013767188,0.000008832512,0.000015629663,0.000029377787,0.000033922635],"domain_scores_gemma":[0.9999254,0.000011807514,0.000013816354,0.000007646965,0.000007831077,0.000033471424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016151238,0.0003022726,0.00040834548,0.00024688544,0.00015063016,0.0003907372,0.00025115494,0.00021896845,0.0015463362],"category_scores_gemma":[0.00011535049,0.000115111055,0.00028623504,0.0001621792,0.00017522786,0.0002003943,0.00014258866,0.0008386995,0.00032599602],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015058924,0.0008655054,0.0014134392,0.00006334265,0.000028943352,0.000049795468,0.000015885671,0.0005669902,0.98833233,0.000050826144,0.00033140313,0.00677575],"study_design_scores_gemma":[0.00023340355,0.01073058,0.016762136,0.000008854079,0.00007362911,0.00032167663,0.000046236808,0.003809649,0.9664208,0.000039491377,0.0015437467,0.000009741131],"about_ca_topic_score_codex":0.0015314493,"about_ca_topic_score_gemma":0.0027275574,"teacher_disagreement_score":0.0015463362,"about_ca_system_score_codex":0.0005172803,"about_ca_system_score_gemma":0.00037532442,"threshold_uncertainty_score":0.005172968},"labels":[],"label_agreement":null},{"id":"W2886242456","doi":"10.1158/1557-3265.ovca17-pr06","title":"Abstract PR06: ARIEL3: A phase 3, randomized, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian cancer (OC)","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"","keywords":"Medicine; BRCA mutation; Internal medicine; PARP inhibitor; Clinical endpoint; Oncology; Placebo; Population; Cancer; Ovarian cancer; Clinical trial; Pathology; Biology; Genetics; Poly ADP ribose polymerase","score_opus":0.3540392569924878,"score_gpt":0.5998549478083863,"score_spread":0.24581569081589855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886242456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97551507,0.0044605737,0.0014490196,0.0008498204,0.0008250795,0.0104154395,0.0028311696,0.00056833535,0.0030854999],"genre_scores_gemma":[0.9740824,0.001968587,0.003189321,0.0018931736,0.0006662169,0.011397128,0.0017642549,0.00007157596,0.004967369],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991714,0.0004316339,0.00005319184,0.00015583906,0.0000611214,0.00012688006],"domain_scores_gemma":[0.9987478,0.00032842188,0.00026875123,0.00010250008,0.00008388166,0.00046861795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026060506,0.0020944222,0.0035310276,0.0005763914,0.00063879136,0.0012058119,0.0015090333,0.0025715297,0.009001961],"category_scores_gemma":[0.0017612409,0.0008360991,0.0019023744,0.0005445362,0.0014473489,0.001200826,0.00041995602,0.004999945,0.0020104311],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9750208,0.011595774,0.00017989163,0.00033738045,0.0003801482,0.000020523345,0.000024683693,0.00017100153,0.003067743,0.00006395573,0.00068258756,0.008455516],"study_design_scores_gemma":[0.91069794,0.08746122,0.00069301756,0.000013120596,0.00015744663,0.000016982469,0.000007318816,0.00028374846,0.00031076182,0.0000679488,0.0002808206,0.000009756371],"about_ca_topic_score_codex":0.0009131003,"about_ca_topic_score_gemma":0.0020876632,"teacher_disagreement_score":0.009001961,"about_ca_system_score_codex":0.0007824453,"about_ca_system_score_gemma":0.0017911232,"threshold_uncertainty_score":0.030114591},"labels":[],"label_agreement":null},{"id":"W2886291380","doi":"10.1158/1557-3265.hemmal17-39","title":"Abstract 39: XPO1 inhibitor, KPT-8602, is well tolerated and highly active against AML blasts and LICs","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Tolerability; Medicine; Internal medicine; Oncology; Pharmacology; Chemotherapy; Leukemia; Cancer research; Adverse effect","score_opus":0.08652697351121018,"score_gpt":0.4459001832331325,"score_spread":0.3593732097219223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886291380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98175436,0.004072253,0.002799267,0.00030730377,0.000080094214,0.0002713048,0.0028530462,0.0004678125,0.007394577],"genre_scores_gemma":[0.98318017,0.0014413587,0.0015427,0.00015679617,0.000032201388,0.00011758105,0.007320668,0.000031694377,0.006176882],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998324,0.000024653451,0.000020569656,0.000023383638,0.00006157485,0.000037277576],"domain_scores_gemma":[0.99991035,0.000009505874,0.000016945907,0.000011060372,0.000013026191,0.000039137034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018858229,0.00041344968,0.00048859755,0.00018398865,0.0001675642,0.0003044156,0.00029804627,0.00033227308,0.0037336869],"category_scores_gemma":[0.00013262003,0.00013984341,0.00017828897,0.00022493348,0.0001503221,0.00019341205,0.00016124247,0.000938154,0.0012039796],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020977769,0.0012591939,0.0011408853,0.00015756194,0.00003954096,0.00030487953,0.00004250083,0.00063113857,0.96718407,0.00024124904,0.0024655182,0.024435729],"study_design_scores_gemma":[0.001806343,0.021267245,0.028114388,0.000018875915,0.00012582737,0.004118741,0.00003478573,0.0031284117,0.91136765,0.00011460395,0.029880073,0.00002312324],"about_ca_topic_score_codex":0.0006004002,"about_ca_topic_score_gemma":0.0007458218,"teacher_disagreement_score":0.0037336869,"about_ca_system_score_codex":0.00022594503,"about_ca_system_score_gemma":0.0003320682,"threshold_uncertainty_score":0.012490451},"labels":[],"label_agreement":null},{"id":"W2886737665","doi":"10.1158/1557-3265.hemmal17-pr07","title":"Abstract PR07: MicroRNA-130a regulates hematopoietic stem cell self-renewal and erythroid differentiation","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Stem cell; Biology; Haematopoiesis; Cell biology; Hematopoietic stem cell; microRNA; Cancer research; Bone marrow; Myeloid; Immunology; Genetics; Gene","score_opus":0.07848085978517919,"score_gpt":0.4226937424081225,"score_spread":0.34421288262294336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886737665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9646735,0.0027778326,0.019776208,0.00029845748,0.00018560195,0.00019019443,0.0026086017,0.0008285831,0.008661009],"genre_scores_gemma":[0.9761731,0.0006957328,0.011090659,0.00019084451,0.000023334007,0.00009546918,0.0025622435,0.00013666555,0.009031965],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99971443,0.00002937207,0.00002698558,0.000084832995,0.00010340281,0.00004099533],"domain_scores_gemma":[0.99989855,0.000011259889,0.00003285704,0.000008926652,0.000017721037,0.000030622094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017876051,0.0003563705,0.00029064092,0.0002762859,0.00018023187,0.00035763998,0.00027208717,0.0002541879,0.0025722573],"category_scores_gemma":[0.00013474944,0.00017495007,0.00034006053,0.00016330673,0.0002598587,0.00018845519,0.00030318578,0.0007224989,0.0013127589],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008437056,0.000018432293,0.00015486128,0.000023874596,0.0000031294978,0.000027992095,0.0000051739594,0.000032964792,0.9978612,0.00014457693,0.000115427494,0.001527996],"study_design_scores_gemma":[0.000031922755,0.00040891694,0.0035085296,0.0000069116063,0.000021720363,0.00041687494,0.000019984143,0.0019559453,0.98707294,0.00010606017,0.006443319,0.000006892952],"about_ca_topic_score_codex":0.00045147995,"about_ca_topic_score_gemma":0.00054520025,"teacher_disagreement_score":0.0025722573,"about_ca_system_score_codex":0.00030388057,"about_ca_system_score_gemma":0.00037305587,"threshold_uncertainty_score":0.008605123},"labels":[],"label_agreement":null},{"id":"W2886785709","doi":"10.1158/1557-3265.ovca17-ia19","title":"Abstract IA19: Granulosa cell and other rare ovarian cancers: Genomic-derived diagnostics and emergent management strategies","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Ovarian cancer; Pathognomonic; Cancer; Medicine; Cancer research; Granulosa cell; Ovary; Oncology; Internal medicine; Biology; Disease","score_opus":0.1702701235940406,"score_gpt":0.4768807712659098,"score_spread":0.3066106476718692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886785709","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008268799,0.27507022,0.011643198,0.58099765,0.033669837,0.00027068245,0.0017777584,0.0010895834,0.0872122],"genre_scores_gemma":[0.18547648,0.42578152,0.024830319,0.18053547,0.09723502,0.00029835408,0.005144895,0.0005063499,0.080191605],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990392,0.00029074537,0.00009730144,0.00012271701,0.00033420257,0.00011593034],"domain_scores_gemma":[0.9961119,0.0011229055,0.00055801537,0.00021652589,0.0012417583,0.00074892066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024640698,0.0005210489,0.0006727919,0.0016649948,0.000834813,0.0024412782,0.0010547232,0.0020944523,0.015537797],"category_scores_gemma":[0.007197733,0.00022987726,0.00045727365,0.0010646685,0.0012141954,0.0016451512,0.0014331193,0.003215162,0.0041939435],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016343693,0.000060287053,0.0040808376,0.00073741894,0.000049035007,0.0037592875,0.00012032214,0.00034452463,0.0023191317,0.014737013,0.6241137,0.34951496],"study_design_scores_gemma":[0.00009946921,0.00017012608,0.0062972624,0.0020922245,0.000085038824,0.017021898,0.00041200817,0.00047991503,0.0024429434,0.021518385,0.9493303,0.000050382107],"about_ca_topic_score_codex":0.0025385935,"about_ca_topic_score_gemma":0.0031899347,"teacher_disagreement_score":0.015537797,"about_ca_system_score_codex":0.0021780562,"about_ca_system_score_gemma":0.003012843,"threshold_uncertainty_score":0.051979125},"labels":[],"label_agreement":null},{"id":"W2887007511","doi":"10.1158/1557-3265.ovca17-b39","title":"Abstract B39: The origins of endometriosis-associated cancers","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Clear cell; Histogenesis; Biology; Ovarian cancer; Clear cell carcinoma; Pathology; Cell of origin; Context (archaeology); Ovary; Cancer research; Endometriosis; Carcinoma; Cancer; Immunohistochemistry; Endocrinology; Medicine; Genetics; Immunology","score_opus":0.3315301287534566,"score_gpt":0.5830435419013121,"score_spread":0.2515134131478555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887007511","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96296483,0.0210488,0.002486265,0.00081991527,0.00008634528,0.00004178691,0.0027283907,0.000064502274,0.009759194],"genre_scores_gemma":[0.9903685,0.004403068,0.0015891996,0.00016483903,0.00003721014,0.000013261662,0.0013448214,0.00001436268,0.0020647487],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998332,0.000018456676,0.000010564215,0.00004506377,0.0000408713,0.000051708652],"domain_scores_gemma":[0.9997842,0.000020854373,0.000067564564,0.000018252797,0.00004218818,0.00006696637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023296077,0.0002144072,0.00019236685,0.0008326275,0.00043950367,0.0006061727,0.00022196045,0.00044555063,0.0019647353],"category_scores_gemma":[0.0003839347,0.00015698744,0.00021926363,0.0006863853,0.00025910314,0.00034485335,0.0004973564,0.0003160043,0.00087529083],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065426703,0.000051574298,0.19248524,0.0006880398,0.00009313987,0.0037871723,0.00047753757,0.00027735633,0.7591373,0.0067197294,0.0017928772,0.033835854],"study_design_scores_gemma":[0.00002608783,0.0002047006,0.8540813,0.00016621056,0.00007091921,0.010078999,0.0009563029,0.00088424544,0.07812512,0.0026631341,0.05270619,0.000036788224],"about_ca_topic_score_codex":0.0019865052,"about_ca_topic_score_gemma":0.0014639219,"teacher_disagreement_score":0.0019865052,"about_ca_system_score_codex":0.00048430008,"about_ca_system_score_gemma":0.00029995275,"threshold_uncertainty_score":0.0065727234},"labels":[],"label_agreement":null},{"id":"W2887168129","doi":"10.1158/1557-3265.ovca17-a63","title":"Abstract A63: Estrogen receptor signaling in fallopian tube epithelia of BRCA mutation carriers","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Estrogen receptor; Serous carcinoma; Biology; Cancer research; Carcinogenesis; Fallopian tube; Ovarian cancer; Estrogen; Serous fluid; BRCA mutation; Tissue microarray; Laser capture microdissection; Cancer; Pathology; Medicine; Breast cancer; Gene expression; Genetics; Gene","score_opus":0.20567328374580335,"score_gpt":0.5237894266931445,"score_spread":0.3181161429473412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887168129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991736,0.00017241576,0.000096008494,0.000013044627,0.0000024930175,0.000007002445,0.00032853524,0.000006928055,0.00020003079],"genre_scores_gemma":[0.99880874,0.000110090354,0.00030265134,0.000019090028,0.0000040950126,0.000016291206,0.0004046907,0.0000031833772,0.00033123992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999405,0.000007873207,0.0000054665766,0.000016021688,0.000015969868,0.000014182831],"domain_scores_gemma":[0.99990547,0.00002535743,0.000026940434,0.0000057552256,0.00001630609,0.000020085126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000111511894,0.00014176467,0.00018548396,0.0012024146,0.00023256573,0.00021950902,0.000074565185,0.0002112163,0.0017777035],"category_scores_gemma":[0.0002759476,0.00007486265,0.00012711999,0.00041598044,0.0001318051,0.00008244376,0.000103886705,0.00011691533,0.00021154157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017228521,0.0001017786,0.57412535,0.00009122261,0.000054671928,0.002334878,0.0002695904,0.00014761591,0.40943852,0.00005669929,0.00037795975,0.011278826],"study_design_scores_gemma":[0.000008794877,0.00023039679,0.98260653,0.000005044668,0.000027335529,0.0021258087,0.00018398023,0.0002323232,0.014002186,0.00004484115,0.0005297173,0.000003085526],"about_ca_topic_score_codex":0.0010279273,"about_ca_topic_score_gemma":0.0009911758,"teacher_disagreement_score":0.0017777035,"about_ca_system_score_codex":0.0001414212,"about_ca_system_score_gemma":0.00009967811,"threshold_uncertainty_score":0.0059470534},"labels":[],"label_agreement":null},{"id":"W2887314135","doi":"10.1158/1557-3265.ovca17-a45","title":"Abstract A45: Treatment patterns and outcomes among platinum-refractory/resistant ovarian cancer patients","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Fallopian tube; Ovarian cancer; Refractory (planetary science); Internal medicine; Fallopian tube cancer; Medical record; Cancer; Proportional hazards model; Stage (stratigraphy); Gynecology","score_opus":0.1824123986265077,"score_gpt":0.5047659988453095,"score_spread":0.3223536002188018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887314135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942583,0.0011905597,0.000067580564,0.00026363676,0.0000057276034,0.000019628167,0.0029295615,0.0000059200556,0.0012591148],"genre_scores_gemma":[0.99865615,0.00020461135,0.000050951177,0.00005085389,0.0000064142987,0.0000070896635,0.0009582609,0.00000130576,0.00006438964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992176,0.00012957472,0.00019168908,0.0001618148,0.00018851341,0.00011079796],"domain_scores_gemma":[0.9943218,0.0007364344,0.003574768,0.00016523272,0.00069058576,0.00051108294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005976768,0.000091527596,0.0002405137,0.0009819678,0.0004096725,0.00068126264,0.00029930056,0.00025425456,0.0015610192],"category_scores_gemma":[0.0041701472,0.00010909126,0.0003708284,0.0023583085,0.00033980355,0.0004434101,0.00039097102,0.00032465244,0.00014348749],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023854296,0.000004267664,0.9988152,0.000014167802,0.000015976208,0.000019689958,0.000031419397,0.000022349659,0.00002304597,0.000008397852,0.00014763161,0.00087405177],"study_design_scores_gemma":[0.0000032806877,0.000020033156,0.9992175,0.000019222422,0.000011895408,0.0001786246,0.00014469241,0.00009201122,0.000036006106,0.000011483663,0.0002633501,0.0000018120408],"about_ca_topic_score_codex":0.05941949,"about_ca_topic_score_gemma":0.0711839,"teacher_disagreement_score":0.05941949,"about_ca_system_score_codex":0.001489082,"about_ca_system_score_gemma":0.0013045626,"threshold_uncertainty_score":0.118147254},"labels":[],"label_agreement":null},{"id":"W2887473711","doi":"10.1158/1557-3265.ovca17-ia27","title":"Abstract IA27: Functional genetic architecture of serous ovarian cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ovarian cancer; Kinome; Cancer; Serous fluid; Serous ovarian cancer; Biology; Proteomics; RNA interference; Cancer research; Gene; Bioinformatics; Genetics; RNA","score_opus":0.2532353941073682,"score_gpt":0.531655943034265,"score_spread":0.2784205489268968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887473711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815244,0.0017771726,0.0058062337,0.00061269494,0.000056498626,0.00006206161,0.0029486644,0.00035040788,0.006861812],"genre_scores_gemma":[0.99340147,0.0005539802,0.0019332949,0.000089113746,0.000010030519,0.000022903925,0.0015313827,0.00004963481,0.0024080721],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99989116,0.000015406,0.000009902376,0.000020620186,0.000040416664,0.00002253189],"domain_scores_gemma":[0.9998198,0.00001838321,0.000065576896,0.000020416703,0.000022820268,0.000053093234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001308686,0.00027390677,0.00015875683,0.0008493642,0.00026557772,0.00048395814,0.0002589456,0.00023232216,0.0033847739],"category_scores_gemma":[0.00022306941,0.00012516075,0.0002638781,0.00046720976,0.00039014875,0.00013083765,0.0003935694,0.00047082597,0.000726346],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003786726,0.000041902622,0.014819137,0.00011032682,0.000034657816,0.0012319703,0.00006113687,0.0006195096,0.96324646,0.003219661,0.0012002189,0.015036256],"study_design_scores_gemma":[0.00013605025,0.0010025352,0.28109714,0.00008455161,0.00019954008,0.020618996,0.0005152888,0.0064075943,0.6247814,0.0047441167,0.06036054,0.000052188545],"about_ca_topic_score_codex":0.0012539756,"about_ca_topic_score_gemma":0.0011239145,"teacher_disagreement_score":0.0033847739,"about_ca_system_score_codex":0.00051628606,"about_ca_system_score_gemma":0.0004822991,"threshold_uncertainty_score":0.011323154},"labels":[],"label_agreement":null},{"id":"W2887662642","doi":"10.1158/1557-3265.hemmal17-ia06","title":"Abstract IA06: Intratumor heterogeneity and its role in therapeutic escape in multiple myeloma","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"CD38; Unfolded protein response; Biology; Plasma cell; Cancer research; Bortezomib; XBP1; Multiple myeloma; Bone marrow; Stem cell; Endoplasmic reticulum; Immunology; CD34; Cell biology","score_opus":0.2986004711141817,"score_gpt":0.5336421423536849,"score_spread":0.2350416712395032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887662642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942081,0.0012650626,0.00225539,0.000057494974,0.0000069414805,0.000019558209,0.00028327559,0.00007697714,0.0018270463],"genre_scores_gemma":[0.9977082,0.00019909309,0.00083449,0.000020028036,0.0000037680584,0.000012415119,0.000281622,0.000013003204,0.00092739775],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99990475,0.000013093248,0.0000064447436,0.000026041665,0.000022393573,0.000027263282],"domain_scores_gemma":[0.99991274,0.000012230119,0.000027891996,0.000012540786,0.00001650582,0.000018163762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015293989,0.0001504437,0.00018433282,0.0002957701,0.00014691785,0.00039184693,0.00021320688,0.00023458473,0.0016235899],"category_scores_gemma":[0.00014517822,0.00008194722,0.0001427266,0.00021389347,0.00013723773,0.00017285119,0.0003056329,0.0003959217,0.00044490088],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014281913,0.00003091232,0.0036812683,0.000029870214,0.0000061177543,0.0000746125,0.000032223623,0.0001869067,0.99054736,0.00023376445,0.00008441113,0.0049497755],"study_design_scores_gemma":[0.00001965038,0.00072372635,0.102257505,0.000019270034,0.00003805691,0.0019674574,0.0002069743,0.0057145148,0.8800546,0.00042778518,0.008559686,0.000010835301],"about_ca_topic_score_codex":0.000501532,"about_ca_topic_score_gemma":0.00024913345,"teacher_disagreement_score":0.0016235899,"about_ca_system_score_codex":0.0002783718,"about_ca_system_score_gemma":0.00011555845,"threshold_uncertainty_score":0.0054314733},"labels":[],"label_agreement":null},{"id":"W2887696598","doi":"10.1158/1557-3265.sarcomas17-ia23","title":"Abstract IA23: Variation in the immune cell infiltrate and expression of PD-L1 in sarcoma subtypes","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Immunohistochemistry; Sarcoma; Pathology; Leiomyosarcoma; Immune system; Immune checkpoint; Undifferentiated Pleomorphic Sarcoma; Cancer research; Tumor microenvironment; Medicine; Soft tissue sarcoma; Liposarcoma; Immunotherapy; Biology; Immunology","score_opus":0.1783881133905404,"score_gpt":0.4959678738169798,"score_spread":0.31757976042643943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887696598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99882454,0.00020656626,0.00015554951,0.00000804194,0.000003367671,0.000005635787,0.00023149616,0.0000086335385,0.00055615196],"genre_scores_gemma":[0.99928564,0.00004517821,0.00009355681,0.000007442269,0.0000036405322,0.00000765832,0.00025926315,0.000008898035,0.00028862443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974686,0.000041307525,0.00003300234,0.00008428061,0.0000423346,0.000052171665],"domain_scores_gemma":[0.99926394,0.00014986454,0.00024518915,0.000057921923,0.00012566369,0.00015748414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031590037,0.00020473088,0.00020530482,0.001386225,0.00024892358,0.0005758442,0.000268115,0.00032178304,0.0038867597],"category_scores_gemma":[0.0010482006,0.00014085205,0.00026444654,0.0007936425,0.0002405128,0.00018316493,0.00030279986,0.000307204,0.0013546454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095627457,0.000069607755,0.86651397,0.000041100546,0.0001488852,0.0006488552,0.00025129996,0.00019854872,0.12111439,0.00013375314,0.0004541589,0.009469137],"study_design_scores_gemma":[0.000009552716,0.00014898539,0.9903314,0.000008379281,0.000028296558,0.0023479026,0.00029694202,0.00034691844,0.005331295,0.00013212206,0.0010101831,0.00000811993],"about_ca_topic_score_codex":0.0007347826,"about_ca_topic_score_gemma":0.00052119023,"teacher_disagreement_score":0.0038867597,"about_ca_system_score_codex":0.00019279469,"about_ca_system_score_gemma":0.000082869556,"threshold_uncertainty_score":0.013002515},"labels":[],"label_agreement":null},{"id":"W2887701123","doi":"10.1158/1557-3265.ovca17-pr03","title":"Abstract PR03: Arginine deprivation as a potential targeted therapy for clear cell ovarian carcinoma","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cancer research; Biology; Clear cell; Arginine; Proteome; Ovarian cancer; Cancer; Transcriptome; ARID1A; Clear cell carcinoma; Targeted therapy; Carcinoma; Bioinformatics; Biochemistry; Gene expression; Gene; Genetics; Mutation; Amino acid","score_opus":0.11223018719703866,"score_gpt":0.4853299066377258,"score_spread":0.37309971944068715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887701123","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9362805,0.051605757,0.004298502,0.0011205995,0.0003212818,0.00020739903,0.0011471715,0.00023180277,0.004786861],"genre_scores_gemma":[0.978136,0.012276818,0.004799894,0.0006087695,0.00008634406,0.00008174065,0.0014651198,0.000033907334,0.0025114533],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999174,0.000013307546,0.000007917932,0.000019856077,0.000026897522,0.000014652269],"domain_scores_gemma":[0.99995387,0.0000067949522,0.000010888281,0.000005287404,0.000009162251,0.000013982176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014813918,0.0002240149,0.00036824562,0.00028430155,0.00017705398,0.00038496125,0.00024511974,0.00024971584,0.0014284538],"category_scores_gemma":[0.000101695376,0.00007288116,0.00042656637,0.0002769547,0.0001775099,0.00026428045,0.00026453074,0.00051162794,0.00042783795],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023739703,0.00039653393,0.0040233773,0.00068444194,0.00012407225,0.00067445554,0.00004036781,0.00059073215,0.88610435,0.00034131503,0.0018006677,0.10284578],"study_design_scores_gemma":[0.00097466103,0.011641683,0.04820045,0.0001356557,0.00047898106,0.0065838955,0.00019563803,0.0058650346,0.8473444,0.00090863305,0.077606164,0.00006479099],"about_ca_topic_score_codex":0.00035012703,"about_ca_topic_score_gemma":0.0005852576,"teacher_disagreement_score":0.0014284538,"about_ca_system_score_codex":0.00026664435,"about_ca_system_score_gemma":0.00032392005,"threshold_uncertainty_score":0.004778683},"labels":[],"label_agreement":null},{"id":"W2887768917","doi":"10.1158/1557-3265.sarcomas17-b39","title":"Abstract B39: Investigation of the effects of alterations in the glutamate receptor, GRIK2, on osteosarcoma tumorigenesis","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; Health PEI; University of Toronto","funders":"","keywords":"Osteosarcoma; Cancer research; Biology; Carcinogenesis; Tumor suppressor gene; Cancer; Genetics","score_opus":0.07634274441964216,"score_gpt":0.43592124257357495,"score_spread":0.3595784981539328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887768917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998566,0.00062589714,0.0002957846,0.000025938138,0.0000059095255,0.000006556225,0.0002006728,0.0000074317127,0.00026577222],"genre_scores_gemma":[0.99806803,0.0003714372,0.00042322258,0.000022714596,0.000003154787,0.000010074869,0.00039615884,0.0000052752384,0.0006998013],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999354,0.000011194167,0.0000054340626,0.000016039645,0.000017150816,0.000014681543],"domain_scores_gemma":[0.999931,0.000017544467,0.000015082334,0.000009435908,0.0000070106203,0.00001984783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010645211,0.00018023135,0.00017696335,0.00016374489,0.000098362805,0.000096292395,0.00013028017,0.00014576914,0.0013242402],"category_scores_gemma":[0.00011553443,0.0000777816,0.00020004093,0.00012165122,0.00014088496,0.00008982175,0.00008623486,0.00019225206,0.00018399078],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001201643,0.000015533853,0.0007149437,0.000013113365,0.00000393747,0.000069076785,0.0000047537687,0.000028887438,0.9985581,0.000009838105,0.000010087414,0.00045159317],"study_design_scores_gemma":[0.00002122554,0.0011171275,0.045786247,0.0000030421106,0.00002775086,0.0008302079,0.000036212066,0.00043880337,0.95062536,0.00003392999,0.0010766244,0.0000034285702],"about_ca_topic_score_codex":0.0007214088,"about_ca_topic_score_gemma":0.0008326255,"teacher_disagreement_score":0.0013242402,"about_ca_system_score_codex":0.00017909917,"about_ca_system_score_gemma":0.00012230853,"threshold_uncertainty_score":0.004429996},"labels":[],"label_agreement":null},{"id":"W2887944091","doi":"10.1158/1078-0432.ccr-18-1244","title":"A Clinical and Molecular Phase II Trial of Oral ENMD-2076 in Ovarian Clear Cell Carcinoma (OCCC): A Study of the Princess Margaret Phase II Consortium","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Princess Margaret Cancer Centre; BC Cancer Agency; Ottawa Hospital; University of Toronto; University Health Network","funders":"Princess Margaret Cancer Foundation","keywords":"Medicine; Phases of clinical research; Clear cell carcinoma; Phase (matter); Oncology; Ovarian cancer; Internal medicine; Clinical trial; Carcinoma; Gynecology; Cancer; Chemistry","score_opus":0.14065275832213786,"score_gpt":0.5115108080783575,"score_spread":0.3708580497562196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887944091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968695,0.0010161062,0.00019823715,0.00025636624,0.00002210366,0.0006071791,0.00032733157,0.000019669078,0.0006834621],"genre_scores_gemma":[0.9920521,0.0010445724,0.0014582225,0.0006457582,0.000059121183,0.0010310607,0.0019028287,0.0000113620645,0.0017950032],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99973077,0.00015568455,0.000011166907,0.000034182307,0.000030506957,0.000037695252],"domain_scores_gemma":[0.9995233,0.00008350771,0.00008372764,0.00003354272,0.000033532237,0.00024240291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014234518,0.00067493203,0.00082972436,0.00025476923,0.00028313682,0.00048079513,0.00048261666,0.00067583576,0.0021612193],"category_scores_gemma":[0.00052065396,0.00027065276,0.00047296126,0.00022450431,0.00047513863,0.00031444128,0.00023252537,0.0012505155,0.00034041554],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6112515,0.06277915,0.039736044,0.0011598412,0.002150084,0.0006509818,0.00041485767,0.0045447634,0.0942538,0.0006249783,0.009386453,0.17304756],"study_design_scores_gemma":[0.55700344,0.38346842,0.04072096,0.00005547143,0.0006299404,0.00084897113,0.00009406071,0.0031512168,0.008910659,0.00021699953,0.0048574265,0.000042355507],"about_ca_topic_score_codex":0.00088071456,"about_ca_topic_score_gemma":0.0029701132,"teacher_disagreement_score":0.0021612193,"about_ca_system_score_codex":0.0006993465,"about_ca_system_score_gemma":0.0011927384,"threshold_uncertainty_score":0.007528007},"labels":[],"label_agreement":null},{"id":"W2887969083","doi":"10.1158/1557-3265.ovca17-a01","title":"Abstract A01: Distinct mechanism of action of DNA-damaging agent dianhydrogalactitol (VAL-083) suggests combination therapy with PARP inhibitors","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Cancer research; DNA repair; DNA damage; Ovarian cancer; Homologous recombination; Cancer; Cancer cell; Biology; Genome instability; DNA; Medicine; Genetics","score_opus":0.25897635765149857,"score_gpt":0.5231007719225399,"score_spread":0.26412441427104133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887969083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91069585,0.05082802,0.008830416,0.0018226068,0.0007359406,0.00038941094,0.0018909983,0.0006868875,0.024119882],"genre_scores_gemma":[0.98059,0.006224294,0.004499248,0.0003986807,0.00006685078,0.00012123019,0.0011371206,0.000049917686,0.006912721],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999386,0.000010948142,0.00000496636,0.000017314194,0.0000135706905,0.0000144867345],"domain_scores_gemma":[0.99996185,0.0000041303115,0.000008143726,0.0000045775882,0.0000059885137,0.00001536146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000067621324,0.00040820322,0.0002657801,0.0003020007,0.00014494915,0.0003552227,0.00031180706,0.00040738238,0.0029876556],"category_scores_gemma":[0.00007424547,0.000106197724,0.00030524007,0.000276342,0.0001513952,0.00019646643,0.00023081219,0.0007645593,0.0009541038],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024829188,0.0006334063,0.0013130167,0.0006421051,0.00009389446,0.00076343666,0.000050784696,0.0010315377,0.8794078,0.0014197401,0.0041278927,0.10803338],"study_design_scores_gemma":[0.00064263283,0.0064963126,0.0076661026,0.00006756481,0.00022759436,0.0049501765,0.000064515756,0.003847714,0.88091403,0.000722287,0.09436509,0.000035995992],"about_ca_topic_score_codex":0.0004365041,"about_ca_topic_score_gemma":0.00048579858,"teacher_disagreement_score":0.0029876556,"about_ca_system_score_codex":0.00029410518,"about_ca_system_score_gemma":0.00017625676,"threshold_uncertainty_score":0.009994686},"labels":[],"label_agreement":null},{"id":"W2888359685","doi":"10.1158/1078-0432.ccr-18-0110","title":"Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Temozolomide; Internal medicine; Rash; Adverse effect; Discontinuation; Phases of clinical research; Radiation therapy; Surgery; Oncology; Clinical trial","score_opus":0.16392363722883577,"score_gpt":0.5337312416333149,"score_spread":0.36980760440447913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888359685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99633116,0.0010875084,0.0003124956,0.00013566339,0.00006402432,0.001367929,0.00025461375,0.000026689744,0.00042003623],"genre_scores_gemma":[0.995187,0.0008496667,0.0008183693,0.00030150675,0.00011056433,0.0014096557,0.0008139677,0.000009533392,0.0004998449],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994236,0.00030221793,0.00004657814,0.00009604782,0.000048980553,0.000082566105],"domain_scores_gemma":[0.9989656,0.000116514326,0.00026333192,0.00009370013,0.00008155923,0.0004793283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016846651,0.0012485998,0.0022276912,0.0003513865,0.000367268,0.00081881636,0.0008047865,0.00076598243,0.0016529592],"category_scores_gemma":[0.0011132037,0.00061965024,0.0010852644,0.00046658175,0.0006496719,0.000677838,0.00041345798,0.002299293,0.00044199047],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8046571,0.074140534,0.021690084,0.00067246513,0.0016653087,0.0002564296,0.00025559778,0.0017743339,0.024509106,0.00011372507,0.0016248496,0.0686406],"study_design_scores_gemma":[0.48671877,0.48114145,0.025503155,0.00003457348,0.0006730529,0.00032315383,0.00007135569,0.0013398755,0.002719472,0.00010673763,0.001338756,0.000029585295],"about_ca_topic_score_codex":0.0011103769,"about_ca_topic_score_gemma":0.002598815,"teacher_disagreement_score":0.0022276912,"about_ca_system_score_codex":0.0010611033,"about_ca_system_score_gemma":0.0021029536,"threshold_uncertainty_score":0.008909464},"labels":[],"label_agreement":null},{"id":"W2890008571","doi":"10.1158/1557-3265.aacriaslc18-a02","title":"Abstract A02: Oncogenic drivers of lung cancer induce production of CCL5 and recruitment of regulatory T-cells","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Immune system; Cancer research; Biology; Carcinogenesis; Chemokine; Lung cancer; Tumor microenvironment; Adenocarcinoma; KRAS; Cytokine; Immunology; Oncogene; Cancer; Medicine; Pathology; Cell cycle","score_opus":0.23750262096241123,"score_gpt":0.5197486930926917,"score_spread":0.2822460721302804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890008571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951806,0.00045836924,0.0022245294,0.000039186194,0.000015715377,0.000031433407,0.000916066,0.00013413191,0.0010000011],"genre_scores_gemma":[0.9932774,0.00020448242,0.0022528651,0.000039511004,0.0000097222555,0.00005942577,0.001665825,0.00002737022,0.002463408],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997017,0.000034095,0.000029251074,0.00006108326,0.000097501725,0.00007644828],"domain_scores_gemma":[0.999853,0.000028355244,0.000035487214,0.000022219278,0.000017638018,0.000043223885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016195128,0.0003377295,0.00018903542,0.00053260865,0.00012602097,0.0003379783,0.00013485446,0.00020432194,0.001807869],"category_scores_gemma":[0.00013585706,0.00012884865,0.00022163965,0.00027247734,0.00018477294,0.00013136244,0.00018637035,0.00043406535,0.0004422183],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005164506,0.000015641594,0.00031351973,0.000009528317,0.0000016363878,0.000016135466,0.0000044763515,0.000020343597,0.9991437,0.00002538414,0.00002332712,0.00037452503],"study_design_scores_gemma":[0.000011336905,0.00019749836,0.011471246,0.0000024715257,0.000006420972,0.00019218035,0.000020810854,0.00087579293,0.985859,0.000023651224,0.0013365569,0.0000030366816],"about_ca_topic_score_codex":0.00064794667,"about_ca_topic_score_gemma":0.00091407576,"teacher_disagreement_score":0.001807869,"about_ca_system_score_codex":0.00032041862,"about_ca_system_score_gemma":0.0001660638,"threshold_uncertainty_score":0.0060479045},"labels":[],"label_agreement":null},{"id":"W2890307745","doi":"10.1158/1557-3265.aacriaslc18-b21","title":"Abstract B21: Investigating targeted driver mutations and PD-L1 expression for improved therapy of non-small cell lung cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"KRAS; Lung cancer; Medicine; ROS1; Targeted therapy; Immunotherapy; Cancer research; Immunohistochemistry; Oncology; Cancer; Adenocarcinoma; Internal medicine; Pathology; Colorectal cancer","score_opus":0.15439677921671938,"score_gpt":0.5357251731605476,"score_spread":0.3813283939438282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890307745","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926468,0.0038583889,0.000768997,0.00014675906,0.000029688403,0.00010424219,0.00041613908,0.000039094997,0.0019899393],"genre_scores_gemma":[0.996738,0.0008155252,0.00080026727,0.00008094214,0.000015770021,0.000049225397,0.00041307998,0.000007276988,0.0010798402],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984646,0.000035980218,0.000010442481,0.000033252818,0.000050205857,0.000023615541],"domain_scores_gemma":[0.9998548,0.000036655376,0.000031847198,0.0000072212515,0.000030341605,0.000039110084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056474336,0.0002139971,0.00038153678,0.00046463448,0.00015597315,0.0005140758,0.00020620805,0.00031558974,0.0025361124],"category_scores_gemma":[0.0003419782,0.000107714404,0.00024935373,0.00030456277,0.0001773434,0.00021140104,0.00014844658,0.00029796813,0.000436783],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008141991,0.0015492258,0.11074038,0.00045910777,0.00012377994,0.0007646,0.00009122732,0.0006258489,0.78168815,0.0001765037,0.0017605391,0.093878746],"study_design_scores_gemma":[0.00056989293,0.024824014,0.50514483,0.0000539884,0.00033076367,0.003722914,0.00019861951,0.005113759,0.44636866,0.00025586833,0.013390187,0.000026487929],"about_ca_topic_score_codex":0.00059681095,"about_ca_topic_score_gemma":0.00058985944,"teacher_disagreement_score":0.0025361124,"about_ca_system_score_codex":0.00047181483,"about_ca_system_score_gemma":0.00029570158,"threshold_uncertainty_score":0.008484185},"labels":[],"label_agreement":null},{"id":"W2890545119","doi":"10.1158/1078-0432.ccr-18-1106","title":"Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; University of British Columbia","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Bladder cancer; Chemotherapy; Cancer; Medicine; Neoadjuvant therapy; Oncology; Pathology; Cancer research; Internal medicine; Breast cancer","score_opus":0.30430948962792254,"score_gpt":0.5521982739499504,"score_spread":0.24788878432202782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890545119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99940157,0.00020007833,0.00012837365,0.000009803978,0.00000129296,0.0000070480714,0.000047654743,0.0000024544963,0.00020168776],"genre_scores_gemma":[0.9994823,0.000062346364,0.00017026605,0.000010178696,0.0000017904308,0.000010095835,0.00020065476,0.0000013418918,0.00006098075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975985,0.000060254682,0.000027681266,0.00004870962,0.00006904933,0.00003452284],"domain_scores_gemma":[0.9997179,0.000061471816,0.00008911929,0.00003166568,0.00005033358,0.00004947074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002505532,0.00013372596,0.00019946611,0.00039622848,0.0002059255,0.0002790366,0.00014912886,0.00019582533,0.00044287764],"category_scores_gemma":[0.0007417893,0.000074699485,0.00013859225,0.00029426586,0.00023724364,0.00012170135,0.00020426293,0.00015594577,0.00010521404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017747891,0.0001004793,0.8355616,0.00010266266,0.0000807772,0.00035240166,0.00037796327,0.00043913638,0.14587341,0.00008143023,0.00009750571,0.015157806],"study_design_scores_gemma":[0.000012043105,0.0003936369,0.98860383,0.000007261686,0.000031174615,0.0009754772,0.00023393342,0.0007004175,0.00860691,0.000064995416,0.00036547985,0.000004810244],"about_ca_topic_score_codex":0.0006097168,"about_ca_topic_score_gemma":0.0011809489,"teacher_disagreement_score":0.0006097168,"about_ca_system_score_codex":0.00031165432,"about_ca_system_score_gemma":0.00021804239,"threshold_uncertainty_score":0.0022612214},"labels":[],"label_agreement":null},{"id":"W2891851777","doi":"10.1158/1557-3265.aacriaslc18-b36","title":"Abstract B36: Novel miRNAs as tissue-of-origin markers for distinguishing malignant pleural mesothelioma from lung adenocarcinoma","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"BAP1; microRNA; Biology; Gene; Mesothelioma; Cancer research; Computational biology; Pathology; Genetics; Medicine","score_opus":0.38594165304862765,"score_gpt":0.587748639821873,"score_spread":0.20180698677324532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891851777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99150544,0.00088515755,0.0055194865,0.0000480212,0.000016828659,0.000039232804,0.0014521906,0.00011036878,0.0004232317],"genre_scores_gemma":[0.9862694,0.00017159992,0.010881851,0.000023970684,0.000010702252,0.000033699245,0.0022519135,0.000018440956,0.00033831547],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99971277,0.00005148239,0.000038993552,0.00009744526,0.00007060524,0.000028804023],"domain_scores_gemma":[0.99947673,0.00021830012,0.000103196086,0.00003719827,0.00008008961,0.00008452488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045184614,0.0003149216,0.00048684023,0.0010196635,0.00030613478,0.00049416523,0.0001823068,0.0003509506,0.0011310084],"category_scores_gemma":[0.0013138457,0.00017824564,0.00043750476,0.0004962256,0.00015174944,0.00018428608,0.00029937478,0.0002843349,0.0005901643],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024128377,0.00016333062,0.36938548,0.00028325227,0.00019743499,0.0007604171,0.00018286108,0.0032375432,0.5822773,0.00021430681,0.0008435855,0.04004158],"study_design_scores_gemma":[0.00014392588,0.0013650854,0.72084355,0.000061420484,0.0005037157,0.0062928903,0.00027613825,0.06525554,0.19660988,0.00085860514,0.007725671,0.00006359146],"about_ca_topic_score_codex":0.00061290327,"about_ca_topic_score_gemma":0.0010231097,"teacher_disagreement_score":0.0011310084,"about_ca_system_score_codex":0.00019130448,"about_ca_system_score_gemma":0.0003083263,"threshold_uncertainty_score":0.0037835836},"labels":[],"label_agreement":null},{"id":"W2892162567","doi":"10.1158/1557-3265.aacriaslc18-a26","title":"Abstract A26: Identification of a novel therapeutic target in lung adenocarcinoma","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Toronto Western Hospital","funders":"","keywords":"Gene knockdown; Cancer research; Biology; Adenocarcinoma; Transcription factor; Lung cancer; Cancer; Internal medicine; Medicine; Gene; Genetics","score_opus":0.20470871919288708,"score_gpt":0.518514897499439,"score_spread":0.31380617830655194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892162567","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94930893,0.03418294,0.0036929953,0.0012280798,0.00019905208,0.00030472525,0.003938524,0.00038949985,0.0067551895],"genre_scores_gemma":[0.97820973,0.008279253,0.004648487,0.00042631337,0.00007943183,0.00015473929,0.0045528556,0.000032171134,0.0036170897],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99991536,0.000015321082,0.000007434151,0.000022297083,0.000020555986,0.000019094965],"domain_scores_gemma":[0.9999304,0.000008591749,0.00001609227,0.000005077754,0.000012477541,0.000027378992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022701068,0.00030834982,0.00055295386,0.00051695993,0.00021629829,0.00052780507,0.00022254513,0.00039343451,0.0030988115],"category_scores_gemma":[0.00016712476,0.00010018354,0.0004513182,0.0005470912,0.00013696124,0.00019965068,0.0002067662,0.0005100799,0.0009640038],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004338976,0.0011521602,0.02192484,0.0011882023,0.00022386786,0.0014668896,0.00005497236,0.0023600832,0.7347065,0.00094392296,0.0069286004,0.22471096],"study_design_scores_gemma":[0.0028220753,0.0217232,0.19347471,0.00039139015,0.001232877,0.013719356,0.00032949934,0.018681834,0.5915085,0.0023146104,0.15370733,0.00009465682],"about_ca_topic_score_codex":0.0005366801,"about_ca_topic_score_gemma":0.001196011,"teacher_disagreement_score":0.0030988115,"about_ca_system_score_codex":0.00045296462,"about_ca_system_score_gemma":0.0004150342,"threshold_uncertainty_score":0.010366559},"labels":[],"label_agreement":null},{"id":"W2894741998","doi":"10.1158/1078-0432.ccr-18-0729","title":"Proteogenomic Characterization of Patient-Derived Xenografts Highlights the Role of REST in Neuroendocrine Differentiation of Castration-Resistant Prostate Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Novo Nordisk Fonden; Kræftens Bekæmpelse","keywords":"Prostate cancer; Neuroendocrine differentiation; Rest (music); Prostate; Medicine; Cancer; Castration; Cancer research; Oncology; Biology; Internal medicine; Hormone","score_opus":0.08203419535733544,"score_gpt":0.4303867489776065,"score_spread":0.34835255362027107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894741998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961504,0.000673865,0.0016246445,0.000038678994,0.000008789933,0.000014599743,0.00112108,0.000041126088,0.00032682074],"genre_scores_gemma":[0.99299735,0.0005609447,0.0024063569,0.000043079213,0.0000055689106,0.0000185097,0.0032560274,0.00002310522,0.0006892211],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999404,0.0000066667917,0.0000042059764,0.000015170879,0.000021948434,0.000011603055],"domain_scores_gemma":[0.9999187,0.00001095908,0.000020256964,0.000011024817,0.000015946674,0.000023073653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000119301185,0.0002882105,0.00023766224,0.0002757643,0.0001550007,0.00026687782,0.00011892158,0.0001473709,0.00079014344],"category_scores_gemma":[0.00011757159,0.00010273097,0.00026651166,0.00025483096,0.0001262755,0.00010974757,0.00017684039,0.0003692718,0.00024390189],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000156572,0.000018278075,0.0051253918,0.000029349567,0.000024374054,0.00012454351,0.000015206418,0.000103458275,0.9929477,0.000020033687,0.00007304895,0.0013619841],"study_design_scores_gemma":[0.000026658738,0.0007336602,0.35955048,0.0000130643075,0.000123872,0.0044768695,0.0001439747,0.004466617,0.6257052,0.00009957363,0.00464443,0.000015676242],"about_ca_topic_score_codex":0.0005683036,"about_ca_topic_score_gemma":0.00076733,"teacher_disagreement_score":0.00079014344,"about_ca_system_score_codex":0.00016487778,"about_ca_system_score_gemma":0.00016398926,"threshold_uncertainty_score":0.0026432872},"labels":[],"label_agreement":null},{"id":"W2895037322","doi":"10.1158/1557-3265.aacriaslc18-a07","title":"Abstract A07: Alterations in G2/M phase associated transcriptional networks highlight lung cancer predisposition in COPD patients","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"COPD; Lung cancer; Medicine; Cancer; Internal medicine; Adenocarcinoma; Lung; Oncology; Pulmonary function testing; Pathology","score_opus":0.14603581078943673,"score_gpt":0.5227637700563039,"score_spread":0.3767279592668672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895037322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99810314,0.00021355721,0.0005929679,0.00004474234,0.0000023264668,0.000006774922,0.0006850529,0.000017695695,0.00033357117],"genre_scores_gemma":[0.99877924,0.000049806942,0.00030898256,0.000016479169,0.0000036166703,0.000006516647,0.0006574309,0.0000037328034,0.000174186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989104,0.00001982551,0.0000072323546,0.000041071416,0.000016547307,0.000024173947],"domain_scores_gemma":[0.99966633,0.00009907409,0.00011744823,0.000021941349,0.00003269635,0.00006256431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001572003,0.00017759757,0.00023438866,0.0006192021,0.00018210753,0.00029999192,0.00013732229,0.00021945419,0.002832352],"category_scores_gemma":[0.00061352627,0.00010449465,0.00024468452,0.00067777047,0.00015711218,0.00017127341,0.00020953859,0.0002008781,0.00030649925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011654692,0.000070296766,0.90465033,0.000098162134,0.00019049291,0.00020808233,0.00009774327,0.0011646842,0.07997389,0.00019800726,0.00062360195,0.011559281],"study_design_scores_gemma":[0.0000123640975,0.00011072705,0.988822,0.0000071589234,0.00007704596,0.00042072023,0.0000937452,0.0042678723,0.0053494573,0.0002929109,0.00054131757,0.0000047876],"about_ca_topic_score_codex":0.0009829617,"about_ca_topic_score_gemma":0.0013358326,"teacher_disagreement_score":0.002832352,"about_ca_system_score_codex":0.00018939155,"about_ca_system_score_gemma":0.00018409624,"threshold_uncertainty_score":0.009475172},"labels":[],"label_agreement":null},{"id":"W2895906214","doi":"10.1158/1078-0432.ccr-18-2820","title":"Thyroid Nodule DNA Methylation Signatures: An Important Diagnostic Annotation","year":2018,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Faculty of Medicine, McGill University","keywords":"DNA methylation; Thyroid cancer; Thyroid nodules; Thyroid; Methylation; Biology; Computational biology; DNA; Somatic cell; Cancer research; Pathology; Medicine; Genetics; Gene; Gene expression","score_opus":0.19653227359316308,"score_gpt":0.5191612934268579,"score_spread":0.32262901983369485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895906214","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026531957,0.028359435,0.01284155,0.89446896,0.015430535,0.00013020726,0.0010512361,0.00065260683,0.020533565],"genre_scores_gemma":[0.40907156,0.03208231,0.0275541,0.39841065,0.08718617,0.00022982761,0.0021468038,0.00039139326,0.042927276],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993662,0.00016136005,0.000055750977,0.00012493636,0.00020711414,0.0000845752],"domain_scores_gemma":[0.9985196,0.0006281936,0.00008609114,0.0001440069,0.0004642371,0.00015792325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009407946,0.00031963782,0.00053591764,0.000666858,0.0006676847,0.0010603832,0.00042320866,0.002657923,0.0026379118],"category_scores_gemma":[0.0042688465,0.0002451146,0.00021771727,0.000366297,0.0007636906,0.0007142625,0.0006041232,0.004903518,0.0029867964],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003913367,0.000059330465,0.019009339,0.00022046338,0.000040095372,0.011304811,0.00023810215,0.000363952,0.02904965,0.004461024,0.59748554,0.3373764],"study_design_scores_gemma":[0.0001295543,0.00025173387,0.01932469,0.00046614627,0.000112393005,0.07025928,0.00053572835,0.005657715,0.0195107,0.031288814,0.85237795,0.00008536623],"about_ca_topic_score_codex":0.0010457708,"about_ca_topic_score_gemma":0.0019435004,"teacher_disagreement_score":0.002657923,"about_ca_system_score_codex":0.0010306549,"about_ca_system_score_gemma":0.00039235584,"threshold_uncertainty_score":0.008824706},"labels":[],"label_agreement":null},{"id":"W2896250667","doi":"10.1158/1078-0432.ccr-18-0320","title":"Expression of AR-V7 and ARv567es in Circulating Tumor Cells Correlates with Outcomes to Taxane Therapy in Men with Metastatic Prostate Cancer Treated in TAXYNERGY","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; Université de Montréal; Sanofi (Canada)","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health","keywords":"Prostate cancer; Taxane; Medicine; Androgen receptor; Circulating tumor cell; Oncology; Cancer; Internal medicine; Prostate; Cabazitaxel; Androgen deprivation therapy; Metastatic breast cancer; Cancer research; Metastasis; Breast cancer","score_opus":0.1444049626610932,"score_gpt":0.4881122768051551,"score_spread":0.3437073141440619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896250667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99956876,0.00014085116,0.000059432212,0.000011184759,0.00000190017,0.0000049999117,0.00006893489,0.0000018962292,0.00014200354],"genre_scores_gemma":[0.99960965,0.000034739904,0.00007224086,0.000009919699,0.0000027440344,0.0000047019385,0.00012251173,9.818274e-7,0.00014263042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985313,0.000030840532,0.000010847107,0.00004140674,0.000043352655,0.000020366839],"domain_scores_gemma":[0.99978405,0.00005108895,0.000091673784,0.000012155236,0.000024396812,0.00003666855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019391875,0.00008364371,0.00022315451,0.00013806952,0.00011311794,0.00028710935,0.000116782394,0.00015368735,0.0012969892],"category_scores_gemma":[0.00049855775,0.00008504217,0.00010115568,0.00014727411,0.00014931211,0.000121452336,0.00012660224,0.00023010487,0.00013602882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067466795,0.0003059311,0.8901042,0.00007063012,0.000125154,0.00020706494,0.00014685091,0.00039407806,0.08079626,0.00007704986,0.00036471122,0.020661443],"study_design_scores_gemma":[0.00014948311,0.0029063823,0.9835632,0.00000909362,0.00007334525,0.00073687104,0.00011558398,0.0012779628,0.010653636,0.000052905736,0.00045646782,0.000005104417],"about_ca_topic_score_codex":0.0006379736,"about_ca_topic_score_gemma":0.001145246,"teacher_disagreement_score":0.0012969892,"about_ca_system_score_codex":0.0002136719,"about_ca_system_score_gemma":0.000118796575,"threshold_uncertainty_score":0.0043388605},"labels":[],"label_agreement":null},{"id":"W2896608282","doi":"10.1158/1078-0432.ccr-18-0704","title":"Regulation of eIF4F Translation Initiation Complex by the Peptidyl Prolyl Isomerase FKBP7 in Taxane-resistant Prostate Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Terry Fox Foundation; Camargo Foundation; Agence Nationale de la Recherche","keywords":"Taxane; Translation (biology); Prostate cancer; Prostate; Cancer; Biology; Internal medicine; Cancer research; Medicine; Genetics; Messenger RNA; Breast cancer; Gene","score_opus":0.2187812640927564,"score_gpt":0.4967308246524777,"score_spread":0.2779495605597213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896608282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952683,0.0023739897,0.0012150557,0.000100986006,0.000022920305,0.000017755292,0.00038180663,0.00008369304,0.0005355458],"genre_scores_gemma":[0.99581283,0.00086205266,0.0011975277,0.000040920248,0.000005084908,0.00002797065,0.0007232438,0.000013288192,0.0013170476],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991596,0.000011408919,0.000007176354,0.000016496306,0.000031510226,0.000017511693],"domain_scores_gemma":[0.99995315,0.0000064934743,0.00001415531,0.0000042097704,0.000010307266,0.000011731706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008062693,0.00025089143,0.00026657621,0.0002606644,0.00021538907,0.00024262971,0.00015341237,0.00024806472,0.0008176437],"category_scores_gemma":[0.0000810622,0.00012048592,0.00024767808,0.00016653824,0.00014829336,0.000082232,0.00009665743,0.00035567707,0.00027998185],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100479025,0.00001591766,0.00053314184,0.000042313637,0.000009357501,0.00005430982,0.000008019811,0.000089050045,0.99821174,0.000031060114,0.00006380127,0.0008408514],"study_design_scores_gemma":[0.000021514055,0.00021807312,0.016779741,0.0000057364764,0.00003798342,0.0003325497,0.000031583255,0.002459742,0.9777346,0.000029370967,0.0023425,0.0000065641325],"about_ca_topic_score_codex":0.0015658649,"about_ca_topic_score_gemma":0.001844948,"teacher_disagreement_score":0.0015658649,"about_ca_system_score_codex":0.0004888097,"about_ca_system_score_gemma":0.00022201148,"threshold_uncertainty_score":0.003546536},"labels":[],"label_agreement":null},{"id":"W2896952615","doi":"10.1158/1078-0432.ccr-18-1854","title":"Ketoconazole and Posaconazole Selectively Target HK2-expressing Glioblastoma Cells","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Occupational Cancer Research Centre; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research; National Institutes of Health","keywords":"Posaconazole; Ketoconazole; Glioma; Azole; Cancer research; Biology; Pharmacology; In vivo; In vitro; Biochemistry; Itraconazole; Genetics","score_opus":0.07158397649095095,"score_gpt":0.4482799889607672,"score_spread":0.37669601246981627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896952615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890961,0.005712055,0.001526906,0.00015439275,0.000039103368,0.000094855364,0.0008452819,0.00008079389,0.0024503751],"genre_scores_gemma":[0.9926621,0.0032764375,0.0014978502,0.000086144,0.000012466731,0.00003246184,0.00088591507,0.000009326187,0.0015373513],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990106,0.000015357422,0.000011161739,0.000016824511,0.000032253673,0.000023267032],"domain_scores_gemma":[0.99994016,0.000011803342,0.000014079892,0.000006397964,0.000016674505,0.000010873366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010756773,0.00037661204,0.0004296221,0.00028077338,0.00014810782,0.00027095768,0.00022493135,0.00021670619,0.0015078541],"category_scores_gemma":[0.000097499185,0.00009212505,0.00025619395,0.0003189639,0.00013481601,0.00014474019,0.000118395576,0.00034530179,0.0002716786],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036679677,0.00012861448,0.00111842,0.0001609539,0.000022283255,0.00008949664,0.00001204469,0.00033804035,0.99152803,0.00005704197,0.00017677141,0.0060013933],"study_design_scores_gemma":[0.000090158836,0.0024038528,0.009262298,0.000017648093,0.00007648107,0.00038718357,0.000044981825,0.0011792327,0.9838626,0.000031239702,0.0026366748,0.000007658861],"about_ca_topic_score_codex":0.0015843379,"about_ca_topic_score_gemma":0.0050760163,"teacher_disagreement_score":0.0015843379,"about_ca_system_score_codex":0.00030785284,"about_ca_system_score_gemma":0.00030261287,"threshold_uncertainty_score":0.0050442815},"labels":[],"label_agreement":null},{"id":"W2897073503","doi":"10.1158/1078-0432.ccr-18-1640","title":"Activation of KRAS Mediates Resistance to Targeted Therapy in MET Exon 14–mutant Non–small Cell Lung Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"KRAS; Cancer research; Lung cancer; Crizotinib; Medicine; Targeted therapy; Exon; Mutation; Cancer; Biology; Oncology; Internal medicine; Colorectal cancer; Gene; Genetics","score_opus":0.14412588355530465,"score_gpt":0.5362777339219142,"score_spread":0.3921518503666096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897073503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99961805,0.00011776254,0.0000898003,0.0000063668135,8.523391e-7,0.000004986924,0.000031212538,0.0000031642278,0.00012773072],"genre_scores_gemma":[0.99967694,0.000040975898,0.00008530171,0.0000053496256,0.0000011418135,0.0000028162494,0.000090514084,0.0000011332143,0.00009586697],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99985075,0.000026774273,0.00001576693,0.000031704305,0.000046635567,0.000028437504],"domain_scores_gemma":[0.999813,0.00003857637,0.0000684765,0.000022985805,0.00001944001,0.000037508074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019724708,0.0001701556,0.00032689734,0.00028843727,0.00021994584,0.00029542853,0.0001547914,0.00023189327,0.0011616965],"category_scores_gemma":[0.00026770862,0.00015012585,0.00026829095,0.00022482821,0.00019073005,0.0001049419,0.00021649554,0.00023574506,0.00021247205],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001511327,0.0001612325,0.29106233,0.00009694466,0.00009795178,0.0025041124,0.00014842671,0.000436182,0.69329643,0.00016110553,0.00012667492,0.010397318],"study_design_scores_gemma":[0.00005905614,0.0020790042,0.8063048,0.000011851712,0.00009709635,0.016665002,0.00023033141,0.0022856737,0.17071041,0.00016245543,0.0013847853,0.000009623518],"about_ca_topic_score_codex":0.00029671626,"about_ca_topic_score_gemma":0.000642782,"teacher_disagreement_score":0.0011616965,"about_ca_system_score_codex":0.00030739003,"about_ca_system_score_gemma":0.0001819581,"threshold_uncertainty_score":0.0038862824},"labels":[],"label_agreement":null},{"id":"W2897369942","doi":"10.1158/1078-0432.ccr-18-2014","title":"A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"AbbVie","keywords":"Veliparib; Carboplatin; Medicine; Etoposide; Internal medicine; Tolerability; Oncology; Pharmacokinetics; Chemotherapy; Pharmacology; Adverse effect; Surgery; Cisplatin","score_opus":0.12093273205170117,"score_gpt":0.5074382325365686,"score_spread":0.3865055004848674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897369942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983606,0.0006155608,0.00020629709,0.000064680855,0.000020089296,0.00037905812,0.00007506482,0.0000128299325,0.00026586812],"genre_scores_gemma":[0.9979697,0.00036991294,0.00056423736,0.00015635967,0.000043140702,0.00031630226,0.00029395128,0.000005274764,0.00028094862],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99951017,0.0002410946,0.00003729116,0.00008718829,0.000053115884,0.00007108856],"domain_scores_gemma":[0.9994808,0.000095787844,0.0001296394,0.000047150203,0.000029983245,0.00021668007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009170906,0.00078352727,0.0014752279,0.00025063704,0.00027906484,0.00060478837,0.00056979386,0.0004954023,0.0011220905],"category_scores_gemma":[0.00068386534,0.00040425966,0.0009890986,0.00032617882,0.00055393606,0.00044805775,0.00024926034,0.002002242,0.00025971432],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50353086,0.114744104,0.04210801,0.0010644128,0.002435933,0.0006847378,0.00064291677,0.004630504,0.1399348,0.00018502171,0.0016383133,0.18840037],"study_design_scores_gemma":[0.28120294,0.6491793,0.05440854,0.00004094075,0.0007977904,0.00068709784,0.00008783359,0.0022441046,0.008799114,0.00011557241,0.002405865,0.00003087357],"about_ca_topic_score_codex":0.0004067115,"about_ca_topic_score_gemma":0.0012802894,"teacher_disagreement_score":0.0014752279,"about_ca_system_score_codex":0.0006583883,"about_ca_system_score_gemma":0.0010897154,"threshold_uncertainty_score":0.0048500896},"labels":[],"label_agreement":null},{"id":"W2897588250","doi":"10.1158/1557-3265.tcm17-b43","title":"Abstract B43: Validation of a network-based strategy for the optimization of combinatorial target selection in breast cancer therapy","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Breast cancer; Cancer; Cancer research; Biology; Cancer cell; Transfection; Druggability; Gene knockdown; Cell culture; Epithelial–mesenchymal transition; Metastasis; Genetics; Gene","score_opus":0.23979882175580491,"score_gpt":0.5339322935763673,"score_spread":0.2941334718205624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897588250","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5907898,0.0017347011,0.3909607,0.00065126433,0.00014533669,0.00043511632,0.0014116914,0.002179332,0.011692043],"genre_scores_gemma":[0.91158736,0.00054789253,0.08433837,0.00010975934,0.0000120601035,0.0002640901,0.0007371238,0.00014949279,0.002253857],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997497,0.000064982516,0.0000114552395,0.000058924445,0.000082050545,0.000032936096],"domain_scores_gemma":[0.9998,0.00007542035,0.000034808745,0.000019730303,0.00003937319,0.000030667736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005567221,0.0006888207,0.000510499,0.00047284726,0.00021386573,0.0005593163,0.00042169067,0.00034142635,0.0026294384],"category_scores_gemma":[0.0005583639,0.00020133427,0.00043226106,0.0003321936,0.00023106497,0.00027364105,0.00034615822,0.0005479115,0.00049378735],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005712343,0.0004313721,0.0010796662,0.00031711324,0.00011188742,0.0001328871,0.000028132883,0.27662528,0.65766585,0.0056956895,0.0013819027,0.055959005],"study_design_scores_gemma":[0.00006327992,0.00071554753,0.0009378032,0.000014665581,0.00006978319,0.000071581264,0.000013445798,0.78176296,0.21074724,0.001815747,0.0037670946,0.000020839403],"about_ca_topic_score_codex":0.0014505404,"about_ca_topic_score_gemma":0.0010204308,"teacher_disagreement_score":0.0026294384,"about_ca_system_score_codex":0.0006895166,"about_ca_system_score_gemma":0.00056725484,"threshold_uncertainty_score":0.008796334},"labels":[],"label_agreement":null},{"id":"W2898267235","doi":"10.1158/1078-0432.ccr-18-1775","title":"Polygenic Determinants for Subsequent Breast Cancer Risk in Survivors of Childhood Cancer: The St Jude Lifetime Cohort Study (SJLIFE)","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; St. Jude Children's Research Hospital","keywords":"Medicine; Breast cancer; Cancer; Childhood cancer; Cohort; Demography; Cohort study; Oncology; Gerontology; Internal medicine","score_opus":0.06764580768560206,"score_gpt":0.47175850113078166,"score_spread":0.4041126934451796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898267235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993801,0.00011084177,0.000075119904,0.000033432727,0.0000024304056,0.000003372978,0.0003157516,0.0000014287864,0.00007756651],"genre_scores_gemma":[0.99917334,0.00011403116,0.000120745324,0.00001720167,0.0000057389643,0.000005190243,0.00044848985,0.0000011879117,0.00011410099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998037,0.00006438684,0.000016130763,0.0000560159,0.00002931265,0.000030503103],"domain_scores_gemma":[0.9992725,0.00012890075,0.00029412293,0.00013467098,0.00005349561,0.00011626559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006675111,0.00020855374,0.00018763241,0.00028951647,0.0002938902,0.0003018743,0.00019061186,0.00024904747,0.0008269421],"category_scores_gemma":[0.0010834669,0.00015990416,0.00032075297,0.0004939041,0.000181342,0.0001469299,0.00026656478,0.0003065533,0.00008894613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009624403,0.000010682886,0.99889094,0.0000032270025,0.000062300984,0.000035128156,0.000027746713,0.00003802275,0.00020451135,0.000012814646,0.000072835275,0.00054558157],"study_design_scores_gemma":[0.000006991137,0.000030403005,0.99951327,0.0000029652742,0.000027951484,0.000108523025,0.00003327977,0.00013977008,0.000037910868,0.0000101640735,0.00008763304,0.000001339803],"about_ca_topic_score_codex":0.009490463,"about_ca_topic_score_gemma":0.015652793,"teacher_disagreement_score":0.009490463,"about_ca_system_score_codex":0.00019204759,"about_ca_system_score_gemma":0.00025409437,"threshold_uncertainty_score":0.018870413},"labels":[],"label_agreement":null},{"id":"W2899903837","doi":"10.1158/1078-0432.ccr-18-2312","title":"Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase–mutant Glioma","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; National Institute of Neurological Disorders and Stroke; Friedberg Charitable Foundation; Making Headway Foundation","keywords":"Isocitrate dehydrogenase; Glioma; Mutant; Ligand (biochemistry); Notch signaling pathway; IDH1; Cancer research; Cell; Chemistry; Biology; Cell biology; Biochemistry; Enzyme; Signal transduction; Receptor; Gene","score_opus":0.20052542380987765,"score_gpt":0.5100328340572646,"score_spread":0.309507410247387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899903837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981336,0.0008565292,0.00042470518,0.0000512815,0.0000037875386,0.000012419358,0.00008505768,0.0000202687,0.00041242642],"genre_scores_gemma":[0.99929094,0.0001648039,0.00028324942,0.000019747964,0.0000017886682,0.000004372926,0.000112930786,0.000002904115,0.00011923296],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986184,0.000024813064,0.000013474094,0.000025000976,0.00005562574,0.000019167614],"domain_scores_gemma":[0.9998827,0.000026426973,0.000037112302,0.000016480424,0.000018615025,0.000018704017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032444173,0.00020360996,0.0002853843,0.00017749939,0.000108472625,0.00041980215,0.00021183019,0.0002020358,0.0005655939],"category_scores_gemma":[0.00031729243,0.00009902574,0.00016015394,0.00020040404,0.00019914951,0.00016666915,0.00012995311,0.0003192815,0.00014945271],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002200808,0.0002077091,0.038515456,0.000120091456,0.00007106904,0.00023629094,0.00005196572,0.001222513,0.92930317,0.00009473752,0.0002590668,0.0277171],"study_design_scores_gemma":[0.00022992482,0.003285932,0.14731438,0.000021754204,0.00021927177,0.0024825016,0.00015734874,0.0076144678,0.83521974,0.00020911905,0.0032302793,0.000015337862],"about_ca_topic_score_codex":0.0008597198,"about_ca_topic_score_gemma":0.0012785632,"teacher_disagreement_score":0.0008597198,"about_ca_system_score_codex":0.00053772674,"about_ca_system_score_gemma":0.00027087942,"threshold_uncertainty_score":0.0039014816},"labels":[],"label_agreement":null},{"id":"W2900294328","doi":"10.1158/1078-0432.ccr-18-2474","title":"Evaluation of Prophylactic Corticosteroid Eye Drop Use in the Management of Corneal Abnormalities Induced by the Antibody–Drug Conjugate Mirvetuximab Soravtansine","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Drug-Induced Ocular Toxicity","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre","funders":"ImmunoGen","keywords":"Eye drop; Medicine; Corticosteroid; Conjugate; Drug; Ophthalmology; Eye disease; Antibody; Dermatology; Surgery; Immunology; Pharmacology","score_opus":0.35554043263166224,"score_gpt":0.549723792954956,"score_spread":0.19418336032329375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900294328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976615,0.0014457088,0.00024493024,0.00005042856,0.000008378614,0.00011965235,0.000047712165,0.000015485943,0.0004062107],"genre_scores_gemma":[0.99889034,0.00047901296,0.0003701368,0.000045741243,0.000010594256,0.00003156936,0.000050900562,0.0000020503926,0.000119688964],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996786,0.000120004435,0.000035559882,0.000047864884,0.0000866588,0.000031385047],"domain_scores_gemma":[0.99949276,0.000115891875,0.00025114018,0.000030129791,0.000044020282,0.00006609305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005264751,0.00027520643,0.00052595616,0.00012702825,0.00011559228,0.00022352183,0.00022774866,0.000189339,0.0006859769],"category_scores_gemma":[0.00079551345,0.00007265515,0.00035880745,0.00015678206,0.00017483,0.00012748245,0.00009343622,0.0004160788,0.00009928755],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05023496,0.0069111255,0.13641134,0.0010331665,0.00073459564,0.0012874922,0.00035124595,0.0026545224,0.4248677,0.00010903593,0.00080049975,0.3746044],"study_design_scores_gemma":[0.007376232,0.3943686,0.36935455,0.00011465188,0.0012026023,0.004973954,0.0002425061,0.0052510584,0.21107851,0.000067306966,0.0059296996,0.00004022568],"about_ca_topic_score_codex":0.00059189054,"about_ca_topic_score_gemma":0.001630739,"teacher_disagreement_score":0.0006859769,"about_ca_system_score_codex":0.0004418285,"about_ca_system_score_gemma":0.00069927215,"threshold_uncertainty_score":0.0032057762},"labels":[],"label_agreement":null},{"id":"W2903219008","doi":"10.1158/1557-3265.sarcomas17-pr12","title":"Abstract PR12: Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University","funders":"","keywords":"Methyltransferase; Methylation; Histone H3; Histone methylation; EZH2; Cancer research; Histone; Histone methyltransferase; Epigenetics; Biology; Genetics; DNA methylation; Gene; Gene expression","score_opus":0.1913232032067228,"score_gpt":0.5394218543045863,"score_spread":0.34809865109786353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903219008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801112,0.002060509,0.003020403,0.00061798474,0.0002097364,0.000056188273,0.0017855209,0.00078298623,0.011355498],"genre_scores_gemma":[0.97649926,0.0006563909,0.0008502098,0.000117488955,0.000028296265,0.000028781802,0.00090776174,0.00007919319,0.020832596],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998877,0.000012497801,0.000008487792,0.000027911947,0.00003739572,0.000025945832],"domain_scores_gemma":[0.9998932,0.000010785103,0.000025552783,0.000011970536,0.000011557923,0.00004697559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000091659655,0.00025322588,0.00020435544,0.00026256056,0.00018949452,0.00029421202,0.00018971741,0.00024946814,0.0109285675],"category_scores_gemma":[0.00009212294,0.00014695639,0.00019221725,0.00017046317,0.00022226817,0.00014622729,0.000301597,0.00053094735,0.0024833302],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002881474,0.00003672835,0.00056153524,0.000037863672,0.0000042505367,0.00014057237,0.000014613373,0.000073851355,0.99455243,0.00016507776,0.00089894276,0.0032260083],"study_design_scores_gemma":[0.00008713399,0.0007738078,0.019875683,0.000012782687,0.000018421135,0.0017058258,0.00009161605,0.00079671876,0.9648655,0.00020196411,0.011559612,0.000010928285],"about_ca_topic_score_codex":0.0006498187,"about_ca_topic_score_gemma":0.00084141514,"teacher_disagreement_score":0.0109285675,"about_ca_system_score_codex":0.00026922362,"about_ca_system_score_gemma":0.00018765262,"threshold_uncertainty_score":0.0365597},"labels":[],"label_agreement":null},{"id":"W2903639063","doi":"10.1158/1078-0432.ccr-18-3241","title":"Molecular Subtype Not Immune Response Drives Outcomes in Endometrial Carcinoma","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; BC Cancer Agency; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Immune system; Carcinoma; Endometrial cancer; Biology; Medicine; Oncology; Internal medicine; Immunology; Cancer; Cancer research","score_opus":0.1818455456843697,"score_gpt":0.5098285662629609,"score_spread":0.3279830205785912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903639063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99933666,0.00021816838,0.000110458124,0.000019208954,0.000002757628,0.0000043972855,0.00010608329,0.0000023793104,0.00019987997],"genre_scores_gemma":[0.999729,0.000037621987,0.00005335493,0.000007345968,0.000004281593,0.0000027552082,0.000103747654,0.0000011337564,0.00006073645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997907,0.000057097426,0.00002059245,0.00005735075,0.00003765023,0.000036575337],"domain_scores_gemma":[0.9992894,0.0001484946,0.0003127567,0.000094991694,0.00004163322,0.00011278488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005552478,0.00017526314,0.00025707972,0.00033596516,0.00019963794,0.00036930226,0.0002805855,0.00027218965,0.0014748058],"category_scores_gemma":[0.0012922309,0.00011641561,0.0004180219,0.00034203116,0.0002026528,0.00021534697,0.00032462395,0.0002715999,0.000228403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044701493,0.000014135155,0.995501,0.000013933272,0.00005401641,0.000048513313,0.000019326326,0.000096748,0.0020643196,0.000023479606,0.000038418424,0.0016790916],"study_design_scores_gemma":[0.000007666676,0.00014981354,0.9978669,0.0000057988273,0.000055059685,0.00034137326,0.000106747786,0.00064956927,0.0005170823,0.00009785177,0.00019964311,0.0000026405846],"about_ca_topic_score_codex":0.0007138889,"about_ca_topic_score_gemma":0.0011495546,"teacher_disagreement_score":0.0014748058,"about_ca_system_score_codex":0.00017767922,"about_ca_system_score_gemma":0.00018973695,"threshold_uncertainty_score":0.004933715},"labels":[],"label_agreement":null},{"id":"W2905948744","doi":"10.1158/1078-0432.ccr-18-1726","title":"SMAD4 Loss in Colorectal Cancer Patients Correlates with Recurrence, Loss of Immune Infiltrate, and Chemoresistance","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Office of Extramural Research, National Institutes of Health; National Cancer Institute; Society of Memorial Sloan Kettering; National Institute of Diabetes and Digestive and Kidney Diseases; Stand Up To Cancer; Association for Academic Surgery; Memorial Sloan-Kettering Cancer Center; American Society of Colon and Rectal Surgeons; American College of Surgeons; U.S. Department of Veterans Affairs; Dana-Farber/Harvard Cancer Center; Howard Hughes Medical Institute","keywords":"Cohort; Medicine; Interquartile range; Colorectal cancer; Internal medicine; Oncology; Cancer; Immune system; Chemotherapy; Gastroenterology; Adjuvant therapy; Immunology","score_opus":0.07200764511862745,"score_gpt":0.4443375698646952,"score_spread":0.37232992474606774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905948744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997212,0.00007339521,0.000035749916,0.000011410549,0.0000014676459,0.0000022548556,0.00007724,0.0000017731761,0.000075613534],"genre_scores_gemma":[0.99965584,0.000023108056,0.000043814183,0.0000060184466,0.000004023847,0.0000031070342,0.0001912495,6.3561424e-7,0.00007214519],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985707,0.000032389722,0.000017076294,0.00003523447,0.000026119515,0.000032136868],"domain_scores_gemma":[0.99937963,0.00011921136,0.00030929036,0.00005153188,0.000044331802,0.000095954056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003013863,0.0001823541,0.00025832787,0.0003590372,0.00023832687,0.00029517288,0.00021766289,0.0002677165,0.0013240983],"category_scores_gemma":[0.00088885915,0.00016550104,0.00025228172,0.00030721864,0.00020705347,0.00021334761,0.00018782286,0.00032326631,0.00017259196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086302764,0.00003306547,0.99534214,0.000007307145,0.000029081411,0.000105763495,0.000016366643,0.000048711212,0.0022726662,0.000007942897,0.000055657278,0.0012182985],"study_design_scores_gemma":[0.000022889744,0.00027430902,0.99785906,0.0000023178245,0.000035387813,0.00074129755,0.000048775837,0.0003080747,0.00057394995,0.000016818247,0.00011425886,0.0000027341605],"about_ca_topic_score_codex":0.00084029866,"about_ca_topic_score_gemma":0.0012354243,"teacher_disagreement_score":0.0013240983,"about_ca_system_score_codex":0.0001994741,"about_ca_system_score_gemma":0.00018536639,"threshold_uncertainty_score":0.004429519},"labels":[],"label_agreement":null},{"id":"W2906736778","doi":"10.1158/1557-3265.tcm17-b01","title":"Abstract B01: MicroRNA expression in tumors and liquid biopsy samples from patients with pancreatic ductal adenocarcinoma: Identification of clinically relevant pathways","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"microRNA; Pancreatic cancer; Adenocarcinoma; Medicine; Cancer; Carcinogenesis; Cancer research; Oncology; Disease; Biopsy; TaqMan; Pancreas; Pathology; Internal medicine; Real-time polymerase chain reaction; Gene; Biology; Genetics","score_opus":0.06847028850402621,"score_gpt":0.3833829684711695,"score_spread":0.3149126799671433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906736778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906267,0.0009819715,0.002126307,0.000069972935,0.000015565394,0.00005962855,0.0049562417,0.00009096449,0.0010726182],"genre_scores_gemma":[0.9845576,0.00048107875,0.005324097,0.00006856231,0.0000117795025,0.00021036004,0.008284214,0.000025056856,0.0010372776],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99977165,0.00003236445,0.000028074266,0.000084561594,0.000050304086,0.00003297525],"domain_scores_gemma":[0.9998541,0.00004216736,0.000037665184,0.000010870377,0.000026464248,0.000028679586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020467311,0.00023199146,0.0003472766,0.0005738854,0.00029360002,0.0005684307,0.0001328742,0.00021275402,0.0028486294],"category_scores_gemma":[0.00040138979,0.00011568391,0.00028631554,0.0008957364,0.00012828826,0.00014475605,0.00029715052,0.0003018228,0.0006881046],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006164845,0.0004418441,0.42724097,0.00069951575,0.0002943666,0.001310049,0.00035023052,0.0007904672,0.5080382,0.00018634336,0.002312203,0.05217089],"study_design_scores_gemma":[0.00017717491,0.0018414906,0.848563,0.000048603273,0.00030776157,0.0052581397,0.0005369815,0.0044708787,0.12960508,0.0003097066,0.008853269,0.000027981567],"about_ca_topic_score_codex":0.00029821738,"about_ca_topic_score_gemma":0.0003308191,"teacher_disagreement_score":0.0028486294,"about_ca_system_score_codex":0.00020061337,"about_ca_system_score_gemma":0.00027329323,"threshold_uncertainty_score":0.009529591},"labels":[],"label_agreement":null},{"id":"W2907345836","doi":"10.1158/1078-0432.ccr-18-2366","title":"Central Nervous System Metastasis in Patients with HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from SystHERs","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Lapatinib; Metastatic breast cancer; Metastasis; Brain metastasis; Internal medicine; Oncology; Breast cancer; Trastuzumab; Cancer","score_opus":0.08659103759164789,"score_gpt":0.42443793086899023,"score_spread":0.33784689327734235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907345836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99731255,0.00047345593,0.000041437368,0.00012503135,0.000006934051,0.00001371194,0.0015622184,0.00000336006,0.0004612933],"genre_scores_gemma":[0.9964483,0.00034842466,0.00006655136,0.000110901754,0.000027705271,0.000026756497,0.0027329756,0.000002128137,0.00023623393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997664,0.000043736738,0.000031761097,0.0000631481,0.000060787224,0.000034245193],"domain_scores_gemma":[0.99910045,0.000121013865,0.0005037645,0.000036642286,0.000098505625,0.00013963989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039539745,0.00015666982,0.00028159664,0.00043016163,0.00025352667,0.0003179365,0.00023215121,0.0002597346,0.0015183302],"category_scores_gemma":[0.0011961533,0.00011360773,0.00031420722,0.0006737107,0.00014071338,0.00032019388,0.00025633248,0.00033565448,0.00021820753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005532804,0.00006502016,0.9964964,0.000024602285,0.00007413987,0.00007561332,0.000022396747,0.000048785096,0.00030254302,0.0000127453,0.00051634817,0.0018080724],"study_design_scores_gemma":[0.00007517765,0.00026326656,0.99837095,0.000015650168,0.000073121955,0.00034069121,0.000058969807,0.0001631784,0.00011597606,0.00002173101,0.0004961259,0.000005157882],"about_ca_topic_score_codex":0.0031241179,"about_ca_topic_score_gemma":0.00777647,"teacher_disagreement_score":0.0031241179,"about_ca_system_score_codex":0.00036208262,"about_ca_system_score_gemma":0.0004432324,"threshold_uncertainty_score":0.006211877},"labels":[],"label_agreement":null},{"id":"W2907461092","doi":"10.1158/1078-0432.ccr-17-3177","title":"TAp73 Modifies Metabolism and Positively Regulates Growth of Cancer Stem–Like Cells in a Redox-Sensitive Manner","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre; Izaak Walton Killam Health Centre; Hamilton Health Sciences; Dalhousie University","funders":"Institute of Cancer Research; Canadian Institutes of Health Research; Government of Canada","keywords":"Stem cell; Cancer stem cell; Biology; Cancer research; Homeobox protein NANOG; Gene knockdown; PIN1; Cancer cell; Radioresistance; Stem cell marker; Cell biology; Cancer; Embryonic stem cell; Cell culture; Induced pluripotent stem cell; Biochemistry; Genetics; Enzyme","score_opus":0.08704335735485506,"score_gpt":0.4470245646643515,"score_spread":0.3599812073094964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907461092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99465334,0.0016811262,0.001987794,0.000100208345,0.000033132805,0.00001721987,0.00030808817,0.00014207125,0.0010769878],"genre_scores_gemma":[0.99814475,0.00044516963,0.00040214718,0.000028331619,0.0000067250385,0.000012053093,0.00018852194,0.000009946415,0.0007623647],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992466,0.00001148421,0.0000050872445,0.000017081047,0.000022960063,0.00001865099],"domain_scores_gemma":[0.9999459,0.0000047895924,0.00001826947,0.0000065093736,0.000009631376,0.000014926887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000072278664,0.0002837624,0.00017371301,0.00021227765,0.00015177665,0.00026107952,0.00016686234,0.0001498234,0.0009605569],"category_scores_gemma":[0.00007501064,0.00006680687,0.00016422867,0.00017218842,0.00020760242,0.00017667354,0.00012417088,0.0002822622,0.00020563926],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092703136,0.000017352962,0.00018837854,0.000020219426,0.0000043613627,0.000035907855,0.0000050620392,0.000031036387,0.9984847,0.00004449549,0.000043724012,0.0010321457],"study_design_scores_gemma":[0.000012050624,0.0001430772,0.003629188,0.0000025143108,0.00001858278,0.00012321529,0.000023718261,0.00068554987,0.9938222,0.00005280903,0.0014838355,0.0000031688437],"about_ca_topic_score_codex":0.00039353262,"about_ca_topic_score_gemma":0.0005582304,"teacher_disagreement_score":0.0009605569,"about_ca_system_score_codex":0.0002794293,"about_ca_system_score_gemma":0.00016901047,"threshold_uncertainty_score":0.0032134056},"labels":[],"label_agreement":null},{"id":"W2908547172","doi":"10.1158/1078-0432.ccr-18-1593","title":"Low-pass Whole-genome Sequencing of Circulating Cell-free DNA Demonstrates Dynamic Changes in Genomic Copy Number in a Squamous Lung Cancer Clinical Cohort","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"Genentech","keywords":"Copy-number variation; Cell-free fetal DNA; Lung cancer; Cancer; Oncology; Internal medicine; Gene dosage; Digital polymerase chain reaction; Medicine; Biology; Cancer research; Genome; Genetics; Gene; Polymerase chain reaction; Gene expression","score_opus":0.05407335958969898,"score_gpt":0.4347490197746901,"score_spread":0.3806756601849911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908547172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968119,0.00026589227,0.0022502781,0.000024168807,0.0000032098858,0.000020410895,0.00034503127,0.000032739055,0.00024628214],"genre_scores_gemma":[0.99737906,0.00008025713,0.0016448804,0.00003473035,0.000004818377,0.000023459581,0.0006074916,0.000008872507,0.0002164068],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999723,0.000032905165,0.000021049607,0.000117248295,0.000079206104,0.000026494312],"domain_scores_gemma":[0.99965644,0.00012608261,0.000071813876,0.00005011471,0.00005901916,0.00003652013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004035854,0.00019263392,0.00025690917,0.0006414656,0.00018875246,0.0003418273,0.00023447338,0.00030732233,0.00094511244],"category_scores_gemma":[0.001047693,0.00012028251,0.00015227633,0.00031161038,0.00022960872,0.00016642522,0.00021684881,0.00021167274,0.00019632374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007284471,0.00008096397,0.62338805,0.00007121147,0.0001339268,0.00048204063,0.00021774454,0.0006696141,0.34799755,0.00009556669,0.00025569875,0.02587923],"study_design_scores_gemma":[0.000032078162,0.00056666974,0.9093137,0.00001110166,0.00008734355,0.003065027,0.0001200927,0.0034685694,0.08194848,0.00012871157,0.0012469054,0.0000112758835],"about_ca_topic_score_codex":0.0014160392,"about_ca_topic_score_gemma":0.0023242603,"teacher_disagreement_score":0.0014160392,"about_ca_system_score_codex":0.00027504537,"about_ca_system_score_gemma":0.00020032839,"threshold_uncertainty_score":0.0031617284},"labels":[],"label_agreement":null},{"id":"W2909211125","doi":"10.1158/1078-0432.ccr-18-0220","title":"Combining Vascular Normalization with an Oncolytic Virus Enhances Immunotherapy in a Preclinical Model of Advanced-Stage Ovarian Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Guelph","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute","keywords":"Oncolytic virus; Ovarian cancer; Medicine; Stage (stratigraphy); Immunotherapy; Normalization (sociology); Oncology; Cancer research; Cancer; Internal medicine; Biology","score_opus":0.14686448932855425,"score_gpt":0.510548833969384,"score_spread":0.36368434464082977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909211125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995452,0.0005161145,0.0031106966,0.00007494269,0.000025671276,0.00009295751,0.000103748585,0.00011108096,0.0005129302],"genre_scores_gemma":[0.9954151,0.00039564652,0.0031920497,0.000025718131,0.000016933667,0.00007003237,0.00014086481,0.00001400387,0.0007296024],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983144,0.000032120937,0.000012370234,0.000026907524,0.000049914648,0.000047119403],"domain_scores_gemma":[0.999866,0.000022820495,0.000051324965,0.000016424105,0.000012658445,0.00003070019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024574643,0.00048698945,0.00039666137,0.00027199404,0.000114641014,0.00028960672,0.00024462643,0.00027457374,0.0006020178],"category_scores_gemma":[0.00013620884,0.00011433129,0.0002974107,0.00015437367,0.00031364275,0.0002466885,0.00017085453,0.0008183351,0.00011577618],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022141324,0.00024315424,0.00015016514,0.000031656644,0.0000060075795,0.000016994234,0.000013120332,0.00025903241,0.9968683,0.000077866775,0.000031625084,0.0020806657],"study_design_scores_gemma":[0.000059911603,0.003063168,0.0011562645,0.0000036340318,0.000019309318,0.000088957066,0.0000081681,0.0014665681,0.99325246,0.00002879018,0.0008499108,0.000002849717],"about_ca_topic_score_codex":0.00071596587,"about_ca_topic_score_gemma":0.0008973834,"teacher_disagreement_score":0.00071596587,"about_ca_system_score_codex":0.00044570674,"about_ca_system_score_gemma":0.00039707925,"threshold_uncertainty_score":0.00323385},"labels":[],"label_agreement":null},{"id":"W2909651539","doi":"10.1158/1078-0432.ccr-18-2792","title":"Integrated Molecular Analysis of Undifferentiated Uterine Sarcomas Reveals Clinically Relevant Molecular Subtypes","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Stockholms Läns Landsting; Radiumhemmets Forskningsfonder; Magnus Bergvalls Stiftelse; Cancerfonden","keywords":"Biology; Immunohistochemistry; Extracellular matrix; Phenotype; Cancer research; Pathology; Gene expression; Leiomyosarcoma; Sarcoma; Copy-number variation; Gene; Medicine; Genetics; Immunology","score_opus":0.11585057728458059,"score_gpt":0.5068512462304975,"score_spread":0.3910006689459169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909651539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99852693,0.00034744482,0.0006435078,0.0000120196255,0.0000012776698,0.000010131968,0.0002744429,0.000011875571,0.00017226853],"genre_scores_gemma":[0.9976109,0.00012089638,0.0014917048,0.000010346246,0.0000030003207,0.0000121210105,0.0006644617,0.0000031612187,0.00008332457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972326,0.000049154598,0.0000365931,0.0000838107,0.00007167506,0.000035525678],"domain_scores_gemma":[0.999624,0.00009767823,0.00012615802,0.00005830676,0.000054706423,0.000039083163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004876342,0.00023488622,0.0002996409,0.0010913184,0.0002294089,0.00042829744,0.00023745206,0.00018825602,0.00057949324],"category_scores_gemma":[0.00091160816,0.00012891747,0.0002394927,0.0007069723,0.0002586458,0.00019593438,0.00045212923,0.00014918418,0.00012129423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005372745,0.00004301261,0.89354,0.000110359535,0.00008691927,0.0006860475,0.00014787173,0.00078037044,0.084110044,0.0001228116,0.00011749248,0.019717867],"study_design_scores_gemma":[0.000027174003,0.00025501565,0.9686683,0.000024180354,0.00019395332,0.0044340864,0.0002622982,0.0046018185,0.01999528,0.0003305904,0.0011960941,0.00001132079],"about_ca_topic_score_codex":0.00072497706,"about_ca_topic_score_gemma":0.0016671766,"teacher_disagreement_score":0.0010913184,"about_ca_system_score_codex":0.00021499718,"about_ca_system_score_gemma":0.00028852996,"threshold_uncertainty_score":0.0025789142},"labels":[],"label_agreement":null},{"id":"W2910164268","doi":"10.1158/1078-0432.ccr-18-0432","title":"CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":672,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health; Deutsche Krebshilfe","keywords":"Cancer; Antigen; Medicine; Cancer research; Solid tumor; Pathology; Immunology; Internal medicine","score_opus":0.14806278979406062,"score_gpt":0.49720794026348103,"score_spread":0.3491451504694204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910164268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859831,0.004484355,0.0045570084,0.00020163793,0.000043218584,0.00017372532,0.00052407995,0.00027707455,0.0037558377],"genre_scores_gemma":[0.9912225,0.0028848045,0.002790626,0.000083179555,0.000019435036,0.00008900474,0.00090416404,0.000037461297,0.001968863],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998981,0.000016033662,0.0000065910804,0.00001547682,0.000027060434,0.000036791273],"domain_scores_gemma":[0.9999119,0.000013801735,0.000019882536,0.0000076425395,0.000013948907,0.000032795426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024110726,0.00038121123,0.00027724268,0.00019955686,0.00013180435,0.00024201607,0.00023873782,0.0003650309,0.0022796427],"category_scores_gemma":[0.00009307357,0.00011334489,0.00025048127,0.00011976932,0.00023153979,0.00025397303,0.00011381006,0.0008258408,0.00055298815],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069859426,0.0006971121,0.0010868916,0.00018751876,0.00003554148,0.00012999342,0.000052616895,0.00068739697,0.98262423,0.00038757455,0.0005919692,0.012820522],"study_design_scores_gemma":[0.00025954688,0.009905544,0.0038144086,0.00001799394,0.00007550609,0.0005836009,0.000034643166,0.0013039884,0.9790908,0.00006437361,0.004844186,0.000005344748],"about_ca_topic_score_codex":0.0014014989,"about_ca_topic_score_gemma":0.0018382532,"teacher_disagreement_score":0.0022796427,"about_ca_system_score_codex":0.00027157218,"about_ca_system_score_gemma":0.000528319,"threshold_uncertainty_score":0.007626176},"labels":[],"label_agreement":null},{"id":"W2910189085","doi":"10.1158/1557-3265.sarcomas17-ia02","title":"Abstract IA02: Modeling sarcoma susceptibility: The Li-Fraumeni syndrome paradigm","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Li–Fraumeni syndrome; Sarcoma; Cancer; Germline; Rhabdomyosarcoma; Medicine; Germline mutation; Mutation; Phenotype; Disease; Genetics; Cancer research; Biology; Gene; Internal medicine; Pathology","score_opus":0.35550486910566403,"score_gpt":0.5366505580109427,"score_spread":0.1811456889052787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910189085","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03565899,0.05027388,0.41749656,0.3401097,0.008521937,0.0002603396,0.002915058,0.0011566138,0.14360702],"genre_scores_gemma":[0.5937398,0.06076773,0.24868101,0.034105774,0.008227372,0.0009013425,0.0020344423,0.00037416493,0.051168334],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99886,0.0007257846,0.00003782111,0.00016599144,0.00016270125,0.000047707337],"domain_scores_gemma":[0.9980678,0.0009803732,0.000185475,0.00018780096,0.00029704667,0.00028146218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029234067,0.00081157085,0.00044785364,0.001459918,0.0006767236,0.0022577955,0.0014039756,0.0012073134,0.004687265],"category_scores_gemma":[0.004492584,0.00027504537,0.0007120401,0.00062688807,0.002415389,0.0023565579,0.0018690588,0.003103933,0.0011385324],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010513366,0.00008409008,0.004046484,0.00029523196,0.0000665095,0.000464565,0.0005724343,0.012733264,0.0017872867,0.78468776,0.107831195,0.08732603],"study_design_scores_gemma":[0.000031196443,0.0001072041,0.0011614803,0.00033163186,0.000055886638,0.000924705,0.00040222995,0.01925108,0.000667073,0.80140704,0.17561594,0.000044596585],"about_ca_topic_score_codex":0.0027260752,"about_ca_topic_score_gemma":0.0024418193,"teacher_disagreement_score":0.004687265,"about_ca_system_score_codex":0.0021456655,"about_ca_system_score_gemma":0.0017586832,"threshold_uncertainty_score":0.015680492},"labels":[],"label_agreement":null},{"id":"W2910269253","doi":"10.1158/1078-0432.ccr-18-2847","title":"Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II–III Melanoma","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health; Swim Across America; U.S. Food and Drug Administration; Herbert Irving Comprehensive Cancer Center, Columbia University","keywords":"Medicine; Oncology; Melanoma; Internal medicine; Proportional hazards model; Stage (stratigraphy); Receiver operating characteristic; Survival analysis; Cohort; Population; Area under the curve; Immunotherapy; Cancer; Cancer research; Biology","score_opus":0.14415378547743973,"score_gpt":0.45528315525464214,"score_spread":0.3111293697772024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910269253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964657,0.00019078632,0.0022019022,0.00005748644,0.000007998434,0.00004166026,0.00043549668,0.000031888158,0.0005670411],"genre_scores_gemma":[0.9986821,0.000019484953,0.0008255706,0.000020367504,0.000010261447,0.000020458123,0.00033979866,0.0000036164495,0.00007830286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996045,0.0001488926,0.000039781615,0.00007034826,0.00009201439,0.00004443745],"domain_scores_gemma":[0.998418,0.00042844325,0.0006112225,0.00011087306,0.00021724604,0.00021433964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001355199,0.00043306453,0.0002865884,0.00073897763,0.00014811235,0.0004293478,0.00022174766,0.00036481832,0.0012520427],"category_scores_gemma":[0.0030778106,0.00009677373,0.00040022403,0.00032957597,0.00021268122,0.0002654208,0.0003902393,0.0005183188,0.00039698844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047371272,0.00005981441,0.98826504,0.0000142629215,0.000052056246,0.000033242362,0.000018944851,0.00046992744,0.0038206873,0.000026888929,0.00018428983,0.006581123],"study_design_scores_gemma":[0.00004890749,0.0008514184,0.98423463,0.000014567621,0.00008697701,0.0006798696,0.000049985385,0.008452987,0.0048513636,0.00012107156,0.0005975183,0.000010658307],"about_ca_topic_score_codex":0.00031663125,"about_ca_topic_score_gemma":0.0002638738,"teacher_disagreement_score":0.001355199,"about_ca_system_score_codex":0.00020498599,"about_ca_system_score_gemma":0.00022743727,"threshold_uncertainty_score":0.007167101},"labels":[],"label_agreement":null},{"id":"W2910527546","doi":"10.1158/1078-0432.ccr-18-3042","title":"Genomic Landscape of Pancreatic Adenocarcinoma in Younger versus Older Patients: Does Age Matter?","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"National Cancer Institute","keywords":"Carcinogenesis; Pancreatic cancer; Transcriptome; Biology; Cohort; Oncology; Cancer; Adenocarcinoma; Gene; Somatic cell; Medicine; Population; Bioinformatics; Cancer research; Internal medicine; Genetics; Gene expression","score_opus":0.12479651735188922,"score_gpt":0.48326242158549404,"score_spread":0.3584659042336048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910527546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949286,0.0019477943,0.00032467197,0.00026358265,0.000012242957,0.0000071289924,0.0018806969,0.000008398324,0.0006268939],"genre_scores_gemma":[0.9977913,0.0004592512,0.00016170405,0.00009645952,0.000021609572,0.0000056546237,0.0013203868,0.000008037223,0.00013565752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995079,0.000110658424,0.000046946072,0.00020898825,0.00006058327,0.00006502637],"domain_scores_gemma":[0.99865156,0.00040710464,0.0005461335,0.00013588797,0.000091788956,0.00016763576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064541056,0.00013140617,0.00039237432,0.0006669864,0.00024804793,0.00070374,0.00023624842,0.00032996867,0.0019734849],"category_scores_gemma":[0.0024961815,0.000097219825,0.00034365823,0.0010587208,0.00023863361,0.00056308974,0.000387837,0.00034479206,0.000311244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044848304,0.000013570365,0.9874701,0.000049728736,0.00014387965,0.00014536131,0.00014096696,0.00009680722,0.0028230024,0.00009899459,0.00030633376,0.008262754],"study_design_scores_gemma":[0.000004848078,0.000073775445,0.99765754,0.0000139257145,0.00005903122,0.00040999925,0.00015517334,0.00016973799,0.00022577547,0.00021491031,0.0010111565,0.000004041599],"about_ca_topic_score_codex":0.0009841509,"about_ca_topic_score_gemma":0.001804919,"teacher_disagreement_score":0.0019734849,"about_ca_system_score_codex":0.00021838362,"about_ca_system_score_gemma":0.00018002439,"threshold_uncertainty_score":0.0066019297},"labels":[],"label_agreement":null},{"id":"W2910852524","doi":"10.1158/1078-0432.ccr-18-2291","title":"Developing Allogeneic Double-Negative T Cells as a Novel Off-the-Shelf Adoptive Cellular Therapy for Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Canadian Cancer Society","keywords":"Adoptive cell transfer; Cancer; Medicine; Cancer therapy; Cell therapy; Cancer research; Immunology; Biology; Immune system; T cell; Internal medicine; Stem cell; Cell biology","score_opus":0.36519421318107037,"score_gpt":0.542524949221723,"score_spread":0.17733073604065264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910852524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97460055,0.0030010515,0.01880452,0.00011701519,0.00007233048,0.00031734185,0.0002146188,0.00012509545,0.0027474915],"genre_scores_gemma":[0.9875777,0.000998549,0.009096685,0.000101211626,0.000024181301,0.00012958578,0.00035479627,0.000016235192,0.001701201],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998599,0.000027753773,0.000013592133,0.000034727404,0.000046458168,0.000017527285],"domain_scores_gemma":[0.9999273,0.00001611283,0.000015163304,0.00001536556,0.000011691596,0.00001447243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021423944,0.00031871887,0.0002127575,0.00020853405,0.000073095885,0.00030319966,0.00023650873,0.0002629965,0.00097654434],"category_scores_gemma":[0.00017695576,0.00008521541,0.00013416405,0.00011454561,0.0001512489,0.00017620834,0.00020446577,0.00047077305,0.00029955493],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016451643,0.00017858924,0.00064510584,0.000058525307,0.000009189861,0.00010540324,0.000033830394,0.000405317,0.9845552,0.0002877929,0.00012906542,0.013427517],"study_design_scores_gemma":[0.000117677635,0.002958984,0.0024464244,0.000018610128,0.00007899983,0.0012887996,0.000026402415,0.0030593418,0.9791753,0.00015920112,0.010663569,0.000006645487],"about_ca_topic_score_codex":0.000074133975,"about_ca_topic_score_gemma":0.0001543697,"teacher_disagreement_score":0.00097654434,"about_ca_system_score_codex":0.00011366635,"about_ca_system_score_gemma":0.00012772629,"threshold_uncertainty_score":0.0032668114},"labels":[],"label_agreement":null},{"id":"W2910893459","doi":"10.1158/1078-0432.ccr-18-2435","title":"Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin Lymphoma","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"Seattle Genetics; Takeda Oncology; Takeda Pharmaceutical Company","keywords":"Brentuximab vedotin; Medicine; Chemotherapy; Stage (stratigraphy); Oncology; Lymphoma; Internal medicine; Hodgkin lymphoma; Biology","score_opus":0.10157173452621963,"score_gpt":0.4519525788486962,"score_spread":0.35038084432247657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910893459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930138,0.005509744,0.000072254166,0.00014559095,0.00005195475,0.00020329317,0.00023990251,0.000010550084,0.00075286586],"genre_scores_gemma":[0.99671364,0.001773174,0.00013053807,0.00035015904,0.00007845775,0.00015637613,0.00027221916,0.0000022499767,0.0005231612],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995784,0.0002640363,0.000027403099,0.000053291926,0.00004208861,0.000034802186],"domain_scores_gemma":[0.99939394,0.00016362216,0.00020453768,0.000030199504,0.00005181257,0.00015588924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090568553,0.00023975795,0.0009360558,0.0002068796,0.00023354031,0.00039124765,0.00019778116,0.0003231332,0.0016142143],"category_scores_gemma":[0.000833772,0.00018354955,0.00051377574,0.00026554987,0.00023082957,0.00026932862,0.00015408895,0.0004766549,0.00019881976],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5712258,0.014831591,0.18026173,0.0026552775,0.0056511103,0.0003209502,0.00042305732,0.00078957697,0.014329145,0.00017363571,0.0047336314,0.2046045],"study_design_scores_gemma":[0.20051582,0.28026256,0.5006645,0.0003248381,0.00400123,0.00056729646,0.00034119023,0.0011705067,0.0021142792,0.00027062718,0.009731248,0.000035824403],"about_ca_topic_score_codex":0.0012591267,"about_ca_topic_score_gemma":0.0040731505,"teacher_disagreement_score":0.99874085,"about_ca_system_score_codex":0.0004177982,"about_ca_system_score_gemma":0.0005906102,"threshold_uncertainty_score":0.0054000616},"labels":[],"label_agreement":null},{"id":"W2911100812","doi":"10.1158/1078-0432.ccr-18-3102","title":"Vaccine-Induced Memory CD8+ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health; Susan G. Komen; National Center for Research Resources; U.S. Department of Defense","keywords":"Breast cancer; CD8; Cancer; Medicine; Immunology; Human breast; Cytotoxic T cell; Virology; Biology; Cancer research; Immune system; Internal medicine; Genetics; In vitro","score_opus":0.14847070663198816,"score_gpt":0.48826244016385645,"score_spread":0.3397917335318683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911100812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98774976,0.0041193306,0.002552719,0.001221768,0.0001946075,0.0005593864,0.0007999627,0.00024820847,0.002554212],"genre_scores_gemma":[0.9899187,0.0025842206,0.0021013792,0.00045646992,0.00013439785,0.0005295563,0.0010649328,0.000028119413,0.0031821593],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997482,0.00009490895,0.000014861315,0.00003933452,0.000025654062,0.00007705065],"domain_scores_gemma":[0.9998585,0.00003094018,0.000022378214,0.000024010173,0.000019461637,0.000044713448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011438461,0.0007746595,0.0005478744,0.0002834555,0.00016727365,0.00052642263,0.00040475265,0.00077601674,0.004185661],"category_scores_gemma":[0.00026726408,0.00020748032,0.00040626642,0.0001489461,0.0004454173,0.00053105416,0.00021421592,0.002136566,0.0005959592],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011970219,0.014953238,0.0011548792,0.0005423754,0.00012730491,0.0001944557,0.00017005495,0.00093540887,0.9318822,0.00095016515,0.002820225,0.034299523],"study_design_scores_gemma":[0.03054324,0.26427275,0.018691463,0.00025809536,0.0005088511,0.0016157996,0.00029662513,0.005031917,0.6420411,0.0013566036,0.035339933,0.000043645192],"about_ca_topic_score_codex":0.0003520316,"about_ca_topic_score_gemma":0.00042709042,"teacher_disagreement_score":0.004185661,"about_ca_system_score_codex":0.00044910196,"about_ca_system_score_gemma":0.00055838627,"threshold_uncertainty_score":0.014002383},"labels":[],"label_agreement":null},{"id":"W2911174524","doi":"10.1158/1078-0432.ccr-18-3325","title":"Postprogression Outcomes for Osimertinib versus Standard-of-Care EGFR-TKI in Patients with Previously Untreated EGFR-mutated Advanced Non–Small Cell Lung Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"AstraZeneca","keywords":"Osimertinib; Medicine; Gefitinib; Internal medicine; Erlotinib; T790M; Hazard ratio; Lung cancer; Oncology; Erlotinib Hydrochloride; Tyrosine-kinase inhibitor; Performance status; Epidermal growth factor receptor; Confidence interval; Cancer","score_opus":0.0551726375942707,"score_gpt":0.5012714979434845,"score_spread":0.44609886034921375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911174524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985557,0.0006939799,0.000054281256,0.0000952276,0.000024144565,0.00008840218,0.000112218266,0.0000059776753,0.00036997593],"genre_scores_gemma":[0.99869126,0.0002688006,0.00007665282,0.00013597634,0.0000481761,0.000119352364,0.0003244603,0.0000017561622,0.00033355865],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9995167,0.00020244603,0.000040986135,0.000072404495,0.000058551686,0.00010895417],"domain_scores_gemma":[0.9988324,0.00026082114,0.00034781257,0.00005766811,0.000048979877,0.0004524249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013691813,0.0006195944,0.0010389765,0.00024984922,0.00034446974,0.00063137617,0.000500697,0.00074582535,0.0017551156],"category_scores_gemma":[0.0012420092,0.0002068802,0.0017283643,0.0001994028,0.0005286635,0.0006652998,0.00031791255,0.0016013745,0.00034649085],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8180475,0.01943208,0.06645565,0.0003662142,0.0020746577,0.00026709173,0.00025980265,0.001738731,0.0062329276,0.00018403574,0.0015607922,0.08338051],"study_design_scores_gemma":[0.09823578,0.64689696,0.24402058,0.000092169605,0.0017101645,0.00042098816,0.0002163974,0.0025482797,0.0035429315,0.00038267596,0.0018820332,0.000051110634],"about_ca_topic_score_codex":0.0005017902,"about_ca_topic_score_gemma":0.0013963119,"teacher_disagreement_score":0.0017551156,"about_ca_system_score_codex":0.00085810304,"about_ca_system_score_gemma":0.00068227656,"threshold_uncertainty_score":0.0072410107},"labels":[],"label_agreement":null},{"id":"W2912476769","doi":"10.1158/1078-0432.ccr-18-0716","title":"Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"National Institute on Deafness and Other Communication Disorders; National Cancer Institute; National Institutes of Health","keywords":"Head and neck squamous-cell carcinoma; microRNA; Cancer research; Biology; DNA methylation; Suppressor; Methylation; Cell growth; Cancer; Head and neck cancer; Gene; Gene expression; Genetics","score_opus":0.056148427722121245,"score_gpt":0.41274236913526746,"score_spread":0.3565939414131462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912476769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98719585,0.002183804,0.007630218,0.000111998845,0.000027022215,0.00010396698,0.0012032173,0.00021527344,0.0013286223],"genre_scores_gemma":[0.98880017,0.00048671878,0.008204957,0.00008025114,0.00000616252,0.000065021035,0.0014789583,0.000028953049,0.0008487567],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979025,0.000028791177,0.000017133256,0.000052317726,0.000083445215,0.000028047867],"domain_scores_gemma":[0.99988353,0.000023481016,0.000042473323,0.000010934058,0.000017360857,0.000022206546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023107819,0.00035687195,0.00033013197,0.00037884642,0.00015542931,0.00027674407,0.00029369607,0.00027333756,0.0009431892],"category_scores_gemma":[0.00024103186,0.00021939373,0.00031821214,0.00016370304,0.00020319513,0.00010044593,0.00016196532,0.000283711,0.00042421298],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014583117,0.000024727698,0.00064245355,0.000029923942,0.000011640416,0.000045532797,0.0000046149275,0.00022634366,0.99692196,0.00006461833,0.000041271378,0.0018411105],"study_design_scores_gemma":[0.000030893523,0.0005592806,0.012264817,0.000005162816,0.00007661651,0.0006079288,0.000015155848,0.0045835096,0.9797497,0.00012272918,0.00197614,0.000007931056],"about_ca_topic_score_codex":0.0008136553,"about_ca_topic_score_gemma":0.001479566,"teacher_disagreement_score":0.0009431892,"about_ca_system_score_codex":0.00046098567,"about_ca_system_score_gemma":0.00045354245,"threshold_uncertainty_score":0.003344655},"labels":[],"label_agreement":null},{"id":"W2913581799","doi":"10.1158/1078-0432.ccr-18-3205","title":"Tissue 2-Hydroxyglutarate as a Biomarker for <i>Isocitrate Dehydrogenase</i> Mutations in Gliomas","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Princess Margaret Cancer Foundation","keywords":"Isocitrate dehydrogenase; Glioma; Biomarker; IDH1; Medicine; Internal medicine; Pathology; Oncology; Mutation; Biology; Cancer research; Genetics; Enzyme; Gene; Biochemistry","score_opus":0.21092626147187787,"score_gpt":0.550235907418832,"score_spread":0.3393096459469541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913581799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976987,0.0011997218,0.00062223244,0.000025617275,0.000005131313,0.000008982446,0.00006574241,0.000026726202,0.00034718018],"genre_scores_gemma":[0.9989919,0.00015225586,0.0006767679,0.000013811252,0.0000054258294,0.000005578377,0.000085144224,0.000002839857,0.00006626531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997807,0.00007057127,0.000022886064,0.000046733272,0.000053520213,0.000025593486],"domain_scores_gemma":[0.999522,0.00013347759,0.00015918662,0.000028379503,0.00008976179,0.00006731854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005187258,0.00035604008,0.0002572837,0.0009495875,0.000109212735,0.0003975059,0.00016055944,0.0002445024,0.0005849738],"category_scores_gemma":[0.0010098496,0.00013311833,0.00013217475,0.0003458684,0.00025701305,0.00020502078,0.00014381364,0.00024827436,0.00028071154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002160005,0.00009266479,0.87879914,0.000097815304,0.00011085152,0.00032895128,0.000068176836,0.00042583776,0.10151838,0.000036935904,0.00014655823,0.016214652],"study_design_scores_gemma":[0.00005445283,0.0014774643,0.88918823,0.000026030553,0.00021111903,0.0044903737,0.00016105399,0.0048517473,0.09871013,0.000115683004,0.00069415104,0.000019638925],"about_ca_topic_score_codex":0.00050001213,"about_ca_topic_score_gemma":0.0005250458,"teacher_disagreement_score":0.0009495875,"about_ca_system_score_codex":0.00018670384,"about_ca_system_score_gemma":0.00015104683,"threshold_uncertainty_score":0.0027433038},"labels":[],"label_agreement":null},{"id":"W2914383329","doi":"10.1158/1078-0432.ccr-18-2700","title":"Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Ottawa Hospital","funders":"","keywords":"Nomogram; Medicine; Resection; Sarcoma; Overall survival; Oncology; Surgery; Radiology; Pathology","score_opus":0.1877519679765976,"score_gpt":0.48272904545825895,"score_spread":0.29497707748166135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914383329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985322,0.00016025946,0.0006546531,0.00005598907,0.000006871523,0.00002146662,0.00029437768,0.000010441342,0.00026361458],"genre_scores_gemma":[0.99867564,0.00008903835,0.00043227847,0.000014644347,0.000014232175,0.000023723018,0.00069879944,0.00000347162,0.000048146416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952245,0.00021787312,0.00004832922,0.000096024705,0.00007834872,0.000036850055],"domain_scores_gemma":[0.997931,0.00096676435,0.0005744048,0.00016613418,0.00015064554,0.00021119266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002088645,0.0005006128,0.0004026631,0.0013336779,0.00028954487,0.00068872754,0.00041877697,0.0003590158,0.0010291865],"category_scores_gemma":[0.005270638,0.00017422359,0.00051472423,0.00076828484,0.00031994304,0.0007148099,0.00059140223,0.00043222235,0.00027383183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002083874,0.000021043512,0.99445057,0.00001245489,0.000058883736,0.000050553313,0.00005153761,0.00027621305,0.000101591686,0.0000131870665,0.0001245682,0.00463094],"study_design_scores_gemma":[0.00007560712,0.00052036095,0.9897057,0.000024708233,0.00013586678,0.00097062165,0.0002904925,0.0072348486,0.00020231101,0.00012485268,0.000699442,0.000015276313],"about_ca_topic_score_codex":0.001093385,"about_ca_topic_score_gemma":0.001113776,"teacher_disagreement_score":0.002088645,"about_ca_system_score_codex":0.00033964225,"about_ca_system_score_gemma":0.00034108394,"threshold_uncertainty_score":0.011045992},"labels":[],"label_agreement":null},{"id":"W2914742512","doi":"10.1158/1078-0432.ccr-18-1122","title":"Keratinocyte Carcinomas: Current Concepts and Future Research Priorities","year":2019,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Genentech; National Cancer Institute; National Institutes of Health; LEO Pharma; Galderma; Cancer Research UK; Castle Biosciences; Regeneron Pharmaceuticals; Sanofi; Valeant Pharmaceuticals International; Pfizer","keywords":"Basal cell carcinoma; Keratinocyte; Microbiome; Skin cancer; Carcinogenesis; Immune system; Immunology; Immunosuppression; Medicine; Carcinoma; Cancer research; Biology; Cancer; Oncology; Bioinformatics; Internal medicine; Basal cell; Genetics","score_opus":0.7242988999928114,"score_gpt":0.699467554352779,"score_spread":0.02483134564003242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914742512","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033639844,0.99855214,0.000063663145,0.0007234742,0.00028399608,0.000004008364,0.000014378606,0.000005171783,0.0003194799],"genre_scores_gemma":[0.0003441517,0.99867034,0.00014713207,0.0003586391,0.0002795356,0.0000068291833,0.000019163881,0.0000011399613,0.00017311993],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99921715,0.0002163863,0.00015883848,0.00011544124,0.00021768219,0.000074641306],"domain_scores_gemma":[0.996296,0.0021500338,0.00035301008,0.000091735026,0.0009389179,0.00017035747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026827764,0.0010284613,0.0024845116,0.0036554378,0.00050478487,0.0025670547,0.0015013702,0.002103504,0.007011354],"category_scores_gemma":[0.0039137974,0.00039129838,0.0012959266,0.0038480582,0.0010891327,0.004338877,0.0011416189,0.002762568,0.0019181133],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014117146,0.00008720843,0.0003215998,0.0767426,0.00017414619,0.00024878175,0.0001790712,0.00028786017,0.0006426267,0.008044295,0.04465324,0.86847746],"study_design_scores_gemma":[0.000024759222,0.000098057506,0.0008947596,0.034548305,0.00031953925,0.0011534165,0.00034439022,0.00009136636,0.0001753447,0.007094807,0.95522213,0.0000331578],"about_ca_topic_score_codex":0.0020660136,"about_ca_topic_score_gemma":0.003372342,"teacher_disagreement_score":0.007011354,"about_ca_system_score_codex":0.0013614414,"about_ca_system_score_gemma":0.004904095,"threshold_uncertainty_score":0.023455322},"labels":[],"label_agreement":null},{"id":"W2915611428","doi":"10.1158/1078-0432.ccr-18-4099","title":"Clonotypic Diversity of the T-cell Receptor Corroborates the Immature Precursor Origin of Cutaneous T-cell Lymphoma","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Novo Nordisk Fonden; University of Alberta; Kræftens Bekæmpelse; Canadian Dermatology Foundation","keywords":"Lymphoma; Biology; Receptor; Cell; Immunology; Cancer research; Genetics","score_opus":0.09349993334393683,"score_gpt":0.4264704848692246,"score_spread":0.33297055152528776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915611428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985606,0.00020635102,0.00065230945,0.000004359744,0.0000011909684,0.000006081367,0.00006611093,0.000016299293,0.00048668802],"genre_scores_gemma":[0.9993773,0.000051120453,0.00036790653,0.0000053763174,0.0000014850809,0.0000035788044,0.000100912475,0.0000038367366,0.00008862117],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999107,0.00001312478,0.000008851077,0.000029043105,0.000019048715,0.000019225727],"domain_scores_gemma":[0.9998159,0.000058076188,0.000027610811,0.0000386983,0.0000305345,0.000029207082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010900466,0.00012959116,0.00011909546,0.0003116291,0.000106482876,0.00018421635,0.000100516736,0.00015478846,0.0016650591],"category_scores_gemma":[0.00023730494,0.00006616796,0.000082748964,0.00015788033,0.00014665653,0.00011722913,0.00012282745,0.00020608916,0.00035650743],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018513347,0.00001801332,0.021943543,0.00004210477,0.000008363089,0.00060996617,0.000083221115,0.000044762877,0.974484,0.00003738046,0.000016655036,0.0025268875],"study_design_scores_gemma":[0.000039465693,0.0011443761,0.45521688,0.00002633564,0.00013554507,0.034832824,0.00041473308,0.003097302,0.50236607,0.0003027901,0.0024108647,0.000012846649],"about_ca_topic_score_codex":0.00028890377,"about_ca_topic_score_gemma":0.00031373216,"teacher_disagreement_score":0.0016650591,"about_ca_system_score_codex":0.00009256472,"about_ca_system_score_gemma":0.000056295503,"threshold_uncertainty_score":0.0055701733},"labels":[],"label_agreement":null},{"id":"W2917891638","doi":"10.1158/1078-0432.ccr-18-2599","title":"Multiplexed (18-Plex) Measurement of Signaling Targets and Cytotoxic T Cells in Trastuzumab-Treated Patients using Imaging Mass Cytometry","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fluidigm (Canada)","funders":"Hellenic Cooperative Oncology Group; National Cancer Institute; National Center for Advancing Translational Sciences; National Human Genome Research Institute; National Institute of General Medical Sciences; Breast Cancer Research Foundation","keywords":"Trastuzumab; Cytotoxic T cell; Medicine; Cancer research; Mass cytometry; CD8; PI3K/AKT/mTOR pathway; Antibody; Immune system; Internal medicine; Oncology; Cancer; Immunology; Breast cancer; Biology; Signal transduction; Cell biology; Phenotype","score_opus":0.3013185643104747,"score_gpt":0.5159816777818874,"score_spread":0.2146631134714127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917891638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971392,0.00028913445,0.001643255,0.000034180943,0.000009005725,0.000051717077,0.00030832874,0.000040005194,0.00048515567],"genre_scores_gemma":[0.9971258,0.00009307679,0.0017737391,0.000068954556,0.000020405972,0.000072116076,0.00042292345,0.0000037577583,0.00041922543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99959975,0.00008636981,0.000034471715,0.00013450248,0.00010226273,0.000042691656],"domain_scores_gemma":[0.9996586,0.00008907016,0.00012707782,0.00002938878,0.0000479898,0.00004785927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051478384,0.00030446667,0.00034035972,0.0006597007,0.00013678934,0.0005516599,0.00019264383,0.0003083889,0.0008785241],"category_scores_gemma":[0.0007340753,0.00011858539,0.00014291481,0.00042166753,0.00016598593,0.00017639226,0.00018107297,0.0004016328,0.00022865881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005229649,0.0011632646,0.73439103,0.00010313638,0.00015640566,0.00061764114,0.00030797618,0.0020134596,0.21612455,0.00015981784,0.00090974616,0.03882325],"study_design_scores_gemma":[0.00033644418,0.0061209863,0.7788195,0.000021873702,0.0002554627,0.0030151068,0.00016417156,0.016828347,0.19139092,0.00028006377,0.0027329565,0.000034204495],"about_ca_topic_score_codex":0.0002543542,"about_ca_topic_score_gemma":0.00024552838,"teacher_disagreement_score":0.0008785241,"about_ca_system_score_codex":0.00028605934,"about_ca_system_score_gemma":0.000118216194,"threshold_uncertainty_score":0.0029389262},"labels":[],"label_agreement":null},{"id":"W2921298834","doi":"10.1158/1078-0432.ccr-18-3767","title":"PD-1 Blockade Following Isolated Limb Perfusion with Vaccinia Virus Prevents Local and Distant Relapse of Soft-tissue Sarcoma","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Rosetrees Trust; Royal College of Surgeons of England; National Institute for Health and Care Research; Sarcoma UK; Cancer Research UK; Wellcome Trust; Wellcome","keywords":"Oncolytic virus; Sarcoma; Medicine; Soft tissue sarcoma; Cancer research; Blockade; Vaccinia; Immune checkpoint; In vivo; Ex vivo; Immune system; Immunology; Immunotherapy; Pathology; Internal medicine; Biology; Receptor","score_opus":0.04330766504549396,"score_gpt":0.4263609598860653,"score_spread":0.3830532948405714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921298834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982078,0.00053331465,0.0006709691,0.000021582751,0.000015203025,0.000025222038,0.000055125838,0.000043798933,0.00042692912],"genre_scores_gemma":[0.99848723,0.00023146412,0.0004103455,0.000013250069,0.0000068326076,0.000019606457,0.0001311273,0.0000070623646,0.000693131],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994314,0.0000078552575,0.0000034221093,0.000012818838,0.000010370404,0.000022337974],"domain_scores_gemma":[0.9999341,0.000014584285,0.000018542483,0.000008477135,0.0000049595787,0.000019277804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007414783,0.00028059434,0.00024118241,0.00012948913,0.00007294443,0.00018692794,0.00017384093,0.00014941937,0.0010018063],"category_scores_gemma":[0.00008436007,0.00007594928,0.00014793323,0.000058596903,0.00019074694,0.000116197014,0.00010515697,0.00059514266,0.0002288743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047294286,0.0003360406,0.00030081146,0.00005076968,0.000005803299,0.00003942579,0.000018128767,0.00018585786,0.99290437,0.000056346747,0.00007560975,0.0055539715],"study_design_scores_gemma":[0.00011241187,0.0063184067,0.003909287,0.000010733533,0.000021174063,0.0002680608,0.000022705754,0.0014915464,0.98677397,0.000031078594,0.0010375386,0.000003044307],"about_ca_topic_score_codex":0.00034792162,"about_ca_topic_score_gemma":0.00048435113,"teacher_disagreement_score":0.0010018063,"about_ca_system_score_codex":0.00016451329,"about_ca_system_score_gemma":0.00021910608,"threshold_uncertainty_score":0.0033513904},"labels":[],"label_agreement":null},{"id":"W2922113267","doi":"10.1158/1078-0432.ccr-18-3791","title":"HERC3-Mediated SMAD7 Ubiquitination Degradation Promotes Autophagy-Induced EMT and Chemoresistance in Glioblastoma","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"National Natural Science Foundation of China","keywords":"Autophagy; Cancer research; Downregulation and upregulation; U87; Biology; Temozolomide; Glioma; Epithelial–mesenchymal transition; Brain tumor; Pathology; Medicine; Apoptosis; Gene","score_opus":0.12349272573939302,"score_gpt":0.4866531611964809,"score_spread":0.36316043545708787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922113267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950117,0.002115909,0.00077602797,0.000115979026,0.0000174519,0.000023103787,0.00082812284,0.000073194016,0.0010385863],"genre_scores_gemma":[0.99777216,0.0005412418,0.00033504833,0.000049943126,0.0000044275757,0.000013235934,0.0006712431,0.0000066366147,0.00060615025],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998933,0.000012932133,0.000009041749,0.000014345123,0.00003372788,0.00003661074],"domain_scores_gemma":[0.99992466,0.0000055681703,0.000023707744,0.000008257862,0.000019787092,0.000018047083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012916319,0.0002525744,0.00027556586,0.00048760002,0.00025007204,0.00031031898,0.00009388734,0.00017065916,0.0010730476],"category_scores_gemma":[0.00008707358,0.00010027128,0.00034829514,0.00029482358,0.00019461189,0.000096889984,0.00018062825,0.00028355498,0.00022852649],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005772422,0.00005696043,0.0031806496,0.00012472819,0.00002601688,0.00015278447,0.000016298658,0.00019343555,0.9928878,0.00009692632,0.00021277486,0.0024743876],"study_design_scores_gemma":[0.000040759085,0.00020462468,0.059561823,0.000017519636,0.000050055518,0.00057302334,0.000085844746,0.00228352,0.9345719,0.00010109014,0.0024983916,0.000011429277],"about_ca_topic_score_codex":0.0017337045,"about_ca_topic_score_gemma":0.0029604055,"teacher_disagreement_score":0.0017337045,"about_ca_system_score_codex":0.0006061343,"about_ca_system_score_gemma":0.0004338893,"threshold_uncertainty_score":0.0043978095},"labels":[],"label_agreement":null},{"id":"W2925764871","doi":"10.1158/1078-0432.ccr-18-2811","title":"Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation Combination","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Axon Guidance and Neuronal Signaling","field":"Neuroscience","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; AstraZeneca; Genentech; Institute of Cancer Research; National Cancer Institute; Radiological Society of North America; U.S. Department of Veterans Affairs","keywords":"Cancer research; Stromal cell; Tumor microenvironment; Fibrosis; Stroma; Tumor progression; In vivo; Radiation therapy; Pancreatic tumor; Pancreatic cancer; Medicine; Biology; Immunology; Pathology; Cancer; Internal medicine; Tumor cells; Immunohistochemistry","score_opus":0.12917069821093818,"score_gpt":0.4312660463519997,"score_spread":0.30209534814106154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2925764871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99493897,0.0019695263,0.0012093598,0.00008231076,0.00005765347,0.00008097207,0.00011129085,0.00006182059,0.0014880452],"genre_scores_gemma":[0.9965431,0.0010197507,0.00094812206,0.000044021876,0.000024759307,0.00010038724,0.00015126888,0.000010546244,0.001158196],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998913,0.00002443119,0.000011098156,0.000017970024,0.000026077947,0.000029104816],"domain_scores_gemma":[0.99995077,0.000008030496,0.000011813277,0.000008668004,0.0000035527205,0.00001709673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015403169,0.00035313767,0.00046560302,0.00025884612,0.0001557073,0.0002558959,0.00024422372,0.00021901815,0.0015401021],"category_scores_gemma":[0.000094439914,0.00011722657,0.00029816278,0.00019614899,0.00021214492,0.00017609581,0.00024060546,0.0006596124,0.00021424351],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042067543,0.0020287524,0.00082236086,0.00020677934,0.000102294594,0.00012204939,0.000038137092,0.0010712242,0.9735752,0.00015296995,0.00034787474,0.017325554],"study_design_scores_gemma":[0.00087956333,0.015464924,0.005326575,0.00001586406,0.00018978475,0.00041074434,0.000042284675,0.0020388097,0.969877,0.00007248513,0.0056677777,0.000014235513],"about_ca_topic_score_codex":0.00028670725,"about_ca_topic_score_gemma":0.0005652932,"teacher_disagreement_score":0.0015401021,"about_ca_system_score_codex":0.00015817175,"about_ca_system_score_gemma":0.00026078374,"threshold_uncertainty_score":0.0051521063},"labels":[],"label_agreement":null},{"id":"W2928679018","doi":"10.1158/1078-0432.ccr-18-2683","title":"Ultra-sensitive <i>EGFR</i> T790M Detection as an Independent Prognostic Marker for Lung Cancer Patients Harboring <i>EGFR</i> del19 Mutations and Treated with First-generation TKIs","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"T790M; Lung cancer; Mutation; Medicine; Digital polymerase chain reaction; Internal medicine; Oncology; Cancer; Incidence (geometry); Clinical significance; Tyrosine kinase; Cancer research; Epidermal growth factor receptor; Biology; Gene; Polymerase chain reaction; Gefitinib; Genetics","score_opus":0.06552080965534572,"score_gpt":0.4572230571841265,"score_spread":0.39170224752878074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2928679018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993274,0.00025072892,0.00021841306,0.000013624492,0.0000029156045,0.0000059091094,0.000052198684,0.0000042522897,0.00012458148],"genre_scores_gemma":[0.9995939,0.00004294167,0.000193384,0.000011834157,0.000005055634,0.0000047418066,0.000093885945,7.9569173e-7,0.000053446056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977905,0.000048485865,0.000021824819,0.000062627005,0.00005636261,0.00003163764],"domain_scores_gemma":[0.999356,0.00020577716,0.0002531363,0.000040385403,0.000059030688,0.0000856369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042652126,0.00014775334,0.00027197978,0.0003703742,0.00014364603,0.0003591031,0.00017900544,0.00027289486,0.00067083625],"category_scores_gemma":[0.00081384263,0.00012164683,0.0001514056,0.00022701175,0.00025395365,0.0001994393,0.00017758692,0.00029621625,0.00015181834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011373181,0.00010131051,0.9491148,0.000027323918,0.00003840157,0.0001367935,0.0000339642,0.0001102726,0.044350274,0.000019378627,0.00006390853,0.004866172],"study_design_scores_gemma":[0.000030263838,0.0010463372,0.9748497,0.000005874947,0.000077286284,0.0014393162,0.000060410635,0.0015575206,0.020511935,0.00004457155,0.00036814442,0.000008662759],"about_ca_topic_score_codex":0.00028623393,"about_ca_topic_score_gemma":0.000381525,"teacher_disagreement_score":0.00067083625,"about_ca_system_score_codex":0.00020524433,"about_ca_system_score_gemma":0.00016706789,"threshold_uncertainty_score":0.0022556782},"labels":[],"label_agreement":null},{"id":"W2932040760","doi":"10.1158/1078-0432.ccr-18-3179","title":"Clinical and Genome-wide Analysis of Cisplatin-induced Tinnitus Implicates Novel Ototoxic Mechanisms","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hearing, Cochlea, Tinnitus, Genetics","field":"Neuroscience","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"National Institute of General Medical Sciences; National Institutes of Health; National Cancer Institute; National Institute for Health and Care Research","keywords":"Tinnitus; Medicine; Cisplatin; Genome-wide association study; Internal medicine; Logistic regression; Vertigo; SNP; Oncology; Audiology; Single-nucleotide polymorphism; Chemotherapy; Surgery; Genetics; Biology; Genotype","score_opus":0.37200874438749126,"score_gpt":0.5347343641947591,"score_spread":0.1627256198072678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2932040760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997603,0.00063942734,0.000857261,0.00008957886,0.0000074999516,0.000011046684,0.00047733696,0.000019510137,0.00029540635],"genre_scores_gemma":[0.99918693,0.00015181258,0.0002450218,0.000028169705,0.000007757129,0.000006087155,0.00025537645,0.000004953742,0.00011390423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995919,0.00010497303,0.000048072296,0.0001229657,0.00009088184,0.000041212166],"domain_scores_gemma":[0.99842346,0.0003856593,0.0007558408,0.00014256746,0.0001662176,0.00012630211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052397145,0.0002643036,0.00033645445,0.00071296626,0.00025473037,0.0005362631,0.00029575598,0.00027433067,0.0026416807],"category_scores_gemma":[0.0019867935,0.00017624583,0.0004890591,0.0010175253,0.00034319365,0.0001992156,0.00042936564,0.00036939222,0.00025384472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011870085,0.000069645066,0.96644866,0.00009029586,0.0004289168,0.00050284667,0.00009065031,0.0002483074,0.021542657,0.00008747954,0.000290355,0.009013214],"study_design_scores_gemma":[0.000027183103,0.00015275797,0.9963595,0.00000948821,0.00023028313,0.00085538573,0.000057701047,0.00061253714,0.0013131252,0.00010995401,0.00026698512,0.0000049873343],"about_ca_topic_score_codex":0.0012144812,"about_ca_topic_score_gemma":0.0012612592,"teacher_disagreement_score":0.0026416807,"about_ca_system_score_codex":0.00019259479,"about_ca_system_score_gemma":0.0002810677,"threshold_uncertainty_score":0.008837283},"labels":[],"label_agreement":null},{"id":"W2933974970","doi":"10.1158/1078-0432.ccr-18-3558","title":"Molecular Characterization of Neuroendocrine-like Bladder Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AXYS Technologies (Canada); University of British Columbia","funders":"","keywords":"Bladder cancer; Cystectomy; Medicine; Cohort; Oncology; Internal medicine; Subtyping; Cancer; Neuroendocrine tumors; Pathology; Prospective cohort study","score_opus":0.13018276175129784,"score_gpt":0.49513753211973555,"score_spread":0.3649547703684377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2933974970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976815,0.00033013045,0.0012102688,0.00004535613,0.0000032124901,0.0000116408555,0.00048992777,0.000014653005,0.00021333004],"genre_scores_gemma":[0.9977902,0.000082395476,0.0009634927,0.000015887348,0.0000030793005,0.000009961162,0.0010417423,0.0000028292548,0.00009037953],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997868,0.000050596896,0.000020273925,0.00006507646,0.00005436554,0.000022962722],"domain_scores_gemma":[0.9995666,0.000111678055,0.00013053599,0.000050175244,0.000093481154,0.000047448415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005966366,0.00018769449,0.00026057794,0.0005938168,0.00019659816,0.00039803033,0.000297506,0.0002026582,0.00047026217],"category_scores_gemma":[0.0010834035,0.000090024034,0.00023542969,0.00048758258,0.00017028222,0.00015188046,0.0002653001,0.00025693906,0.00015404548],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038662198,0.000058480462,0.931307,0.00008329913,0.00009677891,0.00020783684,0.000088194036,0.0022799456,0.05304161,0.00010529976,0.0003555191,0.011989483],"study_design_scores_gemma":[0.000012403984,0.00017596166,0.9757524,0.0000173354,0.00006785777,0.0009991974,0.00013000522,0.011370418,0.0104554985,0.00022900512,0.00078058057,0.000009140726],"about_ca_topic_score_codex":0.0011144149,"about_ca_topic_score_gemma":0.0020055643,"teacher_disagreement_score":0.0011144149,"about_ca_system_score_codex":0.00028637834,"about_ca_system_score_gemma":0.0002970845,"threshold_uncertainty_score":0.0031554103},"labels":[],"label_agreement":null},{"id":"W2937760511","doi":"10.1158/1078-0432.ccr-18-3818","title":"Proteomics-Derived Biomarker Panel Improves Diagnostic Precision to Classify Endometrioid and High-grade Serous Ovarian Carcinoma","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Alberta; Western University","funders":"","keywords":"Biomarker; Serous fluid; Ovarian cancer; Ovarian carcinoma; Proteomics; Medicine; Oncology; Serous carcinoma; Carcinoma; Pathology; Internal medicine; Cancer; Biology","score_opus":0.15454026730898407,"score_gpt":0.4503316551360649,"score_spread":0.2957913878270808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2937760511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413705,0.00088609237,0.003987937,0.000100422694,0.000013885762,0.000036057994,0.0003864854,0.00006785848,0.00038423514],"genre_scores_gemma":[0.99260956,0.00018651476,0.005995119,0.00011012812,0.000014624633,0.00002562027,0.0008083128,0.0000070745464,0.00024303967],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993255,0.0001738107,0.00005799132,0.00017379894,0.00020742176,0.00006148496],"domain_scores_gemma":[0.999342,0.00025339122,0.00013631977,0.000063068524,0.00014095748,0.00006433372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016441207,0.0004670851,0.00047363233,0.000857312,0.00019451095,0.00075274537,0.00026418295,0.00043715604,0.00075245637],"category_scores_gemma":[0.0017135824,0.00020922972,0.00028967133,0.0004047629,0.00018437713,0.00035147916,0.0004075436,0.0004462988,0.00026438778],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026142118,0.0003556967,0.17117019,0.00020514781,0.00036620215,0.00013082537,0.00008941933,0.0020482484,0.7867807,0.00007715937,0.0005738541,0.03558836],"study_design_scores_gemma":[0.00014884486,0.002376163,0.65402657,0.00006241311,0.00053636887,0.0013586042,0.00015711485,0.03731376,0.30137247,0.0003817306,0.0022164765,0.000049492486],"about_ca_topic_score_codex":0.0002999476,"about_ca_topic_score_gemma":0.00054163823,"teacher_disagreement_score":0.0016441207,"about_ca_system_score_codex":0.00021962794,"about_ca_system_score_gemma":0.00020617405,"threshold_uncertainty_score":0.008695066},"labels":[],"label_agreement":null},{"id":"W2939485990","doi":"10.1158/1078-0432.ccr-19-0624","title":"Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":597,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lung cancer; Medicine; Cancer; Cell-free fetal DNA; Cell; Oncology; Pathology; Bioinformatics; Internal medicine; Biology; Genetics","score_opus":0.06481302330116015,"score_gpt":0.4362565269020118,"score_spread":0.37144350360085165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939485990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984132,0.00037243392,0.0003055493,0.000101498816,0.000009843349,0.000017838203,0.00017633957,0.000012307297,0.0005909388],"genre_scores_gemma":[0.9993247,0.00004248802,0.00036025207,0.000054772616,0.000008537032,0.0000063398406,0.00013290587,0.0000013242585,0.00006867699],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915135,0.00029055847,0.000082684004,0.00024807957,0.0001596511,0.00006770712],"domain_scores_gemma":[0.9972459,0.0013435326,0.0005497729,0.00016192638,0.00039936017,0.00029954416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012843418,0.00020256103,0.00033181155,0.00050542114,0.0001999656,0.0006033541,0.0002768779,0.00046800004,0.00093773665],"category_scores_gemma":[0.0054299943,0.00017724671,0.00016499935,0.0003241842,0.0002443707,0.00037402537,0.000287315,0.00036971614,0.0002368192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005791205,0.00004283365,0.98988545,0.000013554516,0.000025980644,0.00009351358,0.000037345246,0.00014870387,0.0015574277,0.000017256703,0.00022879029,0.0073701064],"study_design_scores_gemma":[0.00007254211,0.0012280238,0.98749626,0.000024741023,0.00006963989,0.0013513538,0.00016185445,0.0049273414,0.0038580543,0.000086500535,0.0007110395,0.000012666569],"about_ca_topic_score_codex":0.0010641788,"about_ca_topic_score_gemma":0.0023509187,"teacher_disagreement_score":0.0012843418,"about_ca_system_score_codex":0.00041117,"about_ca_system_score_gemma":0.00029347133,"threshold_uncertainty_score":0.0067923665},"labels":[],"label_agreement":null},{"id":"W2939906752","doi":"10.1158/1078-0432.ccr-17-0375","title":"High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing Sarcoma","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Optometric Education Trust Fund; Dalhousie University; Izaak Walton Killam Health Centre","funders":"National Cancer Institute; Pediatric Cancer Research Foundation","keywords":"Sarcoma; Ewing's sarcoma; Cancer research; Medicine; Focal adhesion; Aurora inhibitor; Aurora kinase; Kinase; Malignancy; Aurora B kinase; Cell growth; Internal medicine; Pathology; Cell; Biology; Cancer; Cell cycle; Cell biology; Biochemistry","score_opus":0.07070187374029319,"score_gpt":0.4188239804210002,"score_spread":0.34812210668070703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939906752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807468,0.006114108,0.0046136105,0.00034961678,0.00005431938,0.0007983335,0.0020000592,0.00027570006,0.0050473246],"genre_scores_gemma":[0.9856278,0.003986935,0.005799767,0.00016117057,0.00002516599,0.00022359168,0.0018860648,0.0000208521,0.0022686077],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997298,0.000054348187,0.000022506138,0.000049626695,0.00010047207,0.000043211265],"domain_scores_gemma":[0.99987483,0.000029331039,0.000025880256,0.000010927146,0.000025763655,0.000033297587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035526688,0.0007196646,0.0008583193,0.0010577762,0.00032406708,0.00047581122,0.00038124758,0.00032972524,0.0023905514],"category_scores_gemma":[0.00023281998,0.0003177068,0.00057825545,0.0006349289,0.00021566403,0.00024723876,0.000372729,0.00052456337,0.00042463193],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006306842,0.0014516613,0.0016810084,0.00037636448,0.00018296739,0.00022443089,0.000025456866,0.0028067525,0.97051203,0.00016409274,0.00068853045,0.021256099],"study_design_scores_gemma":[0.0011046177,0.02094228,0.013898749,0.00005909939,0.00086214975,0.0013052246,0.000085264226,0.008689888,0.94283557,0.00017436052,0.009995172,0.000047552283],"about_ca_topic_score_codex":0.0007302476,"about_ca_topic_score_gemma":0.0031466386,"teacher_disagreement_score":0.0023905514,"about_ca_system_score_codex":0.00042396315,"about_ca_system_score_gemma":0.00060043304,"threshold_uncertainty_score":0.007997215},"labels":[],"label_agreement":null},{"id":"W2940145740","doi":"10.1158/1078-0432.ccr-18-3691","title":"Survival Following Chemotherapy in Ovarian Clear Cell Carcinoma Is Not Associated with Pathological Misclassification of Tumor Histotype","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"Medical Research and Materiel Command; National Health and Medical Research Council","keywords":"Clear cell carcinoma; Oncology; Medicine; Clear cell; Ovarian cancer; Clear-cell adenocarcinoma; Internal medicine; Olaparib; Chemotherapy; Exome sequencing; ARID1A; Exome; Cancer; Serous fluid; Carcinoma; Progression-free survival; Biology; Mutation; Gene","score_opus":0.19237824006158244,"score_gpt":0.4506798602280149,"score_spread":0.25830162016643243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940145740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997793,0.000059461006,0.00005526098,0.0000061096125,7.822093e-7,0.0000015187693,0.00004327188,8.182112e-7,0.00005344419],"genre_scores_gemma":[0.9998073,0.000018529316,0.000030007945,0.0000047160456,7.1344925e-7,0.0000015100034,0.00010807493,6.4892924e-7,0.000028457349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997136,0.00007387864,0.000034734076,0.00008657328,0.000053850417,0.00003738671],"domain_scores_gemma":[0.998601,0.00040654282,0.0005889888,0.00016960903,0.00012116327,0.0001126135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006187815,0.0001270749,0.00022208683,0.00025447403,0.00024625915,0.00033006334,0.00014580361,0.00021639606,0.0008153524],"category_scores_gemma":[0.0026278084,0.00010853273,0.0002048998,0.0003068773,0.00026796883,0.00022930787,0.00038255422,0.00021597084,0.00011055033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003902323,0.000012633835,0.9954195,0.000009277129,0.000035641333,0.00008746209,0.0000747491,0.00008059406,0.0020089105,0.000010212017,0.000020358488,0.001850484],"study_design_scores_gemma":[0.0000064877645,0.0001099044,0.99839383,0.000002752967,0.000029823801,0.00036038857,0.000058428708,0.0004595763,0.00044060627,0.000028087656,0.000108291126,0.0000017762019],"about_ca_topic_score_codex":0.0012936477,"about_ca_topic_score_gemma":0.0019522513,"teacher_disagreement_score":0.0012936477,"about_ca_system_score_codex":0.00024205924,"about_ca_system_score_gemma":0.00018019648,"threshold_uncertainty_score":0.0032724738},"labels":[],"label_agreement":null},{"id":"W2942128858","doi":"10.1158/1078-0432.ccr-19-0404","title":"Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Cancer Institute; Prostate Cancer Foundation","keywords":"Cancer; Prostate cancer; Oncology; DNA methylation; Gene signature; Transcriptome; Internal medicine; Breast cancer; Medicine; Biology; Cancer research; Gene; Gene expression; Genetics","score_opus":0.23426778806581544,"score_gpt":0.5628657953480856,"score_spread":0.3285980072822701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942128858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910829,0.0011039721,0.0018035733,0.0001408568,0.000009615026,0.000023490178,0.005067764,0.000085964486,0.0006817825],"genre_scores_gemma":[0.9938022,0.00016210852,0.0007091388,0.0000631287,0.000008606969,0.000026672875,0.004928679,0.000015358837,0.00028411887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964654,0.000053533346,0.000033137247,0.00015178192,0.00006163143,0.000053368087],"domain_scores_gemma":[0.99921846,0.00023397815,0.00029935766,0.000075991295,0.000099337296,0.00007282762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005905016,0.00026248873,0.00048650554,0.0007780704,0.00023039445,0.0005746421,0.0002902408,0.0002924022,0.0019298686],"category_scores_gemma":[0.0013156247,0.000118575554,0.00042304833,0.0007833955,0.00023094603,0.00025684843,0.00045224902,0.00037377334,0.00038601743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015968776,0.00005757082,0.9281954,0.00015563822,0.00036238667,0.00015759227,0.00006983477,0.0018691714,0.046419248,0.00011282961,0.0011693836,0.019834138],"study_design_scores_gemma":[0.000027365257,0.00019847217,0.98243755,0.000021220798,0.000265355,0.0007366861,0.000115639574,0.007142509,0.0073524658,0.00031190072,0.0013774177,0.000013514422],"about_ca_topic_score_codex":0.0018205435,"about_ca_topic_score_gemma":0.003236297,"teacher_disagreement_score":0.0019298686,"about_ca_system_score_codex":0.000360412,"about_ca_system_score_gemma":0.0003096785,"threshold_uncertainty_score":0.006456077},"labels":[],"label_agreement":null},{"id":"W2942271214","doi":"10.1158/1078-0432.ccr-18-3143","title":"Impact of a Pre-Operative Exercise Intervention on Breast Cancer Proliferation and Gene Expression: Results from the Pre-Operative Health and Body (PreHAB) Study","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Society for Women’s Health Research","keywords":"Medicine; Breast cancer; Body mass index; Cancer; Randomized controlled trial; Internal medicine; Oncology; Physical therapy","score_opus":0.11206343466306762,"score_gpt":0.5397543559851399,"score_spread":0.42769092132207226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942271214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990771,0.00035750828,0.00009975773,0.000050986015,0.000020179588,0.00008030703,0.00012722767,0.000004634533,0.00018231598],"genre_scores_gemma":[0.9980677,0.00040033532,0.00027154517,0.000115997784,0.000073266754,0.00021757095,0.00047336076,0.0000036985823,0.00037658305],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99950874,0.0002482199,0.000028478331,0.00007450348,0.000060189926,0.00007989109],"domain_scores_gemma":[0.9988549,0.0004427619,0.00017824484,0.00015951898,0.000095257405,0.00026935688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012778941,0.00051906705,0.000968511,0.00020043462,0.00024621948,0.00041825388,0.00023292788,0.000513447,0.0018555296],"category_scores_gemma":[0.0011410225,0.0002421229,0.0010593008,0.00021251135,0.00037556086,0.00021993618,0.0003754495,0.0009582981,0.00018989766],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76490873,0.059765555,0.09298884,0.0009419296,0.003327041,0.00009606866,0.00019274304,0.0007244458,0.026243407,0.000076435295,0.00073159346,0.05000321],"study_design_scores_gemma":[0.040427756,0.39899918,0.54951257,0.00007126073,0.0029768145,0.000087733824,0.0002064726,0.00064753793,0.005964964,0.000115767136,0.00095216144,0.000037810358],"about_ca_topic_score_codex":0.00053262716,"about_ca_topic_score_gemma":0.0007960386,"teacher_disagreement_score":0.0018555296,"about_ca_system_score_codex":0.0001873687,"about_ca_system_score_gemma":0.000404219,"threshold_uncertainty_score":0.006758213},"labels":[],"label_agreement":null},{"id":"W2942554478","doi":"10.1158/1078-0432.ccr-18-2867","title":"Efficacy and Safety Analysis of Nelipepimut-S Vaccine to Prevent Breast Cancer Recurrence: A Randomized, Multicenter, Phase III Clinical Trial","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":213,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Interim analysis; Placebo; Breast cancer; Internal medicine; Asymptomatic; Adverse effect; Surgery; Erythema; Biopsy; Cancer; Randomized controlled trial; Gastroenterology; Pathology","score_opus":0.11000180835145747,"score_gpt":0.5228560650361491,"score_spread":0.41285425668469167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942554478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887771,0.0022590677,0.0011008824,0.00046230963,0.00018622604,0.005116616,0.00063749676,0.000067310444,0.0013929801],"genre_scores_gemma":[0.98833895,0.0011269657,0.0018483213,0.00071026693,0.00021235929,0.005663449,0.0007336082,0.000018742527,0.0013473561],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99927205,0.00045534343,0.00004091491,0.00009161565,0.000061856845,0.0000782598],"domain_scores_gemma":[0.99907684,0.00022913497,0.00025747524,0.00008994284,0.00008506072,0.00026154835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002860616,0.001007956,0.0013602219,0.00023407153,0.00038644377,0.0008106716,0.00061808893,0.0012882879,0.003414432],"category_scores_gemma":[0.0014030935,0.0003539999,0.0010996436,0.00025396212,0.00074282,0.0005946935,0.00024344027,0.0020796005,0.0005964763],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92655903,0.026130432,0.00180037,0.0005171031,0.00088393426,0.000076329765,0.00009856134,0.00058701227,0.016698925,0.00017904946,0.001307752,0.02516137],"study_design_scores_gemma":[0.7272311,0.26495287,0.00294356,0.000041868872,0.00042820908,0.00007166831,0.000024297773,0.0006689089,0.0023087317,0.00014077197,0.0011758177,0.000012184105],"about_ca_topic_score_codex":0.0003271592,"about_ca_topic_score_gemma":0.0005697569,"teacher_disagreement_score":0.003414432,"about_ca_system_score_codex":0.0005484557,"about_ca_system_score_gemma":0.0015257181,"threshold_uncertainty_score":0.0151286125},"labels":[],"label_agreement":null},{"id":"W2942989498","doi":"10.1158/1078-0432.ccr-18-3270","title":"Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"F. Hoffmann-La Roche","keywords":"Obinutuzumab; Follicular lymphoma; CHOP; Medicine; Rituximab; Lymphoma; Internal medicine; Vincristine; Diffuse large B-cell lymphoma; Non-Hodgkin's lymphoma; Hazard ratio; Oncology; Immunology; Chemotherapy; Cyclophosphamide; Confidence interval","score_opus":0.024021417322887904,"score_gpt":0.3592285603756434,"score_spread":0.33520714305275545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942989498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989537,0.0005920057,0.000046972513,0.000045980898,0.0000049222713,0.000004541395,0.00009878183,0.0000031658362,0.00024990077],"genre_scores_gemma":[0.99969256,0.000054202632,0.00002629242,0.000019547273,0.000009489911,0.0000037954878,0.00014251744,8.1108476e-7,0.000050655806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997869,0.000070704955,0.000018743955,0.000052523417,0.000037691472,0.000033469983],"domain_scores_gemma":[0.9992712,0.00017959779,0.00029478778,0.00003427213,0.000060474784,0.00015963099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033359378,0.0001328789,0.0003484267,0.00020885242,0.00015145108,0.00028531902,0.00021404566,0.0002899236,0.0011397967],"category_scores_gemma":[0.0013869605,0.00008038641,0.00026075987,0.00032420334,0.0001933429,0.00025592174,0.0001632032,0.00033505453,0.00013394891],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017749241,0.0000500647,0.9918629,0.000016777636,0.000089784226,0.000091187074,0.000018599581,0.00014091807,0.0010976783,0.000015821672,0.00016423366,0.004677183],"study_design_scores_gemma":[0.00008077621,0.00044959487,0.997951,0.0000061403416,0.00007470907,0.0004533601,0.000028188037,0.0004874317,0.00020059914,0.00003523575,0.00022992422,0.000003102073],"about_ca_topic_score_codex":0.00079372,"about_ca_topic_score_gemma":0.0012797852,"teacher_disagreement_score":0.0011397967,"about_ca_system_score_codex":0.00034258154,"about_ca_system_score_gemma":0.0002203562,"threshold_uncertainty_score":0.0038129687},"labels":[],"label_agreement":null},{"id":"W2944179533","doi":"10.1158/1078-0432.ccr-19-0191","title":"<i>NRG1</i> Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in <i>KRAS</i> Wild-Type Pancreatic Ductal Adenocarcinoma","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Lunenfeld-Tanenbaum Research Institute; Vancouver General Hospital; Ontario Institute for Cancer Research; Simon Fraser University; Princess Margaret Cancer Centre; BC Cancer Agency; Pancreas Centre (Canada); Canada's Michael Smith Genome Sciences Centre","funders":"BC Cancer Foundation; Genome British Columbia; Pfizer; Eli Lilly and Company","keywords":"KRAS; Afatinib; Adenocarcinoma; Pancreatic cancer; Cancer research; Medicine; Fusion gene; Oncology; ERBB3; Neuregulin 1; Cancer; Biology; Gene; Internal medicine; Erlotinib; Genetics; Epidermal growth factor receptor; Receptor; Colorectal cancer","score_opus":0.22018577451081692,"score_gpt":0.5155043420277728,"score_spread":0.29531856751695595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944179533","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021352438,0.05196126,0.0014175891,0.8360417,0.070296995,0.00015982821,0.0009788,0.00056356617,0.017227834],"genre_scores_gemma":[0.13283905,0.08094574,0.0013217898,0.5636188,0.1922616,0.00025755944,0.00042757858,0.0002785628,0.028049279],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9983747,0.00054148556,0.0001380707,0.000428821,0.00039468217,0.00012224665],"domain_scores_gemma":[0.9944465,0.0039920993,0.00034820323,0.00017644481,0.0008185207,0.00021812912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003089307,0.00058784464,0.0009377412,0.00047668515,0.00083114393,0.0015945991,0.0012491489,0.006393123,0.0022977062],"category_scores_gemma":[0.006116325,0.00034764595,0.0005286938,0.00057791657,0.0029033287,0.00079088163,0.0005342229,0.0086104255,0.001767549],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011712239,0.00006819198,0.0029583906,0.0005217922,0.000106526284,0.0032468736,0.0002195781,0.00026333999,0.010131291,0.0024508876,0.9144096,0.064452335],"study_design_scores_gemma":[0.00066707877,0.000655599,0.024581928,0.00093416165,0.00040027985,0.006555846,0.0005792114,0.0011069049,0.01620129,0.007221183,0.94093925,0.00015738509],"about_ca_topic_score_codex":0.0034173701,"about_ca_topic_score_gemma":0.0075480267,"teacher_disagreement_score":0.006393123,"about_ca_system_score_codex":0.0020832266,"about_ca_system_score_gemma":0.0012149088,"threshold_uncertainty_score":0.01633805},"labels":[],"label_agreement":null},{"id":"W2944276509","doi":"10.1158/1557-3265.tcm17-b30","title":"Abstract B30: PTEN loss associates with type I and II IFN response in prostate cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"PTEN; Biology; Prostate cancer; Cancer research; Tumor microenvironment; Cancer; Transcriptome; Immune system; Gene; Gene expression; Immunology; PI3K/AKT/mTOR pathway; Genetics; Signal transduction","score_opus":0.08638003052394248,"score_gpt":0.4790214721481295,"score_spread":0.392641441624187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944276509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98840696,0.000937598,0.0008893829,0.00015817684,0.000024546485,0.000013277964,0.008705071,0.00008537045,0.00077965774],"genre_scores_gemma":[0.99386793,0.00015993981,0.00044464183,0.00007715244,0.000012829672,0.000016319851,0.004887822,0.0000268195,0.00050662796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996226,0.000048555085,0.000029079742,0.00013266204,0.00010450896,0.000062572486],"domain_scores_gemma":[0.9993868,0.00013716349,0.0002414417,0.00005279885,0.00006266246,0.00011905781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031564748,0.00022168866,0.00035516237,0.0010172068,0.00038166792,0.0006895721,0.00025129147,0.00030542025,0.0050500915],"category_scores_gemma":[0.0011209474,0.00012326404,0.00045881447,0.0017193166,0.00027120297,0.00016587343,0.00038415784,0.0005054033,0.0006606401],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037687751,0.000118749966,0.86628824,0.00028016226,0.00041000845,0.000812627,0.00012024696,0.0011422909,0.10405582,0.0002522539,0.0037144278,0.019036409],"study_design_scores_gemma":[0.0000374769,0.000169529,0.98146296,0.000027977208,0.00024221551,0.0018516432,0.00013333374,0.0022442918,0.0097647505,0.00049026386,0.0035608641,0.000014681681],"about_ca_topic_score_codex":0.0022418075,"about_ca_topic_score_gemma":0.0018096725,"teacher_disagreement_score":0.0050500915,"about_ca_system_score_codex":0.00029114625,"about_ca_system_score_gemma":0.00035316695,"threshold_uncertainty_score":0.016894221},"labels":[],"label_agreement":null},{"id":"W2945998739","doi":"10.1158/1078-0432.ccr-19-0585","title":"Comprehensive Genomic Profiling Identifies Novel Genetic Predictors of Response to Anti–PD-(L)1 Therapies in Non–Small Cell Lung Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":236,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"Science and Technology Planning Project of Guangdong Province; National Key Research and Development Program of China; Sun Yat-sen University; National Natural Science Foundation of China","keywords":"Lung cancer; Medicine; Oncology; Internal medicine; Immunotherapy; Cancer; Copy-number variation; Cancer research; Gene; Biology; Genetics; Genome","score_opus":0.1172463546394366,"score_gpt":0.4609627422534374,"score_spread":0.3437163876140008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945998739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990609,0.00019636542,0.00021009434,0.000028382408,0.0000015394403,0.000004535744,0.0003505244,0.0000071210907,0.00014048335],"genre_scores_gemma":[0.9992797,0.000040483923,0.00015275137,0.000022117305,0.0000030760752,0.0000048132206,0.0004290427,0.000002041785,0.00006603838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998356,0.000033449847,0.000013817513,0.00006137595,0.00003004164,0.000025709824],"domain_scores_gemma":[0.9996997,0.000075863194,0.00012265089,0.000025590316,0.000028193355,0.00004801819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002139979,0.00020239133,0.0002826497,0.00042838647,0.0001760082,0.00036433156,0.00016256813,0.0002851534,0.00087224954],"category_scores_gemma":[0.00062736054,0.000119661774,0.00016341265,0.00045237216,0.00015978649,0.00015436868,0.00026178942,0.000225592,0.0001485892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088424317,0.00007409971,0.9388314,0.000036439447,0.00013836125,0.00023648674,0.000052858584,0.00055341545,0.046904903,0.000048821064,0.00029605586,0.011942988],"study_design_scores_gemma":[0.000016079397,0.00017379633,0.995144,0.000003426042,0.00005851806,0.0005265257,0.00005068921,0.0011201344,0.00253469,0.000061014412,0.00030728686,0.0000038979924],"about_ca_topic_score_codex":0.0006282006,"about_ca_topic_score_gemma":0.0011323682,"teacher_disagreement_score":0.00087224954,"about_ca_system_score_codex":0.00017274014,"about_ca_system_score_gemma":0.00014622785,"threshold_uncertainty_score":0.002918005},"labels":[],"label_agreement":null},{"id":"W2946829725","doi":"10.1158/1078-0432.ccr-18-3212","title":"Pharmacodynamic and Clinical Results from a Phase I/II Study of the HSP90 Inhibitor Onalespib in Combination with Abiraterone Acetate in Prostate Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute; National Institute for Health and Care Research; Cancer Research UK; Astex Pharmaceuticals","keywords":"Abiraterone acetate; Prostate cancer; Pharmacodynamics; Abiraterone; Medicine; Cancer; Prostate; Oncology; Internal medicine; Pharmacology; Pharmacokinetics; Androgen deprivation therapy; Androgen receptor","score_opus":0.15383574239290693,"score_gpt":0.5354631624239391,"score_spread":0.38162742003103217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946829725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99606174,0.0017404937,0.0003037192,0.00012177761,0.000027265756,0.00036633605,0.00042964373,0.000031874013,0.0009170887],"genre_scores_gemma":[0.9959615,0.0011584267,0.00037272493,0.00019472397,0.000056133315,0.00025725193,0.0011646583,0.000015002675,0.0008195895],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99966764,0.00015536045,0.000017858181,0.000045468623,0.0000494566,0.00006425902],"domain_scores_gemma":[0.99944943,0.00008837512,0.00013128207,0.000043348373,0.000042897766,0.0002446745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007136328,0.0011252719,0.0012851886,0.00031182522,0.0002744068,0.0006906172,0.0005767703,0.0005207624,0.0024628686],"category_scores_gemma":[0.0006016541,0.0003668591,0.00073276064,0.00036062216,0.00053777464,0.0003826093,0.00019510443,0.002097586,0.0003847217],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42153454,0.10380617,0.01190391,0.001183499,0.0023548992,0.00046061445,0.00033358255,0.0073918137,0.27181697,0.00021700545,0.0047602635,0.17423673],"study_design_scores_gemma":[0.15418832,0.76612616,0.04704867,0.00005750108,0.0013592761,0.0007770698,0.000098608274,0.0024222615,0.02321386,0.00018723062,0.004464842,0.000056308036],"about_ca_topic_score_codex":0.0010035383,"about_ca_topic_score_gemma":0.002266591,"teacher_disagreement_score":0.0024628686,"about_ca_system_score_codex":0.0006513893,"about_ca_system_score_gemma":0.00091166125,"threshold_uncertainty_score":0.00823909},"labels":[],"label_agreement":null},{"id":"W2947885304","doi":"10.1158/1078-0432.ccr-18-3720","title":"Molecular Classification of Epithelial Ovarian Cancer Based on Methylation Profiling: Evidence for Survival Heterogeneity","year":2019,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institutes of Health; Government of Canada","keywords":"Epithelial ovarian cancer; Ovarian cancer; Methylation; Biology; DNA methylation; Computational biology; Cancer research; Oncology; Pathology; Cancer; Medicine; Gene; Genetics; Gene expression","score_opus":0.5404776784566071,"score_gpt":0.5762779312042575,"score_spread":0.03580025274765042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947885304","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99800795,0.00061343156,0.00082863745,0.000037516413,0.0000021893097,0.000009064767,0.0003327603,0.000008333194,0.0001601411],"genre_scores_gemma":[0.99935526,0.00006704887,0.00017659197,0.000008092295,0.0000028635045,0.0000041824655,0.0003547136,0.000002338072,0.000028948736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994324,0.00015490864,0.00006326551,0.00019012469,0.000099039564,0.000060290058],"domain_scores_gemma":[0.99868864,0.00047658302,0.0004254949,0.00019331834,0.00011958687,0.000096455806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010421015,0.000144175,0.00032299737,0.0011166784,0.00015944405,0.00040648723,0.0002437931,0.00023288082,0.0007893069],"category_scores_gemma":[0.0021687339,0.000089950576,0.00036009826,0.0007341054,0.00030977267,0.00018580098,0.00041467787,0.0002003406,0.00011634769],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005392426,0.000014549819,0.9782072,0.000042024916,0.00027635533,0.00004495482,0.00009232437,0.00028523552,0.012634239,0.00008562828,0.00010424644,0.007673928],"study_design_scores_gemma":[0.000013716455,0.00007045065,0.99608755,0.000007687802,0.000100232704,0.00019969595,0.00007918918,0.0018345853,0.0010769394,0.0003221416,0.00020303908,0.0000048217157],"about_ca_topic_score_codex":0.0015313289,"about_ca_topic_score_gemma":0.0014766777,"teacher_disagreement_score":0.0015313289,"about_ca_system_score_codex":0.00021799916,"about_ca_system_score_gemma":0.00019254284,"threshold_uncertainty_score":0.0055112243},"labels":[],"label_agreement":null},{"id":"W2951103000","doi":"10.1158/1557-3265.sarcomas17-a04","title":"Abstract A04: Molecular characterization of undifferentiated pleomorphic sarcomas","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sinai Health System; Hospital for Sick Children; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Somatic cell; Biology; KRAS; Gene; Sarcoma; Exome sequencing; Cancer research; ATRX; Exome; Genome; Cancer; Genetics; Mutation; Pathology; Medicine","score_opus":0.26131973651851625,"score_gpt":0.5247509745961815,"score_spread":0.2634312380776652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951103000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99065346,0.000954276,0.004016824,0.000064858126,0.0000118129165,0.000063254745,0.0018355624,0.0001262833,0.0022735794],"genre_scores_gemma":[0.98907393,0.0004576188,0.0052161845,0.00003998255,0.000011724696,0.000036514117,0.004136866,0.00003286906,0.0009943278],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998023,0.000015416652,0.000031730688,0.000059540114,0.00006225633,0.000028841514],"domain_scores_gemma":[0.999603,0.00007700721,0.00008933495,0.00005856914,0.00010482163,0.000067285495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003825307,0.00030637597,0.00017524758,0.001893487,0.00026869794,0.00059572206,0.00025207855,0.00028387606,0.0022030785],"category_scores_gemma":[0.00069788174,0.00013759531,0.00023059046,0.0007335442,0.00032535515,0.00023538547,0.0003252212,0.00024292484,0.0007518131],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046874766,0.000042783777,0.10530552,0.00028116614,0.00004856459,0.0038330858,0.00024785247,0.0005435432,0.8654786,0.0002995508,0.00041707227,0.023033557],"study_design_scores_gemma":[0.000041585587,0.00045122756,0.6409878,0.00006625007,0.00019019679,0.028599255,0.00047755858,0.004234065,0.31063035,0.00041645975,0.01388414,0.000021100392],"about_ca_topic_score_codex":0.0010073526,"about_ca_topic_score_gemma":0.0010783826,"teacher_disagreement_score":0.0022030785,"about_ca_system_score_codex":0.00027287457,"about_ca_system_score_gemma":0.00021738808,"threshold_uncertainty_score":0.0073700547},"labels":[],"label_agreement":null},{"id":"W2951414864","doi":"10.1158/1078-0432.ccr-18-1897","title":"Functional Properties of <i>KIT</i> Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Hyundai Hope On Wheels; Hyundai Motor Group; National Cancer Institute; St. Baldrick's Foundation","keywords":"Gemtuzumab ozogamicin; Medicine; Exon; Myeloid leukemia; Mutation; Internal medicine; Core binding factor; Cancer research; Oncology; Targeted therapy; Tyrosine kinase; Transfection; Cytokine; CD33; Cancer; Biology; Receptor; Gene; Genetics; Stem cell; CD34","score_opus":0.1810267263433989,"score_gpt":0.45773596769156527,"score_spread":0.2767092413481664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951414864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996075,0.00009240079,0.000059866576,0.0000095301775,6.3734376e-7,0.0000031112218,0.000054685075,0.0000021927267,0.00017021595],"genre_scores_gemma":[0.99972636,0.000030848947,0.000050690767,0.000010415457,0.0000016876985,0.0000037583789,0.00012221257,0.0000015717762,0.000052478783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999814,0.00003578994,0.000022796903,0.000038039525,0.00004759873,0.000041855572],"domain_scores_gemma":[0.9994942,0.0001330687,0.00024048383,0.000024462559,0.00004220918,0.000065685075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003772326,0.00017263475,0.00024509194,0.00028713292,0.00010146193,0.00027145207,0.00013922008,0.00021284331,0.0010817039],"category_scores_gemma":[0.0006993142,0.00008026569,0.00012612015,0.00020304446,0.00025359556,0.0001480289,0.00014475496,0.000254353,0.00019577192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00535367,0.00017352185,0.8451581,0.00006224368,0.000120504854,0.00054821704,0.00009652181,0.0003552128,0.12819442,0.00010602273,0.00018404398,0.019647555],"study_design_scores_gemma":[0.000093242226,0.0014839413,0.9759419,0.000011080779,0.000102356265,0.0028172547,0.00010831264,0.0005799784,0.018278815,0.00010674198,0.00046887662,0.000007572334],"about_ca_topic_score_codex":0.00043148693,"about_ca_topic_score_gemma":0.0004376482,"teacher_disagreement_score":0.0010817039,"about_ca_system_score_codex":0.00028211312,"about_ca_system_score_gemma":0.0001487369,"threshold_uncertainty_score":0.0036186576},"labels":[],"label_agreement":null},{"id":"W2952952213","doi":"10.1158/1078-0432.ccr-18-3399","title":"Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic Tumors","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Protein Kinase Regulation and GTPase Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; National Institutes of Health","keywords":"KRAS; Farnesyltransferase; Cancer research; Pancreatic cancer; Prenylation; Cancer; PI3K/AKT/mTOR pathway; Carcinogenesis; EGFR inhibitors; Apoptosis; Mutant; Biology; Epidermal growth factor receptor; Medicine; Colorectal cancer; Internal medicine; Biochemistry","score_opus":0.05554643379333524,"score_gpt":0.383106300371298,"score_spread":0.32755986657796277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952952213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997269,0.0004492769,0.0009495952,0.00008173229,0.000023388217,0.00004356936,0.00021964859,0.000105199455,0.00085852045],"genre_scores_gemma":[0.9963258,0.00032304664,0.0012371509,0.000047960762,0.00000764721,0.000040791863,0.0005562991,0.000011910562,0.001449464],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999895,0.000016794174,0.000009571087,0.00002162717,0.000027652233,0.000029368774],"domain_scores_gemma":[0.9999409,0.000008858699,0.000012839155,0.000010555452,0.0000053991516,0.000021525419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016423101,0.00049412396,0.00034880155,0.00021558425,0.00015338343,0.00021296997,0.00022183267,0.00027705746,0.0013921433],"category_scores_gemma":[0.00008611899,0.000121572724,0.0002929776,0.00017475466,0.00016827686,0.00012782718,0.0001520739,0.00076375867,0.00035066265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087294134,0.00031715556,0.00053928274,0.00004277625,0.000022168566,0.00011482835,0.000015358162,0.00022164943,0.9930803,0.00009219258,0.00019837193,0.0044829873],"study_design_scores_gemma":[0.00012802542,0.0023479883,0.0034017866,0.0000035872552,0.00003736773,0.00071387953,0.000017788041,0.0011992252,0.9899165,0.00003793628,0.0021917215,0.000004166706],"about_ca_topic_score_codex":0.000270952,"about_ca_topic_score_gemma":0.00055810664,"teacher_disagreement_score":0.0013921433,"about_ca_system_score_codex":0.00028595736,"about_ca_system_score_gemma":0.00028424762,"threshold_uncertainty_score":0.004657209},"labels":[],"label_agreement":null},{"id":"W2953124185","doi":"10.1158/1078-0432.ccr-17-1928","title":"Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase Inhibition","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of British Columbia; Ontario Institute for Cancer Research; BC Cancer Agency","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; Canadian Cancer Society Research Institute; National Institutes of Health; Terry Fox Research Institute","keywords":"Ponatinib; Biology; SMARCA4; Cancer research; Ovarian cancer; Kinase; Pharmacology; Cancer; Dasatinib; Cell biology; Genetics; Epigenetics","score_opus":0.17615831490822006,"score_gpt":0.4495610062936092,"score_spread":0.2734026913853891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953124185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930686,0.0022477328,0.0011768537,0.0001591303,0.000033589604,0.000120048804,0.0007193667,0.00014886611,0.00232581],"genre_scores_gemma":[0.9958476,0.0008412289,0.00080492435,0.00005065355,0.0000047827525,0.00003920655,0.0010460889,0.000012785256,0.0013527343],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999039,0.000011805899,0.000013145473,0.000014285997,0.000030214136,0.000026669375],"domain_scores_gemma":[0.99994075,0.0000117202435,0.000010820584,0.00000900113,0.000012631003,0.000014988463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011325543,0.00023277181,0.00041649447,0.00021090257,0.00015610586,0.00029907352,0.00019878297,0.00021937219,0.0018386075],"category_scores_gemma":[0.00017140672,0.0000898885,0.00029651573,0.000257538,0.00013675675,0.00014204043,0.0001554053,0.00048540352,0.00037559826],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061681925,0.00032845317,0.0011287462,0.00020977504,0.000043068478,0.00020285416,0.0000225288,0.0004975996,0.9812645,0.00011258751,0.00049088016,0.015082285],"study_design_scores_gemma":[0.0004451428,0.004738392,0.01327745,0.00001006609,0.00008636016,0.0021881722,0.000048504353,0.0019680427,0.9695495,0.000092546456,0.007583032,0.000012891164],"about_ca_topic_score_codex":0.0006702726,"about_ca_topic_score_gemma":0.0018636999,"teacher_disagreement_score":0.0018386075,"about_ca_system_score_codex":0.0003199165,"about_ca_system_score_gemma":0.0003044693,"threshold_uncertainty_score":0.0061507225},"labels":[],"label_agreement":null},{"id":"W2954314696","doi":"10.1158/1078-0432.ccr-19-0673","title":"Photodynamic Therapy for the Treatment of Vertebral Metastases: A Phase I Clinical Trial","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute; University of Toronto; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Cancer Society","keywords":"Medicine; Photodynamic therapy; Surgery; Clinical trial; Internal medicine","score_opus":0.4374585812987268,"score_gpt":0.6301222492284765,"score_spread":0.1926636679297497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954314696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97903836,0.007621951,0.000872066,0.0011757924,0.00034160417,0.006119576,0.0011639418,0.00014322689,0.0035234487],"genre_scores_gemma":[0.9747669,0.0074618137,0.0016000968,0.0016103904,0.0004856736,0.007977506,0.0014115911,0.000026637892,0.0046592923],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997552,0.00010632557,0.000011679768,0.000041984633,0.0000284866,0.00005631388],"domain_scores_gemma":[0.9996132,0.00008091393,0.0000795714,0.000030081339,0.00003217524,0.00016408597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012008202,0.0011206191,0.0015509578,0.0003283641,0.00042260133,0.0011559922,0.0008391704,0.0017023545,0.0058768387],"category_scores_gemma":[0.00069873995,0.0004784765,0.0011426716,0.00038076192,0.0007904762,0.0005954318,0.00024851187,0.0024254194,0.00083143706],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7902818,0.074432425,0.0026226672,0.0024760189,0.0013273488,0.00028299802,0.0001954448,0.0013300744,0.031666905,0.00055329513,0.0060564084,0.088774666],"study_design_scores_gemma":[0.78269607,0.20952514,0.0027479627,0.00007740658,0.0002693958,0.00012938127,0.000035278867,0.0006067712,0.00188097,0.00013988877,0.0018773606,0.000014398198],"about_ca_topic_score_codex":0.0007525298,"about_ca_topic_score_gemma":0.0016900154,"teacher_disagreement_score":0.0058768387,"about_ca_system_score_codex":0.00067245954,"about_ca_system_score_gemma":0.0015034125,"threshold_uncertainty_score":0.019659996},"labels":[],"label_agreement":null},{"id":"W2955120427","doi":"10.1158/1078-0432.ccr-18-2387","title":"DNA-Dependent Protein Kinase Drives Prostate Cancer Progression through Transcriptional Regulation of the Wnt Signaling Pathway","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; American Association for Cancer Research; Evans Medical Foundation; U.S. Department of Defense","keywords":"Prostate cancer; Wnt signaling pathway; Cancer research; Kinase; Tumor progression; Biology; Cancer; Transcription factor; Prostate; Signal transduction; Gene; Cell biology; Genetics","score_opus":0.15762695585381784,"score_gpt":0.49066662108902065,"score_spread":0.3330396652352028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955120427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961832,0.001548063,0.001115261,0.000070943344,0.000008573179,0.000031192892,0.00040096894,0.0000341071,0.000607706],"genre_scores_gemma":[0.997629,0.00044993375,0.00092866435,0.000018329116,0.000002834955,0.000015411524,0.00035507203,0.0000032113928,0.00059766293],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999887,0.000019983741,0.000007975347,0.000025364752,0.000035997055,0.000023711193],"domain_scores_gemma":[0.9999074,0.000017534856,0.000035692796,0.0000076279625,0.0000073372516,0.000024440626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013512038,0.00022147002,0.0002167066,0.00024665086,0.00012865063,0.00029074875,0.00013269593,0.00012393335,0.0015003284],"category_scores_gemma":[0.0001581722,0.0001289058,0.00019657079,0.00022875454,0.00022722961,0.000119701486,0.0001457141,0.00047734968,0.00022528096],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060758454,0.000104984196,0.0076853368,0.00008155253,0.00003292014,0.00006608728,0.00001570076,0.00035742825,0.9877999,0.00016180467,0.0000854558,0.0030011586],"study_design_scores_gemma":[0.000105024075,0.0012980282,0.08741638,0.0000126421255,0.00006957779,0.0008785172,0.000059000995,0.003372986,0.9041339,0.00019838873,0.002445647,0.000009797244],"about_ca_topic_score_codex":0.00084157666,"about_ca_topic_score_gemma":0.0016374369,"teacher_disagreement_score":0.0015003284,"about_ca_system_score_codex":0.00042095184,"about_ca_system_score_gemma":0.00039634918,"threshold_uncertainty_score":0.0050191283},"labels":[],"label_agreement":null},{"id":"W2955283109","doi":"10.1158/1078-0432.ccr-18-3944","title":"Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Institutes of Health; Ono Pharmaceutical; National Cancer Institute; National Institute for Health and Care Research; Bristol-Myers Squibb","keywords":"Cetuximab; Nivolumab; Medicine; Head and neck; Head and neck squamous-cell carcinoma; Oncology; Basal cell; Internal medicine; Head and neck cancer; Cancer; Surgery; Immunotherapy; Colorectal cancer","score_opus":0.09167109629543041,"score_gpt":0.41982478930838263,"score_spread":0.3281536930129522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955283109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99764746,0.0015771628,0.00005587084,0.00007618664,0.000017916673,0.00008992969,0.00007436205,0.0000072330345,0.00045380008],"genre_scores_gemma":[0.999057,0.00033249817,0.00008289109,0.00013825178,0.000029899846,0.000048048274,0.0001553011,0.0000014694597,0.00015475317],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99951375,0.00020059834,0.000036244543,0.00009248027,0.00009424045,0.00006269272],"domain_scores_gemma":[0.9993973,0.0002012377,0.00017742439,0.000044144042,0.000035878653,0.00014410297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015175259,0.00030935332,0.0008121023,0.00017611984,0.0002193977,0.00048773785,0.0003479427,0.0005654632,0.0012099204],"category_scores_gemma":[0.0013450102,0.00019396184,0.0010748683,0.00021542418,0.000334139,0.0004067113,0.00026270578,0.0009039418,0.00014431449],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5479373,0.013022678,0.14734653,0.0010907616,0.002483971,0.00026439302,0.00025002786,0.003605007,0.036166467,0.0002165524,0.0016768404,0.24593954],"study_design_scores_gemma":[0.10000539,0.31166694,0.56415707,0.00018439905,0.0029438264,0.0007845945,0.00012698738,0.0052435757,0.010248511,0.00027414146,0.00430351,0.00006110238],"about_ca_topic_score_codex":0.0009650279,"about_ca_topic_score_gemma":0.0033630498,"teacher_disagreement_score":0.0015175259,"about_ca_system_score_codex":0.0009186705,"about_ca_system_score_gemma":0.0008239158,"threshold_uncertainty_score":0.008025527},"labels":[],"label_agreement":null},{"id":"W2955389905","doi":"10.1158/1078-0432.ccr-19-0823","title":"Mechanisms of Innate and Acquired Resistance to Anti-EGFR Therapy: A Review of Current Knowledge with a Focus on Rechallenge Therapies","year":2019,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Ectodomain; PTEN; Medicine; Acquired resistance; Cancer; Cancer research; PI3K/AKT/mTOR pathway; Signal transduction; Biology; Internal medicine; Receptor; Genetics","score_opus":0.5085590877799051,"score_gpt":0.5932886371081418,"score_spread":0.08472954932823673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955389905","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000098167875,0.99915624,0.00005420182,0.0001943622,0.00009523291,0.0000030727983,0.0000149208045,0.0000041004237,0.00037974588],"genre_scores_gemma":[0.00045645353,0.99909604,0.000079289704,0.00011174445,0.00007622817,0.0000036955919,0.000016926635,6.4007895e-7,0.00015900169],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998241,0.0000306084,0.000039853283,0.000032359385,0.00005572112,0.000017366829],"domain_scores_gemma":[0.9994986,0.00029912448,0.00006935046,0.000010006748,0.00009661729,0.00002624346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006036078,0.00067203125,0.0011676413,0.0025889692,0.00023345015,0.0008456208,0.0007012141,0.0008532904,0.002805707],"category_scores_gemma":[0.0008505892,0.00025299375,0.0006588042,0.0022149917,0.0003746372,0.0011615383,0.00050039095,0.0012374524,0.000808661],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108638575,0.00010611073,0.00032846484,0.045134977,0.00015542816,0.00022205086,0.00008751828,0.00044315448,0.0014566937,0.0036974894,0.025485892,0.9227735],"study_design_scores_gemma":[0.000023493416,0.00021363936,0.0017948016,0.016177958,0.00037799514,0.0020608932,0.00013284007,0.00019006716,0.0005649702,0.002379714,0.97605133,0.000032335105],"about_ca_topic_score_codex":0.0010338904,"about_ca_topic_score_gemma":0.0018067549,"teacher_disagreement_score":0.002805707,"about_ca_system_score_codex":0.00058857317,"about_ca_system_score_gemma":0.0012032837,"threshold_uncertainty_score":0.009386063},"labels":[],"label_agreement":null},{"id":"W2956922351","doi":"10.1158/1078-0432.ccr-19-0298","title":"Dose-Ranging and Cohort-Expansion Study of Monalizumab (IPH2201) in Patients with Advanced Gynecologic Malignancies: A Trial of the Canadian Cancer Trials Group (CCTG): IND221","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; Juravinski Cancer Centre; Spinal Cord Injury BC; Canadian Cancer Society; Espace pour la vie","funders":"Innate Pharma","keywords":"Medicine; Nausea; Vomiting; Pharmacodynamics; Internal medicine; Adverse effect; Cohort; Tolerability; Gastroenterology; Cancer; Cervical cancer; Endometrial cancer; Response Evaluation Criteria in Solid Tumors; Pharmacokinetics; Clinical trial; Phases of clinical research","score_opus":0.14237343410683095,"score_gpt":0.4662813181220757,"score_spread":0.32390788401524473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956922351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996548,0.000714484,0.00016682224,0.0002419934,0.000049042,0.0011420738,0.00029743335,0.000029647374,0.0008106131],"genre_scores_gemma":[0.9962289,0.00037595234,0.00057241344,0.0004045605,0.000082344246,0.0008690359,0.00048507532,0.000008303009,0.0009734839],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99946123,0.00027458704,0.000020916821,0.00007935698,0.000064708154,0.00009915375],"domain_scores_gemma":[0.99924856,0.00012046008,0.000161137,0.0001097039,0.00006110636,0.00029896924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020950113,0.0009684339,0.0009025602,0.000247654,0.0004439872,0.0005553021,0.0006580684,0.0007588696,0.0021960605],"category_scores_gemma":[0.0012152357,0.00040917704,0.0007192903,0.00023521653,0.0005779485,0.00046577817,0.00030198053,0.002277804,0.0003822077],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82760507,0.054974914,0.01089666,0.00031494244,0.0012003812,0.00013089024,0.00044833997,0.0017016163,0.025096834,0.00020259283,0.003700775,0.07372698],"study_design_scores_gemma":[0.5965937,0.3692268,0.02582233,0.00002363459,0.0005586335,0.0001759533,0.00005462905,0.0011940295,0.0030542428,0.00012543974,0.0031384889,0.000032110016],"about_ca_topic_score_codex":0.0027007253,"about_ca_topic_score_gemma":0.006074576,"teacher_disagreement_score":0.0027007253,"about_ca_system_score_codex":0.0012375065,"about_ca_system_score_gemma":0.0015718057,"threshold_uncertainty_score":0.011079609},"labels":[],"label_agreement":null},{"id":"W2959088509","doi":"10.1158/1078-0432.ccr-19-0113","title":"Clinical and Genome-Wide Analysis of Serum Platinum Levels after Cisplatin-Based Chemotherapy","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Cisplatin; Medicine; Internal medicine; Single-nucleotide polymorphism; Creatinine; Oncology; Genome-wide association study; Chemotherapy; Gastroenterology; Endocrinology; Genotype; Biology; Genetics; Gene","score_opus":0.15595138802417136,"score_gpt":0.5000697512846275,"score_spread":0.34411836326045614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2959088509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988207,0.0003226622,0.00020817624,0.000030362242,0.0000050890435,0.0000048092716,0.0004372036,0.000008514127,0.00016238159],"genre_scores_gemma":[0.99951947,0.000048107522,0.0000751455,0.000012987118,0.0000035112116,0.0000026290236,0.00026820123,0.0000028297775,0.00006704506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995309,0.00012338225,0.000048391983,0.00017838455,0.00006939974,0.00004964986],"domain_scores_gemma":[0.99837863,0.00038523143,0.000696337,0.0001847055,0.00017474977,0.0001802806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048051245,0.00020008824,0.000311004,0.00046984392,0.0002552784,0.0005480306,0.00038859103,0.00035287466,0.0009816076],"category_scores_gemma":[0.0021327264,0.00014085812,0.0004303827,0.0011733148,0.00023432744,0.00019001051,0.00030123547,0.00042860705,0.00013223501],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051747833,0.000021561422,0.9935714,0.000018220891,0.0002719182,0.0001086482,0.000035529996,0.00015472612,0.0030217138,0.0000255269,0.00010760959,0.0021455858],"study_design_scores_gemma":[0.000007953011,0.00007599909,0.9989503,0.000002010579,0.0000896817,0.00017517329,0.000024256991,0.00025952415,0.0002514948,0.000018865512,0.00014247138,0.0000023387229],"about_ca_topic_score_codex":0.0028928253,"about_ca_topic_score_gemma":0.0026742306,"teacher_disagreement_score":0.0028928253,"about_ca_system_score_codex":0.00020506671,"about_ca_system_score_gemma":0.00021378277,"threshold_uncertainty_score":0.005752027},"labels":[],"label_agreement":null},{"id":"W2960549986","doi":"10.1158/1078-0432.ccr-18-3373","title":"Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Imatinib; Medicine; Discontinuation; Chronic myelogenous leukemia; Internal medicine; Imatinib mesylate; Oncology; Tyrosine-kinase inhibitor; Cancer; Leukemia","score_opus":0.2040924732734839,"score_gpt":0.5438174705927702,"score_spread":0.3397249973192863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2960549986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995715,0.00020914612,0.000040360916,0.000015642145,0.0000018582654,0.0000029912774,0.000032805183,0.0000012653189,0.00012443127],"genre_scores_gemma":[0.9997402,0.000033325825,0.00004902098,0.000011446481,0.0000067548863,0.0000039840074,0.000099448145,8.200415e-7,0.000054899323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996344,0.00009800135,0.000057910416,0.00006952982,0.000082834966,0.000057351517],"domain_scores_gemma":[0.99669516,0.0010140488,0.0015366595,0.00012553648,0.00020132946,0.00042738105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085127965,0.00020633372,0.00027693648,0.00029560376,0.00022467371,0.00043765616,0.0002601284,0.00040899607,0.0009515379],"category_scores_gemma":[0.0031442854,0.000119134864,0.00028305745,0.00028582162,0.00019164753,0.00033960308,0.00018854848,0.00053410704,0.00018232991],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000560633,0.000046513604,0.99627763,0.000006185251,0.000018355784,0.000055047534,0.000024948751,0.000059305323,0.00064731063,0.000007251851,0.00003912179,0.0022577895],"study_design_scores_gemma":[0.000020186944,0.00061758823,0.99764246,0.0000054267125,0.000040039853,0.000564663,0.00005577484,0.00052801624,0.00033350626,0.000012558038,0.00017612161,0.000003610236],"about_ca_topic_score_codex":0.00046035502,"about_ca_topic_score_gemma":0.0006513325,"teacher_disagreement_score":0.0009515379,"about_ca_system_score_codex":0.00018522238,"about_ca_system_score_gemma":0.00016901853,"threshold_uncertainty_score":0.0045019984},"labels":[],"label_agreement":null},{"id":"W2960863027","doi":"10.1158/1078-0432.ccr-19-1605","title":"Targeting TGFβ Pathway in Adult Granulosa Cell Tumor: Opening Pandora's Box?","year":2019,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Granulosa cell; Transforming growth factor; Malignancy; Cancer research; Biology; TGF beta signaling pathway; Mutation; Ovary; Cell biology; Pathology; Medicine; Endocrinology; Genetics; Gene","score_opus":0.08824008247851232,"score_gpt":0.43422665896527324,"score_spread":0.3459865764867609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2960863027","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004599287,0.019788489,0.0011105756,0.93163395,0.037383318,0.000029433008,0.00007267385,0.000098384466,0.00528398],"genre_scores_gemma":[0.06512643,0.027036248,0.0026623067,0.7017708,0.17850667,0.00012854433,0.00010778471,0.000057928857,0.024603317],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997168,0.00006772199,0.000042419448,0.000047953115,0.00008304953,0.000041988707],"domain_scores_gemma":[0.9990758,0.0004899071,0.000060451308,0.000052318243,0.00016676313,0.00015471566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008274746,0.00030970093,0.00044040577,0.00023236734,0.0005670678,0.0007264699,0.00042015564,0.0073266095,0.001819944],"category_scores_gemma":[0.0024383848,0.00013371116,0.00041527898,0.00016381124,0.0010127506,0.001204299,0.00039237432,0.007717541,0.0016363568],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005271724,0.00013112044,0.001795832,0.00038054562,0.00004399874,0.027086014,0.00011363708,0.0003329491,0.004394103,0.01071781,0.8455091,0.10896779],"study_design_scores_gemma":[0.00037663706,0.0003652184,0.0021373872,0.00037178863,0.000052135994,0.040865846,0.00020829492,0.001430574,0.0030131126,0.02741446,0.9237129,0.000051684656],"about_ca_topic_score_codex":0.00048107066,"about_ca_topic_score_gemma":0.0007889896,"teacher_disagreement_score":0.0073266095,"about_ca_system_score_codex":0.0011840098,"about_ca_system_score_gemma":0.00056050636,"threshold_uncertainty_score":0.008590698},"labels":[],"label_agreement":null},{"id":"W2963730372","doi":"10.1158/1078-0432.ccr-19-0261","title":"A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":272,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"National Institutes of Health","keywords":"Placebo; Glioblastoma; Medicine; Double blind; Cancer vaccine; Dendritic cell; Oncology; Internal medicine; Cancer; Pathology; Immunotherapy; Cancer research; Immunology; Immune system; Alternative medicine","score_opus":0.05922027509363901,"score_gpt":0.41901466526934705,"score_spread":0.359794390175708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963730372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848994,0.0022443573,0.00070479425,0.0005857238,0.0009238641,0.008671678,0.0006740492,0.00010572494,0.001190326],"genre_scores_gemma":[0.98129797,0.0014567939,0.0015793693,0.0012836497,0.0006813122,0.010907786,0.0008881979,0.000019648016,0.0018852124],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991021,0.0004928278,0.000072984265,0.00013994088,0.000064483305,0.00012775687],"domain_scores_gemma":[0.998708,0.00028088552,0.00029278477,0.00012907585,0.0001246183,0.00046465202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019751517,0.0017213557,0.0033369688,0.00043013413,0.0004989673,0.0009065143,0.0007295927,0.0017793763,0.0049500004],"category_scores_gemma":[0.0021348647,0.00071557023,0.0010607379,0.00036556544,0.0016037388,0.00086375023,0.0003524109,0.002328674,0.00086440553],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9836547,0.007367102,0.00033542726,0.00019339929,0.00023420651,0.000016747876,0.00001894013,0.000118079064,0.0022159216,0.000042582917,0.0003444856,0.005458448],"study_design_scores_gemma":[0.9388487,0.060117718,0.00035939767,0.000009029089,0.00009030962,0.0000089721625,0.0000056289073,0.00012037739,0.00022719149,0.000034336623,0.00017346864,0.0000049811556],"about_ca_topic_score_codex":0.00046851538,"about_ca_topic_score_gemma":0.0009290786,"teacher_disagreement_score":0.0049500004,"about_ca_system_score_codex":0.00060989906,"about_ca_system_score_gemma":0.0016418173,"threshold_uncertainty_score":0.016559362},"labels":[],"label_agreement":null},{"id":"W2964344648","doi":"10.1158/1078-0432.ccr-19-1797","title":"DNA Methylation as a Robust Classifier of Epithelial Ovarian Cancer","year":2019,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research; Princess Margaret Cancer Foundation","keywords":"Epigenetics; DNA methylation; Methylation; Ovarian cancer; Epithelial ovarian cancer; Biology; Cancer research; DNA; Cancer; Bioinformatics; Genetics; Gene; Gene expression","score_opus":0.3528946916214223,"score_gpt":0.5280786966631082,"score_spread":0.17518400504168596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964344648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52065825,0.035525277,0.05579546,0.33303353,0.0136058405,0.00044784322,0.006246695,0.0017494077,0.03293766],"genre_scores_gemma":[0.9515974,0.003243735,0.011198284,0.021622797,0.004652431,0.00017024798,0.0011657072,0.00007428708,0.0062751565],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99903333,0.00043309445,0.00008968599,0.00015176217,0.00022537661,0.00006685064],"domain_scores_gemma":[0.9973062,0.0013745843,0.00021992027,0.00023744832,0.00065098045,0.00021070668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014303916,0.00023268438,0.00065119343,0.00095947215,0.00027726887,0.0006971652,0.00035204436,0.0013253537,0.00092698215],"category_scores_gemma":[0.009860605,0.00015626891,0.00018683313,0.0004723195,0.00036958294,0.0004414576,0.00033173437,0.0015738239,0.0009842841],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002623687,0.00015994553,0.35630473,0.00028009433,0.00020000381,0.0024552667,0.00021794785,0.0032675706,0.037861977,0.003765742,0.16404219,0.4288208],"study_design_scores_gemma":[0.000388988,0.0025569608,0.43197203,0.0005836901,0.00043850613,0.028368603,0.00062736176,0.19168624,0.05792068,0.056522787,0.22865792,0.00027621945],"about_ca_topic_score_codex":0.0010111883,"about_ca_topic_score_gemma":0.0018228109,"teacher_disagreement_score":0.0014303916,"about_ca_system_score_codex":0.00075383217,"about_ca_system_score_gemma":0.00024143874,"threshold_uncertainty_score":0.0075647235},"labels":[],"label_agreement":null},{"id":"W2964673115","doi":"10.1158/1078-0432.ccr-19-1423","title":"The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":394,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Prostate cancer; Lineage (genetic); Cancer; Resistance (ecology); Medicine; Cancer therapy; Biology; Internal medicine; Genetics; Ecology","score_opus":0.1459517182911886,"score_gpt":0.5267830732056228,"score_spread":0.3808313549144342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964673115","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.044489477,0.85357183,0.015799696,0.057708975,0.0015226903,0.0001629924,0.00036783976,0.0003149475,0.026061505],"genre_scores_gemma":[0.5050725,0.46659586,0.0066468124,0.012636933,0.0024796,0.00023180699,0.0004036498,0.00009484749,0.0058380435],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987889,0.0005969972,0.0000621218,0.00012164297,0.00028811744,0.00014223538],"domain_scores_gemma":[0.9981982,0.0008294287,0.00032780477,0.00012362335,0.00029418213,0.00022678087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002410122,0.0002610676,0.0007445577,0.00058690994,0.0006284269,0.0027393627,0.00073115976,0.00093714625,0.0025865224],"category_scores_gemma":[0.0026940564,0.00018364163,0.00033580107,0.0005862541,0.0018622476,0.0016975824,0.0015977062,0.0037395447,0.00066549017],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061072013,0.00019425794,0.011762838,0.0027668981,0.00013429599,0.0010220526,0.0011273343,0.0031873113,0.03586985,0.11926201,0.037780765,0.78628165],"study_design_scores_gemma":[0.000112122645,0.0014803649,0.017550867,0.0017453085,0.00019908123,0.006362994,0.0010391603,0.0037543206,0.02026515,0.079806864,0.8675769,0.00010691688],"about_ca_topic_score_codex":0.00096486736,"about_ca_topic_score_gemma":0.0012691777,"teacher_disagreement_score":0.0027393627,"about_ca_system_score_codex":0.0018468924,"about_ca_system_score_gemma":0.0024541016,"threshold_uncertainty_score":0.013400197},"labels":[],"label_agreement":null},{"id":"W2964970606","doi":"10.1158/1078-0432.ccr-19-0545","title":"CD45+CD326+ Cells are Predictive of Poor Prognosis in Non–Small Cell Lung Cancer Patients","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Institute of Aging","funders":"Japan Society for the Promotion of Science","keywords":"Lung cancer; Malignant pleural effusion; Cancer; Medicine; Pathology; Population; Metastasis; Cancer cell; Cancer research; Pleural effusion; Cell; Carcinoma; Mesenchymal stem cell; Internal medicine; Biology","score_opus":0.10912920161323457,"score_gpt":0.46691263736841004,"score_spread":0.35778343575517546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964970606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993625,0.00021282573,0.000063206746,0.000023253195,0.0000045922593,0.000004141479,0.0000597219,0.0000039550614,0.00026572612],"genre_scores_gemma":[0.9997137,0.00003907228,0.000047966594,0.00000988099,0.000007123386,0.0000040847262,0.000091410846,8.627583e-7,0.00008580181],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998913,0.000025215953,0.000013715062,0.000027110904,0.000019597717,0.00002313959],"domain_scores_gemma":[0.9994973,0.00009320141,0.00015792991,0.00002382344,0.00005349065,0.00017430574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019744577,0.00023555162,0.00020748725,0.0005016778,0.0002587669,0.00035200999,0.00018202195,0.00041593105,0.0021666556],"category_scores_gemma":[0.00077805825,0.00012402236,0.00015757864,0.00035318686,0.00018585271,0.00022121234,0.00022073132,0.00033707844,0.00027483882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018672114,0.000020657752,0.9954294,0.0000074350596,0.000012521197,0.00011083179,0.000017682407,0.00004068922,0.0030286175,0.000009237484,0.0000816892,0.0010545626],"study_design_scores_gemma":[0.000008047257,0.00010790869,0.9976337,0.0000035626597,0.00002339987,0.0009110212,0.00005533066,0.0003945529,0.0006321166,0.000026707592,0.00020137304,0.0000023102532],"about_ca_topic_score_codex":0.00047830932,"about_ca_topic_score_gemma":0.00069719675,"teacher_disagreement_score":0.0021666556,"about_ca_system_score_codex":0.00009368308,"about_ca_system_score_gemma":0.00008511324,"threshold_uncertainty_score":0.007248223},"labels":[],"label_agreement":null},{"id":"W2967929450","doi":"10.1158/1078-0432.ccr-19-1832","title":"Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Nomogram; Head and neck cancer; Confidence interval; Internal medicine; Radiation therapy; Relative risk; Cancer; Body mass index; Oncology; Surgery","score_opus":0.2688763782354809,"score_gpt":0.555436189361305,"score_spread":0.2865598111258241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967929450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781042,0.0033119677,0.013913339,0.00054595247,0.0001176136,0.00021986465,0.0015933372,0.00016721239,0.002026522],"genre_scores_gemma":[0.9959913,0.00020744345,0.0026719715,0.00006937546,0.000044592398,0.000065061555,0.00079409184,0.000010467138,0.00014566434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976903,0.0016865294,0.000113095804,0.00020643245,0.00022916529,0.00007445891],"domain_scores_gemma":[0.9837382,0.012339498,0.0023275507,0.00045654492,0.0004975975,0.00064057723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074952594,0.0009241971,0.0014100906,0.001642187,0.00023144553,0.00093755627,0.0005937011,0.00058026897,0.0017868477],"category_scores_gemma":[0.012973605,0.00018941663,0.0016404245,0.0006655577,0.00042031068,0.0006429915,0.00059151894,0.0010519741,0.0003272459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009419654,0.00043775054,0.905416,0.00026718402,0.0019977381,0.0000817709,0.00006422197,0.023901938,0.00087200926,0.00038390936,0.002224945,0.05493288],"study_design_scores_gemma":[0.0014053095,0.0059519904,0.66383046,0.00015558909,0.002434459,0.0006414367,0.0002642075,0.31778097,0.0012297657,0.0019134438,0.004266458,0.00012579074],"about_ca_topic_score_codex":0.0007118728,"about_ca_topic_score_gemma":0.00059478235,"teacher_disagreement_score":0.0074952594,"about_ca_system_score_codex":0.0005810966,"about_ca_system_score_gemma":0.00039995002,"threshold_uncertainty_score":0.039639175},"labels":[],"label_agreement":null},{"id":"W2969447018","doi":"10.1158/1078-0432.ccr-19-1030","title":"Quantitative Ultrasound Spectroscopy for Differentiation of Hepatocellular Carcinoma from At-Risk and Normal Liver Parenchyma","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Grand Challenges Canada","keywords":"Hepatocellular carcinoma; Parenchyma; Cirrhosis; Medicine; Ultrasound; Liver parenchyma; Carcinoma; Liver cancer; Pathology; Internal medicine; Gastroenterology; Radiology","score_opus":0.22830731858467443,"score_gpt":0.4259238565567501,"score_spread":0.19761653797207565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969447018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919145,0.0008450333,0.006687337,0.000035916943,0.000009505251,0.000040634306,0.000101378995,0.000045589535,0.00032016973],"genre_scores_gemma":[0.9964318,0.000086197295,0.0032821654,0.00001330877,0.0000063578054,0.000027501092,0.000060121143,0.000004818665,0.000087502034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993781,0.00033250227,0.000035401277,0.0000921697,0.00013524496,0.000026670861],"domain_scores_gemma":[0.9987016,0.00064573775,0.00030891402,0.00009455622,0.00014370373,0.00010546518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002271279,0.00034056633,0.0002836753,0.00073669,0.00011826276,0.0003536007,0.00021727246,0.0003823256,0.0009483511],"category_scores_gemma":[0.002679948,0.00016043548,0.00017818922,0.00028993963,0.00032142582,0.00028609752,0.00020237666,0.00027583187,0.00021762367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007891907,0.0007192612,0.5003154,0.00040686427,0.00033466687,0.00021168275,0.00032632778,0.002028825,0.4071398,0.00029971305,0.0002925627,0.08003298],"study_design_scores_gemma":[0.00016671213,0.0063284934,0.8493851,0.000047948983,0.00034907673,0.0017173745,0.00035947716,0.026497718,0.113569744,0.00054423633,0.0009827155,0.00005142208],"about_ca_topic_score_codex":0.00020234869,"about_ca_topic_score_gemma":0.00030801282,"teacher_disagreement_score":0.002271279,"about_ca_system_score_codex":0.00020472718,"about_ca_system_score_gemma":0.00019621782,"threshold_uncertainty_score":0.012011826},"labels":[],"label_agreement":null},{"id":"W2970734757","doi":"10.1158/1078-0432.ccr-18-4121","title":"Phase I Study of the Novel Enhancer of Zeste Homolog 2 (EZH2) Inhibitor GSK2816126 in Patients with Advanced Hematologic and Solid Tumors","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Cancer Institute; Genentech; Pharmacyclics; Eisai; National Institutes of Health; Cancer Research UK; Gilead Sciences; GlaxoSmithKline; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Nausea; Adverse effect; Pharmacokinetics; Response Evaluation Criteria in Solid Tumors; Pharmacodynamics; Regimen; Progressive disease; Internal medicine; Dosing; Gastroenterology; Toxicity; Pharmacology; Chemotherapy; Oncology","score_opus":0.05720851192970894,"score_gpt":0.45829613041150136,"score_spread":0.4010876184817924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970734757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99264055,0.0029337287,0.00065623136,0.00027552655,0.00006259895,0.0012312942,0.00060182594,0.00009972051,0.0014984728],"genre_scores_gemma":[0.99260885,0.0018614528,0.0012866816,0.00032906706,0.00007234209,0.00095498806,0.0012281688,0.000017406383,0.001641151],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99985814,0.000059920658,0.000008881203,0.000024442683,0.000019747265,0.000028750164],"domain_scores_gemma":[0.99970466,0.000042319818,0.00008598379,0.000018158702,0.000020791771,0.00012819906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006227496,0.0009347261,0.0011483529,0.00020260816,0.00021304714,0.00040641928,0.00043673202,0.00048645106,0.0023631565],"category_scores_gemma":[0.00040590137,0.00032994853,0.00062122376,0.0002332112,0.00043909953,0.00037293584,0.00020569886,0.0015567472,0.0005452192],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44329706,0.049466632,0.021532599,0.0026065304,0.0023064674,0.00084494724,0.00050757936,0.008662604,0.21021228,0.00056063087,0.010867628,0.24913497],"study_design_scores_gemma":[0.4432702,0.5029721,0.026879186,0.00008055134,0.0006188553,0.0013440714,0.00008918628,0.0025557415,0.014986194,0.0002775606,0.0068885093,0.00003781787],"about_ca_topic_score_codex":0.00042030046,"about_ca_topic_score_gemma":0.0017755073,"teacher_disagreement_score":0.0023631565,"about_ca_system_score_codex":0.00053965836,"about_ca_system_score_gemma":0.0011197333,"threshold_uncertainty_score":0.007905483},"labels":[],"label_agreement":null},{"id":"W2971665889","doi":"10.1158/1078-0432.ccr-19-1543","title":"Altered Gene Expression along the Glycolysis–Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic Cancer","year":2019,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":232,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University Health Network; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; Ontario Institute for Cancer Research; University of British Columbia; Pancreas Centre (Canada)","funders":"Terry Fox Research Institute","keywords":"Glycolysis; Pancreatic cancer; Cancer; Biology; KRAS; Cancer research; Internal medicine; Oncology; Gene expression profiling; Gene expression; Medicine; Bioinformatics; Gene; Genetics; Colorectal cancer; Metabolism","score_opus":0.12556273716900995,"score_gpt":0.4358670415102314,"score_spread":0.31030430434122147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971665889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99808747,0.000275359,0.0001898214,0.00003004969,0.0000030582096,0.0000036337613,0.001214462,0.000008612583,0.00018735351],"genre_scores_gemma":[0.9983841,0.000103398044,0.0001747909,0.000017762872,0.0000038866024,0.000008775072,0.0011841881,0.000003790878,0.00011923137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980825,0.00003517135,0.000017371109,0.0000698364,0.00003342696,0.000035969377],"domain_scores_gemma":[0.9995246,0.00010273674,0.00022458564,0.000038550425,0.000038846963,0.00007068896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023405926,0.00017848323,0.0002748514,0.00056728267,0.00018828995,0.0005300966,0.00013138512,0.00019418704,0.0011447346],"category_scores_gemma":[0.0006066317,0.00008711868,0.00022232624,0.0011441774,0.00023468026,0.00015268111,0.0003017008,0.0002599935,0.00019219708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001016884,0.000031136893,0.9793032,0.000041483858,0.00010217401,0.00006415661,0.000033332326,0.00023585327,0.015419195,0.000029102875,0.00014212835,0.003581366],"study_design_scores_gemma":[0.000007506123,0.00007693024,0.9971763,0.0000044449203,0.00004899721,0.00014517174,0.00007810349,0.00049369846,0.0016764286,0.000090221736,0.00019899188,0.0000032538185],"about_ca_topic_score_codex":0.0007969596,"about_ca_topic_score_gemma":0.0008020866,"teacher_disagreement_score":0.0011447346,"about_ca_system_score_codex":0.00024824194,"about_ca_system_score_gemma":0.0002252174,"threshold_uncertainty_score":0.0038295388},"labels":[],"label_agreement":null},{"id":"W2972480782","doi":"10.1158/1078-0432.ccr-19-1268","title":"Metastatic Breast Carcinoma–Associated Fibroblasts Have Enhanced Protumorigenic Properties Related to Increased IGF2 Expression","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Jewish General Hospital","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Canadian Cancer Society","keywords":"Stromal cell; Cancer research; Breast cancer; Metastasis; Cancer-Associated Fibroblasts; Cell growth; Tumor microenvironment; Cancer; Biology; Breast carcinoma; In vivo; Pathology; Medicine; Internal medicine","score_opus":0.15152028010092838,"score_gpt":0.46180800441028413,"score_spread":0.31028772430935575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972480782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971697,0.00069399347,0.0008328338,0.000022663784,0.0000083395125,0.000019508767,0.000684054,0.000025600713,0.00054333924],"genre_scores_gemma":[0.996485,0.00039912265,0.0014070176,0.00002150026,0.000011345672,0.00003674336,0.0007992881,0.0000070045126,0.0008329115],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991524,0.000007637435,0.000007150293,0.000020756821,0.000030856925,0.000018314511],"domain_scores_gemma":[0.9998704,0.000024996565,0.00002935201,0.000011414754,0.000029440427,0.0000343384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009020243,0.000229002,0.00017180941,0.0004149954,0.00017510676,0.00020303381,0.000058540216,0.00010277025,0.0013092365],"category_scores_gemma":[0.000115161885,0.00007061651,0.00017404875,0.00028879003,0.0001162308,0.00007582323,0.00008705365,0.00018290801,0.00025050805],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015067027,0.000015643394,0.003684634,0.000026062862,0.000006867262,0.00009174906,0.000022333263,0.000025445013,0.9950051,0.00001178855,0.000023809893,0.0009359917],"study_design_scores_gemma":[0.000020639229,0.00045846828,0.21612619,0.000010091319,0.000057607143,0.0018081769,0.00023124552,0.00080099097,0.77815175,0.00005107946,0.0022731458,0.000010621874],"about_ca_topic_score_codex":0.0011354143,"about_ca_topic_score_gemma":0.0015308653,"teacher_disagreement_score":0.0013092365,"about_ca_system_score_codex":0.00014864474,"about_ca_system_score_gemma":0.00014904441,"threshold_uncertainty_score":0.0043798685},"labels":[],"label_agreement":null},{"id":"W2972559932","doi":"10.1158/1078-0432.ccr-17-3572","title":"A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory <i>BRAF</i> V600 Mutation–Positive Solid Tumors","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institutes of Health; Brain Tumour Charity; National Cancer Institute; KWF Kankerbestrijding; National Institute for Health and Care Research","keywords":"Refractory (planetary science); Pharmacokinetics; Medicine; Dabrafenib; Solid tumor; Mutation; Oncology; Internal medicine; Cancer; Genetics; Biology; Gene","score_opus":0.05948289162910631,"score_gpt":0.45527820933167135,"score_spread":0.39579531770256504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972559932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980646,0.00058661005,0.00022180646,0.00009372496,0.000010828551,0.0002858345,0.0002544705,0.000010318909,0.00047182222],"genre_scores_gemma":[0.99630296,0.00092226814,0.0009835125,0.00018838164,0.00002357178,0.0003163189,0.00077054714,0.000008091016,0.00048433154],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99978477,0.000105115905,0.000011575608,0.00002997841,0.000035487974,0.000033105884],"domain_scores_gemma":[0.9996251,0.00005634302,0.000098277465,0.000021673066,0.000035191544,0.00016335517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051988655,0.00055524835,0.0007688671,0.000149725,0.00022910617,0.00038538882,0.00024792925,0.0003231295,0.001338755],"category_scores_gemma":[0.0005488968,0.0002989136,0.00047691597,0.00021790377,0.00037881013,0.00029698823,0.00014088483,0.001542816,0.00033405813],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22252588,0.06247271,0.30008757,0.0010724423,0.0023814,0.002786758,0.0018464103,0.005113409,0.16861495,0.00069684826,0.0069605806,0.22544107],"study_design_scores_gemma":[0.1685905,0.4391935,0.34301358,0.000093097464,0.00087107957,0.005936696,0.000617203,0.0037829692,0.021224212,0.00022432306,0.016391458,0.000061314524],"about_ca_topic_score_codex":0.0016940694,"about_ca_topic_score_gemma":0.004026027,"teacher_disagreement_score":0.0016940694,"about_ca_system_score_codex":0.00067705096,"about_ca_system_score_gemma":0.001202827,"threshold_uncertainty_score":0.0049123764},"labels":[],"label_agreement":null},{"id":"W2972890374","doi":"10.1158/1078-0432.ccr-19-1050","title":"Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":267,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Mercator Research Center Ruhr; Astellas Pharma; Gilead Sciences; Sirtex Medical; Pfizer; Deutsche Forschungsgemeinschaft; Eli Lilly and Company","keywords":"Prostate cancer; Glutamate carboxypeptidase II; Positron emission tomography; Medicine; Castration; Prostate; Antigen; Cancer; Oncology; Internal medicine; Nuclear medicine; Immunology; Hormone","score_opus":0.09734563871892155,"score_gpt":0.4529922809155325,"score_spread":0.35564664219661096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972890374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993026,0.0003648023,0.00008310851,0.000012876069,0.0000023880698,0.000008840399,0.000068816116,0.00000502356,0.00015153029],"genre_scores_gemma":[0.9997861,0.00004475517,0.000054183773,0.00000855311,0.0000035478254,0.0000023452155,0.000067011926,5.4439226e-7,0.000032935342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997204,0.000120572935,0.000023885752,0.000061694845,0.00005246556,0.000021066602],"domain_scores_gemma":[0.9995427,0.000106091305,0.00018845266,0.0000349192,0.000042423104,0.00008533061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005419194,0.00028640864,0.0002917901,0.00037932364,0.0002221112,0.0002923894,0.00027474057,0.00022356787,0.0006959663],"category_scores_gemma":[0.00115744,0.00020063767,0.00018017105,0.00029697918,0.00021306766,0.00018926228,0.0002296201,0.00019997571,0.00015668043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029955836,0.000035620564,0.9967939,0.000014091694,0.000027256932,0.00013192004,0.00002949522,0.00007509354,0.0007237303,0.000004682242,0.000051419047,0.0018132011],"study_design_scores_gemma":[0.000028878298,0.00038262052,0.9974427,0.0000035875257,0.000025656416,0.001008391,0.00003764235,0.00049681414,0.00042823053,0.000009720531,0.00013304822,0.0000026261446],"about_ca_topic_score_codex":0.0021370966,"about_ca_topic_score_gemma":0.0050819437,"teacher_disagreement_score":0.0021370966,"about_ca_system_score_codex":0.00026798135,"about_ca_system_score_gemma":0.00021260134,"threshold_uncertainty_score":0.004249394},"labels":[],"label_agreement":null},{"id":"W2973096717","doi":"10.1158/1078-0432.ccr-19-1587","title":"Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a <i>de novo</i> low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Decipher Biosciences (Canada)","funders":"National Institutes of Health; National Cancer Institute; Prostate Cancer Foundation; U.S. Department of Defense","keywords":"Prostate cancer; Androgen receptor; Medicine; Oncology; Prostatectomy; Docetaxel; Internal medicine; Cancer; Androgen deprivation therapy; Biochemical recurrence; Androgen; Cancer research; Hormone","score_opus":0.147179231300564,"score_gpt":0.48289782879195847,"score_spread":0.33571859749139443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973096717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986123,0.00021254756,0.00020501643,0.000028089407,0.0000022261431,0.000007969548,0.00061222364,0.00000837271,0.00031118112],"genre_scores_gemma":[0.9985947,0.000055859557,0.00008494827,0.000029906794,0.000004644531,0.0000068111185,0.0011021624,0.000004657123,0.00011629127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997913,0.000030477022,0.000015861986,0.000078459234,0.000043484248,0.00004043468],"domain_scores_gemma":[0.9996495,0.00006221424,0.00014612185,0.000040568448,0.000046114452,0.000055512723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025242296,0.00014123078,0.0003260293,0.00042271757,0.00024660735,0.00064964,0.00020262766,0.0001670182,0.0010947265],"category_scores_gemma":[0.0004767167,0.00010013559,0.00021696318,0.0004551022,0.00025770158,0.00014226463,0.00026305066,0.00028580663,0.00023472187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072897604,0.000067623936,0.9127227,0.000053148637,0.00013590968,0.00014719718,0.00014096189,0.00014993544,0.0793504,0.000118643875,0.00038958743,0.0059947954],"study_design_scores_gemma":[0.000009171772,0.000096619806,0.9966691,0.0000034571262,0.00003239205,0.00029906668,0.000112200614,0.00027021646,0.0020716337,0.00007600183,0.00035668266,0.0000035384246],"about_ca_topic_score_codex":0.0014938726,"about_ca_topic_score_gemma":0.0019213596,"teacher_disagreement_score":0.0014938726,"about_ca_system_score_codex":0.0002642663,"about_ca_system_score_gemma":0.00020159916,"threshold_uncertainty_score":0.0036622286},"labels":[],"label_agreement":null},{"id":"W2973452239","doi":"10.1158/1078-0432.ccr-19-0955","title":"Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Cancer Society Research Institute; Cancer Research Society","keywords":"Temozolomide; Cancer research; Epidermal growth factor receptor; Neurosphere; Mesenchymal stem cell; Biology; Chemistry; In vitro; Glioma; Receptor; Cell biology; Endothelial stem cell; Biochemistry; Adult stem cell","score_opus":0.10371424020935101,"score_gpt":0.44745250896401023,"score_spread":0.34373826875465924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973452239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966067,0.00086496054,0.0012794137,0.00005701207,0.0000136224035,0.000047784786,0.0001525223,0.000090522946,0.00088733603],"genre_scores_gemma":[0.9969722,0.00049217645,0.0011463313,0.000030550127,0.000005533525,0.000027452235,0.00026821843,0.000006399069,0.0010511465],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993813,0.0000067682063,0.0000047233066,0.0000131199085,0.000021020533,0.000016190545],"domain_scores_gemma":[0.9999732,0.000002415124,0.000009181025,0.0000031388174,0.0000043462082,0.000007807366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083007486,0.00031528086,0.00023293588,0.000257749,0.00007208621,0.0002090094,0.0002263584,0.00023084278,0.0008908835],"category_scores_gemma":[0.000054707005,0.000092285336,0.00015399864,0.00015647619,0.00012443674,0.00014922999,0.00011368955,0.0002951709,0.00018452945],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012380032,0.00010378795,0.00012096709,0.000047424823,0.000009204538,0.000020903979,0.000011497886,0.0001628301,0.9956815,0.00012605461,0.000064183965,0.0035277773],"study_design_scores_gemma":[0.00009081937,0.0018305584,0.002782329,0.0000049856044,0.00004682249,0.0001775185,0.000021018603,0.0013604139,0.99136275,0.000033291846,0.002283988,0.000005629546],"about_ca_topic_score_codex":0.00061020866,"about_ca_topic_score_gemma":0.0010037797,"teacher_disagreement_score":0.0008908835,"about_ca_system_score_codex":0.00026410486,"about_ca_system_score_gemma":0.00015145469,"threshold_uncertainty_score":0.0029802918},"labels":[],"label_agreement":null},{"id":"W2974027076","doi":"10.1158/1078-0432.ccr-19-0751","title":"Biomarker Analyses of Response to Cyclin-Dependent Kinase 4/6 Inhibition and Endocrine Therapy in Women with Treatment-Naïve Metastatic Breast Cancer","year":2019,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":221,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Pfizer","keywords":"Palbociclib; Letrozole; Breast cancer; Biomarker; Cyclin-dependent kinase 4; Oncology; Metastatic breast cancer; Medicine; Internal medicine; Cancer; Fulvestrant; Cancer research; Biology; Estrogen receptor; Cell cycle; Tamoxifen; Cyclin-dependent kinase 2","score_opus":0.26475433294806805,"score_gpt":0.543597462485185,"score_spread":0.278843129537117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974027076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953839,0.0025181107,0.00029703238,0.00013556531,0.000016914608,0.00006636733,0.00070862507,0.000023042267,0.00085048063],"genre_scores_gemma":[0.9983557,0.00027085058,0.00035646805,0.00009009521,0.000014382619,0.00004591224,0.0005199255,0.000002118028,0.00034451016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978834,0.00007689335,0.000016743772,0.000048501395,0.000047119174,0.00002253787],"domain_scores_gemma":[0.999605,0.00011707848,0.0001404797,0.000021607828,0.000058824848,0.00005702022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005279741,0.00026804776,0.00040372182,0.0003833276,0.00012485548,0.00027432543,0.00022823016,0.00034699662,0.001166233],"category_scores_gemma":[0.0012371818,0.00012365052,0.00021818504,0.00040507864,0.00013253116,0.00017307796,0.00013785127,0.0003477734,0.00022081764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026646525,0.0006126269,0.88899636,0.00021635853,0.0003858371,0.00032030107,0.00008305462,0.00067611947,0.032986585,0.000060734335,0.00077823916,0.0482373],"study_design_scores_gemma":[0.00045099625,0.007788442,0.9764574,0.000016601298,0.00024956072,0.0009877621,0.000095328105,0.0012681573,0.010738439,0.00010880469,0.0018251237,0.000013330273],"about_ca_topic_score_codex":0.0006574296,"about_ca_topic_score_gemma":0.0009699076,"teacher_disagreement_score":0.001166233,"about_ca_system_score_codex":0.0003003846,"about_ca_system_score_gemma":0.00028675754,"threshold_uncertainty_score":0.003901422},"labels":[],"label_agreement":null},{"id":"W2976929154","doi":"10.1158/1078-0432.ccr-19-1223","title":"Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201)","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Cabozantinib; Chemotherapy; Melanoma; Medicine; Oncology; Randomized controlled trial; Metastatic melanoma; Alliance; Internal medicine; Cancer; Cancer research","score_opus":0.17381039171810975,"score_gpt":0.5433237727058784,"score_spread":0.36951338098776865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2976929154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911931,0.0023264298,0.00046056084,0.0007716419,0.0002796965,0.0016967503,0.0013376569,0.00009169064,0.001842405],"genre_scores_gemma":[0.9875787,0.001242791,0.0012046015,0.000996932,0.0002796262,0.0035363527,0.0020947752,0.000029395698,0.003036915],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994424,0.00036237205,0.00001982427,0.00007987725,0.0000299746,0.00006556065],"domain_scores_gemma":[0.99923944,0.00017761084,0.00022107612,0.00006444213,0.00003930491,0.0002580686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014546439,0.0011446353,0.0017845265,0.00041534452,0.0003249519,0.0008377698,0.0006044221,0.0009934717,0.005982805],"category_scores_gemma":[0.0013037962,0.00041288923,0.001020883,0.00035787906,0.0006375141,0.00053214026,0.00033896993,0.002189816,0.0006893914],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96580017,0.005278629,0.0012122212,0.0002546418,0.0006166976,0.000048012796,0.000044464374,0.000711755,0.0053012245,0.0001432878,0.0017834888,0.018805392],"study_design_scores_gemma":[0.91341007,0.07910348,0.0043087797,0.000025572312,0.00036525735,0.00009222443,0.000020839392,0.00083500065,0.00051881437,0.00028369762,0.0010234945,0.000012898568],"about_ca_topic_score_codex":0.00074394816,"about_ca_topic_score_gemma":0.0022382766,"teacher_disagreement_score":0.005982805,"about_ca_system_score_codex":0.0008596162,"about_ca_system_score_gemma":0.0009137187,"threshold_uncertainty_score":0.020014524},"labels":[],"label_agreement":null},{"id":"W2977198565","doi":"10.1158/1078-0432.ccr-19-1038","title":"Comprehensive Transcriptomic Profiling Identifies Breast Cancer Patients Who May Be Spared Adjuvant Systemic Therapy","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Decipher Biosciences (Canada); Ontario Genomics","funders":"Anna och Edwin Bergers Stiftelse; Fru Berta Kamprads Stiftelse; Medicinska Fakulteten, Lunds Universitet; Gunnar Nilssons Cancerstiftelse; Cancerfonden","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Adjuvant therapy; Cohort; Radiation therapy; Adjuvant; Subgroup analysis; Endocrine system; Cancer; Meta-analysis; Hormone","score_opus":0.12392909294632232,"score_gpt":0.44988547125275363,"score_spread":0.3259563783064313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977198565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813974,0.00058645377,0.0004026348,0.000039174134,0.0000029330936,0.000007952062,0.00056187774,0.000010629087,0.0002485408],"genre_scores_gemma":[0.99780196,0.00017993916,0.0004036814,0.00003863995,0.000008618146,0.0000121133235,0.0014107378,0.000003514909,0.00014087185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982077,0.000033116612,0.000016301243,0.00006257224,0.00003403269,0.000033162345],"domain_scores_gemma":[0.9997131,0.000066931476,0.00013756493,0.000021037378,0.000023445446,0.000037877573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002776355,0.00018840002,0.0005056657,0.000459385,0.00016874107,0.00035053884,0.00015150524,0.00021984876,0.0007471136],"category_scores_gemma":[0.0006156719,0.00006877992,0.0003049434,0.0006189393,0.00015387914,0.00017347599,0.00025956304,0.00016075138,0.0001678298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003338189,0.000102477105,0.8708126,0.000109969784,0.00018527065,0.00030053762,0.00009828518,0.0008954192,0.09528378,0.000103668266,0.00037252923,0.028397225],"study_design_scores_gemma":[0.000041243464,0.0006500666,0.98963517,0.000013648713,0.0001967141,0.0007605004,0.00014473255,0.0016538673,0.005740115,0.00018908232,0.0009650332,0.000009740445],"about_ca_topic_score_codex":0.0003534782,"about_ca_topic_score_gemma":0.0008470741,"teacher_disagreement_score":0.0007471136,"about_ca_system_score_codex":0.0001792495,"about_ca_system_score_gemma":0.00018460686,"threshold_uncertainty_score":0.002499342},"labels":[],"label_agreement":null},{"id":"W2977439680","doi":"10.1158/1557-3265.sarcomas17-b03","title":"Abstract B03: The endochondral bone protein CHM1 sustains an undifferentiated, invasive phenotype promoting lung metastasis in Ewing sarcoma","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Metastasis; Cancer research; Medicine; Sarcoma; RNA interference; Pathogenesis; Pathology; Biology; Cancer; Internal medicine; RNA; Gene","score_opus":0.231150645613191,"score_gpt":0.5121321965991278,"score_spread":0.2809815509859368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977439680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99067277,0.0024324022,0.00255746,0.00020992287,0.000058667592,0.000023616753,0.0017796337,0.0001316128,0.0021337688],"genre_scores_gemma":[0.98830974,0.0006138341,0.0015766295,0.00010279126,0.000013447131,0.000031750093,0.002646313,0.000025372885,0.006680111],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988735,0.000007684213,0.00000753898,0.000030495241,0.000042357107,0.000024675648],"domain_scores_gemma":[0.9999311,0.000011018909,0.000017749046,0.000007748514,0.000011651703,0.000020680132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010875733,0.00028477062,0.00017366133,0.00023087932,0.0002110784,0.00024034752,0.00018451517,0.0002668735,0.0027024301],"category_scores_gemma":[0.00009440903,0.00009113811,0.00020465185,0.00017638183,0.00020922994,0.00013126465,0.00017966583,0.0005135158,0.0008217056],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007691251,0.000015102797,0.00029910257,0.000043908432,0.000003146305,0.000036696983,0.0000067688525,0.00003030839,0.9983575,0.000059222846,0.00011555001,0.0009558074],"study_design_scores_gemma":[0.00001802217,0.00016671799,0.018559132,0.000011111654,0.000017327688,0.00029965656,0.000044944,0.0011030295,0.97497785,0.000050060014,0.0047469805,0.0000051991046],"about_ca_topic_score_codex":0.0008421407,"about_ca_topic_score_gemma":0.0011205145,"teacher_disagreement_score":0.0027024301,"about_ca_system_score_codex":0.00039494326,"about_ca_system_score_gemma":0.00022328817,"threshold_uncertainty_score":0.009040594},"labels":[],"label_agreement":null},{"id":"W2978136097","doi":"10.1158/1078-0432.ccr-19-0526","title":"An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid Tumors","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Agonist; Medicine; Blockade; Receptor; Pharmacology; CD8; Cancer research; Oncology; Internal medicine; Immunology; Immune system","score_opus":0.07808303389853102,"score_gpt":0.4868528207522376,"score_spread":0.4087697868537066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978136097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.867084,0.011249207,0.10076164,0.0033361132,0.00017393891,0.0014916264,0.0023677936,0.0010179898,0.012517609],"genre_scores_gemma":[0.9543075,0.0013020352,0.041768335,0.0004954074,0.00007390818,0.0003722633,0.00078162196,0.000040736646,0.00085821917],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99966335,0.00017456079,0.000021803406,0.00004749131,0.000066433655,0.000026441543],"domain_scores_gemma":[0.9996008,0.00012213129,0.000117534655,0.000026461834,0.000077544435,0.00005553204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014990346,0.00043021003,0.0007302653,0.0005012137,0.0001343954,0.0010672976,0.00039937146,0.00033596085,0.0026971023],"category_scores_gemma":[0.0015542404,0.00017420034,0.00028879746,0.0003315137,0.00019137436,0.0004154494,0.00041197648,0.0007386615,0.00059006974],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010335584,0.0023675512,0.14093867,0.0010016853,0.00027819077,0.00054234837,0.0005097893,0.055447552,0.23083772,0.003924989,0.0067929844,0.547023],"study_design_scores_gemma":[0.0022250393,0.029487487,0.2974074,0.0007785078,0.0014793192,0.0014680311,0.0018448345,0.39210495,0.18970555,0.011084853,0.07226543,0.0001486945],"about_ca_topic_score_codex":0.0007766082,"about_ca_topic_score_gemma":0.0011043382,"teacher_disagreement_score":0.0026971023,"about_ca_system_score_codex":0.0008025974,"about_ca_system_score_gemma":0.0011887143,"threshold_uncertainty_score":0.009022713},"labels":[],"label_agreement":null},{"id":"W2979808878","doi":"10.1158/1078-0432.ccr-19-0603","title":"Metformin Abrogates Age-Associated Ovarian Fibrosis","year":2019,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University; Université de Montréal; Centre Hospitalier de l’Université de Montréal; Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Ovarian cancer; Metformin; Ovulation; Fibrosis; Medicine; Ovary; Oncology; Internal medicine; Cohort; Endocrinology; Cancer; Physiology; Diabetes mellitus; Hormone","score_opus":0.321253355543479,"score_gpt":0.5347019113503512,"score_spread":0.21344855580687216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979808878","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45734814,0.3117098,0.0068078046,0.13111341,0.039029334,0.0012327895,0.0043481784,0.0015568685,0.04685368],"genre_scores_gemma":[0.7550767,0.11578048,0.0034685838,0.069476955,0.012696569,0.0013439499,0.0015477894,0.0001694946,0.040439386],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997286,0.00008287296,0.000016901628,0.000029554507,0.00009463649,0.000047426518],"domain_scores_gemma":[0.99966836,0.00012171177,0.000069229536,0.000033155615,0.000065100045,0.000042510736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005747076,0.00028272517,0.00036556335,0.00023422603,0.00023335357,0.00040086877,0.0004769353,0.0010978815,0.001762055],"category_scores_gemma":[0.0006653243,0.00012357072,0.00023597691,0.00014045788,0.0005014825,0.00028470438,0.0003889105,0.0025694403,0.0004900138],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010283148,0.0021187994,0.0025846339,0.0039035329,0.0003149191,0.001709067,0.0002242115,0.0005292138,0.41648394,0.007887745,0.26323828,0.2907225],"study_design_scores_gemma":[0.0044068843,0.011361408,0.0334937,0.0011705324,0.0004311034,0.0021357199,0.00026688416,0.0014100423,0.26842076,0.0053830985,0.6714131,0.00010679964],"about_ca_topic_score_codex":0.00043006937,"about_ca_topic_score_gemma":0.0012975767,"teacher_disagreement_score":0.001762055,"about_ca_system_score_codex":0.00032767674,"about_ca_system_score_gemma":0.0006013024,"threshold_uncertainty_score":0.005894661},"labels":[],"label_agreement":null},{"id":"W2981115842","doi":"10.1158/1078-0432.ccr-19-1164","title":"Lucitanib for the Treatment of HR+/HER2− Metastatic Breast Cancer: Results from the Multicohort Phase II FINESSE Study","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Institut de Recherches Servier; Servier","keywords":"Medicine; Internal medicine; Clinical endpoint; Oncology; Breast cancer; Metastatic breast cancer; Fibroblast growth factor receptor 1; Cohort; Cancer; Adverse effect; Randomized controlled trial; Receptor","score_opus":0.1920115313090569,"score_gpt":0.5330753072108346,"score_spread":0.3410637759017777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981115842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905414,0.0048841033,0.0005099625,0.00032006638,0.000034798137,0.0007374192,0.0014830972,0.00006304861,0.0014259795],"genre_scores_gemma":[0.9904275,0.0017186049,0.0011043458,0.00065565936,0.000063740874,0.0005744869,0.0042248475,0.000025297271,0.001205447],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994166,0.0003669192,0.000022916991,0.00006564366,0.00006075622,0.00006725222],"domain_scores_gemma":[0.99945456,0.00009304858,0.0001290059,0.00006898567,0.00005957392,0.00019480611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033070242,0.00088585087,0.00095499324,0.00024604346,0.00025929394,0.00067157473,0.00043921132,0.00045627588,0.0013526516],"category_scores_gemma":[0.00094187085,0.0002398,0.00091677177,0.00028868156,0.00033364978,0.00032299338,0.00028265372,0.00073022814,0.0003056192],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6173921,0.016474789,0.09964168,0.001100752,0.0082350345,0.0004066693,0.00045293313,0.003958569,0.050065327,0.00041658085,0.013197913,0.18865757],"study_design_scores_gemma":[0.37886548,0.19961856,0.39082703,0.0001602716,0.005812735,0.0013558823,0.00015118942,0.0021846266,0.005887755,0.000470689,0.014545786,0.00012006398],"about_ca_topic_score_codex":0.0014130648,"about_ca_topic_score_gemma":0.003991586,"teacher_disagreement_score":0.0033070242,"about_ca_system_score_codex":0.0007425839,"about_ca_system_score_gemma":0.0008204608,"threshold_uncertainty_score":0.017489433},"labels":[],"label_agreement":null},{"id":"W2981358604","doi":"10.1158/1078-0432.ccr-19-1495","title":"Deep Learning Based on Standard H&amp;E Images of Primary Melanoma Tumors Identifies Patients at Risk for Visceral Recurrence and Death","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Yale SPORE in Lung Cancer; Swim Across America; Yale Cancer Center; U.S. Food and Drug Administration; Melanoma Research Alliance","keywords":"Medicine; Cohort; Receiver operating characteristic; Melanoma; Population; Adjuvant therapy; Stage (stratigraphy); Oncology; Cancer; Internal medicine; Cutoff; Artificial intelligence; Computer science; Cancer research; Biology","score_opus":0.08991842467784979,"score_gpt":0.43549719619626676,"score_spread":0.345578771518417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981358604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94649464,0.00015870463,0.05006531,0.00038209715,0.000023875506,0.00008969411,0.00058440125,0.00029874837,0.001902494],"genre_scores_gemma":[0.9889219,0.000035018995,0.009934647,0.000052130705,0.000008405039,0.00002889934,0.00033067487,0.000007828616,0.0006805557],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998728,0.000037189246,0.000008044564,0.000037407823,0.000026601232,0.000018058301],"domain_scores_gemma":[0.99963903,0.00015246103,0.0000644339,0.000046340654,0.000064882996,0.00003288515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041929362,0.0003152298,0.00022677552,0.00056459726,0.00014104666,0.00048444787,0.0003760235,0.00033459297,0.002038009],"category_scores_gemma":[0.0020490424,0.0001321716,0.00027152066,0.00026120452,0.00022186124,0.00029568747,0.0003353826,0.00037264335,0.0003745729],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016363736,0.0009204312,0.38853222,0.0001407218,0.00024992594,0.0006096997,0.00015879534,0.26727128,0.033664558,0.0011649363,0.004427826,0.30122334],"study_design_scores_gemma":[0.00003657816,0.0002346692,0.0840859,0.000018492556,0.00002917923,0.00025077796,0.00005470522,0.9030247,0.010518975,0.0011003865,0.0006325383,0.0000130810095],"about_ca_topic_score_codex":0.003914723,"about_ca_topic_score_gemma":0.005555496,"teacher_disagreement_score":0.003914723,"about_ca_system_score_codex":0.0005240541,"about_ca_system_score_gemma":0.00049841544,"threshold_uncertainty_score":0.00778383},"labels":[],"label_agreement":null},{"id":"W2982361973","doi":"10.1158/1078-0432.ccr-19-1611","title":"MAP9 Loss Triggers Chromosomal Instability, Initiates Colorectal Tumorigenesis, and Is Associated with Poor Survival of Patients with Colorectal Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Key Research and Development Program of China; Health and Medical Research Fund","keywords":"Chromosome instability; Colorectal cancer; Cancer research; Carcinogenesis; Cancer; Knockout mouse; Microsatellite instability; Genome instability; Mouse model of colorectal and intestinal cancer; Biology; Azoxymethane; Aneuploidy; Chromosome; Genetics; DNA damage; Gene","score_opus":0.03641800314611702,"score_gpt":0.3696162983407031,"score_spread":0.33319829519458605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982361973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998727,0.00049246236,0.00022436278,0.00002327254,0.00000414281,0.000004253793,0.0002811841,0.000015594893,0.0002275802],"genre_scores_gemma":[0.99916244,0.00015852635,0.00010281133,0.000011525963,0.0000047687363,0.0000039679603,0.00031069433,0.0000027065385,0.00024246797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99990046,0.000015042889,0.000008826812,0.00003247619,0.000024185429,0.00001901933],"domain_scores_gemma":[0.99969923,0.000033160937,0.00014830496,0.000020162675,0.000027864347,0.00007138213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010652156,0.00018953552,0.00022088902,0.00041642386,0.00019039951,0.00017292619,0.00011466572,0.0002039636,0.0018247978],"category_scores_gemma":[0.00032997117,0.000098502474,0.00014222936,0.0003126525,0.00011494807,0.00012786423,0.00019202069,0.00024057842,0.00025541158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017254853,0.00007837929,0.8999972,0.0000788238,0.00010874968,0.0012874028,0.00004567788,0.00009359612,0.08725086,0.000048564903,0.00033956172,0.008945748],"study_design_scores_gemma":[0.000007684001,0.00023294879,0.9900051,0.0000046187856,0.000044522443,0.0025983846,0.000038237857,0.00017708412,0.0061362004,0.000020482617,0.0007316122,0.0000032026485],"about_ca_topic_score_codex":0.00034234894,"about_ca_topic_score_gemma":0.0004730848,"teacher_disagreement_score":0.0018247978,"about_ca_system_score_codex":0.00013662678,"about_ca_system_score_gemma":0.00008999511,"threshold_uncertainty_score":0.006104529},"labels":[],"label_agreement":null},{"id":"W2987428409","doi":"10.1158/1078-0432.ccr-19-1376","title":"Organoid Cultures as Preclinical Models of Non–Small Cell Lung Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":327,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute; Princess Margaret Cancer Centre; Artificial Intelligence in Medicine (Canada); Ontario Institute for Cancer Research; University of Toronto","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Organoid; Lung cancer; Biomarker; Exome sequencing; Cancer research; Medicine; Cancer; Targeted therapy; Pathology; Exome; Biology; Oncology; Internal medicine; Gene; Mutation; Genetics","score_opus":0.22099516130879326,"score_gpt":0.5530273713961305,"score_spread":0.3320322100873372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987428409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77442616,0.028988147,0.16268872,0.0010616261,0.00075143744,0.003559008,0.013661104,0.0016478351,0.013215912],"genre_scores_gemma":[0.8866514,0.011809267,0.075805336,0.00038187802,0.000059089223,0.00254263,0.014577611,0.00020140856,0.007971339],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899834,0.00028716747,0.00011522152,0.00020515319,0.00030947564,0.000084556814],"domain_scores_gemma":[0.99897766,0.0002626554,0.00015475595,0.00024100684,0.00018351994,0.00018040939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015010893,0.0009745428,0.0008630398,0.0010109445,0.0006147443,0.0008485375,0.0009552203,0.0007525327,0.0019381458],"category_scores_gemma":[0.0005351701,0.00028440484,0.0009951859,0.000640173,0.00067689776,0.00068588275,0.00078427646,0.002076619,0.0016527552],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005420197,0.00035523152,0.001850993,0.00039547408,0.000041062016,0.0003375771,0.00019771233,0.0014859912,0.98840314,0.00040501644,0.00066711183,0.005318774],"study_design_scores_gemma":[0.000093822775,0.0036159782,0.007999009,0.000116189265,0.00017556842,0.0013688725,0.00027446885,0.0029413553,0.96092266,0.00026561844,0.022176227,0.000050204868],"about_ca_topic_score_codex":0.0018749438,"about_ca_topic_score_gemma":0.005621185,"teacher_disagreement_score":0.0019381458,"about_ca_system_score_codex":0.00093017385,"about_ca_system_score_gemma":0.0008311911,"threshold_uncertainty_score":0.007938564},"labels":[],"label_agreement":null},{"id":"W2988731068","doi":"10.1158/1078-0432.ccr-19-2078","title":"Pembrolizumab in Combination with the Oncolytic Virus Pelareorep and Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma: A Phase Ib Study","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"National Cancer Institute; National Institute on Aging; Cancer Prevention and Research Institute of Texas","keywords":"Pembrolizumab; Medicine; Oncolytic virus; Gemcitabine; Chemotherapy; Pancreatic cancer; Internal medicine; Oncology; Irinotecan; Response Evaluation Criteria in Solid Tumors; Immunotherapy; Gastroenterology; Progressive disease; Cancer; Colorectal cancer","score_opus":0.04132572632792689,"score_gpt":0.4330337923661132,"score_spread":0.3917080660381863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988731068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930368,0.0038618783,0.00032320098,0.00033537048,0.00007645564,0.0009761425,0.00022943002,0.00004905313,0.0011116759],"genre_scores_gemma":[0.99268746,0.0030220256,0.0009639645,0.0005913471,0.0001316211,0.0011070742,0.0006237938,0.000014738524,0.0008580516],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995983,0.00018706286,0.000026401447,0.00006181104,0.000045162622,0.000081160644],"domain_scores_gemma":[0.99943537,0.00009945955,0.00009804109,0.000054189306,0.000033348693,0.00027953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013096987,0.0011258315,0.0022869078,0.00046881224,0.0004874727,0.0010439935,0.00073250406,0.0011465494,0.001708993],"category_scores_gemma":[0.0006856906,0.00060910085,0.0012367954,0.00053158466,0.0006743936,0.00084475667,0.00027035593,0.0027400465,0.00050685304],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48599094,0.14055027,0.0155290095,0.0020884194,0.003636914,0.00074579846,0.00069656817,0.004604836,0.085620776,0.00034680087,0.0032888914,0.25690082],"study_design_scores_gemma":[0.40473342,0.563174,0.020529835,0.00009931035,0.00088660215,0.00060328114,0.00009035991,0.0016144447,0.0045229187,0.00013639205,0.0035741515,0.000035262157],"about_ca_topic_score_codex":0.00080276304,"about_ca_topic_score_gemma":0.0016970993,"teacher_disagreement_score":0.0022869078,"about_ca_system_score_codex":0.00089778414,"about_ca_system_score_gemma":0.0011921694,"threshold_uncertainty_score":0.0069264174},"labels":[],"label_agreement":null},{"id":"W2988973848","doi":"10.1158/1078-0432.ccr-18-3717","title":"A Th1/IFNγ Gene Signature Is Prognostic in the Adjuvant Setting of Resectable High-Risk Melanoma but Not in Non–Small Cell Lung Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"GlaxoSmithKline Biologicals; Agence Nationale de la Recherche","keywords":"Melanoma; Medicine; Gene signature; Oncology; Lymph node; Immunotherapy; Internal medicine; Lung cancer; Cancer; Adjuvant therapy; Cancer research; Gene expression; Gene; Biology","score_opus":0.06522862528922822,"score_gpt":0.42706495668085354,"score_spread":0.3618363313916253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988973848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995789,0.00007763279,0.00018901296,0.000009742501,0.0000017579242,0.000015249379,0.00005622759,0.0000029696916,0.0000685412],"genre_scores_gemma":[0.9995426,0.00002085536,0.00024089786,0.000012970139,0.000002677027,0.000011805077,0.00011701224,0.000001065755,0.00005013458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996872,0.000133934,0.000022507838,0.0000631322,0.000060688573,0.000032633016],"domain_scores_gemma":[0.9989641,0.0002913819,0.0004409563,0.00011097921,0.00007135475,0.00012121032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012651659,0.00024515294,0.00032473664,0.00018396621,0.000117171134,0.00021625706,0.00014794408,0.00019632092,0.0006169289],"category_scores_gemma":[0.0012660121,0.00010444155,0.0002100685,0.00014016395,0.00029923866,0.00013193676,0.00012210937,0.00032450823,0.00011363936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016510705,0.0010464799,0.7792444,0.00011246186,0.00016844473,0.00011833069,0.00007417144,0.0015196794,0.17981,0.000028546428,0.000109302506,0.021257509],"study_design_scores_gemma":[0.00029292228,0.012663624,0.94779444,0.0000116495485,0.00017410339,0.0004767284,0.000048149646,0.0028979043,0.035204176,0.00008960989,0.00033765056,0.000009092427],"about_ca_topic_score_codex":0.0001929247,"about_ca_topic_score_gemma":0.00039979958,"teacher_disagreement_score":0.0012651659,"about_ca_system_score_codex":0.00019857536,"about_ca_system_score_gemma":0.00028757838,"threshold_uncertainty_score":0.0066909194},"labels":[],"label_agreement":null},{"id":"W2989987839","doi":"10.1158/1078-0432.ccr-19-2853","title":"Statin Use Is Associated with Lower Risk of PTEN-Null and Lethal Prostate Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"National Cancer Institute; Dana-Farber/Harvard Cancer Center; American Cancer Society","keywords":"Prostate cancer; Medicine; PTEN; Oncology; Internal medicine; Statin; Prostate; Cancer; Proportional hazards model; Relative risk; Disease; Confidence interval; Biology; Apoptosis; PI3K/AKT/mTOR pathway","score_opus":0.07824013329194157,"score_gpt":0.43781383465050205,"score_spread":0.3595737013585605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989987839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979663,0.0010822308,0.00015251816,0.00006403901,0.000005094534,0.0000051156485,0.00046078247,0.0000072264434,0.00025669945],"genre_scores_gemma":[0.99955004,0.00012937479,0.000046932924,0.000014993226,0.000005387466,0.0000016440341,0.00018015523,0.0000011679692,0.00007027435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999617,0.000094575764,0.000040056977,0.000105247214,0.00007575129,0.00006736104],"domain_scores_gemma":[0.9985916,0.00024224626,0.00077363855,0.00013209066,0.00008859204,0.00017187778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040849188,0.000163684,0.00044613372,0.00041413805,0.00022783423,0.00043252672,0.00023859175,0.00028760196,0.0013999263],"category_scores_gemma":[0.0015799121,0.00020184016,0.000755049,0.00078590587,0.00023882867,0.00020768182,0.0003376324,0.0004772625,0.00012253242],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006721559,0.000023942537,0.9964031,0.000025194668,0.00021905746,0.00005370758,0.00001674172,0.000052890002,0.0011320439,0.000016588212,0.000043544274,0.0013409294],"study_design_scores_gemma":[0.000009793147,0.0000627437,0.9990803,0.000004722136,0.00014737633,0.00012321307,0.00002127919,0.00018555908,0.00024359062,0.0000432963,0.00007501627,0.0000030137971],"about_ca_topic_score_codex":0.0046156235,"about_ca_topic_score_gemma":0.00533065,"teacher_disagreement_score":0.0046156235,"about_ca_system_score_codex":0.00024617394,"about_ca_system_score_gemma":0.00044527018,"threshold_uncertainty_score":0.009177566},"labels":[],"label_agreement":null},{"id":"W2990519743","doi":"10.1158/1078-0432.ccr-19-2350","title":"Baseline Characteristics, Treatment Patterns, and Outcomes in Patients with HER2-Positive Metastatic Breast Cancer by Hormone Receptor Status from SystHERs","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Metastatic breast cancer; Breast cancer; Chemotherapy; Oncology; Population; Cancer; Hormone therapy; Confidence interval; Gastroenterology","score_opus":0.04489257946605979,"score_gpt":0.42035268426264466,"score_spread":0.37546010479658487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990519743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978648,0.00016821575,0.000050461018,0.00005847956,0.0000044092935,0.000013067669,0.0015485702,0.0000023301184,0.00028982395],"genre_scores_gemma":[0.9958502,0.00011960621,0.00006180201,0.00009776498,0.000019922925,0.000030694573,0.0036283801,0.0000020801485,0.00018954425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99965024,0.000068266105,0.000043185006,0.000114634706,0.0000784552,0.000045344677],"domain_scores_gemma":[0.9991474,0.0001233262,0.00047723186,0.000052915126,0.000082036,0.00011700737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049025955,0.00019232558,0.00032863754,0.00050869276,0.0002964123,0.00034192475,0.00026961716,0.00030805217,0.0015931847],"category_scores_gemma":[0.0012330061,0.00018911347,0.00034531183,0.00081147073,0.00017499176,0.0004232133,0.00030546627,0.0003522871,0.00023656104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004565361,0.0000642221,0.9973322,0.000011366955,0.00007052449,0.000054804503,0.000032620504,0.00004637025,0.00027932055,0.000015844096,0.00048013858,0.0011560679],"study_design_scores_gemma":[0.00011073877,0.0003522911,0.9983163,0.000008516795,0.000064499356,0.0002732884,0.00009057184,0.0002244479,0.000104976636,0.00002310876,0.00042557725,0.0000056552035],"about_ca_topic_score_codex":0.004043766,"about_ca_topic_score_gemma":0.0071358634,"teacher_disagreement_score":0.004043766,"about_ca_system_score_codex":0.00037139343,"about_ca_system_score_gemma":0.00038972107,"threshold_uncertainty_score":0.008040428},"labels":[],"label_agreement":null},{"id":"W2990636802","doi":"10.1158/1078-0432.ccr-19-3645","title":"Metformin in Gynecologic Cancers: Opening a New Window for Prevention and Treatment?","year":2019,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Metformin; Medicine; PI3K/AKT/mTOR pathway; Diabetes mellitus; Type 2 diabetes; Drug; Cancer; Internal medicine; Oncology; Pharmacology; Endocrinology; Signal transduction; Biology","score_opus":0.29951833120537447,"score_gpt":0.527646728476705,"score_spread":0.22812839727133055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990636802","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026174213,0.011427674,0.00010438276,0.95878506,0.027614461,0.000009548479,0.00003062947,0.00002222558,0.0017442745],"genre_scores_gemma":[0.004211287,0.021363739,0.0003585761,0.74427676,0.2236203,0.00004756534,0.000037105157,0.000021611422,0.006062976],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985215,0.00044880508,0.00016176562,0.00019217252,0.00052856543,0.0001472953],"domain_scores_gemma":[0.9959394,0.0023400958,0.00026023117,0.0001652279,0.0007224129,0.000572582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002531086,0.0008574606,0.001486396,0.00081500673,0.001834341,0.002179465,0.0011062588,0.021399284,0.006349424],"category_scores_gemma":[0.01006191,0.00040878402,0.0013750526,0.00045550213,0.0025105737,0.004458443,0.0010060219,0.023789411,0.005551204],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020430751,0.00008240619,0.00037596482,0.00023536176,0.000025076732,0.0034160342,0.000065481945,0.00011610191,0.00058636686,0.0061236313,0.93629396,0.052475214],"study_design_scores_gemma":[0.00037090812,0.00029188168,0.0011856186,0.0009485657,0.000047834907,0.006197702,0.0002079384,0.0004309714,0.00040450125,0.020607108,0.9692342,0.00007277679],"about_ca_topic_score_codex":0.0015917821,"about_ca_topic_score_gemma":0.0030680846,"teacher_disagreement_score":0.021399284,"about_ca_system_score_codex":0.0033036657,"about_ca_system_score_gemma":0.0018038799,"threshold_uncertainty_score":0.02396983},"labels":[],"label_agreement":null},{"id":"W2991225937","doi":"10.1158/1078-0432.ccr-19-1623","title":"Identification of Hypermutation and Defective Mismatch Repair in ctDNA from Metastatic Prostate Cancer","year":2019,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Ottawa Regional Cancer Foundation; Jewish General Hospital; Montreal General Hospital; BC Cancer Agency; Ottawa Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; Prostate Cancer Canada; Government of Canada; Prostate Cancer Foundation","keywords":"Somatic hypermutation; Biology; Cancer research; MSH2; MLH1; Prostate cancer; DNA repair; DNA mismatch repair; MSH6; Microsatellite instability; Cancer; Genetics; Allele; Gene; Microsatellite; Antibody","score_opus":0.09185235799688074,"score_gpt":0.4557856532562543,"score_spread":0.36393329525937357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991225937","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99854565,0.0003944645,0.00059557304,0.000016610076,0.0000022491906,0.00001108265,0.00018616328,0.000017351818,0.00023088437],"genre_scores_gemma":[0.9992188,0.00007991043,0.00034298305,0.000015107886,0.0000033191293,0.000005382503,0.0002543761,0.0000036236734,0.00007644933],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983156,0.000023345117,0.00002003509,0.00005199761,0.000051352035,0.0000216239],"domain_scores_gemma":[0.99963164,0.000092047514,0.00011815044,0.00004099507,0.000052462397,0.00006481943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021722275,0.00024191041,0.00023113593,0.0008537633,0.0002600706,0.00030057537,0.00022692281,0.00025509298,0.0015803274],"category_scores_gemma":[0.0008126809,0.0001473785,0.00013570597,0.0006715619,0.00022031438,0.00011567994,0.0002580037,0.00026518732,0.0002536224],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000739059,0.000056216726,0.78102905,0.00018636986,0.00009825797,0.003470657,0.0002833774,0.0003587277,0.19777967,0.00011269835,0.0002094178,0.015676474],"study_design_scores_gemma":[0.00004189717,0.00063021336,0.8858862,0.000028064762,0.00009695191,0.038719345,0.00019278706,0.0015893107,0.07105196,0.00015001433,0.0016019966,0.000011125278],"about_ca_topic_score_codex":0.0009777644,"about_ca_topic_score_gemma":0.0012646641,"teacher_disagreement_score":0.0015803274,"about_ca_system_score_codex":0.00026236736,"about_ca_system_score_gemma":0.00019889713,"threshold_uncertainty_score":0.0052866936},"labels":[],"label_agreement":null},{"id":"W2992828409","doi":"10.1158/1078-0432.ccr-19-2177","title":"Efficacy and Safety of Dabrafenib in Pediatric Patients with <i>BRAF</i> V600 Mutation–Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":212,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health; Brain Tumour Charity","keywords":"Refractory (planetary science); Medicine; Glioma; Dabrafenib; Mutation; Internal medicine; Oncology; Cancer research; Cancer; Biology; Genetics; Gene; Metastatic melanoma","score_opus":0.0816485706614812,"score_gpt":0.46173054034874544,"score_spread":0.38008196968726427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992828409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964228,0.0023409594,0.00015385004,0.00008722389,0.0000074868376,0.00012344928,0.0003788589,0.000011535814,0.00047367098],"genre_scores_gemma":[0.9968917,0.0013790046,0.00032630938,0.00015213282,0.000022331396,0.00010663715,0.0009393687,0.0000053996646,0.00017720181],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99956876,0.00022209817,0.000038357943,0.000054206568,0.00006684247,0.00004966169],"domain_scores_gemma":[0.99924904,0.00016138099,0.00027963702,0.000051592164,0.000063102125,0.00019518237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011312077,0.00055244577,0.0009578085,0.00017777989,0.00018405516,0.0005141581,0.00028090374,0.00036402952,0.00077576016],"category_scores_gemma":[0.0009675444,0.0002126496,0.00073248136,0.0003396149,0.0003418227,0.00034778615,0.00015231177,0.0011336489,0.00022790136],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.286437,0.013402569,0.34593284,0.0016205921,0.0047469935,0.0012895727,0.0009986855,0.005499105,0.06361436,0.00026629987,0.0059441584,0.27024785],"study_design_scores_gemma":[0.096589886,0.2972839,0.5722482,0.00017054382,0.0023107645,0.003951586,0.00040046035,0.0027725762,0.014721605,0.00016994585,0.009310281,0.00007026786],"about_ca_topic_score_codex":0.0010432448,"about_ca_topic_score_gemma":0.0023500198,"teacher_disagreement_score":0.0011312077,"about_ca_system_score_codex":0.0008788197,"about_ca_system_score_gemma":0.00084755366,"threshold_uncertainty_score":0.0063763857},"labels":[],"label_agreement":null},{"id":"W2993443964","doi":"10.1158/1557-3265.ovcasymp18-ap11","title":"Abstract AP11: IDENTIFYING FUNCTIONAL NONCODING SOMATIC MUTATIONS IN OVARIAN CANCER","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biology; Somatic cell; Epigenetics; Ovarian cancer; Epigenomics; Germline; Genetics; Transcriptome; Germline mutation; Gene; Cancer research; Cancer; Mutation; DNA methylation; Gene expression","score_opus":0.39906320040213733,"score_gpt":0.5608800758984523,"score_spread":0.16181687549631502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993443964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9353903,0.0048058555,0.015939947,0.00037654812,0.00013832201,0.00012928354,0.039282016,0.00095052965,0.0029872924],"genre_scores_gemma":[0.93454504,0.0015114193,0.018068908,0.00049812574,0.00006185122,0.00017669145,0.04187464,0.00026153977,0.0030017127],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99948174,0.000038735576,0.000036509184,0.00021619191,0.00017656617,0.00005038402],"domain_scores_gemma":[0.9993332,0.0002657946,0.00013789427,0.000073359384,0.00012644262,0.000063220265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005668782,0.0004812443,0.00046440537,0.00086352555,0.00036495173,0.0007915727,0.00042532937,0.0006156772,0.0027282697],"category_scores_gemma":[0.0009446862,0.00024433856,0.00048712967,0.0011081732,0.00025000577,0.00026139212,0.000623107,0.00065845984,0.00096346706],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001167118,0.00012167274,0.13972771,0.0015447062,0.00037740785,0.0006206159,0.00015978349,0.0057401913,0.78301066,0.00059880054,0.006243285,0.06068802],"study_design_scores_gemma":[0.00013891513,0.0005883689,0.55913955,0.00016854882,0.0005667918,0.0031992712,0.00037904433,0.043846413,0.34911388,0.001576432,0.041179396,0.00010343765],"about_ca_topic_score_codex":0.0015276449,"about_ca_topic_score_gemma":0.0027735466,"teacher_disagreement_score":0.0027282697,"about_ca_system_score_codex":0.00032852913,"about_ca_system_score_gemma":0.00040746242,"threshold_uncertainty_score":0.009127021},"labels":[],"label_agreement":null},{"id":"W2995708246","doi":"10.1158/1078-0432.ccr-19-2898","title":"Agrin in the Muscularis Mucosa Serves as a Biomarker Distinguishing Hyperplastic Polyps from Sessile Serrated Lesions","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"National Cancer Institute; National Institutes of Health; Howard Hughes Medical Institute","keywords":"Agrin; Pathology; Muscularis mucosae; Hyperplastic Polyp; Biomarker; Cancer; Medicine; Biology; Internal medicine; Colorectal cancer; Receptor","score_opus":0.24666628707058716,"score_gpt":0.5181322915281089,"score_spread":0.2714660044575218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995708246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987295,0.0004876862,0.00039850164,0.000017293174,0.0000027988558,0.000008817576,0.0000851109,0.000016675533,0.0002535058],"genre_scores_gemma":[0.9978034,0.00021921452,0.0016302903,0.000016775482,0.000006772939,0.000006906517,0.00020842503,0.000003149562,0.00010498164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960726,0.00008311997,0.000063532105,0.000089167916,0.00012342159,0.00003348558],"domain_scores_gemma":[0.9989759,0.00020707173,0.00051701354,0.00007439491,0.00011792124,0.00010782873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008237483,0.00027557035,0.00020840028,0.0011667229,0.00016154227,0.00035848055,0.00018659067,0.00022616854,0.00086382515],"category_scores_gemma":[0.0012193065,0.0001435644,0.00020275233,0.00052813697,0.00041191306,0.00029938103,0.00031716147,0.00022470628,0.00020183882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011255548,0.000061188985,0.69688165,0.0002713297,0.00013084397,0.0006759334,0.0001394471,0.00021746905,0.28960976,0.00005130153,0.00010173874,0.0107337395],"study_design_scores_gemma":[0.00001419591,0.00032696148,0.96693903,0.000023558587,0.00007155651,0.0025279797,0.00014548565,0.0012080848,0.028218385,0.000055637727,0.00046290047,0.0000063314983],"about_ca_topic_score_codex":0.0004046124,"about_ca_topic_score_gemma":0.00109789,"teacher_disagreement_score":0.0011667229,"about_ca_system_score_codex":0.00021537406,"about_ca_system_score_gemma":0.00017106254,"threshold_uncertainty_score":0.004356444},"labels":[],"label_agreement":null},{"id":"W2996090129","doi":"10.1158/1078-0432.ccr-19-1638","title":"A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"National Cancer Institute; V Foundation for Cancer Research","keywords":"Carboplatin; Gemcitabine; Internal medicine; Medicine; Topotecan; Neutropenia; Ovarian cancer; Clinical endpoint; Oncology; Leukopenia; Phases of clinical research; Chemotherapy; Cancer; Gastroenterology; Clinical trial; Cisplatin","score_opus":0.11383850301501602,"score_gpt":0.48292877681981006,"score_spread":0.36909027380479403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996090129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99259394,0.001002575,0.00034744985,0.00052709447,0.0002373742,0.0035882436,0.00052176206,0.00006290595,0.001118626],"genre_scores_gemma":[0.98963416,0.0007166294,0.0010508379,0.0011468886,0.0002246423,0.0039086156,0.0010809735,0.000019728417,0.0022175843],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99953973,0.00025582378,0.000021878917,0.000088920046,0.000023782568,0.00006985041],"domain_scores_gemma":[0.9990501,0.00021649417,0.00018893332,0.00008674583,0.000047745776,0.00041005752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014614703,0.0013024631,0.0019398504,0.00033184697,0.0003787119,0.0008521147,0.00074130134,0.0015082023,0.005368322],"category_scores_gemma":[0.0013364651,0.000552181,0.0009369709,0.0003804733,0.0010031372,0.00071101415,0.00040575612,0.0026979349,0.0006842473],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96533984,0.013696672,0.0010863774,0.00022009858,0.00040016757,0.00005846856,0.000052755087,0.0004845097,0.0051607876,0.000105934494,0.00090881845,0.012485635],"study_design_scores_gemma":[0.92145497,0.07569549,0.0012896078,0.000009917924,0.00013356093,0.00003639147,0.000014540015,0.00038858625,0.0004716406,0.000088477624,0.00040953624,0.0000071961545],"about_ca_topic_score_codex":0.0009950403,"about_ca_topic_score_gemma":0.0018759372,"teacher_disagreement_score":0.005368322,"about_ca_system_score_codex":0.0009224192,"about_ca_system_score_gemma":0.0015178077,"threshold_uncertainty_score":0.01795882},"labels":[],"label_agreement":null},{"id":"W2996325740","doi":"10.1158/1078-0432.ccr-19-2202","title":"Preclinical Evaluation of a Novel SHIP1 Phosphatase Activator for Inhibition of PI3K Signaling in Malignant B Cells","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada)","funders":"Grantová Agentura České Republiky; Cancer Research UK; Bloodwise; Kay Kendall Leukaemia Fund; Blood Cancer UK; Gilead Sciences","keywords":"Activator (genetics); Cancer research; Signal transduction; PI3K/AKT/mTOR pathway; Phosphatase; Chemistry; Medicine; Cell biology; Biology; Phosphorylation; Internal medicine; Receptor","score_opus":0.26786961306371754,"score_gpt":0.5193038078117423,"score_spread":0.2514341947480248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996325740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939792,0.0021421271,0.0015967035,0.00011985388,0.00005107283,0.00028833002,0.00042829654,0.000096041615,0.0012982879],"genre_scores_gemma":[0.9942825,0.0015716027,0.0019221285,0.00005663267,0.000018005696,0.00018765124,0.0008477631,0.000009438949,0.001104323],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987566,0.000034965295,0.000010451174,0.000016356691,0.00003057864,0.000031888463],"domain_scores_gemma":[0.99988794,0.000015799324,0.0000260614,0.00001338316,0.000018921399,0.000037810853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049735093,0.0005480515,0.00034682962,0.0003164692,0.00015805884,0.00035100215,0.0003956638,0.00039008475,0.0014453159],"category_scores_gemma":[0.0001413558,0.00016500974,0.00034107923,0.00025035403,0.00022686941,0.00023903007,0.00013926256,0.00093275064,0.0003015576],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028763441,0.005200733,0.0005929663,0.0003014884,0.00007019432,0.00012388811,0.00007761893,0.0013730301,0.97541285,0.000262722,0.0005257309,0.013182427],"study_design_scores_gemma":[0.0022443186,0.10319965,0.006860535,0.000033629676,0.00021431649,0.00044663262,0.00007672499,0.0035276636,0.87686485,0.000112157075,0.006403116,0.000016467506],"about_ca_topic_score_codex":0.0008213327,"about_ca_topic_score_gemma":0.0012530831,"teacher_disagreement_score":0.0014453159,"about_ca_system_score_codex":0.00033449696,"about_ca_system_score_gemma":0.0005050371,"threshold_uncertainty_score":0.004835069},"labels":[],"label_agreement":null},{"id":"W2999416926","doi":"10.1158/1078-0432.ccr-19-0374","title":"Deep Learning to Distinguish Benign from Malignant Renal Lesions Based on Routine MR Imaging","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Biomedical Imaging and Bioengineering; NIH Clinical Center; National Cancer Institute; National Institutes of Health; National Natural Science Foundation of China; Radiological Society of North America","keywords":"Medicine; Renal cell carcinoma; Deep learning; Radiomics; Artificial intelligence; Radiology; Pathology; Computer science","score_opus":0.2554288077278997,"score_gpt":0.48534024218560434,"score_spread":0.22991143445770462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999416926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9612691,0.00032351282,0.037359286,0.00016360999,0.000021998196,0.000028489563,0.00015110051,0.00023363726,0.00044935828],"genre_scores_gemma":[0.9912975,0.00006288642,0.008147213,0.0000424247,0.000010756546,0.000011112664,0.00021134448,0.0000067805827,0.00020998875],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99967813,0.00010662463,0.000025478916,0.000082011975,0.00006550298,0.000042148484],"domain_scores_gemma":[0.9992797,0.00035153996,0.00011216701,0.000065589804,0.00013578942,0.00005517098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012791717,0.0006137757,0.0005429508,0.000721372,0.00013625548,0.0004655165,0.0003985693,0.0004275611,0.00040946205],"category_scores_gemma":[0.0027834757,0.00020314359,0.000531458,0.00023074684,0.00020152038,0.00050388736,0.00039488022,0.00046962066,0.00014784679],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014874121,0.00079119776,0.31597015,0.00010995854,0.0005543083,0.00038332064,0.00012416331,0.3896673,0.023818076,0.00051414274,0.0018861379,0.26469377],"study_design_scores_gemma":[0.000016360422,0.0002502729,0.016502481,0.00001253034,0.000075560056,0.000122073,0.000021848986,0.9771423,0.005127853,0.00057020254,0.00014746035,0.0000109921875],"about_ca_topic_score_codex":0.003269716,"about_ca_topic_score_gemma":0.004508472,"teacher_disagreement_score":0.003269716,"about_ca_system_score_codex":0.00053404196,"about_ca_system_score_gemma":0.0005618663,"threshold_uncertainty_score":0.006765008},"labels":[],"label_agreement":null},{"id":"W3000030645","doi":"10.1158/1078-0432.ccr-19-0098","title":"Transient Sox9 Expression Facilitates Resistance to Androgen-Targeted Therapy in Prostate Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Prostate Cancer Canada","keywords":"Prostate cancer; SOX2; Cancer research; Gene knockdown; Medicine; Prostate; Cancer stem cell; Cancer; Androgen deprivation therapy; Transcription factor; Biology; Internal medicine; Cell culture","score_opus":0.29335312432817967,"score_gpt":0.5166158266727627,"score_spread":0.22326270234458306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000030645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953869,0.000663996,0.0021435646,0.0000759643,0.000039838083,0.000044636243,0.0003623456,0.00016603683,0.0011166704],"genre_scores_gemma":[0.9960907,0.0003129143,0.0010676401,0.000015136733,0.0000054316197,0.000022189948,0.00038667864,0.000016621501,0.002082504],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998789,0.000018202858,0.000013543092,0.000026198268,0.00004045257,0.00002266078],"domain_scores_gemma":[0.9999217,0.000012914739,0.000018939241,0.000016005932,0.000006517938,0.0000238616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011763069,0.00019215731,0.00018374235,0.0001361534,0.00014498454,0.0003258764,0.00015513525,0.00015470007,0.001814298],"category_scores_gemma":[0.00008203847,0.000093534356,0.0001851011,0.00013464592,0.00021641198,0.00012448955,0.00016098378,0.00042915222,0.0003934835],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008175055,0.000046762278,0.00022130317,0.000021233345,0.0000033466233,0.000037185095,0.000010367163,0.000057757476,0.9986111,0.00006468764,0.00003869438,0.0008058497],"study_design_scores_gemma":[0.0000136797935,0.00034350992,0.0024107948,0.0000025986126,0.000011414819,0.00020816042,0.000016734912,0.0007210203,0.9944764,0.000018150336,0.0017757313,0.0000020190978],"about_ca_topic_score_codex":0.00064001343,"about_ca_topic_score_gemma":0.0010325458,"teacher_disagreement_score":0.001814298,"about_ca_system_score_codex":0.00026204486,"about_ca_system_score_gemma":0.00022222898,"threshold_uncertainty_score":0.0060694814},"labels":[],"label_agreement":null},{"id":"W3000192411","doi":"10.1158/1078-0432.ccr-19-3359","title":"Determining the Optimal Adjuvant Therapy for Improving Survival in Elderly Patients with Glioblastoma: A Systematic Review and Network Meta-analysis","year":2020,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Temozolomide; Internal medicine; Meta-analysis; Oncology; Cochrane Library; Chemoradiotherapy; Randomized controlled trial; Radiation therapy; Confidence interval; Subgroup analysis","score_opus":0.35345175243092775,"score_gpt":0.5265643516734971,"score_spread":0.1731125992425694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000192411","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01166163,0.98469454,0.0012403408,0.00037357572,0.00015671841,0.0005277361,0.00091768336,0.0000395283,0.00038822397],"genre_scores_gemma":[0.3912488,0.59852177,0.005224861,0.0011479654,0.00032209593,0.0017262792,0.0014181457,0.00004408149,0.00034603258],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9893526,0.00646907,0.002351846,0.0008902028,0.00072295056,0.00021327236],"domain_scores_gemma":[0.97935516,0.01599765,0.002914635,0.00047018073,0.0009944888,0.00026785888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015742237,0.002347927,0.014825756,0.006217912,0.00045917218,0.0025114003,0.0017731348,0.0017412083,0.002989068],"category_scores_gemma":[0.03433438,0.0011096426,0.029071853,0.0061497884,0.0005969324,0.0017008333,0.001469995,0.001615239,0.00022707715],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027586364,0.000035742753,0.0052188435,0.2480404,0.7302574,0.000076331096,0.00006854141,0.0011081231,0.00018715257,0.00015084096,0.00047439552,0.011623588],"study_design_scores_gemma":[0.0006845976,0.0001722607,0.0027550806,0.013099218,0.98169553,0.00003765073,0.000024936051,0.00038209013,0.00006888729,0.00021715858,0.0008462239,0.000016310161],"about_ca_topic_score_codex":0.0062037287,"about_ca_topic_score_gemma":0.013589409,"teacher_disagreement_score":0.015742237,"about_ca_system_score_codex":0.0024483674,"about_ca_system_score_gemma":0.0026732665,"threshold_uncertainty_score":0.08325392},"labels":[],"label_agreement":null},{"id":"W3000205532","doi":"10.1158/1078-0432.ccr-19-1606","title":"A Combinatorial Strategy for Targeting <i>BRAF</i> V600E-Mutant Cancers with BRAFV600E Inhibitor (PLX4720) and Tyrosine Kinase Inhibitor (Ponatinib)","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"Intramural Research Program; National Institutes of Health","keywords":"Ponatinib; Tyrosine-kinase inhibitor; Cancer research; Tyrosine kinase; MEK inhibitor; Medicine; Mutant; Kinase; Dasatinib; Cancer; Pharmacology; Biology; Imatinib; Internal medicine; Myeloid leukemia; Genetics; Receptor; MAPK/ERK pathway","score_opus":0.11930498942149106,"score_gpt":0.41560940435192795,"score_spread":0.2963044149304369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000205532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9694066,0.0032482694,0.019205462,0.00019145344,0.00009433429,0.00062962476,0.0005253476,0.000423341,0.006275649],"genre_scores_gemma":[0.98697484,0.0011027453,0.009532505,0.000080216894,0.000011992743,0.00014789563,0.00025596973,0.000020651802,0.001873223],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998876,0.000012625731,0.000008145971,0.000026478943,0.000037119953,0.000028112836],"domain_scores_gemma":[0.9999641,0.0000037183506,0.000009412943,0.0000036877643,0.0000049089767,0.000014121756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011945805,0.00044269973,0.0004648128,0.0004205576,0.00014238447,0.0003729812,0.0003105202,0.0002134933,0.0009258787],"category_scores_gemma":[0.00007460402,0.00020254673,0.00032831717,0.00028049323,0.00015279674,0.00021809583,0.0003542271,0.0003524136,0.00031604405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032994905,0.00031345218,0.0002756925,0.00015865483,0.00005224213,0.00012055764,0.000014988103,0.0012122929,0.9775524,0.00027602975,0.00032664256,0.019367212],"study_design_scores_gemma":[0.00022644502,0.0035980786,0.0024341557,0.000009973676,0.00015477209,0.0007720706,0.000024068224,0.005386505,0.98108,0.00008743448,0.006203981,0.000022619235],"about_ca_topic_score_codex":0.00042572405,"about_ca_topic_score_gemma":0.0016006733,"teacher_disagreement_score":0.0009258787,"about_ca_system_score_codex":0.00028415874,"about_ca_system_score_gemma":0.00026890836,"threshold_uncertainty_score":0.0030973554},"labels":[],"label_agreement":null},{"id":"W3000411451","doi":"10.1158/1078-0432.ccr-19-3023","title":"Diverse <i>AR</i> Gene Rearrangements Mediate Resistance to Androgen Receptor Inhibitors in Metastatic Prostate Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Institutes of Health; Prostate Cancer Foundation of Australia; National Cancer Institute; National Institute for Health and Care Research; U.S. Department of Veterans Affairs","keywords":"Androgen receptor; Prostate cancer; Cancer research; Prostate; Cancer; Gene; Biology; Medicine; Oncology; Internal medicine; Genetics","score_opus":0.26812945031345203,"score_gpt":0.5093051652964752,"score_spread":0.24117571498302315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000411451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99838436,0.00060959376,0.0003735586,0.00002844993,0.000002067832,0.000009792188,0.00013304586,0.000021672275,0.00043746916],"genre_scores_gemma":[0.99937063,0.00016750756,0.00014870227,0.000013722413,0.0000021208,0.0000042857646,0.00016682666,0.000004393042,0.00012174365],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998938,0.000019466424,0.0000050588,0.00002315519,0.000038234495,0.000020298385],"domain_scores_gemma":[0.9999019,0.000027748558,0.000034470595,0.0000071399086,0.000009644839,0.000019061412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013657587,0.00017961941,0.00019221466,0.0002626527,0.00012941161,0.0002493378,0.00015488057,0.00016194016,0.001183406],"category_scores_gemma":[0.00026998037,0.00013418592,0.00018174914,0.00020606634,0.0001843244,0.00008322124,0.00011273447,0.0002801944,0.00016434459],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006713881,0.000110932924,0.038900435,0.000067980414,0.00006932664,0.00025684357,0.000053017076,0.0013076548,0.94947535,0.00020750571,0.000180416,0.008699084],"study_design_scores_gemma":[0.000090974994,0.0015213027,0.66951287,0.000014514719,0.00017773928,0.004062569,0.0001616237,0.0041361935,0.31749013,0.0003472676,0.002466862,0.000017971637],"about_ca_topic_score_codex":0.0010234929,"about_ca_topic_score_gemma":0.0011038502,"teacher_disagreement_score":0.001183406,"about_ca_system_score_codex":0.00024320016,"about_ca_system_score_gemma":0.00016872224,"threshold_uncertainty_score":0.0039589405},"labels":[],"label_agreement":null},{"id":"W3000415041","doi":"10.1158/1078-0432.ccr-19-2027","title":"Impact of EGFR-TKI Treatment on the Tumor Immune Microenvironment in <i>EGFR</i> Mutation–Positive Non–Small Cell Lung Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":247,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Kindai University; AstraZeneca Canada","keywords":"Lung cancer; Medicine; Cancer; Immune system; Cancer research; Mutation; Tumor microenvironment; Immunology; Oncology; Biology; Internal medicine; Gene; Genetics","score_opus":0.12114822744041158,"score_gpt":0.4691180432962325,"score_spread":0.34796981585582093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000415041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99929965,0.0004342616,0.000041850362,0.000010161097,0.0000019685735,0.000005683255,0.000046838857,0.0000018269046,0.00015765267],"genre_scores_gemma":[0.99976987,0.00007032232,0.00003544205,0.000010596225,0.0000030884626,0.0000035831613,0.00008025825,6.694977e-7,0.000026127625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981314,0.000055834134,0.000023202969,0.000040228704,0.000033155924,0.00003444171],"domain_scores_gemma":[0.9995981,0.00011562036,0.0001773526,0.00002290365,0.000025772519,0.00006035724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031823094,0.00014126756,0.0003382239,0.00016666121,0.00016557745,0.00031187307,0.0001568148,0.00017195808,0.0005186106],"category_scores_gemma":[0.000541172,0.00008361707,0.00026171107,0.0001780547,0.00020277553,0.00020894544,0.00013898397,0.0002096239,0.00011093187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047143847,0.00018408576,0.95213085,0.00010768341,0.00012709024,0.00057591824,0.00005358673,0.0002068041,0.021965263,0.000025795485,0.000118044096,0.019790482],"study_design_scores_gemma":[0.000057932393,0.0015311943,0.9922316,0.000007543198,0.00007821773,0.0012819426,0.00007034351,0.00038134019,0.0039914334,0.000023497092,0.00034080382,0.000004109717],"about_ca_topic_score_codex":0.000551515,"about_ca_topic_score_gemma":0.00086737756,"teacher_disagreement_score":0.000551515,"about_ca_system_score_codex":0.0003709967,"about_ca_system_score_gemma":0.0002141365,"threshold_uncertainty_score":0.0026917458},"labels":[],"label_agreement":null},{"id":"W3001389567","doi":"10.1158/1078-0432.ccr-19-2485","title":"PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell Carcinoma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Western University; Princess Margaret Cancer Centre","funders":"Associazione Italiana per la Ricerca sul Cancro; Ministero dell’Istruzione, dell’Università e della Ricerca","keywords":"Head and neck squamous-cell carcinoma; Mutant; Radioresistance; Cancer research; PI3K/AKT/mTOR pathway; Biology; Downregulation and upregulation; Cell culture; Cell; Cancer; Gene; Cell biology; Signal transduction; Head and neck cancer; Genetics","score_opus":0.1176647177057211,"score_gpt":0.40948098520557774,"score_spread":0.2918162674998567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001389567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99104965,0.0033423768,0.0007083809,0.00012975495,0.00004219627,0.00010342658,0.0015159644,0.00022645293,0.0028817568],"genre_scores_gemma":[0.99440765,0.0016337663,0.00068528444,0.00007538046,0.0000074335862,0.000081628306,0.0016750009,0.000026685817,0.0014070588],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991417,0.000005397962,0.0000050785143,0.000015045391,0.00003145505,0.000028774844],"domain_scores_gemma":[0.99996185,0.0000047325993,0.000009235957,0.0000047641433,0.0000069132375,0.0000125389015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011088914,0.00030856451,0.00041455711,0.00044468144,0.00020594083,0.00038403022,0.00022890157,0.00015303864,0.0022342307],"category_scores_gemma":[0.00011654301,0.00012472495,0.00031128523,0.00034733786,0.00014370919,0.00015351613,0.0002236523,0.00057538913,0.00045289635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023525683,0.00075238507,0.0041083745,0.00044683233,0.000085055115,0.00018742423,0.0000336772,0.0011254257,0.94354,0.00019531311,0.0016207785,0.045552164],"study_design_scores_gemma":[0.00041470985,0.0041521247,0.06028203,0.000042742693,0.00022619081,0.0007865252,0.00011744858,0.0035233598,0.91852283,0.00019840563,0.01171527,0.00001843247],"about_ca_topic_score_codex":0.0012953435,"about_ca_topic_score_gemma":0.0044015585,"teacher_disagreement_score":0.0022342307,"about_ca_system_score_codex":0.0005549013,"about_ca_system_score_gemma":0.0005141584,"threshold_uncertainty_score":0.007474184},"labels":[],"label_agreement":null},{"id":"W3001423058","doi":"10.1158/1078-0432.ccr-19-3258","title":"ANG1005, a Brain-Penetrating Peptide–Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":243,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Université Laval","keywords":"Medicine; Taxane; Clinical endpoint; Metastatic breast cancer; Paclitaxel; Cancer; Internal medicine; Phases of clinical research; Population; Breast cancer; Meningeal carcinomatosis; Oncology; Response Evaluation Criteria in Solid Tumors; Cerebrospinal fluid; Chemotherapy; Clinical trial","score_opus":0.11517241701475196,"score_gpt":0.43399114336250183,"score_spread":0.3188187263477499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001423058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99814487,0.0012999478,0.00008307146,0.0000470401,0.0000057208063,0.000023924353,0.00004550682,0.000012116678,0.00033783304],"genre_scores_gemma":[0.9992261,0.000350447,0.000113576876,0.000042265565,0.000010387111,0.000013701613,0.00012039007,0.0000013869715,0.0001217445],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999915,0.00003287033,0.0000065811796,0.000015755242,0.000016228554,0.000013605643],"domain_scores_gemma":[0.99986374,0.000040599363,0.000036596146,0.0000075335834,0.000008976521,0.00004254046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027321195,0.00027611104,0.00040530844,0.000112924696,0.00010489768,0.00019429855,0.00015843562,0.00019748682,0.00078501593],"category_scores_gemma":[0.00044539967,0.00012244984,0.00019648441,0.00015344792,0.0001283033,0.0001369188,0.00007397522,0.00033422344,0.00017903752],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07227579,0.0071227546,0.39537802,0.00070320925,0.0012443683,0.0031453392,0.00043609014,0.0025088529,0.20154847,0.00012555598,0.0032044728,0.31230715],"study_design_scores_gemma":[0.0147772655,0.11647703,0.8230458,0.000054488988,0.0008944076,0.008259191,0.00016626486,0.0050981613,0.025262535,0.00011203341,0.0058188974,0.000033802924],"about_ca_topic_score_codex":0.0005699405,"about_ca_topic_score_gemma":0.0014467122,"teacher_disagreement_score":0.00078501593,"about_ca_system_score_codex":0.00026105338,"about_ca_system_score_gemma":0.00025323578,"threshold_uncertainty_score":0.0026261806},"labels":[],"label_agreement":null},{"id":"W3001655014","doi":"10.1158/1078-0432.ccr-19-1431","title":"First-in-Human Phase I Study of ABBV-838, an Antibody–Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"AbbVie","keywords":"Medicine; Neutropenia; Leukopenia; Pharmacokinetics; Adverse effect; Internal medicine; Gastroenterology; Toxicity","score_opus":0.13314455515717813,"score_gpt":0.4959936230890403,"score_spread":0.3628490679318622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001655014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99334407,0.0017252059,0.00055698724,0.00027316945,0.000056059205,0.0017263194,0.00072053936,0.0000929531,0.0015048418],"genre_scores_gemma":[0.99250424,0.0010123753,0.0012201234,0.0005363492,0.00007029228,0.0010542966,0.001246103,0.000029918065,0.0023264734],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996964,0.00012371517,0.000014873207,0.00004905437,0.0000359672,0.00007996089],"domain_scores_gemma":[0.99963725,0.000039706578,0.000082171144,0.000025503157,0.000027733991,0.00018756695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011147558,0.0012239937,0.0011691103,0.0003085404,0.00040719993,0.0007249035,0.0006412828,0.00074617367,0.0032180347],"category_scores_gemma":[0.0004884581,0.0005277251,0.0007918306,0.00029326574,0.0006125861,0.000612163,0.00027658607,0.0025973087,0.00085288397],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44501814,0.14283073,0.019309951,0.0013433634,0.00193954,0.00062856404,0.0008584916,0.006111741,0.16028503,0.00045817014,0.010262514,0.21095386],"study_design_scores_gemma":[0.31336594,0.6426339,0.02316358,0.00004695318,0.0004309375,0.0005874756,0.000086959626,0.0019662755,0.011957725,0.000196851,0.005525751,0.00003758702],"about_ca_topic_score_codex":0.0010376851,"about_ca_topic_score_gemma":0.0036702221,"teacher_disagreement_score":0.0032180347,"about_ca_system_score_codex":0.000994341,"about_ca_system_score_gemma":0.0013718918,"threshold_uncertainty_score":0.010765374},"labels":[],"label_agreement":null},{"id":"W3002753972","doi":"10.1158/1078-0432.ccr-19-2803","title":"A Four-Chemokine Signature Is Associated with a T-cell–Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; McGill University; McGill University Health Centre; University of Toronto; University Health Network; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Canadian Friends of Hebrew University; National Cancer Institute; Pancreatic Cancer Canada Foundation; Canadian Institutes of Health Research; Alexander von Humboldt-Stiftung","keywords":"Pancreatic cancer; Phenotype; Chemokine; Medicine; Signature (topology); Cancer; Metastasis; Cancer research; Pathology; Biology; Immunology; Inflammation; Internal medicine; Gene; Genetics","score_opus":0.22700519688983825,"score_gpt":0.4832452065972855,"score_spread":0.2562400097074472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002753972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993197,0.00009990202,0.00012486633,0.0000149559,0.0000012996123,0.0000042789425,0.00031934702,0.000007442175,0.000108182634],"genre_scores_gemma":[0.99911636,0.000041911175,0.0001856626,0.000015059646,0.0000029591147,0.000009828644,0.0005034241,0.000002863923,0.000121894234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998416,0.00002608757,0.000013085106,0.000046259473,0.000037854268,0.00003505926],"domain_scores_gemma":[0.99958616,0.000059716072,0.00019514546,0.00003243677,0.000040965613,0.00008548371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002148949,0.00017008942,0.00031220925,0.00043751372,0.00018873374,0.00030686386,0.00015568636,0.00018955684,0.0013799531],"category_scores_gemma":[0.0004972533,0.00012139906,0.00021970899,0.00044884454,0.00024389678,0.00010745751,0.0002587785,0.0002803347,0.00017131554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018438601,0.00007883941,0.78470826,0.00010606646,0.00012563144,0.00040784906,0.00009893281,0.00035383957,0.20519234,0.00006800383,0.00031807422,0.006698341],"study_design_scores_gemma":[0.000023920544,0.00023373391,0.9896786,0.0000068499007,0.000059191214,0.0011445232,0.00009011296,0.0008063074,0.0074529224,0.00007942489,0.0004180477,0.000006394321],"about_ca_topic_score_codex":0.0007939897,"about_ca_topic_score_gemma":0.0011512389,"teacher_disagreement_score":0.0013799531,"about_ca_system_score_codex":0.00025464757,"about_ca_system_score_gemma":0.00025425456,"threshold_uncertainty_score":0.0046164393},"labels":[],"label_agreement":null},{"id":"W3003699744","doi":"10.1158/1078-0432.ccr-19-2576","title":"Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86)","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada); Alberta Cancer Foundation; Juravinski Cancer Centre; Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Cabozantinib; Endometrial cancer; Medicine; Cancer; Oncology; Internal medicine","score_opus":0.3313439728088638,"score_gpt":0.548327161618752,"score_spread":0.21698318880988815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003699744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98148984,0.006433888,0.00047395588,0.0014232387,0.00018669307,0.004521521,0.00177295,0.00007875368,0.0036191],"genre_scores_gemma":[0.97996885,0.004164001,0.0019082084,0.0022513778,0.00045921336,0.0044598524,0.003042572,0.0000221179,0.0037238293],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99931276,0.00047164876,0.00002693181,0.000081340135,0.00005560177,0.000051649266],"domain_scores_gemma":[0.9987122,0.00022598029,0.00026616268,0.00008779542,0.00011650542,0.0005912522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034942117,0.0009652338,0.0010931649,0.0003658721,0.00058400637,0.00069980486,0.00064195454,0.0011674406,0.0033827575],"category_scores_gemma":[0.0016320546,0.00050538767,0.00087297213,0.00046574706,0.00066844205,0.00039432442,0.0003560912,0.0016446295,0.0004648868],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8662897,0.017866902,0.014142969,0.0009089106,0.001859999,0.00021361293,0.0003006586,0.0012012514,0.012774932,0.00023918564,0.00897184,0.0752301],"study_design_scores_gemma":[0.8833625,0.09477314,0.016799543,0.000049577277,0.00054026104,0.00012199901,0.00003652571,0.000606285,0.00053902104,0.00007164733,0.0030828756,0.000016652379],"about_ca_topic_score_codex":0.0042491443,"about_ca_topic_score_gemma":0.011431921,"teacher_disagreement_score":0.0042491443,"about_ca_system_score_codex":0.0010385192,"about_ca_system_score_gemma":0.0026351768,"threshold_uncertainty_score":0.018479407},"labels":[],"label_agreement":null},{"id":"W3004063334","doi":"10.1158/1078-0432.ccr-19-1945","title":"Predictive Biomarkers for Adjuvant Capecitabine Benefit in Early-Stage Triple-Negative Breast Cancer in the FinXX Clinical Trial","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"Canadian Institutes of Health Research; National Institutes of Health; Academy of Finland; Mayo Clinic; Breast Cancer Research Foundation; Syöpäjärjestöt; Canadian Cancer Society","keywords":"Capecitabine; Medicine; Oncology; Internal medicine; Hazard ratio; Triple-negative breast cancer; Taxane; Breast cancer; Adjuvant; Proportional hazards model; Cancer; Confidence interval; Colorectal cancer","score_opus":0.20394803757435861,"score_gpt":0.5027236238608903,"score_spread":0.29877558628653167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004063334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994619,0.0032284313,0.00028838083,0.00019953243,0.000061926905,0.00016180263,0.00048272323,0.000015066072,0.00094320875],"genre_scores_gemma":[0.9976484,0.0003439939,0.00031783423,0.0001659589,0.00005482224,0.00015447737,0.0008343986,0.0000027597036,0.0004773956],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9993197,0.00042342144,0.000033846845,0.0001181903,0.000057633388,0.000047213063],"domain_scores_gemma":[0.9988206,0.00054827624,0.0003354263,0.000076801625,0.000058554895,0.0001602767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029470369,0.0005690009,0.0011085364,0.0001404015,0.00019618958,0.0006255708,0.0002670649,0.00048171426,0.0020680516],"category_scores_gemma":[0.0022787102,0.00015132448,0.00077512243,0.00019930149,0.00027347126,0.00037996893,0.00021796153,0.0007389322,0.00016010112],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82876265,0.001193571,0.11357836,0.0008413156,0.0029653294,0.00014417515,0.00006546604,0.0017286909,0.0075928727,0.00022868531,0.002047666,0.040851217],"study_design_scores_gemma":[0.19393656,0.10898831,0.65806854,0.00042925405,0.010981938,0.0009972625,0.00015938605,0.008051627,0.008193567,0.0017164384,0.008369521,0.00010760354],"about_ca_topic_score_codex":0.00023802507,"about_ca_topic_score_gemma":0.0005200536,"teacher_disagreement_score":0.0029470369,"about_ca_system_score_codex":0.00036933093,"about_ca_system_score_gemma":0.0004149355,"threshold_uncertainty_score":0.015585601},"labels":[],"label_agreement":null},{"id":"W3004420993","doi":"10.1158/1078-0432.ccr-19-2427","title":"Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib as First-Line Therapy in Patients with Metastatic Renal Cell Carcinoma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Sunitinib; Renal cell carcinoma; Medicine; Oncology; Internal medicine; Carcinoma; Phases of clinical research; Toxicity","score_opus":0.25170793116755175,"score_gpt":0.4626059476047845,"score_spread":0.21089801643723277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004420993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954928,0.0016534254,0.00025216403,0.00019986376,0.00004896013,0.00070780586,0.0006802441,0.000035929206,0.0009287657],"genre_scores_gemma":[0.9964156,0.0005888746,0.00044954618,0.0002232136,0.000070244976,0.0005443894,0.0009855882,0.000011460312,0.00071110297],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992836,0.00039556134,0.000038843446,0.000100907826,0.00009886374,0.000082251194],"domain_scores_gemma":[0.9990854,0.00021414242,0.00026946556,0.00009350809,0.000068627036,0.00026881386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020914774,0.0009655898,0.002065541,0.00031094562,0.00029449855,0.0007543665,0.00045209468,0.0006784154,0.002117361],"category_scores_gemma":[0.0012404982,0.00034950871,0.001790824,0.00029136587,0.0005396841,0.00056160934,0.00027030695,0.0015335302,0.00037210007],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86693007,0.022354078,0.020379044,0.000487846,0.003954178,0.00022139098,0.00016396867,0.0029649395,0.019718584,0.00009559594,0.0021168585,0.06061335],"study_design_scores_gemma":[0.40548828,0.50680435,0.07597928,0.000037546728,0.0018389428,0.00043820386,0.000068827954,0.0014622323,0.004907192,0.00014071412,0.0027890643,0.000045414563],"about_ca_topic_score_codex":0.0007910949,"about_ca_topic_score_gemma":0.0026267236,"teacher_disagreement_score":0.002117361,"about_ca_system_score_codex":0.0010495656,"about_ca_system_score_gemma":0.0011740191,"threshold_uncertainty_score":0.011060953},"labels":[],"label_agreement":null},{"id":"W3005735196","doi":"10.1158/1078-0432.ccr-19-3924","title":"Translating Basic Science Discoveries into Improved Outcomes for Glioblastoma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; Cancer Research UK","keywords":"Glioblastoma; Key (lock); Clinical Oncology; Medicine; Medical physics; Oncology; Cancer; Computer science; Internal medicine; Cancer research","score_opus":0.256009561707791,"score_gpt":0.5487617880853866,"score_spread":0.29275222637759557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005735196","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017116634,0.22592576,0.0064015808,0.71056247,0.020060806,0.0002488117,0.0018942249,0.000393306,0.017396407],"genre_scores_gemma":[0.2743455,0.48177913,0.023197912,0.17980327,0.030633138,0.0004347261,0.0029835065,0.00028522857,0.0065377043],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9951806,0.002407944,0.0006544831,0.00028789908,0.00085550005,0.0006135612],"domain_scores_gemma":[0.9731608,0.01729953,0.0019868056,0.0007926002,0.004914168,0.0018461322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022530576,0.0006480301,0.00092250225,0.0016695457,0.0006977551,0.0050738086,0.000810653,0.002147657,0.0060827495],"category_scores_gemma":[0.0518552,0.00024069083,0.0012068741,0.0013289213,0.0014820434,0.0033466886,0.0031437445,0.0049660658,0.0016862898],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013420901,0.00045013012,0.011078174,0.0043734456,0.0005769049,0.00045225938,0.0007647903,0.0017290163,0.0033292875,0.040153265,0.23116478,0.70458585],"study_design_scores_gemma":[0.00086133194,0.003012839,0.026544362,0.012480965,0.0015338891,0.0007703749,0.0026426527,0.0020822955,0.012406397,0.17632982,0.76109236,0.00024265714],"about_ca_topic_score_codex":0.0029111232,"about_ca_topic_score_gemma":0.0057428577,"teacher_disagreement_score":0.022530576,"about_ca_system_score_codex":0.0034208829,"about_ca_system_score_gemma":0.010089858,"threshold_uncertainty_score":0.11915445},"labels":[],"label_agreement":null},{"id":"W3006614516","doi":"10.1158/1078-0432.ccr-19-2230","title":"<i>Kdm6a</i> Deficiency Activates Inflammatory Pathways, Promotes M2 Macrophage Polarization, and Causes Bladder Cancer in Cooperation with <i>p53</i> Dysfunction","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Macrophage; Inflammation; Macrophage polarization; Cancer; Cancer research; Bladder cancer; Medicine; Immunology; Biology; Internal medicine; In vitro; Genetics","score_opus":0.1170406606635378,"score_gpt":0.41247045517879666,"score_spread":0.29542979451525886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006614516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99640155,0.0008323947,0.001471241,0.00010124978,0.00002189914,0.000029619308,0.00049549557,0.000077320874,0.0005692154],"genre_scores_gemma":[0.9972307,0.00039249193,0.0009160934,0.000048255857,0.000009475445,0.000037899867,0.00039653457,0.000017326473,0.000951153],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997923,0.000035313155,0.000030687213,0.00005145203,0.00004178841,0.000048559436],"domain_scores_gemma":[0.99981934,0.000016982802,0.000068404086,0.000017527913,0.00001110301,0.00006662295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017206238,0.00046755126,0.0003352357,0.00037912873,0.00020560808,0.00022419117,0.00018886839,0.00034740975,0.0013946665],"category_scores_gemma":[0.00009875019,0.00016920008,0.00032275758,0.00017873647,0.00042370334,0.00013368923,0.00022755786,0.00052386033,0.00039510897],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001511721,0.000024272362,0.0005526261,0.00003004328,0.000005100881,0.00007226796,0.000006308949,0.000020339392,0.99877137,0.000024541103,0.000026210064,0.00031558183],"study_design_scores_gemma":[0.000028648263,0.00056426896,0.016446412,0.000009032251,0.000035469457,0.0011968734,0.00004334137,0.0005297663,0.97970575,0.00004002386,0.001394812,0.000005702168],"about_ca_topic_score_codex":0.00035876347,"about_ca_topic_score_gemma":0.00055327435,"teacher_disagreement_score":0.0013946665,"about_ca_system_score_codex":0.00024910946,"about_ca_system_score_gemma":0.00016630228,"threshold_uncertainty_score":0.004665613},"labels":[],"label_agreement":null},{"id":"W3006773245","doi":"10.1158/1078-0432.ccr-19-3091","title":"Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor α","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Cancer Society","funders":"National Cancer Institute; National Institutes of Health; Canadian Cancer Society; National Institute of General Medical Sciences; Breast Cancer Research Foundation","keywords":"Anastrozole; Breast cancer; Estrogen receptor; Estrogen; Medicine; Oncology; Cancer; Internal medicine; Tamoxifen","score_opus":0.14223765566882268,"score_gpt":0.451958645979411,"score_spread":0.3097209903105883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006773245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964516,0.0027314802,0.00021308717,0.000057472804,0.000010454514,0.000013973298,0.00013734738,0.000007327544,0.00037727243],"genre_scores_gemma":[0.999265,0.00023864981,0.000087061555,0.000028530287,0.000016825006,0.0000069743523,0.00014445896,0.0000011839082,0.00021131852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952626,0.00014367515,0.00004686199,0.00008304162,0.0001682914,0.00003196859],"domain_scores_gemma":[0.9975164,0.0008419136,0.0011075123,0.00015559503,0.00018046482,0.00019803499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006895659,0.0001763625,0.000330484,0.00044833292,0.00011452749,0.00027051088,0.00014278473,0.00033537523,0.0013127927],"category_scores_gemma":[0.0020768216,0.000117753356,0.00035355266,0.00034925176,0.00012659053,0.00012771983,0.0001054531,0.0003567063,0.00014610952],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026602805,0.00042486962,0.91966486,0.00014540368,0.0011259427,0.00021892805,0.000038993898,0.00018517136,0.03373886,0.00008270468,0.00021397919,0.017557481],"study_design_scores_gemma":[0.00024881854,0.0038947782,0.9911697,0.000007963568,0.00033098654,0.00047881287,0.000014064464,0.00016789424,0.0030533927,0.000050968752,0.000578076,0.000004603868],"about_ca_topic_score_codex":0.00028347658,"about_ca_topic_score_gemma":0.00037293142,"teacher_disagreement_score":0.0013127927,"about_ca_system_score_codex":0.00018034877,"about_ca_system_score_gemma":0.00010672329,"threshold_uncertainty_score":0.00439173},"labels":[],"label_agreement":null},{"id":"W3006968198","doi":"10.1158/1078-0432.ccr-19-3136","title":"Design and Conduct of Early Clinical Studies of Immunotherapy: Recommendations from the Task Force on Methodology for the Development of Innovative Cancer Therapies 2019 (MDICT)","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"European Society for Medical Oncology; Merck; AstraZeneca","keywords":"Clinical trial; Drug development; Task force; Medicine; Immunotherapy; Task (project management); Cancer; Test (biology); Intensive care medicine; Drug; Pharmacology; Internal medicine; Political science; Management","score_opus":0.8178733737580474,"score_gpt":0.6530636985540562,"score_spread":0.16480967520399115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006968198","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035138226,0.245515,0.46149147,0.12438999,0.019544626,0.1198761,0.004861438,0.0015030231,0.019304488],"genre_scores_gemma":[0.014983729,0.080355056,0.7579317,0.033575904,0.0047440846,0.10210624,0.0019930245,0.00036744846,0.0039428067],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.4271775,0.45603594,0.05957606,0.0071648657,0.046453886,0.0035917833],"domain_scores_gemma":[0.303733,0.42087612,0.08359907,0.043492474,0.13822354,0.0100759715],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.5962295,0.003878527,0.007469543,0.0058145104,0.0022507035,0.012222603,0.008908575,0.013275031,0.005066431],"category_scores_gemma":[0.4969041,0.0032293317,0.0088433465,0.004336152,0.007913597,0.0062743216,0.0056728986,0.01526902,0.005771574],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061039235,0.0010999544,0.0046575353,0.05872922,0.0020118807,0.00047255692,0.0013739894,0.0031288918,0.00498284,0.037687086,0.115222804,0.7645293],"study_design_scores_gemma":[0.007050555,0.0060388576,0.011984039,0.13985506,0.0050225407,0.0010337791,0.0009005945,0.0034844992,0.012321742,0.050583597,0.7612045,0.0005202944],"about_ca_topic_score_codex":0.003447221,"about_ca_topic_score_gemma":0.0045890887,"teacher_disagreement_score":0.5962295,"about_ca_system_score_codex":0.00680681,"about_ca_system_score_gemma":0.076275796,"threshold_uncertainty_score":0.497921},"labels":[],"label_agreement":null},{"id":"W3009312185","doi":"10.1158/1078-0432.ccr-19-3087","title":"Cancer Antigen Discovery Is Enabled by RNA Sequencing of Highly Purified Malignant and Nonmalignant Cells","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Health and Care Research Wales; Cancer Research Wales; Cancer Research UK; Wellcome Trust; Medical Research Council; Wellcome","keywords":"Antigen; Cancer; Biology; RNA; Immunology; Immunity; Cancer research; Immune system; Gene; Genetics","score_opus":0.13254637811976525,"score_gpt":0.4114010023717912,"score_spread":0.278854624252026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009312185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9004721,0.0016461402,0.09227373,0.00016695757,0.000069229885,0.00017566439,0.0022701346,0.00030978312,0.0026162516],"genre_scores_gemma":[0.92171,0.0014171985,0.06857312,0.0001871886,0.00005371873,0.00018850566,0.0056737047,0.00012754177,0.0020690851],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972993,0.00005270386,0.000020070438,0.00007390205,0.000089258836,0.000034143835],"domain_scores_gemma":[0.9997178,0.00009096995,0.000055797882,0.000039957384,0.00007235458,0.000023213679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034536858,0.00033380665,0.00020520423,0.0003774421,0.00021492665,0.0003516536,0.0001477904,0.00024462736,0.0007998873],"category_scores_gemma":[0.0005449218,0.00011736504,0.00021725506,0.0002362205,0.000246487,0.00012952716,0.00021370714,0.00038711505,0.00059853756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003660619,0.0000056127938,0.00032451726,0.000022484624,0.000003367238,0.000017224243,0.000013418758,0.00006822638,0.997767,0.00004182991,0.000016818667,0.0016828807],"study_design_scores_gemma":[0.000008594621,0.00020904759,0.0060965195,0.000007843169,0.000029135545,0.00022711906,0.000037782487,0.0019306666,0.988074,0.00014143626,0.0032337313,0.0000042425518],"about_ca_topic_score_codex":0.00022192176,"about_ca_topic_score_gemma":0.0005515868,"teacher_disagreement_score":0.0007998873,"about_ca_system_score_codex":0.00015293989,"about_ca_system_score_gemma":0.00022121888,"threshold_uncertainty_score":0.002675891},"labels":[],"label_agreement":null},{"id":"W3010406759","doi":"10.1158/1078-0432.ccr-19-0514","title":"PARP Inhibition Enhances Radiotherapy of SMAD4-Deficient Human Head and Neck Squamous Cell Carcinomas in Experimental Models","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"National Cancer Institute; National Institutes of Health; National Institute of Dental and Craniofacial Research; U.S. Department of Veterans Affairs","keywords":"Olaparib; Head and neck squamous-cell carcinoma; Cancer research; PARP inhibitor; Gene knockdown; DNA damage; Biology; Radiation therapy; Head and neck cancer; Medicine; Poly ADP ribose polymerase; Cell culture; Internal medicine; Gene; DNA; Genetics","score_opus":0.31904800252865156,"score_gpt":0.5218961593901456,"score_spread":0.202848156861494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010406759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883889,0.0024576725,0.0034643153,0.00021556814,0.0001604206,0.0003318506,0.0016971149,0.00033105502,0.002953016],"genre_scores_gemma":[0.9846268,0.0022560058,0.0033261064,0.00012629961,0.000031412685,0.00043604313,0.0022103144,0.0000447498,0.006942254],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997342,0.00005631876,0.000025910078,0.000057616566,0.00007402573,0.000052000232],"domain_scores_gemma":[0.9998833,0.000014413008,0.000032952245,0.00003071247,0.000012834413,0.000025840227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030097394,0.0006785464,0.00039872815,0.0005559638,0.00027301876,0.00029913167,0.0004776223,0.00046127202,0.004310572],"category_scores_gemma":[0.000115223615,0.0002740308,0.0008891998,0.00022793352,0.0003317761,0.0002610788,0.00019126893,0.0010094316,0.0008802111],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001919035,0.0011112768,0.00034700468,0.00017409067,0.000046552366,0.000114018454,0.000027689764,0.00029330116,0.9917611,0.0001279843,0.00038159674,0.003696274],"study_design_scores_gemma":[0.00016821724,0.004245284,0.0027564575,0.000012925856,0.0000674859,0.00028013185,0.000029933264,0.00072464143,0.9894248,0.000036483067,0.002246189,0.00000737629],"about_ca_topic_score_codex":0.00088786497,"about_ca_topic_score_gemma":0.0014791919,"teacher_disagreement_score":0.004310572,"about_ca_system_score_codex":0.00047386155,"about_ca_system_score_gemma":0.00043682443,"threshold_uncertainty_score":0.0144203305},"labels":[],"label_agreement":null},{"id":"W3011022719","doi":"10.1158/1078-0432.ccr-19-3797","title":"Small-Cell Carcinoma of the Ovary, Hypercalcemic Type–Genetics, New Treatment Targets, and Current Management Guidelines","year":2020,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":170,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill Genome Centre; Jewish General Hospital; Princess Margaret Cancer Centre; BC Cancer Agency; Spinal Cord Injury BC; McGill University; McGill University Health Centre","funders":"H2020 European Research Council; National Cancer Institute; Canadian Institutes of Health Research; Cancer Research UK; U.S. Department of Defense","keywords":"SMARCA4; Biology; Cancer; Ovarian cancer; Chromatin remodeling; Cancer research; Genetics; Epigenetics; Gene","score_opus":0.4798473550500737,"score_gpt":0.5424238971364708,"score_spread":0.06257654208639707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011022719","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006638731,0.99717355,0.0001108234,0.0010577209,0.00043360842,0.00000546117,0.000025896732,0.000010622748,0.0011159615],"genre_scores_gemma":[0.0005042445,0.9970879,0.00022669027,0.0009651317,0.00052188436,0.000007949131,0.00009282293,0.0000021942635,0.00059116044],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997867,0.000042105567,0.000038080954,0.000033658285,0.00007701703,0.000022443755],"domain_scores_gemma":[0.9995161,0.00023380714,0.00006139608,0.000012654811,0.00013079692,0.000045202898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000682419,0.0006251858,0.0010847849,0.002444018,0.0002657312,0.0007847807,0.0008985213,0.0010331805,0.0028884904],"category_scores_gemma":[0.0010932814,0.00026345323,0.00054483686,0.0019769075,0.00042374173,0.0012717486,0.00048033133,0.0022146483,0.0014877816],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005645149,0.000046948346,0.0002862721,0.009519095,0.00007481833,0.00033899109,0.00003500586,0.00035675906,0.00045430943,0.0026657486,0.111161135,0.87500453],"study_design_scores_gemma":[0.000018279896,0.000037090205,0.00079809356,0.00591547,0.00010729592,0.0023849302,0.00003958396,0.000085405765,0.0001069803,0.0021332076,0.9883585,0.00001503028],"about_ca_topic_score_codex":0.001955626,"about_ca_topic_score_gemma":0.0045638126,"teacher_disagreement_score":0.0028884904,"about_ca_system_score_codex":0.0009430297,"about_ca_system_score_gemma":0.0013814225,"threshold_uncertainty_score":0.009662986},"labels":[],"label_agreement":null},{"id":"W3011562658","doi":"10.1158/1078-0432.ccr-19-3724","title":"GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":346,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; McGill University Health Centre; McGill University; University Health Network; Kingston General Hospital; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Pancreatic Cancer Canada Foundation; Canadian Cancer Society Research Institute; Hebrew University of Jerusalem; Government of Ontario; Princess Margaret Cancer Foundation","keywords":"Pancreatic cancer; GATA6; In situ hybridization; Biology; Basal (medicine); Internal medicine; FOLFIRINOX; Oncology; KRAS; Cancer research; Pathology; Medicine; Cancer; Gene expression; Gene; Genetics; Colorectal cancer","score_opus":0.26176401326758264,"score_gpt":0.5403275624752844,"score_spread":0.2785635492077017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011562658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99812084,0.0008824216,0.00031151896,0.000034122702,0.0000074650593,0.00000958645,0.00029139096,0.0000066330363,0.00033605826],"genre_scores_gemma":[0.9989856,0.00015250906,0.0002301143,0.00003607102,0.000006399664,0.000007022586,0.00041372256,0.000002493357,0.0001660755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997342,0.00008349832,0.000020791334,0.000076942735,0.000057342153,0.000027316095],"domain_scores_gemma":[0.9996356,0.000101981524,0.00011536981,0.00004131601,0.000043913813,0.00006180957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007365675,0.00016809293,0.00034700258,0.00017414919,0.00013257173,0.0004903217,0.00015145123,0.00024079274,0.0011396289],"category_scores_gemma":[0.0007171633,0.00013294099,0.0002624029,0.00022419181,0.00030038803,0.00023646091,0.0002211843,0.00036760655,0.0002363536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01627959,0.00017174383,0.8841477,0.0002278291,0.0002594108,0.00011036634,0.00009635261,0.0005845182,0.074002475,0.0001120333,0.0004128894,0.023595117],"study_design_scores_gemma":[0.00024529637,0.0017641028,0.97964805,0.00002763374,0.00019471256,0.0006730469,0.00015673072,0.001953526,0.014112561,0.0002676384,0.00094498234,0.0000116683],"about_ca_topic_score_codex":0.0003346006,"about_ca_topic_score_gemma":0.0005723046,"teacher_disagreement_score":0.0011396289,"about_ca_system_score_codex":0.00022569958,"about_ca_system_score_gemma":0.000117259435,"threshold_uncertainty_score":0.0038953424},"labels":[],"label_agreement":null},{"id":"W3013049033","doi":"10.1158/1078-0432.ccr-19-3519","title":"Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Health and Medical Research Council; Institut Gustave-Roussy; National Cancer Institute; National Institutes of Health; Fondation ARC pour la Recherche sur le Cancer; Division of Arctic Sciences; CNIB","keywords":"Trametinib; Cancer research; MAPK/ERK pathway; Trisomy; Leukemia; Medicine; Biology; Immunology; Signal transduction; Genetics","score_opus":0.15015795195833076,"score_gpt":0.4291317123065044,"score_spread":0.2789737603481736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013049033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99786645,0.0006757869,0.0005680543,0.0000340876,0.0000049473842,0.000019838875,0.00036097126,0.000030588406,0.00043920102],"genre_scores_gemma":[0.9980597,0.00051221426,0.0005065773,0.000020342759,0.0000022973334,0.000019832047,0.0006482644,0.000005560144,0.00022517671],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998944,0.000018244644,0.000008995564,0.000022366492,0.000034226196,0.000021836644],"domain_scores_gemma":[0.9999268,0.000015177445,0.000027740332,0.000010373459,0.0000058706432,0.000014001599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013630513,0.00024508446,0.00019547925,0.00021563748,0.00012342577,0.00036481206,0.00011229469,0.00015366096,0.00089285284],"category_scores_gemma":[0.00014172346,0.00009011456,0.00015942703,0.00015641129,0.0001799585,0.00012315513,0.00023463662,0.00037477742,0.0001586633],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038843785,0.00008112585,0.00836557,0.000073695854,0.000030197421,0.00026925505,0.000019223318,0.0002851004,0.98458385,0.00012930731,0.0001066607,0.005667598],"study_design_scores_gemma":[0.0000955498,0.0025297832,0.10209003,0.000027540973,0.00016512108,0.006812401,0.00011678794,0.0028154363,0.8764483,0.00020339509,0.008680118,0.000015570879],"about_ca_topic_score_codex":0.0004196413,"about_ca_topic_score_gemma":0.0006976543,"teacher_disagreement_score":0.00089285284,"about_ca_system_score_codex":0.00022601828,"about_ca_system_score_gemma":0.00025027886,"threshold_uncertainty_score":0.0029868484},"labels":[],"label_agreement":null},{"id":"W3013575560","doi":"10.1158/1078-0432.ccr-19-1714","title":"Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4+PD-1+ Cells and Inferior Survival in Patients with Newly Diagnosed Multiple Myeloma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Blood Cancer UK; Cancer Research UK; Canadian Institute for Theoretical Astrophysics","keywords":"Immune system; CD8; Multiple myeloma; Bone marrow; Immunology; Medicine; FOXP3; IL-2 receptor; Cytotoxic T cell; T cell; Cancer research; Biology; In vitro","score_opus":0.07903201766159101,"score_gpt":0.37426237699981585,"score_spread":0.29523035933822483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013575560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99928963,0.0003729337,0.00009639251,0.00001521419,0.0000033980941,0.0000036568208,0.00005973304,0.0000059484983,0.00015299475],"genre_scores_gemma":[0.99969506,0.000052978983,0.000062481675,0.00000961735,0.000006904798,0.0000030613364,0.00007661828,8.1040173e-7,0.00009244159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998894,0.000019875719,0.00001174885,0.000035641337,0.000023800056,0.000019429857],"domain_scores_gemma":[0.9996605,0.00006550407,0.00014717419,0.000017574233,0.00003013916,0.00007906305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022219316,0.000291544,0.00030905646,0.00046984392,0.00025063992,0.00030027636,0.00018522062,0.0002817371,0.001380621],"category_scores_gemma":[0.0005420669,0.0001276911,0.00016021213,0.0002750068,0.00018790919,0.00016549726,0.00020705424,0.00039031685,0.0001481875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092890806,0.000064375155,0.9821098,0.000029176708,0.00004226063,0.00031181565,0.00006453633,0.00013544726,0.011540846,0.000019585888,0.00010534468,0.004647948],"study_design_scores_gemma":[0.000019850157,0.00036875313,0.9957486,0.0000059849085,0.000042887295,0.0019087872,0.00006521465,0.00039096858,0.001201285,0.000033691496,0.00021080376,0.0000032715186],"about_ca_topic_score_codex":0.00043673723,"about_ca_topic_score_gemma":0.0004877676,"teacher_disagreement_score":0.001380621,"about_ca_system_score_codex":0.00015820978,"about_ca_system_score_gemma":0.00012757257,"threshold_uncertainty_score":0.0046186447},"labels":[],"label_agreement":null},{"id":"W3014043586","doi":"10.1158/1078-0432.ccr-19-1627","title":"Generation of Genetically Engineered Mouse Lung Organoid Models for Squamous Cell Lung Cancers Allows for the Study of Combinatorial Immunotherapy","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"CRISPR; Cancer research; Organoid; Biology; Immunotherapy; Immune checkpoint; Genome editing; Cancer; Immunology; Immune system; Gene; Cell biology; Genetics","score_opus":0.1164828579181202,"score_gpt":0.46028509772617604,"score_spread":0.34380223980805585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014043586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76733595,0.005417984,0.2113483,0.000853929,0.00042133455,0.00082823914,0.004772232,0.0022614182,0.006760674],"genre_scores_gemma":[0.91451514,0.0030526554,0.069525175,0.00016788692,0.000039587903,0.00072250835,0.0031347317,0.00025858416,0.008583674],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99956375,0.00006569128,0.000044395823,0.00011378767,0.00015721218,0.000055135588],"domain_scores_gemma":[0.9995741,0.000059016777,0.0001510913,0.00007757498,0.00003241893,0.00010579264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006200203,0.00089070905,0.000513799,0.0009087874,0.00032214736,0.0006285045,0.00058530585,0.00079136976,0.0024362158],"category_scores_gemma":[0.00019731236,0.00031106567,0.0007770542,0.00028866756,0.0005924146,0.0004959948,0.00043990123,0.0015497892,0.0009212927],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052409516,0.000047661597,0.00019387627,0.00005551037,0.0000085560505,0.000058394762,0.00001546745,0.00021356718,0.9976368,0.00046281962,0.000083389205,0.0011716011],"study_design_scores_gemma":[0.00003092539,0.00036300087,0.0009739787,0.000015910104,0.00003182723,0.00037160065,0.000018185838,0.0012818823,0.99118245,0.00009993983,0.0056211734,0.000009191269],"about_ca_topic_score_codex":0.0005301438,"about_ca_topic_score_gemma":0.0012412593,"teacher_disagreement_score":0.0024362158,"about_ca_system_score_codex":0.0006107841,"about_ca_system_score_gemma":0.0006069671,"threshold_uncertainty_score":0.0081499815},"labels":[],"label_agreement":null},{"id":"W3016549455","doi":"10.1158/1078-0432.ccr-19-3979","title":"FDA Approval Summary: Pembrolizumab plus Lenvatinib for Endometrial Carcinoma, a Collaborative International Review under Project Orbis","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"","keywords":"Lenvatinib; Pembrolizumab; Medicine; Endometrial cancer; Internal medicine; Oncology; Expanded access; Clinical trial; Cancer; Thyroid cancer; Immunotherapy","score_opus":0.44594234753397727,"score_gpt":0.5660444547712383,"score_spread":0.12010210723726106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016549455","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015026676,0.41262928,0.00877921,0.12198152,0.0319692,0.0070870616,0.013118421,0.0011818412,0.38822684],"genre_scores_gemma":[0.09234675,0.36172563,0.027977604,0.11226053,0.023352541,0.004575883,0.019683503,0.00055149145,0.35752615],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99579763,0.0013353223,0.00034146337,0.00037271657,0.001869195,0.00028382186],"domain_scores_gemma":[0.99480444,0.0008584275,0.0006748267,0.00015751613,0.0031103056,0.00039454649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009053146,0.0007889076,0.00061559153,0.0022330892,0.0007122342,0.0030187587,0.0009796848,0.0028106542,0.0102726305],"category_scores_gemma":[0.0077192937,0.0003008919,0.0011787399,0.0016392424,0.00054657593,0.001073069,0.0005619836,0.0020920718,0.0053622657],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047087343,0.00013977961,0.00072798633,0.0028450976,0.00012463608,0.00029015925,0.00010028908,0.00022683408,0.0037855562,0.0070620277,0.6789628,0.30526397],"study_design_scores_gemma":[0.00019785245,0.00038049577,0.0018233758,0.0006606734,0.00010380295,0.0002371636,0.000023596775,0.00007833724,0.0009472951,0.0003926594,0.99514186,0.000012963612],"about_ca_topic_score_codex":0.0027090865,"about_ca_topic_score_gemma":0.00677867,"teacher_disagreement_score":0.0102726305,"about_ca_system_score_codex":0.0023098048,"about_ca_system_score_gemma":0.008665661,"threshold_uncertainty_score":0.047878146},"labels":[],"label_agreement":null},{"id":"W3019679892","doi":"10.1158/1078-0432.ccr-19-3925","title":"Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic Melanoma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; Université de Montréal","funders":"Cancer Council Queensland; Amgen Australia; Melanoma Institute Australia; Omeros Corporation; Compass Therapeutics; QIMR Berghofer Medical Research Institute; Bristol-Myers Squibb; Tizona Therapeutics; National Health and Medical Research Council; Amgen","keywords":"Immunotherapy; Melanoma; Metastatic melanoma; Medicine; Cancer research; Nivolumab; Cancer; Immunology; Oncology; Internal medicine","score_opus":0.20826737304915743,"score_gpt":0.48994314227045405,"score_spread":0.2816757692212966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3019679892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993875,0.00019490303,0.00008324797,0.000015016758,0.0000015828256,0.0000038997205,0.000054721913,0.0000031480167,0.0002560091],"genre_scores_gemma":[0.9997539,0.00003815888,0.000057504614,0.000006290067,0.0000029222974,0.0000023078926,0.000066503955,9.024315e-7,0.00007137174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988616,0.000018815936,0.000015187586,0.000036678066,0.000024876408,0.00001827657],"domain_scores_gemma":[0.9996921,0.000049755996,0.00016419301,0.000020348534,0.00001961449,0.00005394795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020327477,0.0001331328,0.00018054887,0.00035026425,0.00023962998,0.00022579277,0.00011226086,0.00019804914,0.0012543853],"category_scores_gemma":[0.0006739602,0.00010828432,0.00012706048,0.00024049148,0.00021990787,0.00012596462,0.000120031356,0.00024031018,0.00013671722],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008749653,0.000075204196,0.95226467,0.000048899594,0.000045305453,0.0007879545,0.000076190525,0.00014693702,0.03989673,0.00008777626,0.00019088393,0.0055044033],"study_design_scores_gemma":[0.00002378163,0.00036819206,0.98746955,0.000010609342,0.000060673123,0.00485413,0.00008094368,0.0005155319,0.0058305385,0.00007493673,0.0007070494,0.0000041526696],"about_ca_topic_score_codex":0.0006258377,"about_ca_topic_score_gemma":0.0010118835,"teacher_disagreement_score":0.0012543853,"about_ca_system_score_codex":0.0002738796,"about_ca_system_score_gemma":0.00015379275,"threshold_uncertainty_score":0.004196346},"labels":[],"label_agreement":null},{"id":"W3020750541","doi":"10.1158/1078-0432.ccr-19-2541","title":"Analysis of Released Circulating Tumor Cells During Surgery for Non-Small Cell Lung Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Seventh Framework Programme; Kurt Weill Foundation for Music; KWF Kankerbestrijding; European Commission; European Federation of Pharmaceutical Industries and Associations; Innovative Medicines Initiative","keywords":"Circulating tumor cell; Medicine; Lung cancer; Cancer; Pathology; Lung cancer surgery; Lung; Cardiothoracic surgery; Pulmonary vein; Primary tumor; Aneuploidy; Internal medicine; Oncology; Surgery; Metastasis; Biology","score_opus":0.15786400504802434,"score_gpt":0.4797961012943811,"score_spread":0.32193209624635677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020750541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976949,0.0010040407,0.00069331186,0.000013621863,0.00001054516,0.00003255075,0.00021884248,0.000019511228,0.00031270675],"genre_scores_gemma":[0.99767643,0.00025404035,0.0007651642,0.000024207215,0.000014643291,0.00004632463,0.0006189525,0.000008029533,0.00059214426],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997062,0.000052142583,0.000022473605,0.000072427756,0.00010052079,0.000046173485],"domain_scores_gemma":[0.99958867,0.000099497,0.000105894615,0.000026944128,0.00008391834,0.00009510463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002163148,0.00021311523,0.00046516827,0.00044795655,0.00018253484,0.00046272043,0.0001562892,0.00027551752,0.001351243],"category_scores_gemma":[0.0007145205,0.00010410646,0.00014715396,0.0003368012,0.00014839804,0.000158988,0.00017040792,0.00035779446,0.00037632743],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006563215,0.00030181694,0.35004207,0.00025197325,0.000076313925,0.0013141192,0.0003924988,0.00022885094,0.60470533,0.000057956557,0.00037365183,0.035692178],"study_design_scores_gemma":[0.00012187698,0.0048421193,0.86831534,0.000023460267,0.00013566908,0.003571186,0.0003180994,0.0018184263,0.11869971,0.000050019553,0.0020818706,0.000022227818],"about_ca_topic_score_codex":0.0005047236,"about_ca_topic_score_gemma":0.00061295787,"teacher_disagreement_score":0.001351243,"about_ca_system_score_codex":0.00019356074,"about_ca_system_score_gemma":0.00016014416,"threshold_uncertainty_score":0.0045203567},"labels":[],"label_agreement":null},{"id":"W3021570777","doi":"10.1158/1078-0432.ccr-20-0152","title":"NSABP B-41, a Randomized Neoadjuvant Trial: Genes and Signatures Associated with Pathologic Complete Response","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Breast cancer; Oncology; Trastuzumab; Medicine; Internal medicine; Estrogen receptor; Proportional hazards model; Cancer; Biology; Cancer research","score_opus":0.49011177305954695,"score_gpt":0.5634234850545039,"score_spread":0.07331171199495695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021570777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99758923,0.0011554526,0.00024201557,0.0003202744,0.000026397931,0.00010045008,0.00031686327,0.00001528802,0.00023398125],"genre_scores_gemma":[0.99773455,0.00028839058,0.00046618909,0.00019625628,0.000033248787,0.00022566394,0.00076705177,0.0000039732477,0.00028462405],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99908733,0.00065247586,0.0000410458,0.00010537761,0.00007007983,0.000043679363],"domain_scores_gemma":[0.99914575,0.00032977448,0.00027429443,0.000056470566,0.000038517883,0.00015521004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018546105,0.00048157948,0.00083346147,0.00016744649,0.0002190457,0.0005561875,0.0001907395,0.00039013964,0.0011494927],"category_scores_gemma":[0.0021283347,0.00017927361,0.00057783915,0.00025714491,0.0004579142,0.00030474167,0.00021025103,0.0007492422,0.00012384534],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7970182,0.002884837,0.09987196,0.00084376585,0.0037504302,0.0001869394,0.00013376135,0.007490312,0.020391576,0.00023597012,0.0017329552,0.06545946],"study_design_scores_gemma":[0.26111844,0.14829127,0.5060814,0.00035471914,0.007327765,0.0014854902,0.0004041454,0.043063108,0.018209662,0.0034873483,0.010044909,0.00013182047],"about_ca_topic_score_codex":0.00034798717,"about_ca_topic_score_gemma":0.00073511736,"teacher_disagreement_score":0.0018546105,"about_ca_system_score_codex":0.0004548372,"about_ca_system_score_gemma":0.0009842119,"threshold_uncertainty_score":0.009808242},"labels":[],"label_agreement":null},{"id":"W3023810398","doi":"10.1158/1078-0432.ccr-19-3402","title":"Pharmacokinetics, Safety, and Antitumor Effect of Apalutamide with Abiraterone Acetate plus Prednisone in Metastatic Castration-Resistant Prostate Cancer: Phase Ib Study","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec; BC Cancer Agency","funders":"Janssen Research and Development; Cancer Research UK","keywords":"Abiraterone acetate; Prednisone; Prostate cancer; Medicine; Pharmacokinetics; Pharmacology; Adverse effect; Enzalutamide; Internal medicine; Antiandrogen; Cancer; Urology; Oncology; Androgen receptor; Androgen deprivation therapy","score_opus":0.17911497121785097,"score_gpt":0.5338944760008876,"score_spread":0.3547795047830366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023810398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998638,0.00063439575,0.00019415897,0.000036789857,0.000009639339,0.00013448141,0.000099984616,0.00002271799,0.00022993203],"genre_scores_gemma":[0.9982838,0.0003910759,0.00049059605,0.0000683775,0.00004153951,0.00010162134,0.0003471218,0.000011959125,0.00026392375],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992106,0.0003363862,0.00004346003,0.00014243038,0.00016666575,0.0001004515],"domain_scores_gemma":[0.9990625,0.0001277987,0.00026400876,0.00007586416,0.000059434013,0.00041041005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009121365,0.0007639876,0.0017281009,0.00037077698,0.00036305407,0.0008198059,0.0005853419,0.00048986624,0.0014514661],"category_scores_gemma":[0.0010790825,0.00050198945,0.0009901362,0.0004992028,0.0006180327,0.00055251684,0.0002567226,0.0016515463,0.0004126612],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4519167,0.065002665,0.042902905,0.00062763115,0.0030439277,0.00065737084,0.0005585241,0.0052374075,0.2835657,0.00012882172,0.0015440534,0.1448143],"study_design_scores_gemma":[0.12826054,0.7196939,0.10568745,0.0000429403,0.0017160747,0.0021458738,0.00015619196,0.0053747706,0.033549495,0.00012951992,0.0031634185,0.00007978844],"about_ca_topic_score_codex":0.0017756544,"about_ca_topic_score_gemma":0.0030816698,"teacher_disagreement_score":0.0017756544,"about_ca_system_score_codex":0.00107961,"about_ca_system_score_gemma":0.0016051243,"threshold_uncertainty_score":0.007833123},"labels":[],"label_agreement":null},{"id":"W3024176153","doi":"10.1158/1078-0432.ccr-19-4088","title":"FGFR2c Mesenchymal Isoform Expression Is Associated with Poor Prognosis and Further Refines Risk Stratification within Endometrial Cancer Molecular Subtypes","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"Translational Research Institute Australia; Cancer Australia","keywords":"Endometrial cancer; Oncology; Internal medicine; Cohort; Proportional hazards model; Medicine; Biomarker; Cancer; Risk stratification; Biology","score_opus":0.1229546010085618,"score_gpt":0.43718025295547,"score_spread":0.31422565194690816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024176153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99923146,0.00017633317,0.00016021225,0.000013030611,0.0000010108488,0.000004951563,0.00015456528,0.0000039356487,0.00025454554],"genre_scores_gemma":[0.99932027,0.000061483704,0.00020322693,0.0000067033707,0.0000020875164,0.000003858478,0.00023251623,0.0000018073479,0.00016799023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984694,0.00003178456,0.000015491623,0.000040340365,0.000038241564,0.000027103393],"domain_scores_gemma":[0.9996892,0.00005320525,0.000114988354,0.00003407312,0.000059597907,0.000048971662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044309828,0.00020172916,0.00018368893,0.00080098526,0.00021587347,0.00040020436,0.00017811754,0.00021184132,0.0008920668],"category_scores_gemma":[0.00071843946,0.00012090601,0.00021356861,0.00042602018,0.00017982266,0.00009119497,0.00028361392,0.00021770754,0.00018319217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034952376,0.000007380023,0.98664004,0.000011715638,0.0000365707,0.00009111414,0.000040504594,0.00011025757,0.009350669,0.000017091275,0.0000651541,0.0032799903],"study_design_scores_gemma":[0.000006340497,0.000034541183,0.99762744,0.000003788742,0.000027732845,0.00034651684,0.00004671212,0.00063787185,0.0010285025,0.000022473141,0.00021571261,0.0000023416208],"about_ca_topic_score_codex":0.0068252804,"about_ca_topic_score_gemma":0.010682026,"teacher_disagreement_score":0.0068252804,"about_ca_system_score_codex":0.00024845576,"about_ca_system_score_gemma":0.00020225416,"threshold_uncertainty_score":0.013571084},"labels":[],"label_agreement":null},{"id":"W3025061287","doi":"10.1158/1078-0432.ccr-19-1905","title":"Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase–Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic Type","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Centre for Advancing Health Outcomes; BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Terry Fox Research Institute","keywords":"Ovarian cancer; Cancer research; Biology; Cancer; Serous carcinoma; Ovarian carcinoma; Ovary; Clear cell carcinoma; Medicine; Internal medicine; Endocrinology","score_opus":0.1806472035196014,"score_gpt":0.41809896221176307,"score_spread":0.23745175869216167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025061287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992963,0.00022406632,0.00016981325,0.000014889886,0.0000034276895,0.000012601934,0.000037723486,0.000011347414,0.00022973368],"genre_scores_gemma":[0.9993573,0.00009952854,0.00023699117,0.000011520242,0.0000013047865,0.000010235651,0.00009914032,0.0000014447892,0.00018268498],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995744,0.0000054760612,0.0000052423247,0.000009566819,0.000011881328,0.000010342285],"domain_scores_gemma":[0.99996316,0.0000057886687,0.000008808846,0.000004496545,0.000003846979,0.000013880244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000107377935,0.00017728422,0.00014696816,0.0001316801,0.0000898771,0.00016755189,0.000102567974,0.00013116543,0.0004729964],"category_scores_gemma":[0.00010040418,0.000065035485,0.00010886265,0.000096944794,0.00013267112,0.00011606335,0.00010374434,0.0002217646,0.00008137626],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009872512,0.00019742605,0.003899175,0.00005020798,0.00001745243,0.00009591407,0.000024798519,0.0003152144,0.98455113,0.00004775201,0.00012573182,0.009687898],"study_design_scores_gemma":[0.00019256349,0.005175535,0.04496104,0.000006498385,0.000044116463,0.0012713384,0.00009565295,0.005393898,0.93941987,0.000067391455,0.0033655472,0.0000065067816],"about_ca_topic_score_codex":0.00051142485,"about_ca_topic_score_gemma":0.0009267591,"teacher_disagreement_score":0.00051142485,"about_ca_system_score_codex":0.00023360222,"about_ca_system_score_gemma":0.00018334175,"threshold_uncertainty_score":0.0016949177},"labels":[],"label_agreement":null},{"id":"W3025233783","doi":"10.1158/1078-0432.1065.11.3","title":"Expression of the FOXP1 Transcription Factor Is Strongly Associated with Inferior Survival in Patients with Diffuse Large B-Cell Lymphoma","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"International Prognostic Index; Diffuse large B-cell lymphoma; Tissue microarray; Lymphoma; Internal medicine; Immunohistochemistry; Survival analysis; Oncology; Biology; Medicine; Pathology; Cancer research","score_opus":0.08804545974782862,"score_gpt":0.40457450689216684,"score_spread":0.3165290471443382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025233783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993456,0.00022443794,0.00007101994,0.00003146362,0.0000041958247,0.0000014577168,0.00009200977,0.000004644948,0.00022523239],"genre_scores_gemma":[0.9996574,0.000051624378,0.000035447803,0.000012149432,0.00000812654,0.0000016038848,0.0001366286,0.0000015442603,0.00009546585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99986815,0.00002643836,0.000011077809,0.000033129618,0.000026218435,0.000034974135],"domain_scores_gemma":[0.9993305,0.00015722812,0.0002467728,0.000034167122,0.000068143854,0.00016325859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002644531,0.00020280163,0.0002640077,0.00054643763,0.00033679383,0.00037381507,0.00018120115,0.00028984813,0.0014434383],"category_scores_gemma":[0.00092123786,0.0001264484,0.00014951342,0.0005341173,0.0002934839,0.00023059553,0.00020164608,0.00043518626,0.00021528704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004397384,0.000026718119,0.993789,0.000009437081,0.000022351112,0.00025040904,0.000032326057,0.000056013436,0.0032170138,0.000011223444,0.00010320157,0.0020426053],"study_design_scores_gemma":[0.000009887664,0.00009037708,0.99828184,0.0000028555962,0.000022418737,0.0007952303,0.00006023231,0.0002382843,0.00027859746,0.000028580742,0.00018918708,0.0000024573455],"about_ca_topic_score_codex":0.001441216,"about_ca_topic_score_gemma":0.0017128796,"teacher_disagreement_score":0.0014434383,"about_ca_system_score_codex":0.00020326761,"about_ca_system_score_gemma":0.00016312744,"threshold_uncertainty_score":0.0048288107},"labels":[],"label_agreement":null},{"id":"W3025611427","doi":"10.1158/1557-3265.ovcasymp18-dp-002","title":"Abstract DP-002: COMPARISON OF POTENTIAL OVARIAN CANCER BIOMARKERS BY MASS SPECTROMETRY-BASED PROTEOMIC ANALYSIS OF RESIDUAL PAP TEST FLUID, CERVICAL SWABS, AND TUMOR TISSUE FROM AN OVARIAN CANCER PATIENT","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Ovarian cancer; Cervical cancer; Medicine; Cancer; Oncology; Cervix; Biomarker; Pap test; Fallopian tube; Fallopian tube cancer; Proteomics; Population; Pathology; Internal medicine; Biology; Gynecology","score_opus":0.04006122757461836,"score_gpt":0.4393047707121899,"score_spread":0.3992435431375715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025611427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99504375,0.0010109894,0.001257218,0.00014442964,0.00006041072,0.000060893697,0.0013582181,0.00004128254,0.0010228374],"genre_scores_gemma":[0.99218994,0.00045342592,0.003254002,0.00019337963,0.000034278044,0.00004541519,0.0023710555,0.000022475073,0.0014359883],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979943,0.00001818569,0.000016143853,0.00005823052,0.00007233524,0.00003578976],"domain_scores_gemma":[0.9998486,0.000035027093,0.000018900455,0.000010569243,0.000051352767,0.000035453297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021811828,0.00033693144,0.0002859298,0.00078352314,0.00028852362,0.00053781027,0.0002310381,0.00051875843,0.001441669],"category_scores_gemma":[0.0005447613,0.000100317186,0.0003503865,0.0005110082,0.00018916631,0.00018170115,0.00034923395,0.0003380924,0.0005332126],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010716931,0.00020508099,0.07273986,0.00019323225,0.00009837914,0.001881797,0.00019450946,0.00013954533,0.9080987,0.00008434674,0.00071873754,0.014574123],"study_design_scores_gemma":[0.00006960523,0.0017415311,0.47910428,0.00003225031,0.00024015394,0.009995513,0.00087102794,0.003645059,0.49498636,0.00015173947,0.009128993,0.000033477976],"about_ca_topic_score_codex":0.0008951942,"about_ca_topic_score_gemma":0.00057835464,"teacher_disagreement_score":0.001441669,"about_ca_system_score_codex":0.00016123618,"about_ca_system_score_gemma":0.00016922783,"threshold_uncertainty_score":0.00482285},"labels":[],"label_agreement":null},{"id":"W3026647982","doi":"10.1158/1557-3265.ovcasymp18-gmm-048","title":"Abstract GMM-048: CTDNA RESPONSE TO THE PARP INHIBITOR RUCAPARIB PREDICTS PROGRESSION-FREE SURVIVAL AND BEST OVERALL RESPONSE ON THE ARIEL2 TRIAL","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"PARP inhibitor; Loss of heterozygosity; Oncology; Medicine; Internal medicine; Ovarian cancer; Progression-free survival; Cancer; Biology; Allele; Chemotherapy; Genetics; Poly ADP ribose polymerase; DNA; Gene","score_opus":0.2549700596045747,"score_gpt":0.530908562304738,"score_spread":0.27593850270016335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026647982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887636,0.0028270776,0.00027407796,0.0006353286,0.000077887715,0.00019051062,0.0037178444,0.000119803415,0.0033938265],"genre_scores_gemma":[0.99367756,0.00027065098,0.00035771614,0.0002893464,0.0001025981,0.00016708516,0.0036633909,0.000015860447,0.0014558439],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99945825,0.00028876818,0.000027394268,0.00012457796,0.000052731666,0.000048216967],"domain_scores_gemma":[0.99925584,0.0002559134,0.00017098973,0.00007431724,0.00005504202,0.00018795388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014300797,0.000383612,0.000862029,0.00016873896,0.00013712811,0.0006267862,0.00042418326,0.00045637094,0.004392856],"category_scores_gemma":[0.0013692635,0.0001377723,0.00055094523,0.00023291477,0.0002161171,0.00038311878,0.00024303072,0.0011544148,0.00050443475],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.68898416,0.002247197,0.14912431,0.0011098523,0.003377001,0.00016944988,0.00011772898,0.003900482,0.01898596,0.00031385236,0.012332993,0.11933705],"study_design_scores_gemma":[0.1613454,0.11782517,0.67326385,0.00023071788,0.005698232,0.00081477774,0.0001613179,0.012709429,0.009498109,0.001040492,0.017303301,0.00010916982],"about_ca_topic_score_codex":0.0003738813,"about_ca_topic_score_gemma":0.0011540212,"teacher_disagreement_score":0.004392856,"about_ca_system_score_codex":0.00039004182,"about_ca_system_score_gemma":0.0003539589,"threshold_uncertainty_score":0.014695585},"labels":[],"label_agreement":null},{"id":"W3026903046","doi":"10.1158/1078-0432.ccr-19-4121","title":"EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Genomics; Ozmosis Research (Canada); Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"Ontario Institute for Cancer Research; Princess Margaret Cancer Foundation","keywords":"Olaparib; Ovarian cancer; Medicine; PARP inhibitor; Oncology; Clinical trial; Internal medicine; Phases of clinical research; Open label; Cancer; Cancer research; Poly ADP ribose polymerase; Biology","score_opus":0.5458711143040862,"score_gpt":0.62167981321802,"score_spread":0.07580869891393383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026903046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938943,0.0009741282,0.00030858174,0.0003337681,0.00007996809,0.002086425,0.0008387338,0.00006343306,0.0014206346],"genre_scores_gemma":[0.99034077,0.0007872844,0.0013984306,0.0007410213,0.00016819581,0.0023120828,0.0020407427,0.000022367134,0.0021891538],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999567,0.0002300781,0.000021333699,0.000071184055,0.00003927627,0.00007111539],"domain_scores_gemma":[0.99925715,0.00011610856,0.00015272987,0.00007056943,0.000045791745,0.00035775092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019780262,0.0012344604,0.0014527958,0.00035471827,0.00044989167,0.0010469975,0.000800725,0.0010587197,0.004517343],"category_scores_gemma":[0.0010944318,0.0004496192,0.00080863276,0.0003370156,0.0011426482,0.000990548,0.0004943798,0.00268585,0.0006959593],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8613972,0.05257536,0.0048973807,0.0005376054,0.00075889705,0.00016586737,0.00027992565,0.0016211047,0.022020273,0.00039505615,0.003540153,0.05181116],"study_design_scores_gemma":[0.7491607,0.23847021,0.006506316,0.000024656816,0.00020985014,0.00016837717,0.00005910707,0.0011075503,0.0021212038,0.00025430135,0.0018962622,0.000021465938],"about_ca_topic_score_codex":0.0006857717,"about_ca_topic_score_gemma":0.0021817498,"teacher_disagreement_score":0.004517343,"about_ca_system_score_codex":0.00092109345,"about_ca_system_score_gemma":0.0014456249,"threshold_uncertainty_score":0.015112042},"labels":[],"label_agreement":null},{"id":"W3026964763","doi":"10.1158/1078-0432.ccr-19-2881","title":"A Pan-cancer Clinical Study of Personalized Neoantigen Vaccine Monotherapy in Treating Patients with Various Types of Advanced Solid Tumors","year":2020,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Key Research and Development Program of China; Natural Science Foundation of Zhejiang Province; National Natural Science Foundation of China","keywords":"Medicine; Cancer; Solid tumor; Cancer vaccine; Cancer research; Immunology; Oncology; Immunotherapy; Internal medicine","score_opus":0.1010132812869398,"score_gpt":0.46083688428528996,"score_spread":0.35982360299835014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026964763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933815,0.0027660178,0.00036202517,0.00016490054,0.00006868691,0.0017793581,0.00036904227,0.000035537167,0.0010730034],"genre_scores_gemma":[0.99301904,0.001328279,0.0011375581,0.00046424623,0.000101956764,0.0019723307,0.0008395582,0.000010524515,0.0011264945],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996785,0.00013266377,0.000022141223,0.00007484975,0.000028964096,0.00006293202],"domain_scores_gemma":[0.99960893,0.000039210026,0.00006601102,0.0000389536,0.000039909926,0.00020695274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001282535,0.0007281521,0.0017530599,0.0003145777,0.00037088533,0.00057159347,0.00032550626,0.0007022022,0.0026925516],"category_scores_gemma":[0.00048763398,0.0002916288,0.00092014094,0.00037910836,0.00046133794,0.0007116473,0.00035759635,0.0013222949,0.0005810867],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6353067,0.085730664,0.02823374,0.0014566903,0.0016315447,0.00028448174,0.00035110553,0.0023241432,0.046387132,0.0002557055,0.0025743037,0.19546372],"study_design_scores_gemma":[0.19823088,0.7480237,0.04146238,0.000059715832,0.0008711536,0.00029701574,0.00008977241,0.0014234462,0.0044280314,0.00017588222,0.004910323,0.00002766922],"about_ca_topic_score_codex":0.0003628335,"about_ca_topic_score_gemma":0.0010115645,"teacher_disagreement_score":0.0026925516,"about_ca_system_score_codex":0.00059774425,"about_ca_system_score_gemma":0.001137858,"threshold_uncertainty_score":0.009007454},"labels":[],"label_agreement":null},{"id":"W3033000728","doi":"10.1158/1557-3265.liqbiop20-pr03","title":"Abstract PR03: Genome-wide 5-hydroxymethylcytosine profiles in circulating cell-free DNA and survival in patients with multiple myeloma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Multiple myeloma; Proportional hazards model; Cell-free fetal DNA; Oncology; Internal medicine; Population; 5-Hydroxymethylcytosine; Digital polymerase chain reaction; Gene; DNA methylation; Polymerase chain reaction; Biology; Gene expression; Genetics","score_opus":0.06360966468007413,"score_gpt":0.3646550897543313,"score_spread":0.3010454250742572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033000728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966,0.00032718535,0.0003514799,0.00006870511,0.000005504216,0.0000060376974,0.002398761,0.000019299783,0.00022314228],"genre_scores_gemma":[0.99795437,0.000046310408,0.0002403225,0.000031474156,0.000009300461,0.000009837006,0.0014959773,0.0000042751176,0.00020816078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998337,0.000030694166,0.00001542324,0.00007030401,0.000026872378,0.000023128483],"domain_scores_gemma":[0.999532,0.000091979724,0.00019418032,0.000035769302,0.000059240403,0.000086881504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029865067,0.00018160605,0.00021205249,0.00040921816,0.0002274134,0.00033973117,0.00029421286,0.00032609023,0.001494167],"category_scores_gemma":[0.0007873662,0.0001184857,0.00023480963,0.000688526,0.000117316704,0.00022739627,0.0002807134,0.00039143753,0.0002249944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004026947,0.000019044786,0.9941711,0.000019582023,0.00005967509,0.000050121802,0.000026020634,0.00016319762,0.0017861787,0.000017919265,0.00032010706,0.0029642174],"study_design_scores_gemma":[0.000009526298,0.00009026868,0.99806446,0.000003923393,0.00004364721,0.00022017627,0.000033051,0.00073017296,0.00043847706,0.000035500638,0.0003278415,0.0000030747817],"about_ca_topic_score_codex":0.0022266516,"about_ca_topic_score_gemma":0.0025067006,"teacher_disagreement_score":0.0022266516,"about_ca_system_score_codex":0.00025866256,"about_ca_system_score_gemma":0.00021937615,"threshold_uncertainty_score":0.004998505},"labels":[],"label_agreement":null},{"id":"W3033003220","doi":"10.1158/1557-3265.liqbiop20-a59","title":"Abstract A59: Biologic rationale for radiation-induced release of circulating tumor DNA","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cancer research; Head and neck squamous-cell carcinoma; Apoptosis; Cell culture; Medicine; Radiation therapy; In vivo; Molecular biology; Pathology; Cancer; Cisplatin; Biology; Chemistry; Head and neck cancer; Internal medicine; Chemotherapy","score_opus":0.2742260958633189,"score_gpt":0.48633998003640105,"score_spread":0.21211388417308213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033003220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97498035,0.01250108,0.00687038,0.00046432728,0.00016833973,0.00014351317,0.00068003696,0.00011962385,0.0040723886],"genre_scores_gemma":[0.99505484,0.0010518957,0.0015253096,0.00012458448,0.00004595146,0.000055476485,0.00042308617,0.000015071942,0.0017037727],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972945,0.000057824363,0.00003175847,0.0000750278,0.00007011028,0.000035899277],"domain_scores_gemma":[0.99955875,0.00011746494,0.00013148024,0.000054816122,0.00006867697,0.00006886652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045074697,0.0002834947,0.00029396894,0.00034014985,0.0001560941,0.00050899276,0.0002728116,0.00056572683,0.004294912],"category_scores_gemma":[0.00059176673,0.0001426016,0.00033249555,0.00016817196,0.00041954088,0.00039029846,0.00022633033,0.00057354337,0.0010524367],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008795907,0.00012922272,0.0045780223,0.00017222986,0.000019648447,0.00036870345,0.00004202103,0.0002115992,0.9853839,0.000773614,0.00018956346,0.0072519365],"study_design_scores_gemma":[0.00015258142,0.0042381384,0.034382977,0.0000691336,0.000077949844,0.0039040262,0.000090016605,0.0024826676,0.94505715,0.0009254641,0.008604222,0.000015756688],"about_ca_topic_score_codex":0.00019849018,"about_ca_topic_score_gemma":0.000121673846,"teacher_disagreement_score":0.004294912,"about_ca_system_score_codex":0.00053259317,"about_ca_system_score_gemma":0.00018969533,"threshold_uncertainty_score":0.014367878},"labels":[],"label_agreement":null},{"id":"W3033918338","doi":"10.1158/1557-3265.liqbiop20-a39","title":"Abstract A39: Concordance of 5-hydroxymethylcytosine-modified genes from circulating cell-free DNA and positron emission tomography in multiple myeloma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Concordance; Medicine; Positron emission tomography; Digital polymerase chain reaction; Epigenetics; Cell-free fetal DNA; Oncology; Internal medicine; Nuclear medicine; Pathology; Gene; Polymerase chain reaction; Biology; Genetics","score_opus":0.1038816234453874,"score_gpt":0.402363634402437,"score_spread":0.2984820109570496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033918338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741226,0.00041227537,0.0006942884,0.000051434163,0.000009697143,0.0000078608,0.0007169012,0.000024731367,0.0006704865],"genre_scores_gemma":[0.99889416,0.000047515947,0.00044849282,0.000032052136,0.000005397781,0.000007009792,0.00042958267,0.0000061779842,0.00012969707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994886,0.00008139161,0.000047954465,0.00018433666,0.00013392195,0.00006383398],"domain_scores_gemma":[0.9987387,0.00037457354,0.0003889637,0.00010097898,0.00029790305,0.0000988861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005979511,0.00017005148,0.00022904284,0.00079990714,0.00023263271,0.00055622804,0.00023657976,0.0003647966,0.0017226074],"category_scores_gemma":[0.0018433013,0.00014964308,0.0002001367,0.00088972424,0.0002521557,0.00022950342,0.00029795305,0.00032200798,0.00029907437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005994404,0.00001939405,0.96100193,0.00004166826,0.00008467436,0.00020525588,0.0001204895,0.0003411594,0.030519444,0.00009751471,0.00027030546,0.0066985614],"study_design_scores_gemma":[0.00000914349,0.00012999754,0.9869069,0.0000091493175,0.000051665524,0.0007122744,0.000111064226,0.0018166661,0.009336826,0.00011773725,0.00079092744,0.00000767689],"about_ca_topic_score_codex":0.0021246742,"about_ca_topic_score_gemma":0.0020643205,"teacher_disagreement_score":0.0021246742,"about_ca_system_score_codex":0.00041140371,"about_ca_system_score_gemma":0.00019494395,"threshold_uncertainty_score":0.0057626963},"labels":[],"label_agreement":null},{"id":"W3034497617","doi":"10.1158/1557-3265.aacrahns19-a35","title":"Abstract A35: Diagnostic performance and timing of post-treatment 18F-FDG PET/CT for head and neck cancer surveillance: A meta-analysis of reported studies","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Head and neck cancer; Head and neck; Nuclear medicine; Meta-analysis; Cancer; Internal medicine; Confidence interval; Oncology; Surgery","score_opus":0.46416252462490215,"score_gpt":0.5781511218199314,"score_spread":0.1139885971950293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034497617","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.044286195,0.94690686,0.0025938638,0.0009898954,0.00070368295,0.00035487505,0.0027978725,0.00015340642,0.0012133636],"genre_scores_gemma":[0.85649174,0.13226733,0.00431907,0.0016550034,0.00070877816,0.000904118,0.0024133148,0.00014666915,0.0010939118],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9850289,0.0089666685,0.0024542045,0.002111482,0.0010555114,0.0003832192],"domain_scores_gemma":[0.965462,0.026050573,0.004696293,0.0017486066,0.0016226602,0.00041981487],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.018104892,0.002837438,0.00902094,0.0039525637,0.00064454135,0.0042614467,0.0019960857,0.002454746,0.005158539],"category_scores_gemma":[0.042998787,0.0015741565,0.053956803,0.003795301,0.00064279087,0.0017609248,0.0013795511,0.0024769856,0.0005991366],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046957755,0.000016337835,0.013783821,0.026666997,0.94879586,0.000086686014,0.000030542633,0.00061019877,0.0002832224,0.00007186098,0.0007888799,0.0041698227],"study_design_scores_gemma":[0.0008134219,0.00015698852,0.0102840485,0.002186705,0.9850343,0.000073060706,0.00001832476,0.00043975963,0.00012293438,0.00018338159,0.00066865137,0.000018467848],"about_ca_topic_score_codex":0.0069174976,"about_ca_topic_score_gemma":0.008365278,"teacher_disagreement_score":0.9909791,"about_ca_system_score_codex":0.0015378906,"about_ca_system_score_gemma":0.0011114612,"threshold_uncertainty_score":0.09574896},"labels":[],"label_agreement":null},{"id":"W3034627609","doi":"10.1158/1557-3265.advprecmed20-26","title":"Abstract 26: A novel electronic platform to improve clinical trial workflow and screening","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Scientific Computing and Data Management","field":"Decision Sciences","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Clinical trial; Workflow; Computer science; Web application; Medicine; Password; Workload; Android (operating system); World Wide Web; Phone; Medical physics; Database; Pathology; Operating system","score_opus":0.7814822954328613,"score_gpt":0.6425963769664341,"score_spread":0.13888591846642717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034627609","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05307729,0.00194317,0.6480373,0.005386592,0.0031264464,0.012023947,0.012389268,0.23097397,0.03304193],"genre_scores_gemma":[0.1972518,0.0015954457,0.7334216,0.0055961204,0.0015361421,0.009036427,0.011544328,0.010155066,0.029863063],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930233,0.0029202455,0.0010738086,0.0010871713,0.0014589848,0.00043653426],"domain_scores_gemma":[0.9724209,0.013185617,0.0025436077,0.0055267643,0.003443284,0.002879833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013174907,0.0013636657,0.0009064949,0.0018010864,0.00051269215,0.0029274528,0.002471292,0.0011795003,0.029317928],"category_scores_gemma":[0.028724313,0.0010008634,0.0011413166,0.0010989284,0.0005285663,0.0029968368,0.00425999,0.0012879886,0.017384704],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068045184,0.0011689439,0.009822035,0.0016881231,0.00025627052,0.0010811305,0.0008990898,0.0038942937,0.01867399,0.006033631,0.19237877,0.75729924],"study_design_scores_gemma":[0.0069736363,0.0072928476,0.03314372,0.0013837295,0.001020522,0.0029450783,0.00042200077,0.107189775,0.047939934,0.025050996,0.76558584,0.0010519507],"about_ca_topic_score_codex":0.0005264005,"about_ca_topic_score_gemma":0.0006517162,"teacher_disagreement_score":0.029317928,"about_ca_system_score_codex":0.00061758666,"about_ca_system_score_gemma":0.002897934,"threshold_uncertainty_score":0.09807819},"labels":[],"label_agreement":null},{"id":"W3035208766","doi":"10.1158/1078-0432.ccr-20-0621","title":"Immunotherapy of Ipilimumab and Nivolumab in Patients with Advanced Neuroendocrine Tumors: A Subgroup Analysis of the CA209-538 Clinical Trial for Rare Cancers","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sierra Oncology; Australian Government; Eisai; BeiGene; Sanofi; Clovis Oncology; AstraZeneca; Bristol-Myers Squibb; Amgen","keywords":"Nivolumab; Ipilimumab; Medicine; Clinical endpoint; Internal medicine; Clinical trial; Response Evaluation Criteria in Solid Tumors; Progressive disease; Neuroendocrine tumors; Immunotherapy; Gastroenterology; Oncology; Phases of clinical research; Surgery; Cancer; Chemotherapy","score_opus":0.14580141064000737,"score_gpt":0.4961921606803399,"score_spread":0.3503907500403325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035208766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916285,0.0057702414,0.0002555638,0.00024920786,0.0001047653,0.0005106632,0.00066707545,0.000019591269,0.0007943815],"genre_scores_gemma":[0.9975262,0.00054038176,0.00020798457,0.00022458767,0.00010124061,0.00029014176,0.0008062004,0.000009483932,0.00029373213],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99809045,0.0010071524,0.00025584977,0.0002843761,0.00015580562,0.00020640617],"domain_scores_gemma":[0.9985374,0.00043942657,0.0003511564,0.00027580938,0.00011596453,0.0002802941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033859015,0.0010930538,0.002711587,0.0005306165,0.00038149624,0.0010398033,0.0005052824,0.0008404063,0.0015581301],"category_scores_gemma":[0.0024170775,0.0003237944,0.0055701416,0.0006379411,0.00038485922,0.00046975364,0.000483518,0.001024547,0.0002744908],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8114825,0.0019518611,0.09950923,0.0011532109,0.03570523,0.0005130857,0.00021407338,0.0016553781,0.010619167,0.00017654797,0.0023126781,0.03470707],"study_design_scores_gemma":[0.39996362,0.108704485,0.40291992,0.00035665295,0.06585564,0.0017335541,0.0005579866,0.005863204,0.004259267,0.0012054901,0.008388038,0.00019211546],"about_ca_topic_score_codex":0.00087045244,"about_ca_topic_score_gemma":0.002517914,"teacher_disagreement_score":0.0033859015,"about_ca_system_score_codex":0.0008629983,"about_ca_system_score_gemma":0.0010201772,"threshold_uncertainty_score":0.017906547},"labels":[],"label_agreement":null},{"id":"W3035251856","doi":"10.1158/1557-3265.aacrahns19-a07","title":"Abstract A07: Improved prognosis of HPV-positive oropharyngeal cancers is associated with a suppression of TGF-β-mediated immune evasion","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Oncology; Cancer research; Carcinogenesis; Internal medicine; HPV infection; Cancer; Cervical cancer","score_opus":0.08140809866806785,"score_gpt":0.4213435920293677,"score_spread":0.33993549336129986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035251856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951751,0.001396669,0.0006210961,0.00009929935,0.000027604716,0.00000921619,0.001581654,0.000045422727,0.0010437483],"genre_scores_gemma":[0.99704486,0.00038593254,0.00024398297,0.000056955058,0.000016034879,0.000009660891,0.0015009975,0.000013398232,0.00072826067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998958,0.000012073789,0.000008808842,0.000031035404,0.000027642027,0.000024647492],"domain_scores_gemma":[0.9997794,0.00003153256,0.000086026055,0.000019801415,0.00003956887,0.00004365263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016802596,0.00019351074,0.00022257229,0.0003512378,0.00018864236,0.000387463,0.00011956426,0.0001710981,0.0029669097],"category_scores_gemma":[0.00030248996,0.00006513119,0.00035243022,0.00042624402,0.00015051918,0.00013826357,0.00022860496,0.00040110078,0.00044328396],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025313909,0.00022240833,0.5192208,0.00034763102,0.00036735018,0.00055296515,0.00011158539,0.0002987006,0.4471712,0.0002536081,0.0019516931,0.026970621],"study_design_scores_gemma":[0.000019041632,0.00032131746,0.961139,0.000022417555,0.00019227221,0.00077929907,0.00011920364,0.0005762306,0.034082767,0.00019667197,0.002544315,0.0000075463204],"about_ca_topic_score_codex":0.0010348561,"about_ca_topic_score_gemma":0.00083971553,"teacher_disagreement_score":0.0029669097,"about_ca_system_score_codex":0.00014784114,"about_ca_system_score_gemma":0.00022258204,"threshold_uncertainty_score":0.009925306},"labels":[],"label_agreement":null},{"id":"W3035309353","doi":"10.1158/1557-3265.aacrahns19-ia02","title":"Abstract IA02: Utilizing patient-derived xenografts for prognostication and biomarker discovery","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Oncology; Head and neck squamous-cell carcinoma; Internal medicine; Biomarker; Hazard ratio; Radiation therapy; Cohort; Cancer; Precision medicine; Personalized medicine; Bioinformatics; Head and neck cancer; Pathology; Biology; Confidence interval","score_opus":0.4849151068034955,"score_gpt":0.5792740164811869,"score_spread":0.09435890967769145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035309353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97993565,0.0017673861,0.011834564,0.0002783925,0.000110411456,0.00029568217,0.0029939462,0.00030858497,0.002475503],"genre_scores_gemma":[0.98352665,0.0007953041,0.0079801455,0.00013421974,0.00002521058,0.00018787775,0.0060875094,0.00003164408,0.0012313805],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995334,0.00018142773,0.000038728493,0.000088514134,0.0001044302,0.00005357754],"domain_scores_gemma":[0.9992588,0.00018279506,0.00011150129,0.00020711735,0.00013597176,0.00010386861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022145628,0.0003951476,0.00040827482,0.00043565736,0.00019184535,0.0012555526,0.00039623416,0.00042522437,0.0014358022],"category_scores_gemma":[0.0010977628,0.00021255351,0.00029713495,0.0004620012,0.0002719606,0.00043718852,0.000493537,0.0010183578,0.0006128614],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040547904,0.0019113311,0.081997655,0.00026665215,0.00020476714,0.00034944358,0.0001876413,0.003858282,0.851949,0.0013552733,0.0039279354,0.049937297],"study_design_scores_gemma":[0.0005149729,0.017215457,0.11428901,0.000087455555,0.0004139822,0.0039923056,0.00042500242,0.045165997,0.7928246,0.001029804,0.023967206,0.00007414913],"about_ca_topic_score_codex":0.0007026487,"about_ca_topic_score_gemma":0.0005633606,"teacher_disagreement_score":0.0022145628,"about_ca_system_score_codex":0.0003525616,"about_ca_system_score_gemma":0.00038847193,"threshold_uncertainty_score":0.0117118955},"labels":[],"label_agreement":null},{"id":"W3035392667","doi":"10.1158/1557-3265.advprecmed20-14","title":"Abstract 14: Computer-aided discovery of small-molecule inhibitors targeting neural transcription factor BRN2 in neuroendocrine prostate tumors","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; SOX2; Androgen receptor; Cancer research; LNCaP; Enzalutamide; Transcription factor; Medicine; Bioinformatics; Biology; Cancer; Internal medicine; Gene; Genetics","score_opus":0.19186769514599047,"score_gpt":0.45159321359909393,"score_spread":0.25972551845310343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035392667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8406113,0.008302051,0.102423154,0.001531109,0.00033152115,0.00049342244,0.008614653,0.006004212,0.031688623],"genre_scores_gemma":[0.9234052,0.0027582706,0.059867408,0.00029171412,0.000032413234,0.00042565333,0.007488545,0.00017680046,0.0055540656],"study_design_codex":"simulation_or_modeling","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986637,0.00003451427,0.000006654852,0.000025787722,0.000042573207,0.000024029718],"domain_scores_gemma":[0.9999075,0.000047141464,0.000012415851,0.0000047296257,0.000015373198,0.000012879478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036665492,0.0010176969,0.001233922,0.00036506812,0.00023111652,0.00075737445,0.000708068,0.0005691043,0.004067946],"category_scores_gemma":[0.00043828908,0.0002543462,0.00094896794,0.00034863947,0.00019084265,0.00029256145,0.00042550048,0.0005701991,0.00054237776],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001051452,0.00071047334,0.0035116298,0.0009131467,0.0004437766,0.00068695814,0.000048414528,0.894335,0.037118606,0.006376637,0.0070920265,0.047711916],"study_design_scores_gemma":[0.00030021174,0.0005764654,0.00047200042,0.000017867724,0.000104054816,0.00007453865,0.000019612593,0.98190814,0.011055698,0.0010101197,0.004442219,0.000019127177],"about_ca_topic_score_codex":0.0035827563,"about_ca_topic_score_gemma":0.005128977,"teacher_disagreement_score":0.004067946,"about_ca_system_score_codex":0.00052345527,"about_ca_system_score_gemma":0.0009870051,"threshold_uncertainty_score":0.013608694},"labels":[],"label_agreement":null},{"id":"W3035473078","doi":"10.1158/1078-0432.ccr-20-1345","title":"A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Bendamustine; Rituximab; Lenalidomide; Medicine; Bortezomib; Follicular lymphoma; Internal medicine; Oncology; Lymphoma; Follicular phase; Multiple myeloma","score_opus":0.25055410467248995,"score_gpt":0.5022630588164514,"score_spread":0.25170895414396144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035473078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99181306,0.0015011096,0.00056221784,0.00045747604,0.00026894064,0.0034434698,0.0006550899,0.000085060754,0.0012135899],"genre_scores_gemma":[0.9885505,0.0010384276,0.0015414321,0.0012195441,0.00031817742,0.0040383097,0.0010650468,0.000028391562,0.0022001779],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990151,0.00061399525,0.000048230162,0.00013555383,0.000063853106,0.00012321748],"domain_scores_gemma":[0.99862003,0.0003007598,0.0002820512,0.00012084937,0.0000814787,0.00059495267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030377903,0.0013025022,0.0022998333,0.000377778,0.00041363438,0.0010439269,0.0012805937,0.0015718462,0.0062088813],"category_scores_gemma":[0.0017512903,0.0006668701,0.0015719628,0.0003724841,0.0011594098,0.0009128681,0.00043615248,0.0034482172,0.0012126323],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96979576,0.014074982,0.00068542035,0.00016514296,0.00048191275,0.00002289142,0.00003554,0.00025635012,0.0030356054,0.000048628866,0.0005293475,0.010868397],"study_design_scores_gemma":[0.9107876,0.08665569,0.0015010905,0.000011831213,0.00017967807,0.000018219569,0.000010930944,0.00023864712,0.00022977646,0.00006177064,0.00029676218,0.000008003491],"about_ca_topic_score_codex":0.00088901207,"about_ca_topic_score_gemma":0.0024703296,"teacher_disagreement_score":0.0062088813,"about_ca_system_score_codex":0.0010695466,"about_ca_system_score_gemma":0.0017149176,"threshold_uncertainty_score":0.020770729},"labels":[],"label_agreement":null},{"id":"W3035482294","doi":"10.1158/1557-3265.aacrahns19-ia20","title":"Abstract IA20: Radiotherapy plus cetuximab or cisplatin in human papilloma-virus positive oropharyngeal cancer (NRG 1016): A randomized multicenter noninferiority trial*","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Cetuximab; Medicine; Radiation therapy; Internal medicine; Cisplatin; Oncology; Randomized controlled trial; Cancer; Toxicity; Chemotherapy; Colorectal cancer","score_opus":0.2837699504210207,"score_gpt":0.5554884715866064,"score_spread":0.2717185211655857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035482294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836579,0.005571682,0.0006044961,0.0008579861,0.0006342912,0.0054801847,0.0008722586,0.00010896294,0.002212196],"genre_scores_gemma":[0.98392636,0.0030862472,0.0014994823,0.0011282248,0.0006444274,0.0049888752,0.0014252731,0.000026444408,0.0032747204],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99873334,0.0008322177,0.00009092233,0.00016248773,0.00007753302,0.00010347693],"domain_scores_gemma":[0.9989416,0.00025872813,0.00026748257,0.00008932396,0.00007978973,0.00036306056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003062012,0.0016856976,0.0024746975,0.00046862147,0.00041876198,0.0012516755,0.0011060154,0.0017713357,0.005871737],"category_scores_gemma":[0.0023473762,0.0006423374,0.0020305696,0.0005450953,0.0011366366,0.00083838793,0.0004933945,0.0023130488,0.0009739858],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98429906,0.004056127,0.00053331885,0.00039469288,0.000815181,0.000027314412,0.000020666961,0.00019790194,0.0017145969,0.000056257755,0.00046239732,0.0074225124],"study_design_scores_gemma":[0.9565602,0.041293986,0.0007951122,0.000025721436,0.0004870386,0.000018475517,0.000007441058,0.00024958773,0.00022059653,0.000056142326,0.00027900274,0.0000066749076],"about_ca_topic_score_codex":0.0010312201,"about_ca_topic_score_gemma":0.002242246,"teacher_disagreement_score":0.005871737,"about_ca_system_score_codex":0.00093849597,"about_ca_system_score_gemma":0.0017201428,"threshold_uncertainty_score":0.01964295},"labels":[],"label_agreement":null},{"id":"W3035496509","doi":"10.1158/1078-0432.ccr-20-0224","title":"<i>ESR1</i> Mutations and Overall Survival on Fulvestrant versus Exemestane in Advanced Hormone Receptor–Positive Breast Cancer: A Combined Analysis of the Phase III SoFEA and EFECT Trials","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute for Health and Care Research; Cancer Research UK; AstraZeneca","keywords":"Fulvestrant; Exemestane; Oncology; Breast cancer; Medicine; Internal medicine; Hormone receptor; Estrogen receptor; Oestrogen receptor; Cancer; Aromatase","score_opus":0.22071949580049685,"score_gpt":0.5247294331244319,"score_spread":0.304009937323935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035496509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942058,0.0043621073,0.0002720127,0.00022712926,0.000054740292,0.00014307797,0.0003484712,0.000011694729,0.00037501648],"genre_scores_gemma":[0.9976877,0.0007226686,0.00034704624,0.00015789992,0.000118944416,0.00012557392,0.0006011317,0.000005241961,0.00023382365],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99688965,0.0024093112,0.0001586684,0.00019886943,0.00020918898,0.00013438534],"domain_scores_gemma":[0.99432486,0.00345182,0.0011207847,0.00030247393,0.0002346313,0.000565559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007958407,0.0009090053,0.0025309466,0.0004996534,0.000195325,0.0009514227,0.00049962907,0.00071315956,0.0012541309],"category_scores_gemma":[0.0045256233,0.00033338778,0.004142479,0.00043475835,0.00045592306,0.00063897186,0.00044007672,0.0014696255,0.000118038115],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87043434,0.002275531,0.06680716,0.00063283625,0.018458452,0.000092337024,0.00009031105,0.0019107615,0.006572322,0.00010617917,0.0009094583,0.03171037],"study_design_scores_gemma":[0.37485176,0.21412592,0.3335664,0.00028776765,0.054340206,0.00062057475,0.00025378555,0.009005491,0.008854928,0.00056094234,0.0034215078,0.00011076289],"about_ca_topic_score_codex":0.00043067572,"about_ca_topic_score_gemma":0.001251982,"teacher_disagreement_score":0.007958407,"about_ca_system_score_codex":0.00056806725,"about_ca_system_score_gemma":0.0006726771,"threshold_uncertainty_score":0.042088628},"labels":[],"label_agreement":null},{"id":"W3035783198","doi":"10.1158/1557-3265.liqbiop20-pr12","title":"Abstract PR12: Detection of EV-based signatures in prostate cancer using microflow cytometry and machine learning","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Prostate cancer; Medicine; Cancer; Prostate; Circulating tumor cell; Oncology; Disease; Internal medicine; Metastasis","score_opus":0.12890442906112817,"score_gpt":0.4540095612408493,"score_spread":0.32510513217972115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035783198","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43694896,0.006465005,0.533777,0.0025385492,0.00058203365,0.0004702582,0.0036688468,0.008226406,0.0073228944],"genre_scores_gemma":[0.66435516,0.0021591603,0.32072023,0.0009791726,0.00017950778,0.00054992543,0.0034036376,0.00024075748,0.0074124974],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9995468,0.00007506977,0.00002324165,0.00014039894,0.00016001983,0.00005438796],"domain_scores_gemma":[0.9997043,0.00008286621,0.00005791027,0.00003135935,0.00008802725,0.00003545136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008617727,0.00045869424,0.0004152091,0.0011369995,0.00024796659,0.00075888267,0.000453076,0.00073351484,0.0015173531],"category_scores_gemma":[0.000937386,0.00019726681,0.00039012008,0.00062295917,0.00027540038,0.0005260926,0.00053461286,0.000830352,0.0006352321],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006369531,0.0001993285,0.012769428,0.00035575073,0.00007869545,0.00018343049,0.00009646024,0.0119169755,0.73658293,0.0030077808,0.011958765,0.22221346],"study_design_scores_gemma":[0.000065234075,0.00054276566,0.023347208,0.000061954874,0.000046934703,0.00064743584,0.000069704656,0.36092848,0.5939586,0.003017249,0.017194515,0.00011998051],"about_ca_topic_score_codex":0.0007011136,"about_ca_topic_score_gemma":0.0005876525,"teacher_disagreement_score":0.0015173531,"about_ca_system_score_codex":0.0004756047,"about_ca_system_score_gemma":0.00032180693,"threshold_uncertainty_score":0.0050760508},"labels":[],"label_agreement":null},{"id":"W3035811149","doi":"10.1158/1557-3265.liqbiop20-a09","title":"Abstract A09: Cerebrospinal fluid (CSF) as a source of ctDNA for diagnosis and monitoring of pediatric patients with midline diffuse gliomas","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"PDGFRA; Medicine; Liquid biopsy; Digital polymerase chain reaction; Glioma; Biopsy; Pathology; Cerebrospinal fluid; Exome sequencing; DNA sequencing; KRAS; Oncology; Mutation; Internal medicine; Cancer research; Gene; Polymerase chain reaction; Biology; Cancer; Genetics","score_opus":0.19299139592350156,"score_gpt":0.47066060735530274,"score_spread":0.2776692114318012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035811149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934417,0.0015279393,0.0030232577,0.00015350814,0.000027786116,0.000106511216,0.0006773766,0.00012072882,0.0009211798],"genre_scores_gemma":[0.99279237,0.00033217084,0.0059981304,0.00008940827,0.000024685956,0.000052123145,0.0004999987,0.000017312528,0.00019369552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961996,0.00007414756,0.0000491066,0.00012143226,0.000095745556,0.00003959468],"domain_scores_gemma":[0.99924445,0.00023762225,0.00018761239,0.00004517687,0.00017077528,0.00011435444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038980113,0.00043690545,0.00033228166,0.0009708942,0.00029682688,0.0006328292,0.00034311286,0.00040865116,0.0007835078],"category_scores_gemma":[0.0014808226,0.00015626819,0.00018499259,0.0004313485,0.00034026694,0.0002910788,0.00023771483,0.00037373079,0.00029193843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021443036,0.00021072486,0.73177195,0.0003049154,0.00007280303,0.010996847,0.0005086959,0.0006298472,0.19451872,0.0001309088,0.0008007471,0.057909563],"study_design_scores_gemma":[0.00015670845,0.004442008,0.65021014,0.00016885473,0.0002318341,0.047844093,0.0009070744,0.0057133315,0.28422207,0.00020643187,0.00583407,0.00006340379],"about_ca_topic_score_codex":0.0011023785,"about_ca_topic_score_gemma":0.0010221209,"teacher_disagreement_score":0.0011023785,"about_ca_system_score_codex":0.0004099444,"about_ca_system_score_gemma":0.0004862959,"threshold_uncertainty_score":0.002974391},"labels":[],"label_agreement":null},{"id":"W3035885874","doi":"10.1158/1557-3265.liqbiop20-b02","title":"Abstract B02: Genomic and transcriptomic profiling of urine in prostate cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Prostate cancer; Biopsy; Liquid biopsy; Prostate; Oncology; Internal medicine; Cancer; Urology","score_opus":0.2969214302281731,"score_gpt":0.5315786752484376,"score_spread":0.23465724502026453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035885874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97780377,0.0011686655,0.005196125,0.00030274293,0.00004874476,0.00018747232,0.012889601,0.00028844766,0.002114453],"genre_scores_gemma":[0.9680158,0.00047394246,0.012663179,0.0003519459,0.000025038722,0.000085145,0.01564827,0.00004834189,0.0026882708],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99963117,0.000027287007,0.000015211047,0.00009602783,0.00013847539,0.000091766284],"domain_scores_gemma":[0.99951947,0.00007060074,0.00005321961,0.000023879993,0.0002434784,0.00008937189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003224697,0.00031039174,0.0003189076,0.000813798,0.00057594053,0.0006626412,0.00026018545,0.00034052672,0.0010327888],"category_scores_gemma":[0.00085455197,0.00010841656,0.00025444006,0.00087906956,0.00030837746,0.00011084727,0.0003201963,0.00035871097,0.0003125297],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014808831,0.0002580667,0.2527796,0.00029550187,0.00014555045,0.0006164438,0.0004108203,0.0023695722,0.66792035,0.00034397378,0.005559291,0.067819946],"study_design_scores_gemma":[0.000043536085,0.00090233266,0.88158286,0.000039091465,0.00012510973,0.0011904488,0.0006035735,0.011349499,0.092005044,0.00021830267,0.011879232,0.00006094827],"about_ca_topic_score_codex":0.13007057,"about_ca_topic_score_gemma":0.16048823,"teacher_disagreement_score":0.13007057,"about_ca_system_score_codex":0.0011173136,"about_ca_system_score_gemma":0.002144856,"threshold_uncertainty_score":0.25862694},"labels":[],"label_agreement":null},{"id":"W3036029166","doi":"10.1158/1557-3265.liqbiop20-a03","title":"Abstract A03: Evaluation of the Oncomine Pan-Cancer Cell-Free Assay for liquid biopsy profiling","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Liquid biopsy; Cell-free fetal DNA; Cancer; Biopsy; Cancer research; Medicine; Breast cancer; Circulating tumor cell; Pathology; Oncology; Biology; Internal medicine; Metastasis; Genetics","score_opus":0.2808353810248177,"score_gpt":0.5125716169410852,"score_spread":0.23173623591626752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036029166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97654086,0.0020558096,0.015034968,0.00015860148,0.00010056099,0.0003349991,0.0019929057,0.0003690691,0.0034121727],"genre_scores_gemma":[0.9803104,0.000236768,0.014626694,0.00015037607,0.00001870496,0.00019447811,0.0025140136,0.000043060427,0.0019055976],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998064,0.00049004244,0.00010932052,0.00049241196,0.00071365654,0.00013053018],"domain_scores_gemma":[0.99916613,0.00030220204,0.00010762877,0.00011877593,0.00021252331,0.00009276923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010728703,0.00050818536,0.00038638336,0.00074313255,0.00022641147,0.0008076872,0.00043004146,0.00053657393,0.0032384803],"category_scores_gemma":[0.0018113729,0.00016411846,0.00019312475,0.00055067876,0.00030117919,0.0002148781,0.00025351942,0.00041561932,0.00073987787],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004303595,0.0004895054,0.14392954,0.00024798472,0.00020267177,0.0006580043,0.00027129016,0.0011779908,0.78357154,0.0004042354,0.0016385429,0.06310506],"study_design_scores_gemma":[0.00020998046,0.005498344,0.2141834,0.000044961223,0.0002223995,0.005710251,0.00019192303,0.01685073,0.7449636,0.00020548218,0.011866229,0.00005285646],"about_ca_topic_score_codex":0.0009940687,"about_ca_topic_score_gemma":0.0015021991,"teacher_disagreement_score":0.0032384803,"about_ca_system_score_codex":0.00033985067,"about_ca_system_score_gemma":0.00023689556,"threshold_uncertainty_score":0.01083374},"labels":[],"label_agreement":null},{"id":"W3036225830","doi":"10.1158/1557-3265.liqbiop20-b64","title":"Abstract B64: Translating the ClarityDxProstate microflow cytometry extracellular vesicle assay to the clinic: A real-world experience in progress","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Micralyne","funders":"","keywords":"Workflow; Test (biology); Medical physics; Sample (material); Medicine; Prostate cancer; Data collection; Work flow; Medical education; Computer science; Cancer; Internal medicine; Database; Sociology; Engineering; Biology","score_opus":0.21281164757609514,"score_gpt":0.509439539924372,"score_spread":0.2966278923482768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036225830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6750488,0.0044283546,0.11141137,0.12819949,0.0066585024,0.0042291475,0.0031523528,0.0064907256,0.060381275],"genre_scores_gemma":[0.7635924,0.0032810702,0.16403815,0.03299612,0.0013709872,0.001482112,0.0037871606,0.002480561,0.026971392],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.98211724,0.008782194,0.00074472267,0.0011916142,0.0051943758,0.0019698564],"domain_scores_gemma":[0.9664973,0.009290618,0.001032025,0.0030176148,0.012846835,0.0073155826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03552391,0.0009407274,0.00052545336,0.0005562378,0.003427794,0.007223008,0.0027452663,0.0028074966,0.008129837],"category_scores_gemma":[0.035594992,0.0006193373,0.000877983,0.00074913335,0.002858258,0.0022120483,0.0035143362,0.005862736,0.004446192],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030751517,0.008483996,0.0689251,0.0009247362,0.00018888658,0.007781206,0.03198635,0.005675765,0.062114757,0.0053290767,0.21996625,0.58554876],"study_design_scores_gemma":[0.0013676576,0.02329318,0.089189425,0.0013778165,0.00027848312,0.009761526,0.060599193,0.024124173,0.121195965,0.0107723,0.6571717,0.0008686292],"about_ca_topic_score_codex":0.014935828,"about_ca_topic_score_gemma":0.013249702,"teacher_disagreement_score":0.03552391,"about_ca_system_score_codex":0.0031221167,"about_ca_system_score_gemma":0.010382408,"threshold_uncertainty_score":0.18787062},"labels":[],"label_agreement":null},{"id":"W3036323339","doi":"10.1158/1557-3265.liqbiop20-a26","title":"Abstract A26: Defining VALUE: Routine liquid biopsy in NSCLC diagnosis—a Canadian trial in progress","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre; Ottawa Hospital; Spinal Cord Injury BC; Juravinski Cancer Centre; Jewish General Hospital","funders":"","keywords":"Medicine; Cohort; Lung cancer; Oncology; Internal medicine; Genotyping; Liquid biopsy; Cancer; Clinical trial; Cohort study; Genotype; Gene","score_opus":0.15421329737390355,"score_gpt":0.4722666979571562,"score_spread":0.31805340058325265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036323339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7563428,0.06124591,0.004502129,0.064343534,0.0037241254,0.017814286,0.037837826,0.00051188836,0.053677525],"genre_scores_gemma":[0.9329271,0.012390495,0.012586367,0.012655443,0.0009299732,0.0037274377,0.0121311,0.00011495712,0.012537171],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99583167,0.0024798068,0.00015438691,0.0003619458,0.00080030016,0.00037184934],"domain_scores_gemma":[0.9909128,0.0012006344,0.0011672704,0.0003796651,0.0034786563,0.002860867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00888233,0.0009777625,0.0016309625,0.00032454476,0.0014978623,0.001830528,0.0013084505,0.001994205,0.0045038047],"category_scores_gemma":[0.0118007595,0.00028377565,0.0017386317,0.0011499915,0.0011278806,0.00060094177,0.0006214838,0.0023675663,0.00051485695],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49728492,0.0052839313,0.047260925,0.0036726245,0.0043698056,0.00029423545,0.00056258816,0.004328792,0.006076851,0.0034999757,0.13722871,0.2901367],"study_design_scores_gemma":[0.48906687,0.094544984,0.23300208,0.003597949,0.00745602,0.00035486312,0.00065974856,0.008893913,0.002317322,0.0019629977,0.15782286,0.00032048483],"about_ca_topic_score_codex":0.6859884,"about_ca_topic_score_gemma":0.78501284,"teacher_disagreement_score":0.31401157,"about_ca_system_score_codex":0.021879744,"about_ca_system_score_gemma":0.05846127,"threshold_uncertainty_score":0.6317217},"labels":[],"label_agreement":null},{"id":"W3036403360","doi":"10.1158/1557-3265.liqbiop20-a07","title":"Abstract A07: Sequential ctDNA analysis detected preclinical relapse in patients with metastatic colorectal cancer from the Exactis trial (NCT00984048)","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; Genome British Columbia","funders":"","keywords":"KRAS; Neuroblastoma RAS viral oncogene homolog; Medicine; Colorectal cancer; Internal medicine; Oncology; Cetuximab; Cancer; Clinical trial","score_opus":0.14013004500586354,"score_gpt":0.4502684330671032,"score_spread":0.3101383880612396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036403360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784923,0.002383937,0.00043505192,0.00083139236,0.00011794552,0.0004699957,0.009922282,0.00011784793,0.007229192],"genre_scores_gemma":[0.97499484,0.000517242,0.0017601891,0.0009154804,0.00014174092,0.00043123603,0.019280788,0.0000354865,0.0019230212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99934095,0.00027568013,0.000047924066,0.00016157508,0.00011043342,0.00006350821],"domain_scores_gemma":[0.9988242,0.00030600443,0.00020839188,0.00013528673,0.00018953499,0.00033660998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019249016,0.00045894354,0.0009104051,0.00022971426,0.0003425004,0.0008923937,0.00044442675,0.00052395294,0.004999186],"category_scores_gemma":[0.0025210716,0.00020117672,0.00044611335,0.00037299577,0.00038934377,0.00042012022,0.0004146091,0.0010682202,0.00078104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33480987,0.0034645011,0.33770087,0.002068624,0.0024981438,0.00055565394,0.00036602945,0.0036232516,0.048402093,0.0011654112,0.04509792,0.22024755],"study_design_scores_gemma":[0.10651369,0.09402923,0.73698753,0.00032492066,0.0029009688,0.0021906977,0.00025838907,0.00878235,0.014292379,0.0015796905,0.031975623,0.00016451086],"about_ca_topic_score_codex":0.0015018757,"about_ca_topic_score_gemma":0.0053178445,"teacher_disagreement_score":0.004999186,"about_ca_system_score_codex":0.0008096625,"about_ca_system_score_gemma":0.0008973347,"threshold_uncertainty_score":0.01672393},"labels":[],"label_agreement":null},{"id":"W3036427315","doi":"10.1158/1078-0432.ccr-20-0103","title":"Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; BC Cancer Agency; Foothills Medical Centre; Canadian Centre for Applied Research in Cancer Control; Vancouver General Hospital; Alberta Health Services; University of British Columbia","funders":"National Cancer Institute; Cancer Council Tasmania; Cancer Council Victoria; Horizon 2020 Framework Programme; Peter MacCallum Foundation; BC Cancer Foundation; University College London Hospitals NHS Foundation Trust; Medical Research and Materiel Command; Eisai; Canada Excellence Research Chairs, Government of Canada; Bundesministerium für Bildung und Forschung; Canada Research Chairs; Canadian Institutes of Health Research; Cancer Institute NSW; Cancer Australia; Mayo Clinic; Ovarian Cancer Action; Michael Smith Health Research BC; National Health and Medical Research Council; AstraZeneca; Invitae; Daiichi-Sankyo; MacroGenics; National Institute for Health and Care Research; Clovis Oncology; Cancer Research UK; University College London; Cancer Council NSW; Ovarian Cancer Australia; National Institutes of Health; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Celgene; Carrick Therapeutics; Ignyta; U.S. Department of Defense; Eli Lilly and Company; Cancer Council South Australia; Deutsches Krebsforschungszentrum; Pfizer; European Commission; Breast Cancer Research Foundation; American Oil Chemists' Society; National Center for Advancing Translational Sciences; Medical Research Council; Teva Pharmaceutical Industries; American Cancer Society","keywords":"Serous fluid; Ovarian carcinoma; Serous carcinoma; Oncology; Ovarian cancer; Serous ovarian cancer; Gene expression; Gene expression profiling; Clinical trial; Internal medicine; Gene; Medicine; Bioinformatics; Biology; Cancer; Genetics","score_opus":0.18082035205129865,"score_gpt":0.4301660530588109,"score_spread":0.24934570100751224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036427315","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9652617,0.0002010372,0.031501267,0.0001409511,0.000013306482,0.000089141926,0.0020446712,0.0001633165,0.00058451534],"genre_scores_gemma":[0.9773661,0.00005355717,0.018985083,0.000053015814,0.000009796405,0.00008710648,0.0031749404,0.000017445867,0.00025293685],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991702,0.00024456973,0.00007107455,0.00019831263,0.00024936371,0.00006638784],"domain_scores_gemma":[0.99805105,0.0009406719,0.00030197878,0.00022648809,0.00039357992,0.000086249645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002243595,0.00046504525,0.0005578559,0.0007026601,0.00025572832,0.00065969693,0.00046062676,0.00032805998,0.0007317359],"category_scores_gemma":[0.0038344355,0.00016718516,0.00050945336,0.0004497122,0.00031032873,0.00022602174,0.00053506455,0.00064792385,0.00032370703],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009101984,0.00026646664,0.8604468,0.00011800976,0.00026744374,0.00008659002,0.0000761565,0.038544767,0.039585937,0.00040574215,0.0009856276,0.05830629],"study_design_scores_gemma":[0.0001332309,0.0010984017,0.51341987,0.000057836478,0.00023647994,0.0004535663,0.00013947653,0.41686875,0.06422471,0.0013789946,0.0019494856,0.000039210892],"about_ca_topic_score_codex":0.002775486,"about_ca_topic_score_gemma":0.0036687076,"teacher_disagreement_score":0.002775486,"about_ca_system_score_codex":0.00047991233,"about_ca_system_score_gemma":0.0010336264,"threshold_uncertainty_score":0.011865377},"labels":[],"label_agreement":null},{"id":"W3036495611","doi":"10.1158/1557-3265.liqbiop20-a45","title":"Abstract A45: HPV sequencing facilitates ultrasensitive detection of HPV circulating tumor DNA","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Oncology; Internal medicine; Cervix; Minimal residual disease; Chemoradiotherapy; Cancer; Precision medicine; Adjuvant; Personalized medicine; Cervical cancer; Disease; Stage (stratigraphy); Pathology; Bioinformatics; Biology","score_opus":0.16988952353825193,"score_gpt":0.43819685596189784,"score_spread":0.2683073324236459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036495611","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8545321,0.0018866219,0.12564512,0.0005844385,0.0002624441,0.00049637136,0.009201974,0.0022299911,0.005160909],"genre_scores_gemma":[0.8933826,0.0006215996,0.09140028,0.0007981729,0.00008358357,0.00059179234,0.0079077175,0.00030831527,0.0049058776],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990024,0.0002553882,0.000060459668,0.00039252025,0.00022521967,0.000064058506],"domain_scores_gemma":[0.99925154,0.00025655518,0.0001173545,0.0001120063,0.00020266252,0.000059907554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011818329,0.0005302638,0.000409644,0.00035286843,0.00027314006,0.0008297106,0.00045504796,0.0005991297,0.0055258726],"category_scores_gemma":[0.0014827254,0.00037204102,0.0004422564,0.00025846585,0.0003989116,0.00040365444,0.0004401128,0.0006218911,0.00171779],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042086202,0.00009869492,0.0054924036,0.00013097866,0.000041780015,0.00002343128,0.00006705148,0.00088959973,0.97734135,0.0001847666,0.00093835086,0.014370712],"study_design_scores_gemma":[0.00007246777,0.0011946178,0.015811158,0.00003261261,0.00011684306,0.000316685,0.000055449895,0.020836512,0.950687,0.00041843066,0.01042,0.000038330418],"about_ca_topic_score_codex":0.0008877631,"about_ca_topic_score_gemma":0.0012955329,"teacher_disagreement_score":0.0055258726,"about_ca_system_score_codex":0.00039699525,"about_ca_system_score_gemma":0.0003854695,"threshold_uncertainty_score":0.018485963},"labels":[],"label_agreement":null},{"id":"W3036558735","doi":"10.1158/1557-3265.liqbiop20-pr13","title":"Abstract PR13: Comprehensive detection of ctDNA in localized head and neck cancer by genome- and methylome-based analysis","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"DNA methylation; Head and neck squamous-cell carcinoma; Differentially methylated regions; CpG site; Methylation; Biology; Cancer research; Oncology; Deep sequencing; Methylated DNA immunoprecipitation; Cancer; Bisulfite sequencing; Head and neck cancer; Internal medicine; Medicine; Gene; Genome; Genetics; Gene expression","score_opus":0.11981526546952159,"score_gpt":0.4595226261646075,"score_spread":0.3397073606950859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036558735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93389064,0.0027822608,0.041104056,0.00022567467,0.00005161822,0.00022165169,0.018151283,0.0015825278,0.0019903842],"genre_scores_gemma":[0.9477923,0.000584276,0.037600346,0.0002791444,0.000029862309,0.00020631557,0.011246222,0.00012144164,0.0021401928],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99955887,0.000050867104,0.000024515406,0.00020215184,0.00012848964,0.000035063655],"domain_scores_gemma":[0.99973506,0.000052681167,0.00005682904,0.000037771486,0.00008258205,0.000035059136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005125287,0.00045385168,0.00038011002,0.0008021918,0.00022178741,0.00037463682,0.0004038862,0.00039594623,0.00181949],"category_scores_gemma":[0.0006484396,0.00022963891,0.0003622318,0.0004884134,0.0002290055,0.00019346277,0.0005351347,0.00042930772,0.0006307299],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058405945,0.000047904272,0.07327606,0.0002423949,0.00017269277,0.00019080853,0.000068083296,0.0016144911,0.89015955,0.00012601406,0.0016839957,0.031834014],"study_design_scores_gemma":[0.00007561086,0.0006867961,0.29370776,0.00004482171,0.00023274818,0.0026259816,0.00009816503,0.023927346,0.6697417,0.00042716367,0.008375695,0.00005618959],"about_ca_topic_score_codex":0.0020225546,"about_ca_topic_score_gemma":0.0034113328,"teacher_disagreement_score":0.0020225546,"about_ca_system_score_codex":0.0003032861,"about_ca_system_score_gemma":0.0003562684,"threshold_uncertainty_score":0.0060868263},"labels":[],"label_agreement":null},{"id":"W3036571224","doi":"10.1158/1557-3265.liqbiop20-ia11","title":"Abstract IA11: Clinical applications of liquid biopsy in multiple myeloma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Liquid biopsy; Genetic heterogeneity; Exome sequencing; Biopsy; Somatic evolution in cancer; Circulating tumor cell; Biology; Multiple myeloma; Tumour heterogeneity; Exome; Pathology; Medicine; Cancer; Gene; Genetics; Mutation; Immunology; Metastasis; Phenotype","score_opus":0.39895135993122754,"score_gpt":0.5661026930599158,"score_spread":0.16715133312868824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036571224","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53720397,0.20036748,0.13769607,0.015678145,0.0037458732,0.0022453365,0.005433225,0.009433726,0.08819606],"genre_scores_gemma":[0.8951149,0.016081296,0.07159287,0.004094259,0.0014053059,0.00059252715,0.0021216199,0.0005231642,0.00847402],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991411,0.0003335934,0.000053926033,0.00013802038,0.00025754044,0.00007583252],"domain_scores_gemma":[0.99850935,0.00039630037,0.00020039445,0.000109141954,0.00050270115,0.00028207075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002810324,0.0008359577,0.00072026014,0.0014861362,0.0005423279,0.002450375,0.0008215933,0.0012776953,0.007053118],"category_scores_gemma":[0.002850026,0.00035686532,0.0004011352,0.0011287691,0.00046593935,0.0009190067,0.0009117024,0.0012829192,0.003987145],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006335698,0.00048536892,0.15610425,0.0014037438,0.00022654369,0.0078079836,0.00038351887,0.0026854626,0.09673827,0.0015573053,0.02299812,0.7032737],"study_design_scores_gemma":[0.001109311,0.009656262,0.43395787,0.0038759715,0.00074650906,0.069068864,0.0021080384,0.08073444,0.14367461,0.005968181,0.24866961,0.00043032394],"about_ca_topic_score_codex":0.00285128,"about_ca_topic_score_gemma":0.0020245817,"teacher_disagreement_score":0.007053118,"about_ca_system_score_codex":0.0009411115,"about_ca_system_score_gemma":0.0007308582,"threshold_uncertainty_score":0.023594975},"labels":[],"label_agreement":null},{"id":"W3036616154","doi":"10.1158/1557-3265.liqbiop20-a24","title":"Abstract A24: Identifying the genomic and clinical features of AKT1/PIK3CA mutant metastatic prostate cancer using circulating tumor DNA","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Hôpital Saint-Luc; Juravinski Cancer Centre; Spinal Cord Injury BC","funders":"","keywords":"Prostate cancer; AKT1; PTEN; Cancer research; Medicine; Population; Androgen receptor; Oncology; PI3K/AKT/mTOR pathway; Internal medicine; Biology; Genetics; Cancer; Signal transduction","score_opus":0.25000678003527,"score_gpt":0.5076130006979055,"score_spread":0.2576062206626355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036616154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99327856,0.0004482194,0.002089703,0.00007311978,0.0000125445395,0.00005185152,0.0029457863,0.000081458136,0.001018675],"genre_scores_gemma":[0.9944699,0.0001104696,0.0024287524,0.000048546655,0.000014014583,0.00003007786,0.0023541746,0.000015732516,0.00052838685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979514,0.000020359272,0.00001983919,0.00008756868,0.000040040664,0.000037089983],"domain_scores_gemma":[0.99964297,0.000094520336,0.0000776679,0.000029446366,0.000062948326,0.00009246648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002878812,0.00024311601,0.00023412333,0.0011432999,0.00024359675,0.00050820084,0.00028391153,0.0002882825,0.0030298133],"category_scores_gemma":[0.0009411451,0.00015624732,0.00014608543,0.0007078976,0.00022825671,0.00014269218,0.00035655758,0.0003378847,0.0005702986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015033584,0.000121538644,0.76526314,0.00025064216,0.00013491839,0.0018190568,0.00035293595,0.0009958606,0.1728792,0.0003197437,0.0023951947,0.053964406],"study_design_scores_gemma":[0.00015532777,0.00096747593,0.8877421,0.00006620805,0.000207889,0.015829546,0.00039264755,0.0077768215,0.07546454,0.0008322672,0.010533389,0.00003177524],"about_ca_topic_score_codex":0.0013764113,"about_ca_topic_score_gemma":0.0019087582,"teacher_disagreement_score":0.0030298133,"about_ca_system_score_codex":0.00027202128,"about_ca_system_score_gemma":0.00026350148,"threshold_uncertainty_score":0.01013577},"labels":[],"label_agreement":null},{"id":"W3036626624","doi":"10.1158/1557-3265.liqbiop20-pr09","title":"Abstract PR09: Frequency and etiology of ctDNA-positive metastatic prostate cancer with BRCA2, ATM, or CDK12 mutations","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"PTEN; Cancer research; Prostate cancer; Mutation; Cancer; CDKN2A; Germline mutation; Biology; DNA repair; Germline; DNA damage; Somatic cell; Gene; Medicine; Genetics; DNA; PI3K/AKT/mTOR pathway; Signal transduction","score_opus":0.3145723633926266,"score_gpt":0.5531282130071178,"score_spread":0.23855584961449117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036626624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99812347,0.00035677725,0.00015036597,0.000049505346,0.0000061115697,0.000007872101,0.0004055501,0.000017435932,0.0008830052],"genre_scores_gemma":[0.9995852,0.000053021733,0.000055367775,0.000010253139,0.000008838354,0.0000027339788,0.00017223874,0.000003762675,0.00010855816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996369,0.00005876191,0.00003609798,0.00013005259,0.00008272537,0.00005544139],"domain_scores_gemma":[0.99916625,0.00015941249,0.00035174115,0.000044614106,0.00006667672,0.00021133391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017386265,0.00028340417,0.00023315208,0.001412536,0.00035595795,0.0003553158,0.00063082186,0.0005336499,0.0060002785],"category_scores_gemma":[0.0015706081,0.00019725121,0.00023288635,0.0008605041,0.0003496252,0.00025944973,0.00041118098,0.00043894656,0.00080472784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013372579,0.000021690787,0.99462974,0.00001231097,0.000020550018,0.0010880424,0.00002896376,0.00003945865,0.0019121362,0.000026783575,0.00017356724,0.0019130463],"study_design_scores_gemma":[0.0000059529225,0.000116403105,0.9842387,0.000004309251,0.000023210923,0.014423011,0.00010551566,0.00025906335,0.0005227274,0.000034290893,0.0002619802,0.0000049080454],"about_ca_topic_score_codex":0.0018631838,"about_ca_topic_score_gemma":0.0010136632,"teacher_disagreement_score":0.0060002785,"about_ca_system_score_codex":0.00015594516,"about_ca_system_score_gemma":0.00017345248,"threshold_uncertainty_score":0.020072937},"labels":[],"label_agreement":null},{"id":"W3036776981","doi":"10.1158/1557-3265.liqbiop20-a18","title":"Abstract A18: Plasma circulating tumor DNA is scarce and confounded by clonal hematopoiesis in metastatic renal cell carcinoma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Renal cell carcinoma; Medicine; Oncology; BAP1; Concordance; Internal medicine; Cancer; Liquid biopsy; Somatic cell; Cell-free fetal DNA; Carcinoma; Cancer research; Gene; Biology; Genetics","score_opus":0.12766778935219425,"score_gpt":0.41968372821671307,"score_spread":0.2920159388645188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036776981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99681264,0.001211885,0.0007786506,0.00007107286,0.000010615168,0.000007119438,0.00022318438,0.000022370976,0.00086244475],"genre_scores_gemma":[0.9993285,0.000078934565,0.0003288768,0.000030352137,0.0000098023365,0.0000031548393,0.00009744368,0.000005115626,0.00011784109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99959344,0.00008670763,0.000047478254,0.000107729444,0.00012412136,0.00004057182],"domain_scores_gemma":[0.9986853,0.00060243526,0.00034614254,0.000075197444,0.00018971515,0.00010119259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006280964,0.00016724704,0.00031871372,0.0009102195,0.00027400025,0.00059433206,0.00023334846,0.0002923261,0.0026156998],"category_scores_gemma":[0.002491022,0.00011961671,0.00008523182,0.00058027916,0.0004006613,0.00025525258,0.00027149142,0.0002464856,0.00036437914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008173277,0.00002833099,0.892036,0.00012334043,0.00005911717,0.001262269,0.00021945388,0.00027892302,0.08891963,0.00015821178,0.00039471645,0.01570264],"study_design_scores_gemma":[0.000015418529,0.00033652975,0.9565413,0.00002526967,0.000061915685,0.0074740294,0.00026039252,0.0014994732,0.031873863,0.00024070409,0.001663845,0.0000073123733],"about_ca_topic_score_codex":0.0010487355,"about_ca_topic_score_gemma":0.0009439465,"teacher_disagreement_score":0.0026156998,"about_ca_system_score_codex":0.00025544298,"about_ca_system_score_gemma":0.00017359412,"threshold_uncertainty_score":0.008750379},"labels":[],"label_agreement":null},{"id":"W3036855997","doi":"10.1158/1078-0432.ccr-20-1024","title":"Population-based Screening for <i>BRAF</i> V600E in Metastatic Colorectal Cancer Reveals Increased Prevalence and Poor Prognosis","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Vancouver Coastal Health","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Internal medicine; Colorectal cancer; Cohort; Oncology; Population; Cancer","score_opus":0.2893940405667775,"score_gpt":0.5203612844790028,"score_spread":0.23096724391222528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036855997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996313,0.000062923646,0.000053446165,0.000021696196,0.0000024066526,0.0000028924069,0.000077718854,0.0000029601088,0.00014469658],"genre_scores_gemma":[0.9998449,0.000020370928,0.000019900817,0.000010067582,0.000004636026,0.0000013765891,0.00007547404,6.415216e-7,0.000022702081],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936205,0.00017202974,0.00004735802,0.00023702056,0.000103428974,0.00007814111],"domain_scores_gemma":[0.99825233,0.0002812019,0.00088103133,0.00020090117,0.00017792612,0.00020652215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093281514,0.00017960281,0.0002689704,0.00062162295,0.00030806803,0.00054432714,0.00033009858,0.0003703248,0.0012691347],"category_scores_gemma":[0.0026893779,0.00020374551,0.00034028932,0.00050582696,0.00042322965,0.0003773198,0.0003949834,0.00046177508,0.00019480496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009147619,0.000015590487,0.9987896,0.0000033319595,0.000037100523,0.00003982169,0.00001624314,0.000028788294,0.0003153063,0.000005199568,0.00004040908,0.0006173018],"study_design_scores_gemma":[0.0000075942817,0.000123139,0.9990159,0.0000026147002,0.00003835121,0.00028811753,0.000081396814,0.0001864283,0.0001712468,0.0000185601,0.00006420328,0.0000023935559],"about_ca_topic_score_codex":0.003157626,"about_ca_topic_score_gemma":0.0043741968,"teacher_disagreement_score":0.003157626,"about_ca_system_score_codex":0.00029477663,"about_ca_system_score_gemma":0.00022554254,"threshold_uncertainty_score":0.0062784553},"labels":[],"label_agreement":null},{"id":"W3037199155","doi":"10.1158/1078-0432.ccr-20-1376","title":"Measurement Tool of Chemotherapy Sensitivity in Advanced Ovarian Cancer","year":2020,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ovarian cancer; Chemotherapy; Medicine; Cancer; Oncology; Sensitivity (control systems); Internal medicine; Gynecology; Engineering","score_opus":0.29676594274671286,"score_gpt":0.5097095074310191,"score_spread":0.2129435646843062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037199155","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08590108,0.031736862,0.013973216,0.79967374,0.014509054,0.00025779312,0.0013863211,0.0005564464,0.05200553],"genre_scores_gemma":[0.78160495,0.0074895546,0.008183524,0.17484209,0.014469657,0.00034713603,0.00044018446,0.00007153937,0.012551408],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.998207,0.0011119506,0.00015020098,0.00011770614,0.00033759722,0.000075654905],"domain_scores_gemma":[0.994155,0.0040650344,0.00043217035,0.00028664566,0.0008973713,0.00016373312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018061531,0.0002627346,0.0005476353,0.0005404552,0.00030881053,0.000718537,0.000373288,0.0018427015,0.0015124925],"category_scores_gemma":[0.013916932,0.00014680876,0.00017737216,0.000483563,0.0005456918,0.00038893163,0.00026138886,0.0026536956,0.0011962907],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001221245,0.00019489336,0.17067209,0.0003699846,0.000093025206,0.009117875,0.00050538237,0.00093794434,0.0039902534,0.0063306657,0.5156612,0.2909055],"study_design_scores_gemma":[0.0005372044,0.0023348895,0.1766342,0.0016449854,0.00016981346,0.066931084,0.0018917433,0.023270516,0.012561692,0.03775183,0.67608625,0.00018570776],"about_ca_topic_score_codex":0.0013391988,"about_ca_topic_score_gemma":0.0014659594,"teacher_disagreement_score":0.0018427015,"about_ca_system_score_codex":0.0010786606,"about_ca_system_score_gemma":0.00033124612,"threshold_uncertainty_score":0.009552002},"labels":[],"label_agreement":null},{"id":"W3037825755","doi":"10.1158/1557-3265.ovcasymp18-nt-111","title":"Abstract NT-111: THE ANTIPROGESTIN/ANTIGLUCOCORTICOID MIFEPRISTONE AND THE HIV PROTEASE INHIBITOR NELFINAVIR CAUSE ENDOPLASMIC RETICULUM STRESS AND POTENTIATE THE TOXICITY OF PROTEASOME INHIBITION IN HIGH-GRADE SEROUS EPITHELIAL OVARIAN CANCER CELLS","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Unfolded protein response; Nelfinavir; Medicine; Proteasome inhibitor; Antiglucocorticoid; Internal medicine; Mifepristone; Cancer research; Pharmacology; Endoplasmic reticulum; Immunology; Biology; Glucocorticoid receptor; Multiple myeloma; Viral load; Glucocorticoid; Cell biology","score_opus":0.03140910232338638,"score_gpt":0.35399222389871887,"score_spread":0.3225831215753325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037825755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98704785,0.0065046377,0.0008491466,0.00044854914,0.00029339845,0.0000610833,0.0009050306,0.0000934771,0.0037967514],"genre_scores_gemma":[0.9927738,0.0014585487,0.0008180827,0.00016044486,0.00003181361,0.000048542865,0.0011916107,0.000006754479,0.003510466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998816,0.000020831001,0.00001707492,0.000021403519,0.000034404602,0.000024621066],"domain_scores_gemma":[0.999946,0.000010103535,0.000009133357,0.0000073175984,0.000008208024,0.000019228146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010346703,0.000268586,0.00035226965,0.00013096447,0.00016836917,0.00027996823,0.00020412664,0.00030138055,0.0019207735],"category_scores_gemma":[0.000100590565,0.000087270346,0.0002788151,0.00013559111,0.00015380302,0.00017915075,0.00016648602,0.0006376958,0.00044645494],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016931456,0.00054575456,0.0013088076,0.00029352828,0.0000423353,0.0004918858,0.00004354088,0.00025714282,0.9823261,0.0002252999,0.0014170783,0.011355237],"study_design_scores_gemma":[0.00019947597,0.0031132693,0.013425994,0.00002617818,0.000060835333,0.0013482006,0.00008106981,0.0016854011,0.96778274,0.000080372745,0.01218452,0.000011993786],"about_ca_topic_score_codex":0.0007539238,"about_ca_topic_score_gemma":0.0010058001,"teacher_disagreement_score":0.0019207735,"about_ca_system_score_codex":0.00018619755,"about_ca_system_score_gemma":0.00028804239,"threshold_uncertainty_score":0.0064255595},"labels":[],"label_agreement":null},{"id":"W3038401324","doi":"10.1158/1078-0432.ccr-20-2224","title":"COVID-19 Testing in Patients with Cancer: Does One Size Fit All?","year":2020,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Cancer; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Medicine; Virology; Internal medicine; Disease; Outbreak; Infectious disease (medical specialty)","score_opus":0.7817379536491433,"score_gpt":0.6893391093756028,"score_spread":0.0923988442735405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038401324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000057952875,0.99818206,0.000025807187,0.0013131762,0.00010120297,0.000004272327,0.000021254787,0.0000015783825,0.00029273887],"genre_scores_gemma":[0.0010008184,0.9980868,0.00009356112,0.00061352504,0.00010987238,0.0000069038288,0.000023650791,9.3844835e-7,0.00006398008],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998988,0.00036664502,0.00020350218,0.00010588226,0.00026764962,0.00006836481],"domain_scores_gemma":[0.9957048,0.0030022762,0.00042342738,0.00005820847,0.0006745603,0.00013668879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00256518,0.00049710996,0.0019671698,0.001996633,0.00031796074,0.0015901423,0.0012423984,0.001507216,0.0035846909],"category_scores_gemma":[0.009364335,0.00031271746,0.0014561801,0.0024571246,0.0006531454,0.0018255833,0.00076827244,0.0018243949,0.00064673374],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016544749,0.000030036183,0.0010292829,0.077447794,0.0006125453,0.00014300412,0.00017144068,0.00020390701,0.00017071646,0.0030108402,0.0324762,0.88453865],"study_design_scores_gemma":[0.00012141951,0.0002743288,0.005150955,0.23634031,0.0025223547,0.00146834,0.0006500246,0.0001603245,0.00021580132,0.0038339533,0.7492085,0.00005373482],"about_ca_topic_score_codex":0.010199523,"about_ca_topic_score_gemma":0.022813067,"teacher_disagreement_score":0.010199523,"about_ca_system_score_codex":0.0013510913,"about_ca_system_score_gemma":0.0052330177,"threshold_uncertainty_score":0.020280302},"labels":[],"label_agreement":null},{"id":"W3038487399","doi":"10.1158/1078-0432.ccr-20-0219","title":"A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive <i>TP53</i> -mutant Ovarian Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Centre Hospitalier de l’Université de Montréal; Princess Margaret Cancer Centre","funders":"Merck; AstraZeneca","keywords":"Carboplatin; Medicine; Tolerability; Internal medicine; Chemotherapy; Oncology; Adverse effect; Ovarian cancer; Response Evaluation Criteria in Solid Tumors; Gastroenterology; Placebo; Clinical endpoint; Hazard ratio; Pemetrexed; Cancer; Progression-free survival; Randomized controlled trial; Surgery; Phases of clinical research; Confidence interval; Cisplatin; Pathology","score_opus":0.20556782163680917,"score_gpt":0.4904681500289786,"score_spread":0.2849003283921694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038487399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98986924,0.0021534804,0.00036306935,0.00056885864,0.00030941362,0.004266289,0.000996545,0.000057148925,0.0014159842],"genre_scores_gemma":[0.9871114,0.0012005029,0.0014605841,0.0013172834,0.00030460538,0.0045469142,0.0017296954,0.000012846804,0.0023162097],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99953747,0.00026122888,0.000027440445,0.00008366066,0.000032291486,0.000058005447],"domain_scores_gemma":[0.9994881,0.000103935155,0.00011375486,0.000035639336,0.00003594641,0.00022253755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012296594,0.0013182336,0.0019120834,0.00035799938,0.00040953682,0.00080487895,0.0006414717,0.0012452044,0.00441677],"category_scores_gemma":[0.0010112624,0.0006049901,0.00107719,0.00038070476,0.0007902695,0.00066592824,0.00032501415,0.001855142,0.0007917635],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.969234,0.009146723,0.0014321657,0.00026660835,0.00062524836,0.00003415559,0.000038489605,0.0003050049,0.0046368456,0.00008217273,0.00069890666,0.013499777],"study_design_scores_gemma":[0.92172813,0.07429216,0.002300483,0.000011930657,0.0002346375,0.000029549277,0.000013663637,0.0002691397,0.00043206988,0.000093458555,0.0005864724,0.000008412665],"about_ca_topic_score_codex":0.00079037383,"about_ca_topic_score_gemma":0.0023028771,"teacher_disagreement_score":0.00441677,"about_ca_system_score_codex":0.00079694827,"about_ca_system_score_gemma":0.0015998924,"threshold_uncertainty_score":0.014775574},"labels":[],"label_agreement":null},{"id":"W3038927235","doi":"10.1158/1557-3265.ovca19-b67","title":"Abstract B67: Analysis of function and inhibition of PGE2 pathway members MRP4 and EP4 in treatment of ovarian cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ovarian cancer; Autocrine signalling; Cancer research; Cancer; Paracrine signalling; Tissue microarray; Medicine; Prostaglandin E2 receptor; Tumor progression; Biology; Internal medicine; Receptor","score_opus":0.1835258073397451,"score_gpt":0.47528489579623057,"score_spread":0.29175908845648546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038927235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887707,0.0059806905,0.0010612903,0.0003839214,0.00018382406,0.00017759399,0.000477152,0.00006653832,0.0028982272],"genre_scores_gemma":[0.9885223,0.0035578078,0.0014521114,0.00022474265,0.000046485828,0.0001345715,0.00091635896,0.000014795378,0.005130946],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999305,0.000012569565,0.0000068578624,0.000007579142,0.000020648824,0.000021788464],"domain_scores_gemma":[0.99995685,0.0000074215313,0.0000068032846,0.000004727478,0.000008450208,0.000015752985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012455035,0.00020871407,0.0003112511,0.00029830323,0.000113144684,0.00021474315,0.00016765115,0.00022159844,0.0027477527],"category_scores_gemma":[0.00011278748,0.00010154498,0.00028708007,0.00018060586,0.00013261611,0.00013502933,0.000117256306,0.0006631643,0.00039715515],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040131793,0.0010900185,0.0007194983,0.00040671165,0.00006551198,0.00022359892,0.000036195128,0.00033288973,0.9594969,0.0003337738,0.0010297702,0.03225186],"study_design_scores_gemma":[0.001784974,0.026700532,0.014983844,0.000043171865,0.0002318542,0.00082108565,0.00013220825,0.0018053699,0.93074447,0.00017336203,0.02256175,0.000017342345],"about_ca_topic_score_codex":0.00045903958,"about_ca_topic_score_gemma":0.0006438436,"teacher_disagreement_score":0.0027477527,"about_ca_system_score_codex":0.00013854733,"about_ca_system_score_gemma":0.00026769636,"threshold_uncertainty_score":0.009192109},"labels":[],"label_agreement":null},{"id":"W3039237605","doi":"10.1158/1078-0432.ccr-19-2717","title":"Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor Homoharringtonine","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health; American Cancer Society","keywords":"Homoharringtonine; Cancer research; Cell culture; In vivo; Cancer; Biology; Medicine; Pathology; Myeloid leukemia; Internal medicine; Genetics","score_opus":0.1933720482402241,"score_gpt":0.46582339799895034,"score_spread":0.2724513497587262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039237605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957747,0.0011498606,0.0012803269,0.000053359065,0.000009690846,0.00004671572,0.00052391575,0.000073317584,0.0010881835],"genre_scores_gemma":[0.99675614,0.0005574802,0.0009618587,0.00003157289,0.0000015982937,0.00002750894,0.0005713558,0.000014798903,0.0010778204],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985075,0.00001767027,0.000013996423,0.000035111912,0.000059197562,0.000023267416],"domain_scores_gemma":[0.99985206,0.0000347925,0.000054507807,0.000017684253,0.000021907055,0.00001908986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011171943,0.00030678924,0.0003165356,0.00018223119,0.00013723878,0.00025240227,0.0001324479,0.00020431571,0.0012710927],"category_scores_gemma":[0.00014369548,0.000117555894,0.00020505577,0.0001593995,0.0001499333,0.00012333482,0.0001253864,0.00037363582,0.00033502866],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008717292,0.000020399602,0.00054833473,0.000027418802,0.0000074161244,0.000059671354,0.000009909279,0.00013449522,0.9977847,0.00001815635,0.00004566204,0.001256797],"study_design_scores_gemma":[0.000010313403,0.00029887608,0.0053817607,0.0000028274333,0.00001303075,0.00035011384,0.000020660224,0.00034120696,0.9928133,0.000009915995,0.00075517676,0.0000027871201],"about_ca_topic_score_codex":0.0011382045,"about_ca_topic_score_gemma":0.0019082413,"teacher_disagreement_score":0.0012710927,"about_ca_system_score_codex":0.0003959472,"about_ca_system_score_gemma":0.0001868082,"threshold_uncertainty_score":0.004252255},"labels":[],"label_agreement":null},{"id":"W3039765753","doi":"10.1158/1557-3265.ovca19-a74","title":"Abstract A74: The HIV protease inhibitor nelfinavir, alone or in combination with the proteasome inhibitor bortezomib, is cytotoxic to high-grade serous ovarian cancer cells regardless of platinum sensitivity","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Bortezomib; Unfolded protein response; Nelfinavir; Proteasome inhibitor; Proteasome; Cancer research; Medicine; Pharmacology; Ovarian cancer; Cancer; Multiple myeloma; Immunology; Endoplasmic reticulum; Biology; Internal medicine; Cell biology","score_opus":0.11290561721237395,"score_gpt":0.40891170304770197,"score_spread":0.296006085835328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039765753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99197245,0.0044462457,0.00047685785,0.00009597339,0.000094455725,0.0000470833,0.00052346074,0.00006734192,0.0022761745],"genre_scores_gemma":[0.9952278,0.0011812734,0.0007358061,0.000037307014,0.000016874868,0.000030224073,0.0007418278,0.000006478648,0.002022396],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988675,0.00002232728,0.000014920866,0.000019607609,0.000030284407,0.00002613574],"domain_scores_gemma":[0.9999454,0.000011255746,0.000009499646,0.00000749114,0.0000080002055,0.000018292894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008624654,0.0002853631,0.0003031384,0.00020003959,0.00016893828,0.00020548381,0.00018323777,0.0002511904,0.0025300065],"category_scores_gemma":[0.0000961135,0.00008232058,0.00021817964,0.00022524812,0.00012452221,0.00014976384,0.00012064308,0.00036738164,0.00032292103],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012200117,0.0003175834,0.0007088518,0.0001386595,0.000026121766,0.00010322643,0.000021919,0.0001585657,0.9887489,0.000095759904,0.00038057382,0.008079727],"study_design_scores_gemma":[0.00014806859,0.0035325866,0.0060920496,0.000011904947,0.00003903761,0.00043012714,0.00002543074,0.00064390415,0.9846015,0.000034891287,0.0044352678,0.0000051642332],"about_ca_topic_score_codex":0.00066990854,"about_ca_topic_score_gemma":0.0010615779,"teacher_disagreement_score":0.0025300065,"about_ca_system_score_codex":0.00017801227,"about_ca_system_score_gemma":0.00022772783,"threshold_uncertainty_score":0.00846374},"labels":[],"label_agreement":null},{"id":"W3040096066","doi":"10.1158/1078-0432.ccr-19-3884","title":"Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular Carcinoma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; Cancer Research UK; Exelixis","keywords":"Cabozantinib; Medicine; Placebo; Hepatocellular carcinoma; Internal medicine; Gastroenterology; Confidence interval; Alpha-fetoprotein; Oncology; Cancer; Pathology","score_opus":0.36167135628376856,"score_gpt":0.4810952114332623,"score_spread":0.11942385514949372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040096066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98317033,0.014983679,0.00020826935,0.000449367,0.00015304478,0.000249635,0.00018446628,0.000029770097,0.00057133305],"genre_scores_gemma":[0.99638665,0.0022745468,0.00023767095,0.00028369983,0.00020953375,0.00016187096,0.0001827185,0.0000043351893,0.0002590191],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991035,0.00061265915,0.00005935675,0.00006740148,0.00008883133,0.00006820138],"domain_scores_gemma":[0.99855834,0.00043698598,0.00051848777,0.000075097734,0.00010620638,0.00030491545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028463115,0.00083409256,0.0021328381,0.00032452124,0.000300159,0.00095093425,0.00039337846,0.00085397775,0.0010727124],"category_scores_gemma":[0.0028122785,0.00034738056,0.0014235121,0.00039749226,0.00061655714,0.00041572753,0.00026300325,0.0014929197,0.00020618014],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9371958,0.0047076824,0.017471131,0.00073915784,0.0033158255,0.00007589279,0.00007686447,0.00053991855,0.0040806336,0.00005761112,0.00057779485,0.031161753],"study_design_scores_gemma":[0.6213413,0.22423404,0.14207418,0.00015440826,0.005224063,0.00027220574,0.000091466245,0.0024569503,0.00198516,0.00028738444,0.0018346476,0.000044288776],"about_ca_topic_score_codex":0.0008174197,"about_ca_topic_score_gemma":0.0012492137,"teacher_disagreement_score":0.0028463115,"about_ca_system_score_codex":0.00067529007,"about_ca_system_score_gemma":0.0007998343,"threshold_uncertainty_score":0.015052915},"labels":[],"label_agreement":null},{"id":"W3040374725","doi":"10.1158/1557-3265.ovca19-a56","title":"Abstract A56: Novel L-sugar linked glycosylated antitumor ether lipids for killing platinum-resistant human epithelial ovarian cancer cells","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Cancer research; Serous fluid; Ovarian cancer; Apoptosis; Cell culture; In vivo; Cancer cell; Cell; Chemistry; Medicine; Cancer; Biology; Internal medicine; Biochemistry","score_opus":0.20815642011168242,"score_gpt":0.48736925114549595,"score_spread":0.27921283103381356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040374725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98687124,0.004426683,0.0037663241,0.00013294247,0.000058134672,0.00017179704,0.0007713836,0.00011040716,0.0036911438],"genre_scores_gemma":[0.98855805,0.0022385523,0.0049411324,0.00010110351,0.000012025162,0.000072399656,0.00065357663,0.000017528271,0.0034056166],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999664,0.0000065379463,0.0000039521187,0.000007359592,0.0000077459645,0.000008031847],"domain_scores_gemma":[0.9999697,0.0000029009786,0.000006840528,0.0000039720603,0.000005815133,0.000010735573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006323643,0.00028447536,0.00018134304,0.00022554555,0.000081014594,0.00015367944,0.00018539166,0.00023216628,0.0010027116],"category_scores_gemma":[0.00007561528,0.000071834846,0.000236055,0.00018690637,0.00008925251,0.00013492971,0.00019300381,0.00029727348,0.00033534886],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029894986,0.0001007076,0.000182747,0.00012446323,0.000013196124,0.00011351966,0.000020599351,0.00036806037,0.9875825,0.00014613445,0.00018186327,0.010867224],"study_design_scores_gemma":[0.0001695425,0.0025107074,0.0021934123,0.000025341275,0.000044496708,0.00043331407,0.000026788908,0.000953126,0.98237544,0.000053901178,0.011200915,0.000013060105],"about_ca_topic_score_codex":0.00036458138,"about_ca_topic_score_gemma":0.00054378057,"teacher_disagreement_score":0.0010027116,"about_ca_system_score_codex":0.00012450796,"about_ca_system_score_gemma":0.00012045766,"threshold_uncertainty_score":0.0033543706},"labels":[],"label_agreement":null},{"id":"W3041199890","doi":"10.1158/1557-3265.ovcasymp18-nt-117","title":"Abstract NT-117: INHIBITION OF PARG, SENSITIZES OVARIAN CANCER CELLS TO PARP INHIBITORS AND DNA DAMAGING AGENTS","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Poly ADP ribose polymerase; Synthetic lethality; DNA repair; Cancer research; Biology; Molecular biology; PARP inhibitor; Cisplatin; DNA damage; Blot; Ovarian cancer; Cell culture; Cancer; Chemistry; DNA; Polymerase; Biochemistry; Genetics; Gene; Chemotherapy","score_opus":0.18412665830304098,"score_gpt":0.5119869042786367,"score_spread":0.3278602459755957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041199890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98382205,0.0058218157,0.0018862647,0.000384884,0.00019712244,0.00015097653,0.0030234784,0.00035178498,0.004361607],"genre_scores_gemma":[0.9842355,0.002703281,0.0024304702,0.00019477696,0.000027008327,0.0001679675,0.0059430394,0.000039585382,0.004258325],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998927,0.000014083052,0.00001583628,0.000020664966,0.0000317384,0.000025010786],"domain_scores_gemma":[0.9999443,0.000008759691,0.000009556172,0.000009692877,0.000008969781,0.00001870023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007220055,0.00031825795,0.00040860873,0.0002394934,0.00012807021,0.0002445518,0.00028577802,0.00027689373,0.0028294579],"category_scores_gemma":[0.00009338758,0.000104660285,0.00023986312,0.0002771996,0.0001699283,0.00016360411,0.00014725768,0.0006673771,0.00068842527],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000928497,0.00029937396,0.00038658883,0.00025732667,0.000031594343,0.00017941507,0.000026011361,0.00022136516,0.9895392,0.0001050051,0.0011936512,0.006831952],"study_design_scores_gemma":[0.00017104499,0.0018906394,0.005111671,0.000013324788,0.000050646267,0.00070101855,0.00003436123,0.0007762854,0.98167074,0.000035711324,0.009537261,0.0000072159596],"about_ca_topic_score_codex":0.00080779684,"about_ca_topic_score_gemma":0.00096719654,"teacher_disagreement_score":0.0028294579,"about_ca_system_score_codex":0.00021513805,"about_ca_system_score_gemma":0.00024473865,"threshold_uncertainty_score":0.009465516},"labels":[],"label_agreement":null},{"id":"W3042708039","doi":"10.1158/1078-0432.ccr-20-1695","title":"Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":365,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"National Institute of Dental and Craniofacial Research; National Cancer Institute; National Human Genome Research Institute; National Institutes of Health","keywords":"Medicine; Head and neck cancer; Pembrolizumab; Adjuvant; Oncology; Head and neck; Human papillomavirus; Clinical trial; Cancer; Phases of clinical research; Internal medicine; Surgery; Immunotherapy","score_opus":0.26414410117852,"score_gpt":0.5533957850436777,"score_spread":0.2892516838651577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042708039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955108,0.0021828888,0.00019057878,0.0002412703,0.00008536177,0.0009453586,0.00030031585,0.00003380768,0.0005097483],"genre_scores_gemma":[0.9931438,0.0019220478,0.0007438663,0.00051074044,0.00015049487,0.0015349438,0.0006483361,0.000011051273,0.0013347305],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997304,0.00013299406,0.00001850599,0.00004564779,0.000030084606,0.000042378786],"domain_scores_gemma":[0.99965024,0.000043264936,0.0000813891,0.000032176584,0.000021448415,0.0001714734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012211319,0.0009682508,0.0011559118,0.00017390956,0.00030968589,0.00067562325,0.00046741823,0.0008129746,0.0019711168],"category_scores_gemma":[0.00047926686,0.00038861367,0.00081611535,0.00019584643,0.0005068446,0.00044413583,0.00021699813,0.0018928618,0.00046102187],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79785836,0.055860054,0.010680041,0.0011492522,0.0017884474,0.00017229185,0.0002380402,0.0014246935,0.04593548,0.00013667649,0.0025917056,0.08216487],"study_design_scores_gemma":[0.64316165,0.32507885,0.021999653,0.0000833018,0.00091960584,0.00024902265,0.00007076774,0.0011870597,0.0044550416,0.000100731086,0.0026670003,0.000027374592],"about_ca_topic_score_codex":0.0006682777,"about_ca_topic_score_gemma":0.0024822897,"teacher_disagreement_score":0.0019711168,"about_ca_system_score_codex":0.0006796042,"about_ca_system_score_gemma":0.0011117449,"threshold_uncertainty_score":0.006594062},"labels":[],"label_agreement":null},{"id":"W3043818052","doi":"10.1158/1078-0432.ccr-20-1170","title":"Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Rosetrees Trust; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Amgen","keywords":"Medicine; Pembrolizumab; Head and neck; Head and neck squamous-cell carcinoma; Oncology; Basal cell; Head and neck cancer; Internal medicine; Radiology; Pathology; Cancer research; Cancer; Immunotherapy; Surgery","score_opus":0.2267127426001978,"score_gpt":0.5082349306894123,"score_spread":0.2815221880892145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043818052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966994,0.0015705174,0.000104854094,0.00014865836,0.000039866994,0.00065150915,0.00022786838,0.00002469169,0.00053262],"genre_scores_gemma":[0.9939832,0.0016010993,0.0005457259,0.00047089584,0.00014465733,0.0008781822,0.00087382505,0.000013693418,0.0014887574],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99960107,0.00019851663,0.000018587256,0.000057979607,0.000050065748,0.00007384039],"domain_scores_gemma":[0.9994873,0.000072253715,0.000114590446,0.00003827406,0.000030774525,0.00025679712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020355703,0.0012268259,0.0014828991,0.00037046603,0.00030702597,0.0007497357,0.00088517886,0.0008007708,0.00254404],"category_scores_gemma":[0.00067447685,0.0005249235,0.0011303121,0.00030516792,0.0007093928,0.0006473754,0.0002622388,0.0018717198,0.0006217041],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.61970717,0.14511599,0.01887398,0.0016264786,0.0034666539,0.0003610583,0.000455511,0.002428952,0.074277565,0.00025927,0.005328549,0.1280989],"study_design_scores_gemma":[0.4175217,0.54971504,0.021707281,0.000047236965,0.0011121096,0.00033586565,0.00008139507,0.0010576402,0.006041899,0.00010063984,0.0022509873,0.0000282523],"about_ca_topic_score_codex":0.0012923257,"about_ca_topic_score_gemma":0.0030580333,"teacher_disagreement_score":0.00254404,"about_ca_system_score_codex":0.0009624729,"about_ca_system_score_gemma":0.001569856,"threshold_uncertainty_score":0.0107652545},"labels":[],"label_agreement":null},{"id":"W3043953022","doi":"10.1158/1557-3265.ovcasymp18-gmm-047","title":"Abstract GMM-047: GENOMIC CHARACTERIZATION OF ADULT-TYPE GRANULOSA CELL TUMORS: IMPLICATIONS FOR PATHOGENESIS AND TREATMENT OF RECURRENT DISEASE","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Missense mutation; Debulking; Carcinogenesis; Biology; Somatic cell; Disease; Germline mutation; Mutation; Cancer research; Pathogenesis; Internal medicine; Oncology; Ovarian cancer; Medicine; Cancer; Genetics; Gene; Immunology","score_opus":0.1611342047733008,"score_gpt":0.47134396792011934,"score_spread":0.3102097631468186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043953022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941673,0.0008628796,0.0014148296,0.00010259151,0.00001106816,0.000021932961,0.0023701803,0.000053614724,0.0009956204],"genre_scores_gemma":[0.99148893,0.00039881162,0.00311319,0.00009421182,0.000010582942,0.000020084157,0.00428393,0.000022491475,0.00056775287],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999132,0.000010020948,0.000008349714,0.000021518481,0.000028350487,0.00001847837],"domain_scores_gemma":[0.99982256,0.000041238072,0.000055263317,0.0000190709,0.000030426161,0.000031524898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001455297,0.00015989196,0.00017738942,0.0005676386,0.00016679776,0.00030057968,0.00015678296,0.00029006487,0.0011988385],"category_scores_gemma":[0.00034992697,0.00006772968,0.0001947914,0.0006061291,0.00017526413,0.000096451746,0.00019577082,0.0002468692,0.00032801807],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050113274,0.000046881214,0.17486262,0.00015834396,0.000042645912,0.0017747589,0.00021184217,0.0004926887,0.79222786,0.0002551637,0.00081544684,0.028610617],"study_design_scores_gemma":[0.000027640262,0.00039652042,0.8186691,0.00003089661,0.000097858385,0.011209231,0.0003445011,0.0023462751,0.15442218,0.00034053074,0.012102033,0.000013208804],"about_ca_topic_score_codex":0.0013526975,"about_ca_topic_score_gemma":0.0014710439,"teacher_disagreement_score":0.0013526975,"about_ca_system_score_codex":0.00022191602,"about_ca_system_score_gemma":0.00015940772,"threshold_uncertainty_score":0.0040104985},"labels":[],"label_agreement":null},{"id":"W3045112382","doi":"10.1158/1557-3265.ovca19-ia05","title":"Abstract IA05: Molecular analysis of exceptional response in high-grade serous ovarian cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; BC Cancer Agency","funders":"","keywords":"Ovarian cancer; Medicine; Oncology; Internal medicine; Disease; Serous fluid; Serous carcinoma; Stage (stratigraphy); Cancer; Biology","score_opus":0.25871876786432835,"score_gpt":0.5325381897356704,"score_spread":0.273819421871342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045112382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99922943,0.00011055398,0.00016035224,0.000011067312,0.0000013342466,0.0000045218408,0.00020994108,0.000007449633,0.0002652927],"genre_scores_gemma":[0.99916863,0.000037338334,0.00023897638,0.000011949604,0.0000019824104,0.0000038756893,0.0004120002,0.0000019799993,0.00012330203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999174,0.000016583288,0.00000913644,0.000016692613,0.000017408116,0.000022802109],"domain_scores_gemma":[0.9997763,0.00005458728,0.00006409083,0.000021909575,0.00002912396,0.000053963096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014692724,0.00010111962,0.00012855191,0.0006219483,0.00024592175,0.00027185483,0.00011207539,0.00016671,0.0011050507],"category_scores_gemma":[0.00038726858,0.000056234978,0.00013505238,0.00038459423,0.00015198563,0.000068487236,0.00022066968,0.0001591128,0.00016077224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056233426,0.0000530796,0.8755555,0.00005095364,0.000037929178,0.0011917328,0.00018772768,0.0003267125,0.11215892,0.000071091774,0.00024853778,0.009555531],"study_design_scores_gemma":[0.0000068242275,0.00022966243,0.9845947,0.0000035983485,0.000026726799,0.0026588896,0.00016465441,0.00049994705,0.010888266,0.000041009964,0.00088296155,0.0000028059108],"about_ca_topic_score_codex":0.0009596289,"about_ca_topic_score_gemma":0.0011002702,"teacher_disagreement_score":0.0011050507,"about_ca_system_score_codex":0.00016317365,"about_ca_system_score_gemma":0.00009162242,"threshold_uncertainty_score":0.0036967397},"labels":[],"label_agreement":null},{"id":"W3045600614","doi":"10.1158/1078-0432.ccr-19-2303","title":"Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Stand Up To Cancer; National Institutes of Health; U.S. National Library of Medicine; U.S. Department of Defense","keywords":"Enzalutamide; Prostate cancer; Biology; Cancer research; Transcriptome; Cancer; Internal medicine; Androgen receptor; Gene; Medicine; Genetics; Gene expression","score_opus":0.2182588947202795,"score_gpt":0.504447810987608,"score_spread":0.28618891626732856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045600614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995284,0.00027456754,0.00008438765,0.000008199785,6.042271e-7,0.0000018675905,0.00005473255,0.0000032888518,0.000044019966],"genre_scores_gemma":[0.9996425,0.00008011313,0.00007180795,0.000006100719,0.0000015120138,0.0000023444672,0.00013540621,0.0000012290874,0.000059042264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99990094,0.000018758898,0.0000071672725,0.00002737944,0.000029840065,0.000016020655],"domain_scores_gemma":[0.9996513,0.000053044256,0.00020968748,0.000018311424,0.000028200084,0.000039332062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018336081,0.00021120803,0.00023696241,0.0005014507,0.00010956342,0.00022122182,0.00014740997,0.00015267456,0.00083201646],"category_scores_gemma":[0.00049155153,0.00012227436,0.00012732233,0.00032740476,0.00018187534,0.00009005005,0.0001502698,0.0001569611,0.000093841154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012727107,0.000039181115,0.88635516,0.000049652248,0.00018513664,0.00044255896,0.00007088514,0.00034081194,0.10402957,0.000018444203,0.00007884111,0.007117073],"study_design_scores_gemma":[0.000014387182,0.0001413011,0.9942696,0.0000030764259,0.000049846465,0.00084214605,0.000033222834,0.00042870286,0.004042619,0.000016032209,0.00015604775,0.0000030423073],"about_ca_topic_score_codex":0.001217466,"about_ca_topic_score_gemma":0.0016206253,"teacher_disagreement_score":0.001217466,"about_ca_system_score_codex":0.00016586219,"about_ca_system_score_gemma":0.00010367067,"threshold_uncertainty_score":0.0027834177},"labels":[],"label_agreement":null},{"id":"W3046405914","doi":"10.1158/1078-0432.ccr-20-1268","title":"Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Vancouver General Hospital; Canadian Centre for Applied Research in Cancer Control; Calgary Laboratory Services; BC Cancer Agency; McMaster University; University of British Columbia","funders":"BC Cancer Foundation; Terry Fox Research Institute; Barts Charity","keywords":"Endometrial cancer; Oncology; Internal medicine; Carcinoma; Ovarian cancer; Microsatellite instability; Subtyping; Medicine; Stage (stratigraphy); Cohort; Multivariate analysis; Cancer; Biology; Gene","score_opus":0.3531191638856132,"score_gpt":0.5288495869320633,"score_spread":0.1757304230464501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046405914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99069583,0.004286069,0.00093045016,0.0004104941,0.000041542535,0.000034504013,0.00057287846,0.000019282665,0.0030089426],"genre_scores_gemma":[0.99849164,0.0003826244,0.0005117439,0.000053376833,0.000023183748,0.000006769155,0.000299292,0.0000032262478,0.00022807402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99957496,0.00014109646,0.00006099798,0.000068574474,0.000093522955,0.000060810136],"domain_scores_gemma":[0.9990746,0.00023241983,0.00032004944,0.00012075757,0.000100397134,0.0001517528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083986117,0.00024705025,0.00024509357,0.00053749967,0.00024771917,0.0004919999,0.00019873296,0.00024016429,0.0019113928],"category_scores_gemma":[0.0033582472,0.00009847251,0.0004571932,0.0005340839,0.00022500084,0.0002543181,0.00039079253,0.00030872162,0.0002988857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005005529,0.00000902109,0.98273534,0.000040727857,0.000091566835,0.0001340473,0.000031285195,0.00019720048,0.0018719073,0.000077669756,0.0001999788,0.014110701],"study_design_scores_gemma":[0.000017322896,0.00011229911,0.99474156,0.00004022347,0.00016632161,0.0011593704,0.00010285832,0.00076678244,0.00066099013,0.00030636918,0.00191964,0.0000062919307],"about_ca_topic_score_codex":0.0012533875,"about_ca_topic_score_gemma":0.003384803,"teacher_disagreement_score":0.0019113928,"about_ca_system_score_codex":0.0003184516,"about_ca_system_score_gemma":0.00034684746,"threshold_uncertainty_score":0.006394267},"labels":[],"label_agreement":null},{"id":"W3046570011","doi":"10.1158/1078-0432.ccr-20-0389","title":"Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; Canadian Institutes of Health Research; Susan G. Komen; Cancer Research Society; U.S. Department of Defense","keywords":"Medicine; Breast cancer; Stimulation; Cancer research; Cancer; Oncogene; Breast tumor; Immunology; Oncology; Internal medicine; Cell cycle","score_opus":0.15730860877575703,"score_gpt":0.45464304760665103,"score_spread":0.297334438830894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046570011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99753237,0.00040813486,0.0011645778,0.000037625276,0.0000361112,0.000056905952,0.000073969495,0.000046462916,0.00064379635],"genre_scores_gemma":[0.9968838,0.00023093159,0.001508887,0.000035878333,0.000020261148,0.00005637105,0.0001402141,0.000010128444,0.0011134922],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998184,0.000029631361,0.000015763262,0.000040086677,0.000034642933,0.000061471655],"domain_scores_gemma":[0.99988174,0.000025362297,0.000025135976,0.000019272697,0.0000118238895,0.000036707967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017292735,0.000531479,0.00041818514,0.0001474343,0.00007730407,0.0002732638,0.00019007557,0.00029224224,0.0008392076],"category_scores_gemma":[0.00012683714,0.00015119123,0.00024647432,0.00009606173,0.00020958354,0.00022492533,0.00019496719,0.0010002856,0.00026677302],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005582834,0.00032550082,0.00017786647,0.000040443552,0.000009958738,0.000021600423,0.000018682522,0.00031341257,0.99629825,0.00005493817,0.00004189304,0.0021390223],"study_design_scores_gemma":[0.00022148168,0.005117685,0.0018884283,0.000011826068,0.00003995594,0.00012326946,0.000020974612,0.002456956,0.9886391,0.000045919845,0.0014304644,0.000003915994],"about_ca_topic_score_codex":0.00023189062,"about_ca_topic_score_gemma":0.00038643274,"teacher_disagreement_score":0.0008392076,"about_ca_system_score_codex":0.00019374707,"about_ca_system_score_gemma":0.0002344155,"threshold_uncertainty_score":0.0028074384},"labels":[],"label_agreement":null},{"id":"W3048696534","doi":"10.1158/1557-3265.advprecmed20-ia23","title":"Abstract IA23: ctDNA as predictive biomarkers for response and toxicity with immunotherapy","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Response Evaluation Criteria in Solid Tumors; Oncology; Internal medicine; Immunotherapy; Biomarker; Cancer; Circulating tumor DNA; Confidence interval; Clinical endpoint; Antibody; Phases of clinical research; Toxicity; Clinical trial; Immunology; Biology","score_opus":0.10845599450065652,"score_gpt":0.4648178219648009,"score_spread":0.3563618274641444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048696534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803728,0.008845938,0.003043327,0.00025321002,0.000056335117,0.00020717588,0.002754562,0.00018700829,0.0042796214],"genre_scores_gemma":[0.99615866,0.0003392135,0.0013090186,0.00009628975,0.000030762727,0.00009155816,0.0012098572,0.000016839247,0.0007478959],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988482,0.0003695109,0.00014747072,0.00023761777,0.0003110576,0.000086120366],"domain_scores_gemma":[0.9963767,0.0010295772,0.0014710184,0.00022190425,0.000578982,0.00032172966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017699004,0.0005424915,0.00071557675,0.0013911242,0.00024870815,0.001095092,0.00048089918,0.000526531,0.0033782818],"category_scores_gemma":[0.0039724982,0.00020057418,0.00043087715,0.0009159379,0.00034635433,0.00050033134,0.0003511012,0.0008349335,0.00074448035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076705716,0.00030112162,0.8844303,0.00021917305,0.0005038814,0.00020418616,0.00008362021,0.0022072736,0.044806186,0.00012890123,0.0016941072,0.057750672],"study_design_scores_gemma":[0.00030661732,0.004923625,0.9366931,0.00008601301,0.00037372147,0.0025105467,0.00009558071,0.0076431003,0.042406883,0.0003362135,0.0045804097,0.00004426042],"about_ca_topic_score_codex":0.0009991371,"about_ca_topic_score_gemma":0.0009049498,"teacher_disagreement_score":0.0033782818,"about_ca_system_score_codex":0.00075592054,"about_ca_system_score_gemma":0.00037349053,"threshold_uncertainty_score":0.011301458},"labels":[],"label_agreement":null},{"id":"W3048778838","doi":"10.1158/1557-3265.bladder19-b07","title":"Abstract B07: A long noncoding RNA-based genomic classifier identifies a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Genome British Columbia","funders":"","keywords":"Bladder cancer; Cystectomy; Subtyping; Long non-coding RNA; Biology; Gene expression profiling; Transcriptome; Oncology; Bioinformatics; Cancer research; Cancer; Gene expression; Medicine; Internal medicine; RNA; Gene; Genetics","score_opus":0.11645136599012818,"score_gpt":0.41645603578359797,"score_spread":0.3000046697934698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048778838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943863,0.0001576427,0.0026926133,0.00013433311,0.000012332609,0.000025331236,0.0019678953,0.00011276589,0.0005107458],"genre_scores_gemma":[0.9910885,0.000037812846,0.0030597576,0.000053376458,0.00001530726,0.000028443315,0.0053756787,0.000016602551,0.00032438696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997904,0.0000367459,0.000016982975,0.000082260965,0.00004067451,0.000033013373],"domain_scores_gemma":[0.99955934,0.00012294752,0.000075952725,0.00003980388,0.000113745176,0.00008814199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049823185,0.00030187835,0.00046310193,0.0008458062,0.0003618273,0.0006283332,0.00033660253,0.00045641596,0.0018617477],"category_scores_gemma":[0.0012191219,0.00007482524,0.00034203462,0.000499218,0.00020331256,0.00017536158,0.0004183783,0.00039043132,0.0008221929],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024654467,0.00032549544,0.88406694,0.00011181845,0.00031244892,0.0002443008,0.00014331097,0.0053464603,0.04470182,0.00024196497,0.005819478,0.056220476],"study_design_scores_gemma":[0.00022140413,0.0010461145,0.8306855,0.000051729658,0.00039961172,0.0011885471,0.0004928752,0.14685829,0.014609051,0.001217292,0.0031734165,0.000056179753],"about_ca_topic_score_codex":0.0024502757,"about_ca_topic_score_gemma":0.0032171842,"teacher_disagreement_score":0.0024502757,"about_ca_system_score_codex":0.00031708166,"about_ca_system_score_gemma":0.00054739375,"threshold_uncertainty_score":0.006228149},"labels":[],"label_agreement":null},{"id":"W3048885656","doi":"10.1158/1557-3265.advprecmed20-33","title":"Abstract 33: Drug sensitivity prediction modeling from genomics, transcriptomics and inferred protein activity","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Genomics; Proteomics; Computational biology; Copy-number variation; Precision medicine; Systems biology; Computer science; Drug response; DNA microarray; Personalized medicine; Bioinformatics; Biology; Genome; Drug; Gene; Genetics; Gene expression","score_opus":0.3413089172699922,"score_gpt":0.48297643960563164,"score_spread":0.14166752233563945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048885656","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5530089,0.0033670743,0.3823944,0.002169382,0.00013099502,0.00034554978,0.045182,0.008833964,0.0045677717],"genre_scores_gemma":[0.914434,0.00095851085,0.055969037,0.00031992942,0.000059299407,0.0003392198,0.025627943,0.00014744772,0.0021446182],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997547,0.000054068976,0.000016552469,0.00011528501,0.000034246492,0.000025186193],"domain_scores_gemma":[0.9995586,0.00028055106,0.000051359613,0.000028834045,0.000056276393,0.000024399968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007658266,0.0010423677,0.0006335449,0.000995029,0.00020504658,0.00090914307,0.0006946602,0.0008695021,0.0018656559],"category_scores_gemma":[0.0013408387,0.00033119463,0.0012257812,0.0006849523,0.0002556469,0.0005179938,0.0003912956,0.00063190976,0.0004996708],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033528177,0.00017338674,0.011546502,0.00028161812,0.00018170169,0.00022565508,0.000019043198,0.9465035,0.00709757,0.0009985686,0.0046419553,0.027995242],"study_design_scores_gemma":[0.000013522859,0.00003709575,0.001289067,0.000005661227,0.0000243739,0.000030961986,0.0000032782327,0.99545115,0.0016606806,0.000857305,0.0006207128,0.0000061845835],"about_ca_topic_score_codex":0.0064279353,"about_ca_topic_score_gemma":0.003863512,"teacher_disagreement_score":0.0064279353,"about_ca_system_score_codex":0.0009344972,"about_ca_system_score_gemma":0.0010885996,"threshold_uncertainty_score":0.012781084},"labels":[],"label_agreement":null},{"id":"W3048908406","doi":"10.1158/1557-3265.bladder19-pr08","title":"Abstract PR08: The genomic landscape of metastatic urothelial carcinoma from circulating tumor DNA","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"PTEN; ARID1A; Somatic cell; Cancer research; Bladder cancer; Cancer; Medicine; DNA sequencing; Circulating tumor cell; Oncology; Germline mutation; Gene; Mutation; Biology; Internal medicine; Metastasis; PI3K/AKT/mTOR pathway; Genetics","score_opus":0.288795444234291,"score_gpt":0.4772809954703104,"score_spread":0.1884855512360194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048908406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937104,0.0011988524,0.0015226575,0.0001346458,0.000012745621,0.000015918615,0.001925431,0.00006728796,0.0014120743],"genre_scores_gemma":[0.99654084,0.0002148344,0.0010318747,0.000070644826,0.000015239423,0.000012493693,0.0016042886,0.000024524204,0.0004852594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998135,0.000021660022,0.0000138611695,0.00006676612,0.00005548202,0.0000286828],"domain_scores_gemma":[0.99963534,0.00009347065,0.00011167434,0.00003063886,0.0000737162,0.000055166885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002259724,0.00014719857,0.0002012646,0.0004998663,0.00015231656,0.0004892654,0.00017692723,0.0002096657,0.0031505777],"category_scores_gemma":[0.0009957108,0.00010602986,0.0001137326,0.000531533,0.00016092315,0.00019033598,0.00025745254,0.0002481461,0.0005939507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012586914,0.000069891925,0.5593115,0.00030774862,0.00009467946,0.0019632133,0.00030754224,0.0008747767,0.3688563,0.00052225194,0.0031549996,0.06327834],"study_design_scores_gemma":[0.000049155322,0.00053407875,0.9223431,0.00004434812,0.00009569067,0.010330854,0.00028915572,0.0036984023,0.0534974,0.0008176186,0.008282041,0.000018232744],"about_ca_topic_score_codex":0.00072526967,"about_ca_topic_score_gemma":0.0007427166,"teacher_disagreement_score":0.0031505777,"about_ca_system_score_codex":0.0001931196,"about_ca_system_score_gemma":0.00012647036,"threshold_uncertainty_score":0.01053977},"labels":[],"label_agreement":null},{"id":"W3049131576","doi":"10.1158/1078-0432.ccr-20-1412","title":"Phase I and Pharmacokinetic Study of Romidepsin in Patients with Cancer and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Cancer Institute; National Institutes of Health","keywords":"Romidepsin; Medicine; Pharmacokinetics; Cancer; Internal medicine; Cohort; Organ dysfunction; Adverse effect; Dosing; Malignancy; Oncology","score_opus":0.13290511353278187,"score_gpt":0.4682802849682226,"score_spread":0.3353751714354407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049131576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979842,0.00035226776,0.0002955043,0.00010679841,0.000010657951,0.00038038247,0.00024411456,0.000014106718,0.00061188877],"genre_scores_gemma":[0.9972709,0.00022653582,0.0007116302,0.00029049825,0.000032667685,0.0002592443,0.0008194478,0.0000066730186,0.00038233193],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999511,0.00027992172,0.000029359875,0.00005919827,0.000072665425,0.000047884936],"domain_scores_gemma":[0.9992963,0.000101032754,0.00016497869,0.00010117178,0.00007343584,0.00026311833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015239451,0.0005099885,0.00068790396,0.00013656166,0.00018182177,0.0004161155,0.00030435174,0.000361764,0.0009939082],"category_scores_gemma":[0.0009029516,0.00019682343,0.00045296957,0.0002427822,0.00034411674,0.00034248832,0.00022292399,0.001133053,0.0002427894],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40397608,0.048709646,0.21531749,0.00062243897,0.0023605144,0.00096750853,0.0006631705,0.004887241,0.1390424,0.000367111,0.0066697574,0.17641659],"study_design_scores_gemma":[0.18667635,0.53840166,0.24335474,0.00003632433,0.00083058974,0.002271099,0.00013637112,0.0045343363,0.017148186,0.0002374814,0.0063163596,0.000056571575],"about_ca_topic_score_codex":0.000588546,"about_ca_topic_score_gemma":0.0010093311,"teacher_disagreement_score":0.0015239451,"about_ca_system_score_codex":0.00057420385,"about_ca_system_score_gemma":0.0011267536,"threshold_uncertainty_score":0.008059442},"labels":[],"label_agreement":null},{"id":"W3049165631","doi":"10.1158/1557-3265.bladder19-b23","title":"Abstract B23: <i>FGFR3</i> mutations and their relation to FGFR3 expression and clinical outcome in a large radical cystectomy cohort: Implications for anti-FGFR3 bladder cancer treatment?","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Fibroblast growth factor receptor 3; Cystectomy; Immunohistochemistry; Bladder cancer; Medicine; Cancer research; Internal medicine; Oncology; Pathology; Cancer; Gastroenterology; Fibroblast growth factor; Receptor","score_opus":0.26661711812524264,"score_gpt":0.5438236918028955,"score_spread":0.27720657367765283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049165631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99912065,0.00020412926,0.00005581675,0.00006529779,0.00000450844,0.0000044928806,0.0003099241,0.0000044543003,0.00023065608],"genre_scores_gemma":[0.999476,0.000039654613,0.000037128637,0.000024566149,0.000013674647,0.0000056926992,0.0003012344,0.0000027134051,0.0000992911],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968123,0.000060532264,0.00003382882,0.000119531425,0.00005299887,0.000051852974],"domain_scores_gemma":[0.9992768,0.00011219975,0.0002938169,0.00006347525,0.00007877926,0.00017508272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062031945,0.00018332043,0.00034515548,0.00048016355,0.00040315188,0.0006295071,0.0003599241,0.0004051346,0.0029919154],"category_scores_gemma":[0.0014006743,0.00013372926,0.00029003556,0.00055507506,0.00029655985,0.00030748497,0.00025379754,0.00034121747,0.0005028692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026148607,0.00002246797,0.99691856,0.0000056462895,0.000043185155,0.000100537756,0.000027776352,0.000029372695,0.0009911295,0.000009688507,0.0002591863,0.0013308767],"study_design_scores_gemma":[0.00001529234,0.000116976975,0.9983051,0.00000442338,0.000036796402,0.0007092435,0.00007554568,0.00019649045,0.00023082171,0.000023026774,0.00028282942,0.0000034481463],"about_ca_topic_score_codex":0.002760191,"about_ca_topic_score_gemma":0.0024025422,"teacher_disagreement_score":0.0029919154,"about_ca_system_score_codex":0.00023904875,"about_ca_system_score_gemma":0.0001932574,"threshold_uncertainty_score":0.010008931},"labels":[],"label_agreement":null},{"id":"W3049182325","doi":"10.1158/1078-0432.ccr-20-2429","title":"Moving Beyond BRCA—Incorporating Molecular Assays into Ovarian Cancer Trials","year":2020,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Government of Ontario; Ontario Institute for Cancer Research","keywords":"Ovarian cancer; Oncology; Medicine; Prospective cohort study; Clinical trial; Internal medicine; Cancer; Serous fluid; Gynecology; Bioinformatics; Biology","score_opus":0.2014871628831764,"score_gpt":0.5089592626528809,"score_spread":0.3074720997697046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049182325","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0049016406,0.009320353,0.0017348607,0.9665335,0.011000939,0.00025256956,0.00025690318,0.00010625024,0.005892957],"genre_scores_gemma":[0.041586917,0.004485529,0.005915009,0.9122937,0.032773577,0.00066095684,0.00016072014,0.000059865797,0.0020637999],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97465456,0.019158468,0.0016076937,0.0011379704,0.002645584,0.00079569913],"domain_scores_gemma":[0.9213793,0.06061993,0.0031941803,0.0025317422,0.005099094,0.007175784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03566552,0.00057002576,0.0017614841,0.00076857454,0.0009835445,0.0042537446,0.0019523081,0.015873829,0.0040065353],"category_scores_gemma":[0.06829069,0.0005649506,0.0014083936,0.0009375303,0.0029919925,0.005574292,0.0022645127,0.014986904,0.0031280483],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008719425,0.0007848717,0.012264527,0.0008343175,0.0004252946,0.0024379678,0.00033008095,0.0020382607,0.0061511477,0.027856123,0.46915537,0.46900257],"study_design_scores_gemma":[0.011750661,0.0053578718,0.016254252,0.0028421308,0.0005279403,0.0028934728,0.00035570524,0.008019669,0.0050786193,0.15741742,0.7892205,0.00028172595],"about_ca_topic_score_codex":0.0011005176,"about_ca_topic_score_gemma":0.002309796,"teacher_disagreement_score":0.03566552,"about_ca_system_score_codex":0.0037158858,"about_ca_system_score_gemma":0.00433317,"threshold_uncertainty_score":0.18861961},"labels":[],"label_agreement":null},{"id":"W3049239269","doi":"10.1158/1078-0432.ccr-20-1439","title":"A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination–deficient Pancreatic Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Queen's University; University of Toronto; Lunenfeld-Tanenbaum Research Institute; Occupational Cancer Research Centre; Princess Margaret Cancer Centre; McGill University; McGill Genome Centre; Ontario Institute for Cancer Research; McGill University and Génome Québec Innovation Centre; McGill University Health Centre","funders":"Canadian Cancer Society Research Institute; Cancer Research Society; McGill University Health Centre; Terry Fox Research Institute; Ontario Institute for Cancer Research; Princess Margaret Cancer Foundation","keywords":"Transcriptome; Pancreatic cancer; Homologous recombination; PARP inhibitor; Cancer research; Biology; Genome instability; Cancer; Medicine; Oncology; Internal medicine; Gene; Genetics; Poly ADP ribose polymerase; DNA damage; Gene expression; DNA","score_opus":0.2549166930190127,"score_gpt":0.5434493464092846,"score_spread":0.28853265339027184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049239269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967224,0.0004896064,0.0008823453,0.000095971285,0.000021334488,0.0004565366,0.00071234803,0.000023481662,0.00059601327],"genre_scores_gemma":[0.99417853,0.00021242861,0.0012453058,0.0001835727,0.000033231674,0.00071108644,0.0028031634,0.000013463482,0.0006191908],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9993685,0.0003043705,0.000044194036,0.00012715693,0.00008584436,0.00006992221],"domain_scores_gemma":[0.99906725,0.00015683542,0.0001983253,0.00022644147,0.000090213696,0.00026106637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029173458,0.00062630785,0.00082096294,0.0002507061,0.00030920617,0.00067397015,0.0004437566,0.00071285147,0.0020850266],"category_scores_gemma":[0.0009986821,0.00023516273,0.00064333447,0.00028885363,0.0005588228,0.0005335138,0.00040297068,0.0011149012,0.0005567998],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35190803,0.038193583,0.23492548,0.00065825996,0.0018342468,0.00082551426,0.00025493297,0.0069199675,0.28607646,0.000920846,0.0034842396,0.07399843],"study_design_scores_gemma":[0.06829831,0.5253224,0.26214978,0.000085651845,0.002795263,0.0028519102,0.00025307978,0.01306217,0.11178963,0.0014718436,0.011834268,0.00008581823],"about_ca_topic_score_codex":0.00018935635,"about_ca_topic_score_gemma":0.0002871222,"teacher_disagreement_score":0.0029173458,"about_ca_system_score_codex":0.00053229294,"about_ca_system_score_gemma":0.0008489734,"threshold_uncertainty_score":0.015428603},"labels":[],"label_agreement":null},{"id":"W3049299021","doi":"10.1158/1557-3265.bladder19-b10","title":"Abstract B10: A simple immunohistochemical algorithm to evaluate molecular subtypes and clinical associations in non-muscle invasive bladder cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Bladder cancer; Immunohistochemistry; Subtyping; Tissue microarray; Antibody; Algorithm; Stage (stratigraphy); Transcriptome; Cancer; Oncology; Pathology; Medicine; Internal medicine; Biology; Immunology; Gene expression; Gene; Computer science","score_opus":0.17980585000074653,"score_gpt":0.5288131608495097,"score_spread":0.34900731084876313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049299021","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2962751,0.0008534206,0.67205524,0.0010921612,0.00023743449,0.00319544,0.011843471,0.008890959,0.0055567753],"genre_scores_gemma":[0.36214548,0.00023591319,0.6201832,0.00034981684,0.00009407541,0.0022041705,0.010840127,0.00042233846,0.003524823],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984977,0.00034299353,0.00023369456,0.00039293588,0.0003910316,0.00014163631],"domain_scores_gemma":[0.99705005,0.0010698313,0.00035164077,0.00016178006,0.0011625303,0.00020407159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032061767,0.0012880382,0.0011008332,0.004460661,0.0005965491,0.0018314343,0.0020021705,0.0008046412,0.006472223],"category_scores_gemma":[0.007716259,0.0005509274,0.00093373714,0.0015350166,0.0003327191,0.00072563643,0.0012115043,0.00087488606,0.0033773845],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021611052,0.0006077178,0.3992236,0.00039061974,0.0008663547,0.00033083186,0.00019886812,0.036097676,0.02540263,0.0013329949,0.034087755,0.4992998],"study_design_scores_gemma":[0.0006421595,0.00043446917,0.12812229,0.00012097978,0.0003504601,0.0011072013,0.00028338225,0.8374226,0.009870048,0.005626917,0.015902165,0.000117338386],"about_ca_topic_score_codex":0.008921522,"about_ca_topic_score_gemma":0.010328806,"teacher_disagreement_score":0.008921522,"about_ca_system_score_codex":0.0010678184,"about_ca_system_score_gemma":0.0017849606,"threshold_uncertainty_score":0.021651745},"labels":[],"label_agreement":null},{"id":"W3049302966","doi":"10.1158/1557-3265.bladder19-ia10","title":"Abstract IA10: Developing rational combination therapy with checkpoint inhibitors","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Ottawa Hospital","funders":"","keywords":"Dasatinib; Cabozantinib; Medicine; Immunotherapy; Cancer research; In vivo; Druggability; Combination therapy; Cancer; Cancer immunotherapy; Melanoma; Pharmacology; Internal medicine; Imatinib; Biology; Myeloid leukemia","score_opus":0.3418735799590187,"score_gpt":0.5133392790341231,"score_spread":0.17146569907510445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049302966","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86964035,0.029026572,0.054041985,0.0017602593,0.0007066087,0.0015382265,0.0021775991,0.0015601681,0.0395482],"genre_scores_gemma":[0.95606816,0.00930518,0.02288184,0.00046885415,0.000103308965,0.000483584,0.0013380597,0.00009470016,0.009256345],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998902,0.000016792652,0.000007500491,0.000027449998,0.000031151205,0.000026935604],"domain_scores_gemma":[0.9999496,0.0000051703205,0.000011074929,0.0000047420103,0.000010300665,0.000019117064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024382726,0.00070926273,0.00047677374,0.0004923027,0.000118419506,0.0005407649,0.00051008404,0.00030903527,0.0026713032],"category_scores_gemma":[0.00015154642,0.00023006735,0.0003365465,0.00029928974,0.00014189721,0.00026333623,0.0003001321,0.0008570097,0.0009916943],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002341245,0.0021966111,0.0019059817,0.000809042,0.00026539864,0.00039926238,0.00006118559,0.024505451,0.6938674,0.0036182252,0.009329853,0.26070037],"study_design_scores_gemma":[0.0031930055,0.018128589,0.0050698705,0.0001683943,0.00059361407,0.0016143721,0.00005568912,0.08966691,0.7510319,0.0017931492,0.12858115,0.0001033651],"about_ca_topic_score_codex":0.00067258195,"about_ca_topic_score_gemma":0.0014460573,"teacher_disagreement_score":0.0026713032,"about_ca_system_score_codex":0.00053771393,"about_ca_system_score_gemma":0.0005542511,"threshold_uncertainty_score":0.008936405},"labels":[],"label_agreement":null},{"id":"W3049491040","doi":"10.1158/1557-3265.bladder19-ia22","title":"Abstract IA22: Realizing the potential of targeted therapy in non-muscle invasive bladder cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Medicine; Targeted therapy; Disease; Cancer; Immune checkpoint; Clinical trial; Immunotherapy; Oncology; Bioinformatics; Internal medicine; Biology","score_opus":0.23171613068035943,"score_gpt":0.4963890871256152,"score_spread":0.2646729564452558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049491040","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024949064,0.36198905,0.017973593,0.17383158,0.12777658,0.00055639434,0.0032764666,0.0028030598,0.28684434],"genre_scores_gemma":[0.1298388,0.20940132,0.011325023,0.03625909,0.029002815,0.00023522157,0.0017942296,0.00060897315,0.58153456],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977607,0.000047337446,0.000013759594,0.00004703567,0.00007254487,0.000043246822],"domain_scores_gemma":[0.9996556,0.00003987671,0.000032495464,0.000024446243,0.00010457114,0.00014295634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008381487,0.0006239164,0.000364318,0.0007210318,0.00047941445,0.0023555276,0.00068861427,0.0015590903,0.032299478],"category_scores_gemma":[0.00065003085,0.0001874752,0.0004671599,0.00040645179,0.0005296789,0.0014561275,0.0009532833,0.0018163786,0.009147178],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042967693,0.00010395178,0.00044677753,0.0009844007,0.00003401351,0.0005141736,0.00010832142,0.0004937441,0.021348264,0.021362867,0.674352,0.27982187],"study_design_scores_gemma":[0.00008125105,0.0002666445,0.0009063971,0.00024867847,0.00003155513,0.0008698625,0.00007067505,0.00046861116,0.011625125,0.00470849,0.9806948,0.000027963895],"about_ca_topic_score_codex":0.0017534805,"about_ca_topic_score_gemma":0.0017482368,"teacher_disagreement_score":0.032299478,"about_ca_system_score_codex":0.0012801979,"about_ca_system_score_gemma":0.001156398,"threshold_uncertainty_score":0.10805255},"labels":[],"label_agreement":null},{"id":"W3049491391","doi":"10.1158/1557-3265.bladder19-ia21","title":"Abstract IA21: Intravesical gene therapy for NMIBC","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"College of Physicians and Surgeons of Ontario","funders":"","keywords":"Medicine; Oncolytic virus; Genetic enhancement; Oncology; Clinical trial; Bladder cancer; Refractory (planetary science); Internal medicine; Urothelium; Cystectomy; Gene; Cancer; Urinary system","score_opus":0.4833733599109263,"score_gpt":0.5783440767573926,"score_spread":0.09497071684646635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049491391","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7404957,0.13054301,0.021154903,0.010531542,0.0048647295,0.0011639041,0.0034334927,0.0015876839,0.08622516],"genre_scores_gemma":[0.90726453,0.035930626,0.0070294547,0.0015716741,0.00058115553,0.0002827491,0.00274464,0.00014226862,0.0444529],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989295,0.0000158238,0.0000065316017,0.000018003364,0.00003895126,0.00002771755],"domain_scores_gemma":[0.99992967,0.000009130072,0.000011287301,0.0000072901457,0.00001933592,0.000023321973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024819293,0.00033991225,0.00030483757,0.0005529193,0.00023681267,0.0006311406,0.00030664157,0.0006514051,0.0029400329],"category_scores_gemma":[0.00016537249,0.00007856252,0.00035595373,0.00036867574,0.0002831527,0.00028512868,0.00022083575,0.00095838535,0.00089992944],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017470396,0.0011992626,0.0017282898,0.0008676872,0.00009706354,0.00080108666,0.0001227087,0.0012569446,0.7502279,0.005047938,0.020284636,0.21661952],"study_design_scores_gemma":[0.0016280339,0.013135563,0.0155931,0.0002484344,0.00030441824,0.0052174125,0.00010453644,0.00538453,0.66893893,0.0015403356,0.28782937,0.000075335935],"about_ca_topic_score_codex":0.0018961295,"about_ca_topic_score_gemma":0.0016477102,"teacher_disagreement_score":0.0029400329,"about_ca_system_score_codex":0.00083751685,"about_ca_system_score_gemma":0.000585878,"threshold_uncertainty_score":0.009835362},"labels":[],"label_agreement":null},{"id":"W3049551640","doi":"10.1158/1557-3265.bladder19-a04","title":"Abstract A04: DNA damage repair gene mutations and associated tumor immune landscape as biomarkers of response to immunotherapy in muscle-invasive urothelial cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"TIGIT; Immune system; Immunotherapy; Biology; Immune checkpoint; Cancer research; Bladder cancer; Cancer; Transcriptome; Cancer immunotherapy; Tumor microenvironment; Biomarker; DNA repair; Immunology; Gene; Gene expression; Genetics","score_opus":0.11395063758917365,"score_gpt":0.4625871172768211,"score_spread":0.34863647968764744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049551640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99547994,0.0007562042,0.0007318298,0.000046158766,0.0000074130353,0.000017897362,0.0025443276,0.000028412327,0.0003877918],"genre_scores_gemma":[0.9951691,0.00019223533,0.0011414984,0.000050778883,0.000009070042,0.000036509104,0.0029231948,0.000007391924,0.00047011927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998118,0.000030531635,0.000018756007,0.000059452275,0.0000492622,0.000030308054],"domain_scores_gemma":[0.99957675,0.00011248031,0.00017154583,0.000025984507,0.00006764157,0.00004552297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003165407,0.0001578427,0.00025424582,0.0009860491,0.00018025885,0.00040764344,0.00013780684,0.00019932713,0.0012875752],"category_scores_gemma":[0.0006010059,0.000057642526,0.00020478085,0.00089710474,0.00015327246,0.00014285036,0.00019804762,0.00023042344,0.00023930872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014855847,0.0000989768,0.7507847,0.0002460932,0.00015828716,0.0002390489,0.00014127792,0.00069113716,0.21957102,0.00009615803,0.0008303979,0.025657285],"study_design_scores_gemma":[0.0000079402,0.00022816888,0.9735643,0.000016527585,0.00006479283,0.00052243494,0.00017528115,0.001662926,0.022226805,0.00012366075,0.0014001346,0.0000070470423],"about_ca_topic_score_codex":0.0006581073,"about_ca_topic_score_gemma":0.0010704527,"teacher_disagreement_score":0.0012875752,"about_ca_system_score_codex":0.00021449615,"about_ca_system_score_gemma":0.00013118182,"threshold_uncertainty_score":0.0043073893},"labels":[],"label_agreement":null},{"id":"W3064306546","doi":"10.1158/1078-0432.ccr-20-2081","title":"Biomarkers of Osimertinib Response in Patients with Refractory, EGFR-T790M–positive Non–Small Cell Lung Cancer and Central Nervous System Metastases: The APOLLO Study","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Power Generation","funders":"Key Technology Research and Development Program of Shandong; Shandong Academy of Medical Sciences; Shandong First Medical University; AstraZeneca","keywords":"Osimertinib; T790M; Medicine; Internal medicine; Lung cancer; Oncology; Adverse effect; Cancer; Erlotinib; Epidermal growth factor receptor; Adenocarcinoma; ROS1","score_opus":0.07101337098720283,"score_gpt":0.45536085617458893,"score_spread":0.3843474851873861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3064306546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99617106,0.0016077628,0.00017300679,0.00018642933,0.000039365274,0.00018268611,0.00057632645,0.000008335302,0.0010550786],"genre_scores_gemma":[0.99728703,0.00038204287,0.00029849567,0.00023980568,0.00010082518,0.00022317395,0.0009105135,0.0000045661704,0.0005536996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994848,0.00022034686,0.00003658416,0.00015099728,0.00006223775,0.00004512176],"domain_scores_gemma":[0.99841106,0.00033857962,0.0007037441,0.00014853399,0.00013871929,0.0002592248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017975988,0.0007374497,0.00064686785,0.00023775449,0.0002571437,0.0011914166,0.00048373884,0.0005812603,0.0010885767],"category_scores_gemma":[0.001918811,0.00032475335,0.00070444855,0.0003456107,0.00050354673,0.0008139668,0.0005043456,0.00095256465,0.00030481984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16811414,0.0037943868,0.76475686,0.00068715954,0.00289393,0.00028565153,0.0002746238,0.0008001404,0.008015262,0.00035596403,0.0041726674,0.045849297],"study_design_scores_gemma":[0.05556514,0.04472265,0.87343067,0.00016902384,0.004025063,0.0010719057,0.00029948493,0.005917481,0.0043670842,0.0007789554,0.009538325,0.00011429528],"about_ca_topic_score_codex":0.0005816918,"about_ca_topic_score_gemma":0.0009854353,"teacher_disagreement_score":0.0017975988,"about_ca_system_score_codex":0.00081931305,"about_ca_system_score_gemma":0.0007060035,"threshold_uncertainty_score":0.009506762},"labels":[],"label_agreement":null},{"id":"W3064741431","doi":"10.1158/1078-0432.ccr-20-0037","title":"Phase I Study of P-cadherin–targeted Radioimmunotherapy with 90Y-FF-21101 Monoclonal Antibody in Solid Tumors","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; Cancer Prevention and Research Institute of Texas; University of Texas MD Anderson Cancer Center; Canadian Association of Thoracic Surgeons; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy; FUJIFILM Pharmaceuticals U.S.A.; Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston; National Cancer Institute; National Institutes of Health","keywords":"Radioimmunotherapy; Medicine; Pharmacokinetics; Response Evaluation Criteria in Solid Tumors; Antibody; Dosimetry; Monoclonal antibody; Cancer; Toxicity; Internal medicine; Cancer research; Pathology; Oncology; Nuclear medicine; Phases of clinical research; Immunology","score_opus":0.35263451389578604,"score_gpt":0.6222635232220715,"score_spread":0.2696290093262854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3064741431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956033,0.0007099205,0.0010485996,0.000139043,0.000053653926,0.0011640384,0.0003564739,0.00010074542,0.0008241865],"genre_scores_gemma":[0.99145764,0.00082089077,0.0020215367,0.00029458955,0.00007260745,0.0015141779,0.0018874393,0.00004684421,0.0018842991],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99969244,0.00010715501,0.00001415143,0.00006183114,0.000038798575,0.000085611915],"domain_scores_gemma":[0.99958223,0.0000623035,0.00008763156,0.0000538417,0.00004274505,0.00017131152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088620296,0.0014154224,0.0015308332,0.000394535,0.00043392423,0.0007902605,0.0009273995,0.0010343485,0.0016646057],"category_scores_gemma":[0.00037593106,0.0004814769,0.00081747153,0.00037206284,0.00076531596,0.0005215207,0.00027246046,0.0023705685,0.0006190738],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15775727,0.12997514,0.008715374,0.0009673134,0.0011730257,0.0006495551,0.000643247,0.008402282,0.5871554,0.0006615224,0.0053121834,0.09858765],"study_design_scores_gemma":[0.10553387,0.7697,0.015101722,0.000045654073,0.00049736234,0.00093304325,0.0001026446,0.0050250744,0.09799542,0.00023928942,0.0047856974,0.00004023003],"about_ca_topic_score_codex":0.0013433581,"about_ca_topic_score_gemma":0.0014852209,"teacher_disagreement_score":0.0016646057,"about_ca_system_score_codex":0.0010236255,"about_ca_system_score_gemma":0.0013915529,"threshold_uncertainty_score":0.0074269176},"labels":[],"label_agreement":null},{"id":"W3080756819","doi":"10.1158/1078-0432.ccr-20-1916","title":"Concentration-dependent Early Antivascular and Antitumor Effects of Itraconazole in Non–Small Cell Lung Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; American Cancer Society; Canadian Institutes of Health Research; Comprehensive Cancer Center, City of Hope; Cancer Prevention and Research Institute of Texas; National Heart, Lung, and Blood Institute; U.S. Department of Defense","keywords":"Itraconazole; Medicine; Pharmacokinetics; Lung cancer; Internal medicine; Pharmacodynamics; Urology; Pharmacology","score_opus":0.06980497137660392,"score_gpt":0.42388596198538864,"score_spread":0.35408099060878473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080756819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99906975,0.0004534911,0.000121688536,0.000016158554,0.0000057474554,0.000020360141,0.00003855093,0.000012144769,0.00026225334],"genre_scores_gemma":[0.9994373,0.000089378176,0.000119893906,0.000018398552,0.000005895613,0.000013421905,0.00008112667,0.0000023537034,0.00023227393],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998417,0.0000486694,0.000009523423,0.000022253742,0.000038225466,0.000039610833],"domain_scores_gemma":[0.9998035,0.000049048354,0.00004333971,0.000022908904,0.000024249965,0.000057047862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021296267,0.00019914306,0.0003564976,0.00011372739,0.00013021745,0.0002791827,0.00012126764,0.00018895701,0.0014214417],"category_scores_gemma":[0.00034175316,0.00010398968,0.00019038282,0.00011213279,0.00021797048,0.00015539804,0.00010033086,0.00055566395,0.00023075256],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020250777,0.0028822643,0.015986778,0.00016769952,0.000110054105,0.00026187263,0.00008927356,0.0010471769,0.90718883,0.000099354314,0.00068846426,0.05122748],"study_design_scores_gemma":[0.0027605167,0.13473165,0.24954498,0.000029221208,0.00033836183,0.001917296,0.0001588453,0.0062313257,0.59976053,0.0001595563,0.004338127,0.000029641773],"about_ca_topic_score_codex":0.00044371665,"about_ca_topic_score_gemma":0.001139402,"teacher_disagreement_score":0.0014214417,"about_ca_system_score_codex":0.00035324524,"about_ca_system_score_gemma":0.00026840734,"threshold_uncertainty_score":0.0047552586},"labels":[],"label_agreement":null},{"id":"W3081113288","doi":"10.1158/1078-0432.ccr-20-1064","title":"Entospletinib in Combination with Induction Chemotherapy in Previously Untreated Acute Myeloid Leukemia: Response and Predictive Significance of <i>HOXA9</i> and <i>MEIS1</i> Expression","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Gilead Sciences","keywords":"Myeloid leukemia; Induction chemotherapy; Medicine; Chemotherapy; Leukemia; Oncology; Induction therapy; Cancer research; Internal medicine; Immunology","score_opus":0.07628086996969083,"score_gpt":0.41372091109930226,"score_spread":0.33744004112961146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081113288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991291,0.00040419388,0.00007980668,0.000031108146,0.0000055761648,0.00004146615,0.00006301487,0.0000067082274,0.00023904398],"genre_scores_gemma":[0.99926597,0.00016051035,0.00014383567,0.00002904969,0.000011888317,0.00003452053,0.00020299776,0.0000017328612,0.00014943826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997768,0.00008252819,0.000022134851,0.00004634713,0.00003987797,0.00003228363],"domain_scores_gemma":[0.9996784,0.00007422002,0.00011276736,0.000018850908,0.000018339217,0.00009751424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055560016,0.00041791232,0.00072438276,0.00020207952,0.00016675229,0.00038935101,0.00028338848,0.00031333702,0.0007192862],"category_scores_gemma":[0.0004976431,0.00015320466,0.00032270714,0.00023153142,0.00023225993,0.0002286913,0.00014301801,0.0007056833,0.00017800649],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3235622,0.010919375,0.34006572,0.00044963197,0.0014023528,0.00093832787,0.0003709034,0.007197311,0.124130905,0.00014909444,0.0019028443,0.18891127],"study_design_scores_gemma":[0.030940274,0.26495913,0.63983035,0.00007410342,0.0013145308,0.0025947252,0.00017429648,0.0136724,0.042016994,0.00020004471,0.004149834,0.00007336144],"about_ca_topic_score_codex":0.00036039003,"about_ca_topic_score_gemma":0.0013502571,"teacher_disagreement_score":0.00072438276,"about_ca_system_score_codex":0.0005179706,"about_ca_system_score_gemma":0.00037333978,"threshold_uncertainty_score":0.0037581325},"labels":[],"label_agreement":null},{"id":"W3081537514","doi":"10.1158/1557-3265.ovca19-ia12","title":"Abstract IA12: The Ovarian Tumour Tissue Analysis Consortium: Stratified Prognosis of Ovarian Tumors (OTTA-SPOT) signature for high-grade serous ovarian cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Serous fluid; Ovarian cancer; Medicine; Oncology; Serous ovarian cancer; Internal medicine; Survival analysis; Stage (stratigraphy); Cancer; Gene signature; Gene expression profiling; Cancer research; Gene; Pathology; Gene expression; Biology","score_opus":0.10911010935483385,"score_gpt":0.4338333837737218,"score_spread":0.324723274418888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081537514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9583054,0.0140621755,0.004522101,0.0006736822,0.00011172652,0.0001254949,0.020709883,0.00012980789,0.0013598064],"genre_scores_gemma":[0.98846227,0.00078068126,0.0009973778,0.00012442391,0.000049178874,0.00007854948,0.009158526,0.000035276444,0.0003138128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979457,0.00073561684,0.00020500428,0.00055613497,0.00043514,0.00012234035],"domain_scores_gemma":[0.99577063,0.0014725891,0.001412189,0.0005185167,0.00053592806,0.00029009362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046264734,0.00057075184,0.0012480791,0.0021144494,0.00040389813,0.0011641613,0.0007322197,0.00044743207,0.0013294789],"category_scores_gemma":[0.006149596,0.00019444458,0.0029189333,0.0036942216,0.00026660215,0.00027915396,0.0007870496,0.0004856338,0.00022056367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004216557,0.000046548612,0.95357394,0.0007987724,0.01839989,0.00018435546,0.00004610913,0.00214,0.0045056157,0.000114345945,0.002217252,0.013756655],"study_design_scores_gemma":[0.0002627467,0.0004610671,0.96548116,0.00013581304,0.020693248,0.00061771774,0.00008879613,0.0064138467,0.0023049642,0.00034327115,0.0031562126,0.00004111712],"about_ca_topic_score_codex":0.0060836836,"about_ca_topic_score_gemma":0.00680867,"teacher_disagreement_score":0.0060836836,"about_ca_system_score_codex":0.000660258,"about_ca_system_score_gemma":0.0008559639,"threshold_uncertainty_score":0.024467409},"labels":[],"label_agreement":null},{"id":"W3081572286","doi":"10.1158/1557-3265.ovca19-b25","title":"Abstract B25: SMARCA4/BRG1 and AP-1 co-regulate an epithelial-like signature in small-cell carcinoma of ovary, hypercalcemic type (SCCOHT)","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"SMARCA4; Biology; Carcinogenesis; Transcription factor; Chromatin immunoprecipitation; Gene; Cancer research; Chromatin remodeling; Molecular biology; Gene expression; Cell biology; Genetics; Promoter","score_opus":0.14489329157898453,"score_gpt":0.4363896479653528,"score_spread":0.2914963563863683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081572286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971552,0.0008161946,0.0007326854,0.000104744395,0.000030237701,0.000022293374,0.00044008688,0.00006218145,0.0006364079],"genre_scores_gemma":[0.99511,0.00022383267,0.0005788335,0.0000643886,0.000008266127,0.000032577944,0.0008779645,0.000019047542,0.0030849841],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998221,0.000019083864,0.000015194276,0.000035233206,0.0000661456,0.000042352727],"domain_scores_gemma":[0.9998696,0.000015052958,0.000038483493,0.000016796985,0.000012530047,0.000047551963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010292874,0.00029631087,0.00022598058,0.0003924587,0.0001762045,0.00029251986,0.00019307487,0.0002713548,0.002227637],"category_scores_gemma":[0.000098756784,0.00016462032,0.0002510319,0.00023266353,0.00024761813,0.000085436404,0.00021106249,0.0005085686,0.00061119325],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005304678,0.000017229391,0.00046303982,0.000012232892,0.0000030802255,0.000113487884,0.000007685601,0.000013194846,0.9990175,0.000031874224,0.00004050211,0.00022715647],"study_design_scores_gemma":[0.000048719347,0.0003574373,0.05319393,0.0000068546874,0.000028694812,0.0020224426,0.00009481049,0.0009335828,0.9394413,0.000054634307,0.003812708,0.0000048573556],"about_ca_topic_score_codex":0.0010490237,"about_ca_topic_score_gemma":0.0011371494,"teacher_disagreement_score":0.002227637,"about_ca_system_score_codex":0.00031516547,"about_ca_system_score_gemma":0.00015663757,"threshold_uncertainty_score":0.00745219},"labels":[],"label_agreement":null},{"id":"W3081580576","doi":"10.1158/1557-3265.ovca19-b15","title":"Abstract B15: BRCA haploinsufficiency promotes gluconeogenesis in fallopian tube epithelial cells","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Cancer research; Ovarian cancer; Cancer; Genetics","score_opus":0.27079254864067154,"score_gpt":0.48897631166554273,"score_spread":0.2181837630248712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081580576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950701,0.0010858455,0.00044762346,0.00015468561,0.00004953337,0.00003458643,0.0015413723,0.00006897191,0.0015471814],"genre_scores_gemma":[0.9940566,0.00047358155,0.0006229943,0.00010336255,0.000007484053,0.000054415228,0.0018989404,0.000015032687,0.0027675913],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998809,0.000019655761,0.00001886165,0.00002728469,0.000027911303,0.000025434045],"domain_scores_gemma":[0.99991333,0.000018686387,0.000015150112,0.000015160171,0.000009452656,0.000028236733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000121458936,0.00013737324,0.00019881256,0.00028124652,0.00016465782,0.0002601465,0.00014780986,0.00022186758,0.004075836],"category_scores_gemma":[0.00011421633,0.00009075116,0.00015495725,0.00024613543,0.00017624028,0.00007915502,0.00015799765,0.0002869854,0.00056504435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000520249,0.00010390993,0.0014428475,0.00009028988,0.000010420401,0.00025013593,0.000046206776,0.000062506435,0.9943072,0.00013763402,0.0005345118,0.002494056],"study_design_scores_gemma":[0.00017075175,0.0016121841,0.07945579,0.000041962685,0.000050939805,0.0014300531,0.0002377484,0.0017289532,0.89962196,0.000149558,0.015487578,0.000012468595],"about_ca_topic_score_codex":0.0016739682,"about_ca_topic_score_gemma":0.0015043969,"teacher_disagreement_score":0.004075836,"about_ca_system_score_codex":0.00021398035,"about_ca_system_score_gemma":0.0002551657,"threshold_uncertainty_score":0.01363498},"labels":[],"label_agreement":null},{"id":"W3081585330","doi":"10.1158/1078-0432.ccr-20-1037","title":"Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with <i>BRAF</i> -Mutant Metastatic Non–Small Cell Lung Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fondation ARC pour la Recherche sur le Cancer; Agence Nationale de la Recherche; CNIB","keywords":"Cancer research; Medicine; Lung cancer; Targeted therapy; Cancer; Mutant; Mutation; MAPK/ERK pathway; Oncology; MEK inhibitor; Internal medicine; Kinase; Biology; Gene; Genetics","score_opus":0.03991987997554902,"score_gpt":0.3516546455948795,"score_spread":0.3117347656193305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081585330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994097,0.00012354649,0.00016532866,0.000023568111,0.00000285112,0.000005243722,0.00013049919,0.0000057231737,0.00013360739],"genre_scores_gemma":[0.9994822,0.000032409276,0.00014402908,0.00002758044,0.000007532383,0.0000052227215,0.00017614999,0.000002173281,0.00012274637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981064,0.000043115506,0.000013987267,0.000072464194,0.000030612628,0.000029235884],"domain_scores_gemma":[0.99944764,0.00016816986,0.00019884745,0.000031674695,0.00007782709,0.00007590333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036594237,0.00027333517,0.00034326105,0.0005671613,0.00023306851,0.0005283434,0.00019857593,0.00040382516,0.0018194468],"category_scores_gemma":[0.0011867858,0.00016088971,0.00015800835,0.00033382126,0.00018619292,0.00024993307,0.00016053526,0.0002622093,0.00029250677],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006591762,0.00007677721,0.97944975,0.000023884983,0.00004600738,0.0002729657,0.000121510515,0.00018960524,0.013273024,0.000041334144,0.00020367937,0.005642251],"study_design_scores_gemma":[0.0000367787,0.000580682,0.9927676,0.000007825911,0.000049421393,0.0014486619,0.00022177708,0.0014843077,0.00265917,0.00008376651,0.00065355736,0.000006471798],"about_ca_topic_score_codex":0.0012386875,"about_ca_topic_score_gemma":0.0010572321,"teacher_disagreement_score":0.0018194468,"about_ca_system_score_codex":0.0003194453,"about_ca_system_score_gemma":0.000171574,"threshold_uncertainty_score":0.006086707},"labels":[],"label_agreement":null},{"id":"W3081683990","doi":"10.1158/1557-3265.ovca19-a20","title":"Abstract A20: Characterizing chromosome instability in chemonaïve, chemosensitive, and chemoresistant high-grade serous ovarian cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Chromosome instability; Serous fluid; Cancer research; Cancer; Biology; Fluorescence in situ hybridization; Ovarian cancer; Aneuploidy; Chromosome; Genome instability; Cell; Pathology; Medicine; Genetics; Gene; DNA damage","score_opus":0.21575253268963548,"score_gpt":0.46320195287107513,"score_spread":0.24744942018143964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081683990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984921,0.0002925016,0.00048063303,0.00001233778,0.000002825349,0.000020325833,0.0002518887,0.000015618907,0.00043176048],"genre_scores_gemma":[0.9984029,0.00010756922,0.00055835355,0.000022203352,0.0000023626274,0.000022359214,0.0005175177,0.000005510788,0.00036120942],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99990606,0.000012804641,0.000010505034,0.00002296165,0.000029588184,0.000018120163],"domain_scores_gemma":[0.99981517,0.000037355974,0.00004161617,0.00002112433,0.000043368498,0.000041360847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017197676,0.00011979511,0.0001435781,0.00068150455,0.00015205027,0.00021900728,0.00010249075,0.00020907856,0.0014351316],"category_scores_gemma":[0.00032210498,0.00007176761,0.00009702182,0.00037549337,0.00013604722,0.00010572717,0.00017199233,0.00015062786,0.00016593511],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060939405,0.000067935594,0.10466739,0.000053387274,0.00002084675,0.0003443122,0.00012434274,0.0001720436,0.8863077,0.000068515255,0.00013747916,0.0074266335],"study_design_scores_gemma":[0.000033653017,0.0010604126,0.8104514,0.000008353754,0.00003734742,0.0037401943,0.00035162203,0.0025248178,0.17845337,0.000078954035,0.0032494552,0.000010497299],"about_ca_topic_score_codex":0.0012366924,"about_ca_topic_score_gemma":0.0014602231,"teacher_disagreement_score":0.0014351316,"about_ca_system_score_codex":0.00015064998,"about_ca_system_score_gemma":0.00008127513,"threshold_uncertainty_score":0.0048009753},"labels":[],"label_agreement":null},{"id":"W3081728205","doi":"10.1158/1557-3265.ovca19-b23","title":"Abstract B23: CDK4/6 and MEK inhibitor combination in low-grade serous ovarian cancer cell lines","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Western University; University of British Columbia","funders":"","keywords":"Palbociclib; Trametinib; CDKN2A; Cancer research; Cyclin-dependent kinase 6; MEK inhibitor; Ovarian cancer; Medicine; Cancer; Oncology; Cell cycle; Internal medicine; Biology; Cyclin-dependent kinase; Breast cancer; Kinase; MAPK/ERK pathway; Metastatic breast cancer; Genetics","score_opus":0.21134993783408693,"score_gpt":0.5066971788215023,"score_spread":0.2953472409874154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081728205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98684454,0.0048850356,0.0010702265,0.00018387129,0.00008833455,0.00020005995,0.0031964947,0.00019437354,0.003336984],"genre_scores_gemma":[0.9868776,0.0021562364,0.0024112528,0.00012852272,0.00002101079,0.0002696081,0.0046333284,0.00002641357,0.0034758898],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997862,0.000051190847,0.000032652035,0.000029950304,0.00006683342,0.000033121534],"domain_scores_gemma":[0.9998518,0.000025506466,0.0000135426735,0.00003097549,0.00004134328,0.00003667628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028398595,0.00031447486,0.0006063906,0.00043551927,0.00028526218,0.00040618802,0.0003708574,0.0002791074,0.0032410459],"category_scores_gemma":[0.00017149959,0.00012309842,0.00035890818,0.0005419349,0.00013082579,0.00013949022,0.00017649573,0.00066534965,0.00083340064],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00414878,0.0023794128,0.00678854,0.00082276505,0.0002061278,0.00067033473,0.0002042964,0.0017430674,0.93822557,0.00028185642,0.006182614,0.038346626],"study_design_scores_gemma":[0.00081147224,0.01034479,0.02476334,0.000052066902,0.00025562517,0.0014147335,0.00016818466,0.0036615257,0.93742526,0.00006949762,0.021006739,0.000026825168],"about_ca_topic_score_codex":0.0034340578,"about_ca_topic_score_gemma":0.0044635655,"teacher_disagreement_score":0.0034340578,"about_ca_system_score_codex":0.0002734363,"about_ca_system_score_gemma":0.000423561,"threshold_uncertainty_score":0.010842323},"labels":[],"label_agreement":null},{"id":"W3081752008","doi":"10.1158/1557-3265.ovca19-b17","title":"Abstract B17: Modeling ovarian cancer in mice using in vivo electroporation and CRISPR-mediated genome editing","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Spinal Cord Injury BC; McGill University","funders":"","keywords":"Ovarian cancer; Biology; Cancer research; Metastasis; Cancer; Fallopian tube; Serous fluid; Ovarian carcinoma; Electroporation; Carcinogenesis; Pathology; Medicine; Gene; Genetics","score_opus":0.129065900603426,"score_gpt":0.49461079838572136,"score_spread":0.3655448977822954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081752008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7068438,0.0034305772,0.25743428,0.0016020673,0.0008027842,0.0014047046,0.008046368,0.005188585,0.015246841],"genre_scores_gemma":[0.8173411,0.0041395626,0.13727655,0.0007145913,0.00009585383,0.002633041,0.004851289,0.001239506,0.03170849],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999539,0.000058567955,0.00005530131,0.00011942794,0.00014036638,0.00008730871],"domain_scores_gemma":[0.99960893,0.00005030995,0.00013274475,0.00004861707,0.00003498865,0.00012442835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064279145,0.00066639617,0.00050097273,0.0012226932,0.00031934056,0.0007323341,0.0008031808,0.0012046518,0.004190591],"category_scores_gemma":[0.00026568587,0.00056788157,0.0007637209,0.00035502308,0.0006589938,0.00042764022,0.0006695329,0.00167123,0.001119696],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021335574,0.00015286867,0.00040824234,0.00014572204,0.000029239285,0.0002139756,0.00007152604,0.0010780579,0.99035877,0.0018308632,0.0006759036,0.004821474],"study_design_scores_gemma":[0.00021372615,0.0010526035,0.0020818124,0.000087533874,0.00010466186,0.0011910078,0.00008106406,0.008975782,0.94648325,0.0007859079,0.038894597,0.000048069836],"about_ca_topic_score_codex":0.0014027982,"about_ca_topic_score_gemma":0.0013531292,"teacher_disagreement_score":0.004190591,"about_ca_system_score_codex":0.0004306942,"about_ca_system_score_gemma":0.00053763215,"threshold_uncertainty_score":0.014018953},"labels":[],"label_agreement":null},{"id":"W3081872965","doi":"10.1158/1557-3265.ovca19-b78","title":"Abstract B78: Improving chemotherapy response of immunologically cold high-grade serous ovarian cancer with loss of PTEN using STING agonist","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"PTEN; Ovarian cancer; Cancer research; CD8; Carboplatin; Tumor microenvironment; Biology; Immune system; Chemotherapy; Medicine; Cancer; Immunology; Cisplatin; Internal medicine; PI3K/AKT/mTOR pathway; Apoptosis","score_opus":0.17442062526095364,"score_gpt":0.44368292081746646,"score_spread":0.2692622955565128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081872965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997948,0.0005767964,0.00049619994,0.00008370936,0.000039279275,0.000039631697,0.00014748459,0.000040862917,0.0006280487],"genre_scores_gemma":[0.9967033,0.0005074702,0.0008894352,0.00008061939,0.00001788707,0.000058701993,0.00024386149,0.000008230638,0.0014904842],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999391,0.0000067965366,0.0000051878096,0.000010089869,0.000016101621,0.0000226337],"domain_scores_gemma":[0.99995327,0.0000032450273,0.000012584101,0.0000040108052,0.0000030335782,0.0000238812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008732903,0.00025295033,0.00028635786,0.00021755978,0.00008408652,0.00016323185,0.00018409712,0.00021788258,0.0015772494],"category_scores_gemma":[0.00007039967,0.00008071132,0.00019325408,0.00013663057,0.00014875193,0.00014468555,0.00014943504,0.00052928145,0.00024621948],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014832473,0.00061750744,0.0004450391,0.00009997745,0.00001554142,0.000071064664,0.000020342863,0.00022898405,0.98745817,0.00009757769,0.00021819577,0.0092444895],"study_design_scores_gemma":[0.00070525403,0.020597609,0.010147259,0.000024149203,0.00009708703,0.0005326853,0.00005878398,0.00210964,0.96039176,0.00009353337,0.005228186,0.000014136571],"about_ca_topic_score_codex":0.00024012878,"about_ca_topic_score_gemma":0.00040320068,"teacher_disagreement_score":0.0015772494,"about_ca_system_score_codex":0.000111920104,"about_ca_system_score_gemma":0.0001585816,"threshold_uncertainty_score":0.0052764416},"labels":[],"label_agreement":null},{"id":"W3081919169","doi":"10.1158/1557-3265.ovca19-b74","title":"Abstract B74: Identifying conserved properties of the epithelial-mesenchymal transition in cancer using highly multiplexed single-cell RNA sequencing","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Epithelial–mesenchymal transition; Biology; Vimentin; Cancer research; Metastasis; Cancer; Genetics; Immunology","score_opus":0.37256042302417275,"score_gpt":0.4425755350657491,"score_spread":0.07001511204157634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081919169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79198015,0.0034974653,0.17063852,0.00053065707,0.00023417461,0.00034382363,0.02426545,0.0034653384,0.005044461],"genre_scores_gemma":[0.80544746,0.0014466265,0.16879095,0.0004971394,0.000091038506,0.0005541243,0.01796543,0.0006451243,0.004562143],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999393,0.00006827432,0.000030085037,0.00024416394,0.00020009569,0.0000642964],"domain_scores_gemma":[0.99954826,0.00015488066,0.00008839347,0.000051383136,0.000115275165,0.0000417769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007723008,0.0004274733,0.0004862932,0.00062271225,0.00046548524,0.0007630127,0.00037405262,0.0005547495,0.0016233472],"category_scores_gemma":[0.00084334525,0.00026503287,0.00041360382,0.0005425091,0.00033264107,0.0002566049,0.00029931313,0.00067828974,0.00080706546],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107275366,0.000029812712,0.0019892,0.0001191674,0.000028280618,0.00003403615,0.000051824045,0.0012485945,0.9859373,0.00029695875,0.0006640801,0.009493319],"study_design_scores_gemma":[0.000027290458,0.00033717722,0.045394313,0.00003692818,0.00008335301,0.00027528105,0.00011164294,0.040240288,0.8986383,0.0009496141,0.0138505455,0.00005525019],"about_ca_topic_score_codex":0.0015931975,"about_ca_topic_score_gemma":0.004058819,"teacher_disagreement_score":0.0016233472,"about_ca_system_score_codex":0.0004216814,"about_ca_system_score_gemma":0.0005314395,"threshold_uncertainty_score":0.005430579},"labels":[],"label_agreement":null},{"id":"W3081960426","doi":"10.1158/1557-3265.ovca19-b09","title":"Abstract B09: Single-cell RNA sequencing of normal endometrial organoids uncovers novel cell-type markers for prognostication of primary tumor samples","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Biology; Pathology; Population; Organoid; Staining; Epithelium; Cell type; Cell; Clear cell; Immunohistochemistry; Cell biology; Immunology; Medicine","score_opus":0.35111697221303606,"score_gpt":0.460006824660809,"score_spread":0.10888985244777294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081960426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95414835,0.0018020795,0.029030303,0.000118814074,0.00007570042,0.00016566234,0.011724488,0.00053169864,0.0024028802],"genre_scores_gemma":[0.93793106,0.0008347211,0.041341096,0.00015922457,0.000026274847,0.0004387295,0.015899725,0.0002746084,0.0030945817],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99966574,0.000035730824,0.000030031266,0.00014345026,0.00008465244,0.000040433766],"domain_scores_gemma":[0.99970824,0.00007994926,0.000038934926,0.00005158448,0.00008621392,0.00003507351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034475818,0.00030904793,0.0003385157,0.00069238595,0.00033440226,0.0004952687,0.00017326223,0.00030914843,0.0014458927],"category_scores_gemma":[0.00054205704,0.00017388254,0.00025326308,0.00041558032,0.00021118327,0.000105019186,0.00020015312,0.0002935768,0.0011663679],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016112828,0.0000091303755,0.0035596977,0.000039540897,0.000011176169,0.00007817704,0.000050400966,0.00012286525,0.99250096,0.00003397011,0.0001462166,0.0032868788],"study_design_scores_gemma":[0.00003222201,0.00043463617,0.11768138,0.000032181317,0.000110671775,0.0011952951,0.00023653498,0.0069319303,0.86300844,0.00018575105,0.010125529,0.000025332236],"about_ca_topic_score_codex":0.0010259061,"about_ca_topic_score_gemma":0.0013124826,"teacher_disagreement_score":0.0014458927,"about_ca_system_score_codex":0.00025161824,"about_ca_system_score_gemma":0.0002407707,"threshold_uncertainty_score":0.0048369765},"labels":[],"label_agreement":null},{"id":"W3082003040","doi":"10.1158/1557-3265.ovca19-a61","title":"Abstract A61: FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Ovarian cancer; Cisplatin; Wnt signaling pathway; Cancer; Cancer cell; KRAS; Chemotherapy; Biology; Signal transduction; Medicine; Internal medicine; Cell biology; Colorectal cancer","score_opus":0.10917654808904187,"score_gpt":0.452831612145723,"score_spread":0.3436550640566811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082003040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984092,0.00024114159,0.00034703434,0.000048852085,0.000011710644,0.0000077271425,0.0004086413,0.000027045946,0.00049874437],"genre_scores_gemma":[0.99703974,0.000166109,0.0002948878,0.000031768133,0.000005525225,0.000011134809,0.0006290094,0.000009444648,0.0018123998],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999908,0.000005164556,0.000007658999,0.00002373128,0.00003389194,0.000021654136],"domain_scores_gemma":[0.9999316,0.000007636394,0.000026239659,0.000008747049,0.0000076912975,0.000018039085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056134948,0.00015667744,0.00017766785,0.000259055,0.00015770069,0.0003059107,0.00007515677,0.00016913557,0.0016349863],"category_scores_gemma":[0.00010189902,0.00008391438,0.00014095914,0.00018634087,0.00013169117,0.000097073185,0.00016856482,0.0002848442,0.00027106208],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015374698,0.000015241518,0.002657822,0.000017087543,0.0000046483783,0.000102888545,0.000012509778,0.00004559712,0.9944324,0.0000722991,0.00008547765,0.0024002448],"study_design_scores_gemma":[0.000037095302,0.00060793984,0.1334665,0.000012529453,0.00005112414,0.0015016466,0.00014314824,0.0023164388,0.857511,0.00019896771,0.0041418793,0.000011767043],"about_ca_topic_score_codex":0.0004352684,"about_ca_topic_score_gemma":0.0006145083,"teacher_disagreement_score":0.0016349863,"about_ca_system_score_codex":0.00024575696,"about_ca_system_score_gemma":0.00015300626,"threshold_uncertainty_score":0.0054695606},"labels":[],"label_agreement":null},{"id":"W3082009283","doi":"10.1158/1557-3265.ovca19-a29","title":"Abstract A29: Anticancer effects of polo-like kinase-4 inhibitor (CFI-400945) in ovarian cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ovarian cancer; Biology; Cell cycle; Cancer research; Cancer; Mitosis; Carcinogenesis; Propidium iodide; Cell growth; Viability assay; Mitotic catastrophe; BUB1; Cancer cell; Molecular biology; Cell; Apoptosis; Cell biology; Programmed cell death; Genetics; Gene","score_opus":0.08396940545288109,"score_gpt":0.4509874401042446,"score_spread":0.3670180346513635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082009283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98889554,0.005542885,0.0006626633,0.00019040017,0.00007412533,0.00011061358,0.0011068033,0.00011621837,0.0033006559],"genre_scores_gemma":[0.9911049,0.0021835444,0.0010762787,0.00011857265,0.000022280841,0.000064412874,0.0016123597,0.000012707826,0.003804837],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999498,0.000007878936,0.0000068320724,0.0000099175495,0.000013854547,0.00001182199],"domain_scores_gemma":[0.9999436,0.00001451499,0.0000096064205,0.0000053774293,0.0000102100485,0.00001656267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010605443,0.00027828052,0.00030451457,0.00043814376,0.00014241895,0.00014597109,0.00015479008,0.00025213504,0.003531509],"category_scores_gemma":[0.00010418789,0.00007827216,0.000219165,0.00029812753,0.000100475336,0.00012387629,0.00011889019,0.0004450228,0.0003453676],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022392783,0.0006534529,0.0012133463,0.0003840036,0.000039987764,0.00031802544,0.000034436285,0.00047149154,0.968592,0.000118390155,0.0008325726,0.025103003],"study_design_scores_gemma":[0.0004570019,0.008478642,0.017125387,0.000028486396,0.00011132579,0.0009221952,0.000052571282,0.0015012271,0.9616252,0.00008678896,0.009599588,0.000011576674],"about_ca_topic_score_codex":0.0009321563,"about_ca_topic_score_gemma":0.0007979548,"teacher_disagreement_score":0.003531509,"about_ca_system_score_codex":0.00018286497,"about_ca_system_score_gemma":0.00026397218,"threshold_uncertainty_score":0.011814117},"labels":[],"label_agreement":null},{"id":"W3082195774","doi":"10.1158/1557-3265.ovca19-b20","title":"Abstract B20: Endometrial cancer molecular risk stratification in endometrioid ovarian cancers: A novel application of precision medicine","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Endometrial cancer; Medicine; Oncology; Internal medicine; Cohort; Biomarker; Ovarian cancer; Risk stratification; Stage (stratigraphy); Carcinoma; Cancer; Gynecology; Biology","score_opus":0.2736672719692938,"score_gpt":0.5276586418675896,"score_spread":0.2539913698982958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082195774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5921883,0.16848247,0.17783171,0.02357691,0.0013599892,0.00030968414,0.004118258,0.0017741764,0.030358452],"genre_scores_gemma":[0.9273015,0.012417116,0.05424603,0.0016496162,0.0009406076,0.00008212497,0.0010744688,0.00007498686,0.0022135056],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99930704,0.00024578528,0.000051242343,0.0001887611,0.0001668555,0.000040279498],"domain_scores_gemma":[0.99896026,0.00038928955,0.00028232572,0.00011575161,0.00018762253,0.00006470558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027267742,0.0005003695,0.0007643153,0.0018782001,0.0003850073,0.0021206713,0.00055210677,0.00076350215,0.0026003243],"category_scores_gemma":[0.003609055,0.00027295758,0.0005235623,0.0011396257,0.0005086418,0.0007556591,0.00080991065,0.0009027481,0.00076783844],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001466473,0.00024454203,0.1688918,0.0009044221,0.0006080127,0.0004102943,0.00026974897,0.006516039,0.0721246,0.008317142,0.009866127,0.73038083],"study_design_scores_gemma":[0.0006527897,0.0034216787,0.60076743,0.0018045335,0.0019128094,0.0069028903,0.00074829935,0.11085874,0.08123358,0.06859045,0.12277095,0.00033571155],"about_ca_topic_score_codex":0.00093738694,"about_ca_topic_score_gemma":0.0010665928,"teacher_disagreement_score":0.0027267742,"about_ca_system_score_codex":0.0009212677,"about_ca_system_score_gemma":0.0007415246,"threshold_uncertainty_score":0.014420748},"labels":[],"label_agreement":null},{"id":"W3082323076","doi":"10.1158/1557-3265.aacrahns19-pr02","title":"Abstract PR02: Mutational analysis of head and neck squamous cell carcinoma stratified by smoking status","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Western University","funders":"","keywords":"Cohort; Hazard ratio; Oncology; Internal medicine; Head and neck squamous-cell carcinoma; Medicine; Biomarker; Head and neck cancer; Cancer; Biology; Genetics; Confidence interval","score_opus":0.14664713453045164,"score_gpt":0.46046830920406023,"score_spread":0.3138211746736086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082323076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801664,0.0060888934,0.00069599674,0.00016477761,0.00006573618,0.000042479114,0.011568996,0.000040286137,0.0011665099],"genre_scores_gemma":[0.99572206,0.00035233094,0.00018001122,0.00006121396,0.00003150358,0.000015357045,0.00296415,0.000011733315,0.00066179904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991578,0.00016486006,0.00010766319,0.00032959075,0.00017953066,0.000060592727],"domain_scores_gemma":[0.99861586,0.00041514437,0.00041346927,0.00019909527,0.00023937732,0.00011706619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013224139,0.000279179,0.00044846092,0.0012257845,0.00026927036,0.00076177757,0.00063153106,0.000445464,0.00466123],"category_scores_gemma":[0.002916822,0.00019531028,0.0017817698,0.001629823,0.00016983954,0.00035911234,0.00044361537,0.00039547792,0.00050041574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021427602,0.000025458612,0.9809955,0.00025005432,0.0027812603,0.000111493115,0.00003861968,0.00025012778,0.0021699357,0.000043675198,0.0010152207,0.010176019],"study_design_scores_gemma":[0.000034620054,0.00016102422,0.9964051,0.000030815387,0.0012955822,0.00029980438,0.000043859694,0.000469153,0.00040862962,0.00007609431,0.0007691621,0.000006243313],"about_ca_topic_score_codex":0.005818128,"about_ca_topic_score_gemma":0.0069199116,"teacher_disagreement_score":0.005818128,"about_ca_system_score_codex":0.00024230398,"about_ca_system_score_gemma":0.000283905,"threshold_uncertainty_score":0.01559335},"labels":[],"label_agreement":null},{"id":"W3082378104","doi":"10.1158/1557-3265.ovca19-b30","title":"Abstract B30: The effect of OCP use on the incidence of precancerous p53 lesions in fallopian tube fimbria","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Serous fluid; Fallopian tube; Immunohistochemistry; Serous carcinoma; Cohort; Ovarian cancer; Fimbria; Gynecology; Cancer; Internal medicine; Gastroenterology; Oncology; Biology","score_opus":0.3328179012131451,"score_gpt":0.5237653982364876,"score_spread":0.19094749702334252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082378104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982052,0.00052327494,0.000042961135,0.000050958628,0.000015045482,0.000031174815,0.00059659255,0.0000055302166,0.00052932143],"genre_scores_gemma":[0.99849343,0.00014793889,0.00007804237,0.000036125213,0.000014482527,0.000030808904,0.00033773374,0.0000021078674,0.0008592246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997154,0.00007411031,0.000023766772,0.00005939407,0.000073329305,0.000054091917],"domain_scores_gemma":[0.9985746,0.00043459528,0.0004482104,0.00007630931,0.00014181131,0.00032447066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061698304,0.00024233495,0.00031468927,0.0005291286,0.00020970928,0.00033522293,0.00023469616,0.00044538247,0.0045990734],"category_scores_gemma":[0.0018546697,0.00012307096,0.00047037267,0.00036210354,0.00020319087,0.00019573422,0.00019507782,0.00042900434,0.0004035246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05070111,0.0021754273,0.90200067,0.00025040781,0.00053869875,0.00035451815,0.000108194334,0.00016999734,0.009032469,0.000033432287,0.0009045629,0.033730622],"study_design_scores_gemma":[0.00015906652,0.0065656225,0.99107283,0.000011175894,0.00014795188,0.00017157286,0.000033225788,0.000121519464,0.0012356834,0.000015455846,0.00046171137,0.0000041809326],"about_ca_topic_score_codex":0.0036232737,"about_ca_topic_score_gemma":0.002257162,"teacher_disagreement_score":0.0045990734,"about_ca_system_score_codex":0.0002879523,"about_ca_system_score_gemma":0.0003633645,"threshold_uncertainty_score":0.015385389},"labels":[],"label_agreement":null},{"id":"W3082463050","doi":"10.1158/1557-3265.ovca19-b68","title":"Abstract B68: Characterization of microtentacle phenotype and function in ovarian carcinomas","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Serous fluid; Ovarian cancer; Cancer research; Paclitaxel; Phenotype; Cell; Clear cell; Biology; Cell culture; Ovary; Clear cell carcinoma; Cancer; Pathology; Medicine; Carcinoma; Internal medicine; Endocrinology; Genetics","score_opus":0.09823373659038087,"score_gpt":0.39928781956033993,"score_spread":0.30105408296995906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082463050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998262,0.0002908441,0.0005675183,0.000011673662,0.0000038359544,0.000009310552,0.00019075332,0.000016936681,0.0006470986],"genre_scores_gemma":[0.99632853,0.00021053686,0.0012843896,0.000012651067,0.0000036642996,0.00002436797,0.0006146592,0.000009291083,0.001511805],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99994326,0.000004420901,0.0000062338695,0.000011548101,0.000019448275,0.000015084505],"domain_scores_gemma":[0.9999064,0.000009293839,0.000024170284,0.000008378373,0.000023372015,0.000028309769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051839088,0.00012296655,0.00008380098,0.0004224046,0.00010595042,0.00014816955,0.00006758542,0.00014179751,0.0015632705],"category_scores_gemma":[0.00008956328,0.000060880644,0.00008715839,0.00021179204,0.000066471206,0.000103193204,0.00010297901,0.000101751044,0.00034566506],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076956516,0.000007947411,0.003774957,0.000016888922,0.000002306962,0.0000686818,0.000019068864,0.00001560121,0.99458545,0.000017286531,0.000017389742,0.0013974643],"study_design_scores_gemma":[0.000018799952,0.00049491593,0.32907924,0.000013672848,0.000019809571,0.0024697348,0.00026865635,0.0016706272,0.6612613,0.0000641865,0.004628973,0.000010171219],"about_ca_topic_score_codex":0.00083826215,"about_ca_topic_score_gemma":0.00090727216,"teacher_disagreement_score":0.0015632705,"about_ca_system_score_codex":0.00010932975,"about_ca_system_score_gemma":0.00007550935,"threshold_uncertainty_score":0.0052297115},"labels":[],"label_agreement":null},{"id":"W3082472664","doi":"10.1158/1557-3265.aacrahns19-b13","title":"Abstract B13: Utilizing metabolic reprogramming to regulate fibroblast phenotype and reduce radiation fibrosis","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Extracellular matrix; Cell biology; Fibrosis; Fibroblast; Extracellular; Catabolism; Biology; Chemistry; Cancer research; Biochemistry; Metabolism; Internal medicine; Medicine","score_opus":0.15286944115330237,"score_gpt":0.459307420152495,"score_spread":0.3064379789991926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082472664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732213,0.004126189,0.0147179635,0.00047115472,0.00025004076,0.00019371432,0.0012002817,0.00035981464,0.0054595494],"genre_scores_gemma":[0.9771962,0.0026458108,0.010289424,0.00027933222,0.000032521442,0.00019807866,0.0011261035,0.000065941924,0.008166628],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987173,0.000013626792,0.00001301069,0.00003429724,0.000038326343,0.000028927041],"domain_scores_gemma":[0.9999261,0.000009451388,0.000020855347,0.000009110695,0.000013391203,0.000021135942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017468154,0.0004195619,0.00031629848,0.00024201353,0.00020835438,0.000348588,0.00025065735,0.000561955,0.0034655472],"category_scores_gemma":[0.000103848375,0.00012197449,0.0004287752,0.00020557927,0.00022987726,0.00018425236,0.0002506994,0.0005406623,0.000611874],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022399153,0.000054346743,0.000118932534,0.00010215127,0.000007485862,0.000030144618,0.000008089362,0.00008259715,0.996086,0.00012641591,0.00009148166,0.0030684194],"study_design_scores_gemma":[0.00004408972,0.00077956694,0.0017325163,0.000016753222,0.00003676646,0.00018853434,0.00002128732,0.00047507856,0.9921079,0.00008623784,0.0045033856,0.00000774451],"about_ca_topic_score_codex":0.00054490956,"about_ca_topic_score_gemma":0.0005755243,"teacher_disagreement_score":0.0034655472,"about_ca_system_score_codex":0.00022497037,"about_ca_system_score_gemma":0.00028769654,"threshold_uncertainty_score":0.011593342},"labels":[],"label_agreement":null},{"id":"W3082502320","doi":"10.1158/1557-3265.ovca19-b80","title":"Abstract B80: Predictive treatment response models for epithelial ovarian cancer: Comparison of 2D, 3D, and in vivo models","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Carboplatin; Clonogenic assay; In vivo; Medicine; Flow cytometry; Ovarian cancer; Oncology; Cancer research; Cell culture; Cancer; Internal medicine; Chemotherapy; Immunology; Biology; Cisplatin","score_opus":0.4434920125753466,"score_gpt":0.5492669548155007,"score_spread":0.1057749422401541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082502320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7841269,0.0051458282,0.19120017,0.0008138002,0.0001866683,0.00041734966,0.007245952,0.0021345154,0.008728924],"genre_scores_gemma":[0.94478893,0.0026264815,0.044360425,0.00014534759,0.0000260009,0.00039508837,0.004252981,0.00020883477,0.0031959126],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99970216,0.000085326246,0.000025136807,0.00005316709,0.00010602841,0.000028121056],"domain_scores_gemma":[0.9994537,0.00022924587,0.000103075676,0.00007741709,0.000088524386,0.00004801526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008487461,0.0007820332,0.00045195816,0.0010469995,0.00017258473,0.0009782345,0.00046197494,0.0007182173,0.002028643],"category_scores_gemma":[0.0006687708,0.00033701787,0.0008010257,0.00067760836,0.00026332017,0.00039862556,0.00041475377,0.00063687126,0.0006154827],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002030151,0.0012562397,0.017280933,0.00086124433,0.00026296632,0.00035293476,0.00025780732,0.32240507,0.5833238,0.0024123543,0.004020834,0.06553564],"study_design_scores_gemma":[0.00012494651,0.0014449713,0.015734538,0.000056025376,0.0001547344,0.0005135824,0.000135487,0.79320186,0.17945291,0.0011323488,0.007950072,0.000098544726],"about_ca_topic_score_codex":0.0050254967,"about_ca_topic_score_gemma":0.0028395283,"teacher_disagreement_score":0.0050254967,"about_ca_system_score_codex":0.0006983265,"about_ca_system_score_gemma":0.0004284291,"threshold_uncertainty_score":0.00999248},"labels":[],"label_agreement":null},{"id":"W3082625691","doi":"10.1158/1557-3265.ovca19-a03","title":"Abstract A03: PrOTYPE (Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE): The development and validation of a clinical-grade consensus classifier for the molecular subtypes of high-grade serous tubo-ovarian cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Serous fluid; Oncology; Ovarian cancer; Ovarian carcinoma; Subtyping; Serous carcinoma; Internal medicine; Medicine; Serous ovarian cancer; Bioinformatics; Biology; Cancer","score_opus":0.21686505764707673,"score_gpt":0.4494716190603984,"score_spread":0.23260656141332167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082625691","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96797335,0.00027448396,0.016628873,0.0002978975,0.00004844315,0.00028054143,0.012439048,0.00055071164,0.0015066565],"genre_scores_gemma":[0.9631728,0.000048436348,0.014335097,0.00009386524,0.000024591662,0.00015101214,0.02149672,0.000045655874,0.0006319044],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986318,0.00037626803,0.00014982888,0.00037151462,0.0003455249,0.00012510818],"domain_scores_gemma":[0.99643886,0.001337753,0.00047128464,0.00046142223,0.0009169592,0.0003736825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040343837,0.00066615734,0.00057261257,0.001292764,0.00041923687,0.0011286578,0.0010362378,0.00079510536,0.001444654],"category_scores_gemma":[0.007066411,0.00015501799,0.0008294378,0.0006187532,0.00026971407,0.00034769883,0.0008898379,0.00072000665,0.0008623185],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014032361,0.00033825793,0.9021056,0.00013504548,0.00047223736,0.00011447442,0.00007240241,0.020739553,0.0059982645,0.0002428967,0.007362721,0.06101536],"study_design_scores_gemma":[0.0004694521,0.0011111819,0.6409675,0.00008784512,0.0005206098,0.00058063073,0.000244283,0.33291975,0.017009046,0.0014798114,0.004546412,0.00006346694],"about_ca_topic_score_codex":0.010150323,"about_ca_topic_score_gemma":0.012437641,"teacher_disagreement_score":0.010150323,"about_ca_system_score_codex":0.00088268245,"about_ca_system_score_gemma":0.0016745038,"threshold_uncertainty_score":0.021336138},"labels":[],"label_agreement":null},{"id":"W3082626489","doi":"10.1158/1557-3265.aacrahns19-a36","title":"Abstract A36: Impact of feeding tube use on swallowing-related quality of life and weight in oropharyngeal cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Swallowing; Feeding tube; Head and neck cancer; Dysphagia; Quality of life (healthcare); Gastrostomy; Internal medicine; Medical record; Radiation therapy; Weight change; Cancer; Weight loss; Physical therapy; Surgery; Obesity","score_opus":0.4824869306125832,"score_gpt":0.5807312704666258,"score_spread":0.09824433985404257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082626489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989195,0.00046708918,0.00002880992,0.000028771672,0.0000046844193,0.000010843244,0.00031427373,0.000002130755,0.00022395514],"genre_scores_gemma":[0.99950385,0.00011026377,0.000063990556,0.000012281278,0.000004691265,0.000008492402,0.00022336264,8.3731993e-7,0.000072189825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999553,0.00013705462,0.00007276668,0.00006834056,0.00010880134,0.000060015936],"domain_scores_gemma":[0.99838066,0.0002685492,0.0009920608,0.000038782153,0.00013574491,0.00018409634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074222207,0.00020908416,0.0003563255,0.0006606039,0.00027429458,0.00045732007,0.0002316195,0.00022903935,0.0015294016],"category_scores_gemma":[0.002964252,0.00011289789,0.00078484206,0.001029334,0.0001976247,0.00035387333,0.00044640258,0.0004006831,0.00016234786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025344494,0.00006299197,0.9960997,0.000033258348,0.00008338111,0.000026575104,0.000045691566,0.000043275788,0.00014142058,0.0000051557117,0.000075906915,0.0031290962],"study_design_scores_gemma":[0.0000061784017,0.00021539553,0.9993924,0.0000068578724,0.000030999137,0.00007152619,0.00004597824,0.000082143415,0.000060500923,0.0000053716008,0.000080696176,0.0000020001085],"about_ca_topic_score_codex":0.0031601214,"about_ca_topic_score_gemma":0.0038049803,"teacher_disagreement_score":0.0031601214,"about_ca_system_score_codex":0.00053226633,"about_ca_system_score_gemma":0.00035108716,"threshold_uncertainty_score":0.006283462},"labels":[],"label_agreement":null},{"id":"W3082964825","doi":"10.1158/1557-3265.ovca19-b29","title":"Abstract B29: Ovarian hormones regulate C/EBPD induced EMT/MET transition in the human fallopian tube epithelia","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Fallopian tube; Biology; Epithelial–mesenchymal transition; Ovarian cancer; Luteal phase; Estrogen receptor; Estrogen; Follicular phase; Internal medicine; Oviduct; Vimentin; Progesterone receptor; Cancer research; Immunohistochemistry; Endocrinology; Downregulation and upregulation; Breast cancer; Cancer; Medicine; Immunology; Gene; Genetics; Anatomy","score_opus":0.41849112727763477,"score_gpt":0.535127154435102,"score_spread":0.11663602715746718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082964825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994259,0.0022965623,0.0006517857,0.00009520148,0.000029617242,0.000041941315,0.0010165435,0.000027494534,0.0015817978],"genre_scores_gemma":[0.99114215,0.0012075687,0.0010211021,0.00008015894,0.000010406794,0.00006865329,0.001631416,0.000009284462,0.0048293076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999416,0.000009238175,0.000005095745,0.000011188216,0.00001505028,0.000017866583],"domain_scores_gemma":[0.999972,0.000005279025,0.0000046022783,0.0000033524434,0.0000059129325,0.000008792356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006992769,0.0001323878,0.00018745482,0.0002312843,0.00018359996,0.00021091905,0.0000771595,0.00014469396,0.0031567854],"category_scores_gemma":[0.000080737496,0.00008479989,0.00016346735,0.00019449445,0.00013140065,0.000093142386,0.00011311038,0.00020235815,0.00047890586],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088104984,0.000053880663,0.0018062037,0.00008983713,0.000006257325,0.0001985537,0.000039872284,0.000030773146,0.99362355,0.000046319754,0.00019082124,0.0030328997],"study_design_scores_gemma":[0.0001165929,0.0012839446,0.15999272,0.000020813823,0.00003579598,0.0012312551,0.0002699332,0.0006651616,0.8272953,0.00009320762,0.008986399,0.000008812076],"about_ca_topic_score_codex":0.0012774579,"about_ca_topic_score_gemma":0.0012795519,"teacher_disagreement_score":0.0031567854,"about_ca_system_score_codex":0.00017563668,"about_ca_system_score_gemma":0.0001870506,"threshold_uncertainty_score":0.010560513},"labels":[],"label_agreement":null},{"id":"W3083506235","doi":"10.1158/1078-0432.ccr-20-1967","title":"Statins as Anticancer Agents in the Era of Precision Medicine","year":2020,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":197,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute; Canadian Cancer Society","keywords":"Mevalonate pathway; Medicine; HMG-CoA reductase; Statin; Limiting; Cancer; Pharmacology; Reductase; Precision medicine; Clinical trial; Bioinformatics; Oncology; Internal medicine; Enzyme; Biology; Pathology","score_opus":0.38114504290175316,"score_gpt":0.6128752310255142,"score_spread":0.23173018812376106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083506235","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000063448235,0.99815816,0.000092178605,0.0006401097,0.0003192896,0.0000021889919,0.000010873134,0.000006252663,0.00070755096],"genre_scores_gemma":[0.00040911505,0.9981535,0.00014122821,0.00045382505,0.00035561857,0.0000037848195,0.00001908269,0.0000014500969,0.00046235157],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997727,0.000054490025,0.000029593919,0.00003384999,0.00008503932,0.000024249057],"domain_scores_gemma":[0.99960035,0.00020774332,0.000034386434,0.000012725274,0.00010495259,0.00003976829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007703111,0.00057991897,0.001081092,0.0017636628,0.0002781988,0.0010720183,0.00062989036,0.001180427,0.0032157092],"category_scores_gemma":[0.00096824527,0.00022005427,0.00043630798,0.0014739017,0.0004808197,0.0016705737,0.00084526796,0.0027034162,0.0019630082],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101688805,0.00005922202,0.00011843484,0.01024252,0.00007832075,0.00020880236,0.00006839542,0.00032801076,0.0015382993,0.012432883,0.055933047,0.9188905],"study_design_scores_gemma":[0.000014220532,0.000046801033,0.00024956182,0.0018692521,0.000044591467,0.00044292433,0.000026920437,0.000053654116,0.00019337074,0.0028812143,0.99416745,0.000010062109],"about_ca_topic_score_codex":0.0007171538,"about_ca_topic_score_gemma":0.001785581,"teacher_disagreement_score":0.0032157092,"about_ca_system_score_codex":0.0008289803,"about_ca_system_score_gemma":0.0010704568,"threshold_uncertainty_score":0.0107575655},"labels":[],"label_agreement":null},{"id":"W3085958492","doi":"10.1158/1078-0432.ccr-20-1781","title":"Immunomodulation in Pomalidomide, Dexamethasone, and Daratumumab-Treated Patients with Relapsed/Refractory Multiple Myeloma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Bristol-Myers Squibb Canada","keywords":"Pomalidomide; Daratumumab; Multiple myeloma; Lenalidomide; Medicine; Immunology; Immune system; CD8; Cancer research; T cell; Oncology; Internal medicine","score_opus":0.15593329845042367,"score_gpt":0.4489423615434022,"score_spread":0.2930090630929786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3085958492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972064,0.002030611,0.00007411095,0.000082963845,0.000015539668,0.00003944958,0.00008655272,0.000008722636,0.00045558676],"genre_scores_gemma":[0.99922025,0.00023851286,0.00012879964,0.000108678745,0.000024064764,0.000016783546,0.00011204338,0.0000012923235,0.00014962436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998115,0.000065203436,0.000019173065,0.000038413975,0.000039036026,0.000026669197],"domain_scores_gemma":[0.99979824,0.000040703308,0.000061455765,0.00000975669,0.0000151179165,0.000074690055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037331754,0.00024914558,0.0006287798,0.00022489876,0.00026413583,0.0003426694,0.00015840208,0.0002427482,0.000678236],"category_scores_gemma":[0.0005988411,0.00012667566,0.00026777346,0.00020454884,0.00012149669,0.00016214333,0.00014068079,0.00047253314,0.0001381048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048664246,0.0029302298,0.7307494,0.00036939155,0.000763736,0.0037452367,0.0005502175,0.0008513861,0.07078318,0.00010889182,0.0015813634,0.13890275],"study_design_scores_gemma":[0.0026506786,0.033926025,0.9431685,0.0000629086,0.0005325703,0.005702497,0.00021506933,0.0015501998,0.0077318633,0.00012418635,0.004313211,0.000022252862],"about_ca_topic_score_codex":0.00040568205,"about_ca_topic_score_gemma":0.0009763495,"teacher_disagreement_score":0.000678236,"about_ca_system_score_codex":0.00037178467,"about_ca_system_score_gemma":0.0002747775,"threshold_uncertainty_score":0.0026974678},"labels":[],"label_agreement":null},{"id":"W3087061153","doi":"10.1158/1078-0432.ccr-20-1042","title":"Delving into Early-onset Pancreatic Ductal Adenocarcinoma: How Does Age Fit In?","year":2020,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary; Canada's Michael Smith Genome Sciences Centre; Pancreas Centre (Canada); Spinal Cord Injury BC; Ontario Institute for Cancer Research; Ottawa Hospital; BC Cancer Agency","funders":"National Cancer Institute; BC Cancer Foundation; National Human Genome Research Institute; Canada Foundation for Innovation; Canadian Institutes of Health Research; Genome British Columbia","keywords":"CDKN2A; Biology; Pancreatic cancer; Cancer research; Indel; Age of onset; Cancer; Oncology; Genetics; Gene; Internal medicine; Medicine; Single-nucleotide polymorphism; Genotype","score_opus":0.29224385595906394,"score_gpt":0.5175891987228776,"score_spread":0.22534534276381363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087061153","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9676889,0.019255139,0.0010116576,0.008479482,0.00045230196,0.000014639063,0.00062501297,0.000034864745,0.002437908],"genre_scores_gemma":[0.9925942,0.0048393584,0.00040175242,0.0010267221,0.00027787642,0.0000071580403,0.00026993183,0.000017847608,0.00056508265],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99964046,0.00010368901,0.000030383104,0.00010065183,0.0000521889,0.000072660696],"domain_scores_gemma":[0.9984242,0.00031786028,0.0005809884,0.000092663926,0.0001993135,0.00038497502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007139144,0.00031851293,0.00066981826,0.00060887623,0.000457232,0.0012691928,0.00047995834,0.0008703791,0.0022389935],"category_scores_gemma":[0.003000355,0.00018157957,0.00047707377,0.00090253097,0.00044397305,0.0018092558,0.0006785803,0.0010470488,0.000603918],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006698258,0.00011503945,0.9502799,0.00013142968,0.00011558028,0.0008251781,0.00048252233,0.00007934676,0.0027103794,0.00039894195,0.0018546492,0.04233734],"study_design_scores_gemma":[0.000013265395,0.00032746381,0.9841404,0.00026410903,0.0001264013,0.0026814372,0.003285596,0.000360372,0.0007018458,0.0020674954,0.006003672,0.000027941682],"about_ca_topic_score_codex":0.00094116793,"about_ca_topic_score_gemma":0.0014220705,"teacher_disagreement_score":0.0022389935,"about_ca_system_score_codex":0.00031261015,"about_ca_system_score_gemma":0.00048046437,"threshold_uncertainty_score":0.007490158},"labels":[],"label_agreement":null},{"id":"W3088801732","doi":"10.1158/1078-0432.ccr-20-1966","title":"Autoantibody Landscape in Patients with Advanced Prostate Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; National Cancer Institute; Vetenskapsrådet","keywords":"Autoantibody; Medicine; Prostate cancer; Cancer; Prostate; Oncology; Internal medicine; Immunology; Antibody","score_opus":0.11474085859844223,"score_gpt":0.4903821128765842,"score_spread":0.37564125427814193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088801732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990538,0.00041879923,0.000077559744,0.000026645606,0.0000024056246,0.000004516469,0.0000938413,0.0000069665107,0.00031551693],"genre_scores_gemma":[0.99970657,0.000074616,0.000056791014,0.000020639474,0.0000060993066,0.000002100477,0.000087819506,0.0000010514296,0.00004433353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998425,0.000033569442,0.000012108359,0.00005154616,0.000035148278,0.000025051662],"domain_scores_gemma":[0.9997528,0.00004583342,0.000106237945,0.000013129593,0.00002622166,0.00005586522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017049976,0.00024333932,0.0002828767,0.00052896846,0.00031013647,0.00033297105,0.0001749067,0.0002820736,0.0014761623],"category_scores_gemma":[0.00051689544,0.00012015228,0.00014338546,0.00061773526,0.00019304597,0.00018910499,0.00023088219,0.00026477652,0.000194716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023072366,0.000035176712,0.98925567,0.000028557011,0.00004179829,0.00039593678,0.0000562811,0.00008764217,0.0057985894,0.000022699296,0.00011426825,0.0039327787],"study_design_scores_gemma":[0.000007259635,0.00020791173,0.99569917,0.0000041647327,0.0000293293,0.002886366,0.00007450986,0.00022085512,0.0005515155,0.000030787123,0.0002854705,0.0000026654952],"about_ca_topic_score_codex":0.0008386564,"about_ca_topic_score_gemma":0.0010014594,"teacher_disagreement_score":0.0014761623,"about_ca_system_score_codex":0.00016054627,"about_ca_system_score_gemma":0.00015144025,"threshold_uncertainty_score":0.0049383044},"labels":[],"label_agreement":null},{"id":"W3089217886","doi":"10.1158/1557-3265.covid-19-po-041","title":"Abstract PO-041: The impact of the COVID-19 pandemic on cancer patients","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pandemic; Cancer; Breast cancer; Coronavirus disease 2019 (COVID-19); Lung cancer; Colorectal cancer; Health care; Family medicine; Internal medicine; Disease","score_opus":0.713070638420338,"score_gpt":0.6866610436061756,"score_spread":0.026409594814162385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089217886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95487237,0.0016169448,0.00017312677,0.02023352,0.000283434,0.00015057648,0.005929581,0.000026968077,0.016713545],"genre_scores_gemma":[0.9906819,0.0013575609,0.00022201192,0.0037784218,0.00019233018,0.0001313215,0.0015128662,0.0000069138932,0.0021167302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990773,0.00041615,0.000100733174,0.000055579287,0.00015091484,0.00019925056],"domain_scores_gemma":[0.9940593,0.0012801647,0.0021092463,0.00012520963,0.0009687328,0.0014573362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013558174,0.00013950246,0.00018784148,0.0004350894,0.0009146154,0.00088270096,0.00029816988,0.0007367781,0.00908475],"category_scores_gemma":[0.01010222,0.0001142877,0.00032176246,0.0007173232,0.0003148003,0.00094222714,0.00094407966,0.00106224,0.001060666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017705768,0.00016279507,0.92073315,0.00030252876,0.000033323468,0.0003366546,0.0023836067,0.00015402357,0.00019327986,0.00021830515,0.0420653,0.03323998],"study_design_scores_gemma":[0.000026202644,0.00040376358,0.9666689,0.00030449693,0.000030034662,0.0005335973,0.012113693,0.0002911491,0.00019352125,0.0001870244,0.019219318,0.000028286999],"about_ca_topic_score_codex":0.011881868,"about_ca_topic_score_gemma":0.009659303,"teacher_disagreement_score":0.011881868,"about_ca_system_score_codex":0.0012509772,"about_ca_system_score_gemma":0.0013271025,"threshold_uncertainty_score":0.030391574},"labels":[],"label_agreement":null},{"id":"W3090217457","doi":"10.1158/1078-0432.ccr-20-1693","title":"A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor–Positive Breast Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Astellas Pharma; Pfizer","keywords":"Enzalutamide; Exemestane; Medicine; Cohort; Breast cancer; Internal medicine; Population; Oncology; Placebo; Adverse effect; Prostate cancer; Clinical endpoint; Metastatic breast cancer; Cancer; Randomized controlled trial; Androgen receptor; Aromatase; Pathology","score_opus":0.07947601488622333,"score_gpt":0.46731957051276596,"score_spread":0.3878435556265426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090217457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97584116,0.004643848,0.0009811339,0.0011125314,0.0011201838,0.010916563,0.002350911,0.0001450997,0.002888542],"genre_scores_gemma":[0.973531,0.0026842558,0.0021983793,0.001858133,0.0008026354,0.0122692585,0.002331428,0.00003138509,0.0042934883],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990386,0.00057800364,0.000050708142,0.00017708624,0.00005947086,0.00009616751],"domain_scores_gemma":[0.9987587,0.00035543105,0.00031201338,0.00012004021,0.00008564532,0.00036822355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020849262,0.0020268701,0.0031082574,0.00043708188,0.0004934575,0.0011439458,0.00090486614,0.0017363267,0.008428287],"category_scores_gemma":[0.0025325443,0.0007344445,0.0018873806,0.0004272036,0.0013016826,0.0010547106,0.00039033513,0.0030003595,0.0011483594],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98625153,0.0051392987,0.00031950185,0.00027527445,0.000538933,0.000024680254,0.000022331546,0.00013933491,0.0015374214,0.000051816492,0.00047247196,0.0052273],"study_design_scores_gemma":[0.97019684,0.02858815,0.00051136425,0.000011865787,0.00016496552,0.000011104339,0.0000065196605,0.00010582852,0.00011941056,0.000048908933,0.00023046906,0.000004711937],"about_ca_topic_score_codex":0.0006784413,"about_ca_topic_score_gemma":0.0020836897,"teacher_disagreement_score":0.008428287,"about_ca_system_score_codex":0.00074256834,"about_ca_system_score_gemma":0.0015532958,"threshold_uncertainty_score":0.028195381},"labels":[],"label_agreement":null},{"id":"W3091368850","doi":"10.1158/1078-0432.ccr-20-3331","title":"DNA Methylation Profiling of Premalignant Lesions as a Path to Ovarian Cancer Early Detection","year":2020,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Canada Research Chairs; Canadian Institutes of Health Research; Government of Ontario; Ontario Institute for Cancer Research; Princess Margaret Cancer Foundation","keywords":"Serous fluid; DNA methylation; Methylation; Biology; Cancer research; Ovarian cancer; Fallopian tube; Epithelial ovarian cancer; DNA; Pathology; Cancer; Medicine; Genetics; Gene; Gene expression","score_opus":0.2878266441754698,"score_gpt":0.5183152205383363,"score_spread":0.23048857636286652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091368850","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05175849,0.02780468,0.0038924292,0.880643,0.016255235,0.00014277513,0.0005117411,0.00044234082,0.018549269],"genre_scores_gemma":[0.49736035,0.030554717,0.0075488347,0.3688664,0.06740942,0.00026658957,0.00045552876,0.00012486761,0.027413236],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99958795,0.00016306815,0.000040368745,0.000044500666,0.00012293686,0.00004113449],"domain_scores_gemma":[0.99857974,0.0007863539,0.00010029095,0.00008248269,0.00029592632,0.00015523666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000759861,0.00026500912,0.00044370734,0.0006284784,0.0004144538,0.0006219083,0.0003103959,0.0034985975,0.0016022499],"category_scores_gemma":[0.0034643747,0.00020443145,0.00021170886,0.00032257978,0.00048305254,0.00041361604,0.00022281538,0.0038154814,0.00150559],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013006673,0.00020558319,0.055316355,0.00043979922,0.000057275276,0.0152168395,0.0002894381,0.00050589064,0.029185107,0.003729978,0.58344483,0.31030825],"study_design_scores_gemma":[0.0005100238,0.0016031029,0.077377096,0.0007332557,0.00021058014,0.053824496,0.0007437297,0.009222308,0.04217216,0.02678629,0.7866826,0.00013435665],"about_ca_topic_score_codex":0.0007228391,"about_ca_topic_score_gemma":0.0015475663,"teacher_disagreement_score":0.0034985975,"about_ca_system_score_codex":0.0008038618,"about_ca_system_score_gemma":0.00036902382,"threshold_uncertainty_score":0.0058324337},"labels":[],"label_agreement":null},{"id":"W3091465868","doi":"10.1158/1557-3265.covid-19-po-068","title":"Abstract PO-068: Efforts to define biochemical and pharmacologic pathways potentially beneficial to both cancer and COVID-19 patients","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Windsor","funders":"","keywords":"Cancer; Medicine; Oncogene; Hydroxychloroquine; Drug repositioning; Pharmacology; Coronavirus disease 2019 (COVID-19); Drug; Bioinformatics; Biology; Cell cycle; Internal medicine; Disease","score_opus":0.32684767632827366,"score_gpt":0.539831035403601,"score_spread":0.21298335907532734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091465868","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020865928,0.85599726,0.0037689586,0.027792068,0.008680546,0.002229444,0.032961167,0.0005105315,0.047194127],"genre_scores_gemma":[0.093172364,0.7974519,0.01682366,0.013504548,0.007676706,0.0023856775,0.03789931,0.00022017217,0.03086563],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99907076,0.00025638673,0.0002543818,0.00011771221,0.00023929983,0.000061488885],"domain_scores_gemma":[0.995602,0.001305679,0.00083210604,0.0001229994,0.0016072612,0.000529921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027712714,0.00072407426,0.0013474977,0.005229087,0.0005957752,0.0030919209,0.00073642225,0.0010548839,0.041071504],"category_scores_gemma":[0.007171641,0.000216052,0.0017957191,0.0041682133,0.0002948604,0.0028641066,0.0009652196,0.0010202932,0.007313232],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036258164,0.0002935787,0.0062458133,0.20330688,0.0009737079,0.001525454,0.00051783636,0.0001782587,0.015971053,0.0044639306,0.17524767,0.58764994],"study_design_scores_gemma":[0.0005385125,0.0015702922,0.018178089,0.045969285,0.0038913093,0.0024331564,0.0010407313,0.00022781036,0.005284922,0.004207705,0.9165874,0.00007078191],"about_ca_topic_score_codex":0.0008192588,"about_ca_topic_score_gemma":0.0020936092,"teacher_disagreement_score":0.041071504,"about_ca_system_score_codex":0.0012016892,"about_ca_system_score_gemma":0.004843789,"threshold_uncertainty_score":0.13739789},"labels":[],"label_agreement":null},{"id":"W3091560225","doi":"10.1158/1078-0432.ccr-20-2682","title":"Clinical and Genome-Wide Analysis of Multiple Severe Cisplatin-Induced Neurotoxicities in Adult-Onset Cancer Survivors","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health; University of Chicago","keywords":"Cisplatin; Medicine; Cancer; Oncology; Internal medicine; Chemotherapy","score_opus":0.3250167528719663,"score_gpt":0.5483750320847276,"score_spread":0.2233582792127613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091560225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99880326,0.00030726945,0.0001232901,0.000026501184,0.0000048738225,0.0000050945387,0.00055697554,0.0000051939,0.0001675209],"genre_scores_gemma":[0.99923396,0.00009348499,0.00007640974,0.000017241722,0.000005420244,0.000004717857,0.00043157802,0.0000024204242,0.00013466769],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977165,0.000047306097,0.000029799154,0.00009308982,0.000031744792,0.000026423331],"domain_scores_gemma":[0.99937063,0.00009559114,0.0002682705,0.00007298933,0.000080851096,0.00011163805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030976324,0.00024691885,0.0003093498,0.00050706015,0.00034821616,0.0004313979,0.00024856473,0.00033966426,0.0014712842],"category_scores_gemma":[0.0008446854,0.00018402709,0.0005257597,0.0010397859,0.00015598592,0.00016948686,0.00033102417,0.0003639686,0.0001490521],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000239692,0.000017697721,0.99667263,0.000014700371,0.00022765699,0.00010473306,0.00003065308,0.000045100835,0.00126716,0.000013308154,0.00012374617,0.0012427986],"study_design_scores_gemma":[0.0000047803,0.000041386487,0.9994031,0.0000019272375,0.00007663777,0.00014094995,0.000029270435,0.00010122594,0.00008601271,0.000012866905,0.00010029146,0.0000015694919],"about_ca_topic_score_codex":0.0031208494,"about_ca_topic_score_gemma":0.0041627935,"teacher_disagreement_score":0.0031208494,"about_ca_system_score_codex":0.00011539725,"about_ca_system_score_gemma":0.00016936746,"threshold_uncertainty_score":0.0062053204},"labels":[],"label_agreement":null},{"id":"W3091570384","doi":"10.1158/1078-0432.ccr-20-1163","title":"Genome and Transcriptome Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pancreas Centre (Canada); University of British Columbia; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"Canada Foundation for Innovation","keywords":"Pembrolizumab; Context (archaeology); Medicine; Immune checkpoint; Nivolumab; Oncology; Cancer; Internal medicine; Immunotherapy; Transcriptome; Population; Tumor microenvironment; Lung cancer; Cancer research; Biology; Gene; Gene expression; Genetics","score_opus":0.1321516415974539,"score_gpt":0.4743217142130647,"score_spread":0.3421700726156108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091570384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99699956,0.00033885063,0.00044327503,0.000036762092,0.000002638201,0.000007012609,0.0018358614,0.000014154515,0.00032194675],"genre_scores_gemma":[0.9966587,0.00012881051,0.00041590433,0.000040904262,0.0000030535869,0.000015170951,0.002443274,0.0000073431434,0.0002867505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99990165,0.000014530669,0.000006070388,0.00003511645,0.000022624092,0.000019930343],"domain_scores_gemma":[0.99981004,0.00003707374,0.00007626962,0.000016668328,0.000034471603,0.000025482448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014302987,0.00016632464,0.00025666287,0.00040196546,0.0001778082,0.00040584433,0.00010790449,0.00020236586,0.00091572676],"category_scores_gemma":[0.0003624344,0.00008555755,0.00013010052,0.00060260016,0.00012483537,0.00011547804,0.00020614397,0.00023660253,0.00019697868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084847107,0.000067476,0.7818201,0.00007559369,0.00017860095,0.00014280161,0.00012533677,0.0007113099,0.20288593,0.00006595738,0.00049836055,0.012580058],"study_design_scores_gemma":[0.000004807663,0.00007313149,0.9950836,0.0000036039444,0.00003239207,0.00018519786,0.000088592875,0.00061985827,0.0034036294,0.000048140748,0.00045455687,0.0000025179102],"about_ca_topic_score_codex":0.001981418,"about_ca_topic_score_gemma":0.0030013637,"teacher_disagreement_score":0.001981418,"about_ca_system_score_codex":0.00018152918,"about_ca_system_score_gemma":0.00015195606,"threshold_uncertainty_score":0.0039398074},"labels":[],"label_agreement":null},{"id":"W3091625009","doi":"10.1158/1078-0432.ccr-20-1068","title":"Phase Ib Dose-escalation/Expansion Trial of Ribociclib in Combination With Everolimus and Exemestane in Postmenopausal Women with HR+, HER2− Advanced Breast Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Cancer Institute; Novartis","keywords":"Exemestane; Everolimus; Postmenopausal women; Clinical trial; Breast cancer; Phases of clinical research; Cancer","score_opus":0.10019270655209407,"score_gpt":0.48215270754783834,"score_spread":0.3819600009957443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091625009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99756336,0.0006459486,0.00021974904,0.0001210459,0.00002977178,0.0006876769,0.0001724756,0.000037081663,0.0005229694],"genre_scores_gemma":[0.9953126,0.0005334893,0.0012137563,0.00030640126,0.000060873328,0.0009466493,0.00065033406,0.000013231679,0.0009625583],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996275,0.00016529723,0.000029912011,0.000059004004,0.00005317828,0.000065159984],"domain_scores_gemma":[0.9995671,0.0000613933,0.0001058258,0.000057467012,0.00002750107,0.00018075012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011848808,0.0008689546,0.0015980006,0.00032631287,0.0003533394,0.00054247625,0.0007080451,0.0007906333,0.001863205],"category_scores_gemma":[0.0006509089,0.0004344468,0.0006397109,0.00037373096,0.0004953291,0.0005311721,0.00029492506,0.002805432,0.00043767516],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5457235,0.107946254,0.010522016,0.0006317948,0.0014172777,0.00035218964,0.0005102689,0.0039425017,0.17378722,0.0002323091,0.0033927937,0.15154189],"study_design_scores_gemma":[0.35705596,0.590911,0.025270246,0.000042813095,0.00061377214,0.0006011687,0.000087019034,0.0021668852,0.019784752,0.00016656386,0.0032609305,0.000038789927],"about_ca_topic_score_codex":0.00069548626,"about_ca_topic_score_gemma":0.0020994262,"teacher_disagreement_score":0.001863205,"about_ca_system_score_codex":0.0006746864,"about_ca_system_score_gemma":0.00095617457,"threshold_uncertainty_score":0.006266296},"labels":[],"label_agreement":null},{"id":"W3091793382","doi":"10.1158/1078-0432.ccr-20-1835","title":"Transcriptional Subtypes Resolve Tumor Heterogeneity and Identify Vulnerabilities to MEK Inhibition in Lung Adenocarcinoma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Microsemi (Canada)","funders":"Genentech","keywords":"KRAS; Adenocarcinoma; Cancer research; Biology; Druggability; Phenotype; Lung cancer; Population; Cancer; Medicine; Oncology; Genetics; Gene; Colorectal cancer","score_opus":0.20612529336943977,"score_gpt":0.5282688890374881,"score_spread":0.3221435956680484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091793382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90606314,0.04773408,0.013231051,0.016000675,0.00088491663,0.0002309163,0.004164054,0.0004338656,0.011257247],"genre_scores_gemma":[0.9638218,0.017174928,0.0052427873,0.005610557,0.00044323533,0.000090616,0.001817133,0.00009737851,0.0057014674],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99967647,0.00005817285,0.000023528604,0.00008404216,0.000113014445,0.000044836896],"domain_scores_gemma":[0.99963796,0.00011767013,0.000058358197,0.00005091714,0.00009691169,0.000038184382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007441559,0.00029804086,0.00042559643,0.0004723044,0.00021967338,0.00085239,0.00035699143,0.0005808522,0.0013699803],"category_scores_gemma":[0.00078613847,0.00016202203,0.0002815376,0.00037221995,0.0005826734,0.00048807714,0.0005291021,0.0015273329,0.0005381746],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018201246,0.00022439161,0.044606756,0.0007175678,0.00012236783,0.0004165633,0.00030364122,0.0013086395,0.7872863,0.002485297,0.012851524,0.14785677],"study_design_scores_gemma":[0.00014249953,0.0018376108,0.14186591,0.00022843684,0.0002691677,0.0029424564,0.0008484649,0.0049839597,0.7447246,0.004751174,0.09731969,0.00008608229],"about_ca_topic_score_codex":0.0009153089,"about_ca_topic_score_gemma":0.0035761865,"teacher_disagreement_score":0.0013699803,"about_ca_system_score_codex":0.00067099545,"about_ca_system_score_gemma":0.0005934439,"threshold_uncertainty_score":0.004868448},"labels":[],"label_agreement":null},{"id":"W3091923748","doi":"10.1158/1078-0432.ccr-20-2831","title":"Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular Characteristics","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University Health Network; University of Calgary; Canada's Michael Smith Genome Sciences Centre; Ontario Institute for Cancer Research; Ottawa Hospital; BC Cancer Agency; University of British Columbia; Pancreas Centre (Canada)","funders":"BC Cancer Foundation","keywords":"Subtyping; KRAS; Oncology; Internal medicine; Adenocarcinoma; Biology; Medicine; Cancer; Cancer research; Colorectal cancer","score_opus":0.22815498509106677,"score_gpt":0.50826000173129,"score_spread":0.28010501664022325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091923748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985896,0.0001511665,0.00080708286,0.000008774685,0.0000023500343,0.000015491247,0.000175293,0.000018014138,0.00023227997],"genre_scores_gemma":[0.99832016,0.00003052932,0.0008752985,0.000018637318,0.0000035955404,0.000012691621,0.0006283716,0.0000095852465,0.000101169586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981571,0.00036590395,0.00031268518,0.00052756997,0.00049556594,0.00014112439],"domain_scores_gemma":[0.9968592,0.00081794366,0.0009873376,0.0006970333,0.00043179144,0.0002066791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001652288,0.00026360172,0.00046534967,0.00082937663,0.00038059245,0.00086734816,0.0004475929,0.0003778781,0.00095477264],"category_scores_gemma":[0.0032401895,0.00020171762,0.0003819433,0.0005993273,0.00041850915,0.0002461101,0.00053836184,0.00032429112,0.0004367522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009844988,0.00006994067,0.9470621,0.000058232607,0.00021681067,0.00020615406,0.00016157301,0.0002320677,0.043908555,0.00006793845,0.00008755208,0.0069447034],"study_design_scores_gemma":[0.000028175005,0.00020553159,0.9783102,0.000013032308,0.0001446999,0.0021026582,0.00022918322,0.0013549532,0.0170037,0.00017036777,0.0004271298,0.000010433715],"about_ca_topic_score_codex":0.0009572419,"about_ca_topic_score_gemma":0.0021826925,"teacher_disagreement_score":0.001652288,"about_ca_system_score_codex":0.0003737174,"about_ca_system_score_gemma":0.0003160805,"threshold_uncertainty_score":0.00873822},"labels":[],"label_agreement":null},{"id":"W3091967376","doi":"","title":"Evaluating the impact of COVID-19 on medical oncology workforce and cancer care in Canada: A serial survey study","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Family medicine; Workforce; Pandemic; Health care; Cancer; Internal medicine; Coronavirus disease 2019 (COVID-19); Disease","score_opus":0.7988329319751516,"score_gpt":0.7403036557498638,"score_spread":0.05852927622528781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091967376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908766,0.00013984743,0.00013552707,0.00045234078,0.000012899201,0.00026871442,0.006318735,0.000010542077,0.001784687],"genre_scores_gemma":[0.99128634,0.00035535547,0.0006442593,0.0005963194,0.000012236646,0.00034401985,0.004664018,0.0000080259915,0.0020893957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973768,0.00032140737,0.00021259335,0.00027895634,0.0010372604,0.0007730557],"domain_scores_gemma":[0.9918242,0.00045442997,0.0015374392,0.00022107307,0.004115223,0.0018475883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024569775,0.0004346808,0.00037031897,0.0016390863,0.0031977969,0.00128264,0.0013092826,0.0007735142,0.0021266604],"category_scores_gemma":[0.0061486317,0.00057119865,0.00075670105,0.0047172923,0.0007237545,0.0006905994,0.0017364754,0.0012091261,0.0003718302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003951142,0.00010129373,0.9939482,0.00003199708,0.000037372498,0.000036427613,0.0015967094,0.00007292762,0.00009743534,0.000041482468,0.0012309543,0.0027655866],"study_design_scores_gemma":[0.0000042304737,0.000039656912,0.99642354,0.000016524873,0.000008099748,0.000016332864,0.0024889559,0.0001637795,0.00003486382,0.0000062458103,0.0007912288,0.0000065538106],"about_ca_topic_score_codex":0.99103445,"about_ca_topic_score_gemma":0.99448,"teacher_disagreement_score":0.9683041,"about_ca_system_score_codex":0.031695884,"about_ca_system_score_gemma":0.054895565,"threshold_uncertainty_score":0.22997081},"labels":[],"label_agreement":null},{"id":"W3092102011","doi":"","title":"Performance comparison of fiveextraction kits for SARS-CoV-2 RNA extraction","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"SARS-CoV-2 detection and testing","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nucleic acid; RNA; RNA extraction; Nucleic acid methods; Medicine; Virology; Biology; Biochemistry","score_opus":0.6460183383802717,"score_gpt":0.6232131681331471,"score_spread":0.022805170247124584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092102011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84165806,0.018711476,0.117717996,0.0015107252,0.002540173,0.0030512845,0.0041243345,0.004058697,0.00662735],"genre_scores_gemma":[0.7333526,0.012891879,0.2108779,0.002566672,0.00060241454,0.00290805,0.017639907,0.0011427144,0.018017877],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.97727764,0.004515144,0.0023724663,0.004612349,0.009712364,0.0015100562],"domain_scores_gemma":[0.9881967,0.004850605,0.0010205405,0.0008019486,0.0045730406,0.000557151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010010513,0.0030548035,0.0017411048,0.0038945745,0.001308514,0.0030283316,0.0024036705,0.0030894203,0.0028737902],"category_scores_gemma":[0.018863084,0.0018856208,0.0017156443,0.0023715792,0.0018944498,0.0017127858,0.003050273,0.0018012638,0.003637013],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006936179,0.0015788861,0.021727234,0.002281218,0.00065330736,0.00026855257,0.0015662585,0.002249552,0.899386,0.00070906646,0.0025205193,0.06012335],"study_design_scores_gemma":[0.00016389808,0.005880961,0.027790114,0.00041725632,0.00090720743,0.0010312587,0.001119872,0.011082314,0.93948025,0.00045762636,0.011337666,0.00033165808],"about_ca_topic_score_codex":0.0021283734,"about_ca_topic_score_gemma":0.0036377665,"teacher_disagreement_score":0.010010513,"about_ca_system_score_codex":0.0010448227,"about_ca_system_score_gemma":0.001482625,"threshold_uncertainty_score":0.052941263},"labels":[],"label_agreement":null},{"id":"W3092148112","doi":"10.1158/1078-0432.ccr-20-2065","title":"Intratumoral Injection of <i>Clostridium novyi</i> -NT Spores in Patients with Treatment-refractory Advanced Solid Tumors","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Phenomenome Discoveries (Canada)","funders":"","keywords":"Medicine; Refractory (planetary science); Internal medicine; Sepsis; Gastroenterology; Pathology; Biology","score_opus":0.06962906226986716,"score_gpt":0.4379649103277885,"score_spread":0.36833584805792136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092148112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975477,0.00077213143,0.000324549,0.00008761724,0.000015755804,0.00016644107,0.00011170169,0.000021419763,0.00095265656],"genre_scores_gemma":[0.99848145,0.0003585494,0.00042399045,0.00012753744,0.000018163139,0.000081306425,0.00021395358,0.0000047046965,0.00029031382],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998982,0.000037144535,0.0000073271635,0.00001669191,0.00001533326,0.000025367843],"domain_scores_gemma":[0.99982494,0.000038534658,0.00004655518,0.000016955144,0.000011582667,0.000061443105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003251967,0.00033340938,0.00064722926,0.00012906347,0.00023375441,0.0002696385,0.00017494055,0.00026631786,0.0007950758],"category_scores_gemma":[0.00027852392,0.00012200415,0.0002683477,0.0001844844,0.0002477754,0.00020680405,0.00012911542,0.0005540826,0.00023371605],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11567055,0.027703231,0.12345017,0.0011191737,0.0007109767,0.003478103,0.0007083967,0.007987988,0.40962967,0.00046459565,0.007449683,0.3016274],"study_design_scores_gemma":[0.025343481,0.61426574,0.22698286,0.00015354701,0.0005797595,0.009575063,0.00043061146,0.009385245,0.09647059,0.00037100288,0.016375942,0.000066194036],"about_ca_topic_score_codex":0.00080793805,"about_ca_topic_score_gemma":0.0017133695,"teacher_disagreement_score":0.00080793805,"about_ca_system_score_codex":0.0005668795,"about_ca_system_score_gemma":0.0005328115,"threshold_uncertainty_score":0.004113078},"labels":[],"label_agreement":null},{"id":"W3092243224","doi":"10.1158/1078-0432.ccr-20-3292","title":"Project Orbis: Global Collaborative Review Program","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Excellence; Confidentiality; Center of excellence; Regulatory science; Marketing authorization; Global health; Program evaluation","score_opus":0.6066273559795285,"score_gpt":0.7039953562276421,"score_spread":0.09736800024811354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092243224","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010219475,0.06288636,0.0992345,0.23240589,0.06881329,0.06278067,0.024073105,0.015387546,0.42419916],"genre_scores_gemma":[0.09445879,0.0381739,0.20897739,0.10482668,0.039172597,0.10047203,0.04329616,0.008754128,0.3618685],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.82936573,0.11112639,0.008269694,0.009213016,0.035644658,0.0063805017],"domain_scores_gemma":[0.7048867,0.04929713,0.026032088,0.02955011,0.14225248,0.047981497],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.20789257,0.0015506861,0.0021718317,0.006587865,0.003103275,0.013931499,0.005718365,0.0043447968,0.10727802],"category_scores_gemma":[0.16129008,0.0008957731,0.0021897878,0.0050329007,0.0029505012,0.006050489,0.015672186,0.0058527454,0.06068665],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001261788,0.0002961874,0.00083302835,0.003779468,0.00018216783,0.00021380567,0.00039022052,0.0004850365,0.0012404612,0.013241357,0.7468814,0.231195],"study_design_scores_gemma":[0.0005815809,0.00023349808,0.001127029,0.0016847744,0.000045771303,0.00018386981,0.00012525375,0.00041216673,0.0003828921,0.004718575,0.9904723,0.00003235019],"about_ca_topic_score_codex":0.0013319466,"about_ca_topic_score_gemma":0.0016806714,"teacher_disagreement_score":0.20789257,"about_ca_system_score_codex":0.0058511198,"about_ca_system_score_gemma":0.09057817,"threshold_uncertainty_score":0.9768095},"labels":[],"label_agreement":null},{"id":"W3092313383","doi":"10.1158/1557-3265.covid-19-po-026","title":"Abstract PO-026: Minimize impact of pandemic on radiation oncology department: Experience from a moderate-sized regional cancer program in the battle against COVID-19 virus","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Windsor Regional Hospital; Western University","funders":"","keywords":"Personal protective equipment; Medicine; Pandemic; Radiation oncology; Cancer; Family medicine; Coronavirus disease 2019 (COVID-19); Battle; Medical emergency; Radiation therapy; Surgery; Disease; Internal medicine","score_opus":0.3772477089078819,"score_gpt":0.6440477560393814,"score_spread":0.26680004713149946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092313383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93341875,0.0013295322,0.0022078303,0.028938066,0.0007929935,0.0006986743,0.00059825816,0.0002932129,0.031722654],"genre_scores_gemma":[0.9578409,0.0016251125,0.00521477,0.012524575,0.0003273181,0.0003149547,0.0007414683,0.0002536536,0.021157227],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99841356,0.0007830133,0.0000379911,0.00011116415,0.0001432162,0.0005111381],"domain_scores_gemma":[0.99461704,0.00040147675,0.0002302815,0.00012710597,0.00062213227,0.0040019997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030227466,0.00042805643,0.00019437895,0.00018212976,0.004712327,0.0018156673,0.0017898456,0.0010985327,0.009979904],"category_scores_gemma":[0.00438463,0.0002968903,0.00046845913,0.00022628589,0.0011240634,0.0010985369,0.0046590576,0.0027515315,0.0019896699],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011842599,0.009611708,0.1699499,0.0012435752,0.00010619617,0.012703255,0.12231816,0.0024452712,0.009805802,0.0017743893,0.29310277,0.37575474],"study_design_scores_gemma":[0.00032986744,0.0170487,0.14229216,0.0005761457,0.000101531885,0.010177898,0.38873404,0.0017596061,0.0045319726,0.001266816,0.43298924,0.00019209426],"about_ca_topic_score_codex":0.008454332,"about_ca_topic_score_gemma":0.020686992,"teacher_disagreement_score":0.009979904,"about_ca_system_score_codex":0.0016729573,"about_ca_system_score_gemma":0.007355084,"threshold_uncertainty_score":0.03338611},"labels":[],"label_agreement":null},{"id":"W3092318104","doi":"10.1158/1557-3265.covid-19-s12-01","title":"Abstract S12-01: High mortality among hospital-acquired COVID-19 infection in patients with cancer: An observational cohort study from Quebec and British Columbia","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McGill University; Hôpital Charles-Le Moyne; Centre Hospitalier de l’Université de Montréal; Hôpital Maisonneuve-Rosemont; Hôpital du Sacré-Cœur de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Cancer; Incidence (geometry); Intensive care unit; Population; Cohort study; Coronavirus disease 2019 (COVID-19); Emergency medicine; Observational study; Cohort; Pediatrics; Internal medicine; Intensive care medicine; Disease; Infectious disease (medical specialty); Environmental health","score_opus":0.355947358486343,"score_gpt":0.5422539438001731,"score_spread":0.1863065853138301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092318104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818124,0.000755614,0.00018066626,0.00025985198,0.000024635052,0.00012610578,0.01495126,0.000015292606,0.0018743103],"genre_scores_gemma":[0.9942643,0.00030786372,0.00011793516,0.00020253123,0.00000982564,0.000070776994,0.004340157,0.000006228081,0.00068033347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907565,0.00010012855,0.00009316893,0.00025579086,0.00021166026,0.00026358105],"domain_scores_gemma":[0.996979,0.00017927076,0.0007290044,0.00020816905,0.0011560431,0.0007485114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006588293,0.00053886627,0.0007431956,0.0011777607,0.002783457,0.0016650066,0.0014759557,0.00062389503,0.0029414236],"category_scores_gemma":[0.0019965095,0.0005067661,0.00070502347,0.0046944404,0.00062631356,0.00047379968,0.0008757889,0.0009610939,0.0004813117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055340195,0.000026328073,0.99791414,0.000020342799,0.000049526032,0.00007706671,0.0001459187,0.00003693088,0.00010969498,0.000019606401,0.0010248804,0.0005202165],"study_design_scores_gemma":[0.000016707798,0.000024110863,0.9982304,0.0000396566,0.000027963595,0.00010017511,0.0005337898,0.00022833554,0.000033037584,0.000010292355,0.00074660033,0.000008879573],"about_ca_topic_score_codex":0.9682151,"about_ca_topic_score_gemma":0.97750264,"teacher_disagreement_score":0.031784892,"about_ca_system_score_codex":0.013179793,"about_ca_system_score_gemma":0.012489829,"threshold_uncertainty_score":0.09562653},"labels":[],"label_agreement":null},{"id":"W3092334961","doi":"10.1158/1078-0432.ccr-20-2380","title":"Phase I Study of Lysine-Specific Demethylase 1 Inhibitor, CC-90011, in Patients with Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin Lymphoma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Institute for Health and Care Research; Cancer Research UK; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Neutropenia; Lymphoma; Refractory (planetary science); Gastroenterology; Cancer; Context (archaeology); Oncology; Chemotherapy","score_opus":0.08114341508681919,"score_gpt":0.43927453802527827,"score_spread":0.35813112293845906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092334961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658966,0.000977868,0.00025593644,0.00010988778,0.000023659564,0.0009189194,0.00039106753,0.000041571453,0.00069143943],"genre_scores_gemma":[0.9958442,0.00074180466,0.0008295401,0.00024214719,0.00003787082,0.00055685086,0.0010124542,0.000009789468,0.00072536746],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99976736,0.00009410843,0.000015943957,0.000042374977,0.000034185967,0.000045992336],"domain_scores_gemma":[0.99961394,0.000043627762,0.00007287445,0.00003272012,0.000033960492,0.00020283078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008245725,0.0008208354,0.0012722265,0.00029262115,0.00027373186,0.00053540966,0.0004685125,0.00049325905,0.0018707579],"category_scores_gemma":[0.00045838542,0.00039468266,0.0005668387,0.00032046292,0.0005952292,0.0004912129,0.000220821,0.0016005391,0.00048072895],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4178513,0.09152216,0.058000702,0.0015321453,0.0022702995,0.0006952276,0.0008801005,0.0062394757,0.21272302,0.00052359304,0.0068329237,0.20092909],"study_design_scores_gemma":[0.27520406,0.64131606,0.0583043,0.000053376218,0.00080781785,0.0008566461,0.00016945676,0.0031502633,0.014597624,0.00020506674,0.005293105,0.000042238767],"about_ca_topic_score_codex":0.0012565234,"about_ca_topic_score_gemma":0.0041443934,"teacher_disagreement_score":0.0018707579,"about_ca_system_score_codex":0.00085907825,"about_ca_system_score_gemma":0.0012174319,"threshold_uncertainty_score":0.006258309},"labels":[],"label_agreement":null},{"id":"W3092540063","doi":"","title":"Factors affecting COVID-19 outcomes incancer patients: A first report from Guy's Cancer Centre inLondon","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Internal medicine; Cancer; Disease; Pediatrics; Infectious disease (medical specialty)","score_opus":0.6203812390119073,"score_gpt":0.6331490667619192,"score_spread":0.01276782775001184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092540063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966646,0.001107152,0.00006278514,0.00022508488,0.000015635927,0.000030713993,0.0010094105,0.0000073970195,0.00087715336],"genre_scores_gemma":[0.9975278,0.0007357384,0.000083374056,0.00017759192,0.000024493349,0.000027448103,0.001138964,0.000005237473,0.00027946595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993331,0.000116420095,0.00008595478,0.00011623903,0.00010421558,0.00024394451],"domain_scores_gemma":[0.99801755,0.00034535537,0.00078209536,0.00012586197,0.00021515747,0.0005140453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041523363,0.0004458948,0.00044350946,0.0013529138,0.00093224813,0.0011067764,0.000384531,0.00073532964,0.0026667337],"category_scores_gemma":[0.0015829899,0.0005145979,0.0005994947,0.0023549867,0.0004891127,0.0004887934,0.0016548708,0.0008190208,0.0005273776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008373704,0.00002541757,0.99549234,0.000057943238,0.000026825037,0.0011688994,0.0006931684,0.000017150332,0.00010040368,0.00001178162,0.0007128558,0.0016093925],"study_design_scores_gemma":[0.000012113012,0.0000900431,0.99553704,0.00004604582,0.000026618494,0.0019288699,0.0015242235,0.000029147031,0.000038787268,0.000008115743,0.0007465615,0.000012546866],"about_ca_topic_score_codex":0.043717735,"about_ca_topic_score_gemma":0.045458496,"teacher_disagreement_score":0.043717735,"about_ca_system_score_codex":0.0014288301,"about_ca_system_score_gemma":0.0012515695,"threshold_uncertainty_score":0.08692658},"labels":[],"label_agreement":null},{"id":"W3092571841","doi":"","title":"Operationalizing a prioritized COVID-19testing strategy at a Canadian tertiary care cancer center","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Internal medicine; Lung cancer; Population; Neutropenia; Surgery; Chemotherapy","score_opus":0.6061589732590208,"score_gpt":0.6413230180004906,"score_spread":0.035164044741469835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092571841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94296956,0.00092889863,0.0031675654,0.012993062,0.000179463,0.0031346323,0.0023475755,0.00041419867,0.033865206],"genre_scores_gemma":[0.9810357,0.00045503743,0.011356766,0.0033060254,0.00006393529,0.00036967194,0.0013083874,0.00003324412,0.0020711173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943869,0.00074649206,0.00023118992,0.0005370382,0.0013596938,0.002738737],"domain_scores_gemma":[0.9891396,0.0004957848,0.00071958645,0.00022960246,0.003461068,0.005954333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042901854,0.0007336501,0.00027362982,0.0013683562,0.006124247,0.0029791682,0.0027533993,0.0006323532,0.0039092996],"category_scores_gemma":[0.00604065,0.000410151,0.00036654904,0.0020073252,0.0013547228,0.0008277635,0.0038317519,0.0011826409,0.0003200413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063201925,0.0012906244,0.82893336,0.00035470398,0.00013545448,0.0008026128,0.0053039156,0.0054361317,0.0043474413,0.0022679102,0.03410643,0.11638944],"study_design_scores_gemma":[0.00030778683,0.0021839784,0.8987935,0.0005000375,0.00020480597,0.00054421695,0.03188837,0.017076673,0.0029886654,0.0008581291,0.044499356,0.00015442532],"about_ca_topic_score_codex":0.96973574,"about_ca_topic_score_gemma":0.9893086,"teacher_disagreement_score":0.08010028,"about_ca_system_score_codex":0.08010028,"about_ca_system_score_gemma":0.20353484,"threshold_uncertainty_score":0.5811709},"labels":[],"label_agreement":null},{"id":"W3092635944","doi":"10.1158/1078-0432.ccr-20-2925","title":"Comparative Genomics Reveals Distinct Immune-oncologic Pathways in African American Men with Prostate Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Decipher Biosciences (Canada)","funders":"National Cancer Institute; Prostate Cancer Foundation; U.S. Department of Defense","keywords":"Prostate cancer; Proinflammatory cytokine; Transcriptome; Immune system; Prostate; Cancer; Cancer research; Tumor microenvironment; Medicine; Biology; Immunology; Inflammation; Gene; Internal medicine; Gene expression; Genetics","score_opus":0.34410766421591554,"score_gpt":0.5275851019976024,"score_spread":0.1834774377816869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092635944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990858,0.0003422805,0.000102215025,0.00003083009,0.0000024405022,0.0000031516374,0.00022376952,0.000002316022,0.00020719547],"genre_scores_gemma":[0.9994659,0.00011474065,0.00011503922,0.00003067699,0.0000046418227,0.000004453775,0.00018214934,0.0000013957844,0.00008106805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998375,0.000036856225,0.000006283997,0.000053145035,0.000024026915,0.000042079326],"domain_scores_gemma":[0.9998909,0.00002245147,0.000044171826,0.000008659016,0.000012458333,0.000021196807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020146467,0.00014255088,0.00019683562,0.0006354368,0.0004764986,0.00031816514,0.00010893607,0.00016996216,0.0015481137],"category_scores_gemma":[0.0003705201,0.000104559134,0.00022588688,0.00084795384,0.00018203184,0.00013482527,0.0002735573,0.00017812467,0.00010889089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060853316,0.000080227575,0.96899927,0.000043820484,0.00014637926,0.00023537956,0.00032897538,0.00013053964,0.019120809,0.00019105605,0.00025384012,0.009861274],"study_design_scores_gemma":[0.000004434453,0.00007136962,0.9982876,0.000005004702,0.000033915174,0.00023733971,0.00033819006,0.00018690544,0.00042839567,0.00010781715,0.00029637746,0.0000026820117],"about_ca_topic_score_codex":0.0023509883,"about_ca_topic_score_gemma":0.003355808,"teacher_disagreement_score":0.0023509883,"about_ca_system_score_codex":0.00014459356,"about_ca_system_score_gemma":0.00023895373,"threshold_uncertainty_score":0.0051789284},"labels":[],"label_agreement":null},{"id":"W3092636096","doi":"10.1158/1078-0432.ccr-20-2868","title":"A Cyclin D1–Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell Lymphoma","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"European Regional Development Fund; Instituto de Salud Carlos III; National Cancer Institute; Agència de Gestió d'Ajuts Universitaris i de Recerca; Generalitat de Catalunya; Ministerio de Economía y Competitividad; National Institutes of Health; Institució Catalana de Recerca i Estudis Avançats; Centres de Recerca de Catalunya","keywords":"Cyclin D1; Mantle cell lymphoma; Cancer research; Cyclin D; Biology; Cyclin; Cyclin A2; Cyclin B; Cell cycle; Chromatin; Cyclin D2; Lymphoma; Gene; Genetics; Immunology","score_opus":0.4512327535473243,"score_gpt":0.5734693192376064,"score_spread":0.12223656569028207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092636096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994506,0.00012853273,0.00014072456,0.0000128865895,0.000001247163,0.000003965268,0.00010533081,0.0000052193996,0.00015151125],"genre_scores_gemma":[0.9995351,0.000031941203,0.00010153896,0.000008623339,0.000003594705,0.000004923539,0.00024375544,0.00000150696,0.00006907062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99991965,0.000017577599,0.0000073927104,0.00002484988,0.00001653404,0.000013956306],"domain_scores_gemma":[0.9997297,0.00007196965,0.00007869944,0.000019628176,0.00003149006,0.000068587186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021634654,0.00015229928,0.00018205908,0.0004768378,0.00012816403,0.00027913507,0.00013264254,0.00018035702,0.0009456515],"category_scores_gemma":[0.00048274,0.00007468118,0.000106704356,0.00029972292,0.0001850577,0.00012836965,0.00022181787,0.0002552263,0.00013013974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011556573,0.00006514478,0.95507836,0.000025393336,0.000037354555,0.00008310027,0.000040643226,0.00031799346,0.037417784,0.000026967544,0.00014756004,0.005603997],"study_design_scores_gemma":[0.000019515259,0.00013666328,0.9954326,0.0000033760223,0.000025523601,0.00032141653,0.0000414918,0.0009910741,0.0027346448,0.000040062572,0.00025093567,0.0000026046412],"about_ca_topic_score_codex":0.0004111179,"about_ca_topic_score_gemma":0.00049440784,"teacher_disagreement_score":0.0009456515,"about_ca_system_score_codex":0.00016586267,"about_ca_system_score_gemma":0.000099235775,"threshold_uncertainty_score":0.0031635165},"labels":[],"label_agreement":null},{"id":"W3092934524","doi":"10.1158/1557-3265.ovcasymp18-dp-005","title":"Abstract DP-005: RNA-SEQUENCING OF FALLOPIAN TUBE – FIMBRIA AND HGSC FROM BRCA MUTATION CARRIERS","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Fallopian tube; Biology; BRCA mutation; Internal medicine; Laser capture microdissection; Medicine; Gynecology; Pathology; Genetics; Gene; Cancer; Ovarian cancer; Gene expression","score_opus":0.21271193833168642,"score_gpt":0.5040314976737521,"score_spread":0.29131955934206566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092934524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9638587,0.0022736436,0.0054986323,0.00015842405,0.00009958317,0.00031795306,0.024041364,0.0001992983,0.003552431],"genre_scores_gemma":[0.91223,0.0013765941,0.023002196,0.0004905253,0.00006374321,0.0007562965,0.052761223,0.00024320258,0.009076203],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997918,0.000017552104,0.000012486298,0.00006491092,0.00007737683,0.00003588881],"domain_scores_gemma":[0.9997693,0.000063825304,0.000025362006,0.000035613884,0.00007833945,0.000027665612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000260876,0.00021766558,0.00028102778,0.00081968564,0.0005443912,0.00043237588,0.00027243161,0.00039026627,0.0033843429],"category_scores_gemma":[0.0006823393,0.00015366623,0.00028584394,0.00054340856,0.00027206642,0.00009036919,0.0002955429,0.00029602597,0.0010277858],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000722855,0.000057352907,0.028519982,0.00027559078,0.000065746906,0.0010689403,0.00059797365,0.0002537837,0.9500062,0.0001466397,0.0019101279,0.016374683],"study_design_scores_gemma":[0.00011019671,0.00089342217,0.6731189,0.00014360332,0.00024588645,0.0057612252,0.0015152548,0.003719618,0.26258287,0.00037205548,0.051501103,0.000035933197],"about_ca_topic_score_codex":0.0032478631,"about_ca_topic_score_gemma":0.005498164,"teacher_disagreement_score":0.0033843429,"about_ca_system_score_codex":0.00024741562,"about_ca_system_score_gemma":0.00035037863,"threshold_uncertainty_score":0.011321783},"labels":[],"label_agreement":null},{"id":"W3093653710","doi":"10.1158/1078-0432.ccr-20-2669","title":"Early 3+3 Trial Dose-Escalation Phase I Clinical Trial Design and Suitability for Immune Checkpoint Inhibitors","year":2020,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Nivolumab; Ipilimumab; Pembrolizumab; Adverse effect; Internal medicine; Toxicity; Oncology; Renal cell carcinoma; Incidence (geometry); Melanoma; Clinical trial; Lung cancer; Cancer; Immunotherapy; Cancer research","score_opus":0.6305114855276522,"score_gpt":0.6382727501066128,"score_spread":0.007761264578960536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093653710","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33988225,0.43134296,0.0982349,0.0070345555,0.0064820144,0.085748844,0.010070897,0.0016753435,0.019528259],"genre_scores_gemma":[0.8542498,0.01940129,0.038364857,0.0050041145,0.0009868328,0.073956825,0.0037432183,0.00036021924,0.0039328267],"study_design_codex":"randomized_trial","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.92378867,0.06216695,0.0072055375,0.0032237729,0.0027933572,0.00082162005],"domain_scores_gemma":[0.95756954,0.025941944,0.008330201,0.0048860726,0.002468436,0.0008038363],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.07739396,0.0020055282,0.007277972,0.0011104172,0.0005206237,0.0030676282,0.0015054754,0.0018454767,0.00836821],"category_scores_gemma":[0.06417426,0.00094161514,0.016982524,0.001566357,0.0010471012,0.0027403801,0.0014066959,0.0032502783,0.0008953669],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52983296,0.0011015312,0.013003394,0.08720675,0.25794673,0.0002616678,0.0003125142,0.003937427,0.0045626867,0.003410358,0.0050297077,0.093394265],"study_design_scores_gemma":[0.5047628,0.06868953,0.032416057,0.012694012,0.312906,0.0005751587,0.00017515173,0.010921405,0.0037158793,0.017646736,0.035226207,0.0002710712],"about_ca_topic_score_codex":0.00027873617,"about_ca_topic_score_gemma":0.0007614288,"teacher_disagreement_score":0.92260605,"about_ca_system_score_codex":0.001459733,"about_ca_system_score_gemma":0.0019032276,"threshold_uncertainty_score":0.40930325},"labels":[],"label_agreement":null},{"id":"W3093953010","doi":"10.1158/1557-3265.covid-19-po-075","title":"Abstract PO-075: Performance comparison of five extraction kits for SARS-CoV-2 RNA extraction","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"SARS-CoV-2 detection and testing","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Cancer Research; Ontario Institute for Cancer Research","funders":"","keywords":"Nucleic acid; Nucleic acid methods; RNA; RNA extraction; Medicine; Coronavirus disease 2019 (COVID-19); Virology; Biology; Infectious disease (medical specialty); Disease; Internal medicine; Biochemistry","score_opus":0.5439409312405266,"score_gpt":0.5992797718588352,"score_spread":0.05533884061830863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093953010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86574703,0.010266743,0.10212682,0.00077557296,0.0014632904,0.0030791506,0.004971267,0.0034411454,0.008129093],"genre_scores_gemma":[0.76381665,0.006231331,0.19655414,0.0014066002,0.0003694324,0.0025002183,0.017017113,0.0010931483,0.011011363],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.98851544,0.0034671866,0.001169312,0.0021410563,0.0042189662,0.00048808678],"domain_scores_gemma":[0.994899,0.0020494824,0.00048581662,0.00034049005,0.0019341828,0.00029110425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075351177,0.001535043,0.0010570977,0.0023200745,0.0007983179,0.002339933,0.0015085277,0.0018883573,0.0046550264],"category_scores_gemma":[0.012336489,0.00094754045,0.0011479985,0.0014764555,0.001192166,0.0012457774,0.0014071285,0.0009874988,0.0044917674],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011422958,0.0023717398,0.02414837,0.0027503443,0.0005453756,0.00023012683,0.001007629,0.002999124,0.8477408,0.00075314636,0.0050095706,0.10102077],"study_design_scores_gemma":[0.00028375906,0.012800443,0.038534235,0.00037772386,0.00091893494,0.0011478297,0.00091977,0.025086228,0.89978594,0.0004720744,0.01939571,0.0002773936],"about_ca_topic_score_codex":0.0012556871,"about_ca_topic_score_gemma":0.0016780014,"teacher_disagreement_score":0.0075351177,"about_ca_system_score_codex":0.0005747158,"about_ca_system_score_gemma":0.0009968128,"threshold_uncertainty_score":0.039849997},"labels":[],"label_agreement":null},{"id":"W3093968467","doi":"10.1158/1557-3265.ovcasymp18-nt-101","title":"Abstract NT-101: QUADRA: A PHASE 2, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE SINGLE-AGENT NIRAPARIB TREATMENT IN PATIENTS WITH RELAPSED OVARIAN CANCER (ROC) WHO HAVE RECEIVED ≥3 PRIOR CHEMOTHERAPY REGIMENS","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Population; Ovarian cancer; Clinical endpoint; Progressive disease; Progression-free survival; Carboplatin; Oncology; Refractory (planetary science); Gastroenterology; Phases of clinical research; Surgery; Clinical trial; Cancer; Cisplatin","score_opus":0.3252451303081464,"score_gpt":0.5403688162190448,"score_spread":0.21512368591089837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093968467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98387516,0.0024418265,0.0009008912,0.0006443189,0.0002051704,0.0057031773,0.003079695,0.00019462025,0.0029551273],"genre_scores_gemma":[0.97967106,0.0014076008,0.0024589025,0.0014247434,0.00019375944,0.0053299963,0.004493965,0.00004469811,0.0049752668],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999595,0.00020195548,0.000028115117,0.000079462414,0.000043110238,0.000052337247],"domain_scores_gemma":[0.99916077,0.000113092174,0.00017226218,0.00007820513,0.0000657005,0.00040995673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001776569,0.0015368331,0.0020048956,0.00029653215,0.00037671276,0.0010808825,0.00105412,0.0011755225,0.009177753],"category_scores_gemma":[0.0009873948,0.00067906623,0.00143693,0.00028722818,0.0008331609,0.0011804844,0.00038564188,0.0030965437,0.0016663912],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8299266,0.071452044,0.0043638544,0.0012709073,0.0013537626,0.00023334917,0.0001455207,0.0013760624,0.0339545,0.00022352053,0.0041750055,0.051524896],"study_design_scores_gemma":[0.62015563,0.36703303,0.0069546225,0.00004552307,0.0003667573,0.0003279881,0.000039289513,0.0011774047,0.0017016627,0.0001608294,0.0020025482,0.000034685207],"about_ca_topic_score_codex":0.0004973166,"about_ca_topic_score_gemma":0.0018219694,"teacher_disagreement_score":0.009177753,"about_ca_system_score_codex":0.00091053394,"about_ca_system_score_gemma":0.0013867293,"threshold_uncertainty_score":0.030702591},"labels":[],"label_agreement":null},{"id":"W3094254214","doi":"10.1158/1078-0432.ccr-20-2710","title":"Expanded Low Allele Frequency <i>RAS</i> and <i>BRAF</i> V600E Testing in Metastatic Colorectal Cancer as Predictive Biomarkers for Cetuximab in the Randomized CO.17 Trial","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Cancer Society; Ottawa Hospital; Spinal Cord Injury BC; University of British Columbia; University of British Columbia Hospital","funders":"National Cancer Institute; National Institutes of Health","keywords":"Cetuximab; Colorectal cancer; Medicine; Oncology; Randomized controlled trial; Internal medicine; Cancer","score_opus":0.2660523858537944,"score_gpt":0.5230790893976734,"score_spread":0.257026703543879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094254214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99581474,0.0022795966,0.00021565586,0.00036051002,0.00009771797,0.00029858187,0.00017863177,0.0000159638,0.00073855685],"genre_scores_gemma":[0.99680424,0.0005528276,0.00056942727,0.00026223695,0.00015960391,0.00041165546,0.00043987035,0.000010514355,0.00078960735],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99838674,0.0011068224,0.0000735369,0.00020575666,0.0000953225,0.0001318289],"domain_scores_gemma":[0.99693644,0.0011076151,0.0009455114,0.0001688073,0.00021435495,0.00062718504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028187193,0.0009922482,0.0020082223,0.00028808,0.0002595868,0.0010873388,0.00045244527,0.00082819245,0.0021634097],"category_scores_gemma":[0.0027063694,0.00042569483,0.0013484246,0.00029302677,0.0008288769,0.00064358715,0.0004039222,0.0020782838,0.00029313966],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9547491,0.0013936711,0.02011579,0.00032797703,0.0018054572,0.00006837118,0.00006134788,0.0006888413,0.0049096863,0.0001087062,0.0010226094,0.014748472],"study_design_scores_gemma":[0.7565447,0.14618893,0.06962326,0.00023151499,0.008495868,0.0005189017,0.00011987049,0.0073303813,0.0073616514,0.0005132981,0.0029925385,0.00007908069],"about_ca_topic_score_codex":0.00075558777,"about_ca_topic_score_gemma":0.0023236943,"teacher_disagreement_score":0.0028187193,"about_ca_system_score_codex":0.00095245213,"about_ca_system_score_gemma":0.0014123296,"threshold_uncertainty_score":0.014907002},"labels":[],"label_agreement":null},{"id":"W3094745505","doi":"10.1158/1078-0432.ccr-20-1830","title":"OX40 Agonist BMS-986178 Alone or in Combination With Nivolumab and/or Ipilimumab in Patients With Advanced Solid Tumors","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Ottawa Hospital; Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre","funders":"Ono Pharmaceutical; Fundació Institut de Recerca Hospital Universitari Vall d’Hebron; Bristol-Myers Squibb","keywords":"Nivolumab; Ipilimumab; Medicine; Combination therapy; Internal medicine; Rash; Adverse effect; Pharmacodynamics; Oncology; Clinical endpoint; Pharmacology; Cancer; Pharmacokinetics; Clinical trial; Immunotherapy","score_opus":0.11479046437595773,"score_gpt":0.4554999773211006,"score_spread":0.34070951294514285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094745505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964858,0.0022679952,0.00009398113,0.00007835974,0.000029403434,0.00015152842,0.00008563022,0.000018864393,0.0007884628],"genre_scores_gemma":[0.99724233,0.0013219839,0.00027019632,0.00014666215,0.00006510086,0.00010261542,0.00027644902,0.000003825719,0.00057081354],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9998536,0.000054755685,0.000014037715,0.00002288112,0.000026712782,0.000027943168],"domain_scores_gemma":[0.9998653,0.000021033276,0.000041509054,0.000007357066,0.000011208337,0.000053652657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046580765,0.000438046,0.00083979557,0.00017244622,0.00013953159,0.00031118494,0.00021795779,0.00026749965,0.0014131967],"category_scores_gemma":[0.00022527133,0.00014600283,0.0003942987,0.0001687541,0.00022746522,0.00024155248,0.000121012694,0.0007558175,0.00045898752],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27483824,0.031185959,0.041484565,0.0020252748,0.0016161859,0.0005482903,0.00027726585,0.0035094111,0.20401189,0.00028460828,0.0036348598,0.4365834],"study_design_scores_gemma":[0.16872102,0.6960191,0.08238096,0.00013531622,0.0013439212,0.0017118081,0.00012207337,0.0028398521,0.03240105,0.00021630173,0.01406564,0.00004297911],"about_ca_topic_score_codex":0.00028371264,"about_ca_topic_score_gemma":0.0008996024,"teacher_disagreement_score":0.0014131967,"about_ca_system_score_codex":0.00027838294,"about_ca_system_score_gemma":0.00051055447,"threshold_uncertainty_score":0.004727602},"labels":[],"label_agreement":null},{"id":"W3096094105","doi":"10.1158/1078-0432.ccr-20-3299","title":"Immune Infiltrate in the Primary Tumor Predicts Effect of Adjuvant Radiotherapy in Breast Cancer; Results from the Randomized SweBCG91RT Trial","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Genomics","funders":"Stiftelsen Jubileumsklinikens Forskningsfond mot Cancer; Cancerfonden","keywords":"Immune system; Breast cancer; Medicine; Radiation therapy; Adjuvant; Oncology; CD8; FOXP3; Immunohistochemistry; Cancer; Primary tumor; Internal medicine; Pathology; Cancer research; Immunology; Metastasis","score_opus":0.1057210141369547,"score_gpt":0.45448103614844715,"score_spread":0.3487600220114925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096094105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99093115,0.00624824,0.00037235988,0.00042161884,0.00015553371,0.0002617948,0.0007622305,0.000022337948,0.0008246764],"genre_scores_gemma":[0.9962691,0.0010012648,0.00030222084,0.0003185845,0.00017826373,0.00025824225,0.0010831117,0.000010317118,0.00057883724],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99879956,0.0007748379,0.00005965514,0.00018873361,0.00009677363,0.000080370824],"domain_scores_gemma":[0.99850744,0.0005105462,0.00050880905,0.00017959936,0.00007094116,0.00022256402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002847913,0.00081886945,0.0016868865,0.00015674991,0.00019930585,0.00080436986,0.00040647679,0.00079411495,0.0024239733],"category_scores_gemma":[0.0023317102,0.00022968094,0.0023105699,0.00026256533,0.00059834274,0.0005156966,0.00031248084,0.0015311074,0.00034400454],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93358785,0.0018404798,0.027218208,0.0010741088,0.0076530823,0.00006863975,0.000042031883,0.0017364124,0.004880099,0.00019590805,0.0014558116,0.020247325],"study_design_scores_gemma":[0.6535899,0.11444752,0.19192779,0.0003667922,0.022567866,0.00057014043,0.00010486893,0.0063739386,0.004197134,0.0017429102,0.004002072,0.000109065775],"about_ca_topic_score_codex":0.00039175598,"about_ca_topic_score_gemma":0.00091149966,"teacher_disagreement_score":0.002847913,"about_ca_system_score_codex":0.00043747682,"about_ca_system_score_gemma":0.00053327816,"threshold_uncertainty_score":0.0150613785},"labels":[],"label_agreement":null},{"id":"W3096456848","doi":"10.1158/1557-3265.covid-19-po-005","title":"Abstract PO-005: Barriers to implementation of virtual collection of patient-reported data in the COVID-19 era","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Anxiety; Ambulatory; Depression (economics); Cohort; Distress; Family medicine; Hospital Anxiety and Depression Scale; Coronavirus disease 2019 (COVID-19); Disease; Psychiatry; Internal medicine","score_opus":0.5865058885918766,"score_gpt":0.658088010241047,"score_spread":0.07158212164917044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096456848","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94455093,0.0010837764,0.004004861,0.028756276,0.0002749257,0.002241918,0.0007599844,0.00023047042,0.018096833],"genre_scores_gemma":[0.9883583,0.00038693385,0.0051946826,0.003966961,0.00007505019,0.0010059288,0.00017739824,0.00004714399,0.0007876396],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.93345904,0.04971768,0.0049220375,0.0018205262,0.0068193115,0.0032614567],"domain_scores_gemma":[0.7992954,0.14008251,0.023101173,0.010332929,0.0118188355,0.015369106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.058780946,0.00025290812,0.00036395853,0.0004568456,0.0023976443,0.004154184,0.0029551561,0.00075245457,0.007571671],"category_scores_gemma":[0.1603749,0.00046849353,0.00045813536,0.000601397,0.001468526,0.0020473795,0.004419188,0.0016545006,0.0006998882],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010691922,0.0014167528,0.55022454,0.0025193826,0.00015939336,0.0009396682,0.06968567,0.00059497904,0.0018033123,0.0021926777,0.036549896,0.33284456],"study_design_scores_gemma":[0.00023578206,0.0030281513,0.74585015,0.0047744485,0.0001276888,0.0016990919,0.17267914,0.0064225076,0.0016737247,0.0010697435,0.06223264,0.00020706265],"about_ca_topic_score_codex":0.032736287,"about_ca_topic_score_gemma":0.021597274,"teacher_disagreement_score":0.058780946,"about_ca_system_score_codex":0.0032509859,"about_ca_system_score_gemma":0.013817783,"threshold_uncertainty_score":0.31086713},"labels":[],"label_agreement":null},{"id":"W3096511412","doi":"10.1158/1078-0432.ccr-20-2657","title":"Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with <i>PIK3CA</i> -Mutant Cancers","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institutes of Health; Memorial Sloan-Kettering Cancer Center; Genentech; F. Hoffmann-La Roche","keywords":"Mutant; Cancer; Gene isoform; Medicine; Cancer research; Chemistry; Internal medicine; Biochemistry; Gene","score_opus":0.11630573657272726,"score_gpt":0.4793883154789074,"score_spread":0.3630825789061802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096511412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968009,0.0005888117,0.00029780803,0.0001300042,0.00004267183,0.00079275144,0.000646072,0.000045609493,0.00065548863],"genre_scores_gemma":[0.9932799,0.00070944836,0.0011834197,0.00035453023,0.00006904396,0.0012321549,0.0020280865,0.000020597303,0.0011228076],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997235,0.00008743924,0.00002003967,0.00006910776,0.000027421456,0.00007254257],"domain_scores_gemma":[0.9995289,0.000045078417,0.00010145566,0.00003772842,0.00003733851,0.00024967102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009914502,0.0015022146,0.0019159566,0.00045252824,0.00032903004,0.00089965895,0.000708394,0.0008066576,0.0022693565],"category_scores_gemma":[0.0005886649,0.00064478064,0.0009206044,0.0004903077,0.00050145236,0.0009667529,0.00047518394,0.0017619797,0.00056174904],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7835374,0.036216605,0.02937021,0.0004962106,0.0019071922,0.00024622306,0.00026354654,0.003555187,0.055272885,0.00036572613,0.0041192053,0.08464949],"study_design_scores_gemma":[0.44589242,0.5138871,0.027644806,0.000032383814,0.0008014422,0.00037000023,0.00009439775,0.0024105608,0.0064183096,0.0002990467,0.0021011208,0.000048374255],"about_ca_topic_score_codex":0.0008837988,"about_ca_topic_score_gemma":0.002033811,"teacher_disagreement_score":0.0022693565,"about_ca_system_score_codex":0.000987473,"about_ca_system_score_gemma":0.0013871441,"threshold_uncertainty_score":0.007591784},"labels":[],"label_agreement":null},{"id":"W3097004036","doi":"10.1158/1078-0432.ccr-20-2558","title":"Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Centro de Investigación Biomédica en Red de Cáncer; Ministerio de Ciencia e Innovación; Canadian Institutes of Health Research; Generalitat de Catalunya","keywords":"Lymphoma; DNA; Population; Cell; Circulating tumor DNA; Cancer research; Biology; Cancer; Medicine; Computational biology; Genetics; Immunology; Environmental health","score_opus":0.09376157918107385,"score_gpt":0.4439612368853415,"score_spread":0.35019965770426764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097004036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99969697,0.00006401226,0.00007890879,0.000007638637,0.0000011344621,0.0000035778294,0.00006194124,0.0000015633451,0.000084228035],"genre_scores_gemma":[0.9998202,0.000020021147,0.000027129432,0.000008868999,0.0000027263095,0.0000027449082,0.000091572845,8.0898496e-7,0.000026040008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999585,0.00012352374,0.000028729346,0.00014728396,0.00007232848,0.000043224045],"domain_scores_gemma":[0.99932146,0.0001733675,0.00018194679,0.00008395826,0.000088436645,0.00015090841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000600721,0.00026911535,0.00037731283,0.0006376754,0.00030075712,0.000621577,0.00022942465,0.00045014522,0.00076854957],"category_scores_gemma":[0.0018459485,0.00028298754,0.00022845133,0.00047798303,0.0003298375,0.00043840046,0.0003131357,0.00040228307,0.00022873905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017309506,0.000038378523,0.9979766,0.0000036953047,0.000045896297,0.00011051998,0.000045396035,0.00003648015,0.00088713027,0.000007143022,0.000022748955,0.0006528693],"study_design_scores_gemma":[0.000024020825,0.00028960872,0.9978077,0.000002472894,0.000040292925,0.0010001726,0.00012595797,0.00035628225,0.00019280348,0.00002461167,0.00013106554,0.0000049404352],"about_ca_topic_score_codex":0.0010501557,"about_ca_topic_score_gemma":0.0008821625,"teacher_disagreement_score":0.0010501557,"about_ca_system_score_codex":0.00020154382,"about_ca_system_score_gemma":0.000147619,"threshold_uncertainty_score":0.0031769872},"labels":[],"label_agreement":null},{"id":"W3097296206","doi":"10.1158/1078-0432.ccr-20-1900","title":"Uncovering Clinically Relevant Gene Fusions with Integrated Genomic and Transcriptomic Profiling of Metastatic Cancers","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia; Pancreas Centre (Canada); Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Ipsen; BC Cancer Foundation; Vancouver Coastal Health Research Institute; Eisai; Amgen; Pfizer; Canada Research Chairs; AstraZeneca; Eli Lilly and Company","keywords":"Transcriptome; RNA-Seq; Computational biology; Gene; Fusion gene; Biology; Genome; RNA; Cancer; Contig; Breakpoint; Genetics; Bioinformatics; Gene expression; Chromosomal translocation","score_opus":0.11794533500012697,"score_gpt":0.4254958928007959,"score_spread":0.307550557800669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097296206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856564,0.001449404,0.008493485,0.00012401749,0.000012637254,0.000050346232,0.003078176,0.00018664786,0.00094875816],"genre_scores_gemma":[0.9875721,0.00041005216,0.008285653,0.000118049196,0.00001422488,0.000037366644,0.0032130547,0.00003056672,0.0003189557],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996761,0.00004590926,0.000025245266,0.00011354559,0.00009993975,0.000039231065],"domain_scores_gemma":[0.999691,0.00009168833,0.000074040254,0.00003425966,0.00007431906,0.000034755263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005238221,0.00029405663,0.00033358426,0.0012029954,0.00018977604,0.00055256503,0.00020607794,0.00032192815,0.0007650134],"category_scores_gemma":[0.0010067961,0.00017156581,0.00032847276,0.00078141445,0.00020090108,0.00021119797,0.00036291117,0.0002857459,0.00022808614],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061049126,0.000062374296,0.3998705,0.0002860015,0.00022609084,0.00064317795,0.00017355084,0.0037314685,0.5533736,0.00028945174,0.00097599777,0.039757326],"study_design_scores_gemma":[0.00004849363,0.00046431887,0.7712855,0.000079021156,0.00049895776,0.0040842746,0.0004802592,0.03417227,0.18134122,0.0010475918,0.006454971,0.00004327125],"about_ca_topic_score_codex":0.0012746425,"about_ca_topic_score_gemma":0.0025536232,"teacher_disagreement_score":0.0012746425,"about_ca_system_score_codex":0.00038617072,"about_ca_system_score_gemma":0.00023537403,"threshold_uncertainty_score":0.0028018355},"labels":[],"label_agreement":null},{"id":"W3099373597","doi":"10.1158/1557-3265.covid-19-s02-01","title":"Abstract S02-01: Clinical characteristics and outcomes of coronavirus 2019 disease (COVID-19) in cancer patients treated with immune checkpoint inhibitors (ICI)","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital","funders":"","keywords":"Medicine; Internal medicine; Cancer; Lung cancer; Renal cell carcinoma; Gastroenterology","score_opus":0.46103567889242325,"score_gpt":0.5935201240567259,"score_spread":0.1324844451643027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3099373597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99892116,0.00009135083,0.00003136638,0.000022319784,0.000007171888,0.000013150975,0.00066851487,0.0000015362217,0.00024355414],"genre_scores_gemma":[0.998401,0.00003073533,0.000038679525,0.00003571776,0.000018751507,0.000018660401,0.0013595723,0.000001628582,0.00009520503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956995,0.000075583564,0.00008038266,0.00010995162,0.00006176185,0.0001023592],"domain_scores_gemma":[0.99784064,0.00024104172,0.001026569,0.000079806756,0.00019810692,0.00061382516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005161062,0.0002696822,0.00047361723,0.0006843846,0.0004829724,0.00068846997,0.00031092545,0.00050934823,0.0021171474],"category_scores_gemma":[0.0015234352,0.00021561878,0.0005682633,0.0010108612,0.00030892715,0.0005477956,0.0005134614,0.00066370715,0.0003405454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016429734,0.000024464094,0.9992205,0.000006356457,0.000019648116,0.00006147047,0.00002074143,0.000023771096,0.00013150508,0.0000047072135,0.000089036555,0.00023364417],"study_design_scores_gemma":[0.000014750854,0.00023877704,0.99892277,0.0000054430643,0.000012157478,0.00038529217,0.000109610824,0.00011547592,0.000053197982,0.000008008992,0.00013146151,0.0000030212814],"about_ca_topic_score_codex":0.0015929199,"about_ca_topic_score_gemma":0.0016334692,"teacher_disagreement_score":0.0021171474,"about_ca_system_score_codex":0.00046801966,"about_ca_system_score_gemma":0.00042586974,"threshold_uncertainty_score":0.0070825815},"labels":[],"label_agreement":null},{"id":"W3100080748","doi":"10.1158/1078-0432.ccr-20-3305","title":"Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti–PD-(L)1 Therapy","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health; Bristol-Myers Squibb; AstraZeneca; York University; Syndax Pharmaceuticals; Memorial Sloan-Kettering Cancer Center; Genentech; Parker Institute for Cancer Immunotherapy; Damon Runyon Cancer Research Foundation; Roswell Park Cancer Institute","keywords":"Pembrolizumab; Medicine; Oncology; Internal medicine; Immunotherapy; Cancer","score_opus":0.18471186659029343,"score_gpt":0.4600124273515743,"score_spread":0.2753005607612809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3100080748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983205,0.0009500949,0.00005532478,0.000088307126,0.000012256542,0.00005372217,0.00009550745,0.0000055006412,0.0004187937],"genre_scores_gemma":[0.9986386,0.0004471864,0.00016030925,0.000145709,0.000033701876,0.000042718628,0.0003660271,0.0000016814705,0.00016422282],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996916,0.000110270084,0.00002715421,0.00007154455,0.000048365342,0.00005106835],"domain_scores_gemma":[0.9995598,0.00008587701,0.000105566585,0.000026951624,0.000025289195,0.0001964592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008797169,0.00038550163,0.0010725004,0.00016261527,0.00025054172,0.00033787667,0.00021942826,0.00034723326,0.00060124084],"category_scores_gemma":[0.0008125664,0.0001641864,0.0006131957,0.00024281879,0.00018744911,0.00035829912,0.00025335414,0.0007103484,0.00013504877],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2552434,0.010228161,0.43077317,0.0009818003,0.0027986306,0.0032080063,0.0006260298,0.0051448704,0.057587877,0.0002412622,0.0044448227,0.22872195],"study_design_scores_gemma":[0.030754793,0.16162151,0.78471094,0.00015314374,0.0014311485,0.0036635408,0.0001646495,0.006011565,0.0051414887,0.00016552581,0.0061295712,0.000052084804],"about_ca_topic_score_codex":0.00086103025,"about_ca_topic_score_gemma":0.0027256024,"teacher_disagreement_score":0.0010725004,"about_ca_system_score_codex":0.00067822443,"about_ca_system_score_gemma":0.0006736099,"threshold_uncertainty_score":0.0049209},"labels":[],"label_agreement":null},{"id":"W3105254545","doi":"10.1158/1078-0432.ccr-20-2845","title":"AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":238,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Digital Payment Technologies (Canada)","funders":"Amgen","keywords":"Cancer research; Medicine; Cell; Lung cancer; Ligand (biochemistry); Small molecule; T cell; Oncology; Internal medicine; Receptor; Chemistry; Immunology; Immune system","score_opus":0.307856614907692,"score_gpt":0.5039285427276453,"score_spread":0.1960719278199533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105254545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945379,0.0018276358,0.001568558,0.00006711586,0.000018079209,0.00006189258,0.00024020016,0.00009323635,0.0015854633],"genre_scores_gemma":[0.99734133,0.00056419946,0.0008261312,0.000045585548,0.0000074714458,0.000041825668,0.00025362513,0.0000075502226,0.000912285],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998503,0.000023134713,0.000010247705,0.000021643906,0.000056341367,0.00003833393],"domain_scores_gemma":[0.99992645,0.00001272076,0.000020629412,0.000008062015,0.000009589432,0.000022584103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017442039,0.00039354034,0.00030318173,0.00028048496,0.00010616249,0.0002781052,0.00020462979,0.00031728458,0.0009980595],"category_scores_gemma":[0.000097478456,0.00009029675,0.00022215779,0.0001539606,0.00020653963,0.0002198863,0.000114417795,0.0005666164,0.0003541111],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003190587,0.00027227603,0.0004508379,0.0000670509,0.000018703631,0.000041328323,0.000019587276,0.0005883358,0.9921302,0.00007915277,0.00012020789,0.0058931937],"study_design_scores_gemma":[0.00009515287,0.00811886,0.0051706205,0.000009663199,0.000044787263,0.00029619306,0.000025558275,0.0015359649,0.9824624,0.000042380685,0.0021874562,0.000011082517],"about_ca_topic_score_codex":0.00071032235,"about_ca_topic_score_gemma":0.001772573,"teacher_disagreement_score":0.0009980595,"about_ca_system_score_codex":0.0003926245,"about_ca_system_score_gemma":0.00027120503,"threshold_uncertainty_score":0.0033388138},"labels":[],"label_agreement":null},{"id":"W3107160425","doi":"10.1158/1557-3265.covid-19-po-016","title":"Abstract PO-016: Evaluating the impact of COVID-19 on medical oncology workforce and cancer care in Canada: A serial survey study","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Medical Association; London Health Sciences Centre; Juravinski Cancer Centre; Dalhousie University; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Family medicine; Workforce; Pandemic; Cancer; Telemedicine; Descriptive statistics; Coronavirus disease 2019 (COVID-19); Health care; Internal medicine; Disease","score_opus":0.7351629325218344,"score_gpt":0.7154716212251118,"score_spread":0.019691311296722636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107160425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863214,0.0001235802,0.0001242288,0.00033133323,0.00001185399,0.00037120655,0.0104738735,0.000014482843,0.0022281157],"genre_scores_gemma":[0.98834723,0.00024547987,0.00058349303,0.00045599462,0.000013263633,0.00048019193,0.007370861,0.000012019123,0.002491411],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977203,0.00032682272,0.00018236434,0.00026422195,0.00094072294,0.0005656659],"domain_scores_gemma":[0.9916825,0.00046521568,0.0013402913,0.0002450597,0.004446218,0.0018208103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024754144,0.0004241184,0.0003822041,0.0014813415,0.0027930336,0.0013268605,0.001361096,0.00068719103,0.0024799388],"category_scores_gemma":[0.0068539456,0.00047300788,0.000672673,0.00430496,0.0007124959,0.00062014593,0.0013877183,0.0010851005,0.0006284488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006888294,0.00014383848,0.99292916,0.000055669272,0.00004188218,0.000036656307,0.0013882793,0.000080161306,0.000117225805,0.00004030279,0.0020477963,0.0030501802],"study_design_scores_gemma":[0.000005664683,0.000054651908,0.99715185,0.000016223035,0.0000066224457,0.00001335186,0.0016780989,0.00014495802,0.000036951624,0.0000055966057,0.0008803983,0.0000056550425],"about_ca_topic_score_codex":0.9825721,"about_ca_topic_score_gemma":0.9854095,"teacher_disagreement_score":0.9760363,"about_ca_system_score_codex":0.023963686,"about_ca_system_score_gemma":0.037923355,"threshold_uncertainty_score":0.17386955},"labels":[],"label_agreement":null},{"id":"W3107233990","doi":"10.1158/1557-3265.covid-19-po-010","title":"Abstract PO-010: Changes in lung cancer treatment as a result of the COVID19 pandemic: A prospective observational study","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Lung cancer; Cancer; Internal medicine; Oncology; Disease; Chemotherapy; Observational study","score_opus":0.5394165053367164,"score_gpt":0.6014951800348053,"score_spread":0.06207867469808892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107233990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969689,0.00033055915,0.00011108611,0.00006180251,0.000011191291,0.000037173933,0.0020029282,0.0000036762624,0.0004726821],"genre_scores_gemma":[0.9974017,0.00011593011,0.00008789773,0.00008560584,0.000020628782,0.00006017416,0.002074444,0.0000031324987,0.0001506004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849653,0.00052779313,0.00022182545,0.00035188088,0.00022509016,0.00017680711],"domain_scores_gemma":[0.99531317,0.0007400838,0.0026993777,0.00036044238,0.0002950002,0.00059187005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013097223,0.00033335123,0.0004335662,0.0007702686,0.0006750955,0.0010514566,0.00077673624,0.00080169085,0.0021238895],"category_scores_gemma":[0.0035607049,0.00046798892,0.0009030075,0.0018097794,0.00039509413,0.0010296156,0.0008153901,0.0012269831,0.0005129749],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024237207,0.00005461238,0.99913883,0.000015342934,0.00006111877,0.00003124274,0.000033644108,0.0000164769,0.000043399752,0.0000083597915,0.00012055245,0.00023417492],"study_design_scores_gemma":[0.00003494165,0.00029069948,0.99873286,0.000016300628,0.000055446424,0.00015442687,0.000249664,0.00016917278,0.000035470926,0.000019825993,0.0002348008,0.0000063861094],"about_ca_topic_score_codex":0.0058386354,"about_ca_topic_score_gemma":0.005821792,"teacher_disagreement_score":0.0058386354,"about_ca_system_score_codex":0.0006532743,"about_ca_system_score_gemma":0.0006761044,"threshold_uncertainty_score":0.011609316},"labels":[],"label_agreement":null},{"id":"W3108011737","doi":"10.1158/1557-3265.ovcasymp18-ap17","title":"Abstract AP17: MOLECULAR AND FUNCTIONAL HETEROGENEITY OF CANCER ASSOCIATED FIBROBLASTS IN HIGH-GRADE SEROUS OVARIAN CANCER","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Ovarian cancer; Cancer-Associated Fibroblasts; Cancer research; Fibroblast activation protein, alpha; Stromal cell; Biology; Serous fluid; Cancer cell; Gene signature; Cancer; Gene expression profiling; Medicine; Pathology; Gene expression; Gene; Genetics","score_opus":0.09476513747629156,"score_gpt":0.4506435567951621,"score_spread":0.35587841931887054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108011737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99832624,0.00072954793,0.00027422476,0.000021340245,0.000005265328,0.00000995126,0.00034138598,0.0000075938533,0.00028437463],"genre_scores_gemma":[0.99883217,0.00019422545,0.00024437185,0.000014391323,0.000006797804,0.000012527795,0.00047826252,0.000003107884,0.00021423232],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999167,0.000014831069,0.000010189688,0.000021654594,0.000017026607,0.000019660363],"domain_scores_gemma":[0.9997788,0.000051092677,0.000058035614,0.000020482328,0.000035030927,0.000056602406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017295076,0.00012870916,0.00012505602,0.0007787213,0.0001833769,0.00037792118,0.00011348375,0.00022993624,0.0017304049],"category_scores_gemma":[0.000304462,0.00007548386,0.00014858098,0.0005005186,0.00015097426,0.00013406953,0.00016873142,0.0001879807,0.0003147841],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017975455,0.00008022834,0.3300581,0.0001729389,0.000082922656,0.0016771527,0.00020359953,0.00014046364,0.6537328,0.00019210442,0.00034017192,0.011521947],"study_design_scores_gemma":[0.000045261182,0.00034255223,0.933197,0.000018282844,0.000074116666,0.006894852,0.0005717216,0.0009037641,0.054645218,0.00023212997,0.0030620766,0.000012999354],"about_ca_topic_score_codex":0.00047493645,"about_ca_topic_score_gemma":0.0003412661,"teacher_disagreement_score":0.0017304049,"about_ca_system_score_codex":0.000104323495,"about_ca_system_score_gemma":0.000092641014,"threshold_uncertainty_score":0.005788803},"labels":[],"label_agreement":null},{"id":"W3108808294","doi":"10.1158/1557-3265.covid-19-s09-03","title":"Abstract S09-03: Factors affecting COVID-19 outcomes in cancer patients: A first report from Guy’s Cancer Centre in London","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Coronavirus disease 2019 (COVID-19); Internal medicine; Disease; Proportional hazards model; Logistic regression; Infectious disease (medical specialty)","score_opus":0.49247092586206714,"score_gpt":0.6148091543827036,"score_spread":0.12233822852063642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108808294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784783,0.0054319683,0.00016176654,0.0011612155,0.000056633045,0.00008834537,0.009672893,0.000027253467,0.004921599],"genre_scores_gemma":[0.99235594,0.0019125103,0.00010479226,0.00028107403,0.00005710087,0.000046562433,0.004268364,0.000014917147,0.00095872104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993667,0.00014666177,0.00011463608,0.0001096836,0.000120606404,0.00014179824],"domain_scores_gemma":[0.99693346,0.000532001,0.0011762365,0.0001783542,0.0005362464,0.0006437747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000504574,0.00033836113,0.0004921744,0.0016032906,0.00052260305,0.0010463768,0.0004648002,0.00057149545,0.0037132953],"category_scores_gemma":[0.002234015,0.0003675384,0.0005113417,0.0029765505,0.0004432867,0.0004108544,0.0013508821,0.00058381574,0.0009114979],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016129167,0.000015666736,0.9891868,0.00023234994,0.000052692205,0.0017851861,0.00098656,0.0000767359,0.00021136302,0.000038968126,0.0039622616,0.0032901852],"study_design_scores_gemma":[0.000018454584,0.00007045132,0.99428236,0.00012156226,0.000022716269,0.0017169263,0.0015272793,0.00004382799,0.00007279445,0.000011896475,0.0020966502,0.000015061403],"about_ca_topic_score_codex":0.082371786,"about_ca_topic_score_gemma":0.07674914,"teacher_disagreement_score":0.082371786,"about_ca_system_score_codex":0.0020149462,"about_ca_system_score_gemma":0.0013894221,"threshold_uncertainty_score":0.16378462},"labels":[],"label_agreement":null},{"id":"W3109580766","doi":"10.1158/1557-3265.covid-19-po-065","title":"Abstract PO-065: National Clinical Trials Network biobanking during the COVID-19 pandemic","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Biobank; Receipt; Staffing; Clinical trial; Pandemic; Medicine; Tissue bank; Family medicine; Coronavirus disease 2019 (COVID-19); Business; Disease; Pathology; Bioinformatics; Nursing; Accounting; Biology","score_opus":0.857763410917281,"score_gpt":0.7006660696538014,"score_spread":0.15709734126347963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109580766","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06245628,0.003045426,0.015607542,0.61905825,0.011956706,0.005933676,0.018238364,0.0051807426,0.258523],"genre_scores_gemma":[0.4972787,0.0038835523,0.063173875,0.27216312,0.010982827,0.010853569,0.042765737,0.002947765,0.09595087],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.97328067,0.013395038,0.0020451972,0.002266675,0.006045917,0.0029664899],"domain_scores_gemma":[0.89372003,0.026506374,0.007268559,0.014160074,0.01889102,0.03945403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0811769,0.00045294838,0.0005006946,0.0013048844,0.0046931016,0.008828145,0.0028564092,0.0045081656,0.03396269],"category_scores_gemma":[0.10767036,0.0006595247,0.00063632615,0.0014723865,0.0015688266,0.0046483628,0.0064780205,0.0078739645,0.009140226],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090330915,0.00028987465,0.014167002,0.00022075036,0.000046015764,0.0006031651,0.0008495788,0.0011425221,0.0010120843,0.013774129,0.871991,0.09500062],"study_design_scores_gemma":[0.0010573295,0.00077405694,0.04402001,0.00076464465,0.000038587856,0.00058492995,0.0024889188,0.004756071,0.0013744931,0.015216481,0.9287839,0.00014065133],"about_ca_topic_score_codex":0.013732642,"about_ca_topic_score_gemma":0.024589827,"teacher_disagreement_score":0.0811769,"about_ca_system_score_codex":0.011461895,"about_ca_system_score_gemma":0.035864368,"threshold_uncertainty_score":0.4293096},"labels":[],"label_agreement":null},{"id":"W3109674153","doi":"10.1158/1078-0432.ccr-20-3609","title":"A Randomized Phase IIb Study of Low-dose Tamoxifen in Chest-irradiated Cancer Survivors at Risk for Breast Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Tamoxifen; Breast cancer; Placebo; Population; Clinical endpoint; Cancer; Internal medicine; Urology; Adverse effect; Oncology; Randomized controlled trial; Pathology","score_opus":0.15704947367863586,"score_gpt":0.5059863750775024,"score_spread":0.3489369013988666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109674153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9695739,0.004318683,0.001178086,0.0011174992,0.0007277201,0.018725693,0.001760987,0.0001665095,0.0024309212],"genre_scores_gemma":[0.96272624,0.0031719161,0.002848975,0.002390783,0.0006182153,0.021353163,0.0017620109,0.00002789519,0.005100931],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992874,0.00040476018,0.000049629056,0.00010203325,0.000055991673,0.00010015579],"domain_scores_gemma":[0.9990694,0.00017353267,0.00025560806,0.00008621044,0.00008855974,0.00032664035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021382407,0.0014667601,0.0022337597,0.0003645527,0.00046569956,0.00090501265,0.00082833203,0.0019321992,0.007860306],"category_scores_gemma":[0.001928441,0.0007683379,0.0012559755,0.00035170524,0.0010073372,0.00078346115,0.0003284452,0.0025917238,0.0011654028],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96735126,0.013773589,0.0008775188,0.0005572558,0.0005532088,0.00003545285,0.000057881618,0.00015510811,0.00601086,0.00008754002,0.0008668373,0.00967341],"study_design_scores_gemma":[0.9284254,0.06934369,0.0011383258,0.000021863816,0.00019935644,0.000015364276,0.00001403502,0.00012296622,0.00025697472,0.000059670943,0.00039617813,0.0000062197587],"about_ca_topic_score_codex":0.0007157118,"about_ca_topic_score_gemma":0.002290649,"teacher_disagreement_score":0.007860306,"about_ca_system_score_codex":0.0006468299,"about_ca_system_score_gemma":0.0016509396,"threshold_uncertainty_score":0.026295304},"labels":[],"label_agreement":null},{"id":"W3110393829","doi":"10.1158/1557-3265.covid-19-po-029","title":"Abstract PO-029: Operationalizing a prioritized COVID-19 testing strategy at a Canadian tertiary care cancer center","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Internal medicine; Population; Lung cancer; Neutropenia; Febrile neutropenia; Emergency medicine; Chemotherapy","score_opus":0.644612724772619,"score_gpt":0.6324277666012751,"score_spread":0.012184958171343907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110393829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90843916,0.0010671304,0.0059054377,0.02083214,0.00022763916,0.0043246346,0.00288492,0.001071403,0.05524755],"genre_scores_gemma":[0.97309136,0.00041014876,0.017302236,0.003842088,0.00007073201,0.0003602131,0.0016486977,0.00007014422,0.0032043331],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962658,0.00061369274,0.00013402116,0.00041471934,0.0008566216,0.0017152156],"domain_scores_gemma":[0.98860514,0.0005036313,0.0005533687,0.00022986608,0.0036929513,0.006415053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041340603,0.0007117355,0.00024847113,0.0013717819,0.005883985,0.0033448155,0.0031304385,0.0007224848,0.004751397],"category_scores_gemma":[0.0062606074,0.00038962465,0.0003516578,0.0014826476,0.0011217342,0.0006835086,0.0034797068,0.0011019201,0.0004760249],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012042121,0.0015047219,0.6614839,0.0004621617,0.00013506705,0.001404524,0.0053722966,0.008669542,0.0071428907,0.0031473904,0.08545404,0.22401921],"study_design_scores_gemma":[0.000540139,0.0027380926,0.8285134,0.0006842259,0.00022956672,0.0006803712,0.037283078,0.043675657,0.004316114,0.0015942529,0.07950724,0.00023793726],"about_ca_topic_score_codex":0.9622633,"about_ca_topic_score_gemma":0.98286045,"teacher_disagreement_score":0.07316409,"about_ca_system_score_codex":0.07316409,"about_ca_system_score_gemma":0.171829,"threshold_uncertainty_score":0.5308451},"labels":[],"label_agreement":null},{"id":"W3112621369","doi":"10.1158/1078-0432.ccr-20-3310","title":"Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"DOD Prostate Cancer Research Program; Congressionally Directed Medical Research Programs; University of Alberta; University of California, San Francisco; University of Virginia; National Cancer Institute; National Institutes of Health; Prostate Cancer Foundation; UVA Cancer Center; U.S. Department of Defense","keywords":"Prostate cancer; Cancer; Prostate; Medicine; Pathology; Internal medicine","score_opus":0.13616052490480357,"score_gpt":0.45134942868840977,"score_spread":0.3151889037836062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112621369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9706255,0.008714194,0.017679622,0.0002215157,0.000029684721,0.00007575237,0.00018826239,0.00015070417,0.002314668],"genre_scores_gemma":[0.98862326,0.0019702082,0.008074653,0.00008051595,0.00001437742,0.00002070311,0.00019791751,0.000012923553,0.0010053689],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998648,0.000039131628,0.0000051978836,0.000028107908,0.00003092973,0.000031820007],"domain_scores_gemma":[0.9999461,0.000010757292,0.000015650976,0.0000071272975,0.000007176105,0.0000132293735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022462424,0.0003242154,0.00022244795,0.00016881622,0.00008835118,0.00038592378,0.00026823697,0.00037415605,0.0010756053],"category_scores_gemma":[0.000112294256,0.00011997551,0.00021775527,0.00013338655,0.0002027183,0.00023723456,0.00017708945,0.00031936617,0.000410185],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012695955,0.000028251801,0.0004335369,0.00008121893,0.0000111733625,0.00007322182,0.000010296741,0.00036438598,0.995366,0.00014811798,0.00006330008,0.0032935718],"study_design_scores_gemma":[0.000030351597,0.00066311087,0.002676793,0.000007841595,0.000029574232,0.0010446291,0.000015261829,0.0043214145,0.9874442,0.0000360862,0.003722339,0.000008459925],"about_ca_topic_score_codex":0.0007173373,"about_ca_topic_score_gemma":0.00048583126,"teacher_disagreement_score":0.0010756053,"about_ca_system_score_codex":0.00033045784,"about_ca_system_score_gemma":0.00016711694,"threshold_uncertainty_score":0.0035982132},"labels":[],"label_agreement":null},{"id":"W3115651269","doi":"10.1158/1078-0432.ccr-20-2563","title":"LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mood Disorders Association of British Columbia; Aegera Therapeutics (Canada)","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; KRAS; In vivo; Biology; Cancer research; Mutant; MAPK/ERK pathway; Kinase; Cell culture; Mutation; Cell biology; Genetics; Gene","score_opus":0.19876116464915,"score_gpt":0.45473027212063105,"score_spread":0.25596910747148105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115651269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831467,0.0064404425,0.0045759557,0.00025153792,0.000051781804,0.00021928441,0.00061491446,0.0002347735,0.0044644647],"genre_scores_gemma":[0.9901164,0.0021290954,0.0032318933,0.00008479742,0.000021345013,0.00008223113,0.000708873,0.00001713539,0.0036081101],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992216,0.00001412177,0.000006117097,0.00001442556,0.000025204468,0.000018038452],"domain_scores_gemma":[0.9999633,0.000004160378,0.00000908043,0.0000051500865,0.000004271123,0.000014042844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018125557,0.00047974332,0.00025994718,0.00023367573,0.00012687464,0.00021289282,0.00029994844,0.00028750955,0.0013741925],"category_scores_gemma":[0.00006103341,0.0001353498,0.0002896396,0.00011154539,0.00016677295,0.00015153906,0.00014123482,0.00060552,0.00045195187],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034193284,0.00013695953,0.00031919172,0.00007856775,0.00001781968,0.000120614524,0.000010452128,0.00027598464,0.99012357,0.00014656426,0.00019809653,0.008230277],"study_design_scores_gemma":[0.00029344033,0.00338637,0.0029955502,0.000008385295,0.00004386396,0.0013013126,0.000013772691,0.00085704617,0.9847131,0.000058507176,0.0063156397,0.0000129848595],"about_ca_topic_score_codex":0.00029564014,"about_ca_topic_score_gemma":0.000935262,"teacher_disagreement_score":0.0013741925,"about_ca_system_score_codex":0.00029798827,"about_ca_system_score_gemma":0.00033660268,"threshold_uncertainty_score":0.0045971274},"labels":[],"label_agreement":null},{"id":"W3118147665","doi":"10.1158/1078-0432.ccr-20-3313","title":"Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNET","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"National Cancer Institute; Instituto de Salud Carlos III; Gobierno de Navarra; Universidad de Navarra; European Commission; U.S. Department of Defense","keywords":"Oncolytic virus; Proinflammatory cytokine; Oncolytic adenovirus; Immune system; Biology; Cancer research; Medicine; Immunology; Inflammation","score_opus":0.18617702485926932,"score_gpt":0.45050545955993476,"score_spread":0.26432843470066547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118147665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968773,0.0008018689,0.0014307031,0.00003769438,0.000023148981,0.00003149784,0.0002985831,0.00005517325,0.0004439887],"genre_scores_gemma":[0.9957711,0.0006302767,0.0016920689,0.000023310231,0.0000067043125,0.000042081803,0.0003917762,0.000012390165,0.0014303331],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984765,0.000024096827,0.000019100191,0.00004044629,0.00003726922,0.000031370157],"domain_scores_gemma":[0.9999018,0.000012578245,0.00003289897,0.000013180795,0.000013113716,0.00002647389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023544427,0.00037281305,0.00026871997,0.00022226076,0.00008907829,0.00029492902,0.00014479512,0.00015509961,0.0006837995],"category_scores_gemma":[0.00009589946,0.00009133892,0.00020883829,0.00012114398,0.0002283551,0.00019227903,0.0001031389,0.00061111717,0.00022954194],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039662278,0.00012140188,0.00032756446,0.000051537372,0.000006819097,0.000036073467,0.000015011968,0.00015018936,0.9973732,0.000033626446,0.000038213653,0.0014497057],"study_design_scores_gemma":[0.000036378635,0.0019796554,0.0030990448,0.0000081190365,0.000027003436,0.00024808513,0.00003809871,0.0012579616,0.9924102,0.00002470061,0.0008670756,0.000003717676],"about_ca_topic_score_codex":0.00034651384,"about_ca_topic_score_gemma":0.00050645485,"teacher_disagreement_score":0.0006837995,"about_ca_system_score_codex":0.0002543108,"about_ca_system_score_gemma":0.0002949484,"threshold_uncertainty_score":0.0022875667},"labels":[],"label_agreement":null},{"id":"W3118507153","doi":"10.1158/1078-0432.ccr-20-3706","title":"Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":196,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada); Spinal Cord Injury BC; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"National Institutes of Health","keywords":"Medicine; Refractory (planetary science); Chills; Rituximab; Lymphoma; Internal medicine; Clinical endpoint; Gastroenterology; Adverse effect; Nivolumab; Phases of clinical research; Surgery; Chemotherapy; Cancer; Clinical trial; Immunotherapy","score_opus":0.159802523185442,"score_gpt":0.4642106808345872,"score_spread":0.3044081576491452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118507153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98889995,0.004405322,0.00057901477,0.00037954721,0.00010174555,0.002001352,0.0007669997,0.00013577132,0.0027301845],"genre_scores_gemma":[0.9892202,0.0027387382,0.0011205174,0.0010001331,0.00013162941,0.0013301183,0.0016706865,0.000031403408,0.0027567486],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998337,0.000058304977,0.000011209437,0.00003224461,0.000024079722,0.0000404556],"domain_scores_gemma":[0.99978596,0.000022708084,0.00004813233,0.000017489874,0.000017902245,0.000107841275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075960654,0.0009785654,0.0013148686,0.00028794573,0.00028979202,0.00068712555,0.0004256001,0.0006789885,0.0028404626],"category_scores_gemma":[0.00041696226,0.00036430152,0.00077442586,0.00026311286,0.00035954325,0.00040007484,0.00021329551,0.001682189,0.0008469248],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3926809,0.09182391,0.01917649,0.002396789,0.0024893302,0.000820854,0.0006085392,0.005219415,0.16608596,0.0005404467,0.012821382,0.305336],"study_design_scores_gemma":[0.45847,0.49233207,0.02392421,0.00012766612,0.0008711725,0.00081638363,0.00008736206,0.0022916077,0.010588078,0.00029126077,0.010162023,0.00003804098],"about_ca_topic_score_codex":0.0006493482,"about_ca_topic_score_gemma":0.0022175268,"teacher_disagreement_score":0.0028404626,"about_ca_system_score_codex":0.0005949402,"about_ca_system_score_gemma":0.0009843385,"threshold_uncertainty_score":0.009502292},"labels":[],"label_agreement":null},{"id":"W3118514290","doi":"10.1158/1078-0432.ccr-20-2378","title":"Double-hit Signature with <i>TP53</i> Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOP","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College; CancerCare Manitoba","funders":"National Cancer Institute; National Institutes of Health; City of Hope","keywords":"Diffuse large B-cell lymphoma; Rituximab; Vincristine; Lymphoma; Germinal center; Cell of origin; Oncology; Medicine; Internal medicine; PTEN; Cancer research; Cyclophosphamide; Biology; B cell; Cancer; Immunology; Chemotherapy; Genetics; PI3K/AKT/mTOR pathway","score_opus":0.06245815259684164,"score_gpt":0.3858503799449771,"score_spread":0.3233922273481355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118514290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99976224,0.000072685834,0.00004624914,0.0000070546375,7.262084e-7,0.0000018522217,0.00002900702,0.0000020267714,0.0000781282],"genre_scores_gemma":[0.99983966,0.000017489263,0.00004293453,0.0000061437186,0.0000020970517,0.0000011718035,0.000076308264,6.654728e-7,0.000013517413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998683,0.000027906346,0.000013573283,0.00003925096,0.000023812767,0.000027102215],"domain_scores_gemma":[0.9996922,0.00006308586,0.00011784362,0.00002581662,0.000026852256,0.00007428641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022074184,0.00022062466,0.00025770426,0.00051023654,0.0001968912,0.00033927496,0.00017970575,0.00023922112,0.0004806297],"category_scores_gemma":[0.0006095881,0.00012798878,0.00015141917,0.00037188624,0.00025551507,0.00017970163,0.0002762319,0.00021573046,0.00010978765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001874558,0.000012920863,0.9953863,0.000004573604,0.000017785598,0.000267028,0.000026879177,0.000068020054,0.0025478115,0.0000053992085,0.00002935584,0.0014465258],"study_design_scores_gemma":[0.000011645106,0.00012538247,0.996639,0.0000021817204,0.000029232884,0.0021129039,0.00007669267,0.00036798668,0.0005052693,0.000022702547,0.00010471224,0.000002240338],"about_ca_topic_score_codex":0.00070440734,"about_ca_topic_score_gemma":0.0008956596,"teacher_disagreement_score":0.00070440734,"about_ca_system_score_codex":0.00017047895,"about_ca_system_score_gemma":0.00013958682,"threshold_uncertainty_score":0.0016078353},"labels":[],"label_agreement":null},{"id":"W3119089372","doi":"10.1158/1078-0432.ccr-20-4576","title":"A Bispecific Single-Domain Antibody Boosts Autologous Vγ9Vδ2-T Cell Responses Toward CD1d in Chronic Lymphocytic Leukemia","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Vrije Universiteit Amsterdam; Victoria University; ZonMw; Worldwide Cancer Research","keywords":"Chronic lymphocytic leukemia; Cancer research; T cell; Antigen; Immunotherapy; Leukemia; Immunology; Antibody; Population; Medicine; Immune system","score_opus":0.27903878791525544,"score_gpt":0.531461172556048,"score_spread":0.25242238464079253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119089372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994469,0.00018439598,0.000093994866,0.000009416682,0.0000026168739,0.000011657663,0.000035947327,0.000008099507,0.00020678644],"genre_scores_gemma":[0.99930966,0.00010437616,0.0001093689,0.000019640185,0.0000050784415,0.000016450229,0.0001394111,0.0000018757379,0.0002940878],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989784,0.000017579932,0.0000069274065,0.000022496699,0.000017471759,0.000037686095],"domain_scores_gemma":[0.99994195,0.000012577263,0.000011541391,0.0000067116102,0.0000057947154,0.00002133692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017022264,0.00031082114,0.00027708148,0.00018805312,0.00018012966,0.00023446309,0.00014142039,0.00020408265,0.0010293331],"category_scores_gemma":[0.00013319147,0.00010298883,0.00013888489,0.0001317414,0.0001750405,0.00013266949,0.00019737537,0.00030838806,0.0002249009],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004511787,0.001415759,0.022878714,0.00013031859,0.00003200909,0.00048848614,0.00020736088,0.0005668774,0.94608474,0.0000800982,0.00041136288,0.023192458],"study_design_scores_gemma":[0.0023313744,0.06507714,0.24231845,0.0000495293,0.00019388786,0.0074781524,0.0005139323,0.005751448,0.6646414,0.00019137624,0.011423561,0.000029704363],"about_ca_topic_score_codex":0.00093391875,"about_ca_topic_score_gemma":0.0010242576,"teacher_disagreement_score":0.0010293331,"about_ca_system_score_codex":0.00041640733,"about_ca_system_score_gemma":0.00018394376,"threshold_uncertainty_score":0.0034434795},"labels":[],"label_agreement":null},{"id":"W3119730599","doi":"10.1158/1078-0432.ccr-20-3241","title":"Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC)","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Cancer Institute; Dana-Farber Cancer Institute; University of Texas MD Anderson Cancer Center; Stanford University; Language Literacy and Culture, University of Maryland, Baltimore County","keywords":"Cancer; Biomarker; Clinical trial; Medicine; Harmonization; Cancer immunotherapy; Cancer biomarkers; Immunotherapy; Oncology; Computational biology; Internal medicine; Biology","score_opus":0.36760951917107715,"score_gpt":0.5418912594727787,"score_spread":0.17428174030170157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119730599","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028261725,0.018115107,0.31819364,0.13980629,0.0139697,0.013066731,0.16552386,0.045435216,0.25762776],"genre_scores_gemma":[0.1403327,0.008892363,0.44280744,0.022049919,0.004424731,0.017393807,0.288467,0.007872277,0.06775978],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98479295,0.006071986,0.0011562017,0.0023576259,0.0041793003,0.0014418834],"domain_scores_gemma":[0.9077272,0.015218466,0.006658525,0.018254504,0.03089458,0.021246772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.052210778,0.0014160427,0.0013998697,0.005660622,0.0023665628,0.007191806,0.005604751,0.0022723963,0.037143722],"category_scores_gemma":[0.04978008,0.00073423656,0.000981279,0.0066652806,0.0015294688,0.0052705905,0.013223669,0.004044434,0.019566845],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009410215,0.00024463268,0.010670815,0.0009102987,0.000116371804,0.000110657726,0.00034220377,0.0042499076,0.0026152811,0.03219822,0.6739306,0.27366993],"study_design_scores_gemma":[0.00022175827,0.00014547563,0.0046548764,0.00051660603,0.00006097492,0.00013649538,0.00013744606,0.010823727,0.0029312181,0.009392277,0.9709075,0.00007162258],"about_ca_topic_score_codex":0.0090284115,"about_ca_topic_score_gemma":0.005686239,"teacher_disagreement_score":0.052210778,"about_ca_system_score_codex":0.008401771,"about_ca_system_score_gemma":0.036604922,"threshold_uncertainty_score":0.2761203},"labels":[],"label_agreement":null},{"id":"W3120084637","doi":"10.1158/1078-0432.ccr-20-2404","title":"ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Foundation; BC Cancer Agency","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; National Institutes of Health","keywords":"ARID1A; Colorectal cancer; Microsatellite instability; Biology; Cancer research; DNA mismatch repair; Cancer; Frameshift mutation; MSH2; Mutation; Gene; Genetics; Microsatellite","score_opus":0.06817987287177463,"score_gpt":0.43061713285217196,"score_spread":0.36243725998039733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120084637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99952793,0.00011400006,0.00005063341,0.000018139326,0.0000026495343,0.0000038774524,0.000062892665,0.0000023287348,0.0002176021],"genre_scores_gemma":[0.9997476,0.000025927478,0.00005334168,0.000009222106,0.0000060274483,0.000003412137,0.000099014884,9.4258803e-7,0.000054573316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998171,0.000029749877,0.000026248366,0.00006279673,0.000030625877,0.000033500655],"domain_scores_gemma":[0.9995677,0.000089307185,0.00016708727,0.000019010173,0.000033867454,0.00012308816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024370525,0.00022703383,0.00026796907,0.000986229,0.0003473046,0.00037084945,0.00024285605,0.00038606414,0.0021730866],"category_scores_gemma":[0.0009811737,0.0001200428,0.00022745505,0.00052289024,0.00023742874,0.00028051678,0.00029648523,0.00022309346,0.00038360266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027305592,0.00002034965,0.9950053,0.000009105363,0.000015211821,0.0005305337,0.000039113882,0.000038677,0.002713926,0.00002628708,0.000075160235,0.0012531831],"study_design_scores_gemma":[0.000010900967,0.00016419434,0.99360585,0.0000047375065,0.00002625196,0.004656157,0.00020582411,0.00040816423,0.0005429167,0.00007132254,0.00029981037,0.0000038536414],"about_ca_topic_score_codex":0.00045992102,"about_ca_topic_score_gemma":0.00057145016,"teacher_disagreement_score":0.0021730866,"about_ca_system_score_codex":0.00013849673,"about_ca_system_score_gemma":0.0001383716,"threshold_uncertainty_score":0.00726974},"labels":[],"label_agreement":null},{"id":"W3120833111","doi":"10.1158/1078-0432.ccr-20-3708","title":"<i>BRCA2</i> , <i>ATM</i> , and <i>CDK12</i> Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical Aggression","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Alberta Cancer Foundation; BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"Canadian Institutes of Health Research; Prostate Cancer Canada; Government of Canada; Prostate Cancer Foundation","keywords":"Biology; Prostate cancer; Cancer research; Context (archaeology); Cancer; Genome instability; Allele; PTEN; Primary tumor; Chromoplexy; Mutation; Copy-number variation; Genetics; DNA damage; Gene; Metastasis; Genome; DNA; Apoptosis","score_opus":0.13646479669692277,"score_gpt":0.48600994150724286,"score_spread":0.34954514481032006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120833111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984263,0.0001628684,0.0005066315,0.000023335595,0.0000015875316,0.0000063556217,0.00034984338,0.000038468424,0.0004847067],"genre_scores_gemma":[0.9991302,0.000058873164,0.00029530554,0.000020131067,0.0000025622794,0.000004191677,0.0003027935,0.000016208505,0.00016955074],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999841,0.000019914847,0.000009472926,0.00006944829,0.00003250822,0.000027713679],"domain_scores_gemma":[0.99968565,0.00006108508,0.00013861163,0.000025468686,0.0000234759,0.000065784625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018433106,0.00020899286,0.00020600113,0.00053940946,0.00011923385,0.00042478033,0.00020552496,0.00023725606,0.0019685323],"category_scores_gemma":[0.0004061708,0.0001386438,0.00013131961,0.00033180363,0.00027180297,0.00014792166,0.00017948724,0.00026954158,0.00037406263],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015942547,0.000092841634,0.3584373,0.00008366603,0.00009485298,0.0006307706,0.00013926683,0.00058483356,0.6202496,0.00021600278,0.00047031548,0.017406244],"study_design_scores_gemma":[0.000018944078,0.0003162334,0.9237263,0.000009304238,0.00008135607,0.004049637,0.00012654143,0.0016229,0.0687331,0.000192677,0.0011120284,0.000010863677],"about_ca_topic_score_codex":0.00051592593,"about_ca_topic_score_gemma":0.0006643963,"teacher_disagreement_score":0.0019685323,"about_ca_system_score_codex":0.00020215778,"about_ca_system_score_gemma":0.00017176682,"threshold_uncertainty_score":0.006585419},"labels":[],"label_agreement":null},{"id":"W3121885177","doi":"10.1158/1078-0432.ccr-19-2163","title":"CEACAM7 Is an Effective Target for CAR T-cell Therapy of Pancreatic Ductal Adenocarcinoma","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Pancreatic Cancer Research Fund; Cancer Research UK; Pancreatic Cancer UK","keywords":"Cancer research; Pancreatic cancer; In vivo; Pancreas; Adenocarcinoma; Pancreatic ductal adenocarcinoma; Cancer; Antigen; Cell culture; Medicine; Cell; Biology; Immunology; Internal medicine","score_opus":0.3368971767084059,"score_gpt":0.5813869141696257,"score_spread":0.24448973746121982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121885177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848157,0.005124955,0.004905566,0.0002306025,0.00004236867,0.00010874354,0.00016027478,0.00013608455,0.0044756294],"genre_scores_gemma":[0.99551827,0.0009381107,0.0016952682,0.00008169843,0.000018765639,0.00004800541,0.00022188526,0.000012812918,0.0014651754],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984753,0.000028595938,0.000008427652,0.000026267071,0.000053217384,0.000036009817],"domain_scores_gemma":[0.9999232,0.000016010046,0.000010394793,0.0000088923325,0.000019360816,0.00002216021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016199498,0.00022471441,0.00033088314,0.00023527263,0.00015297226,0.00048012077,0.00018838925,0.00041830254,0.0022366045],"category_scores_gemma":[0.00015494898,0.00009293292,0.00022506565,0.00016508246,0.00020908573,0.00016150606,0.00014679378,0.00054827804,0.00055284],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010425539,0.0000737433,0.0007447618,0.00008134477,0.000014402584,0.00009332843,0.000014740533,0.00017841515,0.9937605,0.0001914318,0.0001581022,0.0045848475],"study_design_scores_gemma":[0.000062251485,0.0016510172,0.0049908445,0.000016086176,0.00007335954,0.0009005226,0.000051820356,0.0029152136,0.98209757,0.000099433666,0.0071359966,0.0000058843902],"about_ca_topic_score_codex":0.0004607058,"about_ca_topic_score_gemma":0.000551442,"teacher_disagreement_score":0.0022366045,"about_ca_system_score_codex":0.0003464093,"about_ca_system_score_gemma":0.00035977573,"threshold_uncertainty_score":0.007482171},"labels":[],"label_agreement":null},{"id":"W3126582315","doi":"10.1158/1557-3265.endomet20-ia006","title":"Abstract IA006: Endocrine therapy and ER/PR combinations","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Endocrine system; Cancer; Medicine; Endometrial cancer; Cancer therapy; Oncology; Targeted therapy; Internal medicine; Hormone","score_opus":0.16414589948594605,"score_gpt":0.5076604830383367,"score_spread":0.3435145835523906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126582315","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07839411,0.47195938,0.0025115474,0.056827143,0.017793473,0.00074181426,0.008732562,0.0010057932,0.36203417],"genre_scores_gemma":[0.37802386,0.3432051,0.008380405,0.020955788,0.014812748,0.00043080922,0.012318586,0.0002223009,0.22165036],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997173,0.000096292526,0.000024780771,0.000024673662,0.00010101904,0.000035917226],"domain_scores_gemma":[0.99965644,0.00010361881,0.00004680748,0.00001968453,0.00006460461,0.00010878126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008541828,0.00049140793,0.0005058619,0.00091509265,0.00040761955,0.0013429219,0.0005407092,0.00076442864,0.031128116],"category_scores_gemma":[0.00091427297,0.00022573615,0.0005326051,0.0008202849,0.00021861319,0.00047328597,0.00042211256,0.0012602282,0.006432794],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076463707,0.00080021133,0.0025983022,0.0017846285,0.00012755356,0.0010926807,0.000056615314,0.00068550976,0.020559773,0.0035715587,0.28775805,0.67331886],"study_design_scores_gemma":[0.0025014682,0.010424881,0.022529718,0.0011802469,0.000363004,0.0047764378,0.00009324056,0.0006269808,0.017279316,0.0027427776,0.93742555,0.000056333265],"about_ca_topic_score_codex":0.0008209172,"about_ca_topic_score_gemma":0.0026688322,"teacher_disagreement_score":0.031128116,"about_ca_system_score_codex":0.00065190165,"about_ca_system_score_gemma":0.0007425765,"threshold_uncertainty_score":0.104133904},"labels":[],"label_agreement":null},{"id":"W3127425164","doi":"10.1158/1557-3265.endomet20-ia017","title":"Abstract IA017: Molecular classification and stratification: Diving deeper","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Categorization; Homogeneous; Risk stratification; Stratification (seeds); Context (archaeology); Endometrial cancer; Clinical Practice; Computational biology; Cancer; Medicine; Bioinformatics; Oncology; Biology; Computer science; Internal medicine; Artificial intelligence; Family medicine","score_opus":0.18706746734110394,"score_gpt":0.4963170204378261,"score_spread":0.3092495530967222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127425164","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052970243,0.04255959,0.04859575,0.84780085,0.028227394,0.0003204446,0.003135233,0.0011613857,0.022902368],"genre_scores_gemma":[0.18298216,0.11103448,0.24407162,0.2930271,0.10424982,0.00126844,0.013824386,0.003259774,0.046282187],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98429203,0.008624586,0.0018956508,0.0011458946,0.0034697135,0.00057206396],"domain_scores_gemma":[0.9092184,0.032641612,0.006449364,0.011246905,0.0343422,0.006101548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.044994023,0.0012027646,0.0020927757,0.008185115,0.0021059727,0.012322605,0.0034685754,0.0033728934,0.020917408],"category_scores_gemma":[0.1426418,0.0010810709,0.0022032368,0.006333671,0.006225312,0.013456801,0.007288536,0.014928212,0.010988161],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024732313,0.000050025392,0.0076433336,0.001064095,0.00017734747,0.0001326328,0.00078092515,0.00077848847,0.0007315956,0.039752543,0.548315,0.40032676],"study_design_scores_gemma":[0.00012834209,0.00022564385,0.01441619,0.009678507,0.00034867425,0.0007676446,0.0019568403,0.0048196493,0.00086054637,0.32832727,0.6382558,0.00021488869],"about_ca_topic_score_codex":0.007951227,"about_ca_topic_score_gemma":0.0081508495,"teacher_disagreement_score":0.044994023,"about_ca_system_score_codex":0.0049832533,"about_ca_system_score_gemma":0.012129976,"threshold_uncertainty_score":0.23795402},"labels":[],"label_agreement":null},{"id":"W3127454388","doi":"10.1158/1078-0432.ccr-20-3260","title":"Emergence of Enzalutamide Resistance in Prostate Cancer is Associated with BCL-2 and IKKB Dependencies","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University of British Columbia; University Health Network","funders":"Medical Research Council; Imperial Experimental Cancer Medicine Centre; Royal Marsden NHS Foundation Trust; Department of Health and Social Care; National Institute for Health and Care Research; Cancer Council NSW; Cancer Research UK; Academy of Medical Sciences; Prostate Cancer Canada; Prostate Cancer Foundation; Movember Foundation; Prostate Cancer UK; U.S. Department of Defense","keywords":"Enzalutamide; Prostate cancer; Cancer; Medicine; Prostate; Oncology; Resistance (ecology); Internal medicine; Biology; Androgen receptor","score_opus":0.13677567847113423,"score_gpt":0.4662400923479494,"score_spread":0.32946441387681513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127454388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936085,0.0030217385,0.0014201868,0.00009169188,0.000015146317,0.00003864031,0.000416165,0.000116910756,0.0012709359],"genre_scores_gemma":[0.9965502,0.0010130695,0.000778384,0.000037920483,0.0000037351008,0.000020787988,0.0005994945,0.000008875954,0.0009875852],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985886,0.000018850787,0.000017136848,0.000025464136,0.00005254854,0.000027084803],"domain_scores_gemma":[0.9998803,0.00001619761,0.000040630053,0.000017369115,0.000020825415,0.000024646873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015000766,0.00033493157,0.00027632172,0.00029039942,0.0001711929,0.00043357883,0.00018420212,0.00015767077,0.0011749414],"category_scores_gemma":[0.00012382267,0.00013263836,0.00023719069,0.00029892073,0.000187663,0.00012925264,0.00016626598,0.0006141353,0.00028721255],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017895937,0.000078125806,0.0022367267,0.000067868335,0.000016303102,0.00016661658,0.000013509714,0.00013157474,0.994218,0.00007878994,0.00008837892,0.002725017],"study_design_scores_gemma":[0.00006133345,0.0009631996,0.031474262,0.000012487186,0.00007356119,0.0028582488,0.00006277493,0.0012965978,0.9596661,0.000077251985,0.003443096,0.000011250526],"about_ca_topic_score_codex":0.0008478364,"about_ca_topic_score_gemma":0.0020286497,"teacher_disagreement_score":0.0011749414,"about_ca_system_score_codex":0.00036919754,"about_ca_system_score_gemma":0.00033355627,"threshold_uncertainty_score":0.003930509},"labels":[],"label_agreement":null},{"id":"W3127498707","doi":"10.1158/1557-3265.endomet20-ia002","title":"Abstract IA002: Histopathological classification of endometrial cancers and surrogate markers of genomic subtypes","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute","funders":"","keywords":"Serous carcinoma; Carcinoma; Endometrial cancer; Serous fluid; Pathology; Clear cell carcinoma; Hematopathology; Biology; Medicine; Cancer; Oncology; Internal medicine; Cytogenetics; Ovarian cancer; Gene; Genetics","score_opus":0.308582051854038,"score_gpt":0.5043293247517843,"score_spread":0.1957472728977463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127498707","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91211665,0.03457833,0.011558009,0.0023871488,0.0007158396,0.00026417692,0.00667593,0.00025671607,0.031447306],"genre_scores_gemma":[0.9744776,0.0045883963,0.0063871783,0.00028922997,0.00037941124,0.00013280814,0.0078116227,0.000049768063,0.0058839815],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99941444,0.00024964908,0.00008891331,0.00006565554,0.00013810856,0.000043298107],"domain_scores_gemma":[0.9985954,0.00030158416,0.00043187165,0.00011608679,0.00039524748,0.00015978764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015041062,0.00030496897,0.00021243154,0.0026121642,0.0002070207,0.0011828397,0.00037822267,0.00037355552,0.0023315062],"category_scores_gemma":[0.0035589493,0.000103978084,0.00027717714,0.0016185851,0.00026188575,0.00039079215,0.0006840309,0.00047035608,0.00084619346],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015101195,0.00007030679,0.83317363,0.00040368692,0.00013699775,0.00040477078,0.00017077423,0.0005815726,0.017669784,0.0016616546,0.008582058,0.13563462],"study_design_scores_gemma":[0.00003232975,0.00037224434,0.96534294,0.00030597125,0.00011210171,0.004312332,0.00036751514,0.0019471459,0.0033466707,0.0014860975,0.022349693,0.000024873329],"about_ca_topic_score_codex":0.0010032954,"about_ca_topic_score_gemma":0.0009851007,"teacher_disagreement_score":0.0026121642,"about_ca_system_score_codex":0.0004584925,"about_ca_system_score_gemma":0.00029967062,"threshold_uncertainty_score":0.0079545975},"labels":[],"label_agreement":null},{"id":"W3128925387","doi":"10.1158/1557-3265.endomet20-pr002","title":"Abstract PR002: Global proteomic profiling of endometrial carcinomas identify prognostic markers","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Vancouver General Hospital; Genome British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Endometrial cancer; Oncology; Cohort; Internal medicine; Medicine; Disease; Ovarian cancer; Microsatellite instability; Overall survival; Bioinformatics; Cancer; Biology; Gene; Genetics; Microsatellite","score_opus":0.12846969803580674,"score_gpt":0.4809768805282262,"score_spread":0.3525071824924194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128925387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98959315,0.0011104816,0.0031327577,0.00011063695,0.000016189979,0.000039796458,0.0049524475,0.00016281124,0.0008816892],"genre_scores_gemma":[0.9829556,0.00047524163,0.0070983446,0.000080060316,0.000017881563,0.000041200437,0.008295348,0.000055388933,0.0009808401],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999845,0.00002154753,0.00001612051,0.000050472176,0.000044013756,0.000022854558],"domain_scores_gemma":[0.9998167,0.000030791536,0.000042033254,0.000033084598,0.000051918843,0.00002542317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040811702,0.0003338744,0.00031239772,0.0007057593,0.00017873937,0.0006209485,0.00018801815,0.0002590456,0.0013298937],"category_scores_gemma":[0.0006117413,0.00017597112,0.00031005486,0.00079058664,0.00014837852,0.00027843736,0.0004691757,0.00030091486,0.00060478144],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013093904,0.000051842886,0.14790453,0.00028854693,0.00016651096,0.00032448533,0.00011287442,0.0007308168,0.81941336,0.000114488575,0.0017411774,0.027842034],"study_design_scores_gemma":[0.00004825886,0.0006797102,0.792649,0.00003287568,0.00022258812,0.0029249047,0.0002818745,0.006764223,0.18962798,0.00034446365,0.0063922387,0.000031909203],"about_ca_topic_score_codex":0.00058419537,"about_ca_topic_score_gemma":0.0007053814,"teacher_disagreement_score":0.0013298937,"about_ca_system_score_codex":0.0001590808,"about_ca_system_score_gemma":0.00020384968,"threshold_uncertainty_score":0.0044489503},"labels":[],"label_agreement":null},{"id":"W3129520566","doi":"10.1158/1078-0432.ccr-20-4573","title":"Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":380,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Cancer Institute; National Institutes of Health; Progenics Pharmaceuticals","keywords":"Prostate cancer; Medicine; Cancer; Prostate; Biochemical recurrence; Oncology; Radiology; Internal medicine; Prostatectomy","score_opus":0.14964507020304046,"score_gpt":0.5127410395060567,"score_spread":0.3630959693030162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129520566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996849,0.0013206409,0.00028434378,0.00006614537,0.000012012193,0.00019902733,0.0005875488,0.000044981316,0.0006363835],"genre_scores_gemma":[0.9966197,0.00031215206,0.00096688257,0.00012315626,0.00003937151,0.00010743569,0.0014944139,0.000020537476,0.0003163296],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9985948,0.00081560184,0.000069886075,0.00024788443,0.00017376895,0.00009802387],"domain_scores_gemma":[0.9972887,0.0006217111,0.00085529103,0.00039595392,0.0004392378,0.0003991496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005113722,0.0012083373,0.00094420783,0.0004032987,0.00043554712,0.0008641248,0.00070366863,0.0008515696,0.0011926475],"category_scores_gemma":[0.0027744346,0.00036101448,0.001022981,0.00050055934,0.0007223382,0.0005662539,0.00031423778,0.00075971114,0.0004155213],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.540962,0.00972155,0.32701188,0.0006305972,0.0028415462,0.00028446902,0.0005456752,0.0018374872,0.028756065,0.00017996192,0.0032328395,0.083995916],"study_design_scores_gemma":[0.07521854,0.20775296,0.6848928,0.00013441208,0.00491822,0.0021156198,0.00034175042,0.0056005493,0.014109246,0.00019063515,0.0045236577,0.00020161642],"about_ca_topic_score_codex":0.0030450544,"about_ca_topic_score_gemma":0.0040576877,"teacher_disagreement_score":0.005113722,"about_ca_system_score_codex":0.0008923762,"about_ca_system_score_gemma":0.00075213844,"threshold_uncertainty_score":0.027044237},"labels":[],"label_agreement":null},{"id":"W3129637558","doi":"10.1158/1078-0432.ccr-20-4834","title":"A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health; Johns Hopkins University; International Association for the Study of Lung Cancer; Bristol-Myers Squibb","keywords":"Microbiome; Metagenomics; Biomarker; Computational biology; Immune system; Gut microbiome; Biology; Medicine; Cancer; Bioinformatics; Oncology; Immunology; Internal medicine; Genetics; Gene","score_opus":0.15755910695582312,"score_gpt":0.4892872831924687,"score_spread":0.33172817623664563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129637558","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38191506,0.0005206548,0.6051242,0.0010397873,0.00016489907,0.00032086004,0.0036873594,0.0051215817,0.0021056216],"genre_scores_gemma":[0.755966,0.00014435727,0.23716782,0.0004197428,0.0000774927,0.00041838337,0.0044417935,0.00024783926,0.0011165736],"study_design_codex":"simulation_or_modeling","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99932826,0.00026022297,0.000043336342,0.00022920681,0.00007064785,0.00006832265],"domain_scores_gemma":[0.9985044,0.0009292994,0.0001152674,0.00019553659,0.00017806662,0.00007750084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020987531,0.0009338226,0.0012116376,0.0008845659,0.00053682027,0.0010518072,0.0011486685,0.00077963306,0.0023447033],"category_scores_gemma":[0.0071288194,0.00050026644,0.0016410657,0.0007643633,0.0003900106,0.00068699656,0.0012413741,0.00091174635,0.0003982176],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096414424,0.00051688246,0.048208963,0.00026264493,0.0011014834,0.00022673323,0.00009613553,0.83283174,0.0065856483,0.003023059,0.0029271601,0.1032554],"study_design_scores_gemma":[0.000029229037,0.00005131559,0.0015648066,0.0000034923526,0.000037745944,0.000012452646,0.000009833067,0.996813,0.00035193292,0.0009288451,0.00019144164,0.000005937849],"about_ca_topic_score_codex":0.0098989,"about_ca_topic_score_gemma":0.012897476,"teacher_disagreement_score":0.0098989,"about_ca_system_score_codex":0.0006048587,"about_ca_system_score_gemma":0.0023253064,"threshold_uncertainty_score":0.019682586},"labels":[],"label_agreement":null},{"id":"W3130253087","doi":"10.1158/1078-0432.ccr-20-4338","title":"FDA Approval Summary: Nivolumab with Ipilimumab and Chemotherapy for Metastatic Non–small Cell Lung Cancer, A Collaborative Project Orbis Review","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"U.S. Food and Drug Administration; National Institutes of Health","keywords":"Nivolumab; Ipilimumab; Medicine; Oncology; Chemotherapy; Cancer; Lung cancer; Internal medicine; Immunotherapy; Intensive care medicine","score_opus":0.14277968763737794,"score_gpt":0.5034665726369157,"score_spread":0.3606868849995378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130253087","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004538642,0.6307847,0.0020361189,0.09147292,0.028426146,0.0032457376,0.0064464146,0.00071858737,0.23233074],"genre_scores_gemma":[0.036674023,0.54847944,0.005820181,0.106247984,0.017511142,0.0033072156,0.009697976,0.00029083286,0.27197117],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961358,0.0010495258,0.00036594737,0.00034917513,0.0018469497,0.00025258373],"domain_scores_gemma":[0.99209243,0.001144434,0.0012159374,0.00018418672,0.0047144494,0.0006485995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008568355,0.0009029188,0.00090241357,0.0023390395,0.0006990516,0.002846302,0.0011126,0.004105603,0.015995504],"category_scores_gemma":[0.007526379,0.00034025576,0.0011850557,0.001884466,0.0006250416,0.0012902631,0.0006274033,0.0022866293,0.008006864],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021778203,0.00006503895,0.0002892739,0.0035085464,0.000062734565,0.00013149848,0.00004256735,0.0001000403,0.000905947,0.0026903036,0.7848227,0.20716353],"study_design_scores_gemma":[0.00023260213,0.0001858118,0.0017456411,0.0023508694,0.000092815004,0.00015483297,0.00002663758,0.000064188825,0.00021550704,0.00038118308,0.99453837,0.000011436365],"about_ca_topic_score_codex":0.00665113,"about_ca_topic_score_gemma":0.014335596,"teacher_disagreement_score":0.015995504,"about_ca_system_score_codex":0.0031905551,"about_ca_system_score_gemma":0.010854365,"threshold_uncertainty_score":0.05351031},"labels":[],"label_agreement":null},{"id":"W3130683366","doi":"10.1158/1078-0432.ccr-20-3365","title":"Mutations in the IFNγ-JAK-STAT Pathway Causing Resistance to Immune Checkpoint Inhibitors in Melanoma Increase Sensitivity to Oncolytic Virus Treatment","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Children's Hospital of Eastern Ontario; McGill University; McGill University Health Centre","funders":"Terry Fox Research Institute; Canadian Cancer Society","keywords":"Oncolytic virus; Melanoma; Cancer research; Vesicular stomatitis virus; Herpes simplex virus; Biology; Immune checkpoint; RNA interference; Virology; Immune system; Immunology; Medicine; Virus; Immunotherapy; Gene; RNA","score_opus":0.18968747413423104,"score_gpt":0.5040336254214045,"score_spread":0.31434615128717347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130683366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977187,0.0004269845,0.00086696306,0.000026775337,0.000008083682,0.000020641814,0.00024555778,0.00004705734,0.0006393207],"genre_scores_gemma":[0.9987503,0.00013822055,0.00055735995,0.00001513617,0.000001705852,0.0000074773147,0.00016300021,0.000007032639,0.0003598178],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998926,0.000013564348,0.0000129802,0.000028814206,0.000034599605,0.000017400911],"domain_scores_gemma":[0.9998865,0.000029536915,0.000038181384,0.000012833915,0.000012856432,0.0000200714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114358656,0.00020796101,0.00021975508,0.00028183783,0.00010455226,0.00024819103,0.00009971737,0.00022933543,0.0016259484],"category_scores_gemma":[0.0001683894,0.000106924366,0.00024928767,0.00013259272,0.000120524885,0.000093399954,0.000115658106,0.00033244895,0.0002992926],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012204819,0.000034468572,0.0038569595,0.000023982022,0.00001274079,0.00012326895,0.000010166789,0.00019988556,0.9935195,0.000043274238,0.000041868614,0.0020118507],"study_design_scores_gemma":[0.000034645207,0.0006523081,0.07231785,0.000013994632,0.0000619256,0.0034462237,0.00004995518,0.003352542,0.91798276,0.0001011424,0.0019796113,0.0000070591577],"about_ca_topic_score_codex":0.00042586753,"about_ca_topic_score_gemma":0.0005549359,"teacher_disagreement_score":0.0016259484,"about_ca_system_score_codex":0.00022038457,"about_ca_system_score_gemma":0.000115702,"threshold_uncertainty_score":0.005439341},"labels":[],"label_agreement":null},{"id":"W3133560731","doi":"10.1158/1557-3265.adi21-po-025","title":"Abstract PO-025: Differentiation of benign from clinically significant prostate cancer tissues using convolution neural networks on raw micro-ultrasound data","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prostate cancer; Medicine; Biopsy; Ultrasound; Prostate; Radiology; Cancer; Convolutional neural network; Prostate biopsy; Artificial intelligence; Computer science; Internal medicine","score_opus":0.22390549835778356,"score_gpt":0.5266286732634722,"score_spread":0.3027231749056886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133560731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7330314,0.0006607866,0.25519797,0.00049865426,0.0001250044,0.00025691604,0.0021870334,0.0034609886,0.0045812884],"genre_scores_gemma":[0.93769205,0.00015505432,0.055276256,0.00012374559,0.000029777895,0.00011101277,0.0027776759,0.00009536272,0.0037391623],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998228,0.000026088597,0.000010981107,0.000060898696,0.00003850034,0.000040727762],"domain_scores_gemma":[0.99973756,0.00008840826,0.000032117034,0.000031062355,0.00008355763,0.0000273616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005799228,0.00056963525,0.00027073637,0.00056203717,0.00017347878,0.00050371117,0.0005358824,0.0005159269,0.002564003],"category_scores_gemma":[0.0013561253,0.00019249033,0.00046078398,0.00025021107,0.0002022048,0.00040517456,0.00052416377,0.00038974558,0.00073175546],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015443204,0.00053277577,0.07629984,0.00023324692,0.00026865458,0.00054868206,0.00016294754,0.15372655,0.071750194,0.0014453855,0.011682528,0.68180484],"study_design_scores_gemma":[0.0000148700165,0.00016152485,0.016297586,0.000015114718,0.00003811341,0.00017320213,0.000026925607,0.9658889,0.01590073,0.0005889998,0.00088091777,0.000013249047],"about_ca_topic_score_codex":0.0069344044,"about_ca_topic_score_gemma":0.0066519654,"teacher_disagreement_score":0.0069344044,"about_ca_system_score_codex":0.0004531803,"about_ca_system_score_gemma":0.0006725762,"threshold_uncertainty_score":0.013788104},"labels":[],"label_agreement":null},{"id":"W3133660616","doi":"10.1158/1557-3265.adi21-po-005","title":"Abstract PO-005: An efficient digitized annotation platform for pathology-oriented dataset generation in AI research","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Annotation; Computer science; Digital pathology; Workflow; Prostate cancer; Artificial intelligence; Grading (engineering); Pathology; Pattern recognition (psychology); Cancer; Medicine; Biology; Database","score_opus":0.33612034587353407,"score_gpt":0.6047761300816308,"score_spread":0.2686557842080967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133660616","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009591472,0.00027130896,0.7897865,0.0004565929,0.00024242159,0.0012228781,0.021327497,0.1730052,0.004096028],"genre_scores_gemma":[0.04068409,0.0002020456,0.87982464,0.00035904555,0.000076605254,0.0022519294,0.06521425,0.0076277643,0.0037595823],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99811316,0.00030561953,0.0002194629,0.0006623244,0.00056144793,0.0001380535],"domain_scores_gemma":[0.9969969,0.0006573423,0.00022101773,0.0010916267,0.0007494037,0.00028380266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003812438,0.0014888927,0.0007980061,0.003200184,0.0008759646,0.0030928468,0.0029816634,0.0013535557,0.020194124],"category_scores_gemma":[0.007543852,0.001013261,0.0015098534,0.0017741448,0.0007643739,0.0021741115,0.0047615953,0.0017377761,0.01359258],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023562603,0.00065309607,0.007265638,0.0014781868,0.00037944026,0.0012519554,0.0009288153,0.01679085,0.090704225,0.013667487,0.23797764,0.6265464],"study_design_scores_gemma":[0.00092158513,0.00084067916,0.016627403,0.00032794106,0.00013452541,0.0012896303,0.0006352758,0.46696034,0.16831847,0.0495351,0.29402372,0.00038540355],"about_ca_topic_score_codex":0.0018135227,"about_ca_topic_score_gemma":0.002418039,"teacher_disagreement_score":0.020194124,"about_ca_system_score_codex":0.00079439115,"about_ca_system_score_gemma":0.0018339622,"threshold_uncertainty_score":0.06755602},"labels":[],"label_agreement":null},{"id":"W3133947338","doi":"10.1158/1557-3265.adi21-pr-06","title":"Abstract PR-06: Utilizing biological domain knowledge and machine learning methods to improve cellular segmentation on multiplex fluorescence and imaging mass cytometry datasets improves the quality of single-cell data obtained","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Computer science; Segmentation; Artificial intelligence; Pipeline (software); Multiplex; Pattern recognition (psychology); Image segmentation; Machine learning; Bioinformatics; Biology","score_opus":0.29188449620046086,"score_gpt":0.5077303671023771,"score_spread":0.2158458709019162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133947338","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0853829,0.0008379317,0.87429905,0.0015022965,0.00032864843,0.0002565946,0.0033479843,0.028846482,0.005198095],"genre_scores_gemma":[0.1464987,0.00042655063,0.836642,0.00047543,0.00015095487,0.00019268077,0.010115946,0.0015950863,0.0039025352],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9988984,0.00018906649,0.0000784442,0.0004150027,0.00033284005,0.00008617087],"domain_scores_gemma":[0.9971511,0.0007341687,0.00020018045,0.00085600204,0.00087864796,0.00017994289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034629118,0.0014060329,0.00078904827,0.0017254322,0.0005617726,0.0018197517,0.0016606555,0.0017007913,0.0046786503],"category_scores_gemma":[0.0038266568,0.00038918626,0.0012588138,0.0012592576,0.0007074397,0.0018211537,0.0012074468,0.0018927673,0.004401404],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071585225,0.00084261224,0.0064869006,0.0005887084,0.00025903442,0.0003343585,0.00019027496,0.08970456,0.40845105,0.009937459,0.048275653,0.43421355],"study_design_scores_gemma":[0.00006739686,0.00015030065,0.004084045,0.000031949865,0.000046145302,0.00020732352,0.00006511466,0.7774515,0.19621797,0.0062229154,0.0154036535,0.000051666884],"about_ca_topic_score_codex":0.002750655,"about_ca_topic_score_gemma":0.0037007614,"teacher_disagreement_score":0.0046786503,"about_ca_system_score_codex":0.0010665028,"about_ca_system_score_gemma":0.0013527012,"threshold_uncertainty_score":0.018313825},"labels":[],"label_agreement":null},{"id":"W3134000566","doi":"10.1158/1557-3265.adi21-po-053","title":"Abstract PO-053: Machine learning CADx process for classification of lung nodules below the Lung-RADS 4A threshold in LDCT scans","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Nodule (geology); Medicine; Artificial intelligence; Radiology; Lung; Lung cancer; Parenchyma; Lung cancer screening; Computer science; Computed tomography; Pathology; Internal medicine","score_opus":0.17894207556434416,"score_gpt":0.5377358738865021,"score_spread":0.35879379832215796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134000566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7904625,0.00048667053,0.19404998,0.0007792742,0.00012081375,0.00044661315,0.0020113727,0.0061582173,0.0054845028],"genre_scores_gemma":[0.93950635,0.000051869123,0.05486801,0.000104697596,0.00003048077,0.00019568033,0.0020785604,0.0000644025,0.0031000099],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993839,0.00017776515,0.000057950427,0.00018298191,0.000115104405,0.00008235505],"domain_scores_gemma":[0.9982002,0.0011184609,0.00010017313,0.000101349586,0.0004151107,0.00006473334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022371185,0.00063574483,0.00057258154,0.0015681081,0.00046019358,0.00116369,0.0006955035,0.00088109093,0.0059141405],"category_scores_gemma":[0.004945031,0.00017792436,0.0006154437,0.0005796443,0.00027236177,0.00039980857,0.00048040022,0.00079340884,0.0015265173],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013729854,0.00093249325,0.13486859,0.00016203684,0.00015985455,0.00030979412,0.00021959994,0.20357306,0.011887395,0.0014183252,0.00834672,0.6367491],"study_design_scores_gemma":[0.000011178265,0.00012228702,0.010158222,0.000007762758,0.00000896365,0.000035433164,0.00002880825,0.98509336,0.0038679894,0.000317137,0.000341928,0.000006882212],"about_ca_topic_score_codex":0.009784939,"about_ca_topic_score_gemma":0.004352436,"teacher_disagreement_score":0.009784939,"about_ca_system_score_codex":0.00081262906,"about_ca_system_score_gemma":0.0008612781,"threshold_uncertainty_score":0.019784808},"labels":[],"label_agreement":null},{"id":"W3134516012","doi":"10.1158/1557-3265.adi21-po-033","title":"Abstract PO-033: The impact of the variation of CT scanner on the prediction of HPV status in head &amp; neck cancer patients","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Scanner; Radiomics; Medicine; Cancer imaging; Artificial intelligence; Head and neck; Head and neck squamous-cell carcinoma; Head and neck cancer; Robustness (evolution); Cancer; Radiology; Computer science; Medical physics; Nuclear medicine; Radiation therapy; Internal medicine; Surgery","score_opus":0.1461867473918891,"score_gpt":0.5199791602515118,"score_spread":0.3737924128596227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134516012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912355,0.0004186423,0.0037583297,0.00058765477,0.00007398748,0.00004428726,0.0023390308,0.0001582386,0.0013843236],"genre_scores_gemma":[0.9966413,0.000048674465,0.0013617566,0.000048553648,0.000020647742,0.000017481714,0.0014417795,0.000027181948,0.0003926825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984541,0.00071965304,0.000109091896,0.00034416368,0.00028098957,0.00009192532],"domain_scores_gemma":[0.9886314,0.00908095,0.00068087486,0.00062187127,0.0006628605,0.00032206124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003715199,0.00042122963,0.00046946964,0.00061547366,0.0002526777,0.0011536991,0.000674581,0.0006719204,0.0041541304],"category_scores_gemma":[0.0163164,0.00021015843,0.00082043814,0.00063486357,0.00040816725,0.0005608519,0.0005610083,0.0009820242,0.0009577533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004192409,0.00040290388,0.87118596,0.00016261061,0.00059829745,0.00026407425,0.000114273455,0.034519102,0.0083574075,0.0002254421,0.0042293766,0.07574814],"study_design_scores_gemma":[0.000093260685,0.0016861564,0.79235655,0.0000483813,0.00043979997,0.00080653926,0.0002935276,0.18545304,0.015816744,0.00063247426,0.0022956815,0.00007786301],"about_ca_topic_score_codex":0.0046359017,"about_ca_topic_score_gemma":0.0033613096,"teacher_disagreement_score":0.0046359017,"about_ca_system_score_codex":0.00044051599,"about_ca_system_score_gemma":0.00047648273,"threshold_uncertainty_score":0.019648075},"labels":[],"label_agreement":null},{"id":"W3134562253","doi":"10.1158/1557-3265.adi21-ia-03","title":"Abstract IA-03: Unsupervised resolution of intra- and inter-tumoral heterogeneity using deep learning","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"AI in cancer detection","field":"Computer Science","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Artificial intelligence; Deep learning; Computer science; Context (archaeology); Machine learning; Artificial neural network; Deep neural networks; Cancer; Scalability; Medicine; Biology; Database","score_opus":0.28727151812221824,"score_gpt":0.514604831551338,"score_spread":0.22733331342911972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134562253","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12841994,0.0006002552,0.85579264,0.0011066506,0.0001906075,0.00015749382,0.0019934552,0.007115334,0.004623618],"genre_scores_gemma":[0.67096186,0.000243212,0.31469148,0.00048198385,0.00007837652,0.00017051502,0.004550594,0.0006181493,0.008203807],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99946064,0.00013081824,0.000028701623,0.00016641787,0.00014488173,0.00006854081],"domain_scores_gemma":[0.99869233,0.00040627224,0.00013344467,0.0003181762,0.00036045493,0.00008932604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017315808,0.0006413834,0.0004967537,0.0011122476,0.0003197287,0.001243708,0.0012607668,0.00071326026,0.0016908885],"category_scores_gemma":[0.0031871444,0.00042605028,0.0006541811,0.0007319587,0.00052524154,0.0007705483,0.0014215946,0.0016313703,0.0007808242],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054007175,0.00033800182,0.021625577,0.00021195067,0.0002639432,0.00027777694,0.0002540252,0.22750433,0.078705646,0.0116267195,0.039102953,0.619549],"study_design_scores_gemma":[0.000020401456,0.000056455487,0.0032206287,0.00001854936,0.000027223185,0.00010840439,0.00003462243,0.95966834,0.025580268,0.007030751,0.004215947,0.000018364595],"about_ca_topic_score_codex":0.0042940658,"about_ca_topic_score_gemma":0.0068041505,"teacher_disagreement_score":0.0042940658,"about_ca_system_score_codex":0.0010800451,"about_ca_system_score_gemma":0.0012552632,"threshold_uncertainty_score":0.009157538},"labels":[],"label_agreement":null},{"id":"W3134750715","doi":"10.1158/1557-3265.adi21-ia-15","title":"Abstract IA-15: Platforms to improve reproducibility in artificial intelligence research","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Reproducibility; Computer science; Transparency (behavior); Artificial intelligence; Field (mathematics); Data science; Mathematics","score_opus":0.3980621339270541,"score_gpt":0.6218056127994603,"score_spread":0.22374347887240625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134750715","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reproducibility","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"reproducibility","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033284273,0.004294594,0.76572716,0.04302714,0.00704567,0.0046926043,0.0077775433,0.04676026,0.08739073],"genre_scores_gemma":[0.20122935,0.0018125137,0.7383425,0.005046995,0.0029731074,0.007123481,0.010380322,0.0074271564,0.025664557],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9416904,0.029734038,0.0059155007,0.00605384,0.013659964,0.0029463372],"domain_scores_gemma":[0.73184466,0.083708026,0.018026318,0.091566496,0.05590712,0.018947367],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.115199216,0.0017205226,0.002115478,0.0061532804,0.003288186,0.018277716,0.006616383,0.004439121,0.022911564],"category_scores_gemma":[0.17694919,0.0019100404,0.003065344,0.0037279972,0.0051325792,0.014819203,0.030964525,0.0059110858,0.015932828],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041847974,0.0009048032,0.013593324,0.001787113,0.0005918388,0.000987696,0.00548164,0.0074804653,0.022933044,0.3337224,0.18153714,0.42679584],"study_design_scores_gemma":[0.0011831652,0.0012945756,0.010621884,0.0020872003,0.00041822603,0.00073326717,0.0016342012,0.031848617,0.037024684,0.3342694,0.57824755,0.0006372027],"about_ca_topic_score_codex":0.0019637847,"about_ca_topic_score_gemma":0.0009584374,"teacher_disagreement_score":0.8848008,"about_ca_system_score_codex":0.0038307852,"about_ca_system_score_gemma":0.011869395,"threshold_uncertainty_score":0.609239},"labels":[],"label_agreement":null},{"id":"W3134874642","doi":"10.1158/1557-3265.adi21-po-018","title":"Abstract PO-018: Computational staining of tumor hypoxia from H&amp;E images using convolutional neural networks","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Domtar (Canada); University of Toronto","funders":"","keywords":"Hypoxia (environmental); Stain; H&E stain; Tumor hypoxia; Staining; Pathology; Biology; Convolutional neural network; Necrosis; Chemistry; Medicine; Internal medicine; Radiation therapy; Artificial intelligence; Oxygen; Computer science","score_opus":0.21495130912935417,"score_gpt":0.5289596260580025,"score_spread":0.31400831692864833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134874642","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35906038,0.00078960235,0.6198036,0.0009345674,0.00018808235,0.00022579453,0.0022119489,0.011129461,0.0056565655],"genre_scores_gemma":[0.82778555,0.00029026772,0.15829158,0.00024122908,0.000049632104,0.00015849849,0.003378063,0.0002673546,0.009537816],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998678,0.000020648748,0.0000063576877,0.00005122364,0.000028646633,0.00002536134],"domain_scores_gemma":[0.99970514,0.00012500293,0.000034794753,0.000032590713,0.000081191225,0.000021235961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000611435,0.0008246868,0.00031516785,0.00070041773,0.00018165438,0.00069643307,0.000990522,0.000975633,0.0035320024],"category_scores_gemma":[0.0012552339,0.00035653176,0.00056755554,0.000358613,0.0002708358,0.00040216552,0.0005084792,0.00060397206,0.0008728989],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039400472,0.0002068764,0.005477708,0.00013181756,0.00012240527,0.00018430105,0.000039911112,0.7392365,0.018791918,0.0013750149,0.0064166705,0.22762288],"study_design_scores_gemma":[0.0000022977456,0.000012959187,0.00031956247,0.000003782353,0.000003417345,0.000007439791,0.0000018022781,0.9976115,0.0016518875,0.00020042308,0.00018285173,0.0000020316422],"about_ca_topic_score_codex":0.014347068,"about_ca_topic_score_gemma":0.012023358,"teacher_disagreement_score":0.014347068,"about_ca_system_score_codex":0.0010970153,"about_ca_system_score_gemma":0.00081259775,"threshold_uncertainty_score":0.02852714},"labels":[],"label_agreement":null},{"id":"W3134979252","doi":"10.1158/1557-3265.adi21-po-052","title":"Abstract PO-052: Exploring patient derived xenografts based pharmacogenomic data for precision oncology","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Pharmacogenomics; Precision medicine; Personalized medicine; Drug response; Metadata; Computational biology; Cancer; Medicine; Visualization; Bioinformatics; Oncology; Computer science; Cancer research; Biology; Drug; Internal medicine; Pharmacology; Data mining; Pathology; World Wide Web","score_opus":0.5907452067820693,"score_gpt":0.6136193960953055,"score_spread":0.02287418931323615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134979252","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19796652,0.003807715,0.2652716,0.0031908038,0.00051145087,0.00063256687,0.3727395,0.13549154,0.02038832],"genre_scores_gemma":[0.5246163,0.001828827,0.18515469,0.0008439298,0.00014668267,0.00082514,0.27266598,0.008950056,0.0049683643],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989943,0.00030920355,0.000087693355,0.00025464463,0.00029901403,0.00005511989],"domain_scores_gemma":[0.99568605,0.002335958,0.00037219,0.00087658846,0.00048998254,0.00023922717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029697502,0.0007645695,0.0007404072,0.0014838983,0.00022951086,0.0019381441,0.00095086725,0.0006518022,0.015559628],"category_scores_gemma":[0.007070926,0.0003540377,0.001220139,0.0014737949,0.00026249772,0.0010578104,0.0012642225,0.00079256704,0.0033337288],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008063669,0.00085576,0.10142436,0.0041212756,0.0016200097,0.002091326,0.00073619105,0.089012966,0.0942798,0.01684995,0.33161458,0.34933013],"study_design_scores_gemma":[0.0012437074,0.0022219797,0.08169191,0.0006229111,0.00083718466,0.0031651899,0.00050223485,0.3905005,0.12957335,0.032278165,0.35706717,0.00029579457],"about_ca_topic_score_codex":0.00200553,"about_ca_topic_score_gemma":0.0018620179,"teacher_disagreement_score":0.015559628,"about_ca_system_score_codex":0.00056886073,"about_ca_system_score_gemma":0.0010946889,"threshold_uncertainty_score":0.05205208},"labels":[],"label_agreement":null},{"id":"W3135064215","doi":"10.1158/1557-3265.adi21-po-031","title":"Abstract PO-031: Evaluating clinical utility of organs-at-risk segmentation in head &amp; neck cancer by simple open-source 3D CNNs","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Segmentation; Contouring; Computer science; Artificial intelligence; Deep learning; Workflow; Medical physics; Benchmark (surveying); Test set; Source code; Machine learning; Medicine","score_opus":0.3223459396933597,"score_gpt":0.6205568415552344,"score_spread":0.2982109018618747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135064215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9159814,0.0028542664,0.04874863,0.002077856,0.00042830373,0.00066974625,0.011613138,0.0072435387,0.010383161],"genre_scores_gemma":[0.9584286,0.00038018197,0.024178239,0.00038197634,0.0000997438,0.00023384677,0.012745388,0.00067217456,0.0028797556],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991529,0.0003021704,0.00005560343,0.00022021047,0.00020816168,0.000060910268],"domain_scores_gemma":[0.9972187,0.0015535632,0.00020993224,0.0003598266,0.00041811852,0.00023988784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030913844,0.0010838226,0.00058318704,0.0010641919,0.00029189972,0.0013186805,0.001694725,0.0015641244,0.0038846908],"category_scores_gemma":[0.010915895,0.00039182042,0.0009502971,0.0005277462,0.0006149368,0.0007292649,0.0011459619,0.0009321674,0.0017925594],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00541037,0.0011135612,0.1411907,0.0011497583,0.001401462,0.0008909925,0.00040586287,0.3486637,0.02064263,0.0014935783,0.04735729,0.43028003],"study_design_scores_gemma":[0.00032295915,0.0020086782,0.04265379,0.00014485342,0.00031454608,0.0010361501,0.00019829348,0.9170674,0.027562829,0.0019874824,0.006619564,0.000083377534],"about_ca_topic_score_codex":0.009517836,"about_ca_topic_score_gemma":0.010089005,"teacher_disagreement_score":0.009517836,"about_ca_system_score_codex":0.0012688471,"about_ca_system_score_gemma":0.00092729484,"threshold_uncertainty_score":0.018924892},"labels":[],"label_agreement":null},{"id":"W3135160265","doi":"10.1158/1557-3265.adi21-po-060","title":"Abstract PO-060: Individualized prediction of meningioma recurrence risk over prolonged time periods","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Meningioma; Medicine; Grading (engineering); Cohort; Internal medicine; Oncology; Proportional hazards model; Surgery; Radiology","score_opus":0.1284431035524994,"score_gpt":0.5132298910673004,"score_spread":0.384786787514801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135160265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9304042,0.00076101243,0.059331696,0.00045898097,0.000058678,0.00009404856,0.005857158,0.0013198995,0.0017142755],"genre_scores_gemma":[0.9795568,0.00013591837,0.01598316,0.000039214952,0.00003465189,0.00006338803,0.0030449796,0.000059694583,0.0010821309],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99966574,0.000071898496,0.000026878397,0.000106839914,0.00009048182,0.000038200265],"domain_scores_gemma":[0.9983311,0.0007411371,0.00041749995,0.00012717683,0.00026583695,0.0001172549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009580138,0.00037292892,0.00039350093,0.00065363426,0.00020151326,0.00051954424,0.0003238021,0.0004240422,0.0018445643],"category_scores_gemma":[0.004379375,0.00016247034,0.0005013759,0.00043056163,0.00011082022,0.00036501678,0.00030226223,0.0006758158,0.00064965297],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013662801,0.00019275917,0.81201994,0.00014366001,0.00019299185,0.0003232409,0.00010003076,0.06009943,0.009677254,0.00037998272,0.0045496263,0.11095489],"study_design_scores_gemma":[0.000043083455,0.00080161745,0.48857546,0.000057904505,0.00021544963,0.0010992114,0.00009731959,0.48788053,0.01588162,0.0018196047,0.003461863,0.00006624523],"about_ca_topic_score_codex":0.0035640837,"about_ca_topic_score_gemma":0.004391198,"teacher_disagreement_score":0.0035640837,"about_ca_system_score_codex":0.00038187904,"about_ca_system_score_gemma":0.0005200838,"threshold_uncertainty_score":0.0070866942},"labels":[],"label_agreement":null},{"id":"W3135237341","doi":"10.1158/1557-3265.adi21-po-010","title":"Abstract PO-010: Feature pyramid network for revealing tumour infiltrating lymphocyte presence and distribution in a whole slide image","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Pyramid (geometry); Breast cancer; Artificial intelligence; Computer science; Segmentation; Convolutional neural network; Feature (linguistics); Ductal carcinoma; Medicine; Cancer; Pathology; Internal medicine","score_opus":0.08339589710955707,"score_gpt":0.4877396388125088,"score_spread":0.40434374170295173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135237341","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44874537,0.000385097,0.52911246,0.00052648643,0.000118404656,0.00019705966,0.0024810445,0.013142365,0.005291709],"genre_scores_gemma":[0.8851045,0.00010131796,0.10573933,0.00013081866,0.00002378519,0.00009505387,0.002353114,0.00012377207,0.006328364],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9999027,0.000009804556,0.0000032600246,0.00003722524,0.000024236002,0.000022835658],"domain_scores_gemma":[0.9998554,0.00004100526,0.0000127605845,0.000019605144,0.000054048487,0.000017197925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028855802,0.0005538553,0.00024434298,0.000530896,0.00020456541,0.000328207,0.00076701783,0.0006212788,0.0037407158],"category_scores_gemma":[0.00067871454,0.00020396612,0.00036850566,0.00031891247,0.00021185911,0.00039931797,0.0004325628,0.00037856173,0.0007219246],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007965701,0.0003569697,0.006460509,0.00012251009,0.00013229328,0.00048349192,0.000104248276,0.36479762,0.09602369,0.0020487746,0.013446156,0.5152271],"study_design_scores_gemma":[0.000005518536,0.00006414212,0.0012016514,0.0000027150222,0.000007500901,0.00002915127,0.000007692824,0.99049556,0.007251286,0.00045626922,0.0004739052,0.0000046054206],"about_ca_topic_score_codex":0.011618112,"about_ca_topic_score_gemma":0.009830585,"teacher_disagreement_score":0.011618112,"about_ca_system_score_codex":0.0007896707,"about_ca_system_score_gemma":0.00047521156,"threshold_uncertainty_score":0.023100972},"labels":[],"label_agreement":null},{"id":"W3135323275","doi":"10.1158/1557-3265.adi21-po-051","title":"Abstract PO-051: Development of web-based quality-assurance tool for radiotherapy target delineation for head and neck cancer: Quality evaluation of nasopharyngeal carcinoma","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Nasopharyngeal carcinoma; Cavernous sinus; Clivus; Head and neck cancer; Radiation therapy; Radiology; Surgery; Skull","score_opus":0.42138889878580277,"score_gpt":0.5952276152792926,"score_spread":0.1738387164934898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135323275","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5425895,0.00093010056,0.32517773,0.0011379573,0.00017335097,0.0071784826,0.027977398,0.08598405,0.008851356],"genre_scores_gemma":[0.679805,0.00024849988,0.28914338,0.00026515577,0.00007345706,0.0033929339,0.022865467,0.0019675994,0.002238525],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99421763,0.0024800198,0.0009930126,0.00074354204,0.0014288313,0.00013695272],"domain_scores_gemma":[0.9756353,0.0116112735,0.0042071138,0.0019620808,0.005800152,0.0007840925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0108883865,0.0007437241,0.00071051193,0.0034035507,0.00027122805,0.0022988794,0.0010453006,0.00066770887,0.004236473],"category_scores_gemma":[0.036206324,0.00040108128,0.0008718279,0.0014296698,0.00025395388,0.0019869343,0.0014168614,0.00047062538,0.0017213312],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028763942,0.0019726998,0.30828843,0.0020807409,0.0005152661,0.0003017681,0.0013292542,0.01571565,0.0095935,0.001093808,0.026941184,0.6292913],"study_design_scores_gemma":[0.0010191876,0.002662365,0.47324035,0.00064133323,0.0004940866,0.000992212,0.00086345896,0.44692186,0.034968775,0.00318136,0.03470366,0.00031132821],"about_ca_topic_score_codex":0.001690586,"about_ca_topic_score_gemma":0.0014534184,"teacher_disagreement_score":0.0108883865,"about_ca_system_score_codex":0.00078076206,"about_ca_system_score_gemma":0.0013690172,"threshold_uncertainty_score":0.057583988},"labels":[],"label_agreement":null},{"id":"W3135388836","doi":"10.1158/1557-3265.adi21-po-094","title":"Abstract PO-094: Socioeconomic status and utilization of cancer surgeries in the United States, Canada, and Australia","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sinai Health System; Princess Margaret Cancer Centre; Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Socioeconomic status; Residence; Demography; Population; Census; Gerontology; Environmental health","score_opus":0.48982473848663044,"score_gpt":0.5658570414180496,"score_spread":0.07603230293141916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135388836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98523474,0.00062740303,0.000086158114,0.0006534308,0.0000147924,0.000038071285,0.0074155247,0.00000921334,0.0059205983],"genre_scores_gemma":[0.9969811,0.00039215613,0.000108586806,0.00010200719,0.0000067172678,0.000022720911,0.0018124946,0.0000032106755,0.0005709667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994722,0.000059964517,0.00006032507,0.000072511684,0.00019690712,0.00013811128],"domain_scores_gemma":[0.9976788,0.00009154463,0.0005454884,0.000045098768,0.0010148917,0.0006241268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038145244,0.00015776417,0.00018674409,0.0013020489,0.0012889495,0.0007763415,0.00049381464,0.00018292913,0.0017416112],"category_scores_gemma":[0.0024913324,0.00014023359,0.0003530032,0.0027645272,0.0004375865,0.00031222412,0.0009051796,0.00038585038,0.0001734773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010334265,0.000010518991,0.99648607,0.000025259416,0.00003260685,0.00002540003,0.00030722332,0.000050711893,0.000030410787,0.00006383447,0.001135082,0.0018227437],"study_design_scores_gemma":[7.900802e-7,0.0000035040027,0.9990277,0.000017836199,0.000005639074,0.000014963813,0.00041668845,0.00007680071,0.000010030212,0.000010111348,0.00041398115,0.000001961313],"about_ca_topic_score_codex":0.97047675,"about_ca_topic_score_gemma":0.97538835,"teacher_disagreement_score":0.029523253,"about_ca_system_score_codex":0.0066305865,"about_ca_system_score_gemma":0.011388317,"threshold_uncertainty_score":0.05939418},"labels":[],"label_agreement":null},{"id":"W3135511891","doi":"10.1158/1557-3265.adi21-pr-07","title":"Abstract PR-07: ORCESTRA: A platform for orchestrating and sharing high-throughput multimodal data analyses","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Computer science; Pipeline (software); Bioconductor; Data sharing; Cloud computing; Interface (matter); Open science; Biological data; Data science; Bioinformatics; Biology","score_opus":0.6543166387282022,"score_gpt":0.6159407247364818,"score_spread":0.03837591399172047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135511891","genre_codex":"software","genre_gemma":"software","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"software","genre_consensus":"software","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0058011184,0.00061487406,0.3277968,0.0012636939,0.00043744498,0.0013049883,0.04508939,0.6066426,0.011049067],"genre_scores_gemma":[0.12505457,0.001678658,0.43244988,0.0031084213,0.0004229753,0.0046223737,0.26525757,0.15228614,0.015119417],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929831,0.0013221528,0.00084635685,0.0018461979,0.0023373454,0.0006648049],"domain_scores_gemma":[0.9884388,0.0029471456,0.00065313675,0.0050423276,0.0014061326,0.0015124942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009136989,0.004140528,0.0025257273,0.0029553964,0.0013256371,0.0067029265,0.009028109,0.0021703008,0.036366735],"category_scores_gemma":[0.01811692,0.0019850677,0.0034715715,0.0033759335,0.002541233,0.007486131,0.013212182,0.0039244858,0.01910835],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007829788,0.0004456637,0.0061809174,0.002607571,0.0018181241,0.002417995,0.0017017658,0.027516976,0.04721633,0.043918286,0.719841,0.1385056],"study_design_scores_gemma":[0.002195728,0.0004279223,0.006882605,0.000534154,0.0004735525,0.000986161,0.000437825,0.29013437,0.07075338,0.081992045,0.54409826,0.001084006],"about_ca_topic_score_codex":0.010262018,"about_ca_topic_score_gemma":0.007656029,"teacher_disagreement_score":0.036366735,"about_ca_system_score_codex":0.0026458146,"about_ca_system_score_gemma":0.0051605217,"threshold_uncertainty_score":0.12165886},"labels":[],"label_agreement":null},{"id":"W3135512879","doi":"10.1158/1557-3265.adi21-po-066","title":"Abstract PO-066: Data standardization, integration and meta-analysis of preclinical pharmacogenomics studies for gene expression biomarker discovery","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Pharmacogenomics; Precision medicine; Biomarker discovery; Medicine; Biomarker; Computational biology; Drug; Gene expression profiling; Meta-analysis; Bioinformatics; Drug response; Drug discovery; Oncology; Biology; Gene expression; Gene; Pharmacology; Internal medicine; Proteomics; Genetics; Pathology","score_opus":0.5378205243746687,"score_gpt":0.5835645967090327,"score_spread":0.04574407233436406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135512879","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.081416115,0.08233423,0.6454009,0.0085640205,0.0023316112,0.004498625,0.16018341,0.010988164,0.004283031],"genre_scores_gemma":[0.65135103,0.0089409705,0.26382238,0.0022120338,0.0007477456,0.010167518,0.058484666,0.0030802605,0.0011934534],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.80833024,0.14818764,0.015247693,0.017206123,0.00998024,0.0010480105],"domain_scores_gemma":[0.7069284,0.22759014,0.012267203,0.045933843,0.0057568583,0.001523633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.13329081,0.0021663506,0.007281835,0.009029657,0.00094751973,0.005944441,0.004689419,0.0022040305,0.008101471],"category_scores_gemma":[0.26222813,0.001687938,0.023413805,0.01511,0.0014781097,0.0027999936,0.004745443,0.0035275426,0.0011143305],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069950004,0.00015852097,0.09389307,0.042121574,0.71631134,0.0006086996,0.00037493135,0.024137158,0.004038861,0.0055730566,0.026872652,0.07891513],"study_design_scores_gemma":[0.008210118,0.0026707377,0.15130511,0.0088308845,0.58204305,0.0015259833,0.0006099129,0.07591323,0.008990029,0.043152098,0.11613496,0.0006138035],"about_ca_topic_score_codex":0.002977141,"about_ca_topic_score_gemma":0.0031701908,"teacher_disagreement_score":0.13329081,"about_ca_system_score_codex":0.0012022152,"about_ca_system_score_gemma":0.0045580864,"threshold_uncertainty_score":0.7049176},"labels":[],"label_agreement":null},{"id":"W3135515631","doi":"10.1158/1557-3265.adi21-ia-22","title":"Abstract IA-22: Automated treatment planning and quality assurance in radiation oncology","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Radiation oncology; Medical physics; Quality assurance; Radiation treatment planning; Medicine; Radiation therapy; Process (computing); Radiation Therapist; Quality (philosophy); Radiation dose; Computer science; Nuclear medicine; Radiology; Pathology","score_opus":0.2702572538348785,"score_gpt":0.6378806920907509,"score_spread":0.36762343825587246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135515631","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.056429822,0.0016988758,0.854766,0.0024156615,0.00034761164,0.0008930936,0.0036544548,0.071324706,0.008469663],"genre_scores_gemma":[0.38984948,0.00043232425,0.5963268,0.00052159745,0.00015621503,0.0005296811,0.006247356,0.0014111446,0.004525315],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99672264,0.0012937174,0.00022203867,0.0006598097,0.0009726506,0.00012917355],"domain_scores_gemma":[0.99196273,0.0034933186,0.00075309345,0.0014668361,0.002028756,0.000295266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003856149,0.0008726469,0.0009789687,0.0020516512,0.00065811607,0.002517532,0.0017534056,0.0011517095,0.0048572193],"category_scores_gemma":[0.012461459,0.0005061805,0.0010541175,0.0014415496,0.000685689,0.0009759203,0.0014802141,0.0011220713,0.0024379152],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005102879,0.0002920316,0.007989164,0.00035027985,0.00019422149,0.00024557917,0.00025965503,0.1835165,0.007126476,0.004230976,0.05276684,0.74251807],"study_design_scores_gemma":[0.00008521546,0.00010837201,0.003417609,0.000046718673,0.000039153252,0.00014036357,0.000058793878,0.9620102,0.012745037,0.007412034,0.013901103,0.000035441506],"about_ca_topic_score_codex":0.010013779,"about_ca_topic_score_gemma":0.0077073304,"teacher_disagreement_score":0.010013779,"about_ca_system_score_codex":0.0021854495,"about_ca_system_score_gemma":0.003177429,"threshold_uncertainty_score":0.02039355},"labels":[],"label_agreement":null},{"id":"W3135664299","doi":"10.1158/1557-3265.adi21-po-049","title":"Abstract PO-049: Pseudo-alignment resolution in discriminating mouse reads","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Computational biology; Genome; Computer science; Transcriptome; Reference genome; Genomics; Biology; Cancer; Human genome; Genetics; Gene; Gene expression","score_opus":0.1622169808329385,"score_gpt":0.5192425174540776,"score_spread":0.35702553662113906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135664299","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29088795,0.0031355396,0.64746916,0.0006377876,0.00071675435,0.0002858596,0.009235364,0.041087188,0.00654439],"genre_scores_gemma":[0.29843867,0.0006155673,0.6658779,0.00076736225,0.000152107,0.0003573773,0.024598777,0.0044648596,0.0047274036],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99725014,0.000742585,0.0002272805,0.00077202846,0.0008125818,0.00019532748],"domain_scores_gemma":[0.99483526,0.0024364537,0.0005406656,0.0010000207,0.0009455219,0.00024203063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044487407,0.0008902263,0.0006670719,0.0015905859,0.0006157406,0.0013856309,0.001208857,0.0013853058,0.0036602602],"category_scores_gemma":[0.01030457,0.00048385598,0.0008072889,0.0015388364,0.00048647798,0.0012477599,0.0011284632,0.001425596,0.0040476834],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005040952,0.0003830674,0.029317731,0.0014944411,0.0004922254,0.0010420113,0.0006148189,0.028249478,0.54075575,0.0077420897,0.023544183,0.36132327],"study_design_scores_gemma":[0.0002205829,0.0013364473,0.027540002,0.00018821555,0.00018416265,0.0020996002,0.0003608836,0.41221616,0.506832,0.0097471345,0.039018117,0.0002567122],"about_ca_topic_score_codex":0.00086094823,"about_ca_topic_score_gemma":0.0018573161,"teacher_disagreement_score":0.0044487407,"about_ca_system_score_codex":0.00035877494,"about_ca_system_score_gemma":0.0006825191,"threshold_uncertainty_score":0.023527503},"labels":[],"label_agreement":null},{"id":"W3135672875","doi":"10.1158/1557-3265.adi21-ia-17","title":"Abstract IA-17: Plumbing the depths of the non-coding cancer genome","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Genome; Exome; Exome sequencing; Cancer; Genomics; Computational biology; Biology; Human genome; Cancer genome sequencing; Gene; Genetics; Evolutionary biology; Mutation","score_opus":0.13169538982336648,"score_gpt":0.4832118392757842,"score_spread":0.3515164494524177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135672875","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04828694,0.11771746,0.19515388,0.41769996,0.07050697,0.00034381525,0.017152121,0.02168454,0.11145427],"genre_scores_gemma":[0.34673044,0.10321454,0.19713539,0.11908986,0.022128897,0.000641984,0.022060301,0.007601628,0.18139708],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.998914,0.00024906333,0.000050500494,0.00021026787,0.0004373733,0.00013874868],"domain_scores_gemma":[0.9957463,0.0014376378,0.00029366947,0.00040277583,0.0010097435,0.0011097895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002952843,0.000865524,0.00055630144,0.0017969487,0.00092979945,0.0044134767,0.0010888153,0.0021568686,0.018092442],"category_scores_gemma":[0.009127984,0.00058806286,0.0006343449,0.0013645263,0.0016033021,0.0034605628,0.0032862816,0.005085916,0.0067568836],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003063004,0.000038834547,0.0029445642,0.0007049153,0.00007310409,0.00048799333,0.00063077087,0.0014384222,0.022588333,0.040959254,0.7306828,0.19914469],"study_design_scores_gemma":[0.00005743897,0.000120703444,0.0033177247,0.0005503174,0.000071625065,0.0011002313,0.0005375424,0.0021554586,0.018207448,0.04529704,0.928513,0.000071594615],"about_ca_topic_score_codex":0.002666494,"about_ca_topic_score_gemma":0.003973051,"teacher_disagreement_score":0.018092442,"about_ca_system_score_codex":0.0019419073,"about_ca_system_score_gemma":0.0025938745,"threshold_uncertainty_score":0.060525298},"labels":[],"label_agreement":null},{"id":"W3135698840","doi":"10.1158/1557-3265.adi21-po-034","title":"Abstract PO-034: The prediction of mandibular osteoradionecrosis in head and neck cancer patients using CT-derived radiomics features","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Osteoradionecrosis; Medicine; Head and neck cancer; Mandible (arthropod mouthpart); Radiation therapy; Radiation treatment planning; Cancer; Complication; Radiology; Surgery; Internal medicine","score_opus":0.19789527404879495,"score_gpt":0.48880836885793605,"score_spread":0.29091309480914107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135698840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928576,0.00017748885,0.0046250317,0.00011284568,0.000011746181,0.000038115813,0.0014646729,0.000052426643,0.00066006306],"genre_scores_gemma":[0.99786466,0.000042666717,0.0010065204,0.000007545825,0.0000048423285,0.000016419892,0.00085775414,0.0000033620418,0.00019623115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988365,0.000026170927,0.000017879116,0.000027059605,0.000029259134,0.000016024429],"domain_scores_gemma":[0.999265,0.00031698262,0.0001894359,0.000034432313,0.00012196087,0.00007212991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044895647,0.00043902837,0.0002929603,0.0009276545,0.0001657362,0.00069939345,0.00031684566,0.00041419864,0.0019524957],"category_scores_gemma":[0.0025921923,0.00018995434,0.0005376798,0.00042635537,0.0001467693,0.00024037756,0.00035893588,0.00041840223,0.00042691294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002964556,0.000056683028,0.9784615,0.000017332379,0.000046968176,0.00012805148,0.000017531103,0.011162865,0.0008072376,0.00004267819,0.00027912072,0.008683576],"study_design_scores_gemma":[0.000030877585,0.0004023693,0.71798164,0.000029023822,0.00015253396,0.0006743687,0.0001598652,0.27816862,0.0014333634,0.00025302803,0.0006880896,0.00002626451],"about_ca_topic_score_codex":0.004049377,"about_ca_topic_score_gemma":0.0030476148,"teacher_disagreement_score":0.004049377,"about_ca_system_score_codex":0.0002641328,"about_ca_system_score_gemma":0.00028218955,"threshold_uncertainty_score":0.008051634},"labels":[],"label_agreement":null},{"id":"W3135782998","doi":"10.1158/1078-0432.ccr-20-4948","title":"Amplifying the Voice of the Whispering Cancer","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Cancer; Serous ovarian cancer; Ovarian cancer; Serous fluid; Disease; DNA sequencing; Clinical Practice","score_opus":0.20949564679357313,"score_gpt":0.5149692730327153,"score_spread":0.3054736262391422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135782998","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68168974,0.0042875377,0.25128087,0.0034317395,0.0035872466,0.0010582418,0.004592683,0.0033191943,0.046752833],"genre_scores_gemma":[0.64637923,0.0021774338,0.24620803,0.0038455003,0.0005555266,0.00060633884,0.008160299,0.00082749384,0.091240086],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99930525,0.000091751426,0.000028633463,0.00027137488,0.00016491869,0.00013814564],"domain_scores_gemma":[0.9991328,0.0002996876,0.00008040799,0.00008745336,0.0002799575,0.00011977751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005666785,0.000685887,0.00039323542,0.0010506581,0.0005868825,0.00069778034,0.00040592926,0.0009955036,0.014707462],"category_scores_gemma":[0.0015122822,0.00035209034,0.0006755193,0.00047287694,0.00046655646,0.00042124488,0.00071379263,0.0014777299,0.0074925385],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000180888,0.0000403041,0.001281419,0.00012550855,0.000022903194,0.0006129166,0.0002948994,0.00011370393,0.97083783,0.001063293,0.0021784317,0.023247905],"study_design_scores_gemma":[0.0000893194,0.0008426053,0.012126107,0.00010241282,0.0001460534,0.002387608,0.00058698416,0.0063996296,0.890656,0.0022886284,0.08432313,0.00005149645],"about_ca_topic_score_codex":0.0007447035,"about_ca_topic_score_gemma":0.0012606771,"teacher_disagreement_score":0.014707462,"about_ca_system_score_codex":0.00033880223,"about_ca_system_score_gemma":0.00064856827,"threshold_uncertainty_score":0.04920143},"labels":[],"label_agreement":null},{"id":"W3135830244","doi":"10.1158/1557-3265.adi21-po-030","title":"Abstract PO-030: Radiomics for head and neck cancer prognostication: results from the RADCURE machine learning challenge","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Radiomics; Medicine; Head and neck cancer; Medical physics; Head and neck; Retrospective cohort study; Radiological weapon; Radiation therapy; Machine learning; Cohort; Artificial intelligence; Cancer; Radiology; Internal medicine; Computer science; Surgery","score_opus":0.20398189249554993,"score_gpt":0.515686907057502,"score_spread":0.31170501456195204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135830244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70138174,0.048019346,0.05055487,0.047391012,0.008464115,0.0021288504,0.089683376,0.023322286,0.029054414],"genre_scores_gemma":[0.6883649,0.005121956,0.058884457,0.007447592,0.002345821,0.0009943205,0.21834715,0.0014033756,0.017090358],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99344254,0.0034112674,0.00030981825,0.0011249572,0.0012859919,0.0004254435],"domain_scores_gemma":[0.98707783,0.006643917,0.0004127966,0.0016395965,0.0025205635,0.0017052294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014569155,0.0028177868,0.0022721381,0.0014650626,0.0007590229,0.002165996,0.0028973636,0.0034701035,0.0037497233],"category_scores_gemma":[0.024225147,0.00040864918,0.0022548137,0.0010539477,0.0011510063,0.0016258716,0.0029158972,0.0028953338,0.004814889],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044813193,0.0036126908,0.04926904,0.0022887324,0.0017593361,0.0006632055,0.00022237367,0.06789489,0.0042183297,0.0018654399,0.55894643,0.30477825],"study_design_scores_gemma":[0.0032724626,0.007516338,0.093307756,0.0010657811,0.0012952824,0.0021210148,0.0010434093,0.696283,0.020176832,0.013720878,0.1596952,0.00050204224],"about_ca_topic_score_codex":0.011375536,"about_ca_topic_score_gemma":0.008852487,"teacher_disagreement_score":0.014569155,"about_ca_system_score_codex":0.0013927971,"about_ca_system_score_gemma":0.0026737042,"threshold_uncertainty_score":0.07704997},"labels":[],"label_agreement":null},{"id":"W3136029171","doi":"10.1158/1078-0432.ccr-21-0533","title":"Back from the Brink: EGFR Inhibition in Gastroesophageal Cancer","year":2021,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Imperial College London; Institute of Cancer Research; Cancer Research UK; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; European Commission; Royal Marsden NHS Foundation Trust","keywords":"Gastroesophageal Junction; Medicine; Cancer; Internal medicine; Randomized controlled trial; Oncology; EGFR inhibitors; Adenocarcinoma; Epidermal growth factor receptor","score_opus":0.28612898814509646,"score_gpt":0.5044456923864901,"score_spread":0.2183167042413936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136029171","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020950245,0.0054132533,0.00007936285,0.9737355,0.018731192,0.000007699674,0.00005129737,0.000026544947,0.0017455083],"genre_scores_gemma":[0.0030693803,0.0055947886,0.00015240822,0.9247149,0.062483538,0.000022996337,0.00003907021,0.000023640107,0.003899294],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970688,0.0010930169,0.0002532533,0.00028511422,0.0010862439,0.00021350992],"domain_scores_gemma":[0.9919435,0.0048744297,0.00034453548,0.00023440915,0.0015981894,0.001004937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003571013,0.0008235105,0.0014929026,0.0009922477,0.002312108,0.0028993052,0.0013605588,0.02190275,0.0068806843],"category_scores_gemma":[0.018897396,0.0004377173,0.0012094548,0.00063966645,0.0022793987,0.004851534,0.0012507966,0.035601147,0.009545895],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006760565,0.000028673056,0.00025263362,0.00005984099,0.000011527707,0.00064470863,0.000034671175,0.000051811476,0.00014250922,0.00113109,0.9797983,0.017776556],"study_design_scores_gemma":[0.00034492018,0.00023572803,0.0016244927,0.0009572408,0.000047942645,0.003928894,0.00034529902,0.0005611468,0.00041837821,0.016437585,0.97502023,0.000078103876],"about_ca_topic_score_codex":0.0035278746,"about_ca_topic_score_gemma":0.004357191,"teacher_disagreement_score":0.02190275,"about_ca_system_score_codex":0.0036150736,"about_ca_system_score_gemma":0.002155221,"threshold_uncertainty_score":0.026229262},"labels":[],"label_agreement":null},{"id":"W3137074789","doi":"10.1158/1078-0432.ccr-20-4731","title":"Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health","keywords":"Atypical teratoid rhabdoid tumor; Relevance (law); Germline; Medicine; Clinical significance; Prospective cohort study; Pathology; Oncology; Pediatrics; Biology; Genetics; Immunohistochemistry; Political science; Gene","score_opus":0.08958350623803407,"score_gpt":0.43671492812234936,"score_spread":0.3471314218843153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137074789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98239833,0.015126758,0.00035839248,0.00029732272,0.000062363375,0.00042603325,0.00064804987,0.0000064520673,0.00067620375],"genre_scores_gemma":[0.99682,0.0014298114,0.00047152332,0.00018751914,0.000059190035,0.000326327,0.00056725385,0.000004915567,0.00013341874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98779815,0.009258832,0.0012053873,0.00092845707,0.0005379071,0.00027136676],"domain_scores_gemma":[0.98160684,0.008092962,0.006771891,0.0015045288,0.00096340495,0.0010603394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014083179,0.00047203145,0.0009939044,0.00033531914,0.00044248792,0.0011668663,0.0005857621,0.00087083864,0.0011274382],"category_scores_gemma":[0.013726612,0.0002965231,0.0020390325,0.0008494893,0.00084309006,0.0008762108,0.00052595366,0.0011205332,0.00012847286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3244474,0.0017656458,0.59020317,0.002034088,0.021139685,0.00017926692,0.0005117421,0.001242822,0.0042528333,0.00038594313,0.0011383278,0.05269919],"study_design_scores_gemma":[0.1066357,0.11771194,0.74019605,0.00085641496,0.02075341,0.00072776456,0.0008052236,0.0014020774,0.0043183193,0.0004338287,0.0060681766,0.00009112227],"about_ca_topic_score_codex":0.0006204649,"about_ca_topic_score_gemma":0.0026709563,"teacher_disagreement_score":0.014083179,"about_ca_system_score_codex":0.00080860156,"about_ca_system_score_gemma":0.00106927,"threshold_uncertainty_score":0.07447982},"labels":[],"label_agreement":null},{"id":"W3137264502","doi":"10.1158/1557-3265.covid-19-21-p12","title":"Abstract P12: Colorectal cancer screening in Appalachian Kentucky primary care clinics during COVID-19","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Telehealth; Staffing; Family medicine; Quarter (Canadian coin); Psychological intervention; Cancer screening; Nursing; Telemedicine; Health care; Cancer","score_opus":0.18931332140737395,"score_gpt":0.5115773748071514,"score_spread":0.32226405339977743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137264502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826943,0.00041029553,0.00021702945,0.002271927,0.0000761845,0.0010048776,0.00808879,0.00007068307,0.005165884],"genre_scores_gemma":[0.9879292,0.00030619168,0.0010544177,0.0015617182,0.00005979961,0.0020151879,0.003442336,0.000020528436,0.0036105544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984035,0.00032182137,0.00017363031,0.000265482,0.00028737498,0.0005481309],"domain_scores_gemma":[0.9933708,0.0010848066,0.0013830723,0.0002188309,0.0013544684,0.002588086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015856125,0.00028274485,0.00029640892,0.00075754157,0.004943703,0.0018813064,0.001223672,0.0008436743,0.0076226634],"category_scores_gemma":[0.0044544614,0.0005357425,0.00034950575,0.0012337851,0.0006024882,0.00080436177,0.0029073323,0.0013934127,0.0005755328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000492907,0.0009304598,0.9314828,0.0006095895,0.000049726754,0.0016497592,0.012775816,0.00026342933,0.00233642,0.00010118624,0.018390955,0.030916942],"study_design_scores_gemma":[0.000032679432,0.0003000849,0.9814511,0.00020380985,0.0000116289975,0.00013592611,0.012976922,0.00017770694,0.00022330828,0.000017991773,0.0044478076,0.000021032649],"about_ca_topic_score_codex":0.48526022,"about_ca_topic_score_gemma":0.64397424,"teacher_disagreement_score":0.48526022,"about_ca_system_score_codex":0.0089733265,"about_ca_system_score_gemma":0.013024051,"threshold_uncertainty_score":0.9648714},"labels":[],"label_agreement":null},{"id":"W3137853903","doi":"10.1158/1078-0432.ccr-21-0315","title":"Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Veterinary Oncology Research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"National Center for Advancing Translational Sciences; Virginia-Maryland College of Veterinary Medicine; Ohio State University; Cancer Center, University of Colorado; National Cancer Institute; National Institutes of Health; University of California, Davis; Morris Animal Foundation","keywords":"Medicine; Carboplatin; Osteosarcoma; Sirolimus; Internal medicine; Clinical endpoint; Oncology; Adjuvant therapy; Adverse effect; Population; Clinical trial; Chemotherapy; Surgery; Pathology; Cisplatin","score_opus":0.1637366620973989,"score_gpt":0.5384553562192401,"score_spread":0.3747186941218412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137853903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99767286,0.000785491,0.00013704007,0.00016402647,0.00010814823,0.0006250601,0.00019907086,0.000013094495,0.0002952724],"genre_scores_gemma":[0.99620557,0.00063242554,0.00043900392,0.00029708256,0.00019158039,0.0009329669,0.00042140254,0.0000060019997,0.00087392697],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989429,0.00058092957,0.00007468561,0.00019182508,0.00007818405,0.00013146792],"domain_scores_gemma":[0.9984452,0.00030585565,0.00058506406,0.00018813698,0.00008528123,0.00039038862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002268877,0.0013883885,0.0025772501,0.00034328233,0.0003515978,0.0010375179,0.00073555287,0.0018298781,0.0029810541],"category_scores_gemma":[0.0018071582,0.00055842375,0.0015930434,0.00033575046,0.0015563027,0.00089931535,0.00037785253,0.001978661,0.0004297995],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.980924,0.009344291,0.001846953,0.00014834845,0.00050992065,0.000022072752,0.000025696183,0.00023216505,0.0023263628,0.00004785476,0.00019303757,0.00437938],"study_design_scores_gemma":[0.6659304,0.3237522,0.0066350424,0.000035867688,0.0007824663,0.00006352139,0.00005413835,0.0008478053,0.0011529117,0.00014171842,0.0005828481,0.000021119658],"about_ca_topic_score_codex":0.0005743719,"about_ca_topic_score_gemma":0.0010787027,"teacher_disagreement_score":0.0029810541,"about_ca_system_score_codex":0.0008949059,"about_ca_system_score_gemma":0.0009757892,"threshold_uncertainty_score":0.01199913},"labels":[],"label_agreement":null},{"id":"W3138826270","doi":"10.1158/1557-3265.covid-19-21-p06","title":"Abstract P06: Anticancer agent 3-deazauridine has the potential to be effective against COVID-19 due to its inhibition of replication of RNA viruses","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"RNA; In vitro; Viral replication; Mechanism of action; Pharmacology; RNA polymerase; Biology; Nucleoside analogue; Polymerase; Virology; Nucleoside; Virus; Enzyme; Cancer research; Chemistry; Biochemistry; Gene","score_opus":0.24367581103339855,"score_gpt":0.5114422097861301,"score_spread":0.26776639875273156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138826270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9560724,0.021798419,0.004410846,0.0006471117,0.00035701084,0.00033028668,0.0010209956,0.00034081534,0.0150221195],"genre_scores_gemma":[0.9789853,0.00433866,0.0048522684,0.00028942456,0.000107149615,0.000098187615,0.0010986407,0.000034098044,0.010196333],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999943,0.000012608286,0.000005465975,0.000012327097,0.000013905748,0.000012571701],"domain_scores_gemma":[0.999941,0.000010261925,0.000012068428,0.0000071582554,0.000010822579,0.000018722616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000101093385,0.00027730508,0.00035092235,0.00023610317,0.00016705322,0.00018885003,0.00030058972,0.0004917872,0.0046142805],"category_scores_gemma":[0.00009802001,0.0000923909,0.00021710948,0.00017906912,0.00014474295,0.00013765437,0.00011879987,0.00069316366,0.00113237],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00280921,0.00089863554,0.000560674,0.00038321858,0.000030222925,0.0005286132,0.000036885256,0.00023822238,0.93276256,0.00034148848,0.0014565577,0.059953775],"study_design_scores_gemma":[0.00054686965,0.018807137,0.0055766795,0.000034131714,0.00006677569,0.0033957693,0.00001699479,0.000580458,0.93855035,0.00011669467,0.03229745,0.000010582712],"about_ca_topic_score_codex":0.00027544188,"about_ca_topic_score_gemma":0.0004020749,"teacher_disagreement_score":0.0046142805,"about_ca_system_score_codex":0.00014667332,"about_ca_system_score_gemma":0.00014159943,"threshold_uncertainty_score":0.015436351},"labels":[],"label_agreement":null},{"id":"W3139290764","doi":"10.1158/1078-0432.ccr-20-4068","title":"Structural Variants at the <i>BRCA1/2</i> Loci are a Common Source of Homologous Repair Deficiency in High-grade Serous Ovarian Carcinoma","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NIHR Imperial Biomedical Research Centre; Medical Research Council; Sierra Oncology; National Institute for Health and Care Research; Cancer Research UK; NuCana; Ovarian Cancer Action; AstraZeneca; UK Research and Innovation; Wellcome Trust; Pancreatic Cancer UK; Beatson Cancer Charity; Pfizer","keywords":"Serous fluid; Biology; Ovarian carcinoma; Serous carcinoma; Structural variation; Homologous recombination; Somatic cell; Ovarian cancer; Homologous chromosome; Genome; Genetics; Carcinoma; Cancer; Cancer research; Gene","score_opus":0.17509979765269706,"score_gpt":0.46818482929358285,"score_spread":0.2930850316408858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3139290764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99926025,0.00022872984,0.00018991833,0.0000106833795,0.0000014402895,0.0000032724565,0.00017209805,0.000010007006,0.00012368055],"genre_scores_gemma":[0.9996057,0.000058180383,0.0001191107,0.000009488724,0.0000026438945,0.0000016636426,0.00016877426,0.0000027245915,0.000031691005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982363,0.00002647874,0.000023603205,0.000060544407,0.00004571435,0.00002005885],"domain_scores_gemma":[0.99933416,0.00012518879,0.00036104379,0.00007627543,0.00003058777,0.00007263669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002825357,0.00016149374,0.00020242047,0.000550253,0.00019451095,0.000368548,0.00017116468,0.00019249474,0.0011045665],"category_scores_gemma":[0.0007218024,0.000121686375,0.00018904929,0.00051052915,0.0002806714,0.000113377966,0.00026013484,0.00023157113,0.00012375244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059211126,0.00003114285,0.92569304,0.000067420835,0.00013129962,0.0005949834,0.00008736828,0.00026152944,0.0661136,0.00008520403,0.00016345318,0.0061789122],"study_design_scores_gemma":[0.000010117562,0.000104590305,0.99045765,0.000006389969,0.000054647782,0.0022109621,0.00006840093,0.00030981432,0.0064285444,0.000074824,0.00027032875,0.0000036504],"about_ca_topic_score_codex":0.0006994038,"about_ca_topic_score_gemma":0.001125119,"teacher_disagreement_score":0.0011045665,"about_ca_system_score_codex":0.00012673365,"about_ca_system_score_gemma":0.00013233088,"threshold_uncertainty_score":0.0036951303},"labels":[],"label_agreement":null},{"id":"W3144540201","doi":"10.1158/1078-0432.ccr-20-4928","title":"Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor–Positive Advanced Breast Cancer (EVERMET)","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Associazione Italiana per la Ricerca sul Cancro","keywords":"Exemestane; Medicine; Everolimus; Oncology; Internal medicine; Cancer; Breast cancer; Hormone receptor; Hormone; Metformin; Gynecology; Tamoxifen; Insulin","score_opus":0.0373254637907493,"score_gpt":0.42699258617912095,"score_spread":0.38966712238837165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3144540201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99965954,0.00014465388,0.000023725317,0.0000083047735,0.0000018800811,0.0000030977733,0.00005579915,9.677681e-7,0.00010205227],"genre_scores_gemma":[0.99974376,0.000039718234,0.000025609219,0.000011248927,0.0000043309665,0.0000030590838,0.00014039982,6.1677997e-7,0.000031317428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996226,0.00017322024,0.000030830626,0.000074057854,0.00004864347,0.000050650713],"domain_scores_gemma":[0.99923897,0.00021353045,0.00029782893,0.000078208715,0.00003754586,0.00013402966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076107157,0.00020756699,0.00035709946,0.00017289865,0.0001657076,0.00040193656,0.00017447628,0.00025309387,0.00054159586],"category_scores_gemma":[0.0011533112,0.0001311628,0.00051836495,0.00033173597,0.00018965718,0.00019593553,0.00019764883,0.00034180057,0.00008137176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070934086,0.00024873423,0.9857611,0.000020151265,0.0002592588,0.000087130175,0.000035129688,0.00041271266,0.0012250398,0.000021760805,0.000073501295,0.0047621983],"study_design_scores_gemma":[0.00008790667,0.0019002035,0.9965894,0.0000035028788,0.0001131964,0.0001508814,0.00002772762,0.00065187295,0.00030607832,0.000022778186,0.00014231032,0.000004193361],"about_ca_topic_score_codex":0.00069509534,"about_ca_topic_score_gemma":0.00092767255,"teacher_disagreement_score":0.00076107157,"about_ca_system_score_codex":0.00029994873,"about_ca_system_score_gemma":0.0002456703,"threshold_uncertainty_score":0.0040249825},"labels":[],"label_agreement":null},{"id":"W3152686641","doi":"10.1158/1078-0432.ccr-20-4117","title":"Development and Validation of a Novel Nomogram for Individualized Prediction of Survival in Cancer of Unknown Primary","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC","funders":"National Cancer Institute","keywords":"Nomogram; Medicine; Concordance; Confidence interval; Cancer; Internal medicine; Proportional hazards model; Oncology; Bootstrapping (finance); Cohort; Mathematics","score_opus":0.4392417437457821,"score_gpt":0.5518497954606548,"score_spread":0.1126080517148727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3152686641","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9230431,0.0012218662,0.07185716,0.00040180725,0.00007637939,0.00027684515,0.0015213456,0.00035530978,0.0012462398],"genre_scores_gemma":[0.97829366,0.00015121834,0.020317443,0.000039193306,0.000031616928,0.00010108968,0.0009204711,0.000016918708,0.00012839145],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99818087,0.0010923843,0.0001151782,0.00023388858,0.0002828951,0.00009483068],"domain_scores_gemma":[0.9925483,0.0043006795,0.0009561865,0.0007799033,0.0010418211,0.00037318494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009091384,0.0008646737,0.0008853143,0.001937506,0.00054662494,0.0018862727,0.0008266049,0.00059477834,0.0007944351],"category_scores_gemma":[0.01467129,0.00024342518,0.0006979104,0.0010043326,0.00041717634,0.00075396505,0.0010076497,0.00089479506,0.00031563514],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007131773,0.00019078287,0.8680602,0.0001164512,0.00025596516,0.00015928363,0.00014852449,0.03532566,0.0018700451,0.00038805165,0.0025598225,0.09021214],"study_design_scores_gemma":[0.00015877352,0.00071564555,0.28500322,0.000110968904,0.00028042714,0.00078948477,0.00030108978,0.70469576,0.0033003294,0.0010382768,0.0035447385,0.0000613133],"about_ca_topic_score_codex":0.0023152386,"about_ca_topic_score_gemma":0.0028694894,"teacher_disagreement_score":0.009091384,"about_ca_system_score_codex":0.0007792049,"about_ca_system_score_gemma":0.0011555017,"threshold_uncertainty_score":0.048080385},"labels":[],"label_agreement":null},{"id":"W3152849619","doi":"10.1158/1557-3265.radsci21-po-091","title":"Abstract PO-091: Does volumetric-modulated arc therapy improve anal cancer treatment outcome and reduce toxicity: A single institution experience","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal and Anal Carcinomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Windsor Regional Hospital","funders":"","keywords":"Medicine; Anal cancer; Anal canal; Radiation therapy; Rectum; Cancer; Surgery; Radiology; Internal medicine","score_opus":0.34585747750921897,"score_gpt":0.5328197080830454,"score_spread":0.18696223057382638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3152849619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99464697,0.0014925885,0.0009237907,0.00022484655,0.0000420351,0.000364935,0.00033779888,0.000051824412,0.0019151687],"genre_scores_gemma":[0.9941241,0.0017084625,0.0020209735,0.00030801442,0.00009410614,0.00024008672,0.00056376896,0.000043405584,0.0008969858],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991242,0.00040330953,0.0001175768,0.00013997308,0.00012826805,0.00008660827],"domain_scores_gemma":[0.99840456,0.00046362705,0.00034187804,0.0002484852,0.00016299117,0.00037854933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001760319,0.00030430098,0.0006287843,0.00031947487,0.0005190292,0.00089811266,0.0006039171,0.0004887897,0.0037646894],"category_scores_gemma":[0.0032980873,0.00016200704,0.0007337735,0.00044993585,0.00041195174,0.0006344879,0.00058571604,0.00082348374,0.0012236481],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026258605,0.058868755,0.28213832,0.0016224139,0.0014270354,0.0030394192,0.0026584833,0.0028151777,0.021569151,0.00047055492,0.007725093,0.59140694],"study_design_scores_gemma":[0.0123103345,0.40972993,0.4975691,0.00097007374,0.0015382867,0.0151977,0.0028377923,0.0056168307,0.02185231,0.0005271778,0.031641647,0.00020888829],"about_ca_topic_score_codex":0.00056050665,"about_ca_topic_score_gemma":0.00080944615,"teacher_disagreement_score":0.0037646894,"about_ca_system_score_codex":0.00057840836,"about_ca_system_score_gemma":0.00086357404,"threshold_uncertainty_score":0.012594163},"labels":[],"label_agreement":null},{"id":"W3153749982","doi":"10.1158/1557-3265.radsci21-ia-016","title":"Abstract IA-016: Metabolic deregulation drives a redox vulnerability in pancreatic cancer","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"","keywords":"Biology; DNA damage; NOX4; Reactive oxygen species; Pancreatic cancer; Cell biology; NADPH oxidase; Cancer research; Cancer; Biochemistry; Genetics; DNA","score_opus":0.11444656588045558,"score_gpt":0.4888990426172907,"score_spread":0.3744524767368351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153749982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99188995,0.0014288506,0.002180482,0.0003485796,0.000098181496,0.000028966788,0.00130943,0.00013550236,0.0025800478],"genre_scores_gemma":[0.9935493,0.0007589807,0.0006206858,0.0001137746,0.000012778262,0.00003047911,0.0015529366,0.000027639557,0.0033335346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998627,0.000017716986,0.000012575787,0.000045889283,0.00002627714,0.00003479257],"domain_scores_gemma":[0.9998666,0.000011038688,0.000038042035,0.000018513492,0.000015453785,0.00005024979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012819728,0.00022016028,0.00024156629,0.00024137084,0.0002369484,0.0005862092,0.00020623559,0.00033788744,0.0041835173],"category_scores_gemma":[0.0001494614,0.00014620136,0.00036201844,0.00039193788,0.00025318968,0.000174751,0.00037844141,0.0009709381,0.0009718321],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041427638,0.000093811155,0.004159339,0.000095643256,0.000021563645,0.00035697344,0.000026858,0.000106601954,0.99046654,0.00029272726,0.00030661936,0.0036589864],"study_design_scores_gemma":[0.00007967964,0.0013416595,0.116905235,0.000047937923,0.00011988899,0.0055970554,0.00046677882,0.0029638237,0.8473932,0.00083728385,0.024225077,0.00002235145],"about_ca_topic_score_codex":0.0003479178,"about_ca_topic_score_gemma":0.00024110312,"teacher_disagreement_score":0.0041835173,"about_ca_system_score_codex":0.00037764045,"about_ca_system_score_gemma":0.00021948558,"threshold_uncertainty_score":0.01399529},"labels":[],"label_agreement":null},{"id":"W3153994123","doi":"10.1158/1557-3265.radsci21-po-021","title":"Abstract PO-021: Single-cell DNA sequencing as a means to directly examine the size and frequency of radiation-induced mutations - An exploratory study","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Ionizing radiation; Copy-number variation; DNA sequencing; DNA; Population; Mutation frequency; Irradiation; Biology; Molecular biology; Genetics; Mutation; Genome; Gene; Medicine","score_opus":0.16537739625218054,"score_gpt":0.4388811372250284,"score_spread":0.2735037409728479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153994123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97577363,0.00072000053,0.020658765,0.000057357018,0.000019865487,0.0001943426,0.00092526287,0.00013512677,0.0015156867],"genre_scores_gemma":[0.97545856,0.00047035975,0.019842371,0.000087235705,0.000013659527,0.00020605483,0.0015912307,0.00010173484,0.002228851],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9995351,0.0001614689,0.00002720436,0.00012742046,0.000112000256,0.000036923022],"domain_scores_gemma":[0.99952006,0.00018973995,0.00005555987,0.000106243504,0.00007965851,0.000048707367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062930136,0.00027770404,0.000404093,0.00043679695,0.0002308223,0.00032298538,0.00026596972,0.0005025697,0.0018441386],"category_scores_gemma":[0.00051106693,0.00014692599,0.00027821818,0.00031099425,0.0002586754,0.0002455972,0.00023783089,0.00037735436,0.0004958854],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007937599,0.0000614489,0.0014930184,0.000031214524,0.0000075303956,0.000053661126,0.00003014664,0.00013904998,0.9955973,0.000039141036,0.000036659483,0.002431485],"study_design_scores_gemma":[0.000013496331,0.0017275478,0.03325008,0.000007065225,0.000047774825,0.0011808579,0.000111023466,0.0034815914,0.95696545,0.00013015544,0.003071127,0.00001390291],"about_ca_topic_score_codex":0.00034920132,"about_ca_topic_score_gemma":0.00027704,"teacher_disagreement_score":0.0018441386,"about_ca_system_score_codex":0.00011882875,"about_ca_system_score_gemma":0.00011227617,"threshold_uncertainty_score":0.0061692595},"labels":[],"label_agreement":null},{"id":"W3154186241","doi":"10.1158/1557-3265.radsci21-ia-014","title":"Abstract IA-014: Strategies to enhance the immunogenicity of radiation therapy","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunogenicity; Immune system; Cancer research; Cancer; Immunology; Medicine; CD8; Immune checkpoint; Immunotherapy; Oncolytic virus; Cancer immunotherapy; Internal medicine","score_opus":0.1999027175686072,"score_gpt":0.5693669929650879,"score_spread":0.36946427539648063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154186241","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6414697,0.12231341,0.08787545,0.01328668,0.0053011035,0.0015237867,0.0019159706,0.0035912562,0.122722566],"genre_scores_gemma":[0.8935497,0.03307167,0.021171218,0.0041799583,0.00064390193,0.0005645414,0.0015116531,0.00031964804,0.044987597],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997881,0.00005443861,0.000011327908,0.000030215504,0.00005787664,0.000058047222],"domain_scores_gemma":[0.9998134,0.000022928845,0.00003771174,0.000024856956,0.000042270727,0.000058944497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062048144,0.00044774907,0.0003962857,0.000535328,0.0002330003,0.0009600491,0.0006155587,0.00077941397,0.011140042],"category_scores_gemma":[0.000421278,0.00018329841,0.0006366325,0.00029847902,0.00032723907,0.0006201805,0.00061465555,0.0019472241,0.003341023],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010931653,0.0012990785,0.0008681221,0.0013396334,0.00013168376,0.00025364125,0.000103901555,0.002058655,0.80114067,0.008206194,0.011509313,0.17199594],"study_design_scores_gemma":[0.0003998199,0.009953424,0.004108153,0.0004395318,0.00034106718,0.0015379225,0.00018401528,0.0060137124,0.64974064,0.0048476234,0.32237023,0.00006388643],"about_ca_topic_score_codex":0.00033821247,"about_ca_topic_score_gemma":0.0004071906,"teacher_disagreement_score":0.011140042,"about_ca_system_score_codex":0.0005821238,"about_ca_system_score_gemma":0.0005374052,"threshold_uncertainty_score":0.03726715},"labels":[],"label_agreement":null},{"id":"W3154268917","doi":"10.1158/1557-3265.radsci21-ia-018","title":"Abstract IA-018: Molecular landmarks of tumor hypoxia across cancer types","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Hypoxia (environmental); PTEN; Tumor hypoxia; Cancer; Metastasis; Cancer research; Chromosome instability; Tumor progression; Medicine; Pathology; Biology; Internal medicine; Apoptosis; Gene; PI3K/AKT/mTOR pathway; Radiation therapy; Genetics; Chemistry; Oxygen","score_opus":0.09560782771025017,"score_gpt":0.5008821585949651,"score_spread":0.40527433088471493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154268917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907093,0.0012802078,0.0028083588,0.00014401239,0.000020643336,0.00002384073,0.0012458896,0.00010732294,0.0036604365],"genre_scores_gemma":[0.99537575,0.00030164333,0.0013715075,0.00004303189,0.000007044245,0.00003029835,0.0008120343,0.00001803048,0.002040723],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998348,0.000017770912,0.000012616639,0.00006160026,0.00004125734,0.00003193835],"domain_scores_gemma":[0.9996866,0.000040054798,0.000131128,0.00002725146,0.00005174048,0.00006330658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018595073,0.0001303352,0.00016191437,0.00074152777,0.0003124439,0.00057867635,0.00020853564,0.0003174428,0.002545054],"category_scores_gemma":[0.0003497419,0.00014678777,0.00015501208,0.0006752026,0.00027268185,0.00024244635,0.00046583876,0.0004111573,0.00053967914],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005049604,0.000032035692,0.11806606,0.000118976524,0.000043571235,0.0003201735,0.00020764365,0.00046343738,0.8620947,0.0011366291,0.0006911093,0.01632075],"study_design_scores_gemma":[0.000017127719,0.00034291882,0.7632679,0.00003173494,0.00006683803,0.0022152732,0.00048242073,0.0026912235,0.22053394,0.0011509671,0.009171668,0.000028000166],"about_ca_topic_score_codex":0.0009072968,"about_ca_topic_score_gemma":0.0010777387,"teacher_disagreement_score":0.002545054,"about_ca_system_score_codex":0.00038191615,"about_ca_system_score_gemma":0.00019395481,"threshold_uncertainty_score":0.008514047},"labels":[],"label_agreement":null},{"id":"W3154990503","doi":"10.1158/1557-3265.radsci21-po-100","title":"Abstract PO-100: Theragnostic tumor-targeted manganese dioxide-loaded polymer-lipid nanoparticles for magnetic resonance image-guided radiation therapy","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"In vivo; Biodistribution; Magnetic resonance imaging; Radiation therapy; Tumor hypoxia; MRI contrast agent; Gadolinium; Ex vivo; Biomedical engineering; Materials science; Cancer research; In vitro; Chemistry; Medicine; Radiology; Biochemistry","score_opus":0.10425540994843938,"score_gpt":0.40709329249065185,"score_spread":0.30283788254221244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154990503","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96041715,0.0018030115,0.031565942,0.00027006038,0.000065722495,0.00009776089,0.000152678,0.00029534975,0.005332394],"genre_scores_gemma":[0.98273104,0.0006631185,0.010771018,0.00007473891,0.0000087802355,0.000059899907,0.00014467984,0.000032923985,0.0055137225],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99995494,0.000006074557,0.0000026712444,0.000013922447,0.000014716736,0.000007721529],"domain_scores_gemma":[0.9999683,0.0000041457365,0.000011690359,0.0000025562977,0.0000074291866,0.000005894427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008992905,0.00028130712,0.00009113968,0.00011596246,0.00007591547,0.00019020302,0.00017491252,0.0002540217,0.00080834003],"category_scores_gemma":[0.00010082806,0.00008952886,0.00011080184,0.000071347946,0.00012530548,0.00020326527,0.00016864455,0.0002317474,0.00030077173],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004097557,0.000019276185,0.00009577473,0.000039749855,0.0000031705238,0.000033390923,0.0000064563073,0.000198036,0.99669987,0.00014751761,0.00009310422,0.0026226125],"study_design_scores_gemma":[0.000009836834,0.0001446835,0.00044439218,0.0000040666782,0.000008770548,0.00007988093,0.0000061481123,0.0031486952,0.993256,0.00003878352,0.0028544178,0.0000043292657],"about_ca_topic_score_codex":0.00041833223,"about_ca_topic_score_gemma":0.00048208833,"teacher_disagreement_score":0.00080834003,"about_ca_system_score_codex":0.00024307382,"about_ca_system_score_gemma":0.00017734442,"threshold_uncertainty_score":0.0027041435},"labels":[],"label_agreement":null},{"id":"W3155830986","doi":"10.1158/1557-3265.radsci21-po-077","title":"Abstract PO-077: Study evaluating metastatic castrate resistant prostate cancer (mCRPC) treatment using 177Lu-PNT2002 PSMA therapy after second-line hormonal treatment (SPLASH) - Trial in progress","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Enzalutamide; Clinical endpoint; Prostate cancer; Radionuclide therapy; Oncology; Cabazitaxel; Internal medicine; Hormonal therapy; Docetaxel; Androgen deprivation therapy; Abiraterone acetate; Metastatic breast cancer; Clinical trial; Progression-free survival; Prednisone; Chemotherapy; Cancer; Breast cancer; Androgen receptor","score_opus":0.5805525165238268,"score_gpt":0.6232808433027445,"score_spread":0.04272832677891769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155830986","genre_codex":"empirical","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773373,0.0016460337,0.0009225992,0.0011511947,0.00019755484,0.010970979,0.0033167754,0.00021648253,0.0042410633],"genre_scores_gemma":[0.9519628,0.0022258675,0.00522243,0.002569592,0.00047246757,0.014874866,0.012150535,0.00012505749,0.010396388],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9985998,0.0009939389,0.000049479546,0.00011912686,0.00009152268,0.00014609766],"domain_scores_gemma":[0.9980646,0.0004054351,0.00024477768,0.00017199542,0.0001410957,0.000972152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052258437,0.002184153,0.0024061368,0.0006034873,0.00062519114,0.0013219033,0.0015188848,0.002127451,0.007928664],"category_scores_gemma":[0.0017262076,0.0006087788,0.0019103294,0.00053458405,0.0016893196,0.0014918426,0.00059036,0.0038881055,0.002558846],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8967024,0.047645327,0.0038731385,0.00068523217,0.0009872091,0.00017384368,0.00020342343,0.00093039713,0.012111816,0.00031069852,0.0031833118,0.033193197],"study_design_scores_gemma":[0.6776156,0.31549123,0.0034059845,0.000028774193,0.00023345026,0.000083874234,0.00003301508,0.00047799395,0.0010383724,0.00017227099,0.001404384,0.000014970139],"about_ca_topic_score_codex":0.001304775,"about_ca_topic_score_gemma":0.0018684488,"teacher_disagreement_score":0.007928664,"about_ca_system_score_codex":0.00087182457,"about_ca_system_score_gemma":0.003082634,"threshold_uncertainty_score":0.027637184},"labels":[],"label_agreement":null},{"id":"W3156003299","doi":"10.1158/1557-3265.radsci21-ia-027","title":"Abstract IA-027: Dysregulated metabolic and immune pathways underlying radiation fibrosis and lymphedema","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lymphedema; Downregulation and upregulation; Fibrosis; Medicine; Cancer research; Extracellular matrix; Bioinformatics; Cell biology; Cancer; Internal medicine; Biology; Breast cancer; Biochemistry","score_opus":0.14173307935739887,"score_gpt":0.4551732197972243,"score_spread":0.31344014043982543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156003299","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86231023,0.056148376,0.016201261,0.0046351016,0.0015656342,0.0003425706,0.034429617,0.0015147398,0.022852518],"genre_scores_gemma":[0.92584056,0.02153374,0.005973794,0.002484981,0.00037987772,0.0006170842,0.022716166,0.00026597825,0.020187896],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996606,0.000042707812,0.000026167483,0.0001097797,0.000084618354,0.00007612518],"domain_scores_gemma":[0.99977547,0.000022407296,0.00007956102,0.000017751343,0.000037598486,0.00006717399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030378875,0.00056247984,0.000641028,0.00065590825,0.00046748042,0.00094508537,0.0003729714,0.00072088814,0.008456223],"category_scores_gemma":[0.00025321794,0.00021448714,0.000750442,0.0006705502,0.00045607216,0.0003167342,0.00057600037,0.0015993995,0.0027842026],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032611596,0.00024070349,0.014942878,0.00272342,0.00029068073,0.0022443875,0.0002117694,0.00066490896,0.9307176,0.0019245384,0.010882886,0.031895],"study_design_scores_gemma":[0.0007239604,0.0031602632,0.3063691,0.0015084229,0.001512172,0.01819692,0.001519907,0.0048676976,0.4628814,0.0059660757,0.19308816,0.0002058886],"about_ca_topic_score_codex":0.00049172,"about_ca_topic_score_gemma":0.0005530796,"teacher_disagreement_score":0.008456223,"about_ca_system_score_codex":0.00039368236,"about_ca_system_score_gemma":0.0005648354,"threshold_uncertainty_score":0.0282889},"labels":[],"label_agreement":null},{"id":"W3156148127","doi":"10.1158/1078-0432.ccr-20-4746","title":"Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":348,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Novartis Pharmaceuticals Corporation","keywords":"Medicine; Internal medicine; Adverse effect; Melanoma; Cancer; Antibody; Lung cancer; Gastroenterology; Oncology; Colorectal cancer; Ovarian cancer; Immunology; Cancer research","score_opus":0.15449859783446931,"score_gpt":0.553803520585191,"score_spread":0.3993049227507217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156148127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914732,0.0014293144,0.000658202,0.00060947187,0.00019719375,0.002466033,0.0009154375,0.00011702378,0.0021341613],"genre_scores_gemma":[0.988076,0.0011980891,0.001903933,0.00087106746,0.00022349729,0.0026347733,0.0023420763,0.000034146204,0.002716421],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995104,0.00024881377,0.00002858913,0.00007840817,0.000042196065,0.00009158735],"domain_scores_gemma":[0.999148,0.00011885015,0.00014459269,0.00006794778,0.00006493498,0.00045566045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020620564,0.002085357,0.0020912874,0.00047901386,0.0004764164,0.0011790156,0.00089635106,0.0013741716,0.003684193],"category_scores_gemma":[0.001004693,0.0007547526,0.0013569122,0.00040050226,0.0012104351,0.00090209156,0.00034741667,0.00427046,0.0009802646],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8060346,0.09826834,0.0030486293,0.000610101,0.0010468231,0.00015301243,0.00015985256,0.0035503148,0.037652962,0.00028651295,0.0040882137,0.0451005],"study_design_scores_gemma":[0.65314806,0.33517647,0.0033173622,0.000028228827,0.00029711582,0.0001224086,0.000027092645,0.0019917588,0.0044107107,0.00018278461,0.0012806786,0.000017372877],"about_ca_topic_score_codex":0.0009256098,"about_ca_topic_score_gemma":0.0014596941,"teacher_disagreement_score":0.003684193,"about_ca_system_score_codex":0.0011322917,"about_ca_system_score_gemma":0.002276726,"threshold_uncertainty_score":0.01232487},"labels":[],"label_agreement":null},{"id":"W3156560386","doi":"10.1158/1557-3265.radsci21-po-086","title":"Abstract PO-086: Selective radiosensitization in preclinical models of HPV-negative squamous cell carcinoma","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Radioresistance; Cancer research; Clonogenic assay; Cell cycle; Radiosensitivity; Medicine; Cancer; Viability assay; Flow cytometry; Radiation therapy; Cell culture; Oncology; Pharmacology; Biology; Immunology; Internal medicine","score_opus":0.25444523328433466,"score_gpt":0.5329115100054382,"score_spread":0.2784662767211036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156560386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737627,0.00268015,0.01061579,0.00047198206,0.0002925267,0.0007277227,0.0037191666,0.00083876355,0.0068912706],"genre_scores_gemma":[0.96631825,0.002207129,0.0125576155,0.00017890955,0.00003931321,0.0011658728,0.0035472726,0.00014889636,0.013836661],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995883,0.00007503008,0.000046235542,0.00008945991,0.00012102655,0.00007995835],"domain_scores_gemma":[0.9997825,0.000028424123,0.000042050175,0.00004268289,0.00004585249,0.000058388738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005486562,0.00084339065,0.00059848075,0.0007716303,0.00037294847,0.00042020893,0.0006592118,0.0006381341,0.004773842],"category_scores_gemma":[0.00018878054,0.00034849244,0.0005671892,0.00036677168,0.0004148971,0.00045210592,0.00022949818,0.0019864182,0.00089693844],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084614917,0.0012946797,0.00022576278,0.00018024303,0.000020659161,0.000047163812,0.000038942537,0.00026844276,0.9920779,0.00020839958,0.00056127046,0.0042303503],"study_design_scores_gemma":[0.0001015208,0.004599005,0.0015091398,0.000013872417,0.00003489165,0.00012520554,0.00002968129,0.00084805884,0.98935485,0.000064819935,0.0033112427,0.000007642519],"about_ca_topic_score_codex":0.0010554092,"about_ca_topic_score_gemma":0.0019059977,"teacher_disagreement_score":0.004773842,"about_ca_system_score_codex":0.00047986934,"about_ca_system_score_gemma":0.00068389036,"threshold_uncertainty_score":0.01597011},"labels":[],"label_agreement":null},{"id":"W3156631419","doi":"10.1158/1557-3265.radsci21-po-071","title":"Abstract PO-071: Characterizing transcriptomic indicators of radiosensitivity in cancer and identifying sensitizing therapeutic agents","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Radiosensitivity; Transcriptome; Computational biology; Cancer; Radiogenomics; Personalized medicine; Precision medicine; Radiation therapy; Cancer research; Gene signature; Gene; Medicine; Bioinformatics; Biology; Oncology; Gene expression; Genetics; Internal medicine; Radiomics","score_opus":0.20042949771509042,"score_gpt":0.5208171468069441,"score_spread":0.3203876490918537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156631419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8252085,0.0016715936,0.05149086,0.001652122,0.00008214418,0.00028792562,0.10939951,0.0027979808,0.0074094404],"genre_scores_gemma":[0.8548273,0.0012407067,0.045141183,0.00031129818,0.00004281485,0.00038279063,0.094746076,0.00022123693,0.0030866715],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99970907,0.00006160754,0.000013257898,0.00010913884,0.000087037806,0.000019914212],"domain_scores_gemma":[0.99934787,0.00034799686,0.00011027759,0.000073472685,0.00008198895,0.000038413524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006157271,0.00039786266,0.0005216271,0.000787089,0.00024528315,0.0007577882,0.00035286642,0.0004247121,0.0033547143],"category_scores_gemma":[0.0018727373,0.00016981589,0.00053412793,0.0010600802,0.0003206157,0.00043374355,0.00041480042,0.0004972929,0.000777788],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028992163,0.0006498976,0.17268763,0.0021751693,0.0005432631,0.00050522445,0.0002764282,0.21454044,0.41163364,0.009343231,0.029239448,0.15550645],"study_design_scores_gemma":[0.00018332098,0.0017322482,0.27575535,0.00011764608,0.0003101957,0.0006037912,0.0003763332,0.5050861,0.15993655,0.020766106,0.035013165,0.00011918769],"about_ca_topic_score_codex":0.001980533,"about_ca_topic_score_gemma":0.0025895159,"teacher_disagreement_score":0.0033547143,"about_ca_system_score_codex":0.00058424607,"about_ca_system_score_gemma":0.0005681087,"threshold_uncertainty_score":0.011222661},"labels":[],"label_agreement":null},{"id":"W3158848810","doi":"10.1158/1078-0432.ccr-20-4394","title":"Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Victoria; Spinal Cord Injury BC; University of British Columbia","funders":"CIHR Skin Research Training Centre; BC Cancer Foundation; Terry Fox Research Institute; Canadian Cancer Society; Michael Smith Health Research BC; Paul G. Allen Frontiers Group; Canadian Institutes of Health Research; Cancer Research Society","keywords":"TIGIT; Biology; CD8; Tumor-infiltrating lymphocytes; Ovarian cancer; Immunology; Cancer research; Immune system; Immunotherapy; Cancer","score_opus":0.1289289768247405,"score_gpt":0.44337428432989584,"score_spread":0.3144453075051553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158848810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994916,0.00015937135,0.00009784802,0.0000034689538,0.0000012422405,0.0000050302056,0.00006698522,0.0000049883192,0.00016955158],"genre_scores_gemma":[0.9996276,0.00004346652,0.00011987706,0.000004708516,0.0000016083939,0.0000063630864,0.000101437035,0.0000015712388,0.00009347063],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99993587,0.0000082446795,0.0000057820557,0.000016359874,0.000017635106,0.000015985806],"domain_scores_gemma":[0.9998934,0.000025537345,0.000026102958,0.000011064236,0.00001827151,0.00002566709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000098079945,0.00007614371,0.00015382575,0.00033039958,0.00012876918,0.00026749735,0.00006544529,0.00017663832,0.00071742444],"category_scores_gemma":[0.00021523921,0.000059826732,0.000061210194,0.00025456698,0.000105443345,0.00010966221,0.00011037254,0.00012396598,0.00013746183],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016172185,0.00010014335,0.24960726,0.000081363425,0.000026267828,0.0004902915,0.00022722603,0.00028882266,0.7312531,0.000065811786,0.00013566643,0.016106863],"study_design_scores_gemma":[0.000041041672,0.0011140044,0.8554914,0.000014998202,0.00008760626,0.0032319913,0.000506957,0.0032391779,0.13405706,0.00012099895,0.0020842561,0.000010571218],"about_ca_topic_score_codex":0.00028983073,"about_ca_topic_score_gemma":0.00040023585,"teacher_disagreement_score":0.00071742444,"about_ca_system_score_codex":0.00012959054,"about_ca_system_score_gemma":0.00007419635,"threshold_uncertainty_score":0.0024000406},"labels":[],"label_agreement":null},{"id":"W3159120388","doi":"10.1158/1078-0432.ccr-20-4259","title":"Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Veliparib; Medicine; Carboplatin; Internal medicine; Hazard ratio; Etoposide; Placebo; Oncology; Lung cancer; Chemotherapy; Clinical endpoint; Surgery; Confidence interval; Clinical trial; Pathology; Cisplatin; Biology","score_opus":0.11156764103209474,"score_gpt":0.509988089102433,"score_spread":0.3984204480703383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159120388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99177414,0.002885946,0.00045045477,0.0003751342,0.00017531654,0.0031021873,0.0004257465,0.000047869537,0.0007632206],"genre_scores_gemma":[0.98949975,0.002599267,0.0013294085,0.0008966565,0.00041534132,0.0032029531,0.0008444752,0.00001653629,0.001195623],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991228,0.0005291294,0.00005286611,0.00013079934,0.00006428809,0.00010006407],"domain_scores_gemma":[0.99913543,0.00021205863,0.00020930424,0.000072620525,0.000052099,0.00031856002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023902648,0.0014174714,0.0028819565,0.00035844877,0.00042364924,0.0012018861,0.0010059936,0.0013573309,0.0040129493],"category_scores_gemma":[0.0012600601,0.0009029334,0.0017732548,0.000498964,0.0010409391,0.0009927006,0.00043392528,0.0027360183,0.0006160813],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9232209,0.036837168,0.0028053115,0.0006663062,0.0013798821,0.00011011886,0.0000775432,0.0006556709,0.007182662,0.00007749329,0.0007145144,0.02627253],"study_design_scores_gemma":[0.8690756,0.1267062,0.0025131325,0.000019110252,0.00039723032,0.000059879254,0.000016343261,0.0003301992,0.00031029328,0.000051006766,0.0005099478,0.000010987897],"about_ca_topic_score_codex":0.0006626605,"about_ca_topic_score_gemma":0.001986493,"teacher_disagreement_score":0.0040129493,"about_ca_system_score_codex":0.00084372255,"about_ca_system_score_gemma":0.001706152,"threshold_uncertainty_score":0.013424635},"labels":[],"label_agreement":null},{"id":"W3165701213","doi":"10.1158/1078-0432.ccr-21-1625","title":"Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbotsford Veterinary Clinic; University of the Fraser Valley; Interior Health; BC Cancer Agency; Spinal Cord Injury BC; Island Health; University of British Columbia","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute; Canadian Cancer Society; Prostate Cancer Canada; Institute of Cancer Research; Jane ja Aatos Erkon Säätiö; Prostate Cancer Foundation; Government of Canada; Academy of Finland","keywords":"Enzalutamide; Prostate cancer; Androgen receptor; Somatic cell; Cancer research; Oncology; Biology; Genotype; Mutation; Internal medicine; Cancer; Abiraterone; Exome sequencing; Medicine; Gene; Genetics","score_opus":0.1548736304656693,"score_gpt":0.48229699450883784,"score_spread":0.3274233640431685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165701213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998679,0.00032223144,0.00033052574,0.000023427894,0.0000023765565,0.000016893948,0.00027630158,0.000014613663,0.00033459862],"genre_scores_gemma":[0.99913824,0.00005390485,0.00019320588,0.00003108654,0.000002343812,0.000010959856,0.00036157356,0.000004039572,0.00020452416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999741,0.0000408602,0.000015075731,0.00008732885,0.000083426705,0.000032347194],"domain_scores_gemma":[0.999554,0.000060989714,0.00020692954,0.00004113058,0.00005117212,0.0000857441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000247339,0.00017112208,0.00027520827,0.00034634737,0.00019442418,0.00044271303,0.000230329,0.00023320744,0.0016462753],"category_scores_gemma":[0.0008550349,0.00014713951,0.00014112215,0.00040259745,0.00021722233,0.00020603373,0.0002740839,0.00045257958,0.00018913383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004932028,0.00044412556,0.54575664,0.00015408009,0.0002465413,0.0007694591,0.00031602674,0.0021842911,0.39984939,0.00029383533,0.0004383032,0.04461532],"study_design_scores_gemma":[0.00007788378,0.0023541206,0.95268005,0.000014237262,0.00007600541,0.0025964691,0.00012016752,0.002065268,0.038633604,0.00014432347,0.0012247739,0.0000132444275],"about_ca_topic_score_codex":0.0014874316,"about_ca_topic_score_gemma":0.0019482808,"teacher_disagreement_score":0.0016462753,"about_ca_system_score_codex":0.0004895201,"about_ca_system_score_gemma":0.0003188733,"threshold_uncertainty_score":0.00550735},"labels":[],"label_agreement":null},{"id":"W3166074522","doi":"10.1158/1078-0432.ccr-20-4175","title":"Heterogeneity in <i>NECTIN4</i> Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Decipher Biosciences (Canada)","funders":"National Center for Advancing Translational Sciences; Council for Science, Technology and Innovation; A.P. Giannini Foundation; Svenska Läkaresällskapet; National Cancer Institute; National Institutes of Health; Vetenskapsrådet; Giannini Foundation of Agricultural Economics","keywords":"Urothelial cancer; Cancer; Oncology; Medicine; Internal medicine; Cancer research; Bladder cancer; Biology","score_opus":0.15900562498021772,"score_gpt":0.5352728762811759,"score_spread":0.37626725130095817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166074522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987925,0.0002731829,0.00030961496,0.000021539468,0.0000014206738,0.000006819501,0.0003156806,0.0000116528745,0.0002675225],"genre_scores_gemma":[0.99888116,0.00010350626,0.0002179627,0.000027798511,0.0000018230039,0.00000945647,0.0005939499,0.000006452025,0.00015804706],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997404,0.000044961973,0.000029120301,0.000075323784,0.000058369078,0.000051862626],"domain_scores_gemma":[0.9996972,0.00005899079,0.00011103015,0.000042965155,0.00005184184,0.00003799183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026737573,0.000124207,0.00029579352,0.00029479826,0.00023234409,0.00051281287,0.0001774713,0.0002064449,0.00088183087],"category_scores_gemma":[0.0004584715,0.00013258349,0.00024755084,0.00032007668,0.0002660864,0.00016640713,0.0002657193,0.00030673135,0.00020947345],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072377827,0.000039428203,0.18352698,0.00014612128,0.000121958205,0.000148024,0.00012980207,0.0003509999,0.807881,0.00008641397,0.00021203744,0.006633539],"study_design_scores_gemma":[0.000019339052,0.00037864601,0.85941726,0.000020285523,0.0001409849,0.0011244892,0.00041437335,0.0012950576,0.13565943,0.00012179604,0.0013970359,0.000011203883],"about_ca_topic_score_codex":0.0013123901,"about_ca_topic_score_gemma":0.0015367293,"teacher_disagreement_score":0.0013123901,"about_ca_system_score_codex":0.0003307267,"about_ca_system_score_gemma":0.00023266776,"threshold_uncertainty_score":0.0029500127},"labels":[],"label_agreement":null},{"id":"W3166259184","doi":"10.1158/1078-0432.ccr-21-0358","title":"Blood Biomarker Landscape in Patients with High-risk Nonmetastatic Castration-Resistant Prostate Cancer Treated with Apalutamide and Androgen-Deprivation Therapy as They Progress to Metastatic Disease","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Prevention of Organ Failure; University of British Columbia","funders":"Janssen Research and Development","keywords":"Prostate cancer; Androgen receptor; Medicine; Androgen deprivation therapy; Enzalutamide; Internal medicine; Oncology; Biomarker; Proportional hazards model; Metastasis; Cancer; Androgen; Antiandrogen; Biology; Hormone","score_opus":0.07527895759064986,"score_gpt":0.42445680304503575,"score_spread":0.3491778454543859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166259184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994235,0.00026244827,0.000041520045,0.000020724821,0.0000022881693,0.0000037509676,0.00008941675,0.0000026369241,0.00015381571],"genre_scores_gemma":[0.99970967,0.00003529287,0.000028235772,0.00001967364,0.0000040009736,0.0000029879843,0.00014532695,6.119009e-7,0.000054202108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980956,0.000049303453,0.000016305508,0.00005256951,0.0000391385,0.000033175922],"domain_scores_gemma":[0.9996282,0.00007628055,0.00014510017,0.000017454973,0.000042114956,0.00009089676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017016908,0.00014936978,0.00043700417,0.00036959612,0.00020248862,0.00040742528,0.00016536067,0.00027807947,0.0008190317],"category_scores_gemma":[0.0007098388,0.000119709715,0.00018784667,0.0005014409,0.00015975388,0.00024261976,0.00011318698,0.00029521622,0.00012579466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037017702,0.00012465827,0.9825273,0.000023545346,0.000121899655,0.00033301543,0.00009034535,0.00014115022,0.005411052,0.000027077767,0.00018084145,0.007317387],"study_design_scores_gemma":[0.000049761573,0.0009870105,0.9970799,0.0000029112562,0.0000494318,0.00063156296,0.00007405308,0.0003555199,0.0005278882,0.00002947688,0.00020821116,0.000004212046],"about_ca_topic_score_codex":0.0009202627,"about_ca_topic_score_gemma":0.0012406985,"teacher_disagreement_score":0.0009202627,"about_ca_system_score_codex":0.00029826455,"about_ca_system_score_gemma":0.0001560633,"threshold_uncertainty_score":0.0027399063},"labels":[],"label_agreement":null},{"id":"W3166273369","doi":"10.1158/1557-3265.ovcasymp18-gmm-020","title":"Abstract GMM-020: CELL OF ORIGIN, MUTATION AND MICROENVIRONMENT: MODELING EARLY EVENTS OF ENDOMETRIOSIS ASSOCIATED CANCERS","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Clear cell; Histogenesis; Ovarian cancer; Cell of origin; Pathology; Cancer research; Cell; Clear cell carcinoma; Carcinoma; Cancer; Immunohistochemistry; Medicine; Immunology; Genetics","score_opus":0.15687738574329968,"score_gpt":0.4777591788075257,"score_spread":0.32088179306422604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166273369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96975327,0.0004310513,0.024479631,0.00011393013,0.00002889536,0.00005690238,0.0012185018,0.0002185514,0.0036992726],"genre_scores_gemma":[0.98157835,0.00031376936,0.015697517,0.00002573825,0.000007945716,0.000070350274,0.0005463798,0.000035024088,0.001724918],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9999628,0.000009742248,0.0000014983655,0.000010776415,0.0000063298016,0.000008861658],"domain_scores_gemma":[0.9999145,0.00003573242,0.000015091151,0.0000059426607,0.000011498077,0.000017216533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012605824,0.00032570277,0.00022064526,0.0002929578,0.00014076989,0.00034325698,0.00033500406,0.00049492915,0.0013570279],"category_scores_gemma":[0.00020436793,0.0001489765,0.0003788836,0.0002372943,0.00014943146,0.00014670017,0.00029899285,0.00025227378,0.0002219867],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030868698,0.00018242135,0.016952902,0.0001899217,0.000044682456,0.00022598586,0.000068346846,0.8484742,0.120672815,0.004284068,0.000660774,0.0079352],"study_design_scores_gemma":[0.00001170946,0.00010976928,0.0033863017,0.0000055214596,0.000012091693,0.00005824951,0.000033408654,0.98786956,0.007009247,0.0004519329,0.0010444359,0.000007821426],"about_ca_topic_score_codex":0.005159736,"about_ca_topic_score_gemma":0.003097424,"teacher_disagreement_score":0.005159736,"about_ca_system_score_codex":0.00043094534,"about_ca_system_score_gemma":0.00035410083,"threshold_uncertainty_score":0.01025939},"labels":[],"label_agreement":null},{"id":"W3166889753","doi":"10.1158/1557-3265.ovcasymp18-dp-006","title":"Abstract DP-006: THE EFFECT OF AGE AND OCP USE ON THE INCIDENCE OF PRE-CANCEROUS P53 LESIONS AND THE DEVELOPMENT OF HIGH GRADE SEROUS OVARIAN CARCINOMA","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Serous fluid; Serous carcinoma; Incidence (geometry); Ovarian cancer; Cohort; Cancer; Hysterectomy; Immunohistochemistry; Gynecology; Internal medicine; Oncology; Pathology","score_opus":0.16101491038278817,"score_gpt":0.45373327138641445,"score_spread":0.29271836100362625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166889753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956844,0.0009414079,0.00013428417,0.000113527574,0.000045170727,0.00005296205,0.0014708315,0.000008683786,0.0015487213],"genre_scores_gemma":[0.9966388,0.00022480811,0.00017063823,0.00007362922,0.00003636987,0.000053943448,0.0006683013,0.0000031575057,0.002130324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970824,0.00008528275,0.000022623663,0.000063071,0.000074972566,0.000045752513],"domain_scores_gemma":[0.9987896,0.0002966331,0.0004444077,0.000055127784,0.00013437193,0.00027990964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005800643,0.00020561258,0.00019690751,0.00047687828,0.0001853047,0.00037384962,0.00030626645,0.0003027652,0.007237572],"category_scores_gemma":[0.0012671677,0.00011797037,0.00034398533,0.0004599355,0.0001802728,0.00024867922,0.00021494695,0.00046674412,0.00052143395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011818161,0.0006788975,0.9646132,0.00017276515,0.00023105573,0.00025345766,0.00005039471,0.000075670745,0.0061250716,0.00004155298,0.0008798197,0.015060053],"study_design_scores_gemma":[0.00010635625,0.003481331,0.9933066,0.000010576883,0.0001272715,0.0003649731,0.000052674775,0.000112464404,0.0012085622,0.00003237724,0.0011931215,0.000003819971],"about_ca_topic_score_codex":0.0013172652,"about_ca_topic_score_gemma":0.0010163336,"teacher_disagreement_score":0.007237572,"about_ca_system_score_codex":0.00025414306,"about_ca_system_score_gemma":0.0002887928,"threshold_uncertainty_score":0.024212122},"labels":[],"label_agreement":null},{"id":"W3167506735","doi":"10.1158/1557-3265.ovcasymp18-nt-118","title":"Abstract NT-118: SEQUENTIAL THERAPEUTIC TARGETING OF OVARIAN CANCER HARBORING DYSFUNCTIONAL BRCA1","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Ovarian cancer; Olaparib; Chemotherapy; Medicine; Cancer research; Cisplatin; Paclitaxel; Debulking; Cancer; Oncology; PARP inhibitor; Carboplatin; Doxorubicin; Internal medicine; Biology; Poly ADP ribose polymerase","score_opus":0.2990487219853393,"score_gpt":0.5437371260757348,"score_spread":0.24468840409039544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167506735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836272,0.006207718,0.0030981232,0.0002811083,0.00018289746,0.0001606892,0.0010921614,0.00016378351,0.005186327],"genre_scores_gemma":[0.9905944,0.002310241,0.0022913099,0.000118099306,0.000023599643,0.00010638536,0.0013824067,0.00001854747,0.0031549137],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999951,0.000005754116,0.0000048744564,0.000011118036,0.00001653511,0.000010634482],"domain_scores_gemma":[0.99996996,0.000003429405,0.0000068359054,0.000003750736,0.0000058942683,0.000010182984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007067983,0.00022686158,0.00027969797,0.00017007678,0.00010617889,0.00018870116,0.000291954,0.0002174281,0.0025012898],"category_scores_gemma":[0.00009103831,0.00007674687,0.00021345055,0.00015795803,0.00011996327,0.00018140115,0.00014733788,0.000519416,0.00028541696],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025139125,0.00071011396,0.0006283694,0.0004814389,0.00003684924,0.00022438879,0.000033453398,0.0006028599,0.9513552,0.00035408683,0.002024311,0.041034974],"study_design_scores_gemma":[0.0007373761,0.008970037,0.005767964,0.0000374598,0.00013720884,0.002543147,0.00004626713,0.002693394,0.9565605,0.00020852967,0.022280898,0.000017272185],"about_ca_topic_score_codex":0.00048459746,"about_ca_topic_score_gemma":0.0006285782,"teacher_disagreement_score":0.0025012898,"about_ca_system_score_codex":0.00021307378,"about_ca_system_score_gemma":0.00022717264,"threshold_uncertainty_score":0.008367598},"labels":[],"label_agreement":null},{"id":"W3167814974","doi":"10.1158/1078-0432.ccr-21-0180","title":"Clinical and Functional Characterization of Atypical <i>KRAS</i> / <i>NRAS</i> Mutations in Metastatic Colorectal Cancer","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; American Society of Clinical Oncology","keywords":"KRAS; Neuroblastoma RAS viral oncogene homolog; Colorectal cancer; Cancer research; Mutation; Cancer; Biology; Exon; HRAS; Medicine; Oncology; Genetics; Gene","score_opus":0.22248604584047627,"score_gpt":0.5158019717685142,"score_spread":0.2933159259280379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167814974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990075,0.00034734,0.00015925636,0.00001611346,0.0000021820135,0.000009297127,0.00013063154,0.000005198278,0.00032253147],"genre_scores_gemma":[0.9995883,0.000058592803,0.00014312513,0.000011437345,0.0000035667574,0.000004375671,0.00014841951,0.000001972134,0.00004015144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995828,0.00008831959,0.00005773555,0.00012598692,0.000101304984,0.000043849734],"domain_scores_gemma":[0.9986089,0.00035112444,0.00053806696,0.00010407879,0.00021717655,0.00018068125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078247336,0.0002606112,0.000318207,0.0006396744,0.00022032994,0.0003389809,0.00029487137,0.0003439088,0.0009713596],"category_scores_gemma":[0.0018383118,0.00013671932,0.00018917641,0.00043531237,0.0004496115,0.00024972038,0.00022503946,0.00025255198,0.0002175573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065358257,0.000030395473,0.98319757,0.000032611413,0.000033348846,0.00039726697,0.000031352043,0.000108420005,0.011165476,0.000024734685,0.00008305053,0.0042422395],"study_design_scores_gemma":[0.000015182416,0.0004433321,0.99128026,0.0000076126635,0.000044556116,0.0040967064,0.00006984617,0.00036554795,0.003271329,0.000050864543,0.00034990895,0.000004894066],"about_ca_topic_score_codex":0.0008660471,"about_ca_topic_score_gemma":0.001362339,"teacher_disagreement_score":0.0009713596,"about_ca_system_score_codex":0.00027253997,"about_ca_system_score_gemma":0.00019945757,"threshold_uncertainty_score":0.0041381717},"labels":[],"label_agreement":null},{"id":"W3168019520","doi":"10.1158/1557-3265.ovcasymp18-gmm-027","title":"Abstract GMM-027: DYNLL1 INHIBITS DNA END RESECTION IN BRCA1-DEFICIENT CELLS AND REGULATES PARP INHIBITOR SENSITIVITY","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Olaparib; Cancer research; Homologous recombination; DNA repair; PARP inhibitor; Genome instability; Ovarian cancer; Cisplatin; Chemistry; Molecular biology; Germline; Ovarian carcinoma; DNA damage; DNA; Poly ADP ribose polymerase; Cancer; Biology; Polymerase; Genetics; Gene; Chemotherapy","score_opus":0.04839840193250962,"score_gpt":0.44204335009585777,"score_spread":0.39364494816334816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168019520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97978127,0.0039701024,0.0066414527,0.0006112001,0.00018009696,0.0001336872,0.0037276002,0.0009465888,0.004007966],"genre_scores_gemma":[0.98891175,0.0006841448,0.002457732,0.00021622237,0.000011051011,0.000069218644,0.0023903847,0.00006611961,0.005193241],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997985,0.000022606337,0.000024573605,0.00005880314,0.000052252835,0.000043421616],"domain_scores_gemma":[0.9998503,0.000025133579,0.000043158972,0.000015819653,0.000014000475,0.000051632418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001583465,0.0002944365,0.000398758,0.00025770944,0.00025870005,0.00043722417,0.00035539846,0.0004287341,0.002213915],"category_scores_gemma":[0.00013658393,0.00015936515,0.0002464569,0.00014817606,0.00029924608,0.00014465423,0.0003020974,0.00063328684,0.0009043537],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017944533,0.00005816571,0.00054594385,0.00008271415,0.000007907922,0.000121701996,0.000017547136,0.00013321835,0.9965071,0.0001034874,0.00034866345,0.0018939608],"study_design_scores_gemma":[0.00003875397,0.00032718803,0.005294636,0.000011103897,0.000021397853,0.00038283865,0.000053335163,0.001561613,0.9841813,0.000035455767,0.008079764,0.000012745234],"about_ca_topic_score_codex":0.0009936194,"about_ca_topic_score_gemma":0.0015792617,"teacher_disagreement_score":0.002213915,"about_ca_system_score_codex":0.0005280629,"about_ca_system_score_gemma":0.00035627693,"threshold_uncertainty_score":0.0074062943},"labels":[],"label_agreement":null},{"id":"W3170342365","doi":"10.1158/1557-3265.ovcasymp18-nt-089","title":"Abstract NT-089: TRAIL-EXPRESSING ONCOLYTIC VACCINIA VIRUS COMBINED WITH SMALL-MOLECULE DRUG PAC1 IS A POTENTIALLY EFFECTIVE TREATMENT ALTERNATIVE FOR OVARIAN CANCERS","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Oncolytic virus; Vaccinia; Ovarian cancer; Apoptosis; Carboplatin; Cancer research; Cancer; Pharmacology; Medicine; Cancer cell; Virus; Virology; Biology; Immunology; Internal medicine; Recombinant DNA; Chemotherapy","score_opus":0.0821276485905985,"score_gpt":0.44772578225851367,"score_spread":0.36559813366791516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170342365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97293234,0.011650388,0.0068328055,0.00047478103,0.00021348537,0.00020911834,0.0012365275,0.00023741859,0.006213028],"genre_scores_gemma":[0.984738,0.0025864837,0.0047859787,0.0001067296,0.000028748327,0.00006975156,0.0014081356,0.000024326131,0.0062518665],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999386,0.000007563203,0.000006095913,0.000013332116,0.000022285145,0.000012162809],"domain_scores_gemma":[0.9999702,0.0000032831495,0.000009697195,0.0000034989662,0.000005899674,0.0000075086346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077801036,0.00021734934,0.0002231009,0.00013507092,0.00010389226,0.00026471444,0.00016021487,0.00023605749,0.001821582],"category_scores_gemma":[0.00006268503,0.000053959397,0.0001778823,0.00013585355,0.000102737824,0.00017202973,0.00011278156,0.00041238987,0.00046506943],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004108265,0.00012969466,0.00030403511,0.00014567425,0.000010114015,0.000090702386,0.000012227528,0.00018084556,0.9858958,0.00024847206,0.00044307037,0.012128493],"study_design_scores_gemma":[0.0000927958,0.0013848322,0.0014475064,0.000012344322,0.00003245959,0.0006727644,0.0000104272685,0.00083053723,0.98227423,0.000057295532,0.013180262,0.000004687535],"about_ca_topic_score_codex":0.00035761492,"about_ca_topic_score_gemma":0.00034452803,"teacher_disagreement_score":0.001821582,"about_ca_system_score_codex":0.000265618,"about_ca_system_score_gemma":0.00020072264,"threshold_uncertainty_score":0.0060938},"labels":[],"label_agreement":null},{"id":"W3171679244","doi":"10.1158/1078-0432.ccr-21-0748","title":"Relevance of Platinum-free Interval and <i>BRCA</i> Reversion Mutations for Veliparib Monotherapy after Progression on Carboplatin/Paclitaxel for g <i>BRCA</i> Advanced Breast Cancer (BROCADE3 Crossover)","year":2021,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"AbbVie","keywords":"Carboplatin; Veliparib; Medicine; Paclitaxel; BRCA mutation; Oncology; Breast cancer; Internal medicine; Cancer; Chemotherapy; Cisplatin; Genetics; Biology; DNA","score_opus":0.14512049466977472,"score_gpt":0.5106776394598908,"score_spread":0.36555714479011603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171679244","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987962,0.0006319711,0.00006829149,0.000048062673,0.000012729779,0.000069178575,0.00007486753,0.000007276759,0.0002913991],"genre_scores_gemma":[0.99958605,0.00010041098,0.000075672775,0.000044109154,0.000015620206,0.000021448122,0.000093724186,0.0000018245096,0.0000610731],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9996191,0.00017847517,0.000032817763,0.00008292808,0.000031350577,0.0000553507],"domain_scores_gemma":[0.99924904,0.00023050363,0.00025820476,0.00006484649,0.00003170569,0.00016566397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011287207,0.0002749966,0.0006646035,0.00015232919,0.00019474591,0.00070332637,0.0002798172,0.0005118357,0.0012664311],"category_scores_gemma":[0.0009926751,0.00017393642,0.0007226666,0.00017916373,0.00037354697,0.00030538213,0.00015936031,0.0011095533,0.00014028308],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8250059,0.0064633526,0.039222144,0.0003593665,0.0012098054,0.00020348407,0.0001986792,0.0014710831,0.044258785,0.00016421349,0.0007713344,0.08067182],"study_design_scores_gemma":[0.2804289,0.49411175,0.19687507,0.000103881895,0.002312079,0.0010330888,0.00013070229,0.0026823427,0.019189922,0.00031266426,0.0027595249,0.000060104514],"about_ca_topic_score_codex":0.00044203998,"about_ca_topic_score_gemma":0.0009957971,"teacher_disagreement_score":0.0012664311,"about_ca_system_score_codex":0.00051561865,"about_ca_system_score_gemma":0.0004165997,"threshold_uncertainty_score":0.005969286},"labels":[],"label_agreement":null},{"id":"W3172767700","doi":"10.1158/1557-3265.ovcasymp18-gmm-030","title":"Abstract GMM-030: MODELS AND ANALYTIC TECHNIQUES OF MULLERIAN TISSUE-DERIVED ORGANOIDS","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Organoid; Matrigel; Biology; Carcinogenesis; Ovarian cancer; Cancer research; Serous fluid; Progenitor cell; Stem cell; Cellular differentiation; Cell biology; Cancer; Angiogenesis; Genetics; Gene","score_opus":0.2760829646416126,"score_gpt":0.5471925888043477,"score_spread":0.27110962416273515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172767700","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17901734,0.0053482754,0.77527034,0.00079715106,0.00049450184,0.0027697657,0.010670036,0.003642674,0.021989979],"genre_scores_gemma":[0.41551092,0.004541712,0.5459242,0.00022439503,0.000052760097,0.004434422,0.009457673,0.00080925744,0.019044582],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9991497,0.0001451302,0.00009250373,0.00017807026,0.00034437733,0.000090238515],"domain_scores_gemma":[0.99922013,0.000154254,0.00014619372,0.00022014698,0.00013692773,0.00012230725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015155764,0.0007546865,0.00042353515,0.0014570187,0.00078162266,0.0009815118,0.0012646472,0.00089270144,0.0028224785],"category_scores_gemma":[0.00069193606,0.00055500126,0.0008708253,0.00069800083,0.00063312816,0.0005176367,0.001289162,0.0016793356,0.0028661692],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014135402,0.00007454774,0.0008351045,0.00025987008,0.000020077707,0.00064533384,0.00036672552,0.0032975504,0.977101,0.005247928,0.00092625734,0.011084191],"study_design_scores_gemma":[0.000039036437,0.0004251395,0.002645819,0.0001281024,0.000055152774,0.0016898024,0.0002093514,0.012268944,0.89283425,0.0015422384,0.08809194,0.00007024462],"about_ca_topic_score_codex":0.0025851093,"about_ca_topic_score_gemma":0.0033618484,"teacher_disagreement_score":0.0028224785,"about_ca_system_score_codex":0.0010230498,"about_ca_system_score_gemma":0.00085858844,"threshold_uncertainty_score":0.009442151},"labels":[],"label_agreement":null},{"id":"W3173401695","doi":"10.1158/1078-0432.ccr-21-0809","title":"5-Year Outcomes with Cobimetinib plus Vemurafenib in <i>BRAF</i> V600 Mutation–Positive Advanced Melanoma: Extended Follow-up of the coBRIM Study","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":182,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche; Roche","keywords":"Vemurafenib; Medicine; Placebo; Internal medicine; Melanoma; Gastroenterology; Surgery; Metastatic melanoma; Pathology; Cancer research; Cancer","score_opus":0.0778736949624746,"score_gpt":0.4348568937526744,"score_spread":0.3569831987901998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173401695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99115527,0.0053061717,0.00026133363,0.00023495467,0.00008907547,0.00022952202,0.0017632679,0.000018827723,0.0009415654],"genre_scores_gemma":[0.9951874,0.0008045188,0.00017586874,0.00028145773,0.00014074155,0.00018479586,0.002647927,0.0000057598854,0.0005716005],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9988715,0.0005640742,0.00008229022,0.00019883749,0.00012932533,0.00015400164],"domain_scores_gemma":[0.9970872,0.00047690366,0.0011582378,0.0002711651,0.0001865047,0.0008200582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044732043,0.0007909725,0.0014563404,0.0003195178,0.00055893604,0.0011724884,0.00058917707,0.0013649474,0.002123832],"category_scores_gemma":[0.0026099277,0.00029785422,0.0031297018,0.00043610422,0.0004000083,0.0007556356,0.00057839736,0.0018502595,0.000379168],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78103775,0.00576015,0.14883363,0.0008591524,0.011086506,0.0003124931,0.00018444621,0.00263818,0.003812097,0.0001278682,0.0042516147,0.041096136],"study_design_scores_gemma":[0.16109063,0.14084597,0.67390364,0.00034169457,0.013358212,0.0007149058,0.00012437942,0.002681444,0.0020669675,0.00038953344,0.004359004,0.00012361587],"about_ca_topic_score_codex":0.0010181512,"about_ca_topic_score_gemma":0.001755988,"teacher_disagreement_score":0.0044732043,"about_ca_system_score_codex":0.00073355366,"about_ca_system_score_gemma":0.00067499315,"threshold_uncertainty_score":0.023656905},"labels":[],"label_agreement":null},{"id":"W3173510214","doi":"10.1158/1078-0432.ccr-20-4027","title":"Combined EZH2 Inhibition and IKAROS Degradation Leads to Enhanced Antitumor Activity in Diffuse Large B-cell Lymphoma","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Vector Institute; Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute; Canadian Hematology Society; BC Cancer Foundation; Natural Sciences and Engineering Research Council of Canada; Princess Margaret Cancer Foundation; Leukemia and Lymphoma Society of Canada","keywords":"Lenalidomide; Cancer research; Vorinostat; EZH2; Medicine; Diffuse large B-cell lymphoma; Panobinostat; Epigenetics; Biology; Lymphoma; Immunology; Histone deacetylase; Multiple myeloma; Histone; Genetics; Gene","score_opus":0.08207514444780283,"score_gpt":0.4472204411841452,"score_spread":0.3651452967363424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173510214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995097,0.0016166517,0.0014088153,0.00008765658,0.000019348814,0.000026147081,0.00048227032,0.00017692364,0.0010851813],"genre_scores_gemma":[0.9972709,0.00047375957,0.0007333576,0.00005102423,0.000004272304,0.000020397347,0.00041786194,0.0000138207915,0.0010145378],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998779,0.000013369006,0.000010991101,0.0000302382,0.000039660124,0.000027742628],"domain_scores_gemma":[0.99995947,0.0000059808517,0.000011401476,0.0000052978617,0.0000041625613,0.000013630977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013186557,0.00023787715,0.00033307105,0.00017264331,0.000080300524,0.0002756957,0.0001230638,0.00015722158,0.0011403962],"category_scores_gemma":[0.000077882694,0.00010200072,0.00018787498,0.00012215106,0.00014642374,0.0001100457,0.0001329756,0.0004102249,0.00030214034],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017665682,0.00004189781,0.00039236783,0.000043102074,0.000012454948,0.00003255883,0.000005357552,0.00014118616,0.9965837,0.000024041243,0.00007006493,0.0024765395],"study_design_scores_gemma":[0.000071113835,0.00071103324,0.0065070665,0.0000046390887,0.00004211254,0.0002808026,0.000026126312,0.0011657242,0.9885909,0.000027183602,0.002568997,0.0000043816535],"about_ca_topic_score_codex":0.00033477036,"about_ca_topic_score_gemma":0.0009735655,"teacher_disagreement_score":0.0011403962,"about_ca_system_score_codex":0.00026302005,"about_ca_system_score_gemma":0.0001466887,"threshold_uncertainty_score":0.0038149953},"labels":[],"label_agreement":null},{"id":"W3173578209","doi":"10.1158/1078-0432.ccr-21-0110","title":"Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Head and neck squamous-cell carcinoma; DNA methylation; Methylation; CpG site; Cancer research; Head and neck cancer; Biology; Oncology; Internal medicine; Cancer; DNA; Medicine; Gene; Genetics; Gene expression","score_opus":0.08902114054578578,"score_gpt":0.4266173834050939,"score_spread":0.3375962428593081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173578209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988201,0.00024022609,0.0005616881,0.000012276482,0.000002253317,0.00000817737,0.00020047555,0.0000123837235,0.00014240027],"genre_scores_gemma":[0.9990465,0.000053767188,0.00043703517,0.000016263599,0.0000030147244,0.000007777431,0.00033905884,0.0000028863703,0.000093666975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982125,0.000024780747,0.000012634143,0.00007107334,0.00004793439,0.000022396443],"domain_scores_gemma":[0.9997688,0.000053416163,0.00006577567,0.000024431924,0.000053277476,0.000034357607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023643386,0.00017471302,0.00027579113,0.00041634188,0.00017925531,0.00035191266,0.00018881474,0.0002556001,0.00080436066],"category_scores_gemma":[0.00061580597,0.00014480313,0.00011512302,0.0002748755,0.00019062585,0.00016658398,0.00023195166,0.00022109089,0.00015476631],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001171053,0.00010194103,0.6454259,0.00012197371,0.00011114837,0.00033522735,0.00023672295,0.0007139911,0.33337453,0.0000960796,0.0002560077,0.0180553],"study_design_scores_gemma":[0.000029597426,0.0005592102,0.9134161,0.000010725878,0.00010940459,0.0014413579,0.0002532893,0.005585035,0.0774989,0.00019608345,0.0008864565,0.000013841139],"about_ca_topic_score_codex":0.0016005071,"about_ca_topic_score_gemma":0.0024341515,"teacher_disagreement_score":0.0016005071,"about_ca_system_score_codex":0.0003577314,"about_ca_system_score_gemma":0.00021996094,"threshold_uncertainty_score":0.0031823516},"labels":[],"label_agreement":null},{"id":"W3174618187","doi":"10.1158/1078-0432.ccr-21-0649","title":"A Personalized Mass Spectrometry–Based Assay to Monitor M-Protein in Patients with Multiple Myeloma (EasyM)","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Princess Margaret Cancer Centre; D2L (Canada)","funders":"Canadian Cancer Society Research Institute","keywords":"Multiple myeloma; Cancer; Ideal (ethics); Myeloma protein; Immunopathology","score_opus":0.12011536654454748,"score_gpt":0.46543167783069944,"score_spread":0.345316311286152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174618187","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99222857,0.0014449923,0.004572899,0.00013457575,0.000028719718,0.00010891055,0.0004243629,0.0001240909,0.0009328455],"genre_scores_gemma":[0.99274725,0.00014672507,0.0061243325,0.00021294063,0.0000383935,0.00005383299,0.0003197733,0.0000072506245,0.0003496086],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99921775,0.00021648756,0.00006101248,0.00021548156,0.0002328132,0.000056429093],"domain_scores_gemma":[0.9994349,0.00013634049,0.00020163697,0.00006726865,0.00008963421,0.00007026177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001014313,0.0005325122,0.00049581047,0.0006468025,0.0001807304,0.0004054182,0.00033240553,0.00048654657,0.0007079172],"category_scores_gemma":[0.0012280043,0.00019973409,0.00020027797,0.00031974728,0.00021887475,0.00026299222,0.00041898416,0.0004624528,0.00030591886],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043932367,0.00077737635,0.6421101,0.0002074639,0.00025050162,0.0006180028,0.00015292893,0.0011321027,0.2716274,0.00017286713,0.0012467188,0.07731131],"study_design_scores_gemma":[0.0003993056,0.008915127,0.73525864,0.000031872525,0.00026194192,0.0065441914,0.00009883083,0.01501104,0.22962669,0.000277883,0.0035122093,0.00006224954],"about_ca_topic_score_codex":0.00016477704,"about_ca_topic_score_gemma":0.0003813328,"teacher_disagreement_score":0.001014313,"about_ca_system_score_codex":0.00026574513,"about_ca_system_score_gemma":0.00015368428,"threshold_uncertainty_score":0.005364239},"labels":[],"label_agreement":null},{"id":"W3176956457","doi":"10.1158/1078-0432.ccr-21-0793","title":"Standard-Dose Pembrolizumab Plus Alternate-Dose Ipilimumab in Advanced Melanoma: KEYNOTE-029 Cohort 1C, a Phase 2 Randomized Study of Two Dosing Schedules","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Princess Margaret Cancer Centre","funders":"Merck Sharp and Dohme","keywords":"Ipilimumab; Pembrolizumab; Medicine; Cohort; Regimen; Internal medicine; Adverse effect; Dosing; Melanoma; Incidence (geometry); Gastroenterology; Oncology; Cancer; Immunotherapy","score_opus":0.13851459770828084,"score_gpt":0.5370049475480762,"score_spread":0.3984903498397953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176956457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989781,0.0012445899,0.0004314087,0.00031793496,0.00015973514,0.0049892296,0.0015783074,0.00006855273,0.0014290606],"genre_scores_gemma":[0.9845077,0.0012151719,0.0018290684,0.0008055891,0.00028791302,0.005747162,0.0020065964,0.000033826505,0.0035670442],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99921405,0.00035044528,0.00005559734,0.00017489099,0.00008379359,0.000121210134],"domain_scores_gemma":[0.9987839,0.00016318922,0.00030649846,0.00013925819,0.00008457316,0.00052264193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028115364,0.0018856891,0.0016200438,0.00066297443,0.0005717139,0.0011611875,0.001081976,0.0016134076,0.006252561],"category_scores_gemma":[0.0012185043,0.0009020405,0.0011476941,0.00047588922,0.0011596064,0.0011754245,0.00040895632,0.0037955232,0.0014313877],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8752188,0.078709945,0.0031023188,0.00055726507,0.00067183364,0.0000898157,0.00011956432,0.0008512583,0.014896252,0.00019888098,0.0023759427,0.023208156],"study_design_scores_gemma":[0.71761376,0.27383527,0.0042635966,0.000023981567,0.0003263134,0.00008349421,0.000024268533,0.0004455471,0.0019335042,0.00010711936,0.0013209531,0.000022172682],"about_ca_topic_score_codex":0.00072647544,"about_ca_topic_score_gemma":0.001668223,"teacher_disagreement_score":0.006252561,"about_ca_system_score_codex":0.0013727858,"about_ca_system_score_gemma":0.0017413212,"threshold_uncertainty_score":0.02091688},"labels":[],"label_agreement":null},{"id":"W3180432673","doi":"10.1158/1078-0432.ccr-21-2052","title":"Immune Profiling Mass Cytometry Assay Harmonization: Multicenter Experience from CIMAC-CIDC","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Cancer Institute","keywords":"Mass cytometry; Immune system; Flow cytometry; Harmonization; Profiling (computer programming); Medicine; Immunology; Biology; Computer science","score_opus":0.1634933270471794,"score_gpt":0.46553082141990565,"score_spread":0.30203749437272626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180432673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8499719,0.008755079,0.10802902,0.0039363643,0.0006600458,0.0076342337,0.004207812,0.0022590351,0.014546476],"genre_scores_gemma":[0.8957518,0.0015170426,0.08029786,0.00249908,0.0006730989,0.0036104093,0.012265409,0.0010849453,0.002300439],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.932092,0.03558581,0.003656915,0.010864477,0.0151702035,0.0026306885],"domain_scores_gemma":[0.93722427,0.010097228,0.0053866724,0.018794043,0.024133623,0.004364193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.123765886,0.0017502701,0.001287541,0.0019345429,0.0018078294,0.003233511,0.0052933665,0.002026772,0.0025575527],"category_scores_gemma":[0.056059252,0.000645092,0.0010951202,0.002214249,0.0024842233,0.0013224789,0.0050858073,0.002373183,0.0014815235],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016278833,0.011166204,0.3116877,0.0014716578,0.0024181723,0.0010909582,0.008586265,0.022290718,0.09676454,0.0050431397,0.040785942,0.4824159],"study_design_scores_gemma":[0.0035469953,0.038036183,0.6241109,0.0009284695,0.0014816524,0.0036559803,0.0027265823,0.025064716,0.14848286,0.0021358004,0.14942214,0.0004077483],"about_ca_topic_score_codex":0.0044903285,"about_ca_topic_score_gemma":0.0019533117,"teacher_disagreement_score":0.123765886,"about_ca_system_score_codex":0.003280469,"about_ca_system_score_gemma":0.005949476,"threshold_uncertainty_score":0.65454435},"labels":[],"label_agreement":null},{"id":"W3182408948","doi":"10.1158/1078-0432.ccr-20-4607","title":"Integrative Profiling of T790M-Negative EGFR-Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic Opportunities","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Medical Research Council; Canada Digital Adoption Program; National Research Foundation","keywords":"T790M; Transcriptome; Biology; Cancer research; Exome; EGFR inhibitors; Gene expression profiling; Exome sequencing; Genetics; Gene; Bioinformatics; KRAS; Epidermal growth factor receptor; Mutation; Cancer; Gene expression","score_opus":0.3480102590733958,"score_gpt":0.5620181373188999,"score_spread":0.21400787824550416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182408948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976528,0.00033794504,0.0009557884,0.000032920714,0.0000018961789,0.000010855831,0.0006412522,0.000014054935,0.00035256028],"genre_scores_gemma":[0.99714166,0.00019953909,0.0009006082,0.00004095524,0.0000034340458,0.000016334912,0.0013828566,0.000008294939,0.00030638347],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99993134,0.000008694113,0.0000047471453,0.000023131735,0.000019264464,0.000012774278],"domain_scores_gemma":[0.99992883,0.000017308246,0.00002262572,0.000007239743,0.000012317919,0.000011716226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013383706,0.00012889215,0.00018972048,0.00026404115,0.0001614705,0.0002602306,0.00009717989,0.00016073712,0.00063642225],"category_scores_gemma":[0.00023497829,0.00006824744,0.00017347929,0.00024336252,0.00011778659,0.000111792004,0.00023210939,0.00016310271,0.00019863408],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040856953,0.000033306333,0.09737676,0.0000759957,0.00004035874,0.0002781433,0.000119809236,0.00038985308,0.8886367,0.00011724523,0.00013100573,0.012392147],"study_design_scores_gemma":[0.000017495,0.00037995778,0.87502223,0.000019226158,0.00009262492,0.001813362,0.00032201977,0.004967221,0.11427058,0.0004645047,0.0026203352,0.0000104712],"about_ca_topic_score_codex":0.0005074941,"about_ca_topic_score_gemma":0.0012590027,"teacher_disagreement_score":0.00063642225,"about_ca_system_score_codex":0.00015013416,"about_ca_system_score_gemma":0.00014665346,"threshold_uncertainty_score":0.002129078},"labels":[],"label_agreement":null},{"id":"W3182557860","doi":"10.1158/1078-0432.ccr-21-1509","title":"MRN Complex and Cancer Risk: Old Bottles, New Wine","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre; Jewish General Hospital; McGill University Health Centre; Université de Montréal; Montreal Clinical Research Institute; Université du Québec à Montréal","funders":"Canadian Institutes of Health Research; “la Caixa” Foundation","keywords":"Cancer; Breast cancer; Germline; Gene; PALB2; Germline mutation; Mutation; Haematopoiesis","score_opus":0.20197259521193967,"score_gpt":0.502888515363479,"score_spread":0.30091592015153934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182557860","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002847895,0.85416377,0.00059018226,0.13235326,0.0073406473,0.00000497475,0.00013002398,0.00004092877,0.0025282763],"genre_scores_gemma":[0.03791183,0.87070113,0.0016551239,0.04012586,0.0416771,0.00001859545,0.00016089914,0.00007694439,0.0076725455],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9992787,0.0002489925,0.00007416927,0.00015332567,0.00018229175,0.000062545],"domain_scores_gemma":[0.9961506,0.0024271954,0.0002254613,0.00022825912,0.0005313476,0.00043714655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002634637,0.0006869504,0.0012664667,0.0015609324,0.0009009216,0.005159151,0.00083918724,0.004393719,0.005818095],"category_scores_gemma":[0.005813521,0.00030712754,0.0005659833,0.0017883043,0.003572233,0.0077593504,0.0017076918,0.005794953,0.0011672581],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001528998,0.00020192593,0.020319782,0.0033358652,0.000568586,0.0010089631,0.0014910819,0.00043859385,0.002799243,0.06426509,0.24617633,0.6578655],"study_design_scores_gemma":[0.00009066183,0.00036883028,0.021806672,0.0046994993,0.00038299465,0.002135411,0.0031904553,0.0006724625,0.0007511612,0.16062829,0.8050815,0.0001920653],"about_ca_topic_score_codex":0.00216909,"about_ca_topic_score_gemma":0.003248555,"teacher_disagreement_score":0.005818095,"about_ca_system_score_codex":0.0011244334,"about_ca_system_score_gemma":0.0008123832,"threshold_uncertainty_score":0.01946348},"labels":[],"label_agreement":null},{"id":"W3185088911","doi":"10.1158/1078-0432.ccr-21-2180","title":"Liquid Biopsy Goes Viral: Next-Generation Sequencing to Enhance HPV Detection","year":2021,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Liquid biopsy; DNA sequencing; Biopsy; DNA; Virology; Human papillomavirus; Papillomaviridae; Identification (biology); Medicine; Biology; Computational biology; Cancer; Pathology; Cervical cancer; Genetics; Internal medicine","score_opus":0.46929229180281046,"score_gpt":0.5522497215502418,"score_spread":0.08295742974743131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185088911","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035809365,0.023235574,0.008992146,0.9078071,0.040365838,0.00018897816,0.00015997658,0.0003893031,0.015280111],"genre_scores_gemma":[0.033311453,0.034156214,0.016538916,0.7616017,0.11892299,0.00024616046,0.0002223232,0.00018573656,0.034814443],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977908,0.00072930614,0.00018842869,0.00022169211,0.00090227503,0.00016740873],"domain_scores_gemma":[0.99614114,0.0023876112,0.00016731455,0.00015266509,0.0007618578,0.00038932933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002350294,0.0007510397,0.00075105403,0.0010127047,0.00094159134,0.0016006023,0.0009774407,0.012193851,0.0041426932],"category_scores_gemma":[0.009155574,0.00048291028,0.0009393087,0.0004349656,0.0016648117,0.0023345926,0.0006327822,0.013287446,0.005851833],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034359377,0.00015936357,0.004471082,0.00038513975,0.00005453332,0.018134324,0.00023983589,0.00042011685,0.012217553,0.0045300475,0.770904,0.18814039],"study_design_scores_gemma":[0.00014050922,0.00043361148,0.0034845069,0.0005632713,0.000051768347,0.04181229,0.00028428124,0.0024220499,0.0068692085,0.016732795,0.9271324,0.000073321775],"about_ca_topic_score_codex":0.0015263197,"about_ca_topic_score_gemma":0.0029193328,"teacher_disagreement_score":0.012193851,"about_ca_system_score_codex":0.0018642151,"about_ca_system_score_gemma":0.0008932763,"threshold_uncertainty_score":0.013858736},"labels":[],"label_agreement":null},{"id":"W3185315144","doi":"10.1158/1078-0432.ccr-21-1034","title":"FDA Approval Summary: Osimertinib for Adjuvant Treatment of Surgically Resected Non–Small Cell Lung Cancer, a Collaborative Project Orbis Review","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"","keywords":"Osimertinib; Medicine; Internal medicine; Lung cancer; Oncology; Population; Placebo; non-small cell lung cancer (NSCLC); Cancer; Surgery; Family medicine; Pathology; Adenocarcinoma; Alternative medicine; Environmental health","score_opus":0.20001285098560964,"score_gpt":0.5691318612122892,"score_spread":0.3691190102266796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185315144","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0042308075,0.5699536,0.0021566153,0.09084487,0.035399567,0.0021122782,0.010480401,0.0005960443,0.28422582],"genre_scores_gemma":[0.032227412,0.5432345,0.0040609296,0.0873378,0.018889697,0.0017519334,0.011748844,0.0002250926,0.30052376],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99878556,0.00033685678,0.00011329416,0.00012561743,0.0005371203,0.00010155128],"domain_scores_gemma":[0.99716896,0.0005104571,0.00045656454,0.000069333204,0.001513311,0.00028135141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035617477,0.00073437515,0.0007322235,0.001490468,0.00040522634,0.0017868563,0.0009087182,0.0027339982,0.02466422],"category_scores_gemma":[0.0037646466,0.00018362308,0.0008625293,0.0012758414,0.0004275964,0.0009222716,0.00037278817,0.0019635248,0.01029631],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016359832,0.000049326834,0.00016207351,0.0018587591,0.000038654503,0.000092294766,0.000019040415,0.00007984628,0.0005821124,0.0021776787,0.8143611,0.18041562],"study_design_scores_gemma":[0.00019171386,0.00012697617,0.0010411935,0.0012906189,0.000058268528,0.00012725183,0.00001523244,0.000041691834,0.00016136306,0.00034331187,0.9965953,0.0000070855663],"about_ca_topic_score_codex":0.0026564556,"about_ca_topic_score_gemma":0.0067441915,"teacher_disagreement_score":0.02466422,"about_ca_system_score_codex":0.0015297687,"about_ca_system_score_gemma":0.004218938,"threshold_uncertainty_score":0.082510054},"labels":[],"label_agreement":null},{"id":"W3185777435","doi":"10.1158/1078-0432.ccr-21-0310","title":"Niraparib for Advanced Breast Cancer with Germline <i>BRCA1</i> and <i>BRCA2</i> Mutations: the EORTC 1307-BCG/BIG5–13/TESARO PR-30–50–10-C BRAVO Study","year":2021,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kelowna General Hospital; Institute of Cancer Research","funders":"Daiichi Sankyo Europe; National Cancer Institute; Genentech; Eisai; Cancer Research UK; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; National Cancer Research Institute; GlaxoSmithKline; Celgene; Amgen; University of Texas MD Anderson Cancer Center; Pfizer; MacroGenics; Cancer Research Institute","keywords":"Breast cancer; Oncology; Medicine; Germline; Internal medicine; Cancer; Germline mutation; Mutation; Genetics; Biology; Gene","score_opus":0.22352135960730762,"score_gpt":0.525599806114159,"score_spread":0.3020784465068514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185777435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818808,0.011132969,0.0003668913,0.00049470115,0.00019306414,0.0008614685,0.0011756499,0.0000319988,0.0038625135],"genre_scores_gemma":[0.9911494,0.0028509432,0.0005115897,0.00086586084,0.0001835437,0.00054317905,0.0020601894,0.0000170635,0.001818291],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994154,0.0003404533,0.000024643121,0.00007560554,0.00007176501,0.00007214875],"domain_scores_gemma":[0.99958915,0.00008028453,0.00008675457,0.00005570877,0.000032752592,0.00015531151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015155944,0.0006024316,0.0012025686,0.00016077346,0.000167596,0.00092135766,0.0007134417,0.0006904898,0.0018166872],"category_scores_gemma":[0.00069578725,0.0003271527,0.0010916007,0.00026051633,0.00046835263,0.00034128106,0.00027237707,0.0013300843,0.0004734466],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8226325,0.013990718,0.028443335,0.001560456,0.0037667197,0.00031082527,0.00015352959,0.002234342,0.027424982,0.00049143523,0.0060063507,0.092984885],"study_design_scores_gemma":[0.77023196,0.131515,0.07561494,0.0003059919,0.0034668238,0.0009322628,0.00010666476,0.001634951,0.0035337748,0.0006096206,0.011994128,0.00005396627],"about_ca_topic_score_codex":0.0011038929,"about_ca_topic_score_gemma":0.0035612634,"teacher_disagreement_score":0.0018166872,"about_ca_system_score_codex":0.00056200475,"about_ca_system_score_gemma":0.0008009077,"threshold_uncertainty_score":0.008015335},"labels":[],"label_agreement":null},{"id":"W3186399416","doi":"10.1158/1078-0432.ccr-21-1059","title":"Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Genentech; bluebird bio; Agios Pharmaceuticals; TG Therapeutics; Regeneron Pharmaceuticals; Alexion Pharmaceuticals; Gilead Sciences; Sanofi; Legend Biotech; Celgene; AstraZeneca; Pfizer; Amgen; GlaxoSmithKline; Multiple Myeloma Research Foundation; Foundation for the National Institutes of Health","keywords":"Multiple myeloma; Medicine; Drug; Residual; Intensive care medicine; Minimal residual disease; Disease; Internal medicine; Pharmacology; Computer science","score_opus":0.3248483922535994,"score_gpt":0.5827453539241509,"score_spread":0.25789696167055154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186399416","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005464804,0.2984206,0.03350904,0.38885,0.03449084,0.002659547,0.012591099,0.0022829613,0.2217312],"genre_scores_gemma":[0.23229729,0.37879372,0.12675618,0.10494666,0.060425207,0.007946484,0.03057205,0.0017360374,0.05652644],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9711013,0.015719624,0.0043817814,0.001622366,0.0061682863,0.0010067017],"domain_scores_gemma":[0.91122216,0.032945964,0.012239261,0.008328512,0.024311459,0.010952693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0485017,0.0008182232,0.0030189122,0.0046784016,0.00092399894,0.009201116,0.003410433,0.004302355,0.030124163],"category_scores_gemma":[0.14239347,0.00047223328,0.002204304,0.007431446,0.0024851332,0.008284708,0.0056182514,0.0065550827,0.010921816],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005046807,0.00009675527,0.002490054,0.0024227062,0.0001102091,0.00007307658,0.00008560874,0.00067735754,0.0001947895,0.034314297,0.2648723,0.69415814],"study_design_scores_gemma":[0.00034371397,0.00039615226,0.0069868234,0.00698344,0.00016511862,0.0003117077,0.00017339767,0.00221159,0.00025107592,0.042654786,0.9394424,0.00007992172],"about_ca_topic_score_codex":0.0028802126,"about_ca_topic_score_gemma":0.0034949123,"teacher_disagreement_score":0.0485017,"about_ca_system_score_codex":0.0050294707,"about_ca_system_score_gemma":0.014289817,"threshold_uncertainty_score":0.2565046},"labels":[],"label_agreement":null},{"id":"W3188472626","doi":"10.1158/1078-0432.ccr-21-1497","title":"Single-Agent Ibrutinib for Rituximab-Refractory Waldenström Macroglobulinemia: Final Analysis of the Substudy of the Phase III InnovateTM Trial","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Pharmacyclics","keywords":"Ibrutinib; Medicine; Rituximab; Waldenstrom macroglobulinemia; Internal medicine; Macroglobulinemia; Refractory (planetary science); Gastroenterology; Phases of clinical research; Progression-free survival; Neutropenia; Response Evaluation Criteria in Solid Tumors; Surgery; Clinical trial; Oncology; Lymphoma; Chemotherapy; Leukemia; Chronic lymphocytic leukemia","score_opus":0.4036895078357418,"score_gpt":0.5643537866182178,"score_spread":0.16066427878247597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3188472626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97237474,0.017510073,0.0009978818,0.0007612505,0.00018046338,0.0016189382,0.0033230542,0.000080483085,0.003153119],"genre_scores_gemma":[0.98589385,0.0032518085,0.0011804531,0.00073107687,0.00020771014,0.0012342107,0.0067127068,0.000028693003,0.0007595319],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9986765,0.0008246642,0.00009306378,0.00012895957,0.00014940125,0.00012732789],"domain_scores_gemma":[0.998694,0.00028625297,0.00038427033,0.000178746,0.00016072781,0.0002960099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056251846,0.00066884735,0.0014361584,0.0002512062,0.0003574276,0.001076917,0.00060632674,0.0007027843,0.0014442935],"category_scores_gemma":[0.0020244804,0.00025032205,0.0016793773,0.00044453543,0.00034636472,0.0005156236,0.0003828813,0.0015553042,0.00041858116],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.67060024,0.007611079,0.06644964,0.0036144198,0.022970606,0.00033856177,0.00055158534,0.0025846937,0.030774835,0.00054193573,0.018709555,0.17525283],"study_design_scores_gemma":[0.5500972,0.13488685,0.25694084,0.0005707477,0.019677915,0.0012064001,0.0002478639,0.0025274812,0.009607392,0.0006406596,0.023478372,0.00011823793],"about_ca_topic_score_codex":0.00074938714,"about_ca_topic_score_gemma":0.003337632,"teacher_disagreement_score":0.0056251846,"about_ca_system_score_codex":0.0007447831,"about_ca_system_score_gemma":0.00094301614,"threshold_uncertainty_score":0.029749215},"labels":[],"label_agreement":null},{"id":"W3190925155","doi":"10.1158/1557-3265.adi21-po-070","title":"Abstract PO-070: Bimodality of gene expression in cancer patient tumors as interpretable biomarkers for drug sensitivity","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Pharmacogenomics; Interpretability; Machine learning; Artificial intelligence; Cancer; Medicine; Computational biology; Computer science; Bioinformatics; Internal medicine; Biology; Pharmacology","score_opus":0.18362114788459208,"score_gpt":0.5302001339865907,"score_spread":0.34657898610199867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190925155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6044923,0.0025289264,0.34842697,0.0051092585,0.00025870954,0.0002457583,0.0250338,0.0052220104,0.008682282],"genre_scores_gemma":[0.947164,0.00036184577,0.042254806,0.00032947375,0.000081088176,0.00011398726,0.007016875,0.00014665203,0.0025313634],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9995629,0.00011047375,0.000026314521,0.00013657621,0.00012544214,0.000038230373],"domain_scores_gemma":[0.99795485,0.0013417471,0.00023702222,0.00017520312,0.00019607939,0.000095207615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001586826,0.00048092284,0.0005007536,0.0014013775,0.00025987753,0.0011324681,0.00044478913,0.000556777,0.0028078118],"category_scores_gemma":[0.0043726503,0.00022841172,0.00061001064,0.0009999732,0.00078236486,0.00063737493,0.00066147867,0.0010724866,0.00084613834],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022188653,0.00040772374,0.33019078,0.0006804199,0.00038159362,0.0012480447,0.000555288,0.17117791,0.08744559,0.01333931,0.026194151,0.36616036],"study_design_scores_gemma":[0.000092040624,0.000547935,0.18677795,0.00007059921,0.00014589501,0.0013317056,0.00031349508,0.7140991,0.049128726,0.03363645,0.013708936,0.00014714239],"about_ca_topic_score_codex":0.0016031746,"about_ca_topic_score_gemma":0.0021062403,"teacher_disagreement_score":0.0028078118,"about_ca_system_score_codex":0.00060491316,"about_ca_system_score_gemma":0.00072793075,"threshold_uncertainty_score":0.009393096},"labels":[],"label_agreement":null},{"id":"W3194677003","doi":"10.1158/1078-0432.ccr-20-4504","title":"Angiokines Associated with Targeted Therapy Outcomes in Patients with Non–Clear Cell Renal Cell Carcinoma","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Cancer Research UK; Novartis; Pfizer","keywords":"Renal cell carcinoma; Medicine; Oncology; Targeted therapy; Clear cell renal cell carcinoma; Internal medicine; Cancer","score_opus":0.1068312780066365,"score_gpt":0.4086008308021558,"score_spread":0.3017695527955193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194677003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998931,0.000544529,0.00007437695,0.00005202157,0.0000039347506,0.000011105763,0.00013280574,0.0000024514484,0.00024784304],"genre_scores_gemma":[0.99961936,0.00007205791,0.000051674127,0.000022850576,0.000010576802,0.000006880645,0.00015638217,7.045988e-7,0.000059476504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967825,0.000098533834,0.00003237368,0.00007445474,0.00007097187,0.00004539125],"domain_scores_gemma":[0.99878985,0.00027635807,0.0006300799,0.000046508092,0.00009113792,0.00016609444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052556256,0.00018562461,0.00033478855,0.00022507938,0.00022708211,0.00041271627,0.0001856609,0.0003199339,0.0009487009],"category_scores_gemma":[0.0012820129,0.00008786639,0.00027980199,0.00045028253,0.0002428623,0.00034619222,0.00021961496,0.0004419932,0.00011834128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027797665,0.00012698582,0.9876699,0.00005251536,0.00012215032,0.00010181533,0.0000406342,0.00024973165,0.0017468381,0.00003410386,0.0001557998,0.0069199363],"study_design_scores_gemma":[0.00014935559,0.000899493,0.9965753,0.0000092467335,0.00013320865,0.00041689188,0.000053057684,0.00072588096,0.0005135693,0.00009577564,0.00042330395,0.00000495204],"about_ca_topic_score_codex":0.0007436423,"about_ca_topic_score_gemma":0.0014703815,"teacher_disagreement_score":0.0009487009,"about_ca_system_score_codex":0.00043175413,"about_ca_system_score_gemma":0.0004232696,"threshold_uncertainty_score":0.003173709},"labels":[],"label_agreement":null},{"id":"W3194849531","doi":"10.1158/1078-0432.ccr-21-0573","title":"Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell Lymphoma","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Biology; microRNA; PI3K/AKT/mTOR pathway; Wnt signaling pathway; Cancer research; BCL6; Epigenetics; GATA3; Gene expression profiling; Lymphoma; T cell; Protein kinase B; Signal transduction; Immunology; B cell; Gene expression; Transcription factor; Genetics; Gene","score_opus":0.1145110103807511,"score_gpt":0.4535532877613276,"score_spread":0.33904227738057646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194849531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949705,0.0014201297,0.0016336913,0.000023364415,0.000006899543,0.000030321737,0.0012562049,0.00005515928,0.0006037667],"genre_scores_gemma":[0.9950956,0.00030890026,0.0019506328,0.00004225559,0.0000100306015,0.00006402506,0.002020835,0.000023994333,0.00048370793],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997907,0.000024945683,0.000020490465,0.000087163695,0.00004749795,0.00002910128],"domain_scores_gemma":[0.9998375,0.0000394783,0.00005217301,0.0000182371,0.000030679857,0.000021890864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023032876,0.00014104304,0.00031245194,0.00066621834,0.00017528818,0.0004823614,0.00010692691,0.0002150878,0.0008157989],"category_scores_gemma":[0.00040424598,0.000107862004,0.00017867138,0.00051134685,0.00012520421,0.00011143812,0.00021953015,0.00018386451,0.00023391137],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012814507,0.000053842374,0.09305785,0.00019681598,0.00012933988,0.00024086425,0.00019170894,0.0002465369,0.88654673,0.000082138584,0.0003012772,0.017671395],"study_design_scores_gemma":[0.000066252105,0.0005966865,0.8358456,0.000030513349,0.0004247519,0.0034287118,0.00030695723,0.0027782167,0.15012932,0.00024084002,0.0061310623,0.000021075035],"about_ca_topic_score_codex":0.00023344616,"about_ca_topic_score_gemma":0.00044176975,"teacher_disagreement_score":0.0008157989,"about_ca_system_score_codex":0.00012121965,"about_ca_system_score_gemma":0.00012511422,"threshold_uncertainty_score":0.0027291775},"labels":[],"label_agreement":null},{"id":"W3197412385","doi":"10.1158/1078-0432.ccr-21-1864","title":"Clinical Activity of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumor Harboring Heterogeneous <i>KIT/PDGFRA</i> Mutations in the Phase III INVICTUS Study","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Cancer Institute; U.S. Food and Drug Administration; Deciphera Pharmaceuticals","keywords":"PDGFRA; Medicine; Exon; GiST; Internal medicine; Stromal tumor; Placebo; Tyrosine-kinase inhibitor; Mutation; Oncology; Gastroenterology; Cancer research; Pathology; Stromal cell; Biology; Cancer; Genetics; Gene","score_opus":0.14031149998290443,"score_gpt":0.5113444287207737,"score_spread":0.37103292873786925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197412385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947424,0.0026564952,0.00017766375,0.00014073176,0.000024649602,0.00022142219,0.00046141574,0.000031682153,0.0015435783],"genre_scores_gemma":[0.9971175,0.0007572124,0.00029193598,0.00023441478,0.000039545423,0.00013508943,0.0010224117,0.000007257909,0.00039465967],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997346,0.00013106853,0.000018549998,0.000042540487,0.0000373629,0.000035764377],"domain_scores_gemma":[0.9997073,0.00005494193,0.000096846714,0.000022773873,0.000024528097,0.00009354738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085843465,0.0004451594,0.00096377323,0.00015218851,0.00016390141,0.0005463533,0.0002838238,0.00034835527,0.0010273615],"category_scores_gemma":[0.0005563951,0.00014994074,0.000749805,0.00021369758,0.00024482966,0.0002842842,0.00018302753,0.0010550211,0.00025408954],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4975479,0.014748376,0.104229614,0.0016099447,0.0047435933,0.0005480921,0.00042359214,0.0049643237,0.1053808,0.00038301185,0.009086751,0.2563339],"study_design_scores_gemma":[0.31082895,0.28282896,0.36546692,0.00017530234,0.0038044206,0.0024157958,0.0002651605,0.004762059,0.017004024,0.00067538425,0.011657979,0.00011503495],"about_ca_topic_score_codex":0.00033707346,"about_ca_topic_score_gemma":0.0012541411,"teacher_disagreement_score":0.0010273615,"about_ca_system_score_codex":0.0004631156,"about_ca_system_score_gemma":0.0005291142,"threshold_uncertainty_score":0.004539907},"labels":[],"label_agreement":null},{"id":"W3197498721","doi":"10.1158/1078-0432.ccr-21-0261","title":"Safety and Antitumor Activity of α-PD-L1 Antibody as Monotherapy or in Combination with α-TIM-3 Antibody in Patients with Microsatellite Instability–High/Mismatch Repair–Deficient Tumors","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Eli Lilly and Company","keywords":"Antibody; Cancer; Combination therapy; Microsatellite; Immunotherapy; Clinical trial","score_opus":0.05442876539091771,"score_gpt":0.44188418583987726,"score_spread":0.38745542044895953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197498721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973013,0.0012288393,0.0001910658,0.00011074969,0.00002335231,0.00014012575,0.00012370585,0.000026510608,0.0008544576],"genre_scores_gemma":[0.9983006,0.00038022123,0.00029148848,0.00015630313,0.000039258997,0.00012675111,0.000222661,0.0000050654235,0.0004776664],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997874,0.000091378446,0.000018922528,0.000035163375,0.000022997448,0.000044161694],"domain_scores_gemma":[0.9997379,0.00004649607,0.00006704462,0.000017049217,0.000014144896,0.000117228796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006457093,0.00049946934,0.0008792505,0.00022949882,0.00025341258,0.0004533456,0.00019518257,0.00035023136,0.0014813027],"category_scores_gemma":[0.0005027604,0.00018830161,0.0005445593,0.00017904931,0.00023684134,0.00035605484,0.0001366359,0.0009905702,0.00042005835],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33521134,0.030399468,0.094635636,0.0008484411,0.0015667118,0.0010345847,0.0003808666,0.005124109,0.17843772,0.000275827,0.006112905,0.34597242],"study_design_scores_gemma":[0.1050177,0.73151124,0.116276026,0.00010756424,0.0010919495,0.002973522,0.00014501072,0.0061430517,0.028240701,0.00021513105,0.008235608,0.00004251091],"about_ca_topic_score_codex":0.0002725488,"about_ca_topic_score_gemma":0.0008603607,"teacher_disagreement_score":0.0014813027,"about_ca_system_score_codex":0.0005689215,"about_ca_system_score_gemma":0.0005154447,"threshold_uncertainty_score":0.004955411},"labels":[],"label_agreement":null},{"id":"W3198912637","doi":"10.1158/1078-0432.ccr-21-1466","title":"FDA Approval Summary: Nivolumab in Combination with Ipilimumab for the Treatment of Unresectable Malignant Pleural Mesothelioma","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"U.S. Food and Drug Administration; National Institutes of Health","keywords":"Nivolumab; Ipilimumab; Regimen; Pemetrexed; Carboplatin; Gemcitabine; Chemotherapy regimen; Clinical trial","score_opus":0.17917776392836887,"score_gpt":0.4791178402547532,"score_spread":0.2999400763263843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198912637","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14646412,0.08674134,0.009876743,0.093988374,0.015659373,0.0061043208,0.026244815,0.004245053,0.6106759],"genre_scores_gemma":[0.5108645,0.041070834,0.0131532075,0.077433884,0.011825188,0.0027225127,0.03063881,0.00053079537,0.31176025],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990908,0.00027252513,0.000050410876,0.00011130673,0.00036809896,0.000106805346],"domain_scores_gemma":[0.9985423,0.00026349787,0.0002168533,0.000064560925,0.0005817181,0.00033109882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023357992,0.00056259136,0.00046604595,0.000731655,0.00057388184,0.0011784547,0.0008588527,0.0030169683,0.0161407],"category_scores_gemma":[0.0021200236,0.00022863221,0.000902918,0.0005964416,0.0003957081,0.0005008846,0.00029601666,0.001793518,0.007594123],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034101193,0.00070217066,0.0024764824,0.0011269503,0.00017294099,0.0008093619,0.00011308137,0.00046802138,0.016656006,0.0026599376,0.66643554,0.3049694],"study_design_scores_gemma":[0.0050863656,0.0057020253,0.025609793,0.0010035986,0.00031132667,0.0013245954,0.000054568267,0.0011503329,0.003909968,0.0006347933,0.95516014,0.00005242382],"about_ca_topic_score_codex":0.0020116887,"about_ca_topic_score_gemma":0.0064891516,"teacher_disagreement_score":0.0161407,"about_ca_system_score_codex":0.0009793218,"about_ca_system_score_gemma":0.0020822168,"threshold_uncertainty_score":0.053996027},"labels":[],"label_agreement":null},{"id":"W3198937635","doi":"10.1158/1078-0432.ccr-21-1834","title":"Diagnostic Accuracy of FEC-PET/CT, FDG-PET/CT, and Diffusion-Weighted MRI in Detection of Nodal Metastases in Surgically Treated Endometrial and Cervical Carcinoma","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute","funders":"Medical Research Council; University College London; Barts Health NHS Trust; Cancer Research UK; Engineering and Physical Sciences Research Council; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Royal Marsden NHS Foundation Trust; King's College London; Queen Mary University of London","keywords":"Medicine; Endometrial cancer; Stage (stratigraphy); NODAL; Radiology; Nuclear medicine; Cervical cancer; Prospective cohort study; Neuroradiology; Carcinoma; Diffusion MRI; PET-CT; Cancer; Histology; Positron emission tomography; Magnetic resonance imaging; Internal medicine","score_opus":0.10909551798548808,"score_gpt":0.4453468425651754,"score_spread":0.3362513245796873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198937635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996884,0.00013790686,0.00005244212,0.000008501004,0.0000018456175,0.0000045008087,0.000027539105,0.0000013498653,0.000077550416],"genre_scores_gemma":[0.99981993,0.00002030823,0.00008793296,0.0000049920427,0.0000030518481,0.0000029156897,0.000045807046,4.5586444e-7,0.000014568136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986947,0.0006472355,0.00015760804,0.0002276462,0.00018396853,0.00008881769],"domain_scores_gemma":[0.9952678,0.0024554469,0.0012063055,0.0003673185,0.0003712516,0.00033185427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002266207,0.00028633,0.000261916,0.0006201099,0.0001853457,0.0004869198,0.00041615815,0.0005384591,0.0008913599],"category_scores_gemma":[0.010853434,0.000389233,0.00030093122,0.00023979432,0.00044131267,0.0003234627,0.00037858702,0.00026104742,0.00021111802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005566189,0.000038995542,0.99707484,0.000008446465,0.000033603246,0.000053749576,0.000045537225,0.000054463922,0.0007721593,0.0000048688794,0.00001612769,0.0013405199],"study_design_scores_gemma":[0.000047311067,0.00049936963,0.9966456,0.000010872489,0.000056155484,0.0007397655,0.00014321941,0.0009666615,0.00079764216,0.000017319564,0.00007062093,0.0000055354535],"about_ca_topic_score_codex":0.001078637,"about_ca_topic_score_gemma":0.0017469707,"teacher_disagreement_score":0.002266207,"about_ca_system_score_codex":0.00029332054,"about_ca_system_score_gemma":0.0001905401,"threshold_uncertainty_score":0.011985004},"labels":[],"label_agreement":null},{"id":"W3200301921","doi":"10.1158/1078-0432.ccr-21-1157","title":"Multiomic Analysis Reveals Comprehensive Tumor Heterogeneity and Distinct Immune Subtypes in Multifocal Intrahepatic Cholangiocarcinoma","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"National Science Fund for Distinguished Young Scholars; Natural Science Foundation of Guangdong Province; National Natural Science Foundation of China","keywords":"Epigenome; Immune system; Intrahepatic Cholangiocarcinoma; Genetic heterogeneity; Cancer; Immunotherapy","score_opus":0.17541128769535624,"score_gpt":0.4786505103527479,"score_spread":0.30323922265739167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200301921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980446,0.00029820408,0.001189636,0.000026910257,0.0000014029359,0.0000064737173,0.00028249391,0.0000118507305,0.00013841351],"genre_scores_gemma":[0.9986823,0.00006526697,0.0006951705,0.000021283273,0.0000026659218,0.000012895817,0.00039490638,0.00000596091,0.000119616685],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998324,0.00002650449,0.000015567355,0.000057890575,0.000037792495,0.000029781957],"domain_scores_gemma":[0.9997719,0.000047029196,0.00010325698,0.000025186842,0.0000250358,0.000027633383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023848168,0.00015241986,0.00023111564,0.0007102273,0.0001740416,0.00025432438,0.00011141974,0.00016486835,0.0005820567],"category_scores_gemma":[0.00036808872,0.00010271568,0.00019300566,0.00042424392,0.00017234315,0.00014028522,0.0002973455,0.00019864658,0.00010367076],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008009633,0.000048659636,0.34979752,0.000118078795,0.00017209619,0.00024453687,0.0002666791,0.00075794716,0.63152665,0.0001222193,0.00017874055,0.015965946],"study_design_scores_gemma":[0.00001164254,0.00014380341,0.96950567,0.0000097136235,0.000090873415,0.0008086451,0.0001881984,0.0027179408,0.025547186,0.0002575971,0.00070805877,0.000010800014],"about_ca_topic_score_codex":0.00043162474,"about_ca_topic_score_gemma":0.0009655512,"teacher_disagreement_score":0.0007102273,"about_ca_system_score_codex":0.00017134381,"about_ca_system_score_gemma":0.0001057656,"threshold_uncertainty_score":0.0019472241},"labels":[],"label_agreement":null},{"id":"W3201084964","doi":"10.1158/1078-0432.ccr-21-1504","title":"First-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy; University of Texas MD Anderson Cancer Center; National Cancer Institute; Associazione Italiana per la Ricerca sul Cancro; Ministero della Salute; Eli Lilly and Company","keywords":"Gemcitabine; Pancreatic cancer; Cancer; Phases of clinical research; Receptor; Pancreatic disease; Chemotherapy","score_opus":0.16789559233049986,"score_gpt":0.4950953371301059,"score_spread":0.327199744799606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201084964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99028087,0.0017244945,0.0009473656,0.00038437394,0.0001124584,0.0029503496,0.0014483645,0.00014182032,0.0020097822],"genre_scores_gemma":[0.9852314,0.0013050793,0.0021423914,0.0007964031,0.00016986585,0.00265904,0.0031744775,0.0000586725,0.004462743],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997167,0.00011612497,0.000012547357,0.00005384494,0.000028241977,0.00007252181],"domain_scores_gemma":[0.9995777,0.0000464207,0.000075469274,0.000044050437,0.000037125228,0.00021926488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012369403,0.00157004,0.0014233129,0.00024396517,0.00040191124,0.0008957018,0.0006978964,0.00086060463,0.004323177],"category_scores_gemma":[0.00050906744,0.00053360866,0.0008752713,0.00027098897,0.00071526616,0.0007553732,0.0003175742,0.0028145595,0.0010277492],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43512315,0.17112412,0.01750481,0.0013033813,0.0015855253,0.0005713684,0.0005574897,0.0036437982,0.20284672,0.00056399073,0.013859796,0.15131581],"study_design_scores_gemma":[0.3037765,0.6586601,0.014296858,0.000033601365,0.00043983656,0.00040915914,0.000080588965,0.0014230753,0.0151189715,0.00020821988,0.005522461,0.000030579922],"about_ca_topic_score_codex":0.00086088217,"about_ca_topic_score_gemma":0.0023369484,"teacher_disagreement_score":0.004323177,"about_ca_system_score_codex":0.00091261073,"about_ca_system_score_gemma":0.0017593104,"threshold_uncertainty_score":0.014462471},"labels":[],"label_agreement":null},{"id":"W3201522366","doi":"10.1158/1078-0432.ccr-21-2681","title":"Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma","year":2021,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences","keywords":"Immunotherapy; Clinical trial; Glioblastoma; Medicine; Evasion (ethics); Immunosuppression; Immune system; Immunology; Cancer research; Internal medicine","score_opus":0.7811385410991778,"score_gpt":0.7086286206520389,"score_spread":0.07250992044713889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201522366","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004104626,0.9631401,0.0136041315,0.016369874,0.0011175757,0.0013507367,0.00008341912,0.000058758607,0.00386493],"genre_scores_gemma":[0.011323974,0.90871763,0.059014477,0.012899521,0.0015593371,0.0049042488,0.00017950975,0.000044885222,0.0013564808],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98498523,0.0114560975,0.0014300095,0.0005653853,0.001293035,0.00027023372],"domain_scores_gemma":[0.9772397,0.01857564,0.0014478914,0.00045655784,0.0016142802,0.0006658398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.033119693,0.001387113,0.0040993295,0.0026372683,0.00051821186,0.004124805,0.0029927364,0.0046713618,0.0025139805],"category_scores_gemma":[0.029539192,0.0006773256,0.0020932558,0.0016171049,0.0025671916,0.0037339441,0.0024185702,0.006465324,0.001152133],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006687972,0.00020292448,0.00035287967,0.048143044,0.0006105698,0.0002963448,0.0003271344,0.0028363238,0.001409468,0.10552201,0.021981614,0.81764895],"study_design_scores_gemma":[0.0016448218,0.0018189597,0.0010328323,0.10636234,0.0014793463,0.0010335078,0.0004602675,0.0024650046,0.00081624015,0.14841467,0.7343592,0.00011281169],"about_ca_topic_score_codex":0.00079306494,"about_ca_topic_score_gemma":0.0016867011,"teacher_disagreement_score":0.033119693,"about_ca_system_score_codex":0.0029216032,"about_ca_system_score_gemma":0.009695094,"threshold_uncertainty_score":0.17515576},"labels":[],"label_agreement":null},{"id":"W3202236569","doi":"10.1158/1078-0432.ccr-21-1181","title":"Phase I/IIa Trial of BMS-986148, an Anti-mesothelin Antibody–drug Conjugate, Alone or in Combination with Nivolumab in Patients with Advanced Solid Tumors","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Princess Margaret Cancer Centre","funders":"Ono Pharmaceutical; Università degli Studi di Milano; Bristol-Myers Squibb","keywords":"Nivolumab; Maximum tolerated dose; Clinical trial; Solid tumor; Immunotherapy; Phases of clinical research; Cytotoxic T cell","score_opus":0.14198669748668777,"score_gpt":0.559179952943152,"score_spread":0.41719325545646424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202236569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99297464,0.0030938569,0.00027545006,0.00024848388,0.00013600197,0.0010853031,0.0004182389,0.000072999675,0.0016950796],"genre_scores_gemma":[0.99246335,0.0019858105,0.0008082107,0.00044677095,0.00018828253,0.00080193684,0.001131231,0.000018953742,0.0021555428],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997793,0.00010442322,0.000014533033,0.000039635604,0.000021632672,0.000040469375],"domain_scores_gemma":[0.99970704,0.000037207268,0.00007223295,0.000022224554,0.000018054998,0.00014319224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010101704,0.0013750317,0.0014339548,0.00026672368,0.0002889272,0.0007238994,0.00056622154,0.00083363295,0.0026111954],"category_scores_gemma":[0.00041297838,0.00048794132,0.0009551448,0.000305681,0.000655057,0.0005277565,0.00021998337,0.001989847,0.00084917725],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7404884,0.040198006,0.0066493833,0.0013245075,0.0012033458,0.0002649024,0.00021761357,0.002360571,0.094733275,0.00024553228,0.0037154881,0.10859907],"study_design_scores_gemma":[0.5006267,0.47466275,0.013566478,0.000046033492,0.00048541994,0.00029082192,0.00004615156,0.0011586219,0.0062866644,0.000115341005,0.0026907804,0.00002421015],"about_ca_topic_score_codex":0.0006010876,"about_ca_topic_score_gemma":0.0019004723,"teacher_disagreement_score":0.0026111954,"about_ca_system_score_codex":0.0006629005,"about_ca_system_score_gemma":0.00097554235,"threshold_uncertainty_score":0.008735299},"labels":[],"label_agreement":null},{"id":"W3202714042","doi":"10.1158/1078-0432.ccr-19-2384","title":"HPV Sequencing Facilitates Ultrasensitive Detection of HPV Circulating Tumor DNA","year":2021,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; Sunnybrook Health Science Centre","funders":"University of Toronto; Princess Margaret Cancer Foundation; Cancer Research Society; Conquer Cancer Foundation","keywords":"Digital polymerase chain reaction; Genotyping; Oncology; Medicine; Internal medicine; Cancer; Cervical cancer; DNA sequencing; Liquid biopsy; DNA; Genotype; Polymerase chain reaction; Biology; Gene; Genetics","score_opus":0.15038175896277925,"score_gpt":0.4312074346837192,"score_spread":0.28082567572093997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202714042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90266204,0.004698845,0.08638212,0.00045402913,0.00015097867,0.0003112552,0.0024892995,0.0006173883,0.0022339614],"genre_scores_gemma":[0.9510794,0.0014234097,0.04339257,0.0003567634,0.000068614165,0.00022011505,0.0017720634,0.00007783208,0.0016092369],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99920005,0.00027037275,0.00003944432,0.0002263569,0.00020243767,0.000061365834],"domain_scores_gemma":[0.99896836,0.0004628694,0.00022502673,0.000107487256,0.00017913169,0.00005706232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010633897,0.00044304904,0.00033801893,0.00039169475,0.00015057114,0.0005395596,0.00035055855,0.00049330137,0.0023302885],"category_scores_gemma":[0.0019839883,0.00028938425,0.0002904642,0.0002093303,0.000319294,0.0004412958,0.00039196236,0.0005938638,0.00050805457],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009332713,0.00024448792,0.022061711,0.0003637035,0.000056515066,0.000049204315,0.000076590695,0.0012013913,0.9380172,0.000253752,0.00045898755,0.036283225],"study_design_scores_gemma":[0.00009967742,0.0023931093,0.033829197,0.00005986012,0.00014447774,0.0007483761,0.000065749184,0.015226378,0.94102013,0.0005315868,0.0058538434,0.00002757306],"about_ca_topic_score_codex":0.0004849117,"about_ca_topic_score_gemma":0.00094776705,"teacher_disagreement_score":0.0023302885,"about_ca_system_score_codex":0.00031611335,"about_ca_system_score_gemma":0.0004435054,"threshold_uncertainty_score":0.007795632},"labels":[],"label_agreement":null},{"id":"W3202810469","doi":"10.1158/1078-0432.ccr-21-1942","title":"Predictive Significance of an Optimized Panel for Basal-like Breast Cancer: Results from the Canadian Cancer Trials Group MA.5 and MA.12 Phase III Clinical Trials","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Centre for Advancing Health Outcomes; McMaster University Medical Centre; Queen's University; University of British Columbia","funders":"Canadian Cancer Society","keywords":"Breast cancer; Tamoxifen; Anthracycline; Internal medicine; Basal (medicine); Oncology; Medicine; Nestin; Placebo; Chemotherapy; Cancer; Tissue microarray; Biology; Pathology","score_opus":0.41819848585384484,"score_gpt":0.5558475683230675,"score_spread":0.13764908246922264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202810469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9220258,0.049734134,0.0023251933,0.0046272916,0.00025610678,0.0023339563,0.010301947,0.00019768026,0.008197992],"genre_scores_gemma":[0.98684514,0.002482787,0.0020763532,0.0012727323,0.0001631627,0.00096772943,0.0052605057,0.000029998608,0.0009015866],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99265,0.005135667,0.00029015937,0.0006142316,0.0009357076,0.0003742941],"domain_scores_gemma":[0.989461,0.0046921396,0.0024634139,0.0008082783,0.0014644895,0.001110554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014931921,0.0013056011,0.0022709689,0.0003697015,0.00050271896,0.0012152593,0.0011359703,0.001225969,0.0016142774],"category_scores_gemma":[0.018236408,0.00031289877,0.0021419912,0.00086386094,0.0007078713,0.0006626103,0.00049307477,0.001665786,0.00023651413],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7381083,0.0012372396,0.10121225,0.0021435155,0.019074285,0.00008936527,0.0002495032,0.0067829797,0.0054283715,0.00080953643,0.015391804,0.10947292],"study_design_scores_gemma":[0.25038788,0.06900184,0.6112103,0.0007476426,0.028277561,0.00031547595,0.00016640834,0.0126541685,0.0028591917,0.0013699929,0.022730328,0.0002792511],"about_ca_topic_score_codex":0.056873992,"about_ca_topic_score_gemma":0.13014388,"teacher_disagreement_score":0.056873992,"about_ca_system_score_codex":0.0038652376,"about_ca_system_score_gemma":0.005016923,"threshold_uncertainty_score":0.113085866},"labels":[],"label_agreement":null},{"id":"W3204661301","doi":"10.1158/1078-0432.ccr-21-2160","title":"First-in-Class Anti-immunoglobulin–like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"Merck","keywords":"Pembrolizumab; Immunotherapy; Antibody; Mechanism (biology); Cancer; Mechanism of action; Inflammation; Tumor cells","score_opus":0.058578049202519425,"score_gpt":0.41581195227931544,"score_spread":0.35723390307679603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204661301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985683,0.00067063037,0.00018961007,0.00007275636,0.000015798843,0.00011553529,0.00005614616,0.000020602294,0.00029041857],"genre_scores_gemma":[0.998429,0.00043844062,0.00040716978,0.00006214776,0.00003177865,0.00008521384,0.00015634065,0.0000051682905,0.00038462662],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997646,0.0000984718,0.0000148297895,0.00003183728,0.000032879496,0.000057371028],"domain_scores_gemma":[0.9997899,0.000037031474,0.000058659025,0.000023571454,0.000014485118,0.000076301556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006740096,0.0007012098,0.0010461609,0.0002096235,0.00020574653,0.00038826,0.00041156786,0.00036253943,0.0014375759],"category_scores_gemma":[0.00031208902,0.000247235,0.000379613,0.00017550342,0.00047449954,0.00036747218,0.00019147182,0.001484268,0.00039145863],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11148756,0.056822315,0.0240363,0.001077677,0.0008015565,0.00069205824,0.00045224305,0.0037830942,0.6218228,0.00033716517,0.0028599247,0.17582746],"study_design_scores_gemma":[0.072118655,0.70713615,0.08008467,0.00005766766,0.000653136,0.0027293793,0.00013148584,0.0048106695,0.12507112,0.00020349819,0.0069658333,0.00003772712],"about_ca_topic_score_codex":0.00039733484,"about_ca_topic_score_gemma":0.001051138,"teacher_disagreement_score":0.0014375759,"about_ca_system_score_codex":0.0006231943,"about_ca_system_score_gemma":0.00065714587,"threshold_uncertainty_score":0.004809141},"labels":[],"label_agreement":null},{"id":"W3207287416","doi":"10.1158/1078-0432.ccr-21-0158","title":"Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: An Open-Label, Four-Arm, Phase II Study","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Carboplatin; Chemotherapy; Toxicity; Phases of clinical research; Combination chemotherapy","score_opus":0.247773716913073,"score_gpt":0.5161284923830547,"score_spread":0.26835477546998165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207287416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99707127,0.001257288,0.00017450114,0.00012207495,0.0000547453,0.000751258,0.00018749182,0.00003110408,0.00035011437],"genre_scores_gemma":[0.9948242,0.0012899794,0.0010374472,0.0003441692,0.00014777188,0.0008589834,0.00050803105,0.0000112851,0.0009781126],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99948585,0.00025479493,0.000042707437,0.00008461154,0.000059538186,0.00007245973],"domain_scores_gemma":[0.99925536,0.00012420003,0.00022961912,0.00006867393,0.000050653598,0.0002714693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001377135,0.0009376554,0.0020909163,0.00047566203,0.00030746858,0.0007566563,0.00071223045,0.00082571816,0.0025169333],"category_scores_gemma":[0.0009650117,0.00054546556,0.0011731102,0.00044338178,0.00066097704,0.00089484797,0.00030638793,0.0020381564,0.00044970022],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6392008,0.1405549,0.019202827,0.0014470458,0.00210656,0.00022253633,0.00027835526,0.0019890736,0.05084766,0.00009987692,0.0014995087,0.14255075],"study_design_scores_gemma":[0.3430711,0.633523,0.016074385,0.000031825617,0.00053734274,0.00022981851,0.00005582487,0.0009919581,0.0035532415,0.00006962295,0.001837309,0.000024588548],"about_ca_topic_score_codex":0.00056979305,"about_ca_topic_score_gemma":0.0017405977,"teacher_disagreement_score":0.0025169333,"about_ca_system_score_codex":0.00067405787,"about_ca_system_score_gemma":0.0011522406,"threshold_uncertainty_score":0.008419931},"labels":[],"label_agreement":null},{"id":"W3207996654","doi":"10.1158/1078-0432.ccr-21-0299","title":"Single-Cell Analysis Reveals EP4 as a Target for Restoring T-Cell Infiltration and Sensitizing Prostate Cancer to Immunotherapy","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Fundamental Research Funds for the Central Universities; National Key Research and Development Program of China; East China Normal University; China Postdoctoral Science Foundation; Chinese Academy of Sciences; Government of Jiangxi Province; Shanghai Municipal Education Commission; National Natural Science Foundation of China","keywords":"Prostate cancer; Immunotherapy; Prostate; Immune system; Infiltration (HVAC); Tumor microenvironment; Cancer immunotherapy","score_opus":0.1351798117403934,"score_gpt":0.46384618897005325,"score_spread":0.32866637722965986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207996654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98321366,0.0013459848,0.013156838,0.00010477158,0.00003535692,0.000043957436,0.0011962833,0.00013564074,0.00076745456],"genre_scores_gemma":[0.9894154,0.00079526653,0.0059382324,0.000076228345,0.00001639887,0.00006793695,0.0013964946,0.000026137956,0.002268051],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999391,0.000007365605,0.0000046847663,0.000015527456,0.000021224325,0.000012172087],"domain_scores_gemma":[0.9999542,0.000010274518,0.000011774491,0.0000058734922,0.000009568523,0.000008339672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001073029,0.00020445406,0.00024323052,0.00019010075,0.000091871334,0.0002302124,0.00014799516,0.0001890547,0.0013877851],"category_scores_gemma":[0.000094052666,0.0000757589,0.00019264052,0.00012981798,0.00013719311,0.00012487845,0.00013135844,0.0005133983,0.00032813975],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007035023,0.000010898359,0.000344564,0.000025408044,0.000004729435,0.000021974678,0.0000028799393,0.00012967763,0.9980057,0.000025475763,0.000042656877,0.0013157482],"study_design_scores_gemma":[0.000014104866,0.00026704412,0.009357995,0.0000036916456,0.000027961,0.00015201299,0.000021247299,0.0031746514,0.9853234,0.000069128546,0.0015847452,0.0000039375504],"about_ca_topic_score_codex":0.00017334172,"about_ca_topic_score_gemma":0.00025740935,"teacher_disagreement_score":0.0013877851,"about_ca_system_score_codex":0.00014966134,"about_ca_system_score_gemma":0.00015471644,"threshold_uncertainty_score":0.004642546},"labels":[],"label_agreement":null},{"id":"W3209155643","doi":"10.1158/1078-0432.ccr-21-2057","title":"Clinically Tractable Outcome Prediction of Non-WNT/Non-SHH Medulloblastoma Based on TPD52 IHC in a Multicohort Study","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Canada's Michael Smith Genome Sciences Centre; Children's & Women's Health Centre of British Columbia; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; University of British Columbia; Russian Science Foundation; Hannah's Heroes Foundation; Stand Up To Cancer; Killam Trusts; Entertainment Industry Foundation; St. Baldrick's Foundation; American Association for Cancer Research","keywords":"Medulloblastoma; Risk stratification; Immunohistochemistry; Outcome (game theory); Profiling (computer programming)","score_opus":0.26778158282489006,"score_gpt":0.5644021618732276,"score_spread":0.2966205790483375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209155643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99899393,0.00013975396,0.00048777112,0.00001835969,0.0000062511463,0.0000160772,0.00022585593,0.0000052426603,0.00010682565],"genre_scores_gemma":[0.99908984,0.000036236113,0.00028957933,0.000016916492,0.000006178405,0.000015213789,0.00046845397,0.000004624129,0.00007284568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99942243,0.00018510626,0.000040323815,0.00022251975,0.000075500946,0.00005410934],"domain_scores_gemma":[0.99906963,0.00017185825,0.00025971336,0.0002668447,0.00011240598,0.00011945338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017757178,0.00035836588,0.00036343362,0.00058843265,0.0004043119,0.00066634757,0.00033594147,0.0002821005,0.0009647057],"category_scores_gemma":[0.0020080397,0.00022049995,0.0005660429,0.00032309533,0.0003813539,0.00033240457,0.0006604396,0.00037140565,0.0002152817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001391061,0.00014084284,0.98337674,0.000026681242,0.00039239164,0.0002078303,0.00014260747,0.00031734855,0.008788721,0.00006395622,0.00029091368,0.0048608277],"study_design_scores_gemma":[0.00007322042,0.0008302399,0.9893469,0.000015606844,0.00042650953,0.0009729115,0.00034473286,0.0035546802,0.0030572603,0.00030969037,0.0010524362,0.000015866044],"about_ca_topic_score_codex":0.0012206138,"about_ca_topic_score_gemma":0.0019432461,"teacher_disagreement_score":0.0017757178,"about_ca_system_score_codex":0.00037184544,"about_ca_system_score_gemma":0.00031715422,"threshold_uncertainty_score":0.00939095},"labels":[],"label_agreement":null},{"id":"W3211458171","doi":"10.1158/1078-0432.ccr-21-1688","title":"Association of Neutrophil-to-Lymphocyte Ratio with Efficacy of First-Line Avelumab plus Axitinib vs. Sunitinib in Patients with Advanced Renal Cell Carcinoma Enrolled in the Phase 3 JAVELIN Renal 101 Trial","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"National Cancer Institute; Merck KGaA; Pfizer","keywords":"Medicine; Avelumab; Axitinib; Sunitinib; Internal medicine; Renal cell carcinoma; Renal carcinoma; Oncology; Lymphocyte; Gastroenterology; Urology; Nivolumab; Immunotherapy; Cancer","score_opus":0.08944128772444122,"score_gpt":0.41519119164430157,"score_spread":0.32574990391986036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211458171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99620736,0.0026829075,0.00012759886,0.00014979235,0.00004541372,0.000082616985,0.00020512022,0.000015954354,0.00048327373],"genre_scores_gemma":[0.99877685,0.00030862313,0.00010831345,0.00012756322,0.000053364183,0.00006956484,0.0003132119,0.0000029179469,0.0002396617],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9992048,0.0004650916,0.00005796314,0.000113789334,0.00008183434,0.00007644323],"domain_scores_gemma":[0.99883217,0.0003625209,0.00040590134,0.00008041807,0.000048266556,0.0002707319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023645542,0.0003739829,0.0010817369,0.00013304979,0.0001667351,0.00077951903,0.00039262278,0.0004715464,0.0010777881],"category_scores_gemma":[0.0017480438,0.00016299792,0.0011011914,0.00015094662,0.00028392533,0.0005591726,0.00023730447,0.0014270548,0.00017137517],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77903634,0.00608477,0.10973748,0.0007107245,0.0050730337,0.000121098696,0.000105249,0.002821181,0.011436052,0.0001982683,0.0022268086,0.082449],"study_design_scores_gemma":[0.18906751,0.30511257,0.47351885,0.00012987407,0.005326998,0.0009525456,0.00013830441,0.011339778,0.008104387,0.0008236228,0.0053953985,0.000090230154],"about_ca_topic_score_codex":0.00022944938,"about_ca_topic_score_gemma":0.00069571857,"teacher_disagreement_score":0.0023645542,"about_ca_system_score_codex":0.0004848761,"about_ca_system_score_gemma":0.00055684365,"threshold_uncertainty_score":0.012505114},"labels":[],"label_agreement":null},{"id":"W4200069316","doi":"10.1158/1078-0432.ccr-21-3032","title":"Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2− Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":263,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute; Novartis Institutes for BioMedical Research; Astex Pharmaceuticals; Novartis Pharmaceuticals Corporation","keywords":"Overall survival; Randomized controlled trial; Endocrine system; Clinical trial; Breast cancer; Cancer","score_opus":0.12727510173342405,"score_gpt":0.5170188085085538,"score_spread":0.3897437067751297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200069316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99337476,0.0031496515,0.00019530294,0.0004837952,0.00016476423,0.00060699077,0.0005821026,0.00003680323,0.0014059211],"genre_scores_gemma":[0.9950329,0.0010374205,0.00034554725,0.00052752555,0.00016978264,0.0007695759,0.0008775164,0.000006467016,0.001233301],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99942833,0.00036260995,0.000026366539,0.00007192174,0.000041428677,0.00006934089],"domain_scores_gemma":[0.99924004,0.00017214743,0.0002157537,0.000058506455,0.00004318705,0.00027030852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020969722,0.00091283943,0.0014173446,0.0003088082,0.00023853217,0.00083038607,0.00064613094,0.0008835164,0.003663047],"category_scores_gemma":[0.0014759275,0.00026591317,0.0020542673,0.0002472925,0.0005991708,0.00046617945,0.00039489247,0.0020229935,0.00045925073],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96949077,0.004373324,0.0026512512,0.00039083665,0.0014466791,0.00003769629,0.000042370713,0.0005360792,0.0024505793,0.000092029506,0.0007520745,0.017736312],"study_design_scores_gemma":[0.8416811,0.13783427,0.014587309,0.000075498036,0.0022950012,0.000099417804,0.000043675245,0.001031273,0.0008389566,0.00020045637,0.0012892385,0.000023793194],"about_ca_topic_score_codex":0.0006569505,"about_ca_topic_score_gemma":0.002648399,"teacher_disagreement_score":0.003663047,"about_ca_system_score_codex":0.00069677393,"about_ca_system_score_gemma":0.0010716149,"threshold_uncertainty_score":0.012254059},"labels":[],"label_agreement":null},{"id":"W4200169768","doi":"10.1158/1078-0432.ccr-21-3762","title":"Detecting Neuroendocrine Prostate Cancer Through Tissue-Informed Cell-Free DNA Methylation Analysis","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"National Cancer Institute; U.S. Department of Defense","keywords":"Prostate cancer; DNA methylation; Methylation; DNA; Prostate; PCA3; Cancer","score_opus":0.2299962849316558,"score_gpt":0.5587790777569874,"score_spread":0.3287827928253316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200169768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9136296,0.0018368191,0.08001153,0.00026737992,0.000022805603,0.00008314994,0.0025262749,0.0005033435,0.0011190717],"genre_scores_gemma":[0.97555274,0.0004092442,0.02189708,0.000111840614,0.000016677199,0.000047421054,0.0013566397,0.000019150266,0.0005892954],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99976295,0.00004668233,0.000009893726,0.00009864693,0.00006775115,0.000014136619],"domain_scores_gemma":[0.9996393,0.00013475264,0.00011158269,0.000045092038,0.000047322075,0.000022015476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044629112,0.00038662247,0.0003414804,0.0004246394,0.00012191124,0.00035644407,0.00034213244,0.0003242228,0.00066604343],"category_scores_gemma":[0.0011390353,0.00025287172,0.00030023284,0.00020136136,0.00021997497,0.00022526273,0.0003984652,0.00044152327,0.00022934593],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087308267,0.00014171495,0.34603447,0.0003323078,0.0004277465,0.00028418127,0.00012436854,0.0253548,0.5484994,0.00052907993,0.00064505683,0.07675372],"study_design_scores_gemma":[0.00008539499,0.0008999373,0.32323524,0.00006445951,0.00038143754,0.0019743585,0.00014337976,0.29667044,0.3690556,0.0024427616,0.0049423394,0.000104648876],"about_ca_topic_score_codex":0.0012517071,"about_ca_topic_score_gemma":0.0036464233,"teacher_disagreement_score":0.0012517071,"about_ca_system_score_codex":0.00026458903,"about_ca_system_score_gemma":0.00028807094,"threshold_uncertainty_score":0.0024888515},"labels":[],"label_agreement":null},{"id":"W4200186763","doi":"10.1158/1078-0432.ccr-21-3329","title":"Transcriptomic Determinants of Response to Pembrolizumab Monotherapy across Solid Tumor Types","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Merck Sharp and Dohme; Merck","keywords":"Pembrolizumab; Biology; Cancer research; Oncology; Angiogenesis; Internal medicine; Cancer; Medicine; Immunotherapy; Genetics","score_opus":0.2046272144022776,"score_gpt":0.5705772446636609,"score_spread":0.3659500302613833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200186763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987607,0.00021585388,0.00024683494,0.000016822463,0.0000013880057,0.000008635555,0.0005804088,0.0000043562654,0.00016503298],"genre_scores_gemma":[0.9986135,0.000081292514,0.00021752516,0.00002067162,0.0000033486713,0.000020790876,0.0009305543,0.0000031111738,0.00010923883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967337,0.000083273844,0.000025539928,0.00010152221,0.000068191104,0.00004813687],"domain_scores_gemma":[0.99928963,0.00024862197,0.00028320018,0.000059742153,0.00006792695,0.00005091066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043912802,0.00013156363,0.00030850922,0.00035993167,0.00013605566,0.00028037533,0.000097261,0.00016712333,0.0011304762],"category_scores_gemma":[0.0011861258,0.000082071325,0.00020138612,0.00047721385,0.00021326808,0.00014765363,0.00015872836,0.00019878111,0.000174107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003179731,0.00011733133,0.8469384,0.000103365564,0.0003207313,0.0001123737,0.00012472786,0.0010252513,0.13214932,0.000066600674,0.00017898537,0.015683241],"study_design_scores_gemma":[0.000031849377,0.0003910726,0.99190336,0.000004762547,0.00008611699,0.00026694915,0.000078312005,0.0010924423,0.0057725124,0.000056324578,0.00031193125,0.00000440147],"about_ca_topic_score_codex":0.0007763528,"about_ca_topic_score_gemma":0.0011938876,"teacher_disagreement_score":0.0011304762,"about_ca_system_score_codex":0.00023471628,"about_ca_system_score_gemma":0.0002064593,"threshold_uncertainty_score":0.0037817955},"labels":[],"label_agreement":null},{"id":"W4200296775","doi":"10.1158/1078-0432.ccr-21-1798","title":"ImmunoPET of Ovarian and Pancreatic Cancer with AR9.6, a Novel MUC16-Targeted Therapeutic Antibody","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NorQuest College","funders":"National Institute of Biomedical Imaging and Bioengineering; National Cancer Institute; NIH Clinical Center; National Institutes of Health","keywords":"Pancreatic cancer; Ovarian cancer; Medicine; Antibody; Cancer; Cancer research; Radioimmunotherapy; Oncology; Internal medicine; Immunology; Monoclonal antibody","score_opus":0.11579354080471728,"score_gpt":0.4892384749472916,"score_spread":0.37344493414257435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200296775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98639226,0.0036539102,0.0062778746,0.00021024876,0.000047522903,0.00013144629,0.00021407314,0.00013947977,0.002933268],"genre_scores_gemma":[0.98781514,0.0020925798,0.00718355,0.000095517404,0.000017902437,0.00005421241,0.00035675266,0.000017373592,0.0023670022],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999851,0.00002672749,0.000011340014,0.00002958661,0.00004674895,0.000034676556],"domain_scores_gemma":[0.9999256,0.000010085385,0.00002888372,0.00001229122,0.0000103641905,0.000012809179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023822283,0.0003420196,0.0002380607,0.0001663827,0.00008653388,0.00024011802,0.00029961436,0.00033367585,0.00097536243],"category_scores_gemma":[0.00014264035,0.00014034555,0.00031303425,0.000118390155,0.0001540653,0.00019204173,0.00017805539,0.00054395705,0.00042089348],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014761684,0.00009778628,0.00026754235,0.000068479574,0.00000957609,0.000079306206,0.000009558937,0.000184667,0.99483585,0.000111652334,0.00006634635,0.004121535],"study_design_scores_gemma":[0.00009810761,0.0025573308,0.0029876693,0.000011356595,0.00004844799,0.0014097549,0.0000138425885,0.0015928157,0.9849414,0.000044696742,0.006289647,0.0000049161654],"about_ca_topic_score_codex":0.0002968982,"about_ca_topic_score_gemma":0.0003405613,"teacher_disagreement_score":0.00097536243,"about_ca_system_score_codex":0.00031462716,"about_ca_system_score_gemma":0.00023086985,"threshold_uncertainty_score":0.003262937},"labels":[],"label_agreement":null},{"id":"W4200388798","doi":"10.1158/1078-0432.ccr-21-1090","title":"The Effect of Corticosteroids on Prostate Cancer Outcome Following Treatment with Enzalutamide: A Multivariate Analysis of the Phase III AFFIRM Trial","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Astellas Pharma; National Institute for Health and Care Research; Prostate Cancer Foundation of Australia; Pfizer; National Cancer Institute; National Institutes of Health; Conquer Cancer Foundation; Prostate Cancer Foundation","keywords":"Enzalutamide; Prostate cancer; Multivariate analysis; Clinical trial; Outcome (game theory); Cancer; Phases of clinical research","score_opus":0.19438336259119904,"score_gpt":0.5706155863813225,"score_spread":0.37623222379012344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200388798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99590886,0.0027610706,0.00020930768,0.00023367134,0.000041973108,0.000052036547,0.0004297284,0.000014188524,0.00034902434],"genre_scores_gemma":[0.9984856,0.000423741,0.00017466086,0.00007982195,0.00006998555,0.000048098478,0.00043740985,0.0000072140942,0.00027352019],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99712425,0.0021740522,0.00011487526,0.0002502938,0.00017385095,0.00016261567],"domain_scores_gemma":[0.9939389,0.002862885,0.0017967919,0.00065937836,0.00019312689,0.00054896454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069792187,0.00085640204,0.0020499064,0.00021099349,0.00024857966,0.0009315529,0.00057996425,0.00046395735,0.0019008043],"category_scores_gemma":[0.005497848,0.00021682895,0.003676477,0.0003641038,0.0004414128,0.0005278587,0.0005429633,0.0012675058,0.00014973486],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6923662,0.0011391202,0.24785657,0.00047103746,0.024391957,0.00014791675,0.00007603624,0.0021197952,0.0027071927,0.00015805595,0.001501026,0.027065175],"study_design_scores_gemma":[0.05983213,0.056252856,0.8257848,0.00015592613,0.035913587,0.00044258917,0.00019646052,0.014667126,0.0027670388,0.0007806779,0.003095048,0.00011162555],"about_ca_topic_score_codex":0.0010511897,"about_ca_topic_score_gemma":0.0019613535,"teacher_disagreement_score":0.0069792187,"about_ca_system_score_codex":0.0004865582,"about_ca_system_score_gemma":0.0011048997,"threshold_uncertainty_score":0.036910057},"labels":[],"label_agreement":null},{"id":"W4200437646","doi":"10.1158/1078-0432.ccr-21-3238","title":"From Basic Science to Clinical Translation in Kidney Cancer: A Report from the Second Kidney Cancer Research Summit","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Summit; Kidney cancer; Renal cell carcinoma; Translational research; Kidney; Basic research; Cancer; Kidney disease","score_opus":0.42649645808653047,"score_gpt":0.5751800096660913,"score_spread":0.1486835515795608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200437646","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028708878,0.22635493,0.0015323773,0.6696771,0.08565859,0.00014028099,0.00071215146,0.00015155193,0.012902165],"genre_scores_gemma":[0.053284287,0.5023224,0.0048988205,0.2808315,0.11455848,0.00063826767,0.002790296,0.00038870488,0.04028732],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9907258,0.0027548387,0.00055353914,0.0005453501,0.0036949923,0.0017254676],"domain_scores_gemma":[0.97223026,0.010055138,0.00091680716,0.00061398034,0.006272534,0.009911249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029619044,0.0011689952,0.0009985327,0.0013378845,0.002219791,0.009348199,0.0012410489,0.007321004,0.0076039513],"category_scores_gemma":[0.031916715,0.000553684,0.0014291322,0.0016658914,0.00221292,0.0059727463,0.0068792934,0.014937679,0.003899167],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017476815,0.00014725674,0.00067413424,0.0014163075,0.0000318339,0.00027934852,0.00063929555,0.0002726917,0.00078303774,0.0054014972,0.900768,0.0894118],"study_design_scores_gemma":[0.000041092557,0.00014048809,0.0020167104,0.0013086504,0.00003352543,0.0001577405,0.0007218013,0.00012554694,0.0008269513,0.0027351666,0.9918502,0.000042081407],"about_ca_topic_score_codex":0.004660241,"about_ca_topic_score_gemma":0.007868044,"teacher_disagreement_score":0.029619044,"about_ca_system_score_codex":0.0058287866,"about_ca_system_score_gemma":0.02103877,"threshold_uncertainty_score":0.15664232},"labels":[],"label_agreement":null},{"id":"W4200557046","doi":"10.1158/1078-0432.ccr-21-1291","title":"Co-Targeting of MDM2 and CDK4/6 with Siremadlin and Ribociclib for the Treatment of Patients with Well-Differentiated or Dedifferentiated Liposarcoma: Results from a Proof-of-Concept, Phase Ib Study","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Novartis Pharmaceuticals Corporation","keywords":"Discontinuation; Regimen; Medicine; Internal medicine; Gastroenterology; Toxicity; Surgery","score_opus":0.16442287932536198,"score_gpt":0.49352622930669265,"score_spread":0.3291033499813307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200557046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941468,0.0024781148,0.0008257291,0.00020715981,0.000046973644,0.0008122501,0.00037725904,0.000064652915,0.001041011],"genre_scores_gemma":[0.99407697,0.0015437827,0.0020269856,0.00021895849,0.00004496382,0.00057849515,0.0008132859,0.000017019418,0.0006795893],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99960035,0.00016327153,0.000034134784,0.000057876092,0.00006173329,0.00008275272],"domain_scores_gemma":[0.9996214,0.00006606002,0.00008816462,0.00003693569,0.000028313738,0.0001590554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017104939,0.00088788156,0.0012633102,0.00040603764,0.00023549501,0.0008791416,0.0007852232,0.00062700006,0.0012699788],"category_scores_gemma":[0.00040439956,0.00036399046,0.0008358489,0.00036674546,0.00063309586,0.00073046994,0.00032635083,0.0022244619,0.00037998034],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21496916,0.0948464,0.010769979,0.0018056177,0.0019566347,0.00051482435,0.0006018668,0.007332207,0.4781011,0.00065899646,0.0039854767,0.18445776],"study_design_scores_gemma":[0.18370609,0.69354355,0.022913532,0.00009671027,0.001439635,0.00092972594,0.00019516739,0.0035972223,0.08507265,0.00023813926,0.00820676,0.000060939812],"about_ca_topic_score_codex":0.0005053407,"about_ca_topic_score_gemma":0.0020370113,"teacher_disagreement_score":0.0017104939,"about_ca_system_score_codex":0.00075047277,"about_ca_system_score_gemma":0.0010792238,"threshold_uncertainty_score":0.009046018},"labels":[],"label_agreement":null},{"id":"W4205484767","doi":"10.1158/1078-0432.ccr-21-3261","title":"Anti-CD79B Antibody–Drug Conjugate DCDS0780A in Patients with B-Cell Non-Hodgkin Lymphoma: Phase 1 Dose-Escalation Study","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Neutropenia; Lymphoma; Internal medicine; Adverse effect; Phases of clinical research; Diffuse large B-cell lymphoma; Rituximab; Nausea; Gastroenterology; Pharmacokinetics; Oncology; Chemotherapy","score_opus":0.11104047886958199,"score_gpt":0.516506773739555,"score_spread":0.405466294869973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205484767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983475,0.00071180356,0.00011590953,0.000083204504,0.000012644574,0.00030237055,0.00009182991,0.000020703692,0.00031390568],"genre_scores_gemma":[0.99719846,0.0006407814,0.00055886596,0.00029212792,0.000042187283,0.00035284058,0.00041458575,0.000007625594,0.00049251405],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996697,0.00014250424,0.000020187514,0.000050963597,0.00005011614,0.00006651802],"domain_scores_gemma":[0.9996495,0.00006792434,0.00007530063,0.000033119908,0.000030361076,0.00014367547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010248345,0.0008585929,0.0013352978,0.00031860406,0.00023608605,0.0005159729,0.00048423134,0.00059798476,0.0012451813],"category_scores_gemma":[0.0006160805,0.00037064392,0.00058602536,0.00027764952,0.00049569446,0.0004741783,0.00024773265,0.0015196146,0.0004435179],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29221296,0.14596018,0.06768222,0.0013004956,0.0023430865,0.00078724796,0.0011309978,0.0067466493,0.12620644,0.00032669303,0.0042175176,0.35108548],"study_design_scores_gemma":[0.24457173,0.6785772,0.05808839,0.000051121006,0.0005843218,0.0008019781,0.00009801421,0.002807346,0.01018591,0.00016984006,0.004028152,0.0000360011],"about_ca_topic_score_codex":0.0005625855,"about_ca_topic_score_gemma":0.0010958597,"teacher_disagreement_score":0.0013352978,"about_ca_system_score_codex":0.0007261369,"about_ca_system_score_gemma":0.0007937786,"threshold_uncertainty_score":0.0054198503},"labels":[],"label_agreement":null},{"id":"W4205646635","doi":"10.1158/1078-0432.ccr-21-3530","title":"Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Loxo Oncology; Eli Lilly Japan; Chugai Pharmaceutical; EMD Serono; Genentech; Ignyta; Eli Lilly and Company; Ono Pharmaceutical; Sanofi; Kyowa Hakko Kirin; Teijin Pharma; Daiichi-Sankyo; Halozyme; Mirati Therapeutics; National Center for Advancing Translational Sciences; Les Laboratories Pierre Fabre; Regeneron Pharmaceuticals; Pfizer; Symphogen; Bristol-Myers Squibb; AstraZeneca; Shire; Taiho Pharmaceutical; F. Hoffmann-La Roche; Novartis Pharma; AbbVie; Spectrum Pharmaceuticals; Medtronic Japan; Amgen; Bayer","keywords":"Osimertinib; Adjuvant; Lung cancer; Quality of life (healthcare); Clinical trial; Phases of clinical research; Epidermal growth factor receptor","score_opus":0.16964995954985748,"score_gpt":0.5233249970360567,"score_spread":0.3536750374861992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205646635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928975,0.005124331,0.00009202497,0.0003119064,0.00012108516,0.00026716245,0.00042143822,0.000009814209,0.0007546396],"genre_scores_gemma":[0.9961404,0.0012809718,0.0001924782,0.000400751,0.00016818567,0.0003474733,0.0010050978,0.0000027555432,0.00046191222],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9995396,0.00026565816,0.000029172652,0.000051617506,0.000049864782,0.00006419199],"domain_scores_gemma":[0.99953365,0.000100424775,0.00015569573,0.00002932433,0.000033565342,0.00014727667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016824012,0.00075238675,0.0014308658,0.00016006586,0.0002880281,0.00093069114,0.00040531176,0.00078646664,0.001163347],"category_scores_gemma":[0.00094097346,0.00022399439,0.0014230249,0.00026542888,0.00041924306,0.00044185336,0.00023595057,0.0017025417,0.00023051683],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82726526,0.007744207,0.09627789,0.0012532504,0.0047754236,0.0002084317,0.00017859162,0.0014203956,0.006770815,0.00021126262,0.0038265814,0.050067876],"study_design_scores_gemma":[0.49093112,0.18627775,0.3064416,0.00026794928,0.0055362135,0.000379654,0.00020366863,0.0021451341,0.0021812583,0.00037762173,0.0051928316,0.000065224885],"about_ca_topic_score_codex":0.0005614595,"about_ca_topic_score_gemma":0.0016032243,"teacher_disagreement_score":0.0016824012,"about_ca_system_score_codex":0.00044036523,"about_ca_system_score_gemma":0.00053316966,"threshold_uncertainty_score":0.008897483},"labels":[],"label_agreement":null},{"id":"W4206499749","doi":"10.1158/1078-0432.ccr-21-0664","title":"Single-Cell Immune Mapping of Melanoma Sentinel Lymph Nodes Reveals an Actionable Immunotolerant Microenvironment","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Center for Research Resources; National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health","keywords":"Melanoma; Lymph; Immune system; Immunity; Antibody; Immunotherapy; Stage (stratigraphy); Clinical trial","score_opus":0.16042761551657023,"score_gpt":0.4227069855418419,"score_spread":0.2622793700252717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206499749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99501896,0.00043170562,0.004116676,0.000020881882,0.000006208544,0.000026982349,0.00007282143,0.000044269553,0.00026155767],"genre_scores_gemma":[0.9952539,0.00013861708,0.0042103454,0.00001693052,0.0000058813366,0.000022996102,0.00007724198,0.0000059040067,0.0002681246],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99994683,0.000009247628,0.0000030614474,0.00001983713,0.000011220534,0.00000971943],"domain_scores_gemma":[0.9999273,0.000018444334,0.000017352346,0.000009459462,0.000010683796,0.000016652963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015190161,0.0001766444,0.00018877929,0.0001664768,0.00008436828,0.00014237211,0.000119554,0.0001957792,0.0009253029],"category_scores_gemma":[0.00012715612,0.00008663718,0.00012791534,0.000058823152,0.0001584453,0.00014336439,0.00009715385,0.00019058952,0.00025125578],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008862018,0.000011118148,0.0010162535,0.000028620821,0.0000019071296,0.000038815033,0.000012208149,0.00007445479,0.9977549,0.000016455755,0.000009970806,0.00094665267],"study_design_scores_gemma":[0.000036809954,0.00072332675,0.020070018,0.0000068202835,0.000026941041,0.001194465,0.00007348786,0.0045091817,0.97256976,0.000104083476,0.0006812282,0.0000040372943],"about_ca_topic_score_codex":0.0002168211,"about_ca_topic_score_gemma":0.00032741664,"teacher_disagreement_score":0.0009253029,"about_ca_system_score_codex":0.000121986,"about_ca_system_score_gemma":0.00010072649,"threshold_uncertainty_score":0.003095448},"labels":[],"label_agreement":null},{"id":"W4206901398","doi":"10.1158/1078-0432.ccr-21-3284","title":"Targeting Refractory Mantle Cell Lymphoma for Imaging and Therapy Using C-X-C Chemokine Receptor Type 4 Radioligands","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Spinal Cord Injury BC","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute","keywords":"Radioligand; CXCR4; Medicine; Mantle cell lymphoma; Cancer research; Chemokine receptor; Biodistribution; Lymphoma; Pathology; Receptor; Internal medicine; Chemokine; Biology; In vivo","score_opus":0.20004507388978945,"score_gpt":0.4930952004430603,"score_spread":0.2930501265532709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206901398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887572,0.0054584723,0.0045271274,0.00013210466,0.000010002361,0.00007815343,0.00008120343,0.00007871594,0.0008770288],"genre_scores_gemma":[0.9954845,0.00088075164,0.002959123,0.00009178093,0.000013216599,0.000037959926,0.0001452546,0.000010214086,0.000377209],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986625,0.000052731466,0.0000064279843,0.000022288377,0.000030074896,0.000022233351],"domain_scores_gemma":[0.9999163,0.000018206212,0.00003493235,0.000009543936,0.0000074070185,0.0000135823775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003222773,0.00032679233,0.00033686767,0.00022027448,0.000111123605,0.00035103963,0.00032420983,0.00040041195,0.00073588727],"category_scores_gemma":[0.00022599974,0.00011421666,0.00024641652,0.00016831764,0.0002771412,0.00017481849,0.00021307151,0.00026495886,0.00022181724],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00134265,0.00018899815,0.013982191,0.00028266333,0.00006403144,0.0004415861,0.000051564763,0.0016012349,0.9603591,0.00016419787,0.00024090428,0.021280896],"study_design_scores_gemma":[0.0010800153,0.013119027,0.047198445,0.00006155459,0.0004510939,0.008455019,0.00013577759,0.015633026,0.9033102,0.00021702949,0.010294008,0.00004471649],"about_ca_topic_score_codex":0.0008489496,"about_ca_topic_score_gemma":0.0011914014,"teacher_disagreement_score":0.0008489496,"about_ca_system_score_codex":0.000504204,"about_ca_system_score_gemma":0.00029290194,"threshold_uncertainty_score":0.0036582947},"labels":[],"label_agreement":null},{"id":"W4206906266","doi":"10.1158/1078-0432.ccr-21-3213","title":"Preoperative Chemoradiotherapy plus Nivolumab before Surgery in Patients with Microsatellite Stable and Microsatellite Instability–High Locally Advanced Rectal Cancer","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"Ono Pharmaceutical","keywords":"Nivolumab; Colorectal cancer; Microsatellite; Microsatellite instability; Chemoradiotherapy","score_opus":0.06211335748150452,"score_gpt":0.40588523366044776,"score_spread":0.3437718761789432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206906266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971342,0.0021085124,0.00017229095,0.00012030485,0.000018546123,0.00005409234,0.000032773354,0.000010952121,0.00034826703],"genre_scores_gemma":[0.9989453,0.00044127446,0.0003437516,0.00008490981,0.000022581618,0.000022979746,0.00007335378,0.000001456491,0.00006428562],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99979275,0.000100009296,0.000018964145,0.000031593543,0.000025475203,0.00003124933],"domain_scores_gemma":[0.99967,0.00009158503,0.00007360222,0.000020050184,0.000019258181,0.00012539554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005628848,0.00025330123,0.0006081069,0.00016563067,0.00021221736,0.00026770835,0.00022369454,0.000219504,0.00045528574],"category_scores_gemma":[0.00072166015,0.00015635777,0.00041076337,0.00016383639,0.00024858417,0.00020978766,0.00014124518,0.00047748527,0.0001418358],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.088794075,0.004988808,0.5524887,0.0010413058,0.0011289436,0.0020557838,0.0006474633,0.0046831896,0.053136036,0.00017117329,0.0024251773,0.28843942],"study_design_scores_gemma":[0.010221132,0.16718742,0.7883891,0.00020185026,0.0013184402,0.006358765,0.0005750651,0.00853624,0.0104354415,0.0002752585,0.0064391736,0.00006213688],"about_ca_topic_score_codex":0.0007760097,"about_ca_topic_score_gemma":0.0029769046,"teacher_disagreement_score":0.0007760097,"about_ca_system_score_codex":0.00047525528,"about_ca_system_score_gemma":0.0007711837,"threshold_uncertainty_score":0.003448248},"labels":[],"label_agreement":null},{"id":"W4210277591","doi":"10.1158/1078-0432.ccr-21-2572","title":"Somatic and Germline Genomic Alterations in Very Young Women with Breast Cancer","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Susan G. Komen; Breast Cancer Research Foundation","keywords":"Somatic cell; Germline; Breast cancer; Gene; Germline mutation; Young adult","score_opus":0.06363039054810755,"score_gpt":0.43218876076061347,"score_spread":0.3685583702125059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210277591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993667,0.00027740625,0.000052632284,0.000006756376,0.0000018815891,0.0000038716844,0.00017094839,0.0000016969814,0.000118079704],"genre_scores_gemma":[0.9994566,0.00012004301,0.000080988015,0.000015216094,0.0000045992924,0.0000051731954,0.00025779405,9.80746e-7,0.000058664416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998704,0.000021741844,0.000015196677,0.000041844043,0.000025015237,0.00002583546],"domain_scores_gemma":[0.99954224,0.000104755694,0.00022774923,0.000021674412,0.000026418074,0.0000771675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019951042,0.00012354882,0.00020979968,0.00052788784,0.00021694663,0.00023203746,0.000103254526,0.00021674235,0.0009516013],"category_scores_gemma":[0.0008667396,0.00011501067,0.00015051113,0.00049136835,0.00017889265,0.00013087346,0.00022743117,0.000116920004,0.00015309382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013145174,0.000009850572,0.9964366,0.000011021549,0.000016373066,0.00031288774,0.000038358496,0.000021150749,0.0013884779,0.000007083114,0.000040033625,0.0015866876],"study_design_scores_gemma":[0.000004714377,0.000084268184,0.99800676,0.0000034844347,0.000014609927,0.0014239487,0.0000672347,0.000031673342,0.00022441789,0.0000141629525,0.00012322677,0.000001450654],"about_ca_topic_score_codex":0.001212254,"about_ca_topic_score_gemma":0.0021590989,"teacher_disagreement_score":0.001212254,"about_ca_system_score_codex":0.00012235646,"about_ca_system_score_gemma":0.0001498597,"threshold_uncertainty_score":0.0031833649},"labels":[],"label_agreement":null},{"id":"W4210342713","doi":"10.1158/1078-0432.ccr-21-3940","title":"Tumor Genomic Testing for &amp;gt;4,000 Men with Metastatic Castration-resistant Prostate Cancer in the Phase III Trial PROfound (Olaparib)","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Centre Hospitalier de l’Université de Montréal","funders":"Merck Sharp and Dohme; National Institute for Health and Care Research; Merck; AstraZeneca","keywords":"Olaparib; Prostate cancer; Homologous recombination; Cancer; Clinical trial; Homologous chromosome; Prostate","score_opus":0.4004069388603253,"score_gpt":0.5604908869630105,"score_spread":0.16008394810268523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210342713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979778,0.00045575615,0.00037751472,0.000039663202,0.0000047708522,0.00006359061,0.0005187092,0.000022873679,0.00053942495],"genre_scores_gemma":[0.99790937,0.00010775225,0.0007988014,0.000060779428,0.0000130185845,0.000038480677,0.0008240995,0.000004205359,0.00024356328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935895,0.00021177782,0.000053301825,0.00016463273,0.00015979975,0.000051669045],"domain_scores_gemma":[0.99930274,0.00021128196,0.00023710188,0.000058435235,0.00009014216,0.00010030175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015269011,0.0002932993,0.00032679542,0.0003926376,0.00021245968,0.00041860848,0.0002797257,0.0002732737,0.0010417695],"category_scores_gemma":[0.0015289984,0.0002037564,0.00015398792,0.00029569736,0.00030186336,0.00029615723,0.0003342327,0.00030045133,0.0002911651],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024416165,0.00023758215,0.96465975,0.00005820924,0.00005798485,0.00022215785,0.00009626763,0.0005229114,0.008614081,0.000036328096,0.00043862237,0.02261452],"study_design_scores_gemma":[0.0003508884,0.0056484626,0.980055,0.000014823647,0.000085066255,0.0017029671,0.000085966356,0.0016166364,0.008447457,0.000066416105,0.0019168558,0.0000094521665],"about_ca_topic_score_codex":0.00056406687,"about_ca_topic_score_gemma":0.00087344047,"teacher_disagreement_score":0.0015269011,"about_ca_system_score_codex":0.00030221412,"about_ca_system_score_gemma":0.00026264894,"threshold_uncertainty_score":0.008075178},"labels":[],"label_agreement":null},{"id":"W4211106526","doi":"10.1158/1078-0432.ccr-21-3045","title":"Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast Cancer","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; Gilead Sciences; National Cancer Institute; National Institutes of Health; Breast Cancer Alliance; Sierra Oncology; Ipsen; Genentech; Deutsche Krebshilfe; G1 Therapeutics; Stand Up To Cancer; EMD Serono; Mersana Therapeutics; Merck KGaA; Dana-Farber/Harvard Cancer Center; GlaxoSmithKline; Breast Cancer Research Foundation; Pfizer; Symphogen; Carrick Therapeutics; American Association for Cancer Research; AstraZeneca; Eli Lilly and Company; Astex Pharmaceuticals","keywords":"Olaparib; PARP inhibitor; Clinical trial; Breast cancer; Cancer; Phases of clinical research; Poly ADP ribose polymerase","score_opus":0.2879403571378599,"score_gpt":0.59430337590085,"score_spread":0.3063630187629901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211106526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870378,0.00435582,0.00062820123,0.0009504527,0.00015257213,0.0027844445,0.0012561791,0.00013392547,0.0027006427],"genre_scores_gemma":[0.98634976,0.0020573826,0.002152879,0.0012668133,0.00023855473,0.0025809284,0.0026491636,0.000027088137,0.0026773498],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99965405,0.00019924126,0.00001600476,0.000048520782,0.000036289133,0.000045821642],"domain_scores_gemma":[0.99957055,0.00008137345,0.00012984418,0.00003156779,0.000027446038,0.00015918147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012704718,0.00094191486,0.0013995277,0.0003059781,0.00024702575,0.0007009075,0.00044340713,0.0006379469,0.0055063413],"category_scores_gemma":[0.0008830249,0.00026708757,0.00064477266,0.00027740345,0.0003628342,0.00049346336,0.00028088447,0.0019853162,0.0008957727],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73634225,0.033446163,0.007865724,0.0013484398,0.0012906536,0.00031673472,0.00016974991,0.002353537,0.040774632,0.00028357562,0.006354892,0.16945365],"study_design_scores_gemma":[0.6934753,0.27953544,0.015316321,0.000087018365,0.00033241155,0.00060858694,0.000036390204,0.0016135026,0.00313976,0.00029257854,0.005537201,0.000025511965],"about_ca_topic_score_codex":0.00028673842,"about_ca_topic_score_gemma":0.0011209031,"teacher_disagreement_score":0.0055063413,"about_ca_system_score_codex":0.0005542273,"about_ca_system_score_gemma":0.0011346964,"threshold_uncertainty_score":0.018420517},"labels":[],"label_agreement":null},{"id":"W4211162951","doi":"10.1158/1078-0432.ccr-21-3385","title":"Breast Cancer Index Is a Predictive Biomarker of Treatment Benefit and Outcome from Extended Tamoxifen Therapy: Final Analysis of the Trans-aTTom Study","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"Ontario Institute for Cancer Research; Cancer Research UK; BioTheranostics; Breast Cancer Research Foundation","keywords":"Tamoxifen; Medicine; Oncology; Breast cancer; Biomarker; Cancer; Internal medicine; Gynecology; Biology","score_opus":0.1883936244206094,"score_gpt":0.4851362055094422,"score_spread":0.2967425810888328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211162951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949981,0.0015637117,0.001002178,0.000118329204,0.000026391384,0.00018073496,0.0012431118,0.000020218038,0.0008472008],"genre_scores_gemma":[0.99650335,0.00015790663,0.00070811337,0.000101065736,0.00006713432,0.0001574693,0.0018819113,0.000011898014,0.00041113346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99721295,0.0019531266,0.00012070902,0.00029151735,0.0002880348,0.00013378228],"domain_scores_gemma":[0.9952678,0.0016900834,0.0009410589,0.0012926093,0.00031740256,0.00049097673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010916477,0.00078868703,0.0015503302,0.00020540213,0.00019729917,0.00085772533,0.00082842365,0.00058824144,0.0013570414],"category_scores_gemma":[0.005318258,0.0003794406,0.0019686888,0.00033515613,0.00047802608,0.0005057197,0.00069418474,0.0010744112,0.00024666308],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45339245,0.0013887626,0.4722791,0.0006627315,0.018517205,0.00022269344,0.00023749153,0.0015349429,0.008658585,0.00035518853,0.002429537,0.0403214],"study_design_scores_gemma":[0.024029043,0.043291915,0.899893,0.00007945178,0.018762331,0.0005592634,0.00013310948,0.0052863467,0.0036133633,0.00054363854,0.0037412937,0.000067134366],"about_ca_topic_score_codex":0.00047689033,"about_ca_topic_score_gemma":0.00087010296,"teacher_disagreement_score":0.010916477,"about_ca_system_score_codex":0.00023073914,"about_ca_system_score_gemma":0.00044080205,"threshold_uncertainty_score":0.057732522},"labels":[],"label_agreement":null},{"id":"W4211216207","doi":"10.1158/1078-0432.ccr-21-3597","title":"Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With <i>NTRK</i> Fusion-Positive Solid Tumors","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Roche","keywords":"Solid tumor; Cancer; Clinical trial; Disease; Chemotherapy","score_opus":0.042792781397966974,"score_gpt":0.4593572099433715,"score_spread":0.4165644285454045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211216207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810276,0.00516364,0.0008280416,0.00017119688,0.000019942321,0.0001849368,0.00907588,0.000066102686,0.0034626052],"genre_scores_gemma":[0.98864347,0.0005755604,0.0005799327,0.00012463724,0.000028848253,0.00006077312,0.009634614,0.000011616244,0.0003405494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868125,0.00047480274,0.00019868437,0.00021773668,0.00034304967,0.00008435071],"domain_scores_gemma":[0.9955205,0.0013056243,0.0018093757,0.00034315768,0.0007559217,0.00026540447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037802984,0.0003129134,0.0011615946,0.00081366586,0.00019521776,0.0010178947,0.0004881351,0.00026854887,0.0013173028],"category_scores_gemma":[0.004406633,0.00016253993,0.0011183774,0.0011861139,0.0001692656,0.0006645141,0.0004618266,0.0004702178,0.00022842041],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09364973,0.0005616075,0.7328649,0.0015607685,0.0104348995,0.0002364521,0.00018824296,0.004028783,0.009504139,0.00030220053,0.004050836,0.14261733],"study_design_scores_gemma":[0.00426494,0.006842385,0.96670413,0.00012171271,0.0075782663,0.00079135236,0.00007180461,0.0026695433,0.0031670972,0.00013294045,0.0076242103,0.000031721236],"about_ca_topic_score_codex":0.0018697493,"about_ca_topic_score_gemma":0.0036468913,"teacher_disagreement_score":0.0037802984,"about_ca_system_score_codex":0.0009736607,"about_ca_system_score_gemma":0.00082325743,"threshold_uncertainty_score":0.019992411},"labels":[],"label_agreement":null},{"id":"W4212771317","doi":"10.1158/1078-0432.ccr-21-0885","title":"Natural History and Characteristics of <i>ERBB2</i> -mutated Hormone Receptor–positive Metastatic Breast Cancer: A Multi-institutional Retrospective Case–control Study from AACR Project GENIE","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy; National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health; Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation; Unicancer; Vanderbilt University; Institut Gustave-Roussy; Puma Biotechnology; Princess Margaret Cancer Foundation; Memorial Sloan-Kettering Cancer Center; University of Texas MD Anderson Cancer Center; Cancer Prevention and Research Institute of Texas; American Association for Cancer Research","keywords":"Natural history; Retrospective cohort study; Metastatic breast cancer; Hormone; Cancer; Breast cancer","score_opus":0.11103847282270961,"score_gpt":0.4503884108544883,"score_spread":0.33934993803177865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212771317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999102,0.00015481254,0.000101979684,0.000008520652,0.0000023801767,0.00001957028,0.0003568671,0.0000041598087,0.00024964052],"genre_scores_gemma":[0.99889,0.00008872515,0.00010112582,0.000018258328,0.000010425847,0.00002533238,0.0007027374,0.000003213904,0.00016015337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994318,0.00013236594,0.000045834004,0.00021535678,0.000093364855,0.000081190396],"domain_scores_gemma":[0.9993741,0.0001358709,0.0002296254,0.00011032582,0.00005825917,0.00009191004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000640267,0.000409264,0.00043212905,0.0010776535,0.00045196633,0.0005056062,0.00038342646,0.00038041075,0.0019070004],"category_scores_gemma":[0.001139389,0.00040839336,0.00031701155,0.0008283854,0.00032906953,0.00026602705,0.0004137016,0.0002705003,0.00040712112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025568964,0.00009878089,0.99682105,0.000017526521,0.000054204942,0.0005893562,0.00008256183,0.000030106075,0.000776674,0.000018225586,0.00015690854,0.001098892],"study_design_scores_gemma":[0.000051628154,0.0002805814,0.99613696,0.00000874118,0.00004876262,0.00251016,0.00015264086,0.00013489804,0.00015874559,0.00001722568,0.0004943239,0.0000053653225],"about_ca_topic_score_codex":0.0034663065,"about_ca_topic_score_gemma":0.0028903382,"teacher_disagreement_score":0.0034663065,"about_ca_system_score_codex":0.0003406475,"about_ca_system_score_gemma":0.00024144657,"threshold_uncertainty_score":0.006892264},"labels":[],"label_agreement":null},{"id":"W4212829041","doi":"10.1158/1078-0432.ccr-16-0732","title":"CD103 and Intratumoral Immune Response in Breast Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia; BC Cancer Agency","funders":"Canadian Cancer Society Research Institute","keywords":"Medicine; Breast cancer; Tumor-infiltrating lymphocytes; Internal medicine; CD8; Cancer; Context (archaeology); Immune system; Oncology; Basal (medicine); Confidence interval; Gastroenterology; Immunotherapy; Immunology; Biology","score_opus":0.15605407737987972,"score_gpt":0.5203377031857345,"score_spread":0.3642836258058547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212829041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963883,0.0023573285,0.00021593756,0.00009223331,0.000009194782,0.000004348024,0.0001273129,0.000014494672,0.0007907874],"genre_scores_gemma":[0.9993451,0.00021289958,0.00007338272,0.000024042904,0.000007732454,0.0000029653581,0.00008678957,0.000002882287,0.00024414388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998659,0.000035403908,0.000010571967,0.000028004872,0.000029038094,0.000030948057],"domain_scores_gemma":[0.9996518,0.000072696035,0.00015911106,0.000022849246,0.000040704494,0.000052854764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002270477,0.00013028228,0.00018206204,0.00032963254,0.00012790081,0.0004134921,0.00013565822,0.00021700021,0.0018818957],"category_scores_gemma":[0.0005383724,0.000076810415,0.00011901564,0.0004287319,0.00015742771,0.00019004475,0.00021814367,0.00044910287,0.00036228928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010462771,0.000105149404,0.9557489,0.00008431686,0.00010469013,0.0003418921,0.000064462234,0.00026003466,0.012623388,0.00006125478,0.0005039128,0.029055694],"study_design_scores_gemma":[0.00002336959,0.00021831154,0.98999584,0.000024360625,0.00007577295,0.0026269902,0.00015199916,0.0008743787,0.0040568304,0.00016492745,0.0017803352,0.0000068868176],"about_ca_topic_score_codex":0.0006048039,"about_ca_topic_score_gemma":0.0009178196,"teacher_disagreement_score":0.0018818957,"about_ca_system_score_codex":0.00023431604,"about_ca_system_score_gemma":0.00010922679,"threshold_uncertainty_score":0.006295562},"labels":[],"label_agreement":null},{"id":"W4213348369","doi":"10.1158/1078-0432.ccr-21-0344","title":"Targeting the Ubiquitin–Proteasome System Using the UBA1 Inhibitor TAK-243 is a Potential Therapeutic Strategy for Small-Cell Lung Cancer","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research; International Association for the Study of Lung Cancer; Weill Cornell Medical College; Canada Foundation for Innovation; National Center for Advancing Translational Sciences; Temerty Faculty of Medicine, University of Toronto; Ontario Institute for Cancer Research; Lung Cancer Research Foundation; National Cancer Institute; University of Toronto; Memorial Sloan-Kettering Cancer Center; American Society of Clinical Oncology; Cancer Research Society; National Institutes of Health; Conquer Cancer Foundation","keywords":"Lung cancer; Cancer; Gene; Therapeutic approach; Cell culture; Targeted therapy","score_opus":0.27928867953338987,"score_gpt":0.5313512002930797,"score_spread":0.2520625207596898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213348369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9498312,0.041001808,0.0040379213,0.00057453325,0.00014589312,0.00018817885,0.0006264698,0.00030897887,0.00328514],"genre_scores_gemma":[0.9868019,0.009066644,0.0018090219,0.00015707193,0.00004132562,0.0000867772,0.0006574592,0.000011363267,0.0013684109],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999138,0.000014227008,0.0000091010825,0.000017466988,0.000024172425,0.000021197007],"domain_scores_gemma":[0.99993014,0.0000129901,0.000022265413,0.000006733887,0.000009246963,0.00001854602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022058321,0.00042546255,0.00044100356,0.0002844412,0.00018449056,0.000506451,0.0003270856,0.0002848548,0.0017361483],"category_scores_gemma":[0.0001046075,0.00013113079,0.00046100718,0.00026380713,0.00025744812,0.00025834807,0.00016336607,0.0007986185,0.0005090869],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011614806,0.00058970787,0.0014844706,0.00050837547,0.00006903643,0.0002330753,0.000034322195,0.000817439,0.958616,0.00021051681,0.00061897613,0.035656657],"study_design_scores_gemma":[0.00039885787,0.01343171,0.012812123,0.00006496587,0.00026643652,0.0016715785,0.00010010731,0.0027704819,0.9546171,0.00022218253,0.013612868,0.000031603977],"about_ca_topic_score_codex":0.00021983344,"about_ca_topic_score_gemma":0.0007364664,"teacher_disagreement_score":0.0017361483,"about_ca_system_score_codex":0.0002927869,"about_ca_system_score_gemma":0.00030760813,"threshold_uncertainty_score":0.005807936},"labels":[],"label_agreement":null},{"id":"W4220672244","doi":"10.1158/1078-0432.ccr-21-3087","title":"A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Institute of Cancer Research","funders":"National Cancer Institute; Ipsen; Shionogi; Astellas Pharma; Eisai; National Institute for Health and Care Research; Cancer Research UK; Genentech; MEI Pharma; Incyte; Taiho Pharmaceutical; F. Hoffmann-La Roche; Daiichi Sankyo Europe; Sanofi; Amgen; Pfizer; Les Laboratories Pierre Fabre; G1 Therapeutics; Celgene; Carrick Therapeutics; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Tolerability; Medicine; Adverse effect; Abiraterone acetate; Prostate cancer; Pharmacodynamics; Rash; Pharmacokinetics; Internal medicine; Pharmacology; Cancer; Oncology; Androgen deprivation therapy","score_opus":0.07900168100914737,"score_gpt":0.477995984189011,"score_spread":0.3989943031798636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220672244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944267,0.0020429709,0.0005363307,0.00016603335,0.000041405503,0.001137788,0.00048854586,0.000043677745,0.0011165342],"genre_scores_gemma":[0.992301,0.0019073518,0.0015482294,0.00037741679,0.00009810357,0.0009904917,0.0014006468,0.000011877525,0.0013649727],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997274,0.00011363234,0.000021293135,0.000054175274,0.000038000773,0.00004540279],"domain_scores_gemma":[0.999648,0.000054232994,0.000092146154,0.000032022468,0.000026657919,0.00014698454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083359046,0.0010488324,0.0013121426,0.00028015007,0.00032311812,0.00053203985,0.000460782,0.0006040222,0.0021258593],"category_scores_gemma":[0.00044565642,0.00036261894,0.0006925087,0.0003731183,0.00056654244,0.00049775856,0.00024152485,0.0017756697,0.00057176704],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4740212,0.07483208,0.02082303,0.002060988,0.0016221891,0.00065420155,0.00042507454,0.005756188,0.20637013,0.00042591814,0.0039233244,0.20908572],"study_design_scores_gemma":[0.3024374,0.65585476,0.020622026,0.0000390486,0.00053999084,0.0007343158,0.00005573528,0.0013142662,0.013739472,0.00015198597,0.004483768,0.000027273058],"about_ca_topic_score_codex":0.00036884274,"about_ca_topic_score_gemma":0.0011127621,"teacher_disagreement_score":0.0021258593,"about_ca_system_score_codex":0.0005000541,"about_ca_system_score_gemma":0.0011397174,"threshold_uncertainty_score":0.007111728},"labels":[],"label_agreement":null},{"id":"W4220783948","doi":"10.1158/1078-0432.ccr-21-3089","title":"Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Pembrolizumab; Clinical trial; Tumor microenvironment; Urothelial cancer; Biomarker; Immunotherapy","score_opus":0.31333517696105834,"score_gpt":0.554651027683863,"score_spread":0.24131585072280465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220783948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.942171,0.05011973,0.0008979798,0.0014475704,0.00015928189,0.0005297404,0.0025068815,0.00006188148,0.002106052],"genre_scores_gemma":[0.99138004,0.0041614547,0.00086121034,0.0006869649,0.00017741193,0.00030735848,0.0019548433,0.000010878975,0.00045989465],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9981364,0.0011329099,0.00013661536,0.00026934053,0.00019583342,0.00012886229],"domain_scores_gemma":[0.9961482,0.0012528698,0.0016606236,0.0002848738,0.00023741882,0.00041611138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006099244,0.00094462984,0.0015980167,0.00026987612,0.00023402735,0.0014575656,0.00063659635,0.00079483044,0.001477297],"category_scores_gemma":[0.005031929,0.00022751164,0.0025337744,0.0005496324,0.00054180576,0.0011629758,0.0005570087,0.0017752623,0.00022391838],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7086227,0.002753613,0.08428189,0.005272508,0.02064051,0.00014601689,0.00021620643,0.0034750868,0.0083247395,0.0007304267,0.004536945,0.1609995],"study_design_scores_gemma":[0.28150085,0.19668226,0.45211014,0.0015992346,0.035300374,0.00076900603,0.000341397,0.004666663,0.0055966503,0.0020039508,0.019234933,0.00019453738],"about_ca_topic_score_codex":0.0004214712,"about_ca_topic_score_gemma":0.0013552455,"teacher_disagreement_score":0.006099244,"about_ca_system_score_codex":0.0008473994,"about_ca_system_score_gemma":0.00095910113,"threshold_uncertainty_score":0.032256246},"labels":[],"label_agreement":null},{"id":"W4220938340","doi":"10.1158/1078-0432.ccr-21-4283","title":"Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, <i>IDH</i> -wildtype: <i>Post Hoc</i> Analysis of the EORTC Randomized Phase III CATNON Trial","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Medac; Brain Tumour Charity; Cancer Australia; National Health and Medical Research Council; Cancer Research UK; Y-mAbs Therapeutics; Agios Pharmaceuticals; Seagen; Douglas Pharmaceuticals; Pfizer; NRG Oncology; Teva Pharmaceutical Industries; Medical Research Council; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Temozolomide; Medicine; Oncology; Radiation therapy; Internal medicine; IDH1; O-6-methylguanine-DNA methyltransferase; Anaplastic astrocytoma; Glioma; Chemoradiotherapy; Isocitrate dehydrogenase; Dacarbazine; Cancer research; Chemotherapy; Methyltransferase; Astrocytoma; Methylation; Biology; Mutation; Gene","score_opus":0.05724010652066623,"score_gpt":0.44655402154756285,"score_spread":0.3893139150268966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220938340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99469805,0.0022602545,0.00017747175,0.00041915145,0.00031676225,0.0006207448,0.00043021402,0.000026104639,0.0010512894],"genre_scores_gemma":[0.99542195,0.0010143787,0.00039942662,0.00043530468,0.00022214917,0.00061283534,0.0006526931,0.000009104563,0.0012321471],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9992392,0.0005185598,0.00003768164,0.00009551697,0.00003773137,0.00007137658],"domain_scores_gemma":[0.9990694,0.00028975212,0.0002471388,0.00007281405,0.000053957145,0.00026696222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002108046,0.0008679864,0.0018868309,0.00023962196,0.00018648963,0.00067206135,0.0005608428,0.0005737142,0.002465715],"category_scores_gemma":[0.0014868099,0.00032087043,0.0017505809,0.00026610517,0.0006305547,0.0005745835,0.00029142923,0.0017931269,0.0003071381],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97660464,0.0028650782,0.0022364657,0.00038105,0.001685848,0.00003131436,0.000036460897,0.000654493,0.0021164701,0.00009544301,0.0009669708,0.012325744],"study_design_scores_gemma":[0.73351103,0.2437685,0.015174701,0.000065051994,0.002556912,0.00008929819,0.0000564365,0.0016595481,0.0012161122,0.00033673222,0.0015345188,0.00003113532],"about_ca_topic_score_codex":0.0010570795,"about_ca_topic_score_gemma":0.0039873817,"teacher_disagreement_score":0.002465715,"about_ca_system_score_codex":0.0010724958,"about_ca_system_score_gemma":0.0013980643,"threshold_uncertainty_score":0.011148572},"labels":[],"label_agreement":null},{"id":"W4223610239","doi":"10.1158/1078-0432.ccr-22-0591","title":"Report of the First International Symposium on NUT Carcinoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Nut; Bromodomain; Cancer; Carcinoma; Prioritization; Brazil nut; Disease","score_opus":0.1017946249134702,"score_gpt":0.45095810889381865,"score_spread":0.34916348398034847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223610239","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015557403,0.023606168,0.0034362702,0.12462559,0.7523224,0.00062493095,0.001584193,0.00045108734,0.077792004],"genre_scores_gemma":[0.09648716,0.023604082,0.0045866137,0.062665746,0.33846122,0.00080475747,0.0040480974,0.0006023861,0.46873993],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980495,0.0003321239,0.000083277606,0.0003048005,0.0007359719,0.00049433013],"domain_scores_gemma":[0.99556893,0.00034636835,0.00016600796,0.0001129462,0.0012497207,0.0025560386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003442983,0.0016152344,0.00065434386,0.0010353965,0.0018499697,0.0031314327,0.001123178,0.004003372,0.034299072],"category_scores_gemma":[0.003751687,0.00038160136,0.0014048879,0.00038603766,0.0006405639,0.0017381592,0.0035447532,0.006159769,0.012541984],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027438087,0.00013392267,0.0010058392,0.00037199215,0.00004309503,0.0016204141,0.00039137976,0.00016051956,0.002541824,0.0018101748,0.9613937,0.030252751],"study_design_scores_gemma":[0.00003575186,0.00020704551,0.0018077741,0.00014229189,0.000030959873,0.0006593687,0.00037349205,0.00014001105,0.0006825211,0.0007007877,0.9951971,0.000022971422],"about_ca_topic_score_codex":0.0016169222,"about_ca_topic_score_gemma":0.0038500729,"teacher_disagreement_score":0.034299072,"about_ca_system_score_codex":0.0017019971,"about_ca_system_score_gemma":0.0030712294,"threshold_uncertainty_score":0.11474186},"labels":[],"label_agreement":null},{"id":"W4223960133","doi":"10.1158/1078-0432.ccr-22-0470","title":"Malic Enzyme 1 Absence in Synovial Sarcoma Shifts Antioxidant System Dependence and Increases Sensitivity to Ferroptosis Induction with ACXT-3102","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of General Medical Sciences; Wipe Out Kids' Cancer; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Sarcoma Foundation of America","keywords":"Enzyme; Enzyme inducer; Antioxidant; Medicine; Sarcoma; Synovial sarcoma; Biology; Immunology; Cancer research; Pathology; Biochemistry","score_opus":0.13912075405950103,"score_gpt":0.43691397312854974,"score_spread":0.2977932190690487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223960133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978502,0.0007810631,0.00079673453,0.000056151923,0.000010170559,0.000012239463,0.00015253706,0.000032384265,0.00030853946],"genre_scores_gemma":[0.99794227,0.00029281763,0.0006974603,0.000021738175,0.000003852897,0.00001214163,0.00031704342,0.0000066671264,0.00070599775],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981016,0.00003670169,0.00002608797,0.000035988112,0.000060980685,0.000030051362],"domain_scores_gemma":[0.9997944,0.000032404558,0.00008373071,0.000025814876,0.000020617777,0.000042978514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018542295,0.00032596616,0.00029002284,0.00021742396,0.000097115306,0.00023435739,0.00016164579,0.00021226006,0.00090679683],"category_scores_gemma":[0.00017764467,0.00011483456,0.00018890675,0.00016700132,0.00028519012,0.00017176617,0.0001582217,0.00049970625,0.00021288979],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018798388,0.000027089935,0.00047812113,0.000024859788,0.0000032859812,0.000038771435,0.0000075327257,0.000036597216,0.99858737,0.000017876315,0.000014127068,0.000576425],"study_design_scores_gemma":[0.000014621586,0.0005762725,0.0045734816,0.0000041800877,0.000011131518,0.00041362492,0.000031683532,0.0005015524,0.9931507,0.000018636558,0.0007015052,0.0000024903093],"about_ca_topic_score_codex":0.00053141796,"about_ca_topic_score_gemma":0.00083438517,"teacher_disagreement_score":0.00090679683,"about_ca_system_score_codex":0.00027276817,"about_ca_system_score_gemma":0.00019090144,"threshold_uncertainty_score":0.0030335188},"labels":[],"label_agreement":null},{"id":"W4224035803","doi":"10.1158/1078-0432.ccr-21-3807","title":"Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Merck Sharp and Dohme","keywords":"Pembrolizumab; Phases of clinical research; Clinical trial; Adverse effect; Immunotherapy; Expanded access; Hepatocellular cancer","score_opus":0.6690422892842558,"score_gpt":0.5552228490778292,"score_spread":0.11381944020642665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224035803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97895926,0.0093805995,0.00070829585,0.00083909434,0.00012176024,0.0014942406,0.004862119,0.00010066256,0.0035340923],"genre_scores_gemma":[0.9833778,0.0032278306,0.00088864914,0.00096740865,0.0001832215,0.0012157433,0.008753928,0.000024946476,0.0013603847],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993383,0.00035477962,0.00006252392,0.00009438859,0.00008367239,0.00006632187],"domain_scores_gemma":[0.99840754,0.00031427652,0.00059228897,0.00019592248,0.00011732283,0.00037264358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029539426,0.000757337,0.0010417253,0.0001831087,0.00028653073,0.0009842302,0.0005476168,0.00062288885,0.0027253649],"category_scores_gemma":[0.0021223845,0.000217721,0.0008862351,0.00031642092,0.00044107632,0.0008346739,0.00036385827,0.001668173,0.00072158],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7839877,0.016571205,0.018253943,0.003004645,0.004816082,0.00032573382,0.0002827777,0.0024959499,0.028604425,0.00034739956,0.014833117,0.12647697],"study_design_scores_gemma":[0.69412136,0.20367698,0.07098951,0.00035901787,0.0034088108,0.0011262511,0.00013392494,0.0017051134,0.007044354,0.000500309,0.01685131,0.00008303456],"about_ca_topic_score_codex":0.0004961494,"about_ca_topic_score_gemma":0.0015443189,"teacher_disagreement_score":0.0029539426,"about_ca_system_score_codex":0.0006991219,"about_ca_system_score_gemma":0.0009061132,"threshold_uncertainty_score":0.015622139},"labels":[],"label_agreement":null},{"id":"W4225423587","doi":"10.1158/1078-0432.ccr-21-4115","title":"A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell Carcinoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada); Princess Margaret Cancer Centre","funders":"National Cancer Institute; Ipsen; Eisai; Rijksuniversiteit Groningen; Medical Research Council; G1 Therapeutics; Genentech; Janssen Scientific Affairs; Advanced Accelerator Applications; EMD Serono; Karyopharm Therapeutics; Merck KGaA; Daiichi Sankyo Europe; Sanofi; Exelixis; GlaxoSmithKline; Bristol-Myers Squibb; AstraZeneca; Astellas Pharma; Celldex Therapeutics; Pfizer","keywords":"Durvalumab; Nivolumab; Renal cell carcinoma; Phases of clinical research; Kidney cancer; Immunotherapy","score_opus":0.1397838591136135,"score_gpt":0.45797407594542655,"score_spread":0.31819021683181303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225423587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992152,0.0016430583,0.0005649276,0.00033767134,0.00028385816,0.0033695558,0.00038408808,0.00006146432,0.0012034171],"genre_scores_gemma":[0.99030495,0.001137939,0.0015428255,0.0008038175,0.00033383828,0.0034921966,0.00058009184,0.000018360037,0.0017858827],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99919456,0.0004708223,0.000039566174,0.00012887939,0.0000639024,0.000102370745],"domain_scores_gemma":[0.9989517,0.00023718976,0.00021362322,0.00009431357,0.000058353795,0.0004448339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020450028,0.0016010543,0.0030418525,0.00036185095,0.00042191386,0.0010141665,0.00092232163,0.0013169096,0.0040776674],"category_scores_gemma":[0.0013888943,0.00092115096,0.0012938571,0.0003616947,0.0013115123,0.0010473531,0.00044370777,0.0029232732,0.0009760946],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95417905,0.021210033,0.0011981669,0.00026745937,0.00075436354,0.000049256047,0.00007905323,0.0006253634,0.004768147,0.00009843522,0.0005901739,0.016180513],"study_design_scores_gemma":[0.8384328,0.15770143,0.001772668,0.000012448908,0.00020678902,0.000047447942,0.000023014629,0.0006256375,0.00053833006,0.00010005617,0.00052497006,0.000014490042],"about_ca_topic_score_codex":0.0005898004,"about_ca_topic_score_gemma":0.0016666926,"teacher_disagreement_score":0.0040776674,"about_ca_system_score_codex":0.000910249,"about_ca_system_score_gemma":0.001525822,"threshold_uncertainty_score":0.013641179},"labels":[],"label_agreement":null},{"id":"W4226061009","doi":"10.1158/1078-0432.ccr-21-3594","title":"Release of IFNγ by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fondazione Italiana per la Ricerca sul Cancro; Associazione Italiana per la Ricerca sul Cancro; Trent University; Nottingham Trent University; Università di Bologna; European Hematology Association","keywords":"Bone marrow; Immune system; Myeloid leukemia; Myeloid cells; Cancer research; Myeloid; Tumor microenvironment; Leukemia; Medicine; Immunology; Biology","score_opus":0.04421120546019155,"score_gpt":0.3496647265720719,"score_spread":0.3054535211118804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226061009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99629945,0.0013005604,0.0014243148,0.000049435665,0.000023481727,0.000022531603,0.00029458597,0.000039445284,0.00054620346],"genre_scores_gemma":[0.9973349,0.00045914008,0.0010008789,0.000045811266,0.000015551783,0.00002326092,0.000281395,0.000009211596,0.00082987477],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983346,0.000031740943,0.000019306497,0.000034331955,0.000041588803,0.000039534953],"domain_scores_gemma":[0.9999347,0.000007661688,0.000021579486,0.000010680299,0.0000066824,0.000018709217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001372749,0.00033359378,0.0003440049,0.0001870663,0.00009119183,0.00028945436,0.00007614749,0.0001478778,0.00097122946],"category_scores_gemma":[0.00008185756,0.00008134864,0.00022116635,0.00013469935,0.00018358351,0.0001044535,0.00017275166,0.00043627177,0.00032674219],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026693434,0.000027695787,0.00090928073,0.000027231426,0.000004862883,0.000037738646,0.000012213482,0.00005281684,0.9969188,0.00003786858,0.000026260033,0.0016783493],"study_design_scores_gemma":[0.000056314213,0.0006312471,0.015493685,0.000012187028,0.00004319799,0.00024635418,0.000077556506,0.001042213,0.98019683,0.00009198624,0.0021040177,0.000004430343],"about_ca_topic_score_codex":0.00016931079,"about_ca_topic_score_gemma":0.00027002566,"teacher_disagreement_score":0.00097122946,"about_ca_system_score_codex":0.00018953336,"about_ca_system_score_gemma":0.00014375824,"threshold_uncertainty_score":0.0032491088},"labels":[],"label_agreement":null},{"id":"W4226541608","doi":"10.1158/1078-0432.ccr-22-0336","title":"Double Trouble: Whole-Genome Doubling Distinguishes Early from Late Ovarian Cancer","year":2022,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Genomics; University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"University of Toronto; Ontario Institute for Cancer Research","keywords":"Ovarian cancer; Biology; Serous ovarian cancer; Stage (stratigraphy); Serous fluid; Cancer; Genome; Genetics; Gene","score_opus":0.3034459126468498,"score_gpt":0.49461046412122717,"score_spread":0.1911645514743774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226541608","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006218303,0.004324182,0.0005661538,0.96409166,0.01739653,0.000026506928,0.00014090973,0.000083677565,0.0071519827],"genre_scores_gemma":[0.07815453,0.006698071,0.0009167973,0.8115883,0.087347984,0.00006788474,0.00018401287,0.000077274955,0.014965172],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99872893,0.0005059204,0.00013198264,0.00019630579,0.00030486172,0.00013194616],"domain_scores_gemma":[0.99545324,0.0030301462,0.00021771534,0.0002724488,0.0005983448,0.00042808003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015461788,0.00041185773,0.0009979493,0.00045913935,0.000978522,0.0013733696,0.0006811688,0.010568649,0.0025717583],"category_scores_gemma":[0.0103542805,0.0003030485,0.00040646747,0.00039974033,0.001224337,0.001014353,0.0004651878,0.010130919,0.003540301],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055088877,0.00006885351,0.009840421,0.00012333074,0.000046517136,0.015088185,0.00016804523,0.00021676766,0.0030715999,0.003589001,0.8953478,0.07188873],"study_design_scores_gemma":[0.00043943414,0.00057740003,0.020022925,0.00039499564,0.00010673221,0.071678564,0.0010004719,0.0025881422,0.0047456017,0.034889042,0.8634294,0.00012728691],"about_ca_topic_score_codex":0.001279062,"about_ca_topic_score_gemma":0.0020618562,"teacher_disagreement_score":0.010568649,"about_ca_system_score_codex":0.0015323187,"about_ca_system_score_gemma":0.0007220615,"threshold_uncertainty_score":0.011117756},"labels":[],"label_agreement":null},{"id":"W4233779081","doi":"10.1158/1078-0432.ccr-15-2119","title":"Cotargeting Androgen Receptor Splice Variants and mTOR Signaling Pathway for the Treatment of Castration-Resistant Prostate Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; U.S. Department of Defense","keywords":"Enzalutamide; PI3K/AKT/mTOR pathway; Prostate cancer; Androgen receptor; Protein kinase B; Cancer research; Everolimus; Cancer; Biology; Medicine; Pharmacology; Signal transduction; Internal medicine; Cell biology","score_opus":0.3324940879289064,"score_gpt":0.5156486817377322,"score_spread":0.18315459380882576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233779081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926634,0.00308624,0.0013489492,0.000118394746,0.0000710585,0.00012740579,0.00034465894,0.00012876913,0.0021111562],"genre_scores_gemma":[0.99321824,0.0019112673,0.002013993,0.000073535615,0.000019738347,0.000078094155,0.0005532661,0.000013841609,0.0021180045],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988174,0.0000194736,0.000011069068,0.000022742508,0.000039440303,0.00002548396],"domain_scores_gemma":[0.9999652,0.0000040316386,0.00000892431,0.0000043342025,0.0000039018037,0.000013608999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015700975,0.00044915956,0.0004139912,0.00023725268,0.00013166781,0.00029020317,0.00031632712,0.0001957583,0.001178333],"category_scores_gemma":[0.000051059582,0.00011858426,0.00030558862,0.00022362266,0.00021271082,0.00017690734,0.00013892885,0.0007101998,0.0002608991],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064059364,0.0004966075,0.00028312986,0.0001051805,0.00003551591,0.00006698329,0.00001715316,0.00045776472,0.9901794,0.00018817486,0.00017710363,0.007352443],"study_design_scores_gemma":[0.00040594864,0.011533452,0.005335201,0.000012504819,0.00014572113,0.0007482684,0.00003615699,0.0020074798,0.9722605,0.000044081826,0.0074542407,0.000016412527],"about_ca_topic_score_codex":0.001025589,"about_ca_topic_score_gemma":0.0028799209,"teacher_disagreement_score":0.001178333,"about_ca_system_score_codex":0.00029687048,"about_ca_system_score_gemma":0.00040055477,"threshold_uncertainty_score":0.0039418936},"labels":[],"label_agreement":null},{"id":"W4245892875","doi":"10.1158/1078-0432.ccr-10-0612","title":"Prognostic Gene Expression Signature for Squamous Cell Carcinoma of Lung","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Lung cancer; Gene signature; Oncology; Proportional hazards model; Microarray; Medicine; Internal medicine; Biology; Gene expression; Gene; Genetics","score_opus":0.08483545460264628,"score_gpt":0.45442803077028016,"score_spread":0.36959257616763386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245892875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947285,0.0011180309,0.0025553997,0.000081114915,0.000009513445,0.000033043416,0.0010790678,0.000053349486,0.00034201043],"genre_scores_gemma":[0.9958165,0.00015565255,0.002146134,0.000036333804,0.000008576163,0.000020750467,0.0016628364,0.000005605696,0.00014769938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997191,0.000057522688,0.00002714548,0.00007240824,0.00009514463,0.000028725859],"domain_scores_gemma":[0.9994867,0.00014328278,0.000163766,0.000047429465,0.00010948397,0.000049335682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006457945,0.00025250672,0.0004864856,0.0006035641,0.00014949945,0.00044056572,0.0001912144,0.00021760853,0.0008160857],"category_scores_gemma":[0.0011366388,0.00008283289,0.00026524015,0.0005470492,0.0002033087,0.00016537833,0.0002380142,0.00024127925,0.00030469228],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013651783,0.00018860286,0.7655778,0.00034420472,0.00025217762,0.00021577487,0.00007672821,0.0024213623,0.16741385,0.0001474197,0.0008590465,0.06113784],"study_design_scores_gemma":[0.0000674031,0.0009591957,0.929287,0.000040541163,0.00034337363,0.0013188169,0.00011382234,0.013477222,0.05179477,0.00038784553,0.0021894914,0.000020548516],"about_ca_topic_score_codex":0.0004342381,"about_ca_topic_score_gemma":0.00084912434,"teacher_disagreement_score":0.0008160857,"about_ca_system_score_codex":0.0002755354,"about_ca_system_score_gemma":0.00045181214,"threshold_uncertainty_score":0.0034153461},"labels":[],"label_agreement":null},{"id":"W4253016827","doi":"10.1158/1078-0432.ccr-14-1648","title":"Correction: <i>Bim</i> Polymorphisms: Influence on Function and Response to Treatment in Children with Acute Lymphoblastic Leukemia","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lymphoblastic Leukemia; Medicine; Oncology; Gain of function; Cancer research; Immunology; Leukemia; Biology; Genetics; Mutation; Gene","score_opus":0.04091675697615162,"score_gpt":0.39659206627390964,"score_spread":0.35567530929775804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253016827","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005450639,0.0010272685,0.0009925683,0.15130131,0.8428967,0.000027992552,0.0016106074,0.00045055925,0.0011479403],"genre_scores_gemma":[0.049802985,0.007158737,0.008823883,0.25724733,0.5859465,0.00032445265,0.0033671618,0.0020465986,0.08528234],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.994628,0.0012057658,0.001030417,0.00069229584,0.0018831235,0.00056045945],"domain_scores_gemma":[0.9582634,0.016465306,0.0027808493,0.0021700049,0.01864074,0.001679779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062512043,0.0020834685,0.0020023277,0.0025116308,0.0021128522,0.0029902917,0.003346541,0.0073269843,0.02342265],"category_scores_gemma":[0.09827849,0.00096741266,0.0020657876,0.0017147152,0.0020618918,0.0016391394,0.0017521074,0.011784655,0.011485287],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007289211,0.0000051010916,0.00025691887,0.00012761926,0.000031288826,0.00055403524,0.0000713321,0.000047461257,0.00006235399,0.0005587774,0.99337137,0.0048408294],"study_design_scores_gemma":[0.00024423885,0.000053334385,0.0034398607,0.0008635637,0.00023785184,0.003759078,0.0002583411,0.0008989859,0.000847782,0.0034897167,0.98579955,0.0001078405],"about_ca_topic_score_codex":0.014540265,"about_ca_topic_score_gemma":0.010533265,"teacher_disagreement_score":0.02342265,"about_ca_system_score_codex":0.0034891728,"about_ca_system_score_gemma":0.004721279,"threshold_uncertainty_score":0.07835662},"labels":[],"label_agreement":null},{"id":"W4255988408","doi":"10.1158/1078-0432.ccr-18-3495","title":"DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies—Response","year":2019,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Identification (biology); Medicine; Environmental health; Biology","score_opus":0.18028178170922693,"score_gpt":0.5100405164702307,"score_spread":0.3297587347610038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255988408","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008882543,0.00062631787,0.00009148036,0.9867889,0.010490777,0.00002210677,0.00008125839,0.00001822575,0.0009926644],"genre_scores_gemma":[0.0069873733,0.0011539122,0.0005131022,0.95278156,0.035484876,0.00008319449,0.00010090477,0.000015458172,0.0028796007],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963406,0.0011817057,0.0007443917,0.00041646906,0.00075026334,0.00056654133],"domain_scores_gemma":[0.9868558,0.0057566455,0.0009616826,0.00042196846,0.002847402,0.0031564368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038109694,0.0007080484,0.001414622,0.00095589855,0.0028533032,0.0029600395,0.0017683972,0.042362355,0.0036165821],"category_scores_gemma":[0.026859052,0.00069473207,0.0013397442,0.0008595126,0.0016404705,0.0023464877,0.001993164,0.026104096,0.00241905],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000109673005,0.00013970479,0.008720495,0.000099709,0.000033111795,0.0030333512,0.00024197505,0.00012548004,0.0003335045,0.0012849758,0.9684973,0.01738084],"study_design_scores_gemma":[0.0007851938,0.00048221418,0.022967279,0.001888803,0.00015580909,0.007960573,0.0028138317,0.0023341617,0.0007249124,0.010087782,0.9495942,0.00020524066],"about_ca_topic_score_codex":0.0090951435,"about_ca_topic_score_gemma":0.012254485,"teacher_disagreement_score":0.042362355,"about_ca_system_score_codex":0.0038658145,"about_ca_system_score_gemma":0.00608795,"threshold_uncertainty_score":0.028048515},"labels":[],"label_agreement":null},{"id":"W4280651407","doi":"10.1158/1078-0432.ccr-21-3811","title":"VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors – Efficacy, Safety, and Biomarker Results","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Ottawa Hospital; Sunnybrook Health Science Centre","funders":"Roche","keywords":"Fulvestrant; Venetoclax; Internal medicine; Medicine; Metastatic breast cancer; Oncology; Cancer; Clinical endpoint; Breast cancer; Hazard ratio; Estrogen receptor; Randomized controlled trial; Confidence interval; Leukemia; Chronic lymphocytic leukemia","score_opus":0.11383709289944145,"score_gpt":0.5007041477483942,"score_spread":0.3868670548489528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280651407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98923033,0.0026990145,0.000531719,0.00047450542,0.00026203255,0.0029770262,0.001096785,0.00010788832,0.0026206342],"genre_scores_gemma":[0.988206,0.0014822813,0.0010964018,0.0007251665,0.00018383808,0.001844947,0.0018247269,0.000021928161,0.0046145525],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994295,0.00033958323,0.000019746105,0.00008687814,0.000039911974,0.000084262705],"domain_scores_gemma":[0.99911433,0.00017705085,0.00019544363,0.00009472765,0.000043303353,0.00037511918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019340364,0.0012221471,0.0013655331,0.00046224013,0.00026827637,0.0011347807,0.0009422402,0.0012384576,0.0068080863],"category_scores_gemma":[0.0012757655,0.0005223174,0.0008613778,0.0005084894,0.0012898117,0.0007775942,0.00040881225,0.0021904693,0.0009004711],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93545836,0.019596998,0.0013056219,0.0003241011,0.0005326711,0.00006291243,0.00007431604,0.00063980883,0.012009729,0.0002943122,0.0012083761,0.02849271],"study_design_scores_gemma":[0.8767454,0.11744345,0.003151263,0.000020855192,0.00022191292,0.00006204066,0.000026708176,0.0004628325,0.0007881829,0.00014648662,0.00091719656,0.000013767215],"about_ca_topic_score_codex":0.0010997395,"about_ca_topic_score_gemma":0.0030338778,"teacher_disagreement_score":0.0068080863,"about_ca_system_score_codex":0.00084753585,"about_ca_system_score_gemma":0.0013642854,"threshold_uncertainty_score":0.022775292},"labels":[],"label_agreement":null},{"id":"W4282922005","doi":"10.1158/1078-0432.ccr-20-4774","title":"Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Patients with Breast Cancer","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"National Human Genome Research Institute; National Cancer Institute; National Institutes of Health; Eli Lilly and Company; Universitätsklinikum Erlangen; National Institute of General Medical Sciences; Sanofi; AstraZeneca; Chugai Pharmaceutical; Breast Cancer Research Foundation","keywords":"Genome-wide association study; Biology; Locus (genetics); Genotyping; Breast cancer; Genotype; Chemotherapy; Genetic association; Genetics; Gene; Oncology; Cancer; Medicine; Single-nucleotide polymorphism","score_opus":0.06316643415099286,"score_gpt":0.4527562737164417,"score_spread":0.38958983956544885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282922005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991278,0.00029710788,0.00015960578,0.000049350056,0.0000037625603,0.0000052177234,0.00020366794,0.0000044738517,0.00014905185],"genre_scores_gemma":[0.9994741,0.000056020777,0.00016104737,0.000027634425,0.000004636923,0.00000500585,0.00018584142,0.0000016532954,0.000084154985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996691,0.00009070771,0.000038953418,0.000103277285,0.00005335962,0.000044538752],"domain_scores_gemma":[0.99939895,0.00013838883,0.0003254224,0.000045686607,0.00003347094,0.000058083315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037990353,0.00026265168,0.00026280948,0.00038115928,0.00022803918,0.00039040955,0.00023355211,0.00043652387,0.0013568592],"category_scores_gemma":[0.0014449883,0.0001288634,0.0003247509,0.0006843611,0.00020942274,0.00010775078,0.00023698204,0.00031815452,0.00013484777],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010388229,0.00006553053,0.98892784,0.000037577975,0.0002093975,0.00023029576,0.00004625199,0.00015050094,0.005159133,0.000046057965,0.0001102873,0.0039782166],"study_design_scores_gemma":[0.000051669518,0.00014290038,0.998108,0.000008501629,0.00011355165,0.00046185325,0.00003796673,0.00027541854,0.0005595867,0.00006186379,0.00017527315,0.0000032964817],"about_ca_topic_score_codex":0.0013564754,"about_ca_topic_score_gemma":0.0016726466,"teacher_disagreement_score":0.0013568592,"about_ca_system_score_codex":0.00021150426,"about_ca_system_score_gemma":0.00021892795,"threshold_uncertainty_score":0.0045391917},"labels":[],"label_agreement":null},{"id":"W4282935821","doi":"10.1158/1078-0432.ccr-21-4020","title":"First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Genentech","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Adverse effect; Pharmacokinetics; Cancer; Nausea; Agonist; Oncology; Gastroenterology; Receptor","score_opus":0.11390939730489072,"score_gpt":0.5092122895520722,"score_spread":0.3953028922471815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282935821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925417,0.0021976933,0.00063371443,0.0002934396,0.00007513561,0.0021267207,0.0008055638,0.000094973344,0.0012311516],"genre_scores_gemma":[0.98982227,0.001961238,0.0018458058,0.00037736364,0.00011450228,0.0014669702,0.001601693,0.000035242305,0.002775068],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999653,0.00017934508,0.00001401914,0.000043278793,0.000030237767,0.00008007609],"domain_scores_gemma":[0.9996111,0.000054101853,0.00008039418,0.00003735166,0.000028130538,0.0001888976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012565318,0.0013821675,0.0015471522,0.00023086347,0.00036095944,0.0006451012,0.0006739275,0.0007904868,0.003533021],"category_scores_gemma":[0.00044150182,0.00052082894,0.00085550355,0.00025673705,0.00075470086,0.00057041354,0.00029687386,0.0027591793,0.0008569003],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37590912,0.122237176,0.016552093,0.0023932958,0.0017817048,0.000829651,0.00085066643,0.006086911,0.26482835,0.0005373893,0.00848392,0.19950977],"study_design_scores_gemma":[0.23191722,0.7260371,0.015607998,0.000055077227,0.00041188727,0.0007902427,0.00007643144,0.0010021364,0.017546033,0.00015558473,0.006369456,0.000030934854],"about_ca_topic_score_codex":0.0006540726,"about_ca_topic_score_gemma":0.0022222109,"teacher_disagreement_score":0.003533021,"about_ca_system_score_codex":0.0006995248,"about_ca_system_score_gemma":0.001383972,"threshold_uncertainty_score":0.011819184},"labels":[],"label_agreement":null},{"id":"W4282937035","doi":"10.1158/1078-0432.ccr-21-3648","title":"Improved Efficacy of Tafasitamab plus Lenalidomide versus Systemic Therapies for Relapsed/Refractory DLBCL: RE-MIND2, an Observational Retrospective Matched Cohort Study","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; University of Alberta","funders":"National Cancer Institute","keywords":"Lenalidomide; Medicine; Internal medicine; Rituximab; Hazard ratio; Clinical endpoint; Propensity score matching; Diffuse large B-cell lymphoma; Oncology; Cohort; Surgery; Lymphoma; Multiple myeloma; Clinical trial; Confidence interval","score_opus":0.3554271189949901,"score_gpt":0.5253473410827839,"score_spread":0.16992022208779384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282937035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983911,0.0005414841,0.00017896536,0.000036746373,0.000017389319,0.000050257335,0.00061332213,0.000004131515,0.00016666029],"genre_scores_gemma":[0.9983682,0.00013157586,0.00017832068,0.00008017523,0.000036411864,0.000036396934,0.00108204,0.0000025303518,0.000084339554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987226,0.00044134547,0.0001446435,0.00043413314,0.00016420265,0.00009308309],"domain_scores_gemma":[0.9975897,0.00031578974,0.0012225934,0.00042638875,0.00015268367,0.00029274714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022263792,0.00039686338,0.00065072096,0.00035535273,0.00030699992,0.00075094815,0.00056880433,0.00040670956,0.0008667805],"category_scores_gemma":[0.0034112318,0.00033464623,0.0011387869,0.00044117807,0.0002457066,0.00040727892,0.00051197334,0.00064475456,0.00019646718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02869971,0.0009130748,0.9547363,0.00012611522,0.0030076334,0.0002078309,0.00012294295,0.0002657316,0.0023013956,0.000085332686,0.0007333964,0.008800576],"study_design_scores_gemma":[0.0057484913,0.0076842154,0.9768346,0.000046980007,0.0025294821,0.0011695281,0.00022506081,0.0019938778,0.0008665906,0.00014542247,0.002719653,0.0000361376],"about_ca_topic_score_codex":0.001325903,"about_ca_topic_score_gemma":0.0025943446,"teacher_disagreement_score":0.0022263792,"about_ca_system_score_codex":0.0006588412,"about_ca_system_score_gemma":0.0005556462,"threshold_uncertainty_score":0.011774361},"labels":[],"label_agreement":null},{"id":"W4282945728","doi":"10.1158/1078-0432.ccr-22-0541","title":"PD-L1 Crosslinking as a New Strategy of 4-1BB Agonism Immunotherapy","year":2022,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NYU Grossman School of Medicine; York University; U.S. Department of Veterans Affairs","keywords":"Immunotherapy; Agonism; Cancer immunotherapy; Tumor microenvironment; Immune system; Cancer research; Medicine; Immunology; Political science","score_opus":0.3209360935131581,"score_gpt":0.5552180262642052,"score_spread":0.23428193275104714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282945728","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037947115,0.097265534,0.014000074,0.760276,0.048262287,0.00041063767,0.0001911111,0.0006485874,0.040998742],"genre_scores_gemma":[0.2601124,0.066156924,0.012162697,0.5338734,0.080272585,0.0007086658,0.00018320847,0.00011614096,0.046413995],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99962974,0.00012916801,0.000030078278,0.000055348177,0.00010674318,0.000048957074],"domain_scores_gemma":[0.9997043,0.00018022874,0.000019303412,0.000022217922,0.000030032365,0.000043854096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064079807,0.0004533067,0.0005107803,0.0002879957,0.0005450657,0.00087305816,0.00039330366,0.0060797087,0.0015828785],"category_scores_gemma":[0.0011805558,0.0002290354,0.00056592555,0.00014432357,0.0010917875,0.0009877251,0.00038986784,0.0072872248,0.0017857688],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00171484,0.0010415944,0.0019466209,0.0011965976,0.00014695995,0.040983908,0.0003495955,0.002749952,0.040175304,0.055988226,0.5709291,0.28277725],"study_design_scores_gemma":[0.0011042664,0.0009773597,0.0011513586,0.0002164451,0.00006305126,0.027049003,0.00010841174,0.0032373164,0.016636956,0.035234094,0.914154,0.000067817244],"about_ca_topic_score_codex":0.00016749823,"about_ca_topic_score_gemma":0.0004445702,"teacher_disagreement_score":0.0060797087,"about_ca_system_score_codex":0.001127711,"about_ca_system_score_gemma":0.00040929954,"threshold_uncertainty_score":0.008182108},"labels":[],"label_agreement":null},{"id":"W4285026485","doi":"10.1158/1078-0432.ccr-21-3817","title":"Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary","funders":"National Cancer Institute; Medical Research Council; National Institutes of Health; BC Cancer Foundation; Servier; Cancer Institute NSW; Department of Health and Social Care; Evans Medical Foundation; National Institute for Health and Care Research; National Health and Medical Research Council; American Society of Hematology; Cancer Research UK; Michael Smith Health Research BC; Cycle for Survival; Bristol-Myers Squibb; AstraZeneca; Damon Runyon Cancer Research Foundation; NIHR Cambridge Biomedical Research Centre; Breast Cancer Research Foundation","keywords":"Disease; Ovarian carcinoma; Ovarian cancer; Carcinoma; Medicine; Oncology; Pathology; Internal medicine; Biology; Cancer","score_opus":0.08317223521178556,"score_gpt":0.4592187793860846,"score_spread":0.376046544174299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285026485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99833846,0.0006518099,0.00038899772,0.000030835017,0.0000040357772,0.00001805714,0.00033694334,0.000008037245,0.0002227597],"genre_scores_gemma":[0.9987997,0.000109661516,0.0002517081,0.000022424636,0.0000084873745,0.000015352272,0.00071502157,0.000006717178,0.000070961585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99944144,0.00008323135,0.00006923746,0.00017835753,0.00014511889,0.000082645405],"domain_scores_gemma":[0.99830097,0.00039271385,0.0007341071,0.00017971179,0.00018063157,0.00021186254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086910406,0.00028800502,0.0005590018,0.0013511968,0.00038096818,0.00084967504,0.00024200269,0.0003934775,0.0011388052],"category_scores_gemma":[0.0024060465,0.00013938759,0.00033987532,0.0005831181,0.0003513602,0.000339612,0.0004824824,0.00030996118,0.00023659282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044987362,0.000024597273,0.9871365,0.000026406342,0.00008155599,0.000070399925,0.00005035513,0.000102103586,0.008482556,0.000042788943,0.000069261696,0.003463562],"study_design_scores_gemma":[0.000016219214,0.00012473337,0.995695,0.000011195222,0.000053555188,0.00078723894,0.00018770127,0.0006563093,0.0018747667,0.00015407422,0.0004334168,0.000005861775],"about_ca_topic_score_codex":0.0011652347,"about_ca_topic_score_gemma":0.0014372387,"teacher_disagreement_score":0.0013511968,"about_ca_system_score_codex":0.00036682413,"about_ca_system_score_gemma":0.0003317606,"threshold_uncertainty_score":0.0045963526},"labels":[],"label_agreement":null},{"id":"W4286716459","doi":"10.1158/1078-0432.ccr-22-1780","title":"WNT Medulloblastoma Limbo: How Low Can We Go?","year":2022,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Wnt signaling pathway; Medicine; Biology; Internet privacy; Cancer research; Computer science; Genetics","score_opus":0.256441914147651,"score_gpt":0.5087600331448544,"score_spread":0.2523181189972034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286716459","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017154159,0.0060938867,0.00013578536,0.98462325,0.0050747246,0.000011831956,0.00005093573,0.000031728465,0.0022625618],"genre_scores_gemma":[0.028995754,0.019125864,0.0010488589,0.8987538,0.044713095,0.00006682271,0.00012366954,0.0000551622,0.0071168705],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991472,0.00024249386,0.00014378552,0.000090750145,0.00024838062,0.00012745547],"domain_scores_gemma":[0.998242,0.0007891078,0.0001333452,0.000068029,0.00036305518,0.0004043998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012040989,0.00051809376,0.0009878041,0.00056135457,0.0015313225,0.0015633345,0.0008463052,0.0149016725,0.0024948413],"category_scores_gemma":[0.009180681,0.00030919735,0.0007731716,0.00045213694,0.001657392,0.0038743087,0.000774192,0.018017888,0.0036591317],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028547843,0.00014166198,0.008078522,0.00033142566,0.00006337056,0.023894485,0.0003113067,0.00042265517,0.001654186,0.0061465655,0.85451734,0.104153074],"study_design_scores_gemma":[0.00038802018,0.00046792836,0.009594155,0.0016114892,0.00017681159,0.08194764,0.0019944664,0.001710113,0.0014269191,0.0557035,0.844804,0.0001750269],"about_ca_topic_score_codex":0.006706439,"about_ca_topic_score_gemma":0.011768179,"teacher_disagreement_score":0.0149016725,"about_ca_system_score_codex":0.003381118,"about_ca_system_score_gemma":0.0024852573,"threshold_uncertainty_score":0.024531841},"labels":[],"label_agreement":null},{"id":"W4290975632","doi":"10.1158/1078-0432.ccr-22-1623","title":"Taking the Road Less Traveled: Following Molecular Trail Markers","year":2022,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Scope (computer science); Medicine; Targeted therapy; Cancer; Internal medicine","score_opus":0.2958377884899446,"score_gpt":0.5160971397425603,"score_spread":0.22025935125261575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290975632","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00092465826,0.0039719874,0.0003659315,0.9769521,0.013992349,0.00001652028,0.00004260752,0.000045415414,0.0036884465],"genre_scores_gemma":[0.011210772,0.0062022926,0.00079483277,0.9349852,0.037815925,0.00003206101,0.000064237356,0.000035854475,0.00885873],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982868,0.0006422435,0.00017817746,0.00016380979,0.00049749424,0.00023153576],"domain_scores_gemma":[0.9962566,0.0017617116,0.0002669728,0.00019300652,0.0007403686,0.0007813381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017289789,0.00048979546,0.0009307625,0.0005070768,0.0021459605,0.0023201795,0.00079206756,0.014302524,0.00488382],"category_scores_gemma":[0.014472274,0.00031763353,0.00083844905,0.00046922648,0.0016899864,0.0039504883,0.0008486204,0.021480257,0.0055148075],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011316581,0.00006617473,0.0014635669,0.00009096614,0.000021815515,0.0048607183,0.00012954148,0.00013141493,0.00057275826,0.0033840274,0.9289098,0.060256053],"study_design_scores_gemma":[0.00021956007,0.00027618802,0.0024635615,0.0005356661,0.000053594464,0.018609483,0.0008248416,0.0007667786,0.00058132794,0.028798822,0.94679433,0.000075912816],"about_ca_topic_score_codex":0.0029699958,"about_ca_topic_score_gemma":0.0058529535,"teacher_disagreement_score":0.014302524,"about_ca_system_score_codex":0.0026428478,"about_ca_system_score_gemma":0.002233392,"threshold_uncertainty_score":0.01917535},"labels":[],"label_agreement":null},{"id":"W4293145363","doi":"10.1158/1078-0432.1319.11.3","title":"Transcriptional Profiling Identifies Gene Expression Changes Associated with IFN-α Tolerance in Hepatitis C–Related Hepatocellular Carcinoma Cells","year":2005,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Hepatocellular carcinoma; Hepatitis C virus; Biology; Gene expression; Gene expression profiling; DNA microarray; Cell culture; Microarray; Hepatitis B virus; Gene; Microarray analysis techniques; Interferon; Fold change; Virology; Cancer research; Cytotoxic T cell; Molecular biology; Virus; Genetics; In vitro","score_opus":0.09923167277216344,"score_gpt":0.38477752177957,"score_spread":0.28554584900740654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293145363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947127,0.0008962587,0.0020162957,0.00005911704,0.000016892598,0.000033283763,0.0013942583,0.00003346448,0.00083776575],"genre_scores_gemma":[0.9918445,0.0007215508,0.0021180583,0.00007879119,0.000015002554,0.00008926994,0.003251898,0.000013079184,0.0018678015],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999859,0.000016567934,0.000012059604,0.00004088397,0.00004387749,0.000027626356],"domain_scores_gemma":[0.9999019,0.000017124092,0.00002467676,0.000011542471,0.000027995306,0.000016691845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114240735,0.00019502557,0.00028177013,0.0003747674,0.0002186311,0.0003205781,0.000104202896,0.00018260133,0.0009783566],"category_scores_gemma":[0.00013503396,0.00009553627,0.00022966565,0.00058630947,0.00017691983,0.00012202243,0.00015220854,0.00031615284,0.00044889847],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016448105,0.000024633848,0.0021421288,0.00003387794,0.0000057362076,0.000030911473,0.000030714295,0.000039776904,0.9966079,0.000025886831,0.000028895349,0.00086517446],"study_design_scores_gemma":[0.00002161506,0.00044567315,0.23783176,0.000017990646,0.00006584025,0.00035658476,0.0004139798,0.003141572,0.75517416,0.00012190593,0.0023926161,0.000016407042],"about_ca_topic_score_codex":0.0005485875,"about_ca_topic_score_gemma":0.0006774579,"teacher_disagreement_score":0.0009783566,"about_ca_system_score_codex":0.0002373975,"about_ca_system_score_gemma":0.0002117979,"threshold_uncertainty_score":0.003272891},"labels":[],"label_agreement":null},{"id":"W4293253462","doi":"10.1158/1078-0432.ccr-22-1183","title":"Outcomes in Patients with Poor-Risk Cytogenetics with or without <i>TP53</i> Mutations Treated with Venetoclax and Azacitidine","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Genentech","keywords":"Venetoclax; Azacitidine; Cytogenetics; Medicine; Oncology; Genetics; Internal medicine; Biology; Leukemia; DNA methylation; Gene; Chromosome; Chronic lymphocytic leukemia","score_opus":0.10386829991800524,"score_gpt":0.45484040116070207,"score_spread":0.35097210124269684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293253462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989519,0.00065367506,0.000050964416,0.000029531659,0.0000067410497,0.000015811742,0.00008925319,0.0000024674046,0.00019957809],"genre_scores_gemma":[0.99938095,0.0001327669,0.00006750125,0.00004549752,0.000016819673,0.000018855022,0.0002686081,8.413711e-7,0.00006818728],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997892,0.00007477512,0.000020196321,0.000050542323,0.000025624258,0.000039786308],"domain_scores_gemma":[0.9992768,0.0001905992,0.00030898,0.000033685807,0.000027017584,0.00016285144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045082,0.0001771646,0.000637932,0.00022979378,0.00025606574,0.00029184576,0.00016548985,0.00030967084,0.0010804906],"category_scores_gemma":[0.001030921,0.000084239335,0.0003579782,0.00028361255,0.00025051043,0.00024674894,0.00020387999,0.00040713645,0.000119416465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058760654,0.00082904677,0.8936385,0.00018860228,0.000661693,0.00058955105,0.00019669018,0.0011316373,0.008859308,0.00008338288,0.000538394,0.03452254],"study_design_scores_gemma":[0.0050934376,0.02318774,0.96441114,0.00005429299,0.00078160956,0.001994593,0.00016171389,0.0010814872,0.0018258307,0.00017498586,0.0012119887,0.000021073361],"about_ca_topic_score_codex":0.000622863,"about_ca_topic_score_gemma":0.0015043755,"teacher_disagreement_score":0.0010804906,"about_ca_system_score_codex":0.0003629328,"about_ca_system_score_gemma":0.00029189527,"threshold_uncertainty_score":0.0036146045},"labels":[],"label_agreement":null},{"id":"W4293493167","doi":"10.1158/1078-0432.ccr-22-1665","title":"A Phase II Randomized Trial of Chemoradiation with or without Metformin in Locally Advanced Cervical Cancer","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Princess Margaret Cancer Centre; London Health Sciences Centre; Ontario Institute for Cancer Research; University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute; Radiological Society of North America","keywords":"Metformin; Medicine; Tumor hypoxia; Clinical endpoint; Cervical cancer; Internal medicine; Cancer; Phases of clinical research; Hypoxia (environmental); Randomized controlled trial; Nuclear medicine; Gastroenterology; Clinical trial; Radiation therapy; Insulin","score_opus":0.09879995500953231,"score_gpt":0.4950499952168761,"score_spread":0.3962500402073438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293493167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870745,0.0024218636,0.0004199052,0.00067779096,0.00062121,0.0067718397,0.000644166,0.00006704968,0.0013017663],"genre_scores_gemma":[0.9804905,0.0019065932,0.0017074333,0.001214452,0.0005839287,0.009792839,0.0008135845,0.00002583971,0.003464725],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992488,0.00042156767,0.00003636059,0.00013240986,0.000048221988,0.000112638845],"domain_scores_gemma":[0.9989667,0.00026769956,0.00025114662,0.00009973482,0.000062552004,0.00035222425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018373757,0.002017772,0.003035397,0.0006044688,0.0004820622,0.0011543313,0.000988854,0.0019386801,0.007271233],"category_scores_gemma":[0.0020234212,0.0007653579,0.0016205189,0.0004803927,0.0012211413,0.0011135739,0.0005134301,0.0028523863,0.0009725264],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9827696,0.0088404175,0.0003555662,0.00026788271,0.0003542847,0.000023253855,0.000024624924,0.00018516839,0.0018613146,0.000050923398,0.0002629676,0.00500389],"study_design_scores_gemma":[0.9232061,0.07494922,0.0007569194,0.000014920945,0.00020779266,0.000015874632,0.000015148331,0.00021077224,0.0002541017,0.00007275478,0.000288274,0.000008055259],"about_ca_topic_score_codex":0.00080729125,"about_ca_topic_score_gemma":0.0022293918,"teacher_disagreement_score":0.007271233,"about_ca_system_score_codex":0.0009618661,"about_ca_system_score_gemma":0.0015225412,"threshold_uncertainty_score":0.024324715},"labels":[],"label_agreement":null},{"id":"W4293755987","doi":"10.1158/1078-0432.ccr-22-0931","title":"Detection of <i>BRCA1</i> , <i>BRCA2</i> , and <i>ATM</i> Alterations in Matched Tumor Tissue and Circulating Tumor DNA in Patients with Prostate Cancer Screened in PROfound","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; BC Cancer Agency","funders":"MSD K.K.; Merck Sharp and Dohme; Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Cancer; Prostate cancer; Concordance; Prostate; Oncology; Internal medicine; Cancer research; Frameshift mutation; Pathology; Gene; Mutation; Biology; Genetics","score_opus":0.07236811365894866,"score_gpt":0.42781302760158463,"score_spread":0.355444913942636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293755987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99933165,0.00018340946,0.00012428238,0.000010755172,0.0000011308593,0.000010968764,0.00007374886,0.000008050115,0.00025598358],"genre_scores_gemma":[0.9995289,0.000036193767,0.00022161918,0.00002433935,0.0000021062917,0.000004592218,0.00013023849,0.0000013844985,0.000050585677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969566,0.00008901555,0.000024825886,0.00009213403,0.00006915977,0.000029354323],"domain_scores_gemma":[0.9995994,0.00010605059,0.00012797365,0.000033480785,0.00004737062,0.000085741456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053016125,0.00020850163,0.00021330305,0.00035066504,0.00015111166,0.00029396106,0.00022068314,0.00020269104,0.0006359684],"category_scores_gemma":[0.0010426665,0.00014990414,0.00014154478,0.00018305283,0.000227715,0.00012679119,0.00023560709,0.00020686087,0.00010807511],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021812683,0.00012750097,0.9582235,0.000049401842,0.000051337465,0.00019884181,0.00012909684,0.00035138073,0.024381384,0.000038793558,0.0001861061,0.014081344],"study_design_scores_gemma":[0.00017535921,0.0037891192,0.9769208,0.000020085476,0.0001216006,0.0024897614,0.00013342126,0.0013434734,0.014293129,0.000059324357,0.00064475805,0.000009103014],"about_ca_topic_score_codex":0.0012071461,"about_ca_topic_score_gemma":0.0020122,"teacher_disagreement_score":0.0012071461,"about_ca_system_score_codex":0.00025114106,"about_ca_system_score_gemma":0.00023447606,"threshold_uncertainty_score":0.0028038025},"labels":[],"label_agreement":null},{"id":"W4295279694","doi":"10.1158/1078-0432.ccr-22-2365","title":"Multi-omics Uncovering Different Faces of Clear Cell Ovarian Cancer","year":2022,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ovarian cancer; Histopathology; Transcriptome; Omics; Cancer; Bioinformatics; Medicine; Computational biology; Biology; Oncology; Pathology; Internal medicine; Gene; Genetics; Gene expression","score_opus":0.29137582988529676,"score_gpt":0.5071514451621641,"score_spread":0.2157756152768674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295279694","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006977791,0.003870688,0.00040094473,0.9732261,0.019171504,0.000019895115,0.000098369834,0.000057587313,0.0024572907],"genre_scores_gemma":[0.00977892,0.0068689873,0.00092889665,0.9000718,0.07591299,0.00005966838,0.00013221354,0.0000535745,0.00619289],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9967752,0.0012329646,0.00038607663,0.00031887187,0.0010112333,0.00027568205],"domain_scores_gemma":[0.9890254,0.006610079,0.00035425753,0.00042757337,0.0025096522,0.0010729743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045481925,0.0006678919,0.0013920274,0.000896662,0.0021887212,0.0026031951,0.0012181005,0.019373627,0.0037652596],"category_scores_gemma":[0.018646898,0.00063915184,0.0011348466,0.0005977642,0.0020033552,0.0029170394,0.0012360746,0.023494525,0.005503626],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011630637,0.000034258115,0.0011558428,0.00008212462,0.000024933128,0.0031212638,0.00007973702,0.000097989396,0.00066347694,0.002055788,0.9567514,0.0358169],"study_design_scores_gemma":[0.00028398968,0.00020964803,0.0033425724,0.00054763415,0.00008754579,0.014113876,0.00057584635,0.0017432715,0.0012317956,0.031098958,0.9466663,0.0000986421],"about_ca_topic_score_codex":0.0036983902,"about_ca_topic_score_gemma":0.006969146,"teacher_disagreement_score":0.019373627,"about_ca_system_score_codex":0.0036801347,"about_ca_system_score_gemma":0.0026396022,"threshold_uncertainty_score":0.02670139},"labels":[],"label_agreement":null},{"id":"W4295926274","doi":"10.1158/1557-3265.sarcomas22-ia004","title":"Abstract IA004: Mesenchymal progenitors and sarcomagenesis","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Mesenchymal stem cell; Biology; Malignancy; Progenitor cell; Synovial sarcoma; Cancer research; Oncogene; Gene expression profiling; Sarcoma; Pathology; Cell; Gene expression; Cell biology; Stem cell; Medicine; Gene; Cell cycle; Genetics","score_opus":0.3176879498878943,"score_gpt":0.5495010493922831,"score_spread":0.23181309950438878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295926274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94932705,0.008135813,0.012070954,0.00065478886,0.00014417958,0.000076097895,0.0030235057,0.00067169184,0.025895907],"genre_scores_gemma":[0.9602737,0.002991263,0.0046021007,0.00018442342,0.000049957398,0.00005708008,0.0037593984,0.00012160916,0.027960509],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998957,0.0000114637,0.000009244113,0.00002583291,0.000037116184,0.000020676755],"domain_scores_gemma":[0.9998367,0.000018025474,0.000046463025,0.000015266949,0.000024440249,0.000059102807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012704231,0.00025484868,0.0001802525,0.0006798406,0.00026348667,0.0007236163,0.00027765826,0.00040323855,0.003488836],"category_scores_gemma":[0.00015070286,0.00015967224,0.00016089983,0.00038473855,0.0002714627,0.00018093147,0.00046362597,0.0007440006,0.0017087904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011357854,0.000048921876,0.001879688,0.00008278103,0.00000380433,0.0003250214,0.00004744883,0.00019886717,0.9855237,0.0018835954,0.00066088233,0.009231717],"study_design_scores_gemma":[0.000030302268,0.00040603208,0.033479046,0.00007169077,0.000027487657,0.0023758104,0.00019245275,0.0024111453,0.90152043,0.0016617692,0.05780634,0.000017516613],"about_ca_topic_score_codex":0.00068527024,"about_ca_topic_score_gemma":0.0006139723,"teacher_disagreement_score":0.003488836,"about_ca_system_score_codex":0.00040077532,"about_ca_system_score_gemma":0.00036347794,"threshold_uncertainty_score":0.011671305},"labels":[],"label_agreement":null},{"id":"W4295926377","doi":"10.1158/1557-3265.sarcomas22-ia013","title":"Abstract IA013: Rhabdomyosarcoma: visions through the looking glass","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Skeletal muscle; Rhabdomyosarcoma; Biology; Reprogramming; Myogenesis; Progenitor cell; Transdifferentiation; PAX3; Cell biology; Hedgehog signaling pathway; Cancer research; Pathology; Stem cell; Endocrinology; Sarcoma; Cell; Medicine; Genetics; Signal transduction; Transcription factor","score_opus":0.3047955314711789,"score_gpt":0.5562692599534251,"score_spread":0.25147372848224625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295926377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4817471,0.03169836,0.029982727,0.022460693,0.0028033939,0.00024102515,0.0018941995,0.003153608,0.42601892],"genre_scores_gemma":[0.8523985,0.007189516,0.010022613,0.0023453536,0.00044166652,0.000033611577,0.0005406939,0.00023557054,0.12679252],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999392,0.000006341307,0.000004167092,0.000011110401,0.0000220021,0.000017174892],"domain_scores_gemma":[0.99994147,0.00000819058,0.000011429901,0.000007804766,0.000008940258,0.000022174732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010902482,0.0002398318,0.00014612945,0.0007299216,0.0004232841,0.0005811487,0.00021753137,0.0008578803,0.008646683],"category_scores_gemma":[0.00013340793,0.00014653771,0.00020922774,0.0002272049,0.0006180268,0.00052858517,0.00048090928,0.0008813009,0.0025322011],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007633233,0.00017510609,0.025072651,0.00062777195,0.000053243137,0.10015424,0.00083407894,0.0010871337,0.30033675,0.122151375,0.11297823,0.33576608],"study_design_scores_gemma":[0.000073918134,0.0005126074,0.025326798,0.0003359239,0.00007635668,0.39336792,0.00061257876,0.0021207104,0.06765376,0.03451992,0.47531283,0.00008671122],"about_ca_topic_score_codex":0.0015358917,"about_ca_topic_score_gemma":0.001946282,"teacher_disagreement_score":0.008646683,"about_ca_system_score_codex":0.0006111498,"about_ca_system_score_gemma":0.00033940742,"threshold_uncertainty_score":0.028926075},"labels":[],"label_agreement":null},{"id":"W4295926608","doi":"10.1158/1557-3265.sarcomas22-pr009","title":"Abstract PR009: A new invasive zebrafish model of ewing sarcoma reveals EWSR1-FLI1-driven dysregulation of heparan sulfate proteoglycan metabolism and ERK signaling in developing tumors","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Zebrafish; Biology; Tumor microenvironment; Sarcoma; Cancer research; FLI1; Angiogenesis; Metastasis; Oncogene; Cancer; Extracellular matrix; Tumor progression; Pathology; Cell biology; Medicine; Genetics; Cell cycle; Gene; Transcription factor","score_opus":0.2603058729008565,"score_gpt":0.46422186871624077,"score_spread":0.20391599581538428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295926608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9399794,0.0012877757,0.041097984,0.00092374766,0.0002139455,0.00040441286,0.007139993,0.0013480313,0.0076048374],"genre_scores_gemma":[0.9301481,0.001183506,0.029508315,0.00023352848,0.000027575843,0.0006342147,0.003748468,0.00046757067,0.034048628],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996798,0.000018181712,0.000027856313,0.00010009121,0.00011564459,0.000058474852],"domain_scores_gemma":[0.99976784,0.000023523642,0.00007791583,0.000022203723,0.00002794125,0.00008055483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024101808,0.0008929635,0.0005130899,0.0010270053,0.00046604726,0.00033737757,0.0007211369,0.000974553,0.0036837573],"category_scores_gemma":[0.00013696188,0.00041261455,0.0006549559,0.00024526936,0.0007844533,0.0005002267,0.0005352127,0.0016414962,0.0011814636],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054774253,0.000023373223,0.00007723583,0.000025879646,0.0000034603274,0.00016167438,0.000020344729,0.00010029644,0.99838006,0.0004505951,0.00009762574,0.00060467515],"study_design_scores_gemma":[0.00008213298,0.0004711614,0.0036512462,0.00002520262,0.000038786256,0.0009084424,0.00006215902,0.0028274318,0.983353,0.00034717825,0.008204362,0.000028802724],"about_ca_topic_score_codex":0.004669143,"about_ca_topic_score_gemma":0.0062468657,"teacher_disagreement_score":0.004669143,"about_ca_system_score_codex":0.0013005307,"about_ca_system_score_gemma":0.00074661395,"threshold_uncertainty_score":0.0123233795},"labels":[],"label_agreement":null},{"id":"W4295926931","doi":"10.1158/1557-3265.sarcomas22-b017","title":"Abstract B017: Tumor-secreted collagen VI weakens endothelium and promotes metastasis","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Intravasation; Extravasation; Metastasis; Sarcoma; Alveolar soft part sarcoma; Pathology; Cancer research; Synovial sarcoma; Extracellular matrix; Cancer; Tumor microenvironment; Medicine; Biology; Internal medicine; Cell biology","score_opus":0.11993578108711443,"score_gpt":0.4463411391255693,"score_spread":0.32640535803845483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295926931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8136637,0.06558651,0.015674464,0.020990325,0.00686383,0.00029829366,0.005572626,0.0015685466,0.069781505],"genre_scores_gemma":[0.85636365,0.02411768,0.004131147,0.0016475659,0.0012996778,0.00011950451,0.002882925,0.00010559974,0.10933227],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988806,0.000012758445,0.0000065797844,0.000026706057,0.000048911712,0.00001698133],"domain_scores_gemma":[0.9998735,0.000016047281,0.000026024663,0.000005542556,0.000035536304,0.000043313947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018517047,0.0004067702,0.00024867497,0.00039771345,0.0002547051,0.0005650952,0.00026539725,0.0005620375,0.012057664],"category_scores_gemma":[0.00021283804,0.0001279496,0.00019169085,0.00024428358,0.00024373266,0.0002633882,0.0002505637,0.0005789862,0.0022410834],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076869386,0.00013118172,0.0033965239,0.0007065633,0.000034328757,0.000913715,0.000045386667,0.00014148728,0.9319058,0.001733718,0.01786063,0.042362034],"study_design_scores_gemma":[0.0003240293,0.0017703045,0.08218162,0.00023825378,0.00012352644,0.004896835,0.0002109938,0.003346092,0.7450234,0.0013818515,0.16045351,0.000049537746],"about_ca_topic_score_codex":0.0010477763,"about_ca_topic_score_gemma":0.00095426885,"teacher_disagreement_score":0.012057664,"about_ca_system_score_codex":0.00048680237,"about_ca_system_score_gemma":0.00037597888,"threshold_uncertainty_score":0.040336907},"labels":[],"label_agreement":null},{"id":"W4295927922","doi":"10.1158/1557-3265.sarcomas22-a017","title":"Abstract A017: Multiple intratumoral sources of kit ligand promote oncogenic kit signaling in gastrointestinal stomal tumor","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"GiST; Cancer research; Biology; Imatinib; Sarcoma; Receptor tyrosine kinase; Proto-Oncogene Proteins c-kit; Tyrosine kinase; Stromal cell; Signal transduction; Haematopoiesis; Medicine; Pathology; Cell biology; Stem cell factor; Stem cell","score_opus":0.1788180577479082,"score_gpt":0.4708245986269581,"score_spread":0.29200654087904987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295927922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98263425,0.0013100288,0.0030848351,0.0004333398,0.0001494998,0.00006204604,0.0035355298,0.00040909913,0.008381434],"genre_scores_gemma":[0.9720619,0.0008027077,0.002939804,0.00026298882,0.000048164617,0.00013342733,0.005089056,0.00014093568,0.018521076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998425,0.000011206243,0.000010726582,0.0000383476,0.00006122508,0.000035895937],"domain_scores_gemma":[0.9998667,0.0000134604425,0.000024806372,0.000009946561,0.000016966595,0.00006818588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094293864,0.00033716843,0.0002587943,0.00040499077,0.0002139728,0.00051674293,0.00016472394,0.0003437364,0.010520506],"category_scores_gemma":[0.00008713754,0.00012786326,0.0002629925,0.00023346528,0.00026206463,0.0002258453,0.0002783161,0.00089933974,0.0030513695],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037719516,0.000060484377,0.00036478086,0.000061676496,0.0000059853837,0.00008395487,0.000012879488,0.000036144334,0.99593973,0.000112314025,0.00044332267,0.0025016295],"study_design_scores_gemma":[0.00008454053,0.0010609393,0.018053848,0.000023977329,0.000036062713,0.0007318352,0.00015305071,0.0012619955,0.9705275,0.00018464522,0.007872555,0.000008978492],"about_ca_topic_score_codex":0.00036388656,"about_ca_topic_score_gemma":0.00041264822,"teacher_disagreement_score":0.010520506,"about_ca_system_score_codex":0.00028632427,"about_ca_system_score_gemma":0.0002556937,"threshold_uncertainty_score":0.035194635},"labels":[],"label_agreement":null},{"id":"W4295928022","doi":"10.1158/1557-3265.sarcomas22-a029","title":"Abstract A029: SQ3370: CAPAC platform enables tumor-localized therapy and minimizes systemic toxicities","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Fibrosarcoma; Melanoma; Doxorubicin; Cardiotoxicity; Cancer research; Cancer; Tumor progression; Sarcoma; Pharmacology; Toxicity; Immune system; Chemotherapy; Pathology; Internal medicine; Immunology","score_opus":0.1882774525846776,"score_gpt":0.4036110118378102,"score_spread":0.21533355925313258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295928022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9682616,0.0010929361,0.013011681,0.00023249279,0.000098587385,0.00022237955,0.001928446,0.0011345072,0.014017413],"genre_scores_gemma":[0.98203987,0.00048701008,0.005084608,0.00012181187,0.000019049694,0.000103198945,0.0012346486,0.00009932764,0.0108103985],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988544,0.000009872579,0.0000049639134,0.000025193835,0.000049300088,0.000025184827],"domain_scores_gemma":[0.9999145,0.0000064864153,0.000021408183,0.000006743608,0.000024806184,0.000025998865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013210608,0.00042251532,0.00018573899,0.00025181024,0.000107052714,0.00024652155,0.0002104793,0.0004727609,0.0056854975],"category_scores_gemma":[0.00010644033,0.00014485119,0.00018208704,0.00018144664,0.000181461,0.00021008991,0.00016088356,0.0005001184,0.0015722563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016062536,0.000047005986,0.000091858754,0.00005582892,0.0000046854952,0.000051824965,0.000008315046,0.00019022326,0.9943845,0.00021392616,0.0008682108,0.0039229807],"study_design_scores_gemma":[0.000050810122,0.00092516793,0.0012868423,0.0000053615663,0.000013870183,0.00026557985,0.000008651821,0.0015742185,0.9880961,0.000047126585,0.007715029,0.000011336902],"about_ca_topic_score_codex":0.00073446264,"about_ca_topic_score_gemma":0.00081924524,"teacher_disagreement_score":0.0056854975,"about_ca_system_score_codex":0.00030989884,"about_ca_system_score_gemma":0.00027097526,"threshold_uncertainty_score":0.019019902},"labels":[],"label_agreement":null},{"id":"W4295941831","doi":"10.1158/1557-3265.sarcomas22-pr005","title":"Abstract PR005: PRC2 inactivating mutations amplify cell death in response to DNMT1-targeted therapy through enhanced viral mimicry in malignant peripheral nerve sheath tumor","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"PRC2; Cancer research; Biology; Context (archaeology); EZH2; Cancer; Epigenetics; Genetics","score_opus":0.1878447620197086,"score_gpt":0.5002895845280105,"score_spread":0.31244482250830197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295941831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986668,0.0014496793,0.0051316223,0.00021361042,0.000094239396,0.00014514188,0.0012790496,0.00040530568,0.004613462],"genre_scores_gemma":[0.9915105,0.00037324618,0.0022899306,0.000057781024,0.000008671499,0.00007023757,0.0008542794,0.000032684507,0.0048028454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982184,0.000021313146,0.000016993456,0.00003960079,0.000063860745,0.00003630402],"domain_scores_gemma":[0.9999274,0.0000137907255,0.00001858095,0.000009821062,0.000007892062,0.000022562552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018802301,0.000344505,0.00031171227,0.00023615046,0.0001291521,0.0002999722,0.0002503144,0.0002936426,0.0031747902],"category_scores_gemma":[0.00011960986,0.00011616665,0.00022722267,0.00016881332,0.00022592349,0.00020886994,0.00020064857,0.0008479381,0.00055556756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001586547,0.00006357852,0.0001249411,0.000031784697,0.000006847163,0.000034135075,0.000011179355,0.00011621592,0.9966904,0.00016272173,0.00017107087,0.0024285074],"study_design_scores_gemma":[0.000026233827,0.0007707801,0.0011199629,0.000002432744,0.000016849654,0.00017613961,0.000009118411,0.0011892498,0.9943988,0.000029640198,0.0022582689,0.00000265409],"about_ca_topic_score_codex":0.00090540375,"about_ca_topic_score_gemma":0.0009013793,"teacher_disagreement_score":0.0031747902,"about_ca_system_score_codex":0.00039280005,"about_ca_system_score_gemma":0.00022785224,"threshold_uncertainty_score":0.010620713},"labels":[],"label_agreement":null},{"id":"W4295941875","doi":"10.1158/1557-3265.sarcomas22-ia030","title":"Abstract IA030: A population-based, whole genome sequencing approach to mapping the genetic basis of mesenchymal malignancies","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Cancer; Sarcoma; Population; Germline; Cancer research; Genetics; Medicine; Pathology; Gene","score_opus":0.345362259371808,"score_gpt":0.46008287812621484,"score_spread":0.11472061875440687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295941875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8892334,0.00071852363,0.07803706,0.0005271483,0.00008316286,0.00057324115,0.022301449,0.000605031,0.007920977],"genre_scores_gemma":[0.9337292,0.00042906642,0.052249186,0.00046473273,0.00006702756,0.00047217766,0.008060562,0.00015447444,0.0043735355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951243,0.000169658,0.000022907347,0.00017605504,0.00008599292,0.000032979846],"domain_scores_gemma":[0.99955803,0.00018302636,0.000081595295,0.00006184594,0.000058443868,0.00005710134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00105583,0.0003250064,0.00029226314,0.0014347018,0.00032829618,0.0006109451,0.0003903591,0.00042520184,0.002929398],"category_scores_gemma":[0.0014503787,0.00020202501,0.00050994795,0.0011706187,0.00021989089,0.00007248719,0.00044842137,0.000555843,0.0004496269],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021006733,0.00039402762,0.41853765,0.00022392673,0.0016162597,0.0031757401,0.00086043106,0.009211196,0.39892146,0.006401158,0.014436301,0.14412118],"study_design_scores_gemma":[0.0003530179,0.0009845771,0.91369885,0.00004584806,0.0009009853,0.004824373,0.00038773392,0.019657277,0.029745758,0.0029603287,0.026377814,0.000063386826],"about_ca_topic_score_codex":0.0066877557,"about_ca_topic_score_gemma":0.010232716,"teacher_disagreement_score":0.0066877557,"about_ca_system_score_codex":0.0003212218,"about_ca_system_score_gemma":0.0005613864,"threshold_uncertainty_score":0.013297677},"labels":[],"label_agreement":null},{"id":"W4295941886","doi":"10.1158/1557-3265.sarcomas22-b019","title":"Abstract B019: BRCA1:NRF2 pathway as a new therapeutic target in ewing sarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"DNA damage; FLI1; PARP1; Cancer research; Biology; Transcription factor; Context (archaeology); Phenotype; RNA interference; Sarcoma; Cell biology; Bioinformatics; Medicine; Genetics; RNA; DNA; Gene; Pathology; Poly ADP ribose polymerase; Polymerase","score_opus":0.16525420234078558,"score_gpt":0.4926300326044087,"score_spread":0.3273758302636231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295941886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6148251,0.31561503,0.0139626,0.011996403,0.0028086505,0.00078913063,0.0034850102,0.0011844464,0.03533358],"genre_scores_gemma":[0.9077686,0.059798617,0.005711514,0.0021632006,0.0005113407,0.00028966484,0.0026575904,0.00005664732,0.021042878],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999423,0.0000124168755,0.0000059460804,0.000012060056,0.000012717954,0.0000144972355],"domain_scores_gemma":[0.9999591,0.0000055270048,0.000008019137,0.000004962007,0.000009294204,0.000013106778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028989735,0.00033845552,0.00042774156,0.00027450465,0.0001914189,0.00036487554,0.00028258044,0.0005820304,0.0064649805],"category_scores_gemma":[0.000084903535,0.00008914092,0.00036734922,0.00021507201,0.00017634484,0.00042351682,0.00027149866,0.0011202161,0.001358577],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005359007,0.0016209915,0.0009188287,0.0030975768,0.00017354707,0.001052823,0.00009354112,0.00060611556,0.76710093,0.004415878,0.01185361,0.2037071],"study_design_scores_gemma":[0.003171157,0.017634517,0.009357149,0.0006825065,0.00060274015,0.0056957793,0.00017731736,0.001625662,0.6469318,0.0047267023,0.30932987,0.0000646569],"about_ca_topic_score_codex":0.00015358861,"about_ca_topic_score_gemma":0.00030808803,"teacher_disagreement_score":0.0064649805,"about_ca_system_score_codex":0.00024885664,"about_ca_system_score_gemma":0.00025956033,"threshold_uncertainty_score":0.021627545},"labels":[],"label_agreement":null},{"id":"W4295941939","doi":"10.1158/1557-3265.sarcomas22-a009","title":"Abstract A009: Proteogenomic prioritization of immunotherapeutic targets in rhabdomyosarcoma nominate MEGF10 for preclinical development","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Computational biology; Fusion gene; Proteogenomics; Fusion protein; Computer science; Bioinformatics; Medicine; Gene; Biology; Gene expression; Transcriptome; Genetics","score_opus":0.29701397235758425,"score_gpt":0.5497866693933298,"score_spread":0.2527726970357455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295941939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.776267,0.0025273033,0.047994725,0.0011638558,0.0002724201,0.00058026396,0.14755547,0.013207048,0.01043197],"genre_scores_gemma":[0.5963819,0.0011055599,0.10884149,0.00038959933,0.00008510638,0.00046845575,0.28593913,0.001138644,0.0056501515],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995913,0.00004412647,0.000026801043,0.000116585965,0.00015557112,0.00006553822],"domain_scores_gemma":[0.9993655,0.00015111179,0.00010110683,0.00006293692,0.00020091815,0.00011840094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012312405,0.0009167189,0.0007254933,0.00197316,0.00045137215,0.0012711823,0.00045850824,0.00050501304,0.007208222],"category_scores_gemma":[0.0013083989,0.00022746285,0.000844329,0.0014217137,0.00021738186,0.00048042773,0.00076926325,0.00053294864,0.0035854878],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004916205,0.00074581994,0.10718749,0.0017568758,0.0007243778,0.0005403209,0.0001337096,0.016652295,0.5806373,0.002219742,0.10872655,0.17575933],"study_design_scores_gemma":[0.00059289683,0.002205167,0.22303744,0.00019205156,0.00062558934,0.001189996,0.00033910092,0.19474155,0.46063033,0.006131937,0.11013171,0.00018233975],"about_ca_topic_score_codex":0.0019398385,"about_ca_topic_score_gemma":0.0031529,"teacher_disagreement_score":0.007208222,"about_ca_system_score_codex":0.0006293644,"about_ca_system_score_gemma":0.0010654259,"threshold_uncertainty_score":0.024113953},"labels":[],"label_agreement":null},{"id":"W4295941942","doi":"10.1158/1557-3265.sarcomas22-ia015","title":"Abstract IA015: ASPSCR1-TFE3 reprograms transcription by organizing enhancer loops","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"TFE3; Enhancer; Chromatin; Biology; Transcription factor; Fusion gene; Chromosomal translocation; Cell biology; Molecular biology; Gene; Genetics","score_opus":0.12438702366991018,"score_gpt":0.4627755114023473,"score_spread":0.3383884877324371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295941942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790466,0.0020206743,0.0091372635,0.00047032424,0.00016413683,0.000033927736,0.0030341377,0.0007876667,0.005305402],"genre_scores_gemma":[0.97755766,0.00057724264,0.004196407,0.00011325793,0.000024593175,0.000022495402,0.0044637113,0.00013458746,0.012910136],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998591,0.00000889753,0.000010192989,0.00003518233,0.000058986105,0.00002756467],"domain_scores_gemma":[0.9999242,0.000011565603,0.000020418523,0.0000104610945,0.000009825611,0.000023663595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009585576,0.00033542668,0.00019045072,0.0002084265,0.00023013253,0.00035898775,0.0002470559,0.00027088512,0.0049239593],"category_scores_gemma":[0.00010757286,0.00012864829,0.00027008567,0.00021485967,0.00029637755,0.00014778011,0.00024047728,0.00055613817,0.0019084786],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007059315,0.0000063323514,0.000118421354,0.000016617974,0.0000017553591,0.000026608148,0.000005088609,0.000024609522,0.9988298,0.000057556696,0.00010508163,0.00073750113],"study_design_scores_gemma":[0.0000072491794,0.000050860406,0.0042538764,0.0000028495226,0.000005724284,0.00020976749,0.0000145225695,0.0003735523,0.99090564,0.00003375491,0.004139892,0.0000024603692],"about_ca_topic_score_codex":0.0010239815,"about_ca_topic_score_gemma":0.0015773021,"teacher_disagreement_score":0.0049239593,"about_ca_system_score_codex":0.0006124539,"about_ca_system_score_gemma":0.00023719115,"threshold_uncertainty_score":0.01647234},"labels":[],"label_agreement":null},{"id":"W4295942126","doi":"10.1158/1557-3265.sarcomas22-a020","title":"Abstract A020: Combined inhibition of SHP2 and CDK4/6 is active in preclinical models of NF1-associated malignant peripheral nerve sheath tumor","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; MAPK/ERK pathway; Kinase; CDKN2A; Cell growth; Cyclin-dependent kinase; Cell cycle; Biology; Medicine; Cell biology; Cancer; Internal medicine","score_opus":0.2322144808109041,"score_gpt":0.47092321202846615,"score_spread":0.23870873121756206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295942126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988981,0.002781754,0.0017175605,0.00029284906,0.00020198038,0.00031615558,0.0016091269,0.0003264046,0.0037732695],"genre_scores_gemma":[0.98502594,0.0020589058,0.0025304938,0.00009599383,0.000046902842,0.00070033147,0.0024141131,0.000036346024,0.007091066],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997924,0.00003664019,0.000016330843,0.00003573293,0.000061475934,0.00005742167],"domain_scores_gemma":[0.99983525,0.000015396281,0.000034012934,0.000019387531,0.00002119316,0.000074726166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003914607,0.00088413444,0.0005440294,0.0006469249,0.00029265127,0.0003490424,0.00053089927,0.0005069777,0.0031161725],"category_scores_gemma":[0.00013816183,0.00021706849,0.00044493354,0.00035064577,0.0003595688,0.00039786095,0.00015210929,0.0016729303,0.00063182577],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0089640515,0.0062619797,0.0005091131,0.00037873778,0.00012151813,0.00018272814,0.00007461602,0.0010051812,0.9664048,0.00036611437,0.0017350334,0.013996125],"study_design_scores_gemma":[0.002084636,0.051017214,0.0052691144,0.00003568143,0.00017457263,0.00040069502,0.00008936482,0.0030401053,0.9304568,0.00017062691,0.007239583,0.000021523492],"about_ca_topic_score_codex":0.0012462706,"about_ca_topic_score_gemma":0.0025225242,"teacher_disagreement_score":0.0031161725,"about_ca_system_score_codex":0.00043057313,"about_ca_system_score_gemma":0.0007138501,"threshold_uncertainty_score":0.010424614},"labels":[],"label_agreement":null},{"id":"W4295942147","doi":"10.1158/1557-3265.sarcomas22-a030","title":"Abstract A030: Investigating the feasibility of <i>in-vivo</i> histotripsy ablation for osteosarcoma using an orthotopic murine model and a canine model of spontaneous disease","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Osteosarcoma; Ablation; Amputation; In vivo; Cancer; Surgery; Pathology; Urology; Internal medicine","score_opus":0.30618471270867514,"score_gpt":0.49112171373625557,"score_spread":0.18493700102758043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295942147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996851,0.0002687701,0.0020245581,0.00004964072,0.000018320516,0.00012723656,0.00011176163,0.00003226895,0.00051646127],"genre_scores_gemma":[0.99450797,0.0003322983,0.0035285323,0.000065839355,0.000014311088,0.00017131503,0.00033022685,0.000017228833,0.0010322306],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99974793,0.000057384295,0.00002173572,0.000052866202,0.00006193743,0.000058092515],"domain_scores_gemma":[0.9997154,0.000057495494,0.00010022687,0.000030513704,0.00003751743,0.00005883269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067290285,0.00031989117,0.0002956342,0.00031158273,0.00017577491,0.0003219521,0.0003806888,0.00035042575,0.0012952251],"category_scores_gemma":[0.0002531489,0.0001852003,0.0003336482,0.00013412209,0.00048298252,0.0003084304,0.00017730468,0.0005243794,0.00024763864],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020311591,0.0012971924,0.0011280349,0.00008973263,0.000019496885,0.00005181488,0.00005162415,0.0003279649,0.99184906,0.00012631975,0.00013797327,0.0028896204],"study_design_scores_gemma":[0.00048452354,0.07143272,0.01231219,0.000020732541,0.0001364462,0.0007768885,0.00024271518,0.004228918,0.9067668,0.00010331746,0.0034740826,0.000020833386],"about_ca_topic_score_codex":0.0010260572,"about_ca_topic_score_gemma":0.0012849584,"teacher_disagreement_score":0.0012952251,"about_ca_system_score_codex":0.0003391134,"about_ca_system_score_gemma":0.0002893801,"threshold_uncertainty_score":0.0043330193},"labels":[],"label_agreement":null},{"id":"W4295942165","doi":"10.1158/1557-3265.sarcomas22-b026","title":"Abstract B026: Expression levels of chaperonin containing TCP1 in cancer are among the highest in sarcomas","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sarcoma; Cancer; Biology; Immunohistochemistry; Cancer research; Rhabdomyosarcoma; Pathology; Carcinogenesis; Chaperonin; Medicine; Gene; Genetics","score_opus":0.23654894479987706,"score_gpt":0.5082964728689009,"score_spread":0.2717475280690238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295942165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.940809,0.0035203886,0.0007636408,0.00028692733,0.00007007745,0.00001776053,0.051090416,0.00022109694,0.0032206592],"genre_scores_gemma":[0.96262527,0.0010706019,0.0006508855,0.00011907164,0.000049299797,0.00003075614,0.033834636,0.000059398157,0.0015601132],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997787,0.00002051642,0.000019222583,0.00007759996,0.00006091216,0.000043103482],"domain_scores_gemma":[0.999491,0.00008731126,0.00018130052,0.00003340501,0.00012504745,0.00008185521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022583238,0.00022432672,0.00033269115,0.0009855556,0.00032299245,0.00066940987,0.00016911508,0.00027140163,0.0047321203],"category_scores_gemma":[0.0007097522,0.00014215696,0.00026167487,0.0016960148,0.00016003959,0.00017423836,0.00032885975,0.00034496648,0.0011307902],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026403375,0.00007003734,0.7858502,0.0009238231,0.00035545515,0.00069627934,0.0003063324,0.00051710627,0.15655735,0.00028856206,0.019668072,0.0321264],"study_design_scores_gemma":[0.000023979363,0.00007940507,0.98022836,0.00004950019,0.00013021902,0.0012149219,0.00018077587,0.00049293693,0.00902043,0.00020910575,0.0083594015,0.000010916766],"about_ca_topic_score_codex":0.0024731243,"about_ca_topic_score_gemma":0.0025430832,"teacher_disagreement_score":0.0047321203,"about_ca_system_score_codex":0.00024568106,"about_ca_system_score_gemma":0.0002012383,"threshold_uncertainty_score":0.015830576},"labels":[],"label_agreement":null},{"id":"W4295942177","doi":"10.1158/1557-3265.sarcomas22-b029","title":"Abstract B029: Flip-flopping of fusion-positive rhabdomyosarcoma regulating intratumoral heterogeneity for metastasis","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metastasis; Rhabdomyosarcoma; Fusion gene; Biology; Cancer research; Cell fusion; Phenotype; Sarcoma; Motility; Cancer; Cell; Gene; Cell biology; Pathology; Medicine; Genetics","score_opus":0.15936884543052762,"score_gpt":0.48096175701511606,"score_spread":0.32159291158458847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295942177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914402,0.00091340306,0.0033412168,0.00023786425,0.0000920721,0.00007611544,0.00061953923,0.00013839453,0.0031412714],"genre_scores_gemma":[0.99479806,0.0002709859,0.0011473286,0.00009003704,0.000009614332,0.000059364036,0.00050831743,0.000024049645,0.0030921719],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988246,0.000013228456,0.000008828942,0.00003058369,0.000030922693,0.000033986948],"domain_scores_gemma":[0.99993336,0.000010133002,0.0000142961335,0.000007997722,0.000009289888,0.00002489066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013919816,0.00021689099,0.00016761503,0.00021145347,0.00024264405,0.00018913277,0.00017685168,0.00038384943,0.004363975],"category_scores_gemma":[0.00011448806,0.00010324281,0.00023820465,0.000106712694,0.00021632161,0.00016174217,0.00020109101,0.00052690454,0.00076469855],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009117829,0.00003480278,0.00018374115,0.000032428776,0.0000044444223,0.000095169875,0.000014120831,0.0000579722,0.99791044,0.00023585634,0.00019155536,0.0011482766],"study_design_scores_gemma":[0.00008503155,0.0006841925,0.0077519445,0.00002237109,0.00003491418,0.00096447096,0.00010790324,0.004116899,0.9772486,0.00021133079,0.008759518,0.000012859568],"about_ca_topic_score_codex":0.00076425524,"about_ca_topic_score_gemma":0.00079864316,"teacher_disagreement_score":0.004363975,"about_ca_system_score_codex":0.00027082805,"about_ca_system_score_gemma":0.00020674571,"threshold_uncertainty_score":0.014598966},"labels":[],"label_agreement":null},{"id":"W4295942202","doi":"10.1158/1557-3265.sarcomas22-a036","title":"Abstract A036: Surfaceome profiling of rhabdomyosarcoma reveals B7-H3 as a mediator of immune evasion","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rhabdomyosarcoma; Immune system; Cancer research; Fusion protein; Biology; Transcriptome; Cell; Medicine; Immunology; Pathology; Gene expression; Gene; Sarcoma","score_opus":0.2516707009864865,"score_gpt":0.5368047343414423,"score_spread":0.2851340333549558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295942202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941624,0.0006052087,0.0022093717,0.000058631576,0.0000120330515,0.00001400285,0.002199153,0.00006332745,0.00067572214],"genre_scores_gemma":[0.9871242,0.00050266896,0.004124726,0.00009649711,0.000011592122,0.00002251761,0.006655086,0.000028107823,0.0014345307],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991584,0.0000067932683,0.0000052974283,0.000021922247,0.000031795666,0.000018312427],"domain_scores_gemma":[0.9999337,0.000009154871,0.000019260671,0.000004973379,0.000018850436,0.000014043994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013532786,0.0002471294,0.00017547833,0.00038093404,0.000174252,0.00024256586,0.0001237062,0.0002579063,0.0011346343],"category_scores_gemma":[0.00011738775,0.000070563256,0.00024142055,0.00031681455,0.00013607318,0.00012616717,0.00021722067,0.00022821515,0.00063911226],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105086496,0.000009274466,0.0049264748,0.000032021922,0.000010010678,0.00006690032,0.000012604819,0.00007139461,0.99316263,0.000020763488,0.00011090839,0.0014718921],"study_design_scores_gemma":[0.000015995596,0.00035706235,0.31777808,0.000019922263,0.000057211357,0.0013016104,0.0001929854,0.004854499,0.671858,0.00018974068,0.0033607427,0.000014136704],"about_ca_topic_score_codex":0.0008308343,"about_ca_topic_score_gemma":0.00096917327,"teacher_disagreement_score":0.0011346343,"about_ca_system_score_codex":0.00016916652,"about_ca_system_score_gemma":0.00014886644,"threshold_uncertainty_score":0.003795743},"labels":[],"label_agreement":null},{"id":"W4295942208","doi":"10.1158/1557-3265.sarcomas22-ia001","title":"Abstract IA001: An overview of applying discovery science to care for patients in need: working together to advance our understanding and treatment of sarcomas","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Malignancy; GiST; Medicine; Sarcoma; Immunotherapy; Clear-cell sarcoma; Bioinformatics; Stromal cell; Pathology; Cancer; Biology; Internal medicine","score_opus":0.4855192293999712,"score_gpt":0.5612200227417874,"score_spread":0.07570079334181617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295942208","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006726833,0.8569903,0.008138433,0.09733919,0.010603813,0.00021281806,0.00021369502,0.00053197896,0.02529713],"genre_scores_gemma":[0.0042938553,0.93944615,0.012624587,0.0284535,0.0082223425,0.00027839775,0.0004115743,0.00013946721,0.006130083],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960628,0.0018225187,0.00053022837,0.00030672166,0.000949415,0.0003282751],"domain_scores_gemma":[0.99091876,0.0044233482,0.00059858913,0.00032790675,0.0019262338,0.0018051503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010134835,0.0012894504,0.0012769245,0.0051107123,0.0009817432,0.0058391388,0.0019024144,0.004969415,0.009490239],"category_scores_gemma":[0.0135140335,0.00063736405,0.0018258718,0.0034701824,0.0017853965,0.0059921704,0.0059498763,0.0096517755,0.005438385],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008546637,0.00013100763,0.00045753462,0.0044840127,0.00009595057,0.00021227435,0.00023013681,0.0003909877,0.00044730384,0.015684685,0.17498392,0.80279666],"study_design_scores_gemma":[0.00003513607,0.00016987801,0.0007134535,0.010665888,0.00007019495,0.0006614744,0.00020432794,0.00026794596,0.00019506035,0.013288794,0.9736854,0.000042527015],"about_ca_topic_score_codex":0.001886277,"about_ca_topic_score_gemma":0.0028950667,"teacher_disagreement_score":0.010134835,"about_ca_system_score_codex":0.0039018553,"about_ca_system_score_gemma":0.008046452,"threshold_uncertainty_score":0.05359876},"labels":[],"label_agreement":null},{"id":"W4295942215","doi":"10.1158/1557-3265.sarcomas22-a016","title":"Abstract A016: Selective delivery of fibroblast activation protein conjugated dual phosphoinositide 3-kinase–AKT Kinase-mTOR inhibitor associated with decreased tumor proliferation and on-target toxicity in high-grade soft-tissue sarcomas","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fibroblast activation protein, alpha; PI3K/AKT/mTOR pathway; Protein kinase B; HT1080; Cancer research; Fibrosarcoma; Flow cytometry; Biology; Cell growth; Fibroblast; Cell culture; Molecular biology; Medicine; Cancer; Pathology; Phosphorylation; Cell biology; Signal transduction; Internal medicine; Biochemistry","score_opus":0.05381510034112087,"score_gpt":0.3746805325944472,"score_spread":0.32086543225332637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295942215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935045,0.0011583036,0.0016739105,0.00008713995,0.000087114444,0.00004119192,0.00041239485,0.00011144795,0.0029237482],"genre_scores_gemma":[0.9893707,0.0008057034,0.0025214143,0.00006109121,0.00001784067,0.00006276622,0.00092755305,0.00002500645,0.0062078955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993503,0.000008066145,0.0000066716284,0.000015468022,0.000021021067,0.000013718776],"domain_scores_gemma":[0.9999641,0.0000051544343,0.000009571036,0.000002912197,0.0000055295004,0.0000128305055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000090443245,0.00029288235,0.00016906558,0.00015543835,0.00007591845,0.00020186634,0.0001653416,0.00025765563,0.0022111833],"category_scores_gemma":[0.000066485845,0.000095166666,0.0001990734,0.00011436466,0.000105432286,0.00013689048,0.000084871965,0.00035556877,0.00051854784],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037232222,0.00012291597,0.000060118447,0.000054013723,0.000004200818,0.000048452093,0.0000071344743,0.000051964904,0.99709713,0.00005101763,0.00016715453,0.001963651],"study_design_scores_gemma":[0.000091828115,0.0025541184,0.0017679861,0.000008554404,0.000018293254,0.00042847247,0.000012587227,0.00085025834,0.9918881,0.000020343554,0.002354084,0.0000051940683],"about_ca_topic_score_codex":0.00048919313,"about_ca_topic_score_gemma":0.0003810897,"teacher_disagreement_score":0.0022111833,"about_ca_system_score_codex":0.00014395562,"about_ca_system_score_gemma":0.00016541933,"threshold_uncertainty_score":0.007397175},"labels":[],"label_agreement":null},{"id":"W4295942218","doi":"10.1158/1557-3265.sarcomas22-b020","title":"Abstract B020: Multimodal single-cell analyses reveal identification of unique transcriptional subgroups in ewing sarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transcriptome; Biology; Epigenomics; Carcinogenesis; Computational biology; Genetics; Gene; RNA-Seq; Gene expression; Gene expression profiling; Context (archaeology); DNA methylation","score_opus":0.39169184515969646,"score_gpt":0.5312422513209689,"score_spread":0.13955040616127246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295942218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98976594,0.00039026022,0.006069324,0.000032996988,0.000010052598,0.00002523148,0.002726245,0.00012668184,0.00085333484],"genre_scores_gemma":[0.9842982,0.0002099147,0.0066993665,0.000052174666,0.000006813376,0.000051363666,0.006757885,0.000073540614,0.0018507487],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999026,0.000007194307,0.000006763623,0.000034893084,0.000031301413,0.00001711222],"domain_scores_gemma":[0.9998871,0.000023891807,0.000013431097,0.000014989559,0.000034832796,0.000025775644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016296997,0.0001635308,0.00023273587,0.00040043125,0.00019304027,0.000343237,0.000108709544,0.00023554936,0.0013639708],"category_scores_gemma":[0.00017659286,0.0001007142,0.00014949404,0.00024513097,0.00014627387,0.00018630603,0.0003060528,0.0002469405,0.00058486976],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031688443,0.0000044457456,0.00081392174,0.000009758303,0.0000019147592,0.000012552802,0.000017839342,0.000036250756,0.99824274,0.000014457821,0.000025640657,0.0007888646],"study_design_scores_gemma":[0.000008292953,0.0002891034,0.1730229,0.000009153001,0.000031140495,0.00039927094,0.00025202316,0.005707847,0.8159998,0.0002592386,0.004005251,0.00001593671],"about_ca_topic_score_codex":0.00074710936,"about_ca_topic_score_gemma":0.0010153832,"teacher_disagreement_score":0.0013639708,"about_ca_system_score_codex":0.0001424066,"about_ca_system_score_gemma":0.00009066673,"threshold_uncertainty_score":0.0045629144},"labels":[],"label_agreement":null},{"id":"W4295942221","doi":"10.1158/1557-3265.sarcomas22-a006","title":"Abstract A006: Defining the microenvironment of alveolar soft part sarcoma &amp; it’s role in therapeutic outcomes","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; University of Calgary","funders":"","keywords":"Carfilzomib; Tumor microenvironment; Cancer research; In vivo; Proteasome inhibitor; Medicine; Biology; Immunology; Multiple myeloma; Tumor cells","score_opus":0.14790023389142132,"score_gpt":0.4477827533221845,"score_spread":0.29988251943076316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295942221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9622607,0.018165708,0.004627192,0.0021654787,0.00013420345,0.000093646326,0.0012593206,0.00008837756,0.011205417],"genre_scores_gemma":[0.993269,0.0029774874,0.0018225984,0.00023453891,0.00009579724,0.000039600265,0.0005039696,0.0000109321845,0.0010460584],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99983203,0.000041665124,0.0000117616055,0.000022853672,0.00005714854,0.000034567765],"domain_scores_gemma":[0.9997259,0.000049793707,0.00010023223,0.00001077034,0.000039056365,0.00007420515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003661224,0.00014618727,0.00018152538,0.0005033879,0.00017984923,0.00078261876,0.00014713615,0.00031353845,0.0032810208],"category_scores_gemma":[0.00039575587,0.00005867625,0.00016569164,0.00043599927,0.0002691564,0.00038150515,0.00032952696,0.00054036966,0.0005576539],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022762036,0.0005290131,0.15741155,0.0011834415,0.00009271048,0.0029982228,0.00041602607,0.0012141864,0.6146237,0.006414819,0.0050524785,0.20778768],"study_design_scores_gemma":[0.00009470371,0.0036783444,0.7152793,0.000421685,0.00017068873,0.017804457,0.0019160884,0.0044616233,0.16553026,0.0057853195,0.08481242,0.00004516616],"about_ca_topic_score_codex":0.00041028316,"about_ca_topic_score_gemma":0.00045674478,"teacher_disagreement_score":0.0032810208,"about_ca_system_score_codex":0.00033735042,"about_ca_system_score_gemma":0.00037416496,"threshold_uncertainty_score":0.010976136},"labels":[],"label_agreement":null},{"id":"W4295942229","doi":"10.1158/1557-3265.sarcomas22-b011","title":"Abstract B011: Two epigenetically distinct cellular states in osteosarcoma are regulated by a cluster-specific set of pioneer transcription factors","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Transcription factor; Chromatin; Genetics; Epigenetics; Osteosarcoma; Wnt signaling pathway; Cancer research; Cell biology; Signal transduction; Gene","score_opus":0.11942672350961929,"score_gpt":0.4228259930126541,"score_spread":0.3033992695030348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295942229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97296596,0.0016023122,0.0076271687,0.00019858156,0.000076597695,0.000045604684,0.012158999,0.00057942927,0.004745374],"genre_scores_gemma":[0.96797425,0.00047895144,0.005185569,0.00020143397,0.000017984305,0.00007199866,0.015386188,0.00022832643,0.010455271],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997774,0.000008937359,0.000007490495,0.000092184724,0.00007090185,0.0000431355],"domain_scores_gemma":[0.9998418,0.00001741193,0.000038280115,0.000010537248,0.000036775735,0.00005512574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001259699,0.00028191687,0.0002881418,0.00049434305,0.00056267047,0.00052879885,0.0001921619,0.00028495936,0.005242125],"category_scores_gemma":[0.00016634431,0.00017829034,0.0003051074,0.000505294,0.00027150253,0.00015546622,0.00040907756,0.00055538176,0.001353323],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027729344,0.000017485634,0.004783424,0.00007178243,0.000011210087,0.000048488087,0.000055035613,0.000105372055,0.9907782,0.00022288041,0.0006295465,0.0029991784],"study_design_scores_gemma":[0.00006344828,0.00037760145,0.5233239,0.00007107091,0.00009673305,0.0007351736,0.0003947165,0.0033555354,0.44664836,0.00069815345,0.024174433,0.00006082113],"about_ca_topic_score_codex":0.0056383302,"about_ca_topic_score_gemma":0.007215142,"teacher_disagreement_score":0.0056383302,"about_ca_system_score_codex":0.0005047707,"about_ca_system_score_gemma":0.0004681772,"threshold_uncertainty_score":0.0175367},"labels":[],"label_agreement":null},{"id":"W4296122525","doi":"10.1158/1557-3265.sarcomas22-b005","title":"Abstract B005: Hypoxic sarcoma spheroid on a chip: Insights into treatment response","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Polytechnique Montréal","funders":"","keywords":"Tirapazamine; Hypoxia (environmental); Cancer research; Tumor hypoxia; Metastasis; Sarcoma; Spheroid; Soft tissue sarcoma; Pathology; Biology; Cell culture; Radiation therapy; Medicine; Cancer; In vitro; Internal medicine; Chemistry; Cytotoxicity","score_opus":0.11701635820593707,"score_gpt":0.4561327114930263,"score_spread":0.3391163532870892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296122525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8849493,0.0051978426,0.0904213,0.0010266075,0.00060068,0.00019030286,0.006677546,0.0027878662,0.008148585],"genre_scores_gemma":[0.95023584,0.0016865584,0.037998192,0.00037688302,0.000071468145,0.00026680558,0.0032381087,0.00016293998,0.005963136],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998367,0.000016961554,0.000008117793,0.000037538164,0.000076066885,0.000024679739],"domain_scores_gemma":[0.9998653,0.000059713326,0.000018415773,0.00001053635,0.000032177613,0.000013814866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023240614,0.0003559284,0.0003337942,0.00020776143,0.00012768258,0.00022632515,0.00028626778,0.00055048615,0.0029862584],"category_scores_gemma":[0.0002313533,0.00014678553,0.0003232158,0.0001620129,0.00014444954,0.00015106959,0.00016191421,0.00024555202,0.00081476255],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009854054,0.00004663541,0.00044956815,0.00023343672,0.000014798521,0.000058279424,0.000033385295,0.0025102184,0.98756754,0.00014142013,0.0015468665,0.0072992197],"study_design_scores_gemma":[0.000020955638,0.0004572789,0.004285003,0.000010640958,0.0000394159,0.00011519525,0.000039336366,0.02686045,0.95970064,0.00012391337,0.008326492,0.000020646143],"about_ca_topic_score_codex":0.0010298932,"about_ca_topic_score_gemma":0.0011842264,"teacher_disagreement_score":0.0029862584,"about_ca_system_score_codex":0.00039611026,"about_ca_system_score_gemma":0.0002551234,"threshold_uncertainty_score":0.0099900365},"labels":[],"label_agreement":null},{"id":"W4296122547","doi":"10.1158/1557-3265.sarcomas22-a024","title":"Abstract A024: <i>In vitro</i> efficacy of a novel dual PARP-HDAC inhibitor in ewing sarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Olaparib; PARP1; PARP inhibitor; Cancer research; Poly ADP ribose polymerase; Histone deacetylase; Viability assay; Biology; DNA damage; DNA repair; Histone; Molecular biology; Pharmacology; In vitro; Polymerase; Biochemistry; DNA","score_opus":0.31842042250211033,"score_gpt":0.5424239836674453,"score_spread":0.22400356116533493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296122547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9731188,0.010445227,0.003596121,0.00035074574,0.00030573952,0.00025190177,0.0028384475,0.00034205557,0.008750888],"genre_scores_gemma":[0.98246014,0.003038322,0.0032688805,0.00016807114,0.00006714763,0.00014053722,0.0042021275,0.000039989365,0.006614851],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998323,0.000037273305,0.000020279953,0.000036423484,0.00003808832,0.00003555711],"domain_scores_gemma":[0.9998894,0.000020535253,0.000020622509,0.0000132977475,0.000022469856,0.000033580716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030280853,0.0005778108,0.000410176,0.00028117653,0.00015736227,0.0002717219,0.00041705387,0.0003767005,0.0040941373],"category_scores_gemma":[0.00015608354,0.00014544383,0.00036743574,0.00024343029,0.0001372109,0.00026765603,0.00013462911,0.0008688747,0.0009335895],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017793692,0.0008841398,0.0002626649,0.00025458235,0.000048530095,0.00008428551,0.000019368646,0.00055260374,0.9834027,0.00013523037,0.0011207121,0.0114557855],"study_design_scores_gemma":[0.0005389592,0.01200691,0.0026309018,0.000017321974,0.00010593958,0.00036004858,0.000018685132,0.0022664752,0.9771823,0.000042341715,0.004819508,0.000010592922],"about_ca_topic_score_codex":0.0012522867,"about_ca_topic_score_gemma":0.0013569109,"teacher_disagreement_score":0.0040941373,"about_ca_system_score_codex":0.00034578156,"about_ca_system_score_gemma":0.00030010464,"threshold_uncertainty_score":0.013696194},"labels":[],"label_agreement":null},{"id":"W4296122564","doi":"10.1158/1557-3265.sarcomas22-b030","title":"Abstract B030: Induction chemotherapy plus concurrent chemoradiotherapy led to clinical complete response in locally advanced sinonasal rhabdosarcomas","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Induction chemotherapy; Ifosfamide; Chemotherapy; Epirubicin; Chemoradiotherapy; Radiation therapy; Surgery; Regimen; Chemotherapy regimen; Mucositis; Oncology; Internal medicine; Cisplatin; Cyclophosphamide","score_opus":0.28195634774366884,"score_gpt":0.548296853707072,"score_spread":0.2663405059634032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296122564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997575,0.0010127501,0.00039501005,0.000042790947,0.000022488315,0.00008910246,0.00009228726,0.00003741626,0.00073316443],"genre_scores_gemma":[0.99858946,0.00027141883,0.00044247904,0.000040090017,0.000013712315,0.00003917295,0.00023670703,0.0000076004135,0.00035936257],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999342,0.000013665775,0.000007985861,0.0000133836,0.000012183071,0.00001862916],"domain_scores_gemma":[0.99985754,0.000030798787,0.000017828252,0.00002596277,0.000013139687,0.00005466157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020252608,0.0002327836,0.00059848675,0.00016022864,0.00017624078,0.0001523937,0.00022068588,0.00024878688,0.0011790184],"category_scores_gemma":[0.00022048228,0.000110436435,0.0003204464,0.00013609848,0.00019016674,0.00009825031,0.00013347255,0.0005464999,0.00029580787],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032165777,0.0065184375,0.033306833,0.00088264915,0.0002628143,0.011371773,0.00048380406,0.0036876302,0.7343072,0.0002765604,0.002241912,0.17449468],"study_design_scores_gemma":[0.011637066,0.18579085,0.3349022,0.00014227987,0.00074976153,0.026494786,0.00023628061,0.0134756155,0.4132423,0.00030494365,0.0129413875,0.000082592465],"about_ca_topic_score_codex":0.00072585023,"about_ca_topic_score_gemma":0.00097648706,"teacher_disagreement_score":0.0011790184,"about_ca_system_score_codex":0.0002352899,"about_ca_system_score_gemma":0.0003395728,"threshold_uncertainty_score":0.0039441586},"labels":[],"label_agreement":null},{"id":"W4296130292","doi":"10.1158/1557-3265.sarcomas22-a025","title":"Abstract A025: Profiling tumor infiltrating immune cells for better understanding tumor status and better response to therapeutic strategy in soft tissue sarcomas","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Tumor microenvironment; Cytotoxic T cell; CD8; Immunotherapy; Population; Soft tissue sarcoma; Cancer research; Biology; Immunology; Pathology; Sarcoma; Medicine","score_opus":0.19018373584370069,"score_gpt":0.4578564706370328,"score_spread":0.2676727347933321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.970053,0.006430077,0.017999692,0.00028031503,0.00010246005,0.0003125187,0.0026529382,0.00032483484,0.0018441894],"genre_scores_gemma":[0.9757808,0.002067446,0.016857084,0.00034979652,0.00008774545,0.00031649953,0.00240248,0.00003654093,0.0021016395],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997062,0.000055653265,0.000034724777,0.00007455645,0.00008449116,0.00004442468],"domain_scores_gemma":[0.99974996,0.000051857478,0.000058658472,0.000018479688,0.00007833592,0.00004274916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059284526,0.00040648918,0.00048025558,0.0014981149,0.00025509493,0.00073752383,0.00016969918,0.00048076262,0.002479703],"category_scores_gemma":[0.000393551,0.00016048184,0.00035267623,0.00054138224,0.00020438389,0.00048031737,0.00029859488,0.00049992016,0.0006915181],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007336813,0.0001822831,0.04502642,0.0004529022,0.000047689493,0.00015349658,0.00013681778,0.0004990743,0.9173205,0.00016102067,0.0007356756,0.034550466],"study_design_scores_gemma":[0.00013543524,0.0029125735,0.31822234,0.00019898145,0.0004997832,0.002487231,0.00088119094,0.017437909,0.6339127,0.001513247,0.021706212,0.00009241652],"about_ca_topic_score_codex":0.0002671706,"about_ca_topic_score_gemma":0.0003251524,"teacher_disagreement_score":0.002479703,"about_ca_system_score_codex":0.00022635903,"about_ca_system_score_gemma":0.0002504789,"threshold_uncertainty_score":0.008295417},"labels":[],"label_agreement":null},{"id":"W4296130312","doi":"10.1158/1557-3265.sarcomas22-b015","title":"Abstract B015: Targeting hexosamine biosynthesis pathway for the treatment of desmoid tumors","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Biology; Cancer research; Glycosylation; Pentose phosphate pathway; Glycolysis; Glutamine; Enzyme; Cancer; Cancer cell; In vivo; Biochemistry; Amino acid; Genetics","score_opus":0.3603920543739465,"score_gpt":0.5343802714644572,"score_spread":0.1739882170905107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9613752,0.024358774,0.0038519285,0.0009891826,0.00057864754,0.0005655048,0.0009690834,0.00028176972,0.007030032],"genre_scores_gemma":[0.97120976,0.011866158,0.004685752,0.00047706146,0.00011516912,0.0002441134,0.0017630624,0.000030298474,0.009608637],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99993956,0.0000100116795,0.000006288458,0.0000084479025,0.000019529367,0.000016126525],"domain_scores_gemma":[0.99996865,0.0000026713142,0.0000054018874,0.000002661534,0.0000046450036,0.00001604512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014757198,0.00035700214,0.00029832654,0.00041906303,0.00015814808,0.00025036262,0.00023693327,0.00032175818,0.0025898681],"category_scores_gemma":[0.000061909,0.0000739894,0.00030965754,0.00025396285,0.00017122393,0.00017481466,0.00020108296,0.0006927846,0.00045718948],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038129492,0.0011017305,0.0005105391,0.0006386094,0.000093366536,0.000346504,0.000035871475,0.00038917217,0.93517786,0.0005340668,0.001468745,0.055890534],"study_design_scores_gemma":[0.0020618958,0.02055015,0.012543239,0.00010035437,0.00027004388,0.0015134998,0.0000679237,0.0021865962,0.9150452,0.0003880707,0.04524252,0.000030582603],"about_ca_topic_score_codex":0.00080568204,"about_ca_topic_score_gemma":0.0009836564,"teacher_disagreement_score":0.0025898681,"about_ca_system_score_codex":0.00023172883,"about_ca_system_score_gemma":0.00031550397,"threshold_uncertainty_score":0.008664012},"labels":[],"label_agreement":null},{"id":"W4296130327","doi":"10.1158/1557-3265.sarcomas22-pr001","title":"Abstract PR001: Oncogene-induced matrix reorganization controls CD8+ T cell immunity in the UPS microenvironment","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; YAP1; Cancer research; Cell biology; T cell; CD8; Biology; Extracellular matrix; Cytotoxic T cell; Immunology; Immune system","score_opus":0.19123344588355604,"score_gpt":0.507720672679515,"score_spread":0.316487226795959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953621,0.0004992518,0.0012068456,0.0001681033,0.000041352854,0.000029018109,0.00066881324,0.00012220925,0.0019023512],"genre_scores_gemma":[0.9938823,0.00020833289,0.0008770214,0.00006450719,0.000013126859,0.00004788632,0.00065327366,0.000031286716,0.004222267],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999853,0.000017263317,0.000010991853,0.000037963306,0.0000323006,0.00004845321],"domain_scores_gemma":[0.9998994,0.0000095456135,0.00003210943,0.000010008661,0.000008184239,0.000040702304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000690985,0.0003241369,0.00017709467,0.00024000839,0.00017288383,0.00028971248,0.00019061241,0.00027768288,0.0038122549],"category_scores_gemma":[0.00008260343,0.00011802179,0.00019188743,0.00014157678,0.00038308412,0.00019527043,0.00024630822,0.00094344164,0.0009128324],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025182503,0.000056573506,0.00016375551,0.000030990293,0.0000017424004,0.00004386801,0.00001008941,0.000055425015,0.9980445,0.00009668119,0.00009988327,0.001144581],"study_design_scores_gemma":[0.000050137172,0.0007625717,0.007939434,0.000010003326,0.000015006949,0.00022228203,0.00009740027,0.0015840026,0.9859278,0.00009804742,0.0032879412,0.0000052786263],"about_ca_topic_score_codex":0.00032914957,"about_ca_topic_score_gemma":0.0005097108,"teacher_disagreement_score":0.0038122549,"about_ca_system_score_codex":0.0003049521,"about_ca_system_score_gemma":0.00018766013,"threshold_uncertainty_score":0.012753248},"labels":[],"label_agreement":null},{"id":"W4296130351","doi":"10.1158/1557-3265.sarcomas22-b022","title":"Abstract B022: Subclonal somatic copy number alterations emerge and dominate in relapsed/refractory osteosarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CDKN2A; Osteosarcoma; Copy-number variation; Copy number analysis; Biology; Primary tumor; Cancer; PTEN; Oncology; Cancer research; Genome; Medicine; Bioinformatics; Metastasis; Genetics; Gene","score_opus":0.08365818104733569,"score_gpt":0.45483999030479816,"score_spread":0.37118180925746247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986312,0.000119515236,0.0003108797,0.000022693754,0.0000018539006,0.000005120395,0.00033868448,0.00003175082,0.0005383615],"genre_scores_gemma":[0.9975775,0.000074451484,0.0006630668,0.000034911653,0.000003882959,0.0000068465615,0.0011031897,0.000038237744,0.00049797207],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998136,0.000015876141,0.000014280947,0.00006053982,0.0000664747,0.000029150055],"domain_scores_gemma":[0.999795,0.000044869248,0.000075529024,0.000024682264,0.000025096764,0.000034739456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023710252,0.00024456883,0.00033350315,0.00059077237,0.0003031196,0.00051717804,0.0002060078,0.0004351935,0.0021799225],"category_scores_gemma":[0.0005988705,0.00020464735,0.00024409012,0.0005943527,0.00026766217,0.00014796667,0.00024013221,0.0002556981,0.00054297],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013541512,0.00010996846,0.45687312,0.00012880572,0.00014164158,0.005003868,0.0005558199,0.0020147662,0.500521,0.00036683885,0.0010961796,0.031833902],"study_design_scores_gemma":[0.00006988398,0.00042801513,0.93321705,0.00002771156,0.00012412497,0.015212824,0.00044229557,0.005081478,0.040606488,0.0006210754,0.0041483785,0.000020723908],"about_ca_topic_score_codex":0.0016445692,"about_ca_topic_score_gemma":0.0030250854,"teacher_disagreement_score":0.0021799225,"about_ca_system_score_codex":0.0002469862,"about_ca_system_score_gemma":0.00014437793,"threshold_uncertainty_score":0.0072925687},"labels":[],"label_agreement":null},{"id":"W4296130369","doi":"10.1158/1557-3265.sarcomas22-b007","title":"Abstract B007: Patterns and quantitation of migration and metastasis in a zebrafish xenograft model of ewing sarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Zebrafish; Cancer research; mCherry; Metastasis; Biology; Cancer; Sarcoma; Cell culture; Medicine; Pathology; Green fluorescent protein; Gene; Genetics","score_opus":0.18096489866269738,"score_gpt":0.4893366989973695,"score_spread":0.3083718003346721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9493406,0.0021455605,0.031558413,0.0005814167,0.00022450142,0.00043920756,0.00523618,0.0012936752,0.0091804275],"genre_scores_gemma":[0.92903304,0.001776711,0.037605163,0.00016562654,0.000026579972,0.0007355892,0.0035972584,0.00038070118,0.0266793],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997638,0.000021490681,0.000018877345,0.00005651423,0.00008524179,0.00005417342],"domain_scores_gemma":[0.99975055,0.00003326146,0.00005122027,0.000021259742,0.00006495643,0.000078770245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036593855,0.00059037725,0.00027236436,0.001460673,0.00036077434,0.00025501955,0.0002443912,0.0005709156,0.0027366972],"category_scores_gemma":[0.00014728127,0.0002908222,0.00041048738,0.0003823708,0.00031972074,0.0003820334,0.0002722706,0.0012113088,0.000805083],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106657564,0.000053098913,0.0002606588,0.000024065755,0.0000036327656,0.00007438552,0.00003612112,0.000094780815,0.9978387,0.00014456842,0.000186586,0.0011766019],"study_design_scores_gemma":[0.000045655106,0.0010630499,0.009961361,0.000026809374,0.000033902314,0.000473205,0.00012479776,0.0044342247,0.9799788,0.00013404393,0.003698549,0.00002559076],"about_ca_topic_score_codex":0.008885967,"about_ca_topic_score_gemma":0.009424833,"teacher_disagreement_score":0.008885967,"about_ca_system_score_codex":0.000708176,"about_ca_system_score_gemma":0.0005417505,"threshold_uncertainty_score":0.017668486},"labels":[],"label_agreement":null},{"id":"W4296130372","doi":"10.1158/1557-3265.sarcomas22-pr013","title":"Abstract PR013: Novel mechanisms of ezrin function in osteosarcoma metastasis","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ezrin; Moesin; Radixin; Cell biology; Cancer research; Metastasis; Cytoplasm; Osteosarcoma; Biology; Chemistry; Cytoskeleton; Cell; Cancer; Biochemistry","score_opus":0.30703902764628305,"score_gpt":0.49338982125546393,"score_spread":0.1863507936091809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756546,0.008131148,0.009116446,0.0005215108,0.000055001965,0.00007839304,0.00020916975,0.00015875933,0.0060749594],"genre_scores_gemma":[0.9911737,0.0019695463,0.0016663768,0.000095133866,0.000016014694,0.000025099107,0.00032150612,0.0000074836926,0.0047251354],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993336,0.0000075945604,0.0000049981163,0.000014618641,0.00002243271,0.000017060504],"domain_scores_gemma":[0.99997675,0.0000027715207,0.000006113354,0.0000018777099,0.0000049368227,0.000007629707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000098384764,0.00032575557,0.00020518935,0.00015350207,0.00014958631,0.00022614699,0.00023301407,0.00028299456,0.0016176092],"category_scores_gemma":[0.000074200034,0.000081331265,0.00018138177,0.00009578421,0.00016356917,0.00026964903,0.00016054443,0.00034692566,0.00039893595],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013644416,0.000026449392,0.00055876595,0.00012092456,0.000007044892,0.00039707136,0.000016585864,0.00011494637,0.9926535,0.0011951711,0.00018141401,0.004591707],"study_design_scores_gemma":[0.00007166101,0.00046675198,0.016953332,0.000018003217,0.00004973811,0.0019636045,0.00007999702,0.0051112226,0.965416,0.0007856541,0.009072677,0.000011309097],"about_ca_topic_score_codex":0.00044564556,"about_ca_topic_score_gemma":0.0004803657,"teacher_disagreement_score":0.0016176092,"about_ca_system_score_codex":0.00033612375,"about_ca_system_score_gemma":0.00015690977,"threshold_uncertainty_score":0.005411446},"labels":[],"label_agreement":null},{"id":"W4296130403","doi":"10.1158/1557-3265.sarcomas22-ia011","title":"Abstract IA011: Identifying tumor-restricted target antigens for adoptive cellular immunotherapy to treat Ewing Sarcoma using multi-omic discovery platforms","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Major histocompatibility complex; Immunotherapy; Antigen; Biology; Transcriptome; Cancer research; Sarcoma; Computational biology; Immunology; Medicine; Immune system; Gene; Gene expression; Genetics; Pathology","score_opus":0.3662698473752391,"score_gpt":0.5264424264069669,"score_spread":0.16017257903172782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8964517,0.015375212,0.060099956,0.0011456433,0.0003886895,0.0005294479,0.015285475,0.0017365592,0.0089873625],"genre_scores_gemma":[0.83671594,0.009883233,0.094232075,0.0009349344,0.00017034981,0.00052462023,0.04357495,0.00028531515,0.01367853],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999757,0.000021323882,0.000020978378,0.00006579427,0.0000949441,0.00003996985],"domain_scores_gemma":[0.9998833,0.0000145601425,0.000029464853,0.00001447345,0.00003106463,0.000027137201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042614207,0.0006392584,0.00055860373,0.000787684,0.0002860157,0.0010984705,0.0003312862,0.0003742433,0.002092942],"category_scores_gemma":[0.00025105558,0.0001920119,0.00052636064,0.0007122872,0.00024207537,0.0004889682,0.0005522449,0.00079983776,0.0011759553],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024108929,0.00005081837,0.0013863196,0.00017225981,0.000020954583,0.00004637579,0.000013655955,0.00035663715,0.9821072,0.00023470471,0.0010109143,0.014359072],"study_design_scores_gemma":[0.00007890503,0.001018703,0.0153654255,0.00004883259,0.00022346969,0.00070820184,0.00008413827,0.010282817,0.9401337,0.0006469968,0.03137697,0.00003181063],"about_ca_topic_score_codex":0.00025707972,"about_ca_topic_score_gemma":0.00041577686,"teacher_disagreement_score":0.002092942,"about_ca_system_score_codex":0.00043992803,"about_ca_system_score_gemma":0.0005320074,"threshold_uncertainty_score":0.007001519},"labels":[],"label_agreement":null},{"id":"W4296130404","doi":"10.1158/1557-3265.sarcomas22-a039","title":"Abstract A039: IGFBP5 is induced by tumor-suppressive naïve stromal cells and regulates GAS2-associated apoptosis in rhabdomyosarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stromal cell; Cancer research; Rhabdomyosarcoma; Mesenchymal stem cell; Growth factor; Biology; CTGF; Paracrine signalling; Pathology; Sarcoma; Medicine; Internal medicine; Receptor","score_opus":0.13515736810277104,"score_gpt":0.45796195318848537,"score_spread":0.3228045850857143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99762315,0.0004783202,0.00060741924,0.000026270818,0.000010457646,0.000009987686,0.00074684457,0.00003446427,0.0004631566],"genre_scores_gemma":[0.9960038,0.0002379565,0.00058014045,0.000038683185,0.0000056174713,0.000015169139,0.001686979,0.000009574258,0.0014221497],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998964,0.000011854153,0.0000074841178,0.000020609834,0.00003602978,0.000027628153],"domain_scores_gemma":[0.9999343,0.00000967039,0.00001618329,0.000007063796,0.000011662481,0.000021007385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000089088826,0.00018853859,0.00017607483,0.00024531194,0.00013760857,0.00021051883,0.000088034125,0.00011608527,0.0019790358],"category_scores_gemma":[0.00007840267,0.00007300915,0.00020122278,0.00016055792,0.00013689647,0.000057844063,0.00011588077,0.00025418718,0.0004385137],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020567316,0.000023154676,0.002876871,0.00002418803,0.0000065517943,0.00008670455,0.000012995759,0.000029124374,0.99555284,0.000021713257,0.000059890503,0.0011002332],"study_design_scores_gemma":[0.000036959664,0.00088846864,0.21458821,0.000010376379,0.00005138246,0.0012675646,0.00019701435,0.0011904028,0.77909076,0.000060784172,0.0026115798,0.0000065209506],"about_ca_topic_score_codex":0.0012581281,"about_ca_topic_score_gemma":0.0016992164,"teacher_disagreement_score":0.0019790358,"about_ca_system_score_codex":0.00020442267,"about_ca_system_score_gemma":0.0001928414,"threshold_uncertainty_score":0.0066204667},"labels":[],"label_agreement":null},{"id":"W4296130406","doi":"10.1158/1557-3265.sarcomas22-a013","title":"Abstract A013: CDK2 and CDK4/6 inhibition in GIST: Mechanisms of response and resistance","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cyclin D1; Cancer research; Cyclin-dependent kinase; Palbociclib; Cyclin-dependent kinase 2; Cell cycle; GiST; Biology; Cell growth; Hyperphosphorylation; Kinase; Cell culture; Cell; Cell biology; Cancer; Biochemistry; Genetics","score_opus":0.1671865645841084,"score_gpt":0.511879329938308,"score_spread":0.34469276535419957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834035,0.008701016,0.0015431504,0.0004968858,0.000047635025,0.00006916217,0.000417998,0.00013463339,0.005186038],"genre_scores_gemma":[0.99521303,0.001256429,0.0010378989,0.00006721012,0.000027542788,0.000026411943,0.00029893863,0.000010756871,0.0020617847],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99989426,0.00001792171,0.000007638062,0.000018927367,0.000038094968,0.000023090546],"domain_scores_gemma":[0.99993443,0.000015033762,0.000015065669,0.00000641856,0.000013169477,0.000015939611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002624727,0.00028178812,0.00036648088,0.00024263827,0.00012815841,0.00036205607,0.00016883296,0.0002580603,0.0035692675],"category_scores_gemma":[0.00017367724,0.000087849716,0.00015901406,0.0001761069,0.00021140589,0.00019104782,0.0001239726,0.0005613027,0.00063113694],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022364773,0.00023628611,0.007592563,0.00020357873,0.00004287045,0.00037142052,0.000036735302,0.0008012147,0.93799204,0.00038639232,0.0010461357,0.049054313],"study_design_scores_gemma":[0.00033186603,0.0041784383,0.04389858,0.000017653056,0.000067778354,0.0034213706,0.000054407083,0.004041183,0.93147814,0.000376788,0.012119914,0.000013926519],"about_ca_topic_score_codex":0.0003980552,"about_ca_topic_score_gemma":0.00044367524,"teacher_disagreement_score":0.0035692675,"about_ca_system_score_codex":0.00046900174,"about_ca_system_score_gemma":0.00017341199,"threshold_uncertainty_score":0.01194042},"labels":[],"label_agreement":null},{"id":"W4296130421","doi":"10.1158/1557-3265.sarcomas22-a023","title":"Abstract A023: Identifying new therapeutic indications for afamitresgene autoleucel (“afami-cel” [formerly ADP-A2M4]) in adult and pediatric sarcomas using MAGE-A4 immunohistochemistry","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Leiomyosarcoma; Sarcoma; Medicine; Immunohistochemistry; Synovial sarcoma; Undifferentiated Pleomorphic Sarcoma; Liposarcoma; Tissue microarray; Pathology; Cancer; Dermatofibrosarcoma protuberans; Cancer research; Soft tissue sarcoma; Internal medicine","score_opus":0.2983232906111273,"score_gpt":0.5464183236075497,"score_spread":0.24809503299642244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953685,0.0014549388,0.0005238761,0.00009765435,0.000008643262,0.000040589337,0.0010458733,0.000017559443,0.001442351],"genre_scores_gemma":[0.99496484,0.0008170096,0.0018133752,0.000076651515,0.000014916877,0.000048328333,0.0015569729,0.000005609027,0.0007022457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998672,0.000019967269,0.0000148461695,0.00003497213,0.00003575193,0.000027225626],"domain_scores_gemma":[0.99973196,0.000041567928,0.000097259406,0.000011396696,0.00006988637,0.000047984264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000420803,0.00013349573,0.00015317091,0.0006029294,0.00020320113,0.00037032182,0.00019665065,0.00027270993,0.0014011794],"category_scores_gemma":[0.00043631336,0.0001102193,0.00015513333,0.0005244061,0.0001517713,0.00028489335,0.00013682053,0.00017406583,0.00034477003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026284761,0.0001507625,0.76070476,0.00023306237,0.000060590035,0.0017693221,0.00017751208,0.0006052582,0.1862152,0.00016035244,0.0018134331,0.04548138],"study_design_scores_gemma":[0.000063797874,0.00087265455,0.9190988,0.000045904624,0.000103669874,0.0057696467,0.0004436558,0.0019083563,0.06256181,0.000091147485,0.009028848,0.000011758045],"about_ca_topic_score_codex":0.0020811388,"about_ca_topic_score_gemma":0.0036228488,"teacher_disagreement_score":0.0020811388,"about_ca_system_score_codex":0.00062534335,"about_ca_system_score_gemma":0.0005644183,"threshold_uncertainty_score":0.0046874285},"labels":[],"label_agreement":null},{"id":"W4296130424","doi":"10.1158/1557-3265.sarcomas22-pr003","title":"Abstract PR003: YAP1 is a key regulator of EWS-FLI1-dependent malignant transformation upon IGF1 mediated reprogramming of bone mesenchymal stem cell-like cells","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mesenchymal stem cell; Biology; Reprogramming; Cancer research; Cre recombinase; Cell biology; Embryonic stem cell; Conditional gene knockout; Carcinogenesis; Progenitor cell; Stem cell; YAP1; Phenotype; Transcription factor; Transgene; Genetically modified mouse; Genetics; Cell; Cancer; Gene","score_opus":0.0930435449656888,"score_gpt":0.40128951716136296,"score_spread":0.3082459721956742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924987,0.0012355024,0.003551912,0.000108648856,0.000029689494,0.000028317541,0.001128395,0.00015005257,0.0012688331],"genre_scores_gemma":[0.99357057,0.00035748363,0.0009983514,0.000041717234,0.000007089356,0.00003803211,0.0014350725,0.000042545427,0.0035091261],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988353,0.000012630665,0.0000100943325,0.000031980082,0.00003473438,0.00002696619],"domain_scores_gemma":[0.9999136,0.000013440089,0.00003246312,0.000007792633,0.00000715125,0.000025597647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011609933,0.0003785888,0.00017058122,0.00018556496,0.00014515137,0.00021337079,0.00017828609,0.0002450709,0.0025262064],"category_scores_gemma":[0.00007622464,0.00011656067,0.0002035923,0.000104054256,0.00022553201,0.0001311553,0.00023086678,0.00049513933,0.00067672844],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004268305,0.000005817605,0.000092950744,0.0000151640415,0.0000010957507,0.00004069727,0.0000041781486,0.000017464961,0.9994192,0.000032991746,0.000021653605,0.0003062054],"study_design_scores_gemma":[0.000009693503,0.00010747338,0.004971939,0.000004304498,0.000008487453,0.00031250378,0.000023854895,0.00058948854,0.99207157,0.0000264033,0.0018717567,0.0000024942808],"about_ca_topic_score_codex":0.00039867972,"about_ca_topic_score_gemma":0.0004805784,"teacher_disagreement_score":0.0025262064,"about_ca_system_score_codex":0.00024157966,"about_ca_system_score_gemma":0.00014203285,"threshold_uncertainty_score":0.008450985},"labels":[],"label_agreement":null},{"id":"W4296130436","doi":"10.1158/1557-3265.sarcomas22-pr006","title":"Abstract PR006: Multi-modal single-cell profiling of sarcomas from archival tissue reveals mechanisms of resistance to immune checkpoint inhibitors","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Cancer research; Sarcoma; Melanoma; Immune checkpoint; Gene expression profiling; Immune system; Genetics; Immunotherapy; Pathology; Medicine; Gene; Gene expression","score_opus":0.09436888889503806,"score_gpt":0.4111122386363418,"score_spread":0.3167433497413037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130436","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842993,0.00045310025,0.010985301,0.00009208398,0.0000133416615,0.000042461783,0.0027059,0.00024083853,0.0011676624],"genre_scores_gemma":[0.9870139,0.0001991314,0.0084007885,0.00006721772,0.0000106072175,0.000035393692,0.0028319857,0.00006409013,0.0013770022],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998727,0.000010189753,0.00000882692,0.000045986388,0.000041836996,0.000020420957],"domain_scores_gemma":[0.9998944,0.000020885771,0.00002149689,0.000023002016,0.000022392296,0.000017830778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019503766,0.00014752627,0.00016422947,0.0004356254,0.00015233253,0.000364661,0.00016400006,0.00023472747,0.0013852464],"category_scores_gemma":[0.00022071681,0.00011365561,0.00015221957,0.00024542565,0.00016028594,0.00013913553,0.00025034472,0.0003078449,0.00052841264],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010528373,0.000009840387,0.007186423,0.000025225885,0.000008991737,0.00008744216,0.000043305587,0.0001285118,0.98644096,0.00005024303,0.00018064417,0.0057332464],"study_design_scores_gemma":[0.00001770721,0.00034816295,0.23045392,0.000013637839,0.00005890825,0.0031248317,0.00026156474,0.007681011,0.74972236,0.0003455191,0.007957546,0.000014907552],"about_ca_topic_score_codex":0.00044678937,"about_ca_topic_score_gemma":0.0009188263,"teacher_disagreement_score":0.0013852464,"about_ca_system_score_codex":0.0001253356,"about_ca_system_score_gemma":0.00010672125,"threshold_uncertainty_score":0.0046340823},"labels":[],"label_agreement":null},{"id":"W4296130466","doi":"10.1158/1557-3265.sarcomas22-a002","title":"Abstract A002: Dynamic single cell imaging of cancer stem cells and clonality in fusion-negative rhabdomyosarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stem cell; Cancer research; Cancer stem cell; Biology; Rhabdomyosarcoma; Zebrafish; Mesenchymal stem cell; Pathology; Immunology; Medicine; Sarcoma; Cell biology; Genetics","score_opus":0.07259922346754358,"score_gpt":0.4318356706227993,"score_spread":0.3592364471552557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130466","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9376174,0.0011699651,0.05207778,0.0003365366,0.00008712533,0.000088341185,0.0010707297,0.0010071063,0.006545106],"genre_scores_gemma":[0.94509125,0.0005424565,0.044470295,0.00014390839,0.000021736078,0.00013648394,0.00085411995,0.00021414964,0.008525746],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99991035,0.000007744482,0.000005617582,0.00002253129,0.000041541774,0.000012151336],"domain_scores_gemma":[0.99983585,0.00004863269,0.000024124229,0.000013922781,0.00004419143,0.000033276356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025169383,0.00016081026,0.00013595671,0.000443191,0.00019669229,0.00032061967,0.00023245843,0.00039731478,0.0025469142],"category_scores_gemma":[0.00018987269,0.00013158623,0.000111469795,0.00020729938,0.00020764301,0.00024046695,0.00021257579,0.00045697796,0.00044054596],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003909099,0.0000132737605,0.00050200126,0.000019250943,0.0000025279162,0.00005924451,0.000024428924,0.00015644454,0.9959435,0.00021328217,0.00021750912,0.0028094791],"study_design_scores_gemma":[0.000019039784,0.0001458009,0.013982472,0.00001152457,0.000010799057,0.0006036632,0.00008288927,0.016310032,0.9637037,0.00025760176,0.004858035,0.000014411855],"about_ca_topic_score_codex":0.0014116552,"about_ca_topic_score_gemma":0.0018443852,"teacher_disagreement_score":0.0025469142,"about_ca_system_score_codex":0.00029986698,"about_ca_system_score_gemma":0.00018450111,"threshold_uncertainty_score":0.008520246},"labels":[],"label_agreement":null},{"id":"W4296130467","doi":"10.1158/1557-3265.sarcomas22-a031","title":"Abstract A031: Interplay of YAP1, β-catenin and the SS18-SSX fusion protein in synovial sarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"YAP1; Gene knockdown; Biology; Luciferase; Cancer research; Fusion protein; Immunoprecipitation; Fusion gene; Catenin; Wnt signaling pathway; Transcription factor; Molecular biology; Cell biology; Cell culture; Transfection; Signal transduction; Gene; Genetics","score_opus":0.06392768346209672,"score_gpt":0.45270183964580657,"score_spread":0.38877415618370986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130467","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973296,0.0010461935,0.0009430727,0.000041926694,0.000008561772,0.000014369934,0.00021567372,0.000025320225,0.00037529317],"genre_scores_gemma":[0.99747795,0.0004531154,0.0007156918,0.000017985403,0.000005018406,0.000020471824,0.00050937897,0.000004601987,0.00079575664],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989355,0.000014458147,0.000013206568,0.000025608462,0.000034687528,0.000018430243],"domain_scores_gemma":[0.99991584,0.000014789969,0.000024502817,0.0000070560304,0.000012114179,0.00002558511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017306625,0.0002585659,0.0001979451,0.0002751256,0.00017357906,0.00024984684,0.0001318916,0.00024486257,0.0013165835],"category_scores_gemma":[0.00010998747,0.00011618239,0.00024782028,0.00019793569,0.00021006509,0.00017433974,0.00018032419,0.00029018658,0.00040011492],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014180879,0.000021410558,0.0013614474,0.000044674445,0.000006298055,0.00015358416,0.000011922965,0.000046938632,0.99739957,0.000035639896,0.000036527235,0.00074011646],"study_design_scores_gemma":[0.000031990523,0.0006812916,0.031447176,0.000008116102,0.00003817425,0.0022783421,0.000095993404,0.0020935747,0.96109664,0.00008433084,0.0021378351,0.0000066500447],"about_ca_topic_score_codex":0.00047744115,"about_ca_topic_score_gemma":0.00042639257,"teacher_disagreement_score":0.0013165835,"about_ca_system_score_codex":0.0003032364,"about_ca_system_score_gemma":0.00018402236,"threshold_uncertainty_score":0.004404366},"labels":[],"label_agreement":null},{"id":"W4296130470","doi":"10.1158/1557-3265.sarcomas22-a027","title":"Abstract A027: Characterization of WEE1 kinase activity in myxoid liposarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Wee1; Biology; Cancer research; Cell cycle; Cell biology; RNA interference; Kinase; Cell; Genetics; Cyclin-dependent kinase 1; Gene","score_opus":0.12478293002885647,"score_gpt":0.46489507755022913,"score_spread":0.34011214752137264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130470","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934917,0.001077662,0.0026910966,0.000052501066,0.000014117634,0.000057788584,0.001681682,0.000058227608,0.00087523897],"genre_scores_gemma":[0.9855202,0.00069060805,0.0050738254,0.000039827493,0.000015663047,0.000084610176,0.005616529,0.000018423345,0.0029404084],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999273,0.000007410753,0.000010403215,0.000017109509,0.000024715071,0.000013149002],"domain_scores_gemma":[0.9999144,0.000014559178,0.000018844948,0.0000074764052,0.000019433919,0.000025305382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014058907,0.00024250137,0.0001479414,0.00047421464,0.000111215835,0.00019147455,0.00013059459,0.00019805253,0.001937871],"category_scores_gemma":[0.000109653316,0.000092856826,0.00019567301,0.00023032392,0.00010763103,0.00013448989,0.00012230992,0.00026034625,0.0008199883],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005418104,0.000012539725,0.00049174455,0.00002195878,0.0000019986883,0.00007293916,0.000007059376,0.000013775687,0.9987884,0.00002115196,0.0000141651535,0.00050007016],"study_design_scores_gemma":[0.00001897058,0.00037287525,0.022128327,0.000007188558,0.000019518233,0.0014859978,0.000043504962,0.000573743,0.97274697,0.00005303744,0.0025460022,0.000003917314],"about_ca_topic_score_codex":0.00021253788,"about_ca_topic_score_gemma":0.00022570281,"teacher_disagreement_score":0.001937871,"about_ca_system_score_codex":0.0001167648,"about_ca_system_score_gemma":0.00012651511,"threshold_uncertainty_score":0.00648278},"labels":[],"label_agreement":null},{"id":"W4296130471","doi":"10.1158/1557-3265.sarcomas22-ia022","title":"Abstract IA022: Arginine, serine, xCT and ME, the therapeutic metabolism of different sarcomas","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Arginine; Downregulation and upregulation; Cancer research; Biology; Argininosuccinate synthase; Arginine deiminase; Osteosarcoma; Metabolic pathway; Cell biology; Metabolism; Biochemistry; Arginase; Amino acid","score_opus":0.12441773565574786,"score_gpt":0.4802922963051505,"score_spread":0.35587456064940265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130471","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75203586,0.15955903,0.0120761,0.006950738,0.003065183,0.00036101224,0.0068769827,0.0012628837,0.057812225],"genre_scores_gemma":[0.8933474,0.03595173,0.0064540426,0.0013026437,0.0005852284,0.00020629381,0.008830059,0.00025647055,0.053066194],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998491,0.000023995548,0.000012253062,0.000030112318,0.000058591548,0.000025880725],"domain_scores_gemma":[0.99991226,0.000008588029,0.000020178726,0.000008142009,0.00001814734,0.00003271612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029348867,0.0004876442,0.000311608,0.00044376805,0.00020776737,0.0006808586,0.00027049516,0.00042138586,0.005303877],"category_scores_gemma":[0.00017758286,0.00014282626,0.00030367728,0.00051012466,0.00018503227,0.00035393712,0.00039955214,0.0010118744,0.0018233133],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016461917,0.00017242886,0.00093353295,0.0005361115,0.000049722912,0.00030348275,0.000045838315,0.0003967776,0.934443,0.0015944713,0.0070923134,0.052786168],"study_design_scores_gemma":[0.00022386684,0.0026616289,0.009979175,0.0000973355,0.00014786227,0.0039038877,0.00008041847,0.0012785661,0.7877585,0.000992803,0.19283655,0.000039374154],"about_ca_topic_score_codex":0.00061271107,"about_ca_topic_score_gemma":0.0006616823,"teacher_disagreement_score":0.005303877,"about_ca_system_score_codex":0.0006281727,"about_ca_system_score_gemma":0.0004516153,"threshold_uncertainty_score":0.01774329},"labels":[],"label_agreement":null},{"id":"W4296130475","doi":"10.1158/1557-3265.sarcomas22-b013","title":"Abstract B013: STEAP1 facilitates iron transport in ewing sarcoma to support mitochondrial activity","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"","keywords":"Gene knockdown; Mitochondrion; Cancer research; Cell biology; Extracellular; Intracellular; Biology; Transmembrane protein; Chemistry; Biochemistry; Apoptosis; Receptor","score_opus":0.13688262544019467,"score_gpt":0.4913750992696567,"score_spread":0.35449247382946203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130475","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835433,0.003705036,0.0055205985,0.0006789573,0.00019094412,0.00004834006,0.0021200175,0.00020899274,0.0039837183],"genre_scores_gemma":[0.9893243,0.00085330993,0.0013777643,0.00013366075,0.000017532491,0.000044352066,0.0021272704,0.000035737234,0.006085947],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989617,0.000011563514,0.000012518747,0.000031011394,0.000027455242,0.00002126793],"domain_scores_gemma":[0.99990094,0.000014595238,0.000024345578,0.000011782356,0.000016061163,0.000032230142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001475893,0.0002654352,0.000261622,0.00014587147,0.00023952856,0.00027683433,0.00024871764,0.00044480714,0.0057146708],"category_scores_gemma":[0.00014368178,0.000118030795,0.00026864518,0.00017417957,0.00020369793,0.000314115,0.0003306955,0.00072155555,0.002088182],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022084094,0.000028723714,0.00025047097,0.00009576308,0.0000050458953,0.00011880957,0.000013135672,0.00006017268,0.9976036,0.0002393546,0.00025084388,0.0011133519],"study_design_scores_gemma":[0.000071264374,0.0003209233,0.008110371,0.000026607215,0.000024829713,0.0008588083,0.00008567235,0.0021509791,0.9760159,0.0002583671,0.012066775,0.00000959358],"about_ca_topic_score_codex":0.00032905134,"about_ca_topic_score_gemma":0.00024784083,"teacher_disagreement_score":0.0057146708,"about_ca_system_score_codex":0.0003174404,"about_ca_system_score_gemma":0.0001601399,"threshold_uncertainty_score":0.019117534},"labels":[],"label_agreement":null},{"id":"W4296130477","doi":"10.1158/1557-3265.sarcomas22-a038","title":"Abstract A038: Enrollment of pediatric and adolescent patients with MAGE-A4+ advanced synovial sarcoma into cohort 2 of SPEARHEAD-1: a phase 2 trial of afamitresgene autoleucel (“afami-cel” [formerly ADP-A2M4])","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Synovial sarcoma; Sarcoma; Cohort; Internal medicine; Soft tissue sarcoma; Oncology; Surgery; Pathology","score_opus":0.0989514237550265,"score_gpt":0.48197742497487267,"score_spread":0.3830260012198462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97467065,0.0011563216,0.00075175794,0.0009999995,0.0001871834,0.008946642,0.009346068,0.000088017194,0.0038533933],"genre_scores_gemma":[0.9701791,0.0009072522,0.0024825837,0.0019574158,0.00025747874,0.010707619,0.00991598,0.0000405526,0.0035520156],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99945754,0.0002292695,0.000039867366,0.00014109872,0.000050082912,0.00008208699],"domain_scores_gemma":[0.9992218,0.00008011013,0.00013933585,0.000047115605,0.000050778424,0.00046084635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011960834,0.00054709485,0.0007255424,0.00023005532,0.00053013826,0.0006993558,0.0005553497,0.0007606536,0.013739923],"category_scores_gemma":[0.0012829963,0.00034575537,0.0010261295,0.0003339263,0.00033428942,0.00056741305,0.0004481964,0.0016348391,0.0019653647],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.57517195,0.03422591,0.19360991,0.0009904589,0.0019177232,0.0013734292,0.000946463,0.001132384,0.021925414,0.0009767682,0.038290855,0.12943879],"study_design_scores_gemma":[0.41838974,0.2702828,0.2540416,0.0003571137,0.001731812,0.0022149598,0.00073443574,0.0023030466,0.006550513,0.0012618506,0.042051308,0.000080793674],"about_ca_topic_score_codex":0.0016937,"about_ca_topic_score_gemma":0.0043630283,"teacher_disagreement_score":0.013739923,"about_ca_system_score_codex":0.00094193185,"about_ca_system_score_gemma":0.0026881606,"threshold_uncertainty_score":0.0459646},"labels":[],"label_agreement":null},{"id":"W4296130482","doi":"10.1158/1557-3265.sarcomas22-b009","title":"Abstract B009: Establishing new cell lines from undifferentiated pleomorphic sarcoma for sarcoma research","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sarcoma; Cell culture; Undifferentiated Pleomorphic Sarcoma; In vivo; Fusion gene; Cancer; Pathology; Immunohistochemistry; Soft tissue sarcoma; Cell; Cancer research; Biology; Mesenchymal stem cell; Medicine; Gene; Internal medicine; Genetics","score_opus":0.46337885103049303,"score_gpt":0.5448217628848551,"score_spread":0.08144291185436203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.60061723,0.027713103,0.15681213,0.0044834865,0.003863251,0.0068644984,0.108974025,0.0039439467,0.08672831],"genre_scores_gemma":[0.5130401,0.015946925,0.14630741,0.0018004162,0.0003778143,0.0047079492,0.22677352,0.00085899397,0.09018688],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999308,0.00007816453,0.000100979596,0.00010720701,0.0003241304,0.00008148944],"domain_scores_gemma":[0.9994444,0.00007524126,0.00004055974,0.00011154881,0.0002330013,0.00009522513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008765352,0.0005626013,0.0005642758,0.00096962904,0.00067749637,0.0007836105,0.00068172184,0.0005812171,0.008113297],"category_scores_gemma":[0.0006121283,0.0003062927,0.0006372438,0.0012848703,0.00034530967,0.00045792118,0.0006339704,0.0015618437,0.0077786855],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043907814,0.00027919834,0.0027164426,0.00048296573,0.000036343296,0.0005002732,0.00024610775,0.00025571737,0.94531125,0.0016633573,0.014707038,0.033362225],"study_design_scores_gemma":[0.0001863908,0.0010106574,0.022487145,0.00015110028,0.00020917584,0.002660069,0.0002297781,0.0021111602,0.7376398,0.00043418698,0.23281763,0.00006291016],"about_ca_topic_score_codex":0.002087571,"about_ca_topic_score_gemma":0.0032154233,"teacher_disagreement_score":0.008113297,"about_ca_system_score_codex":0.00041891885,"about_ca_system_score_gemma":0.00080292014,"threshold_uncertainty_score":0.02714169},"labels":[],"label_agreement":null},{"id":"W4296130495","doi":"10.1158/1557-3265.sarcomas22-ia025","title":"Abstract IA025: Using genetically engineered mouse models to study sarcoma metastasis","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Metastasis; Sarcoma; Cancer research; Biology; Pathology; Undifferentiated Pleomorphic Sarcoma; Lung; Soft tissue sarcoma; Medicine; Cancer; Internal medicine; Genetics","score_opus":0.5064369323713099,"score_gpt":0.550279210240197,"score_spread":0.04384227786888706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296130495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84426135,0.008218342,0.101609156,0.002825279,0.0013406369,0.0019088502,0.015982753,0.003990865,0.01986265],"genre_scores_gemma":[0.8845571,0.0056198095,0.05851444,0.0010669011,0.00019769413,0.0031657952,0.012228704,0.00070307835,0.033946425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991055,0.00018235648,0.00012150017,0.0001935854,0.00024813184,0.0001489884],"domain_scores_gemma":[0.9993806,0.00009604277,0.00015561133,0.00008078485,0.000081608436,0.0002053153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001132733,0.001333116,0.00060715165,0.002549548,0.00060474453,0.0009211927,0.0009795836,0.0015792361,0.0058922223],"category_scores_gemma":[0.00040449767,0.00050468364,0.00083147665,0.0006723112,0.00079512206,0.0008568341,0.0005553365,0.0029462564,0.002204857],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029354094,0.00046380784,0.0003665568,0.00014603585,0.000027069518,0.00022185521,0.0000466039,0.0003155927,0.9925256,0.0015840959,0.0008979449,0.0031112465],"study_design_scores_gemma":[0.00030037534,0.002997218,0.0037234998,0.00011478695,0.0001020183,0.0019026147,0.00010708701,0.0066860747,0.9565928,0.00086164096,0.026567934,0.000044026576],"about_ca_topic_score_codex":0.0012463228,"about_ca_topic_score_gemma":0.0017549719,"teacher_disagreement_score":0.0058922223,"about_ca_system_score_codex":0.0010318033,"about_ca_system_score_gemma":0.00057181716,"threshold_uncertainty_score":0.019711435},"labels":[],"label_agreement":null},{"id":"W4296131107","doi":"10.1158/1557-3265.sarcomas22-ia020","title":"Abstract IA020: Reprogramming of myogenic transcription factors in rhabdomyosarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transcription factor; Biology; Chromatin; Cellular differentiation; Progenitor cell; Rhabdomyosarcoma; Chromatin immunoprecipitation; Reprogramming; Enhancer; MYF5; Skeletal muscle; Cell biology; PAX3; Myogenic regulatory factors; Promoter; Cancer research; Genetics; Gene expression; Gene; Stem cell; Myogenin; Endocrinology; Pathology; Sarcoma; Medicine","score_opus":0.34312296318789337,"score_gpt":0.5313530501840579,"score_spread":0.1882300869961645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841918,0.002114897,0.004639472,0.0001305173,0.00008114847,0.00006951675,0.0008765552,0.00020011251,0.0076959706],"genre_scores_gemma":[0.98443943,0.0009158624,0.0028049683,0.00010681738,0.000018707322,0.00006184757,0.001526559,0.00006356502,0.010062292],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985623,0.00002452015,0.000014529094,0.000035461206,0.000039427974,0.000029743724],"domain_scores_gemma":[0.99995506,0.000008371537,0.000010340712,0.000006673951,0.0000045354327,0.000015052321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001598025,0.00023815127,0.00016110079,0.00023710748,0.00015633184,0.00025239505,0.00023092337,0.0002593911,0.0022195103],"category_scores_gemma":[0.00008514499,0.00012154108,0.00021210327,0.0001349983,0.00016540797,0.00013619702,0.00024876863,0.00039644045,0.0010201052],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064364525,0.000017232405,0.00018946856,0.000029124578,0.0000018824759,0.000051900966,0.000013175035,0.00006744919,0.99747187,0.00015651628,0.000055173732,0.0018818611],"study_design_scores_gemma":[0.000019640222,0.0003576747,0.007167278,0.00001130269,0.000014888309,0.0006993954,0.00005261357,0.0011558947,0.9796495,0.00012907198,0.010735497,0.000007284465],"about_ca_topic_score_codex":0.0003633072,"about_ca_topic_score_gemma":0.0004518362,"teacher_disagreement_score":0.0022195103,"about_ca_system_score_codex":0.00027579584,"about_ca_system_score_gemma":0.00015204448,"threshold_uncertainty_score":0.0074249506},"labels":[],"label_agreement":null},{"id":"W4296131108","doi":"10.1158/1557-3265.sarcomas22-b023","title":"Abstract B023: Prospective clinical genomic profiling of ewing sarcoma: <i>ERF</i> and <i>FGFR1</i> mutations as recurrent secondary alterations of potential biological and therapeutic relevance","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CDKN2A; Cancer research; Clonogenic assay; Biology; Sarcoma; Gene expression profiling; Epigenetics; Amplicon; Gene knockdown; Medicine; Oncology; Bioinformatics; Genetics; Cancer; Gene; In vivo; Gene expression; Pathology; Polymerase chain reaction","score_opus":0.1993466371871482,"score_gpt":0.49573992973248443,"score_spread":0.2963932925453362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9709179,0.00034864232,0.0009652633,0.00016739036,0.00001765564,0.000101164565,0.025869617,0.00008368229,0.0015286586],"genre_scores_gemma":[0.9361153,0.00016097583,0.0014919726,0.00024763585,0.00004169862,0.00012876459,0.060747854,0.000052331026,0.001013466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966836,0.000053515017,0.00003645163,0.00013183392,0.00006132333,0.000048432667],"domain_scores_gemma":[0.9993111,0.00011449204,0.00012921613,0.00010405588,0.00013961007,0.00020148822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006573861,0.00031833138,0.00036314374,0.0005510474,0.00043259392,0.00070715864,0.0003276096,0.00046667745,0.002792991],"category_scores_gemma":[0.0009047817,0.00017631658,0.00024295124,0.00081281964,0.00020130393,0.00020999038,0.0005713745,0.00044479847,0.001223996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031924308,0.00030237072,0.9051456,0.00014808206,0.0001771087,0.0013575816,0.0001570063,0.0008234816,0.056069918,0.0002015384,0.010822572,0.021602364],"study_design_scores_gemma":[0.00021137019,0.000813066,0.9735059,0.00002923326,0.00015942965,0.0034301914,0.00015494124,0.0012129719,0.009732598,0.00016241685,0.010567134,0.000020741014],"about_ca_topic_score_codex":0.0019685472,"about_ca_topic_score_gemma":0.0025885012,"teacher_disagreement_score":0.002792991,"about_ca_system_score_codex":0.00035660484,"about_ca_system_score_gemma":0.0004567722,"threshold_uncertainty_score":0.009343445},"labels":[],"label_agreement":null},{"id":"W4296131130","doi":"10.1158/1557-3265.sarcomas22-pr010","title":"Abstract PR010: Development of a pre-clinical metastatic model of human sarcoma to identify therapeutic targets","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sarcoma; Medicine; Metastasis; Disease; Mesenchymal stem cell; Cancer research; In vivo; Radiation therapy; Cancer; Oncology; Pathology; Bioinformatics; Internal medicine; Biology","score_opus":0.32255989377809996,"score_gpt":0.5619909653106611,"score_spread":0.2394310715325611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.840219,0.0033704678,0.112785935,0.0016517836,0.0009122477,0.0019373692,0.00951143,0.0018673285,0.027744317],"genre_scores_gemma":[0.9015051,0.0020086751,0.053693272,0.0004112362,0.00004612963,0.0011078594,0.0063368217,0.00031376706,0.034577075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994548,0.00006845053,0.00005568174,0.0001206954,0.00022048087,0.00007992914],"domain_scores_gemma":[0.999624,0.000065646265,0.000073651005,0.00005839936,0.000060069273,0.00011826497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071414304,0.0005366927,0.00037659946,0.00066635007,0.000421063,0.0005402245,0.0007967736,0.0008216446,0.0044882973],"category_scores_gemma":[0.00027186467,0.00033101122,0.0005552152,0.00028254703,0.00051670894,0.00047675555,0.0004898478,0.002148624,0.0019338625],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018161435,0.0003172707,0.0002378032,0.00009482451,0.00000937866,0.00017823957,0.000048670998,0.0004930654,0.99266326,0.0011467542,0.0008359185,0.0037932536],"study_design_scores_gemma":[0.00010392772,0.0018585485,0.0015812432,0.000037123777,0.00003354276,0.0010285137,0.000067959896,0.004922212,0.9725027,0.00031334258,0.017532395,0.000018491914],"about_ca_topic_score_codex":0.003377126,"about_ca_topic_score_gemma":0.0032322186,"teacher_disagreement_score":0.0044882973,"about_ca_system_score_codex":0.00065354863,"about_ca_system_score_gemma":0.0010664606,"threshold_uncertainty_score":0.015014827},"labels":[],"label_agreement":null},{"id":"W4296131173","doi":"10.1158/1557-3265.sarcomas22-a015","title":"Abstract A015: Biochemical and preclinical anti-tumor activity of a bi-steric mTORC1-selective inhibitor in fusion positive rhabdomyosarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"mTORC1; Allosteric regulation; Cancer research; Rhabdomyosarcoma; PI3K/AKT/mTOR pathway; In vivo; Medicine; Cancer; Pharmacology; Biology; Internal medicine; Sarcoma; Signal transduction; Pathology; Cell biology; Receptor","score_opus":0.09778614397781617,"score_gpt":0.463755349017009,"score_spread":0.36596920503919284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99387896,0.0022436837,0.0008305946,0.00007693237,0.000043187134,0.00009810134,0.00059791864,0.00010123366,0.0021293263],"genre_scores_gemma":[0.9936866,0.0009723239,0.0018914182,0.00004147171,0.000013906314,0.000063806976,0.0014063183,0.000012535255,0.0019116333],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991,0.0000150657315,0.000012898857,0.000015915208,0.000026946364,0.00001916638],"domain_scores_gemma":[0.9999262,0.000011720521,0.0000123736245,0.0000085368765,0.000013639418,0.000027505179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022837492,0.00036448787,0.00034303468,0.00025620617,0.00012479191,0.00019653125,0.0002617098,0.0002268099,0.0017260268],"category_scores_gemma":[0.00010772189,0.00009873043,0.00024655683,0.00023665467,0.0001516709,0.00016220009,0.000108556844,0.00054989784,0.00045815934],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019421977,0.0010917931,0.0005122284,0.00018305657,0.00003473311,0.000114244795,0.000026116488,0.00070375856,0.9850407,0.00014404398,0.000491692,0.009715254],"study_design_scores_gemma":[0.0006394078,0.027993381,0.00731151,0.000022012984,0.00010668592,0.0006516569,0.000044054217,0.0026973574,0.95672065,0.000051741794,0.0037456604,0.000016050826],"about_ca_topic_score_codex":0.0010061479,"about_ca_topic_score_gemma":0.0018023092,"teacher_disagreement_score":0.0017260268,"about_ca_system_score_codex":0.00020876105,"about_ca_system_score_gemma":0.0003145903,"threshold_uncertainty_score":0.0057741404},"labels":[],"label_agreement":null},{"id":"W4296131175","doi":"10.1158/1557-3265.sarcomas22-a007","title":"Abstract A007: Resident memory T cells express PD-1 in high grade liposarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CD8; Liposarcoma; Population; Cancer research; Pembrolizumab; Immunotherapy; Immune system; Medicine; Immunology; Biology; Pathology; Sarcoma","score_opus":0.25340882664836867,"score_gpt":0.5239702194661223,"score_spread":0.27056139281775365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99898165,0.0001742994,0.00028738595,0.000017518554,0.0000032532034,0.000011310808,0.00006166013,0.000013947244,0.0004489376],"genre_scores_gemma":[0.9991885,0.00003463564,0.00023214702,0.000018728395,0.00001023602,0.000012114987,0.00017683633,0.000002986304,0.00032374196],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999416,0.000011656138,0.000008471953,0.000014806297,0.000011037789,0.000012388763],"domain_scores_gemma":[0.99983585,0.00005595411,0.000032392032,0.000019593863,0.000020334757,0.00003571622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018488748,0.0001666218,0.00013739498,0.0004414576,0.00012727329,0.00024032188,0.00009945461,0.0002347154,0.0034539537],"category_scores_gemma":[0.00031564388,0.000090435664,0.00009793583,0.00017298342,0.00017208717,0.00017951566,0.00017461707,0.00029611177,0.00058710435],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039319056,0.0004052584,0.22834213,0.00022079014,0.000033019198,0.0045751925,0.00027964765,0.0003330222,0.7342319,0.00021513201,0.00082506676,0.02660698],"study_design_scores_gemma":[0.0005630072,0.005703717,0.7426865,0.000051095372,0.00013310117,0.04980117,0.0008288296,0.0036699295,0.18981886,0.0006674527,0.006052382,0.000023910608],"about_ca_topic_score_codex":0.000118931224,"about_ca_topic_score_gemma":0.00009527835,"teacher_disagreement_score":0.0034539537,"about_ca_system_score_codex":0.000118480835,"about_ca_system_score_gemma":0.00007724696,"threshold_uncertainty_score":0.011554599},"labels":[],"label_agreement":null},{"id":"W4296131180","doi":"10.1158/1557-3265.sarcomas22-ia007","title":"Abstract IA007: B cell immunity generation in tertiary lymphoid structures, a major determinant of sarcoma immune response to immunotherapy","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sarcoma; Immunotherapy; CD8; Immune system; Cancer immunotherapy; Cancer research; Biology; Immunology; Cancer; Medicine; Pathology; Internal medicine","score_opus":0.0796667208367007,"score_gpt":0.4202296403562986,"score_spread":0.34056291951959794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983809,0.0003115285,0.00036973326,0.000022040713,0.000002213659,0.000010361304,0.00032854144,0.000020780604,0.00055395975],"genre_scores_gemma":[0.9988643,0.000054088814,0.00026977307,0.000018933093,0.0000048827837,0.000011463698,0.0004501162,0.000005274143,0.00032108926],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998994,0.000021172822,0.00000763542,0.000026033704,0.00002272188,0.000023058665],"domain_scores_gemma":[0.9998005,0.00003379954,0.00006770589,0.000021227132,0.0000323411,0.00004449748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018283741,0.00012263026,0.00018162892,0.0004009152,0.00014543676,0.00028807012,0.000103261125,0.00015346681,0.0022965786],"category_scores_gemma":[0.00025217375,0.000082315324,0.00017640505,0.00025654104,0.00015879679,0.00011237856,0.00017915228,0.00034405882,0.00037750258],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019995791,0.00012765983,0.10899301,0.00010734648,0.000045948294,0.0001803375,0.00007622481,0.00028229,0.87584263,0.00013408052,0.00033454198,0.0118764015],"study_design_scores_gemma":[0.000075186435,0.0013289915,0.87782747,0.000016989177,0.00007549294,0.001390397,0.0001330099,0.0015162325,0.11522549,0.00023927334,0.0021650905,0.0000064148016],"about_ca_topic_score_codex":0.00033451864,"about_ca_topic_score_gemma":0.00028540744,"teacher_disagreement_score":0.0022965786,"about_ca_system_score_codex":0.00022051108,"about_ca_system_score_gemma":0.0001360205,"threshold_uncertainty_score":0.0076828003},"labels":[],"label_agreement":null},{"id":"W4296131254","doi":"10.1158/1557-3265.sarcomas22-a005","title":"Abstract A005: STING activation overcomes immune escape in osteosarcoma metastasis","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Guelph","funders":"","keywords":"Sting; Stimulator of interferon genes; Cancer research; Metastasis; Immune system; Cancer; Tumor microenvironment; Cancer cell; Downregulation and upregulation; Medicine; Immunotherapy; Innate immune system; Immunology; Biology; Internal medicine; Gene","score_opus":0.22584793915273674,"score_gpt":0.49713505180733997,"score_spread":0.27128711265460326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98482263,0.004707773,0.0022808134,0.00055606157,0.0003041192,0.00009952517,0.00069848524,0.0003647819,0.0061658244],"genre_scores_gemma":[0.992176,0.0012772776,0.00074114953,0.00012398532,0.000037754147,0.000040724637,0.000556647,0.000017955044,0.005028555],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999912,0.000012293068,0.00000866299,0.000013300192,0.00002057057,0.00003306977],"domain_scores_gemma":[0.99993277,0.000007659196,0.00001415139,0.000006100012,0.000008716515,0.000030636373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013173299,0.00027688264,0.0002907629,0.0002529344,0.00012312789,0.00035021934,0.00018827611,0.00029065867,0.005720409],"category_scores_gemma":[0.000109857196,0.000086710825,0.00030589674,0.00013345627,0.00017473518,0.00021407647,0.00016973219,0.00089633226,0.00069632556],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012303407,0.00037035978,0.00056132,0.00022537324,0.000025012947,0.00010733837,0.000026476344,0.00025922444,0.978144,0.00066551246,0.0009401466,0.017444892],"study_design_scores_gemma":[0.00038513285,0.008614569,0.009812902,0.000052701773,0.00011859844,0.00052994094,0.00010286741,0.0033243126,0.9541004,0.00042849366,0.022515938,0.000014117],"about_ca_topic_score_codex":0.00048808366,"about_ca_topic_score_gemma":0.00079141575,"teacher_disagreement_score":0.005720409,"about_ca_system_score_codex":0.0002373717,"about_ca_system_score_gemma":0.00031748973,"threshold_uncertainty_score":0.019136667},"labels":[],"label_agreement":null},{"id":"W4296131270","doi":"10.1158/1557-3265.sarcomas22-a037","title":"Abstract A037: TT-00420, a novel kinase inhibitor potentially benefiting c-Myc amplified/overexpressed osteosarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osteosarcoma; Cancer research; Clonogenic assay; Immunohistochemistry; Kinase; Medicine; Oncogene; Aurora A kinase; In vivo; Biology; Internal medicine; Cancer; Cell cycle","score_opus":0.11173200425652956,"score_gpt":0.42800626540463466,"score_spread":0.3162742611481051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797667,0.010219874,0.0013771978,0.0003376301,0.00023465302,0.00023556425,0.0008643305,0.00027477156,0.0066892477],"genre_scores_gemma":[0.98501045,0.0050873803,0.0015205952,0.00044505292,0.00006065706,0.00016365136,0.0019506227,0.0000270891,0.005734396],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999422,0.000008356505,0.0000053970275,0.000011775158,0.000012444662,0.00001994739],"domain_scores_gemma":[0.99996793,0.0000030498268,0.0000046425694,0.0000024821957,0.000004266905,0.000017535884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001378418,0.00050336437,0.0004032293,0.00028385656,0.00015701754,0.00036952444,0.00030548548,0.0004328571,0.002533342],"category_scores_gemma":[0.00008064139,0.0001372533,0.00032637882,0.00027084094,0.00015936168,0.00022619226,0.0001663148,0.00075689686,0.00063762045],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006200361,0.0034694774,0.0017059965,0.00068496814,0.00015802162,0.0009181476,0.000084970714,0.0012382315,0.89882994,0.0011317042,0.0047014244,0.08087681],"study_design_scores_gemma":[0.01122281,0.094293475,0.037423838,0.00016080515,0.0008435935,0.007273969,0.00017710427,0.012041912,0.76728266,0.0007759754,0.06836293,0.00014084451],"about_ca_topic_score_codex":0.0006010666,"about_ca_topic_score_gemma":0.0012001438,"teacher_disagreement_score":0.002533342,"about_ca_system_score_codex":0.00019545187,"about_ca_system_score_gemma":0.00043065706,"threshold_uncertainty_score":0.008474886},"labels":[],"label_agreement":null},{"id":"W4296131277","doi":"10.1158/1557-3265.sarcomas22-b014","title":"Abstract B014: Metabolic reprogramming in high-grade sarcomas: repurposing anti-cholesterol agents as a novel therapeutic strategy","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; Mount Sinai Hospital; SickKids Foundation; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Simvastatin; PI3K/AKT/mTOR pathway; Mevalonate pathway; Pharmacology; Cancer research; Doxorubicin; In vivo; Protein kinase B; Cell growth; Statin; Medicine; Biology; Chemotherapy; Signal transduction; Internal medicine; Cell biology; Enzyme; Biochemistry","score_opus":0.1915888944670585,"score_gpt":0.48370998691447675,"score_spread":0.29212109244741824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9182052,0.046813153,0.009683747,0.003084852,0.0004575238,0.00061981054,0.0016276815,0.0004399661,0.019067973],"genre_scores_gemma":[0.9505373,0.022684341,0.0098594595,0.0006887809,0.00017992238,0.00020629365,0.001972063,0.000040526356,0.013831196],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999273,0.000014364981,0.000008332102,0.000009978146,0.000021599504,0.000018426665],"domain_scores_gemma":[0.9999442,0.000007081862,0.000011281741,0.000005840389,0.000012704111,0.000018748762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002196721,0.000468596,0.00037879875,0.00049016444,0.00018173545,0.00048114406,0.0003450387,0.0004897299,0.004378672],"category_scores_gemma":[0.00010470231,0.000121835925,0.00037851738,0.00031431086,0.00022830417,0.00025332344,0.00023978241,0.0007523256,0.0011202435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012784131,0.00054372574,0.0014387849,0.00052490947,0.00004585379,0.00035661634,0.000033148255,0.00040951808,0.9335824,0.0009689425,0.0015956904,0.05922195],"study_design_scores_gemma":[0.00068653526,0.0073251976,0.0114023965,0.00012328994,0.00021180641,0.0022585576,0.00008964668,0.0016975115,0.9294849,0.00059182703,0.046100736,0.00002751238],"about_ca_topic_score_codex":0.00047130484,"about_ca_topic_score_gemma":0.0010563985,"teacher_disagreement_score":0.004378672,"about_ca_system_score_codex":0.00031995552,"about_ca_system_score_gemma":0.0004294051,"threshold_uncertainty_score":0.0146481395},"labels":[],"label_agreement":null},{"id":"W4296131311","doi":"10.1158/1557-3265.sarcomas22-b021","title":"Abstract B021: Long non-coding RNAs that are required for robust cell growth in ewing Sarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Sarcoma; Long non-coding RNA; Cancer research; Ewing's sarcoma; Cell growth; Oncogene; Phenotype; GAS5; FLI1; Synovial sarcoma; Downregulation and upregulation; Cell; Gene; Genetics; Cell cycle; Medicine; Pathology; Transcription factor","score_opus":0.19794022146894258,"score_gpt":0.4504245992308467,"score_spread":0.25248437776190413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95500517,0.002562243,0.019989146,0.00040724908,0.0002402875,0.00021543958,0.013300091,0.0017372862,0.0065430263],"genre_scores_gemma":[0.96037287,0.0007043153,0.013173982,0.00030296211,0.000023029826,0.00015992853,0.013535479,0.0005313032,0.011196164],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996886,0.000025879484,0.000042035,0.0000644145,0.00013625149,0.000042877517],"domain_scores_gemma":[0.99970764,0.000056601722,0.00006934896,0.000038717957,0.000034616805,0.00009312452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019752902,0.00049387605,0.00044219484,0.00031839818,0.00029952495,0.00036910092,0.00027240926,0.00040585457,0.0041190796],"category_scores_gemma":[0.00021976743,0.00021528457,0.00039956623,0.0002326245,0.00025067767,0.00017262816,0.0003579045,0.00081343786,0.002174452],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003148179,0.000010242195,0.00007967829,0.000018142688,0.0000022999743,0.00003645695,0.00000355827,0.000041239888,0.9990945,0.000038115028,0.00008426322,0.0005601397],"study_design_scores_gemma":[0.000012514995,0.00012184914,0.003975619,0.000007586126,0.000011838793,0.00024450573,0.000016593753,0.0008117169,0.9892237,0.0000438339,0.0055221464,0.000008137375],"about_ca_topic_score_codex":0.0009868987,"about_ca_topic_score_gemma":0.0016498137,"teacher_disagreement_score":0.0041190796,"about_ca_system_score_codex":0.000460248,"about_ca_system_score_gemma":0.00037061283,"threshold_uncertainty_score":0.01377964},"labels":[],"label_agreement":null},{"id":"W4296131321","doi":"10.1158/1557-3265.sarcomas22-pr012","title":"Abstract PR012: Targeted sequencing of 2,138 bone and soft tissue sarcomas reveals commonly altered pathways, subtype-independent genetic clusters, and potential therapeutic targets","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Biology; Epigenetics; Liposarcoma; Sarcoma; Undifferentiated Pleomorphic Sarcoma; Chondrosarcoma; Receptor tyrosine kinase; Leiomyosarcoma; Chromatin remodeling; Pathology; Soft tissue sarcoma; Genetics; Medicine; Gene; Signal transduction","score_opus":0.14971942415406328,"score_gpt":0.4294639470151369,"score_spread":0.27974452286107365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909339,0.00039347121,0.0019476891,0.00005071026,0.000006205302,0.000052171996,0.0053722523,0.00007958914,0.0011638787],"genre_scores_gemma":[0.9878419,0.00021584368,0.0028516282,0.00007192859,0.000008198955,0.000053609565,0.007958205,0.000047402587,0.00095129997],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9995763,0.000043879478,0.00004256239,0.00015189477,0.00013765489,0.000047791113],"domain_scores_gemma":[0.99967325,0.00007220144,0.00008142296,0.000049091144,0.00006860248,0.00005544219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041293565,0.0002508424,0.00034108735,0.0006410546,0.00023796427,0.0003941151,0.00029355357,0.0002893495,0.0018165506],"category_scores_gemma":[0.0009692947,0.00018080728,0.000405474,0.0007330913,0.0001929293,0.0001083027,0.00033436465,0.0002688653,0.0005291034],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024615428,0.00012398206,0.43046606,0.00026353198,0.00022036232,0.0024503495,0.00035680758,0.0014150834,0.49442732,0.0002921975,0.001753467,0.065769374],"study_design_scores_gemma":[0.00015792312,0.0011307325,0.8822466,0.00003657673,0.00031366292,0.012963886,0.0003096579,0.0040106797,0.089879975,0.00034981684,0.0085784495,0.000022084048],"about_ca_topic_score_codex":0.002351108,"about_ca_topic_score_gemma":0.004027752,"teacher_disagreement_score":0.002351108,"about_ca_system_score_codex":0.00032325214,"about_ca_system_score_gemma":0.00044618605,"threshold_uncertainty_score":0.006076932},"labels":[],"label_agreement":null},{"id":"W4296131396","doi":"10.1158/1557-3265.sarcomas22-a019","title":"Abstract A019: Phase 1, first-in-human, dose-expansion study of oral TP-1287, a cyclin dependent kinase 9 (CDK9) inhibitor, in patients with sarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Sarcoma; Internal medicine; Cancer; Oncology; Synovial sarcoma; Neutropenia; Chemotherapy; Gastroenterology; Pathology","score_opus":0.13262587911092769,"score_gpt":0.5003120973935415,"score_spread":0.36768621828261383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907188,0.0007101669,0.0007537877,0.0003303942,0.00006217652,0.0035484089,0.0015794268,0.00010347678,0.0021934656],"genre_scores_gemma":[0.98476124,0.0010264312,0.0021878174,0.00088972494,0.000105694184,0.0034441988,0.0032141618,0.0000387175,0.004332009],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99976367,0.00009696529,0.000015877498,0.000043872806,0.000031833577,0.000047808142],"domain_scores_gemma":[0.9995259,0.00008727568,0.000082546205,0.00003235887,0.000035030716,0.0002369012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009808639,0.0013338729,0.0012487307,0.00033095223,0.00046879728,0.00076500647,0.00068154774,0.0008882098,0.0066738194],"category_scores_gemma":[0.0006878813,0.00057192566,0.00075068476,0.000313005,0.0006872421,0.0008227881,0.0004027602,0.0032760405,0.0019415591],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44968417,0.22844048,0.019484352,0.00158145,0.0008293166,0.0012055754,0.00074513396,0.004979037,0.14005017,0.00064477976,0.011757009,0.14059864],"study_design_scores_gemma":[0.35917354,0.6143159,0.013550242,0.000049186758,0.00020471042,0.00073834165,0.00010665708,0.0012680872,0.0060417172,0.00025294072,0.0042713014,0.000027373317],"about_ca_topic_score_codex":0.00069255027,"about_ca_topic_score_gemma":0.0017460737,"teacher_disagreement_score":0.0066738194,"about_ca_system_score_codex":0.00075206993,"about_ca_system_score_gemma":0.0018413048,"threshold_uncertainty_score":0.022326112},"labels":[],"label_agreement":null},{"id":"W4296131397","doi":"10.1158/1557-3265.sarcomas22-pr011","title":"Abstract PR011: Characterization of the precancerous and cancer microenvironment in a zebrafish sarcoma model","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Biology; Sarcoma; Zebrafish; Cancer research; Cancer; Transcriptome; Population; Cancer cell; Pathology; Medicine; Gene expression; Genetics; Gene","score_opus":0.15388921823071502,"score_gpt":0.4630678657189183,"score_spread":0.30917864748820323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94402444,0.0007210008,0.043075204,0.00030306133,0.0000734076,0.00042158604,0.0069393828,0.0008095166,0.0036324954],"genre_scores_gemma":[0.9258469,0.0009253038,0.04691398,0.00022332415,0.000014572663,0.00084684824,0.006633503,0.00041197173,0.018183557],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99976057,0.000012694584,0.000016053198,0.00006668331,0.00010117826,0.000042752716],"domain_scores_gemma":[0.99976355,0.000026924436,0.00006987672,0.000022559416,0.00005304915,0.00006405519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023681628,0.0003968543,0.00026271906,0.00091983285,0.00040529046,0.0002880333,0.00033116495,0.0004969363,0.0022873494],"category_scores_gemma":[0.0001776865,0.00028073162,0.00045598304,0.0002522538,0.00040330927,0.0002826384,0.0003682774,0.0008914295,0.0007520252],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003409441,0.000010788169,0.00029510658,0.000021504224,0.000002424993,0.000058715796,0.000020458354,0.00011684571,0.99858,0.00009734524,0.00006473821,0.00069805543],"study_design_scores_gemma":[0.000026075397,0.0004505137,0.011111803,0.000019554058,0.00003295309,0.00047591783,0.00010840614,0.0042677037,0.9785539,0.00012650195,0.0048026387,0.00002406934],"about_ca_topic_score_codex":0.007091887,"about_ca_topic_score_gemma":0.010976285,"teacher_disagreement_score":0.007091887,"about_ca_system_score_codex":0.0008240749,"about_ca_system_score_gemma":0.0007036384,"threshold_uncertainty_score":0.014101207},"labels":[],"label_agreement":null},{"id":"W4296131408","doi":"10.1158/1557-3265.sarcomas22-ia017","title":"Abstract IA017: Impact of oxygen and nutrient availability on sarcoma tumor neighborhood","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hypoxia (environmental); Bioenergetics; Biology; Mitochondrion; Reactive oxygen species; Glycolysis; Oxidative stress; Cellular respiration; Cell biology; Metabolism; Oxygen; Biochemistry; Chemistry","score_opus":0.10030697199652322,"score_gpt":0.4633063034763304,"score_spread":0.3629993314798072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84677875,0.040235497,0.0011083124,0.0047621625,0.0015934507,0.000117069714,0.003538576,0.000347159,0.101519],"genre_scores_gemma":[0.95929855,0.011191946,0.0008900602,0.00034872067,0.0002078265,0.00004582756,0.0024588655,0.000053050393,0.025505252],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983954,0.000027079606,0.0000075431067,0.000020799396,0.00006523425,0.000039862527],"domain_scores_gemma":[0.99983406,0.00004006105,0.000022011936,0.0000082250945,0.00002509035,0.00007048335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014768052,0.00017867242,0.00027084688,0.0005804462,0.00037414036,0.0005743155,0.00022230484,0.00034413903,0.009024688],"category_scores_gemma":[0.0004115306,0.0000633048,0.00015422479,0.0004947065,0.00023666347,0.00017907612,0.00044777023,0.0003776937,0.0012097423],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005897669,0.00076268247,0.040663827,0.001591201,0.00011464226,0.005063285,0.00034283384,0.0040917695,0.3197364,0.0069899866,0.094349824,0.5203958],"study_design_scores_gemma":[0.00033891128,0.003149968,0.371396,0.00039869925,0.00029683847,0.00933684,0.0014682042,0.0062402007,0.16765717,0.004493122,0.43514362,0.000080434875],"about_ca_topic_score_codex":0.0051746685,"about_ca_topic_score_gemma":0.0063212165,"teacher_disagreement_score":0.009024688,"about_ca_system_score_codex":0.0009280077,"about_ca_system_score_gemma":0.0006456582,"threshold_uncertainty_score":0.030190587},"labels":[],"label_agreement":null},{"id":"W4296131450","doi":"10.1158/1557-3265.sarcomas22-a021","title":"Abstract A021: Chimeric antigen receptor armored natural killer cell immunotherapy for osteosarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chimeric antigen receptor; Immunotherapy; NK-92; Immunology; Antibody-dependent cell-mediated cytotoxicity; Cancer immunotherapy; Cancer research; Antigen; Biology; Immune system; Natural killer T cell; T cell; Antibody; Medicine; Monoclonal antibody","score_opus":0.17991780428112386,"score_gpt":0.5114094580274091,"score_spread":0.33149165374628525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8759744,0.05591014,0.021244824,0.0033075304,0.0017319837,0.0007426782,0.00089068187,0.0008455855,0.03935208],"genre_scores_gemma":[0.942437,0.014131505,0.006661365,0.0006178692,0.00022172046,0.00019678687,0.0014270211,0.000054456374,0.034252226],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991286,0.000011984902,0.0000057280213,0.000012192436,0.000038229424,0.000018997342],"domain_scores_gemma":[0.9999745,0.0000028538088,0.00000491328,0.0000020782998,0.0000070629485,0.000008713371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025460435,0.00027015546,0.00019510089,0.00033706316,0.00011024336,0.0002753668,0.00023085972,0.0005097876,0.0035481974],"category_scores_gemma":[0.00007004021,0.00007198963,0.0003372454,0.00019426909,0.0001315028,0.00021136881,0.00020760123,0.00041661205,0.0009378234],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022211124,0.0014084838,0.0010785768,0.0008929282,0.000074237556,0.0009671905,0.000069913134,0.0014550062,0.7888167,0.0038881362,0.009327105,0.18980065],"study_design_scores_gemma":[0.0034790167,0.025042411,0.011311428,0.00022887003,0.00036410213,0.009208508,0.00010950234,0.0109888315,0.6769788,0.0030110849,0.25921416,0.00006323527],"about_ca_topic_score_codex":0.00051268114,"about_ca_topic_score_gemma":0.0005445558,"teacher_disagreement_score":0.0035481974,"about_ca_system_score_codex":0.00028078113,"about_ca_system_score_gemma":0.00047695212,"threshold_uncertainty_score":0.011869907},"labels":[],"label_agreement":null},{"id":"W4296131451","doi":"10.1158/1557-3265.sarcomas22-ia006","title":"Abstract IA006: Immunobiology of sarcomas and therapeutic implications","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Immunotherapy; Immune system; Immunosuppression; Chemokine; Biology; Cancer; Cancer immunotherapy; Myeloid; Immunology; Medicine; Cancer research","score_opus":0.22327808832325258,"score_gpt":0.5027934221824263,"score_spread":0.2795153338591737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9346089,0.022475282,0.030647345,0.0016732826,0.0002135213,0.00007127168,0.0003863677,0.00020160842,0.009722556],"genre_scores_gemma":[0.9834051,0.004565597,0.00930938,0.00020563112,0.000066000706,0.000019701589,0.00024177863,0.000017455104,0.0021693865],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999336,0.000015611262,0.000004686216,0.000010763007,0.000022140686,0.000013238522],"domain_scores_gemma":[0.99994874,0.000007313021,0.000010740243,0.000005529937,0.000012361684,0.000015237312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002343232,0.00022606333,0.00010323966,0.0006254313,0.00015499833,0.00041442158,0.00020692537,0.00026633666,0.0011497216],"category_scores_gemma":[0.00012752549,0.00009057461,0.00012228683,0.00030969386,0.00037139907,0.00028530377,0.00026043315,0.00043231322,0.00029261218],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009172754,0.00003682319,0.0058105695,0.00016591285,0.000008481563,0.00024819284,0.000077540804,0.00094603153,0.9634296,0.0028240753,0.0005463967,0.025814742],"study_design_scores_gemma":[0.000025990223,0.0009393665,0.14779797,0.00016660344,0.00006789806,0.006484949,0.0008967875,0.018200478,0.75837505,0.008694783,0.058311835,0.00003833355],"about_ca_topic_score_codex":0.00031794014,"about_ca_topic_score_gemma":0.00026884733,"teacher_disagreement_score":0.0011497216,"about_ca_system_score_codex":0.00024381356,"about_ca_system_score_gemma":0.00021227644,"threshold_uncertainty_score":0.0038461685},"labels":[],"label_agreement":null},{"id":"W4296131454","doi":"10.1158/1557-3265.sarcomas22-a022","title":"Abstract A022: Targeting of soft tissue sarcoma cancer stem cells improves doxorubicin-sensitivity <i>in vitro</i>","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer stem cell; Cancer research; Biology; EZH2; Population; Stem cell; Doxorubicin; Stem cell marker; Side population; Cancer; Epigenetics; Medicine; Chemotherapy; Genetics; Gene","score_opus":0.13738816973783124,"score_gpt":0.46875047331177977,"score_spread":0.3313623035739485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909678,0.0012157632,0.0019961488,0.00017118857,0.00008410906,0.000091532216,0.0020589016,0.00017388556,0.0032407134],"genre_scores_gemma":[0.98560405,0.00094356696,0.002393733,0.00015280013,0.000020033995,0.000117217496,0.00430038,0.00003258376,0.0064356327],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990416,0.000011457872,0.000009431283,0.00002337,0.000028549925,0.00002301543],"domain_scores_gemma":[0.9999528,0.000008464014,0.000009471437,0.0000039730917,0.000007630878,0.000017772601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009736651,0.00027648723,0.0002525166,0.00021335554,0.000106488566,0.00031995217,0.00012216633,0.00018094906,0.0026780027],"category_scores_gemma":[0.00007436607,0.00007206236,0.00021333051,0.00016933437,0.000119134624,0.000114305134,0.00008891866,0.00039499262,0.00071285764],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003489618,0.000121393816,0.00017638659,0.000049561182,0.0000067154347,0.000023615125,0.000009022827,0.000120580036,0.9966377,0.000050940853,0.00033113736,0.0021239184],"study_design_scores_gemma":[0.000051599807,0.0014902705,0.004094057,0.0000069913244,0.00002166395,0.00008257272,0.000028922768,0.0011297679,0.98965466,0.00002590349,0.0034094972,0.0000039972474],"about_ca_topic_score_codex":0.00061710563,"about_ca_topic_score_gemma":0.0008088498,"teacher_disagreement_score":0.0026780027,"about_ca_system_score_codex":0.0001540637,"about_ca_system_score_gemma":0.00020515764,"threshold_uncertainty_score":0.0089588165},"labels":[],"label_agreement":null},{"id":"W4296131459","doi":"10.1158/1557-3265.sarcomas22-pr007","title":"Abstract PR007: A single cysteine in PAX3-FOXO1 is relevant for transactivation and survival of rhabdomyosarcoma cells","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transactivation; Druggability; PAX3; Transcription factor; Rhabdomyosarcoma; Alveolar rhabdomyosarcoma; Cancer research; Fusion protein; Biology; Fusion gene; Gene; Computational biology; Genetics; Medicine; Sarcoma; Pathology","score_opus":0.18265198724247023,"score_gpt":0.46694751755715164,"score_spread":0.2842955303146814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844587,0.0013151537,0.0061109164,0.00045070334,0.00017019198,0.00006869862,0.0022498372,0.0004033778,0.004772458],"genre_scores_gemma":[0.9863517,0.00043768226,0.0031102323,0.00009801954,0.00001679732,0.000027873002,0.0023477424,0.00009619492,0.007513757],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999,0.000009719123,0.000008032762,0.000023018032,0.000042434625,0.000016872471],"domain_scores_gemma":[0.9999324,0.000011854976,0.000019199962,0.0000068975382,0.0000081625585,0.000021540209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007890098,0.0002208867,0.0002167002,0.00017844529,0.0002349505,0.0001833741,0.00023535834,0.0003174422,0.006531581],"category_scores_gemma":[0.00009999733,0.00007955784,0.0002998984,0.00018866014,0.00021864176,0.000112256464,0.00020001785,0.00042243864,0.0016414453],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085514424,0.00000891209,0.00009094251,0.000027898785,0.0000029184118,0.00013791138,0.0000048560087,0.000029084968,0.99841595,0.00008160566,0.00010947124,0.0010048669],"study_design_scores_gemma":[0.00002141622,0.000097025855,0.004317851,0.0000049950363,0.000011379145,0.0009160883,0.000022013215,0.00045690307,0.9890209,0.0000707806,0.0050542164,0.000006409474],"about_ca_topic_score_codex":0.00093114347,"about_ca_topic_score_gemma":0.0009928987,"teacher_disagreement_score":0.006531581,"about_ca_system_score_codex":0.00033941213,"about_ca_system_score_gemma":0.00030855305,"threshold_uncertainty_score":0.021850288},"labels":[],"label_agreement":null},{"id":"W4296131466","doi":"10.1158/1557-3265.sarcomas22-b004","title":"Abstract B004: ATR-CHK1-WEE1 pathway is a critical dependency in the context of DNA damage and replicative stress in osteosarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gemcitabine; Cancer research; In vivo; Context (archaeology); Combination therapy; Wee1; Apoptosis; Osteosarcoma; DNA damage; Medicine; Biology; Cell cycle; Pharmacology; Cancer; Internal medicine; DNA; Genetics","score_opus":0.14914140813665563,"score_gpt":0.4927554206707957,"score_spread":0.34361401253414003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905951,0.0034591372,0.001553301,0.000165212,0.000035312398,0.00006305173,0.0017286079,0.00010464443,0.002295596],"genre_scores_gemma":[0.99135417,0.0014522003,0.0014627088,0.000071577044,0.000008054928,0.00005227278,0.002833308,0.000022633152,0.0027430486],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986553,0.000016367589,0.000014174724,0.000028307748,0.000054834203,0.000020720348],"domain_scores_gemma":[0.9999273,0.000013600647,0.000018817105,0.000008040308,0.000010953124,0.000021276886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015983236,0.00033529292,0.00035326174,0.00029268055,0.0002274208,0.00037153027,0.00019547311,0.0002985943,0.004075948],"category_scores_gemma":[0.00010795451,0.00016625345,0.00024868752,0.00028346822,0.00017698933,0.00016498503,0.0001982186,0.0005539062,0.0006883984],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022678394,0.000050785275,0.0004896217,0.00004948447,0.00000624941,0.00003886037,0.0000063789917,0.00008831291,0.99730587,0.00004502868,0.00009987638,0.001592621],"study_design_scores_gemma":[0.000050466522,0.0012976126,0.027424574,0.000015898271,0.00004109094,0.00046877927,0.000045940476,0.0012626267,0.9643274,0.00007898249,0.00498025,0.0000063866246],"about_ca_topic_score_codex":0.00085500156,"about_ca_topic_score_gemma":0.0012777713,"teacher_disagreement_score":0.004075948,"about_ca_system_score_codex":0.00029564407,"about_ca_system_score_gemma":0.00029462323,"threshold_uncertainty_score":0.013635397},"labels":[],"label_agreement":null},{"id":"W4296131467","doi":"10.1158/1557-3265.sarcomas22-pr004","title":"Abstract PR004: Fusion protein-driven IGF-IR signals deregulate hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"YAP1; Hippo signaling pathway; Biology; Transcriptome; Cell biology; Cancer research; Signal transduction; Molecular biology; Gene expression; Transcription factor; Genetics; Gene","score_opus":0.1123395446283583,"score_gpt":0.42786766692127537,"score_spread":0.31552812229291705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924231,0.0008667032,0.003235213,0.00013474893,0.000027946802,0.00003667013,0.0014665026,0.00014899965,0.001660166],"genre_scores_gemma":[0.99301904,0.00028945509,0.002011568,0.000046042773,0.000009884491,0.000034868284,0.0021329224,0.000020468078,0.0024355836],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998747,0.000011863384,0.000010611535,0.000026252084,0.0000413572,0.00003513051],"domain_scores_gemma":[0.99993193,0.000012564789,0.00002209928,0.000007684577,0.000006028123,0.000019692941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013387778,0.00033526766,0.00016997982,0.00026246745,0.00018183529,0.0002431524,0.00017658023,0.00021585883,0.0027224752],"category_scores_gemma":[0.00010312661,0.00009829107,0.00023051332,0.000206108,0.00024482966,0.00014567896,0.00023325236,0.000419328,0.00078544434],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011776144,0.000011297527,0.0002629632,0.0000234837,0.0000031318318,0.00009611666,0.0000064649566,0.000050625964,0.99869686,0.00006167414,0.00008827784,0.0005813869],"study_design_scores_gemma":[0.000017709963,0.00017647962,0.007401519,0.0000046282416,0.000011749717,0.0007061507,0.000033485267,0.0010133014,0.98779964,0.000048731,0.002782564,0.0000039929564],"about_ca_topic_score_codex":0.0005343347,"about_ca_topic_score_gemma":0.00061250996,"teacher_disagreement_score":0.0027224752,"about_ca_system_score_codex":0.0004146237,"about_ca_system_score_gemma":0.00018931138,"threshold_uncertainty_score":0.00910759},"labels":[],"label_agreement":null},{"id":"W4296131473","doi":"10.1158/1557-3265.sarcomas22-ia014","title":"Abstract IA014: Stem cell and developmental hierarchies in rhabdomyosarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rhabdomyosarcoma; Biology; Embryonic stem cell; Stem cell; Progenitor cell; PAX3; Myogenesis; Alveolar rhabdomyosarcoma; Cell; Cancer; Cancer research; Myocyte; Cell biology; Pathology; Sarcoma; Genetics; Medicine; Gene","score_opus":0.22868827506617864,"score_gpt":0.4833754516739351,"score_spread":0.2546871766077564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95316803,0.011735776,0.005883222,0.0006082463,0.000107972635,0.000070917566,0.00087549095,0.00032558708,0.02722479],"genre_scores_gemma":[0.9605815,0.0035842,0.0056007504,0.00011959736,0.000048274305,0.00004202412,0.0020064053,0.000034633766,0.027982622],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99993145,0.000007435519,0.000005989697,0.000012651403,0.000030778832,0.00001170097],"domain_scores_gemma":[0.99994636,0.000008929616,0.0000088724455,0.000003134279,0.0000144059195,0.000018299525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016735135,0.00013129356,0.00012124001,0.0009583995,0.00022765291,0.00028468127,0.00015105418,0.00020857123,0.0023927665],"category_scores_gemma":[0.00008918233,0.00010236249,0.00008692234,0.00031139358,0.0002318694,0.00016477532,0.00020667438,0.0002578741,0.0005017208],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021687991,0.000028667888,0.005775902,0.00011938223,0.000004718566,0.0005491889,0.0001403567,0.0002751903,0.9558617,0.0031530454,0.0015004034,0.03237463],"study_design_scores_gemma":[0.000055358956,0.0010009917,0.20717882,0.000086194195,0.000048105325,0.0049974797,0.0005191348,0.0035096,0.70017546,0.0032013517,0.07918718,0.000040412815],"about_ca_topic_score_codex":0.0011560549,"about_ca_topic_score_gemma":0.0020321298,"teacher_disagreement_score":0.0023927665,"about_ca_system_score_codex":0.000389067,"about_ca_system_score_gemma":0.00027144665,"threshold_uncertainty_score":0.008004606},"labels":[],"label_agreement":null},{"id":"W4296131477","doi":"10.1158/1557-3265.sarcomas22-a004","title":"Abstract A004: Radiation-induced changes to the immune microenvironment in an immunocompetent mouse model of Ewing sarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Sarcoma; Tumor microenvironment; Cancer research; Medicine; Ewing's sarcoma; Humanized mouse; Cancer; Flow cytometry; Radiation therapy; Pathology; Immunology; Biology; Internal medicine","score_opus":0.27151079211520096,"score_gpt":0.47744228893006985,"score_spread":0.2059314968148689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831198,0.0011956717,0.0077670957,0.0003897632,0.00015573698,0.00026701897,0.0028376426,0.0005879193,0.0036794385],"genre_scores_gemma":[0.9697779,0.00092814135,0.009830938,0.00025192817,0.00005270011,0.000652126,0.0028782163,0.00016477983,0.015463181],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995053,0.00006790399,0.00006681922,0.00014965764,0.00012347632,0.00008691672],"domain_scores_gemma":[0.9995552,0.00007516955,0.00013627994,0.00007597385,0.000038743965,0.00011861397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047841537,0.00082594,0.0003788634,0.0012084784,0.00031266885,0.00052501354,0.00044845985,0.0009829163,0.004484704],"category_scores_gemma":[0.00015846024,0.0002842609,0.0005733026,0.00034490367,0.00060322596,0.0005458497,0.00027604707,0.0020959538,0.0009286862],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044970427,0.00030553245,0.00018656708,0.000037460595,0.0000058697733,0.00010272346,0.00004072262,0.0001123286,0.997297,0.0001968689,0.00015541178,0.0011098532],"study_design_scores_gemma":[0.00010821733,0.0027547185,0.0033041337,0.000019125975,0.000024601512,0.0005130181,0.0000633667,0.0014645953,0.9876079,0.00014117394,0.003987728,0.000011455001],"about_ca_topic_score_codex":0.00043491606,"about_ca_topic_score_gemma":0.0005341353,"teacher_disagreement_score":0.004484704,"about_ca_system_score_codex":0.0004707546,"about_ca_system_score_gemma":0.00025878145,"threshold_uncertainty_score":0.015002847},"labels":[],"label_agreement":null},{"id":"W4296131481","doi":"10.1158/1557-3265.sarcomas22-a011","title":"Abstract A011: Emergence of persister cells following bromodomain inhibition in Ewing sarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bromodomain; Epigenetics; Reprogramming; Biology; Cancer research; Sarcoma; Population; BRD4; Metastasis; Bioinformatics; Cell; Medicine; Cancer; Genetics; Pathology; Gene","score_opus":0.14420935822956252,"score_gpt":0.46009484590988436,"score_spread":0.3158854876803219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907608,0.0011280256,0.0034859611,0.00012447394,0.00007360734,0.000046353718,0.002552543,0.00013991004,0.0016884068],"genre_scores_gemma":[0.98444355,0.00042837783,0.0029447663,0.0001823591,0.000020706928,0.000086163585,0.0037367628,0.0000657247,0.008091689],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998704,0.0000074338595,0.000011957439,0.000038938902,0.000049643764,0.000021660737],"domain_scores_gemma":[0.9998161,0.000052831805,0.000031369556,0.000018386385,0.00003792059,0.000043469696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000112816844,0.00013047596,0.0002597111,0.00023080714,0.00022542194,0.0003010457,0.0001135526,0.00028074445,0.0028180506],"category_scores_gemma":[0.00014330469,0.000083016195,0.00023917231,0.0001597993,0.00017580978,0.00016707808,0.00016352878,0.00068739697,0.0006679536],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000677318,0.000020611244,0.00034184358,0.000017928514,0.000002881943,0.000049665257,0.000022378968,0.000028320494,0.99797744,0.000037293317,0.00007914966,0.0013548274],"study_design_scores_gemma":[0.000018572779,0.0005007115,0.023546726,0.000007681999,0.000019650035,0.0003706311,0.00011543099,0.0013520601,0.96902037,0.000103374914,0.0049341335,0.0000106579555],"about_ca_topic_score_codex":0.0006668027,"about_ca_topic_score_gemma":0.0005836591,"teacher_disagreement_score":0.0028180506,"about_ca_system_score_codex":0.00020635733,"about_ca_system_score_gemma":0.00012693381,"threshold_uncertainty_score":0.009427309},"labels":[],"label_agreement":null},{"id":"W4296131621","doi":"10.1158/1557-3265.sarcomas22-a018","title":"Abstract A018: YAP signaling promotes resistance to MEK and AKT inhibition in NF1-related MPNSTs","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hippo signaling pathway; Cancer research; Protein kinase B; MAPK/ERK pathway; PI3K/AKT/mTOR pathway; Biology; Regulator; YAP1; Signal transduction; Medicine; Transcription factor; Cell biology; Genetics","score_opus":0.11617355183190625,"score_gpt":0.4548698895354254,"score_spread":0.33869633770351915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972367,0.000596513,0.0005149733,0.0001477978,0.000031217958,0.000020085636,0.0004905367,0.000048123005,0.00091396924],"genre_scores_gemma":[0.99718034,0.00027945466,0.00040771623,0.000042886957,0.0000080697555,0.000029634743,0.0006151736,0.000008809165,0.001427888],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999095,0.000011558178,0.000008410758,0.000020141237,0.000027110027,0.000023286653],"domain_scores_gemma":[0.9999387,0.00001077773,0.000013144664,0.0000054823754,0.00000810442,0.000023808178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010760261,0.00018768053,0.00018456287,0.00021644392,0.00018976808,0.000272056,0.00014492357,0.00023460355,0.0037166802],"category_scores_gemma":[0.0001069977,0.00009290163,0.00026163197,0.00015352492,0.0001997455,0.00021665453,0.00012424479,0.00080124254,0.0005147029],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005747036,0.0001981473,0.0010325583,0.000055543413,0.000013337133,0.000104697385,0.000020822106,0.00015311009,0.99477047,0.00012525308,0.00032846536,0.0026229648],"study_design_scores_gemma":[0.00013794255,0.0026503187,0.030617207,0.000013752333,0.00003776711,0.0012139315,0.00012724016,0.0032190885,0.9562697,0.00018099968,0.005521576,0.000010501519],"about_ca_topic_score_codex":0.00065727957,"about_ca_topic_score_gemma":0.0006920442,"teacher_disagreement_score":0.0037166802,"about_ca_system_score_codex":0.00030373753,"about_ca_system_score_gemma":0.00019087066,"threshold_uncertainty_score":0.012433529},"labels":[],"label_agreement":null},{"id":"W4296131712","doi":"10.1158/1557-3265.sarcomas22-a008","title":"Abstract A008: Mechanisms of immune escape in NF1-associated peripheral nerve sheath tumors","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Neurofibromatosis; Tumor microenvironment; Immune system; Plexiform neurofibroma; Pathology; Malignant peripheral nerve sheath tumor; Neurofibroma; Malignant transformation; Cancer research; Immunology","score_opus":0.1600386488271176,"score_gpt":0.4603252899569611,"score_spread":0.3002866411298435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95655787,0.01726914,0.00914779,0.00086309155,0.0001601288,0.00012191952,0.0017165868,0.00030410706,0.013859369],"genre_scores_gemma":[0.9822099,0.0043992307,0.0069560683,0.0001764001,0.00009797007,0.00008325276,0.0018278544,0.00002250232,0.0042267605],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989605,0.00001962856,0.000007920988,0.000024696908,0.000034213852,0.000017480294],"domain_scores_gemma":[0.9998062,0.00004292905,0.000051890976,0.000022747861,0.0000471011,0.00002917999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044692287,0.00028512377,0.000090020345,0.000839118,0.00022622288,0.00068557763,0.0003656177,0.0003427057,0.0035477187],"category_scores_gemma":[0.0003218502,0.0000951722,0.00012181746,0.0003826421,0.00031966955,0.0005336288,0.00039268867,0.00031496512,0.0008089287],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005709831,0.00016008798,0.033906497,0.000701255,0.000030872703,0.0010275019,0.00023070902,0.0013342123,0.88695365,0.0035159453,0.003042134,0.06852621],"study_design_scores_gemma":[0.00011255996,0.001371936,0.32571,0.0002760186,0.00008689288,0.015593365,0.0009612704,0.0065148254,0.5540806,0.0056806304,0.08955562,0.00005630309],"about_ca_topic_score_codex":0.00056594686,"about_ca_topic_score_gemma":0.00034366723,"teacher_disagreement_score":0.0035477187,"about_ca_system_score_codex":0.00033159426,"about_ca_system_score_gemma":0.0001678847,"threshold_uncertainty_score":0.011868358},"labels":[],"label_agreement":null},{"id":"W4296131773","doi":"10.1158/1557-3265.sarcomas22-ia012","title":"Abstract IA012: Intratumoral activation of double-stranded RNA sensors induces systemic immune response to irradiated sarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Immune system; Myeloid; Population; Medicine; Flow cytometry; Sarcoma; Immunotherapy; Myeloid leukemia; Myeloid sarcoma; Immunology; Pathology","score_opus":0.14683342578410435,"score_gpt":0.43717555549101444,"score_spread":0.2903421297069101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914778,0.00090048794,0.00400764,0.000088787114,0.00005737827,0.000060670787,0.0008088563,0.00023003087,0.0023683948],"genre_scores_gemma":[0.99125975,0.00033780324,0.0025225356,0.00006251384,0.00001568547,0.00007388677,0.0013849437,0.000037746086,0.0043052463],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984884,0.00001702714,0.00001267103,0.000042011277,0.000034521825,0.00004493157],"domain_scores_gemma":[0.9999094,0.000019097348,0.000025228868,0.000012348237,0.000007782233,0.000026122427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011509931,0.00041675108,0.0002540544,0.00024207262,0.00006892891,0.00025879798,0.00018620853,0.00033140436,0.002035092],"category_scores_gemma":[0.00009183578,0.00011553465,0.0002755296,0.00015115172,0.00019683919,0.00017982145,0.00011263819,0.00086926715,0.000620059],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022160946,0.00005466049,0.000077652665,0.000021845302,0.0000026078353,0.000010337499,0.0000050377575,0.00005221957,0.9988047,0.00003603437,0.00004588228,0.00066742377],"study_design_scores_gemma":[0.000021691909,0.00077486644,0.0014548969,0.0000041510552,0.000010121962,0.000064183725,0.000011223604,0.0010548795,0.9958801,0.000018533894,0.0007024688,0.0000027749363],"about_ca_topic_score_codex":0.00032326294,"about_ca_topic_score_gemma":0.00031112914,"teacher_disagreement_score":0.002035092,"about_ca_system_score_codex":0.00023092159,"about_ca_system_score_gemma":0.00013039961,"threshold_uncertainty_score":0.0068080425},"labels":[],"label_agreement":null},{"id":"W4296131779","doi":"10.1158/1557-3265.sarcomas22-ia009","title":"Abstract IA009: Oncogenic transcription factors drive highly tumor-specific LincRNA","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; FLI1; Polyadenylation; Gene; Genetics; Transcription factor; Reprogramming; Cancer research; Computational biology; RNA","score_opus":0.1973601308724714,"score_gpt":0.4642146375165321,"score_spread":0.2668545066440607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5923044,0.009779124,0.14718269,0.003562049,0.00596935,0.0007251232,0.098794,0.023400167,0.11828303],"genre_scores_gemma":[0.7633637,0.0021036319,0.044812024,0.00076310924,0.0003642693,0.00038539947,0.081281535,0.0027216438,0.10420462],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99969125,0.000020046858,0.000030041254,0.00011949546,0.000103717524,0.000035580415],"domain_scores_gemma":[0.9998311,0.000029783452,0.0000394236,0.00003359314,0.000025582258,0.00004044408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016879385,0.00042232242,0.00035216688,0.00045732007,0.00041970992,0.0007195285,0.0005270894,0.00061356573,0.014343527],"category_scores_gemma":[0.00027091274,0.00018666487,0.00031242662,0.00053151906,0.00027845753,0.00031545284,0.00046343068,0.0010690662,0.009892957],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000956807,0.0000255665,0.00021532881,0.000077015306,0.0000058437336,0.000085809676,0.000012173232,0.00007078181,0.9909298,0.00078218686,0.0031888762,0.004510981],"study_design_scores_gemma":[0.000030707553,0.00010752193,0.004266517,0.000019849613,0.00002149309,0.00046965262,0.000030735857,0.0017741517,0.90705913,0.00048138955,0.085721165,0.00001764655],"about_ca_topic_score_codex":0.0006799566,"about_ca_topic_score_gemma":0.0008476053,"teacher_disagreement_score":0.014343527,"about_ca_system_score_codex":0.0006854727,"about_ca_system_score_gemma":0.0003170596,"threshold_uncertainty_score":0.047983885},"labels":[],"label_agreement":null},{"id":"W4296131781","doi":"10.1158/1557-3265.sarcomas22-ia019","title":"Abstract IA019: How to target lung metastasis: dynamic changes in chromatin accessibility during osteosarcoma lung metastasis expose vulnerabilities","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metastasis; Reprogramming; Osteosarcoma; Chromatin; Cancer research; Biology; Transcription factor; Lung cancer; Epigenomics; Context (archaeology); Cancer; Medicine; Pathology; Cell; DNA methylation; Genetics; Gene expression","score_opus":0.07549966012525675,"score_gpt":0.4429263766585873,"score_spread":0.3674267165333306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8725878,0.015193937,0.04854055,0.0042062835,0.0007176475,0.00044587505,0.0053006997,0.003614963,0.049392328],"genre_scores_gemma":[0.93776184,0.004931234,0.011878824,0.0006728031,0.00006585204,0.00012779307,0.0024534257,0.0003468096,0.04176135],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986684,0.000008450334,0.0000087966155,0.000026164495,0.00006419102,0.000025403991],"domain_scores_gemma":[0.9998894,0.00001976237,0.000026710119,0.000015707208,0.0000188298,0.000029645818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015878028,0.00030991892,0.0003168931,0.00025157313,0.00025434597,0.00050248805,0.00023337292,0.00041549635,0.005850504],"category_scores_gemma":[0.00018101567,0.00021981334,0.00023211802,0.00020360725,0.00026698294,0.00026961305,0.00032747284,0.00090471044,0.0014512637],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048970098,0.000012291003,0.0003574871,0.000050079787,0.0000036865486,0.00007341684,0.000016184438,0.00011673575,0.99202454,0.0002768314,0.00069799396,0.0063218037],"study_design_scores_gemma":[0.000025138392,0.0003140171,0.008539244,0.000022445738,0.00003120618,0.0005972208,0.000059876304,0.00096868025,0.95663476,0.00032362438,0.03246778,0.000016089629],"about_ca_topic_score_codex":0.0013748594,"about_ca_topic_score_gemma":0.0030860957,"teacher_disagreement_score":0.005850504,"about_ca_system_score_codex":0.0004371254,"about_ca_system_score_gemma":0.00037359862,"threshold_uncertainty_score":0.01957184},"labels":[],"label_agreement":null},{"id":"W4296131819","doi":"10.1158/1557-3265.sarcomas22-ia010","title":"Abstract IA010: Novel targeted therapy approaches in NF1-MPNST","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; CDKN2A; Medicine; Targeted therapy; MAPK/ERK pathway; MEK inhibitor; Kinase; Cancer; Small molecule; Trametinib; Receptor tyrosine kinase; Internal medicine; Biology; Receptor; Cell biology","score_opus":0.5848092251588513,"score_gpt":0.5210043826787708,"score_spread":0.06380484248008045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43922126,0.3406316,0.038700394,0.007895877,0.0029640985,0.0011372444,0.0027966644,0.0020012418,0.1646516],"genre_scores_gemma":[0.68269163,0.1609938,0.024331477,0.0016448864,0.0006349542,0.00049393956,0.0025878425,0.00016346973,0.12645808],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999566,0.000005159319,0.0000018831954,0.0000092650735,0.000014724116,0.000012245641],"domain_scores_gemma":[0.9999764,0.0000026022713,0.000003714678,0.0000013648515,0.0000054727766,0.000010399768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018515158,0.0003492764,0.00025295274,0.00059370446,0.00024716428,0.0004748441,0.000460688,0.00034652275,0.0063636824],"category_scores_gemma":[0.00006483794,0.00010961578,0.00031431118,0.00029053455,0.00020759074,0.00025336185,0.00026352308,0.00062333397,0.0012010015],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013993477,0.0007917467,0.0012525006,0.0010588226,0.00006419769,0.00072717457,0.000116422074,0.0016415522,0.394966,0.0076078605,0.02720814,0.56316626],"study_design_scores_gemma":[0.0014774789,0.009374569,0.02164166,0.00053754024,0.00034076336,0.0072394405,0.00015798552,0.0065980884,0.33899632,0.003331195,0.6102177,0.000087255044],"about_ca_topic_score_codex":0.0035608609,"about_ca_topic_score_gemma":0.009096949,"teacher_disagreement_score":0.0063636824,"about_ca_system_score_codex":0.00097371166,"about_ca_system_score_gemma":0.0007588262,"threshold_uncertainty_score":0.021288693},"labels":[],"label_agreement":null},{"id":"W4296131821","doi":"10.1158/1557-3265.sarcomas22-ia005","title":"Abstract IA005: On the use of stem cells to generate sarcomas in vitro models","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osteosarcoma; Mesenchymal stem cell; Sarcoma; Cancer research; Palbociclib; Biology; Cancer; Stem cell; Pathology; Medicine; Breast cancer; Genetics; Metastatic breast cancer","score_opus":0.6391396871612506,"score_gpt":0.5202599128007791,"score_spread":0.11887977436047148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296131821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36020216,0.07595093,0.3127451,0.006790721,0.004371846,0.00210866,0.017934605,0.00484079,0.21505505],"genre_scores_gemma":[0.67791766,0.04920573,0.13783701,0.0032753262,0.0006471894,0.0016942088,0.026735099,0.0009894436,0.10169831],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994154,0.00015506492,0.000059861348,0.00007593918,0.00024400232,0.000049786173],"domain_scores_gemma":[0.9994622,0.00016861234,0.00006002708,0.00011269395,0.00013106794,0.00006545649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011062883,0.00075443834,0.0004324303,0.0011963767,0.00040270417,0.001169141,0.00066091627,0.0008803449,0.0057716486],"category_scores_gemma":[0.00046342117,0.00027215254,0.0008761404,0.0006550948,0.00038038302,0.00046467368,0.0006872565,0.0017079267,0.00478115],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020193671,0.00032883734,0.0006558386,0.0004899517,0.000028155704,0.00029068958,0.00010997143,0.00069976464,0.9544695,0.0041038925,0.005346465,0.033275116],"study_design_scores_gemma":[0.00004480168,0.001161283,0.0022675022,0.00020639594,0.00011738371,0.00069749204,0.00007265092,0.0025613701,0.85677063,0.0015078349,0.13456495,0.00002767479],"about_ca_topic_score_codex":0.0010453515,"about_ca_topic_score_gemma":0.0010039294,"teacher_disagreement_score":0.0057716486,"about_ca_system_score_codex":0.00052951457,"about_ca_system_score_gemma":0.0004095616,"threshold_uncertainty_score":0.01930803},"labels":[],"label_agreement":null},{"id":"W4296132037","doi":"10.1158/1557-3265.sarcomas22-a003","title":"Abstract A003: ASAP1 regulates myogenic differentiation in rhabdomyosarcoma by modulating YAP localization","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rhabdomyosarcoma; Gene knockdown; Cancer research; Biology; Differentiation therapy; Cellular differentiation; C2C12; Transcription factor; Cell biology; Myocyte; Myogenesis; Medicine; Cell culture; Sarcoma; Pathology; Genetics; Gene","score_opus":0.07127616747834303,"score_gpt":0.4317119212047263,"score_spread":0.36043575372638326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296132037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413425,0.0012183853,0.001857379,0.00020311185,0.00003790674,0.000016534583,0.0010617845,0.00013749673,0.0013332526],"genre_scores_gemma":[0.99484813,0.00051214657,0.00094837934,0.00005379428,0.000008158005,0.000037923724,0.001132885,0.000027234095,0.0024314574],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99995494,0.0000050049066,0.0000043134587,0.000012868229,0.000013185507,0.0000096502745],"domain_scores_gemma":[0.9999616,0.000006433326,0.000011071694,0.0000031631002,0.0000036336924,0.000014170814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060700935,0.0003121786,0.00016221168,0.00012466882,0.00018781856,0.0001751836,0.00019147403,0.00023552174,0.002835106],"category_scores_gemma":[0.000057597743,0.00008666957,0.00020625938,0.00009823327,0.00021381251,0.00015451477,0.00015499492,0.00052630575,0.0006389755],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014884991,0.000013203308,0.00015402594,0.000045960303,0.000003364473,0.000050967723,0.00000619878,0.00004467039,0.99860054,0.0000744169,0.00007744379,0.00078043784],"study_design_scores_gemma":[0.000030934414,0.00020148374,0.006887777,0.000007447164,0.000017142014,0.00024677147,0.00003014267,0.0011285589,0.9885194,0.00007723186,0.0028492059,0.000003967115],"about_ca_topic_score_codex":0.00029467716,"about_ca_topic_score_gemma":0.00035653854,"teacher_disagreement_score":0.002835106,"about_ca_system_score_codex":0.00021567267,"about_ca_system_score_gemma":0.00014335866,"threshold_uncertainty_score":0.009484351},"labels":[],"label_agreement":null},{"id":"W4296132068","doi":"10.1158/1557-3265.sarcomas22-b008","title":"Abstract B008: Investigating the evolution of undifferentiated soft tissue sarcomas in a genetically engineered mouse model","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transcriptome; Cancer; Biology; Computational biology; Cell; Cancer research; Genetically engineered; Evolutionary biology; Genetics; Gene; Gene expression","score_opus":0.21958898226071574,"score_gpt":0.47666652990306135,"score_spread":0.2570775476423456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296132068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9563106,0.0012930095,0.02395436,0.00050259265,0.00009672103,0.00018695885,0.0077670566,0.0005912362,0.009297559],"genre_scores_gemma":[0.9261145,0.0018365452,0.036980815,0.00042206226,0.000023887056,0.00025658924,0.0071650106,0.00033674086,0.026863955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999777,0.000020191857,0.000012743386,0.000051165774,0.0000982611,0.000040730483],"domain_scores_gemma":[0.99971455,0.000046705143,0.0000754552,0.00002549856,0.00006326972,0.0000744742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003554117,0.00031383958,0.00021707802,0.001093234,0.00032593976,0.0004263692,0.0003490013,0.00048005555,0.00266421],"category_scores_gemma":[0.00021588971,0.00021298947,0.0003260768,0.00045484956,0.000349341,0.00027833466,0.00024900996,0.0008518821,0.00074336946],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094200645,0.00003509941,0.0013245003,0.000025897398,0.0000056720387,0.00007955672,0.000030491492,0.00018021432,0.9949744,0.00043493553,0.00025330135,0.0025618493],"study_design_scores_gemma":[0.0000356906,0.0006385086,0.042558733,0.000034176002,0.0000437001,0.0007843075,0.00014297821,0.0052410522,0.9376805,0.00043935975,0.012375327,0.000025697806],"about_ca_topic_score_codex":0.0052493685,"about_ca_topic_score_gemma":0.010545169,"teacher_disagreement_score":0.0052493685,"about_ca_system_score_codex":0.0009215591,"about_ca_system_score_gemma":0.0005758961,"threshold_uncertainty_score":0.010437667},"labels":[],"label_agreement":null},{"id":"W4296132074","doi":"10.1158/1557-3265.sarcomas22-a028","title":"Abstract A028: Growth factor signaling and kinase inhibitors regulate oncogenesis in desmoid fibromatosis by modulating activity of the beta-catenin transcription target ABL1","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Carcinogenesis; Biology; HIF1A; Small hairpin RNA; Gene knockdown; Cell growth; Ectopic expression; Molecular biology; Gene expression; Cell culture; Angiogenesis; Gene; Genetics","score_opus":0.15152071865197944,"score_gpt":0.43058453969579924,"score_spread":0.27906382104381977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296132074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99102145,0.0021916125,0.0015055242,0.00019932576,0.000040944396,0.000043169177,0.00282917,0.00015593124,0.0020128654],"genre_scores_gemma":[0.9891991,0.0012874805,0.0017812969,0.00014513086,0.000016139866,0.00007035554,0.0033997945,0.000037092377,0.00406358],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999062,0.000005986947,0.0000055099244,0.000027346701,0.000037719128,0.00001736198],"domain_scores_gemma":[0.99995244,0.000006711201,0.00001535449,0.000003309046,0.000009221146,0.00001301833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011323298,0.00027659137,0.00025176583,0.0002476422,0.00018648733,0.0003865403,0.00012713914,0.0001735405,0.0028657238],"category_scores_gemma":[0.00009336665,0.00009943508,0.0002370033,0.00019529073,0.000119075696,0.00014942135,0.0001078584,0.0003737755,0.0006303149],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019769598,0.000041261515,0.0012462806,0.00007630048,0.000012439603,0.00003107578,0.000009890447,0.000112023925,0.99449146,0.00005297573,0.00028298554,0.0034455191],"study_design_scores_gemma":[0.00006624677,0.0005811561,0.05628334,0.00001507016,0.000064177344,0.00041703903,0.00005215223,0.0028552578,0.9321433,0.00012440367,0.0073884265,0.000009424453],"about_ca_topic_score_codex":0.0007651676,"about_ca_topic_score_gemma":0.0014642453,"teacher_disagreement_score":0.0028657238,"about_ca_system_score_codex":0.000410672,"about_ca_system_score_gemma":0.00025793607,"threshold_uncertainty_score":0.009586811},"labels":[],"label_agreement":null},{"id":"W4296132100","doi":"10.1158/1557-3265.sarcomas22-ia024","title":"Abstract IA024: Identification of a “hypoxic secretome” and its role in metastasis","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Intravasation; Extravasation; Metastasis; Biology; Primary tumor; Zebrafish; In vivo; Tumor microenvironment; Cell migration; Cancer research; Angiogenesis; Cell; Cancer; Immunology; Tumor cells; Genetics; Gene","score_opus":0.11420576854677382,"score_gpt":0.4668150607762514,"score_spread":0.35260929222947757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296132100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98253214,0.0042099706,0.0049452325,0.0005094026,0.00008023215,0.00006939,0.0024376167,0.00010063655,0.0051154145],"genre_scores_gemma":[0.9778855,0.0017015527,0.0054967534,0.0001692024,0.000090592395,0.000051269806,0.0054942197,0.000037192698,0.009073666],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999546,0.0000056674994,0.0000037542711,0.000009930753,0.000013018817,0.000013105793],"domain_scores_gemma":[0.99989843,0.00001311416,0.000023213668,0.000007522114,0.000021173528,0.000036427038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000118796466,0.00026316955,0.00017769175,0.00041003898,0.00014310342,0.00033138887,0.00015065285,0.00024018764,0.002087271],"category_scores_gemma":[0.00013242594,0.00009757955,0.00017678474,0.00021743534,0.00015652589,0.00015624195,0.00016384406,0.0002894237,0.00067957246],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010479802,0.000009834001,0.0006360545,0.000019815294,0.0000024844242,0.00011884189,0.000004927184,0.00002965878,0.9978188,0.00009040479,0.000089655165,0.0010747482],"study_design_scores_gemma":[0.000039759183,0.00047526308,0.071871914,0.000021556416,0.000031049884,0.002037461,0.00007581797,0.0024385317,0.91006225,0.00034432719,0.012591123,0.000011048942],"about_ca_topic_score_codex":0.0008839491,"about_ca_topic_score_gemma":0.0004689859,"teacher_disagreement_score":0.002087271,"about_ca_system_score_codex":0.00032169162,"about_ca_system_score_gemma":0.00018012399,"threshold_uncertainty_score":0.0069826245},"labels":[],"label_agreement":null},{"id":"W4296132170","doi":"10.1158/1557-3265.sarcomas22-b010","title":"Abstract B010: The NuRD subunit CHD4 is essential for ewing sarcoma cell survival as it regulates global chromatin architecture","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Chromatin remodeling; Chromatin; Cancer research; Cell biology; Enhancer; Gene silencing; Transcription factor; Genetics; Gene","score_opus":0.11532073987946757,"score_gpt":0.48042341452219844,"score_spread":0.3651026746427309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296132170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857772,0.00168695,0.0069024717,0.0001507805,0.000053246175,0.00003311671,0.0025167896,0.00024613622,0.0026332778],"genre_scores_gemma":[0.9874271,0.0003655102,0.0029063262,0.000044304732,0.000006685978,0.000017741751,0.0031695173,0.000040274066,0.006022588],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998741,0.000011169978,0.000014343411,0.000029124085,0.00005510649,0.000016146614],"domain_scores_gemma":[0.9999225,0.000012296504,0.000023531815,0.000008646499,0.000012596345,0.00002040249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000076343356,0.00027954442,0.00020984228,0.00023293654,0.00017559416,0.00020086604,0.00026432957,0.00020114853,0.0030329765],"category_scores_gemma":[0.0001336789,0.000099087985,0.00013829245,0.00013835893,0.00019083772,0.00012124428,0.00023869005,0.00027011655,0.00086514064],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051306943,0.0000056460594,0.0002994713,0.000028730838,0.0000027830622,0.000035483703,0.0000029215096,0.000032860153,0.99860114,0.000048624268,0.00003434302,0.0008567192],"study_design_scores_gemma":[0.0000061559263,0.00004260787,0.0046266373,0.000002887826,0.000010514594,0.0002141242,0.000009887291,0.000444694,0.9919429,0.000028733855,0.0026687006,0.0000021941762],"about_ca_topic_score_codex":0.0009261999,"about_ca_topic_score_gemma":0.0009385179,"teacher_disagreement_score":0.0030329765,"about_ca_system_score_codex":0.00042854677,"about_ca_system_score_gemma":0.00020131412,"threshold_uncertainty_score":0.01014632},"labels":[],"label_agreement":null},{"id":"W4296132225","doi":"10.1158/1557-3265.sarcomas22-a014","title":"Abstract A014: The novel anti-inflammatory agent GML (GM1-targeted linoleate-containing TLR2 ligand) inhibits sarcoma metastasis to the lung","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; University of Calgary; Jewish General Hospital","funders":"","keywords":"Medicine; Osteosarcoma; Metastasis; Sarcoma; Cancer; Lung cancer; Cancer research; Lung; Inflammation; Oncology; Immunology; Internal medicine; Pathology","score_opus":0.14012707583881473,"score_gpt":0.4314698483256254,"score_spread":0.2913427724868107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296132225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904113,0.0028246373,0.0022301078,0.00034990642,0.00013758996,0.00016123448,0.0007233978,0.00016134969,0.0030005102],"genre_scores_gemma":[0.9899406,0.0011131638,0.0023845828,0.00019411115,0.000035213623,0.00011700881,0.00096152077,0.000011271987,0.0052426336],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999366,0.000015281965,0.000006419002,0.000009434683,0.000015428488,0.000016901933],"domain_scores_gemma":[0.9999639,0.0000061327155,0.000007532298,0.0000033851666,0.0000059759063,0.000013142739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105312916,0.0003088432,0.00025458663,0.00020624048,0.00009925547,0.00015570344,0.00018748165,0.00034206428,0.002921506],"category_scores_gemma":[0.000084747095,0.00007003106,0.00022820751,0.00008958626,0.0001445278,0.00015430465,0.00014901726,0.0005954022,0.0005124325],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016410757,0.00063996285,0.00018466839,0.00014250919,0.000014235589,0.000063338135,0.000012684673,0.00013317844,0.99047637,0.0001036543,0.00034651338,0.0062416983],"study_design_scores_gemma":[0.0005860118,0.009568265,0.003178636,0.000019729907,0.000039547725,0.00027632774,0.000027497952,0.0013891188,0.9794714,0.00006759012,0.0053690406,0.0000068835416],"about_ca_topic_score_codex":0.00038715027,"about_ca_topic_score_gemma":0.0005618714,"teacher_disagreement_score":0.002921506,"about_ca_system_score_codex":0.00012380106,"about_ca_system_score_gemma":0.00028431104,"threshold_uncertainty_score":0.009773374},"labels":[],"label_agreement":null},{"id":"W4296132263","doi":"10.1158/1557-3265.sarcomas22-ia029","title":"Abstract IA029: The origins of leiomyosarcoma: implications for prognosis and defining new therapeutic options","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Biology; Subtyping; Leiomyosarcoma; Disease; Homologous recombination; Somatic evolution in cancer; Computational biology; Cancer research; Bioinformatics; Cancer; Genetics; Gene; Pathology; Medicine","score_opus":0.40296244925285774,"score_gpt":0.5583171902239384,"score_spread":0.1553547409710807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296132263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96833146,0.016600404,0.0069480566,0.002326694,0.000055305398,0.000025369674,0.0027220142,0.00019239906,0.0027984078],"genre_scores_gemma":[0.9857635,0.0043317326,0.0046481173,0.00025923544,0.00005989069,0.000029654093,0.003578333,0.000041919193,0.0012876355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989617,0.000023226592,0.0000060109264,0.00003231503,0.00002191613,0.000020373991],"domain_scores_gemma":[0.99967885,0.00007100847,0.00014329435,0.0000159705,0.000036951515,0.000053972966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031100787,0.00025775094,0.00028867248,0.0005531386,0.00022958987,0.0006568581,0.0002378216,0.00036962944,0.0017612057],"category_scores_gemma":[0.0005661465,0.00010959759,0.00022375085,0.00056316465,0.00027955935,0.00035271037,0.0003661582,0.00051435176,0.0005297566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017511151,0.00013065316,0.5149721,0.00085042656,0.00019243988,0.0011354126,0.00030131254,0.006077212,0.34469318,0.0030698695,0.005108368,0.12171797],"study_design_scores_gemma":[0.000036456055,0.0005186802,0.8919015,0.0004398075,0.00018639145,0.0032348137,0.00075355836,0.016409043,0.052940533,0.0064155804,0.027106171,0.00005757153],"about_ca_topic_score_codex":0.00063679786,"about_ca_topic_score_gemma":0.00073800085,"teacher_disagreement_score":0.0017612057,"about_ca_system_score_codex":0.0005547823,"about_ca_system_score_gemma":0.00032556523,"threshold_uncertainty_score":0.0058918},"labels":[],"label_agreement":null},{"id":"W4296229618","doi":"10.1158/1557-3265.sarcomas22-b012","title":"Abstract B012: Visualization of EWSR1’s colocalization with phosphorylated RNA-Polymerase II reveals its concentration at a subset of active regions of transcription in ewing sarcoma cells","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Nucleoplasm; Chromatin; Transcription (linguistics); Colocalization; Cell biology; Molecular biology; RNA polymerase II; Gene; Gene expression; Nucleolus; Genetics; Nucleus; Promoter","score_opus":0.10457179872516426,"score_gpt":0.4295636478471105,"score_spread":0.32499184912194623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296229618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9296979,0.0035092765,0.043971762,0.00060181617,0.00016318959,0.00007541088,0.0039770906,0.0012372831,0.016766284],"genre_scores_gemma":[0.94374204,0.0014700047,0.028218161,0.00019564951,0.00004040121,0.00015168506,0.004697098,0.00037014586,0.021114754],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989223,0.000007724147,0.0000077518935,0.000037145375,0.000029556357,0.000025524701],"domain_scores_gemma":[0.99990726,0.00001827971,0.0000128494175,0.000010548172,0.000018965286,0.000032106313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012985934,0.00035293252,0.00021110778,0.00051813555,0.00027274113,0.00034071214,0.00026145217,0.00037232734,0.0069356714],"category_scores_gemma":[0.00007196526,0.00023253712,0.00020400036,0.00037097232,0.00020831148,0.0002741555,0.0002710099,0.0009035423,0.0022120725],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003001998,0.000009169155,0.000060217983,0.000022347156,0.0000018518801,0.000032848162,0.000013607908,0.000021320207,0.99903095,0.00012009298,0.00010805817,0.00054956286],"study_design_scores_gemma":[0.000015693173,0.0000619876,0.009724994,0.000014360352,0.000007224655,0.00036360166,0.000046055397,0.0016629429,0.9834058,0.00016743998,0.004521322,0.000008536023],"about_ca_topic_score_codex":0.0013271405,"about_ca_topic_score_gemma":0.00095197,"teacher_disagreement_score":0.0069356714,"about_ca_system_score_codex":0.0003689512,"about_ca_system_score_gemma":0.00018344841,"threshold_uncertainty_score":0.02320218},"labels":[],"label_agreement":null},{"id":"W4296230819","doi":"10.1158/1557-3265.sarcomas22-pr002","title":"Abstract PR002: Antigen presentation and processing pathway is associated with early relapse after neoadjuvant immune checkpoint blockade (ICB) in dedifferentiated liposarcomas (DDLPS)","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Internal medicine; Ipilimumab; Nivolumab; Immune checkpoint; Cancer research; Immunotherapy; Cancer","score_opus":0.12053491375295862,"score_gpt":0.42974891539985205,"score_spread":0.30921400164689344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296230819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99967873,0.00013884602,0.00003984783,0.000010426678,0.0000010656207,0.0000035423668,0.000058855003,0.0000021678643,0.00006647271],"genre_scores_gemma":[0.99966156,0.00004169713,0.00004539785,0.000009129757,0.0000019028599,0.0000063865023,0.00014850005,7.4589593e-7,0.000084770436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99992335,0.000019001074,0.0000089968025,0.00001933403,0.000012643763,0.000016778162],"domain_scores_gemma":[0.99978393,0.000043896296,0.00009924887,0.000011291804,0.00001373419,0.000047907877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018734243,0.00013820229,0.00023398451,0.00017753088,0.00009587176,0.0002302798,0.00010554977,0.00014599212,0.0010627371],"category_scores_gemma":[0.0002788728,0.00006461044,0.00019546361,0.00018549015,0.00015592318,0.00011533882,0.00015601939,0.00024213771,0.00013914204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019274738,0.0005265779,0.72279847,0.00020368137,0.00014099327,0.00078708614,0.0001119129,0.00050096057,0.23133652,0.00005068507,0.00028536387,0.023982977],"study_design_scores_gemma":[0.000133585,0.0030064022,0.9799011,0.000010815716,0.000119009484,0.001808017,0.00015015843,0.0007767309,0.013598624,0.00005090383,0.0004391728,0.0000054509196],"about_ca_topic_score_codex":0.000142298,"about_ca_topic_score_gemma":0.00018657962,"teacher_disagreement_score":0.0010627371,"about_ca_system_score_codex":0.00014387796,"about_ca_system_score_gemma":0.00010628537,"threshold_uncertainty_score":0.0035552382},"labels":[],"label_agreement":null},{"id":"W4296230849","doi":"10.1158/1557-3265.sarcomas22-a012","title":"Abstract A012: Targeting the dysregulation of transcription and splicing in Ewing sarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"FLI1; RNA splicing; Sarcoma; Cancer research; Biology; Pediatric cancer; Transcription (linguistics); Alternative splicing; Transcription factor; RNA polymerase II; RNA; Medicine; Cancer; Genetics; Gene expression; Messenger RNA; Gene; Promoter; Pathology","score_opus":0.24553507439983985,"score_gpt":0.5033545763057851,"score_spread":0.2578195019059452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296230849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95824915,0.007154245,0.022432452,0.0006989077,0.00035765613,0.0002957684,0.0029495,0.0010778123,0.0067845033],"genre_scores_gemma":[0.9717568,0.003221842,0.011311039,0.00023972889,0.00004193343,0.00013061284,0.0030940392,0.00012107069,0.010082882],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997991,0.000020777954,0.000027463364,0.0000527422,0.000074573676,0.00002539912],"domain_scores_gemma":[0.9999069,0.000016927033,0.000026524267,0.0000111684485,0.000014508341,0.00002387322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021243174,0.0004880106,0.0003588146,0.00028760443,0.00017735559,0.00041447574,0.0003367476,0.00038505558,0.0026007586],"category_scores_gemma":[0.00011723629,0.00018910842,0.00036477414,0.00022321216,0.00023835369,0.00025480616,0.0002219158,0.00091469253,0.00080842053],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004797326,0.000026605894,0.000078649166,0.000038096034,0.0000036687136,0.000032926164,0.0000046370697,0.00006305954,0.99806446,0.00012413815,0.00008129564,0.0014345163],"study_design_scores_gemma":[0.00002535257,0.00032028655,0.0008870894,0.000006548411,0.000023433591,0.00021298908,0.000012953457,0.0009313677,0.9927658,0.000070870505,0.0047387024,0.0000046249656],"about_ca_topic_score_codex":0.00051479856,"about_ca_topic_score_gemma":0.0007147633,"teacher_disagreement_score":0.0026007586,"about_ca_system_score_codex":0.00036423604,"about_ca_system_score_gemma":0.00031373365,"threshold_uncertainty_score":0.00870043},"labels":[],"label_agreement":null},{"id":"W4296230868","doi":"10.1158/1557-3265.sarcomas22-ia023","title":"Abstract IA023: Therapeutic efficacy of trametinib and ganitumab in RAS-mutated rhabdomyosarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Trametinib; Rhabdomyosarcoma; MEK inhibitor; Cancer research; Insulin-like growth factor 1 receptor; MAPK/ERK pathway; Growth inhibition; Medicine; Cell culture; Pharmacology; Biology; Kinase; Internal medicine; Receptor; Pathology; Sarcoma; Growth factor; Cell biology","score_opus":0.27523679926290046,"score_gpt":0.5358248635606823,"score_spread":0.2605880642977818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296230868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956175,0.0016691495,0.0002611797,0.000097440876,0.000036792797,0.00007755931,0.00029089916,0.00006913469,0.001880363],"genre_scores_gemma":[0.9976432,0.00042497384,0.00049093226,0.0000320371,0.000013626952,0.000038154725,0.000583732,0.0000057677694,0.00076756364],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998723,0.000028537692,0.000011325038,0.000018543036,0.000028468648,0.00004076553],"domain_scores_gemma":[0.9999157,0.000013282573,0.000015325633,0.0000065810964,0.000008325618,0.000040638504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002664413,0.00041686092,0.0005284217,0.000318288,0.00016425388,0.00035423433,0.00034506255,0.00032795614,0.0014580403],"category_scores_gemma":[0.0001656722,0.00012662917,0.0002935505,0.00023421975,0.00018467466,0.00017705448,0.00016779796,0.00079321605,0.00034020338],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015693715,0.0043377117,0.003299137,0.00035472194,0.00020023593,0.00040663368,0.000082746024,0.0023064837,0.9066596,0.00023324732,0.0015087735,0.06491697],"study_design_scores_gemma":[0.0047947606,0.10031733,0.051539317,0.00005059039,0.00040969052,0.0033616303,0.00013154461,0.010311771,0.82059175,0.0000932157,0.008356444,0.00004206091],"about_ca_topic_score_codex":0.0021224217,"about_ca_topic_score_gemma":0.0043681394,"teacher_disagreement_score":0.0021224217,"about_ca_system_score_codex":0.00051193085,"about_ca_system_score_gemma":0.00056273484,"threshold_uncertainty_score":0.0048776865},"labels":[],"label_agreement":null},{"id":"W4296230870","doi":"10.1158/1557-3265.sarcomas22-b016","title":"Abstract B016: Cytokines derived from tumor-initiating osteosarcoma cells mediate a novel self-seeding mechanism relevant to growth of primary and metastatic tumors","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osteosarcoma; Primary tumor; Metastasis; Medicine; Cancer research; Cytokine; Pathology; Cancer; Immunology; Internal medicine","score_opus":0.16208994367974286,"score_gpt":0.4220858515937117,"score_spread":0.25999590791396887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296230870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841239,0.0032041878,0.0056363572,0.00028431762,0.00017849024,0.00011641473,0.0010242997,0.0001438442,0.005288251],"genre_scores_gemma":[0.98766625,0.0010826465,0.0034402472,0.00011569538,0.000060530016,0.00008938669,0.0012546788,0.000028621109,0.0062619746],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985814,0.000020692509,0.00001146773,0.000025105173,0.000036386064,0.0000482157],"domain_scores_gemma":[0.99986017,0.000020201376,0.00003180927,0.000011034301,0.00002371397,0.000053009364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001429016,0.0005744754,0.00024105413,0.00018361922,0.00012748817,0.00036381284,0.00018421284,0.00035030366,0.0031445874],"category_scores_gemma":[0.00012691118,0.00012442512,0.00030697417,0.0001232892,0.00023728005,0.00017576333,0.00016156999,0.0007573893,0.0012951512],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002605345,0.000054350585,0.0002886129,0.00006558277,0.0000021933365,0.000092967326,0.00001538116,0.000035300116,0.9977175,0.00016869628,0.00013665366,0.0011622418],"study_design_scores_gemma":[0.00014700346,0.0015656671,0.010016471,0.000034804547,0.000022679264,0.0007997355,0.000074670796,0.0012423983,0.9794973,0.00017772839,0.0064135687,0.000007927108],"about_ca_topic_score_codex":0.00029166663,"about_ca_topic_score_gemma":0.00028207898,"teacher_disagreement_score":0.0031445874,"about_ca_system_score_codex":0.00022092398,"about_ca_system_score_gemma":0.00022848924,"threshold_uncertainty_score":0.010519683},"labels":[],"label_agreement":null},{"id":"W4296230878","doi":"10.1158/1557-3265.sarcomas22-a026","title":"Abstract A026: PROX1 transcription factor regulates rhabdomyosarcoma growth, myogenic properties and therapeutic targets","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rhabdomyosarcoma; Gene silencing; Cancer research; Transcription factor; Fibroblast growth factor receptor; Medicine; Cancer; Cell growth; Soft tissue sarcoma; Internal medicine; Biology; Fibroblast growth factor; Receptor; Sarcoma; Pathology; Gene; Genetics","score_opus":0.31319916886824317,"score_gpt":0.45291315579706715,"score_spread":0.13971398692882397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296230878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82407784,0.07317728,0.022926599,0.008484547,0.0040466916,0.00048277472,0.012996116,0.0022610005,0.051547192],"genre_scores_gemma":[0.84400696,0.024691796,0.008312899,0.0007747927,0.00048968283,0.00023658208,0.009332509,0.00027966395,0.11187511],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998865,0.000009071078,0.000008855827,0.00002879134,0.00004778174,0.00001900485],"domain_scores_gemma":[0.99994504,0.000004664697,0.000012339012,0.0000030480353,0.000015178967,0.000019741261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018863748,0.00038065287,0.00031867693,0.00036611196,0.00037063492,0.0005384214,0.00030787778,0.0005231308,0.010353988],"category_scores_gemma":[0.00010052949,0.00016671109,0.0002786716,0.00028655038,0.00025299905,0.0004058472,0.00034910298,0.0006085372,0.0031417815],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005124905,0.00004961214,0.00055463455,0.0004488091,0.000011525046,0.0002195442,0.00003612966,0.00014096785,0.9787233,0.0012129708,0.0042050886,0.013884873],"study_design_scores_gemma":[0.00013926417,0.0006055201,0.016717114,0.000061218794,0.000069720634,0.0013158505,0.00014723123,0.0014112352,0.8741835,0.00057768007,0.104741335,0.000030439378],"about_ca_topic_score_codex":0.0007425839,"about_ca_topic_score_gemma":0.0009496992,"teacher_disagreement_score":0.010353988,"about_ca_system_score_codex":0.0005033888,"about_ca_system_score_gemma":0.00051786617,"threshold_uncertainty_score":0.03463751},"labels":[],"label_agreement":null},{"id":"W4296230882","doi":"10.1158/1557-3265.sarcomas22-ia008","title":"Abstract IA008: Altering the T cell receptor repertoire in the sarcoma tumor immune microenvironment","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CD8; T-cell receptor; Immune system; Tumor microenvironment; Sarcoma; T cell; Medicine; Pathology; Cancer research; Immunology","score_opus":0.09819048760532795,"score_gpt":0.4058954515903464,"score_spread":0.30770496398501845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296230882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973985,0.00051185593,0.00033927147,0.00008008827,0.0000313664,0.00003859899,0.00012223642,0.00007714687,0.0014008123],"genre_scores_gemma":[0.997299,0.00022090472,0.0007443883,0.0000978138,0.000025599857,0.00004127805,0.00040794347,0.000015599111,0.0011475019],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998994,0.00002718224,0.000006630549,0.00002055521,0.00001330515,0.000032803742],"domain_scores_gemma":[0.9999174,0.000017110646,0.000012068304,0.000012162505,0.000008055656,0.00003318171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015189147,0.00024019885,0.00036134175,0.00018272309,0.0001058765,0.00034622144,0.0002032178,0.00028081136,0.00393614],"category_scores_gemma":[0.00019272594,0.00008586593,0.00018689976,0.00016053494,0.00017210832,0.00014336045,0.0001874661,0.00071523176,0.0008501371],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015164931,0.0038954045,0.009318089,0.00023116141,0.000074075455,0.00030186807,0.000106300526,0.0012717905,0.8435596,0.0003874215,0.0023220852,0.123367205],"study_design_scores_gemma":[0.012892914,0.29573095,0.08086388,0.00011414283,0.00058844325,0.004937728,0.00036013068,0.012067215,0.5653246,0.0006590365,0.026398348,0.00006263841],"about_ca_topic_score_codex":0.0004032024,"about_ca_topic_score_gemma":0.00045597955,"teacher_disagreement_score":0.00393614,"about_ca_system_score_codex":0.0001765378,"about_ca_system_score_gemma":0.00019383428,"threshold_uncertainty_score":0.013167679},"labels":[],"label_agreement":null},{"id":"W4296230891","doi":"10.1158/1557-3265.sarcomas22-b006","title":"Abstract B006: Development of a NF1-MPNST-PDX liquid biopsy model using whole-genome sequencing and quantitative PCR of mouse-derived cell-free DNA","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Liquid biopsy; Context (archaeology); Biopsy; Minimal residual disease; Cancer research; Medicine; Digital polymerase chain reaction; Metastasis; Pathology; Cancer; Biology; Internal medicine; Polymerase chain reaction; Gene; Genetics","score_opus":0.40742507552583124,"score_gpt":0.4962657346942285,"score_spread":0.08884065916839728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296230891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8073255,0.0012476363,0.1726593,0.0007245743,0.00033668402,0.0015785642,0.008609418,0.0020405608,0.005477883],"genre_scores_gemma":[0.8370499,0.0011191625,0.13268322,0.0005175843,0.000038822844,0.002343264,0.007759351,0.0004319433,0.01805669],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994697,0.00004609622,0.00003762321,0.00016376728,0.00023449631,0.000048335332],"domain_scores_gemma":[0.99961483,0.00005414944,0.0001278462,0.000044001106,0.000060580333,0.00009857354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007458097,0.00060232857,0.0003171642,0.00067873846,0.00032269853,0.0005977528,0.00052856957,0.00087548775,0.0027984588],"category_scores_gemma":[0.00029394397,0.00030671965,0.00045951505,0.00024910306,0.00046743744,0.00050418096,0.00031863988,0.0013966917,0.0013972278],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001814201,0.00017397339,0.00038931603,0.000042678148,0.000008030886,0.00006228353,0.00003353775,0.00021827062,0.9962006,0.00032314283,0.00022956562,0.0021369888],"study_design_scores_gemma":[0.00005357667,0.0012463253,0.003313006,0.000024416624,0.000026400689,0.00041311572,0.000050316226,0.0048067835,0.98392916,0.00018664285,0.0059339246,0.000016326097],"about_ca_topic_score_codex":0.0013331991,"about_ca_topic_score_gemma":0.0016289079,"teacher_disagreement_score":0.0027984588,"about_ca_system_score_codex":0.00059788214,"about_ca_system_score_gemma":0.00049134495,"threshold_uncertainty_score":0.0093618035},"labels":[],"label_agreement":null},{"id":"W4296230896","doi":"10.1158/1557-3265.sarcomas22-ia026","title":"Abstract IA026: Epigenetic and genomic features define distinct cellular states with possible therapeutic relevance in osteosarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Epigenetics; Cancer research; Wnt signaling pathway; Epigenome; Osteosarcoma; Genetics; Chromatin; DNA methylation; Signal transduction; Gene; Gene expression","score_opus":0.05614931332798369,"score_gpt":0.39189029388011654,"score_spread":0.33574098055213286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296230896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.969009,0.0019170115,0.004861635,0.00013631607,0.00003642401,0.000045970424,0.020675944,0.00026435312,0.0030533716],"genre_scores_gemma":[0.9591784,0.0006030892,0.00453481,0.00020739263,0.00001580381,0.00008540582,0.03174416,0.00011507767,0.0035157795],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998419,0.000008129822,0.000010743582,0.00006165046,0.000049298324,0.000028157543],"domain_scores_gemma":[0.9998467,0.000028401588,0.000042796906,0.000016917073,0.00004383304,0.000021304391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017179614,0.00018196311,0.00030694518,0.00056151435,0.00032424013,0.0005135863,0.00017882051,0.00028450004,0.0026031756],"category_scores_gemma":[0.00027141636,0.00014894667,0.00033357757,0.0007038369,0.00017527114,0.0001640537,0.00035371905,0.00035472825,0.0005714845],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004853163,0.000033363587,0.0350217,0.000266749,0.000060904724,0.00010920257,0.000157626,0.0009005991,0.94812906,0.00033433962,0.0011568113,0.013344271],"study_design_scores_gemma":[0.000039678835,0.0003742868,0.71376497,0.00007409363,0.00022554469,0.0010763676,0.00040586796,0.008645868,0.25379452,0.0007095952,0.020833684,0.000055547145],"about_ca_topic_score_codex":0.002383703,"about_ca_topic_score_gemma":0.0045381086,"teacher_disagreement_score":0.0026031756,"about_ca_system_score_codex":0.0002889495,"about_ca_system_score_gemma":0.0002867994,"threshold_uncertainty_score":0.008708477},"labels":[],"label_agreement":null},{"id":"W4296230903","doi":"10.1158/1557-3265.sarcomas22-b027","title":"Abstract B027: The development of a multiscale transcriptional atlas of sarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Tumors and Oncological Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Princess Margaret Cancer Centre; Mount Sinai Hospital; SickKids Foundation","funders":"","keywords":"Sarcoma; KRAS; Pediatric cancer; Biology; Cancer; Synovial sarcoma; Pathology; Computational biology; Bioinformatics; Medicine; Genetics","score_opus":0.44633063959098834,"score_gpt":0.5580363148271056,"score_spread":0.11170567523611724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296230903","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26948673,0.0011426888,0.3921513,0.001164962,0.0001867697,0.00055498333,0.29374337,0.022770006,0.018799175],"genre_scores_gemma":[0.2595724,0.00050002005,0.39238444,0.0004982531,0.000098660006,0.0012013427,0.33521459,0.002082251,0.008448081],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991411,0.00014553033,0.00004983563,0.0003246244,0.0002784567,0.00006046028],"domain_scores_gemma":[0.9991229,0.00020577743,0.000097085285,0.0001949479,0.00028040414,0.00009894981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010495441,0.00041377536,0.0004200035,0.0013810904,0.0004534653,0.00074677693,0.0009008976,0.00046234104,0.0049146037],"category_scores_gemma":[0.0018801705,0.00033440703,0.0006434357,0.0014167859,0.0002798487,0.00040084487,0.0011868028,0.0007237042,0.0021062503],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007686262,0.00026561745,0.086547285,0.00081701356,0.00049900543,0.00043206374,0.000563756,0.058306288,0.42973483,0.015620612,0.16288206,0.24356271],"study_design_scores_gemma":[0.0002253291,0.00042189777,0.21605757,0.0001525495,0.00037000852,0.0011141443,0.00033920392,0.28037187,0.14701897,0.012878183,0.34092006,0.00013030543],"about_ca_topic_score_codex":0.00916831,"about_ca_topic_score_gemma":0.01912981,"teacher_disagreement_score":0.00916831,"about_ca_system_score_codex":0.0010850509,"about_ca_system_score_gemma":0.001600709,"threshold_uncertainty_score":0.018229842},"labels":[],"label_agreement":null},{"id":"W4296230941","doi":"10.1158/1557-3265.sarcomas22-pr008","title":"Abstract PR008: The 3D epigenome of rhabdomyosarcoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Epigenome; Enhancer; Computational biology; Epigenomics; Biology; Rhabdomyosarcoma; CRISPR; Genomics; BRD4; Cancer; Cancer research; Transcription factor; Genetics; Gene; Acetylation; Genome; Medicine; Sarcoma; Bromodomain; Gene expression; DNA methylation; Pathology","score_opus":0.1983545853358762,"score_gpt":0.5093861959494298,"score_spread":0.3110316106135536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296230941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8928069,0.003571641,0.058740165,0.0009385056,0.00021956435,0.0000960949,0.023969186,0.0029568346,0.016701123],"genre_scores_gemma":[0.90000266,0.0022494937,0.04732715,0.00038752894,0.000046857407,0.00011043794,0.025911825,0.0009435242,0.023020547],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999293,0.0000052679566,0.0000024748833,0.000021082502,0.000031599728,0.000010221876],"domain_scores_gemma":[0.99994373,0.000010860677,0.000011388853,0.000009341299,0.000012831419,0.000011701493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010312956,0.00017495523,0.0001785028,0.00038795828,0.00017973455,0.00028859737,0.00017180794,0.00020004722,0.004048908],"category_scores_gemma":[0.0001235051,0.00022779316,0.00026566687,0.00031922763,0.00013084126,0.00020238844,0.00039977118,0.00037886898,0.000980977],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012745312,0.000006401449,0.0019349995,0.00007593072,0.000012462261,0.00013004751,0.00005904463,0.00072930666,0.9815229,0.00065610185,0.0016858642,0.01305956],"study_design_scores_gemma":[0.000033260338,0.00025084717,0.18380706,0.00004388456,0.00008194986,0.0020331445,0.00024630027,0.0116599,0.7304806,0.0020399462,0.06925573,0.00006738923],"about_ca_topic_score_codex":0.0016137202,"about_ca_topic_score_gemma":0.0032370046,"teacher_disagreement_score":0.004048908,"about_ca_system_score_codex":0.00031388027,"about_ca_system_score_gemma":0.00016066956,"threshold_uncertainty_score":0.013544977},"labels":[],"label_agreement":null},{"id":"W4296230942","doi":"10.1158/1557-3265.sarcomas22-b018","title":"Abstract B018: A robust system to study human soft-tissue sarcoma lung metastasis","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pathology; Metastasis; Liposarcoma; Soft tissue sarcoma; Sarcoma; Population; Medicine; Cancer research; Cell sorting; Rhabdomyosarcoma; Cancer; Immunology; Internal medicine; Flow cytometry","score_opus":0.20738427786761057,"score_gpt":0.5370896528250181,"score_spread":0.3297053749574075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296230942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74956524,0.0065589184,0.19835594,0.0014961207,0.0007144639,0.0017579423,0.024200777,0.0068185255,0.010532149],"genre_scores_gemma":[0.8276674,0.0028846345,0.11040638,0.00060260633,0.000108575485,0.0015640783,0.0355949,0.00077091175,0.020400489],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994438,0.000111411384,0.00006257102,0.0001338304,0.00016887429,0.00007954554],"domain_scores_gemma":[0.99976236,0.000049760347,0.000031561383,0.00004913468,0.00005028419,0.00005681824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006791588,0.0006002471,0.0004904769,0.0007543999,0.0004135027,0.00069149403,0.00070562103,0.0006226633,0.0042261137],"category_scores_gemma":[0.00036329005,0.00030765947,0.00046659468,0.00040862156,0.00020808994,0.00030203207,0.000679026,0.0011888371,0.0041754437],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012541458,0.000090593974,0.00038887843,0.000061544735,0.000009966338,0.00006872676,0.000017108685,0.00018663547,0.993975,0.0002664257,0.0010231084,0.0037866237],"study_design_scores_gemma":[0.00012520207,0.0009925191,0.0038741734,0.00002967034,0.000052443607,0.00086080167,0.000044797413,0.007128852,0.95422757,0.00023596169,0.03238906,0.000038871927],"about_ca_topic_score_codex":0.0018311004,"about_ca_topic_score_gemma":0.0018107056,"teacher_disagreement_score":0.0042261137,"about_ca_system_score_codex":0.00051646057,"about_ca_system_score_gemma":0.00043608696,"threshold_uncertainty_score":0.014137745},"labels":[],"label_agreement":null},{"id":"W4296709146","doi":"10.1158/1078-0432.ccr-22-0979","title":"CD8+ Tumor-Infiltrating Lymphocyte Abundance Is a Positive Prognostic Indicator in Nasopharyngeal Cancer","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Public Health Ontario; University of Toronto; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research; Princess Margaret Cancer Foundation; Ministry of Health, Ontario","keywords":"Tumor-infiltrating lymphocytes; Immune system; CD8; Cohort; Oncology; Medicine; T-cell receptor; Internal medicine; T cell; Biology; Immunology","score_opus":0.13594631134784171,"score_gpt":0.4920593935842087,"score_spread":0.35611308223636695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296709146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981127,0.0007259391,0.00034953858,0.000047561705,0.000010259704,0.000012165495,0.00032311594,0.000020502635,0.00039841278],"genre_scores_gemma":[0.99877435,0.00019179289,0.0003427625,0.000025093868,0.000009011351,0.000018068902,0.0004267465,0.0000043924692,0.00020780756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998487,0.000024071565,0.000015496438,0.000054423224,0.000038313327,0.000019018382],"domain_scores_gemma":[0.99975926,0.000052449486,0.00007399032,0.000025791674,0.00004747336,0.000041022126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038198207,0.00018747163,0.00027356512,0.0003276605,0.00030260882,0.00041460927,0.00021995694,0.00025841533,0.0013162155],"category_scores_gemma":[0.0008659831,0.00013420626,0.00016257247,0.00032456114,0.00022646978,0.00023840369,0.00033685935,0.00031809264,0.00027623112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079060707,0.000050768118,0.9617281,0.00007779224,0.00007046465,0.00008171806,0.000063458756,0.00028954417,0.020728251,0.000024865341,0.0004072552,0.015687138],"study_design_scores_gemma":[0.000024615674,0.00024090546,0.9895864,0.00002140371,0.00015123807,0.0004936036,0.00022294481,0.0024497027,0.0051875715,0.000115895666,0.0014970077,0.000008691537],"about_ca_topic_score_codex":0.0010635889,"about_ca_topic_score_gemma":0.0024299764,"teacher_disagreement_score":0.0013162155,"about_ca_system_score_codex":0.00022978215,"about_ca_system_score_gemma":0.00022451911,"threshold_uncertainty_score":0.004403174},"labels":[],"label_agreement":null},{"id":"W4300690741","doi":"10.1158/1078-0432.ccr-22-1389","title":"Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Cancer Institute","keywords":"Renal cell carcinoma; Blockade; Medicine; Immune checkpoint; Oncology; Internal medicine; Receptor","score_opus":0.0864684432790599,"score_gpt":0.40851093129502614,"score_spread":0.32204248801596624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4300690741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99953485,0.00016045282,0.00005973875,0.000016631035,0.0000020115965,0.0000039059164,0.00012298426,0.0000017193499,0.00009765891],"genre_scores_gemma":[0.9996307,0.000037783648,0.000038216014,0.000010082198,0.0000039042047,0.0000044128988,0.00022365381,6.7372105e-7,0.00005056353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997968,0.00004354176,0.000018445831,0.000058560723,0.000048366463,0.000034304583],"domain_scores_gemma":[0.9995241,0.00006337324,0.00024561814,0.00003790662,0.00004444871,0.000084577114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031743888,0.0001737826,0.0003033983,0.0003065203,0.00021944393,0.00029785847,0.00016150005,0.00020917966,0.0009581384],"category_scores_gemma":[0.0008241632,0.00010189018,0.00023588943,0.000434801,0.0002043198,0.00022173139,0.0002163449,0.00036713376,0.00012024272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052485784,0.000045524765,0.996249,0.0000074196887,0.000056978075,0.000025967991,0.0000115781495,0.00006549342,0.0014232055,0.000006769673,0.000037688664,0.0015455822],"study_design_scores_gemma":[0.000008959619,0.00015278408,0.9993049,0.000001633963,0.00002103633,0.00007864343,0.000021054475,0.00018741933,0.00015863578,0.000008520497,0.00005525125,0.000001184012],"about_ca_topic_score_codex":0.0011703862,"about_ca_topic_score_gemma":0.002010173,"teacher_disagreement_score":0.0011703862,"about_ca_system_score_codex":0.00027585845,"about_ca_system_score_gemma":0.00021435221,"threshold_uncertainty_score":0.0032052994},"labels":[],"label_agreement":null},{"id":"W4304695096","doi":"10.1158/1078-0432.ccr-22-2576","title":"hENT1 Expression Predicts Response to Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Ductal Adenocarcinoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; McGill University Health Centre; Nova Scotia Cancer Centre; Princess Margaret Cancer Centre; Cancer Care South East; Ontario Institute for Cancer Research; Dalhousie University; University of Toronto","funders":"Canadian Cancer Society Research Institute; Terry Fox Research Institute; Pancreatic Cancer Canada Foundation; Ministère des Services à l'enfance et des Services sociaux et communautaires, Gouvernement de l’Ontario; QEII Foundation; Princess Margaret Cancer Foundation","keywords":"Gemcitabine; Nab-paclitaxel; Pancreatic ductal adenocarcinoma; Paclitaxel; Medicine; Oncology; Adenocarcinoma; Internal medicine; Pancreatic cancer; Cancer research; Chemotherapy; Cancer","score_opus":0.0802004714635329,"score_gpt":0.4485903897248844,"score_spread":0.3683899182613515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304695096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99959475,0.00022352168,0.000040388964,0.000012775959,0.0000024034887,0.0000042349216,0.00005077907,0.000001597422,0.00006964612],"genre_scores_gemma":[0.99965155,0.00007081089,0.00007164019,0.000009960385,0.0000056773024,0.0000053536855,0.00012082178,9.210967e-7,0.00006327696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973875,0.000101490994,0.000026124097,0.0000630247,0.000044237564,0.0000264007],"domain_scores_gemma":[0.9991835,0.0002661279,0.00032247507,0.000049027054,0.00005044787,0.00012845133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007224855,0.00020230355,0.00038427117,0.00030707367,0.00017005196,0.0004765002,0.00017606861,0.00029867972,0.00079479674],"category_scores_gemma":[0.0013054749,0.00015672196,0.00033348124,0.00036864833,0.00023682982,0.00024292392,0.00023290081,0.00031889457,0.0001517451],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005340129,0.000097800556,0.9866959,0.000024332854,0.0000927747,0.00007257241,0.000028384982,0.00027240318,0.0028058945,0.00000796067,0.000048822065,0.0045131547],"study_design_scores_gemma":[0.00016838823,0.0014398888,0.9943552,0.0000069423754,0.00013271735,0.00046622418,0.00007498566,0.0013519687,0.0016649446,0.000035870253,0.0002969213,0.0000059430226],"about_ca_topic_score_codex":0.00048444833,"about_ca_topic_score_gemma":0.0006230848,"teacher_disagreement_score":0.00079479674,"about_ca_system_score_codex":0.0003485828,"about_ca_system_score_gemma":0.0001846044,"threshold_uncertainty_score":0.0038208961},"labels":[],"label_agreement":null},{"id":"W4304758122","doi":"10.1158/1078-0432.ccr-22-1206","title":"Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta; BC Cancer Agency; Foothills Medical Centre; Alberta Health Services; University of British Columbia; Canadian Centre for Applied Research in Cancer Control; Vancouver General Hospital","funders":"National Cancer Institute; Cancer Council Tasmania; Cancer Council South Australia; BC Cancer Foundation; National Center for Advancing Translational Sciences; Medical Research Council; Peter MacCallum Foundation; Medical Research and Materiel Command; NSW Ministry of Health; Cancer Council Victoria; University of New South Wales; Canadian Institutes of Health Research; Cancer Institute NSW; Ovarian Cancer Research Fund; Cancer Australia; University of Cambridge; University of Pittsburgh; Calgary Laboratory Services; Ovarian Cancer Action; Michael Smith Health Research BC; Faculty of Medicine and Health, University of Sydney; Translational Cancer Research Network; Korea Health Industry Development Institute; National Institute for Health and Care Research; Cancer Council NSW; Ovarian Cancer Australia; National Institutes of Health; U.S. Department of Defense; National Health and Medical Research Council; Cancer Research UK; National Science Foundation","keywords":"Gene expression profiling; Ovarian cancer; Oncology; Gene expression; Cancer research; Biology; Pathology; Medicine; Internal medicine; Gene; Cancer; Genetics","score_opus":0.09656373803480299,"score_gpt":0.427403472762598,"score_spread":0.330839734727795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304758122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994023,0.00025743412,0.00008168068,0.000014821361,0.0000012293723,0.0000036747665,0.00015203077,0.000002401727,0.00008444824],"genre_scores_gemma":[0.9994276,0.0000912196,0.00013298941,0.00001051221,0.000002012225,0.0000070791216,0.0002761303,7.233337e-7,0.000051653577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983776,0.00004017479,0.000012728612,0.000036844813,0.00003441908,0.000037966496],"domain_scores_gemma":[0.99968874,0.00008751503,0.00012939732,0.000021737438,0.00002764052,0.000044904715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033033438,0.000120794684,0.00020189735,0.00044366188,0.00011390994,0.00027940932,0.00009257152,0.00014042735,0.0004841626],"category_scores_gemma":[0.0007775812,0.000057028952,0.00015146798,0.00055359275,0.00025306805,0.00009695736,0.00015561051,0.00017151349,0.00008206875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065987476,0.000043097407,0.9667796,0.00004327145,0.00005119491,0.00006758509,0.00004420417,0.000100202466,0.028060047,0.000021867067,0.00006299731,0.0040660007],"study_design_scores_gemma":[0.000011062692,0.00018892475,0.9952884,0.000005229599,0.000036461843,0.00033441992,0.00007421104,0.0003769416,0.003431703,0.000026627684,0.00022417959,0.0000019517986],"about_ca_topic_score_codex":0.0007795339,"about_ca_topic_score_gemma":0.0010088105,"teacher_disagreement_score":0.0007795339,"about_ca_system_score_codex":0.00021189787,"about_ca_system_score_gemma":0.00018998876,"threshold_uncertainty_score":0.0017469525},"labels":[],"label_agreement":null},{"id":"W4307230056","doi":"10.1158/1078-0432.ccr-22-2235","title":"Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib Study","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":227,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston; Novartis Pharmaceuticals UK Limited; University of Texas MD Anderson Cancer Center; F. Hoffmann-La Roche; Genentech; AstraZeneca; Novartis Pharmaceuticals Corporation; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Tolerability; Adverse effect; Sting; Internal medicine; Pharmacodynamics; Gastroenterology; Agonist; Refractory (planetary science); Pharmacokinetics; Pharmacology; Oncology; Receptor","score_opus":0.28112111726796624,"score_gpt":0.5536109955576296,"score_spread":0.27248987828966337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307230056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99704224,0.0012518496,0.00038391256,0.000092544506,0.000035343808,0.0004410031,0.00018629756,0.000048355305,0.00051863],"genre_scores_gemma":[0.99642795,0.0009897079,0.0007297788,0.00016290662,0.00007363331,0.0004393855,0.0005277181,0.000012681332,0.0006363505],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99973816,0.00010903215,0.000018948214,0.000048370086,0.000031688014,0.00005383829],"domain_scores_gemma":[0.9997197,0.000039590443,0.00006058114,0.00003320139,0.000017516422,0.00012948415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009206013,0.0010735113,0.0014350578,0.00035161184,0.00023741358,0.0006298312,0.00064401055,0.0006872343,0.0014676696],"category_scores_gemma":[0.000380236,0.0003695336,0.0008909051,0.0003315987,0.00061208656,0.0005965104,0.0002422386,0.0017290547,0.00043508442],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43224642,0.112811245,0.010957918,0.0015512313,0.0021356991,0.0005576636,0.00056463014,0.005953738,0.22262836,0.00036036145,0.0029231706,0.2073095],"study_design_scores_gemma":[0.20669334,0.7562623,0.01127554,0.0000403891,0.00060831674,0.0005367007,0.000073191586,0.0023118923,0.019565448,0.00012812685,0.0024758861,0.000028956158],"about_ca_topic_score_codex":0.0004971303,"about_ca_topic_score_gemma":0.0008484178,"teacher_disagreement_score":0.0014676696,"about_ca_system_score_codex":0.0005133073,"about_ca_system_score_gemma":0.0006971682,"threshold_uncertainty_score":0.004909873},"labels":[],"label_agreement":null},{"id":"W4307341849","doi":"10.1158/1078-0432.ccr-22-2429","title":"Electronic Nicotine Delivery Systems: An Updated Policy Statement from the American Association for Cancer Research and the American Society of Clinical Oncology","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Nicotine; Medicine; Smoking cessation; Tobacco industry; Tobacco harm reduction; Environmental health; Addiction; Tobacco control; Public health; Tobacco smoke; Surgeon general; Psychiatry; Pathology","score_opus":0.3783230909307632,"score_gpt":0.6267669960401643,"score_spread":0.24844390510940106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307341849","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009411277,0.034762975,0.005837025,0.56704956,0.073890276,0.003078931,0.017044088,0.0031920818,0.29420388],"genre_scores_gemma":[0.005000886,0.05751241,0.015830671,0.53985965,0.020805527,0.005767991,0.019391123,0.0006807008,0.33515102],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9873219,0.0020434002,0.0012909385,0.00064411305,0.00733357,0.0013661765],"domain_scores_gemma":[0.95977116,0.00885059,0.0033322666,0.0018270148,0.021300534,0.0049184086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012827317,0.0014231929,0.0017630224,0.0033877352,0.0029527645,0.006307113,0.0040281233,0.024658334,0.053785227],"category_scores_gemma":[0.025271574,0.0011798504,0.0019728455,0.005962835,0.0016498867,0.0045324555,0.0024002302,0.018763611,0.053675257],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002418918,0.000086663036,0.00014188679,0.00017773437,0.0000048601482,0.00003955814,0.00001839761,0.00006558103,0.00016938584,0.0018534925,0.9612305,0.03618768],"study_design_scores_gemma":[0.000039020655,0.000029064491,0.00090151234,0.00052192423,0.00001290327,0.000061384526,0.000035043227,0.0000774708,0.00012335781,0.0009570195,0.9972193,0.000021925538],"about_ca_topic_score_codex":0.028144654,"about_ca_topic_score_gemma":0.05584628,"teacher_disagreement_score":0.053785227,"about_ca_system_score_codex":0.0056387153,"about_ca_system_score_gemma":0.030040145,"threshold_uncertainty_score":0.17992955},"labels":[],"label_agreement":null},{"id":"W4307492599","doi":"10.1158/1078-0432.ccr-22-2145","title":"Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma","year":2022,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Medicine; Sunitinib; Tolerability; Internal medicine; Clinical endpoint; Response Evaluation Criteria in Solid Tumors; Oncology; Randomized controlled trial; Progressive disease; Soft tissue sarcoma; Phases of clinical research; Tyrosine-kinase inhibitor; Surgery; Clinical trial; Gastroenterology; Adverse effect; Cancer; Chemotherapy; Soft tissue","score_opus":0.41087224671313327,"score_gpt":0.5635958806909772,"score_spread":0.15272363397784394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307492599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828318,0.0026831275,0.0009617289,0.0013474086,0.0007263437,0.00782152,0.0012934555,0.00017640577,0.0021582514],"genre_scores_gemma":[0.98081756,0.0015066776,0.002011668,0.0015844678,0.00046534115,0.008014105,0.0018743327,0.000029936644,0.0036957548],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992261,0.0004674097,0.000045126606,0.00010724035,0.00005621809,0.00009787186],"domain_scores_gemma":[0.9984388,0.00040730173,0.00032831775,0.0001184563,0.0000992988,0.0006079193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002675103,0.0018157795,0.002889566,0.00036873954,0.0004857717,0.001093866,0.0009411756,0.0014670353,0.007038953],"category_scores_gemma":[0.0019185023,0.0008003543,0.0013414602,0.00029394563,0.0012472603,0.000805788,0.00042311466,0.0033680545,0.001079321],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9705545,0.009835615,0.00087030046,0.00034203054,0.00057515805,0.000071135226,0.00004609308,0.0006304682,0.004621858,0.00011837011,0.0013457745,0.010988752],"study_design_scores_gemma":[0.9472658,0.050610434,0.0006907029,0.000009850469,0.00012513592,0.000035590143,0.0000093620765,0.00037176008,0.0003388352,0.00008488368,0.00045074377,0.000006935616],"about_ca_topic_score_codex":0.0007920593,"about_ca_topic_score_gemma":0.002242837,"teacher_disagreement_score":0.007038953,"about_ca_system_score_codex":0.001024976,"about_ca_system_score_gemma":0.002171588,"threshold_uncertainty_score":0.02354765},"labels":[],"label_agreement":null},{"id":"W4307498458","doi":"10.1158/1078-0432.ccr-21-3143","title":"Meta-Analysis of the Test–Retest Repeatability of [18F]-Fluorodeoxyglucose Standardized Uptake Values: Implications for Assessment of Tumor Response","year":2022,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Repeatability; Reproducibility; Medicine; Nuclear medicine; Standardized uptake value; Generalizability theory; Fluorodeoxyglucose; Coefficient of variation; Positron emission tomography; Statistics; Mathematics","score_opus":0.7496982872703446,"score_gpt":0.6773012996534533,"score_spread":0.07239698761689128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307498458","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.078109734,0.90175235,0.013121369,0.0015318322,0.0012675856,0.00048429362,0.0020013566,0.00032395858,0.0014074643],"genre_scores_gemma":[0.93218946,0.052713875,0.008596813,0.0021069457,0.0008856153,0.0010396077,0.0014201256,0.00025722914,0.00079035334],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.93373656,0.045644253,0.007707746,0.00839985,0.0036834304,0.00082805404],"domain_scores_gemma":[0.8114089,0.15886118,0.011800254,0.012646865,0.004654201,0.00062861416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0693957,0.0033197256,0.01079414,0.0032955583,0.0008333061,0.004195425,0.003028614,0.003138187,0.001582886],"category_scores_gemma":[0.13709794,0.0014963932,0.041243646,0.0041163047,0.0014300117,0.0026058163,0.0016264437,0.0026720974,0.000307422],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004317592,0.000029650368,0.03640611,0.018805575,0.9272457,0.00018999026,0.000093895425,0.001383179,0.00045977137,0.00022681354,0.00067970547,0.010162088],"study_design_scores_gemma":[0.00075517705,0.0004854942,0.032079056,0.0020056693,0.9600808,0.0001894067,0.000055632223,0.0011327001,0.00043712294,0.0010412803,0.0016896274,0.000048046782],"about_ca_topic_score_codex":0.0041828537,"about_ca_topic_score_gemma":0.0058184783,"teacher_disagreement_score":0.0693957,"about_ca_system_score_codex":0.0015040633,"about_ca_system_score_gemma":0.0013262939,"threshold_uncertainty_score":0.36700392},"labels":[],"label_agreement":null},{"id":"W4307970770","doi":"10.1158/1078-0432.ccr-21-3577","title":"Olaparib Efficacy in Patients with Metastatic Castration-resistant Prostate Cancer and <i>BRCA1, BRCA2</i> , or <i>ATM</i> Alterations Identified by Testing Circulating Tumor DNA","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Juravinski Cancer Centre; Institute of Cancer Research","funders":"Medical Research Council; National Institute for Health and Care Research; AstraZeneca","keywords":"Olaparib; Medicine; Enzalutamide; Hazard ratio; Internal medicine; Oncology; Cohort; Prostate cancer; Population; Cancer; Confidence interval; Progression-free survival; PARP inhibitor; Chemotherapy; Poly ADP ribose polymerase; Biology; Genetics","score_opus":0.18852185491737347,"score_gpt":0.46875579997177996,"score_spread":0.28023394505440646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307970770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976794,0.0015145594,0.00006462496,0.00004097928,0.000007285973,0.000043486107,0.00017849547,0.0000070084893,0.00046415775],"genre_scores_gemma":[0.99919456,0.00025751296,0.00011591664,0.00006087721,0.000014331285,0.000014593943,0.00024756562,9.960366e-7,0.00009363871],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997608,0.000096718606,0.000021173239,0.00004537799,0.000050774815,0.000025077748],"domain_scores_gemma":[0.99952674,0.00012273136,0.00015000463,0.000024041861,0.00002628979,0.00015018242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005414671,0.00029160906,0.00053595396,0.0002423137,0.00011626595,0.00046154775,0.00026568357,0.0001813242,0.0006785192],"category_scores_gemma":[0.00083801855,0.00013355723,0.00034124398,0.00023768624,0.00018456744,0.00020994875,0.0001863757,0.00046248827,0.00009452308],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16340685,0.004377623,0.6406936,0.00048377647,0.0019911325,0.0007516029,0.00024563642,0.0025123463,0.024926448,0.00016610305,0.0016347487,0.15881006],"study_design_scores_gemma":[0.021133428,0.09302488,0.87101537,0.00010562246,0.0011909596,0.0025374216,0.00023519901,0.002827984,0.004206134,0.00026727899,0.0034172207,0.00003846493],"about_ca_topic_score_codex":0.00053272286,"about_ca_topic_score_gemma":0.0018317204,"teacher_disagreement_score":0.0006785192,"about_ca_system_score_codex":0.00037929614,"about_ca_system_score_gemma":0.0004853191,"threshold_uncertainty_score":0.002863586},"labels":[],"label_agreement":null},{"id":"W4308523453","doi":"10.1158/1078-0432.ccr-22-2191","title":"Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Capecitabine; Internal medicine; Oncology; Medicine; Breast cancer; Triple-negative breast cancer; Basal (medicine); Cancer; Colorectal cancer","score_opus":0.07225856200408001,"score_gpt":0.42869648930679166,"score_spread":0.3564379273027116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308523453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972466,0.001332128,0.00029989536,0.00009638773,0.000013787518,0.000021806358,0.00018468653,0.0000075553544,0.00079720956],"genre_scores_gemma":[0.999485,0.0001118096,0.00012242989,0.000032596465,0.000014125184,0.000007822495,0.00011764775,0.0000014128302,0.00010702341],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995105,0.0002354015,0.000032393444,0.00010397238,0.00007185567,0.000045822057],"domain_scores_gemma":[0.9978022,0.001293403,0.00049180887,0.00016062257,0.000048365546,0.00020355043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021141001,0.0002605511,0.0005477212,0.00018869218,0.00011305733,0.00039431182,0.00022237544,0.0002941447,0.0022993116],"category_scores_gemma":[0.0032596872,0.00012946542,0.00063460675,0.00017182907,0.00022806655,0.0002406557,0.00021194355,0.00050995965,0.00017734307],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047307946,0.00020645742,0.9096105,0.00015974835,0.0014225483,0.00008993252,0.00003634545,0.0013299958,0.00658127,0.00009680591,0.00030589465,0.032852553],"study_design_scores_gemma":[0.00087321416,0.004155311,0.9853357,0.00003504334,0.0014934288,0.00039531925,0.00004821001,0.0049822046,0.0016662771,0.00021997184,0.0007857627,0.000009597434],"about_ca_topic_score_codex":0.0005296357,"about_ca_topic_score_gemma":0.0010094657,"teacher_disagreement_score":0.0022993116,"about_ca_system_score_codex":0.00023925214,"about_ca_system_score_gemma":0.0002598359,"threshold_uncertainty_score":0.01118058},"labels":[],"label_agreement":null},{"id":"W4308684444","doi":"10.1158/1078-0432.ccr-22-2781","title":"Molecular Monitoring in Endometrial Cancer—Ready for Prime Time?","year":2022,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Endometrial cancer; Cancer; Oncology; Disease; Medicine; Risk stratification; Internal medicine; Stage (stratigraphy); Bioinformatics; Biology","score_opus":0.2103175373538921,"score_gpt":0.5118544432595084,"score_spread":0.3015369059056162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308684444","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010619671,0.0132490685,0.00060909014,0.9548336,0.027945815,0.000017269984,0.000047557016,0.000056287594,0.0021793093],"genre_scores_gemma":[0.01745549,0.01897069,0.0016169332,0.7306417,0.22485766,0.00006818419,0.00008786633,0.000044983226,0.0062565454],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980136,0.000724278,0.00025532555,0.00021916012,0.0006242523,0.0001633563],"domain_scores_gemma":[0.9930213,0.0042694095,0.0003866426,0.00032785622,0.0012625388,0.000732364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032791998,0.0006800849,0.0009342702,0.0005502638,0.00092326064,0.0016729851,0.0011129779,0.016883273,0.0036932286],"category_scores_gemma":[0.01426594,0.0004180827,0.0007938827,0.00042725005,0.0018441597,0.0028948782,0.0005354178,0.016471628,0.0041671763],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043559851,0.000105380976,0.00266257,0.00042365745,0.00003612446,0.010055279,0.00009443425,0.0002530442,0.002877879,0.0055979798,0.8964422,0.08101601],"study_design_scores_gemma":[0.000341686,0.0005695454,0.003841256,0.0007174591,0.00007399174,0.025341667,0.0003094386,0.0011788886,0.0022774385,0.023807535,0.9414549,0.000086219065],"about_ca_topic_score_codex":0.00077937497,"about_ca_topic_score_gemma":0.0009055561,"teacher_disagreement_score":0.016883273,"about_ca_system_score_codex":0.0017700444,"about_ca_system_score_gemma":0.0010655497,"threshold_uncertainty_score":0.01734227},"labels":[],"label_agreement":null},{"id":"W4309093661","doi":"10.1158/1078-0432.ccr-22-2074","title":"A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Imperial Experimental Cancer Medicine Centre; National Institute for Health and Care Research; Sierra Oncology; Cancer Research UK","keywords":"Gemcitabine; Medicine; Neutropenia; Internal medicine; Cancer; Tolerability; Nausea; Lung cancer; Cervical cancer; Gastroenterology; Oncology; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Adverse effect; Chemotherapy","score_opus":0.12067813214337975,"score_gpt":0.5118891438458054,"score_spread":0.39121101170242567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309093661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962172,0.0009593293,0.0002922766,0.00019632126,0.00006433686,0.00096159085,0.00029105082,0.000057779253,0.00096007844],"genre_scores_gemma":[0.9950003,0.00083649246,0.001008033,0.00031157408,0.00010167198,0.000760439,0.00091039797,0.000013721347,0.0010572914],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99973327,0.00012389307,0.000015395843,0.000047475427,0.00002711885,0.000052759864],"domain_scores_gemma":[0.99963045,0.000057098616,0.00007294665,0.00002448013,0.00002408066,0.00019090954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009059039,0.0011309491,0.0012424013,0.0003848985,0.00033598792,0.0006688082,0.00047397133,0.0006032955,0.002724165],"category_scores_gemma":[0.00047881636,0.00035400747,0.000668551,0.00039935487,0.00067979266,0.00043630713,0.00021988084,0.0021101697,0.00052276195],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6575366,0.06429698,0.00916928,0.0010490407,0.0011334422,0.00037203444,0.00022053561,0.0035802745,0.09607582,0.00038776695,0.0042686737,0.16190948],"study_design_scores_gemma":[0.4870971,0.48976833,0.010025159,0.000039091097,0.00046929653,0.00030047612,0.000043938813,0.0022561313,0.0076846033,0.00015514682,0.0021341082,0.000026664424],"about_ca_topic_score_codex":0.00088031974,"about_ca_topic_score_gemma":0.0024542208,"teacher_disagreement_score":0.002724165,"about_ca_system_score_codex":0.00084996695,"about_ca_system_score_gemma":0.0017054025,"threshold_uncertainty_score":0.009113252},"labels":[],"label_agreement":null},{"id":"W4310153812","doi":"10.1158/1078-0432.ccr-21-1888","title":"Therapeutic Targeting of LIF Overcomes Macrophage-mediated Immunosuppression of the Local Tumor Microenvironment","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; Interface Biologics (Canada)","funders":"National Institutes of Health; Fundación BBVA; Fundación Ramón Areces; Fundación Científica Asociación Española Contra el Cáncer; Mitacs; Canada Research Chairs","keywords":"Immunosuppression; Tumor microenvironment; Macrophage; Cancer research; Medicine; Immunology; Tumor cells; Biology; In vitro","score_opus":0.11709788437567349,"score_gpt":0.45783317048563105,"score_spread":0.34073528610995757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310153812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98886263,0.0035073417,0.005452412,0.00023478527,0.000029850993,0.00008268388,0.000132838,0.00015064093,0.0015467923],"genre_scores_gemma":[0.9957563,0.0008401152,0.0023264205,0.000054817927,0.000028570275,0.00005068819,0.0001359027,0.00001023397,0.0007970069],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999918,0.000015948945,0.000004181805,0.000010390575,0.000021361962,0.00003017436],"domain_scores_gemma":[0.99993145,0.000015955125,0.000020897563,0.0000067257456,0.00000687614,0.000018092149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016315078,0.00029994018,0.00032723375,0.00027510754,0.00012178227,0.0002482637,0.00015265563,0.00019273901,0.0008568697],"category_scores_gemma":[0.000108516375,0.00004776844,0.00015688539,0.00010279377,0.00022064422,0.00014111245,0.00014540889,0.0005411627,0.0001952507],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037068612,0.00020407356,0.0005390782,0.00007915481,0.000007637829,0.000056080316,0.000019594749,0.00034942,0.9853731,0.00022237339,0.00012687998,0.01265192],"study_design_scores_gemma":[0.00007759969,0.0023054217,0.0016508129,0.000010624411,0.000029674928,0.00042409124,0.000019352337,0.0014311585,0.9902462,0.0000720365,0.003730359,0.000002823532],"about_ca_topic_score_codex":0.00020518799,"about_ca_topic_score_gemma":0.0004322609,"teacher_disagreement_score":0.0008568697,"about_ca_system_score_codex":0.00024040208,"about_ca_system_score_gemma":0.0003194773,"threshold_uncertainty_score":0.0028665662},"labels":[],"label_agreement":null},{"id":"W4310961831","doi":"10.1158/1078-0432.ccr-22-1983","title":"Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"National Cancer Institute; AstraZeneca","keywords":"Tremelimumab; Durvalumab; Hepatocellular carcinoma; Medicine; Oncology; Carcinoma; Internal medicine; Cancer; Immunotherapy; Nivolumab","score_opus":0.3085699116471894,"score_gpt":0.45173078754274426,"score_spread":0.14316087589555487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310961831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983323,0.0005468059,0.000520948,0.00005610249,0.0000039679467,0.00003500844,0.0002405463,0.000021093803,0.00024321541],"genre_scores_gemma":[0.99934286,0.00006484046,0.00019321064,0.000033589517,0.0000055859014,0.00002068157,0.00024047999,0.0000044305716,0.00009436031],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982992,0.00096280774,0.00010777666,0.00029156532,0.00024778716,0.00009092016],"domain_scores_gemma":[0.9970592,0.0015377699,0.0008214512,0.00027551642,0.00013671319,0.00016943247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035360844,0.00033161772,0.0007765545,0.00037951497,0.0001478341,0.00052480865,0.0003893846,0.00036633504,0.001404096],"category_scores_gemma":[0.0047117323,0.0002284213,0.001480057,0.00035077368,0.00019075732,0.0004586324,0.00034465353,0.0007526511,0.00026764328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10411875,0.0019960478,0.78949904,0.00046127697,0.006568663,0.00035960414,0.0003260978,0.017376872,0.019501945,0.00022891795,0.00081096886,0.05875174],"study_design_scores_gemma":[0.0025365786,0.029487105,0.89984435,0.000032795284,0.0031259973,0.0011350622,0.00018493527,0.0494777,0.010633124,0.0004896945,0.0029868751,0.00006581103],"about_ca_topic_score_codex":0.00078167475,"about_ca_topic_score_gemma":0.0007774541,"teacher_disagreement_score":0.0035360844,"about_ca_system_score_codex":0.00091269595,"about_ca_system_score_gemma":0.00048470488,"threshold_uncertainty_score":0.018700838},"labels":[],"label_agreement":null},{"id":"W4313453191","doi":"10.1158/1078-0432.ccr-22-2323","title":"Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"National Cancer Institute; Genentech; National Institutes of Health; Institut National de la Santé et de la Recherche Médicale; Regeneron Pharmaceuticals; BeiGene; Daiichi Sankyo Europe; Sanofi; Université de Paris; G1 Therapeutics; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Resampling; Phase (matter); Decision support system; Computer science; Artificial intelligence; Chemistry","score_opus":0.2819218439402065,"score_gpt":0.627311248327568,"score_spread":0.34538940438736154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313453191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6762671,0.0033055102,0.31061998,0.0013188836,0.00013024923,0.0029533817,0.002621173,0.00054485316,0.0022390059],"genre_scores_gemma":[0.9512163,0.00019108226,0.045262042,0.00030582625,0.00004139595,0.0011102594,0.0016814688,0.000058698035,0.00013289979],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.90061074,0.0902628,0.0023432465,0.0032540062,0.0032723984,0.00025687934],"domain_scores_gemma":[0.56399834,0.36491826,0.02574655,0.034220975,0.0098807085,0.0012352223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1712738,0.0009499599,0.0012073329,0.0010873062,0.00049680134,0.0017643379,0.0014380764,0.0009955572,0.0008075517],"category_scores_gemma":[0.29474488,0.00069198024,0.002090739,0.00072749244,0.00104722,0.0010043049,0.0012643063,0.0015995601,0.00018309035],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024365775,0.00093988725,0.5407206,0.0011260144,0.010119011,0.0004658673,0.0012706546,0.23466423,0.0042418335,0.005355303,0.005254881,0.171476],"study_design_scores_gemma":[0.0017228457,0.0076537114,0.07968294,0.00033366782,0.0031220294,0.0005624969,0.00025326596,0.88762236,0.0049426006,0.007354462,0.0065981043,0.00015146598],"about_ca_topic_score_codex":0.0015687346,"about_ca_topic_score_gemma":0.0015275017,"teacher_disagreement_score":0.1712738,"about_ca_system_score_codex":0.0009386042,"about_ca_system_score_gemma":0.0013281077,"threshold_uncertainty_score":0.90579325},"labels":[],"label_agreement":null},{"id":"W4313453618","doi":"10.1158/1078-0432.ccr-22-1768","title":"Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Cancer Institute; National Institute of Dental and Craniofacial Research; U.S. Department of Veterans Affairs","keywords":"Head and neck cancer; Neoadjuvant therapy; Oncology; Medicine; Head and neck; Internal medicine; Overall survival; Cancer; Surgery; Breast cancer","score_opus":0.36083228052320226,"score_gpt":0.5684159966494018,"score_spread":0.20758371612619952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313453618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98357785,0.014371272,0.0006151697,0.00021233145,0.000049789607,0.00004793204,0.00041541032,0.000015939171,0.0006943739],"genre_scores_gemma":[0.9986513,0.0007630073,0.0001056986,0.00008792396,0.00004349241,0.000014020435,0.00024764703,0.0000023115028,0.000084605665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889475,0.0006118545,0.000109311084,0.00017262691,0.00013714605,0.00007424867],"domain_scores_gemma":[0.9985247,0.0006766372,0.00049511535,0.00013364691,0.000077700824,0.00009219056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022407626,0.00025311726,0.0008713453,0.000267604,0.00013811704,0.00044070458,0.00017898188,0.00031829407,0.00094596826],"category_scores_gemma":[0.0031035729,0.00013767091,0.0015208031,0.00034773978,0.00026636026,0.0002734345,0.00027355575,0.00034140405,0.000086677006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053998966,0.00040007458,0.83220494,0.001132003,0.016980348,0.00020817218,0.000086550455,0.0014770285,0.0133015765,0.000116704745,0.00078939466,0.07930426],"study_design_scores_gemma":[0.0012216455,0.010123495,0.96677786,0.00011995699,0.0151790315,0.0005717552,0.00011162873,0.0015017241,0.0022303169,0.00023949619,0.0019045852,0.000018409406],"about_ca_topic_score_codex":0.00060060533,"about_ca_topic_score_gemma":0.0017555635,"teacher_disagreement_score":0.0022407626,"about_ca_system_score_codex":0.00029492506,"about_ca_system_score_gemma":0.00039643687,"threshold_uncertainty_score":0.011850417},"labels":[],"label_agreement":null},{"id":"W4313597888","doi":"10.1158/1078-0432.ccr-22-0794","title":"LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Departamento de Salud, Gobierno de Navarra; Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España; National Cancer Institute; Associazione Italiana per la Ricerca sul Cancro; Ministerio de Ciencia e Innovación","keywords":"Biology; Effector; Cancer research; Gene expression profiling; Gene expression; Gene; Cell biology; Genetics","score_opus":0.1630158994598232,"score_gpt":0.46739954534286066,"score_spread":0.30438364588303746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313597888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9689669,0.012941143,0.0058216345,0.00069720973,0.000077571174,0.0001124348,0.0047124154,0.0005569434,0.0061136973],"genre_scores_gemma":[0.98544264,0.002708329,0.002751732,0.00020969688,0.000027261389,0.00010629678,0.005094736,0.00004780318,0.003611539],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977463,0.000029055109,0.000013413509,0.00006208356,0.00007228635,0.000048449318],"domain_scores_gemma":[0.99986696,0.000011389911,0.000040573676,0.000013603096,0.000035929694,0.000031677406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020624169,0.00044715087,0.00025518567,0.00043264282,0.0003500419,0.00058221346,0.00019975199,0.0002576507,0.0019692774],"category_scores_gemma":[0.0001664038,0.000121980884,0.0002934769,0.00040392278,0.0002506263,0.00025416244,0.00035280522,0.0004744627,0.0005593221],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038932386,0.000040417424,0.0026047851,0.00021069103,0.00002762758,0.00011960188,0.000026283069,0.00031626233,0.9910279,0.00026334517,0.0005888151,0.0043849885],"study_design_scores_gemma":[0.00005928966,0.00039943215,0.04685215,0.000061052764,0.0001071908,0.0007260834,0.00021297784,0.005700282,0.91871685,0.00022469087,0.026921017,0.00001897315],"about_ca_topic_score_codex":0.0009975305,"about_ca_topic_score_gemma":0.0021793873,"teacher_disagreement_score":0.0019692774,"about_ca_system_score_codex":0.0008386916,"about_ca_system_score_gemma":0.0006706007,"threshold_uncertainty_score":0.006587863},"labels":[],"label_agreement":null},{"id":"W4317254563","doi":"10.1158/1078-0432.ccr-22-2263","title":"A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":219,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development","funders":"Medical Research Council; Cancer Research UK","keywords":"Cancer; Monocarboxylate transporter; Medicine; Transporter; Pharmacology; Internal medicine; Oncology; Chemistry; Biochemistry","score_opus":0.11840909832250741,"score_gpt":0.4943255930660395,"score_spread":0.3759164947435321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317254563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99553126,0.0011500674,0.00038281473,0.000228527,0.00005026999,0.0013009172,0.00044401377,0.000054029744,0.0008580684],"genre_scores_gemma":[0.99500567,0.0007102941,0.0011507386,0.00039391717,0.000061066756,0.0009051216,0.0008679217,0.000014389336,0.0008909229],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99956876,0.00017688306,0.000026961428,0.000085947424,0.000048808037,0.00009262739],"domain_scores_gemma":[0.9993906,0.00008375262,0.00014699434,0.00006900244,0.000039020266,0.00027048957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012857144,0.0014212541,0.0014648667,0.0004650508,0.00038555823,0.0006969157,0.0006549484,0.000837696,0.0021209428],"category_scores_gemma":[0.00082779635,0.00048587154,0.0009083049,0.00050404086,0.0006991449,0.000629698,0.00031614624,0.0025612533,0.0005782978],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5596911,0.10620896,0.01854752,0.0009853845,0.001533475,0.00046892613,0.0007535837,0.006900414,0.13253567,0.00035174412,0.0042821136,0.16774124],"study_design_scores_gemma":[0.41732115,0.5457877,0.022775104,0.00003281702,0.00037768824,0.00047020428,0.000056473797,0.0017726878,0.0075970725,0.00023113153,0.0035407366,0.00003732398],"about_ca_topic_score_codex":0.0006539184,"about_ca_topic_score_gemma":0.0016544476,"teacher_disagreement_score":0.0021209428,"about_ca_system_score_codex":0.00091750274,"about_ca_system_score_gemma":0.0011222055,"threshold_uncertainty_score":0.0070952773},"labels":[],"label_agreement":null},{"id":"W4318925936","doi":"10.1158/1078-0432.ccr-22-3484","title":"Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in <i>EGFR</i> -Mutant Lung Adenocarcinomas","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Cancer Institute; Royal College of Physicians and Surgeons of Canada; National Institutes of Health; Memorial Sloan-Kettering Cancer Center; Pfizer","keywords":"Osimertinib; T790M; Medicine; Lung cancer; Combination therapy; Oncology; Gefitinib; Acquired resistance; Internal medicine; Epidermal growth factor receptor; Regimen; Afatinib; Pharmacology; Cancer; Erlotinib","score_opus":0.10603535078340894,"score_gpt":0.498558414973884,"score_spread":0.39252306419047506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318925936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6929835,0.14359608,0.0111969495,0.04355397,0.030918967,0.0028357124,0.0054706405,0.0013999196,0.06804423],"genre_scores_gemma":[0.84392947,0.047674883,0.005866783,0.010862807,0.037511047,0.00076023856,0.0045429463,0.00015392028,0.048697863],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996438,0.000102728416,0.000043660868,0.000070730035,0.000081123864,0.00005791052],"domain_scores_gemma":[0.9993625,0.0001526522,0.0001250067,0.000035853565,0.00013983993,0.00018409961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090770796,0.00068882137,0.0005686089,0.00017625422,0.00026979024,0.00067144545,0.00051988184,0.0011027309,0.005807695],"category_scores_gemma":[0.000702991,0.00014864687,0.00041258353,0.00020998459,0.00024369641,0.00031449672,0.0001611584,0.0010179427,0.0012646364],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024261393,0.003557583,0.011356211,0.004277365,0.0007998248,0.007649182,0.00022193584,0.0011863242,0.10640115,0.0011408541,0.32595357,0.51319474],"study_design_scores_gemma":[0.015455194,0.0836227,0.04223219,0.0005704678,0.0021404442,0.033695735,0.00025874143,0.0038153573,0.17722456,0.0009494622,0.6399298,0.000105365376],"about_ca_topic_score_codex":0.0002821067,"about_ca_topic_score_gemma":0.000487796,"teacher_disagreement_score":0.005807695,"about_ca_system_score_codex":0.00059613615,"about_ca_system_score_gemma":0.00075938215,"threshold_uncertainty_score":0.01942867},"labels":[],"label_agreement":null},{"id":"W4318926335","doi":"10.1158/1078-0432.ccr-22-1989","title":"Biomarker Data from the Phase III KATHERINE Study of Adjuvant T-DM1 versus Trastuzumab for Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"Genentech; F. Hoffmann-La Roche","keywords":"Trastuzumab; Breast cancer; Medicine; Oncology; Adjuvant; Biomarker; Internal medicine; Adjuvant therapy; Neoadjuvant therapy; Cancer; Biology","score_opus":0.5670680553339,"score_gpt":0.6237006534623429,"score_spread":0.0566325981284429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318926335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963414,0.0015875493,0.00016563956,0.00014327733,0.000020353631,0.00013742915,0.0011402244,0.00000951672,0.00045451443],"genre_scores_gemma":[0.9933914,0.00065719703,0.00045449543,0.00030570396,0.000033285545,0.00025083555,0.003983785,0.000008896191,0.0009144901],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9986833,0.0008406936,0.00006707348,0.00017446768,0.00015690451,0.00007767529],"domain_scores_gemma":[0.9979253,0.0007263502,0.0005751821,0.00023652456,0.00012263666,0.00041400455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004258445,0.00048392423,0.0012782898,0.00018005684,0.00020893708,0.00079091213,0.0005887645,0.00061253615,0.0012037944],"category_scores_gemma":[0.002733581,0.00026219332,0.0010347768,0.00032515766,0.00040343078,0.00045261453,0.00037445652,0.0007907452,0.0002666507],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7464586,0.004594681,0.17348345,0.00074267737,0.014008242,0.0001474014,0.00025722294,0.0016272774,0.013775885,0.00015377277,0.0022982378,0.04245256],"study_design_scores_gemma":[0.16419001,0.13707791,0.67501265,0.00011193087,0.009579664,0.00044955517,0.00015745303,0.0014379941,0.0050426093,0.0002285416,0.0066398717,0.00007179573],"about_ca_topic_score_codex":0.0011476055,"about_ca_topic_score_gemma":0.002675836,"teacher_disagreement_score":0.004258445,"about_ca_system_score_codex":0.0006178716,"about_ca_system_score_gemma":0.0007196969,"threshold_uncertainty_score":0.022521019},"labels":[],"label_agreement":null},{"id":"W4319338186","doi":"10.1158/1078-0432.ccr-22-3032","title":"Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without <i>MYCN</i> Amplification: A Children's Oncology Group (COG) Report","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; Hope Foundation; Ohio State University; National Cancer Institute; St. Baldrick's Foundation","keywords":"Neuroblastoma; Histology; Internal medicine; Univariate analysis; Oncology; Medicine; Multivariate analysis; Stage (stratigraphy); Cog; Confidence interval; Biology; Genetics","score_opus":0.1945378628366252,"score_gpt":0.525337744972106,"score_spread":0.3307998821354807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319338186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99957424,0.00011060678,0.000020242145,0.000013678103,0.0000015849159,0.0000025539796,0.00014970863,0.0000010160055,0.00012639945],"genre_scores_gemma":[0.9995055,0.00006115251,0.00004547087,0.000013250016,0.000004234454,0.0000040583404,0.00031747436,0.0000011067704,0.000047616726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985015,0.000036776604,0.000010736357,0.000041648,0.000029522549,0.00003116151],"domain_scores_gemma":[0.9994697,0.00015344933,0.0002050395,0.000030496461,0.000031981603,0.00010937379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000356027,0.00018450763,0.00018568657,0.00023321564,0.0002418297,0.00031175476,0.00013298447,0.0001806057,0.000821389],"category_scores_gemma":[0.0006664755,0.00007721853,0.00021916375,0.00026728882,0.00023177567,0.00016162607,0.00017733581,0.00021427312,0.00010403223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009089549,0.000035552963,0.9958448,0.0000074412915,0.000042828615,0.00012482163,0.000027703492,0.000060642287,0.00077089196,0.000009582237,0.000116010284,0.0020508703],"study_design_scores_gemma":[0.000021984955,0.00031116276,0.9984762,0.0000024625094,0.000055715354,0.00045905286,0.000055483903,0.00007394584,0.00028473244,0.000010361117,0.00024669073,0.0000021702924],"about_ca_topic_score_codex":0.002915901,"about_ca_topic_score_gemma":0.005319941,"teacher_disagreement_score":0.002915901,"about_ca_system_score_codex":0.00041687285,"about_ca_system_score_gemma":0.00041349346,"threshold_uncertainty_score":0.005797863},"labels":[],"label_agreement":null},{"id":"W4319341650","doi":"10.1158/1078-0432.ccr-22-3298","title":"Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics","year":2023,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; Janssen Pharmaceuticals; Loxo Oncology; Genentech; Sierra Oncology; PharmaMar; European Society for Medical Oncology; Astellas Pharma; Generalitat de Catalunya; Fundación Científica Asociación Española Contra el Cáncer; MacroGenics; Menarini Group; F-star Therapeutics; Banco Bilbao Vizcaya Argentaria; BeiGene; Agios Pharmaceuticals; Merck KGaA; Regeneron Pharmaceuticals; Les Laboratories Pierre Fabre; Principia Biopharma; Fundació la Marató de TV3; Fundación BBVA; Symphogen; Pfizer; Incyte; F. Hoffmann-La Roche; Ministerio de Ciencia e Innovación; European Commission; Sanofi; Centres de Recerca de Catalunya; GlaxoSmithKline; Instituto de Salud Carlos III; Amgen; Celgene; Agència de Gestió d'Ajuts Universitaris i de Recerca; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Antigen; Immunosurveillance; Immunogenicity; Cancer; Cancer research; Biology; T cell; Cancer immunotherapy; Immune system; Immunology; Immunotherapy; Genetics","score_opus":0.5256608444183113,"score_gpt":0.4866425423422372,"score_spread":0.039018302076074096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319341650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976421,0.0003278206,0.0015188181,0.000026300648,0.000002755334,0.000015275788,0.00012605664,0.000008804608,0.00033200387],"genre_scores_gemma":[0.99730575,0.00024905585,0.0017454933,0.000045965808,0.0000049620066,0.00001580123,0.0003825036,0.000005455866,0.00024507396],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989974,0.000021199196,0.000006443519,0.00002631385,0.000024841045,0.00002150982],"domain_scores_gemma":[0.99990845,0.0000216094,0.000033731958,0.00000887029,0.000013023309,0.000014283649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001462588,0.00023177832,0.00014728254,0.00016317754,0.00009151075,0.00022477936,0.0001248012,0.00019275701,0.0009399815],"category_scores_gemma":[0.0001526274,0.00006808305,0.00016230189,0.00012266815,0.00012285661,0.00012440424,0.00015933234,0.00031310497,0.00022437956],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009761582,0.00001973874,0.0029490853,0.000039983588,0.0000074879595,0.000044761604,0.000011208707,0.00015309804,0.9950944,0.0000314982,0.000020739593,0.0015303324],"study_design_scores_gemma":[0.00003000501,0.0008421203,0.05010649,0.0000129648115,0.00005869074,0.0018890892,0.000097405195,0.005269649,0.9394009,0.00019898002,0.00208562,0.000008080732],"about_ca_topic_score_codex":0.0001294189,"about_ca_topic_score_gemma":0.0001389241,"teacher_disagreement_score":0.0009399815,"about_ca_system_score_codex":0.00015417862,"about_ca_system_score_gemma":0.00009885326,"threshold_uncertainty_score":0.0031446218},"labels":[],"label_agreement":null},{"id":"W4319461346","doi":"10.1158/1078-0432.ccr-22-2206","title":"<i>CCNE1</i> and <i>PLK1</i> Mediate Resistance to Palbociclib in HR+/HER2− Metastatic Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Associazione Italiana per la Ricerca sul Cancro; Università degli Studi di Napoli Federico II; AstraZeneca; Pfizer","keywords":"Palbociclib; Medicine; Capecitabine; Metastatic breast cancer; Oncology; Internal medicine; Breast cancer; Estrogen receptor; Cancer; Cancer research; Colorectal cancer","score_opus":0.21797034272938606,"score_gpt":0.5550666118599532,"score_spread":0.3370962691305671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319461346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99873227,0.0004849838,0.00008508427,0.000043409822,0.0000024669705,0.00001928387,0.00012929509,0.000010670508,0.0004924091],"genre_scores_gemma":[0.9990349,0.00021097147,0.00013410789,0.000039620445,0.0000052639975,0.000019549581,0.00026832134,0.0000037043878,0.0002836669],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998983,0.000021421272,0.000006490877,0.000021629676,0.000029110184,0.0000231511],"domain_scores_gemma":[0.9998436,0.000036112604,0.000058052938,0.000013378177,0.000014098551,0.000034783876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025221126,0.00020720711,0.00027294195,0.00022350073,0.00015518955,0.00042654198,0.00017116599,0.00014493837,0.0019103413],"category_scores_gemma":[0.00032191127,0.00013916685,0.00013112003,0.00018147555,0.00027347388,0.00019560922,0.00013535329,0.00042048242,0.00026863543],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009946823,0.0011252586,0.17593654,0.00028809215,0.00014190667,0.00037119904,0.00009994223,0.0013131314,0.77384424,0.00023819851,0.0010775705,0.03561718],"study_design_scores_gemma":[0.00078718405,0.0061570476,0.74447167,0.000028208864,0.00015305355,0.0022849725,0.00025628076,0.0035488294,0.23861955,0.0002592157,0.0034171797,0.000016799364],"about_ca_topic_score_codex":0.0006966657,"about_ca_topic_score_gemma":0.0011634151,"teacher_disagreement_score":0.0019103413,"about_ca_system_score_codex":0.0005453348,"about_ca_system_score_gemma":0.00027554616,"threshold_uncertainty_score":0.006390691},"labels":[],"label_agreement":null},{"id":"W4321367032","doi":"10.1158/1078-0432.ccr-22-2765","title":"Tumor Mutational Burden as a Predictor of Survival with Durvalumab and/or Tremelimumab Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; AstraZeneca","keywords":"Durvalumab; Tremelimumab; Medicine; Head and neck squamous-cell carcinoma; Oncology; Internal medicine; Confidence interval; Head and neck cancer; Chemotherapy; Hazard ratio; Immunotherapy; Cancer; Nivolumab","score_opus":0.27141715895329493,"score_gpt":0.5069175933917128,"score_spread":0.2355004344384179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321367032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99940276,0.00037105937,0.00003653197,0.000011044072,0.0000015620863,0.0000033810995,0.00008476798,0.0000018917403,0.00008710845],"genre_scores_gemma":[0.9997105,0.000060430502,0.00005317747,0.0000067484343,0.0000026851967,0.0000025433794,0.00012147059,8.542514e-7,0.000041641702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996952,0.00007815083,0.00003649689,0.00008086208,0.00008179123,0.000027599765],"domain_scores_gemma":[0.9989511,0.00020839153,0.00053359574,0.00008517079,0.00008197077,0.00013975703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000697942,0.00014963937,0.00032882649,0.00026487675,0.00012225652,0.00027284387,0.00024299782,0.00019914248,0.000768122],"category_scores_gemma":[0.0013102294,0.00012267072,0.00033998128,0.00027439895,0.00017716392,0.0001788819,0.00020211247,0.00025291342,0.00009600687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020412211,0.000023768307,0.99119955,0.000017409791,0.00014723615,0.00004724787,0.000016232801,0.0001585029,0.0019741138,0.000006262046,0.000058711164,0.0043098587],"study_design_scores_gemma":[0.000029148943,0.0003130975,0.9982064,0.00000557849,0.00009502113,0.0002335883,0.000019931915,0.0004342447,0.00051275926,0.0000077116665,0.00013991026,0.0000025389716],"about_ca_topic_score_codex":0.0020801628,"about_ca_topic_score_gemma":0.0041824444,"teacher_disagreement_score":0.0020801628,"about_ca_system_score_codex":0.00039130397,"about_ca_system_score_gemma":0.000259801,"threshold_uncertainty_score":0.0041360855},"labels":[],"label_agreement":null},{"id":"W4321611729","doi":"10.1158/1078-0432.ccr-22-1936","title":"Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre","funders":"NIHR Cambridge Biomedical Research Centre; European Commission; Fonds de Recherche du Québec - Santé; Kidney Foundation of Canada; National Institute for Health and Care Research; Cancer Research Society; Cancer Research UK; Ministère de l'Éducation et de l'Enseignement supérieur; McGill University; World Health Organization","keywords":"Medicine; Renal cell carcinoma; Cohort; Oncology; Internal medicine; Clear cell renal cell carcinoma; Adjuvant therapy; Cancer","score_opus":0.3207378210906531,"score_gpt":0.4987843110072705,"score_spread":0.17804648991661742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321611729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99672985,0.0008518349,0.0015381257,0.00016647598,0.000011256913,0.000026800992,0.00031289653,0.000016225746,0.00034660625],"genre_scores_gemma":[0.9980294,0.00019602093,0.0012143055,0.00007267141,0.000012448583,0.000012966026,0.00037441752,0.0000032942328,0.00008444572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99957365,0.00018899882,0.00003829665,0.00009604273,0.000060976497,0.000042085037],"domain_scores_gemma":[0.99913365,0.00036563392,0.00025806637,0.000082764745,0.00008060807,0.00007927605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015173214,0.0002702178,0.00033729686,0.0006478732,0.00019779927,0.00044657436,0.00025157578,0.00030494775,0.00054189796],"category_scores_gemma":[0.0031048807,0.00011385064,0.0002090983,0.00043549834,0.00022277844,0.00022650843,0.0003585896,0.00027567492,0.00011424869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006297678,0.00006342656,0.96272266,0.00003756742,0.000098626544,0.000120754754,0.00007204725,0.0013691686,0.008135807,0.0000675491,0.0002725572,0.02640998],"study_design_scores_gemma":[0.0000823378,0.0006638766,0.975089,0.00004815306,0.00025329943,0.0008719946,0.00020060007,0.012949875,0.0071077235,0.00068701623,0.0020322674,0.000013765119],"about_ca_topic_score_codex":0.0015060173,"about_ca_topic_score_gemma":0.0031512608,"teacher_disagreement_score":0.0015173214,"about_ca_system_score_codex":0.00030392985,"about_ca_system_score_gemma":0.00046454926,"threshold_uncertainty_score":0.008024454},"labels":[],"label_agreement":null},{"id":"W4321748193","doi":"10.1158/1078-0432.ccr-22-2955","title":"Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Medicine; Lymphoma; Follicular lymphoma; Angioimmunoblastic T-cell lymphoma; T cell; Internal medicine; Adverse effect; Oncology; Peripheral T-cell lymphoma; Refractory (planetary science); Pharmacodynamics; Gastroenterology; Immunology; Pharmacokinetics; Immune system","score_opus":0.07551008948559883,"score_gpt":0.395376646050156,"score_spread":0.31986655656455715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321748193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982368,0.0010085497,0.00013082165,0.000036455083,0.0000031131458,0.000038843187,0.000043674278,0.000013327311,0.0004885421],"genre_scores_gemma":[0.9991366,0.00033132054,0.0002007333,0.000060766488,0.000010858579,0.000019266508,0.00010551786,0.0000015367992,0.00013334524],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999925,0.000026595899,0.0000074528216,0.000011015396,0.000012899777,0.000016977618],"domain_scores_gemma":[0.99988043,0.00003100446,0.00003198651,0.000008402577,0.000007669167,0.00004058084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027414763,0.00020774559,0.00039629402,0.00012309372,0.00013417249,0.00021146375,0.00018262031,0.0001576452,0.00063116645],"category_scores_gemma":[0.00031110662,0.00008518714,0.00013764203,0.00016995941,0.00018498182,0.00016224942,0.00010007087,0.00035733325,0.00018913746],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049491156,0.0037513142,0.44717932,0.0007912091,0.00044686114,0.0043679993,0.00073735864,0.0036259224,0.16633818,0.0003229508,0.0025301808,0.32041752],"study_design_scores_gemma":[0.01520859,0.21376427,0.6879058,0.00014063164,0.001130738,0.01482206,0.00053257216,0.0070556775,0.045325782,0.0003902175,0.013686524,0.00003714949],"about_ca_topic_score_codex":0.0003749561,"about_ca_topic_score_gemma":0.0009273907,"teacher_disagreement_score":0.00063116645,"about_ca_system_score_codex":0.00028949132,"about_ca_system_score_gemma":0.0002592655,"threshold_uncertainty_score":0.002111435},"labels":[],"label_agreement":null},{"id":"W4324132617","doi":"10.1158/1078-0432.ccr-22-3291","title":"Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; University of California, San Francisco; U.S. Department of Defense; U.S. Department of Energy; University of California, Davis; University of Alberta; DOD Prostate Cancer Research Program; School of Veterinary Medicine, University of California, Davis","keywords":"Radioimmunotherapy; Prostate cancer; Medicine; Cancer; Antibody; Immunotherapy; Cancer research; Oncology; Monoclonal antibody; Internal medicine; Immunology","score_opus":0.34073345702044033,"score_gpt":0.5932641462564825,"score_spread":0.25253068923604216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324132617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9678255,0.015157154,0.012876186,0.00016839603,0.000056158806,0.00012886424,0.00014906489,0.00030854638,0.0033301725],"genre_scores_gemma":[0.9921218,0.0032480552,0.0031350767,0.00006136898,0.000019717178,0.000024855086,0.00016926299,0.000016004413,0.0012038436],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9999081,0.000015563355,0.0000050781205,0.000020116328,0.000028941338,0.000022105185],"domain_scores_gemma":[0.9999776,0.000002046216,0.000008910363,0.0000031202937,0.0000028466388,0.000005472454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001077706,0.00028633056,0.00024982015,0.00022554018,0.00011341571,0.00025481224,0.00021177468,0.00018881366,0.00073510857],"category_scores_gemma":[0.00006477806,0.00009531516,0.0003030433,0.00019564951,0.00017553037,0.00014662564,0.00017422308,0.0002878705,0.00031492696],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049272535,0.00021182619,0.0012274979,0.0002606963,0.00005938113,0.00020794476,0.000045176937,0.0016541713,0.9635515,0.00033431113,0.00042100903,0.031533707],"study_design_scores_gemma":[0.000092996095,0.0027551192,0.00729265,0.000019472342,0.00010099483,0.0018548673,0.000023937688,0.004366384,0.9744626,0.00007611874,0.008939553,0.000015259662],"about_ca_topic_score_codex":0.00078119227,"about_ca_topic_score_gemma":0.00071792887,"teacher_disagreement_score":0.00078119227,"about_ca_system_score_codex":0.00036713813,"about_ca_system_score_gemma":0.00021847212,"threshold_uncertainty_score":0.0026637912},"labels":[],"label_agreement":null},{"id":"W4361190864","doi":"10.1158/1078-0432.ccr-22-2535","title":"A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Saskatchewan Cancer Agency; Centre hospitalier de l'Université Laval; Saskatoon Medical Imaging; University of Saskatchewan; Centre hospitalier universitaire de Québec; Royal University Hospital","funders":"National Institute of Neurological Disorders and Stroke; Canadian Institutes of Health Research; Saskatchewan Health Research Foundation; National Cancer Institute; Genome Canada","keywords":"Bispecific antibody; EPH receptor A2; Cancer; Medicine; Antibody; Cancer therapy; Epidermal growth factor receptor; Cancer research; Antibody therapy; Oncology; Internal medicine; Immunology; Monoclonal antibody; Receptor","score_opus":0.700667143084389,"score_gpt":0.6785639125598978,"score_spread":0.022103230524491257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361190864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.672837,0.0044504665,0.31074274,0.00054286723,0.00012337502,0.00085460074,0.00076100504,0.0010067852,0.008681134],"genre_scores_gemma":[0.85425246,0.0022220064,0.13605052,0.0003065807,0.000034479413,0.0004973682,0.00082977477,0.00012511773,0.0056816596],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99933124,0.00012822148,0.00004588992,0.00014623968,0.00025887325,0.00008964902],"domain_scores_gemma":[0.9997956,0.000023837665,0.00006294161,0.00004041076,0.00004845685,0.000028742254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087339187,0.0007546476,0.0004381124,0.0006466296,0.00023726285,0.00046989674,0.0003886946,0.00040693022,0.0011105653],"category_scores_gemma":[0.00037348806,0.00027902942,0.00028959016,0.0003248695,0.00028167103,0.00035464982,0.0006511506,0.00060983683,0.00061232934],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008291185,0.00006493721,0.0004889579,0.000047163914,0.000015003799,0.000053215357,0.000020841879,0.00087069796,0.98622197,0.00075366604,0.00020721786,0.011173333],"study_design_scores_gemma":[0.0000124872695,0.00026198642,0.0006275115,0.0000056278145,0.000022923903,0.00020487324,0.0000069229704,0.0037004382,0.9899866,0.00013996668,0.005021495,0.000009245424],"about_ca_topic_score_codex":0.00021113615,"about_ca_topic_score_gemma":0.0006117113,"teacher_disagreement_score":0.0011105653,"about_ca_system_score_codex":0.00042466493,"about_ca_system_score_gemma":0.00045871915,"threshold_uncertainty_score":0.0046189427},"labels":[],"label_agreement":null},{"id":"W4362451642","doi":"10.1158/1078-0432.ccr-22-3136","title":"Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Cancer Institute; Gilead Sciences","keywords":"Medicine; Chemoimmunotherapy; Clinical endpoint; Internal medicine; Adverse effect; Oncology; Randomized controlled trial; Surgery; Lymphoma; Rituximab","score_opus":0.10425728756673605,"score_gpt":0.4631420898558782,"score_spread":0.3588848022891421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362451642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99840254,0.0010416552,0.000045978893,0.00007302475,0.000022698385,0.00006713519,0.00008196265,0.000005303954,0.0002596407],"genre_scores_gemma":[0.9991008,0.00032093198,0.000078710116,0.00011839069,0.000042266794,0.00006158468,0.000113841204,0.0000012445385,0.00016216184],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99956447,0.00023195417,0.00003822755,0.0000536468,0.00003897134,0.00007269156],"domain_scores_gemma":[0.9994518,0.00017240096,0.0001722409,0.000036208097,0.000019947669,0.00014738545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010746814,0.00038255804,0.0009987626,0.00028808933,0.00018699265,0.0005077232,0.000270334,0.00048809714,0.0016448795],"category_scores_gemma":[0.0013563088,0.00017993276,0.0011565357,0.00023557183,0.00038464135,0.0003642885,0.00026358917,0.0006969168,0.00018784113],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9157548,0.004633712,0.026879525,0.0003399355,0.0014886934,0.00011034127,0.00008687265,0.00073721504,0.0064481883,0.000068674555,0.00037899805,0.043073025],"study_design_scores_gemma":[0.27693364,0.5774661,0.13187759,0.00011684461,0.0037293627,0.00042846947,0.0002774448,0.00311764,0.0036136585,0.00037831382,0.0020170629,0.000043975808],"about_ca_topic_score_codex":0.00045939806,"about_ca_topic_score_gemma":0.0014470099,"teacher_disagreement_score":0.0016448795,"about_ca_system_score_codex":0.00047647452,"about_ca_system_score_gemma":0.00047728393,"threshold_uncertainty_score":0.0056835413},"labels":[],"label_agreement":null},{"id":"W4362456136","doi":"10.1158/1078-0432.ccr-22-3207","title":"SALVO: Single-Arm Trial of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Clinical Oncology Group","funders":"","keywords":"Medicine; Ipilimumab; Nivolumab; Internal medicine; Melanoma; Adjuvant therapy; Adjuvant; Radiation therapy; Surgery; Oncology; Gastroenterology; Cancer; Immunotherapy","score_opus":0.2984597270626484,"score_gpt":0.5228688469826615,"score_spread":0.22440911992001306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362456136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992257,0.0029127195,0.00034615333,0.000787758,0.00032723576,0.0011288153,0.0005951355,0.000082978455,0.0015622514],"genre_scores_gemma":[0.9884235,0.0015716893,0.0011496455,0.000763301,0.00042383053,0.0024595943,0.0012136331,0.000022953636,0.00397179],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996118,0.00020566247,0.000021632428,0.00006599535,0.00003522089,0.00005960012],"domain_scores_gemma":[0.99937266,0.00010899665,0.00016848858,0.00005103721,0.000030405252,0.00026845583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014576925,0.0014264847,0.0012562884,0.00029031772,0.00029099113,0.0009370445,0.00071822654,0.0010506546,0.0041550836],"category_scores_gemma":[0.0010931003,0.00039179667,0.0015482339,0.00017879972,0.0008701286,0.00077673997,0.0005068823,0.00187389,0.000760447],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9603944,0.005890533,0.0018858945,0.0007428046,0.0011075073,0.000084570966,0.0000972798,0.0007621386,0.006418983,0.00023138117,0.0015297242,0.02085473],"study_design_scores_gemma":[0.87904155,0.11223768,0.0038845812,0.00006774545,0.00064816664,0.00009902848,0.00004033778,0.0009985002,0.0011019474,0.00024097854,0.0016200527,0.00001948962],"about_ca_topic_score_codex":0.0004953728,"about_ca_topic_score_gemma":0.0013169855,"teacher_disagreement_score":0.0041550836,"about_ca_system_score_codex":0.00061727123,"about_ca_system_score_gemma":0.0011696545,"threshold_uncertainty_score":0.013900101},"labels":[],"label_agreement":null},{"id":"W4362457702","doi":"10.1158/1078-0432.ccr-22-2998","title":"Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"Cilag; Astellas Pharma; Killam Trusts; ZonMw; Prostate Cancer Foundation","keywords":"Enzalutamide; Abiraterone; Prostate cancer; Medicine; Oncology; Cancer; Internal medicine; Prostate; Androgen receptor","score_opus":0.3526424261395648,"score_gpt":0.5554773306580965,"score_spread":0.20283490451853164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362457702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99923515,0.00044645378,0.00006694958,0.000017057031,0.000002569817,0.0000065518457,0.00012619665,0.0000040088266,0.00009509268],"genre_scores_gemma":[0.9996233,0.00006993171,0.00004924737,0.0000148418685,0.000004862664,0.0000040416107,0.00018092277,0.0000012707636,0.00005144873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993793,0.00021459798,0.00005592296,0.00015125285,0.0001348514,0.0000640919],"domain_scores_gemma":[0.9967589,0.00076644676,0.0018737528,0.0001806924,0.00015658993,0.00026369307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011224957,0.00025501347,0.00040025817,0.00032020698,0.00019986552,0.0004964073,0.00037722033,0.0004248137,0.00082426966],"category_scores_gemma":[0.0032109045,0.00016943402,0.000378368,0.00041363577,0.00027694838,0.00034069087,0.00027351896,0.00049330795,0.00012084515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056996658,0.0001612505,0.98271346,0.000042917807,0.00017417388,0.00006500928,0.00004993817,0.00024417185,0.0028304288,0.00001118961,0.00007535255,0.007932563],"study_design_scores_gemma":[0.00006402518,0.0009753383,0.9975299,0.0000067511137,0.00007247168,0.00019248253,0.000027822556,0.00036376764,0.0005957397,0.000019826775,0.00014743854,0.0000043194436],"about_ca_topic_score_codex":0.0014313742,"about_ca_topic_score_gemma":0.0020123972,"teacher_disagreement_score":0.0014313742,"about_ca_system_score_codex":0.0005889589,"about_ca_system_score_gemma":0.00036992857,"threshold_uncertainty_score":0.005936384},"labels":[],"label_agreement":null},{"id":"W4365504267","doi":"10.1158/1078-0432.ccr-22-3145","title":"Adjuvant Nivolumab versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results from CheckMate 238","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Pharmacyclics; EMD Serono; Eli Lilly and Company; Ono Pharmaceutical; Eisai; Seagen; Castle Biosciences; University of Miami; Pfizer; Incyte; BeiGene; Regeneron Pharmaceuticals; Mylan; Les Laboratories Pierre Fabre; Sun Pharma; Gilead Sciences; Sanofi; GlaxoSmithKline; Amgen; Qbiotics; Samsung; Bristol-Myers Squibb; AstraZeneca; PharmaMar; Jounce Therapeutics; Celgene","keywords":"Ipilimumab; Nivolumab; Medicine; Adjuvant; Melanoma; Oncology; Stage (stratigraphy); Internal medicine; Biomarker; Cancer; Immunotherapy; Cancer research; Biology","score_opus":0.26881148328013926,"score_gpt":0.49505869565078864,"score_spread":0.22624721237064938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365504267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960756,0.0026774576,0.00015538718,0.00008911416,0.000033962817,0.00011341167,0.00035943434,0.00002177886,0.0004737602],"genre_scores_gemma":[0.99691224,0.0009336973,0.00025769626,0.00016576116,0.000062390456,0.00009106475,0.0010196387,0.0000068965787,0.0005505492],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99957377,0.00021882284,0.000030276893,0.00006084638,0.00006869936,0.000047496338],"domain_scores_gemma":[0.99911755,0.00024212802,0.00028177357,0.000081645965,0.000055901488,0.00022095873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019662168,0.00056651246,0.0010525349,0.00031459387,0.00017657384,0.0005427708,0.0005046533,0.0005636474,0.0011457255],"category_scores_gemma":[0.0012242093,0.00017849276,0.0011200919,0.00021377052,0.0002743869,0.00039455434,0.00018778561,0.0011524607,0.00024775107],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72045267,0.01478292,0.055652164,0.0011156666,0.0042518256,0.0002986842,0.00020286454,0.0045543206,0.03491352,0.0001699318,0.0030499625,0.16055548],"study_design_scores_gemma":[0.15230294,0.5789469,0.22920786,0.0001913795,0.005600604,0.0009254512,0.00010168413,0.0077293897,0.018912833,0.0002876516,0.005717857,0.00007550054],"about_ca_topic_score_codex":0.0006063256,"about_ca_topic_score_gemma":0.0011907087,"teacher_disagreement_score":0.0019662168,"about_ca_system_score_codex":0.0006898485,"about_ca_system_score_gemma":0.0004942248,"threshold_uncertainty_score":0.010398507},"labels":[],"label_agreement":null},{"id":"W4366982411","doi":"10.1158/1078-0432.ccr-22-3413","title":"Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; Canadian Institutes of Health Research; Chugai Pharmaceutical; EMD Serono; Genentech; Mirati Therapeutics; National Cancer Institute; Royal College of Physicians and Surgeons of Canada; Conquer Cancer Foundation; Gilead Sciences; Merck KGaA; Regeneron Pharmaceuticals; Prostate Cancer Foundation; American Society of Clinical Oncology; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; Pfizer; Takeda Oncology; Amgen","keywords":"KRAS; Cancer research; Lung cancer; STK11; Microsatellite instability; Biology; Adenocarcinoma; Missense mutation; Cancer; Medicine; Pathology; Mutation; Gene; Internal medicine; Colorectal cancer; Genetics","score_opus":0.12049070787620193,"score_gpt":0.5108255109347748,"score_spread":0.3903348030585729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366982411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995956,0.00008715633,0.000049564747,0.00000971357,0.0000010124542,0.0000034061698,0.00008560534,0.000003004925,0.00016501237],"genre_scores_gemma":[0.99972564,0.000023511502,0.000044920933,0.000006967307,0.0000029957444,0.000003532365,0.0001533457,9.811364e-7,0.000038038703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978334,0.000040540694,0.000027212907,0.000065815846,0.00004614984,0.000037021942],"domain_scores_gemma":[0.99952316,0.00008925672,0.00020407504,0.000031951546,0.000041732404,0.0001098664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037049945,0.00015261589,0.00017708827,0.0005705631,0.00023242517,0.0003053364,0.00021106952,0.00022384772,0.0011209708],"category_scores_gemma":[0.00075772573,0.00013984928,0.00014360835,0.00038401576,0.00035455835,0.00022404308,0.0001934091,0.00013944633,0.00022726493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020515626,0.000011366227,0.9941585,0.000007004847,0.000015516911,0.0003526889,0.000019238152,0.00004369933,0.004026136,0.000011857731,0.00005660617,0.00109229],"study_design_scores_gemma":[0.0000057986827,0.00009915004,0.9965249,0.000001621609,0.000013123446,0.002526104,0.00006032733,0.00013893539,0.00048773442,0.000017348342,0.00012281074,0.0000020574912],"about_ca_topic_score_codex":0.0007114161,"about_ca_topic_score_gemma":0.0014966413,"teacher_disagreement_score":0.0011209708,"about_ca_system_score_codex":0.00021352811,"about_ca_system_score_gemma":0.00015363269,"threshold_uncertainty_score":0.0037500858},"labels":[],"label_agreement":null},{"id":"W4367601287","doi":"10.1158/1078-0432.ccr-23-0411","title":"Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; BC Children's Hospital; University of Toronto","funders":"Hospital for Sick Children; Stand Up To Cancer; St. Baldrick's Foundation","keywords":"Nivolumab; Medicine; Mutation; Refractory (planetary science); Oncology; Internal medicine; Cancer research; Cancer; Immunotherapy; Biology; Genetics","score_opus":0.12479639771476266,"score_gpt":0.47622004907038723,"score_spread":0.3514236513556246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367601287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99241537,0.0061323675,0.0002564299,0.00015242049,0.000018402672,0.0001245588,0.00022011227,0.000015149207,0.00066521286],"genre_scores_gemma":[0.99697804,0.001617407,0.00065861875,0.00015480582,0.000026097312,0.00008166529,0.00030983778,0.0000067499786,0.00016678491],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996611,0.00018060945,0.000026267457,0.000043541655,0.00004101825,0.00004751272],"domain_scores_gemma":[0.99945146,0.00020222345,0.00017323815,0.000029653189,0.00003781569,0.00010571743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088233897,0.00035806847,0.0007282485,0.00012647084,0.00016215556,0.00040017083,0.00026340905,0.00027472695,0.00074356253],"category_scores_gemma":[0.00085400906,0.000116242336,0.00045618476,0.00016919702,0.00028081163,0.00028036625,0.00018871177,0.0007532075,0.00012929295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18601048,0.005632782,0.36716262,0.0027425662,0.0022427295,0.0016435103,0.00043349486,0.005713413,0.071511015,0.00063758425,0.0037087745,0.35256112],"study_design_scores_gemma":[0.061722655,0.3139298,0.51111674,0.001025609,0.0031139436,0.013564594,0.00058942067,0.0057169353,0.05911213,0.0006340007,0.029420814,0.00005340496],"about_ca_topic_score_codex":0.0008332613,"about_ca_topic_score_gemma":0.0027997326,"teacher_disagreement_score":0.00088233897,"about_ca_system_score_codex":0.0007932792,"about_ca_system_score_gemma":0.0010673068,"threshold_uncertainty_score":0.005755663},"labels":[],"label_agreement":null},{"id":"W4367602020","doi":"10.1158/1078-0432.ccr-22-2595","title":"Maveropepimut-S, a DPX-Based Immune-Educating Therapy, Shows Promising and Durable Clinical Benefit in Patients with Recurrent Ovarian Cancer, a Phase II Trial","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Hospital; Université de Montréal; University of Calgary; MEG-3 (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Adverse effect; Internal medicine; Ovarian cancer; Clinical trial; Confidence interval; Phases of clinical research; Cyclophosphamide; Population; Progressive disease; Surgery; Cancer; Randomized controlled trial; Gastroenterology; Chemotherapy","score_opus":0.34198666322784144,"score_gpt":0.5729524062175213,"score_spread":0.23096574298967987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367602020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98889124,0.006476091,0.00038425135,0.00044851532,0.00007184675,0.0010219129,0.00057736784,0.00006804142,0.0020608814],"genre_scores_gemma":[0.9898878,0.003087001,0.0011493271,0.00056843157,0.00020702771,0.0011951141,0.0018561713,0.000015040408,0.002034132],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997377,0.00016219588,0.00001692336,0.000027410499,0.00002902551,0.000026741594],"domain_scores_gemma":[0.99949384,0.0001451132,0.0001415231,0.000036494832,0.000021473548,0.00016155357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001067285,0.0005286421,0.0006244271,0.00021937868,0.000174757,0.00037576747,0.00040770974,0.0005541204,0.0027259507],"category_scores_gemma":[0.000809455,0.00016054275,0.00046362865,0.00021768636,0.00031160444,0.00027439996,0.00016728419,0.0012498331,0.00035440357],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5603931,0.027140753,0.022084318,0.0020691855,0.0016359506,0.00043901324,0.00023517171,0.002255036,0.057127934,0.0004552063,0.0070314878,0.31913283],"study_design_scores_gemma":[0.57845485,0.3757523,0.02488583,0.00007785236,0.0006336663,0.0007264709,0.000035909605,0.0013834422,0.011518932,0.00016921658,0.0063411947,0.00002036618],"about_ca_topic_score_codex":0.0002517435,"about_ca_topic_score_gemma":0.00088523584,"teacher_disagreement_score":0.0027259507,"about_ca_system_score_codex":0.00029023777,"about_ca_system_score_gemma":0.00054238964,"threshold_uncertainty_score":0.009119213},"labels":[],"label_agreement":null},{"id":"W4367840089","doi":"10.1158/1078-0432.ccr-23-0252","title":"Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hearing, Cochlea, Tinnitus, Genetics","field":"Neuroscience","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Institute on Deafness and Other Communication Disorders; National Cancer Institute; National Institutes of Health; American Cancer Society","keywords":"Medicine; Acetylcysteine; Cisplatin; Adverse effect; Ototoxicity; Confidence interval; Internal medicine; Surgery; Chemotherapy; Antioxidant","score_opus":0.33838107767748327,"score_gpt":0.5554029596086443,"score_spread":0.217021881931161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367840089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897344,0.0039063473,0.0008153259,0.00033936178,0.00012858915,0.00366466,0.0006036687,0.000078732446,0.00072876364],"genre_scores_gemma":[0.98740226,0.0034220817,0.0022176383,0.000722551,0.00016721556,0.004377417,0.0007044148,0.000024580864,0.00096177746],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993266,0.0003836769,0.00004868164,0.00009974278,0.00006997512,0.00007131906],"domain_scores_gemma":[0.9988587,0.0002752411,0.00035859284,0.000111307294,0.00009041128,0.00030573524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015904193,0.0010196534,0.0020080092,0.00029743253,0.0003074035,0.00065443496,0.0007154653,0.00095616264,0.0020093531],"category_scores_gemma":[0.0015900567,0.00040075855,0.0011376922,0.0003851477,0.0010357916,0.0005985706,0.00025331887,0.0023230917,0.00033372678],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8974913,0.025142092,0.0067162625,0.0013227874,0.0019763135,0.00019046056,0.00016631336,0.0010769704,0.013913347,0.00023647545,0.0015168717,0.05025089],"study_design_scores_gemma":[0.7021806,0.28738624,0.005443559,0.00007167225,0.0005841181,0.00017389728,0.000032710213,0.0004856203,0.0020313112,0.00010121644,0.0014946003,0.000014399477],"about_ca_topic_score_codex":0.00081525295,"about_ca_topic_score_gemma":0.001943395,"teacher_disagreement_score":0.0020093531,"about_ca_system_score_codex":0.00092512526,"about_ca_system_score_gemma":0.002003958,"threshold_uncertainty_score":0.00841105},"labels":[],"label_agreement":null},{"id":"W4376132428","doi":"10.1158/1078-0432.ccr-23-0447","title":"Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"Janssen Pharmaceuticals; Genentech; Ipsen; Eisai; Daiichi-Sankyo; Revolution Medicines; National Institutes of Health; ECOG-ACRIN Cancer Research Group; Chugai Pharmaceutical; Seagen; Agios Pharmaceuticals; Parker Institute for Cancer Immunotherapy; Novocure; Pharmavite; American College of Radiology Imaging Network; Celgene; Eli Lilly and Company; AstraZeneca; National Cancer Institute; Amylin Pharmaceuticals; Pfizer; Array BioPharma; U.S. Department of Defense","keywords":"Medicine; Internal medicine; Colorectal cancer; Gastroenterology; Vitamin D and neurology; Proportional hazards model; Confidence interval; Oncology; Cancer","score_opus":0.33032852930551826,"score_gpt":0.5443492344998098,"score_spread":0.2140207051942915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376132428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99345374,0.003007587,0.00013438966,0.00043146536,0.000022707663,0.000086500455,0.0020541712,0.0000099057315,0.00079945545],"genre_scores_gemma":[0.9953875,0.0008916618,0.00032313846,0.0004813583,0.000037183698,0.0000509202,0.0025370542,0.0000041306785,0.00028716473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993876,0.00033038258,0.0000325408,0.0000810951,0.000128701,0.00003967789],"domain_scores_gemma":[0.99822444,0.000511689,0.0006320009,0.00018544999,0.00019279408,0.00025361477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029193438,0.0003293479,0.00042387767,0.00032428774,0.0002013264,0.00041208667,0.0003302604,0.00035197122,0.0011175281],"category_scores_gemma":[0.0024373343,0.00017329611,0.00042599888,0.0005138788,0.00032665278,0.00015879223,0.00035204372,0.0005992765,0.00015482226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041808125,0.0008290501,0.92554516,0.00034377936,0.0012180518,0.00009907221,0.00011786149,0.00039753344,0.004335703,0.0000531908,0.0033776148,0.02187482],"study_design_scores_gemma":[0.003769928,0.002520706,0.99024993,0.000038374095,0.0008251349,0.00016748061,0.00005659955,0.0003215148,0.00033025045,0.000037469898,0.0016738999,0.000008820101],"about_ca_topic_score_codex":0.010658121,"about_ca_topic_score_gemma":0.019408904,"teacher_disagreement_score":0.010658121,"about_ca_system_score_codex":0.0005725234,"about_ca_system_score_gemma":0.0011331064,"threshold_uncertainty_score":0.021192133},"labels":[],"label_agreement":null},{"id":"W4376640530","doi":"10.1158/1078-0432.ccr-23-0652","title":"An Attempt to Stretch the Benefit: Rechallenge with PARP Inhibitors in Ovarian Cancer","year":2023,"lang":"en","type":"editorial","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Olaparib; Ovarian cancer; Poly ADP ribose polymerase; Synthetic lethality; PARP inhibitor; Medicine; Homologous recombination; BRCA mutation; Cancer; Cancer research; Oncology; Internal medicine; Biology; DNA repair; Genetics; Gene; Polymerase","score_opus":0.29480428928941865,"score_gpt":0.5911166845717124,"score_spread":0.29631239528229375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376640530","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001366124,0.026333254,0.00033651502,0.07466358,0.89609885,0.000033980363,0.000049288647,0.00009417886,0.0022536719],"genre_scores_gemma":[0.0009709612,0.02116304,0.00020757341,0.07346301,0.89624196,0.00003481995,0.000039103565,0.00004429075,0.007835256],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980654,0.00039136922,0.00025770368,0.00022825795,0.00094022305,0.000117086944],"domain_scores_gemma":[0.9918902,0.00436084,0.00034033373,0.00018260673,0.0021247505,0.0011013382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057417527,0.002544162,0.0019876182,0.0013744837,0.0017717185,0.003600401,0.0027504433,0.012291578,0.005016707],"category_scores_gemma":[0.012553251,0.0007437277,0.0018921673,0.00070006103,0.0020083734,0.004190263,0.0010507996,0.026963338,0.00463718],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011630856,0.000029714183,0.000028946852,0.00030766177,0.000033124456,0.00017037654,0.000018008475,0.0000483824,0.0002090047,0.00083685917,0.9777711,0.020430565],"study_design_scores_gemma":[0.00018051028,0.00012630875,0.0002656925,0.00037717712,0.00008274174,0.00044833496,0.000033014177,0.0002008161,0.00026281955,0.0016325221,0.9963652,0.000024836707],"about_ca_topic_score_codex":0.0009815394,"about_ca_topic_score_gemma":0.0026893714,"teacher_disagreement_score":0.012291578,"about_ca_system_score_codex":0.0021564264,"about_ca_system_score_gemma":0.0014968421,"threshold_uncertainty_score":0.030365705},"labels":[],"label_agreement":null},{"id":"W4377940137","doi":"10.1158/1078-0432.ccr-23-0580","title":"The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Genentech; National Institutes of Health; Revolution Medicines; National Center for Advancing Translational Sciences; Seagen; Gilead Sciences; Sanofi; G1 Therapeutics; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca; American Association for Cancer Research","keywords":"Medicine; Oncology; KRAS; Internal medicine; Cohort; Cancer; Lung cancer; Response Evaluation Criteria in Solid Tumors; Docetaxel; Confidence interval; Ramucirumab; Nivolumab; ROS1; Immunotherapy; Clinical trial; Adenocarcinoma; Phases of clinical research; Colorectal cancer","score_opus":0.1501539766493789,"score_gpt":0.5403167405984413,"score_spread":0.39016276394906235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377940137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6924991,0.0011178701,0.0030085188,0.00070593436,0.000045403234,0.0006813572,0.2999884,0.00022092316,0.0017324687],"genre_scores_gemma":[0.5088998,0.0005664521,0.0076303524,0.00064808514,0.00008576466,0.0013903552,0.47969967,0.00009142016,0.0009879792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978265,0.0005504567,0.00018994088,0.0008681336,0.00044434858,0.00012044786],"domain_scores_gemma":[0.99397755,0.0012181782,0.0016222149,0.0017482184,0.0008824975,0.00055124226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032476825,0.0005107455,0.0007913856,0.0019565728,0.0006400107,0.0011588554,0.0014559557,0.0009224416,0.002142765],"category_scores_gemma":[0.007580674,0.00046761055,0.0005022426,0.0030454423,0.00042669388,0.00073236064,0.0013041085,0.00082752464,0.0010879983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015813141,0.00033241382,0.9452875,0.00028777623,0.00062824285,0.0007425871,0.0003620192,0.0028358472,0.0018237823,0.0005354294,0.02593237,0.01965075],"study_design_scores_gemma":[0.0006864849,0.00054274726,0.9485413,0.00017323006,0.00038777187,0.0026337,0.00048304137,0.0047358335,0.0012736261,0.00048294602,0.039963312,0.00009600985],"about_ca_topic_score_codex":0.03558503,"about_ca_topic_score_gemma":0.05023105,"teacher_disagreement_score":0.03558503,"about_ca_system_score_codex":0.0018244184,"about_ca_system_score_gemma":0.0027413436,"threshold_uncertainty_score":0.07075584},"labels":[],"label_agreement":null},{"id":"W4377940540","doi":"10.1158/1078-0432.ccr-22-3929","title":"Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre","funders":"National Cancer Institute; National Institutes of Health; Incyte","keywords":"Downregulation and upregulation; Myeloid leukemia; Myeloid; Cancer research; PIM1; Medicine; Kinase; Cancer; Biology; Phosphorylation; Internal medicine; Biochemistry; Gene","score_opus":0.14336709991185606,"score_gpt":0.4944972494709286,"score_spread":0.3511301495590725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377940540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99175996,0.0017446685,0.002246193,0.0002427786,0.000066355395,0.00015940315,0.00044813906,0.00017495579,0.0031576564],"genre_scores_gemma":[0.9951121,0.0007773871,0.0022674457,0.00007968331,0.000018162164,0.00007058951,0.00035479644,0.000014069019,0.0013057124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998816,0.000020755053,0.000008999131,0.000014294358,0.0000426109,0.00003186324],"domain_scores_gemma":[0.99993277,0.000016193486,0.000016616059,0.0000074651994,0.0000048655525,0.000022115051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002283453,0.00033012786,0.00033925893,0.0003480248,0.00015907428,0.00033181408,0.00019154578,0.00017519796,0.0014573594],"category_scores_gemma":[0.00014830426,0.00011476975,0.00019785775,0.00017924403,0.00021021995,0.00016693283,0.00018029496,0.00070974143,0.00043403596],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055664545,0.0004904726,0.0005080518,0.000077333185,0.000013889096,0.00008546284,0.00002306391,0.0004935499,0.98530316,0.00022769516,0.00038272317,0.011838066],"study_design_scores_gemma":[0.00017947023,0.0040308353,0.005503321,0.000010028715,0.000039131377,0.00042016467,0.00003131394,0.0030031982,0.9807401,0.00008472982,0.0059509166,0.0000067713913],"about_ca_topic_score_codex":0.0002565616,"about_ca_topic_score_gemma":0.000844648,"teacher_disagreement_score":0.0014573594,"about_ca_system_score_codex":0.0003381999,"about_ca_system_score_gemma":0.00026504754,"threshold_uncertainty_score":0.004875362},"labels":[],"label_agreement":null},{"id":"W4378746656","doi":"10.1158/1078-0432.ccr-22-3971","title":"The DRD2 Antagonist Haloperidol Mediates Autophagy-Induced Ferroptosis to Increase Temozolomide Sensitivity by Promoting Endoplasmic Reticulum Stress in Glioblastoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"Nanfang Hospital; Natural Science Foundation of Guangdong Province; National Natural Science Foundation of China","keywords":"Haloperidol; Autophagy; Endoplasmic reticulum; Temozolomide; Antagonist; Glioblastoma; Pharmacology; Medicine; Cancer research; Internal medicine; Chemistry; Biology; Receptor; Cell biology; Dopamine; Apoptosis","score_opus":0.09647110070336866,"score_gpt":0.45152724862333127,"score_spread":0.3550561479199626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378746656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950193,0.0026372324,0.0009976141,0.00013371275,0.00002288079,0.000029548786,0.0002689874,0.00006502541,0.0008257345],"genre_scores_gemma":[0.9960019,0.0014759345,0.0010453095,0.00008258184,0.000012888599,0.00004008728,0.0003041389,0.000009270587,0.0010279035],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999416,0.000011012376,0.000004949726,0.0000084163485,0.000016243743,0.000017711727],"domain_scores_gemma":[0.9999541,0.0000031115085,0.000013179876,0.000004001616,0.000006751868,0.000018807526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008769512,0.00030244442,0.00034557495,0.00016945922,0.00013462781,0.00012266137,0.00015580042,0.00015044355,0.0006873433],"category_scores_gemma":[0.00006086381,0.0000903648,0.00020741823,0.00009816547,0.0001444658,0.000094562296,0.00013434327,0.00030795,0.00023081944],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044105426,0.000051387837,0.00035412508,0.00006700569,0.000010873665,0.000083438055,0.000011713553,0.000062435625,0.9974618,0.00002874627,0.00010402678,0.0013234133],"study_design_scores_gemma":[0.000115011,0.0012094179,0.010401588,0.000010376817,0.000038390655,0.00043431245,0.000041857114,0.0009650807,0.98438996,0.00004004889,0.0023441957,0.0000096778385],"about_ca_topic_score_codex":0.00076849246,"about_ca_topic_score_gemma":0.0018610788,"teacher_disagreement_score":0.00076849246,"about_ca_system_score_codex":0.00029914282,"about_ca_system_score_gemma":0.0002943478,"threshold_uncertainty_score":0.0022993684},"labels":[],"label_agreement":null},{"id":"W4379535356","doi":"10.1158/1078-0432.ccr-22-3897","title":"A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; iCo Therapeutics (Canada); University of British Columbia","funders":"Mitacs; National Research Council Canada; St. Baldrick's Foundation","keywords":"Olaparib; PARP inhibitor; PARP1; Cancer research; DNA damage; Vorinostat; Biology; Comet assay; Ex vivo; Histone deacetylase; Poly ADP ribose polymerase; Molecular biology; In vivo; Biochemistry; Histone; DNA","score_opus":0.4469852012513099,"score_gpt":0.5868546534968304,"score_spread":0.1398694522455205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379535356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95881134,0.018982004,0.012895344,0.0003253924,0.00008894325,0.00020858884,0.0014951417,0.0002733512,0.006919939],"genre_scores_gemma":[0.9864652,0.004071117,0.005819314,0.000077343946,0.000012744002,0.000060528168,0.0010960634,0.00001480658,0.0023830093],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990356,0.000013826361,0.000009721698,0.000027854525,0.000030467016,0.000014485094],"domain_scores_gemma":[0.99995995,0.000004198468,0.000013857054,0.000006340036,0.0000058826017,0.000009898298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015083094,0.00036178002,0.0002312801,0.00018306855,0.00009426375,0.00018937654,0.00026902376,0.00027137317,0.0011236425],"category_scores_gemma":[0.00008932923,0.00010395112,0.00020134676,0.00020139187,0.0001540164,0.00025275722,0.00016790135,0.00048814437,0.00042208342],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015396162,0.000059879716,0.00020147134,0.00012711364,0.0000116463125,0.00008328298,0.000009903752,0.000264421,0.99063,0.00021539138,0.00017122735,0.008071687],"study_design_scores_gemma":[0.00008353577,0.0010776412,0.0017086058,0.000011940736,0.000035133286,0.0009186745,0.00001035796,0.0012157827,0.98844904,0.00004127079,0.0064422362,0.000005821965],"about_ca_topic_score_codex":0.00038888492,"about_ca_topic_score_gemma":0.0006472079,"teacher_disagreement_score":0.0011236425,"about_ca_system_score_codex":0.00035755374,"about_ca_system_score_gemma":0.00015543716,"threshold_uncertainty_score":0.003758967},"labels":[],"label_agreement":null},{"id":"W4380992939","doi":"10.1158/1078-0432.ccr-23-0797","title":"Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"Eisai; Seagen; Ontario Institute for Cancer Research; Novocure; Regeneron Pharmaceuticals; Princess Margaret Cancer Foundation; Genentech; PharmaMar; AstraZeneca","keywords":"Olaparib; PARP inhibitor; Ovarian cancer; Cancer research; Cancer; Medicine; Oncology; DNA; Pharmacology; Internal medicine; Poly ADP ribose polymerase; Biology; Genetics; Polymerase","score_opus":0.2764266495127368,"score_gpt":0.565274280103611,"score_spread":0.2888476305908742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380992939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992926,0.00025774955,0.00011061834,0.000033711854,0.0000038589455,0.00005061034,0.00008887873,0.0000067827436,0.00015523953],"genre_scores_gemma":[0.9987249,0.00009726666,0.00045395363,0.0000943652,0.000011238803,0.000049113285,0.00036843272,0.0000036001043,0.00019732834],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99978274,0.00007862538,0.000010636639,0.000058806138,0.000041553314,0.000027579],"domain_scores_gemma":[0.99953735,0.00012968594,0.00013375604,0.000037980364,0.00003480159,0.00012637358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070760556,0.00029603246,0.0004648702,0.00019788172,0.00019583036,0.00044826584,0.00018893431,0.0003346252,0.00083415495],"category_scores_gemma":[0.00099054,0.00021588478,0.00019038554,0.00014771053,0.0003189119,0.00028944138,0.00015457725,0.000645084,0.00014217621],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13515508,0.00589615,0.4607495,0.00029017878,0.0006471588,0.0004891962,0.0005107695,0.0030518484,0.23849992,0.0001733722,0.0011151136,0.15342179],"study_design_scores_gemma":[0.030340223,0.17272264,0.71302074,0.000037445232,0.00088526343,0.0019860878,0.0002601429,0.008028952,0.06766845,0.00029251355,0.004722463,0.00003503569],"about_ca_topic_score_codex":0.00050521764,"about_ca_topic_score_gemma":0.0012985318,"teacher_disagreement_score":0.00083415495,"about_ca_system_score_codex":0.0004586424,"about_ca_system_score_gemma":0.0005546504,"threshold_uncertainty_score":0.0037422776},"labels":[],"label_agreement":null},{"id":"W4381434619","doi":"10.1158/1078-0432.ccr-22-3815","title":"The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Occupational Cancer Research Centre; Vancouver General Hospital; University of British Columbia","funders":"U.S. Army Medical Research and Development Command; National Cancer Institute; AstraZeneca; Novocure; National Health and Medical Research Council; Canadian Institutes of Health Research; National Institutes of Health; Janet D. Cottrelle Foundation; Medical Research Council; PharmaMar; Medical Research and Materiel Command; Eisai; European Commission; BC Cancer Foundation; Seagen; Deutsche Forschungsgemeinschaft; VGH and UBC Hospital Foundation; Marshfield Clinic Research Foundation; Amgen; Mersana Therapeutics; Stryker; Victorian Cancer Agency; Michael Smith Health Research BC; Memorial Sloan-Kettering Cancer Center","keywords":"Immune system; Serous fluid; Biology; Serous carcinoma; Clear cell; Carcinoma; Clear cell carcinoma; Ovarian carcinoma; Pathology; Cancer research; Immunohistochemistry; Ovarian cancer; Immunology; Medicine; Cancer","score_opus":0.10071752740082382,"score_gpt":0.4737054319116363,"score_spread":0.37298790451081243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381434619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992085,0.00050816406,0.00008444709,0.000007131012,0.0000013404474,0.0000032468156,0.000035567104,0.0000023276175,0.00014927627],"genre_scores_gemma":[0.99969983,0.00009935967,0.00007973448,0.0000039878378,0.0000026308076,0.0000029561083,0.00006017796,0.0000011154455,0.000050346545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997664,0.00007100386,0.000025184325,0.00005131075,0.00004454415,0.000041580144],"domain_scores_gemma":[0.99917346,0.00026252706,0.00028158433,0.000084478765,0.00008708123,0.00011087541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007161819,0.00016991355,0.00025567834,0.0005975748,0.00018404797,0.00034774488,0.00020950082,0.00022665555,0.00069602265],"category_scores_gemma":[0.0014019995,0.00012525913,0.00024155706,0.00033298437,0.00026581154,0.00027623322,0.00041038173,0.00019019232,0.00012801721],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006725276,0.000011244398,0.99132216,0.000016142132,0.000029468232,0.0000924338,0.00004176191,0.00006426254,0.003863392,0.000012143909,0.00002163854,0.003852858],"study_design_scores_gemma":[0.0000066930534,0.00012172624,0.9981838,0.000006349947,0.000028014552,0.00049956207,0.00010127633,0.0002482921,0.00063887186,0.000033234173,0.00012974816,0.0000024022877],"about_ca_topic_score_codex":0.00057367235,"about_ca_topic_score_gemma":0.0010836734,"teacher_disagreement_score":0.0007161819,"about_ca_system_score_codex":0.00020398751,"about_ca_system_score_gemma":0.000107842665,"threshold_uncertainty_score":0.0037875772},"labels":[],"label_agreement":null},{"id":"W4381597538","doi":"10.1158/1078-0432.ccr-23-0563","title":"Assessment of Homologous Recombination Deficiency in Ovarian Cancer","year":2023,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Princess Margaret Cancer Foundation","keywords":"Ovarian cancer; Homologous recombination; Homologous chromosome; Biomarker; Chemotherapy; Medicine; Cancer; Oncology; Cancer research; Internal medicine; Biology; Genetics; DNA; Gene","score_opus":0.42896126329092593,"score_gpt":0.6229724124775339,"score_spread":0.19401114918660795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381597538","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009675667,0.04472753,0.0018454873,0.8991872,0.02517044,0.00015183198,0.00021672361,0.00016389717,0.018861283],"genre_scores_gemma":[0.13479884,0.047069747,0.003382258,0.69334674,0.10487713,0.00022883482,0.0003466994,0.00006680089,0.015883004],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986595,0.0004647961,0.00020065217,0.00010792914,0.00046606778,0.00010110442],"domain_scores_gemma":[0.99713,0.0015957515,0.00020716766,0.00014316922,0.0006955995,0.00022834672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019209179,0.00035672143,0.00080018,0.0006916361,0.00071557093,0.00095263135,0.00063730904,0.006973394,0.0012986839],"category_scores_gemma":[0.010693591,0.0002638192,0.00045484048,0.00053405436,0.0011149399,0.00093312387,0.0004330321,0.0068649193,0.0024638297],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004156151,0.000115048606,0.015578641,0.00039733297,0.000034723435,0.024828594,0.00016439846,0.0002489804,0.0034794726,0.0035061154,0.7874239,0.16380717],"study_design_scores_gemma":[0.00033000342,0.0008045587,0.025276013,0.0013254669,0.00010963514,0.123081625,0.0003955357,0.002897793,0.0041056075,0.021749916,0.81984705,0.00007680683],"about_ca_topic_score_codex":0.0018764953,"about_ca_topic_score_gemma":0.0033320056,"teacher_disagreement_score":0.006973394,"about_ca_system_score_codex":0.0020094411,"about_ca_system_score_gemma":0.00090212736,"threshold_uncertainty_score":0.0145795345},"labels":[],"label_agreement":null},{"id":"W4382138807","doi":"10.1158/1078-0432.ccr-22-3915","title":"Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency; University of British Columbia Hospital; McGill University Health Centre","funders":"Eisai; AstraZeneca","keywords":"Endometrial cancer; Microsatellite instability; Medicine; Internal medicine; Interim analysis; Biomarker; Cancer; Interim; Oncology; Clinical trial; Microsatellite; Biology; Gene","score_opus":0.39387890691050975,"score_gpt":0.5904624695724283,"score_spread":0.19658356266191856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382138807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903589,0.005907034,0.00045351073,0.00029780305,0.00005254441,0.00050771784,0.0009163659,0.000071016206,0.0014350925],"genre_scores_gemma":[0.99150014,0.0013983797,0.0015606572,0.0004945402,0.000102088205,0.0006376477,0.0031415932,0.000023031032,0.001141843],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994066,0.0003931863,0.00002739682,0.000048274702,0.00006990348,0.00005466751],"domain_scores_gemma":[0.99915814,0.00019428993,0.00030016032,0.00009327549,0.000066491775,0.00018767026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024135893,0.00078950473,0.0011611765,0.00023191494,0.00019482986,0.0005746024,0.0003615663,0.0004826836,0.0013148184],"category_scores_gemma":[0.0012381832,0.00024513004,0.00083360163,0.00020334902,0.0003284424,0.00041324476,0.00023268063,0.000900778,0.00030238242],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5643908,0.013532539,0.093127586,0.0014408834,0.003422726,0.00040992352,0.00038368517,0.0045058816,0.061441187,0.0003122188,0.006991923,0.25004068],"study_design_scores_gemma":[0.2049634,0.5319055,0.21061125,0.00016557753,0.0038843765,0.0015616649,0.0001396204,0.0034125643,0.026479967,0.00046158608,0.01633752,0.00007700511],"about_ca_topic_score_codex":0.0001934447,"about_ca_topic_score_gemma":0.0005892074,"teacher_disagreement_score":0.0024135893,"about_ca_system_score_codex":0.00046556088,"about_ca_system_score_gemma":0.00066061685,"threshold_uncertainty_score":0.012764394},"labels":[],"label_agreement":null},{"id":"W4382363527","doi":"10.1158/1078-0432.ccr-22-3146","title":"Early Clearance of Plasma <i>Epidermal Growth Factor Receptor</i> Mutations as a Predictor of Outcome on Osimertinib in Advanced Non–Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Osimertinib; Lung cancer; Erlotinib; Medicine; T790M; Gefitinib; Internal medicine; Oncology; Epidermal growth factor receptor; Tyrosine-kinase inhibitor; Confidence interval; Genotyping; Cancer; Genotype; Biology","score_opus":0.1159411974898816,"score_gpt":0.4822468623266429,"score_spread":0.3663056648367613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382363527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991704,0.00029958689,0.00008269576,0.000018818559,0.0000034784084,0.00001970724,0.00020406449,0.0000034815746,0.00019767352],"genre_scores_gemma":[0.99954057,0.000036064597,0.000058762864,0.00001564017,0.000007883264,0.000013111692,0.0002498171,0.0000012533039,0.00007695864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99939775,0.00023206926,0.000041640986,0.00014978487,0.000110056884,0.00006865006],"domain_scores_gemma":[0.9982882,0.00055467687,0.00057623367,0.00013652605,0.0001107777,0.00033349305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017934573,0.0003535975,0.0005062454,0.00027203734,0.00021979907,0.0006519995,0.0003329758,0.0003735787,0.0010403462],"category_scores_gemma":[0.0016613022,0.00015989013,0.0011270746,0.0002921099,0.00030171117,0.00033199918,0.000345908,0.0007087154,0.00019063696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038811725,0.00047806383,0.9414588,0.00010417092,0.0012501673,0.00016416794,0.000112888876,0.0004985477,0.0053191558,0.00005636673,0.00032525812,0.011420744],"study_design_scores_gemma":[0.0011171594,0.00890351,0.9832312,0.000022850245,0.0010858551,0.0008881257,0.00009633128,0.001780741,0.0020113357,0.00011976657,0.0007249884,0.000018193652],"about_ca_topic_score_codex":0.0006399793,"about_ca_topic_score_gemma":0.0009564465,"teacher_disagreement_score":0.0017934573,"about_ca_system_score_codex":0.0004847569,"about_ca_system_score_gemma":0.00040640376,"threshold_uncertainty_score":0.0094848275},"labels":[],"label_agreement":null},{"id":"W4384120297","doi":"10.1158/1078-0432.ccr-22-3273","title":"Dual Role of CXCL8 in Maintaining the Mesenchymal State of Glioblastoma Stem Cells and M2-Like Tumor-Associated Macrophages","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Microsemi (Canada)","funders":"National Natural Science Foundation of China","keywords":"Mesenchymal stem cell; Cancer research; Paracrine signalling; Biology; Tumor microenvironment; PI3K/AKT/mTOR pathway; Tumor progression; Reprogramming; Stem cell; STAT3; Signal transduction; Cell; Cell biology; Cancer; Receptor; Genetics; Tumor cells","score_opus":0.0687867065602474,"score_gpt":0.409275471952482,"score_spread":0.3404887653922346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384120297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99516463,0.0015144657,0.0019098922,0.000115473464,0.000015491592,0.000031332696,0.00030127147,0.00007044736,0.0008769933],"genre_scores_gemma":[0.9968041,0.00048556976,0.0014843083,0.000051586518,0.0000082813685,0.000031774896,0.00020771472,0.0000071708573,0.00091947656],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999033,0.000015496664,0.000007886306,0.00001812974,0.000022533473,0.000032605847],"domain_scores_gemma":[0.99993074,0.0000041420712,0.00002443644,0.0000046236933,0.000011912722,0.000024190937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012587421,0.0002649106,0.0001467441,0.00024620304,0.0001516427,0.00022071134,0.000094840165,0.000115988005,0.0008806834],"category_scores_gemma":[0.000059000504,0.00004839163,0.00013684557,0.00012932501,0.00021389367,0.0001537888,0.00017562481,0.00030260507,0.00013541874],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023200177,0.00003571375,0.003695066,0.00012666105,0.000007108135,0.000086294145,0.000039465376,0.00011508646,0.9902388,0.00022288231,0.00010118843,0.005099748],"study_design_scores_gemma":[0.000052226937,0.00055177533,0.035643425,0.00002905797,0.000046534606,0.0006042778,0.00017842688,0.0021844406,0.9547026,0.00019625048,0.0058020554,0.000008974806],"about_ca_topic_score_codex":0.00037779167,"about_ca_topic_score_gemma":0.0007314842,"teacher_disagreement_score":0.0008806834,"about_ca_system_score_codex":0.00025040534,"about_ca_system_score_gemma":0.0003362021,"threshold_uncertainty_score":0.002946198},"labels":[],"label_agreement":null},{"id":"W4384126750","doi":"10.1158/1078-0432.ccr-23-0731","title":"Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; London Health Sciences Centre; Western University; Sinai Health System; Princess Margaret Cancer Centre","funders":"","keywords":"Cabazitaxel; Medicine; Prostate cancer; Abiraterone acetate; Prostatectomy; Urology; Neoadjuvant therapy; Interquartile range; Internal medicine; Taxane; Cancer; Oncology; Surgery; Androgen deprivation therapy","score_opus":0.14416452154978565,"score_gpt":0.49555460349638536,"score_spread":0.3513900819465997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384126750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892814,0.004803913,0.00041315216,0.000575134,0.0001378089,0.0025256362,0.000659065,0.000067985755,0.001535862],"genre_scores_gemma":[0.9902092,0.0024566036,0.0016860327,0.00077455904,0.0002597711,0.0021789079,0.0010863798,0.000012767749,0.0013355984],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993857,0.00039507318,0.000036877354,0.000076226715,0.000051067964,0.000054944794],"domain_scores_gemma":[0.99911016,0.00017257426,0.00024355584,0.000066931505,0.000057449233,0.00034934707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021523794,0.0012408934,0.001467701,0.00025336692,0.00026273634,0.0010046221,0.00080827647,0.00082752696,0.0028574306],"category_scores_gemma":[0.0010797991,0.00040814932,0.0009155331,0.00036897673,0.0008134763,0.00041553972,0.00027338183,0.0021207267,0.00059275294],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92476064,0.016175376,0.004960008,0.00084235094,0.0009900623,0.000081718856,0.000095561074,0.0011471699,0.009501951,0.00012905846,0.001402243,0.03991383],"study_design_scores_gemma":[0.8878202,0.10442751,0.004484744,0.000055435987,0.000468872,0.00013676436,0.000024839319,0.0005217799,0.0009966329,0.00007062399,0.0009795108,0.000013113517],"about_ca_topic_score_codex":0.0010925647,"about_ca_topic_score_gemma":0.0037747035,"teacher_disagreement_score":0.0028574306,"about_ca_system_score_codex":0.0007499351,"about_ca_system_score_gemma":0.0023445229,"threshold_uncertainty_score":0.011383057},"labels":[],"label_agreement":null},{"id":"W4384338565","doi":"10.1158/1078-0432.ccr-22-3645","title":"Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Stand Up To Cancer; Kom op tegen Kanker; KWF Kankerbestrijding; H2020 European Research Council; Genentech; Fonds Wetenschappelijk Onderzoek; European Commission","keywords":"Breast cancer; CD8; Involution (esoterism); Medicine; Lactation; Breastfeeding; Mammary gland; Metastasis; Oncology; Immunohistochemistry; Internal medicine; Cancer; Pathology; Immune system; Immunology; Pregnancy; Biology","score_opus":0.1374312629244737,"score_gpt":0.4961736187855473,"score_spread":0.3587423558610736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384338565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99904543,0.00034054022,0.0001421317,0.000030675903,0.0000037225843,0.000005182303,0.0001674155,0.000004152985,0.00026080885],"genre_scores_gemma":[0.9992747,0.00019630181,0.00012492039,0.000020702773,0.000007866058,0.0000100352945,0.00029104197,0.0000017365358,0.00007269009],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989104,0.000020307854,0.000011337938,0.000026566022,0.000018540519,0.000032164942],"domain_scores_gemma":[0.99968004,0.000063823245,0.00016115891,0.000016915641,0.000023113707,0.00005495102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016957043,0.00017367309,0.00024149123,0.0003917496,0.00024999052,0.0003440503,0.00014356893,0.00020262999,0.00091193005],"category_scores_gemma":[0.00072590413,0.00008861182,0.00015053409,0.0004623809,0.0001585556,0.00017232442,0.00031891977,0.00023801236,0.00016528972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006418706,0.000033123117,0.9858795,0.000036264457,0.000026331301,0.0005015042,0.00008380465,0.000049099046,0.0063937493,0.000023761548,0.00011586944,0.006215219],"study_design_scores_gemma":[0.000006078035,0.0001332515,0.9970983,0.00000858744,0.00002575737,0.0015974329,0.00020789,0.00013765441,0.0005112455,0.000060481616,0.00021012001,0.0000031230788],"about_ca_topic_score_codex":0.00039341502,"about_ca_topic_score_gemma":0.00046124237,"teacher_disagreement_score":0.00091193005,"about_ca_system_score_codex":0.00014066482,"about_ca_system_score_gemma":0.00015671957,"threshold_uncertainty_score":0.003050685},"labels":[],"label_agreement":null},{"id":"W4384664196","doi":"10.1158/1078-0432.ccr-22-3493","title":"Learning Individual Survival Models from PanCancer Whole Transcriptome Data","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Alberta Health; University of Alberta; Northern Alberta Institute of Technology","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institute for Advanced Research","keywords":"Non-negative matrix factorization; Computer science; Probabilistic logic; Survival analysis; Cancer; Artificial intelligence; Logistic regression; Concordance; Machine learning; Matrix decomposition; Medicine; Internal medicine","score_opus":0.6870446561583559,"score_gpt":0.5744614016642153,"score_spread":0.11258325449414053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384664196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6842189,0.0008010707,0.30648705,0.0010345287,0.000056414385,0.000114643655,0.0040200944,0.0018195155,0.0014477887],"genre_scores_gemma":[0.93930113,0.0002181569,0.05106863,0.000207464,0.00004350561,0.00016563534,0.0067850607,0.000093671115,0.002116712],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99947304,0.00016383438,0.000022287348,0.00023043616,0.00006776167,0.00004263323],"domain_scores_gemma":[0.9982509,0.0010923239,0.00021606492,0.00017778779,0.00018908092,0.000073706346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023273206,0.0008360374,0.00058836926,0.0005421325,0.00026562507,0.0005185824,0.00068775774,0.00067270594,0.0010217611],"category_scores_gemma":[0.004440925,0.00025430354,0.0011811976,0.0004067264,0.0004206899,0.0006783563,0.0006227523,0.0014870812,0.00050897745],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055662706,0.00018599785,0.06234503,0.00011982211,0.00025328004,0.00015011326,0.00016647397,0.84303075,0.0057681357,0.00171906,0.0032500238,0.08245468],"study_design_scores_gemma":[0.000012299094,0.00006900361,0.005865601,0.000009108298,0.00002187922,0.00005486897,0.000022384509,0.98817307,0.0019764279,0.0032165155,0.00056493,0.0000138605255],"about_ca_topic_score_codex":0.0050364025,"about_ca_topic_score_gemma":0.0065095746,"teacher_disagreement_score":0.0050364025,"about_ca_system_score_codex":0.001098752,"about_ca_system_score_gemma":0.00072721933,"threshold_uncertainty_score":0.01230818},"labels":[],"label_agreement":null},{"id":"W4384923460","doi":"10.1158/1078-0432.ccr-23-0757","title":"Molecular Residual Disease in Breast Cancer: Detection and Therapeutic Interception","year":2023,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Breast cancer; Oncology; Disease; Clinical trial; Internal medicine; Minimal residual disease; Cancer; Immunotherapy; Leukemia","score_opus":0.20596612864847821,"score_gpt":0.5311124960904527,"score_spread":0.32514636744197456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384923460","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000049495724,0.9989397,0.00006730718,0.00021639782,0.00013746125,0.000003640747,0.000012940578,0.0000049164314,0.0005681422],"genre_scores_gemma":[0.00030036602,0.9990251,0.00009489631,0.00016565988,0.000104147904,0.0000051837696,0.000020650481,0.0000011163373,0.00028281703],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999752,0.000053631436,0.00003103023,0.00003920214,0.00010135189,0.000022874323],"domain_scores_gemma":[0.99962986,0.00020830178,0.000039931358,0.000012198602,0.00008277047,0.000026918166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007169812,0.00079687877,0.0014811122,0.0024022427,0.00023613602,0.0009559018,0.001036259,0.001135165,0.0031248338],"category_scores_gemma":[0.0009110833,0.00029749237,0.0005743612,0.0019408772,0.0005266372,0.001338755,0.00067989377,0.0021165502,0.0022710012],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000078630066,0.00006161875,0.00012565301,0.017884212,0.00007536064,0.00012898324,0.000041750754,0.00032091423,0.0010581998,0.0035947682,0.029168092,0.9474618],"study_design_scores_gemma":[0.000021647695,0.00010680478,0.00061309984,0.005104838,0.00009565074,0.0011453377,0.00004139946,0.00007580826,0.00031585118,0.0022538612,0.99020875,0.000016949165],"about_ca_topic_score_codex":0.00082732906,"about_ca_topic_score_gemma":0.0015569112,"teacher_disagreement_score":0.0031248338,"about_ca_system_score_codex":0.0007154346,"about_ca_system_score_gemma":0.0009659933,"threshold_uncertainty_score":0.010453582},"labels":[],"label_agreement":null},{"id":"W4384926137","doi":"10.1158/1078-0432.ccr-23-1044","title":"A Phase II Study of Optimized Individualized Adaptive Radiotherapy for Hepatocellular Carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institutes of Health; Varian Medical Systems; AstraZeneca; National Cancer Institute; Foundation for the National Institutes of Health","keywords":"Medicine; Toxicity; Confidence interval; Hepatocellular carcinoma; Liver function; Cumulative incidence; Internal medicine; Liver cancer; Phases of clinical research; Radiation therapy; Nuclear medicine; Urology; Oncology; Gastroenterology; Cohort","score_opus":0.522405078117951,"score_gpt":0.5322347014615424,"score_spread":0.009829623343591387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384926137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978823,0.00015846388,0.00085997017,0.000045509776,0.000009468643,0.0007451036,0.000058722468,0.000023244716,0.00021704998],"genre_scores_gemma":[0.9953667,0.00016570506,0.0025896728,0.000097790886,0.000020954565,0.0011725829,0.00022252847,0.00001035318,0.00035374693],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994654,0.0003219063,0.000020772468,0.00007447951,0.00006616591,0.000051321433],"domain_scores_gemma":[0.9995584,0.000079667785,0.00014222623,0.000071891736,0.00003137846,0.00011646878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016193712,0.000968403,0.00093898835,0.00030516676,0.00018776949,0.0004200295,0.00056310155,0.00043162264,0.0010708516],"category_scores_gemma":[0.0008015343,0.00029224728,0.0005309066,0.00031887388,0.00073952647,0.00035752167,0.00031738685,0.0010056697,0.00020961631],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50351024,0.14359516,0.044590037,0.00077385193,0.0022546626,0.0002985765,0.00045215763,0.038453408,0.1088778,0.00083365495,0.0013562433,0.15500422],"study_design_scores_gemma":[0.22840041,0.7123741,0.030208563,0.000021595539,0.0005238591,0.0003146248,0.00010043075,0.01267923,0.013494621,0.0004158965,0.0014297542,0.00003696093],"about_ca_topic_score_codex":0.0009549414,"about_ca_topic_score_gemma":0.001385092,"teacher_disagreement_score":0.0016193712,"about_ca_system_score_codex":0.00076818786,"about_ca_system_score_gemma":0.0016243082,"threshold_uncertainty_score":0.008564115},"labels":[],"label_agreement":null},{"id":"W4385264542","doi":"10.1158/1078-0432.ccr-23-0092","title":"Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pharmacodynamics; Pharmacokinetics; Dosing; Toxicity; Internal medicine; Refractory (planetary science); Oncology; Pharmacology; Gastroenterology","score_opus":0.1257635174782911,"score_gpt":0.530262130136968,"score_spread":0.4044986126586769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385264542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99523526,0.0017232237,0.00073417526,0.00016674699,0.00005210515,0.00087731745,0.0003917708,0.000071885086,0.0007475886],"genre_scores_gemma":[0.990207,0.0020899011,0.0027858668,0.00032419147,0.00011208085,0.00090496696,0.0017788352,0.00003202894,0.001765057],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99969816,0.00012907672,0.000016951151,0.000054313256,0.0000500782,0.000051486695],"domain_scores_gemma":[0.9996666,0.000040220202,0.000096833246,0.000031716972,0.000032506516,0.00013208062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010940686,0.0012251128,0.0016355383,0.0002837627,0.00037024962,0.00058418565,0.0007337707,0.0006948559,0.0020269328],"category_scores_gemma":[0.00038530325,0.0004228542,0.0006225316,0.0002935077,0.0005767104,0.00050687674,0.00025061818,0.0019891027,0.0006252185],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18431245,0.080389895,0.016105676,0.0017696407,0.001159228,0.00081032875,0.00050226535,0.00783883,0.51589125,0.00042213703,0.0052252593,0.18557307],"study_design_scores_gemma":[0.19555575,0.71357924,0.02518445,0.000066188775,0.0005432365,0.0016414174,0.00008600547,0.0031395492,0.053283814,0.00019067178,0.0066821435,0.00004757353],"about_ca_topic_score_codex":0.0006237077,"about_ca_topic_score_gemma":0.0018938647,"teacher_disagreement_score":0.0020269328,"about_ca_system_score_codex":0.0005561517,"about_ca_system_score_gemma":0.0011207589,"threshold_uncertainty_score":0.006780803},"labels":[],"label_agreement":null},{"id":"W4385294482","doi":"10.1158/1078-0432.ccr-23-0348","title":"A Pilot Study Omitting Radiation in the Treatment of Children with Newly Diagnosed Wnt-Activated Medulloblastoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Matthew Larson Foundation for Pediatric Brain Tumors","keywords":"Medicine; Medulloblastoma; Radiation therapy; Chemotherapy; Clinical endpoint; Surgery; Pediatrics; Randomized controlled trial; Pathology","score_opus":0.22181997310335447,"score_gpt":0.5000883141730914,"score_spread":0.27826834106973697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385294482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982002,0.0007360332,0.0001664442,0.00007739798,0.000023912744,0.00041889542,0.00013205675,0.000016568092,0.00022851923],"genre_scores_gemma":[0.9959221,0.0011773411,0.001135547,0.00012257013,0.00008681359,0.0008402374,0.000390552,0.000009912953,0.00031501],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993311,0.00038144004,0.00005845546,0.00009723664,0.000049581082,0.00008223408],"domain_scores_gemma":[0.99878234,0.00041814518,0.0002516802,0.00013168067,0.00007205535,0.00034413367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010354602,0.0007548245,0.0011751625,0.00026596693,0.00040168068,0.00036052646,0.0007219697,0.00064596225,0.0017979445],"category_scores_gemma":[0.0012889458,0.00025620885,0.0010101045,0.00034874718,0.0007561053,0.00046291013,0.0003409565,0.0015633875,0.00023258812],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5915327,0.115646325,0.056442685,0.0018199334,0.0017937175,0.0014141123,0.0011015272,0.002153809,0.040892117,0.00032512457,0.0010589616,0.18581893],"study_design_scores_gemma":[0.061517343,0.89428794,0.036390863,0.00005805821,0.0005512138,0.0006074025,0.00012801483,0.0003136057,0.0037809496,0.000050214345,0.0022999519,0.000014375035],"about_ca_topic_score_codex":0.0017956729,"about_ca_topic_score_gemma":0.003983891,"teacher_disagreement_score":0.0017979445,"about_ca_system_score_codex":0.0007223805,"about_ca_system_score_gemma":0.0015163602,"threshold_uncertainty_score":0.0060147047},"labels":[],"label_agreement":null},{"id":"W4385294836","doi":"10.1158/1078-0432.ccr-23-0538","title":"Integrated Genomic and Transcriptomic Analysis Improves Disease Classification and Risk Stratification of MDS with Ring Sideroblasts","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Uppsala Multidisciplinary Center for Advanced Computational Science; National Cancer Institute; Radiumhemmets Forskningsfonder; Vetenskapsrådet; Karolinska Institutet; Associazione Italiana per la Ricerca sul Cancro; Cancerfonden; Knut och Alice Wallenbergs Stiftelse; Science for Life Laboratory; Fondazione AIRC per la ricerca sul cancro ETS","keywords":"Transcriptome; Myelodysplastic syndromes; Biology; Myeloid; Genetics; NPM1; Computational biology; Cancer research; Bioinformatics; Gene; Oncology; Bone marrow; Medicine; Immunology; Gene expression; Karyotype; Chromosome","score_opus":0.16458143430260408,"score_gpt":0.4683414891179336,"score_spread":0.3037600548153295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385294836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960069,0.0003935119,0.002302236,0.000065687535,0.0000049281953,0.000013439744,0.000877362,0.000046233792,0.0002897054],"genre_scores_gemma":[0.996012,0.00012405345,0.0020932176,0.000033006254,0.000012029483,0.000011748378,0.0015387001,0.000009787832,0.00016554403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997663,0.000053471023,0.000023979515,0.00008621153,0.0000424602,0.000027613996],"domain_scores_gemma":[0.99967146,0.000068700305,0.00013213063,0.000036300637,0.00004383246,0.000047505964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049035094,0.00040043352,0.0004104154,0.0010028674,0.00018048588,0.00046734096,0.00017911437,0.00022107571,0.0010556882],"category_scores_gemma":[0.0007988578,0.00011162318,0.0003395877,0.0006173636,0.00014858154,0.0001975373,0.00043704684,0.00027178018,0.00024929622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001176157,0.00011909999,0.85403234,0.0000879359,0.0002589539,0.000119505596,0.00010724965,0.0017482615,0.109106645,0.0001010533,0.00036397218,0.03277886],"study_design_scores_gemma":[0.000019253826,0.00028578198,0.9785421,0.000022909426,0.00021119519,0.00042805853,0.00013598126,0.009456315,0.00991432,0.00037543965,0.0005978373,0.000010774616],"about_ca_topic_score_codex":0.00050149637,"about_ca_topic_score_gemma":0.0009044041,"teacher_disagreement_score":0.0010556882,"about_ca_system_score_codex":0.00016486505,"about_ca_system_score_gemma":0.0001837639,"threshold_uncertainty_score":0.0035316348},"labels":[],"label_agreement":null},{"id":"W4385442241","doi":"10.1158/1078-0432.ccr-23-0887","title":"hENT1 as a Predictive Biomarker in PDAC—Response","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Biomarker; Medicine; Oncology; FOLFIRINOX; Population; Biomarker discovery; Internal medicine; Computational biology; Bioinformatics; Biology; Cancer; Gene; Genetics; Colorectal cancer","score_opus":0.4565912749497369,"score_gpt":0.650337593659994,"score_spread":0.1937463187102571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385442241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43518373,0.14944752,0.02740858,0.3069192,0.025122078,0.0010252949,0.0100638205,0.0016653539,0.04316442],"genre_scores_gemma":[0.9131238,0.01178195,0.014522593,0.03496117,0.009948077,0.000490597,0.004352065,0.00039156573,0.010428209],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99785066,0.0007847452,0.00019675777,0.00040613368,0.0006109331,0.00015081353],"domain_scores_gemma":[0.9929155,0.0033134683,0.0006401231,0.00051701226,0.0018387277,0.00077524927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072872974,0.00042951485,0.0010387419,0.0007138984,0.0004220989,0.0020433704,0.0008734642,0.0011906271,0.0035598492],"category_scores_gemma":[0.010827618,0.0002037226,0.00084709097,0.0008188796,0.0005597526,0.0011687975,0.0005194635,0.0034243735,0.0015196444],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025746813,0.000463169,0.19719906,0.001984802,0.0011179307,0.002122089,0.00058555574,0.004756639,0.038082026,0.0033514886,0.25558588,0.46900457],"study_design_scores_gemma":[0.0021280402,0.0075457953,0.31690416,0.0014958496,0.0021068433,0.01041214,0.0013682976,0.032297198,0.11362617,0.021663608,0.4899259,0.00052608177],"about_ca_topic_score_codex":0.0010049394,"about_ca_topic_score_gemma":0.0017510419,"teacher_disagreement_score":0.0072872974,"about_ca_system_score_codex":0.0017852426,"about_ca_system_score_gemma":0.00071299856,"threshold_uncertainty_score":0.03853935},"labels":[],"label_agreement":null},{"id":"W4385483365","doi":"10.1158/1078-0432.ccr-23-0917","title":"The New NCI Precision Medicine Trials","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Cancer Institute","keywords":"Precision medicine; Clinical trial; Medicine; Medical physics; Targeted therapy; Matching (statistics); Intensive care medicine; Oncology; Cancer; Internal medicine; Pathology","score_opus":0.4534873555288127,"score_gpt":0.6143864141593111,"score_spread":0.16089905863049836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385483365","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016012598,0.16734548,0.17901808,0.239095,0.051153984,0.070477664,0.036701825,0.0029532793,0.23724207],"genre_scores_gemma":[0.079150066,0.055129647,0.42492312,0.19364688,0.017982477,0.16662396,0.017901653,0.0013188784,0.043323368],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.84500724,0.12063774,0.008528326,0.0065241037,0.017538777,0.00176389],"domain_scores_gemma":[0.8696664,0.06586707,0.016201554,0.023661373,0.0155575,0.009046087],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.20668387,0.0014657681,0.0030285188,0.0020823565,0.0017581126,0.009957141,0.0038315225,0.004610439,0.02086788],"category_scores_gemma":[0.1715091,0.0010658391,0.0029855187,0.0032559405,0.0034939442,0.006297268,0.0067086155,0.009694504,0.004087169],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014842233,0.00052015466,0.0026937972,0.0057744337,0.0016666362,0.000112103226,0.00043162538,0.0018172506,0.0011740214,0.21912096,0.25821906,0.49362773],"study_design_scores_gemma":[0.018377699,0.0037368487,0.0030800512,0.005029794,0.00095143437,0.00020433227,0.00011946899,0.001373205,0.0011340514,0.07609485,0.8897517,0.00014661158],"about_ca_topic_score_codex":0.0033380205,"about_ca_topic_score_gemma":0.00720985,"teacher_disagreement_score":0.20668387,"about_ca_system_score_codex":0.007888222,"about_ca_system_score_gemma":0.026482372,"threshold_uncertainty_score":0.97830003},"labels":[],"label_agreement":null},{"id":"W4385575581","doi":"10.1158/1078-0432.ccr-22-3361","title":"Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of High-Grade Anal Intraepithelial Neoplasia in HIV+ Men","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"ZonMw; Leids Universitair Medisch Centrum; Amsterdam University Medical Centers","keywords":"Medicine; Anal cancer; Rash; Internal medicine; Vaccination; Immune system; Gastroenterology; Confidence interval; Cancer; Immunology","score_opus":0.3443210838136157,"score_gpt":0.570862439480992,"score_spread":0.22654135566737632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385575581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99695,0.0018752812,0.00046291584,0.000052924177,0.000013136182,0.00016256461,0.00003660665,0.00001542039,0.0004311358],"genre_scores_gemma":[0.9977981,0.0009130676,0.00073944376,0.000062474544,0.00003337697,0.00012481601,0.00006860178,0.000001897126,0.00025819277],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99991775,0.000044515727,0.0000048187335,0.00001001549,0.000013103411,0.000009789418],"domain_scores_gemma":[0.9998878,0.000028488588,0.000038089962,0.000010369603,0.0000070721626,0.000028099146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003996348,0.00024315009,0.0003205885,0.0001362838,0.00013235977,0.00012431506,0.00016922122,0.00022417791,0.0011777853],"category_scores_gemma":[0.00032593016,0.000090396345,0.00021186314,0.0000904863,0.00020118516,0.00012753923,0.00010514815,0.00035688694,0.000143027],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06717496,0.019373477,0.08499209,0.0017709538,0.00040055191,0.0005272444,0.00043686363,0.0029773207,0.25653535,0.00034494026,0.0010423984,0.5644238],"study_design_scores_gemma":[0.023312384,0.70989853,0.1804188,0.00027360904,0.00036404832,0.0029863478,0.00024133424,0.002318858,0.07320261,0.0003376424,0.006627449,0.000018347095],"about_ca_topic_score_codex":0.000101699545,"about_ca_topic_score_gemma":0.00016533812,"teacher_disagreement_score":0.0011777853,"about_ca_system_score_codex":0.00011952013,"about_ca_system_score_gemma":0.00024711128,"threshold_uncertainty_score":0.0039401054},"labels":[],"label_agreement":null},{"id":"W4385716931","doi":"10.1158/1078-0432.ccr-22-2181","title":"HDACi-dependent Microenvironmental Normalization Overcomes Tumor Burden–induced T-cell Exhaustion","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute","keywords":"Cancer research; Reprogramming; Biology; Tumor microenvironment; Immunotherapy; T cell; CD8; Cell; Cytotoxic T cell; Transcriptome; Immunology; Immune system","score_opus":0.2326283083407908,"score_gpt":0.5135318852890013,"score_spread":0.2809035769482105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385716931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99439937,0.00090347085,0.0027679843,0.000070268565,0.000039907452,0.000049109574,0.00035081967,0.00017599062,0.0012430499],"genre_scores_gemma":[0.9963814,0.0005200216,0.0011046171,0.000038636856,0.000014611292,0.000041873012,0.00033170765,0.000028061746,0.001539033],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999094,0.000006631254,0.0000063801467,0.000022406473,0.000024330533,0.000030765594],"domain_scores_gemma":[0.9999429,0.0000054883517,0.00002336977,0.000006998599,0.0000049038563,0.000016302893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000071238144,0.0004383708,0.00026379558,0.00019328135,0.00009843496,0.0002250384,0.00020859888,0.00012227459,0.0012925435],"category_scores_gemma":[0.00005423426,0.00009096247,0.0002162288,0.00012656277,0.00027065485,0.00015326485,0.00017946346,0.0005511698,0.00026314094],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011385099,0.00005688846,0.00016495054,0.000034192843,0.000004488274,0.000014451909,0.0000071045324,0.00013721976,0.9971705,0.00006254413,0.000043479056,0.0021903578],"study_design_scores_gemma":[0.000029149234,0.0008582279,0.002916827,0.0000046280907,0.0000244059,0.00008545298,0.000022362881,0.0009530347,0.9934934,0.00003103666,0.0015779478,0.0000035098926],"about_ca_topic_score_codex":0.00032700362,"about_ca_topic_score_gemma":0.00088815734,"teacher_disagreement_score":0.0012925435,"about_ca_system_score_codex":0.0002585965,"about_ca_system_score_gemma":0.00023881822,"threshold_uncertainty_score":0.004324019},"labels":[],"label_agreement":null},{"id":"W4385751197","doi":"10.1158/1078-0432.ccr-23-1137","title":"Safety, Immunologic, and Clinical Activity of Durvalumab in Combination with Olaparib or Cediranib in Advanced Leiomyosarcoma: Results of the DAPPER Clinical Trial.","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Durvalumab; Medicine; Olaparib; Immunotherapy; Response Evaluation Criteria in Solid Tumors; Immune system; Internal medicine; Oncology; Tumor microenvironment; Toxicity; Immunology; Phases of clinical research; Nivolumab; Biology","score_opus":0.3288032443135986,"score_gpt":0.5626271940113787,"score_spread":0.23382394969778014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385751197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99637514,0.0019495642,0.0001286597,0.00017808388,0.000027556101,0.00021329649,0.00038520154,0.000020485104,0.0007220129],"genre_scores_gemma":[0.9965887,0.00099611,0.00038415482,0.00024437468,0.00006321057,0.00027469287,0.0007210013,0.0000060898014,0.00072176114],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99973506,0.00014327084,0.000015868718,0.00003625568,0.000026827862,0.000042742166],"domain_scores_gemma":[0.99955636,0.000086213,0.00012891831,0.0000326662,0.00001608343,0.00017970352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011054634,0.00084443885,0.001112971,0.00019884024,0.00016610387,0.0006339707,0.00046712495,0.0005326632,0.0014864242],"category_scores_gemma":[0.000667097,0.0002681756,0.0005276345,0.00021836655,0.0005055727,0.00042462934,0.00018827936,0.0012619182,0.00027892838],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8357794,0.011617848,0.0113123,0.0007241069,0.0015415892,0.0002904362,0.00013671783,0.0019928757,0.0349219,0.00018887062,0.0024594937,0.09903438],"study_design_scores_gemma":[0.6355096,0.31776205,0.03234283,0.000056508074,0.0010799031,0.0007077296,0.00006692209,0.0021062612,0.007041107,0.00029626614,0.0029983965,0.00003242888],"about_ca_topic_score_codex":0.00042144913,"about_ca_topic_score_gemma":0.0012103751,"teacher_disagreement_score":0.0014864242,"about_ca_system_score_codex":0.0006051957,"about_ca_system_score_gemma":0.0005523596,"threshold_uncertainty_score":0.005846262},"labels":[],"label_agreement":null},{"id":"W4385791542","doi":"10.1158/1078-0432.ccr-23-0370","title":"Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Shared Health","funders":"National Institute of Environmental Health Sciences; Cancer Research UK; National Cancer Institute; National Institute for Health and Care Research; Myriad Genetics","keywords":"Carboplatin; Docetaxel; Immune system; Oncology; Medicine; Internal medicine; Breast cancer; Triple-negative breast cancer; Cancer; Chemotherapy; Immunology; Cancer research; Cisplatin","score_opus":0.21338475753544037,"score_gpt":0.5400903936612291,"score_spread":0.32670563612578873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385791542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99835336,0.00053860684,0.00031077128,0.00008130521,0.000006518386,0.00007152717,0.0003913606,0.000009979975,0.00023647351],"genre_scores_gemma":[0.99775773,0.00009722595,0.00057381456,0.00004194089,0.000016531918,0.00011257078,0.0011703996,0.0000041664002,0.00022566896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995697,0.00027102663,0.000017152,0.000070926406,0.000041635838,0.000029616449],"domain_scores_gemma":[0.9995307,0.00016567859,0.00012535043,0.00003622511,0.00003892968,0.000103159146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001845353,0.0003653691,0.0007244069,0.000182621,0.00015283274,0.00047133878,0.0002252477,0.00025116882,0.0012554786],"category_scores_gemma":[0.0015787391,0.00010841037,0.00056494767,0.00024093443,0.00018081021,0.00022660542,0.00024785195,0.0004933679,0.00013152864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29962575,0.0020630755,0.5296167,0.00073016516,0.004966693,0.0001464321,0.00023135792,0.009481763,0.029075136,0.00022461626,0.0029069665,0.12093139],"study_design_scores_gemma":[0.018561553,0.033196732,0.9068266,0.00008511075,0.0050666803,0.00048673464,0.00016647307,0.025345882,0.0065518767,0.0011111358,0.0025491547,0.000052101288],"about_ca_topic_score_codex":0.0008081156,"about_ca_topic_score_gemma":0.0018167157,"teacher_disagreement_score":0.001845353,"about_ca_system_score_codex":0.000371985,"about_ca_system_score_gemma":0.0004410084,"threshold_uncertainty_score":0.009759307},"labels":[],"label_agreement":null},{"id":"W4385827803","doi":"10.1158/1078-0432.ccr-23-0621","title":"Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health; Pfizer","keywords":"Medicine; Neuroblastoma RAS viral oncogene homolog; KRAS; Internal medicine; Oncology; Progression-free survival; Confidence interval; MEK inhibitor; Proportional hazards model; Ovarian cancer; Selumetinib; Chemotherapy; Logistic regression; Cancer; MAPK/ERK pathway; Biology; Colorectal cancer; Signal transduction","score_opus":0.2301253681193695,"score_gpt":0.5375087817184303,"score_spread":0.3073834135990608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385827803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99581194,0.0019991267,0.00018592684,0.00010927907,0.000014105226,0.000085742395,0.0010976518,0.000011585858,0.000684585],"genre_scores_gemma":[0.9976125,0.00029559262,0.00027693936,0.000119926925,0.0000141024175,0.00005064011,0.0013599666,0.0000041341164,0.00026616722],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993412,0.00030160192,0.00005710409,0.00012615541,0.000113113885,0.000060920876],"domain_scores_gemma":[0.99859375,0.00043049318,0.0006688419,0.00006488782,0.00008601119,0.00015587201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001704635,0.00029505443,0.000604914,0.00039335428,0.00015263438,0.0005397008,0.00022419565,0.0003096233,0.0019081215],"category_scores_gemma":[0.0026844735,0.00015062599,0.0005095471,0.00047928374,0.00021097739,0.000397465,0.00018623429,0.0004870995,0.0001784725],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19933876,0.0022153782,0.64937973,0.0007921912,0.0020032881,0.00020652341,0.00015112718,0.0026367093,0.022157986,0.00017925141,0.002189609,0.1187495],"study_design_scores_gemma":[0.008876945,0.034527056,0.9398797,0.00008024547,0.002058255,0.00072019064,0.00009857041,0.0024043343,0.007416739,0.00024300488,0.0036570495,0.000037760125],"about_ca_topic_score_codex":0.00053752784,"about_ca_topic_score_gemma":0.0018261629,"teacher_disagreement_score":0.0019081215,"about_ca_system_score_codex":0.00064184784,"about_ca_system_score_gemma":0.00041095508,"threshold_uncertainty_score":0.009015083},"labels":[],"label_agreement":null},{"id":"W4386691447","doi":"10.1158/1078-0432.ccr-23-1953","title":"Rerouting the GPS Directing Immunotherapy in Endometrial Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Endometrial cancer; Immunotherapy; Global Positioning System; Cancer; Medicine; Cancer immunotherapy; Cancer research; Oncology; Internal medicine; Computer science; Telecommunications","score_opus":0.3971738174280782,"score_gpt":0.5891527291047443,"score_spread":0.19197891167666603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386691447","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10799422,0.47374487,0.029228017,0.31590822,0.015996253,0.00030565204,0.00049751136,0.0009139202,0.05541141],"genre_scores_gemma":[0.6133002,0.22820254,0.034314737,0.07903137,0.0149607165,0.00026401426,0.0003993445,0.0002865695,0.029240487],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99937785,0.00027522322,0.00004977528,0.00006446353,0.000120075805,0.00011256447],"domain_scores_gemma":[0.9991289,0.000323764,0.00013871568,0.00009635422,0.00016735544,0.00014488642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015702589,0.00034939527,0.0005300665,0.0007257775,0.00039240706,0.0019009254,0.0005317742,0.0013979512,0.0027946332],"category_scores_gemma":[0.0029389618,0.00029093702,0.00038443168,0.00049903675,0.00095348724,0.0020977177,0.0011399166,0.002928011,0.0024932732],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001396373,0.00023793062,0.007108071,0.0009521955,0.000100602345,0.0011723195,0.00037038507,0.0026684795,0.022363579,0.017680788,0.09149984,0.85444957],"study_design_scores_gemma":[0.00084621593,0.0020312571,0.008193152,0.001594688,0.00025553556,0.0061209835,0.001285652,0.005574856,0.016851109,0.0570792,0.9000633,0.00010413032],"about_ca_topic_score_codex":0.0012162611,"about_ca_topic_score_gemma":0.0030857448,"teacher_disagreement_score":0.0027946332,"about_ca_system_score_codex":0.0010556455,"about_ca_system_score_gemma":0.0010364426,"threshold_uncertainty_score":0.009348929},"labels":[],"label_agreement":null},{"id":"W4386708615","doi":"10.1158/1078-0432.ccr-23-0873","title":"Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; National Institute of General Medical Sciences; University of California, San Francisco; National Institutes of Health; National Cancer Institute; St. Baldrick's Foundation; Rally Foundation","keywords":"Cancer research; Metastasis; Drug; Medicine; Osteosarcoma; Genome; Cancer; Oncology; Biology; Internal medicine; Pharmacology; Gene; Genetics","score_opus":0.423596895930628,"score_gpt":0.5438498985017948,"score_spread":0.12025300257116678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386708615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97098774,0.0029957492,0.01468149,0.00028428246,0.000112053036,0.0006306438,0.003984486,0.00038805773,0.0059354575],"genre_scores_gemma":[0.97075146,0.0023728027,0.014538492,0.00016435125,0.000013286012,0.00050279207,0.0061334474,0.000058024667,0.0054651885],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996997,0.000037653444,0.000037885304,0.00005918585,0.00013137957,0.00003426339],"domain_scores_gemma":[0.9999083,0.000017482726,0.00002169207,0.000017928594,0.00001628505,0.000018189996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036011392,0.00043935265,0.00048126717,0.0003487407,0.00025655158,0.00041535773,0.00026814465,0.0003477769,0.0019694413],"category_scores_gemma":[0.0001628137,0.00017697111,0.0003486809,0.00033796218,0.00028371613,0.00020732707,0.00020973665,0.0010770598,0.0005072588],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026299382,0.0003116051,0.00076540053,0.000098642435,0.000018254726,0.00007058894,0.0000474601,0.00062199985,0.9921949,0.0002963118,0.0004805865,0.0048312265],"study_design_scores_gemma":[0.00010786415,0.0031516275,0.007989979,0.000013967399,0.000054745422,0.0006328188,0.00006204451,0.002495483,0.9774966,0.00009552726,0.007888113,0.0000112113],"about_ca_topic_score_codex":0.0017291205,"about_ca_topic_score_gemma":0.0032615364,"teacher_disagreement_score":0.0019694413,"about_ca_system_score_codex":0.0005010876,"about_ca_system_score_gemma":0.00039785012,"threshold_uncertainty_score":0.0065883994},"labels":[],"label_agreement":null},{"id":"W4386784013","doi":"10.1158/1557-3265.aacrahns23-pr09","title":"Abstract PR09: Detection of minimal residual disease in post-surgical drain fluid can predict locoregional recurrence in HPV-negative head and neck cancer patients","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lymph; Head and neck squamous-cell carcinoma; Internal medicine; Head and neck cancer; Oncology; Cancer; Minimal residual disease; Adjuvant therapy; Pathology","score_opus":0.16329571815896235,"score_gpt":0.49489171245945446,"score_spread":0.33159599430049214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961643,0.00066514855,0.0010992205,0.00008512009,0.000024154648,0.000030581927,0.0011494458,0.00007917852,0.0007029397],"genre_scores_gemma":[0.99669564,0.000099244615,0.0015499233,0.000060512735,0.000018204097,0.000022351995,0.0010123125,0.000013020408,0.0005288114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99965155,0.00007044105,0.00003180916,0.00012091895,0.00008282549,0.000042449905],"domain_scores_gemma":[0.9993267,0.00020583531,0.00018896852,0.000047116955,0.00011917323,0.000112293565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005478504,0.00028717698,0.0003091157,0.00053162494,0.00018208235,0.00069729704,0.00036158453,0.0004354263,0.0029066755],"category_scores_gemma":[0.0014507034,0.00015630962,0.00025103881,0.00031515464,0.00020717985,0.00029146034,0.00034765125,0.00043139048,0.0008046275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018530572,0.00014827221,0.93350005,0.00010931761,0.000059500573,0.00017336912,0.00007055208,0.0002843165,0.042475287,0.0000352424,0.00088357425,0.020407401],"study_design_scores_gemma":[0.000045651137,0.001411537,0.96316195,0.000029350776,0.00009328912,0.0016618305,0.00016837631,0.0034145813,0.028260015,0.00009947864,0.0016335926,0.00002035814],"about_ca_topic_score_codex":0.0005389492,"about_ca_topic_score_gemma":0.00086707785,"teacher_disagreement_score":0.0029066755,"about_ca_system_score_codex":0.00018885596,"about_ca_system_score_gemma":0.00012895903,"threshold_uncertainty_score":0.009723842},"labels":[],"label_agreement":null},{"id":"W4386784015","doi":"10.1158/1557-3265.aacrahns23-po-097","title":"Abstract PO-097: Tumor-associated extracellular vesicles from HPV+ oropharyngeal cancer lymphatic fluid trigger an anti-tumor response through activation of the cGAS-STING pathway","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lymph; Cancer research; Immune system; Lymphatic system; Cancer; Lymph node; Innate immune system; Medicine; Biology; Immunology; Pathology; Internal medicine","score_opus":0.12806657144046976,"score_gpt":0.4386644268716819,"score_spread":0.3105978554312121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954652,0.0010969416,0.0014459172,0.00008262365,0.00003646693,0.000032184314,0.00068394217,0.000029684523,0.001127115],"genre_scores_gemma":[0.9948754,0.0005120487,0.0011760336,0.00007447902,0.000013355698,0.000039673385,0.0014051119,0.000014440925,0.00188943],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999894,0.000014593955,0.00000886507,0.000024066987,0.000025794461,0.00003274849],"domain_scores_gemma":[0.9999492,0.000009990791,0.000011684162,0.0000054811785,0.00001307999,0.000010472296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009819543,0.00019151949,0.00021272036,0.00013068989,0.00016045063,0.00037767662,0.00010190816,0.00020966088,0.0025156324],"category_scores_gemma":[0.00012899187,0.000062499814,0.00028074204,0.00012307928,0.00015396839,0.00026507306,0.00030233312,0.00036352267,0.0005338241],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025023814,0.000029474872,0.0018780797,0.00009384951,0.000009022488,0.00009352581,0.000025183677,0.000057919224,0.9952715,0.00006054556,0.00009319326,0.0021374498],"study_design_scores_gemma":[0.000023647906,0.0005579871,0.024763811,0.000023768007,0.000027227607,0.00070158206,0.00018039453,0.0009055258,0.9685264,0.00012061806,0.0041627977,0.0000061406627],"about_ca_topic_score_codex":0.00036801715,"about_ca_topic_score_gemma":0.00024226657,"teacher_disagreement_score":0.0025156324,"about_ca_system_score_codex":0.00024107621,"about_ca_system_score_gemma":0.00019477728,"threshold_uncertainty_score":0.008415639},"labels":[],"label_agreement":null},{"id":"W4386784019","doi":"10.1158/1557-3265.aacrahns23-pr05","title":"Abstract PR05: Changing the radiation and immune-oncology paradigm in patients with head and neck squamous cell carcinoma (HNSCC) with the radioenhancer NBTXR3: From bench to bedside","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Head and neck squamous-cell carcinoma; Internal medicine; Radiation therapy; Cancer; Abscopal effect; Head and neck cancer; Immunotherapy; Cancer research","score_opus":0.10090439691586149,"score_gpt":0.46654931991425297,"score_spread":0.36564492299839146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897808,0.0041061398,0.00057310145,0.00077282306,0.00009181374,0.00024247164,0.00053375895,0.000078478544,0.0038207164],"genre_scores_gemma":[0.9945815,0.0012197428,0.0011970204,0.0004461542,0.00005140792,0.00009087048,0.00081236736,0.0000110869,0.0015896738],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998925,0.000024467034,0.000008245524,0.000025217903,0.000021108763,0.000028532768],"domain_scores_gemma":[0.99992824,0.000008296238,0.000011770873,0.0000050957265,0.000012314471,0.000034248023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003686179,0.00017336618,0.0003181897,0.00013363532,0.00022502874,0.00036620517,0.0002833161,0.000293805,0.002852194],"category_scores_gemma":[0.00019400974,0.00008506164,0.0003278233,0.00018000364,0.00020958233,0.00029641768,0.00019531493,0.00042061188,0.0005993567],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03684423,0.0047475635,0.20234296,0.0012636425,0.00024273379,0.0021466184,0.00034753568,0.001356645,0.24400112,0.0005084012,0.018868726,0.48732987],"study_design_scores_gemma":[0.005555618,0.0986267,0.76058,0.00025840546,0.0008318824,0.008775586,0.00089815125,0.0037053586,0.07907682,0.0004308378,0.041211847,0.000048772647],"about_ca_topic_score_codex":0.0017430893,"about_ca_topic_score_gemma":0.0045288447,"teacher_disagreement_score":0.002852194,"about_ca_system_score_codex":0.000591542,"about_ca_system_score_gemma":0.00085195474,"threshold_uncertainty_score":0.009541571},"labels":[],"label_agreement":null},{"id":"W4386784022","doi":"10.1158/1557-3265.aacrahns23-pr11","title":"Abstract PR11: Allogeneic memory-like natural killer (NK) cell therapy with IL-15 superagonist with or without ipilimumab for advanced, incurable head and neck cancer: A phase 1 trial","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ipilimumab; Internal medicine; Oncology; Regimen; Cohort; Immunotherapy; Cyclophosphamide; Cancer; Chemotherapy; Gastroenterology","score_opus":0.19200859287251712,"score_gpt":0.5151618163253213,"score_spread":0.3231532234528042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99447966,0.00082609855,0.0004197053,0.00031385408,0.00011047059,0.0019584198,0.0007086605,0.00007962112,0.0011034491],"genre_scores_gemma":[0.99118865,0.0009368413,0.0010382327,0.00041903273,0.00009528349,0.0020604536,0.0014382439,0.000017747858,0.0028055522],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99977285,0.00010459477,0.000011972772,0.000050506762,0.000017022161,0.00004315588],"domain_scores_gemma":[0.99963844,0.000053396976,0.000062466876,0.000033158412,0.000023797262,0.00018869624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000999445,0.0011240949,0.0011133596,0.0002119484,0.00033156143,0.0008706777,0.00089716585,0.00093967473,0.003969635],"category_scores_gemma":[0.0004405792,0.0003468531,0.0007778143,0.00020719822,0.0007169758,0.0006844762,0.00032081935,0.0032192555,0.00073583506],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8128046,0.06099059,0.003120727,0.0007917615,0.0006608088,0.00017937746,0.0002103009,0.002276007,0.049933486,0.00037498452,0.003924445,0.06473293],"study_design_scores_gemma":[0.5588679,0.42760503,0.00342494,0.00003242626,0.00028576422,0.00017240395,0.00004329812,0.0009969505,0.006665806,0.00016029055,0.0017277717,0.000017499862],"about_ca_topic_score_codex":0.000624653,"about_ca_topic_score_gemma":0.0013455984,"teacher_disagreement_score":0.003969635,"about_ca_system_score_codex":0.00064538745,"about_ca_system_score_gemma":0.0015728081,"threshold_uncertainty_score":0.013279796},"labels":[],"label_agreement":null},{"id":"W4386784024","doi":"10.1158/1557-3265.aacrahns23-pr12","title":"Abstract PR12: High-dimensional spatial analysis of the tumor-microenvironment to determine metastatic disease progression and response and resistance to therapy in head and neck cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Tumor microenvironment; Medicine; CD8; Head and neck squamous-cell carcinoma; Cancer; Primary tumor; Head and neck cancer; Tumor progression; Mass cytometry; Cytotoxic T cell; T cell; Cancer research; Pathology; Oncology; Internal medicine; Immunology; Metastasis; Biology; Phenotype","score_opus":0.1293566082335363,"score_gpt":0.4868440163052318,"score_spread":0.35748740807169543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947168,0.0007077636,0.0030734732,0.000038400136,0.000008376988,0.000032511914,0.00067719666,0.00009700648,0.00064843136],"genre_scores_gemma":[0.99535537,0.00014742654,0.0031845153,0.000018265451,0.000004439029,0.000050233943,0.0005873052,0.0000094918005,0.0006429641],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998925,0.000017160288,0.00000753018,0.000026819216,0.00003570316,0.000020287018],"domain_scores_gemma":[0.999915,0.000016208185,0.00001979834,0.0000073953415,0.000025329613,0.000016305921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014966377,0.00014789755,0.0002123404,0.0005466963,0.0001686986,0.00032525748,0.00013079573,0.00023607051,0.0016258615],"category_scores_gemma":[0.00018143868,0.00010762836,0.00020668618,0.00030167235,0.000101356236,0.000138945,0.00017118442,0.00025438477,0.0003081406],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084421475,0.00009908094,0.034588322,0.0000972132,0.00004441556,0.00009241491,0.00006714581,0.0012543958,0.9461587,0.00006963574,0.00041144647,0.016272916],"study_design_scores_gemma":[0.00003895112,0.0010121731,0.4773714,0.000011619859,0.00009100006,0.0014211691,0.00031489402,0.030074146,0.48680645,0.00016318876,0.0026640214,0.00003090793],"about_ca_topic_score_codex":0.0014008251,"about_ca_topic_score_gemma":0.0011472508,"teacher_disagreement_score":0.0016258615,"about_ca_system_score_codex":0.00024789685,"about_ca_system_score_gemma":0.00009311289,"threshold_uncertainty_score":0.005439043},"labels":[],"label_agreement":null},{"id":"W4386784036","doi":"10.1158/1557-3265.aacrahns23-po-098","title":"Abstract PO-098: Development of radioimmunotherapy using IL7 and FLT3 in a murine HPV related head and neck squamous cell carcinoma model","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Head and neck squamous-cell carcinoma; Radioimmunotherapy; Immunotherapy; Cancer research; Head and neck cancer; Radiation therapy; Oncology; Cancer; Pathology; Internal medicine; Antibody; Immunology; Monoclonal antibody","score_opus":0.17343725823923717,"score_gpt":0.4806751162262364,"score_spread":0.3072378579869992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824159,0.0017343216,0.009549187,0.00036123945,0.00020054549,0.00072616176,0.0015028345,0.00040957693,0.0031003812],"genre_scores_gemma":[0.9775199,0.001312042,0.011537143,0.0001500844,0.00004880591,0.0009769974,0.0015128057,0.000057789563,0.0068844534],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997054,0.000039698454,0.000023032919,0.00006772335,0.00008569054,0.000078458106],"domain_scores_gemma":[0.9998443,0.000017671942,0.000043001444,0.00002101473,0.000018959317,0.000055020308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043717457,0.00061968365,0.00040813183,0.00055389677,0.00018713354,0.00033621717,0.00058382103,0.0007660427,0.0015494485],"category_scores_gemma":[0.00009679874,0.00018279087,0.0005027614,0.00017511129,0.00037840748,0.00039014893,0.00017435188,0.0013434567,0.00060832314],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045119692,0.00081070623,0.00012892898,0.0000781779,0.000009056121,0.00004403126,0.000024829642,0.0003271693,0.9949891,0.0002191569,0.00018602014,0.0027316113],"study_design_scores_gemma":[0.00015571539,0.0065227854,0.0010006718,0.00001519048,0.000031587537,0.00015209257,0.000022154352,0.0012922557,0.9870905,0.00005505156,0.0036554057,0.0000067132632],"about_ca_topic_score_codex":0.00082411495,"about_ca_topic_score_gemma":0.0009147479,"teacher_disagreement_score":0.0015494485,"about_ca_system_score_codex":0.0004381711,"about_ca_system_score_gemma":0.00047020905,"threshold_uncertainty_score":0.0051834583},"labels":[],"label_agreement":null},{"id":"W4386784049","doi":"10.1158/1557-3265.aacrahns23-po-082","title":"Abstract PO-082: Antigen presentation and inflammatory effects on immune surveillance: Window of opportunity metformin monotherapy trial for squamous cell carcinoma of the head and neck (HNSCC)","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Head and neck squamous-cell carcinoma; Metformin; Oncology; Tumor microenvironment; Internal medicine; Cancer; Cancer research; Head and neck cancer","score_opus":0.191521908110743,"score_gpt":0.489257773891176,"score_spread":0.297735865780433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979657,0.00067686813,0.00007410565,0.00012385625,0.00003963368,0.00027794036,0.00030783124,0.000013699725,0.0005204629],"genre_scores_gemma":[0.9969171,0.00039711592,0.00041008723,0.0001756587,0.00006835016,0.00051914534,0.00041646615,0.000006230897,0.0010899437],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9998462,0.00006654086,0.0000123092095,0.000029423269,0.000016627713,0.000028851997],"domain_scores_gemma":[0.9997607,0.000041798176,0.000049829123,0.000018773766,0.000024699902,0.000104308405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005842853,0.00048699367,0.00088611344,0.00018090334,0.00025788666,0.0006677878,0.0003064595,0.0005846067,0.0032345778],"category_scores_gemma":[0.00039960453,0.00021533095,0.00060465635,0.00018457203,0.0003092165,0.00049040513,0.00022671738,0.0012034309,0.00031605942],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90482235,0.010404041,0.006359675,0.0005692737,0.00086701004,0.00007892533,0.00006864513,0.000649947,0.040043436,0.00013916298,0.0009711728,0.035026263],"study_design_scores_gemma":[0.43710783,0.5089492,0.038375523,0.00006929481,0.0014590498,0.00013105887,0.000120526216,0.0016937876,0.009536242,0.00023288094,0.0022825978,0.000041969426],"about_ca_topic_score_codex":0.00034979073,"about_ca_topic_score_gemma":0.0012101128,"teacher_disagreement_score":0.0032345778,"about_ca_system_score_codex":0.00033689276,"about_ca_system_score_gemma":0.0005551888,"threshold_uncertainty_score":0.010820687},"labels":[],"label_agreement":null},{"id":"W4386784057","doi":"10.1158/1557-3265.aacrahns23-pr06","title":"Abstract PR06: Cooperative HPV and YAP-mediated oncogenic reprogramming of oral progenitors into cancer stem cells at single cell resolution","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Cancer research; Carcinogenesis; Progenitor cell; Reprogramming; Stem cell; Ectopic expression; Cancer stem cell; SOX2; Cell cycle; Cell biology; Cell; Cancer; Cell culture; Transcription factor; Genetics; Gene","score_opus":0.18493714544601422,"score_gpt":0.4691208612884535,"score_spread":0.2841837158424393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812455,0.00066762936,0.012991637,0.00008472702,0.000028772916,0.00007986412,0.0009631142,0.00024569963,0.0036930644],"genre_scores_gemma":[0.97337395,0.0005706624,0.01411404,0.00004773452,0.000009134347,0.0000932684,0.00134699,0.00009533261,0.010348806],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999877,0.00000940706,0.000013594413,0.000036709887,0.00004021194,0.000023120796],"domain_scores_gemma":[0.99991536,0.000014019798,0.000023068647,0.000014826495,0.000011077529,0.000021574153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001626576,0.00018417613,0.00016754199,0.00017539736,0.00013161734,0.00038981377,0.0002703175,0.00027708733,0.0021976733],"category_scores_gemma":[0.00008315009,0.00014587495,0.00021299414,0.00011535929,0.00018874723,0.0002283577,0.0003323732,0.00054312195,0.0006936894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027364282,0.0000116506335,0.00007663707,0.000013425524,0.0000010964476,0.000020729114,0.000009266107,0.000039992214,0.99869764,0.00012807018,0.00003401087,0.00094010564],"study_design_scores_gemma":[0.0000067684323,0.00010254818,0.001444951,0.0000030136534,0.0000035372966,0.00011017185,0.000018408915,0.00093529024,0.9949803,0.000038514663,0.0023539849,0.0000025281124],"about_ca_topic_score_codex":0.0004015641,"about_ca_topic_score_gemma":0.0005581803,"teacher_disagreement_score":0.0021976733,"about_ca_system_score_codex":0.00020562299,"about_ca_system_score_gemma":0.0001654736,"threshold_uncertainty_score":0.0073519945},"labels":[],"label_agreement":null},{"id":"W4386784072","doi":"10.1158/1557-3265.aacrahns23-po-086","title":"Abstract PO-086: Generation of HPV-negative tobacco-associated oral cancer models using <i>p53</i> and <i>Cdkn2a</i> mutant mice","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CDKN2A; Carcinogenesis; Cancer research; Cancer; Head and neck squamous-cell carcinoma; Mutant; Biology; Mutation; Pathology; Medicine; Head and neck cancer; Genetics; Gene","score_opus":0.45212773899170855,"score_gpt":0.5253322490276097,"score_spread":0.07320451003590112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95165914,0.0011261927,0.028833998,0.00059592695,0.00031097254,0.0012318112,0.008061235,0.0011156072,0.007065078],"genre_scores_gemma":[0.89161235,0.0020537495,0.033843428,0.00046278795,0.00009227759,0.0026439412,0.009246316,0.00090607634,0.05913916],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991134,0.00009927742,0.00012639734,0.0002619191,0.00024014428,0.00015895638],"domain_scores_gemma":[0.99923956,0.00007319989,0.00025463817,0.00011654516,0.00006889773,0.0002472073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000805715,0.0011910093,0.0006111385,0.0018227632,0.0007319831,0.0006941596,0.0011866677,0.0013365034,0.006341749],"category_scores_gemma":[0.00020048603,0.0007544549,0.0011073237,0.000611558,0.0010036353,0.000788572,0.0006364038,0.0025018775,0.002635656],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043512307,0.00037158537,0.00029744324,0.000064278356,0.00001378673,0.00012608588,0.00005164157,0.00008032634,0.9966439,0.00049412524,0.00022882037,0.0011929658],"study_design_scores_gemma":[0.00018180057,0.0016764713,0.0037967828,0.00003851863,0.00006960755,0.0009916268,0.00011076267,0.0011978972,0.9829196,0.00018394199,0.008810055,0.000022968497],"about_ca_topic_score_codex":0.0010400787,"about_ca_topic_score_gemma":0.0015684337,"teacher_disagreement_score":0.006341749,"about_ca_system_score_codex":0.0006423846,"about_ca_system_score_gemma":0.00061210844,"threshold_uncertainty_score":0.02121526},"labels":[],"label_agreement":null},{"id":"W4386784082","doi":"10.1158/1557-3265.aacrahns23-po-085","title":"Abstract PO-085: Inhibition of ATR as a therapeutic strategy to enhance immunotherapy in head and neck cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Head and neck squamous-cell carcinoma; Cancer research; Immunotherapy; In vivo; Tumor microenvironment; Medicine; Cancer; Head and neck cancer; Immune system; Bone marrow; Cancer immunotherapy; Cancer cell; Immunology; Biology; Internal medicine","score_opus":0.17252176993906557,"score_gpt":0.5376926346770885,"score_spread":0.36517086473802296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802951,0.008731592,0.00285253,0.0006598631,0.00013042998,0.00022068503,0.00089150283,0.00021543393,0.0060027903],"genre_scores_gemma":[0.9869141,0.0033254358,0.0033984622,0.00023192423,0.000047322577,0.00011691983,0.0011135815,0.000020989017,0.004831211],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998987,0.000012673704,0.000008931661,0.000021364116,0.000030340043,0.000027990704],"domain_scores_gemma":[0.99995863,0.0000045597403,0.000009339211,0.0000055885544,0.0000066875646,0.000015209545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020316606,0.0003486207,0.00030715507,0.00029230549,0.000141684,0.00035913545,0.00030315746,0.00028841663,0.0031523963],"category_scores_gemma":[0.00006206393,0.000090912086,0.00022470113,0.00020958853,0.00024783684,0.00023175955,0.0001739643,0.0009677187,0.00070080796],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079875294,0.0005673759,0.00073148735,0.00027371326,0.000031356118,0.00010887707,0.000019720459,0.0004354211,0.97043085,0.00036968564,0.0010262774,0.0252064],"study_design_scores_gemma":[0.00035799813,0.006036934,0.0072608725,0.00003435656,0.00011562169,0.00078584964,0.00004876509,0.0016819729,0.96683073,0.00013416035,0.016702212,0.00001061448],"about_ca_topic_score_codex":0.0003290002,"about_ca_topic_score_gemma":0.0006856171,"teacher_disagreement_score":0.0031523963,"about_ca_system_score_codex":0.00030450063,"about_ca_system_score_gemma":0.00039133828,"threshold_uncertainty_score":0.01054585},"labels":[],"label_agreement":null},{"id":"W4386784084","doi":"10.1158/1557-3265.aacrahns23-pr08","title":"Abstract PR08: Personalized therapeutic mRNA nano-vaccines are effective across multiple preclinical and translational models of head and neck cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Immune system; Metastasis; Head and neck cancer; Immunotherapy; Head and neck squamous-cell carcinoma; Cancer research; Thyroid cancer; Lung cancer; Pathology; Oncology; Immunology; Internal medicine","score_opus":0.22381519966349672,"score_gpt":0.5364004730391201,"score_spread":0.31258527337562336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98637867,0.0018075339,0.0059543587,0.00039919085,0.00011093155,0.00044059232,0.00084819517,0.0002486139,0.0038120053],"genre_scores_gemma":[0.98394066,0.001085872,0.006385653,0.00016331032,0.000032668602,0.0003527059,0.0013189828,0.000040724644,0.0066793454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972266,0.000045194523,0.000022067934,0.00005770168,0.00009595157,0.000056467783],"domain_scores_gemma":[0.999881,0.00001930758,0.000036091613,0.000016927725,0.000024146953,0.000022385291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004510655,0.00035068157,0.00036122327,0.00025871262,0.00014689517,0.00033401483,0.00028875755,0.0005258472,0.0033315797],"category_scores_gemma":[0.00016849379,0.00012770937,0.00024504054,0.00013946016,0.0003362412,0.00035849083,0.00020094264,0.00100325,0.00051701],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003950852,0.00035569418,0.0002565923,0.000121864294,0.000012841745,0.000039577244,0.000026411819,0.00024345276,0.98920447,0.00019830922,0.00050746975,0.008638331],"study_design_scores_gemma":[0.00015044048,0.009163194,0.0034061684,0.000022410277,0.000059728485,0.00038109734,0.000041218806,0.0011972032,0.9774155,0.000068665424,0.008085115,0.00000918579],"about_ca_topic_score_codex":0.000697528,"about_ca_topic_score_gemma":0.0013637383,"teacher_disagreement_score":0.0033315797,"about_ca_system_score_codex":0.00048627582,"about_ca_system_score_gemma":0.00046157133,"threshold_uncertainty_score":0.011145234},"labels":[],"label_agreement":null},{"id":"W4386784088","doi":"10.1158/1557-3265.aacrahns23-po-089","title":"Abstract PO-089: Opioid-mediated suppression of anti-tumor immunity via peripheral OPRM1 signaling in head and neck squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Head and neck squamous-cell carcinoma; Tumor microenvironment; Cancer; Immunosurveillance; Immune system; CD8; Opioid; Opioid receptor; Cancer research; Head and neck cancer; Pharmacology; Immunology; Internal medicine; Receptor","score_opus":0.10647650643643697,"score_gpt":0.44080423744586267,"score_spread":0.3343277310094257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99609035,0.0011688868,0.0005031231,0.00018485542,0.000055756467,0.000044398144,0.00046740222,0.000051839514,0.0014332978],"genre_scores_gemma":[0.99634176,0.0005353111,0.0004892288,0.00008937598,0.000014447157,0.00006211681,0.00052212534,0.000005972037,0.0019395998],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988854,0.000013695132,0.000008469088,0.000018850124,0.000026770993,0.00004366381],"domain_scores_gemma":[0.99995637,0.000004258668,0.000010201137,0.0000052479513,0.0000055204046,0.000018366618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010676145,0.0002605039,0.0003317141,0.00014240686,0.00017180499,0.00026764098,0.00021172661,0.00025699564,0.0023870221],"category_scores_gemma":[0.00006868155,0.00009419438,0.00024373824,0.000121379395,0.00023904281,0.00017763466,0.00014833141,0.0010310855,0.0005030145],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005366207,0.000250328,0.00040374394,0.000094502044,0.000007499924,0.00007491764,0.000014711948,0.00008691933,0.99461067,0.00008851186,0.00023148554,0.0036000186],"study_design_scores_gemma":[0.00029202076,0.0067529944,0.024004238,0.000024144409,0.000067028544,0.000671086,0.00018089943,0.002413571,0.9598633,0.00013634795,0.005583731,0.000010664911],"about_ca_topic_score_codex":0.00044037282,"about_ca_topic_score_gemma":0.000748469,"teacher_disagreement_score":0.0023870221,"about_ca_system_score_codex":0.00021731369,"about_ca_system_score_gemma":0.00033262838,"threshold_uncertainty_score":0.0079853535},"labels":[],"label_agreement":null},{"id":"W4386784091","doi":"10.1158/1557-3265.aacrahns23-pr10","title":"Abstract PR10: A decade in the making: Screening ctDNA detection in HPV-associated HNSCC","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Digital polymerase chain reaction; Medicine; Biobank; Head and neck squamous-cell carcinoma; Internal medicine; Oncology; Liquid biopsy; Cancer; Head and neck cancer; Bioinformatics; Biology; Polymerase chain reaction; Gene; Genetics","score_opus":0.2335351691490474,"score_gpt":0.5510196840192118,"score_spread":0.3174845148701644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784091","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32561916,0.36898133,0.046572644,0.20587283,0.022501908,0.0002731808,0.0014149996,0.0013841761,0.027379813],"genre_scores_gemma":[0.7202914,0.14093837,0.04186673,0.054673586,0.01266645,0.00017593188,0.0014821739,0.0003677232,0.027537625],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99824584,0.00059975334,0.0002009518,0.00033938745,0.00046509964,0.00014902014],"domain_scores_gemma":[0.99414486,0.0016113609,0.00054678845,0.00039125906,0.002327403,0.0009782509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011438783,0.00060611614,0.0006315825,0.00082630175,0.00040318607,0.0030568605,0.0009494672,0.0019876768,0.003193752],"category_scores_gemma":[0.008018098,0.00029073932,0.00029709528,0.000630524,0.0013066311,0.0030747384,0.0011295585,0.002784744,0.0010783246],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017041642,0.00028505488,0.07497655,0.0010714978,0.00012284002,0.00080426387,0.0009315133,0.00081933074,0.049895838,0.005905435,0.05441633,0.80906713],"study_design_scores_gemma":[0.00019738513,0.0065067406,0.1125055,0.0032935445,0.00033087205,0.012233676,0.0045578396,0.00543517,0.067275696,0.01147126,0.77588284,0.00030944753],"about_ca_topic_score_codex":0.0015047516,"about_ca_topic_score_gemma":0.00176303,"teacher_disagreement_score":0.011438783,"about_ca_system_score_codex":0.0012341047,"about_ca_system_score_gemma":0.0018957623,"threshold_uncertainty_score":0.06049484},"labels":[],"label_agreement":null},{"id":"W4386784097","doi":"10.1158/1557-3265.aacrahns23-po-092","title":"Abstract PO-092: Molecular characterization of the salivary adenoid cystic carcinoma tumor immune landscape by anatomic subsite","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adenoid cystic carcinoma; Salivary gland; Immune system; Antibody-dependent cell-mediated cytotoxicity; Perineural invasion; Ductal cells; Pathology; Biology; Cancer research; Medicine; Cancer; Carcinoma; Immunology; Internal medicine; Immunohistochemistry; Antibody; Monoclonal antibody","score_opus":0.07939533876808473,"score_gpt":0.43014877345654523,"score_spread":0.3507534346884605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9340054,0.0030134204,0.005588807,0.0003143187,0.00005486336,0.00011792865,0.05244889,0.0004090955,0.004047165],"genre_scores_gemma":[0.91812783,0.0008361601,0.006244221,0.00015432051,0.00003465498,0.00025614916,0.072516896,0.00008415873,0.0017455923],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996201,0.000039171446,0.000033859124,0.00015128223,0.00009523896,0.000060402162],"domain_scores_gemma":[0.9997147,0.00006988256,0.000069234855,0.000046886384,0.000054917193,0.000044381693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004236256,0.00028657526,0.00043326893,0.0010199056,0.00036224697,0.0009244226,0.0003209775,0.00035262952,0.004221605],"category_scores_gemma":[0.0008207107,0.00012609082,0.00044556233,0.0016169671,0.00026105737,0.0003344322,0.00058683055,0.00047296195,0.0012095937],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002596245,0.00031897606,0.4677558,0.0018627733,0.00072404905,0.0007015396,0.00029082512,0.004589229,0.4189836,0.0010587386,0.013821935,0.08729634],"study_design_scores_gemma":[0.00012913585,0.00055359444,0.86382705,0.00012772842,0.000562581,0.0025776455,0.0004530599,0.011396373,0.07876448,0.001725816,0.039825767,0.000056718774],"about_ca_topic_score_codex":0.0011317919,"about_ca_topic_score_gemma":0.0015416316,"teacher_disagreement_score":0.004221605,"about_ca_system_score_codex":0.00030605454,"about_ca_system_score_gemma":0.00059036876,"threshold_uncertainty_score":0.0141227245},"labels":[],"label_agreement":null},{"id":"W4386784100","doi":"10.1158/1557-3265.aacrahns23-po-090","title":"Abstract PO-090: Characterizing the intra-tumoral microbiome of laryngeal squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stage (stratigraphy); Microbiome; Biology; Pathology; Cancer; Fluorescence in situ hybridization; Fusobacterium; Fusobacteria; Bacteria; Cancer research; Medicine; Internal medicine; 16S ribosomal RNA; Gene; Bacteroides; Bioinformatics; Bacteroidetes","score_opus":0.24568409128979568,"score_gpt":0.4928071972130673,"score_spread":0.24712310592327164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962613,0.00035389033,0.0009002894,0.00004635723,0.0000065508943,0.000027741684,0.0017160922,0.000016232463,0.0006715777],"genre_scores_gemma":[0.99526703,0.00020015372,0.0017625618,0.000038462873,0.000007137895,0.00003671039,0.0022630726,0.000008867578,0.000416058],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998727,0.00001938685,0.000010947535,0.000035118177,0.000035654066,0.000026134725],"domain_scores_gemma":[0.9997472,0.000039780727,0.000058714948,0.000017159497,0.000084213156,0.000052863998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026651344,0.0001380008,0.00022756567,0.00070998905,0.000310353,0.00042029886,0.00014119389,0.00024710325,0.0009885267],"category_scores_gemma":[0.00046693993,0.0000782068,0.00019226709,0.0006354059,0.00015803955,0.0002195176,0.00043620673,0.00021321114,0.0004529436],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005215154,0.00006017901,0.86311793,0.00012607212,0.0000390611,0.00022552468,0.00021517702,0.00045205659,0.11453074,0.000039975508,0.00051855907,0.020153139],"study_design_scores_gemma":[0.000005973147,0.00027498088,0.9776139,0.000020099284,0.00003794021,0.00073046464,0.00051597605,0.0017966619,0.017277027,0.00007504608,0.0016444189,0.0000075293224],"about_ca_topic_score_codex":0.0020125369,"about_ca_topic_score_gemma":0.0026955276,"teacher_disagreement_score":0.0020125369,"about_ca_system_score_codex":0.00033494114,"about_ca_system_score_gemma":0.00033725667,"threshold_uncertainty_score":0.004001677},"labels":[],"label_agreement":null},{"id":"W4386784280","doi":"10.1158/1557-3265.aacrahns23-po-057","title":"Abstract PO-057: Systemic delivery of miR-27a* using ultrasound-targeted microbubble cavitation causes tumor regression","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Microbubbles; In vivo; PI3K/AKT/mTOR pathway; microRNA; Head and neck squamous-cell carcinoma; Medicine; Epidermal growth factor receptor; Small interfering RNA; AKT1; Biology; RNA; Pathology; Radiation therapy; Cancer; Ultrasound; Signal transduction; Gene; Head and neck cancer; Internal medicine; Cell biology","score_opus":0.18205564370450825,"score_gpt":0.4512908888412515,"score_spread":0.26923524513674324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877957,0.0011135371,0.0053516957,0.00023276119,0.0001339928,0.00010733417,0.0007038526,0.0003693642,0.00419181],"genre_scores_gemma":[0.9871638,0.0005452522,0.0035599421,0.0001061273,0.00002330814,0.00013264192,0.0008027225,0.0000708929,0.0075952746],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998951,0.000008300016,0.00000638914,0.000029021388,0.00003095061,0.000030173327],"domain_scores_gemma":[0.99994004,0.0000116607,0.000014029962,0.0000071866357,0.0000071965665,0.000019891992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102103084,0.00025960215,0.00025410333,0.00015854609,0.00012036352,0.00015694344,0.00019459889,0.00030015386,0.0016335088],"category_scores_gemma":[0.000056647314,0.00009302317,0.00024679318,0.00010662868,0.00027682562,0.00013382264,0.00010746315,0.000778977,0.00041495723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019966491,0.00009121097,0.00003975917,0.00002284325,0.000003303428,0.000027897637,0.000007779187,0.00007646434,0.99825865,0.000082649916,0.00017632419,0.0010134355],"study_design_scores_gemma":[0.000019649598,0.0005682943,0.00046215332,0.0000017483658,0.000006460252,0.000043101074,0.0000075736302,0.0009547151,0.9968353,0.000014773003,0.0010842715,0.0000020622858],"about_ca_topic_score_codex":0.0011079151,"about_ca_topic_score_gemma":0.000923628,"teacher_disagreement_score":0.0016335088,"about_ca_system_score_codex":0.0002752689,"about_ca_system_score_gemma":0.00030817173,"threshold_uncertainty_score":0.0054646134},"labels":[],"label_agreement":null},{"id":"W4386784286","doi":"10.1158/1557-3265.aacrahns23-po-072","title":"Abstract PO-072: Durvalumab in combination with radioactive iodine in recurrent/metastatic thyroid cancers: Update on clinical and correlative analyses","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Durvalumab; Clinical endpoint; Thyroid cancer; Cancer; Internal medicine; Oncology; Clinical trial; Adverse effect; Response Evaluation Criteria in Solid Tumors; Thyroid; Phases of clinical research; Immunotherapy; Pembrolizumab","score_opus":0.3937507872669719,"score_gpt":0.5837503913856752,"score_spread":0.1899996041187033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784286","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11450363,0.8662952,0.0015782018,0.0052969065,0.00045492104,0.00027086402,0.000857678,0.00008194582,0.010660613],"genre_scores_gemma":[0.42663538,0.5537012,0.004061813,0.0069546644,0.0019822891,0.00047229405,0.0031406123,0.0000892599,0.0029625501],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991059,0.0003751507,0.00014103939,0.00012195923,0.00020006702,0.00005585703],"domain_scores_gemma":[0.9956151,0.0023285698,0.00073357415,0.00018329265,0.0009673779,0.00017201698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069220914,0.0005251289,0.0019462903,0.000807092,0.00015467264,0.0016515047,0.0009312459,0.000747859,0.0016597069],"category_scores_gemma":[0.003780322,0.00026962205,0.0010100597,0.0013582704,0.00054321333,0.0009009994,0.00035554726,0.0016617277,0.00052396697],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007379554,0.0007134146,0.013414231,0.0042596464,0.0016137677,0.00026653465,0.00012112479,0.0008417514,0.01110174,0.00093550154,0.007152356,0.95220035],"study_design_scores_gemma":[0.014271375,0.085259974,0.19222675,0.011075903,0.016262002,0.0058695097,0.0008106653,0.0067605753,0.032311577,0.003961936,0.6309572,0.00023251702],"about_ca_topic_score_codex":0.00077378005,"about_ca_topic_score_gemma":0.0013795497,"teacher_disagreement_score":0.0069220914,"about_ca_system_score_codex":0.0010351135,"about_ca_system_score_gemma":0.0012045887,"threshold_uncertainty_score":0.03660798},"labels":[],"label_agreement":null},{"id":"W4386784291","doi":"10.1158/1557-3265.aacrahns23-po-076","title":"Abstract PO-076: Adrenergic regulation of the anti-tumor immune response in <i>p53</i>-deficient tumors","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Adrenergic; Cancer research; Biology; Signal transduction; Carcinogenesis; Immunotherapy; Tumor progression; Cell biology; Receptor; Cancer; Immunology; Genetics","score_opus":0.1329765041863686,"score_gpt":0.4631956074872942,"score_spread":0.33021910330092563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885972,0.0011681315,0.0031021333,0.00042364514,0.00010959607,0.000044795433,0.0033399821,0.00022483406,0.0029895667],"genre_scores_gemma":[0.9890132,0.0005892859,0.001570453,0.00021541669,0.000022699774,0.00008694255,0.0031222894,0.00008809778,0.0052915392],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997826,0.000025097315,0.000020182095,0.00005470175,0.000058474783,0.00005889891],"domain_scores_gemma":[0.9998685,0.000016030575,0.00003508178,0.000014855055,0.000012336396,0.00005330907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001454154,0.00024415483,0.00028990756,0.00031189094,0.000195306,0.00043502965,0.0001952803,0.0002872594,0.0041747103],"category_scores_gemma":[0.000109888824,0.00011458428,0.0003109631,0.00024102312,0.0002655562,0.00018272552,0.0001471113,0.0011228326,0.0010023854],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024908184,0.00004947397,0.0005848489,0.000026299746,0.000005715286,0.000055164102,0.000006619657,0.00003474889,0.99759454,0.0000706943,0.00019328637,0.0011295518],"study_design_scores_gemma":[0.000060168135,0.0006651136,0.02201078,0.000010963976,0.000034078388,0.0006205011,0.00008921155,0.0012603626,0.969556,0.00011870424,0.005565745,0.000008358567],"about_ca_topic_score_codex":0.00052521797,"about_ca_topic_score_gemma":0.0006391573,"teacher_disagreement_score":0.0041747103,"about_ca_system_score_codex":0.00024934398,"about_ca_system_score_gemma":0.00018442882,"threshold_uncertainty_score":0.0139657855},"labels":[],"label_agreement":null},{"id":"W4386784297","doi":"10.1158/1557-3265.aacrahns23-po-079","title":"Abstract PO-079: The impact of statin use on anti-PD-1 monotherapy for recurrent head and neck squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Head and neck squamous-cell carcinoma; Medicine; Tumor microenvironment; Cancer research; Immunotherapy; Internal medicine; Cancer; Head and neck cancer","score_opus":0.1962131180835801,"score_gpt":0.5101702422875223,"score_spread":0.3139571242039422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99763215,0.001317263,0.00004597901,0.00015738765,0.000031906246,0.000030723553,0.00019487547,0.000008925907,0.00058088504],"genre_scores_gemma":[0.9985216,0.00043458364,0.00009896517,0.00009351792,0.000019902249,0.000018251907,0.00028499862,0.0000042077145,0.0005239543],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998185,0.000051076433,0.000019216035,0.000031070023,0.00003984926,0.000040415303],"domain_scores_gemma":[0.9997938,0.000042194908,0.000045903984,0.000012444667,0.000026126732,0.00007950802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030978158,0.00014869748,0.0006649975,0.00015421244,0.00014520576,0.00034328183,0.00023690978,0.00030345473,0.0014834089],"category_scores_gemma":[0.0004503124,0.00006288134,0.00044963122,0.00020038207,0.000120479956,0.0002364289,0.00016145202,0.0005870884,0.00029001897],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16411662,0.011764641,0.13491681,0.00080779725,0.0019917497,0.00095429365,0.000220343,0.002000378,0.29765835,0.0002596221,0.0037367365,0.38157266],"study_design_scores_gemma":[0.004625799,0.18444206,0.7101045,0.00014204573,0.0032607424,0.0013070587,0.0005731304,0.006239379,0.07751061,0.00024741222,0.011476862,0.000070418464],"about_ca_topic_score_codex":0.0011253726,"about_ca_topic_score_gemma":0.0032524015,"teacher_disagreement_score":0.0014834089,"about_ca_system_score_codex":0.00032304513,"about_ca_system_score_gemma":0.00050842663,"threshold_uncertainty_score":0.004962504},"labels":[],"label_agreement":null},{"id":"W4386784301","doi":"10.1158/1557-3265.aacrahns23-po-078","title":"Abstract PO-078: Tissue-resident memory CD8+ T cells correlate with anti-PD-1 response in head and neck cancer and expand upon cDC1 activation in tumor-draining lymph nodes to overcome PD-1 resistance","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Head and neck squamous-cell carcinoma; Cancer research; Immunotherapy; CD8; Cytotoxic T cell; Adoptive cell transfer; Medicine; Flow cytometry; Lymph node; Antigen; T cell; Cancer; Immunology; Immune system; Biology; Head and neck cancer; In vitro; Internal medicine","score_opus":0.09185202323616003,"score_gpt":0.4365398006842508,"score_spread":0.34468777744809076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960794,0.00047422718,0.00062395463,0.00007745703,0.000018116298,0.00007993309,0.0006971515,0.00010231254,0.0018474035],"genre_scores_gemma":[0.99323964,0.0001636888,0.0009059043,0.00006840805,0.0000152164,0.00015295396,0.0013906185,0.00002252672,0.0040409993],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99989593,0.000015026274,0.000006825342,0.00002487077,0.000027025844,0.00003036216],"domain_scores_gemma":[0.99991465,0.000013867239,0.000015099863,0.000007807727,0.000013341413,0.000035144913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014545493,0.00021921766,0.00027382764,0.00019560025,0.00013724138,0.0002859342,0.00013512322,0.00024912728,0.0054453737],"category_scores_gemma":[0.00012688081,0.00011077098,0.00012629248,0.00013317914,0.000190561,0.00017406915,0.00012326956,0.0008453255,0.0007475658],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020404884,0.00048249838,0.0073069353,0.00011571658,0.000012357105,0.00008240494,0.000038107966,0.00014639349,0.977146,0.00006083587,0.0009240973,0.011644173],"study_design_scores_gemma":[0.00053277647,0.016135411,0.13518468,0.000025384132,0.000101286045,0.0014598904,0.00014724697,0.0022109891,0.8365258,0.00015478177,0.0075088544,0.000012803431],"about_ca_topic_score_codex":0.00031786558,"about_ca_topic_score_gemma":0.00048404376,"teacher_disagreement_score":0.0054453737,"about_ca_system_score_codex":0.00019367502,"about_ca_system_score_gemma":0.0002515717,"threshold_uncertainty_score":0.01821655},"labels":[],"label_agreement":null},{"id":"W4386784303","doi":"10.1158/1557-3265.aacrahns23-po-074","title":"Abstract PO-074: The evolution of the tumor immune microenvironment in immunosuppressed patients with cutaneous squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunosuppression; Tumor microenvironment; Immunotherapy; Immune system; Medicine; Merkel cell carcinoma; Immunology; Cancer; Cancer research; Pathology; Carcinoma; Internal medicine","score_opus":0.052667563233526574,"score_gpt":0.375440506160833,"score_spread":0.32277294292730646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99949217,0.00009963248,0.00003284769,0.000010132733,0.0000019435506,0.000003434209,0.000038283157,0.0000018507856,0.00031970628],"genre_scores_gemma":[0.99980503,0.000023444898,0.00002380463,0.00001062477,0.0000037919315,0.0000022746478,0.000046681806,7.042567e-7,0.0000836194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99991155,0.000016678578,0.000010691791,0.000020685526,0.000016011829,0.00002435919],"domain_scores_gemma":[0.9997458,0.0000511293,0.000084914325,0.000013057774,0.000031977444,0.00007325226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009729486,0.000112698355,0.00015646798,0.0004778454,0.00030857333,0.0003062425,0.000100196245,0.00016935487,0.0020171881],"category_scores_gemma":[0.000471979,0.00006612172,0.0001202277,0.00034356653,0.00013941854,0.00017578312,0.00015371371,0.00021972743,0.00019114348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044710148,0.000074316245,0.9830378,0.000020433246,0.000020144833,0.0019377595,0.00017442841,0.000041986394,0.008984732,0.000030441672,0.00010587358,0.005125037],"study_design_scores_gemma":[0.000010323408,0.00037178115,0.99155176,0.0000060408365,0.000030312276,0.005345399,0.0003603363,0.00021767677,0.001574309,0.00003087419,0.0004980305,0.0000032327791],"about_ca_topic_score_codex":0.00042378335,"about_ca_topic_score_gemma":0.0003769373,"teacher_disagreement_score":0.0020171881,"about_ca_system_score_codex":0.00012286997,"about_ca_system_score_gemma":0.00009575425,"threshold_uncertainty_score":0.0067481995},"labels":[],"label_agreement":null},{"id":"W4386784309","doi":"10.1158/1557-3265.aacrahns23-po-071","title":"Abstract PO-071: Pseudonormal morphology of adenoid cystic carcinoma cells subverts the antitumor reactivity of immune cells","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Adenoid cystic carcinoma; Cancer research; Cancer; Biology; Cancer cell; Jurkat cells; Immunology; T cell; Carcinoma","score_opus":0.17708490283718875,"score_gpt":0.46790349730647524,"score_spread":0.2908185944692865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943145,0.0007303842,0.0014071711,0.00014222832,0.00007435148,0.00005193204,0.00053635525,0.00010088673,0.002642242],"genre_scores_gemma":[0.9923315,0.00034054427,0.0010377842,0.00007121265,0.00001381757,0.00010851397,0.0010463521,0.000024236626,0.005026064],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999691,0.00004569347,0.00002999121,0.000060447648,0.000085300715,0.000087549706],"domain_scores_gemma":[0.9998623,0.00003058669,0.000020393363,0.000029038378,0.000015104517,0.000042492637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014442034,0.00031871887,0.00027382138,0.00023188132,0.00018391412,0.00033191466,0.0001956706,0.0003781282,0.0035749376],"category_scores_gemma":[0.00013400217,0.00012071546,0.00026360777,0.0001966439,0.00032621986,0.0002045227,0.0001856949,0.0009775925,0.0008237373],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010280543,0.00009174345,0.00017342884,0.000027433493,0.0000028435097,0.00006237571,0.000024140505,0.00002902585,0.9984964,0.00010615808,0.00009890077,0.000784683],"study_design_scores_gemma":[0.000029955712,0.0010597337,0.004739996,0.0000060825064,0.000012579722,0.0004379906,0.00008461681,0.0007928471,0.98911536,0.000052507068,0.0036646738,0.0000036346707],"about_ca_topic_score_codex":0.00056106684,"about_ca_topic_score_gemma":0.0004882423,"teacher_disagreement_score":0.0035749376,"about_ca_system_score_codex":0.00024702554,"about_ca_system_score_gemma":0.0002166721,"threshold_uncertainty_score":0.011959374},"labels":[],"label_agreement":null},{"id":"W4386784314","doi":"10.1158/1557-3265.aacrahns23-po-068","title":"Abstract PO-068: Harmony between transdifferentiated neuron and immunosuppressive tumor microenvironment","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Biology; Cancer research; Microvesicles; Cancer cell; Tumor progression; Immune system; Cell biology; microRNA; Cancer; Immunology","score_opus":0.1254023933263422,"score_gpt":0.449786883796585,"score_spread":0.32438449047024276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921996,0.00086212,0.0042193998,0.000095130854,0.000039514493,0.000029533327,0.0002662132,0.00010048021,0.0021880576],"genre_scores_gemma":[0.9947336,0.00030197963,0.0021023317,0.000048525966,0.0000068952895,0.000029940462,0.00027773646,0.00002466575,0.0024744065],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999864,0.000014668711,0.000012574172,0.000038083755,0.00004147256,0.000029311092],"domain_scores_gemma":[0.9999101,0.000011251916,0.000023824736,0.000014188949,0.000015360109,0.000025275944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000110955465,0.00019935907,0.00015551159,0.00014405463,0.00012009707,0.0003411111,0.00016251451,0.00016844351,0.0012409661],"category_scores_gemma":[0.000095184994,0.00009057686,0.00017575077,0.00011966863,0.00020396807,0.00023470802,0.00023214391,0.00052451034,0.00036918925],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004217449,0.000016841994,0.00036305474,0.000018539717,0.0000022062138,0.000045089957,0.000009919696,0.000029502267,0.9977502,0.00013391615,0.00003575802,0.0015527415],"study_design_scores_gemma":[0.000011394065,0.00029160755,0.007675732,0.000005227679,0.000012879095,0.0003660506,0.000067765846,0.0009928955,0.98718333,0.000092928596,0.0032969732,0.000003160188],"about_ca_topic_score_codex":0.000205868,"about_ca_topic_score_gemma":0.00025509857,"teacher_disagreement_score":0.0012409661,"about_ca_system_score_codex":0.00017589646,"about_ca_system_score_gemma":0.00015520849,"threshold_uncertainty_score":0.0041514635},"labels":[],"label_agreement":null},{"id":"W4386784320","doi":"10.1158/1557-3265.aacrahns23-po-066","title":"Abstract PO-066: Complete pathological response following neoadjuvant chemotherapy and recurrence free survival in patients with p16-positive oropharyngeal cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Docetaxel; Lymphovascular invasion; Neoadjuvant therapy; Oncology; Regimen; Neck dissection; Cancer; Surgery; Internal medicine; Radiation therapy; Adverse effect; Chemotherapy; Metastasis; Breast cancer","score_opus":0.2170873572515408,"score_gpt":0.49979107848798054,"score_spread":0.2827037212364397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994717,0.00010520914,0.00002785094,0.000009117991,0.0000018317311,0.0000054564684,0.0001890511,0.0000014484134,0.00018838017],"genre_scores_gemma":[0.99963486,0.00003308003,0.000022062588,0.000005858371,0.0000024654728,0.0000042824395,0.00021640492,5.911336e-7,0.00008029586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998128,0.000032760978,0.000028808965,0.00004708425,0.000043710577,0.00003475419],"domain_scores_gemma":[0.999305,0.00011162817,0.00037818032,0.000037641916,0.00006138903,0.00010617477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031132085,0.00010901868,0.0002041753,0.00036646865,0.00024081822,0.00039906756,0.00020147082,0.0002174457,0.0017205259],"category_scores_gemma":[0.00096860144,0.00012742581,0.00024117185,0.0005069212,0.00018529764,0.00028887982,0.00025818136,0.00023986334,0.0003156881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020358952,0.00002246731,0.99850214,0.0000063803245,0.000011787178,0.00009259882,0.000018060156,0.000025229043,0.0002793891,0.0000033658587,0.000035462494,0.0007994398],"study_design_scores_gemma":[0.000009150853,0.00028559027,0.99832124,0.0000032109283,0.000019109959,0.00078212935,0.00007494419,0.0001109281,0.00020439802,0.0000073256265,0.00017998971,0.0000020257464],"about_ca_topic_score_codex":0.0010982874,"about_ca_topic_score_gemma":0.001467191,"teacher_disagreement_score":0.0017205259,"about_ca_system_score_codex":0.0002430875,"about_ca_system_score_gemma":0.00024337503,"threshold_uncertainty_score":0.0057557225},"labels":[],"label_agreement":null},{"id":"W4386784328","doi":"10.1158/1557-3265.aacrahns23-po-046","title":"Abstract PO-046: Relationship of HPV16 E6 seropositivity with circulating tumor tissue modified HPV DNA before head and neck cancer diagnosis","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Serology; Cancer; Incidence (geometry); Biomarker; Head and neck cancer; Oncology; Population; Internal medicine; Antibody; Multiplex; Disease; Antigen; Pathology; Immunology; Bioinformatics; Biology","score_opus":0.31103649288256346,"score_gpt":0.5347342473916546,"score_spread":0.22369775450909118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975726,0.00022230051,0.0001498958,0.00006387642,0.000023197803,0.000016994047,0.00090252387,0.000015338179,0.0010333036],"genre_scores_gemma":[0.9990086,0.000032074524,0.00007308623,0.000018064422,0.000014859474,0.000011750328,0.00038877636,0.0000034657205,0.0004493778],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996687,0.00006279807,0.00003222306,0.000108724824,0.00005496381,0.000072650764],"domain_scores_gemma":[0.99718034,0.0008615255,0.0010167323,0.00016550462,0.00032302723,0.0004529383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049384,0.0002158177,0.00020945788,0.00072390353,0.0003830706,0.0006772514,0.00046588734,0.000657377,0.0074104387],"category_scores_gemma":[0.0036295836,0.00023775653,0.00021893108,0.00070179976,0.00024345118,0.0005340582,0.00032785707,0.0009977126,0.00091241376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046084775,0.000047004072,0.9978132,0.000010443391,0.00001711933,0.00011769607,0.00002822433,0.000026305963,0.00043577692,0.00001085299,0.00014635072,0.00088614295],"study_design_scores_gemma":[0.000010924352,0.00027850442,0.99817884,0.0000061272813,0.000020986128,0.0004953513,0.00012429692,0.00022947896,0.00031887935,0.000022655155,0.00031086185,0.0000031098523],"about_ca_topic_score_codex":0.0029266928,"about_ca_topic_score_gemma":0.0014421826,"teacher_disagreement_score":0.0074104387,"about_ca_system_score_codex":0.0002747809,"about_ca_system_score_gemma":0.0003066641,"threshold_uncertainty_score":0.024790406},"labels":[],"label_agreement":null},{"id":"W4386784339","doi":"10.1158/1557-3265.aacrahns23-po-050","title":"Abstract PO-050: Preliminary results from an early-phase, open-label study of tolinapant and radiation in cisplatin-ineligible patients with previously untreated, locally advanced head and neck cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Head and neck cancer; Cisplatin; Radiation therapy; Adjuvant; Cancer; Phases of clinical research; Oncology; Toxicity; Internal medicine; Chemotherapy; Surgery; Gastroenterology; Urology","score_opus":0.17596785457609776,"score_gpt":0.530724536578169,"score_spread":0.3547566820020712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921405,0.0010614218,0.0008082973,0.0002289433,0.000107077234,0.003300384,0.0009880589,0.00006282044,0.0013026186],"genre_scores_gemma":[0.98809916,0.0010344929,0.0022663465,0.0005150738,0.0002259026,0.0035294204,0.0022843634,0.000032333184,0.0020129029],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9988971,0.0006221702,0.000080155914,0.00017529848,0.000077386445,0.00014784069],"domain_scores_gemma":[0.9983614,0.00041731377,0.0002176715,0.00022332213,0.00012239901,0.00065787614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029812127,0.0015799076,0.002731945,0.00045298965,0.00061178155,0.0011200064,0.0012418714,0.0014780217,0.0055324277],"category_scores_gemma":[0.001769913,0.0005930645,0.0017851042,0.000483613,0.0015709528,0.0015431929,0.000514673,0.0034700194,0.0011986227],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8056941,0.11361657,0.0030348762,0.0007633033,0.0006930844,0.00020604729,0.0002657136,0.000920238,0.027010271,0.00012008069,0.0009856841,0.0466901],"study_design_scores_gemma":[0.20537424,0.78637505,0.00440024,0.000023084545,0.0002595219,0.00009148585,0.000044267224,0.00035963795,0.0020696854,0.00007129907,0.00091623067,0.000015195223],"about_ca_topic_score_codex":0.00084091537,"about_ca_topic_score_gemma":0.0015742643,"teacher_disagreement_score":0.0055324277,"about_ca_system_score_codex":0.00091642764,"about_ca_system_score_gemma":0.0020266937,"threshold_uncertainty_score":0.018507779},"labels":[],"label_agreement":null},{"id":"W4386784341","doi":"10.1158/1557-3265.aacrahns23-po-048","title":"Abstract PO-048: Baseline blood DNA methylation-based immune profiles are associated with survival outcomes in head and neck cancer patients on immune checkpoint therapy","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Internal medicine; Head and neck squamous-cell carcinoma; Immunotherapy; Immune system; Hazard ratio; Biomarker; Ipilimumab; DNA methylation; Pembrolizumab; Proportional hazards model; Cancer; Head and neck cancer; Immunology; Confidence interval; Biology","score_opus":0.16669272135349594,"score_gpt":0.47080515836399994,"score_spread":0.304112437010504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991936,0.000081550854,0.00009228822,0.00002404146,0.0000027959563,0.000004635436,0.00035291223,0.000004428875,0.0002437507],"genre_scores_gemma":[0.9994766,0.000013459323,0.00005137607,0.000014848426,0.0000037742836,0.000005888888,0.00026659336,0.0000014165623,0.00016594715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987113,0.00003196691,0.000012188834,0.000036708345,0.000021746297,0.00002629684],"domain_scores_gemma":[0.99951565,0.00012189179,0.00018840245,0.000027755912,0.00005340921,0.00009294739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023295677,0.00014075552,0.00018884048,0.00028433002,0.00017379451,0.0002970899,0.00018310852,0.00028066552,0.0020721238],"category_scores_gemma":[0.00086346385,0.000076652,0.00020027204,0.00035006227,0.00015719746,0.0002279835,0.00018275791,0.00043354926,0.0002518765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008887562,0.000049694307,0.99253803,0.000010550945,0.00003518172,0.000042116735,0.0000253804,0.00008060876,0.0026134704,0.000010701125,0.0001530869,0.0035523407],"study_design_scores_gemma":[0.000011805222,0.0002212269,0.9986707,0.0000019719703,0.000023272847,0.000115973155,0.000041794476,0.00029968045,0.00043669104,0.00002205098,0.00015300838,0.0000018357346],"about_ca_topic_score_codex":0.00093977957,"about_ca_topic_score_gemma":0.000963972,"teacher_disagreement_score":0.0020721238,"about_ca_system_score_codex":0.00017984751,"about_ca_system_score_gemma":0.00016081808,"threshold_uncertainty_score":0.0069319606},"labels":[],"label_agreement":null},{"id":"W4386784343","doi":"10.1158/1557-3265.aacrahns23-po-058","title":"Abstract PO-058: Piloting a novel strategy to rapidly implement smoking cessation treatment for newly-diagnosed head and neck cancer patients","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Smoking cessation; Head and neck cancer; Abstinence; Pharmacotherapy; Survivorship curve; Cancer; Population; Internal medicine; Physical therapy; Oncology; Family medicine; Psychiatry; Pathology","score_opus":0.44375714622356643,"score_gpt":0.5787604659957757,"score_spread":0.13500331977220925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9676164,0.00013643858,0.004384149,0.0017203041,0.00024403243,0.021414403,0.00036131925,0.000450502,0.0036724696],"genre_scores_gemma":[0.94064754,0.00015562998,0.032952588,0.0016169498,0.00017799827,0.021972086,0.00028926626,0.000029350802,0.0021586714],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99733824,0.001562004,0.00017804484,0.0003165893,0.00027405762,0.00033099583],"domain_scores_gemma":[0.99446845,0.001849008,0.0006492198,0.00042683817,0.0005130606,0.002093431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057280273,0.0006168187,0.00052918534,0.0004086167,0.0009978656,0.0010847455,0.001310685,0.0012726646,0.008245124],"category_scores_gemma":[0.010333175,0.0003583871,0.0007951084,0.00018545655,0.000704103,0.0010908195,0.0015446204,0.0015550323,0.0012605637],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04394053,0.29972798,0.033053726,0.0014440152,0.00029279815,0.00024421743,0.0014126869,0.004199063,0.012337147,0.00086407136,0.0067149545,0.59576887],"study_design_scores_gemma":[0.065146364,0.8263788,0.071715556,0.00025750618,0.0004120297,0.0001742919,0.0015652843,0.010449968,0.008707364,0.00071630423,0.014357228,0.00011932342],"about_ca_topic_score_codex":0.0022373388,"about_ca_topic_score_gemma":0.0037209324,"teacher_disagreement_score":0.008245124,"about_ca_system_score_codex":0.0011032027,"about_ca_system_score_gemma":0.005589827,"threshold_uncertainty_score":0.030293047},"labels":[],"label_agreement":null},{"id":"W4386784346","doi":"10.1158/1557-3265.aacrahns23-po-049","title":"Abstract PO-049: The neural landscape is associated with functional outcomes for patients with oropharyngeal squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dysphagia; Swallowing; Cancer; Internal medicine; Oncology; Tumor microenvironment; Pathology; Surgery","score_opus":0.1884219372258508,"score_gpt":0.4529086158012062,"score_spread":0.26448667857535546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987942,0.00021256194,0.0000552747,0.000045515888,0.000007171038,0.000006292473,0.00044083275,0.0000029189885,0.00043520602],"genre_scores_gemma":[0.99937576,0.00005047982,0.000036122154,0.000015053216,0.0000050312537,0.0000056223903,0.00032963874,8.9110364e-7,0.00018148599],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998944,0.00001866037,0.000016324286,0.000024153404,0.000024149487,0.000022229016],"domain_scores_gemma":[0.999514,0.00005597441,0.00023320894,0.000018443077,0.00007784519,0.00010065474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018316579,0.00016651205,0.0002038555,0.00039431034,0.0002827451,0.00043310417,0.00019406488,0.000268741,0.0021995017],"category_scores_gemma":[0.00084613747,0.000067627705,0.00031435763,0.0005755902,0.0001695132,0.0002584252,0.0002955274,0.00043099566,0.00028241696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002256424,0.00004337965,0.9962721,0.000015731817,0.00004496849,0.00007216574,0.000014052493,0.00004886006,0.00092714577,0.000008721448,0.00012886226,0.0021984805],"study_design_scores_gemma":[0.000003920394,0.00010257896,0.9992581,0.0000032867147,0.000024632007,0.00011717969,0.00006370475,0.00015561332,0.00013958802,0.000019387706,0.00010991838,0.0000019971048],"about_ca_topic_score_codex":0.0011450399,"about_ca_topic_score_gemma":0.002069109,"teacher_disagreement_score":0.0021995017,"about_ca_system_score_codex":0.00022828433,"about_ca_system_score_gemma":0.00018167084,"threshold_uncertainty_score":0.007358074},"labels":[],"label_agreement":null},{"id":"W4386784348","doi":"10.1158/1557-3265.aacrahns23-po-061","title":"Abstract PO-061: Utilizing T cell receptor-based therapy to treat anaplastic thyroid cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"vaccines and immunoinformatics approaches","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Epitope; Biology; Cancer research; Chimeric antigen receptor; Major histocompatibility complex; Antigen; Cancer; Immunotherapy; Immunology; Genetics","score_opus":0.21965958097910038,"score_gpt":0.47337040580110656,"score_spread":0.2537108248220062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9643966,0.0153541,0.007450697,0.00087716174,0.0003280563,0.0004928275,0.003435179,0.0005684585,0.0070968443],"genre_scores_gemma":[0.9618301,0.008560218,0.013729729,0.0008504255,0.00011337752,0.0002998731,0.009150626,0.00008416219,0.005381474],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988186,0.000015732663,0.000007904327,0.00002719797,0.000039818806,0.000027529099],"domain_scores_gemma":[0.9999312,0.000010023871,0.000013735035,0.000007910825,0.000014828668,0.000022324884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024952024,0.00030322248,0.00024757138,0.00045311247,0.00020625525,0.000598446,0.00030328034,0.0003360134,0.0023178614],"category_scores_gemma":[0.00016571739,0.000092363516,0.00036586964,0.0003955043,0.00016858941,0.00025749797,0.00026229784,0.00069468963,0.000975388],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069456873,0.0004962723,0.003010836,0.00039101642,0.00005657347,0.00033772975,0.00002733354,0.0005437892,0.9352732,0.00022905134,0.0022656424,0.056673985],"study_design_scores_gemma":[0.0004223306,0.0052417656,0.02747285,0.0000842391,0.00028290946,0.0031651517,0.00009325583,0.0063793347,0.8800713,0.00058854127,0.076162554,0.00003576251],"about_ca_topic_score_codex":0.00034977606,"about_ca_topic_score_gemma":0.00037435265,"teacher_disagreement_score":0.0023178614,"about_ca_system_score_codex":0.00024905437,"about_ca_system_score_gemma":0.0004144678,"threshold_uncertainty_score":0.0077540874},"labels":[],"label_agreement":null},{"id":"W4386784350","doi":"10.1158/1557-3265.aacrahns23-po-053","title":"Abstract PO-053: Chemical suppression of DHFR induces NRF2 inhibition and tumor regression","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"In vivo; Cancer research; Head and neck squamous-cell carcinoma; In vitro; Bystander effect; Transcription factor; Biology; Effector; Cancer; Cell culture; Medicine; Immunology; Head and neck cancer; Gene; Genetics","score_opus":0.1969939012870086,"score_gpt":0.513957397760949,"score_spread":0.31696349647394034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888388,0.0015952418,0.0024332365,0.00032105815,0.00010294774,0.0000991008,0.0019502145,0.00022403298,0.004435458],"genre_scores_gemma":[0.9895523,0.0007690521,0.0016742768,0.00010056703,0.000014965357,0.0000727961,0.001864782,0.000031672356,0.0059195743],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998872,0.000012755003,0.0000106224625,0.000023238525,0.00003129926,0.00003477939],"domain_scores_gemma":[0.9999217,0.000013758318,0.000017295779,0.000011830318,0.000010170573,0.00002534798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011166214,0.00033184414,0.00024446996,0.00022630897,0.00014580083,0.00019702227,0.00033393712,0.00031949312,0.004250121],"category_scores_gemma":[0.00008079641,0.000101083846,0.00032454878,0.00018934785,0.00022838515,0.0001685854,0.00012255521,0.00081344607,0.00065424753],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049454917,0.00027745916,0.00012065898,0.0000813477,0.000015236477,0.000059277514,0.000014478919,0.00010799753,0.99595106,0.00014795858,0.00033642832,0.0023935966],"study_design_scores_gemma":[0.0000487202,0.00097630435,0.00089624315,0.0000043889136,0.000013001033,0.00011684048,0.000015479476,0.0003620623,0.99490416,0.000027192675,0.002632829,0.0000027240212],"about_ca_topic_score_codex":0.0014303038,"about_ca_topic_score_gemma":0.0017434476,"teacher_disagreement_score":0.004250121,"about_ca_system_score_codex":0.0003364434,"about_ca_system_score_gemma":0.00035202576,"threshold_uncertainty_score":0.014218032},"labels":[],"label_agreement":null},{"id":"W4386784365","doi":"10.1158/1557-3265.aacrahns23-po-042","title":"Abstract PO-042: Next generation liquid biopsy for diagnosis and prognostication in HPV+OPSCC","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Liquid biopsy; Digital polymerase chain reaction; Concordance; Genotyping; Medicine; Whole genome sequencing; Oncology; DNA sequencing; Ion semiconductor sequencing; Genome; Computational biology; Internal medicine; Cancer; Gene; Biology; Genotype; Polymerase chain reaction; Genetics","score_opus":0.3277659022950732,"score_gpt":0.5108360468936506,"score_spread":0.1830701445985774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9121188,0.006583439,0.06708125,0.0009501853,0.00024290686,0.0005331719,0.0050067613,0.0026096327,0.0048738476],"genre_scores_gemma":[0.94694,0.0008544871,0.045873128,0.0003759661,0.00010194947,0.00025216112,0.0025033378,0.00012278912,0.002976154],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99934155,0.00016005198,0.00004231098,0.0002047918,0.00020051423,0.00005080786],"domain_scores_gemma":[0.9994863,0.00017636367,0.00008351696,0.00005931413,0.00013248807,0.00006198048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001537076,0.0005631805,0.00050113245,0.000879227,0.00025846288,0.0010982883,0.00067018316,0.00068994315,0.0030178218],"category_scores_gemma":[0.0016383202,0.00028908122,0.00033887586,0.00040759976,0.0003159793,0.0005511209,0.0006057962,0.00057678926,0.000837518],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004620538,0.00051288225,0.32344607,0.0005910043,0.000344192,0.00059403654,0.00016253085,0.0072631924,0.35952792,0.00068269257,0.0074004163,0.29485452],"study_design_scores_gemma":[0.00028220066,0.0037286426,0.28472158,0.00018182665,0.00044879693,0.004221418,0.00027119622,0.18455674,0.5011859,0.0019316465,0.018332427,0.00013759648],"about_ca_topic_score_codex":0.0012717734,"about_ca_topic_score_gemma":0.0018608007,"teacher_disagreement_score":0.0030178218,"about_ca_system_score_codex":0.0004950263,"about_ca_system_score_gemma":0.00053697044,"threshold_uncertainty_score":0.010095596},"labels":[],"label_agreement":null},{"id":"W4386784370","doi":"10.1158/1557-3265.aacrahns23-po-024","title":"Abstract PO-024: Analysis of the NOTCH pathway in HNSCC: A target with a wide prognostic and therapeutic potential","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiac tumors and thrombi","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"HES1; Notch signaling pathway; Cyclin D1; Cancer research; Transcriptome; Internal medicine; CDKN2A; Medicine; Survival analysis; Gene expression; Gene; Oncology; Biology; Cancer; Cell cycle; Genetics","score_opus":0.12500469046507554,"score_gpt":0.47096878238817874,"score_spread":0.3459640919231032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97536814,0.0076081865,0.0031059461,0.00073644234,0.00006195974,0.00009350664,0.0054350966,0.00015207024,0.007438566],"genre_scores_gemma":[0.97786474,0.0029196318,0.004297265,0.00026300462,0.00007054823,0.000094872375,0.007494227,0.000051291165,0.0069444915],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99992573,0.000008736885,0.0000060332272,0.000021231128,0.00002695239,0.000011264137],"domain_scores_gemma":[0.9999237,0.000013625811,0.000017080412,0.000006191598,0.000019968624,0.000019371408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003052939,0.00022694166,0.0002433138,0.0003512358,0.0001692196,0.00041319674,0.0001975501,0.00021860925,0.0048728758],"category_scores_gemma":[0.00018444449,0.00008110186,0.00018119474,0.00044934714,0.00015997521,0.00017775616,0.0002132384,0.00031713757,0.00089833554],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004747183,0.0002776779,0.1355058,0.0007400261,0.00014650164,0.00090983417,0.0000743731,0.0009590378,0.694185,0.00053465046,0.006176794,0.15574317],"study_design_scores_gemma":[0.00037728684,0.0026899574,0.4198618,0.00012861923,0.00046340603,0.005133553,0.00023540252,0.0054666745,0.5173195,0.0013074109,0.04699223,0.00002415884],"about_ca_topic_score_codex":0.000418978,"about_ca_topic_score_gemma":0.00043767848,"teacher_disagreement_score":0.0048728758,"about_ca_system_score_codex":0.00036458243,"about_ca_system_score_gemma":0.0003219868,"threshold_uncertainty_score":0.016301453},"labels":[],"label_agreement":null},{"id":"W4386784371","doi":"10.1158/1557-3265.aacrahns23-po-031","title":"Abstract PO-031: Integrated bioinformatics and functional spatial analysis platform for the discovery of predictive biomarkers in oral cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Proportional hazards model; Immunotherapy; Cancer; Oncology; Tumor microenvironment; Medicine; Survival analysis; Cancer immunotherapy; Internal medicine; Bioinformatics; Biology; Immunology","score_opus":0.24601114962425674,"score_gpt":0.4923340481755268,"score_spread":0.24632289855127004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784371","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1759078,0.0013365673,0.6935086,0.0013737028,0.0002249298,0.0004944774,0.025815895,0.095521666,0.0058164275],"genre_scores_gemma":[0.48795867,0.00082423387,0.46933785,0.0007441676,0.00012529141,0.001103468,0.03173862,0.0039996537,0.004168007],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9996177,0.00007690962,0.000020929832,0.00013958353,0.00011428975,0.000030522682],"domain_scores_gemma":[0.99953234,0.00016737546,0.00006280327,0.000070549155,0.000109424676,0.000057614157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014341992,0.0009862492,0.00082643086,0.0011514862,0.00042227434,0.0014082065,0.0012008253,0.00068551,0.005125939],"category_scores_gemma":[0.0023016953,0.00037438193,0.0011806778,0.0006735637,0.00036930892,0.0006738009,0.001367447,0.00091412413,0.0019983754],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035404768,0.001308729,0.06415696,0.0015960919,0.001395229,0.0012861385,0.00074217946,0.2547761,0.18364307,0.01964276,0.08687068,0.38104162],"study_design_scores_gemma":[0.00013119212,0.00024836653,0.008878164,0.000036053378,0.00012825821,0.00020800896,0.00008026178,0.9425457,0.021606525,0.010997144,0.015072914,0.000067316374],"about_ca_topic_score_codex":0.0030183455,"about_ca_topic_score_gemma":0.0037300687,"teacher_disagreement_score":0.005125939,"about_ca_system_score_codex":0.00056656403,"about_ca_system_score_gemma":0.0017096065,"threshold_uncertainty_score":0.017147958},"labels":[],"label_agreement":null},{"id":"W4386784375","doi":"10.1158/1557-3265.aacrahns23-po-032","title":"Abstract PO-032: Association of a polymorphic variant in <i>JMJD1C</i> with tumor recurrence after adjuvant chemoradiation therapy in head and neck squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Head and neck squamous-cell carcinoma; Internal medicine; Oncology; Radiation therapy; Single-nucleotide polymorphism; Head and neck cancer; Chemotherapy; Cancer research; Genotype; Biology; Gene; Genetics","score_opus":0.07027693472209179,"score_gpt":0.39758671297690823,"score_spread":0.32730977825481644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99961674,0.000048896014,0.000037074067,0.000015438065,0.0000041005615,0.0000045616994,0.00014488226,0.0000022472848,0.00012602963],"genre_scores_gemma":[0.9997063,0.0000102235745,0.00002900429,0.000009679283,0.0000051997267,0.0000026419777,0.00012475607,0.0000013899465,0.000110701716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999785,0.00003063769,0.000032640288,0.00007893427,0.000039671944,0.000033047912],"domain_scores_gemma":[0.9994516,0.00007278705,0.00023967476,0.00003261873,0.0000646329,0.00013873402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002158537,0.00025072452,0.00022785224,0.00048825232,0.0005107723,0.00036233902,0.0003498751,0.00039649187,0.0016919611],"category_scores_gemma":[0.00059134245,0.0001142634,0.00033098285,0.0005863612,0.00021505888,0.00012306016,0.00019555999,0.00044934222,0.0002444581],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010039976,0.00012562251,0.98809636,0.000020362611,0.00009780608,0.0015073832,0.000098986646,0.000049285252,0.006904167,0.000018362538,0.00021272019,0.0018650364],"study_design_scores_gemma":[0.00002599226,0.00022242825,0.99637777,0.0000034971956,0.00006172411,0.0021164715,0.00007844448,0.00022305254,0.00070816086,0.000019224766,0.00015895502,0.0000042676643],"about_ca_topic_score_codex":0.003833097,"about_ca_topic_score_gemma":0.0028941117,"teacher_disagreement_score":0.003833097,"about_ca_system_score_codex":0.0002352569,"about_ca_system_score_gemma":0.00016155212,"threshold_uncertainty_score":0.0076215267},"labels":[],"label_agreement":null},{"id":"W4386784380","doi":"10.1158/1557-3265.aacrahns23-po-038","title":"Abstract PO-038: Metabolic-inflammatory investigation of head and neck cancer patient reported neuropsychological factors via multiomics integration of the plasma metabolome, lipidome, and circulating inflammation cytokines","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metabolome; Lipidome; Inflammation; Medicine; Internal medicine; Immunology; Cytokine; Oncology; Bioinformatics; Metabolite; Lipid metabolism; Biology","score_opus":0.19252822911477752,"score_gpt":0.4591610412550331,"score_spread":0.2666328121402556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912888,0.00021023939,0.00529283,0.00011351119,0.000011334326,0.0001338683,0.002229908,0.000054318494,0.0006651298],"genre_scores_gemma":[0.99480397,0.00007307358,0.0035783441,0.000028330876,0.000011110709,0.00012512406,0.001062765,0.0000069523335,0.00031028927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998355,0.00005014994,0.000012843642,0.000055498112,0.000023645029,0.00002230296],"domain_scores_gemma":[0.9997073,0.000065432716,0.00009585178,0.00002808499,0.00005618812,0.000047270623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003614737,0.00033370097,0.00034840076,0.00073167274,0.00030104915,0.00061935297,0.0002258072,0.00021728738,0.0020601372],"category_scores_gemma":[0.0009884001,0.00013434634,0.00044499355,0.0008799767,0.00010806399,0.00038406462,0.00047678853,0.00034433595,0.00023783972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002296034,0.0005053995,0.9265226,0.0001828206,0.00050921453,0.00025718944,0.00018236751,0.004099213,0.019569924,0.00025253987,0.0010247187,0.044597905],"study_design_scores_gemma":[0.00006888808,0.0009694115,0.9569913,0.000025142032,0.00027518967,0.0004129479,0.00025459015,0.033333316,0.0056565558,0.00073124864,0.0012602946,0.000021139169],"about_ca_topic_score_codex":0.0018534528,"about_ca_topic_score_gemma":0.0028858301,"teacher_disagreement_score":0.0020601372,"about_ca_system_score_codex":0.00033034384,"about_ca_system_score_gemma":0.00035974642,"threshold_uncertainty_score":0.0068918467},"labels":[],"label_agreement":null},{"id":"W4386784381","doi":"10.1158/1557-3265.aacrahns23-po-012","title":"Abstract PO-012: Spatial transcriptomic analysis of HPV-related and HPV-unrelated head and neck squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Head and neck squamous-cell carcinoma; Transcriptome; Biology; Cell; Tumor microenvironment; Stroma; Cell type; Phenotype; Computational biology; Cancer research; Cancer; Pathology; Head and neck cancer; Gene; Medicine; Gene expression; Immunohistochemistry; Genetics; Immunology","score_opus":0.09196648190980143,"score_gpt":0.40242211420409635,"score_spread":0.3104556322942949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99275714,0.00017435712,0.0030526854,0.000017430331,0.0000047131894,0.000025533627,0.0032970903,0.000084921565,0.00058621675],"genre_scores_gemma":[0.98593706,0.00008930784,0.004550655,0.000023987119,0.0000032902506,0.00006501572,0.00859505,0.000052044335,0.000683578],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998336,0.000012105064,0.000010381279,0.00006501438,0.000054406053,0.000024494659],"domain_scores_gemma":[0.99984944,0.00002820032,0.000029084063,0.000019654111,0.000053249314,0.000020367095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016256362,0.0001515895,0.0001870267,0.00053080416,0.00026378524,0.0003667708,0.00016861256,0.00021216171,0.0014533493],"category_scores_gemma":[0.0003054284,0.00010302163,0.00028137874,0.00061897794,0.00017582905,0.00013661792,0.00031135793,0.00016353298,0.00035479775],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007001368,0.00006313666,0.12389435,0.00021185607,0.000065940185,0.0001939678,0.00014777276,0.0027640595,0.8550019,0.00020214831,0.0004911925,0.016263464],"study_design_scores_gemma":[0.000030032912,0.00046298208,0.59384537,0.000021959937,0.00014984554,0.0012932254,0.00053944136,0.026457204,0.37188205,0.00034797844,0.0049493173,0.00002057964],"about_ca_topic_score_codex":0.0019895306,"about_ca_topic_score_gemma":0.0027595428,"teacher_disagreement_score":0.0019895306,"about_ca_system_score_codex":0.00031168555,"about_ca_system_score_gemma":0.00037317077,"threshold_uncertainty_score":0.0048618913},"labels":[],"label_agreement":null},{"id":"W4386784382","doi":"10.1158/1557-3265.aacrahns23-po-017","title":"Abstract PO-017: Targeting murine oral tumors by pharmacological inhibition of b-catenin/CBP epigenetic activity","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Population; Immune system; Wnt signaling pathway; Biology; Cancer research; 4-Nitroquinoline 1-oxide; Cell; Carcinogen; Catenin; Phenotype; Epigenetics; Fibroblast; Cancer; Immunology; Cell culture; Medicine; Carcinogenesis; Cell biology; Genetics; Signal transduction","score_opus":0.30353936019203775,"score_gpt":0.5424886403528237,"score_spread":0.23894928016078598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97791183,0.0020693792,0.010264135,0.00040657545,0.00017253867,0.0002571375,0.0031634534,0.0006382157,0.0051167416],"genre_scores_gemma":[0.97204834,0.001599562,0.007874401,0.0002453794,0.00002535258,0.000429386,0.003575582,0.00021015492,0.013991848],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999706,0.000022475057,0.000019221423,0.00008556875,0.0000906993,0.00007608755],"domain_scores_gemma":[0.999882,0.000014713977,0.000029837905,0.00001692406,0.000014759091,0.00004182765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026320646,0.00049728266,0.0003364872,0.00043596126,0.0002250223,0.00040467354,0.0004658407,0.00046705283,0.0035161616],"category_scores_gemma":[0.000093642615,0.00024788338,0.00044412355,0.00022448486,0.00053211086,0.00022877309,0.0002000951,0.001266676,0.00092280196],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009263482,0.00006730861,0.00006295441,0.000038321163,0.000004893661,0.000019056517,0.000009614614,0.000048351838,0.998418,0.00011581959,0.00011014482,0.0010129315],"study_design_scores_gemma":[0.0000403714,0.0004936596,0.0013678983,0.000008665329,0.000021519874,0.00008977464,0.000028015864,0.00068201433,0.99340606,0.000046117682,0.0038113492,0.0000044066287],"about_ca_topic_score_codex":0.0012847534,"about_ca_topic_score_gemma":0.0023295593,"teacher_disagreement_score":0.0035161616,"about_ca_system_score_codex":0.0004152736,"about_ca_system_score_gemma":0.00045441964,"threshold_uncertainty_score":0.011762738},"labels":[],"label_agreement":null},{"id":"W4386784391","doi":"10.1158/1557-3265.aacrahns23-po-026","title":"Abstract PO-026: Intra-tumor heterogeneity of HPV integration and its association with focal genomic instability in oropharyngeal cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Carcinogenesis; Cancer; Genome instability; Biology; Genome; Somatic cell; Genetics; Cancer research; Phylogenetic tree; Gene; Oncology; Medicine; DNA; DNA damage","score_opus":0.09390790174029202,"score_gpt":0.45111336547855396,"score_spread":0.35720546373826195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992418,0.00022504087,0.00017739764,0.000009956321,0.0000018234778,0.0000042391225,0.00009003975,0.000005122168,0.00024461292],"genre_scores_gemma":[0.9997172,0.000035087272,0.000048224214,0.000002772329,0.0000031431205,0.0000020686107,0.00007393635,0.0000023656448,0.00011525551],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979943,0.000036386424,0.000022995666,0.000059431135,0.000042951484,0.0000388764],"domain_scores_gemma":[0.9993648,0.00009679083,0.00026606373,0.000054551332,0.0000757845,0.00014203429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029307342,0.00019897982,0.00019424851,0.0010397389,0.00027798855,0.00048526286,0.00025660978,0.00030074766,0.0029075714],"category_scores_gemma":[0.00074429275,0.00014276431,0.00021695034,0.0008687493,0.0002878395,0.00025404955,0.00035091935,0.00035187678,0.00031471357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088414276,0.00005001916,0.9678131,0.00003917081,0.00009660461,0.000739383,0.000103265025,0.00007654738,0.025657853,0.00004750936,0.00007816597,0.004414114],"study_design_scores_gemma":[0.0000055705837,0.00010654341,0.9957314,0.0000026583868,0.00004202983,0.0015034297,0.000114552015,0.00022808496,0.001995455,0.000049178216,0.00021789565,0.0000031384748],"about_ca_topic_score_codex":0.0012546411,"about_ca_topic_score_gemma":0.00067148835,"teacher_disagreement_score":0.0029075714,"about_ca_system_score_codex":0.00014423001,"about_ca_system_score_gemma":0.00012818983,"threshold_uncertainty_score":0.009726822},"labels":[],"label_agreement":null},{"id":"W4386784394","doi":"10.1158/1557-3265.aacrahns23-po-035","title":"Abstract PO-035: Immune profiles of long-term survivors of patients with head and neck squamous carcinoma on immune checkpoint inhibitor therapy","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Head and neck squamous-cell carcinoma; Medicine; Immune system; Cancer; Oncology; Head and neck cancer; Pembrolizumab; CD8; Internal medicine; Immune checkpoint; Immunology; Cancer research","score_opus":0.11894448955992439,"score_gpt":0.4381471259585031,"score_spread":0.3192026363985787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990982,0.00014691337,0.00006294625,0.00004002649,0.0000053277677,0.000007232446,0.00025912625,0.00000471614,0.00037552652],"genre_scores_gemma":[0.9987525,0.000059860504,0.00007756505,0.00005514203,0.00000817069,0.000013032069,0.00046826096,0.0000017149348,0.0005637924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999306,0.000008890287,0.0000065324334,0.000014920837,0.000017392531,0.000021572403],"domain_scores_gemma":[0.99976,0.00003306001,0.00005802998,0.000009429123,0.000041793042,0.00009771202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012926053,0.00012620688,0.00019214321,0.00030501783,0.0002916377,0.00025669837,0.00013144966,0.000252925,0.0018306988],"category_scores_gemma":[0.00041409995,0.00005860943,0.00012702693,0.00021177973,0.00013593675,0.000193697,0.00022383705,0.00030770816,0.00035499127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089304475,0.00008552137,0.9709446,0.000026543255,0.000029638291,0.00040401268,0.00024647976,0.000075190364,0.014802128,0.000013255849,0.0005364102,0.011943185],"study_design_scores_gemma":[0.0000083167115,0.0005582639,0.9966156,0.000004212012,0.000016936765,0.0006255116,0.00021122003,0.00008913663,0.0012737674,0.000011342279,0.0005823093,0.00000342267],"about_ca_topic_score_codex":0.0010051974,"about_ca_topic_score_gemma":0.001644563,"teacher_disagreement_score":0.0018306988,"about_ca_system_score_codex":0.00018985079,"about_ca_system_score_gemma":0.00015517623,"threshold_uncertainty_score":0.0061243176},"labels":[],"label_agreement":null},{"id":"W4386784398","doi":"10.1158/1557-3265.aacrahns23-po-025","title":"Abstract PO-025: The effect of tissue of origin on oncogenesis in HPV-related malignancies: Comparative analysis of molecular and immune signatures in HPV-positive head and neck cancer and cervical cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Carcinogenesis; CDKN2A; Head and neck cancer; Cervical cancer; Cancer; HPV infection; Medicine; Cancer research; Immune system; Somatic cell; Biology; Oncology; Internal medicine; Gene; Immunology; Genetics","score_opus":0.11250546472890705,"score_gpt":0.5185266317447995,"score_spread":0.40602116701589247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99793917,0.0005578018,0.00033387155,0.00001412121,0.0000027200801,0.000008001672,0.00057999976,0.000010422738,0.00055384537],"genre_scores_gemma":[0.99846715,0.000109127235,0.00023931815,0.000014649728,0.0000032456971,0.000010377379,0.0008649772,0.000007821881,0.00028329378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997645,0.00004421424,0.000017872042,0.000069634974,0.000053179683,0.00005065457],"domain_scores_gemma":[0.99973303,0.00009541828,0.00005816932,0.000025640053,0.00003405873,0.000053597647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030136158,0.00012759348,0.0002490292,0.0007563712,0.00019986648,0.00045861313,0.00017221979,0.00018158875,0.002688098],"category_scores_gemma":[0.00044819125,0.00006676585,0.00023534712,0.00062186527,0.0002217244,0.00019470246,0.00030767353,0.00017455016,0.0003558565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003344468,0.00008514501,0.57756245,0.00026040585,0.0002281079,0.00034521765,0.0001562342,0.0002585016,0.40130624,0.000137129,0.00021311245,0.016102942],"study_design_scores_gemma":[0.0000076270476,0.0003036209,0.97491974,0.000007687938,0.00009561933,0.0006906286,0.00014320102,0.0005078103,0.022506114,0.00006886695,0.0007460574,0.0000031063498],"about_ca_topic_score_codex":0.00054567907,"about_ca_topic_score_gemma":0.00052360346,"teacher_disagreement_score":0.002688098,"about_ca_system_score_codex":0.00015293872,"about_ca_system_score_gemma":0.00017395103,"threshold_uncertainty_score":0.008992612},"labels":[],"label_agreement":null},{"id":"W4386784411","doi":"10.1158/1557-3265.aacrahns23-po-043","title":"Abstract PO-043: Development of an automated multi-objective model utilizing delta radiomics to predict locoregional recurrence in head and neck cancer patients treated with primary radiation","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Head and neck squamous-cell carcinoma; Head and neck cancer; Radiomics; Cancer; Radiology; Internal medicine","score_opus":0.13507518765071339,"score_gpt":0.4879719196419132,"score_spread":0.35289673199119986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784411","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78362405,0.0012125453,0.20601124,0.0011435429,0.00020309228,0.00023642303,0.0016725609,0.0012174095,0.0046790494],"genre_scores_gemma":[0.98650324,0.000108550936,0.010224567,0.000120451856,0.000033638513,0.00013611262,0.00079109945,0.000018830828,0.0020635508],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998348,0.00003369202,0.000011349307,0.000055659788,0.000026883685,0.000037551912],"domain_scores_gemma":[0.99969673,0.00013957753,0.000038812843,0.0000104723285,0.000083879,0.000030472569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006308137,0.0007519005,0.00066017156,0.00058977655,0.00029542684,0.00076339016,0.0007927785,0.0008373911,0.0016291079],"category_scores_gemma":[0.0009450651,0.0003033992,0.0009467599,0.00020025046,0.00024362764,0.0002751605,0.00051578926,0.0007314856,0.0002751765],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018309611,0.00019002997,0.01886781,0.000050848175,0.00011564215,0.00014097324,0.00003319978,0.94518065,0.0015007633,0.00026673987,0.0011089218,0.03236128],"study_design_scores_gemma":[0.0000038237363,0.000037389033,0.0008836212,0.0000025415547,0.000009417659,0.0000075072885,0.000004054346,0.99877506,0.00013469317,0.0000680131,0.00007131737,0.0000025389356],"about_ca_topic_score_codex":0.019032141,"about_ca_topic_score_gemma":0.01163727,"teacher_disagreement_score":0.019032141,"about_ca_system_score_codex":0.0006551776,"about_ca_system_score_gemma":0.0009860788,"threshold_uncertainty_score":0.03784275},"labels":[],"label_agreement":null},{"id":"W4386784419","doi":"10.1158/1557-3265.aacrahns23-po-016","title":"Abstract PO-016: SSTR2 use and molecular profile in EBV-positive nasopharyngeal carcinoma: A single institution experience","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Somatostatin receptor 2; Immunohistochemistry; Medicine; Nasopharyngeal carcinoma; Malignancy; Microsatellite instability; Internal medicine; Oncology; Biopsy; Pathology; Cancer research; Somatostatin receptor; Receptor; Biology; Radiation therapy; Microsatellite; Gene; Genetics","score_opus":0.2902034492759341,"score_gpt":0.5352508114987602,"score_spread":0.24504736222282608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99879706,0.00029871054,0.00014702884,0.00002375767,0.000004452348,0.000012924818,0.00006335976,0.000008428855,0.00064424286],"genre_scores_gemma":[0.9992736,0.00019080681,0.00012713262,0.000024753195,0.0000093710205,0.0000063136986,0.00008768274,0.000006977659,0.00027340837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962306,0.00006259933,0.000061633626,0.0000920476,0.000085245316,0.00007551035],"domain_scores_gemma":[0.9992975,0.0001260871,0.00015648307,0.00008006517,0.00008066481,0.0002592091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041886195,0.0003867117,0.00034109905,0.00053663715,0.0006455477,0.0006922286,0.00036858313,0.00039195563,0.0022432383],"category_scores_gemma":[0.001142449,0.0002742321,0.0003837819,0.0007448345,0.00032448163,0.0005716586,0.000720346,0.00044038668,0.0009745232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027594608,0.0003183859,0.95599264,0.000054851604,0.000054968277,0.026100747,0.00071955007,0.00011065313,0.003871827,0.000025593334,0.00022329684,0.012251592],"study_design_scores_gemma":[0.000050628376,0.0022720736,0.7995298,0.00004696518,0.00013207231,0.18773721,0.0023861476,0.00067571807,0.004729171,0.00007223245,0.0023300014,0.00003803175],"about_ca_topic_score_codex":0.001337359,"about_ca_topic_score_gemma":0.001588247,"teacher_disagreement_score":0.0022432383,"about_ca_system_score_codex":0.00039330163,"about_ca_system_score_gemma":0.00044251827,"threshold_uncertainty_score":0.0075044036},"labels":[],"label_agreement":null},{"id":"W4386784420","doi":"10.1158/1557-3265.aacrahns23-po-045","title":"Abstract PO-045: Utility of circulating tumor tissue modified viral (TTMV)-HPV DNA to resolve clinically indeterminate findings in patients following definitive treatment for HPV-driven oropharyngeal cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cohort; Indeterminate; Internal medicine; Retrospective cohort study; Cancer; Oncology; Disease; Cohort study; Pathology","score_opus":0.310588114899989,"score_gpt":0.5418097745061936,"score_spread":0.2312216596062046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988024,0.00024503993,0.00012483052,0.000035431098,0.000006106519,0.0000111037625,0.00037132803,0.0000046982445,0.000399137],"genre_scores_gemma":[0.99956924,0.000037777252,0.000099636076,0.00001397152,0.000006748407,0.0000045095308,0.00021420832,0.0000010278524,0.00005283387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994523,0.00017196573,0.00007248694,0.00013582116,0.0001066464,0.000060886116],"domain_scores_gemma":[0.9969409,0.0008663802,0.0014806279,0.00013363436,0.00032054586,0.00025781157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010136714,0.00017079638,0.0002123564,0.00048482875,0.00028005955,0.00075975567,0.0004216191,0.0002981858,0.0013754619],"category_scores_gemma":[0.0046751834,0.00013003455,0.0002433421,0.0005468493,0.00026973826,0.00042445003,0.00032955242,0.00039569268,0.0002618306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014574027,0.000016102273,0.99780756,0.000008832882,0.000012933199,0.000039728624,0.000018838951,0.000034892473,0.000116512514,0.0000071186782,0.0000789927,0.0017128411],"study_design_scores_gemma":[0.000013985255,0.0003862252,0.9972671,0.000016243894,0.000038323233,0.00055848324,0.00017003245,0.0007749905,0.0004000867,0.00003418409,0.00033542403,0.0000050205185],"about_ca_topic_score_codex":0.0022545357,"about_ca_topic_score_gemma":0.002793545,"teacher_disagreement_score":0.0022545357,"about_ca_system_score_codex":0.00038756293,"about_ca_system_score_gemma":0.0003503629,"threshold_uncertainty_score":0.0053608418},"labels":[],"label_agreement":null},{"id":"W4386784425","doi":"10.1158/1557-3265.aacrahns23-po-039","title":"Abstract PO-039: Discovery and validation of methylated DNA markers of human papillomavirus associated oropharyngeal squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"NOP; Medicine; Internal medicine; Pathology; Receptor","score_opus":0.20127442093818648,"score_gpt":0.4931162133207433,"score_spread":0.2918417923825568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99746454,0.0003060974,0.0012425998,0.000027305121,0.0000061179467,0.000038204475,0.00047082113,0.00003053619,0.0004137935],"genre_scores_gemma":[0.99566525,0.00013064661,0.002295507,0.000032859014,0.0000057031993,0.000046864792,0.0012658148,0.000011593833,0.00054571265],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99970895,0.000049703856,0.000029529754,0.0000793824,0.00010009184,0.00003232901],"domain_scores_gemma":[0.9996037,0.00010215075,0.000075463024,0.000053477575,0.00010961423,0.00005559632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050651666,0.00020831128,0.00024502396,0.00039201727,0.00020665998,0.00036339724,0.00020828348,0.00025191013,0.0013587679],"category_scores_gemma":[0.0009443122,0.000102055004,0.00015362346,0.00029748984,0.00023992328,0.0001217667,0.00033780996,0.00025556647,0.00040505215],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012981734,0.00016755801,0.16056022,0.00016062116,0.00005930115,0.00034779854,0.0001193963,0.0004027539,0.815776,0.0000756703,0.0002785654,0.02075395],"study_design_scores_gemma":[0.00005871078,0.0024847076,0.4101922,0.000029827863,0.000121954276,0.0031706286,0.0001936884,0.0033997719,0.57622296,0.00011116459,0.0040025706,0.00001190593],"about_ca_topic_score_codex":0.00057181576,"about_ca_topic_score_gemma":0.00052732084,"teacher_disagreement_score":0.0013587679,"about_ca_system_score_codex":0.00016645443,"about_ca_system_score_gemma":0.00021052807,"threshold_uncertainty_score":0.0045455694},"labels":[],"label_agreement":null},{"id":"W4386784429","doi":"10.1158/1557-3265.aacrahns23-po-036","title":"Abstract PO-036: A deep learning alternative to regional molecular testing for HPV status","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Population; Digital pathology; Cancer; Pathology; Cohort; Oncology; Digital image analysis; Artificial intelligence; Internal medicine; Computer science","score_opus":0.29081775354541795,"score_gpt":0.5751571198133621,"score_spread":0.2843393662679442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784429","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14534613,0.0011789773,0.82683724,0.0013819468,0.0003252088,0.00024309766,0.0017672733,0.014175279,0.008744842],"genre_scores_gemma":[0.7850308,0.00030539167,0.1928005,0.0006810075,0.000084947154,0.00032945946,0.0030957456,0.00046330172,0.017208803],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99970645,0.00006678228,0.000014173793,0.00011807491,0.000054455402,0.000039973052],"domain_scores_gemma":[0.99963987,0.00013080215,0.000026235532,0.000058429927,0.000106522064,0.000038181282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010234929,0.0009081531,0.0005906527,0.00046441643,0.00024915175,0.0007219301,0.0018905507,0.0010968293,0.007031341],"category_scores_gemma":[0.0015427088,0.00037064106,0.00086259545,0.00037654382,0.0003691312,0.00071750314,0.0011796654,0.0016377845,0.0019183671],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044850737,0.00032087573,0.005171229,0.00011740073,0.00022732218,0.00017411403,0.00005519037,0.62557507,0.0060186004,0.0029445873,0.011415977,0.34753114],"study_design_scores_gemma":[0.000011719824,0.000045142886,0.00017666402,0.0000066622533,0.000008812745,0.000013571684,0.0000042335623,0.99670225,0.001274052,0.0010481037,0.0007048435,0.0000039836345],"about_ca_topic_score_codex":0.009517935,"about_ca_topic_score_gemma":0.008726406,"teacher_disagreement_score":0.009517935,"about_ca_system_score_codex":0.00073693716,"about_ca_system_score_gemma":0.0011404493,"threshold_uncertainty_score":0.023522198},"labels":[],"label_agreement":null},{"id":"W4386784459","doi":"10.1158/1557-3265.aacrahns23-po-008","title":"Abstract PO-008: Association of plasma Epstein-Barr virus DNA and clinical response in patients with recurrent and/or metastatic nasopharyngeal cancer treated with pembrolizumab or standard-of-care chemotherapy in KEYNOTE-122","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Pembrolizumab; Oncology; Gemcitabine; Viral load; Clinical trial; Chemotherapy; Cancer; Immunology; Virus; Immunotherapy","score_opus":0.0866717300103274,"score_gpt":0.457640037991458,"score_spread":0.3709683079811306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975368,0.00048203112,0.00011737992,0.000058769125,0.000020826556,0.0002064056,0.00078323716,0.00001739858,0.0007771194],"genre_scores_gemma":[0.9979882,0.00009966203,0.0001382424,0.00005167485,0.000026348893,0.00016286991,0.0009594515,0.00000345306,0.00057015225],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995591,0.00016325204,0.00003438334,0.00014654094,0.000049035665,0.000047597987],"domain_scores_gemma":[0.99931574,0.00015727019,0.00018223282,0.000078624704,0.000039155486,0.00022695964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008956387,0.0004197633,0.0008340326,0.0001807847,0.00015299853,0.00050711137,0.00050547655,0.0005263125,0.0054535843],"category_scores_gemma":[0.00131419,0.00020626764,0.00065210514,0.00027632012,0.00032924625,0.0005635145,0.00027570568,0.000973766,0.00055988785],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83816755,0.008077164,0.076284304,0.00069409655,0.0012036592,0.00012924743,0.0000935095,0.00095861085,0.031284608,0.00011881558,0.0018440236,0.04114434],"study_design_scores_gemma":[0.11289602,0.4152512,0.45347297,0.00007952802,0.0016100364,0.00054619747,0.00011664103,0.0027324336,0.009044284,0.00030510404,0.0038925926,0.000053005173],"about_ca_topic_score_codex":0.00020429079,"about_ca_topic_score_gemma":0.00035242888,"teacher_disagreement_score":0.0054535843,"about_ca_system_score_codex":0.0004302549,"about_ca_system_score_gemma":0.0004324507,"threshold_uncertainty_score":0.018244088},"labels":[],"label_agreement":null},{"id":"W4386784474","doi":"10.1158/1557-3265.aacrahns23-po-005","title":"Abstract PO-005: Phase 1/2 study of Ad/PNP with fludarabine for the treatment of head &amp; neck squamous cell carcinoma (HNSCC)","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Antimetabolite; Prodrug; Gemcitabine; Fludarabine; Cytosine deaminase; Adverse effect; Nucleoside analogue; Internal medicine; Head and neck squamous-cell carcinoma; Head and neck cancer; Toxicity; Chemotherapy; Oncology; Pharmacology; Cancer; Gastroenterology; Nucleoside; Genetic enhancement; Biology","score_opus":0.24518795781810954,"score_gpt":0.5326432941716704,"score_spread":0.2874553363535609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880717,0.00082263985,0.00079982367,0.00042572847,0.00012314903,0.005506229,0.0012397751,0.00012047103,0.002890461],"genre_scores_gemma":[0.98013705,0.0009873956,0.0031708302,0.0008425446,0.00011497843,0.004952781,0.003201993,0.00003914661,0.0065532546],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99961424,0.0001623193,0.00001604551,0.00006623467,0.00004698148,0.00009409366],"domain_scores_gemma":[0.99964845,0.000041051782,0.000038750164,0.000031090105,0.000030494904,0.00021013411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018321204,0.0016242099,0.0010922655,0.00060738984,0.0005035098,0.0011606965,0.0011812886,0.0012903793,0.0036735525],"category_scores_gemma":[0.00042513237,0.00048165774,0.0009111384,0.00028136908,0.0011074091,0.0007143142,0.00033555547,0.0029095626,0.00090432743],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30482244,0.26420793,0.007630192,0.0010592063,0.0010504314,0.0008297263,0.0005989021,0.005127124,0.25489557,0.0013497714,0.010425089,0.14800355],"study_design_scores_gemma":[0.25295573,0.700938,0.0077761016,0.000047659243,0.00031976696,0.00040303118,0.000107789434,0.0025226497,0.0291112,0.00030553903,0.0054837544,0.000028744822],"about_ca_topic_score_codex":0.0026141652,"about_ca_topic_score_gemma":0.0040920787,"teacher_disagreement_score":0.0036735525,"about_ca_system_score_codex":0.0011280172,"about_ca_system_score_gemma":0.0020210133,"threshold_uncertainty_score":0.012289286},"labels":[],"label_agreement":null},{"id":"W4386784480","doi":"10.1158/1557-3265.aacrahns23-po-003","title":"Abstract PO-003: Lenvatinib with or without pembrolizumab versus chemotherapy for treatment of recurrent or metastatic head and neck squamous cell carcinoma that progressed on platinum therapy and immunotherapy: Phase 2 LEAP-009","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Pembrolizumab; Medicine; Lenvatinib; Cetuximab; Oncology; Internal medicine; Docetaxel; Head and neck squamous-cell carcinoma; Chemotherapy; Head and neck cancer; Radiation therapy; Immunotherapy; Cancer; Colorectal cancer","score_opus":0.43604045562691957,"score_gpt":0.5483569098400536,"score_spread":0.11231645421313402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726208,0.0034698914,0.000843568,0.0013162161,0.00050498825,0.009816537,0.0039187605,0.0002384356,0.00727085],"genre_scores_gemma":[0.97198975,0.0016875818,0.002409117,0.0019419668,0.00037313043,0.008290597,0.0045106374,0.000060861526,0.0087363385],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995022,0.00024862433,0.00003108508,0.00007831314,0.000047761507,0.00009193874],"domain_scores_gemma":[0.99938047,0.00010056971,0.00011688385,0.000045599973,0.0000387723,0.0003177314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015264112,0.0011937489,0.0017866427,0.00047294912,0.000421838,0.0012071655,0.00114726,0.0014171556,0.0112834135],"category_scores_gemma":[0.0010828814,0.00046206525,0.0017450502,0.00036825912,0.00075235637,0.001106594,0.00045048067,0.0041385763,0.0014173419],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91872793,0.022869647,0.0010790096,0.000601893,0.0007908509,0.00008455971,0.000059828955,0.0008003415,0.009296763,0.00023604816,0.003358066,0.04209503],"study_design_scores_gemma":[0.83019423,0.1611532,0.0037756504,0.000045443096,0.00042615237,0.000080848535,0.000022848873,0.0007378757,0.0015582069,0.00019666825,0.0017936374,0.000015199771],"about_ca_topic_score_codex":0.0008977139,"about_ca_topic_score_gemma":0.0021537398,"teacher_disagreement_score":0.0112834135,"about_ca_system_score_codex":0.001030863,"about_ca_system_score_gemma":0.0019965246,"threshold_uncertainty_score":0.037746847},"labels":[],"label_agreement":null},{"id":"W4386784489","doi":"10.1158/1557-3265.aacrahns23-po-009","title":"Abstract PO-009: Phase 3 KEYNOTE-630 study of adjuvant pembrolizumab in high-risk locally advanced cutaneous squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Perineural invasion; Pembrolizumab; Lymph node; Radiation therapy; Cancer; Surgery; Oncology; Pathology; Internal medicine; Immunotherapy","score_opus":0.12783249203628913,"score_gpt":0.4910254474834192,"score_spread":0.36319295544713004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790396,0.0043892195,0.00078366825,0.0009709856,0.00030550594,0.0055554374,0.00282534,0.0002663664,0.0058637587],"genre_scores_gemma":[0.97569054,0.0035323284,0.0017320786,0.0023684779,0.00022488085,0.0051922756,0.0037924189,0.000053969085,0.0074130935],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997805,0.00009339565,0.000013565543,0.00003540223,0.000028496941,0.000048698083],"domain_scores_gemma":[0.9996006,0.000056466597,0.00008735882,0.000031641623,0.000040008716,0.00018392164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015017327,0.0011039932,0.001127385,0.0002673385,0.00037726603,0.0011306717,0.00076807005,0.0011874321,0.007796839],"category_scores_gemma":[0.0007197929,0.0004020019,0.0010443188,0.00033214132,0.00061267166,0.00072764046,0.00034344598,0.0031975992,0.0016316957],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71146935,0.074150994,0.005802204,0.0031045692,0.0020432747,0.0004200662,0.00028506984,0.0028170126,0.06357604,0.0006726436,0.015953615,0.11970514],"study_design_scores_gemma":[0.78080016,0.20080468,0.009053579,0.00011121434,0.00055712886,0.00024560656,0.000059427446,0.0010074077,0.0028366975,0.00030483992,0.0041955644,0.000023699911],"about_ca_topic_score_codex":0.0010558154,"about_ca_topic_score_gemma":0.0024787206,"teacher_disagreement_score":0.007796839,"about_ca_system_score_codex":0.0007967709,"about_ca_system_score_gemma":0.0016694401,"threshold_uncertainty_score":0.026083052},"labels":[],"label_agreement":null},{"id":"W4386784494","doi":"10.1158/1557-3265.aacrahns23-po-001","title":"Abstract PO-001: Circulating tumor-tissue modified HPV DNA testing in the clinical workup of patients at risk for HPV-positive oropharynx cancer: The IDEA-HPV Study","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Otorhinolaryngology; Tonsil; Internal medicine; Cancer; Prospective cohort study; Head and neck cancer; Oncology; Pathology; Surgery","score_opus":0.40623413109106743,"score_gpt":0.5660215393564944,"score_spread":0.15978740826542692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99848443,0.00022212739,0.00011456077,0.000078531586,0.000018183124,0.00015556834,0.0004044704,0.0000033124668,0.0005187758],"genre_scores_gemma":[0.9983961,0.00012286346,0.00029249606,0.00009948014,0.0000393953,0.00012099812,0.0006710956,0.000003872704,0.0002537472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888235,0.00061284733,0.00009237568,0.00020198035,0.00012088584,0.00008960106],"domain_scores_gemma":[0.9976318,0.00051767874,0.0006626834,0.00019318928,0.00027185996,0.0007228177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002887683,0.0006678135,0.0003784587,0.00059382984,0.00045044138,0.0011090296,0.00063778664,0.00072978076,0.0024711052],"category_scores_gemma":[0.0038182628,0.0005515169,0.0005780862,0.0007032643,0.00052084186,0.001012681,0.0009329226,0.0009939148,0.00091396074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005132485,0.000790783,0.9909155,0.000046735575,0.00011519608,0.00006728691,0.00013053139,0.000038134283,0.00040155233,0.000018770503,0.00022993748,0.0021129658],"study_design_scores_gemma":[0.0025752725,0.014849161,0.9788715,0.00005053215,0.00035467368,0.0005804573,0.0007768092,0.00059085677,0.00029313157,0.00006593765,0.0009645289,0.00002697532],"about_ca_topic_score_codex":0.0010877154,"about_ca_topic_score_gemma":0.0011505043,"teacher_disagreement_score":0.002887683,"about_ca_system_score_codex":0.0003167804,"about_ca_system_score_gemma":0.00057624857,"threshold_uncertainty_score":0.015271723},"labels":[],"label_agreement":null},{"id":"W4386784510","doi":"10.1158/1557-3265.aacrahns23-po-002","title":"Abstract PO-002: Pembrolizumab as neoadjuvant and adjuvant therapy in combination with standard of care in resectable, locally advanced head and neck squamous cell carcinoma: Phase 3 KEYNOTE-689","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pembrolizumab; Head and neck squamous-cell carcinoma; Adjuvant; Radiation therapy; Neoadjuvant therapy; Internal medicine; Larynx; Oncology; Adjuvant therapy; Stage (stratigraphy); Head and neck cancer; Surgery; Cancer; Immunotherapy","score_opus":0.09353327907684729,"score_gpt":0.47623034522521074,"score_spread":0.38269706614836346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9648457,0.0027847332,0.0016401897,0.0014196566,0.00038281194,0.013763959,0.005139972,0.00040403375,0.009618955],"genre_scores_gemma":[0.96415395,0.001854904,0.004154544,0.0015834182,0.00026572868,0.012411579,0.004780119,0.000076247496,0.010719519],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997063,0.00012839113,0.000018028728,0.000055658584,0.000036090987,0.000055471526],"domain_scores_gemma":[0.99960333,0.000045614055,0.00006803568,0.00003343302,0.000026256423,0.00022333737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010489183,0.00093715877,0.0012419701,0.00046814865,0.0004685551,0.0008965732,0.001121099,0.0012300243,0.012477015],"category_scores_gemma":[0.0006326959,0.00043137235,0.0008524672,0.00033085473,0.00069763866,0.00082584284,0.000369769,0.0028912907,0.0018752553],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78133357,0.061959177,0.002169941,0.00087472115,0.00074930466,0.00013871798,0.000117443924,0.0011155837,0.04327092,0.0004478971,0.011862763,0.095959954],"study_design_scores_gemma":[0.75050133,0.23728979,0.0038880166,0.000047865073,0.00025811954,0.00010756022,0.00002426989,0.00069656066,0.0033209473,0.00019637168,0.0036526085,0.000016604412],"about_ca_topic_score_codex":0.0007560516,"about_ca_topic_score_gemma":0.0023219571,"teacher_disagreement_score":0.012477015,"about_ca_system_score_codex":0.0007607348,"about_ca_system_score_gemma":0.0016336606,"threshold_uncertainty_score":0.04173976},"labels":[],"label_agreement":null},{"id":"W4386784545","doi":"10.1158/1557-3265.aacrahns23-po-099","title":"Abstract PO-099: Short-term outcomes of an extended endoscopic endonasal resection of a clival giant cell tumor with adjuvant RANK-L inhibitor therapy: Case report","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bone Tumor Diagnosis and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Endoscopic endonasal surgery; Magnetic resonance imaging; Radiology; Neurosurgery; Clivus; Surgery; Skull; Denosumab; Adjuvant therapy; Headaches; Pathology; Chemotherapy","score_opus":0.2127769529602967,"score_gpt":0.5049925198938775,"score_spread":0.2922155669335808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914847,0.0030608801,0.0011702736,0.0006829177,0.00014733622,0.00007963012,0.00016671771,0.00005229302,0.0031552042],"genre_scores_gemma":[0.9970469,0.00060528354,0.00043390784,0.00036559583,0.00014738558,0.000020239007,0.000263108,0.0000120573695,0.0011056502],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99965334,0.00003328958,0.000056353692,0.000073036936,0.00006896031,0.000114913084],"domain_scores_gemma":[0.99886405,0.00015446116,0.0002625126,0.0001561097,0.00009466148,0.0004682302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027339876,0.0005989984,0.0007311671,0.0005584672,0.00096221804,0.0010281986,0.0006069327,0.0019010558,0.0011868185],"category_scores_gemma":[0.0013286056,0.00026932659,0.00096332654,0.0003922356,0.00068031246,0.0007980988,0.0009593382,0.0016898835,0.00088334334],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020069398,0.00033415487,0.027489379,0.000062111525,0.000058863803,0.9604696,0.00025026983,0.00014607552,0.002688402,0.0001292782,0.00034787704,0.007823205],"study_design_scores_gemma":[0.00003566445,0.0008728538,0.031419493,0.000034096163,0.000067389796,0.9643097,0.0003259858,0.0004820729,0.0009309877,0.0001347195,0.0013605196,0.000026573118],"about_ca_topic_score_codex":0.0009943856,"about_ca_topic_score_gemma":0.0017821048,"teacher_disagreement_score":0.0019010558,"about_ca_system_score_codex":0.0007181009,"about_ca_system_score_gemma":0.00067362277,"threshold_uncertainty_score":0.005210221},"labels":[],"label_agreement":null},{"id":"W4386784548","doi":"10.1158/1557-3265.aacrahns23-pr04","title":"Abstract PR04: Deciphering radiotherapy resistance mechanisms in HPV negative and positive head and neck cancers","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Head and neck squamous-cell carcinoma; Radioresistance; Medicine; Radiation therapy; Head and neck cancer; Cancer research; Oncology; Cancer; Biomarker; Internal medicine; Biology","score_opus":0.11592758785667295,"score_gpt":0.48270314275624726,"score_spread":0.3667755548995743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7313429,0.22855608,0.009406681,0.006480253,0.0011897391,0.00040887378,0.0064131874,0.0007248919,0.015477376],"genre_scores_gemma":[0.9213565,0.053308494,0.0060543944,0.0017091233,0.00056019233,0.0002007428,0.0074356245,0.000086389475,0.009288616],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996346,0.00005233688,0.00002259957,0.00007710107,0.00014103318,0.00007217448],"domain_scores_gemma":[0.99957544,0.000059078007,0.000096819436,0.000030545445,0.00016150992,0.00007662957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088544376,0.00034468918,0.00066398864,0.0013542972,0.00035630714,0.0013972231,0.0006628819,0.00085640076,0.0046144673],"category_scores_gemma":[0.0008044572,0.00026083394,0.00077838893,0.0009646215,0.00033635617,0.0011596124,0.0005853597,0.0011783363,0.0013323564],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002967606,0.000679749,0.18727708,0.0077744727,0.00055670564,0.0015932454,0.00073269894,0.0025373625,0.2913798,0.0032104678,0.032266643,0.4690242],"study_design_scores_gemma":[0.00019475582,0.005341895,0.6452055,0.0018931053,0.0015468664,0.012036541,0.0030144344,0.012113432,0.09380443,0.0063131014,0.2183738,0.00016224252],"about_ca_topic_score_codex":0.0011915591,"about_ca_topic_score_gemma":0.0010860452,"teacher_disagreement_score":0.0046144673,"about_ca_system_score_codex":0.00073706504,"about_ca_system_score_gemma":0.00082153495,"threshold_uncertainty_score":0.015436947},"labels":[],"label_agreement":null},{"id":"W4386784562","doi":"10.1158/1557-3265.aacrahns23-pr01","title":"Abstract PR01: Lymph node colonization promotes distant tumor metastasis through the induction of tumor-specific immune tolerance","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metastasis; Immune system; Cancer research; Tumor progression; Immunotherapy; Lymphatic system; Biology; Immunology; Adoptive cell transfer; Cancer; FOXP3; Primary tumor; Medicine; T cell; Internal medicine","score_opus":0.2273694373695485,"score_gpt":0.4783466230660269,"score_spread":0.25097718569647837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933768,0.00044102664,0.002615521,0.00011512024,0.000032472544,0.00003557776,0.0004085218,0.000144324,0.002830548],"genre_scores_gemma":[0.99311745,0.00023934159,0.0012356121,0.00007618511,0.000018947721,0.0000394805,0.00083917705,0.000037928938,0.004395883],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998504,0.000020052234,0.000009557991,0.000029949399,0.00004121846,0.00004875549],"domain_scores_gemma":[0.9998654,0.000026810438,0.000034015487,0.000016084245,0.000014192198,0.00004351826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010754208,0.00035422135,0.00024970016,0.00020405327,0.00011153891,0.00022532565,0.00020278848,0.0002310522,0.0033438492],"category_scores_gemma":[0.00011266537,0.000078377925,0.00021553432,0.00012290067,0.00020158033,0.00012076416,0.0001654015,0.000900502,0.00082627265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013923513,0.00008612743,0.00017280647,0.000017606988,0.000001973681,0.00005758373,0.000005660764,0.000057844067,0.9981035,0.00007942993,0.00010495686,0.00117328],"study_design_scores_gemma":[0.00006831365,0.002102986,0.005520119,0.000008825134,0.000014304414,0.0007514412,0.00003105354,0.0014413128,0.9873645,0.0000949032,0.0025974268,0.0000048423362],"about_ca_topic_score_codex":0.0003695243,"about_ca_topic_score_gemma":0.00029458982,"teacher_disagreement_score":0.0033438492,"about_ca_system_score_codex":0.0001743798,"about_ca_system_score_gemma":0.00017344521,"threshold_uncertainty_score":0.011186302},"labels":[],"label_agreement":null},{"id":"W4386784564","doi":"10.1158/1557-3265.aacrahns23-po-095","title":"Abstract PO-095: TGF-β carrying exosomes in plasma of HNSCC as potential biomarkers of disease progression in patients with HNSCC","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Transforming growth factor; Flow cytometry; Cancer; Tumor progression; Carcinogenesis; Microvesicles; Plasma cell; Head and neck squamous-cell carcinoma; Biology; Medicine; Pathology; Head and neck cancer; Molecular biology; Antibody; Internal medicine; Immunology; microRNA; Gene","score_opus":0.05410638398017381,"score_gpt":0.4489318950366423,"score_spread":0.3948255110564685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99792826,0.0007238718,0.00044059154,0.00002893504,0.000008994054,0.000012442538,0.00047077704,0.000018840115,0.00036720914],"genre_scores_gemma":[0.99844825,0.0001392151,0.00048954785,0.000020594003,0.000011591288,0.000014604756,0.0005663694,0.0000035994226,0.00030619744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998925,0.000024236007,0.000015221394,0.000027924434,0.00002713388,0.00001288925],"domain_scores_gemma":[0.9997961,0.000052401218,0.00006283291,0.000015263011,0.0000471631,0.00002624241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029168607,0.00016094925,0.00018841961,0.00046242436,0.00017501863,0.00039573511,0.00009607566,0.00024454432,0.0012665035],"category_scores_gemma":[0.0004691102,0.00007833205,0.00015885434,0.0003034631,0.00011234525,0.00023856376,0.00020778639,0.00027665438,0.00018593355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030671621,0.00011341733,0.8356972,0.00017033755,0.00012475823,0.0005771481,0.00019802284,0.0002465539,0.13826817,0.00009003472,0.00052469,0.02092251],"study_design_scores_gemma":[0.000049313287,0.000992247,0.95851105,0.000029736411,0.0001692609,0.0025574456,0.0003624553,0.0017818612,0.032984484,0.00015780056,0.002393055,0.000011321953],"about_ca_topic_score_codex":0.00033438441,"about_ca_topic_score_gemma":0.00025283845,"teacher_disagreement_score":0.0012665035,"about_ca_system_score_codex":0.00013012001,"about_ca_system_score_gemma":0.00010585549,"threshold_uncertainty_score":0.004236877},"labels":[],"label_agreement":null},{"id":"W4386784566","doi":"10.1158/1557-3265.aacrahns23-po-100","title":"Abstract PO-100: <i>Fusobacterium nucleatum</i> promotes epithelial-mesenchymal transition (EMT) of oral squamous cell carcinoma (OSCC) via INHBA-dependent SMAD/Laminin332/PI3K/AKT pathway","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Oral Health Pathology and Treatment","field":"Dentistry","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fusobacterium nucleatum; Transcriptome; Biology; Cancer research; Carcinogenesis; Epithelial–mesenchymal transition; SNAI1; Microbiology; Downregulation and upregulation; Gene expression; Cancer; Gene; Porphyromonas gingivalis; Genetics; Bacteria","score_opus":0.16724656185439732,"score_gpt":0.4586291961713074,"score_spread":0.29138263431691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797121,0.003406633,0.0043184995,0.0008043127,0.0003193557,0.000116675445,0.0053007444,0.00048548408,0.005536286],"genre_scores_gemma":[0.9861119,0.0012985374,0.0018648665,0.0003799608,0.000046801655,0.00015037526,0.004346185,0.000066505876,0.0057348358],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997458,0.000024409797,0.000017842893,0.000058483616,0.00008230148,0.000071086884],"domain_scores_gemma":[0.99991155,0.000011312939,0.000024580815,0.000007060968,0.000019520628,0.000025999161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012549944,0.0004056714,0.00034944876,0.00032802369,0.00032882995,0.00045245685,0.00017843218,0.00037161738,0.005609925],"category_scores_gemma":[0.00016671285,0.00013388033,0.00036484335,0.00036102362,0.00030965518,0.00025970364,0.0002756744,0.0008026073,0.0010306946],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044965406,0.00005880592,0.0012607217,0.0001406236,0.000018039327,0.000120002296,0.000019354775,0.00006389389,0.99414283,0.000057822603,0.000624891,0.0030434562],"study_design_scores_gemma":[0.00008943288,0.0010461977,0.051374216,0.00005377825,0.00010625239,0.00084689097,0.00036536946,0.0018086211,0.92971736,0.00020249744,0.014371145,0.00001816028],"about_ca_topic_score_codex":0.0014965087,"about_ca_topic_score_gemma":0.0017253779,"teacher_disagreement_score":0.005609925,"about_ca_system_score_codex":0.00034432413,"about_ca_system_score_gemma":0.00035408782,"threshold_uncertainty_score":0.018767059},"labels":[],"label_agreement":null},{"id":"W4386784570","doi":"10.1158/1557-3265.aacrahns23-po-093","title":"Abstract PO-093: Crenolanib improves PD-1 response and overall survival in immune checkpoint inhibitor resistant murine models of oral squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Tumor microenvironment; Cancer research; Head and neck squamous-cell carcinoma; Cancer; Immunotherapy; Head and neck cancer; Internal medicine","score_opus":0.1850307409278701,"score_gpt":0.45823194634657,"score_spread":0.27320120541869986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99399143,0.00090942887,0.0009709304,0.00023562272,0.00008708867,0.000104737985,0.0013430596,0.0001819583,0.002175826],"genre_scores_gemma":[0.9907065,0.0007281602,0.0014257854,0.00011518707,0.000017356828,0.00018997549,0.0011927069,0.00002875231,0.0055955295],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999754,0.000036117082,0.000024552975,0.00004485915,0.000061488696,0.00007899959],"domain_scores_gemma":[0.999848,0.0000110928095,0.00004597574,0.000020977504,0.000013854948,0.00006001373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002891548,0.0007686518,0.00059132837,0.0006390906,0.00021762037,0.00040590236,0.0004950688,0.0006271898,0.002580849],"category_scores_gemma":[0.0000734056,0.0002386493,0.0005187814,0.00025937578,0.00036328795,0.0003657096,0.00016640205,0.0019196604,0.0006981878],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016936728,0.0014396522,0.0002542841,0.00008447412,0.000018150842,0.000051001218,0.000026330581,0.00026554524,0.9924804,0.00011487932,0.00032977085,0.003241949],"study_design_scores_gemma":[0.0003665401,0.009348208,0.00413438,0.000017580589,0.00005837428,0.00020205237,0.00008057079,0.001700719,0.98159033,0.00006726628,0.0024221682,0.000011855484],"about_ca_topic_score_codex":0.0010519872,"about_ca_topic_score_gemma":0.0015292262,"teacher_disagreement_score":0.002580849,"about_ca_system_score_codex":0.00048427124,"about_ca_system_score_gemma":0.00049292296,"threshold_uncertainty_score":0.008633792},"labels":[],"label_agreement":null},{"id":"W4386784577","doi":"10.1158/1557-3265.aacrahns23-pr02","title":"Abstract PR02: Tumor sequestered, neoantigen specific T cells are dynamically increased in circulation following neoadjuvant immunotherapy","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; CD8; Tumor microenvironment; Immune checkpoint; T cell; T-cell receptor; Immunotherapy; Cancer research; Transcriptome; Antigen; Memory T cell; Cytotoxic T cell; Immunology; Immune system; Gene; Genetics","score_opus":0.18612098032476052,"score_gpt":0.48044560482625437,"score_spread":0.2943246245014939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971073,0.0006614015,0.0007194222,0.000048818732,0.000018765953,0.000015449765,0.0003668983,0.000043874406,0.001018057],"genre_scores_gemma":[0.9972523,0.00013050216,0.00046174272,0.00006583537,0.000014574676,0.00003254841,0.0006660792,0.000013604242,0.0013627375],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999274,0.000010975325,0.0000047437957,0.000020965868,0.000015884461,0.000020054043],"domain_scores_gemma":[0.99992585,0.00002045912,0.000018435197,0.000006345893,0.000009512904,0.000019312462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007303345,0.00012336869,0.00016556135,0.00012674114,0.000072034534,0.00020560024,0.000059297534,0.0001578287,0.0022041227],"category_scores_gemma":[0.00018276158,0.000068090194,0.00007183375,0.000121292265,0.00009284619,0.000110753026,0.00007420576,0.00040125012,0.00046039786],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012208651,0.000049237166,0.0034562321,0.000056645426,0.000006066845,0.00016676635,0.000033965593,0.00006131312,0.9895292,0.000026044336,0.00016933698,0.0052244216],"study_design_scores_gemma":[0.00014535921,0.0052101156,0.21193676,0.000026887417,0.000097226155,0.0043544974,0.0002591553,0.003328145,0.76561403,0.00023080962,0.008782823,0.000014157139],"about_ca_topic_score_codex":0.00012656457,"about_ca_topic_score_gemma":0.00012299107,"teacher_disagreement_score":0.0022041227,"about_ca_system_score_codex":0.00010556539,"about_ca_system_score_gemma":0.000076529155,"threshold_uncertainty_score":0.007373512},"labels":[],"label_agreement":null},{"id":"W4386784603","doi":"10.1158/1557-3265.aacrahns23-pr07","title":"Abstract PR07: Oncogene addition to MYB-NFIB in adenoid cystic carcinomas induced in transgenic mice","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"MYB; Cancer research; Biology; Adenoid cystic carcinoma; Oncogene; Cancer; Carcinoma; Cell cycle; Transcription factor; Genetics; Gene","score_opus":0.3975003673302855,"score_gpt":0.5573241507492802,"score_spread":0.15982378341899472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97704154,0.0012134137,0.0082321875,0.0005567441,0.00018684089,0.0003231571,0.007891701,0.0009791742,0.0035752086],"genre_scores_gemma":[0.95529,0.0009694922,0.009945021,0.0003169466,0.00006198537,0.0007803354,0.010820719,0.0005763179,0.021239154],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999196,0.000080495556,0.000087283486,0.0002294851,0.00022234314,0.00018435002],"domain_scores_gemma":[0.99931014,0.000093180846,0.0002437159,0.00008664124,0.000052355026,0.00021400437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034828787,0.0007645768,0.00048263368,0.0010471012,0.00033985457,0.00059922336,0.00058250624,0.0011360002,0.0038923281],"category_scores_gemma":[0.00021976681,0.00051135564,0.0007569885,0.00047496404,0.000790512,0.00047522422,0.0003374088,0.002631226,0.0017344664],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015471927,0.000073065465,0.000094577365,0.000025623525,0.000005812027,0.0000660473,0.000021978312,0.000041302505,0.9987943,0.00015704741,0.00009466246,0.00047085615],"study_design_scores_gemma":[0.00010558511,0.00078840926,0.003581171,0.000017014429,0.000029212275,0.0005691046,0.00007971236,0.0014566209,0.98874974,0.000101388585,0.0045084157,0.000013588274],"about_ca_topic_score_codex":0.00089035573,"about_ca_topic_score_gemma":0.0010804305,"teacher_disagreement_score":0.0038923281,"about_ca_system_score_codex":0.00070030557,"about_ca_system_score_gemma":0.000370675,"threshold_uncertainty_score":0.013021171},"labels":[],"label_agreement":null},{"id":"W4386784615","doi":"10.1158/1557-3265.aacrahns23-po-080","title":"Abstract PO-080: Statin in combination with cisplatin makes favorable tumor-immune microenvironment for immunotherapy of head and neck squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Head and neck squamous-cell carcinoma; Medicine; Tumor microenvironment; Immunotherapy; Cisplatin; Cancer research; Immunogenic cell death; Cancer; Combination therapy; Immune system; Statin; Internal medicine; Head and neck cancer; Immunology; Chemotherapy","score_opus":0.05841426286036372,"score_gpt":0.3942780151165683,"score_spread":0.3358637522562046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99316794,0.0035113809,0.0010656095,0.00030762865,0.00013662245,0.000104255145,0.00018692872,0.000047059555,0.001472651],"genre_scores_gemma":[0.9943305,0.0016219085,0.001332138,0.00012413587,0.000042304157,0.000065178814,0.00017157105,0.000008181154,0.0023040087],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999074,0.000016327334,0.000012398575,0.000016136251,0.000022930475,0.000024838628],"domain_scores_gemma":[0.9999666,0.0000029837342,0.000005605771,0.000002866139,0.000005691633,0.000016262364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104763036,0.00018353031,0.00039935566,0.00019577116,0.00020034691,0.00026518427,0.00017245361,0.0002237197,0.0018067937],"category_scores_gemma":[0.000070380935,0.00008597548,0.00023579855,0.00015162419,0.00015100751,0.00023578394,0.0002531904,0.00037425218,0.00034595482],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093201234,0.0002688471,0.000870412,0.00017622161,0.000019526511,0.00012808284,0.000022760934,0.00011253289,0.9877082,0.00013137372,0.00037285735,0.009257155],"study_design_scores_gemma":[0.00026274176,0.003751084,0.0075395466,0.000015533486,0.00012717496,0.00043350822,0.000068064066,0.0010017444,0.9782849,0.00007409001,0.008430085,0.000011452428],"about_ca_topic_score_codex":0.00052634865,"about_ca_topic_score_gemma":0.0013096705,"teacher_disagreement_score":0.0018067937,"about_ca_system_score_codex":0.0001749177,"about_ca_system_score_gemma":0.0004548212,"threshold_uncertainty_score":0.006044328},"labels":[],"label_agreement":null},{"id":"W4386784622","doi":"10.1158/1557-3265.aacrahns23-po-091","title":"Abstract PO-091: Leveraging tissue-resident CD103+ NK cells for adoptive cell therapy in head and neck cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Head and neck squamous-cell carcinoma; NK-92; Cancer research; Adoptive cell transfer; Granzyme; Perforin; Biology; Granzyme B; Lymphokine-activated killer cell; Population; Immunotherapy; Immunology; Interleukin 21; Cancer; T cell; Medicine; Head and neck cancer; CD8; Immune system","score_opus":0.23225291198068368,"score_gpt":0.4944557688991713,"score_spread":0.26220285691848766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824598,0.0019848235,0.010966308,0.00022060442,0.000104538,0.00029879957,0.00047726915,0.00018965996,0.0032982235],"genre_scores_gemma":[0.98605585,0.0009134652,0.00812438,0.00009817647,0.000022832402,0.00014944491,0.00049373246,0.000028872224,0.0041133445],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998802,0.000015361877,0.000010852244,0.000027385791,0.00003600814,0.000030200054],"domain_scores_gemma":[0.9999522,0.0000072648804,0.0000095964315,0.000009075032,0.000008752812,0.000013053348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015414465,0.00022592909,0.00026340704,0.00016647394,0.00013074261,0.00041612028,0.00023042058,0.00026317986,0.0015530518],"category_scores_gemma":[0.000082402265,0.000065393884,0.00017537363,0.0001276497,0.00016287286,0.00019734133,0.00018308095,0.00084206,0.00048900687],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011846307,0.00017885154,0.00037572611,0.00005268712,0.0000055976325,0.0000628623,0.00002043783,0.00020221551,0.98905075,0.000119743614,0.0002161845,0.009596479],"study_design_scores_gemma":[0.000042898544,0.0008834171,0.0024320807,0.000008332552,0.00002476416,0.0003436313,0.000032471507,0.001633785,0.98972344,0.000041719817,0.004828665,0.000004684518],"about_ca_topic_score_codex":0.00069106615,"about_ca_topic_score_gemma":0.0009634358,"teacher_disagreement_score":0.0015530518,"about_ca_system_score_codex":0.00020976065,"about_ca_system_score_gemma":0.00027063934,"threshold_uncertainty_score":0.0051954985},"labels":[],"label_agreement":null},{"id":"W4386784641","doi":"10.1158/1557-3265.aacrahns23-po-075","title":"Abstract PO-075: Immunosuppression allows for proliferation of alternative splicing events in a murine model of tobacco-associated oral cavity squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"RNA splicing; Immunosuppression; Alternative splicing; Biology; Cancer research; Carcinogenesis; Cancer; Immune system; Molecular biology; Gene isoform; Gene; Immunology; Genetics; RNA","score_opus":0.17678999382888944,"score_gpt":0.47423213055533747,"score_spread":0.29744213672644804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99296063,0.00045660938,0.0021214138,0.0001945517,0.00008722657,0.0002063343,0.0014493216,0.0001884944,0.0023352874],"genre_scores_gemma":[0.98368233,0.0005319708,0.0035083352,0.00017770205,0.000039542498,0.0004918819,0.0018280047,0.000099305034,0.009640954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991455,0.00012823798,0.00009098207,0.000188562,0.00027865428,0.00016791264],"domain_scores_gemma":[0.99946135,0.00006841007,0.00015094795,0.00010592355,0.00003692273,0.00017640587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006161031,0.00069928117,0.00046453686,0.0010906185,0.00043997442,0.0005703728,0.0005892116,0.0009868884,0.003338035],"category_scores_gemma":[0.00017942103,0.00035874962,0.00068530097,0.00042809884,0.0007536939,0.000436408,0.00029810963,0.0018073458,0.0012675589],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085634,0.00081900286,0.0005120984,0.000062941,0.000011699434,0.00028098116,0.000060557595,0.0001801764,0.99497765,0.00036275474,0.00018818525,0.0016874948],"study_design_scores_gemma":[0.00032930245,0.0110706445,0.008157079,0.000049154976,0.00007739427,0.0013087378,0.00017700154,0.0034829667,0.9682187,0.0002594618,0.006846605,0.000022955528],"about_ca_topic_score_codex":0.0007728058,"about_ca_topic_score_gemma":0.0012490245,"teacher_disagreement_score":0.003338035,"about_ca_system_score_codex":0.0006531681,"about_ca_system_score_gemma":0.00051859976,"threshold_uncertainty_score":0.011166871},"labels":[],"label_agreement":null},{"id":"W4386784647","doi":"10.1158/1557-3265.aacrahns23-po-088","title":"Abstract PO-088: TRPV1+ sensory neurons provide a tumor supportive environment through recruitment of MDSCs","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston Health Sciences Centre; Université de Montréal","funders":"","keywords":"Immune system; Tumor microenvironment; Cancer research; Flow cytometry; Population; Cancer; Biology; Tumor progression; Head and neck squamous-cell carcinoma; Pathology; Immunology; Medicine; Head and neck cancer; Internal medicine","score_opus":0.44478725668513786,"score_gpt":0.5335756045926386,"score_spread":0.08878834790750079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98155105,0.001663997,0.0056781354,0.0008008721,0.0002439477,0.00013653541,0.0026481878,0.0005038755,0.0067733177],"genre_scores_gemma":[0.9802373,0.0007029789,0.00260768,0.00031041817,0.000066497036,0.00017246275,0.0014755566,0.00009498627,0.014332211],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998024,0.000020345675,0.000017370943,0.000052494786,0.000049818944,0.000057504338],"domain_scores_gemma":[0.9998714,0.000014163997,0.000028371967,0.000013467414,0.000016232027,0.000056363835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013281188,0.0003387798,0.00031171643,0.00028865048,0.00021235722,0.00041872464,0.0002053806,0.00046257183,0.0077598095],"category_scores_gemma":[0.00009512111,0.00013555141,0.00027409772,0.00012477182,0.00032222446,0.00029726414,0.00026922877,0.0016080813,0.0017901226],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042679088,0.00011799266,0.00029327383,0.00012248474,0.000004720588,0.00007463125,0.00002729144,0.0000676612,0.9948041,0.0002811329,0.00052518107,0.003254615],"study_design_scores_gemma":[0.0001358721,0.0017359898,0.008198058,0.000040235143,0.000033031884,0.0005071936,0.00021625591,0.0012245383,0.97531384,0.00037104794,0.01221324,0.00001069653],"about_ca_topic_score_codex":0.00019377643,"about_ca_topic_score_gemma":0.00039341295,"teacher_disagreement_score":0.0077598095,"about_ca_system_score_codex":0.000253272,"about_ca_system_score_gemma":0.0002603728,"threshold_uncertainty_score":0.025959134},"labels":[],"label_agreement":null},{"id":"W4386784651","doi":"10.1158/1557-3265.aacrahns23-pr03","title":"Abstract PR03: Cholinergic modulation of tumor infiltrating lymphocytes in oral squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Cancer research; Immune system; T cell; Acetylcholine; Cholinergic; Cancer; Cytotoxic T cell; Biology; Immunotherapy; Immunology; Medicine; Internal medicine; Endocrinology; In vitro","score_opus":0.1762293950171087,"score_gpt":0.47428584431576953,"score_spread":0.2980564492986608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972446,0.0007998318,0.00037982047,0.000029929915,0.000015359128,0.000030088235,0.0001506235,0.000026271871,0.0013234735],"genre_scores_gemma":[0.9963415,0.00036931367,0.00030923772,0.00003662791,0.000015227995,0.00005227158,0.0002895922,0.0000054114194,0.0025807784],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999223,0.000012269487,0.0000080888285,0.000014413626,0.000018808469,0.000024154722],"domain_scores_gemma":[0.9999614,0.000007892346,0.0000069002317,0.000004413453,0.000006336642,0.0000130396575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000116948446,0.00020334747,0.00017749296,0.00021633356,0.00009896135,0.00014723705,0.00014441056,0.00024938013,0.0029325471],"category_scores_gemma":[0.000074990756,0.000063730426,0.00018193987,0.00018321174,0.000100719764,0.00012624769,0.000115510855,0.0003727475,0.00059277855],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075712946,0.00013904012,0.0018050955,0.00008042958,0.000005364056,0.00016970269,0.000023922774,0.00004479027,0.99087405,0.000035254292,0.00009796997,0.0059672343],"study_design_scores_gemma":[0.00024810547,0.006050193,0.104951,0.000029092053,0.00007889171,0.0021420373,0.00027293342,0.0015251784,0.8800832,0.00015566414,0.004454741,0.000008991583],"about_ca_topic_score_codex":0.00023966265,"about_ca_topic_score_gemma":0.00024197131,"teacher_disagreement_score":0.0029325471,"about_ca_system_score_codex":0.000121266254,"about_ca_system_score_gemma":0.00010253854,"threshold_uncertainty_score":0.0098103285},"labels":[],"label_agreement":null},{"id":"W4386784656","doi":"10.1158/1557-3265.aacrahns23-po-084","title":"Abstract PO-084: Deletion of macrophage migration inhibitory factor promotes antitumoral T cell infiltration and inhibits MDSC recruitment to the head and neck cancer microenvironment","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Macrophage Migration Inhibitory Factor","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Macrophage migration inhibitory factor; Tumor microenvironment; Head and neck squamous-cell carcinoma; Cancer research; Immune system; Immunotherapy; Cytokine; Cancer; Immunology; Metastasis; Tumor progression; T cell; Biology; Medicine; Head and neck cancer; Internal medicine","score_opus":0.18603205683042648,"score_gpt":0.4403780744964843,"score_spread":0.2543460176660578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963399,0.00036224382,0.0012176448,0.0001317462,0.000045830988,0.000048256632,0.0005837948,0.00010552056,0.0011650741],"genre_scores_gemma":[0.99291974,0.0002543096,0.0016120973,0.00008345034,0.00002025006,0.0001364836,0.0009166236,0.000032300555,0.004024603],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983037,0.000028276589,0.000022455655,0.00003272003,0.000035679772,0.000050554627],"domain_scores_gemma":[0.9998448,0.000017329021,0.000040905776,0.000016741107,0.000011331187,0.00006887164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113639035,0.000498348,0.00030584363,0.00027534133,0.00017782244,0.00024017894,0.00032255487,0.0003562786,0.0023291982],"category_scores_gemma":[0.000091495225,0.00016189044,0.00026013434,0.00013344025,0.0004109212,0.00018112738,0.00018000345,0.00095848995,0.0006907696],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043739617,0.00017435933,0.00013654749,0.000040045656,0.0000034858276,0.000041267307,0.00001293361,0.00007160955,0.9980021,0.00008454429,0.00010068908,0.000895096],"study_design_scores_gemma":[0.00014333417,0.0023553814,0.003037533,0.000010222409,0.00002192312,0.00024178934,0.000056611178,0.0013617473,0.99010676,0.00006785281,0.0025909506,0.000005862208],"about_ca_topic_score_codex":0.00051029515,"about_ca_topic_score_gemma":0.00049001194,"teacher_disagreement_score":0.0023291982,"about_ca_system_score_codex":0.00022653305,"about_ca_system_score_gemma":0.00029460498,"threshold_uncertainty_score":0.0077919364},"labels":[],"label_agreement":null},{"id":"W4386784698","doi":"10.1158/1557-3265.aacrahns23-po-081","title":"Abstract PO-081: Patterns of immune susceptibility in young, non-smoking, oral cancer patients","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Immunology; Disease; Cancer; Cellulitis; Internal medicine","score_opus":0.19162552331834976,"score_gpt":0.51452188487533,"score_spread":0.32289636155698026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998599,0.00011911621,0.000025988367,0.000028304696,0.0000034710524,0.000011156904,0.0008906447,0.0000026376094,0.00031971987],"genre_scores_gemma":[0.9991578,0.00005811201,0.000043994325,0.000034442874,0.0000072118146,0.000012469504,0.0005346616,0.0000015041861,0.00014985463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970067,0.00003686,0.000048017228,0.00008261309,0.00006167769,0.0000700836],"domain_scores_gemma":[0.9987056,0.0001337058,0.00069991924,0.000040636965,0.00012568598,0.0002944333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033279744,0.00016394517,0.00024252101,0.0009263261,0.00049720757,0.00071450823,0.0002904894,0.00041824792,0.0030347968],"category_scores_gemma":[0.0013905666,0.00022200089,0.00029929745,0.0012302,0.0002109492,0.00056483515,0.00036462463,0.00045167044,0.00050387584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016860864,0.000011520591,0.9995648,0.000003669414,0.000004500656,0.000032957552,0.000029788982,0.0000043169225,0.00006788672,0.000002628243,0.000041694602,0.00021934342],"study_design_scores_gemma":[0.0000015114626,0.00004041092,0.99952495,0.000002727309,0.0000042323004,0.00018434935,0.00012538415,0.000025874902,0.00002274491,0.0000042716497,0.000062551284,0.0000010530429],"about_ca_topic_score_codex":0.0065306313,"about_ca_topic_score_gemma":0.00805032,"teacher_disagreement_score":0.0065306313,"about_ca_system_score_codex":0.00034647912,"about_ca_system_score_gemma":0.0004865236,"threshold_uncertainty_score":0.012985289},"labels":[],"label_agreement":null},{"id":"W4386784705","doi":"10.1158/1557-3265.aacrahns23-po-077","title":"Abstract PO-077: High-throughput 3D-spheroid invasion assay: A powerful tool to identify novel drugs targeting tumor micro-environment in HNSCC","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Structural Genomics Consortium; University Health Network","funders":"","keywords":"Head and neck squamous-cell carcinoma; Cancer; Cancer research; Cancer cell; Metastasis; Tumor microenvironment; Cancer-Associated Fibroblasts; Cell; Tumor progression; Medicine; Biology; Head and neck cancer; Internal medicine","score_opus":0.15989032263657513,"score_gpt":0.4776897109230515,"score_spread":0.31779938828647636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784705","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68954104,0.014885088,0.22087428,0.0025627506,0.0006952934,0.0018994212,0.026153639,0.009984903,0.033403605],"genre_scores_gemma":[0.71712977,0.01042162,0.19813642,0.0005196044,0.00008891384,0.0020127816,0.02273131,0.00059471896,0.048364874],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999335,0.00015283006,0.00006523505,0.0001080823,0.00028104603,0.000057797304],"domain_scores_gemma":[0.9998204,0.000062039,0.000027075834,0.000029416673,0.00003905589,0.000022010105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060898275,0.0008069736,0.0008663198,0.0008477968,0.00044769808,0.00061011326,0.0004157,0.00058163743,0.004184401],"category_scores_gemma":[0.00022756026,0.00033200995,0.00062946184,0.0007686119,0.0003050821,0.00046639482,0.00038552683,0.00085455924,0.0023191452],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012690168,0.00012828237,0.0004891756,0.00023696848,0.000020447773,0.0001196597,0.000041934625,0.00032449205,0.987359,0.00035876228,0.0025452178,0.0082491655],"study_design_scores_gemma":[0.000018537006,0.00032713177,0.003586908,0.000013556893,0.00003511039,0.00027865596,0.000019474342,0.0024754186,0.9824368,0.00008024595,0.010705498,0.000022703285],"about_ca_topic_score_codex":0.001410431,"about_ca_topic_score_gemma":0.0021784035,"teacher_disagreement_score":0.004184401,"about_ca_system_score_codex":0.0003174964,"about_ca_system_score_gemma":0.00054010993,"threshold_uncertainty_score":0.01399821},"labels":[],"label_agreement":null},{"id":"W4386784719","doi":"10.1158/1557-3265.aacrahns23-po-096","title":"Abstract PO-096: Cytokines in the lumen of exosomes are undetectable by immunoassays distorting cytokine profiles in HNC patients and healthy donors","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytokine; Proinflammatory cytokine; Immune system; Flow cytometry; Medicine; Immunology; Chemistry; Molecular biology; Biology; Inflammation","score_opus":0.08385418372164645,"score_gpt":0.44326365749828817,"score_spread":0.35940947377664173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99900573,0.00016793335,0.00013958605,0.000013178832,0.000006125495,0.000008314045,0.00024974698,0.000006711507,0.00040271942],"genre_scores_gemma":[0.9991774,0.000045363617,0.0001473017,0.00002793266,0.0000072861485,0.000015109191,0.00033476594,0.0000027157162,0.00024218202],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996891,0.000054473465,0.00004365635,0.00009448054,0.00006495887,0.00005340274],"domain_scores_gemma":[0.9996619,0.000098097364,0.00009575387,0.000032017913,0.000057147372,0.000055004763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029221884,0.00025248266,0.00020042506,0.00048046024,0.00023299475,0.00046890677,0.00012119307,0.00025761043,0.0020131385],"category_scores_gemma":[0.00091683154,0.000118790005,0.000104157705,0.00027915023,0.0002342774,0.0001838887,0.00023483066,0.0002532312,0.00039036898],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021969208,0.00017997928,0.8241987,0.000072219016,0.00006561777,0.0010730949,0.00046128337,0.000069835376,0.16066861,0.00008671457,0.0003566116,0.010570366],"study_design_scores_gemma":[0.000026167689,0.0006540996,0.9728405,0.000010230443,0.00004412386,0.003123429,0.0005226984,0.0002794379,0.021549933,0.00007014828,0.0008718343,0.000007315992],"about_ca_topic_score_codex":0.00044023807,"about_ca_topic_score_gemma":0.0002531863,"teacher_disagreement_score":0.0020131385,"about_ca_system_score_codex":0.00013568267,"about_ca_system_score_gemma":0.000087550325,"threshold_uncertainty_score":0.006734669},"labels":[],"label_agreement":null},{"id":"W4386784726","doi":"10.1158/1557-3265.aacrahns23-po-087","title":"Abstract PO-087: Single-cell transcriptome analysis reveals functional changes in tumor-infiltrating macrophages after nutraceutical momordicine-I treatment in head &amp; neck cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Transcriptome; Cancer; Immune system; Monocyte; Cancer research; Head and neck cancer; Medicine; Macrophage; Head and neck squamous-cell carcinoma; Cancer cell; Biology; Immunology; Internal medicine; Gene expression; Gene; Genetics","score_opus":0.24839053509630055,"score_gpt":0.47687369616853587,"score_spread":0.22848316107223532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99229527,0.0018196761,0.002043803,0.00009994599,0.0000671897,0.000050985822,0.002718803,0.000043179836,0.0008611073],"genre_scores_gemma":[0.98827714,0.0011248401,0.0025140522,0.00019827057,0.00002595335,0.00019952608,0.0040812134,0.000026250293,0.003552884],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999112,0.000008412754,0.0000062238323,0.000027979497,0.000019859875,0.000026254818],"domain_scores_gemma":[0.99995637,0.0000066857074,0.000009644492,0.0000038928415,0.000011910766,0.00001144877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009249105,0.00016914798,0.0003233477,0.00018252057,0.00018989839,0.00023816581,0.00010301819,0.00022803285,0.0014050069],"category_scores_gemma":[0.00008140413,0.00008273177,0.00031168197,0.00019467945,0.00015417098,0.00014980182,0.00014785805,0.00042913566,0.00035370403],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032971433,0.00003271611,0.0011884763,0.00007075845,0.000007660371,0.000029065997,0.000031112213,0.000042431202,0.9964743,0.00001827784,0.00009033457,0.0016851092],"study_design_scores_gemma":[0.00006421158,0.0017473113,0.13477702,0.000034802462,0.00013138233,0.000308516,0.0005951232,0.003511184,0.85205704,0.00018413574,0.0065623983,0.000027020362],"about_ca_topic_score_codex":0.00038853326,"about_ca_topic_score_gemma":0.0005640838,"teacher_disagreement_score":0.0014050069,"about_ca_system_score_codex":0.00011393047,"about_ca_system_score_gemma":0.00015791466,"threshold_uncertainty_score":0.004700184},"labels":[],"label_agreement":null},{"id":"W4386784744","doi":"10.1158/1557-3265.aacrahns23-po-070","title":"Abstract PO-070: New patient-derived head and neck cancer xenograft (PDX) panel for drug development, immuno-oncology and translational research","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cetuximab; Medicine; Head and neck squamous-cell carcinoma; Oncology; Radiation therapy; Internal medicine; Head and neck cancer; Docetaxel; Cancer; Cancer research; Colorectal cancer","score_opus":0.35876907313791295,"score_gpt":0.5591379491896306,"score_spread":0.2003688760517176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784744","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97460866,0.0018834379,0.007861411,0.00023204072,0.00009162202,0.0007245214,0.009329636,0.00024821013,0.0050203507],"genre_scores_gemma":[0.9322167,0.0018644828,0.017292678,0.00037651218,0.000029348521,0.0008729801,0.041282672,0.00007708847,0.0059875436],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996716,0.00006123761,0.00003089351,0.00006592456,0.00011544088,0.00005491147],"domain_scores_gemma":[0.99981004,0.00003048358,0.000018101411,0.000044220054,0.000047183734,0.000049960014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073972164,0.00042053513,0.0004169744,0.00035852584,0.00022508152,0.00043001198,0.00037239055,0.00039232592,0.002603309],"category_scores_gemma":[0.00020472796,0.00016891428,0.00039420245,0.0003146176,0.00016143863,0.00022932536,0.000310798,0.0010220878,0.00083217066],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010539271,0.0010375399,0.004384592,0.000112110116,0.00006086486,0.00021810373,0.00006276477,0.0010579552,0.9761677,0.0003438304,0.003353482,0.012147083],"study_design_scores_gemma":[0.0004319843,0.011084827,0.03786018,0.000042236854,0.00026517003,0.0035219055,0.00012133123,0.0068724635,0.9049464,0.00024027753,0.03458277,0.000030556836],"about_ca_topic_score_codex":0.00086703786,"about_ca_topic_score_gemma":0.0010039079,"teacher_disagreement_score":0.002603309,"about_ca_system_score_codex":0.0002953277,"about_ca_system_score_gemma":0.00037546275,"threshold_uncertainty_score":0.008708954},"labels":[],"label_agreement":null},{"id":"W4386784745","doi":"10.1158/1557-3265.aacrahns23-po-060","title":"Abstract PO-060: Novel combination of TRIP13 and Aurora kinase A inhibition demonstrated extensive DNA damage and immunogenic cell death in RB-deficient cancers","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Apoptosis; Retinoblastoma; Retinoblastoma protein; DNA damage; Cell cycle checkpoint; Programmed cell death; Cancer; Cancer cell; Cell growth; Mitosis; Mad2; Chemistry; Cell cycle; Biology; Cell biology; DNA; Genetics","score_opus":0.08942050629643282,"score_gpt":0.4157472379388378,"score_spread":0.32632673164240494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871344,0.002657183,0.003634194,0.00017925577,0.00010645591,0.00009934371,0.0011159,0.00022849109,0.004844763],"genre_scores_gemma":[0.9883166,0.0012642255,0.00329808,0.00014186428,0.0000139574795,0.000091311966,0.0017287545,0.000046170007,0.0050991205],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989486,0.000011029529,0.000014608504,0.00002493672,0.0000314755,0.000023031838],"domain_scores_gemma":[0.9999404,0.0000079663705,0.000009108393,0.000008585119,0.000010298331,0.000023718769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011340067,0.00032343742,0.00034927655,0.0002223184,0.00012117586,0.0002369118,0.00027614104,0.00031347267,0.0024760114],"category_scores_gemma":[0.00007310641,0.000109726425,0.00028911373,0.00017485683,0.00012860438,0.00019952965,0.00014872229,0.00068869075,0.0006373595],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025430913,0.000102079386,0.00012875008,0.00007168257,0.0000128669,0.00011211044,0.000008661361,0.00009123081,0.9960012,0.00006769916,0.00022783388,0.0029216046],"study_design_scores_gemma":[0.000028899942,0.001124274,0.0015978235,0.0000038657076,0.000028025883,0.0005371284,0.000012205572,0.00065829273,0.9929087,0.000024283447,0.003071439,0.00000516988],"about_ca_topic_score_codex":0.00056139904,"about_ca_topic_score_gemma":0.0006482386,"teacher_disagreement_score":0.0024760114,"about_ca_system_score_codex":0.0001607612,"about_ca_system_score_gemma":0.00018014426,"threshold_uncertainty_score":0.008283079},"labels":[],"label_agreement":null},{"id":"W4386784760","doi":"10.1158/1557-3265.aacrahns23-po-047","title":"Abstract PO-047: A novel saliva miRNA panel of promising diagnostic biomarkers for oral cancer: The association of miR-21 with smoking history","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Saliva; Receiver operating characteristic; Medicine; Internal medicine; Cancer; microRNA; Area under the curve; Confidence interval; Oncology; Basal cell; Head and neck cancer; Carcinogenesis; Gastroenterology; Biology; Gene","score_opus":0.20641294505106358,"score_gpt":0.45435106100955214,"score_spread":0.24793811595848855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9716484,0.007083589,0.013362521,0.00032919276,0.00012120921,0.00013831758,0.0038390679,0.00044689,0.00303082],"genre_scores_gemma":[0.9812416,0.0012678996,0.011937636,0.00019565485,0.000061012364,0.00021031698,0.002741062,0.000055386026,0.0022893685],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9993606,0.00013455188,0.000058986956,0.00018183234,0.00021526568,0.000048703776],"domain_scores_gemma":[0.9995017,0.0001356235,0.00012278587,0.00003943035,0.00014290189,0.000057568126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010134793,0.0007308362,0.0005416372,0.0010450548,0.00029631652,0.0009764852,0.00028439265,0.00055071636,0.0021438634],"category_scores_gemma":[0.0011599665,0.00035308296,0.00042004712,0.0006761576,0.0002974643,0.00029447608,0.00046474766,0.00050701445,0.0010622315],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021626463,0.0004125123,0.22224915,0.0004389609,0.0004956721,0.00032669885,0.00018157554,0.00090395194,0.7093547,0.0002300743,0.001543793,0.06170019],"study_design_scores_gemma":[0.000117877324,0.0023268946,0.44345602,0.000084408784,0.0011857784,0.004226943,0.00025977677,0.014879875,0.5175814,0.00073715847,0.01504721,0.00009670798],"about_ca_topic_score_codex":0.000282609,"about_ca_topic_score_gemma":0.00043275088,"teacher_disagreement_score":0.0021438634,"about_ca_system_score_codex":0.00017389034,"about_ca_system_score_gemma":0.00034839427,"threshold_uncertainty_score":0.007171929},"labels":[],"label_agreement":null},{"id":"W4386784763","doi":"10.1158/1557-3265.aacrahns23-po-063","title":"Abstract PO-063: Environment-induced YAP1 transcriptional reprogramming drives head and neck cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"YAP1; Carcinogenesis; Reprogramming; Biology; Epigenetics; Cancer research; Chromatin; Context (archaeology); Cancer; Genetics; Transcription factor; Gene","score_opus":0.21282331511592836,"score_gpt":0.5013046931243521,"score_spread":0.28848137800842377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97270423,0.0014139911,0.010397356,0.00043388014,0.0001445872,0.000095460186,0.004946719,0.00056220277,0.009301629],"genre_scores_gemma":[0.98335683,0.000597905,0.0024002458,0.00015768819,0.000014710726,0.00008241081,0.0026222682,0.00013570361,0.010632372],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997898,0.000013497429,0.000014632735,0.00007625127,0.000058168902,0.00004762586],"domain_scores_gemma":[0.99988496,0.000009943972,0.000034215172,0.000015172875,0.000015266287,0.00004038771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016850117,0.000293979,0.00020757194,0.00029638121,0.00035336698,0.00037474008,0.0003277811,0.00037571625,0.006985844],"category_scores_gemma":[0.00009797282,0.00019096388,0.0004281217,0.00020668501,0.00044064366,0.0002987683,0.00063448393,0.001033149,0.0015099109],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010965846,0.000027377097,0.0005775041,0.00006789551,0.0000052834607,0.00006881072,0.000023933855,0.000054139127,0.9968363,0.00027129162,0.00022267136,0.0017351515],"study_design_scores_gemma":[0.00002477676,0.00024986538,0.013412739,0.000015283413,0.000039092636,0.00031933287,0.00013074385,0.0013929049,0.9737265,0.00019945794,0.010479083,0.000010258861],"about_ca_topic_score_codex":0.00090767717,"about_ca_topic_score_gemma":0.0014534538,"teacher_disagreement_score":0.006985844,"about_ca_system_score_codex":0.0004887408,"about_ca_system_score_gemma":0.0005290834,"threshold_uncertainty_score":0.023369968},"labels":[],"label_agreement":null},{"id":"W4386784804","doi":"10.1158/1557-3265.aacrahns23-po-044","title":"Abstract PO-044: Correlation between circulating tumor DNA and tumor volume in head and neck cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Head and neck cancer; Cancer; Primary tumor; Tonsil; Oncology; Radiation therapy; Pathology; Internal medicine; Metastasis","score_opus":0.1378141845069413,"score_gpt":0.4696687542100075,"score_spread":0.33185456970306615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99341595,0.00048557224,0.00054247637,0.000040261606,0.000009062296,0.00001933133,0.0046507204,0.000036729856,0.00079982425],"genre_scores_gemma":[0.99713194,0.000056717297,0.0004150755,0.000009179304,0.000005670699,0.000020768566,0.0021001832,0.0000075820567,0.0002528735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956626,0.000080202575,0.00006019701,0.00014111999,0.00011709739,0.00003509513],"domain_scores_gemma":[0.99834883,0.0006135114,0.00060785614,0.000112236434,0.00022179433,0.00009569415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006149204,0.00013080385,0.00025403913,0.00074347365,0.00012820144,0.00045555705,0.00033394826,0.00017682521,0.003246249],"category_scores_gemma":[0.002845248,0.00013336532,0.00020548244,0.0009043369,0.00016705354,0.00035000287,0.0003434609,0.00028617008,0.00033866224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020793761,0.000006852456,0.99610907,0.000021494447,0.000024959356,0.000024213758,0.000017185295,0.00012710209,0.0003690668,0.000015981728,0.00016838916,0.0029078105],"study_design_scores_gemma":[0.000010696231,0.00011427269,0.99685836,0.0000067894975,0.00003550481,0.00033929298,0.000058636142,0.0011190863,0.00072148803,0.00003780678,0.0006945358,0.0000034861657],"about_ca_topic_score_codex":0.003394723,"about_ca_topic_score_gemma":0.0024834233,"teacher_disagreement_score":0.003394723,"about_ca_system_score_codex":0.00042786304,"about_ca_system_score_gemma":0.00027364964,"threshold_uncertainty_score":0.010859787},"labels":[],"label_agreement":null},{"id":"W4386784819","doi":"10.1158/1557-3265.aacrahns23-po-056","title":"Abstract PO-056: The effect of timing of post-operative radiation on outcomes in anaplastic thyroid cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Cancer; Surgery; Regimen; Stage (stratigraphy); Thyroid cancer; Thyroidectomy; Anaplastic thyroid cancer; Thyroid; Internal medicine","score_opus":0.16533171795332535,"score_gpt":0.5509622340987879,"score_spread":0.3856305161454625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99212426,0.0011936616,0.00032547562,0.00033851646,0.00006503457,0.0000393286,0.0037787405,0.000030542393,0.0021043867],"genre_scores_gemma":[0.9974685,0.00020503115,0.00019560217,0.00005393278,0.00004523346,0.000032565964,0.0013551849,0.000013034244,0.00063098595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921536,0.0002492706,0.00009355898,0.00015672379,0.00017594398,0.000109180386],"domain_scores_gemma":[0.99362093,0.0028636928,0.0020774633,0.00022300739,0.00036683385,0.00084808696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017003225,0.00019829498,0.000295073,0.0004983318,0.0002302392,0.0007294526,0.0006383084,0.00032206383,0.005815263],"category_scores_gemma":[0.007984806,0.00009756094,0.0012255703,0.0009821127,0.00019118031,0.0006007971,0.0004603728,0.00078002585,0.0005367909],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065376926,0.00018861722,0.9714074,0.00020191952,0.0005519812,0.000061232415,0.000073745665,0.00033404116,0.0003511431,0.00005693007,0.0013356844,0.018899724],"study_design_scores_gemma":[0.000111322755,0.0017732397,0.9946681,0.00003880367,0.0006148603,0.0001208532,0.00017570893,0.00062676857,0.00033597875,0.00011125642,0.0014155813,0.0000075816724],"about_ca_topic_score_codex":0.002576222,"about_ca_topic_score_gemma":0.0026058336,"teacher_disagreement_score":0.005815263,"about_ca_system_score_codex":0.00056975416,"about_ca_system_score_gemma":0.00087957893,"threshold_uncertainty_score":0.019454002},"labels":[],"label_agreement":null},{"id":"W4386784857","doi":"10.1158/1557-3265.aacrahns23-po-018","title":"Abstract PO-018: Pathological analysis of newly established immunocompetent mice with full HPV16 genome integration","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Carcinogenesis; Genome; Transgene; Phenotype; Gene; CRISPR; Genetically modified mouse; Cancer research; Locus (genetics); Virology; Genetics","score_opus":0.24909723091226774,"score_gpt":0.5202106468539504,"score_spread":0.2711134159416826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94881207,0.0020502752,0.025075909,0.0004304099,0.00048198705,0.00036328935,0.010465732,0.0011063138,0.011214062],"genre_scores_gemma":[0.9418406,0.0013480636,0.014241025,0.00040533286,0.00008417616,0.0006202231,0.0065172375,0.00065529486,0.03428805],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993036,0.000039719376,0.00006283838,0.00030668193,0.00015955427,0.00012771416],"domain_scores_gemma":[0.99882454,0.000135047,0.00028576286,0.00016058853,0.00014046376,0.00045350302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057830993,0.00095318333,0.00041142467,0.0017567038,0.00045580577,0.00066869374,0.00044271935,0.0012627232,0.006195591],"category_scores_gemma":[0.000305834,0.00050658133,0.0008874223,0.00042337392,0.00072824646,0.0008237561,0.0005416953,0.0030076827,0.0025877072],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023398489,0.0001759543,0.000609445,0.0000487409,0.000013289246,0.0005397836,0.000055209035,0.00007273574,0.9966814,0.00026499858,0.00015216788,0.0011522495],"study_design_scores_gemma":[0.00010774583,0.002029157,0.028037546,0.000062595456,0.00007671983,0.0052823597,0.00024711672,0.0023318322,0.9546864,0.0004563046,0.006635978,0.00004611962],"about_ca_topic_score_codex":0.0004381711,"about_ca_topic_score_gemma":0.0005394565,"teacher_disagreement_score":0.006195591,"about_ca_system_score_codex":0.0003892514,"about_ca_system_score_gemma":0.00024086623,"threshold_uncertainty_score":0.020726383},"labels":[],"label_agreement":null},{"id":"W4386784868","doi":"10.1158/1557-3265.aacrahns23-po-040","title":"Abstract PO-040: Comparing digital image analysis with a manual scoring approach for quantification of p63 and BRCA1 protein expression in oropharyngeal squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tissue microarray; Biomarker; Context (archaeology); Immunohistochemistry; Medicine; Oncology; Digital image analysis; Digital pathology; Digital polymerase chain reaction; Rank correlation; Pathology; Internal medicine; Biology; Gene; Polymerase chain reaction; Computer science","score_opus":0.13791106912026352,"score_gpt":0.46955963288802705,"score_spread":0.3316485637677635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8816625,0.0015128894,0.10523762,0.00019991882,0.00021668452,0.0005907868,0.0014918403,0.0017259863,0.0073616835],"genre_scores_gemma":[0.8541133,0.00046276845,0.14101677,0.00011179912,0.000060284474,0.0006269027,0.0010572075,0.0003055615,0.002245438],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968605,0.0011586748,0.00024118925,0.0006202632,0.0009825432,0.00013684743],"domain_scores_gemma":[0.9959965,0.0015491536,0.00069581426,0.00049121596,0.0011009309,0.00016644664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005704768,0.00044853144,0.0003802362,0.0027448274,0.00033635902,0.0012457086,0.0007740319,0.00047712063,0.005232963],"category_scores_gemma":[0.0069019226,0.00040384728,0.00034503193,0.0014496117,0.0007593456,0.00081990624,0.00090707076,0.00044272988,0.00086013693],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011204376,0.0010380707,0.12617561,0.0015689534,0.00059437787,0.0003734432,0.0005725591,0.0056747613,0.607105,0.0016824468,0.0031839432,0.2408264],"study_design_scores_gemma":[0.00025828579,0.004504713,0.51379913,0.00013109462,0.0005214268,0.0025723171,0.000916703,0.11149002,0.35579625,0.0014642315,0.008358597,0.00018712363],"about_ca_topic_score_codex":0.0011678399,"about_ca_topic_score_gemma":0.0015439425,"teacher_disagreement_score":0.005704768,"about_ca_system_score_codex":0.00070145715,"about_ca_system_score_gemma":0.0003578987,"threshold_uncertainty_score":0.030170083},"labels":[],"label_agreement":null},{"id":"W4386784870","doi":"10.1158/1557-3265.aacrahns23-po-034","title":"Abstract PO-034: Optimizing chemotherapeutic regimen through metabolic interrogation to maximize radiosensitizing effects in HNSCC","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Regimen; Medicine; Head and neck squamous-cell carcinoma; Cisplatin; Oncology; Clonogenic assay; Internal medicine; Cancer research; Cancer; Chemotherapy; Pharmacology; Head and neck cancer; Cell; Chemistry","score_opus":0.1402687006411864,"score_gpt":0.4750643421025106,"score_spread":0.3347956414613242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910144,0.0011953828,0.0057017403,0.00013737813,0.00002695083,0.000132636,0.0004895594,0.00014841628,0.001153669],"genre_scores_gemma":[0.9841899,0.0008876853,0.012352625,0.00011269015,0.000009135605,0.00014922842,0.0006864225,0.000039939536,0.0015722372],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998733,0.000014619826,0.000009266343,0.000033572265,0.00004745483,0.000021764376],"domain_scores_gemma":[0.9999167,0.000009978526,0.000028240758,0.000007688294,0.000020177256,0.000017255756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020356066,0.00039995683,0.00027502753,0.0003042302,0.00015039709,0.00036787527,0.00032359594,0.00031636268,0.0012022738],"category_scores_gemma":[0.00014008644,0.00013620585,0.0002561588,0.00025582855,0.00025187148,0.00023207864,0.00019588339,0.0005403555,0.00022859318],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031844238,0.00016273613,0.00064596825,0.00008443171,0.000008817221,0.000022837417,0.0000093354365,0.0010276779,0.99320894,0.000058495687,0.000115030554,0.0043372577],"study_design_scores_gemma":[0.000033891432,0.0018381837,0.0026460104,0.000006802525,0.000025873247,0.000082084916,0.000015874677,0.002812881,0.991045,0.000040750707,0.0014456435,0.000007050293],"about_ca_topic_score_codex":0.0009432633,"about_ca_topic_score_gemma":0.0013646504,"teacher_disagreement_score":0.0012022738,"about_ca_system_score_codex":0.0005040202,"about_ca_system_score_gemma":0.00046676132,"threshold_uncertainty_score":0.004022062},"labels":[],"label_agreement":null},{"id":"W4386784873","doi":"10.1158/1557-3265.aacrahns23-po-022","title":"Abstract PO-022: Characterizing genetic and molecular differences in head and neck cancer based on history of smoking","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Internal medicine; Oncology; Copy-number variation; Head and neck cancer; Gene; Biology; Genetics; Genome","score_opus":0.14606455084829548,"score_gpt":0.44436361362577276,"score_spread":0.2982990627774773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984968,0.0001459627,0.00017121251,0.000017369646,0.0000034142245,0.000007082301,0.00084537163,0.0000047769486,0.00030791754],"genre_scores_gemma":[0.9987413,0.00002912768,0.00016133174,0.0000132314035,0.000004528148,0.00000878353,0.00083446235,0.0000031021027,0.00020403095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999777,0.000046227688,0.000027762057,0.00006574667,0.000048277303,0.00003498749],"domain_scores_gemma":[0.9994585,0.00019786613,0.000155204,0.00004764728,0.000062971354,0.00007769668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032936677,0.00013496805,0.00019817098,0.00073271315,0.00023203791,0.00037653287,0.00023075695,0.00023274984,0.002579142],"category_scores_gemma":[0.0011193926,0.000075124386,0.00023489719,0.00079852366,0.00017718555,0.00018545106,0.00023696263,0.00019723635,0.00028133098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021208778,0.000021128419,0.9930322,0.000015425469,0.000045060122,0.00006337381,0.000026069349,0.00003911256,0.004010504,0.000010781496,0.00009145901,0.0024327594],"study_design_scores_gemma":[0.0000038927933,0.00006402307,0.9984193,0.000001560558,0.000022036536,0.00034777896,0.000040159866,0.00016575262,0.0007324873,0.000020493937,0.00018142353,0.0000011886964],"about_ca_topic_score_codex":0.0012422571,"about_ca_topic_score_gemma":0.0016846322,"teacher_disagreement_score":0.002579142,"about_ca_system_score_codex":0.00013937747,"about_ca_system_score_gemma":0.00013033074,"threshold_uncertainty_score":0.00862813},"labels":[],"label_agreement":null},{"id":"W4386784876","doi":"10.1158/1557-3265.aacrahns23-po-021","title":"Abstract PO-021: TCGA differentially expressed genes between Caucasians and African Americans at variable analytic stringencies","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gene; False positive paradox; Biology; Genetics; Gene expression profiling; Gene expression; Genome","score_opus":0.18565194679647956,"score_gpt":0.48402737358175113,"score_spread":0.29837542678527157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97179294,0.00081743265,0.011305028,0.00035103233,0.00004541476,0.000097055905,0.011934392,0.00047456636,0.0031820936],"genre_scores_gemma":[0.98297805,0.000121963945,0.009397897,0.00012016666,0.000026668109,0.00022119068,0.005964969,0.000090048576,0.0010789508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989503,0.00020678542,0.00009248333,0.0003319437,0.00025560588,0.00016289142],"domain_scores_gemma":[0.9981477,0.0011611496,0.00026886858,0.00014256263,0.0001772749,0.00010232533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015341531,0.00027873032,0.0005084804,0.0014199412,0.0009018188,0.0010100087,0.00039668992,0.00038469804,0.0051881964],"category_scores_gemma":[0.0033508788,0.000099198216,0.0005577328,0.0022719349,0.00051719206,0.0002927174,0.0003908888,0.00043216138,0.00045693616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004441776,0.00019043974,0.7108279,0.00086652103,0.00086737797,0.0009435128,0.0006806343,0.003290722,0.18998031,0.0016654322,0.008143372,0.07810204],"study_design_scores_gemma":[0.000096871525,0.0003718079,0.92976904,0.00004251011,0.00047990496,0.0016314226,0.00040112404,0.007798506,0.05043003,0.0014350523,0.00751142,0.000032318374],"about_ca_topic_score_codex":0.0024136202,"about_ca_topic_score_gemma":0.002666243,"teacher_disagreement_score":0.0051881964,"about_ca_system_score_codex":0.0004731547,"about_ca_system_score_gemma":0.0007171527,"threshold_uncertainty_score":0.017356277},"labels":[],"label_agreement":null},{"id":"W4386784878","doi":"10.1158/1557-3265.aacrahns23-po-020","title":"Abstract PO-020: Gene regulatory network connectivity analysis identifies novel candidate effectors of HNSC tumorigenesis","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computational biology; Biology; Gene regulatory network; In silico; Gene; Genomics; Centrality; Effector; Bioinformatics; Genetics; Genome; Gene expression","score_opus":0.07971410392852883,"score_gpt":0.4296161905851667,"score_spread":0.34990208665663786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87651956,0.0008519017,0.10509515,0.0006278912,0.00005147281,0.00012049143,0.009983205,0.002717955,0.004032364],"genre_scores_gemma":[0.96783644,0.00017565675,0.02008193,0.00010575486,0.000024030953,0.000061005463,0.009863761,0.00010830809,0.0017431364],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99985933,0.000028244525,0.000004135784,0.00006720167,0.000022378379,0.000018597077],"domain_scores_gemma":[0.999742,0.000119494,0.00004060758,0.000026375394,0.00004180022,0.00002963308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004178705,0.00039783554,0.00029929515,0.0007339473,0.00024050775,0.00046856742,0.00034130464,0.00034707919,0.003403795],"category_scores_gemma":[0.0012093777,0.0001525033,0.0006213988,0.00042659606,0.00025899324,0.0003399688,0.00035501175,0.00046411547,0.00042590284],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016551103,0.00059402245,0.24150361,0.000899034,0.00087020197,0.0008068033,0.00022695013,0.3902055,0.14088215,0.01314021,0.021844035,0.1873724],"study_design_scores_gemma":[0.00005567584,0.00019095864,0.051824808,0.000026539466,0.00012119181,0.00021733066,0.00007800465,0.920891,0.014778046,0.007985379,0.0038076483,0.000023363216],"about_ca_topic_score_codex":0.0036296265,"about_ca_topic_score_gemma":0.0041497103,"teacher_disagreement_score":0.0036296265,"about_ca_system_score_codex":0.00047618782,"about_ca_system_score_gemma":0.00051057176,"threshold_uncertainty_score":0.011386812},"labels":[],"label_agreement":null},{"id":"W4386784884","doi":"10.1158/1557-3265.aacrahns23-po-023","title":"Abstract PO-023: The AP-1 transcription factor component, JunB, regulates the expression of HPV genes in head and neck cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Head and neck squamous-cell carcinoma; Medicine; Cancer; Demethylating agent; Oncology; Head and neck cancer; Internal medicine; Biology; DNA methylation; Gene expression; Gene","score_opus":0.23566906724455877,"score_gpt":0.49256622737408556,"score_spread":0.2568971601295268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98437065,0.008053448,0.0016838064,0.00034535347,0.00013952603,0.000043099706,0.0012338698,0.00009668604,0.0040335655],"genre_scores_gemma":[0.9871573,0.001500586,0.0008717199,0.00015849808,0.000022693679,0.00003825396,0.0016714252,0.000022382195,0.008557051],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999186,0.000009146685,0.0000054556967,0.000023122971,0.000025663403,0.000018023236],"domain_scores_gemma":[0.99994624,0.0000064535725,0.0000112470325,0.0000047629246,0.00001392902,0.000017445214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010136435,0.0002224821,0.000115436094,0.00017267854,0.00025125267,0.00030531632,0.00021131137,0.00024117163,0.0044772956],"category_scores_gemma":[0.00009082154,0.000093892,0.00019190702,0.00014845522,0.00016285562,0.00016059435,0.00016182824,0.0005286361,0.0010704492],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029409712,0.000056687106,0.0009472902,0.00006759114,0.0000054274005,0.000048093483,0.000014484777,0.000022034978,0.9956797,0.000068595924,0.00017879381,0.0026172101],"study_design_scores_gemma":[0.00007504066,0.00072341715,0.06839792,0.000031100804,0.000050567745,0.00077732,0.00017064123,0.0012193371,0.91874796,0.00016923614,0.009631297,0.0000062149547],"about_ca_topic_score_codex":0.0007343517,"about_ca_topic_score_gemma":0.0007125896,"teacher_disagreement_score":0.0044772956,"about_ca_system_score_codex":0.00029803545,"about_ca_system_score_gemma":0.00020580989,"threshold_uncertainty_score":0.014978051},"labels":[],"label_agreement":null},{"id":"W4386784887","doi":"10.1158/1557-3265.aacrahns23-po-028","title":"Abstract PO-028: Clinical and genomic correlates of intratumoral HPV for oropharyngeal and cervical cancers","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Internal medicine; Cervical cancer; Immunohistochemistry; Adenocarcinoma; Papillomaviridae; HPV infection; Cancer; Cancer research","score_opus":0.30706306598563743,"score_gpt":0.5526484824295512,"score_spread":0.2455854164439138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99534154,0.0010573545,0.00037401,0.00009912226,0.00001765717,0.0000209499,0.0013575368,0.000023867697,0.0017079889],"genre_scores_gemma":[0.9985246,0.00009212252,0.00016423633,0.000013685767,0.000012603723,0.000014674594,0.0008462592,0.000006929183,0.00032496877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974126,0.00004785387,0.000031480635,0.000070820824,0.00006481363,0.000043809443],"domain_scores_gemma":[0.9990947,0.00019860841,0.00030991455,0.000056313504,0.00017423969,0.00016617111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004377676,0.0002159062,0.00019929901,0.00078107906,0.0002617485,0.0006337503,0.00030195518,0.00030744952,0.006142681],"category_scores_gemma":[0.0016957533,0.00009606283,0.00021638349,0.000932808,0.0002474595,0.0003936071,0.0004041406,0.00038723703,0.0009008925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049424014,0.000024257133,0.9911595,0.00005143352,0.000054595468,0.00015149075,0.00002937516,0.000057723348,0.0021153667,0.000031540265,0.0002988584,0.005531605],"study_design_scores_gemma":[0.000010170172,0.0001352582,0.9964618,0.00001027409,0.000064241,0.0009552024,0.000101485515,0.00028871626,0.0009590416,0.00008633597,0.00092407136,0.0000035274336],"about_ca_topic_score_codex":0.0006650663,"about_ca_topic_score_gemma":0.0006261978,"teacher_disagreement_score":0.006142681,"about_ca_system_score_codex":0.00027177605,"about_ca_system_score_gemma":0.00028317136,"threshold_uncertainty_score":0.020549297},"labels":[],"label_agreement":null},{"id":"W4386784892","doi":"10.1158/1557-3265.aacrahns23-po-037","title":"Abstract PO-037: Biomarkers for early diagnosis of human papillomavirus-related oropharyngeal cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Concordance; Cancer; Internal medicine; Incidence (geometry); Oncology; Population; Digital polymerase chain reaction; HPV infection; Cervical cancer; Immunology; Polymerase chain reaction; Biology","score_opus":0.35943467488921416,"score_gpt":0.5758789169351914,"score_spread":0.2164442420459773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92440116,0.032196254,0.00928035,0.0026594885,0.0007336612,0.00077110744,0.012139955,0.00076017616,0.017057799],"genre_scores_gemma":[0.975201,0.0036866101,0.010221061,0.00088971434,0.00041504117,0.0003833537,0.0045969756,0.000046603604,0.0045595053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991304,0.00029528362,0.00007817069,0.00015169386,0.00026543418,0.000078981044],"domain_scores_gemma":[0.99871254,0.00026335334,0.00043430395,0.00006527367,0.0003899775,0.00013444091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016375794,0.0005924109,0.00049178535,0.0015376667,0.00022254491,0.0012290048,0.00058167655,0.0006715063,0.004017858],"category_scores_gemma":[0.0022020023,0.00017666965,0.00026642403,0.0012320242,0.00032205984,0.00073292543,0.00045383698,0.0004908134,0.0013625479],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023949782,0.0005969192,0.8240775,0.0007538239,0.00026285957,0.00029431577,0.00006969989,0.00047432055,0.017829001,0.0004935696,0.0083845565,0.14436829],"study_design_scores_gemma":[0.00031810103,0.0049060914,0.9233279,0.00034674045,0.00044395134,0.0027430016,0.00026843592,0.0037864326,0.028575912,0.0012453672,0.03398281,0.000055219978],"about_ca_topic_score_codex":0.00052173523,"about_ca_topic_score_gemma":0.0004541871,"teacher_disagreement_score":0.004017858,"about_ca_system_score_codex":0.0004267272,"about_ca_system_score_gemma":0.0005620876,"threshold_uncertainty_score":0.013441086},"labels":[],"label_agreement":null},{"id":"W4386784919","doi":"10.1158/1557-3265.aacrahns23-po-027","title":"Abstract PO-027: Clinical and genetic associations of biological sex and survival in head and neck squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Head and neck squamous-cell carcinoma; Larynx; Medicine; Hazard ratio; Oncology; Head and neck cancer; Proportional hazards model; Internal medicine; Immune system; Cancer; Population; Immunology; Confidence interval; Surgery","score_opus":0.43370994652978534,"score_gpt":0.5522812862250743,"score_spread":0.11857133969528899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889608,0.0012509068,0.00036088395,0.0003411836,0.00006384637,0.00001071396,0.0075787706,0.00002134144,0.0014114982],"genre_scores_gemma":[0.9960098,0.00014676544,0.00012939054,0.00006710798,0.000034970893,0.000009188609,0.0030858663,0.000012872216,0.0005038756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99965525,0.00007551897,0.000033896016,0.00010129523,0.000060809456,0.00007327029],"domain_scores_gemma":[0.99887496,0.00031186227,0.00032567393,0.0001282369,0.0001614249,0.00019783739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047701166,0.000179592,0.000269557,0.0004968371,0.00037182507,0.000703567,0.00033144795,0.00033539248,0.0060458686],"category_scores_gemma":[0.0019965987,0.00009979405,0.00065441435,0.000960686,0.00022219867,0.00034894724,0.0004511532,0.00063792523,0.0005657044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031596053,0.000022494629,0.9934255,0.000043704775,0.00017183537,0.000097863565,0.00002775489,0.00010581272,0.0010967347,0.000047912537,0.00087303494,0.0037714317],"study_design_scores_gemma":[0.000012758442,0.000062236126,0.9968125,0.000013285546,0.00011156467,0.0003365792,0.0001139073,0.0005280062,0.00040922323,0.00018239956,0.001412383,0.0000050504214],"about_ca_topic_score_codex":0.0019186876,"about_ca_topic_score_gemma":0.0026679453,"teacher_disagreement_score":0.0060458686,"about_ca_system_score_codex":0.00018834489,"about_ca_system_score_gemma":0.00028897566,"threshold_uncertainty_score":0.020225465},"labels":[],"label_agreement":null},{"id":"W4386784925","doi":"10.1158/1557-3265.aacrahns23-po-007","title":"Abstract PO-007: A phase 2 open-label study of conditionally active biologic, ozuriftamab vedotin (BA3021) in PD-1/L1 failure patients with recurrent or metastatic squamous cell carcinoma of the head and neck","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Internal medicine; Head and neck squamous-cell carcinoma; Cancer; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Head and neck cancer; Cancer research; Clinical trial","score_opus":0.3121192668751875,"score_gpt":0.541136698782141,"score_spread":0.2290174319069535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917163,0.0013472863,0.0006713382,0.00040293066,0.00012681025,0.0026066133,0.0010010478,0.00013423666,0.0019934562],"genre_scores_gemma":[0.98810285,0.0010770079,0.0016518256,0.00071326,0.000115836854,0.0027966928,0.0018958133,0.000034581986,0.003612167],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99975747,0.000087155895,0.000012832479,0.000054277847,0.00002691385,0.00006127091],"domain_scores_gemma":[0.99966514,0.000042354397,0.000049482802,0.000028375964,0.000033057317,0.00018162756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012469052,0.0012684956,0.0012357803,0.00032249923,0.00037546223,0.001055997,0.0007259,0.001137345,0.0048778797],"category_scores_gemma":[0.0005685632,0.0004491418,0.0009492944,0.0002620981,0.0008669903,0.0011566948,0.00030070753,0.0027013267,0.0012273694],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6291031,0.11656621,0.004448968,0.0013581486,0.001257752,0.00034294228,0.00045339152,0.0024747339,0.10243049,0.0008358482,0.0075176074,0.13321072],"study_design_scores_gemma":[0.48422417,0.4984373,0.0053790603,0.000038097798,0.00029544538,0.00026213503,0.00008215818,0.0017791939,0.005352405,0.0003432349,0.0037743705,0.000032367185],"about_ca_topic_score_codex":0.00082410674,"about_ca_topic_score_gemma":0.0020987631,"teacher_disagreement_score":0.0048778797,"about_ca_system_score_codex":0.0009213563,"about_ca_system_score_gemma":0.0013973216,"threshold_uncertainty_score":0.016318083},"labels":[],"label_agreement":null},{"id":"W4386784930","doi":"10.1158/1557-3265.aacrahns23-ia09","title":"Abstract IA09: Characterization of hypoxic tumor microenvironment in HPV-negative HNSCC","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Head and neck squamous-cell carcinoma; Tumor microenvironment; Cancer research; Cetuximab; Proinflammatory cytokine; Pembrolizumab; Immune system; Tumor hypoxia; Epidermal growth factor receptor; Biology; Medicine; Immunotherapy; Immunology; Cancer; Antibody; Internal medicine; Radiation therapy; Inflammation; Head and neck cancer","score_opus":0.10285606595722134,"score_gpt":0.43867301735123265,"score_spread":0.3358169513940113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925965,0.0021622658,0.0014512273,0.000038527072,0.000020762323,0.00008380353,0.0011750609,0.0000603879,0.0024115203],"genre_scores_gemma":[0.99180436,0.00083551387,0.0028769781,0.00005921576,0.000016597962,0.000088236186,0.002886681,0.000017416176,0.00141495],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998816,0.000012266263,0.0000131904,0.000028760302,0.00003053307,0.000033599325],"domain_scores_gemma":[0.9999,0.000007752034,0.00001543272,0.0000068140075,0.000038076265,0.000032017197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011723629,0.00018247009,0.00018368333,0.0012713252,0.00025998708,0.00026212234,0.00012761708,0.00024740005,0.001849357],"category_scores_gemma":[0.00011877744,0.000100307625,0.00018718264,0.00072328805,0.00013727398,0.00013242896,0.00020733754,0.00018707539,0.00055648736],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039379753,0.00006307938,0.044891745,0.00016306915,0.000019307085,0.00059803086,0.00012954645,0.00010458993,0.9471687,0.00006227436,0.0002091347,0.0061966428],"study_design_scores_gemma":[0.000035638346,0.000949431,0.56511587,0.00006462761,0.00015948284,0.0074289762,0.0010635409,0.003658074,0.41032225,0.00021013664,0.010969726,0.00002227778],"about_ca_topic_score_codex":0.0013871606,"about_ca_topic_score_gemma":0.0012909325,"teacher_disagreement_score":0.001849357,"about_ca_system_score_codex":0.00017560521,"about_ca_system_score_gemma":0.0001853199,"threshold_uncertainty_score":0.0061867237},"labels":[],"label_agreement":null},{"id":"W4386784950","doi":"10.1158/1557-3265.aacrahns23-po-010","title":"Abstract PO-010: Operationalizing the health care system electronic medical record to create head and neck cancer research and screening databases","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Population; Head and neck cancer; Database; Medical record; Cancer; Internal medicine; Environmental health; Computer science","score_opus":0.4936907479239351,"score_gpt":0.6245566259056378,"score_spread":0.13086587798170268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784950","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31999823,0.0008246008,0.32663137,0.008667201,0.0005551678,0.024188938,0.25314087,0.025075441,0.04091817],"genre_scores_gemma":[0.31573358,0.00041666534,0.51334393,0.0009771687,0.00034584236,0.0055856123,0.159182,0.0011521567,0.003263018],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.98788863,0.004742084,0.002895012,0.0020938017,0.0020059668,0.00037447718],"domain_scores_gemma":[0.9414869,0.022507118,0.008254129,0.015235769,0.008584826,0.003931286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030921863,0.0004516726,0.0005294434,0.006108087,0.00081938534,0.0055055628,0.0023983023,0.00056934403,0.005458718],"category_scores_gemma":[0.05749323,0.0005947828,0.0005593608,0.005236211,0.00062480307,0.0043866243,0.0043956866,0.00079811935,0.0026827115],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015337717,0.0009622519,0.48284355,0.0012400878,0.0003254893,0.0005501112,0.0033326305,0.005548634,0.008284775,0.02153865,0.0799864,0.39385366],"study_design_scores_gemma":[0.0010153705,0.0016134304,0.57981867,0.0012443878,0.00033090243,0.001089954,0.0055856276,0.08319548,0.022045655,0.014280659,0.28955176,0.00022802032],"about_ca_topic_score_codex":0.006130583,"about_ca_topic_score_gemma":0.00404179,"teacher_disagreement_score":0.030921863,"about_ca_system_score_codex":0.0015639509,"about_ca_system_score_gemma":0.004809878,"threshold_uncertainty_score":0.16353238},"labels":[],"label_agreement":null},{"id":"W4386784974","doi":"10.1158/1557-3265.aacrahns23-ia03","title":"Abstract IA03: Head and Neck Cancer Takes a Nerve, Cancer neuroscience: emerging hallmark of cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Neuroscience; Head and neck cancer; Medicine; Disease; Bioinformatics; Internal medicine; Psychology; Biology","score_opus":0.2724653147544931,"score_gpt":0.5583761924075247,"score_spread":0.2859108776530316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784974","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010249002,0.24974045,0.003109918,0.4442233,0.11737657,0.00029886345,0.0020351536,0.0006604414,0.1723063],"genre_scores_gemma":[0.124079145,0.30987346,0.006773393,0.10705076,0.09020604,0.00023902231,0.0024531954,0.00025856352,0.35906646],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9995228,0.00010078895,0.000034952685,0.00006181073,0.00020543128,0.000074323914],"domain_scores_gemma":[0.99882346,0.00010641162,0.00010589744,0.000043172997,0.0005789465,0.00034218296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014132943,0.0004433666,0.00051835907,0.0009980472,0.0012334149,0.0033820036,0.0007051401,0.001960439,0.027699497],"category_scores_gemma":[0.0012847584,0.00019597195,0.00031642275,0.0010880346,0.0017380698,0.001371351,0.0010739481,0.0034105727,0.007271134],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015458146,0.00006265211,0.0013581301,0.0005217229,0.000012004267,0.00025236353,0.00010994886,0.000054853797,0.0024823362,0.0052879713,0.8806587,0.10904474],"study_design_scores_gemma":[0.000049734183,0.0001731611,0.013091783,0.001106736,0.00003624756,0.0017458872,0.00047981896,0.00020373109,0.0018579619,0.0059112143,0.975317,0.000026694895],"about_ca_topic_score_codex":0.011246533,"about_ca_topic_score_gemma":0.0322403,"teacher_disagreement_score":0.027699497,"about_ca_system_score_codex":0.0039631547,"about_ca_system_score_gemma":0.0053934823,"threshold_uncertainty_score":0.09266406},"labels":[],"label_agreement":null},{"id":"W4386784975","doi":"10.1158/1557-3265.aacrahns23-ia12","title":"Abstract IA12: Fluorescence guided surgery: Rapidly evolving applications","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Head and neck cancer; Head and neck; Head and neck squamous-cell carcinoma; Positron emission tomography; Population; In vivo; Fluorescence-lifetime imaging microscopy; Nuclear medicine; Radiology; Pathology; Fluorescence; Surgery; Internal medicine","score_opus":0.25158662532294557,"score_gpt":0.4744027410106534,"score_spread":0.22281611568770782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784975","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09579101,0.6108179,0.14364405,0.053039517,0.004976272,0.00037977047,0.001179338,0.0026720664,0.08749997],"genre_scores_gemma":[0.44435912,0.2809788,0.17318735,0.012955777,0.0044614864,0.0002711064,0.0014909104,0.00048030497,0.081815034],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994049,0.00011959232,0.000029277078,0.0001419123,0.00023630688,0.000068009664],"domain_scores_gemma":[0.99932885,0.00014545,0.00005457008,0.00003623787,0.0003065739,0.00012839319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022379241,0.0005868851,0.00043005275,0.000623637,0.0002775709,0.0014104398,0.00092112465,0.0019304298,0.007675573],"category_scores_gemma":[0.0009210615,0.00022616705,0.00031859553,0.0005551523,0.0010332183,0.0012802681,0.0006691202,0.0015552508,0.0027577078],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003740426,0.00024111597,0.0012994083,0.00090406166,0.00003332356,0.0002353563,0.00016263289,0.001217368,0.14662959,0.012492141,0.042507056,0.79390395],"study_design_scores_gemma":[0.00014246695,0.0022559308,0.008639339,0.0007741676,0.00005864154,0.0049700695,0.00029545312,0.012265313,0.18012126,0.011045079,0.77929336,0.00013905235],"about_ca_topic_score_codex":0.001916191,"about_ca_topic_score_gemma":0.0014518076,"teacher_disagreement_score":0.007675573,"about_ca_system_score_codex":0.0012979889,"about_ca_system_score_gemma":0.0011222151,"threshold_uncertainty_score":0.025677323},"labels":[],"label_agreement":null},{"id":"W4386784985","doi":"10.1158/1557-3265.aacrahns23-ia04","title":"Abstract IA04: Evaluating the therapeutic potential of ATR inhibitor BAY 1895344 and radiation therapy for head and neck squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cancer research; Medicine; Head and neck squamous-cell carcinoma; DNA damage; Clonogenic assay; Bay; Cell cycle; Cell; Radiation therapy; Pathology; Biology; Head and neck cancer; Cancer; Internal medicine; DNA","score_opus":0.15207032718322125,"score_gpt":0.4795662263999439,"score_spread":0.3274958992167226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958103,0.002099886,0.00027068844,0.00009750065,0.00004725609,0.00021130028,0.00033165,0.000040272484,0.0010911331],"genre_scores_gemma":[0.99468046,0.0017323155,0.0006866361,0.000071486065,0.000023603881,0.00013512526,0.0006598763,0.000007947587,0.0020025345],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999113,0.000022927856,0.00000837042,0.000012628896,0.000018119687,0.000026610223],"domain_scores_gemma":[0.99992394,0.000012050787,0.000015083322,0.0000086042955,0.000010767235,0.000029482522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026433056,0.00031291938,0.00046734314,0.00031382582,0.00016270971,0.00030284113,0.00034154224,0.000363382,0.0029832544],"category_scores_gemma":[0.00011991193,0.00015132362,0.00039228855,0.00026455877,0.00019353657,0.00025371116,0.00013378015,0.00071114727,0.00038228626],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019794736,0.014100709,0.0029626202,0.0005886479,0.00020161709,0.00018882856,0.00008007241,0.0015384228,0.9059957,0.00025451812,0.0011520331,0.05314205],"study_design_scores_gemma":[0.0044473843,0.26541564,0.03053636,0.00004847622,0.00066962506,0.00055007316,0.00014561426,0.0034999773,0.6869902,0.00009926962,0.007568893,0.000028342181],"about_ca_topic_score_codex":0.0016930624,"about_ca_topic_score_gemma":0.0029212434,"teacher_disagreement_score":0.0029832544,"about_ca_system_score_codex":0.00032088053,"about_ca_system_score_gemma":0.0005949807,"threshold_uncertainty_score":0.009979963},"labels":[],"label_agreement":null},{"id":"W4386784997","doi":"10.1158/1557-3265.aacrahns23-po-015","title":"Abstract PO-015: The genetic landscape of head and neck cancer using brush biopsy","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biopsy; Cancer; Medicine; Dysplasia; Head and neck cancer; Pathology; Brush; Carcinoma; Internal medicine","score_opus":0.18345076807742708,"score_gpt":0.49816070425210146,"score_spread":0.31470993617467435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964527,0.0002914499,0.002374383,0.00002006353,0.000003702231,0.0000237775,0.0003631709,0.00003359586,0.0004372939],"genre_scores_gemma":[0.99670595,0.000095974,0.0024051806,0.000015150764,0.0000023843534,0.000012684399,0.00050014735,0.000013816638,0.00024877719],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99986553,0.000019126708,0.000008316202,0.00004500836,0.00003981964,0.000022161612],"domain_scores_gemma":[0.9998258,0.00005279071,0.000022894039,0.000027553871,0.000047000613,0.000024106046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002505852,0.0001845956,0.00021116051,0.0007072446,0.00028464544,0.00053852354,0.00020806772,0.0003110488,0.0017126211],"category_scores_gemma":[0.0005599369,0.00011663339,0.00022852236,0.00048764373,0.00023468495,0.00022782922,0.00037853702,0.00017133777,0.0002805954],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001180071,0.0000623934,0.4311406,0.00016972373,0.00013608493,0.0022085593,0.0005278123,0.001994623,0.53375655,0.00025897135,0.00028170625,0.02828284],"study_design_scores_gemma":[0.000020654026,0.00042321862,0.8494804,0.000020202724,0.00016091917,0.007567826,0.0010915274,0.020640094,0.1168307,0.0005150484,0.003221557,0.000027742291],"about_ca_topic_score_codex":0.0036230553,"about_ca_topic_score_gemma":0.0040791724,"teacher_disagreement_score":0.0036230553,"about_ca_system_score_codex":0.0002956841,"about_ca_system_score_gemma":0.00014642584,"threshold_uncertainty_score":0.0072039366},"labels":[],"label_agreement":null},{"id":"W4386785088","doi":"10.1158/1557-3265.aacrahns23-po-011","title":"Abstract PO-011: Analysis of nuclear receptor expression in head and neck cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nuclear receptor; Retinoic acid receptor; Thyroid hormone receptor; Receptor; Biology; Calcitriol receptor; Peroxisome proliferator-activated receptor gamma; Retinoic acid receptor beta; Cancer research; Head and neck squamous-cell carcinoma; Peroxisome proliferator-activated receptor; Internal medicine; Retinoic acid; Retinoid X receptor; Endocrinology; Cancer; Head and neck cancer; Transcription factor; Gene; Medicine; Genetics","score_opus":0.136762165708987,"score_gpt":0.4933823949709415,"score_spread":0.35662022926195447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386785088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9483013,0.0026307947,0.0023663528,0.00020356393,0.00005233092,0.00013462736,0.041638665,0.00029791237,0.0043744477],"genre_scores_gemma":[0.94356954,0.0007052085,0.0034898124,0.00018681568,0.000027067794,0.00024580053,0.04865403,0.000100961995,0.0030207452],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996244,0.000046497793,0.000029828454,0.00011367677,0.00011937732,0.000066236156],"domain_scores_gemma":[0.9996568,0.00008837196,0.00007794233,0.000042729574,0.000090894595,0.000043283664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046235096,0.00016927303,0.0002814799,0.00097468065,0.0003131623,0.00059334014,0.00027837022,0.00025504243,0.004331191],"category_scores_gemma":[0.00073384587,0.00010727518,0.0003384689,0.0012842537,0.00018841207,0.00013058152,0.00035956586,0.00027421955,0.0012469353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030382995,0.00014815123,0.6676102,0.0014715786,0.0004672588,0.00044047163,0.0002915776,0.001464746,0.25665718,0.00036227802,0.013076324,0.054971892],"study_design_scores_gemma":[0.000060935814,0.00033665643,0.94141847,0.000056860103,0.00025483948,0.0009504343,0.000355053,0.0024142854,0.03224953,0.000187598,0.021696953,0.00001830866],"about_ca_topic_score_codex":0.0039204247,"about_ca_topic_score_gemma":0.0054204413,"teacher_disagreement_score":0.004331191,"about_ca_system_score_codex":0.00043032464,"about_ca_system_score_gemma":0.00057955814,"threshold_uncertainty_score":0.014489293},"labels":[],"label_agreement":null},{"id":"W4386785090","doi":"10.1158/1557-3265.aacrahns23-ia05","title":"Abstract IA05: Nodal and systemic Immune effects of radiation in HNSCC","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Immunotherapy; Metastasis; Medicine; Lymph; Cancer; Lymph node; Cancer research; Radiation therapy; Antigen; Immunology; Pathology; Internal medicine","score_opus":0.1254624242287148,"score_gpt":0.5101282871669741,"score_spread":0.38466586293825933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386785090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9702928,0.01770515,0.0015256951,0.00038866966,0.00023499283,0.000106569256,0.0004140665,0.00015121086,0.009180801],"genre_scores_gemma":[0.9844525,0.0043290504,0.0012063275,0.00021310008,0.00014196704,0.00005963948,0.0005133477,0.000024788918,0.009059273],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999219,0.000016766206,0.0000052330874,0.000020436944,0.000021420226,0.0000141139035],"domain_scores_gemma":[0.99992466,0.00002943661,0.000011680577,0.000004958354,0.000012310657,0.000016927172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030161452,0.00022534565,0.00029742118,0.00055945467,0.00015284964,0.00024061397,0.00016544646,0.0002672539,0.004504388],"category_scores_gemma":[0.0001569834,0.00006292897,0.00026577988,0.00021548994,0.00027892596,0.00011177133,0.00013779003,0.00035599238,0.00028362853],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00460473,0.0008135132,0.014612582,0.0008925607,0.00011347387,0.00042322118,0.00012007906,0.0006337756,0.8290503,0.0005161478,0.0040258826,0.14419381],"study_design_scores_gemma":[0.00042898467,0.031267557,0.35326988,0.0001810802,0.0004784283,0.0036718228,0.00030755406,0.0021794068,0.58268666,0.00037411964,0.025127305,0.000027183527],"about_ca_topic_score_codex":0.0010332888,"about_ca_topic_score_gemma":0.0013154604,"teacher_disagreement_score":0.004504388,"about_ca_system_score_codex":0.0004263698,"about_ca_system_score_gemma":0.00024368064,"threshold_uncertainty_score":0.01506865},"labels":[],"label_agreement":null},{"id":"W4387157118","doi":"10.1158/1078-0432.ccr-23-1397","title":"Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"Leids Universitair Medisch Centrum; KWF Kankerbestrijding; Universiteit Leiden","keywords":"PTEN; Stage (stratigraphy); Medicine; Internal medicine; Oncology; Microsatellite instability; Endometrial cancer; Disease; Immunohistochemistry; Carcinoma; Retrospective cohort study; Cohort; Gynecology; Pathology; Cancer; Biology; Gene","score_opus":0.2405595691848712,"score_gpt":0.5248642001528636,"score_spread":0.2843046309679924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387157118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99857366,0.0009298736,0.00008664677,0.000017414308,0.0000010497755,0.000009436283,0.00013700093,0.0000019030474,0.00024299644],"genre_scores_gemma":[0.99936384,0.00029347002,0.00008467031,0.000010673774,0.000003256168,0.000004097078,0.0001918757,9.70411e-7,0.000047219834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997645,0.00004759923,0.000036429003,0.000059865702,0.000055768993,0.000035785506],"domain_scores_gemma":[0.99920875,0.00016581726,0.00035907773,0.000058694855,0.00012656115,0.00008098848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060304085,0.00014868386,0.00018883328,0.00089553633,0.00021909522,0.0003991737,0.0002831962,0.00019878129,0.00058067834],"category_scores_gemma":[0.0018631677,0.00009041505,0.00014012853,0.0007388533,0.00040127253,0.00021387654,0.00018943255,0.00011348711,0.000088911365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018319322,0.000008360296,0.9930415,0.000035333465,0.000027635364,0.00023286908,0.0000622892,0.000049516326,0.0019298318,0.00001906363,0.000038882346,0.0043715723],"study_design_scores_gemma":[0.000006643989,0.0000763689,0.9974234,0.000013669371,0.000040835595,0.0014743315,0.00013637682,0.000120083976,0.00038682704,0.000030939835,0.00028804532,0.0000023393632],"about_ca_topic_score_codex":0.0062890854,"about_ca_topic_score_gemma":0.011868227,"teacher_disagreement_score":0.0062890854,"about_ca_system_score_codex":0.0004908988,"about_ca_system_score_gemma":0.00040130122,"threshold_uncertainty_score":0.012504995},"labels":[],"label_agreement":null},{"id":"W4387296735","doi":"10.1158/1078-0432.ccr-23-1735","title":"Intratumoral Delivery of Chimeric Antigen Receptor T Cells Targeting CD133 Effectively Treats Brain Metastases","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Canada Foundation for Innovation; Mitacs; Canada Research Chairs","keywords":"Chimeric antigen receptor; Medicine; Antigen; Population; Cancer research; Cancer stem cell; Metastasis; Immunotherapy; Immunology; Oncology; Cancer; Internal medicine; Immune system","score_opus":0.20659055628028922,"score_gpt":0.5196007385964388,"score_spread":0.31301018231614963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387296735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.727414,0.1549716,0.015815137,0.05758972,0.0066021094,0.0004358446,0.00046681904,0.0012878033,0.035417046],"genre_scores_gemma":[0.8972518,0.06719448,0.004800412,0.010709283,0.0031134982,0.00020146849,0.0002486326,0.00012544454,0.016354939],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992406,0.00001742029,0.000003344539,0.000015433625,0.000023794619,0.000015943446],"domain_scores_gemma":[0.999936,0.000026301204,0.000010345684,0.0000042679244,0.000011500757,0.000011629003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023118751,0.00024740738,0.00022962841,0.00018619363,0.0001221873,0.0003368325,0.00023748215,0.00057590706,0.0006306355],"category_scores_gemma":[0.0001748972,0.00006433752,0.0001594299,0.00014219113,0.0006028133,0.0002498292,0.0001487471,0.0014216724,0.00029872442],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017350116,0.0005953649,0.00074983283,0.0008414338,0.00006537298,0.0010918444,0.000132177,0.0011206943,0.7497582,0.0053476095,0.041975062,0.19658744],"study_design_scores_gemma":[0.0014503791,0.005856609,0.0066815303,0.00020622833,0.00022029756,0.0035443334,0.00022383184,0.0039415862,0.6846535,0.0021221025,0.29104382,0.000055785],"about_ca_topic_score_codex":0.0005053807,"about_ca_topic_score_gemma":0.0013169735,"teacher_disagreement_score":0.0006306355,"about_ca_system_score_codex":0.00043580582,"about_ca_system_score_gemma":0.00047211605,"threshold_uncertainty_score":0.0031619668},"labels":[],"label_agreement":null},{"id":"W4387297143","doi":"10.1158/1078-0432.ccr-23-2260","title":"Deciphering the Pathways to PARP Sensitivity in Pancreatic Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"Ontario Institute for Cancer Research","keywords":"PALB2; Olaparib; Pancreatic cancer; PARP inhibitor; Reversion; Medicine; Cancer; Oncology; Clinical trial; Poly ADP ribose polymerase; DNA repair; Cancer research; BRCA mutation; Internal medicine; Bioinformatics; Mutation; Biology; Genetics; Germline mutation; DNA; Breast cancer; Phenotype; Polymerase","score_opus":0.49625347445507545,"score_gpt":0.5922869451710471,"score_spread":0.09603347071597162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387297143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95684636,0.03069882,0.0043682978,0.0033044345,0.00014196968,0.000056710294,0.0016438527,0.00006982793,0.0028696107],"genre_scores_gemma":[0.98681927,0.008676025,0.001767479,0.00074813724,0.00010454743,0.00002491631,0.0007697285,0.000011784659,0.0010779836],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997713,0.00006820292,0.00001562371,0.00006463977,0.000040151706,0.00004005315],"domain_scores_gemma":[0.9992594,0.0002871376,0.00020309306,0.00006677885,0.00009795309,0.000085625696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053531246,0.00030509025,0.00045865664,0.00096188893,0.00021235863,0.001124292,0.00035588077,0.0005029198,0.0014554621],"category_scores_gemma":[0.0012664993,0.00021320605,0.0003678311,0.0011628784,0.00031636358,0.0009829547,0.00045338017,0.0012039732,0.0002906235],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028075648,0.00042214987,0.6972516,0.0006366937,0.0008068383,0.0019335146,0.00046510855,0.0017400263,0.07092178,0.0016630831,0.003941241,0.21741028],"study_design_scores_gemma":[0.00016904822,0.0012593239,0.9180167,0.00017973136,0.0006437299,0.0042087114,0.0011897874,0.0045182067,0.04104477,0.009263445,0.019435065,0.00007140954],"about_ca_topic_score_codex":0.00076280296,"about_ca_topic_score_gemma":0.0012155274,"teacher_disagreement_score":0.0014554621,"about_ca_system_score_codex":0.00034082474,"about_ca_system_score_gemma":0.00035755662,"threshold_uncertainty_score":0.004868984},"labels":[],"label_agreement":null},{"id":"W4387439283","doi":"10.1158/1078-0432.ccr-23-0229","title":"Comprehensive Single-Cell Immune Profiling Defines the Patient Multiple Myeloma Microenvironment Following Oncolytic Virus Therapy in a Phase Ib Trial","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"National Cancer Institute; L. K. Whittier Foundation","keywords":"Medicine; Multiple myeloma; Oncolytic virus; Bone marrow; Immune system; Bortezomib; Cytotoxic T cell; Thalidomide; Cytokine; Immunology; Tumor microenvironment; Dexamethasone; Internal medicine; Cancer research; Biology; In vitro","score_opus":0.2025749589462749,"score_gpt":0.4697949480140262,"score_spread":0.26721998906775135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387439283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99564064,0.0015963424,0.0005865867,0.00012158308,0.000027850914,0.0008212824,0.00025424204,0.000042074764,0.00090938195],"genre_scores_gemma":[0.9968143,0.00039828668,0.00088122825,0.00019920364,0.000028552502,0.0006743907,0.0005323322,0.000009871472,0.00046190346],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996705,0.00012665635,0.000021034435,0.000064583954,0.0000485992,0.0000685917],"domain_scores_gemma":[0.9997074,0.00003257876,0.000083759434,0.000038121136,0.000019645267,0.00011848935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011075257,0.00053811795,0.0009136421,0.0002230252,0.0002465829,0.000837985,0.00041586766,0.0005752029,0.0014664626],"category_scores_gemma":[0.0004734606,0.00020198822,0.000408702,0.00024792852,0.00040669422,0.00054240075,0.0002766615,0.0017051842,0.00035280501],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28379288,0.041269083,0.032713287,0.00070724543,0.0009439179,0.0002627638,0.000534709,0.004880275,0.39359263,0.00058270065,0.003241214,0.23747931],"study_design_scores_gemma":[0.14433338,0.6494015,0.09026007,0.00012385588,0.0008120273,0.0015627396,0.00022085488,0.0054823346,0.09388319,0.00074414373,0.013113286,0.00006268903],"about_ca_topic_score_codex":0.00020543838,"about_ca_topic_score_gemma":0.0005233445,"teacher_disagreement_score":0.0014664626,"about_ca_system_score_codex":0.0006139035,"about_ca_system_score_gemma":0.0007012606,"threshold_uncertainty_score":0.005857229},"labels":[],"label_agreement":null},{"id":"W4387449703","doi":"10.1158/1078-0432.ccr-23-2187","title":"Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Stand Up To Cancer; National Cancer Institute; National Institutes of Health; BC Cancer Foundation; Lotte and John Hecht Memorial Foundation; American Association for Cancer Research; St. Baldrick's Foundation; Michael Smith Health Research BC; Cancer Prevention and Research Institute of Texas","keywords":"Sarcoma; Proteome; Ewing's sarcoma; Biology; Computational biology; Cancer research; Medicine; Bioinformatics; Pathology","score_opus":0.3823527999098875,"score_gpt":0.5881203503505607,"score_spread":0.20576755044067313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387449703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99630105,0.0006376471,0.0022551604,0.000019647441,0.0000035510498,0.000011297263,0.00042665482,0.000022051338,0.00032296253],"genre_scores_gemma":[0.992834,0.0008569654,0.0039586863,0.000031519514,0.000004222347,0.000021225393,0.0016026138,0.000013280256,0.00067758124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993026,0.000005965138,0.0000047234953,0.000019872172,0.000026455338,0.00001262037],"domain_scores_gemma":[0.9999474,0.000006977798,0.000015543483,0.0000060676443,0.000013800659,0.000010176813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014724126,0.00030996502,0.0001974889,0.00040937148,0.00013846756,0.00022543698,0.00010205354,0.00013822575,0.0004230794],"category_scores_gemma":[0.00010921836,0.000078929355,0.00022460325,0.0003402462,0.00015283783,0.00027407656,0.00027666258,0.00024404195,0.000117548945],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058189566,0.0000075486996,0.0040425807,0.000027142903,0.000009687926,0.000050776405,0.000017826676,0.00011551118,0.9940714,0.000029900566,0.000026332178,0.0015430233],"study_design_scores_gemma":[0.0000110771925,0.00028274074,0.21153846,0.000011284581,0.00007693805,0.0012535148,0.00017042353,0.004717254,0.7788791,0.00020773392,0.0028418256,0.000009632535],"about_ca_topic_score_codex":0.00040750843,"about_ca_topic_score_gemma":0.00059104693,"teacher_disagreement_score":0.0004230794,"about_ca_system_score_codex":0.00021325934,"about_ca_system_score_gemma":0.00014625546,"threshold_uncertainty_score":0.0015473366},"labels":[],"label_agreement":null},{"id":"W4387526419","doi":"10.1158/1078-0432.ccr-23-2005","title":"A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"Stand Up To Cancer; Genentech; Ipsen; Seagen; National Cancer Institute; Bayer; Servier; Pfizer; Incyte; Moderna; Revolution Medicines; Merck KGaA; Boston Scientific Corporation; National Institutes of Health; Helsinn; Bristol-Myers Squibb; Dana-Farber/Harvard Cancer Center; Pharmavite; American Association for Cancer Research; Amgen; EMD Serono; Lustgarten Foundation; Hale Family Center for Pancreatic Cancer Research; AstraZeneca; Eli Lilly and Company; Celgene","keywords":"Gemcitabine; Medicine; Internal medicine; Oncology; Cohort; Biomarker; Adverse effect; Pancreatic cancer; Cancer; Gastroenterology; Biology","score_opus":0.17277172623650477,"score_gpt":0.5296481500083204,"score_spread":0.35687642377181567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387526419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99712545,0.00035838512,0.0002929627,0.000111031106,0.000026655853,0.0010071683,0.00052526145,0.000028881226,0.0005241426],"genre_scores_gemma":[0.99235725,0.00036927825,0.0011374652,0.00035282678,0.000083870225,0.0012872199,0.0032845745,0.000021973307,0.0011055847],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993673,0.0002777259,0.000028268667,0.00012960008,0.00008235832,0.000114802],"domain_scores_gemma":[0.9989705,0.0001268255,0.00018068739,0.00017031525,0.000076178476,0.00047554058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023081847,0.0013633526,0.0015376586,0.00035844825,0.0006050475,0.00084864546,0.00076430145,0.0007670822,0.0018894523],"category_scores_gemma":[0.0009766453,0.00047535016,0.0011705986,0.00036705867,0.0008798497,0.00082221004,0.00056431507,0.0029728946,0.00054721424],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5707792,0.11607963,0.101502106,0.00037387174,0.0018077677,0.0008524173,0.0006227622,0.0031393317,0.1040066,0.00021764591,0.0054782303,0.095140465],"study_design_scores_gemma":[0.18301113,0.6927147,0.10237258,0.000031447755,0.00090091256,0.0011404557,0.00018065568,0.0019361122,0.013002199,0.0001629497,0.0044888356,0.000058035715],"about_ca_topic_score_codex":0.00096015027,"about_ca_topic_score_gemma":0.0023698695,"teacher_disagreement_score":0.0023081847,"about_ca_system_score_codex":0.0012101296,"about_ca_system_score_gemma":0.0018036977,"threshold_uncertainty_score":0.012207031},"labels":[],"label_agreement":null},{"id":"W4387798496","doi":"10.1158/1078-0432.ccr-22-3627","title":"Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients with Metastatic Urothelial Carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Spinal Cord Injury BC; McMaster University; BC Cancer Agency","funders":"EMD Serono; Genentech; Servier; Loxo Oncology; Astellas Pharma; Daiichi-Sankyo; Natera; National Center for Advancing Translational Sciences; Seagen; G1 Therapeutics; Sanofi; Exelixis; Jazz Pharmaceuticals; Advanced Accelerator Applications; Regeneron Pharmaceuticals; Helsinn; CTI Biopharma; Gilead Sciences; Bristol-Myers Squibb; Myriad Genetics; AstraZeneca; Mereo BioPharma; Pfizer","keywords":"Medicine; Pharmacokinetics; Adverse effect; Nausea; Internal medicine; Tolerability; Oncology; Population; Cancer; Urology; Pharmacology; Gastroenterology","score_opus":0.17311337001717203,"score_gpt":0.5108023116460696,"score_spread":0.33768894162889757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387798496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99811363,0.0004533737,0.00022653728,0.00007680585,0.000016659546,0.0005403557,0.00015396699,0.000026808348,0.0003918406],"genre_scores_gemma":[0.9977411,0.00022377587,0.00069493236,0.00016889344,0.00002380477,0.0003742151,0.00034999024,0.000007867885,0.00041540616],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99952006,0.00020589084,0.000034522855,0.00009838698,0.00006706953,0.00007397904],"domain_scores_gemma":[0.9993625,0.00008996924,0.00017899707,0.00007549887,0.0000414775,0.00025164566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001230169,0.0009515565,0.0014060696,0.00033335917,0.0003097668,0.0005948234,0.00052633556,0.0005977258,0.0017524543],"category_scores_gemma":[0.00093750434,0.00044875877,0.0007715582,0.0003684386,0.0006778086,0.00051219395,0.00027398198,0.0023241288,0.00043599718],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49382207,0.1116025,0.04563575,0.0006821057,0.0019795063,0.00043819458,0.0008470221,0.009573927,0.14331329,0.0003144402,0.002897191,0.18889399],"study_design_scores_gemma":[0.18608142,0.7337803,0.058042657,0.00003430681,0.0004431659,0.000584607,0.00010263769,0.0038224175,0.013776649,0.00019931096,0.0030928853,0.000039568466],"about_ca_topic_score_codex":0.0004676101,"about_ca_topic_score_gemma":0.0013138539,"teacher_disagreement_score":0.0017524543,"about_ca_system_score_codex":0.00095897267,"about_ca_system_score_gemma":0.0010578134,"threshold_uncertainty_score":0.0069578886},"labels":[],"label_agreement":null},{"id":"W4387866093","doi":"10.1158/1078-0432.ccr-23-1013","title":"Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Medical Research Council; National Institute for Health and Care Research; Department of Health and Social Care; Cancer Research UK","keywords":"Medicine; Internal medicine; Oncology; Tissue microarray; Cohort; Biomarker; Chemoradiotherapy; Confidence interval; Retrospective cohort study; Radiation therapy; Head and neck squamous-cell carcinoma; Head and neck cancer; Cancer","score_opus":0.3880223645681154,"score_gpt":0.5308270891723218,"score_spread":0.1428047246042064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387866093","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884254,0.00042013096,0.008914557,0.0001912771,0.000032100055,0.00030503183,0.0012267026,0.00011914022,0.00036579513],"genre_scores_gemma":[0.9882686,0.00012320411,0.008755302,0.00007941172,0.000042790736,0.00018228126,0.002337767,0.000023144445,0.00018741988],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99706703,0.0018083282,0.00013685413,0.000488631,0.00035783512,0.00014136404],"domain_scores_gemma":[0.99173474,0.0046323575,0.0010195856,0.0013029263,0.0009767303,0.00033370627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014769385,0.0009965479,0.00111697,0.00089233625,0.00035049306,0.0011005286,0.0010392586,0.00060516543,0.00091684604],"category_scores_gemma":[0.0205962,0.00034510906,0.001259798,0.0005536059,0.00035663985,0.0005420251,0.0010618733,0.0011747126,0.0003188851],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022246225,0.0007007436,0.9330636,0.00009833333,0.0012294792,0.00008772252,0.000106113795,0.013321932,0.0012769646,0.00017265216,0.0013808319,0.04633699],"study_design_scores_gemma":[0.0010580689,0.0074244654,0.5798816,0.00009030094,0.0025297112,0.00074604363,0.0002694829,0.39789936,0.004543051,0.0012188534,0.0042462884,0.00009276648],"about_ca_topic_score_codex":0.0026911844,"about_ca_topic_score_gemma":0.0023875523,"teacher_disagreement_score":0.014769385,"about_ca_system_score_codex":0.0008564142,"about_ca_system_score_gemma":0.0016895762,"threshold_uncertainty_score":0.07810891},"labels":[],"label_agreement":null},{"id":"W4387950431","doi":"10.1158/1078-0432.ccr-23-1079","title":"A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health; Sierra Oncology; University of Pennsylvania; AstraZeneca","keywords":"Cancer research; Ovarian cancer; Medicine; Antibody-drug conjugate; Flow cytometry; Cancer; Antibody; Internal medicine; Immunology; Monoclonal antibody","score_opus":0.1463424974379257,"score_gpt":0.5155802340373745,"score_spread":0.3692377365994488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387950431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99787545,0.00071383687,0.0006747903,0.000032586926,0.000005881664,0.000014454279,0.00005456627,0.000021583654,0.0006069228],"genre_scores_gemma":[0.99768424,0.00039254912,0.0007848156,0.000020593381,0.0000044401027,0.000016524538,0.0002239608,0.00000508193,0.00086785754],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998603,0.00002428159,0.000011524776,0.000024511271,0.000044074746,0.000035191697],"domain_scores_gemma":[0.9999342,0.000011760901,0.000017314513,0.000007920814,0.000011223785,0.000017594457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016741424,0.00020893627,0.00021352303,0.00018662393,0.00010005589,0.00019096442,0.00014552764,0.0002139357,0.0012027622],"category_scores_gemma":[0.000089306915,0.00011537677,0.00015287282,0.00012022712,0.00018140288,0.00021536587,0.00010193906,0.00034918432,0.00022373229],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025064373,0.00008437629,0.0011376383,0.00003790786,0.00001298478,0.00003462258,0.000011224719,0.000105648454,0.99587554,0.000034173197,0.000049771472,0.0023655153],"study_design_scores_gemma":[0.000040819505,0.0013733276,0.0061183707,0.000003006214,0.000026966927,0.000313896,0.000019043902,0.0008746805,0.99032295,0.000013254794,0.0008917305,0.000001886474],"about_ca_topic_score_codex":0.0007218668,"about_ca_topic_score_gemma":0.0006507306,"teacher_disagreement_score":0.0012027622,"about_ca_system_score_codex":0.00029473225,"about_ca_system_score_gemma":0.00017582938,"threshold_uncertainty_score":0.0040236115},"labels":[],"label_agreement":null},{"id":"W4388487685","doi":"10.1158/1078-0432.ccr-23-2249","title":"Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"AstraZeneca","keywords":"Olaparib; Medicine; Clinical endpoint; Cohort; Bevacizumab; Internal medicine; Oncology; Durvalumab; PARP inhibitor; Adverse effect; Cancer; Clinical trial; Chemotherapy; Nivolumab; Poly ADP ribose polymerase; Biology","score_opus":0.317749283599929,"score_gpt":0.5762641648363642,"score_spread":0.25851488123643523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388487685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979196,0.0007392771,0.00018533572,0.00009429802,0.000028082133,0.0003861312,0.0003893878,0.000014965971,0.00024293619],"genre_scores_gemma":[0.9966936,0.00067619106,0.0006170615,0.00022691464,0.00007485049,0.00040221214,0.00092001096,0.000009414548,0.00037974693],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99905485,0.00048894284,0.00005115174,0.00020028319,0.00011237098,0.00009244416],"domain_scores_gemma":[0.99877447,0.00019132248,0.00028877181,0.00022783184,0.00006953358,0.00044814154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026936438,0.0011697604,0.0013734272,0.0003346242,0.0004187296,0.0010696012,0.0008105743,0.00069717114,0.0015447432],"category_scores_gemma":[0.0015946422,0.00052373926,0.0015997048,0.0004023715,0.0006992395,0.00080936134,0.00043711936,0.002026873,0.00039710104],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76132953,0.070044145,0.062378377,0.00049309374,0.005566805,0.0003368253,0.00035335904,0.0018842401,0.024875874,0.0001892275,0.0021133674,0.07043512],"study_design_scores_gemma":[0.47864518,0.39485496,0.10867206,0.00006093469,0.0037933157,0.00096933305,0.00021007597,0.0033979723,0.00534688,0.00029825215,0.0036674938,0.00008355404],"about_ca_topic_score_codex":0.0010425588,"about_ca_topic_score_gemma":0.0023467334,"teacher_disagreement_score":0.0026936438,"about_ca_system_score_codex":0.0009873008,"about_ca_system_score_gemma":0.0015369209,"threshold_uncertainty_score":0.01424551},"labels":[],"label_agreement":null},{"id":"W4388488241","doi":"10.1158/1078-0432.ccr-23-2365","title":"Methodical Manipulation of the TME in Ovarian Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Ovarian cancer; Bevacizumab; Tumor microenvironment; Chemotherapy; Medicine; Cancer; Cancer research; Oncology; Biology; Internal medicine","score_opus":0.5819015776579184,"score_gpt":0.6383872710847307,"score_spread":0.05648569342681231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388488241","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23623592,0.02710709,0.665329,0.004037227,0.0046955124,0.0021453588,0.0019714048,0.0019521757,0.05652629],"genre_scores_gemma":[0.56785345,0.019782657,0.36816987,0.0022221312,0.00048442214,0.0050331717,0.0010578452,0.00060770696,0.0347887],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995803,0.00010437147,0.000027815051,0.00012232205,0.00010450185,0.00006068718],"domain_scores_gemma":[0.9997687,0.0000716507,0.000044131102,0.000069430025,0.000027046715,0.000019137007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008318932,0.00044733915,0.00020888349,0.0004920529,0.0005543674,0.0004236458,0.0004902205,0.0005628255,0.0048448993],"category_scores_gemma":[0.0005961123,0.00029510452,0.0003003903,0.00036823875,0.0006205897,0.00045726687,0.00078699406,0.0011523081,0.0016215885],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019130383,0.0000808413,0.00029926994,0.00037614352,0.000015549933,0.00026469736,0.000147177,0.0002769244,0.9653292,0.0051426794,0.0019341077,0.025942212],"study_design_scores_gemma":[0.00016604159,0.0005018213,0.0027715554,0.0000854075,0.000046490906,0.0014419123,0.00015419925,0.0028867302,0.83137244,0.0026251974,0.15787545,0.00007275796],"about_ca_topic_score_codex":0.00045814802,"about_ca_topic_score_gemma":0.00091043377,"teacher_disagreement_score":0.0048448993,"about_ca_system_score_codex":0.00026062017,"about_ca_system_score_gemma":0.00047011493,"threshold_uncertainty_score":0.016207814},"labels":[],"label_agreement":null},{"id":"W4388775253","doi":"10.1158/1078-0432.ccr-23-2580","title":"PRESSING Need of Precision Care in HER2-Positive Colorectal Cancer: The ELEPHANT in the Room","year":2023,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency; University of British Columbia Hospital","funders":"National Cancer Institute; National Institutes of Health","keywords":"Colorectal cancer; Medicine; Oncology; Internal medicine; Cancer","score_opus":0.18643439741669132,"score_gpt":0.5258799573231061,"score_spread":0.3394455599064148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388775253","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003187621,0.004609764,0.00012646982,0.9816492,0.012064787,0.000006797632,0.000018810273,0.000020078523,0.001185307],"genre_scores_gemma":[0.0046215504,0.009321358,0.0006118021,0.8885894,0.09310245,0.000033029784,0.000030181187,0.000024190931,0.0036660936],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963726,0.0014836981,0.00047073627,0.0004023097,0.00095473754,0.00031594335],"domain_scores_gemma":[0.98511326,0.008532174,0.00063515455,0.00064450986,0.0024872501,0.0025876113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047614933,0.00062967156,0.001494436,0.0006830817,0.002419416,0.0025508846,0.001459633,0.029979628,0.00598878],"category_scores_gemma":[0.019356089,0.0005429317,0.0013742305,0.00065043115,0.0038716043,0.0067723966,0.0014490334,0.035302963,0.0039826483],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014029085,0.000062945,0.0008608269,0.00015729657,0.00002647006,0.0035202617,0.00010263233,0.00012814126,0.00038670644,0.0034856626,0.9599324,0.031196278],"study_design_scores_gemma":[0.00025779425,0.000259747,0.002017906,0.0010564595,0.000055995482,0.011858773,0.0006622737,0.00061853306,0.00044275908,0.024127485,0.95853156,0.00011063478],"about_ca_topic_score_codex":0.0026736301,"about_ca_topic_score_gemma":0.0060844477,"teacher_disagreement_score":0.029979628,"about_ca_system_score_codex":0.003845772,"about_ca_system_score_gemma":0.0037537103,"threshold_uncertainty_score":0.02790314},"labels":[],"label_agreement":null},{"id":"W4388897642","doi":"10.1158/1078-0432.ccr-23-0133","title":"A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor–positive/HER2-negative Advanced or Metastatic Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Université Laval; Princess Margaret Cancer Centre","funders":"","keywords":"Dysgeusia; Fulvestrant; Medicine; Metastatic breast cancer; Internal medicine; Breast cancer; Tolerability; Exemestane; Aromatase inhibitor; Oncology; Cancer; Pharmacodynamics; Adverse effect; Estrogen receptor; Pharmacokinetics; Aromatase","score_opus":0.07633842613163684,"score_gpt":0.4556095102528649,"score_spread":0.37927108412122806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388897642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99414957,0.0015131532,0.00038605262,0.00025053573,0.00007165234,0.002073716,0.00047989615,0.000066827335,0.0010085424],"genre_scores_gemma":[0.99246526,0.0016288832,0.0011291136,0.0005249329,0.00011551706,0.001690643,0.0011184576,0.000019347784,0.0013078944],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996543,0.00016660386,0.000020736765,0.000058722486,0.00003132027,0.00006833347],"domain_scores_gemma":[0.9995753,0.000071670605,0.00008123962,0.00004723496,0.000027416085,0.00019707829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011780272,0.0014716723,0.0019855318,0.0004715401,0.00034989312,0.0006664279,0.00069096015,0.00093478087,0.0035894457],"category_scores_gemma":[0.0007116785,0.0006489136,0.0012980674,0.00043249808,0.0009635134,0.00077977654,0.00030141763,0.002346481,0.0008320026],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6575503,0.13045952,0.009733697,0.0013071479,0.0017948833,0.00046145523,0.00038982733,0.0030393244,0.078474194,0.00026926922,0.0029131705,0.11360725],"study_design_scores_gemma":[0.4978689,0.48760453,0.008428667,0.000026823807,0.00043215122,0.00021535301,0.000050562132,0.000723986,0.0032830494,0.000070668895,0.0012750182,0.000020276735],"about_ca_topic_score_codex":0.0008756259,"about_ca_topic_score_gemma":0.0018731492,"teacher_disagreement_score":0.0035894457,"about_ca_system_score_codex":0.0007103795,"about_ca_system_score_gemma":0.0012883542,"threshold_uncertainty_score":0.012007892},"labels":[],"label_agreement":null},{"id":"W4389057791","doi":"10.1158/1078-0432.ccr-23-1601","title":"Modulating Gut Microbiota Prevents Anastomotic Leak to Reduce Local Implantation and Dissemination of Colorectal Cancer Cells after Surgery","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Natural Sciences and Engineering Research Council of Canada; Institut Du Cancer de Montréal; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Colorectal cancer; Anastomosis; Medicine; Gut flora; Cancer; Metastasis; Internal medicine; Downregulation and upregulation; Colorectal surgery; Gastroenterology; Surgery; Cancer research; Oncology; Immunology; Abdominal surgery; Biology","score_opus":0.08448730452799805,"score_gpt":0.4939471788505934,"score_spread":0.40945987432259534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389057791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99445844,0.00271963,0.0015391348,0.00026016508,0.00008713715,0.00007420285,0.00010679098,0.00009108516,0.00066342024],"genre_scores_gemma":[0.9928126,0.0024748656,0.0025398564,0.00026896506,0.0000357271,0.00008939066,0.0001937255,0.000022597813,0.0015622006],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998832,0.000026150006,0.000009284629,0.000016362008,0.000027285661,0.000037677528],"domain_scores_gemma":[0.9998591,0.000009437588,0.000053121654,0.000009345569,0.000018852586,0.000050135484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013337815,0.00039048807,0.0005099018,0.0002588409,0.00018197544,0.0002897763,0.00018337724,0.0003137262,0.0013417521],"category_scores_gemma":[0.0002192022,0.000097272045,0.00028600043,0.00014385273,0.00019595755,0.0001701673,0.0002500656,0.0007762771,0.0002380616],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025225668,0.001370438,0.001501824,0.00037632656,0.00004776124,0.00006344745,0.000054640954,0.000175897,0.973423,0.0000863417,0.0002665133,0.020111175],"study_design_scores_gemma":[0.0008763697,0.038093675,0.06407112,0.00026549297,0.00039261015,0.0006652141,0.000522013,0.0024745334,0.8764154,0.00032996893,0.015856162,0.000037502246],"about_ca_topic_score_codex":0.00029443903,"about_ca_topic_score_gemma":0.0006829004,"teacher_disagreement_score":0.0013417521,"about_ca_system_score_codex":0.00018224824,"about_ca_system_score_gemma":0.000340636,"threshold_uncertainty_score":0.004488647},"labels":[],"label_agreement":null},{"id":"W4389573510","doi":"10.1158/1078-0432.ccr-23-2080","title":"Development of a Practical Nomogram for Personalized Anemia Management in Patients Treated with Ataxia Telangiectasia and Rad3-related Inhibitor Camonsertib","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Anemia; Medicine; Hemoglobin; Erythropoietin; Adverse effect; Nomogram; Oncology; Internal medicine","score_opus":0.0934636605667614,"score_gpt":0.4507604682030388,"score_spread":0.35729680763627736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389573510","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4228203,0.00302053,0.5522943,0.003531278,0.00031099143,0.00091531075,0.0066766357,0.004511186,0.005919542],"genre_scores_gemma":[0.8743451,0.00044805088,0.1193952,0.00044371618,0.00015866003,0.000575881,0.0033651988,0.0001280804,0.0011400923],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9983393,0.00081531855,0.00014785455,0.0002861475,0.0002963391,0.00011508249],"domain_scores_gemma":[0.9935773,0.0040367274,0.000931412,0.0002265389,0.00093002996,0.00029795876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054585757,0.0014321492,0.0015736619,0.003288733,0.0006592014,0.0016583463,0.00085626857,0.00087424315,0.0019107452],"category_scores_gemma":[0.012119622,0.00036034296,0.001373044,0.0010371434,0.00032964133,0.00082915375,0.0007852783,0.0014205112,0.00064064964],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016489594,0.0007401673,0.3358259,0.0003612971,0.0008352169,0.0003676693,0.00020544608,0.36073616,0.0029341907,0.002182824,0.019983053,0.2741791],"study_design_scores_gemma":[0.000060883016,0.00039139672,0.022439307,0.000081354105,0.00016265397,0.00020728722,0.00008167204,0.97103477,0.001100966,0.0009513204,0.0034321675,0.00005631387],"about_ca_topic_score_codex":0.004997203,"about_ca_topic_score_gemma":0.0056736674,"teacher_disagreement_score":0.0054585757,"about_ca_system_score_codex":0.0010922649,"about_ca_system_score_gemma":0.0018076719,"threshold_uncertainty_score":0.02886808},"labels":[],"label_agreement":null},{"id":"W4390535948","doi":"10.1158/1078-0432.ccr-23-3275","title":"Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO.17 and CO.20 Randomized Clinical Trials","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital; Canadian Cancer Society; Queen's University; Spinal Cord Injury BC; University of British Columbia; University of British Columbia Hospital","funders":"Daiichi Sankyo Europe; Ipsen; Astellas Pharma; Eisai; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer; Genentech; Coherus Biosciences; Agios Pharmaceuticals; Michael Smith Health Research BC; Canadian Cancer Society; GlaxoSmithKline","keywords":"Cetuximab; Colorectal cancer; Medicine; KRAS; Internal medicine; Oncology; Transverse colon; Oxaliplatin; Randomized controlled trial; Confidence interval; Cancer; Gastroenterology","score_opus":0.2936647154532566,"score_gpt":0.5987890595446822,"score_spread":0.3051243440914256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390535948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66237974,0.32765445,0.0020180796,0.00064022024,0.0005902062,0.0011722895,0.00360941,0.00009455378,0.0018410756],"genre_scores_gemma":[0.98465896,0.011373788,0.00088722457,0.0003708158,0.00030419277,0.00070893404,0.0013522103,0.000021190852,0.0003226257],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9880398,0.008620781,0.0011073981,0.001149609,0.00070843264,0.00037392296],"domain_scores_gemma":[0.9858338,0.0071685435,0.0048540514,0.00087470346,0.0007603144,0.0005085249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014019898,0.0015681852,0.007626899,0.0013328869,0.00027377153,0.0016370245,0.000564332,0.001302524,0.0014025477],"category_scores_gemma":[0.014350951,0.00067505817,0.011586888,0.0019376433,0.00055441674,0.00067250244,0.0007535492,0.0010649383,0.00014635088],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45464623,0.00020418689,0.048660908,0.0113140065,0.46303338,0.0001598873,0.000067168345,0.001688576,0.0017874198,0.00014280272,0.0016373749,0.016658138],"study_design_scores_gemma":[0.115112215,0.017504413,0.106680006,0.0014734305,0.75262046,0.00028676479,0.00009220743,0.0024591475,0.00093238347,0.0004356426,0.002310901,0.000092468705],"about_ca_topic_score_codex":0.0020244247,"about_ca_topic_score_gemma":0.0041997544,"teacher_disagreement_score":0.014019898,"about_ca_system_score_codex":0.0008818477,"about_ca_system_score_gemma":0.000949252,"threshold_uncertainty_score":0.07414514},"labels":[],"label_agreement":null},{"id":"W4390618089","doi":"10.1158/1078-0432.ccr-23-2085","title":"An Immune Gene Expression Risk Score for Distant Metastases after Radiotherapy for Cervical Cancer","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Terry Fox Research Institute","keywords":"Medicine; Immune system; Oncology; Internal medicine; Cohort; Proportional hazards model; Framingham Risk Score; Cervical cancer; Hazard ratio; Immune checkpoint; Cancer; Immunotherapy; Immunology; Disease; Confidence interval","score_opus":0.22604172941150627,"score_gpt":0.556202302323792,"score_spread":0.33016057291228573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390618089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997488,0.0003073836,0.0012439387,0.00008196398,0.000008212982,0.000024071504,0.0005067804,0.000017800832,0.0003219224],"genre_scores_gemma":[0.9977666,0.000060487877,0.0013098599,0.000029172079,0.000010427747,0.000019671521,0.0006428106,0.00000399514,0.00015686639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997844,0.000069214206,0.000015373244,0.000054274187,0.00005017651,0.000026563239],"domain_scores_gemma":[0.9995121,0.00014742962,0.00019902365,0.000028067006,0.000053824577,0.000059641647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005431085,0.00037432965,0.0003191351,0.0006725044,0.00013981087,0.00033699378,0.0002397904,0.00029201776,0.00094850647],"category_scores_gemma":[0.0014923981,0.00008782786,0.0003890012,0.00033539985,0.0001810533,0.00014076049,0.00037989885,0.00032527142,0.00019236207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005729482,0.00004320594,0.98483014,0.00003506165,0.000121746496,0.00003356027,0.000019882758,0.0011456166,0.0039597857,0.000043391257,0.00025484516,0.00893983],"study_design_scores_gemma":[0.000051918225,0.00040636133,0.98680824,0.000013043935,0.00017950992,0.00024327656,0.00004668407,0.009945211,0.001627593,0.00016585605,0.00050144363,0.000010801258],"about_ca_topic_score_codex":0.0011631487,"about_ca_topic_score_gemma":0.0017174836,"teacher_disagreement_score":0.0011631487,"about_ca_system_score_codex":0.00033757047,"about_ca_system_score_gemma":0.0003371191,"threshold_uncertainty_score":0.0031731129},"labels":[],"label_agreement":null},{"id":"W4391100668","doi":"10.1158/1078-0432.ccr-23-3504","title":"KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Daiichi Sankyo Europe; National Cancer Institute; Pharmacyclics; Syöpäsäätiö; Mersana Therapeutics; Fonds Wetenschappelijk Onderzoek; Seagen; Incyte; Massachusetts General Hospital; Vlaamse regering; Leukemia and Lymphoma Society; Celgene; Bristol-Myers Squibb; AstraZeneca; Pfizer","keywords":"Lymphoma; Cancer research; Cell; Medicine; Biology; Immunology; Genetics","score_opus":0.09780909894217026,"score_gpt":0.44468662170203926,"score_spread":0.346877522759869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391100668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98995054,0.0043456513,0.0025214886,0.00030239255,0.000019923602,0.00019001527,0.00011990343,0.00015631362,0.0023937994],"genre_scores_gemma":[0.99604094,0.0007667073,0.0022260204,0.00019165636,0.0000378782,0.00007342992,0.00016997456,0.000007050748,0.00048635344],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999534,0.000011217163,0.0000048023758,0.000008905612,0.000008029743,0.000013787127],"domain_scores_gemma":[0.9999629,0.0000063414636,0.000012442512,0.000004180007,0.0000028307304,0.000011324942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013577702,0.00023840097,0.00032527855,0.00009359235,0.00009782458,0.00027886083,0.00022392177,0.0002133885,0.00071275973],"category_scores_gemma":[0.000105785766,0.000053028536,0.00012282406,0.00010141695,0.00012871713,0.0001561246,0.00013705713,0.00034051144,0.0002532235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061175,0.0016036658,0.039863277,0.00053766096,0.00011147357,0.002472843,0.00025130424,0.0018031566,0.70263964,0.0008703693,0.0025235184,0.24120556],"study_design_scores_gemma":[0.0075956937,0.054374076,0.17579404,0.00024186925,0.0011583646,0.04705671,0.0003932224,0.012846946,0.62110066,0.0012316741,0.07815094,0.00005578915],"about_ca_topic_score_codex":0.00019823977,"about_ca_topic_score_gemma":0.00061711215,"teacher_disagreement_score":0.00071275973,"about_ca_system_score_codex":0.00024472814,"about_ca_system_score_gemma":0.00026998628,"threshold_uncertainty_score":0.0023843646},"labels":[],"label_agreement":null},{"id":"W4391100943","doi":"10.1158/1078-0432.ccr-23-3018","title":"Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Oncology; Internal medicine; Cancer; Odds ratio; Univariate analysis; Bioinformatics; Biology; Multivariate analysis","score_opus":0.12913537536461436,"score_gpt":0.5055657955285745,"score_spread":0.3764304201639601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391100943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99919003,0.00024366107,0.00006075143,0.000031815827,0.0000037855498,0.0000049066875,0.00034020937,0.0000028375885,0.000121929035],"genre_scores_gemma":[0.99931145,0.0000993943,0.000064968524,0.000021091006,0.000007027724,0.0000044542544,0.00045385174,0.0000010363095,0.00003676734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970454,0.000059480833,0.000048423197,0.00006676305,0.00006158852,0.000059154932],"domain_scores_gemma":[0.9984529,0.00024559695,0.00095144316,0.000055560125,0.00011121944,0.00018323786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004254776,0.00021520721,0.00023987456,0.0005274847,0.00020768262,0.00034487358,0.00022470734,0.00025589514,0.00081409543],"category_scores_gemma":[0.0021379774,0.00012740334,0.0003038858,0.0005831798,0.00022935926,0.00028236178,0.0003280287,0.0003946932,0.000121653895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009087149,0.000010766538,0.99887663,0.000005241595,0.000020690322,0.000042342144,0.0000053301533,0.00003580194,0.00009659695,0.0000040527707,0.000039610128,0.0007719989],"study_design_scores_gemma":[0.0000046589903,0.00006118853,0.9992429,0.0000033017948,0.000019172143,0.0002981251,0.000029321225,0.00017987723,0.000077653625,0.000017637243,0.00006461824,0.0000016930953],"about_ca_topic_score_codex":0.0025996605,"about_ca_topic_score_gemma":0.0053964253,"teacher_disagreement_score":0.0025996605,"about_ca_system_score_codex":0.00031771106,"about_ca_system_score_gemma":0.00030984567,"threshold_uncertainty_score":0.005169034},"labels":[],"label_agreement":null},{"id":"W4391219346","doi":"10.1158/1078-0432.ccr-23-0131","title":"Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Center for Protein Therapeutics, University at Buffalo; National Center for Advancing Translational Sciences; Division of Chemical, Bioengineering, Environmental, and Transport Systems; National Cancer Institute; Medical Research Council; National Institutes of Health; Queen's University; Cancer Research UK; Queen's University Belfast; Health and Social Care Northern Ireland; State University of New York; University at Buffalo; National Science Foundation; New York State Department of Health; New York State Stem Cell Science; Roswell Park Cancer Institute; Science Foundation Ireland","keywords":"Pancreatic cancer; Medicine; Cancer; Cancer research; Oncology; Internal medicine","score_opus":0.2801648771054774,"score_gpt":0.5619495589661623,"score_spread":0.2817846818606849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391219346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9548767,0.003024084,0.036461003,0.00029810073,0.000097817356,0.00027215626,0.0011574818,0.0005820342,0.0032305815],"genre_scores_gemma":[0.97770554,0.0012497966,0.016157052,0.00014735074,0.000017123306,0.00020742364,0.00075610424,0.000051277926,0.0037083523],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998344,0.00002456645,0.000008248396,0.000047113026,0.000057520767,0.000028135266],"domain_scores_gemma":[0.9999378,0.000009804263,0.000015986203,0.00001151867,0.000009410764,0.000015552718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019998563,0.00041497804,0.0004195725,0.00030728747,0.00013069175,0.00033535765,0.00022920428,0.0003575643,0.0015194237],"category_scores_gemma":[0.00010591739,0.00017910652,0.00025786256,0.00018611003,0.00014940569,0.0002386468,0.00028319942,0.00062978204,0.0005236496],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010044124,0.00007173749,0.00019170945,0.000034845725,0.000010159279,0.00005083599,0.000009325124,0.00018006327,0.9958476,0.000116764044,0.00012099846,0.0032654307],"study_design_scores_gemma":[0.000026029951,0.000869303,0.0015070428,0.000004348449,0.00003661958,0.0005911342,0.000016899758,0.0024821335,0.99066013,0.00005739107,0.0037415507,0.000007449269],"about_ca_topic_score_codex":0.00019340265,"about_ca_topic_score_gemma":0.0005311982,"teacher_disagreement_score":0.0015194237,"about_ca_system_score_codex":0.00027480788,"about_ca_system_score_gemma":0.00019845043,"threshold_uncertainty_score":0.005082965},"labels":[],"label_agreement":null},{"id":"W4391486548","doi":"10.1158/1078-0432.ccr-23-3414","title":"Antibody–Drug Conjugates: Advancing from Magic Bullet to Biological Missile","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Princess Margaret Cancer Foundation","keywords":"Magic bullet; Drug; Conjugate; Missile; Medicine; Antibody-drug conjugate; Virology; Antibody; Pharmacology; Immunology; Biology; Engineering; Monoclonal antibody; Bioinformatics","score_opus":0.39801736688730605,"score_gpt":0.6481958773268562,"score_spread":0.2501785104395502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391486548","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.057365973,0.5916317,0.24474809,0.03706823,0.005596474,0.0002495432,0.00025889976,0.0014953869,0.06158569],"genre_scores_gemma":[0.411248,0.33969364,0.14296283,0.016051812,0.0030781403,0.0002683427,0.00026018836,0.0003761974,0.08606086],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99961406,0.00008000137,0.000015338786,0.00007100509,0.00018779421,0.000031773645],"domain_scores_gemma":[0.99972636,0.00012626748,0.00004147005,0.000016659973,0.00005239427,0.000036789483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008333494,0.0005660771,0.00042527082,0.0007636699,0.00033005455,0.0012701923,0.00047115053,0.001447519,0.003159115],"category_scores_gemma":[0.0006043196,0.00035468533,0.00023226193,0.00037556925,0.0012985176,0.0025524707,0.0011197692,0.002413542,0.0021366675],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004582062,0.00023538312,0.0005040667,0.0014480286,0.000053480504,0.0007859592,0.00036392553,0.0013323902,0.2826147,0.121519774,0.041027397,0.5496567],"study_design_scores_gemma":[0.00009916612,0.001311438,0.0004644052,0.00019645663,0.00003454314,0.0024909293,0.00012621097,0.0042935433,0.34480283,0.03273367,0.61337113,0.0000757337],"about_ca_topic_score_codex":0.0002209714,"about_ca_topic_score_gemma":0.00043478777,"teacher_disagreement_score":0.003159115,"about_ca_system_score_codex":0.0007432944,"about_ca_system_score_gemma":0.0002558571,"threshold_uncertainty_score":0.010568261},"labels":[],"label_agreement":null},{"id":"W4391755468","doi":"10.1158/1078-0432.ccr-23-2436","title":"Validation of the Prognostic Performance of Breast Cancer Index in Hormone Receptor–Positive Postmenopausal Breast Cancer Patients in the TEAM Trial","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Research Canada; University of Toronto; McMaster University; Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Medicine; Oncology; Cancer; Hormone receptor; Internal medicine; Oestrogen receptor; Postmenopausal women; Gynecology","score_opus":0.047094359813305994,"score_gpt":0.41680607250780793,"score_spread":0.3697117126945019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391755468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963188,0.0009905149,0.00024407283,0.0002497472,0.00010131942,0.00027738113,0.0006149358,0.000017064403,0.001186073],"genre_scores_gemma":[0.9960788,0.0003813079,0.0005411506,0.00017220923,0.00017567292,0.00037188007,0.0017790642,0.0000091077045,0.0004908826],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99722457,0.0020502785,0.00012483732,0.00030207942,0.00017526586,0.0001230762],"domain_scores_gemma":[0.99560285,0.0013540725,0.00149308,0.00059162884,0.00023776386,0.0007206484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076027964,0.00071418216,0.001498192,0.00022632147,0.00030605923,0.0009496305,0.0006416068,0.000633985,0.0013959669],"category_scores_gemma":[0.008604582,0.00020013211,0.0010938195,0.00036713076,0.00047984076,0.0005791244,0.00062683906,0.0009244908,0.00036309526],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72084653,0.0016811029,0.23402508,0.00039096078,0.0031209062,0.0000799455,0.00016686147,0.0014263995,0.0020428635,0.00022264276,0.0028325147,0.033164218],"study_design_scores_gemma":[0.22234376,0.14242879,0.6034616,0.00030806885,0.010162138,0.00050590234,0.00022168891,0.010780707,0.0024548566,0.0013191211,0.0058710915,0.00014216479],"about_ca_topic_score_codex":0.0008424505,"about_ca_topic_score_gemma":0.0013605685,"teacher_disagreement_score":0.0076027964,"about_ca_system_score_codex":0.00042368638,"about_ca_system_score_gemma":0.0008356427,"threshold_uncertainty_score":0.040207922},"labels":[],"label_agreement":null},{"id":"W4391954074","doi":"10.1158/1078-0432.ccr-23-1977","title":"Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; BioTheranostics; Breast Cancer Research Foundation","keywords":"Aromatase inhibitor; Oncology; Breast cancer; Medicine; Internal medicine; Cancer; Aromatase; Oestrogen receptor; Hormone receptor; Mammary gland; Clinical trial; Gynecology","score_opus":0.052693379451328,"score_gpt":0.4262709043848459,"score_spread":0.37357752493351787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391954074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922835,0.0037080457,0.0002733675,0.0005113417,0.000055944638,0.00019266483,0.0012368324,0.000023868548,0.0017143762],"genre_scores_gemma":[0.99436283,0.00090228993,0.0003822278,0.00034237182,0.00015070001,0.0002140117,0.0030773398,0.000009005168,0.00055921247],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9986959,0.0009531607,0.00003742659,0.00011575465,0.00013267096,0.00006521627],"domain_scores_gemma":[0.99847704,0.00057294464,0.0004396995,0.00019593556,0.000063268526,0.00025105965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042092535,0.0007052836,0.001280299,0.0001615267,0.0001643739,0.00058725436,0.0004418228,0.00047182586,0.0013183678],"category_scores_gemma":[0.0030477438,0.000185301,0.0012702256,0.000275733,0.00043611028,0.00042539302,0.00044244682,0.0012158065,0.0001912341],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7411735,0.0023533707,0.14212611,0.0015035265,0.012294925,0.00016938595,0.00016733816,0.008388413,0.0064511723,0.0006898985,0.006164531,0.078517765],"study_design_scores_gemma":[0.21042758,0.06818717,0.6729929,0.00035851705,0.01888505,0.00051898597,0.00012884305,0.015262917,0.002706625,0.002711777,0.0077165184,0.000103121434],"about_ca_topic_score_codex":0.0008661716,"about_ca_topic_score_gemma":0.0017584934,"teacher_disagreement_score":0.0042092535,"about_ca_system_score_codex":0.00041014102,"about_ca_system_score_gemma":0.0005696187,"threshold_uncertainty_score":0.022260904},"labels":[],"label_agreement":null},{"id":"W4392200462","doi":"10.1158/1078-0432.ccr-23-3683","title":"Adult-Onset Cancer Predisposition Syndromes in Children and Adolescents—To Test or not to Test?","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Institutes of Health; Deutsche Kinderkrebsstiftung; National Cancer Institute; Bundesministerium für Bildung und Forschung","keywords":"Cancer; Test (biology); Medicine; Internal medicine; Biology","score_opus":0.1519779809321879,"score_gpt":0.5388848803922281,"score_spread":0.38690689946004025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392200462","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14193973,0.45832765,0.0065441546,0.3393994,0.009347979,0.00024681038,0.0022598736,0.00047429162,0.041460067],"genre_scores_gemma":[0.59178746,0.25394982,0.01826482,0.11515707,0.009138123,0.00035377717,0.0023066706,0.00023888548,0.008803347],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984041,0.00073360757,0.00016301862,0.0001869007,0.000335133,0.00017725736],"domain_scores_gemma":[0.9946802,0.002133175,0.0007203748,0.00027522465,0.0011847866,0.001006181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026726208,0.00033444437,0.00072992296,0.00066010957,0.00063115504,0.0013757863,0.00087248435,0.0021593291,0.0033191326],"category_scores_gemma":[0.014104838,0.00021482423,0.00029139395,0.0007856539,0.0015079409,0.0021849826,0.00082902855,0.003074861,0.0014676984],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004657387,0.00031336566,0.24094746,0.0012220457,0.00012948547,0.0052226335,0.0009930108,0.00028559094,0.0015963255,0.008061742,0.14789182,0.59287083],"study_design_scores_gemma":[0.00031368798,0.0021972964,0.24748152,0.015556882,0.00051476504,0.07733197,0.0092613,0.0009372507,0.0036514127,0.033817746,0.608723,0.000213155],"about_ca_topic_score_codex":0.004764285,"about_ca_topic_score_gemma":0.0062411316,"teacher_disagreement_score":0.004764285,"about_ca_system_score_codex":0.00077929924,"about_ca_system_score_gemma":0.001947416,"threshold_uncertainty_score":0.014134347},"labels":[],"label_agreement":null},{"id":"W4392284408","doi":"10.1158/1078-0432.ccr-23-3211","title":"Improved Risk-Stratification Scheme for Mismatch-Repair Proficient Stage II Colorectal Cancers Using the Digital Pathology Biomarker QuantCRC","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"National Cancer Institute; National Institutes of Health","keywords":"Risk stratification; Colorectal cancer; Biomarker; Medicine; Stage (stratigraphy); Oncology; Internal medicine; Stratification (seeds); Pathology; Cancer; Cancer research; Biology","score_opus":0.2804708397165649,"score_gpt":0.5291300416129961,"score_spread":0.24865920189643126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392284408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99468046,0.00027583196,0.0035840094,0.00008541331,0.000015630774,0.00016862927,0.00036435525,0.00004750269,0.00077815563],"genre_scores_gemma":[0.9950877,0.00006460791,0.004153769,0.000053838954,0.000012410256,0.000043158623,0.00040063148,0.000005734776,0.0001780598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986749,0.00041636216,0.0001045405,0.00030431827,0.00040456434,0.00009528594],"domain_scores_gemma":[0.9973807,0.00041442193,0.0010970741,0.00047408382,0.00041195893,0.00022169527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002989095,0.00041072263,0.0005199059,0.0011389734,0.00023574708,0.0008555977,0.0005105009,0.0003388258,0.0012977318],"category_scores_gemma":[0.0048265597,0.00020696188,0.00043966415,0.0008043066,0.00040249884,0.00052145857,0.00090940244,0.00036919946,0.00025650434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030642166,0.00025744335,0.9490687,0.000075959586,0.00013630453,0.000053959306,0.00009409637,0.0012568854,0.010677816,0.00016740548,0.00042290843,0.034724135],"study_design_scores_gemma":[0.00021055467,0.0037398653,0.9657934,0.00003570843,0.00029882675,0.00063442695,0.00015441721,0.014685635,0.011895087,0.00038584135,0.0021234143,0.000042904165],"about_ca_topic_score_codex":0.0012300658,"about_ca_topic_score_gemma":0.002544593,"teacher_disagreement_score":0.002989095,"about_ca_system_score_codex":0.0006625806,"about_ca_system_score_gemma":0.0005457295,"threshold_uncertainty_score":0.015808046},"labels":[],"label_agreement":null},{"id":"W4392353979","doi":"10.1158/1557-3265.endo24-a023","title":"Abstract A023: Assessing the reproducibility crisis in vaginal microbiome studies for clinical applications in endometrial cancer","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Microbiome; Endometrial cancer; Cancer; Medicine; Gynecology; Reproducibility; Gynecologic cancer; Oncology; Obstetrics; Bioinformatics; Biology; Internal medicine; Ovarian cancer; Chemistry","score_opus":0.6871145669750996,"score_gpt":0.7213390838931715,"score_spread":0.03422451691807182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392353979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reproducibility","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reproducibility","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7535238,0.016282752,0.18068095,0.0056695607,0.0013023285,0.0013688806,0.027908647,0.0062967907,0.0069662575],"genre_scores_gemma":[0.9070409,0.0008348042,0.07593259,0.0012099795,0.00031920406,0.00090387976,0.012132871,0.000900392,0.00072546647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9599251,0.022557152,0.0050731213,0.0057224915,0.0059482683,0.0007738504],"domain_scores_gemma":[0.81018853,0.12340103,0.018999027,0.021984415,0.022915069,0.0025118664],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.07422977,0.0012010307,0.001594089,0.0027316916,0.0016492382,0.0064126593,0.0016249462,0.0018961321,0.0026197599],"category_scores_gemma":[0.19760117,0.00068375614,0.0029381337,0.0027499108,0.0012180633,0.0016169824,0.003461936,0.0016969297,0.0013079547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035399806,0.00024280755,0.84018886,0.0029935632,0.005263993,0.00042867995,0.0011654019,0.009083176,0.017151205,0.0012262149,0.010792965,0.10792314],"study_design_scores_gemma":[0.0007272864,0.0034885798,0.73729604,0.0027172235,0.0060411287,0.0031625926,0.002325882,0.12354722,0.053257637,0.015465863,0.05150383,0.00046673766],"about_ca_topic_score_codex":0.001712344,"about_ca_topic_score_gemma":0.0026129906,"teacher_disagreement_score":0.9257702,"about_ca_system_score_codex":0.0006510169,"about_ca_system_score_gemma":0.002366698,"threshold_uncertainty_score":0.39256924},"labels":[],"label_agreement":null},{"id":"W4392354575","doi":"10.1158/1557-3265.endo24-ia021","title":"Abstract IA021: Novel genomic features of POLE-mutant tumors: the utility for tumor classification and identification of new driver alleles","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Identification (biology); Allele; Mutant; Genetics; Computational biology; Biology; Gene","score_opus":0.3565290860206652,"score_gpt":0.559035939852931,"score_spread":0.2025068538322658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392354575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9485277,0.00023507647,0.044006266,0.00013627854,0.000015785605,0.000059285205,0.005088617,0.0009516549,0.0009793022],"genre_scores_gemma":[0.96952224,0.000050527662,0.023620991,0.00003411564,0.000017297227,0.000040538675,0.006215812,0.00005656812,0.0004418272],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997814,0.000040434203,0.000020110483,0.00008647015,0.000049357623,0.000022212307],"domain_scores_gemma":[0.9994716,0.00021056831,0.00012867965,0.00005191384,0.00007705284,0.000060124818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005429182,0.00035052313,0.00042429485,0.0015037747,0.00021175429,0.00070486026,0.00039864797,0.00041998786,0.0014249099],"category_scores_gemma":[0.0013565451,0.00011732475,0.000481125,0.0007103599,0.0001956163,0.00023543193,0.000332747,0.0003475101,0.0005469209],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017779131,0.0003463816,0.5851376,0.00030040072,0.00036937045,0.00092949386,0.00010314436,0.0710098,0.22596973,0.0013590493,0.003635087,0.109061934],"study_design_scores_gemma":[0.00005214934,0.00026182266,0.1927261,0.000026009464,0.000092797774,0.0012568459,0.00007346538,0.7751845,0.025795989,0.0022376606,0.00225553,0.000037103837],"about_ca_topic_score_codex":0.0013507014,"about_ca_topic_score_gemma":0.0013075623,"teacher_disagreement_score":0.0015037747,"about_ca_system_score_codex":0.00027548574,"about_ca_system_score_gemma":0.0003017454,"threshold_uncertainty_score":0.004766822},"labels":[],"label_agreement":null},{"id":"W4392354872","doi":"10.1158/1557-3265.endo24-b012","title":"Abstract B012: Application of shallow whole genome sequencing to identify therapeutic opportunities in p53abn endometrial cancers","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Endometrial cancer; Computational biology; Genome; DNA sequencing; Biology; Whole genome sequencing; Medicine; Cancer; Oncology; Genetics; Gene","score_opus":0.3042572367857805,"score_gpt":0.5198236201400745,"score_spread":0.21556638335429407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392354872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961067,0.00054937275,0.0019454919,0.00005468889,0.0000049488335,0.00002692571,0.00067726255,0.00003360553,0.00060094683],"genre_scores_gemma":[0.99421763,0.00020806062,0.004158166,0.000050917082,0.0000048302795,0.00002080986,0.0011029234,0.000011342312,0.00022528233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998293,0.000036444086,0.000016280985,0.000041871663,0.00005097373,0.000025038124],"domain_scores_gemma":[0.99965894,0.000091406975,0.0000720653,0.000039487884,0.00008189778,0.000056180685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046584697,0.00018992556,0.00019337535,0.0007887171,0.00017982298,0.0003776118,0.00015977019,0.00023312095,0.00091012847],"category_scores_gemma":[0.0009726602,0.0001250188,0.00019385737,0.0005840437,0.00017946243,0.00012056246,0.00033568902,0.00021206404,0.00023080537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016642121,0.000081554135,0.5542475,0.00026566946,0.00015695582,0.0008433615,0.00024526828,0.0014578006,0.36257634,0.00015496502,0.00095909904,0.07734734],"study_design_scores_gemma":[0.000057506106,0.0008176201,0.90887076,0.000049809074,0.00018273067,0.0035339636,0.00027621785,0.0072959843,0.07492749,0.00045109927,0.0035204596,0.000016420638],"about_ca_topic_score_codex":0.0018623733,"about_ca_topic_score_gemma":0.002666839,"teacher_disagreement_score":0.0018623733,"about_ca_system_score_codex":0.00027153932,"about_ca_system_score_gemma":0.0002855171,"threshold_uncertainty_score":0.0037029982},"labels":[],"label_agreement":null},{"id":"W4392356397","doi":"10.1158/1557-3265.endo24-pr002","title":"Abstract PR002: Proteomic profiling of endometrial carcinomas","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Profiling (computer programming); Endometrial cancer; Pathology; Medicine; Biology; Oncology; Cancer research; Internal medicine; Cancer; Computer science","score_opus":0.1807300411545962,"score_gpt":0.5319758282461884,"score_spread":0.35124578709159215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392356397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99232495,0.000979993,0.002816831,0.0000650244,0.0000127808225,0.00004243932,0.0025302966,0.00006901693,0.0011587354],"genre_scores_gemma":[0.98202765,0.0005576579,0.008179369,0.00006624255,0.000017963122,0.00006909822,0.0076972977,0.000036412304,0.0013482438],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997718,0.000033542776,0.000027058126,0.000065107764,0.00007343681,0.000029091265],"domain_scores_gemma":[0.9998324,0.000030934156,0.00002566102,0.000020665275,0.00006775197,0.000022622955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034664333,0.00030121885,0.00029848958,0.0012559395,0.0002596487,0.00041764666,0.00017550008,0.00024017389,0.0009740077],"category_scores_gemma":[0.00064664194,0.00012518367,0.00025388683,0.0011931339,0.00014157001,0.00019069003,0.00038059664,0.00018357161,0.0004761204],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005765338,0.00004467644,0.05577127,0.00023125252,0.00008357825,0.0003575743,0.00014209955,0.0003500923,0.9260769,0.00006491333,0.00055126206,0.015749896],"study_design_scores_gemma":[0.000024293195,0.00047627202,0.7404279,0.000026644038,0.00013964032,0.0028103522,0.00046191594,0.0035301237,0.24586634,0.00014502514,0.006068902,0.000022498882],"about_ca_topic_score_codex":0.00061923754,"about_ca_topic_score_gemma":0.00063618965,"teacher_disagreement_score":0.0012559395,"about_ca_system_score_codex":0.00015267222,"about_ca_system_score_gemma":0.00017086024,"threshold_uncertainty_score":0.0032583475},"labels":[],"label_agreement":null},{"id":"W4392365779","doi":"10.1158/1557-3265.endo24-a012","title":"Abstract A012: Genomic landscape of somatic alterations identified in endometrial cancer using liquid biopsy","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Somatic cell; Endometrial cancer; Liquid biopsy; Biopsy; Medicine; Cancer; Biology; Pathology; Cancer research; Internal medicine; Genetics; Gene","score_opus":0.18547459517312048,"score_gpt":0.5091650082183805,"score_spread":0.32369041304526003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392365779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967714,0.00036483712,0.00048950996,0.00003806617,0.0000030690915,0.000011532128,0.001784402,0.000014171696,0.00052294886],"genre_scores_gemma":[0.9985123,0.000050062943,0.00023256388,0.000021268066,0.0000047168323,0.00000643118,0.0010449961,0.0000030616245,0.00012448271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99954385,0.00010622182,0.000057658795,0.00012354352,0.00011616381,0.000052568772],"domain_scores_gemma":[0.99827445,0.00048728433,0.0008424856,0.000096997646,0.00020275284,0.00009607967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005790871,0.0001439194,0.00018400585,0.0010487444,0.00018369469,0.00075136835,0.0002141612,0.00017509592,0.003192697],"category_scores_gemma":[0.0019794558,0.000093626724,0.00017184643,0.0013207727,0.00024362671,0.00024740052,0.0003298466,0.00019614636,0.0003887954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047801124,0.000016503665,0.9893216,0.000030145044,0.00006133891,0.00022018743,0.000030053217,0.00008418551,0.004974929,0.000035657096,0.00021038162,0.0045370804],"study_design_scores_gemma":[0.0000110521305,0.00016156885,0.99368036,0.00001301266,0.000066435336,0.0020223805,0.00015145527,0.0006854941,0.0023651714,0.00007484328,0.00076415355,0.0000039864885],"about_ca_topic_score_codex":0.0009427628,"about_ca_topic_score_gemma":0.0008357757,"teacher_disagreement_score":0.003192697,"about_ca_system_score_codex":0.00018133094,"about_ca_system_score_gemma":0.00016784773,"threshold_uncertainty_score":0.010680616},"labels":[],"label_agreement":null},{"id":"W4392366210","doi":"10.1158/1557-3265.endo24-b031","title":"Abstract B031: High risk no specific molecular profile (HR-NSMP) endometrial cancer can be stratified into three subgroups based on tumor grade and estrogen receptor status with differing clinicopathologic characteristics and outcomes","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Endometrial cancer; Cancer; Oncology; Medicine; Estrogen; Internal medicine; Estrogen receptor; Gynecology; Biology; Breast cancer","score_opus":0.12428776110260238,"score_gpt":0.43816423849051256,"score_spread":0.3138764773879102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392366210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99910456,0.00009160483,0.0001361128,0.000013424155,0.0000012733144,0.000009344272,0.0003581725,0.0000029038004,0.00028252383],"genre_scores_gemma":[0.99900705,0.00003566263,0.0001531348,0.000014671367,0.0000032792302,0.000009716056,0.0006224813,0.0000019075899,0.0001521332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998149,0.000038712213,0.000025055198,0.000045764416,0.0000386053,0.00003694823],"domain_scores_gemma":[0.99948645,0.00011187173,0.00019434284,0.00006128136,0.000060502924,0.00008551946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040535346,0.00014889867,0.00019441565,0.0004027428,0.00022684623,0.00029918476,0.00019978911,0.00017100056,0.0022145514],"category_scores_gemma":[0.00095338403,0.00009376468,0.00020613591,0.00035581226,0.00023095946,0.0001733622,0.00035757403,0.00020220944,0.00035878658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038343467,0.0000134674165,0.99436766,0.00001388648,0.000026313912,0.00012611288,0.000029561272,0.00003947264,0.0022142017,0.000015871854,0.00009404665,0.0026760742],"study_design_scores_gemma":[0.000011698027,0.00011210604,0.9978397,0.0000047643407,0.000025863936,0.00082508626,0.00006887263,0.00014108367,0.0006880337,0.000044925648,0.00023608805,0.0000017575252],"about_ca_topic_score_codex":0.0012743288,"about_ca_topic_score_gemma":0.0019758823,"teacher_disagreement_score":0.0022145514,"about_ca_system_score_codex":0.00016359506,"about_ca_system_score_gemma":0.00020242375,"threshold_uncertainty_score":0.00740844},"labels":[],"label_agreement":null},{"id":"W4392366211","doi":"10.1158/1557-3265.endo24-b026","title":"Abstract B026: Substratification of mismatch repair deficient (MMRd) endometrial cancers can provide prognostic and predictive refinement","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Endometrial cancer; Medicine; Oncology; Internal medicine; Cancer research; Cancer","score_opus":0.20691190906621246,"score_gpt":0.4939742819427068,"score_spread":0.2870623728764944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392366211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962024,0.0009921183,0.00042176407,0.000084729,0.000014343279,0.000011585781,0.00096474,0.000013571969,0.0012947383],"genre_scores_gemma":[0.9986651,0.00016344969,0.0003159358,0.000022310784,0.000013027648,0.0000053708413,0.00060446287,0.0000024978112,0.00020801858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996979,0.00006518385,0.000055402856,0.00006876754,0.00006913328,0.000043566313],"domain_scores_gemma":[0.99871063,0.0002816526,0.00054347306,0.000118498276,0.00019835663,0.0001474043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009134036,0.00022420977,0.0002027243,0.0011759547,0.00023973006,0.0006344066,0.00031130214,0.00027055654,0.0025790855],"category_scores_gemma":[0.0022270712,0.000116607145,0.00024866973,0.0008172141,0.00022042953,0.0002955736,0.0005123375,0.0002784971,0.00046989744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001477505,0.0000052085857,0.99546415,0.000013947222,0.000018760325,0.00007353403,0.000017393224,0.00004114003,0.0007681935,0.000018729597,0.00012260834,0.003308492],"study_design_scores_gemma":[0.0000072438766,0.00008086391,0.9952182,0.000021612903,0.0000487084,0.0014751974,0.00013588935,0.0004908302,0.0012294466,0.000089932146,0.0011986266,0.000003460918],"about_ca_topic_score_codex":0.0010609952,"about_ca_topic_score_gemma":0.0017456316,"teacher_disagreement_score":0.0025790855,"about_ca_system_score_codex":0.00021492052,"about_ca_system_score_gemma":0.000163603,"threshold_uncertainty_score":0.008627951},"labels":[],"label_agreement":null},{"id":"W4392366375","doi":"10.1158/1557-3265.endo24-pr006","title":"Abstract PR006: ARID1A/B mutations retarget mSWI/SNF chromatin remodeler activity and define a spectrum of dedifferentiation in endometrial carcinoma","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"ARID1A; Chromatin; Cancer research; Biology; Mutation; Chromatin remodeling; Genetics; Gene; Medicine","score_opus":0.12941386280768014,"score_gpt":0.4651211312747568,"score_spread":0.33570726846707666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392366375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99652725,0.0003979723,0.0013327308,0.000032663505,0.0000056959834,0.000017440168,0.00074847665,0.000040966246,0.0008967495],"genre_scores_gemma":[0.99667513,0.00019503658,0.0013820285,0.00003473958,0.0000030636077,0.000012670503,0.0008415928,0.000015910053,0.00083986856],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999336,0.000006268183,0.00000799735,0.000018836308,0.000022024837,0.000011277813],"domain_scores_gemma":[0.9999175,0.000012115309,0.000030894917,0.000009389802,0.000009468737,0.00002071518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000074996045,0.00018768123,0.000100891055,0.00033785927,0.00011033718,0.00017199905,0.000116617375,0.00017611177,0.0012398474],"category_scores_gemma":[0.00012862045,0.00011233163,0.00012860316,0.0001809877,0.00015226893,0.00007403196,0.00016611115,0.00019853524,0.00046116472],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001369813,0.0000120930945,0.0079700565,0.000021498097,0.000006830859,0.00047682988,0.000020179381,0.00004064461,0.9895107,0.000054630018,0.00005273525,0.0016967175],"study_design_scores_gemma":[0.000028534709,0.00036241525,0.28652394,0.000011916247,0.000030355523,0.0154021485,0.00018033118,0.0017342858,0.6902337,0.00022344508,0.005259741,0.00000916511],"about_ca_topic_score_codex":0.0003136027,"about_ca_topic_score_gemma":0.0004337491,"teacher_disagreement_score":0.0012398474,"about_ca_system_score_codex":0.0001013342,"about_ca_system_score_gemma":0.000061843384,"threshold_uncertainty_score":0.004147649},"labels":[],"label_agreement":null},{"id":"W4393221527","doi":"10.1158/1078-0432.ccr-23-3689","title":"Targeted and Shallow Whole-Genome Sequencing Identifies Therapeutic Opportunities in p53abn Endometrial Cancers","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; Vancouver Coastal Health Research Institute; Canadian Cancer Society","keywords":"Endometrial cancer; Medicine; Carcinosarcoma; Serous fluid; Ovarian cancer; Whole genome sequencing; DNA sequencing; Cancer; Oncology; Internal medicine; Cancer research; Biology; Genome; Gene; Carcinoma; Genetics","score_opus":0.5458716065322252,"score_gpt":0.5526852119305065,"score_spread":0.006813605398281242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393221527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978321,0.0007001218,0.0009668852,0.000049016064,0.0000016334325,0.000014318952,0.00015943573,0.000013806668,0.0002626363],"genre_scores_gemma":[0.99809045,0.00022408318,0.0013682512,0.000039756073,0.0000021933988,0.000010092349,0.0002003272,0.0000026381754,0.00006233785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985373,0.00004090216,0.000012523566,0.00003259145,0.000035107867,0.000025067597],"domain_scores_gemma":[0.99973756,0.00008388962,0.00008473098,0.000025419076,0.000031714662,0.00003669805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039227222,0.00016769607,0.00018483461,0.0003787141,0.000113536575,0.00025444105,0.00011798454,0.00020655754,0.0004596134],"category_scores_gemma":[0.00092182617,0.000113284485,0.00016058562,0.00026653046,0.00021281143,0.00014298214,0.00028103663,0.00015378644,0.00007625546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021539277,0.00007515186,0.5409096,0.00028130625,0.00015277865,0.00091887504,0.00024630985,0.0020158603,0.34062642,0.00024955338,0.00045730322,0.11191292],"study_design_scores_gemma":[0.00010374926,0.0008724911,0.90811086,0.00008024266,0.00023352471,0.004646676,0.00037728046,0.009940533,0.071707934,0.00082814746,0.0030841331,0.000014504211],"about_ca_topic_score_codex":0.00054744905,"about_ca_topic_score_gemma":0.0016215761,"teacher_disagreement_score":0.00054744905,"about_ca_system_score_codex":0.00023587141,"about_ca_system_score_gemma":0.0002779093,"threshold_uncertainty_score":0.0020745397},"labels":[],"label_agreement":null},{"id":"W4393307842","doi":"10.1158/1078-0432.ccr-23-3840","title":"Solid Organ Transplant Recipients Exhibit More <i>TET2</i> -Mutant Clonal Hematopoiesis of Indeterminate Potential Not Driven by Increased Transplantation Risk","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Institute of General Medical Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; Vanderbilt University Medical Center; NIH Office of the Director; National Institute for Occupational Safety and Health; Centers for Disease Control and Prevention; National Cancer Institute; National Institutes of Health; Edward P. Evans Foundation; Canadian Institutes of Health Research; Leukemia and Lymphoma Society; Burroughs Wellcome Fund","keywords":"Transplantation; Population; Biobank; Malignancy; Haematopoiesis; Internal medicine; Biology; Oncology; Medicine; Immunology; Bioinformatics; Genetics; Stem cell","score_opus":0.06296916830744788,"score_gpt":0.46586794977371754,"score_spread":0.4028987814662697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393307842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99912995,0.000083147985,0.00022288486,0.000029385987,0.0000014914856,0.000005087377,0.00018538434,0.000009785791,0.0003327845],"genre_scores_gemma":[0.9993868,0.00003251971,0.00018116688,0.000028899503,0.0000041496687,0.0000045860334,0.00025809483,0.0000019140948,0.00010184389],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976844,0.000048621343,0.000024981098,0.00006316383,0.000055813216,0.00003903565],"domain_scores_gemma":[0.99911636,0.00013921794,0.00048759324,0.00010420113,0.00005496017,0.000097738004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043378343,0.00014694307,0.00017910532,0.0003504172,0.00022141132,0.0004910401,0.00020203656,0.00017923686,0.002415451],"category_scores_gemma":[0.0010629107,0.00006867375,0.00013370326,0.00046456806,0.00020592807,0.00020109348,0.00031015452,0.00027623004,0.00023037444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033780988,0.00006848796,0.97698545,0.000030711493,0.000037509308,0.000120486926,0.000075252676,0.00010053206,0.015213497,0.00010648755,0.00017178377,0.0067520565],"study_design_scores_gemma":[0.000014089329,0.00021586874,0.99399453,0.0000066741354,0.00003579489,0.0010519413,0.00009883954,0.0002401777,0.0037290896,0.00012862777,0.00048072042,0.0000036608023],"about_ca_topic_score_codex":0.0005984509,"about_ca_topic_score_gemma":0.00084389385,"teacher_disagreement_score":0.002415451,"about_ca_system_score_codex":0.00017375873,"about_ca_system_score_gemma":0.00017516923,"threshold_uncertainty_score":0.0080804825},"labels":[],"label_agreement":null},{"id":"W4393950098","doi":"10.1158/1078-0432.ccr-23-4033","title":"Update on Cancer Predisposition Syndromes and Surveillance Guidelines for Childhood Brain Tumors","year":2024,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Jewish General Hospital; University of Toronto; Hospital for Sick Children; SickKids Foundation","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health; Deutsche Kinderkrebsstiftung; Hospital Research Foundation; Bundesministerium für Bildung und Forschung; St. Baldrick's Foundation","keywords":"Genetic predisposition; Context (archaeology); Germline; Medicine; Cancer; Li–Fraumeni syndrome; Brain tumor; Germline mutation; Neurofibromatosis; Family history; Disease; Pathology; Mutation; Internal medicine; Biology; Genetics","score_opus":0.34623046507544936,"score_gpt":0.5982013689547085,"score_spread":0.2519709038792592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393950098","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018276725,0.97743887,0.0008862621,0.010607169,0.0049442486,0.000052311534,0.00050315645,0.00012487939,0.00526038],"genre_scores_gemma":[0.0010030317,0.9828789,0.0016986598,0.0076295673,0.0027174812,0.00008922028,0.001157848,0.000016182437,0.0028091925],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9993687,0.00018822339,0.00013313106,0.0000630226,0.00020121888,0.000045768476],"domain_scores_gemma":[0.99730504,0.0012781838,0.00032234407,0.00004360261,0.0008738854,0.00017705024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001561046,0.00078689656,0.0013652958,0.002778432,0.00029412424,0.00093224726,0.001673311,0.002074398,0.0058326568],"category_scores_gemma":[0.004306712,0.00032672036,0.0011077045,0.0022332529,0.00034331947,0.0013573108,0.00082294404,0.003087253,0.0032582735],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036343277,0.000029472747,0.00030910145,0.0073911906,0.000063096784,0.00025939938,0.000050012775,0.0004082891,0.00023555622,0.0021091667,0.37986895,0.60923946],"study_design_scores_gemma":[0.00001588482,0.00003145743,0.0006518458,0.006595337,0.00010222911,0.0010961525,0.000026011467,0.00007358787,0.00005826473,0.0008363124,0.99050057,0.000012309865],"about_ca_topic_score_codex":0.00340701,"about_ca_topic_score_gemma":0.007591601,"teacher_disagreement_score":0.0058326568,"about_ca_system_score_codex":0.001293392,"about_ca_system_score_gemma":0.002312007,"threshold_uncertainty_score":0.019512117},"labels":[],"label_agreement":null},{"id":"W4396813958","doi":"10.1158/1078-0432.ccr-24-0268","title":"Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Ottawa; Ottawa Hospital; University of British Columbia","funders":"BC Cancer Foundation; Michael Smith Health Research BC; AstraZeneca","keywords":"Durvalumab; Medicine; Colorectal cancer; Microsatellite instability; Tremelimumab; Internal medicine; Pembrolizumab; Immunotherapy; Oncology; Biomarker; Cancer; Gastroenterology; Ipilimumab; Biology; Allele; Microsatellite","score_opus":0.1396367048201123,"score_gpt":0.5080197485062736,"score_spread":0.3683830436861613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396813958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955552,0.0028773746,0.0001518809,0.00027874525,0.000062540974,0.00012912565,0.0002786097,0.00001842802,0.0006481305],"genre_scores_gemma":[0.9979346,0.00043031306,0.0002456997,0.00015791807,0.00008732349,0.00012135684,0.000499119,0.000005924246,0.0005177356],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99913955,0.00053395604,0.00003634892,0.00015031493,0.00006716456,0.000072694755],"domain_scores_gemma":[0.99781406,0.000714318,0.0007944519,0.00013701622,0.0000937287,0.00044643536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020930863,0.0007772908,0.0015285814,0.00021493567,0.00016793786,0.00095283013,0.0004671619,0.0006101953,0.0010549256],"category_scores_gemma":[0.0024696586,0.00027714914,0.0010309991,0.00022213851,0.0004069174,0.00048582203,0.00031083063,0.0015490922,0.0002224223],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9294297,0.0013862962,0.032880094,0.00045088844,0.0022951076,0.00007009562,0.00007247329,0.0014117012,0.006983408,0.00011689519,0.0012523617,0.023650961],"study_design_scores_gemma":[0.47650146,0.24186873,0.24114226,0.00024017748,0.010635725,0.00072837644,0.00015274635,0.013282821,0.009673422,0.0006623142,0.0049874573,0.00012445459],"about_ca_topic_score_codex":0.00053851714,"about_ca_topic_score_gemma":0.0018211225,"teacher_disagreement_score":0.0020930863,"about_ca_system_score_codex":0.00086722994,"about_ca_system_score_gemma":0.0007351958,"threshold_uncertainty_score":0.011069477},"labels":[],"label_agreement":null},{"id":"W4397012901","doi":"10.1158/1557-3265.bladder24-a007","title":"Abstract A007: Circulating tumor DNA and tissue staining analyses reveal heterogeneous <i>ERBB2</i>/HER2 status in urothelial cancer","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Urothelial cancer; Cancer; Staining; Pathology; DNA; Cancer research; Medicine; Biology; Bladder cancer; Internal medicine; Genetics","score_opus":0.2944178235038861,"score_gpt":0.5736665748808023,"score_spread":0.2792487513769162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397012901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966577,0.0004047835,0.0013973697,0.000039405695,0.000009347202,0.0000148178915,0.00071339763,0.00007256655,0.00069058477],"genre_scores_gemma":[0.9966409,0.00009040699,0.0019855776,0.00003350742,0.0000065953536,0.000012956164,0.00081167615,0.000013460848,0.00040491702],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99983466,0.000021599193,0.000018933351,0.0000572102,0.000040481038,0.000026993845],"domain_scores_gemma":[0.99967957,0.0001192335,0.000056137713,0.000021358823,0.000066412125,0.00005732174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029025326,0.00020408558,0.00021676054,0.0009907788,0.0002445399,0.0004007037,0.0001488744,0.0002512354,0.0037487475],"category_scores_gemma":[0.0007054359,0.00008410168,0.00012381322,0.00057533017,0.00018899539,0.00011854479,0.00018898836,0.00018470547,0.0005328425],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019206424,0.00008385745,0.45453265,0.00017293225,0.000052322237,0.0016423668,0.00028932214,0.0003694693,0.501877,0.00013934752,0.0010033681,0.037916534],"study_design_scores_gemma":[0.000073424264,0.00082044175,0.8195844,0.000036870424,0.00011117967,0.010349368,0.00040317906,0.0031001472,0.16122033,0.0002502781,0.0040337853,0.000016489505],"about_ca_topic_score_codex":0.0010646309,"about_ca_topic_score_gemma":0.0010650819,"teacher_disagreement_score":0.0037487475,"about_ca_system_score_codex":0.0002460151,"about_ca_system_score_gemma":0.0001430371,"threshold_uncertainty_score":0.012540817},"labels":[],"label_agreement":null},{"id":"W4397012914","doi":"10.1158/1557-3265.bladder24-pr003","title":"Abstract PR003: T cell receptor repertoire and diversity are prognostic markers in bladder cancer","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Bladder cancer; Cancer; Receptor; Repertoire; Biology; Medicine; Cancer research; Pathology; Internal medicine","score_opus":0.17832695203342278,"score_gpt":0.480906556418253,"score_spread":0.3025796043848302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397012914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990109,0.00021970157,0.00013554176,0.000027074766,0.0000028801526,0.0000027252852,0.00027615446,0.0000082451015,0.0003167848],"genre_scores_gemma":[0.999619,0.000025650039,0.00005744791,0.0000065255545,0.0000041485278,0.0000024105877,0.00020150532,0.0000020021444,0.00008126626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987614,0.000030709343,0.000012388757,0.000031746746,0.000021289257,0.000027630149],"domain_scores_gemma":[0.99941814,0.00019591107,0.00015801095,0.00004203525,0.000077314005,0.000108643784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027068166,0.00012450166,0.00022786616,0.0004708242,0.0002498759,0.00042893997,0.0001963082,0.00025750263,0.0026779224],"category_scores_gemma":[0.0011449816,0.000091600064,0.00018091006,0.0005984979,0.00016981039,0.0002540871,0.00030140037,0.0003467559,0.00028995928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005950466,0.000013070517,0.98950225,0.000012718241,0.000027107882,0.00006564567,0.00002977883,0.00009851528,0.0044729374,0.000011261162,0.00017229035,0.0049993778],"study_design_scores_gemma":[0.000007566552,0.00010316949,0.9977708,0.00000349177,0.000028831319,0.00048773666,0.000065187305,0.0005994133,0.000698867,0.000049030114,0.00018312018,0.0000027789292],"about_ca_topic_score_codex":0.0007308811,"about_ca_topic_score_gemma":0.00061159115,"teacher_disagreement_score":0.0026779224,"about_ca_system_score_codex":0.00014673304,"about_ca_system_score_gemma":0.00009292281,"threshold_uncertainty_score":0.0089585185},"labels":[],"label_agreement":null},{"id":"W4397012996","doi":"10.1158/1557-3265.bladder24-a021","title":"Abstract A021: The role of MGAT5 in sex-dependent regulation of CD8+ T cells in muscle-invasive bladder cancer","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Prevention of Organ Failure; University of British Columbia","funders":"","keywords":"Bladder cancer; Cancer; Cytotoxic T cell; Cancer research; CD8; Medicine; Biology; Pathology; Immunology; Internal medicine; Immune system; In vitro; Genetics","score_opus":0.12674183756787558,"score_gpt":0.4799487102532005,"score_spread":0.3532068726853249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397012996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9721621,0.017980943,0.0012856773,0.0009172169,0.00038109368,0.00004630719,0.0010842272,0.00011241648,0.00603012],"genre_scores_gemma":[0.99141955,0.00163095,0.00034006327,0.00020499103,0.000103159946,0.000024986477,0.00058091595,0.000018350645,0.005676926],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99986553,0.000029828481,0.0000093880335,0.000028017284,0.000023322078,0.000043785523],"domain_scores_gemma":[0.9998764,0.000012073946,0.000034625653,0.000007603027,0.000021984566,0.000047420275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018428838,0.00025961775,0.00021054874,0.00025387062,0.00021791666,0.0004251804,0.00026573832,0.0003560311,0.007142833],"category_scores_gemma":[0.00016634051,0.000110987945,0.00033015368,0.00018682958,0.00017182122,0.00024205368,0.00025134993,0.00056429993,0.0013468022],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053656846,0.00032734696,0.029373853,0.0006668154,0.000109389825,0.00092979806,0.00015720994,0.00036507656,0.9120456,0.0007089631,0.0030673125,0.046882946],"study_design_scores_gemma":[0.00040385328,0.0037516688,0.72652096,0.00019998683,0.0002421699,0.0026549303,0.0006467713,0.0029947783,0.23131801,0.0012246437,0.030003369,0.000038868577],"about_ca_topic_score_codex":0.00043608845,"about_ca_topic_score_gemma":0.0004770333,"teacher_disagreement_score":0.007142833,"about_ca_system_score_codex":0.00028569138,"about_ca_system_score_gemma":0.00018390482,"threshold_uncertainty_score":0.023895204},"labels":[],"label_agreement":null},{"id":"W4397013178","doi":"10.1158/1557-3265.bladder24-a004","title":"Abstract A004: Clinical test design affects tumor tissue and ctDNA FGFR gene status in metastatic urothelial cancer: a prospective study","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Jewish General Hospital; University of Calgary; University of Alberta; Baker Hughes (Canada); Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Urothelial cancer; Cancer; Medicine; Oncology; Circulating tumor DNA; Prospective cohort study; Internal medicine; Cancer research; Bladder cancer","score_opus":0.25675409485827455,"score_gpt":0.5592329056097901,"score_spread":0.30247881075151556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397013178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935719,0.0011184678,0.0017978979,0.00024398463,0.000076596705,0.0003642987,0.0010052634,0.000039918756,0.0017815713],"genre_scores_gemma":[0.997675,0.00005537581,0.0007234152,0.0002712176,0.000038579292,0.00016296018,0.00042670793,0.000026603784,0.000620227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98927784,0.006044303,0.000805347,0.0020309726,0.0012550475,0.0005865204],"domain_scores_gemma":[0.9806113,0.010143872,0.0037434315,0.0022235857,0.0019683652,0.0013094643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0118038505,0.0007952069,0.00049058284,0.0004249881,0.0008574063,0.0012894253,0.0013625264,0.0013333636,0.008011748],"category_scores_gemma":[0.022534648,0.0004516915,0.0015953023,0.0007610353,0.0010405629,0.00076918077,0.0004842468,0.0009640055,0.0012798907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04389387,0.0016700365,0.9320057,0.00019792106,0.0017877619,0.00033606062,0.00033036555,0.00031381674,0.0036271866,0.0003323629,0.0023673968,0.013137527],"study_design_scores_gemma":[0.0044712867,0.036644556,0.94478816,0.00009594237,0.002169067,0.0010097488,0.00028237485,0.002543379,0.0019654506,0.00048861385,0.0054778676,0.00006364906],"about_ca_topic_score_codex":0.0047522807,"about_ca_topic_score_gemma":0.0051153284,"teacher_disagreement_score":0.0118038505,"about_ca_system_score_codex":0.0011221439,"about_ca_system_score_gemma":0.0012650471,"threshold_uncertainty_score":0.062425494},"labels":[],"label_agreement":null},{"id":"W4399367382","doi":"10.1158/1078-0432.ccr-23-3552","title":"Concurrent RB1 Loss and <i>BRCA</i> Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Vancouver General Hospital; Alberta Health Services; University of British Columbia; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; Foothills Medical Centre; University of Alberta; University of Calgary","funders":"HORIZON EUROPE European Research Council; Medical Research Council; National Center for Advancing Translational Sciences; National Cancer Institute; U.S. Army Medical Research and Development Command; Cancer Institute NSW; Canadian Institutes of Health Research; Janet D. Cottrelle Foundation; Krebsliga Schweiz; Medical Research and Materiel Command; Eisai; Ovarian Cancer Action; AstraZeneca; National Health and Medical Research Council; Cancer Research UK; Swedish Cancer Foundation; Bundesministerium für Bildung und Forschung; Michael Smith Health Research BC; Genentech; Victorian Cancer Agency; Clovis Oncology; National Institutes of Health; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; U.S. Department of Defense","keywords":"Ovarian carcinoma; Ovarian cancer; Biology; Cancer research; Germline; CD8; Transcriptome; Serous carcinoma; Cancer; Immunology; Immune system; Gene expression; Genetics; Gene","score_opus":0.14307757489155112,"score_gpt":0.46852175686945,"score_spread":0.3254441819778989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399367382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99965894,0.00012459893,0.00005154776,0.000008318086,9.816538e-7,0.0000020022032,0.000083616345,0.0000031041177,0.00006699682],"genre_scores_gemma":[0.99967694,0.00004168731,0.000064457985,0.000008329762,0.0000015986325,0.0000021239441,0.00016890223,0.000001161571,0.000034956513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999188,0.0000143481575,0.000009124732,0.000025331183,0.000015134107,0.000017119599],"domain_scores_gemma":[0.9997745,0.000040081635,0.00010421261,0.00002279031,0.000018671715,0.000039757506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018513022,0.00011940167,0.00021274814,0.0002876812,0.00022421427,0.00031642843,0.00012913388,0.00013857533,0.00074803154],"category_scores_gemma":[0.0004058925,0.0000907155,0.00017632465,0.00032031874,0.00019234265,0.00012512364,0.00018920041,0.00016885196,0.00011316983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004902683,0.000022714205,0.9811327,0.000021707474,0.00003828797,0.00016376874,0.00004463239,0.00012464513,0.014583714,0.000011154534,0.00008556431,0.003280733],"study_design_scores_gemma":[0.000010280411,0.000104506384,0.9957075,0.0000039720753,0.0000475751,0.00096465077,0.00010058575,0.00041990785,0.002332004,0.000023950042,0.00028315088,0.0000020383313],"about_ca_topic_score_codex":0.0011308457,"about_ca_topic_score_gemma":0.0017480695,"teacher_disagreement_score":0.0011308457,"about_ca_system_score_codex":0.00021895175,"about_ca_system_score_gemma":0.000161116,"threshold_uncertainty_score":0.0025024414},"labels":[],"label_agreement":null},{"id":"W4399430519","doi":"10.1158/1078-0432.ccr-23-3720","title":"Inhibition of Aberrantly Overexpressed Polo-like Kinase 4 Is a Potential Effective Treatment for DNA Damage Repair–Deficient Uterine Leiomyosarcoma","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Health and Medical Research Fund; Eisai; Gilead Sciences; Food and Health Bureau; GlaxoSmithKline; Agios Pharmaceuticals; AstraZeneca; Servier; Pfizer","keywords":"Leiomyosarcoma; DNA damage; Cancer research; DNA repair; Biology; Kinase; DNA; Medicine; Pathology; Cell biology; Genetics","score_opus":0.06411064824331272,"score_gpt":0.4521222992991124,"score_spread":0.3880116510557997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399430519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904875,0.0068366933,0.0009950327,0.00015487733,0.000036064892,0.00005908995,0.00021489427,0.00008421145,0.0011316953],"genre_scores_gemma":[0.99430746,0.002774899,0.0011739128,0.000050292063,0.0000117264835,0.000058775007,0.00050489843,0.0000052020864,0.001112817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994206,0.0000098163,0.000008421652,0.000011729854,0.000015527177,0.000012464663],"domain_scores_gemma":[0.99996555,0.0000060786083,0.000012279044,0.0000035634278,0.000003091381,0.000009389357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012458718,0.00029190836,0.00026178817,0.00023544495,0.00009265489,0.00012651969,0.00021828513,0.00017420299,0.000954688],"category_scores_gemma":[0.00007385124,0.00009369451,0.00021088346,0.00016323777,0.00016422538,0.00011322294,0.00012597039,0.00041301307,0.00015876546],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008689099,0.00022455957,0.0011210005,0.00022090759,0.000032206714,0.00013833512,0.00001733091,0.00037629108,0.9810929,0.00010868181,0.00021725016,0.015581697],"study_design_scores_gemma":[0.0003269639,0.005273338,0.012534824,0.000024327142,0.00012092994,0.00089048356,0.000031561085,0.0013926604,0.9720276,0.00005861569,0.0073087374,0.000009931229],"about_ca_topic_score_codex":0.00023481903,"about_ca_topic_score_gemma":0.0006114123,"teacher_disagreement_score":0.000954688,"about_ca_system_score_codex":0.00024167872,"about_ca_system_score_gemma":0.00022223173,"threshold_uncertainty_score":0.003193736},"labels":[],"label_agreement":null},{"id":"W4399527680","doi":"10.1158/1078-0432.ccr-24-0237","title":"Neuroblastoma Predisposition and Surveillance—An Update from the 2023 AACR Childhood Cancer Predisposition Workshop","year":2024,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; McGill University; University of Toronto; Jewish General Hospital","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; Bundesministerium für Bildung und Forschung; Servier; Moderna; National Cancer Institute; Deutsche Kinderkrebsstiftung; Incyte; Hospital Research Foundation; Alexion Pharmaceuticals; AstraZeneca; St. Baldrick's Foundation; Sanofi","keywords":"Genetic predisposition; Medicine; Neuroblastoma; Germline; Cancer; Genetic testing; Costello syndrome; Li–Fraumeni syndrome; Disease; Hypoventilation; Pediatric cancer; Genetics; Germline mutation; Internal medicine; Gene; Mutation; Biology","score_opus":0.22640092945184542,"score_gpt":0.5568631645452621,"score_spread":0.33046223509341666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399527680","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007563761,0.98910636,0.00008665496,0.0054399283,0.0027684746,0.000021238568,0.00017694241,0.00002407878,0.0023007244],"genre_scores_gemma":[0.00039214414,0.9926709,0.00024308363,0.0037177685,0.0014987165,0.000027107739,0.00027719355,0.00000737877,0.0011656621],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990682,0.0002009929,0.00022333939,0.00008999063,0.00033192307,0.00008558082],"domain_scores_gemma":[0.9974164,0.00087526,0.00042027005,0.000054026743,0.001008138,0.00022586816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023121664,0.00080807816,0.0017660427,0.0047127316,0.00036516992,0.0014610437,0.0014492259,0.0021556069,0.007968604],"category_scores_gemma":[0.0050374446,0.00050396303,0.0012156229,0.0042179744,0.00034334796,0.0018159421,0.001268867,0.0026385314,0.004937191],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005775379,0.000026763633,0.00027576476,0.014875785,0.0001022541,0.00017672272,0.00005275113,0.00015152035,0.00019966497,0.0011455298,0.33038253,0.65255296],"study_design_scores_gemma":[0.00002026238,0.000042166917,0.00068432605,0.019277863,0.00018383744,0.00074591016,0.000035883895,0.000038662227,0.000044341807,0.0004293319,0.9784788,0.000018630226],"about_ca_topic_score_codex":0.0042539765,"about_ca_topic_score_gemma":0.011523289,"teacher_disagreement_score":0.007968604,"about_ca_system_score_codex":0.0019035293,"about_ca_system_score_gemma":0.0036689898,"threshold_uncertainty_score":0.026657641},"labels":[],"label_agreement":null},{"id":"W4399533928","doi":"10.1158/1078-0432.ccr-23-3994","title":"Clinical Updates and Surveillance Recommendations for DNA Replication Repair Deficiency Syndromes in Children and Young Adults","year":2024,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Servier; Alexion Pharmaceuticals","keywords":"Medicine; Replication (statistics); Pediatrics; Virology","score_opus":0.31294531001535014,"score_gpt":0.5912576726138743,"score_spread":0.27831236259852415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399533928","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02180949,0.119996555,0.027169794,0.39091334,0.02646746,0.005251519,0.044709302,0.009361394,0.3543212],"genre_scores_gemma":[0.12309415,0.2362649,0.16459215,0.1876133,0.037160184,0.014774943,0.096770525,0.001809986,0.13791983],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967244,0.0011012406,0.0010231668,0.00017950071,0.0007421255,0.00022959981],"domain_scores_gemma":[0.98123574,0.0054092137,0.0023784954,0.00044688556,0.008210068,0.0023196093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030626769,0.0007135651,0.000889793,0.0031312585,0.00068281457,0.0013954133,0.0012386858,0.0030513895,0.028510572],"category_scores_gemma":[0.024823133,0.00035547334,0.0011331306,0.0020361897,0.00024988924,0.0015762562,0.0013450128,0.0035646188,0.012146002],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084577296,0.00009645755,0.0069986503,0.0006608118,0.00003671199,0.000436297,0.00019074844,0.00029026793,0.0002546216,0.0011287053,0.7845312,0.205291],"study_design_scores_gemma":[0.00014686362,0.00008601377,0.015977787,0.003032644,0.000070855705,0.001449398,0.0003073376,0.00045575853,0.00030129057,0.0012832197,0.97683495,0.000053938118],"about_ca_topic_score_codex":0.007028688,"about_ca_topic_score_gemma":0.009136592,"teacher_disagreement_score":0.028510572,"about_ca_system_score_codex":0.0013453447,"about_ca_system_score_gemma":0.003137947,"threshold_uncertainty_score":0.095377386},"labels":[],"label_agreement":null},{"id":"W4400582488","doi":"10.1158/1078-0432.ccr-24-0255","title":"Circulating Tumor DNA Dynamics Reveal <i>KRAS G12C</i> Mutation Heterogeneity and Response to Treatment with the KRAS G12C Inhibitor Divarasib in Solid Tumors","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Roche (Canada)","funders":"National Center for Advancing Translational Sciences","keywords":"KRAS; Circulating tumor DNA; Cancer research; Mutation; Dynamics (music); DNA; Medicine; Biology; Cancer; Internal medicine; Genetics; Colorectal cancer; Psychology","score_opus":0.06284397043373981,"score_gpt":0.44475733961434427,"score_spread":0.3819133691806045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400582488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993812,0.00020953428,0.000110846646,0.000019851486,0.00000208592,0.000012125902,0.00010549006,0.000009865907,0.00014886261],"genre_scores_gemma":[0.9993789,0.00005352815,0.00018848559,0.00002896047,0.000004599409,0.000011640739,0.00020472663,0.000002949686,0.00012604088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999866,0.000026666887,0.000010020952,0.00004732157,0.000027720134,0.000022228045],"domain_scores_gemma":[0.99967253,0.00006876829,0.00013134393,0.000018914905,0.000037020418,0.0000713528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023444968,0.00021168464,0.00038916102,0.00028120363,0.00016262766,0.00030990562,0.00016470086,0.00022694618,0.0011724365],"category_scores_gemma":[0.00053485524,0.00015575823,0.00012311897,0.00021729732,0.0002239837,0.00017250345,0.00016102032,0.00040054618,0.00017526429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014585827,0.0005806906,0.690523,0.00012341898,0.00017126143,0.000248082,0.000230566,0.0012363987,0.23380636,0.00004801558,0.0006440821,0.057802305],"study_design_scores_gemma":[0.0005290186,0.010013298,0.9396596,0.000013895685,0.00017126193,0.0011665163,0.00021035523,0.0032877899,0.043535065,0.000102839054,0.0012945422,0.000015839281],"about_ca_topic_score_codex":0.0009898097,"about_ca_topic_score_gemma":0.0015868292,"teacher_disagreement_score":0.0011724365,"about_ca_system_score_codex":0.00035186234,"about_ca_system_score_gemma":0.00020074176,"threshold_uncertainty_score":0.0039221644},"labels":[],"label_agreement":null},{"id":"W4400582528","doi":"10.1158/1078-0432.ccr-24-0103","title":"CSF1R Inhibition in Patients with Advanced Solid Tumors or Tenosynovial Giant Cell Tumor: A Phase I Study of Vimseltinib","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Musculoskeletal synovial abnormalities and treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Deciphera Pharmaceuticals","keywords":"Tolerability; Medicine; Response Evaluation Criteria in Solid Tumors; Adverse effect; Pharmacodynamics; Internal medicine; Pharmacokinetics; Cancer; Oncology; Phases of clinical research; Gastroenterology; Clinical trial","score_opus":0.09549809635702675,"score_gpt":0.5008536952762315,"score_spread":0.4053555989192047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400582528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936307,0.0032376626,0.00035334576,0.00026253608,0.00007290482,0.0009960742,0.00035518655,0.00005670246,0.0010349493],"genre_scores_gemma":[0.9953727,0.0014683965,0.0007231397,0.00030970876,0.000057794176,0.0006374665,0.0005661397,0.000010664117,0.00085401227],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998,0.00006983989,0.000014196333,0.00003474851,0.000024577439,0.00005670021],"domain_scores_gemma":[0.9997199,0.000041155858,0.0000691019,0.000019860148,0.00002366966,0.00012621093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008198465,0.0009965184,0.0013766655,0.00026852815,0.00029516136,0.0008136491,0.00056708674,0.0008381786,0.0019617623],"category_scores_gemma":[0.00053518155,0.0003466293,0.0011371224,0.00024597006,0.00056042627,0.0005808378,0.00020195144,0.0020647852,0.00043134482],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.56701684,0.06720475,0.011754105,0.0023167045,0.0022584372,0.00066361664,0.0007492109,0.005082269,0.1234944,0.0006484,0.0056333756,0.21317793],"study_design_scores_gemma":[0.43045115,0.53557616,0.01511187,0.00011169349,0.0006721432,0.00083406776,0.0001415365,0.0027347403,0.009608809,0.00025670265,0.004453366,0.00004777123],"about_ca_topic_score_codex":0.00072306034,"about_ca_topic_score_gemma":0.002604851,"teacher_disagreement_score":0.0019617623,"about_ca_system_score_codex":0.0009062056,"about_ca_system_score_gemma":0.001308888,"threshold_uncertainty_score":0.0065749884},"labels":[],"label_agreement":null},{"id":"W4400881768","doi":"10.1158/1078-0432.ccr-24-1165","title":"Update on Genetic Counselor Practice and Recommendations for Pediatric Cancer Predisposition Evaluation and Surveillance","year":2024,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Genetic testing; Genetic predisposition; Medicine; Pediatric cancer; Genetic counseling; Cancer; Psychosocial; Referral; Li–Fraumeni syndrome; Germline mutation; Family medicine; Internal medicine; Genetics; Disease; Mutation; Psychiatry; Biology","score_opus":0.436359363290116,"score_gpt":0.649259299999234,"score_spread":0.21289993670911805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400881768","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013618021,0.98189145,0.00056842924,0.011784004,0.0016371051,0.000049494174,0.0003192031,0.000051564108,0.00356258],"genre_scores_gemma":[0.0010328062,0.99099976,0.0015309358,0.0044320244,0.00055687275,0.00006264299,0.00042745436,0.000010603778,0.0009468718],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975199,0.00090676127,0.00048635656,0.00018171944,0.0007916594,0.00011362194],"domain_scores_gemma":[0.9932193,0.0033317744,0.00073067157,0.000103576924,0.002357682,0.0002569707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004664476,0.0008210216,0.0013880269,0.00400723,0.00044865572,0.0015899567,0.002126019,0.002606751,0.009357344],"category_scores_gemma":[0.015945887,0.00044782658,0.0019111707,0.0028531689,0.00051829556,0.0018370872,0.0012301668,0.003318795,0.003154252],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003452097,0.00003798448,0.00029347287,0.020772593,0.00014861472,0.0001314804,0.00016452913,0.00021203706,0.00010158933,0.0029815314,0.20318845,0.7719332],"study_design_scores_gemma":[0.000038778748,0.000032185984,0.0009854145,0.061906837,0.0003703062,0.0006563853,0.00011172919,0.00008353754,0.000060867478,0.0014665155,0.9342629,0.000024495266],"about_ca_topic_score_codex":0.0100450255,"about_ca_topic_score_gemma":0.018108362,"teacher_disagreement_score":0.0100450255,"about_ca_system_score_codex":0.0024012146,"about_ca_system_score_gemma":0.0059711277,"threshold_uncertainty_score":0.031303406},"labels":[],"label_agreement":null},{"id":"W4401123275","doi":"10.1158/1078-0432.ccr-24-1317","title":"Pharmacologic Inhibition of EIF4A Blocks NRF2 Synthesis to Prevent Osteosarcoma Metastasis","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia; Dalhousie University; Provincial Health Services Authority; BC Cancer Agency","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; eFFECTOR Therapeutics; Alex's Lemonade Stand Foundation for Childhood Cancer; Conquer Cancer Foundation","keywords":"Osteosarcoma; Metastasis; Medicine; Cancer research; Cancer; Internal medicine","score_opus":0.15312296505146408,"score_gpt":0.5063316279496912,"score_spread":0.35320866289822717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401123275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97665477,0.013833888,0.004309862,0.00056479085,0.0002196773,0.0002229912,0.00084609597,0.00036442434,0.0029835012],"genre_scores_gemma":[0.98786354,0.0055719432,0.003327302,0.00012269983,0.000037322465,0.00015113523,0.00059588737,0.000024214265,0.0023059726],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998889,0.000017267394,0.000017022205,0.0000206432,0.000027417493,0.000028764734],"domain_scores_gemma":[0.99993825,0.000009054564,0.000022552858,0.0000075936996,0.000009202443,0.000013367021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023147643,0.00047232784,0.0004933169,0.00027861475,0.00016987711,0.00020998537,0.00028058336,0.0002604602,0.0019000066],"category_scores_gemma":[0.00013951537,0.00014007589,0.0003561139,0.00015881496,0.00023377132,0.00020436305,0.00015174366,0.0006986717,0.00047583296],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006148973,0.00039695358,0.00019422226,0.0003330297,0.00003107734,0.00004886989,0.000013302969,0.00019343224,0.98981607,0.00014747285,0.00026617438,0.0079445215],"study_design_scores_gemma":[0.0004087217,0.00586156,0.004280535,0.000049610415,0.00009219105,0.00039029168,0.00004906345,0.0014925682,0.9765663,0.00011927962,0.010677331,0.000012475036],"about_ca_topic_score_codex":0.00027826114,"about_ca_topic_score_gemma":0.0008985072,"teacher_disagreement_score":0.0019000066,"about_ca_system_score_codex":0.000228569,"about_ca_system_score_gemma":0.0003546113,"threshold_uncertainty_score":0.0063561797},"labels":[],"label_agreement":null},{"id":"W4401384858","doi":"10.1158/1078-0432.ccr-24-0154","title":"Genotype-Directed Synthetic Cytotoxicity of ATR Inhibition with Radiotherapy","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Telesta Therapeutics (Canada)","funders":"National Cancer Institute; National Institutes of Health","keywords":"Cytotoxicity; Genotype; Radiation therapy; Medicine; Cancer research; Biology; Pharmacology; Genetics; Internal medicine; Gene; In vitro","score_opus":0.0734370622179909,"score_gpt":0.44233275585148085,"score_spread":0.36889569363348995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401384858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99248767,0.0015114192,0.0029985951,0.00006459218,0.00003160232,0.00008869923,0.0003659812,0.00014076728,0.002310637],"genre_scores_gemma":[0.9955384,0.0006657508,0.0018617648,0.000031383053,0.000009417889,0.000052172298,0.0005117954,0.000026324728,0.0013030169],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975187,0.000053737254,0.0000299324,0.000052492687,0.00007311689,0.0000387849],"domain_scores_gemma":[0.9997849,0.00005377107,0.000066989865,0.000046968755,0.000017108703,0.000030276358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025767283,0.00049075607,0.0003328038,0.00027778666,0.00009436448,0.00023032504,0.00036349357,0.00031559452,0.0018945688],"category_scores_gemma":[0.00020057856,0.00015785039,0.0002953801,0.00015488974,0.00021280962,0.00013380019,0.00022537443,0.0005751616,0.00045904596],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028344584,0.00013730815,0.00023451762,0.000053162086,0.00001284577,0.000048339814,0.000011445548,0.00069902046,0.9951775,0.00013482838,0.000056492663,0.0031511437],"study_design_scores_gemma":[0.00004724577,0.0025568374,0.0016725706,0.000008057108,0.000027339374,0.0004926791,0.0000059044514,0.0008831446,0.99313676,0.00003272666,0.0011321044,0.000004572407],"about_ca_topic_score_codex":0.00021142987,"about_ca_topic_score_gemma":0.0002769967,"teacher_disagreement_score":0.0018945688,"about_ca_system_score_codex":0.00023235097,"about_ca_system_score_gemma":0.0002656319,"threshold_uncertainty_score":0.0063379407},"labels":[],"label_agreement":null},{"id":"W4401626626","doi":"10.1158/1078-0432.ccr-24-1170","title":"Oxygen-Enhanced MRI Detects Incidence, Onset, and Heterogeneity of Radiation-Induced Hypoxia Modification in HPV-Associated Oropharyngeal Cancer","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Medical Research Council; Manchester Biomedical Research Centre; Cancer Research UK Manchester Centre; Cancer Research UK; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Royal Marsden NHS Foundation Trust","keywords":"Hypoxia (environmental); Incidence (geometry); Radiation tolerance; Radiation therapy; Medicine; Oxygen; Cancer; Pathology; Internal medicine; Chemistry; Physics","score_opus":0.10142531751398728,"score_gpt":0.4581648820716775,"score_spread":0.3567395645576902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401626626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989235,0.00014602019,0.0006117091,0.00001109668,0.00000209265,0.000013341071,0.00009056783,0.000011790679,0.00018989362],"genre_scores_gemma":[0.999042,0.000040394778,0.0004973187,0.0000100792495,0.0000036051333,0.000021077498,0.00015338602,0.0000043928835,0.00022769104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981374,0.000060994513,0.0000122465535,0.000056478584,0.00003324197,0.000023232209],"domain_scores_gemma":[0.999569,0.000098014374,0.00022034631,0.000035881705,0.000044243046,0.000032599703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004876886,0.00020965107,0.00023925396,0.00028132348,0.000114872244,0.00023938381,0.00023623016,0.00027105096,0.0011099698],"category_scores_gemma":[0.0011687907,0.0001918728,0.00016310239,0.0001479383,0.00019538405,0.00022893673,0.00023039686,0.00021052404,0.00018504006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027425264,0.00023322325,0.87329555,0.00007720679,0.0001567982,0.00011982405,0.00014790933,0.0008917705,0.10294064,0.00005325645,0.00019449065,0.019146811],"study_design_scores_gemma":[0.00003631858,0.0018324192,0.96584386,0.0000076117353,0.0001144375,0.00066618907,0.00010570756,0.002380912,0.028346611,0.000066009256,0.00058822054,0.000011728651],"about_ca_topic_score_codex":0.0009884321,"about_ca_topic_score_gemma":0.0014104048,"teacher_disagreement_score":0.0011099698,"about_ca_system_score_codex":0.00029308684,"about_ca_system_score_gemma":0.00015428274,"threshold_uncertainty_score":0.0037131906},"labels":[],"label_agreement":null},{"id":"W4401715124","doi":"10.1158/1078-0432.ccr-24-1023","title":"Novel <i>ERBB2</i> Variant Potentially Associated with Resistance against Anti-HER2 Monoclonal Antibody–Based Therapy in <i>ERBB2</i> -Amplified Metastatic Colorectal Cancer","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; National Cancer Center Japan; Institute of Genetics; Daiichi Sankyo Company; Japan Agency for Medical Research and Development; Clinical Trial Center, China Medical University Hospital","keywords":"Medicine; Colorectal cancer; Targeted therapy; Monoclonal antibody; Oncology; Internal medicine; Trastuzumab; Monoclonal; Cancer; Acquired resistance; Antibody; Immunology; Breast cancer","score_opus":0.15744454983030268,"score_gpt":0.4806459276473874,"score_spread":0.3232013778170847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401715124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99976593,0.000027494607,0.00006001407,0.000010274111,0.0000010809725,0.00000445371,0.000075318305,0.000002368151,0.00005300705],"genre_scores_gemma":[0.99958354,0.000012537266,0.00014415871,0.000024032612,0.000003776459,0.0000040765244,0.00018665078,0.0000025852776,0.000038604245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999772,0.000042753447,0.000025360094,0.00008206138,0.000038126687,0.000039667608],"domain_scores_gemma":[0.9994698,0.00010211009,0.0002778429,0.00003328194,0.000033678883,0.00008321593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002782094,0.00026108077,0.00031700972,0.00044482943,0.0003207955,0.0003566031,0.00018784919,0.00033204825,0.00072599895],"category_scores_gemma":[0.0006063637,0.0001252767,0.00032727435,0.00055189023,0.00030703563,0.00011501802,0.000173126,0.00036485295,0.00012168522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021993404,0.00017493323,0.8912301,0.000046886827,0.00017498762,0.004400863,0.0002001933,0.0004669782,0.095048554,0.00008995898,0.0003002914,0.0056669936],"study_design_scores_gemma":[0.00008029611,0.0005299356,0.9832759,0.0000062473064,0.000114482405,0.006733358,0.00013271431,0.0011736389,0.0074867513,0.00006264241,0.0003912456,0.000012807838],"about_ca_topic_score_codex":0.0012487373,"about_ca_topic_score_gemma":0.0019394757,"teacher_disagreement_score":0.0012487373,"about_ca_system_score_codex":0.00023246664,"about_ca_system_score_gemma":0.0001759555,"threshold_uncertainty_score":0.002482891},"labels":[],"label_agreement":null},{"id":"W4401910107","doi":"10.1158/1078-0432.ccr-24-0953","title":"Pediatric Cancer Screening in Hereditary Gastrointestinal Cancer Risk Syndromes: An Update from the AACR Childhood Cancer Predisposition Working Group","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Institutes of Health; National Cancer Institute; St. Baldrick's Foundation","keywords":"Cancer; Medicine; Genetic predisposition; Childhood cancer; Oncology; Internal medicine; Disease","score_opus":0.1835065454047581,"score_gpt":0.48948358941619763,"score_spread":0.30597704401143955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401910107","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004133245,0.79498184,0.0021792045,0.16500725,0.011334989,0.0001847873,0.0018266732,0.00028161146,0.020070381],"genre_scores_gemma":[0.013540075,0.9330175,0.005286707,0.03356872,0.009390022,0.00026659638,0.0025106505,0.00009993904,0.0023198263],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969704,0.0008890616,0.0007413409,0.00021846428,0.00096210407,0.00021858684],"domain_scores_gemma":[0.98797846,0.0044876146,0.001479401,0.00022265027,0.004890733,0.00094112527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004613821,0.00061002397,0.0010189358,0.0034388965,0.0005384309,0.0014844192,0.00096921995,0.0021113749,0.0030652406],"category_scores_gemma":[0.017817877,0.00038897392,0.00095798646,0.0030597025,0.000578718,0.0021387618,0.0015067784,0.0044076457,0.0013435258],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059759826,0.00006572403,0.009285282,0.0026841154,0.00010945239,0.00044556282,0.00036181032,0.00024577306,0.00019660157,0.0014292139,0.35967448,0.62544215],"study_design_scores_gemma":[0.00005320293,0.000100367666,0.024253191,0.01835545,0.0002930683,0.0033835552,0.00047458117,0.00019395418,0.00018861968,0.0011155861,0.95151806,0.00007027531],"about_ca_topic_score_codex":0.011272842,"about_ca_topic_score_gemma":0.020455092,"teacher_disagreement_score":0.011272842,"about_ca_system_score_codex":0.0014452299,"about_ca_system_score_gemma":0.0033497913,"threshold_uncertainty_score":0.024400473},"labels":[],"label_agreement":null},{"id":"W4401978856","doi":"10.1158/1078-0432.ccr-24-1611","title":"Update on Pediatric Cancer Surveillance Recommendations for Patients with Neurofibromatosis Type 1, Noonan Syndrome, CBL Syndrome, Costello Syndrome, and Related RASopathies","year":2024,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; Manchester Biomedical Research Centre; National Institute for Health and Care Research; American Lebanese Syrian Associated Charities; National Cancer Institute; National Institutes of Health; Alexion Pharmaceuticals","keywords":"Costello syndrome; Noonan syndrome; Medicine; Neurofibromatosis; Genetic counseling; Cancer; Pediatrics; Population; Internal medicine; Pathology; Genetics; Colorectal cancer","score_opus":0.10647572175923184,"score_gpt":0.4623505615400932,"score_spread":0.3558748397808613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401978856","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006256666,0.9412208,0.0014031444,0.030833783,0.008007004,0.00021067559,0.0026821934,0.0002280335,0.014788583],"genre_scores_gemma":[0.0021690675,0.96651053,0.0044152187,0.014274416,0.0027576783,0.0002644343,0.004348749,0.00003329256,0.00522661],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99881136,0.00038808526,0.00027773555,0.00007879658,0.0003757572,0.00006817773],"domain_scores_gemma":[0.99600935,0.0011453051,0.0005487881,0.00006567736,0.0019995498,0.0002312564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002713749,0.0005339218,0.0009928618,0.002685065,0.00028348956,0.0009466188,0.001444167,0.0017858325,0.005245538],"category_scores_gemma":[0.0068911193,0.00033952214,0.0012248928,0.0023759943,0.00024928385,0.0012229489,0.00083479675,0.0022089856,0.0029094492],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044271317,0.000030539763,0.0006187376,0.0067447755,0.00008298427,0.00013912088,0.00006849131,0.00019961613,0.00022936345,0.0017083634,0.43920812,0.5509256],"study_design_scores_gemma":[0.000023311137,0.000030094327,0.001299203,0.0070160003,0.00013979054,0.0004601833,0.00004309765,0.00005181305,0.00009157857,0.00047498674,0.9903584,0.0000115568755],"about_ca_topic_score_codex":0.005783451,"about_ca_topic_score_gemma":0.012797,"teacher_disagreement_score":0.005783451,"about_ca_system_score_codex":0.0015783852,"about_ca_system_score_gemma":0.0039526336,"threshold_uncertainty_score":0.017548084},"labels":[],"label_agreement":null},{"id":"W4402484216","doi":"10.1158/1078-0432.ccr-24-1098","title":"Update on Recommendations for Cancer Screening and Surveillance in Children with Genomic Instability Disorders","year":2024,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Institutes of Health; Deutsche Kinderkrebsstiftung; National Cancer Institute; Bundesministerium für Bildung und Forschung; St. Baldrick's Foundation","keywords":"Bloom syndrome; Xeroderma pigmentosum; Genome instability; Nijmegen breakage syndrome; Cancer; Ataxia-telangiectasia; Chromosome instability; Medicine; Fanconi anemia; Genetics; Oncology; DNA repair; Internal medicine; Biology; DNA damage; Chromosome","score_opus":0.1827902056911555,"score_gpt":0.5230871474230745,"score_spread":0.340296941731919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402484216","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021817698,0.9449683,0.00093616423,0.026919546,0.009398829,0.00017389111,0.0011383935,0.00016801499,0.016078718],"genre_scores_gemma":[0.00073684915,0.97009397,0.0027441778,0.015031965,0.002171638,0.00018137603,0.0016340588,0.000022528817,0.007383541],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988574,0.00033362178,0.0002276698,0.00007809644,0.0004297033,0.00007346878],"domain_scores_gemma":[0.9966593,0.0011619595,0.00039901622,0.000056395238,0.0015150373,0.0002083684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019272271,0.00085315463,0.0014843359,0.003127492,0.00038172762,0.0011775313,0.0018691736,0.0031882036,0.01337746],"category_scores_gemma":[0.006447378,0.0004174206,0.0016927418,0.0023258098,0.00035418538,0.0015922308,0.0010121188,0.0038150938,0.007673815],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004974439,0.000049201815,0.00018103038,0.010151144,0.00008135699,0.00021440058,0.000062906736,0.0001592443,0.00025998708,0.0017931258,0.51170975,0.47528812],"study_design_scores_gemma":[0.00002083345,0.000021791082,0.00040394324,0.007338664,0.00009453418,0.00043500346,0.000024973595,0.000023717106,0.000040519524,0.00050599757,0.99108034,0.0000097863685],"about_ca_topic_score_codex":0.004985481,"about_ca_topic_score_gemma":0.009462386,"teacher_disagreement_score":0.01337746,"about_ca_system_score_codex":0.0017730327,"about_ca_system_score_gemma":0.0032008612,"threshold_uncertainty_score":0.04475206},"labels":[],"label_agreement":null},{"id":"W4402510201","doi":"10.1158/1078-0432.ccr-24-1883","title":"Plasma ctDNA as a Treatment Response Biomarker in Metastatic Cancers: Evaluation by the RECIST Working Group","year":2024,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Cancer Society; Canada's Michael Smith Genome Sciences Centre; Ottawa Hospital; Queen's University; University of British Columbia","funders":"","keywords":"Response Evaluation Criteria in Solid Tumors; Medicine; Biomarker; Oncology; Internal medicine; Cancer; Chemotherapy; Progressive disease; Biology","score_opus":0.4827449657168289,"score_gpt":0.6010260226461113,"score_spread":0.11828105692928237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402510201","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011797506,0.9971488,0.00028499193,0.0010938222,0.00027929744,0.000012589755,0.00003627034,0.000008258539,0.0010180149],"genre_scores_gemma":[0.0015266129,0.99561834,0.00068151765,0.0010249008,0.00031379424,0.00003947535,0.00009731113,0.0000055574505,0.0006924352],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992955,0.00023196341,0.00009583377,0.00012591813,0.00020081538,0.000050021856],"domain_scores_gemma":[0.99750715,0.0014713187,0.00020391704,0.00005083255,0.0006721646,0.000094572926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037591066,0.00086135976,0.0019391433,0.0022033763,0.00021412202,0.00161068,0.0012357079,0.0016302267,0.002250367],"category_scores_gemma":[0.003803972,0.0003788244,0.001046468,0.0016851184,0.00069550454,0.0015162259,0.0007511113,0.003565171,0.0018825863],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016780983,0.00005371484,0.00033350472,0.008226259,0.00016051972,0.00006023383,0.00003503658,0.0004342945,0.0005863247,0.0041690622,0.02472146,0.9610518],"study_design_scores_gemma":[0.00010578122,0.0003185822,0.0017272551,0.009016447,0.00037282603,0.0007700564,0.000070958915,0.0002961797,0.00087277085,0.0039170007,0.98248565,0.00004638782],"about_ca_topic_score_codex":0.0016824972,"about_ca_topic_score_gemma":0.0022716,"teacher_disagreement_score":0.0037591066,"about_ca_system_score_codex":0.0014664151,"about_ca_system_score_gemma":0.0023426397,"threshold_uncertainty_score":0.019880235},"labels":[],"label_agreement":null},{"id":"W4402558603","doi":"10.1158/1078-0432.ccr-24-1374","title":"Update on Whole-Body MRI Surveillance for Pediatric Cancer Predisposition Syndromes","year":2024,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Cancer; Multidisciplinary approach; Childhood cancer; Genetic predisposition; Pathology; Internal medicine; Disease","score_opus":0.38083414348320976,"score_gpt":0.6134111564983921,"score_spread":0.2325770130151823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402558603","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008604613,0.99643326,0.00013170212,0.001287147,0.0007523685,0.000013319938,0.00009745563,0.000013041296,0.001185599],"genre_scores_gemma":[0.00055964506,0.9970866,0.00029588005,0.0011360612,0.0003511252,0.000016463548,0.00013461045,0.0000038398434,0.00041575864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99910444,0.00024158214,0.00022945837,0.000087416774,0.00028449646,0.00005248236],"domain_scores_gemma":[0.99680436,0.0016357981,0.00044066834,0.000055666,0.0009776655,0.00008584896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001996978,0.0006607289,0.0014162639,0.003531039,0.0002340615,0.0010929742,0.0011416489,0.0015376931,0.0050185868],"category_scores_gemma":[0.0049811965,0.00035388384,0.0017456989,0.0025876507,0.00033531818,0.0013717982,0.0007294244,0.001840143,0.001627219],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105328305,0.00003508535,0.00027192893,0.061242938,0.00030647943,0.00019846253,0.000120685814,0.0002093605,0.0006381077,0.0028799523,0.113045946,0.8209458],"study_design_scores_gemma":[0.000028583401,0.00007137892,0.0010057957,0.033186592,0.00060892524,0.0008049819,0.000040988798,0.000052433777,0.00018168811,0.00064722967,0.96335334,0.000018103252],"about_ca_topic_score_codex":0.0025648763,"about_ca_topic_score_gemma":0.00447875,"teacher_disagreement_score":0.0050185868,"about_ca_system_score_codex":0.00092379085,"about_ca_system_score_gemma":0.0026485615,"threshold_uncertainty_score":0.01678884},"labels":[],"label_agreement":null},{"id":"W4402840630","doi":"10.1158/1078-0432.ccr-24-2100","title":"Update on Surveillance for Wilms Tumor and Hepatoblastoma in Beckwith–Wiedemann Syndrome and Other Predisposition Syndromes","year":2024,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; Deutsche Kinderkrebsstiftung; Hospital Research Foundation; Alex's Lemonade Stand Foundation for Childhood Cancer; St. Baldrick's Foundation; Rally Foundation; Damon Runyon Cancer Research Foundation","keywords":"Hepatoblastoma; Medicine; Wilms' tumor; Context (archaeology); Beckwith–Wiedemann syndrome; Genetic predisposition; Cancer; Pediatrics; Intensive care medicine; Pathology; Internal medicine; Disease; Genetics; Biology","score_opus":0.15836542130704495,"score_gpt":0.5139456760334001,"score_spread":0.3555802547263552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402840630","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011392964,0.995992,0.0001344137,0.0015896745,0.0006974864,0.000013885838,0.00013113771,0.00001633716,0.0013112527],"genre_scores_gemma":[0.0005602101,0.996503,0.00032633773,0.0014124563,0.0004172311,0.000016591755,0.00024489232,0.0000033291315,0.0005159184],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994567,0.000149755,0.00011859064,0.000052046613,0.00019093425,0.00003190046],"domain_scores_gemma":[0.99812084,0.0009267886,0.0002430635,0.000034677316,0.00059050607,0.00008410117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001450436,0.0005142378,0.0013290003,0.0031001726,0.00020985348,0.00088679,0.0010578502,0.0014328784,0.0040322],"category_scores_gemma":[0.003717498,0.00025797862,0.001288028,0.0021344065,0.00025167823,0.0011374869,0.00063873315,0.0015806322,0.0014586651],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074437754,0.00003702616,0.00038026355,0.028475279,0.00024718372,0.00024079268,0.000086889544,0.0002063789,0.00046110555,0.0019674238,0.12316722,0.844656],"study_design_scores_gemma":[0.000035915713,0.000068937756,0.0013152001,0.02133505,0.00062291475,0.0010779931,0.00004592634,0.00006372211,0.0001246127,0.0008990985,0.974393,0.000017566916],"about_ca_topic_score_codex":0.0031825714,"about_ca_topic_score_gemma":0.006462525,"teacher_disagreement_score":0.0040322,"about_ca_system_score_codex":0.00077394926,"about_ca_system_score_gemma":0.00231337,"threshold_uncertainty_score":0.013489008},"labels":[],"label_agreement":null},{"id":"W4402859830","doi":"10.1158/1078-0432.ccr-23-3523","title":"The Tumor Immune Microenvironment Drives Survival Outcomes and Therapeutic Response in an Integrated Molecular Analysis of Gastric Adenocarcinoma","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; Alberta Cancer Foundation; University of Alberta","funders":"Canadian Institutes of Health Research; Edmonton Civic Employees Charitable Assistance Fund","keywords":"Immunotherapy; Oncology; Internal medicine; Tumor microenvironment; Medicine; Microsatellite instability; Adjuvant; Chemotherapy; Subgroup analysis; Cancer; Survival analysis; Immune system; Immunology; Biology; Meta-analysis; Allele; Gene","score_opus":0.1226612006777825,"score_gpt":0.47501022213912314,"score_spread":0.3523490214613406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402859830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992083,0.0001277597,0.00046494108,0.000024861702,0.0000016629161,0.000007464054,0.000094591756,0.0000062210115,0.00006431647],"genre_scores_gemma":[0.99940646,0.00002007384,0.00037016332,0.0000103808525,0.0000027067554,0.0000052201945,0.00015694479,0.0000019234337,0.000026070473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993249,0.0003019648,0.00004398981,0.00016625029,0.000103648876,0.00005926814],"domain_scores_gemma":[0.9988967,0.000345163,0.000393145,0.00015647477,0.00010915098,0.00009928524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024767607,0.00034274752,0.00048025214,0.0007275493,0.00019987601,0.00063088886,0.00024903918,0.0002539728,0.0004539642],"category_scores_gemma":[0.002828019,0.000164265,0.00052595773,0.00054071564,0.00028536908,0.00031958727,0.00046476183,0.00040749522,0.00010155194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009932248,0.0001101198,0.9804073,0.00002558213,0.00028443302,0.000032421292,0.000042602845,0.0014351035,0.00726348,0.000026006212,0.000081359714,0.009298336],"study_design_scores_gemma":[0.000024391786,0.0003263734,0.98458415,0.0000058906094,0.00021086787,0.00014306142,0.00006137102,0.012818527,0.0015679519,0.000110587265,0.00014137152,0.0000054730335],"about_ca_topic_score_codex":0.0011790472,"about_ca_topic_score_gemma":0.0017455202,"teacher_disagreement_score":0.0024767607,"about_ca_system_score_codex":0.0004179978,"about_ca_system_score_gemma":0.0005010618,"threshold_uncertainty_score":0.013098538},"labels":[],"label_agreement":null},{"id":"W4403486661","doi":"10.1158/1078-0432.ccr-24-2105","title":"Genomic Landscape of ctDNA and Real-World Outcomes in Advanced Endometrial Cancer","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"KRAS; PTEN; Medicine; Oncology; Internal medicine; Mutation; Cancer; ARID1A; Endometrial cancer; Cohort; Germline mutation; Retrospective cohort study; Cancer research; Gene; Colorectal cancer; Genetics; Biology","score_opus":0.10559196244007478,"score_gpt":0.5011542992905622,"score_spread":0.3955623368504874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403486661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990916,0.0003348416,0.00012681886,0.000015353802,0.0000013259802,0.0000060119814,0.00027159543,0.0000014491293,0.0001510502],"genre_scores_gemma":[0.99952245,0.000060068327,0.000097572134,0.0000075539724,0.000002156698,0.000004972651,0.0002735912,7.9556196e-7,0.0000308634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935836,0.0002341473,0.00008014262,0.00015871767,0.00011594062,0.000052730018],"domain_scores_gemma":[0.99746335,0.0004759159,0.0015271676,0.00025680827,0.0001509626,0.00012577602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011376977,0.00017386895,0.00017989383,0.0007612453,0.00019168537,0.0005853354,0.0002853057,0.00027150282,0.0009373562],"category_scores_gemma":[0.0038686336,0.0001326156,0.00018979647,0.00077612104,0.000442636,0.00036403612,0.00045287848,0.00022360923,0.0001632678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000317906,0.000017999473,0.99713457,0.000017862021,0.000052412313,0.000044868822,0.00003036318,0.00009295005,0.00081155525,0.000018029814,0.000019919687,0.0014415758],"study_design_scores_gemma":[0.00001416744,0.000261436,0.9974152,0.00001061488,0.000048418762,0.00075755076,0.00009952438,0.00027830037,0.00074843765,0.00005249395,0.00030953702,0.000004363298],"about_ca_topic_score_codex":0.0007948129,"about_ca_topic_score_gemma":0.0010837405,"teacher_disagreement_score":0.0011376977,"about_ca_system_score_codex":0.00030903643,"about_ca_system_score_gemma":0.00018897343,"threshold_uncertainty_score":0.0060168505},"labels":[],"label_agreement":null},{"id":"W4403539151","doi":"10.1158/1078-0432.ccr-24-1562","title":"Phase Ib Study of the Immunocytokine Simlukafusp Alfa (FAP-IL2v) in Combination with Cetuximab in Patients with Head and Neck Squamous Cell Carcinoma","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Foundation Medicine; European Society for Medical Oncology; PharmaMar; Les Laboratories Pierre Fabre; AstraZeneca; Amgen; Pfizer; Astellas Pharma; F. Hoffmann-La Roche","keywords":"Cetuximab; Medicine; Pharmacodynamics; Internal medicine; Head and neck squamous-cell carcinoma; Tolerability; Oncology; Pharmacokinetics; Phases of clinical research; Adverse effect; Gastroenterology; Response Evaluation Criteria in Solid Tumors; Head and neck cancer; Clinical trial; Colorectal cancer; Cancer","score_opus":0.08702096082543363,"score_gpt":0.454809325563476,"score_spread":0.36778836473804233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403539151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99557745,0.0015357467,0.00030755764,0.0001431657,0.00005623032,0.0012437857,0.00021785218,0.00004411397,0.0008740492],"genre_scores_gemma":[0.9953426,0.000951346,0.00078909646,0.00024918246,0.000076452496,0.0010087356,0.00065523916,0.000012617508,0.0009147566],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997092,0.00011974629,0.000019445633,0.000049737395,0.000036032554,0.00006592038],"domain_scores_gemma":[0.9996375,0.000051884886,0.00008507161,0.000028217692,0.000033528966,0.00016380711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010087745,0.0012305528,0.0016431856,0.0003187526,0.00032584532,0.0007206656,0.00076184183,0.00093586405,0.0016479556],"category_scores_gemma":[0.0004948067,0.00047426284,0.00086883205,0.00030832927,0.00063394295,0.0005077878,0.00027608234,0.0019920375,0.0005409446],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5791578,0.090680666,0.012169383,0.0015940819,0.0015302775,0.0005889644,0.00051000965,0.00803995,0.15341656,0.0003152319,0.0030770015,0.14892003],"study_design_scores_gemma":[0.35860625,0.6071219,0.011694239,0.000052027928,0.00045857008,0.00042228415,0.000089045156,0.0024639736,0.016093018,0.000120364864,0.0028476915,0.000030627496],"about_ca_topic_score_codex":0.0016119267,"about_ca_topic_score_gemma":0.0038226035,"teacher_disagreement_score":0.0016479556,"about_ca_system_score_codex":0.001257368,"about_ca_system_score_gemma":0.0019265237,"threshold_uncertainty_score":0.009122908},"labels":[],"label_agreement":null},{"id":"W4403831332","doi":"10.1158/1078-0432.ccr-24-2488","title":"Update on Surveillance Guidelines in Emerging Wilms Tumor Predisposition Syndromes","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Servier; Alexion Pharmaceuticals","keywords":"Wilms' tumor; Medicine; Wilms tumour; Genetic predisposition; Cancer; Pathology; Internal medicine; Disease","score_opus":0.1281392065172287,"score_gpt":0.5224941601153741,"score_spread":0.3943549535981454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403831332","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004849196,0.19723737,0.019924002,0.62534314,0.054091122,0.0014912968,0.008513786,0.0021484958,0.086401634],"genre_scores_gemma":[0.029008644,0.36536145,0.098390944,0.3748231,0.05151932,0.0035304339,0.031671815,0.00083082856,0.04486359],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98860234,0.004484264,0.003615496,0.00040141,0.0024228827,0.00047363472],"domain_scores_gemma":[0.9404057,0.01728051,0.004714652,0.0010654584,0.033328533,0.0032051334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014335271,0.000853889,0.0015752757,0.0040285042,0.0009846996,0.0024849477,0.0027529295,0.0075846314,0.0066981027],"category_scores_gemma":[0.057185166,0.0006083797,0.0022588721,0.0026700317,0.0007759243,0.0027585719,0.0023740884,0.008749668,0.0046394253],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047770063,0.000055991302,0.0022763985,0.00126401,0.000057695874,0.0003676448,0.0002598981,0.00042685162,0.00025509228,0.0027690534,0.80497885,0.18724088],"study_design_scores_gemma":[0.00004041952,0.00004967288,0.0034274824,0.0067523615,0.000102200014,0.0007609851,0.00019949563,0.0003419472,0.00015402763,0.0019701326,0.9861596,0.00004174479],"about_ca_topic_score_codex":0.013622527,"about_ca_topic_score_gemma":0.019107621,"teacher_disagreement_score":0.014335271,"about_ca_system_score_codex":0.0027996632,"about_ca_system_score_gemma":0.007798709,"threshold_uncertainty_score":0.075813115},"labels":[],"label_agreement":null},{"id":"W4403890847","doi":"10.1158/1078-0432.ccr-23-3518","title":"Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Sunnybrook Health Science Centre","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Oncology; Chemotherapy; Proportional hazards model; Progression-free survival; Cancer; Immunotherapy","score_opus":0.08274151803402123,"score_gpt":0.46282926744188796,"score_spread":0.3800877494078667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403890847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99854857,0.0009325735,0.00014106506,0.000054230677,0.0000041125336,0.00002335299,0.000117092466,0.000006009046,0.0001728916],"genre_scores_gemma":[0.99961495,0.000075059565,0.000097495315,0.000024105973,0.0000052585324,0.000012747907,0.00008764087,0.0000013052063,0.00008138956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940324,0.00032466374,0.000049760692,0.0000936671,0.000091840084,0.000036803624],"domain_scores_gemma":[0.9989538,0.00040377353,0.00041262817,0.00006701466,0.00003989636,0.00012281646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017575643,0.0001890253,0.00048668525,0.00015200042,0.00013479777,0.00033889106,0.00024949835,0.0003012335,0.0008887965],"category_scores_gemma":[0.0020022725,0.00014125327,0.00048794993,0.00019849396,0.00018375496,0.00026456304,0.00017478249,0.000532139,0.00009733959],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1786203,0.0025816208,0.67779696,0.00048467057,0.0031583086,0.00014311595,0.00012853788,0.004148702,0.032486018,0.0001130633,0.00085955265,0.099479176],"study_design_scores_gemma":[0.0041825767,0.023367556,0.95977145,0.00003630873,0.0010784625,0.00039755282,0.000032513773,0.0051111975,0.004726226,0.00011373829,0.00116662,0.000015701953],"about_ca_topic_score_codex":0.00036060775,"about_ca_topic_score_gemma":0.0009395432,"teacher_disagreement_score":0.0017575643,"about_ca_system_score_codex":0.0004273796,"about_ca_system_score_gemma":0.00034145857,"threshold_uncertainty_score":0.009294987},"labels":[],"label_agreement":null},{"id":"W4404165259","doi":"10.1158/1078-0432.ccr-24-1240","title":"Genomic, Epigenomic, and Transcriptomic Inter- and Intratumor Heterogeneity in Desmoid Tumors","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute; University of Toronto; Princess Margaret Cancer Centre; Artificial Intelligence in Medicine (Canada); McGill University; McGill University Health Centre","funders":"National Cancer Institute; Desmoid Tumor Research Foundation","keywords":"Epigenomics; Transcriptome; Biology; Cancer research; Computational biology; Genetics; Medicine; DNA methylation; Gene; Gene expression","score_opus":0.22377268011993665,"score_gpt":0.5242642067212291,"score_spread":0.3004915266012924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404165259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99878496,0.00020051516,0.000742236,0.000010001969,7.4645675e-7,0.0000041107583,0.00013907159,0.0000062892886,0.00011212324],"genre_scores_gemma":[0.9991829,0.00007291601,0.00037063437,0.00000905671,0.000002433219,0.000008064767,0.00024130636,0.000003116227,0.00010960205],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998559,0.000023705501,0.000010063968,0.000051726787,0.000036154674,0.000022544462],"domain_scores_gemma":[0.9997749,0.000074267904,0.000080840306,0.000019445297,0.000023600385,0.000027070831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016451252,0.00012103544,0.00015410483,0.0005129781,0.000112921036,0.00020221966,0.000077910474,0.0001212014,0.00040810555],"category_scores_gemma":[0.00037622396,0.00008436788,0.00009849402,0.00026302808,0.0001951115,0.00014570203,0.0001504909,0.00015258534,0.000079767124],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034931852,0.000028027376,0.17779377,0.000045839497,0.00006759151,0.00028969737,0.00016010286,0.0004273679,0.81455547,0.000089615954,0.00005156459,0.006141706],"study_design_scores_gemma":[0.000006892903,0.00015330342,0.94278514,0.000003764503,0.00004794535,0.0013209678,0.00013274747,0.0016616539,0.053156484,0.00017508752,0.0005481939,0.000007802709],"about_ca_topic_score_codex":0.00028831244,"about_ca_topic_score_gemma":0.0005281979,"teacher_disagreement_score":0.0005129781,"about_ca_system_score_codex":0.00013043654,"about_ca_system_score_gemma":0.00008288006,"threshold_uncertainty_score":0.0013652444},"labels":[],"label_agreement":null},{"id":"W4404165262","doi":"10.1158/1078-0432.ccr-24-1612","title":"Randomized Phase II Study of Durvalumab with or without Tremelimumab in Patients with Metastatic Castration-Resistant Prostate Cancer","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; University of Toronto; Sunnybrook Hospital; Kingston Health Sciences Centre; Canadian Cancer Society; CancerCare Manitoba; University of Manitoba; Juravinski Cancer Centre; Hamilton Health Sciences; Baker Hughes (Canada); Canadian Centre for Applied Research in Cancer Control; University Health Network; Saskatchewan Cancer Agency; Occupational Cancer Research Centre; Ottawa Hospital; Sunnybrook Health Science Centre; Kelowna General Hospital; London Health Sciences Centre; Interior Health; Princess Margaret Cancer Centre; BC Cancer Agency; Queen's University; Spinal Cord Injury BC","funders":"Canadian Cancer Society","keywords":"Durvalumab; Tremelimumab; Prostate cancer; Medicine; Oncology; Castration; Internal medicine; Prostate; Flutamide; Cancer; Randomized controlled trial; Immunotherapy; Hormone; Androgen receptor; Nivolumab","score_opus":0.2214674561537067,"score_gpt":0.5506320744122234,"score_spread":0.32916461825851673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404165262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917787,0.0009252537,0.0005031071,0.00046992808,0.0002471183,0.004070181,0.0007562573,0.00007667226,0.001172855],"genre_scores_gemma":[0.98945355,0.0006730927,0.0015086831,0.0008045446,0.00022295315,0.003589485,0.001115508,0.000025486403,0.002606759],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994228,0.0003051183,0.000027237464,0.00010317654,0.00004120574,0.00010042063],"domain_scores_gemma":[0.9991641,0.0001506359,0.00015800078,0.00009060709,0.00004565771,0.0003909483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018052282,0.0016009453,0.002194477,0.0003123224,0.0003792994,0.0009172313,0.0010206695,0.0011722656,0.0058101956],"category_scores_gemma":[0.001139947,0.0007317889,0.0010886114,0.00031038732,0.0010300458,0.0008333304,0.0003341878,0.002687419,0.0010137212],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93779814,0.02560767,0.001761006,0.00034532824,0.0006564247,0.000066487846,0.00010526644,0.0005354913,0.01120547,0.00019161003,0.000999267,0.020727847],"study_design_scores_gemma":[0.88640743,0.10967618,0.0018824418,0.000009601854,0.00015450006,0.000044079567,0.000018516459,0.0003537469,0.0007220071,0.000096862146,0.00062546093,0.000009128077],"about_ca_topic_score_codex":0.0006690756,"about_ca_topic_score_gemma":0.0024390486,"teacher_disagreement_score":0.0058101956,"about_ca_system_score_codex":0.0010055902,"about_ca_system_score_gemma":0.0014431244,"threshold_uncertainty_score":0.019437075},"labels":[],"label_agreement":null},{"id":"W4404305717","doi":"10.1158/1557-3265.liqbiop24-pr004","title":"Abstract PR004: Biological insights into tissue-agnostic plasma cfDNA methylation signature for surveillance of head and neck tumor recurrence","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Head and neck; Head and neck cancer; Medicine; Methylation; DNA methylation; Pathology; Oncology; Cancer; Internal medicine; Biology; Surgery; DNA; Genetics; Gene","score_opus":0.10978618114041143,"score_gpt":0.4808599707084507,"score_spread":0.37107378956803927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404305717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97289884,0.0015519345,0.017645665,0.0005886854,0.000052592273,0.00013006598,0.0040462073,0.0005895408,0.0024966085],"genre_scores_gemma":[0.98108613,0.00027689655,0.013702075,0.00028449536,0.00003155755,0.00006200698,0.0027427538,0.000043829034,0.0017702266],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99973696,0.000041061914,0.000015508218,0.00009806432,0.00008637153,0.000021998698],"domain_scores_gemma":[0.9996486,0.000091802896,0.00009605533,0.000042329353,0.00008663645,0.000034593573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000599457,0.00024829875,0.00029091706,0.00050168496,0.00014130864,0.00040651186,0.00035022467,0.00045119107,0.0015782792],"category_scores_gemma":[0.0012466937,0.00014035212,0.00025440077,0.00024026642,0.00018475374,0.00017567119,0.00028758933,0.0004218143,0.0004259873],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015556173,0.00010740405,0.19753087,0.00028542563,0.00014157704,0.0002481233,0.00009558556,0.0024736337,0.69497955,0.00024750317,0.002724807,0.099609956],"study_design_scores_gemma":[0.0001024709,0.0017676846,0.37658125,0.00005854501,0.0002842715,0.0022831992,0.00011428675,0.03496075,0.573424,0.0006579822,0.009702522,0.00006296592],"about_ca_topic_score_codex":0.0011918854,"about_ca_topic_score_gemma":0.0019117565,"teacher_disagreement_score":0.0015782792,"about_ca_system_score_codex":0.00039911646,"about_ca_system_score_gemma":0.00033805755,"threshold_uncertainty_score":0.005279839},"labels":[],"label_agreement":null},{"id":"W4404305723","doi":"10.1158/1557-3265.liqbiop24-pr003","title":"Abstract PR003: ctDNA release kinetics and fragmentation to monitor treatment response and resistance in esophageal adenocarcinoma","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McGill University Health Centre","funders":"","keywords":"Esophageal adenocarcinoma; Kinetics; Fragmentation (computing); Adenocarcinoma; Cancer research; Medicine; Esophageal cancer; Oncology; Chemistry; Internal medicine; Biology; Cancer","score_opus":0.0753115833577441,"score_gpt":0.45641381450280005,"score_spread":0.3811022311450559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404305723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98756313,0.0040810723,0.0056839786,0.0001310441,0.000020080977,0.0000830261,0.0012841228,0.00016300431,0.0009903825],"genre_scores_gemma":[0.9916366,0.0007539585,0.0046473513,0.00010054778,0.000011913142,0.00008700175,0.00115749,0.00003344895,0.0015715926],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99975544,0.000041542313,0.000023335171,0.00007396351,0.000082902705,0.000022770497],"domain_scores_gemma":[0.9995334,0.00011605895,0.0001404947,0.000038959275,0.00012095518,0.00005016755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051098457,0.0002499045,0.00027297164,0.0006994665,0.00017589243,0.00050113606,0.00021611585,0.0005668557,0.0015291899],"category_scores_gemma":[0.000940947,0.00016847836,0.00022870633,0.00055967754,0.00019120857,0.00033460028,0.0002541273,0.00047113776,0.00045351865],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027864403,0.00013765172,0.1739334,0.0003747204,0.00010392826,0.00030289503,0.00029211643,0.0011670202,0.7708724,0.0000697547,0.0005504368,0.049409244],"study_design_scores_gemma":[0.00005265372,0.0027921076,0.5010316,0.000057010915,0.000176626,0.003211486,0.00032773588,0.007406274,0.48026696,0.00019405695,0.004448294,0.000035288598],"about_ca_topic_score_codex":0.00081084616,"about_ca_topic_score_gemma":0.0008698194,"teacher_disagreement_score":0.0015291899,"about_ca_system_score_codex":0.00037032113,"about_ca_system_score_gemma":0.00020050647,"threshold_uncertainty_score":0.0051156282},"labels":[],"label_agreement":null},{"id":"W4404305779","doi":"10.1158/1557-3265.liqbiop24-b021","title":"Abstract B021: tRNA fragments extracted from patient plasma extra cellular vesicles display potential as biomarkers for high-grade glioma","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Beatrice Hunter Cancer Research Institute; Atlantic Cancer Research Institute; Dalhousie University","funders":"","keywords":"Glioma; Vesicle; Cancer research; Chemistry; Medicine; Pathology; Biology; Biochemistry","score_opus":0.0830709705604627,"score_gpt":0.43061400200269606,"score_spread":0.34754303144223336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404305779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99049896,0.0018306737,0.0036150315,0.00018674365,0.00006400132,0.00002787408,0.0024213037,0.00016178556,0.0011936473],"genre_scores_gemma":[0.9908303,0.0005932605,0.0034162847,0.00011050789,0.000023902085,0.000023889483,0.0029228488,0.000046808233,0.0020322138],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99987686,0.000016864022,0.000013805963,0.00003136503,0.000039384107,0.000021726419],"domain_scores_gemma":[0.9998807,0.000038211685,0.00003023309,0.000007973465,0.000028457593,0.000014385657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021655088,0.00025867688,0.0003443717,0.0007812313,0.00019339102,0.0005512389,0.00017419635,0.00049117074,0.003449915],"category_scores_gemma":[0.00047685145,0.00009016932,0.00023586421,0.0004308451,0.00012889486,0.00017184873,0.00026690634,0.00035078923,0.00085798407],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011136681,0.000041722567,0.016168488,0.00021919368,0.00005554672,0.0004459707,0.00006668703,0.00017133108,0.9654651,0.00010837026,0.0006240341,0.015519832],"study_design_scores_gemma":[0.00005639855,0.000672253,0.3423383,0.00005193745,0.00019712758,0.0063619935,0.00038293598,0.0029442285,0.64062935,0.0005671951,0.005758973,0.000039358827],"about_ca_topic_score_codex":0.00054111396,"about_ca_topic_score_gemma":0.00037563997,"teacher_disagreement_score":0.003449915,"about_ca_system_score_codex":0.00020073757,"about_ca_system_score_gemma":0.00012087708,"threshold_uncertainty_score":0.011541128},"labels":[],"label_agreement":null},{"id":"W4404305804","doi":"10.1158/1557-3265.liqbiop24-b001","title":"Abstract B001: ctDNA release kinetics and fragmentation to monitor treatment response and resistance in esophageal adenocarcinoma","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McGill University Health Centre","funders":"","keywords":"Esophageal adenocarcinoma; Fragmentation (computing); Medicine; Esophageal cancer; Kinetics; Adenocarcinoma; Cancer research; Oncology; Internal medicine; Cancer; Biology","score_opus":0.07626756224814428,"score_gpt":0.4565329583700693,"score_spread":0.380265396121925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404305804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85072964,0.035872564,0.048859578,0.0042413296,0.0017225572,0.0014427445,0.01785666,0.003718065,0.035556763],"genre_scores_gemma":[0.90569484,0.006582622,0.028967887,0.0016394695,0.00033556676,0.00061381713,0.00861564,0.0006373655,0.04691281],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99937767,0.00015372872,0.00004199596,0.000100460915,0.0002793934,0.00004675107],"domain_scores_gemma":[0.9985482,0.0005874302,0.00020908349,0.000090772504,0.00042472078,0.00013982516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001585534,0.00048644666,0.00044157822,0.0015898993,0.00029079948,0.0008722001,0.00037379208,0.0009826439,0.009886056],"category_scores_gemma":[0.002945856,0.00030449656,0.00031645922,0.0007703868,0.00020914934,0.0004862002,0.0003455097,0.0007610908,0.0033382426],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007565636,0.0003277839,0.025929041,0.00081596186,0.00011092313,0.00037042462,0.00026690558,0.0014654377,0.8167861,0.00030502529,0.02057018,0.12548666],"study_design_scores_gemma":[0.00023594065,0.0044000754,0.1498448,0.00015860866,0.00021693068,0.0025504958,0.00027879275,0.01138044,0.80799836,0.00051629316,0.022309776,0.00010957882],"about_ca_topic_score_codex":0.0013090582,"about_ca_topic_score_gemma":0.0010279126,"teacher_disagreement_score":0.009886056,"about_ca_system_score_codex":0.0006628661,"about_ca_system_score_gemma":0.00044379002,"threshold_uncertainty_score":0.033072174},"labels":[],"label_agreement":null},{"id":"W4404305885","doi":"10.1158/1557-3265.liqbiop24-b064","title":"Abstract B064: Prevalence and clinical relevance of clonal hematopoiesis in metastatic urologic malignancies","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Clinical significance; Oncology; Cancer; Haematopoiesis; Intensive care medicine; Internal medicine; Stem cell; Biology","score_opus":0.14223305191781999,"score_gpt":0.49106979060416095,"score_spread":0.34883673868634096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404305885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989202,0.00018864917,0.00008723818,0.000026665532,0.0000021706571,0.0000064048622,0.0003403849,0.000005541435,0.0004228816],"genre_scores_gemma":[0.9996296,0.000025361996,0.00008846493,0.000008654516,0.0000030177152,0.0000026098373,0.0001785947,0.0000016484969,0.00006203349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963737,0.00006301026,0.00003218734,0.00011858109,0.00009574658,0.000053181593],"domain_scores_gemma":[0.9989215,0.0002763086,0.00040623525,0.00006071767,0.00016161836,0.00017370052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005000362,0.00014283307,0.00019176872,0.0009855612,0.00041394247,0.0004784336,0.000300877,0.00038059047,0.0033560619],"category_scores_gemma":[0.002288144,0.000114478564,0.00011048341,0.0007993905,0.00035162378,0.00015745683,0.00031759113,0.00027880527,0.00036573975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014664711,0.000012288241,0.9954698,0.000010362501,0.000007866267,0.0000649341,0.000022142325,0.00004160795,0.0026060683,0.000013873701,0.00008566765,0.0015186766],"study_design_scores_gemma":[0.000004606571,0.00007086605,0.9978167,0.0000048884426,0.000008741402,0.0008099428,0.0000651747,0.00017459862,0.00085991406,0.000018553224,0.00016432114,0.000001835344],"about_ca_topic_score_codex":0.004874356,"about_ca_topic_score_gemma":0.0035996295,"teacher_disagreement_score":0.004874356,"about_ca_system_score_codex":0.00036033677,"about_ca_system_score_gemma":0.00027133178,"threshold_uncertainty_score":0.0112271905},"labels":[],"label_agreement":null},{"id":"W4404305890","doi":"10.1158/1557-3265.liqbiop24-b011","title":"Abstract B011: Circulating tumor DNA profiling in colorectal cancer to detect guideline-based targeted mutations at a Quebec health care center","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Colorectal cancer; Guideline; Medicine; Circulating tumor DNA; Profiling (computer programming); Oncology; Cancer; DNA profiling; Internal medicine; DNA; Pathology; Biology; Genetics","score_opus":0.08300783161549298,"score_gpt":0.4843207700583968,"score_spread":0.40131293844290383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404305890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98941857,0.0003944,0.00039068493,0.0006635945,0.000027418095,0.00021937436,0.004055265,0.000031729654,0.0047991197],"genre_scores_gemma":[0.9944616,0.00011931625,0.0005006956,0.00034559428,0.000013613892,0.000057093064,0.0011651723,0.000008086784,0.0033288691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999731,0.00003851943,0.000011739731,0.00006318297,0.00007420581,0.00008123515],"domain_scores_gemma":[0.9989291,0.00009431475,0.00015052035,0.00002934211,0.0004757413,0.0003210087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033199158,0.0002081443,0.00019303418,0.00052454736,0.000926267,0.00053073233,0.00048706305,0.0003275153,0.005785464],"category_scores_gemma":[0.0010656223,0.00014761393,0.00017362509,0.00075232267,0.00020820682,0.0001748977,0.00026253652,0.00042829523,0.00054032716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002995046,0.000110197245,0.97522825,0.000060007045,0.000031702137,0.0007598297,0.00032714824,0.00020715337,0.0035906793,0.00007287797,0.0065012854,0.012811358],"study_design_scores_gemma":[0.000024042867,0.00016319472,0.9952909,0.000026967184,0.000014297285,0.00024251979,0.00029108676,0.0007302064,0.00044703693,0.0000105547715,0.0027512575,0.000008070928],"about_ca_topic_score_codex":0.85885924,"about_ca_topic_score_gemma":0.89259315,"teacher_disagreement_score":0.14114076,"about_ca_system_score_codex":0.00837978,"about_ca_system_score_gemma":0.005783141,"threshold_uncertainty_score":0.2839439},"labels":[],"label_agreement":null},{"id":"W4404305892","doi":"10.1158/1557-3265.liqbiop24-b050","title":"Abstract B050: Frequent monitoring of NSCLC immunotherapy using an mDETECT liquid biopsy reveals unexpected complexity and opportunities","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Immunotherapy; Liquid biopsy; Medicine; Biopsy; Oncology; Internal medicine; Cancer","score_opus":0.6264189750004209,"score_gpt":0.5694848793649353,"score_spread":0.05693409563548557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404305892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8910452,0.0054211426,0.050152738,0.008284695,0.0023136593,0.0006632381,0.0064698546,0.0034567118,0.032192647],"genre_scores_gemma":[0.8876025,0.0016305286,0.05024825,0.0030221017,0.00035079417,0.00023363429,0.0024272017,0.0002892373,0.054195784],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9995024,0.000050526098,0.000035785648,0.000118044394,0.00024082823,0.000052502164],"domain_scores_gemma":[0.9995554,0.000089709334,0.00006372244,0.00003407139,0.0001619912,0.00009508315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073166616,0.00026582775,0.00024484695,0.00082075526,0.0004176859,0.0008031107,0.0006190098,0.00070133584,0.0056487233],"category_scores_gemma":[0.00109179,0.00020659478,0.00011586021,0.0004194769,0.00027582792,0.00044256996,0.00037871278,0.0006262816,0.0017482176],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010287405,0.0002544002,0.04374153,0.00026079488,0.00003497692,0.0011824904,0.0001934582,0.0007150817,0.74313575,0.0015495139,0.031754334,0.17614886],"study_design_scores_gemma":[0.000111652436,0.0013653153,0.14749858,0.000073266,0.00005686769,0.0050320276,0.0002615265,0.0106643345,0.7458939,0.0009482414,0.08796538,0.00012876574],"about_ca_topic_score_codex":0.0047856783,"about_ca_topic_score_gemma":0.007851226,"teacher_disagreement_score":0.0056487233,"about_ca_system_score_codex":0.00075494434,"about_ca_system_score_gemma":0.0006985938,"threshold_uncertainty_score":0.018896878},"labels":[],"label_agreement":null},{"id":"W4404305902","doi":"10.1158/1557-3265.liqbiop24-b071","title":"Abstract B071: Identifying the clinical utility of CSF as a source of liquid biopsy in pediatric brain tumors","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Alberta","funders":"","keywords":"Medicine; Liquid biopsy; Pathology; Biopsy; Brain biopsy; Intensive care medicine; Cancer; Internal medicine","score_opus":0.3158458056615881,"score_gpt":0.5751759539285666,"score_spread":0.2593301482669785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404305902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952173,0.0016633596,0.0019527839,0.000057656453,0.000016756836,0.000051228115,0.0004101004,0.00004183622,0.0005889315],"genre_scores_gemma":[0.99384344,0.0005157597,0.0048567764,0.000053065058,0.000016417387,0.000033296245,0.00052060175,0.000018703811,0.00014195326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994273,0.00016679094,0.000058247162,0.00012635677,0.0001472863,0.000074065996],"domain_scores_gemma":[0.9989237,0.00045739024,0.0002087544,0.00004913937,0.00026457972,0.00009636282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080007524,0.000434264,0.0003938982,0.0015262259,0.0003537666,0.0007930551,0.00027824574,0.00040545705,0.00095369306],"category_scores_gemma":[0.0022842677,0.00015682586,0.0001965946,0.0007816647,0.00042245092,0.00029698372,0.00032284684,0.00033704276,0.00034436912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013428566,0.00007863638,0.81960195,0.00020693621,0.00006816844,0.0025856865,0.00033927,0.00037662333,0.14249097,0.000059376827,0.00044267887,0.032406855],"study_design_scores_gemma":[0.00005044317,0.0011862108,0.8614718,0.00010801884,0.00019183544,0.013552863,0.0011840351,0.0049554133,0.11401209,0.00012436984,0.0031334157,0.000029429919],"about_ca_topic_score_codex":0.0022951683,"about_ca_topic_score_gemma":0.0020423585,"teacher_disagreement_score":0.0022951683,"about_ca_system_score_codex":0.00032562454,"about_ca_system_score_gemma":0.00035432115,"threshold_uncertainty_score":0.004563689},"labels":[],"label_agreement":null},{"id":"W4404305937","doi":"10.1158/1557-3265.liqbiop24-b070","title":"Abstract B070: Dissecting EV dynamics in the sequestration of doxorubicin from breast cancer cells","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Mass Spectrometry Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"","keywords":"Breast cancer; Doxorubicin; Medicine; Cancer; Cancer research; Internal medicine; Chemotherapy","score_opus":0.13826979921980034,"score_gpt":0.5184922660968538,"score_spread":0.3802224668770535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404305937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98274106,0.00092104817,0.011421241,0.00026877187,0.000060758808,0.00004861386,0.0006741306,0.00016737197,0.003696937],"genre_scores_gemma":[0.9732623,0.0010270854,0.01802485,0.0001536608,0.000018446412,0.000101875085,0.0008894559,0.000069782734,0.006452519],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999362,0.0000053082726,0.000004307902,0.000018790392,0.00002109588,0.000014247232],"domain_scores_gemma":[0.99994206,0.000015820773,0.0000102952945,0.000003942687,0.000016890119,0.000011029091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012504755,0.00018216432,0.00015331147,0.000147168,0.00023145106,0.00027473376,0.00014355934,0.00029850606,0.0018731019],"category_scores_gemma":[0.00009950821,0.0001046066,0.0001324556,0.0001234619,0.00014134625,0.00027112436,0.0001930964,0.0003919917,0.00069880515],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050356626,0.000013416944,0.0002813176,0.00002537544,0.0000017218902,0.00004903158,0.00002435278,0.00015426036,0.99783486,0.00016560662,0.00014908015,0.0012507775],"study_design_scores_gemma":[0.000010842124,0.00013854208,0.00615614,0.000011242459,0.000007344604,0.00018892263,0.00006527198,0.007575822,0.9820172,0.00016660077,0.003650975,0.000011020699],"about_ca_topic_score_codex":0.0009379873,"about_ca_topic_score_gemma":0.000805725,"teacher_disagreement_score":0.0018731019,"about_ca_system_score_codex":0.00033701866,"about_ca_system_score_gemma":0.00019501682,"threshold_uncertainty_score":0.0062661767},"labels":[],"label_agreement":null},{"id":"W4404305938","doi":"10.1158/1557-3265.liqbiop24-b013","title":"Abstract B013: An mDETECT assay for monitoring treatment response in metastatic breast cancer patients","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Medicine; Metastatic breast cancer; Breast cancer; Oncology; Cancer; Internal medicine","score_opus":0.19326708635712458,"score_gpt":0.5655350008236277,"score_spread":0.37226791446650315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404305938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93089336,0.009825649,0.014675827,0.0014914916,0.00026941887,0.000756115,0.023800436,0.0025379886,0.015749708],"genre_scores_gemma":[0.9497579,0.00083727826,0.023333738,0.0013365959,0.00010612625,0.00074056105,0.01485467,0.0001200762,0.00891312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987355,0.00038161245,0.000104850384,0.00021315803,0.0004807671,0.000084158026],"domain_scores_gemma":[0.9987016,0.0003546371,0.0002771188,0.00007861806,0.0004279974,0.00015997725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010707577,0.0004162883,0.0006741905,0.0016413991,0.00029119814,0.0007766825,0.00061398605,0.000812511,0.0039770366],"category_scores_gemma":[0.002709531,0.00031197746,0.00022729202,0.0011548118,0.00017218431,0.00025619494,0.00033534854,0.0008661106,0.0019394442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006079567,0.0007520692,0.71867603,0.00029717153,0.00018320484,0.00035847968,0.00018515946,0.0012329599,0.15174355,0.00035754772,0.019654304,0.10048005],"study_design_scores_gemma":[0.00047611172,0.004567622,0.8320766,0.00011856862,0.00020541699,0.0030168018,0.0001879555,0.012979151,0.11564177,0.00043656104,0.030198008,0.00009542742],"about_ca_topic_score_codex":0.0017845597,"about_ca_topic_score_gemma":0.0023695629,"teacher_disagreement_score":0.0039770366,"about_ca_system_score_codex":0.00071963004,"about_ca_system_score_gemma":0.0002727484,"threshold_uncertainty_score":0.013304472},"labels":[],"label_agreement":null},{"id":"W4404305959","doi":"10.1158/1557-3265.liqbiop24-b069","title":"Abstract B069: Spatial and single-cell proteomic landscaping of the hypoxic microenvironment in glioblastoma","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Glioblastoma; Tumor microenvironment; Cancer research; Hypoxia (environmental); Medicine; Biology; Pathology; Computational biology; Tumor cells; Chemistry","score_opus":0.05809141532808029,"score_gpt":0.37986134425617,"score_spread":0.32176992892808975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404305959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944411,0.0010991235,0.002277241,0.00007273847,0.000019554343,0.000024559622,0.0012366166,0.000044764052,0.0007843542],"genre_scores_gemma":[0.99388534,0.0007197545,0.0029406126,0.00004866943,0.000010877363,0.000030467707,0.0012951067,0.000010117703,0.0010590508],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999622,0.0000040560653,0.0000022728454,0.000009614097,0.000011693767,0.0000102181675],"domain_scores_gemma":[0.9999753,0.0000022549425,0.0000061178894,0.0000022104298,0.000005958362,0.000008110933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006794062,0.00013598705,0.00015439738,0.00023013362,0.0001323637,0.00020466415,0.00007939155,0.00012826575,0.0006192042],"category_scores_gemma":[0.00007436976,0.000066954126,0.00012387676,0.00016322905,0.00010153016,0.00009551806,0.00011656235,0.0001524107,0.0002662247],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015076679,0.00001514635,0.0012000728,0.000027009582,0.000004132659,0.000046683774,0.0000096683025,0.00005846334,0.9961344,0.000022875476,0.000076632634,0.0022540444],"study_design_scores_gemma":[0.000016168438,0.00061182765,0.147952,0.000011361802,0.00003736589,0.0013471734,0.00014302215,0.0030937258,0.84299034,0.00013251098,0.003649829,0.000014676071],"about_ca_topic_score_codex":0.00057537126,"about_ca_topic_score_gemma":0.0008126194,"teacher_disagreement_score":0.0006192042,"about_ca_system_score_codex":0.00012228392,"about_ca_system_score_gemma":0.00011015131,"threshold_uncertainty_score":0.0020714402},"labels":[],"label_agreement":null},{"id":"W4404305976","doi":"10.1158/1557-3265.liqbiop24-a008","title":"Abstract A008: Adaptive immune receptor repertoire characterization highlights the importance of interplay between B and T cells in disease progression","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Immune system; Disease; Repertoire; Biology; Immunology; Receptor; Medicine; Pathology; Genetics","score_opus":0.0642727596746989,"score_gpt":0.43419069465497795,"score_spread":0.36991793498027903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404305976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912464,0.0020576692,0.0033630757,0.00014860329,0.000017178392,0.00001833135,0.00059361215,0.00009646912,0.002458732],"genre_scores_gemma":[0.99568945,0.00035748372,0.002286708,0.000100688725,0.000021606604,0.000014432866,0.0005250035,0.000019269595,0.0009853893],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99980026,0.000042278276,0.0000176064,0.00005455574,0.00004689572,0.00003843971],"domain_scores_gemma":[0.9997142,0.00008315892,0.000063243526,0.00002972603,0.00006121436,0.000048386184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041095293,0.00017740903,0.00024435835,0.00074540253,0.00017216659,0.0005164034,0.00018437872,0.00028615454,0.004564131],"category_scores_gemma":[0.00046537918,0.000087417095,0.0001476663,0.0004039018,0.00018975613,0.00025248024,0.00026976396,0.00042218217,0.0010015768],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087645324,0.00007735219,0.072621174,0.00016449761,0.000028053926,0.0002343789,0.000092594884,0.00018529584,0.89355934,0.00012673285,0.000504646,0.03152959],"study_design_scores_gemma":[0.000058319634,0.001782328,0.69243616,0.00009190502,0.000119551194,0.0071175294,0.00037321608,0.003287376,0.28346056,0.00084007025,0.010408132,0.000024814015],"about_ca_topic_score_codex":0.00032523455,"about_ca_topic_score_gemma":0.00023365926,"teacher_disagreement_score":0.004564131,"about_ca_system_score_codex":0.00015063547,"about_ca_system_score_gemma":0.000100917045,"threshold_uncertainty_score":0.015268564},"labels":[],"label_agreement":null},{"id":"W4404306006","doi":"10.1158/1557-3265.liqbiop24-ia018","title":"Abstract IA018: Liquid biopsy in head and neck cancers: A model for tissue-agnostic MRD detection","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Head and neck; Medicine; Head and neck cancer; Biopsy; Liquid biopsy; Pathology; Radiology; Cancer; Surgery; Internal medicine","score_opus":0.38384814825591657,"score_gpt":0.5960689238606206,"score_spread":0.21222077560470404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404306006","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03570784,0.18539661,0.48037875,0.12061293,0.047034256,0.0018742544,0.0030531015,0.00798466,0.11795767],"genre_scores_gemma":[0.24452257,0.18636812,0.3371034,0.030636903,0.0131173665,0.0020583577,0.0030115503,0.001489724,0.18169197],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986714,0.00043389565,0.00006764014,0.00021852732,0.00050100224,0.00010759364],"domain_scores_gemma":[0.9986331,0.0004768784,0.00017456675,0.00013335481,0.0003747133,0.00020736938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002993377,0.0010300595,0.0008085088,0.0015203195,0.00056001055,0.0035920392,0.0020214403,0.0028554464,0.006734584],"category_scores_gemma":[0.0034870629,0.0006184083,0.00065881235,0.00090058695,0.0022603816,0.002609001,0.0017409017,0.0037782178,0.004535266],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011460534,0.00043409516,0.0044579,0.0024198683,0.00007867396,0.0023300957,0.00033428703,0.0043528434,0.1380431,0.082857355,0.2598704,0.5036753],"study_design_scores_gemma":[0.00015483219,0.0019633607,0.0049273195,0.0017058217,0.00014103697,0.0077076205,0.00046221097,0.02711718,0.09689758,0.052646186,0.8059831,0.0002936927],"about_ca_topic_score_codex":0.0015695564,"about_ca_topic_score_gemma":0.0016329591,"teacher_disagreement_score":0.006734584,"about_ca_system_score_codex":0.0021437858,"about_ca_system_score_gemma":0.0016949076,"threshold_uncertainty_score":0.022529423},"labels":[],"label_agreement":null},{"id":"W4404306062","doi":"10.1158/1557-3265.liqbiop24-b004","title":"Abstract B004: Biological insights into tissue-agnostic plasma cfDNA methylation signature for surveillance of head and neck tumor recurrence","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Head and neck; Head and neck cancer; Medicine; Methylation; DNA methylation; Pathology; Computational biology; Cancer; Internal medicine; Biology; Surgery; DNA; Genetics; Gene; Gene expression","score_opus":0.11003506870615119,"score_gpt":0.4808216580985556,"score_spread":0.3707865893924044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404306062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36811757,0.08680903,0.08378793,0.09735586,0.017535996,0.002350557,0.06476493,0.008541651,0.27073643],"genre_scores_gemma":[0.6498472,0.025727462,0.040905762,0.009337211,0.0046651512,0.00076130143,0.029691594,0.0009601512,0.23810412],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996081,0.000107068954,0.000017734566,0.00007361963,0.00015267194,0.000040872696],"domain_scores_gemma":[0.99954236,0.0001486837,0.000047490772,0.000029512054,0.00013918927,0.00009271067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001459845,0.0006436338,0.0004861166,0.0015771548,0.00039615238,0.0016158189,0.0005429661,0.00094855897,0.03471538],"category_scores_gemma":[0.0018450103,0.00028887595,0.0004456887,0.0005652129,0.00030771169,0.0005286756,0.00054996833,0.0011111817,0.007977184],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036932346,0.00034132102,0.014511468,0.0010556827,0.00013569635,0.00071091973,0.00014212848,0.0015457592,0.3652943,0.003910672,0.2779659,0.330693],"study_design_scores_gemma":[0.0007152826,0.0040934095,0.1217797,0.0005793759,0.0005661544,0.0037177093,0.00040508682,0.011040428,0.41540378,0.011525922,0.42994902,0.00022404754],"about_ca_topic_score_codex":0.0013585194,"about_ca_topic_score_gemma":0.0016882512,"teacher_disagreement_score":0.03471538,"about_ca_system_score_codex":0.0009800746,"about_ca_system_score_gemma":0.0010024704,"threshold_uncertainty_score":0.116134524},"labels":[],"label_agreement":null},{"id":"W4404374818","doi":"10.1158/1078-0432.ccr-24-1947","title":"Update on Pediatric Surveillance Recommendations for <i>PTEN</i> Hamartoma Tumor Syndrome, <i>DICER1-</i> Related Tumor Predisposition, and Tuberous Sclerosis Complex","year":2024,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Tuberous Sclerosis Complex Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre; Hospital for Sick Children; University of Toronto","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; Manchester Biomedical Research Centre; National Cancer Institute; National Institutes of Health; Department of Health and Social Care; National Institute for Health and Care Research","keywords":"PTEN; Tuberous sclerosis; Medicine; Multidisciplinary approach; Hamartoma; Genetic predisposition; Pediatrics; Oncology; Pathology; PI3K/AKT/mTOR pathway; Disease; Genetics; Biology","score_opus":0.4323668482449535,"score_gpt":0.539893201562797,"score_spread":0.10752635331784344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404374818","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002459492,0.9825973,0.0004462025,0.008035208,0.0020368285,0.000047577592,0.0007782893,0.00006788224,0.0057447194],"genre_scores_gemma":[0.0011182057,0.9899974,0.0012314066,0.0037736401,0.00088536047,0.0000644016,0.00095694425,0.000012053379,0.0019605565],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992055,0.00023282791,0.00019784833,0.00006185998,0.00025291505,0.000049038612],"domain_scores_gemma":[0.9971336,0.0012149089,0.00044388926,0.00004341546,0.0010322634,0.00013190862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017631248,0.00053055555,0.0010925828,0.0030805143,0.00029840422,0.0009942657,0.0010359994,0.0014493384,0.008922307],"category_scores_gemma":[0.0059694042,0.00031953945,0.0013271031,0.00241063,0.00027097244,0.001393564,0.0007002765,0.0019754374,0.0034723834],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006573992,0.000035416306,0.00051651633,0.01726731,0.0001344711,0.00025597797,0.000112204485,0.00019081509,0.000344423,0.0024906688,0.27301183,0.7055745],"study_design_scores_gemma":[0.000024307523,0.000028230183,0.0010710076,0.015641756,0.00024246509,0.00084061583,0.00005558829,0.000035019795,0.00009669045,0.000620895,0.98132986,0.000013539591],"about_ca_topic_score_codex":0.004160952,"about_ca_topic_score_gemma":0.007887886,"teacher_disagreement_score":0.008922307,"about_ca_system_score_codex":0.0010594941,"about_ca_system_score_gemma":0.0029649634,"threshold_uncertainty_score":0.029848099},"labels":[],"label_agreement":null},{"id":"W4404395566","doi":"10.1158/1078-0432.ccr-24-2983","title":"Divergent Clinical and Immunologic Outcomes Based on <i>STK11</i> Co-mutation Status in Resectable <i>KRAS-</i> Mutant Lung Cancers Following Neoadjuvant Immune Checkpoint Blockade","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McGill University; McGill University Health Centre","funders":"Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University; Swim Across America; American Lung Association; Mark Foundation For Cancer Research; Bristol-Myers Squibb; LUNGevity Foundation; National Cancer Institute; National Institutes of Health; Conquer Cancer Foundation","keywords":"KRAS; Immune checkpoint; Medicine; Lung cancer; Cancer research; Oncology; Context (archaeology); Cancer; Immunotherapy; Neoadjuvant therapy; Internal medicine; STK11; Biology; Colorectal cancer; Breast cancer","score_opus":0.1293539012176479,"score_gpt":0.506675577321772,"score_spread":0.37732167610412415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404395566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995436,0.00009298537,0.00006823397,0.000010714043,0.0000027022488,0.000008934222,0.00008363756,0.0000036731383,0.00018540962],"genre_scores_gemma":[0.99950135,0.00004784613,0.000063626685,0.000017911523,0.000002436986,0.000014654219,0.00021420767,0.0000018160886,0.0001361396],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998574,0.000020963624,0.0000134035845,0.00003763472,0.000032879536,0.000037660713],"domain_scores_gemma":[0.9998154,0.00002875165,0.00006914088,0.000011678722,0.000016635577,0.000058434165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017301427,0.00014553595,0.00023967157,0.0001911466,0.000121487654,0.00028556693,0.000094570045,0.00018549881,0.0008132069],"category_scores_gemma":[0.00021048854,0.000075596814,0.0001507398,0.00014367438,0.0002526358,0.00014988742,0.0001548106,0.00033192037,0.00016488518],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006644625,0.00033905572,0.14725621,0.00007862447,0.00005754473,0.00033331453,0.0001292728,0.00037583272,0.8349363,0.000049815822,0.00017236448,0.00962694],"study_design_scores_gemma":[0.00006745351,0.0053241835,0.8857082,0.000010366412,0.0001034184,0.0015658416,0.00032267516,0.0013182381,0.10465282,0.00008194687,0.0008308678,0.000014021475],"about_ca_topic_score_codex":0.00018168018,"about_ca_topic_score_gemma":0.00042363288,"teacher_disagreement_score":0.0008132069,"about_ca_system_score_codex":0.00021683618,"about_ca_system_score_gemma":0.00013045681,"threshold_uncertainty_score":0.0027204752},"labels":[],"label_agreement":null},{"id":"W4404636870","doi":"10.1158/1078-0432.ccr-24-2582","title":"Early Hepatic Decompensation Identifies Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab or Sorafenib at Highest Risk of Death","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital","funders":"","keywords":"Medicine; Internal medicine; Hepatocellular carcinoma; Decompensation; Sorafenib; Bevacizumab; Hazard ratio; Gastroenterology; Cumulative incidence; Cirrhosis; Atezolizumab; Lenvatinib; Incidence (geometry); Hepatic encephalopathy; Proportional hazards model; Oncology; Cancer; Chemotherapy; Confidence interval; Cohort; Immunotherapy","score_opus":0.18040252179863495,"score_gpt":0.39883108197148526,"score_spread":0.2184285601728503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404636870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99905366,0.00045643415,0.00014401716,0.0000455519,0.000004575446,0.0000050407484,0.00007327433,0.0000044782364,0.00021307936],"genre_scores_gemma":[0.99957985,0.00007449769,0.00009612222,0.000012293438,0.0000110649125,0.0000023247815,0.00015882976,0.0000010828387,0.00006383749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980026,0.00007214529,0.000018761373,0.000039695333,0.00003224516,0.000036935533],"domain_scores_gemma":[0.9985268,0.00036035772,0.0007099848,0.00006258986,0.00007340028,0.00026671443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050532504,0.00023223757,0.00042104596,0.00036418572,0.00014141593,0.00039966297,0.00017655532,0.00027011812,0.0011834207],"category_scores_gemma":[0.0014756521,0.00010617393,0.0005134705,0.00033261665,0.00017334057,0.00025632686,0.00029327415,0.00046995835,0.00012796865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017570923,0.00006071517,0.9912243,0.000020329513,0.0000977755,0.00010842659,0.000017846261,0.00021792388,0.00097513845,0.000015359283,0.000084279876,0.005420852],"study_design_scores_gemma":[0.00007021124,0.0004968683,0.99653167,0.000009468986,0.00014585558,0.00062099774,0.000047467354,0.0014956001,0.00034363518,0.000056561494,0.0001759448,0.0000057764955],"about_ca_topic_score_codex":0.00062862167,"about_ca_topic_score_gemma":0.0013368216,"teacher_disagreement_score":0.0011834207,"about_ca_system_score_codex":0.00019134827,"about_ca_system_score_gemma":0.00030846626,"threshold_uncertainty_score":0.0039589405},"labels":[],"label_agreement":null},{"id":"W4404637171","doi":"10.1158/1078-0432.ccr-24-0841","title":"Phase Ib Pharmacodynamic Study of the MNK Inhibitor Tomivosertib (eFT508) Combined With Paclitaxel in Patients With Refractory Metastatic Breast Cancer","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McGill University; University of British Columbia; Canada's Michael Smith Genome Sciences Centre; University of British Columbia Hospital; University of Alberta; Ontario Institute for Cancer Research; BC Cancer Agency; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Stand Up To Cancer Canada","keywords":"Paclitaxel; Medicine; Breast cancer; Metastatic breast cancer; Pharmacodynamics; Cancer; Pharmacokinetics; Pharmacology; Clinical trial; Refractory (planetary science); Oncology; Internal medicine; Cancer research; Biology","score_opus":0.0711306112331,"score_gpt":0.4781960152094174,"score_spread":0.4070654039763174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404637171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944945,0.0011392656,0.0005332979,0.00034617572,0.000066560184,0.0013822061,0.00066913286,0.00008733432,0.0012815682],"genre_scores_gemma":[0.99436355,0.00069535786,0.0010470024,0.00036573905,0.00008181983,0.0011749349,0.0011006495,0.000023053884,0.0011479058],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99971277,0.00011295949,0.00001675426,0.000048654027,0.000034758734,0.00007395838],"domain_scores_gemma":[0.9997229,0.000032249336,0.000069601265,0.00003068409,0.000023349792,0.00012113846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066395075,0.0010358667,0.0015346959,0.00041841978,0.0003971624,0.0008475028,0.00060920685,0.0010071151,0.002426398],"category_scores_gemma":[0.00063398614,0.00045996945,0.00073005795,0.0004426128,0.00062694843,0.00065238983,0.00022238052,0.002339676,0.0006653481],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48383653,0.124842346,0.01101572,0.00089377875,0.0014133222,0.000467125,0.00032637367,0.0067557744,0.20076331,0.0004703323,0.0052376096,0.16397773],"study_design_scores_gemma":[0.26558855,0.6703482,0.022712097,0.00005380458,0.0006103915,0.00093613256,0.000116152514,0.0035737038,0.030949079,0.00031613,0.0047323387,0.00006337468],"about_ca_topic_score_codex":0.0010242523,"about_ca_topic_score_gemma":0.0026513215,"teacher_disagreement_score":0.002426398,"about_ca_system_score_codex":0.0012857022,"about_ca_system_score_gemma":0.0012377694,"threshold_uncertainty_score":0.009328485},"labels":[],"label_agreement":null},{"id":"W4404749160","doi":"10.1158/1078-0432.ccr-24-2061","title":"Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer Biopsies","year":2024,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"DOD Prostate Cancer Research Program; National Cancer Institute; Genentech; National Institutes of Health; Astellas Pharma; Institute for Prostate Cancer Research; Celgene; U.S. Department of Defense; Sanofi; Prostate Cancer Foundation; Eli Lilly and Company; Bristol-Myers Squibb; Pfizer; V Foundation for Cancer Research; Intuitive Surgical; Doris Duke Charitable Foundation; Amgen","keywords":"Prostate cancer; Neuroendocrine differentiation; Medicine; Adenocarcinoma; Pathology; Context (archaeology); Enzalutamide; Prostate; Androgen deprivation therapy; Androgen receptor; Chromogranin A; Lineage markers; Neuroendocrine tumors; Synaptophysin; Cancer; Immunohistochemistry; Cancer research; Phenotype; Internal medicine; Biology","score_opus":0.6165722208737369,"score_gpt":0.6663704275781906,"score_spread":0.049798206704453785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404749160","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015922256,0.98642147,0.0029943867,0.0047649615,0.0014763344,0.000121608864,0.00018002525,0.00006696431,0.0038151206],"genre_scores_gemma":[0.003435357,0.9762215,0.011961587,0.004110419,0.0015552809,0.00024665974,0.0004947053,0.000022332006,0.0019521001],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980628,0.000665642,0.00038833695,0.00023124815,0.0005663536,0.00008566943],"domain_scores_gemma":[0.9963477,0.001282393,0.00049904396,0.00014856143,0.0015478655,0.00017434674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047251116,0.0016831148,0.0019785564,0.005331525,0.0005001251,0.0022045309,0.002622815,0.0024727702,0.004391659],"category_scores_gemma":[0.0053313784,0.0005869256,0.0015414057,0.002354739,0.0014804285,0.0023382818,0.0013870992,0.004257432,0.0037340613],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010105986,0.000085559324,0.00053415966,0.032499846,0.00019125864,0.00044629182,0.0001728908,0.00078553386,0.0011330072,0.023175279,0.08755259,0.8533224],"study_design_scores_gemma":[0.000027699507,0.0000895052,0.0017709893,0.032575116,0.00027370782,0.0021145702,0.00013355163,0.00030925783,0.00036480022,0.00831733,0.9539792,0.00004433259],"about_ca_topic_score_codex":0.003939235,"about_ca_topic_score_gemma":0.005261284,"teacher_disagreement_score":0.005331525,"about_ca_system_score_codex":0.0028134743,"about_ca_system_score_gemma":0.0054752664,"threshold_uncertainty_score":0.024989069},"labels":[],"label_agreement":null},{"id":"W4404756545","doi":"10.1158/1078-0432.ccr-24-2171","title":"Update on Cancer Screening in Children with Syndromes of Bone Lesions, Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome, and Other Rare Syndromes","year":2024,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; National Institutes of Health; National Institute for Health and Care Research; Canadian Imperial Bank of Commerce; Manchester Biomedical Research Centre; American Association for Cancer Research","keywords":"Medicine; Cancer; Pathology; Renal cell carcinoma; Leiomyoma; Internal medicine","score_opus":0.24163367179375494,"score_gpt":0.4943200126923375,"score_spread":0.25268634089858255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404756545","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037942198,0.903707,0.0025537221,0.029396884,0.016445981,0.00025286464,0.0031642558,0.00044782602,0.04023724],"genre_scores_gemma":[0.011589535,0.9119967,0.006414911,0.025904227,0.023322096,0.00031504067,0.006890312,0.000086502776,0.013480627],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993339,0.00017046431,0.00014215389,0.00006351522,0.00023543467,0.000054589975],"domain_scores_gemma":[0.9970868,0.001056984,0.00032431027,0.00004379207,0.001249952,0.00023824794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008280918,0.0006383537,0.000932457,0.0029273287,0.00028744515,0.000777139,0.0007518206,0.0015507421,0.0067308974],"category_scores_gemma":[0.0044435547,0.00029834875,0.00097153033,0.0014442441,0.00020212424,0.0010698814,0.00064227346,0.0020304702,0.0023125426],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107793465,0.00008517192,0.002699974,0.004305729,0.00014344534,0.0008237849,0.0001047305,0.00039887067,0.0006081704,0.00075952744,0.4563641,0.53359866],"study_design_scores_gemma":[0.0000534599,0.00010463228,0.008035525,0.008513414,0.00034652374,0.0047427574,0.00010018342,0.00019634874,0.00022083495,0.0006064939,0.9770472,0.000032721447],"about_ca_topic_score_codex":0.006509199,"about_ca_topic_score_gemma":0.012937931,"teacher_disagreement_score":0.0067308974,"about_ca_system_score_codex":0.0010313075,"about_ca_system_score_gemma":0.0010128509,"threshold_uncertainty_score":0.022517025},"labels":[],"label_agreement":null},{"id":"W4404958353","doi":"10.1158/1078-0432.ccr-24-0581","title":"Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Western University; BC Children's Hospital; Nova Scotia Health Authority; Montreal Children's Hospital; Izaak Walton Killam Health Centre; Hospital for Sick Children; London Health Sciences Centre; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Cancer Institute","keywords":"Trk receptor; Medicine; Central nervous system; Glioma; Internal medicine; Retrospective cohort study; Oncology; Cohort; Histology; Pathology; Cancer research; Neurotrophin; Receptor","score_opus":0.20912988148926817,"score_gpt":0.5262566743083362,"score_spread":0.3171267928190681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404958353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99940467,0.000100830104,0.0000234175,0.000010028544,0.0000019663298,0.0000030670622,0.00024631686,0.0000012421158,0.00020835298],"genre_scores_gemma":[0.99944645,0.000039935265,0.000014474289,0.000005348831,0.0000035513656,0.0000038123342,0.00042972204,9.767689e-7,0.000055768694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998054,0.000029295374,0.000027322258,0.000051066854,0.000037429887,0.000049561677],"domain_scores_gemma":[0.99894637,0.00015385199,0.0005542907,0.00004465587,0.0000816674,0.00021913393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028620881,0.00018373202,0.00024335625,0.0004358235,0.00023250032,0.00033167997,0.0002007412,0.00024847305,0.0013077111],"category_scores_gemma":[0.0011897786,0.00010012127,0.00022607303,0.0005136428,0.00022118723,0.00030028407,0.00024530492,0.00027788998,0.00025500424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019632906,0.000018746048,0.99826163,0.0000047445365,0.000017153196,0.00023214832,0.00001913995,0.000043876385,0.0003274116,0.000008508226,0.000060544033,0.0008097253],"study_design_scores_gemma":[0.000010217787,0.00013878517,0.99795014,0.0000030340855,0.000014070322,0.0014803667,0.00006484587,0.00009160821,0.00011668029,0.00001508702,0.00011234836,0.0000028495313],"about_ca_topic_score_codex":0.0011129376,"about_ca_topic_score_gemma":0.0013382515,"teacher_disagreement_score":0.0013077111,"about_ca_system_score_codex":0.00027134523,"about_ca_system_score_gemma":0.00022356512,"threshold_uncertainty_score":0.004374802},"labels":[],"label_agreement":null},{"id":"W4404959524","doi":"10.1158/1078-0432.ccr-24-2469","title":"The Society for Immunotherapy of Cancer Perspective on Tissue-Based Technologies for Immuno-Oncology Biomarker Discovery and Application","year":2024,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada); McGill University; Jewish General Hospital","funders":"National Cancer Institute","keywords":"Immunotherapy; Cancer; Medicine; Biomarker; Cancer immunotherapy; Precision oncology; Oncology; Biomarker discovery; Clinical Oncology; Perspective (graphical); Cancer research; Internal medicine; Biology; Computer science; Proteomics","score_opus":0.29019097892027956,"score_gpt":0.6372890486359728,"score_spread":0.34709806971569324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404959524","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011989894,0.9717755,0.00059681194,0.01141834,0.009934669,0.000027832297,0.00006210436,0.00004592071,0.0060190335],"genre_scores_gemma":[0.0010959051,0.9770129,0.0012073681,0.010534353,0.004018307,0.000045121385,0.000094034585,0.000013860792,0.005978203],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990934,0.00019411714,0.00010589515,0.000113371134,0.0003883619,0.00010485016],"domain_scores_gemma":[0.9977621,0.0008187668,0.00018999999,0.00007314067,0.0008846777,0.00027135716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031235132,0.0010865078,0.0011092885,0.0026438248,0.00045828187,0.0025895406,0.0012123724,0.0033894547,0.005036971],"category_scores_gemma":[0.002398834,0.00033177424,0.0010256832,0.003007198,0.001277747,0.0034137068,0.0015038349,0.009887163,0.0053428174],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009513153,0.00008991056,0.00014186837,0.00485737,0.00006088795,0.00015467798,0.000061815306,0.0002765861,0.0019507059,0.018424204,0.28492728,0.6889595],"study_design_scores_gemma":[0.000011317178,0.0000518712,0.00012173091,0.0008875005,0.000017777138,0.00019607355,0.000011981388,0.000034949375,0.00016197364,0.0014091565,0.99708897,0.0000068311256],"about_ca_topic_score_codex":0.0012853764,"about_ca_topic_score_gemma":0.002797465,"teacher_disagreement_score":0.005036971,"about_ca_system_score_codex":0.001818382,"about_ca_system_score_gemma":0.0040365607,"threshold_uncertainty_score":0.016850352},"labels":[],"label_agreement":null},{"id":"W4405234144","doi":"10.1158/1078-0432.ccr-24-2334","title":"Association between Locoregional Failure and <i>NFE2L2/KEAP1/CUL3</i> Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hamilton Health Sciences; Juravinski Cancer Centre","funders":"National Institute of Dental and Craniofacial Research; National Cancer Institute","keywords":"Medicine; Randomized controlled trial; Cancer; Oncology; Internal medicine","score_opus":0.1768726517848916,"score_gpt":0.5444452930986137,"score_spread":0.3675726413137221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405234144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968046,0.0018227709,0.00016417904,0.00010363949,0.000034369685,0.00047783088,0.00021675334,0.000016062679,0.00035975367],"genre_scores_gemma":[0.99864644,0.00026874672,0.00021695762,0.00013499087,0.00003931831,0.00022971789,0.00027403582,0.000004163169,0.00018574418],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979962,0.0011361394,0.00017118544,0.00040206622,0.00015726307,0.00013712203],"domain_scores_gemma":[0.9984616,0.0004096558,0.0005391412,0.0001643245,0.0000623376,0.0003628209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034294948,0.00071287964,0.0015570734,0.00022208176,0.0002845296,0.0006476389,0.00081574713,0.00085742836,0.002340637],"category_scores_gemma":[0.0021998063,0.00037993758,0.0014735282,0.0003300023,0.0010093143,0.00037976776,0.00031924408,0.0011230716,0.0002886037],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9188382,0.003404498,0.03725831,0.00055953884,0.0021314144,0.00007188778,0.0000987688,0.000858758,0.0066599487,0.00007961259,0.0005556556,0.029483324],"study_design_scores_gemma":[0.48750082,0.3705539,0.1277948,0.00012030691,0.0046231854,0.00050886115,0.00012406513,0.0019385911,0.004347768,0.0002350409,0.0021955983,0.000056962654],"about_ca_topic_score_codex":0.0010755786,"about_ca_topic_score_gemma":0.0022228612,"teacher_disagreement_score":0.0034294948,"about_ca_system_score_codex":0.0011823947,"about_ca_system_score_gemma":0.0009321047,"threshold_uncertainty_score":0.018137097},"labels":[],"label_agreement":null},{"id":"W4405319343","doi":"10.1158/1078-0432.ccr-24-2523","title":"Sacituzumab Govitecan in Patients with Relapsed/Refractory Advanced Head and Neck Squamous Cell Carcinoma: Results from the Phase II TROPiCS-03 Basket Study","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Gilead Sciences","keywords":"Medicine; Internal medicine; Neutropenia; Mucositis; Adverse effect; Nausea; Phases of clinical research; Head and neck squamous-cell carcinoma; Febrile neutropenia; Surgery; Clinical endpoint; Oncology; Chemotherapy; Gastroenterology; Head and neck cancer; Cancer; Clinical trial","score_opus":0.1086492114854232,"score_gpt":0.4598629325768382,"score_spread":0.351213721091415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405319343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941241,0.0032399886,0.00015665454,0.00023751262,0.00003307932,0.00048856065,0.0008390253,0.00003597602,0.0008451089],"genre_scores_gemma":[0.99140525,0.0027682763,0.0006330534,0.0006695658,0.000105949184,0.000521091,0.0031159804,0.000022891232,0.000757923],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996393,0.00016737658,0.000027132648,0.000051749776,0.000055223318,0.000059199323],"domain_scores_gemma":[0.999424,0.00009098868,0.00015941195,0.00004229196,0.000051807852,0.00023153063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018709529,0.0009218024,0.0016503023,0.00030792766,0.00025964226,0.00089605135,0.0007079965,0.00067671493,0.0013436025],"category_scores_gemma":[0.0008343553,0.00031420452,0.0012087806,0.00054899754,0.00052070286,0.00068281806,0.0003108389,0.0014930981,0.00042942518],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58534867,0.032969363,0.08323441,0.0013801815,0.0043136454,0.00062690215,0.0007316522,0.0047504255,0.047387876,0.00027095285,0.010827628,0.22815828],"study_design_scores_gemma":[0.54188615,0.2985256,0.14032653,0.00015179972,0.0025641571,0.0010809834,0.0002681955,0.0031859726,0.004812589,0.00027845358,0.006852996,0.00006650353],"about_ca_topic_score_codex":0.0022419803,"about_ca_topic_score_gemma":0.006794551,"teacher_disagreement_score":0.0022419803,"about_ca_system_score_codex":0.0010409139,"about_ca_system_score_gemma":0.0014050866,"threshold_uncertainty_score":0.009894729},"labels":[],"label_agreement":null},{"id":"W4405368058","doi":"10.1158/1078-0432.ccr-24-0439","title":"Phase 1/2 Study of the Indoleamine 2,3-Dioxygenase 1 Inhibitor Linrodostat Mesylate Combined with Nivolumab or Nivolumab and Ipilimumab in Advanced Solid Tumors or Hematologic Malignancies","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; University Health Network; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Nivolumab; Ipilimumab; Medicine; Pharmacodynamics; Adverse effect; Mesylate; Internal medicine; Pharmacology; Oncology; Pharmacokinetics; Melanoma; Cancer; Immunotherapy; Cancer research; Chemistry","score_opus":0.16615465021824888,"score_gpt":0.47784201619372335,"score_spread":0.3116873659754745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405368058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958697,0.0007541786,0.0003444741,0.0001934052,0.00006153838,0.0015410912,0.00036849987,0.00004791147,0.00081910845],"genre_scores_gemma":[0.9901952,0.0010963654,0.0021687269,0.0006356093,0.00014861695,0.0021928938,0.0013982317,0.00002576165,0.0021386296],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99959165,0.00020418304,0.000018184306,0.0000707625,0.000047095305,0.00006814828],"domain_scores_gemma":[0.9995395,0.0000537771,0.00011886724,0.000039360304,0.000024401503,0.00022400438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012416696,0.0017936016,0.0016924903,0.0004082783,0.000344737,0.0007901784,0.0008047344,0.000959197,0.0023850005],"category_scores_gemma":[0.0005248469,0.0007067126,0.000991162,0.00032435977,0.00085360993,0.00071384263,0.0002785316,0.0027502272,0.0006053702],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5552556,0.19013578,0.011882303,0.0008277959,0.0015086537,0.00045344204,0.0003124592,0.0035635924,0.14518303,0.0003761282,0.0036066254,0.08689466],"study_design_scores_gemma":[0.43039215,0.541757,0.010078422,0.000028282631,0.00045494182,0.00038308956,0.00004900923,0.0013439113,0.012636547,0.00013495154,0.0027139809,0.000027719887],"about_ca_topic_score_codex":0.00067327777,"about_ca_topic_score_gemma":0.0020127466,"teacher_disagreement_score":0.0023850005,"about_ca_system_score_codex":0.00090280746,"about_ca_system_score_gemma":0.0016428322,"threshold_uncertainty_score":0.007978559},"labels":[],"label_agreement":null},{"id":"W4405368113","doi":"10.1158/1078-0432.ccr-24-1779","title":"Complete Remissions of HER2-Positive Trastuzumab-Resistant Xenografts Using a Potent [225Ac]Ac-Labeled Anti-HER2 Antibody–Drug Radioconjugate","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital; Canadian Nuclear Laboratories; University of Saskatchewan; Saskatoon Medical Imaging; Université Laval; Centre hospitalier de l'Université Laval; Hôtel-Dieu de Québec","funders":"Canadian Institutes of Health Research","keywords":"Trastuzumab; Biodistribution; Medicine; Pharmacology; Cancer; Internal medicine; Breast cancer; Chemistry; In vitro","score_opus":0.32613720757807146,"score_gpt":0.588059894922568,"score_spread":0.2619226873444966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405368113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953811,0.001178725,0.0012573437,0.00007838583,0.000026810301,0.000063456195,0.00023250637,0.00010317172,0.0016783765],"genre_scores_gemma":[0.9973826,0.0004118193,0.0004316535,0.000035464072,0.000007770002,0.000023228402,0.0003406287,0.000013133938,0.0013537203],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993,0.0000073932456,0.0000049477485,0.000013440079,0.00002120552,0.000022972275],"domain_scores_gemma":[0.999943,0.0000065830714,0.000013740831,0.000012736036,0.0000043954833,0.000019542664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014025431,0.00021193386,0.00030636837,0.00012165518,0.00012755019,0.00021404709,0.00018967726,0.00018970149,0.00071843906],"category_scores_gemma":[0.00008090852,0.00008793563,0.00015696096,0.00010567456,0.00011005903,0.00015929664,0.000101743,0.000461853,0.00017433676],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010280163,0.00055786804,0.0008854835,0.000081664504,0.000042232212,0.00015907292,0.000051834468,0.0007588865,0.9813968,0.00016434015,0.0005575006,0.014316325],"study_design_scores_gemma":[0.000655998,0.011426812,0.0136370845,0.000010891823,0.00009926338,0.001335536,0.0000469129,0.0030330683,0.9607827,0.00008730347,0.008872894,0.000011421957],"about_ca_topic_score_codex":0.00068900426,"about_ca_topic_score_gemma":0.0010077299,"teacher_disagreement_score":0.00071843906,"about_ca_system_score_codex":0.00028913165,"about_ca_system_score_gemma":0.00017489537,"threshold_uncertainty_score":0.002403438},"labels":[],"label_agreement":null},{"id":"W4405424757","doi":"10.1158/1078-0432.ccr-24-2200","title":"HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; National Institutes of Health; Swim Across America","keywords":"Gemcitabine; HMGA2; Pancreatic cancer; Oncology; Internal medicine; Medicine; Immunohistochemistry; Mesothelin; Cohort; Pathology; Cancer research; Chemotherapy; Biology; Cancer","score_opus":0.22268691232988727,"score_gpt":0.465861301035083,"score_spread":0.24317438870519573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405424757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987649,0.00039745585,0.00017344933,0.000027343689,0.0000034241225,0.00000500826,0.00043686698,0.0000066565417,0.00018492626],"genre_scores_gemma":[0.9986357,0.0001565449,0.0001814059,0.000023132892,0.00000637191,0.0000071838076,0.00082848436,0.000003767219,0.00015737404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987054,0.000022813329,0.000014326462,0.000049568975,0.00002408456,0.00001873528],"domain_scores_gemma":[0.99975556,0.000047566857,0.000077762474,0.000031881988,0.000027846525,0.000059410733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035964782,0.00015358349,0.00028020242,0.0004000535,0.00021643363,0.0005479674,0.00019028573,0.00023009325,0.00093418395],"category_scores_gemma":[0.0006115877,0.000101595055,0.00026704633,0.0003660844,0.00017453486,0.00017583674,0.0003145273,0.00024434555,0.00023475723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042418868,0.000015898444,0.9900898,0.000020991933,0.00006468289,0.00005687732,0.000036400612,0.00010529031,0.0057877293,0.000013901535,0.00008551262,0.0032986985],"study_design_scores_gemma":[0.000012747295,0.00007741546,0.99603087,0.000010044291,0.00008824183,0.00046842606,0.00014796383,0.0007239839,0.0018617276,0.00007591687,0.0004988819,0.0000037650616],"about_ca_topic_score_codex":0.0011670986,"about_ca_topic_score_gemma":0.0019631183,"teacher_disagreement_score":0.0011670986,"about_ca_system_score_codex":0.00021419939,"about_ca_system_score_gemma":0.00018135963,"threshold_uncertainty_score":0.0031251311},"labels":[],"label_agreement":null},{"id":"W4405803075","doi":"10.1158/1078-0432.ccr-24-2729","title":"Challenges to Innovation Arising from Current Companion Diagnostic Regulations and Suggestions for Improvements","year":2024,"lang":"en","type":"editorial","venue":"Clinical Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Astellas Pharma; Regeneron Pharmaceuticals; International Association for the Study of Lung Cancer; Eisai; Daiichi Sankyo Europe; Sanofi; Genentech; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer","keywords":"Flexibility (engineering); Companion diagnostic; Risk analysis (engineering); Diagnostic test; Quality (philosophy); Consistency (knowledge bases); Medicine; Clinical trial; Diagnostic accuracy; Unintended consequences; Medical physics; Precision medicine; New product development; Business; Computer science; Marketing; Pathology; Cancer","score_opus":0.16174615951432111,"score_gpt":0.5629987054769863,"score_spread":0.40125254596266513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405803075","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006639211,0.013187854,0.00078733516,0.20027718,0.78273064,0.000021963475,0.000027285956,0.00014118484,0.0027602518],"genre_scores_gemma":[0.0011264785,0.014271048,0.0010812735,0.10707915,0.8624329,0.000039877894,0.00002903487,0.000081923754,0.01385829],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9866088,0.0026209978,0.0014358336,0.0013571176,0.0073483554,0.0006289345],"domain_scores_gemma":[0.9152128,0.048322022,0.0029815587,0.002244781,0.024309449,0.0069294004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027519958,0.0027654527,0.002127541,0.00249322,0.003875159,0.012962752,0.0046173898,0.024108885,0.008998567],"category_scores_gemma":[0.07220904,0.0010156024,0.0023665505,0.0014599034,0.007501537,0.013722017,0.002616026,0.0380161,0.0064472686],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024686187,0.000017019238,0.00002255433,0.0002689298,0.000013711397,0.0001761303,0.00006517735,0.00007803795,0.00008852739,0.004969227,0.9806991,0.013576822],"study_design_scores_gemma":[0.000026133303,0.000020492887,0.00006491729,0.00031135674,0.000019315929,0.0002167334,0.00010396949,0.00017665814,0.000093212846,0.0083136335,0.99063,0.000023687326],"about_ca_topic_score_codex":0.0015891811,"about_ca_topic_score_gemma":0.0036407108,"teacher_disagreement_score":0.027519958,"about_ca_system_score_codex":0.0050000846,"about_ca_system_score_gemma":0.0074074552,"threshold_uncertainty_score":0.14554119},"labels":[],"label_agreement":null},{"id":"W4406229659","doi":"10.1158/1078-0432.ccr-24-3472","title":"Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Association of Medical Oncologists; Canadian Cancer Society Research Institute; EMD Serono; Genentech; Astellas Pharma; Break Through Cancer; Celgene; Symphogen; Bristol-Myers Squibb; AstraZeneca; Princess Margaret Cancer Foundation; Amgen; Pfizer; Agios Pharmaceuticals; GlaxoSmithKline","keywords":"Circulating tumor DNA; Breast cancer; Medicine; Internal medicine; Oncology; Cancer; Stage (stratigraphy); Carcinogenesis; Biology","score_opus":0.08430180109231573,"score_gpt":0.4622361139770893,"score_spread":0.3779343128847736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406229659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99848014,0.00073173456,0.00043525532,0.000012781944,0.0000036193787,0.000012912132,0.00014801919,0.000008291678,0.0001673398],"genre_scores_gemma":[0.99905974,0.00016692241,0.000497982,0.00001223684,0.00000477771,0.000010184275,0.00015906355,0.0000015010322,0.00008768588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958307,0.00011194424,0.00003896463,0.00011597752,0.000115074545,0.00003493693],"domain_scores_gemma":[0.9989158,0.00033363525,0.0004936145,0.00007649484,0.00009834982,0.00008214599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006217779,0.0002060025,0.00025632346,0.00052526285,0.00012280403,0.00036018068,0.00026019142,0.0002693484,0.0005338798],"category_scores_gemma":[0.0019711496,0.00017990805,0.000110493325,0.0004952795,0.00027485346,0.00020067442,0.00022181637,0.00024708535,0.00017505667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016547876,0.000107333355,0.96030784,0.00008399614,0.000045993875,0.00015754414,0.000090677466,0.00031275506,0.023790125,0.00003040056,0.000094027084,0.013324494],"study_design_scores_gemma":[0.00006706843,0.0019478502,0.96975416,0.000020984524,0.000097623364,0.0031103308,0.00012957005,0.0019844589,0.021917328,0.00010322288,0.0008527351,0.0000147080455],"about_ca_topic_score_codex":0.0005306883,"about_ca_topic_score_gemma":0.00083216355,"teacher_disagreement_score":0.0006217779,"about_ca_system_score_codex":0.0002312448,"about_ca_system_score_gemma":0.00019573684,"threshold_uncertainty_score":0.0032883286},"labels":[],"label_agreement":null},{"id":"W4406529540","doi":"10.1158/1078-0432.ccr-24-3460","title":"Development, Review, and Activation of Thoracic Oncology Investigator-Initiated Trials","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Clinical trial; Oncology; Internal medicine; Medical physics","score_opus":0.9229359243482055,"score_gpt":0.7965946298669643,"score_spread":0.1263412944812412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406529540","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6521219,0.19262323,0.036743984,0.017860651,0.004274151,0.052113518,0.0056398665,0.0005405761,0.038082104],"genre_scores_gemma":[0.8948909,0.029181007,0.04442896,0.0030242382,0.002868357,0.019744242,0.002429944,0.0001722097,0.0032601524],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.6590818,0.27627772,0.025313232,0.00833876,0.02842183,0.00256667],"domain_scores_gemma":[0.36808613,0.30904213,0.2081298,0.03269586,0.06545921,0.016586818],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.2575695,0.00070474943,0.0013789389,0.004756477,0.0011398293,0.0057257903,0.0020821781,0.001659221,0.003300056],"category_scores_gemma":[0.40181267,0.00068692386,0.0011695331,0.003821208,0.0018142315,0.0035106658,0.002163108,0.0016593941,0.0014566372],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018854003,0.00197518,0.2869816,0.027372045,0.001700774,0.0011083477,0.004107715,0.0015741729,0.005819715,0.008814631,0.033392046,0.6082998],"study_design_scores_gemma":[0.014330309,0.031835835,0.50807494,0.025718853,0.00432119,0.005642504,0.004749139,0.0067974054,0.020518545,0.009453882,0.3680882,0.0004692415],"about_ca_topic_score_codex":0.00032621674,"about_ca_topic_score_gemma":0.00072103966,"teacher_disagreement_score":0.2575695,"about_ca_system_score_codex":0.0030324503,"about_ca_system_score_gemma":0.022084735,"threshold_uncertainty_score":0.915549},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W4406665586","doi":"10.1158/1078-0432.ccr-24-2753","title":"Population Pharmacokinetics of Orvacabtagene Autoleucel, an Autologous BCMA-Directed Chimeric Antigen Receptor T-cell Product, in Patients with Relapsed/Refractory Multiple Myeloma","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aurinia (Canada)","funders":"","keywords":"Multiple myeloma; Cmax; Population; Medicine; Pharmacokinetics; Oncology; Immunology; Pharmacology; Internal medicine","score_opus":0.08116083786380267,"score_gpt":0.4550818260549206,"score_spread":0.3739209881911179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406665586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99827063,0.00025732466,0.0011695342,0.000028635315,0.0000020034329,0.00003117873,0.000070716516,0.00001935876,0.00015057556],"genre_scores_gemma":[0.99921954,0.00009231473,0.00043846044,0.00003362976,0.0000035292032,0.000020455103,0.00011574102,0.0000038534117,0.00007246322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996729,0.00018257284,0.000011858569,0.000059439255,0.00005152351,0.000021768728],"domain_scores_gemma":[0.9995394,0.0001968475,0.0001586373,0.000044531233,0.00001996508,0.00004065662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083266443,0.00031734296,0.0005785542,0.000116664974,0.00009557646,0.0004015706,0.00027851065,0.00032546994,0.00038759952],"category_scores_gemma":[0.0016363941,0.00021048992,0.00039629178,0.00016282054,0.00020863388,0.00042368541,0.00022592931,0.0006225568,0.000088494184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.117441505,0.005800056,0.31808737,0.00049267994,0.0020475462,0.0007979402,0.0010772825,0.2334445,0.12316291,0.00090176146,0.0014893913,0.19525708],"study_design_scores_gemma":[0.008944551,0.17158534,0.38697496,0.000053954118,0.0017661569,0.0017681976,0.0004137948,0.37321705,0.04805226,0.001211089,0.0058930814,0.000119468765],"about_ca_topic_score_codex":0.0010873486,"about_ca_topic_score_gemma":0.0008188745,"teacher_disagreement_score":0.0010873486,"about_ca_system_score_codex":0.0006000621,"about_ca_system_score_gemma":0.00046520974,"threshold_uncertainty_score":0.004403591},"labels":[],"label_agreement":null},{"id":"W4406665590","doi":"10.1158/1078-0432.ccr-24-3128","title":"Randomized Phase II Study of Bevacizumab with Weekly Anetumab Ravtansine or Weekly Paclitaxel in Platinum-Resistant/Refractory High-Grade Ovarian Cancer (NCI Trial)","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Genentech","keywords":"Medicine; Internal medicine; Bevacizumab; Neutropenia; Ovarian cancer; Clinical endpoint; Paclitaxel; Oncology; Refractory (planetary science); Progression-free survival; Phases of clinical research; Mesothelin; Gastroenterology; Urology; Cancer; Randomized controlled trial; Chemotherapy","score_opus":0.18897456220348152,"score_gpt":0.5220860365257134,"score_spread":0.33311147432223187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406665590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99087596,0.0014667991,0.00051469606,0.00062190066,0.00030505468,0.0030261995,0.0011580363,0.00012674293,0.0019046399],"genre_scores_gemma":[0.9870281,0.0011168093,0.0015780961,0.0009419688,0.00027443838,0.0033216756,0.0020433739,0.000036562582,0.003659081],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994961,0.000307565,0.00002120113,0.00007587826,0.000032822547,0.000066460496],"domain_scores_gemma":[0.9991387,0.00015158001,0.00020215516,0.00008502097,0.00004464028,0.00037784092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017055463,0.0013834421,0.0018095899,0.00036040685,0.00036217758,0.0009751934,0.0009272595,0.0011976075,0.0056003197],"category_scores_gemma":[0.0013710819,0.00059895555,0.000886681,0.00029998447,0.0007641012,0.0006471592,0.00036414753,0.0028539954,0.00084940874],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9523493,0.016301733,0.0013652835,0.000258763,0.0007078418,0.000059886654,0.0000665829,0.00069892406,0.0074180025,0.0001559964,0.0018827763,0.018734913],"study_design_scores_gemma":[0.927565,0.06751715,0.002350725,0.000012578558,0.0002462507,0.00005109833,0.000014571304,0.000556501,0.00063583103,0.00012009225,0.0009198936,0.000010441106],"about_ca_topic_score_codex":0.0018098439,"about_ca_topic_score_gemma":0.0049351044,"teacher_disagreement_score":0.0056003197,"about_ca_system_score_codex":0.001052144,"about_ca_system_score_gemma":0.0013619168,"threshold_uncertainty_score":0.018734992},"labels":[],"label_agreement":null},{"id":"W4406833871","doi":"10.1158/1557-3265.targetedtherap-b027","title":"Abstract B027: Investigating NRF2-mediated radioresistance in HPV-negative head and neck squamous cell carcinoma preclinical models","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Radioresistance; Head and neck squamous-cell carcinoma; Head and neck; Medicine; Basal cell; Head and neck cancer; Cancer research; Oncology; Pathology; Radiation therapy; Internal medicine; Surgery","score_opus":0.1644090731531915,"score_gpt":0.4689146897931072,"score_spread":0.3045056166399157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406833871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95951414,0.004491944,0.014632474,0.00078733766,0.0004626953,0.001277472,0.009461415,0.00073991716,0.008632612],"genre_scores_gemma":[0.93718374,0.0039055848,0.015797632,0.00037034135,0.00005406314,0.0028656696,0.010071177,0.00017514972,0.029576682],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999556,0.0000815949,0.00004557511,0.00008892387,0.00013719889,0.00009075058],"domain_scores_gemma":[0.99956304,0.000047400892,0.000064429994,0.0000854682,0.00013595985,0.000103666855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009544002,0.00086590217,0.00065658963,0.0006707269,0.00041277608,0.0004566155,0.0007430468,0.0009009655,0.007520213],"category_scores_gemma":[0.00026711763,0.00036584644,0.00093807536,0.00040336157,0.0004399144,0.0004973069,0.00027597576,0.0018988305,0.0015641527],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001689628,0.001881442,0.0006038422,0.0004074847,0.0000619568,0.00008806636,0.00007955647,0.00071145454,0.98762,0.00048617448,0.0014196183,0.004950869],"study_design_scores_gemma":[0.00022234557,0.010858847,0.002712234,0.00004009075,0.00010562305,0.00018607349,0.00008952041,0.0021301992,0.974613,0.00016818837,0.008855551,0.0000182621],"about_ca_topic_score_codex":0.0024493842,"about_ca_topic_score_gemma":0.003002922,"teacher_disagreement_score":0.007520213,"about_ca_system_score_codex":0.0006988855,"about_ca_system_score_gemma":0.0009572132,"threshold_uncertainty_score":0.02515757},"labels":[],"label_agreement":null},{"id":"W4406833883","doi":"10.1158/1557-3265.targetedtherap-b016","title":"Abstract B016: Targeting the angiotensin receptor in cancer-associated fibroblasts improves tumour perfusion, oxygenation, and radiotherapy response","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Medicine; Oxygenation; Cancer; Perfusion; Radiation therapy; Receptor; Cancer research; Angiotensin II; Oncology; Internal medicine","score_opus":0.04477540321370125,"score_gpt":0.4245369218310078,"score_spread":0.3797615186173065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406833883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98761797,0.0042927866,0.0019377129,0.00047781036,0.000519611,0.00011462358,0.00046368464,0.00025175727,0.0043241023],"genre_scores_gemma":[0.98660207,0.0017010291,0.0014320494,0.00029762893,0.000084408806,0.00009601767,0.00069361913,0.000037272246,0.009055787],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999207,0.000009738475,0.0000066925745,0.0000140507655,0.000022911021,0.00002595139],"domain_scores_gemma":[0.99994266,0.000007053219,0.000010383551,0.0000050039907,0.0000069804864,0.00002790028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001246882,0.00028215133,0.00043932104,0.00016402836,0.000105120474,0.00021596653,0.00018499717,0.00030716005,0.005757948],"category_scores_gemma":[0.000110683985,0.00008752737,0.0002789345,0.00010108578,0.00012530286,0.00016734161,0.000092324764,0.0009346562,0.000962827],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059786905,0.0012695427,0.00034348303,0.000208546,0.00003260696,0.00007101188,0.000017552886,0.00014464471,0.9753777,0.00011180519,0.0010986767,0.015345764],"study_design_scores_gemma":[0.0016984,0.033640943,0.012327409,0.000052204334,0.000151226,0.00086939783,0.00009501962,0.0022216346,0.9383823,0.00017977897,0.010355723,0.00002581831],"about_ca_topic_score_codex":0.00052365864,"about_ca_topic_score_gemma":0.0006399247,"teacher_disagreement_score":0.005757948,"about_ca_system_score_codex":0.00012427251,"about_ca_system_score_gemma":0.00023644311,"threshold_uncertainty_score":0.019262314},"labels":[],"label_agreement":null},{"id":"W4406833916","doi":"10.1158/1557-3265.targetedtherap-ia08","title":"Abstract IA08: Theragnostics &amp; external beam radiation dose absorbed - Similarities, differences and thoughts for the future","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"External beam radiation; Medicine; Radiation; Medical physics; Nuclear medicine; Radiation therapy; Internal medicine; Physics; Optics","score_opus":0.10603975608696287,"score_gpt":0.5036678228059782,"score_spread":0.39762806671901535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406833916","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017137693,0.5285411,0.015167234,0.17199376,0.110540256,0.0004303075,0.0013477326,0.001129926,0.16913581],"genre_scores_gemma":[0.015273729,0.6457044,0.014065748,0.07654149,0.056697644,0.00061549665,0.0024327536,0.00092308386,0.18774569],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975284,0.0007142194,0.00023537871,0.00028501614,0.0010510195,0.00018605363],"domain_scores_gemma":[0.9932904,0.0018726379,0.00039010626,0.0002657199,0.003559162,0.00062184926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048805675,0.0008490741,0.0009911663,0.0033360077,0.0009473594,0.0053445688,0.0020802568,0.0039107497,0.036264442],"category_scores_gemma":[0.010665183,0.00039337753,0.0013436672,0.0035452598,0.0023196605,0.0053215763,0.0025544905,0.0059062513,0.027898092],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056981717,0.00006288346,0.00041455933,0.0027774062,0.000017575867,0.00012648555,0.00039692078,0.0002863979,0.0006272283,0.017668325,0.67866015,0.29890516],"study_design_scores_gemma":[0.000003539516,0.000027206372,0.0006868438,0.0017951626,0.000008545594,0.00035052293,0.00023492164,0.00005990824,0.00015081397,0.0040961117,0.9925718,0.000014621399],"about_ca_topic_score_codex":0.0042795474,"about_ca_topic_score_gemma":0.0033104443,"teacher_disagreement_score":0.036264442,"about_ca_system_score_codex":0.0038029654,"about_ca_system_score_gemma":0.0051348684,"threshold_uncertainty_score":0.12131667},"labels":[],"label_agreement":null},{"id":"W4406834038","doi":"10.1158/1557-3265.targetedtherap-p011","title":"Abstract P011: STN1 (OBFC1) promotes DNA double-strand break repair in a potentially CTC1-STN1-TEN1 (CST) complex-independent role in pancreatic cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"DNA; Pancreatic cancer; DNA repair; Cancer; Homologous recombination; Cancer research; Biology; Genetics","score_opus":0.09368675203698996,"score_gpt":0.45092708273639587,"score_spread":0.3572403306994059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406834038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98030317,0.004756548,0.0028595736,0.00049031025,0.00011115643,0.00004531628,0.0070610493,0.00028248952,0.004090451],"genre_scores_gemma":[0.9854833,0.001107089,0.0010698282,0.00014199187,0.000013200212,0.00003014708,0.006517396,0.000049040154,0.0055880956],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998778,0.000007700763,0.000007677928,0.000041661708,0.000044188397,0.00002100051],"domain_scores_gemma":[0.9998734,0.000011030701,0.000046050893,0.000008157073,0.000016318809,0.000045071298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013535625,0.00034765905,0.00028724654,0.0002144847,0.00028015516,0.0004330938,0.00020448233,0.00030624014,0.007232709],"category_scores_gemma":[0.00015355053,0.00012479299,0.000356317,0.00024814444,0.00018166355,0.00019024909,0.00029480585,0.0006053463,0.0014980957],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010582469,0.00006471022,0.005646137,0.0003577865,0.00004076298,0.00032926936,0.000026263626,0.00052305596,0.9822649,0.00027991857,0.001736774,0.0076721176],"study_design_scores_gemma":[0.00010472467,0.000590712,0.1203438,0.000069218055,0.000093691066,0.0023128807,0.000118868404,0.006673766,0.8493637,0.00038023526,0.019928452,0.000020033502],"about_ca_topic_score_codex":0.0011083204,"about_ca_topic_score_gemma":0.0016026809,"teacher_disagreement_score":0.007232709,"about_ca_system_score_codex":0.00055881246,"about_ca_system_score_gemma":0.0003338569,"threshold_uncertainty_score":0.02419579},"labels":[],"label_agreement":null},{"id":"W4406834106","doi":"10.1158/1557-3265.targetedtherap-p008","title":"Abstract P008: Evaluating associations between genomic classifier and digital pathology based mutli-modal AI biomarkers in oligometastatic castration-sensitive prostate cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of New Brunswick","funders":"","keywords":"Prostate cancer; Medicine; Classifier (UML); Pathology; Digital pathology; Cancer; Oncology; Internal medicine; Artificial intelligence; Computer science","score_opus":0.15360829387418082,"score_gpt":0.5487248457129404,"score_spread":0.3951165518387596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406834106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99655044,0.0005243601,0.00080154405,0.000044240463,0.000010991831,0.000034295153,0.0014361173,0.000023183538,0.00057468715],"genre_scores_gemma":[0.99844825,0.00006170814,0.0005863086,0.000014613922,0.000010219058,0.000016158392,0.00067343557,0.0000062145905,0.00018309831],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995054,0.0001071832,0.00005641913,0.00014517011,0.00013914444,0.000046652192],"domain_scores_gemma":[0.99809223,0.0005270838,0.00070822623,0.00012422331,0.0003521751,0.0001960989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068869203,0.00025617905,0.0002880388,0.0012853189,0.00025264567,0.0008305455,0.00033733516,0.0002748008,0.0029792788],"category_scores_gemma":[0.0028070386,0.00011970228,0.00031183116,0.0012246531,0.00024081295,0.00038088395,0.0005505589,0.00034151555,0.00048051155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040611334,0.000030293988,0.99047816,0.000052245367,0.00008426328,0.00008298316,0.000025697034,0.00012744458,0.0014500518,0.000028662465,0.0002451634,0.00698898],"study_design_scores_gemma":[0.000012524982,0.00043322,0.99447095,0.000015165538,0.00011268744,0.0007762519,0.00011866736,0.0016497257,0.0016086292,0.00008094757,0.00071356964,0.0000077503355],"about_ca_topic_score_codex":0.00084684975,"about_ca_topic_score_gemma":0.0012012979,"teacher_disagreement_score":0.0029792788,"about_ca_system_score_codex":0.00029102855,"about_ca_system_score_gemma":0.00027212632,"threshold_uncertainty_score":0.0099666715},"labels":[],"label_agreement":null},{"id":"W4407392464","doi":"10.1158/1078-0432.ccr-24-3278","title":"Update on Cancer and Central Nervous System Tumor Surveillance in Pediatric <i>NF2</i> -, <i>SMARCB1</i> -, and <i>LZTR1</i> -Related Schwannomatosis","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; Manchester Biomedical Research Centre; National Cancer Institute; National Institutes of Health; Deutsche Kinderkrebsstiftung; American Lebanese Syrian Associated Charities; National Institute for Health and Care Research; Department of Health and Social Care; Servier; Hospital Research Foundation; Alexion Pharmaceuticals","keywords":"Neurofibromatosis type 2; SMARCB1; Medicine; Schwannoma; Neurofibromatoses; Meningioma; Acoustic neuroma; Oncology; Pathology; Internal medicine; Neurofibromatosis; Surgery; Biology; Gene","score_opus":0.058320933855205655,"score_gpt":0.4134866590835648,"score_spread":0.35516572522835915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407392464","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017169957,0.92789656,0.0013765629,0.038933907,0.015356487,0.00006531463,0.0008636944,0.00021598281,0.013574571],"genre_scores_gemma":[0.0074455263,0.93964547,0.0032844825,0.020359717,0.022390768,0.00010458475,0.0019290507,0.000049268343,0.0047910553],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988582,0.0003122079,0.00030787423,0.00010615817,0.0003208531,0.000094619776],"domain_scores_gemma":[0.9924614,0.0032256716,0.0010065925,0.00014038682,0.0025459044,0.0006200748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021531342,0.00057165365,0.0013277681,0.0037833038,0.00042764307,0.0014622798,0.0011464659,0.0021607422,0.0033202844],"category_scores_gemma":[0.007065739,0.00040621823,0.00088490185,0.0037088364,0.0004523624,0.0023369584,0.00087757985,0.0032302423,0.0016089712],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007867699,0.00005042031,0.0030807124,0.0042637954,0.00010456061,0.0006377591,0.00014075497,0.00043433838,0.00040218534,0.00136303,0.39908504,0.59035873],"study_design_scores_gemma":[0.000023015778,0.000083441104,0.0053164414,0.006863109,0.00021228734,0.0028626863,0.00015674136,0.00018543792,0.00013838538,0.0005699359,0.98356116,0.000027384276],"about_ca_topic_score_codex":0.0064715575,"about_ca_topic_score_gemma":0.018139984,"teacher_disagreement_score":0.0064715575,"about_ca_system_score_codex":0.001766918,"about_ca_system_score_gemma":0.0022890018,"threshold_uncertainty_score":0.012867749},"labels":[],"label_agreement":null},{"id":"W4407392510","doi":"10.1158/1078-0432.ccr-24-1818","title":"AZD8701, an Antisense Oligonucleotide Targeting FOXP3 mRNA, as Monotherapy and in Combination with Durvalumab: A Phase I Trial in Patients with Advanced Solid Tumors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"AstraZeneca","keywords":"Durvalumab; Medicine; Tolerability; Combination therapy; Adverse effect; Internal medicine; Toxicity; Pharmacology; Cancer; Urology; Oncology; Gastroenterology; Immunotherapy","score_opus":0.06226559789994827,"score_gpt":0.4923652683580123,"score_spread":0.430099670458064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407392510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995271,0.0024799001,0.00032802508,0.00024672406,0.000056996618,0.00037815544,0.000271974,0.0000522451,0.0009149757],"genre_scores_gemma":[0.9948237,0.001976983,0.0010009971,0.00029747735,0.00009008248,0.00031930828,0.0006368197,0.00000915754,0.0008454999],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998134,0.00007693819,0.000012929606,0.00002772941,0.000027818909,0.000041359275],"domain_scores_gemma":[0.99974376,0.0000552674,0.000045137454,0.000016134798,0.000015971931,0.00012366349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069805305,0.0008052898,0.0010887929,0.0002938826,0.00022626517,0.00048783806,0.0005001213,0.0005404601,0.0012364391],"category_scores_gemma":[0.0003953275,0.00025738898,0.00052765664,0.0002880465,0.0005217696,0.00042353818,0.00019049704,0.0014726684,0.00032301495],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42140612,0.04917463,0.017314766,0.0014900528,0.0022271203,0.0007092385,0.0005859346,0.0058423416,0.13691273,0.00068077614,0.0059952913,0.35766095],"study_design_scores_gemma":[0.48620704,0.45871073,0.02419798,0.00006337966,0.000787454,0.0008788044,0.00010138913,0.004691722,0.019310994,0.00025346645,0.004761851,0.00003521186],"about_ca_topic_score_codex":0.00078421447,"about_ca_topic_score_gemma":0.0020151322,"teacher_disagreement_score":0.0012364391,"about_ca_system_score_codex":0.0006664247,"about_ca_system_score_gemma":0.00073863124,"threshold_uncertainty_score":0.004835248},"labels":[],"label_agreement":null},{"id":"W4407564894","doi":"10.1158/1078-0432.ccr-24-1210","title":"Prevalence of Mismatch Repair Deficiency in Primary Prostate Cancer in a Large Prospective Cohort","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"Eisai; Daiichi-Sankyo; Irish Cancer Society; Wellcome Trust; Harvard T.H. Chan School of Public Health; Harvard University; National Cancer Institute; Brigham and Women's Hospital; Prostate Cancer Foundation; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Amgen; Pfizer; Revolution Medicines","keywords":"MSH2; Medicine; Microsatellite instability; MSH6; PMS2; Prostate cancer; Lynch syndrome; Prostate; Prospective cohort study; MLH1; Prostatectomy; Tissue microarray; Oncology; Internal medicine; Cancer; Pathology; DNA mismatch repair; Colorectal cancer; Biology","score_opus":0.06988423598424741,"score_gpt":0.48806543569206384,"score_spread":0.4181811997078164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407564894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994012,0.00017782536,0.00009433352,0.000021711981,0.000004834901,0.0000081872395,0.0001756032,0.000004628474,0.000111606874],"genre_scores_gemma":[0.99962044,0.000057354333,0.000051401596,0.000013440826,0.000007563912,0.000007539498,0.00018882443,0.0000014357307,0.0000520975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905807,0.00027834703,0.000070873,0.00032654882,0.00016887368,0.000097318225],"domain_scores_gemma":[0.9985707,0.00028642814,0.00046353266,0.00023098553,0.00012305478,0.00032523306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010039791,0.00032784956,0.0004482782,0.00075108727,0.00065751985,0.0006653614,0.00046368453,0.0005559471,0.0018375516],"category_scores_gemma":[0.0020818908,0.0005178504,0.00035184206,0.000731745,0.0004581777,0.0004412809,0.00053086155,0.00059034064,0.00035287533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007270928,0.000017109529,0.9992029,0.0000039859888,0.000030502802,0.00006090315,0.000024311397,0.0000119568995,0.00024343983,0.0000044095045,0.000031262927,0.00029660366],"study_design_scores_gemma":[0.000009778828,0.00012925465,0.99872476,0.00000250447,0.00003175316,0.00076100463,0.000074860676,0.0000895297,0.00008540858,0.000009765735,0.000078411715,0.0000029065582],"about_ca_topic_score_codex":0.0025284667,"about_ca_topic_score_gemma":0.0025479137,"teacher_disagreement_score":0.0025284667,"about_ca_system_score_codex":0.00023733052,"about_ca_system_score_gemma":0.00039216568,"threshold_uncertainty_score":0.006147206},"labels":[],"label_agreement":null},{"id":"W4407909785","doi":"10.1158/1078-0432.ccr-24-3271","title":"Update on Retinoblastoma Predisposition and Surveillance Recommendations for Children","year":2025,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"Hospital Research Foundation; St. Baldrick's Foundation","keywords":"Retinoblastoma; Medicine; Penetrance; Disease; Genetic predisposition; Cancer; Genetic counseling; Germline mutation; Germline; Pediatrics; Pathology; Internal medicine; Mutation; Genetics; Biology","score_opus":0.24508427939212235,"score_gpt":0.6048086880280561,"score_spread":0.35972440863593375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407909785","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011753295,0.98779476,0.0002398413,0.0051373458,0.001974975,0.000035523488,0.0003528264,0.00004844629,0.00429873],"genre_scores_gemma":[0.00052537885,0.9927037,0.00056592026,0.0033402038,0.000711926,0.000036810998,0.0004231477,0.0000084568865,0.0016844965],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99934787,0.00017429214,0.000149563,0.00005586886,0.00023054313,0.000041968928],"domain_scores_gemma":[0.9976162,0.00117018,0.0003172168,0.000042012314,0.0007430835,0.00011139032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013221205,0.00060980197,0.0011735567,0.002667911,0.00026775096,0.00090725266,0.0013609773,0.0018696194,0.010893317],"category_scores_gemma":[0.0056691985,0.00033825214,0.0013477877,0.0018008549,0.00024889343,0.001337678,0.0006822811,0.0023128828,0.004090905],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000556143,0.000030377643,0.00017931283,0.021519708,0.00011593602,0.00017310846,0.00007558994,0.0001817576,0.00025397644,0.0016739164,0.24612029,0.72962034],"study_design_scores_gemma":[0.000018808212,0.00002909103,0.000462252,0.017397434,0.00017086713,0.000569923,0.000027233713,0.00002742499,0.00005635411,0.00053502,0.9806949,0.0000107766755],"about_ca_topic_score_codex":0.0039876923,"about_ca_topic_score_gemma":0.0074664224,"teacher_disagreement_score":0.010893317,"about_ca_system_score_codex":0.0010759829,"about_ca_system_score_gemma":0.0021583696,"threshold_uncertainty_score":0.036441743},"labels":[],"label_agreement":null},{"id":"W4408028458","doi":"10.1158/1078-0432.ccr-24-1724","title":"Health-Related Quality of Life in Patients with HR+/HER2− Early Breast Cancer Treated with Ribociclib Plus a Nonsteroidal Aromatase Inhibitor: Results from the NATALEE Trial","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Aromatase inhibitor; Breast cancer; Quality of life (healthcare); Hospital Anxiety and Depression Scale; Internal medicine; Oncology; Cancer; Clinical trial; Anxiety; Tamoxifen; Psychiatry","score_opus":0.11877911940044678,"score_gpt":0.47198029307840106,"score_spread":0.3532011736779543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408028458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867561,0.0106089385,0.0001229167,0.0004937305,0.00009226999,0.000234781,0.0005182958,0.000011664959,0.0011613539],"genre_scores_gemma":[0.9946561,0.0022960338,0.00023790797,0.00058191566,0.0001305147,0.00040952588,0.001033025,0.000002957773,0.00065201183],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994473,0.00036081616,0.00003559243,0.000048353064,0.0000622743,0.000045654888],"domain_scores_gemma":[0.9995376,0.000115358285,0.00017464707,0.00003647844,0.000030895026,0.00010503582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016878576,0.00049763144,0.00090734434,0.00012900282,0.0001445154,0.0005429532,0.00035803398,0.00043726916,0.001236687],"category_scores_gemma":[0.0010283265,0.00012123504,0.0010464435,0.00023501032,0.00029382127,0.00029716978,0.00025462257,0.000959437,0.00018261473],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7649733,0.007877701,0.08203017,0.0021337834,0.0071055843,0.00019070682,0.00015371732,0.0015298383,0.008782488,0.00023107679,0.005027943,0.119963706],"study_design_scores_gemma":[0.49002194,0.13423195,0.3540389,0.00037841406,0.0067356196,0.0006169248,0.00017223488,0.0021034093,0.0026661535,0.00053182564,0.008428873,0.000073758805],"about_ca_topic_score_codex":0.0003378657,"about_ca_topic_score_gemma":0.001506054,"teacher_disagreement_score":0.0016878576,"about_ca_system_score_codex":0.00040600664,"about_ca_system_score_gemma":0.0003849998,"threshold_uncertainty_score":0.008926332},"labels":[],"label_agreement":null},{"id":"W4408363509","doi":"10.1158/1078-0432.ccr-24-3301","title":"Update on Cancer Screening Recommendations for Individuals with Li–Fraumeni Syndrome","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Li–Fraumeni syndrome; Medicine; Cancer; Germline; Genetic predisposition; Population; Intervention (counseling); Modalities; Oncology; Germline mutation; Internal medicine; Gene; Genetics; Mutation; Environmental health; Psychiatry; Biology; Disease","score_opus":0.2692035386000909,"score_gpt":0.5625922580384279,"score_spread":0.29338871943833705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408363509","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005873036,0.1795206,0.021208672,0.6365511,0.026216595,0.0018991047,0.0127517255,0.0019317156,0.11404752],"genre_scores_gemma":[0.04374003,0.3542793,0.09985768,0.3680881,0.016777555,0.005151723,0.044919387,0.000740729,0.066445455],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950788,0.0015779485,0.0012665727,0.00022462454,0.0014823058,0.00036976504],"domain_scores_gemma":[0.9809523,0.0045807105,0.0014548856,0.0003187315,0.01151098,0.0011824262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008641216,0.0005945063,0.0008901597,0.0031520503,0.000941033,0.0014801325,0.0026174693,0.005048982,0.0071117454],"category_scores_gemma":[0.028433926,0.0004513156,0.002053551,0.0018778096,0.00057357753,0.0016563729,0.0021200497,0.006735805,0.0047528693],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000545075,0.00007299908,0.0023458044,0.0013003203,0.000057822577,0.00027378168,0.00021218885,0.0004589889,0.00038883157,0.0026057374,0.7482057,0.24402328],"study_design_scores_gemma":[0.000049588925,0.000057212037,0.004635214,0.0054907664,0.00014806679,0.0007169933,0.00019924127,0.00022350979,0.00031548744,0.0019335737,0.9861909,0.000039481896],"about_ca_topic_score_codex":0.019652445,"about_ca_topic_score_gemma":0.026415339,"teacher_disagreement_score":0.019652445,"about_ca_system_score_codex":0.002867565,"about_ca_system_score_gemma":0.007687353,"threshold_uncertainty_score":0.045699656},"labels":[],"label_agreement":null},{"id":"W4408388714","doi":"10.1158/1078-0432.ccr-24-2198","title":"Mutational Landscape of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Association with Immune Checkpoint Inhibitor Outcomes","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"AstraZeneca","keywords":"Durvalumab; Head and neck squamous-cell carcinoma; Tremelimumab; Medicine; Oncology; Internal medicine; Head and neck cancer; Immunotherapy; Eagle; Cancer; Cancer research; Biology; Pembrolizumab; Ipilimumab","score_opus":0.10291388378504208,"score_gpt":0.4685357877704034,"score_spread":0.3656219039853613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408388714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99910766,0.00040509878,0.000042869524,0.000014129402,0.0000013185589,0.0000073017773,0.00019579024,0.000002997761,0.00022287437],"genre_scores_gemma":[0.999567,0.00007960407,0.00004892656,0.000011928882,0.0000028693082,0.000004009726,0.00021809571,0.000001169786,0.000066364126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978954,0.00003440777,0.00002088681,0.00007288412,0.000055201923,0.000027196731],"domain_scores_gemma":[0.9995134,0.000063500636,0.00026931477,0.00003940311,0.00005436597,0.000060100272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004624464,0.00014505327,0.00030540425,0.00032190175,0.00013090928,0.00028154053,0.00022712802,0.0002186013,0.0013686436],"category_scores_gemma":[0.0007123798,0.00009283743,0.00023957812,0.00027646322,0.00021480027,0.00017576301,0.00016908105,0.00021215927,0.0001500626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033074596,0.00011435328,0.97388613,0.00007442728,0.0003163912,0.00020658714,0.000047184043,0.00026492786,0.009584454,0.00002880982,0.00025257427,0.011916715],"study_design_scores_gemma":[0.000038015514,0.0005111117,0.99687296,0.000011259625,0.00010485615,0.00080165785,0.0000485198,0.00028086692,0.0011194479,0.000022765684,0.00018475084,0.0000038633348],"about_ca_topic_score_codex":0.0024565754,"about_ca_topic_score_gemma":0.004528563,"teacher_disagreement_score":0.0024565754,"about_ca_system_score_codex":0.0004336844,"about_ca_system_score_gemma":0.000248967,"threshold_uncertainty_score":0.0048844814},"labels":[],"label_agreement":null},{"id":"W4408505231","doi":"10.1158/1078-0432.ccr-24-2971","title":"The Dynamically Evolving Cell States and Ecosystem from Benign Nevi to Melanoma","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"National Key Research and Development Program of China; Science-Health Joint Medical Scientific Research Project of Chongqing; Natural Science Foundation of Chongqing; National Natural Science Foundation of China","keywords":"Melanoma; Malignant transformation; Cancer research; Biology; Melanocyte; Nevus; Transcriptome; Immune checkpoint; Immune system; Medicine; Immunology; Immunotherapy; Gene expression; Gene; Genetics","score_opus":0.060556040875511544,"score_gpt":0.44841885688119926,"score_spread":0.3878628160056877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408505231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99607486,0.0007583809,0.0018528533,0.000048320137,0.0000055463247,0.00001804106,0.00020338534,0.000037568865,0.0010009803],"genre_scores_gemma":[0.9975248,0.00034775116,0.0014381373,0.000050028455,0.00000535707,0.000016533213,0.00025487653,0.000010875576,0.0003516048],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99986625,0.000025020143,0.000006815552,0.000045940946,0.00003707059,0.000018869865],"domain_scores_gemma":[0.9998841,0.000025505806,0.000036887726,0.0000105600875,0.00001984671,0.00002300551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017739009,0.00014626326,0.00018506193,0.0005234116,0.00025892362,0.0004595748,0.00010323208,0.00018981911,0.0007034557],"category_scores_gemma":[0.0003119305,0.00011997918,0.00012952359,0.0001871969,0.00030453896,0.00023439358,0.00024968229,0.00024358444,0.00017698697],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002444588,0.000043869604,0.1753357,0.000120323086,0.00004080939,0.0008614806,0.00048573376,0.00043793782,0.80279773,0.00036491145,0.00020534199,0.01906178],"study_design_scores_gemma":[0.0000105907475,0.00026008402,0.8873016,0.000038027574,0.000055247852,0.0059894137,0.0010097063,0.0038417259,0.09559168,0.0011398811,0.0047426703,0.000019361998],"about_ca_topic_score_codex":0.000435241,"about_ca_topic_score_gemma":0.00080165954,"teacher_disagreement_score":0.0007034557,"about_ca_system_score_codex":0.00018101551,"about_ca_system_score_gemma":0.000137066,"threshold_uncertainty_score":0.0023533106},"labels":[],"label_agreement":null},{"id":"W4408592042","doi":"10.1158/1078-0432.ccr-24-0254","title":"Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with <i>BRAF</i> V600-Mutant Metastatic Melanoma","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; McGill University; University of Toronto; Jewish General Hospital","funders":"Memorial Sloan-Kettering Cancer Center; Pfizer; National Cancer Institute; Foundation for the National Institutes of Health","keywords":"Medicine; Metastatic melanoma; Melanoma; Adverse effect; MEK inhibitor; Clinical endpoint; Internal medicine; Oncology; Phases of clinical research; Clinical trial; Cancer research; MAPK/ERK pathway; Kinase","score_opus":0.10792660299837883,"score_gpt":0.4474522176663169,"score_spread":0.33952561466793807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408592042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957074,0.0015302962,0.0004213079,0.0004323058,0.000042285883,0.00025284477,0.0006976024,0.000047026522,0.000868878],"genre_scores_gemma":[0.99533254,0.00064851163,0.00096220954,0.0005032044,0.00006235882,0.00032693913,0.0014534114,0.000011584644,0.0006991383],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995882,0.0002628034,0.00001586445,0.000066640976,0.000029739747,0.000036700825],"domain_scores_gemma":[0.99936706,0.0001452468,0.00019554546,0.000047431753,0.000042709897,0.00020204675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017330172,0.00065389,0.0005944391,0.00014351733,0.00018956877,0.00053410174,0.00029079587,0.00042547574,0.0017833954],"category_scores_gemma":[0.0012274547,0.00021682895,0.00063343265,0.00016506939,0.00032241375,0.00042839668,0.00026752413,0.0010056591,0.00022209127],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72681785,0.015041235,0.06823248,0.00042288378,0.002695816,0.000112914604,0.00021382782,0.0038051067,0.022207843,0.00028770964,0.005298393,0.15486403],"study_design_scores_gemma":[0.42444342,0.3859653,0.1659691,0.000081083606,0.003053072,0.00042478734,0.00014931703,0.0067597074,0.005788046,0.00063144905,0.0066560376,0.00007876225],"about_ca_topic_score_codex":0.0007006808,"about_ca_topic_score_gemma":0.0020113986,"teacher_disagreement_score":0.0017833954,"about_ca_system_score_codex":0.0006632699,"about_ca_system_score_gemma":0.0007759487,"threshold_uncertainty_score":0.009165168},"labels":[],"label_agreement":null},{"id":"W4408695657","doi":"10.1158/1078-0432.ccr-24-3905","title":"Precision Endocrine Therapy in Endometrial Cancer: Has Its Time Finally Come?","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Endometrial cancer; Endocrine system; Medicine; Cancer; Cancer therapy; Oncology; Gynecology; Internal medicine; Hormone","score_opus":0.34561102202869826,"score_gpt":0.5738653788999695,"score_spread":0.2282543568712712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408695657","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003700493,0.4326241,0.0005746256,0.51883984,0.04513731,0.000009604803,0.000059613616,0.000028916525,0.0023559222],"genre_scores_gemma":[0.00800243,0.57484794,0.0010824666,0.2685963,0.14343832,0.000029703357,0.000054384716,0.000041309053,0.003907124],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965842,0.0013595064,0.00043224907,0.00030647015,0.0010936732,0.00022389591],"domain_scores_gemma":[0.9839399,0.011387177,0.00063043163,0.00034395643,0.003006917,0.0006915174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068513337,0.0005282968,0.0015474845,0.00060776074,0.0011063173,0.0026342496,0.0014956156,0.006556403,0.0031678758],"category_scores_gemma":[0.018128786,0.00030503585,0.0009527634,0.00072754716,0.0035185467,0.0051029716,0.0012612074,0.012661282,0.0012457697],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004182763,0.00004038643,0.00041769468,0.0020393683,0.00011377526,0.0006676856,0.0002536531,0.00042114817,0.0008691308,0.026019646,0.69024324,0.27849603],"study_design_scores_gemma":[0.00007998272,0.00019576092,0.00055952376,0.001604924,0.00006600069,0.0008387519,0.00025041067,0.00016592415,0.00035031972,0.016875422,0.978963,0.00004990097],"about_ca_topic_score_codex":0.0029112673,"about_ca_topic_score_gemma":0.012354269,"teacher_disagreement_score":0.0068513337,"about_ca_system_score_codex":0.0022724345,"about_ca_system_score_gemma":0.0040842914,"threshold_uncertainty_score":0.036233723},"labels":[],"label_agreement":null},{"id":"W4408889678","doi":"10.1158/1078-0432.ccr-24-3475","title":"Modeling MRD Changes in Myeloma to Understand Treatment Effects, Predict Outcomes, and Investigate Curative Potential","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Janssen Research and Development; National Cancer Institute","keywords":"Minimal residual disease; Clinical trial; Medicine; Oncology; Residual; Disease; Multiple myeloma; Selection (genetic algorithm); Internal medicine; Computer science; Machine learning; Algorithm; Leukemia","score_opus":0.23244624773717434,"score_gpt":0.53304227182326,"score_spread":0.30059602408608566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408889678","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45916957,0.0039952253,0.5273548,0.0020634125,0.0000948709,0.00032281416,0.0012938933,0.00038707932,0.0053183152],"genre_scores_gemma":[0.9538886,0.0016555779,0.040574916,0.0002654035,0.000030255173,0.00038572858,0.00040621005,0.00004844298,0.0027448938],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99967027,0.00014584909,0.00001709223,0.00006134368,0.000056555145,0.00004885514],"domain_scores_gemma":[0.9989555,0.0007025824,0.00019994973,0.000044902597,0.00006932772,0.000027771326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013811699,0.00074658904,0.0007342485,0.0004387173,0.00019880061,0.00064048206,0.0008745952,0.0007904567,0.0007035479],"category_scores_gemma":[0.0033185666,0.0003915626,0.0010791298,0.0003993092,0.00045015267,0.0007567951,0.00045684102,0.00089542277,0.00017044075],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043925305,0.000030897267,0.0017504335,0.000058242098,0.000033996137,0.000023456629,0.000018402103,0.99185854,0.0017881932,0.0013865912,0.00012204022,0.0028852338],"study_design_scores_gemma":[0.000014430891,0.000063731546,0.0007562645,0.0000080334485,0.000018778685,0.000020414147,0.0000065439654,0.9959121,0.0009301236,0.0017340403,0.00052936154,0.00000625852],"about_ca_topic_score_codex":0.01176865,"about_ca_topic_score_gemma":0.0071521928,"teacher_disagreement_score":0.01176865,"about_ca_system_score_codex":0.002033276,"about_ca_system_score_gemma":0.0013047012,"threshold_uncertainty_score":0.023400247},"labels":[],"label_agreement":null},{"id":"W4408890340","doi":"10.1158/1078-0432.ccr-24-1763","title":"A Proteogenomic View of Synchronous Endometrioid Endometrial and Ovarian Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"Novo Nordisk Fonden; National Cancer Institute; Ovarian Cancer Research Alliance","keywords":"Endometrial cancer; Proteogenomics; Ovarian cancer; Proteome; Stromal cell; Proteomics; Biology; Oncology; Cancer research; Metastasis; Cancer; Medicine; Internal medicine; Computational biology; Bioinformatics; Gene; Genomics; Genome; Genetics","score_opus":0.18350262832182185,"score_gpt":0.5261286637757375,"score_spread":0.3426260354539157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408890340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99409443,0.0017997967,0.0026695076,0.00010407214,0.0000042291754,0.00001631115,0.00035588376,0.000032304553,0.0009233876],"genre_scores_gemma":[0.99604034,0.0005888174,0.0025678736,0.000055633733,0.0000103519005,0.00001140511,0.0005176148,0.0000062423246,0.00020171439],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999281,0.000010417212,0.0000058936166,0.00002068508,0.000019650766,0.000015280639],"domain_scores_gemma":[0.99987376,0.000019526036,0.00004484352,0.00001392724,0.00002183053,0.000026156218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000160653,0.0002475303,0.00017193232,0.0016086547,0.0001867692,0.00032963377,0.00014957132,0.00015361849,0.0005373089],"category_scores_gemma":[0.0002853204,0.000118050826,0.00018850803,0.0007458943,0.00022830632,0.00022353546,0.00032729525,0.00018280446,0.00012531684],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005448738,0.000049735965,0.3646487,0.0002451087,0.00015342959,0.0021973425,0.00039123162,0.0013705274,0.5934235,0.00068185135,0.00045474776,0.035838902],"study_design_scores_gemma":[0.0000131099605,0.00019561384,0.9525971,0.000026013011,0.00011208845,0.008513211,0.00039344403,0.0050343163,0.029307276,0.00083084643,0.0029654976,0.000011418996],"about_ca_topic_score_codex":0.00086572237,"about_ca_topic_score_gemma":0.001429403,"teacher_disagreement_score":0.0016086547,"about_ca_system_score_codex":0.00019517755,"about_ca_system_score_gemma":0.00017791656,"threshold_uncertainty_score":0.0017974973},"labels":[],"label_agreement":null},{"id":"W4409264686","doi":"10.1158/1078-0432.ccr-24-3791","title":"The Society for Immunotherapy of Cancer Perspective on Liquid Biopsy– and Radiomics-Based Technologies for Immuno-oncology Biomarker Discovery and Application","year":2025,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada); McGill University; Ontario Institute for Cancer Research; Jewish General Hospital","funders":"National Cancer Institute","keywords":"Biomarker; Biomarker discovery; Medicine; Medical physics; Radiomics; Emerging technologies; Biobank; Computer science; Data science; Bioinformatics; Artificial intelligence; Proteomics; Biology","score_opus":0.0982077720343121,"score_gpt":0.5355280600723976,"score_spread":0.43732028803808554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409264686","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008820801,0.077034384,0.0051687025,0.6741093,0.2214815,0.0002480033,0.00060565013,0.0005226082,0.019947806],"genre_scores_gemma":[0.013986115,0.1677249,0.025967225,0.5138514,0.20296201,0.0008598733,0.00162878,0.00053441024,0.07248533],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9878198,0.002641719,0.0012034324,0.001528325,0.005469292,0.0013374563],"domain_scores_gemma":[0.9692891,0.0046282094,0.0023026078,0.0015385827,0.0149531355,0.007288379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020060986,0.0016213754,0.0014196315,0.002499772,0.0018244348,0.009718948,0.002689732,0.014566765,0.007836264],"category_scores_gemma":[0.016107611,0.0006850718,0.002074076,0.003288777,0.003821852,0.006545628,0.0048201308,0.032849196,0.008146013],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081697624,0.0000906519,0.00046825284,0.0004049117,0.00003063895,0.000090626316,0.00006997885,0.00020808946,0.0011153208,0.011820515,0.89479834,0.090820976],"study_design_scores_gemma":[0.000017261074,0.000066306864,0.00038365024,0.00025269206,0.000015339614,0.00009924541,0.00003294505,0.000121217774,0.00027662556,0.0021526995,0.9965648,0.00001732642],"about_ca_topic_score_codex":0.003681621,"about_ca_topic_score_gemma":0.0072914413,"teacher_disagreement_score":0.020060986,"about_ca_system_score_codex":0.0051697367,"about_ca_system_score_gemma":0.01874892,"threshold_uncertainty_score":0.10609388},"labels":[],"label_agreement":null},{"id":"W4409412811","doi":"10.1158/1078-0432.ccr-24-1845","title":"A Prospective Study Consortium for the Discovery and Validation of Early Detection Markers for Ovarian Cancer – Baseline Findings for CA125","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; School of Public Health, Imperial College London; Instituto de Salud Carlos III; World Cancer Research Fund; Medical Research Council; Centers for Disease Control and Prevention; Institut Gustave-Roussy; Deutsche Krebshilfe; Vetenskapsrådet; Ministero della Salute; Cancerfonden; Congressionally Directed Medical Research Programs; ZonMw; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche; Mutuelle Générale de l'Education Nationale; U.S. Department of Defense; Associazione Italiana per la Ricerca sul Cancro; Imperial College London; Deutsches Krebsforschungszentrum; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; European Commission; Compagnia di San Paolo; Cancer Research UK; World Health Organization; Universitetet i Tromsø; NIHR Imperial Biomedical Research Centre; Centre International de Recherche sur le Cancer; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Biomarker; Prospective cohort study; Medicine; Ovarian cancer; Oncology; Cancer; Stage (stratigraphy); Internal medicine; Malignancy; Biomarker discovery; Disease; Biology; Proteomics","score_opus":0.14954379900309872,"score_gpt":0.5181273117367589,"score_spread":0.36858351273366013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409412811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9252687,0.0032653252,0.016230486,0.0011651395,0.00047271093,0.006202627,0.038056385,0.00023105156,0.009107573],"genre_scores_gemma":[0.94230944,0.0006054888,0.017645411,0.000748977,0.00022287395,0.006109132,0.030519579,0.00012325759,0.0017158322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9910998,0.004568803,0.00078693265,0.0017926721,0.0013628056,0.00038889714],"domain_scores_gemma":[0.97402215,0.0037125128,0.00537505,0.0075645745,0.0068195798,0.002506025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012342743,0.00081905787,0.00083892216,0.0013551125,0.0013562255,0.0018708585,0.00091495714,0.0008283723,0.0023054718],"category_scores_gemma":[0.024731524,0.00061262085,0.00095841597,0.0029716373,0.0004119268,0.0006163424,0.0023169077,0.0010393031,0.0006377502],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041320436,0.00025036142,0.96983844,0.00028396843,0.0013299836,0.00023946863,0.0003180541,0.00028947726,0.0024507851,0.0011976681,0.006499455,0.013170298],"study_design_scores_gemma":[0.0023453943,0.0015148405,0.97089845,0.0002377602,0.0018343239,0.0009721662,0.0003656527,0.0012694779,0.0019180212,0.0007010282,0.017886076,0.000056828707],"about_ca_topic_score_codex":0.005170389,"about_ca_topic_score_gemma":0.007829349,"teacher_disagreement_score":0.012342743,"about_ca_system_score_codex":0.00083805324,"about_ca_system_score_gemma":0.0032519905,"threshold_uncertainty_score":0.06527543},"labels":[],"label_agreement":null},{"id":"W4409478525","doi":"10.1158/1078-0432.ccr-24-3525","title":"Update on Surveillance in Von Hippel–Lindau Disease","year":2025,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"St. Baldrick's Foundation","keywords":"Medicine; Von Hippel–Lindau disease; Disease; Cancer; Genetic predisposition; Childhood cancer; Intervention (counseling); Intensive care medicine; Bioinformatics; Pathology; Internal medicine; Psychiatry","score_opus":0.1871020730340491,"score_gpt":0.5520508886084972,"score_spread":0.364948815574448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409478525","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000070073394,0.99634296,0.00013486276,0.0014563581,0.0010083527,0.000006731631,0.00004476228,0.0000121964085,0.0009237021],"genre_scores_gemma":[0.00055657077,0.99653614,0.0002619515,0.0012935464,0.00068921497,0.000009693625,0.00010873561,0.0000036855677,0.00054035796],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994936,0.0001312309,0.00009290263,0.000062021376,0.00017107383,0.000049057617],"domain_scores_gemma":[0.9984207,0.0008557255,0.00014609542,0.000026491638,0.00045400497,0.00009711192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015960983,0.0007153419,0.0013980084,0.0024347433,0.00029406114,0.0011465263,0.001336847,0.0018057739,0.004411267],"category_scores_gemma":[0.003386359,0.00029998334,0.0010402551,0.0017921807,0.00041110537,0.0016837303,0.0008375491,0.0029383614,0.00193311],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089227935,0.000037651134,0.00018901321,0.014397893,0.000112748545,0.00022808503,0.000055564116,0.00033742553,0.00037990778,0.0032179242,0.12340584,0.8575488],"study_design_scores_gemma":[0.000019668978,0.000057643036,0.00044779794,0.0084974235,0.00016853212,0.0008139218,0.000029926181,0.000070300615,0.00011641959,0.0010074148,0.98875684,0.000014223716],"about_ca_topic_score_codex":0.0020688116,"about_ca_topic_score_gemma":0.0039799046,"teacher_disagreement_score":0.004411267,"about_ca_system_score_codex":0.0012238654,"about_ca_system_score_gemma":0.0017783043,"threshold_uncertainty_score":0.014757216},"labels":[],"label_agreement":null},{"id":"W4409907961","doi":"10.1158/1078-0432.ccr-25-0073","title":"INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Institute of Cancer Research","funders":"EMD Serono; Genentech; Qbiotics; Ipsen; Daiichi Sankyo Europe; LEO Pharma; Gilead Sciences; Servier; Eisai; Astellas Pharma; Eli Lilly and Company; Ono Pharmaceutical; Coherus Biosciences; Rakuten Medical; BeiGene; Relay Therapeutics; Seagen; Agios Pharmaceuticals; Les Laboratories Pierre Fabre; Regeneron Pharmaceuticals; Pfizer; Incyte; F. Hoffmann-La Roche; Sanofi; Exelixis; Directorate for Biological Sciences; GlaxoSmithKline; Amgen; AstraZeneca; Bristol-Myers Squibb","keywords":"Cetuximab; Medicine; Head and neck; Head and neck squamous-cell carcinoma; Basal cell; Head and neck cancer; Oncology; Placebo; Phases of clinical research; Internal medicine; Cancer; Pathology; Chemotherapy; Surgery; Colorectal cancer","score_opus":0.148584438661407,"score_gpt":0.5159044063151957,"score_spread":0.3673199676537887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409907961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97749853,0.008270551,0.0010409947,0.0008875732,0.000598304,0.0074862395,0.001368658,0.00034832227,0.0025008924],"genre_scores_gemma":[0.977711,0.004125139,0.0024797884,0.0015634774,0.00054913614,0.008283019,0.0013347222,0.000046683377,0.0039069313],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992111,0.00042986774,0.000045185872,0.00013599236,0.00008561421,0.00009223281],"domain_scores_gemma":[0.99917775,0.0001725063,0.00026367835,0.000055277156,0.000058419846,0.0002724036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023660643,0.0018919053,0.0022590011,0.0006894844,0.0006813133,0.0013344149,0.001384724,0.0022386175,0.0055399095],"category_scores_gemma":[0.0016930971,0.0008452201,0.0013735632,0.0004474178,0.0011877131,0.0011839422,0.00056458026,0.0031588133,0.001188511],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94939464,0.022632139,0.00075705396,0.0011860869,0.0010970671,0.00003850403,0.000086545886,0.00032422887,0.005935552,0.0001244141,0.0012121894,0.017211713],"study_design_scores_gemma":[0.9441539,0.053060785,0.0011915301,0.000025619358,0.0002784149,0.000021030644,0.000012395236,0.00024552224,0.00046249572,0.000050765728,0.0004870468,0.000010505784],"about_ca_topic_score_codex":0.0010184316,"about_ca_topic_score_gemma":0.0033828588,"teacher_disagreement_score":0.0055399095,"about_ca_system_score_codex":0.0010075124,"about_ca_system_score_gemma":0.0014927144,"threshold_uncertainty_score":0.018532872},"labels":[],"label_agreement":null},{"id":"W4409916105","doi":"10.1158/1078-0432.ccr-24-2701","title":"A Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor–Positive Breast Cancer: The BRACELET-01/PrE0113 Study","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"Oncolytics Biotech; Pfizer","keywords":"Paclitaxel; Avelumab; Metastatic breast cancer; Breast cancer; Oncology; Hormone receptor; Medicine; Internal medicine; Mammary gland; Cancer; Hormone; Randomized controlled trial; Immunotherapy","score_opus":0.08095628293231082,"score_gpt":0.487306013923848,"score_spread":0.40634973099153715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409916105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98600733,0.0042837407,0.0007442772,0.00071504223,0.00044818805,0.0033119977,0.0014424028,0.00016956277,0.0028773544],"genre_scores_gemma":[0.97665036,0.0043966114,0.0020171718,0.0017792042,0.00043406073,0.004487782,0.002619979,0.00007033876,0.007544507],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995658,0.0002379534,0.000018440076,0.000062544175,0.000040547915,0.000074705036],"domain_scores_gemma":[0.99928266,0.00016659609,0.0001777624,0.000067338,0.000036612153,0.00026908726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017109971,0.0018756337,0.0023366106,0.00042079698,0.0003444898,0.001155034,0.0012481939,0.0013480193,0.008050803],"category_scores_gemma":[0.0010362343,0.0008609716,0.0016979309,0.0004643237,0.0010458571,0.0010093157,0.0003158627,0.0038934872,0.001398543],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93901867,0.024266133,0.000844545,0.0006043821,0.0009920722,0.00005256587,0.00005218849,0.00058520935,0.007844062,0.00015462306,0.0018635909,0.023721902],"study_design_scores_gemma":[0.8875007,0.10817818,0.0018297038,0.00002461214,0.00033141705,0.000062787054,0.000020234853,0.0004028605,0.00058927323,0.00010364736,0.0009406515,0.000015781015],"about_ca_topic_score_codex":0.0009439331,"about_ca_topic_score_gemma":0.0029118392,"teacher_disagreement_score":0.008050803,"about_ca_system_score_codex":0.0009833093,"about_ca_system_score_gemma":0.0013979458,"threshold_uncertainty_score":0.026932597},"labels":[],"label_agreement":null},{"id":"W4410119734","doi":"10.1158/1078-0432.ccr-25-0423","title":"Pediatric Cancer Predisposition and Surveillance Update: Summary Perspective and Future Directions","year":2025,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; St. Baldrick's Foundation","keywords":"Perspective (graphical); Cancer; Medicine; Environmental health; Intensive care medicine; Computer science; Internal medicine; Artificial intelligence","score_opus":0.1265205553772792,"score_gpt":0.5565805325251523,"score_spread":0.4300599771478731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410119734","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000048722897,0.9957689,0.00005795077,0.0026287092,0.0009965241,0.0000053369213,0.00004071556,0.0000067858236,0.0004463328],"genre_scores_gemma":[0.0003322163,0.9968868,0.00017858786,0.0015038549,0.0007788292,0.000009238709,0.00006984889,0.000001994725,0.00023867132],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99925643,0.00020977945,0.00017362542,0.00008777042,0.0002025777,0.00006969523],"domain_scores_gemma":[0.9947989,0.0027017384,0.0006693744,0.0000765426,0.0015041677,0.00024931392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031053098,0.0007413384,0.0017240791,0.0036147402,0.00030958315,0.0016792198,0.001003111,0.0019359419,0.0054689217],"category_scores_gemma":[0.0071753804,0.0004112051,0.0014261982,0.0035603112,0.00043381072,0.0029153104,0.0009372097,0.0034743322,0.001612417],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000162055,0.000052678235,0.00042761004,0.05556042,0.00029373853,0.00021401506,0.00017143098,0.00035368162,0.0004357471,0.006470308,0.16671011,0.7691483],"study_design_scores_gemma":[0.000023606612,0.0000705061,0.00075399765,0.031087883,0.00042586777,0.0006366939,0.00010841037,0.00006527145,0.00007936216,0.0017578836,0.9649708,0.00001978346],"about_ca_topic_score_codex":0.0032441653,"about_ca_topic_score_gemma":0.0071511227,"teacher_disagreement_score":0.0054689217,"about_ca_system_score_codex":0.0016925895,"about_ca_system_score_gemma":0.0046536187,"threshold_uncertainty_score":0.018295407},"labels":[],"label_agreement":null},{"id":"W4410491589","doi":"10.1158/1078-0432.ccr-25-0369","title":"A Phase II Study of Perioperative Avelumab plus Chemotherapy for Patients with Resectable Gastric Cancer or Gastroesophageal Junction Cancer – The MONEO Study","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Servier; Astellas Pharma; Daiichi-Sankyo; Generalitat de Catalunya; Agencia Estatal de Investigación; Incyte; Centres de Recerca de Catalunya; Jazz Pharmaceuticals; Regeneron Pharmaceuticals; BeiGene; Merck KGaA; Daiichi Sankyo Europe; Fundación Cellex; Sanofi; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Gastroesophageal Junction; Medicine; Avelumab; Cancer; Perioperative; Chemotherapy; Internal medicine; Oncology; Adenocarcinoma; Gastroenterology; Surgery; Immunotherapy","score_opus":0.142831375325894,"score_gpt":0.5226747736308411,"score_spread":0.3798433983049472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410491589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99568933,0.0019172269,0.00035467008,0.00024325144,0.00007160069,0.0006578258,0.0002732692,0.000021871929,0.0007710521],"genre_scores_gemma":[0.9932555,0.0011912336,0.0013229215,0.00055857695,0.00016322719,0.0010541438,0.00095760816,0.000010203226,0.0014865244],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997236,0.00014867904,0.000012270935,0.000042224267,0.00003036107,0.000042767242],"domain_scores_gemma":[0.9996866,0.000038556343,0.000069051515,0.000036296024,0.00001744486,0.0001521197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012608856,0.0007359458,0.0010727221,0.00020006362,0.00021373201,0.0005007569,0.0004120814,0.00051652675,0.0015032722],"category_scores_gemma":[0.0004753581,0.00029315532,0.0008475378,0.00016900981,0.000462006,0.00036408295,0.00022952727,0.0013763399,0.000330909],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.68119687,0.077086605,0.04077788,0.0011399965,0.0020500056,0.00025437016,0.00021821506,0.001959629,0.06892911,0.00032960964,0.0031770566,0.12288062],"study_design_scores_gemma":[0.34907874,0.57653344,0.058410995,0.0000486041,0.000818412,0.0004528826,0.0000716192,0.0017105357,0.007557789,0.00014656634,0.0051338393,0.000036551748],"about_ca_topic_score_codex":0.00030311555,"about_ca_topic_score_gemma":0.0011588257,"teacher_disagreement_score":0.0015032722,"about_ca_system_score_codex":0.00045959302,"about_ca_system_score_gemma":0.0008288524,"threshold_uncertainty_score":0.0066683292},"labels":[],"label_agreement":null},{"id":"W4410580854","doi":"10.1158/1078-0432.ccr-24-3192","title":"Mechanism of Initial Favorable Response to Decitabine in <i>TP53</i> -Mutated MDS/AML and Potential Mechanisms of Subsequent Relapse","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome Canada","funders":"Innovation and Technology Commission; Croucher Foundation; University Grants Committee; Li Shu Fan Medical Foundation","keywords":"Decitabine; Mechanism (biology); Azacitidine; Cancer research; Leukemia; Medicine; Myelodysplastic syndromes; Biology; Internal medicine; Genetics; DNA methylation; Gene; Bone marrow","score_opus":0.09173280905897802,"score_gpt":0.4895852973011111,"score_spread":0.3978524882421331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410580854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964371,0.0014013918,0.0011151128,0.00011165472,0.000007379606,0.00005176136,0.00017810293,0.0000526756,0.00064490124],"genre_scores_gemma":[0.99914956,0.00015013936,0.00027813157,0.000032613258,0.0000048126076,0.00001928617,0.000091103466,0.0000032859375,0.00027106286],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998791,0.000022192879,0.000009312802,0.000037811384,0.000020943535,0.00003061242],"domain_scores_gemma":[0.9998882,0.000013973499,0.00005792004,0.000010723799,0.000009043997,0.000020159756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024732153,0.00027793553,0.00033876477,0.00028599743,0.00017942187,0.00041841657,0.00023505086,0.00022065055,0.0012286332],"category_scores_gemma":[0.00023552106,0.000109046654,0.00015848789,0.00013680056,0.00023408582,0.0001529781,0.00023233122,0.0002726733,0.00023324435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029136322,0.0002296225,0.09041948,0.00018847997,0.00006119807,0.0010450813,0.00020020297,0.0009779192,0.86766684,0.00090498605,0.00042005684,0.034972496],"study_design_scores_gemma":[0.00014218454,0.0022754844,0.6012848,0.000068527224,0.00015953342,0.0050984235,0.00048127575,0.011492501,0.37283525,0.001220983,0.0049122064,0.000028860713],"about_ca_topic_score_codex":0.0003340024,"about_ca_topic_score_gemma":0.0004305376,"teacher_disagreement_score":0.0012286332,"about_ca_system_score_codex":0.0005211257,"about_ca_system_score_gemma":0.000248478,"threshold_uncertainty_score":0.0041101575},"labels":[],"label_agreement":null},{"id":"W4411255039","doi":"10.1158/1557-3265.sabcs24-p2-08-26","title":"Abstract P2-08-26: FLEX: A Real-World Evidence, Full Transcriptome Study in 30,000 Patients with Early-Stage Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"FLEX; Cancer; Medicine; Transcriptome; Breast cancer; Stage (stratigraphy); Oncology; Internal medicine; Biology; Gene; Genetics; Computer science; Gene expression; Telecommunications","score_opus":0.16654400283689585,"score_gpt":0.5251134407569966,"score_spread":0.35856943792010076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411255039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83375597,0.004616449,0.002527257,0.0028395723,0.00014401325,0.0013760352,0.14909168,0.00013435126,0.005514654],"genre_scores_gemma":[0.86452204,0.0012891311,0.0049874475,0.003272834,0.00030432185,0.0029030966,0.12072008,0.00012758322,0.0018733633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977927,0.00092109,0.00034512446,0.0005202797,0.00025605632,0.00016464377],"domain_scores_gemma":[0.99226165,0.0019611034,0.0014769721,0.0018625967,0.0012414475,0.0011962418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046246643,0.0004824021,0.001062193,0.00086957286,0.0011729454,0.0019983144,0.0010490712,0.0010473127,0.0060431124],"category_scores_gemma":[0.009641307,0.0005367955,0.0011505088,0.0020342227,0.00065141387,0.0012813543,0.0020229078,0.0013805354,0.0024608255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013855706,0.0015385856,0.9039581,0.0019033524,0.003350509,0.000894877,0.0009022346,0.00076294225,0.0027560329,0.000998089,0.04116089,0.027918695],"study_design_scores_gemma":[0.0038811052,0.002514322,0.94237113,0.00090588,0.0023436272,0.0017318174,0.0016873897,0.0012827305,0.0008912396,0.0016595745,0.040560625,0.00017060016],"about_ca_topic_score_codex":0.0035214385,"about_ca_topic_score_gemma":0.0070910584,"teacher_disagreement_score":0.0060431124,"about_ca_system_score_codex":0.0009759464,"about_ca_system_score_gemma":0.0016341513,"threshold_uncertainty_score":0.024457872},"labels":[],"label_agreement":null},{"id":"W4411284824","doi":"10.1158/1557-3265.sabcs24-ps19-04","title":"Abstract PS19-04: Exploring the broad societal value of pembrolizumab in triple-negative breast cancer in Canada","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Triple-negative breast cancer; Pembrolizumab; Breast cancer; Medicine; Cancer; Value (mathematics); Oncology; Gynecology; Internal medicine; Immunotherapy; Statistics","score_opus":0.17892154257603307,"score_gpt":0.4915326437501494,"score_spread":0.3126111011741163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411284824","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29505768,0.3620637,0.004787646,0.044704247,0.00062727847,0.0031328916,0.16777673,0.0001742948,0.12167544],"genre_scores_gemma":[0.83470774,0.133193,0.00793446,0.0030945183,0.00013145237,0.00065930915,0.015616473,0.00004873075,0.0046143094],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99660933,0.0008128038,0.00029217423,0.0002226905,0.0016759598,0.00038702754],"domain_scores_gemma":[0.98628044,0.0029921231,0.0010486566,0.00015308445,0.008793458,0.00073226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004834769,0.00052793766,0.00087934517,0.0075212624,0.0016086164,0.0036594272,0.0012047453,0.0006647865,0.0037200875],"category_scores_gemma":[0.01796139,0.0002337272,0.002198125,0.013957175,0.00066459173,0.0006648533,0.00085646316,0.00079922675,0.00024049355],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026742853,0.00049677014,0.15498908,0.12557782,0.0076732826,0.0027878627,0.0039717155,0.024158975,0.002659643,0.03537231,0.13202341,0.5076149],"study_design_scores_gemma":[0.0011848162,0.0010174682,0.44924885,0.09068094,0.019815616,0.0011998026,0.012842405,0.025481356,0.0033194625,0.008086972,0.38664398,0.00047835123],"about_ca_topic_score_codex":0.9864318,"about_ca_topic_score_gemma":0.9916835,"teacher_disagreement_score":0.11060015,"about_ca_system_score_codex":0.11060015,"about_ca_system_score_gemma":0.26119003,"threshold_uncertainty_score":0.802464},"labels":[],"label_agreement":null},{"id":"W4411285140","doi":"10.1158/1557-3265.sabcs24-ps5-07","title":"Abstract PS5-07: Financial difficulty over time in young adults with breast cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Cancer; Medicine; Oncology; Internal medicine","score_opus":0.07618288971698177,"score_gpt":0.40306856796497054,"score_spread":0.32688567824798875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411285140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938251,0.00026689842,0.00006223659,0.00022777273,0.00001807385,0.00008257158,0.0043720854,0.000005268978,0.0011399045],"genre_scores_gemma":[0.9959973,0.00027243036,0.0001669958,0.00010594773,0.000022086237,0.00013056201,0.0028244592,0.0000019252818,0.00047826968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951875,0.00009049536,0.00010128951,0.00007416445,0.000098265045,0.000116999516],"domain_scores_gemma":[0.9972391,0.0002644925,0.0016691716,0.000067803216,0.00034384552,0.0004155959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009227804,0.00026867437,0.0002811615,0.0009871348,0.0007359729,0.00085310586,0.000416617,0.00037360628,0.0032522795],"category_scores_gemma":[0.003974472,0.00017407614,0.00053778186,0.0014581535,0.0002690997,0.0006572755,0.00088631106,0.000753547,0.0004590083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021274313,0.00002940145,0.99814856,0.000017101745,0.000013959874,0.00002297364,0.00011213379,0.000015912405,0.000015091216,0.000010159483,0.00036749532,0.0012260445],"study_design_scores_gemma":[0.000002607049,0.000045821493,0.99920374,0.00001424269,0.0000058562805,0.00004153036,0.0003683692,0.000046835434,0.000014402649,0.000013302462,0.0002410777,0.0000021644425],"about_ca_topic_score_codex":0.01914132,"about_ca_topic_score_gemma":0.032088514,"teacher_disagreement_score":0.01914132,"about_ca_system_score_codex":0.0007122512,"about_ca_system_score_gemma":0.0011314465,"threshold_uncertainty_score":0.03805983},"labels":[],"label_agreement":null},{"id":"W4411285509","doi":"10.1158/1557-3265.sabcs24-p3-08-22","title":"Abstract P3-08-22: Tucatinib, Trastuzumab and Capecitabine with brain and/or spinal radiotherapy (XRT) in patients with HER2+ metastatic breast cancer and leptomeningeal disease: A multi-centre phase II, single arm feasibility study (\"CLIMB LMD\"; NCT06016387)","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Capecitabine; Trastuzumab; Medicine; Radiation therapy; Metastatic breast cancer; Breast cancer; Oncology; Cancer; Internal medicine; Colorectal cancer","score_opus":0.13026874419272086,"score_gpt":0.5033111665503891,"score_spread":0.37304242235766827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411285509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796228,0.0014359498,0.000419921,0.00090591336,0.00013905701,0.010924031,0.0037098655,0.000117195836,0.0027251826],"genre_scores_gemma":[0.97539955,0.0011842924,0.0016952729,0.0015745534,0.00023644014,0.011230161,0.0043099336,0.000037507,0.004332372],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99934024,0.00032443868,0.000036937978,0.00009081738,0.0000710554,0.00013661261],"domain_scores_gemma":[0.9986517,0.00010270558,0.00023859958,0.000061697996,0.00010815394,0.00083727855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002427139,0.0016816837,0.0020860813,0.00039768367,0.0006577612,0.0012817535,0.0013074502,0.0015865004,0.0072830557],"category_scores_gemma":[0.0010568801,0.0007157435,0.0014597671,0.0006229779,0.0009616484,0.00088236586,0.0005096277,0.0034719114,0.0017411172],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8810152,0.05622316,0.005786208,0.0007733353,0.0009176299,0.00018773452,0.00017965406,0.00090876775,0.015481521,0.00011858633,0.0061781355,0.03223009],"study_design_scores_gemma":[0.7238236,0.2609897,0.011467572,0.00003254911,0.00029157,0.00011358448,0.000048273858,0.000335408,0.0009903505,0.00006214609,0.0018251588,0.000020130832],"about_ca_topic_score_codex":0.0069972556,"about_ca_topic_score_gemma":0.021729259,"teacher_disagreement_score":0.0072830557,"about_ca_system_score_codex":0.0020281042,"about_ca_system_score_gemma":0.006045513,"threshold_uncertainty_score":0.024364293},"labels":[],"label_agreement":null},{"id":"W4411286445","doi":"10.1158/1557-3265.sabcs24-p5-03-01","title":"Abstract P5-03-01: Open-label, randomized, multicenter, phase 3, ELAINE 3 study of the efficacy and safety of lasofoxifene plus abemaciclib for treating ER+/HER2-, locally advanced or metastatic breast cancer with an ESR1 mutation","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Metastatic breast cancer; Oncology; Breast cancer; Phases of clinical research; Cancer; Internal medicine; Open label; Randomized controlled trial; Clinical trial","score_opus":0.1548699941123187,"score_gpt":0.5548477553664776,"score_spread":0.39997776125415885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411286445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850033,0.0017811217,0.0011111201,0.00088719046,0.00030608475,0.0054457774,0.0026938147,0.00023076743,0.002540727],"genre_scores_gemma":[0.9772134,0.0016945497,0.003097938,0.0024099285,0.0005320612,0.0061799157,0.0035851097,0.00008384686,0.005203227],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992686,0.00039767887,0.000029888557,0.00012205544,0.00006711868,0.00011466309],"domain_scores_gemma":[0.9988318,0.00025458596,0.00026536168,0.000094558905,0.00008729013,0.00046634386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027723573,0.0021333932,0.0023549409,0.00047237036,0.0005989687,0.001611257,0.001191373,0.0019084977,0.0058126966],"category_scores_gemma":[0.0016241318,0.0008218466,0.0018551315,0.00044384145,0.0015524656,0.0013274577,0.00041458991,0.005191013,0.0014953492],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9476977,0.024621096,0.00094592996,0.00035442735,0.00086381834,0.000082292165,0.00011329459,0.00050560257,0.008603597,0.00016934701,0.0019092108,0.014133748],"study_design_scores_gemma":[0.9060805,0.0901171,0.0018035193,0.000013274851,0.00021774597,0.00004599935,0.000026864263,0.00042988374,0.000570901,0.00011533803,0.0005658279,0.000013131861],"about_ca_topic_score_codex":0.0016626329,"about_ca_topic_score_gemma":0.003736169,"teacher_disagreement_score":0.0058126966,"about_ca_system_score_codex":0.00097348075,"about_ca_system_score_gemma":0.0017987322,"threshold_uncertainty_score":0.01944542},"labels":[],"label_agreement":null},{"id":"W4411287331","doi":"10.1158/1557-3265.sabcs24-p3-06-01","title":"Abstract P3-06-01: Occupational exposure to ionizing radiation in female physicians and risk of breast cancer: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ionizing radiation; Medicine; Breast cancer; Meta-analysis; Cancer; Occupational exposure; Oncology; Non-ionizing radiation; Gynecology; Environmental health; Internal medicine; Irradiation","score_opus":0.3120725502798826,"score_gpt":0.5688611876200128,"score_spread":0.2567886373401302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411287331","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0055396333,0.99002856,0.0009855325,0.00035364387,0.00024837616,0.001038669,0.0013803593,0.00004655142,0.0003786082],"genre_scores_gemma":[0.1487868,0.83729607,0.0042073787,0.0012696892,0.00048211621,0.0053234864,0.0018424806,0.000049833943,0.00074217597],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9887476,0.004788496,0.0036657506,0.0009630953,0.0014838887,0.00035115087],"domain_scores_gemma":[0.97791547,0.015445557,0.0035554299,0.0006572228,0.0021392587,0.00028694872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014012452,0.0025475477,0.017736457,0.0074421572,0.000889651,0.0038117226,0.0023651787,0.0026562195,0.007221179],"category_scores_gemma":[0.03986923,0.0013047813,0.035104156,0.009952413,0.0008185386,0.0022893494,0.0017540308,0.00182067,0.000498371],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007828391,0.000026558702,0.00397887,0.6997288,0.28667375,0.0001569923,0.00010341841,0.00026262872,0.00017924828,0.0001200786,0.00086875225,0.0071181175],"study_design_scores_gemma":[0.0004912304,0.00018793292,0.005174626,0.08423724,0.9066661,0.00015218096,0.00007711273,0.00021667738,0.00013119407,0.00020651241,0.0024279635,0.00003122055],"about_ca_topic_score_codex":0.006602607,"about_ca_topic_score_gemma":0.013519482,"teacher_disagreement_score":0.017736457,"about_ca_system_score_codex":0.0027461383,"about_ca_system_score_gemma":0.005710194,"threshold_uncertainty_score":0.07410586},"labels":[],"label_agreement":null},{"id":"W4411287483","doi":"10.1158/1557-3265.sabcs24-p4-01-08","title":"Abstract P4-01-08: PYNK at 20: From SABCS Inspiration to Multisite Clinical, Research, and Educational Program for Young Women with Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Cancer; Oncology; Internal medicine; Gynecology; Family medicine; Gerontology","score_opus":0.24732005577582888,"score_gpt":0.5148930023642165,"score_spread":0.26757294658838765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411287483","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15706208,0.002652718,0.0063288724,0.117109895,0.015543848,0.006833885,0.0074037258,0.0057740016,0.681291],"genre_scores_gemma":[0.17213306,0.0025028724,0.013241078,0.01723161,0.002672615,0.0036614202,0.0046205525,0.001015569,0.78292125],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993413,0.00013772571,0.000019556403,0.000056393194,0.00014945751,0.00029550988],"domain_scores_gemma":[0.99181527,0.00017811736,0.00012444537,0.00011237729,0.00076095853,0.007008747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015624006,0.0002929656,0.00020918324,0.00054744014,0.0032515961,0.001791084,0.001151382,0.0009678639,0.22215259],"category_scores_gemma":[0.0023741787,0.00032900085,0.00027338366,0.00031029913,0.0006430541,0.000931253,0.0063705933,0.0025080566,0.04378868],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026453406,0.0005825108,0.005523947,0.00024980577,0.000005206389,0.00037044278,0.0009210086,0.000053346535,0.0011638473,0.0007042565,0.82693326,0.16322778],"study_design_scores_gemma":[0.00018035673,0.000676191,0.041758824,0.0003266946,0.00000778744,0.0006456705,0.00403729,0.00014772166,0.00084579765,0.0004117101,0.9509347,0.000027139962],"about_ca_topic_score_codex":0.0064853686,"about_ca_topic_score_gemma":0.02791864,"teacher_disagreement_score":0.22215259,"about_ca_system_score_codex":0.0022420026,"about_ca_system_score_gemma":0.01073816,"threshold_uncertainty_score":0.74317443},"labels":[],"label_agreement":null},{"id":"W4411287522","doi":"10.1158/1557-3265.sabcs24-p1-03-28","title":"Abstract P1-03-28: Agreement between the DESTINY-Breast04/06 VENTANA 4B5 HER2 IHC clinical trial assay and other comparator assays for HER2-low breast cancer: Overall results of a large-scale, multicenter global ring study","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Immunohistochemistry; Pathology; Cancer; Oncology; Internal medicine","score_opus":0.20641135838187216,"score_gpt":0.5548789198231137,"score_spread":0.34846756144124147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411287522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850033,0.0022549375,0.0033431435,0.00016995515,0.000060435996,0.0009803533,0.004827669,0.00014028932,0.0032198918],"genre_scores_gemma":[0.99087477,0.0001328292,0.0025278884,0.00022926807,0.000046744306,0.00052568194,0.004903742,0.00006761657,0.0006914933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97768503,0.015657712,0.0010380242,0.0030633032,0.0022335753,0.00032243406],"domain_scores_gemma":[0.96923256,0.013413646,0.0066620335,0.0041429508,0.004986574,0.0015623057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.031474512,0.00085593044,0.000988977,0.00074534677,0.00034707438,0.00106046,0.0011708757,0.0008961734,0.0028063047],"category_scores_gemma":[0.018281184,0.00041207214,0.0012847969,0.0006570954,0.0010164692,0.0008859737,0.0017428054,0.00086057215,0.0011152369],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2986514,0.0023144325,0.5815233,0.0014710363,0.012197832,0.00013113667,0.0010585387,0.0032574253,0.028155578,0.00031528118,0.010752277,0.060171787],"study_design_scores_gemma":[0.018987488,0.041798577,0.9051512,0.00014779659,0.005353236,0.000588685,0.00032945327,0.0055670687,0.016139548,0.0002811164,0.005520393,0.00013554031],"about_ca_topic_score_codex":0.0007942379,"about_ca_topic_score_gemma":0.0012463109,"teacher_disagreement_score":0.031474512,"about_ca_system_score_codex":0.00065343996,"about_ca_system_score_gemma":0.00047144212,"threshold_uncertainty_score":0.16645515},"labels":[],"label_agreement":null},{"id":"W4411287533","doi":"10.1158/1557-3265.sabcs24-ps16-09","title":"Abstract PS16-09: A decision support intervention to promote the use of preventive therapy among women at high risk for invasive breast cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Intervention (counseling); Cancer; Intensive care medicine; Oncology; Internal medicine; Nursing","score_opus":0.10643425305857977,"score_gpt":0.4764172836697689,"score_spread":0.3699830306111891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411287533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873892,0.00020455605,0.0010086612,0.0023266166,0.00016611427,0.0027666248,0.0005837817,0.00033907482,0.0052154777],"genre_scores_gemma":[0.9682767,0.00069306756,0.017194739,0.0009616135,0.0001411708,0.0046648164,0.0006575037,0.000020374951,0.0073900423],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999548,0.00022486201,0.000042994445,0.00004881047,0.00007614362,0.00005907639],"domain_scores_gemma":[0.99824095,0.00068540097,0.00024263625,0.00005166098,0.00008054764,0.0006987374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010495395,0.0004696218,0.00037068984,0.0003602602,0.00049172045,0.0003780453,0.00063980604,0.00052598305,0.016111134],"category_scores_gemma":[0.003641448,0.00022883677,0.0002874964,0.00021751455,0.00018391325,0.00037516237,0.0007053122,0.0009159261,0.0012192717],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018336497,0.09875175,0.0464078,0.0022430364,0.00018143428,0.00051403116,0.0029168322,0.0012121525,0.0069877277,0.0005219109,0.02939344,0.79253334],"study_design_scores_gemma":[0.06924297,0.27476376,0.5363495,0.0015923154,0.0009039212,0.0010257643,0.0066241333,0.014736853,0.013465023,0.0021913797,0.07888845,0.00021594256],"about_ca_topic_score_codex":0.0011139144,"about_ca_topic_score_gemma":0.0021752673,"teacher_disagreement_score":0.016111134,"about_ca_system_score_codex":0.0003605622,"about_ca_system_score_gemma":0.002013862,"threshold_uncertainty_score":0.053897142},"labels":[],"label_agreement":null},{"id":"W4411287646","doi":"10.1158/1557-3265.sabcs24-p2-03-01","title":"Abstract P2-03-01: Sexual health in unpartnered women after breast cancer: Report from a joint analysis of two international multi-site prospective cohorts of young breast cancer survivors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Cancer; Prospective cohort study; Oncology; Gerontology; Internal medicine","score_opus":0.10374469337103288,"score_gpt":0.5014941183113505,"score_spread":0.3977494249403176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411287646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99814665,0.0001299541,0.00006810787,0.000021370659,0.0000062452846,0.000020011172,0.0013658556,0.0000027722904,0.0002391209],"genre_scores_gemma":[0.9970016,0.000116228475,0.00006716654,0.000030050425,0.0000139170625,0.000038391958,0.0023530377,0.0000042779748,0.0003752932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994759,0.00017163604,0.000061719365,0.000110358,0.00010365711,0.00007679019],"domain_scores_gemma":[0.99841714,0.0001814927,0.00060601503,0.00020550015,0.00025330426,0.00033649383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012140191,0.00033519577,0.00040690033,0.000839908,0.0005464452,0.0008333542,0.00050521066,0.0003833294,0.0017001],"category_scores_gemma":[0.0016146254,0.00031470126,0.0006760374,0.0015185587,0.00028299162,0.00044034616,0.000920753,0.0004356993,0.00044464457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001154076,0.000025902664,0.99895835,0.000007275851,0.00005867998,0.00003773016,0.000088555134,0.000012403119,0.00010792447,0.0000035314317,0.00009483849,0.00048945943],"study_design_scores_gemma":[0.000011118104,0.00006417313,0.9993212,0.0000037803895,0.000034766002,0.00009596428,0.0002657192,0.000036745827,0.00003644968,0.0000031526688,0.00012438625,0.000002529395],"about_ca_topic_score_codex":0.011045944,"about_ca_topic_score_gemma":0.01066642,"teacher_disagreement_score":0.011045944,"about_ca_system_score_codex":0.00022577748,"about_ca_system_score_gemma":0.00039646935,"threshold_uncertainty_score":0.021963298},"labels":[],"label_agreement":null},{"id":"W4411287723","doi":"10.1158/1557-3265.sabcs24-p1-06-02","title":"Abstract P1-06-02: Remote functional cognitive rehabilitation in Breast Cancer Patients, a single center retrospective study","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Center (category theory); Breast cancer; Retrospective cohort study; Cognition; Cancer; Rehabilitation; Single Center; Oncology; Physical medicine and rehabilitation; Physical therapy; Internal medicine; Psychiatry","score_opus":0.10918668829412125,"score_gpt":0.49107608830392374,"score_spread":0.3818894000098025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411287723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99913603,0.0001674585,0.00009110136,0.000021552218,0.0000056413637,0.00008922334,0.00023693622,0.0000034662553,0.00024868737],"genre_scores_gemma":[0.9988562,0.00011994997,0.00010573167,0.00008283682,0.000021078984,0.00011719625,0.0004777862,0.000004032959,0.00021518349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991549,0.00023086228,0.00013099916,0.00022799666,0.00013793372,0.000117231306],"domain_scores_gemma":[0.99871063,0.00027117593,0.00035467584,0.00014468895,0.00019124552,0.00032759574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008084152,0.0005375071,0.00076829334,0.0011912652,0.0010903344,0.00083338155,0.00058156095,0.0008410513,0.0036858472],"category_scores_gemma":[0.0016523941,0.0006324451,0.0006068092,0.001527637,0.0005183027,0.0006129727,0.0006270542,0.0006135631,0.0011159356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032216177,0.0005824457,0.995959,0.00006109322,0.00005758008,0.0008635905,0.00039291376,0.000021503613,0.0003283965,0.000010743191,0.0001628,0.0012378771],"study_design_scores_gemma":[0.00017677242,0.00271929,0.98892725,0.000035701913,0.00013834871,0.0041360753,0.002583843,0.00018604324,0.00022823949,0.000024407684,0.00082098186,0.000022986038],"about_ca_topic_score_codex":0.0043606283,"about_ca_topic_score_gemma":0.0034862245,"teacher_disagreement_score":0.0043606283,"about_ca_system_score_codex":0.0003914913,"about_ca_system_score_gemma":0.00077549554,"threshold_uncertainty_score":0.012330413},"labels":[],"label_agreement":null},{"id":"W4411288229","doi":"10.1158/1557-3265.sabcs24-ps9-05","title":"Abstract PS9-05: Somatic Structural Variation in Breast Cancer and its Application in Longitudinal Analysis of Circulating Tumor DNA in Early Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Somatic cell; Medicine; Circulating tumor DNA; Cancer; Oncology; Internal medicine; Cancer research; Pathology; Biology; Genetics; Gene","score_opus":0.05107939086591847,"score_gpt":0.436898555841891,"score_spread":0.3858191649759726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411288229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87968653,0.001074673,0.029031072,0.00047973188,0.00010268522,0.00024265859,0.082066,0.0026860293,0.004630706],"genre_scores_gemma":[0.9252815,0.0002255165,0.035239458,0.00018160793,0.00006482115,0.00033386887,0.035607807,0.0004546568,0.0026106003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823654,0.00050159666,0.00012506309,0.0007089514,0.00031757998,0.000110190784],"domain_scores_gemma":[0.9949362,0.002227598,0.0010559426,0.0006550482,0.0006131745,0.0005119297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031479313,0.0003785013,0.00045997975,0.0016939983,0.00049780036,0.0014645988,0.0008367709,0.00055824016,0.008549988],"category_scores_gemma":[0.008071996,0.00029173197,0.0005369904,0.002524058,0.00044480502,0.00043659465,0.0009455132,0.00066028006,0.0016667307],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003301872,0.00016064309,0.87863714,0.00048733904,0.0009951971,0.00037465617,0.00042543962,0.0051722475,0.030430835,0.0010945414,0.011509619,0.0674104],"study_design_scores_gemma":[0.00027877925,0.0012624224,0.88680965,0.00010012469,0.00066958315,0.0016623295,0.00033305647,0.040677585,0.030672887,0.0020291868,0.03541884,0.00008560484],"about_ca_topic_score_codex":0.0046213823,"about_ca_topic_score_gemma":0.0072885943,"teacher_disagreement_score":0.008549988,"about_ca_system_score_codex":0.00059300807,"about_ca_system_score_gemma":0.00094371726,"threshold_uncertainty_score":0.02860254},"labels":[],"label_agreement":null},{"id":"W4411288788","doi":"10.1158/1557-3265.sabcs24-p3-11-18","title":"Abstract P3-11-18: Prognostic significance of lobular versus ductal histology in HER2-positive breast cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Histology; Breast cancer; Cancer; Pathology; Oncology; Internal medicine","score_opus":0.10078710803102031,"score_gpt":0.47843219884641064,"score_spread":0.3776450908153903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411288788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99596184,0.0009230604,0.00017945474,0.00014347168,0.00001528034,0.000009839411,0.0015036736,0.0000180106,0.0012453683],"genre_scores_gemma":[0.9988493,0.00008483843,0.0000852419,0.00001904291,0.000010803476,0.0000032932342,0.0005048448,0.0000042432885,0.00043836088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984944,0.000022354163,0.000011186097,0.000028637418,0.000043200984,0.00004522897],"domain_scores_gemma":[0.9987902,0.00017658205,0.00044292666,0.00004123806,0.00021692658,0.00033219767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037138828,0.00023990315,0.00017668837,0.0004440634,0.0003493898,0.000775152,0.0004343389,0.00029888086,0.0045148777],"category_scores_gemma":[0.0012794957,0.0000830641,0.0002395372,0.0009308986,0.0004266945,0.00019861381,0.00027692755,0.00042285302,0.0005097307],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021490667,0.0000061723385,0.9970795,0.000010203015,0.000020473639,0.000089216745,0.000011915729,0.000050242314,0.00034092774,0.000009558428,0.0002890289,0.0018778275],"study_design_scores_gemma":[0.000009723454,0.000040762312,0.9981919,0.000010319773,0.00003318016,0.00057899114,0.000107349646,0.0002861874,0.00025863308,0.000038980597,0.00044122452,0.000002813399],"about_ca_topic_score_codex":0.045413513,"about_ca_topic_score_gemma":0.06292229,"teacher_disagreement_score":0.045413513,"about_ca_system_score_codex":0.00089463097,"about_ca_system_score_gemma":0.0011147031,"threshold_uncertainty_score":0.090298355},"labels":[],"label_agreement":null},{"id":"W4411288900","doi":"10.1158/1557-3265.sabcs24-p3-12-26","title":"Abstract P3-12-26: Partial breast re-irradiation using ultra hypofractionation: A Phase 2 multi- institutional study","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Phase (matter); Irradiation; Oncology; Chemistry; Physics","score_opus":0.4941946214710811,"score_gpt":0.6313563039220824,"score_spread":0.1371616824510013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411288900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864829,0.0012079743,0.0019740204,0.00031299988,0.00012412765,0.0062876698,0.0020469893,0.00016399668,0.0013991641],"genre_scores_gemma":[0.96628124,0.002230062,0.005987589,0.0016811589,0.00026783606,0.012694422,0.0051496523,0.00012040801,0.005587773],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9990766,0.00037573444,0.000052391482,0.00017786596,0.000115502524,0.00020183632],"domain_scores_gemma":[0.99898106,0.00007600092,0.00017789596,0.00022484659,0.0000858399,0.0004543369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00336639,0.0022333039,0.0021855962,0.00045456673,0.00090680586,0.0014570277,0.0014235257,0.0016167616,0.005249759],"category_scores_gemma":[0.0007569358,0.00076719734,0.0023222973,0.00075648836,0.0014943286,0.0011095601,0.00072406494,0.0036360195,0.001904409],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4550481,0.3698147,0.010822102,0.0013510237,0.0023300212,0.00042542323,0.0004547333,0.0024781704,0.079874195,0.00038050665,0.005052409,0.07196869],"study_design_scores_gemma":[0.1731052,0.7982839,0.015606309,0.000060564693,0.00076063734,0.0003684625,0.00012140492,0.0007293456,0.0063676937,0.00027861536,0.004265782,0.000052093397],"about_ca_topic_score_codex":0.0009120561,"about_ca_topic_score_gemma":0.0011942527,"teacher_disagreement_score":0.005249759,"about_ca_system_score_codex":0.0008325462,"about_ca_system_score_gemma":0.0026052028,"threshold_uncertainty_score":0.01780343},"labels":[],"label_agreement":null},{"id":"W4411288963","doi":"10.1158/1557-3265.sabcs24-gs1-08","title":"Abstract GS1-08: Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: results from an international cohort study","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Breast cancer; Cohort; Cancer; Internal medicine; Cohort study","score_opus":0.0560054673001109,"score_gpt":0.4601311686947561,"score_spread":0.4041257013946452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411288963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901598,0.0012422565,0.00024448257,0.00014105685,0.000024952064,0.000039575367,0.007486498,0.000012249592,0.0006491919],"genre_scores_gemma":[0.9936221,0.00047073534,0.00023810305,0.000110732,0.00002794507,0.000050987048,0.0051035187,0.000013136032,0.0003627613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992841,0.0001891193,0.00007995391,0.00024771274,0.00009808142,0.000101100624],"domain_scores_gemma":[0.9973834,0.00046110858,0.0010488189,0.0004224119,0.00028334087,0.00040087203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015870135,0.0004640027,0.00040698104,0.0008924272,0.00044319627,0.0007415677,0.0005846162,0.00048312158,0.002857447],"category_scores_gemma":[0.003750511,0.0002185138,0.0012735516,0.0018849837,0.00030855864,0.00040550128,0.000797273,0.0007227672,0.00038687504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077530334,0.00003398205,0.99531,0.00007269214,0.00055726996,0.00012480898,0.00013594558,0.00007065238,0.00019377658,0.0000390283,0.0007810604,0.001905477],"study_design_scores_gemma":[0.00007744199,0.00018731912,0.99743146,0.000037453392,0.00064691517,0.00028568806,0.00020957532,0.00012814307,0.000056421766,0.000046980444,0.00088384835,0.000008723856],"about_ca_topic_score_codex":0.012205907,"about_ca_topic_score_gemma":0.012517436,"teacher_disagreement_score":0.012205907,"about_ca_system_score_codex":0.0003457237,"about_ca_system_score_gemma":0.0005271296,"threshold_uncertainty_score":0.0242697},"labels":[],"label_agreement":null},{"id":"W4411289080","doi":"10.1158/1557-3265.sabcs24-p4-04-14","title":"Abstract P4-04-14: Economic analysis of germline genetic testing to assess for hereditary breast cancer: a systematic review","year":2025,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genetic testing; Germline; Breast cancer; Medicine; Cancer; Germline mutation; Oncology; Internal medicine; Genetics; Biology; Mutation; Gene","score_opus":0.315159796038709,"score_gpt":0.579580750645394,"score_spread":0.2644209546066851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411289080","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024591256,0.99238455,0.00046232954,0.00087842566,0.00021707545,0.0012663831,0.0014583315,0.000018456145,0.0008552424],"genre_scores_gemma":[0.056659218,0.936948,0.0016357655,0.0011120494,0.0001922329,0.0024003312,0.00068447413,0.000015009632,0.00035294966],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9887918,0.005636647,0.002906255,0.00050098175,0.0018654843,0.0002988809],"domain_scores_gemma":[0.95150405,0.03914046,0.005463569,0.0004522161,0.003118634,0.0003210888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0116215795,0.001610355,0.008517627,0.008081745,0.0005108246,0.0032625736,0.0018830247,0.0021229337,0.008902275],"category_scores_gemma":[0.07404357,0.0008224397,0.0096302265,0.009404422,0.00076157507,0.0022982343,0.0011780008,0.0016358435,0.00037339673],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031154408,0.000017972683,0.00078076374,0.9617936,0.020554408,0.000080370046,0.0000626592,0.00023294555,0.000056502107,0.00035686497,0.001668222,0.0140841305],"study_design_scores_gemma":[0.0008006706,0.00022168017,0.0039403415,0.8697819,0.11382347,0.00025667986,0.00019941502,0.00038535407,0.00015194817,0.00083856954,0.0095604025,0.00003948099],"about_ca_topic_score_codex":0.008754702,"about_ca_topic_score_gemma":0.016372295,"teacher_disagreement_score":0.0116215795,"about_ca_system_score_codex":0.0063249194,"about_ca_system_score_gemma":0.010395675,"threshold_uncertainty_score":0.06146151},"labels":[],"label_agreement":null},{"id":"W4411289211","doi":"10.1158/1557-3265.sabcs24-p4-02-02","title":"Abstract P4-02-02: Hospitalizations and emergency visits for Ontario breast cancer patients undergoing neoadjuvant chemotherapy with pembrolizumab: A population-based analysis","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pembrolizumab; Breast cancer; Chemotherapy; Oncology; Cancer; Population; Neoadjuvant therapy; Internal medicine; Immunotherapy","score_opus":0.053933127609821885,"score_gpt":0.4515621291709281,"score_spread":0.3976290015611062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411289211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919525,0.00020838037,0.000065120854,0.00008712604,0.0000055943333,0.000058030877,0.0067469967,0.000007368397,0.00086892745],"genre_scores_gemma":[0.99632436,0.00013944593,0.000065701446,0.000037747704,0.0000081142725,0.000035723166,0.0030122916,0.0000032083954,0.00037336565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992618,0.00006638911,0.000085811625,0.00014420495,0.00025665155,0.00018514853],"domain_scores_gemma":[0.9979394,0.00013831264,0.0009947851,0.00008644008,0.00041367376,0.0004274451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038288932,0.0003694743,0.00042477407,0.0011131432,0.0009705936,0.0006852967,0.0009950313,0.00045880946,0.0027687885],"category_scores_gemma":[0.0015799106,0.0004774234,0.0009676024,0.0027653715,0.00039274222,0.0003424867,0.00075295445,0.0005266545,0.00023408761],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007626931,0.0000127425255,0.9989453,0.000016663285,0.000063101535,0.00003433245,0.000059523863,0.00003783513,0.00008402244,0.0000073795572,0.00029706894,0.0003657031],"study_design_scores_gemma":[0.000008306795,0.000017641134,0.99946433,0.0000054562875,0.000019010637,0.00003258743,0.0001650502,0.00012802763,0.00001084833,0.0000026640455,0.00014321099,0.0000029185496],"about_ca_topic_score_codex":0.84878135,"about_ca_topic_score_gemma":0.85652053,"teacher_disagreement_score":0.15121865,"about_ca_system_score_codex":0.0067952015,"about_ca_system_score_gemma":0.0058792876,"threshold_uncertainty_score":0.30421835},"labels":[],"label_agreement":null},{"id":"W4411289215","doi":"10.1158/1557-3265.sabcs24-p4-04-11","title":"Abstract P4-04-11: Managing Wait Time Between Surgery and Treatment Initiation Plan in Patients with Breast Cancer: a Mixed-method Approach","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Cancer; Surgery; Internal medicine","score_opus":0.15213721061533678,"score_gpt":0.3996779161633874,"score_spread":0.2475407055480506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411289215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9645158,0.0005634601,0.014656149,0.0017000571,0.0001272197,0.0152794495,0.0007018292,0.00005898626,0.0023970476],"genre_scores_gemma":[0.89569384,0.0005066501,0.05321154,0.0013329623,0.000083527884,0.04733432,0.00032946578,0.000042483836,0.0014652116],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9749605,0.020266335,0.0012763974,0.0012883138,0.0013511254,0.00085734716],"domain_scores_gemma":[0.9537654,0.035402965,0.0042412253,0.0014761129,0.003371996,0.0017422294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.031472012,0.00061935297,0.00071809755,0.0016510198,0.0026979821,0.0029175123,0.002025284,0.0009462098,0.005743481],"category_scores_gemma":[0.043344215,0.0008215631,0.0015693255,0.0013271777,0.0012937333,0.0015591714,0.0031719755,0.0018353916,0.0006193701],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008509156,0.027173532,0.26880187,0.0063303285,0.0011695243,0.00086341554,0.3142022,0.002191422,0.0030298736,0.0055815587,0.0061316863,0.3560155],"study_design_scores_gemma":[0.006385998,0.061261017,0.2765655,0.004699512,0.0018532565,0.0007556686,0.56953764,0.025109053,0.0076065,0.009987934,0.035630945,0.00060705637],"about_ca_topic_score_codex":0.004758091,"about_ca_topic_score_gemma":0.009874581,"teacher_disagreement_score":0.031472012,"about_ca_system_score_codex":0.0046540494,"about_ca_system_score_gemma":0.009151505,"threshold_uncertainty_score":0.16644192},"labels":[],"label_agreement":null},{"id":"W4411289429","doi":"10.1158/1557-3265.sabcs24-p3-07-07","title":"Abstract P3-07-07: 10-Year Local Recurrence Rates Following Selective Omission of Re-excision for Patients with Ductal Carcinoma in Situ and Margins","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ductal carcinoma; In situ; Carcinoma; Carcinoma in situ; Oncology; Internal medicine; Cancer; Chemistry; Breast cancer","score_opus":0.10258889666480478,"score_gpt":0.49554457372993577,"score_spread":0.392955677065131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411289429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981261,0.000277853,0.00007026598,0.00004003295,0.0000056682065,0.000014162161,0.0010733028,0.000008646429,0.00038394815],"genre_scores_gemma":[0.9988311,0.000055068176,0.000040303414,0.000020344256,0.0000056329714,0.0000082189445,0.0008121193,0.000002956256,0.0002243376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963534,0.000043337754,0.000024889388,0.000080128455,0.00012811428,0.00008816543],"domain_scores_gemma":[0.9985751,0.00020211434,0.00066460995,0.00010773306,0.00023886061,0.00021151385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004643354,0.00014666661,0.00025517837,0.0004011694,0.00028778188,0.00042691236,0.0006130645,0.00027264468,0.0021006623],"category_scores_gemma":[0.0014713529,0.00013735071,0.0006411884,0.00057587,0.00019931117,0.0001913928,0.00033662128,0.00043809717,0.0002791766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033221536,0.000021229675,0.9963887,0.000020246276,0.000060320985,0.00005697177,0.000031441443,0.00006904704,0.00015236074,0.000006301424,0.0003318724,0.002529383],"study_design_scores_gemma":[0.000012091245,0.00012816428,0.9990884,0.000009719954,0.00005772367,0.00018366618,0.00007774016,0.00013326849,0.000108527594,0.000009047463,0.0001886142,0.000003007264],"about_ca_topic_score_codex":0.07217438,"about_ca_topic_score_gemma":0.1287235,"teacher_disagreement_score":0.07217438,"about_ca_system_score_codex":0.001493586,"about_ca_system_score_gemma":0.0012743948,"threshold_uncertainty_score":0.14350855},"labels":[],"label_agreement":null},{"id":"W4411289704","doi":"10.1158/1557-3265.sabcs24-p4-04-09","title":"Abstract P4-04-09: Supporting the Knowledge Translation of Exercise Recommendations for People with Bone Metastases using Experience-based Co-Design","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Educational Games and Gamification","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Knowledge translation; Medicine; Translation (biology); Knowledge management; Computer science","score_opus":0.554718448280733,"score_gpt":0.6273219973605612,"score_spread":0.07260354907982813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411289704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.541326,0.0013424912,0.28897882,0.011310348,0.0007555519,0.09010244,0.0011421121,0.00220083,0.06284138],"genre_scores_gemma":[0.5508423,0.0009499559,0.399478,0.0017857085,0.000103580605,0.04135417,0.0005917662,0.00026013923,0.0046344926],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9395964,0.050945465,0.0022899047,0.0017887024,0.003889083,0.0014904717],"domain_scores_gemma":[0.8929775,0.0781937,0.0043126293,0.0102412095,0.010240829,0.004034168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08138058,0.0009251076,0.00069413974,0.0014019535,0.0020485353,0.005268861,0.0025835568,0.001896893,0.008572086],"category_scores_gemma":[0.11159967,0.0006328841,0.0013640742,0.001179224,0.002364507,0.0040435065,0.009493157,0.0023599975,0.0021922626],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022399828,0.011722381,0.012613412,0.010976534,0.00020045985,0.00085939287,0.10742939,0.0017404027,0.008067157,0.0076597515,0.015946733,0.8205443],"study_design_scores_gemma":[0.01190329,0.0535053,0.07249801,0.026634112,0.0016079412,0.0026809005,0.21259697,0.028453352,0.04161253,0.059617583,0.48827186,0.0006181933],"about_ca_topic_score_codex":0.0011384353,"about_ca_topic_score_gemma":0.0011882071,"teacher_disagreement_score":0.08138058,"about_ca_system_score_codex":0.002399851,"about_ca_system_score_gemma":0.012527035,"threshold_uncertainty_score":0.43038678},"labels":[],"label_agreement":null},{"id":"W4411289779","doi":"10.1158/1557-3265.sabcs24-p4-06-09","title":"Abstract P4-06-09: Does Age Impact Patient Involvement in Treatment Decision Making: Results from the Canadian Breast Cancer Network (CBCN) Assessment Project","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Medicine; Cancer; Gynecology; Oncology; Family medicine; Internal medicine","score_opus":0.21166987938525822,"score_gpt":0.48540969345232327,"score_spread":0.27373981406706505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411289779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874008,0.000224865,0.00008374863,0.0012353342,0.000026984919,0.00045464956,0.003235502,0.0000134030515,0.0073246607],"genre_scores_gemma":[0.9958473,0.0002279458,0.00032026996,0.00028356223,0.000010679147,0.00042190694,0.0014240214,0.000008507746,0.0014559565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963721,0.0013235778,0.0002280096,0.0001848372,0.001132641,0.0007587993],"domain_scores_gemma":[0.9737065,0.0077864937,0.0039751544,0.00058730406,0.009466597,0.004478065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067372983,0.00030662783,0.0004388855,0.0010539503,0.0026978066,0.0016372934,0.0014399971,0.00069121865,0.0043772985],"category_scores_gemma":[0.028336074,0.00022815292,0.0012264929,0.0017077016,0.0007756597,0.0010950493,0.0019358027,0.0012786826,0.0005116306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004693712,0.00068419834,0.9641952,0.00015147752,0.000076649056,0.00006356539,0.007582878,0.00016328563,0.000043683478,0.00009458506,0.0054882616,0.020986926],"study_design_scores_gemma":[0.000036501555,0.00028139784,0.9778969,0.00013673035,0.00006605098,0.000027533433,0.017810905,0.0003670526,0.00009261666,0.000081529564,0.0031760426,0.00002669966],"about_ca_topic_score_codex":0.6994182,"about_ca_topic_score_gemma":0.6975266,"teacher_disagreement_score":0.3005818,"about_ca_system_score_codex":0.012237695,"about_ca_system_score_gemma":0.02248089,"threshold_uncertainty_score":0.604704},"labels":[],"label_agreement":null},{"id":"W4411289812","doi":"10.1158/1557-3265.sabcs24-p3-12-05","title":"Abstract P3-12-05: Real-world use of sacituzumab govitecan (SG) in the management of metastatic triple-negative breast cancer (mTNBC) through a Canadian Patient Support Program (PSP)","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Triple-negative breast cancer; Medicine; Metastatic breast cancer; Cancer; Oncology; Breast cancer; Internal medicine","score_opus":0.24053259445637507,"score_gpt":0.5369587132434502,"score_spread":0.29642611878707514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411289812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99359596,0.00024125169,0.000091050955,0.00025547514,0.00000819346,0.00023347643,0.0037295928,0.000013458043,0.0018315912],"genre_scores_gemma":[0.9951527,0.00020717965,0.0003081553,0.00025334556,0.000018316323,0.00011218076,0.0028146794,0.000005535961,0.0011278949],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99957806,0.000059743787,0.00001667726,0.00007847512,0.0001545471,0.00011249236],"domain_scores_gemma":[0.9991406,0.00005566944,0.00029874174,0.000039755494,0.0001358025,0.0003294707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005173511,0.00018482862,0.00021002363,0.00024358236,0.0010577429,0.00065507076,0.0004975584,0.00029952495,0.0023094346],"category_scores_gemma":[0.0009017723,0.00013779357,0.0003406433,0.00069565163,0.00040737385,0.00019888442,0.0003034767,0.0006063961,0.0002958646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013240454,0.002772506,0.9039903,0.0002425681,0.0004089304,0.00045373425,0.0006058167,0.0008412525,0.0036690664,0.00020918057,0.009717429,0.063848756],"study_design_scores_gemma":[0.001088973,0.0034846817,0.98623264,0.000046838468,0.00017868789,0.00031105996,0.00029657132,0.00061510544,0.00068300153,0.000042167347,0.007001861,0.000018341823],"about_ca_topic_score_codex":0.5147332,"about_ca_topic_score_gemma":0.7212553,"teacher_disagreement_score":0.4852668,"about_ca_system_score_codex":0.008553643,"about_ca_system_score_gemma":0.010421125,"threshold_uncertainty_score":0.9762493},"labels":[],"label_agreement":null},{"id":"W4411289858","doi":"10.1158/1557-3265.sabcs24-p3-07-03","title":"Abstract P3-07-03: Real-world comparison of safety and effectiveness of dose dense (2-weekly) versus weekly paclitaxel given with trastuzumab as neoadjuvant treatment in HER2-positive early stage breast cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Trastuzumab; Medicine; Paclitaxel; Oncology; Breast cancer; Stage (stratigraphy); Internal medicine; Cancer","score_opus":0.14634287494718778,"score_gpt":0.5437414468488628,"score_spread":0.39739857190167505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411289858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986979,0.0002886847,0.00010568005,0.000022579556,0.000005836715,0.00016340688,0.0004242375,0.000009586771,0.0002820721],"genre_scores_gemma":[0.9989737,0.00008514852,0.00021976633,0.000028001397,0.000016273894,0.00011560611,0.00047959053,0.0000028979098,0.00007889646],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9985715,0.00096669496,0.00009956473,0.00013442717,0.00016195928,0.00006579414],"domain_scores_gemma":[0.9948179,0.002161908,0.001968619,0.0003137181,0.00031431016,0.00042361923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002448592,0.00024578438,0.00059366314,0.0003544933,0.00019552828,0.0005071928,0.0003999351,0.00048423756,0.0020066442],"category_scores_gemma":[0.004164138,0.00015975647,0.000779401,0.00073767983,0.00042409168,0.0003679261,0.00022642832,0.00054789876,0.00022064065],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8018403,0.012755166,0.09974101,0.00070021866,0.0015857393,0.00014761802,0.00016398758,0.0055271173,0.007046012,0.000102657505,0.0010986332,0.06929151],"study_design_scores_gemma":[0.08391773,0.44863287,0.4493471,0.00008463461,0.0016752644,0.00045112465,0.00014853355,0.0065203365,0.007027845,0.00015613089,0.0019772402,0.00006125478],"about_ca_topic_score_codex":0.0029184143,"about_ca_topic_score_gemma":0.0029068857,"teacher_disagreement_score":0.0029184143,"about_ca_system_score_codex":0.0016670759,"about_ca_system_score_gemma":0.0011378634,"threshold_uncertainty_score":0.012949526},"labels":[],"label_agreement":null},{"id":"W4411290570","doi":"10.1158/1557-3265.sabcs24-p2-11-15","title":"Abstract P2-11-15: Axillary Pathologic Complete Response in Triple-Negative Breast Cancer Patients with Mammary Pathologic Complete Response: A Systematic Review","year":2025,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Complete response; Triple-negative breast cancer; Cancer; Triple negative; Pathology; Oncology; Internal medicine; Chemotherapy","score_opus":0.3170601579605599,"score_gpt":0.5545073676760174,"score_spread":0.23744720971545746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411290570","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0042503476,0.9886678,0.0005090004,0.00059073634,0.00020135858,0.0025017622,0.0026382161,0.000030461979,0.0006102406],"genre_scores_gemma":[0.08598828,0.8989304,0.0022272172,0.0018805388,0.00024608837,0.008246794,0.0018945237,0.000027149314,0.000559006],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9848363,0.004845153,0.006527771,0.0010860636,0.0023537518,0.00035096277],"domain_scores_gemma":[0.9616194,0.024599878,0.009629366,0.00070664665,0.003069416,0.00037531042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012826816,0.0016069165,0.011540529,0.00967461,0.00072486926,0.003202363,0.0024340923,0.002070539,0.006461202],"category_scores_gemma":[0.04799955,0.0009403313,0.00954256,0.011002098,0.0013411383,0.002917181,0.0018166977,0.0010056798,0.0003777407],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015523437,0.0000063801904,0.0007970114,0.98449004,0.007955029,0.000045183147,0.00011217213,0.000043166063,0.00009406529,0.00008482973,0.0005754641,0.0056415363],"study_design_scores_gemma":[0.0004676298,0.00016886217,0.0054773004,0.8831085,0.10348354,0.00026563925,0.00025321913,0.000111699774,0.00015998211,0.00029564786,0.0061713546,0.00003653099],"about_ca_topic_score_codex":0.007406582,"about_ca_topic_score_gemma":0.018222768,"teacher_disagreement_score":0.012826816,"about_ca_system_score_codex":0.0044071916,"about_ca_system_score_gemma":0.010854304,"threshold_uncertainty_score":0.06783551},"labels":[],"label_agreement":null},{"id":"W4411290823","doi":"10.1158/1557-3265.sabcs24-p5-10-06","title":"Abstract P5-10-06: Retrospective, population-based cohort study on associations between tumor size, receptor status, &amp; regional nodal positivity rates for early-stage breast cancer: implications for decision between upfront surgery vs neoadjuvant systemic therapy","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Stage (stratigraphy); Retrospective cohort study; Oncology; Cancer; Cohort; Internal medicine; Gynecology; Biology","score_opus":0.12867735206575742,"score_gpt":0.4946366017761994,"score_spread":0.36595924971044197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411290823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98976713,0.00014384744,0.00013730746,0.00004849602,0.0000087795715,0.00006933728,0.009108665,0.00000679185,0.0007097429],"genre_scores_gemma":[0.9955577,0.00005890568,0.00011637781,0.000055260454,0.000008533335,0.000053678952,0.0036979187,0.0000037414334,0.00044785778],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992549,0.00009267259,0.00007274178,0.0002431578,0.00018430887,0.00015222494],"domain_scores_gemma":[0.99843234,0.0001337674,0.0006207973,0.00020621278,0.00030919263,0.0002976146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085502444,0.00032933665,0.0002895319,0.0007970557,0.0009778077,0.00071135274,0.00078759354,0.00040966313,0.0024701566],"category_scores_gemma":[0.0017740172,0.0004844587,0.0005377454,0.0018594436,0.00047785247,0.00044896224,0.0004931502,0.00051160477,0.0004471029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009745737,0.000016144228,0.9990182,0.000008927566,0.00004012177,0.000032546614,0.00006154701,0.000015006156,0.000105294974,0.000013487759,0.0003240914,0.0002672649],"study_design_scores_gemma":[0.000015525487,0.000040753523,0.9992632,0.000006252026,0.000028783275,0.00005519749,0.00011765149,0.00008331593,0.000031728134,0.0000077486275,0.00034714656,0.0000027447165],"about_ca_topic_score_codex":0.4209225,"about_ca_topic_score_gemma":0.46905208,"teacher_disagreement_score":0.4209225,"about_ca_system_score_codex":0.0028589363,"about_ca_system_score_gemma":0.0030271786,"threshold_uncertainty_score":0.8369449},"labels":[],"label_agreement":null},{"id":"W4411290861","doi":"10.1158/1557-3265.sabcs24-p4-08-02","title":"Abstract P4-08-02: Identifying unique transcriptomes associated with HER2+ breast cancer recurrence at the single-cell level","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Medicine; Transcriptome; Cancer; Oncology; Internal medicine; Computational biology; Biology; Genetics; Gene; Gene expression","score_opus":0.45902800883359274,"score_gpt":0.5609312424808137,"score_spread":0.10190323364722098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411290861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8931328,0.004961829,0.04328061,0.0012813475,0.00058133213,0.00028991004,0.047377937,0.0021027105,0.0069915275],"genre_scores_gemma":[0.87205017,0.0025234963,0.046188597,0.0014181962,0.00019913964,0.0006325652,0.06365849,0.0006514498,0.012677862],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999671,0.000022012755,0.00002132038,0.00010656734,0.000119426964,0.000059702463],"domain_scores_gemma":[0.99966645,0.00008696855,0.000056462777,0.000034983193,0.00011897443,0.000036142446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041976254,0.00031889547,0.00048193053,0.00060165697,0.00047063705,0.0008189584,0.00031345803,0.0005509707,0.003881175],"category_scores_gemma":[0.0005835079,0.00020192582,0.00053668267,0.00056806725,0.00023971176,0.00029337424,0.00048357423,0.0008592764,0.0018035544],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028694206,0.00004668284,0.010563471,0.00035123195,0.00005427087,0.000347723,0.00014680621,0.00045703663,0.9699275,0.00018118123,0.0036138147,0.01402337],"study_design_scores_gemma":[0.000036515077,0.00046868646,0.18097736,0.00009182104,0.0002032935,0.0022181894,0.0005675454,0.00946589,0.76315755,0.00073757244,0.041992337,0.00008323313],"about_ca_topic_score_codex":0.0012120301,"about_ca_topic_score_gemma":0.0018508515,"teacher_disagreement_score":0.003881175,"about_ca_system_score_codex":0.0003207172,"about_ca_system_score_gemma":0.0004929082,"threshold_uncertainty_score":0.012983859},"labels":[],"label_agreement":null},{"id":"W4411291066","doi":"10.1158/1557-3265.sabcs24-p2-06-16","title":"Abstract P2-06-16: Addressing Thermal and Battery Efficiency in AI Enhanced Portable Ultrasound Screening Protocols for Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Infrared Thermography in Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Breast cancer; Battery (electricity); Ultrasound; Internal medicine; Radiology","score_opus":0.18739584994741895,"score_gpt":0.5563357357897002,"score_spread":0.3689398858422812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411291066","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8357127,0.004346176,0.11742351,0.0048355707,0.00039640372,0.01015048,0.00039414028,0.0018615072,0.024879431],"genre_scores_gemma":[0.9113169,0.0014539298,0.079335615,0.0011247535,0.00012512848,0.003668231,0.00020096682,0.00011406993,0.0026604133],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959239,0.0024053527,0.0003492973,0.00020848923,0.00097366667,0.0001393928],"domain_scores_gemma":[0.9857503,0.007952579,0.0017328202,0.0006497958,0.0034162507,0.00049824116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008680203,0.0004357039,0.00032619186,0.00061185414,0.00047470425,0.0011080101,0.0012747032,0.00056580687,0.0035407972],"category_scores_gemma":[0.035539642,0.00024768256,0.00035384737,0.0004129221,0.0003512117,0.0011000265,0.0011332219,0.0004823676,0.0005926012],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038384153,0.0026760336,0.05959092,0.003643364,0.00024087034,0.000520211,0.0023582987,0.006826561,0.036692537,0.0014076794,0.01060462,0.87160057],"study_design_scores_gemma":[0.0017336197,0.054272965,0.39864615,0.0071712337,0.002421813,0.005666938,0.008991237,0.20593868,0.19133262,0.006492757,0.11672809,0.0006039389],"about_ca_topic_score_codex":0.0019380907,"about_ca_topic_score_gemma":0.0025930516,"teacher_disagreement_score":0.008680203,"about_ca_system_score_codex":0.0011353976,"about_ca_system_score_gemma":0.0018770803,"threshold_uncertainty_score":0.045905888},"labels":[],"label_agreement":null},{"id":"W4411291227","doi":"10.1158/1557-3265.sabcs24-p1-10-07","title":"Abstract P1-10-07: PROgress Tracker Breast Cancer Registry: Feasibility of a Longitudinal Peer-Led, National Patient-Reported Outcomes (PRO) Registry","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer registry; Medicine; Breast cancer; Patient registry; Cancer; Medical physics; Oncology; Family medicine; Internal medicine","score_opus":0.3995001306552787,"score_gpt":0.58418274641182,"score_spread":0.18468261575654132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411291227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6448601,0.0004766533,0.017074872,0.022775002,0.0008110169,0.12321546,0.127061,0.002690069,0.061035864],"genre_scores_gemma":[0.74618065,0.00060307677,0.06390789,0.0043109944,0.00036893325,0.108380765,0.060516052,0.00053932006,0.015192272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98125535,0.007769826,0.0013010588,0.001506087,0.0056897164,0.002477786],"domain_scores_gemma":[0.953628,0.008373917,0.0032660572,0.004785699,0.020953739,0.008992556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04107955,0.000520922,0.00053864135,0.0008480763,0.0038754093,0.0033649395,0.0031347836,0.00094273494,0.014212294],"category_scores_gemma":[0.04897591,0.00057991955,0.0008231327,0.0013222245,0.001051691,0.0022242207,0.0036667124,0.0017283519,0.0050753877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012125455,0.008043807,0.44867006,0.0010137685,0.00029261058,0.00041494734,0.008005081,0.0018255307,0.002655925,0.0033281578,0.28292307,0.23070161],"study_design_scores_gemma":[0.008230127,0.008302342,0.7947426,0.00092801586,0.00032153292,0.0003770518,0.011007694,0.008161848,0.0032632672,0.0009693457,0.16339569,0.00030050185],"about_ca_topic_score_codex":0.5453588,"about_ca_topic_score_gemma":0.61892164,"teacher_disagreement_score":0.5453588,"about_ca_system_score_codex":0.015065933,"about_ca_system_score_gemma":0.08514112,"threshold_uncertainty_score":0.9146374},"labels":[],"label_agreement":null},{"id":"W4411291454","doi":"10.1158/1557-3265.sabcs24-p1-01-05","title":"Abstract P1-01-05: Conducting Ancillary Studies during an Active NCTN/NCORP Screening Trial – The TMIST (ECOG-ACRIN EA1151) Experience","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Internal medicine","score_opus":0.5735997401750292,"score_gpt":0.6294568798058396,"score_spread":0.055857139630810404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411291454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76152754,0.0033106115,0.008935643,0.041442536,0.004452889,0.084893644,0.0087038195,0.0010418702,0.08569141],"genre_scores_gemma":[0.78527224,0.0017029247,0.028536342,0.0256833,0.0043863584,0.12920617,0.005702275,0.00027859383,0.019231811],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9753508,0.021222642,0.0005993517,0.00078920077,0.0010868486,0.0009510332],"domain_scores_gemma":[0.95859104,0.016933113,0.004158653,0.0047070035,0.003887591,0.011722633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.057786398,0.0005180597,0.0009561399,0.00025824909,0.0020147199,0.0018533461,0.0012435279,0.002212424,0.019554546],"category_scores_gemma":[0.052691095,0.00046055389,0.0008429689,0.00043251604,0.0008297078,0.0015113889,0.0016327183,0.0037162865,0.003885831],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3161061,0.035097614,0.0405424,0.0020459301,0.000959662,0.0010003413,0.0037752327,0.0008731166,0.0030620939,0.0030639605,0.22121772,0.37225583],"study_design_scores_gemma":[0.36556104,0.3099558,0.12201033,0.0026514924,0.0010889753,0.0011288245,0.0026655672,0.0033447018,0.00407567,0.0048630238,0.18242577,0.0002288364],"about_ca_topic_score_codex":0.0026809243,"about_ca_topic_score_gemma":0.004918693,"teacher_disagreement_score":0.057786398,"about_ca_system_score_codex":0.001524094,"about_ca_system_score_gemma":0.010864773,"threshold_uncertainty_score":0.30560732},"labels":[],"label_agreement":null},{"id":"W4411291466","doi":"10.1158/1557-3265.sabcs24-p1-04-09","title":"Abstract P1-04-09: Evaluating the Necessity and Impact of Cardiac Imaging on Breast Cancer Care in Northwestern Ontario","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Breast cancer; Intensive care medicine; Oncology; Internal medicine","score_opus":0.137985187996293,"score_gpt":0.5609468726863178,"score_spread":0.4229616846900248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411291466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887398,0.0003879935,0.00010357683,0.0014251095,0.000017981884,0.00023057917,0.0055404506,0.000013492992,0.0035409378],"genre_scores_gemma":[0.9948578,0.00042701932,0.00035355866,0.0005514138,0.000029946685,0.00018211933,0.0021419206,0.000009269957,0.0014468791],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983267,0.00020637157,0.00014238448,0.0002467743,0.0005125174,0.00056527666],"domain_scores_gemma":[0.98975766,0.00066131086,0.0027151727,0.00026341077,0.0035386872,0.0030637025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001098042,0.00023495025,0.00033536213,0.0009016443,0.0032397474,0.0013164387,0.0016199134,0.0004768069,0.0023413552],"category_scores_gemma":[0.0042799334,0.0004335899,0.00050587545,0.002708691,0.0009925294,0.00046906035,0.0015793918,0.0007245074,0.0003135501],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010459984,0.00006767606,0.99317944,0.000076946504,0.000034403874,0.00012604246,0.0013320572,0.000065797314,0.00018346625,0.00006391579,0.0022223736,0.002543195],"study_design_scores_gemma":[0.000019234209,0.000054149074,0.9952401,0.00006768402,0.000023712153,0.000058636168,0.0026465864,0.00018591879,0.000057145604,0.00001783006,0.0016194953,0.0000095534315],"about_ca_topic_score_codex":0.9827959,"about_ca_topic_score_gemma":0.99293643,"teacher_disagreement_score":0.05497549,"about_ca_system_score_codex":0.05497549,"about_ca_system_score_gemma":0.06366572,"threshold_uncertainty_score":0.39887702},"labels":[],"label_agreement":null},{"id":"W4411291480","doi":"10.1158/1557-3265.sabcs24-p2-11-18","title":"Abstract P2-11-18: Patterns of Treatment in Older Patients with Early-Stage Triple Negative Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Triple-negative breast cancer; Stage (stratigraphy); Medicine; Breast cancer; Cancer; Oncology; Internal medicine; Biology","score_opus":0.1123254802411527,"score_gpt":0.49916572405282017,"score_spread":0.3868402438116675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411291480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923194,0.0011809468,0.000114339375,0.0002143203,0.000010651388,0.00003138377,0.0044639064,0.000008342481,0.001656706],"genre_scores_gemma":[0.99764913,0.00034983802,0.00009540054,0.000046624566,0.000009300693,0.00001516416,0.0015399812,0.0000029689147,0.00029155728],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996526,0.00004651201,0.000048244332,0.00006983812,0.00009611894,0.00008657048],"domain_scores_gemma":[0.9980227,0.00015167777,0.0012441248,0.000044335913,0.00032314935,0.00021406116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042172303,0.00010714125,0.00021994709,0.0008230171,0.00038249695,0.00045776254,0.00032208103,0.00022103671,0.002329187],"category_scores_gemma":[0.0018254077,0.00007998253,0.00032741693,0.0019837664,0.00016621858,0.00023711179,0.00030123576,0.00033803677,0.0002792429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051847877,0.000008672611,0.99735665,0.000014740415,0.000013426036,0.00004928146,0.00004113621,0.000022013986,0.00006235408,0.0000095498035,0.000296229,0.0020741178],"study_design_scores_gemma":[0.0000022235747,0.000021736105,0.9991967,0.000015361686,0.0000087927665,0.00018219755,0.00014445873,0.000050370178,0.000030422345,0.000010928747,0.0003353023,0.0000015236609],"about_ca_topic_score_codex":0.057322454,"about_ca_topic_score_gemma":0.09273041,"teacher_disagreement_score":0.057322454,"about_ca_system_score_codex":0.0009993194,"about_ca_system_score_gemma":0.0014287076,"threshold_uncertainty_score":0.11397755},"labels":[],"label_agreement":null},{"id":"W4411291698","doi":"10.1158/1557-3265.sabcs24-p2-09-01","title":"Abstract P2-09-01: Preliminary Findings from the Breast Cancer Combined Visualization And Characterization Tools (bCOMBAT): Low-Dose PEM and Liquid Biopsy Study","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Cancer; Biopsy; Visualization; Liquid biopsy; Radiology; Pathology; Internal medicine; Computer science; Data mining","score_opus":0.13836652519548148,"score_gpt":0.5183740489704546,"score_spread":0.3800075237749731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411291698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929133,0.0005224075,0.00050280086,0.0008288116,0.000021437649,0.0004513861,0.0010550979,0.000030417246,0.0036743481],"genre_scores_gemma":[0.9889649,0.00045796804,0.0020654113,0.00076363026,0.00009688306,0.00026868083,0.0030811068,0.000049858667,0.004251473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895203,0.00048069964,0.000042418906,0.00012715839,0.00029274714,0.00010496117],"domain_scores_gemma":[0.99795216,0.00062551926,0.00016573227,0.0001905705,0.00036096456,0.0007051018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031361356,0.00053548545,0.00035388433,0.00040579188,0.00047866444,0.0006481329,0.000777835,0.0007046598,0.0035251717],"category_scores_gemma":[0.0027613726,0.00023470598,0.00030504633,0.0003504471,0.0006299266,0.000328908,0.0006894831,0.00064860284,0.00093568396],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052294303,0.013676697,0.7492351,0.0003304019,0.0005179786,0.0041647414,0.0019020853,0.0003732538,0.06780758,0.00038125532,0.012372274,0.096944325],"study_design_scores_gemma":[0.002860012,0.027266331,0.9469078,0.00004021499,0.00023306716,0.00316785,0.0005768547,0.00048315435,0.009362146,0.00012833977,0.008934284,0.00004003873],"about_ca_topic_score_codex":0.013859933,"about_ca_topic_score_gemma":0.012628664,"teacher_disagreement_score":0.013859933,"about_ca_system_score_codex":0.0008236576,"about_ca_system_score_gemma":0.001419095,"threshold_uncertainty_score":0.027558506},"labels":[],"label_agreement":null},{"id":"W4411489613","doi":"10.1158/1078-0432.ccr-24-3912","title":"<i>ERBB2</i> /HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Abbotsford Veterinary Clinic; Spinal Cord Injury BC; BC Cancer Agency; Kelowna General Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; Bladder Cancer Advocacy Network","keywords":"Genotype; Immunohistochemistry; Biology; Cancer; DNA sequencing; Tumour heterogeneity; Cancer research; Biomarker; Fluorescence in situ hybridization; Pathology; DNA; Medicine; Gene; Genetics; Immunology","score_opus":0.1118459611401712,"score_gpt":0.5057213308847733,"score_spread":0.39387536974460213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411489613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990226,0.00027437913,0.00018662238,0.000014117949,0.0000012055946,0.000005733181,0.00016013661,0.000005549777,0.00032964206],"genre_scores_gemma":[0.9995029,0.000049395425,0.0001905834,0.000011634936,0.0000024173055,0.0000043681803,0.000156739,0.000002502268,0.00007946464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997019,0.00004011459,0.000045100027,0.00010578932,0.00006905962,0.00003805373],"domain_scores_gemma":[0.99940526,0.00013104886,0.0002366439,0.00006752015,0.00007440751,0.000085093714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035833023,0.00016879626,0.00018022807,0.00065313175,0.00021993261,0.00039327424,0.00021718029,0.000248619,0.0011685637],"category_scores_gemma":[0.0012637211,0.00013932485,0.0001134261,0.00041183416,0.00023943423,0.00024888298,0.00030740176,0.0001947992,0.0002301843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032009583,0.000009850444,0.9750045,0.000019951744,0.000021165124,0.00043009443,0.000087283704,0.00008609094,0.020299204,0.000015719961,0.000049380145,0.00365665],"study_design_scores_gemma":[0.0000067381957,0.000121488665,0.9857802,0.0000075862886,0.00003054616,0.004940314,0.00012926753,0.00028635614,0.008308133,0.000028762126,0.00035661156,0.000003970057],"about_ca_topic_score_codex":0.0014589687,"about_ca_topic_score_gemma":0.0019789631,"teacher_disagreement_score":0.0014589687,"about_ca_system_score_codex":0.00025541082,"about_ca_system_score_gemma":0.00012966606,"threshold_uncertainty_score":0.0039091706},"labels":[],"label_agreement":null},{"id":"W4411541911","doi":"10.1158/1078-0432.ccr-24-4354","title":"Update on Tumor Surveillance for Children with Hereditary Pheochromocytoma/Paraganglioma Syndromes","year":2025,"lang":"en","type":"review","venue":"Clinical Cancer Research","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"St. Baldrick's Foundation","keywords":"Pheochromocytoma; Paraganglioma; Medicine; Pathology; Pediatrics","score_opus":0.2285366944589447,"score_gpt":0.5441405957109416,"score_spread":0.31560390125199694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411541911","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062286677,0.62556744,0.0062994245,0.22263218,0.044273745,0.00055592915,0.010472466,0.0012989311,0.082671165],"genre_scores_gemma":[0.022502456,0.76517665,0.017341172,0.11449503,0.035737913,0.00096576894,0.020447545,0.00033275745,0.023000637],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977314,0.0006109499,0.0005368384,0.000160708,0.0007979083,0.00016216164],"domain_scores_gemma":[0.98677653,0.004190357,0.0013213691,0.00018015911,0.0065282923,0.0010033655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030965277,0.000616496,0.0010694457,0.002245593,0.0005244538,0.0015313289,0.0013655293,0.0029821936,0.0066575976],"category_scores_gemma":[0.018982733,0.00033765158,0.0014079678,0.0012893381,0.0002929625,0.0019122581,0.0012613846,0.004457025,0.0028595224],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007977585,0.000051847306,0.0026731705,0.0028176599,0.00011131192,0.00044139024,0.00018970964,0.00028496585,0.0003055733,0.0016139605,0.60276586,0.38866487],"study_design_scores_gemma":[0.00005252829,0.00005863582,0.0042628534,0.008288904,0.0002088942,0.0009424326,0.000109413224,0.00013504957,0.00018519374,0.00080678676,0.9849207,0.000028536999],"about_ca_topic_score_codex":0.008954595,"about_ca_topic_score_gemma":0.017539827,"teacher_disagreement_score":0.008954595,"about_ca_system_score_codex":0.0018134381,"about_ca_system_score_gemma":0.0033734736,"threshold_uncertainty_score":0.022271872},"labels":[],"label_agreement":null},{"id":"W4411604374","doi":"10.1158/1078-0432.ccr-24-3720","title":"Artificial Intelligence Algorithm Predicts Response to Immune Checkpoint Inhibitors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; York University","keywords":"Immune system; Computer science; Immune checkpoint; Artificial intelligence; Computational biology; Immunology; Medicine; Biology; Immunotherapy","score_opus":0.19196513426731834,"score_gpt":0.5307325766693138,"score_spread":0.3387674424019955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411604374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9312578,0.0006413513,0.06351843,0.0007307106,0.000060807422,0.00010168798,0.0009359167,0.0005959727,0.002157258],"genre_scores_gemma":[0.9885506,0.00008215614,0.009653689,0.00012725175,0.00003006017,0.000048536793,0.0009635643,0.000009261678,0.0005349001],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997209,0.00009383753,0.000029417168,0.000066398905,0.000053346303,0.00003600347],"domain_scores_gemma":[0.9984865,0.000942394,0.00021532635,0.00006377235,0.00023939012,0.000052536507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081229926,0.000482644,0.00045601107,0.0009324903,0.00014020792,0.0004430235,0.00040072398,0.0004838417,0.0009250472],"category_scores_gemma":[0.0037159107,0.00010980953,0.00041433112,0.00032028576,0.000161167,0.00020171358,0.00025709075,0.00049827126,0.0002857246],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077162223,0.0007098271,0.3675227,0.00009723101,0.0004520642,0.00023894354,0.000048454312,0.44538626,0.0042856317,0.00040749952,0.003919782,0.17616],"study_design_scores_gemma":[0.000016010572,0.00010483866,0.015973961,0.000008584148,0.000026725023,0.00005874189,0.000009077776,0.98237956,0.0008104703,0.0004020009,0.00020551484,0.000004435722],"about_ca_topic_score_codex":0.002711761,"about_ca_topic_score_gemma":0.0017921678,"teacher_disagreement_score":0.002711761,"about_ca_system_score_codex":0.00045086342,"about_ca_system_score_gemma":0.00049529155,"threshold_uncertainty_score":0.0053919554},"labels":[],"label_agreement":null},{"id":"W4411643060","doi":"10.1158/1078-0432.ccr-24-3860","title":"Updated Recommendations for Pediatric Surveillance in Hereditary Endocrine Neoplasia Syndromes: Multiple Endocrine Neoplasias, Hyperparathyroidism–Jaw Tumor Syndrome, and Carney Complex","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"Ipsen; Deutsche Kinderkrebsstiftung; Bundesministerium für Bildung und Forschung; St. Baldrick's Foundation","keywords":"Penetrance; Endocrine system; Multiple endocrine neoplasia; Medicine; Pheochromocytoma; Hyperparathyroidism; Genetic testing; Carney complex; Bioinformatics; Pathology; Internal medicine; Phenotype; Biology; Genetics; Hormone","score_opus":0.16728557429756463,"score_gpt":0.4984775767315684,"score_spread":0.33119200243400376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411643060","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009976329,0.23494856,0.028052498,0.597676,0.024328524,0.0015360643,0.0090075685,0.0024602436,0.09201423],"genre_scores_gemma":[0.086172186,0.45790714,0.1709867,0.21682462,0.019177074,0.004284572,0.019752564,0.00073685485,0.024158249],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98855954,0.0048270584,0.0034277334,0.0005551535,0.0021429148,0.0004875877],"domain_scores_gemma":[0.9418349,0.020985784,0.006244919,0.0012645829,0.025531985,0.0041378946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009556176,0.00086564856,0.0010698615,0.0041773575,0.0010158665,0.0021143658,0.0024091376,0.004230589,0.012365404],"category_scores_gemma":[0.06529978,0.00044514777,0.001939051,0.0027020485,0.0008153403,0.0034379829,0.0022860125,0.006690442,0.0042121285],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009152993,0.00017985271,0.010610118,0.0024681475,0.00009333759,0.00051756273,0.0006420199,0.0005653942,0.00033795048,0.0032181607,0.5472805,0.43399546],"study_design_scores_gemma":[0.00016535936,0.00011403296,0.016487831,0.021212792,0.0003635865,0.0017860371,0.0016318759,0.000701759,0.00048641933,0.004778104,0.9521491,0.0001230073],"about_ca_topic_score_codex":0.01607665,"about_ca_topic_score_gemma":0.029566128,"teacher_disagreement_score":0.01607665,"about_ca_system_score_codex":0.0025161195,"about_ca_system_score_gemma":0.008936033,"threshold_uncertainty_score":0.05053848},"labels":[],"label_agreement":null},{"id":"W4411643375","doi":"10.1158/1078-0432.ccr-25-0597","title":"Radiation Concepts and Considerations for Pediatric Cancer Predisposition Syndrome Surveillance: A Report from the 2023 AACR Childhood Cancer Predisposition Workshop","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Terry Fox Foundation; Physicians' Services Incorporated Foundation; Radiological Society of North America","keywords":"Medicine; Cancer; Genetic predisposition; Childhood cancer; Ionizing radiation; Pediatric cancer; Radiation exposure; Medical physics; Pathology; Nuclear medicine; Internal medicine; Disease","score_opus":0.1335779421386495,"score_gpt":0.5210780326276089,"score_spread":0.3875000904889594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411643375","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020476906,0.32988602,0.0083485795,0.57822806,0.013306848,0.0003846981,0.00035372705,0.00025212063,0.04876309],"genre_scores_gemma":[0.13103591,0.66699797,0.021498926,0.134422,0.023734223,0.0005509291,0.00061052,0.00017520976,0.020974234],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99840933,0.00053021096,0.0002687214,0.00008980255,0.00051941845,0.00018248871],"domain_scores_gemma":[0.996856,0.0015281908,0.00042896665,0.000078856276,0.00067773386,0.00043022115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034624082,0.0006313367,0.00031972348,0.0011989458,0.0010326864,0.0013043173,0.00097321864,0.003946394,0.0022455652],"category_scores_gemma":[0.0049958853,0.00034613168,0.0008089974,0.00097487995,0.00063066464,0.001407154,0.00082379184,0.0046796096,0.0006020611],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009745288,0.00038796163,0.029456114,0.0016667072,0.000073776064,0.03719293,0.0015435661,0.001639774,0.0021163723,0.0058739088,0.45418662,0.46576476],"study_design_scores_gemma":[0.000018134351,0.00022071274,0.013279599,0.0028143814,0.00008698639,0.039424777,0.0012421232,0.00037687097,0.0009187743,0.0013782568,0.940185,0.00005446595],"about_ca_topic_score_codex":0.007174324,"about_ca_topic_score_gemma":0.013961053,"teacher_disagreement_score":0.007174324,"about_ca_system_score_codex":0.0019855099,"about_ca_system_score_gemma":0.0046856147,"threshold_uncertainty_score":0.018311143},"labels":[],"label_agreement":null},{"id":"W4412110964","doi":"10.1158/1078-0432.ccr-25-0111","title":"Optimal Factors That Influence the Establishment of Successful Primary Human Soft-Tissue Sarcoma Cell Lines","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Muscular Dystrophy Canada; Hospital for Sick Children; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Sinai Health System","funders":"Canadian Institutes of Health Research; Canada Foundation for Innovation","keywords":"Sarcoma; Soft tissue; Soft tissue sarcoma; Medicine; Cell culture; Cancer research; Pathology; Biology; Genetics","score_opus":0.1386466768010725,"score_gpt":0.49468875857627753,"score_spread":0.356042081775205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412110964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987668,0.0023191276,0.0063497974,0.00006300213,0.00004050811,0.0003309104,0.00083280687,0.000081315884,0.0023146213],"genre_scores_gemma":[0.9880705,0.0010920782,0.00724444,0.00006492232,0.0000250693,0.00027216735,0.0023327547,0.000044683697,0.00085332524],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992617,0.00020135762,0.00015823821,0.0001391977,0.00015750439,0.00008213682],"domain_scores_gemma":[0.99881786,0.0005903355,0.00015128139,0.00012808498,0.00017751729,0.00013484419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079257006,0.00033703842,0.0005256773,0.0003656184,0.00027096286,0.0006070819,0.00023478657,0.00025594348,0.001960047],"category_scores_gemma":[0.001763223,0.00021369186,0.00023730178,0.00029106962,0.000269729,0.00029083775,0.00055401423,0.00044915423,0.0007363408],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012152896,0.00043440083,0.017537752,0.0002525941,0.000042344232,0.00028119498,0.00023726802,0.0014971101,0.96295255,0.00023852469,0.0005474841,0.014763411],"study_design_scores_gemma":[0.000048946924,0.003005875,0.05539899,0.000065262895,0.00009715078,0.00070850895,0.0002044881,0.002697955,0.9320013,0.00013020424,0.0056134355,0.000027968246],"about_ca_topic_score_codex":0.00059331727,"about_ca_topic_score_gemma":0.001560248,"teacher_disagreement_score":0.001960047,"about_ca_system_score_codex":0.00031329578,"about_ca_system_score_gemma":0.00040812674,"threshold_uncertainty_score":0.0065569878},"labels":[],"label_agreement":null},{"id":"W4412163643","doi":"10.1158/1557-3265.aimachine-a023","title":"Abstract A023: Spatially resolved drug response predictions reveal fibroblast-associated resistances in <i>in situ</i> lung cancer samples","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung cancer; In situ; Drug response; Drug; Cancer; Medicine; Fibroblast; Carcinoma in situ; Cancer research; Pathology; Internal medicine; Oncology; Biology; Chemistry; Pharmacology; Cell culture; Genetics","score_opus":0.06551512070625558,"score_gpt":0.42111601519396274,"score_spread":0.35560089448770715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93580455,0.0005622221,0.05453033,0.00017355214,0.000037688806,0.00005157879,0.0052096886,0.0013667451,0.002263742],"genre_scores_gemma":[0.96857566,0.00027729847,0.026230056,0.00012124237,0.000010777838,0.00008406211,0.0036144543,0.0001488147,0.00093772775],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.999846,0.000016651704,0.000007675384,0.00006875399,0.0000444676,0.000016467911],"domain_scores_gemma":[0.9998049,0.00007589231,0.000033044158,0.000017608314,0.000054070144,0.00001448966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032878638,0.00045627874,0.0002916263,0.00030583577,0.00022505685,0.0004572902,0.00029362188,0.00054106826,0.0012827567],"category_scores_gemma":[0.00038856067,0.00020356281,0.00048685184,0.00026156064,0.0001920454,0.00022797327,0.00017324522,0.00036828686,0.0004932936],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028464058,0.00007561815,0.018369628,0.00019808981,0.00007432067,0.00019671948,0.000107002365,0.032699484,0.9350019,0.00025764646,0.00081770006,0.011917163],"study_design_scores_gemma":[0.000020043211,0.00029070224,0.040291194,0.000015341746,0.00008012676,0.00028987505,0.00021440822,0.29524276,0.6599112,0.00052220566,0.0030736502,0.000048431153],"about_ca_topic_score_codex":0.0031903123,"about_ca_topic_score_gemma":0.0050587263,"teacher_disagreement_score":0.0031903123,"about_ca_system_score_codex":0.00034709257,"about_ca_system_score_gemma":0.0002843525,"threshold_uncertainty_score":0.006343484},"labels":[],"label_agreement":null},{"id":"W4412163645","doi":"10.1158/1557-3265.aimachine-a062","title":"Abstract A062: Uncovering Social and Clinical Determinants of Baseline Distress Prior to Radiation Therapy: An Explainable Machine Learning Approach","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Baseline (sea); Distress; Medicine; Radiation therapy; Psychology; Intensive care medicine; Psychotherapist; Clinical psychology; Surgery; Political science","score_opus":0.13878671856935565,"score_gpt":0.5319197666372175,"score_spread":0.39313304806786187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68802637,0.00042394554,0.30498534,0.00306886,0.000050167182,0.00015159814,0.0016200136,0.00042097748,0.0012527643],"genre_scores_gemma":[0.97856253,0.0000664593,0.020190734,0.00011068679,0.000047251368,0.000060854374,0.00057431165,0.000015195195,0.00037197798],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99890006,0.00077651674,0.000040418752,0.00016688064,0.000057494253,0.000058681875],"domain_scores_gemma":[0.9935627,0.005006315,0.0006591389,0.00034764037,0.00030618533,0.00011810307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034171345,0.0007957344,0.00040702836,0.00123713,0.0003816228,0.0009726662,0.0007172577,0.0008383276,0.0017760872],"category_scores_gemma":[0.011195405,0.00023934522,0.0009235673,0.0006093685,0.0005639811,0.00062746403,0.00081497646,0.0012379374,0.00015322334],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000501257,0.00049296557,0.38886505,0.00016888537,0.0007356904,0.00032921066,0.0005455281,0.49423045,0.0017324978,0.0068747406,0.00269187,0.10283185],"study_design_scores_gemma":[0.000019709314,0.00009344342,0.024786575,0.000023155817,0.000048684116,0.00004320737,0.00007956886,0.96460605,0.00032356023,0.009614511,0.0003479893,0.000013540549],"about_ca_topic_score_codex":0.0066404776,"about_ca_topic_score_gemma":0.0060381508,"teacher_disagreement_score":0.0066404776,"about_ca_system_score_codex":0.0007663362,"about_ca_system_score_gemma":0.001092995,"threshold_uncertainty_score":0.01807177},"labels":[],"label_agreement":null},{"id":"W4412163652","doi":"10.1158/1557-3265.aimachine-b007","title":"Abstract B007: TheBlueScrubs-v1: A Large-Scale Curated Dataset with ∼11 Billion Oncology Tokens for AI-Driven Cancer Research","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Scale (ratio); Oncology; Precision oncology; Medicine; Internal medicine; Clinical Oncology; Computer science; Computational biology; Biology; Cartography; Geography","score_opus":0.23548338623858694,"score_gpt":0.6182858435125832,"score_spread":0.38280245727399625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163652","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024406964,0.002670615,0.009642882,0.0019749666,0.0006461253,0.00062934955,0.93781585,0.016504077,0.0057090903],"genre_scores_gemma":[0.013487789,0.00029269216,0.015227058,0.00045072244,0.00009764936,0.00071286527,0.967172,0.0008378612,0.00172136],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99718285,0.0007612861,0.0003150646,0.0008615227,0.0006524061,0.00022696864],"domain_scores_gemma":[0.9921616,0.0034258699,0.00051674433,0.0015307292,0.0017146814,0.0006504945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027797576,0.0019485089,0.0010240839,0.004467074,0.0017530568,0.0018763748,0.0026715242,0.002915086,0.014717857],"category_scores_gemma":[0.013898417,0.0006275489,0.0016531401,0.003562731,0.0011293918,0.0017874236,0.003261079,0.0024266706,0.022594303],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007879137,0.00033879766,0.0068336283,0.0036581755,0.00019942487,0.0006940938,0.0004179704,0.0046251942,0.015494285,0.0021030398,0.91565937,0.049188085],"study_design_scores_gemma":[0.0011773452,0.0005982335,0.028683754,0.001080283,0.00029930664,0.0016308568,0.0008581182,0.03633344,0.02558158,0.0056901244,0.8977994,0.00026763027],"about_ca_topic_score_codex":0.01441477,"about_ca_topic_score_gemma":0.027977142,"teacher_disagreement_score":0.014717857,"about_ca_system_score_codex":0.0015757655,"about_ca_system_score_gemma":0.0040016654,"threshold_uncertainty_score":0.04923612},"labels":[],"label_agreement":null},{"id":"W4412163656","doi":"10.1158/1557-3265.aimachine-pr-04","title":"Abstract PR-04: A practical framework for operationalizing responsible and equitable AI in healthcare: Tackling bias, inequity, and implementation challenges","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; University of Toronto; Toronto Metropolitan University; University Health Network; Hamilton Health Sciences; Princess Margaret Cancer Centre","funders":"","keywords":"Operationalization; Health care; Health equity; Business; Political science; Medicine; Public economics; Economics; Economic growth","score_opus":0.7817136551151166,"score_gpt":0.7334528669107033,"score_spread":0.04826078820441326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163656","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025405143,0.00057498756,0.92107576,0.04395085,0.0002774546,0.0037609318,0.0005948147,0.0016291506,0.025595611],"genre_scores_gemma":[0.039815363,0.00027011914,0.9524545,0.0022885166,0.0000692585,0.0031682479,0.00039631478,0.0001364398,0.0014013329],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.7751522,0.19254938,0.009963573,0.008151733,0.011493875,0.0026892463],"domain_scores_gemma":[0.7515565,0.19221777,0.007729592,0.021412635,0.021756973,0.005326483],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.23448959,0.002761172,0.0014910947,0.00595371,0.004322855,0.013885628,0.00922644,0.008093026,0.010539629],"category_scores_gemma":[0.22435938,0.001740561,0.0033652,0.0033737684,0.019029617,0.013046866,0.016301177,0.010965047,0.0028979022],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056788376,0.00016828872,0.0014114649,0.0012528594,0.00006355079,0.00021544685,0.005533101,0.013351087,0.00045331178,0.90430695,0.012447407,0.06073967],"study_design_scores_gemma":[0.00012306382,0.00019434135,0.0005035325,0.0028855496,0.00007991101,0.00024093005,0.003039765,0.04476569,0.0012293479,0.8386129,0.10822824,0.00009677795],"about_ca_topic_score_codex":0.009010481,"about_ca_topic_score_gemma":0.011217847,"teacher_disagreement_score":0.23448959,"about_ca_system_score_codex":0.011515165,"about_ca_system_score_gemma":0.050975103,"threshold_uncertainty_score":0.9440106},"labels":[],"label_agreement":null},{"id":"W4412163664","doi":"10.1158/1557-3265.aimachine-a042","title":"Abstract A042: Real-world clinical multi-omics and AI/ML analyses reveal bifurcation of drug resistance mechanisms to CDK4/6 inhibitors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Drug resistance; Omics; Computational biology; Medicine; Biology; Pharmacology; Bioinformatics; Genetics","score_opus":0.2503190552700628,"score_gpt":0.5727243588979769,"score_spread":0.3224053036279141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89429474,0.0014967235,0.04473672,0.0021146,0.00012172803,0.00008531759,0.053610235,0.0015529887,0.0019869811],"genre_scores_gemma":[0.9367326,0.00030708505,0.015725903,0.00036011077,0.000073849355,0.00009399647,0.04579509,0.0001618675,0.00074966287],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9992841,0.00021311308,0.000045870955,0.00026811988,0.00008667063,0.00010215306],"domain_scores_gemma":[0.99854195,0.0007053792,0.00023165945,0.00026138566,0.00015280813,0.00010679311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019069804,0.0007109657,0.0007031099,0.001325867,0.0004432816,0.0012296307,0.000673086,0.0007360269,0.0023772188],"category_scores_gemma":[0.0037402324,0.00023729408,0.0013542384,0.0014366343,0.00042378576,0.0004624938,0.00092728826,0.0009077252,0.0008166933],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026001267,0.0003543058,0.70224255,0.00069366104,0.0020303312,0.0013711613,0.00037044787,0.13196191,0.041173283,0.0043395534,0.030338284,0.082524344],"study_design_scores_gemma":[0.00014028033,0.00031760338,0.42010862,0.000099035205,0.0004238936,0.0011375594,0.000537472,0.53284854,0.010177948,0.015018859,0.019079147,0.000110979345],"about_ca_topic_score_codex":0.0046138796,"about_ca_topic_score_gemma":0.005337605,"teacher_disagreement_score":0.0046138796,"about_ca_system_score_codex":0.0005750144,"about_ca_system_score_gemma":0.00060153403,"threshold_uncertainty_score":0.0100851655},"labels":[],"label_agreement":null},{"id":"W4412163674","doi":"10.1158/1557-3265.aimachine-a026","title":"Abstract A026: GenAI and Physics Assisted Methods for the Design and Development of USP1 Inhibitors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug development; Medicine; Medical physics; Physics; Pharmacology; Drug","score_opus":0.5759676318210664,"score_gpt":0.6597587551175987,"score_spread":0.08379112329653238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163674","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08423292,0.008792711,0.82588905,0.0038569975,0.0009757217,0.00039782113,0.0013478666,0.0043830895,0.07012388],"genre_scores_gemma":[0.43815726,0.006743503,0.5131435,0.000990784,0.00025715763,0.0007787745,0.0013986626,0.0005978011,0.037932567],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997403,0.00007557085,0.000009992667,0.0000390165,0.00011760218,0.000017518856],"domain_scores_gemma":[0.999705,0.00013190316,0.000031901516,0.000031682004,0.000070280956,0.000029168437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008604992,0.0006009979,0.00056644954,0.00049459684,0.00029957748,0.000746024,0.0008030437,0.0008169603,0.009429847],"category_scores_gemma":[0.00080025056,0.0003619096,0.0007745107,0.00048347565,0.00049617334,0.00045292315,0.0008189618,0.0011142992,0.001796385],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038106827,0.0002696945,0.0010103512,0.000821053,0.00015062424,0.00031263212,0.00012327486,0.5948753,0.05830855,0.1033332,0.015548696,0.22486563],"study_design_scores_gemma":[0.00015521882,0.00037278084,0.0004618704,0.000057698984,0.00003644082,0.0001003977,0.000026205344,0.90963733,0.0147436205,0.036329642,0.038033012,0.000045755743],"about_ca_topic_score_codex":0.001071101,"about_ca_topic_score_gemma":0.0010517241,"teacher_disagreement_score":0.009429847,"about_ca_system_score_codex":0.0006373686,"about_ca_system_score_gemma":0.0008714255,"threshold_uncertainty_score":0.031545937},"labels":[],"label_agreement":null},{"id":"W4412163675","doi":"10.1158/1557-3265.aimachine-b008","title":"Abstract B008: Fine-tuned large language model accurately estimates progression-free survival from radiology reports in immune checkpoint inhibitor–treated cancers","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Immune checkpoint; Cancer; Oncology; Internal medicine; Radiology; Cancer research; Immunotherapy","score_opus":0.10724996230744933,"score_gpt":0.5259392477263349,"score_spread":0.4186892854188856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8541307,0.004198374,0.09140448,0.004201869,0.00047691326,0.00033572485,0.027939271,0.013139253,0.0041734246],"genre_scores_gemma":[0.94664705,0.00036492504,0.02548742,0.00068858237,0.00012156647,0.00018713495,0.023448205,0.00020527934,0.0028497756],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9994141,0.00016370491,0.00004185603,0.00024894095,0.000059335016,0.000072176656],"domain_scores_gemma":[0.9981988,0.0012313395,0.00013093946,0.00014675802,0.00020877167,0.000083459425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018776719,0.0013016714,0.0008175479,0.00085708406,0.00033319427,0.0010036711,0.0015874244,0.0012407883,0.0022087975],"category_scores_gemma":[0.0053909435,0.00043627532,0.0015079007,0.0004209332,0.00034183054,0.0006597677,0.00068104453,0.0015282902,0.0008202486],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013104792,0.00044912045,0.034626897,0.00024764994,0.00037870408,0.00041107505,0.00009951698,0.87700415,0.0037913467,0.000719748,0.015462187,0.065499194],"study_design_scores_gemma":[0.00006447398,0.000087126136,0.0025426561,0.000014949941,0.00004655496,0.000042746582,0.00001285564,0.99486005,0.00085775164,0.0007172362,0.0007391179,0.000014445662],"about_ca_topic_score_codex":0.033535056,"about_ca_topic_score_gemma":0.033082195,"teacher_disagreement_score":0.033535056,"about_ca_system_score_codex":0.0016231107,"about_ca_system_score_gemma":0.0015180468,"threshold_uncertainty_score":0.066679716},"labels":[],"label_agreement":null},{"id":"W4412163678","doi":"10.1158/1557-3265.aimachine-a063","title":"Abstract A063: Artificial Intelligence in Cytopathology and Histopathology of Cancer: The Evolution to Precision Pathology","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytopathology; Histopathology; Pathology; Cancer; Anatomical pathology; Medicine; Premalignant lesion; Cytology; Internal medicine; Immunohistochemistry","score_opus":0.12663274599736044,"score_gpt":0.5545919012089935,"score_spread":0.4279591552116331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163678","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017938528,0.11112602,0.2001681,0.38783306,0.05500457,0.00047885245,0.0026430553,0.0020298131,0.22277799],"genre_scores_gemma":[0.24145019,0.12713854,0.24989894,0.0592751,0.034977645,0.0006350771,0.0026620275,0.0010583615,0.28290412],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99712926,0.0010908464,0.00021723272,0.00030776954,0.0011843622,0.000070418144],"domain_scores_gemma":[0.99026555,0.004450518,0.00054350705,0.00071833644,0.003597685,0.00042443373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061215973,0.0007372958,0.0004996622,0.0026351607,0.0011289556,0.0069681825,0.0012697986,0.003157767,0.011836338],"category_scores_gemma":[0.010365882,0.00040595498,0.00071855175,0.003179384,0.004135686,0.0044305166,0.0020464035,0.0049214456,0.004043391],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001332937,0.00010197648,0.0018753494,0.0008879008,0.000069528396,0.00028550005,0.0003958876,0.0037129794,0.0028551735,0.22794837,0.40449956,0.35723454],"study_design_scores_gemma":[0.000045542434,0.0002858377,0.0075347074,0.0014672658,0.00005389824,0.00096920424,0.00047785637,0.012841479,0.0047523747,0.31300923,0.65842825,0.00013433778],"about_ca_topic_score_codex":0.0036448126,"about_ca_topic_score_gemma":0.0022526605,"teacher_disagreement_score":0.011836338,"about_ca_system_score_codex":0.0032132766,"about_ca_system_score_gemma":0.0031030583,"threshold_uncertainty_score":0.039596558},"labels":[],"label_agreement":null},{"id":"W4412163685","doi":"10.1158/1557-3265.aimachine-a035","title":"Abstract A035: Denoising Models Enhance Detection of Tumor-Derived cfDNA fragments and Cancer Tissue signal in Liquid Biopsy","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Liquid biopsy; Cancer; Biopsy; Cancer detection; Medicine; Pathology; Internal medicine","score_opus":0.10298027075811987,"score_gpt":0.48492029384417645,"score_spread":0.38194002308605657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163685","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1782899,0.00076519605,0.81596094,0.0008574915,0.00013510635,0.000066902336,0.00029004397,0.001692107,0.0019422733],"genre_scores_gemma":[0.8283585,0.0003720002,0.16261661,0.0005932257,0.000083670195,0.00009978938,0.0008666897,0.00024955568,0.006760135],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997595,0.000076591066,0.000012107412,0.000080943675,0.000040437713,0.000030372526],"domain_scores_gemma":[0.99910116,0.0005759705,0.00006594975,0.000046572528,0.00015825155,0.000052102776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016746616,0.0008491247,0.00066956994,0.00047094875,0.00020897674,0.0006393398,0.0009299217,0.0012986214,0.0011272125],"category_scores_gemma":[0.003585779,0.00048090285,0.0008895192,0.00021473515,0.00044723912,0.00066652,0.0007148696,0.0012099077,0.00045158862],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004994268,0.0001429395,0.0061257584,0.0001280605,0.00013498579,0.00014118936,0.00010830206,0.8636572,0.02195978,0.0030897467,0.0019504302,0.102062196],"study_design_scores_gemma":[0.0000034972268,0.000019256076,0.00015750178,0.0000030924555,0.000005414824,0.000008798435,0.0000025255968,0.99790156,0.0013607694,0.0003960059,0.0001386272,0.000002973245],"about_ca_topic_score_codex":0.0076383664,"about_ca_topic_score_gemma":0.007205185,"teacher_disagreement_score":0.0076383664,"about_ca_system_score_codex":0.00070262264,"about_ca_system_score_gemma":0.00081512984,"threshold_uncertainty_score":0.0151878},"labels":[],"label_agreement":null},{"id":"W4412163698","doi":"10.1158/1557-3265.aimachine-a034","title":"Abstract A034: A robust ensemble-feature selection and machine learning approach to identify true somatic variants","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Somatic cell; Feature selection; Artificial intelligence; Selection (genetic algorithm); Feature (linguistics); Machine learning; Computer science; Ensemble learning; Computational biology; Biology; Genetics; Gene","score_opus":0.14004128679786548,"score_gpt":0.5022422850503581,"score_spread":0.3622009982524926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163698","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05854757,0.00040816932,0.9367737,0.00030270003,0.000058670277,0.00012267918,0.00038663123,0.0026991018,0.0007008325],"genre_scores_gemma":[0.5873434,0.00017793494,0.40653697,0.00034059378,0.00013321477,0.00038631907,0.0018899891,0.00029725806,0.002894256],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99806136,0.00083896867,0.00012149247,0.00042820975,0.00038733927,0.00016262592],"domain_scores_gemma":[0.9966839,0.0018027578,0.00018586067,0.00039289222,0.00082571304,0.00010885695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054777754,0.0017569521,0.0017211467,0.0019105659,0.00073655177,0.0010172514,0.0021127576,0.0015174261,0.0014792242],"category_scores_gemma":[0.006687077,0.0006163127,0.0020059787,0.0011109975,0.00045966878,0.0008905441,0.0015920132,0.002168702,0.0008243455],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048336247,0.00034932897,0.01053219,0.000072171475,0.00066055724,0.00021041269,0.000092371694,0.61959213,0.010047295,0.0015515976,0.004537355,0.35187128],"study_design_scores_gemma":[0.0000071608456,0.0000450344,0.00044493988,0.0000033968454,0.00002048431,0.000018668012,0.0000042092465,0.9975649,0.0010987569,0.00058102934,0.00020462374,0.000006699744],"about_ca_topic_score_codex":0.0061887945,"about_ca_topic_score_gemma":0.005673178,"teacher_disagreement_score":0.0061887945,"about_ca_system_score_codex":0.00070646853,"about_ca_system_score_gemma":0.0013625609,"threshold_uncertainty_score":0.028969586},"labels":[],"label_agreement":null},{"id":"W4412163702","doi":"10.1158/1557-3265.aimachine-pr-05","title":"Abstract PR-05: Learning the Language of Somatic Mutations: A Large Language Model Approach to Precision Oncology","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Biomedical Text Mining and Ontologies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Precision oncology; Somatic cell; Oncology; Medicine; Computational biology; Language model; Natural language processing; Internal medicine; Computer science; Artificial intelligence; Biology; Genetics; Cancer; Gene","score_opus":0.13813087850948066,"score_gpt":0.5422115612473367,"score_spread":0.404080682737856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163702","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09125699,0.0009942508,0.8897695,0.0044158404,0.00020375881,0.00015138084,0.0023471413,0.007580348,0.003280854],"genre_scores_gemma":[0.7638505,0.00041764337,0.22234128,0.0013700766,0.00024968537,0.00023892132,0.005031324,0.0004783567,0.0060221367],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9990847,0.0004117967,0.00003954002,0.00030731852,0.00009985854,0.00005684843],"domain_scores_gemma":[0.9963983,0.0026979418,0.00015454624,0.00028870886,0.00033936367,0.000121057645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020805032,0.000896115,0.0006775644,0.00078031357,0.00041189027,0.0011363968,0.0015976643,0.001081826,0.0033356387],"category_scores_gemma":[0.005732516,0.0004085092,0.0013969224,0.0005872118,0.00054142583,0.0015318057,0.0012832383,0.002794811,0.0009451538],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005082619,0.00037354618,0.0047151116,0.00022236073,0.00028138453,0.00035356352,0.00031892798,0.60998887,0.005733816,0.0177134,0.023051618,0.33673918],"study_design_scores_gemma":[0.000013869078,0.000032577587,0.00016041797,0.00000708528,0.000013473379,0.000020924414,0.000011606386,0.9909616,0.0004966686,0.0076475767,0.0006279564,0.0000061837463],"about_ca_topic_score_codex":0.009736247,"about_ca_topic_score_gemma":0.009766894,"teacher_disagreement_score":0.009736247,"about_ca_system_score_codex":0.0013250558,"about_ca_system_score_gemma":0.0013741251,"threshold_uncertainty_score":0.019359112},"labels":[],"label_agreement":null},{"id":"W4412163704","doi":"10.1158/1557-3265.aimachine-b028","title":"Abstract B028: Assessing variability in training deep models in delineating Prostate gland anatomy between clinical experts","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Medical Imaging and Analysis","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prostate gland; Prostate cancer; Prostate; Medicine; Anatomy; Pathology; Biology; Medical physics; Cancer; Internal medicine","score_opus":0.31012676839339437,"score_gpt":0.5719112199459427,"score_spread":0.26178445155254837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8864243,0.0012967386,0.10661032,0.00071279285,0.00021557811,0.00016477481,0.00095196924,0.0011923449,0.0024312122],"genre_scores_gemma":[0.97944874,0.00008028008,0.018060433,0.0002312923,0.000051960953,0.00008430453,0.0013651734,0.00013547168,0.00054230465],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.98800045,0.006548369,0.0008567796,0.0026105281,0.0016544636,0.000329504],"domain_scores_gemma":[0.91385555,0.06536034,0.0046659326,0.007049454,0.0074354466,0.0016332465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024214683,0.0009891179,0.0006808709,0.0013032747,0.0006101191,0.0015441601,0.0013692374,0.0021831226,0.0014139141],"category_scores_gemma":[0.08404483,0.0004513352,0.00079545093,0.0007285449,0.0012638248,0.0012051482,0.0019250362,0.0016772441,0.0006130975],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0089963,0.00091003784,0.2538618,0.00088144356,0.0026233036,0.0007330094,0.0020452726,0.42323425,0.023234252,0.0024422128,0.0141154565,0.2669226],"study_design_scores_gemma":[0.00022256887,0.00184149,0.070356466,0.00016462976,0.00032718468,0.0007413629,0.00045098018,0.889687,0.028482437,0.004880317,0.0026771685,0.0001683743],"about_ca_topic_score_codex":0.0037291932,"about_ca_topic_score_gemma":0.0027616774,"teacher_disagreement_score":0.024214683,"about_ca_system_score_codex":0.0012153283,"about_ca_system_score_gemma":0.00088620547,"threshold_uncertainty_score":0.128061},"labels":[],"label_agreement":null},{"id":"W4412163706","doi":"10.1158/1557-3265.aimachine-a051","title":"Abstract A051: Multi-omic explainable machine learning improves cancer treatment outcome prediction","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Outcome (game theory); Medicine; Artificial intelligence; Bioinformatics; Computer science; Internal medicine; Biology; Mathematics","score_opus":0.20157133297784077,"score_gpt":0.5564497345569215,"score_spread":0.3548784015790807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52818835,0.002089295,0.44596833,0.0076120975,0.00041857432,0.00016268938,0.007954186,0.004631596,0.0029748697],"genre_scores_gemma":[0.9320634,0.00021985848,0.059378553,0.0006114806,0.00029305505,0.0001391582,0.0056842347,0.0002680332,0.0013421057],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99820304,0.0009682598,0.00007341499,0.0004932444,0.00017075552,0.00009123372],"domain_scores_gemma":[0.99443924,0.003421137,0.0004833762,0.0007826115,0.0006336916,0.00023987898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047431844,0.0012795427,0.0009413724,0.0009692195,0.0005983382,0.001307505,0.00128553,0.0014476196,0.005728359],"category_scores_gemma":[0.01209647,0.00036423065,0.0021202194,0.00084996334,0.0005105355,0.0011613916,0.0016546722,0.002117873,0.001046025],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001556899,0.0006629744,0.14996865,0.0004066365,0.002814349,0.00025269398,0.000218508,0.5317316,0.0075759385,0.0028411977,0.023991602,0.277979],"study_design_scores_gemma":[0.00005961076,0.00021373999,0.012216372,0.000027916602,0.00018632902,0.00004926758,0.000020071308,0.9793779,0.0016831957,0.0048910617,0.0012490079,0.00002539328],"about_ca_topic_score_codex":0.0052853385,"about_ca_topic_score_gemma":0.0036412093,"teacher_disagreement_score":0.005728359,"about_ca_system_score_codex":0.0009936695,"about_ca_system_score_gemma":0.0011457157,"threshold_uncertainty_score":0.025084674},"labels":[],"label_agreement":null},{"id":"W4412163707","doi":"10.1158/1557-3265.aimachine-pr-07","title":"Abstract PR-07: Automated segmentation pipeline for radiological imaging using UniverSeg and similarity-guided support set retrieval","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pipeline (software); Radiological weapon; Segmentation; Similarity (geometry); Artificial intelligence; Medicine; Computer science; Set (abstract data type); Pattern recognition (psychology); Computer vision; Radiology; Image (mathematics)","score_opus":0.23329529516041245,"score_gpt":0.5787951067437557,"score_spread":0.3454998115833432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163707","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03894024,0.0005883989,0.8795857,0.00036497414,0.00011960992,0.0003879387,0.0013996593,0.076821886,0.0017915784],"genre_scores_gemma":[0.29346633,0.00027018707,0.69483495,0.00041064966,0.00007292328,0.00037217658,0.005255774,0.0018326854,0.0034843988],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99948585,0.000075957425,0.00003798963,0.00018625897,0.00015355504,0.000060343962],"domain_scores_gemma":[0.9994497,0.0001593437,0.00004098229,0.0001391847,0.00015549109,0.000055364275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009758501,0.0011529576,0.0010467287,0.0013497126,0.0004343861,0.0013132347,0.0020778992,0.001412635,0.0074827094],"category_scores_gemma":[0.0028947638,0.0004989678,0.00095757167,0.0008847712,0.00040596892,0.0013784827,0.0015179282,0.00097616663,0.00423335],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010455957,0.00027290633,0.0024880795,0.0003262021,0.00015519385,0.00038168818,0.00029143383,0.09238908,0.049499236,0.004298647,0.037612356,0.81123954],"study_design_scores_gemma":[0.00005219509,0.00015294025,0.0006301772,0.000013836285,0.000016372744,0.00017556205,0.000054524626,0.9674788,0.023016661,0.003422406,0.004958822,0.000027663269],"about_ca_topic_score_codex":0.005264941,"about_ca_topic_score_gemma":0.0046130633,"teacher_disagreement_score":0.0074827094,"about_ca_system_score_codex":0.0007913219,"about_ca_system_score_gemma":0.0010673816,"threshold_uncertainty_score":0.025032163},"labels":[],"label_agreement":null},{"id":"W4412163708","doi":"10.1158/1557-3265.aimachine-a043","title":"Abstract A043: Mutational profiling and machine learning for risk stratification and biomarker identification in intraductal papillary mucinous neoplasms progressing to pancreatic cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Risk stratification; Biomarker; Medicine; Pancreatic cancer; Pathology; Profiling (computer programming); Pancreas; Oncology; Internal medicine; Cancer research; Cancer; Biology; Computer science","score_opus":0.18592273104664248,"score_gpt":0.5364256847718474,"score_spread":0.3505029537252049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94636023,0.0006644396,0.04949521,0.00025169758,0.000024175404,0.000074050426,0.0018552215,0.00042892326,0.0008461459],"genre_scores_gemma":[0.97576153,0.0001215191,0.021998115,0.00004786886,0.000013656409,0.000051325827,0.0015697189,0.00002414382,0.0004122811],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993992,0.00026238034,0.00005273046,0.00015336185,0.00009175279,0.00004055914],"domain_scores_gemma":[0.99901783,0.0004976687,0.00017098668,0.00009102928,0.00015944842,0.00006296605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00144345,0.00046456937,0.00041482513,0.0013888619,0.00030340612,0.00084230397,0.000311709,0.00039500638,0.0010368382],"category_scores_gemma":[0.0030602496,0.00017267014,0.0006143329,0.0006864017,0.0002273813,0.00031610433,0.00040300316,0.0005486471,0.00044766266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020595016,0.00052475155,0.6738623,0.00018755863,0.0004531969,0.0003743088,0.00015211213,0.054740414,0.08598351,0.00081711344,0.0021806404,0.17866461],"study_design_scores_gemma":[0.000054221473,0.00075376447,0.27735534,0.000035931087,0.00018332746,0.0006253019,0.00011584061,0.6856435,0.031481117,0.0018644589,0.001846053,0.000041162362],"about_ca_topic_score_codex":0.0019096887,"about_ca_topic_score_gemma":0.0021270057,"teacher_disagreement_score":0.0019096887,"about_ca_system_score_codex":0.00033509286,"about_ca_system_score_gemma":0.0005781168,"threshold_uncertainty_score":0.0076337457},"labels":[],"label_agreement":null},{"id":"W4412163710","doi":"10.1158/1557-3265.aimachine-b029","title":"Abstract B029: Confident Filtering in the context of primary Gleason pattern classification","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gait Recognition and Analysis","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Context (archaeology); Medicine; Primary (astronomy); Cancer; Prostate cancer; Pathology; Internal medicine; Biology","score_opus":0.25802725184872427,"score_gpt":0.48350119102772054,"score_spread":0.22547393917899627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6332553,0.004032742,0.33787015,0.0040563866,0.0007076741,0.00030519406,0.0047319923,0.007349764,0.007690926],"genre_scores_gemma":[0.94822776,0.00031948552,0.044047292,0.0003045838,0.00026540898,0.000054189066,0.003707582,0.00016843333,0.0029053006],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99806875,0.00040208895,0.00010704445,0.00053989457,0.00061382324,0.000268367],"domain_scores_gemma":[0.99262285,0.0042297305,0.00069899665,0.00082503434,0.001158027,0.0004654461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041870824,0.0011231492,0.00092050125,0.0014990653,0.0005618773,0.0014229171,0.0016295111,0.0016717083,0.004050631],"category_scores_gemma":[0.01780951,0.000273063,0.0006884621,0.0008699504,0.00052320986,0.001416908,0.0012231575,0.0018206589,0.0013918126],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040044333,0.00083166687,0.07834452,0.00059435365,0.0004047245,0.0009933044,0.0002561789,0.21158883,0.02002865,0.004379704,0.04587802,0.6326956],"study_design_scores_gemma":[0.000068661,0.00027269102,0.017428119,0.00006431241,0.000070293674,0.0004029868,0.00006731076,0.95384943,0.019166483,0.0043381187,0.0042341664,0.000037385955],"about_ca_topic_score_codex":0.011511459,"about_ca_topic_score_gemma":0.008386403,"teacher_disagreement_score":0.011511459,"about_ca_system_score_codex":0.0010885784,"about_ca_system_score_gemma":0.0015409786,"threshold_uncertainty_score":0.022888899},"labels":[],"label_agreement":null},{"id":"W4412163711","doi":"10.1158/1557-3265.aimachine-pr-06","title":"Abstract PR-06: Analysis of pathologists’ intraobserver, interobserver and AI agreement in breast cancer HER2 scoring: AI-assessed intra-sample tumor heterogeneity relates to lower agreement among pathologists and with AI","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Cancer; Pathology; Radiology; Internal medicine","score_opus":0.07702883829687934,"score_gpt":0.47380851972291194,"score_spread":0.3967796814260326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834532,0.00030239028,0.013437602,0.00006450454,0.00004262945,0.00014236702,0.0002615161,0.00010404496,0.0021917713],"genre_scores_gemma":[0.99703336,0.00001957987,0.0024861493,0.000021642576,0.000015242826,0.00006349821,0.00016176069,0.000022171964,0.0001766639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.96838814,0.0189939,0.0032918314,0.003792553,0.0050119096,0.0005217091],"domain_scores_gemma":[0.8671628,0.09794671,0.014819822,0.0067061367,0.011977308,0.0013872783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02915453,0.00049628917,0.0004225665,0.0023044366,0.00047452733,0.0010047436,0.0008686661,0.00076039915,0.0017003242],"category_scores_gemma":[0.07656926,0.0003514604,0.001164209,0.0010349064,0.000969733,0.0013003666,0.0012619044,0.0005214136,0.0005029265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090991386,0.00010658722,0.9781014,0.00016358866,0.0005928041,0.00006489488,0.0009919064,0.001100112,0.0016200114,0.00015031997,0.00044074326,0.015757792],"study_design_scores_gemma":[0.000049042086,0.0012713296,0.9750079,0.00004377888,0.00026055184,0.00072810554,0.0012719821,0.017203985,0.0028209758,0.0004695474,0.00083922484,0.00003358196],"about_ca_topic_score_codex":0.00072126096,"about_ca_topic_score_gemma":0.0006240963,"teacher_disagreement_score":0.02915453,"about_ca_system_score_codex":0.00041013103,"about_ca_system_score_gemma":0.0003824481,"threshold_uncertainty_score":0.15418571},"labels":[],"label_agreement":null},{"id":"W4412163712","doi":"10.1158/1557-3265.aimachine-a017","title":"Abstract A017: Personalizing treatment selection for prostate cancer using causal machine learning","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prostate cancer; Cancer; Selection (genetic algorithm); Prostate; Medicine; Artificial intelligence; Oncology; Computer science; Internal medicine","score_opus":0.22192562760509268,"score_gpt":0.5782361287465765,"score_spread":0.35631050114148377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163712","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16236201,0.0046097636,0.8111154,0.009380432,0.0005066,0.0017898821,0.0029645704,0.00238199,0.0048893774],"genre_scores_gemma":[0.88264686,0.00067669223,0.11159536,0.0012591606,0.00037176517,0.0011181379,0.0012922568,0.000120099816,0.00091976265],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.97332776,0.023612648,0.00065442757,0.0013705151,0.00071548315,0.00031918992],"domain_scores_gemma":[0.82401097,0.1618957,0.005779751,0.004525588,0.0027188885,0.0010690328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04642258,0.0011479077,0.0016899689,0.0022280738,0.000733496,0.0019905847,0.0017738163,0.0016449398,0.005668701],"category_scores_gemma":[0.12943172,0.0006986843,0.002721952,0.0016048156,0.00120112,0.002047445,0.0016302096,0.0028714042,0.00040282743],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004756496,0.00063364743,0.07061129,0.0023153846,0.0035935668,0.00025424178,0.00030023255,0.59966034,0.0010556678,0.023119591,0.011809455,0.28189015],"study_design_scores_gemma":[0.0006490842,0.0005293751,0.0025785137,0.00020603875,0.00064748974,0.000049030336,0.00002625739,0.95701325,0.0006309122,0.03597253,0.0016649159,0.000032498465],"about_ca_topic_score_codex":0.0036317413,"about_ca_topic_score_gemma":0.0031993948,"teacher_disagreement_score":0.04642258,"about_ca_system_score_codex":0.0016505718,"about_ca_system_score_gemma":0.003545085,"threshold_uncertainty_score":0.24550903},"labels":[],"label_agreement":null},{"id":"W4412163719","doi":"10.1158/1557-3265.aimachine-b015","title":"Abstract B015: Large language models to predict cancer risk from free-text clinical notes","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Biomedical Text Mining and Ontologies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; University Health Network; University of Toronto; North Pacific Marine Science Organization; Princess Margaret Cancer Centre","funders":"","keywords":"Cancer; Medicine; Linguistics; Computer science; Internal medicine; Philosophy","score_opus":0.17617279812456935,"score_gpt":0.5355322737544392,"score_spread":0.3593594756298699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6067453,0.0046082535,0.17824705,0.010734419,0.00091838907,0.001398695,0.16559908,0.023736207,0.008012711],"genre_scores_gemma":[0.7743015,0.0007858332,0.09220918,0.0011671366,0.0004114502,0.000802958,0.12357484,0.00032258005,0.0064244666],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990264,0.0004126426,0.000073516334,0.00030602724,0.00010265616,0.00007875028],"domain_scores_gemma":[0.9932541,0.005200262,0.00025808983,0.00042364185,0.0006372391,0.00022659094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031248678,0.001510074,0.0006210192,0.0015034361,0.00062581804,0.0013394622,0.0020517176,0.0011017454,0.0052840076],"category_scores_gemma":[0.014528538,0.0005244246,0.0014580347,0.00087900343,0.00034765125,0.0011070404,0.0012428724,0.0016634744,0.002457957],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040309066,0.0013868226,0.19627285,0.0011057487,0.0012265429,0.0010124535,0.000730479,0.28488824,0.0030019726,0.004105739,0.14664492,0.35559332],"study_design_scores_gemma":[0.00026784075,0.00018462486,0.011941304,0.000099188626,0.00013788929,0.00009652994,0.00012634983,0.9761326,0.0007827233,0.0042502754,0.0059254398,0.000055265045],"about_ca_topic_score_codex":0.10686603,"about_ca_topic_score_gemma":0.13098317,"teacher_disagreement_score":0.10686603,"about_ca_system_score_codex":0.0024645433,"about_ca_system_score_gemma":0.0026438965,"threshold_uncertainty_score":0.212488},"labels":[],"label_agreement":null},{"id":"W4412163721","doi":"10.1158/1557-3265.aimachine-a028","title":"Abstract A028: Automated Rule Synthesis from Literature for Agent-Based Modeling of the Tumor Microenvironment","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Biomedical Text Mining and Ontologies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Cancer research; Computer science; Medicine; Computational biology; Tumor cells; Biology","score_opus":0.10806087661033964,"score_gpt":0.4620204237970602,"score_spread":0.35395954718672057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163721","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0135046225,0.0012193756,0.9077352,0.0009719787,0.000250736,0.0008317351,0.010995344,0.0580242,0.00646682],"genre_scores_gemma":[0.08089612,0.0007252636,0.8920637,0.00029000378,0.000091202055,0.00070711423,0.020081725,0.0019574657,0.0031874552],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9978005,0.0007612871,0.0002519486,0.0004387059,0.000667025,0.00008043628],"domain_scores_gemma":[0.9932789,0.004442578,0.0003195491,0.0007878112,0.0009956465,0.00017541635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031277684,0.0013439059,0.000695411,0.0039017105,0.0007111084,0.0026106478,0.0023748418,0.0011301398,0.013461897],"category_scores_gemma":[0.013926385,0.0005662396,0.0023297577,0.0012711599,0.0007556709,0.001461167,0.0025580795,0.0010404444,0.0040798895],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052092626,0.0004367562,0.004335792,0.004377961,0.00048605844,0.0019369798,0.0008511035,0.2660973,0.025661835,0.06597218,0.071678735,0.5576444],"study_design_scores_gemma":[0.00015734074,0.00013796384,0.0004786331,0.00032585688,0.0001373437,0.00046945992,0.00014559552,0.83659214,0.01702954,0.045750942,0.098706394,0.00006872639],"about_ca_topic_score_codex":0.0044650724,"about_ca_topic_score_gemma":0.0074707028,"teacher_disagreement_score":0.013461897,"about_ca_system_score_codex":0.0009090789,"about_ca_system_score_gemma":0.0027054008,"threshold_uncertainty_score":0.045034528},"labels":[],"label_agreement":null},{"id":"W4412163722","doi":"10.1158/1557-3265.aimachine-a015","title":"Abstract A015: Precision medicine approach to melanoma immunotherapy: Predicting response, adverse events, and hospital admissions using machine learning and explainable artificial intelligence","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Medicine; Adverse effect; Precision medicine; Melanoma; Artificial intelligence; Machine learning; Intensive care medicine; Medical physics; Computer science; Internal medicine; Cancer; Pathology; Cancer research","score_opus":0.12511467088594824,"score_gpt":0.5043422509448524,"score_spread":0.37922758005890417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7257893,0.007262648,0.22515325,0.018437935,0.00032574488,0.0006167908,0.0148673095,0.001694793,0.0058522937],"genre_scores_gemma":[0.95925146,0.00066042994,0.0339735,0.00049616,0.00018088604,0.00014725508,0.004586576,0.00001874307,0.0006849614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984004,0.00087597815,0.00014716414,0.0003056308,0.00020944586,0.00006137564],"domain_scores_gemma":[0.98953235,0.007801019,0.0012543544,0.00047514783,0.0007613709,0.00017571426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040299525,0.00078333274,0.0006571662,0.002692334,0.00048526385,0.0019010359,0.00084897625,0.0008645547,0.0019071674],"category_scores_gemma":[0.013059275,0.00025532438,0.0013726531,0.0018255841,0.00041365804,0.00083275244,0.000784685,0.0014212399,0.00025657236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080377026,0.00063118525,0.39402878,0.00079547614,0.0015941721,0.0003428911,0.00027480407,0.3831718,0.0013063317,0.004709641,0.012457475,0.19988374],"study_design_scores_gemma":[0.00008372003,0.0003676248,0.055325072,0.00018605762,0.00024688576,0.00014538768,0.00013308204,0.92479825,0.0012031627,0.014158347,0.003305974,0.00004640625],"about_ca_topic_score_codex":0.009995822,"about_ca_topic_score_gemma":0.007402993,"teacher_disagreement_score":0.009995822,"about_ca_system_score_codex":0.0018123697,"about_ca_system_score_gemma":0.0015295306,"threshold_uncertainty_score":0.021312714},"labels":[],"label_agreement":null},{"id":"W4412163723","doi":"10.1158/1557-3265.aimachine-b003","title":"Abstract B003: Towards machine learning fairness in glioblastoma: An evaluation of protected attributes in publicly available clinical datasets","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Glioblastoma; Computer science; Medicine; Artificial intelligence; Cancer research","score_opus":0.27140211578424217,"score_gpt":0.564677647575961,"score_spread":0.2932755317917188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8479655,0.0053787325,0.095566615,0.007420559,0.0008334589,0.0013960139,0.028520167,0.0031496722,0.009769259],"genre_scores_gemma":[0.91090125,0.00041799634,0.056799136,0.0011337899,0.00030056338,0.00060371496,0.028614571,0.00017942446,0.0010494511],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9663468,0.021581458,0.0024089508,0.004377484,0.0044812444,0.00080407213],"domain_scores_gemma":[0.88753074,0.07725458,0.007196541,0.015950615,0.009504178,0.0025633504],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.069876134,0.0009737887,0.001058865,0.0024066796,0.0016435995,0.0038087834,0.0019797818,0.0021698403,0.0027405547],"category_scores_gemma":[0.15986891,0.00029922667,0.0015431782,0.002475437,0.0021248073,0.0026589332,0.004197262,0.0020526883,0.0009866229],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01130202,0.0022108431,0.45716473,0.0025147954,0.0032763008,0.00042328204,0.00155381,0.18003625,0.0040855343,0.0185894,0.070707574,0.24813542],"study_design_scores_gemma":[0.0020314404,0.0037433817,0.17924747,0.0013189332,0.0007841909,0.0013199404,0.0017569338,0.7000131,0.013736339,0.057809956,0.037957266,0.0002809802],"about_ca_topic_score_codex":0.0046796096,"about_ca_topic_score_gemma":0.0034870098,"teacher_disagreement_score":0.93012387,"about_ca_system_score_codex":0.0023314597,"about_ca_system_score_gemma":0.0033140415,"threshold_uncertainty_score":0.36954474},"labels":[],"label_agreement":null},{"id":"W4412163724","doi":"10.1158/1557-3265.aimachine-a009","title":"Abstract A009: AI-driven metabolomics and synthetic drug design for targeting CNS metastases","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metabolomics; Medicine; Drug; Computational biology; Pharmacology; Bioinformatics; Biology","score_opus":0.11176606254873372,"score_gpt":0.4711870729761719,"score_spread":0.3594210104274382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163724","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45698714,0.004281863,0.5156641,0.0016882974,0.00020005432,0.00044410495,0.004772311,0.0031296595,0.012832393],"genre_scores_gemma":[0.75484496,0.002484843,0.23228252,0.00024402313,0.000061626146,0.00035625347,0.0035169923,0.0002580288,0.005950772],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998604,0.00002512075,0.000008174099,0.000041637624,0.000051021958,0.0000135935],"domain_scores_gemma":[0.9997974,0.00006146685,0.000043243042,0.0000122947895,0.000068389156,0.000017200142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005522807,0.0005470633,0.0003912758,0.00056698354,0.00017146001,0.00071781944,0.00037231244,0.00036295407,0.002430553],"category_scores_gemma":[0.00067335734,0.00021282179,0.00048600356,0.00060707965,0.00025081873,0.00044134003,0.00039,0.0003746806,0.0006865881],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011114021,0.00035483556,0.0057193353,0.0010018671,0.00016286795,0.00029998942,0.00006676723,0.18966213,0.6212166,0.0067853723,0.0063168146,0.16730212],"study_design_scores_gemma":[0.000091147784,0.0007677715,0.0050494336,0.000036097583,0.00008818437,0.00023363088,0.00004132042,0.7204679,0.25497964,0.00333492,0.014859214,0.00005071967],"about_ca_topic_score_codex":0.0021542974,"about_ca_topic_score_gemma":0.0022037989,"teacher_disagreement_score":0.002430553,"about_ca_system_score_codex":0.0007369063,"about_ca_system_score_gemma":0.0008178896,"threshold_uncertainty_score":0.008131027},"labels":[],"label_agreement":null},{"id":"W4412163726","doi":"10.1158/1557-3265.aimachine-b043","title":"Abstract B043: Cellular localization as a prognostic indicator in invasive breast cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Cancer; Breast cancer; Medicine; Oncology; Pathology; Internal medicine","score_opus":0.1948853610627769,"score_gpt":0.5672121022401246,"score_spread":0.37232674117734776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9683507,0.00091883476,0.0074485373,0.000768096,0.00008762278,0.000040911335,0.019142533,0.0007087729,0.0025339604],"genre_scores_gemma":[0.98321885,0.00014517482,0.002763854,0.000050811595,0.000042394957,0.00002808969,0.011953538,0.000049545535,0.00174768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976295,0.00004740531,0.000019103147,0.00007376915,0.00005960924,0.000037243433],"domain_scores_gemma":[0.99838686,0.0007354358,0.00023562308,0.00012773104,0.00033711942,0.00017713956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000919664,0.0004602706,0.00037839738,0.0011568746,0.0002515681,0.00071321026,0.0005582753,0.0005970018,0.0067107915],"category_scores_gemma":[0.0032065574,0.00016509347,0.0005908588,0.0010483654,0.00025783895,0.00031861497,0.00049788976,0.0006775106,0.0016650289],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014919634,0.00014383555,0.92770034,0.0001593875,0.00025854498,0.00016834194,0.000057850826,0.017843965,0.004656995,0.00015976721,0.008767473,0.038591523],"study_design_scores_gemma":[0.00007449457,0.00036094664,0.86971813,0.00006137395,0.0002571883,0.0006424361,0.00013981912,0.11756047,0.0051055388,0.0009043726,0.0051251105,0.000050011615],"about_ca_topic_score_codex":0.022666676,"about_ca_topic_score_gemma":0.022036286,"teacher_disagreement_score":0.022666676,"about_ca_system_score_codex":0.00082228414,"about_ca_system_score_gemma":0.000775248,"threshold_uncertainty_score":0.045069456},"labels":[],"label_agreement":null},{"id":"W4412163728","doi":"10.1158/1557-3265.aimachine-b048","title":"Abstract B048: Large Scale, AI-Enabled, Spatial Signal Processing of Breast Cancer Pathology Identifies Consensus Tissue Structures Related to Biology and Outcomes","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"AI in cancer detection","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Cancer; Scale (ratio); Pathology; Medicine; Biology; Computational biology; Internal medicine; Cartography","score_opus":0.06175049177618674,"score_gpt":0.4973120765686493,"score_spread":0.43556158479246254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66887474,0.0004064061,0.31542557,0.00045778276,0.000097732795,0.00013067234,0.004985763,0.005440363,0.004180979],"genre_scores_gemma":[0.8386181,0.00017540298,0.15212469,0.000076295306,0.0000351143,0.00016452916,0.004789634,0.00028473974,0.0037315602],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998258,0.0000341851,0.0000075394787,0.000049371203,0.00005948271,0.000023713992],"domain_scores_gemma":[0.99974626,0.00006675437,0.00004305722,0.000042922828,0.00007218585,0.00002884342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005609575,0.00038175273,0.00023906745,0.00092547474,0.00021253953,0.0005211795,0.00049792207,0.0003683908,0.003512785],"category_scores_gemma":[0.001167097,0.0001746151,0.00036207712,0.00075902324,0.000306411,0.00044222144,0.0005735097,0.00039341915,0.0012001621],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011813599,0.00041764637,0.036463264,0.00030211572,0.00015288174,0.00035200355,0.00021607532,0.081740364,0.4976155,0.0030493615,0.013916835,0.3645926],"study_design_scores_gemma":[0.00003897937,0.0003368928,0.06291698,0.000020501506,0.00005899922,0.00059746543,0.0001336221,0.8341343,0.089796074,0.0029240388,0.008989721,0.00005245728],"about_ca_topic_score_codex":0.004660314,"about_ca_topic_score_gemma":0.00693036,"teacher_disagreement_score":0.004660314,"about_ca_system_score_codex":0.00047270214,"about_ca_system_score_gemma":0.0005788363,"threshold_uncertainty_score":0.011751473},"labels":[],"label_agreement":null},{"id":"W4412163730","doi":"10.1158/1557-3265.aimachine-b041","title":"Abstract B041: A Cellular Network-Aware Foundation Model Improves Single-Cell Level Predictions","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Wireless Body Area Networks","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Foundation (evidence); Computer science; Medicine; Computational biology; Biology; History","score_opus":0.20307209482385777,"score_gpt":0.42202974138715865,"score_spread":0.21895764656330088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163730","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29602644,0.00086126983,0.6856647,0.0017260989,0.00026869492,0.00007317603,0.0017540789,0.005554922,0.008070633],"genre_scores_gemma":[0.92968684,0.00025183256,0.062003203,0.00042473388,0.0000688979,0.00010544288,0.0024569256,0.00044659828,0.004555467],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99986625,0.00002794352,0.0000056116905,0.000052040043,0.000023626753,0.000024521472],"domain_scores_gemma":[0.99936277,0.0003348143,0.000048947968,0.00007572473,0.00010310238,0.00007465874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005367566,0.0008848015,0.0007273288,0.0004594651,0.00028531876,0.0007695283,0.0013403,0.001177113,0.0029337143],"category_scores_gemma":[0.0019672548,0.00031177144,0.0009495553,0.00028584315,0.00044722314,0.0012848808,0.00091180106,0.0013299425,0.0008197563],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007368804,0.000045398792,0.0012523091,0.00004323663,0.000024265533,0.000052923722,0.000025351146,0.97290415,0.003128876,0.0036529144,0.0023789422,0.016417967],"study_design_scores_gemma":[0.000003185965,0.000008119106,0.00004374884,0.0000016763544,0.00000209456,0.000003186299,0.000002287881,0.9978757,0.00025395036,0.0016943875,0.0001101852,0.0000015594287],"about_ca_topic_score_codex":0.007914125,"about_ca_topic_score_gemma":0.0075960034,"teacher_disagreement_score":0.007914125,"about_ca_system_score_codex":0.00087640254,"about_ca_system_score_gemma":0.0011768641,"threshold_uncertainty_score":0.015736103},"labels":[],"label_agreement":null},{"id":"W4412163731","doi":"10.1158/1557-3265.aimachine-a020","title":"Abstract A020: Machine learning models of RNA expression landscapes help predict overall tumor response to chemotherapy in cholangiocarcinoma","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemotherapy; Oncology; Medicine; Expression (computer science); RNA; Cancer research; Computational biology; Biology; Internal medicine; Computer science; Genetics; Gene","score_opus":0.1292653265625747,"score_gpt":0.45105965007869037,"score_spread":0.3217943235161157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9263535,0.0004639574,0.06829592,0.0005414541,0.000038168262,0.00009134626,0.0015522793,0.00070344226,0.0019599355],"genre_scores_gemma":[0.9853468,0.00006473842,0.011896691,0.000066671884,0.000018647741,0.00006840257,0.0015679958,0.00003626644,0.00093370053],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99972075,0.00016120437,0.0000112735415,0.00006352211,0.00001990499,0.000023261106],"domain_scores_gemma":[0.9986267,0.0010602648,0.00008419422,0.00004887042,0.00013963759,0.00004042295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002110739,0.000713004,0.00039796563,0.00064685824,0.00022948527,0.00063867046,0.00037757528,0.00043188178,0.0019823944],"category_scores_gemma":[0.004090367,0.0002488742,0.0006711825,0.0002864794,0.00019924296,0.00035863317,0.00036739686,0.0005474764,0.0004379625],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011970442,0.0002807226,0.059644032,0.00006814174,0.00025456818,0.00009207363,0.00003979876,0.87979704,0.0028551547,0.00028114862,0.0019238397,0.053566396],"study_design_scores_gemma":[0.000010787479,0.00005298099,0.003919463,0.000004634322,0.00001037579,0.000011590253,0.000005897273,0.995317,0.00027556662,0.0003265906,0.00006183658,0.0000033061779],"about_ca_topic_score_codex":0.00532145,"about_ca_topic_score_gemma":0.0036601056,"teacher_disagreement_score":0.00532145,"about_ca_system_score_codex":0.0006856991,"about_ca_system_score_gemma":0.0004982627,"threshold_uncertainty_score":0.011162758},"labels":[],"label_agreement":null},{"id":"W4412163732","doi":"10.1158/1557-3265.aimachine-b020","title":"Abstract B020: Automated classification of thymic epithelial tumors. A novel deep learning approach","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Deep learning; Pathology; Medicine; Cancer; Cancer research; Artificial intelligence; Computer science; Internal medicine","score_opus":0.1413354508483994,"score_gpt":0.5147644851405606,"score_spread":0.37342903429216123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163732","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22963679,0.002594926,0.7411769,0.0015041829,0.0003607661,0.00036581358,0.0046676407,0.012688442,0.007004587],"genre_scores_gemma":[0.7355955,0.0006634782,0.23429365,0.0009057595,0.00024805067,0.00034781065,0.012702085,0.00031951893,0.014924139],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99952996,0.000064578075,0.00003084136,0.0001687692,0.000107976855,0.000097919925],"domain_scores_gemma":[0.99962914,0.000077323755,0.000039261482,0.000054520297,0.00015545436,0.000044278047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008982974,0.0011192088,0.0006976613,0.0016093955,0.00038146824,0.0009787561,0.001657654,0.0014738104,0.0024518417],"category_scores_gemma":[0.0011789055,0.00041707893,0.00094542216,0.0009684976,0.00027362746,0.00081044674,0.0013284018,0.0011890692,0.0015101726],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042404595,0.00041764218,0.0075276424,0.00017276887,0.00017604373,0.00020347287,0.00007557357,0.13848145,0.0225521,0.0017232135,0.023906754,0.8043393],"study_design_scores_gemma":[0.000016103575,0.00005507183,0.0011998197,0.000012448886,0.00001943177,0.00006206856,0.000018169112,0.9919012,0.004061091,0.0013176582,0.0013281213,0.000008872382],"about_ca_topic_score_codex":0.008641457,"about_ca_topic_score_gemma":0.008548512,"teacher_disagreement_score":0.008641457,"about_ca_system_score_codex":0.0009038351,"about_ca_system_score_gemma":0.0010471621,"threshold_uncertainty_score":0.01718229},"labels":[],"label_agreement":null},{"id":"W4412163733","doi":"10.1158/1557-3265.aimachine-a052","title":"Abstract A052: The S-RACE Platform: Empowering Healthcare Real-World Data with Artificial Intelligence (AI) Using a Cloud-Based Approach","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Artificial Intelligence in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Race (biology); Cloud computing; Computer science; Health care; Artificial intelligence; Data science; Medicine; Biology; Operating system; Political science","score_opus":0.8049209988426096,"score_gpt":0.707454911255144,"score_spread":0.09746608758746556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163733","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06503937,0.001219878,0.47877958,0.008025793,0.0013376878,0.002398119,0.0695431,0.32638356,0.047272902],"genre_scores_gemma":[0.44154727,0.0011955851,0.4231469,0.0030643796,0.0005937523,0.0015095182,0.09232731,0.016959295,0.019656008],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975509,0.0005434086,0.0002402998,0.00057729596,0.0008450563,0.00024308254],"domain_scores_gemma":[0.99354446,0.0015840887,0.00038683877,0.002316582,0.0012781157,0.0008899311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004358428,0.0011483381,0.000757921,0.0014051748,0.0006814058,0.00451497,0.0025843065,0.00077243225,0.020827515],"category_scores_gemma":[0.009474976,0.00057770644,0.001160649,0.0017231021,0.0008987773,0.004312693,0.0041058366,0.001695863,0.009588876],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008072998,0.001084257,0.014970612,0.0013117028,0.00038692504,0.0014682726,0.0014896207,0.03744141,0.03203483,0.088950016,0.59836817,0.21442123],"study_design_scores_gemma":[0.001138606,0.0008742459,0.0095006935,0.0003996742,0.00014166662,0.00059798924,0.0005268263,0.5123794,0.035377663,0.06587073,0.37290552,0.00028700638],"about_ca_topic_score_codex":0.0066341073,"about_ca_topic_score_gemma":0.0043608705,"teacher_disagreement_score":0.020827515,"about_ca_system_score_codex":0.0010460329,"about_ca_system_score_gemma":0.0025578095,"threshold_uncertainty_score":0.06967491},"labels":[],"label_agreement":null},{"id":"W4412163734","doi":"10.1158/1557-3265.aimachine-a031","title":"Abstract A031: Unsupervised graph-based visualization of variational autoencoder latent spaces reveals hidden multiple myeloma subtypes","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"AI in cancer detection","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Autoencoder; Visualization; Multiple myeloma; Artificial intelligence; Graph; Pattern recognition (psychology); Computer science; Computational biology; Medicine; Biology; Theoretical computer science; Artificial neural network; Internal medicine","score_opus":0.1465657502516099,"score_gpt":0.46955915706531387,"score_spread":0.322993406813704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163734","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43973792,0.00033671968,0.5471585,0.0010857423,0.00010433109,0.000085121224,0.0036856893,0.0049484232,0.0028575817],"genre_scores_gemma":[0.89670634,0.00015863309,0.097259596,0.00010418076,0.00003348759,0.000067642664,0.003212472,0.00040563176,0.002052075],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9998406,0.000052192234,0.000007084567,0.00004890715,0.000026826294,0.000024459769],"domain_scores_gemma":[0.9993881,0.00031641274,0.000055975208,0.000077661134,0.00010773978,0.000054108663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073273166,0.0006479118,0.00032898894,0.0011973686,0.00035116833,0.0009228768,0.000539822,0.0005739921,0.0035398551],"category_scores_gemma":[0.0020949575,0.00023471093,0.0008257916,0.00056288077,0.00038063095,0.00070650154,0.0006901385,0.00092308165,0.00046373162],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000976785,0.00027927785,0.036814872,0.00023910147,0.00030050176,0.00047061557,0.00091324525,0.6800885,0.057214744,0.030532828,0.02141309,0.17075647],"study_design_scores_gemma":[0.0000095038695,0.000019526542,0.002522415,0.000010055237,0.000006057527,0.000028322895,0.000051332376,0.9869207,0.002464026,0.0069915275,0.00096593413,0.000010667812],"about_ca_topic_score_codex":0.0072146533,"about_ca_topic_score_gemma":0.007186265,"teacher_disagreement_score":0.0072146533,"about_ca_system_score_codex":0.0006634036,"about_ca_system_score_gemma":0.0006344776,"threshold_uncertainty_score":0.014345348},"labels":[],"label_agreement":null},{"id":"W4412163735","doi":"10.1158/1557-3265.aimachine-a003","title":"Abstract A003: An active learning platform for predictive oncology in rare cancers","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Precision oncology; Internal medicine; Clinical Oncology; Cancer; Cancer research","score_opus":0.1482777133428529,"score_gpt":0.5362465280913922,"score_spread":0.3879688147485393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163735","genre_codex":"methods","genre_gemma":"software","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"software","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0075568054,0.00090610894,0.9353301,0.0014226786,0.0004814847,0.0002214613,0.002674475,0.04554344,0.0058635203],"genre_scores_gemma":[0.305139,0.001641572,0.65412194,0.0021240723,0.0006629072,0.0017998543,0.010954976,0.0032888474,0.020266848],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992532,0.00024201984,0.000041733434,0.00015637693,0.00026881386,0.000037828315],"domain_scores_gemma":[0.99817204,0.0011982542,0.00009473484,0.00015262891,0.00023892912,0.00014337913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022216644,0.0011166326,0.0007780982,0.0009995222,0.00036830883,0.0016665363,0.002240725,0.0015906935,0.018719012],"category_scores_gemma":[0.0051996037,0.0005339142,0.001149202,0.00051020854,0.0006048794,0.0013299937,0.0020332257,0.0026651388,0.0058937976],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013536608,0.000495751,0.002687847,0.0006176349,0.0002935578,0.00041138803,0.0001304165,0.36259547,0.019004501,0.0308409,0.109503925,0.47206494],"study_design_scores_gemma":[0.00009631463,0.00012896485,0.00018310086,0.000024116829,0.000020430733,0.00004242423,0.0000084174035,0.96173483,0.0036126135,0.021313224,0.012809885,0.000025674924],"about_ca_topic_score_codex":0.0013316225,"about_ca_topic_score_gemma":0.0014587527,"teacher_disagreement_score":0.018719012,"about_ca_system_score_codex":0.00052774244,"about_ca_system_score_gemma":0.00085305626,"threshold_uncertainty_score":0.062621355},"labels":[],"label_agreement":null},{"id":"W4412163736","doi":"10.1158/1557-3265.aimachine-a048","title":"Abstract A048: Weakly supervised prediction of <i>EGFR</i> mutation status and early metastasis of lung adenocarcinoma whole slide histopathology images using artificial intelligence","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Histopathology; Adenocarcinoma; Metastasis; Medicine; Lung; Lung cancer; Pathology; Oncology; Cancer; Internal medicine","score_opus":0.147712398576796,"score_gpt":0.49030721034938923,"score_spread":0.3425948117725932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78844863,0.0005958055,0.20263964,0.00034186622,0.00014394299,0.00021641997,0.0009534243,0.004159097,0.0025012111],"genre_scores_gemma":[0.9427929,0.0000879836,0.052724957,0.00010260479,0.000040782164,0.000082405655,0.0016394878,0.000045407018,0.0024834343],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.999554,0.00009477621,0.000036014768,0.00015452216,0.00011211362,0.000048644077],"domain_scores_gemma":[0.9990729,0.00031380594,0.000102546655,0.00008410773,0.00036086334,0.000065707885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008499216,0.00097217574,0.00056575297,0.0010004796,0.00024114794,0.0006091807,0.00079087034,0.0008235313,0.00094308454],"category_scores_gemma":[0.0017679579,0.00019670298,0.00077511434,0.0003953077,0.0002833115,0.00036314997,0.0004333821,0.00059257075,0.00047590464],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011058849,0.0010236591,0.048182774,0.00019717502,0.00041979243,0.0006531485,0.00010418841,0.46776357,0.088403985,0.0005664375,0.0072035054,0.3843759],"study_design_scores_gemma":[0.0000049978303,0.00006983016,0.0035236657,0.000003269646,0.000013973864,0.000034592707,0.000008715198,0.990726,0.005345753,0.00012406887,0.0001395017,0.000005576844],"about_ca_topic_score_codex":0.006387903,"about_ca_topic_score_gemma":0.00534558,"teacher_disagreement_score":0.006387903,"about_ca_system_score_codex":0.0005534023,"about_ca_system_score_gemma":0.00055680034,"threshold_uncertainty_score":0.012701392},"labels":[],"label_agreement":null},{"id":"W4412163737","doi":"10.1158/1557-3265.aimachine-a021","title":"Abstract A021: Improving cardiotoxicity prediction for oncology drugs via domain-specific adaptation","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Sunnybrook Hospital; McMaster University","funders":"","keywords":"Cardiotoxicity; Medicine; Oncology; Internal medicine; Cancer; Pharmacology; Chemotherapy","score_opus":0.24175000458675547,"score_gpt":0.5435452181652249,"score_spread":0.3017952135784695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74670833,0.0075240186,0.20579247,0.0028446752,0.0004960825,0.0004073086,0.013192338,0.014692932,0.008341834],"genre_scores_gemma":[0.9292462,0.0008796863,0.05321453,0.0007632777,0.00014970584,0.00021130114,0.01235458,0.00018506365,0.0029956636],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99961096,0.00012444297,0.000024008692,0.00015779446,0.00004597523,0.0000369172],"domain_scores_gemma":[0.9989619,0.0006235104,0.000087672284,0.000105961124,0.0001661514,0.000054782664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011447972,0.0014029578,0.00079148024,0.0009192904,0.0001753661,0.0005975905,0.0010538327,0.0009808948,0.0015892],"category_scores_gemma":[0.0023634455,0.000273429,0.0014431875,0.0005395665,0.00022557007,0.0005595538,0.0005393732,0.0013172702,0.00070427475],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053964386,0.00051869306,0.014360151,0.00025384667,0.0003621177,0.00019982253,0.000034296892,0.8559956,0.008828093,0.00041740568,0.010955232,0.107535146],"study_design_scores_gemma":[0.000024144892,0.00009547123,0.0016284506,0.0000113114775,0.000043936434,0.000036830053,0.00000671406,0.994406,0.0021053117,0.0004973815,0.001132779,0.000011685599],"about_ca_topic_score_codex":0.009011699,"about_ca_topic_score_gemma":0.007144267,"teacher_disagreement_score":0.009011699,"about_ca_system_score_codex":0.00074607163,"about_ca_system_score_gemma":0.0008322567,"threshold_uncertainty_score":0.017918468},"labels":[],"label_agreement":null},{"id":"W4412163738","doi":"10.1158/1557-3265.aimachine-a064","title":"Abstract A064: Dynamics in automatic CT based body composition and blood biomarkers in predicting mortality on immune therapy treated solid malignancy patients","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Malignancy; Medicine; Solid tumor; Immune system; Internal medicine; Oncology; Cancer; Immunology","score_opus":0.06093815350943812,"score_gpt":0.4830402115322952,"score_spread":0.4221020580228571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552613,0.00029980595,0.0006560841,0.00005997532,0.00001450311,0.00002602171,0.0023430954,0.000072645824,0.0010016973],"genre_scores_gemma":[0.9962443,0.00007466756,0.00076180475,0.000029694613,0.000018640987,0.00003300086,0.002423738,0.000013813558,0.00040032962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997099,0.000097403914,0.00003845303,0.00007027051,0.000050219973,0.000033683762],"domain_scores_gemma":[0.99906796,0.00022431655,0.00030610067,0.00007712713,0.00019747426,0.00012705218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064697326,0.00035843477,0.0003751558,0.0009886868,0.00020951261,0.00072907977,0.00030471673,0.00031509425,0.0021934605],"category_scores_gemma":[0.0021014803,0.0001547427,0.00043026434,0.0008942586,0.00014971415,0.00030087153,0.0005083985,0.0003439011,0.00055104296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011784694,0.000075326745,0.9843604,0.000031254407,0.00007672831,0.00005529148,0.000039143422,0.00071910606,0.00093685597,0.0000401568,0.000797854,0.011689428],"study_design_scores_gemma":[0.000040592087,0.0003357355,0.9890287,0.000022484994,0.00006986872,0.0002579761,0.00008530725,0.008235662,0.0007871927,0.00010792766,0.0010174676,0.00001099626],"about_ca_topic_score_codex":0.002137846,"about_ca_topic_score_gemma":0.002311657,"teacher_disagreement_score":0.0021934605,"about_ca_system_score_codex":0.00029120455,"about_ca_system_score_gemma":0.00025372085,"threshold_uncertainty_score":0.0073378086},"labels":[],"label_agreement":null},{"id":"W4412163743","doi":"10.1158/1557-3265.aimachine-a027","title":"Abstract A027: Multiscale systems approach to target tumor ecosystem responses for therapeutic benefit","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Computational biology; Biology","score_opus":0.29748111601541166,"score_gpt":0.5397355488544545,"score_spread":0.24225443283904285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163743","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09805801,0.0007183864,0.87712497,0.0019914694,0.00027776384,0.0002548294,0.0009532265,0.0010667082,0.01955471],"genre_scores_gemma":[0.848237,0.0008431839,0.14158215,0.00045071973,0.00017822528,0.00073812396,0.0005187344,0.000305095,0.0071467],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981576,0.00005823547,0.000007844727,0.000042409127,0.00004855798,0.000027202423],"domain_scores_gemma":[0.99958974,0.00021804846,0.000051354746,0.000034486035,0.00006363177,0.000042706048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005448862,0.00069550314,0.0007305322,0.00046088456,0.00040300278,0.0009800531,0.0010466909,0.001445419,0.004372403],"category_scores_gemma":[0.0011568525,0.00042876354,0.0010370051,0.00028802344,0.00066851533,0.0006138787,0.001260631,0.0011751384,0.00044840729],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029251942,0.000051982326,0.0008242136,0.00007855687,0.00004398198,0.00006667715,0.00003391515,0.9685847,0.010822833,0.014375122,0.0008513158,0.0042375145],"study_design_scores_gemma":[0.000002837328,0.000008433788,0.00006787835,0.0000022553902,0.0000029737555,0.0000036440078,0.00000447152,0.9977502,0.00029890038,0.0014995517,0.0003555734,0.0000031831012],"about_ca_topic_score_codex":0.0050984635,"about_ca_topic_score_gemma":0.0034811276,"teacher_disagreement_score":0.0050984635,"about_ca_system_score_codex":0.0008738272,"about_ca_system_score_gemma":0.0010936378,"threshold_uncertainty_score":0.014627099},"labels":[],"label_agreement":null},{"id":"W4412163744","doi":"10.1158/1557-3265.aimachine-b054","title":"Abstract B054: Identification of spatial motifs linked to tumor genotype using graph attention networks","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Computing and Algorithms","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Identification (biology); Genotype; Computational biology; Biology; Genetics; Gene; Ecology","score_opus":0.2135867134938683,"score_gpt":0.5661440929592809,"score_spread":0.35255737946541266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163744","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24380518,0.00054197194,0.74690884,0.000818895,0.00007618625,0.00007472122,0.0009869505,0.003337001,0.0034502272],"genre_scores_gemma":[0.8920664,0.00020004644,0.10063833,0.0002775347,0.000061829225,0.00007154076,0.0024410456,0.00023161531,0.0040116464],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971396,0.00007018145,0.000009399491,0.00012041865,0.000042102107,0.00004393435],"domain_scores_gemma":[0.99884534,0.000656974,0.00014957922,0.0000927009,0.00017853251,0.00007696411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066645106,0.0008284623,0.00047477306,0.0013721341,0.00032820983,0.00066664227,0.0011535666,0.001120127,0.001998927],"category_scores_gemma":[0.0026930585,0.00040178697,0.00075030146,0.000678634,0.000618957,0.000871088,0.00082016725,0.0010850716,0.0005014144],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025839102,0.00011049123,0.0068839737,0.00013525628,0.000104247774,0.0001510442,0.000089789246,0.8692886,0.01703533,0.008030938,0.0047625424,0.0931494],"study_design_scores_gemma":[0.000003429088,0.000011201646,0.00039188785,0.0000028826125,0.000004103224,0.000008381943,0.000005874302,0.99651426,0.001002385,0.0019026423,0.0001501529,0.0000027749666],"about_ca_topic_score_codex":0.011568118,"about_ca_topic_score_gemma":0.012273726,"teacher_disagreement_score":0.011568118,"about_ca_system_score_codex":0.0009196956,"about_ca_system_score_gemma":0.0007480166,"threshold_uncertainty_score":0.023001611},"labels":[],"label_agreement":null},{"id":"W4412163745","doi":"10.1158/1557-3265.aimachine-b016","title":"Abstract B016: Multi-Agent Framework for Deep Research in Cancer Immunogenomics via TCR Datasets and Scientific Literature Search","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada); Inro Consultants (Canada)","funders":"","keywords":"Cancer; T-cell receptor; Medicine; Computer science; Internal medicine; Immunology; T cell","score_opus":0.2479773072360743,"score_gpt":0.5931168608633651,"score_spread":0.3451395536272908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163745","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011507154,0.00044498348,0.9680284,0.0015601149,0.00006584785,0.00043639858,0.002144674,0.012701849,0.003110575],"genre_scores_gemma":[0.10298905,0.00032566412,0.89036304,0.0003231002,0.00002801651,0.0004949167,0.003415798,0.0003213195,0.0017390415],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989236,0.00047937394,0.00010717323,0.00021035112,0.00022128441,0.000058237463],"domain_scores_gemma":[0.9980374,0.0011284244,0.00014845192,0.00024394743,0.00023772553,0.00020403751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003998337,0.0007294776,0.00064534997,0.003638487,0.0010918919,0.0028215542,0.0019970909,0.0011186822,0.004611625],"category_scores_gemma":[0.0061455253,0.0005261881,0.0017930262,0.0016996089,0.00074623764,0.0020122651,0.003384769,0.001006401,0.0007976939],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072301633,0.00042891584,0.009548449,0.0016237627,0.0006963695,0.0010815788,0.0013114803,0.5342083,0.014630628,0.16607584,0.028595177,0.24107644],"study_design_scores_gemma":[0.00005910584,0.000027778147,0.00027595178,0.000051355622,0.00004534245,0.000047672624,0.000107325825,0.9528369,0.001608402,0.029858364,0.015059994,0.000021946846],"about_ca_topic_score_codex":0.015578168,"about_ca_topic_score_gemma":0.027772652,"teacher_disagreement_score":0.015578168,"about_ca_system_score_codex":0.0015351869,"about_ca_system_score_gemma":0.0036358694,"threshold_uncertainty_score":0.030974984},"labels":[],"label_agreement":null},{"id":"W4412163746","doi":"10.1158/1557-3265.aimachine-a002","title":"Abstract A002: A Bayesian Machine Learning Approach for Estimating Treatment Effects in Decentralized Clinical Trials","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bayesian probability; Clinical trial; Machine learning; Artificial intelligence; Medicine; Computer science; Intensive care medicine; Internal medicine","score_opus":0.882817471872725,"score_gpt":0.7654210037911113,"score_spread":0.11739646808161364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163746","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020951545,0.00035271354,0.9959609,0.00054854713,0.000039947634,0.00016306897,0.00010885145,0.00013480744,0.0005959908],"genre_scores_gemma":[0.18263015,0.0011205105,0.8085192,0.00076288934,0.00046535485,0.0020261225,0.00048735898,0.00012890916,0.0038595337],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.97611666,0.02038361,0.00055089634,0.0013106148,0.0013825685,0.00025568288],"domain_scores_gemma":[0.938263,0.0552785,0.0022921003,0.0013283407,0.002237149,0.0006009319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030657815,0.0012178278,0.0032380295,0.0027700304,0.00074834237,0.0022820202,0.0027219986,0.0023154004,0.0052212775],"category_scores_gemma":[0.074971646,0.0012159854,0.0018115651,0.0028836287,0.0017923325,0.0022759237,0.001822247,0.003754784,0.00085526844],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043703738,0.00016228734,0.0027308506,0.0004649085,0.0004757125,0.00018944095,0.0001429374,0.648862,0.0005508298,0.18169716,0.006231118,0.15805571],"study_design_scores_gemma":[0.00010696869,0.00006400411,0.00036761392,0.000056147546,0.0000492266,0.000032993783,0.0000096724225,0.907991,0.0001243243,0.0896962,0.0014856168,0.00001622855],"about_ca_topic_score_codex":0.0063480977,"about_ca_topic_score_gemma":0.005828176,"teacher_disagreement_score":0.030657815,"about_ca_system_score_codex":0.0021817381,"about_ca_system_score_gemma":0.0037256589,"threshold_uncertainty_score":0.16213596},"labels":[],"label_agreement":null},{"id":"W4412163748","doi":"10.1158/1557-3265.aimachine-b024","title":"Abstract B024: Artificial intelligence enables the ethical reconstruction and social value realization of global cancer research: From technological innovation to humanistic care","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Realization (probability); Humanism; Value (mathematics); Artificial intelligence; Computer science; Engineering ethics; Knowledge management; Management science; Psychology; Machine learning; Engineering; Political science; Mathematics","score_opus":0.47269931309277596,"score_gpt":0.6113395670003337,"score_spread":0.1386402539075577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163748","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012379685,0.0066483305,0.071214356,0.53543,0.0048383023,0.00013136517,0.00027474246,0.00031742104,0.3687657],"genre_scores_gemma":[0.80019605,0.011796515,0.044291984,0.050957713,0.005080058,0.0004588596,0.00041371197,0.0005543633,0.08625081],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99053895,0.006735124,0.00019117077,0.0007061816,0.0012849838,0.0005435954],"domain_scores_gemma":[0.9853764,0.009025844,0.0007498038,0.0014113187,0.002095172,0.0013414811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01315262,0.0006314351,0.00045428865,0.0012590633,0.005333485,0.015584863,0.0014430878,0.007212792,0.019405691],"category_scores_gemma":[0.015634239,0.00032623886,0.0008239324,0.0013363671,0.0205103,0.0076873424,0.0073143365,0.007662164,0.0038429324],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022021306,0.000029573646,0.00030941726,0.00011273807,0.000009971635,0.000064639775,0.0010013706,0.0009743709,0.000167718,0.9400568,0.041825842,0.015425524],"study_design_scores_gemma":[0.000016916032,0.000023941353,0.0003868533,0.00043578105,0.000011703289,0.000079496494,0.0012784183,0.0034208074,0.0004676095,0.81250966,0.18134104,0.000027875332],"about_ca_topic_score_codex":0.0037309881,"about_ca_topic_score_gemma":0.0028017436,"teacher_disagreement_score":0.019405691,"about_ca_system_score_codex":0.0061251894,"about_ca_system_score_gemma":0.008176788,"threshold_uncertainty_score":0.0695585},"labels":[],"label_agreement":null},{"id":"W4412163749","doi":"10.1158/1557-3265.aimachine-a037","title":"Abstract A037: Survival-based subtyping of lung cancer through integrated genomic and methylation signatures","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Subtyping; Lung cancer; Methylation; DNA methylation; Cancer; Biology; Computational biology; Medicine; Cancer research; Oncology; Genetics; Gene; Gene expression; Computer science","score_opus":0.2018856130309438,"score_gpt":0.5448642608443551,"score_spread":0.34297864781341136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91913927,0.0005782568,0.059643142,0.0003946032,0.00002884861,0.00013876137,0.015863461,0.0019488642,0.0022647637],"genre_scores_gemma":[0.952083,0.00011186429,0.033750936,0.00006799993,0.000025588844,0.00008727775,0.012924515,0.00013642534,0.00081238005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995295,0.000105432584,0.000030670955,0.00018588327,0.000104589155,0.00004393772],"domain_scores_gemma":[0.99926597,0.00021379482,0.00014955988,0.000112635724,0.00014555242,0.00011245499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011640604,0.0004985927,0.00048380066,0.001345037,0.0002955497,0.00084714347,0.0005066738,0.00026365853,0.0025236728],"category_scores_gemma":[0.0018338008,0.0001619763,0.000867587,0.001121833,0.00021880941,0.00024180711,0.00090236374,0.00049010606,0.0008700096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017410468,0.00020811724,0.7517852,0.0002117168,0.0007760932,0.00023646957,0.0002560235,0.021778781,0.06919075,0.00097410165,0.007920354,0.14492136],"study_design_scores_gemma":[0.00013327545,0.00067781174,0.622865,0.00004933718,0.00051169255,0.0010008694,0.00022211527,0.33045805,0.030410763,0.0053255176,0.008276469,0.000069047506],"about_ca_topic_score_codex":0.005108344,"about_ca_topic_score_gemma":0.006569958,"teacher_disagreement_score":0.005108344,"about_ca_system_score_codex":0.0005156632,"about_ca_system_score_gemma":0.0008527044,"threshold_uncertainty_score":0.0101572275},"labels":[],"label_agreement":null},{"id":"W4412163750","doi":"10.1158/1557-3265.aimachine-b019","title":"Abstract B019: Clinician-AI evaluation of prognostic information extraction in head and neck cancer using an on-premises LLM","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; University of Calgary; McGill University Health Centre; McGill University","funders":"","keywords":"Premises; Head and neck cancer; Medicine; Head and neck; Cancer; Oncology; Internal medicine; Surgery","score_opus":0.2956370655473759,"score_gpt":0.6309681627015147,"score_spread":0.3353310971541388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163750","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8699454,0.0009599318,0.04900728,0.002500197,0.00044220392,0.0016221693,0.049295463,0.016547382,0.00968003],"genre_scores_gemma":[0.8504182,0.00019545844,0.088374354,0.00048926653,0.000090204565,0.0006168209,0.055972163,0.00019391868,0.0036496113],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980527,0.0007425287,0.00022984594,0.00054153055,0.0003143183,0.00011901483],"domain_scores_gemma":[0.9941596,0.003156738,0.00031225997,0.0011635561,0.00080912386,0.0003987354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034713997,0.0005809806,0.00035519,0.0010060832,0.00045321166,0.001060101,0.0012736577,0.0009766504,0.0065245167],"category_scores_gemma":[0.0140539715,0.00021569713,0.0006498001,0.0006870702,0.0004451469,0.0009353613,0.0018494151,0.0007448661,0.0026390648],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009472227,0.003569046,0.22683273,0.002296164,0.0006250925,0.0017880691,0.0014462215,0.08181553,0.014483736,0.0035175455,0.13088436,0.5232693],"study_design_scores_gemma":[0.0012286621,0.0024647468,0.10486933,0.00033460936,0.00019880252,0.0013642762,0.0016625462,0.7986588,0.026971927,0.004873371,0.05724282,0.00013019188],"about_ca_topic_score_codex":0.011605301,"about_ca_topic_score_gemma":0.016100472,"teacher_disagreement_score":0.011605301,"about_ca_system_score_codex":0.0016545698,"about_ca_system_score_gemma":0.001684228,"threshold_uncertainty_score":0.023075461},"labels":[],"label_agreement":null},{"id":"W4412163754","doi":"10.1158/1557-3265.aimachine-b010","title":"Abstract B010: From RECIST to reality: A foundation model pipeline for scalable therapy response evaluation","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vector Institute; Structural Genomics Consortium; University Health Network","funders":"","keywords":"Pipeline (software); Medicine; Foundation (evidence); Response Evaluation Criteria in Solid Tumors; Medical physics; Computer science; Oncology; Intensive care medicine; Internal medicine; Chemotherapy; Progressive disease; Programming language; Political science","score_opus":0.5985100643909758,"score_gpt":0.6717496096403198,"score_spread":0.07323954524934406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163754","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010222973,0.00031149658,0.93452466,0.0008626194,0.0000865234,0.0001983701,0.0023797818,0.048145507,0.0032681162],"genre_scores_gemma":[0.29935622,0.0004472277,0.67687476,0.0010223918,0.00011317629,0.000633173,0.009307524,0.006084884,0.006160622],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.999385,0.00014341228,0.000033628145,0.00019001307,0.00019205919,0.0000558826],"domain_scores_gemma":[0.99858093,0.0006525676,0.00010224213,0.00022798742,0.00034310095,0.00009314954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019095516,0.0013801891,0.00080601487,0.000901814,0.0005407888,0.002103456,0.0022805887,0.0012933409,0.013449814],"category_scores_gemma":[0.006177798,0.0008200723,0.0016965299,0.00047823254,0.0006168563,0.001187643,0.0021090284,0.0021273033,0.005032058],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007877363,0.00017690234,0.003944668,0.00035664355,0.00024737042,0.00030101486,0.00018026504,0.64448583,0.008562103,0.015868206,0.05234176,0.27274746],"study_design_scores_gemma":[0.000020757187,0.000021236361,0.00012263717,0.00001242402,0.0000076021583,0.000021954382,0.00000838467,0.9902277,0.0014253097,0.005210961,0.0029133135,0.0000077871155],"about_ca_topic_score_codex":0.013989012,"about_ca_topic_score_gemma":0.017034957,"teacher_disagreement_score":0.013989012,"about_ca_system_score_codex":0.0015251131,"about_ca_system_score_gemma":0.0024260588,"threshold_uncertainty_score":0.044994116},"labels":[],"label_agreement":null},{"id":"W4412163755","doi":"10.1158/1557-3265.aimachine-b056","title":"Abstract B056: Deep Antigen Sets, a new deep-learning framework, enables in vivo modeling of patient neoantigens for effective targeted immunotherapy design","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Medicine; Antigen; In vivo; Cancer; Cancer immunotherapy; Immunology; Immune system; Biology; Internal medicine","score_opus":0.08061014837542442,"score_gpt":0.43722896135294687,"score_spread":0.35661881297752246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163755","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14889331,0.0015644213,0.83594745,0.0012245405,0.00018390831,0.00012494624,0.002169657,0.00395615,0.00593564],"genre_scores_gemma":[0.8084228,0.00069299596,0.17905524,0.00067061733,0.000085062,0.00023114156,0.0037290556,0.00021462773,0.006898455],"study_design_codex":"simulation_or_modeling","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997094,0.00008894702,0.000012596928,0.000063233936,0.00009504195,0.000030597825],"domain_scores_gemma":[0.9996623,0.00011934235,0.000047954203,0.00004539126,0.00008489437,0.00004020607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091549987,0.00078789156,0.00042275104,0.00041810918,0.00017161948,0.0006207914,0.0011980565,0.0007101629,0.0024364325],"category_scores_gemma":[0.0015308332,0.00030984005,0.000572775,0.0002720187,0.00044150287,0.0006266148,0.0009223894,0.0013339072,0.00071711856],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003078256,0.00016351114,0.0028592267,0.00014089425,0.00010046018,0.00010110558,0.00004510244,0.85485643,0.015332241,0.00871839,0.01006827,0.10730647],"study_design_scores_gemma":[0.000011939285,0.000048628848,0.00015241998,0.0000063514312,0.000006375518,0.00001618821,0.0000025880076,0.99305856,0.0028652276,0.0027153809,0.0011116536,0.000004690229],"about_ca_topic_score_codex":0.0043636807,"about_ca_topic_score_gemma":0.004283723,"teacher_disagreement_score":0.0043636807,"about_ca_system_score_codex":0.00083271123,"about_ca_system_score_gemma":0.0012741982,"threshold_uncertainty_score":0.008676589},"labels":[],"label_agreement":null},{"id":"W4412163759","doi":"10.1158/1557-3265.aimachine-b001","title":"Abstract B001: Jarvais: A modular framework to standardize machine learning workflows and accelerate reproducible AI in oncology – benchmarking against a human-developed model for predicting emergency department visits during cancer treatment","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Benchmarking; Workflow; Modular design; Medicine; Cancer; Emergency department; Cancer treatment; Oncology; Medical physics; Computer science; Internal medicine; Business; Nursing; Operating system; Database","score_opus":0.16115820120713506,"score_gpt":0.549015948345654,"score_spread":0.38785774713851895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163759","genre_codex":"software","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reproducibility","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"reproducibility","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011167175,0.0002116011,0.27137223,0.0009613353,0.00038862525,0.0006910464,0.01364467,0.6972424,0.004320884],"genre_scores_gemma":[0.1993837,0.00048442968,0.5177254,0.0025390992,0.0003376985,0.0035176708,0.08584026,0.18167642,0.008495252],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9953725,0.0013710113,0.00045672557,0.0011393452,0.0013017888,0.00035869182],"domain_scores_gemma":[0.9880432,0.005232663,0.00096389937,0.0029839175,0.001974647,0.0008016585],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.010383364,0.0027624601,0.0009958147,0.0016197044,0.0009250463,0.0031633452,0.0049120486,0.0014152965,0.020334011],"category_scores_gemma":[0.03161592,0.0016201485,0.002492998,0.0008587349,0.0020693324,0.003712503,0.005711101,0.0041956743,0.018191505],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003572628,0.0011649118,0.031367555,0.0029081262,0.0008660795,0.0007626907,0.0014065407,0.09527196,0.028199183,0.030619858,0.55381835,0.2500421],"study_design_scores_gemma":[0.0007231551,0.00055093964,0.010670456,0.00042184762,0.00012216727,0.00038416075,0.0000934674,0.75023365,0.042232323,0.038457286,0.15571496,0.00039554533],"about_ca_topic_score_codex":0.0050379676,"about_ca_topic_score_gemma":0.003685133,"teacher_disagreement_score":0.98961663,"about_ca_system_score_codex":0.0013743652,"about_ca_system_score_gemma":0.0053915745,"threshold_uncertainty_score":0.06802404},"labels":[],"label_agreement":null},{"id":"W4412163760","doi":"10.1158/1557-3265.aimachine-b042","title":"Abstract B042: Identifying single-cell transcriptomic signatures and changes underlying the evolution of fusion-negative rhabdomyosarcoma in Li-Fraumeni Syndrome mice","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Li–Fraumeni syndrome; Transcriptome; Rhabdomyosarcoma; Cancer research; Biology; Fusion gene; Medicine; Computational biology; Genetics; Pathology; Gene; Sarcoma; Mutation; Gene expression","score_opus":0.11104567529600426,"score_gpt":0.4398445259677684,"score_spread":0.3287988506717642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9521207,0.0005263985,0.02390257,0.00017847204,0.000048776143,0.000044732282,0.020650757,0.0011058076,0.001421732],"genre_scores_gemma":[0.9614131,0.00039119378,0.016844647,0.00035342356,0.000017290477,0.00022370195,0.014406871,0.0008562281,0.005493454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997756,0.000017305396,0.000009679085,0.00008377896,0.000069266025,0.00004444726],"domain_scores_gemma":[0.9997284,0.00005282082,0.00008111378,0.000018954463,0.000030492982,0.00008821687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026617927,0.00038311936,0.00032850972,0.0005454934,0.00024194039,0.00039612406,0.00027386314,0.0004720827,0.0024617678],"category_scores_gemma":[0.00022332075,0.00026206835,0.00053701346,0.00021729564,0.00033521585,0.00017163208,0.0002862596,0.00093651615,0.00086271757],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001295415,0.000013113644,0.0014226509,0.000032377313,0.000012302575,0.00005377958,0.000025906,0.00036867883,0.9965463,0.00014724051,0.00019894393,0.0010491591],"study_design_scores_gemma":[0.000059563947,0.0005301798,0.14202794,0.0000731855,0.00008463758,0.0006273654,0.0002313056,0.025431188,0.8221433,0.00093597337,0.0077953762,0.00005988216],"about_ca_topic_score_codex":0.0014427307,"about_ca_topic_score_gemma":0.0023177478,"teacher_disagreement_score":0.0024617678,"about_ca_system_score_codex":0.00032802275,"about_ca_system_score_gemma":0.00020550127,"threshold_uncertainty_score":0.008235395},"labels":[],"label_agreement":null},{"id":"W4412163761","doi":"10.1158/1557-3265.aimachine-b018","title":"Abstract B018: Practical benchmarking of large language models for structuring synthetic prostate cancer histopathology statements in English and Finnish","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prostate cancer; Histopathology; Benchmarking; Medicine; Cancer; Structuring; Pathology; Medical physics; Internal medicine","score_opus":0.09570608012282598,"score_gpt":0.5610822752971152,"score_spread":0.4653761951742892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163761","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8459217,0.0012540516,0.08816916,0.001309801,0.0005381732,0.0007313273,0.016021887,0.03330255,0.012751249],"genre_scores_gemma":[0.8859777,0.00029743623,0.08310977,0.00033950794,0.00006049198,0.0004831618,0.02502307,0.0013006512,0.003408137],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979417,0.0010440673,0.00015174909,0.000502813,0.00024090434,0.0001187686],"domain_scores_gemma":[0.9848262,0.012391203,0.00024937338,0.0008081004,0.0013924817,0.00033258487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044889087,0.0016761674,0.0005034131,0.0008188085,0.0005112774,0.0011325652,0.0017551958,0.0017729932,0.0059531513],"category_scores_gemma":[0.018267741,0.0004784694,0.0010343234,0.0006309764,0.00065588474,0.0014283995,0.0010979406,0.0013007561,0.0025442191],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029830942,0.0011172844,0.01507904,0.0015310266,0.00049313874,0.0012845433,0.0017987401,0.7154257,0.010546804,0.0038950578,0.047522396,0.1983231],"study_design_scores_gemma":[0.0002909533,0.00044224746,0.0028310332,0.0000744825,0.00006920646,0.00016319756,0.00053388637,0.978609,0.008991047,0.001939992,0.0059889485,0.00006611622],"about_ca_topic_score_codex":0.02113212,"about_ca_topic_score_gemma":0.015531643,"teacher_disagreement_score":0.02113212,"about_ca_system_score_codex":0.0017131789,"about_ca_system_score_gemma":0.0013566454,"threshold_uncertainty_score":0.042018235},"labels":[],"label_agreement":null},{"id":"W4412163764","doi":"10.1158/1557-3265.aimachine-b023","title":"Abstract B023: Deep learning-based prediction of immune checkpoint inhibitor efficacy in brain metastases using brain MRI","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Brain metastasis; Immune system; Immune checkpoint; Oncology; Immunotherapy; Cancer; Internal medicine; Metastasis; Immunology","score_opus":0.19127722830192934,"score_gpt":0.5427043204363934,"score_spread":0.35142709213446405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163764","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80486095,0.008416745,0.12608545,0.0038289065,0.00033067857,0.0003836906,0.04118347,0.008841749,0.006068332],"genre_scores_gemma":[0.93991125,0.0009861675,0.025996247,0.0005622282,0.00014173405,0.00018457051,0.028859174,0.0001761856,0.0031824086],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99976844,0.0000648165,0.000014471731,0.000080073274,0.00003483737,0.000037406273],"domain_scores_gemma":[0.99961394,0.00014444905,0.00006632017,0.00003693337,0.00009011581,0.00004825493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008449535,0.00093843834,0.00052767125,0.0008835222,0.0001621036,0.00059850875,0.00083541183,0.0007423381,0.0017578447],"category_scores_gemma":[0.002247136,0.0002768132,0.00087359577,0.00046387952,0.00019626984,0.00036397437,0.00054380775,0.0008455725,0.00080377265],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024856287,0.00076023676,0.10730949,0.0009637998,0.0012873927,0.0007673994,0.00008749887,0.4719401,0.024524016,0.0013941982,0.07365224,0.31482795],"study_design_scores_gemma":[0.000083718754,0.0002152368,0.0121943625,0.00006530434,0.00011862588,0.00017044699,0.000020277916,0.9768124,0.0060077067,0.0011889713,0.0031018318,0.00002108982],"about_ca_topic_score_codex":0.016325373,"about_ca_topic_score_gemma":0.019744445,"teacher_disagreement_score":0.016325373,"about_ca_system_score_codex":0.0008168116,"about_ca_system_score_gemma":0.0009281102,"threshold_uncertainty_score":0.03246075},"labels":[],"label_agreement":null},{"id":"W4412163772","doi":"10.1158/1557-3265.aimachine-a018","title":"Abstract A018: Accelerating drug discovery at an HBCU with AI/ML: Text mining, computational modeling, and drug repurposing approaches","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Biomedical Text Mining and Ontologies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug repositioning; Drug; Repurposing; Drug discovery; Computer science; Medicine; Pharmacology; Bioinformatics; Engineering; Biology","score_opus":0.22641333346967343,"score_gpt":0.4743242718112853,"score_spread":0.24791093834161185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163772","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10073698,0.0038734328,0.8107602,0.02026491,0.00069805887,0.0008186115,0.0069009867,0.031620894,0.024325935],"genre_scores_gemma":[0.23212439,0.0028543219,0.74835795,0.0015252273,0.00039294641,0.0003521652,0.005427094,0.00077727635,0.008188609],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99938226,0.00019539519,0.000041648484,0.00010794144,0.00024138237,0.000031358246],"domain_scores_gemma":[0.99735415,0.0014087645,0.00022135137,0.00024225061,0.00061833556,0.00015508963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016707472,0.0009107539,0.0005588244,0.0022862614,0.00058840966,0.001965288,0.0009286773,0.00057518075,0.0071236813],"category_scores_gemma":[0.003507298,0.0003447513,0.00085012853,0.001523922,0.000440706,0.001455153,0.00082170137,0.0012645845,0.001972712],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046174423,0.0006100883,0.008709525,0.0009841134,0.00024529095,0.00041368272,0.00018808807,0.14649272,0.041886434,0.02894266,0.08768767,0.68337804],"study_design_scores_gemma":[0.0000957241,0.0002175387,0.0017440146,0.000094768446,0.000072335766,0.00011272313,0.000092404756,0.92108446,0.01777709,0.022726718,0.03593386,0.000048393802],"about_ca_topic_score_codex":0.00599818,"about_ca_topic_score_gemma":0.0076617226,"teacher_disagreement_score":0.0071236813,"about_ca_system_score_codex":0.0009678791,"about_ca_system_score_gemma":0.0023712947,"threshold_uncertainty_score":0.02383107},"labels":[],"label_agreement":null},{"id":"W4412163773","doi":"10.1158/1557-3265.aimachine-b053","title":"Abstract B053: Empowering AI-driven prediction of the tumor microenvironment from histopathology images via molecular annotation","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Histopathology; Annotation; Medicine; Pathology; Computer science; Artificial intelligence","score_opus":0.04307666403992606,"score_gpt":0.46314826344673304,"score_spread":0.420071599406807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163773","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2031301,0.0051918193,0.65499073,0.002444949,0.0007360441,0.0005861694,0.044982385,0.07784921,0.010088634],"genre_scores_gemma":[0.5007,0.0017994212,0.4106777,0.0010178313,0.00028603178,0.00057751057,0.0727538,0.0017150338,0.01047263],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99958605,0.00005227602,0.000022205615,0.00019012525,0.00009720228,0.00005219039],"domain_scores_gemma":[0.9993936,0.0001911937,0.00006745462,0.00010058533,0.00017661895,0.0000706107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066686183,0.0012399176,0.00069904665,0.0019698602,0.0003704975,0.0015197324,0.0014617556,0.0017067305,0.005403419],"category_scores_gemma":[0.0017390788,0.00040852357,0.0009743631,0.0008924548,0.0003145243,0.0006441305,0.0009708891,0.00086531864,0.004519048],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016453264,0.0005866956,0.028472072,0.0012068335,0.00038609313,0.0012948859,0.00020827964,0.15592718,0.18003975,0.0022532912,0.092750624,0.53522897],"study_design_scores_gemma":[0.00002891586,0.00011340544,0.004679851,0.0000551926,0.00004868677,0.00025923486,0.000067873945,0.95597935,0.025601696,0.0022761482,0.010851709,0.000037925107],"about_ca_topic_score_codex":0.008011968,"about_ca_topic_score_gemma":0.011153256,"teacher_disagreement_score":0.008011968,"about_ca_system_score_codex":0.00070057326,"about_ca_system_score_gemma":0.00083928596,"threshold_uncertainty_score":0.0180763},"labels":[],"label_agreement":null},{"id":"W4412163776","doi":"10.1158/1557-3265.aimachine-a030","title":"Abstract A030: Advancing Pharmacogenomic Modeling: Robust Dose-Response Curve Fitting and Drug Combination Analytics in the Next-Generation PharmacoGx Framework","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Pharmacogenomics; Medicine; Drug response; Drug; Analytics; Computational biology; Pharmacology; Computer science; Bioinformatics; Data science; Biology","score_opus":0.4284215070863578,"score_gpt":0.5580699025537492,"score_spread":0.12964839546739143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163776","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006413606,0.0007216858,0.8553066,0.0017124336,0.00020864309,0.00022220958,0.013021155,0.11581835,0.006575259],"genre_scores_gemma":[0.12554473,0.0015681484,0.818266,0.0015766027,0.00030194537,0.0007324573,0.032310236,0.013358111,0.0063419226],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9983777,0.0004653461,0.00011721912,0.00033253172,0.0006191449,0.000088100955],"domain_scores_gemma":[0.99764,0.00089636067,0.00014833832,0.0006614523,0.00046714465,0.00018672721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005249269,0.0013351357,0.0010352599,0.0009342355,0.00038895293,0.0029314612,0.002663213,0.0008955554,0.015581913],"category_scores_gemma":[0.007589187,0.00070170546,0.0021150259,0.0008676531,0.00073249463,0.0025682943,0.0028889093,0.0022180427,0.00634811],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017376125,0.000412082,0.008495473,0.0011784026,0.00056432764,0.00049714284,0.00037223042,0.3006836,0.016147086,0.12017504,0.28254724,0.26718974],"study_design_scores_gemma":[0.00020686936,0.00015019425,0.0012495776,0.00012899844,0.00007220949,0.00015847191,0.00003208414,0.77073103,0.009988206,0.07575245,0.14144053,0.00008937199],"about_ca_topic_score_codex":0.006085388,"about_ca_topic_score_gemma":0.0042647985,"teacher_disagreement_score":0.015581913,"about_ca_system_score_codex":0.0011273533,"about_ca_system_score_gemma":0.0023355326,"threshold_uncertainty_score":0.052126646},"labels":[],"label_agreement":null},{"id":"W4412163777","doi":"10.1158/1557-3265.aimachine-b009","title":"Abstract B009: missense-kinase-toolkit: A toolkit to facilitate kinase sequence and structure-based modeling for property predictions","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Missense mutation; Computational biology; Kinase; Computer science; Sequence (biology); Property (philosophy); Bioinformatics; Biology; Genetics; Mutation; Gene","score_opus":0.23733933988297573,"score_gpt":0.4575650997632885,"score_spread":0.2202257598803128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163777","genre_codex":"methods","genre_gemma":"software","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"software","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023790078,0.0002886072,0.5918988,0.00054847315,0.00020212751,0.0003384397,0.03131669,0.34500527,0.006611415],"genre_scores_gemma":[0.28573352,0.00067836134,0.5848859,0.00084700034,0.000079741934,0.0016586388,0.06785472,0.04787665,0.010385469],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.99952924,0.0001055854,0.00004051779,0.00011451201,0.00015550436,0.00005462966],"domain_scores_gemma":[0.9987914,0.0007182239,0.00007609432,0.00016176952,0.00016212661,0.00009041881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001765541,0.0016491754,0.0008441898,0.0007790171,0.0005573542,0.0012476025,0.004148223,0.0012025806,0.021938952],"category_scores_gemma":[0.0044183806,0.0009280201,0.0020829816,0.0006136833,0.00085775607,0.0015893219,0.0022520795,0.0026908463,0.009200016],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008310618,0.00043666136,0.00898413,0.0015917819,0.00051469146,0.00086135435,0.000357909,0.696467,0.013709303,0.03474128,0.18344642,0.058058478],"study_design_scores_gemma":[0.00011239029,0.000033521508,0.00065667747,0.00003514401,0.000018420142,0.00007980837,0.000016819944,0.96280795,0.0038900063,0.010112575,0.022197276,0.000039400962],"about_ca_topic_score_codex":0.010441652,"about_ca_topic_score_gemma":0.013267874,"teacher_disagreement_score":0.021938952,"about_ca_system_score_codex":0.0011142546,"about_ca_system_score_gemma":0.0024980404,"threshold_uncertainty_score":0.07339311},"labels":[],"label_agreement":null},{"id":"W4412163778","doi":"10.1158/1557-3265.aimachine-a045","title":"Abstract A045: Unlocking deep learning for cell-free DNA-based early colorectal cancer detection","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Cell-free fetal DNA; Deep learning; Computational biology; Cancer; Medicine; Artificial intelligence; Biology; Oncology; Cancer research; Computer science; Internal medicine; Genetics","score_opus":0.06499498445537204,"score_gpt":0.4453659088239044,"score_spread":0.38037092436853237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163778","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2838699,0.0024230406,0.6946824,0.0020505337,0.00036715236,0.00019256618,0.00200023,0.008840887,0.005573211],"genre_scores_gemma":[0.86840326,0.00045934817,0.120038405,0.0009077646,0.00008802104,0.00018192678,0.0025306328,0.00013266416,0.007258019],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.999777,0.000049498773,0.000009682387,0.00007181604,0.000054097003,0.00003788621],"domain_scores_gemma":[0.9995059,0.00021069907,0.00003696352,0.000047966227,0.00015384042,0.000044657878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000737514,0.0008789415,0.0004947626,0.0004622644,0.00020810282,0.0005424633,0.0013443565,0.0009767457,0.002604685],"category_scores_gemma":[0.0018454881,0.00028036113,0.00057015044,0.00029591678,0.00041947435,0.000768428,0.00096733007,0.0012755084,0.0009266091],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008625298,0.000553089,0.008424765,0.00025156047,0.00018965434,0.00022576307,0.000079452344,0.55882317,0.034550607,0.0036799654,0.012599867,0.3797596],"study_design_scores_gemma":[0.000009157647,0.00005650545,0.00022390687,0.000004636941,0.0000068850204,0.000012769885,0.0000035022201,0.99510574,0.0033804593,0.0008208443,0.0003711777,0.0000044362955],"about_ca_topic_score_codex":0.006980716,"about_ca_topic_score_gemma":0.0058863037,"teacher_disagreement_score":0.006980716,"about_ca_system_score_codex":0.00082966825,"about_ca_system_score_gemma":0.000777921,"threshold_uncertainty_score":0.013880193},"labels":[],"label_agreement":null},{"id":"W4412163782","doi":"10.1158/1557-3265.aimachine-a016","title":"Abstract A016: A computational chemistry and AI-driven framework for structure-based drug design informed by underlying factors of mutation-induced drug resistance: A study of KRAS","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Drug resistance; KRAS; Mutation; Pharmacology; Computational biology; Medicine; Chemistry; Cancer research; Genetics; Biology; Gene","score_opus":0.2333151667370733,"score_gpt":0.5473814584485645,"score_spread":0.31406629171149114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163782","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06702871,0.0007280349,0.91153955,0.0017112298,0.0002294794,0.0002044796,0.000496448,0.0014800332,0.016581934],"genre_scores_gemma":[0.4704037,0.00062355865,0.52041966,0.0004876124,0.00017276936,0.00073478674,0.0005044457,0.00038767594,0.0062657413],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99974185,0.00012971643,0.000009465557,0.000026779477,0.000069257476,0.000022930682],"domain_scores_gemma":[0.9992779,0.00043270027,0.000054060616,0.00004851173,0.000110352026,0.00007656432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011199825,0.00078719243,0.000959981,0.00057236216,0.00051575043,0.0009854443,0.0015828605,0.0013570705,0.0045837574],"category_scores_gemma":[0.0017121156,0.0005367402,0.0010069611,0.0004591553,0.0009145706,0.00061519153,0.0012086194,0.001438104,0.0005225313],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000616763,0.000055185505,0.00030925035,0.00005404499,0.000028381934,0.000045283236,0.000014342789,0.9735293,0.0010604357,0.01743555,0.0008244053,0.006582119],"study_design_scores_gemma":[0.000014566669,0.000010327365,0.000018077739,0.0000027545511,0.0000021964463,0.0000021446247,0.000001761301,0.9971275,0.00007255695,0.002455847,0.00029053545,0.0000018082505],"about_ca_topic_score_codex":0.004482938,"about_ca_topic_score_gemma":0.003796033,"teacher_disagreement_score":0.0045837574,"about_ca_system_score_codex":0.0007297766,"about_ca_system_score_gemma":0.0015963368,"threshold_uncertainty_score":0.015334129},"labels":[],"label_agreement":null},{"id":"W4412163785","doi":"10.1158/1557-3265.aimachine-b050","title":"Abstract B050: Spatially aware transcriptomic topic modeling reveals novel signals of spatial organization in glioblastoma","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Computing and Algorithms","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Glioblastoma; Transcriptome; Computational biology; Computer science; Neuroscience; Biology; Cancer research; Medicine; Gene; Gene expression; Genetics","score_opus":0.16588334508549793,"score_gpt":0.5168066541332751,"score_spread":0.35092330904777713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163785","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8364542,0.0009151547,0.15700999,0.0005722516,0.000056029872,0.000036400997,0.0030515194,0.0010641108,0.0008403083],"genre_scores_gemma":[0.97466516,0.00021060313,0.020094033,0.000069463254,0.000070158174,0.000050778784,0.004144438,0.000126666,0.00056858564],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998202,0.000044725974,0.000009361029,0.00006925999,0.000024004374,0.000032488108],"domain_scores_gemma":[0.9994968,0.00027697126,0.000068394154,0.00004396018,0.000075917116,0.000037970272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007334058,0.00040746978,0.0004128113,0.00056697486,0.00023745206,0.0005398238,0.00038864012,0.0003597742,0.00082908105],"category_scores_gemma":[0.001814633,0.00017114918,0.0008838165,0.00054194423,0.0002884579,0.00039340963,0.00044773924,0.00048326392,0.0002519356],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018883455,0.00028081107,0.16677487,0.0005692054,0.000706291,0.00073352415,0.000685814,0.49822268,0.14837514,0.00915285,0.015908964,0.1567015],"study_design_scores_gemma":[0.000023746346,0.0000518521,0.027388487,0.000013343494,0.0000684598,0.0000799078,0.0000929684,0.95897424,0.0072685517,0.0044574924,0.001558689,0.000022330723],"about_ca_topic_score_codex":0.0056859446,"about_ca_topic_score_gemma":0.0052481163,"teacher_disagreement_score":0.0056859446,"about_ca_system_score_codex":0.00043061373,"about_ca_system_score_gemma":0.00047080466,"threshold_uncertainty_score":0.01130569},"labels":[],"label_agreement":null},{"id":"W4412163786","doi":"10.1158/1557-3265.aimachine-b051","title":"Abstract B051: Elastic net discovery of DNA methylation biomarkers for non-invasive diagnosis and recurrence detection in head and neck cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Head and neck cancer; Medicine; Cancer; DNA methylation; Head and neck; Oncology; Pathology; Computational biology; Internal medicine; Surgery; Biology; Gene; Genetics; Gene expression","score_opus":0.11094399157241973,"score_gpt":0.4773775593495343,"score_spread":0.36643356777711455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163786","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7420486,0.0012227296,0.24425958,0.0021656724,0.0001799995,0.00048363162,0.0036491952,0.0014961314,0.0044943974],"genre_scores_gemma":[0.91963583,0.0002996801,0.070569456,0.00041696985,0.00010211583,0.00031535196,0.0056536966,0.00012269324,0.0028842622],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9989348,0.00050478603,0.000071863884,0.00024267734,0.00015872819,0.00008713469],"domain_scores_gemma":[0.9951839,0.0033865978,0.0004489006,0.0003062439,0.00050677825,0.00016751346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075694323,0.0012312281,0.0009939626,0.002146034,0.0005784431,0.0013555101,0.0014393891,0.0011477289,0.0032007545],"category_scores_gemma":[0.011883396,0.00054546795,0.0012057682,0.0010492392,0.0007207635,0.0008803496,0.0014971736,0.0014523455,0.00067887397],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023015293,0.0006987976,0.09130952,0.00031785146,0.00079942984,0.00027628863,0.00008142294,0.7884931,0.004241238,0.0022176863,0.0051150047,0.10414814],"study_design_scores_gemma":[0.000028131599,0.00009537131,0.003713865,0.000019413514,0.00002891284,0.000023402881,0.000013908658,0.99363613,0.000895278,0.001298881,0.00023688424,0.000009828602],"about_ca_topic_score_codex":0.0058467668,"about_ca_topic_score_gemma":0.004693908,"teacher_disagreement_score":0.0075694323,"about_ca_system_score_codex":0.0011879009,"about_ca_system_score_gemma":0.0014753212,"threshold_uncertainty_score":0.040031433},"labels":[],"label_agreement":null},{"id":"W4412163788","doi":"10.1158/1557-3265.aimachine-a036","title":"Abstract A036: Genomic alterations associate with distinct tumor dynamics in NSCLC: A genomics-informed Bayesian hierarchical modeling approach","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genomics; Computational biology; Bayesian probability; Biology; Dynamics (music); Bioinformatics; Computer science; Genome; Genetics; Psychology; Gene; Artificial intelligence","score_opus":0.06061821309429859,"score_gpt":0.4179376750218751,"score_spread":0.3573194619275765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163788","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29320008,0.00018779894,0.7021056,0.001235714,0.000023442797,0.00011627808,0.0011500831,0.00054817373,0.0014328053],"genre_scores_gemma":[0.9132426,0.000093012546,0.083337724,0.0001885038,0.000044543973,0.00013521867,0.0012063874,0.00007222592,0.0016797812],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99942845,0.00030857217,0.000021597749,0.00013172778,0.000057837504,0.00005192814],"domain_scores_gemma":[0.9986333,0.0009939168,0.0001421232,0.000058105943,0.000108379616,0.00006410596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002077466,0.00041751013,0.0005413409,0.0009296825,0.00039689365,0.0007777039,0.00093407615,0.0007016834,0.0016065226],"category_scores_gemma":[0.0046505206,0.00041717794,0.0014719758,0.00051110855,0.0004117739,0.0004692676,0.0007336246,0.0007840654,0.00022780665],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013383004,0.00009619635,0.020595446,0.00003098989,0.00015367765,0.00013399069,0.00011403626,0.94620126,0.001927048,0.0075419745,0.000904458,0.022167044],"study_design_scores_gemma":[0.0000041724284,0.0000072006037,0.0011101573,0.0000015752145,0.0000075811454,0.0000082868555,0.000006449965,0.99674207,0.00007250822,0.0019612175,0.000074989664,0.000003718868],"about_ca_topic_score_codex":0.030348497,"about_ca_topic_score_gemma":0.023622274,"teacher_disagreement_score":0.030348497,"about_ca_system_score_codex":0.0010578411,"about_ca_system_score_gemma":0.0013043234,"threshold_uncertainty_score":0.060343742},"labels":[],"label_agreement":null},{"id":"W4412163789","doi":"10.1158/1557-3265.aimachine-b049","title":"Abstract B049: Deep Learning Enables Identification of Cell Types and Clusters (iCTC) in Immune Tumor Ecosystems for Prognostic Assessment in Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Identification (biology); Immune system; Biology; Immunology; Medicine; Computational biology; Genetics; Ecology","score_opus":0.06900483981934394,"score_gpt":0.4937628554574379,"score_spread":0.424758015638094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163789","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52618885,0.001009575,0.44749406,0.0012286585,0.00017936295,0.00019820863,0.008110074,0.0097043635,0.005886912],"genre_scores_gemma":[0.8018842,0.00026344447,0.18787435,0.00028399585,0.000053114338,0.00022136378,0.005259957,0.00016062177,0.0039989376],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997409,0.000040282845,0.0000132194955,0.000083287494,0.00007506917,0.000047190864],"domain_scores_gemma":[0.99957484,0.00011064419,0.000069678616,0.00005036935,0.00014363501,0.000050887764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060416956,0.000580275,0.0003360262,0.0010762807,0.00027058387,0.0006841573,0.00060778565,0.0006682048,0.0028013587],"category_scores_gemma":[0.0011941225,0.00022047367,0.000383408,0.0007618469,0.00028121835,0.00045895687,0.00073942036,0.000767882,0.0013206626],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007811793,0.0007293613,0.07277885,0.00028171428,0.00020354243,0.00023858513,0.00016575097,0.107540354,0.26850843,0.003883329,0.023911873,0.520977],"study_design_scores_gemma":[0.000026970514,0.00012041278,0.014771317,0.000018407069,0.00003068935,0.00007029653,0.00003751823,0.9328059,0.045715116,0.0024923629,0.0038877956,0.00002313564],"about_ca_topic_score_codex":0.0053236564,"about_ca_topic_score_gemma":0.0059001376,"teacher_disagreement_score":0.0053236564,"about_ca_system_score_codex":0.000707256,"about_ca_system_score_gemma":0.0008643451,"threshold_uncertainty_score":0.010585308},"labels":[],"label_agreement":null},{"id":"W4412163791","doi":"10.1158/1557-3265.aimachine-b005","title":"Abstract B005: Designing ethically aligned AI to support palliative care in hematologic malignancies: Ethical considerations for equity and patient-centered care","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Palliative care; Medicine; Hematologic Neoplasms; Intensive care medicine; Ethical issues; Equity (law); Nursing; Family medicine; Cancer; Engineering ethics; Internal medicine; Political science","score_opus":0.7046387215741549,"score_gpt":0.6796605728077869,"score_spread":0.024978148766367947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163791","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04573263,0.0014136595,0.59189737,0.17956254,0.0011748319,0.0037941225,0.00048195926,0.0009181549,0.17502469],"genre_scores_gemma":[0.4491307,0.0012877961,0.51706356,0.011531463,0.00029726923,0.0024266308,0.00045124008,0.00026936503,0.017541898],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9639412,0.029169032,0.00094515877,0.0013304524,0.0031176682,0.0014965242],"domain_scores_gemma":[0.9357826,0.04598537,0.0029423456,0.0038128758,0.0069098985,0.004566955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.040433962,0.00056144124,0.00040016315,0.0010719207,0.0054769884,0.012236704,0.0024781392,0.0047016777,0.011766],"category_scores_gemma":[0.06447712,0.0005906271,0.0010584096,0.00081514305,0.011238985,0.0060815443,0.010597328,0.006342301,0.0023736933],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014665036,0.00052449043,0.0058480124,0.00082463317,0.000059419828,0.0006172039,0.016202305,0.02184576,0.0024538,0.8102358,0.0413359,0.099906065],"study_design_scores_gemma":[0.0001311488,0.00027070486,0.0015764196,0.0015414269,0.00006234087,0.00050533056,0.017612554,0.057002828,0.0037800458,0.6780463,0.23937482,0.00009615029],"about_ca_topic_score_codex":0.0040007588,"about_ca_topic_score_gemma":0.0049567414,"teacher_disagreement_score":0.040433962,"about_ca_system_score_codex":0.00608713,"about_ca_system_score_gemma":0.02516751,"threshold_uncertainty_score":0.21383774},"labels":[],"label_agreement":null},{"id":"W4412163792","doi":"10.1158/1557-3265.aimachine-a049","title":"Abstract A049: Development of a tri-modal contrast learning model integrating pathology-text and CT-text for clinical oncology tasks","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Precision oncology; Medicine; Contrast (vision); Clinical Oncology; Pathology; Modal; Medical physics; Anatomical pathology; Radiology; Computer science; Internal medicine; Artificial intelligence; Cancer; Precision medicine; Immunohistochemistry","score_opus":0.23504182417906772,"score_gpt":0.590668948559425,"score_spread":0.35562712438035726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163792","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1188045,0.0011765731,0.86440873,0.001649929,0.00029421228,0.00031082655,0.0019441729,0.0076385927,0.0037724574],"genre_scores_gemma":[0.6580944,0.0003899217,0.32367817,0.0014426525,0.00021066931,0.000552343,0.005494998,0.00041246734,0.009724376],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99931276,0.00018418721,0.00002959537,0.000303515,0.00009640799,0.00007362596],"domain_scores_gemma":[0.9988594,0.00052251696,0.00007901694,0.0001486554,0.00029545673,0.00009493661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018733917,0.0011389854,0.00068923604,0.000848512,0.00041455653,0.0010905447,0.0020818224,0.0020695776,0.0038320848],"category_scores_gemma":[0.00433761,0.00040830692,0.0014279485,0.0006191443,0.0005221477,0.0017511367,0.0016551103,0.0027002231,0.0021280544],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012796086,0.0010136839,0.0068713645,0.0002844673,0.00030676983,0.0003850638,0.00030392513,0.31576434,0.030784462,0.005829297,0.02279819,0.61437887],"study_design_scores_gemma":[0.000020739275,0.00010377374,0.0004331783,0.000012274917,0.000024730647,0.00005424632,0.000020888583,0.99259686,0.0033641842,0.0022603413,0.0010957336,0.00001305465],"about_ca_topic_score_codex":0.006238258,"about_ca_topic_score_gemma":0.006289482,"teacher_disagreement_score":0.006238258,"about_ca_system_score_codex":0.00085521827,"about_ca_system_score_gemma":0.0012783635,"threshold_uncertainty_score":0.012819529},"labels":[],"label_agreement":null},{"id":"W4412163793","doi":"10.1158/1557-3265.aimachine-b031","title":"Abstract B031: Artificial Intelligence-Enhanced Image Analysis of Peripheral Blood Smears Supports the Diagnosis and Monitoring of Acute Promyelocytic Leukemia","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Digital Imaging for Blood Diseases","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Acute promyelocytic leukemia; Medicine; Peripheral blood; Leukemia; Pathology; Immunology; Biology; Cell culture; Retinoic acid","score_opus":0.1302920745080761,"score_gpt":0.4843128852277128,"score_spread":0.35402081071963676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163793","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.63118887,0.0053482023,0.31012782,0.0010285573,0.0005647503,0.0006667878,0.008757624,0.028381644,0.013935697],"genre_scores_gemma":[0.823942,0.0012674927,0.15583958,0.00028216848,0.00008447908,0.00021730324,0.008408464,0.00024322704,0.009715322],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99969363,0.00004053265,0.000020064695,0.000100954145,0.00011135116,0.00003357184],"domain_scores_gemma":[0.99961084,0.00008284282,0.00004504949,0.00004035762,0.00018846174,0.0000323853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007768187,0.0009812929,0.00045829432,0.00074700854,0.00014059617,0.0008098674,0.00073408545,0.00069520297,0.0030410443],"category_scores_gemma":[0.001245593,0.00020411436,0.00052560214,0.00047406688,0.00013299882,0.00046105243,0.00035547692,0.0004116452,0.0017244853],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016830048,0.0008026594,0.013992138,0.0004598554,0.00019936993,0.00031821296,0.00004627832,0.06716385,0.20654182,0.00062319415,0.022724178,0.6854454],"study_design_scores_gemma":[0.000043906915,0.00037478167,0.015228397,0.000038868402,0.00008563866,0.00022393007,0.000017343087,0.8927871,0.08598339,0.00038194258,0.0048105596,0.000024185276],"about_ca_topic_score_codex":0.0076309717,"about_ca_topic_score_gemma":0.0049969167,"teacher_disagreement_score":0.0076309717,"about_ca_system_score_codex":0.0005183778,"about_ca_system_score_gemma":0.0007648337,"threshold_uncertainty_score":0.015173137},"labels":[],"label_agreement":null},{"id":"W4412163796","doi":"10.1158/1557-3265.aimachine-a006","title":"Abstract A006: Data Curation and Knowledge Integration Pipeline for Biomarker Discovery","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Biomedical Text Mining and Ontologies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Data curation; Pipeline (software); Data science; Biomarker; Medicine; Data integration; Biomarker discovery; Computational biology; Computer science; Biology; Data mining; Proteomics","score_opus":0.41854907872434727,"score_gpt":0.6062314006747581,"score_spread":0.18768232195041085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163796","genre_codex":"software","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021185684,0.0005430286,0.36750063,0.001055304,0.00028837982,0.0016858499,0.18459387,0.43719745,0.005016972],"genre_scores_gemma":[0.015207541,0.00067550386,0.5888225,0.0009571126,0.00013504628,0.0026544102,0.36816674,0.018065242,0.0053158193],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9972146,0.0004377783,0.00043504933,0.00088542857,0.0008689419,0.00015810916],"domain_scores_gemma":[0.99440384,0.0019062466,0.00035052447,0.001336809,0.0015519809,0.00045061015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004807425,0.004133721,0.0021704033,0.008657182,0.0014739599,0.0052445554,0.003765478,0.0015961796,0.0633984],"category_scores_gemma":[0.0136929555,0.0016752931,0.00351138,0.0058163935,0.00061226427,0.0034222945,0.005252362,0.0030774802,0.051563777],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012533324,0.0004657638,0.004435375,0.004140853,0.0007474146,0.0007477604,0.0004954059,0.00667609,0.021493986,0.007289386,0.688295,0.26395968],"study_design_scores_gemma":[0.0012174934,0.00051402627,0.012315242,0.00090380525,0.00058540225,0.00094297255,0.0005181322,0.19274189,0.050262224,0.061232653,0.67826796,0.0004982303],"about_ca_topic_score_codex":0.0074625853,"about_ca_topic_score_gemma":0.007836832,"teacher_disagreement_score":0.0633984,"about_ca_system_score_codex":0.0011809185,"about_ca_system_score_gemma":0.0053472286,"threshold_uncertainty_score":0.21208876},"labels":[],"label_agreement":null},{"id":"W4412163797","doi":"10.1158/1557-3265.aimachine-b017","title":"Abstract B017: Check: A hybrid continuous-learning framework for enhancing factual reliability in clinical language models","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Topic Modeling","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reliability (semiconductor); Computer science; Medicine; Natural language processing; Psychology; Reliability engineering; Engineering","score_opus":0.18614910490314512,"score_gpt":0.5355942354535079,"score_spread":0.3494451305503628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163797","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03843705,0.0008612401,0.9496384,0.0011914858,0.0000738712,0.00021051895,0.0009434084,0.0074754055,0.0011686026],"genre_scores_gemma":[0.53114474,0.0003063349,0.46241426,0.00074146804,0.00014447745,0.0003158556,0.0027293635,0.00040439062,0.001799076],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99738616,0.001329813,0.0001613704,0.0005247611,0.00048895366,0.00010902584],"domain_scores_gemma":[0.98956746,0.0074115447,0.0005180098,0.0008805193,0.0012725194,0.00034992932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069326186,0.0009587612,0.00086169917,0.0017688771,0.00043111484,0.0018911499,0.002518308,0.0016285001,0.0030168865],"category_scores_gemma":[0.018948887,0.0004461548,0.00094277726,0.0008457469,0.00091184967,0.0019784311,0.0020949107,0.0022681896,0.00095119386],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076266844,0.0004930412,0.01056829,0.00036303268,0.00029820928,0.00024500568,0.00042367415,0.43949828,0.0068156547,0.009998263,0.012205098,0.5183288],"study_design_scores_gemma":[0.000018051362,0.000047425525,0.00024080972,0.000017833367,0.000013355148,0.000016252414,0.00001508531,0.9946561,0.00086214166,0.003341283,0.0007620268,0.0000096499125],"about_ca_topic_score_codex":0.008356071,"about_ca_topic_score_gemma":0.011135363,"teacher_disagreement_score":0.008356071,"about_ca_system_score_codex":0.0011424005,"about_ca_system_score_gemma":0.00235371,"threshold_uncertainty_score":0.03666359},"labels":[],"label_agreement":null},{"id":"W4412163798","doi":"10.1158/1557-3265.aimachine-b040","title":"Abstract B040: Literature-scaled immunological gene set annotation using AI-powered immune cell knowledge graph (ICKG)","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"vaccines and immunoinformatics approaches","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Annotation; Gene; Computational biology; Graph; Biology; Immunology; Computer science; Genetics; Theoretical computer science","score_opus":0.13461211621388794,"score_gpt":0.47618732162706473,"score_spread":0.34157520541317676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163798","genre_codex":"dataset","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03452252,0.0047374917,0.34233472,0.0062136203,0.0016681554,0.001917028,0.48593205,0.063079745,0.059594695],"genre_scores_gemma":[0.11304787,0.0032292504,0.506159,0.0010846187,0.00027361987,0.0013212838,0.35872424,0.0044278805,0.011732251],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99843746,0.00029434974,0.00022292184,0.0003936257,0.00055945356,0.00009226324],"domain_scores_gemma":[0.99337786,0.0031984055,0.00049952907,0.00075145403,0.0018488703,0.00032389184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029788977,0.001378786,0.0005613016,0.016346982,0.0012108404,0.0032316302,0.0013373246,0.0011879727,0.022586148],"category_scores_gemma":[0.013233166,0.0005440556,0.0015597586,0.007919154,0.000652731,0.002426703,0.0029661,0.0011322389,0.008745351],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080469175,0.0002783323,0.016048996,0.017504608,0.00064248685,0.0026354827,0.0027739133,0.025661295,0.043921493,0.055030905,0.48081037,0.35388744],"study_design_scores_gemma":[0.00013396992,0.000152589,0.010949579,0.002302719,0.0007720794,0.0010241816,0.0013736245,0.048300534,0.02250933,0.061650008,0.85061115,0.00022033583],"about_ca_topic_score_codex":0.010585191,"about_ca_topic_score_gemma":0.017759956,"teacher_disagreement_score":0.022586148,"about_ca_system_score_codex":0.0015051679,"about_ca_system_score_gemma":0.0041142977,"threshold_uncertainty_score":0.075558126},"labels":[],"label_agreement":null},{"id":"W4412163800","doi":"10.1158/1557-3265.aimachine-b058","title":"Abstract B058: An informed machine learning-based blood test for risk assessment of lethal and common cancers","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"COVID-19 diagnosis using AI","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Test (biology); Risk assessment; Oncology; Cancer; Blood test; Internal medicine; Intensive care medicine; Computer science; Biology; Computer security","score_opus":0.20412498499858905,"score_gpt":0.5990526704937809,"score_spread":0.3949276854951918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163800","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.106663905,0.0014877046,0.8682022,0.005164247,0.0005625287,0.00059641956,0.0036464774,0.0063317018,0.007344843],"genre_scores_gemma":[0.65358835,0.00050220254,0.33354583,0.0015329778,0.00032626413,0.00048562937,0.0028386666,0.0001181488,0.0070618913],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99910384,0.00035068239,0.000063205145,0.00016693045,0.00026563858,0.00004963793],"domain_scores_gemma":[0.9984646,0.00075447763,0.00018419138,0.000106821295,0.00039774086,0.00009223882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00166615,0.0005852442,0.0006489074,0.001271318,0.0002537189,0.00076752494,0.0009999003,0.0010238679,0.0039034567],"category_scores_gemma":[0.007264346,0.00026092996,0.00049176824,0.0005573045,0.0002650301,0.00048592017,0.0006952149,0.00090481655,0.0014156948],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017922762,0.0004670505,0.066779636,0.00020166097,0.00025793593,0.00075405877,0.000061002964,0.11583308,0.010481627,0.008257567,0.035576466,0.75953764],"study_design_scores_gemma":[0.00018451865,0.0003350362,0.015064629,0.000053440966,0.00008420748,0.0006350847,0.00002003482,0.95337194,0.010336241,0.011684476,0.008161289,0.00006922374],"about_ca_topic_score_codex":0.0024526708,"about_ca_topic_score_gemma":0.0022477456,"teacher_disagreement_score":0.0039034567,"about_ca_system_score_codex":0.0006109174,"about_ca_system_score_gemma":0.0011261426,"threshold_uncertainty_score":0.013058364},"labels":[],"label_agreement":null},{"id":"W4412163802","doi":"10.1158/1557-3265.aimachine-a014","title":"Abstract A014: Machine Learning-Guided Discovery of Drug Combinations Targeting PI3K and mTOR Pathways Using Cell Line and PDX Data","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"PI3K/AKT/mTOR pathway; Drug discovery; Computational biology; Medicine; Bioinformatics; Biology; Signal transduction; Cell biology","score_opus":0.26484641605504405,"score_gpt":0.5520178040006288,"score_spread":0.2871713879455848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163802","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84109527,0.00126024,0.14212763,0.0009169534,0.00010388665,0.00027244675,0.0071750795,0.003717676,0.0033308798],"genre_scores_gemma":[0.95166487,0.00024300355,0.041077323,0.00013171842,0.000023525068,0.0001722373,0.0055581247,0.00005082122,0.0010784422],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99971515,0.00009955297,0.000021638216,0.000074495416,0.00006856167,0.000020594114],"domain_scores_gemma":[0.9990237,0.000586172,0.00010873376,0.00007665946,0.00016145171,0.00004330752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013205594,0.0010591475,0.0007633828,0.0008154418,0.00020913959,0.00086722954,0.0006029121,0.0006797765,0.0013469203],"category_scores_gemma":[0.0021029606,0.0003318786,0.0010286366,0.0005176436,0.00031070824,0.00050667673,0.0003413258,0.00085902336,0.00036581646],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003904864,0.0003248274,0.012192598,0.00013616862,0.00019204812,0.00007910993,0.00001325305,0.9447998,0.011243285,0.00067903195,0.0019698762,0.027979575],"study_design_scores_gemma":[0.00001187646,0.00011088828,0.0005931608,0.0000028326278,0.000013374627,0.00000873734,0.0000025575655,0.9954905,0.0032637212,0.00022115446,0.0002763669,0.0000047310596],"about_ca_topic_score_codex":0.00603193,"about_ca_topic_score_gemma":0.0039980332,"teacher_disagreement_score":0.00603193,"about_ca_system_score_codex":0.0009490462,"about_ca_system_score_gemma":0.0010371251,"threshold_uncertainty_score":0.011993647},"labels":[],"label_agreement":null},{"id":"W4412163803","doi":"10.1158/1557-3265.aimachine-b006","title":"Abstract B006: Using large language models for scalable extraction of real-world progression events across multiple cancer types","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Biomedical Text Mining and Ontologies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Computer science; Scalability; Extraction (chemistry); Medicine; Internal medicine; Chemistry; Database","score_opus":0.2221175994035013,"score_gpt":0.6034192008268803,"score_spread":0.381301601423379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163803","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09869745,0.002182539,0.777882,0.0035911566,0.0005814385,0.0011246953,0.04445817,0.06784624,0.0036362733],"genre_scores_gemma":[0.26440662,0.0005414493,0.663772,0.00083402224,0.00019835627,0.0009090314,0.0651534,0.0012637863,0.0029212302],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9971871,0.001168497,0.00034459968,0.0008145488,0.00036494926,0.000120314675],"domain_scores_gemma":[0.98912597,0.007554626,0.00063323363,0.0012860226,0.0011413587,0.00025884554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005256624,0.0017622001,0.0006679441,0.0023008129,0.0007658226,0.0022203636,0.001557189,0.0012056251,0.005310883],"category_scores_gemma":[0.021267084,0.00061708095,0.002672448,0.0014189591,0.00053298345,0.0028231791,0.0024794224,0.0022813547,0.004299686],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020687582,0.000670922,0.043090638,0.002509259,0.0008607274,0.0011016019,0.0017965285,0.0963306,0.02139459,0.007917749,0.09217531,0.7300833],"study_design_scores_gemma":[0.00027156484,0.0003071756,0.008315811,0.00021877485,0.00022546866,0.00040696288,0.000547138,0.9288609,0.013721396,0.01851787,0.028464004,0.00014286776],"about_ca_topic_score_codex":0.013969025,"about_ca_topic_score_gemma":0.02105846,"teacher_disagreement_score":0.013969025,"about_ca_system_score_codex":0.0011029562,"about_ca_system_score_gemma":0.0025206795,"threshold_uncertainty_score":0.027800024},"labels":[],"label_agreement":null},{"id":"W4412163804","doi":"10.1158/1557-3265.aimachine-b057","title":"Abstract B057: DrBioRight: an AI chat assistant enabling scalable and flexible multi-omics analysis in cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Scalability; Computer science; Computational biology; Medicine; World Wide Web; Biology; Internal medicine; Database","score_opus":0.21692395987851304,"score_gpt":0.5446135379684263,"score_spread":0.3276895780899132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163804","genre_codex":"software","genre_gemma":"software","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"software","genre_consensus":"software","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026186807,0.0006272062,0.45650205,0.0016480725,0.00048258266,0.0006597016,0.010116677,0.48049486,0.023282059],"genre_scores_gemma":[0.27284268,0.0006975077,0.5783406,0.0034857197,0.00043057115,0.0021369134,0.03290726,0.036929972,0.07222887],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9986457,0.0003729711,0.000080789985,0.00034819904,0.0004306673,0.000121564066],"domain_scores_gemma":[0.99598855,0.0022508188,0.00013742292,0.0005042319,0.0006408034,0.00047820207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025917646,0.0014035017,0.0006437095,0.00088413706,0.0006813594,0.001628869,0.0025022943,0.0012343251,0.038724978],"category_scores_gemma":[0.006655457,0.000551232,0.0008314462,0.00046115485,0.00053555536,0.0018365679,0.003733529,0.0015419056,0.0186223],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005958572,0.000814057,0.0038451445,0.0019453045,0.00021874889,0.002797558,0.002913666,0.010821995,0.1073148,0.01825449,0.5185629,0.32655266],"study_design_scores_gemma":[0.0011529787,0.000632468,0.004085634,0.00036384916,0.00015948607,0.0014119775,0.000615433,0.30288363,0.1069539,0.028152643,0.5531766,0.00041138037],"about_ca_topic_score_codex":0.0033394452,"about_ca_topic_score_gemma":0.003209966,"teacher_disagreement_score":0.038724978,"about_ca_system_score_codex":0.0007004731,"about_ca_system_score_gemma":0.0010744055,"threshold_uncertainty_score":0.12954801},"labels":[],"label_agreement":null},{"id":"W4412163805","doi":"10.1158/1557-3265.aimachine-b030","title":"Abstract B030: Multiple instance learning of large-scale DNA organization to characterize prostate cancer aggressiveness","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Prostate cancer; Cancer; Prostate; Scale (ratio); Medicine; Oncology; Computational biology; Biology; Internal medicine; Geography; Cartography","score_opus":0.06962003020005936,"score_gpt":0.4523497106650309,"score_spread":0.3827296804649715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163805","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43817455,0.0031579838,0.5262577,0.0024375932,0.00053079467,0.00040796067,0.006749681,0.016753549,0.0055301115],"genre_scores_gemma":[0.88463145,0.00023491049,0.10284646,0.00046508288,0.0001678772,0.00017241399,0.008255963,0.00025056413,0.0029752774],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.999148,0.00026564856,0.00004734255,0.00026096153,0.00014442773,0.00013364339],"domain_scores_gemma":[0.99821186,0.0008964375,0.00015055723,0.00020683189,0.00031294156,0.00022145237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024532566,0.0015831671,0.0012746911,0.0015301956,0.00043639904,0.0015217904,0.0022064184,0.0020045568,0.00314181],"category_scores_gemma":[0.0039873174,0.00042896162,0.0015037382,0.0010888838,0.00046569956,0.0010427376,0.0012888194,0.0024274301,0.0011834336],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020853912,0.0012567658,0.027787557,0.00040634585,0.0007457153,0.00037119526,0.00013781077,0.5367512,0.0138446605,0.0030253602,0.03200419,0.3815839],"study_design_scores_gemma":[0.000020330268,0.000073342926,0.001197045,0.000008959221,0.000015808033,0.000023461625,0.000012010345,0.9953744,0.0016522387,0.0012465129,0.00036736327,0.0000085700585],"about_ca_topic_score_codex":0.0064469962,"about_ca_topic_score_gemma":0.0037108774,"teacher_disagreement_score":0.0064469962,"about_ca_system_score_codex":0.0009935924,"about_ca_system_score_gemma":0.00090862595,"threshold_uncertainty_score":0.012974203},"labels":[],"label_agreement":null},{"id":"W4412163806","doi":"10.1158/1557-3265.aimachine-a025","title":"Abstract A025: PicoGen: A structure-grounded generative AI model for drugging undruggable targets, including the TEAD–YAP axis","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell Image Analysis Techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science; Medicine; Computational biology; Cancer research; Biology","score_opus":0.1359265961266201,"score_gpt":0.5229733592768661,"score_spread":0.387046763150246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163806","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06355046,0.0014674746,0.90616494,0.0021231892,0.00025689203,0.00013726202,0.0017095931,0.0035535216,0.021036705],"genre_scores_gemma":[0.85897005,0.0007787195,0.11829701,0.0010930345,0.00018530479,0.00036806488,0.0020992688,0.0005421158,0.01766637],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.999869,0.000033002056,0.0000049273544,0.000037097005,0.000033540728,0.000022465521],"domain_scores_gemma":[0.99957126,0.00026429037,0.000030357252,0.000031594438,0.000057788813,0.000044700173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004274075,0.00072553585,0.00064477144,0.00040380305,0.00031800105,0.0008981589,0.001596223,0.0012848305,0.0064422823],"category_scores_gemma":[0.0014791003,0.00043804728,0.00096345507,0.0003151898,0.0009267635,0.00064691534,0.0010972641,0.0017378259,0.0009825666],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003760664,0.000017868239,0.00044945066,0.000034040186,0.000019749745,0.00004730787,0.000016225336,0.9780411,0.0006665663,0.009912364,0.0019952825,0.008762296],"study_design_scores_gemma":[0.000004029125,0.0000066791767,0.000018033967,0.0000029700805,0.0000024377591,0.000005755186,0.0000013062777,0.9971769,0.00012859155,0.0022330023,0.00041865782,0.0000016818508],"about_ca_topic_score_codex":0.008105157,"about_ca_topic_score_gemma":0.0076383958,"teacher_disagreement_score":0.008105157,"about_ca_system_score_codex":0.00095120433,"about_ca_system_score_gemma":0.0010852531,"threshold_uncertainty_score":0.02155155},"labels":[],"label_agreement":null},{"id":"W4412163807","doi":"10.1158/1557-3265.aimachine-a008","title":"Abstract A008: AI-Predict: Artificial intelligence-mediated drug synergy prediction and validation in cancer models","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Drug; Cancer drugs; Artificial intelligence; Medicine; Computer science; Pharmacology; Internal medicine","score_opus":0.280417761268561,"score_gpt":0.543195176155506,"score_spread":0.26277741488694506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163807","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18340696,0.0039104186,0.6641616,0.0074861143,0.001174097,0.00086764246,0.03352994,0.07325651,0.032206647],"genre_scores_gemma":[0.6890439,0.0008879665,0.25373587,0.0012651682,0.0003563274,0.0010378836,0.037491754,0.0014197542,0.01476144],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9995833,0.00014594507,0.000021080716,0.00012857921,0.000089658635,0.000031429412],"domain_scores_gemma":[0.9988955,0.00067560124,0.000062585386,0.00012910749,0.00017953267,0.000057516096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014044143,0.001621641,0.00065270456,0.00092849723,0.0003215809,0.00092713186,0.0015817236,0.0013762828,0.011460523],"category_scores_gemma":[0.0038229506,0.00037844718,0.0011038445,0.00064271,0.00040068614,0.00069726084,0.0008471269,0.0017158908,0.0027289302],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024017424,0.00015940753,0.0030031577,0.00023568391,0.00015049483,0.00008786235,0.000021010663,0.8897024,0.0009646548,0.0033381004,0.042394843,0.059702266],"study_design_scores_gemma":[0.0000136364615,0.000025112957,0.00012352556,0.00000784925,0.000005115478,0.0000066298394,0.0000015334189,0.9969085,0.00034159777,0.0013299515,0.0012337177,0.0000028216289],"about_ca_topic_score_codex":0.009690888,"about_ca_topic_score_gemma":0.007046572,"teacher_disagreement_score":0.011460523,"about_ca_system_score_codex":0.0009783854,"about_ca_system_score_gemma":0.0012285858,"threshold_uncertainty_score":0.038339257},"labels":[],"label_agreement":null},{"id":"W4412163808","doi":"10.1158/1557-3265.aimachine-a005","title":"Abstract A005: Monotherapy cancer drug-blind response prediction is limited to intraclass generalization","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Drug; Medicine; Generalization; Cancer drugs; Oncology; Pharmacology; Internal medicine; Mathematics","score_opus":0.23828161650978824,"score_gpt":0.5728428275790751,"score_spread":0.3345612110692869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163808","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7307715,0.0011418319,0.25738767,0.0017491758,0.0001578126,0.0001627465,0.0011794164,0.002727471,0.004722302],"genre_scores_gemma":[0.9878088,0.000059795006,0.009900386,0.00020534384,0.000019452813,0.000033834705,0.0005473293,0.000060926577,0.0013642319],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99718577,0.0012985488,0.00015060426,0.00073104666,0.00040666683,0.00022728859],"domain_scores_gemma":[0.9896578,0.0063854703,0.00090034923,0.0019030559,0.00077105605,0.00038219744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008906647,0.0012700235,0.0015544188,0.0004965331,0.00037460736,0.0013406313,0.0010674557,0.0016714743,0.0024043336],"category_scores_gemma":[0.021129008,0.0005477246,0.0013029502,0.00034741685,0.0012899756,0.001917406,0.0013039793,0.002339073,0.0008102302],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024513206,0.0005084758,0.021138007,0.00022643364,0.0003954651,0.00021374736,0.00009725193,0.8730063,0.009835562,0.003172732,0.0044253212,0.08452949],"study_design_scores_gemma":[0.000025551752,0.00027126272,0.0024271675,0.000010402302,0.000022439743,0.000039915973,0.000010390305,0.9907851,0.0033337402,0.0028408768,0.00021606253,0.000017137612],"about_ca_topic_score_codex":0.007491659,"about_ca_topic_score_gemma":0.0037538316,"teacher_disagreement_score":0.008906647,"about_ca_system_score_codex":0.0011986798,"about_ca_system_score_gemma":0.0013955522,"threshold_uncertainty_score":0.047103405},"labels":[],"label_agreement":null},{"id":"W4412163810","doi":"10.1158/1557-3265.aimachine-b059","title":"Abstract B059: Cancer Recurrence and Anxiety/Depression: High Accuracy Artificial Intelligence Predictive Modeling","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Depression (economics); Anxiety; Cancer; Medicine; Psychiatry; Clinical psychology; Psychology; Oncology; Internal medicine","score_opus":0.19788921596295983,"score_gpt":0.5589213086711612,"score_spread":0.36103209270820136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163810","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7309233,0.0048418315,0.2091033,0.0144034,0.00075326016,0.00040469077,0.023738666,0.005158769,0.010672747],"genre_scores_gemma":[0.94192004,0.00065327034,0.036728367,0.0006366712,0.00024854508,0.00018408525,0.015776634,0.00007490528,0.0037774404],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9993383,0.0003126876,0.000040202238,0.00014623889,0.00009414613,0.000068437],"domain_scores_gemma":[0.99789643,0.0014154892,0.0001134186,0.00017057775,0.0003185123,0.00008550465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020756936,0.0011122338,0.00075711653,0.00074318814,0.00046666118,0.0011043146,0.0013240826,0.0012134626,0.0024857987],"category_scores_gemma":[0.005308007,0.00040879883,0.0013094866,0.0008318638,0.00033934656,0.0005402824,0.00092368963,0.002353928,0.0007072995],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005092959,0.0008806976,0.04054189,0.00017897738,0.0005869081,0.00023878826,0.00007189669,0.82439256,0.00064899045,0.0024929312,0.03104002,0.09841699],"study_design_scores_gemma":[0.000021191821,0.000025671321,0.0021857165,0.000008687415,0.000017256372,0.000011928474,0.000008819511,0.9960007,0.00012927182,0.0011559242,0.00042900143,0.000005812759],"about_ca_topic_score_codex":0.04307519,"about_ca_topic_score_gemma":0.026245205,"teacher_disagreement_score":0.04307519,"about_ca_system_score_codex":0.0009864668,"about_ca_system_score_gemma":0.0011269061,"threshold_uncertainty_score":0.085648954},"labels":[],"label_agreement":null},{"id":"W4412163813","doi":"10.1158/1557-3265.aimachine-b002","title":"Abstract B002: Fairness by Design: End-to-End Bias Evaluation for LLM-Generated Data","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ethics and Social Impacts of AI","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"End-to-end principle; Computer science; End user; Medicine; Computer network; World Wide Web","score_opus":0.87220080924877,"score_gpt":0.7180107518801088,"score_spread":0.1541900573686612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163813","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04251895,0.0019973733,0.9067592,0.0024253754,0.0013497624,0.032066964,0.004366652,0.0028785197,0.0056372574],"genre_scores_gemma":[0.32565194,0.00021698825,0.61602795,0.0016749566,0.00035436076,0.05194653,0.0018690391,0.0005790778,0.0016791645],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.3574557,0.57219154,0.026097402,0.021232164,0.021216502,0.0018067069],"domain_scores_gemma":[0.14224465,0.7476436,0.026938263,0.061137035,0.02015128,0.0018851979],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.5485125,0.002712683,0.003819794,0.003398235,0.00315238,0.0059746495,0.0045337467,0.0065756026,0.019872162],"category_scores_gemma":[0.71728116,0.0018742078,0.010059119,0.0029683572,0.00866984,0.0052870433,0.0073501705,0.0056695077,0.0020753222],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054078855,0.002558422,0.12693669,0.017301062,0.03875398,0.00097224896,0.005512228,0.066444725,0.003935309,0.10893609,0.045778427,0.528792],"study_design_scores_gemma":[0.025032807,0.021749891,0.06317176,0.007401663,0.013313445,0.0014286188,0.0016645263,0.5481739,0.018251903,0.22138217,0.07766701,0.0007623083],"about_ca_topic_score_codex":0.0019404783,"about_ca_topic_score_gemma":0.0016075913,"teacher_disagreement_score":0.45148748,"about_ca_system_score_codex":0.004575829,"about_ca_system_score_gemma":0.0070781205,"threshold_uncertainty_score":0.5567645},"labels":[],"label_agreement":null},{"id":"W4412163814","doi":"10.1158/1557-3265.aimachine-a010","title":"Abstract A010: Benchmarking 3D against 2D deep learning-driven image-based profiling for predicting biological relationships amongst genes","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Benchmarking; Profiling (computer programming); Computational biology; Deep learning; Gene; Biology; Artificial intelligence; Computer science; Medicine; Genetics; Business","score_opus":0.1869479642711576,"score_gpt":0.4713965524421148,"score_spread":0.2844485881709572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163814","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7049655,0.0030358897,0.17192414,0.0020692348,0.00077143713,0.0005175071,0.03346152,0.07157967,0.011675117],"genre_scores_gemma":[0.796405,0.0005372676,0.1459009,0.0009972298,0.00004927027,0.00035303453,0.05027286,0.0016459165,0.003838536],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9991379,0.00019614173,0.000048157355,0.0002856421,0.00024257996,0.000089528905],"domain_scores_gemma":[0.99898297,0.00047894957,0.000052789088,0.00018364242,0.00020388773,0.00009777902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016334942,0.001829211,0.0008583401,0.0011521204,0.00041316304,0.001265707,0.002407024,0.0017135759,0.0040789186],"category_scores_gemma":[0.0028368616,0.0004930858,0.002035746,0.0009616704,0.0010501212,0.0008696611,0.001382116,0.0015934971,0.0015515338],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012276878,0.00063794886,0.0095092375,0.0007168334,0.0005832634,0.00033644406,0.00009326156,0.847552,0.017502978,0.0030483336,0.029489866,0.08930209],"study_design_scores_gemma":[0.000041934392,0.00011537057,0.00083903346,0.000008488687,0.000010814021,0.000024762041,0.000015617132,0.9931937,0.003953031,0.0007316571,0.0010532762,0.000012293326],"about_ca_topic_score_codex":0.015478698,"about_ca_topic_score_gemma":0.013283734,"teacher_disagreement_score":0.015478698,"about_ca_system_score_codex":0.0016569282,"about_ca_system_score_gemma":0.0011001047,"threshold_uncertainty_score":0.030777216},"labels":[],"label_agreement":null},{"id":"W4412163815","doi":"10.1158/1557-3265.aimachine-a019","title":"Abstract A019: A fully transparent and automatable form of AI for biomarker and new target discovery using diverse multi-omics data","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biomarker; Biomarker discovery; Computational biology; Omics; Computer science; Bioinformatics; Medicine; Biology; Proteomics; Genetics; Gene","score_opus":0.36954026111179117,"score_gpt":0.5258084279340924,"score_spread":0.15626816682230127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163815","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0075514885,0.000097233875,0.98388034,0.000892016,0.000120431905,0.00009659623,0.00037682327,0.0027555563,0.0042294776],"genre_scores_gemma":[0.32355565,0.00022679998,0.6671273,0.00068232947,0.00013539939,0.00030562686,0.0010148275,0.0006025558,0.0063495534],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9975278,0.00092669734,0.00017309362,0.0006760522,0.0005798775,0.000116500945],"domain_scores_gemma":[0.9933083,0.002447507,0.00051565655,0.0024421331,0.0008938136,0.00039257933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029862358,0.0006776445,0.0005064529,0.001722741,0.001268742,0.0029279527,0.001802758,0.0010919492,0.0062805684],"category_scores_gemma":[0.009153801,0.00048087654,0.001564668,0.0009582936,0.0028327708,0.0037425978,0.0043772007,0.002154968,0.0015817899],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023243076,0.00014452131,0.0023454959,0.0002915781,0.00016244862,0.0005172127,0.00059179694,0.12411135,0.021959582,0.7376108,0.014234658,0.09779804],"study_design_scores_gemma":[0.000031331612,0.00007218745,0.00030079484,0.000048045866,0.000058342386,0.000109417655,0.00010565328,0.5099023,0.008845313,0.4567882,0.023688776,0.000049666636],"about_ca_topic_score_codex":0.0039774557,"about_ca_topic_score_gemma":0.0039898558,"teacher_disagreement_score":0.0062805684,"about_ca_system_score_codex":0.0010712827,"about_ca_system_score_gemma":0.0021905745,"threshold_uncertainty_score":0.021010578},"labels":[],"label_agreement":null},{"id":"W4412163816","doi":"10.1158/1557-3265.aimachine-a050","title":"Abstract A050: Multimodal integration of H&amp;E slides and matched targeted DNA sequencing data for enhanced cancer subtype identification","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Identification (biology); Computational biology; DNA sequencing; DNA; Medicine; Biology; Cancer research; Genetics","score_opus":0.22026097765459376,"score_gpt":0.5179459816815548,"score_spread":0.2976850040269611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163816","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.585773,0.0010043522,0.37993407,0.0011245069,0.0003459671,0.00021864542,0.00801021,0.017768253,0.005821161],"genre_scores_gemma":[0.8468215,0.00022508649,0.13665873,0.00039546844,0.000083080515,0.0001258105,0.009320225,0.0003632121,0.006006999],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99958855,0.000098316435,0.000016743075,0.00014941879,0.000101392165,0.000045496512],"domain_scores_gemma":[0.9993498,0.00018676059,0.00005438341,0.00012370826,0.00020511952,0.00008029387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014466234,0.00085056527,0.00035062054,0.0010433864,0.00021129084,0.0005890729,0.0007917979,0.0006190567,0.0028997795],"category_scores_gemma":[0.0022805126,0.00024775366,0.00068418856,0.00038976248,0.00021062825,0.00064423156,0.0011284251,0.00067775627,0.0013548486],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015830622,0.0009118529,0.11030939,0.00027620696,0.0006240569,0.0005638704,0.0002629892,0.18129358,0.108278535,0.0017295103,0.032437906,0.561729],"study_design_scores_gemma":[0.000027112428,0.00020749366,0.011592162,0.000020961894,0.000070670125,0.00019070001,0.00007807132,0.95128274,0.029948302,0.0016463593,0.004898086,0.0000374441],"about_ca_topic_score_codex":0.008617503,"about_ca_topic_score_gemma":0.01465665,"teacher_disagreement_score":0.008617503,"about_ca_system_score_codex":0.00051515276,"about_ca_system_score_gemma":0.0007226625,"threshold_uncertainty_score":0.017134666},"labels":[],"label_agreement":null},{"id":"W4412163818","doi":"10.1158/1557-3265.aimachine-a044","title":"Abstract A044: Developing a digital twin framework for colorectal cancer outcome prediction and robust clinical trial simulation","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Outcome (game theory); Medicine; Clinical trial; Cancer; Oncology; Internal medicine; Mathematics","score_opus":0.35160112972281476,"score_gpt":0.6146728912783317,"score_spread":0.2630717615555169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163818","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015805664,0.00011473395,0.9821114,0.00045012336,0.00003030184,0.00008561756,0.00021674273,0.00036630163,0.0008191276],"genre_scores_gemma":[0.45231465,0.00019496963,0.54338616,0.00031730588,0.00007438845,0.00061079423,0.0007119773,0.00013933386,0.0022503552],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99793553,0.0014093338,0.00009783676,0.00026471532,0.00020403146,0.00008858029],"domain_scores_gemma":[0.9931235,0.0050502755,0.0004263355,0.00049318204,0.0005868336,0.00031991157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00717413,0.00062298385,0.00084881886,0.0008088821,0.00035897453,0.0012559114,0.0018761952,0.0012479603,0.0035178396],"category_scores_gemma":[0.019963758,0.00072833116,0.0011693994,0.0005620878,0.0011027766,0.001114795,0.001825313,0.0017084538,0.0003960185],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009801088,0.000029823317,0.0016189828,0.000035680398,0.00006770659,0.00005127663,0.000039369486,0.96636057,0.00037748454,0.016207533,0.00040788282,0.0147057],"study_design_scores_gemma":[0.0000060409743,0.000008837459,0.000055193363,0.000002756617,0.0000037098155,0.000004523109,0.0000015964667,0.9949941,0.00008990032,0.0046960134,0.00013539713,0.000001982512],"about_ca_topic_score_codex":0.011268644,"about_ca_topic_score_gemma":0.009824882,"teacher_disagreement_score":0.011268644,"about_ca_system_score_codex":0.0015755361,"about_ca_system_score_gemma":0.002935337,"threshold_uncertainty_score":0.03794092},"labels":[],"label_agreement":null},{"id":"W4412163819","doi":"10.1158/1557-3265.aimachine-b052","title":"Abstract B052: Utilizing Dimensionality Reduction for Classification of Cell Senescence and Immune Synapse Formation via Imaging Flow Cytometry","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Senescence; Flow cytometry; Cellular senescence; Immune system; Immunological synapse; Cell biology; Cell; Biology; Chemistry; Neuroscience; Immunology; T cell; Biochemistry; Phenotype","score_opus":0.10899985483038212,"score_gpt":0.4973195803481481,"score_spread":0.388319725517766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163819","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24751714,0.0008746059,0.73660177,0.0008763388,0.00023742985,0.00052720594,0.004215313,0.006632624,0.0025175514],"genre_scores_gemma":[0.46792603,0.00045611846,0.51406056,0.0002592174,0.0001436577,0.00086872594,0.012753073,0.00024493353,0.0032877128],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9987766,0.0002650825,0.00011637436,0.0003161661,0.0003682971,0.00015752674],"domain_scores_gemma":[0.99883884,0.00027700598,0.00012131122,0.00017394855,0.00051464594,0.00007424714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020298306,0.00097156037,0.0010547095,0.0022902272,0.0005733966,0.0017696897,0.00083224045,0.0011401931,0.001679056],"category_scores_gemma":[0.0036821247,0.00023279001,0.0013613371,0.0014655141,0.00035994023,0.0006099819,0.0007771853,0.00096838136,0.0014529818],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009775297,0.0007674969,0.024675054,0.0003834819,0.00038146082,0.00028863098,0.0003422159,0.07618718,0.2212215,0.00512068,0.019773096,0.6498817],"study_design_scores_gemma":[0.00003726673,0.00017432326,0.013467583,0.000022628587,0.00004737294,0.00016038536,0.00008785886,0.9350211,0.04198997,0.0040042056,0.0049284548,0.00005882763],"about_ca_topic_score_codex":0.0031050798,"about_ca_topic_score_gemma":0.0018179,"teacher_disagreement_score":0.0031050798,"about_ca_system_score_codex":0.00078501523,"about_ca_system_score_gemma":0.0011428006,"threshold_uncertainty_score":0.010734916},"labels":[],"label_agreement":null},{"id":"W4412163820","doi":"10.1158/1557-3265.aimachine-b060","title":"Abstract B060: DIGIONE: From Fragmentation to Federation: Enabling Scalable Oncology RWE (Real World Evidence) through an international hospital based Cancer OMOP (Observational Medical Outcomes Partnership) Network","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Observational study; Medicine; General partnership; Cancer; Medical physics; Oncology; Internal medicine; Intensive care medicine; Business","score_opus":0.43704388804110184,"score_gpt":0.5485966909366976,"score_spread":0.11155280289559577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163820","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03747466,0.004805056,0.413167,0.0948565,0.003176537,0.003913454,0.1546101,0.07808435,0.2099124],"genre_scores_gemma":[0.20127581,0.0031356674,0.49845406,0.01555557,0.0013952337,0.0040901448,0.22555298,0.009417593,0.041122925],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98811287,0.005910577,0.00087927526,0.0022716906,0.0020958402,0.0007296048],"domain_scores_gemma":[0.94721544,0.017578525,0.0029117952,0.018814608,0.006327896,0.0071517904],"candidate_categories":["scholarly_communication"],"consensus_categories":[],"category_scores_codex":[0.03309225,0.0008699562,0.00077273446,0.003588184,0.0011848486,0.00801776,0.0029779645,0.0018733863,0.023817206],"category_scores_gemma":[0.065918945,0.00073855073,0.0013170023,0.0036840127,0.0014609235,0.01000481,0.01668612,0.0027916767,0.011677596],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082949013,0.00021465022,0.016868701,0.0008560932,0.00026352218,0.00031681493,0.0016350757,0.012240814,0.0020003966,0.098158106,0.622407,0.24420935],"study_design_scores_gemma":[0.00032276916,0.00029666952,0.010627859,0.0012167608,0.000105940635,0.0002549774,0.0009187405,0.026420599,0.002323115,0.10848158,0.8489207,0.0001102424],"about_ca_topic_score_codex":0.011008789,"about_ca_topic_score_gemma":0.0082695605,"teacher_disagreement_score":0.9919822,"about_ca_system_score_codex":0.0033125062,"about_ca_system_score_gemma":0.010208804,"threshold_uncertainty_score":0.17501062},"labels":[],"label_agreement":null},{"id":"W4412163824","doi":"10.1158/1557-3265.aimachine-a029","title":"Abstract A029: Validation of a Deep Learning Serial Computed Tomography Response Biomarker for Predicting Overall Survival in Metastatic Kidney Cancer Treated with Immune Checkpoint Inhibitors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Kidney cancer; Medicine; Biomarker; Cancer; Oncology; Immune system; Internal medicine; Immunology; Biology","score_opus":0.07322595110256533,"score_gpt":0.45973526590854913,"score_spread":0.38650931480598383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99239564,0.00064885337,0.002888702,0.00021833584,0.000025679272,0.00007210032,0.0028457239,0.00011285451,0.0007921477],"genre_scores_gemma":[0.99433726,0.00011099668,0.0022385754,0.00007859465,0.000018396455,0.000047370188,0.0029128832,0.000007628382,0.00024833914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956673,0.00012697953,0.000052298597,0.00011605397,0.000089421985,0.000048515623],"domain_scores_gemma":[0.9987513,0.00027441815,0.00032451167,0.00009424924,0.00040096114,0.00015447554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010949789,0.0003634317,0.00046205643,0.000642185,0.000212079,0.0006818268,0.00052391,0.00046066474,0.0009355463],"category_scores_gemma":[0.0027361508,0.00017948724,0.00047567335,0.0004829609,0.00020202674,0.0002493057,0.000452615,0.0005360513,0.00032287947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003251963,0.000497004,0.8926004,0.00020219838,0.0004399914,0.00032350613,0.00007058113,0.014289016,0.01646767,0.00017715419,0.0036462296,0.06803429],"study_design_scores_gemma":[0.00041086838,0.0025309776,0.7359409,0.00010929361,0.000561546,0.0013429486,0.0002248294,0.2253963,0.027478889,0.0005151375,0.005417603,0.00007074348],"about_ca_topic_score_codex":0.0055143186,"about_ca_topic_score_gemma":0.0065100463,"teacher_disagreement_score":0.0055143186,"about_ca_system_score_codex":0.00061877765,"about_ca_system_score_gemma":0.0008258644,"threshold_uncertainty_score":0.010964453},"labels":[],"label_agreement":null},{"id":"W4412163825","doi":"10.1158/1557-3265.aimachine-b011","title":"Abstract B011: Pan-cancer immunotherapy response prediction using the CURE AI large clinicogenomic foundation model","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Medicine; Cancer; Foundation (evidence); Cancer immunotherapy; Oncology; Immunology; Internal medicine; History","score_opus":0.18830264592713986,"score_gpt":0.5809798997474049,"score_spread":0.3926772538202651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163825","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6090491,0.0019443833,0.33188382,0.009383991,0.00045187143,0.0005688949,0.022841642,0.007853266,0.01602309],"genre_scores_gemma":[0.94857854,0.00023649742,0.035929594,0.0010332034,0.00010548372,0.00030484676,0.00929728,0.00015084245,0.0043637664],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99953663,0.00020191845,0.000017452077,0.00010977603,0.00007751358,0.000056776382],"domain_scores_gemma":[0.9983095,0.0010210605,0.00014972399,0.0001680931,0.00022210053,0.00012954121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020752007,0.0006602958,0.00064370065,0.0006938332,0.0002637893,0.0008841104,0.0006584665,0.00094769173,0.0041011814],"category_scores_gemma":[0.0058163633,0.00029132146,0.0009955871,0.00047141293,0.00040099217,0.00052803423,0.00059116184,0.0016013455,0.00059858774],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008893978,0.0002458068,0.027791329,0.00017629552,0.00028117406,0.0002470097,0.000042533353,0.8780601,0.0027719736,0.008054516,0.023084246,0.058355566],"study_design_scores_gemma":[0.00007151929,0.000090341025,0.0015397512,0.000010464008,0.000025282734,0.000030266168,0.0000054859306,0.9919733,0.00076979003,0.0038255225,0.0016467527,0.000011670483],"about_ca_topic_score_codex":0.008104667,"about_ca_topic_score_gemma":0.0069254846,"teacher_disagreement_score":0.008104667,"about_ca_system_score_codex":0.00083595887,"about_ca_system_score_gemma":0.0015524869,"threshold_uncertainty_score":0.01611501},"labels":[],"label_agreement":null},{"id":"W4412163826","doi":"10.1158/1557-3265.aimachine-b045","title":"Abstract B045: Deep learning–guided spatial dissection of melanoma uncovers compartmentalized tumor states associated with response and resistance to immunotherapy and its combination with MAPK inhibitors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Melanoma; Immunotherapy; Medicine; Cancer research; Dissection (medical); Cancer; Resistance (ecology); Biology; Internal medicine; Surgery; Ecology","score_opus":0.03419208873550194,"score_gpt":0.37361467248780256,"score_spread":0.3394225837523006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9532636,0.00064569066,0.04132035,0.0002306296,0.000031676824,0.000028696499,0.0019809888,0.00097009825,0.0015282579],"genre_scores_gemma":[0.9811849,0.00012986119,0.015044323,0.00008785148,0.000009079093,0.000041593983,0.0021513507,0.0000655182,0.0012854604],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999923,0.000014628406,0.0000030474334,0.000027210635,0.000015871232,0.000016258877],"domain_scores_gemma":[0.9999194,0.000022227749,0.000019296927,0.000009073454,0.000015901005,0.000014165109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029637304,0.00040706,0.00030529712,0.00033523474,0.00012535245,0.00030051693,0.00028450167,0.00028840016,0.0015124262],"category_scores_gemma":[0.00036610724,0.00017252879,0.00046368875,0.00019180859,0.00018305214,0.0002128092,0.00025686386,0.0004260263,0.0003232287],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023455273,0.00048584654,0.03651448,0.00035568277,0.00025641432,0.00018368401,0.000093127994,0.1453451,0.66575015,0.0012078773,0.006107955,0.14135425],"study_design_scores_gemma":[0.000062051644,0.00037441778,0.024287142,0.000016599348,0.00007901349,0.000087270826,0.00004889762,0.89491856,0.077138916,0.0011098034,0.0018553276,0.00002190811],"about_ca_topic_score_codex":0.0033869203,"about_ca_topic_score_gemma":0.004456735,"teacher_disagreement_score":0.0033869203,"about_ca_system_score_codex":0.0004095013,"about_ca_system_score_gemma":0.0004385982,"threshold_uncertainty_score":0.006734431},"labels":[],"label_agreement":null},{"id":"W4412163828","doi":"10.1158/1557-3265.aimachine-b013","title":"Abstract B013: Emotional tone classification as a tool for psychosocial risk detection in oncology: An AI-powered chatbot","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Polytechnique Montréal; McGill University","funders":"","keywords":"Psychosocial; Tone (literature); Chatbot; Medicine; Oncology; Psychology; Internal medicine; Natural language processing; Computer science; Psychiatry; Linguistics","score_opus":0.22254297164388626,"score_gpt":0.6170841533903375,"score_spread":0.39454118174645125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163828","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5587472,0.0020737376,0.19639859,0.0050669783,0.0017353159,0.0028680158,0.029651,0.17847212,0.024987098],"genre_scores_gemma":[0.7114514,0.00040477488,0.21203296,0.0027610506,0.0003837013,0.0025673101,0.0315478,0.0031852226,0.035665795],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99875915,0.0005906009,0.00006468453,0.00028651798,0.00019025335,0.00010882788],"domain_scores_gemma":[0.9934042,0.0050134445,0.00021853628,0.00043748936,0.00047390623,0.00045250924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019284328,0.0014606251,0.0005553778,0.0008735607,0.00053761754,0.0009248115,0.0012154996,0.001371272,0.013021189],"category_scores_gemma":[0.008811962,0.00027088332,0.00047908418,0.0002917264,0.000389418,0.0014148369,0.0015635586,0.0011308457,0.0072678407],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044952394,0.0030645954,0.034882054,0.003742005,0.00019855633,0.0024546052,0.0071615106,0.01594524,0.086588636,0.003933529,0.24203132,0.5955027],"study_design_scores_gemma":[0.0007583127,0.0047166143,0.08342035,0.001024101,0.00024234262,0.002098271,0.0035770948,0.62455,0.06655366,0.012907443,0.19969513,0.0004568087],"about_ca_topic_score_codex":0.0015877329,"about_ca_topic_score_gemma":0.002413603,"teacher_disagreement_score":0.013021189,"about_ca_system_score_codex":0.00066978246,"about_ca_system_score_gemma":0.0003953929,"threshold_uncertainty_score":0.043560266},"labels":[],"label_agreement":null},{"id":"W4412163829","doi":"10.1158/1557-3265.aimachine-b027","title":"Abstract B027: Multimodal prediction of pathological complete response in esophageal cancer using automated machine learning and variational autoencoder-based synthetic data augmentation","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Autoencoder; Pathological; Artificial intelligence; Esophageal cancer; Medicine; Machine learning; Cancer; Computer science; Pattern recognition (psychology); Deep learning; Pathology; Internal medicine","score_opus":0.23480719697752436,"score_gpt":0.5437777774325331,"score_spread":0.3089705804550087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163829","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52165264,0.00027615033,0.47578308,0.00038399428,0.000046941408,0.00006693119,0.0003884853,0.0005940567,0.0008077105],"genre_scores_gemma":[0.94808966,0.00004059755,0.050712246,0.000040075323,0.000017368384,0.000051136616,0.0005207148,0.000033448567,0.0004948496],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996681,0.00016519094,0.000015375897,0.00008092832,0.00004323997,0.000027194881],"domain_scores_gemma":[0.99909365,0.0005470254,0.00007891805,0.000084555606,0.00016296172,0.00003283594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014438404,0.00043071515,0.00036544315,0.00042702796,0.00015061753,0.00035885687,0.0004570843,0.000424357,0.0006948754],"category_scores_gemma":[0.002987207,0.00022370329,0.0005822246,0.00024586666,0.00032501106,0.00040175536,0.0004659065,0.00057125307,0.00014389785],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041705917,0.00017952852,0.016831722,0.00005820816,0.00013591452,0.00011365769,0.00008227014,0.82876354,0.014175442,0.0010443138,0.0012224476,0.1369758],"study_design_scores_gemma":[0.0000017587366,0.000018195202,0.0008237449,0.0000011928248,0.000002494896,0.000009373798,0.0000025914057,0.99808,0.00085240696,0.00014712436,0.000058855214,0.0000022314377],"about_ca_topic_score_codex":0.0034716292,"about_ca_topic_score_gemma":0.0026292007,"teacher_disagreement_score":0.0034716292,"about_ca_system_score_codex":0.0005005291,"about_ca_system_score_gemma":0.00052401965,"threshold_uncertainty_score":0.007635832},"labels":[],"label_agreement":null},{"id":"W4412163831","doi":"10.1158/1557-3265.aimachine-b046","title":"Abstract B046: Enhancing the Diagnosis and Monitoring of Chronic Lymphocytic Leukemia with Artificial Intelligence-Driven Peripheral Blood Smear Image Analysis","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Digital Imaging for Blood Diseases","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chronic lymphocytic leukemia; Medicine; Peripheral blood; Leukemia; Blood smear; Pathology; Internal medicine","score_opus":0.11511020060978346,"score_gpt":0.4568416712885259,"score_spread":0.34173147067874243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163831","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61051774,0.0026971824,0.35424027,0.0012616141,0.00030049888,0.0004652961,0.0046648956,0.018929457,0.0069231433],"genre_scores_gemma":[0.84283984,0.00053395575,0.14941148,0.00040305476,0.00007068079,0.00013413919,0.0032309056,0.00016861304,0.0032073585],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997805,0.000038760016,0.000014570813,0.00006105504,0.00007455174,0.000030562114],"domain_scores_gemma":[0.9996612,0.000070437505,0.000038718634,0.000028723209,0.00016606154,0.000034894907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005305206,0.0005920313,0.00033053977,0.0011298249,0.00012173141,0.00056671957,0.00060934096,0.00055768335,0.0016720559],"category_scores_gemma":[0.0011229407,0.00019886298,0.00035607012,0.00034329656,0.00009586489,0.0003462589,0.00038688575,0.00027407813,0.00077134615],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015160533,0.0004384188,0.040683262,0.00042606337,0.00016547654,0.0007400734,0.00008761336,0.047008228,0.19511557,0.00051842816,0.015970737,0.6973301],"study_design_scores_gemma":[0.000038038856,0.00024083865,0.020494709,0.000034347548,0.000061454484,0.00035063515,0.000035393274,0.9135097,0.0611876,0.00042332985,0.0036004388,0.000023450888],"about_ca_topic_score_codex":0.004880732,"about_ca_topic_score_gemma":0.0045823175,"teacher_disagreement_score":0.004880732,"about_ca_system_score_codex":0.0005059323,"about_ca_system_score_gemma":0.0003757005,"threshold_uncertainty_score":0.009704649},"labels":[],"label_agreement":null},{"id":"W4412163832","doi":"10.1158/1557-3265.aimachine-a001","title":"Abstract A001: Harnessing machine learning for the virtual screening of natural compounds as both EGFR and HER2 inhibitors in colorectal Cancer: A novel therapeutic approach","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Medicine; Cancer; Virtual screening; EGFR inhibitors; Cancer research; Bioinformatics; Internal medicine; Epidermal growth factor receptor; Biology; Drug discovery","score_opus":0.1491537711549479,"score_gpt":0.4877908820314224,"score_spread":0.3386371108764745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163832","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29853475,0.004356723,0.680507,0.0011070812,0.000250069,0.0002884839,0.0019529797,0.005869422,0.0071334164],"genre_scores_gemma":[0.8746012,0.0012052343,0.118247,0.00030630917,0.00010879936,0.00022642237,0.0024446438,0.00011419901,0.002746128],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996008,0.00015572239,0.000018397983,0.00007538045,0.00010946149,0.000040179333],"domain_scores_gemma":[0.9996773,0.00012313254,0.000042399613,0.000041596388,0.00007913408,0.000036389858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085748633,0.0010921572,0.0010927478,0.00083093013,0.00023229713,0.0008328914,0.00072161196,0.0005800505,0.0012577047],"category_scores_gemma":[0.0011234028,0.00022607087,0.0011258856,0.00069260836,0.00022510513,0.0006947327,0.00080539606,0.0009407103,0.0004445329],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002891307,0.0003276202,0.0031288567,0.00025875028,0.00034444427,0.00010685763,0.000028589317,0.8062409,0.01648453,0.0030432607,0.0038572124,0.16588984],"study_design_scores_gemma":[0.000007151762,0.0001321546,0.0002091451,0.000004921995,0.000018753984,0.000015417001,0.0000034704121,0.9958055,0.0025314754,0.00073124893,0.0005330322,0.000007617862],"about_ca_topic_score_codex":0.0016914906,"about_ca_topic_score_gemma":0.0014998057,"teacher_disagreement_score":0.0016914906,"about_ca_system_score_codex":0.00032754027,"about_ca_system_score_gemma":0.00058838585,"threshold_uncertainty_score":0.0045349},"labels":[],"label_agreement":null},{"id":"W4412163836","doi":"10.1158/1557-3265.aimachine-b044","title":"Abstract B044: Distributed Transcriptomic Modeling for Biomarker Discovery in Immuno-Oncology","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Biomarker discovery; Transcriptome; Precision oncology; Medicine; Biomarker; Computational biology; Oncology; Cancer; Biology; Internal medicine; Proteomics; Gene; Genetics; Gene expression","score_opus":0.24217793872567472,"score_gpt":0.550050595073161,"score_spread":0.3078726563474863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163836","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11294941,0.0007206762,0.8721153,0.0014049296,0.0001528999,0.00017748374,0.00398645,0.0070476406,0.0014451864],"genre_scores_gemma":[0.75533545,0.00041805313,0.23550835,0.0004053872,0.00012428197,0.00039547653,0.005231536,0.00039727017,0.0021842308],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993948,0.00021592769,0.000023892278,0.0002420345,0.0000787001,0.000044581262],"domain_scores_gemma":[0.9988422,0.0006706858,0.00009960263,0.0001489321,0.00017312942,0.00006557866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021063345,0.000891384,0.0008864428,0.0005888035,0.0004438806,0.0012052549,0.0015345527,0.00086355885,0.0021860132],"category_scores_gemma":[0.0033928312,0.00054949935,0.0016210652,0.0008990746,0.0006229565,0.000678386,0.0009928363,0.001308068,0.0005863425],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028231557,0.00009331165,0.006406969,0.00008762258,0.00019655663,0.000093501476,0.000047547022,0.96491367,0.0029229487,0.0022912498,0.0021877722,0.020476636],"study_design_scores_gemma":[0.000020825048,0.000016970977,0.0003953268,0.000002663954,0.000011287375,0.000006614776,0.0000063719567,0.9962668,0.0003936459,0.0024615487,0.00041501844,0.0000029119963],"about_ca_topic_score_codex":0.01718783,"about_ca_topic_score_gemma":0.012412656,"teacher_disagreement_score":0.01718783,"about_ca_system_score_codex":0.0011771214,"about_ca_system_score_gemma":0.001802352,"threshold_uncertainty_score":0.034175575},"labels":[],"label_agreement":null},{"id":"W4412163844","doi":"10.1158/1557-3265.aimachine-a032","title":"Abstract A032: Using machine learning to tackle tumor heterogeneity","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor heterogeneity; Cancer; Medicine; Computer science; Internal medicine","score_opus":0.1972787579798199,"score_gpt":0.5708786982592107,"score_spread":0.3735999402793908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163844","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15992956,0.0028952325,0.8154197,0.0023284766,0.0005899749,0.00027913912,0.004048239,0.0099935215,0.004516245],"genre_scores_gemma":[0.75306517,0.0004939025,0.22996368,0.0008569951,0.00059643376,0.00032842532,0.0093755815,0.0008598546,0.004459997],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.99829835,0.0007025603,0.00008579972,0.0004717183,0.00027309358,0.00016852877],"domain_scores_gemma":[0.99596536,0.0025052868,0.00027492506,0.00043965253,0.0005973962,0.00021728376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044824933,0.0015268873,0.0015900567,0.0024288197,0.0006313595,0.0019399658,0.0020450018,0.0016638024,0.0027698525],"category_scores_gemma":[0.007467433,0.0005808212,0.0020753092,0.0016025252,0.00054293376,0.0014439085,0.0017024048,0.0018195143,0.0012643514],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000639758,0.00040380773,0.02567102,0.00032841405,0.00093121664,0.00038363904,0.00010595903,0.69491893,0.004402004,0.004113094,0.017713746,0.2503884],"study_design_scores_gemma":[0.000016640342,0.000032585274,0.0006064978,0.0000072498956,0.000017429269,0.000022214615,0.0000090465155,0.99446386,0.0003015343,0.0039456473,0.00057001936,0.0000071629584],"about_ca_topic_score_codex":0.0053275363,"about_ca_topic_score_gemma":0.0039342297,"teacher_disagreement_score":0.0053275363,"about_ca_system_score_codex":0.00083530555,"about_ca_system_score_gemma":0.0012087782,"threshold_uncertainty_score":0.02370596},"labels":[],"label_agreement":null},{"id":"W4412163847","doi":"10.1158/1557-3265.aimachine-b039","title":"Abstract B039: Detecting obesity-associated histopathology characteristics in breast cancer using an AI foundation model","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Disease and Adiposity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Histopathology; Breast cancer; Medicine; Obesity; Cancer; Oncology; Pathology; Internal medicine","score_opus":0.18916254516848993,"score_gpt":0.5256313007403636,"score_spread":0.3364687555718736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163847","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74517924,0.0004744447,0.24626634,0.0009710625,0.000115723866,0.00018945339,0.0015832912,0.0015589221,0.0036615166],"genre_scores_gemma":[0.9766188,0.00006737244,0.0194952,0.00010129034,0.00003750074,0.00008519438,0.0014888907,0.000048096874,0.0020575006],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971825,0.00008156675,0.000012942131,0.000088431356,0.000037651807,0.00006113077],"domain_scores_gemma":[0.99909294,0.00048788945,0.00009786143,0.00005605749,0.00019171706,0.00007348239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010275627,0.00070329953,0.00049940863,0.0008291766,0.0003394066,0.00080660346,0.00083496614,0.00072778406,0.0018198098],"category_scores_gemma":[0.0022050196,0.0002546738,0.0010075249,0.00032174407,0.0003849394,0.0004151442,0.0007521549,0.0008599263,0.00055752206],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000875478,0.0002576465,0.056802712,0.00009097633,0.0002594563,0.00016473386,0.000098871955,0.8269324,0.0047623394,0.0020457031,0.0039631715,0.10374645],"study_design_scores_gemma":[0.0000057649627,0.00002841454,0.0020602683,0.0000036495449,0.000008869236,0.000015839043,0.00000763901,0.9971386,0.00019456612,0.00042140682,0.00011115685,0.0000038153676],"about_ca_topic_score_codex":0.01354781,"about_ca_topic_score_gemma":0.007590409,"teacher_disagreement_score":0.01354781,"about_ca_system_score_codex":0.00093600276,"about_ca_system_score_gemma":0.00079112395,"threshold_uncertainty_score":0.026937902},"labels":[],"label_agreement":null},{"id":"W4412163849","doi":"10.1158/1557-3265.aimachine-b038","title":"Abstract B038: Machine learning used to validate neutrophil classification in Triple Negative Breast Cancer patients","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Medicine; Triple-negative breast cancer; Breast cancer; Triple negative; Oncology; Internal medicine","score_opus":0.19228561539028818,"score_gpt":0.5138475830742069,"score_spread":0.32156196768391865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163849","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92673504,0.0023013784,0.031927243,0.0015212124,0.00034340506,0.00042637406,0.027964342,0.003630444,0.0051505994],"genre_scores_gemma":[0.9497202,0.00027782388,0.022938512,0.00045408684,0.00011140039,0.0003796877,0.0240557,0.00014321225,0.0019194717],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99900347,0.0003012425,0.00010352703,0.00030397918,0.00018701503,0.00010088551],"domain_scores_gemma":[0.99805486,0.0008541423,0.00022505884,0.00015241175,0.00052733585,0.00018621095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020053163,0.0007058309,0.00065394986,0.0017941368,0.00041866335,0.0010745815,0.00070033624,0.0009884998,0.004403423],"category_scores_gemma":[0.005937854,0.0001508695,0.00054490333,0.0007176279,0.00023912876,0.00032729618,0.00070138794,0.00091237423,0.0026366261],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003812003,0.00088799413,0.6691337,0.00060395175,0.00061325025,0.00056164584,0.00019979992,0.025090225,0.020354725,0.0006953918,0.03820186,0.23984545],"study_design_scores_gemma":[0.0004009206,0.0020346646,0.28667963,0.00040556048,0.00045430232,0.0016699779,0.0005451561,0.64906645,0.034017503,0.003651472,0.020970354,0.00010401331],"about_ca_topic_score_codex":0.0027385382,"about_ca_topic_score_gemma":0.0024639901,"teacher_disagreement_score":0.004403423,"about_ca_system_score_codex":0.00049510936,"about_ca_system_score_gemma":0.00060409907,"threshold_uncertainty_score":0.014730871},"labels":[],"label_agreement":null},{"id":"W4412163851","doi":"10.1158/1557-3265.aimachine-a011","title":"Abstract A011: Interpretable machine learning for discovery, evaluation and clinical translation of context-specific dependencies","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Machine Learning in Healthcare","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Inro Consultants (Canada); Roche (Canada)","funders":"","keywords":"Context (archaeology); Translation (biology); Artificial intelligence; Computer science; Natural language processing; Machine learning; Medicine; Biology","score_opus":0.33467449982982905,"score_gpt":0.5760950646150794,"score_spread":0.24142056478525037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163851","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0444478,0.0006707535,0.93789357,0.001288419,0.0001460564,0.00018990882,0.0026378995,0.011165214,0.0015604218],"genre_scores_gemma":[0.6432662,0.00041375845,0.34855443,0.0004773974,0.00010940519,0.0004863513,0.0040362566,0.0009364077,0.0017197751],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986518,0.00078509067,0.00006518659,0.00023933503,0.00020968249,0.000048894257],"domain_scores_gemma":[0.9951533,0.0035524385,0.00030028675,0.00044602517,0.0003941827,0.00015372042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036838131,0.000998111,0.0006651883,0.0009982004,0.00023857741,0.0010577706,0.0011937846,0.0008853189,0.0052507804],"category_scores_gemma":[0.013297073,0.00035524773,0.0010096687,0.0005128151,0.00051831163,0.00067413424,0.0011289346,0.001511746,0.0008576449],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012911656,0.00031576547,0.012223253,0.0004337689,0.00039158648,0.00048521982,0.0001006134,0.6753435,0.008158025,0.014798856,0.021838231,0.26462004],"study_design_scores_gemma":[0.000038727427,0.00009110998,0.00039610695,0.00001717261,0.000017550263,0.0000528129,0.0000052273103,0.9872398,0.0014822922,0.0096216835,0.0010288318,0.000008721964],"about_ca_topic_score_codex":0.0022214158,"about_ca_topic_score_gemma":0.0026894098,"teacher_disagreement_score":0.0052507804,"about_ca_system_score_codex":0.00070010935,"about_ca_system_score_gemma":0.0010183651,"threshold_uncertainty_score":0.019482136},"labels":[],"label_agreement":null},{"id":"W4412163852","doi":"10.1158/1557-3265.aimachine-a054","title":"Abstract A054: Multimodal LLM-Driven Intervention for Precision Risk Prediction in Lung Cancer Surgery","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lung cancer; Intervention (counseling); Cancer; Surgery; Oncology; Internal medicine; Nursing","score_opus":0.11368957863770339,"score_gpt":0.5594096166642134,"score_spread":0.44572003802651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163852","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16088781,0.00100554,0.80774736,0.004439279,0.00023728992,0.00025974106,0.0030850149,0.017925262,0.0044127605],"genre_scores_gemma":[0.82096153,0.00022517682,0.17337912,0.0005997281,0.00006708471,0.00028340172,0.001835596,0.0003445498,0.002303916],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.99936837,0.00028582057,0.000039094,0.00015859005,0.00010027974,0.000047828085],"domain_scores_gemma":[0.99836415,0.0010642991,0.00016417251,0.00014390913,0.0001754387,0.000088103625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017102577,0.0008340592,0.00041556763,0.0005628861,0.00027209416,0.0009378336,0.0010376272,0.0009084313,0.004537206],"category_scores_gemma":[0.0072923047,0.00032602245,0.00072496565,0.00023400079,0.0005315046,0.0010450016,0.0017393212,0.0011602604,0.00091642153],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008767083,0.0004148067,0.020935949,0.00038405886,0.0001644401,0.00047245406,0.000588625,0.6276889,0.010588769,0.0059528355,0.014119305,0.3178132],"study_design_scores_gemma":[0.000023242159,0.000072467396,0.0006148519,0.000021733771,0.000018712397,0.00004196836,0.000023819304,0.99065757,0.0027323428,0.0043944772,0.0013839671,0.000014859584],"about_ca_topic_score_codex":0.004912144,"about_ca_topic_score_gemma":0.005466461,"teacher_disagreement_score":0.004912144,"about_ca_system_score_codex":0.0011809089,"about_ca_system_score_gemma":0.0014253977,"threshold_uncertainty_score":0.015178442},"labels":[],"label_agreement":null},{"id":"W4412163853","doi":"10.1158/1557-3265.aimachine-b034","title":"Abstract B034: Decoding the Leukocyte Effect: How Cell Retention Shapes ML Outcomes in Platelet RNA-based Cancer Detection","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Platelet; Medicine; Cell; RNA; Decoding methods; Cancer detection; Cancer research; Immunology; Biology; Internal medicine; Biochemistry; Computer science; Gene; Algorithm","score_opus":0.08066441607132022,"score_gpt":0.4593110553046897,"score_spread":0.3786466392333695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163853","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8916243,0.0036893052,0.08461875,0.0028460214,0.00026801875,0.000115941766,0.010615932,0.0017636715,0.004458023],"genre_scores_gemma":[0.9776593,0.00041163104,0.012906282,0.0005509309,0.00013220675,0.000104958744,0.0064763715,0.00013156468,0.0016267931],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991709,0.00035223205,0.00004201924,0.0002469137,0.00009804638,0.000089940935],"domain_scores_gemma":[0.9975955,0.0015141251,0.0002253942,0.00018582409,0.00033413392,0.00014504798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026176574,0.0006986484,0.0006503295,0.0007466713,0.00043170867,0.0014746808,0.0007938827,0.0010273522,0.0029544595],"category_scores_gemma":[0.008133545,0.000186836,0.0006889399,0.0006121971,0.00042939957,0.00062123203,0.0007321007,0.0011945775,0.0018224065],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035919936,0.00044662278,0.6352136,0.000669893,0.00087729463,0.00036001953,0.00037915376,0.07141111,0.065913305,0.0018717519,0.02167478,0.1975905],"study_design_scores_gemma":[0.00016619726,0.00078901916,0.17576846,0.00017887318,0.0005403666,0.0004631485,0.00036242272,0.76329345,0.041410152,0.008101638,0.008799821,0.00012650833],"about_ca_topic_score_codex":0.004903665,"about_ca_topic_score_gemma":0.004555355,"teacher_disagreement_score":0.004903665,"about_ca_system_score_codex":0.00052254024,"about_ca_system_score_gemma":0.00085507287,"threshold_uncertainty_score":0.013843656},"labels":[],"label_agreement":null},{"id":"W4412163854","doi":"10.1158/1557-3265.aimachine-a013","title":"Abstract A013: Facilitating AI-Based Hit Discovery through the Development of the AIRCHECK Platform","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Medical Imaging and Analysis","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; Structural Genomics Consortium","funders":"","keywords":"Medicine; Computer science","score_opus":0.22016094514071274,"score_gpt":0.506431172155065,"score_spread":0.28627022701435223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163854","genre_codex":"software","genre_gemma":"software","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"software","genre_consensus":"software","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03551462,0.0031289826,0.21569318,0.0043070256,0.001443001,0.0012991796,0.22125416,0.47574353,0.041616354],"genre_scores_gemma":[0.146015,0.002137206,0.29061943,0.0024394558,0.000450349,0.0014401508,0.5336979,0.013034757,0.01016567],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959591,0.000660563,0.00039149192,0.0010212965,0.0016967356,0.00027085107],"domain_scores_gemma":[0.9909781,0.0032379497,0.00059227634,0.0028579193,0.0015315522,0.0008021263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053906287,0.0017299759,0.0011910172,0.0038592168,0.0008895488,0.0049850782,0.00501397,0.0017594309,0.025603965],"category_scores_gemma":[0.015257252,0.0008040809,0.0021966372,0.0025150068,0.0010469337,0.0063060164,0.0062101022,0.0030953076,0.015808973],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047046733,0.0012105195,0.011396602,0.0039315727,0.0007176955,0.0009846574,0.00050932413,0.052126393,0.026021894,0.04426927,0.60769075,0.24643667],"study_design_scores_gemma":[0.0012266212,0.0008807705,0.0069247843,0.0005447414,0.0003055106,0.0005323834,0.00024288744,0.3144096,0.037384793,0.059216693,0.5779191,0.00041204697],"about_ca_topic_score_codex":0.006116641,"about_ca_topic_score_gemma":0.00561791,"teacher_disagreement_score":0.025603965,"about_ca_system_score_codex":0.0013422372,"about_ca_system_score_gemma":0.0036324093,"threshold_uncertainty_score":0.08565384},"labels":[],"label_agreement":null},{"id":"W4412163855","doi":"10.1158/1557-3265.aimachine-a004","title":"Abstract A004: Integrating high-throughput screening with ligand-based pharmacophore modeling and virtual screening strategies to optimize exonuclease 1 inhibitor design","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced biosensing and bioanalysis techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacophore; Virtual screening; Ligand (biochemistry); High-throughput screening; Computational biology; Throughput; Combinatorial chemistry; Computer science; Exonuclease; Pharmacology; Medicine; Chemistry; Biology; Bioinformatics; Biochemistry; DNA; Receptor; Polymerase","score_opus":0.12163549211423999,"score_gpt":0.471039321416599,"score_spread":0.349403829302359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163855","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47809666,0.0011191203,0.5004539,0.0010306875,0.00008450721,0.00074250513,0.0018675035,0.005848072,0.010757062],"genre_scores_gemma":[0.801788,0.0006348761,0.19382139,0.00015728468,0.000016255539,0.00038686697,0.001064579,0.0001894198,0.0019414196],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994795,0.00021824139,0.000023079028,0.000049292812,0.00019374523,0.00003619042],"domain_scores_gemma":[0.9996711,0.0001673125,0.000039815008,0.000025055657,0.00006804997,0.000028734617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014627798,0.0011973891,0.0011281709,0.0006666792,0.0003766343,0.0014031155,0.000999357,0.0006142568,0.0023234675],"category_scores_gemma":[0.0011374967,0.00041751296,0.00085900124,0.0006034077,0.000300947,0.0007339816,0.0006519243,0.00071224576,0.0004792086],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054843555,0.0009075867,0.0025428592,0.00018970532,0.00021780125,0.00021882121,0.0000464638,0.8234364,0.10325243,0.004705111,0.0021038926,0.061830517],"study_design_scores_gemma":[0.0000870978,0.00030425756,0.00043221598,0.000003975433,0.00004056709,0.000026239612,0.000011583107,0.96779174,0.029566808,0.00083901,0.00088021543,0.000016218522],"about_ca_topic_score_codex":0.0031644143,"about_ca_topic_score_gemma":0.0031578601,"teacher_disagreement_score":0.0031644143,"about_ca_system_score_codex":0.0011144344,"about_ca_system_score_gemma":0.0011285524,"threshold_uncertainty_score":0.008085787},"labels":[],"label_agreement":null},{"id":"W4412163856","doi":"10.1158/1557-3265.aimachine-b014","title":"Abstract B014: Are histopathology foundation models clinically ready for survival prediction?","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Histopathology; Medicine; Foundation (evidence); Pathology; History","score_opus":0.3062119964964399,"score_gpt":0.5841844480305458,"score_spread":0.27797245153410594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163856","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5905478,0.0073431307,0.34566814,0.0125170285,0.0009363625,0.00032332522,0.018543327,0.011445792,0.01267513],"genre_scores_gemma":[0.9504026,0.00072643755,0.034069084,0.00075347535,0.00026341295,0.00012011497,0.010332126,0.00041748094,0.002915272],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99927634,0.00026979583,0.00003112047,0.00023145956,0.000121634344,0.0000696881],"domain_scores_gemma":[0.9968899,0.0017870947,0.0002532718,0.00041508657,0.0004529919,0.00020162803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003024585,0.0010160857,0.00069834915,0.0007383673,0.00027973158,0.0012235583,0.0014462328,0.0009162788,0.0043552117],"category_scores_gemma":[0.0122555075,0.00031241708,0.0009019352,0.00048289483,0.00048199992,0.0013023764,0.0009767988,0.0017609886,0.002215194],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019244888,0.00028564368,0.14407365,0.0006253301,0.0006636422,0.00039917597,0.00021336539,0.34331653,0.0064609647,0.005910733,0.07792903,0.41819748],"study_design_scores_gemma":[0.00008168648,0.0003005102,0.011962964,0.00012768139,0.00011862777,0.00024142758,0.000101903715,0.96493584,0.0026947532,0.0127942795,0.006608864,0.000031420044],"about_ca_topic_score_codex":0.009175946,"about_ca_topic_score_gemma":0.011040299,"teacher_disagreement_score":0.009175946,"about_ca_system_score_codex":0.00093112653,"about_ca_system_score_gemma":0.0012900758,"threshold_uncertainty_score":0.018245101},"labels":[],"label_agreement":null},{"id":"W4412163857","doi":"10.1158/1557-3265.aimachine-b012","title":"Abstract B012: Prompting Large Language Models to Predict Adverse Events during Cancer Treatment","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Artificial Intelligence in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Adverse effect; Cancer; Medicine; Intensive care medicine; Oncology; Internal medicine","score_opus":0.5986622321742983,"score_gpt":0.6997175649584702,"score_spread":0.10105533278417189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163857","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77315384,0.0016272388,0.17498203,0.005450069,0.000610004,0.0006018365,0.015076464,0.023611153,0.004887444],"genre_scores_gemma":[0.93585134,0.00020716443,0.051991884,0.00060422486,0.00016829955,0.0002325111,0.009001084,0.00017036185,0.0017732139],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.99837035,0.00096116855,0.00012614757,0.0003366461,0.000121231315,0.000084474],"domain_scores_gemma":[0.9857555,0.011750119,0.00063181453,0.00056092156,0.0009625572,0.00033901873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005265129,0.0013098969,0.0006336144,0.0010063641,0.00029225476,0.0010662691,0.0011039118,0.001022434,0.0043601976],"category_scores_gemma":[0.017168604,0.0003452532,0.0012150869,0.0004700058,0.00023706727,0.001106214,0.001000768,0.0015431291,0.0014371141],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041768216,0.0015213426,0.11705474,0.0006228626,0.0007051069,0.00045200382,0.00032649192,0.50250274,0.0038306848,0.0013661438,0.028087767,0.33935338],"study_design_scores_gemma":[0.00012281974,0.0004263897,0.004885744,0.000046083635,0.0000812482,0.000046053665,0.00005288989,0.9897432,0.0015614629,0.0017837704,0.0012209683,0.000029323282],"about_ca_topic_score_codex":0.0094769085,"about_ca_topic_score_gemma":0.008180165,"teacher_disagreement_score":0.0094769085,"about_ca_system_score_codex":0.0011024078,"about_ca_system_score_gemma":0.0015460507,"threshold_uncertainty_score":0.027845025},"labels":[],"label_agreement":null},{"id":"W4412163859","doi":"10.1158/1557-3265.aimachine-ia01","title":"Abstract IA01: The impact of bringing complex data to the point of care","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Medical Coding and Health Information","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Point of care; Intensive care medicine; Data science; Computer science; Nursing","score_opus":0.9087592362411606,"score_gpt":0.7781554849029165,"score_spread":0.1306037513382441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163859","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004730259,0.01014363,0.0039484138,0.9040545,0.0107461605,0.00011572728,0.0044311616,0.0005073533,0.061322723],"genre_scores_gemma":[0.4601607,0.0636673,0.05266551,0.3167611,0.034097873,0.000738999,0.012198507,0.001883515,0.05782657],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9376585,0.039840695,0.0024707883,0.0018691246,0.016711708,0.0014491006],"domain_scores_gemma":[0.61750007,0.27168489,0.0123547595,0.017529778,0.06342526,0.017505229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.064394295,0.00066315325,0.0007889821,0.0044126366,0.0031184694,0.015180485,0.0026255257,0.00406626,0.05280918],"category_scores_gemma":[0.325405,0.0005441233,0.0016654396,0.0064038937,0.004014703,0.0076056933,0.008678393,0.008851872,0.007281553],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023677033,0.00008906713,0.007426485,0.00081109494,0.00008869975,0.0001423643,0.0007146535,0.000813327,0.00018361934,0.037704747,0.71951795,0.23227125],"study_design_scores_gemma":[0.00017847032,0.0003296535,0.030122694,0.007335554,0.0002983752,0.00046469265,0.004957365,0.0031004725,0.0011503043,0.09340874,0.85846716,0.00018657673],"about_ca_topic_score_codex":0.03703953,"about_ca_topic_score_gemma":0.033850405,"teacher_disagreement_score":0.064394295,"about_ca_system_score_codex":0.012214206,"about_ca_system_score_gemma":0.022112643,"threshold_uncertainty_score":0.34055364},"labels":[],"label_agreement":null},{"id":"W4412163863","doi":"10.1158/1557-3265.aimachine-ia03","title":"Abstract IA03: Accelerating oncology drug discovery with the power of microscopy &amp; AI","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell Image Analysis Techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Drug discovery; Drug; Internal medicine; Oncology; Pharmacology; Bioinformatics; Biology","score_opus":0.0785102391528594,"score_gpt":0.5303171162217778,"score_spread":0.4518068770689184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163863","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0143927345,0.03543671,0.21246262,0.08679335,0.012519987,0.0018051903,0.055102002,0.14712502,0.43436235],"genre_scores_gemma":[0.14100242,0.025008071,0.46665126,0.02675461,0.0079122465,0.0016143221,0.06756506,0.0072055776,0.25628638],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969939,0.0007318874,0.00011715291,0.00028868922,0.0016601246,0.00020820173],"domain_scores_gemma":[0.99317956,0.001171955,0.00040603743,0.0008872234,0.0029650803,0.0013901525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051438822,0.0010594659,0.0011133447,0.0034339812,0.0007183823,0.0047985814,0.0025114443,0.0015701783,0.07519286],"category_scores_gemma":[0.0070933886,0.0005285267,0.00073680823,0.0024077776,0.0007639927,0.0022219033,0.0026278808,0.0030942585,0.036592294],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000194842,0.00009685955,0.00058775157,0.00027173612,0.00003142495,0.000051459334,0.000025858728,0.0007664125,0.009449281,0.0075262086,0.73188573,0.24911244],"study_design_scores_gemma":[0.00023087811,0.00029593505,0.0027122102,0.00018082953,0.000061348444,0.00029987466,0.000042239022,0.016391333,0.022540454,0.011407256,0.94576347,0.00007421293],"about_ca_topic_score_codex":0.0066099805,"about_ca_topic_score_gemma":0.0067647444,"teacher_disagreement_score":0.07519286,"about_ca_system_score_codex":0.003905578,"about_ca_system_score_gemma":0.0034038126,"threshold_uncertainty_score":0.2515452},"labels":[],"label_agreement":null},{"id":"W4412163864","doi":"10.1158/1557-3265.aimachine-b026","title":"Abstract B026: Artificial Intelligence Apps for Medical Image Analysis using pyCERR and Cancer Genomics Cloud","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cloud computing; Genomics; Cancer; Computer science; Data science; Medicine; Computational biology; World Wide Web; Biology; Genome; Genetics; Internal medicine; Operating system; Gene","score_opus":0.21203693097384477,"score_gpt":0.588695933687648,"score_spread":0.37665900271380326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163864","genre_codex":"software","genre_gemma":"software","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"software","genre_consensus":"software","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01100885,0.0008882445,0.37271243,0.0014467106,0.0003134815,0.0011475395,0.016925082,0.5740446,0.021513036],"genre_scores_gemma":[0.21978442,0.0022487543,0.5609128,0.0033260263,0.00043977716,0.0028805432,0.09492843,0.08651605,0.028963165],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99879587,0.00017671511,0.00009462433,0.0002729112,0.0004960344,0.00016384097],"domain_scores_gemma":[0.99842095,0.00038945343,0.000112107184,0.00038767172,0.0004003758,0.00028938847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018609673,0.0014891033,0.00091662677,0.0012686875,0.000492779,0.0024096773,0.0029100662,0.00072628784,0.02499327],"category_scores_gemma":[0.0046250047,0.0006591138,0.0016158873,0.00083149446,0.00055624923,0.0019728304,0.0036147216,0.0016118286,0.017951164],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024113953,0.0006078799,0.010891521,0.0020342872,0.00044170988,0.001491073,0.001032846,0.02224518,0.025104558,0.033541035,0.59071964,0.30947885],"study_design_scores_gemma":[0.00068308966,0.0002782471,0.013893271,0.0005463709,0.0001504138,0.0012418634,0.0002434677,0.35183826,0.048085764,0.043194212,0.5394749,0.00037009447],"about_ca_topic_score_codex":0.003675356,"about_ca_topic_score_gemma":0.0035624802,"teacher_disagreement_score":0.02499327,"about_ca_system_score_codex":0.0008319062,"about_ca_system_score_gemma":0.0016783888,"threshold_uncertainty_score":0.08361083},"labels":[],"label_agreement":null},{"id":"W4412163866","doi":"10.1158/1557-3265.aimachine-b032","title":"Abstract B032: Generative modeling (AI) for the analysis of Single-Cell RNA-seq data of radioresistant malignant pediatric brain tumors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Radioresistance; RNA-Seq; Medicine; Computational biology; Pathology; Cancer research; Biology; Internal medicine; Gene expression; Transcriptome; Radiation therapy; Genetics; Gene","score_opus":0.2566648837387934,"score_gpt":0.47246699489415556,"score_spread":0.21580211115536213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163866","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12400778,0.0005747419,0.8641038,0.00055457535,0.00011111765,0.00010901616,0.0031234843,0.006116069,0.0012994768],"genre_scores_gemma":[0.69322485,0.00043266575,0.29106212,0.00054433395,0.000071044415,0.0004880863,0.009712436,0.0010012331,0.0034631663],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996629,0.00011983672,0.000014397565,0.00011878298,0.000056530356,0.000027644655],"domain_scores_gemma":[0.9989066,0.00083534856,0.000056682184,0.0000685355,0.000092518196,0.00004024401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014419552,0.00080623385,0.000528398,0.000568838,0.0002953694,0.00074349315,0.001135052,0.0012359486,0.001883609],"category_scores_gemma":[0.0024996817,0.00051268627,0.0016130805,0.0005043247,0.0005161852,0.00037832005,0.0006306048,0.001544874,0.00057737145],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012058418,0.000056496032,0.0022846702,0.00009664359,0.0001285187,0.00008972865,0.000076633136,0.96989113,0.009290243,0.0020793127,0.0010625834,0.014823462],"study_design_scores_gemma":[0.0000030009382,0.000009052341,0.00018978465,0.0000022002769,0.0000038142155,0.000009770846,0.0000037782725,0.9975337,0.0010875392,0.0009091433,0.00024314605,0.0000050340777],"about_ca_topic_score_codex":0.00806248,"about_ca_topic_score_gemma":0.0085976655,"teacher_disagreement_score":0.00806248,"about_ca_system_score_codex":0.00083578925,"about_ca_system_score_gemma":0.00064087776,"threshold_uncertainty_score":0.016031086},"labels":[],"label_agreement":null},{"id":"W4412163867","doi":"10.1158/1557-3265.aimachine-a024","title":"Abstract A024: AI-Integrated Framework for Predicting ADME and Toxicological Profiles: A Hybrid Data- and Physics-Driven Approach","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"ADME; Computer science; Computational biology; Medicine; Pharmacology; Biology; Pharmacokinetics","score_opus":0.26691127914115126,"score_gpt":0.5244278441977622,"score_spread":0.25751656505661097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163867","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019908769,0.00041548477,0.97045004,0.0004195427,0.00007410614,0.00011228615,0.0010108714,0.0046041734,0.0030047284],"genre_scores_gemma":[0.54347116,0.00053582835,0.44507977,0.0005633257,0.0001938008,0.00053929444,0.0028901596,0.00045506487,0.006271588],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973243,0.0000526141,0.000015077945,0.00006620594,0.00010667131,0.000026920132],"domain_scores_gemma":[0.999491,0.00022537752,0.000043478653,0.00004020642,0.00015629559,0.00004364399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000957204,0.0010399711,0.00078486075,0.0012069334,0.0002964202,0.0011644484,0.0017878049,0.0014138166,0.0037947223],"category_scores_gemma":[0.0018118384,0.00043844766,0.0012715153,0.0006280416,0.00042094442,0.0007259283,0.00095794717,0.0011345164,0.0009158576],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007254227,0.00011012273,0.0010811453,0.00008458095,0.00007953696,0.00009334566,0.000016949003,0.9537868,0.0025962584,0.003190877,0.002113186,0.03677482],"study_design_scores_gemma":[0.0000031897214,0.000009573632,0.00004645474,0.0000029354644,0.000003627716,0.0000063278208,0.0000010924265,0.99842936,0.000297662,0.0008571517,0.00034011056,0.0000025578313],"about_ca_topic_score_codex":0.012064676,"about_ca_topic_score_gemma":0.00847621,"teacher_disagreement_score":0.012064676,"about_ca_system_score_codex":0.0007833697,"about_ca_system_score_gemma":0.0017755681,"threshold_uncertainty_score":0.023988903},"labels":[],"label_agreement":null},{"id":"W4412163869","doi":"10.1158/1557-3265.aimachine-b037","title":"Abstract B037: AI-powered virtual tissues from spatial proteomics for clinical diagnostics and biomedical discovery","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Proteomics; Computational biology; Medicine; Data science; Computer science; Biology","score_opus":0.5421546771818586,"score_gpt":0.6767384420996166,"score_spread":0.13458376491775803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163869","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020068085,0.00069291116,0.96296436,0.0023448966,0.000247755,0.00015183311,0.0019281375,0.004905713,0.0066962624],"genre_scores_gemma":[0.4702757,0.001045783,0.5085891,0.0010873707,0.00026147143,0.00047505816,0.004828666,0.00076027645,0.012676702],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991854,0.00035714946,0.000039975504,0.00013763635,0.00022289935,0.000056965746],"domain_scores_gemma":[0.99775,0.0009841268,0.0001835708,0.0005512124,0.00030463608,0.00022653403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031655154,0.0006864697,0.00066331605,0.0010832543,0.0003321388,0.0019019825,0.0017180379,0.00086900586,0.0063962284],"category_scores_gemma":[0.0059086876,0.0004890698,0.0013138471,0.0008240168,0.0010659015,0.001715756,0.0028619028,0.0014640675,0.002275273],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010335394,0.00020261227,0.007285427,0.00065403327,0.0003538492,0.00055556203,0.0003766847,0.3794835,0.033890877,0.14975919,0.05191536,0.37448934],"study_design_scores_gemma":[0.00005637962,0.00011995987,0.0009315128,0.000041601466,0.00004202387,0.00021438538,0.000047047535,0.84460795,0.0093211485,0.12522608,0.019357817,0.000034055956],"about_ca_topic_score_codex":0.0024835356,"about_ca_topic_score_gemma":0.0042298757,"teacher_disagreement_score":0.0063962284,"about_ca_system_score_codex":0.0012549404,"about_ca_system_score_gemma":0.0022411987,"threshold_uncertainty_score":0.021397531},"labels":[],"label_agreement":null},{"id":"W4412163871","doi":"10.1158/1557-3265.aimachine-b033","title":"Abstract B033: Identifying triple-negative breast cancer patients at high risk of worse prognosis using molecular features derived from histology images","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Histology; Medicine; Breast cancer; Triple-negative breast cancer; Cancer; Triple negative; Pathology; Oncology; Internal medicine","score_opus":0.06299291689022113,"score_gpt":0.4667548794082291,"score_spread":0.40376196251800794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97730654,0.00031189068,0.01798982,0.0002344559,0.00002804875,0.00006945589,0.0025666144,0.00050700246,0.0009862521],"genre_scores_gemma":[0.9797838,0.00012061892,0.0150707755,0.00003362589,0.00002049838,0.000035968747,0.0039953273,0.000034532335,0.00090481015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998907,0.000022238431,0.0000069807897,0.00003934531,0.00001831193,0.00002227133],"domain_scores_gemma":[0.99981326,0.0000443669,0.000033854332,0.00001608529,0.00005984949,0.00003258631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032214614,0.00053356186,0.00037056106,0.0015056088,0.00018356547,0.0005785332,0.0003639171,0.0005013621,0.0016425255],"category_scores_gemma":[0.0007096704,0.00014894383,0.0004883694,0.00052232464,0.00011605051,0.00025973486,0.00034450964,0.00024601296,0.0006366288],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029317115,0.0005582791,0.5898395,0.00028796922,0.00044262348,0.0011345142,0.00020201509,0.054976225,0.10062392,0.00068794866,0.008002217,0.24031311],"study_design_scores_gemma":[0.000050041643,0.00041774192,0.31227532,0.00003059994,0.00022562196,0.0008630891,0.0002907213,0.6671454,0.015470316,0.0011115223,0.0020828347,0.000036744237],"about_ca_topic_score_codex":0.009339892,"about_ca_topic_score_gemma":0.010983213,"teacher_disagreement_score":0.009339892,"about_ca_system_score_codex":0.00044173375,"about_ca_system_score_gemma":0.0003566548,"threshold_uncertainty_score":0.018571079},"labels":[],"label_agreement":null},{"id":"W4412163872","doi":"10.1158/1557-3265.aimachine-a022","title":"Abstract A022: Deep Learning Meets Transcriptomics: CNN-1D Powered Interpretation of probe based transcriptome array in Prostate Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transcriptome; Prostate cancer; Artificial intelligence; Interpretation (philosophy); Computational biology; Deep learning; Computer science; Cancer; Biology; Medicine; Bioinformatics; Internal medicine; Gene expression; Gene; Genetics","score_opus":0.046700899971770134,"score_gpt":0.45865300075473747,"score_spread":0.41195210078296735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163872","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18890734,0.0012015669,0.78637904,0.002070672,0.0002567209,0.00013782727,0.004027197,0.010289821,0.0067297653],"genre_scores_gemma":[0.78026885,0.0005228856,0.20820442,0.00066177273,0.0000720834,0.00020033043,0.0035203004,0.0004540652,0.0060951724],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983287,0.000036579386,0.0000055300397,0.00005236543,0.000048913582,0.000023750235],"domain_scores_gemma":[0.99979013,0.000089473106,0.000019967614,0.000030296995,0.000049679038,0.00002044045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005789409,0.00077214226,0.00032189256,0.00042401085,0.00018654425,0.0007477276,0.0009105904,0.0006812042,0.0025755481],"category_scores_gemma":[0.0013489197,0.00033278126,0.00069978886,0.0003564855,0.00031910895,0.0004350162,0.00063727476,0.00078551355,0.00060302735],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038281505,0.00014184164,0.007905646,0.0002309988,0.00015686294,0.0003512838,0.000081551196,0.72878176,0.0630994,0.0060111787,0.012090997,0.18076572],"study_design_scores_gemma":[0.0000045226507,0.00001676866,0.00050184864,0.0000048387687,0.0000054504953,0.000020254969,0.000005443239,0.9931083,0.004381939,0.0012743828,0.0006703112,0.0000058910646],"about_ca_topic_score_codex":0.009993618,"about_ca_topic_score_gemma":0.010201184,"teacher_disagreement_score":0.009993618,"about_ca_system_score_codex":0.000947077,"about_ca_system_score_gemma":0.0009395727,"threshold_uncertainty_score":0.019870877},"labels":[],"label_agreement":null},{"id":"W4412163873","doi":"10.1158/1557-3265.aimachine-b036","title":"Abstract B036: Machine learning-based and marker-based combined strategy for circulating tumor cells candidates' detection","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Circulating tumor cell; Tumor cells; Cancer; Medicine; Computer science; Cancer research; Artificial intelligence; Computational biology; Internal medicine; Biology; Metastasis","score_opus":0.0928434296276607,"score_gpt":0.4815294511441824,"score_spread":0.38868602151652165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163873","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21014708,0.0025471968,0.76426005,0.001558046,0.00039567295,0.0005651356,0.0046673897,0.011964726,0.0038946487],"genre_scores_gemma":[0.630744,0.0005324976,0.34756878,0.00084414805,0.00030172197,0.00067298143,0.012288029,0.0004806083,0.0065671857],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99868697,0.00044451124,0.0000782028,0.00037543284,0.00026092495,0.00015394292],"domain_scores_gemma":[0.99850357,0.00062487577,0.00008824948,0.00017357884,0.00046016474,0.00014966684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002604301,0.0018587223,0.0019744881,0.0015294993,0.0005408819,0.0012624045,0.0020197711,0.0017369417,0.003552131],"category_scores_gemma":[0.003792194,0.00046207936,0.0017005218,0.0009813813,0.00034588887,0.00088109775,0.0013369266,0.001771253,0.002485942],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019021047,0.0012996288,0.03595313,0.0005060337,0.0007949595,0.00063782954,0.0001451316,0.33960032,0.06595381,0.0024686528,0.024203394,0.52653503],"study_design_scores_gemma":[0.00003360461,0.00014038009,0.0014855748,0.000010629141,0.000050791412,0.00005698272,0.000012099171,0.98982006,0.006024757,0.00081936806,0.0015283866,0.000017298995],"about_ca_topic_score_codex":0.0055429474,"about_ca_topic_score_gemma":0.0049280985,"teacher_disagreement_score":0.0055429474,"about_ca_system_score_codex":0.00071860035,"about_ca_system_score_gemma":0.0014353831,"threshold_uncertainty_score":0.013773024},"labels":[],"label_agreement":null},{"id":"W4412163875","doi":"10.1158/1557-3265.aimachine-a058","title":"Abstract A058: Multimodal generative AI jointly learns pathology and clinical data to synthesize a multinational lung cancer cohort","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"AI in cancer detection","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung cancer; Cohort; Cancer; Medicine; Multinational corporation; Pathology; Generative grammar; Computer science; Artificial intelligence; Internal medicine; Business","score_opus":0.2597887378410895,"score_gpt":0.5770479330291616,"score_spread":0.31725919518807205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54272276,0.00033691394,0.44563004,0.0015037757,0.00015448112,0.00022946083,0.004824112,0.002267829,0.00233063],"genre_scores_gemma":[0.93470824,0.000069040776,0.057612423,0.00025487185,0.000053877215,0.00017809715,0.004672716,0.000117030766,0.0023336068],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99961543,0.00020844223,0.00001214408,0.00011186674,0.00002526799,0.000026866383],"domain_scores_gemma":[0.99809116,0.0012855661,0.00012202468,0.0002540655,0.00014808717,0.00009902434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028684938,0.0005272725,0.00034148234,0.0004961352,0.00021997478,0.0005060551,0.000913341,0.00071124797,0.0033762613],"category_scores_gemma":[0.0049697235,0.00030339308,0.0010566199,0.00030914045,0.00042953447,0.00032886508,0.00086599676,0.0010975458,0.00052549446],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005108277,0.00014676494,0.03302641,0.00006830211,0.00026905176,0.00019892058,0.00015105223,0.8999997,0.002735663,0.003676581,0.004218774,0.05499793],"study_design_scores_gemma":[0.000021386217,0.000051979587,0.00219111,0.0000089931755,0.000013205088,0.000034430243,0.000018489862,0.99456257,0.0006719791,0.0018721415,0.00054465776,0.000009130008],"about_ca_topic_score_codex":0.007864486,"about_ca_topic_score_gemma":0.007653338,"teacher_disagreement_score":0.007864486,"about_ca_system_score_codex":0.00074010063,"about_ca_system_score_gemma":0.0006491137,"threshold_uncertainty_score":0.015637398},"labels":[],"label_agreement":null},{"id":"W4412163877","doi":"10.1158/1557-3265.aimachine-pr-03","title":"Abstract PR-03 Inferring genomic properties and histologic subtypes of solid tumors from H&amp;E whole-slide images","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pathology; Medicine; Cancer research; Computational biology; Biology","score_opus":0.19351091864998232,"score_gpt":0.4968909905268948,"score_spread":0.30338007187691246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6688961,0.0009818589,0.2245478,0.00088113,0.00011774629,0.00032017386,0.0701124,0.024120696,0.010022059],"genre_scores_gemma":[0.8556513,0.00021976377,0.07632284,0.00020074454,0.000030050016,0.00014133926,0.06261559,0.000520378,0.0042979447],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9996063,0.00006971643,0.00001903932,0.00019125918,0.00008139157,0.000032234537],"domain_scores_gemma":[0.99915254,0.00039398784,0.000086570755,0.00017173258,0.000153373,0.000041690328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010530163,0.00062634435,0.00027709734,0.0010841137,0.00017651964,0.00079936907,0.0005809532,0.00048089324,0.0050081285],"category_scores_gemma":[0.0027527642,0.00025823826,0.0009217247,0.0005143424,0.0002542526,0.00046393657,0.00055344973,0.0005127374,0.0018749848],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011822035,0.00028517816,0.38011867,0.00074275665,0.0008392838,0.0007832485,0.00024704766,0.26422277,0.0325365,0.002793876,0.04477439,0.27147406],"study_design_scores_gemma":[0.00006535347,0.00018454067,0.054689303,0.00004947226,0.000100595156,0.00055118,0.00012223162,0.9125831,0.015620787,0.0042633866,0.011742912,0.000027101582],"about_ca_topic_score_codex":0.009133583,"about_ca_topic_score_gemma":0.012356875,"teacher_disagreement_score":0.009133583,"about_ca_system_score_codex":0.0007857464,"about_ca_system_score_gemma":0.0006389423,"threshold_uncertainty_score":0.01816082},"labels":[],"label_agreement":null},{"id":"W4412163879","doi":"10.1158/1557-3265.aimachine-a060","title":"Abstract A060: OncoMindPro: An AI-augmented assistant to oncologists","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Intensive care medicine","score_opus":0.22834382197644307,"score_gpt":0.6400331546755982,"score_spread":0.4116893326991551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163879","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32616922,0.0011277811,0.51755434,0.0044600717,0.00051819405,0.0017580558,0.01929037,0.08765687,0.041465025],"genre_scores_gemma":[0.6071752,0.0002944766,0.36322013,0.00064490206,0.00011864363,0.0006439396,0.013120943,0.000954137,0.013827651],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989341,0.00040362292,0.00008039951,0.00022506515,0.0002969673,0.000059819624],"domain_scores_gemma":[0.9969997,0.0012243777,0.00021819668,0.0006341102,0.00057881355,0.00034475778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022915876,0.00056208944,0.00030103108,0.0009224355,0.00038590832,0.0011096721,0.0009175508,0.00041240343,0.01094079],"category_scores_gemma":[0.005845636,0.00031828647,0.00042043775,0.0006058784,0.00029041877,0.0012571801,0.0023785003,0.00062808505,0.0029047856],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032154385,0.0008644567,0.05328604,0.0007508833,0.00019048995,0.0014496594,0.0018563523,0.016837392,0.030763453,0.0030225324,0.12866198,0.7591013],"study_design_scores_gemma":[0.0006009895,0.0015179543,0.056608167,0.00031111445,0.0003135629,0.0032991974,0.0021186308,0.46174955,0.06902798,0.01163122,0.39255092,0.00027069767],"about_ca_topic_score_codex":0.0029173447,"about_ca_topic_score_gemma":0.004186371,"teacher_disagreement_score":0.01094079,"about_ca_system_score_codex":0.0007587427,"about_ca_system_score_gemma":0.0016394368,"threshold_uncertainty_score":0.03660059},"labels":[],"label_agreement":null},{"id":"W4412163881","doi":"10.1158/1557-3265.aimachine-a046","title":"Abstract A046: Cell states and neighborhoods in distinct clinical stages of primary and metastatic esophageal adenocarcinoma","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Esophageal adenocarcinoma; Adenocarcinoma; Medicine; Primary (astronomy); Oncology; Esophageal cancer; Cancer research; Internal medicine; Cancer","score_opus":0.14439424247349258,"score_gpt":0.5110673304092923,"score_spread":0.3666730879357997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907314,0.0004971307,0.002114323,0.00009222731,0.000021872966,0.000015806125,0.0051272935,0.00008690791,0.0013131322],"genre_scores_gemma":[0.98985285,0.00022503592,0.0020234543,0.000086928034,0.00001678722,0.000055896442,0.0056569767,0.00004275352,0.0020393229],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998543,0.000012078423,0.0000103543825,0.00006658051,0.000031416024,0.00002514677],"domain_scores_gemma":[0.99980026,0.00004651844,0.00004836451,0.000014661287,0.00004975436,0.00004045537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016412284,0.000110370114,0.00025965984,0.0006935744,0.00045837642,0.0005654365,0.0001598915,0.00031651356,0.0038428502],"category_scores_gemma":[0.00036570712,0.00013086123,0.00028971027,0.0006935816,0.00019136233,0.00021651681,0.00036995573,0.00027644425,0.0008418081],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010321648,0.000061621125,0.30369428,0.0001939432,0.000117803815,0.00025464242,0.00048809982,0.00089672825,0.667954,0.00049636915,0.0022662422,0.02254416],"study_design_scores_gemma":[0.000013963184,0.00016610538,0.9560078,0.000016412188,0.000062688145,0.00064842694,0.00059631356,0.0033286645,0.034734767,0.00045007752,0.003954334,0.000020538295],"about_ca_topic_score_codex":0.0015325667,"about_ca_topic_score_gemma":0.0029396147,"teacher_disagreement_score":0.0038428502,"about_ca_system_score_codex":0.00023093347,"about_ca_system_score_gemma":0.00020285559,"threshold_uncertainty_score":0.012855649},"labels":[],"label_agreement":null},{"id":"W4412163882","doi":"10.1158/1557-3265.aimachine-a056","title":"Abstract A056: Integrative Machine Learning Approaches for Predicting Prostate Cancer Risk Using Multi-Omics Data","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prostate cancer; Omics; Cancer; Prostate; Medicine; Computational biology; Artificial intelligence; Machine learning; Computer science; Bioinformatics; Internal medicine; Biology","score_opus":0.3757576763179307,"score_gpt":0.5336097729368587,"score_spread":0.15785209661892802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163882","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12696494,0.004969492,0.8307015,0.0025764364,0.00043336352,0.0005071783,0.020946775,0.009141959,0.0037583325],"genre_scores_gemma":[0.4165186,0.0016884006,0.55557126,0.0004635094,0.00041370885,0.00080660207,0.021128839,0.00058776984,0.0028212913],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9976127,0.0011414817,0.00014474506,0.0005502621,0.00046023476,0.00009056403],"domain_scores_gemma":[0.9971129,0.0017969197,0.00024000951,0.00025971816,0.000436213,0.00015430142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007840825,0.0020752738,0.0014923903,0.003003646,0.0006868889,0.0023073975,0.0018179405,0.0008501958,0.0061567635],"category_scores_gemma":[0.010256324,0.00048026544,0.0026174234,0.0028304374,0.0004528625,0.0011292789,0.0018598958,0.001679223,0.0021988929],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015534064,0.0009530148,0.15328209,0.0023969016,0.0071380613,0.0008943994,0.00051684177,0.26948658,0.017129974,0.009514491,0.040528875,0.49660537],"study_design_scores_gemma":[0.00011573657,0.00040695196,0.03122785,0.00018934737,0.000616245,0.00036835938,0.00014973954,0.934764,0.0036234343,0.014992115,0.013465607,0.0000806598],"about_ca_topic_score_codex":0.0035564713,"about_ca_topic_score_gemma":0.0037512898,"teacher_disagreement_score":0.007840825,"about_ca_system_score_codex":0.0005918288,"about_ca_system_score_gemma":0.0016351887,"threshold_uncertainty_score":0.041466773},"labels":[],"label_agreement":null},{"id":"W4412163883","doi":"10.1158/1557-3265.aimachine-a038","title":"Abstract A038: Unmasking hidden mutational footprints of therapy in pediatric tumors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Cancer; Cancer research; Oncology; Internal medicine","score_opus":0.2380721496292062,"score_gpt":0.5708286162095034,"score_spread":0.3327564665802972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95580244,0.0023029419,0.02976758,0.00022737839,0.00004309757,0.00004282626,0.009332329,0.0010582838,0.0014231658],"genre_scores_gemma":[0.9612422,0.0006718341,0.025621623,0.00008344362,0.000029579816,0.0000384018,0.011454349,0.0001789347,0.00067966396],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99967647,0.000055055207,0.000020106723,0.000121816796,0.0000885279,0.000037983835],"domain_scores_gemma":[0.99920756,0.00030886958,0.00022073957,0.00009427882,0.00011918981,0.000049347404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005583296,0.0003883183,0.00042138787,0.0009920449,0.00022501651,0.00047336245,0.00027879223,0.000366995,0.0013741407],"category_scores_gemma":[0.0013812747,0.000170259,0.00055990566,0.0011073506,0.00019211571,0.00025634692,0.00035002522,0.00049626624,0.0005884511],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012139155,0.00019681576,0.26961133,0.0006098452,0.00057458185,0.0008369937,0.00022726723,0.027551142,0.54346216,0.00086190447,0.003974628,0.15087944],"study_design_scores_gemma":[0.00006487765,0.0007012512,0.51140654,0.00008291396,0.0005510539,0.0029741973,0.00027768317,0.2320026,0.22533545,0.003117711,0.023403358,0.00008238798],"about_ca_topic_score_codex":0.0018954563,"about_ca_topic_score_gemma":0.0031412079,"teacher_disagreement_score":0.0018954563,"about_ca_system_score_codex":0.0002563391,"about_ca_system_score_gemma":0.00040113827,"threshold_uncertainty_score":0.004597008},"labels":[],"label_agreement":null},{"id":"W4412163884","doi":"10.1158/1557-3265.aimachine-a007","title":"Abstract A007: Bayesian Counterfactual Machine Learning Individualizes Radiation Modality Selection to Mitigate Immunosuppression","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunosuppression; Modality (human–computer interaction); Counterfactual thinking; Medicine; Bayesian probability; Selection (genetic algorithm); Machine learning; Artificial intelligence; Computer science; Psychology; Internal medicine","score_opus":0.08295983461883612,"score_gpt":0.5184355499048301,"score_spread":0.435475715285994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163884","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41953862,0.0005577532,0.57427496,0.0017576884,0.00013965456,0.00042987804,0.00054691103,0.0005105907,0.0022439372],"genre_scores_gemma":[0.95068544,0.00010910683,0.04780175,0.00024574337,0.00007121974,0.00014608214,0.0002940148,0.000020220323,0.0006264045],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9879078,0.009839952,0.0002771665,0.0012064426,0.0005510059,0.00021766295],"domain_scores_gemma":[0.94722825,0.045433115,0.0034896093,0.0024354733,0.0009768794,0.00043670667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024948614,0.00067070965,0.0010289855,0.00125848,0.0005414266,0.0015380365,0.0014799203,0.0010654345,0.0028771688],"category_scores_gemma":[0.061008718,0.00044575517,0.001566102,0.00073943275,0.0015157365,0.001017295,0.0012161869,0.0014101664,0.0002624439],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044179447,0.000992708,0.20861803,0.0004037245,0.0025424743,0.0004987472,0.00080070586,0.49929908,0.003995234,0.031946283,0.0030655314,0.24341945],"study_design_scores_gemma":[0.00013833257,0.0003775105,0.012360157,0.00004078704,0.0002336613,0.00010928791,0.000044836062,0.96853024,0.0009976247,0.01643058,0.0007051964,0.00003182896],"about_ca_topic_score_codex":0.0029347425,"about_ca_topic_score_gemma":0.0020258103,"teacher_disagreement_score":0.024948614,"about_ca_system_score_codex":0.000893968,"about_ca_system_score_gemma":0.001307835,"threshold_uncertainty_score":0.13194245},"labels":[],"label_agreement":null},{"id":"W4412163886","doi":"10.1158/1557-3265.aimachine-a040","title":"Abstract A040: Digital Controls: An Efficient, Robust, and Privacy-Preserving Bayesian Tool for Adaptive Information Borrowing from External Data","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Distributed Sensor Networks and Detection Algorithms","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science; Bayesian probability; Internet privacy; Medicine; Data mining; Artificial intelligence","score_opus":0.16592162432776952,"score_gpt":0.44112254087147434,"score_spread":0.2752009165437048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163886","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018754173,0.00013905599,0.9965294,0.00025303807,0.000026735872,0.00010546064,0.00009580659,0.00043346058,0.0005416906],"genre_scores_gemma":[0.28867504,0.0005519916,0.7033485,0.00093721395,0.00029031155,0.00095486076,0.00061175285,0.0004816439,0.0041487035],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98903275,0.0062491586,0.0004575574,0.0017165286,0.0022052985,0.00033862493],"domain_scores_gemma":[0.9690824,0.020550778,0.0026348832,0.004510641,0.0023152523,0.00090614805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019753456,0.0016735188,0.0022028354,0.0025079122,0.00091318734,0.0026151154,0.004756834,0.0024058747,0.0077022007],"category_scores_gemma":[0.07204094,0.0013339345,0.0017368335,0.0019450837,0.0043457127,0.00437537,0.0054170876,0.004554734,0.0013578306],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006755629,0.00024097264,0.0028824192,0.0003844692,0.00024848824,0.00032977524,0.0004437816,0.43551973,0.003552261,0.29634875,0.0072525963,0.25212124],"study_design_scores_gemma":[0.00010594377,0.00007982509,0.0002213603,0.00006014296,0.000035573023,0.000053991145,0.000015429516,0.9158866,0.0018171131,0.07918428,0.002508433,0.000031194588],"about_ca_topic_score_codex":0.0038288876,"about_ca_topic_score_gemma":0.0030847653,"teacher_disagreement_score":0.019753456,"about_ca_system_score_codex":0.0020425927,"about_ca_system_score_gemma":0.0042811627,"threshold_uncertainty_score":0.10446751},"labels":[],"label_agreement":null},{"id":"W4412163888","doi":"10.1158/1557-3265.aimachine-a061","title":"Abstract A061: Machine Learning and Causal Inference-Based Predictive Risk Modeling of Unplanned Radiation Treatment Interruption","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Causal inference; Inference; Machine learning; Artificial intelligence; Computer science; Medicine; Pathology","score_opus":0.22478854432152584,"score_gpt":0.5553079831702357,"score_spread":0.3305194388487098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163888","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33270773,0.0006133079,0.66018367,0.001830093,0.00010758772,0.00017663637,0.0013009124,0.0008613796,0.0022185917],"genre_scores_gemma":[0.932993,0.00018886791,0.06317112,0.00016643819,0.000080172766,0.00019527043,0.0011858076,0.00003801216,0.001981312],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99930525,0.000399512,0.000031427382,0.0001419684,0.00006339659,0.00005841226],"domain_scores_gemma":[0.9959557,0.0032319066,0.00026648983,0.00009720736,0.00036512714,0.00008359086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036181873,0.000769708,0.00062940904,0.00075944833,0.0004216601,0.00086013693,0.0011354829,0.000890755,0.002363955],"category_scores_gemma":[0.0073028263,0.00041037137,0.000989665,0.00050030585,0.00047633602,0.00047227496,0.00067154755,0.0015866554,0.00023972939],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006822968,0.00007815867,0.006829912,0.000029220697,0.00007745694,0.00004178971,0.000028210661,0.97679645,0.00019173812,0.001592984,0.000697181,0.0135687115],"study_design_scores_gemma":[0.0000031361496,0.0000082072565,0.0004337111,0.000003610664,0.000004123421,0.000003269313,0.0000023224768,0.99867463,0.00004876666,0.0007577388,0.000058971316,0.0000015043623],"about_ca_topic_score_codex":0.02063065,"about_ca_topic_score_gemma":0.010153557,"teacher_disagreement_score":0.02063065,"about_ca_system_score_codex":0.0010107856,"about_ca_system_score_gemma":0.0019060302,"threshold_uncertainty_score":0.04102117},"labels":[],"label_agreement":null},{"id":"W4412163890","doi":"10.1158/1557-3265.aimachine-ia02","title":"Abstract IA02: Cancer-specific foundation models: Friend or foe in healthcare AI?","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Foundation (evidence); Cancer; Medicine; Health care; Intensive care medicine; Internal medicine; Political science","score_opus":0.38100412618073143,"score_gpt":0.569603953917716,"score_spread":0.18859982773698458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163890","genre_codex":"methods","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03978438,0.013122839,0.6009059,0.29827672,0.004200587,0.00017910809,0.002915506,0.0062771183,0.034337875],"genre_scores_gemma":[0.6572135,0.009663452,0.26934153,0.030746844,0.003919889,0.0005070356,0.004034572,0.0017254925,0.022847688],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9984213,0.0009872485,0.000053103122,0.00022734265,0.00020224035,0.00010878651],"domain_scores_gemma":[0.990258,0.0057929372,0.00034165214,0.0016174443,0.0011624133,0.0008275432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005714839,0.00071980315,0.001038827,0.0006263837,0.0005549732,0.0027329025,0.001900989,0.0019784302,0.008866317],"category_scores_gemma":[0.023985565,0.0004583555,0.0008889168,0.00069458614,0.0016469683,0.003929178,0.001999125,0.0054543037,0.003341965],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005812812,0.00018342276,0.008774988,0.0005733309,0.00030866533,0.00031050056,0.00065097766,0.1150383,0.0017074029,0.17750666,0.2872254,0.40713903],"study_design_scores_gemma":[0.00008576082,0.00014026054,0.0014633699,0.0004163884,0.00009054943,0.0002855228,0.00021374875,0.46686536,0.0014517957,0.4516259,0.077280335,0.000081069506],"about_ca_topic_score_codex":0.005915865,"about_ca_topic_score_gemma":0.005694497,"teacher_disagreement_score":0.008866317,"about_ca_system_score_codex":0.0015404401,"about_ca_system_score_gemma":0.0023642574,"threshold_uncertainty_score":0.03022331},"labels":[],"label_agreement":null},{"id":"W4412163894","doi":"10.1158/1557-3265.aimachine-a047","title":"Abstract A047: Building clinically relevant and interpretable multi-modal machine learning algorithms to predict glioblastoma disease progression","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Glioblastoma; Modal; Algorithm; Disease; Medicine; Artificial intelligence; Computer science; Machine learning; Pathology; Cancer research","score_opus":0.06239027585795424,"score_gpt":0.5170713691029938,"score_spread":0.4546810932450395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163894","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.118743226,0.00029356577,0.87019557,0.0006217871,0.000056226807,0.0002050753,0.000903405,0.007902109,0.001079071],"genre_scores_gemma":[0.52870363,0.000094432435,0.4659143,0.00039616783,0.000086350345,0.00043775316,0.0027780924,0.00027372842,0.0013154648],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9992755,0.00022873071,0.0000611459,0.00023489613,0.00013365151,0.00006609185],"domain_scores_gemma":[0.9983645,0.00082111463,0.0001468314,0.00012364643,0.00047457544,0.000069259615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002123644,0.0010194917,0.0005637393,0.0014729314,0.00049181655,0.0011674572,0.0011998952,0.0014202164,0.0024946267],"category_scores_gemma":[0.006118166,0.00036037064,0.0014107554,0.00046565494,0.00040474895,0.00074711256,0.0011644596,0.0011529701,0.0011435922],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062699936,0.00064731436,0.020968253,0.00014449087,0.00030616592,0.00023201643,0.00017072956,0.41198522,0.020058576,0.0023651428,0.008781836,0.5337132],"study_design_scores_gemma":[0.0000133472095,0.00003920177,0.0008355112,0.0000064768133,0.000012142555,0.000024634879,0.000009876111,0.9951898,0.0021824418,0.0013738134,0.00030567704,0.000007173665],"about_ca_topic_score_codex":0.006971572,"about_ca_topic_score_gemma":0.005191412,"teacher_disagreement_score":0.006971572,"about_ca_system_score_codex":0.0009277747,"about_ca_system_score_gemma":0.0014800725,"threshold_uncertainty_score":0.013861954},"labels":[],"label_agreement":null},{"id":"W4412163898","doi":"10.1158/1557-3265.aimachine-a053","title":"Abstract A053: A pre-operative Artificial Intelligence-based model to estimate the risk of cancer specific mortality in patients with non-metastatic kidney cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Kidney cancer; Medicine; Oncology; Internal medicine","score_opus":0.14283247737582186,"score_gpt":0.565024378943111,"score_spread":0.42219190156728914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84115607,0.000596629,0.14821705,0.0014165492,0.00014215118,0.00027516126,0.0033475757,0.0011023951,0.0037463026],"genre_scores_gemma":[0.9857395,0.00006772142,0.011255324,0.00010590639,0.000025833908,0.0001617105,0.0011039315,0.000020864749,0.0015191498],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99961936,0.00015713983,0.00002145913,0.00010219055,0.000050168994,0.000049643604],"domain_scores_gemma":[0.99828315,0.0012371856,0.00011462869,0.0000611714,0.00022047143,0.00008334796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017793882,0.00079622975,0.00063328474,0.00070842064,0.0002869435,0.0009368311,0.00096992386,0.0009503044,0.0035648847],"category_scores_gemma":[0.003690803,0.00024804389,0.0010733226,0.0003865766,0.00033046355,0.00035995772,0.00066631386,0.0011222402,0.0005285023],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041963893,0.00022903949,0.031550772,0.000052622945,0.00017793236,0.0001637632,0.000054584732,0.94393706,0.00051200966,0.0008211295,0.0016149397,0.020466544],"study_design_scores_gemma":[0.000014830454,0.000078580844,0.002435891,0.0000073121896,0.000016252969,0.000015592645,0.000007999156,0.9967648,0.00010809019,0.00040863117,0.0001368574,0.000005124295],"about_ca_topic_score_codex":0.024405617,"about_ca_topic_score_gemma":0.010491977,"teacher_disagreement_score":0.024405617,"about_ca_system_score_codex":0.001040324,"about_ca_system_score_gemma":0.0012929282,"threshold_uncertainty_score":0.04852712},"labels":[],"label_agreement":null},{"id":"W4412163899","doi":"10.1158/1557-3265.aimachine-b022","title":"Abstract B022: Prediction of radiotherapy-Induced esophagitis in non-small cell lung cancer using a 3D vision foundation model","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Lung cancer; Esophagitis; Cancer; Foundation (evidence); Internal medicine; Oncology; Disease; Reflux","score_opus":0.1599760508482635,"score_gpt":0.5298609495884697,"score_spread":0.36988489874020625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.638443,0.0006715618,0.3539619,0.0005583117,0.00011445935,0.00021285184,0.0016217681,0.0018984036,0.0025176376],"genre_scores_gemma":[0.9750727,0.00009756733,0.022689529,0.00007330412,0.000015355785,0.00008102095,0.0010959314,0.000025332047,0.0008492499],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99985385,0.000029239767,0.000009282419,0.00005192379,0.000028807539,0.000026862412],"domain_scores_gemma":[0.99957305,0.0002504724,0.000043064298,0.000023858192,0.0000880031,0.000021560123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005410036,0.00060415204,0.00044177184,0.00068819994,0.00019166144,0.0006150447,0.0006751534,0.0008680252,0.0009688561],"category_scores_gemma":[0.0013069628,0.00033238778,0.0011436979,0.0003087764,0.0002490128,0.0002647096,0.0003871669,0.00068972394,0.00024055454],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013183895,0.00014466592,0.0066924337,0.00003160947,0.00005524173,0.00007558762,0.000013345391,0.9468344,0.0020826452,0.0002990204,0.00082960323,0.042809512],"study_design_scores_gemma":[0.0000020904183,0.000014158144,0.00044408903,0.000001476278,0.0000029362961,0.0000069974562,0.0000010135682,0.9992048,0.00023747284,0.000055407436,0.00002804246,0.0000015142632],"about_ca_topic_score_codex":0.022640936,"about_ca_topic_score_gemma":0.011584759,"teacher_disagreement_score":0.022640936,"about_ca_system_score_codex":0.00088523957,"about_ca_system_score_gemma":0.00095021696,"threshold_uncertainty_score":0.045018315},"labels":[],"label_agreement":null},{"id":"W4412163900","doi":"10.1158/1557-3265.aimachine-a033","title":"Abstract A033: Utilizing machine learning algorithms to identify methylation regions predictive of outcome in ICI-treated patients: Insights from the longitudinal RADIOHEAD study","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Outcome (game theory); Algorithm; Methylation; Computer science; Machine learning; Medicine; Artificial intelligence; Oncology; Biology; Mathematics; Genetics","score_opus":0.19383250777942687,"score_gpt":0.5438099278505826,"score_spread":0.34997742007115573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99668187,0.00014326138,0.0021297925,0.00013198926,0.0000023534453,0.0000148191975,0.00059865724,0.000018329114,0.00027881807],"genre_scores_gemma":[0.9972615,0.000038874205,0.0015478312,0.000054940963,0.000010142017,0.000017146373,0.0008773879,0.000008021168,0.0001841167],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99947566,0.00036803607,0.000014353347,0.00008489171,0.000030969215,0.000026143338],"domain_scores_gemma":[0.9975407,0.0014169745,0.0003749379,0.0003689934,0.00014085349,0.00015765037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003030257,0.00024428428,0.0002826904,0.00033079987,0.00018095563,0.00044399506,0.00043185975,0.0002922314,0.000981357],"category_scores_gemma":[0.004504055,0.000115913586,0.0006806805,0.0002750123,0.00021222059,0.00018108456,0.00030769172,0.0005864626,0.00024237008],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035737476,0.00030277375,0.958476,0.000044305587,0.00059193076,0.00016193626,0.0001625786,0.007940548,0.004649088,0.00025104656,0.0011837669,0.022662293],"study_design_scores_gemma":[0.0004070642,0.0025200746,0.83652467,0.000024149022,0.0005393424,0.00044379607,0.0002710386,0.15195273,0.004354442,0.0011024852,0.0018238567,0.000036266327],"about_ca_topic_score_codex":0.003768839,"about_ca_topic_score_gemma":0.004167394,"teacher_disagreement_score":0.003768839,"about_ca_system_score_codex":0.00027959052,"about_ca_system_score_gemma":0.00038238903,"threshold_uncertainty_score":0.016025722},"labels":[],"label_agreement":null},{"id":"W4412163902","doi":"10.1158/1557-3265.aimachine-a057","title":"Abstract A057: Multimodal AI Modeling of Clinical Panel-Based Sequencing for HRD Detection in Ovarian Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Artificial Intelligence in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Medicine; Computational biology; DNA sequencing; Cancer; Oncology; Artificial intelligence; Bioinformatics; Computer science; Biology; Internal medicine; Genetics; Gene","score_opus":0.8227929207050889,"score_gpt":0.7389504298564317,"score_spread":0.08384249084865725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6946086,0.0008082824,0.2967218,0.0012295098,0.000062161955,0.00016805928,0.001960592,0.0015447482,0.002896153],"genre_scores_gemma":[0.9857248,0.00007082649,0.01220334,0.00011179357,0.00002017004,0.00007459248,0.00060879556,0.000025406174,0.0011602181],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99979323,0.000076736884,0.000009300552,0.00006620017,0.000021776208,0.000032693482],"domain_scores_gemma":[0.9993587,0.0004296583,0.000067053195,0.000025131285,0.00007569468,0.00004372745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097047054,0.00083006755,0.000532205,0.00066386187,0.00022009038,0.0007145011,0.0005712547,0.00073193497,0.0020413916],"category_scores_gemma":[0.00225539,0.0002709732,0.00084927847,0.00031614804,0.0003498421,0.0003087296,0.0005626163,0.00088394823,0.00034324714],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012839567,0.000059837737,0.00734588,0.000024413515,0.00006077089,0.000067412504,0.00002928401,0.9686743,0.0013017965,0.0003738557,0.0004690628,0.021464866],"study_design_scores_gemma":[0.0000016281326,0.00001358702,0.00051841623,0.0000014506163,0.000003450279,0.0000061293435,0.0000029285125,0.9990397,0.0001197007,0.00024972475,0.000041250136,0.000001948012],"about_ca_topic_score_codex":0.01614747,"about_ca_topic_score_gemma":0.010770043,"teacher_disagreement_score":0.01614747,"about_ca_system_score_codex":0.0008816306,"about_ca_system_score_gemma":0.0006496215,"threshold_uncertainty_score":0.032106936},"labels":[],"label_agreement":null},{"id":"W4412163903","doi":"10.1158/1557-3265.aimachine-b021","title":"Abstract B021: Current oncological large language model research lacks reproducibility, transparency, and long term support","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Term (time); Transparency (behavior); Current (fluid); Reproducibility; Medicine; Medical physics; Computer science; Intensive care medicine; Engineering; Computer security; Physics; Statistics; Mathematics","score_opus":0.32363014499013987,"score_gpt":0.6342184687243343,"score_spread":0.3105883237341944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163903","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reproducibility","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reproducibility","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.046973918,0.12972091,0.3467606,0.25479338,0.0114523955,0.003641638,0.08988104,0.011123236,0.105652794],"genre_scores_gemma":[0.425514,0.07165401,0.3060272,0.058326945,0.010559376,0.009990726,0.08828793,0.011609425,0.018030407],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.85498923,0.08822163,0.018615862,0.0097735515,0.026509129,0.0018905959],"domain_scores_gemma":[0.24411458,0.5709214,0.04151999,0.08164598,0.05803122,0.0037667765],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.18831374,0.00124382,0.0024364104,0.0077129262,0.0023091028,0.019713707,0.004624129,0.0032771372,0.041654713],"category_scores_gemma":[0.5771513,0.0015943069,0.0045554196,0.014569605,0.004380554,0.019916005,0.008130401,0.005420762,0.018062616],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020952816,0.00021603123,0.024181306,0.059129015,0.0025399025,0.00057853933,0.005427884,0.004174226,0.0027722947,0.16783902,0.29422817,0.4368184],"study_design_scores_gemma":[0.0005425683,0.00040400622,0.013531923,0.043216076,0.0020153746,0.0010518271,0.0029721176,0.011981678,0.0043857847,0.21763398,0.70195055,0.0003142604],"about_ca_topic_score_codex":0.0052106115,"about_ca_topic_score_gemma":0.00437216,"teacher_disagreement_score":0.8116863,"about_ca_system_score_codex":0.004896058,"about_ca_system_score_gemma":0.023277046,"threshold_uncertainty_score":0.9959101},"labels":[],"label_agreement":null},{"id":"W4412163904","doi":"10.1158/1557-3265.aimachine-a059","title":"Abstract A059: CP-Fuse: A Comprehensive Assessment of Clinico-Pathological Fusion in TCGA Survival Prediction","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke; Jewish General Hospital; Q & T Research; McGill University","funders":"","keywords":"Pathological; Medicine; Oncology; Fuse (electrical); Internal medicine; Engineering","score_opus":0.40194063977625666,"score_gpt":0.6448293611972163,"score_spread":0.24288872142095969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8444118,0.0041098506,0.11945155,0.0019025771,0.00035410785,0.00029841,0.012182423,0.010493476,0.006795898],"genre_scores_gemma":[0.96305925,0.00027783448,0.025774922,0.0002366175,0.000100886915,0.00009403192,0.009117303,0.00016409924,0.0011751357],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99850154,0.00051289523,0.000070234186,0.0004192405,0.000355731,0.00014038112],"domain_scores_gemma":[0.99786276,0.0010475352,0.00016974537,0.00025904662,0.00044046828,0.00022048305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048547974,0.0015179537,0.0010063297,0.0022957854,0.0005229115,0.0009505099,0.0012896894,0.0016851319,0.0021909028],"category_scores_gemma":[0.007728064,0.00027990044,0.0014563154,0.0009924774,0.00048716957,0.0010369172,0.001921965,0.0012607427,0.0006768197],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030746153,0.0007347301,0.12874909,0.0004546074,0.0020073927,0.00030388875,0.00021053282,0.4202834,0.007616516,0.001742257,0.027621219,0.40720174],"study_design_scores_gemma":[0.00008058726,0.0005583216,0.016848978,0.00005309006,0.0002108005,0.00019271685,0.00010053924,0.9736091,0.004109374,0.0018897739,0.0022963854,0.000050428294],"about_ca_topic_score_codex":0.012704393,"about_ca_topic_score_gemma":0.010976802,"teacher_disagreement_score":0.012704393,"about_ca_system_score_codex":0.0010167495,"about_ca_system_score_gemma":0.0013518609,"threshold_uncertainty_score":0.02567494},"labels":[],"label_agreement":null},{"id":"W4412163905","doi":"10.1158/1557-3265.aimachine-a012","title":"Abstract A012: AI-assisted Design of Novel NRF2Mut Inhibitors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Synthesis and Biological Evaluation","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Computational biology; Pharmacology; Biology","score_opus":0.5758945951923626,"score_gpt":0.5891812392391099,"score_spread":0.013286644046747287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7945099,0.032053977,0.07993072,0.0022549173,0.0008536947,0.002166255,0.0059742155,0.0019497911,0.08030658],"genre_scores_gemma":[0.9536689,0.007965556,0.02204689,0.00053783786,0.000048123853,0.0004696627,0.0015828965,0.00007024311,0.013609939],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999138,0.000012147543,0.0000078694675,0.000021816919,0.00002485163,0.000019595149],"domain_scores_gemma":[0.99995863,0.0000034483944,0.000009237839,0.0000036822125,0.000012252489,0.000012788594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018713553,0.00045616718,0.00034463446,0.0004638497,0.00020823046,0.00030861306,0.00044669694,0.0003504371,0.0058169914],"category_scores_gemma":[0.00015471439,0.00014180159,0.00034954387,0.00043408293,0.00012968795,0.00036920243,0.0003232919,0.0005102876,0.0016649987],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011533196,0.0009169902,0.00064881006,0.0020276313,0.00015307238,0.0006827809,0.00015388914,0.007216871,0.8396128,0.009830016,0.0094906865,0.12811321],"study_design_scores_gemma":[0.0010118041,0.008909164,0.002090014,0.00022439219,0.00023898431,0.0009161747,0.000110270936,0.023326205,0.801563,0.002284442,0.15919454,0.00013098495],"about_ca_topic_score_codex":0.00054464216,"about_ca_topic_score_gemma":0.0012616797,"teacher_disagreement_score":0.0058169914,"about_ca_system_score_codex":0.00033480994,"about_ca_system_score_gemma":0.00027667786,"threshold_uncertainty_score":0.019459784},"labels":[],"label_agreement":null},{"id":"W4412163909","doi":"10.1158/1557-3265.aimachine-a041","title":"Abstract A041: A Hybrid Active Learning (AL) Random Forest Model with KNN Imputation to Predict Recurrence in Ductal Carcinoma In Situ (DCIS) of the Breast","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"AI in cancer detection","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ductal carcinoma; In situ; Random forest; Medicine; Carcinoma in situ; Oncology; Breast cancer; Carcinoma; Internal medicine; Artificial intelligence; Cancer; Computer science; Chemistry","score_opus":0.07290023780787054,"score_gpt":0.4324860707928705,"score_spread":0.35958583298499996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163909","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31380183,0.001150362,0.67587584,0.001817504,0.00021584338,0.0003709377,0.0016220986,0.0021180126,0.0030275357],"genre_scores_gemma":[0.88828546,0.00018735151,0.105300605,0.00033628114,0.00020091757,0.0003759542,0.0013555607,0.00009574438,0.0038620732],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99889827,0.0007202767,0.000040835417,0.000181258,0.00008757578,0.00007184899],"domain_scores_gemma":[0.99562764,0.003393652,0.00019079175,0.00015879158,0.0005145407,0.0001145982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071348934,0.00086734316,0.0012540789,0.0010569979,0.00043675237,0.0011405483,0.0025987765,0.0015350531,0.0022356384],"category_scores_gemma":[0.007984232,0.00046498518,0.0014112674,0.000725071,0.0003583849,0.0007189558,0.00073392806,0.0013954245,0.00074620143],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091693393,0.00036441037,0.00958882,0.000087034765,0.00026825574,0.000110100555,0.00006339238,0.89571255,0.00059975294,0.0017686883,0.003974817,0.08654522],"study_design_scores_gemma":[0.000034003704,0.000061255596,0.00031618902,0.000006655884,0.00001545979,0.000008552081,0.000002838019,0.99884146,0.00009916827,0.00048726826,0.00012084689,0.0000063140265],"about_ca_topic_score_codex":0.011230944,"about_ca_topic_score_gemma":0.009242308,"teacher_disagreement_score":0.011230944,"about_ca_system_score_codex":0.0007827772,"about_ca_system_score_gemma":0.0010494532,"threshold_uncertainty_score":0.037733436},"labels":[],"label_agreement":null},{"id":"W4412163913","doi":"10.1158/1557-3265.aimachine-a039","title":"Abstract A039: Pediatric pan-cancer characterization of transposable elements and their modulation by germline <i>TP53</i> variants","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Germline; Transposable element; Cancer; Biology; Genetics; Cancer research; Medicine; Computational biology; Genome; Gene","score_opus":0.04704075578717955,"score_gpt":0.3958971033129096,"score_spread":0.3488563475257301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99116737,0.00086717604,0.0013902796,0.00003956255,0.00000834113,0.000018339573,0.005741948,0.00007784213,0.0006890521],"genre_scores_gemma":[0.9887039,0.00052410876,0.0023923873,0.000058931655,0.0000114014565,0.000031753516,0.0076190825,0.000066180204,0.0005921954],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998248,0.000013154704,0.00001631201,0.0000749575,0.000036634356,0.00003421664],"domain_scores_gemma":[0.9997602,0.000058536465,0.000076539276,0.000019380124,0.00003811744,0.000047200956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016804918,0.00022102766,0.00031656725,0.0006800308,0.00026984245,0.0003762254,0.00018264208,0.00027146115,0.0023443387],"category_scores_gemma":[0.00039374764,0.00011124998,0.00029994873,0.0009037111,0.00014886785,0.00012075277,0.0002294273,0.0002516127,0.0004781391],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018504371,0.00007214025,0.46651432,0.0003599101,0.00013935055,0.0020483069,0.00038647756,0.0007475137,0.4965046,0.00028952828,0.0013536034,0.02973376],"study_design_scores_gemma":[0.000041359883,0.000542476,0.89851826,0.000053031024,0.00020366223,0.014826582,0.00040620222,0.0024354616,0.07118841,0.000298191,0.011466347,0.00002001558],"about_ca_topic_score_codex":0.0016909721,"about_ca_topic_score_gemma":0.002205157,"teacher_disagreement_score":0.0023443387,"about_ca_system_score_codex":0.00019710664,"about_ca_system_score_gemma":0.00016729743,"threshold_uncertainty_score":0.0078426},"labels":[],"label_agreement":null},{"id":"W4412163914","doi":"10.1158/1557-3265.aimachine-b035","title":"Abstract B035: Deep learning-based spatially resolved immune clustering in the tumor microenvironment predicts distant metastasis risk in high-grade prostate cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prostate cancer; Tumor microenvironment; Metastasis; Cancer; Immune system; Medicine; Distant metastasis; Oncology; Internal medicine; Immunology","score_opus":0.048547004041495964,"score_gpt":0.4292443246157977,"score_spread":0.3806973205743017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917686,0.00023276317,0.005890231,0.00022465047,0.000016483931,0.000018857098,0.0010295524,0.0001308464,0.0006880647],"genre_scores_gemma":[0.9970783,0.000036007437,0.0015213337,0.000032195516,0.000007260088,0.000012500503,0.0008566467,0.00000687079,0.0004489216],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99986756,0.00003709847,0.00000721043,0.000042167085,0.000025006053,0.000020989562],"domain_scores_gemma":[0.9997391,0.000066756955,0.00005210975,0.000024776304,0.000051030802,0.000066248314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006544318,0.00033805353,0.00027891056,0.00046794742,0.0001951515,0.00056124036,0.0005822038,0.00033869146,0.0025132142],"category_scores_gemma":[0.0012483407,0.00014392516,0.00044396185,0.00034122038,0.00019477654,0.00027337088,0.00051419536,0.0004824313,0.0004071498],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023162824,0.00068189786,0.8347569,0.00014114121,0.00039869008,0.00018560696,0.000090669906,0.04431853,0.01632648,0.00047789322,0.0058352323,0.094470665],"study_design_scores_gemma":[0.00015589863,0.00083957764,0.4401025,0.0000492644,0.00025612657,0.0003831686,0.00017175595,0.5469563,0.007945831,0.0015200889,0.0015778018,0.000041618725],"about_ca_topic_score_codex":0.007957168,"about_ca_topic_score_gemma":0.007915671,"teacher_disagreement_score":0.007957168,"about_ca_system_score_codex":0.00058844325,"about_ca_system_score_gemma":0.00058013457,"threshold_uncertainty_score":0.015821695},"labels":[],"label_agreement":null},{"id":"W4412163915","doi":"10.1158/1557-3265.aimachine-b047","title":"Abstract B047: Path2Space: An AI approach for cancer biomarker discovery via histopathology inferred spatial transcriptomics","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Histopathology; Transcriptome; Biomarker; Biomarker discovery; Medicine; Computational biology; Pathology; Biology; Internal medicine; Gene; Proteomics; Genetics; Gene expression","score_opus":0.15510649728027157,"score_gpt":0.481690051543773,"score_spread":0.3265835542635014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412163915","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032699477,0.00061252,0.9373908,0.0017198374,0.0002777929,0.00019554568,0.005741724,0.016657159,0.0047052056],"genre_scores_gemma":[0.3484998,0.00067152426,0.6233243,0.0014381735,0.00036393994,0.0005380577,0.013300714,0.0012158585,0.010647743],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9996617,0.00007722803,0.000013490476,0.00012801141,0.00009348916,0.000026070864],"domain_scores_gemma":[0.99939585,0.00028275582,0.000052431522,0.00008358199,0.00013124497,0.00005412199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008171682,0.0008755845,0.0005312243,0.0011545791,0.00034988814,0.0010541726,0.0012573099,0.00090812193,0.0071726767],"category_scores_gemma":[0.002397278,0.0004082371,0.00092626305,0.0008394124,0.0005116852,0.0007266901,0.0014023961,0.0013690034,0.002067303],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009955281,0.0003054114,0.014610717,0.0004763051,0.0003965407,0.0006071579,0.00020921511,0.36716264,0.041680384,0.02403919,0.06913556,0.48038143],"study_design_scores_gemma":[0.00003861042,0.000079479294,0.0008840811,0.000013183497,0.000025276286,0.00008682789,0.000026178937,0.96763813,0.0040109884,0.018764794,0.008414781,0.000017662207],"about_ca_topic_score_codex":0.0049780537,"about_ca_topic_score_gemma":0.007598545,"teacher_disagreement_score":0.0071726767,"about_ca_system_score_codex":0.0006786515,"about_ca_system_score_gemma":0.0013653752,"threshold_uncertainty_score":0.023994982},"labels":[],"label_agreement":null},{"id":"W4412203029","doi":"10.1158/1078-0432.ccr-25-0100","title":"Phase I Clinical Trial of the Bifunctional EGFR/TGF-β Fusion Protein Ficerafusp Alfa (BCA101) Alone and in Combination with Pembrolizumab for Advanced Solid Tumors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; EMD Serono; MacroGenics; Regeneron Pharmaceuticals; Belfer Center for Science and International Affairs, Harvard University; Seagen; Gilead Sciences; AstraZeneca; Pfizer; Coherus Biosciences; Bristol-Myers Squibb","keywords":"Medicine; Pembrolizumab; Tolerability; Combination therapy; Rash; Internal medicine; Adverse effect; Pharmacodynamics; Cetuximab; Response Evaluation Criteria in Solid Tumors; Pharmacokinetics; Phases of clinical research; Oncology; Gastroenterology; Pharmacology; Cancer; Clinical trial; Immunotherapy","score_opus":0.16525816706271146,"score_gpt":0.5464717634505963,"score_spread":0.3812135963878849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412203029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951219,0.0013103576,0.00039975412,0.00029090192,0.00010958319,0.0013361071,0.00038342155,0.0000669458,0.0009809148],"genre_scores_gemma":[0.99310064,0.0010838122,0.0012614651,0.000376691,0.0001351842,0.0014204358,0.0010497437,0.000017650598,0.00155433],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996486,0.00015170364,0.00001689012,0.000057750356,0.000042337142,0.00008279997],"domain_scores_gemma":[0.9993581,0.000092652306,0.00014189525,0.000053668573,0.000038689177,0.0003149774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011345132,0.0016296059,0.0020536936,0.00034916672,0.00040525149,0.00092901266,0.0008159022,0.001214092,0.0025964219],"category_scores_gemma":[0.0006378134,0.0005117057,0.00094179634,0.00037503653,0.0011557384,0.0008273031,0.0002707093,0.0037278985,0.00083108974],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7098134,0.10577501,0.0036285436,0.0007566837,0.0011576691,0.00026583814,0.000277244,0.0039761234,0.10147886,0.00030521804,0.0027135564,0.06985188],"study_design_scores_gemma":[0.43737054,0.5465097,0.004813694,0.00002282758,0.00029144966,0.00021899455,0.0000402934,0.0014476395,0.00783826,0.00012837104,0.0012987707,0.000019545658],"about_ca_topic_score_codex":0.0008381391,"about_ca_topic_score_gemma":0.001533923,"teacher_disagreement_score":0.0025964219,"about_ca_system_score_codex":0.0009890284,"about_ca_system_score_gemma":0.00158674,"threshold_uncertainty_score":0.008685827},"labels":[],"label_agreement":null},{"id":"W4412430993","doi":"10.1158/1078-0432.ccr-24-3726","title":"Molecular Characterization of Residual Muscle-Invasive Bladder Cancer Identifies a Scar-Like Transcriptomic Profile with Favorable Prognosis after Neoadjuvant Therapy","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"René Vogels Stichting; Deutsche Forschungsgemeinschaft","keywords":"Bladder cancer; Cystectomy; Medicine; Neoadjuvant therapy; Oncology; Gene expression profiling; Pathology; Internal medicine; Cancer; Gene expression; Biology; Gene; Breast cancer","score_opus":0.08110261616488323,"score_gpt":0.4377643613611631,"score_spread":0.35666174519627986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412430993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99947995,0.00008765085,0.00020301122,0.000011200695,0.0000011381394,0.00000589424,0.00012989755,0.000005832124,0.00007537148],"genre_scores_gemma":[0.9987041,0.000053925072,0.0004767336,0.00001569038,0.0000025958193,0.00001178502,0.0006211617,0.0000021666658,0.00011183726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984753,0.000025720308,0.000014874676,0.000045091154,0.000037654416,0.000029016743],"domain_scores_gemma":[0.99963224,0.00007119936,0.00013975007,0.000040816107,0.000062104504,0.000053894124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027818343,0.00015915424,0.00027153155,0.0003708521,0.00018022259,0.0003058909,0.00014567438,0.00018629112,0.00055128796],"category_scores_gemma":[0.0006290154,0.00007635086,0.00016628182,0.00027403448,0.00021979572,0.00010904332,0.00017298921,0.00018317069,0.0001441992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014442601,0.00012311642,0.67480195,0.00011273312,0.000070663606,0.0003001255,0.00026290232,0.0006220376,0.30574384,0.00004285347,0.00021594687,0.01625965],"study_design_scores_gemma":[0.00001562237,0.0005927529,0.97480655,0.000014452825,0.00006237005,0.00087543105,0.00034835245,0.0033927606,0.019367026,0.00004372749,0.00047384176,0.000007027708],"about_ca_topic_score_codex":0.0007836691,"about_ca_topic_score_gemma":0.0014034349,"teacher_disagreement_score":0.0007836691,"about_ca_system_score_codex":0.00018072454,"about_ca_system_score_gemma":0.00020380245,"threshold_uncertainty_score":0.0018442273},"labels":[],"label_agreement":null},{"id":"W4412629665","doi":"10.1158/1078-0432.ccr-25-1248","title":"Genomic and Epigenomic ctDNA Profiling in Liquid Biopsies from Heavily Pretreated Patients with DNA Damage Response–Deficient Tumors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Daiichi Sankyo Europe; Astellas Pharma; Seagen; Eisai; MacroGenics; AstraZeneca; National Cancer Institute; Novocure; Revolution Medicines; Pfizer; Amgen","keywords":"Liquid biopsy; Population; Cancer research; DNA repair; Context (archaeology); Epigenomics; Medicine; Biology; Cancer; Internal medicine; Gene; DNA methylation; Genetics","score_opus":0.09597505638137298,"score_gpt":0.4711381872705757,"score_spread":0.3751631308892027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412629665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961248,0.0006829554,0.0013948549,0.000044633183,0.0000053794242,0.00007801154,0.00085520465,0.000026169944,0.00078795996],"genre_scores_gemma":[0.9959759,0.00027562314,0.0014098296,0.00014359773,0.0000108231125,0.000069804104,0.0017417591,0.000010279045,0.0003625085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978715,0.00004441612,0.000022231592,0.00006877303,0.00005172274,0.000025699852],"domain_scores_gemma":[0.9997267,0.00007269774,0.00007890114,0.000025270609,0.000044900382,0.000051513165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002378352,0.00021882652,0.00026245267,0.0006880036,0.00020561219,0.00035831844,0.00017128223,0.00027802063,0.0015244596],"category_scores_gemma":[0.0006229283,0.0001154461,0.00009800347,0.00044863537,0.00019702602,0.00015046092,0.00019694884,0.0002799098,0.00031698888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048527163,0.00023222313,0.62104046,0.00013465896,0.00010528807,0.0018599256,0.0003537203,0.0006719535,0.33670363,0.00014818771,0.0008046925,0.033092543],"study_design_scores_gemma":[0.00015887493,0.002812199,0.9300313,0.00003596171,0.00014906056,0.00765176,0.0003823598,0.0020326178,0.053822957,0.000108468375,0.002800621,0.000013749406],"about_ca_topic_score_codex":0.0009368754,"about_ca_topic_score_gemma":0.0014656857,"teacher_disagreement_score":0.0015244596,"about_ca_system_score_codex":0.00014586216,"about_ca_system_score_gemma":0.00019302536,"threshold_uncertainty_score":0.0050997734},"labels":[],"label_agreement":null},{"id":"W4412789893","doi":"10.1158/1078-0432.ccr-25-0112","title":"Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; National Institute of Allergy and Infectious Diseases; American Cancer Society; U.S. Department of Veterans Affairs; National Institute of Dental and Craniofacial Research; Cancer Prevention and Research Institute of Texas","keywords":"Head and neck squamous-cell carcinoma; Cancer research; Radioresistance; Haploinsufficiency; Carcinogenesis; Gene knockdown; Cancer; Biology; Tumor progression; Radiation therapy; Head and neck cancer; Medicine; Pathology; Cell culture; Internal medicine; Phenotype","score_opus":0.05149188685661864,"score_gpt":0.428044041155628,"score_spread":0.37655215429900935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412789893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978315,0.0008345852,0.0005582408,0.00004155785,0.000006810107,0.00001614276,0.00022472562,0.000038420327,0.0004481155],"genre_scores_gemma":[0.9986112,0.0002887059,0.00023914986,0.000019703444,0.0000022343615,0.00001327557,0.00018979805,0.0000047994617,0.00063108077],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998958,0.000011807717,0.000009316848,0.000026417492,0.000035842128,0.000020820335],"domain_scores_gemma":[0.9999254,0.000008372821,0.000023190574,0.000013678681,0.000012759445,0.000016570772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016395579,0.00021066259,0.00027184963,0.00025236112,0.00017872677,0.00020882575,0.00014213704,0.00022739022,0.0013585842],"category_scores_gemma":[0.00010518626,0.000101526486,0.00023316988,0.00018703491,0.00023585928,0.00013592652,0.00015384657,0.00028362364,0.00030783698],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021507383,0.00004306147,0.0034189115,0.000046519675,0.000012328414,0.00019646388,0.000023259981,0.000050834326,0.9941326,0.000051077353,0.000052398886,0.0017574091],"study_design_scores_gemma":[0.000036971876,0.00074748707,0.11472553,0.000014771872,0.00009675041,0.0029400585,0.00016834577,0.0011575295,0.87712604,0.00009717161,0.0028773926,0.000011976062],"about_ca_topic_score_codex":0.00070321676,"about_ca_topic_score_gemma":0.001087243,"teacher_disagreement_score":0.0013585842,"about_ca_system_score_codex":0.00035593877,"about_ca_system_score_gemma":0.0002653092,"threshold_uncertainty_score":0.0045449734},"labels":[],"label_agreement":null},{"id":"W4413111570","doi":"10.1158/1078-0432.ccr-22-3683","title":"Increased ErbB2 Signaling Is an Early Adaptation to Androgen Signaling Inhibition and Persists in Castration-Resistant Prostate Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Foundation Medicine; Puma Biotechnology; Bristol-Myers Squibb; Prostate Cancer Foundation","keywords":"Prostate cancer; Castration; Androgen; Cancer; Medicine; Prostate; Internal medicine; Oncology; Endocrinology; Biology; Hormone","score_opus":0.20686718664398343,"score_gpt":0.5004136707466903,"score_spread":0.2935464841027069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413111570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995994,0.0017141303,0.00070348906,0.00005761155,0.000007913112,0.000024607803,0.00031806575,0.00011004782,0.0010701179],"genre_scores_gemma":[0.9982064,0.00043799955,0.00024790852,0.00003242123,0.0000055683377,0.000012511304,0.00032942518,0.000010172414,0.0007174959],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998265,0.000015743994,0.000009664562,0.000039039965,0.00007233665,0.000036772224],"domain_scores_gemma":[0.99983,0.000014853435,0.00006488067,0.000019804269,0.000022561237,0.00004790684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017818072,0.00029745352,0.0003112983,0.00040892046,0.00021708361,0.00047403545,0.00017808375,0.00017816288,0.001617131],"category_scores_gemma":[0.00015358538,0.00015914148,0.0002523871,0.00032939852,0.00025126248,0.000201728,0.00017274987,0.0005278365,0.00029882844],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040262213,0.00008352531,0.014633741,0.000060727834,0.000020762522,0.00027240295,0.000029668814,0.00011314701,0.9792499,0.00006554763,0.00011014264,0.004957814],"study_design_scores_gemma":[0.00003356264,0.0018518231,0.61158884,0.00001464918,0.00006784923,0.005518951,0.00016554649,0.0010767082,0.37521443,0.000095295545,0.004353812,0.000018592622],"about_ca_topic_score_codex":0.0010191594,"about_ca_topic_score_gemma":0.001131371,"teacher_disagreement_score":0.001617131,"about_ca_system_score_codex":0.00047196503,"about_ca_system_score_gemma":0.0002761653,"threshold_uncertainty_score":0.005409837},"labels":[],"label_agreement":null},{"id":"W4413114152","doi":"10.1158/1078-0432.ccr-25-0570","title":"Adapting Laser Interstitial Thermal Therapy for the Treatment of Naturally Occurring Intracranial Tumors in Dogs","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Veterinary Orthopedics and Neurology","field":"Veterinary","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational and Environmental Medical Association of Canada","funders":"National Institute of General Medical Sciences; Cancer Research Institute","keywords":"Medicine; Laser therapy; Pathology; Laser; Optics","score_opus":0.3488139768996327,"score_gpt":0.5629243383002953,"score_spread":0.21411036140066259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413114152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96783864,0.00080013764,0.02892844,0.00013722345,0.000051149676,0.00034091622,0.00020396496,0.00014615527,0.0015533848],"genre_scores_gemma":[0.96435636,0.0011308198,0.03241593,0.00008978935,0.000017950078,0.00030018712,0.0005787467,0.000044612578,0.001065725],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99971384,0.000059014223,0.000024909841,0.0000658537,0.000089338726,0.0000470209],"domain_scores_gemma":[0.9997582,0.00005012096,0.00007020035,0.000056926692,0.000033681954,0.000030817024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006585593,0.00029026432,0.00020891476,0.00046136876,0.00029156235,0.00036222418,0.0004321865,0.000398912,0.0007668688],"category_scores_gemma":[0.0004606483,0.00021141917,0.00032674122,0.00018541145,0.00065884314,0.00038736608,0.00035473212,0.00036937406,0.00027009984],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075963093,0.0006893306,0.007937303,0.00036950875,0.00004498585,0.0011936822,0.00045062005,0.00402702,0.95680416,0.000687635,0.000689911,0.026346298],"study_design_scores_gemma":[0.00043710615,0.02406246,0.043257814,0.00015344507,0.0003730243,0.032543454,0.00091261626,0.014031903,0.8415133,0.0006660038,0.041919354,0.00012964437],"about_ca_topic_score_codex":0.00086837064,"about_ca_topic_score_gemma":0.0018097725,"teacher_disagreement_score":0.00086837064,"about_ca_system_score_codex":0.00041170284,"about_ca_system_score_gemma":0.0005671562,"threshold_uncertainty_score":0.0034828186},"labels":[],"label_agreement":null},{"id":"W4413787387","doi":"10.1158/1078-0432.ccr-25-1648","title":"A First-in-Human Study of ATM Inhibitor Lartesertib as Monotherapy in Patients with Advanced Solid Tumors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Princess Margaret Cancer Centre; University Health Network","funders":"BeiGene; Merck KGaA; American Association for Cancer Research; AstraZeneca; GlaxoSmithKline; Amgen","keywords":"Medicine; Adverse effect; Pharmacokinetics; Rash; Tolerability; Maculopapular rash; Toxicity; Pharmacodynamics; Internal medicine; Response Evaluation Criteria in Solid Tumors; Pharmacology; Anemia; Mucositis; Gastroenterology; Phases of clinical research","score_opus":0.03361998146685217,"score_gpt":0.4489923089937287,"score_spread":0.41537232752687653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413787387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936871,0.0018944439,0.0007108275,0.00029261337,0.000106630934,0.0012180023,0.0008334699,0.00010022554,0.0011567587],"genre_scores_gemma":[0.9913078,0.0014741458,0.0013730484,0.00057653507,0.00018916126,0.0009509313,0.0016862301,0.000040258707,0.00240188],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99932015,0.0003561113,0.0000349599,0.00011240007,0.00007986595,0.00009667874],"domain_scores_gemma":[0.9993042,0.00013024149,0.00016900663,0.00008299799,0.00006156803,0.00025198128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019434098,0.0014402968,0.0019465245,0.0003599809,0.00040813044,0.0010292679,0.0006861541,0.00090970885,0.0036366966],"category_scores_gemma":[0.0010090615,0.0006392261,0.0012746535,0.00037795646,0.0009268435,0.0011027692,0.000277784,0.0031221982,0.00096660596],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4639143,0.18417351,0.015419977,0.0018432495,0.0025032382,0.0007392794,0.00048770182,0.004660879,0.15625621,0.00037260808,0.0061235423,0.16350546],"study_design_scores_gemma":[0.17631124,0.795339,0.011358833,0.00003351867,0.00052152434,0.0005443358,0.000071643495,0.0015725588,0.010373476,0.00013369523,0.003700668,0.00003958949],"about_ca_topic_score_codex":0.00062206364,"about_ca_topic_score_gemma":0.0019089145,"teacher_disagreement_score":0.0036366966,"about_ca_system_score_codex":0.001086232,"about_ca_system_score_gemma":0.0015820361,"threshold_uncertainty_score":0.012165904},"labels":[],"label_agreement":null},{"id":"W4413836422","doi":"10.1158/1078-0432.ccr-24-4342","title":"Phase I Dose-Escalation Trial Combining Olaparib and Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; AstraZeneca; AstraZeneca United States","keywords":"Medicine; Olaparib; Pneumonitis; Esophagitis; Internal medicine; PARP inhibitor; Radiation therapy; Adverse effect; Oncology; Gastroenterology; Urology; Surgery; Lung","score_opus":0.24740009084507647,"score_gpt":0.6157291510270154,"score_spread":0.36832906018193895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413836422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959531,0.0007699714,0.0003149171,0.00018752855,0.00007399282,0.0016541346,0.0002770179,0.00006347413,0.0007058516],"genre_scores_gemma":[0.99424875,0.0005421002,0.0010808385,0.00036560092,0.00010363544,0.0018024183,0.0007849129,0.00001426349,0.001057512],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995734,0.0001935051,0.000030170639,0.00008513481,0.000040848365,0.000076894714],"domain_scores_gemma":[0.9990251,0.00016121483,0.00022967703,0.00009834408,0.00004679755,0.00043884382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013749937,0.0013520663,0.0017782324,0.0003949689,0.00038022184,0.0009878164,0.001052717,0.0010150863,0.0027962376],"category_scores_gemma":[0.00087226985,0.00055468234,0.0010310541,0.00043829743,0.0010574537,0.000737398,0.00039495967,0.0037256216,0.0005243579],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7716689,0.10737618,0.0060423585,0.00067633047,0.0009983798,0.00023315693,0.00024725543,0.004357439,0.041049168,0.00019226271,0.0020911586,0.065067396],"study_design_scores_gemma":[0.57741994,0.4084127,0.0067992737,0.000024452105,0.00026561273,0.00020543828,0.000036101283,0.0016689476,0.003856026,0.0001588337,0.0011288368,0.000023887722],"about_ca_topic_score_codex":0.0005262937,"about_ca_topic_score_gemma":0.001628956,"teacher_disagreement_score":0.0027962376,"about_ca_system_score_codex":0.0009022782,"about_ca_system_score_gemma":0.0015175171,"threshold_uncertainty_score":0.009354353},"labels":[],"label_agreement":null},{"id":"W4413984867","doi":"10.1158/1078-0432.ccr-25-1796","title":"Prognosis and Biological Characteristics of ER-Low Metastatic Breast Cancer: Results from a Multicenter Cohort and the TONIC Trial","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada; Università degli Studi di Padova; Ministero della Salute; Gilead Sciences","keywords":"Medicine; Breast cancer; Internal medicine; Retrospective cohort study; Cohort; Metastatic breast cancer; Oncology; Metastasis; Prospective cohort study; Cohort study; Gastroenterology; Cancer","score_opus":0.10126012981366476,"score_gpt":0.463870641970623,"score_spread":0.3626105121569582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413984867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976313,0.0006668266,0.00009274447,0.00006755242,0.000016109565,0.000050233215,0.0011227682,0.000004427913,0.00034801807],"genre_scores_gemma":[0.9948047,0.0003182512,0.00013979603,0.000110658766,0.00006020218,0.00008430421,0.0042362167,0.000007305958,0.00023862913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852544,0.000796511,0.000118859156,0.00029808865,0.00016167371,0.00009946778],"domain_scores_gemma":[0.9967327,0.0004916121,0.0012694349,0.0006769989,0.0003074307,0.0005218838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038447913,0.00056015496,0.00103743,0.00029978206,0.00030373372,0.00074294495,0.000525654,0.00048770255,0.0014540338],"category_scores_gemma":[0.0033482811,0.00026234737,0.0010175077,0.0006225295,0.00033702687,0.00069309765,0.0005866194,0.00059117336,0.0002687866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22707666,0.0010272422,0.7443875,0.00034944792,0.003675165,0.000218404,0.00025532328,0.00065050484,0.004516258,0.00019247104,0.003017431,0.014633559],"study_design_scores_gemma":[0.026059292,0.022143675,0.9416423,0.00011552984,0.0034051922,0.000976019,0.00037900129,0.0011251954,0.00089286343,0.00016589876,0.003024503,0.00007051955],"about_ca_topic_score_codex":0.000931549,"about_ca_topic_score_gemma":0.0017218252,"teacher_disagreement_score":0.0038447913,"about_ca_system_score_codex":0.00045466705,"about_ca_system_score_gemma":0.00049353816,"threshold_uncertainty_score":0.020333469},"labels":[],"label_agreement":null},{"id":"W4414162081","doi":"10.1158/1078-0432.ccr-25-1513","title":"Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Immunocore; National Cancer Institute; Memorial Sloan-Kettering Cancer Center","keywords":"Adverse effect; Incidence (geometry); Pooled analysis; Clinical trial; Cancer; MEDLINE","score_opus":0.08419773544247613,"score_gpt":0.49156527494688634,"score_spread":0.4073675395044102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414162081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96122336,0.028282497,0.0028156757,0.00014360616,0.00004403302,0.00079742866,0.0049694744,0.00008440657,0.0016394663],"genre_scores_gemma":[0.993005,0.0025482986,0.00068376167,0.00018763187,0.00009390155,0.00034813414,0.0029040922,0.000012148711,0.00021709685],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9933013,0.0030540861,0.001075572,0.0010455059,0.0013183615,0.00020522758],"domain_scores_gemma":[0.99016833,0.003246285,0.004893839,0.0007616005,0.0006760514,0.00025400645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010870381,0.0007480604,0.0019012077,0.0012476732,0.00031501646,0.0009640758,0.00040557454,0.0007150597,0.0011958617],"category_scores_gemma":[0.008888755,0.0004047023,0.004644581,0.001243516,0.00037065241,0.00047304854,0.00053951715,0.00058415835,0.00018398462],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12981677,0.0011395614,0.57954395,0.0058994754,0.11995068,0.00038179284,0.0002505539,0.004580728,0.0125780655,0.00019189485,0.0020929421,0.14357364],"study_design_scores_gemma":[0.013418677,0.041965816,0.8606123,0.0006379265,0.06481566,0.0016013064,0.00013621764,0.0035948139,0.005953338,0.00041039265,0.0067511187,0.00010245862],"about_ca_topic_score_codex":0.00039937484,"about_ca_topic_score_gemma":0.00077748415,"teacher_disagreement_score":0.010870381,"about_ca_system_score_codex":0.00078606245,"about_ca_system_score_gemma":0.00074228505,"threshold_uncertainty_score":0.05748874},"labels":[],"label_agreement":null},{"id":"W4414754886","doi":"10.1158/1078-0432.ccr-25-2186","title":"Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; London Health Sciences Centre","funders":"National Institute of Biomedical Imaging and Bioengineering; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health; Veracyte; NRG Oncology; BeiGene; Congressionally Directed Medical Research Programs; Center for Cancer Research; Elekta; National Comprehensive Cancer Network; Academic Medical Organization of Southwestern Ontario; London Health Sciences Centre; National Center for Advancing Translational Sciences; Seagen; Association of Canadian Universities for Research in Astronomy; Nvidia; Moonshot Research and Development Program; AstraZeneca; Dartmouth College; Prostate Cancer Foundation; Cancer Moonshot; U.S. Department of Defense","keywords":"Prostate cancer; Transcriptome; Prostate; External beam radiotherapy; Radiation therapy; Biomarker; External beam radiation; Imaging biomarker","score_opus":0.08590075633874196,"score_gpt":0.4708184571642968,"score_spread":0.3849177008255549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414754886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770916,0.00052003126,0.0005836991,0.000023445176,0.00000298312,0.000007906038,0.0009462953,0.00001615256,0.00019034483],"genre_scores_gemma":[0.99741095,0.00021851248,0.0004160631,0.000027681885,0.0000043688638,0.000015719444,0.0016866722,0.0000054523266,0.00021444102],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99990606,0.000014541185,0.0000052709606,0.000036170975,0.000022027569,0.000015956135],"domain_scores_gemma":[0.9998425,0.000026239824,0.00007441586,0.000014485674,0.000018700304,0.000023631173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013272339,0.00014811332,0.0002912709,0.0003008635,0.00013522092,0.00035159008,0.00012263271,0.00015138177,0.0008451214],"category_scores_gemma":[0.00027581977,0.00010607425,0.00020135175,0.00041267986,0.00013587947,0.00013199868,0.00020267635,0.000240334,0.00021969096],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018983496,0.00015356202,0.47264457,0.00019234525,0.00022000313,0.00024581983,0.00021476662,0.0008277228,0.5019632,0.00008962108,0.0003827663,0.021167293],"study_design_scores_gemma":[0.00001614337,0.00032786586,0.97466725,0.000011703943,0.000106496685,0.00074303395,0.00013068183,0.0012103898,0.02195249,0.0000921217,0.0007330314,0.000008749461],"about_ca_topic_score_codex":0.0004458372,"about_ca_topic_score_gemma":0.0008136674,"teacher_disagreement_score":0.0008451214,"about_ca_system_score_codex":0.00013922923,"about_ca_system_score_gemma":0.00015321109,"threshold_uncertainty_score":0.002827227},"labels":[],"label_agreement":null},{"id":"W4415226237","doi":"10.1158/1078-0432.ccr-24-4010","title":"Leveraging Medulloblastoma Clonal Dynamics to Overcome Treatment Resistance","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); Population Health Research Institute; McMaster University Medical Centre; Hospital for Sick Children; Hamilton Health Sciences; University of Toronto; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Medulloblastoma; Dynamics (music); Cancer; Acquired resistance; Drug resistance; Chemotherapy","score_opus":0.19611104703557689,"score_gpt":0.5517871050590704,"score_spread":0.35567605802349345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415226237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813752,0.0026576289,0.010945843,0.0003035119,0.000064161344,0.00022678722,0.0006242974,0.0007003856,0.0031021442],"genre_scores_gemma":[0.9917155,0.0013776346,0.0045877383,0.00011563837,0.000013447953,0.00008733164,0.0004290703,0.000053138003,0.0016205026],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998629,0.000010204134,0.000007685285,0.000032458935,0.000057104,0.000029719991],"domain_scores_gemma":[0.9998915,0.000019172972,0.000033923105,0.000015234944,0.000018155513,0.00002191653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015513258,0.00031081194,0.00030326008,0.00032869235,0.00016142277,0.00038717611,0.00023534195,0.0002149607,0.0013541223],"category_scores_gemma":[0.00023487903,0.00012015045,0.00020504209,0.00014612165,0.00016288155,0.00023063952,0.00030077144,0.00064791396,0.0003159091],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008304918,0.00008321971,0.0007568369,0.00007057244,0.0000113526285,0.000045617515,0.000026215379,0.00086755067,0.9846838,0.00021804511,0.0003072174,0.012846408],"study_design_scores_gemma":[0.000031963136,0.0008720678,0.005340158,0.000012774268,0.000042114316,0.0003645064,0.00004173449,0.0053241323,0.97911835,0.00013628017,0.008707287,0.000008642842],"about_ca_topic_score_codex":0.0006946308,"about_ca_topic_score_gemma":0.0021469207,"teacher_disagreement_score":0.0013541223,"about_ca_system_score_codex":0.000438929,"about_ca_system_score_gemma":0.0003202296,"threshold_uncertainty_score":0.0045300126},"labels":[],"label_agreement":null},{"id":"W4415355988","doi":"10.1158/1078-0432.ccr-24-3785","title":"Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; National Cancer Institute","keywords":"Melanoma; Stage (stratigraphy); microRNA; Adjuvant; Cancer; Selection (genetic algorithm)","score_opus":0.03678259806618832,"score_gpt":0.42436566030159667,"score_spread":0.38758306223540834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415355988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991277,0.00012078438,0.00028406523,0.00001862557,0.0000032842145,0.0000047354247,0.00019037911,0.000006671017,0.00024384762],"genre_scores_gemma":[0.9994678,0.000026293807,0.00013018853,0.0000085276915,0.0000036289064,0.0000045251195,0.00026792966,0.0000023258447,0.000088909066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997509,0.0000620918,0.000030385128,0.000083245286,0.000044158904,0.000029176206],"domain_scores_gemma":[0.9990938,0.00020549296,0.0004011832,0.00007703797,0.0001107931,0.00011186628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005224379,0.00031355754,0.0002399855,0.0004500731,0.00022213534,0.0004119329,0.0001540261,0.00027473323,0.00089109363],"category_scores_gemma":[0.0017802278,0.00011248685,0.00032433908,0.00033057164,0.00021435712,0.00015370024,0.00029210825,0.0003680005,0.00022293949],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021177731,0.000015585372,0.9964729,0.0000066284088,0.000044988963,0.0000241275,0.000021137766,0.000155012,0.0015796996,0.000011074938,0.000060032526,0.0013970332],"study_design_scores_gemma":[0.0000069854664,0.00009366331,0.9976592,0.0000034901777,0.000045593337,0.00020531849,0.000037877046,0.0009877738,0.0007522754,0.000046128225,0.00015851506,0.0000032277544],"about_ca_topic_score_codex":0.00078341825,"about_ca_topic_score_gemma":0.0011952935,"teacher_disagreement_score":0.00089109363,"about_ca_system_score_codex":0.00021483796,"about_ca_system_score_gemma":0.0001762522,"threshold_uncertainty_score":0.002981007},"labels":[],"label_agreement":null},{"id":"W4415586443","doi":"10.1158/1078-0432.ccr-25-1459","title":"PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with <i>PIK3CA</i> -Mutated Solid Tumors and in Preclinical Models","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Princess Margaret Cancer Centre; University Health Network; Discovery Centre","funders":"","keywords":"Precision oncology; Solid tumor; Cancer; Precision medicine; Cooperativity","score_opus":0.07439259426989839,"score_gpt":0.4929038867641238,"score_spread":0.41851129249422536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415586443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873685,0.0040381635,0.0017124043,0.00028992567,0.00008063009,0.0001917692,0.0003903014,0.00031595814,0.005612351],"genre_scores_gemma":[0.9953418,0.0009340819,0.0012074686,0.00010421484,0.000024221861,0.000074523756,0.00063121796,0.000029885347,0.0016526661],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985695,0.00002311652,0.000010843126,0.000031652813,0.0000372999,0.00004007928],"domain_scores_gemma":[0.9998971,0.000013085559,0.000031372485,0.00001262785,0.000009414564,0.000036365385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003221016,0.0005027664,0.000602957,0.00026068182,0.00014139598,0.000600812,0.00035372426,0.00028168608,0.0023569388],"category_scores_gemma":[0.00023173039,0.00020252453,0.0005262317,0.00023723187,0.0002289459,0.00029094008,0.00019667335,0.0012623738,0.00060480676],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012818067,0.0050355745,0.0033201529,0.00046209025,0.00027519956,0.0002768189,0.000090051384,0.0024175507,0.871676,0.00049474114,0.002162624,0.10097123],"study_design_scores_gemma":[0.011626138,0.09094683,0.043000516,0.00010137427,0.00088462763,0.0035828857,0.0001600387,0.009197454,0.81185174,0.0004852989,0.02809824,0.000064834996],"about_ca_topic_score_codex":0.00042246922,"about_ca_topic_score_gemma":0.0013333414,"teacher_disagreement_score":0.0023569388,"about_ca_system_score_codex":0.00045212443,"about_ca_system_score_gemma":0.00045840553,"threshold_uncertainty_score":0.0078848},"labels":[],"label_agreement":null},{"id":"W4415586548","doi":"10.1158/1078-0432.ccr-24-4369","title":"Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children’s Oncology Group","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Stage (stratigraphy); Identification (biology); Clinical Oncology; Group (periodic table); Cancer; Neoplasm staging","score_opus":0.11198657946332789,"score_gpt":0.5161100474194166,"score_spread":0.40412346795608867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415586548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915426,0.004130562,0.00069338916,0.00019133781,0.00004380039,0.00004398558,0.0006753791,0.00001458682,0.0026643986],"genre_scores_gemma":[0.99694306,0.0014222173,0.0006430951,0.000069842776,0.000035833953,0.000018461893,0.000587926,0.0000059331887,0.00027356684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981445,0.000034922694,0.00002086527,0.000045718945,0.00005359281,0.000030441937],"domain_scores_gemma":[0.99926704,0.00026722928,0.00016088567,0.000050019764,0.00018256015,0.000072157854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004392645,0.0002550001,0.00015223074,0.00061775825,0.00026712552,0.00024019358,0.00014070104,0.00018721868,0.00059106183],"category_scores_gemma":[0.0016104586,0.00006813254,0.00019538999,0.00050531613,0.000282256,0.00018681781,0.0001617121,0.00028825886,0.00011550425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001420886,0.000009914696,0.98694116,0.000044438144,0.000038190035,0.0005659051,0.000089468645,0.00013750595,0.00074399135,0.00006139668,0.0007958163,0.0104302205],"study_design_scores_gemma":[0.000021737702,0.00012857704,0.98482066,0.00005196315,0.00016847817,0.006834021,0.00031318012,0.00032299396,0.0017517138,0.00007285556,0.005500709,0.000012969558],"about_ca_topic_score_codex":0.018015074,"about_ca_topic_score_gemma":0.015261695,"teacher_disagreement_score":0.018015074,"about_ca_system_score_codex":0.0004986642,"about_ca_system_score_gemma":0.000958637,"threshold_uncertainty_score":0.035820484},"labels":[],"label_agreement":null},{"id":"W4415621606","doi":"10.1158/1078-0432.ccr-25-3143","title":"On the Road to ROME: Defining Tissue–Liquid Concordance in Precision Oncology","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Concordance; Profiling (computer programming); Precision oncology; Precision medicine; Biopsy; Cancer; Liquid biopsy","score_opus":0.1089342623394439,"score_gpt":0.5243590187521124,"score_spread":0.4154247564126685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415621606","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00055815285,0.0761391,0.0033185962,0.8871608,0.029998235,0.000031082865,0.000098811855,0.000041758012,0.0026535364],"genre_scores_gemma":[0.019750014,0.038308926,0.0041152574,0.833643,0.10167013,0.00015761754,0.000113251364,0.0001291893,0.0021125637],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.95641685,0.027428636,0.0032158724,0.0030434148,0.008946237,0.0009490041],"domain_scores_gemma":[0.863171,0.11318277,0.0049375594,0.0023986928,0.014599386,0.0017106722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.044304624,0.0007302949,0.0019815264,0.0012465015,0.0022491063,0.0063575613,0.0037012924,0.01673709,0.0020742628],"category_scores_gemma":[0.12507394,0.00058243267,0.001473548,0.0010180203,0.012963044,0.008616969,0.0040916163,0.028666645,0.0013857867],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005212312,0.000032966553,0.0015690362,0.0016324966,0.00022950112,0.00042332133,0.0010841688,0.00045523766,0.00067281694,0.056829333,0.79843813,0.13811174],"study_design_scores_gemma":[0.00021737453,0.00033572013,0.0026703135,0.006106096,0.0002736237,0.0009907638,0.001232709,0.0011193105,0.0018351448,0.12587817,0.85910976,0.00023098497],"about_ca_topic_score_codex":0.004470922,"about_ca_topic_score_gemma":0.009917438,"teacher_disagreement_score":0.044304624,"about_ca_system_score_codex":0.0042260657,"about_ca_system_score_gemma":0.007420365,"threshold_uncertainty_score":0.23430806},"labels":[],"label_agreement":null},{"id":"W4415764619","doi":"10.1158/1078-0432.ccr-25-2851","title":"Biomarkers in High-Grade Serous Ovarian Cancer: Context Is Everything","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Context (archaeology); Serous fluid; Serous ovarian cancer; Biomarker; Serous carcinoma; Ovarian carcinoma; Carcinoma","score_opus":0.19691061443441976,"score_gpt":0.531483358529785,"score_spread":0.33457274409536525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415764619","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033751622,0.26647845,0.00048087226,0.6810108,0.050586637,0.000008182184,0.00011065897,0.000019709747,0.0009671459],"genre_scores_gemma":[0.011469464,0.3216792,0.0010738365,0.42848462,0.23479025,0.000034829234,0.00011777905,0.000049770246,0.0023002462],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9920751,0.0037373002,0.0011180536,0.00085388427,0.0019257072,0.0002899877],"domain_scores_gemma":[0.9480097,0.03737769,0.00196717,0.0006541416,0.010823327,0.0011679665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01117625,0.0008098265,0.0027052127,0.0012342193,0.0013195863,0.0035934711,0.0024525824,0.009549382,0.0021007124],"category_scores_gemma":[0.040909346,0.00048294154,0.0014137223,0.0013711543,0.0047244057,0.005890786,0.0016911791,0.021516798,0.0011351228],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003578916,0.000023147417,0.001061645,0.0033931374,0.00030214104,0.00062278926,0.00047389048,0.00035478253,0.0006931575,0.016006244,0.80919516,0.16751596],"study_design_scores_gemma":[0.00010618515,0.00016762559,0.002529605,0.010590527,0.00023863696,0.0014830489,0.0007133453,0.00041257136,0.0005323737,0.03633143,0.946748,0.00014667056],"about_ca_topic_score_codex":0.0064059147,"about_ca_topic_score_gemma":0.011896488,"teacher_disagreement_score":0.01117625,"about_ca_system_score_codex":0.0027772964,"about_ca_system_score_gemma":0.0037322345,"threshold_uncertainty_score":0.05910635},"labels":[],"label_agreement":null},{"id":"W4416084768","doi":"10.1158/1078-0432.ccr-25-1946","title":"Machine Learning–Based Prediction of Distant Recurrence Risk and Ribociclib Treatment Effect in HR+/HER2− Early Breast Cancer Using Real-World and NATALEE Data","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"Astellas Pharma; Astex Pharmaceuticals; Seagen; Invitae; Gilead Sciences; BeiGene; Daiichi Sankyo Europe; Sanofi; Veracyte; Novartis Institutes for BioMedical Research; Amgen; Pfizer; Novartis Pharmaceuticals Corporation; AstraZeneca; Eli Lilly and Company","keywords":"Breast cancer; Cancer; MEDLINE; Risk assessment; Patient data","score_opus":0.1877959057952461,"score_gpt":0.5374822287604847,"score_spread":0.3496863229652386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416084768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936194,0.0005257112,0.0025028107,0.00040745182,0.000016382079,0.000068746616,0.0021739781,0.000055794848,0.00062968046],"genre_scores_gemma":[0.9937656,0.00009731437,0.0020741054,0.000076581324,0.000014881658,0.00004770012,0.003723528,0.0000054595885,0.00019473354],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9979358,0.0013474071,0.00013036118,0.00032129596,0.00018457779,0.00008054353],"domain_scores_gemma":[0.98969823,0.007119037,0.0014663738,0.0009507949,0.00055503397,0.00021054181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008547862,0.0004720049,0.0005095544,0.0008971641,0.00017706142,0.00069339457,0.0006595697,0.00051766285,0.00065842224],"category_scores_gemma":[0.016171442,0.00017259821,0.000784992,0.0005903317,0.0003461543,0.00046820712,0.00057310757,0.0008395327,0.00025088424],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031904937,0.00095769175,0.76032114,0.00024285066,0.0010466559,0.0002202064,0.00011650668,0.18684624,0.0009130772,0.0005004641,0.0032866767,0.04235801],"study_design_scores_gemma":[0.00046295277,0.0013833863,0.26512972,0.000084749874,0.00033928832,0.00028126207,0.00010523499,0.7272336,0.0016524864,0.0010268744,0.0022472423,0.000053173477],"about_ca_topic_score_codex":0.005615572,"about_ca_topic_score_gemma":0.00692278,"teacher_disagreement_score":0.008547862,"about_ca_system_score_codex":0.00086809474,"about_ca_system_score_gemma":0.00062252796,"threshold_uncertainty_score":0.04520595},"labels":[],"label_agreement":null},{"id":"W4416202622","doi":"10.1158/1078-0432.ccr-25-3334","title":"Novel High-Dose Chemotherapy Regimens in Relapsed/Refractory Germ Cell Cancer: Have We Made Progress?","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Chemotherapy; Germ cell; Germ cell tumors; Cell; Stem cell; Cancer","score_opus":0.13242648239890045,"score_gpt":0.5134600046485386,"score_spread":0.38103352224963816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416202622","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037634704,0.90277123,0.0014891272,0.048556525,0.0029668876,0.000089505134,0.00020282752,0.000106925814,0.00618221],"genre_scores_gemma":[0.16302419,0.8009119,0.0047933166,0.018779868,0.0074834987,0.00016744778,0.0004579582,0.00005788684,0.0043239295],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99955124,0.0001916145,0.000054141965,0.000058903424,0.00006717648,0.00007696351],"domain_scores_gemma":[0.99880004,0.0004596263,0.00023886818,0.00007118644,0.00022663105,0.00020372213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002605458,0.00035120215,0.0011166943,0.00029266966,0.0002368752,0.0014405656,0.00070399186,0.00097091036,0.0051558553],"category_scores_gemma":[0.0022735666,0.00014421447,0.0007759398,0.00042534253,0.0007091941,0.0030400539,0.00041925703,0.0027127475,0.001028184],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028069578,0.00087569456,0.0017820913,0.002141425,0.00024853685,0.00020357876,0.00015291599,0.00076134317,0.002498848,0.0031053885,0.017078033,0.9683452],"study_design_scores_gemma":[0.011292661,0.03872673,0.045730777,0.011809707,0.0020657799,0.0046095517,0.001792203,0.0030978946,0.005277549,0.01758614,0.85771817,0.00029275697],"about_ca_topic_score_codex":0.00066870556,"about_ca_topic_score_gemma":0.0037594745,"teacher_disagreement_score":0.0051558553,"about_ca_system_score_codex":0.0006051392,"about_ca_system_score_gemma":0.0010636516,"threshold_uncertainty_score":0.017248094},"labels":[],"label_agreement":null},{"id":"W4416239499","doi":"10.1158/1078-0432.ccr-25-3040","title":"Real-World Outcomes of Elacestrant in ER+, HER2−, <i>ESR1</i> -Mutant Metastatic Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovative Research Group (Canada)","funders":"Menarini Group","keywords":"Metastatic breast cancer; Breast cancer; PI3K/AKT/mTOR pathway; Cancer; MEDLINE","score_opus":0.16887152885739296,"score_gpt":0.562525891090164,"score_spread":0.39365436223277106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416239499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98910844,0.0013733797,0.00019212528,0.0002910141,0.000025129664,0.000039618866,0.008146323,0.000008215113,0.00081581046],"genre_scores_gemma":[0.99159425,0.00026764587,0.0001278241,0.00008824956,0.000029612069,0.00005197095,0.0076817027,0.000003295449,0.00015550085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786997,0.001061479,0.0002311843,0.00047199684,0.00020741497,0.00015794141],"domain_scores_gemma":[0.99073774,0.0029313418,0.0047990885,0.00046802787,0.0004004549,0.0006633826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031927894,0.00033803697,0.000614161,0.00040520955,0.00026719505,0.0008789808,0.00047764095,0.00049110706,0.002358839],"category_scores_gemma":[0.009625803,0.0001698878,0.0011719195,0.0008885662,0.00032243467,0.0008127898,0.0005887474,0.00089132163,0.00033295644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03955327,0.000718225,0.929078,0.00050922687,0.0024942295,0.00023400714,0.00017747334,0.0050096004,0.0004719061,0.00041681645,0.0040262826,0.01731099],"study_design_scores_gemma":[0.0024904464,0.0053758025,0.9787204,0.00018214223,0.0015139853,0.0006073672,0.00029530673,0.0053370846,0.00061950006,0.0007207472,0.004070318,0.00006681387],"about_ca_topic_score_codex":0.0022714974,"about_ca_topic_score_gemma":0.002675841,"teacher_disagreement_score":0.0031927894,"about_ca_system_score_codex":0.0011714067,"about_ca_system_score_gemma":0.00047607435,"threshold_uncertainty_score":0.016885221},"labels":[],"label_agreement":null},{"id":"W4416328850","doi":"10.1158/1078-0432.ccr-25-1834","title":"Clinicogenomic Characterization of Primary Sclerosing Cholangitis–Associated Biliary Tract Cancers","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Foundation; University Health Network; University of Toronto; Toronto General Hospital; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Terry Fox Research Institute; Cholangiocarcinoma Foundation; Princess Margaret Cancer Foundation","keywords":"Biliary tract cancer; Biliary tract; Immunotherapy; Primary sclerosing cholangitis; Retrospective cohort study; Clinical trial; Prospective cohort study","score_opus":0.24221617536378215,"score_gpt":0.5035686205855475,"score_spread":0.2613524452217654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416328850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99752504,0.00052634266,0.0003491446,0.000032808093,0.000002644515,0.000009813214,0.0010952717,0.0000099196795,0.00044904012],"genre_scores_gemma":[0.9979017,0.00016764668,0.0003275921,0.000036634498,0.0000052691157,0.000012523096,0.0014246939,0.0000058162877,0.00011819222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997594,0.000048307127,0.000026418571,0.00007454889,0.00005169009,0.000039618262],"domain_scores_gemma":[0.99965596,0.000056016383,0.00017722795,0.00003111751,0.000040433137,0.000039288083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024499264,0.00016739733,0.0002529209,0.0009227844,0.00020599483,0.00034672546,0.00011768128,0.00016957495,0.0008409659],"category_scores_gemma":[0.0005300228,0.000094456394,0.00020097005,0.00094356446,0.00024936753,0.000113364236,0.00027638205,0.00012190402,0.00015555964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005655677,0.00003017737,0.910438,0.00011111948,0.00013110579,0.0006298764,0.00013833937,0.00035533332,0.07878704,0.00009919326,0.0002709168,0.008443364],"study_design_scores_gemma":[0.0000068429185,0.000078739096,0.9939062,0.000007860221,0.00005148484,0.0016732495,0.000106375206,0.00045585187,0.0029287294,0.00006929575,0.00071211375,0.0000033124163],"about_ca_topic_score_codex":0.0009571671,"about_ca_topic_score_gemma":0.001948251,"teacher_disagreement_score":0.0009571671,"about_ca_system_score_codex":0.00019795983,"about_ca_system_score_gemma":0.00017282515,"threshold_uncertainty_score":0.0028132796},"labels":[],"label_agreement":null},{"id":"W4416331414","doi":"10.1158/1078-0432.ccr-25-2440","title":"Cergutuzumab Amunaleukin in Combination with Atezolizumab in Patients with Carcinoembryonic Antigen–Positive Advanced/Metastatic Solid Tumors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"F. Hoffmann-La Roche; Roche","keywords":"Atezolizumab; Carcinoembryonic antigen; Pharmacodynamics; Solid tumor; Cancer; Pharmacokinetics","score_opus":0.07898439884002029,"score_gpt":0.5006161356055636,"score_spread":0.42163173676554333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416331414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997519,0.0016465145,0.0001413297,0.00011268561,0.000023033892,0.00012049529,0.000051114082,0.0000140876555,0.00037170795],"genre_scores_gemma":[0.9986994,0.00052701886,0.00024612685,0.00013083534,0.00003865435,0.00007378385,0.000115130155,0.000002836303,0.00016614038],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996561,0.0001611655,0.00002792494,0.000048546568,0.000047652884,0.000058611644],"domain_scores_gemma":[0.99961025,0.000091217036,0.000104122075,0.000024577697,0.000025026906,0.00014480851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007721065,0.00048540882,0.0013854086,0.00022162317,0.00022666226,0.00044566896,0.0003195772,0.0004084496,0.0006838835],"category_scores_gemma":[0.0007482579,0.0002297217,0.0006906389,0.00026625974,0.00032888766,0.0003665731,0.00019773214,0.0010497331,0.00017410351],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4097138,0.021949766,0.107906684,0.00095038576,0.0024624579,0.001587761,0.0005994579,0.006694018,0.1119854,0.0002600781,0.0026275122,0.3332627],"study_design_scores_gemma":[0.18338756,0.61950743,0.16235286,0.00012149416,0.0017682532,0.0026855369,0.00018922388,0.0062340917,0.015614929,0.00026602947,0.007813056,0.00005966602],"about_ca_topic_score_codex":0.0005042989,"about_ca_topic_score_gemma":0.0014464256,"teacher_disagreement_score":0.0013854086,"about_ca_system_score_codex":0.000590682,"about_ca_system_score_gemma":0.0007048599,"threshold_uncertainty_score":0.004285693},"labels":[],"label_agreement":null},{"id":"W4416866070","doi":"10.1158/1078-0432.ccr-25-3327","title":"A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"National Institute of Biomedical Imaging and Bioengineering; National Institutes of Health; National Cancer Institute; U.S. Department of Defense; National Heart, Lung, and Blood Institute; U.S. Department of Veterans Affairs","keywords":"Docetaxel; Prostate cancer; Androgen receptor; Prostate; Clinical trial; Cancer; Androgen","score_opus":0.15096268327338347,"score_gpt":0.5233388552715308,"score_spread":0.3723761719981473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416866070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8837429,0.0007000585,0.11041898,0.0011849226,0.00007932251,0.00017170762,0.00095220114,0.0007137427,0.0020362306],"genre_scores_gemma":[0.9853242,0.00012455377,0.012934615,0.00011422832,0.000030184472,0.00010005829,0.00071782456,0.000013249952,0.0006410015],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9997644,0.00007144699,0.000016416456,0.00006486138,0.00005216044,0.000030690044],"domain_scores_gemma":[0.99851114,0.0010672797,0.00020332319,0.000046271864,0.00011833831,0.000053642067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010740167,0.0005799273,0.00060070667,0.0009924349,0.0002756597,0.0008641087,0.0007076039,0.00061997515,0.0010576663],"category_scores_gemma":[0.0029885338,0.00026131634,0.0007886678,0.0004152651,0.000376841,0.00031572123,0.00037864098,0.00063805387,0.00022438793],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008441317,0.00053474674,0.07869061,0.000075753866,0.0002660445,0.00027599218,0.000052354306,0.84829485,0.0021335923,0.0007563213,0.0014254012,0.06665019],"study_design_scores_gemma":[0.000016284746,0.000070215414,0.0038903595,0.0000031751551,0.000026572676,0.000041048257,0.0000049917912,0.99520916,0.00025700172,0.00036587208,0.00011120011,0.0000040621],"about_ca_topic_score_codex":0.010744384,"about_ca_topic_score_gemma":0.0068107075,"teacher_disagreement_score":0.010744384,"about_ca_system_score_codex":0.0011758836,"about_ca_system_score_gemma":0.0012190825,"threshold_uncertainty_score":0.021363735},"labels":[],"label_agreement":null},{"id":"W4416998054","doi":"10.1158/1078-0432.ccr-25-2426","title":"FET-Rearranged Myoepithelial Tumors Are Clinically Heterogeneous and Epigenetically Distinct from <i>PLAG1</i> -Rearranged Adnexal and Salivary Gland Myoepithelial Tumors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"National Cancer Institute; Cycle for Survival; U.S. Department of Defense","keywords":"Salivary gland; Myoepithelial cell; Myoepithelioma; Mammary gland; Cancer","score_opus":0.09446466903178602,"score_gpt":0.44692566264135386,"score_spread":0.35246099360956784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416998054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992254,0.00021572255,0.00017977753,0.000005956546,7.9118894e-7,0.000005496472,0.0001438131,0.000006105482,0.00021693853],"genre_scores_gemma":[0.99950635,0.000058332877,0.00012245668,0.000005384878,0.0000016920662,0.0000035384678,0.00024091947,0.000002165759,0.00005912973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999819,0.000023267587,0.000030225288,0.00006734761,0.000032505333,0.000027609132],"domain_scores_gemma":[0.9996952,0.000050177296,0.00016737542,0.000031439402,0.000021254753,0.000034710953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028943835,0.00017358254,0.00023394683,0.0006533736,0.00015339439,0.00037985065,0.00013341327,0.00014387563,0.00112946],"category_scores_gemma":[0.00062002364,0.000121420824,0.0002069159,0.0004458098,0.00024719446,0.00023759746,0.0003025015,0.00010859194,0.00017532847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005317572,0.000020879392,0.9404016,0.000046021458,0.00011303041,0.0008033591,0.00015770794,0.00015379599,0.05047643,0.0000765907,0.00005656047,0.00716215],"study_design_scores_gemma":[0.000013239464,0.0001775585,0.98765147,0.000009385285,0.00008861569,0.00542009,0.00023980124,0.00029822352,0.0054836744,0.00011028432,0.00050273776,0.0000047796716],"about_ca_topic_score_codex":0.0004292629,"about_ca_topic_score_gemma":0.0008840153,"teacher_disagreement_score":0.00112946,"about_ca_system_score_codex":0.00014742516,"about_ca_system_score_gemma":0.00011863582,"threshold_uncertainty_score":0.003778398},"labels":[],"label_agreement":null},{"id":"W4417201089","doi":"10.1158/1557-3265.earlyonsetca25-b002","title":"Abstract B002: Addressing knowledge gaps in early-onset cancers: Radiological insights into oncogenic-immune dynamics of anaplastic Wilms tumors","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Radiological weapon; Wilms' tumor; Immune system; Personalized medicine; Radiological imaging; Immunophenotyping","score_opus":0.0754728213299657,"score_gpt":0.4553193133154719,"score_spread":0.3798464919855062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201089","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3500101,0.3548968,0.080865465,0.090998635,0.009877505,0.0004043387,0.068356074,0.0027435047,0.041847516],"genre_scores_gemma":[0.76803315,0.10171823,0.053339202,0.009525625,0.0074588093,0.00046184912,0.04607125,0.0007230466,0.012668806],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989826,0.00028292235,0.00012794494,0.00026251847,0.00025610926,0.00008787625],"domain_scores_gemma":[0.9951662,0.0022187016,0.00074782304,0.00036365504,0.00111376,0.00038989662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040207286,0.00053011376,0.0008069479,0.004408198,0.0006630433,0.0029793822,0.00089545094,0.0012581743,0.017401084],"category_scores_gemma":[0.0110887345,0.00028386142,0.0006143235,0.0039048493,0.00078584894,0.0024842492,0.001979177,0.001395487,0.0031856874],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001053024,0.00012446675,0.10232088,0.012497584,0.0006661987,0.002154824,0.0016535661,0.0026841715,0.03218115,0.011315403,0.12582767,0.7075211],"study_design_scores_gemma":[0.00012140702,0.00026639574,0.23800397,0.005872747,0.0009402615,0.006632013,0.0029238323,0.0053405715,0.019407647,0.03927825,0.6810123,0.00020058385],"about_ca_topic_score_codex":0.0016514882,"about_ca_topic_score_gemma":0.002060147,"teacher_disagreement_score":0.017401084,"about_ca_system_score_codex":0.0008105789,"about_ca_system_score_gemma":0.0021563948,"threshold_uncertainty_score":0.0582124},"labels":[],"label_agreement":null},{"id":"W4417201092","doi":"10.1158/1557-3265.earlyonsetca25-a004","title":"Abstract A004: Paid Family Leave as a Cancer Prevention Strategy? The association of state paid family leave implementation with early-onset breast and endometrial cancer incidence","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Incidence (geometry); Quartile; Breast cancer; Breastfeeding; Socioeconomic status; Endometrial cancer; Cancer prevention; Cancer","score_opus":0.12455884813667735,"score_gpt":0.5340931242522976,"score_spread":0.40953427611562027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923131,0.0014477122,0.000281053,0.0029181459,0.000107615764,0.00003683447,0.0014881649,0.000015840087,0.0013915662],"genre_scores_gemma":[0.9984816,0.00018966089,0.00009500891,0.00022274531,0.000067838635,0.00002429329,0.00043749716,0.0000036430706,0.00047781112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987834,0.0005228326,0.00007723476,0.00024227684,0.00014764522,0.00022654387],"domain_scores_gemma":[0.99477816,0.0013711248,0.0023860447,0.00023962113,0.0003489832,0.0008760331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001906201,0.00014673683,0.00024610423,0.0002825519,0.00042403003,0.00086190243,0.0008912341,0.0006547783,0.006417033],"category_scores_gemma":[0.007768452,0.00013540531,0.001083694,0.0006353396,0.00029735116,0.0005781653,0.00049679703,0.0008592817,0.00018695575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011630266,0.00033664797,0.9758942,0.00016740322,0.00040714134,0.000049392456,0.00019851967,0.00019997975,0.00015883845,0.00032280223,0.0026611537,0.018440943],"study_design_scores_gemma":[0.00006253278,0.000292383,0.9974612,0.00008611166,0.00021853388,0.000019560084,0.00030374504,0.00030657463,0.000055664284,0.00009003621,0.0010993045,0.0000044112694],"about_ca_topic_score_codex":0.02813971,"about_ca_topic_score_gemma":0.024367373,"teacher_disagreement_score":0.02813971,"about_ca_system_score_codex":0.0009546161,"about_ca_system_score_gemma":0.001724771,"threshold_uncertainty_score":0.055951834},"labels":[],"label_agreement":null},{"id":"W4417201093","doi":"10.1158/1557-3265.earlyonsetca25-b001","title":"Abstract B001: Implementation Science-Informed Development of a Comprehensive Early Onset Cancer Program: Provider Perspectives","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychosocial; Thematic analysis; Descriptive statistics; Clinical Oncology; MEDLINE; Radiation oncology; Needs assessment; Cancer","score_opus":0.33060855438891495,"score_gpt":0.5652553798403559,"score_spread":0.23464682545144094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201093","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2514972,0.0045080977,0.030868752,0.5078331,0.002027298,0.006708017,0.002471101,0.00046272977,0.19362357],"genre_scores_gemma":[0.89252704,0.0068159117,0.05371022,0.026857082,0.0004842033,0.0044711223,0.0012435969,0.0001057034,0.013785147],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.97935313,0.015846912,0.0008094779,0.0003620344,0.0024532909,0.0011750492],"domain_scores_gemma":[0.94457084,0.034298696,0.002757141,0.0013502939,0.009388481,0.007634514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.037273277,0.00025499548,0.00021811975,0.0010070533,0.0029057525,0.0045125275,0.0011123155,0.0023814237,0.016071958],"category_scores_gemma":[0.058183465,0.0002643802,0.00033144196,0.0012626505,0.0023241385,0.0033174765,0.0048381607,0.0032832203,0.0012862007],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020804207,0.003340551,0.04117285,0.0073301485,0.00006471406,0.00063650217,0.09020264,0.0018130314,0.002657512,0.06496139,0.27192482,0.5156878],"study_design_scores_gemma":[0.0003296741,0.0019297262,0.08730664,0.014934048,0.00011957006,0.00075097336,0.2713412,0.005813547,0.0046287,0.03742899,0.5752869,0.00012998568],"about_ca_topic_score_codex":0.0060571055,"about_ca_topic_score_gemma":0.0064564445,"teacher_disagreement_score":0.037273277,"about_ca_system_score_codex":0.006543408,"about_ca_system_score_gemma":0.03927821,"threshold_uncertainty_score":0.19712228},"labels":[],"label_agreement":null},{"id":"W4417201094","doi":"10.1158/1557-3265.earlyonsetca25-a017","title":"Abstract A017: Equity and the age cutoff problem: Rethinking early detection and screening in Nigeria","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Epidemiology; Referral; Cancer registry; Cancer screening; Health equity; Cancer prevention; Cancer; Equity (law); Public health","score_opus":0.21507151025959742,"score_gpt":0.5369919488974084,"score_spread":0.321920438637811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201094","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80375797,0.028480632,0.0062184567,0.13574688,0.0011987765,0.00033541865,0.001309456,0.000022761194,0.022929637],"genre_scores_gemma":[0.9860394,0.006227593,0.002652621,0.004191434,0.00015524872,0.00011095655,0.00015874856,0.0000074984396,0.00045654032],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9944358,0.0034083743,0.00043836946,0.00041475636,0.00069331785,0.00060935563],"domain_scores_gemma":[0.97967714,0.012801461,0.0034333845,0.00076729036,0.0021737064,0.001146997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021836266,0.00022517597,0.00033854926,0.0021954912,0.0018787187,0.0031205483,0.0010427565,0.0009542565,0.0023767247],"category_scores_gemma":[0.039422717,0.0002272933,0.00032419965,0.0027224363,0.002188314,0.0045648506,0.0037412415,0.0020391673,0.00009988973],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002088911,0.00023586252,0.6078899,0.0022962918,0.00008327208,0.0007180396,0.025561474,0.00078820396,0.0003691927,0.05583179,0.010163267,0.29585385],"study_design_scores_gemma":[0.000052063642,0.00043206243,0.66028,0.022515334,0.00032056507,0.0011843875,0.17504528,0.0038557556,0.0015129626,0.06374932,0.070947155,0.0001051544],"about_ca_topic_score_codex":0.030601883,"about_ca_topic_score_gemma":0.037923653,"teacher_disagreement_score":0.030601883,"about_ca_system_score_codex":0.004098366,"about_ca_system_score_gemma":0.012600856,"threshold_uncertainty_score":0.11548257},"labels":[],"label_agreement":null},{"id":"W4417201097","doi":"10.1158/1557-3265.earlyonsetca25-b005","title":"Abstract B005: Comparative genomic analysis between early-onset and average-onset colorectal cancer patients at the Cleveland Clinic","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Cancer; Disease; Stage (stratigraphy); Exome sequencing; Etiology; Exome","score_opus":0.10612365787113569,"score_gpt":0.47475380503733106,"score_spread":0.36863014716619535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99580765,0.00016491026,0.00020443519,0.00006710587,0.000008885816,0.000016739856,0.002703667,0.000014361557,0.0010122022],"genre_scores_gemma":[0.99712497,0.000042103387,0.0003377704,0.00005877787,0.0000104867,0.000015616573,0.0022089935,0.000006246822,0.00019508423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99944085,0.00008713968,0.000049429866,0.00019701477,0.00010140938,0.00012416586],"domain_scores_gemma":[0.9985922,0.00024789415,0.000425523,0.0001106849,0.00031840385,0.00030514164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005033315,0.00018237374,0.00025339882,0.0017009614,0.00088914216,0.000648128,0.00035015005,0.00033607346,0.0033142352],"category_scores_gemma":[0.0021386447,0.00017240644,0.00023611216,0.001156917,0.00026943625,0.00024663133,0.0005567104,0.00034759377,0.00035614602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017623148,0.000028201202,0.99105936,0.000021426536,0.00003695485,0.0003228762,0.00022300129,0.00007284067,0.002718902,0.000059790265,0.0011755743,0.0041048126],"study_design_scores_gemma":[0.0000073326446,0.00007154834,0.9979358,0.0000074918294,0.000015104569,0.0005507843,0.00021739205,0.00017541728,0.00023124123,0.000020225914,0.00076303276,0.0000048269276],"about_ca_topic_score_codex":0.016143078,"about_ca_topic_score_gemma":0.02075882,"teacher_disagreement_score":0.016143078,"about_ca_system_score_codex":0.0005227056,"about_ca_system_score_gemma":0.00041468302,"threshold_uncertainty_score":0.032098234},"labels":[],"label_agreement":null},{"id":"W4417201098","doi":"10.1158/1557-3265.earlyonsetca25-a022","title":"Abstract A022: Exploring the association of quantitative fecal immunochemical test (qFIT) with red-flag symptoms of early onset colorectal cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colonoscopy; Colorectal cancer; Abdominal pain; Odds ratio; Logistic regression; Triage; Test (biology)","score_opus":0.15479361769203548,"score_gpt":0.47992181848812215,"score_spread":0.3251282007960867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988269,0.00019629851,0.0006038266,0.00035468896,0.000031562635,0.000040720468,0.009448802,0.000024290575,0.0010307429],"genre_scores_gemma":[0.9945748,0.000062201616,0.0005526761,0.00014063064,0.000032979002,0.000064047956,0.004048141,0.000010600704,0.0005139145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997437,0.00093891803,0.000343216,0.00050669146,0.00040585134,0.00036832047],"domain_scores_gemma":[0.98049647,0.0061324784,0.009593107,0.00087046577,0.0017427113,0.0011647197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030555876,0.00036106337,0.00028306636,0.0013944269,0.00044994187,0.00110244,0.0007967766,0.0006173645,0.004405999],"category_scores_gemma":[0.0155105265,0.00024958278,0.0010788887,0.002049693,0.00032756367,0.000834784,0.0009119714,0.0010691015,0.0006631899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007352717,0.000028173117,0.998784,0.000017497876,0.0000424863,0.000017294415,0.00001873151,0.00004527947,0.000035188365,0.0000143359475,0.0003148787,0.0006085699],"study_design_scores_gemma":[0.000010486433,0.0001698697,0.9976827,0.000021914544,0.000054133136,0.00010529169,0.00017982088,0.0011119879,0.0001005892,0.00003632435,0.00052090565,0.000005931897],"about_ca_topic_score_codex":0.013313529,"about_ca_topic_score_gemma":0.012282672,"teacher_disagreement_score":0.013313529,"about_ca_system_score_codex":0.0007364282,"about_ca_system_score_gemma":0.0012217596,"threshold_uncertainty_score":0.026472092},"labels":[],"label_agreement":null},{"id":"W4417201100","doi":"10.1158/1557-3265.earlyonsetca25-a003","title":"Abstract A003: Unfinished Stories: Consequences of Melanoma Clinical Trial Discontinuation and Non-Publication","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Discontinuation; Clinical trial; Psychological intervention; Melanoma; Logistic regression; MEDLINE; Clinical research; Cancer","score_opus":0.24084318701766835,"score_gpt":0.550600989740054,"score_spread":0.3097578027223856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3004283,0.1829406,0.032458004,0.28130877,0.010570829,0.008953286,0.114432245,0.0016945165,0.06721351],"genre_scores_gemma":[0.871939,0.0293104,0.016303577,0.046209965,0.005692972,0.0079236245,0.014511707,0.0007923504,0.0073163956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.6289853,0.22006372,0.08585327,0.010890243,0.050463922,0.0037436262],"domain_scores_gemma":[0.09079653,0.7086266,0.1507335,0.023726195,0.022475021,0.0036421493],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.25153843,0.0007612246,0.0017532645,0.009898045,0.0027907463,0.008008356,0.0024997485,0.0035118654,0.018038882],"category_scores_gemma":[0.6421352,0.00089851575,0.0062279645,0.018356247,0.0030103032,0.0065091923,0.0037303183,0.004207667,0.0026405426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014098685,0.00043206738,0.39056927,0.08458656,0.01674973,0.0026937558,0.004211999,0.0014109298,0.00077921874,0.013486618,0.18376298,0.2872181],"study_design_scores_gemma":[0.004267385,0.002199412,0.4508724,0.09922866,0.024025435,0.0076757614,0.0056914072,0.0070035225,0.0034419638,0.0563074,0.3387364,0.0005502496],"about_ca_topic_score_codex":0.0022380915,"about_ca_topic_score_gemma":0.0034001458,"teacher_disagreement_score":0.99648815,"about_ca_system_score_codex":0.0040198313,"about_ca_system_score_gemma":0.008370026,"threshold_uncertainty_score":0.9229864},"labels":[],"label_agreement":null},{"id":"W4417201101","doi":"10.1158/1557-3265.earlyonsetca25-a030","title":"Abstract A030: The role of liquid biopsies in optimizing early-onset non-small cell lung cancer (NSCLC) cancer screening and detection in underserved populations globally","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung cancer; Cancer; Lung cancer screening; Liquid biopsy; Medical diagnosis; Cancer screening; Health equity; Health care","score_opus":0.083402006360489,"score_gpt":0.4294044453057617,"score_spread":0.3460024389452727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201101","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027704937,0.83272356,0.031424362,0.064023934,0.008601435,0.0015320664,0.01727063,0.0005235865,0.016195549],"genre_scores_gemma":[0.5104027,0.35460705,0.057290513,0.045573663,0.010014874,0.002538155,0.008441268,0.000693586,0.010438186],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.96753067,0.026455544,0.0017410609,0.0014599016,0.0024920467,0.00032088108],"domain_scores_gemma":[0.92873937,0.053414937,0.00726237,0.002075947,0.007504115,0.0010032048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.036158852,0.0012595592,0.0019064695,0.0015810927,0.00041220945,0.0036225063,0.001776121,0.0020398945,0.011921176],"category_scores_gemma":[0.11205182,0.0004972303,0.0076189917,0.0021996798,0.0006519647,0.0024141886,0.0017532351,0.0024031412,0.0016092025],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012145422,0.00021118406,0.04852961,0.09918889,0.07633573,0.00024187815,0.0005182655,0.004866653,0.0019624594,0.012439718,0.12772399,0.6158363],"study_design_scores_gemma":[0.004654323,0.0060472204,0.13585302,0.14413476,0.23084196,0.0010945502,0.0013338834,0.016803302,0.007993701,0.046430275,0.40435752,0.0004554491],"about_ca_topic_score_codex":0.0073753987,"about_ca_topic_score_gemma":0.008598959,"teacher_disagreement_score":0.036158852,"about_ca_system_score_codex":0.0018662295,"about_ca_system_score_gemma":0.004236314,"threshold_uncertainty_score":0.19122851},"labels":[],"label_agreement":null},{"id":"W4417201103","doi":"10.1158/1557-3265.earlyonsetca25-b011","title":"Abstract B011: Associations between county-level air pollutants and early-onset breast cancer incidence rates in the U.S","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Incidence (geometry); Air pollutants; Cancer; Epidemiology; Cancer registry","score_opus":0.22805712930865624,"score_gpt":0.5491948911517422,"score_spread":0.321137761843086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905273,0.0004504962,0.00034475993,0.00014753532,0.000023047021,0.000010180063,0.0076749153,0.00003456031,0.0007872397],"genre_scores_gemma":[0.9941754,0.00016928528,0.00030265521,0.00004646949,0.000014497265,0.00001234171,0.0044133468,0.0000063100606,0.0008598718],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998016,0.000059368384,0.00001667849,0.00006249065,0.000033226286,0.000026615222],"domain_scores_gemma":[0.99907696,0.00017253742,0.00028755347,0.00006396957,0.00028367992,0.00011533415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038161082,0.000253806,0.00019428093,0.00060986157,0.00022989434,0.00038649794,0.00024196485,0.00021852566,0.00291889],"category_scores_gemma":[0.0010165123,0.00015854852,0.00048625446,0.0010328946,0.000085099855,0.00014650112,0.00028851593,0.00032768457,0.00040599058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007232977,0.000022833296,0.997426,0.000016191521,0.00010686702,0.000017843575,0.000019984904,0.00013868358,0.00015807002,0.000012206289,0.0007735768,0.001235399],"study_design_scores_gemma":[0.0000043413143,0.000023516553,0.9992398,0.0000059536674,0.00004353655,0.00002649055,0.000042597927,0.00025886335,0.000054821005,0.000010921955,0.0002876637,0.0000014458087],"about_ca_topic_score_codex":0.052696884,"about_ca_topic_score_gemma":0.062569894,"teacher_disagreement_score":0.052696884,"about_ca_system_score_codex":0.00026186756,"about_ca_system_score_gemma":0.0006186282,"threshold_uncertainty_score":0.10478032},"labels":[],"label_agreement":null},{"id":"W4417201104","doi":"10.1158/1557-3265.earlyonsetca25-a015","title":"Abstract A015: Retinoblastoma points to solutions for Early-Onset Cancers","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Retinopathy of Prematurity Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Public Health Ontario; Princess Margaret Cancer Centre","funders":"","keywords":"Retinoblastoma; Cancer; Childhood cancer; Clinical trial; Disease; Incidence (geometry); Childhood blindness","score_opus":0.29143358387595214,"score_gpt":0.5680200163333963,"score_spread":0.27658643245744413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201104","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3318987,0.106183164,0.048445985,0.23043597,0.023589687,0.00375606,0.07176024,0.0068873116,0.17704293],"genre_scores_gemma":[0.8399539,0.022008961,0.047549162,0.024639068,0.008528964,0.0023057044,0.018001176,0.0006325941,0.03638046],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9962368,0.0021431802,0.00031470592,0.00030451972,0.00083961204,0.00016105814],"domain_scores_gemma":[0.98284525,0.009595023,0.002383617,0.0007655975,0.0030449603,0.0013655254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005270108,0.0005963191,0.0009561832,0.0015456687,0.0007275191,0.002672077,0.0010490378,0.0012201872,0.0598695],"category_scores_gemma":[0.03221901,0.0002533534,0.0020309386,0.0016542752,0.0005059188,0.0014147803,0.001296502,0.0021297631,0.008127749],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012352698,0.0007623396,0.055089645,0.0038090819,0.0015958849,0.00023100748,0.00022900265,0.0014414731,0.0016950762,0.006515567,0.28696817,0.62931013],"study_design_scores_gemma":[0.009920957,0.011350019,0.23438026,0.0109079955,0.006931038,0.002157813,0.0019781329,0.013206548,0.008595765,0.05816542,0.64201754,0.00038850613],"about_ca_topic_score_codex":0.0020925924,"about_ca_topic_score_gemma":0.0025689919,"teacher_disagreement_score":0.0598695,"about_ca_system_score_codex":0.0011459204,"about_ca_system_score_gemma":0.0017626482,"threshold_uncertainty_score":0.20028341},"labels":[],"label_agreement":null},{"id":"W4417201105","doi":"10.1158/1557-3265.earlyonsetca25-a014","title":"Abstract A014: Prognostic value of tumor asphericity on initial staging 18F- FDG PET/CT in patients with breast cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Univariate; Proportional hazards model; Multivariate analysis; Univariate analysis; Breast carcinoma; Breast tumor; Multivariate statistics; Statistical software","score_opus":0.11281469332313845,"score_gpt":0.528996056236658,"score_spread":0.4161813629135196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978053,0.00050093187,0.00025407659,0.000047738708,0.000013582324,0.000008046793,0.00061315455,0.000011965333,0.000745207],"genre_scores_gemma":[0.99889416,0.00008458694,0.00015719724,0.0000069709795,0.000018732324,0.0000073851,0.000628869,0.0000033115894,0.00019882283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998215,0.00003735439,0.000033041677,0.000033647004,0.00004492708,0.000029556184],"domain_scores_gemma":[0.9989254,0.00032141863,0.00038788465,0.000050754552,0.00014761848,0.00016695028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004717575,0.00026068976,0.00022195326,0.00085466437,0.0002500339,0.0005566932,0.00022947825,0.0003625228,0.002937047],"category_scores_gemma":[0.0020685145,0.00016102016,0.0003486975,0.0009465958,0.00018147501,0.00042846877,0.00025602084,0.0003477938,0.0005765582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029040274,0.000012039211,0.9967547,0.000010498824,0.000022377679,0.00010359013,0.000011772117,0.00008128201,0.00032695913,0.00000709054,0.00011173196,0.0022675558],"study_design_scores_gemma":[0.00000790712,0.00010894643,0.9977943,0.0000060250877,0.000042109194,0.0007578636,0.000053773336,0.000647545,0.00027767668,0.00003806484,0.0002608755,0.0000049851033],"about_ca_topic_score_codex":0.00069398264,"about_ca_topic_score_gemma":0.0008218341,"teacher_disagreement_score":0.002937047,"about_ca_system_score_codex":0.00021388654,"about_ca_system_score_gemma":0.00018640253,"threshold_uncertainty_score":0.009825408},"labels":[],"label_agreement":null},{"id":"W4417201106","doi":"10.1158/1557-3265.earlyonsetca25-a019","title":"Abstract A019: Clinical characteristics and outcomes of primary cardiac leiomyosarcoma cases from 2015-2025: A literature review","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiac tumors and thrombi","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Leiomyosarcoma; Radiation therapy; Cardiac Tumors; Biopsy; Chemotherapy; Metastasis; Multimodal therapy; Distant metastasis; Cancer","score_opus":0.15570059842303902,"score_gpt":0.545287501120192,"score_spread":0.38958690269715296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201106","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0072288234,0.9895201,0.0001365036,0.00042364045,0.00012586161,0.000094880634,0.0014698008,0.000011901078,0.000988621],"genre_scores_gemma":[0.044277843,0.9526477,0.00041792635,0.00066918385,0.00025042705,0.000149459,0.001371685,0.00000752045,0.00020827645],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9980134,0.00017663039,0.0012075966,0.0002239597,0.00031499576,0.00006343655],"domain_scores_gemma":[0.9927579,0.0035894115,0.0023370024,0.00011765074,0.0010764651,0.000121566096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014821028,0.0005894734,0.001727926,0.01871577,0.00058078876,0.0014187861,0.0010849847,0.0009569957,0.0043896036],"category_scores_gemma":[0.007721412,0.00045105434,0.0021140277,0.015953656,0.00067523704,0.0021817426,0.0009016782,0.0004016885,0.0005463033],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036577295,0.00006242694,0.026234115,0.7243581,0.0026354084,0.0032135742,0.0013309736,0.00020238024,0.0011980134,0.0007290393,0.012768101,0.22690211],"study_design_scores_gemma":[0.00013155278,0.00042596032,0.09830737,0.6872719,0.02756702,0.039327018,0.0041010235,0.00022171275,0.0011698108,0.0011403781,0.14018355,0.00015271774],"about_ca_topic_score_codex":0.0026116287,"about_ca_topic_score_gemma":0.004907708,"teacher_disagreement_score":0.01871577,"about_ca_system_score_codex":0.0011183108,"about_ca_system_score_gemma":0.0034855886,"threshold_uncertainty_score":0.014684737},"labels":[],"label_agreement":null},{"id":"W4417201107","doi":"10.1158/1557-3265.earlyonsetca25-b008","title":"Abstract B008: Neighborhood fast food, alcohol, and fruit/vegetable expenditure and early-onset colorectal cancer: A statewide spatio-ecological analysis in Alabama","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Cancer registry; Incidence (geometry); Cancer; Cancer incidence; Covariate; Weighting; Consumption (sociology)","score_opus":0.09087566074048499,"score_gpt":0.46995773348455994,"score_spread":0.37908207274407496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99832803,0.00008009245,0.00009772292,0.00006820963,0.0000032673431,0.00000900858,0.0012573148,0.000006748266,0.00014960342],"genre_scores_gemma":[0.9982835,0.000052666874,0.00021101012,0.000026751737,0.00000475559,0.000019935946,0.0011551423,0.0000032986654,0.00024283248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995988,0.00014664128,0.000030684205,0.00009991325,0.00005270278,0.00007127572],"domain_scores_gemma":[0.9991032,0.00016354461,0.00023465481,0.000089958594,0.00021640536,0.00019231491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000701172,0.0002797009,0.00029442474,0.0014290798,0.0009095047,0.00075898966,0.00075472164,0.00032513906,0.002152148],"category_scores_gemma":[0.0012143493,0.00025123372,0.0008735995,0.0022454187,0.000274479,0.00028055636,0.0010353995,0.00036358056,0.00023740747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031615185,0.00004265598,0.9982151,0.0000119298575,0.00014646901,0.000038546394,0.000119325035,0.00018200936,0.0001848213,0.000018539207,0.0002594989,0.0007494684],"study_design_scores_gemma":[0.0000035765524,0.000015815473,0.99810576,0.000008711798,0.000057091343,0.000032481712,0.00068434747,0.00084687443,0.000028107494,0.00001459834,0.00019970955,0.000002870288],"about_ca_topic_score_codex":0.38288078,"about_ca_topic_score_gemma":0.4081109,"teacher_disagreement_score":0.38288078,"about_ca_system_score_codex":0.001425987,"about_ca_system_score_gemma":0.002041655,"threshold_uncertainty_score":0.7613043},"labels":[],"label_agreement":null},{"id":"W4417201109","doi":"10.1158/1557-3265.earlyonsetca25-a011","title":"Abstract A011: Early Onset Cancer Incidence: A Model for the Role of Diagnostic Advances","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Incidence (geometry); Disease; Cancer; Natural history; Breast cancer; Age of onset; Epidemiology","score_opus":0.20411485168681887,"score_gpt":0.5843376517744753,"score_spread":0.3802228000876564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6847152,0.0019082337,0.21931744,0.017015908,0.000604877,0.00069502334,0.018002091,0.001025692,0.056715623],"genre_scores_gemma":[0.94760275,0.0009234422,0.010743901,0.0008399106,0.00015460243,0.00050501776,0.0025016135,0.000114619244,0.036614116],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99875903,0.0006097671,0.000040909938,0.00027820692,0.00009125547,0.00022085963],"domain_scores_gemma":[0.9939938,0.0040616845,0.0007757977,0.00028300585,0.00044470595,0.00044104076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002883489,0.0009443487,0.0010797225,0.0016044008,0.00062555145,0.0020434046,0.0027901253,0.0026785096,0.018191013],"category_scores_gemma":[0.011751764,0.0006859485,0.0020160684,0.0013112251,0.0012801632,0.0016998856,0.0011723645,0.002660681,0.0018198029],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034700066,0.00021983749,0.031310953,0.00013635644,0.00016311031,0.0003063906,0.00030054155,0.8699898,0.0007575889,0.08302189,0.0051081395,0.008338339],"study_design_scores_gemma":[0.00024378444,0.0002513369,0.007564268,0.000067671186,0.00012485297,0.00021010381,0.00018384625,0.9516123,0.00018939655,0.034718923,0.004777704,0.000055881763],"about_ca_topic_score_codex":0.046446603,"about_ca_topic_score_gemma":0.020810217,"teacher_disagreement_score":0.046446603,"about_ca_system_score_codex":0.0024363026,"about_ca_system_score_gemma":0.0018760168,"threshold_uncertainty_score":0.09235251},"labels":[],"label_agreement":null},{"id":"W4417201110","doi":"10.1158/1557-3265.earlyonsetca25-a027","title":"Abstract A027: Mode of presentation and symptoms at diagnosis of early- and late-onset colorectal cancer: a large retrospective AI-powered analysis","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Presentation (obstetrics); Retrospective cohort study; Colorectal cancer; Odds ratio; Cohort; Stage (stratigraphy); Cancer","score_opus":0.05923124217897015,"score_gpt":0.4890505128601146,"score_spread":0.42981927068114445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830573,0.0020486335,0.0016394773,0.00014178058,0.000038897113,0.00033828896,0.011590858,0.0000388298,0.0011059667],"genre_scores_gemma":[0.9912458,0.00032027168,0.00073246524,0.00013577876,0.000037282192,0.00030854353,0.0068644197,0.000024064766,0.00033135555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99401784,0.0021169672,0.001105101,0.0014276697,0.0010000197,0.00033241973],"domain_scores_gemma":[0.9840268,0.005058116,0.004868559,0.0029056885,0.0022636128,0.00087723567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004700014,0.00043775153,0.0007192399,0.0022696825,0.00061144173,0.0012409443,0.00096948224,0.00058349536,0.0031929216],"category_scores_gemma":[0.016676875,0.0005399565,0.0014729139,0.0028180573,0.00052704295,0.0008144442,0.0011339119,0.00059915514,0.0010879968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005529161,0.000046057696,0.9949745,0.00021127159,0.0005392995,0.00012259046,0.00010543465,0.000053688556,0.00025529147,0.00003993434,0.0010260183,0.0020730274],"study_design_scores_gemma":[0.00009662129,0.0002799373,0.9957942,0.00010330473,0.0005458591,0.00044124105,0.0003013689,0.0005627505,0.0001449994,0.00006281664,0.0016500999,0.000016669343],"about_ca_topic_score_codex":0.0049046236,"about_ca_topic_score_gemma":0.005962408,"teacher_disagreement_score":0.0049046236,"about_ca_system_score_codex":0.0006191417,"about_ca_system_score_gemma":0.00086993794,"threshold_uncertainty_score":0.024856389},"labels":[],"label_agreement":null},{"id":"W4417201112","doi":"10.1158/1557-3265.earlyonsetca25-a021","title":"Abstract A021: A human-induced pluripotent stem cell (hiPSC)-derived cardiac spheroids (hiPSC-CSs) platform for individualized cancer drug cardiotoxicity assessment.","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cardiotoxicity; Induced pluripotent stem cell; Drug; Clinical trial; Cancer; Drug development; Cancer cell; Spheroid; Adverse effect","score_opus":0.14955042343294137,"score_gpt":0.49417189537815787,"score_spread":0.34462147194521653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7115368,0.009948538,0.24550202,0.0011847245,0.00091855903,0.0012218923,0.011898629,0.0071670306,0.010621803],"genre_scores_gemma":[0.8704864,0.0026728369,0.113214076,0.0005042283,0.0000898563,0.0006631208,0.0054757423,0.00020606421,0.006687763],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997633,0.000023739163,0.000023800234,0.00005682111,0.00011239545,0.000019858131],"domain_scores_gemma":[0.9998196,0.000023953093,0.000040997144,0.000024256115,0.00005202873,0.000039106693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035355147,0.00040187314,0.0002541804,0.00040531773,0.00020000964,0.0003983938,0.00035574895,0.00054920034,0.001102555],"category_scores_gemma":[0.0002366682,0.00019108136,0.00034649947,0.00020371619,0.0002034937,0.00028680952,0.00031719383,0.000494418,0.0005803464],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004022585,0.000024177405,0.00018371452,0.00007965729,0.000009803421,0.000070790855,0.000013903579,0.00036927065,0.9923132,0.00016914314,0.0008852985,0.0058407807],"study_design_scores_gemma":[0.000018182645,0.00023518437,0.001652938,0.000008163921,0.00003424454,0.00023929203,0.0000125829365,0.004824037,0.9853644,0.000088490706,0.00750285,0.00001957504],"about_ca_topic_score_codex":0.0009974673,"about_ca_topic_score_gemma":0.0012582731,"teacher_disagreement_score":0.001102555,"about_ca_system_score_codex":0.0003565759,"about_ca_system_score_gemma":0.0004316644,"threshold_uncertainty_score":0.0036884546},"labels":[],"label_agreement":null},{"id":"W4417201213","doi":"10.1158/1557-3265.earlyonsetca25-pr001","title":"Abstract PR001: Risk prediction modeling for colorectal adenomas in persons under age 50: a risk-stratified approach to early onset colorectal cancer prevention","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Colonoscopy; Cohort; Area under the curve; Incidence (geometry); Cohort study; Disease; Predictive value","score_opus":0.19948045139744863,"score_gpt":0.48391518517979376,"score_spread":0.28443473378234513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75158584,0.0022108657,0.22540171,0.0052031837,0.00038488786,0.0007974194,0.008444577,0.0013872107,0.0045843814],"genre_scores_gemma":[0.95689017,0.0005007017,0.036695093,0.00030874356,0.00016534049,0.00030212148,0.0029327127,0.0000619525,0.0021432603],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99924636,0.0004150661,0.000044183744,0.00016456757,0.00007092558,0.000058926355],"domain_scores_gemma":[0.99739635,0.0017247921,0.0002805894,0.00013321175,0.0003216857,0.00014329396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032559528,0.000945797,0.00094537047,0.0011488798,0.00032982303,0.001321931,0.0012491381,0.0008559456,0.0047317343],"category_scores_gemma":[0.008562139,0.00036973358,0.0023935556,0.00057987147,0.0002110935,0.0004552332,0.0009832835,0.0014961254,0.00078375614],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027407059,0.0010139239,0.52791256,0.0005313813,0.0022863178,0.00079263176,0.00030314425,0.323352,0.001751866,0.0041482784,0.014248853,0.12091824],"study_design_scores_gemma":[0.000111308975,0.00055170426,0.032448146,0.0001174093,0.00045701547,0.00025937287,0.00010429282,0.96043617,0.0003108437,0.0033270486,0.0018426378,0.0000340889],"about_ca_topic_score_codex":0.010054889,"about_ca_topic_score_gemma":0.005675729,"teacher_disagreement_score":0.010054889,"about_ca_system_score_codex":0.0005251482,"about_ca_system_score_gemma":0.0011715038,"threshold_uncertainty_score":0.01999271},"labels":[],"label_agreement":null},{"id":"W4417201219","doi":"10.1158/1557-3265.earlyonsetca25-pr002","title":"Abstract PR002: Clinical, pathological, and molecular differences in early- and late-onset colorectal cancer: Results from a multicenter study","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Incidence (geometry); Colorectal adenoma; Odds ratio; Adenoma; Stage (stratigraphy); Cohort; Cohort study","score_opus":0.18655809943819782,"score_gpt":0.5056002351971923,"score_spread":0.31904213575899454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981974,0.00028265332,0.00013356945,0.000041700554,0.000008887599,0.00004782077,0.0010226745,0.0000045446604,0.00026068088],"genre_scores_gemma":[0.9982066,0.000088426736,0.00018119659,0.000053315205,0.000027686325,0.000049328635,0.0011899221,0.000005070398,0.00019851516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987041,0.00056582125,0.00012732267,0.000342859,0.00016285265,0.0000970867],"domain_scores_gemma":[0.99625033,0.00054936216,0.0015515063,0.0004946829,0.00054916565,0.0006049963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030682217,0.00047353577,0.00039569833,0.00062054145,0.00040599058,0.00069603,0.0005766967,0.0005805787,0.0014432424],"category_scores_gemma":[0.0036304856,0.00026571297,0.00068865495,0.0009863094,0.00032315077,0.00060504524,0.0006285794,0.0004163621,0.00040582614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029095337,0.00022827569,0.99401456,0.00002792328,0.00024973173,0.000070509566,0.00009371212,0.000022356655,0.0007093309,0.000010363687,0.0002065393,0.0014571212],"study_design_scores_gemma":[0.0002633706,0.00096815894,0.9977174,0.0000080443115,0.00015122759,0.000191572,0.00017655191,0.00009096256,0.00012660798,0.000011320024,0.00028930593,0.000005712535],"about_ca_topic_score_codex":0.0020985503,"about_ca_topic_score_gemma":0.002037756,"teacher_disagreement_score":0.0030682217,"about_ca_system_score_codex":0.00022708622,"about_ca_system_score_gemma":0.00031924195,"threshold_uncertainty_score":0.01622653},"labels":[],"label_agreement":null},{"id":"W4417201242","doi":"10.1158/1557-3265.earlyonsetca25-b021","title":"Abstract B021: Survival differences between early onset (&amp;lt; 50 years) and average onset (≥ 50 years) colorectal cancer among African Americans in metropolitan Detroit","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Epidemiology; Proportional hazards model; Cancer; Metropolitan area; Survival analysis; Surveillance, Epidemiology, and End Results","score_opus":0.15099019781181341,"score_gpt":0.4858320395385569,"score_spread":0.33484184172674347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992124,0.00004523409,0.000024874682,0.000048442213,0.0000019898957,0.000003016128,0.00049323065,9.170292e-7,0.00016987497],"genre_scores_gemma":[0.99937195,0.000022060887,0.00003987197,0.0000254837,0.0000044526173,0.000005986443,0.00035585696,6.3815816e-7,0.0001737414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998272,0.000056601908,0.000014443213,0.000037612303,0.000023256884,0.00004094721],"domain_scores_gemma":[0.9994832,0.000075093056,0.0002221264,0.000029984032,0.00006665654,0.00012294215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047905513,0.00014440218,0.00013375095,0.0005011036,0.00038582648,0.00032340287,0.00022518089,0.00019627021,0.0015843539],"category_scores_gemma":[0.0009807004,0.00009929939,0.00018766335,0.0005646771,0.0001609273,0.00029869028,0.00045015075,0.00024389027,0.00017413954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055973574,0.000016590015,0.9986082,0.000004070679,0.00001320555,0.000022929573,0.000102963335,0.00001476139,0.00021510114,0.000009173994,0.00012936462,0.0008077304],"study_design_scores_gemma":[0.0000016254504,0.000018966513,0.99952686,0.0000027232416,0.000006177147,0.000024439712,0.00022616528,0.000066922774,0.00003619514,0.000005527467,0.00008374143,7.484466e-7],"about_ca_topic_score_codex":0.034335874,"about_ca_topic_score_gemma":0.06140774,"teacher_disagreement_score":0.034335874,"about_ca_system_score_codex":0.000396291,"about_ca_system_score_gemma":0.0003086919,"threshold_uncertainty_score":0.068272054},"labels":[],"label_agreement":null},{"id":"W4417201252","doi":"10.1158/1557-3265.earlyonsetca25-c005","title":"Abstract C005: APC Mutation-induced Retardation of Tissue Renewal is Fundamental to Colon Tumorigenesis","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Carcinogenesis; Crypt; Cancer; Phenotype; Cell; Stem cell","score_opus":0.27730323294716963,"score_gpt":0.590147371553084,"score_spread":0.3128441386059144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7780248,0.0705599,0.0263195,0.0145131415,0.002343671,0.00029686818,0.00987676,0.0027138705,0.095351584],"genre_scores_gemma":[0.9400765,0.009484814,0.0040473016,0.0006288833,0.00027742356,0.000035990557,0.0032294036,0.00008119033,0.04213856],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998597,0.000019195304,0.000010256884,0.000027814176,0.000063755324,0.000019220877],"domain_scores_gemma":[0.99983263,0.000027922202,0.000039577393,0.000012782411,0.00004002483,0.000046959893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029293625,0.00025927735,0.00025155323,0.0004373678,0.00021670783,0.0005487323,0.00034908566,0.00040449266,0.011549871],"category_scores_gemma":[0.00029299327,0.00011735944,0.00010762795,0.00028207735,0.0003805342,0.00020244518,0.00015051702,0.00055603613,0.0016791136],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018825495,0.00021105801,0.008802791,0.00077523343,0.000031763688,0.0015588929,0.00009458906,0.0008405535,0.8408531,0.009711336,0.032641247,0.1025969],"study_design_scores_gemma":[0.00016347691,0.0015452824,0.18894628,0.00026107513,0.000090337206,0.0065595387,0.00018316616,0.005292292,0.57352215,0.002952482,0.22043625,0.000047667592],"about_ca_topic_score_codex":0.0069711627,"about_ca_topic_score_gemma":0.0053394637,"teacher_disagreement_score":0.011549871,"about_ca_system_score_codex":0.0010356919,"about_ca_system_score_gemma":0.0010136223,"threshold_uncertainty_score":0.038638115},"labels":[],"label_agreement":null},{"id":"W4417201254","doi":"10.1158/1557-3265.earlyonsetca25-b037","title":"Abstract B037: Early-Onset Cancer: A Focus on Pregnancy-Associated Cases","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pregnancy; Cancer; Incidence (geometry); Breast cancer; Thyroid cancer; Young adult; Ectopic pregnancy","score_opus":0.3092114205533619,"score_gpt":0.5821282712034643,"score_spread":0.2729168506501024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9733025,0.0059244363,0.00041546873,0.00075357617,0.000060703584,0.000088033405,0.010888173,0.00004386172,0.00852317],"genre_scores_gemma":[0.9933389,0.0024640062,0.00020704219,0.0001990139,0.000053180138,0.000039235358,0.0031925323,0.00001021264,0.0004959336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999495,0.000070029506,0.000084108615,0.00011121974,0.00011327942,0.00012627403],"domain_scores_gemma":[0.9986519,0.00025625117,0.00058306166,0.00005314168,0.00023126199,0.00022428473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041706683,0.00018066666,0.00015934449,0.0021595561,0.00039831406,0.0006417597,0.00041147452,0.00028726706,0.0035982702],"category_scores_gemma":[0.0017019762,0.00014189641,0.0003068536,0.0028128093,0.00023044189,0.0004694003,0.00073120644,0.00038693316,0.00048535079],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004055903,0.000015643922,0.9914894,0.00010520412,0.000023459463,0.0004008698,0.00011278652,0.000035054378,0.00021776899,0.000065466345,0.0018459487,0.0056479215],"study_design_scores_gemma":[0.0000029330263,0.00002430909,0.9950546,0.00014039129,0.000022558414,0.0017175889,0.0006595925,0.00011207443,0.00012362307,0.000028618046,0.0021104997,0.000003176679],"about_ca_topic_score_codex":0.023920655,"about_ca_topic_score_gemma":0.025547775,"teacher_disagreement_score":0.023920655,"about_ca_system_score_codex":0.00051526027,"about_ca_system_score_gemma":0.0010982492,"threshold_uncertainty_score":0.047562838},"labels":[],"label_agreement":null},{"id":"W4417201256","doi":"10.1158/1557-3265.earlyonsetca25-pr008","title":"Abstract PR008: Incidence of early onset colorectal, kidney, uterine and pancreatic cancer by county-level obesity prevalence in the U.S., 2010-2022","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Obesity; Pancreatic cancer; Kidney cancer; Incidence (geometry); Cancer; Cancer registry; Diabetes mellitus; Confidence interval","score_opus":0.1467561604789134,"score_gpt":0.5068258905119367,"score_spread":0.36006973003302334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9284722,0.0014618963,0.00042596954,0.00035537197,0.00005216468,0.00003584552,0.06661363,0.000106096835,0.0024768547],"genre_scores_gemma":[0.9685893,0.000568062,0.00032427788,0.00011414379,0.000035116725,0.000043050455,0.02933574,0.00001349364,0.0009768559],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964964,0.0000630031,0.00004073834,0.00011087462,0.000080032914,0.000055677512],"domain_scores_gemma":[0.9983347,0.00016399038,0.00074077473,0.00008301463,0.00047640025,0.00020119904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049333385,0.00026390803,0.0001875755,0.0015095149,0.0002494843,0.00059076893,0.00041897898,0.00027726992,0.001847034],"category_scores_gemma":[0.0016801336,0.00023141355,0.00054972986,0.0020960325,0.0001427511,0.0003696067,0.0006527773,0.00046873177,0.00042180906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004953748,0.000014922425,0.9955922,0.00003631363,0.000082394814,0.000021031894,0.000028180042,0.00011542296,0.00011497715,0.00002294603,0.002548087,0.0013739994],"study_design_scores_gemma":[0.0000040771565,0.000017066863,0.99901235,0.000010546937,0.000030608993,0.000057943744,0.00007714174,0.00020591584,0.000047266785,0.000007627388,0.0005273597,0.0000021123506],"about_ca_topic_score_codex":0.0801054,"about_ca_topic_score_gemma":0.08909664,"teacher_disagreement_score":0.0801054,"about_ca_system_score_codex":0.00057740754,"about_ca_system_score_gemma":0.00075107405,"threshold_uncertainty_score":0.15927827},"labels":[],"label_agreement":null},{"id":"W4417201259","doi":"10.1158/1557-3265.earlyonsetca25-ia003","title":"Abstract IA003: Trends in cancer mortality in young adults in selected upper-middle and high-income countries with focus on colorectal cancer: an update to 2026.","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Latin Americans; Poisson regression; Young adult; Colorectal cancer; Cancer; Mortality rate; Population","score_opus":0.06920934810645309,"score_gpt":0.47676286655675515,"score_spread":0.4075535184503021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201259","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10971015,0.062395148,0.0032468776,0.0026791203,0.0017262631,0.0004154329,0.8067146,0.0009835201,0.012128833],"genre_scores_gemma":[0.25204548,0.035238564,0.006647268,0.0014390085,0.0010456955,0.0014184975,0.6953275,0.00018304748,0.0066549685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993949,0.00008377007,0.00017700922,0.00008830425,0.00019609604,0.000059909635],"domain_scores_gemma":[0.9969903,0.00025428677,0.00072409725,0.00008926893,0.0016058657,0.00033608844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018409226,0.00085129216,0.0007827276,0.0060072592,0.00022514914,0.0012702866,0.00061979966,0.0006604292,0.003442819],"category_scores_gemma":[0.0032723898,0.00033060912,0.0012316721,0.009432733,0.00013288904,0.0010503428,0.0009547071,0.00080536725,0.0027728612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049909484,0.00010240229,0.67379427,0.0045348965,0.0005657508,0.000261147,0.00046045976,0.0008528769,0.00057718117,0.00043903803,0.19704397,0.12086892],"study_design_scores_gemma":[0.000069480906,0.00011187827,0.88216,0.0016922655,0.00028385472,0.00046028188,0.00036359383,0.00086367666,0.00037735875,0.00015071487,0.113422394,0.00004446829],"about_ca_topic_score_codex":0.032757062,"about_ca_topic_score_gemma":0.026248157,"teacher_disagreement_score":0.032757062,"about_ca_system_score_codex":0.00079026684,"about_ca_system_score_gemma":0.0014126713,"threshold_uncertainty_score":0.0651328},"labels":[],"label_agreement":null},{"id":"W4417201262","doi":"10.1158/1557-3265.earlyonsetca25-c004","title":"Abstract C004: Colonic Tissue Renewal, Retinoic Acid Signaling, Early-onset CRC","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Retinoic acid; Calcitriol receptor; Retinoid X receptor gamma; Retinoid; Retinoic acid receptor; Germline mutation; Somatic cell; Retinoid X receptor; Vitamin","score_opus":0.08375311066845019,"score_gpt":0.4879194193459572,"score_spread":0.40416630867750697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7377433,0.16621274,0.007556367,0.019162498,0.0037935548,0.00045385008,0.005236759,0.00060665974,0.05923424],"genre_scores_gemma":[0.8754665,0.05232679,0.005381374,0.0028104554,0.0015104049,0.00029163907,0.0035883866,0.000048172216,0.058576237],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985623,0.000028232454,0.000011577198,0.0000347184,0.000042659867,0.000026599522],"domain_scores_gemma":[0.9998338,0.000032710752,0.000043938697,0.0000077229,0.000039178925,0.00004250164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024400097,0.00046516873,0.00030257966,0.0007558816,0.00037003754,0.00044952644,0.00043642527,0.0008136581,0.014915021],"category_scores_gemma":[0.0002294531,0.00009911614,0.0003187532,0.00054832426,0.0004032274,0.0002517039,0.0002947904,0.00092284114,0.0023330585],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007219327,0.0011942494,0.03223388,0.00504506,0.0001650753,0.0063995593,0.00018625255,0.0007565187,0.67874956,0.0067268624,0.04032392,0.2209997],"study_design_scores_gemma":[0.0008403827,0.0069141053,0.2910137,0.0009181308,0.0006129738,0.021263672,0.0007377226,0.0028261652,0.3988947,0.005798909,0.2700694,0.00011012363],"about_ca_topic_score_codex":0.0013532302,"about_ca_topic_score_gemma":0.0014342688,"teacher_disagreement_score":0.014915021,"about_ca_system_score_codex":0.0005779014,"about_ca_system_score_gemma":0.00056518486,"threshold_uncertainty_score":0.049895704},"labels":[],"label_agreement":null},{"id":"W4417201266","doi":"10.1158/1557-3265.earlyonsetca25-b038","title":"Abstract B038: Differences in metabolomic profiles predictive of fatigue in early-onset vs. later-onset colorectal cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Logistic regression; Quality of life (healthcare); Prospective cohort study; Cancer; Cohort; Metabolomics; Stage (stratigraphy)","score_opus":0.1543884835307184,"score_gpt":0.5044586403563902,"score_spread":0.3500701568256718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966934,0.00021491648,0.00007901375,0.00004761244,0.000007956276,0.000010444632,0.0026210356,0.0000057534817,0.00031982723],"genre_scores_gemma":[0.997449,0.0000555248,0.00012011809,0.00004266526,0.000007910891,0.000011470841,0.002019988,0.0000034891793,0.00028973442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989235,0.000024543637,0.000012058051,0.000030366424,0.00001522842,0.000025449015],"domain_scores_gemma":[0.99949145,0.000066668406,0.00021126182,0.00003896645,0.00008478479,0.00010677015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023908043,0.00022504975,0.00024764123,0.00045667228,0.0002636334,0.00053145114,0.0001279407,0.00027078466,0.0025018991],"category_scores_gemma":[0.00084585167,0.00010067291,0.00026426985,0.0008670659,0.00009577581,0.00019295432,0.00027725458,0.00033073616,0.00040134462],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009788125,0.000051980223,0.9933595,0.000022155036,0.0000622409,0.000049168895,0.000030077705,0.00004470816,0.0027582594,0.000009300344,0.00036097152,0.0022728206],"study_design_scores_gemma":[0.000010136893,0.00010717497,0.99935144,0.000002732482,0.000015632942,0.00008040818,0.0000376724,0.00009368575,0.00014683783,0.000008641421,0.00014394912,0.0000017879238],"about_ca_topic_score_codex":0.0037295087,"about_ca_topic_score_gemma":0.004582974,"teacher_disagreement_score":0.0037295087,"about_ca_system_score_codex":0.00019417594,"about_ca_system_score_gemma":0.00013359073,"threshold_uncertainty_score":0.008369684},"labels":[],"label_agreement":null},{"id":"W4417201280","doi":"10.1158/1557-3265.earlyonsetca25-pr005","title":"Abstract PR005: Uncovering the Etiology of Early-Onset Gastric Cancer in Latinos Through Germline and Tumor Genomic Profiling","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Germline; Germline mutation; Cancer; Etiology; Disease; Epigenetics; Microbiome; Somatic cell; MLH1","score_opus":0.08547236932481178,"score_gpt":0.4635764095743373,"score_spread":0.37810404024952554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898066,0.0014581104,0.0014509466,0.000521662,0.000023663031,0.000038716116,0.0043819514,0.00006367461,0.0022546093],"genre_scores_gemma":[0.99327964,0.00084435596,0.001654439,0.0003406784,0.000023258983,0.000033875753,0.0027700537,0.000039075025,0.0010147559],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998734,0.000021680064,0.000007457982,0.00004906301,0.000017835404,0.000030461042],"domain_scores_gemma":[0.9996966,0.000056381617,0.00010736024,0.000026677937,0.00007045161,0.000042497915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039737296,0.00027230565,0.00021797567,0.00088083115,0.00036389282,0.00059787877,0.00026155167,0.00027665202,0.002949769],"category_scores_gemma":[0.0010042776,0.0001226078,0.00033806113,0.0009497803,0.00025965588,0.00021866738,0.00054632593,0.0003226133,0.0004095907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036550406,0.000063421685,0.9549879,0.00018702405,0.00018597912,0.0010249183,0.000521286,0.00017001652,0.020442924,0.00029067,0.001278565,0.020481737],"study_design_scores_gemma":[0.000032709602,0.00012986863,0.9856829,0.00011792353,0.00021571833,0.0016980738,0.0013658981,0.00069851027,0.0029327997,0.0005936808,0.0065201237,0.000011875443],"about_ca_topic_score_codex":0.008013973,"about_ca_topic_score_gemma":0.0077560428,"teacher_disagreement_score":0.008013973,"about_ca_system_score_codex":0.0003365634,"about_ca_system_score_gemma":0.0004588475,"threshold_uncertainty_score":0.015934646},"labels":[],"label_agreement":null},{"id":"W4417201282","doi":"10.1158/1557-3265.earlyonsetca25-c014","title":"Abstract C014: Unexplained familial early-onset colorectal cancer: Determining a shared etiology by tumor mutational signature profiling","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Toronto","funders":"","keywords":"MUTYH; Colorectal cancer; KRAS; Lynch syndrome; Correlation; Cancer","score_opus":0.10496106752459723,"score_gpt":0.4926459510388146,"score_spread":0.38768488351421737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99835473,0.00012676667,0.0003896475,0.00001900859,0.0000024496628,0.0000142095405,0.00045486164,0.000012381471,0.0006259432],"genre_scores_gemma":[0.9989221,0.000038218433,0.0003311057,0.00001480259,0.0000035876424,0.000004489388,0.00047442407,0.000005619721,0.00020568568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997547,0.000032895543,0.000029780607,0.00008255022,0.0000575788,0.00004249398],"domain_scores_gemma":[0.9995271,0.000100975165,0.00013921129,0.0000616858,0.00009832071,0.00007275118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031078202,0.00024829613,0.00024174602,0.0014131684,0.00046555395,0.00036416628,0.00021126262,0.0003145,0.003175613],"category_scores_gemma":[0.0011991913,0.00011069222,0.00017401307,0.0009781449,0.00025218938,0.000118235585,0.0003567546,0.00015199925,0.00043580355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052196573,0.000037348866,0.9589592,0.00006580886,0.0000551489,0.004187227,0.00020501442,0.00011546886,0.02634923,0.00015567163,0.00045064135,0.008897365],"study_design_scores_gemma":[0.000009685312,0.00015189945,0.98059374,0.0000127300345,0.00004593539,0.013454237,0.00018985332,0.00040017697,0.0041630636,0.000093288225,0.0008789313,0.000006520451],"about_ca_topic_score_codex":0.003008651,"about_ca_topic_score_gemma":0.0031244252,"teacher_disagreement_score":0.003175613,"about_ca_system_score_codex":0.00024894185,"about_ca_system_score_gemma":0.0002099087,"threshold_uncertainty_score":0.010623515},"labels":[],"label_agreement":null},{"id":"W4417201283","doi":"10.1158/1557-3265.earlyonsetca25-pr004","title":"Abstract PR004: Mutational signature profiling identifies a distinct subgroup of early-onset colorectal cancer associated with younger age at diagnosis, recent birth year and specific genomic features","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Toronto","funders":"","keywords":"Colorectal cancer; Exome sequencing; Microsatellite instability; Genomics; Exome; DNA sequencing; Cancer; Cluster analysis","score_opus":0.049182731363140914,"score_gpt":0.3934973011669421,"score_spread":0.34431456980380115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973574,0.00013603752,0.00031446049,0.00003283842,0.0000031008663,0.0000070499477,0.0017964821,0.000024234647,0.00032821277],"genre_scores_gemma":[0.99624664,0.00005349882,0.00034587175,0.00001502573,0.000005999546,0.0000063155408,0.0029863988,0.000011210584,0.0003289603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997594,0.000028917088,0.000024086017,0.00009961161,0.000048305974,0.00003976786],"domain_scores_gemma":[0.9993899,0.00012088811,0.0002445638,0.0000670007,0.00007542308,0.0001022048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030961947,0.00022919379,0.00029747337,0.0011463412,0.00022715011,0.0005062418,0.00024727295,0.00026320972,0.0032891817],"category_scores_gemma":[0.0012935165,0.00010224699,0.00037525647,0.0011167433,0.00015066478,0.00017077618,0.00038513873,0.00025189357,0.0004741921],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001000766,0.000027179518,0.9673692,0.000058402136,0.000118802,0.00045531956,0.00009170928,0.0001427409,0.02073036,0.000046107718,0.0006368563,0.009322556],"study_design_scores_gemma":[0.00000962169,0.00007582755,0.99681336,0.0000053922317,0.000058946574,0.0009090584,0.00007610806,0.00029624728,0.0012477128,0.00003799469,0.00046647192,0.0000032287292],"about_ca_topic_score_codex":0.002162149,"about_ca_topic_score_gemma":0.002679205,"teacher_disagreement_score":0.0032891817,"about_ca_system_score_codex":0.00020395563,"about_ca_system_score_gemma":0.0002660623,"threshold_uncertainty_score":0.011003435},"labels":[],"label_agreement":null},{"id":"W4417201294","doi":"10.1158/1557-3265.earlyonsetca25-b026","title":"Abstract B026: Pre-diagnostic disease and medication history in early-onset pancreatic cancer from large-scale registry and EHR data","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pancreatic cancer; Danish; Disease; Cancer registry; Cancer; Logistic regression; Medical prescription; Gastrointestinal cancer","score_opus":0.19141287182337618,"score_gpt":0.5272541118584195,"score_spread":0.33584124003504334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7782804,0.0017791633,0.0022157559,0.00030966057,0.000058032463,0.00014103454,0.21515653,0.00013499749,0.0019245149],"genre_scores_gemma":[0.8831153,0.0005525447,0.0035970102,0.00008327727,0.000035100096,0.00021217909,0.11191825,0.000034112447,0.00045225173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965754,0.00069972663,0.0010806735,0.0008998697,0.00042576596,0.0003185621],"domain_scores_gemma":[0.9864879,0.004311002,0.0054470245,0.0019552652,0.001164814,0.0006339589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002867059,0.0003630032,0.00071302435,0.004040709,0.00047347188,0.0017118988,0.0006766962,0.00048833777,0.003921307],"category_scores_gemma":[0.012336071,0.00038763924,0.0010717436,0.009141596,0.00022880404,0.00076197286,0.0011633248,0.0005497741,0.0010127824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013069769,0.000019086398,0.99512595,0.00021772266,0.00019107205,0.00009090532,0.00007893299,0.00033780703,0.00017519784,0.000087980654,0.0016083261,0.0019363943],"study_design_scores_gemma":[0.000023985895,0.000031762997,0.99384475,0.00010170073,0.00015883576,0.000317141,0.00026256783,0.0011269362,0.00023214439,0.00009284017,0.0037926706,0.00001471953],"about_ca_topic_score_codex":0.030889483,"about_ca_topic_score_gemma":0.03250186,"teacher_disagreement_score":0.030889483,"about_ca_system_score_codex":0.00066578924,"about_ca_system_score_gemma":0.0017522633,"threshold_uncertainty_score":0.061419368},"labels":[],"label_agreement":null},{"id":"W4417201295","doi":"10.1158/1557-3265.earlyonsetca25-c030","title":"Abstract C030: Effect of palmitic acid exposure in normal colon organoids derived from young versus older individuals","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Organoid; Colorectal cancer; Matrigel; Palmitic acid; Crypt; Rectum","score_opus":0.10488224099725385,"score_gpt":0.4974944077884912,"score_spread":0.39261216679123734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99330795,0.0012684709,0.000988377,0.00016451764,0.000104072344,0.000050704897,0.002200037,0.000038934788,0.0018768429],"genre_scores_gemma":[0.9884326,0.00078243617,0.0016009384,0.00023847188,0.000030087696,0.0001750072,0.0037469822,0.00003397892,0.0049594333],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996164,0.00006776913,0.00005444634,0.000111872716,0.00007173865,0.00007769695],"domain_scores_gemma":[0.9996265,0.00008780309,0.000044665612,0.000047804773,0.000057231522,0.00013601077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031089937,0.00027761588,0.00042324455,0.00031048676,0.00029121424,0.0003443148,0.00016266906,0.00040623292,0.0036921722],"category_scores_gemma":[0.00017547833,0.00013062885,0.0005050337,0.00022816336,0.00026319668,0.00023675329,0.0003210687,0.0008387647,0.00090651517],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000995937,0.000110467125,0.0006990525,0.000060148035,0.000009041771,0.00014215393,0.00009493908,0.00004677963,0.996407,0.00003612799,0.00019967047,0.0011986897],"study_design_scores_gemma":[0.00008753375,0.0048782057,0.038218476,0.00002598071,0.000057356072,0.00061940606,0.0005372334,0.00050479826,0.9476534,0.00007124382,0.0073213154,0.000025001302],"about_ca_topic_score_codex":0.0014437711,"about_ca_topic_score_gemma":0.0018367629,"teacher_disagreement_score":0.0036921722,"about_ca_system_score_codex":0.00025997864,"about_ca_system_score_gemma":0.00020626803,"threshold_uncertainty_score":0.0123515725},"labels":[],"label_agreement":null},{"id":"W4417201296","doi":"10.1158/1557-3265.earlyonsetca25-b019","title":"Abstract B019: Lifestyle and reproductive factors and early-onset invasive epithelial ovarian cancer risk","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St Mary's Hospital Centre; Université de Montréal; McGill University","funders":"","keywords":"Ovarian cancer; Odds ratio; Logistic regression; Body mass index; Risk factor; Population; Epithelial ovarian cancer; Serous fluid","score_opus":0.12782186633567866,"score_gpt":0.48470631159900196,"score_spread":0.3568844452633233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793042,0.0027870105,0.0005306142,0.00061760604,0.000050453727,0.00009283109,0.013700745,0.00004334778,0.0028733127],"genre_scores_gemma":[0.9940989,0.00046432027,0.00043260117,0.00008192282,0.00004324735,0.00002908481,0.002907333,0.000005544182,0.0019369257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973387,0.00005225743,0.000020974468,0.000065417116,0.0000652777,0.00006215129],"domain_scores_gemma":[0.9986337,0.00019950274,0.0005245831,0.00005829512,0.0003059793,0.00027787292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046781183,0.00031699854,0.00024055454,0.0007764875,0.00047342991,0.00072424405,0.00051504915,0.00025948635,0.006087883],"category_scores_gemma":[0.0019632706,0.0001455401,0.0005865893,0.0012908077,0.00025924103,0.00020444002,0.00037576747,0.00045079962,0.0002905365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008577976,0.000017400527,0.99669445,0.00003425431,0.00008073031,0.000038210965,0.000034204888,0.00004748697,0.00013723221,0.00003085104,0.00043461137,0.0023647873],"study_design_scores_gemma":[0.000006213537,0.000025832667,0.999079,0.000015447871,0.00004348465,0.000048993883,0.000048153044,0.00012280268,0.00005107396,0.00001986802,0.0005370186,0.0000021879378],"about_ca_topic_score_codex":0.4026323,"about_ca_topic_score_gemma":0.3351085,"teacher_disagreement_score":0.4026323,"about_ca_system_score_codex":0.0014884952,"about_ca_system_score_gemma":0.0027149352,"threshold_uncertainty_score":0.8005774},"labels":[],"label_agreement":null},{"id":"W4417201302","doi":"10.1158/1557-3265.earlyonsetca25-pr003","title":"Abstract PR003: Exploring the exposome impact in early-onset colon and rectal cancer using methylation scores","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Exposome; Colorectal cancer; DNA methylation; Biomarker; Cancer; Methylation; Population; Cohort","score_opus":0.30324142490203715,"score_gpt":0.5534668886680574,"score_spread":0.25022546376602023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8713111,0.009825596,0.058257204,0.00088743144,0.00014740165,0.00027484412,0.05308164,0.0007907518,0.005424034],"genre_scores_gemma":[0.96688277,0.0012863221,0.020463826,0.00021119161,0.000068781104,0.00018954396,0.009128124,0.000107600215,0.0016618018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992249,0.0002644481,0.000052599833,0.00028733807,0.00012764784,0.000042916236],"domain_scores_gemma":[0.9990753,0.00034622187,0.00023463168,0.000115281946,0.00016879107,0.000059765014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013520934,0.00048121996,0.0005046055,0.0013280825,0.00022222495,0.0008024857,0.00046378444,0.00032366137,0.0044276067],"category_scores_gemma":[0.0034496202,0.00019037265,0.0014581901,0.0021218825,0.00016879271,0.00030478556,0.00074475043,0.00047971983,0.0005165327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020120132,0.00012308007,0.7992601,0.0024133525,0.007830937,0.0002888111,0.00027406064,0.0064172936,0.055753138,0.0009927197,0.0047133993,0.11992116],"study_design_scores_gemma":[0.00018249877,0.0010059254,0.9265346,0.00028071846,0.006454296,0.00061298057,0.0002786399,0.018220356,0.025353298,0.0029246402,0.018076368,0.000075667274],"about_ca_topic_score_codex":0.0046193493,"about_ca_topic_score_gemma":0.0067053465,"teacher_disagreement_score":0.0046193493,"about_ca_system_score_codex":0.00023597982,"about_ca_system_score_gemma":0.00060784066,"threshold_uncertainty_score":0.014811814},"labels":[],"label_agreement":null},{"id":"W4417201305","doi":"10.1158/1557-3265.earlyonsetca25-c011","title":"Abstract C011: Distinct peripheral immune signatures in early-onset colorectal cancer reveal candidate biomarkers for risk stratification","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Chemokine; Human leukocyte antigen; Peripheral blood mononuclear cell; Cytokine; Biomarker; Immunity; Colorectal cancer","score_opus":0.05961776792758723,"score_gpt":0.4325553703664647,"score_spread":0.37293760243887747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99634737,0.0008522063,0.000759343,0.00008347863,0.000023719185,0.000030686944,0.00091547525,0.00002588937,0.00096186507],"genre_scores_gemma":[0.9970958,0.00016317931,0.0007961717,0.000076574746,0.0000445936,0.000022155344,0.0010804703,0.0000081924845,0.00071293506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997956,0.000045043726,0.000019377352,0.000062598665,0.00003323886,0.00004410427],"domain_scores_gemma":[0.9994555,0.00011644668,0.00015565178,0.00003779191,0.0001014993,0.00013309425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041069253,0.00029876034,0.0003980364,0.00071828713,0.000226301,0.00059791945,0.00017688728,0.00033850165,0.003797009],"category_scores_gemma":[0.00085424347,0.00009082075,0.00020412372,0.00070006336,0.00016284756,0.00017736963,0.00029123452,0.00038859696,0.0007922314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068608066,0.0002470648,0.8623916,0.00022376348,0.00010536505,0.0005024572,0.000093207265,0.00027330997,0.09415678,0.000103528124,0.0015553728,0.033486668],"study_design_scores_gemma":[0.000029455554,0.0004996358,0.9930687,0.000017918492,0.000048109847,0.00065335765,0.000066833156,0.000688703,0.0039501064,0.00007795813,0.00089007436,0.000009061427],"about_ca_topic_score_codex":0.0007636582,"about_ca_topic_score_gemma":0.00075868703,"teacher_disagreement_score":0.003797009,"about_ca_system_score_codex":0.0002175797,"about_ca_system_score_gemma":0.00022014472,"threshold_uncertainty_score":0.012702227},"labels":[],"label_agreement":null},{"id":"W4417201306","doi":"10.1158/1557-3265.earlyonsetca25-c036","title":"Abstract C036: The Neurological and Immunological Interplay in Cancer Progression and Treatment Response","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Cancer; Tumor progression; Immunotherapy; Psychoneuroimmunology; Mechanism (biology); Neurotransmitter Agents; Neuroimmunology; Cytokine; Phenotype","score_opus":0.17554515572638496,"score_gpt":0.5608560426691778,"score_spread":0.3853108869427928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201306","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16608606,0.20927674,0.0074863243,0.37854207,0.02168623,0.0007234715,0.0041374643,0.00056251563,0.21149915],"genre_scores_gemma":[0.80372876,0.08420018,0.007343249,0.033119805,0.012763362,0.000501953,0.0019912156,0.0001865872,0.0561649],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9984653,0.0006940299,0.00010403922,0.00014557315,0.0004223091,0.00016883158],"domain_scores_gemma":[0.9970906,0.0008221577,0.0005178106,0.00009538487,0.0008316931,0.00064238056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035347692,0.000275016,0.0006238587,0.001407061,0.00086485007,0.0031255807,0.00060131936,0.0015324922,0.018219197],"category_scores_gemma":[0.0055238265,0.00011350139,0.0005134698,0.0013524166,0.0011344078,0.0009864226,0.0013065353,0.0023380616,0.0019495311],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026548568,0.0005233455,0.048106283,0.0026494241,0.000244865,0.0011523976,0.0012325173,0.0016673128,0.008711111,0.024518311,0.27022156,0.638318],"study_design_scores_gemma":[0.00038158972,0.002197263,0.31050438,0.003761256,0.0003806487,0.0038256773,0.002681476,0.0035652756,0.0074877026,0.04421941,0.62081754,0.00017775617],"about_ca_topic_score_codex":0.004535968,"about_ca_topic_score_gemma":0.0067292303,"teacher_disagreement_score":0.018219197,"about_ca_system_score_codex":0.0025705711,"about_ca_system_score_gemma":0.0043973895,"threshold_uncertainty_score":0.060949326},"labels":[],"label_agreement":null},{"id":"W4417201309","doi":"10.1158/1557-3265.earlyonsetca25-b035","title":"Abstract B035: Multilevel Insights into Obesity, Race/Ethnicity, and Survival in Early-Onset Colorectal Cancer in Georgia","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Obesity; Proportional hazards model; Cancer; Cohort; Marital status; Body mass index; Cohort study; Retrospective cohort study","score_opus":0.11693370066834648,"score_gpt":0.5077404522054478,"score_spread":0.39080675153710137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99359655,0.00023189506,0.00033507933,0.00039273803,0.00001644717,0.00003022747,0.0045966133,0.00001722605,0.0007831498],"genre_scores_gemma":[0.99744886,0.0000909772,0.00048147343,0.00008674848,0.000007063017,0.000032761127,0.0015210204,0.0000057552297,0.00032533705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994999,0.000164189,0.000027634826,0.00014588641,0.000049857856,0.000112493755],"domain_scores_gemma":[0.9985892,0.00024613418,0.0004415433,0.00016925723,0.00023560566,0.00031827655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089106435,0.00030135727,0.00031333492,0.0010645873,0.0007769787,0.00075395213,0.0008276074,0.0004639463,0.0021843538],"category_scores_gemma":[0.0025325322,0.00025224997,0.0010080722,0.0020646753,0.00037874546,0.00034386473,0.0013543308,0.0008829407,0.0003332832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006873257,0.000031779753,0.996274,0.000033266137,0.00013852459,0.000051925126,0.00022632256,0.00024100897,0.00014844011,0.00007802694,0.0008310861,0.0018768142],"study_design_scores_gemma":[0.0000029289413,0.000033191736,0.9984068,0.000026606547,0.00006491974,0.000035425575,0.0003634685,0.0005941243,0.000023167215,0.00006441742,0.0003795561,0.0000053474323],"about_ca_topic_score_codex":0.21186313,"about_ca_topic_score_gemma":0.3406088,"teacher_disagreement_score":0.21186313,"about_ca_system_score_codex":0.0017932362,"about_ca_system_score_gemma":0.002421425,"threshold_uncertainty_score":0.42125988},"labels":[],"label_agreement":null},{"id":"W4417201312","doi":"10.1158/1557-3265.earlyonsetca25-pr006","title":"Abstract PR006: Temporal Trends in the Incidence of Obesity-Associated Cancers in Puerto Rico, 2000–2022: Disproportionate Increases Among Younger Adults","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Incidence (geometry); Cancer; Thyroid cancer; Cancer incidence; Standardized rate; Public health; Behavioral Risk Factor Surveillance System; Young adult","score_opus":0.09723857094561612,"score_gpt":0.49679555465873215,"score_spread":0.39955698371311604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9547052,0.0012778904,0.0003716379,0.00083692366,0.00002803577,0.000042838983,0.03909034,0.000044716344,0.003602509],"genre_scores_gemma":[0.98359275,0.0006861572,0.00027890137,0.0001641803,0.00003510269,0.00005751663,0.0141990585,0.000009348625,0.0009770324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998503,0.000027203361,0.00001532352,0.00004176502,0.000031629366,0.000033734013],"domain_scores_gemma":[0.99943477,0.000044229517,0.00028889,0.00003763711,0.00014772786,0.000046725392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029582283,0.00017132092,0.000092330134,0.0007284873,0.00018847425,0.0003512733,0.00027370575,0.00014096196,0.0016736949],"category_scores_gemma":[0.000999308,0.00008304034,0.00028944688,0.0012879813,0.00010659108,0.00026753917,0.00048192136,0.00023682982,0.00023619774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006147096,0.000008403915,0.99099284,0.000060293267,0.000059662143,0.00006374576,0.00012991231,0.00013992078,0.00034405693,0.000053118525,0.003152149,0.004934413],"study_design_scores_gemma":[0.0000023872499,0.000007775767,0.99788636,0.000016849337,0.000020401527,0.000055687327,0.00021200147,0.00019948599,0.0000784677,0.000014740188,0.0015040153,0.0000019117917],"about_ca_topic_score_codex":0.08553086,"about_ca_topic_score_gemma":0.08102996,"teacher_disagreement_score":0.08553086,"about_ca_system_score_codex":0.0006414619,"about_ca_system_score_gemma":0.0005547963,"threshold_uncertainty_score":0.17006606},"labels":[],"label_agreement":null},{"id":"W4417201316","doi":"10.1158/1557-3265.earlyonsetca25-a025","title":"Abstract A025: Accelerated aging as a predictor for early onset colorectal cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colonoscopy; Colorectal cancer; Informed consent; Prospective cohort study; Cancer; Disease; Demographics; Young adult","score_opus":0.23635967442976202,"score_gpt":0.5543422393817735,"score_spread":0.3179825649520115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905854,0.0014507594,0.0004526335,0.00038756448,0.00009735753,0.000047466918,0.004394631,0.00002832947,0.0025560264],"genre_scores_gemma":[0.99711156,0.00019764905,0.00046328854,0.00010200827,0.00008205347,0.000031572647,0.001457985,0.0000065590366,0.0005473318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995067,0.00013590578,0.00007219354,0.00011824309,0.000100583275,0.00006641191],"domain_scores_gemma":[0.99531245,0.00065905874,0.0021902102,0.000234568,0.0007822173,0.0008214757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008505632,0.00030663397,0.00021622138,0.00080270256,0.0005061549,0.0008371825,0.00042703748,0.00041347963,0.0066491077],"category_scores_gemma":[0.0039822888,0.00015859341,0.0005239739,0.0010485182,0.00019018016,0.00040580545,0.0004912466,0.00070433685,0.0007080947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040011815,0.00002868206,0.996135,0.000057516543,0.000053586216,0.000074935066,0.000024534938,0.000030120178,0.00021288217,0.000035101064,0.00065917865,0.0022883313],"study_design_scores_gemma":[0.000011631254,0.00020805995,0.99828374,0.000028557748,0.00007239073,0.0002801414,0.000066351975,0.00019871669,0.0000878497,0.000058953912,0.0006996709,0.0000039901797],"about_ca_topic_score_codex":0.0033539187,"about_ca_topic_score_gemma":0.003972021,"teacher_disagreement_score":0.0066491077,"about_ca_system_score_codex":0.00030825136,"about_ca_system_score_gemma":0.0006360387,"threshold_uncertainty_score":0.0222435},"labels":[],"label_agreement":null},{"id":"W4417201375","doi":"10.1158/1557-3265.earlyonsetca25-c025","title":"Abstract C025: Endometrial cancer mutation patterns by age with possible increased TP53 and decreased PTEN mutations in patients 50+ years old","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"PTEN; Endometrial cancer; KRAS; Stage (stratigraphy); Cancer; Histology; Medical record","score_opus":0.09224893516064057,"score_gpt":0.4686459342393317,"score_spread":0.3763969990786911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99883956,0.00010557979,0.00003919147,0.00003169639,0.0000043095265,0.0000063458706,0.00046812472,0.0000023765808,0.0005028394],"genre_scores_gemma":[0.9995359,0.000027478372,0.000039960327,0.000028737968,0.0000063437938,0.0000059298095,0.00023343769,9.857525e-7,0.000121352474],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980336,0.000032429954,0.000028197408,0.000052147054,0.00003244858,0.00005140463],"domain_scores_gemma":[0.9992562,0.00016132489,0.0003527849,0.0000318305,0.000057338242,0.00014044702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002498347,0.00014474281,0.00018087937,0.00089769723,0.00039598378,0.00036205107,0.00020446283,0.00031050242,0.004437058],"category_scores_gemma":[0.0013096168,0.00014002502,0.0002626577,0.0008530929,0.00020160052,0.00038276633,0.00026410838,0.00027564968,0.00037988037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008374562,0.000008199806,0.9990269,0.0000029355072,0.0000073204656,0.000120552744,0.000021634292,0.000013825837,0.0001597788,0.000008539168,0.00009738426,0.00044914312],"study_design_scores_gemma":[0.000004745219,0.00006419182,0.9985214,0.000004794113,0.000011698709,0.0008806895,0.00014692954,0.00009848065,0.0000789606,0.000017161994,0.00016905827,0.0000020969428],"about_ca_topic_score_codex":0.0028616267,"about_ca_topic_score_gemma":0.0038482556,"teacher_disagreement_score":0.004437058,"about_ca_system_score_codex":0.00019893581,"about_ca_system_score_gemma":0.00020595321,"threshold_uncertainty_score":0.014843464},"labels":[],"label_agreement":null},{"id":"W4417201441","doi":"10.1158/1557-3265.earlyonsetca25-pr015","title":"Abstract PR015: Multidimensional assessment of toxicities and survivorship among people with early-onset colorectal cancer – Results from the ColoCare Study","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Survivorship curve; Colorectal cancer; Incidence (geometry); Socioeconomic status; Quality of life (healthcare); Cohort; Cancer; Prospective cohort study","score_opus":0.12370613819137811,"score_gpt":0.49693509335273034,"score_spread":0.37322895516135224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816269,0.00060657266,0.00015834488,0.00025714957,0.00003794881,0.00032994576,0.015652362,0.000012848981,0.0013180308],"genre_scores_gemma":[0.9835917,0.00029914096,0.00034277717,0.00015474952,0.00004511536,0.00045994084,0.014269286,0.0000064146107,0.0008308505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902713,0.00041907936,0.00010779602,0.00018146266,0.000163245,0.00010124877],"domain_scores_gemma":[0.9965229,0.00050188875,0.0013226159,0.00038311255,0.0005137985,0.00075563043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017525987,0.00056013255,0.0005462942,0.00089484797,0.0006690622,0.0010159361,0.0007561618,0.00064240256,0.001986923],"category_scores_gemma":[0.0050059645,0.00029601468,0.0014646051,0.001626162,0.00027219977,0.0006435792,0.0016945315,0.00095260644,0.0004642343],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000838628,0.0001522506,0.9958955,0.00005716737,0.00025898058,0.00004998553,0.000097261945,0.00005871867,0.00007457439,0.000019059977,0.00091742154,0.0015803698],"study_design_scores_gemma":[0.00013891085,0.0003001267,0.9985281,0.000019210478,0.00011868322,0.0000554154,0.00019161015,0.00008256799,0.00003344924,0.00001353259,0.00051067397,0.000007721689],"about_ca_topic_score_codex":0.009983258,"about_ca_topic_score_gemma":0.012335305,"teacher_disagreement_score":0.009983258,"about_ca_system_score_codex":0.0004773169,"about_ca_system_score_gemma":0.0006589662,"threshold_uncertainty_score":0.019850314},"labels":[],"label_agreement":null},{"id":"W4417201463","doi":"10.1158/1557-3265.earlyonsetca25-pr014","title":"Abstract PR014: FIT for red flag signs and symptoms of early onset colorectal cancer: low value or viable diagnostic tool?","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Incidence (geometry); Hazard ratio; Population; Proportional hazards model; Confidence interval; Cumulative incidence; Cohort; Anemia","score_opus":0.1358743743193789,"score_gpt":0.4912567668193131,"score_spread":0.3553823924999342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98132116,0.002534274,0.0010829894,0.0030789285,0.00018622554,0.00010371598,0.0067280615,0.000058274236,0.004906399],"genre_scores_gemma":[0.9968656,0.0002671946,0.00071730855,0.0002656237,0.00011756142,0.000033548935,0.0013868439,0.000006975411,0.00033941603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814904,0.0009082378,0.00022234413,0.00018176853,0.0004035196,0.00013513792],"domain_scores_gemma":[0.9898101,0.0032007266,0.0050101248,0.00026477547,0.0011576191,0.00055661815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026394164,0.00031196378,0.00042426982,0.0008460214,0.00022384216,0.0012212622,0.0007500609,0.00066671026,0.0041275616],"category_scores_gemma":[0.017973294,0.00018167152,0.00051597314,0.0013419241,0.00031598742,0.0009079038,0.0005364571,0.0007842839,0.00088542135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028083744,0.000031432195,0.9936022,0.00007041703,0.000040924337,0.000046000314,0.0000200173,0.000029895575,0.00006248654,0.00003510028,0.00101956,0.0047610668],"study_design_scores_gemma":[0.00009238938,0.000885617,0.9942212,0.00023183622,0.00016724611,0.0005879631,0.0003231214,0.0014317124,0.0002333301,0.00019765564,0.0016142341,0.000013726786],"about_ca_topic_score_codex":0.0020106665,"about_ca_topic_score_gemma":0.0026727684,"teacher_disagreement_score":0.0041275616,"about_ca_system_score_codex":0.00030148428,"about_ca_system_score_gemma":0.00055867794,"threshold_uncertainty_score":0.013958693},"labels":[],"label_agreement":null},{"id":"W4417201520","doi":"10.1158/1557-3265.earlyonsetca25-a009","title":"Abstract A009: Mutation Matters: ATM and BRCA1/2 Shape Divergent Coagulopathy Programs in Pancreatic Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Germline mutation; Germline; Coagulation; Mutation; Factor V; Coagulopathy; Fibrinogen; Pancreatic cancer","score_opus":0.27396842602099336,"score_gpt":0.54578884735587,"score_spread":0.2718204213348766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94622135,0.006192978,0.0044862167,0.0023452444,0.00025358613,0.000036917412,0.033315852,0.0005744321,0.0065733874],"genre_scores_gemma":[0.9729917,0.001957122,0.002150772,0.0011112839,0.00016066966,0.00004458488,0.018361608,0.00017800444,0.003044279],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99961334,0.00004055143,0.000020208488,0.00019153013,0.00008622983,0.00004802004],"domain_scores_gemma":[0.9996239,0.000116557305,0.00011277089,0.000027395408,0.000056578043,0.00006285452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038612084,0.00024172805,0.0004206847,0.00060398824,0.00040840835,0.0012451558,0.0002429179,0.00048060244,0.009968053],"category_scores_gemma":[0.0011760304,0.00016371334,0.00046318205,0.0010693113,0.00034798018,0.00050818943,0.0005094716,0.00066184095,0.001713102],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004127443,0.0001452258,0.417672,0.0016272516,0.00078596646,0.00104207,0.0007299244,0.0026793992,0.40180492,0.0058821617,0.040042322,0.12346138],"study_design_scores_gemma":[0.00007203886,0.00032502756,0.9271683,0.00018866039,0.00026434686,0.0018420861,0.0007038727,0.005189566,0.023385143,0.0064632143,0.03434499,0.000052807893],"about_ca_topic_score_codex":0.0009593492,"about_ca_topic_score_gemma":0.0011645516,"teacher_disagreement_score":0.009968053,"about_ca_system_score_codex":0.00031358594,"about_ca_system_score_gemma":0.0003850589,"threshold_uncertainty_score":0.033346415},"labels":[],"label_agreement":null},{"id":"W4417201521","doi":"10.1158/1557-3265.earlyonsetca25-a001","title":"Abstract A001: Unravelling the molecular structural and functional roles of the homologous Mouse double minute RINGs interface for targeted anticancer design","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer therapy; Cancer; Downregulation and upregulation; Cancer cell; Flexibility (engineering); Mechanism (biology); Folding (DSP implementation); Homologous chromosome; Apoptosis","score_opus":0.10592126432558735,"score_gpt":0.43500387880241587,"score_spread":0.3290826144768285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.915561,0.008143143,0.053085007,0.0010746516,0.00029762217,0.00012333172,0.002131045,0.0018556197,0.017728599],"genre_scores_gemma":[0.96777534,0.0034494617,0.021479623,0.00012652428,0.000028614144,0.00008777223,0.0025031907,0.00020065832,0.0043489453],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995005,0.000005662082,0.0000017183967,0.000009013187,0.000021133104,0.000012453747],"domain_scores_gemma":[0.99996126,0.00001014782,0.0000066107727,0.0000032789708,0.0000096928,0.0000090935155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015842459,0.00054130866,0.00035255557,0.0001045705,0.00024354893,0.0004238676,0.00045697056,0.00037697732,0.012569374],"category_scores_gemma":[0.00018754583,0.00016479463,0.00028507703,0.00011485887,0.00014258323,0.0005978528,0.00033411672,0.0007982422,0.0012437239],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013850675,0.0003893833,0.0048808665,0.0017255889,0.00013154169,0.0007230282,0.00022717334,0.06899018,0.80757815,0.019811919,0.012491343,0.081665836],"study_design_scores_gemma":[0.00029289618,0.001392004,0.006566507,0.00019250522,0.0001768658,0.0004994958,0.0003460649,0.53344285,0.37874818,0.009233939,0.06901415,0.00009450013],"about_ca_topic_score_codex":0.0013906307,"about_ca_topic_score_gemma":0.00096865353,"teacher_disagreement_score":0.012569374,"about_ca_system_score_codex":0.0003101347,"about_ca_system_score_gemma":0.00038929645,"threshold_uncertainty_score":0.042048752},"labels":[],"label_agreement":null},{"id":"W4417201523","doi":"10.1158/1557-3265.earlyonsetca25-c010","title":"Abstract C010: Association of a germline KDM3C polymorphism with early cancer diagnosis","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Single-nucleotide polymorphism; SNP; Loss of heterozygosity; Cohort; Cancer; Biobank; Prospective cohort study; Germline; Uniparental disomy","score_opus":0.08950192909358919,"score_gpt":0.4964822151284823,"score_spread":0.4069802860348931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99540377,0.00033210163,0.0002640465,0.00024311028,0.000046369478,0.000016161734,0.0025462385,0.000016520038,0.0011317095],"genre_scores_gemma":[0.99860007,0.000040521376,0.00018650146,0.00007396123,0.000022945485,0.000009078262,0.00050865364,0.000005007176,0.0005531313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956304,0.0000768835,0.000052616426,0.0001463629,0.000089236026,0.00007178807],"domain_scores_gemma":[0.99806005,0.00071452954,0.0006475253,0.00011107584,0.00020226417,0.00026460245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043646607,0.00023415792,0.00025457717,0.00055694685,0.000448244,0.00037770922,0.00038070497,0.0005741685,0.010255841],"category_scores_gemma":[0.0028177546,0.00014592253,0.0003607312,0.00080590736,0.00022848097,0.000152945,0.00023246132,0.0006422719,0.00057152455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010189264,0.000042210977,0.9931931,0.00004527363,0.00008858654,0.0006049809,0.0000558946,0.00005868473,0.00159373,0.00005499142,0.0012766842,0.0019669514],"study_design_scores_gemma":[0.000046668938,0.00014084912,0.9961598,0.000026311758,0.00008709856,0.0015810153,0.000072325085,0.00030802292,0.00050321576,0.00007472234,0.0009926219,0.0000073336605],"about_ca_topic_score_codex":0.013180996,"about_ca_topic_score_gemma":0.0076810266,"teacher_disagreement_score":0.013180996,"about_ca_system_score_codex":0.00036480319,"about_ca_system_score_gemma":0.0003533042,"threshold_uncertainty_score":0.03430921},"labels":[],"label_agreement":null},{"id":"W4417201604","doi":"10.1158/1557-3265.earlyonsetca25-c008","title":"Abstract C008: Characterizing factors associated with early onset breast cancer to inform tailored strategies for cancer risk assessment, screening, and treatment","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Family history; Retrospective cohort study; Cancer; Medical record; Cohort; Natural history; Categorical variable; Continuous variable","score_opus":0.15403152309469603,"score_gpt":0.5014860557292843,"score_spread":0.34745453263458825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9606336,0.0044817072,0.0029826118,0.0041044247,0.00014594922,0.00021099065,0.018496737,0.00012758018,0.008816445],"genre_scores_gemma":[0.9883978,0.0010575766,0.003282999,0.0006190867,0.00014251668,0.00007567647,0.0051586377,0.000024219991,0.001241361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99939525,0.00018892509,0.0000901947,0.000117511605,0.00013094847,0.00007721695],"domain_scores_gemma":[0.99553055,0.001347011,0.0017082937,0.00020101789,0.0006841276,0.00052896247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001300491,0.0002568477,0.00028242636,0.0017188035,0.00046218792,0.0011292777,0.00044606865,0.00043237957,0.0063460856],"category_scores_gemma":[0.0067327973,0.00012748281,0.00032043114,0.0018272601,0.00022498948,0.0004950452,0.0005465403,0.00067384075,0.0009873159],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005725141,0.000033859284,0.98469985,0.000071702605,0.00002678582,0.00008525384,0.000044140663,0.00008360959,0.00020803332,0.00007130314,0.0036392706,0.010978851],"study_design_scores_gemma":[0.0000074945096,0.000055351375,0.99581295,0.000091017966,0.000031163578,0.0003587888,0.0002512164,0.00040763948,0.00021497394,0.00020066844,0.0025608253,0.000007898014],"about_ca_topic_score_codex":0.009613002,"about_ca_topic_score_gemma":0.01359455,"teacher_disagreement_score":0.009613002,"about_ca_system_score_codex":0.0005976973,"about_ca_system_score_gemma":0.0011934919,"threshold_uncertainty_score":0.021229744},"labels":[],"label_agreement":null},{"id":"W4417201605","doi":"10.1158/1557-3265.earlyonsetca25-ia001","title":"Abstract IA001: Integrative cancer population sciences to decipher the etiology of early-onset colorectal cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Cancer; Incidence (geometry); Pancreatic cancer; Population; Obesity; Prostate cancer; Etiology; Kidney cancer; Epidemiology","score_opus":0.12233761220798132,"score_gpt":0.5356147811761156,"score_spread":0.41327716896813427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5643328,0.03893731,0.21970782,0.017057827,0.0013913027,0.0017963607,0.10840292,0.005075053,0.04329861],"genre_scores_gemma":[0.8686404,0.008871304,0.08140624,0.0012608652,0.0006014792,0.0013106567,0.02886362,0.00041810804,0.008627246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912006,0.00046403985,0.000032802815,0.00018111264,0.00011802625,0.00008398986],"domain_scores_gemma":[0.9986765,0.0006634156,0.00012117265,0.00014022973,0.0002464331,0.0001522618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028153707,0.00083617517,0.0011083358,0.0037734034,0.0005598657,0.0016455271,0.0009512727,0.00068136654,0.014282566],"category_scores_gemma":[0.0053236512,0.00025464175,0.002874457,0.004489738,0.00022244923,0.0005910942,0.0013643244,0.0012706909,0.0011579992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005920577,0.00042417098,0.5847097,0.002054872,0.007171066,0.00041800804,0.00070049986,0.008585761,0.0030034103,0.013439567,0.029077621,0.3498232],"study_design_scores_gemma":[0.00018126945,0.00077531935,0.84285355,0.0006469173,0.0053779962,0.0006949918,0.0021045168,0.05321738,0.0010524135,0.028102476,0.064910844,0.00008223698],"about_ca_topic_score_codex":0.016818205,"about_ca_topic_score_gemma":0.010479257,"teacher_disagreement_score":0.016818205,"about_ca_system_score_codex":0.0009940085,"about_ca_system_score_gemma":0.0024067126,"threshold_uncertainty_score":0.047779918},"labels":[],"label_agreement":null},{"id":"W4417201607","doi":"10.1158/1557-3265.earlyonsetca25-a018","title":"Abstract A018: Colorectal Cancer Screening Remains Low Despite High Burden And Rising Early-Onset Cases In Puerto Rico, 2016–2021","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer screening; Colorectal cancer; Odds ratio; Public health; Cancer screening; Odds; Cancer; Young adult; Health insurance","score_opus":0.12217843182286921,"score_gpt":0.48584548695658264,"score_spread":0.36366705513371345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9729931,0.001548134,0.00040202655,0.003164362,0.00006785275,0.000053416687,0.017422225,0.000037240177,0.004311645],"genre_scores_gemma":[0.99305665,0.00046107988,0.0002726964,0.00043607835,0.000048397935,0.000041472384,0.004807521,0.000008304228,0.0008677318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997063,0.00007833332,0.000027668066,0.000067010995,0.000053853364,0.00006684178],"domain_scores_gemma":[0.99888533,0.00011460414,0.0006236528,0.000068538604,0.00022104266,0.00008692653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006420849,0.00020796715,0.00013604334,0.00055000524,0.00033775205,0.00057275424,0.00038823372,0.00021604684,0.0022710552],"category_scores_gemma":[0.0025435681,0.000089969624,0.00035851492,0.0010773009,0.00022431112,0.0004105013,0.0006916641,0.00033276348,0.00026652793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010082895,0.000015455102,0.98460776,0.00012863816,0.00010781022,0.00014986364,0.00025329643,0.00017533253,0.00039829253,0.00014720333,0.005003508,0.008911959],"study_design_scores_gemma":[0.000007621019,0.000019641962,0.99427795,0.00008327555,0.00007524517,0.00012615154,0.0009055851,0.00047698643,0.0001858911,0.00007604026,0.0037601152,0.000005506411],"about_ca_topic_score_codex":0.1658921,"about_ca_topic_score_gemma":0.14067051,"teacher_disagreement_score":0.1658921,"about_ca_system_score_codex":0.001022453,"about_ca_system_score_gemma":0.0012303927,"threshold_uncertainty_score":0.329853},"labels":[],"label_agreement":null},{"id":"W4417201691","doi":"10.1158/1557-3265.earlyonsetca25-c034","title":"Abstract C034: Obesity-Linked Leptin Signaling Promotes Immune Checkpoint Expression and Tumor Cell Survival","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Regulation of Appetite and Obesity","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Leptin; Gene knockdown; Adipokine; Immune system; Immune checkpoint; Leptin receptor; Tumor progression; Downregulation and upregulation; Gene silencing; Apoptosis","score_opus":0.1718553186604019,"score_gpt":0.4593158004566219,"score_spread":0.28746048179621997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9644136,0.01408536,0.004809091,0.0011083215,0.0004195786,0.00015720398,0.0043209707,0.00041033133,0.0102755595],"genre_scores_gemma":[0.97629434,0.0036089849,0.00250063,0.00044003368,0.00007733441,0.00017953441,0.0041134986,0.00008137468,0.012704336],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998683,0.00001151798,0.0000105581485,0.000028647028,0.00003679923,0.000044142736],"domain_scores_gemma":[0.9999145,0.000007910844,0.000019434905,0.0000072408825,0.000019792235,0.000031122414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010725798,0.00040632123,0.00030221033,0.0003067214,0.00030875165,0.00036366962,0.0002468786,0.000488311,0.008872781],"category_scores_gemma":[0.000095824405,0.00011662538,0.00044329662,0.0003105726,0.00020007603,0.00020647542,0.00022645162,0.00082548684,0.002010409],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012450835,0.0001109489,0.00028873622,0.00022273771,0.000016565024,0.000116886156,0.000013434558,0.00007457557,0.9918223,0.0002480713,0.00089661364,0.004944028],"study_design_scores_gemma":[0.0002772317,0.0011543625,0.011073628,0.000051860847,0.000055738306,0.0005999941,0.00007561579,0.0011574021,0.9689143,0.00025383793,0.01637434,0.000011733116],"about_ca_topic_score_codex":0.0008897464,"about_ca_topic_score_gemma":0.0008529717,"teacher_disagreement_score":0.008872781,"about_ca_system_score_codex":0.0004399138,"about_ca_system_score_gemma":0.00056025374,"threshold_uncertainty_score":0.029682398},"labels":[],"label_agreement":null},{"id":"W4417201693","doi":"10.1158/1557-3265.earlyonsetca25-b003","title":"Abstract B003: Risk Factors, Clinical and Molecular Characteristics of de novo Metastatic Early Onset Colorectal Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; KRAS; Cancer; Disease; Exome sequencing; Stage (stratigraphy); Clinical significance","score_opus":0.08045071176639222,"score_gpt":0.4749801635350249,"score_spread":0.3945294517686327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99062645,0.00036315032,0.0003501881,0.00023210453,0.000023372637,0.000028839646,0.006454861,0.000032768294,0.001888327],"genre_scores_gemma":[0.99270743,0.000121113255,0.0005313171,0.000059471076,0.00003725259,0.000033577202,0.0052744057,0.000016665792,0.0012186246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982953,0.000034103105,0.000019178551,0.000042599982,0.000044805114,0.00002976722],"domain_scores_gemma":[0.99908197,0.00016180704,0.00025376317,0.000043870245,0.00015932959,0.00029920603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003306794,0.00029397846,0.00022812637,0.00079174986,0.00032218453,0.00038309637,0.00030242593,0.00033300373,0.011805381],"category_scores_gemma":[0.0016076977,0.00010587416,0.00026291274,0.0010442233,0.0001286613,0.0002469019,0.00030410432,0.00042860868,0.0014081756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006844105,0.000053621745,0.9908434,0.00004468556,0.00004260986,0.00018743085,0.000025396943,0.00004397532,0.0017296581,0.000027981887,0.0017497438,0.004566992],"study_design_scores_gemma":[0.000018979126,0.00011636684,0.99782676,0.00001128777,0.000027193291,0.0005602825,0.000051311323,0.00016246633,0.00022598222,0.000042734242,0.00095337984,0.0000033247277],"about_ca_topic_score_codex":0.0027008692,"about_ca_topic_score_gemma":0.002711062,"teacher_disagreement_score":0.011805381,"about_ca_system_score_codex":0.00027008774,"about_ca_system_score_gemma":0.0002911246,"threshold_uncertainty_score":0.039492965},"labels":[],"label_agreement":null},{"id":"W4417201745","doi":"10.1158/1557-3265.earlyonsetca25-b034","title":"Abstract B034: Sex and Racial Disparities in Time to Treatment for Early-Onset Colorectal Cancer Across a Four-Level Rurality Classification in the United States","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rurality; Colorectal cancer; Incidence (geometry); Proportional hazards model; Cohort; Disadvantaged; Census; Health equity; Retrospective cohort study; Cohort study","score_opus":0.33904326321870853,"score_gpt":0.5681588964899411,"score_spread":0.22911563327123258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99355197,0.00012571343,0.00017633571,0.00012444925,0.000009213953,0.000013049029,0.005448827,0.000006901458,0.00054337684],"genre_scores_gemma":[0.9972101,0.00006459769,0.00015981543,0.000040883748,0.000007974381,0.000024157624,0.0021725323,0.0000030177582,0.0003169078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996605,0.00007639703,0.000037168546,0.0000898976,0.000053758482,0.00008223647],"domain_scores_gemma":[0.99850696,0.00016893931,0.0009300944,0.000078947036,0.00015370514,0.00016132082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058794604,0.00013972652,0.00013796185,0.0005320974,0.00034349546,0.0003919586,0.00036643213,0.00018061104,0.0025250798],"category_scores_gemma":[0.0020382428,0.00012607398,0.00046487435,0.0011198593,0.00016151609,0.00026675875,0.00049834035,0.00037334728,0.00020217165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056252604,0.000020900567,0.9981142,0.000009845809,0.000032834458,0.000013650962,0.000051532785,0.00007286031,0.000052020492,0.000032419717,0.00044161346,0.0011017445],"study_design_scores_gemma":[0.000006631975,0.000030669715,0.9989353,0.000011713351,0.000027547372,0.000034997764,0.00017253072,0.00033856858,0.000047394034,0.000034551587,0.00035770307,0.000002327545],"about_ca_topic_score_codex":0.040849913,"about_ca_topic_score_gemma":0.04521945,"teacher_disagreement_score":0.040849913,"about_ca_system_score_codex":0.00047123997,"about_ca_system_score_gemma":0.0007977335,"threshold_uncertainty_score":0.08122432},"labels":[],"label_agreement":null},{"id":"W4417201812","doi":"10.1158/1557-3265.earlyonsetca25-c006","title":"Abstract C006: Association of high birth weight with risk of early-onset colorectal cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Birth, Development, and Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Birth weight; Gestational age; Confounding; Colorectal cancer; Logistic regression; Percentile; Incidence (geometry); Population; Record linkage; Fetal macrosomia","score_opus":0.09046669444400228,"score_gpt":0.48687465152503173,"score_spread":0.39640795708102944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930577,0.0007696841,0.0002636295,0.00030428098,0.000038356422,0.000012146366,0.0042314203,0.000025033445,0.001297667],"genre_scores_gemma":[0.9974017,0.00015769381,0.00027334393,0.00004186615,0.00003870262,0.000008326781,0.0015796882,0.000005974116,0.00049262145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968386,0.000061064224,0.000033794662,0.00009611058,0.00008815575,0.000036953566],"domain_scores_gemma":[0.9963277,0.0008028719,0.001645319,0.0002062817,0.0005298359,0.00048799848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054868654,0.00028055182,0.00018931463,0.00072125,0.00030836803,0.00051802763,0.00043410299,0.00032535862,0.006578603],"category_scores_gemma":[0.0036141323,0.00013560339,0.00039513817,0.00084891426,0.00018441335,0.00017351237,0.0002516247,0.0004886008,0.00036109763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012885408,0.000010386594,0.9983821,0.000015579995,0.00006859102,0.000039085193,0.00000924009,0.00002680574,0.00015170506,0.000013383564,0.00027229675,0.0008818268],"study_design_scores_gemma":[0.000006705358,0.000042160114,0.9993992,0.0000071738623,0.000033060183,0.00011694726,0.000014761676,0.00013594807,0.000046963087,0.000016187438,0.00017926877,0.0000015747888],"about_ca_topic_score_codex":0.019290835,"about_ca_topic_score_gemma":0.010259796,"teacher_disagreement_score":0.019290835,"about_ca_system_score_codex":0.00032967937,"about_ca_system_score_gemma":0.00044032288,"threshold_uncertainty_score":0.03835708},"labels":[],"label_agreement":null},{"id":"W4417201848","doi":"10.1158/1557-3265.earlyonsetca25-pr011","title":"Abstract PR011: Early-onset colorectal cancer is characterized by transcriptional changes indicating increased epithelial-mesenchymal transition and metastatic potential","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Microsatellite instability; Cancer; Incidence (geometry); Rectum; Metastasis; Gene; Primary tumor; Overall survival; Survival rate","score_opus":0.09945902048054259,"score_gpt":0.45815969730083167,"score_spread":0.35870067682028905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6603629,0.008603945,0.025689594,0.0007048432,0.00045660077,0.00012079589,0.28309375,0.0029883317,0.017979184],"genre_scores_gemma":[0.70344716,0.003556358,0.01716529,0.0010111545,0.00013724559,0.00021232478,0.2571716,0.0011839984,0.0161148],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99969006,0.00001732515,0.000017243934,0.00017151245,0.00006981396,0.000034070392],"domain_scores_gemma":[0.99954295,0.000096337266,0.000138399,0.000041554995,0.000117409545,0.00006331874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002773889,0.0003064373,0.0004940058,0.00041843893,0.0004871742,0.0006832099,0.0003239577,0.00032585277,0.0076817567],"category_scores_gemma":[0.00070139696,0.00021025645,0.00046936757,0.0010332784,0.0003486355,0.0004785679,0.00067118474,0.0004268509,0.0028650777],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018319205,0.000058964477,0.13126604,0.0030083815,0.00036142312,0.0006679031,0.00042035992,0.0021203528,0.76776683,0.002054804,0.033326324,0.057116732],"study_design_scores_gemma":[0.000115946,0.0006200874,0.7011066,0.00023304315,0.00050872285,0.0031440011,0.00055055757,0.0060033393,0.12506212,0.0027645556,0.15978712,0.00010388347],"about_ca_topic_score_codex":0.0044617793,"about_ca_topic_score_gemma":0.008172493,"teacher_disagreement_score":0.0076817567,"about_ca_system_score_codex":0.00044934868,"about_ca_system_score_gemma":0.00055051374,"threshold_uncertainty_score":0.025698066},"labels":[],"label_agreement":null},{"id":"W4417201849","doi":"10.1158/1557-3265.earlyonsetca25-b036","title":"Abstract B036: Non-steroidal anti-inflammatory drugs use and risk of colorectal cancer molecular subtypes: A systematic review and meta-analysis","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Microsatellite instability; Cancer; CpG site; MEDLINE; Meta-analysis; Drug; Relative risk","score_opus":0.0893934564786214,"score_gpt":0.4590180619095947,"score_spread":0.3696246054309733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201849","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028438657,0.99485093,0.00040314978,0.00019433514,0.00014275227,0.00022609695,0.0010661639,0.000024493358,0.00024829808],"genre_scores_gemma":[0.114704244,0.87915325,0.0018434986,0.0009671833,0.00031068287,0.001087479,0.0013403296,0.000033155116,0.0005601515],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9928652,0.002993193,0.0022397158,0.0007917732,0.00083180814,0.0002782406],"domain_scores_gemma":[0.9861384,0.009741021,0.002359878,0.00035712952,0.0012073957,0.0001961821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008549325,0.002496496,0.015948612,0.006758788,0.0006513961,0.0030081447,0.0018592009,0.0019678748,0.0064786063],"category_scores_gemma":[0.022679646,0.0011845778,0.032767292,0.009420751,0.0006513884,0.0015548222,0.0013856139,0.0015470844,0.0005422201],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009684316,0.000014119315,0.0038379803,0.5956258,0.38921142,0.00012702464,0.000062751635,0.00035002094,0.0002322532,0.00010773391,0.0009734865,0.008488872],"study_design_scores_gemma":[0.00038771288,0.00012290724,0.0051793545,0.04541795,0.9458137,0.00013514601,0.00004695106,0.00014898989,0.00009872521,0.00016968446,0.0024554036,0.000023419594],"about_ca_topic_score_codex":0.011526672,"about_ca_topic_score_gemma":0.02202773,"teacher_disagreement_score":0.015948612,"about_ca_system_score_codex":0.0023039125,"about_ca_system_score_gemma":0.0041254316,"threshold_uncertainty_score":0.04521364},"labels":[],"label_agreement":null},{"id":"W4417201852","doi":"10.1158/1557-3265.earlyonsetca25-a012","title":"Abstract A012: A Deep Learning Framework for Predicting Survival in Gastric Cancer: A Comparative Analysis with Traditional Cox Regression","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Machine Learning in Healthcare","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Proportional hazards model; Deep learning; Concordance; Cancer; Regression; Dropout (neural networks); Survival analysis; Cohort","score_opus":0.3125153198919803,"score_gpt":0.5669539830587064,"score_spread":0.2544386631667261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69636464,0.006384444,0.28734985,0.0030742893,0.00042486005,0.00020058214,0.0020935133,0.001671235,0.0024366048],"genre_scores_gemma":[0.9613384,0.0008234242,0.0350229,0.00017950231,0.00009495758,0.00009201602,0.0012746969,0.00005407646,0.0011200353],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99867755,0.00076624536,0.00006957877,0.0001685854,0.000230816,0.00008725917],"domain_scores_gemma":[0.9940852,0.004222289,0.000282754,0.00029945254,0.0008259859,0.00028425563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007907617,0.0010407076,0.0008725343,0.0016072309,0.00027654285,0.0010520929,0.0011712828,0.0007592302,0.0019827546],"category_scores_gemma":[0.010692406,0.00024507465,0.0011859258,0.0008213863,0.00036141966,0.0010607329,0.0012296248,0.001360571,0.00035626724],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030642923,0.0007109692,0.114226125,0.00034272013,0.001271037,0.00022185563,0.00009324157,0.59119606,0.0013228895,0.0046371566,0.0064311107,0.27648252],"study_design_scores_gemma":[0.00003649923,0.0002767287,0.0031378649,0.000020591371,0.000056189325,0.000027527743,0.000015200917,0.99480224,0.00021624411,0.001164473,0.0002362915,0.000010159364],"about_ca_topic_score_codex":0.011580687,"about_ca_topic_score_gemma":0.0069330647,"teacher_disagreement_score":0.011580687,"about_ca_system_score_codex":0.0011444308,"about_ca_system_score_gemma":0.0017081838,"threshold_uncertainty_score":0.04181999},"labels":[],"label_agreement":null},{"id":"W4417201919","doi":"10.1158/1557-3265.earlyonsetca25-c027","title":"Abstract C027: Association of Binge Drinking with Early-Onset Colorectal Cancer: A Comparison to Late-Onset Cancers","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Binge drinking; Colorectal cancer; Alcohol consumption; Logistic regression; Family history; Confidence interval; Cancer","score_opus":0.28035565824938213,"score_gpt":0.5823786918049523,"score_spread":0.30202303355557014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99417984,0.0025344184,0.00023985736,0.00007995622,0.000041674637,0.000051711027,0.0018896862,0.000005042941,0.0009778278],"genre_scores_gemma":[0.9980483,0.0002656894,0.00012091329,0.000037264574,0.000031156596,0.00002712654,0.001215297,0.0000033264046,0.000250926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985979,0.000362515,0.00016104973,0.00037310936,0.00034001557,0.00016535437],"domain_scores_gemma":[0.99694246,0.00075040193,0.0012927557,0.00016375184,0.00036918066,0.000481436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015894193,0.00041047062,0.00047077463,0.0015159594,0.00049025513,0.00073478505,0.0005865834,0.0005805456,0.004803496],"category_scores_gemma":[0.0034815148,0.00019558254,0.0011411748,0.0014073297,0.00026232385,0.00048210283,0.00071923237,0.0005718553,0.00022690615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011288226,0.000053302556,0.99566346,0.000119527685,0.0005402713,0.00007478881,0.000025608428,0.00003430252,0.00029170184,0.000027678223,0.00019369903,0.0018467712],"study_design_scores_gemma":[0.00004269445,0.00030152226,0.9982876,0.000036891295,0.00024421787,0.0002299781,0.00010963363,0.00024753157,0.000097693635,0.000021733073,0.00037652667,0.0000039396486],"about_ca_topic_score_codex":0.009627449,"about_ca_topic_score_gemma":0.009983302,"teacher_disagreement_score":0.009627449,"about_ca_system_score_codex":0.0004402089,"about_ca_system_score_gemma":0.00051112345,"threshold_uncertainty_score":0.019142866},"labels":[],"label_agreement":null},{"id":"W4417201952","doi":"10.1158/1557-3265.earlyonsetca25-b033","title":"Abstract B033: A Comparative Study of Cervical Cancer Treatment Outcomes Between Reproductive-Aged and Post-Menopausal Women in a Tertiary Hospital in Bangladesh.","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cervical cancer; Stage (stratigraphy); Chemotherapy; Cancer; Breast cancer; Hysterectomy; Cancer treatment","score_opus":0.18311796990997045,"score_gpt":0.5427053126358621,"score_spread":0.35958734272589166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967344,0.0002589882,0.000023759058,0.00007622486,0.0000030317246,0.00007255975,0.0023157797,0.0000023009418,0.00051295396],"genre_scores_gemma":[0.9980958,0.00024899797,0.000051187457,0.00008254972,0.000004710991,0.00007528174,0.0011891387,0.0000015347489,0.00025076786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99937683,0.00012875252,0.00014860621,0.0001034451,0.00011573894,0.00012675495],"domain_scores_gemma":[0.9981493,0.0002682489,0.00088726904,0.000056807552,0.00026531977,0.00037299795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060475554,0.00025126536,0.00043559552,0.0009811774,0.000674229,0.00064405415,0.00042608456,0.00044679746,0.0028043198],"category_scores_gemma":[0.0020097652,0.00031922277,0.00047268474,0.0025441477,0.00034802995,0.00052447035,0.0006741815,0.0004557034,0.000715136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018392631,0.000083752384,0.9966286,0.00009611713,0.00003163401,0.00018987937,0.0007194839,0.000015528889,0.00018364274,0.0000110599485,0.00019625854,0.0016601582],"study_design_scores_gemma":[0.000023219422,0.00038323685,0.9961701,0.000038151,0.000023535396,0.00024556904,0.0026794118,0.000028005217,0.000051398136,0.000008621251,0.00034105725,0.0000076384495],"about_ca_topic_score_codex":0.030172762,"about_ca_topic_score_gemma":0.03899389,"teacher_disagreement_score":0.030172762,"about_ca_system_score_codex":0.0014655914,"about_ca_system_score_gemma":0.0014552078,"threshold_uncertainty_score":0.05999428},"labels":[],"label_agreement":null},{"id":"W4417202165","doi":"10.1158/1557-3265.earlyonsetca25-c001","title":"Abstract C001: Novel Sex-Specific Metabolic Phenotypes in Early Onset Colorectal Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Proportional hazards model; Hazard ratio; Cohort; Metabolomics; Metabolite; Cancer; Incidence (geometry); Multivariate analysis","score_opus":0.17629729535422098,"score_gpt":0.5174849194151687,"score_spread":0.3411876240609477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834767,0.0030045242,0.0010166559,0.00026389115,0.000036242516,0.000023794119,0.011147709,0.000049252227,0.0009813366],"genre_scores_gemma":[0.9908015,0.0007121547,0.00088756386,0.00011945591,0.000039507497,0.00001827733,0.00670679,0.000020704567,0.0006941805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998621,0.000022346281,0.000012305098,0.000052396485,0.000028058337,0.000022881095],"domain_scores_gemma":[0.99946207,0.00008707324,0.00024730337,0.000048533308,0.00006787074,0.00008704419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003331819,0.00034491072,0.00038975655,0.00054539205,0.00023022314,0.00061669707,0.00019642785,0.00024078286,0.0026633902],"category_scores_gemma":[0.00069721736,0.00009354801,0.00042048865,0.0010125928,0.00019240043,0.00016363765,0.00036075045,0.00036879932,0.00044195214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036275112,0.000090433954,0.90610427,0.00034061196,0.00041651758,0.00067541684,0.00009634966,0.00044474768,0.05900203,0.0001744058,0.0017268817,0.027300885],"study_design_scores_gemma":[0.000028384478,0.00024242082,0.9917311,0.000015593392,0.000116303236,0.0009594039,0.000059798615,0.0005974774,0.0043745264,0.00019697772,0.0016660132,0.000011949258],"about_ca_topic_score_codex":0.00146089,"about_ca_topic_score_gemma":0.002011385,"teacher_disagreement_score":0.0026633902,"about_ca_system_score_codex":0.0002471313,"about_ca_system_score_gemma":0.00032517532,"threshold_uncertainty_score":0.00891},"labels":[],"label_agreement":null},{"id":"W4417202207","doi":"10.1158/1557-3265.earlyonsetca25-pr013","title":"Abstract PR013: Distinct Oral Bacterial Signatures in Rectal Cancer Tumors Associated with Age of Onset and Treatment Response","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fusobacterium nucleatum; Colorectal cancer; Bacteroides fragilis; Prevotella; Fusobacterium; Microbiome; Bacteroides; Cancer","score_opus":0.0914458160654076,"score_gpt":0.4862841877622393,"score_spread":0.3948383716968317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962727,0.0007213392,0.00045568525,0.00006762584,0.000010061965,0.000015259433,0.0020673585,0.00001851904,0.00037146328],"genre_scores_gemma":[0.99635315,0.00019657024,0.0005990731,0.00007849627,0.000011274411,0.000024551078,0.0021954465,0.000014483894,0.0005268315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997435,0.00004398755,0.000024432098,0.000082500264,0.000048819038,0.00005671009],"domain_scores_gemma":[0.99954385,0.00006401693,0.00021246076,0.00002961619,0.00007331238,0.000076813565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022720231,0.00020694293,0.00051002717,0.0005115187,0.00021685955,0.00053638296,0.00013494141,0.00024902445,0.0019451542],"category_scores_gemma":[0.0007231161,0.0001363436,0.00038591438,0.00092617876,0.00017923293,0.00020058066,0.00038508754,0.00038800325,0.00038708255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018746373,0.00005216457,0.922561,0.00013639493,0.00014019826,0.00023720169,0.00015211776,0.00020933234,0.060697153,0.000034652363,0.00058849977,0.013316663],"study_design_scores_gemma":[0.000007680108,0.00024168973,0.9957209,0.000012428118,0.00006248014,0.0004320013,0.0002470004,0.00036879827,0.002134578,0.000030551524,0.00073512923,0.000006817611],"about_ca_topic_score_codex":0.0021895773,"about_ca_topic_score_gemma":0.0026798958,"teacher_disagreement_score":0.0021895773,"about_ca_system_score_codex":0.000235808,"about_ca_system_score_gemma":0.00020879647,"threshold_uncertainty_score":0.006507218},"labels":[],"label_agreement":null},{"id":"W4417202221","doi":"10.1158/1557-3265.earlyonsetca25-c018","title":"Abstract C018: Urinary Arsenic and Other Heavy Metals in Gallbladder Cancer Patients: A Pilot Study Correlating Exposure with Drinking Water and Assessing Carcinogenic Risk in Northeast India","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Arsenic contamination and mitigation","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Arsenic; Urine; Cadmium; Urinary system; Carcinogen; Inductively coupled plasma mass spectrometry; Incidence (geometry); Risk assessment","score_opus":0.07444173828058152,"score_gpt":0.40642744509406675,"score_spread":0.3319857068134852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99969876,0.000014886597,0.000031102732,0.000013333051,0.0000012997359,0.000010013602,0.00008466098,0.0000023581572,0.00014360214],"genre_scores_gemma":[0.9996897,0.00001638476,0.000052794705,0.000018096764,0.0000028189995,0.000007295796,0.0000797593,8.5783137e-7,0.00013224511],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979,0.0000482841,0.000024932298,0.00004966226,0.00004166186,0.000045466295],"domain_scores_gemma":[0.9994804,0.00013021515,0.000111481575,0.000046525693,0.00008890451,0.0001424872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028362527,0.0002700625,0.000220785,0.0005995236,0.00070603576,0.00047177184,0.00021669814,0.00033106963,0.0015348252],"category_scores_gemma":[0.0008339841,0.0002686485,0.00036834707,0.00070826506,0.00035600664,0.00021968762,0.00037291436,0.0003637593,0.00037626107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030185448,0.00021490533,0.99528533,0.00001738622,0.00001882473,0.00053622935,0.00050471537,0.000022783031,0.001961365,0.000006023204,0.000063597545,0.0010670029],"study_design_scores_gemma":[0.000029449298,0.0012694452,0.99450004,0.0000040228524,0.00004329452,0.0016617811,0.0011454141,0.00009939233,0.0010067727,0.000014763465,0.00021761039,0.000007801866],"about_ca_topic_score_codex":0.006118062,"about_ca_topic_score_gemma":0.0055651464,"teacher_disagreement_score":0.006118062,"about_ca_system_score_codex":0.0003318011,"about_ca_system_score_gemma":0.00058871874,"threshold_uncertainty_score":0.012164891},"labels":[],"label_agreement":null},{"id":"W4417202225","doi":"10.1158/1557-3265.earlyonsetca25-b027","title":"Abstract B027: Early-Onset Head and Neck Cancer: Implications for Risk Stratification and Survival","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quartile; Odds; Logistic regression; Odds ratio; Proportional hazards model; Comorbidity; Hazard ratio; Incidence (geometry); Cancer registry","score_opus":0.3188056550330601,"score_gpt":0.5935237472237115,"score_spread":0.2747180921906514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9668256,0.0050361357,0.0037650142,0.0038642453,0.00019021162,0.00007043222,0.016542643,0.00005435966,0.0036514865],"genre_scores_gemma":[0.99221134,0.0006958189,0.0012931183,0.0002117046,0.00013146893,0.000035931804,0.0049261777,0.000010703317,0.00048373183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992611,0.00029859514,0.000084641826,0.00013342303,0.00013117398,0.00009105187],"domain_scores_gemma":[0.9969382,0.0009147057,0.0010450426,0.00013108403,0.00060582504,0.00036518558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018528026,0.00021580905,0.00024195354,0.0009375933,0.00025277337,0.0007154189,0.00053733424,0.0003051083,0.0032716775],"category_scores_gemma":[0.005424378,0.000096196665,0.00048566452,0.0019975898,0.00019113785,0.00053150003,0.000533143,0.00051933975,0.0003477822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007450266,0.000015306523,0.99084234,0.00004828486,0.00006592386,0.000027843407,0.000027668388,0.0002431079,0.000078779245,0.00009460688,0.0015675501,0.0069140866],"study_design_scores_gemma":[0.000009924759,0.000037488167,0.99669844,0.000062824714,0.000068575864,0.00011151435,0.00010283407,0.0013751569,0.000073983465,0.00024414368,0.0012099165,0.000005275425],"about_ca_topic_score_codex":0.017348956,"about_ca_topic_score_gemma":0.017166657,"teacher_disagreement_score":0.017348956,"about_ca_system_score_codex":0.00052748545,"about_ca_system_score_gemma":0.0010014366,"threshold_uncertainty_score":0.03449595},"labels":[],"label_agreement":null},{"id":"W4417202229","doi":"10.1158/1557-3265.earlyonsetca25-c009","title":"Abstract C009: Distinct metabolic and genetic alterations in tumors from early-onset versus late-onset colorectal cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metabolome; Metabolomics; Metabolite; Colorectal cancer; Cancer; Metabolism; Metabolic pathway; Sphingolipid; Homovanillic acid","score_opus":0.07868139299405447,"score_gpt":0.45288099462004316,"score_spread":0.3741996016259887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951441,0.00062239694,0.00072395225,0.00005673367,0.000009233428,0.00001983052,0.002699693,0.000029933457,0.0006941118],"genre_scores_gemma":[0.99415946,0.0002686561,0.0012517017,0.0000455339,0.000005443458,0.0000220694,0.003529875,0.00001450562,0.0007027363],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99988985,0.000009279284,0.000009158896,0.00004028585,0.000028394688,0.000023037654],"domain_scores_gemma":[0.99982184,0.000030944448,0.000066555556,0.000011887468,0.00003037975,0.000038426682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010673417,0.00022338635,0.00023894073,0.0007302831,0.00025760283,0.0003443612,0.00012174975,0.00022662747,0.0023172835],"category_scores_gemma":[0.00026170854,0.000082445964,0.00028200503,0.00080944307,0.0001460453,0.000097507924,0.00026384112,0.00024694807,0.00029768303],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003264808,0.00009476501,0.23661998,0.0002706554,0.00022796771,0.001520322,0.00009638723,0.0003561918,0.73611885,0.00020331674,0.00064250897,0.020584153],"study_design_scores_gemma":[0.000031531858,0.00028431794,0.94510967,0.000020507256,0.00012501159,0.0027922094,0.00012842141,0.0012335494,0.047828976,0.00025488163,0.0021772373,0.000013681767],"about_ca_topic_score_codex":0.0015597645,"about_ca_topic_score_gemma":0.0024151294,"teacher_disagreement_score":0.0023172835,"about_ca_system_score_codex":0.00031052643,"about_ca_system_score_gemma":0.0001995991,"threshold_uncertainty_score":0.007752061},"labels":[],"label_agreement":null},{"id":"W4417202239","doi":"10.1158/1557-3265.earlyonsetca25-b007","title":"Abstract B007: Genetic and clinical profiles of early-onset prostate cancer in Puerto Rican men: A preliminary characterization","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prostate cancer; Puerto rican; Germline; Incidence (geometry); Prostatectomy; Family history; Survivorship curve; Cancer; Centenarian","score_opus":0.11818066842839774,"score_gpt":0.5097840422258235,"score_spread":0.39160337379742577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99903536,0.00011394508,0.00006901317,0.00002142186,0.0000010115009,0.000014009089,0.0003418972,0.000001723117,0.0004016815],"genre_scores_gemma":[0.999433,0.000060513536,0.00008861309,0.000014498878,0.000002905068,0.0000069926423,0.00027405558,8.4177367e-7,0.000118670185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999093,0.00002193191,0.00000889444,0.000018735987,0.000020209074,0.000020816844],"domain_scores_gemma":[0.99982905,0.000028146198,0.00005563304,0.000020417147,0.000041456402,0.000025251753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018737941,0.00011414404,0.00009620786,0.00063593633,0.00029042517,0.00021436794,0.00015544902,0.00011240504,0.001160727],"category_scores_gemma":[0.0005416532,0.000063954285,0.00014117963,0.0006195372,0.00014041316,0.0001004602,0.00025744125,0.00008868113,0.00017529905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005234344,0.00001111728,0.99517965,0.000009486143,0.000009496589,0.00033075857,0.00015058092,0.000029284656,0.0011903625,0.000018513796,0.00010375364,0.0029146047],"study_design_scores_gemma":[0.0000016435148,0.000026239699,0.998637,0.0000027046146,0.000007556607,0.0005845158,0.00026710765,0.00009348913,0.00010956213,0.0000087183225,0.00026016153,0.0000012204869],"about_ca_topic_score_codex":0.01344815,"about_ca_topic_score_gemma":0.013112906,"teacher_disagreement_score":0.01344815,"about_ca_system_score_codex":0.00019423333,"about_ca_system_score_gemma":0.0001867537,"threshold_uncertainty_score":0.026739717},"labels":[],"label_agreement":null},{"id":"W4417202273","doi":"10.1158/1557-3265.earlyonsetca25-c026","title":"Abstract C026: Disparate response to chemoradiation in early onset vs late onset rectal cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cohort; Logistic regression; Confounding; Colorectal cancer; Stage (stratigraphy); Cancer; Complete response; Comorbidity","score_opus":0.17096961343915115,"score_gpt":0.5512412144512254,"score_spread":0.38027160101207425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97621596,0.00040791227,0.0002902814,0.00017134982,0.000033652283,0.000042877713,0.021265326,0.000015911713,0.001556776],"genre_scores_gemma":[0.98548025,0.00008421784,0.0003201142,0.00015462699,0.000042327447,0.000053750762,0.013042033,0.000015662381,0.00080707466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989526,0.00022149798,0.0001456642,0.0003384018,0.00018538361,0.00015635836],"domain_scores_gemma":[0.9966091,0.00084918336,0.0015729541,0.0002735626,0.00032313573,0.00037208942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009957326,0.000260923,0.00039398097,0.0006609131,0.00039069843,0.0008809369,0.00054394983,0.00039743428,0.00582007],"category_scores_gemma":[0.0041755806,0.00012739726,0.0007201085,0.0015475706,0.0002425897,0.00042558895,0.00066302816,0.00050567917,0.00070516695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008029432,0.000039102368,0.9945018,0.000065455664,0.00010595242,0.00006697348,0.000036893718,0.00009036217,0.000355519,0.000031005053,0.0012614578,0.002642619],"study_design_scores_gemma":[0.000044560038,0.00013882125,0.9974721,0.00002418403,0.00008395559,0.0003764233,0.00011935443,0.0003010901,0.00019799315,0.000044220353,0.0011901634,0.000007038907],"about_ca_topic_score_codex":0.005336023,"about_ca_topic_score_gemma":0.009780592,"teacher_disagreement_score":0.00582007,"about_ca_system_score_codex":0.00057714176,"about_ca_system_score_gemma":0.00070362806,"threshold_uncertainty_score":0.019470036},"labels":[],"label_agreement":null},{"id":"W4417202796","doi":"10.1158/1557-3265.earlyonsetca25-ia004","title":"Abstract IA004: Cancer: A tango of miscommunication between oncogenic stem cells and their microenvironment","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stem cell; Cancer stem cell; Tumor microenvironment; Immune system; Crosstalk; Niche; Epigenetics","score_opus":0.24224315779095065,"score_gpt":0.5115488506098214,"score_spread":0.26930569281887073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39000863,0.17558733,0.043113913,0.19132215,0.03261897,0.00018325177,0.0050707427,0.0054514506,0.15664358],"genre_scores_gemma":[0.7027554,0.05422303,0.01256935,0.022241136,0.004395768,0.000108020075,0.0026066948,0.0007743386,0.20032631],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997117,0.000039859176,0.000011742304,0.00006216348,0.00012668862,0.00004782207],"domain_scores_gemma":[0.9995945,0.00005617996,0.000053888285,0.000045108383,0.00011362602,0.00013671958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004053336,0.00032993374,0.00030685303,0.00060733827,0.00063719216,0.0017902299,0.0004630843,0.0010898868,0.0088142995],"category_scores_gemma":[0.00061775325,0.00019385073,0.0003068384,0.00052794593,0.0010241416,0.0010537334,0.00084359077,0.0029877934,0.0026087714],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081189425,0.00022886184,0.008314264,0.0008611231,0.000106699954,0.0016258004,0.00074015936,0.0008434199,0.5101449,0.06275375,0.20452854,0.20904066],"study_design_scores_gemma":[0.00006193894,0.000544927,0.013721628,0.0002778872,0.000094461284,0.0031501316,0.0007711216,0.0012675783,0.1846388,0.016213756,0.7791902,0.00006755609],"about_ca_topic_score_codex":0.0008211949,"about_ca_topic_score_gemma":0.00075657084,"teacher_disagreement_score":0.0088142995,"about_ca_system_score_codex":0.0010471835,"about_ca_system_score_gemma":0.0005917704,"threshold_uncertainty_score":0.029486775},"labels":[],"label_agreement":null},{"id":"W4417202810","doi":"10.1158/1557-3265.earlyonsetca25-c013","title":"Abstract C013: Spatial immune profiling of early- and late-onset colorectal cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Colorectal cancer; Cytotoxic T cell; T cell; Biomarker; Immunotherapy; Cell; Intestinal mucosa","score_opus":0.08931991019248108,"score_gpt":0.45182928892275503,"score_spread":0.36250937873027395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99264246,0.0010961012,0.0030503552,0.000045560737,0.0000086301525,0.000036680754,0.001169691,0.0001304694,0.0018200135],"genre_scores_gemma":[0.9914835,0.00030022088,0.00540847,0.00003444508,0.000008701939,0.000045912646,0.0014439782,0.000023670751,0.0012510811],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99989104,0.000012770778,0.000008009656,0.0000362695,0.00002411263,0.000027838827],"domain_scores_gemma":[0.99990845,0.0000138734895,0.00001826471,0.000007640166,0.000029078015,0.00002270883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016422271,0.00012911628,0.00015671256,0.0011276143,0.00020342562,0.000301641,0.000115703995,0.0002873287,0.0038679943],"category_scores_gemma":[0.0001700424,0.0001002773,0.00014211345,0.0007015457,0.00010686117,0.00015757563,0.00017384773,0.0001492162,0.0004822182],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010122005,0.00004321352,0.119791955,0.00025701863,0.000031748812,0.00044079553,0.00011249427,0.00027884106,0.85044986,0.00014981175,0.00071638305,0.026715757],"study_design_scores_gemma":[0.000025517458,0.00037729193,0.83637744,0.000029263052,0.000088338544,0.003651664,0.00033370807,0.0044222334,0.14807741,0.00013116066,0.006468375,0.000017564824],"about_ca_topic_score_codex":0.0016244048,"about_ca_topic_score_gemma":0.002414091,"teacher_disagreement_score":0.0038679943,"about_ca_system_score_codex":0.00023449998,"about_ca_system_score_gemma":0.00013743297,"threshold_uncertainty_score":0.012939692},"labels":[],"label_agreement":null},{"id":"W4417202875","doi":"10.1158/1557-3265.earlyonsetca25-pr010","title":"Abstract PR010: Early-life penicillin blooms colibactin-positive Escherichia coli and drives DNA damage and tumorigenesis","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Penicillin; Antibiotics; Escherichia coli; DNA damage; Carcinogenesis; Immune system; Cancer; Enterobacteriaceae; Colorectal cancer","score_opus":0.0664400352800343,"score_gpt":0.45798192169637,"score_spread":0.3915418864163357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97687304,0.0017021439,0.009282952,0.00053923123,0.0001061633,0.0000718106,0.007762001,0.0005511145,0.0031114593],"genre_scores_gemma":[0.98103106,0.0010455381,0.0051711784,0.0003736233,0.000021358346,0.000081839156,0.00553455,0.0000924098,0.006648396],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99975675,0.000022756783,0.000011854984,0.0000861282,0.00007257814,0.00004993787],"domain_scores_gemma":[0.99981993,0.00001922598,0.000067660025,0.000016500526,0.00002555593,0.00005111744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000118347816,0.00034394584,0.00028298027,0.00021753405,0.00019999115,0.00047924038,0.0001722367,0.00044544743,0.002484572],"category_scores_gemma":[0.0001424991,0.0001367038,0.00033122464,0.000238627,0.00026125158,0.0002233167,0.00043575684,0.0008349717,0.00055956206],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022698537,0.000042686068,0.0031760072,0.00011114422,0.00001154302,0.00011165895,0.000030429881,0.00012211286,0.9924338,0.00016746463,0.0003638028,0.0032022141],"study_design_scores_gemma":[0.000029348526,0.0013341442,0.08992894,0.00007845711,0.000053541076,0.000826898,0.0004308607,0.0029584495,0.88863814,0.00051623123,0.015172272,0.0000327512],"about_ca_topic_score_codex":0.0010466216,"about_ca_topic_score_gemma":0.0015277562,"teacher_disagreement_score":0.002484572,"about_ca_system_score_codex":0.0004501388,"about_ca_system_score_gemma":0.000346995,"threshold_uncertainty_score":0.008311689},"labels":[],"label_agreement":null},{"id":"W4417202878","doi":"10.1158/1557-3265.earlyonsetca25-b013","title":"Abstract B013: Epidemiology of early-onset gastrointestinal cancers in Nepal: A scoping review","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Incidence (geometry); Epidemiology; Cancer; Gastrointestinal cancer; Observational study; Colorectal cancer; Disease; Gallbladder cancer; Hepatocellular carcinoma","score_opus":0.403006158684619,"score_gpt":0.6358457422332121,"score_spread":0.23283958354859313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202878","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015303075,0.9925368,0.00034645954,0.0012625247,0.00035380566,0.00091098476,0.0013867802,0.00001588681,0.0016565318],"genre_scores_gemma":[0.008603178,0.9869069,0.0008080168,0.0010146261,0.000172388,0.0012113411,0.0007968788,0.000007946548,0.00047873412],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99420035,0.0015517981,0.0025538777,0.0005267392,0.0009403585,0.00022695654],"domain_scores_gemma":[0.9718223,0.019120269,0.0046785553,0.00045873987,0.003673529,0.00024656075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009031091,0.0012692182,0.0035704735,0.021606522,0.0012606387,0.004396461,0.0017890639,0.002330924,0.008675797],"category_scores_gemma":[0.042223893,0.0011852895,0.0043294663,0.018501665,0.0011015822,0.00452509,0.002938089,0.001668451,0.00087326486],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009108225,0.000023951947,0.0021291196,0.9014106,0.0018946999,0.00031505324,0.0009765113,0.00016266012,0.0002380889,0.00068583764,0.006503113,0.085569285],"study_design_scores_gemma":[0.00001913036,0.00004430364,0.004258804,0.962925,0.004296934,0.0003748253,0.00051448663,0.00004293082,0.00009438725,0.0002719422,0.027140418,0.000016844802],"about_ca_topic_score_codex":0.010053745,"about_ca_topic_score_gemma":0.01743826,"teacher_disagreement_score":0.021606522,"about_ca_system_score_codex":0.0035184314,"about_ca_system_score_gemma":0.015888056,"threshold_uncertainty_score":0.0477615},"labels":[],"label_agreement":null},{"id":"W4417202888","doi":"10.1158/1557-3265.earlyonsetca25-pr016","title":"Abstract PR016: Supplement And Medication Use in Early-Onset Colorectal Cancer: An Analysis of the Ohio Colorectal Cancer Prevention Initiative","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Magnesium in Health and Disease","field":"Nursing","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Odds ratio; Cancer; Cancer prevention; Marital status; MEDLINE; Psychological intervention","score_opus":0.1728360929633381,"score_gpt":0.5399743512214655,"score_spread":0.3671382582581274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850022,0.00062438485,0.00013377501,0.00020046152,0.000025844907,0.00005906043,0.013074762,0.000010435308,0.00086908345],"genre_scores_gemma":[0.99206394,0.0002560327,0.00019242996,0.00016650233,0.00004183655,0.000082848775,0.006648619,0.000006953951,0.0005408246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988827,0.0002860669,0.00015437657,0.00025332402,0.00028588934,0.00013769863],"domain_scores_gemma":[0.99592495,0.00045554704,0.0023738474,0.00023664278,0.0004409231,0.0005680594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011037944,0.00036705207,0.0004308786,0.0014115713,0.0007623241,0.0008924587,0.0008475411,0.00054531015,0.0022029988],"category_scores_gemma":[0.003090506,0.00035537625,0.001207471,0.0039030246,0.00021500168,0.000613571,0.0010730057,0.0010524042,0.00027128702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105282925,0.000043367458,0.9986124,0.000029531084,0.0001079471,0.000019695257,0.00003298272,0.000017348792,0.000038153976,0.0000076034885,0.00038086335,0.0006047703],"study_design_scores_gemma":[0.000010224212,0.000044812554,0.9993911,0.000012007905,0.00006747458,0.000032536413,0.00009491569,0.00009078512,0.000011815811,0.000005877769,0.00023586974,0.000002562616],"about_ca_topic_score_codex":0.04965646,"about_ca_topic_score_gemma":0.046928395,"teacher_disagreement_score":0.04965646,"about_ca_system_score_codex":0.00054786244,"about_ca_system_score_gemma":0.00094792247,"threshold_uncertainty_score":0.098734856},"labels":[],"label_agreement":null},{"id":"W4417202891","doi":"10.1158/1557-3265.earlyonsetca25-c037","title":"Abstract C037: Fructose-induced Akkermansia muciniphila promotes colorectal cancer progression through N-acetylneuraminic acid-mediated macrophage reprogramming","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Diet, Metabolism, and Disease","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Akkermansia muciniphila; Immune system; Macrophage polarization; Tumor progression; Mucin; Colorectal cancer; Macrophage; Tumor microenvironment","score_opus":0.17724204208167457,"score_gpt":0.5575806879932992,"score_spread":0.3803386459116246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98102736,0.004170642,0.004566085,0.00049837946,0.00019486254,0.00008795464,0.006228612,0.00029274714,0.0029334466],"genre_scores_gemma":[0.9841965,0.0019116753,0.0031279079,0.0003883032,0.000041923347,0.00011169605,0.004641855,0.00007141529,0.0055087707],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998153,0.00002132411,0.000011594602,0.00005135889,0.00005238774,0.00004805925],"domain_scores_gemma":[0.9998791,0.000009730429,0.00003499744,0.000010195896,0.000031507658,0.000034463665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016509315,0.00033250632,0.000263505,0.00034084843,0.0002721157,0.0003700751,0.00013342116,0.00038590044,0.0031582653],"category_scores_gemma":[0.00015410954,0.000101557955,0.00038944493,0.00030106722,0.00019669849,0.00021809645,0.00029843833,0.0005627732,0.00075595937],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038124106,0.000025691263,0.0008079941,0.00014013094,0.0000129679,0.00009712189,0.00002057558,0.00005278855,0.9952689,0.00007211941,0.0002756156,0.0028448652],"study_design_scores_gemma":[0.000062665014,0.0009586429,0.052022863,0.000095496245,0.00008191396,0.0008770026,0.0002944051,0.0017533512,0.9236135,0.000291835,0.019914972,0.000033340602],"about_ca_topic_score_codex":0.0010992597,"about_ca_topic_score_gemma":0.0012952283,"teacher_disagreement_score":0.0031582653,"about_ca_system_score_codex":0.00027800712,"about_ca_system_score_gemma":0.000349345,"threshold_uncertainty_score":0.01056546},"labels":[],"label_agreement":null},{"id":"W4417202897","doi":"10.1158/1557-3265.earlyonsetca25-c003","title":"Abstract C003: Neonatal Dried Blood Spot Metabolomics Reveals Signatures of Early-Onset Myeloproliferative Neoplasms","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dried blood spot; Metabolomics; Confounding; Metabolome; Pathogenesis; Population; Etiology; Case-control study; Cancer","score_opus":0.0636110965128289,"score_gpt":0.4400740854778404,"score_spread":0.3764629889650115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98395336,0.002830104,0.0059649134,0.00029571046,0.000064260974,0.000036601326,0.0050771977,0.00013268308,0.0016450699],"genre_scores_gemma":[0.9869546,0.0015045161,0.0066920076,0.00025147162,0.000040171577,0.000045345012,0.002744152,0.000032986583,0.001734671],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998348,0.000025711226,0.000012712064,0.000055982764,0.000052583568,0.000018191],"domain_scores_gemma":[0.9997943,0.000040044753,0.00007532453,0.000016595264,0.00004940012,0.000024431383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003198503,0.00036492164,0.00024524995,0.0006457563,0.00021296632,0.00058767543,0.00019734865,0.00037283293,0.0024041245],"category_scores_gemma":[0.0005780964,0.000110732544,0.00024245582,0.0006247986,0.00023649792,0.00016478145,0.00032444976,0.00036887315,0.0003709587],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015324613,0.00012527211,0.22720331,0.00041078904,0.00029000524,0.0015815232,0.00029888787,0.00044109978,0.715689,0.00056385057,0.0016931464,0.050170686],"study_design_scores_gemma":[0.000016765476,0.00039279464,0.8454468,0.00008289962,0.00016758358,0.0044623683,0.00047459351,0.0017677867,0.14050063,0.00081132347,0.005844243,0.000032109496],"about_ca_topic_score_codex":0.0011613773,"about_ca_topic_score_gemma":0.0012441386,"teacher_disagreement_score":0.0024041245,"about_ca_system_score_codex":0.00022348943,"about_ca_system_score_gemma":0.0001840887,"threshold_uncertainty_score":0.008042574},"labels":[],"label_agreement":null},{"id":"W4417202902","doi":"10.1158/1557-3265.earlyonsetca25-c020","title":"Abstract C020: Novel insights from the investigation of experimental mutational signatures in early-onset colorectal cancer and colonic polyps","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Colorectal cancer; COSMIC cancer database; Exome sequencing; Cancer; Exome; Mutation; Germline mutation","score_opus":0.06869939336294499,"score_gpt":0.43638423401340753,"score_spread":0.36768484065046253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97881293,0.0013248281,0.014239748,0.000071152645,0.00001687181,0.00005090795,0.0030136402,0.0002574351,0.0022124785],"genre_scores_gemma":[0.9786491,0.00031701816,0.015228789,0.00006210369,0.00003084096,0.00003642749,0.0051835715,0.000087718065,0.00040447846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99934727,0.00012644286,0.00006248103,0.00022050363,0.00018684991,0.00005652453],"domain_scores_gemma":[0.99879944,0.00035399687,0.00029597987,0.00019740725,0.00020022913,0.00015284972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009631711,0.00043213234,0.00047569556,0.002111618,0.000321903,0.00090114836,0.00033706528,0.00041115162,0.0018846806],"category_scores_gemma":[0.0019131546,0.0001375696,0.00048584744,0.0019247395,0.00034174664,0.00026973773,0.00060835853,0.0003063447,0.0005057631],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016758324,0.00025282605,0.4714053,0.0008395948,0.00084493717,0.00082772196,0.0003175646,0.0036322505,0.42345035,0.0010942373,0.00159578,0.09406371],"study_design_scores_gemma":[0.000030944437,0.00048165242,0.92523676,0.00005597551,0.00033739078,0.0032837745,0.00017042196,0.012427981,0.05179305,0.0010796598,0.0050584157,0.000044049964],"about_ca_topic_score_codex":0.0013199275,"about_ca_topic_score_gemma":0.0024828187,"teacher_disagreement_score":0.002111618,"about_ca_system_score_codex":0.00031257948,"about_ca_system_score_gemma":0.00047250546,"threshold_uncertainty_score":0.00630486},"labels":[],"label_agreement":null},{"id":"W4417202966","doi":"10.1158/1557-3265.earlyonsetca25-b028","title":"Abstract B028: Co-occurring social determinants of endometrial cancer disparities in All of Us","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cohort; Logistic regression; Social determinants of health; Socioeconomic status; Cluster (spacecraft); Health equity; Incidence (geometry); Odds ratio; Odds","score_opus":0.3903586450962635,"score_gpt":0.6332562303121234,"score_spread":0.2428975852158599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417202966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953869,0.00016092812,0.00035877124,0.00017675757,0.0000073670917,0.000018066881,0.003078236,0.000007278784,0.0008058239],"genre_scores_gemma":[0.99852705,0.000060539747,0.00020246209,0.00004856491,0.000007807808,0.000023065173,0.0009792071,0.0000017925518,0.00014946767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972934,0.00007002942,0.000026059999,0.00007593001,0.00004279572,0.000055829558],"domain_scores_gemma":[0.9991524,0.000106290245,0.00043543542,0.000084191466,0.00010791497,0.00011377741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041262677,0.00012989847,0.00015389177,0.0007537338,0.00038039841,0.00039189844,0.00029050602,0.00023384513,0.0030269169],"category_scores_gemma":[0.0018344879,0.00009579755,0.00029142728,0.0014052565,0.00018163896,0.00022681036,0.0006597727,0.00028333528,0.00012621158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000423127,0.000025066576,0.99644804,0.000017644057,0.000059341775,0.000024690265,0.00007259822,0.00007522652,0.0002117795,0.00010187576,0.0005423187,0.0023789958],"study_design_scores_gemma":[0.0000048995366,0.00001991731,0.99842,0.000015070248,0.0000328313,0.00005849447,0.00017274871,0.00048386466,0.00007499537,0.00011373597,0.00060150464,0.0000020339323],"about_ca_topic_score_codex":0.04252013,"about_ca_topic_score_gemma":0.050131977,"teacher_disagreement_score":0.04252013,"about_ca_system_score_codex":0.00047050428,"about_ca_system_score_gemma":0.0005777582,"threshold_uncertainty_score":0.084545255},"labels":[],"label_agreement":null},{"id":"W4417203745","doi":"10.1158/1557-3265.earlyonsetca25-b020","title":"Abstract B020: Early-onset colorectal cancer mortality trends and birth cohort effect in Mexico, 1998-2023","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Birth, Development, and Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Incidence (geometry); Cohort; Population; Mortality rate; Cohort effect; Cancer; Cohort study","score_opus":0.1454621290408858,"score_gpt":0.5421429742686512,"score_spread":0.3966808452277654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417203745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9610297,0.0009140823,0.0004311478,0.00040906144,0.000057402114,0.000030328945,0.035864316,0.000044810753,0.0012191489],"genre_scores_gemma":[0.98439574,0.0003632615,0.00037179515,0.00007357554,0.000038252478,0.000070162234,0.013208332,0.000014410934,0.0014645325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996302,0.000067570785,0.000031100422,0.00013527651,0.000056220983,0.00007956258],"domain_scores_gemma":[0.9981027,0.00031775463,0.0009362978,0.00018116062,0.00030919406,0.00015290124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014184761,0.00025720967,0.00026982007,0.0008723505,0.0004907175,0.00053530757,0.000603163,0.00037140984,0.003364861],"category_scores_gemma":[0.0027747725,0.00020715813,0.000781877,0.0013946759,0.00012466787,0.00034486584,0.0005341336,0.00052438735,0.0003140084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017412889,0.000016275537,0.99716324,0.00002366307,0.00015239557,0.00003574697,0.00006562214,0.00010104907,0.00006479963,0.000038920567,0.001118515,0.0010457092],"study_design_scores_gemma":[0.0000099353965,0.000026895863,0.998713,0.000010879199,0.00009185897,0.000027763419,0.00007170007,0.00025336,0.000030068668,0.000009845517,0.0007528327,0.0000018781504],"about_ca_topic_score_codex":0.16116932,"about_ca_topic_score_gemma":0.09178577,"teacher_disagreement_score":0.16116932,"about_ca_system_score_codex":0.0008147416,"about_ca_system_score_gemma":0.00077423215,"threshold_uncertainty_score":0.3204624},"labels":[],"label_agreement":null},{"id":"W4417203801","doi":"10.1158/1557-3265.earlyonsetca25-a016","title":"Abstract A016: Cascade Failure in Lynch Syndrome Diagnosis: A Single-Institution Analysis","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lynch syndrome; MLH1; Germline; DNA mismatch repair; Genetic testing; Germline mutation; Microsatellite instability","score_opus":0.18497773573790396,"score_gpt":0.5196342647450558,"score_spread":0.3346565290071518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417203801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974821,0.00034773746,0.00020395142,0.00008480678,0.000009606481,0.000031362717,0.0013878056,0.0000135927985,0.00043895838],"genre_scores_gemma":[0.9986934,0.000082281986,0.00016300258,0.00006986745,0.000015507712,0.000017227581,0.00084181293,0.000010197828,0.000106813175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99686855,0.00080061867,0.00049617287,0.00088058773,0.0005648099,0.00038928157],"domain_scores_gemma":[0.9872406,0.0024851658,0.006248022,0.0013303428,0.0012290197,0.001466808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022465833,0.00043281115,0.0006192491,0.0016778238,0.00076234073,0.0014251244,0.00090348127,0.00056668685,0.004641683],"category_scores_gemma":[0.007919956,0.0005106199,0.0013257684,0.0023373242,0.00049372285,0.000968486,0.0012493042,0.0010446884,0.0006456397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015907569,0.000030302333,0.99841595,0.000017300545,0.00013708252,0.00015020592,0.000040214727,0.00002607115,0.00009390793,0.000018908939,0.00029155856,0.0006193717],"study_design_scores_gemma":[0.00005999986,0.00027435206,0.9960769,0.0000510978,0.00025867746,0.0014321102,0.0005093064,0.0006167344,0.000120185076,0.00006900378,0.0005135274,0.000018039293],"about_ca_topic_score_codex":0.007399959,"about_ca_topic_score_gemma":0.010255545,"teacher_disagreement_score":0.007399959,"about_ca_system_score_codex":0.00094859465,"about_ca_system_score_gemma":0.0010534668,"threshold_uncertainty_score":0.015527964},"labels":[],"label_agreement":null},{"id":"W4417203867","doi":"10.1158/1557-3265.earlyonsetca25-pr007","title":"Abstract PR007: Tumor-adjacent visceral adipose tissue displays an altered transcriptomic landscape in early-onset colorectal cancer patients: Results from the ColoCare Study","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Transcriptome; Adipose tissue; Paracrine signalling; Cancer; Body mass index; Endocrine system","score_opus":0.08424587665218894,"score_gpt":0.46683842374703766,"score_spread":0.3825925470948487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417203867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99244314,0.0005764271,0.00016145298,0.00013701577,0.000015236044,0.000017730084,0.006075341,0.000010661903,0.0005630323],"genre_scores_gemma":[0.9918709,0.00022435376,0.0002788078,0.00016439294,0.000021156528,0.000031441585,0.0067790947,0.0000145748345,0.00061529706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981016,0.000031587344,0.000009781869,0.00008331098,0.00003114268,0.000034136152],"domain_scores_gemma":[0.99962795,0.00009339974,0.00009065011,0.00004184112,0.000060576855,0.00008562354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025371066,0.00021102447,0.00034664036,0.00043285463,0.00032667458,0.0007368115,0.0001996505,0.00029360817,0.0022366086],"category_scores_gemma":[0.000682591,0.000117977695,0.00046303243,0.0007121042,0.00020748429,0.0001420464,0.00048645682,0.00038498326,0.0003321103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005835546,0.000112098576,0.9501299,0.00019577131,0.0005580794,0.0005781377,0.00031601812,0.00015578893,0.030008491,0.00009011472,0.002893681,0.009126379],"study_design_scores_gemma":[0.00007317269,0.00023095545,0.9961182,0.000016076605,0.00017801621,0.00047056132,0.00030767833,0.00014844775,0.0008165967,0.00004866512,0.0015818338,0.00000982106],"about_ca_topic_score_codex":0.0021515358,"about_ca_topic_score_gemma":0.0045341854,"teacher_disagreement_score":0.0022366086,"about_ca_system_score_codex":0.00018631261,"about_ca_system_score_gemma":0.0001987106,"threshold_uncertainty_score":0.007482171},"labels":[],"label_agreement":null},{"id":"W4417203945","doi":"10.1158/1557-3265.earlyonsetca25-pr009","title":"Abstract PR009: Bugs in Space: Spatial Analysis of the Immune-Microbial Axis in Rectal Cancer Reveals a Unique Interface in Young Onset Rectal Cancers","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Immune system; Transcriptome; Microbiome; Digital polymerase chain reaction; Tumor microenvironment; Cancer; Gene expression profiling","score_opus":0.05037476670770128,"score_gpt":0.48062560915743435,"score_spread":0.43025084244973305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417203945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880662,0.0008417444,0.0051953387,0.00017168974,0.000029681383,0.000020412814,0.0041614785,0.00014585606,0.0013675388],"genre_scores_gemma":[0.9923752,0.00027562742,0.0033940647,0.00007844584,0.000015680882,0.000028892458,0.002402662,0.000059204885,0.0013701253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998832,0.000013850996,0.0000062544796,0.0000406862,0.000028738192,0.000027342057],"domain_scores_gemma":[0.9998116,0.000029848668,0.000059826853,0.000015527015,0.000045739092,0.00003750015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014014763,0.00016733637,0.00028710798,0.00047993293,0.00027747222,0.0005803027,0.00015965628,0.00019874984,0.0045258896],"category_scores_gemma":[0.00037195536,0.00013238691,0.00035778165,0.000744269,0.00018094612,0.0003452361,0.00050481065,0.00039338914,0.00077928515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001665685,0.000100422425,0.46837482,0.0005491613,0.00020534468,0.000561594,0.00054589484,0.0015494282,0.46269825,0.0005992195,0.0037991395,0.059351068],"study_design_scores_gemma":[0.0000072634753,0.00018078943,0.97517633,0.000026855914,0.000045509165,0.0006264362,0.000905401,0.002652627,0.016177464,0.0003474318,0.0038365764,0.000017379776],"about_ca_topic_score_codex":0.0026744974,"about_ca_topic_score_gemma":0.003556652,"teacher_disagreement_score":0.0045258896,"about_ca_system_score_codex":0.00024365993,"about_ca_system_score_gemma":0.0002089283,"threshold_uncertainty_score":0.015140653},"labels":[],"label_agreement":null},{"id":"W4417207033","doi":"10.1158/1557-3265.earlyonsetca25-a034","title":"Abstract A034: Model-free scoring system for risk prediction and early detection","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Statistical Methods and Inference","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Receiver operating characteristic; Oracle; Risk assessment; Limiting; Cancer; Disease; Function (biology)","score_opus":0.4999134991118311,"score_gpt":0.6033027314913065,"score_spread":0.10338923237947545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417207033","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033419188,0.00047208666,0.9576757,0.00092216,0.00018882017,0.0003537992,0.0013095272,0.0024630092,0.0031956495],"genre_scores_gemma":[0.6207444,0.00039969652,0.36808178,0.0003842583,0.0002507162,0.0008281837,0.0034823439,0.0002109954,0.005617651],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9949419,0.0026367179,0.0004040402,0.00047909905,0.0013328103,0.00020535356],"domain_scores_gemma":[0.988705,0.005344936,0.00085440144,0.0009956959,0.0037348557,0.0003652191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008581379,0.0014225703,0.0014687232,0.0032686421,0.0006335688,0.002786878,0.0018625453,0.0013922222,0.007025418],"category_scores_gemma":[0.02973034,0.00039186506,0.0010741476,0.0016128463,0.0006002442,0.0014858298,0.001994704,0.0014179724,0.002229588],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010856468,0.00032815832,0.03046018,0.00029063207,0.00036027396,0.00044587028,0.0001413281,0.3158698,0.004326144,0.021706501,0.0310084,0.593977],"study_design_scores_gemma":[0.000041905645,0.0001382465,0.0025594346,0.000029498395,0.000031395433,0.00012946213,0.000016624352,0.9860437,0.0007138357,0.008515704,0.001737514,0.000042830205],"about_ca_topic_score_codex":0.007592683,"about_ca_topic_score_gemma":0.003160288,"teacher_disagreement_score":0.008581379,"about_ca_system_score_codex":0.0013471622,"about_ca_system_score_gemma":0.0025034382,"threshold_uncertainty_score":0.045383215},"labels":[],"label_agreement":null},{"id":"W4417207512","doi":"10.1158/1557-3265.earlyonsetca25-c028","title":"Abstract C028: GSK3β: a therapeutic target in KRAS mutant pancreatic cancers","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"KRAS; Pancreatic cancer; Signal transduction; Kinase; Cell growth; Cancer; Apoptosis; PI3K/AKT/mTOR pathway","score_opus":0.11709746190286066,"score_gpt":0.4884099852648104,"score_spread":0.37131252336194975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417207512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8812806,0.08640992,0.0039990963,0.002526467,0.0006554322,0.000380487,0.0019527667,0.00058138336,0.022213709],"genre_scores_gemma":[0.95864666,0.026327487,0.002808638,0.0005870848,0.00015163628,0.00014591038,0.001627363,0.000038045215,0.0096671],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999541,0.000007243711,0.000004220962,0.0000072222374,0.000013717952,0.000013541839],"domain_scores_gemma":[0.9999697,0.0000030925407,0.000007437307,0.0000021253868,0.0000064969204,0.000011091514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010029757,0.0003880282,0.0002853375,0.00028925764,0.00014597194,0.00031255235,0.00020900702,0.00033540514,0.002917235],"category_scores_gemma":[0.00006039733,0.00008197707,0.00025098593,0.00026895295,0.00012129412,0.00015824613,0.00014807026,0.0008573581,0.0007314647],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002007182,0.0008458135,0.0007635227,0.0010455893,0.000060267477,0.00078194827,0.00004848201,0.0006543405,0.91390043,0.0006981952,0.0044918545,0.07470233],"study_design_scores_gemma":[0.0019935875,0.011920193,0.011330347,0.00022029667,0.00028297552,0.0055427784,0.0000829247,0.0025107535,0.8797615,0.00048241368,0.08582272,0.000049566825],"about_ca_topic_score_codex":0.000495386,"about_ca_topic_score_gemma":0.0012924691,"teacher_disagreement_score":0.002917235,"about_ca_system_score_codex":0.00028562875,"about_ca_system_score_gemma":0.00035514595,"threshold_uncertainty_score":0.009759128},"labels":[],"label_agreement":null},{"id":"W4417207561","doi":"10.1158/1557-3265.earlyonsetca25-c012","title":"Abstract C012: Transcriptional profiling of circulating immune cells from patients with early- and late-onset colorectal cancer reveals sex-specific differences","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Colorectal cancer; Cytotoxic T cell; Peripheral blood mononuclear cell; Cytolysis; Transcriptome; Gene; Effector; Gene expression profiling","score_opus":0.07289251582875907,"score_gpt":0.3730629924072911,"score_spread":0.3001704765785321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417207561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918522,0.0009391969,0.000570455,0.0000754067,0.000024668343,0.000019388312,0.0056896955,0.000037980604,0.00079104194],"genre_scores_gemma":[0.9915376,0.00023884191,0.00054684863,0.00011922006,0.000025171905,0.000046507845,0.0061784233,0.000015565183,0.0012919186],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99985147,0.000014180419,0.000012083377,0.000056961115,0.000027303096,0.000038033588],"domain_scores_gemma":[0.9998411,0.000034563003,0.00004088004,0.000011564432,0.00003409218,0.00003779589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010528129,0.00018150323,0.00025939036,0.000402694,0.00020994093,0.00039646216,0.00008062455,0.00019715609,0.0043529565],"category_scores_gemma":[0.0002431772,0.0000707273,0.0002095044,0.0003884499,0.00010547995,0.000074665724,0.00014114853,0.00029245825,0.0007165898],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040419367,0.00014330805,0.27829713,0.0003044952,0.00013164112,0.00038854714,0.00022634365,0.00020411891,0.6911393,0.00006436537,0.0015361254,0.023522744],"study_design_scores_gemma":[0.00003808462,0.00060782436,0.9571664,0.000018848727,0.000088013774,0.00092239544,0.00023730996,0.0005485083,0.037453644,0.00006069387,0.002847702,0.000010633324],"about_ca_topic_score_codex":0.0006492015,"about_ca_topic_score_gemma":0.0009365589,"teacher_disagreement_score":0.0043529565,"about_ca_system_score_codex":0.00012711501,"about_ca_system_score_gemma":0.00014722624,"threshold_uncertainty_score":0.01456207},"labels":[],"label_agreement":null},{"id":"W4417208722","doi":"10.1158/1557-3265.earlyonsetca25-c021","title":"Abstract C021: Characterizing the clinicopathological, genomic and spatial transcriptomic features of colibactin-induced colorectal cancers","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Loss of heterozygosity; Transcriptome; Colorectal cancer; Context (archaeology); Genomics; Exon; Adenocarcinoma; Gene","score_opus":0.08805616936942935,"score_gpt":0.44045234014387113,"score_spread":0.3523961707744418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417208722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99876547,0.00007641683,0.00021081504,0.000015037052,0.0000010325007,0.0000067535734,0.00073178206,0.000008263949,0.0001844158],"genre_scores_gemma":[0.9977531,0.00003817265,0.00042334734,0.000012957022,0.0000041480757,0.000010234025,0.0015655041,0.0000041970247,0.0001883479],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998141,0.000023939807,0.000016662643,0.000064997235,0.000043886947,0.000036455836],"domain_scores_gemma":[0.9994622,0.0001154068,0.00018751319,0.000039007282,0.000092527465,0.00010325217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031154472,0.00018810602,0.00021432279,0.00095611264,0.00021120522,0.00034157076,0.00016756132,0.00025565617,0.0017809379],"category_scores_gemma":[0.0007535898,0.000069274334,0.00014264633,0.00075999676,0.00023760175,0.0001186451,0.00027010395,0.00015696441,0.00031034174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007894508,0.00003729896,0.90379494,0.00006851725,0.00004210153,0.00029510536,0.0000723082,0.00018783924,0.0891147,0.000027776501,0.00023972936,0.005330206],"study_design_scores_gemma":[0.0000077521545,0.00013812195,0.9900877,0.000004474847,0.00002180909,0.00095922133,0.0000957566,0.00045212096,0.007836107,0.00002230353,0.00037160108,0.000003087493],"about_ca_topic_score_codex":0.0015068565,"about_ca_topic_score_gemma":0.0018152299,"teacher_disagreement_score":0.0017809379,"about_ca_system_score_codex":0.00025859795,"about_ca_system_score_gemma":0.00018888335,"threshold_uncertainty_score":0.0059577823},"labels":[],"label_agreement":null},{"id":"W4417208861","doi":"10.1158/1557-3265.earlyonsetca25-ia002","title":"Abstract IA002: Early-Onset Colorectal Cancer as a Model for Precision Cancer Prevention","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer prevention; Colorectal cancer; Cancer; Disease; Precision medicine; Microbiome; Aspirin; Disease prevention; Breast cancer","score_opus":0.3123093736101132,"score_gpt":0.6194755135353421,"score_spread":0.30716613992522895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417208861","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.059603896,0.17603134,0.050005812,0.4449614,0.065184236,0.00063494634,0.0019030279,0.0015035723,0.20017175],"genre_scores_gemma":[0.45113695,0.18734169,0.04369579,0.06691533,0.01658371,0.0010822468,0.001441797,0.000302566,0.23149993],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995882,0.00014004462,0.000015023083,0.00007368616,0.00012717445,0.000055921686],"domain_scores_gemma":[0.99912614,0.00022636843,0.00008968551,0.00010236158,0.0001303628,0.00032506936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012523314,0.00060511037,0.0005316822,0.00069556845,0.00080064224,0.0023041733,0.00090042816,0.0020042507,0.007946534],"category_scores_gemma":[0.001299649,0.00018785456,0.000530769,0.00042424837,0.0017662563,0.0015235447,0.0020687762,0.0037550482,0.0014627667],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009149932,0.0006304972,0.003418946,0.0017403787,0.00012300025,0.00095217896,0.00086016906,0.002375746,0.023991875,0.28991583,0.42896265,0.24611372],"study_design_scores_gemma":[0.00025660533,0.0010183327,0.0067735533,0.001210194,0.00016664981,0.00094386627,0.0007775866,0.0043154825,0.0067278147,0.14365096,0.83406615,0.000092751754],"about_ca_topic_score_codex":0.0037596654,"about_ca_topic_score_gemma":0.0039400905,"teacher_disagreement_score":0.007946534,"about_ca_system_score_codex":0.0015710157,"about_ca_system_score_gemma":0.002119749,"threshold_uncertainty_score":0.02658379},"labels":[],"label_agreement":null},{"id":"W4417208863","doi":"10.1158/1557-3265.earlyonsetca25-b031","title":"Abstract B031: Clinicopathologic features associated with metastatic early-onset gastric cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Odds ratio; Incidence (geometry); Conditional logistic regression; Disease; Logistic regression; Stage (stratigraphy); Retrospective cohort study; Primary tumor","score_opus":0.2260910781392836,"score_gpt":0.5354485241844146,"score_spread":0.30935744604513093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417208863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988921,0.000356338,0.00007251426,0.000025431002,0.0000050986764,0.000008145736,0.0003463331,0.0000042908227,0.00028973995],"genre_scores_gemma":[0.9994937,0.0000669793,0.000062924104,0.000011073386,0.000012113073,0.000004865791,0.0002560466,0.0000013826698,0.00009079946],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996712,0.00009227617,0.000045157645,0.000068232264,0.00007915322,0.000043940097],"domain_scores_gemma":[0.9981529,0.00029383763,0.0010055694,0.00007271258,0.00016582571,0.00030906603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000561131,0.00028539327,0.00028368668,0.0010872176,0.00031002058,0.00050553266,0.00031627706,0.00034239315,0.002882865],"category_scores_gemma":[0.0016273151,0.00019257184,0.0003851986,0.00096271647,0.0002682055,0.00025648088,0.0002989897,0.00035477252,0.00022966936],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099147146,0.000011300214,0.999044,0.000007360823,0.000021071532,0.00011696815,0.0000068673125,0.000010836159,0.00022039551,0.00000283508,0.000048658076,0.00041040205],"study_design_scores_gemma":[0.0000057538236,0.00006171189,0.9989166,0.0000036967788,0.000022308574,0.00078572397,0.00003151292,0.000047472855,0.000058137837,0.0000059515996,0.000059743892,0.0000012913224],"about_ca_topic_score_codex":0.0028684677,"about_ca_topic_score_gemma":0.003166339,"teacher_disagreement_score":0.002882865,"about_ca_system_score_codex":0.0002629654,"about_ca_system_score_gemma":0.00024931808,"threshold_uncertainty_score":0.009644151},"labels":[],"label_agreement":null},{"id":"W4417208876","doi":"10.1158/1557-3265.earlyonsetca25-b025","title":"Abstract B025: Universal Germline Testing in Young-Onset GI Malignancies: Expanding Access for Underserved Patients","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Germline; Psychosocial; Genetic testing; Cancer; Hereditary Cancer; Lynch syndrome; Colorectal cancer; Germline mutation; Incidence (geometry)","score_opus":0.4066752796112222,"score_gpt":0.5663796199608093,"score_spread":0.15970434034958714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417208876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994013,0.00008232054,0.00045630624,0.0021074712,0.000031544125,0.00057752477,0.00022810408,0.00007188457,0.0024318711],"genre_scores_gemma":[0.99564075,0.000117235264,0.001949497,0.0008077354,0.0000631404,0.00067602843,0.00018053634,0.000004056625,0.0005610071],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994911,0.00021292722,0.000022542903,0.00004611255,0.00004353629,0.00018385187],"domain_scores_gemma":[0.9970642,0.00029292708,0.00042357904,0.00008942961,0.00017330333,0.0019565085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013152324,0.00017806524,0.00015106096,0.00024022795,0.00080418895,0.0004357259,0.00045930347,0.00037883286,0.0063397987],"category_scores_gemma":[0.0033001003,0.00011813957,0.0002515765,0.00019240665,0.0003056335,0.00041204935,0.001612414,0.0005434601,0.0004140723],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017700363,0.009219164,0.75288165,0.00036313193,0.00004237815,0.00055402855,0.0017199487,0.00078679685,0.004542529,0.00034416575,0.015020157,0.21275595],"study_design_scores_gemma":[0.0007988547,0.010820865,0.9753702,0.00020685993,0.00004800827,0.00023842264,0.0029177712,0.0015453295,0.0015551165,0.00017329595,0.0063065407,0.000018800989],"about_ca_topic_score_codex":0.014189359,"about_ca_topic_score_gemma":0.02623117,"teacher_disagreement_score":0.014189359,"about_ca_system_score_codex":0.0011717583,"about_ca_system_score_gemma":0.005908371,"threshold_uncertainty_score":0.02821356},"labels":[],"label_agreement":null},{"id":"W4417209005","doi":"10.1158/1557-3265.earlyonsetca25-c024","title":"Abstract C024: Somatic mutations in early-onset colorectal cancer: insights from a U.S. Hispanic cohort","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Somatic cell; Colorectal cancer; Germline mutation; Lynch syndrome; Exome sequencing; Exome; MLH1","score_opus":0.055268379389918104,"score_gpt":0.4404204596819934,"score_spread":0.38515208029207526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417209005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99728286,0.00008963837,0.000093045746,0.00005043645,0.0000035812595,0.000011814613,0.0019271091,0.0000049308255,0.0005366145],"genre_scores_gemma":[0.99688584,0.0001573856,0.00016532168,0.00007372907,0.000012056054,0.000019423547,0.0021861822,0.00001082953,0.00048933865],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989486,0.000018801373,0.000006496354,0.000041599527,0.000017289774,0.000020837595],"domain_scores_gemma":[0.9997689,0.00002147989,0.00006195953,0.000036624275,0.000047797268,0.000063189465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002849773,0.00023996126,0.00015309309,0.0005647848,0.00055596617,0.00043732132,0.00025756328,0.00019357422,0.0027136714],"category_scores_gemma":[0.0005476766,0.00013965233,0.0002078064,0.00080256065,0.00014853904,0.00015117796,0.0005176634,0.00027300548,0.00037563746],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001805759,0.000045951503,0.99283385,0.000016969287,0.000072931776,0.00044085013,0.00033976467,0.00003810044,0.0020839623,0.000042351247,0.00095593726,0.002948678],"study_design_scores_gemma":[0.000012148047,0.000052197425,0.99683326,0.000010461869,0.00004238589,0.0007093744,0.0007464041,0.0001318992,0.00020810547,0.000037861322,0.0012111539,0.000004777266],"about_ca_topic_score_codex":0.01808933,"about_ca_topic_score_gemma":0.015359621,"teacher_disagreement_score":0.01808933,"about_ca_system_score_codex":0.00018092612,"about_ca_system_score_gemma":0.00026301554,"threshold_uncertainty_score":0.035968065},"labels":[],"label_agreement":null},{"id":"W4417209023","doi":"10.1158/1557-3265.earlyonsetca25-b022","title":"Abstract B022: Trends in the Cumulative Incidence of Second Primary Cancers Among Survivors of Early-Onset Cancer in the United States, 1975-2022","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cumulative incidence; Incidence (geometry); Cumulative risk; Cancer; Context (archaeology); Cancer incidence; Age groups","score_opus":0.1499192146807878,"score_gpt":0.4972420291156923,"score_spread":0.34732281443490454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417209023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95441693,0.0017132602,0.00032489945,0.0003339082,0.00004082813,0.000023508448,0.040144432,0.0000724241,0.002929813],"genre_scores_gemma":[0.979119,0.0007250982,0.00016118142,0.00007775456,0.00003207819,0.000021428456,0.018968698,0.0000057218535,0.0008890327],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997999,0.000023767989,0.000023400948,0.00005530451,0.00005991077,0.000037678376],"domain_scores_gemma":[0.9988772,0.00010606314,0.00042846682,0.000037237416,0.00040847584,0.00014258045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036651632,0.000245582,0.00020208916,0.0015202021,0.0001980227,0.0006231017,0.00035758526,0.0003407729,0.0016561664],"category_scores_gemma":[0.0011829473,0.00014862618,0.00040725718,0.0018458193,0.00011649423,0.00036093226,0.000289071,0.00043401774,0.00038923448],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045783647,0.000019420193,0.9958775,0.00003129617,0.00006525127,0.00003491953,0.00004574371,0.0002212626,0.00012491005,0.0000352375,0.0014253847,0.002073362],"study_design_scores_gemma":[0.0000028488928,0.000015016026,0.99916434,0.000009214036,0.000021205333,0.00005582611,0.00007819572,0.00018180338,0.000035740635,0.0000069244243,0.00042664717,0.0000021997728],"about_ca_topic_score_codex":0.10971917,"about_ca_topic_score_gemma":0.09920824,"teacher_disagreement_score":0.10971917,"about_ca_system_score_codex":0.00075330253,"about_ca_system_score_gemma":0.00079072145,"threshold_uncertainty_score":0.21816105},"labels":[],"label_agreement":null},{"id":"W4417209033","doi":"10.1158/1557-3265.earlyonsetca25-c007","title":"Abstract C007: Age-stratified insight into genomic alterations in colon adenocarcinoma via AACR GENIE v18.0","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Cohort; Cancer; Adenocarcinoma; Incidence (geometry); Colon adenocarcinoma","score_opus":0.09505588414339707,"score_gpt":0.46133266919523813,"score_spread":0.3662767850518411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417209033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5633146,0.007360019,0.0055656885,0.0008989185,0.00023476129,0.00016356993,0.40732792,0.0013546923,0.01377981],"genre_scores_gemma":[0.7846692,0.0016592564,0.006474826,0.0007866603,0.00013888146,0.00034130173,0.19914688,0.00072183734,0.006061129],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991314,0.00016662647,0.000066135595,0.00032295007,0.00015688663,0.00015611097],"domain_scores_gemma":[0.9984263,0.0005380178,0.00034310835,0.0003171963,0.00021818739,0.00015712707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010698207,0.00038826186,0.00064916996,0.0019567357,0.0004208407,0.0010051941,0.00047508764,0.00037819505,0.014262734],"category_scores_gemma":[0.0033992429,0.0002624119,0.0008135247,0.0032070712,0.00019423,0.00022898953,0.0007607486,0.00038795164,0.0025816592],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030387633,0.000062072104,0.8558334,0.001147918,0.001578946,0.00071641576,0.00031384683,0.0015870861,0.01596266,0.000765482,0.06890209,0.0500914],"study_design_scores_gemma":[0.000111053705,0.00019328218,0.94651,0.00017192021,0.000722252,0.0010923818,0.00012312387,0.0012884563,0.0020133944,0.00057076674,0.047177184,0.000026189275],"about_ca_topic_score_codex":0.009335455,"about_ca_topic_score_gemma":0.016691323,"teacher_disagreement_score":0.014262734,"about_ca_system_score_codex":0.00043661587,"about_ca_system_score_gemma":0.00079226727,"threshold_uncertainty_score":0.047713578},"labels":[],"label_agreement":null},{"id":"W4417209066","doi":"10.1158/1557-3265.earlyonsetca25-c023","title":"Abstract C023: Studying early onset cancer: benefits and limitations of studies within the Military Health System","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Population; Etiology; Cohort; Cancer; Military service; Cohort study; Epidemiology; Genetic predisposition","score_opus":0.4457567302058681,"score_gpt":0.5272275364900226,"score_spread":0.08147080628415454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417209066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31897357,0.18779945,0.08117961,0.2516458,0.023927966,0.012143018,0.03796539,0.0004883631,0.08587689],"genre_scores_gemma":[0.7823826,0.027903087,0.09049431,0.05648803,0.017327102,0.012745609,0.005344924,0.00023494619,0.007079341],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.8686721,0.10386301,0.011022066,0.0038232994,0.011439567,0.0011800284],"domain_scores_gemma":[0.4972321,0.3539607,0.030014332,0.03780072,0.07277511,0.008217045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.17937107,0.0009253532,0.001515772,0.0041054604,0.002573349,0.003954936,0.0043768766,0.0020868867,0.0051367786],"category_scores_gemma":[0.30089688,0.00057364587,0.0016742168,0.0073392647,0.0019830444,0.0043376223,0.0039331387,0.0018726536,0.0008717493],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025107516,0.00039071904,0.6159864,0.016454354,0.004301518,0.000496813,0.005072058,0.0015843482,0.0018359174,0.011524948,0.080900855,0.2589413],"study_design_scores_gemma":[0.00063518813,0.0016351095,0.80261827,0.020028288,0.003258066,0.0011267755,0.006091195,0.0048854407,0.002415542,0.01622609,0.14083947,0.00024062004],"about_ca_topic_score_codex":0.03801326,"about_ca_topic_score_gemma":0.0443091,"teacher_disagreement_score":0.17937107,"about_ca_system_score_codex":0.0021564132,"about_ca_system_score_gemma":0.007905163,"threshold_uncertainty_score":0.94861627},"labels":[],"label_agreement":null},{"id":"W4417209333","doi":"10.1158/1557-3265.earlyonsetca25-c017","title":"Abstract C017: Exogenous carcinogenic exposures in early-onset pancreatic carcinogenesis: Insights from alcohol and tobacco-driven models","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Carcinogenesis; Pancreas; Carcinogen; Pancreatitis; Immune system; Pancreatic Intraepithelial Neoplasia; Pancreatic cancer; Metaplasia; Stromal cell","score_opus":0.1380299526074797,"score_gpt":0.4090477430528915,"score_spread":0.2710177904454118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417209333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87055755,0.020739535,0.055156495,0.005468375,0.00090848305,0.00048682836,0.015284398,0.0013595229,0.030038813],"genre_scores_gemma":[0.9230252,0.020684626,0.013953168,0.0014105215,0.00023055005,0.00051889935,0.010443128,0.0003519242,0.029381985],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99961215,0.00004700173,0.000025860283,0.00010396739,0.00014398091,0.0000671292],"domain_scores_gemma":[0.9995554,0.000042103537,0.00010605644,0.00007259758,0.00007668564,0.00014705307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005784106,0.00066505204,0.00051179447,0.0007308456,0.0004529918,0.001088877,0.00060471485,0.00090962043,0.0050459215],"category_scores_gemma":[0.00025744495,0.00026031694,0.000815275,0.00045725226,0.000621053,0.0006557363,0.00092812884,0.002158036,0.001244439],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012064197,0.00040054592,0.0064769583,0.0007709174,0.000083544066,0.00059250055,0.00013624133,0.0006654399,0.9648585,0.0043503963,0.002576936,0.017881703],"study_design_scores_gemma":[0.00017194301,0.002498105,0.050186954,0.00047053813,0.0003600617,0.0027520515,0.0005207977,0.008569537,0.83598,0.006105931,0.09228075,0.00010334813],"about_ca_topic_score_codex":0.0015284022,"about_ca_topic_score_gemma":0.0023658078,"teacher_disagreement_score":0.0050459215,"about_ca_system_score_codex":0.0007818826,"about_ca_system_score_gemma":0.0008981135,"threshold_uncertainty_score":0.016880274},"labels":[],"label_agreement":null},{"id":"W4417209341","doi":"10.1158/1557-3265.earlyonsetca25-c032","title":"Abstract C032: Visceral fat area and age-related differences in visceral adipose tissue gene expression: implications for early-onset colorectal cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Disease and Adiposity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adipokine; Colorectal cancer; Adipose tissue; Intra-Abdominal Fat; Visceral fat; Adiponectin; Cancer; Gene","score_opus":0.13521589041959542,"score_gpt":0.48530372521913806,"score_spread":0.35008783479954264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417209341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99747854,0.000556396,0.00021261118,0.000050892402,0.000008777093,0.000008189682,0.0012401933,0.0000069203525,0.00043743546],"genre_scores_gemma":[0.99836916,0.00010239392,0.00033939412,0.00004482406,0.00002018268,0.0000152370985,0.00070430274,0.0000052129863,0.00039930854],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998592,0.000030438017,0.0000097392685,0.00004897775,0.000021666672,0.000029919518],"domain_scores_gemma":[0.999385,0.00014858843,0.0002478221,0.00003351027,0.000083762774,0.000101379934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021261288,0.00017389962,0.00020802506,0.0005726882,0.00022092863,0.0004091885,0.00018650458,0.00028841995,0.0032568658],"category_scores_gemma":[0.00076035387,0.0000805759,0.00022683457,0.0009798692,0.0001956096,0.00015041014,0.0002010176,0.00027933237,0.0003399547],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001401606,0.000045640016,0.96807164,0.000052478306,0.000047658028,0.0001531277,0.00007817656,0.000085555606,0.024128921,0.00004492103,0.00029484287,0.005595474],"study_design_scores_gemma":[0.0000036033978,0.000078161094,0.99890673,0.0000029816206,0.000009747358,0.00013462988,0.00003853148,0.00008345508,0.0005721044,0.000020697044,0.00014760529,0.0000016292873],"about_ca_topic_score_codex":0.001740239,"about_ca_topic_score_gemma":0.0016930366,"teacher_disagreement_score":0.0032568658,"about_ca_system_score_codex":0.00018029788,"about_ca_system_score_gemma":0.00017176438,"threshold_uncertainty_score":0.010895252},"labels":[],"label_agreement":null},{"id":"W4417209366","doi":"10.1158/1557-3265.earlyonsetca25-b029","title":"Abstract B029: Clinical and Sociodemographic Associations Between Early-Onset and Late-Onset Colorectal Cancer in a U.S.–Mexico Border Population","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Incidence (geometry); Comorbidity; Population; Cancer; Young adult; Population based study; Family history","score_opus":0.1296083776500052,"score_gpt":0.5514340146083316,"score_spread":0.4218256369583264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417209366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989405,0.00006173539,0.000018722567,0.000052273364,0.0000034421082,0.000006155769,0.00060916203,0.0000015152435,0.00030634957],"genre_scores_gemma":[0.998939,0.000047835947,0.00005081297,0.00003686214,0.00000767858,0.00001184496,0.0006345404,0.0000010901671,0.0002704718],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987507,0.000026080683,0.000013261705,0.0000369228,0.000019954385,0.00002877169],"domain_scores_gemma":[0.99950564,0.000048257483,0.00023536646,0.0000293698,0.00007761799,0.0001038079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025974648,0.00018805132,0.00015529938,0.0006175125,0.00065763865,0.00053599686,0.0002571236,0.00029537897,0.00223122],"category_scores_gemma":[0.00084308564,0.0001733222,0.00022869892,0.0007212871,0.0001428949,0.00031991926,0.0003673142,0.00035810482,0.00019672624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033988505,0.000026970893,0.999401,0.0000024238825,0.000010842151,0.00002563591,0.000043853503,0.0000050228423,0.00006836589,0.0000041286166,0.00011061577,0.0002672735],"study_design_scores_gemma":[0.0000025484012,0.000021602966,0.9995468,0.000002470735,0.000006218166,0.000040659095,0.00023345115,0.0000343984,0.000012831942,0.0000029909897,0.000095270945,7.6072246e-7],"about_ca_topic_score_codex":0.030156642,"about_ca_topic_score_gemma":0.033992354,"teacher_disagreement_score":0.030156642,"about_ca_system_score_codex":0.00034377308,"about_ca_system_score_gemma":0.00028414736,"threshold_uncertainty_score":0.059962213},"labels":[],"label_agreement":null},{"id":"W4417209579","doi":"10.1158/1557-3265.earlyonsetca25-a006","title":"Abstract A006: Natural interception of drug resistance in breast cancer: Nanoencapsulation of Terfezia extracts enhances doxorubicin sensitivity in early-onset models","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Doxorubicin; Breast cancer; Anthracycline; Drug; Tolerability; Drug resistance; Cancer","score_opus":0.0552809482355644,"score_gpt":0.40696628480609215,"score_spread":0.35168533657052775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417209579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883327,0.0016651921,0.0070709605,0.0001329584,0.00006252231,0.00006272525,0.00059702044,0.00017554595,0.00190045],"genre_scores_gemma":[0.9888599,0.0009345182,0.0045170486,0.000055532408,0.000010597989,0.000055954984,0.00047938057,0.000030432671,0.0050566425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995506,0.0000058609407,0.0000035260193,0.000010897279,0.000015834186,0.000008738458],"domain_scores_gemma":[0.999944,0.000010268064,0.00001794261,0.0000053814947,0.000010958312,0.000011363999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010401348,0.00023483449,0.00013099058,0.00017985351,0.000071309245,0.00014140393,0.00011128139,0.0002310826,0.0017153894],"category_scores_gemma":[0.00007312258,0.000073232906,0.00020244866,0.00008546019,0.00010660001,0.00014892267,0.00010650308,0.00038503224,0.00030743575],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006624139,0.000024396235,0.000050476516,0.000035316538,0.0000030205977,0.000015539774,0.000007221665,0.00006810533,0.9983436,0.00003604849,0.000051237774,0.0012987944],"study_design_scores_gemma":[0.000010653787,0.00030192002,0.0008819245,0.0000061923856,0.000009671203,0.00005091598,0.0000070028404,0.0006308353,0.996363,0.000015381123,0.0017199819,0.0000025782606],"about_ca_topic_score_codex":0.0004365601,"about_ca_topic_score_gemma":0.000533542,"teacher_disagreement_score":0.0017153894,"about_ca_system_score_codex":0.00011978941,"about_ca_system_score_gemma":0.0000817644,"threshold_uncertainty_score":0.0057385564},"labels":[],"label_agreement":null},{"id":"W4417210744","doi":"10.1158/1557-3265.earlyonsetca25-c031","title":"Abstract C031: Evexomostat (SDX-7320), a methionine aminopeptidase type 2 (METAP2) inhibitor, inhibits obesity-accelerated tumor growth and stimulates weight loss in obese mice","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Weight loss; Ovariectomized rat; Obesity; Adipose tissue; Diet-induced obese; Methionine; Mammary tumor; Weight gain; White adipose tissue","score_opus":0.12070829159836349,"score_gpt":0.47980575682367776,"score_spread":0.35909746522531427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417210744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881671,0.0030461743,0.0018739421,0.0002964344,0.00011542049,0.00012800055,0.0027746963,0.0003086042,0.0032894714],"genre_scores_gemma":[0.9850781,0.0021967634,0.002405938,0.00018171099,0.000036919926,0.00013551721,0.0034350757,0.000047715275,0.006482226],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988985,0.000010392027,0.000008935399,0.000019406865,0.000033899123,0.00003752992],"domain_scores_gemma":[0.99992025,0.0000076093297,0.000019020179,0.0000069880366,0.0000100760435,0.00003588938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011822172,0.000691032,0.0004063079,0.00042609998,0.00015910795,0.00017554393,0.00027874412,0.00036181556,0.0034889022],"category_scores_gemma":[0.000069419155,0.0001221937,0.00029689283,0.00031301813,0.00023433502,0.00018110871,0.00011032561,0.0010081696,0.0006366173],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036663893,0.0004988248,0.00029729222,0.000109974106,0.000018141116,0.00009180981,0.000006004242,0.00011214123,0.98728544,0.00012870364,0.0005650063,0.0072202203],"study_design_scores_gemma":[0.00066803204,0.0047755693,0.005814478,0.000010754748,0.000044561635,0.00045078338,0.000018106328,0.00064740627,0.98327243,0.00004502435,0.0042438814,0.000008916425],"about_ca_topic_score_codex":0.001392817,"about_ca_topic_score_gemma":0.0019283023,"teacher_disagreement_score":0.0034889022,"about_ca_system_score_codex":0.0003436651,"about_ca_system_score_gemma":0.00047297546,"threshold_uncertainty_score":0.011671543},"labels":[],"label_agreement":null},{"id":"W4417210855","doi":"10.1158/1557-3265.earlyonsetca25-pr012","title":"Abstract PR012: Transcriptomic and pathway analyses patterns in early-onset and late-onset microsatellite stable colorectal cancer: Results from the ORIEN Network","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Microsatellite instability; Colorectal cancer; Transcriptome; Microsatellite; Cancer; Germline; Exome; Genomics","score_opus":0.0922474449862485,"score_gpt":0.4380795870415172,"score_spread":0.34583214205526874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417210855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89545506,0.0013946436,0.0022177426,0.00044193686,0.00005000764,0.00012049916,0.09628503,0.00027783544,0.0037572838],"genre_scores_gemma":[0.77943945,0.0007967518,0.00733214,0.00045225758,0.000050657884,0.000249973,0.208859,0.0001412508,0.0026785436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993343,0.00013409053,0.00003585498,0.0002928457,0.00011674043,0.00008619137],"domain_scores_gemma":[0.9993519,0.00015719865,0.00011837968,0.00009244,0.00017075895,0.00010930689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011943653,0.00040689023,0.00033625533,0.0009789747,0.0004517671,0.0007125081,0.0005415667,0.00036578646,0.0023137499],"category_scores_gemma":[0.0016536611,0.00013278174,0.0006305595,0.0010754234,0.00020122468,0.00028292122,0.0012460224,0.00038583548,0.00078758446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044415747,0.00031536282,0.8334612,0.00096060184,0.0012461176,0.0006509329,0.000582038,0.0034294806,0.072109416,0.0005050222,0.023210933,0.059087336],"study_design_scores_gemma":[0.00009679728,0.00043445086,0.97225386,0.00008404186,0.00047327927,0.00083440344,0.0004982168,0.0037301139,0.004821187,0.0003767594,0.016364614,0.0000322695],"about_ca_topic_score_codex":0.0058417716,"about_ca_topic_score_gemma":0.012648998,"teacher_disagreement_score":0.0058417716,"about_ca_system_score_codex":0.00045684274,"about_ca_system_score_gemma":0.00063640834,"threshold_uncertainty_score":0.011615515},"labels":[],"label_agreement":null},{"id":"W4417212708","doi":"10.1158/1557-3265.earlyonsetca25-c035","title":"Abstract C035: Altered developmental programming of intestinal stem cells in a maternal obesogenic environment as a risk factor for EO-CRC","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stem cell; Offspring; Immune system; Carcinogenesis; Pathological; Cancer; Cytokine; Cancer stem cell","score_opus":0.20409664627662627,"score_gpt":0.500907901552438,"score_spread":0.29681125527581176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417212708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99407154,0.00081816997,0.0016758781,0.0002595789,0.000051582367,0.000020434878,0.002066943,0.00005337021,0.0009824915],"genre_scores_gemma":[0.991059,0.00063776807,0.0017959222,0.00024690788,0.00002154414,0.00008511395,0.0015376133,0.00005477005,0.004561447],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99980503,0.000030766347,0.000012976935,0.000058844256,0.00004991785,0.000042439176],"domain_scores_gemma":[0.9995964,0.000048839327,0.0001513319,0.000032652246,0.00003586955,0.00013486836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016819939,0.00035009047,0.00018654263,0.00046373715,0.00023848395,0.0002474996,0.00026292854,0.00045221258,0.0064048343],"category_scores_gemma":[0.00026919335,0.00013374968,0.00031880182,0.00026848566,0.00023901,0.00012541283,0.0002634972,0.00071614026,0.00055947335],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023722034,0.0002104841,0.04786176,0.00014836421,0.00006808595,0.001135417,0.000084948915,0.000092427406,0.9397485,0.0003851693,0.0005868402,0.0073057376],"study_design_scores_gemma":[0.00007575953,0.002050759,0.6729852,0.00012517789,0.00022661817,0.005337104,0.00035407787,0.0010167923,0.3081567,0.0005066742,0.009134346,0.000030690324],"about_ca_topic_score_codex":0.001688924,"about_ca_topic_score_gemma":0.0018707454,"teacher_disagreement_score":0.0064048343,"about_ca_system_score_codex":0.00031231166,"about_ca_system_score_gemma":0.00038657847,"threshold_uncertainty_score":0.02142632},"labels":[],"label_agreement":null},{"id":"W4417213901","doi":"10.1158/1557-3265.earlyonsetca25-b024","title":"Abstract B024: Feasibility of survey-based data collection in a diverse colorectal cancer cohort: Early-onset vs. average-onset","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Cancer; Cohort; Data collection; Quality of life (healthcare); Incidence (geometry); Psychological intervention; Clinical endpoint; Baseline (sea)","score_opus":0.3434410378495047,"score_gpt":0.5548343551026851,"score_spread":0.2113933172531804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417213901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98877,0.00006047382,0.00133481,0.00041729625,0.000029029025,0.0035361827,0.0039323047,0.000042874675,0.0018769702],"genre_scores_gemma":[0.9891131,0.000041841995,0.0026458956,0.0002140328,0.000023072706,0.004768927,0.0027181117,0.000008354093,0.0004665642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98738396,0.00880792,0.0010893986,0.0006705084,0.0013517182,0.0006965326],"domain_scores_gemma":[0.98027575,0.0064729205,0.0032124883,0.0023050795,0.0050377804,0.0026959507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030108858,0.00027236226,0.0003165184,0.0008118408,0.00080498325,0.001120514,0.0010054628,0.0005884683,0.0029915557],"category_scores_gemma":[0.030929249,0.00030914397,0.00063600723,0.0009103943,0.00038653644,0.00079198496,0.0016030433,0.000515068,0.0011568194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018160328,0.0009087176,0.9826697,0.00007786109,0.000048621874,0.000083998646,0.0007225753,0.00024131229,0.0008610136,0.00005596893,0.0011581117,0.011356122],"study_design_scores_gemma":[0.00026741246,0.0021694964,0.9933263,0.00003736034,0.000022858158,0.000097325734,0.0012815003,0.0010078065,0.00043588443,0.00003262243,0.0013079378,0.000013596043],"about_ca_topic_score_codex":0.009978519,"about_ca_topic_score_gemma":0.01069454,"teacher_disagreement_score":0.030108858,"about_ca_system_score_codex":0.0009392617,"about_ca_system_score_gemma":0.0030720981,"threshold_uncertainty_score":0.15923274},"labels":[],"label_agreement":null},{"id":"W4417458323","doi":"10.1158/1078-0432.ccr-25-1818","title":"KEYLYNK-009: Pembrolizumab plus Olaparib in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer after Clinical Benefit from First-Line Pembrolizumab plus Chemotherapy","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Olaparib; Chemotherapy; Breast cancer; Clinical endpoint; Immunotherapy","score_opus":0.18903189963681183,"score_gpt":0.5269343380585764,"score_spread":0.33790243842176454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417458323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99495715,0.0022285054,0.00013853927,0.0002901351,0.00010728052,0.0007012414,0.00032627673,0.000039430175,0.0012114637],"genre_scores_gemma":[0.99610317,0.0008782479,0.0004236697,0.00026735102,0.00006747597,0.0005632895,0.00034722808,0.000007603632,0.0013420589],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99969137,0.00014077227,0.000022980488,0.00005823011,0.000034417782,0.000052220985],"domain_scores_gemma":[0.99965143,0.000065101354,0.00007985541,0.000021177102,0.000022336311,0.00016015887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088183593,0.00046189834,0.0011828205,0.00022165528,0.00022265378,0.0005362069,0.00055579265,0.00057564885,0.005841686],"category_scores_gemma":[0.00072557974,0.0002503025,0.00062624045,0.00017063117,0.00035262952,0.00045721806,0.00025632224,0.0015750343,0.0008500314],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8162826,0.023342803,0.0053734793,0.00094006676,0.0008221085,0.0001310864,0.0001292476,0.00083435833,0.023024777,0.00016166245,0.0021877321,0.12677015],"study_design_scores_gemma":[0.4850168,0.47428092,0.028129302,0.00012681403,0.0009436736,0.00035896202,0.00007343368,0.0015024858,0.0052485066,0.00016892959,0.004119914,0.00003023044],"about_ca_topic_score_codex":0.00062173075,"about_ca_topic_score_gemma":0.002129751,"teacher_disagreement_score":0.005841686,"about_ca_system_score_codex":0.0007500902,"about_ca_system_score_gemma":0.00092112954,"threshold_uncertainty_score":0.019542336},"labels":[],"label_agreement":null},{"id":"W4417506867","doi":"10.1158/1078-0432.ccr-25-3541","title":"Investigating Early Kinetics in Plasma ctDNA and Peripheral T-cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck Squamous Cell Carcinoma","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"Eisai; Genentech; AstraZeneca; Canada Research Chairs; Genomic Health; Natera; Menarini Silicon Biosystems","keywords":"Repertoire; Head and neck; Head and neck squamous-cell carcinoma; T-cell receptor; Peripheral; Head and neck cancer; Receptor","score_opus":0.0896926933238834,"score_gpt":0.4311432024017427,"score_spread":0.3414505090778593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417506867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988477,0.00037495705,0.00024046838,0.000015113586,0.000004680198,0.000039411618,0.00017232618,0.00001132668,0.00029401697],"genre_scores_gemma":[0.9990182,0.00008148274,0.00027057322,0.00004493498,0.0000073379942,0.00004748022,0.00037120975,0.0000044234334,0.00015435407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996432,0.000095018346,0.00002646702,0.00011561719,0.000073761235,0.000045921763],"domain_scores_gemma":[0.9993888,0.00014479301,0.00020405732,0.000058700058,0.00008459881,0.00011903126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089316006,0.00034120443,0.0005349714,0.00035999014,0.00025107592,0.0006041192,0.00029380052,0.00038161644,0.00094931206],"category_scores_gemma":[0.0011992039,0.00022426964,0.00026780536,0.000312009,0.00028526352,0.00035493917,0.00029061295,0.00049528753,0.0002770276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012238899,0.00079275586,0.89153206,0.00016115345,0.00026489206,0.00015900945,0.00019672532,0.0016852817,0.049424764,0.000042156058,0.00042600642,0.043076266],"study_design_scores_gemma":[0.00033021494,0.0063887076,0.9755888,0.000022240341,0.00021186566,0.00056725985,0.00013073183,0.0044349697,0.011148646,0.00009575378,0.0010636596,0.00001719448],"about_ca_topic_score_codex":0.0006387862,"about_ca_topic_score_gemma":0.0009131895,"teacher_disagreement_score":0.00094931206,"about_ca_system_score_codex":0.0004668732,"about_ca_system_score_gemma":0.00035042103,"threshold_uncertainty_score":0.004723549},"labels":[],"label_agreement":null},{"id":"W7113895490","doi":"10.1158/1557-3265.earlyonsetca25-b014","title":"Abstract B014: Early-onset breast cancer and reproductive timing: results from the Mexican Teachers’ Cohort","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Breast cancer; Hazard ratio; Proportional hazards model; Menarche; Incidence (geometry); Prospective cohort study; Cohort; Confidence interval; Cancer","score_opus":0.224946705773405,"score_gpt":0.5321430502352696,"score_spread":0.3071963444618646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113895490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859681,0.00042315017,0.00030693816,0.00023050055,0.000028101556,0.0000334133,0.012293808,0.000015455364,0.0007004891],"genre_scores_gemma":[0.9913175,0.00025996316,0.00019409865,0.00010553393,0.00003254621,0.000064282955,0.0070840246,0.000014638143,0.00092743745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955493,0.00014124764,0.00003538888,0.00012723877,0.000052139072,0.000088966015],"domain_scores_gemma":[0.99813867,0.00043832316,0.00063894567,0.000351815,0.00020689682,0.00022532967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015738636,0.0003318593,0.00027408206,0.0006158894,0.000464679,0.0006640314,0.0005225726,0.0004139405,0.004421492],"category_scores_gemma":[0.0047678947,0.00029264233,0.001312577,0.00097502104,0.00015610391,0.00032398457,0.00060530356,0.0005431242,0.00054552435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005628012,0.000047603477,0.9952341,0.00004918437,0.0003263383,0.00009953858,0.0001585444,0.0000973936,0.00014892462,0.00003370037,0.0015038279,0.0017381421],"study_design_scores_gemma":[0.0000746235,0.00010512859,0.99730825,0.000034507713,0.00028345574,0.00010833174,0.00046378182,0.0002589491,0.0000546793,0.000032281965,0.0012683395,0.000007669935],"about_ca_topic_score_codex":0.041090757,"about_ca_topic_score_gemma":0.02614001,"teacher_disagreement_score":0.041090757,"about_ca_system_score_codex":0.00031695352,"about_ca_system_score_gemma":0.00060395343,"threshold_uncertainty_score":0.081703186},"labels":[],"label_agreement":null},{"id":"W7113896951","doi":"10.1158/1557-3265.earlyonsetca25-b017","title":"Abstract B017: Trends in early-onset colorectal, appendiceal, and anal tumour incidence by histological subtype in Australia from 1990 to 2020: A population-based time-series analysis","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Intraperitoneal and Appendiceal Malignancies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Incidence (geometry); Adenocarcinoma; Cancer; Colorectal cancer; Cohort; Anal cancer; Risk factor; Cohort study","score_opus":0.08128183789650542,"score_gpt":0.4658545856806381,"score_spread":0.38457274778413264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113896951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915902,0.00057758624,0.00031781153,0.00012291931,0.000011127327,0.00004772338,0.0065504485,0.000014627975,0.0007675241],"genre_scores_gemma":[0.9928722,0.00036483924,0.00038191458,0.00006216565,0.000012618774,0.000059678623,0.0055415016,0.000005611843,0.000699449],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994435,0.000120647885,0.000094706,0.00013395614,0.0001381575,0.000068965826],"domain_scores_gemma":[0.99829084,0.00010590398,0.0007376426,0.00009277747,0.0005738288,0.00019905763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001029388,0.00022788832,0.00038867793,0.0012950536,0.00025645498,0.0006031739,0.00047754173,0.0002871006,0.0014542304],"category_scores_gemma":[0.0023909416,0.00028643897,0.0010290904,0.0018513624,0.00020060668,0.00051478215,0.00077367906,0.0005387895,0.00037605866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077672325,0.000021275011,0.99570554,0.000085416585,0.00022452994,0.00006458672,0.00015874328,0.00021868145,0.00022721519,0.000039365495,0.00064361276,0.002533448],"study_design_scores_gemma":[0.0000030075716,0.00002887248,0.99896383,0.000015414364,0.000046463872,0.00006311312,0.00007175167,0.00041862341,0.000027041262,0.0000112751195,0.00034815786,0.0000023099317],"about_ca_topic_score_codex":0.08540961,"about_ca_topic_score_gemma":0.06286764,"teacher_disagreement_score":0.08540961,"about_ca_system_score_codex":0.0009279789,"about_ca_system_score_gemma":0.0009734214,"threshold_uncertainty_score":0.16982496},"labels":[],"label_agreement":null},{"id":"W7113898291","doi":"10.1158/1557-3265.earlyonsetca25-a010","title":"Abstract A010: Are We Delaying Ovarian Cancer Diagnosis in Young Women?: Sensitivity of CA-125 Thresholds for Early-Onset Ovarian cancer in Large Cohort","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Cohort; Gynecologic oncology; Referral; Cancer; Serous fluid; Cohort study","score_opus":0.13548399230222435,"score_gpt":0.4943773748922086,"score_spread":0.35889338258998427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113898291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947542,0.0017380323,0.00039881677,0.0006251864,0.000063386666,0.00003412271,0.0009921225,0.000017339034,0.0013765828],"genre_scores_gemma":[0.99886405,0.0001484569,0.00031494,0.00021241652,0.00004014478,0.000010918848,0.0003111661,0.0000040943496,0.000093791175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99719644,0.0012425224,0.00034580717,0.0006223413,0.00044336298,0.00014944897],"domain_scores_gemma":[0.97374773,0.015694207,0.007073316,0.0010463332,0.0015225692,0.00091575406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006117647,0.00022238624,0.00034981358,0.00077739824,0.00037781868,0.0011308925,0.0006877328,0.00066809176,0.0019907374],"category_scores_gemma":[0.036974337,0.00029848132,0.00067512994,0.00094508263,0.00040748884,0.0009898999,0.0004934375,0.000637357,0.00043949884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009909224,0.000009480155,0.9978529,0.000014693224,0.000037320082,0.00003398006,0.000033426684,0.000029060417,0.00006424907,0.000011082105,0.00020281474,0.0016118555],"study_design_scores_gemma":[0.000016942056,0.00017937648,0.9974185,0.00003562841,0.0000919204,0.00050410774,0.00024117334,0.00064108055,0.00020543444,0.00007104243,0.0005881447,0.0000067632795],"about_ca_topic_score_codex":0.0039590592,"about_ca_topic_score_gemma":0.004065882,"teacher_disagreement_score":0.006117647,"about_ca_system_score_codex":0.00040236575,"about_ca_system_score_gemma":0.00044050906,"threshold_uncertainty_score":0.03235358},"labels":[],"label_agreement":null},{"id":"W7113898421","doi":"10.1158/1557-3265.earlyonsetca25-a028","title":"Abstract A028: Exploring exposure to and metabolism of polycyclic aromatic hydrocarbons (PAHs) in patients with cancer predisposition syndromes (CPS): research in progress","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Toxic Organic Pollutants Impact","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Carcinogen; Cancer; Population; Urine; Aryl hydrocarbon receptor; Genetic predisposition; Polycyclic aromatic hydrocarbon","score_opus":0.13005391682710082,"score_gpt":0.4433132777851479,"score_spread":0.3132593609580471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113898421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950897,0.0013037358,0.00041760443,0.000476693,0.00003228765,0.00013529614,0.0017913909,0.000030799547,0.0007225935],"genre_scores_gemma":[0.9910753,0.0010584819,0.0026883048,0.00037934553,0.000090314956,0.00035811102,0.0033180509,0.000015224073,0.0010168884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999585,0.00015627005,0.000037175843,0.00008527541,0.0000839294,0.000052389158],"domain_scores_gemma":[0.99801683,0.00028844216,0.00047970537,0.00008024744,0.0007423384,0.00039236178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009936686,0.00050573994,0.0003421246,0.0007317993,0.0006715591,0.0007193777,0.00057520816,0.00068962434,0.0029951802],"category_scores_gemma":[0.002005822,0.0002000293,0.00051359093,0.0013640819,0.00020427674,0.0004320732,0.0005267034,0.00042731012,0.0007353415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005011754,0.00042601128,0.979387,0.00016918381,0.00010802123,0.00013897503,0.00016097141,0.000062050305,0.003711143,0.000025376276,0.0010053933,0.014304819],"study_design_scores_gemma":[0.00006758514,0.0013808772,0.99467933,0.000037703674,0.000096601696,0.00033133244,0.0003100753,0.00015062194,0.00088873354,0.000047571637,0.0020017875,0.000007802499],"about_ca_topic_score_codex":0.006381741,"about_ca_topic_score_gemma":0.00699596,"teacher_disagreement_score":0.006381741,"about_ca_system_score_codex":0.00049621,"about_ca_system_score_gemma":0.0012986764,"threshold_uncertainty_score":0.012689233},"labels":[],"label_agreement":null},{"id":"W7113898951","doi":"10.1158/1557-3265.earlyonsetca25-a007","title":"Abstract A007: Calcitonin gene-related peptide (CGRP) and receptor activity-modifying protein 1 (RAMP1) drive tumor cell growth in early-onset human gastric cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Calcitonin gene-related peptide; Immunohistochemistry; Stromal cell; Cancer; Cell growth; Receptor; Calcitonin; Orphan receptor","score_opus":0.08978429515848892,"score_gpt":0.4540710682988611,"score_spread":0.3642867731403722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113898951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99480915,0.0009905801,0.0011978494,0.00013760397,0.000016743865,0.000029025454,0.0013638836,0.00010563431,0.001349473],"genre_scores_gemma":[0.9961577,0.000376174,0.0010377407,0.000073270356,0.000008429125,0.00002533941,0.0011344752,0.000015954396,0.0011709547],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998894,0.000011836853,0.000007357741,0.000027444034,0.000037986996,0.000025875106],"domain_scores_gemma":[0.9998617,0.00002239323,0.000044374257,0.000013403041,0.000022798427,0.000035377227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015612759,0.00018923558,0.00017179779,0.0003192602,0.00016168403,0.0003410293,0.00014113398,0.00025099408,0.003398805],"category_scores_gemma":[0.00020975387,0.00010541238,0.00024581296,0.00030753834,0.00021496457,0.00014769995,0.00020802129,0.00050166727,0.0005131892],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061968376,0.00005712304,0.031534128,0.00016146021,0.000034159308,0.00035254596,0.000065620996,0.00021769424,0.96030205,0.00014885195,0.0005197884,0.005986901],"study_design_scores_gemma":[0.000054326003,0.00074187067,0.5901838,0.00002534773,0.00010999176,0.0046861274,0.00031863156,0.0030564747,0.39379022,0.0002580731,0.0067562955,0.00001883906],"about_ca_topic_score_codex":0.00074126397,"about_ca_topic_score_gemma":0.00082465576,"teacher_disagreement_score":0.003398805,"about_ca_system_score_codex":0.00024409524,"about_ca_system_score_gemma":0.00018285886,"threshold_uncertainty_score":0.011370122},"labels":[],"label_agreement":null},{"id":"W7113898967","doi":"10.1158/1557-3265.earlyonsetca25-a026","title":"Abstract A026: Use of recommended diagnostic breast imaging among women under 40 in a community-based registry","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mammography; Breast cancer; Breast imaging; Medical diagnosis; Breast ultrasound; Cancer registry; Medical imaging; Cancer","score_opus":0.23807074185850866,"score_gpt":0.5038479017184526,"score_spread":0.265777159859944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113898967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99339163,0.00009996123,0.00006419306,0.00015137071,0.000005874711,0.000039496976,0.0049534054,0.000010423046,0.0012835618],"genre_scores_gemma":[0.9968696,0.000068581685,0.00009695514,0.000068339206,0.0000104799265,0.000060905797,0.0026521918,0.0000042002243,0.000168688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979917,0.0006490708,0.00029665546,0.00032974558,0.00047259062,0.00026031098],"domain_scores_gemma":[0.9883393,0.0022323965,0.006309128,0.0006189276,0.0014670274,0.0010332266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013905473,0.00014788302,0.00026226582,0.0020558203,0.0005324698,0.00076016947,0.0007665119,0.00042986835,0.0027373065],"category_scores_gemma":[0.009154286,0.0002336334,0.0003274928,0.003531316,0.00022999785,0.00057054486,0.00063039124,0.0005146965,0.00035121152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003865709,0.000022038332,0.99888164,0.0000061334554,0.000014228514,0.00004232952,0.00005484998,0.000020514048,0.000038427766,0.000012744595,0.00044082804,0.00042750788],"study_design_scores_gemma":[0.0000049657533,0.00002424808,0.9992435,0.000008328675,0.000008900885,0.00010086491,0.00029091412,0.00015077653,0.00002101166,0.0000064669593,0.00013690196,0.0000031714512],"about_ca_topic_score_codex":0.05951596,"about_ca_topic_score_gemma":0.05836236,"teacher_disagreement_score":0.05951596,"about_ca_system_score_codex":0.0006848873,"about_ca_system_score_gemma":0.00127433,"threshold_uncertainty_score":0.11833906},"labels":[],"label_agreement":null},{"id":"W7113898984","doi":"10.1158/1557-3265.earlyonsetca25-a002","title":"Abstract A002: Real-world clinicogenomic comparison of early- and average-onset gastric cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Cohort; Disease; Carcinogenesis; Signet ring cell; Immune system; CDH1; Microsatellite instability; Prospective cohort study","score_opus":0.2608322181748289,"score_gpt":0.5651584282480993,"score_spread":0.3043262100732704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113898984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99687517,0.00012334723,0.00021851968,0.000023467817,0.000005139512,0.00000691109,0.0024927258,0.0000076104398,0.0002471116],"genre_scores_gemma":[0.99715865,0.000028956985,0.00019623936,0.000014349793,0.000009077338,0.000008295809,0.002480945,0.0000036102235,0.00009991746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968064,0.000086352586,0.000031281215,0.00011260545,0.00004162506,0.00004756234],"domain_scores_gemma":[0.9989505,0.00034779517,0.00034222548,0.00012349691,0.000101411555,0.00013447064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006206864,0.00014025165,0.0002756447,0.0006970616,0.00025311823,0.0006680504,0.00021534922,0.0002485721,0.0025394908],"category_scores_gemma":[0.0015361668,0.00009347337,0.00029198686,0.0010158094,0.00017064695,0.00025899647,0.00041920968,0.00020182034,0.00023312318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005904946,0.000023367265,0.9940514,0.000020266974,0.000079113044,0.00009552205,0.00004086984,0.00015342739,0.001642864,0.0000271617,0.00034453577,0.002930915],"study_design_scores_gemma":[0.000009310935,0.00008249798,0.9984773,0.0000035227768,0.000031079344,0.0002905234,0.00010606901,0.0004218931,0.00020719669,0.000039809274,0.00032778885,0.0000030048802],"about_ca_topic_score_codex":0.0016704728,"about_ca_topic_score_gemma":0.0021189617,"teacher_disagreement_score":0.0025394908,"about_ca_system_score_codex":0.00021684634,"about_ca_system_score_gemma":0.00013501002,"threshold_uncertainty_score":0.00849545},"labels":[],"label_agreement":null},{"id":"W7113899212","doi":"10.1158/1557-3265.earlyonsetca25-a023","title":"Abstract A023: Cell-Free DNA: A Paradigm Shift in Cancer Diagnostics and Precision Medicine","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Precision medicine; Precision oncology; Digital polymerase chain reaction; Circulating tumor DNA; Cell-free fetal DNA; Personalized medicine; Cancer; Liquid biopsy; Minimal residual disease","score_opus":0.0977671510184656,"score_gpt":0.48487710132954936,"score_spread":0.38710995031108375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113899212","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062980885,0.4732831,0.10233308,0.31642425,0.045619722,0.00025222186,0.00090997433,0.0012053975,0.05367418],"genre_scores_gemma":[0.12868994,0.4877802,0.11023779,0.14395049,0.058731046,0.0007672779,0.0013999867,0.0009339165,0.067509376],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99384475,0.0022128993,0.0003309424,0.0010062604,0.0022988499,0.00030628685],"domain_scores_gemma":[0.98304635,0.008212508,0.0006787367,0.0009967225,0.005773511,0.0012921627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012628259,0.000830227,0.0012749819,0.0020055405,0.0013158708,0.0061112694,0.002015065,0.008061698,0.010580488],"category_scores_gemma":[0.011604569,0.0004954436,0.0011817934,0.0016439556,0.0071822763,0.0074827475,0.0036800297,0.009758713,0.005871534],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047324502,0.00013705426,0.0008943408,0.003075719,0.00008544071,0.0004889932,0.0006779345,0.0010781109,0.0140166525,0.3171422,0.15241244,0.5095179],"study_design_scores_gemma":[0.000052668598,0.0003604398,0.00057209923,0.0012686211,0.000039559374,0.0010442641,0.00027228502,0.0014203412,0.009226022,0.11597512,0.86967134,0.00009728594],"about_ca_topic_score_codex":0.0016293135,"about_ca_topic_score_gemma":0.00085025,"teacher_disagreement_score":0.012628259,"about_ca_system_score_codex":0.0040000253,"about_ca_system_score_gemma":0.004661329,"threshold_uncertainty_score":0.066785395},"labels":[],"label_agreement":null},{"id":"W7113899263","doi":"10.1158/1557-3265.earlyonsetca25-b006","title":"Abstract B006: Early-onset colorectal cancer: 10 year review of histopathological trends in a tertiary hospital in Accra, Ghana","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Histopathology; Stage (stratigraphy); Pathological; Cancer; Medical diagnosis; Retrospective cohort study; Metastasis","score_opus":0.103804417180166,"score_gpt":0.49542439453428366,"score_spread":0.3916199773541177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113899263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87884253,0.10879231,0.00025505776,0.002006142,0.00015565607,0.00019382042,0.007616373,0.000033812183,0.0021043564],"genre_scores_gemma":[0.91767615,0.07597649,0.0006690649,0.0006038765,0.00019161629,0.00013477454,0.0038327829,0.00001514572,0.0008999471],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916935,0.0001854385,0.00027382286,0.00012680962,0.00013312913,0.00011139534],"domain_scores_gemma":[0.9948161,0.0008488581,0.0030931144,0.00010436564,0.000748159,0.00038933055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013737489,0.00026125656,0.00042008478,0.004385719,0.00061934383,0.0008563236,0.00062854704,0.00044296886,0.0021610097],"category_scores_gemma":[0.0031988123,0.0003821414,0.00035472048,0.00828197,0.00049978745,0.0010003928,0.00062360463,0.0003522055,0.00044284217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018990216,0.00005200476,0.9529105,0.004929179,0.00010819112,0.005739336,0.0026434956,0.000060228853,0.0008917111,0.00007530661,0.003972643,0.028427564],"study_design_scores_gemma":[0.000008493881,0.00008620457,0.9825926,0.0018244305,0.00007869049,0.0041984594,0.0047193994,0.000042751955,0.00012344243,0.000014946887,0.0063021537,0.0000084555],"about_ca_topic_score_codex":0.016077269,"about_ca_topic_score_gemma":0.0218487,"teacher_disagreement_score":0.016077269,"about_ca_system_score_codex":0.0012558558,"about_ca_system_score_gemma":0.0021483544,"threshold_uncertainty_score":0.0319674},"labels":[],"label_agreement":null},{"id":"W7113900680","doi":"10.1158/1557-3265.earlyonsetca25-a033","title":"Abstract A033: Community-Based Pilot Study of Colorectal Cancer Susceptibility and Cardiometabolic Risk in Young Hispanic Adults","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Family history; Young adult; Cancer; Body mass index; Diabetes mellitus; Demographics; Aspirin; Cancer prevention; Descriptive statistics","score_opus":0.16541786361236877,"score_gpt":0.512983973973709,"score_spread":0.3475661103613402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113900680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99457574,0.000047855792,0.00023865409,0.00013641757,0.000016052569,0.0005247224,0.0032857608,0.00001176992,0.0011631033],"genre_scores_gemma":[0.99322045,0.000085881235,0.00081027986,0.0004982563,0.00003530153,0.0011091585,0.0025857296,0.000009439862,0.0016455713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996325,0.00013916864,0.000032016782,0.00006279555,0.00005201527,0.000081508595],"domain_scores_gemma":[0.99904686,0.00008766085,0.00015807027,0.00009018218,0.00027231724,0.00034482215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013458034,0.0004678649,0.00023498968,0.00061258674,0.0012856298,0.000621572,0.00046361474,0.0005366208,0.003138226],"category_scores_gemma":[0.0013755582,0.0004440666,0.0004914721,0.00093517196,0.00028672448,0.00049249816,0.0007275465,0.0008474439,0.0013401315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005053931,0.001400629,0.99176747,0.000039340335,0.00006977854,0.00023508095,0.0009585734,0.00003416025,0.00065977825,0.000037379406,0.0013917332,0.0029006058],"study_design_scores_gemma":[0.00014048498,0.0011837012,0.99450964,0.000021230075,0.000043140295,0.00018740076,0.002378253,0.0001410558,0.00013345716,0.000038032747,0.0012141624,0.000009566635],"about_ca_topic_score_codex":0.026104528,"about_ca_topic_score_gemma":0.037202135,"teacher_disagreement_score":0.026104528,"about_ca_system_score_codex":0.0005140785,"about_ca_system_score_gemma":0.0014349074,"threshold_uncertainty_score":0.051905215},"labels":[],"label_agreement":null},{"id":"W7113901088","doi":"10.1158/1557-3265.earlyonsetca25-b010","title":"Abstract B010: Building a global research nextwork focusing on etiology for early-onset colorectal cancer (EOCRC): findings from the Fight Colorectal Cancer 2025 Barcelona Think Tank","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Incidence (geometry); Psychosocial; Epidemiology; Etiology; Global health; Stakeholder; Cancer","score_opus":0.19721506888130985,"score_gpt":0.5374125838781845,"score_spread":0.3401975149968746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113901088","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0072951633,0.011899321,0.0026726304,0.91634864,0.04841655,0.0003997269,0.0023625412,0.00034824194,0.010257186],"genre_scores_gemma":[0.13666074,0.01882115,0.033171393,0.7437105,0.021909684,0.002410395,0.007406446,0.0007506737,0.035159007],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9795065,0.013210964,0.0005945098,0.0013574545,0.0024305414,0.0029001727],"domain_scores_gemma":[0.9172157,0.03219784,0.0032892188,0.0017862702,0.016089508,0.029421521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04751192,0.0013837031,0.00093318446,0.0021700119,0.005618723,0.010034272,0.0029096277,0.008904442,0.019607328],"category_scores_gemma":[0.03894948,0.0006695814,0.002563085,0.001670084,0.0037233694,0.0059734625,0.010819709,0.013165921,0.0047858283],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046744014,0.00022164147,0.006409221,0.0019494232,0.00010801366,0.00031120947,0.006651648,0.00017953165,0.00063780445,0.0048541897,0.9132561,0.064953774],"study_design_scores_gemma":[0.00041578565,0.00043619194,0.01532505,0.005566685,0.00017864478,0.00023025015,0.041161332,0.0003760753,0.0007314321,0.012116346,0.9233054,0.00015677158],"about_ca_topic_score_codex":0.014488015,"about_ca_topic_score_gemma":0.019037515,"teacher_disagreement_score":0.04751192,"about_ca_system_score_codex":0.011364152,"about_ca_system_score_gemma":0.035040233,"threshold_uncertainty_score":0.25127006},"labels":[],"label_agreement":null},{"id":"W7113902448","doi":"10.1158/1557-3265.earlyonsetca25-a029","title":"Abstract A029: Breast Cancer Screening During Reproductive Years in Women with Germline Pathogenic Variants: Gaps in Counseling and Practice","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Breast cancer screening; Mammography; Breast cancer; Incidence (geometry); Cancer; Family history; Genetic counseling; Logistic regression","score_opus":0.08901040215752168,"score_gpt":0.4935613728343315,"score_spread":0.4045509706768098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113902448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93184197,0.003417063,0.0006962131,0.04467071,0.00029448944,0.00025636028,0.0041298117,0.00009629136,0.0145971505],"genre_scores_gemma":[0.98878866,0.0021484215,0.00125895,0.005287208,0.00016647634,0.00023591596,0.00076310366,0.000009253737,0.0013419843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988067,0.00047339627,0.00014545111,0.00011766056,0.00022561944,0.00023113578],"domain_scores_gemma":[0.9940485,0.002034498,0.0017406836,0.00015970942,0.0008390415,0.0011776387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021653539,0.000103479855,0.00015318318,0.0006856276,0.0009327106,0.00078285066,0.0006492615,0.00076119957,0.005390915],"category_scores_gemma":[0.009702977,0.00016089692,0.00021184536,0.00089424243,0.0003192307,0.0008296118,0.0008702057,0.00070561265,0.0005752112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068533955,0.00039239807,0.87148494,0.0003780095,0.000017172226,0.00039146474,0.0032564308,0.000087922584,0.00034518124,0.00033301197,0.024192853,0.099052034],"study_design_scores_gemma":[0.00001950887,0.00028224266,0.97375214,0.0011023448,0.00002527454,0.00041085962,0.0115433615,0.0006050123,0.00021588762,0.00036450307,0.011659549,0.000019280262],"about_ca_topic_score_codex":0.032618802,"about_ca_topic_score_gemma":0.03349152,"teacher_disagreement_score":0.032618802,"about_ca_system_score_codex":0.0010340677,"about_ca_system_score_gemma":0.0036965653,"threshold_uncertainty_score":0.06485784},"labels":[],"label_agreement":null},{"id":"W7113902549","doi":"10.1158/1557-3265.earlyonsetca25-a035","title":"Abstract A035: A complex clinical evolution: Mediastinal unicentric Castleman disease preceding paraneoplastic pemphigus and bronchiolitis obliterans","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Paraneoplastic pemphigus; Bronchiolitis obliterans; Malignancy; Biopsy; Asymptomatic; Air trapping; Lymph node; Pulmonary function testing","score_opus":0.21921134650627383,"score_gpt":0.5316543470920033,"score_spread":0.3124430005857295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113902549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97808444,0.0035108998,0.0016791789,0.0019701764,0.0002372441,0.00014992952,0.00027780829,0.00008733051,0.014002863],"genre_scores_gemma":[0.9978587,0.00036297808,0.00050418696,0.00042096456,0.0002489139,0.000011871325,0.00007204351,0.000007808233,0.00051241816],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.999574,0.00005038694,0.000049431175,0.00013642451,0.00006169752,0.00012796318],"domain_scores_gemma":[0.9991092,0.00020826119,0.00017868241,0.000062862186,0.00007728958,0.00036366106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003912885,0.001096237,0.0008053807,0.0012649327,0.0018711888,0.0008980826,0.0006842512,0.002261326,0.0028820345],"category_scores_gemma":[0.0019295554,0.000572189,0.00054992794,0.0009831599,0.00084873644,0.0011474934,0.0007854915,0.0020140489,0.00065370277],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074409894,0.000045878955,0.021591524,0.000033053533,0.000011341994,0.97572505,0.00009818801,0.000077535005,0.0010261086,0.00015610637,0.00021964575,0.0009411044],"study_design_scores_gemma":[0.00001557514,0.00009209342,0.017176364,0.000018472847,0.000016523758,0.98135847,0.0001242035,0.0003233432,0.00021162596,0.00019216609,0.00046114452,0.000010017358],"about_ca_topic_score_codex":0.0017712134,"about_ca_topic_score_gemma":0.0021548253,"teacher_disagreement_score":0.0028820345,"about_ca_system_score_codex":0.0007690598,"about_ca_system_score_gemma":0.00045871525,"threshold_uncertainty_score":0.009641349},"labels":[],"label_agreement":null},{"id":"W7113902760","doi":"10.1158/1557-3265.earlyonsetca25-b004","title":"Abstract B004: The Cleveland Clinic’s Young-Onset Colorectal Cancer Center and Registry: Integrating multidisciplinary clinical care and research infrastructure","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colonoscopy; Colorectal cancer; Cancer; Family history; Medical history; Multidisciplinary approach; Medical record; Cancer registry","score_opus":0.14098774666185201,"score_gpt":0.5401648914266247,"score_spread":0.39917714476477273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113902760","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06734361,0.003603898,0.017491706,0.02688315,0.0031671962,0.019141022,0.7051719,0.009355011,0.14784256],"genre_scores_gemma":[0.17116688,0.0026990136,0.070107706,0.008438191,0.0033096122,0.020932868,0.6798693,0.0018758322,0.041600615],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9877843,0.0039553386,0.002055084,0.002121279,0.0029987982,0.0010852655],"domain_scores_gemma":[0.9168688,0.010470899,0.010883101,0.012492993,0.026639266,0.022644822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013996287,0.00086945103,0.0012910087,0.00655385,0.0020009484,0.0036825133,0.0034760449,0.0014445906,0.034374908],"category_scores_gemma":[0.029702108,0.0011492458,0.0006437595,0.0076719313,0.00058203534,0.0025331466,0.004150532,0.0021984482,0.01448561],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044889576,0.00041818034,0.09390429,0.00040417752,0.00010369421,0.00015810273,0.00018464387,0.0003107648,0.0008433751,0.0015340791,0.83671665,0.064973265],"study_design_scores_gemma":[0.0013489558,0.0007772624,0.5847615,0.00097304577,0.00015733906,0.0003263186,0.00052352925,0.0025114755,0.000737663,0.00082887703,0.4068741,0.00017994801],"about_ca_topic_score_codex":0.05140786,"about_ca_topic_score_gemma":0.064912006,"teacher_disagreement_score":0.05140786,"about_ca_system_score_codex":0.0037257648,"about_ca_system_score_gemma":0.015080324,"threshold_uncertainty_score":0.1149956},"labels":[],"label_agreement":null},{"id":"W7113904464","doi":"10.1158/1557-3265.earlyonsetca25-b018","title":"Abstract B018: Early-onset ovarian cancer in U.S. veterans: A National Cancer Database study","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Logistic regression; Cancer; Cohort; Retrospective cohort study; Cohort study; Fallopian tube","score_opus":0.30878318328812354,"score_gpt":0.5968792021292982,"score_spread":0.2880960188411747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113904464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8591668,0.0011320545,0.0002520525,0.0002733641,0.000030623723,0.00020843979,0.13716891,0.000025459507,0.0017422942],"genre_scores_gemma":[0.94476616,0.00064020295,0.00045842514,0.00025698525,0.000034391527,0.00041135153,0.052780095,0.000009402317,0.0006430888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991442,0.00016006692,0.00021308467,0.00022702133,0.00014201675,0.00011365641],"domain_scores_gemma":[0.99793327,0.00034692927,0.00097008026,0.00018925779,0.0002951327,0.0002653957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006521027,0.00022441636,0.00047595095,0.0015692927,0.00054385804,0.00067282206,0.0005669724,0.00037908432,0.0028321957],"category_scores_gemma":[0.0026454898,0.00031267275,0.00045265016,0.0059738057,0.00015162592,0.00050183374,0.00053399685,0.0004554203,0.00040117343],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014925245,0.000043854074,0.9961588,0.00007908201,0.0001078642,0.000059302998,0.00005072996,0.00005214361,0.00008527489,0.000035916644,0.002153996,0.0010238141],"study_design_scores_gemma":[0.00004948809,0.00004276209,0.9974929,0.000044256463,0.0000838207,0.0001644015,0.00019563326,0.00021509606,0.00005199584,0.000022737451,0.0016323566,0.000004550549],"about_ca_topic_score_codex":0.03493328,"about_ca_topic_score_gemma":0.04645825,"teacher_disagreement_score":0.03493328,"about_ca_system_score_codex":0.0007293852,"about_ca_system_score_gemma":0.0012410945,"threshold_uncertainty_score":0.069459856},"labels":[],"label_agreement":null},{"id":"W7113904748","doi":"10.1158/1557-3265.earlyonsetca25-a013","title":"Abstract A013: 225Actinium and tandem 177Lutetium/225Actinium - FAPi therapy in medullary thyroid carcinoma","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Calcitonin; Thyroid carcinoma; Progressive disease; Adverse effect; Thyroid cancer; Medullary thyroid cancer; Carcinoma","score_opus":0.19918230943351187,"score_gpt":0.5324398239048612,"score_spread":0.3332575144713493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113904748","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967277,0.0015648621,0.00019910924,0.000049207756,0.000004748672,0.000023754412,0.00010226565,0.000011144719,0.0013172403],"genre_scores_gemma":[0.99924767,0.00018719853,0.00009993332,0.000022254333,0.000009013559,0.000006607076,0.000086909065,0.0000022932518,0.00033801884],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99992585,0.00001572914,0.00000622523,0.000017133618,0.00001746252,0.000017680852],"domain_scores_gemma":[0.99987686,0.00003300175,0.000023674664,0.000009243789,0.000012420634,0.00004482271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001938267,0.00011110146,0.00026313018,0.00024171421,0.00021668823,0.00023011518,0.00015248165,0.00021963673,0.0014129492],"category_scores_gemma":[0.00031751455,0.000065926535,0.00020727725,0.0002943913,0.00020755631,0.00009238976,0.00013136031,0.0001436804,0.00035699006],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02023473,0.0008265353,0.6312292,0.00044701571,0.00030078564,0.02714871,0.00057201996,0.0015284955,0.18326285,0.00037334906,0.0015006093,0.1325757],"study_design_scores_gemma":[0.000727801,0.02081147,0.88239604,0.000048231886,0.0004293731,0.05450973,0.0003487383,0.0025627404,0.027586835,0.00026207085,0.010282068,0.000034917324],"about_ca_topic_score_codex":0.003625325,"about_ca_topic_score_gemma":0.002594273,"teacher_disagreement_score":0.003625325,"about_ca_system_score_codex":0.0006068919,"about_ca_system_score_gemma":0.0004821897,"threshold_uncertainty_score":0.0072084665},"labels":[],"label_agreement":null},{"id":"W7113904863","doi":"10.1158/1557-3265.earlyonsetca25-b016","title":"Abstract B016: Survival differences after diagnosis of early-onset colorectal cancer by race/ethnicity and neighborhood-level socioeconomic status","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Hazard ratio; Socioeconomic status; Incidence (geometry); Proportional hazards model; Cancer; Comorbidity; Confidence interval; Household income","score_opus":0.13515458615929568,"score_gpt":0.4877126637308485,"score_spread":0.3525580775715528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113904863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99527705,0.000120445045,0.00007735244,0.00007093569,0.000010890308,0.000005961151,0.0037531708,0.0000069730413,0.0006772608],"genre_scores_gemma":[0.99778396,0.00002736549,0.000040943378,0.000011057416,0.0000074616855,0.0000065189565,0.0017473673,0.0000017374279,0.00037362764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998354,0.000030968073,0.0000136719855,0.000050140177,0.000028712384,0.000041092128],"domain_scores_gemma":[0.99916315,0.00016845053,0.00032473003,0.000053070915,0.00012807515,0.00016261303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042940304,0.00015887221,0.00017043653,0.0004384738,0.00026653733,0.00039661507,0.0003081544,0.00018090128,0.0057642264],"category_scores_gemma":[0.0013285675,0.000099905454,0.0004692231,0.00058679195,0.0001136812,0.00025320175,0.0003031852,0.0003421207,0.00037026955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023750473,0.000023900036,0.997644,0.000013144374,0.000067605615,0.000029599787,0.000028305256,0.000069604,0.0000964245,0.000016222639,0.0005539274,0.0012197449],"study_design_scores_gemma":[0.0000056197214,0.000038347684,0.9994968,0.000004121463,0.0000234296,0.000027688715,0.00005136731,0.00018385904,0.000025329939,0.00001279375,0.00012960896,0.0000010580261],"about_ca_topic_score_codex":0.020824082,"about_ca_topic_score_gemma":0.016437804,"teacher_disagreement_score":0.020824082,"about_ca_system_score_codex":0.00027316427,"about_ca_system_score_gemma":0.00039228986,"threshold_uncertainty_score":0.041405737},"labels":[],"label_agreement":null},{"id":"W7113905652","doi":"10.1158/1557-3265.earlyonsetca25-a008","title":"Abstract A008: Psychosocial Survivorship Gaps in Early-Onset Cancers: Opportunities for Digital Health Research","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychosocial; Survivorship curve; Intervention (counseling); Pace; Cancer survivorship; Focus group; Scope (computer science); Health care; Participatory action research","score_opus":0.5751743848689548,"score_gpt":0.6007769247431088,"score_spread":0.025602539874154062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113905652","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0866108,0.1360125,0.02824045,0.6274314,0.010403186,0.0026970946,0.0018924978,0.0007923238,0.105919756],"genre_scores_gemma":[0.65079707,0.19041291,0.066260956,0.062334612,0.0043087993,0.0042401953,0.0016925548,0.00024548877,0.019707527],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952873,0.0032605494,0.0001942886,0.00020816254,0.00064534566,0.0004043507],"domain_scores_gemma":[0.93317443,0.04816069,0.0020454165,0.0022183545,0.007894358,0.0065067085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016122045,0.00046537808,0.00072635774,0.0017647006,0.002205501,0.0070751617,0.0016169238,0.0025674698,0.02619019],"category_scores_gemma":[0.0330637,0.00025944973,0.0011706711,0.0019410269,0.0027242335,0.012425189,0.005734932,0.0042123185,0.0021443928],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029297022,0.001019631,0.009057126,0.00884275,0.000096564065,0.00037150754,0.012648971,0.0003757959,0.00079753774,0.05236464,0.09260606,0.8215265],"study_design_scores_gemma":[0.00023312237,0.0022277066,0.025406552,0.051999595,0.0003868714,0.0012032071,0.131223,0.0016476157,0.0026430334,0.11048196,0.67240393,0.00014339977],"about_ca_topic_score_codex":0.0017269038,"about_ca_topic_score_gemma":0.003084091,"teacher_disagreement_score":0.02619019,"about_ca_system_score_codex":0.003026855,"about_ca_system_score_gemma":0.01358263,"threshold_uncertainty_score":0.087614894},"labels":[],"label_agreement":null},{"id":"W7113906019","doi":"10.1158/1557-3265.earlyonsetca25-a036","title":"Abstract A036: Afferent loop syndrome in a young patient with extrahepatic cholangiocarcinoma: A challenging postoperative anatomy after complex hepatobiliary surgery","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Gallbladder and Bile Duct Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Endoscopic retrograde cholangiopancreatography; Hepatectomy; Biliary tract; Abdomen; Biliary Tract Surgical Procedures; Intrahepatic bile ducts; Common bile duct; Bile duct; Hepatology","score_opus":0.11462528487903748,"score_gpt":0.43952180375927075,"score_spread":0.3248965188802333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113906019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99034697,0.0017004412,0.0011345106,0.002137693,0.00022888365,0.00006830112,0.00017278,0.00009260091,0.0041179047],"genre_scores_gemma":[0.9981,0.00039031784,0.0003405361,0.00043399492,0.00021021899,0.000009027202,0.00007049913,0.000011968559,0.00043348264],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99968266,0.000029461582,0.000044979617,0.00007976307,0.000046697416,0.000116538155],"domain_scores_gemma":[0.99898154,0.00025401075,0.00017686364,0.000043073716,0.00006151928,0.00048297932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022299096,0.0010460184,0.0008463576,0.001406992,0.0016411805,0.00088481285,0.0004934629,0.0024250352,0.0018815392],"category_scores_gemma":[0.0017678149,0.00060886174,0.0007771738,0.00092855823,0.00077512657,0.0013351713,0.0008267841,0.0020766428,0.00044852548],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002887849,0.000021789088,0.017610552,0.000012451652,0.000005162895,0.9809427,0.000085424064,0.000035061144,0.0005769439,0.00005317487,0.00016604658,0.00046190718],"study_design_scores_gemma":[0.000008281357,0.000079721845,0.012259385,0.000010252192,0.000009703146,0.9867938,0.00013131731,0.00018151799,0.0002079281,0.0000860553,0.00022364494,0.000008481682],"about_ca_topic_score_codex":0.0019764116,"about_ca_topic_score_gemma":0.0031909475,"teacher_disagreement_score":0.0024250352,"about_ca_system_score_codex":0.0007919789,"about_ca_system_score_gemma":0.0007039084,"threshold_uncertainty_score":0.0062943697},"labels":[],"label_agreement":null},{"id":"W7113906340","doi":"10.1158/1557-3265.earlyonsetca25-b015","title":"Abstract B015: Impact of sun sensitivity and ultraviolet radiation on the association between blistering sunburns and keratinocyte carcinoma","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sunburn; Confidence interval; Skin cancer; Basal cell; Basal cell carcinoma; Cancer; Cohort; Lifetime risk","score_opus":0.18959147791465997,"score_gpt":0.5269067756470491,"score_spread":0.33731529773238916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113906340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98545825,0.005586691,0.0007723741,0.000648718,0.000107779524,0.000026235997,0.00419385,0.00004537356,0.0031608501],"genre_scores_gemma":[0.9969869,0.0005464139,0.0003475428,0.000088610854,0.00007005098,0.000010915429,0.00094223674,0.000008913842,0.0009984801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883384,0.00052370544,0.00008995116,0.0002023874,0.0002560286,0.000094178955],"domain_scores_gemma":[0.9930599,0.0025704647,0.0024775914,0.0004907428,0.00074906304,0.0006522033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001484046,0.00032518213,0.00024868848,0.0007509631,0.00027399216,0.0007350368,0.00045598065,0.00043336183,0.008789152],"category_scores_gemma":[0.0067958967,0.00021183425,0.0010460244,0.0008966168,0.0002020094,0.00035900468,0.00043536467,0.00067787705,0.0006021202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033676435,0.000028760485,0.9946989,0.000050403636,0.00035544598,0.000033812656,0.000017382275,0.000114990056,0.00034621582,0.000031045107,0.0003808961,0.0036053872],"study_design_scores_gemma":[0.000007554249,0.000069224145,0.99902534,0.000026230982,0.000118643286,0.00008122358,0.000026857027,0.00019364816,0.00010627247,0.00004128693,0.0003012152,0.0000024926478],"about_ca_topic_score_codex":0.010921787,"about_ca_topic_score_gemma":0.008173869,"teacher_disagreement_score":0.010921787,"about_ca_system_score_codex":0.00029133225,"about_ca_system_score_gemma":0.0004653031,"threshold_uncertainty_score":0.029402614},"labels":[],"label_agreement":null},{"id":"W7113906601","doi":"10.1158/1557-3265.earlyonsetca25-b012","title":"Abstract B012: Sociodemographic and clinical determinants associated with early-onset breast cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Logistic regression; Odds ratio; Cohort; Prospective cohort study; Odds; Univariate analysis; Cohort study","score_opus":0.1835118544814505,"score_gpt":0.5601915092745251,"score_spread":0.37667965479307464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113906601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99471515,0.00040055334,0.00010867799,0.00031226885,0.000016995087,0.000020553705,0.0034034664,0.0000056545277,0.0010166481],"genre_scores_gemma":[0.9986494,0.00009019704,0.00008014353,0.000041167455,0.000008795344,0.000011889482,0.00075194205,0.0000020301552,0.00036449797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996464,0.00009496855,0.000045397464,0.000052867188,0.00006881157,0.00009154367],"domain_scores_gemma":[0.99826777,0.00032366425,0.0008476038,0.00008631931,0.00018824353,0.00028631696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061478885,0.00018330557,0.00015882919,0.0008079265,0.00037708966,0.00051182864,0.0004151505,0.00028282544,0.0059188497],"category_scores_gemma":[0.002985597,0.00016042248,0.0004088296,0.0012072944,0.00022628049,0.00028672995,0.00040603164,0.00047362965,0.00042663325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035361067,0.000011249706,0.99897134,0.000013278648,0.000020438032,0.00003224984,0.000022231996,0.000021993823,0.00006826367,0.000013206221,0.00017980897,0.0006104847],"study_design_scores_gemma":[0.0000022694571,0.000018170163,0.9994307,0.000015898524,0.000010764848,0.000073727264,0.00010805977,0.000109187145,0.000019175142,0.000013257733,0.00019753634,0.0000012845564],"about_ca_topic_score_codex":0.02729395,"about_ca_topic_score_gemma":0.0257359,"teacher_disagreement_score":0.02729395,"about_ca_system_score_codex":0.00059333735,"about_ca_system_score_gemma":0.0009662165,"threshold_uncertainty_score":0.05427015},"labels":[],"label_agreement":null},{"id":"W7116681136","doi":"10.1158/1078-0432.ccr-25-1197","title":"INDUCE-3: A Randomized Phase II/III Study of First-line Feladilimab plus Pembrolizumab in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; Princess Margaret Cancer Centre","funders":"EMD Serono; Genentech; Foundation Medicine; MacroGenics; BeiGene; Astellas Pharma; Mylan; Regeneron Pharmaceuticals; Gilead Sciences; Merck KGaA; Daiichi Sankyo Europe; Sanofi; Amgen; Pfizer; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Pembrolizumab; Head and neck squamous-cell carcinoma; Head and neck; Placebo; Basal cell; Phases of clinical research; Head and neck cancer; Carcinoma","score_opus":0.10950279646438475,"score_gpt":0.4662303413668743,"score_spread":0.35672754490248954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116681136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98902166,0.001269652,0.00048944214,0.0004112084,0.00019535898,0.006388752,0.000776404,0.00011678664,0.0013306428],"genre_scores_gemma":[0.98556805,0.00091313047,0.0022238155,0.0011309073,0.00022774204,0.006568999,0.0012370854,0.000034003708,0.002096338],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995413,0.00022207851,0.000024436617,0.00006843883,0.000046921858,0.000096874224],"domain_scores_gemma":[0.99930596,0.00011846786,0.00013798208,0.00007283199,0.0000440543,0.00032073713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019311218,0.0014114872,0.0019845671,0.00039485368,0.00050861976,0.0008161833,0.0009737646,0.0013246451,0.0044855196],"category_scores_gemma":[0.0010461346,0.0006070455,0.001504556,0.0003278611,0.0010429795,0.000834765,0.00039922108,0.0029924107,0.0008565358],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88587445,0.056294043,0.003063366,0.00071087154,0.00087806804,0.00013103327,0.00015149938,0.0009674567,0.016077768,0.00016660815,0.0019240642,0.033760812],"study_design_scores_gemma":[0.8639921,0.13050494,0.0028374873,0.000015958452,0.00023210856,0.00007048066,0.000016787772,0.00046497677,0.0010959506,0.00007532308,0.0006800331,0.000013758569],"about_ca_topic_score_codex":0.00086261187,"about_ca_topic_score_gemma":0.0031974108,"teacher_disagreement_score":0.0044855196,"about_ca_system_score_codex":0.0010709392,"about_ca_system_score_gemma":0.0024650288,"threshold_uncertainty_score":0.015005529},"labels":[],"label_agreement":null},{"id":"W7116801625","doi":"10.1158/1078-0432.ccr-25-2239","title":"Efficacy and Safety of Capivasertib (AZD5363), a Potent, Oral Pan-AKT Inhibitor, in Patients with Relapsed or Refractory B-cell Non–Hodgkin Lymphoma (CAPITAL)","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Kite Pharma; Astex Pharmaceuticals; BeiGene; Gilead Sciences; AstraZeneca; Eli Lilly and Company","keywords":"Refractory (planetary science); Lymphoma; Limiting; Cancer; Clinical trial; Chemotherapy","score_opus":0.0427337186662007,"score_gpt":0.4066724772703794,"score_spread":0.36393875860417874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116801625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950027,0.0029473205,0.00014268092,0.00011783583,0.000021342794,0.00018025674,0.00040156196,0.000029055142,0.0011573115],"genre_scores_gemma":[0.9982309,0.0005637204,0.00016516424,0.00014842661,0.0000352761,0.00007426496,0.00041834757,0.0000034445573,0.00036046607],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99971324,0.0001175777,0.000030193973,0.000054069,0.00005116417,0.00003375845],"domain_scores_gemma":[0.99966717,0.00007693156,0.00009468303,0.000029032488,0.000028650937,0.000103537335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009317589,0.0003494999,0.0006837786,0.00020964588,0.00016846326,0.00047522038,0.00026154716,0.00034809348,0.0014134565],"category_scores_gemma":[0.0007616008,0.00020543621,0.00046908404,0.0002008873,0.00037495393,0.0004082188,0.00017678103,0.00096000475,0.00029454852],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34178293,0.012185303,0.13674678,0.001242523,0.0019705256,0.00072623335,0.0005065291,0.0044898256,0.08451286,0.00025014224,0.005971141,0.40961525],"study_design_scores_gemma":[0.12268204,0.4714578,0.36004594,0.0001650218,0.0019267678,0.0021177162,0.0002323896,0.0062349685,0.023209848,0.00026445813,0.011595974,0.00006721855],"about_ca_topic_score_codex":0.00044935592,"about_ca_topic_score_gemma":0.0011007871,"teacher_disagreement_score":0.0014134565,"about_ca_system_score_codex":0.0005545164,"about_ca_system_score_gemma":0.0005258667,"threshold_uncertainty_score":0.004927635},"labels":[],"label_agreement":null}]}